DRAMP_ID	Sequence	Sequence_Length	Name	Swiss_Prot_Entry	Family	Gene	Source	Activity	Protein_existence	Structure	Structure_Description	PDB_ID	Comments	Target_Organism	Hemolytic_activity	Linear/Cyclic/Branched	N-terminal_Modification	C-terminal_Modification	Other_Modifications	Stereochemistry	Cytotoxicity	Binding_Traget	Pubmed_ID	Reference	Author	Title	SMILES
DRAMP00005	SLGPAIKATRQVCPKATRFVTVSCKKSDCQ	30	Epicidin 280 (Bacteriocin)	O54220	Belongs to the lantibiotic family (Class I bacteriocin)	eciA	Staphylococcus epidermidis BN 280 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) Transiently and partially depolarizes the transmembrane electrical potential and pH gradient of susceptible cells, inhibits the uptake of amino acids and depletes the intracellular ATP pool.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor."	Gram-positive bacteria: Staphylococcus simulans 22 (MIC=0.304 μg/ml), Staphylococcus epidermidis 5 (MIC=3.85 μg/ml), Micrococcus luteus ATCC4698 (MIC=9.7 μg/ml), Staphylococcus carnosus TM300 (MIC=0.175 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic (very possibly)	Oxypropionylation	Not metioned clearly	There are possible lanthionine(Lan)/3-methyllanthionine(Me-Lan) structure association between Thr9 and Cys13, Thr21 and Cys24, Ser23 and Cys29.	L	No cytotoxicity information found	Not found	9726851	Appl Environ Microbiol. 1998 Sep;64(9):3140-3146.	Heidrich C, Pag U, Josten M, Metzger J, Jack RW, Bierbaum G, Jung G, Sahl HG.	Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster.	
DRAMP00017	VTSWSLCTPGCTSPGGGSNCSFCC	24	Microbisporicin A1 (Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Microbispora corallina (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Rich	Not found		"Function: Microbisporicins A1 displayed similar antibacterial activity by selectively blocking peptidoglycan biosynthesis, leading to cytoplasmic accumulation of the UDP-linked precursor.
PTM: Microbisporicin A1 contains five ether rings: S3-C7, T8-C11, S13-C20, S18-C23, and S21-C24. Also, residues T2 and S5 are dehydrated, Trp4 is chlorinated and Pro14 is hydroxylated (3,4-dihydroxylation)."	Human pathogens: L100 Staphylococcus aureus ATCC6538P (MIC≤0.13 μg/ml), L819 Staphylococcus aureus Smith ATCC19636 (MIC≤0.13 μg/ml), L1400 S. aureus MRSA (MIC≤0.13 μg/ml), L613 S. aureus MRSA (MIC≤0.13 μg/ml), L3798 S. aureus VISA (MIC=2 μg/ml), L3798 Staphylococcus epidermidis ATCC12228 (MIC≤0.13 μg/ml), L1729 Staphylococcus haemolyticus met-r (MIC=8 μg/ml), L49 Streptococcus pyogenes (MIC≤0.13 μg/ml), L44 Streptococcus pneumoniae (MIC≤0.13 μg/ml), L559 Enterococcus faecalis (MIC=1 μg/ml), L560 Enterococcus faecalis Van A (MIC=0.5 μg/ml), LA533 Enterococcus faecalis Van A (MIC=1 μg/ml), L568 Enterococcus faecium (MIC=2 μg/ml), L569 Enterococcus faecium Van A (MIC=1 μg/ml), LB518 E. faecium Van A (MIC=2 μg/ml), L884 Lactobacillus garviae (MIC=1 μg/ml), L148 Lactobacillus delbrueckii ATCC04797 (MIC=4 μg/ml), L3607 Clostridium perfringens ATCC13124 (MIC≤0.125 μg/ml), L4018 Clostridium difficile (MIC≤0.125 μg/ml), L4043 Clostridium butyricum (MIC≤0.125 μg/ml), Propionibacterium granulosum ATCC25564 (MIC=0.03 μg/ml), L1329 Propionibacterium acnes (MIC=0.5 μg/ml), Propionibacterium limphophylum ATCC27250 (MIC=0.015 μg/ml), L970 Haemophilus influenzae ATCC19418 (MIC=32 μg/ml), L76 Moraxella catarrhalis ATCC8176 (MIC=0.25 μg/ml), L1613 Neisseria meningitidis ATCC13090V (MIC=0.5 μg/ml), L997 Neisseria gonorrhoeae (MIC=0.25 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation and Cyclization	①There are five thioether intramolecular bridges which link Ala3 and Ala7, Ala8 and Ala11, Ala13 and Ala20, Ala18 and Ala23, respectively. ②The residue at position 2 is (Z)-2,3-didehydrobutyrine (Dhb). ③The residue at position 4 is chloro-tryptophan (ClTrp). ④The residue at position 5 is 2,3-didehydroalanine. ⑤The residue at position 8 is 2-Aminobutyric acid (Abu). ⑥The residue at position 14 is bis-hydroxylated proline.	L	No cytotoxicity information found	Not found	18215770	Chem Biol. 2008 Jan;15(1):22-31.	Castiglione F, Lazzarini A, Carrano L, Corti E, Ciciliato I, Gastaldo L, Candiani P, Losi D, Marinelli F, Selva E, Parenti F.	Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens.	
DRAMP00032	GNGVLKTISHECNMNTWQFLFTCC	24	Ruminococcin A (RumA; Bacteriocin)	P83674, P83676, P83677, Q8VLK0, Q9K381, P83675, P83679, P83680, Q8VLK0	Belongs to the type A lantibiotic family (Class I bacteriocin)	rumA1 AND rumA2 AND 	Ruminococcus gnavus & Ruminococcus hansenii (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. Ruminococcin A is a broad spectrum bacteriocin exhibiting activity against a wide range of pathogenic clostridia and B.longum.
Developmental stage: Highest expression in mid to late logarithmic growth phase, after which expression decreases slowly before leveling off in the stationary growth phase.
Induction: By trypsin.
PTM: There are one didehydrobutyrine (Dhb) at T16, one lanthionine (S9-23) and two Beta-methyllanthionines (T7-C12; T22-C24)."	Gram-positive bacteria: Bifidobacterium longum (strain: ATCC 15707) (MIC=75 µg/ml), Bacillus cereus (strain: Z4222, TZ415) (MIC=75 µg/ml), Eubacterium contortum (strain: ATCC 25540) (MIC=32.5 µg/ml), Ruminococcus obeum (strain: ATCC 29174) (MIC=32.5 µg/ml), R. gnavus (strain: ATCC 29149) (MIC=75 µg/ml), Clostridium perfringens (strain: CpA) (MIC=75 µg/ml), Clostridium difficile serogroup A (strain: B-1) (MIC=75 µg/ml), C. difficile serogroup C (strain: C253) (MIC=75 µg/ml), C. difficile serogroup S3 (strain: 79685) (MIC=75 µg/ml), C. botulinum type A (strain: CIP 38) (MIC=75 µg/ml), C. botulinum type B (strain: NCTC 7273) (MIC=75 µg/ml), C. botulinum type E (strain: NCTC 8266) (MIC=75 µg/ml), C. bifermentans (strain: NCTC 506) (MIC=75 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic (very possibly)	Free	Cyclization (possibly)	① It is highly probable that (i) Ser9 and the putative Cys23 and (ii) the putative His22 and Thr24 are associated in a Lanthionine (Lan) and a 3-methyllanthionine (Me-Lan) residue, respectively. ②The residues at position 7 and 16 are (Z)-2,3-didehydrobutyrine (Dhb).	L	No cytotoxicity information found	Cell membrane	11526013##11741840##12089024	Appl Environ Microbiol. 2001 Sep;67(9):4111-4118.##J Bacteriol. 2002 Jan;184(1):18-28.##Appl Environ Microbiol. 2002 Jul;68(7):3424-3431.	Dabard J, Bridonneau C, Phillipe C, Anglade P, Molle D, Nardi M, Ladiré M, Girardin H, Marcille F, Gomez A, Fons M.##Gomez A, Ladiré M, Marcille F, Fons M.##Marcille F, Gomez A, Joubert P, Ladiré M, Veau G, Clara A, Gavini F, Willems A, Fons M.	Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces.##Trypsin mediates growth phase-dependent transcriptional tegulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiota.##Distribution of genes encoding the trypsin-dependent lantibiotic ruminococcin A among bacteria isolated from human fecal microbiota.	
DRAMP00063	SSSGWLCTLTIECGTIICACR	21	Lantibiotic michiganin-A (Bacteriocin)	Q09T02	Belongs to the type B lantibiotic family (Class I bacteriocin)	micA	Clavibacter michiganensis subsp. Michiganensis (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"MOA: The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. The 62-67 beta-methyllanthionine thioether bond is oxidized to a sulfoxide. This is followed by membrane translocation and cleavage of the modified precursor"	Clavibacter michiganensis subspecies sepedonicus strain 2136 (MIC=30 pmol/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	All of the threonine residues undergo dehydration, and three of them interact with cysteines via thioether bonds to form methyllanthionine bridges	L	No cytotoxicity information found	Not found	16957199	Appl Environ Microbiol. 2006 Sep;72(9):5814-5821.	Holtsmark I, Mantzilas D, Eijsink VG, Brurberg MB.	Purification, characterization, and gene sequence of michiganin A, an actagardine-like lantibiotic produced by the tomato pathogen Clavibacter michiganensis subsp. michiganensis.	
DRAMP00068	MSWLNFLKYIAKYGKKAVSAAWKYKGKVLEWLNVGPTLEWVWQKLKKIAGL	51	Aureocin A53 (Bacteriocin)	Q8GPI4	Belongs to the class II bacteriocin	aucA	Staphylococcus aureus A53 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix	Not found	2N8O	Function: Antibacterial peptide. It causes membrane permeation.	Gram-positive bacteria: Listeria monocytogenes, Staphylococcus simulans (MIC=100 nM), Staphylococcus aureus (MRSA), Streptococcus agalactiae, Micrococcus luteus (MIC=0.15 nM).	[Ref.12054867] No hemolytic activity was detected when purified aureocin A53 was spotted on sheep blood agar plates (data not shown in the reference).	Linear	Formylation	Free		L	No cytotoxicity information found	Cell membrane	12054867	J Mol Biol. 2002 Jun 7;319(3):745-756.	Netz DJ, Pohl R, Beck-Sickinger AG, Selmer T, Pierik AJ, Bastos Mdo C, Sahl HG.	Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C
DRAMP00069	EYHLMNGANGYLTRVNGKTVYRVTKDPVSAVFGVISNCWGSAGAGFGPQH	50	Garvieacin Q (GarQ; Bacteriocin)	No entry found	Belongs to the class II bacteriocin	Not found	Lactococcus garvieae BCC 43578 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus coagulans JCM 2257, Listeria monocytogenes ATCC 19115, L. garvieae strains, E. faecium D48S52, Lactobacillus plantarum BCC 9546, Lactobacillus sakeii JCM 1157, L. ivanovii DMST 9012 (MIC=0.1-1.6 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22210221] Purified GarQ, up to 1 mg/mL, was not cytotoxic to Vero (African green monkey kidney), HepG (human liver hepatocarcinoma) and Caco-2 (human colon adenocarcinoma) cell lines. Vero, HepG2 and Caco-2 have 94 ± 8, 97 ± 4 and 89 ± 7 % survival with indicated concentration (1mg/mL) of purified garvieacin Q compared to that of untreated control using the MTT assay.	Not found	22210221	Appl Environ Microbiol. 2012 Mar;78(5):1619-1623.	Tosukhowong A, Zendo T, Visessanguan W, Roytrakul S, Pumpuang L, Jaresitthikunchai J, Sonomoto K.	Garvieacin Q, a novel class II bacteriocin from Lactococcus garvieae BCC 43578.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CC[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP00074	ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH	44	Enterocin P (Pediocin-like peptide; Bacteriocin)	O30434, Q0GFE0	Belongs to the class IIa bacteriocin	entP	Enterococcus faecium P13 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Bridge	Not found		"Function: Bacteriocin that inhibits the growth of wide range of Gram-positive bacterial species. Does not inhibit the growth of several strains of Gram-negative bacteria. No hemolytic activity against calf blood.
Biophysicochemical properties: pH dependence (Stable between pH 3.0 and pH 7.0); Temperature dependence (Thermostable, retains activity after heating at 100 and 121 degrees Celsius).
PTM: Contains one disulfide bond 11-16."	[Ref.9361419]Gram-positive bacteria: Pediococcus acidilactici (MIC=69 ng/ml), Pediococcus pentosaceus FBB61 (MIC=136 ng/ml), P. pntosaceus FBB63 (MIC=18 ng/ml), Lactococcus lactis BB24 (MIC=22 ng/ml), Enterococcus faecium (MIC=2 ng/ml), E. faecalis (MIC=238 ng/ml), Staphylococcus carnosus (MIC=139 ng/ml), Bacillus cereus (MIC=286 ng/ml), Clostridium sporogenes (MIC=4 ng/ml), Clostridium tyrobutyricum 3, 5CT (MIC=559 ng/ml), C. tyrobutyricum 1754 (MIC=412 ng/ml), Propionibacteruim sp P4 (MIC=37 ng/ml), Propionibacteruim sp P6 (MIC=26 ng/ml), Clostridium tyrobutyricum (MIC=4 ng/ml), Clostridium botulinum (MIC=259 ng/ml), Listeria monocytogenes 7973 (MIC=35 ng/ml), L. monocytogenes LI5sv1/2 (MIC=33 ng/ml), L. monocytogenes 5105 (MIC=18 ng/ml), L. monocytogenes L11sv4 (MIC=39 ng/ml), L. monocytogenes Scott A (MIC=125 ng/ml), Listeria innocua (MIC=395 ng/ml), Streptococcus aureus 137 (MIC=190 ng/ml), S. aureus 196E (MIC=407 ng/ml), S. aureus 349 (MIC=221 ng/ml), S. aureus 361 (MIC=294 ng/ml), S. aureus 472 (MIC=269 ng/ml), Lactobacillus curvatus (MIC=17 ng/ml), L. fermentum (MIC=1 ng/ml), L. sake (MIC=144 ng/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	9361419##17103378	Appl Environ Microbiol. 1997 Nov;63(11):4321-4330.##Mol Nutr Food Res. 2006 Dec;50(12):1229-1238.	Cintas LM, Casaus P, H¥varstein LS, Hern¡ndez PE, Nes IF.##Arlindo S, Calo P, Franco C, Prado M, Cepeda A, Barros-Vel¡zquez J.	Biochemical and genetic characterization of enterocin P, a novel sec-dependent bacteriocin from Enterococcus faecium P13 with a broad antimicrobial spectrum.##Single nucleotide polymorphism analysis of the enterocin P structural gene of Enterococcus faecium strains isolated from nonfermented animal foods.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)O)[C@H](C)CC
DRAMP00089	TTKNYGNGVCNSVNWCQCGNVWASCNLATGCAAWLCKLA	39	Bacteriocin E50-52 (Preclinical)	P85148	Belongs to the class IIa bacteriocin	Not found	Enterococcus faecium (Streptococcus faecium) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Bacteriocin active against the Gram-negative bacteria and the Gram-positive bacteria. When added to the drinking water of chickens, causes a decrease in the levels of Campylobacter jejuni and S. enteritidis in the ceca, and in the levels of S.enteritidis in the liver and spleen.	Gram-negative bacteria: Campylobacter jejuni (MIC=0.025-6.4 µg/ml), Yersinia enterocolitica, Yersinia pseudotuberculosis, Escherichia coli O157:H7 (MIC<1.6 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=0.2-0.8 µg/ml), Staphylococcus epidermidis (MIC=0.2-0.8 µg/ml), Listeria monocytogenes (MIC=2-8 µg/ml), Listeria grayi, Listeria innocua, Listeria ivanovii, Listeria denitrificans (MIC=32 µg/ml), Morganella morganii, Salmonella spp., Shigella dysenteriae.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	18293921	J Agric Food Chem. 2008 Mar 26;56(6):1942-1948.	Svetoch EA, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, Borzenkov VN, Levchuk VP, Svetoch OE, Kovalev YN, Stepanshin YG, Siragusa GR, Seal BS, Stern NJ.	Diverse antimicrobial killing by Enterococcus faecium E 50-52 bacteriocin.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)O
DRAMP00090	VNYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP	48	Carnobacteriocin B2 (CbnB2; Bacteriocin)	P38580	Belongs to the class IIa bacteriocin	cbnB2	Carnobacterium piscicola LV18B (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix (1 helices; 24 residues)	CbnB2 forms a disulfide bond and that this peptide has full antimicrobial activity. NMR results indicate that CbnB2 in TFE has a well-defined central helical structure (residues 18-39) but a disordered N terminus. And the central helical structure is conserved.	1CW5 resolved by NMR.	"Function: Has antibacterial activity against Listeria and Enterococcus.
PTM: Contains one disulfide bond 9-14."	[Ref.8163526]Gram-positive bacteria: Lactobacillus plantarum ATCC 4008 (MIC=2 AU/μg), Pediococcus parvulus ATCC 19371 (MIC=8 AU/μg), Listeria monocytogenes ATCC 15313 (MIC=32 AU/μg), Listeria innocua ATCC 33090 (MIC=16 AU/μg), Enterococcus faecium ATCC 11576 (MIC=16 AU/μg), Enterococcus faecalis ATCC 19433 (MIC=16 AU/μg), Enterococcus faecium ATCC 19434 (MIC=4 AU/μg).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	[Ref.8163526 & Ref.10569926] CbnB2 can easily form a disulfide bond between Cys9 and Cys14	L	No cytotoxicity information found	Not found	8163526##9353214##10569926	J Biol Chem 1994; 269: 12204-12211.##Curr Microbiol. 1997 Dec;35(6):319-326.##Biochemistry. 1999 Nov 23;38(47):15438-15447.	Quadri LE et al Stiles ME.##Herbin S, Mathieu F, Brul© F, Branlant C, Lefebvre G, Lebrihi A.##Wang Y, Henz ME, Gallagher NL, Chai S, Gibbs AC, Yan LZ, Stiles ME, Wishart DS, Vederas JC.	Chemical and genetic characterization of bacteriocins produced by Carnobacterium piscicola LV18B.##Characteristics and genetic determinants of bacteriocin activities produced by Carnobacterium piscicola CP5 isolated from cheese.##Solution structure of carnobacteriocin B2 and implications for structure-activity relationships among type IIa bacteriocins from lactic acid bacteria.	
DRAMP00105	SNDSLWYGVGQFMGKQANCITNHPVKHMIIPGYCLSKILG	40	Enterocin X alpha (Two-peptide bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	enxA	Enterococcus faecium KU-B5 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: EntXalpha and EntXbeta encode a double-glycine-type prepeptide with an 18-residue leader sequence, representing the typical structure of class II bacteriocin prepeptides. When combined, Xalpha and Xbeta display variably enhanced or reduced antibacterial activity toward a panel of indicators compared to each peptide individually. 	Gram-positive bacteria: Enterococcus faecalis JCM 5803 (MIC=50.8 nM), Enterococcus faecalis OU510 (MIC=102 nM), Enterococcus faecium TUA 1344L (MIC=50.8 nM), Enterococcus hirae ATCC 10541 (MIC=50.8 nM), Lactobacillus plantarum ATCC 14917 (MIC=102 nM), Lactobacillus sakeii ssp.sakei JCM 1157 (MIC=50.8 nM), Lactococcus lactis ssp.cremoris ATCC 19257 (MIC=813 nM), Listeria innocua ATCC 33090 (MIC=25.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	20418437	Appl Environ Microbiol. 2010 Jul;76(13):4542-4545. 	Hu CB, Malaphan W, Zendo T, Nakayama J, Sonomoto K.	Enterocin X, a novel two-peptide bacteriocin from Enterococcus faecium KU-B5, has an antibacterial spectrum entirely different from those of its component peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)O
DRAMP00106	IAPIIVAGLGYLVKDAWDHSDQIISGFKKGWNGGRRK	37	Enterocin X beta (Two-peptide bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	enxB	Enterococcus faecium KU-B5 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: EntXalpha and EntXbeta encode a double-glycine-type prepeptide with an 18-residue leader sequence, representing the typical structure of class II bacteriocin prepeptides. When combined, Xalpha and Xbeta display variably enhanced or reduced antibacterial activity toward a panel of indicators compared to each peptide individually. 	Gram-positive bacteria: Enterococcus faecalis JCM 5803 (MIC=813 nM), Enterococcus faecalis OU510 (MIC=813 nM), E. faecium TUA 1344L (MIC=813 nM), Enterococcus hirae ATCC 10541 (MIC=406 nM), Lactobacillus plantarum ATCC 14917 (MIC=813 nM), Lactobacillus sakeii ssp.sakei JCM 1157 (MIC=102 nM), Bacillus circulans JCM 2504 (MIC=3250 nM), Bacillus coagulans JCM 2257 (MIC=3250 nM), Bacillus subtilis JCM 1465 (MIC=3250 nM), Listeria innocua ATCC 33090 (MIC=3250 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	20418437	Appl Environ Microbiol. 2010 Jul;76(13):4542-4545. 	Hu CB, Malaphan W, Zendo T, Nakayama J, Sonomoto K.	Enterocin X, a novel two-peptide bacteriocin from Enterococcus faecium KU-B5, has an antibacterial spectrum entirely different from those of its component peptides.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP00107	TNYGNGVGVPDAIMAGIIKLIFIFNIRQGYNFGKKAT	37	Bacteriocin L-1077	No entry found	Belongs to the class IIa bacteriocin	Not found	Lactobacillus salivarius L-1077 (NRRL B-50053) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Salmonella Enteritidis 1 (MIC=0.19 ug/ml), S. Enteritidis 4 (MIC=0.38 ug/ml), S. Enteritidis 204 (MIC=0.38 ug/ml), S. Enteritidis 237 (MIC=0.19 ug/ml), Salmonella Choleraesuis 434/4 (MIC=0.38 ug/ml), S. Choleraesuis 370 (MIC=0.19 ug/ml), Salmonella Typhimurium 483/6 (MIC=0.19 ug/ml), S. Typhimurium 44/8 (MIC=0.19 ug/ml), Salmonella Gallinarum-Pullorum (MIC=0.19 ug/ml), Escherichia coli HB 101 (MIC=0.19 ug/ml), E. coli-600 (MIC=0.19 ug/ml), E. coli O157:H7 Y-63 (MIC=0.19 ug/ml), E. coli O157:H7 G-35 (MIC=0.19 ug/ml), E. coli O157:H7 OD 30 (MIC=0.19 ug/ml), E. coli O157:H7 T lab 39 (MIC=0.19 ug/ml), Yersinia enterocolitica 03 (MIC=0.76 ug/ml), Y. enterocolitica 09 (MIC=0.76 ug/ml), Y. enterocolitica 11 (MIC=0.76 ug/ml), Citrobacter freundii (MIC=0.76 ug/ml), Klebsiella pneumoniae (MIC=0.76 ug/ml), Shigella dysenteriae (MIC=0.76 ug/ml), Yersinia pseudotuberculosis 4 (MIC=0.76 ug/ml), Y. pseudotuberculosis 99/14 (MIC=0.76 µg/ml), Pseudomonas aeruginosa 508 (MIC=0.38 ug/ml), Proteus mirabilis (MIC=0.38 ug/ml), Morganella morganii (MIC=0.38 µg/ml), Proteus vulgaris 7A (MIC=1.5 ug/ml),Campylobacter jejuni L-4 (MIC=0.09 ug/ml);##Gram-positive bacteria: Clostridium perfringensÂ 13124 (MIC=0.7 ug/ml), Listeria monocytogenes A 9-72 (MIC=0.19 ug/ml), Staphylococcus aureus (MIC=0.76 ug/ml), Staphylococcus epidermidis (MIC=0.76 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	21378051	Appl Environ Microbiol. 2011 Apr;77(8):2749-2754. 	Svetoch EA, Eruslanov BV, Levchuk VP, Perelygin VV, Mitsevich EV, Mitsevich IP, Stepanshin J, Dyatlov I, Seal BS, Stern NJ.	Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP00126	FNRGGYNFGKSVRHVVDAIGSVAGIRGILKSIR	33	Plantaricin E (PlnE; Bacteriocin)	P71470, Q7AKV7	Belongs to the class IIb bacteriocin	plnE	Lactobacillus plantarum (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix (3 helices; 19 residues)	In DPC micelles, PlnE has an N-terminal alpha-helix (residues 10-21), and a C-terminal alpha-helix-like structure (residues 25-31). Both helices in plnE are amphiphilic, while the helix in plnF is polar in its N-terminal half and amphiphilic in its C-terminal half. PlnE has two GxxxG motifs which are putative helix-helix interaction motifs, one at residues 5 to 9 and one at residues 20 to 24.	2JUI resolved by NMR.	Comment: No comments found on DRAMP database	Gram-positive bacteria: Pediococcus pentosaceus Pac 1.0 (MIC=5 nM), Lactobacillus plantarum 965 (MIC=7 nM), Lactobacillus casei subsp.casei NCDO 161 (MIC=20 nM), Lactobacillus casei NCDO 2713 (MIC=150 nM), Lactobacillus sakei NCDO 2714 (MIC=4 nM), Lactobacillus viridescens NCDO 1655 (MIC=2 nM), Pediococcus pentosaceus NCDO 990 (MIC=30 nM), Lactobacillus sakei 706 (MIC=100 nM), Pediococcus acidilactici CH (MIC=10 nM), Lactobacillus curvatus 89 (MIC=5 nM). [PlnE:PlnF=1:1]	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	There is a possible hydrogen bond/salt bridge between Asp17 and Arg26	L	No cytotoxicity information found	Not found	8117074##18555030	Appl Environ Microbiol. 1994 Jan;60(1):160-166.##Biochim Biophys Acta. 2008 Nov;1784(11):1711-1719.	Diep DB, Håvarstein LS, Nissen-Meyer J, Nes IF.##Fimland N, Rogne P, Fimland G, Nissen-Meyer J, Kristiansen P.E.	The gene encoding plantaricin A, a bacteriocin from Lactobacillus plantarum C11, is located on the same transcription unit as an agr-like regulatory system.##Three-dimensional structure of the two peptides that constitute the two-peptide bacteriocin plantaricin EF.	
DRAMP00127	VFHAYSARGVRNNYKSAVGPADWVISAVRGFIHG	34	Plantaricin F (PlnF; Bacteriocin)	P71469, Q7AKV8	Belongs to the class IIb bacteriocin	plnF	Lactobacillus plantarum (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix (1 helices; 26 residues)	In DPC micelles, PlnF has a long central alpha-helix (residues 7-32) with a kink of 38+/-7 degrees at Pro20. There is some flexibility in the helix in the kink region. The helix in plnF is polar in its N-terminal half and amphiphilic in its C-terminal half. plnF has one such motif at residues 30 to 34. The helix in plnF is polar in its N-terminal half and amphiphilic in its C-terminal half. PlnF has one GxxxG motif at residues 30 to 34.	2RLW resolved by NMR.	Function: A strain-specific antagonistic activity was detected at nanomolar concentrations when PlnE and PlnF were combined. Complementary peptides were at least 103 times more active when they were combined than when they were present individually, and optimal activity was obtained when the complementary peptides were present in approximately equal amounts.	Gram-positive bacteria: Pediococcus pentosaceus Pac 1.0 (MIC=5 nM), Lactobacillus plantarum 965 (MIC=7 nM), Lactobacillus casei subsp.casei NCDO 161 (MIC=20 nM), Lactobacillus casei NCDO 2713 (MIC=150 nM), Lactobacillus sakei NCDO 2714 (MIC=4 nM), Lactobacillus viridescens NCDO 1655 (MIC=2 nM), Pediococcus pentosaceus NCDO 990 (MIC=30 nM), Lactobacillus sakei 706 (MIC=100 nM), Pediococcus acidilactici CH (MIC=10 nM), Lactobacillus curvatus 89 (MIC=5 nM). [PlnE:PlnF=1:1]	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	There is a possible hydrogen bond/salt bridge between Asn12/Asn13 and Asp22	L	No cytotoxicity information found	Not found	9603847##19538999##18555030	Appl Environ Microbiol. 1994 Jan;60(1):160-166.##Appl Environ Microbiol. 1998 Jun;64(6):2269-2272.##	Diep DB, Håvarstein LS, Nissen-Meyer J, Nes IF.##Anderssen EL, Diep DB, Nes IF, Eijsink VG, Nissen-Meyer J.##Fimland N, Rogne P, Fimland G, Nissen-Meyer J, Kristiansen P.E.	The gene encoding plantaricin A, a bacteriocin from Lactobacillus plantarum C11, is located on the same transcription unit as an agr-like regulatory system.##Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A.##Three-dimensional structure of the two peptides that constitute the two-peptide bacteriocin plantaricin EF.	
DRAMP00128	GAWKNFWSSLRKGFYDGEAGRAIRR	25	Plantaricin J (PlnJ; Bacteriocin)	P71461, Q7AKW6	Belongs to the class IIb bacteriocin	plnJ	Lactobacillus plantarum C11 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix	In DPC micelles, PlnJ has an N-terminal amphiphilic alpha-helix between Trp-3 and Tyr-15. Crucial residues: Gly-13 in PlnJ is very sensitive, giving more than a 100-fold reduction in activity when large residues replace glycine. Gly-20 in PlnJ was replaced, the activity was reduced less than 10-fold.	2KHF, 2KHG resolved by NMR.	Function: A 1:1 ratio of PlnK and PlanJ is at least 1000 times more active than the individual peptide. 	Gram-positive bacteria: Pediococcus pentosaceus Pac 1.0 (MIC=50 nM), Lactobacillus plantarum 965 (MIC=0.1 nM), L. sake NCDO 2714 (MIC=50 nM), Leptostylus viridescens NCDO 1655 (MIC=5 nM). [PlnJ:PlnK=1:1]	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	9603847##19538999	Appl Environ Microbiol. 1998 Jun;64(6):2269-2272.##Peptides. 2009 Sep;30(9):1613-1621.	Anderssen EL, Diep DB, Nes IF, Eijsink VG, Nissen-Meyer J.##Rogne P, Haugen C, Fimland G, Nissen-Meyer J, Kristiansen PE.	Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A.##Three-dimensional structure of the two-peptide bacteriocin plantaricin JK.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP00129	RRSRKNGIGYAIGYAFGAVERAVLGGSRDYNK	32	Plantaricin K (PlnK; Bacteriocin)	P71460	Belongs to the class IIb bacteriocin	plnK	Lactobacillus plantarum C11 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix 	In DPC micelles, PlnK forms a central amphiphilic alpha-helix between Gly-9 and Leu-24. Crucial residues: Gly-17 in PlnK is very sensitive, giving more than a 100-fold reduction in activity when large residues replace glycine. Gly-7, Gly-9, Gly-24 and Gly-25 in PlnK were replaced, the activity was reduced less than 10-fold.	2KEG, 2KEH resolved by NMR.	Function: A 1:1 ratio of PlnK and PlanJ is at least 1000 times more active than the individual peptide. 	Gram-positive bacteria: Pediococcus pentosaceus Pac 1.0 (MIC=50 nM), Lactobacillus plantarum 965 (MIC=0.1 nM), L. sake NCDO 2714 (MIC=50 nM), Leptostylus viridescens NCDO 1655 (MIC=5 nM). [PlnJ:PlnK=1:1]	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	9603847##19538999	Appl Environ Microbiol. 1998 Jun;64(6):2269-2272.##Peptides. 2009 Sep;30(9):1613-1621.	Anderssen EL, Diep DB, Nes IF, Eijsink VG, Nissen-Meyer J.##Rogne P, Haugen C, Fimland G, Nissen-Meyer J, Kristiansen PE.	Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A.##Three-dimensional structure of the two-peptide bacteriocin plantaricin JK.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C)[C@H](C)CC
DRAMP00136	NRWYCNSAAGGVGGAAVCGLAGYVGEAKENIAGEVRKGWGMAGGFTHNKACKSFPGSGWASG	62	Enterocin E-760 (Bacteriocin)	P85147	Belongs to the class IIb bacteriocin	Not found	Enterococcus sp. (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: The enterocin demonstrated thermostability by retaining activity after 5 min at 100 degrees C and was stable at pH values between 5.0 and 8.7. However, activity was lost below pH 3.0 and above pH 9.5. No hemolytic activity.	[Ref.18086839]Gram-positive bacteria: Listeria monocytogenes 9-72 (MIC=0.1 μg/ml), Staphylococcus epidermidis (MIC=1.6 μg/ml), S. aureus (MIC=1.6 μg/ml);##Gram-negative bacteria: S. enterica serovar Enteritidis 1 (MIC=0.2 μg/ml), S. enterica serovar Enteritidis 4 (MIC=0.4 μg/ml), S. enterica serovar Enteritidis 204 (MIC=0.2 μg/ml), S. enterica serovar Enteritidis 237 (MIC=0.2 μg/ml), S. enterica serovar Choleraesuis 434/4 (MIC=0.4 μg/ml), S. enterica serovar Choleraesuis 370 (MIC=0.4 μg/ml), S. enterica serovar Typhimurium 383/60 (MIC=0.4 μg/ml), S. enterica serovar Typhimurium 320 (MIC=0.2 μg/ml), S. enterica serovar Gallinarum biovar Pullorum (MIC=0.4 μg/ml), Escherichia coli HB101 (MIC=0.1 μg/ml), E. coli C600 (MIC=0.1 μg/ml), E. coli O157:H7 Y-63 (MIC=1.6 μg/ml), E. coli O157:H7 G-3 (MIC=1.6 μg/ml), E. coli O157:H7 OD-3 (MIC=1.6 μg/ml), E. coli O157:H7 T-39 (MIC=1.6 μg/ml), Yersinia enterocolitica 03 (MIC=0.1 μg/ml), Y. enterocolitica 09 (MIC=0.1 μg/ml), Y. enterocolitica 04 (MIC=0.1 μg/ml), Y. pseudotuberculosis ser 4 (MIC=3.2 μg/ml), Y. pseudotuberculosis 14 (MIC=3.2 μg/ml), Citrobacter freundii (MIC=1.6 μg/ml), Klebsiella pneumoniae (MIC=3.2 μg/ml), Shigella dysenteriae (MIC=0.1 μg/ml), Campylobacter jejuni L4 (MIC=0.1 μg/ml), Campylobacter P 1-R (MIC=0.2 μg/ml), Campylobacter P-45 (MIC=0.4 μg/ml), Campylobacter lari R (MIC=0.2 μg/ml), Campylobacter LB 6-R (MIC=0.1 μg/ml), Campylobacter C/D (MIC=0.2 μg/ml),.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	18086839	Antimicrob Agents Chemother. 2008 Mar;52(3):1094-1100.	Line JE, Svetoch EA, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, Levchuk VP, Svetoch OE, Seal BS, Siragusa GR, Stern NJ.	Isolation and purification of enterocin E-760 with broad antimicrobial activity against gram-positive and Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)O)C(C)C
DRAMP00171	LIDHLGAPRWAVDTILGAIAVGNLASWVLALVPGPGWAVKAGLATAAAIVKHQGKAAAAAW	61	Lactocyclicin Q (Bacteriocin)	B9ZZY0	Belongs to the class IIc bacteriocin	lycQ	Lactococcus sp. strain QU 12 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	"Gram-positive bacteria: Lactococcus sp.strain QU 12 (MIC=34.3 µM), Lactococcus lactis subsp.lactis JCM 7638 (MIC=0.141 µM), L. lactis subsp.lactis ATCC 19435 (MIC=0.141 µM), L. lactis subsp.lactis IL1403 (MIC=0.141 µM), L. lactis QU 1 (MIC=0.141 µM), L. lactis subsp.cremoris ATCC 19275 (MIC=0.283 µM), Lactococcus raffinolactis JCM 5706 (MIC=0.71 µM), Lactobacillus sakei subsp.sakei JCM 1157 (MIC=0.015 µM), Lactobacillus casei subsp.casei JCM 1134 (MIC=2.27 µM), Leuconostoc brevis JCM 1059 (MIC=1.14 µM), L. acidophilus JCM 1132 (MIC=2.86 µM), L. coryniformis subsp.coryniformis JCM 1164 (MIC=2.86 µM), L. kimchii JCM 10707 (MIC=0.71 µM), L. mesenteroides subsp.mesenteroides JCM 6124 (MIC=1.03 µM), Weissella cibaria JCM 12495 (MIC=0.71 µM), Pediococcus pentosaceus JCM 5885 (MIC=0.55 µM), P. pentosaceus JCM 5890 (MIC=2.86 µM), P. acidilactici JCM 8797 (MIC=2.86 µM), P. dextrinicus JCM 5887 (MIC=0.141 µM), Enterococcus faecium JCM5804 (MIC=0.71 µM), E. hirae ATCC 10541 (MIC=0.71 µM), E. durans NBRC 100479 (MIC=0.71 µM), E. faecalis JCM 5803 (MIC=0.26 µM), Streptococcus salivarius JCM 5707 (MIC=22.9 µM), S. bovis JCM 5802 (MIC=22.9 µM), Bacillus coagulans JCM 2257 (MIC=0.015 µM), B. circulans JCM 2504 (MIC=0.031 µM), B. subtilis JCM 1465 (MIC=0.064 µM), B. cereus JCM 2152 (MIC=11.4 µM), Micrococcus luteus IFO 12708 (MIC=5.7 µM), Listeria innocua ATCC 33090 (MIC=1.03 µM), L. monocytogenes ATCC BAA-679 (MIC=1.03 µM), Staphylococcus aureus subsp.aureus ATCC 12600 (MIC=91.6 µM);
Gram-negative bacteria: Escherichia coli JM109 (MIC=34.3 µM), E. coli NBRC 3301 (MIC=17.3 µM)."	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	The whole peptide has a cyclic structure in which N and C termini are bound to each other.	L	No cytotoxicity information found	Not found	19139222##21948835	Appl Environ Microbiol. 2009 Mar;75(6):1552-1558.##Appl Environ Microbiol. 2011 Nov;77(22):8164-8170. 	Sawa N, Zendo T, Kiyofuji J, Fujita K, Himeno K, Nakayama J, Sonomoto K.##Masuda Y, Ono H, Kitagawa H, Ito H, Mu F, Sawa N, Zendo T, Sonomoto K.	Identification and characterization of lactocyclicin Q, a novel cyclic bacteriocin produced by Lactococcus sp. strain QU 12.##Identification and characterization of leucocyclicin Q, a novel cyclic bacteriocin produced by Leuconostoc mesenteroides TK41401.	
DRAMP00173	LVNQLGISKSLANTILGAIAVGNLASWVLALVPGPGWATKAALATAETIVKHEGKAAAIAW	61	Leucocyclicin Q (Bacteriocin)	G5ELQ0	Belongs to the class IIc bacteriocin	lcyQ	Leuconostoc mesenteroides TK41401 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		Function: This precursor showed high similarity to the precursor of lactocyclicin Q, a cyclic bacteriocin produced by Lactococcus sp. strain QU 12. This is the first report of a cyclic bacteriocin produced by a strain of the genus Leuconostoc.	Gram-positive bacteria: Lactococcus lactis ssp. lactis JCM 7638 (MIC=0.038 µM), L. lactis ssp. lactis ATCC 19435 (MIC=0.038 µM), L. sp. QU 12 (MIC=1.203 µM), Lactobacillus sakei ssp. sakei JCM 1157 (MIC=0.038 µM), Weissella cibaria JCM 12495 (MIC=2.405 µM), W. paramesenteroides JCM 9890 (MIC=0.075 µM), Pediococcus pentosaceus JCM 5885 (MIC=2.405 µM), P. dextrinicus JCM 5887 (MIC=0.038 µM), Enterococcus faecium JCM 5804 (MIC=0.038 µM), E. faecalis JCM 5803 (MIC=0.15 µM), Streptococcus salivarius JCM 5707 (MIC=2.405 µM), S. bovis JCM 5802 (MIC=0.601 µM), S. mutans JCM 5705 (MIC=19.25 µM), Bacillus coagulans JCM 2257 (MIC=0.075 µM), B. subtilis ssp. subtilis JCM 1465 (MIC=0.601 µM), B. cereus JCM 2152 (MIC=2.405 µM), Kocuria rhizophila NBRC 12708 (MIC=9.623 µM), Listeria innocua ATCC 33090 (MIC=0.601 µM), Leuconostoc mesenteroides ssp. mes. JCM 6124 (MIC=0.3 µM), Escherichia coli JM109 (MIC=38.49 µM), E. coli NBRC 3301 (MIC=38.49 µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	The whole peptide has a cyclic structure in which N and C termini are bound to each other.	L	No cytotoxicity information found	Not found	21948835	Appl Environ Microbiol. 2011 Nov;77(22):8164-8170. 	Masuda Y, Ono H, Kitagawa H, Ito H, Mu F, Sawa N, Zendo T, Sonomoto K.	Identification and characterization of leucocyclicin Q, a novel cyclic bacteriocin produced by Leuconostoc mesenteroides TK41401.	
DRAMP00177	ENDHRMPNNLNRPNNLSKGGAKCGAAIAGGLFGIPKGPLAWAAGLANVYSKCN	53	Enterocin B (EntB; Bacteriocin)	O34017	Belongs to the class IId bacteriocin	entB	Enterococcus faecium T136 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Enterococcus faecalis JCM 5803 (MIC=86.9 nM), Enterococcus faecalis OU510 (MIC=174 nM), E. faecium TUA 1344L (MIC=43.4 nM), E. hirae ATCC 10541 (MIC=5.44 nM), Lactobacillus plantarum ATCC 14917 (MIC=86.9 nM), L. sakei ssp. sakei JCM 1157 (MIC=5.44 nM), Bacillus coagulans JCM 2257 (MIC=89000 nM), Bacillus subtilis JCM 1465 (MIC=44500 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	The peptide has forms a disulfide bond between Cys-23 and Cys-52	L	No cytotoxicity information found	Not found	10224016##9245817	Appl Environ Microbiol. 1999 May;65(5):2170-2178.##Microbiology. 1997 Jul;143 (Pt 7):2287-2294.	Franz CM, Worobo RW, Quadri LE, Schillinger U, Holzapfel WH, Vederas JC, Stiles ME.##Casaus P, Nilsen T, Cintas LM, Nes IF, Hern¡ndez PE, Holo H.	Atypical genetic locus associated with constitutive production of enterocin B by Enterococcus faecium BFE 900.##Enterocin B, a new bacteriocin from Enterococcus faecium T136 which can act synergistically with enterocin A.	
DRAMP00178	MLAKIKAMIKKFPNPYTLAAKLTTYEINWYKQQYGRYPWERPVA	44	Enterocin EJ97 (EntEJ97; Bacteriocin)	Q8KMU4	Belongs to the class IId bacteriocin	ej97a	Enterococcus faecalis EJ97 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus circulans (MIC=12 µg/ml), Bacillus coagulans CECT 12 (MIC=2 µg/ml), Bacillus megaterium (MIC=4 µg/ml), Bacillus stearothermophilus CECT 49 (MIC=14 µg/ml), Bacillus stearothermophilus CECT 148 (MIC=12 µg/ml), Bacillus subtilis (MIC=12 µg/ml), Paenibacillus macerans CECT 19 (MIC=4 µg/ml), Enterococcus faecalis ssp.faecalis S-13 (MIC=6 µg/ml), E. faecalis ssp.faecalis S-14 (MIC=8 µg/ml), E. faecalis ssp.faecalis S-32 (MIC=12 µg/ml), E. faecalis ssp.faecalis S-86 (MIC=8 µg/ml), E. faecalis ssp.liquefaciens S-39 (MIC=6 µg/ml), E. faecalis ssp.liquefaciens S-40 (MIC=8 µg/ml), E. faecalis ssp. liquefaciens S-47 (MIC=12 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	12620853##20385607##9871020	Appl Environ Microbiol. 2003 Mar;69(3):1633-1641.##Protein Eng Des Sel. 2010 Jul;23(7):507-518.##Arch Microbiol. 1998 Dec;171(1):59-65.	S¡nchez-Hidalgo M, Maqueda M, G¡lvez A, Abriouel H, Valdivia E, Mart­nez-Bueno M.##Neira JL, Contreras LM, de los Pa±os OR, S¡nchez-Hidalgo M, Mart­nez-Bueno M, Maqueda M, Rico M.##G¡lvez A, Valdivia E, Abriouel H, Camafeita E, Mendez E, Mart­nez-Bueno M, Maqueda M.	The genes coding for enterocin EJ97 production by Enterococcus faecalis EJ97 are located on a conjugative plasmid.##Structural characterisation of the natively unfolded enterocin EJ97.##Isolation and characterization of enterocin EJ97, a bacteriocin produced by Enterococcus faecalis EJ97.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC
DRAMP00189	KGLGKLIGIDWLLGQAKDAVKQYKKDYKRWH	31	Leucocin Q (Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	LccQ	Leuconostoc pseudomesenteroides QU 15 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Leuc.pseudomesenteroides QU 15 (isolated from Nukadoko) produce at least three bacteriocins, leucocin A, and two novel bacteriocins termed leucocin Q and leucocin 	Gram-positive bacteria: Bacillus circulans JCM 2504T (MIC=4.10 µmol/L), Listeria innocua ATCC 33090 (MIC=0.03 µmol/L), Listeria monocytogenes ATCC BAA-679 (MIC=1.03 µmol/L), Enterococcus faecalis JCM 5803 (MIC=4.10 µmol/L), Lactobacillus plantarum ATCC 14917 (MIC=4.10 µmol/L), Lactobacillus sakei ssp. sakei JCM 1157 (MIC=1.04 µmol/L), Leuconostoc mesenteroides ssp. mesenteroides JCM 6124 (MIC=4.10 µmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	20070442	J Appl Microbiol. 2010 Jul;109(1):282-291.	Sawa N, Okamura K, Zendo T, Himeno K, Nakayama J, Sonomoto K.	Identification and characterization of novel multiple bacteriocins produced by Leuconostoc pseudomesenteroides QU 15.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
DRAMP00190	MNKEYNSISNFKKITNKDLQNINGGFIGRAIGDFVYFGAKGLRESGKLLNYYYKHKH	57	Leucocin N (Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	LccN	Leuconostoc pseudomesenteroides QU 15 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Leuc.pseudomesenteroides QU 15 (isolated from Nukadoko) produce at least three bacteriocins, leucocin A, and two novel bacteriocins termed leucocin Q and leucocin N.	Gram-positive bacteria: Bacillus circulans JCM 2504T (MIC=5.20 µmol/L), Listeria innocua ATCC 33090 (MIC=1.30 µmol/L), Listeria monocytogenes ATCC BAA-679 (MIC=1.30 µmol/L), Enterococcus faecalis JCM 5803 (MIC=5.20 µmol/L), Lactobacillus plantarum ATCC 14917 (MIC=2.60 µmol/L), Lactobacillus sakei ssp. sakei JCM 1157 (MIC=1.30 µmol/L), Leuconostoc mesenteroides ssp. mesenteroides JCM 6124 (MIC=2.60 µmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	20070442	J Appl Microbiol. 2010 Jul;109(1):282-291.	Sawa N, Okamura K, Zendo T, Himeno K, Nakayama J, Sonomoto K.	Identification and characterization of novel multiple bacteriocins produced by Leuconostoc pseudomesenteroides QU 15.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@H](C)CC
DRAMP00191	GGAGHVPEYFVGIGTPISFYG	21	Microcin J25 (MccJ25; Bacteriocin)	Q9X2V7	Belongs to the class I microcin	mcjA	Escherichia coli AY25 (Gram-negative bacteria)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Beta strand	MccJ25 does not have a head-to-tail cyclic structure but rather a side chain to backbone cyclization between Glu8 and the N-terminus. This creates an embedded ring that is threaded by the C-terminal tail of the molecule, forming a noose-like feature. The three-dimensional structure deduced from NMR data suggests that slippage of the noose is prevented by two aromatic residues flanking the embedded ring.	1Q71, 1PP5 resolved by NMR.	"Function: Microcin J25 is a 21 amino acid bacterial peptide that has potent antibacterial activity against Gram-negative bacteria, resulting from its interaction with RNA polymerase.
Induction: At the onset of stationary growth phase.
PTM: Isoglutamyl glycine isopeptide between G1 and E8."	Gram-negative bacteria: Escherichia coli BM21 (MIC=0.08 µg/ml), E. coli AB1133 (MIC=0.02 µg/ml), E. coli RYC816 (MIC=0.04 µg/ml), E. coli AY29 (MIC=0.04 µg/ml), Salmonella species, Shigella flexneri.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization of a N-terminal between Gly and Glu	Free		L	No cytotoxicity information found	Not found	1429464##10092860##14531690##14531661	J Bacteriol. 1992 Nov;174(22):7428-7435.##Eur J Biochem. 1999 Feb;259(3):747-755.##J Am Chem Soc. 2003 Oct 15;125(41):12464-74.##J Am Chem Soc. 2003 Oct 15;125(41):12382-3.	Salom³n RA, Far­as RN.##Blond A, P©duzzi J, Goulard C, Chiuchiolo MJ, Barth©l©my M, Prigent Y, Salom³n RA, Far­as RN, Moreno F, Rebuffat S.##Rosengren KJ, Clark RJ, Daly NL, Göransson U, Jones A, Craik DJ.##Bayro MJ, Mukhopadhyay J, Swapna GV, Huang JY, Ma LC, Sineva E, Dawson PE, Montelione GT, Ebright RH.	Microcin 25, a novel antimicrobial peptide produced by Escherichia coli.##The cyclic structure of microcin J25, a 21-residue peptide antibiotic from Escherichia coli.##Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone.##Structure of antibacterial peptide microcin J25: a 21-residue lariat protoknot.	
DRAMP00201	SCNCVCGVCCSCSP	14	Amythiamicin A/B (Bacteriocin)	P0C912	Belongs to the thiocillin family	Not found	Amycolatopsis sp. (strain MI481-42F4 / FERM P-12739)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has bacteriocidal activity against Gram-positive bacteria: including multi-drug resistant strains such as Staphylococcus aureus MS9610 and Methicillin-resistant S.aureus, but is not active against most Gram-negative bacteria and fungi.
PTM: ①Maturation of thiazole and oxazole containing antibiotics involves the enzymic condensation of a Cys, Ser or Thr with the alpha-carbonyl of the preceding amino acid to form a thioether or ether bond, then dehydration to form a double bond with the alpha-amino nitrogen. Thiazoline or oxazoline rings are dehydrogenated to form thiazole or oxazole rings.  ②Maturation of pyridinyl containing antibiotics involves the cross-linking of a Ser and a Cys-Ser pair usually separated by 7 or 8 residues along the peptide chain. The Ser residues are dehydrated to didehydroalanines, then bonded between their beta carbons. The alpha carbonyl of the Cys condenses with the alpha carbon of the first Ser to form a pyridinyl ring. The ring may be multiply dehydrogenated to form a pyridine ring with loss of the amino nitrogen of the first Ser. ③The diketopiperazine ester in form C may be formed by cyclization and transesterification of the C-terminal dipeptide."	Gram-positive bacteria: Staphylococcus aureus MS9610 (MIC=0.2 µg/ml), Methicillin-resistant S. aureus (MIC=0.2 µg/ml), Staphylococcus aureus FDA209P (MIC=0.1 µg/ml), Micrococcus luteus FDA16 (MIC=0.1 µg/ml), M. luteus IFO3333 (MIC=0.78 µg/ml), M. luteus PCI1001 (MIC=0.2 µg/ml), Bacillus anthracis (MIC=0.1 µg/ml), B. subtilis NRRL B-558 (MIC=0.2 µg/ml), B. subtilis PCI219 (MIC=0.2 µg/ml), B. cereus ATCC 10702 (MIC=0.1 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8040071	J Antibiot (Tokyo). 1994 Jun;47(6):668-674.	Shimanaka K, Kinoshita N, Iinuma H, Hamada M, Takeuchi T.	Novel antibiotics, amythiamicins. I. Taxonomy, fermentation, isolation, physico-chemical properties, and antimicrobial activity.	
DRAMP00204	STNCFCYICCSCSS	14	Thiocillin GE37468 (Antibiotic GE37468; Bacteriocin)	P0C8P9, G1ECL0	Belongs to the thiocillin family	getA	Streptomyces sp. (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Has bacteriocidal activity against both aerobic and anaerobic Gram-positive bacteria. Has poor activity against Gram-negative bacteria, with the exception of B.fragilis. Inhibits bacterial protein biosynthesis by acting on elongation factor Tu (	Gram-positive bacteria: Bacillus subtilis (MIC=0.047 µg/ml), Staphylococcus aureus (MRSA) (MIC=0.047 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization	Free	①GE37468 has a macrocyclic ring composed of 10 residues (Ser1 to Cys10). ②Cys6 converts to a thiazoline while four other Cys residues (Cys4, Cys9, Cys10 and Cys12) are fully desaturated to thiazoles in GE37468. ③Ile8 converts to β-methyl-δ-hydroxy-proline(mhP) through a predicted tandem double hydroxylation/cyclization mechanism.	L	No cytotoxicity information found	Not found	21788474	Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13053-13058.	Young TS, Walsh CT.	Identification of the thiazolyl peptide GE37468 gene cluster from Streptomyces ATCC 55365 and heterologous expression in Streptomyces lividans.	
DRAMP00218	RCTCTTIISSSSTF	14	Plantazolicin (PZN; Bacteriocin)	D3VML5, B3A0N7	Not found	pznA	Bacillus amyloliquefaciens FZB42 & Bacillus pumilus (Bacillus mesentericus) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Peptide antibiotic inhibiting growth of Gram-positive bacteria: in the dimethylated form plantazolicin A. The desmethyl form plantazolicin B has no antibiotic activity. The mode of action appears to be disruption of cell walls and lysis of cells. Has antibacterial activity.	Gram-positive bacteria: Bacillus subtilis HB0042, Bacillus subtilis strain 168, Bacillus megaterium 7A1, Bacillus anthracis (MIC=2-4 µg/ml), Bacillus brevis strain ATCC 8246, Bacillus cereus strain ATCC 14579 and strain CU1065, Bacillus licheniformis strain ATCC 9789, Micrococcus luteus, Bacillus sphaericus, Paenibacillus granivorans and Streptococcus pyogenes (MIC=128 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic (possibly)	Free	Free	10 residues (Cys, Ser/Thr) potentially serve as a site of heterocycle formation	L	No cytotoxicity information found	Not found	20971906	J Bacteriol. 2011 Jan;193(1):215-224.	Scholz R, Molohon KJ, Nachtigall J, Vater J, Markley AL, S¼ssmuth RD, Mitchell DA, Borriss R.	Plantazolicin, a novel microcin B17/streptolysin S-like natural product from Bacillus amyloliquefaciens FZB42.	
DRAMP00222	GETDPNTQLLNDLGNNMAWGAALGAPGGLGSAALGAAGGALQTVGQGLIDHGPVNVFIPVLIGPSWNGSGSGYNSATSSSGSGS	84	Microcin E492 (MccE492; Bacteriocin)	Q9Z4N4	Not found	mceA	Klebsiella pneumoniae RYC492 (Gram-negative bacteria)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Channel-forming bacteriocin. Forms cation-selective channels. Active on enterobacteria, with highest activity against Escherichia coli. The unmodified protein is active against Escherichia coli and S. enteritidis. When the siderophore ester is present at Ser-99, antibacterial activity against these species is increased and activity is also detected against E. cloacae and K. pneumoniae.
PTM: The C-terminal Ser is modified by attachment to a siderophore similar to enterobactin, which can bind one atom of iron. The modification consists of an ester linkage of the serine carboxyl to O6 of a glucose which is linked by a C-glycosidic bond to the 5'-benzoyl of a linear triester of N-(2,3-dihydroxybenzoyl)serine. Presence of the siderophore ester increases the antibacterial activity of the protein."	Gram-negative bacteria: Escherichia coli F (MIC=0.14 µM), Escherichia coli 363 (MIC=0.02 µM), Escherichia coli ML35p (MIC=0.14 µM), Escherichia coli GM1 (MIC=0.04 µM), Escherichia coli GM1 KP1060(MIC=0.65 µM), Escherichia coli W3110 (MIC=0.02 µM), Escherichia coli W3110-KP1344 Pms7 (MIC=0.08 µM), Escherichia coli W3110-6 (MIC=0.32 µM), Escherichia coli C600 (MIC=0.08 µM), Escherichia coli C600 pHX405 (MIC=0.16 µM), Salmonella enteritidis (MIC=0.6 µM), Salmonella typhimurium (MIC=1.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Attachment to a siderophore ester	[Ref.15102848] The post-translational modification consists of a trimer of N-(2,3-dihydroxybnenzoyl)-L-serine linked via a C-glycosidic linkage to a β-D-glucose moiety, itself linked to the MccE492m Ser-84-carboxyl through an O-glycosidic bond.	L	No cytotoxicity information found	Not found	12890026##15102848##7682973	Mol Microbiol. 2003 Aug;49(4):1031-1041.##J Biol Chem. 2004 Jul 2;279(27):28233-28242.##FEBS Lett. 1993 Apr 26;321(2-3):145-148.	Destoumieux-Garz³n D, Thomas X, Santamaria M, Goulard C, Barth©l©my M, Boscher B, Bessin Y, Molle G, Pons AM, Letellier L, Peduzzi J, Rebuffat S.##Thomas X, Destoumieux-Garz³n D, Peduzzi J, Afonso C, Blond A, Birlirakis N, Goulard C, Dubost L, Thai R, Tabet JC, Rebuffat S.##Lagos R, Wilkens M, Vergara C, Cecchi X, Monasterio O.	Microcin E492 antibacterial activity: evidence for a TonB-dependent inner membrane permeabilization on Escherichia coli.##Siderophore peptide, a new type of post-translationally modified antibacterial peptide with potent activity.##Microcin E492 forms ion channels in phospholipid bilayer membrane.	
DRAMP00232	ATPATPTVAQFVIQGSTICLVC	22	Cypemycin (Bacteriocin)	E5KIB6	Belongs to the linaridin family	cypA	Streptomyces sp. OH-4156 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Antibiotic peptide structurally related to lantibiotics. Has cytotoxic activity against mouse P388 leukemia cells (IC50=1.3 μg/ml).	Micrococcus luteus (MIC=0.2 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	[Ref. 10.1016/S0040-4039(00)78407-3] Dimethylation on Ala1	[Ref. 10.1016/S0040-4039(00)78407-3] Decarboxylation and Cyclization on D-Cys64	[Ref. 10.1016/S0040-4039(00)78407-3] ①Thr2, Thr5, Thr7 and Thr17 converts to (E)-2,3-didehydrobutyrine. ②Ile13 and Ile18 converts to L-allo-isoleucine. ③Maturation involves the enzymatic conversion of Cys-19 into 2,3-didehydroalanine followed by formation of a thioether bond with Cys-22. The C-terminal meso-lanthionine then undergoes decarboxylation.	[Ref. 10.1016/S0040-4039(00)78407-3] Mixed (D-Cys19)	[Ref.7802859] IC50 = 1.3 μg/mL against P388 leukemia cells in vitro.	Not found	7802859##Pubmed ID is not available	J Antibiot (Tokyo). 1993 Nov;46(11):1666-1671.##Tetrahedron Lett. 1994 Oct;35(43):8001-8004.	Komiyama K, Otoguro K, Segawa T, Shiomi K, Yang H, Takahashi Y, Hayashi M, Otani T, Omura S.##Minami Y, Yoshida K, Azuma R, Urakawa A, Kawauchi T, Otani T, Komiyama K, Omura S	A new antibiotic, cypemycin. Taxonomy, fermentation, isolation and biological characteristics. ##STRUCTURE OF CYPEMYCIN, A NEW PEPTIDE ANTIBIOTIC.	
DRAMP00244	XTPATPFTPAITEITAAVIAX	21	Hominicin (Bacteriocin)	No entry found	Not found	Not found	Staphylococcus hominis MBBL 2-9 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Hominicin exhibited heat stability up to 121 degrees C for 15min and activity under both acidic and basic conditions (from pH 2.0 to 10.0). 	Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=0.06 µg/ml), S. aureus ATCC (MRSA) 11435 (MIC=0.96 µg/ml), S. aureus (vancomycin-intermediate VISA) CCARM 3501 (MIC=3.82 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Dimethylation on Ile1	Free	①The residue X at position 1 is DmIle (N1, N1-dimethyl-isoleucine).②The residues T at position 2, 5, 8 and 15 are dehydrobutyrine. ③The residue at position 21 is a distinct residue Dmp (N2, N2-dimethyl-1,2-propanediamine) rarely found from biosynthetic antimicrobial peptides.	L	No cytotoxicity information found	Not found	20654578	Biochem Biophys Res Commun. 2010 Aug 20;399(2):133-138. 	Kim PI, Sohng JK, Sung C, Joo HS, Kim EM, Yamaguchi T, Park D, Kim BG.	Characterization and structure identification of an antimicrobial peptide, hominicin, produced by Staphylococcus hominis MBBL 2-9.	
DRAMP00254	WFYQGMNIAIYANIGGVANIIGYTEAAVATLLGAVVAVAPVVP	43	Propionicin-F (Bacteriocin)	Q6E3K9	Not found	pcfA	Propionibacterium freudenreichii subsp. Freudenreichii LMGT 2946 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Bacteriocin with specific antibacterial activity.	Gram-positive bacteria: Propionibacterium freudenreichii ssp. freudenreichii ATCC 6207T (MIC=0.7 nM), P. freudenreichii ssp.shermanii ATCC 9614T (MIC=5.0 nM), P. freudenreichii ATCC 9616 (MIC=20 nM), P. freudenreichii IFO12426 (MIC=2.5 nM), P. freudenreichii LMGT 2842 (MIC=5.0 nM), P. freudenreichii LMGT 3001 (MIC=5.0 nM), P. freudenreichii LMGT 2946, P. freudenreichii LMGT 2956, P. freudenreichii ISU-P24 (MIC=0.7 nM), P. freudenreichii ISU-P59 (MIC=2.5 nM), P. freudenreichii ISU-P83 (MIC=5.0 nM), P. freudenreichii ISU-P98 (MIC=1.3 nM), P. freudenreichii ISU-P104 (MIC=0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	15574930	Appl Environ Microbiol. 2004 Dec;70(12):7303-7310.	Brede DA, Faye T, Johnsborg O, Odeg¥rd I, Nes IF, Holo H.	Molecular and genetic characterization of propionicin F, a bacteriocin from Propionibacterium freudenreichii.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP00275	GSSFCDSKCKLRCSKAGLADRCLKYCGICCEECKCVPSGTYGNKHECPCYRDKKNSKGKSKCP	63	Snakin-1 (StSN1; Cys-rich; Plant defensin)	Q948Z4	Not found	SN1	Solanum tuberosum (potato)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		"Function: Has an antimicrobial activity. Causes a rapid aggregation of both Gram-positive and Gram-negative bacteria, but the antimicrobial activity is not correlated with the capacity to aggregate bacteria.
Tissue specificity: Expressed in tubers, stems, axillary and young floral buds, sepals, petals, stamens and carpels, but not in roots, stolons, shoot apex meristem or young leaves.
Induction: No responses to methyl jasmonate, ethylene, abscisic acid, salicylic acid, isonicotinic acid, indolacetic acid, gibberellic acid and infection with incompatible bacterial or compatible fungual pathogens.
PTM: Six disulfide bonds may be present."	[Ref.9885189] Gram-positive bacteria: Listeria monocytogenes (MIC=10 µg/mL), Listeria innocua (MIC=10 µg/mL), Listeria ivanovii (MIC=10 µg/mL), Clavibacter michiganensis (EC50=1 µM), Ralstonia solanacearum (rfa-) (EC50=30 µM), Rhizobium meliloti (EC50=8 µM).##Fungi: Botrytis cinerea (EC50=2 µM), Fusarium solani (EC50=3 µM), Fusarium culmorum (EC50=2 µM), Fusarium oxysporum f. sp. conglutinans (EC50=10 µM), Fusarium oxysporum f. sp. lycopersici (EC50=20 µM), Plectosphaerella cucumerina (EC50=10 µM), Colletotrichum graminicola (EC50=10 µM), Colletotrichum lagenarium (EC50=10 µM), Bipolaris maydis (EC50=20 µM), Aspergillus flavus (EC50=20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	[Ref.9885189] Six disulfide bonds may be present	L	No cytotoxicity information found	Not found	11891250##9885189	Plant Physiol. 2002 Mar;128(3):951-961.##Mol Plant Microbe Interact. 1999 Jan;12(1):16-23.	Marta Berrocal-Lobo, Ana Segura, Manuel Moreno, Gemma López, Francisco García-Olmedo, Antonio Molina##A Segura, M Moreno, F Madueño, A Molina, F García-Olmedo	Snakin-2, an antimicrobial peptide from potato whose gene is locally induced by wounding and responds to pathogen infection.##Snakin-1, a peptide from potato that is active against plant pathogens.	
DRAMP00336	IPCGESCVWIPCITAIAGCSCKNKVCYT	28	ChaC7 (Chassatide C7; uncyclotides; Plant defensin)	No entry found	Belongs to the Bracelet subfamily, Rubiaceae family	Not found	Chassalia chartacea	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		"IC50=1.2 µM, HD50=11.6 µM.
Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells)."	Gram-negative bacterium: Escherichia coli (MIC=6.4 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 µM), Staphylococcus epidermidis (MIC>80 µM).	[Ref.22467870] HD50 = 11.6 μM against on human red blood cells (Type A). Kalata B1 and melittin were used as the positive control.	Linear	Free	Free		L	[Ref.22467870] IC50 = 1.2 μM targeting on HeLa cells. Kalata B1 was used as the positive control.	Not found	22467870	J Biol Chem. 2012 May 18;287(21):17598-17607.	Nguyen GK, Lim WH, Nguyen PQ, Tam JP.	Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.	CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(C)C
DRAMP00337	AIPCGESCVWIPCISTVIGCSCSNKVCYR	29	ChaC8 (Chassatide C8; uncyclotides; Plant defensin)	No entry found	Belongs to the Bracelet subfamily, Rubiaceae family	Not found	Chassalia chartacea	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		"IC50=1.0 µM, HD50=25.5 µM.
Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells)."	Gram-negative bacterium: Escherichia coli (MIC=6.6 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 µM), Staphylococcus epidermidis (MIC>80 µM).	[Ref.22467870] HD50 = 25.5 μM against human red blood cells (Type A). Kalata B1 and melittin were used as the positive control.	Linear	Free	Free		L	[Ref.22467870] IC50 = 1.0 μM targeting on HeLa cells. Kalata B1 was used as the positive control.	Not found	22467870	J Biol Chem. 2012 May 18;287(21):17598-17607.	Nguyen GK, Lim WH, Nguyen PQ, Tam JP.	Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP00338	IPCGESCVWIPCISGMFGCSCKDKVCYS	28	ChaC11 (Chassatide C11; uncyclotides; Plant defensin)	No entry found	Belongs to the Bracelet subfamily, Rubiaceae family	Not found	Chassalia chartacea	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		"IC50=1.2 µM, HD50=13.3 µM.
Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells)."	Gram-negative bacterium: Escherichia coli (MIC=8.5 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 µM), Staphylococcus epidermidis (MIC>80 µM).	[Ref.22467870] HD50 = 13.3 μM against human red blood cells (Type A). Kalata B1 and melittin were used as the positive control.	Linear	Free	Free		L	[Ref.22467870] IC50 = 5.0 μM targeting on HeLa cells. Kalata B1 was used as the positive control.	Not found	22467870	J Biol Chem. 2012 May 18;287(21):17598-17607.	Nguyen GK, Lim WH, Nguyen PQ, Tam JP.	Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.	CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C
DRAMP00384	GNEGGGHGGHGGYGGYHHHGGGGGGYGGYHGGGGS	35	Cc-GRP (Gly-rich; Plants)	No entry found	Not found	Not found	Coffea canephora	Antimicrobial, Antifungal	Not found	Rich	Not found		Comment: The sequence displayed is only the N-terminal sequence of 7 kD peptide. The peptide was located in the cell wall, cell surface and nucleus of Fusarium oxysporum. 	Fungi: Candida albicans (MIC=90 µg/ml), Candida tropicalis (MIC=180 µg/ml), Colletotrichum lindemuthianum (MIC=90 µg/ml), Fusarium oxysporium (MIC=90 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	23500079	Biochim Biophys Acta. 2013 Mar 15.[Epub ahead of print]	Zottich U, Da Cunha M, Carvalho AO, Dias GB, Casarin N, Vasconcelos IM, Gomes VM.	An antifungal peptide from Coffea canephora seeds with sequence homology to glycine-rich proteins exerts membrane permeabilization and nuclear localization in fungi.	NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)O
DRAMP00385	QLPICGETCVLGGCYTPNCRCQYPICVR	28	Panitide L2 (plants)	No entry found	Not found	Not found	Panicum laxum	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Bridge	Not found		PTM: N-terminus is a pyruglutamyl.	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=2.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Pyroglutamyl modification	Free	There are three disulfide bonds in the peptide structure	L	[Ref.23195955] IC50 = 6.0 μM against HeLa cells. 	Not found	23195955	J Biol Chem. 2013 Feb 1;288(5):3370-3380.	Nguyen GK, Lian Y, Pang EW, Nguyen PQ, Tran TD, Tam JP.	Discovery of linear cyclotides in monocot plant Panicum laxum of Poaceae family provides new insights into evolution and distribution of cyclotides in plants.	
DRAMP00416	KLCERSSGTWSGVCGNNNACKNQCIRLEGAQHGSCNYVFPAHKCICYFPC	50	Raphanus sativus Antifungal Protein 3 (Rs-AFP3; Plant defensin)	O24332, Q39313	Belongs to the DEFL family	AFP3	Raphanus sativus (Radish) & Brassica napus (Rape)	Antimicrobial, Antifungal	Protein inferred from homology	Bridge	Not found		"Function: Possesses antifungal activity sensitive to inorganic cations (By similarity).
PTM: Problely contains four disulfide bonds 3-50; 14-35; 20-44; 24-46."	Fungi: Alternaria brassicicola (MIC=2 µg/ml), Botrytis cinerea (MIC=2 µg/ml), Fusarium culmorum (MIC=2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There are four disulfide bonds between Cys3 and Cys50, Cys14 and Cys35, Cys20 and Cys44, Cys24 and Cys51.	L	No cytotoxicity information found	Not found	7780308##8422949	Plant Cell. 1995 May;7(5):573-588.##FEBS Lett. 1993 Feb 1;316(3):233-240.	Terras FR, Eggermont K, Kovaleva V, Raikhel NV, Osborn RW, Kester A, Rees SB, Torrekens S, Van Leuven F, Vanderleyden J, et al.##Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.	Small cysteine-rich antifungal proteins from radish: their role in host defense.##A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.	
DRAMP00417	QKLCERSSGTWSGVCGNNNACKNQCINLEGARHGSCNYIFPYHRCICYFPC	51	Raphanus sativus Antifungal Protein 4 (Rs-AFP4; Plant defensin)	O24331	Belongs to the DEFL family	AFP4	Raphanus sativus (Radish)	Antimicrobial, Antifungal	Protein inferred from homology	Bridge	Not found		PTM: Contains four disulfide bonds 4-51;15-36;21-45;25-47, and Pyrrolidone carboxylic acid at position 1.	Fungi: Alternaria brassicicola (MIC=5 µg/ml), Botrytis cinerea (MIC=9 µg/ml), Fusarium culmorum (MIC=11 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization of a N-terminal glutamine (Conversion to pyrrolidone carboxylic acid)	Free	There are four disulfide bonds between Cys4 and Cys51, Cys15 and Cys36, Cys21 and Cys45, Cys25 and Cys47.	L	No cytotoxicity information found	Not found	7780308	Plant Cell. 1995 May;7(5):573-588.	Terras FR, Eggermont K, Kovaleva V, Raikhel NV, Osborn RW, Kester A, Rees SB, Torrekens S, Van Leuven F, Vanderleyden J, et al.	Small cysteine-rich antifungal proteins from radish: their role in host defense.	
DRAMP00422	QKLCERPSGTWSGVCGNNNACKNQCINLEKARHGSCNYVFPAHKCICYFPC	51	Defensin-like protein 1 (Sa-AFP1; Plant defensin)	P30231	Belongs to the DEFL family	Not found	Sinapis alba (White mustard) (Brassica hirta)	Antimicrobial, Antifungal	Protein level	Bridge	Not found	1AYJ	Function: Possesses antifungal activity sensitive to inorganic cations.	Fungi: Alternaria brassicola (MIC=1.2 µg/ml), Botrytis cinerea (MIC=1.8 µg/ml), Fusarium culmorum (MIC=4 µg/ml), Fusarium oxysporum f.sp.lycopersici (MIC=6 µg/ml), Pyricularia oryzae (MIC=0.5 µg/ml), Verticillium dahliae (MIC=1.5 µg/ml).##NOTE: In synthetic low ionic strength fungal growth medium.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization of a N-terminal glutamine (Conversion to pyrrolidone carboxylic acid)	Free	There are four disulfide bonds between Cys4 and Cys51, Cys15 and Cys36, Cys21 and Cys45, Cys25 and Cys47.	L	No cytotoxicity information found	Not found	8422949##8836771	FEBS Lett. 1993 Feb 1;316(3):233-240.##Int J Pept Protein Res. 1996 Jun;47(6):437-446.	Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.##Neumann GM, Condron R, Polya GM.	A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.##Purification and mass spectrometry-based sequencing of yellow mustard (Sinapis alba L.) 6 kDa proteins. Identification as antifungal proteins.	
DRAMP00423	QKLCQRPSGTWSGVCGNNNACRNQCINLEKARHGSCNYVFPAHKCICYFPC	50	Defensin-like protein 2 (Sa-AFP2; Plant defensin)	P30232	Not found	Not found	Sinapis alba (White mustard) (Brassica hirta)	Antimicrobial, Antifungal	Not found	Not found	Not found		Function: Possesses antifungal activity sensitive to inorganic cations.	Fungi: Alternaria brassicola (MIC=4.5 µg/ml), Botrytis cinerea (MIC=3.5 µg/ml), Fusarium culmorum (MIC=2.3 µg/ml), Fusarium oxysporum f.sp.lycopersici (MIC=2.3 µg/ml), Pyricularia oryzae (MIC=0.3 µg/ml), Verticillium dahliae (MIC=1.2 µg/ml).##NOTE: In synthetic low ionic strength fungal growth medium.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization of a N-terminal glutamine (Conversion to pyrrolidone carboxylic acid)	Free	①There are four disulfide bonds between Cys4 and Cys51, Cys15 and Cys36, Cys21 and Cys45, Cys25 and Cys47. ②The residue at position 8 is phosphorylated.	L	No cytotoxicity information found	Not found	8422949	FEBS Lett. 1993 Feb 1;316(3):233-240.	Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.	A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.	
DRAMP00425	LMCTHPLDCSN	11	Tn-AFP1 (Trapa natans antifungal peptide; Plant defensin)	No entry found	Not found	Not found	Trapa natans	Antimicrobial, Antifungal	Not found	Not found	Not found		Function: Tn-AFP1 has no adverse effect on red blood cells at concentration of 32 μg/mL.	Yeast: Candida tropicalis (MIC=32 µg/ml).	Tn-AFP1 has no adverse effect on red blood cells at concentration of 32 μg mL−1	Cyclic	Free	Free	There is a disulfide bond between Cys3 and Cys9	L	No cytotoxicity information found	Not found	21736910	Peptides. 2011 Aug;32(8):1741-1747.	Mandal SM, Migliolo L, Franco OL, Ghosh AK.	Identification of an antifungal peptide from Trapa natans fruits with inhibitory effects on Candida tropicalis biofilm formation.	
DRAMP00431	KTCMTKKEGWGRCLIDTTCAHSCRKYGYMGGKCQGITRRCYCLLNC	46	Defensin-like protein 2 (Cp-thionin II; Cp-thionin-2; Gamma-thionin II; Plant defensin)	P84920	Belongs to the DEFL family	Not found	Vigna unguiculata (Cowpea)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli and P. syringae. Does not have antibacterial activity against the phytopathogenic bacteria R. solanacearum, Rhataybacter sp and Erwinia sp. Does not inhibit trypsin, chymotrypsin or alpha-amylases.
Tissue specificity: Present in seeds, cotyledons and leaves. Not found in roots or stems.
Developmental stage: Present in seeds and seedlings, levels decrease with seedling age. Light increases the rate of degradation. Present until 9 days in seedlings kept in the dark, not found after 6 days in seedings kept in the light.
PTM: Contains four disulfide bonds 3-46; 13-33; 19-40; 23-42."	Gram-positive bacterium: Staphylococcus aureus ATTC 25923 (MIC=128 mg/ml);##Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=64 mg/ml), Pseudomonas syringae (MIC=42 mg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	There are four disulfide bonds between Cys3 and Cys46, Cys13 and Cys33, Cys19 and Cys40, Cys23 and Cys42	L	No cytotoxicity information found	Not found	16824043	FEBS J. 2006 Aug;273(15):3489-3497. 	Franco OL, Murad AM, Leite JR, Mendes PA, Prates MV, Bloch C Jr.	Identification of a cowpea gamma-thionin with bactericidal activity.	
DRAMP00436	KTCEHLADTYRGVCFTNASCDDHCKNKAHLISGTCHNWKCFCTQNC	46	Pisum sativum defensin 1 (Psd1; Plant defensin)	P81929	Belongs to the DEFL family	Not found	Pisum sativum (Garden pea)	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	The protein has a globular fold with a triple-stranded antiparalell beta-sheet and an alpha-helix (from residue Asn17 to Leu27). 	1JKZ resolved by NMR.	PTM: Contains four disulfide bonds 3-46; 14-35; 20-40; 24-42.	PD: Aspergillus niger (MIC=12.1 µg/ml), Aspergillus versicolor (MIC<5.0 µg/ml), Fusarium moniliforme (MIC=21.7 µg/ml), Fusarium oxysporum (MIC>100 µg/ml), Fusarium solani (MIC=12.1 µg/ml), Neurospora crassa (MIC=0.04 µg/ml), Saccharomyces cerevisae (MIC>100 µg/ml), Trichophyton mentagrophytes (MIC>100 µg/ml).##PD+: Aspergillus niger (MIC=7.4 µg/ml), Fusarium moniliforme (MIC=33.2 µg/ml), Fusarium oxysporum (MIC=100 µg/ml), Fusarium solani (MIC=79.2 µg/ml), Neurospora crassa (MIC=0.05 µg/ml).##NOTE: PD+: potato dextrose medium supplemented with 1 mM CaCl2.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	There are four disulfide bonds between Cys3 and Cys46, Cys14 and Cys35, Cys20 and Cys40, Cys24 and Cys42	L	No cytotoxicity information found	It interacts with cell-cycle-realted protein cyclin F as the target.	10860545##11697857##11812144	Arch Biochem Biophys. 2000 Jun 15;378(2):278-286.##Arch Biochem Biophys. 2001 Nov 15;395(2):199-207.##J Mol Biol. 2002 Jan 25;315(4):749-757.	Almeida M.S, Cabral K.M, Zingali R.B, Kurtenbach E.##Almeida MS, Cabral KS, de Medeiros LN, Valente AP, Almeida FC, Kurtenbach E.##Almeida MS, Cabral KM, Kurtenbach E, Almeida FC, Valente AP.	Characterization of two novel defense peptides from pea (Pisum sativum) seeds.##cDNA cloning and heterologous expression of functional cysteine-rich antifungal protein Psd1 in the yeast Pichia pastoris.##Solution structure of Pisum sativum defensin 1 by high resolution NMR: plant defensins, identical backbone with different mechanisms of action.	
DRAMP00437	KTCENLSGTFKGPCIPDGNCNKHCRNNEHLLSGRCRDDFRCWCTNRC	47	Pisum sativum defensin 2 (Psd2; Plant defensin)	P81930	Belongs to the DEFL family	Not found	Pisum sativum (Garden pea)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		PTM: Contains four disulfide bonds 3-47; 14-35; 20-41; 24-43.	PD: Aspergillus niger (MIC=10.2 µg/ml), Aspergillus versicolor (MIC=0.34 µg/ml), Fusarium moniliforme (MIC=10.0 µg/ml), Fusarium oxysporum (MIC>100 µg/ml), Fusarium solani (MIC=8.5 µg/ml), Neurospora crassa (MIC<0.5 µg/ml), Saccharomyces cerevisae (MIC>100 µg/ml), Trichophyton mentagrophytes (MIC<100 µg/ml).##PD+: Aspergillus niger (MIC=7.8 µg/ml), Aspergillus versicolor (MIC=5.9 µg/ml), Fusarium moniliforme (MIC=25 µg/ml), Fusarium oxysporum (MIC>100 µg/ml), Fusarium solani (MIC=5.0 µg/ml).##NOTE: PD+ = potato dextrose medium supplemented with 1 mM CaCl2.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	There are four disulfide bonds between Cys3 and Cys47, Cys14 and Cys35, Cys20 and Cys41, Cys24 and Cys43.	L	No cytotoxicity information found	Not found	10860545	Arch Biochem Biophys. 2000 Jun 15;378(2):278-286.	Almeida M.S, Cabral K.M, Zingali R.B, Kurtenbach E.	Characterization of two novel defense peptides from pea (Pisum sativum) seeds.	
DRAMP00450	QKLCQRPSGTWSGVCGNNNACRNQCINLEKARHGSCNYVFPAHKCICYFPC	51	Defensin-like protein 2A (AFP2A; M2A; Plant defensin)	P30232	Belongs to the DEFL family	Not found	Sinapis alba (White mustard) (Brassica hirta)	Antimicrobial, Antifungal	Protein level	Rich	Not found		"Function: Possesses antifungal activity sensitive to inorganic cations.
Subunit structure: Forms oligomers in its native state.
PTM: Contains four disulfide bonds (By similarity)."	Fungi: Alternaria brassicola (MIC=4.5 µg/ml), Botrytis cinerea (MIC=3.5 µg/ml), Fusarium culmorum (MIC=2.3 µg/ml), Fusarium oxysporum f.sp. lycopersici (MIC=2.3 µg/ml), Pyricularia oryzae (MIC=0.3 µg/ml), Verticillium dahliae (MIC=1.2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	[Ref.8422949] Cyclization of a N-terminal glutamine (Conversion to pyrrolidone carboxylic acid)	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	①There are four disulfide bonds between Cys4 and Cys51, Cys15 and Cys36, Cys21 and Cys45, Cys25 and Cys47. ②[Ref.8836771] The residue at position 8 is phosphorylated.	L	No cytotoxicity information found	Not found	8422949##8836771	FEBS Lett. 1993 Feb 1;316(3):233-240.##Int J Pept Protein Res. 1996 Jun;47(6):437-446.	Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.##Neumann GM, Condron R, Polya GM.	A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.##Purification and mass spectrometry-based sequencing of yellow mustard (Sinapis alba L.) 6 kDa proteins. Identification as antifungal proteins.	
DRAMP00454	ATCKAECPTWDSVCINKKPCVACCKKAKFSDGHCSKILRRCLCTKEC	47	Petunia hybrida defensin 1 (PhD1; Cys-rich; Plant defensin)	Q8H6Q1	Belongs to the DEFL family	D1	Petunia hybrida (Petunia)	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	PhD1 has the fold of the cysteine-stabilized alphabeta motif, consisting of an alpha-helix and a triple-stranded antiparallel beta-sheet, except that it contains a fifth disulfide bond from the first loop to the alpha-helix.	1N4N resolved by NMR.	"Function: Plant defense peptide with antifungal activity.
Tissue specificity: Petals.
Domain: The presence of a 'disulfide through disulfide knot' structurally defines this protein as a knottin.
Biophysicochemical properties: pH dependence (Stable under extremes of pH); Temperature dependence (Stable under extremes of temperature).
PTM: Contains five disulfide bonds 3-47; 7-23; 14-34; 20-41; 24-43."	Fungi: Fusarium oxysporum (MIC=10 µg/ml), Botrytis cinerea (MIC=10 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	When compared to other plant defensins, the petunia defensins have an additional fifth disulfide bond. There are five disulfide bonds between Cys3 and Cys47, Cys7 and Cys23, Cys14 and Cys34, Cys20 and Cys41, Cys24 and Cys43.	L	No cytotoxicity information found	Not found	12644678##12846570	Plant Physiol. 2003 Mar;131(3):1283-1293.##Biochemistry. 2003 Jul 15;42(27):8214-8222.	Lay FT, Brugliera F, Anderson MA.##Janssen BJ, Schirra HJ, Lay FT, Anderson MA, Craik DJ.	Isolation and properties of floral defensins from ornamental tobacco and petunia.##Structure of Petunia hybrida defensin 1, a novel plant defensin with five disulfide bonds.	
DRAMP00764	KSLRPRCWIKIKFRCKSLKF	20	Piceain 1 (Plants)	No entry found	Not found	Not found	Picea sitchensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Beta strand (CD)	Not found		"Function: Active against both Gram-postive and Gram-negative bacteria, fungi. It showed weak hemolysis activity against human and rabbit red cells.
PTM: Contains one disulfide bond."	Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=9.38 µg/ml), S. aureus ATCC 43300 (MIC=9.38 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=18.75 µg/ml), Escherichia coli ML-35P (MIC=18.75 µg/ml), Escherichia coli 08040722 (CI) (MIC=75 µg/ml), Escherichia coli 08A866 (CI) (MIC=37.5 µg/ml), Pseudomonas aeruginosa PA01 (MIC=9.38 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=9.38 µg/ml), Pseudomonas aeruginosa 08031014 (CI) (MIC=37.5 µg/ml).##Yeast: Candida albicans ATCC 20032 (MIC=9.38 µg/ml).	[Ref.21644248] At the concentration of 0.0625 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 0.7% & 1.5%; At the concentration of 0.125 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 0.8% & 7.2%; At the concentration of 0.25 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 5.9%&7.8%; At the concentration of 0.5 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 7.6% & 9.5%; At the concentration of 1 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 7.8% & 57.1%.	Cyclic	Free	Free	There is one intra-molecular disulfide bridge formed by Cys7 and Cys15.	L	No cytotoxicity information found	Not found	21644248	J Pept Sci. 2011 Sep;17(9):627-631.	Liu R, Mu L, Liu H, Wei L, Yan T, Chen M, Zhang K, Li J, You D, Lai R.	Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis.	
DRAMP00765	RPRCWIKIKFRCKSLKF	17	Piceain 2 (Plants)	No entry found	Not found	Not found	Picea sitchensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		"Function: Active against both Gram-postive and Gram-negative bacteria, fungi. It showed weak hemolysis activity against human and rabbit red cells.
PTM: Contains one disulfide bond."	Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=9.38 µg/ml), S. aureus ATCC 43300 (MIC=18.75 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=37.5 µg/ml), Escherichia coli ML-35P (MIC=37.5 µg/ml), Escherichia coli 08040722 (CI) (MIC=75 µg/ml), Escherichia coli 08A866 (CI) (MIC=37.5 µg/ml), Pseudomonas aeruginosa PA01 (MIC=9.38 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=18.75 µg/ml), Pseudomonas aeruginosa 08031014 (CI) (MIC=37.5 µg/ml).##Yeast: Candida albicans ATCC 20032 (MIC=18.75 µg/ml).	[Ref.21644248] At the concentration of 0.0625 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 0.6% & 2.2%; At the concentration of 0.125 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 0.8% & 4.7%; At the concentration of 0.25 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 5.2%&5.2%; At the concentration of 0.5 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 5.3% & 12.4%; At the concentration of 1 mg/ml, Piceain 1 induced human & rabbit red cell hemolysis of 11.3% & 66.3%.	Cyclic	Free	Free	There is one intra-molecular disulfide bridge formed by Cys4 and Cys12.	L	No cytotoxicity information found	Not found	21644248	J Pept Sci. 2011 Sep;17(9):627-631.	Liu R, Mu L, Liu H, Wei L, Yan T, Chen M, Zhang K, Li J, You D, Lai R.	Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis.	
DRAMP00766	KVFLGLK	7	JCpep7 (Plants)	No entry found	Not found	Not found	Jatropha curcas	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: JCpep7 killed microbes principally via breaking of their cell walls and membranes, followed by cell lysis.	Gram-negative bacteria: Salmonella typhimurium ATCC 50013 (MIC=48 µg/ml), Shigella dysenteriae ATCC 51302 (MIC=48 µg/ml), Pseudomonas aeruginosa ATCC 27553 (MIC=64 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=40 µg/ml), Bacillus subtilis ATCC 23631 (MIC=24 µg/ml), Streptococcus pneumoniae ATCC 49619 (MIC=56 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	21268582	J Agric Food Chem. 2011 Feb 23;59(4):1145-1151.	Xiao J, Zhang H, Niu L, Wang X.	Efficient Screening of a Novel Antimicrobial Peptide from Jatropha curcas by Cell Membrane Affinity Chromatography.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP00774	GTRCGETCFVLPCWSAKFGCYCQKGFCYRN	30	Hedyotide B1 (hB1; Plants)	No entry found	Belongs to the cyclotide family	Not found	Hedyotis biflora (aerial tissues)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=3.4 µM);##Gram-positive bacteria: Streptococcus salivarius(MIC=5.9 µM), Staphylococcus epidermidis (MIC>80 µM), S. aureus (MIC>80 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There are three disulfide bonds in the peptide structure	L	No cytotoxicity information found	Not found	21979955	J Biol Chem. 2011 Dec 30;286(52):44833-44844.	Nguyen GK, Zhang S, Wang W, Wong CT, Nguyen NT, Tam JP.	Discovery of a linear cyclotide from the bracelet subfamily and its disulfide mapping by top-down mass spectrometry.	
DRAMP00795	GIPCGESCVFIPCITAAIGCSCKSKVCYRN	30	Cliotide T1 (cT1; Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Not found	Not found	Not found		"Function: Cliotide T1 shows stronger antimicrobial activity against the Gram-negative bacteria than the Gram-positive bacteria. It also has hemolytic activity against human type A erythrocytes (HD50=7.1 µM) and cytotoxicity against HeLa Cells (IC50=0.6 µM).
[Note: HD50 refers to the peptide concentration that causes 50% lysis of red blood cells; IC50 refers to the peptide concentration that causes 50% death of HeLa cells]. "	[Ref.21596752]Gram-positive bacteria: Staphylococcus aureus ATCC12600, Enterococcus faecalis ATCC 47077 (less active);##Gram-negative bacteria: Escherichia coli ATCC 700926 (MIC=1.1 µM), Pseudomonas aeruginosa ATCC 39018 (MIC=2.7 µM), Klebsiella pneumonia ATCC 13883 (MIC=4.7 µM).	[Ref.21596752] HD50 = 7.1 μM against human red blood cells	Cyclic	Free	Free	There are three disulfide bonds between Cys4 and Cys20, Cys8 and Cys22, Cys13 and Cys27.	L	[Ref.21596752] IC50=0.6 µM against HeLa cells.	Not found	21596752	J Biol Chem. 2011 Jul 8;286(27):24275-24287.	Nguyen GK, Zhang S, Nguyen NT, Nguyen PQ, Chiu MS, Hardjojo A, Tam JP.	Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.	
DRAMP00798	GIPCGESCVFIPCITGAIGCSCKSKVCYRN	30	Cliotide T4 (cT4; Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Not found	Not found	Not found		"Function: Cliotide T4 shows stronger antimicrobial activity against the Gram-negative bacteria than the Gram-positive bacteria. It also has hemolytic activity against human type A erythrocytes (HD50=8.4 µM) and cytotoxicity against HeLa Cells (IC50=0.6 µM).
[Note: HD50 refers to the peptide concentration that causes 50% lysis of red blood cells; IC50 refers to the peptide concentration that causes 50% death of HeLa cells]. "	[Ref.21596752]Gram-positive bacteria: Staphylococcus aureus ATCC12600, Enterococcus faecalis ATCC 47077 (less active);##Gram-negative bacteria: Escherichia coli ATCC 700926 (MIC=1.3 µM), Pseudomonas aeruginosa ATCC 39018 (MIC=1.9 µM), Klebsiella pneumonia ATCC 13883 (MIC=1.5 µM).	[Ref.21596752] HD50 = 8.4 μM against human red blood cells	Cyclic	Free	Free	There are three disulfide bonds between Cys4 and Cys20, Cys8 and Cys22, Cys13 and Cys27.	L	[Ref.21596752] IC50=0.6 µM against HeLa cells.	Not found	21596752	J Biol Chem. 2011 Jul 8;286(27):24275-24287.	Nguyen GK, Zhang S, Nguyen NT, Nguyen PQ, Chiu MS, Hardjojo A, Tam JP.	Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.	
DRAMP00856	GLPVCGETCVGGTCNTPGCTCSWPVCTRN	29	Kalata-B1 (Plant defensin)	P56254	Belongs to the cyclotide family	OAK1	Oldenlandia affinis 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral	Protein level	Beta strand (3 strands; 7 residues)	Not found	2KHB resolved by NMR.	"Function: Probably participates in a plant defense mechanism. Has antibiotic activity. Has a diuretic effect. Has a uterotonic effect in humans. Active against the Gram-positive S. aureus. Relatively ineffective against Gram-negative bacteria such as E. coli and P. aeruginosa. Inhibitory effect on the growth and development of larvae from H. punctigera. The unmodified form has hemolytic activity, the oxidized form lacks hemolytic activity. If the protein is linearized, hemolytic activity is lost.
MOA: a small number of cyclotides bind to the membrane surface and then insert first into the outer membrane leaflet followed by penetration through the membrane and pore formation. At higher concentrations of cyclotides, destabilization of membranes occurs.
Tissue specificity: Leaves and stems. Lower in roots.
Pharmaceutical use: The uteroactive properties of Kalata have been discovered by African traditional medicine. It is used as an ingredient of a herbal tea to accelerate childbirth.
PTM: Kalata-B1 is a cyclic peptide which contains three disulfide bonds 5-19; 11-21; 14-26."	[Ref.10430870]Gram-positive bacterium: Staphylococcus aureus (MIC=0.26 µM), Micrococcus luteus (MIC=40.4 µM);##Gram-negative bacterium: Klebsiella oxytoca (MIC=54.8 µM);##Fungi: Candida kefyr (MIC=21.4 µM).##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=140 nM).	[Ref.12779323] HD50 = 300 μM against Human type A red blood cells.	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	[Ref.7703226] There are three disulfide bonds between Cys5 and Cys19, Cys9 and Cys21, Cys14 and Cys26.	L	[Ref.18008336]CEM-SS cells:IC50=3500 nM.	Cell membrance	18008336##10430870##7703226##17534989##23129773	Biopolymers. 2008;90(1):51-60.##Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8918.##Biochemistry. 1995 Apr 4;34(13):4147-4158.##Chembiochem. 2007 Jun 18;8(9):1001-1011.##J Biol Chem. 2012 Dec 21;287(52):43884-98. 	Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. ##Tam JP, Lu YA, Yang JL, Chiu KW.##Saether O, Craik DJ, Campbell ID, Sletten K, Juul J, Norman DG.##Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.##Wang CK, Wacklin HP, Craik DJ.	Cyclotides as natural anti-HIV agents.##An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.##Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1.##The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.##Cyclotides insert into lipid bilayers to form membrane pores and destabilize the membrane through hydrophobic and phosphoethanolamine-specific interactions.	
DRAMP00877	GIPCGESCVWIPCISAALGCSCKNKVCYRN	30	Circulin-A (CIRA; Plant defensin)	P56871	Belongs to the cyclotide family	Not found	Chassalia parviflora 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral, Antifungal	Protein level	Alpha helix (1 helices; 4 residues)	"The molecule is stabilised by three disulfide bonds, two of which form an embedded loop completed by the backbone fragments connecting the cysteine residues. A third disulfide bond threads through the centre of this loop to form a ""cystine-knot"" motif. This motif is present in a range of other biologically active proteins, including omega-contoxin GVIA and Cucurbita maxima trypsin inhibitor."	1BH4 resolved by NMR.	"Function: Probably participates in a plant defense mechanism. Has antibiotic activity. Inhibits the cytopathic effects and replication of the human immunodeficiency virus. Relatively ineffective against Gram-negative bacteria such as E. coli and P. aeruginosa.
PTM: This is a cyclic peptide which contains three disulfide bonds 1-17; 5-19; 10-24."	[Ref.10430870]Gram-positive bacterium: Staphylococcus aureus (MIC=0.19 µM).##Gram-negative bacterium: Proteus vulgaris (MIC=54.6 µM).##Fungi: Candida kefyr (MIC=18.6 µM) and Candida tropicalis (MIC=19.4 µM).##NOTE: Medium with 10 mM phosphate buffer.##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=40-260 nM).	[Ref.10430870] EC50 = 1020 μM against blood type A human erythrocytes.	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	[Ref.8920961] There are three disulfide bonds between Cys4 and Cys20, Cys8 and Cys22, Cys13 and Cys27	L	[Ref.18008336]CEM-SS cells:IC50=500 nM.	Not found	18008336##10430870##9878410##8920961	Biopolymers. 2008;90(1):51-60. doi: 10.1002/bip.20886. ##Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8918.##J. Mol. Biol. 1999; 285:333-345. ##Biochem Biophys Res Commun. 1996 Nov 12;228(2):632-8.	Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Tam JP, Lu YA, Yang JL, Chiu KW.##Daly NL, Koltay A, Gustafson KR, Boyd MR, Casas-Finet JR, Craik DJ.##R Derua 1, K R Gustafson, L K Pannell	Cyclotides as natural anti-HIV agents.##An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.##Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activity.##Analysis of the disulfide linkage pattern in circulin A and B, HIV-inhibitory macrocyclic peptides	
DRAMP00878	GVIPCGESCVFIPCISTLLGCSCKNKVCYRN	31	Circulin-B (CIRB; Plant defensin)	P56879	Belongs to the cyclotide family	Not found	Chassalia parviflora 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral, Antifungal	Protein level	Beta strand (5 strands; 10 residues)	Cyclotides are mini-proteins derived from plants that have the characteristic features of a head-to-tail cyclised peptide backbone and a knotted arrangement of their three disulfide bonds.	2ERI resolved by NMR.	"Function: Probably participates in a plant defense mechanism. Has antibiotic activity. Inhibits the cytopathic effects and replication of the human immunodeficiency virus. Active against both Gram-positive and Gram-negative bacteria.
PTM: This is a cyclic peptide which contains three disulfide bonds 5-21; 9-23; 14-28."	[Ref.10430870]Gram-positive bacterium: (L-salt): Staphylococcus aureus (MIC=13.5 µM).##Gram-negative bacteria: (L-salt, H-salt) (MIC µM): Escherichia coli (0.41, >500), Pseudomonas aeruginosa (25.5, 48), Proteus vulgaris (6.8, >500), Klebsiella oxytoca (8.2, 15.6).##Fungi (H-salt): Candida kefyr (MIC=29 µM).##NOTE: L-salt = Medium with 10 mM phosphate buffer; H-salt = L-salt supplemented with 100 mM NaCl.##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=40-260 nM).	[Ref.10430870] EC50 = 550 μM against blood type A human erythrocytes.	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	[Ref.8920961] There are three disulfide bonds between Cys5 and Cys19, Cys9 and Cys21, Cys14 and Cys27.	L	[Ref.10430870] It caused 50% cell growth inhibition of mouse fibroblasts at 820 μM.##[Ref.18008336]CEM-SS cells:IC50=500 nM.	Not found	10430870##18008336##8920961	Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8918.##Biopolymers. 2008;90(1):51-60.##Biochem Biophys Res Commun. 1996 Nov 12;228(2):632-8. doi: 10.1006/bbrc.1996.1708.	Tam JP, Lu YA, Yang JL, Chiu KW.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##R Derua 1, K R Gustafson, L K Pannell	An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.##Cyclotides as natural anti-HIV agents.##Analysis of the disulfide linkage pattern in circulin A and B, HIV-inhibitory macrocyclic peptides	
DRAMP01374	GFLDTFKNLALNAAKSAGVSVLNSLSCKLFKTC	33	Odorranain-D1 (OdD1; Frogs, amphibians, animals)	A6MBK7	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Odorranain-D1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Has no hemolytic activity against red cell.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=16.32 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=8.16 μg/ml), Bacillus subtilis (MIC=8.16 μg/ml).##Yeast: Candida albicans (MIC=4.08 μg/ml).	[Ref:17272268]Non-hemolytic activity against rabbit red blood cells	Cyclic	Free	Cyclization(Cys27 and Cys33)	Disulfide bridge between Cys27 and Cys33.	L	[Ref.17272268]No cytotoxicity information found	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01373	GVLGAVKDLLIGAGKSAAQSVLKTLSCKLSNDC	33	Odorranain-C1 (OdC1; Frogs, amphibians, animals)	A6MBF6	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Odorranain-C1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=8.21 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=4.11 μg/ml), Bacillus subtilis (MIC=16.42 μg/ml).##Yeast: Candida albicans (MIC=2.05 μg/ml).	[Ref:17272268] No detectable hemolytic activity against rabbit red blood cells.	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	[Ref:17272268] There are one disulfide bond between Cys27 and Cys33	L	No cytotoxicity information found	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01372	AALKGCWTKSIPPKPCFGKR	20	Odorranain-B1 (OdB1; Frogs, amphibians, animals)	E7EKD9	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Odorrana hainanensis (Odor frog) (Rana hainanensis)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Homology	Not found	Odorranain-B1 adopts 5.9 % 		"Function: Odorranain-B1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Has no hemolytic activity against red cell. 
Tissue specificity: Expressed by the skin glands."	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=3.21 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=5.83 μg/ml), Bacillus subtilis (MIC=1.85 μg/ml).##Yeast: Candida albicans (MIC=2.4 μg/ml).	[Ref:17272268] No detectable hemolytic activity against rabbit red blood cells.	Cyclic	Free	Free	[Ref:17272268] There are one disulfide bond between Cys6 and Cys16	L	No cytotoxicity information found	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP00933	SAFTVWSGPGCNNRAERYSKCGCSAIHQKGGYDFSYTGQTAALYNQAGCSGVAHTRFGSSARACNPFGWKSIFIQC	76	Antimicrobial peptide 1 (AMP1; MiAMP1; Plant defensin)	P80915	Not found	Not found	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Antifungal	Protein level	Combine helix and strand structure	MiAMP1 is made up of eight beta-strands which are arranged in two Greek key motifs. These Greek key motifs associate to form a Greek key beta-barrel. This structure is unique amongst plant antimicrobial proteins and forms a new class which we term the beta-barrelins. (Ref.2)	1C01 resolved by NMR.	"Function: Antimicrobial peptide which inhibits the growth of a variety of fungi, oomycetes, Gram-positive bacterial phytopatogenes and S.cerevisiae in vitro. No activity against E.coli.
Miscellaneous: Its antimicrobial activity is diminished by calcium an"	Alternaria helianthi (MIC=2-5 µg/ml), Botrytis cinerea (MIC=5-10 µg/ml), Ceratocystis parodoxa (MIC=20 µg/ml), Colletotrichum gloeosporioides (MIC=2-5 µg/ml), Fusurium oxysporum (MIC=2-5 µg/ml), Leptosphaeria maculans (MIC=5 µg/ml), Macrophomina phaseolina (MIC<25 µg/ml), Phytophthoru cryptogea (MIC=5-10 µg/ml), Pythium graminicola (MIC=5 µg/ml), Sclerotinia sclerotiorum spores (MIC=5 µg/ml), Sclerotinia sclerotiorum mycelia (MIC=50 µg/ml), Verticilium dahliae (MIC=2 µg/ml), Clavibacter michiganensis (MIC<10 µg/ml), Saccharomyces cerevisiae (MIC=2-5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	[Ref.10543955] There are three disulfide bonds between Cys11 and Cys64, Cys21 and Cys76, Cys23 and Cys49	L	No cytotoxicity information found	Not found	9108242##10543955	Eur J Biochem. 1997 Mar 15;244(3):743-749.##J Mol Biol. 1999 Oct 29;293(3):629-638.	Marcus JP, Goulter KC, Green JL, Harrison SJ, Manners JM.##McManus AM, Nielsen KJ, Marcus JP, Harrison SJ, Green JL, Manners JM, Craik DJ.	Purification, characterisation and cDNA cloning of an antimicrobial peptide from Macadamia integrifolia.##MiAMP1, a novel protein from Macadamia integrifolia adopts a Greek key beta-barrel fold unique amongst plant antimicrobial proteins.	
DRAMP01004	PQRGEGGRAGNLLREEQEI	19	Cucurmoschin (Plants)	P84158	Not found	Not found	Cucurbita maxima (winter squash)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Has antifungal activity. Inhibits cell-free translation in rabbit reticulocyte lysate system.	Fungi: Botrytis cinerea (MIC=375 µM), Fusarium oxysporum (MIC=375 µM), Mycosphaerella arachidicola (MIC=375 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	14499274	Peptides. 2003 Jul;24(7):969-972.	Wang HX, Ng TB.	Isolation of cucurmoschin, a novel antifungal peptide abundant in arginine, glutamate and glycine residues from black pumpkin seeds.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)CC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP01012	RESPSSRMECYEQAERYGYGGYGGGRYGGGYGSGRGQPVGQGVERSHDDNRNQPR	55	Pg-AMP (Gly-rich; Plants)	P86030	Not found	Not found	Psidium guajava (Guava)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity against the Gram-negative bacteria. Does not have antifungal activity against the human and plant pathogenic fungi F. oxysporum, A. fumigatus and R. solani. 
Subunit structure: Monomer and homodimer. Might act by homodimer formation."	Gram-negative bacteria: Klebsiella sp., Proteus sp., Escherichia coli ATCC 8739 (MIC=72 mg/ml), Klebsiella pneumoniae (MIC=32 mg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	18448201	Peptides. 2008 Aug;29(8):1271-1279.	Pelegrini PB, Murad AM, Silva LP, Dos Santos RC, Costa FT, Tagliari PD, Bloch C Jr, Noronha EF, Miller RN, Franco OL.	Identification of a novel storage glycine-rich peptide from guava (Psidium guajava) seeds with activity against Gram-negative bacteria.	CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)CC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)O
DRAMP01016	QCIGNGGRCNENVGPPYCCSGFCLRQPGQGYGYCKNR	37	Antimicrobial peptide 1 (MJ-AMP1; Plant defensin)	P25403	Belongs to the AMP family	AMP1	Mirabilis jalapa (Garden four-o'clock)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Bridge	Not found		"Function: Possesses antifungal activity and is also active on two tested Gram-positive bacteria: but is non-toxic for Gram-negative bacteria and cultured human cells. 
Tissue specificity: Found only in seeds.
PTM: Contains three disulfide bonds 2-19; 9-23;"	Fungi: Alternaria brassicola (MIC=20 µg/ml), Ascochyta pisi (MIC=200 µg/ml), Botrytis cinerea (MIC=50 µg/ml), Cercospora beticola (MIC=10 µg/ml), Colletotrichum lindemuthianum (MIC=6 µg/ml), Fusarium culmorum (MIC=30 µg/ml), Fusarium oxysporum f.sp.pisi (MIC=15 µg/ml), Fusarium oxysporum f.sp.lycopersici (MIC=200 µg/ml), Nectria haematococca (MIC=15 µg/ml), Phoma betae (MIC=25 µg/ml), Pyrenophora tritici-repentis (MIC=300 µg/ml), Pyricularia oryzae (MIC=6 µg/ml), Rhizoctonia solani (MIC=60 µg/ml), Verticillium dahliae (MIC=12 µg/ml), Venturia inequalis (MIC=12 µg/ml).##Gram-positive bacteria: Bacillus megaterium (MIC=6 µg/ml), Sarcina lutea (MIC=100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Pyroglutamyl modification (Cyclization of a N-terminal glutamine)	Free	There are three disulfide bonds between Cys2 and Cys19, Cys9 and Cys23, Cys18 and Cys34.	L	No cytotoxicity information found	Not found	1733929##7647302	J. Biol. Chem. 1992;267:2228-2233.##Plant Mol. Biol. 1995;28:713-721.	Cammue B.P.A, de Bolle M.F.C, Terras F.R.G, Proost P, van Damme J, Rees S.B, Vanderleyden J, Broekaert W.F.##de Bolle M.F, Eggermont K, Duncan R.E, Osborn R.W, Terras F.R.G, Broekaert W.F.	Isolation and characterization of a novel class of plant antimicrobial peptides from Mirabilis jalapa L. seeds.##Cloning and characterization of two cDNA clones encoding seed-specific antimicrobial peptides from Mirabilis jalapa L.	
DRAMP01017	CIGNGGRCNENVGPPYCCSGFCLRQPNQGYGVCRNR	36	Antimicrobial peptide 2 (MJ-AMP2; Plant defensin)	P25404	Belongs to the AMP family	AMP2	Mirabilis jalapa (Garden four-o'clock)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Bridge 	Not found		Function: Possesses antifungal activity and is also active on two tested Gram-positive bacteria: but is non-toxic for Gram-negative bacteria and cultured human cells. Tissue specificity: Found only in seeds. PTM: Contains three disulfide bonds 1-18; 8-22; 	Fungi: Alternaria brassicola (MIC=6 µg/ml), Ascochyta pisi (MIC=6 µg/ml), Botrytis cinerea (MIC=2 µg/ml), Cercospora beticola (MIC=2 µg/ml), Colletotrichum lindemuthianum (MIC=1 µg/ml), Fusarium culmorum (MIC=3 µg/ml), Fusarium oxysporum f.sp.pisi (MIC=5 µg/ml), Fusarium oxysporum f.sp.lycopersici (MIC=10 µg/ml), Nectria haematococca (MIC=0.5 µg/ml), Phoma betae (MIC=6 µg/ml), Pyrenophora tritici-repentis (MIC=20 µg/ml), Pyricularia oryzae (MIC=0.5 µg/ml), Rhizoctonia solani (MIC=15 µg/ml), Verticillium dahliae (MIC=0.5 µg/ml), Venturia inequalis (MIC=1 µg/ml).##Gram-positive bacteria: Bacillus megaterium (MIC=2 µg/ml), Sarcina lutea (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization of a N-terminal Cys residue (forming a disulfide bond)	Free	There are three disulfide bonds between Cys1 and Cys18, Cys8 and Cys22, Cys17 and Cys33.	L	No cytotoxicity information found	Not found	1733929##7647302	J Biol Chem. 1992 Feb 5;267(4):2228-2233.##Plant Mol Biol. 1995 Jul;28(4):713-721.	Cammue BP, De Bolle MF, Terras FR, Proost P, Van Damme J, Rees SB, Vanderleyden J, Broekaert WF.##De Bolle MF, Eggermont K, Duncan RE, Osborn RW, Terras FR, Broekaert WF.	Isolation and characterization of a novel class of plant antimicrobial peptides form Mirabilis jalapa L. seeds.##Cloning and characterization of two cDNA clones encoding seed-specific antimicrobial peptides from Mirabilis jalapa L.	
DRAMP01018	SIPCGESCVFIPCTVTALLGCSCKSKVCYKN	31	Cyclopsychotride-A (CPT; Plant defensin)	P56872	Not found	Not found	Psychotria longipes 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Has antibiotic activity. Inhibits the cytopathic effects and replication of the human immunodeficiency virus. Active against both Gram-positive and Gram-negative bacteria.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-21; 8-23; 13-28."	Gram-negative bacteria: Escherichia coli (MIC=1.55 µM), Pseudomonas aeruginosa (MIC=13.5 µM), Proteus vulgaris (MIC=13.2 µM), Klebsiella oxytoca (MIC=5.80 µM).##Gram-positive bacteria: Staphylococcus aureus (MIC=39.0 µM), Micrococcus luteus (MIC=48.0 µM).##Fungi: Candida albicans (MIC>500 µM), Candida kefyr (MIC=14.0 µM), Candida tropicalis (MIC=56.5 µM).##NOTE: Medium with 10 mM phosphate buffer.	[Ref.10430870] HD50 = 405 μM against blood type A human erythrocytes.	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	There are three disulfide bonds between Cys4 and Cys21, Cys8 and Cys23, Cys13 and Cys28	L	[Ref.10430870] It caused 50% cell growth inhibition of mouse fibroblasts at 1850 μM.	Not found	10430870##7714530	Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8918.##J Nat Prod. 1994 Dec;57(12):1619-1625.	Tam JP, Lu YA, Yang JL, Chiu KW.##Witherup KM, Bogusky MJ, Anderson PS, Ramjit H, Ransom RW, Wood T, Sardana M. 	An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.##Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes.	
DRAMP01061	SRSELIVHQR	10	Antifungal peptide (Cm-p1; Plants)	B3EWI7	Not found	Not found	Cenchritis muricatus (Beaded periwinkle)	Antimicrobial, Antifungal	Protein level	Not found	Not found	2MP9 resolved by NMR.	Function: The synthetic peptide has antifungal activity. Has no antibacterial or cytotoxic activity.	Fungi: Botrytis cinerea (MIC=20 µM), Fusarium oxysporum (MIC=20 µM), Aspergillus niger (MIC=41 µM), Candida albicans 01U (MIC=13 µM), C. albicans 38U (MIC=7 µM), C. parapsilosis (MIC=105 µM), C. neoformans strain L26 (MIC=209 µM), C. neoformans strain L30 (MIC=209 µM), Trichophyton rubrum (MIC=3 µM).	[Ref.22210491] At the highest evaluated dose (256 μg/mL), Cm-p1 showed no signs of toxicity against human red blood cells.	Linear	Free	Free (very possibly)		L	[Ref.22210491] At the highest evaluated dose (256 μg/mL), Cm-p1 showed no signs of toxicity against RAW 264.7 cells.	Not found	22210491	Biochimie. 2012 Apr;94(4):968-974.	López-Abarrategui C, Alba A, Silva ON, Reyes-Acosta O, Vasconcelos IM, Oliveira JT, Migliolo L, Costa MP, Costa CR, Silva MR, Garay HE, Dias SC, Franco OL, Otero-González AJ.	Functional characterization of a synthetic hydrophilic antifungal peptide derived from the marine snail Cenchritis muricatus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP18193	KRFKKFFKKVKKSVKKRLKKIFKKPMVIGVTIPF	34	Cathelicidin-related peptide crotalicidin	U5KJM4	Belongs to the cathelicidin family.	Not found	Crotalus durissus terrificus (South American rattlesnake)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	alpha helical	Not found	2MWT resolved by NMR	Function: Adopts an amphipathic alpha helical conformation, that may allow to partition into the target membrane (By similarity). Hemolytic activities have been observed on mammalian cells. Expressed by the venom gland.	[Ref.25100358]Gram-negative: E.coli ATCC 25922 (MIC=0.25 μg/mL),P.aeruginosa (MIC=1 μg/mL);##Gram-positive: E.faecalis (MIC=32 μg/mL), S.aureus (MIC=32 μg/mL).	[Ref.25100358] Crotalicidin reached 10% hemolysis at 25 μM. Even so, extrapolation of existing data indicates that 50% hemolysis would be reached at near-millimolar values, which defines an adequate (~2 log) selectivity window.	Cyclic	Free	Amidation		L	No cytotoxicity information found	cell membrane	25100358	Amino Acids 46:2561-2571(2014)	Falcao C.B., de La Torre B.G., Perez-Peinado C., Barron A.E.,Andreu D., Radis-Baptista G.	Vipericidins: a novel family of cathelicidin-related peptides fromthe venom gland of South American pit vipers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C
DRAMP01064	AWKLFDDGV	9	Anticancerous peptide 1 (Cr-ACP1; Plants)	B3EWE7	Not found	Not found	Cycas revoluta (Sago palm)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Protein level	Not found	Not found		Function: The synthetic peptide inhibits cell proliferation and induces apoptosis in cancer-derived cell lines Hep2 (IC50=1.5 mM) and HCT15 and, to a lesser extent, in non-cancerous NIH/3T3 cells. The mode of action is presumably an arrest in the G0/G1 phase. Antiproliferative, proapoptotic and DNA-binding activities are increased by acetylation at Ala-1 and Lys-3. Has a weak hemolytic activity against mouse erythrocytes. Has antibacterial activity. Antibacterial activity is decreased by acetylation. 	[Ref.21882228]Gram-positive bacteria: Staphylococcus epidermidis (MIC=60 µM), Bacillus subtilis (MIC=30 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=30 µM), EEscherichia coli strain ATCC 8739 (MIC=30 µM).	[Ref.21882228] Hemocompatibility study revealed the effectiveness of both the peptides where it showed no significant lysis of normal RBC cells compare to positive control (Triton X-100). Cr-ACP1 induced hemolysis of 7% at the conentration of 1 mM.	Linear	Free	Free		L	[Ref.21882228] IC50 = 1.5 mM in Hep2 (Human epidermoid cancer cells); IC50 = 0.9 mM in HCT15 (human colon carcinoma cells HCT15); Cr-ACP1 induced a cell viability of 66% at the concentration of 4 mM.	DNA	21882228	J Cell Biochem. 2012 Jan;113(1):184-193.	Mandal SM, Migliolo L, Das S, Mandal M, Franco OL, Hazra TK.	Identification and characterization of a bactericidal and proapoptotic peptide from Cycas revoluta seeds with DNA binding properties.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)NCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP01066	PVVDTTGNNPLQQQEEYYV	19	Kunitz-type serine protease inhibitor 1 (Xb-KTI; Plants)	P86930	Not found	Not found	Xanthosoma sagittifolium (Elephant's ear) (Arum sagittifolium)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Function: Serine protease inhibitor. Displays antimicrobial activity against the Gram-negative bacterium S. typhimurium ATCC 14028. Displays a weak hemolytic activity.	[Ref.21520894]Gram-negative bacterium: Salmonella typhimurium ATCC 14028 (MIC=10 µM).	[Ref.21520894] No hemolytic activity was observed for Xb-KTI. The peptide induced a hemolysis of 12% at the highest concentration of 250 μg/mL. Values(OD540) were normalized against 100% lysed erythrocytes (0.1% Triton X-100) and PDB (untreated control)	Linear	Free	Free		L	No cytotoxicity information found	Not found	21520894	J Nat Prod. 2011 May 27;74(5):969-975.	Lima TB, Silva ON, Migliolo L, Souza-Filho CR, Gonçalves EG, Vasconcelos IM, Oliveira JT, Amaral AC, Franco OL.	A Kunitz proteinase inhibitor from corms of Xanthosoma blandum with bactericidal activity.	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP01081	GLKDIFKAGLGSLVKGIAAHVAN	23	Alyteserin-1a (toads, amphibians, animals)	No entry found	Not found	Not found	Alytes obstetricans (European midwife toad)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		"Function: The alyteserin-1 peptides show selective growth inhibitory activity against the Gram-negative bacterium Escherichia coli. The hemolytic activity against human erythrocytes of all peptides tested is relatively weak.
Structural similarity: The alyteserin-1 peptides show limited structural similarity to the ascaphins from the skins of frogs of the family Leiopelmatidae."	[Ref.19463738]Gram-negative bacterium: Escherichia coli (MIC=25 µM).	[Ref:19463738] LC50 > 100 μM against human erthrocytes. Alyteserin-1a induced a hemolysis of 11% at the concentration of 100 μM.	Linear	Free	α-Amidation		L (to be determined)	No cytotoxicity information found	Not found	19463738	Peptides. 2009 Jun;30(6):1069-1073.	Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.	The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O)C(C)C
DRAMP01082	ILGKLLSTAAGLLSNL	16	Alyteserin-2a (toads, amphibians, animals)	No entry found	Not found	Not found	Alytes obstetricans (European midwife toad)	Antimicrobial, Antibacterial, Anti-Gram+,  Cytotoxicity	Not found	Alpha helix	It is helical in 50% TFE.		"Function: The alyteserin-2a is more potent against the Gram-positive bacteria Staphylococcus aureus. The hemolytic activity against human erythrocytes of all peptides tested is relatively weak.
Structural similarity: Alyteserin-2a and alyteserin-2b and -2c show limited sequence identity with bombinin H6, present in the skins of frogs of the family Bombinatoridae."	[Ref.19463738]Gram-positive bacterium: Staphylococcus aureus (MIC=50 µM).	[Ref:19463738] LC50 = 135 μM against human erthrocytes.	Linear	Free	α-Amidation		L (to be determined)	No cytotoxicity information found	Not found	19463738	Peptides. 2009 Jun;30(6):1069-1073.	Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.	The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP01083	GLKEIFKAGLGSLVKGIAAHVAN	23	Alyteserin-1b (toads, amphibians, animals)	No entry found	Not found	Not found	Alytes obstetricans (European midwife toad)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Amtimicrobial peptide. (By similarity)	Gram-negative bacterium: Escherichia coli (MIC=25 µM).	[Ref:19463738] LC50 = 210 μM against human erthrocytes. 	Linear	Free	α-Amidation		L (to be determined)	No cytotoxicity information found	Not found	19463738	Peptides. 2009 Jun;30(6):1069-1073.	Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.	The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O)C(C)C
DRAMP01085	GLKEIFKAGLGSLVKGIAAHVAS	23	Alyteserin-1c (toads, amphibians, animals)	H0USY4	Not found	Not found	Alytes obstetricans (Common midwife toad) (Bufo obstetricans)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Alpha helix	Solution structural studies in the membrane mimicking environments, sodium dodecyl sulphate (SDS), dodecylphosphocholine (DPC), and 1,2-dihexanoyl-sn-glycero-3-phosphatidylcholine (DHPC) micelles, indicate that these peptides display an alpha helical structure between residues Lys(3) and Val(21).(Ref.1)	2L5R resolved by NMR.	Function: Alyteserin-1c shows selective growth-inhibitory activity against Gram-negative bacteria.	Gram-negative bacterium: Escherichia coli (MIC=25 µM).	[Ref:19463738] LC50 = 145 μM against human erthrocytes.	Linear	Free	α-Amidation		L (to be determined)	No cytotoxicity information found	Not found	21565166##19463738	Biochim Biophys Acta. 2011 Aug;1808(8):1975-1984.##Peptides. 2009 Jun;30(6):1069-1073.	Subasinghage AP, O'Flynn D, Conlon JM, Hewage CM.##Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.	Conformational and membrane interaction studies of the antimicrobial peptide alyteserin-1c and its analogue [E4K]alyteserin-1c.##The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)C(C)C
DRAMP01088	GFKEVLKADLGSLVKGIAAHVAN	23	Alyteserin-1Ma (toads, amphibians, animals)	No entry found	Not found	Not found	Alytes maurus (Midwife toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Alyteserin-1Ma has lower antimicrobial potencies (MIC>200 µM).	Gram-negative bacterium: Escherichia coli NCTC 10418 (MIC=214 µM) and Gram-positive bacterium: Staphylococcus aureus NCTC 10788 (MIC=214 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	α-Amidation		L	No cytotoxicity information found	Not found	22800568	Toxicon. 2012 Nov;60(6):967-981.	König E, Zhou M, Wang L, Chen T, Bininda-Emonds OR, Shaw C.	Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): Implications for the evolution of frog skin defensive secretions.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O)C(C)C
DRAMP01089	GFKEVLKAGLGSLVKGIPAHVAN	23	Alyteserin-1Mb (toads, amphibians, animals)	No entry found	Not found	Not found	Alytes maurus (Midwife toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Alyteserin-2Ma has lower antimicrobial potencies (MIC>200 µM).	Gram-negative bacterium: Escherichia coli NCTC 10418 (MIC=217 µM) and Gram-positive bacterium: Staphylococcus aureus NCTC 10788 (MIC=434 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	α-Amidation		L	No cytotoxicity information found	Not found	22800568	Toxicon. 2012 Nov;60(6):967-981.	König E, Zhou M, Wang L, Chen T, Bininda-Emonds OR, Shaw C.	Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): Implications for the evolution of frog skin defensive secretions.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O)C(C)C
DRAMP01090	FIGKLISAASGLLSHL	16	Alyteserin-2Ma (toads, amphibians, animals)	No entry found	Not found	Not found	Alytes maurus (Midwife toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial activity against the Gram-negative bacteria E. coli and Gram-positive bacteria S. aures. It only inhibits C. albicans at very high concentration of 150 microM.	Gram-negative bacterium: Escherichia coli NCTC 10418 (MIC=38.4 µM) and Gram-positive bacterium: Staphylococcus aureus NCTC 10788 (MIC=9.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	α-Amidation		L	No cytotoxicity information found	Not found	22800568	Toxicon. 2012 Nov;60(6):967-981.	König E, Zhou M, Wang L, Chen T, Bininda-Emonds OR, Shaw C.	Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): Implications for the evolution of frog skin defensive secretions.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01091	ILGAIIPLVSGLLSHL	16	Alyteserin-2Mb (toads, amphibians, animals)	No entry found	Not found	Not found	Alytes maurus (Midwife toad)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Not found	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacteria S. aures. It only inhibits C. albicans at very high concentration of 310 microM.	Gram-positive bacterium: Staphylococcus aureus NCTC 10788 (MIC=19.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	α-Amidation		L	No cytotoxicity information found	Not found	22800568	Toxicon. 2012 Nov;60(6):967-981.	König E, Zhou M, Wang L, Chen T, Bininda-Emonds OR, Shaw C.	Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): Implications for the evolution of frog skin defensive secretions.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP01096	GIGSAILSAGKSALKGLAKGLAEHFAN	27	Bombinin-like peptide 2 (BLP-2; toads, amphibians, animals)	P29003	Belongs to the bombinin family	Not found	Bombina orientalis (Oriental fire-bellied toad)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found		"Function: Has antimicrobial activity, but no hemolytic activity. Preference on killing Gram-negative non-enteric bacteria.
Tissue specificity: Expressed by the skin glands."	[Ref.1744108]Gram-negative bacterium: 58% inhibition Neisseria meningitidis 118V C (MIC=20 µg/ml), 98% inhibition Neisseria meningitidis 15240 IAI (MIC=20 µg/ml), 98% inhibition Neisseria meningitidis 126E IC1 (MIC=20 µg/ml), 97% inhibition Neisseria gonorrhoeoe F62 (MIC=20 µg/ml), 99% inhibition Neisseria Iactamica 15323 (MIC=20 µg/ml), 100% inhibition Neisseria Iactamica 15215A (MIC=20 µg/ml), 95% inhibition Neisseria cinerea 15461 (MIC=20 µg/ml).	[Ref:1744108] No significant hemolytic activity was found which suggests a selectivity for prokaryotic over eukaryotic membranes.	Cyclic	Free	Amidation		L	No cytotoxicity information found	Not found	1744108	J. Biol. Chem. 1991; 266: 23103-23111.	Gibson BW, Tang D, Mandrell R, Kelly M, Spindel ER.	Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O)[C@H](C)CC
DRAMP03017	FMPIIGRLMSGSL	13	VESP-VB1 (Insects, animals)	No entry found	Not found	Not found	vespine wasps Vespa bicolor	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antimicrobial activities against standard strains and strong antimicrobial ability against drug-resistant strains. Among the tested drug-resistant strains, Pseudemonas aeruginosa and Staphylococcus aureus were the most sensitive for this kind of antimicrobial peptide. Has a little hemolytic activity.	[Ref.18723059] Gram-negative bacterium: Escherichia coli ATCC25922(MIC=7.5μg/ml), Escherichia coli 23A(MIC=7.5μg/ml), Escherichia coli 27A(MIC=15.0μg/ml), Pseudemonas aeruginosa 3A(MIC=3.75μg/ml), Pseudemonas aeruginosa 7A(MIC=3.75μg/ml), ;## Gram-positive bacterium: Staphylococcus aureus ATCC2592(MIC=1.9μg/ml), Staphylococcus aureus 6A(MIC=3.75μg/ml), Staphylococcus aureus 15A(MIC=1.0μg/ml);## Fungus: Candida albicans ATCC2002(MIC=30.0μg/ml)	[Ref.18723059] VESP-VB1 had a little hemolytic activity of 10.2% against rabbit red blood cells, and of 3.2% against human red blood cells with peptide concentration up to 200 μg/ml	Linear	Free	Free		L	No cytotoxicity information found	Not found	18723059	Peptides. 2008 Nov;29(11):1887-1892.	Chen W, Yang X, Yang X, Zhai L, Lu Z, Liu J, Yu H.	Antimicrobial peptides from the venoms of Vespa bicolor Fabricius.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP01098	GIGAAILSAGKSALKGLAKGLAEHF	25	Bombinin-like peptide 3 (BLP-3; toads, amphibians, animals)	P29004	Belongs to the bombinin family	Not found	Bombina orientalis (Oriental fire-bellied toad)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Alpha helix	Not found		"Function: Has antimicrobial activity, but no hemolytic activity. Preference on killing Gram-negative non-enteric bacteria.
Tissue specificity: Expressed by the skin glands."	[Ref.1744108]Gram-postive bacterium:Bacillus megaterium BmII (MIC=0.3 µM), Staphylococcus aureus Cowan1 (MIC=1.7 µM);##Gram-negative bacterium:59% inhibition Neisseria meningitidis 118V C (MIC=20 µg/ml), 99% inhibition Neisseria meningitidis 15240 IAI (MIC=20 µg/ml), 99% inhibition Neisseria meningitidis 126E IC1 (MIC=20 µg/ml), 99% inhibition Neisseria gonorrhoeoe F62 (MIC=20 µg/ml), 97% inhibitionNeisseria Iactamica 15323 (MIC=20 µg/ml), 100% inhibition Neisseria Iactamica 15215A (MIC=20 µg/ml), 97% inhibition Neisseria cinerea 15461 (MIC=20 µg/ml), Escherichia coli D21 (MIC=1.7 µM), Escherichia coli D22 (MIC=1.5 µM), Yersinia pseudotubercolosis (MIC=0.6 µM), Pseudomonas aeruginosa ATCC 15692 (MIC=9.2 µM);##Fungus:Candida albicans (MIC=0.4 µM).	[Ref:1744108] No significant hemolytic activity was found which suggests a selectivity for prokaryotic over eukaryotic membranes.	Cyclic	Free	Amidation		L	No cytotoxicity information found	Not found	1744108	J Biol Chem. 1991 Dec 5;266(34):23103-23111.	Gibson BW, Tang DZ, Mandrell R, Kelly M, Spindel ER.	Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP01105	RSNKGFNFMVDMIQALSK	18	Maximin-S4 (chain of Maximins-S type B/C; toads, amphibians, animals)	Q5GC92	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Maximin-S3 has an activity against mycoplasma but has no activity against common Gram-positive and Gram-negative bacteria nor fungi. Has no hemolytic activity. Tissue specificity: Expressed by the skin dorsal glands. PTM: Lysine amide at position 18.	[Ref.15649437]Mycoplasma humenis (MIC=46 µM), Ureaplasma urealyticum (MIC=46 µM).	[Ref:15649437] Maximin S1 and S4 had no hemolytic activity.	Linear	Free	Amidation		L	No cytotoxicity information found	Not found	15649437	Biochem Biophys Res Commun. 2005 Feb 18;327(3):945-951.	Wang T, Zhang J, Shen JH, Jin Y, Lee WH, Zhang Y.	Maximins S, a novel group of antimicrobial peptides from toad Bombina maxima.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP02090	FLPMLAGLAASMVPKFVCLITKKC	24	Brevinin-1Lb (Frogs, amphibians, animals)	P82826	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana luteiventris (Spotted frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial activity against  Gram-positive and Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=8 μM);##Gram-negative bacterium: Escherichia coli (MIC=16 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There is a disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02091	FLPFIAGMAAKFLPKIFCAISKKC	24	Brevinin-1Ba (Frogs, amphibians, animals)	P82833	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana berlandieri (Rio Grande leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacteria. 
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP01829	FLPILINLIHKGLL	14	Temporin-1Lc (Temporin 1Lc; Frogs, amphibians, animals)	P82832	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana luteiventris (Spotted frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: Leucine amide at position 14. "	[Ref.10651828] Gram-positive bacterium: Staphylococcus aureus (MIC=125 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	α-Amidation		L	No cytotoxicity information found	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01828	NFLGTLINLAKKIM	14	Temporin-1Lb (Temporin 1Lb; Frogs, amphibians, animals)	P82831	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana luteiventris (Spotted frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: Methionine amide at position 14. "	[Ref.10651828] Gram-positive bacterium: Staphylococcus aureus (MIC=48 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	α-Amidation		L	No cytotoxicity information found	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCSC)C(N)=O
DRAMP01518	GILSLFTGGIKALGKTLFKMAGKAGAEHLACKATNQC	37	Esculentin-2L (Frogs, amphibians, animals)	P82827	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana luteiventris (Great Basin spotted frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=3 μM);##Gram-negative bacterium: Escherichia coli (MIC=6 μM).##Yeast: Candida albicans (MIC=53 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	There is a disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP01827	VLPLISMALGKLL	13	Temporin-1La (Temporin 1La; Frogs, amphibians, animals)	P82830	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana luteiventris (Spotted frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against  Gram-positive bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: Leucine amide at position 13. "	[Ref.10651828] Gram-positive bacterium: Staphylococcus aureus (MIC=60 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	α-Amidation		L	No cytotoxicity information found	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01517	GFSSIFRGVAKFASKGLGKDLARLGVNLVACKISKQC	37	Esculentin-2P (Frogs, amphibians, animals)	P82846	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pipiens (northern leopard frog)	Antimicrobial, Antibacterial, Anti-Gram-, Antiviral	Protein level	Not found	Not found		"Function: Antibacterial activity against  Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-negative bacterium: Escherichia coli (MIC=10 μM).##[Ref.11601906]Virus:##Frog Virus 3: 90% inhibition at 500 µM;##Channel Catfish Virus: 90% inhibition at 50 µM.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	There is a disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found in the reference(s) presented	Not found	11601906##10651828	Virology. 2001 Sep 30;288(2):351-7.##Eur J Biochem. 2000 Feb;267(3):894-900.	Chinchar VG, Wang J, Murti G, Carey C, Rollins-Smith L.##Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Inactivation of frog virus 3 and channel catfish virus by esculentin-2P and ranatuerin-2P, two antimicrobial peptides isolated from frog skin.##Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP01516	GLFSILRGAAKFASKGLGKDLTKLGVDLVACKISKQC	37	Esculentin-2B (Frogs, amphibians, animals)	P82839	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana berlandieri (Rio Grande leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi. 
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=1 μM);##Gram-negative bacterium: Escherichia coli (MIC=1 μM).##Yeast: Candida albicans (MIC=29 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	There is a disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02077	FLPIIAGIAAKVFPKIFCAISKKC	24	Brevinin-1Pb (Frogs, amphibians, animals)	Q8QFQ5	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pipiens (Northern leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=5 μM);##Gram-negative bacterium: Escherichia coli (MIC=14 μM).##Yeast: Candida albicans (MIC=7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	There is a disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	10651828##12413397	Eur J Biochem. 2000 Feb;267(3):894-900.##Biochem J. 2003 Apr 1;371(Pt 1):125-130.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.##Chen T, Farragher S.M, Bjourson A.J, Orr D.F, Rao P, Shaw C.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.##Granular gland transcriptomes in stimulated amphibian skin secretions.	
DRAMP01830	FLPIVGKLLSGLL	13	Temporin-1P (Temporin-1M; Temporin-1CSa; Frogs, amphibians, animals)	P82848	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pipiens (Northern leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacteria. 
Tissue specificity: Expressed by the skin glands.
 PTM: Leucine amide at position 13."	[Ref.10651828] Gram-positive bacterium: Staphylococcus aureus (MIC=110 µM).	[Ref.17451843] LC50 = 75 μM against human erythrocytes.	Cyclic	Free	α‐Amidation		L	No cytotoxicity information found	Not found	10651828##17451843	Eur J Biochem. 2000 Feb;267(3):894-900.##Peptides 2007; 28: 1268-1274.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.##Conlon JM, Al-Dhaheri A, Al-Mutawa E, Al-Kharrge R, Ahmed E, Kolodziejek J, Nowotny N, Nielsen PF, Davidson C.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.##Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP01151	GVGDLIRKAVSVIKNIV	17	Uperin-3.5 (toads, amphibians, animals)	P82042	Not found	Not found	Uperoleia mjobergii (Australian toadlet)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Shows antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Lactococcus lactis (MIC=3 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12.5 µg/ml), Staphylococcus aureus (MIC=50 µg/ml), Staphylococcus epidermidis (MIC=12.5 µg/ml), Streptococcus uberis (MIC=12.5 µg/ml).(Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found	Not found	PubMed ID is not available##15203252	Aust. J. Chem. 1996; 49:475-484.##Peptides. 2004 Jun;25(6):1035-1054.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C
DRAMP01152	GVIDAAKKVVNVLKNLP	17	Uperin-3.6 (toads, amphibians, animals)	P82043	Not found	Not found	Uperoleia mjobergii (Australian toadlet)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix 	In 50% (by vol.) trifluoroethanol, an NMR study and structure calculations indicate that uperin 3.6 adopts a well-defined amphipathic alpha-helix with distinct hydrophilic and hydrophobic faces.(Ref.1)		Function: Shows antibacterial activity gaginst several Gram-positive bacteria. This peptide could inhibit HIV infection at a concentration that is also toxic to T cells (J Virol 2005; 79:11598-11606).	Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Lactococcus lactis (MIC=3 µg/ml), Listeria innocua (MIC=50 µg/ml), Micrococcus luteus (MIC=25 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=12.5 µg/ml), Streptococcus uberis (MIC=12.5 µg/ml).(Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found	Not found	10461748##15203252	J Pept Res. 1999 Aug;54(2):137-145.##Peptides. 2004 Jun;25(6):1035-1054.	Chia BC, Carver JA, Mulhern TD, Bowie JH.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(N)=O)C(C)C)C(C)C)C(C)C
DRAMP01153	GVIAAAKKVVNVLKNLF	17	Ala4-uperin 3.6 (toads, amphibians, animals)	No entry found	Not found	Not found	Uperoleia mjobergii (Australian toadlet)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Shows antibacterial activity gaginst several Gram-positive bacteria.	Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=12 µg/ml), Streptococcus uberis (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found	Not found	10461748	J Pept Res. 1999 Aug;54(2):137-145.	Chia BC, Carver JA, Mulhern TD, Bowie JH.	The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)C(C)C
DRAMP01154	GVIDAAAKVVNVLKNLF	17	Ala7-uperin 3.6 (toads, amphibians, animals)	No entry found	Not found	Not found	Uperoleia mjobergii (Australian toadlet)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Shows antibacterial activity gaginst several Gram-positive bacteria.	Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Leuconostoc lactis (MIC=12 µg/ml), Streptococcus uberis (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found	Not found	10461748	J Pept Res. 1999 Aug;54(2):137-145.	Chia BC, Carver JA, Mulhern TD, Bowie JH.	The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)C(C)C
DRAMP01155	GVIDAAKKVVNVLANLF	17	Ala14-uperin 3.6 (toads, amphibians, animals)	No entry found	Not found	Not found	Uperoleia mjobergii (Australian toadlet)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Shows antibacterial activity gaginst several Gram-positive bacteria.	Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Leuconostoc lactis (MIC=12 µg/ml), Streptococcus uberis (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found	Not found	10461748	J Pept Res. 1999 Aug;54(2):137-145.	Chia BC, Carver JA, Mulhern TD, Bowie JH.	The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)C(C)C
DRAMP01162	AGRGKQGGKVRAKAKTRSSRAGLQFPVGRVHRLLRKGNY	39	Buforin-1 (Buforin I; Fragment of Histone H2A; toads, amphibians, animals)	P55897	Belongs to the histone H2A family	Not found	Bufo gargarizans (Asian toad) (Bufo bufo gargarizans)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.
PTM: Monoubiquitination of C-terminus gives a specific tag for epigenetic transcriptional repression. Following DNA double-strand breaks (DSBs), it is ubiquitinated through 'Lys-63' linkage of ubiquitin moieties."	Gram-positive bacteria: Bacillus subtilis (MIC=4 µg/ml), Staphylococcus aureus (MIC=4 µg/ml), Streptococcus mutans (MIC=8 µg/ml), Streptococcus pneumoniae (MIC=4 µg/ml), Pseudomonas putida (MIC=4 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=8 µg/ml), Salmonella typhimurium (MIC=4 µg/ml), Serratia sp. (MIC=8 µg/ml).##Fungi: Candida albicans (MIC=4 µg/ml), Cryptococcus neoformans (MIC=4 µg/ml), Saccharomyces cerevisiae (MIC=4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	①The residue at position 5 is N6-(2-hydroxyisobutyryl)lysine or N6-acetyllysine. ②The residue at position 9 is N6-(2-hydroxyisobutyryl)lysine or N6-lactoyllysine or N6-succinyllysine. ③The Lys13 has a interchain with G-Cter in ubiquitin. ④The Lys15 has a interchain with G-Cter in ubiquitin. ⑤The residue at position 36 is N6-(2-hydroxyisobutyryl)lysine.	L	No cytotoxicity information found	DNA	8573171##8946958	Biochem Biophys Res Commun. 1996 Jan 5;218(1):408-413.##FEBS Lett. 1996 Nov 25;398(1):87-90.	Park C.B, Kim M.S, Kim S.C.##Yi G.-S, Park C.B, Kim S.C, Cheong C.	A novel antimicrobial peptide from Bufo bufo gargarizans.##Solution structure of an antimicrobial peptide buforin II.	
DRAMP01163	TRSSRAGLQFPVGRVHRLLRK	21	Buforin-2 (Buforin II; Fragment of Histone H2A; toads, amphibians, animals)	P0DQL2	Belongs to the histone H2A family	Not found	Bufo gargarizans (Asian toad) (Bufo bufo gargarizans)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found		"Function: Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. Both buforin II and its derivative buforin IIb (sequence: RAGLQFPVGRLLRRLLRRLLR) showed selective anticancer activity against 62 cancer cell lines (Lee 2008 Cancer Lett 271: 47-51). Buforin II is more potent than buforin I.
PTM: Monoubiquitination of C-terminus gives a specific tag for epigenetic transcriptional repression. Following DNA double-strand breaks (DSBs), it is ubiquitinated through 'Lys-63' linkage of ubiquitin moieties."	Gram-positive bacteria: Bacillus subtilis (MIC=2 µg/ml), Staphylococcus aureus (MIC=4 µg/ml), Streptococcus mutans (MIC=2 µg/ml), Streptococcus pneumoniae (MIC=4 µg/ml), Pseudomonas putida (MIC=2 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=4 µg/ml), Salmonella typhimurium (MIC=1 µg/ml), Serratia sp. (MIC=4 µg/ml).##Fungi: Candida albicans (MIC=1 µg/ml), Cryptococcus neoformans (MIC=1 µg/ml), Saccharomyces cerevisiae (MIC=1 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	① The residue at position 21 is N6-(2-hydroxyisobutyryl)lysine	L	No cytotoxicity information found	DNA	8573171##8946958	Biochem Biophys Res Commun. 1996 Jan 5;218(1):408-413.##FEBS Lett. 1996 Nov 25;398(1):87-90.	Park C.B, Kim M.S, Kim S.C.##Yi G.-S, Park C.B, Kim S.C, Cheong C.	A novel antimicrobial peptide from Bufo bufo gargarizans.##Solution structure of an antimicrobial peptide buforin II.	
DRAMP01164	GIGALSAKGALKGLAKGLAEHFAN	24	Bombinin (toads, amphibians, animals)	P01505	Not found	Not found	Bombina variegata (Yellow-bellied toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antimicrobial and hemolytic activities.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.
Caution: Residue 20 is assigned as E by similarity to other bombin sequences instead of Z (Glutamic acid or Gutamine) given "	[Ref.8223491]Gram-negative bacterium: Escherichia coli D21 (MIC=3 µM);##Gram-positive bacterium: Staphylococcus aureus Cowan 1 (MIC=14 µM).	[Ref.8223491] The lethal concentration (LC, the lowest concentration that inhibits growth) was over 50 μM	Linear	Free	Amidation		L	No cytotoxicity information found	Not found	PubMed ID is not available##8223491	Monatsh. Chem. 1970;101:182-189.##EMBO J. 1993; 12:4829-4832.	Csordas A, Michl H.##Mignogna G, Simmaco M, Kreil G, Barra D.	Isolation and structural resolution of a haemolytically active polypeptide from the immune secretion of a European toad.##Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O
DRAMP01165	FLPVILPVIGKLLNGILGK	19	Preprotemporin-1SKa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana sakuraii (Japanese brown frog)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found	Not found	17174009	Peptides. 2007 Mar;28(3):505-514.	Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.	Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O
DRAMP01167	GILDAIKAIAKAAG	14	Hylaseptin-P1 (HSP1)	P84292	Not found	Not found	Hyla punctata (Polka-dot tree frog) (Spotted tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix 	Not found		Function: Has antibacterial and antifungal activity. A weak hemolytic activity has been detected.	[Ref.14715660]Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.1-8.0 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=48.8-64.0 µg/ml), Escherichia coli ATCC 25922 (MIC=24.4-32.0 µg/ml).	[Ref.14715660] HSP1 MIC concentration (256 μg/mL = 195.2 μM) produced 4.7% hemolysis against human erythrocytes.	Linear	Free	[Ref.11297740] Free  /  [Ref.32828849] Amidation		L	No cytotoxicity information found	Not found	14715660##32828849	"J Biol Chem. 2004 Mar 26;279(13):13018-13026. ##Biochim Biophys Acta Biomembr
. 2021 Jan 1;1863(1):183449. doi: 10.1016/j.bbamem.2020.183449. Epub 2020 Aug 21."	Prates MV, Sfor§a ML, Regis WC, Leite JR, Silva LP, Pertinhez TA, Araºjo AL, Azevedo RB, Spisni A, Bloch C Jr.##Isabela P Gomes 1, Talita L Santos 1, Amanda N de Souza 1, Lúcio O Nunes, Gabriele A Cardoso, Carolina O Matos, Lívia M F Costa, Luciano M Lião, Jarbas M Resende, Rodrigo M Verly	The NMR-derived solution structure of a new cationic antimicrobial peptide from the skin secretion of the anuran Hyla punctata.##Membrane interactions of the anuran antimicrobial peptide HSP1-NH 2: Different aspects of the association to anionic and zwitterionic biomimetic systems	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP01170	NLVSGLIEARKYLEQLHRKLKNCKV	25	Distinctin 2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Phyllomedusa distincta (Tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Alpha helix (1 helices; 17 residues)	Not found	1XKM resolved by NMR	Comment: Distinctin is constituted of two different polypeptide chains connected by an intermolecular disulphide bridge. The entry is the chain 2 of Distinctin	Note: Distinctin chain 2 links to Distinctin chain 1 to form a heterodimeric peptide to exert antibacterial function. ##Gram-positive bacteria: Enterococcus faecalis (MIC=14.5 µM), Staphylococcus aureus (MIC=28.0 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=28.0 µM), Escherichia coli (MIC=14.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	There is an intermolecular disulphide bridge between Distinctin chain 1 (Cys19) and Distinctin chain 2 (Cys22). 	L	No cytotoxicity information found	Not found	11297740	FEBS Lett. 2001 Apr 6;494(1-2):85-89.	Batista CV, Scaloni A, Rigden DJ, Silva LR, Rodrigues Romero A, Dukor R, Sebben A, Talamo F, Bloch C.	A novel heterodimeric antimicrobial peptide from the tree-frog Phyllomedusa distincta.	
DRAMP01174	GLLDFVTGVGKDIFAQLIKQI	21	Ocellatin-4 (Frogs, amphibians, animals)	P85090	Not found	Not found	Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has hemolytic activity against human erythrocytes (HC50=14.3 µM). Has antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands."	[Ref.17884127]Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=64 µM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=64 µM).	[Ref.17884127] HC50 = 14.3 μM against human O+ red blood cells	Linear	Free	Amidation		L	No cytotoxicity information found	Not found	17884127	Toxicon 2007; 50: 1095-1104.	Nascimento A et al Castro MS.	Purification, characterization and homology analysis of ocellatin 4, a cytolytic peptide from the skin secretion of the frog Leptodactylus ocellatus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP01177	GVVDILKGAAKDIAGHLASKVMNKL	25	Ocellatin-F1 (Fallaxin; Frogs, amphibians, animals)	No entry found	Not found	Not found	Leptodactylus fallax (Mountain chicken frog)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found	5U9S##5U9Y##5UA8##5U9R##5U9X##5UA7##5U9Q##5U9V##5UA6	Function: Has low hemolytic activity of fallaxin (HC50>200 µM). 	[Ref.15544856]Gram-negative bacteria: Escherichia coli (MIC=40 µM), Pseudomonas aeruginosa (MIC=80 µM), Enterobacter cloacae (MIC=20 µM), Klebsiella pneumoniae (MIC=80 µM).	[Ref:15544856]HC50>200 μM hemolytic activity of fallaxin	Linear	Free	Amidation	Free	L	[Ref.15544856]No cytotoxicity information found	Not found	15544856	Regul Pept. 2005 Jan 15;124(1-3):173-178.	Rollins-Smith LA, King JD, Nielsen PF, Sonnevend A, Conlon JM.	An antimicrobial peptide from the skin secretions of the mountain chicken frog Leptodactylus fallax (Anura:Leptodactylidae). 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP01182	GLLDTLKGAAKNVVGSLASKVMEKL	25	Ocellatin-P1 (Pentadactylin; Frogs, amphibians, animals)	No entry found	Not found	Not found	Leptodactylus pentadactylus (South American bullfrog) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=25 µM), Klebsiella pneumoniae KK3 9904 (MIC=100 µM), Enterobacter cloacae HNTCC 53001 (MIC=50 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=100 µM);##Gram-positive bacteria: Staphylococcus epidermidis RP62A (MIC=100 µM), Streptococcus Group B HNTCC 80130 (MIC=50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.16236555]No cytotoxicity information found	Not found	16236555	Comp Biochem Physiol C Toxicol Pharmacol. 2005 Aug;141(4):393-397.	King JD, Al-Ghaferi N, Abraham B, Sonnevend A, Leprince J, Nielsen PF, Conlon JM.	Pentadactylin: an antimicrobial peptide from the skin secretions of the South American bullfrog Leptodactylus pentadactylus.	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01184	GVLDILKGAAKDLAGHVATKVI	22	SPX(1-22)(truncated peptide of Syphaxin; Frogs, amphibians, animals)	No entry found	Not found	Not found	Leptodactylus syphax (Burgundy thin-toed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus ATCC 29213 (MIC=14.6 µM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=40.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.17628627]No cytotoxicity information found	Not found	17628627	Toxicon. 2007 Sep 15;50(4):572-580.	Dourado F.S, Leite J.R.S.A, Silva L.P, Melo J.A.T, Bloch C. Jr, Schwartz E.F.	Antimicrobial peptide from the skin secretion of the frog Leptodactylus syphax.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP01185	GVLDILKGAAKDLAGH	16	SPX(1-16)(truncated peptide of Syphaxin; Frogs, amphibians, animals)	No entry found	Not found	Not found	Leptodactylus syphax (Burgundy thin-toed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus ATCC 29213 (MIC=40.5 µM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=10.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.17628627]No cytotoxicity information found	Not found	17628627	Toxicon. 2007 Sep 15;50(4):572-580.	Dourado F.S, Leite J.R.S.A, Silva L.P, Melo J.A.T, Bloch C. Jr, Schwartz E.F.	Antimicrobial peptide from the skin secretion of the frog Leptodactylus syphax.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)NCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP01188	LALKSGGWLRLFGLKDKKH	19	Chensinin-1ZHa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana zhenhaiensis (Chinese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=17 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=35 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=9 µM).##Yeast: Candida albicans ATCC 2002 (MIC=35 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.22943378]No cytotoxicity information found	Not found	22943778	Zoolog Sci. 2012 Sep;29(9):553-558.	Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.	Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O
DRAMP01189	ATNIPFKVHFRCKAAFC	17	Andersonin-W1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Golden crossband frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Active against bacteria and fungi.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=23.5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC>47 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>47 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=47 µg/ml).	[Ref:22029824] It has no hemolytic activity against human red blood cells	Cyclic	Free	Cyclization (Cys12 and Cys17)	Disulfide bond between Cys12 and Cys17.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01190	AVNIPFKVHFRCKAAFC	17	Andersonin-W2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Golden crossband frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Active against bacteria and fungi.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=40.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10.1 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=20.2 µg/ml).	[Ref:22029824] It has no hemolytic activity against human red blood cells	Cyclic	Free	Cyclization (Cys12 and Cys17)	Disulfide bond between Cys12 and Cys17.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01191	GLFSKFAGKGIVNFLIEGVE	20	Andersonin-X1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Golden crossband frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Active against bacteria and fungi.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30.5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=15.3 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=15.3 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=30.5 µg/ml).	[Ref:22029824]Not found	Linear	Free	Free	Free	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(C)C
DRAMP01192	FLPKLFAKITKKNMAHIR	18	Andersonin-Y1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Golden crossband frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Active against bacteria and fungi.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=3.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=1.6 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=1.6 µg/ml).	[Ref:22029824]Not found	Linear	Free	Free	Free	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP01194	TSRCIFYRRKKCS	13	Andersonin-C1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Golden crossband frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Show hemolytic activity against human red blood cells and obvious insulin-stimulating activity at the concentration of 50 Î¼g/mL.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=30 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>120 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=30 µg/ml).	[Ref:22029824] It has 15.2±2.1% hemolytic activity at 50μg/ml against human red blood cells	Cyclic	Free	Free	Disulfide bond between Cys4 and Cys12.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	CC[C@@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)NC1=O
DRAMP01195	FIFPKKNIINSLFGR	15	Andersonin-D1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Golden crossband frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Weakly active against bacteria and fungi. Andersonin-D1 showes obvious insulin-stimulating activity at the concentration of 50 Î¼g/mL.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>126 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=16 µg/ml); ##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=16 µg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP01199	RFIYMKGFGKPRFGKR	16	Hejiangin-A1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana hejiangensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Hejiangin-A1 showes killing effects against the tested strains.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=100 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=25 µg/ml); ##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=25 µg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP01200	IPWKLPATFRPVERPFSKPFCRKD	24	Hejiangin-F1 (frog, amphibians, animals)	No entry found	Not found	Not found	Odorrana hejiangensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Weakly active against bacteria and fungi and has no hemolytic activity under the test conditions.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>100 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=100 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=100 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=100 µg/ml).	[Ref:22029824]Non-hemolytic activity against human red blood cells	Linear	Free	Free	Free	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@@H](C)O
DRAMP01201	AAPRGGKGFFCKLFKDC	17	Schmackerin-C1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana schmackeri	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Schmackerin-C1 showes killing effects against the tested strains. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=100 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=50 µg/ml); ##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=50 µg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys11 and Cys17)	Disulfide bond between Cys11 and Cys17.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01202	GLLDFAKHVIGIASKLG	17	Fallaxidin 3.2 (Frogs, amphibians, animals)	B5LUQ7, B5LUR0, B5LUR1, B5LUQ3	Not found	Not found	Litoria fallax (Eastern dwarf tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Fallaxidin-3.2 shows antibacterial activity against the Gram-positive bacteria.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Enterococcus faecalis (MIC=100 µM), Lactococcus lactis (MIC=500 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.18803332]No cytotoxicity information found	Not found	18803332	Rapid Commun Mass Spectrom. 2008 Oct;22(20):3207-3216.	Jackway RJ, Bowie JH, Bilusich D, Musgrave IF, Surinya-Johnson KH, Tyler MJ, Eichinger PC.	The fallaxidin peptides from the skin secretion of the Eastern Dwarf Tree Frog Litoria fallax. Sequence determination by positive and negative ion electrospray mass spectrometry: antimicrobial activity and cDNA cloning of the fallaxidins.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
DRAMP01203	GLLDLAKHVIGIASKL	16	Fallaxidin 3.1 (Frogs, amphibians, animals)	B5LUQ8, B5LUQ3	Not found	Not found	Litoria fallax (Eastern dwarf tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Fallaxidin-3.1 shows antibacterial activity against the Gram-positive bacteria.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Enterococcus faecalis (MIC=100 µM), Lactococcus lactis (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.18803332]No cytotoxicity information found	Not found	18803332	Rapid Commun Mass Spectrom. 2008 Oct;22(20):3207-3216.	Jackway RJ, Bowie JH, Bilusich D, Musgrave IF, Surinya-Johnson KH, Tyler MJ, Eichinger PC.	The fallaxidin peptides from the skin secretion of the Eastern Dwarf Tree Frog Litoria fallax. Sequence determination by positive and negative ion electrospray mass spectrometry: antimicrobial activity and cDNA cloning of the fallaxidins.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01204	GLLSFLPKVIGVIGHLIHPPS	21	Fallaxidin 4.1 (Frogs, amphibians, animals)	B5LUQ4	Not found	Not found	Litoria fallax (Eastern dwarf tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Fallaxidin-4.1 shows antibacterial activity against the Gram-positive bacteria. Inhibits the formation of NO by neuronal nitric oxide synthase (IC50=13.3 µM).
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Lactococcus lactis (MIC=12 µM), Micrococcus luteus (MIC=100 µM), Staphylococcus epidermidis (MIC=100 µM), Streptococcus uberis (MIC=50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Free	Free	L	[Ref.18803332]No cytotoxicity information found	Not found	18803332	Rapid Commun Mass Spectrom. 2008 Oct;22(20):3207-3216.	Jackway RJ, Bowie JH, Bilusich D, Musgrave IF, Surinya-Johnson KH, Tyler MJ, Eichinger PC.	The fallaxidin peptides from the skin secretion of the Eastern Dwarf Tree Frog Litoria fallax. Sequence determination by positive and negative ion electrospray mass spectrometry: antimicrobial activity and cDNA cloning of the fallaxidins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O
DRAMP01208	SIITMTKEAKLPQLWKQIACRLYNTC	26	Pleurain-A1 (Pleurain A1; Frogs, amphibians, animals)	A8DY01, A8DY00, A8DY02, A8DY03, A8DY04, A8DY09, A8DY10, A8DY15	Not found	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has little hemolytic activity on red blood cells.
Tissue specificity: Expressed by the skin dorsal glands."	[Ref.17764786]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=60 µg/ml), Helicobacter pylori NCTC 11637 (MIC=30 µg/ml);##Gram-positive bacteria: Bacillus dysenteriae (MIC=120 µg/ml), Staphylococcus aureus ATCC 2592 (MIC=15 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=30 µg/ml)..	[Ref:17764786] It has little hemolytic activity on red blood cells even with peptide concentration up to 200 μg/ml	Cyclic	Free	Cyclization (Cys20 and Cys26)	Disulfide bond between Cys20 and Cys26.	L	No cytotoxicity information found	Not found	17764786	Peptides. 2007 Oct;28(10):2069-2074.	Wang X, Song Y, Li J, Liu H, Xu X, Lai R, Zhang K.	A new family of antimicrobial peptides from skin secretions of Rana pleuraden	
DRAMP01209	SIITMTKEAKLPQSWKQIACRLYNTC	26	Pleurain-A2 (Pleurain A2; Frogs, amphibians, animals)	A8B5P0	Not found	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has little hemolytic activity on red blood cells.
Tissue specificity: Expressed by the skin dorsal glands."	[Ref.17764786]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=60 µg/ml), Helicobacter pylori NCTC 11637 (MIC=30 µg/ml);##Gram-positive bacteria: Bacillus dysenteriae (MIC=60 µg/ml), Staphylococcus aureus ATCC 2592 (MIC=15 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=30 µg/ml).	[Ref:17764786] It has little hemolytic activity on red blood cells even with peptide concentration up to 200 μg/ml	Cyclic	Free	Cyclization (Cys20 and Cys26)	Disulfide bond between Cys20 and Cys26.	L	No cytotoxicity information found	Not found	17764786	Peptides. 2007 Oct;28(10):2069-2074.	Wang X, Song Y, Li J, Liu H, Xu X, Lai R, Zhang K.	A new family of antimicrobial peptides from skin secretions of Rana pleuraden.	
DRAMP01214	FLGAIAAALPHVINAVTNAL	20	Kassinatuerin-2Ma (Frogs, amphibians, animals)	No entry found	Not found	Not found	Kassina maculata (African hyperoliid frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Alpha helix	Secondary structure prediction analysis revealed that virtually the entire structure of each kassinatuerin-2 related peptide is composed of alpha-helix, the helix was not amphipathic like many other amphibian skin antimicrobial peptides, in which there is a hydrophobic face and a positively charged faces the latter presumably interacting with the negatively charged glycocalyx of cell membranes.		Function: Natural kassinatuerin-2Ma and their synthetic replicates possessed relatively potent growth inhibitory activity against the Gram-positive bacterium, S. aureus, but were ineffective against the Gram-negative bacterium, E. coli at concentrations up to 200 µM and were relatively ineffective against the pathogenic yeast, C. albicans (120 µM). Also possessed hemolytic activity as demonstrated using horse erythrocytes.	[Ref.19427345]Gram-positive bacterium: Staphylococcus aureus (NCTC 10788) (MIC=16 µM);##Gram-negative bacterium: Escherichia coli (NCTC 10418) (MIC>200 µM) (MIC=120 µM);##Yeast: Candida albicans (NCPF 1467) (MIC=120 µM).	[Ref:19427345]18% hemolytic activity at 16 μM, 45–50% hemolytic activity at 120 μM against horse erythrocytes	Linear 	Free	Amidation	Free	L	[Ref.19427345]No cytotoxicity information found	Not found	19427345	Peptides. 2009 Aug;30(8):1428-1433.	Wang L, Zhou M, McGrath S, Chen T, Gorman SP, Walker B, Shaw C.	A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C
DRAMP01218	GFMKYIGPLIPHAVKAISDLI	21	Kassinatuerin-1 (Frogs, amphibians, animals)	P0C010	Not found	Not found	Kassina senegalensis (Senegal running frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found		"Function: Shows broad-spectrum antimicrobial activity.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-negative bacteria: Escherichia coli (MIC=6.25 µM), Klebsiella pneumoniae (MIC=25 µM), Enterobacter cloacae (MIC=6.25 µM), Pseudomonas aeruginosa (MIC=25 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.25 µM), Staphylococcus epidermidis (MIC=6.25 µM), Enterococcus faecalis (MIC=12.5 µM).##Yeast: Candida albicans (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.15885852]Display cytotoxicity against L929 fibroblasts (LD50=12μM).	Not found	10679222##15885852	Biochem Biophys Res Commun. 2000 Feb 16;268(2):433-436.##Peptides. 2005 Nov;26(11):2104-2110.	Mattute B, Knoop FC, Conlon JM.##Conlon JM, Abraham B, Galadari S, Knoop FC, Sonnevend A, P¡l T.	Kassinatuerin-1: a peptide with broad-spectrum antimicrobial activity isolated from the skin of the hyperoliid frog, Kassina senegalensis.##Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(N)=O
DRAMP01219	SLWENFKNAGKQFILNILDKIRCRVAGGCRT	31	Palustrin-2LTa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Hylarana latouchii (Broad-folded frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Has antibacterial avctivity.	Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=1.7 µM), Bacillus licheniformis X39 (MIC=14 µM), Psychrobacter faecalis X29 (MIC=1.7 µM).	[Ref.22426384] It has hemolytic activities (LD50=220μM) against human erythrocytes	Cyclic	Free	Free	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	22426384	Biochimie. 2012 Jun;94(6):1317-1326.	Wang H, Yu Z, Hu Y, Yu H, Ran R, Xia J, Wang D, Yang S, Yang X, Liu J.	Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC1=O
DRAMP01222	GFMDTAKNVAKNVAVTLIDKLRCKVTGGC	29	Palustrin-2AJ1 (PL2AJ1; Frogs, amphibians, animals)	G3ETQ3	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Displays broad-spectrum antibacterial activity against a range of Gram-positive and Gram-negative bacteria. Has hemolytic activity, low cytotoxicity and low antioxidant activity.
Tissue specificity: Expressed by the skin glands.
PTM: One disulfide bond (C23-C29) and Cleavage on pair of basic residues."	[Ref.21816202]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=20 µM), Enterococcus faecalis ATCC29212 (MIC=20 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=13 µM), Bacillus pyocyaneus CMCCB1010 (MIC=20 µM), Pseudomonas aeruginosa ATCC27853 (MIC=33 µM), Bacillus dysenteriae (MIC=50 µM).	[Ref:21816202] IC50=135 μM against human and rabbit erythrocytes	Cyclic	Free	Cyclization (Cys23 and Cys29)	Disulfide bond between Cys23 and Cys29.	L	[Ref.21816202] Cytotoxicity: the K562 (IC50=58μM) and HT29 mammalian cell lines(IC50=57μM).	Not found	21816202	Biochimie. 2012 Feb;94(2):328-334.	Chen Z, Yang X, Liu Z, Zeng L, Lee W, Zhang Y.	Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis.	
DRAMP01227	ALFSILRGLKKLGNMGQAFVNCKIYKKC	28	Palustrin-1b (Frogs, amphibians, animals)	P84275	Not found	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Tissue specificity: Expressed by the skin glands.	Gram-negative bacterium: Escherichia coli (MIC=8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys22 and Cys28)	Disulfide bond between Cys22 and Cys28.	L	No cytotoxicity information found	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP01228	ALSILRGLEKLAKMGIALTNCKATKKC	27	Palustrin-1c (Frogs, amphibians, animals)	P84276, A7WNV8	Not found	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Antimicrobial activity against Gram-negative bacteria E. coli. Possesses insulin-releasing activity.
Tissue specificity: Expressed by the skin glands."	Gram-negative bacterium: Escherichia coli (MIC=28 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys21 and Cys27)	Disulfide bond between Cys21 and Cys27.	L	No cytotoxicity information found	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP01229	ALSILKGLEKLAKMGIALTNCKATKKC	27	Palustrin-1d (Frogs, amphibians, animals)	P84277	Not found	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Tissue specificity: Expressed by the skin glands.	Gram-negative bacterium: Escherichia coli (MIC=28 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys21 and Cys27)	Disulfide bond between Cys21 and Cys27.	L	No cytotoxicity information found	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP01231	GFFSTVKNLATNVAGTVIDTLKCKVTGGCRS	31	Palustrin-2b (Frogs, amphibians, animals)	P84279, D3UA82	Not found	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Tissue specificity: Expressed by the skin glands.	Gram-negative bacterium: Escherichia coli (MIC=78 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O)NC(=O)CNC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O
DRAMP01232	GFMDTAKNVAKNVAATLLDKLKCKITGGC	29	Palustrin-2ISc (Frogs, amphibians, animals)	G3XHN9	Not found	Not found	Odorrana ishikawae (Ishikawa's frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=25 µM), Bacillus subtilis (MIC=12.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys23 and Cys29)	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	21867685	Biochem Biophys Res Commun. 2011 Sep 9;412(4):673-677. 	Iwakoshi-Ukena E, Soga M, Okada G, Fujii T, Sumida M, Ukena K.	Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning.	
DRAMP01233	GFLSTVKNLATNVAGTVIDTLKCKVTGGCRS	31	Palustrin-2c (Frogs, amphibians, animals)	P84280	Not found	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Tissue specificity: Expressed by the skin glands.	Gram-negative bacterium: Escherichia coli (MIC=120 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O)NC(=O)CNC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O
DRAMP01234	GIFPKIIGKGIKTGIVNGIKSLVKGVGMKVFKAGLNNIGNTGCNEDEC	48	Palustrin-3a (Frogs, amphibians, animals)	P84281	Not found	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Tissue specificity: Expressed by the skin glands.	Gram-negative bacterium: Escherichia coli (MIC=1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys43 and Cys48)	Disulfide bond between Cys43 and Cys48.	L	No cytotoxicity information found	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP01235	GIFPKIIGKGIKTGIVNGIKSLVKGVGMKVFKAGLSNIGNTGCNEDEC	48	Palustrin-3b (Frogs, amphibians, animals)	P84262	Not found	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Tissue specificity: Expressed by the skin glands.	Gram-negative bacterium: Escherichia coli (MIC=1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys43 and Cys48)	Disulfide bond between Cys43 and Cys48.	L	No cytotoxicity information found	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP01237	GFMDTAKNVAKNVAVTLLDKLKCKITGGC	29	Palustrin-2ISa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana ishikawae	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=25 µM), Staphylococcus aureus (MRSA) (MIC=100 µM), Bacillus subtilis (MIC=12.5 µM).##Yeast: Candida albicans (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys23 and Cys29)	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	21193000	Peptides. 2011 Apr;32(4):670-676. 	Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.	Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.	
DRAMP01238	GLWNSIKIAGKKLFVNVLDKIRCKVAGGCKTSPDVE	36	Palustrin-2SIb (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana ishikawae	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=6.3 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.3 µM), S. aureus (MRSA) (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	21911019	Peptides. 2011 Oct;32(10):2052-2057.	Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.2011.	Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC1=O)[C@H](C)CC)C(C)C)C(C)C
DRAMP01244	FFPIGVFCKIFKTC	14	Japonicin-1 (Frogs, amphibians, animals)	P83305	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana japonica (Japanese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Tissue specificity: Expressed by the skin dorsal glands.	Gram-negative bacterium: Escherichia coli (MIC=30 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys8 and Cys14)	Disulfide bond between Cys8 and Cys14.	L	No cytotoxicity information found	Not found	11835990	Peptides. 2002;23:419-425	Isaacson T, Soto A, Iwamuro S, Knoop FC, Conlon JM.	Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica.	
DRAMP01245	FFPLALLCKVFKKC	14	Japonicin-1CDYa (Frogs, amphibians, animals)	B3VZU2	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		"Function: Antimicrobial peptide. Lacks hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands."	[Ref.19539775]Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM);##Gram-negative bacterium: Escherichia coli (MIC=25 µM).	[Ref:19539775] HC50>300 μM against human red blood cells	Cyclic	Free	Cyclization (Cys8 and Cys14)	Disulfide bond between Cys8 and Cys14.	L	No cytotoxicity information found	Not found	19539775	Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.	Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.	Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.	
DRAMP01246	FGLPMLSILPKALCILLKRKC	21	Japonicin-2 (Frogs, amphibians, animals)	P83306	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana japonica (Japanese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Tissue specificity: Expressed by the skin glands.	Gram-negative bacterium: Escherichia coli (MIC=12 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys14 and Cys21)	Disulfide bond between Cys14 and Cys21.	L	No cytotoxicity information found	Not found	11835990	Peptides. 2002;23:419-425.	Isaacson T, Soto A, Iwamuro S, Knoop FC, Conlon JM.	Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica.	
DRAMP01248	FLIGMTHGLICLISRKC	17	Dybowskin-1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana dybowskii (Korea brown frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Dybowskin-1 has low hemolytic activity against human red blood cells (hRBCs).	[Ref.17698251]Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=12.5 µg/ml), Staphylococcus aureus KCTC3881 (MIC=25 µg/ml), Bacillus subtilis ATCC6633 (MIC=50 µg/ml), Staphylococcus epidermidis ATCC 12228 (MIC=60 µg/ml).	[Ref:17698251] It has 0.99% hemolytic activity at 100 μg/ml against huamn red blood cells	Cyclic	Free	Cyclization (Cys11 and Cys17)	Disulfide bond between Cys11 and Cys17.	L	No cytotoxicity information found	Not found	17698251	Peptides 2007; 28: 1532-1539. 	Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.	Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.	
DRAMP01249	FLIGMTQGLICLITRKC	17	Dybowskin-2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana dybowskii (Korea brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Dybowskin-2 has hemolytic activity against human red blood cells (hRBCs).	[Ref.17698251]Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=6.25 µg/ml), Staphylococcus aureus KCTC3881 (MIC=15 µg/ml), Bacillus subtilis ATCC6633 (MIC=25 µg/ml), Staphylococcus epidermidis ATCC12228 (MIC=25 µg/ml);##Gram-negative bacteria: Shigella dysenteriae ATCC9752 (MIC=50 µg/ml), Escherichia coli KCTC2433 (MIC=60 µg/ml), Klebsiella pneumoniae ATCC10031 (MIC=60 µg/ml), Proteus mirabilis ATCC25933 (MIC>100 µg/ml);##Yeast: Candida albicans ATCC36232 (MIC=100 µg/ml).	[Ref:17698251] It has 10.99% hemolytic activity at 100 μg/ml against human red blood cells	Cyclic	Free	Cyclization (Cys11 and Cys17)	Disulfide bond between Cys11 and Cys17.	L	No cytotoxicity information found	Not found	17698251	Peptides 2007; 28: 1532-1539. 	Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.	Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.	
DRAMP01250	GLFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC	33	Dybowskin-3 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana dybowskii (Korea brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Dybowskin-3 has hemolytic activity against human red blood cells (hRBCs).	[Ref.17698251]Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=39 µg/ml), Staphylococcus aureus KCTC3881 (MIC=50 µg/ml), Bacillus subtilis ATCC6633 (MIC=60 µg/ml), Staphylococcus epidermidis ATCC12228 (MIC=60 µg/ml);##Gram-negative bacteria: Shigella dysenteriae ATCC9752 (MIC=15 µg/ml), Escherichia coli KCTC2433 (MIC=15 µg/ml), Klebsiella pneumoniae ATCC10031 (MIC>100 µg/ml);##Yeast: Candida albicans ATCC36232 (MIC=100 µg/ml).	[Ref:17698251] It has 1.86% hemolytic activity at 100 μg/ml against human red blood cells	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	17698251	Peptides 2007; 28: 1532-1539. 	Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.	Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.	
DRAMP01251	VWPLGLVICKALKIC	15	Dybowskin-4 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana dybowskii (Korea brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Dybowskin-4 has relatively greater hemolytic activity against human red blood cells (hRBCs).	[Ref.17698251]Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=1.56 µg/ml), Staphylococcus aureus KCTC3881 (MIC=3.13 µg/ml), Bacillus subtilis ATCC6633 (MIC=6.25 µg/ml), Staphylococcus epidermidis ATCC12228 (MIC=6.25 µg/ml);##Gram-negative bacteria: Shigella dysenteriae ATCC9752 (MIC=30 µg/ml), Escherichia coli KCTC2433 (MIC=15 µg/ml), Klebsiella pneumoniae ATCC10031 (MIC=15 µg/ml);##Yeast: Candida albicans ATCC36232 (MIC=25 µg/ml).	[Ref:17698251] It has 47.58% hemolytic activity at 100 μg/ml against human red blood cells	Cyclic	Free	Cyclization (Cys9 and Cys15)	Disulfide bond between Cys9 and Cys15.	L	No cytotoxicity information found	Not found	17698251	Peptides 2007; 28: 1532-1539. 	Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.	Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.	
DRAMP01252	GLFSVVTGVLKAVGKNVAKNVGGSLLEQLKCKKISGGC	38	Dybowskin-5 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana dybowskii (Korea brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Dybowskin-5 has hemolytic activity against human red blood cells (hRBCs).	[Ref.17698251]Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=6.25 µg/ml), Staphylococcus aureus KCTC3881 (MIC=25 µg/ml), Bacillus subtilis ATCC6633 (MIC=50 µg/ml), Staphylococcus epidermidis ATCC12228 (MIC=50 µg/ml);##Gram-negative bacteria: Shigella dysenteriae ATCC9752 (MIC=50 µg/ml), Escherichia coli KCTC2433 (MIC=60 µg/ml), Klebsiella pneumoniae ATCC10031 (MIC=50 µg/ml);##Yeast: Candida albicans ATCC36232 (MIC=50 µg/ml).	[Ref:17698251] It has 17.84% hemolytic activity at 100 μg/ml against human red blood cells	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	17698251	Peptides 2007; 28: 1532-1539. 	Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.	Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.	
DRAMP01253	FLPLLLAGLPLKLCFLFKKC	20	Dybowskin-6 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana dybowskii (Korea brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Not found	Not found	Not found		Function: Dybowskin-6 has relatively greater hemolytic activity against human red blood cells (hRBCs).	Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=6.25 µg/ml), Staphylococcus aureus KCTC3881 (MIC=12.5 µg/ml), Bacillus subtilis ATCC6633 (MIC=50 µg/ml), Staphylococcus epidermidis ATCC12228 (MIC=50 µg/ml).##Yeast: Candida albicans (MIC=50 µg/ml).	[Ref:17698251] It has 59.39% hemolytic activity at 100 μg/ml against huamn red blood cells	Cyclic	Free	Cyclization (Cys14 and Cys20)	Disulfide bond between Cys14 and Cys20.	L	No cytotoxicity information found	[Ref:17698251]59.39% hemolytic activity at 100 μg/ml against huamn red blood cells	17698251	Peptides. 2007 Aug;28(8):1532-1539.	Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.	Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.	
DRAMP01254	IIPLPLGYFAKKT	13	Dybowskin-1CDYa (Frogs, amphibians, animals)	B5A9S9	Not found	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Tissue specificity: Expressed by the skin glands.	Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM);##Gram-negative bacterium: Escherichia coli (MIC=3 µM). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Free	Free	L	[Ref.19539775]No cytotoxicity information found	Not found	19539775	Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.	Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.	Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC
DRAMP01255	SAVGRHGRRFGLRKHRKH	18	Dybowskin-2CDYa (Chensinin-1; Frogs, amphibians, animals)	B5A9T1	Not found	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		"Function: Antimicrobial peptide. Has activity against the Gram-positive bacteria: S. aureus and the Gram-negative bacteria E. coli. Lacks hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands."	[Ref.19539775] Gram-negative bacterium: Escherichia coli (MIC=3 µM);##Gram-negative bacterium: Staphylococcus aureus (MIC=6 µM).##[Ref.19341344] Gram-positive bacteria: Staphylococcus aureus (MIC=14.4 µM), Bacillus cereus (MIC=14.4 µM), Streptococcus lactis (MIC=14.4 µM).	[Ref:19539775]HC50>300 μM against human red blood cells	Linear 	Free	Free	Free	L	[Ref.19539775]No cytotoxicity information found##[Ref.19341344]No cytotoxicity information found	Not found	19539775##19341344	Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.##Zoolog Sci. 2009 Mar;26(3):220-226.	Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.##Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y.	Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.##Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP01257	GLWSKIKAAGKEAAKAAAKAAGKAALNAVSEAV	33	Dermadistinctin-K (DD K; Frogs, amphibians, animals)	P83638	Not found	Not found	Phyllomedusa distincta (Monkey frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiprotozoal	Protein level	Alpha helix	Not found	2K9B, 2JX6 resolved by NMR.	"Function: Also has antiprotozoal activity against Trypanosoma cruzi. Decreases viability of murine peritoneal cells. Fuses to, and disrupts liposomes.
Tissue specificity: Expressed by the skin glands."	Gram-positive bacteria: Staphylococcus aureus (MIC=4.7 µM), Enterococcus faecalis (MIC>19 µM);Gram-negative bacteria: Pseudomonas aeruginosa (MIC=2.4 µM), Escherichia coli (MIC=0.6 µM).##Fungi: Candida tropicalis (MIC=10.1 µM), Candida guilliermondii (MIC=20.3 µM), Candida albicans (MIC=20.3 µM), Candida albicans ATCC 1023 (MIC=10.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.10477123]No cytotoxicity information found	liposomes	10477123	Peptides. 1999;20(6):679-686.	Batista CV, da Silva LR, Sebben A, Scaloni A, Ferrara L, Paiva GR, Olamendi-Portugal T, Possani LD, Bloch C Jr.	Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP01258	ALWKTLLKNVGKAAGKAALNAVTDMVNQ	28	Dermadistinctin-L (DD L; Frogs, amphibians, animals)	P83639	Not found	Not found	Phyllomedusa distincta (Monkey frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiprotozoal	Protein level	Alpha helix	Not found		"Function: Also has antiprotozoal activity against Trypanosoma cruzi. Decreases viability of murine peritoneal cells. Fuses to, and disrupts liposomes. Show little hemolytic activity against human red blood cells.
Tissue specificity: Expressed by the skin glands."	[Ref.10477123]Gram-positive bacteria: Staphylococcus aureus (MIC=1.3 µM), Enterococcus faecalis (MIC=10 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=40 µM), Escherichia coli (MIC=2.5 µM);##[Ref.17442605]Fungi: Candida tropicalis (MIC=10.9 µM), Candida guilliermondii (MIC=21.8 µM), Candida albicans (MIC=21.8 µM), Candida albicans ATCC 1023 (MIC=10.9 µM).	[Ref:10477123]Show some hemolytic starting at 12.5 μM against human blood	Linear	Free	Free	Free	L	[Ref.10477123]No cytotoxicity information found	liposomes	10477123##12379643##17409003##17442605	Peptides. 1999;20(6):679-686.##J Biol Chem. 2002 Dec 20;277(51):49332-49340.##Comp Biochem Physiol A Mol Integr Physiol. 2008 Nov;151(3):329-335.##Comp Biochem Physiol A Mol Integr Physiol. 2008 Nov;151(3):336-343.	Batista CV, da Silva LR, Sebben A, Scaloni A, Ferrara L, Paiva GR, Olamendi-Portugal T, Possani LD, Bloch C Jr.##Brand GD, Leite JR, Silva LP, Albuquerque S, Prates MV, Azevedo RB, Carregaro V, Silva JS, SÃ¡ VC, BrandÃ£o RA, Bloch C Jr.##Silva LP, Leite JR, Brand GD, Regis WB, Tedesco AC, Azevedo RB, Freitas SM, Bloch C Jr.##Leite JR, Brand GD, Silva LP, KÃ¼ckelhaus SA, Bento WR, AraÃºjo AL, Martins GR, Lazzari AM, Bloch C Jr.	Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.##Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells.##Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta: liposomes fusion and/or lysis investigated by fluorescence and atomic force microscopy.##Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta: Secondary structure, antimicrobial activity, and mammalian cell toxicity.	CSCC[C@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP01259	ALWKTMLKKLGTMALHAGKAAFGAAADTISQ	31	Dermadistinctin-M (DD M; Frogs, amphibians, animals)	P83640	Not found	Not found	Phyllomedusa distincta (Monkey frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands."	Gram-positive bacteria: Staphylococcus aureus (MIC=38 µM), Enterococcus faecalis (MIC>38 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=38 µM), Escherichia coli (MIC=9.7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.10477123]No cytotoxicity information found	Not found	10477123	Peptides. 1999;20(6):679-686.	Batista CV, da Silva LR, Sebben A, Scaloni A, Ferrara L, Paiva GR, Olamendi-Portugal T, Possani LD, Bloch C Jr.	Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP01260	ALWKNMLKGIGKLAGQAALGAVKTLVGAES	30	Dermadistinctin-Q1 (DD Q1; Frogs, amphibians, animals)	P83641	Not found	Not found	Phyllomedusa distincta (Monkey frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands."	Gram-positive bacteria: Staphylococcus aureus (MIC=2.7 µM), Enterococcus faecalis (MIC=22 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=5.4 µM), Escherichia coli (MIC=1.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.10477123]No cytotoxicity information found	Not found	10477123	Peptides. 1999;20(6):679-686.	Batista CV, da Silva LR, Sebben A, Scaloni A, Ferrara L, Paiva GR, Olamendi-Portugal T, Possani LD, Bloch C Jr.	Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP01261	GLWSKIKEAAKTAGLMAMGFVNDMV	25	Dermadistinctin-Q2 (DD Q2; Frogs, amphibians, animals)	P83642	Not found	Not found	Phyllomedusa distincta (Monkey frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands."	Gram-positive bacteria: Staphylococcus aureus (MIC=22 µM), Enterococcus faecalis (MIC=11 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=22 µM), Escherichia coli (MIC=5.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.10477123]To produce hemolysis more than 38 μM peptide concentrations was required. 	Not found	10477123	Peptides. 1999;20(6):679-686.	Batista CV, da Silva LR, Sebben A, Scaloni A, Ferrara L, Paiva GR, Olamendi-Portugal T, Possani LD, Bloch C Jr.	Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP01288	FLSLIPHIVSGVASIAKHF	19	Phylloseptin-1 (PSN-1; Frogs, amphibians, animals)	E3PQH3	Not found	PSN-1	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		Function: PSN-1 displayed broad-spectrum activity against a range of planktonic organisms.	S. aureus (MIC=5 µM), Escherichia coli and Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.20451254]No cytotoxicity information found	Not found	20451254	Mol Immunol. 2010 Jul;47(11-12):2030-2037.	Zhang R, Zhou M, Wang L, McGrath S, Chen T, Chen X, Shaw C.	Phylloseptin-1 (PSN-1) from Phyllomedusa sauvagei skin secretion: a novel broad-spectrum antimicrobial peptide with antibiofilm activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP01301	FLSLIPHAINAVSAIAKHN	19	Phylloseptin-1 (PS-1; Frogs, amphibians, animals)	P84566	Not found	psn1	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiprotozoal	Protein level	Alpha helix (1 helices; 14 residues)	The antimicrobial phylloseptin peptides adopt alpha-helical conformations in membrane environments which are stabilized by electrostatic interactions of the helix dipole as well as other contributions such hydrophobic and capping interactions.(Ref.2)	2JQ0 resolved by NMR.	"Function: Atomic force microscopy experiments indicated that the bacteriolytic properties of these peptides might be related to their disruptive action on the cell membrane. PS-1 did not exhibit significant hemolytic activity on human erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	[Ref.15752569]Gram-positive bacteria: Staphylococcus aureus (MIC=7.9 µM), Enterococcus faecalis (MIC=4.0 µM);##Gram-negative bacteria: Escherichia coli (MIC=7.9 µM), Psecdomonas aeruginosa (MIC=4 µM), Psecdomonas aeruginosa wt (MIC=3 µM).	[Ref:15752569]0.3% hemolytic activity at 4 μM, 0.57% hemolytic activity at 8 μM, 0.6% hemolytic activity at 16 μM, 0.98% hemolytic activity at 32 μM, 1.98% hemolytic activity at 64 μM against human red blood cells	Linear 	Free	Amidation	Free	L	[REf.15752569]No cytotoxicity information found##[Ref.18656510]No cytotoxicity information found	Cell membrane	15752569##18656510	Peptides. 2005 Apr;26(4):565-573.##Peptides. 2008 Oct;29(10):1633-1644. 	Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr.##Resende JM, Moraes CM, Prates MV, Cesar A, Almeida FC, Mundim NC, Valente AP, Bemquerer MP, PilÃ³-Veloso D, Bechinger B.	Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.##Solution NMR structures of the antimicrobial peptides phylloseptin-1, -2, and -3 and biological activity: the role of charges and hydrogen bonding interactions in stabilizing helix conformations.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(N)=O
DRAMP01302	FLSLIPHAINAVSTLVHHF	19	Phylloseptin-2 (PS-2; Frogs, amphibians, animals)	P85881, P84567, Q0VZ43	Not found	psn2	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix (1 helices; 14 residues)	The antimicrobial phylloseptin peptides adopt alpha-helical conformations in membrane environments which are stabilized by electrostatic interactions of the helix dipole as well as other contributions such hydrophobic and capping interactions.(Ref.2)	2JPY resolved by NMR.	"Function: Has antimicrobial activity. PS-2 did not exhibit significant hemolytic activity on human erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	[Ref.18656510][ATCC Strains]: Gram-positive bacteria: S. aureus (MIC=15.1 µM);##Gram-negative bacteria: Escherichia coli (MIC=60.4 µM), Klebsiella pneumoniae (MIC=60.4 µM), Pseudomonas aeruginosa (MIC=60.4 µM);##[Wild Type]: Gram-positive bacteria: S. aureus (MIC=7.6 µM), S. agalactiae (MIC=1.9 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=60.4 µM), A. calcoaceticus (MIC=3.7 µM);##Fungi: Candida albicans (MIC=15.1 µM).	[Ref:15752569]0.1% hemolytic activity at 4 μM, 0.28% hemolytic activity at 4 μM, 0.7% hemolytic activity at 8 μM, 0.8% hemolytic activity at 16 μM, 1.05% hemolytic activity at 32 μM, 2.05% hemolytic activity at 64 μM against human red blood cells	Linear 	Free	Amidation	Free	L	[REf.15752569]No cytotoxicity information found##[Ref.18656510]No cytotoxicity information found	Cell membrane	15752569##18656510	Peptides. 2005 Apr;26(4):565-573.##Peptides. 2008 Oct;29(10):1633-1644. 	Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr.##Resende JM, Moraes CM, Prates MV, Cesar A, Almeida FC, Mundim NC, Valente AP, Bemquerer MP, PilÃ³-Veloso D, Bechinger B.	Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.##Solution NMR structures of the antimicrobial peptides phylloseptin-1, -2, and -3 and biological activity: the role of charges and hydrogen bonding interactions in stabilizing helix conformations.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O)C(C)C
DRAMP01303	FLSLIPHAINAVSALANHG	19	Phylloseptin-3 (PS-3; Frogs, amphibians, animals)	P84568	Not found	psn3	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix (1 helices; 11 residues)	The antimicrobial phylloseptin peptides adopt alpha-helical conformations in membrane environments which are stabilized by electrostatic interactions of the helix dipole as well as other contributions such hydrophobic and capping interactions.(Ref.2)	2JQ1 resolved by NMR.	"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	[ATCC Strains]: Gram-positive bacteria: S. aureus (MIC=32.9 µM);##Gram-negative bacteria: Escherichia coli (MIC=65.6 µM), Klebsiella pneumoniae (MIC=65.6 µM), Pseudomonas aeruginosa (MIC=65.6 µM). NOTE: Initial inoculum of 108 cells/Ml.##[Wild Type]: Gram-positive bacteria: S. aureus (MIC=8.2 µM), S. agalactiae (MIC=4.1 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=32.8 µM), A. calcoaceticus (MIC=4.1 µM).##Fungi: Candida albicans (MIC=8.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.15752569]No cytotoxicity information found##[Ref.18656510]No cytotoxicity information found	Cell membrane	15752569##18656510	Peptides. 2005 Apr;26(4):565-573.##Peptides. 2008 Oct;29(10):1633-1644. 	Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr.##Resende JM, Moraes CM, Prates MV, Cesar A, Almeida FC, Mundim NC, Valente AP, Bemquerer MP, PilÃ³-Veloso D, Bechinger B.	Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.##Solution NMR structures of the antimicrobial peptides phylloseptin-1, -2, and -3 and biological activity: the role of charges and hydrogen bonding interactions in stabilizing helix conformations.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(N)=O)C(C)C
DRAMP01305	FLSLIPHAINAVSAIAKHFG	20	Phylloseptin-7 (PS-7; Frogs, amphibians, animals)	P84572, Q0VZ42	Not found	psn7	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity against the Gram-negative bacteria E. coli and P. aeruginosa, and the Gram-positive bacteria: S. aureus. No hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	[Ref.16963159]Gram-negative bacteria: Escherichia coli (MIC=6 µM), Pseudomonas aeruginosa (MIC=6 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM)	[Ref:16963159]Non-hemolytic activity at 6 μM against human erythrocytes	Linear 	Free	Amidation	Free	L	[Ref.16713656]No cytotoxicity information found	Not found	16963159##16713656	Peptides. 2006 Dec;27(12):3092-3999.##Peptides. 2006 Sep;27(9):2129-2136.	ConceiÃ§Ã£o K, Konno K, Richardson M, Antoniazzi MM, Jared C, Daffre S, Camargo AC, Pimenta DC.##Chen T, Zhou M, Gagliardo R, Walker B, Shaw C.	Isolation and biochemical characterization of peptides presenting antimicrobial activity from the skin of Phyllomedusa hypochondrialis.##Elements of the granular gland peptidome and transcriptome persist in air-dried skin of the South American orange-legged leaf frog, Phyllomedusa hypocondrialis.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(N)=O
DRAMP01306	FLSLIPHAINAVSAIAKHF	19	Phylloseptin-7 (PS-7; Frogs, amphibians, animals)	P85882	Not found	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity but does not inhibit the growth of the fungus C. albicans.
Tissue specificity: Expressed by the skin glands.
PTM: Phenylalanine amide at F19."	Gram-negative bacterium: Escherichia coli ATCC 11775 (MIC=7.2 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 12600 (MIC=3.6 µM), Micrococcus luteus ATCC 49732 (MIC=1.8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.16963159]No cytotoxicity information found##[Ref.17553595]No cytotoxicity information found	Not found	17553595##16963159	Peptides. 2007 Jul;28(7):1331-1343.##Peptides. 2006 Dec;27(12):3092-3099.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.##Conceição K, Konno K, Richardson M, Antoniazzi MM, Jared C, Daffre S, Camargo AC, Pimenta DC.	A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.##Isolation and biochemical characterization of peptides presenting antimicrobial activity from the skin of Phyllomedusa hypochondrialis. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP01314	FLSLLPSIVSGAVSLAKKLG	20	Phylloseptin 12 (PS-12; Frogs, amphibians, animals)	Q17UY9	Not found	psn-12	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive bacterium M. luteus. Does not inhibit the growth of the fungus C. albicans.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	Gram-positive bacterium: Micrococcus luteus ATCC 49732 (MIC=1.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.17553595]No cytotoxicity information found	Not found	17553595	Peptides. 2007 Jul;28(7):1331-1343.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)C)C(C)C
DRAMP01319	RRSRRGRGGGRRGGSGGRGGRGGGGRSGAGSSIAGVGSRGGGGGRHYA	48	Cathelicidin-AL (Gly-rich; Frogs, amphibians, animals)	No entry found	Not found	Not found	Amolops loloensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=6.25 µg/ml), Staphylococcus aureus ATCC43300 (MIC=6.25 µg/ml), Bacillus subtilis (MIC=100 µg/ml);##Gram-negative bacteria: Escherichia coli ML-35P (MIC=25 µg/ml), Psecdomonas aeruginosa PA01 (MIC=12.5 µg/ml), Psecdomonas aeruginosa ATCC27853 (MIC=6.25 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Free	Free	L	[Ref.22009138]No cytotoxic against HUVEC or  RMMCs at the concentration of 0.4 mg/ml.	Not found	22009138	Amino Acids. 2012 Aug;43(2):677-685.	Hao X, Yang H, Wei L, Yang S, Zhu W, Ma D, Yu H, Lai R.	Amphibian cathelicidin fills the evolutionary gap of cathelicidin in vertebrate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP01320	AAFRGCWTKNYSPKPCL	17	Ranacyclin-B-AL1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Amolops loloensis (Ranidae frogs)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Has antibacterial activity.	Gram-positive bacteria: Staphylococcus aureus (MIC=51 µM), Bacillus subtilis (MIC=26 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys16.	L	No cytotoxicity information found	Not found	21927839	Amino Acids. 2012 Jul;43(1):309-316.	Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.	Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.	CC(C)C[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N1)C(=O)O
DRAMP01339	FLPIVGKLLSGLSGLL	16	Amolopin-2a (Frogs, amphibians, animals)	No entry found	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-positive bacteria: Staphylococcus aureus (MIC=2.00 µg/ml), Bacillus dysenteriae (MIC=1.50 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=3.00 µg/ml).##Candida albicans (MIC=6.50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.17000029]Display cytotoxicity against HepG2(IC50=77 mg/ml).	Not found	17000029	Peptides. 2006 Dec;27(12):3085-3091. 	Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.	Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP01341	FLPLAVSLAANFLPKLFCKITKKC	24	Amolopin-1b (Frogs, amphibians, animals)	A0SN42	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-positive bacteria: Staphylococcus aureus (MIC=5.50 µg/ml), Bacillus dysenteriae (MIC=2.20 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=6.50 µg/ml).##Yeast: Candida albicans (MIC=7.50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization(Cys18 and Cys24)	Disulfide bridge between Cys18 and Cys24.	L	[Ref.17000029]Display cytotoxicity against HepG2(IC50=58 mg/ml).	Not found	17000029	Peptides. 2006 Dec;27(12):3085-3091. 	Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.	Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.	
DRAMP01346	VIGSILGALASGLPTLISWIKNR	23	Prepromelittin-related peptide (Frogs, amphibians, animals)	A7BJK5	Not found	prMRP	Rana sakuraii (Japanese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM).##Yeast: Candida albicans (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.17174009]No cytotoxicity information found##[Ref.17826868]No cytotoxicity information found	Not found	17174009##17826868	Peptides. 2007;28(3):505-514.##Peptides. 2007 Oct;28(10):2061-2068.	Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.##Suzuki H, Conlon JM, Iwamuro S.	Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.##Evidence that the genes encoding the melittin-related peptides in the skins of the Japanese frogs Rana sakuraii and Rana tagoi are not orthologous to bee venom melittin genes: developmental- and tissue-dependent gene expression.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP01347	AIGSILGALAKGLPTLISWIKNR	23	Prepromelittin-related peptide (Frogs, amphibians, animals)	A7BJK6	Not found	prMRP	Rana tagoi (Tago frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Alpha helix	Not found	6dst resolved by NMR (related PDB_ID)	Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against C. albicans.	[Ref.12804591]Gram-positive bacterium: Staphylococcus aureus (MIC=3.5 µM);##Gram-negative bacterium: Escherichia coli (MIC=20 µM).##Yeast: Candida albicans (MIC=19 µM).##EL4 T-lymphoma cells (MIC=14 µM).##[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=6.25 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli (MIC=25 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=12.5 μM)	[Ref.27271216] 100% hemolysis at 20 μM against human red blood cells	Linear	Free	Amidation	Free	L	[Ref.12804591]Display cytotoxic against L929 fibroblasts(LC50=20 μM);EL4 T-lymphoma cells(LC50=14 μM).##[Ref.27271216]L929 cells:Cell viability is approximately 10% at the concentration of 6.25 μM.	Not found	12804591##17174009##27271216	Biochem Biophys Res Commun. 2003 Jun 27;306(2):496-500.##Peptides. 2007;28(3):505-514.##Sci Rep. 2016 Jun 8;6:27394.	Conlon JM, Sonnevend A, Patel M, Camasamudram V, Nowotny N, Zilahi E, Iwamuro S, Nielsen PF, Pál T##Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.##Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji	A melittin-related peptide from the skin of the Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties##Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii##Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC
DRAMP01350	FCTMIPIPRCY	11	Tigerinin-1 (Frogs, amphibians, animals)	P82651	Not found	Not found	Rana tigerina (Indian bull frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-positive bacteria: Bacillus subtilis (MIC=30 µg/ml), Staphylococcus aureus ATCC 8530 (MIC=30 µg/ml), Micrococcus luteus MT 166 (MIC=20 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=40 µg/ml), Pseudomonas putida NCIM 2102 (MIC=40 µg/ml).##Fungi: Saccharomyces cerevisiae ATCC 8530 (MIC=80 µg/ml).	[Ref.11031261] It exhibits no hemolytic activity up to a concentration of 200 μg/ml against rat erythrocytes.	Cyclic	Free	Amidation	Disulfide bond between Cys2 and Cys10.	L	No cytotoxicity information found	Cell membrane	11031261	J Biol Chem. 2001 Jan 26;276(4):2701-2707. 	Sai KP, Jagannadham MV, Vairamani M, Raju NP, Devi AS, Nagaraj R, Sitaram N.	Tigerinins: novel antimicrobial peptides from the Indian frog Rana tigerina.	
DRAMP01351	RVCFAIPLPICH	12	Tigerinin-2 (Frogs, amphibians, animals)	P82652	Not found	Not found	Rana tigerina (Indian bull frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-positive bacteria: Bacillus subtilis (MIC=20 µg/ml), Staphylococcus aureus ATCC 8530 (MIC=40 µg/ml), Micrococcus luteus MT 166 (MIC=20 µg/ml).##Gram-negative bacteria: Pseudomonas putida NCIM 2102 (MIC=50 µg/ml), Escherichia coli (MIC=50 µg/ml).##Fungi: Saccharomyces cerevisiae ATCC 8530 (MIC=100 µg/ml).	[Ref.11031261] It exhibits no hemolytic activity up to a concentration of 200 μg/ml against rat erythrocytes.	Cyclic	Free	Amidation	Disulfide bond between Cys3 and Cys11.	L	No cytotoxicity information found	Cell membrane	11031261	J Biol Chem. 2001 Jan 26;276(4):2701-2707. 	Sai KP, Jagannadham MV, Vairamani M, Raju NP, Devi AS, Nagaraj R, Sitaram N.	Tigerinins: novel antimicrobial peptides from the Indian frog Rana tigerina.	
DRAMP01352	RVCYAIPLPICY	12	Tigerinin-3 (Frogs, amphibians, animals)	P82653	Not found	Not found	Rana tigerina (Indian bull frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-positive bacteria: Bacillus subtilis (MIC=30 µg/ml), Staphylococcus aureus ATCC 8530 (MIC=30 µg/ml), Micrococcus luteus MT 166 (MIC=30 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=40 µg/ml), Pseudomonas putida NCIM 2102 (MIC=40 µg/ml).##Fungi: Saccharomyces cerevisiae ATCC 8530 (MIC=80 µg/ml).	[Ref.11031261] It exhibits no hemolytic activity up to a concentration of 200 μg/ml against rat erythrocytes.	Cyclic	Free	Amidation	Disulfide bond between Cys3 and Cys11.	L	No cytotoxicity information found	Cell membrane	11031261	J Biol Chem. 2001 Jan 26;276(4):2701-2707. 	Sai KP, Jagannadham MV, Vairamani M, Raju NP, Devi AS, Nagaraj R, Sitaram N.	Tigerinins: novel antimicrobial peptides from the Indian frog Rana tigerina.	
DRAMP01353	RVCYAIPLPIC	11	Tigerinin-4 (Frogs, amphibians, animals)	P82654	Not found	Not found	Rana tigerina (Indian bull frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Beta strand-turn	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-positive bacterium: Staphylococcus aureus ATCC 8530 (MIC=50 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=60 µg/ml), Pseudomonas putida NCIM 2102 (MIC=60 µg/ml).##Fungi: Saccharomyces cerevisiae ATCC 8530 (MIC=100 µg/ml).	[Ref.11031261] It exhibits no hemolytic activity up to a concentration of 200 μg/ml against rat erythrocytes.	Cyclic	Free	Amidation;Cyclization (Cys3 and Cys11)	Disulfide bond between Cys3 and Cys11.	L	No cytotoxicity information found	Cell membrane	11031261	J Biol Chem. 2001 Jan 26;276(4):2701-2707. 	Sai KP, Jagannadham MV, Vairamani M, Raju NP, Devi AS, Nagaraj R, Sitaram N.	Tigerinins: novel antimicrobial peptides from the Indian frog Rana tigerina.	
DRAMP01354	LVRGCWTKSYPPKPCFVR	18	Peptide leucine arginine (pLR; Frogs, amphibians, animals)	Q90WP7, P82110	Not found	Not found	Rana pipiens (Northern leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Function: Mast cell degranulating peptide. Antiproliferative activity against human breast and ovarian tumor cell lines in vitro. Inhibits granulopoiesis in rat in vitro. Causes histamine release from rat peritoneal mast cells in vitro. Has antibacterial activity against Gram-positive bacteria: B.megaterium Bm11, S. lentus and M.luteus, and antifungal activity against C.tropicalis, C.guiller-mondii and P.nicotianae spores. Has hemolytic activity. The mature peptide inserts into the hydrophobic core of the bacterial cell membrane and increases permeability without disrupting membrane integrity. Probably binds to the outer membrane surface before aggregating to form transmembrane pores.	[Ref.11099505]Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=20 µM), Staphylococcus lentus (MIC=50 µM), Micrococcus luteus (MIC=10 µM);##Fungi: Candida tropicalis (MIC=11 µM), Candida guillermondii (MIC=6.6 µM), Phytophthora nicotianae spores (MIC=75 µM).	[Ref:11099505] It has 2.5% hemolytic activity at 100 μM against human red blood	Cyclic	Free	Free	Disulfide bond between Cys5 and Cys15.	L	No cytotoxicity information found	Not found	11099505	J. Biol. Chem. 2001;276:10145-10152.	Salmon A.L, Cross L.J.M, Irvine A.E, Lappin T.R.J, Dathe M, Krause G, Canning P, Thim L, Beyermann M, Rothemund S, Bienert M, Shaw C.	Peptide leucine arginine, a potent immunomodulatory peptide, isolated and structurally characterized from the skin of the Northern Leopard frog, Rana pipiens.	CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O)C(C)C
DRAMP01355	FLGGLIKIVPAMICAVTKKC	20	Ranalexin (Frogs, amphibians, animals)	P39084	Not found	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Potent microbicidal activity, active against S.aureus and E.coli. It acts as well as a membrane-disruptive agent at higher concentrations.
Tissue specificity: Expressed by the skin dorsal glands.
Developmental stage: Expression starts at metamorphosis and continues into adulthood.
PTM: Contains one disulfide bond 14-20."	Gram-positive bacterium: Staphylococcus aureus (MIC=4 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=32 µg/ml), Pseudomonas aeruginosa (MIC=128 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys14 and Cys20)	Disulfide bond between Cys14 and Cys20.	L	No cytotoxicity information found	Not found	8144672##9578480	J Biol Chem. 1994 Apr 8;269(14):10849-10855.##Eur J Biochem. 1998 Apr 1;253(1):221-228.	Clark DP, Durell S, Maloy WL, Zasloff M.##Vignal E, Chavanieu A, Roch P, Chiche L, Grassy G, Calas B, Aumelas A.	Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.##Solution structure of the antimicrobial peptide ranalexin and a study of its interaction with perdeuterated dodecylphosphocholine micelles.	
DRAMP03024	LKLKSIVSWAKKVL	14	Mastoparan B (MP-B; insects, arthropods, invertebrates, animals)	P21654	Not found	Not found	Vespa basalis (Hornet)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti Mammalian cells, Anti-cancer	Not found	Alpha helix	Tryptophan residue in MP		Function: Mast cell degranulating peptide. Activates G proteins that couple to phospholipase C. Has hemolytic activity.	[Ref.10667861] Gram-positive bacteria: Staphylococcus epidermidis ATTC 12228 (MIC=25 µM), Bacillus subtilis PCI 219 (MIC=25 µM), Enterococcus faecium EFMY-28 (MIC=12.5 µM);##Gram-negative bacterium: Escherichia coli NIHJ JC-2 (MIC=50 µM)	[Ref.10667861] 68.2% hemolysis at the peptide concentration of 100 µM is , 27.9% Hemolysis at 50 µM against human red blood cells.	Linear	Free	Amidation	Free	L	[Ref.10667861]No cytotoxicity information found##[Ref.8555423]No cytotoxicity information found	Not found	10667861##8555423	J Pept Res. 2000 Jan;55(1):51-62.##Biopolymers. 1995 Dec;36(6):793-801	Yu K, Kang S, Park N, Shin J, Kim Y.##Park NG, Yamato Y, Lee S, Sugihara G1995	Relationship between the tertiary structures of mastoparan B and its analogs and their lytic activities studied by NMR spectroscopy.##Interaction of mastoparan-B from venom of a hornet in Taiwan with phospholipid bilayers and its antimicrobial activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C
DRAMP01358	FLGGLFKLVPSVICAVTKKC	20	Ranalexin-Vb (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana virgatipes (Ranidae) (Aquarana)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=12 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys14 and Cys20)	Disulfide bond between Cys14 and Cys20.	L	No cytotoxicity information found	Not found	15996769	Regul Pept 2005; 131: 38-45.	Conlon JM et al Bevier CR.	Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). 	
DRAMP01359	FLGGLMKIIPAAFCAVTKKC	20	Ranalexin-1G (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana grylio (North American pig frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Homology	Not found	Not found		Function: Has growth-inhibitory activity against the gram-positive bacterium Staphylococcus aureus, the gram-negative bacterium Escherichia coli and the yeast, Candida albicans.	Gram-negative bacterium: Escherichia coli (MIC=9 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=18 µM).##Yeast: Candida albicans (MIC=70 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys14 and Cys20)	Disulfide bond between Cys14 and Cys20.	L	No cytotoxicity information found	Not found	10828493	Regul Pept. 2000 Jun 30;90(1-3):53-60.	Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.	Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.	
DRAMP01360	GLLDALSGILGL	12	Frenatin-1 (Frogs, amphibians, animals)	P82021	Not found	Not found	Litoria infrafrenata (Giant tree frog) (White-lipped tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Wide spectrum antimicrobial peptide. Considered to interact with the outer lipid layer of the bacterial cell, penetrate the bacterial membrane, form ion channels, and ultimately kill the cell.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation."	Gram-positive bacteria: Micrococcus luteus (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.9225251]No cytotoxicity information found	Not found	9225251	J Pept Sci. 1996 Mar-Apr;2(2):117-124.	Raftery MJ, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01361	GLLGTLGNLLNGLGL	15	Frenatin-2 (Frogs, amphibians, animals)	P82022	Not found	Not found	Litoria infrafrenata (Giant tree frog) (White-lipped tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Wide spectrum antimicrobial peptide. Considered to interact with the outer lipid layer of the bacterial cell, penetrate the bacterial membrane, form ion channels, and ultimately kill the cell.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation."	Gram-positive bacteria: Micrococcus luteus (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.9225251]No cytotoxicity information found	Not found	9225251	J Pept Sci. 1996 Mar-Apr;2(2):117-124.	Raftery MJ, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(N)=O
DRAMP01362	GLMSVLGHAVGNVLGGLFKS	20	Frenatin-3 (Frogs, amphibians, animals)	P56249	Not found	Not found	Litoria infrafrenata (Giant tree frog) (White-lipped tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Wide spectrum antimicrobial peptide. Considered to interact with the outer lipid layer of the bacterial cell, penetrate the bacterial membrane, form ion channels, and ultimately kill the cell.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands."	Gram-negative bacterium: Escherichia coli (MIC=50 µg/ml);##Gram-positive bacteria: Leuconostoc mesenteroides (MIC=25 µg/ml), Bacillus cereus (MIC=12.5 µg/ml), Micrococcus luteus (MIC=1.5 µg/ml), Pastewella haemolytica (MIC=0.8 µg/ml), Streptococcus uberis (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.9225251]No cytotoxicity information found	Not found	9225251	J Pept Sci. 1996 Mar-Apr;2(2):117-124.	Raftery MJ, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata.	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP01364	GLFGVLAKVAAHVVPAIAEHF	21	Maculatin-1.1 (Frogs, amphibians, animals)	P82066	Not found	Not found	Litoria genimaculata (Green-eyed tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral	Protein level	Alpha helix	Not found		"Function: Maculatin-1.1 shows significant antibacterial activity against Gram-positive bacteria, less against Gram-negative bacteria.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation."	[Ref.15203252]Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Bacillus cereus (MIC=3 µg/ml), Listeria innocua (MIC=100 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=6 µg/ml), Staphylococcus epidermidis (MIC=12 µg/ml), Streptococcus uberis (MIC=3 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=50 µg/ml). ##[Ref.16140737]Virus:HIV:inhibit 50% of PBS-treated HIV infection of T cells(IC50=11.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	No cytotoxicity information found in the reference(s) presented	Not found	16140737##9620615##15203252	J Virol. 2005 Sep;79(18):11598-606. ##J Pept Sci. 1998 Apr;4(2):111-115.##Peptides. 2004; 25: 1035-1054.	VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, Bowie JH, Tyler MJ, Conlon JM, Wade D, Aiken C, Dermody TS, KewalRamani VN, Rollins-Smith LA, Unutmaz D. ##Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.##The maculatin peptides from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP01367	GLLGLLGSVVSHVLPAITQHL	21	Maculatin-1.4 (frog, amphibia, animals)	No entry found	Not found	Not found	Litoria eucnemis (Australian anurans)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		"Function: Shows antibacterial activity against the Gram-positive bacteria.
PTM: C-terminal amidation."	Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Bacillus cereus (MIC=6 µg/ml), Listeria innocua (MIC=100 µg/ml), Micrococcus luteus (MIC=50 µg/ml), Staphylococcus aureus (MIC=50 µg/ml), Staphylococcus epidermidis (MIC=50 µg/ml), Streptococcus uberis (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.15203252]No cytotoxicity information found	Not found	15203252	Peptides. 2004 Jun; 25: 1035-1054.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP01368	GFVDFLKKVAGTIANVVT	18	Maculatin-2.1 (Frogs, amphibians, animals)	P82068	Not found	Not found	Litoria genimaculata (brown-spotted treefrog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Shows antibacterial activity against the Gram-positive bacteria.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation."	Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Micrococcus luteus (MIC=100 µg/ml), Staphylococcus aureus (MIC=100 µg/ml), Staphylococcus epidermidis (MIC=50 µg/ml), Streptococcus uberis (MIC=25 µg/ml). (Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.15203252]No cytotoxicity information found##[Ref.9620615]No cytotoxicity information found	Not found	9620615##15203252	J Pept Sci. 1998 Apr;4(2):111-115.##Peptides. 2004; 25: 1035-1054.	Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The maculatin peptides from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)C(C)C)C(C)C
DRAMP01370	MLCKLSMFGAVLGVPACAIDCLPMGKTGGSCEGGVCGCRKLTFKILWDKKFG	52	Oh-defensin (O. hainana defensin; spiders, animals)	No entry found	Not found	Not found	Ornithoctonus hainana (Venoms)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial and antifungal activities.	Gram-positive bacteria: Staphylococcus aureus (MIC=1.25 µg/ml), Bacillus cereus (MIC=25 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=1.25 µg/ml), Bacillus dysenteriae (MIC=1.25 µg/ml), Pseudomonas aeruginosa (MIC=5 µg/ml).##Yeast: Candida albicans (MIC=1.25 µg/ml).	[Ref.21538709] It has little hemolytic activity, inducing 7% hemolysis at the concentration up to 200 µg/ml (about 36 µM).	Cyclic	Free	Free	Has three disulfide bonds	L	No cytotoxicity information found	Not found	21538709	J Pept Sci. 2011 Jul;17(7):540-544. 	Zhao H, Kong Y, Wang H, Yan T, Feng F, Bian J, Yang Y, Yu H.	A defensin-like antimicrobial peptide from the venoms of spider, Ornithoctonus hainana.	
DRAMP01371	GLLSGILGAGKHIVCGLTGCAKA	23	Odorranain-NR (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Combine helix and strand structure	Odorranain-NR has a large proportion of beta-sheet. In Tris HCl + SDS, odorranain-NR has a major conformation of beta-sheet (79.2%) and a minor conformation of beta-turn (1.3%). In Tris HCl, the beta-sheet has been decreased to 57.1% and the beta-turn has been increased to 10.5%. The beta-sheet has been decreased to 39.8% in water.		"Function: Odorranain-NR exhibits antimicrobial activity against the tested strains except E. coli ATCC25922. Odorranain-NR has little hemolytic activity on red blood cells even with peptide concentration up to 100 mg/ml.
PTM: Odorranain-NR has an intramolecular disulfide-bridged hexapeptide segment, which is a new type of disulfide-bridge motif in amphibian antimicrobial peptides."	[Ref.18282640]Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=9.375 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>100 µg/ml), Bacillus dysenteriae (MIC=37.5 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=18.75 µg/ml).	[Ref:18282640] It has little hemolytic activity at 100 μg/ml against rabbit red blood cells	Cyclic	Free	Free	Disulfide bond between Cys15 and Cys20.	L	No cytotoxicity information found	Not found	18282640	Peptides. 2008 Apr;29(4):529-535. 	Che Q et al Lai R.	A novel antimicrobial peptide from amphibian skin secretions of Odorrana grahami.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC1=O)C(C)C)[C@H](C)CC
DRAMP00931	TCSYTMEA	8	Antimicrobial peptide 3 (Cn-AMP3; Plant defensin)	P86707	Not found	Not found	Cocos nucifera (Coconut palm)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.
Tissue specificity: Found in the liquid endosperm contained in green fruit of coconut palms, also known as coconut water (at protein level).
Subunit structure: Monomer."	[Ref.19111587] Gram-positive bacteria: Bacillus subtilis (MIC=257 μg/ml) and Staphylococcus aureus (MIC=274 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=302 μg/ml) and Pseudomonas aeruginosa (MIC=259 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.19111587]No cytotoxicity information found	Not found	19111587	Peptides. 2009 Apr;30(4):633-637.	Mandal SM, Dey S, Mandal M, Sarkar S, Maria-Neto S, Franco OL.	Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O
DRAMP00930	TESYFVFSVGM	11	Antimicrobial peptide 2 (Cn-AMP2; Plant defensin)	P86706	Not found	Not found	Cocos nucifera (Coconut palm)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.
Tissue specificity: Found in the liquid endosperm contained in green fruit of coconut palms, also known as coconut water (at protein level).
Subunit structure: Monomer."	[Ref.19111587] Gram-positive bacteria: Bacillus subtilis (MIC=150 μg/ml), Staphylococcus aureus (MIC=170 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=170 μg/ml), Pseudomonas aeruginosa (MIC=169 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.19111587]No cytotoxicity information found	Not found	19111587	Peptides. 2009 Apr;30(4):633-637.	Mandal SM, Dey S, Mandal M, Sarkar S, Maria-Neto S, Franco OL.	Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)O
DRAMP00929	SVAGRAQGM	9	Antimicrobial peptide 1 (Cn-AMP1; Plant defensin)	P86705	Not found	Not found	Cocos nucifera (Coconut palm)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Helix	Not found	2N0V resolved by NMR.	"Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.
Tissue specificity: Found in the liquid endosperm contained in green fruit of coconut palms, also known as coconut water (at protein level).
Subunit structure: Monomer."	[Ref.19111587] Gram-positive bacteria: Bacillus subtilis (MIC=76 μg/ml), Staphylococcus aureus (MIC=80 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=82 μg/ml), Pseudomonas aeruginosa (MIC=79 μg/ml). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.19111587]No cytotoxicity information found	Not found	19111587	Peptides. 2009 Apr;30(4):633-637.	Mandal SM, Dey S, Mandal M, Sarkar S, Maria-Neto S, Franco OL.	Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.	CSCC[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)O
DRAMP03542	HKTDSFVGLM	10	Neurokinin A (NKA; chicken, animals)	P19851	Belongs to the tachykinin family.	Not found	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Neuropeptide, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found	1N6T resolved by NMR.	"Function: Tachykinins are active peptides which excite neurons, evoke behavioral responses, are potent vasodilators and secretagogues, and contract (directly or indirectly) many smooth muscles. Antibacterial activity is very low.
PTM: Methionine amide at position 10."	[Ref.18603306] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>500 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC>500 μg/ml) ;## Gram-positive bacteria: Streptococcus mutans NCTC 10449 (MIC> 500 μg/ml), Lactobacillus acidophilus NCTC 1723 (MIC>500 μg/ml), Enterococcus faecalis NCTC 12697 (MIC>500 μg/ml), Staphylococcus aureus ATCC 25923 (MIC>500 μg/ml);## Yeast: Candida albicans NCTC 3179 (MIC>500 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.18603306]No cytotoxicity information found	Not found	18603306	J Neuroimmunol. 2008 Aug 30;200(1-2):11-16.	El Karim IA, Linden GJ, Orr DF, Lundy FT.	Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites.	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)C)C(N)=O
DRAMP03310	FLPLILRKIVTAL	13	Crabrolin (Insects, animals)	P01518 	Not found	Not found	Vespa crabro (European hornet)	Antimicrobial, Antibacterial, Anti Mammalian cells	Protein level	Helix	Not found		Function: Mast cell degranulating peptide. Induces the chemotaxis of neutrophils. Has antimicrobial and hemolytic activity.	No MICs found in DRAMP database	[Ref.6206053] Hemolysis is 20% of total at 10µg/ml against guinea pig red blood cell.	Linear	Free	Amidation	Free	L	[Ref.9273892]No cytotoxicity information found##[Ref.6206053]No cytotoxicity information found	Not found	9273892##6206053	J Pept Res. 1997 Aug;50(2):88-93.##J Biol Chem. 1984 Aug 25;259(16):10106-10111.	Krishnakumari V, Nagaraj R.##Argiolas A, Pisano JJ.	Antimicrobial and hemolytic activities of crabrolin, a 13-residue peptide from the venom of the European hornet, Vespa crabro, and its analogs.##Isolation and characterization of two new peptides, mastoparan C and crabrolin, from the venom of the European hornet, Vespa crabro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O)C(C)C)[C@H](C)CC
DRAMP02344	KVHGSLARAGK	11	40S ribosomal protein S30 (Fish, chordates, animals)	P83328	Belongs to the eukaryotic ribosomal protein eS30 family.	fau	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and low activity against Gram-negative bacteria.	[Ref.12147245] Gram-negetive bacteria: Escherichia coli (EC50>0.3 μM, MBC>0.3 μM), Listonella anguillarum (EC50>0.3 μM, MBC>0.3 μM) ;##Gram-positive bacteria: Bacillus subtilis (EC50=0.15–0.3 μM, MBC>0.3 μM), Planococcus citreus (EC50=0.02–0.04 μM, MBC=0.08 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.12147245]No cytotoxicity information found	Not found	12147245	Biochem Biophys Res Commun. 2002 Aug 9;296(1):167-171.	Fernandes JM, Smith VJ.	A novel antimicrobial function for a ribosomal peptide from rainbow trout skin.	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O
DRAMP02993	YVPLPNVPQPGRRPFPTFPGQGPFNPKIKWPQGY	34	Abaecin (Pro-rich; insects, arthropods, invertebrates, animals)	P15450?	Not found	Not found	Apis mellifera (Honeybee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Rich 	The prolines are in repeated motifs.		Function: This peptide has bactericidal activity.	[Ref.2298215] Gram-negative bacteria: Agrobacterium tumefaciens Gembloux A (MIC=25-50 µg/ml), Erwinia salicis NCPPB 2530 (MIC=25-50 µg/ml), Escherichia coli NCTC 9001 (MIC=25-50 µg/ml), Escherichia coli K514 (MIC=10-25 µg/ml), Pseudomonas syringae pv.tomato NCPPB 1105 (MIC=25-50 µg/ml), Xanthomonas campestris pv. vesicatoria LMG 905 (MIC=5-10 µg/ml);##Gram-positive bacteria: Bacillus megateriurn QMB 1551 (MIC=10-25 µg/ml), Micrococcus lysodeikticus LMG 4050 (MIC=10-25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.2298215]No cytotoxicity information found##[Ref.7961803]No cytotoxicity information found	Not found	2298215##7961803	Eur J Biochem. 1990 Jan 26;187(2):381-386.##J Biol Chem. 1994 Nov 18;269(46):28569-28575.	Casteels P, Ampe C, Riviere L, Van Damme J, Elicone C, Fleming M, Jacobs F, Tempst P.##Casteels-Josson K, Zhang W, Capaci T, Casteels P, Tempst P.	Isolation and characterization of abaecin, a major antibacterial response peptide in the honeybee (Apis mellifera).##Acute Transcriptional  Response of the Honeybee Peptide-Antibiotics Gene  Repertoire and Required Post-translational  Conversion of the Precursor Structures.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP02997	GNNRPVYIPQPRPPHPRL	18	Apidaecin-1B (Apidaecin IB; Insects, animals)	P35581, Q06602, Q06601, Q8WSY8	Belongs to the apidaecin family	Not found	Apis mellifera (Honeybee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found	4E81 resolved by X-ray.	Function: Apidaecins have bactericidal activity; predominantly against Gram-negative bacteria. They seem to interfere with cell propagation.	[Ref.2676519] Gram-negative bacteria: Agrobacterium tumefaciens (MIC=0.2 μg/ml), Erwinia salicis (MIC=0.02 μg/ml), Escherichia coli (MIC=0.1 μg/ml), Pseudomonas syringae (MIC=0.1 μg/ml), Rhizobium meliloti (MIC=0.02 μg/ml), Salmonella Newport (MIC=0.2 μg/ml), Salmonella typhimurium (MIC=0.1 μg/ml), Shigella flexneri (MIC=0.1 μg/ml);##Gram-positive bacteria: Corynebacterium insidiosum (MIC=50 μg/ml), Bacillus megaterium (MIC=100 μg/ml).##[Ref.2298215] Gram-negative bacteria: Agrobacterium tumefaciens Gembloux A (MIC≤1 µg/ml), Erwinia salicis NCPPB 2530 (MIC≤1 µg/ml), Escherichia coli NCTC 9001 (MIC≤1 µg/ml), Escherichia coli K514 (MIC=25-50 µg/ml), Pseudomonas syringae pv.tomato NCPPB 1105 (MIC≤1 µg/ml), Xanthomonas campestris pv. vesicatoria LMG 905 (MIC≥100 µg/ml);##Gram-positive bacteria: Bacillus megateriurn QMB 1551 (MIC=25-50 µg/ml), Bacillus alvei LMG 6922 (MIC=50-100 µg/ml),Micrococcus lysodeikticus LMG 4050 (MIC=25-50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.2298215]No cytotoxicity information found##[Ref.2676519]No cytotoxicity information found	Not found	2676519##2298215	EMBO J. 1989 Aug;8(8):2387-2391.##Eur J Biochem. 1990 Jan 26;187(2):381-386.	Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P.##Casteels P, Ampe C, Riviere L, Van Damme J, Elicone C, Fleming M, Jacobs F, Tempst P.	Apidaecins: antibacterial peptides from honeybees.##Isolation and characterization of abaecin, a major antibacterial response peptide in the honeybee (Apis mellifera).	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP18322	ITPATPFTPAIITEITAAVIA	21	Hominicin (Bacteriocin)	No entry found	Not found	Not found	Staphylococcus hominis MBBL 2-9	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	NMR played a critical role in establishing the peptide primary structure. While the N-terminal residue is an N,N-dimethyl Ile (DmIle), the C-terminus is a N2, N2-dimethyl-1,2-propanediamine (Dmp). In addition, threonines are dehydrated into Dhb. In this sense, this peptide may be classified as a class I variant bacteriocin.		Function: Hominicin exhibited heat stability up to 121 degrees C for 15min and activity under both acidic and basic conditions (from pH 2.0 to 10.0). Hominicin exhibited distinct structural and attractive biochemical characteristics with a high bactericidal activity against MRSA and VISA, heat-tolerance and pH stability.	[Ref.20654578] Gram-positive bacteria:  Staphylococcus aureus  (MIC=0.06 µg/ml), MRSA (MIC=0.96 µg/ml), VISA (MIC=3.82 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	1-DmIle(N,N-dimethyl Ile)-I; 2,5,8,15-DHB(dehydrated threonine)-T;21-Dmp(N2, N2-dimethyl-1,2-propanediamine)-A	L	[Ref.20654578]No cytotoxicity information found	Not found	20654578	Biochem Biophys Res Commun. 2010 Aug 20;399(2):133-138.	Kim PI, Sohng JK, Sung C, Joo HS, Kim EM, Yamaguchi T, Park D, Kim BG. 	Characterization and structure identification of an antimicrobial peptide, hominicin, produced by Staphylococcus hominis MBBL 2-9. 	
DRAMP02840	FKCRRWQWRMKKLGAPSITCVRRAF	25	Lactoferricin B (Lfcin B; mammals, animals)	P24627, E6YCQ7, B3VTM3, B9VPZ5, C7FE01, Q6LBN7, Q19KS1	Belongs to the transferrin family	LTF	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Beta strand (4 strands; 8 residues)	Residues 7-9 form beta1 and residues 17-19 form beta2 (in membrane). This contrasts with X-ray structure where residues 1-13 is helical. Thus, this peptide appears to be able to adopt a different conformation depending on environmental conditions. disulfide bond is not required for the antimicrobial potency.	1LFC resolved by NMR.	"Function: Lactoferricin B  function contributes to the antimicrobial activity. Shows a preferential cleavage at -Arg-Ser-Arg-Arg-|- and -Arg-Arg-Ser-Arg-|-, and of Z-Phe-Arg-|-aminomethylcoumarin sites.
Activity regulation: Inhibited by PMSF and Pefabloc.
PTM: Contains one disulfide bond 3-20"	[Ref.8980754] Gram-negative bacteria:  Escherichia coli L361 (MIC=4 µM or 12.5 µg/ml), Salmonella Salford (MIC=4 µM or 12.5 µg/ml), Escherichia coli O:9 (MIC=6 µM or 18.8 µg/ml), Pseudomonas ﬂuorescens (MIC=10 µM or 31.3 µg/ml)  ;##Gram-positive bacteria: Listeria monocytogenes (MIC=2 µM or 6.3 µg/ml), Staphylococcus aureus (MIC=6 µM or 18.8 µg/ml), Bacillus cereus (MIC=6 µM or 18.8 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys3 and Cys20.	L	No cytotoxicity information found	Not found	8980754##9521752##1490908 	"Antimicrob Agents Chemother. 1997 Jan;41(1):54-59. ##Biochemistry. 1998 Mar 24;37(12):4288-4298.##
J Appl Bacteriol. 1992 Dec;73(6):472-9."	Hoek KS, Milne JM, Grieve PA, Dionysius DA, Smith R. ##Hwang PM, Zhou N, Shan X, Arrowsmith CH, Vogel HJ. ##Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M.1992	"Antibacterial activity in bovine lactoferrin-derived peptides. ##Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. ##
Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. "	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)NC(=O)[C@H]([C@@H](C)O)NC1=O
DRAMP02244	GLFLDTLKGAAKDVAGKLLEGLKCKIAGCKP	31	Ranatuerin-2Ca (Ranatuerin 2Ca; Frogs, amphibians, animals)	P82878	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana clamitans (Green frog) (Lithobates clamitans)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial peptide has defense response to Gram-positive bacterium, defense response to Gram-negative bacterium, male-specific defense response to bacterium, antibacterial humoral response, antibacterial humoral response,  induced systemic resistance, antifungal innate immune response, antifungal humoral response, defense response to fungus (incompatible interaction) in GO analysis.
Tissue specificity: Expressed by the skin glands.
PTM: Disulfide bond at position 24 and 29."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys24 and Cys29.	L	No cytotoxicity information found	Not found	10822101	Peptides. 2000 Apr;21(4):469-476.	Halverson T, Basir YJ, Knoop FC, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)O)NC(=O)CNC(=O)[C@H](C)NC1=O
DRAMP01821	FLPFLASLLTKVL	13	Temporin-1Cc (Temporin 1Cc; Frogs, amphibians, animals)	P82882	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana clamitans (Green frog) (Lithobates clamitans)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against the Gram-positive bacterium Staphylococcus aureus.
Tissue specificity: Expressed by the skin glands. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10822101]No cytotoxicity information found	Not found	10822101	Peptides. 2000 Apr;21(4):469-476.	Halverson T, Basir YJ, Knoop FC, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(N)=O
DRAMP01819	FLPFLAKILTGVL	13	Temporin-1Ca (Temporin 1Ca; Frogs, amphibians, animals)	P82880	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana clamitans (Green frog) (Lithobates clamitans)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against the Gram-positive bacterium Staphylococcus aureus.
Tissue specificity: Expressed by the skin glands. 
PTM: Leucine amide at position 13."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10822101]No cytotoxicity information found	Not found	10822101	Peptides. 2000 Apr;21(4):469-476.	Halverson T, Basir YJ, Knoop FC, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)[C@@H](C)O
DRAMP01357	FLGGLMKAFPAIICAVTKKC	20	Ranalexin-1Cb (Ranatuerin 1Cb; Frogs, amphibians, animals)	P82877	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana clamitans (Green frog) (Lithobates clamitans)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial peptide has defense response to Gram-positive bacterium, defense response to Gram-negative bacterium, male-specific defense response to bacterium, antibacterial humoral response, antibacterial humoral response,  induced systemic resistance, antifungal innate immune response, antifungal humoral response, defense response to fungus (incompatible interaction) in GO analysis.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys14 and Cys20)	Disulfide bond between Cys14 and Cys20.	L	No cytotoxicity information found	Not found	10822101	Peptides. 2000 Apr;21(4):469-476.	Halverson T, Basir YJ, Knoop FC, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.	
DRAMP02246	SMLSVLKNLGKVGLGLVACKINKQC	25	Ranatuerin-1C (Ranatuerin 1C; Frogs, amphibians, animals)	P82875	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana clamitans (Green frog) (Lithobates clamitans)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. 
Tissue specificity: Expressed by the skin glands."	[Ref.10822101] Gram-positive bacterium: Staphylococcus aureus (MIC=55 μM);##Gram-negative bacterium: Escherichia coli (MIC=1.5 μM).##Yeast: Candida albicans (MIC=58 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys19 and Cys25)	Disulfide bond between Cys19 and Cys25.	L	No cytotoxicity information found	Not found	10822101	Peptides. 2000 Apr;21(4):469-476.	Halverson T, Basir YJ, Knoop FC, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.	
DRAMP01394	GLLRASSVWGRKYYVDLAGCAKA	23	Odorranain-W2 (Frogs, amphibians, animals)	A7YL71	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Shows antibacterial and antifungal activities.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 µg/ml), Bacillus dysenteriae (MIC=30 µg/ml), Helicobacter pylori NCTC 11637 (MIC=20 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=5 µg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Free	Free	L	[Ref.17698252]No cytotoxicity information found	Not found	17698252	Peptides. 2007 Aug;28(8):1527-1531. 	Chen L, Li Y, Li J, Xu X, Lai R, Zou Q.	An antimicrobial peptide with antimicrobial activity against Helicobacter pylori.	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
DRAMP01395	VVKCSYRLGSPDSQCN	16	Odorranain-A-OA1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Weakly active against bacteria and fungi.	[Ref.22029824]Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=35.2 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=35.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=17.6 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=17.6 µg/ml).	[Ref:22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Free	Disulfide bond between Cys4 and Cys15.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	CC(C)C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)CNC1=O
DRAMP01396	GFMDTAKNVAKNMAGNLLDNLKCKITKAC	29	Odorranain-F-OA1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Active against bacteria and fungi.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=10 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=2.5 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=2.5 µg/ml).	[Ref:22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys23 and Cys29)	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01397	GFMDTAKNVAKNMAVTLLDNLKCKITKAC	29	Odorranain-F-OA2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Weakly active against bacteria and fungi.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=7.5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=7.5 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3.8 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3.8 µg/ml).	[Ref:22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys23 and Cys29)	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01398	GFMDTAKNVAKNEAGNLLDNLKCKITKAC	29	Odorranain-F-OA3 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Weakly active against bacteria and fungi.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.6 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=12.6 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.3 µg/ml)；##Yeast: Candida albicans ATCC 2002 (MIC=6.3 µg/ml).	[Ref:22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys23 and Cys29)	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01399	GFMATAKNVAKNMDVTLLDNLKCKITKAC	29	Odorranain-F-OA4 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Weakly active against bacteria and fungi.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=4.1 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=4.1 µg/ml)；##Yeast: Candida albicans ATCC 2002 (MIC=4.1 µg/ml).	[Ref:22029824] Not found in the literature	Cyclic	Free	Cyclization (Cys23 and Cys29)	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP18395	FFGHLFRGIINVGKHIHGLLSG	22	moroPC-NH2 (moronecidin-like peptide; fish, animals)	No entry found	Not found	Not found	Parachaenichthys charcoti	Antimicrobial, Antibacterial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against Gram- E. cloacae ATCC 13047 (MIC 25 uM), S. sonnei (ATCC 29930) (MIC 5 uM), Psychrobacter sp. (PAMC 25501) (MIC 2.5 uM), E. coli DH5alpha (MIC 5 uM), Gram+ E. faecalis (ATCC 29212) (MIC 25 uM), S. pyogenes (ATCC 19615) (MIC 2.5 uM), S. aureus (ATCC 33591), L. monocytogenes (ATCC 15313) (MIC 5 uM), and yeast C. tropicalis (ATCC 20115) (MIC 5 uM). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.28122029]No cytotoxicity information found	Not found	28122029	PLoS One. 2017 Jan 25;12(1):e0170821.	Shin SC, Ahn IH, Ahn DH, Lee YM, Lee J, Lee JH, Kim HW, Park H	Characterization of Two Antimicrobial Peptides from Antarctic Fishes (Notothenia coriiceps and Parachaenichthys charcoti)	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(N)=O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP01401	GFMNTAKNVAKNVAVTLLDNLKCKITGGC	29	Odorranain-F-OW1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana wuchuanensis (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli (MIC=2 µM), Pseudomonas aeruginosa (MIC=4 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=4 µM).##Yeast: Candida albicans ATCC 2002 (MIC=2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys23 and Cys29)	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01402	GLFTLIKGAYKLDAPTVACN	20	Odorranain-J-OA1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Weakly active against bacteria and fungi.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=40.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=40.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=20.1 µg/ml)；##Yeast: Candida albicans ATCC 2002 (MIC=20.1 µg/ml).	[Ref:22029824]Not found	Linear	Free	Free	Free	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O
DRAMP01403	GLFTLIKGAYKNDAPTVACN	20	Odorranain-J-OA2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Weakly active against bacteria and fungi.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=40.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=40.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=20.1 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=20.1 µg/ml).	[Ref:22029824]Not found	Linear	Free	Free	Free	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O
DRAMP01409	GILSGILGVGKKLVCGLSGLC	21	Nigrocin-OR1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana rotodora (Chinese odorous frogs)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli (MIC=4 µM), Pseudomonas aeruginosa (MIC=7 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=2 µM).##Yeast: Candida albicans (MIC=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01410	GILSGILGVGKMLVCGLSGLC	21	Nigrocin-OR2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana rotodora (Chinese odorous frogs)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3 µM), Bacillus pyocyaneus CMCCB 10104 (MIC=5 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3 µM).##Yeast: Candida albicans ATCC 2002 (MIC=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01411	GILSGLLGVGKMLVCGLSGLC	21	Nigrocin-OR3 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana rotodora (Chinese odorous frogs)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3 µM), Bacillus pyocyaneus CMCCB 10104 (MIC=6 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6 µM).##Yeast: Candida albicans ATCC 2002 (MIC=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01412	GLLGSLFGAGKKVACALSGLC	21	Nigrocin-2HSa (Frogs, amphibians, animals)	P0C8U0	Not found	Not found	Odorrana hosii (Hose's rock frog) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. 
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 15-21."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=56 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=28 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01413	GLLGSIFGAGKKIACALSGLC	21	Nigrocin-2HSb (Frogs, amphibians, animals)	P0C8U1	Not found	Not found	Odorrana hosii (Hose's rock frog) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. 
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 15-21."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=28 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=14 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01414	GIFSTVFKAGKGIVCGLTGLC	21	Nigrocin-2ISa (Frogs, amphibians, animals)	F1T156	Not found	Not found	Odorrana ishikawae (Ishikawa's frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 µM), Staphylococcus aureus (MRSA) (MIC=12.5 µM), Bacillus subtilis (MIC=12.5 µM).##Yeast: Candida albicans (MIC=50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	[Ref.21193000]No cytotoxicity information found	Not found	21193000	Peptides. 2011 Apr;32(4):670-676. 	Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.	Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.	
DRAMP01415	GILGTVFKAGKGIVCGLTGLC	21	Nigrocin-2ISb (Frogs, amphibians, animals)	F1T157	Not found	Not found	Odorrana ishikawae (Ishikawa's frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-negative bacterium: Escherichia coli (MIC=50 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 µM), Staphylococcus aureus (MRSA) (MIC=12.5 µM), Bacillus subtilis (MIC=12.5 µM).##Yeast: Candida albicans (MIC=50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	21193000	Peptides. 2011 Apr;32(4):670-676. 	Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.	Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.	
DRAMP01416	GILSTVFKAGKGIVCGLSGLC	21	Nigrocin-2ISc (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana ishikawae (Ishikawa's frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=50 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=3 µM).##Yeast: Candida albicans (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	21867685	Biochem Biophys Res Commun. 2011 Sep 9;412(4):673-677. 	Iwakoshi-Ukena E, Soga M, Okada G, Fujii T, Sumida M, Ukena K.	Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning.	
DRAMP01417	GLLSGILGAGKHIVCGLSGLC	21	Nigrocin-2GRa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana grahami (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial against Gram-negative bacterium E. coli. Also has a weak hemolytic activity against human erythrocytes.	[Ref.16621155]Gram-negative bacterium: Escherichia coli (MIC=25 µM).	[Ref:16621155] LC50=295 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	16621155	Peptides. 2006 Sep;27(9):2111-2117.	Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.	Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.	
DRAMP01418	GLFGKILGVGKKVLCGLSGMC	21	Nigrocin-2GRb (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana grahami (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial against the Gram-negative bacterium E. coli and the Gram-positive bacterium S. aureus. Also has a weak hemolytic activity against human erythrocytes.	[Ref.16621155]Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 µM);##Gram-negative bacterium: Escherichia coli (MIC=3 µM);##Yeast: Candida albicans (MIC=50 µM).	[Ref:16621155] LC50=40 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	16621155	Peptides. 2006 Sep;27(9):2111-2117.	Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.	Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.	
DRAMP01419	GLLSGILGAGKNIVCGLSGLC	21	Nigrocin-2GRc (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana grahami (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial against Gram-negative bacterium E. coli. Also has a weak hemolytic activity against human erythrocytes.	[Ref.16621155]Gram-negative bacterium: Escherichia coli (MIC=50 µM).	[Ref:16621155] LC50>500 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	16621155	Peptides. 2006 Sep;27(9):2111-2117.	Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.	Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.	
DRAMP01420	GLLSGILGAGKHIICGLSGLC	21	Nigrocin-OG4 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-negative bacterium: Escherichia coli (MIC>100 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC>100 µg/ml), Bacillus subtilis (MIC>100 µg/ml).##Yeast: Candida albicans (MIC=1.10 µg/ml).	[Ref.17272268] RCH=65.5 ± 7.7% against rabbit red blood cells at 50 μg/ml. RCH, red cell hemolysis.	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01421	GLLSGILGAGKQKVCGLSGLC	21	Nigrocin-OG5 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-negative bacterium: Escherichia coli (MIC=9.37 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=18.75 µg/ml), Bacillus subtilis (MIC=37.50 µg/ml).##Yeast: Candida albicans (MIC=4.68 µg/ml).	[Ref.17272268] RCH=87.2 ± 2.6% against rabbit red blood cells at 50 μg/ml. RCH, red cell hemolysis.	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01422	GLLSGVLGVGKKVLCGLSGLC	21	Nigrosin-OG21 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-negative bacterium: Escherichia coli (MIC=4.68 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=9.37 µg/ml), Bacillus subtilis (MIC=18.75 µg/ml).##Yeast: Candida albicans (MIC=4.68 µg/ml).	[Ref.17272268] RCH=100% against rabbit red blood cells at 50 μg/ml. RCH, red cell hemolysis.	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01423	GLLSGILGAGKHIVCGLSGLR	21	Nigrosin-OG13 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-negative bacterium: Escherichia coli (MIC=4.68 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=9.37 µg/ml), Bacillus subtilis (MIC=18.75 µg/ml).##Yeast: Candida albicans (MIC=1.10 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.17272268]No cytotoxicity information found	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@H](C)CC
DRAMP01426	GLLSGVLGVGKKIVCGLSGLC	21	Nigrocin-1-OA1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	[Ref.22029824]Gram-negative bacteria: Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=10.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10.4 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=5.2 µg/ml).	[Ref:22029824] Not found in the literature	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01427	GIFGKILGVGKKTLCELSGMC	21	Nigrocin-1-OA2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.3 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=6.3 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.3 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3.2 µg/ml).	[Ref:22029824] Not found in the literature	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01428	GIFLKVLGVGKKVLCGVSGLC	21	Nigrocin-1-OA3 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10.8 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=21.6 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=5.4 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=10.8 µg/ml).	[Ref:22029824] Not found in the literature	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01429	GLISGILGVGKKLVCGLSGLC	21	Nigrocin-1-OR1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=23 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=5.8 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=11.5 µg/ml).	[Ref:22029824] Not found in the literature	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01430	GLISGILGVGKMLVCGLSGLC	21	Nigrocin-1-OR2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8.6 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=17.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=8.6 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=8.6 µg/ml)	[Ref:22029824] Not found in the literature	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01431	GLISGLLGVGKMLVCGLSGLC	21	Nigrocin-1-OR3 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=20.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=20.4 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=10.2 µg/ml).	[Ref:22029824] Not found in the literature	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01432	GILGNIVGMGKKIVCGLSGLC	21	Nigrocin-1-OW2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=12.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.2 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3.1 µg/ml).	[Ref:22029824] Not found in the literature	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01433	GILGNIVGMGKKVVCGLSGLC	21	Nigrocin-1-OW3 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.3 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=22.6 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11.3 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=6.7 µg/ml).	[Ref:22029824] Not found in the literature	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01434	GILSGVLGMGKKIVCGLRGLC	21	Nigrocin-1-OW4 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=7.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=14.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3.6 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=7.2 µg/ml).	[Ref:22029824] Not found in the literature	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01435	GILGNIVGMGKQVVCGLSGLC	21	Nigrocin-1-OW5 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=10.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=5.1 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=5.1 µg/ml).	[Ref:22029824] Not found in the literature	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP01436	GILSGVLGMGKKIVCGLSGLC	21	Nigrocin-1-OW1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4.4 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=8.8 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=8.8 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=4.4 µg/ml).	[Ref:22029824] Not found in the literature	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.	
DRAMP18394	RLNTTFRPLNFKMLRFWGQNRNIMKHRGQKVHFSLILSDCKTNKDCPKLRRANVRCRKSYCVPI	64	NCR335 (nodule-specific cysteine-rich peptides; plants)	No entry found	Not found	Not found	Medicago truncatula	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against S. enterica (MIC 16 uM) and L. monocytogenes (MIC 32 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys40 and Cys61,Cys46 and Cys56.	L	[Ref.28167938]No cytotoxicity information found	Not found	28167938	Front Microbiol. 2017 Jan 23;8:51.	Farkas A, Mar	Comparative Analysis of the Bacterial Membrane Disruption Effect of Two Natural Plant Antimicrobial Peptides.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CCCN3C2=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(C)C)C(=O)O
DRAMP01438	GIFGKILGAGKKVLCGLSGLC	21	Nigrocin-2JDa (Frogs, amphibians, animals)	B3A0M6	Not found	Not found	Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. Has hemolytic activity against rabbit erythrocytes. 
PTM: contains one disulfide bond 15-21. "	[Ref.22917879]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=16 µM), Staphylococcus aureus CIB 85462 (MIC=8 µM);##Gram-negative bacteria: Escherichia coli ATCC 25992 (MIC=16 µM), Escherichia coli CIB 84492 (MIC=16 µM);##Yeast: Candida albicans (MIC=63 µM).	[Ref:22917879] It has 80.3 ± 5.5% hemolytic activity at 128 μg/ml against rabbit red blood cells	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22917879	J Proteomics. 2012 Oct 22;75(18):5807-5821.	Liu J, Jiang J, Wu Z, Xie F.	Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: De novo sequencing and analysis of tandem mass spectrometry data.	
DRAMP01439	GIFGKILGVGKKVLCGLSGMC	21	Nigrocin-2JDb (Odorranain-H2; Frogs, amphibians, animals)	B3A0M7	Not found	Not found	Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. Has hemolytic activity against rabbit erythrocytes.
PTM: contains one disulfide bond 15-21. "	[Ref.22917879]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=15 µM), Staphylococcus aureus CIB 85462 (MIC=15 µM);##Gram-negative bacteria: Escherichia coli ATCC 25992 (MIC=8 µM), Escherichia coli CIB 84492 (MIC=8 µM);##Yeast: Candida albicans (MIC=31 µM).	[Ref:22917879] It has 88.4 ± 4.2% hemolytic activity at 128 μg/ml against rabbit red blood cells	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	22917879	J Proteomics. 2012 Oct 22;75(18):5807-5821.	Liu J, Jiang J, Wu Z, Xie F.	Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: De novo sequencing and analysis of tandem mass spectrometry data.	
DRAMP01440	GILSGILGMGKKLVCGLSGLC	21	Nigrocin-2LVb (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana livida (Chinese Odorrana frogs)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. 	Gram-positive bacterium: Staphylococcus aureus (MIC=50 µM);##Gram-negative bacterium: Escherichia coli (MIC=15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	20158520	FEBS J. 2010 Mar;277(6):1519-1531.	Wang L, Evaristo G, Zhou M, Pinkse M, Wang M, Xu Y, Jiang X, Chen T, Rao P, Verhaert P, Shaw C.	Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.	
DRAMP01441	SILSGNFGVGKKIVCGLSGLC	21	Nigrocin-2VB (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana livida (Chinese Odorrana frogs)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial activity against the Gram-negative bacterium E. coli. 	Gram-negative bacterium: Escherichia coli (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	20158520	FEBS J. 2010 Mar;277(6):1519-1531.	Wang L, Evaristo G, Zhou M, Pinkse M, Wang M, Xu Y, Jiang X, Chen T, Rao P, Verhaert P, Shaw C.	Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.	
DRAMP01442	GILSGILGAGKSLVCGLSGLC	21	Nigrocin-2SCa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana schmackeri (Chinese Odorrana frogs)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial activity against the Gram-negative bacterium E. coli. 	Gram-negative bacterium: Escherichia coli (MIC=50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	20158520	FEBS J. 2010 Mar;277(6):1519-1531.	Wang L, Evaristo G, Zhou M, Pinkse M, Wang M, Xu Y, Jiang X, Chen T, Rao P, Verhaert P, Shaw C.	Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.	
DRAMP01443	GILSNVLGMGKKIVCGLSGLC	21	Nigrocin-2SCc (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana schmackeri (Chinese Odorrana frogs)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial activity against the Gram-negative bacterium E. coli. 	Gram-negative bacterium: Escherichia coli (MIC=70 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Not found	20158520	FEBS J. 2010 Mar;277(6):1519-1531.	Wang L, Evaristo G, Zhou M, Pinkse M, Wang M, Xu Y, Jiang X, Chen T, Rao P, Verhaert P, Shaw C.	Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.	
DRAMP01447	GFSSIFRGVAKFASKGLGKDLAKLGVDLVACKISKQC	37	Esculentin-2CHa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Lithobates chiricahuensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: E. coli (MIC=5 µM), K. pneumoniae (MIC=5 µM), P. aeruginosa (MIC=5 µM);##Gram-positive bacterium: S. aureus (MIC=5 µM).##Yeast: C. albicans (MIC=10 µM).	[Ref.21262304] LC50=150 µM against human erythrocytes	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	21262304	Peptides. 2011 Apr;32(4):664-669.	Conlon JM, Mechkarska M, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.	Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.	
DRAMP01452	RISFKKGKGSWIKNGLIKGIKGLGKEISLDVIRTGIDIAGCKIKGEC	47	Esculentin-1LTa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Hylarana latouchii (Broad-folded frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=0.6 µM), Bacillus licheniformis X39 (MIC=10 µM), Staphylococcus carnosus KHS (MIC=1.3 µM), Rhodococcus rhodochrous X15 (MIC=0.3 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=5 µM), Serratia rubidaea X01 (MIC=10 µM), Psychrobacter faecalis X29 (MIC=0.6 µM).##Yeast: Candida albicans ATCC2002 (MIC=80 µM).	[Ref.22426384] LD50>480 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys41 and Cys47)	Disulfide bond between Cys41 and Cys47.	L	No cytotoxicity information found	Not found	22426384	Biochimie. 2012 Jun;94(6):1317-1326.	Wang H, Yu Z, Hu Y, Yu H, Ran R, Xia J, Wang D, Yang S, Yang X, Liu J.	Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.	
DRAMP01453	GIFSLFKAGAKFFGKHLLKQAGKAGAEHLACKATNQC	37	Esculentin-2LTa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Hylarana latouchii (Broad-folded frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=1.6 µM), Bacillus licheniformis X39 (MIC=3.2 µM), Staphylococcus carnosus KHS (MIC=3.2 µM), Rhodococcus rhodochrous X15 (MIC=0.8 µM);##Gram-negative bacterium: Psychrobacter faecalis X29 (MIC=1.6 µM). 	[Ref.22426384] LD50>600 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	22426384	Biochimie. 2012 Jun;94(6):1317-1326.	Wang H, Yu Z, Hu Y, Yu H, Ran R, Xia J, Wang D, Yang S, Yang X, Liu J.	Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.	
DRAMP01454	GLFTLIKGAAKLIGKTVAKEAGKTGLELMACKITNQC	37	Esculentin-2JDa (Frogs, amphibians, animals)	B3A0M8	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity against E. coli and S. aureus strains (Probable).
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 31-37."	Gram-negative bacteria: Escherichia coli (ATCC 25922) (MIC=34 µg/ml), Extended-spectrum ÃŸ-lactamases E. coli (ESBL) (MIC=34 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (ATCC 25923) (MIC=8 µg/ml), Methicillin-resistant S. aureus (MRSA) (MIC=8 µg/ml). 	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	22917879	J Proteomics. 2012 Oct 22;75(18):5807-5821.	Liu J, Jiang J, Wu Z, Xie F.	Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: de novo sequencing and analysis of tandem mass spectrometry data.	
DRAMP01456	GLFSILKGVGKIALKGLAKNMGKMGLDLVSCKISKEC	37	Esculentin-2PLa (Frogs, amphibians, animals)	A7WNV5, D3UA57	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity against the Gram-negative bacterium E. coli, the Gram-positive bacterium: S. aureus and the yeast C. albicans.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 31-37."	Gram-negative bacterium: Escherichia coli (MIC=1 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=10 µM).##Yeast: Candida albicans (MIC=49 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP01457	GIFSKFAGKGIKDLIIKGVKGIAKEAGMDVIRTGIDIAGCKIKGEC	46	Esculentin-1V (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana hainanensis (Chinese frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Shows antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli.	Gram-positive bacterium: Staphylococcus aureus FDA 209P (MIC=4.9 µM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=3.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	16427248	Genomics. 2006 May;87(5):638-644.	Chen T, Zhou M, Chen W, Lorimer J, Rao P, Walker B, Shaw C.	Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.	
DRAMP01458	GIFTLFKGAAKLLGKTLAKEAGKTGLELMACKVTNQC	37	Esculentin-2V (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana hainanensis (Chinese frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Shows antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli.	Gram-positive bacterium: Staphylococcus aureus FDA 209P (MIC=4.4 µM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=2.8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	16427248	Genomics. 2006 May;87(5):638-644.	Chen T, Zhou M, Chen W, Lorimer J, Rao P, Walker B, Shaw C.	Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.	
DRAMP01461	GLFSKFAGKGIKNMIIKGIKGIGKEVGMDVIRTGIDVAGCKIKGEC	46	Esculentin-1S (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana schmackeri (piebald odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Shows antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli.	Gram-positive bacterium: Staphylococcus aureus FDA 209P (MIC=3 µM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=1.7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	16427248	Genomics. 2006 May;87(5):638-644.	Chen T, Zhou M, Chen W, Lorimer J, Rao P, Walker B, Shaw C.	Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.	
DRAMP01462	GLFTLIKGAVKMIGKTVAKEAGKTGLELMACKVTNQC	37	Esculentin-2S (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana schmackeri (piebald odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Shows antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli.	Gram-positive bacterium: Staphylococcus aureus FDA 209P (MIC=2.6 µM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=1.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	16427248	Genomics. 2006 May;87(5):638-644.	Chen T, Zhou M, Chen W, Lorimer J, Rao P, Walker B, Shaw C.	Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.	
DRAMP01469	GIFALIKTAAKFVGKNLLKQAGKAGLEHLACKANNQC	37	Esculentin-2-Ala (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops loloensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Esculentin-2-Ala exhibits hemolytic activity against rabbit red blood cells.	[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2.5 µg/mL), Bacillus dysenteriae (MIC=7.5 µg/mL), Bacillus cereus (MIC=7.5 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=12.5 µg/mL), Bacillus pumilus (MIC=2.5 µg/mL), Acinetobacter calcoaceticus (MIC=25 µg/mL), Psecdomonas aeruginosa (MIC=50 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=2.5 µg/mL)	[Ref:19843479] It has 22% hemolytic activity at 100 μg/mL against rabbit red blood cells	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloen.	
DRAMP01470	GIFSLIKTAAKFVGKNLLKQAGKAGVEHLACKANNQC	37	Esculentin-2-ALb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops loloensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Esculentin-2-Alb exhibits hemolytic activity against rabbit red blood cells.	[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=1.25 µg/mL), Bacillus pumilus (MIC=2.5 µg/mL), Bacillus cereus (MIC=7.5 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=12.5 µg/mL), Bacillus dysenteriae (MIC=7.5 µg/mL), Acinetobacter calcoaceticus (MIC=12.5 µg/mL), Psecdomonas aeruginosa (MIC=50 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=2.5 µg/mL).	[Ref:19843479] It has 17% hemolytic activity at 100 μg/mL against rabbit red blood cells	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloen.	
DRAMP01471	GLFPKINKKKAKTGVFNIIKTVGKEAGMDLIRTGIDTIGCKIKGEC	46	Esculentin-1PLa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (North American pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Shows antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli.	Gram-negative bacterium: Escherichia coli (MIC=1 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP01472	GIFTKINKKKAKTGVFNIIKTIGKEAGMDVIRAGIDTISCKIKGEC	46	Esculentin-1PLb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (North American pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Shows antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli.	Gram-negative bacterium: Escherichia coli (MIC=1 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP18393	AVKPKTAKPKTAKPKTA	17	VK6 (histone derived; reptiles; animals)	No entry found	Not found	Not found	blood plasma, Komodo dragon, Varanus komodoensis	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against P. eruginosa ATCC9027 (EC50 3.6 uM) and S. aureus ATCC 25923 (EC50 3.3 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.28164707]No cytotoxicity information found	Not found	28164707	J Proteome Res. 2017 Apr 7;16(4):1470-1482.	Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML	Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry	CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP01474	GIFSKINKKKAKTGLFNIIKTVGKEAGMDVIRAGIDTISCKIKGEC	46	Esculentin-1ARa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana areolata (crawfish frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Esculentin-1ARa has antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. Also exhibits hemolytic activity against human erythrocytes (HC50=180 µM).	[Ref.12429503]Gram-negative bacterium: Escherichia coli (MIC=2 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=13 µM).	[Ref:12429503] HC50=180 µM against human erythrocytes	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	12429503	Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.	Ali MF, Lips KR, Knoop FC, Fritzsch B, Miller C, Conlon JM.	Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.	
DRAMP01475	GLFPKFNKKKVKTGIFDIIKTVGKEAGMDVLRTGIDVIGCKIKGEC	46	Esculentin-1ARb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana areolata (crawfish frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Esculentin-1ARb has antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. Also exhibits hemolytic activity against human erythrocytes (HC50=120 µM).	[Ref.12429503]Gram-negative bacterium: Escherichia coli (MIC=3 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=60 µM).	[Ref:12429503] HC50=120 µM against human erythrocytes	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	12429503	Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.	Ali MF, Lips KR, Knoop FC, Fritzsch B, Miller C, Conlon JM.	Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.	
DRAMP01476	GIFSLIKGAAQLIGKTVAKEAGKTGLELMACKVTKQC	37	Esculentin-2HSa (Frogs, amphibians, animals)	P0C8T9	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana hosii (Hose's rock frog) (Rana hosii)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 31-37."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=32 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=16 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473.	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01477	GIFSKFGGKAIKNLFIKGAKNIGKEVGMDVIRTGIDVAGCKIKGEC	46	Esculentin-1HSa (Frogs, amphibians, animals)	P0C8T8	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana hosii (Hose's rock frog) (Odorrana hosii)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 40-46."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=12 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01479	GLFSKLNKKKIKSGLIKIIKTAGKEAGLEALRTGIDVIGCKIKGEC	46	Esculentin-1CPa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates capito (North American New World frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Active against bacteria and fungi.	[Ref.19635516]Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=50 µM);##Yeast: Candida albicans (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	19635516	Peptides. 2009 Oct;30(10):1775-1781.	Conlon JM, Meetani MA, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.	Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae).	
DRAMP01480	GFFSLIKGVAKIATKGLAKNLGKMGLDLVGCKISKEC	37	Esculentin-2CPa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates capito (North American New World frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Active against bacteria and fungi.	[Ref.19635516]Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=50 µM);##Yeast: Candida albicans (MIC=25 µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	19635516	Peptides. 2009 Oct;30(10):1775-1781.	Conlon JM, Meetani MA, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.	Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae).	
DRAMP01482	GIFSKFAGKGIKNLLVKGVKNIGKEVGMDVIRTGIDIAGCKIKGEC	46	Esculentin-1ISa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana ishikawae (Japanese Endangered frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Shows antibacterial activity.	Gram-negative bacterium: Escherichia coli (MC=6.3 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 µM), Staphylococcus aureus (MRSA) (MIC=25 µM), Bacillus subtilis (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	21193000	Peptides. 2011 Apr;32(4):670-676. 	Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.	Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.	
DRAMP01483	RIFSKIGGKAIKNLILKGIKNIGKEVGMDVIRTGIDVAGCKIKGEC	46	Esculentin-1ISb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana ishikawae (Japanese Endangered frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity.	Gram-negative bacterium: Escherichia coli (MC=3.1 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 µM), Staphylococcus aureus (MRSA) (MIC=12.5 µM), Bacillus subtilis (MIC=12.5 µM).##Yeast: Candida albicans (MIC=50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	21193000	Peptides. 2011 Apr;32(4):670-676. 	Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.	Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.	
DRAMP01484	GIFSLIKGAAKLITKTVAKEAGKTGLELMACKVTNQC	37	Esculentin-2ISa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana ishikawae (Japanese Endangered frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity.	Gram-negative bacterium: Escherichia coli (MC=12.5 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 µM), Staphylococcus aureus (MRSA) (MIC=25 µM), Bacillus subtilis (MIC=6.3 µM).##Yeast: Candida albicans (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	21193000	Peptides. 2011 Apr;32(4):670-676. 	Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.	Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.	
DRAMP01486	GLFSKFAGKGIKNLIFKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC	46	Esculentin-1GRa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grahami (Odorrana andersonii)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity, also activity against fungus C. albicans.	Gram-negative bacterium: Escherichia coli (MIC=6 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 µM).##Yeast: Candida albicans (MIC>50 µM).	[Ref.16621155] LC50=210 μM against human erythrocytes. 	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	16621155	Peptides 2006; 27: 2111-2117.	Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.	Antimicrobial peptides from diverse families isolated from the skin of the Asia frog, Rana Grahami.	
DRAMP01490	GILSLVKGVAKLAGKGLAKEGGKFGLELIACKIAKQC	37	Esculentin-2A (Frogs, amphibians, animals)	P40845	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (European Edible frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species.	[Ref.8163497]Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.2 µM), Staphylococcus aureus Cowan 1 (MIC=0.8 µM);##Gram-negative bacteria: Escherichia coli D21 (MIC=0.4 µM), Pseudomonas aeruginosa ATCC15692 (MIC=3.5 µM).	[Ref:8163497] Not found in the literature	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	8163497	J Biol Chem. 1994 Apr 22;269(16):11956-11961.	Simmaco M, Mignogna G, Barra D, Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP01491	GIFSKLAGKKLKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC	46	Esculentin-1B (Frogs, amphibians, animals)	P40844	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (European Edible frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli D21 (MIC=0.2 µM), Pseudomonas aeruginosa ATCC15692 (MIC=0.7 µM);##Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.1 µM), Staphylococcus aureus cowan I (MIC=0.4 µM).##Fungi: Candida albicans (MIC=0.5 µM), Saccharomyces cerevisiae (MIC=0.9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	[Ref.8163497]No cytotoxicity information found	Not found	8163497	J Biol Chem. 1994 Apr 22;269(16):11956-11961.	Simmaco M, Mignogna G, Barra D, Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP01493	GLFSKFVGKGIKNFLIKGVKHIGKEVGMDVIRVGIDVAGCKIKGVC	46	Esculentin-1-OA1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-positive bacteria: Bacillus pyocyaneus CMCCB 10104 (MIC=1.2 µg/mL), Staphylococcus aureus ATCC 25923 (MIC=1.2 µg/mL).##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=1.2 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=2.4 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01494	GLFSKFSGKGIKNFLIKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC	46	Esculentin-1-OA2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=2.5 µg/mL);##Gram-positive bacteria: Bacillus pyocyaneus CMCCB 10104 (MIC=2.5 µg/mL), Staphylococcus aureus ATCC 25923 (MIC=1.3 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=1.3 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01495	GLFSKFAGKGIKDLIFKGVKHIGKEVGMDVIRVGIDVAGCKIKGVC	46	Esculentin-1-OA3 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=5.4 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=5.4 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=2.7 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=2.7 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01496	GLFTKFAGKGIKDLIFKGVKHIGKEVGMDVIRVGIDVAGCKIKGVC	46	Esculentin-1-OA4 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=5.6 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2.8 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=2.8 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=5.6 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01497	GLFSKFAGKGIKNFLIKGVKHIGKEVGMDVIRVGIDVAGCKIKGVC	46	Esculentin-1-OA5 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=3.4 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=1.7 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=3.4 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=1.7 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01499	GIFSKISGKAIKNLFIKGAKNVGKEVGMDVVRTGIDVVGCKIKGEC	46	Esculentin-1-OR1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=8.8 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4.4 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=17.6 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=8.8 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01501	GIFSKISGKAIKNLFIKGAKNVGKRVGMDVVRTGMDVVGCKIKGEC	46	Esculentin-1-OR3 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=5.5 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=11 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=11 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=11 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01502	GIFSKISGKAIKNLFIKGAENVGKHVGIDVVRTGIDVVGCKIKGEC	46	Esculentin-1-OR4 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=8.6 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=8.6 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=8.6 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=8.6 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01503	GIFSKISGKAIKNLFIKGAKNVGKEVGIDVVRTGMDVVGCKIKGEC	46	Esculentin-1-OR5 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=4.1 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4.1 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=8.2 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=2.1 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01504	GIFTLIKGAAKLIGKTVAKEAGKTGLELMACKITNQC	37	Esculentin-2-OA1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=8.5 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4.3 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=4.3 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=8.5 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01505	GLFTLIKGAAKLIGKTTAKEAGKTGKLEMACKITNQC	37	Esculentin-2-OA2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=10.8 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=21.6 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=21.6 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP18392	AKKPVAKKAAGGVKKPK	17	VK7 (histone derived; reptiles; animals)	No entry found	Not found	Not found	blood plasma, Komodo dragon, Varanus komodoensis	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against P. eruginosa ATCC9027 (EC50 38.4 uM) and S. aureus ATCC 25923 (EC50 1.3 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.28164707]No cytotoxicity information found	Not found	28164707	J Proteome Res. 2017 Apr 7;16(4):1470-1482.	Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML	Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry	CC(C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP01507	GVFTLIKGATQLIGKTLGKELGKTGLELMACKITNQC	37	Esculentin-2-OR1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=10.8 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=21.6 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=21.6 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=10.8 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01508	GVFTLIKGATQLIGKTLGKEVGKTGLELMACKITKQC	37	Esculentin-2-OR2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=8.1 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4.1 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=16.2 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=8.1 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01509	GVFTLLKGATQLIGKTLGKELGKTGLELMACKITNQC	37	Esculentin-2-OR3 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=7.9 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=7.9 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=7.9 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=15.8 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01510	GVFTLIKGATQLIGKTLGKELGKTGLELMACKITEQC	37	Esculentin-2-OR4 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=3.6 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=3.6 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=3.6 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=3.6 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01511	GVFTLIKGATQLIGKTLGKELGKTGLEIMACKITKQC	37	Esculentin-2-OR5 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=15.8 µg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=15.8 µg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=15.8 µg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=7.9 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	[Ref.22029824]No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01513	GIFSKLGRKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC	46	Esculentin-1 (Frogs, amphibians, animals)	P32414	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (Edible frog) (Pelophylax esculentus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans.  Has hemolytic activity.	Gram-negative bacteria: Escherichia coli D21 (MIC=0.2 µM), Pseudomonas aeruginosaATCC15692 (MIC=0.7 µM);##Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.1 µM), Staphylococcus aureus Cowan1 (MIC=0.4 µM).##Fungi: Candida albicans (MIC=0.5 µM), Saccharomyces cerevisiae (MIC=0.9 µM).	[Ref. 8163497] LC>100μM	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	[Ref.8508915]No cytotoxicity information found	Not found	8508915	FEBS Lett. 1993 Jun 14;324(2):159-161.	Simmaco M, Mignogna G, Barra D, Bossa F.	Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta.	
DRAMP01520	GLLNTFKDWAISIAKGAGKGVLTTLSCKLDKSC	33	Rugosin-A (Frogs, amphibians, animals)	P80954	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Glandirana rugosa (Japanese wrinkled frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity against Gram-positive bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33."	Gram-positive bacteria: Staphylococcus aureus 209P (MIC=6.25 µg/ml), Bacillus subtilis ATCC6633 (MIC=12.5 µg/ml), Micrococcus luteus ATCC9341 (MIC=25 µg/ml), Streptococcus pyogenes COOK (MIC=50 µg/ml);##Gram-negative bacteria: Escherichia coli NIHJ (MIC=100 µg/ml), Pseudomonas aeruginosa PAO-1 (MIC>100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	[Ref.7612013]No cytotoxicity information found	Not found	7612013	Biochem Biophys Res Commun. 1995 Jul 6;212(1):249-254.	Suzuki S, Ohe Y, Kagegawa T, Tatemoto K.	Isolation and characterization of novel antimicrobial peptides, rugosins A, B and C, from the skin of the frog, Rana rugosa.	
DRAMP01521	SLFSLIKAGAKFLGKNLLKQGAQYAACKVSKEC	33	Rugosin-B (Frogs, amphibians, animals)	P80955	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Shows antibacterial activity against both Gram-negative and Gram-positive bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33."	Gram-positive bacteria: Staphylococcus aureus 209P (MIC=6.25 µg/ml), Bacillus subtilis ATCC6633 (MIC=6.25 µg/ml), Micrococcus luteus ATCC9341 (MIC=1.56 µg/ml), Streptococcus pyogenes COOK (MIC=12.5 µg/ml);##Gram-negative bacteria: Escherichia coli NIHJ (MIC=12.5 µg/ml), Pseudomonas aeruginosa PAO-1 (MIC=100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	[Ref.7612013]No cytotoxicity information found	Not found	7612013	Biochem Biophys Res Commun. 1995 Jul 6;212(1):249-254.	Suzuki S, Ohe Y, Kagegawa T, Tatemoto K.	Isolation and characterization of novel antimicrobial peptides, rugosins A, B and C, from the skin of the frog, Rana rugosa.	
DRAMP01524	SIRDKIKTIAIDLAKSAGTGVLKTLICKLDKSC	33	Rugosin-RN1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana nigrovittata	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has weak hemolytic activity gainst rabbit red cells.	[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=4.69 µg/ml), Bacillus subtilis (MIC=9.38 µg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=25.00 µg/ml);##Yeast: Candida albicans ATCC2002 (MIC=5.63 µg/ml)	[Ref:19778602]Show weak hemolytic activity against rabbit red cells	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bridge between Cys27 and Cys33.	L	[Ref.19778602]No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71.	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP01525	SIRDKIKTIAIDLAKSAGMGILKTLICKLDKSC	33	Rugosin-RN3 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana nigrovittata	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=16.51 µg/ml), Bacillus subtilis (MIC=18.75 µg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=25.00 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=15.00 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bridge between Cys27 and Cys33.	L	[Ref.19778602]No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71.	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP01526	SIRDKIKTIAIDLAKSAGTGVLKTLICKLNKSC	33	Rugosin-RN5 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana nigrovittata	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=15.00 µg/ml), Staphylococcus aureus ATCC43300 (MRSA) (MIC=12.50 µg/ml), Bacillus subtilis (MIC=18.75 µg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=25.00 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=18.75 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bridge between Cys27 and Cys33.	L	[Ref.19778602]No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71.	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP01533	CVISAGWNHKIRCKLTGNC	19	Nigroain-B1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Bridge	Not found		PTM: Contains one disulfide bridge.	Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=4.69 µg/ml), S. aureus ATCC43300 (MIC=50.00 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa PA01 (MIC=25.00 µg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=25.00 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys13 and Cys19)	Disulfide bridge between Cys13 and Cys19.	L	[Ref.19778602]No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP01539	FKTWKRPPFQTSCWGIIKE	19	Nigroain-C2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=27.50 µg/ml), S. aureus ATCC43300 (MIC=55.00 µg/ml), Bacillus subtilis (MIC=110.00 µg/ml);##Gram-negative bacteria: Escherichia coli ML-35P (MIC=110.00 µg/ml), Pseudomonas aeruginosa PA01 (MIC=55.00 µg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=55.00 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=13.75 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.19778602]No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC
DRAMP01542	CVHWQTNTARTSCIGP	16	Nigroain-D3 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		PTM: Contains one disulfide bridge.	Gram-positive bacterium: Bacillus subtilis (MIC=55 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=110 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (Cys1 and Cys13)	Free	Disulfide bridge between Cys1 and Cys13.	L	[Ref.19778602]No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP01543	DCTRWIIGINGRICRD	16	Nigroain-E1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Not found	Not found	Not found		Function: Has hemolytic activity against rabbit red cells.	[Ref.19778602]Gram-positive bacterium: Staphylococcus aureus ATCC25923 (MIC=18.75 µg/ml);##Yeast: Candida albicans ATCC2002 (MIC=75 µg/ml).	[Ref:19778602]7.62±1.6% hemolytic activity at 100 µg/ml against rabbit red cells	Cyclic	Free	Free	Disulfide bridge between Cys2 and Cys14.	L	[Ref.19778602]No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP01546	SLWETIKNAGKGFIQNLDKIR	21	Nigroain-K1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. Also has hemolytic activity against rabbit red cells.	[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=9.38 µg/ml), Bacillus subtilis (MIC=21.88 µg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=37.50 µg/ml);##Yeast: Candida albicans ATCC2002 (MIC=32.74 µg/ml).	[Ref:19778602]22.49 ± 4.8% hemolytic activity at 100 µg/ml against rabbit red cells	Linear	Free	Free	Free	L	[Ref.19778602]No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP01547	SLWETIKNAGKGFILNILDKIRCKVAGGCKT	31	Nigroain-K2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. Also has hemolytic activity against rabbit red cells.	[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=11.25 µg/ml), Staphylococcus aureus ATCC43300 (MIC=9.38 µg/ml), Bacillus subtilis (MIC=9.38 µg/ml);##Gram-positive bacteria: Escherichia coli ML-35P (MIC=25.00 µg/ml), Pseudomonas aeruginosa PA01 (MIC=25.00 µg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=25.00 µg/ml);##Yeast: Candida albicans ATCC2002 (MIC=15.00 µg/ml)	[Ref:19778602]85.52 ± 3.26% hemolytic activity at 50 µg/ml against rabbit red cells	Cyclic	Free	Free	Disulfide bridge between Cys23 and Cys29.	L	[Ref.19778602]No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP01549	GLLSVLGSVAKHVLPHVVPVIAEHL	25	Caerin-1.1 (Frogs, amphibians, animals)	P62568, P62569, Q800R2, P56226	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria splendida (Magnificent tree frog) (Litoria gilleni) (Litoria caerulea)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral	Protein level	Alpha helix 	The peptide adopts two well-defined helices from Leu2 to Lys11 and from Val17 to His24 separated by a region of less-defined helicity and greater flexibility.		"Function: Antibacterial and antiviral peptides that adopt an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Secreted by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility.
Miscellaneous: Caerin 1.1 completely inhibits HIV infection of T cells within minutes of exposure to virus at concentrations that were not toxic to target cells (J Virol. 2005 Sep;79(18):11598-606).
PTM: C-terminal amidation."	[Ref.15203252]Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=1.5 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12.5 µg/ml), Staphylococcus aureus (MIC=3-12 µg/ml), Staphylococcus epidermis (MIC=12.5 µg/ml), Streptococcus uberis (MIC=12.5 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=25 µg/ml).##[Ref.16140737]Virus:HIV:inhibit 50% of PBS-treated HIV infection of T cells(IC50=7.8 μM);inhibition of HIV transfer by dendritic cells to T cells(IC50=12.6 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	No cytotoxicity information found in the reference(s) presented	Cell membrane	16140737##9266696##12709067##15203252	J Virol. 2005 Sep;79(18):11598-606. ##Eur J Biochem. 1997 Jul 15;247(2):545-557.##Eur J Biochem. 2003 May;270(9):2068-2081.##Peptides. 2004 Jun;25(6):1035-1054.	VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, Bowie JH, Tyler MJ, Conlon JM, Wade D, Aiken C, Dermody TS, KewalRamani VN, Rollins-Smith LA, Unutmaz D.##Wong H, Bowie JH, Carver JA.##Vanhoye D, Bruston F, Nicolas P, Amiche M.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.##The solution structure and activity of caerin 1.1, an antimicrobial peptide from the Australian green tree frog, Litoria splendida.##Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01550	GLLGAMFKVASKVLPHVVPAITEHF	25	Caerin-1.11 (Frogs, amphibians, animals)	Q800R9	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria caerulea (Green tree frog) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Homology	Not found	Not found		"Function: Antibacterial and antiviral peptides that adopt an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity (By similarity).
PTM: C-terminal amidation."	Gram-negative bacteria: Escherichia coli B (MIC=25 µM), Enterobacter cloacae (MIC=50 µM), Klebsiella pneumoniae (MIC=25 µM);##Gram-positive bacterium: Staphylococcus haemolyticus (MIC=50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.12709067]No cytotoxicity information found##[Ref.22771617]No cytotoxicity information found	Not found	12709067##22771617	Eur J Biochem. 2003 May;270(9):2068-2081.##Peptides. 2012 Sep;37(1):174-188.	Vanhoye D, Bruston F, Nicolas P, Amiche M.##Bowie JH, Separovic F, Tyler MJ.	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.##Host-defense peptides of Australian anurans. Part 2. Structure, activity, mechanism of action, and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)O
DRAMP01552	GLLSVLGSVAQHVLPHVVPVIAEHL	25	Caerin-1.3 (Frogs, amphibians, animals)	P56228	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria caerulea (Australian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation."	Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=50 µg/ml), Micrococcus luteus (MIC=25 µg/ml), Staphylococcus aureus (MIC=6-12 µg/ml), Staphylococcus epidermis (MIC=12 µg/ml), Streptococcus uberis (MIC=25 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=50 µg/ml). (Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.15203252]No cytotoxicity information found	Not found	15203252##PubMed ID is not available	Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01553	GLLSSLSSVAKHVLPHVVPVIAEHL	25	Caerin-1.4 (Frogs, amphibians, animals)	P62544, P56229, P62545, P56229	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria caerulea (Green tree frog) (also Litoria gilleni) (Centralian tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation."	Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=12 µg/ml), Listeria innocua (MIC=100 µg/ml), Micrococcus luteus (MIC=0.4 µg/ml), Staphylococcus aureus (MIC=100 µg/ml), Staphylococcus epidermis (MIC=25 µg/ml), Streptococcus uberis (MIC=100 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=50 µg/ml), Pasteurella multocida (MIC=25 µg/ml). (Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.15203252]No cytotoxicity information found	Not found	15203252##PubMed ID is not available	Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01555	GLLSVLGSVVKHVIPHVVPVIAEHL	25	Caerin-1.5 (Frogs, amphibians, animals)	P56230	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria caerulea (Green tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-,Antiviral	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation."	[Ref.15203252]Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=50 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermis (MIC=25 µg/ml), Streptococcus uberis (MIC=50 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=25 µg/ml). ##[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.26026377]Human endocervical cells End1/E6E7:50% cell death at 12.5 µM.	Not found	26026377##15203252##PubMed ID is not available	Peptides. 2015 Sep;71:296-303. ##Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.	VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01560	GLFGVLGSIAKHVLPHVVPVIAEKL	25	Caerin-1.9 (Frogs, amphibians, animals)	P81252	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria chloris (Blue-thighed frog) (frog skin active peptide family)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin dorsal glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation.
Miscellaneous: Caerin 1.9 completely inhibited HIV infection of T cells within minutes of exposure to virus at concentrations that were not toxic to target cells (J Virol. 2005 Sep;79(18):11598-606)."	[Ref.15203252]Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Leuconostoc lactis (MIC=12 µg/ml), Listeria innocua (MIC=50 µg/ml), Micrococcus luteus (MIC=50 µg/ml), Staphylococcus aureus (MIC=100 µg/ml), Staphylococcus epidermis (MIC=25 µg/ml), Streptococcus uberis (MIC=50 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=50 µg/ml). ##[Ref.16140737]Virus:HIV:inhibit 50% of PBS-treated HIV infection of T cells(IC50=1.2 μM);inhibition of HIV transfer by dendritic cells to T cells(IC50=1.6 μM).##[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	"[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 20	µM."	Not found	26026377##16140737##15203252##9516047	Peptides. 2015 Sep;71:296-303. ##J Virol. 2005 Sep;79(18):11598-606. ##Peptides. 2004 Jun;25(6):1035-1054.##J Pept Res. 1998 Feb;51(2):121-126.	VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, Bowie JH, Tyler MJ, Conlon JM, Wade D, Aiken C, Dermody TS, KewalRamani VN, Rollins-Smith LA, Unutmaz D.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Steinborner ST, Currie GJ, Bowie JH, Wallace JC, Tyler MJ.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP01562	GLVSSIGRALGGLLADVVKSKGQPA	25	Caerin-2.1 (Frogs, amphibians, animals)	P56233, P86485	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria splendida (Magnificent tree frog) (Emerald spotted tree frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands."	Gram-negative bacterium: Pasteurella multocida (MIC=25 µg/ml). (Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.15203252]No  cytotoxicity information found##[Ref.19642086]No  cytotoxicity information found	Not found	15203252##19642086	Peptides. 2004 Jun;25(6):1035-1054.##Rapid Commun Mass Spectrom. 2009 Sep;23(17):2628-2636.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Bilusich D, Jackway RJ, Musgrave IF, Tyler MJ, Bowie JH.	Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##The host-defence skin peptide profiles of Peron's Tree Frog Litoria peronii in winter and summer. Sequence determination by electrospray mass spectrometry and activities of the peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP01563	GLVSSIGRALGGLLADVVKSKEQPA	25	Caerin-2.2 (Frogs, amphibians, animals)	P62570, P62571, P56234	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria gilleni (Centralian tree frog) (also Litoria caerulea) (Green tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antimicrobial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands."	Gram-positive bacterium: Micrococcus luteus (MIC=50 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.15203252]No cytotoxicity information found	Not found	15203252##PubMed ID is not available	Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
DRAMP01567	GLVSSIGKVLGGLLADVVKSKGQPA	25	Caerin-2.6 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	the skin secretions) (hybrid between female Litoria splendida; also male Litoria caerulea 	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity (By similarity).
PTM: C-terminal amidation."	Gram-positive bacterium: Leuconostoc lactis (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Free	Free	L	[Ref.16824041]No cytotoxicity information found	Not found	16824041	FEBS J. 2006 Aug;273(15):3511-3519.	Pukala TL, Bertozzi T, Donnellan SC, Bowie JH, Surinya-Johnson KH, Liu Y, Jackway RJ, Doyle JR, Llewellyn LE, Tyler MJ.	Host-defence peptide profiles of the skin secretions of interspecific hybrid tree frogs and their parents, female Litoria splendida and male Litoria caerulea.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP01568	GLVSSIGKALGGLLVDVVKSKGQPA	25	Caerin-2.7 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	the skin secretions) (hybrid between female Litoria splendida; also male Litoria caerulea 	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity (By similarity).
PTM: C-terminal amidation."	Gram-positive bacterium: Leuconostoc lactis (MIC=50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Free	Free	L	[Ref.16824041]No cytotoxicity information found	Not found	16824041	FEBS J. 2006 Aug;273(15):3511-3519.	Pukala TL, Bertozzi T, Donnellan SC, Bowie JH, Surinya-Johnson KH, Liu Y, Jackway RJ, Doyle JR, Llewellyn LE, Tyler MJ.	Host-defence peptide profiles of the skin secretions of interspecific hybrid tree frogs and their parents, female Litoria splendida and male Litoria caerulea.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP01570	GLWEKIKEKASELVSGIVEGVK	22	Caerin-3.2 (Frogs, amphibians, animals)	P56239	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria caerulea (Green tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation."	Gram-positive bacterium: Micrococcus luteus (MIC=3 µg/ml). (Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.15203252]No cytotoxicity information found	Not found	15203252##PubMed ID is not available	Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP01573	GLWEKVKEKANELVSGIVEGVK	22	Caerin-3.5 (Frogs, amphibians, animals)	P0C2A9	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria gracilenta (Dainty green tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Shows significant activity against Gram-positive organisms, but is less effective against Gram-negative organisms.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacterium: Leuconostoc lactis (MIC=100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.16554081]No cytotoxicity information found	Not found	16554081	Toxicon. 2006 May;47(6):664-675.	Maclean MJ, Brinkworth CS, Bilusich D, Bowie JH, Doyle JR, Llewellyn LE, Tyler MJ.	New caerin antibiotic peptides from the skin secretion of the Dainty Green Tree Frog Litoria gracilenta. Identification using positive and negative ion electrospray mass spectrometry.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP01574	GLWQKIKSAAGDLASGIVEGIKS	23	Caerin-4.1 (Frogs, amphibians, animals)	P56242	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria caerulea (Green tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-,Antiviral	Protein level	Alpha helix 	Not found		"PTM: adopt an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands."	[Ref.15203252]Gram-positive bacterium: Micrococcus luteus (MIC=12 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.15203252]No cytotoxicity information found	Not found	15203252##PubMed ID is not available	Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O
DRAMP01576	GLWQKIKNAAGDLASGIVEGIKS	23	Caerin-4.3 (Frogs, amphibians, animals)	P56244	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria caerulea (Green tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation."	Gram-positive bacterium: Micrococcus luteus (MIC=25 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=50 µg/ml).(Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.15203252]No cytotoxicity information found	Not found	15203252##PubMed ID is not available	Peptides. 2004 Jun;25(6):1035-1054.##J. Chem. Res. 1993; 138: 910-936.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O
DRAMP01577	GLLSVLGSVAKHVLPHVVPVIAEKL	25	Caerin-1.10 (Frogs, amphibians, animals)	P86502, P82104	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria rothii (Roth's tree frog); also Litoria splendida (Magnificent tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-,Antiviral	Protein level	Not found	Not found		"Function: Antibacterial peptide with wide spectrum of activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	[Ref.10601876]Gram-positive bacteria: Leuconostoc lactis (MIC=6 µg/ml), Listeria innocua (MIC=50 µg/ml), Micrococcus luteus (MIC=25 µg/ml), Streptococcus uberis (MIC=50 µg/ml), Staphylococcus epidermidis (MIC=100 µg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=100 µg/ml).##[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	"[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 22	µM."	Not found	26026377##16124032##10601876	Peptides. 2015 Sep;71:296-303. ##Rapid Commun Mass Spectrom. 2005;19(18):2716-2724.##Eur J Biochem. 2000 Jan;267(1):269-275.	VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Brinkworth CS, Bowie JH, Bilusich D, Tyler MJ.##Wabnitz PA, Bowie JH, Tyler MJ, Wallace JC, Smith BP.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##The rothein peptides from the skin secretion of Roth's tree frog Litoria rothii. Sequence determination using positive and negative ion electrospray mass spectrometry.##Differences in the skin peptides of the male and female Australian tree frog Litoria splendida. The discovery of the aquatic male sex pheromone splendipherin, together with phe8 caerulein and a new antibiotic peptide caerin 1.10.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP18389	AKKPVAKKAAGGVKKPKK	18	VK12 (histone derived; animals)	No entry found	Not found	Not found	blood plasma, Komodo dragon, Varanus komodoensis	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against P. eruginosa ATCC9027 (EC50 0.7 uM) and S. aureus ATCC 25923 (EC50 0.8 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.28164707]No cytotoxicity information found	Not found	28164707	J Proteome Res. 2017 Apr 7;16(4):1470-1482.	Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML	Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry	CC(C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP18390	AKAVKPKTAKPKTAKPKTAKA	21	VK11 (histone derived; reptiles; animals)	No entry found	Not found	Not found	blood plasma, Komodo dragon, Varanus komodoensis	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against P. eruginosa ATCC9027 (EC50 2.8 uM) and S. aureus ATCC 25923 (EC50 4.7 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.28164707]No cytotoxicity information found	Not found	28164707	J Proteome Res. 2017 Apr 7;16(4):1470-1482.	Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML	Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP18391	ARTKQTARKSTGGKAPRKQLAT	22	VK10 (histone derived; reptiles; animals)	No entry found	Not found	Not found	blood plasma, Komodo dragon, Varanus komodoensis	Antimicrobial, Antibacterial		Not found	Not found	2PY0, 2NQB, 2IO5, 2FJ7, 1ZLA, 1KX3, 1KX4, 1KX5,1HIO	Comment: No comments found on DRAMP database	Active against P. eruginosa ATCC9027 (EC50 1.3 uM) and S. aureus ATCC 25923 (EC50 2.5 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.28164707]No cytotoxicity information found	Not found	28164707	J Proteome Res. 2017 Apr 7;16(4):1470-1482.	Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML	Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP01584	GLFSVLGSVAKHLLPHVAPIIAEKL	25	Caerin-1.17 (Frogs, amphibians, animals)	P0C2A6	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria gracilenta (Dainty green tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Caerin-1.17 shows significant activity against Gram-positive organisms, but is less effective against Gram-negative organisms.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation."	Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus Strain ATCC 25923 (MIC=50 µg/ml), Staphylococcus aureus Strain ATCC 29213 (MIC=12 µg/ml), Staphylococcus epidermidis (MIC=12 µg/ml), Streptococcus uberis (MIC=25 µg/ml), Pasteurella multocida (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.16554081]No cytotoxicity information found	Not found	16554081	Toxicon. 2006 May;47(6):664-675.	Maclean MJ, Brinkworth CS, Bilusich D, Bowie JH, Doyle JR, Llewellyn LE, Tyler MJ.	New caerin antibiotic peptides from the skin secretion of the Dainty Green Tree Frog Litoria gracilenta. Identification using positive and negative ion electrospray mass spectrometry.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01585	GLFSVLGSVAKHLLPHVVPVIAEKL	25	Caerin-1.18 (Frogs, amphibians, animals)	P0C2A7	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria gracilenta (Dainty green tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Shows significant activity against Gram-positive organisms, but is less effective against Gram-negative organisms.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation."	Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=25 µg/ml), Listeria innocua (MIC=12 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus ATCC 25923 (MIC=12 µg/ml), Staphylococcus aureus ATCC 29213 (MIC=12 µg/ml), Staphylococcus epidermidis (MIC=25 µg/ml), Streptococcus uberis (MIC=25 µg/ml);##Gram-negative bacteria: Pasteurella multocida (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.16554081]No cytotoxicity information found	Not found	16554081	Toxicon. 2006 May;47(6):664-675.	Maclean MJ, Brinkworth CS, Bilusich D, Bowie JH, Doyle JR, Llewellyn LE, Tyler MJ.	New caerin antibiotic peptides from the skin secretion of the Dainty Green Tree Frog Litoria gracilenta. Identification using positive and negative ion electrospray mass spectrometry.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01586	GLFKVLGSVAKHLLPHVAPIIAEKL	25	Caerin-1.19 (Frogs, amphibians, animals)	P0C2A8	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria gracilenta (Dainty green tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-,Antiviral	Protein level	Not found	Not found		"Function: Caerin-1.19 shows significant activity against Gram-positive organisms, but is less effective against Gram-negative organisms.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation."	[Ref.16554081]Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=12 µg/ml), Micrococcus luteus (MIC=25 µg/ml), Staphylococcus aureus Strain ATCC 25923 (MIC=12 µg/ml), Staphylococcus aureus Strain ATCC 29213 (MIC=12 µg/ml), Staphylococcus epidermidis (MIC=12 µg/ml), Streptococcus uberis (MIC=25 µg/ml);##Gram-negative bacteria: Pasteurella multocida (MIC=50 µg/ml).##[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	No cytotoxicity information found in the reference(s) presented	Not found	26026377##16554081	Peptides. 2015 Sep;71:296-303. ##Toxicon. 2006 May;47(6):664-675.	VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Maclean MJ, Brinkworth CS, Bilusich D, Bowie JH, Doyle JR, Llewellyn LE, Tyler MJ.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##New caerin antibiotic peptides from the skin secretion of the Dainty Green Tree Frog Litoria gracilenta. Identification using positive and negative ion electrospray mass spectrometry.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01587	GLFDVIKKVASVIGGL	16	Citropin-1.1 (Frogs, amphibians, animals)	P81835, P81836, P81837	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix	Not found		"Function: Bacteriostatic action for Gram-positive bacteria.
Tissue specificity: Expressed by the dorsal and submental skin glands.
PTM: C-terminal amidation."	Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=6 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=12 µg/ml), Streptococcus uberis (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10504394]No cytotoxicity information found	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01588	GLFAVIKKVASVIGGL	16	Citropin-1.1 sm1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Synthesized modify	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands."	Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Escherichia coli (MIC=100 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=12 µg/ml), Streptococcus uberis (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10504394]No cytotoxicity information found	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01589	GLFDVIAKVASVIGGL	16	Citropin-1.1 sm2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Synthesized modify	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands."	Gram-positive bacteria: Bacillus cereus (MIC=100 µg/ml), Leuconostoc lactis (MIC=25 µg/ml), Micrococcus luteus (MIC=100 µg/ml), Staphylococcus aureus (MIC=100 µg/ml), Staphylococcus epidermidis (MIC=100 µg/ml), Streptococcus uberis (MIC=100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10504394]No cytotoxicity information found	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01590	GLFDVIAKVASVIKKL	16	Citropin 1.1 M14 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: E. coli (MIC=53 µM);##Gram-positive bacterium: S. aureus (MIC=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.20564028]No cytotoxicity information found	Not found	20564028	Biopolymers. 2011;96(2):147-157.	Chia CS, Gong Y, Bowie JH, Zuegg J, Cooper MA. 	Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, and maculatin.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)C(C)C)C(C)C
DRAMP01591	GLFAVIKKVASVIKKL	16	Citropin 1.1 M15 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: E. coli (MIC=53 µM);##Gram-positive bacteria: S. aureus (MIC=3 µM), B. subtilis (MIC=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.20564028]No cytotoxicity information found	Not found	20564028	Biopolymers. 2011;96(2):147-157.	Chia CS, Gong Y, Bowie JH, Zuegg J, Cooper MA. 	Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, and maculatin.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)C(C)C)C(C)C
DRAMP01594	GLFDIIKKVASVVGGL	16	Citropin-1.2 (Frogs, amphibians, animals)	P81840, P81841, P81842, P81843	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands."	Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Leuconostoc lactis (MIC=3 µg/ml), Listeria innocua (MIC=100 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=25 µg/ml), Streptococcus uberis (MIC=12 µg/ml). (Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.15203252]No cytotoxicity information found##[Ref.10504394]No cytotoxicity information found	Not found	10504394##15203252	Eur J Biochem. 1999 Oct;265(2):627-637.##Peptides. 2004 Jun;25(6):1035-1054.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)C(C)C)[C@H](C)CC
DRAMP01600	GLFDIIKKVASVIGGL	16	Citropin-1.3 (Frogs, amphibians, animals)	P81846	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands."	Gram-positive bacteria: Bacillus cereus (MIC=25 µg/ml), Leuconostoc lactis (MIC=6 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12 µg/ml), Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=25 µg/ml), Streptococcus uberis (MIC=25 µg/ml). (Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.15203252]No cytotoxicity information found##[Ref.10504394]No cytotoxicity information found	Not found	10504394##15203252	Eur J Biochem. 1999 Oct;265(2):627-637.##Peptides. 2004 Jun;25(6):1035-1054.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC
DRAMP01601	GLIGSIGKALGGLLVDVLKPKL	22	Citropin-2.1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands."	Gram-positive bacterium: Leuconostoc lactis (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.10504394]No cytotoxicity information found	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
DRAMP01602	GLIGSIGKALGGLLVDVLKPKLQAAS	26	Citropin-2.1.3 (Frogs, amphibians, animals)	P81847, P81848, P81849, P81850	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands."	Gram-positive bacterium: Leuconostoc lactis (MIC=100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.10504394]No cytotoxicity information found	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
DRAMP01603	GLFDVIKKVASVIGLASP	18	Citropin 1.1.3 (Frogs, amphibians, animals)	P81838	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands."	Gram-positive bacteria: Leuconostoc lactis (MIC=50 µg/ml), Streptococcus uberis (MIC=100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10504394]No cytotoxicity information found	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(N)=O
DRAMP01606	GLFDIIKKIAESI	13	Aurein-1.1 (Frogs, amphibians, animals)	P82386	Not found	Not found	Litoria raniformis (Southern bell frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Expressed by the skin dorsal glands.	Gram-positive bacteria: Bacillus cereus (MIC=50 µg/ml), Lactococcus lactis (MIC=25 µg/ml), Listeria innocua (MIC=100 µg/ml), Streptococcus uberis (MIC=100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10951191]No cytotoxicity information found	Cell membrane	10951191	Eur J Biochem. 2000 Sep;267(17):5330-5341.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP01607	GLFDIIKKIAESF	13	Aurein-1.2 (Frogs, amphibians, animals)	P82387	Not found	Not found	Litoria raniformis (Southern bell frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Protein level	Alpha helix (1 helices; 10 residues)	Not found	1VM5 resolved by NMR.	Function: Probably acts by disturbing membrane functions with its amphipathic structure. Aurein 1.2 is HIV active (Wang G et al. 2010 Antimicrob. Agents Chemother. (54) 1343-1346). Aurein 1.2 is also the smallest amphibian peptide to show both antibiotic and Anti-cancer activity. The aurein antibiotics show more activity towards Gram-positive than Gram-negative pathogens. Expressed by the skin dorsal glands.	Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=50 μg/ml), Staphylococcus aureus (MIC=8 μmol/L);##Gram-negative bacteria: Pasteurella multocida (MIC=100 μg/ml), Escherichia coli (MIC=8 μmol/L);##Fungi: Candida albicans (MIC=32 μmol/L)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10951191]No cytotoxicity information found##[Ref.15572363]No cytotoxicity information found	Cell membrane	10951191##15572363##15203252	Eur J Biochem. 2000 Sep;267(17):5330-5341.##J Biol Chem. 2005 Feb 18;280(7):5803-5811.##Peptides. 2004 Jun;25(6):1035-1054.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Wang G, Li Y, Li X.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP01608	GLLDIVKKVVGAFGSL	16	Aurein-2.1 (Frogs, amphibians, animals)	P69016, P69017, P82388	Not found	Not found	Litoria aurea (Green; also golden bell frog); also Litoria raniformis (Southern bell frog)	Antimicrobial, Anti-cancer, Anti-Gram+	Protein level	Not found	Not found		"Function:Antimicrobial activity against Gram-positive bacteria. Probably acts by disturbing membrane functions with its amphipathic structure. The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens.
Tissue specificity: Expressed by the skin glands."	Gram-positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=6 μg/ml), Listeria innocua (MIC=6 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=100 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10951191]No cytotoxicity information found	Cell membrane	10951191##15203252	Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)C(C)C
DRAMP01612	GLFDIVKKVVGAFGSL	16	Aurein-2.5 (Frogs, amphibians, animals)	P69018, P69019, P82392	Not found	Not found	Litoria raniformis (Southern bell frog); also Litoria aurea (Green; also golden bell frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer	Protein level	Not found	Not found		"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands."	[Ref.10951191]Gram-positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=50 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=100 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10951191]No cytotoxicity information found	Cell membrane	10951191##15203252	Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)C(C)C
DRAMP01613	GLFDIAKKVIGVIGSL	16	Aurein-2.6 (Frogs, amphibians, animals)	P82393	Not found	Not found	Litoria raniformis (Southern bell frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer	Protein level	Not found	Not found		"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=6 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=25 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10951191]No cytotoxicity information found	Cell membrane	10951191##15203252	Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C
DRAMP01614	GLFDIVKKIAGHIAGSI	17	Aurein-3.1 (Frogs, amphibians, animals)	P69020, P69021, P82394	Not found	Not found	Litoria raniformis (Southern bell frog); also Litoria aurea (Green; also golden bell frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer	Protein level	Not found	Not found		"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands."	[Ref.10951191]Gram-positive bacteria: Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=100 μg/ml), Streptococcus uberis (MIC=100 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10951191]No cytotoxicity information found	Cell membrane	10951191##15203252	Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP01617	GLFDIVKKIAGHIASSI	17	Aurein-3.2 (Frogs, amphibians, animals)	P69022, P69023, P82395	Not found	Not found	Litoria aurea (green; also golden bell frog); also Litoria raniformis (blue-thighed treefrog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer	Protein level	Not found	Not found		"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Leuconostoc lactis (MIC=6 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=50 μg/ml), Staphylococcus aureus (MIC=50 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10951191]No cytotoxicity information found	Cell membrane	10951191##15203252	Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP01618	GLFDIVKKIAGHIVSSI	17	Aurein-3.3 (Frogs, amphibians, animals)	P82396	Not found	Not found	Litoria raniformis (blue-thighed treefrog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Protein level	Not found	Not found		"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Leuconostoc lactis (MIC=12 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=25 μg/ml), Staphylococcus aureus (MIC=100 μg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=100 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10951191]No cytotoxicity information found	Cell membrane	10951191##15203252	Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)C(N)=O
DRAMP01620	GLMSSIGKALGGLIVDVLKPKTPAS	25	Aurein-5.2 (Frogs, amphibians, animals)	P69030, P82402, P69031, P82402	Not found	Not found	Litoria raniformis (blue-thighed treefrog); also Litoria aurea (Green; also golden bell frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer	Protein level	Not found	Not found		"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Leuconostoc lactis (MIC=100 μg/ml), Streptococcus uberis (MIC=50 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.10951191]No cytotoxicity information found	Cell membrane	10951191##15203252	Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(C)C)[C@H](C)CC
DRAMP01621	IIGPVLGMVGSALGGLLKKI	20	Bombinin-H1 (Frogs, amphibians, animals)	P82282, P82283	Belongs to the bombinin family	Not found	Bombina variegata (European frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antimicrobial.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation and D-amino acid."	[Ref.8223491]Gram-negative bacterium: Escherichia coli D21 (MIC=3.8 µM);##Gram-positive bacterium: Staphylococcus aureus Cowan 1 (MIC=2.1 µM).	[Ref:8223491]Not determined hemolytic activity against human red blood cells.	Linear	Free	Amidation	Free	L	[Ref.8223491]No cytotoxicity information found	Not found	8223491	EMBO J. 1993 Dec;12(12):4829-4832.	Mignogna G, Simmaco M, Kreil G, Barra D.	Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC
DRAMP03722	IFGAIWNGIKSLF	13	Cytotoxic linear peptide IsCT2	Q8MTX2	Belongs to the scorpion NDBP 5 family	Not found	Opisthacanthus madagascariensis (Scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: IsCT2 showed broad activity spectra against microbes (Gram positive and negative bacteria as well as fungi). Has hemolytic activity.	[Ref.12054688] Gram-negetive bacteria: P.aeroginosa ATCC 15442 (MIC>150 μM), P.aeroginosa ATCC 27853 (MIC=68.3 μM), E.coli CCT 1371 (MIC=3.4 μM), Escherichia coli ATCC 25922 (MIC=6.8 μM), P. mirabilis (MIC>150 μM);## Gram-positive bacteria: S.aureus ATCC 25293 (MIC=0.7 μM), S.aureus ATCC 6538 (MIC=3.4 μM), S.saprophyticus (MIC=0.7 μM), B.thuringensis (MIC=17.1 μM),  B.subtilis CCT 2471 (MIC=6.8μM).##[Ref.28657596] Gram-positive bacterium:Staphylococcus aureus (MIC=50μg/mL), B. cereus (MIC=100μg/mL);##Gram-negative bacterium: S. typhimurium (MIC=100μg/mL), Escherichia coli (MIC=50μg/mL)	[Ref.12054688] Showed relatively weak hemolytic activity against sheep red blood cells.##[Ref.28657596] 18% hemolysis at 10 μg/ml, 96% hemolysis at 50 μg/ml against human red blood cells.	Linear	Free	Amidation	Free	L	[Ref.12054688]No cytotoxicity information found##[Ref.28657596]No cytotoxicity information found	Not found	12054688##28657596	Biochem Biophys Res Commun. 2002 May 24;293(5):1514-1522.##Antibiotics (Basel). 2017 Jun 28;6(3). pii: E13.	Dai L, Corzo G, Naoki H, Andriantsiferana M, Nakajima T.##de la Salud Bea R, Petraglia AF, Ascuitto MR, Buck QM.	Purification, structure-Function: analysis, and molecular characterization of novel linear peptides from scorpion Opisthacanthus madagascariensis.##Antibacterial Activity and Toxicity of Analogs of Scorpion Venom IsCT Peptides	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP01626	IIGPVLGLVGSALGGLLKKI	20	Bombinin-H5 (Frogs, amphibians, animals)	P82285	Belongs to the bombinin family	Not found	Bombina variegata (European frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix (1 helices; 16 residues)	Not found	2AP7, 2AP8 resolved by NMR.	"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation and D-amino acid."	[Ref.8223491]Gram-negative bacterium: Escherichia coli D21 (MIC=5.0 µM);##Gram-positive bacterium: Staphylococcus aureus Cowan 1 (MIC=3.0 µM).	[Ref:8223491]Not found	Linear	Free	Amidation	Free	Mixed (2D-aIle(alloisoleucine))	[Ref.8223491]No cytotoxicity information found	Not found	8223491##PubMed ID is not available	EMBO J. 1993 Dec;12(12):4829-4832##TO BE PUBLISHED	Mignogna G, Simmaco M, Kreil G, Barra D.##Zangger K, Jilek A, Khatai L.	Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.##Solution structure and orientation of bombinin H2 and H4 in a membrane-mimetic environment.	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC
DRAMP01627	YPPKPESPGEDASPEEMNKYLTALRHYINLVTRQRY	36	Skin peptide tyrosine-tyrosine (Skin-PYY; SPYY; Frogs, amphibians, animals)	P80952	Belongs to the NPY family	Not found	Phyllomedusa bicolor (Two-colored leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Shows a broad spectrum of antibacterial activity against Gram-positive and Gram-negative bacteria, yeast and fungi.
Tissue specificity: Skin.
PTM: C-terminal amidation (By similarity)."	Gram-negative bacteria: Aeromonas caviae (MIC=40 µg/ml), Escherichia coli (MIC=10 µg/ml);##Gram-positive bacteria: Enterococcus faecalis (MIC=10 µg/ml), Nocardia brasiliensis (MIC=20 µg/ml).##Fungi: Cryptococcus neoformans (MIC=20 µg/ml), Candida albicans (MIC=15 µg/ml), Microsporum canis (MIC=10 µg/ml), Tricophyton rubrum (MIC=15 µg/ml), Arthroderma simii (MIC=10 µg/ml), Aspergillus fumigatus (MIC=80 µg/ml), Aspergillus niger (MIC>100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.8601432]<20% cytotoxic against murine macrophages at the concentration up to 100μg/ml##[Ref.7937944]No cytotoxicity information found	Cell membrane	7937944##8601432	Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10295-10299.##FEBS Lett. 1996 Feb 19;380(3):237-240.	Mor A, Chartrel N, Vaudry H, Nicolas P.##Vouldoukis I, Shai Y, Nicolas P, Mor A.	Skin peptide tyrosine-tyrosine, a member of the pancreatic polypeptide family: isolation, structure, synthesis, and endocrine activity.##Broad spectrum antibiotic activity of the skin-PYY.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C
DRAMP01628	GWMSKIASGIGTFLSGMQQ	19	Phylloxin (Frogs, amphibians, animals)	P81565, Q9PT74	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	PLX	Phyllomedusa bicolor (Two-colored leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix	Not found		"Function: Antimicrobial peptide against the Gram-positive bacteria and the Gram-negative-bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	Gram-negative bacteria: Acholeplasma laidlawii A-PG8 (MIC=12.5 µM), Spiroplasma melliferum BC3 (MIC=50 µM), Rhizobium meliloti 102F34 (MIC=12.5 µM), Escherichia coli K12 (MIC=10 µM);##Gram-positive bacteria: Bacillus megaterium KM (MIC=3.12 µM), Corynebacterium glutamicum ATCC 27853 (MIC=1.56 µM), Micrococcus luteus ATCC 27853 (MIC=3.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.10632707]No cytotoxicity information found	Not found	10632707	Eur J Biochem. 2000 Jan;267(2):370-378.	Pierre TN, Seon AA, Amiche M, Nicolas P.	Phylloxin, a novel peptide antibiotic of the dermaseptin family of antimicrobial/opioid peptide precursors.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)CC)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)[C@@H](C)O
DRAMP01638	GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS	32	Dermaseptin-L1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Hylomantis lemur (Lemur leaf frog)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=8 µM).##Fungi: Batrachochytrium dendrobatidis (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Free	Free	L	[Ref.17561225]Displayed cytotoxic against HepG2 cells(LC50=45μM)	Not found	17561225	Toxicon. 2007 Sep 15;50(4):498-506.	Conlon JM, Woodhams DC, Raza H, Coquet L, Leprince J, Jouenne T, Vaudry H, Rollins-Smith LA.	Peptides with differential cytolytic activity from skin secretions of the lemur leaf frog Hylomantis lemur (Hylidae: Phyllomedusinae).	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP01639	GLWSTIKNVGKEAAIAAGKAALGAL	25	Dermaseptin-1 (DShypo01, DPh-1; Frogs, amphibians, animals)	P84596	Not found	Not found	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiprotozoal	Protein level	Not found	Not found		"Function: Has antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. Also has antiprotozoal activity against L. amazonensis. No hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	[Ref.16963159]Gram-positive bacteria: Micrococcus luteus A270 (MIC=6 µM), Staphylococcus aureus ATCC 6538 (MIC=6 µM);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=6 µM), Pseudomonas aeruginosa ATCC 14502 (MIC=6.6 µM).	[Ref:16844081]Non-hemolytic activity upto 53 μM against human red blood cells;##[Ref.16963159]Non-hemolytic activity at 6 μM against erythrocytes	Linear 	Free	Amidation	Free	L	[Ref.16844081]No cytotoxicity information found##[Ref.16963159]No cytotoxicity information found	Not found	16844081##16963159	Biochem Biophys Res Commun. 2006 Sep 1;347(3):739-746.##Peptides. 2006 Dec;27(12):3092-3099.	Brand GD, Leite JR, de SÃ¡ Mandel SM, Mesquita DA, Silva LP, Prates MV, Barbosa EA, Vinecky F, Martins GR, Galasso JH, Kuckelhaus SA, Sampaio RN, Furtado JR Jr, Andrade AC, Bloch C Jr.##ConceiÃ§Ã£o K, Konno K, Richardson M, Antoniazzi MM, Jared C, Daffre S, Camargo AC, Pimenta DC.	Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia).##Isolation and biochemical characterization of peptides presenting antimicrobial activity from the skin of Phyllomedusa hypochondrialis.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01643	GLWSTIKQKGKEAAIAAAKAAGQAALGAL	29	Dermaseptin-5 (DShypo05, DS 01; Frogs, amphibians, animals)	P84600	Not found	Not found	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiprotozoal	Protein level	Not found	Not found		"Function: Has antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. Also has antiprotozoal activity against L. amazonensis. No hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	[Ref.8306981]Gram-negative bacterium: Escherichia coli (MIC=6.4 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=3.2 µM).	[Ref:8306981]Non-hemolytic activity against rabbit red blood cells.	Linear	Free	Amidation	Free	L	[Ref.12379643]No cytotoxicity information found##[Ref.17442605]No cytotoxicity information found	Not found	12379643##17442605	J Biol Chem. 2002 Dec 20;277(51):49332-49340. ##Comp Biochem Physiol A Mol Integr Physiol. 2008 Nov;151(3):336-343.	Brand GD, Leite JR, Silva LP, Albuquerque S, Prates MV, Azevedo RB, Carregaro V, Silva JS, Sá VC, Brandão RA, Bloch C Jr. ##Leite JRSA, Brand GD, Silva LP, Kückelhaus SAS, Bento WRC, Araújo ALT, Martins GR, Lazzari AM, Bloch C Jr.	Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells. ##Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta: Secondary structure, antimicrobial activity, and mammalian cell toxicity. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01646	GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV	33	Adenoregulin (Dermaseptin BII; Dermaseptin B2; Frogs, amphibians, animals)	P31107, P80283	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	ADR	Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found		"Fountion: Enhances binding of agonists to adenosine A1 receptors, adenosine A2a receptors, alpha-2 adrenergic receptors and 5-hydroxytryptamine 1A receptors. Enhances guanyl nucleotide exchange which may result in the conversion of receptors to a high affinity state complexed with guanyl nucleotide free G-protein. Affects human behavior eliciting profound malaise, followed by listlessness and then euphoria. Possesses a potent antimicrobial activity against bacteria, fungi and protozoa. Lack hemolytic activity. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation at V33 (Amidation in vitro increases antimicrobial activity against some microorganisms such as T. album and S. cerevisia)."	[Ref.8306981]Fungi: Microsporum canis (IP 1194) (MIC=10 µg/ml), Tricophyton rubrum (IP 1400-82) (MIC=15 µg/ml), Arthroderma simii (IP 1063-74) (MIC=30 µg/ml), Aspergillus fumigatus IP (1025-70) (MIC=125 µg/ml), Aerornonas caviae (IP 67-16 T) (MIC=60 µg/ml), Cryptococcus neoformans (IP 960-67) (MIC=15 µg/ml), Cryptococcus neoformans (IP 962-67) (MIC=15 µg/ml), Candida albicans (IP 884-65) (MIC=15 µg/ml);##Gram-negative bacterium: Escherichia coli (IP 76-24) (MIC=15 µg/ml);##Gram-positive bacterium: Nocardia brasiliensis (IP 16-80) (MIC=30 µg/ml).	[Ref:8306981]Lack hemolytic activity against rabbit red blood cells	Linear	Free	Free	Free	L	[Ref.8306981]No cytotoxicity information found##[Ref.1438301]No cytotoxicity information found##[Ref.7842473]No cytotoxicity information found##[Ref.8565049]No cytotoxicity information found	Not found	8306981##1438301##7842473##8565049	Eur J Biochem 1994, 219 (1-2):145-154.##Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10960-10963.##Cell Mol Neurobiol. 1994 Apr;14(2):133-157.##Cell Mol Neurobiol. 1995 Aug;15(4):465-493.	Mor, A, Nicolas, P.##Daly JW, Caceres J, Moni RW, Gusovsky F, Moos M Jr, Seamon KB, Milton K, Myers CW.##Shin Y, Moni RW, Lueders JE, Daly JW.##Moni RW, Romero FS, Daly JW.	Isolation and structure of novel defensive peptides from frog skin.##Frog secretions and hunting magic in the upper Amazon: identification of a peptide that interacts with an adenosine receptor.##Effects of the amphiphilic peptides mastoparan and adenoregulin on receptor binding, G proteins, phosphoinositide breakdown, cyclic AMP generation, and calcium influx.##The amphiphilic peptide adenoregulin enhances agonist binding to A1-adenosine receptors and [35S]GTP gamma S to brain membranes.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP01647	FLSLIPHIVSGVAALAKHLG	20	DRP-PBN1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Phyllomedusa bicolor	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: S. aureus (MIC=12 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.15222751]No cytotoxicity information found	Not found	15222751	Biochemistry. 2004 Jul 6;43(26):8391-8409.	Vanhoye D, Bruston F, El Amri S, Ladram A, Amiche M, Nicolas P.	Membrane association, electrostatic sequestration, and cytotoxicity of Gly-Leu-rich peptide orthologs with differing functions.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C)C(C)C
DRAMP01648	GLVTSLIKGAGKLLGGLFGSVTGGQS	26	Dermaseptin-like PBN2 (DRP-PBN2; Plasticin-B1a; Frogs, amphibians, animals)	Q800R4	Not found	Not found	Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Possesses a potent antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and fungi. Probably acts by disturbing membrane functions with its amphipathic structure.	Gram-negative bacteria: Escherichia coli B (MIC=1.5 µM), Salmonella typhimurium (MIC=3.1 µM), Salmonella enteritidis (MIC=1.5 µM), Enterobacter cloacae (MIC=12.5 µM), Klebsiella pneumoniae (MIC=0.8 µM);##Gram-positive bacteria: Aerococcus viridans (MIC=3.1 µM), Bacillus megaterium (MIC=0.8 µM), Staphylococcus aureus (MIC=3.1 µM), Staphylococcus haemolyticus (MIC=0.8 µM).##Fungi: Saccaromyces cerevisiae (MIC=3.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.12709067]No cytotoxicity information found##[Ref.15222751]No cytotoxicity information found	Not found	12709067##15222751	Eur J Biochem. 2003 May;270(9):2068-2081.##Biochemistry. 2004 Jul 6;43(26):8391-8409.	Vanhoye D, Bruston F, Nicolas P, Amiche M.##Vanhoye D, Bruston F, El Amri S, Ladram A, Amiche M, Nicolas P.	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.##Membrane association, electrostatic sequestration, and cytotoxicity of Gly-Leu-rich peptide orthologs with differing functions.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C
DRAMP01649	AMWKDVLKKIGTVALHAGKAALGAVADTISQ	31	Dermaseptin-BI (Dermaseptin B1; Frogs, amphibians, animals)	P80282	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Possesses a potent antimicrobial activity against bacteria, fungi and protozoa. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation (Potential)."	Gram-negative bacterium: Escherichia coli (IP 76-24) (MIC=15 µg/ml);##Gram-positive bacterium: Nocardia brasiliensis (IP 16-80) (MIC=30 µg/ml).##Fungi: Tricophyton rubrum (IP 1400-82) (MIC=15 µg/ml), Microsporum canis (IP 1194) (MIC=10µg/ml), Arthroderma simii (IP 1063-74) (MIC=30 µg/ml), Cryptococcus neoformans (IP 960-67) (MIC=15 µg/ml), Cryptococcus neofonnans (IP 962-67) (MIC=15 µg/ml), Aspergillus fumigatus (IP 1025-70)(MIC=125 µg/ml), Aerornonas caviae (IP 67-16 T) (MIC=60 µg/ml), Candida albicans (IP 884-65) (MIC=15 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.8306981]No cytotoxicity information found##[Ref.8074751]No cytotoxicity information found	Not found	8306981##8074751	Eur J Biochem. 1994 Jan 15;219(1-2):145-154.##J Biol Chem. 1994 Jul 8;269(27):17847-17852.	Mor A, Nicolas P.##Amiche M, Ducancel F, Mor A, Boulain JC, Menez A, Nicolas P.	Isolation and structure of novel defensive peptides from frog skin.##Precursors of vertebrate peptide antibiotics dermaseptin b and adenoregulin have extensive sequence identities with precursors of opioid peptides dermorphin, dermenkephalin, and deltorphins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)N)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(N)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP01650	ALWKNMLKGIGKLAGQAALGAVKTLVGAE	29	Dermaseptin-B3 (Dermaseptin BIII; Frogs, amphibians, animals)	P81485	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Possesses a potent antimicrobial activity against Gram-positive and Gram-negative bacteria. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin glands."	Gram-negative bacteria: Pseudomonas aeruginosa CIP A22 (MIC=2.3 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=5 µM), Escherichia coli ATCC 25922 (MIC=2.6 µM), E. coli 54127 (MIC=2.3 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25293 (MIC=1.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.9614066]No cytotoxicity information found	Not found	9614066	J Biol Chem. 1998 Jun 12;273(24):14690-14697.	Charpentier S, Amiche M, Mester J, Vouille V, Le Caer JP, Nicolas P, Delfour A.	Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP01651	ALWKDILKNVGKAAGKAVLNTVTDMVNQ	28	Dermaseptin-B4 (Dermaseptin BIV; Frogs, amphibians, animals)	P81486	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix	Not found		"Function: Possesses a potent antimicrobial activity against Gram-positive and Gram-negative bacteria. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	Gram-positive bacteria: Staphylococcus aureus ATCC 25293 (MIC=1.3 µM), S. aureus ATCC 25923 (MIC=3.0 µM);##Gram-negative bacteria: Pseudomonas aeruginosa CIP A22 (MIC=4.6 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=11.6 µM), Escherichia coli ATCC 25922 (MIC=5.0 µM), E. coli 54127 (MIC=2.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.9614066]No cytotoxicity information found	Not found	9614066	J Biol Chem. 1998 Jun 12;273(24):14690-14697.	Charpentier S, Amiche M, Mester J, Vouille V, Le Caer JP, Nicolas P, Delfour A.	Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP01657	ALWKTIIKGAGKMIGSLAKNLLGSQAQPES	30	Dermaseptin DRG3 (Dermaseptin-3; Frogs, amphibians, animals)	P81488, Q90ZK4	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	DRG3	Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor)	Antimicrobial	Transcript level	Not found	Not found		MOA: This peptide is membranotropic and it efficiently depolarizes the plasma membrane.	Several species of mollicutes (MIC=6.25-100 µM), firmicutes (MIC=6.25-100 µM), gracilicutes (MIC=6.25-100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.9540838] No cytotoxicity information found	Not found	9540838	Biochim Biophys Acta. 1998 Mar 9;1396(2):228-236.	Fleury Y, Vouille V, Beven L, Amiche M, WrÃ³blewski H, Delfour A, Nicolas P.	Synthesis, antimicrobial activity and gene structure of a novel member of the dermaseptin B family.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O
DRAMP01668	ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ	34	Dermaseptin-1 (DS I; Dermaseptin-S1, DS1; Frogs, amphibians, animals)	P24302, P80277	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiprotozoal	Protein level	Alpha helix (CD)	Not found		"Function: Possesses a potent antimicrobial activity against bacteria, fungi and protozoa. Probably acts by disturbing membrane functions with its amphipathic structure. This peptide could also inhibit HIV infection at a concentration that is also toxic to T cells (J Virol 2005; 79:11598-11606).
Tissue specificity: Expressed by the skin glands."	Fungi: Microsporum canis (IP 1194) (MIC=50 µg/ml), Tricophyton rubrum (IP 1400-82) (MIC=100 µg/ml), Arthroderma simii (IP 1063-74) (MIC=100 µg/ml), Aspergillus fumigatus (IP 1025-70) (MIC=100 µg/ml), Aerornonas caviae IP (67-16) T (MIC=50 µg/ml), Cryptococcus neoformans (IP 960-67) (MIC=15 µg/ml), Cryptococcus neoformans (IP 962-67) (MIC=15 µg/ml), Candida albicans (IP 884-65) (MIC=60 µg/ml); ##Gram-negative bacterium: Escherichia coli (IP 76-24) (MIC=5 µg/ml);##Gram-positive bacterium: Nocardia brasiliensis (IP 16-80) (MIC=200 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.1909573]No cytotoxicity information found##[Ref.8306981]No cytotoxicity information found	Cell membrane	1909573##8306981	Biochemistry. 1991 Sep 10;30(36):8824-8830.##Eur J Biochem. 1994 Jan 15;219(1-2):145-154. 	Mor A, Nguyen VH, Delfour A, Migliore-Samour D, Nicolas P.##Mor A, Nicolas P.	Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin.##Isolation and structure of novel defensive peptides from frog skin.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP18386	SPKKTKPVKPKKVA	14	VK25 (histone derived; reptiles; animals)	No entry found	Not found	Not found	blood plasma, Komodo dragon, Varanus komodoensis	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against P. eruginosa ATCC9027 (EC50 3.2 uM) and S. aureus ATCC 25923 (EC50 2.5 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.28164707]No cytotoxicity information found	Not found	28164707	J Proteome Res. 2017 Apr 7;16(4):1470-1482.	Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML.	Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP18387	KAAAAKKSPKKPKKPAAAKK	20	VK14 (histone derived;reptiles; animals)	No entry found	Not found	Not found	blood plasma, Komodo dragon, Varanus komodoensis	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against P. eruginosa ATCC9027 (EC50 0.6 uM) and S. aureus ATCC 25923 (EC50 1.2 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.28164707]No cytotoxicity information found	Not found	28164707	J Proteome Res. 2017 Apr 7;16(4):1470-1482.	Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML	Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP18388	AAGGVKKPKKAAAAKKSPKKPKKPAAA	27	VK13 (histone derived; reptiles; animals)	No entry found	Not found	Not found	blood plasma, Komodo dragon, Varanus komodoensis	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against P. eruginosa ATCC9027 (EC50 0.9 uM) and S. aureus ATCC 25923 (EC50 1.0 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.28164707]No cytotoxicity information found	Not found	28164707	J Proteome Res. 2017 Apr 7;16(4):1470-1482.	Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML	Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry	CC(C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP18385	KKSCHTGLKKSAGWVIPIGTLVKNGIIVR	29	cOT2 (reptiles; animals)	No entry found	Not found	Not found	Siamese crocodile, Crocodylus siamensis	Antimicrobial, Antibacterial		Helix	Not found		Comment: No comments found on DRAMP database	Active against E. coli ATCC 25922 (MIC 32 uM), V. cholerae (MIC 8 uM), Gram+ B. megaterium (MIC 8 uM) and B. pumilus TISTR 905 (MIC 16 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.28159460]No cytotoxicity information found	Not found	28159460	Biochim Biophys Acta Biomembr. 2017 May;1859(5):860-869. 	Prajanban BO, Jangpromma N, Araki T, Klaynongsruang S	Antimicrobial effects of novel peptides cOT2 and sOT3 derived from Crocodylus siamensis and Pelodiscus sinensis ovotransferrins	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@H](C)CC
DRAMP01702	GLWSTIKNVGKEAAIAAGKAVLGSL	25	Dermaseptin-H5 (Dermaseptin-like peptide 5, DMS5; Frogs, amphibians, animals)	Q1EJP4	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	Gram-negative bacterium: Escherichia coliEscherichia coli ATCC 11775 (MIC=0.5 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 12600 (MIC=0.5 µM), Micrococcus luteus ATCC 49732 (MIC=2.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.17553595]No cytotoxicity information found	Not found	17553595	Peptides. 2007 Jul;28(7):1331-1343.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP01721	HFLGKLVNLAKKIL	14	[T5k]temporin-DRa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana draytonii 	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Clinical isolates: Propionibacterium acnes strain ATCC 11828 (MIC=6 µM), P. acnes strain 32548 (MIC=6 µM), P. acnes strain 33257 (MIC=12.5 µM), P. acnes strain 50247 (MIC=3 µM), P. acnes strain 18380 (MIC=12.5 µM), P. acnes strain 15725 (MIC=6 µM), P. acnes strain 29903 (MIC=12.5 µM), P. acnes strain 31766 (MIC=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	Mixed (5D-Lys)	[Ref.22374306]No cytotoxicity information found	Not found	22374306	Peptides. 2012 Apr;34(2):275-282.	Popovic S, Urbán E, Lukic M, Conlon JM.	Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP02230	GFLDIINKLGKTFAGHMLDKIKCTIGTCPPSP	32	Ranatuerin-3 (Frogs, amphibians, animals)	P82780 	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacterium S.aureus. Has no detectable hemolytic activity.	[Ref.9784389] Gram-positive bacterium: Staphylococcus aureus (MIC=60 µM).	[Ref.9784389] Have no detectable hemolytic activity at aconcentration of 20µg/ml against human red blood cell.	Cyclic	Free	Free	Disulfide bridge between Cys23 and Cys28.	L	[Ref.9784389]No cytotoxicity information found	Not found	9784389	Biochem Biophys Res Commun. 1998 Sep 29;250(3):589-592.	Goraya J, Knoop FC, Conlon JM.	Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana.	
DRAMP02231	FLPFIARLAAKVFPSIICSVTKKC	24	Ranatuerin-4 (Frogs, amphibians, animals)	P82819 	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacterium S.aureus. Has no detectable hemolytic activity.	[Ref.9784389] Gram-positive bacterium: Staphylococcus aureus (MIC=55 µM).	[Ref.9784389] Have no detectable hemolytic activity at aconcentration of 20µg/ml against human red blood cell.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bridge between Cys18 and Cys24.	L	[Ref.9784389]No cytotoxicity information found	Not found	9784389	Biochem Biophys Res Commun. 1998 Sep 29;250(3):589-592.	Goraya J, Knoop FC, Conlon JM.	Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana.	
DRAMP01731	FLPIAGKLLSGLSGLL	16	Temporin-ALd (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops loloensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Temporin-ALd exhibits hemolytic activity against rabbit red blood cells.	[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=1.25 µg/mL), Bacillus pumilus (MIC=2.5 µg/mL), Bacillus cereus (MIC=15 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=1.25 µg/mL), Bacillus dysenteriae (MIC=5 µg/mL), Acinetobacter calcoaceticus (MIC=15 µg/mL), Psecdomonas aeruginosa (MIC=5 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=1.25 µg/mL).	[Ref:19843479]12% hemolytic activity at 100 μg/mL against rabbit red blood cells	Linear	Free	Amidation	Free	L	[Ref.19843479]No cytotoxicity information found	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01732	FFPIVGKLLFGLSGLL	16	Temporin-ALe (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops loloensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Temporin-ALe exhibits hemolytic activity against rabbit red blood cells.	[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=1.25 µg/mL), Bacillus pumilus (MIC=5 µg/mL), Bacillus cereus (MIC=15 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=1.25 µg/mL), Bacillus dysenteriae (MIC=5 µg/mL), Acinetobacter calcoaceticus (MIC=15 µg/mL), Psecdomonas aeruginosa (MIC=5 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=1.25 µg/mL).	[Ref:19843479]10% hemolytic activity at 100 μg/mL against rabbit red blood cells	Linear	Free	Amidation	Free	L	[Ref.19843479]No cytotoxicity information found	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP01733	FFPIVGKLLSGLSGLL	16	Temporin-ALf (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops loloensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Temporin-ALf exhibits hemolytic activity against rabbit red blood cells.	[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2.5 µg/mL), Bacillus pumilus (MIC=5 µg/mL), Bacillus cereus (MIC=30 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=2.5 µg/mL), Bacillus dysenteriae (MIC=5 µg/mL), Acinetobacter calcoaceticus (MIC=30 µg/mL), Psecdomonas aeruginosa (MIC=5 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=2.5 µg/mL).	[Ref:19843479]7% hemolytic activity at 100 μg/mL against rabbit red blood cells.	Linear	Free	Amidation	Free	L	[Ref.19843479]No cytotoxicity information found	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP01734	FFPIVGKLLFGLFGLL	16	Temporin-ALg (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops loloensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Temporin-ALg exhibits hemolytic activity against rabbit red blood cells.	[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2.5 µg/mL), Bacillus pumilus (MIC=2.5 µg/mL), Bacillus cereus (MIC=30 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=5 µg/mL), Bacillus dysenteriae (MIC=10 µg/mL), Acinetobacter calcoaceticus (MIC=30 µg/mL), Psecdomonas aeruginosa (MIC=7.5 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=1.25 µg/mL).	[Ref:19843479]16% hemolytic activity at 100 μg/mL against rabbit red blood cells.	Linear	Free	Amidation	Free	L	[Ref.19843479]No cytotoxicity information found	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP01735	FLPIVGKLLSGLSGLS	16	Temporin-ALh (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops loloensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Temporin-ALh exhibits hemolytic activity against rabbit red blood cells.	[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2.5 µg/mL), Bacillus pumilus (MIC=7.5 µg/mL), Bacillus cereus (MIC=75 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=5 µg/mL), Bacillus dysenteriae (MIC=20 µg/mL), Acinetobacter calcoaceticus (MIC=60 µg/mL), Psecdomonas aeruginosa (MIC=2.5 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=2.5 µg/mL).	[Ref:19843479]13% hemolytic activity at 100 μg/mL against rabbit red blood cells.	Linear	Free	Amidation	Free	L	[Ref.19843479]No cytotoxicity information found	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(N)=O)C(C)C
DRAMP01736	FFPIVGKLLSGLL	13	Temporin-ALi (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops loloensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Temporin-ALi exhibits hemolytic activity against rabbit red blood cells.	[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=7.5 µg/mL), Bacillus pumilus (MIC=7.5 µg/mL), Bacillus cereus (MIC=75 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=7.5 µg/mL), Bacillus dysenteriae (MIC=20 µg/mL), Acinetobacter calcoaceticus (MIC=60 µg/mL), Psecdomonas aeruginosa (MIC=5 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=5 µg/mL).	[Ref:19843479]21% hemolytic activity at 100 μg/mL against rabbit red blood cells	Linear	Free	Amidation	Free	L	[Ref.19843479]No cytotoxicity information found	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP01737	FFPIVGKLLFGLL	13	Temporin-ALj (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops loloensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Temporin-ALg exhibits hemolytic activity against rabbit red blood cells.	[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=7.5 µg/mL), Bacillus pumilus (MIC=15 µg/mL), Bacillus cereus (MIC=75 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=15 µg/mL), Bacillus dysenteriae (MIC=30 µg/mL), Acinetobacter calcoaceticus (MIC=60 µg/mL), Psecdomonas aeruginosa (MIC=7.5 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=5 µg/mL).	[Ref:19843479]19% hemolytic activity at 100 μg/mL against rabbit red blood cells.	Linear	Free	Amidation	Free	L	[Ref.19843479]No cytotoxicity information found	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP01738	FFPIVGKLLS	10	Temporin-ALk (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops loloensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Temporin-ALk exhibits hemolytic activity against rabbit red blood cells.	[Ref.19843479]Gram-positive bacterium: Staphylococcus aureus ATCC2592 (MIC=15 µg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=30 µg/mL), Bacillus dysenteriae (MIC=60 µg/mL), Acinetobacter calcoaceticus (MIC=75 µg/mL), Psecdomonas aeruginosa (MIC=25 µg/mL);##Yeast: Candida albicans ATCC2002 (MIC=15 µg/mL).	[Ref:19843479]25% hemolytic activity at 100 μg/mL against rabbit red blood cells.	Linear	Free	Amidation	Free	L	[Ref.19843479]No cytotoxicity information found	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(N)=O)C(C)C
DRAMP02229	GLFLDTLKGAAKDVAGKLEGLKCKITGCKLP	31	Ranatuerin-2 (Frogs, amphibians, animals)	P82742 	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacterium S.aureus. Has no detectable hemolytic activity.	[Ref.9784389] Gram-positive bacterium: Staphylococcus aureus (MIC=60 µM).	[Ref.9784389] It has no detectable hemolytic activity at aconcentration of 20µg/ml against human red blood cell.	Cyclic	Free	Free	Disulfide bond between Cys23 and Cys28.	L	No cytotoxicity information found	Not found	9784389	Biochem Biophys Res Commun. 1998 Sep 29;250(3):589-592.	Goraya J, Knoop FC, Conlon JM.	Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)O)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC1=O
DRAMP01750	FLPLVGKILSGLI	13	Temporin-1PLa (Frogs, amphibians, animals)	A7WNV7	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Antimicrobial activity against the Gram-positive bacteria: S. aureus. Tissue specificity: Expressed by the skin glands. PTM: Isoleucine amide at position 13.	Gram-positive bacterium: Staphylococcus aureus (MIC=70 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.11087945]No cytotoxicity information found	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@H](C)CC)C(N)=O
DRAMP01751	FLPGLIAGIAKML	13	Temporin-LT1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana latouchii 	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Temporin-LT1 shows hemolytic activities against rabbit red blood cells (LD50>100 µg/ml).	[Ref.19340924]Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 µM), Bacillus subtilis (MIC=25 µM).	[Ref:19340924]LD50>100 µg/ml against rabbit red blood cells	Linear	Free	Amidation	Free	L	[Ref.19340924]No cytotoxicity information found	Not found	19340924	Biochimie. 2009 Apr;91(4):540-547.	Wang H, Yan X, Yu H, Hu Y, Yu Z, Zheng H, Chen Z, Zhang Z, Liu J.	Isolation, characterization and molecular cloning of new antimicrobial peptides belonging to the brevinin-1 and temporin families from the skin of Hylarana latouchii (Anura: Ranidae).	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01752	FLPIALKALGSIFPKIL	17	Temporin-LT2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana latouchii 	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Temporin-LT2 shows hemolytic activities against rabbit red blood cells (LD50>200 µg/ml).	[Ref.19340924]Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 µM), Bacillus subtilis (MIC=50 µM).	[Ref:19340924]LD50>200 µg/ml against rabbit red blood cells	Linear	Free	Amidation	Free	L	[Ref.19340924]No cytotoxicity information found	Not found	19340924	Biochimie. 2009 Apr;91(4):540-547.	Wang H, Yan X, Yu H, Hu Y, Yu Z, Zheng H, Chen Z, Zhang Z, Liu J.	Isolation, characterization and molecular cloning of new antimicrobial peptides belonging to the brevinin-1 and temporin families from the skin of Hylarana latouchii (Anura: Ranidae).	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01753	FVDLKKIANIINSIFGK	17	Temporin-1CEa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana chensinensis (Chinese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Alpha helix 	Not found		Function: Temporin-1CEa exhibits the greatest ability to inhibit the growth of MCF-7 cells. Also temporin-1CEa shows hemolytic effect to human erythrocytes and has no significant cytotoxicity to normal HUVSMCs at concentrations showed potent antitumor activity. 	[Ref.21871946]Gram-positive bacteria: Staphylococcus aureus (MIC=14.4 µM), Bacillus cereus (MIC=14.4 µM), Streptococcus lactis (MIC=14.4 µM);##Gram-negative bacterium: Escherichia coli (MIC>100 µM).	[Ref:21871946]LD50=99.08 μM against human erythrocytes	Linear	Free	Amidation	Free	L	[Ref.19341344]No cytotoxicity information found##[Ref.21871946]No determined cytotoxic against SMCs at the concentration between 20-60 μM.	Not found	21871946##19341344	Biochimie. 2012 Feb;94(2):434-441.##Zoolog Sci. 2009 Mar;26(3):220-226.	Wang C, Li HB, Li S, Tian LL, Shang DJ.##Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y.	Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis).##Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP01754	ILPILSLIGGLLGK	14	Temporin-1CEb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana chensinensis (Chinese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus (MIC=41 µM), Bacillus cereus (MIC=41 µM), Streptococcus lactis (MIC=41 µM);##Gram-negative bacterium: Escherichia coli (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.19341344]No cytotoxicity information found	Not found	19341344	Zoolog Sci. 2009 Mar;26(3):220-226.	Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y.	Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP01755	FLGALAKIISGIF	13	Temporin-1TSa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana tsushimensis (Tsushima brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=4 µM);##Gram-negative bacterium: Escherichia coli (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.16413829]No cytotoxicity information found	Not found	16413829	Comp Biochem Physiol C Toxicol Pharmacol. 2006 May;143(1):42-49. 	Conlon JM, Al-Ghaferi N, Abraham B, Sonnevend A, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.	Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP01759	FLSAITSLLGKLL	13	Temporin-1SPb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana septentrionalis (mink frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.15556063]No cytotoxicity information found	Not found	15556063	Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.	Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP01764	FLPILGKLLSGIL	13	Temporin-1TGa (Frogs, amphibians, animals)	Q2PGA8	Belongs to the frog skin active peptide family (Brevinin subfamily)	tmpTGa	Rana tagoi (Tago frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=15 µM);##Gram-negative bacterium: Escherichia coli (MIC>100 µM).##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.12804591]No cytotoxicity information found##[Ref.16675060]No cytotoxicity information found	Not found	12804591##16675060	Biochem Biophys Res Commun. 2003 Jun 27;306(2):496-500.##Peptides. 2006 Sep;27(9):2124-2128.	Conlon JM, Sonnevend A, Patel M, Camasamudram V, Nowotny N, Zilahi E, Iwamuro S, Nielsen PF, PÃ¡l T.##Iwamuro S, Nakamura M, Ohnuma A, Conlon JM.	A melittin-related peptide from the skin of the Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties.##Molecular cloning and sequence analyses of preprotemporin mRNAs containing premature stop codons from extradermal tissues of Rana tagoi.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01765	AVDLAKIANKVLSSLF	16	Temporin-1TGb (Frogs, amphibians, animals)	Q2PGA7	Belongs to the frog skin active peptide family (Brevinin subfamily)	tmpTGb	Rana tagoi (Tago frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC>150 µM);##Gram-negative bacterium: Escherichia coli (MIC=37.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.16675060]No cytotoxicity information found	Not found	16675060	Peptides. 2006 Sep;27(9):2124-2128.	Iwamuro S, Nakamura M, Ohnuma A, Conlon JM.	Molecular cloning and sequence analyses of preprotemporin mRNAs containing premature stop codons from extradermal tissues of Rana tagoi.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP01766	FLPVILPVIGKLLSGIL	17	Temporin-1TGc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana tagoi (Tago's brown frog); also Rana sakuraii	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=37.5 µM);##Gram-negative bacterium: Escherichia coli (MIC>150 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.16675060]No cytotoxicity information found	Not found	16675060	Peptides. 2006 Sep;27(9):2124-2128.	Iwamuro S, Nakamura M, Ohnuma A, Conlon JM.	Molecular cloning and sequence analyses of preprotemporin mRNAs containing premature stop codons from extradermal tissues of Rana tagoi.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01768	FLPVILPVIGKLLNGIL	17	Temporin-1SKa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sakuraii (stream brown frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli (MIC>50 µM);##Gram-negative bacteria: Staphylococcus aureus (MIC=25 µM).##Fungi: Candida albicans (MIC>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.17174009]No cytotoxicity information found	Not found	17174009	Peptides. 2007 Mar;28(3):505-514.	Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.	Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP18384	KKSCHTGLDRSAGWVIPIGTLVKKAILPWDRK	32	sOT2 (reptiles; animals)	No entry found	Not found	Not found	Chinese softshell turtle, Pelodiscus sinensis	Antimicrobial, Antibacterial		Helix	Not found		Comment: No comments found on DRAMP database	Active against E. coli ATCC 25922 (MIC 28 uM), V. cholerae (MIC 7 uM), Gram+ B. megaterium (MIC 7 uM) and B. pumilus TISTR 905 (MIC 7 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	[Ref.28159460]No cytotoxicity information found	Not found	28159460	Biochim Biophys Acta Biomembr. 2017 May;1859(5):860-869. 	Prajanban BO, Jangpromma N, Araki T, Klaynongsruang S	Antimicrobial effects of novel peptides cOT2 and sOT2 derived from Crocodylus siamensis and Pelodiscus sinensis ovotransferrins	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O)[C@H](C)CC
DRAMP01771	FLPLLASLFSRLL	13	Temporin-1Oa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana ornativentris (Japanese mountain brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=70 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.17147973]No cytotoxicity information found	Not found	17147973	Peptides. 2007 Mar;28(3):524-532.	Ohnuma A, Conlon JM, Yamaguchi K, Kawasaki H, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.	Antimicrobial peptides from the skin of the Japanese mountain brown frog Rana ornativentris: evidence for polymorphism among preprotemporin mRNAs.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O
DRAMP01773	FLPLLASLFSRLF	13	Temporin-1Oc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana ornativentris (Japanese mountain brown frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.17147973]No cytotoxicity information found	Not found	17147973	Peptides. 2007 Mar;28(3):524-532.	Ohnuma A, Conlon JM, Yamaguchi K, Kawasaki H, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.	Antimicrobial peptides from the skin of the Japanese mountain brown frog Rana ornativentris: evidence for polymorphism among preprotemporin mRNAs.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP01775	FLSGIVGMLGKLFGK	15	Temporin-1Sa (Frogs, amphibians, animals)	B3KYH4	Belongs to the frog skin active peptide family (Brevinin subfamily)	preproTemp-1Sa	Pelophylax saharicus (Sahara frog) (Rana saharica)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Activity against Gram-positive and Gram-negative bacteria, and has hemolytic activity against human erythrocytes.	[Ref.18584916]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=3 µM), Enterococcus faecalis ATCC 29212 (MIC=10 µM), Bacillus megaterium (MIC=2 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10 µM), Escherichia coli ATCC 35218 (MIC=10 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=31 µM);##Fungi: Candida albicans ATCC 90028 (MIC=16 µM), Candida parapsilosis ATCC 22019 (MIC=31 µM), Saccharomyces cerevisiae (MIC=8 µM).	[Ref:18584916]LC50=25 μM against human erythrocytes	Linear	Free	Amidation	Free	L	[Ref.18584916]No cytotoxicity information found	Not found	18584916	Peptides. 2008 Sep;29(9):1526-1523.	Abbassi F, Oury B, Blasco T, Sereno D, Bolbach G, Nicolas P, Hani K, Amiche M, Ladram A	Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP01776	FLPIVTNLLSGLLGK	15	Temporin-1Sb (Temporin-SHb; Frogs, amphibians, animals)	B3KYH5	Belongs to the frog skin active peptide family (Brevinin subfamily)	preproTemp-1Sb	Pelophylax saharicus (Sahara frog) (Rana saharica)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		Function: Activity against Gram-positive and Gram-negative bacteria, and has strong hemolytic activity against human erythrocytes.	[Ref.18584916]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=58 µM), Enterococcus faecalis ATCC 29212 (MIC>116 µM), Bacillus megaterium (MIC=46 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=231 µM), Escherichia coli ATCC 35218 (MIC>116 µM);##Fungi: Aspergillus flavus (MIC=58 µM).	[Ref:18584916]LC50>116 μM against human erythrocytes	Linear	Free	Amidation	Free	L	[Ref.18584916]No cytotoxicity information found	Not found	18584916	Peptides. 2008 Sep;29(9):1526-1523.	Abbassi F, Oury B, Blasco T, Sereno D, Bolbach G, Nicolas P, Hani K, Amiche M, Ladram A	Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)C(C)C
DRAMP01777	FLSHIAGFLSNLFGK	15	Temporin-1Sc (Temporin-SHc; Frogs, amphibians, animals)	B3KYH6	Belongs to the frog skin active peptide family (Brevinin subfamily)	preproTemp-1Sc	Pelophylax saharicus (Sahara frog) (Rana saharica)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Alpha helix	Not found		Function: Activity against a range of Gram-positive and Gram-negative bacteria, and has hemolytic activity against human erythrocytes.	[Ref.18584916]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=10 µg/ml), Enterococcus faecalis ATCC 29212 (MIC>80 µg/ml), Bacillus megaterium (MIC=4 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=161 µg/ml), Escherichia coli ATCC 35218 (MIC>80 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC>161 µg/ml);##Fungi: Aspergillus flavus (MIC=10 µg/ml), Candida albicans ATCC 90028 (MIC=20 µg/ml), Candida parapsilosis ATCC 22019 (MIC=20 µg/ml), Saccharomyces cerevisiae (MIC=10 µg/ml).	[Ref:18584916]LC50>80 μM against human erythrocytes	Linear	Free	Amidation	Free	L	[Ref.18584916]No cytotoxicity information found	Not found	18584916	Peptides. 2008 Sep;29(9):1526-1523.	Abbassi F, Oury B, Blasco T, Sereno D, Bolbach G, Nicolas P, Hani K, Amiche M, Ladram A	Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(N)=O
DRAMP01779	FFFLSRIFGK	10	Temporin-SHf (Frogs, amphibians, animals)	D4YWD1	Belongs to the frog skin active peptide family (Brevinin subfamily)	preproTemp-SHf	Pelophylax saharicus (Sahara frog) (Rana saharica)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 µM);##Gram-negative bacterium: Escherichia coli (MIC=25-200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.20308076]No cytotoxicity information found	Not found	20308076	J Biol Chem. 2010 May 28;285(22):16880-16892.	Abbassi F, Lequin O, Piesse C, Goasdoue N, Foulon T, Nicolas P, Ladram A.	Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(N)=O
DRAMP01780	FLSGIVGMLGKLF	13	Temporin-SHa (Temporin-1Sa; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Pelophylax saharica (North Africa)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus (MIC=3 µM), Bacillus megaterium (MIC=2 µM);##Gram-negative bacterium: Escherichia coli (MIC=10 µM).##Yeast: Candida albicans (MIC=16 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.31614561]Display cytotoxic against human gastric cells(N87 cell:IC50=1558 ± 324μM)	Not found	31614561	Biomolecules. 2019 Oct 11;9(10):598.	Olleik H, Baydoun E, Perrier J, Hijazi A, Raymond J, Manzoni M, Dupuis L, Pauleau G, Goudard Y, Villéon B, Goin G, Sockeel P, Choudhary MI, Pasquale ED, Nadeem-Ul-Haque M, Ali H, Khan AI, Shaheen F, Maresca M. 	Temporin-SHa and Its Analogs as Potential Candidates for the Treatment of Helicobacter pylori. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP01782	FFPLVLGALGSILPKIF	17	Temporin-LTa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana latouchii (broad-folded frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus (MIC=20 µg/ml) and Bacillus subtilis (MIC=10 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.19022312]No cytotoxicity information found	Cell membrance	19022312	Peptides. 2009 Feb;30(2):273-282.	Wang H, Lu Y, Zhang X, Hu Y, Yu H, Liu J, Sun J.	The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae).	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP01783	FIITGLVRGLTKLF	14	Temporin-LTb (Frogs, amphibians, animals)	B9UYA1	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana latouchii (broad-folded frog)	Antimicrobial, Antibacterial, Anti-Gram+	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 µg/ml) and Bacillus subtilis (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.19022312]No cytotoxicity information found	Cell membrance	19022312	Peptides. 2009 Feb;30(2):273-282.	Wang H, Lu Y, Zhang X, Hu Y, Yu H, Liu J, Sun J.	The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae).	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP01784	SLSRFLSFLKIVYPPAF	17	Temporin-LTc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana latouchii (broad-folded frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral	Not found	Not found	Not found		Comment: A mutant of the peptide is also HIV inhibitory (Wang G et al. 2010 Antimicrob. Agents Chemother. 54: 1343-1346).	Gram-positive bacteria: Staphylococcus aureus (MIC=50 µg/ml), Bacillus subtilis (MIC=50 µg/ml);##Gram-negative bacterium: Pseudomonas fluorescens (MIC=100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.19022312]No cytotoxicity information found	Not found	19022312	Peptides. 2009 Feb;30(2):273-282.	Wang H, Lu Y, Zhang X, Hu Y, Yu H, Liu J, Sun J.	The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae).	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP01785	IPPFIKKVLTTVF	13	Temporin-CPa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates capito (New World frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: For this series of peptides, there were not enough material for antimicrobial assays. It displayed hemolytic activity (human red blood cells) at LC50=220 uM. 	[Ref.19635516]Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=50 µM);##Yeast: Candida albicans ATCC 90028 (MIC=25 µM).	[Ref:19635516]LC50=220 μM against human erythrocytes	Linear	Free	Amidation	Free	L	[Ref.19635516]No cytotoxicity information found	Not found	19635516	Peptides. 2009 Oct;30(10):1775-1781.	Conlon JM, Meetani MA, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.	Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae).	CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@H](C)CC
DRAMP01787	AILTTLANWARKFL	14	Temporin-HN1 (Frogs, amphibians, animals)	E7EKD0	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana hainanensis (Hainan odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has hemolytic activity against washed human erythrocytes (IC50=75 µM).	[Ref.22450466]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=37.5 µM), Staphylococcus carnosus KHS (MIC=37.5 µM), Bacillus licheniformis X39 (MIC=19 µM), Rhodococcus rhodochrous X15 (MIC=4.8 µM);##Gram-negative bacteria: Psychrobacter faecalis X29 (MIC=75 µM);##Fungi: Slime mould 090223 (MIC=19 µM), Candida albicans ATCC2002 (MIC=75 µM).	[Ref:22450466]IC50=75 µM against washed human erythrocytes	Linear	Free	Amidation	Free	L	[Ref.22450466]No cytotoxicity information found	Not found	22450466	Peptides. 2012 Jun;35(2):285-290. 	Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.	Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O)[C@@H](C)O
DRAMP01788	NILNTIINLAKKIL	14	Temporin-HN2 (Frogs, amphibians, animals)	E7EKD4	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana hainanensis (Hainan odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=4.8 µM), Staphylococcus carnosus KHS (MIC=19 µM), Bacillus licheniformis X39 (MIC=19 µM),Rhodococcus rhodochrous X15 (MIC=2.4 µM);##Gram-negative bacterium: Psychrobacter faecalis X29 (MIC=37.5 µM).##Fungi: Slime mould 090223 (MIC=9.5 µM) and Candida albicans ATCC2002 (MIC=9.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.22450466]No cytotoxicity information found	Not found	22450466	Peptides. 2012 Jun;35(2):285-290. 	Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.	Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01789	FLSSIGKILGNLL	13	Temporin-1Va (Temporin 1Va; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana virgatipes (Ranidae) (Aquarana)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: It also has weak hemolytic activty.	[Ref.15996769]Gram-positive bacteria: Staphylococcus aureus NCTC8325 (MIC=10 µM), S. aureus (MRSA) T7/20 (MIC=20 µM), S. epidermidis RP62A (MIC=20 µM), Enterococcus faecalis ATCC 29212 (MIC=40 µM), Streptococcus group B HNTCC 80130 (MIC=20 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=40 µM), Klebsiella pneumoniae KK3 9904 (MIC=80 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=160 µM), Enterobacter cloacae HNTCC 53001 (MIC=40 µM);##Yeast: Candida albicans ATCC 90028 (MIC=160 µM).	[Ref:15996769]LD50=120 μM against washed human erythrocytes	Linear	Free	Amidation	Free	L	[Ref.15996769]No cytotoxicity information found	Not found	15996769	Regul Pept. 2005 Nov;131(1-3):38-45.	Conlon JM, Abraham B, Sonnevend A, Jouenne T, Cosette P, Leprince J, Vaudry H, Bevier CR.	Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). 	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP01790	FLSIIAKVLGSLF	13	Temporin-1Vb (Temporin 1Vb; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana virgatipes (Ranidae) (Aquarana)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: It also has weak hemolytic activty.	[Ref.15996769]Gram-positive bacteria: Staphylococcus aureus NCTC8325 (MIC=5 µM), S. aureus (MRSA) T7/20 (MIC=10 µM), S. epidermidis RP62A (MIC=5 µM), Enterococcus faecalis ATCC 29212 (MIC=20 µM), Streptococcus group B HNTCC 80130 (MIC=20 µM).	[Ref:15996769]LD50=30 μM against washed human erythrocytes	Linear	Free	Amidation	Free	L	[Ref.15996769]No cytotoxicity information found	Not found	15996769	Regul Pept. 2005 Nov;131(1-3):38-45.	Conlon JM, Abraham B, Sonnevend A, Jouenne T, Cosette P, Leprince J, Vaudry H, Bevier CR.	Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). 	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@H](C)CC
DRAMP01791	FLPLVTMLLGKLF	13	Temporin-1Vc (Temporin 1Vc; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana virgatipes (Ranidae) (Aquarana)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: It also has weak hemolytic activty.	[Ref.15996769]Gram-positive bacteria: Staphylococcus aureus NCTC8325 (MIC=5 µM), S. aureus (MRSA) T7/20 (MIC=10 µM), S. epidermidis RP62A (MIC=10 µM), Enterococcus faecalis ATCC 29212 (MIC=40 µM), Streptococcus group B HNTCC 80130 (MIC=40 µM);##Gram-negative bacteria: Klebsiella pneumoniae KK3 9904 (MIC=80 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=160 µM), Enterobacter cloacae HNTCC 53001 (MIC=40 µM).	[Ref:15996769]LD50=30 μM against washed human erythrocytes	Linear	Free	Amidation	Free	L	[Ref.15996769]No cytotoxicity information found	Not found	15996769	Regul Pept. 2005 Nov;131(1-3):38-45.	Conlon JM, Abraham B, Sonnevend A, Jouenne T, Cosette P, Leprince J, Vaudry H, Bevier CR.	Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). 	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP01807	FLPLVLGALSGILPKIL	17	Temporin-RN1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana nigrovittata	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=4.69 µg/ml);##Gram-negative bacterium: Pseudomonas aeruginosa PAO1 (MIC=4.7 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.19778602]No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP01808	FFPLLFGALSSHLPKLF	17	Temporin-RN3 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana nigrovittata	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=3.75 µg/ml);##Gram-negative bacterium: Pseudomonas aeruginosa PAO1 (MIC=3.75 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.19778602]No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP01811	FLKPLFNAALKLLP	14	Temporin-Ra (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana ridibunda (marsh frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		At 60 ug/ml, the peptide showed about 1.3% hemolysis.	Gram-negative bacteria: Escherichia coli (MIC=24.2 µg/ml), Klebsiella pneumoniae PTCC 1388 (MIC=31.2 µg/ml);##Gram-positive bacteria: Streptococcus dysgalactiae PTCC 1074 (MIC=33.2 µg/ml), Streptococcus agalactiae PTCC 1365 (MIC=24.7 µg/ml) and Staphylococcus aureus PTCC 1431 (MIC=35.2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.21956830]No cytotoxicity information found	Not found	21956830	J Pept Sci. 2012 Jan;18(1):10-16.	Asoodeh A, Zardini HZ, Chamani J.	Identification and characterization of two novel antimicrobial peptides, temporin-Ra and temporin-Rb, from skin secretions of the marsh frog (Rana ridibunda).	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(N)=O
DRAMP01812	FLPVLAGVLSRA	12	Temporin-Rb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana ridibunda (marsh frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		At 60 ug/ml, the peptide showed about 1.1% hemolysis. 	Gram-positive bacteria: Streptococcus dysgalactiae PTCC 1074 (MIC=21.8 µg/ml), Streptococcus agalactiae PTCC 1365 (MIC=30.5 µg/ml), Staphylococcus aureus PTCC 1431 (MIC=42.1 µg/ml), Staphylococcus typhimurium (MIC=31.8 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=34.5 µg/ml), Klebsiella pneumoniae PTCC 1388 (MIC=35.1 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.21956830]No cytotoxicity information found	Not found	21956830	J Pept Sci. 2012 Jan;18(1):10-16.	Asoodeh A, Zardini HZ, Chamani J.	Identification and characterization of two novel antimicrobial peptides, temporin-Ra and temporin-Rb, from skin secretions of the marsh frog (Rana ridibunda).	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(N)=O
DRAMP01815	FLPLLFGAISHLL	13	Temporin-GH (AMP-5; Frogs, amphibians, animals)	P84858	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana guentheri (Gunther's frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Active against the Gram-positive bacteria S. aureus FDA209P and B. subtilis ATCC 6633, but not active against the Gram-negative bacteria E. coli or the fungus C. albicans.
Tissue specificity: Expressed by the skin glands.
PTM: Leucine amide at position 13."	Gram-positive bacteria: Staphylococcus aureus FDA209P (MIC=44.3 µg/ml), Bacillus subtilis ATCC 6633 (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation	Free	L	[Ref.16979798]No cytotoxicity information found	Not found	16979798	Peptides. 2006 Dec;27(12):3077-3084	Zhou J, McClean S, Thompson A, Zhang Y, Shaw C, Rao P, Bjourson AJ.	Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01816	FLPIIGKLLSGLL	13	Temporin-1CSb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana cascadae (Cascades frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=128 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.17451843]No cytotoxicity information found	Not found	17451843	Peptides 2007; 28: 1268-1274.	Conlon JM, Al-Dhaheri A, Al-Mutawa E, Al-Kharrge R, Ahmed E, Kolodziejek J, Nowotny N, Nielsen PF, Davidson C.	Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01817	FLPLVTGLLSGLL	13	Temporin-1CSc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana cascadae (Cascades frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC>128 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=64 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.17451843]No cytotoxicity information found	Not found	17451843	Peptides 2007; 28: 1268-1274.	Conlon JM, Al-Dhaheri A, Al-Mutawa E, Al-Kharrge R, Ahmed E, Kolodziejek J, Nowotny N, Nielsen PF, Davidson C.	Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(N)=O
DRAMP01818	NFLGTLVNLAKKIL	14	Temporin-1CSd (Temporin-1DRb; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana cascadae (Cascades frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=64 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=16 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.17451843]No cytotoxicity information found	Not found	17451843	Peptides 2007; 28: 1268-1274.	Conlon JM, Al-Dhaheri A, Al-Mutawa E, Al-Kharrge R, Ahmed E, Kolodziejek J, Nowotny N, Nielsen PF, Davidson C.	Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP03510	KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK	37	Cecropin A	P01507	cecropin	Not found	Hyalophora cecropia	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha-helix 	Not found	1D9J	Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity.	[Ref.7140755] Gram-negative bacterium: Escherichia coli D21 (LC=0.19 µM), Escherichia coli D31 (LC=0.21 µM), Serratia marcescens Db11 (LC=4.2 µM), Serratia marcescens Db1108 (LC=2.5 µM), Serratia marcescens Db1121 (LC=4.4 µM), Serratia marcescens Strain 122 (LC=3.2 µM), Pseudomonas aeruginosa OT97 (LC=4.8 µM), Xenorhabdus nematophilus Xn21 (LC=1.4 µM).##[Ref.29925795]Gram-negative bacterium:Escherichia coli CVCC 245 (MIC=4.2 ± 0.35μg/mL);##Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (MIC=198 ± 10.1μg/mL),L. mono. CVCC 1599 (MIC=64.5 ± 3.20μg/mL)	[Ref.29925795] 50% hemolysis at 169 ± 8.20 μg/ml  against sheep red blood cells.	Linear	Free	Amidation	Free	L	[Ref.29925795]No cytotoxicity information found##[Ref.7140755]No cytotoxicity information found	Not found	7140755##29925795	Eur J Biochem. 1982 Sep;127(1):207-217.##Molecules. 2018 Jun 20;23(6):1491.	Hultmark D, Engstr?m A, Bennich H, Kapur R, Boman HG.##Wei X, Wu R, Zhang L, Ahmad B, Si D, Zhang R.	Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae.##Expression, Purification, and Characterization of a Novel Hybrid Peptide with Potent Antibacterial Activity	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@H](C)CC
DRAMP01391	GCSRWIIGIHGQICRD	16	Odorranain-U1 (OdU1; Frogs, amphibians, animals)	A6MBS4	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Odorranain-U1 adopts 60.2% 		Function: Odorranain-U1 exhibites moderate antimicrobial activities against all of the tested microbes.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC>100 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=75.00 μg/ml), Bacillus subtilis (MIC=9.37 μg/ml).##Yeast: Candida albicans (MIC=9.37 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01832	FLPGLLAGLL	10	Temporin-Eca (Frogs, amphibians, animals)	C0HJB9	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Euphlyctis cyanophlyctis (Skittering frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity. Has no or very limited (<3%) hemolytic activity at concentrations of 15 µg/ml and 60 µg/ml, respectively.
Tissue specificity: Expressed by the skin glands."	[Swiss_Prot Entry C0HJB9]Gram-negative bacteria: Escherichia coli HP101BA (MIC=12.3 µM), Klebsiella pneumoniae PTCC1388 (MIC=9.8 µM);##Gram-positive bacteria: Micrococcus luteus PTCC1625 (MIC=8.3 µM), Staphylococcus aureus PTCC1431 (MIC=10.6 µM).	[Ref.Int J Pept Res Ther(2012)18;107.]<3% hemolytic activity at 60 µg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Int. J. Pept. Res. Ther. 2012;18:107-115.	Asoodeh A, Ghorani-Azam A, Chamani JK.	Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.	
DRAMP01833	RAGLKFPVGRVHRLLR	16	Buforin-EC (Frogs, amphibians, animals)	C0HJB7	Belongs to the histone H2A family	Not found	Euphlyctis cyanophlyctis (Skittering frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity. Has no or very limited (<3%) hemolytic activity at concentrations of 15 µg/ml and 60 µg/ml, respectively.
Tissue specificity: Expressed by the skin glands."	[Swiss_Prot Entry C0HJB7]Gram-negative bacteria: Escherichia coli HP101BA (MIC=9.6 µM), Klebsiella pneumoniae PTCC1388 (MIC=10.6 µM);##Gram-positive bacteria: Micrococcus luteus PTCC1625 (MIC=6.0 µM), Staphylococcus aureus PTCC1431 (MIC=8.1 µM).	[Ref.Int J Pept Res Ther(2012)18;107.]<3% hemolytic activity at 60 µg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Int. J. Pept. Res. Ther. 2012;18:107-115.	Asoodeh A, Ghorani-Azam A, Chamani JK.	Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.	
DRAMP01834	FLNALKNFAKTAGKRLKSLLN	21	Cyanophlyctin (Frogs, amphibians, animals)	C0HJB8	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Euphlyctis cyanophlyctis (Skittering frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity. Has no or very limited (<3%) hemolytic activity at concentrations of 15 µg/ml and 60 µg/ml.
Tissue specificity: Expressed by the skin glands."	[Swiss_Prot Entry C0HJB8]Gram-negative bacteria: Escherichia coli HP101BA (MIC=6.4 µM), Klebsiella pneumoniae PTCC1388 (MIC=7.3 µM);##Gram-positive bacteria: Micrococcus luteus PTCC1625 (MIC=4.7 µM), Staphylococcus aureus PTCC1431 (MIC=5.3 µM).	[Ref.Int J Pept Res Ther(2012)18;107.]<3% hemolytic activity at 60 µg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Int. J. Pept. Res. Ther. 2012;18:107-115.	oodeh A, Ghorani-Azam A, Chamani JK.	Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.	
DRAMP01840	GFRDVLKGAAKAFVKTVAGHIAN	23	Ascaphin-1 (Frogs, amphibians, animals)	P0CJ25	Belongs to the ascaphin family	Not found	Ascaphus truei (Coastal tailed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Has a very weak hemolytic activity. Tissue specificity: Expressed by the skin glands. PTM: Asparagine amide at position 23.	[Ref.15207717]Gram-negative bacterium: Escherichia coli (MIC=6 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>50 µM).	[Ref.15207717]HC50>200 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15207717	Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.	Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.	The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.	
DRAMP01842	GFRDVLKGAAKAFVKTVAGHIANI	24	Ascaphin-3 (Frogs, amphibians, animals)	P0CJ27	Belongs to the ascaphin family	Not found	Ascaphus truei (Coastal tailed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Has a very weak hemolytic activity. Tissue specificity: Expressed by the skin glands.	[Ref.15207717]Gram-negative bacterium: Escherichia coli (MIC=6 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>50 µM).	[Ref.15207717]HC50>200 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15207717	Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.	Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.	The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.	
DRAMP01844	GIKDWIKGAAKKLIKTVASNIANQ	24	Ascaphin-5 (Frogs, amphibians, animals)	P0CJ29	Belongs to the ascaphin family	Not found	Ascaphus truei (Coastal tailed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.	[Ref.15207717]Gram-negative bacteria: Escherichia coli (MIC=6 µM), Pseudomonas aeruginosa (MIC=13 µM), Enterobacter cloacae (MIC=6 µM), Klebsiella pneumoniae (MIC=13 µM), Proteus mirabilis (MIC>100 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=50 µM), Staphylococcus epidermidis (MIC=13 µM), Enterococcus faecalis (MIC>100 µM), Streptococcus Group B (MIC=6 µM);##Yeast: Candida albicans (MIC=100 µM).	[Ref.15207717]Not found	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15207717	Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.	Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.	The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.	
DRAMP01846	GFKDWIKGAAKKLIKTVASSIANQ	24	Ascaphin-7 (Frogs, amphibians, animals)	P0CJ31	Belongs to the ascaphin family	Not found	Ascaphus truei (Coastal tailed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Has a very weak hemolytic activity. Tissue specificity: Expressed by the skin glands.	[Ref.15207717]Gram-negative bacterium: Escherichia coli (MIC=3 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=25 µM).	[Ref.15207717]HC50>200 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15207717	Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.	Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.	The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.	
DRAMP01847	GFKDLLKGAAKALVKTVLF	19	Ascaphin-8 (Frogs, amphibians, animals)	P0CJ32	Belongs to the ascaphin family	Not found	Ascaphus truei (Coastal tailed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral	Protein level	Not found	Not found		Function: Antimicrobial peptide that shows similar potency against Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity. Tissue specificity: Expressed by the skin glands. PTM: Phenylalanine amide at position 19.	[Ref.15207717]Gram-negative bacterium: Escherichia coli (MIC=6 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM).	[Ref.15207717]HC50=50 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15207717	Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.	Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.	The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.	
DRAMP01849	DSMGAVKLAKLLIDKMKCEVTKAC	24	Jindongenin-1a (JD1a; Frogs, amphibians, animals)	G3ETQ2	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Displays broad-spectrum antibacterial activity against a range of Gram-positive and Gram-negative bacteria. Also displays antifungal activity against C. albicans ATCC 2002. Has hemolytic activity, low cytotoxicity and low antioxidant activity.	[Ref.21816202]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=17 µM), Enterococcus faecalis ATCC29212 (MIC=60 µM), Staphylococcus aureus (IS 10#)(MIC=40 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=10 µM), Enterobacter cloacae ATCC13047 (MIC=40 µM), Klebsiella pneumoniae ATCC700603 (MIC=15 µM), Bacillus pyocyaneus CMCCB1010 (MIC=17 µM), Pseudomonas aeruginosa ATCC27853 (MIC=23 µM), Bacillus dysenteriae (MIC=40 µM);##Yeast: Candida albicans ATCC2002 (MIC=60 µM).	[Ref.21816202] IC50=150 μM against washed human erythrocytes	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	[Ref.21816202] Cytotoxicity: the K562 (IC50=46μM)and HT29 mammalian cell lines(IC50=40μM).	Not found	21816202	Biochimie. 2012 Feb;94(2):328-334.	Chen Z, Yang X, Liu Z, Zeng L, Lee W, Zhang Y.	Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis.	
DRAMP01869	FFPIIAGMAAKLIPSLFCKITKKC	24	Brevinin-1SPa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana septentrionalis (mink frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes.	[Ref.15556063]Gram-negative bacterium: Escherichia coli (MIC=13 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM);##Yeast: Candida albicans (MIC=7 µM).	[Ref.15556063]HC50=7 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15556063	Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.	Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).	
DRAMP01870	FLPIIAGMAAKVICAITKKC	20	Brevinin-1SPb (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana septentrionalis (mink frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes (HC50=6 µM).	[Ref.15556063]Gram-negative bacterium: Escherichia coli (MIC=50 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=13 µM);##Yeast: Candida albicans (MIC=25 µM).	[Ref.15556063]HC50=25 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15556063	Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.	Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).	
DRAMP01872	FFPIIAGMAAKVICAITKKC	20	Brevinin-1SPd (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana septentrionalis (mink frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes.	[Ref.15556063]Gram-negative bacterium: Escherichia coli (MIC=13 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=3 µM);##Yeast: Candida albicans (MIC=8 µM).	[Ref.15556063]HC50=8 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15556063	Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.	Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).	
DRAMP01873	GIWDTIKSMGKVFAGKILQNL	21	Brevinin-2-related peptide (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana septentrionalis (mink frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		"Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes.
Sequence similarity: This peptide shows limited structural similarity with the N-terminal region of brevinin-2 peptides previously isolated from R. temporaria skin but lacks the C-terminal cyclic heptapeptide domain associated with this family.
PTM: C-terminal amidation."	[Ref.15556063]Gram-negative bacterium: Escherichia coli (MIC=13 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=25 µM);##Yeast: Candida albicans (MIC=70 µM).	[Ref.15556063]HC50=70 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15556063	Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.	Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).	
DRAMP04213	KKLFKKILKYL	11	BP100	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	The peptide adopted with positively charged residues on one face and the hydrophobic residues on the opposite face of the helix		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria.  Has hemolytic activity.	[Ref.29750913] Gram-negative bacteria:Escherichia coli(ATCC 25922)(MIC=2 μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=2μM);Bacillus subtilis(PY79)(MIC=2μM)	[Ref.29750913] 10% hemolysis at 64μM against human red blood cell	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29750913	Biochim Biophys Acta. 2018 Aug;1860(8):1502-1516. 	Carretero GPB, Saraiva GKV, Cauz ACG, Rodrigues MA, Kiyota S, Riske KA, Dos Santos AA, Pinatto-Botelho MF, Bemquerer MP, Gueiros-Filho FJ, Chaimovich H, Schreier S, Cuccovia IM.	Synthesis, biophysical and functional studies of two BP100 analogues modified by a hydrophobic chain and a cyclic peptide.	
DRAMP03571	LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	37	LL-37	P49913,Q71SN9	Belongs to the cathelicidin family	CAMP	Human lysosomes of polymorphonuclear leukocytes	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Protein level	Alpha helix	The peptide adopted 1 helices and 30 residues and a curved amphipathic helix-bend-helix motif spanning residues 2-31 followed by a disordered C-terminal tail. The helical bend is located between residues Gly-14 and Glu-16.	2K6O resolved by NMR	Function:Antibacterial activity against the Gram-positive and Gram-negative bacteria. Has hemolytic activity.	[Ref.29859288] Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=25 ± 0 μg/ml);ESBL-producing Escherichia coli(MIC=33.3 ± 14.4μg/ml);NDM-1 producing Acinetobacter baumannii(MIC=20.8 ± 7.2 μg/ml);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=133.3 ± 57.7μg/ml);##Fungi:Candida albicans (ATCC 90028)(MIC>400μg/ml)	[Ref.29859288] 2.9 ± 0.7% Hemolysis  at 500μg/ml against human red blood cell	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29859288	Gene. 2018 May 30. pii: S0378-1119(18)30617-6.	Wanmakok M, Orrapin S, Intorasoot A, Intorasoot S.	Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.	
DRAMP01748	FFPIVGKRLYGLL	13	Temporin-AJ8 (Frogs, amphibians, animals)	K7Z903 	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops jingdongensis (torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		Function: Shows antimicrobial abilities against microorganisms including Gram-negative and Gram-positive bacteria, and fungi. Has hemolytic activity.	[Ref.22828809] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=70 μg/ml), B. dysenteriae(MIC=18.75 μg/ml) ;## Gram-positive bacteria: Staphylococcus aureus ATCC 2592(MIC=4.7 μg/ml), Bacillus subtilis ATCC 6633(MIC=9.38 μg/ml);## Yeast: Candida albicans ATCC 2002(MIC=37.5 μg/ml).	[Ref.22828809] 1.79% hemolysis at 25μg/ml, 5.22% hemolysis at 50μg/ml, 7.92% hemolysis at 100μg/ml, 10.85% hemolysis at 200μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Amino Acids. 2012 Jul 25.	He X, Yang S, Wei L, Liu R, Lai R, Rong M.	Antimicrobial peptide diversity in the skin of the torrent frog, Amolops jingdongensis.	
DRAMP01879	GAFGDLLKGVAKEAGMKLLNMAQCKLSGKC	30	Brevinin-2LTa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Hylarana latouchii (Broad-folded frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2 µM), Bacillus licheniformis X39 (MIC=8 µM), Staphylococcus carnosus KHS (MIC=2 µM), Rhodococcus rhodochrous X15 (MIC=0.5 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=32.5 µM), Serratia rubidaea X01 (MIC=130 µM), Pseudomonas aeruginosa 1.50 (MIC=65 µM), Psychrobacter faecalis X29 (MIC=0.5 µM).	[Ref.22426384] LD50=520 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys24 and Cys30)	Disulfide bond between Cys24 and Cys30.	L	No cytotoxicity information found	Not found	22426384	Biochimie. 2012 Jun;94(6):1317-1326.	Wang H, Yu Z, Hu Y, Yu H, Ran R, Xia J, Wang D, Yang S, Yang X, Liu J.	Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.	
DRAMP01880	SILDKIKNVALGVARGAGTGILKALLCKLDKSC	33	Brevinin-2LTb (Frogs, amphibians, animals)	No entry found	Not found	Not found	Hylarana latouchii (Broad-folded frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=3.8 µM), Bacillus licheniformis X39 (MIC=3.8 µM), Staphylococcus carnosus KHS (MIC=1.9 µM), Rhodococcus rhodochrous X15 (MIC=1.9 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=30 µM), Serratia rubidaea X01 (MIC=60 µM), Pseudomonas aeruginosa 1.50 (MIC=30 µM), Psychrobacter faecalis X29 (MIC=1.9 µM).	[Ref.22426384] LD50=480 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22426384	Biochimie. 2012 Jun;94(6):1317-1326.	Wang H, Yu Z, Hu Y, Yu H, Ran R, Xia J, Wang D, Yang S, Yang X, Liu J.	Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.	
DRAMP01881	GVLDTFKDVAIGVAKGAGTGVLKALLCKLDKSC	33	Brevinin-2LTc (Frogs, amphibians, animals)	No entry found	Not found	Not found	Hylarana latouchii (Broad-folded frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=60 µM), Rhodococcus rhodochrous X15 (MIC=30 µM);##Gram-negative bacterium: Psychrobacter faecalis X29 (MIC=15 µM).	[Ref.22426384] LD50>480 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22426384	Biochimie. 2012 Jun;94(6):1317-1326.	Wang H, Yu Z, Hu Y, Yu H, Ran R, Xia J, Wang D, Yang S, Yang X, Liu J.	Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.	
DRAMP01885	FFGPLIKIATGVLPNLICKALGKC	24	Brevinin-1TEa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Hylarana temporalis (Indian bronzed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Showes higher antimicrobial activity against Gram-negative than against Gram-positive bacteria.	Gram-negative bacteria: E. coli (NCLM 2064) (MIC=30 µg/ml), P. aeruginosa (ATCC 10145) (MIC=150 µg/ml), V. cholerae (PL 91) (MIC=150 µg/ml);##Gram-positive bacteria: B. cereus (NCLM 2156) (MIC=100 µg/ml), S. aureus (ATCC25923) (MIC>150 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21412958	J Pept Sci. 2011 May;17(5):342-347.	Reshmy V, Preeji V, Parvin A, Santhoshkumar K, George S.	Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).	
DRAMP01886	GIGSMLLGLAKNVGMSLLNKAQCKISGKC	29	Brevinin-2TEa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Hylarana temporalis (Indian bronzed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Showes higher antimicrobial activity against Gram-negative than against Gram-positive bacteria.	Gram-negative bacteria: E. coli (NCLM 2064) (MIC=40 µg/ml), P. aeruginosa (ATCC 10145) (MIC=100 µg/ml), V. cholerae (PL 91) (MIC=150 µg/ml);##Gram-positive bacteria: B. cereus (NCLM 2156) (MIC>150 µg/ml), S. aureus (ATCC25923) (MIC>150 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21412958	J Pept Sci. 2011 May;17(5):342-347.	Reshmy V, Preeji V, Parvin A, Santhoshkumar K, George S.	Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).	
DRAMP01887	GFMGDTLKGIARNAALALMNAAQCKLSGKC	30	Brevinin-2TEb (Frogs, amphibians, animals)	No entry found	Not found	Not found	Hylarana temporalis (Indian bronzed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Showes higher antimicrobial activity against Gram-negative than against Gram-positive bacteria.	Gram-negative bacteria: E. coli (NCLM 2064) (MIC=20 µg/ml), P. aeruginosa (ATCC 10145) (MIC=40 µg/ml), V. cholerae (PL 91) (MIC=60 µg/ml);##Gram-positive bacteria: B. cereus (NCLM 2156) (MIC=150 µg/ml), S. aureus (ATCC25923) (MIC=40 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21412958	J Pept Sci. 2011 May;17(5):342-347.	Reshmy V, Preeji V, Parvin A, Santhoshkumar K, George S.	Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).	
DRAMP01888	FFPTIAGLTKLFCAITKKC	19	Brevinin-1CHc (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana chiricahuensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: E. coli (MIC=80 µM);##Gram-positive bacterium: S. aureus (MIC=20 µM).##Yeast: C. albicans (MIC=20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys13 and Cys19)	Disulfide bond between Cys13 and Cys19.	L	No cytotoxicity information found	Not found	21262304	Peptides. 2011 Apr;32(4):664-669.	Conlon JM, Mechkarska M, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.	Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.	
DRAMP01889	GIGSILGVIAKGLPTLISWIKNR	23	Brevinin-1TOa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana tagoi okiensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: E. coli (MIC=20 µM);##Gram-positive bacterium: S. aureus (MIC=5 µM).##Yeast: C. albicans (MIC=20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19799928	Toxicon. 2010 Feb-Mar;55(2-3):430-435.	Conlon JM, Coquet L, Jouenne T, Leprince J, Vaudry H, Iwamuro S.	Evidence from the primary structures of dermal antimicrobial peptides that Rana tagoi okiensis and Rana tagoi tagoi (Ranidae) are not conspecific subspecies.	
DRAMP01890	FLGAIAGVAAKFLPKVFCFITKKC	24	Brevinin-1VLa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana vaillanti (Central American frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Brevinin-1VLa showes particularly high growth-inhibitory potency (MIC < or =3 microM) against a Gram-positive microorganism Staphylococcus aureus and the opportunistic yeast pathogen Candida albicans and potent cytolytic activity (LC(50)< or =8 microM) against both human erythrocytes and HepG2 hepatoma-derived cells. The peptide ia also active against a Gram-negative microorganism Escherichia coli (MIC< or =50 microM).	Gram-negative bacterium: E. coli (MIC=25 µM);##Gram-positive bacterium: S. aureus (MIC=3 µM).##Yeast: C. albicans (MIC=3 µM).	[Ref.19379837] LC50=8 mM against human erythrocytes	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	[Ref.19379837] LC50=4mM against HepG2 hepatoma-derived cells	Not found	19379837	Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.	Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.	Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).	
DRAMP01891	FLPVIASVAAKVLPKVFCFITKKC	24	Brevinin-1VLc (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana vaillanti (Central American frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Brevinin-1VLc showes particularly high growth-inhibitory potency (MIC < or =3 microM) against a Gram-positive microorganism Staphylococcus aureus and the opportunistic yeast pathogen Candida albicans and potent cytolytic activity (LC(50)< or =8 microM) against both human erythrocytes and HepG2 hepatoma-derived cells. The peptide ia also active against a Gram-negative microorganism Escherichia coli (MIC< or =50 microM).	Gram-negative bacterium: E. coli (MIC=50 µM);##Gram-positive bacterium: S. aureus (MIC=1.5 µM).##Yeast: C. albicans (MIC=3 µM).	[Ref.19379837] LC50=7 mM against human erythrocytes	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	[Ref.19379837] LC50=4mM against HepG2 hepatoma-derived cells	Not found	19379837	Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.	Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.	Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).	
DRAMP01892	FLPLIAGVAANFLPKIFCLISKKC	24	Brevinin-1VLd (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana vaillanti (Central American frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Inhibits the growth of reference strains of S. aureus, E. coli and C. albicans and to lyse human erythrocytes from a healthy donor and HepG2 human hepatoma-derived cells	Gram-negative bacterium: E. coli (MIC>100 µM);##Gram-positive bacterium: S. aureus (MIC=3 µM).##Yeast: C. albicans (MIC=3 µM).	[Ref.19379837] LC50=5 mM against human erythrocytes	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	[Ref.19379837] LC50=6mM against HepG2 hepatoma-derived cells	Not found	19379837	Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.	Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.	Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).	
DRAMP01893	FLPLIAGVAASILPKIFCFITKKC	24	Brevinin-1VLe (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana vaillanti (Central American frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Inhibits the growth of reference strains of S. aureus, E. coli and C. albicans and to lyse human erythrocytes from a healthy donor and HepG2 human hepatoma-derived cells	Gram-negative bacterium: E. coli (MIC>100 µM);##Gram-positive bacterium: S. aureus (MIC=3 µM).##Yeast: C. albicans (MIC=3 µM).	[Ref.19379837] LC50=5 mM against human erythrocytes	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	[Ref.19379837] LC50=7mM against HepG2 hepatoma-derived cells	Not found	19379837	Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.	Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.	Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).	
DRAMP01896	FLSTALKVAANVVPTLFCKITKKC	24	Brevinin-1CG1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Amolops chunganensis (Chungan torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=9 µM), Bacillus licheniformis X39 (IS) (MIC=75 µM);##Gram-negative bacterium: Escherichia coli (ATCC 25922) (MIC=150 µM).##Fungi: Slime mold 090223 (IS) (MIC=75 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22951323	Peptides. 2012 Nov;38(1):41-53.	Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.	Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.	
DRAMP01897	FLPIVAGLAANFLPKIVCKITKKC	24	Brevinin-1CG2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Amolops chunganensis (Chungan torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=9 µM), Bacillus licheniformis X39 (IS) (MIC=75 µM), Enterococcus faecalis 981 (MIC=19 µM), Staphylococcus carnosus KHS (IS) (MIC=9 µM), Staphylococcus aureus (ATCC 25923) (MIC=9 µM);##Gram-negative bacteria: Escherichia coli (ATCC 25922) (MIC=150 µM), Psychrobacter faecalis X29 (IS) (MIC=19 µM), Serratia rubidaea X01 (IS) (MIC=19 µM).##Fungi: Slime mold 090223 (IS) (MIC=4.5 µM), Candida albicans (ATCC 10231) (MIC=150 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22951323	Peptides. 2012 Nov;38(1):41-53.	Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.	Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.	
DRAMP01898	FLSTLLNVASNVVPTLICKITKKC	24	Brevinin-1CG3 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Amolops chunganensis (Chungan torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Primarily active against Gram-positive bacteria. Also highly active against Gram-negative P. faecalis X29 and S. rubidaea.	Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=2.3 µM), Bacillus licheniformis X39 (IS) (MIC=9 µM), Enterococcus faecalis 981 (MIC=75 µM), Staphylococcus carnosus KHS (IS) (MIC=19 µM), Staphylococcus aureus (ATCC 25923) (MIC=19 µM);##Gram-negative bacteria: Escherichia coli (ATCC 25922) (MIC=150 µM), Psychrobacter faecalis X29 (IS) (MIC=4.5 µM), Serratia rubidaea X01 (IS) (MIC=9 µM).##Fungi: Slime mold 090223 (IS) (MIC=9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22951323	Peptides. 2012 Nov;38(1):41-53.	Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.	Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.	
DRAMP01899	FLSTLLNVASKVVPTLFCKITKKC	24	Brevinin-1CG4 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Amolops chunganensis (Chungan torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=2.3 µM), Bacillus licheniformis X39 (IS) (MIC=9 µM), Enterococcus faecalis 981 (MIC=9 µM), Staphylococcus carnosus KHS (IS) (MIC=9 µM), Staphylococcus aureus (ATCC 25923) (MIC=9 µM);##Gram-negative bacterium: Escherichia coli (ATCC 25922) (MIC=150 µM), Pseudomonas aeruginosa 11053 (IS) (MIC=75 µM), Psychrobacter faecalis X29 (IS) (MIC=9 µM), Serratia rubidaea X01 (IS) (MIC=9 µM).##Fungi: Slime mold 090223 (IS) (MIC=9 µM), Candida albicans (ATCC 10231) (MIC=150 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22951323	Peptides. 2012 Nov;38(1):41-53.	Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.	Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.	
DRAMP01900	FLPMLAGLAANFLPKIVCKITKKC	24	Brevinin-1CG5 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Amolops chunganensis (Chungan torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Primarily active against Gram-positive bacteria, escecially R. rhodochrous. Also highly active against Gram-negative P. faecalis X29 and S. rubidaea.	Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=0.6 µM), Bacillus licheniformis X39 (IS) (MIC=2.3 µM), Enterococcus faecalis 981 (MIC=9 µM), Staphylococcus carnosus KHS (IS) (MIC=1.2 µM), Staphylococcus aureus (ATCC 25923) (MIC=9 µM);##Gram-negative bacteria: Escherichia coli (ATCC 25922) (MIC=75 µM), Pseudomonas aeruginosa (CGMCC 1.50) (MIC=75 µM), Pseudomonas aeruginosa 11053 (IS) (MIC=75 µM), Klebsiella pneumoniae 08040724 (IS) (MIC=150 µM), Psychrobacter faecalis X29 (IS) (MIC=9 µM), Serratia rubidaea X01 (IS) (MIC=4.6 µM).##Fungi: Slime mold 090223 (IS) (MIC=4.5 µM), Candida albicans (ATCC 10231) (MIC=437.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22951323	Peptides. 2012 Nov;38(1):41-53.	Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.	Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.	
DRAMP01909	GFSSLFKAGAKYLLKSVGKAGAQQLACKAANNCA	34	Brevinin-2GHa (AMP-1; Frogs, amphibians, animals)	P84860	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana guentheri (Gunther's frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Problely contains one disulfide bond 27-33. "	Gram-positive bacteria: Staphylococcus aureus FDA209P (MIC=14.9 µg/ml), Bacillus subtilis ATCC 6633 (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	16979798	Peptides. 2006 Dec;27(12):3077-3084.	Zhou J, McClean S, Thompson A, Zhang Y, Shaw C, Rao P, Bjourson AJ.	Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri.	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC1=O
DRAMP01910	GVITDALKGAAKTVAAELLRKAHCKLTNSC	30	Brevinin-2GHb (AMP-2; Frogs, amphibians, animals)	A0AEI5	Belongs to the frog skin active peptide family (Brevinin subfamily)	br2GHb	Rana guentheri (Gunther's frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Problely contains one disulfide bond 24-30. "	Gram-positive bacteria: Staphylococcus aureus FDA209P (MIC=16.5 µg/ml), Bacillus subtilis ATCC 6633 (MIC>64 µg/ml);##Gram-negative bacteria: Escherichia coli O111 (MIC=8.2 µg/ml), Escherichia coli ATCC 25922 (MIC=8.2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys24 and Cys30)	Disulfide bond between Cys24 and Cys30.	L	No cytotoxicity information found	Not found	16979798	Peptides. 2006 Dec;27(12):3077-3084.	Zhou J, McClean S, Thompson A, Zhang Y, Shaw C, Rao P, Bjourson AJ.	Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri.	
DRAMP01911	SIWEGIKNAGKGFLVSILDKVRCKVAGGCNP	31	Brevinin-2GHc (AMP-4; Frogs, amphibians, animals)	A0AEI6	Belongs to the frog skin active peptide family (Brevinin subfamily)	br2GHc	Rana guentheri (Gunther's frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Problely contains one disulfide bond 24-30. "	Gram-positive bacteria: Staphylococcus aureus FDA209P (MIC=9.8 µg/ml), Bacillus subtilis ATCC 6633 (MIC>64 µg/ml);##Gram-negative bacteria: Escherichia coli O111 (MIC=19.6 µg/ml), Escherichia coli ATCC 25922 (MIC=9.8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys24 and Cys30.	L	No cytotoxicity information found	Not found	16979798	Peptides. 2006 Dec;27(12):3077-3084.	Zhou J, McClean S, Thompson A, Zhang Y, Shaw C, Rao P, Bjourson AJ.	Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri.	
DRAMP01913	FLPLLAGLAANFLPKIFCKITKKC	24	Brevinin-1GRa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grahami (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	16621155	Peptides. 2006 Sep;27(9):2111-2117.	 Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H. 	Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami. 	
DRAMP01914	GLLDTFKNLALNAAKSAGVSVLNSLSCKLSKTC	33	Brevinin-2GRa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grahami (Asian frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=12.5 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=50 µM).##Yeast: Candida albicans (MIC>100 µM).	[Ref.16621155] LC50=140 μM against human erythrocytes. 	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	16621155##17272268	Peptides. 2006 Sep;27(9):2111-2117.##Mol Cell Proteomics. 2007 May;6(5):882-894. 	Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.##Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.##Anti-infection peptidomics of amphibian skin.	
DRAMP01918	FLPLIAGLAANFLPKIFCAITKKC	24	Brevinin-1PLb (Frogs, amphibians, animals)	A7WNV3	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands."	Gram-positive bacterium: Staphylococcus aureus (MIC=9 µM);##Gram-negative bacterium: Escherichia coli(MIC=26 µM).##Yeast: Candida albicans (MIC=6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17698247##11087945	Peptides. 2007 Aug;28(8):1605-1610.##Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Zhou M, Wang L, Owens DE, Chen T, Walker B, Shaw C.##Basir YJ, Knoop FC, Dulka J, Conlon JM.	Rapid identification of precursor cDNAs encoding five structural classes of antimicrobial peptides from pickerel frog (Rana palustris) skin secretion by single step shotgun cloning.##Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP01919	FLPVIAGVAAKFLPKIFCAITKKC	24	Brevinin-1PLc (Frogs, amphibians, animals)	A7WNV4	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=4 µM);##Gram-negative bacterium: Escherichia coli(MIC=7 µM).##Yeast: Candida albicans (MIC=8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17698247##11087945	Peptides. 2007 Aug;28(8):1605-1610.##Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Zhou M, Wang L, Owens DE, Chen T, Walker B, Shaw C.##Basir YJ, Knoop FC, Dulka J, Conlon JM.	Rapid identification of precursor cDNAs encoding five structural classes of antimicrobial peptides from pickerel frog (Rana palustris) skin secretion by single step shotgun cloning.##Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP01920	FLPILAGLAAKIVPKLFCLATKKC	24	Brevinin-1CSa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana cascadae (Cascades frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Brevinin-1CSa was strongly hemolytic against human erythrocytes. 	[Ref.17451843]Gram-negative bacterium: Escherichia coli (MIC=32 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=2 µM).	[Ref.17451843] LD50=5 µM against human erythrocytes	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	17451843	Peptides. 2007 Jun;28(6):1268-1274.	Conlon JM, Al-Dhaheri A, Al-Mutawa E, Al-Kharrge R, Ahmed E, Kolodziejek J, Nowotny N, Nielsen PF, Davidson C.	Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.	
DRAMP18383	DEDLDE	6	XLAsp-P2 (X. laevis antibacterial peptide-P2; frog, amphibians, animals)	No entry found	Not found	Not found	skin, African clawed frog, Xenopus laevis, Africa	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28299865	J Pept Sci. 2017 Mar 16. in press. doi: 10.1002/psc.	Zhang Y, Liu S, Li S, Cheng Y, Nie L, Wang G, Lv C, Wei W, Cheng C, Hou F, Hao L	Novel short antimicrobial peptide isolated from Xenopus laevis skin	
DRAMP01922	GLFNVFKKVGKNVLKNVAGSLMDNLKCKVSGEC	33	Brevinin-2SKb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sakuraii (Japanese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=3 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17174009	Peptides. 2007 Mar;28(3):505-514.	Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.	Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.	
DRAMP01933	GIMDTLKNLAKTAGKGALQSLVKMASCKLSGQC	33	Brevinin-2Ef (Frogs, amphibians, animals)	P40842	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (Edible frog) (Pelophylax esculentus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity 	[Swiss_Prot Entry P40842]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref.8163497]LC50>100 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163497	J Biol Chem. 1994 Apr 22;269(16):11956-11961.	Simmaco M, Mignogna G, Barra D, Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP01934	GILSTIKDFAIKAGKGAAKGLLEMASCKLSGQC	33	Brevinin-2Ei (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta complex	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		"Function: Potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli. No peptide, at concentrations up to 100 µM, inhibited the growth of the fungal pathogen C. albicans.
Sequence similarity: This peptide shows limited amino acid sequence similarity to the homologous exon gene products that encode the N-terminal flanking peptides of preprocaerulein, preproxenopsin, and preprolevitide."	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14499272	Peptides. 2003 Jul;24(7):955-961.	Ali MF, Knoop FC, Vaudry H, Conlon JM.	Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.	
DRAMP01935	GIFLDKLKNFAKGVAQSLLNKASCKLSGQC	30	Brevinin-2Ej (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta complex	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		"Function: Potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli. No peptide, at concentrations up to 100 µM, inhibited the growth of the fungal pathogen C. albicans.
Sequence similarity: This peptide shows limited amino acid sequence similarity to the homologous exon gene products that encode the N-terminal flanking peptides of preprocaerulein, preproxenopsin, and preprolevitide."	Gram-negative bacterium: Escherichia coli (MIC=2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14499272	Peptides. 2003 Jul;24(7):955-961.	Ali MF, Knoop FC, Vaudry H, Conlon JM.	Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.	
DRAMP01937	GLGSILGKILNVAGKVGKTIGKVADAVGNKE	31	CPRF-Ea (caerulein precursor-related fragment; Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana esculenta complex	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		"Function: Potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli. No peptide, at concentrations up to 100 µM, inhibited the growth of the fungal pathogen C. albicans.
Sequence similarity: This peptide shows limited amino acid sequence similarity to the homologous exon gene products that encode the N-terminal flanking peptides of preprocaerulein, preproxenopsin, and preprolevitide."	Gram-negative bacterium: Escherichia coli (MIC=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14499272	Peptides. 2003 Jul;24(7):955-961.	Ali MF, Knoop FC, Vaudry H, Conlon JM.	Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.	
DRAMP01938	GLGSFLKNAIKIAGKVGSTIGKVADAIGNKE	31	CPRF-Eb (caerulein precursor-related fragment; Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana esculenta complex	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		"Function: Potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli. No peptide, at concentrations up to 100 µM, inhibited the growth of the fungal pathogen C. albicans.
Sequence similarity: This peptide shows limited amino acid sequence similarity to the homologous exon gene products that encode the N-terminal flanking peptides of preprocaerulein, preproxenopsin, and preprolevitide."	Gram-negative bacterium: Escherichia coli (MIC=5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14499272	Peptides. 2003 Jul;24(7):955-961.	Ali MF, Knoop FC, Vaudry H, Conlon JM.	Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.	
DRAMP01939	GLGSFFKNAIKIAGKVGSTIGKVADAIGNKE	31	CPRF-Ec (caerulein precursor-related fragment; Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana esculenta complex	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		"Function: Potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli. No peptide, at concentrations up to 100 µM, inhibited the growth of the fungal pathogen C. albicans.
Sequence similarity: This peptide shows limited amino acid sequence similarity to the homologous exon gene products that encode the N-terminal flanking peptides of preprocaerulein, preproxenopsin, and preprolevitide."	Gram-negative bacterium: Escherichia coli (MIC=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14499272	Peptides. 2003 Jul;24(7):955-961.	Ali MF, Knoop FC, Vaudry H, Conlon JM.	Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.	
DRAMP01940	FLPIIAGVAAKVLPKLFCAITKKC	24	Brevinin-1CHa (Frogs, amphibians, animals)	A7YJE2	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana chiricahuensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		PTM: Contains disulfide bond.	Gram-negative bacteria: E. coli (MIC=10 µM), K. pneumoniae (MIC=40 µM), P. aeruginosa (MIC=20 µM);##Gram-positive bacterium: S. aureus (MIC=2.5 µM).##Yeast: C. albicans (MIC=2.5 µM).(Ref.2)	[Ref.21262304] LC50=5 µM against human erythrocytes	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	17938991##21262304	J Mol Evol. 2007 Nov;65(5):605-615.##Peptides. 2011 Apr;32(4):664-669.	Tennessen JA, Blouin MS.##Conlon JM, Mechkarska M, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.	Selection for antimicrobial peptide diversity in frogs leads to gene duplication and low allelic variation.##Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.	
DRAMP01941	FLPVIAGLAAKVLPKLFCAITKKC	24	Brevinin-1CHb (Frogs, amphibians, animals)	A7YJE4	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana chiricahuensis 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		PTM: Contains disulfide bond.	Gram-negative bacteria: E. coli (MIC=10 µM), K. pneumoniae (MIC=40 µM), P. aeruginosa (MIC=10 µM);##Gram-positive bacterium: S. aureus (MIC=2.5 µM).##Yeast: C. albicans (MIC=2.5 µM).(Ref.2)	[Ref.21262304] LC50=5 µM against human erythrocytes	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	17938991##21262304	J Mol Evol. 2007 Nov;65(5):605-615.##Peptides. 2011 Apr;32(4):664-669.	Tennessen JA, Blouin MS.##Conlon JM, Mechkarska M, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.	Selection for antimicrobial peptide diversity in frogs leads to gene duplication and low allelic variation.##Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.	
DRAMP01942	FLPAIVGAAGQFLPKIFCAISKKC	24	Brevinin-1Sa (Frogs, amphibians, animals)	P82904	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sphenocephala (Southern leopard frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=55 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10604597	J Pept Res. 1999 Dec;54(6):522-527.	Conlon JM, Halverson T, Dulka J, Platz JE, Knoop FC.	Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala.	
DRAMP01943	FLPAIVGAAGKFLPKIFCAISKKC	24	Brevinin-1Sb (Frogs, amphibians, animals)	P82905	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sphenocephala (Southern leopard frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=17 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10604597	J Pept Res. 1999 Dec;54(6):522-527.	Conlon JM, Halverson T, Dulka J, Platz JE, Knoop FC.	Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala.	
DRAMP01944	FFPIVAGVAGQVLKKIYCTISKKC	24	Brevinin-1Sc (Frogs, amphibians, animals)	P82906	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sphenocephala (Southern leopard frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=14 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10604597	J Pept Res. 1999 Dec;54(6):522-527.	Conlon JM, Halverson T, Dulka J, Platz JE, Knoop FC.	Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala.	
DRAMP01949	FLPAVLRVAAKIVPTVFCAISKKC	24	Brevinin-1HSa (Frogs, amphibians, animals)	P0C8S7	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana hosii (Hose's rock frog) (Odorrana hosii)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=24 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01950	FLPAVLRVAAQVVPTVFCAISKKC	24	Brevinin-1HSb (Brevinin-1JDb; Frogs, amphibians, animals)	P0C8S8	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana hosii (Hose's rock frog) (Odorrana hosii)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC>48 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01951	FMGGLIKAATKIVPAAYCAITKKC	24	Brevinin-1PTa (Frogs, amphibians, animals)	P0C8T1	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana picturata (Malaysian fire frog) (Hylarana picturata)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=24 µM).	 	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01953	GLLDSLKNLAINAAKGAGQSVLNTLSCKLSKTC	33	Brevinin-2HSa (Frogs, amphibians, animals)	P0C8S9	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana hosii (Hose's rock frog) (Rana hosii)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=18 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=36 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01955	GAIKDALKGAAKTVAVELLKKAQCKLEKTC	30	Brevinin-2PTa (Frogs, amphibians, animals)	P0C8T3	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana picturata (Malaysian fire frog) (Hylarana picturata)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 24-30."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=18 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=18 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys24 and Cys30)	Disulfide bond between Cys24 and Cys30.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01956	GFKGAFKNVMFGIAKSAGKSALNALACKIDKSC	33	Brevinin-2PTb (Frogs, amphibians, animals)	P0C8T4	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana picturata (Malaysian fire frog) (Hylarana picturata)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=9 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01957	GLLDSFKNAMIGIAKSAGKTALNKIACKIDKTC	33	Brevinin-2PTc (Frogs, amphibians, animals)	P0C8T5	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana picturata (Malaysian fire frog) (Hylarana picturata)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>72 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=18 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01959	GFLDSFKNAMIGVAKSVGKTALSTLACKIDKSC	33	Brevinin-2PTe (Frogs, amphibians, animals)	P0C8T7	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana picturata (Malaysian fire frog) (Hylarana picturata)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=36 µM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=18 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01963	FLPAIVGAAAKFLPKIFCAISKKC	24	Brevinin-1BLa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates blairi (plains leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli, Aspergillus awamori, Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus	[Ref.19254736] Gram-positive bacteria : Staphylococcus aureus(MIC=1.5 μM);##Gram-negative bacteria : Escherichia coli(MIC=25 μM);##Fungi : Candida albicans(MIC=6 μM)	[Ref.19254736] LC50=14 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19254736	Toxicon. 2009 Jun;53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.	Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.	Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.	
DRAMP01965	FLPIIAGIAAKFLPKIFCTISKKC	24	Brevinin-1BLc (Frogs, amphibians, animals)	B6CPR0	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates blairi (leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.19254736]Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=1.5 µM);##Yeast: Candida albicans (MIC=3 µM);##Cancer cells HepG2: (LC50=6 µM)..	[Ref.19254736] LC50=9 μM against human red blood cells.##[Ref.14531844]Non-hemolytic activity against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19254736	Toxicon. 2009 Jun;53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.	Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.	Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.	
DRAMP01968	FLPIIAGAAAKVVEKIFCAISKKC	24	Brevinin-1Yc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates yavapaiensis (North American leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.19254736] Gram-positive bacteria : Staphylococcus aureus(MIC=6 μM);##Gram-negative bacteria : Escherichia coli(MIC=100 μM);##Fungi : Candida albicans(MIC=6 μM)Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM).##Yeast: Candida albicans (MIC=6 µM).##cancer cells HepG2 (LC50=14 µM). 	[Ref.19254736] LC50=13 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19254736	Toxicon. 2009 Jun;53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.	Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.	Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.	
DRAMP01969	FLGSLIGAAIPAIKQLLGLKK	21	Brevinin-1Ja (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana japonica (Japanese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		It can produced cell death of mammalian COS7 cells (LD50=28 µM).	Gram-positive bacterium: Staphylococcus aureus (MIC=15 µM);##Gram-negative bacterium: Escherichia coli (MIC=119 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18558801	Zoolog Sci 2008; 25: 487-491.	Koyama T, Iwamuro S.	Molecular cloning of a cDNA encoding atypical antimicrobial and cytotoxic brevinin-1Ja from the skin of the Japanese brown frog, Rana japonica.	
DRAMP01970	FLPFLLSALPKVFCFFSKKC	20	Brevinin-1ZHa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana zhenhaiensis (Chinese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=8 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=32 µM).##Yeast: Candida albicans ATCC 2002 (MIC>43 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22943778	Zoolog Sci. 2012 Sep;29(9):553-558.	Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.	Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.	
DRAMP01971	FLPLLLSALPSFLCLVFKKC	20	Brevinin-1ZHb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana zhenhaiensis (Chinese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=17 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=33 µM), Pseudomonas aeruginosa ATCC 9027 (MIC>44 µM).##Yeast: Candida albicans ATCC 2002 (MIC>44 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22943778	Zoolog Sci. 2012 Sep;29(9):553-558.	Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.	Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.	
DRAMP01974	GIMRVFKGVLKTAGKSVAKNVAGSFLDRLKCKISGGC	37	Brevinin-2ZHa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana zhenhaiensis (Chinese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=1 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=5 µM).##Yeast: Candida albicans ATCC 2002 (MIC=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22943778	Zoolog Sci. 2012 Sep;29(9):553-558.	Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.	Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.	
DRAMP01986	SLLGTVKDLLIGAGKSAAQSVLKGLSCKLSKDC	33	Brevinin-2HS2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Huia schmackeri (Chinese piebald odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: It shows poor hemolycity activity (LC50=300 uM). 	Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=19 µM), Bacillus licheniformis X39 (MIC=39 µM), Rhodococcus rhodochrous X15 (MIC=9.5 µM);##Gram-negative bacterium: Psychrobacter faecalis X29 (MIC=9.5 µM).##Fungi: Slime mould 090223 (MIC=37.5 µM), Candida albicans ATCC2002 (MIC=19 µM).	LC50=300µM against human erythrocytes	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	18423796	Peptides. 2008 Aug;29(8):1456-1460.	Quan Z, Zhou M, Chen W, Chen T, Walker B, Shaw C.	Novel brevinins from Chinese piebald odorous frog (Huia schmackeri) skin deduced from cloned biosynthetic precursors.	
DRAMP01990	FMGSALRIAAKVLPAALCQIFKKC	24	Brevinin-1LT1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana latouchii (Chinese broad-folded frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity against rabbit red blood cells.	[Ref.19340924]Gram-positive bacteria: Staphylococcus aureus (MIC=6.25 µM), Bacillus subtilis (MIC=6.25 µM);##Gram-negative bacterium: Pseudomonas fluorescens (MIC=100 µM);##Yeast: Candida albicans (MIC=50 µM).	[Ref.19340924]LC50>200 µg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19340924	Biochimie. 2009 Apr;91(4):540-547.	Wang H, Yan X, Yu H, Hu Y, Yu Z, Zheng H, Chen Z, Zhang Z, Liu J.	Isolation, characterization and molecular cloning of new antimicrobial peptides belonging to the brevinin-1 and temporin families from the skin of Hylarana latouchii (Anura: Ranidae).	
DRAMP01994	SLLDTFKNLAVNAAKSAGVSVLNALSCKISRTC	33	Brevinin-2ISa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana ishikawae (Endangered frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli (MIC=50 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 µM), S. aureus (MRSA) (MIC=100 µM), Bacillus subtilis (MIC=12.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21193000	Peptides. 2011 Apr;32(4):670-676. 	Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.	Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.	
DRAMP01995	SFLTTFKDLAIKAAKSAGQSVLSTLSCKLSNTC	33	Brevinin-2ISb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana ishikawae (Endangered frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli (MIC=12.5 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.3 µM), Bacillus subtilis (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21193000	Peptides. 2011 Apr;32(4):670-676. 	Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.	Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.	
DRAMP01996	SVLGTVKDLLIGAGKSAAQSVLTTLSCKLSNSC	33	Brevinin-2ISc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana ishikawae (Endangered frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli (MIC=50 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21193000	Peptides. 2011 Apr;32(4):670-676. 	Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.	Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.	
DRAMP02001	FLPLIASLAANFVPKIFCKITKKC	24	Brevinin-1HN1 (Frogs, amphibians, animals)	E7EKC4	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana hainanensis (Hainan odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity against Gram-positive bacteria and fungi but has weak or no activity against a range of Gram-negative bacteria except P. faecalis. Has hemolytic activity against human erythrocytes (LC50=75 µM).

Tissue specificity: Expressed by the skin glands.

PTM: Contains one disulfide bond."	[Ref.22450466]Gram-positive bacteria: Enterococcus faecium 091299 (MIC=19 µM), Enterococcus faecalis 981 (MIC=19 µM), Staphylococcus aureus ATCC2592 (MIC=1.2 µM), Staphylococcus carnosus KHS (MIC=4.8 µM), Bacillus licheniformis X39 (MIC=2.4 µM), Rhodococcus rhodochrous X15 (MIC=1.2 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=150 µM), Psychrobacter faecalis X29 (MIC=4.8 µM);##Fungi: Slime mould 090223 (MIC=1.2 µM), Candida albicans ATCC2002 (MIC=2.4 µM).	[Ref.22450466] LC50=75 µM against human erythrocytes	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22450466	Peptides. 2012 Jun;35(2):285-290.	Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.	Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.	
DRAMP02004	FLPLIASVAANLVPKIFCKITKKC	24	Brevinin-1V (Frogs, amphibians, animals)	Q2UXV8, E7EKC5	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana versabilis (Chinese bamboo leaf odorous frog) (Rana versabilis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		"Function: Has antimicrobial activity against Gram-positive bacteria and fungi but has weak or no activity against a range of Gram-negative bacteria except P. faecalis. Has hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond."	[Ref.22450466]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=19 µM), Bacillus licheniformis X39 (MIC=37.5 µM), Rhodococcus rhodochrous X15 (MIC=9.5 µM), Enterococcus faecium 091299 (MIC=19 µM), E. faecalis 981 (MIC=19 µM);##Gram-negative bacterium: Psychrobacter faecalis X29 (MIC=9.5 µM);##Fungi: Slime mould 090223 (MIC=1.2 µM), Candida albicans ATCC2002 (MIC=19-37.5 µM).	[Ref.22450466] LC50=75 µM against human erythrocytes	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	16139929##22450466	Peptides. 2006 Jan;27(1):42-48.##Peptides. 2012 Jun;35(2):285-290.	Chen T, Li L, Zhou M, Rao P, Walker B, Shaw C.##Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.	Amphibian skin peptides and their corresponding cDNAs from single lyophilized secretion samples: identification of novel brevinins from three species of Chinese frogs.##Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.	
DRAMP02006	GIWDTLKNVGKAVLGKVLENV	21	Brevinin-2Va (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana virgatipes (Ranidae) (Aquarana)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=12 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15996769	Regul Pept. 2005 Nov;131(1-3):38-45.	Conlon JM, Abraham B, Sonnevend A, Jouenne T, Cosette P, Leprince J, Vaudry H, Bevier CR.	Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). 	
DRAMP02009	FLPVLAGIAAKVVPALFCKITKKC	24	Brevinin-1 (Frogs, amphibians, animals)	P32423	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana brevipoda porsa (Japanese frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and a very high hemolytic activity.	[Ref.1449472]Gram-positive bacterium: Staphylococcus aureus (MIC=8 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=34 µg/ml).	[Ref.1449472] high hemolytic activity	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	1449472	Biochem Biophys Res Commun. 1992 Nov 30;189(1):184-190.	Morikawa N, Hagiwara K, Nakajima T.	Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa.	
DRAMP02010	GLLDSLKGFAATAGKGVLQSLLSTASCKLAKTC	33	Brevinin-2 (Frogs, amphibians, animals)	P32424	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana brevipoda porsa (Japanese frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and a very high hemolytic activity.	[Ref.1449472]Gram-positive bacterium: Staphylococcus aureus (MIC=8 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=4 µg/ml).	[Ref.1449472] high hemolytic activity	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	1449472	Biochem Biophys Res Commun. 1992 Nov 30;189(1):184-190.	Morikawa N, Hagiwara K, Nakajima T.	Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa.	
DRAMP02019	GLFDVVKGVLKGAGKNVAGSLLEQLKCKLSGGC	33	Brevinin-2DYb (Frogs, amphibians, animals)	P0C5X2	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 27-33."	Gram-positive bacterium: Staphylococcus aureus (MIC=30 µM);##Gram-negative bacterium: Escherichia coli (MIC=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	17688900	Toxicon. 2007 Nov;50(6):746-756.	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.	Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.	
DRAMP18381	VVYALKRNGRTLYGF	15	H4-(86-100) (histone-derived)	No entry found	Not found	Not found	rat	Antimicrobial, Antibacterial		Not found	Not found		Fuction: ATP can enahnce its activity, implying its involvement in inhibiting the DNA gyrase activity.	Active against E. coli (LD90 6.68 ug/ml), P. aeruginosa (LD90 4.8 ug/ml), B. subtilis (LD90 17 ug/ml), and S. aureus (14.7 ug.ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18803668	FEBS J. 2008 Nov;275(21):5286-97.	Lemaire S, Trinh TT, Le HT, Tang SC, Hincke M, Wellman-Labadie O, Ziai S.	Antimicrobial effects of H4-(86-100), histogranin and related compounds--possible involvement of DNA gyrase.	
DRAMP18382	VVYTLKRNGRTLYGF	15	HNr (histone-derived)	No entry found	Not found	Not found	rat	Antimicrobial, Antibacterial		Not found	Not found		Fuction: ATP can enahnce its activity, implying its involvement in inhibiting the DNA gyrase activity.	Active against E. coli (LD90 10.3 ug/ml), P. aeruginosa LD90 8.7 ug/ml), and B. subtilis (LD90 14 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18803668	FEBS J. 2008 Nov;275(21):5286-97.	Lemaire S, Trinh TT, Le HT, Tang SC, Hincke M, Wellman-Labadie O, Ziai S.	Antimicrobial effects of H4-(86-100), histogranin and related compounds--possible involvement of DNA gyrase.	
DRAMP02023	GIFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC	33	Brevinin-2DYd (Frogs, amphibians, animals)	P0C5X4	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 27-33."	Gram-positive bacterium: Staphylococcus aureus (MIC=15 µM);##Gram-negative bacterium: Escherichia coli (MIC=15 µM).##NOTE: mixture of Brevinin-2DYc/2DYd	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	17688900	Toxicon. 2007 Nov;50(6):746-756.	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.	Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.	
DRAMP18380	SGRGKTGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYAQRVGAGAPVY	50	Acipensin 1 (Ac1)	No entry found	Not found	Not found	Leukocytes; the Russian Sturgeon, Acipenser gueldenstaedtii	Antimicrobial, Antibacterial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against E. coli ML35p (MIC 0.7 uM), L. monocytogenes EGD (MIC 1.1 uM), MRSA ATCC 33591 (MIC 0.9 uM), C. albicans 820 (MIC 1 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25558400	Acta Naturae. 2014 Oct;6(4):99-109	Shamova OV, Orlov DS, Balandin SV, Shramova EI, Tsvetkova EV, Panteleev PV, Leonova YF, Tagaev AA, Kokryakov VN, Ovchinnikova TV.	Acipensins - Novel Antimicrobial Peptides from Leukocytes of the Russian Sturgeon Acipenser gueldenstaedtii	
DRAMP02025	GLFSVVTGVLKAVGKNVAKNVGGSLLEQLKCKISGGC	37	Brevinin-2DYe (Brevinin-2CDYa; Frogs, amphibians, animals)	P0C5X5	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Active against the Gram-positive bacteria: S. aureus and Gram-negative bacteria E. coli. Tissue specificity: Expressed by the skin glands. PTM: contains one disulfide bond 31-37.	Gram-positive bacterium: Staphylococcus aureus (MIC=15 µM);##Gram-negative bacterium: Escherichia coli (MIC=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	17688900##17698251	Toxicon. 2007 Nov;50(6):746-756.##Peptides. 2007 Aug;28(8):1532-1539.	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.##Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.	Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.##Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.	
DRAMP02026	LLSLALAALPKLFCLIFKKC	20	Brevinin-1CDYa (Frogs, amphibians, animals)	B3VZU0	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has low activity against the Gram-positive bacteria: S. aureus and Gram-negative bacteria E. coli. Has hemolytic activity against human erythrocytes (HC50=125 µM).
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 14-20."	[Swiss_Prot Entry B3VZU0]Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 µM);##Gram-negative bacterium: Escherichia coli (MIC=25 µM)	[Ref.19539775]HC50=125 μM against human red blood cells	Cyclic	Free	Cyclization (Cys14 and Cys20)	Disulfide bond between Cys14 and Cys20.	L	No cytotoxicity information found	Not found	19539775	Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.	Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.	Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.	
DRAMP18379	SGRGKTGGKARAKAKTRSSRAGLQFPVGRVHRLLR	35	Acipensin 2 (Ac2)	No entry found	Not found	Not found	Leukocytes; the Russian Sturgeon, Acipenser gueldenstaedtii	Antimicrobial, Antibacterial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against E. coli ML35p (MIC 0.3 uM), L. monocytogenes EGD (MIC 1.0 uM), MRSA ATCC 33591 (MIC 0.6 uM), C. albicans 820 (MIC 0.9 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25558400	Acta Naturae. 2014 Oct;6(4):99-109.	Shamova OV, Orlov DS, Balandin SV, Shramova EI, Tsvetkova EV, Panteleev PV, Leonova YF, Tagaev AA, Kokryakov VN, Ovchinnikova TV.	Acipensins - Novel Antimicrobial Peptides from Leukocytes of the Russian Sturgeon Acipenser gueldenstaedtii.	
DRAMP02031	ILPLLLGKVVCAITKKC	17	Brevinin-1Da (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dalmatina (European frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		"Sequence alignment suggests that the peptide is derived from brevinin-1 by multiple residue deletions (D for ""dalmatina"" and 'a' to denote the first isoform identified). "	Gram-positive bacterium: Staphylococcus aureus (MIC=7 µM);##Gram-negative bacterium: Escherichia coli (MIC=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys11 and Cys17)	Disulfide bond between Cys11 and Cys17.	L	No cytotoxicity information found	Not found	15050930	Comp Biochem Physiol C Toxicol Pharmacol. 2004 Feb;137(2):191-196.	Conlon JM, Seidel B, Nielsen PF.	An atypical member of the brevinin-1 family of antimicrobial peptides isolated from the skin of the European frog Rana dalmatina.	
DRAMP02032	FLGSIVGALASALPSLISKIRN	22	Brevinin-1TSa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana tsushimensis (Tsushima brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Activity against a range of Gram-positive and Gram-negative bacteria, but hemolytic activity against human erythrocytes.	[Ref.16413829]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=25 µM), Klebsiella pneumoniae KK3 9904 (MIC>100 µM), Enterobacter cloacae HNTCC 53001 (MIC=50 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=50 µM), Proteus mirabilis ATCC 25933 (MIC>100 µM);##Gram-positive bacteria: Staphylococcus aureus NCTC 8325 (MIC=25 µM), Methicillin-resistant Staphylococcus aureus T7/20 (MIC=25 µM), Staphylococcus epidermidis RP62A (MIC=12.5 µM), Enterococcus faecalis ATCC 29212 (MIC=50 µM), Streptococcus group B HNTCC 80130 (MIC=50 µM);##Yeast: Candida albicans ATCC 90028 (MIC=50 µM)	[Ref.16413829]LD50=12 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16413829	Comp Biochem Physiol C Toxicol Pharmacol. 2006 May;143(1):42-49. 	Conlon JM, Al-Ghaferi N, Abraham B, Sonnevend A, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.	Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis.	
DRAMP02033	GIMSLFKGVLKTAGKHVAGSLVDQLKCKITGGC	33	Brevinin-2TSa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana tsushimensis (Tsushima brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Activity against a range of Gram-positive and Gram-negative bacteria, but relatively low hemolytic activity against human erythrocytes.	[Ref.16413829]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3 µM), Klebsiella pneumoniae KK3 9904 (MIC=6 µM), Enterobacter cloacae HNTCC 53001 (MIC=6 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=6 µM), Proteus mirabilis ATCC 25933 (MIC>100 µM);##Gram-positive bacteria: Staphylococcus aureus NCTC 8325 (MIC=12.5 µM), Methicillin-resistant Staphylococcus aureus T7/20 (MIC=25 µM), Staphylococcus epidermidis RP62A (MIC=12.5 µM), Enterococcus faecalis ATCC 29212 (MIC=25 µM);##Yeast: Candida albicans ATCC 90028 (MIC=100 µM).	[Ref.16413829] LD50=100 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	16413829	Comp Biochem Physiol C Toxicol Pharmacol. 2006 May;143(1):42-49. 	Conlon JM, Al-Ghaferi N, Abraham B, Sonnevend A, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.	Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis.	
DRAMP02034	FLPILAGLAAKLVPKVFCSITKKC	24	Brevinin-1AUa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana aurora aurora (Northern red-legged frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Activity against a range of Gram-positive and Gram-negative bacteria, and also shows hemolytic. 	[Ref.15325526]Gram-negative bacteria: Escherichia coli (MIC=13 µM), Pseudomonas aeruginosa (MIC=25 µM), Enterobacter cloacae (MIC=13 µM), Klebsiella pneumoniae (MIC=50 µM), Proteus mirabilis (MIC>50 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3 µM), Staphylococcus epidermidis (MIC=6 µM), Enterococcus faecalis (MIC=13 µM), Streptococcus Group B (MIC=13 µM);##Yeast: Candida albicans (MIC>40 µM).	[Ref.15325526] HC50=5 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	15325526	Dev Comp Immunol. 2005;29(1):83-90.	Conlon JM, Sonnevend A, Davidson C, Demandt A, Jouenne T.	Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.	
DRAMP02035	FLPILAGLAANILPKVFCSITKKC	24	Brevinin-1AUb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana aurora aurora (Northern red-legged frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Activity against a range of Gram-positive and Gram-negative bacteria, and also shows hemolytic activity. 	[Ref.15325526]Gram-negative bacteria: Escherichia coli (MIC=25 µM), Pseudomonas aeruginosa (MIC=25 µM), Enterobacter cloacae (MIC=25 µM), Klebsiella pneumoniae (MIC>50 µM), Proteus mirabilis (MIC>50 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3 µM), Staphylococcus epidermidis (MIC=6 µM), Enterococcus faecalis (MIC=6 µM), Streptococcus Group B (MIC=13 µM);##Yeast: Candida albicans (MIC=3 µM).	[Ref.15325526] HC50=7 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	15325526	Dev Comp Immunol. 2005;29(1):83-90.	Conlon JM, Sonnevend A, Davidson C, Demandt A, Jouenne T.	Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.	
DRAMP02036	GAFGNFLKGVAKKAGLKILSIAQCKLSGTC	30	Brevinin-2-RN1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana nigrovittata	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Brevinin-2-RN1 and -RN2 could induce 17 and 21% Rabbit red blood cell hemolysis, respectively.	Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=3.10 µg/ml), Staphylococcus aureus ATCC43300 (MIC=3.10 µg/ml), Bacillus subtilis (MIC=12.5 µg/ml);##Gram-negative bacteria: Escherichia coli ML-35P (MIC=25 µg/ml), Pseudomonas aeruginosa PA01 (MIC=12.5 µg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=25 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=6.25 µg/ml).	[Ref.21171145] It has 17% hemolysis at 100 µg/ml against rabbit red blood cell	Cyclic	Free	Cyclization (Cys24 and Cys30)	Disulfide bond between Cys24 and Cys30.	L	No cytotoxicity information found	Not found	21171145	J Pept Sci. 2011 Jan;17(1):68-72.	Liu X, Liu R, Wei L, Yang H, Zhang K, Liu J, Lai R.	Two novel antimicrobial peptides from skin secretions of the frog, Rana nigrovittata.	
DRAMP02037	GAFGNFLKGVAKKAGLKILSIAQCKLFGTC	30	Brevinin-2-RN2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana nigrovittata	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Brevinin-2-RN1 and -RN2 could induce 17 and 21% Rabbit red blood cell hemolysis, respectively.	Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=6.25 µg/ml), Staphylococcus aureus ATCC43300 (MIC=6.25 µg/ml), Bacillus subtilis (MIC=12.5 µg/ml);##Gram-negative bacteria: Escherichia coli ML-35P (MIC=50 µg/ml), Pseudomonas aeruginosa PA01 (MIC=12.5 µg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=12.5 µg/ml). Yeast: Candida albicans ATCC2002 (MIC=3.1 µg/m).	[Ref.21171145] It has 21% hemolysis at 100 µg/ml against rabbit red blood cell	Cyclic	Free	Cyclization (Cys24 and Cys30)	Disulfide bond between Cys24 and Cys30.	L	No cytotoxicity information found	Not found	21171145	J Pept Sci. 2011 Jan;17(1):68-72.	Liu X, Liu R, Wei L, Yang H, Zhang K, Liu J, Lai R.	Two novel antimicrobial peptides from skin secretions of the frog, Rana nigrovittata.	
DRAMP02038	VIVFVASVAAEMMQHVYCAASKKC	24	Brevinin-1-OA1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12.4 µg/ml);##Gram-negative bacteria: Bacillus pyocyaneus CMCCB 10104 (MIC=12.4 µg/ml), Escherichia coli ATCC 25922 (MIC=6.2 µg/ml).##Yeast: Candida albicans (MIC=24.8 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP18378	ILELAGNAARDNKKTRIIPRHLQL	24	Acipensin 6 (Ac6)	No entry found	Not found	Not found	Leukocytes; the Russian Sturgeon, Acipenser gueldenstaedtii	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against E. coli ML35p (MIC 2.5 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25558400	Acta Naturae. 2014 Oct;6(4):99-109. 	Shamova OV, Orlov DS, Balandin SV, Shramova EI, Tsvetkova EV, Panteleev PV, Leonova YF, Tagaev AA, Kokryakov VN, Ovchinnikova TV.	Acipensins - Novel Antimicrobial Peptides from Leukocytes of the Russian Sturgeon Acipenser gueldenstaedtii	
DRAMP02040	FLPAVIRVAANVLPTAFCAISKKC	24	Brevinin-1-OA12 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.6 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.6 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=13.2 µg/ml).##Yeast: Candida albicans (MIC=3.3 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02041	LPFVAGVAAEMMQHVYCAASKKC	23	Brevinin-1-OR1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.3 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=42.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10.6 µg/ml).##Yeast: Candida albicans (MIC=10.6 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys17 and Cys23)	Disulfide bond between Cys17 and Cys23.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02042	IDPFVAGVAAEMMQHVYCAASKKC	24	Brevinin-1-OR3 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=9.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=18.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=18.2 µg/ml).##Yeast: Candida albicans (MIC=18.2 µg/ml). 	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02043	INPFVAGVAAEMMQHVYCAASKKC	24	Brevinin-1-OR4 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8.6 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=8.6 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=8.6 µg/ml).##Yeast: Candida albicans (MIC=8.6 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02044	ILPFVAGVAAEMMKHVYCAASKKC	24	Brevinin-1-OR5 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		It differs from AP1824 only at position 14: Q vs. K.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=30.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=15.2 µg/ml).##Yeast: Candida albicans (MIC=7.6 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02045	IIPFVAGVAAEMMEHVYCAASKKC	24	Brevinin-1-OR6 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		It differs from AP1827 at two positions: 2: I vs. L and 14: K vs. E.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=22.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=22.2 µg/ml).##Yeast: Candida albicans (MIC=11.1 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02046	QLPFVAGVACEMCQCVYCAASKKC	24	Brevinin-1-OR7 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.7 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=5.7 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11.4 µg/ml).##Yeast: Candida albicans (MIC=11.4 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02047	ILPFVAGVAAEMMEHVYCAASKKC	24	Brevinin-1-OR8 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=13.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=52.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=26.2 µg/ml).##Yeast: Candida albicans (MIC=13.1 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02048	ILPFVAGVAAMEMEHVYCAASKKC	24	Brevinin-1-OR9 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=9.8 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=9.8 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=4.9 µg/ml).##Yeast: Candida albicans (MIC=9.8 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02049	FLPAVLLVATHVLPTVFCAITRKC	24	Brevinin-1-OR10 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.4 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=27.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.8 µg/ml).##Yeast: Candida albicans (MIC=6.8 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02050	LAFVAGVAAEMMQHVYCAASKKC	23	Brevinin-1-OR11 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=12.4 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12.4 µg/ml).##Yeast: Candida albicans (MIC=12.4 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys17 and Cys23)	Disulfide bond between Cys17 and Cys23.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02051	ILPFVAGVAAEMMQHVYCAASKKC	24	Lividin-1 (Brevinin-1-OR2; Frogs, amphibians, animals)	Q2UXR4	Belongs to the frog skin active peptide family (Brevinin subfamily)	lividin-1	Odorrana rotodora (Chinese odorous frog) (Odorrana livida)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains disulfide bond."	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.8 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=11.6 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11.6 µg/ml).##Yeast: Candida albicans (MIC=5.8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	16713657##22029824	Peptides. 2006 Sep;27(9):2118-2123.##J Proteome Res. 2012 Jan 1;11(1):306-319.	Zhou M, Chen T, Walker B, Shaw C.##Yang X, Lee WH, Zhang Y.	Lividins: novel antimicrobial peptide homologs from the skin secretion of the Chinese Large Odorous frog, Rana (Odorrana) livida. Identification by shotgun cDNA cloning and sequence analysis.##Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02052	SFLDTLKNLAISAAKGAGQSVLSTLSCKLSKTC	33	Lividin-2 (Brevinin-2-OR8; Frogs, amphibians, animals)	Q2UXR3	Belongs to the frog skin active peptide family (Brevinin subfamily)	lividin-2	Odorrana rotodora (Chinese odorous frog) (Odorrana livida)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains disulfide bond."	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=13.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=13.1 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=13.1 µg/ml).##Yeast: Candida albicans (MIC=13.1 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	16713657##22029824	Peptides. 2006 Sep;27(9):2118-2123.##J Proteome Res. 2012 Jan 1;11(1):306-319.	Zhou M, Chen T, Walker B, Shaw C.##Yang X, Lee WH, Zhang Y.	Lividins: novel antimicrobial peptide homologs from the skin secretion of the Chinese Large Odorous frog, Rana (Odorrana) livida. Identification by shotgun cDNA cloning and sequence analysis.##Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02053	SVLGTVKDLLIGAGKSAAQSVLTALSCKLSNSC	33	Lividin-3 (Brevinin-2-OR1; Frogs, amphibians, animals)	Q2UXR2	Belongs to the frog skin active peptide family (Brevinin subfamily)	lividin-3	Odorrana rotodora (Chinese odorous frog) (Odorrana livida)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains disulfide bond."	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=22 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11 µg/ml).##Yeast: Candida albicans (MIC=11 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	16713657##22029824	Peptides. 2006 Sep;27(9):2118-2123.##J Proteome Res. 2012 Jan 1;11(1):306-319.	Zhou M, Chen T, Walker B, Shaw C.##Yang X, Lee WH, Zhang Y.	Lividins: novel antimicrobial peptide homologs from the skin secretion of the Chinese Large Odorous frog, Rana (Odorrana) livida. Identification by shotgun cDNA cloning and sequence analysis.##Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02054	GILDTFKNMALNAAKSAGVSVLNALSCKLSKTC	33	Brevinin-2-OA1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=12.1 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12.1 µg/ml).##Yeast: Candida albicans (MIC=6.0 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02055	GLLDTFKNMALNAAKSAGVSVLNALSCKLSKTC	33	Brevinin-2-OA2 (Brevinin-2E-OG1; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Found in multiple species.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=13.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=6.6 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.6 µg/ml).##Yeast: Candida albicans (MIC=6.6 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02056	GLLDTFKNMAINAAHGAGVSVLNALSCKLKKTC	33	Brevinin-2-OA3 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.3 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=12.6 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.3 µg/ml).##Yeast: Candida albicans (MIC=3.2 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02057	GLLDTFKNLAINAAESAGVSVLNSLSCKLSKTC	33	Brevinin-2-OA4 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=20 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10 µg/ml).##Yeast: Candida albicans (MIC=10 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02058	GLLDGILNANFNAAKSAGTSVLNALSCKLSKTC	33	Brevinin-2-OA5 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30.6 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=30.6 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=30.6 µg/ml).##Yeast: Candida albicans (MIC=30.6 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02059	GVLATVKNLLIGTGDGAAQSVLKTLSCKLSNDC	33	Brevinin-2-OA6 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=44.8 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=22.4 µg/ml).##Yeast: Candida albicans (MIC=11.2 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02060	GVLGTVKDLLIGAGKSAAQSTLKTLSCKISNDC	33	Brevinin-2-OA7 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.8 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=23.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11.6 µg/ml).##Yeast: Candida albicans (MIC=5.8 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02061	GVLATVKNLLNGTGDGAAQSVLKTLSCKLSNDC	33	Brevinin-2-OA8 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=7.9 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=15.8 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=4.0 µg/ml).##Yeast: Candida albicans (MIC=4.0 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02062	GLLDTIKNMALNAAKSAGVSVLNSLSCKLSKTC	33	Brevinin-2-OR2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=6.0 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12.1 µg/ml).##Yeast: Candida albicans (MIC=12.1 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02063	GLIDTIKNMALNAAKSAGVSVLNTLSCKLSKTC	33	Brevinin-2-OR3 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20.6 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=41.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=20.6 µg/ml).##Yeast: Candida albicans (MIC=10.3 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02064	SVLGTVKDLLIGAGKSAAQSVLTANSCKLSNSC	33	Brevinin-2-OR4 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.8 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=11.8 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=5.9 µg/ml).##Yeast: Candida albicans (MIC=11.8 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02065	SFLDTLKNLAISAAKGAGQSVLSTLSCKLSETC	33	Brevinin-2-OR5 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=13.2 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=6.6 µg/ml).##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=6.6 µg/ml).##Fungi: Candida albicans (MIC=6.6 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02066	GLLDTIKNMALNAAKSAGVSVLNSLSCKDSKTC	33	Brevinin-2-OR6 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.8 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=11.6 µg/ml).##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=5.8 µg/ml).##Fungi: Candida albicans (MIC=11.6 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02067	GLLDTIKNMALNAAKSAGVSVLNTLSCKLSKTC	33	Brevinin-2-OR7 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8.6 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=8.6 µg/ml).##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=8.6 µg/ml).##Fungi: Candida albicans (MIC=17.2 µg/ml)	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02068	SFLSTFKELAINAAKNAGQSILHTLSCKLDKTC	33	Brevinin-2-OR9 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20.4 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=20.4 µg/ml).##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=10.2 µg/ml).##Fungi: Candida albicans (MIC=5.1 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02069	SFLSTFKELAINAAKNAGQSLLHTLSCKLDKTC	33	Brevinin-2-OR10 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: It differs from AP1850 only at position 21: L vs. I, so they are predicted to have essentially identical structure and activity.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15.8 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=7.9 µg/ml).##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=7.9 µg/ml).##Fungi: Candida albicans (MIC=15.8 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02070	SVMGTVKDLLIGAGKSAAQSVLKSLSCKISNDC	33	Brevinin-2-OW1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana wuchuanensis (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4.7 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=4.7 µg/ml).##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=9.4 µg/ml).##Fungi: Candida albicans (MIC=4.7 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02071	SVMGTVKDLLIGAGKSAAQSVLKSLSCKLSNDC	33	Brevinin-2-OW2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana wuchuanensis (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.6 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=6.6 µg/ml).##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3.3 µg/ml).##Fungi: Candida albicans (MIC=3.3 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02072	SVMGTVKDLLIGAGKSAAQSVLKALSCKLSKDC	33	Brevinin-2-OW3 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana wuchuanensis (Chinese odorous frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial and antifungal activity. 	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10.5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=21.0 µg/ml).##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10.5 µg/ml).##Fungi: Candida albicans (MIC=10.5 µg/ml).	[Ref.22029824] It shows no hemolytic activity against human red blood cells at the concentration of 50 μg/mL.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319. 	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP02073	FLPAVIRVAANVLPTVFCAISKKC	24	Brevinin-1JDa (Frogs, amphibians, animals)	B3A0M4	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antibacterial and antifungal activity. Has hemolytic activity against rabbit erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bonds."	[Ref.22917879]Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), S. aureus (MRSA) (MIC=32 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=128 µg/ml);##Fungi: Candida albicans (MIC=128 µg/ml).	[Ref.22917879] It has 79.2 ± 6.8% hemolytic activity at 128 μg/mL against rabbit red blood cells	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22917879	J Proteomics. 2012 Oct 22;75(18):5807-5821.	Liu J, Jiang J, Wu Z, Xie F.	Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: De novo sequencing and analysis of tandem mass spectrometry data.	
DRAMP02075	FLPAVLRVAAKVVPTVFCLISKKC	24	Brevinin-1JDc (Frogs, amphibians, animals)	B3A0N0	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial and antifungal activity. Has hemolytic activity against rabbit erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bonds."	[Ref.22917879]Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), S. aureus (MRSA) (MIC=8 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=128 µg/ml).	[Ref.22917879] It has 11.7 ± 3.2% hemolytic activity at 64 μg/mL and 88.4 ± 4.2% hemolytic activity at 128 μg/mL against rabbit red blood cells	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	22917879	J Proteomics. 2012 Oct 22;75(18):5807-5821.	Liu J, Jiang J, Wu Z, Xie F.	Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: De novo sequencing and analysis of tandem mass spectrometry data.	
DRAMP18376	GGGGGGHLVA	10	Peptide fraction II (Gly-rich; insects, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Hemolymph, Antheraea mylitta	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against E. coli and P. aeruginosa.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28302399	Bioorg Med Chem Lett. 2017 Mar 3. in press. 	Dutta SR, Gauri SS, Ghosh T, Halder SK, DasMohapatra PK, Mondal KC, Ghosh AK.	Elucidation of structural and functional integration of a novel antimicrobial peptide from Antheraea mylitta.	
DRAMP18377	MAGGKAGKDSGKAKAKAVSRSARAGLQFPVGRIHRHLK	38	Sphistin (histone-derived, Crustaceans, arthropods, invertebrates, animals)	No entry found	Not found	Not found	haemolymphs, Scylla paramamosain	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against G+ bacteria (S. aureus, C. glutamicum, B. subtilis, M. lysodeikticus, M. luteus) and G- bacteria (S. flexneri, P. stutzeri, and P. fluorescens) (MIC < 1.5 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25558400	Fish Shellfish Immunol. 2015 Dec;47(2):833-46.	Chen B, Fan DQ, Zhu KX, Shan ZG, Chen FY, Hou L, Cai L, Wang KJ.	Mechanism study on a new antimicrobial peptide Sphistin derived from the N-terminus of crab histone H2A identified in haemolymphs of Scylla paramamosain.	
DRAMP01745	LLPNLLKSLL	10	Temporin-K (Frogs, amphibians, animals)	P56923	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9022710	Eur J Biochem. 1996 Dec 15;242(3):788-792.	Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.	Temporins, antimicrobial peptides from the European red frog Rana temporaria.	
DRAMP01746	FVQWFSKFLGRIL	13	Temporin-L (Temporin-1Tl; temporin-Tl; TL; Frogs, amphibians, animals)	P57104	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiparasitic, Anti-cancer	Protein level	Alpha helix	Not found	6GS5 resolved by NMR.	"Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.
PTM: Leucine amide at position 13.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9022710	Eur J Biochem. 1996 Dec 15;242(3):788-792.	Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.	Temporins, antimicrobial peptides from the European red frog Rana temporaria.	
DRAMP02078	FLPVVAGLAAKVLPSIICAVTKKC	24	Brevinin-1SY (Frogs, amphibians, animals)	P82871	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sylvatica (Wood frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=7 µM);##Gram-negative bacterium: Escherichia coli (MIC=45 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11042268	FEBS Lett. 2000 Oct 20;483(2-3):135-138.	Matutte B, Storey KB, Knoop FC, Conlon JM.	Induction: of synthesis of an antimicrobial peptide in the skin of the freeze-tolerant frog, Rana sylvatica, in response to environmental stimuli.	
DRAMP04238	FFHLHFHY	8	PL-101	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria and Gram-positive bacteria.	[Ref.12569105] Gram-negative bacterium: Escherichia coli (MEC=7 μg/ml), Pseudomonas aeruginosa (MEC=10 μg/ml).;##Gram-positive bacteria: Staphylococcus aureus (MEC=3 μg/ml), MRSA (MEC=4 μg/ml) at PH 6.5.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12569105	J Biol Chem. 2003 Apr 11;278(15):13546-53.	Tincu JA, Menzel LP, Azimov R, Sands J, Hong T, Waring AJ, Taylor SW, Lehrer RI.	Plicatamide, an antimicrobial octapeptide from Styela plicata hemocytes.	
DRAMP02778	AHCLAIGRK	9	Defensin (Insects, animals)	O96049	Belongs to the invertebrate defensin family (Type 1 subfamil	Not found	Oryctes rhinoceros (Coconut rhinoceros beetle)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		Function: Shows very strong activity against Staphylococcus aureus. Has no hemolytic activity.	[Ref.10561605] Gram-positive bacteria: Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus aureus (MRSA) (MIC>50 µg/ml);## Gram-negative bacteria: Escherichia coli (MIC=25 µg/ml), Pseudomonas aeruginosa (MIC>50 µg/ml).	[Ref.10561605] Had no hemolytic activity against rabbit erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10561605	Eur. J. Biochem. 1999;266:616-623.	Ishibashi J, Yang J, Saido-Sakanaka H, Nakazawa H, Yamamoto M, Yamakawa M.	Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros.	
DRAMP02084	GIMDTLKNLAKTAGKGALQSLLNKASCKLSGQC	33	Brevinin-2E (Frogs, amphibians, animals)	P32413	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (Edible frog) (Pelophylax esculentus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.	[Ref.8508915]Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.2 µM), Staphylococcus aureus Cowan 1 (MIC=2.0 µM);##Gram-negative bacteria: Escherichia coli D21 (MIC=0.5 µM), Pseudomonas aeruginosa ATCC 15692 (MIC>30 µM).	[Ref.8163497]LC50>100 μM against human red blood cells	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	8508915	FEBS Lett. 1993 Jun 14;324(2):159-161.	Simmaco M, Mignogna G, Barra D, Bossa F.	Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta.	
DRAMP02101	FLPLLAGVVANFLPQIICKIARKC	24	Brevinin-1RTa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops ricketti (Chinese sucker frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		"Function: Brevinin-2RTb has antibacterial activity and hemolytic activity against rabbit red blood cells (LD50=100.0 µg/ml) in vitro.
PTM: Contains one disulfide bond 27-33."	[Ref.22100518]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=6.3 µg/ml), Bacillus licheniformis X39 (MIC=25.0 µg/ml), Rhodococcus rhodochrous X15 (MIC=3.1 µg/ml);##Gram-negative bacteria: Serratia rubidaea X01 (MIC=NA µg/ml), Pseudomonas aeruginosa 1.50 (MIC=NA µg/ml), Psychrobacter faecalis X29 (MIC=12.5 µg/ml).	[Ref.22100518]LD50=100 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22100518	Peptides. 2012 Jan;33(1):27-34.	Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.	Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).	
DRAMP02102	FLGSLLGLVGKVVPTLFCKISKKC	24	Brevinin-1RTb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops ricketti (Chinese sucker frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		"Function: Brevinin-2RTb has antibacterial activity and hemolytic activity against rabbit red blood cells (LD50=200.0 µg/ml) in vitro.
PTM: Contains one disulfide bond 27-33."	[Ref.22100518]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=3.1 µg/ml), Bacillus licheniformis X39 (MIC=25.0 µg/ml), Staphylococcus carnosus KHS (MIC=12.5 µg/ml), Rhodococcus rhodochrous X15 (MIC=3.1 µg/ml);##Gram-negative bacteria: Psychrobacter faecalis X29 (MIC=12.5 µg/ml)	[Ref.22100518]LD50=200 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22100518	Peptides. 2012 Jan;33(1):27-34.	Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.	Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).	
DRAMP02104	GLMSTLKDFGKTAAKEIAQSLLSTASCKLAKTC	33	Brevinin-2RTa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops ricketti (Chinese sucker frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		"Function: Brevinin-2RTb has antibacterial activity and hemolytic activity against rabbit red blood cells in vitro.
PTM: Contains one disulfide bond 27-33."	[Ref.22100518]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=12.5 µg/ml), Bacillus licheniformis X39 (MIC=50.0 µg/ml), Staphylococcus carnosus KHS (MIC=6.3 µg/ml), Rhodococcus rhodochrous X15 (MIC=1.6 µg/ml);##Gram-negative bacteria: Serratia rubidaea X01 (MIC=100.0 µg/ml), Psychrobacter faecalis X29 (MIC=6.3 µg/ml).	[Ref.22100518]LD50>400 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22100518	Peptides. 2012 Jan;33(1):27-34.	Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.	Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).	
DRAMP02105	GILDTLKEFGKTAAKGIAQSLLSTASCKLAKTC	33	Brevinin-2RTb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops ricketti (Chinese sucker frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		"Function: Brevinin-2RTb has antibacterial activity and relatively low hemolytic activity (>400 µg/ml) against rabbit red blood cells in vitro.
PTM: Contains one disulfide bond 27-33."	[Ref.22100518]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=50.0 µg/ml), Bacillus licheniformis X39 (MIC=200.0 µg/ml), Staphylococcus carnosus KHS (MIC=100.0 µg/ml), Rhodococcus rhodochrous X15 (MIC=12.5 µg/ml);##Gram-negative bacteria: Psychrobacter faecalis X29 (MIC=12.5 µg/ml).	[Ref.22100518]LD50>400 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22100518	Peptides. 2012 Jan;33(1):27-34.	Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.	Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).	
DRAMP02114	AWLDKLKSLGKVVGKVALGVAQNYLNPQQ	29	Raniseptin-1 (Rsp-1; Frogs, amphibians, animals)	P86037	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Hypsiboas raniceps (Chaco tree frog) (Hyla roeschmanni)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity against Gram-negative as well as Gram-positive bacteria. And has hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands."	[Ref.18976634]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=10 µM), Xanthomonas citri (MIC<2 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 29313 (MIC=20 µM).	[Ref.18976634]20% hemolytic activity at 80 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18976634	Biochem Biophys Res Commun. 2008 Dec 26;377(4):1057-1061.	Magalhães BS, Melo JA, Leite JR, Silva LP, Prates MV, Vinecky F, Barbosa EA, Verly RM, Mehta A, Nicoli JR, Bemquerer MP, Andrade AC, Bloch C Jr.	Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.	
DRAMP02125	IFGAILPLALGALKNLIK	18	Hylin-a1 (Hy-a1; Frogs, amphibians, animals)	P85982	Not found	Not found	Hypsiboas albopunctatus (Spotted tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found	2N0O resolved by NMR.	"Function: Has antibacterial activity against the Gram-positive bacteria and the Gram-negative bacteria. Has hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands."	[Ref.19056441]Gram-positive bacteria: Staphylococcus aureus ATCC 25926 (MIC=8 µM), Enterococcus faecalis ATCC 29212 (MIC=16 µM), Bacillus subtilis ATCC 19659 (MIC=8 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=32 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=64 µM);##Fungi: Candida albicans ATCC 90028 (MIC=16.7 µM), C. krusei ATCC 6258 (MIC=16.7 µM), C. parapsilosis ATCC 22019 (MIC=67 µM), Cryptococcus neoformans ATCC 90012 (MIC=33.5 µM)	[Ref.19056441]HC50=18 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19056441	Peptides. 2009 Feb;30(2):291-296.	Castro MS, Ferreira TC, Cilli EM, Crusca E Jr, Mendes-Giannini MJ, Sebben A, Ricart CA, Sousa MV, Fontes W.	Hylin a1, the first cytolytic peptide isolated from the arboreal South American frog Hypsiboas albopunctatus (spotted treefrog).	
DRAMP02127	GLLGGLLGPLLGGGGGGGGGLL	22	Leptoglycin (Gly-rich; Frogs, amphibians, animals)	P86267	Not found	Not found	Leptodactylus pentadactylus (Smokey jungle frog) (Rana pentadactyla)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Antimicrobial protein. Has antibacterial activity but not against Gram-positive bacteria Staphylococcus aureus, Micrococcus luteus and Enterococcus faecalis, yeasts Candida albicans and Candida tropicalis and dermatophytes fungi Microsporum canis and Trichophyton rubrum. No hemolytic activity was observed at the 2-200 microM range concentration.
Tissue specificity: Expressed by the skin glands."	[Ref.19298834]Gram-negative bacteria: Escherichia coli ATCC 28922 (MIC=50 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=8 µM);##Fungi: Citrobacter freundii ATCC 8090 (MIC=75 µM)	[Ref.19298834]Non-hemolytic activity was observed at 2-200 μM concentration	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19298834	Toxicon. 2009 Jul;54(1):23-32.	Sousa JC, Berto RF, Gois EA, Fontenele-Cardi NC, Honório JE Jr, Konno K, Richardson M, Rocha MF, Camargo AA, Pimenta DC, Cardi BA, Carvalho KM.	Leptoglycin: a new glycine/leucine-rich antimicrobial peptide isolated from the skin secretion of the South American frog Leptodactylus pentadactylus (Leptodactylidae).	
DRAMP02128	FLGGILNTITGLL	13	Kassorin-S (PreproKassorin-S; Frogs, amphibians, animals)	E6ZBE2	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Kassina senegalensis (Senegal running frog)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial peptide. Has antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Lacks ability to induce contraction of smooth muscle in isolated guinea pig urinary bladder. Elicits histamine release from rat peritoneal mast cells.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	Gram-positive bacterium: Staphylococcus aureus (MIC=30 µM).##Yeast: Candida albicans (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21040978	Mol Immunol. 2011 Jan;48(4):442-451.	Chen H, Wang L, Zeller M, Hornshaw M, Wu Y, Zhou M, Li J, Hang X, Cai J, Chen T, Shaw C.	Kassorins: novel innate immune system peptides from skin secretions of the African hyperoliid frogs, Kassina maculata and Kassina senegalensis.	
DRAMP02129	FIKELLPHLSGIIDSVANAIK	21	Kasstasin (Frogs, amphibians, animals)	G0LWV9	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Kassina maculata (African rhacophorid frog) (Hylambates maculatus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Peptide with potent vasoconstrictor properties. Has moderate antimicrobial activity. Not active against fungus C. albicans. Has hemolytic activity against horse erythrocytes.
Tissue specificity: Expressed by the skin dorsal glands.
Miscellaneous: Kasstasin is a derivation of Kassina, the taxon of origin, and the Ancient Greek word 'stasis' meaning 'stoppage of flow'."	[Ref.21624426]Gram-positive bacterium: Staphylococcus aureus (MIC=55 µM);##Gram-negative bacterium: Escherichia coli (MIC=110 µM).	[Ref.21624426]12.8% hemolytic activity at 125 μM against defibrinated horse blood	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21624426	Biochimie. 2011 Sep;93(9):1537-1542.	Li X, Feng W, Zhou M, Ma C, Chen T, Zeller M, Hornshaw M, Wang L, Shaw C.	Kasstasin: A novel potent vasoconstrictor peptide from the skin secretion of the African red-legged running frog, Kassina maculata.	
DRAMP02130	GFLGPLLKLAAKGVAKVIPHLIPSRQQ	27	Antimicrobial peptide 1 (XT-1; Frogs, amphibians, animals)	P84387	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity against Gram-positive bacterium S. aureus and Gram-negative bacterium E.coli and stronger activity against yeast C. albicans. Enhances the antibacterial activity of XT3. Has hemolytic activity against human red blood cells .
Tissue specificity: Expressed by the skin glands."	[Ref.11738090]Gram-positive bacteria: Staphylococcus aureus (MIC=5 µM);##Gram-negative bacteria: Escherichia coli (MIC=6 µM);##Fungi: Candida albicans (MIC=50 µM)	[Ref.11738090]HC50=90 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11738090	Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.	Ali MF, Soto A, Knoop FC, Conlon JM.	Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).	
DRAMP02131	GVWSTVLGGLKKFAKGGLEAIVNPK	25	Antimicrobial peptide 2 (XT-2; Frogs, amphibians, animals)	P84382	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has very strong antibacterial activity against Gram-positive bacterium S. aureus and very weak activity against Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands."	Gram-positive bacteria: Staphylococcus aureus (MIC>100 µM);##Gram-negative bacteria: Escherichia coli (MIC=8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	11738090	Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.	Ali MF, Soto A, Knoop FC, Conlon JM.	Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).	
DRAMP02133	GVFLDALKKFAKGGMNAVLNPK	22	Antimicrobial peptide 4 (XT-4; Frogs, amphibians, animals)	P84384	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity against Gram-positive bacterium S. aureus and yeast C. albicans, and very weak activity against Gram-negative bacterium E.coli. Has strong hemolytic activity against human red blood cells.
Tissue specificity: Expressed by the skin glands."	[Ref.11738090]Gram-positive bacteria: Staphylococcus aureus (MIC>100 µM);##Gram-negative bacteria: Escherichia coli (MIC=18 µM);##Fungi: Candida albicans (MIC>100 µM).	[Ref.11738090]HC50>150 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	11738090	Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.	Ali MF, Soto A, Knoop FC, Conlon JM.	Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).	
DRAMP02135	GFLGSLLKTGLKVGSNLL	18	Antimicrobial peptide 6 (XT-6; Frogs, amphibians, animals)	P84386	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity against Gram-positive bacterium S. aureus and Gram-negative bacterium E.coli and strong activity against yeast C. albicans. Enhances the antibacterial activity of XT3. Has hemolytic activity against human red blood cells.
Tissue specificity: Expressed by the skin glands."	[Ref.11738090]Gram-positive bacterium: Staphylococcus aureus (MIC=5 µM);##Gram-negative bacterium: Escherichia coli (MIC=5 µM);##Yeast: Candida albicans (MIC=40 µM);##Clinical isolates: Staphylococcus aureus 8325 (MIC=6 µM), Staphylococcus aureus (MRSA) (MIC=7 µM), Staphylococcus epidermidis 1420129 (MIC=3 µM), S. saprophyticus 1950556 (MIC=13 µM), Escherichia coli 25922 (MIC=6 µM), Streptococcus group C 1541035 (MIC=3 µM), Shigella sonnei 1840187 (MIC=35 µM), Pseudomonas aeruginosa 0380972 (MIC=60 µM), Enterobacter cloacae 1441323 (MIC=35 µM)	[Ref.11738090]HC50=70 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	11738090	Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.	Ali MF, Soto A, Knoop FC, Conlon JM.	Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).	
DRAMP02136	GLLGPLLKIAAKVGSNLL	18	Antimicrobial peptide 7 (XT-7; Frogs, amphibians, animals)	P84381	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Has very strong antibacterial activity against many Gram-negative bacteria and the Gram-positive bacteria S.pneumoniae and Enterococcus sp. There is moderate antimicrobial activity against the Gram-negative bacterium P.aeruginosa and yeast C. albicans and weaker activity against the Streptococcal strains and E.coli. Has hemolytic activity against human red blood cells (HC50=70 µM). Seems to disrupt the membranes by adopting an alpha-helical conformation.
Tissue specificity: Expressed by the skin glands.
PTM: Amidation on Leu-18 is required to adopt an alpha-helical conformation in a hydrophobic solvent. The absence of amidation leads to a decrease in cationicity leading to a more than a 10-fold decrease in antimicrobial activities."	Gram-positive bacterium: Staphylococcus aureus (MIC=5 µM);##Gram-negative bacterium: Escherichia coli (MIC=5 µM);##yeast Candida albicans (MIC=40 µM).##Clinical isolates: Staphylococcus aureus 8325 (MIC=6 µM), Staphylococcus aureus (MRSA) (MIC=7 µM), Staphylococcus epidermidis 1420129 (MIC=3 µM), S. saprophyticus 1950556 (MIC=13 µM), Escherichia coli 25922 (MIC=6 µM), Streptococcus group C 1541035 (MIC=3 µM), Shigella sonnei 1840187 (MIC=35 µM), Pseudomonas aeruginosa 0380972 (MIC=60 µM), Enterobacter cloacae 1441323 (MIC=35 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	11738090	Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.	Ali MF, Soto A, Knoop FC, Conlon JM.	Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).	
DRAMP02142	GFLGPLLKLGLKGVAKVLPHLIPSRQQ	27	CPF-SP1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Acinetobacter baumannii (MIC=12,5; Klebsiella pneumoniae=25 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21498136	Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.	Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.	Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.	
DRAMP02219	GILSSFKGVAKGVAKNLAGKLLDELKCKITGC	32	Ranatuerin-2AUa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana aurora aurora (Northern red-legged frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Activity against a range of Gram-positive and Gram-negative bacteria (minimum inhibitory concentrations<20 µM) but low hemolytic activity against human erythrocytes. 	[Ref.15325526]Gram-negative bacteria: Escherichia coli (MIC=5 µM), Pseudomonas aeruginosa (MIC=5 µM), Enterobacter cloacae (MIC=5 µM), Klebsiella pneumoniae (MIC=10 µM), P. mirabilis (MIC>40 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=20 µM), Staphylococcus epidermidis (MIC=20 µM), Enterococcus faecalis (MIC>40 µM), Streptococcus Group B (MIC=20 µM);##Yeast: Candida albicans (MIC>40 µM)	[Ref.15325526]HC50=290 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15325526	Dev Comp Immunol. 2005;29(1):83-90.	Conlon JM, Sonnevend A, Davidson C, Demandt A, Jouenne T.	Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.	
DRAMP02220	GIMDTVKNVAKNLAGQLLDKLKCKITAC	28	Ranatuerin-2PLa (Frogs, amphibians, animals)	A7WNV6	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (North America pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: May have antimicrobial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 23-28."	Gram-negative bacterium: Escherichia coli (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP02221	GIMDTVKNAAKDLAGQLLDKLKCRITGC	28	Ranatuerin-2PLb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (North America pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: May have antimicrobial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands."	Gram-negative bacterium: Escherichia coli (MIC=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP02222	GLLDTIKNTAKNLAVGLLDKIKCKMTGC	28	Ranatuerin-2PLc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (North America pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: May have antimicrobial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands."	Gram-negative bacterium: Escherichia coli (MIC=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP02223	GIMDSVKNVAKNIAGQLLDKLKCKITGC	28	Ranatuerin-2PLd (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (North America pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: May have antimicrobial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands."	Gram-negative bacterium: Escherichia coli (MIC=16 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP02224	GIMDSVKNAAKNLAGQLLDTIKCKITAC	28	Ranatuerin-2PLe (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (North America pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: May have antimicrobial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands."	Gram-negative bacterium: Escherichia coli (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP02225	GIMDTVKNAAKDLAGQLDKLKCRITGC	27	Ranatuerin-2PLf (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (North America pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: May have antimicrobial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands."	Gram-negative bacterium: Escherichia coli (MIC=23 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP18494	FIHHIIGGLFSAGKAIHRLIRRRRR	25	TP4	L0CKG3	Piscidin	TP4	Oreochromis niloticus (Nile tilapia) (Tilapia nilotica)	Antibacterial, Antifungal, anticancer, wound healing, Anti-Gram+, Anti-Gram-, Antimicrobial	Protein level	Alpha helix	1.0x sarkosyl can drive TP4 into a conformational change from a non-structure to an alpha-helical structure, and that LPS can also drive TP4 to an alpha-helical structure but with high hydrophobicity and low solubility.	5H2S	Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. Has hemolytic activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=8 μg/ml; MBC=16 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=16 μg/ml; MBC=32 μg/ml);##Gram-negative bacterium: Pseudomonas aeruginosa (MIC=64 μg/ml; MBC=128 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 2% hemolysis at 0.78 μg/ml, 5% hemolysis at 1.56 μg/ml, 45% hemolysis at 3.13 μg/ml, 85% hemolysis at 6.25 μg/ml, 98% hemolysis at 12.50 μg/ml, 100% hemolysis at 25.00 μg/ml against mouse red blood cell	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	bacterial outer membrane target protein, OprI-binding	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	
DRAMP03002	GIGAVLKVLTTGLPALISWIKRKRQQ	26	Melittin (Allergen Api m 3; Allergen Api m III; Insects, animals)	P01501,P01503	Belongs to the melittin family	MELT	Apis mellifera (Honeybee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found	2MLT, 3QRX, 1BH1	Function: Main toxin of bee venom with strong hemolytic activity. Forms a pore in the cell membrane by inserting into lipid bilayers in an alpha-helical conformation and has multiple effects, probably, as a result of its interaction with negatively charged phospholipids. It inhibits well known transport pumps such as the Na+-K+-ATPase and the H+-K+-ATPase. It increases the permeability of cell membranes to ions, particularly Na+ and indirectly Ca2+, because of the Na+-Ca2+-exchange. It acts synergistically with phospholipase A2. 	[Ref.29783753] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=2 μM), Listeria monocytogenes CMCC 54004 (MIC=1 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 μM), Escherichia coli UB 1005 (MIC=2 μM), Salmonella pullorum C7913 (MIC=8 μM), Salmonella enterica subsp enterica CMCC 50071 (MIC=2 μM)	[Ref.29859288] MHC=1 μM against human red blood cell.##[Ref.2978375] 46.80% hemolysis at 2μM against human red blood cell##[Ref.20472009] Wild-type melittin:AVG ± S.D.(%)=0.077±0.002 (35) against human red blood cell.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane (forms a transmembrane alpha-helix in the cell membrane.)	29859288##29783753##6309516##20472009##20403370##5300771	Gene. 2018 May 30. pii: S0378-1119(18)30617-6.##Molecules. 2018 May 19;23(5). pii: E1220. ##Eur J Biochem. 1983 Sep 1;135(1):123-126.##Peptides. 2010 Aug;31(8):1473-1479.##Toxicon. 2010 Sep 1;56(3):355-362.##Res Dev Tech Rep. 1967 Dec 5:1-13.	Wanmakok M, Orrapin S, Intorasoot A, Intorasoot S.##Hou J, Liu Z, Cao S, Wang H, Jiang C, Hussain MA, Pang S.##Vlasak R, Unger-Ullmann C, Kreil G, Frischauf AM.##Sciani JM, Marques-Porto R, Louren?o Junior A, Orsi Rde O, Ferreira Junior RS, Barraviera B, Pimenta DC.##Ferreira Junior RS, Sciani JM, Marques-Porto R, Junior AL, Orsi Rde O, Barraviera B, Pimenta DC.##Fennell JF, Shipman WH, Cole LJ.	Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.##Broad-Spectrum Antimicrobial Activity and Low Cytotoxicity against Human Cells of a Peptide Derived from Bovine AlphaS1-Casein.##Nucleotide sequence of cloned cDNA coding for honeybee prepromelittin.##Identification of a novel melittin isoform from Africanized Apis mellifera venom.##Africanized honey bee (Apis mellifera) venom profiling: Seasonal variation of	
DRAMP02233	FISAIASMLGKFL	13	Ranatuerin-6 (Frogs, amphibians, animals)	P82821	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial, Antibacterial, Anti-Gram+, Antiviral	Protein level	Not found	Not found		This peptide could inhibit HIV infection <10% at a concentration that is also toxic to T cells (J Virol 2005; 79:11598-11606).	Gram-positive bacterium: Staphylococcus aureus (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9784389	Biochem Biophys Res Commun. 1998 Sep 29;250(3):589-592.	Goraya J, Knoop FC, Conlon JM.	Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana.	
DRAMP02234	FLSAIASMLGKFL	13	Ranatuerin-7 (Frogs, amphibians, animals)	P82822	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacterium S. aureus.
Tissue specificity: Expressed by the skin glands."	Gram-positive bacterium: Staphylococcus aureus (MIC=200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9784389	Biochem Biophys Res Commun. 1998 Sep 29;250(3):589-592.	Goraya J, Knoop FC, Conlon JM.	Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana.	
DRAMP02235	FISAIASFLGKFL	13	Ranatuerin-8 (Frogs, amphibians, animals)	P82823	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacterium S. aureus.
Tissue specificity: Expressed by the skin glands."	Gram-positive bacterium: Staphylococcus aureus (MIC=130 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9784389	Biochem Biophys Res Commun. 1998 Sep 29;250(3):589-592.	Goraya J, Knoop FC, Conlon JM.	Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana.	
DRAMP02236	FLFPLITSFLSKVL	14	Ranatuerin-9 (Frogs, amphibians, animals)	P82824	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial, Antibacterial, Anti-Gram+, Antiviral	Protein level	Not found	Not found		This peptide was found to be HIV active, EC50= 16.7 uM (Wang, G et al., 2010 Antimicrob Agents Chemother 54: 1343).	Gram-positive bacterium: Staphylococcus aureus (MIC=130 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9784389	Biochem Biophys Res Commun. 1998 Sep 29;250(3):589-592.	Goraya J, Knoop FC, Conlon JM.	Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana.	
DRAMP02237	GLMDTIKGVAKTVAASWLDKLKCKITGC	28	Ranatuerin-2Ya (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Not found	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Ranatuerin-2Ya showed appreciably greater cytolytic activity against HepG2 cells (LC(50)=20microM) than against erythrocytes (LC(50)>100microM).	[Ref.19254736] Gram-negative bacterium: Escherichia coli (MIC=50 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=50 µM).	[Ref.19254736] LC50>100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19254736	Toxicon. 2009 Jun;53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.	Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.	Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.	
DRAMP02238	GLADYWRTAFRANFANLGPGIRCKSARC	28	Ranatuerin-2ZHa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana zhenhaiensis (Chinese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=1 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=6 µM).##Yeast: Candida albicans ATCC 2002 (MIC>32 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22943778	Zoolog Sci. 2012 Sep;29(9):553-558.	Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.	Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.	
DRAMP02239	SMISVLKNLGKVGLGFVACKVNKQC	25	Ranatuerin-1Ga (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grylio (North American pig frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=3.5 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=60 µM).##Yeast: Candida albicans (MIC=110 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10828493	Regul Pept. 2000 Jun 30;90(1-3):53-60.	Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.	Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.	
DRAMP02241	GLLLDTLKGAAKDIAGIALEKLKCKITGCKP	31	Ranatuerin-2G (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grylio (North American pig frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=19 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=150 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10828493	Regul Pept. 2000 Jun 30;90(1-3):53-60.	Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.	Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.	
DRAMP01390	TSRCYIGYRRKVVCS	15	Odorranain-T1 (OdT1; Frogs, amphibians, animals)	A6MBS1	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Odorranain-T1 adopts 28.2% turn structure in water solution.		Function: Odorranain-T1 exhibites moderate antimicrobial activities against all of the tested microbes.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=17.50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=35.00 μg/ml), Bacillus subtilis (MIC=17.50 μg/ml).##Yeast: Candida albicans (MIC=8.75 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01389	FLPPSPWKETFRTS	14	Odorranain-S1 (OdS1; Frogs, amphibians, animals)	A6MBS0, A6MBR9	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Odorranain-S1 exhibites moderate antimicrobial activities against all of the tested microbes.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=42.50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=21.25 μg/ml), Bacillus subtilis (MIC=85.00 μg/ml).##Yeast: Candida albicans (MIC=21.25 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP02251	GILSSFKGVAKGVAKDLAGKLLETLKCKITGC	32	Ranatuerin-2CSa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana cascadae (Cascades frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Alpha helix (4 helices; 25 residues)	In a 2,2,2-trifluoroethanol (TFE-d(3))-H(2)O solvent mixture, the structure is characterised by a full length helix-turn-helix conformation between residues I(2)-L(21), L(22)-L(25) and K(26)-T(30), respectively.	2K10 resolved by NMR.	Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has Hemolytic activity against human erythrocytes. 	[Ref.17451843]Gram-negative bacterium:Escherichia coli ATCC 25726 (MIC=5 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10 µM)	[Ref.17451843] LD50=150 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys27 and Cys32)	Disulfide bond between Cys27 and Cys32.	L	No cytotoxicity information found	Not found	17451843##18387372	Peptides. 2007 Jun;28(6):1268-1274.##Biochim Biophys Acta. 2008 Jun;1784(6):924-929.	Conlon JM, Al-Dhaheri A, Al-Mutawa E, Al-Kharrge R, Ahmed E, Kolodziejek J, Nowotny N, Nielsen PF, Davidson C.##Subasinghage AP, Conlon JM, Hewage CM.	Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.##Conformational analysis of the broad-spectrum antibacterial peptide, ranatuerin-2CSa: identification of a full length helix-turn-helix motif.	
DRAMP02252	GLLDAIKDTAQNLFANVLDKIKCKFTKC	28	Ranatuerin 2SKa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sakuraii (Japanese brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=50 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>50 µM).##Yeast: Candida albicans (MIC>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys23 and Cys28)	Disulfide bond between Cys23 and Cys28.	L	No cytotoxicity information found	Not found	17174009	Peptides. 2007 Mar;28(3):505-514.	Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.	Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.	
DRAMP01108	GIGTKILGGVKTALKGALKELASTYVN	27	Maximin-2 (Toads, amphibians, animals)	P83081, P83086, Q58T49	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Maximins are linear cationic peptides and easy to form membrane pore and they may induce a detergent-type disruption of sperm membrane like in the case of magainins.		"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. 
Tissue specificity: Expressed by the skin glands."	[Ref.11835991] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=19.5 µg/ml), Klebsiella pneumoniae (MIC=9 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=19.5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=19.5 µg/ml), Bacillus megatherium (MIC=19.5 µg/ml), Bacillus dysenteriae (MIC=2.7 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3 µg/ml).	[Ref:11835991]Little hemolytic activity at 50 μg/ml against red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP03998	RKKWFW	6	PAF26 (Trp-rich; combinatorial library)	No entry found 	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Synthetic	Rich	In general, positively charged residues (arginine or lysine) and residues with aromatic rings (tryptophan or phenylalanine) rendered antifungal activity.		Function: Antibacterial against Gram-negative bacterium. The antifungal mixture is also antibacterial, with a predominance of basic and aromatic residues.	[Ref.11976121] Gram-negative bacterium: Escherichia coli DH5α (MIC=160 µM, IC50>80 µM);##Fungi: Penicillium digitatum PHI-26 (MIC=20 µM, IC50=11 ± 1 µM), Penicillium italicum PHI-1 (MIC=40 µM,  IC50=22 ± 3 µM), Botrytis cinerea CECT2100 (MIC=60 µM, IC50=38 ± 24 µM), Fusarium oxysporum CECT2866 (MIC=80 µM, IC50=45 ± 4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11976121	Appl Environ Microbiol. 2002 May;68(5):2453-60.	López-García B, Pérez-Payá E, Marcos JF.	Identification of novel hexapeptides bioactive against phytopathogenic fungi through screening of a synthetic peptide combinatorial library.	
DRAMP01107	GIGTKILGGVKTALKGALKELASTYAN	27	Maximin-1 (Toads, amphibians, animals)	P83080, Q58T87	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral, Anti-cancer	Protein level	Not found	Maximins are linear cationic peptides and easy to form membrane pore and they may induce a detergent-type disruption of sperm membrane like in the case of magainins.	7OVZ	"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. Possess a significant cytotoxicity against tumor cell lines. Possess a significant anti-HIV activity. High spermicidal activity.
Toxic dose: LD50 is 8.2 mg/kg by intraperitoneal injection into mice.
Tissue specificity: Expressed by the skin glands."	[Ref.11835991] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=19.5 µg/ml), Klebsiella pneumoniae (MIC=9 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=19.5 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=19.5 µg/ml), Bacillus megatherium (MIC=19.5 µg/ml), Bacillus dysenteriae (MIC=2.7 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3 µg/ml);##Virus: HIV-1 (IC50=15.5 µg/ml, EC50=21.4 µg/ml);##Cancer cell lines: C8166 (IC50=15.3 µg/ml), Molt-4 (IC50=24.3 µg/ml), BIU-87 (IC50=20.5 µg/ml), T24 (IC50=35.4 µg/ml).	[Ref:11835991]Little hemolytic activity at 50 μg/ml against red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP02268	GWASKIGQTLGKIAKVGLKELIQPK	25	Xenopsin precursor fragment (XPF; Frogs, amphibians, animals)	P07198	Belongs to the magainin family	Not found	Xenopus laevis (African clawed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: XPF has antimicrobial activity.
Tissue specificity: XPF is synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa, it is stored as active, processed peptides in large granules within the granular gland secretions of the skin."	Gram-negative bacteria: Escherichia coli (MIC=16-31 µg/ml), K. Pneumonae (MIC=62-125 µg/ml), Pseudomonas aeruginosa (MIC=125-250 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=250-500 µg/ml), Streptococcus faecalis (MIC=250-500 µg/ml).##Yeast: Candida albicans (MIC=250-500 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1717472	J Biol Chem. 1991 Oct 15;266(29):19851-19857.	Moore KS, Bevins CL, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M.	Antimicrobial peptides in the stomach of Xenopus laevis.	
DRAMP02269	GVLSNVIGYLKKLGTGALNAVLKQ	24	Antimicrobial peptide PGQ (PGQ; Frogs, amphibians, animals)	P39080	Belongs to the magainin family	pgq	Xenopus laevis (African clawed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix(potential)	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Is synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. It is stored as active, processed peptides in large granules within the granular gland secretions of the skin."	Gram-negative bacteria: Escherichia coli (MIC=62-250 µg/ml), K. Pneumonae (MIC=125-250 µg/ml), Pseudomonas aeruginosa (MIC=250-500 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=250-500 µg/ml), Streptococcus faecalis (MIC=250-500 µg/ml).##Yeast: Candida albicans (MIC=250-500 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1717472	J Biol Chem. 1991 Oct 15;266(29):19851-19857.	Moore KS, Bevins CL, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M.	Antimicrobial peptides in the stomach of Xenopus laevis.	
DRAMP02271	GIGKFLHSAKKFGKAFVGEIMNS	23	Magainin-2 (Magainin II; chain of Magainins; Frogs, amphibians, animals)	C0HKN6	Belongs to the gastrin/cholecystokinin family. Magainin subfamily.		Xenopus ruwenzoriensis (Uganda clawed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiprotozoal	Protein level	Alpha helix	The secondary structure is shown to be helical in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution.	2MAG, 2LSA resolved by NMR.	"Function: Antimicrobial peptides that inhibit the growth of numerous species of bacteria and fungi and induce osmotic lysis of protozoa. Magainins are membrane lytic agents.
Tissue specificity: Synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. It is stored as active, processed peptides in large granules within the granular gland secretions of the skin."	Gram-negative bacteria: Escherichia coli D31 (MIC=5 µg/ml), Klebsiella pneumoniae (MIC=10 µg/ml), Escherichia coli (MIC=50 µg/ml), Pseudomonas putida (MIC=10 µg/ml), Citrobacter freundii (MIC=30 µg/ml), Enterobacter cloacae (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=100 µg/ml), Serratia marcescens (MIC=100 µg/ml), Proteus mirabilis (MIC>100 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis (MIC=10 µg/ml), Staphylococcus aureus (MIC=50 µg/ml), Streptococcus fecalis (MIC>100 µg/ml).##Protozoa: Paramecium caudatum (MIC=10 µg/ml).##Yeast: Candida albicans (MIC=80 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3299384##9090128##PubMed ID is not available	Proc Natl Acad Sci U S A. 1987 Aug;84(15):5449-5453.##J Biomol NMR. 1997 Feb;9(2):127-135.##To be Published.	Zasloff M.##Gesell J, Zasloff M, Opella SJ.##Vermeer LS, Kozlowska J, Lorenz CD, Mason JA.	Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.##Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution.##All Atom Simulations of the Initial Binding of Magainin and Pleurocidin to Membranes Comprising a Mixture of Anionic and Zwitterionic	
DRAMP02272	GMASKAGAIAGKIAKVALKAL	21	PGLa (chain of PYLa/PGLa A; Frogs, amphibians, animals)	Q99134, B7ZSG6, Q91826	Belongs to the gastrin/cholecystokinin family (Magainin subfamily)	pgla-a AND pgla-b	Xenopus laevis (African clawed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: PGLa display a broad-spectrum of antibacterial activity against a range of Gram-positive and Gram-negative bacteria. PGLa also displays antifungal activity against C. albicans ATCC 14053.
Tissue specificity: Expressed by the skin glands. Synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. Stored as active, processed peptides in large granules within the granular gland secretions of the skin.
PTM: Leucine amide at position 21."	Gram-negative bacteria: Escherichia coli 25922 (MIC=62-125 µg/ml), Klebsiella pneumoniae 13883 (MIC=250-500 µg/ml), Pseudomonas aeruginosa 27853 (MIC=250-500 µg/ml);##Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=125-500 µg/ml), Strepococcus faecalis (MIC>500 µg/ml).##Yeast: Candida albicans 14053 (MIC=250-500 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3606567##1717472	Biochem J. 1987 Apr 1;243(1):113-120.##J Biol Chem. 1991 Oct 15;266(29):19851-19857.	Giovannini MG, Poulter L, Gibson BW, Williams DH.##Moore KS, Bevins CL, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M.	Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones.##Antimicrobial peptides in the stomach of Xenopus laevis.	
DRAMP02273	KIAKVALKAL	10	PGLa-H (chain of PYLa/PGLa A; Frogs, amphibians, animals)	Q99134, B7ZSG6, Q91826	Belongs to the gastrin/cholecystokinin family (Magainin subfamily)	pgla-a AND pgla-b	Xenopus laevis (African clawed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: PGLa-H display a broad-spectrum of antibacterial activity against a range of Gram-positive and Gram-negative bacteria. PGLa-H shows moderate antibacterial activity against the multidrug-resistant methicillin-resistant S. aureus (MRSA) but exhibits hemolytic activity.
Tissue specificity: Expressed by the skin glands. Synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. Stored as active, processed peptides in large granules within the granular gland secretions of the skin.
PTM: Leucine amide at position 10."	[Ref.22014884]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=8.7 µg/ml), Bacillus subtilis (MIC=14.4 µg/ml), Staphylococcus aureus (MRSA) (MIC=67.8 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=23.6 µg/ml)	[Ref.22014884]3.15% hemolytic activity at 100 μg/mL, 7.95% hemolytic activity at 200 μg/mL against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22014884##1717472	Int J Antimicrob Agents. 2011 Dec;38(6):510-515.##J Biol Chem. 1991 Oct 15;266(29):19851-19857.	Hou F, Li J, Pan P, Xu J, Liu L, Liu W, Song B, Li N, Wan J, Gao H.##Moore KS, Bevins CL, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M.	Isolation and characterisation of a new antimicrobial peptide from the skin of Xenopus laevis.##Antimicrobial peptides in the stomach of Xenopus laevis.	
DRAMP02274	SAPRGCWTKSYPPKPCK	17	Ranacyclin-E (Frogs, amphibians, animals)	P83663	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (Edible frog) (Pelophylax esculentus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antibacterial activity. The mature peptide inserts into the hydrophobic core of the bacterial cell membrane and increases permeability without disrupting membrane integrity. Probably binds to the outer membrane surface before aggregating to form transmembrane pores. Has hemolytic activity. Probably binds to the outer membrane surface before aggregating to form transmembrane pores.
Tissue specificity: Expressed by the skin granular glands."	[Ref.14636071]Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3 µM), Staphylococcus lentus (MIC=7 µM), Micrococcus luteus (MIC=5 µM);##Gram-negative bacteria: Yersinia pseudotuberculosis YP III (MIC=9 µM), Pseudomonas syringae pv tabaci (MIC=80 µM);##Fungi: Candida tropicalis (MIC=7.4 µM), C. guillermondii (MIC=3.4 µM), Phytophthora nicotianae spores (MIC=32 µM).	[Ref.14636071] It has 55% hemolytic activity at 100 μM against human erythrocytes	Cyclic	Free	Amidation	Disulfide bond between Cys6 and Cys16.	L	No cytotoxicity information found	Cell membrane	14636071	Biochemistry. 2003 Dec 2;42(47):14023-14035.	Mangoni ML, Papo N, Mignogna G, Andreu D, Shai Y, Barra D, Simmaco M.	Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity.	
DRAMP02275	GALRGCWTKSYPPKPCK	17	Ranacyclin-T (Frogs, amphibians, animals)	P83719	Belongs to the frog skin active peptide family (Brevinin subfamily)	RNCT	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		MOA: The mature peptide inserts into the hydrophobic core of the bacterial cell membrane and increases permeability without disrupting membrane integrity. Probably binds to the outer membrane surface before aggregating to form transmembrane pores. Has hemolytic activity.	[Ref.14636071]Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3 µM), Staphylococcus lentus (MIC=10 µM), Micrococcus luteus (MIC=8 µM);##Gram-negative bacteria: Escherichia coli D21 (MIC=30 µM), Yersinia pseudotuberculosis YP III (MIC=5 µM), Pseudomonas syringae pv tabaci (MIC=16 µM);##Fungi: Candida albicans ATCC 10231 (MIC=22 µM), Candida tropicalis (MIC=14 µM), C. guillermondii (MIC=1 µM), Phytophthora nicotianae spores (MIC=16 µM).	[Ref.14636071] It has 20% hemolytic activity at 100 μM against human erythrocytes	Cyclic	Free	Amidation	Disulfide bond between Cys6 and Cys16.	L	No cytotoxicity information found	Cell membrane	14636071	Biochemistry. 2003 Dec 2;42(47):14023-14035.	Mangoni ML, Papo N, Mignogna G, Andreu D, Shai Y, Barra D, Simmaco M.	Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity.	
DRAMP02276	AALKGCWTKSIPPKPCSGKR	20	Ranacyclin B3 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana grahami (Ranidae frogs)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=11.7 µM).##Yeast: Candida albicans (MIC=23.4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys16.	L	No cytotoxicity information found	Not found	21927839	Amino Acids. 2012 Jul;43(1):309-316.	Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.	Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)N)CSSC[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O
DRAMP02277	AALRGCWTKSIPPKPCSGKR	20	Ranacyclin B5 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana grahami (Ranidae frogs)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=5.8 µM).##Yeast: Candida albicans (MIC=23.1 µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys16.	L	No cytotoxicity information found	Not found	21927839	Amino Acids. 2012 Jul;43(1):309-316.	Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.	Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)N)CSSC[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O
DRAMP02278	AALRGCWTKSIPPKPCPGKR	20	Ranacyclin-B-RL1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana livida (Ranidae frogs)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus (MIC=5.8 µM), Bacillus subtilis (MIC=46.2 µM);##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys16.	L	No cytotoxicity information found	Not found	21927839	Amino Acids. 2012 Jul;43(1):309-316.	Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.	Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O
DRAMP02279	SALVGCWTKSYPPKPCFGR	19	Ranacyclin-B-RN1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana nigrovittata (Ranidae frogs)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys16.	L	No cytotoxicity information found	Not found	21927839	Amino Acids. 2012 Jul;43(1):309-316.	Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.	Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O)C(C)C
DRAMP02280	SALVGCGTKSYPPKPCFGR	19	Ranacyclin-B-RN2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana nigrovittata (Ranidae frogs)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=12.7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys16.	L	No cytotoxicity information found	Not found	21927839	Amino Acids. 2012 Jul;43(1):309-316.	Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.	Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC1=O)C(C)C
DRAMP02281	SALVGCWTKSYPPNPCFGRG	20	Ranacyclin-B-RN6 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana nigrovittata (Ranidae frogs)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=11.7 µM).##Yeast: Candida albicans (MIC=46.7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys16.	L	No cytotoxicity information found	Not found	21927839	Amino Acids. 2012 Jul;43(1):309-316.	Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.	Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O)C(C)C
DRAMP02282	SALVGCWTKSWPPKPCFGRG	20	Ranacyclin-B-LK1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana nigrovittata (Ranidae frogs)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=23 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys16.	L	No cytotoxicity information found	Not found	21927839	Amino Acids. 2012 Jul;43(1):309-316.	Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.	Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O)C(C)C
DRAMP02283	SALVGCWTKSWPPKPCFGR	19	Ranacyclin-B-LK2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana nigrovittata (Ranidae frogs)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MIC=11.8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys16.	L	No cytotoxicity information found	Not found	21927839	Amino Acids. 2012 Jul;43(1):309-316.	Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.	Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O)C(C)C
DRAMP02288	FIGPVLKIAAGILPTAICKIFKKC	24	Gaegurin-RN1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has hemolytic activity against rabbit red cells..	[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=2.34 µg/ml), Staphylococcus aureus ATCC43300 (MIC=9.38 µg/ml), Bacillus subtilis (MIC=4.69 µg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=18.75 µg/ml);##Yeast: Candida albicans ATCC2002 (MIC=4.69 µg/ml)	[Ref.19778602] It has 46.13 ± 1.49% hemolytic activity at 100 μg/ml against rabbit red blood cells	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71.	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP02289	FVGPVLKIAAGILPTAICKIYKKC	24	Gaegurin-RN4 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata 	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Not found	Not found	Not found		Function: Has hemolytic activity against rabbit red cells.	[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=1.17 µg/ml), Staphylococcus aureus ATCC43300 (MIC=9.38 µg/ml), Bacillus subtilis (MIC=2.34 µg/ml);##Yeast: Candida albicans ATCC2002 (MIC=2.34 µg/ml).	[Ref.19778602] It has 18.64 ± 0.25% hemolytic activity at 100 μg/ml against rabbit red blood cells	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71.	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP02290	FLGPIIKIATGILPTAICKFLKKC	24	Gaegurin-RN5 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has hemolytic activity against rabbit red cells.	[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=3.75 µg/ml), Staphylococcus aureus ATCC43300 (MIC=62.50 µg/ml), Bacillus subtilis (MIC=4.69 µg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=37.50 µg/ml);##Yeast: Candida albicans ATCC2002 (MIC=4.69 µg/ml).	[Ref.19778602] It has no detectable hemolysis at the concentration up to 100 μg/ml	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	19778602	Genomics. 2010 Jan;95(1):66-71.	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP02291	SLFSLIKAGAKFLGKNLLKQGACYAACKASKQC	33	Gaegurin-1 (Gaegurin 1; GGN1; Frogs, amphibians, animals)	P80395	Belongs to the frog skin active peptide family (Brevinin subfamily)	GGN1	Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has hemolytic activity against rabbit red cells.	[Ref.7999137]Gram-positive bacteria: Micrococcus luteus (MIC=5 µg/ml), Staphylococcus epidermidis (MIC=50 µg/ml), Bacillus subtilis (MIC=50 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=100 µg/ml), Shigella dysentariae (MIC=25 µg/ml), Pseudomonas putida (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=50 µg/ml), Eshchericia coli (MIC=25 µg/ml).	[Ref.7999137] It has 0.04% hemolytic activity at 0.1 μg/ml, 0.14% hemolytic activity at 1 μg/ml, 0.51% hemolytic activity at 10 μg/ml, 0.59% hemolytic activity at 100 μg/ml against human red blood cells.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	7999137	Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.	Park JM, Jung J-E, Lee BJ.1994	Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.	
DRAMP02292	GIMSIVKDVAKNAAKEAAKGALSTLSCKLAKTC	33	Gaegurin-2 (Gaegurin 2; GGN2; Frogs, amphibians, animals)	P80396	Belongs to the frog skin active peptide family (Brevinin subfamily)	GGN2	Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Micrococcus luteus (MIC=2.5 µg/ml), Staphylococcus epidermidis (MIC=10 µg/ml), Bacillus subtilis (MIC=10 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=25 µg/ml), Shigella dysentariae (MIC=25 µg/ml), Pseudomonas putida (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=50 µg/ml), Eshchericia coli (MIC=75 µg/ml).##Fungi: Saccharomyces cerevisiae (MIC=150 µg/ml), Candida albicans (MIC=150 µg/ml), Salmonella typhimurium (MIC=150 µg/ml), Proteus mirabilis (MIC>200 µg/ml), Serratia marcescens (MIC>200 µg/ml).	[Ref.7999137] It has 0.19% hemolytic activity at 0.1 μg/ml, 0.16% hemolytic activity at 1 μg/ml, 0.31% hemolytic activity at 10 μg/ml, 0.82% hemolytic activity at 100 μg/ml against human red blood cells.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	7999137	Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.	Park JM, Jung JE, Lee BJ.	Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.	
DRAMP02293	GIMSIVKDVAKTAAKEAAKGALSTLSCKLAKTC	33	Gaegurin-3 (Gaegurin 3; GGN3; Frogs, amphibians, animals)	P80397	Belongs to the frog skin active peptide family (Brevinin subfamily)	GGN3	Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Micrococcus luteus (MIC=2.5 µg/ml), Staphylococcus epidermidis (MIC=10 µg/ml), Bacillus subtilis (MIC=10 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=25 µg/ml), Shigella dysentariae (MIC=25 µg/ml), Pseudomonas putida (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=50 µg/ml), Eshchericia coli (MIC=75 µg/ml).##Fungi: Saccharomyces cerevisiae (MIC>200 µg/ml), Candida albicans (MIC>200 µg/ml), Salmonella typhimurium (MIC=150 µg/ml), Proteus mirabilis (MIC>200 µg/ml), Serratia marcescens (MIC>200 µg/ml).	[Ref.7999137] It has 0.11% hemolytic activity at 0.1 μg/ml, 0.12% hemolytic activity at 1 μg/ml, 0.35% hemolytic activity at 10 μg/ml, 1.20% hemolytic activity at 100 μg/ml against human red blood cells.	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	7999137	Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.	Park JM, Jung JE, Lee BJ.	Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.	
DRAMP02294	GILDTLKQFAKGVGKDLVKGAAQGVLSTVSCKLAKTC	37	Gaegurin-4 (Gaegurin 4; GGN4; Frogs, amphibians, animals)	P80398, Q91328, Q98TA6	Belongs to the frog skin active peptide family (Brevinin subfamily)	GGN4	Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiprotozoal	Protein level	Alpha helix (3 helices; 22 residues)	In 100% H2O, Gaegurin 4 contains a nascent turn near its C-terminal Rana box. Under a more hydrophobic condition it forms two amphipathic helices, one long encompassing residues 2-23 and the other consisting of residues 25-34 (Ref.2).	2G9L resolved by NMR.	"Function: Has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, fungi and protozoa. Has hemolytic activity against rabbit red cells.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 31-37."	[Ref.7999137]Gram-positive bacteria: Micrococcus luteus (MIC=2.5 µg/ml), Staphylococcus epidermidis (MIC=10 µg/ml), Bacillus subtilis (MIC=10 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=25 µg/ml), Shigella dysentariae (MIC=25 µg/ml), Pseudomonas putida (MIC=100 µg/ml), Pseudomonas aeruginosa (MIC=100 µg/ml), Eshchericia coli (MIC=75 µg/ml);##Fungi: Saccharomyces cerevisiae (MIC=200 µg/ml), Candida albicans (MIC=200 µg/ml), Salmonella typhimurium (MIC=200 µg/ml), Proteus mirabilis (MIC>200 µg/ml), Serratia marcescens (MIC>200 µg/ml).	[Ref.7999137] It has 0.50% hemolytic activity at 0.1 μg/ml, 0.74% hemolytic activity at 1 μg/ml, 0.78% hemolytic activity at 10 μg/ml, 1.67% hemolytic activity at 100 μg/ml against human red blood cells	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	7999137##17141187##11004488	Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.##Biochem Biophys Res Commun. 2007 Jan 19;352(3):592-597.##Biochim Biophys Acta. 2000 Jun 21;1492(1):185-190.	Park JM, Jung JE, Lee BJ.##Chi SW, Kim JS, Kim DH, Lee SH, Park YH, Han KH.##Kwon SY, Carlson BA, Park JM, Lee BJ.	Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.##Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4.##Structural organization and expression of the gaegurin 4 gene of Rana rugosa.	
DRAMP02295	FLGALFKVASKVLPSVFCAITKKC	24	Gaegurin-5 (Gaegurin 5; GGN5; Brevinin-1EMa; Frogs, amphibians, animals)	P80399, Q91329	Belongs to the frog skin active peptide family (Brevinin subfamily)	GGN5	Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiprotozoal	Protein level	Not found	Not found		Function: Has low hemolytic activity. Has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, fungi and protozoa. PTM: Problely contains one disulfide bond 18-24.	[Ref.7999137]Gram-positive bacteria: Micrococcus luteus (MIC=2.5 µg/ml), Staphylococcus epidermidis (MIC=10 µg/ml), Bacillus subtilis (MIC=10 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=50 µg/ml), Shigella dysentariae (MIC=50 µg/ml), Pseudomonas putida (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=100 µg/ml), Eshchericia coli (MIC=50 µg/ml);##Fungi: Saccharomyces cerevisiae (MIC=50 µg/ml), Candida albicans (MIC=50 µg/ml), Salmonella typhimurium (MIC=200 µg/ml), Proteus mirabilis (MIC>200 µg/ml).	[Ref.7999137] It has 0.19% hemolytic activity at 0.1 μg/ml, 0.31% hemolytic activity at 1 μg/ml, 0.78% hemolytic activity at 10 μg/ml, 1.01% hemolytic activity at 100 μg/ml against human red blood cells	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	7999137	Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.	Park JM, Jung JE, Lee BJ.	Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.	
DRAMP02296	FLPLLAGLAANFLPTIICKISYKC	24	Gaegurin-6 (Gaegurin 6; GGN6; Frogs, amphibians, animals)	P80400	Belongs to the frog skin active peptide family (Brevinin subfamily)	GGN6	Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has low hemolytic activity. Has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, fungi and protozoa. PTM: Problely contains one disulfide bond 18-24.	[Ref.7999137]Gram-positive bacteria: Micrococcus luteus (MIC=2.5 µg/ml), Staphylococcus epidermidis (MIC=10 µg/ml), Bacillus subtilis (MIC=10 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=50 µg/ml), Shigella dysentariae (MIC=50 µg/ml), Pseudomonas putida (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=100 µg/ml), Eshchericia coli (MIC=50 µg/ml);##Fungi: Saccharomyces cerevisiae (MIC=50 µg/ml), Candida albicans (MIC=50 µg/ml), Salmonella typhimurium (MIC=200 µg/ml), Proteus mirabilis (MIC>200 µg/ml), Serratia marcescens (MIC>200 µg/ml).	[Ref.7999137] It has 0.39% hemolytic activity at 0.1 μg/ml, 0.62% hemolytic activity at 1 μg/ml, 0.78% hemolytic activity at 10 μg/ml, 0.86% hemolytic activity at 100 μg/ml against human red blood cells	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	7999137	Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.	Park JM, Jung JE, Lee BJ.	Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.	
DRAMP02300	VIDDLKKVAKKVRRELLCKKHHKKLN	26	Guentherin (AMP-3; Frogs, amphibians, animals)	P84859	Not found	Not found	Rana guentheri (Gunther's frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antimicrobial peptide. Active against the Gram-positive bacteria.
Tissue specificity: Expressed by the skin glands."	Gram-positive bacteria: Staphylococcus aureus FDA209P (MIC=35.5 µg/ml), Bacillus subtilis (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16979798	Peptides. 2006 Dec;27(12):3077-3084.	Zhou J, McClean S, Thompson A, Zhang Y, Shaw C, Rao P, Bjourson AJ.	Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri.	
DRAMP02306	IIEKLVNTALGLLSGL	16	Riparin-2.1 (Frogs, amphibians, animals)	P86127	Not found	Not found	Crinia riparia (Streambank froglet) (Flinders Ranges froglet)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity. Lacks antibacterial activity against the Gram-negative bacteria E. cloacae and E. coli, and against the Gram-positive bacteria B. cereus, E. faecalis, L. innocua, M. luteus, S. aureus, S. epidermidis and S. uberis. Does not inhibit the formation of NO by neuronal nitric oxide synthase. 
Tissue specificity: Expressed by the skin glands."	Gram-positive bacterium: Lactococcus lactis (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16470724	Rapid Commun Mass Spectrom. 2006;20(5):797-803.	Maselli VM, Bilusich D, Bowie JH, Tyler MJ.	Host-defence skin peptides of the Australian streambank froglet Crinia riparia: isolation and sequence determination by positive and negative ion electrospray mass spectrometry.	
DRAMP02307	GLADFLNKAVGKVVDFVKS	19	Deserticolin-1 (Frogs, amphibians, animals)	P86136	Not found	Not found	Crinia deserticola (Desert froglet)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive bacteria. Inhibits the formation of NO by neuronal nitric oxide synthase with an IC50 of 2.4 µM.
Tissue specificity: Expressed by the skin glands."	Gram-positive bacteria: Leuconostoc lactis (MIC=25 µM), Streptococcus uberis (MIC=50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18601958	Regul Pept. 2008 Nov 29;151(1-3):80-87.	Jackway RJ, Pukala TL, Maselli VM, Musgrave IF, Bowie JH, Liu Y, Surinya-Johnson KH, Donnellan SC, Doyle JR, Llewellyn LE, Tyler MJ.	Disulfide-containing peptides from the glandular skin secretions of froglets of the genus Crinia: structure, activity and evolutionary trends.	
DRAMP02308	IIGHLIKTALGMLGL	15	Signiferin-2.1 (Frogs, amphibians, animals)	P86131	Not found	Not found	Crinia signifera (Common eastern froglet)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity against a wide spectrum of Gram-positive bacteria. Lacks antibacterial activity against the Gram-negative bacteria E. cloacae and E. coli. Inhibits the formation of NO by neuronal nitric oxide synthase with an IC50 of 12.4 µM.
Tissue specificity: Expressed by the skin glands."	Gram-positive bacteria: Bacillus cereus (MIC=25 µM), Enterococcus faecalis ATCC 29212 (MIC=100 µM), Leuconostoc lactis (MIC=12 µM), Listeria innocua (MIC=50 µM), Micrococcus luteus ATCC 9341 (MIC=25 µM), Staphylococcus aureus ATCC 29213 (MIC=12 µM), Staphylococcus epidermidis ATCC14990 (MIC=25 µM), Streptococcus uberis (MIC=25 µM). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15317042##16470724##18601958	Rapid Commun Mass Spectrom. 2004;18(18):2155-2161.##Rapid Commun Mass Spectrom. 2006;20(5):797-803.##Regul Pept. 2008 Nov 29;151(1-3):80-87.	Maselli VM, Brinkworth CS, Bowie JH, Tyler MJ.##Maselli VM, Bilusich D, Bowie JH, Tyler MJ.##Jackway RJ, Pukala TL, Maselli VM, Musgrave IF, Bowie JH, Liu Y, Surinya-Johnson KH, Donnellan SC, Doyle JR, Llewellyn LE, Tyler MJ.	Host-defence skin peptides of the Australian Common Froglet Crinia signifera: sequence determination using positive and negative ion electrospray mass spectra.##Host-defence skin peptides of the Australian Streambank Froglet Crinia riparia: isolation and sequence determination by positive and negative ion electrospray mass spectrometry.##Disulfide-containing peptides from the glandular skin secretions of froglets of the genus Crinia: structure, activity and evolutionary trends.	
DRAMP02312	SGRGKTGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYAHRVGAGAPVYL	51	Hipposin (fish, chordates, animals)	P59890	Belongs to the histone H2A family	Not found	Hippoglossus hippoglossus (Atlantic halibut)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram+ (MIC=0.3 µM);##Gram- (MIC=0.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12637028	Biochim Biophys Acta. 2003 Mar 21;1646(1-2):207-215.	Birkemo GA, Luders T, Andersen O, Nes IF, Nissen-Meyer J	Hipposin, a histone-derived antimicrobial peptide in Atlantic halibut (Hippoglossus hippoglossus L.).	
DRAMP02314	RCRFCCRCCPRMRGCGICCRF	21	Hepcidin (fish, chordates, animals)	A1Z0M0	Belongs to the hepcidin family	hamp	Larimichthys crocea (Croceine croaker) (Pseudosciaena crocea)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages.
Tissue specificity: Expressed in all tissues tested, with highest levels of expression in kidney and lowest levels in liver. Intra-peritoneal injection of lipopolysaccharide results in increased expression in heart, spleen and stomach, but not in kidney or liver.
PTM: Contains four disulfide bonds 2-19; 5-8; 6-15; 9-18."	Gram-negative bacteria: Vibrio alginolyticus(MIC=24 µM), V. fluvialis, V. harveyis (MIC=12 µM) and Vibrio parahaemolyticus (MIC=6 µM), Aeromonas hydrophila (MIC=6 µM), Escherichia coli (MIC=24 µM), Escherichia coli BL21(DE3)plysS (MIC=6 µM);##Gram-positive bacteria: Bacillus cereus (MIC=24 µM), Bacillus subtilis (MIC=6 µM), C. glutamicum (MIC=3 µM), Micrococcus luteus (MIC=3 µM), M. lysodeikticus, Staphylococcus aureus (MIC=6 µM) and S.epidermis (MIC=12 µM).##Fungi: Aspergillus niger (MIC=24 µM), F;##Graminearum (MIC=24 µM) and Fusarium solani (MIC=24 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys2 and Cys19; Cys5 and Cys8; Cys6 and Cys15,Cys9 and Cys18.	L	No cytotoxicity information found	Not found	19150638##19344770	Peptides. 2009 Apr;30(4):638-646.##Fish Shellfish Immunol. 2009 Jun;26(6):864-870.	Wang KJ, Cai JJ, Cai L, Qu HD, Yang M, Zhang M.##Zhang J, Yan Q, Ji R, Zou W, Guo G.	Cloning and expression of a hepcidin gene from a marine fish (Pseudosciaena crocea) and the antimicrobial activity of its synthetic peptide.##Isolation and characterization of a hepcidin peptide from the head kidney of large yellow croaker, Pseudosciaena crocea.	CC[C@@H](C)[C@@H]1NC(=O)CNC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)N[C@@H](CSSC[C@H](NC1=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)CSSC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N4)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2
DRAMP02315	FFGWLIKGAIHAGKAIHGLIHRRRH	25	Chrysophsin-1 (fish, chordates, animals)	P83545	Belongs to the pleurocidin family	Not found	Chrysophrys major (Red sea bream) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix 	Not found		Function: Shows hemolytic activity human red blood cells.	[Ref.12581207]Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=0.25 µM), Lactococcus garvieae ATCC 49156 (MIC=10 µM), S.iniae F-8502 (MIC=2.5 µM);##Gram-negative bacteria: Escherichia coli WT-2 (MIC=0.25 µM), Vibrio anguillarum ATCC 19264 (MIC=2.5 µM), Vibriopenaeicida KHA (MIC=10 µM), V. harveyi ATCC 14126 (MIC=2.5 µM), V. vulnificus ATCC 33148 (MIC=5 µM), Aeromonas salmonicida NCMB 1102 (MIC=10 µM), Pseudomonas putida ATCC 12633 (MIC=40 µM).	[Ref.12581207]10% hemolytic activity at 0.25 μM, 80% hemolytic activity at 1 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	12581207	Eur J Biochem. 2003 Feb;270(4):675-686.	Iijima N, Tanimoto N, Emoto Y, Morita Y, Uematsu K, Murakami T, Nakai T.	Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major.	
DRAMP02316	FFGWLIRGAIHAGKAIHGLIHRRRH	25	Chrysophsin-2 (fish, chordates, animals)	P83546	Belongs to the pleurocidin family	Not found	Chrysophrys major (Red sea bream) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix 	Not found		Function: Shows hemolytic activity human red blood cells.	[Ref.12581207]Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=0.25 µM), Lactococcus garvieae ATCC 49156 (MIC=5 µM), S.iniae F-8502 (MIC=1.5 µM);##Gram-negative bacteria: Escherichia coli WT-2 (MIC=0.25 µM), Vibrio anguillarum ATCC 19264 (MIC=1.25 µM), Vibriopenaeicida KHA (MIC=5 µM), V. harveyi ATCC 14126 (MIC=5 µM), V. vulnificus ATCC 33148 (MIC=2.5 µM).	[Ref.12581207]10% hemolytic activity at 0.25 μM, 70% hemolytic activity at 1 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	12581207	Eur J Biochem. 2003 Feb;270(4):675-686.	Iijima N, Tanimoto N, Emoto Y, Morita Y, Uematsu K, Murakami T, Nakai T.	Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major.	
DRAMP02317	FIGLLISAGKAIHDLIRRRH	20	Chrysophsin-3 (fish, chordates, animals)	P83547	Belongs to the pleurocidin family	Not found	Chrysophrys major (Red sea bream) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix 	Not found		Function: Shows hemolytic activity human red blood cells.	[Ref.12581207]Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=0.25 µM), Lactococcus garvieae ATCC 49156 (MIC=10 µM), S.iniae F-8502 (MIC=10 µM);##Gram-negative bacteria: Escherichia coli WT-2 (MIC=0.25 µM), Vibrio anguillarum ATCC 19264 (MIC=10 µM), Vibriopenaeicida KHA (MIC=10 µM), V. harveyi ATCC 14126 (MIC=5 µM), V. vulnificus ATCC 33148 (MIC=10 µM), Aeromonas salmonicida NCMB 1102 (MIC=10 µM), Pseudomonas putida ATCC 12633 (MIC=40 µM).	[Ref.12581207]0% hemolytic activity at 0.25 μM, 10% hemolytic activity at 1 μM against human erythrocytes.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	12581207	Eur J Biochem. 2003 Feb;270(4):675-686.	Iijima N, Tanimoto N, Emoto Y, Morita Y, Uematsu K, Murakami T, Nakai T.	Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major.	
DRAMP02318	FIGGIISFFKRLF	13	Grammistin Pp1 (Group II grammistin; fish, chordates, animals)	P69842	Belongs to the grammistin family (Group 2 subfamily)	Not found	Pogonoperca punctata (Clown grouper) (Bearded grouper)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=3.13 µg/ml), Staphylococcus aureus IAM 1011 (MIC=3.13 µg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=50 µg/ml), Escherichia coli JCM 1649 (MIC>50 µg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=6.25 µg/ml), Salmonella typhimurium S1 (MIC>50 µg/ml), S. putrefaciens IAM 1509 (MIC=6.25 µg/ml), Vibrio anguillarum NCIBM 829 (MIC=12.5 µg/ml), Vibrio parahaemolyticus (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Fish. Sci. 2001 Oct;67:928-933.	Yokota H, Nagashima Y, Shiomi K.	Interaction of grammistins with lipids and their antibacterial activity.	
DRAMP02320	FIGGIISFIKKLF	13	Grammistin PpIIb (Group II grammistin; fish, chordates, animals)	P69844	Belongs to the grammistin family (Group 2 subfamily)	Not found	Pogonoperca punctata (Clown grouper) (Bearded grouper)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has antibacterial activities.	[Ref.Fish. Sci. 2001 Feb;67:163-169.]Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=6.25 µg/ml), Staphylococcus aureus IAM 1011 (MIC=3.13 µg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC>50 µg/ml), Escherichia coli JCM 1649 (MIC=50 µg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=12.5 µg/ml), Salmonella typhimurium S1 (MIC>50 µg/ml), S. putrefaciens IAM 1509 (MIC=6.25 µg/ml), Vibrio anguillarum NCIBM 829 (MIC=12.5 µg/ml), Vibrio parahaemolyticus (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Phospholipids	PubMed ID is not available	Fish. Sci. 2001 Feb;67:163-169.	Shiomi K, Yokota H, Nagashima Y, Ishida M.	Primary and secondary structures of grammistins, peptide toxins isolated from the skin secretion of the soapfish Pogonoperca punctata.	
DRAMP02321	NWRKILGQIASVGAGLLGSLLAGYE	25	Grammistin Pp3 (Group III grammistin; fish, chordates, animals)	P69847	Belongs to the grammistin family (Group 3 subfamily)	Not found	Pogonoperca punctata (Clown grouper) (Bearded grouper)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function:  Has hemolytic activity. Thanks to its abundant amphiphilic alpha-helices, it may integrate into membrane phospholipids, leading to lysis of the membrane.	[Ref.Fish. Sci. 2001 Oct;67:928-933.]Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=50 µg/ml), Staphylococcus aureus IAM 1011 (MIC=50 µg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=50 µg/ml), Escherichia coli JCM 1649 (MIC>50 µg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=25 µg/ml), Salmonella typhimurium S1 (MIC>50 µg/ml), S. putrefaciens IAM 1509 (MIC=12.5 µg/ml), Vibrio anguillarum NCIBM 829 (MIC=50 µg/ml), Vibrio parahaemolyticus (MIC=50 µg/ml).	[Ref.Fish. Sci. 2001 Oct;67:928-933.]75 HU/mg hemolytic activity against horse erythrocytes(1 HU was defined as the amount of peptide causing 50% hemolysis)	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Fish. Sci. 2001 Oct;67:928-933.	Yokota H, Nagashima Y, Shiomi K.	Interaction of grammistins with lipids and their antibacterial activity.	
DRAMP02324	AEVAPAPAAAAPAKAPKKKAAAKPKKAGPS	30	SAMP H1 (fish, chordates, animals)	P84408, Q5GMQ6	Belongs to the histone H1/H5 family	Not found	Salmo salar (Atlantic salmon)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli (MIC=2 µM), Aeromonas salmonicida subsp salmonicida (MIC=4 µM), Vibrio anguillarum (MIC=1 µM) Salmonella typhimurium (MIC=4 µM);##Gram-positive bacteria: Bacillus subtilis (MIC=2 µM), Listeria ivanovii (MIC=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15917539	Antimicrob Agents Chemother. 2005 Jun;49(6):2399-2406.	Luders T, Birkemo G.A, Nissen-Meyer J, Andersen O, Nes I.F.	Proline conformation-dependent antimicrobial activity of a proline-rich histone H1 N-terminal peptide fragment isolated from the skin mucus of Atlantic salmon.	
DRAMP02330	FFHHIFRGIVHVGKTIHRLVTG	22	Piscidin-1 (Pis-1; Piscidin 1; fish, chordates, animals)	Q8UUG0	Belongs to the pleurocidin family	Not found	Morone saxatilis (Striped bass)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found	2JOS, 2OJM resolved by NMR.	Function: Exhibits broad spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria. Also has hemolytic activity. Seems to disrupt the membranes by adopting an alpha helical conformation and forming toroidal pores.	[Ref.11713517]Gram-positive bacteria: Enterococcus faecalis VRE (MIC=5-10 µM), E. faecalis (MIC=2.5-5 µM), Listeria monocytogenes (MIC=2.5-5 µM), Micrococcus luteus (MIC=10-20 µM), Staphylococcus aureus MRSA (MIC=1.25-2.5 µM), S. epidermitis (MIC=5-10 µM), S. saprophiticus (MIC=5-10 µM), Staphylococcus xylosus (MIC>20 µM), S. agalactiae (MIC=1.25-2.5 µM), S. bovis (MIC=1.25-2.5 µM), S. equisimilis (MIC=2.5-5 µM), S. mitis (MIC=1.25-2.5 µM), S. Pneumonae (MIC=1.25-2.5 µM), S. pyrogenes (MIC=1.25-2.5 µM), Streptococcus iniae KST740 ak (MIC=1.25-2.5 µM), S. iniae KSTSi 6P (MIC=1.25-2.5 µM);##Gram-negative bacteria: Aeromonas hydrophila (MIC>20 µM), Burkholderia cepacia (MIC>20 µM), Vibrio Cholera (MIC=2.5-5 µM), Escherichia coli (MIC=5-10 µM), Enterobacter cloacae (MIC=10-20 µM), E. Aerogenes (MIC=10-20 µM), Klebsiella pneumoniae (MIC=2.5-5 µM), K. oxytoca (MIC=5-10 µM), Salmonella choleraesuis (MIC=10-20 µM), S. typhimurium (MIC=10-20 µM), S. arizonae (MIC=10-20 µM), Serratia marcescens (MIC>20 µM), Shigella flexneri (MIC=2.5-5 µM), S. sonnei (MIC=5-10 µM), Yersinia enterocolitica (MIC=2.5-5 µM); Fungi: Neurospora crassa (MIC=1.56-3.12 µM), A. fumigatus (MIC=50-100 µM), F. axysporum (MIC=0.78-1.56 µM), F. culmorum (MIC=0.39-0.78 µM), C. ablicans (MIC=10-20 µM), C. glabrata (MIC=10-20 µM), C. lusitania (MIC=10-20 µM), C. tropacalis (MIC=10-20 µM).	[Ref.11713517]10% hemolytic activity at 5 μg/mL, 60% hemolytic activity at 10 μg/mL, 100% hemolytic activity at 50 μg/mL against human erythrocytes 	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	11713517	Nature. 2001 Nov 15;414(6861):268-269.	Silphaduang U, Noga EJ.	Peptide antibiotics in mast cells of fish.	
DRAMP02331	FFHHIFRGIVHVGKTIHKLVTG	22	Piscidin-2 (Pis-2; fish, chordates, animals)	Q8UUG2	Belongs to the pleurocidin family	Not found	Morone chrysops (White bass)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Exhibits broad spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria as well as against a variety of fungi. Seems to disrupt the membranes by adopting an alpha helical conformation.
Tissue specificity: Expressed in gill, skin, intestine, spleen, anterior kidney, and blood cells."	Gram-positive bacteria: Enterococcus faecalis (MIC=5-10 µM), E. faecalis (MIC=2.5-5 µM), Listeria monocytogenes (MIC=2.5-5 µM), Micrococcus luteus (MIC=10-20 µM), Staphylococcus aureus (MIC=1.25-2.5 µM), S. epidermidis (MIC=5-10 µM), S. saprophiticus (MIC=5-10 µM), S. xylosus (MIC>20 µM), Streptococcus agalactiae (MIC=1.25-2.5 µM), S. bovis (MIC=1.25-2.5 µM), S. equisimilis (MIC=2.5-5 µM), S. mitis (MIC=1.25-2.5 µM), Streptococcus pneumoniae (MIC=1.25-2.5 µM), Streptococcus pyogenes (MIC=1.25-2.5 µM), S. iniae KST740ak (MIC=1.25-2.5 µM), S. iniae KSTSi 6P (MIC=1.25-2.5 µM);##Gram-negative bacteria: Aeromonas hydrophila (MIC>20 µM), Burkholderia cepacia (MIC>20 µM), Vibrio cholera (MIC=2.5-5 µM), Escherichia coli (MIC=5-10 µM), Moraxella catarrhalis (MIC=2.5-5 µM), Neisseria gonorrhoeae (MIC>20 µM), Pseudomonas aeruginosa (MIC=5-10 µM), Enterobacter cloacae (MIC=10-20 µM), E. aerogenes (MIC=10-20 µM), Klebsiella pneumoniae (MIC=2.5-5 µM), K. oxytoca (MIC=5-10 µM), Salmonella choleraesuis (MIC=10-20 µM), Salmonella typhimurium (MIC=10-20 µM), S. arizonae (MIC=10-20 µM), Serratia marcescens (MIC>20 µM), Shigella flexneri (MIC=2.5-5 µM), S. sonnei (MIC=5-10 µM), Yersinia enterocolitica (MIC=2.5-5 µM).##Fungi: Neurospora crassa (MIC=1.56-3.12 µM), Aspergillus fumigatus (MIC=50-100 µM), Fusarium oxysporum (MIC=0.78-1.56 µM), F. culmorum (MIC=0.39-0.78 µM), Candida albicans (MIC=10-20 µM), C. glabrata (MIC=10-20 µM), C. lusitania (MIC=10-20 µM), C. tropicalis (MIC=10-20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	11739390	J Biol Chem. 2002 Feb 15;277(7):5030-5039.	Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.	Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.	
DRAMP02336	KAVAAKKSPKKAKKPATPKKAAKSPKKVKKPAAAAKKAAKSPKKATKAAKPKAAKPKAAKAKKAAPKKK	69	Oncorhyncin II (Oncorhyncin 2; fish, chordates, animals)	P06350, P83374	Belongs to the histone H1/H5 family	Not found	Oncorhynchus mykiss (Rainbow trout)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Potentially important role in mucosal defense. 	Gram-positive bacteria: Planococcus citreus (MIC=0.2-0.4 µM), Micrococcus luteus (MIC=0.2-0.4 µM);##Gram-negative bacteria: Escherichia coli (MIC=0.4-0.8 µM), Listonella anguillarum (MIC=0.4-0.8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12969798	Dev Comp Immunol. 2004 Feb;28(2):127-138. 	Fernandes JM, Molle G, Kemp GD, Smith VJ.	Isolation and characterisation of oncorhyncin II, a histone H1-derived antimicrobial peptide from skin secretions of rainbow trout, Oncorhynchus mykiss.	
DRAMP02337	PKRKSATKGDEPARRSARLSARPVPKPAAKPKKAAAPKKAVKGKKAAENGDAKAEAKVQAAGDGAG	66	Oncorhyncin III (Oncorhyncin 3; fish, chordates, animals)	P02315, P83338	Belongs to the HMGN family	Not found	Oncorhynchus mykiss (Rainbow trout)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Plays a role in mucosal innate host defence.	Gram-positive bacteria: Aerococcus viridans (MIC=0.06-0.12 µM), Bacillus subtilis (MIC=0.25-0.5 µM), Micrococcus luteus (MIC=0.12-0.25 µM), Planococcus citreus (MIC=0.06-0.12 µM);##Gram-negative bacteria: Aeromonas hydrophila (MIC>0.5 µM), Aeromonas salmonicida 004 (MIC>0.5 µM), Escherichia coli (MIC=0.25-0.5 µM), Listonella anguillarum (MIC=0.25-0.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	DNA	12713443	Biochem J. 2003 Jul 15;373(Pt 2):621-628.	Fernandes J.M.O, Saint N, Kemp G.D, Smith V.J.	Oncorhyncin III: a potent antimicrobial peptide derived from the non-histone chromosomal protein H6 of rainbow trout, Oncorhynchus mykiss.	
DRAMP02347	GKGRWLERIGKAGGIIIGGALDHL	24	NRC-1 (fish, chordates, animals)	No entry found	Not found	Not found	Pseudopleuronectes americanus (Winter flounder 1)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		C-terminal NH2, this NRC seris of peptides was identified by gene analysis and biological activity verified using synthetic peptides. 	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=64 µg/ml), Aeromonas salmonicida 97-4 (MIC=64 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=16 µg/ml), Salmonella enterica serovar Typhimurium 14028s (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC>64 µg/ml), Pseudomonas aeruginosa Z61 (MIC=32 µg/ml), Escherichia coli CGSC 4908 (MIC=32 µg/ml), Escherichia coli UB1005 (MIC=32 µg/ml), Escherichia coli DC2 (MIC=32 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 µg/ml).##Yeast: Candida albicans C627 (MIC=64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02348	WLRRIGKGVKIIGGAALDHL	20	NRC-2 (fish, chordates, animals)	No entry found	Not found	Not found	Pseudopleuronectes americanus (Winter flounder 1a)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>128 µg/ml), Aeromonas salmonicida 97-4 (MIC=128 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=64 µg/ml), S. enterica serovar Typhimurium 14028s (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC=64 µg/ml), Pseudomonas aeruginosa Z61 (MIC=32 µg/ml), Escherichia coli CGSC 4908 (MIC=64 µg/ml), E. coli UB1005 (MIC=64 µg/ml), E. coli DC2 (MIC=64 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 µg/ml).##Yeast: Candida albicans C627 (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02349	GRRKRKWLRRIGKGVKIIGGAALDHL	26	NRC-3 (fish, chordates, animals)	No entry found	Not found	Not found	Pseudopleuronectes americanus (Winter flounder 1a-1)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found	6RY9##6RYQ	Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=2 µg/ml), Aeromonas salmonicida 97-4 (MIC=4 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=2 µg/ml), Salmonella enterica serovar Typhimurium 14028s (MIC=8 µg/ml), Pseudomonas aeruginosa K799 (MIC=2 µg/ml), Pseudomonas aeruginosa Z61 (MIC=1 µg/ml), Escherichia coli CGSC 4908 (MIC=2 µg/ml), Escherichia coli UB1005 (MIC=8 µg/ml), Escherichia coli DC2 (MIC=2 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=8 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=8 µg/ml).##Yeast: Candida albicans C627 (MIC=4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02350	GWGSFFKKAAHVGKHVGKAALTHYL	25	Pleurocidin (NRC-4; fish, chordates, animals)	P81941, P81619, Q9PRJ9, Q90ZY0, Q90VW6	Belongs to the pleurocidin family	ple1 AND ple2	Pseudopleuronectes americanus (Winter flounder 2-2.1)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix (1 helices; 19 residues)	From NMR structural studies with the uniformly (15)N-labeled peptide, a structure of pleurocidin is determined to be in a random coil conformation in aqueous solution whereas it assumes an alpha-helical structure in TFE and in dodecylphosphocholine (DPC) micelles.(Ref.2)	1Z64 resolved by NMR.	May play a role in innate host defense.	Gram-negative bacteria: Escherichia coli (MIC=2.2-3.3 µM), Leucothrix mucor (MIC>35.0 µM), Serratia marcescens (MIC>35.0 µM), Pseudomonas aeruginosa (MIC>35.0 µM), Aeromonas salmonicida (MIC=17.7-35.0 µM), Cytophaga aquatilis (MIC=2.2-4.4 µM), Pasteurella haemolytica (MIC=4.4-8.8 µM), Salmonella typhimurium I (MIC=8.8-17.7 µM), Salmonella typhimurium II (MIC=8.8-17.7 µM);##Gram-positive bacteria: Bacillus subtilis (MIC=1.1-2.2 µM), Staphylococcus aureus (MIC=17.7-35.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9115266	J Biol Chem. 1997 May 2;272(18):12008-12013.	Cole A.M, Weis P, Diamond G.	Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder.	
DRAMP02351	FFRLLFHGVHHVGKIKPRA	19	NRC-10 (fish, chordates, animals)	No entry found	Not found	Not found	Pseudopleuronectes americanus (Winter flounder Z)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>64 µg/ml), Aeromonas salmonicida 97-4 (MIC=32 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=16 µg/ml), Salmonella enterica serovar Typhimurium 14028s (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC=32 µg/ml), Pseudomonas aeruginosa Z61 (MIC=8 µg/ml), Escherichia coli CGSC 4908 (MIC=32 µg/ml), Escherichia coli UB1005 (MIC=32 µg/ml), Escherichia coli DC2 (MIC=32 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=32 µg/ml), Staphylococcus aureus C623 (MRSA) (MIC=64 µg/ml).##Yeast: Candida albicans C627 (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02352	GWKKWLRKGAKHLGQAAIK	19	NRC-16 (fish, chordates, animals)	No entry found	Not found	Not found	Glyptocephalus cynoglossus (Witch flounder GC3.8-t)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=2 µg/ml), A. salmonicida 97-4 (MIC=1 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=0.5 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=16 µg/ml), Pseudomonas aeruginosa K799 (MIC=4 µg/ml), Pseudomonas aeruginosa Z61 (MIC=1 µg/ml), Escherichia coli CGSC 4908 (MIC=1 µg/ml), E. coli UB1005 (MIC=2 µg/ml), E. coli DC2 (MIC=0.5 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=16 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=32 µg/ml).##Yeast: Candida albicans C627 (MIC=8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02354	FFRLLFHGVHHGGGYLNAA	19	Pleurocidin-like peptide WFY (fish, chordates, animals)	No entry found	Not found	Not found	Pseudopleuronectes americanus (Winter flounder) (Pleuronectes americanus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida A449 field isolate (MIC>64 µg/ml), A. salmonicida 97-4 field isolate (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC>64 µg/ml), Pseudomonas aeruginosa Z61 (MIC=64 µg/ml), Escherichia coli CGSC4908 triple (MIC=64 µg/ml), Salmonella typhimurium 14028s (MIC>64 µg/ml), Salmonella typhimurium MS7953s (MIC=64 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis (human clinical isolates) (MIC>64 µg/ml), Staphylococcus aureus (MRSA) (MIC>64 µg/ml).##Fungi: Candida albica (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12950255	Eur J Biochem. 2003 Sep;270(18):3720-3730.	Douglas SE, Patrzykat A, Pytyck J, Gallant JW.	Identification, structure and differential expression of novel pleurocidins clustered on the genome of the winter flounder, Pseudopleuronectes americanus (Walbaum).	
DRAMP02357	FLGALIKGAIHGGRFIHGMIQNHH	24	Pleurocidin-like peptide WF3 (NRC-5; fish, chordates, animals)	Q90VW7	Belongs to the pleurocidin family	ple3	Pseudopleuronectes americanus (Winter flounder 3)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>64 µg/ml), A. salmonicida 97-4 (MIC>64 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=64 µg/ml), Salmonella enterica serovar Typhimurium 14028s (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC>64 µg/ml), Pseudomonas aeruginosa Z61 (MIC=32 µg/ml), Escherichia coli CGSC 4908 (MIC=64 µg/ml), Escherichia coli UB1005 (MIC=64 µg/ml), Escherichia coli DC2 (MIC>64 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=32 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=32 µg/ml).##Yeast: Candida albicans C627 (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506##11113283	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.##Dev Comp Immunol. 2001 Mar;25(2):137-147.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.##Douglas SE, Gallant JW, Gong Z, Hew C.	Novel antimicrobial peptides derived from flatfish genes.##Cloning and developmental expression of a family of pleurocidin-like antimicrobial peptides from winter flounder, Pleuronectes americanus (Walbaum).	
DRAMP02358	GWGSIFKHGRHAAKHIGHAAVNHYL	25	Pleurocidin-like peptide WF4 (NRC-6; fish, chordates, animals)	Q90ZX8, Q90ZX9	Belongs to the pleurocidin family	ple4	Pseudopleuronectes americanus (Winter flounder 4-1.1)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found	6RZC	Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=4 µg/ml), A. salmonicida 97-4 (MIC=4 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=4 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=64 µg/ml), Pseudomonas aeruginosa K799 (MIC=16 µg/ml), Pseudomonas aeruginosa Z61 (MIC=4 µg/ml), Escherichia coli CGSC 4908 (MIC=4 µg/ml), E. coli UB1005 (MIC=4 µg/ml), E. coli DC2 (MIC=2 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=32 µg/ml).##Yeast: Candida albicans C627 (MIC=32 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506##11113283	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.##Dev Comp Immunol. 2001 Mar;25(2):137-147.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.##Douglas SE, Gallant JW, Gong Z, Hew C.	Novel antimicrobial peptides derived from flatfish genes.##Cloning and developmental expression of a family of pleurocidin-like antimicrobial peptides from winter flounder, Pleuronectes americanus (Walbaum).	
DRAMP02359	RWGKWFKKATHVGKHVGKAALTAYL	25	Pleurocidin-like peptide YT2 (NRC-7; fish, chordates, animals; Predicted)	Q7SZH1	Not found	ple	Limanda ferruginea (Yellowtail flounder YT2)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=4 µg/ml), A. salmonicida 97-4 (MIC=2 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=2 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=8 µg/ml), Pseudomonas aeruginosa K799 (MIC=4 µg/ml), Pseudomonas aeruginosa Z61 (MIC=2 µg/ml), Escherichia coli CGSC 4908 (MIC=4 µg/ml), E. coli UB1005 (MIC=4 µg/ml), E. coli DC2 (MIC=4 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=64 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=64 µg/ml).##Yeast: Candida albicans C627 (MIC=16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02360	GWKSVFRKAKKVGKTVGGLALDHYLG	26	Pleurocidin-like peptide AP1 (NRC-11; fish, chordates, animals; Predicted)	Q7SZH4	Not found	ple	Hippoglossoides platessoides (American plaice AP1)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=8 µg/ml), A. salmonicida 97-4 (MIC=8 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=4 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=32 µg/ml), Pseudomonas aeruginosa K799 (MIC=32 µg/ml), Pseudomonas aeruginosa Z61 (MIC=4 µg/ml), Escherichia coli CGSC 4908 (MIC=4 µg/ml), E. coli UB1005 (MIC=16µg/ml), E. coli DC2 (MIC=4 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=64 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 µg/ml).##Yeast: Candida albicans C627 (MIC=32 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02361	GWKKWFNRAKKVGKTVGGLAVDHYLG	26	Pleurocidin-like peptide AP2 (NRC-12; fish, chordates, animals; Predicted)	Q7SZH3	Not found	ple	Hippoglossoides platessoides (American plaice AP2)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=2 µg/ml), A. salmonicida 97-4 (MIC=2 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=2 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=8µg/ml), Pseudomonas aeruginosa K799 (MIC=4 µg/ml), Pseudomonas aeruginosa Z61 (MIC=1 µg/ml), Escherichia coli CGSC 4908 (MIC=2 µg/ml), E. coli UB1005 (MIC=8 µg/ml), E. coli DC2 (MIC=2 µg/ml);##Gram-positive bacteria: S. epidermidis C621 (MIC=8 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=16 µg/ml).##Yeast: Candida albicans C627 (MIC=4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02362	GWRTLLKKAEVKTVGKLALKHYL	23	Pleurocidin-like peptide AP3 (NRC-13; fish, chordates, animals; Predicted)	Q7SZH2	Not found	ple	Hippoglossoides platessoides (American plaice AP3)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=4 µg/ml), A. salmonicida 97-4 (MIC=2 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=2 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=8 µg/ml), Pseudomonas aeruginosa K799 (MIC=4 µg/ml), Pseudomonas aeruginosa Z61 (MIC=1 µg/ml), Escherichia coli CGSC 4908 (MIC=2 µg/ml), E. coli UB1005 (MIC=4 µg/ml), E. coli DC2 (MIC=2 µg/ml).##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=4 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=4 µg/ml).##Yeast: Candida albicans C627 (MIC=4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02363	AGWGSIFKHIFKAGKFIHGAIQAHND	26	Pleurocidin-like peptide GcSc4C5 (NRC-14; fish, chordates, animals)	Q7SZH0 	Not found	ple	Glyptocephalus cynoglossus (Witch flounder GcSc4C5)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=32 µg/ml), A. salmonicida 97-4 (MIC=16 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=16 µg/ml), S. enterica serovar Typhimurium 14028s (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC=32 µg/ml), Pseudomonas aeruginosa Z61 (MIC=8 µg/ml), Escherichia coli CGSC 4908 (MIC=16 µg/ml), E. coli UB1005 (MIC=16 µg/ml), E. coli DC2 (MIC=16 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=16 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=16 µg/ml).##Yeast: Candida albicans C627 (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02364	GFWGKLFKLGLHGIGLLHLHL	21	Pleurocidin-like peptide GcSc4B7 (NRC-15; fish, chordates, animals; Predicted)	Q7SZG9	Not found	ple	Glyptocephalus cynoglossus (Witch flounder GcSc4B7)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=8 µg/ml), A. salmonicida 97-4 (MIC=16 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=4 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=16 µg/ml), Pseudomonas aeruginosa K799 (MIC=8 µg/ml), Pseudomonas aeruginosa Z61 (MIC=4 µg/ml), Escherichia coli CGSC 4908 (MIC=8 µg/ml), E. coli UB1005 (MIC=8 µg/ml), E. coli DC2 (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=4 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=4 µg/ml).##Yeast: Candida albicans C627 (MIC=16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02365	GWKKWLRKGAKHLGQAAIKGLAS	23	Pleurocidin-like peptide GC3.8 (NRC-17; fish, chordates, animals; Predicted)	Q7SZG8	Not found	ple	Glyptocephalus cynoglossus (Witch flounder GC3.8)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=2 µg/ml), A. salmonicida 97-4 (MIC=1 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=1 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=8 µg/ml), Pseudomonas aeruginosa K799 (MIC=4 µg/ml), Pseudomonas aeruginosa Z61 (MIC=2 µg/ml), Escherichia coli CGSC 4908 (MIC=1 µg/ml), E. coli UB1005 (MIC=4 µg/ml), E. coli DC2 (MIC=1 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=32 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=16 µg/ml).##Yeast: Candida albicans C627 (MIC=8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02366	GWKKWFTKGERLSQRHFA	18	Pleurocidin-like peptide GC3.2 (NRC-18; fish, chordates, animals; Predicted)	Q7SZG7	Not found	ple	Glyptocephalus cynoglossus (Witch flounder GC3.2)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>64 µg/ml), A. salmonicida 97-4 (MIC=128 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=32 µg/ml), S. enterica serovar Typhimurium 14028s (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC>64 µg/ml), Pseudomonas aeruginosa Z61 (MIC=64 µg/ml), Escherichia coli CGSC 4908 (MIC=64 µg/ml), E. coli UB1005 (MIC=64 µg/ml), E. coli DC2 (MIC=64 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 µg/ml).##Yeast: Candida albicans C627 (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02367	FLGLLFHGVHHVGKWIHGLIHGHH	24	Pleurocidin-like peptide Hb26 (NRC-19; fish, chordates, animals; Predicted)	Q7SZG6	Not found	ple	Hippoglossus hippoglossus (Halibut Hb26)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=64 µg/ml), A. salmonicida 97-4 (MIC>64 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=16 µg/ml), S. enterica serovar Typhimurium 14028s (MIC=64 µg/ml), Pseudomonas aeruginosa K799 (MIC=32 µg/ml), Pseudomonas aeruginosa Z61 (MIC=8 µg/ml), Escherichia coli CGSC 4908 (MIC=32 µg/ml), E. coli UB1005 (MIC=16 µg/ml), E. coli DC2 (MIC=32 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=8 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC=8 µg/ml).##Yeast: Candida albicans C627 (MIC=64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02368	GFLGILFHGVHHGRKKALHMNSERRS	26	Pleurocidin-like peptide Hb18 (NRC-20; fish, chordates, animals; Predicted)	Q7SZG5	Not found	ple	Hippoglossus hippoglossus (Halibut Hb18)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>64 µg/ml), A. salmonicida 97-4 (MIC>64 µg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC>64 µg/ml), S. enterica serovar Typhimurium 14028s (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC>64 µg/ml), Pseudomonas aeruginosa Z61 (MIC=64 µg/ml), Escherichia coli CGSC 4908 (MIC>64 µg/ml), E. coli UB1005 (MIC>64 µg/ml), E. coli DC2 (MIC>64 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 µg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 µg/ml).##Yeast: Candida albicans C627 (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878506	Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.	Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.	Novel antimicrobial peptides derived from flatfish genes.	
DRAMP02374	GCRFCCNCCPNMSGCGVCCRF	21	Bass hepcidin (fish, chordates, animals)	P82951	Belongs to the hepcidin family	hamp	Morone chrysops x Morone saxatilis (white bass x striped sea-bass)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Protein level	Beta strand (2 strands; 6 residues)	Solution structure by NMR indicates that bass hepcidin is very similar to that of human hepcidin, including the presence of an antiparallel beta-sheet, a conserved disulfide-bonding pattern, and a rare vicinal disulfide bond.	1S6W resolved by NMR.	"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages (By similarity). Synthetic bass hepcidin is active in vitro against Gram-negative pathogens and fungi but showes no activity against key Gram-positive pathogens and a single yeast strain tested.
Tissue specificity: Predominantly expressed in liver.
Induction: By bacterial challenge.
PTM: Contains four disulfide bonds 2-19; 5-8; 6-15; 9-18."	Gram-negative bacteria: Escherichia coli ATCC 25,922,351,50 (MIC=22 µM), Escherichia coli ATCC D31K (MIC=11 µM), Klebsiella pneumoniae ATCC 10,031 (MIC=22 µM), P. shigelloides ATCC KST (MIC=11 µM), S. flexneri ATCC 12,022 (MIC=22 µM), Shigella sonnei ATCC 9290 (MIC=44 µM), Y. enterocolitica ATCC 23,715 (MIC=22 µM).##Fungi: Aspergillus niger (MIC=44 µM).	[Ref.15546886] It displays essentially no hemolytic activity toward HSB erythrocytes	Cyclic	Free	Free	Disulfide bonds between Cys2 and Cys19; Cys5 and Cys8; Cys6 and Cys15,Cys9 and Cys18.	L	No cytotoxicity information found	Not found	11985602##15546886	Eur J Biochem. 2002 Apr;269(8):2232-2237.##J Biol Chem. 2005 Mar 11;280(10):9272-9282.	Shike H, Lauth X, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Shimizu C, Bulet P, Burns JC.##Lauth X, Babon JJ, Stannard JA, Singh S, Nizet V, Carlberg JM, Ostland VE, Pennington MW, Norton RS, Westerman ME.	Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge.##Bass hepcidin synthesis, solution structure, antimicrobial activities and synergism, and in vivo hepatic response to bacterial infections.	CSCC[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CSSC[C@@H]4NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC4=O)C(=O)N2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CN)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccccc2)C(=O)O)NC3=O)NC(=O)CNC(=O)[C@H](CO)NC1=O
DRAMP02376	LFGFLIKLIPSLFGALSNIGRNRNQ	25	Grammistin Gs 1 (Grammistin Gs F; Group I grammistin; soapfish, chordates, animals)	P69835	Belongs to the grammistin family (Group 1 subfamily)	Not found	Grammistes sexlineatus (Sixline soapfish) (Golden stripe soapfish)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=25 µg/ml), Staphylococcus aureus IAM 1011 (MIC=6.25 µg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=50 µg/ml), Escherichia coli JCM 1649 (MIC=50 µg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=12.5 µg/ml), Salmonella typhimurium S1 (MIC>50 µg/ml), S. putrefaciens IAM 1509 (MIC=12.5 µg/ml), Vibrio anguillarum NCIBM 829 (MIC=50 µg/ml), Vibrio parahaemolyticus (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Fish. Sci. 2001 Oct;67:928-933.	Yokota H, Nagashima Y, Shiomi K.	Interaction of grammistins with lipids and their antibacterial activity.	
DRAMP02377	LFGFLIPLLPHIIGAIPQVIGAIR	24	Grammistin Gs 2 (Grammistin Gs G; Group I grammistin; soapfish, chordates, animals)	P69836	Belongs to the grammistin family (Group 1 subfamily)	Not found	Grammistes sexlineatus (Sixline soapfish) (Golden stripe soapfish)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=12.5 µg/ml), Staphylococcus aureus IAM 1011 (MIC=6.25 µg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=50 µg/ml), Escherichia coli JCM 1649 (MIC=50 µg/ml), Photobacterium damselae subsp. Piscicida Sp 9587 (MIC=6.25 µg/ml), Salmonella typhimurium S1 (MIC>50 µg/ml), S. putrefaciens IAM 1509 (MIC=6.25 µg/ml), Vibrio anguillarum NCIBM 829 (MIC=25 µg/ml), Vibrio parahaemolyticus (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Fish. Sci. 2001 Oct;67:928-933.	Yokota H, Nagashima Y, Shiomi K.	Interaction of grammistins with lipids and their antibacterial activity.	
DRAMP02378	WWRELLKKLAFTAAGHLGSVLAAKQSGW	28	Grammistin Gs A (Group III grammistin; soapfish, chordates, animals)	P69845	Belongs to the grammistin family (Group 3 subfamily)	Not found	Grammistes sexlineatus (Sixline soapfish) (Golden stripe soapfish)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=25 µg/ml), Staphylococcus aureus IAM 1011 (MIC=12.5 µg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=25 µg/ml), Escherichia coli JCM 1649 (MIC=50 µg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=25 µg/ml), Salmonella typhimurium S1 (MIC>50 µg/ml), S. putrefaciens IAM 1509 (MIC=6.25 µg/ml), Vibrio anguillarum NCIBM 829 (MIC=50 µg/ml), Vibrio parahaemolyticus (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15777955	Toxicon. 2005 Apr;45(5):595-601.	Sugiyama N, Araki M, Ishida M, Nagashima Y, Shiomi K.	Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.	
DRAMP02379	IGGIISFFKRLF	12	Grammistin Gs B (Group II grammistin; soapfish, chordates, animals)	P69839	Belongs to the grammistin family (Group 2 subfamily)	Not found	Grammistes sexlineatus (Sixline soapfish) (Golden stripe soapfish)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=6.25 µg/ml), Staphylococcus aureus IAM 1011 (MIC=6.25 µg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=25 µg/ml), Escherichia coli JCM 1649 (MIC=12.5 µg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=6.25 µg/ml), Salmonella typhimurium S1 (MIC=12.5 µg/ml), S. putrefaciens IAM 1509 (MIC=3.13 µg/ml), Vibrio anguillarum NCIBM 829 (MIC=6.25 µg/ml), Vibrio parahaemolyticus (MIC=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15777955	Toxicon. 2005 Apr;45(5):595-601.	Sugiyama N, Araki M, Ishida M, Nagashima Y, Shiomi K.	Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.	
DRAMP02380	NWRKILGKIAKVAAGLLGSMLAGYQV	26	Grammistin Gs C (Group III grammistin; soapfish, chordates, animals)	P69846	Belongs to the grammistin family (Group 3 subfamily)	Not found	Grammistes sexlineatus (Sixline soapfish) (Golden stripe soapfish)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		MOA: Thanks to its amphiphilic alpha-helice(s), it may integrate into membrane phospholipids, leading to lysis of the membrane.	Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=6.25 µg/ml), Staphylococcus aureus IAM 1011 (MIC=12.5 µg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=25 µg/ml), Escherichia coli JCM 1649 (MIC=12.5 µg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=6.25 µg/ml), Salmonella typhimurium S1 (MIC=12.5 µg/ml), S. putrefaciens IAM 1509 (MIC=6.25 µg/ml), Vibrio anguillarum NCIBM 829 (MIC=12.5 µg/ml), Vibrio parahaemolyticus (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15777955	Toxicon. 2005 Apr;45(5):595-601.	Sugiyama N, Araki M, Ishida M, Nagashima Y, Shiomi K.	Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.	
DRAMP18375	GLDFSQPFPSGEFAVCESCKLGRGKCRKECLENEKPDGNCRLNFLCCRQRI	51	hBD-5 (human beta-defensin 5)	No entry found	Belongs to the beta-defensin family.	Not found	Homo sapiens	Antimicrobial, Antibacterial		bridge	Not found		PTM: There are 7 cysteines, making it likely to form an intermolecular S-S bond.	Active against E. coli K12.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12193721	J Immunol. 2002 Sep 1;169(5):2516-23.	Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T, Kurihara H, Ouchi Y.	Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice.	
DRAMP18373	CMSYGGSCQRSCNGGFRLGGHCGHPKIRCCRRK	33	mBD-6 (Murine beta-defensin 6)	No entry found	Belongs to the beta-defensin family.	Not found	Mus musculus	Antimicrobial, Antibacterial, Anti-Gram-		bridge	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: E. coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11408484	J Biol Chem. 2001 Aug 24;276(34):31510-4	Yamaguchi Y, Fukuhara S, Nagase T, Tomita T, Hitomi S, Kimura S, Kurihara H, Ouchi Y.	A novel mouse beta-defensin, mBD-6, predominantly expressed in skeletal muscle.	
DRAMP18374	FFDEKCNKLKGTCKNNCGKNEELIALCQKSLKCCRTIQPSGSIID	45	hBD-6 (human beta-defensin 6)	No entry found	Belongs to the beta-defensin family.	Not found	Homo sapiens	Antimicrobial, Antibacterial, Anti-Gram-, Chemotactic		beta 	Not found	2LWL 	Comment: No comments found on DRAMP database	Gram-negative bacteria: E. coli K12.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12193721	J Immunol. 2002 Sep 1;169(5):2516-23	Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T, Kurihara H, Ouchi Y.	Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice.	
DRAMP02386	KGRGKQGGKVRAKAKTRSS	19	Parasin I (histone-H2A-derived; catfishes, chordates, animals)	No entry found	Not found	Not found	Parasilurus asotus (Amur catfish)	Antimicrobial, Antibacterial	Not found	Alpha helix 	Not found		Comment: No comments found on DRAMP database	Aeromonas salmonicida (MIC=10 µg/ml), Cytophaga aquatilis (MIC=5 µg/ml), Yersinia rukeri (MIC=15 µg/ml), Edwardsiella ictaluri (MIC=10 µg/ml), Lactococcus garvieae (MIC=10 µg/ml). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	9824303	FEBS Lett 1998; 437: 258-262.	Park IY, Park CB, Kim MS, Kim SC.	Parasin I, an antimicrobial peptide derived from histon H2A in the catfish, Parasilurus asotus.	
DRAMP02390	RPRPNYRPRPIYRP	14	Astacidin 2 (crayfish, Arthropods, animals)	Q0PJU7	Not found	Not found	Pacifastacus leniusculus (signal crayfish)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Predicted	Rich	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Shigella flexneri ATCC 203 (MIC=0.98 µg/ml), Proteus vulgaris OX19 ATCC 6380 (MIC=7.8 µg/ml), Escherichia coli D21 (MIC=3.9 µg/ml), Psedomonas aeruginosa OT 97 (MIC=7.8 µg/ml).##Gram-positive bacteria: Bacillus megateriun B11 (MIC=1.9 µg/ml), Bacillus subtilis ATCC 6633 (MIC=1.95 µg/ml), Staphylococcus aureus JC-1 (MIC=7.8 µg/ml), Micrococcus luteus Ml 11 (MIC=10 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17049601	Dev Comp Immunol. 2007;31(5):441-455. 	Jiravanichpaisal P, Lee SY, Kim YA, Andrén T, Söderhäll I.	Antibacterial peptides in hemocytes and hematopoietic tissue from freshwater crayfish Pacifastacus leniusculus: characterization and expression pattern.	
DRAMP02391	GWFKKAWRKVKHAGRRVLDTAKGVGRHYLNNWLNRYRG	38	Hematopoietic antimicrobial peptide-37 (MgCath37; hagfishes, chordates, animals)	Q71MD7	Not found	CATH37	Myxine glutinosa (Atlantic hagfish)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Propionibacterium acnes ATCC 11827 and 33179 (MIC=2 µg/ml), Staphylococcus epidermidi (MIC=2-4 µg/ml), Streptococcus pyogenes (MIC=4 µg/ml), Enterococcus faecium (MIC=4-8 µg/ml), Staphylococcus aureus ATCC 29213 (MIC=8 µg/ml), Clostridium perfringens ATCC 9081 and 13124 (MIC=4-32 µg/ml), Enterococcus faecalis (MIC=32 µg/ml);##Gram-negative bacteria: Bacteroides spp. ATCC 29771, 43935, 12290 (MIC=0.5-4 µg/ml), Shigella sonnei (MIC=2-4 µg/ml), Xanthomonas maltophilia (MIC=2-8 µg/ml), Salmonella Group B (MIC=4-8 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 µg/ml), Acinetobacter baumannii (MIC=8-16 µg/ml), Escherichia coli ATCC 25922 (MIC=8 µg/ml), Enterobacter aerogenes (MIC=8-16 µg/ml), Enterobacter cloacae (MIC=8-16 µg/ml), Klebsiella pneumoniae (MIC=8-16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15019197	Peptides. 2003 Nov;24(11):1655-1667.	Uzzell T, Stolzenberg ED, Shinnar AE, Zasloff M.	Hagfish intestinal antimicrobial peptides are ancient cathelicidins.	
DRAMP02393	GFFKKAWRKVKHAGRRVLDTAKGVGRHYVNNWLNRYRZ	38	HFIAP-1 (HFIAP-2; hagfishes, chordates, animals)	No entry found	Not found	Not found	Myxine glutinosa (Atlantic hagfish)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		"Function: Has antibacterial against a bank of Gram-negative and Gram-positive bacteria as well as a representative fungal species.
Sequence similarity: Sequences for HFIAP-1 and -2 are identical, but HFIAP-2 is brominated only at residue 7; they differ from MgCath37 by conservative replacements."	Gram-positive bacteria: Propionibacterium acnes ATCC 11827/33179 (MIC=2 µg/ml), Staphylococcus epidermidi (MIC=2-4 µg/ml), Streptococcus pyogenes (MIC=4 µg/ml), Enterococcus faecium (MIC=4-8 µg/ml), Staphylococcus aureus ATCC 29213 (MIC=8 µg/ml), Clostridium perfringens ATCC 9081/13124 (MIC=4-32 µg/ml), Enterococcus faecalis (MIC=32 µg/ml);##Gram-negative bacteria: Bacteroides spp. ATCC 29771/43935/12290 (MIC=0.5-4 µg/ml), Shigella sonnei (MIC=2-4 µg/ml), Xanthomonas maltophilia (MIC=2-8 µg/ml), Salmonella Group B (MIC=4-8 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 µg/ml), Acinetobacter baumannii (MIC=8-16 µg/ml), Escherichia coli ATCC 25922 (MIC=8 µg/ml), Enterobacter aerogenes (MIC=8-16 µg/ml), Enterobacter cloacae (MIC=8-16 µg/ml), Klebsiella pneumoniae (MIC=8-16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15019197	Peptides. 2003 Nov;24(11):1655-1667.	Uzzell T, Stolzenberg ED, Shinnar AE, Zasloff M.	Hagfish intestinal antimicrobial peptides are ancient cathelicidins.	
DRAMP02394	GWFKKAWRKVKNAGRRVLKGVGIHYGVGLIZ	31	HFIAP-3 (hagfishes, chordates, animals)	No entry found	Not found	Not found	Myxine glutinosa (Atlantic hagfish)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial against a bank of Gram-negative and Gram-positive bacteria as well as a representative fungal species. HFIAP-1 and HFIAP-3 exhibit similar inhibitory activity.	Gram-positive bacteria: Propionibacterium acnes ATCC 11827/33179 (MIC=2 µg/ml), Staphylococcus epidermidi (MIC=2-4 µg/ml), Streptococcus pyogenes (MIC=4 µg/ml), Enterococcus faecium (MIC=4-8 µg/ml), Staphylococcus aureus ATCC 29213 (MIC=8 µg/ml), Clostridium perfringens ATCC 9081/13124 (MIC=4-32 µg/ml), Enterococcus faecalis (MIC=32 µg/ml);##Gram-negative bacteria: Bacteroides spp. ATCC 29771/43935/12290 (MIC=0.5-4 µg/ml), Shigella sonnei (MIC=2-4 µg/ml), Xanthomonas maltophilia (MIC=2-8 µg/ml), Salmonella Group B (MIC=4-8 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 µg/ml), Acinetobacter baumannii (MIC=8-16 µg/ml), Escherichia coli ATCC 25922 (MIC=8 µg/ml), Enterobacter aerogenes (MIC=8-16 µg/ml), Enterobacter cloacae (MIC=8-16 µg/ml), Klebsiella pneumoniae (MIC=8-16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15019197	Peptides. 2003 Nov;24(11):1655-1667.	Uzzell T, Stolzenberg ED, Shinnar AE, Zasloff M.	Hagfish intestinal antimicrobial peptides are ancient cathelicidins.	
DRAMP02395	AACSDRAHGHICESFKSFCKDSGRNGVKLRANCKKTCGLC	40	Aurelin (jellyfish, chordates, animals)	Q0MWV8, P84891	Belongs to ShKT domain family	Not found	Aurelia aurita (Moon jellyfish)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Combine helix and strand structure	Not found	2LG4 resolved by NMR.	"Function: Antimicrobial peptide exhibits activity against Gram-positive and Gram-negative bacteria.
Domian: Contains 1 ShKT domain.
PTM: Contains three disulfide bonds (By similarity)."	Gram-positive bacterium: Listeria monocytogenes EGD (MIC=22.64 µg/ml);##Gram-negative bacterium: Escherichia coli ML-35p (MIC=7.66 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys19 and Cys40)	Disulfide bonds between Cys3 and Cys33; Cys12 and Cys37; Cys19 and Cys40.	L	No cytotoxicity information found	Not found	16890198##PubMed ID is not available 	Biochem Biophys Res Commun. 2006 Sep 22;348(2):514-523.##To be Published.	Ovchinnikova TV, Balandin SV, Aleshina GM, Tagaev AA, Leonova YF, Krasnodembsky ED, Men'shenin AV, Kokryakov VN.##Shenkarev Z, Altukhov D, Gizatullina A, Arseniev A, Ovchinnikova T.	Aurelin, a novel antimicrobial peptide from jellyfish Aurelia aurita with structural features of defensins and channel-blocking toxins.##Solution structure of aurelin, a novel antimicrobial peptide.	
DRAMP02397	AVPDVAFNAYG	11	Big defensin (RPD-1)	P86316	Belongs to the big defensin family	Not found	Venerupis philippinarum (Japanese carpet shell) (Tapes japonica)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Protein level	Not found	Not found		Function: Significantly inhibits the growth of Gram-negative and Gram-positive bacteria and fungi in vitro. Has antibacterial activity.	Gram-positive bacteria: Staphylococcus aureus (MIC=9.6 mg/L), Bacillus subtilis (MIC=76.8 mg/L), Micrococcus tetragenus (MIC=38.4 mg/L);##Gram-negative bacteria: Escherichia coli (MIC=76.8 mg/L), Vibrio parahaemolyticus (MIC=19.2 mg/L), Vibrio anguillarum (MIC=19.2 mg/L).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14673509	Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Dec;35(12):1145-8.	Wei YX, Guo DS, Li RG, Chen HW, Chen PX.	Purification of a big defensin from Ruditapes philippinesis and its antibacterial activity.	
DRAMP02402	FLPKMSTKLRVPYRRGTKDYH	21	Antimicrobial peptide scolopin-1	P0CH48	Not found	Not found	Scolopendra mutilans (Chinese red-headed centipede) (Scolopendrasubspinipes mutilans)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial peptide against both Gram-positive, Gram-positive and yeast. Also induces histamine release by mast cells and shows hemolytic activities against both human and rabbit red cells.
Tissue specificity: Expressed by the venom gland."	[Ref.19716842]Gram-negative bacteria: Escherichia coli standard strain (MIC=12.5 µg/ml), E. coli drug-resistant strain (MIC=15 µg/ml);##Gram-positive bacteria: Staphylococcus aureus standard strain (MIC=1.2 µg/ml), S. aureus drug-resistant strain (MIC=5.0 µg/ml), Bacillus dysenteriae standard and drug-resistant strains (MIC=7.5 µg/ml);##Yeast: Candida albicans (MIC=15 µg/ml).	[Ref.19716842]25 ± 2% hemolytic activity at 50 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19716842	Toxicon. 2010 Feb-Mar;55(2-3):274-279.	Peng K, Kong Y, Zhai L, Wu X, Jia P, Liu J, Yu H.	Two novel antimicrobial peptides from centipede venoms.	
DRAMP02403	GILKKFMLHRGTKVYKMRTLSKRSH	25	Antimicrobial peptide scolopin-2	P0CH49	Not found	Not found	Scolopendra mutilans (Chinese red-headed centipede) (Scolopendrasubspinipes mutilans)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial peptide against both Gram-positive, -negative and yeast. Also induces histamine release by mast cells and shows hemolytic activities against both human and rabbit red cells.
Tissue specificity: Expressed by the venom gland."	[Ref.19716842]Gram-negative bacteria: Escherichia coli standard and drug-resistant strains (MIC=5.0 µg/ml);##Gram-positive bacteria: Staphylococcus aureus standard strain (MIC=0.5 µg/ml), S. aureus drug-resistant strain (MIC=1.0 µg/ml), Bacillus dysenteriae standard strain (MIC=2.5 µg/ml), B. dysenteriae drug-resistant strain (MIC=5.0 µg/ml);##Yeast: Candida albicans (MIC=7.5 µg/ml).	[Ref.19716842]32 ± 7% hemolytic activity at 50 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19716842	Toxicon. 2010 Feb-Mar;55(2-3):274-279.	Peng K, Kong Y, Zhai L, Wu X, Jia P, Liu J, Yu H.	Two novel antimicrobial peptides from centipede venoms.	
DRAMP02409	GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSF	34	M-theraphotoxin-Gr1a (M-TRTX-Gr1a; GsMTx-4)	Q7YT39, Q7M3T1	Belongs to the huwentoxin-1 family	Not found	Grammostola rosea (Chilean rose tarantula) (Grammostola spatulata)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Beta strand (5 strands; 9 residues)	Not found	1LU8, 1TYK resolved by NMR.	"Function: This cationic hydrophobic peptide inhibits a lot of different channels and has an antimicrobial activity. It blocks mechanosensitive ion channels (also named stretch-activated channels or SACs), without having effect on whole-cell voltage-sensitive currents. Acts by partitioning into the membrane and perturbing the interface between the channel and the lipid bilayer without necessarily being in physical contact with the channel. Inhibits atrial fibrillation as well as the membrane motor of outer hair cells at low doses. GsMTx-4 exhibites antimicrobial properties and was more active against Gram-positive than Gram-negative bacteria.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: This toxin does not inhibit potassium channels Kv1.1/KCNA1 (IC50>85 µM), Kv1.4/KCNA4 (IC50>85 µM) and Kv11.3/KCNH7 (IC50=53 µM).
PTM: Contains three disulfide bonds."	Gram-positive bacteria: Bacillus subtilis (MIC=0.5 µM), Staphylococcus aureus (MIC=2-4 µM), Staphylococcus epidermidis (MIC=4-8 µM);##Gram-negative bacteria: Salmonella typhimurium (MIC=32.64 µM), Pseudomonas aeruginosa (MIC=8-16 µM), Escherichia coli (MIC=8-16 µM). 	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys2 and Cys17,Cys9 and Cys23,Cys16 and Cys30.	L	No cytotoxicity information found	Not found	PubMed ID is not available##12082099##10779316##163768	Submitted (MAY-2002) to the PDB data bank##J Biol Chem. 2002 Sep 13;277(37):34443-50.##J Gen Physiol. 2000 May;115(5):583-598.##Biochem Biophys Res Commun. 2006 Feb 10;340(2):633-638.	Jung HJ, Lee CW, Earm YE, Kim JI.##Oswald RE, Suchyna TM, McFeeters R, Gottlieb P, Sachs F.##Suchyna TM, Johnson JH, Hamer K, Leykam JF, Gage DA, Clemo HF, Baumgarten CM, Sachs F.##Jung HJ, Kim PI, Lee SK, Lee CW, Eu YJ, Lee DG, Earm YE, Kim JI.	Solution structure of GsMTx-4, a peptide blocker of cation-selective stretch-activated channels.##Solution structure of peptide toxins that block mechanosensitive ion channels.##Identification of a peptide toxin from Grammostola spatulata spider venom that blocks cation-selective stretch-activated channels.##Lipid membrane interaction and antimicrobial activity of GsMTx-4, an inhibitor of mechanosensitive channel.	CC(C)C[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc4ccccc4)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(=O)O)NC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N3)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC2=O
DRAMP02410	FSKYERQKDKRPYSERKNQYTGPQFLYPPERIPPQKVIKWNEEGLPIYEIPGEGGHAEPAAA	62	Antimicrobial peptide lumbricin-1 	O96447	Not found	Not found	Lumbricus rubellus (Humus earthworm)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Displays antimicrobial activity and weak hemolytic activity.
Developmental stage: Adult-specific. Not detected in eggs or 1-week-old worms but abundant in 6-month-old worms.
Induction: Constitutively expressed. Not induced by bacterial infection."	[Ref.9784609]Gram-positive bacteria: Bacillus subtilis ATCC 62037 (MIC=12 µg/ml), Staphylococcus aureus ATCC 15752 (MIC=16 µg/ml), Streptococcus mutans ATCC 25175 (MIC=30 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 27325 (MIC=12 µg/ml), Pseudomonas putidaATCC 17426 (MIC=16 µg/ml), Serratia sp. ATCC 21074 (MIC=16 µg/ml);##Fungi: Candida albicans ATCC 10231 (MIC=16 µg/ml), Cryptococcus neoformance ATCC 34881 (MIC=25 µg/ml), Saccharomyces cerevisiae ATCC 44774 (MIC=12 µg/ml).##NOTE: Minimal inhibitory concentrations were determined by incubating approximately 104–105 CFU/ml of cells with serial dilutions of each peptide in a 96-well microtiter plate.	[Ref.9784609]0.02% hemolytic activity at 5 μg/ml, 0.06% hemolytic activity at 10 μg/ml, 0.14% hemolytic activity at 25 μg/ml, 0.19% hemolytic activity at 50 μg/ml, 0.23% hemolytic activity at 100 μg/ml against human erythrocytes 	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9784609	Biochim Biophys Acta. 1998 Oct 22;1408(1):67-76.	Cho JH, Park CB, Yoon YG, Kim SC.	Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization.	
DRAMP02411	GHLGRPYIGGGGGFNRGGGFHRGGGFHRGGGFHSGGGFHRGGGFHSGGSFGYR	53	Armadillidin (Glyc-rich)	Q64HC7	Not found	Not found	Armadillidium vulgare (Pillbug) (Pill woodlouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive bacterium B. megaterium LM101.
Tissue specificity: Expressed in hemocytes and at very low levels in ovary. Not expressed in adipose tissue, brain, caecum, gut, heart and nervous chain.
PTM C-terminal amidation."	Gram-positive bacteria: Bacillus megaterium LM101 (MIC=0.5-1.25 µM), Enterococcus faecalis LM002, Micrococcus luteus LM610, Listeria ivanovii BUG496;##Gram-negative bacteria: Escherichia coli JM83, Salmonella thyphimurium LM122, Enterobacter cloacae LM111, Citrobacter freundii LM457.##NOTE: Because of the low amount of the purified peptide, this minimal concentration activity is only tested on B. megaterium.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15752546	Dev Comp Immunol. 2005;29(6):489-499.	Herbinière J, Braquart-Varnier C, Grève P, Strub JM, Frère J, Van Dorsselaer A, Martin G.	Armadillidin: a novel glycine-rich antibacterial peptide directed against Gram-positive bacteria in the woodlouse Armadillidium vulgare (terrestrial isopod, crustacean).	
DRAMP02412	SYVGDCGSNGGSCVSSYCPYGNRLNYFCPLGRTCCRHAYV	40	Panusin (Defensin-like peptide 7, PaD7) 	F6KSI8	Belongs to the beta-defensin family	Not found	Panulirus argus (Caribbean spiny lobster) (Palinurus argus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antimicrobial peptide. Has antibacterial activity.
PTM: Contains two disulfide bonds (By similarity)."	Gram-positive bacterium: Staphylococcus aureus ATCC 29737 (MIC=3.46 µM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=4.8 µM).	[Ref.27616720] It shows no hemolytic effect on human red blood cells	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys28,Cys13 and Cys34,Cys18 and Cys35.	L	No cytotoxicity information found	Not found	22885029##PubMed ID is not available	Fish Shellfish Immunol. 2012 Oct;33(4):872-879.##Submitted (FEB-2012) to UniProtKB	Montero-Alejo V, Acosta-Alba J, Perdomo-Morales R, Perera E, Hernández-Rodríguez EW, Estrada MP, Porto-Verdecia M.##Montero-Alejo V, Pacios-Michelena A, Perdomo-Morales R, Crozo G, Vega-Hurtado Y.	Defensin like peptide from Panulirus argus relates structurally with beta defensin from vertebrates.##Panusin, a new defensin-like antimicrobial peptide from the hemocytes of spiny lobster Panulirus argus.	CC(C)C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](N)CO)C(C)C)CSSC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N3)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N2
DRAMP02419	YENPYGCPTDEGKCFDRCNDSEFEGGYCGGSYRATCVCYRT	41	Amblyomma defensin peptide 2 (ADP-2; Ticks, Arthropods, animals)	No entry found	Not found	Not found	Amblyomma hebraeum (Tick)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Escherichia coli (MIC=30 µM) and Staphylococcus aureus (MIC=7.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Has three disulfide bonds	l	No cytotoxicity information found	Not found	14705963	Biochem J. 2004 May 1;379(Pt 3):681-685.	Lai R, Lomas LO, Jonczy J, Turner PC, Rees HH.	Two novel non-cationic defensin-like antimicrobial peptides from haemolymph of the female tick, Amblyomma hebraeum.	
DRAMP02421	ACHAHCQSVGRRGGYCGNFRMTCYCY	26	Hlgut-defensin (H. longicornis midgut defensin; Ticks, Arthropods, animals)	A4GUC3	Not found	Not found	Haemaphysalis longicornis (Bush tick)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Predicted	Not found	Not found		"Function: Both Hlgut-defensin and Hlsal-defensin sequences have antibactrrial activity against a variety of Gram-positive and Gram-negative bacteria.
Induction: By a lipopolysaccharide (LPS) injection."	Gram-positive bacterium: Staphylococcus aureus (MIC=5-25 mg/mL);##Gram-negative bacterium: Escherichia coli (MIC=10-25 mg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17521774	Peptides. 2007 Jun;28(6):1304-1310.	Zhou J, Liao M, Ueda M, Gong H, Xuan X, Fujisaki K.	Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis.	
DRAMP02422	NCIQQCVSKGAQGGYCTNEKCTCY	24	Hlsal-defensin (H. longicornis salivary gland defensin; Ticks, Arthropods, animals)	A4GUC4	Not found	Not found	Haemaphysalis longicornis (Bush tick)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Predicted	Not found	Not found		"Function: Both Hlgut-defensin and Hlsal-defensin sequences have antibactrrial activity against a variety of Gram-positive and Gram-negative bacteria.
Induction: By a lipopolysaccharide (LPS) injection."	Gram-positive bacterium: Staphylococcus aureus (MIC=5-25 mg/mL);##Gram-negative bacterium: Escherichia coli (MIC=10-25 mg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17521774	Peptides. 2007 Jun;28(6):1304-1310.	Zhou J, Liao M, Ueda M, Gong H, Xuan X, Fujisaki K.	Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis.	
DRAMP02423	DFGCARGMIFVCMRRCARMYPGSTGYCQGFRCMCDTMIPIRRPPFIMG	48	HlMS-defensin (Ticks, Arthropods, animals)	No entry found	Not found	Not found	Haemaphysalis longicornis (Tick)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=18.8 µg/ml), Bacillus licheniformis (MIC=9.4 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=28.1 µg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=37.5 µg/ml), Serratia rubidaea (MIC=28.1 µg/ml), Psychrobacter faecalis (MIC=2.3 µg/ml).##Fungi: Candida albicans ATCC2002 (MIC=18.8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22033149	Dev Comp Immunol. 2012 May;37(1):207-211.	Zheng H, Zhou L, Yang X, Wang D, Liu J.	Cloning and characterization of a male-specific defensin-like antimicrobial peptide from the tick Haemaphysalis longicornis.	
DRAMP02425	QLKVDLWGTRSGIQPEQHSSGKSDVRRWRSRY	32	Ixosin-B (Ticks, Arthropods, animals)	A7UDM9	Not found	Not found	Ixodes sinensis (Hard tick)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal and antibacterial activity. Ixosin-B has little hemolytic activity on red blood cells even with peptide
concentrations up to 200 µg/mL."	[Ref.18295522]Gram-positive bacterium: Staphylococcus aureus (MIC=2.5 µg/mL);##Gram-negative bacterium: Escherichia coli (MIC=15 µg/mL);##Yeast: Candida albicans (MIC=7.5 µg/mL).	[Ref.18295522]Little hemolytic activity on rabbit red blood cells up to 200 μg/mL	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18295522	Comp Biochem Physiol B Biochem Mol Biol. 2008 Apr;149(4):557-561.	Liu Z, Liu H, Liu X, Wu X.	Purification and cloning of a novel antimicrobial peptide from salivary glands of the hard tick, Ixodes sinensis.	
DRAMP02427	GGYYCPFFQDKCHRHCRSFGRKAGYCGGFLKKTCICV	37	Ixodes ricinus defensin def1 (Ticks, Arthropods, animals)	No entry found	Not found	def1	Ixodes ricinus (European tick)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Bridge	Not found		Function: Has antibacterial activity against Gram-positive bacteria.	Gram-positive bacteria: Bacillus subtilis (MIC=1.5 µM), Micrococcus luteus(MIC=0.75 µM), Staphylococcus aureus (MRSA) (MIC=50 µM).	[Ref.21504572] It has 2.9% and 75% hemolysis at concentrations of 12.5 μM and 100 μM against human erythrocytes .	Cyclic	Free	Free	Disulfide bonds between Cys5 and Cys26,Cys12 and Cys34,Cys16 and Cys36.	L	No cytotoxicity information found	Not found	21504572	Parasit Vectors. 2011 Apr 19;4(1):63.	Chrudimska T, Slaninova J, Ruzek D, Rudenko N, Grubhoffer L.	Functional characterization of two defensin isoforms of the hard tick Ixodes ricinus.	CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)CN)CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](C(=O)O)C(C)C)NC1=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC3=O)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2
DRAMP02428	GGYYCPFRQDKCHRHCRSFGRKAGYCGGFLKKTCICV	37	Ixodes ricinus defensin def2 (Ticks, Arthropods, animals)	No entry found	Not found	def2	Ixodes ricinus (European tick)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Bridge	Not found		Function: Has antibacterial activity against Gram-positive bacteria.	Gram-positive bacteria: Bacillus subtilis (MIC=0.75 µM), Micrococcus luteus(MIC=0.37 µM), Staphylococcus aureus (MRSA) (MIC=25 µM).	[Ref.21504572] It has 2.0% and 64.6% hemolysis at concentrations of 12.5 μM and 100 μM against human erythrocytes .	Cyclic	Free	Free	Disulfide bonds between Cys5 and Cys26,Cys12 and Cys34,Cys16 and Cys36.	L	No cytotoxicity information found	Not found	21504572	Parasit Vectors. 2011 Apr 19;4(1):63.	Chrudimska T, Slaninova J, Ruzek D, Rudenko N, Grubhoffer L.	Functional characterization of two defensin isoforms of the hard tick Ixodes ricinus.	CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)CN)CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](C(=O)O)C(C)C)NC1=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC3=O)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2
DRAMP02429	QRGSRGQRCGPGEVFNQCGSACPRVCGRPPAQACTLQCVSGCFCRRGYIRTQRGGCIPERQCHQR	65	Chymotrypsin-elastase inhibitor ixodidin (Ticks, Arthropods, animals)	P83516	Not found	Not found	Boophilus microplus (Cattle tick)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Inhibits chymotrypsin and elastase. Has antibacterial activity against Gram-positive bacterium M.luteus and the Gram-negative bacterium E. coli.
PTM: Contains five disulfide bonds."	Escherichia coli (20% inhibition at 1mM), Micrococcus luteus(MIC=0.12-0.24 mM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	pyroglutamic acid	Free	Disulfide bonds between Cys9 and Cys34,Cys18 and Cys42,Cys22 and Cys38,Cys26 and Cys62,Cys44 and Cys56.	L	No cytotoxicity information found	Not found	16191451	Peptides. 2006 Apr;27(4):667-74. 	Fogaça AC, Almeida IC, Eberlin MN, Tanaka AS, Bulet P, Daffre S.	Ixodidin, a novel antimicrobial peptide from the hemocytes of the cattle tick Boophilus microplus with inhibitory activity against serine proteinases.	
DRAMP02430	GLHKVMREVLGYERNSYKKFFLR	23	Ixosin (Ticks, Arthropods, animals)	Q2LKX9	Not found	Not found	Ixodes sinensis (Hard tick)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has antifungal activity against C. albicans. Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. Little hemolytic activity against rabbit erythrocytes.	[Ref.16087274]Gram-postive bacteria: Staphylococcus aureus (MIC=3.7 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=30 µg/ml);##Fungi: Candida albicans (MIC=7.5 µg/ml).	[Ref.16087274]Little hemolytic activity on rabbit red blood cells up to 50 μg/mL	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16087274	Peptides. 2006 Jan;27(1):31-5.	Yu D, Sheng Z, Xu X, Li J, Yang H, Liu Z, Rees HH, Lai R.	A novel antimicrobial peptide from salivary glands of the hard tick, Ixodes sinensis.	
DRAMP02432	PDPGQPWQVKAGRPPCYSIPCRKHDECRVGSCSRCNNGLWGDRTCR	46	Antimicrobial peptide ISAMP (Ticks, Arthropods, animals)	Q8MVA6	Not found	Not found	Ixodes scapularis (Black-legged tick) (Deer tick)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antimicrobial activity and weak hemolytic.
Tissue specificity: Expressed in the fat body, hemocytes and salivary glands of partially-fed female ticks. Not expressed in the midgut."	[Ref.19852941]Gram-positive bacteria: Bacillus cereus (MIC=5.8 µg/ml), Bacillus subtilis (MIC=12.3 µg/ml), Staphylococcus aureus (MIC=10.4 µg/ml);##Gram-negative bacteria: Escherichia coli Edl 933 (MIC=3.2 µg/ml), E. coli MG/655 (MIC=4.2 µg/ml).	[Ref.19852941]Insignificant hemolytic activity even up to 150 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12177149##19852941	J Exp Biol. 2002 Sep;205(Pt 18):2843-2864.##Biochem Biophys Res Commun. 2009 Dec 18;390(3):511-515.	Valenzuela JG, Francischetti IM, Pham VM, Garfield MK, Mather TN, Ribeiro JM.##Pichu S, Ribeiro JM, Mather TN.	Exploring the sialome of the tick Ixodes scapularis.##Purification and characterization of a novel salivary antimicrobial peptide from the tick, Ixodes scapularis.	
DRAMP02433	HHQELCTKGDDALVTELECIRLRISPETNAAFDNAVQQLNCLNRACAYRKMCATNNLEQAMSVYFTNEQIKEIHDAATACDPEAHHEHDH	90	Antimicrobial peptide microplusin (Microplusin; Ticks, Arthropods, animals)	Q86LE5	Not found	Not found	Boophilus microplus (Cattle tick)	Antimicrobial, Antifungal, Antibacterial	Protein level	Alpha helix 	Microplusin consists of five alpha-helices: alpha1 (residues Gly-9 to Arg-21), alpha2 (residues Glu-27 to Asn-40), alpha3 (residues Arg-44 to Thr-54), alpha4 (residues Leu-57 to Tyr-64), and alpha5 (residues Asn-67 to Cys-80). The N and C termini are disordered.	2KNJ resolved by NMR.	"Function: Has bacteriostatic activity against the Gram-positive bacterium M.luteus. Has fungistatic activity against C.neoformans. Binds and sequesters copper and iron ions. Copper-chelating is crucial for antimicrobial activity against M.luteus.
Tissue specificity: Expressed in the hemocytes, fat body and ovaries.
PTM: Contains three disulfide bonds 6-52; 19-80; 41-46."	Micrococcus luteus (MIC=0.38-0.76 µM), Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys52,Cys19 and Cys80,Cys41 and Cys46.	L	No cytotoxicity information found	Metal-binding: copper II and iron II	14642886##19828445	Dev Comp Immunol. 2004 Mar;28(3):191-200.##J Biol Chem. 2009 Dec 11;284(50):34735-34746.	Fogaça AC, Lorenzini DM, Kaku LM, Esteves E, Bulet P, Daffre S.##Silva FD, Rezende CA, Rossi DC, Esteves E, Dyszy FH, Schreier S, Gueiros-Filho F, Campos CB, Pires JR, Daffre S.	Cysteine-rich antimicrobial peptides of the cattle tick Boophilus microplus: isolation, structural characterization and tissue expression profile.##Structure and mode of action of microplusin, a copper II-chelating antimicrobial peptide from the cattle tick Rhipicephalus (Boophilus) microplus.	CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@@H](N)Cc3c[nH]cn3)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N2)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CO)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N2
DRAMP02434	FSRYARMRDSRPWSDRKNNYSGPQFTYPPEKAPPEKLIKWNNEGSPIFEMPAEGGHIEP	59	Antimicrobial peptide lumbricin-PG (Lumbricin-PG)	P86929	Not found	Not found	Pheretima guillelmi (Earthworm) (Metaphire guillelmi)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Displays stronger activity against P. aeruginosa and S. aureus than E. coli. At the concentration of 200 g/ml, it induces 1.5 and 2.1% hemolysis of human and rabbit red blood cells, respectively.	Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=5 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=2.5 µg/m).##Fungi: Candida albicans ATCC 2002.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21539875	Peptides. 2011 Jun;32(6):1146-1150.	Li W, Li S, Zhong J, Zhu Z, Liu J, Wang W.	A novel antimicrobial peptide from skin secretions of the earthworm, Pheretima guillelmi (Michaelsen).	
DRAMP02439	FTCAISCDIKVNGKPCKGSGEKKCSGGWSCKFNVCVKV	38	U-theraphotoxin-Aju1a (U-TRTX-Aju1a; Juruin)	B3EWQ0	Belongs to the huwentoxin-2 family	Not found	Avicularia juruensis (Yellow-banded pinktoe)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has strong antifungal activity. Has no hemolytic activity against human erythrocytes. Probable ion channel inhibitor (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds 3-24; 7-30; 16-35."	[Ref. Front.Microbiol.2012 Sep;3:324-324.]Fungi: Candida albicans MDM8, C. albicans IOC 45588 (MIC=2.5-5 µM), C. krusei IOC 4559 (MIC=2.5-5 µM), C. glabrata IOC 45658 (MIC=2.5-5 µM), C. parapsilosis IOC 456416 (MIC=2.5-5 µM), C. tropicalis IOC 45608 (MIC=2.5-5 µM), C. guilliermondii IOC 455716 (MIC=2.5-5 µM) and Aspergillus niger (MIC=5-10 µM)	[Ref. 22973266] It has no hemolytic activity at 10μM against human human erythrocytes	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys24,Cys7 and Cys30,Cys16 and Cys35.	L	No cytotoxicity information found	Not found	PubMed ID is not available	Front. Microbiol. 2012 Sep;3:324-324.	Ayroza G, Ferreira ILC, Sayegh RSR, Tashima AK, Silva jr PI.	Juruin: an antifungal juruentoxin peptide from the venom of the amazonian pink toe spider, Avicularia juruensis, which contains the inhibitory cystine knot motif.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccccc2)[C@@H](C)O)CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N3)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c3ccccc13)NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC2=O
DRAMP02445	LYKLVKVVLNM	11	Antimicrobial protein BL-A60	B3EWC5	Not found	Not found	Brevibacillus laterosporus (Bacillus laterosporus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial and antifungal activity. In P.capsici, inhibits mycelial growth (EC50=7.89 µg/ml), formation of sporangia (EC50=0.6 µg/ml) and cytospore germination (EC50=21.96 µg/ml).
PTM: Contains a choline moiety at the N-terminus and a tenuazonic acid moiety at the C-terminus.
Biophysicochemical properties: pH dependence (Active between pH 3 and 11); Temperature dependence (Retains >80% activity after 15 min at 100 degrees Celsius)."	Gram-negative bacterium: Pseudomonas solanacearum (MIC=10 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=5 µM).##Fungi: Phytophthora capsici (MIC=15 µM), Botrytis cinerea (MIC=25 µM), Verticillium dahliae (MIC=200 µM), Fusarium oxysporum (MIC=50 µM), Xerocomus vesicolor (MIC=100 µM). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22244810	Peptides. 2012 Feb;33(2):206-211.	Zhao J, Guo L, Zeng H, Yang X, Yuan J, Shi H, Xiong Y, Chen M, Han L, Qiu D.	Purification and characterization of a novel antimicrobial peptide from Brevibacillus laterosporus strain A60.	
DRAMP02446	YSKSLPLSVLNP	12	Antimicrobial protein 1 (Antimicrobial protein AN5-1)	B3EWQ6	Not found	Not found	Paenibacillus alvei (Bacillus alvei)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has a broad inhibitory spectrum against both Gram-positive and -negative bacterial strains.
Miscellaneous: A synthetic peptide has no antibacterial activity against S. agalactiae ATCC 12386, S. epidermidis, P. aeruginosa and methicillin-resistant S. aureus (MRSA).
Biophysicochemical properties: pH dependence (Active between pH 2 and 12); Temperature dependence (Active between 37 and 90 degrees Celsius. Activity is reduced at 100 degrees Celsius and absent at 110 degrees Celsius. Activity is unaffected by storage at -20 degrees Celsius)."	Gram-positive bacteria: Lactobacillus plantarum strain ATCC 8014 (MIC=32 µg/ml), Lactococcus lactis ATCC 11454 (MIC>128 µg/ml), Bacillus cereus strain ATCC 14579 (MIC=64 µg/ml), Staphylococcus aureus (MIC=64 µg/ml), Bacillus subtilis (MIC=32 µg/ml), Bacillus anthracis (MIC=128 µg/ml) and Bacillus licheniformis (MIC>128 µg/ml), Bacillus ﬂexus (MIC=32 µg/ml);##Gram-negative bacteria: Escherichia coli strain ATCC 13076 (MIC=8 µg/ml), Salmonella enteritidis ATCC 13076 (MIC=4 µg/ml), Enterobacter spp. (MIC=16 µg/ml), Serratia marcescens (MIC=32 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23508455	J Ind Microbiol Biotechnol. 2013 Jun;40(6):571-579.	Alkotaini B, Anuar N, Kadhum AA, Sani AA.	Detection of secreted antimicrobial peptides isolated from cell-free culture supernatant of Paenibacillus alvei AN5.	
DRAMP02449	TGVAWRIT	8	Lectin	P86922	Not found	Not found	Ganoderma lucidum (Ling zhi medicinal fungus) (Bracket fungus)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has metal-independent hemagglutinating activity against erythrocytes from human, sheep, goat, rat, rabbit and chicken. Hemagglutinating activity is inhibited by glycoproteins fetuin, asialo-fetuin, fibrinogen, asialo-fibrinogen, thyroglobulin, bovine (BSM) as well as porcine submaxillary mucin and asialo-BSM but not by sugars alpha-L-fucose, D-glucose, D-galactose, D-glucosamine, D-galactosamine, lactose, D-melibiose, D/L-mannose, D-mannosamine, D-raffinose, L-rhamnose, xylose, glacaturonic acid or N-acetylglucosamine. Has antifungal activity. 
Biophysicochemical properties: pH dependence (Hemagglutinating activity is stable from pH 4 to pH 9 but drops sharply below pH 4 and above pH 9); Temperature dependence (Hemagglutinating activity is stable below 60 degrees Celsius but drops sharply to about 20% at 80 degrees Celsius)."	Fungi: Fusarium oxysporum (MIC=20 µg/ml), Penicillium chrysogenum (MIC=35 µg/ml), Aspergillus niger (MIC=50 µg/ml), Cladosporium musae (MIC=60 µg/ml), Botrytis cinerea (MIC=65 µg/ml), Trichophyton rubrum (MIC=65 µg/ml), T. tonsurans (MIC=20 µg/ml), T. interdigitale (MIC=20 µg/ml), Epidermophyton floccosum (MIC=15 µg/ml), Microsporum canis (MIC=70 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21728991	Protein Pept Lett. 2011 Nov;18(11):1150-1157.	U Girjal V, Neelagund S, Krishnappa M.	Ganoderma lucidum: A source for novel bioactive lectin.	
DRAMP02456	DGVCSNRRQCNKEVCGSSYDVAIVGA	26	L-amino-acid oxidase (LAAO; LAO; Dactylomelin-P)	P86163	Belongs to the flavin monoamine oxidase family	Not found	Aplysia dactylomela (Spotted sea hare)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Catalyzes the oxidative deamination of positively charged L-amino acids L-Lys and L-Arg but not of amino acids L-His, L-Asp or L-Glu. Has antibacterial activity. This antibacterial activity is bacteriostatic in the absence of amino acids L-Lys or L-Arg but bactericidal in their presence. The antibacterial effect is largely dependent on H2O2 produced in the oxidative deamination of substrates. Has hemagglutinating activity towards rabbit erythrocytes. Hemagglutinating activity is inhibited by the glycoprotein fetuin, but not by glucose, mannose, galactose, N-acetylglucosamine, N-acetylgalactosamine or sialic acid.
Tissue specificity: Expressed by the ink gland.
Biophysicochemical properties: Kinetic parameters (KM=0.22 mM for L-Lys; KM=0.015 mM for L-Arg); pH dependence (Optimum pH is 8. More than 50% activity is retained between pH 3 and 12. Inactive at pH 2); Temperature dependence (Activity remains stable after 30 min at 55 degrees Celsius)."	Gram-positive bacterium: S. aureus (MIC=15 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10758276	Toxicon. 2000 Oct;38(10):1415-1427.	Melo VM, Duarte AB, Carvalho AF, Siebra EA, Vasconcelos IM.	Purification of a novel antibacterial and haemagglutinating protein from the purple gland of the sea hare, Aplysia dactylomela rang, 1828.	
DRAMP02470	SCTTCECCCSCS	12	Nosiheptide (NOS; Antibiotic 9671-RP)	C6FX52	Belongs to the thiocillin family	nosM	Streptomyces actuosus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Inhibits bacterial protein biosynthesis by binding to ribosomes. Specifically, binds to the complex of 23S rRNA and ribosomal protein L11 (RPLK) in the 50S ribosomal subunit. While allowing a weak binding of elongation factor G (EF-G) to the ribosome and subsequent GTP-hydrolysis, probably impairs conformational changes in both the ribosome and EF-G which are necessary for translocation. In vitro, inhibits a variety of Gram-positive bacteria and inhibits Gram-negative bacterium P. multocida strain A125 (MIC=0.0024 µg/ml). Does not inhibit Gram-negative bacterium E. coli strain ATCC 9637 but does inhibit purified ribosomes from E. coli. In vivo, has no systemic effect in mice infected with staphylococci or streptococci when applied orally or subcutaneously. Has a local effect in mice infected subcutaneously or intraperitoneally with staphylococci when applied immediately afterwards. Is not toxic to mice.
Miscellaneous: The mature peptide is identical to multhiomycin from S. antibioticus strain 8446CC1 (PMID 681244). Used as an antibiotic growth promotant in poultry and pig farming in parts of Asia."	Gram-positive bacteria: Staphylococcus aureus strain 209P (MIC=0.0009 µg/ml), S. aureus strain 133 (MIC=0.0019 µg/ml), S. aureus strain B3 (MIC=0.003 µg/ml), S. aureus strain Hb (MIC=0.003 µg/ml), Micrococcus citreus strain ATCC 8411 (MIC=0.0038 µg/ml), M. lysodeikticus strain ATCC 4698 (MIC=0.003 µg/ml), Sarcina Lutea strain ATCC 9341 (MIC=0.0011 µg/ml), Streptococcus faecalis strain ATCC 9790 (MIC=0.0007 µg/ml), S. viridans (MIC=0.0065 µg/ml), Streptococcus pyogenes hemolyticus strain Dig7 (MIC=0.00028 µg/ml), Diplococcus pneumoniae strain Til (MIC=0.00015 µg/ml), N. catrrhalis (MIC=0.0017 µg/ml), Lactobacillus casei strain ATCC 6633 (MIC=0.003 µg/ml), Bacillus cereus ATCC 6630 (MIC=0.0071 µg/ml) and various isolates of Listeria monocytogenes.##Gram-negative bacterium: P. multocida strain A125 (MIC=0.0024 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19678698##18406324	ACS Chem Biol. 2009 Oct 16;4(10):855-864.##Mol Cell. 2008 Apr 11;30(1):26-38.	Yu Y, Duan L, Zhang Q, Liao R, Ding Y, Pan H, Wendt-Pienkowski E, Tang G, Shen B, Liu W.##Harms JM, Wilson DN, Schluenzen F, Connell SR, Stachelhaus T, Zaborowska Z, Spahn CM, Fucini P.	Nosiheptide biosynthesis featuring a unique indole side ring formation on the characteristic thiopeptide framework.##Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin.	
DRAMP02473	KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF	30	Cathelicidin-BF (Cathelicidin-related protein; Snakes, reptiles, animals)	B6D434	Not found	Not found	Bungarus fasciatus (Banded krait)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Adopts an amphipathic alpha helical conformation, that may allow to partition into the target membrane. No hemolytic and cytotoxic activities have been observed on mammalian cells.
Tissue specificity: Expressed by the venom gland, stomach, trachea, skin, muscle, heart, kidney, lung, brain, intestine, spleen, liver, and ovary.
Miscellaneous: A predicted cleavage site is located at position Val-157-158-Lys, giving a peptide of 34 residues instead of the 30 residues found for the purified protein. The 30 residues cathelicidin-BF could result from a further processing."	[Ref.18795096]Gram-negative bacteria: Pseudomonas aeruginosa ATCC27853 (MIC=1.2 µg/ml), P. aeruginosa IS/DR (MIC=2.3 µg/ml), P. aeruginosa 08031205 IS/DR (MIC=9.4 µg/ml), P. aeruginosa 08031014 IS/DR (MIC=18.7 µg/ml), Escherichia coli ATCC25922 (MIC=2.3 µg/ml), E. coli 08A852 IS/DR (MIC=1.2 µg/ml), E. coli 08A866 IS/DR (MIC=0.6 µg/ml), E. coli 08031017 IS/DR (MIC=2.3 µg/ml), E. coli 08032813 IS/DR (MIC=2.3 µg/ml), E. coli 08040726 IS/DR (MIC=0.6 µg/ml), E. coli 08040722 IS/DR (MIC=0.6 µg/ml), Klebsiella pneumoniae IS/DR (MIC=4.7 µg/ml), K. pneumoniae 08031012 IS/DR (MIC=9.4 µg/ml), K. pneumoniae 08040202 IS/DR (MIC=0.6 µg/ml), K. pneumoniae 08040724 IS/DR (MIC=0.3 µg/ml), Pseudomonas luteola (MIC=1.2 µg/ml), Salmonella Typhi IS/DR (MIC=1.2 µg/ml), Acinetobacter calcoaceticus (MIC=2.3 µg/ml), Sphingobacterium siyangense (MIC=9.4 µg/ml), Saccharibacillus kuerlensis (MIC=4.7 µg/ml);##Gram-positive bacteria: Bacillus subtilis (MIC=9.4 µg/ml), B. pumilus (MIC=9.4 µg/ml), B. cereus (MIC=1.2 µg/ml), Staphylococcus aureus ATCC2592 (MIC=4.7 µg/ml), S. aureus 08A875 IS/DR (MIC=75 µg/ml), S. aureus 08031002 IS/DR (MIC>100 µg/ml), S. aureus 08031013 IS/DR (MIC>100 µg/ml), S. aureus 08032706 IS/DR (MIC>100 µg/ml), S. aureus 08032712 IS/DR (MIC>100 µg/ml), S. aureus 08032810 IS/DR (MIC>100 µg/ml), Enterococcus faecium IS/DR (MIC=150 µg/ml);##Fungi: Aspergillus terreus GIM3.34 (MIC=18.7 µg/ml), Aspergillus nidulans (MIC=18.7 µg/ml), Candida albicans ATCC2002 (MIC=4.7 µg/ml), Pichia pastoris (MIC=0.3 µg/ml).	[Ref.18795096]Non-hemolytic activity at 400 µg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	18795096##18620012	PLoS One. 2008 Sep 16;3(9):e3217.##Peptides. 2008 Oct;29(10):1685-1691.	Wang Y, Hong J, Liu X, Yang H, Liu R, Wu J, Wang A, Lin D, Lai R.##Zhao H, Gan TX, Liu XD, Jin Y, Lee WH, Shen JH, Zhang Y.	Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics.##Identification and characterization of novel reptile cathelicidins from elapid snakes.	
DRAMP02474	KFFRKLKKSVKKRAK	15	cathelicidin-BF15 (Snakes, reptiles, animals)	B6D434	Not found	Not found	Bungarus fasciatus (Banded krait)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Pseudomonas aeruginosa ATCC27853 (MIC=4.7 µg/ml), P. aeruginosa IS/DR (MIC=37.5 µg/ml), P. aeruginosa 08031205 IS/DR (MIC=18.7 µg/ml), P. aeruginosa 08031014 IS/DR (MIC=75 µg/ml), Escherichia coli ATCC25922 (MIC=18.7 µg/ml), E. coli 08A852 IS/DR (MIC=18.7 µg/ml), E. coli 08A866 IS/DR (MIC=18.7 µg/ml), E. coli 08031017 IS/DR (MIC=37.5 µg/ml), E. coli 08040722 IS/DR (MIC=9.4 µg/ml), K. pneumoniae 08040202 IS/DR (MIC=75 µg/ml), Salmonella Typhi IS/DR (MIC=1.2 µg/ml), Saccharibacillus kuerlensis (MIC=4.7 µg/ml).##Gram-positive bacteria: Bacillus subtilis (MIC=75 µg/ml), Staphylococcus aureus ATCC2592 (MIC=75 µg/ml), S. aureus 08A875 IS/DR (MIC=75 µg/ml), S. aureus 08031002 IS/DR (MIC>100 µg/ml).##Fungi: Candida albicans ATCC2002 (MIC=18.7 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18795096	PLoS One. 2008 Sep 16;3(9):e3217.	Wang Y, Hong J, Liu X, Yang H, Liu R, Wu J, Wang A, Lin D, Lai R.	Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics.	
DRAMP02478	IKFEPPLPPKKAHKKFWEDDGIYYPPNHNFP	31	L-amino-acid oxidase (Bm-LAO; LAAO; LAO; Snakes, reptiles, animals)	B3EWI9	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Bothropoides matogrossensis (Pitviper) (Bothrops neuwiedimatogrossensis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiparasitic	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity).
Tissue specificity: Expressed by the venom gland."	Gram-positive bacteria: Bacillus subtilis strain ATCC 6633 (MIC=32 µM), Enterococcus faecalis strain ATCC 12953 (MIC=32 µM), Staphylococcus aureus strain ATCC 29213 (MIC=32 µM), Streptococcus pyogenes strain ATCC 19615 (MIC=8 µM);##Gram-negative bacteria: Escherichia coli strain ATCC 8739 (MIC=4 µM), Klebsiella pneumoniaee strain ATCC 13885 (MIC=2 µM), Proteus mirabilis strain ATCC 25933 (MIC=2 µM), Pseudomonas aeruginosa strain ATCC 15442 (MIC=8 µM), Salmonella typhimurium strain ATCC 14028 (MIC=8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22438972	PLoS One. 2012;7(3):e33639.	Okubo BM, Silva ON, Migliolo L, Gomes DG, Porto WF, Batista CL, Ramos CS, Holanda HH, Dias SC, Franco OL, Moreno SE.	Evaluation of an antimicrobial L-amino acid oxidase and peptide derivatives from Bothropoides mattogrosensis pitviper venom.	
DRAMP02520	KRFKKFFKKLKNSVKKRAKKFFKKPRVIGVSIPF	34	OH-CATH (Snakes, reptiles, animals)	No entry found	Not found	Not found	Ophiophagus hannah (King cobra) (Naja hannah)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8 µg/ml), E. coli ML-35P (MIC=6 µg/ml), E. coli clinic strain (MIC=20 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=4 µg/ml), Pseudomonas aeruginosa PA 01 (MIC=2 µg/ml), Pseudomonas aeruginosa clinic strain (MIC=2 µg/ml), Enterobacter aerogenes clinic strain (MIC=2 µg/ml), E. cloacae clinic strain (MIC=1 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18620012	Peptides. 2008 Oct;29(10):1685-1691.	Zhao H, Gan TX, Liu XD, Jin Y, Lee WH, Shen JH, Zhang Y.	Identification and characterization of novel reptile cathelicidins from elapid snakes.	
DRAMP02522	HVINLEESFQEPEYENHLA	19	L-amino-acid oxidase (LAAO, LAO, Oh-LAAO; Snakes, reptiles, animals)	P81383, A8QL50	Not found	Not found	Ophiophagus hannah (King cobra) (Naja hannah)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: It binds to bacteria and shows antibacterial activities by generating hydrogen peroxide. Binding and antibacterial activities are higher against Gram-positive than against Gram-negative bacteria. May also have an ability to induce hemorrhage, hemolysis, edema, apoptosis.
Tissue specificity: Expressed by the venom gland.
Toxic dose: LD50 is 5 mg/kg by intravenous injection into mice.
Temperature dependence: Exhibits unusual thermal stability. At pH 7.4, the enzyme retains full activity after incubation at 25 degrees Celsius for 30 days. Is stable at alkaline condition and is not inactivated by freezing."	Gram-negative bacteria: Klebsiella pneumonia (MIC=0.4 µM), Pseudomonas aeruginosa (MIC=0.2 µM), Escherichia coli (MIC=0.4 µM), Escherichia coli ATCC 25922 (MIC=0.8 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=0.006 µM), S. epidermidis (MIC=0.012 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Bacterial cell	9304806##2619759##2044840##7886693##21059402	Int J Biochem Cell Biol. 1997 Jun;29(6):911-919.##Biochem Int. 1989 Oct;19(4):937-944.##Int J Biochem. 1991;23(3):323-327.##Toxicon. 1994 Nov;32(11):1349-1358.##Comp Biochem Physiol C Toxicol Pharmacol. 2011 M	Ahn MY, Lee BM, Kim YS.##Tan NH, Saifuddin MN.##Tan NH, Saifuddin MN.##Li ZY, Yu TF, Lian EC.##Lee ML, Tan NH, Fung SY, Sekaran SD.	Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah).##Isolation and characterization of an unusual form of L-amino acid oxidase from King cobra (Ophiophagus hannah) venom.##Substrate specificity of king cobra (Ophiophagus hannah) venom L-amino acid oxidase.##Purification and characterization of L-amino acid oxidase from king cobra (Ophiophagus hannah) venom and its effects on human platelet aggregation.##Antibacterial action of a heat-stabl	
DRAMP02573	QVYKGGYTRPIPRPPPFVRPLPGGPIGPYNGCPVSCRGISFSQARSCCSRLGRCCHVGKGYS	62	Penaeidin-3a (Pen-3a; shrimps, Arthropods, animals)	P81058	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Tissue specificity: Higher expression in hemocytes and to a lesser extent in heart, testis, gills, intestine, lymphonoid organ and hepatopancreas. Traces in eyes and subcuticular epithelium. Not present in the brain.
Developmental stage: Expression decreases 3 hours after microbial challenge to return to control levels after 12 hours and slightly increases after 24 hours.
PTM: C-terminal amidation and contains three disulfide bonds 32-47; 36-54; 48-55."	Gram-positive bacteria: Aerococcus viridans (MIC=0.3-0.6 µM), Micrococcus luteus (MIC=1.25-2.5 µM), Bacillus megaterium (MIC=2.5-5 µM), Enterococcus fecalis (MIC>20 µM), Saphylococcus aureus (MIC>40 µM);##Gram-negative bacteria: Escherichia coli 363 (MI=10-20 µM), Vibrio vulnificus (MIC>20 µM), Salmonella thyphimurium (MIC>40 µM), Klebsiella pneumoniae (MIC>40 µM).##Fungi: Fusarium oxysporum (MIC=5-10 µM), Botrytis cinerea (MIC=5-10 µM), Neurospora crassa (MIC=1.25-2.5 µM), Aspergillus fumigatus (MIC>20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	pyroglutamic acid	Amidation	Disulfide bonds between Cys32 and Cys47,Cys36 and Cys54,Cys48 and Cys55. O-glycosylated on Thr8	L	No cytotoxicity information found	Chitin-binding	9353298##10561573##12842879	J Biol Chem. 1997 Nov 7;272(45):28398-28406.##Eur J Biochem. 1999 Dec;266(2):335-346.##J Biol Chem. 2003 Sep 19;278(38):36859-36867.	Destoumieux D, Bulet P, Loew D, Van Dorsselaer A, Rodriguez J, Bachère E.##Destoumieux D, Bulet P, Strub JM, Van Dorsselaer A, Bachère E.##Yang Y, Poncet J, Garnier J, Zatylny C, Bachère E, Aumelas A.	Penaeidins, a new family of antimicrobial peptides isolated from the shrimp Penaeus vannamei (Decapoda).##Recombinant expression and range of activity of penaeidins, antimicrobial peptides from penaeid shrimp.##Solution structure of the recombinant penaeidin-3, a shrimp antimicrobial peptide.	
DRAMP02574	QVYKGGYARPIPRPPPFVRPLPGGPIGPYNGCPVSCRGISFSQARSCCSRLGRCCHVGKGYSG	63	[T8A]-Penaeidin-3a ([T8A]-Pen-3a; shrimps, Arthropods, animals)	P81058	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix (1 helices; 11 residues)	[T8A]-Pen-3a structure consists of an unconstrained and a constrained part, which roughly match with the proline-rich (1-28 residues) and the cysteine-rich (29-58 residues) domains, respectively. The proline-rich domain does not adopt a constrained structure, whereas the cysteine-rich domain adopts a well-defined structure that consists of a helix (41-50 residues) tightly bound to the upstream (27-40 residues) and the downstream (51-63 	1UEO resolved by NMR.	"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
PTM: Contains three disulfide bonds."	Gram-positive bacteria: Aerococcus viridans (MIC=0.4-0.8 µM), Micrococcus luteus (MIC=0.8-1.6 µM), Bacillus megaterium (MIC=3.12-6.25 µM);##Gram-negative bacteria: Escherichia coli 363 (MI=3.12-6.25 µM), Vibrio vulnificus (MIC>50 µM), Salmonella thyphimurium (MIC>50 µM), Klebsiella pneumoniae (MIC>50 µM).##Fungi: Fusarium oxysporum (MIC=3.12-6.25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	pyroglutamic acid	Amidation	Disulfide bonds between Cys32 and Cys47,Cys36 and Cys54,Cys48 and Cys55. O-glycosylated on Thr8	L	No cytotoxicity information found	Not found	12842879	J Biol Chem. 2003 Sep 19;278(38):36859-36867.	Yang Y, Poncet J, Garnier J, Zatylny C, Bachère E, Aumelas A.	Solution structure of the recombinant penaeidin-3, a shrimp antimicrobial peptide.	
DRAMP18370	RERSKGSKYLYVG	13	Crinicepsin-2 (insects, arthropods, invertebrates, animals)	No entry found	Not found	Not found	working ants, Trichomyrmex criniceps	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: S. aureus (MIC 62 ug/ml), and weakly active against E. coli and V. cholerae (MIC 125 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28346717	Arch Insect Biochem Physiol. 2017 Mar 27. in press.	Bhagavathula N, Meedidoddi V, Bourque S, Vimaladevi R, Kesavakurup S, Selvadurai D, Shrivastava S, Krishnappa C.	Characterization of two novel antimicrobial peptides from the cuticular extracts of the ant Trichomyrmex criniceps (Mayr), (Hymenoptera: Formicidae).	
DRAMP18371	VGVGGGFGR	9	Crinicepsin-1 (insects, arthropods, invertebrates, animals)	No entry found	Not found	Not found	working ants, Trichomyrmex criniceps	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: S. aureus (MIC 125 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28346717	Arch Insect Biochem Physiol. 2017 Mar 27. in press.	Bhagavathula N, Meedidoddi V, Bourque S, Vimaladevi R, Kesavakurup S, Selvadurai D, Shrivastava S, Krishnappa C.	Characterization of two novel antimicrobial peptides from the cuticular extracts of the ant Trichomyrmex criniceps (Mayr), (Hymenoptera: Formicidae).	
DRAMP18372	CHTNGGYCVRAICPPSARRPGSCFPEKNPCCKYM	34	mBD-2 (Murine beta-defensin 2a)	No entry found	Belongs to the beta-defensin family.	Not found	Mus musculus	Anti-cancer		bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10922379	J Biol Chem. 2000 Oct 27;275(43):33314-20. 	Jia HP, Wowk SA, Schutte BC, Lee SK, Vivado A, Tack BF, Bevins CL, McCray PB Jr.	A novel murine beta -defensin expressed in tongue, esophagus, and trachea Cancer cells.	
DRAMP02584	HSSGYTRPLPKPSRPIFIRPIGCDVCYGIPSSTARLCCFRYGDCCHR	47	Penaeidin-4a (Pen-4a; shrimps, Arthropods, animals)	Q95NT0	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity (By similarity).
PTM: Contains three disulfide bonds 23-37; 26-44; 38-45 and C-terminal amidation."	Gram-positive bacteria: Aerococcus viridans (MIC=1.9-2.92 µM), Micrococcus luteus (MIC=1.9-2.92 µM), Bacillus megaterium (MIC>50 µM), Saphylococcus aureus (MIC>50 µM);##Gram-negative bacteria: Escherichia coli 363 (MIC=22-33 µM), Vibrio vulnificus (MIC>50 µM), Salmonella thyphimurium (MIC>50 µM), Klebsiella pneumoniae (MIC>50 µM).##Fungi: Fusarium oxysporum (MIC=0.84-1.26 µM), Botrytis cinerea (MIC=4.38-6.57 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation	Disulfide bonds between Cys23 and Cys37,Cys26 and Cys44,Cys38 and Cys45.	L	No cytotoxicity information found	Chitin-binding	12242595##15084144	Immunogenetics. 2002 Sep;54(6):442-445.##Biochem J. 2004 Jul 1;381(Pt 1):79-86.	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.##Cuthbertson BJ, Bullesbach EE, Fievet J, Bachère E, Gross PS.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.##A new class (penaeidin class 4) of antimicrobial peptides from the Atlantic white shrimp (Litopenaeus setiferus) exhibits target specificity and an independent proline-rich-domain function.	
DRAMP02586	QRGGFTGPIPRPPPHGRPPLGPICNACYRLSFSDVRICCNFLGKCCHLVK	50	Penaeidin-2d (Pen-2d; shrimps, Arthropods, animals)	Q962A9	Belongs to the penaeidin family	Not found	Litopenaeus setiferus (Atlantic white shrimp) (Penaeus setiferus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		"Function: Antibacterial and antifungal activity. Presents chitin-binding activity (By similarity).
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser."	Gram-positive bacteria: Aerococcus viridans (MIC=1.25-2.5 µM), Micrococcus luteus (MIC=2.5-5 µM), Bacillus megaterium (MIC=2.5-5 µM), Enterococcus fecalis (MIC>20 µM), Saphylococcus aureus (MIC>20 µM);##Gram-negative bacteria: Escherichia coli 363 (MIC>40 µM), Vibrio vulnificus (MIC>20 µM), Salmonella thyphimurium (MIC>20 µM), Klebsiella pneumoniae (MIC>20 µM).##Fungi: Fusarium oxysporum (MIC=5-10 µM), Botrytis cinerea (MIC=5-10 µM), Neurospora crassa (MIC=2.5-5 µM), Aspergillus fumigatus (MIC>20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595##10561573	Immunogenetics. 2002 Sep;54(6):442-445.##Eur J Biochem. 1999 Dec;266(2):335-346.	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.##Destoumieux D, Bulet P, Strub JM, Van Dorsselaer A, Bachère E.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.##Recombinant expression and range of activity of penaeidins, antimicrobial peptides from penaeid shrimp.	
DRAMP02591	HSSGYTRPLRKPSRPIFIRPIGCDVCYGIPSSTARLCCFRYGDCCHL	47	Penaeidin-4d (Pen-4d; shrimps, Arthropods, animals)	Q962A7	Belongs to the penaeidin family	Not found	Litopenaeus setiferus (Atlantic white shrimp) (Penaeus setiferus)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Alpha helix (1 helices; 9 residues)	Calculation of PEN4 three-dimensional structure reveales that the PEN4 structure consisted of an unconstrained and a constrained part, which roughly match with the PRD (residues 1-17) and the CRD (residues 18-47), respectively. The global fold of the CRD mainly consisted of a helix (residues 31-41), two turns of type IV (Cys23-Cys26 and Gly42-Cys45 residues), and one loop spanning 27-30 residues (Ref.2).	1XV3 resolved by NMR.	"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity (By similarity).
PTM: Contains three disulfide bonds 23-37; 26-44; 38-45."	Fungi: Fusarium oxysporum (MIC=0.84-1.26 µM), Botrytis cinerea (MIC=4.38-6.57 µM), Penicillium crustosum (MIC=1.26-1.9 µM).## Gram-positive bacteria: Aerococcus viridans (MIC=1.9-2.92 µM), Bacillus megaterium (MIC>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595##15699044	Immunogenetics. 2002 Sep;54(6):442-445.##J Biol Chem. 2005 Apr 22;280(16):16009-18.	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.##Cuthbertson BJ, Yang Y, Bachère E, Büllesbach EE, Gross PS, Aumelas A.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.##Solution structure of synthetic penaeidin-4 with structural and functional comparisons with penaeidin-3.	
DRAMP02603	AALRGALRAVARVGKAILPHVAIANPYVRTPYVHNNP	37	Putative antimicrobial peptide A Northern Europe Heligoland (chordates, animals)	No entry found	Not found	Not found	Ciona intestinalis 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus megaterium (MIC=0.1 µM), Bacillus subtilis (MIC=3.1 µM), Staphylococcus aureus (MIC>25 µM), Staphylococcus epidermidis (MIC=25 µM).##Gram-negative bacteria: Escherichia coli K12 D31 (MIC=0.8 µM), Y. enterocolitica (MIC=3.1 µM), Klebsiella pneumoniae (MIC>25µM), Pseudomonas aeruginosa (MIC=12.5 µM), Serratia marcescens(MIC>25 µM).##Fungi: Candida albicans ATCC 10261 (MIC=6.3 µM), Candida albicans SC 5314 (MIC=6.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17658598	Dev Comp Immunol. 2008;32(3):286-298. 	Fedders H, Leippe M.	A reverse search for antimicrobial peptides in Ciona intestinalis: identification of a gene family expressed in hemocytes and evaluation of activity.	
DRAMP02609	RLGDILQKAREKIEGGLKKLVQKIKDFFGKFAPRTES	37	CjaRL-37 (cathelicidin; primates, mammals, animals)	No entry found	Not found	Not found	Platyrrhini (New World monkeys)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Function: Has antibacterial activity.	In 20% TSB in SPB medium: Escherichia coli (MIC=4 µM), Pseudomonas aeruginosa (MIC>32 µM); Staphylococcus aureus (MIC=32 µM), Enterococcus faecalis (MIC>32 µM).##In 20% SAB in SPB medium: Candida albicans (MIC>32 µM). In 5% SAB in SPB Candida albicans (MIC>32 µM). In 20% SAB in PIL Candida albicans (MIC>32 µM).##In 5% TSB in SPB Escherichia coli (MIC=1 µM), Pseudomonas aeruginosa (MIC=2 µM), Staphylococcus aureus (MIC=8-16 µM).##In 20% TSB in PIL Escherichia coli (MIC>32 µM), Pseudomonas aeruginosa (MIC>32 µM); Staphylococcus aureus (MIC=16 µM), Enterococcus faecalis (MIC>32 µM).##In 50% MH in SPB medium Escherichia coli (MIC>32 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP02650	APIIRRIPYYPEVESDLRIVDCKRSEGFCQEYCNYLETQVGYCSKKKDACCLH	53	Sperm associated antigen 11 isoform C (primates, mammals, animals)	No entry found	Not found	Not found	Macaca mulatta (Rhesus monkey)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=50-100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15229135	Biol Reprod. 2004 Nov;71(5):1453-1460. 	Avellar MC, Honda L, Hamil KG, Yenugu S, Grossman G, Petrusz P, French FS, Hall SH.	Differential expression and antibacterial activity of epididymis protein 2 isoforms in the male reproductive tract of human and rhesus monkey (Macaca mulatta).	
DRAMP02727	SLGNFFRKARKKIGEEFKRIVQRIKDFLQHLIPRTEA	37	HmdSL-37 (cathelicidin; primates, mammals, animals)	No entry found	Not found	Not found	Hylobates sp. (Gibbon)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Function: Has antibacterial activity.	In 20% TSB in SPB medium Escherichia coli (MIC=2 µM), Pseudomonas aeruginosa (MIC=8 µM), Staphylococcus aureus (MIC>32 µM), Enterococcus faecalis (MIC=8 µM).##In 20% SAB in SPB Candida albicans (MIC>32 µM). In 5% SAB in SPB Candida albicans (MIC=8 µM). In 20% SAB in PIL Candida albicans (MIC>32 µM).##In 5% TSB in SPB Escherichia coli (MIC=1 µM), Pseudomonas aeruginosa (MIC=2 µM), Staphylococcus aureus (MIC=2 µM).##In 20% TSB in PIL Escherichia coli (MIC>32 µM), Pseudomonas aeruginosa (MIC=16-32 µM); Staphylococcus aureus (MIC=8-16 µM), Enterococcus faecalis (MIC>32 µM).##In 50% MH in SPB medium Escherichia coli (MIC>32 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP18369	VSFPWSCAALSGVCRQGACLPSELYFGPLGCGKGSLCCVSYFL	43	ccBD(channel catfish beta defensin)	No entry found	Belongs to the beta-defensin family.	Not found	skin, Ictalurus punctatus	Antimicrobial, Antibacterial		bridge	Not found		Comment: No comments found on DRAMP database	Active against Gram- E. coli, E. ictaluri, Y. ruckeri, A. hydrophila, A. veronii, Gram+ S. aureus, S. iniae, and S. agalactiae (MIC 12.5-25 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys7 and Cys37,Cys14 and Cys31,Cys19 and Cys38.	L	No cytotoxicity information found	Not found	28340427	Mol Immunol. 2017 Mar 21;85:256-264.	Zhu J, Wang H, Wang J, Wang X, Peng S, Geng Y, Wang K, Ouyang P, Li Z, Huang X, Chen D.	Identification and characterization of a 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]3CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC(C)C)NC2=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N3)C(=O)N1)C(C)C)C(=O)O
DRAMP02740	YDLSKNCRLRGGICYIGKCPRRFFRSGSCSRGNVCCLRFG	40	TBD-1 (Turtle beta-defensin 1; Reptiles, animals)	P86253	Belongs to the beta-defensin family	Not found	Emys orbicularis (European pond turtle)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacteria methicillin-resistant S. aureus ATCC 33591 and L. monocytogenes EGD, the Gram-negative bacterium E. coli ML53p and the yeast C. albicans 820. Has no hemolytic activity towards human erythrocytes.
PTM: Contains three disulfide bonds 7-35; 14-29; 19-36."	[Ref.19253295]Gram-negative bacterium (LS, HS): Escherichia coli ML35p (MIC=0.65, >20 µmol/L);##Gram-positive bacteria: (LS, HS): Listeria monocytogenes EGD (MIC=0.65, >20 µmol/L), Methicillin-resistant Staphylococcus aureus ATCC 33591 (MIC=5.6, >20 µmol/L).##Yeast: Candida albicans (MIC=5.2, >20 µmol/L).##NOTE: LS (low salt): 10 mmol/L sodium phosphate buffer (pH 7.4) and HS (high salt): 10 mmol/L sodium-phosphate buffer (pH 7.4), 0.1 mol/L sodium chloride.	[Ref.19253295] It has no hemolytic activity against human erythrocytes up to 25 mmol/L	Cyclic	Free	Free	Disulfide bonds between Cys7 and Cys35; Cys14 and Cys29; Cys19 and Cys36.	L	No cytotoxicity information found	Not found	19253295	Proteomics. 2009 Mar;9(5):1364-1373.	Stegemann C, Kolobov A Jr, Leonova YF, Knappe D, Shamova O, Ovchinnikova TV, Kokryakov VN, Hoffmann R.	Isolation, purification and de novo sequencing of TBD-1, the first beta-defensin from leukocytes of reptiles.	CC[C@@H](C)[C@@H]1NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)Cc2ccc(O)cc2)CSSC[C@@H]2NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]([C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)NC2=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N3
DRAMP02768	GLGSVFGRLARILGRVIPKVAKKLGPKVAKVLPKVMKEAIPMAVEMAKSQEEQQPQ	56	Pilosulin-1 (Myr b I; ants, insects, animals)	Q07932, Q9TWC1	Belongs to the pilosulin family	Not found	Myrmecia banksi (Jack jumper ant) (Australian jumper ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Has strong cytotoxic and hemolytic activities. Is more potent against mononuclear leukocytes than against granulocytes. The synthesized peptide 57-76 shows a potent and broad spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria, and also against the fungus C. albicans. Adopts an alpha-helical structure.
Tissue specificity: Expressed by the venom gland.
Allergenic properties: Causes an allergic reaction in human."	[Ref.9813247]Gram-positive bacteria: Micrococcus luteus (MIC=0.5 µM), Enterococcus spp.I-11305b (MIC=2 µM), Enterococcus spp. I-11054 (MIC=2 µM), Staphylococcus simulans 22 (MIC=2 µM), S. haemolyticus I-10925 (MIC=2 µM), S. epidermidis LT1324 (MIC=2 µM), S. aureuss 5185 (MI=2 µM), S. aureuss methicillin-sensitive I-11574 (MIC=2 µM), S. aureuss (MRSA) LT1338 (MIC=3 µM), S. aureuss (MRSA) LT1334 (MIC=1.5 µM);##Gram-negative bacteria: Citrobacter freundii I-11090 (MIC=2 µM), Klebsiella pneumoniae I-10910 (MIC=2 µM), Escherichia coli I-11276b (MIC=4 µM), E. coli O-19592 (MIC=2 µM), Stenotrophomonas maltophilia O-16451 (MIC=2 µM), S. maltophila I-10717 (MIC=2 µM), Pseudomonas aeruginosa 4991 (MIC=4 µM), Pseudomonas aeruginosa I-10968 (MIC=4 µM);##Fungi: Candida albicans I-11301 (MIC=4 µM), Candida albicans I-11134 (MIC>4 µM).	[Ref.9813247]Complete lysis in the presence of pilosulin 1 was obtained at a concentration of 40 μM with evidence of partial lysis visible down to 1.25 μM	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	IgE	9813247##9701394##15639237##8866004	Arch Biochem Biophys. 2005 Feb 15;434(2):358-364.##Cytometry. 1998 Aug 1;32(4):268-273.##Arch Biochem Biophys. 2005 Feb 15;434(2):358-364.##Biochem Mol Biol Int. 1996 Aug;39(5):877-885.	Zelezetsky I, Pag U, Antcheva N, Sahl HG, Tossi A.##King MA, Wu QX, Donovan GR, Baldo BA.##Zelezetsky I, Pag U, Antcheva N, Sahl HG, Tossi A.##Donovan GR, Street MD, Tetaz T, Smith AI, Alewood D, Alewood P, Sutherland SK, Baldo BA.	Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin.##Flow cytometric analysis of cell killing by the jumper ant venom peptide pilosulin 1.##Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin.##Expression of jumper ant (Myrmecia pilosula) venom allergens: post-translational processing of allergen gene products.	
DRAMP02774	CIKNGNGCQPDGSQGNCCSRYCHKEPGWVAGYCR	34	Antimicrobial peptide Alo-1 (Alo-1; knottin-type peptide; Insects, animals)	P83651	Belongs to the AMP family	Not found	Acrocinus longimanus (Giant harlequin beetle)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Has antifungal activity against C. glabrata.
Domain: The presence of a disulfide through disulfide knot' structurally defines this protein as a knottin.
PTM: Contains three disulfide bonds 1-18; 8-22; 17-33."	Fungi: Candida glabrata patient 1 (MIC>64 µg/mL), C. albicans IHEM 8060 (MIC=64 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys1 and Cys18; Cys8 and Cys22; Cys17 and Cys33.	L	No cytotoxicity information found	Not found	14661954	Biochemistry. 2003 Dec 16;42(49):14434-14442.	Barbault F, Landon C, Guenneugues M, Meyer JP, Schott V, Dimarcq JL, Vovelle F.	Solution structure of Alo-3: a new knottin-type antifungal peptide from the insect Acrocinus longimanus.	CC[C@@H](C)[C@@H]1NC(=O)[C@@H](N)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N3)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC2=O
DRAMP02776	CIKNGNGCQPNGSQGNCCSGYCHKQPGWVAGYCRRK	36	Antimicrobial peptide Alo-3 (Alo-3; knottin-type peptide; Insects, animals)	P83653	belongs to the inhibitor cystine-knot family	Not found	Acrocinus longimanus (Giant harlequin beetle)	Antimicrobial, Antifungal	Protein level	Beta strand (3 strands; 8 residues)	Alo-3 contains six cysteine residues forming three disulfide bridges. It exhibits all the structural features characteristic of the knottin fold, namely, a triple-stranded antiparallel beta-sheet with a long flexible loop connecting the first strand to the second strand and a series of turns.	1Q3J resolved by NMR.	"Function: Alo-3 shows a level of activity significantly higher against C. glabrata than Alo-1 or Alo-2.
Domain: The presence of a disulfide through disulfide knot' structurally defines this protein as a knottin.
PTM: Contains three disulfide bonds 1-18; 8-22; 17-33."	Fungi: Candida glabrata patient 1 (MIC=8 µg/mL), C. glabrata ATCC 90030 (MIC=16 µg/mL), C. albicans IHEM 8060 (MIC=16 µg/mL), C. albicans ATCC 36082 (MIC=8 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys1 and Cys18; Cys8 and Cys22; Cys17 and Cys33.	L	No cytotoxicity information found	Not found	14661954	Biochemistry. 2003 Dec 16;42(49):14434-14442.	Barbault F, Landon C, Guenneugues M, Meyer JP, Schott V, Dimarcq JL, Vovelle F.	Solution structure of Alo-3: a new knottin-type antifungal peptide from the insect Acrocinus longimanus.	CC[C@@H](C)[C@@H]1NC(=O)[C@@H](N)CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N3)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CO)NC2=O
DRAMP02777	SLQPGAPNFPMPGSQLPTSITSNIEKQGPNTAATINAQHKTDRYDVGATWSKVIRGPGRSKPNWSIGGTYRW	72	Rhinocerosin (Insects, animals)	O76145	Belongs to the coleoptericin family	Not found	Oryctes rhinoceros (Coconut rhinoceros beetle)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has strong antibacterial activity against Escherichia coli, Streptococcus pyogenes, Staphylococcus aureus but not against Pseudomonas aeruginosa.	Gram-positive bacteria: Staphylococcus aureus (MIC=1 µg/ml), Streptococcus pyogenes (MIC=1 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=1 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9738915	Eur J Biochem. 1998 Aug 1;255(3):734-738.	Yang J, Yamamoto M, Ishibashi J, Taniai K, Yamakawa M.	Isolation, cDNA cloning and gene expression of an antibacterial protein from larvae of the coconut rhinoceros beetle, Oryctes rhinoceros.	
DRAMP01623	LIGPVLGLVGSALGGLLKKI	20	Bombinin-H4 (bombinin H isomers; Frogs, amphibians, animals)	P82284	Belongs to the bombinin family	Not found	Bombina variegata (European frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, hemolytic against mammalian cells, Antifungal	Protein level	Alpha helix	The epimerization reaction is incomplete, or, after racemization, the peptides still containing the L-amino acid in position 2 are partly degraded.		Function: Have antimicrobial activity. Have some hemolytic activity.	[Ref.8223491] Gram-negative bacterium: Escherichia coli D21 (MIC=4.8 µM);##Gram-positive bacterium: Staphylococcus aureus Cowan 1 (MIC=3.3 µM).	[Ref.8223491] Lethal concentration is 14.6 µM against human red blood cell.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8223491	EMBO J. 1993; 12:4829-4832.	Mignogna G, Simmaco M, Kreil G, Barra D.1993	Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.	
DRAMP02779	VTCDLLSFEAKGFAANHSICAAHCLAIGRKGGSCQNGVCVCRN	43	Defensin-A (Defensin A; Insects, animals)	P83669	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Anomala cuprea (Cupreous chafer beetle)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Strong activity against the Gram-positive bacteria M.luteus, B.megaterium and S. aureus. Reduced activity against Gram-positive bacterium B.subtilis and weak activity against Gram-negative bacterium X.japonicus.
PTM: Problely contains three disulfide bonds 3-34; 20-39; 24-41."	Gram-positive bacteria: Bacillus megaterium (MIC=1.2-2.5 µM), Bacillus subtilis (MIC>40 µM), Micrococcus luteus (MIC=1.2-2.5 µM), Staphylococcus aureus (MIC=2.5-5 µM).##Gram-negative bacteria: Enterobacter asbriae (MIC>40 µM), Escherichia coli (MIC>40 µM), Pseudomonas aeruginosa (MIC>40 µM), Serratia marcescens (MIC>40 µM), Xenorhabdus japonicus (MIC>40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys34; Cys20 and Cys39; Cys24 and Cys41.	L	No cytotoxicity information found	Not found	11719071	Insect Biochem Mol Biol. 2001 Dec;32(1):75-84.	Yamauchi H.	Two novel insect defensins from larvae of the cupreous chafer, Anomala cuprea: purification, amino acid sequences and antibacterial activity.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc4ccccc4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)CSSC[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC1=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N3)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N2
DRAMP02780	VTCDLLSFEAKGFAANHSICAAHCLVIGRKGGACQNGVCVCRN	43	Defensin-B (Defensin B; Insects, animals)	P83668	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Anomala cuprea (Cupreous chafer beetle)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Has antibacterial activity against Gram-positive bacteria and the Gram-negative bacterium X. japonicus.
PTM: Problely contains three disulfide bonds 3-34; 20-39; 24-41."	Gram-positive bacteria: Bacillus megaterium (MIC=1.2-2.5 µM), Bacillus subtilis (MIC=20-40 µM), Micrococcus luteus (MIC=1.2-2.5 µM), Staphylococcus aureus (MIC=2.5-5 µM);##Gram-negative bacterium: X. japonicus (MIC=20-40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys34; Cys20 and Cys39; Cys24 and Cys41.	L	No cytotoxicity information found	Not found	11719071	Insect Biochem Mol Biol. 2001 Dec;32(1):75-84.	Yamauchi H.	Two novel insect defensins from larvae of the cupreous chafer, Anomala cuprea: purification, amino acid sequences and antibacterial activity.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)CSSC[C@@H]2NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N3)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC2=O
DRAMP02802	AREASKSLIGTASCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR	46	Paneth cell-specific alpha-defensin 1 (DEFA1; horse defensin; houses, mammals, animals	A6YB85	Not found	DEFA1	Equus caballus (Horse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found	2MXQ resolved by NMR.	Function: Membrane permeabilization is at least an essential part of the peptide's mode of action.	Gram-negative bacteria: Escherichia coli [ATCC 11775 (MBC=0.4 µM); ATCC 25922 (MBC=0.4 µM); ATCC 35218 (MBC=0.4 µM)], E. coli D31 (MBC=0.8 µM), Pseudomonas aeruginosa ATCC 11440 (MBC=3 µM);##Gram-positive bacteria: Staphylococcus aureus [ATCC 6538 (MBC=0.8 µM); ATCC 12600 (MBC=1.5 µM)], Staphylococcus epidermidis ATCC 14990 (MBC=1.5 µM), Enterococcus faecalis ATCC 29212 (MBC=6.1 µM), E. faecalis PEG 205 (wild-type) (MBC=3 µM), Streptococcus pyogenes ATCC 12344 (MBC=0.8 µM), Bacillus megaterium ATCC 14581 (MBC=0.2 µM).##Yeast: Candida albicans ATCC 24433 (MIC=0.8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys14 and Cys44; Cys16 and Cys32; Cys22 and Cys43.	L	No cytotoxicity information found	Not found	17620056	Biochem J. 2007 Oct 15;407(2):267-276.	Bruhn O, Regenhard P, Michalek M, Paul S, Gelhaus C, Jung S, Thaller G, Podschun R, Leippe M, Grötzinger J, Kalm E.	A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)N[C@@H]([C@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC1=O)[C@@H](C)O
DRAMP02809	HPHVCTSYYCSKFCGTAGCTRYGCRNLHRGKLCFCLHCSR	40	Myticin-B (Myt B; Cys-rich; molluscas, animals)	P82102	Not found	Not found	Mytilus galloprovincialis (Mediterranean mussel)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Rich	Not found		"Function: Bacteriolytic activity against Gram-positive bacteria and Gram-negative bacteria. Also possesses antifungal activity against F. oxysporum.
PTM: contains four disulfide bonds."	Gram-positive bacteria: Micrococcus luteus (MBC=1-2 µM), Bacillus megaterium (MBC=1-2 µM), Aerococcus viridans (MBC=2-4 µM).##Gram-negative bacteria: Escherichia coli D31 (MBC=20-10 µM).##Fungi: Fusarium oxysporum (MIC=5-10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	contains four disulfide bonds.	L	No cytotoxicity information found	Not found	10491159	Eur J Biochem. 1999 Oct 1;265(1):71-78.	Mitta G, Hubert F, Noël T, Roch P.	Myticin, a novel cysteine-rich antimicrobial peptide isolated from haemocytes and plasma of the mussel Mytilus galloprovincialis.	
DRAMP02811	GFGCPNNYQCHRHCKSIPGRCGGYCGGWHRLRCTCYRC	38	Defensin MGD-1 (molluscas, animals)	P80571, Q9Y0B0	Not found	FH3	Mytilus galloprovincialis (Mediterranean mussel)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Combine helix and strand structure	The three-dimensional solution structure of MGD-1 has been established using (1)H NMR and mainly consists of a helical part (Asn7-Ser16) and two antiparallel beta-strands (Arg20-Cys25 and Cys33-Arg37), together giving rise to the common cystine-stabilized alpha-beta motif frequently observed in scorpion toxins. In MGD-1, the cystine-stabilized alpha-beta motif is stabilized by four disulfide bonds (Cys4-Cys25, Cys10-Cys33, Cys14-Cys35, 	1FJN resolved by NMR.	"Function: Active against both Gram-positive and Gram-negative bacteria but is not cytotoxic towards human erythrocytes or protozoa.
Transgenic plants: expression of this peptide in tobacco improves resistance to pathogens.
PTM: Contains four disulfide bonds 4-25; 10-33; 14-35; 21-38."	Gram-positive bacteria: Micrococcus luteus (MIC=0.4 µM)&(MBC=1.5 µM), Bacillus megaterium (MIC=0.8 µM)&(MBC=1.5 µM), Staphylococcus aureus (MIC=0.6 µM)&(MBC=1.2 µM), Staphylococcus epidermidis (MIC=3.1 µM)&(MBC=6.2 µM), Enterococcus fecalis (MIC=0.6 µM)&(MBC=1.2 µM), Aerococcus viridans (MIC=0.4 µM)&(MBC=1.5 µM);##Gram-negative bacteria: Escherichia coli D31 (MIC=1.2 µM)&(MBC=1.2 µM), E. coli 363 (MIC=1.2 µM)&(MBC=1.2 µM), Salmonella newport (MIC>100 µM)&(MBC>100 µM), Vibrio alginolyticus (MIC=50 µM)&(MBC>100 µM), Vibrio harveyi (MIC=50 µM)&(MBC=100 µM), Vibrio metshnikovii (MIC>100 µM)&(MBC>100 µM).##NOTE: MIC=minimal inhibitory concentration; MBC = minimal bactericidal concentration.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys4 and Cys25, Cys10 and Cys33, Cys14 and Cys35,Cys21 and Cys38.	L	No cytotoxicity information found	Not found	10564642##8925841##11087396	J. Cell Sci. 1999;112:4233-4242.##Eur. J. Biochem. 1996;240:302-306.##Biochemistry 2000 Nov 28;39(47):14436-47.	Mitta G, Vandenbulcke F, Hubert F, Roch P.##Hubert F, Noeel T, Roch P.##Yang YS, Mitta G, Chavanieu A, Calas B, Sanchez JF, Roch P, Aumelas A.	Mussel defensins are synthesised and processed in granulocytes then released into the plasma after bacterial challenge.##A member of the arthropod defensin family from edible Mediterranean mussels (Mytilus galloprovincialis).##Solution structure and activity of the synthetic four-disulfide bond Mediterranean mussel defensin (MGD-1).	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]5CCCN5C(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc5ccccc5)NC(=O)CN)CSSC[C@H](NC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)CNC(=O)CNC(=O)[C@H](CSSC[C@@H](C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc5ccc(O)cc5)NC3=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H]3CCCN3C1=O)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N4)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N2
DRAMP02813	FHPSLWVLIPQYIQLIRKILKSG	23	Conolysin-Mt1	P0C8S6	Not found	Not found	Conus mustelinus (Weasel cone)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: This cytolytic peptide has ability to disrupt the integrity of cell membranes from both prokaryotes and eukaryotes. It permeabilizes both negatively charged prokaryotic (PE:PG) and zwitterionic eukaryotic (PC:cholesterol) model membranes. It has potent hemolytic activity on human erythrocytes and exhibits low antimicrobial activity against the Gram-negative bacterium E. coli and the Gram-positive bacterium S. aureus. Intracranial injection causes mice to shuffle backward until the encounter an obstacle, at which time the mouse jump into the air. The backward shuffle is reminiscent to the signature dance 'moonwalk' that gained widespread popularity after being performed by Michael Jackson.
Tissue specificity: Expressed by the venom duct.
Miscellaneous: The mature peptide does not contain cysteine residue. Mt1 and Mt2 peptides are found in a ratio of 1:4. Mt1 is more active when intracranially injected."	[Ref.17927208]Gram-positive bacterium: Staphylococcus aureus (MIC=25-50 µM);##Gram-positive bacterium: Escherichia coli (MIC>50 µM).	[Ref.17927208]95% hemolytic activity at 25 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17927208	Biochemistry. 2007 Nov 6;46(44):12586-12593. 	Biggs J.S, Rosenfeld Y, Shai Y, Olivera B.M.	Conolysin-Mt: a conus peptide that disrupts cellular membranes.	
DRAMP02817	VDKGSYLPRPTPPRPIYNRN	20	Pyrrhocoricin	P37362, P80307	Belongs to the drosocin family	Not found	Pyrrhocoris apterus (Sap sucking bug) (Cimex apterus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Combine helix and strand structure	Not found	4EZN resolved by X-ray.	Function: Antibacterial peptide. Affects Gram-negative bacteria E.coli 1106, P.aeruginosa, E.coli D22 and E.cloacae and Gram-positive bacteria M.luteus and B.subtilis.	Gram-positive bacteria: Micrococcus luteus (MIC>80 µM in L.B, P.B), Bacillus megaterium (MIC>80 µM in L.B, P.B);##Gram-negative bacteria: Escherichia coliD22 (MIC=0.3 µM in L.B, P.B), A.tumefaciens (MIC=1.25 µM in LB and 3 µM in PB), Salmonella typhimurium (MIC=5 µM in L.B and 10 µM in P.B).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10076062##8002963##23562829	Biochim Biophys Acta. 1999 Feb 2;1426(3):459-467.##Biochem J. 1994 Jun 1;300 (Pt 2):567-575.##J Mol Biol. 2013 Jul 24;425(14):2463-2479.	Hoffmann R, Bulet P, Urge L, Otvös L Jr.##Cociancich S, Dupont A, Hegy G, Lanot R, Holder F, Hetru C, Hoffmann JA, Bulet P.##Zahn M, Berthold N, Kieslich B, Knappe D, Hoffmann R, Sträter N.	Range of activity and metabolic stability of synthetic antibacterial glycopeptides from insects.##Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus.##Structural Studies on the Forward and Reverse Binding Modes of Peptides to the Chaperone DnaK.	
DRAMP02835	FAEPLPSEEEGESYSKEVPEMEKRYGGFM	29	Enkelytin (one chain of Proenkephalin-A; mammals, animals)	P01211, Q2T9T4	Belongs to the opioid neuropeptide precursor family	PENK	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Micrococcus luteus (MIC=0.2-0.4 µM), Bacillus megaterium (MIC=0.2-0.4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	6952189##8654396	Proc Natl Acad Sci U S A. 1982 Jan;79(2):360-364.##Eur J Biochem. 1996 Feb 1;235(3):516-525.	Comb M, Herbert E, Crea R.##Goumon Y, Strub JM, Moniatte M, Nullans G, Poteur L, Hubert P, Van Dorsselaer A, Aunis D, Metz-Boutigue MH.	Partial characterization of the mRNA that codes for enkephalins in bovine adrenal medulla and human pheochromocytoma.##The C-terminal bisphosphorylated proenkephalin-A-(209-237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity.	
DRAMP01381	GLFTLIKGAAKLIGKTVPKKQARLGMNLWLVKLPTNVKT	39	Odorranain-K1 (OdK1; Frogs, amphibians, animals)	A6MBN8	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Odorranain-K1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=4.68 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=4.68 μg/ml), Bacillus subtilis (MIC=1.10 μg/ml).##Yeast: Candida albicans (MIC=1.10 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01383	ATAWDFGPHGLLPIRPIRIRPLCGKDKS	28	Odorranain-M1 (OdM1; Frogs, amphibians, animals)	A6MBP6	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Odorranain-M1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=9.37 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=4.68 μg/ml), Bacillus subtilis (MIC=75 μg/ml).##Yeast: Candida albicans (MIC=18.75 μg/ml). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP02841	RQKDKRPYSERKNQYTGPQFLYPPERIPPQKVIK	34	Lumbricin I(6–34)	O96447	Not found	Not found	Synthetic construct (derived from residues 6–34 of lumbricin I)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Lumbricin I(6-34) has marginally stronger antimicrobial activities than lumbricin I. Has weak hemolytic activity  when tested against human erythrocytes.	[Ref.9784609]Gram-positive bacteria: Bacillus subtilis ATCC 62037 (MIC=8 µg/ml), Staphylococcus aureus ATCC 15752 (MIC=12 µg/ml), Streptococcus mutans ATCC 25175 (MIC=20 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 27325 (MIC=8 µg/ml), Pseudomonas putidaATCC 17426 (MIC=12 µg/ml), Serratia sp. ATCC 21074 (MIC=12 µg/ml).##Fungi: Candida albicans ATCC 10231 (MIC=12 µg/ml), Cryptococcus neoformance ATCC 34881 (MIC=16 µg/ml), Saccharomyces cerevisiae ATCC 44774 (MIC=8 µg/ml).##NOTE: Minimal inhibitory concentrations were determined by incubating approximately 104–105 CFU/ml of cells with serial dilutions of each peptide in a 96-well microtiter plate..	[Ref.9784609]0.03% hemolytic activity at 5 μg/ml, 0.07% hemolytic activity at 10 μg/ml, 0.13% hemolytic activity at 25 μg/ml, 0.17% hemolytic activity at 50 μg/ml, 0.21% hemolytic activity at 100 μg/ml against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9784609	Biochim Biophys Acta. 1998 Oct 22;1408(1):67-76.	Cho JH, Park CB, Yoon YG, Kim SC.	Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization.	
DRAMP02843	ILKKWPWWPWRRKX	14	chain a, Structure Of An Indolicidin Peptide Derivative With	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Non helix or strand structure	Not found	1QXQ resolved by NMR.	Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli (MIC=8 µg/ml), Pseudomonas aeruginosa (MIC=16 µg/ml), Salmonella typhimurium (MIC=64 µg/ml), S. typhimurium defensin sensitive (MIC=2 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), Staphylococcus aureus (MRSA) (MIC=16 µg/ml), S. epidermidis (MIC=4 µg/ml), Enterococcus faecalis (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11123901	Biochemistry. 2000 Dec 26;39(51):15765-15774.	Rozek A, Friedrich CL, Hancock RE.	Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles.	
DRAMP02844	ILAWKWAWWAWRR	13	CP10A (Indolicidin peptide derivative; mammals, animals)	P33046	Not found	Not found	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix (1 helices; 8 residues)	The structure of CP10A in DPC micelles determined from NMR data is mainly a-helical with elements of 310 helical geometry. 	1HR1 resolved by NMR.	"Function: A derivative of indolicidin, CP10A, has alanine residues substituted for proline residues and has improved activity against Gram-positive organisms.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4 µg/ml), S. aureus SAP0017 MRSA (MIC=4 µg/ml), Staphylococcus haemolyticus Clinical isolate (MIC=2 µg/ml), S. haemolyticus Vancomycin-resistant isolate (MIC=1 µg/ml), Staphylococcus epidermidis Clinical isolate (MIC=2 µg/ml), Enterococcus faecalis ATCC 29212 (MIC=8 µg/ml), Listeria monocytogenes NCTC 7973 (MIC=1 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=1 µg/ml), Corynebacterium xerosis Lab strain (MIC=1 µg/ml).(Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11294848	Antimicrob. Agents Chemother. 1999,43:1542-1548.	Friedrich, C, M. G. Scott, N. Karunaratne, H. Yan, and R. E. Hancock.	"Salt-resistant alpha-helical cationic antimicrobial peptides.##Antibacterial Action of Structurally Diverse Cationic
Peptides on Gram-Positive Bacteria."	
DRAMP02845	ICLKKWPWWPWRRCKX	16	CP-11 (cathelicidin; mammals, animals)	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Non helix or strand structure	Not found	1QX9 resolved by NMR.	Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli (MIC=16 µg/ml), Pseudomonas aeruginosa (MIC=64 µg/ml), Salmonella typhimurium(MIC=64 µg/ml), S. typhimurium defensin sensitive (MIC=4 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), Staphylococcus aureus (MRSA) (MIC=16 µg/ml), S. epidermidis(MIC=8 µg/ml), Enterococcus faecalis (MIC=64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11123901##14640680 	Biochemistry. 2000 Dec 26;39(51):15765-15774.##Biochemistry. 2003 Dec 9;42(48):14130-14138.	Rozek A, Friedrich CL, Hancock RE.##Rozek, A.; Powers, JP.; Friedrich, CL.; Hancock, RE. 	Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles.##Structure-based design of an indolicidin peptide analogue with increased protease stability. 	
DRAMP02849	RFRPPIRRPPIRPPFYPPFRPPIRPPIFPPIRPPFRPPLRFP	42	Bactenecin 5 (mammals, animals)	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Salmonella typhimurium (MIC=2-10 µM), Klebsiella pneumoniae, Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2229048	J Biol Chem. 1990 Nov 5;265(31):18871-18874.	Frank RW, Gennaro R, Schneider K, Przybylski M, Romeo D.	Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils.	
DRAMP02851	RLCRIVVIRVCR	12	Cathelicidin-1 (Bactenecin-1, Bac1; Cyclic dodecapeptide; mammals, animals)	P22226, A5PJA3, Q24JY5	Belongs to the cathelicidin family	CATHL1	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Three disulfide bonds.		"Function: Potent microbicidal activity; active against S.aureus and E.coli.
Tissue specificity: Large granules of neutrophils.
PTM: Contains three disulfide bonds."	Gram-positive bacterium: Staphylococcus aureus (MIC=1-8 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=8-25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys3 and Cys11.	L	No cytotoxicity information found	Not found	3290210	J Biol Chem. 1988 Jul 15;263(20):9573-9575.	Romeo D, Skerlavaj B, Bolognesi M, Gennaro R.	Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC1=O
DRAMP02854	GGLRSLGRKILRAWKKYGPIIVPIIRIG	28	Cathelicidin-5 (Antibacterial peptide BMAP-28; Myeloid antib	P54229, A5PJ96, B9UKL6	Belongs to the cathelicidin family	CATHL5	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found	2NDC	"Function: Exerts a potent antimicrobial activity against Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, and fungi.
PTM: Contains two disulfide bonds. (By similarity)"	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 µM), E. coli ML35 (MIC=2 µM), E. coli D21 (MIC=0.5 µM), Salmonella typhimurium ATCC 14028 (MIC=1 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=1 µM), Serratia marcescens ATCC 8100 (MIC=2 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 µM), Staphylococcus aureus Cowan 1 (MIC=1 µM), Staphylococcus aureus (MRSA) (MIC=4 µM), Staphylococcus epidermidis ATCC 12228 (MIC=1 µM), Bacillus megaterium Bm11 (MIC=2 µM).##Fungi: Candida albicans (MIC=8 µM), Cryptococcus neoformans (MIC=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8910461##8706679	J Biol Chem. 1996 Nov 8;271(45):28375-28381.##Eur J Biochem. 1996 Jun 15;238(3):769-776.	Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M.##Storici P, Tossi A, Lenarcic B, Romeo D.	Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.##Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides.	
DRAMP02855	GRFKRFRKKFKKLFKKLSPVIPLLHLG	27	Cathelicidin-6 (Antibacterial peptide BMAP-27, Myeloid antib	P54228, B9UKM5	Belongs to the cathelicidin family	CATHL6	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix (2 helices; 19 residues)	Not found	2KET resolved by NMR.	"Function: Exerts a potent antimicrobial activity against Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, and fungi.
PTM: Contains two disulfide bonds. (By similarity)"	Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=1 µg/ml), E. coli ML35 (MIC=1 µg/ml), E. coli D21 (MIC=0.25 µg/ml), Salmonella typhimurium ATCC 14028 (MIC=1 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=1 µg/ml), Serratia marcescens ATCC 8100 (MIC=2 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 µg/ml), Staphylococcus aureus Cowan 1 (MIC=2 µg/ml), Staphylococcus aureus (MRSA) (MIC=4 µg/ml), S. epidermidis ATCC 12228 (MIC=1 µg/ml), Bacillus megaterium Bm11 (MIC=2 µg/ml).##Fungi: Candida albicans (MIC=8 µg/ml), Cryptococcus neoformans (MIC=4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8910461##19136450##PubMed ID is not available	J. Biol. Chem. 1996;271:28375-28381.##J. Hered. 2009;100:241-245.##To be Published	Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M.##Gillenwaters EN, Seabury CM, Elliott JS, Womack JE.##Yang S, Jung H, Kim J.	Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.##Sequence analysis and polymorphism discovery in 4 members of the bovine cathelicidin gene family.##solution structure of BMAP-27.	
DRAMP02858	DFASCHTNGGICLPNRCPGHMIQIGICFRPRVKCCRSW	38	Bovine Beta-defensin 1 (bBD-1; BNBD-1; BNDB-1; mammals, animals)	P46159 	Belongs to the beta-defensin family	DEFB1	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Bridge 	Not found		"Function: Has bactericidal activity. Active against E. coli ML35 but not against S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35. (By similarity)"	Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16777238	Vet Immunol Immunopathol. 2006 Sep 15;113(1-2):181-190. 	Aono S, Li C, Zhang G, Kemppainen RJ, Gard J, Lu W, Hu X, Schwartz DD, Morrison EE, Dykstra C, Shi J.	Molecular and functional characterization of bovine beta-defensin-1.	
DRAMP02859	VRNHVTCRINRGFCVPIRCPGRTRQIGTCFGPRIKCCRSW	40	Bovine Beta-defensin 2 (bBD-2; BNBD-2; BNDB-2; mammals, animals)	P46160	Belongs to the beta-defensin family	DEFB2	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge 	Not found		"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 7-36; 14-29; 19-37. (By similarity)"	Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 µg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8454635	J Biol Chem. 1993 Mar 25;268(9):6641-6648.	Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.	Purification, primary structures, and antibacterial activities of Beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.	
DRAMP02860	EGVRNHVTCRINRGFCVPIRCPGRTRQIGTCFGPRIKCCRSW	42	Bovine Beta-defensin 3 (bBD-3; BNBD-3; BNDB-3; mammals, animals)	P46161	Belongs to the beta-defensin family	DEFB3	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge 	Not found		"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)"	Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 µg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8454635##9488394	J Biol Chem. 1993 Mar 25;268(9):6641-6648.##Infect Immun. 1998 Mar;66(3):1045-1056.	Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.##Tarver AP, Clark DP, Diamond G, Russell JP, Erdjument-Bromage H, Tempst P, Cohen KS, Jones DE, Sweeney RW, Wines M, Hwang S, Bevins CL.	Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.##Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.	
DRAMP02861	QRVRNPQSCRWNMGVCIPFLCRVGMRQIGTCFGPRVPCCRR	41	Bovine Beta-defensin 4 (bBD-4; BNBD-4; BNDB-4; mammals, animals)	P46162	Belongs to the beta-defensin family	DEFB4	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)"	Gram-positive bacterium: Staphylococcus aureus 520A (MIC=10-300 µg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##8454635	Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.##J Biol Chem. 1993 Mar 25;268(9):6641-6648.	Yount N.Y, Yuan J, Diamond G, Tarver A, McGuire P.A, McCullough C, Cullor J.S, Bevins C.L, Selsted M.E.##Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.	Molecular cloning and expression of an antimicrobial beta-defensin from bovine neutrophils. Characterization of BNBD-4 cDNA and genomic sequences and localization of the peptide to large granules of mature neutrophils.##Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.	
DRAMP02862	QVVRNPQSCRWNMGVCIPISCPGNMRQIGTCFGPRVPCCRRW	42	Bovine Beta-defensin 5 (bBD-5; BNBD-5; BNDB-5; mammals, animals)	P46163, O97533	Belongs to the beta-defensin family	DEFB5	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Bridge	Not found		"Function: Has bactericidal activity. Active against E. coli ML35 but not against S. aureus 502A.
Tissue specificity: Neutrophilic granules. Alveolar macrophages.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)"	Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8454635	J Biol Chem. 1993 Mar 25;268(9):6641-6648.	Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.	Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.	
DRAMP02863	QGVRNHVTCRIYGGFCVPIRCPGRTRQIGTCFGRPVKCCRRW	42	Bovine Beta-defensin 6 (bBD-6; BNBD-6; BNDB-6; mammals, animals)	P46164	Belongs to the beta-defensin family	DEFB6	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)"	Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 µg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8454635	J Biol Chem. 1993 Mar 25;268(9):6641-6648.	Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.	Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.	
DRAMP02865	VRNFVTCRINRGFCVPIRCPGHRRQIGTCLGPQIKCCR	38	Bovine Beta-defensin 8 (bBD-8; BNBD-8; BNDB-8; mammals, animals)	P46166	Belongs to the beta-defensin family	DEFB8	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 7-36; 14-29; 19-37. (By similarity)"	Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 µg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8454635	J Biol Chem. 1993 Mar 25;268(9):6641-6648.	Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.	Purification, primary structures, and antibacterial activities of Beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.	
DRAMP02866	QGVRNFVTCRINRGFCVPIRCPGHRRQIGTCLAPQIKCCR	40	Bovine Beta-defensin 9 (bBD-9; BNBD-9; BNDB-9; mammals, animals)	P46167, O18814	Belongs to the beta-defensin family	DEFB9	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)"	Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 µg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-301 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8454635##9488394	J Biol Chem. 1993 Mar 25;268(9):6641-6648.##Infect Immun. 1998 Mar;66(3):1045-1056.	Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.##Tarver AP, Clark DP, Diamond G, Russell JP, Erdjument-Bromage H, Tempst P, Cohen KS, Jones DE, Sweeney RW, Wines M, Hwang S, Bevins CL.	Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.##Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.	
DRAMP02867	QGVRSYLSCWGNRGICLLNRCPGRMRQIGTCLAPRVKCCR	40	Bovine Beta-defensin 10 (bBD-10; BNBD-10; BNDB-10; mammals, animals)	P46168, Q5W5G8	Belongs to the beta-defensin family	DEFB10	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)"	Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 µg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8454635##15520886	J Biol Chem. 1993 Mar 25;268(9):6641-6648.##Mamm Genome. 2004 Oct;15(10):834-842.	Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.##Roosen S, Exner K, Paul S, Schröder JM, Kalm E, Looft C.	Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.##Bovine beta-defensins: identification and characterization of novel bovine beta-defensin genes and their expression in mammary gland tissue.	
DRAMP02868	GPLSCRRNGGVCIPIRCPGPMRQIGTCFGRPVKCCRSW	38	Bovine Beta-defensin 11 (bBD-11; BNBD-11; BNDB-11; mammals, animals)	P46169, Q5W5G7	Belongs to the beta-defensin family	DEFB11	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35. (By similarity)"	Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 µg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8454635##15520886	J Biol Chem. 1993 Mar 25;268(9):6641-6648.##Mamm Genome. 2004 Oct;15(10):834-842.	Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.##Roosen S, Exner K, Paul S, Schröder JM, Kalm E, Looft C.	Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.##Bovine beta-defensins: identification and characterization of novel bovine beta-defensin genes and their expression in mammary gland tissue.	
DRAMP02869	GPLSCGRNGGVCIPIRCPVPMRQIGTCFGRPVKCCRSW	38	Bovine Beta-defensin 12 (bBD-12; BNBD-12; BNDB-12; mammals, animals)	P46170	Belongs to the beta-defensin family	DEFB12	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Beta strand	Not found	1BNB resolved by NMR.	"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35. (By similarity)"	Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 µg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8454635##8454636	J Biol Chem. 1993 Mar 25;268(9):6641-6648.##J Biol Chem. 1993 Mar 25;268(9):6649-6653.	Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.##Tang YQ, Selsted ME.	Purification, primary structures, and antibacterial activities of Beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.##Characterization of the disulfide motif in BNBD-12, an antimicrobial beta-defensin peptide from bovine neutrophils.	
DRAMP02870	SGISGPLSCGRNGGVCIPIRCPVPMRQIGTCFGRPVKCCRSW	42	Bovine Beta-defensin 13 (bBD-13; BNBD-13; BNDB-13; mammals, animals)	P46171	Belongs to the beta-defensin family	DEFB13	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found	1BNB	"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)"	Gram-positive bacterium: Staphylococcus aureus (MIC=10-300 µg/ml);##Gram-negative bacterium: Escherichia coli (MIC=10-300 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8454635	J Biol Chem. 1993 Mar 25;268(9):6641-6648.	Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.	Purification, primary structures, and antibacterial activities of Beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.	
DRAMP02872	GRFKRFRKKFKKLFKKLS	18	Myeloid antimicrobial peptide BMAP-27 (1-18) (mammals, animals)	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Also has antifungal activity.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 µM), Escherichia coli ML35 (MIC=4 µM), Escherichia coli D21 (MIC=4 µM), Salmonella typhimurium ATCC 14028 (MIC=4 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=1 µM), Serratia marcescens ATCC 8100 (MIC=2 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 µM), Staphylococcus aureus Cowan 1 (MIC=2 µM), Staphylococcus aureus (MRSA) (MIC=4 µM), Staphylococcus epidermidis ATCC 12228 (MIC=1 µM), Bacillus megaterium Bm11 (MIC=2 µM).##Fungi: Candida albicans (MIC=16 µM), Cryptococcus neoformans (MIC=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8910461	J Biol Chem. 1996 Nov 8;271(45):28375-28381.	Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M.	Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.	
DRAMP02873	GGLRSLGRKILRAWKKYG	18	Myeloid antimicrobial peptide BMAP-28 (1-18) (mammals, animals)	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Also has antifungal activity.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 µM), Escherichia coli ML35 (MIC=0.5 µM), Escherichia coli D21 (MIC=0.5 µM), Salmonella typhimurium ATCC14028 (MIC=2 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=1 µM), Serratia marcescens ATCC 8100 (MIC=2 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 µM), Staphylococcus aureus Cowan 1 (MIC=1 µM), Staphylococcus aureus (MIC=4 µM), Staphylococcus epidermidis ATCC 12228 (MIC=1 µM), Bacillus megaterium Bm11 (MIC=2 µM).##Fungi: Candida albicans (MIC=16 µM), Cryptococcus neoformans (MIC=2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8910461	J Biol Chem. 1996 Nov 8;271(45):28375-28381.	Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M.	Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.	
DRAMP02875	LPVNSPMNKGDTEVMKCIVEVISDTLSKPSPMPVSKECFETLRGDERILSILRHQNLLKELQDLALQGAKERTHQQ	76	Vasostatin-1 (VS-1; N-terminal fragment of Chromogranin-A; mammals, animals)	P05059, P79392, Q2KJ52	Belongs to the chromogranin/secretogranin protein family	CHGA	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found	6R2X	"Function: Vasostatin-1 has antibacterial activity against Gram-positive bacteria M. luteus, B. megaterium. Possesses antifungal activity against N. crassa, A. fumigatus, A. brassicicola, N. hematococca, F. culmorum and F. oxyporum and against the yeast S. cerevisiae and C. albicans.
Miscellaneous: Binds calcium with a low-affinity."	Gram-positive bacteria: Micrococcus luteus (MIC=2 µM), Bacillus megaterium (MIC=0.2 µM).##Fungi: Neurospora crassa (MIC=3 µM), Aspergillus fumigatus (MIC=5 µM), Alternaria brassicicola (MIC=3 µM), Nectria haematococca (MIC=1 µM), Fusarium culmorum (MIC=1 µM), F. oxyporum (MIC=10 µM), Saccharomyces cerevisiae (MIC=10 µM), Candida albicans (MIC=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Binds calcium with a low-affinity.	10753865	J Biol Chem. 2000 Apr 14;275(15):10745-10753.	Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, Aunis D, Metz-Boutigue MH.	Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.	
DRAMP02877	GGLRSLGRKILRAWKKYGPQATPATRQ	27	mBMAP28 (mammals, animals)	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found	2NDC	Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 µM), Escherichia coli ML35 (MIC=0.5 µM), Salmonella typhimurium ATCC 14028 (MIC=1 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=0.5 µM), Serratia marcescens ATCC 8100 (MIC=4 µM).##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=8 µM), Staphylococcus aureus (MRSA) (MIC>64 µM), Staphylococcus epidermidis ATCC 12228 (MIC=2 µM), Bacillus megaterium Bm11 (MIC=2 µM).##Fungi: Candida albicans (MIC=8 µM), Cryptococcus neoformans (MIC=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8910461	J. Biol. Chem. 1996; 271:28375-28381	Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M.1996	Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.	
DRAMP02878	NPVSCVRNKGICVPIRCPGSMKQIGTCVGRAVKCCRKK	38	Tracheal antimicrobial peptide (TAP; mammals, animals)	P25068, O97532	Belongs to the beta-defensin family (LAP/TAP subfamily)	Not found	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antibacterial activity in vitro. In addition, the peptide is active against Candida albicans, indicating a broad spectrum of activity.
Tissue specificity: Tracheal epithelium.
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35. (By similarity)"	Gram-negative bacteria: Escherichia coli D31 (MIC=12-25 µg/ml), Klebsiella pneumoniae 13883 (MIC=12-25 µg/ml), Pseudomonas aeruginosa 27853 (MIC=25-50 µg/ml).##Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=25-50 µg/ml).##Fungi: Candida ablicans (MIC=6-12 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2023943##8506305	Proc Natl Acad Sci U S A. 1991 May 1;88(9):3952-3956.##Proc Natl Acad Sci U S A. 1993 May 15;90(10):4596-4600. 	Diamond G, Zasloff M, Eck H, Brasseur M, Maloy WL, Bevins CL.##Diamond G, Jones DE, Bevins CL.	Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA.##Airway epithelial cells are the site of expression of a mammalian antimicrobial peptide gene.	
DRAMP02903	ILGPILGLVSNALGGLL	17	Bombin H7	No entry found	Not found	Not found	Bombina orientalis 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Bacillus megaterium Bm11 (MIC=3.3 µM);##Gram-negative bacterium: Escherichia coli D22 (MIC=3.7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10333736	Biopolymers. 1998;47(6):435-450.	Simmaco M, Mignogna G, Barra D.	Antimicrobial peptides from amphibian skin: what do they tell us?	
DRAMP02910	LRRIIRKIIHIIKK	14	Ovispirin-2 (OV-2; mammals, animals)	No entry found	Not found	Not found	Ovis aries (Sheep)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=0.03-16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11557478	Antimicrob Agents Chemother. 2001 Oct;45(10):2838-2844.	Saiman L, Tabibi S, Starner TD, San Gabriel P, Winokur PL, Jia HP, McCray PB Jr, Tack BF.	Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.	
DRAMP02911	IRRIIRKIIHIIKK	14	Ovispirin-3 (OV-3; mammals, animals)	No entry found	Not found	Not found	Ovis aries (Sheep)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=1-8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11557478	Antimicrob Agents Chemother. 2001 Oct;45(10):2838-2844.	Saiman L, Tabibi S, Starner TD, San Gabriel P, Winokur PL, Jia HP, McCray PB Jr, Tack BF.	Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.	
DRAMP02912	RGLRRLGRKIAHGVKKYGPTVLRIIRIAG	29	SMAP-29 (Cathelin-related peptide SC5; Myeloid antibacterial peptide MAP-29; mammals, animals)	P49928, P49929	Belongs to the cathelicidin family	Not found	Ovis aries (Sheep)	Antimicrobial, Antibacterial, Antifungal	Protein level	Alpha helix	Not found	1FRY resolved by NMR.	"Function: Broad spectrum bactericidal agent. 
Biophysicochemical properties: Temperature dependence (Thermostable)."	[Ref.8549789][No NaCl]: Escherichia coli DH5a (MIC=0.1 µM), Escherichia coli ML-35p (MIC=0.18 µM), Pseudomonas aeruginosa PAO1 (MIC=0.17 µM), Pseudomonas aeruginosa MR3007 (MIC=0.34 µM), Staphylococcus aureus ATCC (MRSA) 33591 (MIC=1.24 µM), Staphylococcus aureus 93918 (MIC=0.31 µM).##[100 mM NaCl]: Escherichia coli DH5a (MIC=0.07 µM), Escherichia coli ML-35p (MIC=0.12 µM), Pseudomonas aeruginosa PAO1 (MIC=0.08 µM), Pseudomonas aeruginosa MR3007 (MIC=0.18 µM), Staphylococcus aureus ATCC (MRSA) 33591 (MIC=0.65 µM), Staphylococcus aureus 93918 (MIC=0.43 µM).	[Ref.8549789]Not found	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Outer membrane protein I (OprI)	8549789##11932493	FEBS Lett. 1995 Dec 27;377(3):519-522.##Protein Eng. 2002 Mar;15(3):225-232.	Mahoney MM, Lee AY, Brezinski-Caliguri DJ, Huttner KM.##Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF.	Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide.##Impact of single-residue mutations on the structure and Function: of ovispirin/novispirin antimicrobial peptides.	
DRAMP02913	GLFGRLRDSLQRGGQKILEKAERIWCKIKDIFRG	34	SMAP-34 (cathelicidin; mammals, animals)	No entry found	Not found	Not found	Ovis aries (Sheep)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: Has antibacterial activity.	[Ref.10768969][No NaCl]: Escherichia coli DH5a (MIC=0.5 μM), Escherichia coli ML-35p (MIC=1.93 μM), Pseudomonas aeruginosa PAO1 (MIC=0.6 μM), Pseudomonas aeruginosa MR3007 (MIC=2 μM), Staphylococcus aureus ATCC (MRSA) 33591 (MIC=4 μM), Staphylococcus aureus 93918 (MIC=1.96 μM).100 mM NaCl: Escherichia coli DH5a (MIC=0.23 μM), Escherichia coli ML-35p (MIC=1.03 μM), Pseudomonas aeruginosa PAO1 (MIC=0.77 μM), Pseudomonas aeruginosa MR3007 (MIC=1.9 μM), Staphylococcus aureus ATCC (MRSA) 33591 (MIC=13.3 μM), Staphylococcus aureus 93918 (MIC=2.13 μM). 	[Ref.10768969]30% hemolysis at 1000 μg/ml against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10768969	Infect Immun. 2000 May;68(5):2748-2755.	Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray PB Jr, Lehrer RI, Welsh MJ, Tack BF.	Bactericidal activity of mammalian cathelicidin-derived peptides.	
DRAMP02922	KCWNLRGSCREKCIKNEKLYIFCTSGKLCCLKPK	34	Canine beta-defensin (dogs, mammals, animals)	No entry found	Not found	Not found	Canis lupus familiaris (Dog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli 25922 (MIC=20 µg/ml), Escherichia coli 700336 (MIC=50 µg/ml);##Gram-positive bacteria: Klebsiella pneumoniae 10031 (MIC=20 µg/ml), Listeria monocytogenes 19115 (MIC=10 µg/ml), Staphylococcus aureus 10832 (MIC=100 µg/ml), N. gonorrhoeae 10150 (MIC=50 µg/ml).##Fungi: Candida albicans 14053 (MIC=50 µg/ml), Candida albicans 11006 (MIC=5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15845463	Infect Immun. 2005 May;73(5):2611-2620.	Sang Y, Ortega MT, Blecha F, Prakash O, Melgarejo T.	Molecular cloning and characterization of three beta-defensins from canine testes.	
DRAMP02923	KCWNLRGSCREKCIKNEKLYIFCTSGKLCCLKPKFQPNMLQR	42	cBD-1 (Canine beta-defensin 1; dogs, mammals, animals)	No entry found	Not found	Not found	Canis Lupis (Dog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Listeria monocytogenes(MIC=6 mµg/ml), Staphylococcus aureus (MIC=100 mµg/ml);##Gram-negative bacteria: Escherichia coli (MIC=20-25 mµg/ml), Klebsiella pneumoniae (MIC=20 mµg/ml), Neisseria gonorrhoeae (MIC=50 mµg/ml).##Yeast: Candida albicans (MIC=5-50 mµg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15845463	Infect Immun. 2005 May;73(5):2611-2620.	Sang Y, Ortega MT, Blecha F, Prakash O, Melgarejo T.	Molecular cloning and characterization of three beta-defensins from canine testes.	
DRAMP18367	GFGSKPLDSFGLNFF	15	Chaxapeptin (a class 2 lasso peptide; class 1 microcin, bacteriocins)	No entry found	Not found	Not found	Streptomyces leeuwenhoekii Strain C58	Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer		Not found	Not found		Fuction: No activity against the Gram-negative bacteria. It showed dose dependent inhibition of A549 cancer cells.	Gram-positive bacteria: S. aureus and B. subtilis (MIC 30-35 ug/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26402731	J Org Chem. 2015 Oct 16;80(20):10252-60.	Elsayed SS, Trusch F, Deng H, Raab A, Prokes I, Busarakam K, Asenjo JA, Andrews BA, van West P, Bull AT, Goodfellow M, Yi Y, Ebel R, Jaspars M, Rateb ME	Chaxapeptin, a Lasso Peptide from Extremotolerant Streptomyces leeuwenhoekii Strain C58 from the Hyperarid Atacama Desert	
DRAMP18368	SMSGFSKPHD	10	Bacteriocin TSU4 (bacteria, prokaryotes)	No entry found	Not found	Not found	Lactobacillus animalis TSU4	Antimicrobial, Antibacterial		Not found	Not found		Only the N-terminal sequence is available.	Active against A. hydrophila, E. coli, P. aeruginosa, S. typhimurium, S. paratyphi, S. flexneri, and S. aureus (inhibition zone 25-28 mm).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26245257	Appl Biochem Biotechnol. 2015 Sep;177(1):90-104	Sahoo TK, Jena PK, Patel AK, Seshadri S.	Purification and Molecular Characterization of the Novel Highly Potent Bacteriocin TSU4 Produced by Lactobacillus animalis TSU4	
DRAMP02925	RLKELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS	38	Cathelicidin (dogs, mammals, animals)	No entry found	Not found	Not found	Canis lupus familiaris (Dog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli (MIC=1.25 µM), Klebsiella pneumoniae (MIC=1.25 µM), Salmonella serotype Typhimurium (MIC=1.25 µM), Pseudomonas aeruginosa (MIC=1.25 µM), Proteus mirabilis (MIC=1.25 µM), Salmonella serotype Enteritidis (MIC=0.5 µM), Neisseria gonorrhoeae (MIC=0.06 µM).##Gram-positive bacteria: Listeria monocytogenes (MIC=0.5 µM), Staphylococcus aureus (MIC=50 µM).##Fungi: Candida albicans (MIC=12.5-50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17462733	Dev Comp Immunol. 2007;31(12):1278-1296.	Sang Y, Teresa Ortega M, Rune K, Xiau W, Zhang G, Soulages JL, Lushington GH, Fang J, Williams TD, Blecha F, Melgarejo T.	Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide.	
DRAMP02931	SPRVSRRYGRPFGGRPFVGGQFGGRPGCVCIRSPCPCANYG	41	Arasin-likeSp (crabs, Arthropods, animals)	No entry found	Not found	Not found	Scylla paramamosain (Mud crab)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus haemolyticus (MIC=6.25-12.5 µM), Aerococcus viridans (MIC=0.19-0.39 µM), Micrococcus luteus (MIC=0.39-0.78 µM), Bacillus subtilis (MIC=6.25-12.5 µM);##Gram-negative bacteria: Escherichia coli 363 (MIC>50 µM), Aeromonas hydrophila (MIC>50 µM), V. harveyi (MIC=0.78-1.56 µM), Vibrio anguillarum (MIC=3.125-6.25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21220028	Fish Shellfish Immunol. 2011 Feb;30(2):706-712.	Imjongjirak C, Amparyup P, Tassanakajon A.	Two novel antimicrobial peptides, arasin-likeSp and GRPSp, from the mud crab Scylla paramamosain, exhibit the activity against some crustacean pathogenic bacteria.	
DRAMP02932	IPAMEPAARVKRSPGYGGCSPRWACGGYG	29	GRPSp (crabs, Arthropods, animals)	No entry found	Not found	Not found	Scylla paramamosain (Mud crab)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus haemolyticus (MIC>50 µM), Aerococcus viridans (MIC=6.25-12.5 µM), Micrococcus luteus (MIC=12.5-25 µM), Bacillus subtilis (MIC>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21220028	Fish Shellfish Immunol. 2011 Feb;30(2):706-712.	Imjongjirak C, Amparyup P, Tassanakajon A.	Two novel antimicrobial peptides, arasin-likeSp and GRPSp, from the mud crab Scylla paramamosain, exhibit the activity against some crustacean pathogenic bacteria.	
DRAMP02933	RRWCFRVCYRGFCYRKCR	18	Polyphemusin-1 (PM1; crabs, Arthropods, animals)	P14215	Belongs to the tachyplesin/polyphemusin family	Not found	Limulus polyphemus (Atlantic horseshoe crab)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Beta strand (2 strands; 4 residues)	The solution structure of polyphemusin I is determined using (1)H-NMR spectroscopy. Polyphemusin I is found to be an amphipathic, beta-hairpin connected by a type I' beta-turn.	1RKK resolved by NMR.	"Function: PM1 showes high antimicrobial activity against the Gram-negative, Gram-positive and fungal specimens tested.
Tissue specificity: Hemocytes.
PTM: Contains two disulfide bonds 4-17; 8-13 and C-terminal amidation."	Gram-negative bacteria: Escherichia coli UB1005 (MIC=0.5 µg/ml), E. coli DC2 (MIC=1 µg/ml), Salmonella typhimurium (defensin-sensitive) (MIC=0.25 µg/ml), S. typhimurium (MIC=1 µg/ml), Pseudomonas aeruginosa K799 (MIC=2 µg/ml), P. aeruginosa Z61 (MIC=1 µg/ml);##Gram-positive bacteria: Staphylococcus aureus SAP0017 (MIC=2 µg/ml), Staphylococcus epidermidis (MIC=1 µg/ml), Enterococcus faecalis (MIC=1 µg/ml).##Yeasy: Candida albicans (MIC=4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation	Disulfide bond between Cys4 and Cys17,Cys8 and Cys13.	L	No cytotoxicity information found	Not found	2514185##15134657	J Biochem. 1989 Oct;106(4):663-668.##Biochim Biophys Acta. 2004 May 6;1698(2):239-250.	Miyata T, Tokunaga F, Yonega T, Yoshikawa K, Iwanaga S, Niwa M, Takao T, Shimonishi Y.##Powers JP, Rozek A, Hancock RE.	Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity.##Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I.	
DRAMP02934	RRWSFRVSYRGFSYRKSR	18	PM1-S (linear derivative of PM1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	No secondary structure (CD)	The CD spectra of PM1-S indicates that, in all environments (phosphate buffer, TFE, and liposomes), the peptide displays no observable patterns that could be related to structural features. This indicates that PM1-S is a flexible molecule with no favoured conformation.		Function: PM1-S remaines active against Gram-negative bacteria but displayed poor activity to both Gram-positive and fungal microorganisms.	Gram-negative bacteria: Escherichia coli UB1005 (MIC=4 µg/ml), E. coli DC2 (MIC=4 µg/ml), Salmonella typhimurium (defensin-sensitive) (MIC=2 µg/ml), S. typhimurium (MIC=8 µg/ml), Pseudomonas aeruginosa K799 (MIC=32 µg/ml), P. aeruginosa Z61 (MIC=16 µg/ml);##Gram-positive bacteria: Staphylococcus aureus SAP0017 (MIC=32 µg/ml), Staphylococcus epidermidis (MIC=16 µg/ml), Enterococcus faecalis (MIC=2 µg/ml).##Yeasy: Candida albicans (MIC=64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15134657	Biochim Biophys Acta. 2004 May 6;1698(2):239-250.	Powers JP, Rozek A, Hancock RE.	Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I.	
DRAMP02950	YVDREINLFDHYCIISRSPHISRWELKWQATVTCPGWTPVKGKVRGYSNPLSAEREATRDFVQRIVQRGLVTRDEASEWL	80	PtALF5 (Portunus trituberculatus anti-lipopolysaccharide factor isoform 5; crabs, Arthropods, ani	No entry found	Not found	Not found	Portunus trituberculatus (Swimming Crab)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Contains a signal peptide and an LPS-binding Domain: (CIISRSPHISRWELKWQATVTC) and two conserved cysteine residues which can form a disulfide bridge. PtALF5 transcript in hemocytes showes a clear time-dependent response expression pattern with obvious decrease at 6 h and significant increase at 24 h. The recombinant PtALF5 has antimicrobial activity against Gram-negative bacteria Vibrio alginolyticus and Pseudomonas aeruginosa.	Gram-negative bacteria: Vibrio alginolyticus (MIC=3.89-7.78 µM), Edwardsiella tarda (MIC=7.78-15.54 µM), Pseudomonas aeruginosa (MIC=15.54-31.08 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	21362485##22516300	Fish Shellfish Immunol. 2011 Jul;31(1):29-42.##Fish Shellfish Immunol. 2012 Jul;33(1):85-91.	Liu Y, Cui Z, Song C, Wang S, Li Q.##Liu Y, Cui Z, Li X, Song C, Li Q, Wang S.	Multiple isoforms of immune-related genes from hemocytes and eyestalk cDNA libraries of swimming crab Portunus trituberculatus.##Molecular cloning, expression pattern and antimicrobial activity of a new isoform of anti-lipopolysaccharide factor from the swimming crab Portunus trituberculatus.	
DRAMP02951	MARVSLLLIVLSIALVAPSQGFLKDLLFGEAKTALLEDGTTEILDHVCNFRVMPRLRSWELYFRGDVWCPGWTVIKGESL	80	PtALF6 (Portunus trituberculatus anti-lipopolysaccharide factor isoform 6; crabs, Arthropods, ani	No entry found	Not found	Not found	Portunus trituberculatus (Swimming Crab)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Contains a signal peptide and an LPS-binding Domain: (CNFPVMPRLRSWELYFRGDVWC) and two conserved cysteine residues which can form a disulfide bridge.	Gram-negative bacteria: Vibrio alginolyticus L59 (MIC=1.17-2.33 µM), Pseudomonas aeruginosa P25 (MIC=9.32-18.64 µM);##Gram-positive bacteria: Micrococcus luteus M2 (MIC=9.32-18.64 µM), Staphylococcus aureus S7 (MIC=9.32-18.64 µM).##Fungi: Pichia pastoris GS115 (MIC>74.57 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	21362485##23257203	Fish Shellfish Immunol. 2011 Jul;31(1):29-42.##Fish Shellfish Immunol. 2013 Feb;34(2):463-470.	Liu Y, Cui Z, Song C, Wang S, Li Q.##Liu Y, Cui Z, Li X, Song C, Shi G.	Multiple isoforms of immune-related genes from hemocytes and eyestalk cDNA libraries of swimming crab Portunus trituberculatus.##A newly identified anti-lipopolysaccharide factor from the swimming crab Portunus trituberculatus with broad spectrum antimicrobial activity.	
DRAMP02952	MRKGVVTGLFVALVVMCLYLPQPCEAQYEALTAAILTKLSKMWHSDTLNFLGHTCHVSRTPTVKRFKLYWKGKFWCPGWA	80	PtALF7 (Portunus trituberculatus anti-lipopolysaccharide factor isoform 7; crabs, Arthropods, ani	No entry found	Not found	Not found	Portunus trituberculatus (Swimming Crab)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Contains a signal peptide and an LPS-binding Domain: (CHVSRTPTVKRFKLYWKGKFWC) and two conserved cysteine residues which can form a disulfide bridge.	Gram-negative bacteria: Vibrio alginolyticus (MIC=0.51-1.02 µM), Edwardsiella tarda (MIC=2.04-4.07 µM), Pseudomonas aeruginosa (MIC=1.02-2.04 µM);##Gram-positive bacteria: Micrococcus luteus (MIC=32.59-65.19 µM), Staphylococcus aureus (MIC=8.15-16.30 µM).##Fungi: Pichia pastoris (MIC>130.37 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	21362485##23261507	Fish Shellfish Immunol. 2011 Jul;31(1):29-42.##Fish Shellfish Immunol. 2013 Feb;34(2):652-659.	Liu Y, Cui Z, Song C, Wang S, Li Q.##Liu Y, Cui Z, Li X, Song C, Shi G, Wang C.	Multiple isoforms of immune-related genes from hemocytes and eyestalk cDNA libraries of swimming crab Portunus trituberculatus.##Molecular cloning, genomic structure and antimicrobial activity of PtALF7, a unique isoform of anti-lipopolysaccharide factor from the swimming crab Portunus trituberculatus.	
DRAMP02953	SRWPSPGRPRPFPGRPKPIFRPRPCNCYAPPCPCDRW	37	Arasin-1 (Pro-rich, Arg-rich; crabs, Arthropods, animals)	A6XMY0	Not found	Not found	Hyas araneus (Great spider crab) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Corynebacterium glutamicum (MIC=0.8 µM), Listonella anguillarum (MIC=6.3 µM);##Gram-negative bacterium: Escherichia coli (MIC=12.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys25 and Cys34,Cys27 and Cys32.	L	No cytotoxicity information found	Not found	17658600	Dev Comp Immunol. 2008;32(3):275-285.	Stensvag K, Haug T, Sperstad S.V, Rekdal O, Indrevoll B, Styrvold O.B.	Arasin 1, a proline-arginine-rich antimicrobial peptide isolated from the spider crab, Hyas araneus.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N2
DRAMP02956	SHQDCYEALHKCMASHSKPFSCSMKFHMCLQQQ	33	Dolabellanin B2	P83376	Not found	Not found	Dolabella auricularia (Sea hare)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. Also possesses antifungal activity.
PTM: Contains two disulfide bonds. Up to two of the methionines may be oxidized to methionine sulfoxides."	Gram-positive bacteria: Bacillus subtilis RIMD0225014 (MIC=2.5 µg/ml), Staphylococcus aureus IID1677 (MRSA) (MIC=20.0 µg/ml), Listeria monocytogenes VIU206 (MIC=40.0 µg/ml).##Gram-negative bacteria: Haemophilus influenzae IID983 (MIC=5.0 µg/ml), V. vulnificus RIMD2219009 (MIC=5.0 µg/ml), Escherichia coli JM109 (MIC=20.0 µg/ml), E. coli DH5Î± (MIC=40.0 µg/ml).##Fungi: Candida albicans ATCC36232, Candida tropicalis TIMM0313, S. pombe IFO1628, Saccharomyces cerevisiae A581A.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Contains two disulfide bonds. Up to two of the methionines may be oxidized to methionine sulfoxides.	L	No cytotoxicity information found	Not found	12590964	Dev. Comp. Immunol. 2003;27:305-311.	Iijima R, Kisugi J, Yamazaki M.	A novel antimicrobial peptide from the sea hare Dolabella auricularia.	
DRAMP02959	RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP	39	Antibacterial protein PR-39 (pigs, mammals, animals)	P80054, Q9TR84	Belongs to the cathelicidin family	PR39	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Rich	Not found		"Tissue specificity: Small intestine and bone marrow.
PTM: Proline amide at P39."	Gram-negative bacteria: Escherichia coli K12 D21 (MIC=0.3 µM), Escherichia coli Bd2221175 (MIC=0.3 µM), Salmonella typhimurium LT2 (MIC=1µM), Proteus vulgaris Pvll (MIC=300 µM), Pseudomonas aeruginosa OT97 (MIC=200 µM), Acinetobacter calcoaceticus Acl 1 (MIC=3 µM).##Gram-positive bacteria: Bacillus megaterium (MIC=0.3 µM), Bacillus subtilis (MIC=15 µM), Staphylococcus aureus (MIC=200 µM), Streptococcus pyogenes (MIC=2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1765098##7624374	Eur J Biochem. 1991 Dec 18;202(3):849-854.##Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):7085-7089.	Agerberth B, Lee JY, Bergman T, Carlquist M, Boman HG, Mutt V, Jörnvall H.##Gudmundsson GH, Magnusson KP, Chowdhary BP, Johansson M, Andersson L, Boman HG.	Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides.##Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39.	
DRAMP02960	RIIDLLWRVRRPQKPKFVTVWVR	23	Antibacterial peptide PMAP-23 (Myeloid antibacterial peptide 23; pigs, mammals, animals)	P49930	Belongs to the cathelicidin family	PMAP23	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Alpha helix 	Not found		"Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria at concentrations of 2-16 micro molar. Its activity appears to be mediated by its ability to damage bacterial membranes.
PTM: Contains two disulfide bonds (By similarity)."	Gram-negative bacteria: Escherichia coli ML35 (MIC=2 µM), Escherichia coli ATCC 25922 (MIC=4 µM), Salmonella typhimurium ATCC 14028 (MIC=8 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=16 µM).##Gram-positive bacteria: Bacillus megaterium (MIC=2 µM), Staphylococcus aureus ATCC 25923 (MIC=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	8132502	J Biol Chem. 1994 Mar 18;269(11):7855-7858.	Zanetti M, Storici P, Tossi A, Scocchi M, Gennaro R.	Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells.	
DRAMP02961	GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSEFFQS	37	Antibacterial peptide PMAP-37 (Myeloid antibacterial peptide 37; pigs, mammals, animals)	P49932	Belongs to the cathelicidin family	PMAP37	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Alpha helix 	Not found		"Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria with minimal inhibitory concentrations ranging over 1-4 micro molar. Its activity appears to be mediated by its ability to damage bacterial membranes.
PTM: Contains two disulfide bonds (By similarity)."	Gram-negative bacteria: Escherichia coli ML35 (MIC=2 µM), Escherichia coli ATCC 25922 (MIC=1 µM), Escherichia coli D21 (MIC=2 µM), Salmonella typhimurium ATCC 14028 (MIC=4 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=2 µM).##Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=4 µM), Bacillus megaterium local isolate (IC=4 µM), Staphylococcus aureus ATCC 25923 (MIC=32 µM), Staphylococcus aureus Cowan 1 (MIC=64 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	7737198	Eur J Biochem. 1995 Mar 15;228(3):941-946.	Tossi A, Scocchi M, Zanetti M, Storici P, Gennaro R.	PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity.	
DRAMP02228	SMLSVLKNLGKVGLGFVACKINKQC	25	RANATUERIN 1 (Frogs, amphibians, animals)	P82741 	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacterium S.aureus and Gram-negative bacterium E.coli. Has activity against C.albicans. Has no detectable hemolytic activity.	[Ref.9784389] Gram-positive bacterium: Staphylococcus aureus (MIC=50 µM);##Gram-negative bacterium: Escherichia coli (MIC=2 µM);##Yeast: Candida albicans (MIC=70 µM).	[Ref.9784389] It has no detectable hemolytic activity at aconcentration of 20µg/ml against human red blood cell.	Cyclic	Free	Cyclization (Cys19 and Cys25)	Disulfide bond between Cys19 and Cys25.	L	No cytotoxicity information found	Not found	9784389	Biochem Biophys Res Commun. 1998 Sep 29;250(3):589-592.	Goraya J, Knoop FC, Conlon JM.	Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana.	
DRAMP02963	GRFRRLRKKTRKRLKKIGKV	20	PMAP-36(1-20)	No entry found	Not found	Not found	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria. 	Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=6 µM), Bacillus megaterium Bm11 (MIC=3 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12 µM), E. coli ML35 (MIC=12 µM), S. enterica ser. Typhimurium ATCC 14028 (MIC=48 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=3 µM).##Fungi: Candida albicans c.i. (MIC>64 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16128809	FEBS J. 2005 Sep;272(17):4398-4406.	Scocchi M, Zelezetsky I, Benincasa M, Gennaro R, Mazzoli A, Tossi A.	Structural aspects and biological properties of the cathelicidin PMAP-36.	
DRAMP02964	GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLG	34	PMAP-36(1-34)	No entry found	Not found	Not found	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria. 	Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=1 µM), S. aureus 710A (MIC=2 µM), S. aureus SA-62 (MRSA) (MIC=4 µM), Bacillus megaterium Bm11 (MIC=1 µM), S. epidermidis ATCC 12228 (MIC=1 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 µM), E. coli ML35 (MIC=1 µM), E. coli D21 (MIC=1 µM), E. coli D22 (MIC=0.5 µM), S. enterica ser. Typhimurium ATCC 14028 (MIC=1 µM), S. enterica ser. Enteritidis H2 (MIC=1 µM), P. aeruginosa ATCC 27853 (MIC=1 µM), S. marcescens ATCC 8100 (MIC=2 µM).##Fungi: Candida albicans c.i. (MIC=8 µM), Cryptococcus neoformans c.i.(MIC=2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16128809	FEBS J. 2005 Sep;272(17):4398-4406.	Scocchi M, Zelezetsky I, Benincasa M, Gennaro R, Mazzoli A, Tossi A.	Structural aspects and biological properties of the cathelicidin PMAP-36.	
DRAMP02965	GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGC	35	PMAP-36(1-35)2	No entry found	Not found	Not found	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria. 	Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 µM), S. aureus 710A (MIC=2 µM), S. aureus SA-62 (MRSA) (MIC=4 µM), Bacillus megaterium Bm11 (MIC=1 µM), S. epidermidis ATCC 12228 (MIC=1 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 µM), E. coli ML35 (MIC=0.5 µM), E. coli D21 (MIC=0.5 µM), E. coli D22 (MIC=0.5 µM), S. enterica ser. Typhimurium ATCC 14028 (MIC=1 µM), S. enterica ser. Enteritidis H2 (MIC=0.5 µM), P. aeruginosa ATCC 27853 (MIC=1 µM), S. marcescens ATCC 8100 (MIC=2 µM).##Fungi: Candida albicans c.i. (MIC=16 µM), Cryptococcus neoformans c.i.(MIC=2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16128809	FEBS J. 2005 Sep;272(17):4398-4406.	Scocchi M, Zelezetsky I, Benincasa M, Gennaro R, Mazzoli A, Tossi A.	Structural aspects and biological properties of the cathelicidin PMAP-36.	
DRAMP02966	KQATVGDINTERPGILDLKGKAKWDAWNGLKGTSKEDAMKAYINKVEELKKKYGI	55	DBI(32-86) (pigs, mammals, animals)	P12026, A7YB23, Q9TSG2	Belongs to the ACBP family	DBI	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: DBI(32-86) has antibacterial properties.	Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.69 µM);##Gram-negative bacteria: Escherichia coli D22 (MIC=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8375398##3289918	Eur J Biochem. 1993 Sep 1;216(2):623-629.##Eur J Biochem. 1988 Jun 1;174(2):239-245.	Agerberth B, Boman A, Andersson M, Jörnvall H, Mutt V, Boman HG.##Chen ZW, Agerberth B, Gell K, Andersson M, Mutt V, Ostenson CG, Efendić S, Barros-Söderling J, Persson B, Jörnvall H.	Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910.##Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release.	
DRAMP02970	RGGRLCYCRRRFCVCVGR	18	Protegrin-1 (Protegrin 1; PG-1; pigs, mammals, animals)	P32194	Belongs to the cathelicidin family	NPG1	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Beta strand	Not found	1PG1 resolved by NMR.	The sequence of IB-367 is RGGLCYCRGRFCVCVGR and the peptide is active against bacteria and fungi. This peptide showed synergistic effect with LL-37 against P. aeruginosa and E. coli (Yan H & Hancock REW 2001 Antimicrob Agents Chemother 45: 1558-60). PG-1 derivatives were subjected to clinical trials. 	Gram-negative bacteria: Escherichia coli (MIC=64 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=64 µg/ml), Staphylococcus epidermidis (MIC=2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys15,Cys8 and Cys13.	L	[Ref.31399625] Cytotoxicity: 661W cells(IC50=353.4±70.5μM), HEK293T cells(IC50=2760±54.1μM), NIH-3T3 cells(IC50=719.2±59.5μM), SH-SY5Y cells(IC50=590.4±58.2μM), PMN cells(IC50=948.9±64.1μM), and 3D4/2 cells(IC50=391.1±71.3μM)	Cell membrane	8647100	Chem Pharm Bull (Tokyo). 1995 May;43(5):853-858.	Tamamura H, Murakami T, Horiuchi S, Sugihara K, Otaka A, Takada W, Ibuka T, Waki M, Yamamoto N, Fujii N.	Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](Cc3ccc(O)cc3)NC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N2
DRAMP02975	VRRFPWWWPFLRR	13	Tritrpticin (Trp-rich; pigs, mammals, animals)	No entry found	Belongs to the cathelicidin family	Not found	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix (1 helices; 3 residues)	Not found	1D6X resolved by NMR.	Function: Tritrpticin has strong antimicrobial activity with a wide spectrum.	Gram-negative bacteria: Escherichia coli (5 mm), Pseudomonas aeruginosa (3 mm), Klebsiella pneumonia (7 mm), Proteus mirabilis (1 mm);##Gram-positive bacteria: Staphylococcus epidermidis (5 mm), Streptococcus group D (4 mm). [inhibit zones in mm]##Fungi: Aspergillus fumigatus (MIC=250 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8706838##10606506	FEBS Lett. 1996 Jul 15;390(1):95-98.##Biochemistry. 1999 Dec 21;38(51):16749-55.	Lawyer C, Pai S, Watabe M, Borgia P, Mashimo T, Eagleton L, Watabe K.Schibli DJ, Hwang PM, Vogel HJ.##Schibli DJ, Hwang PM, Vogel HJ.	Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides.##Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membrane-bound peptide fold.	
DRAMP02980	GLICESCRKIIQKLEDMVGPQPNEDTVTQAASRVCDKMKILRGVCKKIMRTFLRRISKDILTGKKPQAICVDIKICKE	78	Antimicrobial peptide NK-lysin (NKL; pigs, mammals, animals)	Q29075	Not found	NKL	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Antifungal, Antitumor	Protein level	Alpha helix 	Not found	1NKL resolved by NMR.	"Function: May be an effector molecule of cytotoxic activity. High activity against E. coli and B. megaterium, moderate against A. calcoaceticus and S. pyogenes. Has some antifungal activity against Candida albicans.
Tissue specificity: Cytotoxic T and NK cells. Induction: By interleukin-2.
PTM: Contains three disulfide bonds 4-76; 7-70; 35-45."	[with medium E]: Escherichia coli D21 (MIC=0.5 µM), Escherichia coli Bd2221/75 (MIC=10 µM), Acinetobacter calcoaceticus Ac 11 (MIC=7 µM), Bacillus megaterium Bmll (MIC=1.6 µM);##[without medium E]: Escherichia coli D21 (MIC=8 µM), Escherichia coli Bd2221/75 (MIC=39 µM), Bacillus megaterium Bmll (MIC=0.8 µM), Streptococcus pyogenes w.t. (MIC=34 µM), Candida albicans w.t. (MIC=31 µM).	[Ref.7737114] It exhibits no hemolytic activity at 170 µM against sheep red blood cells.	Cyclic	Free	Free	Disulfide bonds between Cys4 and Cys76; Cys7 and Cys70; Cys35 and Cys45.	L	[Ref.7737114] NK-lysin at 50μg/ml was able to give 90% lysis of 5'Cr-labelled YAC-1 cells in a medium with 2% fetal calf serum(FCS) and 75% lysis in phosphate-buffered saline(PBS), 15% lysis suspended in medium E.	Lipopolysaccharide (LPS)-binding	7737114##9334742	EMBO J. 1995 Apr 18;14(8):1615-1625.##Nat Struct Biol. 1997 Oct;4(10):793-795.	Andersson M, Gunne H, Agerberth B, Boman A, Bergman T, Sillard R, Jörnvall H, Mutt V, Olsson B, Wigzell H, et al.##Liepinsh E, Andersson M, Ruysschaert JM, Otting G.	NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity.##Saposin fold revealed by the NMR structure of NK-lysin.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]3CCCN3C(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N3)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N2
DRAMP03028	IDWKKLLDAAKQIL	14	Polybia-MP1	No entry found	Not found	Not found	Polybia paulista	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix	Not found		Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity.	[Ref.29075946] Gram-positive bacterium: Bacillus subtilis (MIC=12.5μM), Staphylococcus aureus (MIC=18.8μM);##Gram-negative bacterium:Escherichia coli (MIC=75μM), Shigella dysenteriae (MIC=75μM), Klebsiella pneumoniae (MIC=37.5μM)	[Ref.29075946] <1% hemolysis at 12.5μM, 3.2% hemolysis at 25μM against human red blood cells.	stapled peptide	Free	Amidation	tethers Lys6 and Arg10	L	No cytotoxicity information found	Not found	29075946	Arch Pharm Res. 2017 Dec;40(12):1414-1419.	Luong HX, Kim DH, Lee BJ, Kim YW	Antimicrobial activity and stability of stapled helices of polybia-MP1	
DRAMP03721	ILGKIWEGIKSLF	13	IsCT1	Q8MMJ7 	Belongs to the scorpion NDBP 5 family	Not found	Opisthacanthus madagascariensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix 	Residue 6 is important for antibacterial activity, and hemolysis activity		Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity.	[Ref.28657596] Gram-positive bacterium:Staphylococcus aureus (MIC=50μg/mL);##Gram-negative bacterium: S. typhimurium (MIC=100μg/mL), Escherichia coli (MIC=50μg/mL)	[Ref.28657596] 2% hemolysis at 10 μg/ml, 96% hemolysis at 50 μg/ml against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28657596	Antibiotics (Basel). 2017 Jun 28;6(3). pii: E13.	de la Salud Bea R, Petraglia AF, Ascuitto MR, Buck QM.	Antibacterial Activity and Toxicity of Analogs of Scorpion Venom IsCT Peptides	
DRAMP01377	FMPILSCSRFKRC	13	Odorranain-G1 (OdG1; Frogs, amphibians, animals)	A6MBL7, A6MBL8	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Odorranain-G1 adopts 44.1% β-sheet structure in water solution.		Function: Odorranain-G1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Has no hemolytic activity against red cell.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=4.68 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=9.37 μg/ml), Bacillus subtilis (MIC=37.5 μg/ml).##Yeast: Candida albicans (MIC=1.10 μg/ml).	[Ref:17272268] It has no hemolytic activity against rabbit red blood cells	Cyclic	Free	Cyclization (Cys7 and Cys13)	Disulfide bond between Cys7 and Cys13.	L	No cytotoxicity information found	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP02995	QERGSIVIQGTKEGKSRPSLDIDYKQRVYDKNGMTGDAYGGLNIRPGQPSRQHAGFEFGKEYKNGFIKGQSEVQRGPGGRLSPYFGINGGFRF	93	Hymenoptaecin (Insects, animals)	Q10416	Not found	Not found	Apis mellifera (Honeybee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli K514 (MIC=0.5-1 µM), E. coli K514 anaerobic, E. coli NCTC9001 (MIC=1-5 µM), Xanthomonas campestris (MIC=0.5-1 µM), Pseudomonas solanacearum (MIC>10 µM), Erwinia carotovora ssp.(MIC=1-5 µM);##Gram-positive bacteria: Micrococcus lysodeikticus (MIC=1-5 µM), Bacillus megaterium (MIC=0.5-1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8463238	J Biol Chem. 1993 Apr 5;268(10):7044-7054.	Casteels P, Ampe C, Jacobs F, Tempst P.	Functional and chemical characterization of Hymenoptaecin, an antibacterial polypeptide that is infection-inducible in the honeybee (Apis mellifera).	
DRAMP02996	GNNRPIYIPQPRPPHPRL	18	Apidaecin-2 (Apidaecin II; Insects, animals)	Q06601, P11525, P11526, P11527	Belongs to the apidaecin family	APID14	Apis mellifera (Honeybee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Agrobacterium tumefaciens (MIC=0.2 µg/ml), Erwinia salicis (MIC=0.02 µg/ml), Escherichia coli (MIC=0.2 µg/ml), Pseudomonas syringae (MIC=0.1 µg/ml), Rhizobium meliloti (MIC=0.02 µg/ml), Salmonella Newport (MIC=0.2 µg/ml), Salmonella typhimurium (MIC=0.1 µg/ml);##Gram-positive bacteria: Shigella flexneri (MIC=0.1 µg/ml), Corynebacterium insidiosum (MIC=100 µg/ml), Bacillus megaterium (MIC=100 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2676519	EMBO J. 1989 Aug;8(8):2387-2391.	Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P.	Apidaecins: antibacterial peptides from honeybees.	
DRAMP02441	VXLFPVXLFP	10	Gramicidin S	No entry found	Not found	Not found	Bacillus brevis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Beta sheet and beta-turn	The peptide have the C2-symmetrical sequence [cyclo-(Val-Orn-Leu-D-Phe-Pro)2]. The two sequences Val-Orn-Leu form an antiparallel 		Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity.	[Ref.29499484] Gram-positive bacterium:Staphylococcus aureus subsp.aureus CIP 4.83 ATCC 6538 (MIC=3.125μg/mL),Bacillus subtilis subsp. subtilis CIP 52.65 (MIC=3.125μg/ml),Enterococcus faecalis CIP 103015 (MIC=3.125μg/ml),Enterococcus faecalis CIP 103214 (MIC=3.125μg/ml),Bacillus cereus CIP 66.24 (MIC=6.25μg/ml),Streptococcus salivarius CIP 102503 (MIC=3.125μg/ml),Enterococcus faecium CIP 103014 (MIC=3.125μg/ml);##Gram-negative bacterium:Escherichia coli CIP 53.126 ATCC 8739 (MIC=12.5μg/ml),Pseudomonas aeruginosa CIP 82.118 ATCC 9027 (MIC>=100μg/ml)	[Ref.29499484] It has 74% hemolysis at 50μg/ml, 83% hemolysis at 100μg/ml against human red blood cells.	Cyclic	No specific N-terminal	No specific C-terminal	The 'O' in sequence is Ornithine	Mixed(D-Phe)	No cytotoxicity information found	Not found	29499484	Eur J Med Chem. 2018 Apr 10;149:122-128.	Wan Y, Stanovych A, Gori D, Zirah S, Kouklovsky C, Alezra V.	β,γ-diamino acids as building blocks for new analogues of Gramicidin S: Synthesis and biological activity	
DRAMP02998	GNNRPVYIPQPRPPHPRI	18	Apidaecin-1A (Apidaecin IA; Insects, animals)	Q06602, P11525, P11526	Belongs to the apidaecin family	APID73	Apis mellifera (Honeybee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Agrobacterium tumefaciens (MIC=0.2 µg/ml), Erwinia salicis (MIC=0.02 µg/ml), Escherichia coli (MIC=0.1 µg/ml), Pseudomonas syringae (MIC=0.2 µg/ml), Rhizobium meliloti (MIC=0.1 µg/ml), Salmonella Newport (MIC=0.2 µg/ml), Salmonella typhimurium (MIC=0.1 µg/ml), Shigella flexneri (MIC=0.1 µg/ml);##Gram-positive bacteria: Corynebacterium insidiosum (MIC=50 µg/ml), Bacillus megaterium (MIC=150 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2676519	EMBO J. 1989 Aug;8(8):2387-2391.	Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P.	Apidaecins: antibacterial peptides from honeybees.	
DRAMP02999	PFKISIHL	8	Jellein-1 (Jelleine-I; chain of Major royal jelly protein 1; Insects, animals)	O18330, Q548D6	Belongs to the major royal jelly protein family	MRJP1	Apis mellifera (Honeybee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Jellein-1 has antibacterial and antifungal activity.
Tissue specificity: Found in the hypopharyngeal glands of the worker honeybee.
Developmental stage: Produced in the cephalic glands of both the nurse bee and the forager bee. This bee milk protein changes to alpha-glucosidase in accordance with the age-dependent role change of the worker bee.
Miscellaneous: Exhibits a growth factor-like action on primary-cultured rat hepatocytes by stimulating DNA synthesis and protecting cells from apoptosis induced by serum deprivation. Also activates mitogen-activated protein kinase, as well as protein kinase B, a key regulator of cell survival. Degraded proportionally to the period of storage, and is completely lost during storage at 40 degrees Celsius for 30 days. PTM: Histidine amide at H7."	Gram-positive bacteria: Staphylococcus aureus ATCC 6535 (MIC=10 µg/ml), S. saprophyticus (MIC=15 µg/ml), Bacillus subtilis CCT 2471 (MIC=10 µg/ml).##Gram-negative bacteria: Escherichia coli CCT 1371 (MIC=2.5 µg/ml), Enterobacter cloacae ACCT 23355 (MIC=10 µg/ml), Klebsiella pneumoniae ACCT 13883 (MIC=10 µg/ml), Pseudomonas aeruginosa ACCT 27853 (MIC=10 µg/ml).##Yeast: Candida albicans (MIC=2.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15203237##9395329##21516106	Peptides. 2004 Jun;25(6):919-928.##Eur J Biochem. 1997 Nov 1;249(3):797-802.##Nature. 2011 May 26;473(7348):478-483.	Fontana R, Mendes MA, de Souza BM, Konno K, César LM, Malaspina O, Palma MS.##Ohashi K, Natori S, Kubo T.##Kamakura M.	Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera).##Change in the mode of gene expression of the hypopharyngeal gland cells with an age-dependent role change of the worker honeybee Apis mellifera L.##Royalactin induces queen differentiation in honeybees.	
DRAMP03000	TPFKISIHL	9	Jellein-2 (Jelleine-II; chain of Major royal jelly protein 1; Insects, animals)	O18330, Q548D6	Belongs to the major royal jelly protein family	MRJP1	Apis mellifera (Honeybee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Jellein-2 has antibacterial and antifungal activity. Jellein-2 is probably processed to yield jellein-1 and jellein-4.
Tissue specificity: Found in the hypopharyngeal glands of the worker honeybee.
Developmental stage: Produced in the cephalic glands of both the nurse bee and the forager bee. This bee milk protein changes to alpha-glucosidase in accordance with the age-dependent role change of the worker bee.
Miscellaneous: Exhibits a growth factor-like action on primary-cultured rat hepatocytes by stimulating DNA synthesis and protecting cells from apoptosis induced by serum deprivation. Also activates mitogen-activated protein kinase, as well as protein kinase B, a key regulator of cell survival. Degraded proportionally to the period of storage, and is completely lost during storage at 40 degrees Celsius for 30 days. PTM: Leucine amide at L9."	Gram-positive bacteria: Staphylococcus aureus ATCC 6535 (MIC=15 µg/ml), S. saprophyticus (MIC=10 µg/ml), Bacillus subtilis CCT 2471 (MIC=30 µg/ml);##Gram-negative bacteria: Escherichia coli CCT 1371 (MIC=15 µg/ml), Enterobacter cloacae ACCT 23355 (MIC=15 µg/ml), Klebsiella pneumoniae ACCT 13883 (MIC=15 µg/ml), Pseudomonas aeruginosa ACCT 27853 (MIC=15 µg/ml).##Yeast: Candida albicans (MIC=2.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15203237##9395329##21516106	Peptides. 2004 Jun;25(6):919-928.##Eur J Biochem. 1997 Nov 1;249(3):797-802.##Nature. 2011 May 26;473(7348):478-483.	Fontana R, Mendes MA, de Souza BM, Konno K, César LM, Malaspina O, Palma MS.##Ohashi K, Natori S, Kubo T.##Kamakura M.	Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera).##Change in the mode of gene expression of the hypopharyngeal gland cells with an age-dependent role change of the worker honeybee Apis mellifera L.##Royalactin induces queen differentiation in honeybees.	
DRAMP03001	EPFKISIHL	9	Jellein-3 (Jelleine-III; Insects, animals)	P84759	Not found	MRJP1	Apis mellifera (Honeybee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Jellein-3 has antibacterial and antifungal activity.
Tissue specificity: Found in the hypopharyngeal glands of the worker honeybee.
PTM: Leucine amide at L9."	Gram-positive bacteria: Staphylococcus aureus ATCC 6535 (MIC=30 µg/ml), S. saprophyticus (MIC=30 µg/ml);##Gram-negative bacteria: Escherichia coli CCT1371 (MIC=15 µg/ml), Enterobacter cloacae ATCC 23355, Klebsiella pneumoniae ATCC 13883, Pseudomonas aeruginosa ATCC 27853 (MIC=30 µg/ml).##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15203237	Peptides. 2004 Jun;25(6):919-928.	ntana R, Mendes MA, de Souza BM, Konno K, César LM, Malaspina O, Palma MS.	Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera).	
DRAMP03057	GSKKPVPIIYCNRRTGKCQRM	21	Thanatin(insects, arthropods, invertebrates, animals)	P55788 	Not found	Not found	Podisus maculiventris	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Beta strand	Contain C-terminally a loop of 6 residues, delineated by an intramolecular disulfide bridge. This loop carries a strong positive charge in both molecules and contains a central threonine residue, which separates two subgroups of electropositivity.	8TFV	Function: Insect defense peptide with a broad spectrum of activity against Gram-positive and Gram-negative bacteria and fungi. No activity against S.aureus. Stops respiration in bacteria but does not permeabilize their inner membranes. Has no detectable hemolytic activity. 	[Ref.8577744] Gram-positive bacteria: Aerococcus viridans (MIC=0.6-1.2 µM), Micrococcus luteus (MIC=1.2-2.5 µM), Bacillus megaterium (MIC=2.5-5 µM), Bacillus subtilis (MIC=2.5-5 µM), Pediococcus acidilactici (MIC=20-40 µM);##Gram-negative bacteria: Escherichia coli D22 (MIC=0.3-0.6 µM), Escherichia coli D31 (MIC=0.3-0.6 µM), Escherichia coli 1106 (MIC=0.6-1.2 µM), Salmonella typhimurium (MIC=0.6-1.2 µM), Klebsiella pneumoniae (MIC=0.6-1.2 µM), Enterobacter cloacae (MIC=1.2-2.5 µM), Erwinia carotovora (MIC=10-20 µM), Pseudomonas aeruginosa (MIC=20-40 µM);##Fungi: Neurospora crassa (MIC=0.6-1.2 µM), Botrytis cinerea (MIC=1.2-2.5 µM), Nectria haematococca (MIC=1.2-2.5 µM), Trichoderma viride (MIC=1.2-2.5 µM), Alternaria brassicicola (MIC=2.5-5 µM), Fusarium culmorum (MIC=2.5-5 µM), Ascochyta pisi (MIC=5-10µM), Fusarium oxysporum (MIC=10-20 µM).	[Ref.8577744] It exhibits no hemolytic activity at 40 µM against porcine erythrocytes.	Cyclic	Free	Free	Disulfide bond between Cys11 and Cys18.	L	No cytotoxicity information found	Not found	8577744##9760181	Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.##Eur J Biochem. 1998 Sep 1;256(2):404-410.	Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.##Mandard N, Sodano P, Labbe H, Bonmatin JM, Bulet P, Hetru C, Ptak M, Vovelle F.	Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.##Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CN)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03003	GFLSILKKVLPKVMAHMK	18	Melectin (MEP; Insects, animals)	P86170	Not found	Not found	Melecta albifrons (Cuckoo bee) (Melecta punctata)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antimicrobial activity against Gram-positive bacteria as well as Gram-negative bacteria. Stimulates degranulation from rat peritoneal mast cells with an EC50 of 19.4 µM. Has weak hemolytic activity towards rat erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation."	[Ref.18942691]Gram-positive bacteria: Bacillus subtilis (MIC=0.8 µM), Staphylococcus aureus (MIC=6.8 µM);##Gram-negative bacteria: Escherichia coli (MIC=2.0 µM), Pseudomonas aeruginosa (MIC=18.5 µM).	[Ref.18942691]LC50>100 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18942691	Chembiochem. 2008 Nov 24;9(17):2815-2821.	Cerovský V, Hovorka O, Cvacka J, Voburka Z, Bednárová L, Borovicková L, Slaninová J, Fucík V.	Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons.	
DRAMP03007	GFLSALKKYLPIVLKHV	17	Osmin (Insects, animals)	P0CD70	Not found	Not found	Osmia rufa (Red mason bee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix (CD)	In absence of TFE, the spectrum shows a random coil type structure. When increasing the concentration of TFE from 0 to 20%, a transition into an α-helix structure is observed.		"Function: Synthetic peptide exhibits hemolytic activity to human erythrocytes and inhibits bacterial and fungal growth at micromolar concentrations. A synthetic peptide with a free C-terminus shows weaker hemolytic (5.0 HU/mg), antibacterial and antifungal activities.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation."	[Ref.19109988]Gram-positive bacterium: Micrococcus luteus (MIC=1.56-0.78 µM);##Gram-negative bacterium: Escherichia coli SBS363 (MIC=3.125-1.56 µM);##fungi: Fusarium oxysporum (MIC=0.78-0.39 µM).	[Ref.19109988]5.0 HU/mg hemolytic activity against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19109988	Toxicon. 2010 Jan;55(1):20-27.	öcklin R, Favreau P, Thai R, Pflugfelder J, Bulet P, Mebs D.	Structural identification by mass spectrometry of a novel antimicrobial peptide from the venom of the solitary bee Osmia rufa (hymenoptera: megachilidae).	
DRAMP03019	INWLKLGKKILGAL	14	Mastoparan PDD-B	No entry found	Belongs to the mastoparan family	Not found	Polistes dorsalis dorsolis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial activity. PDD-B has hemolytic activity.	[Ref.18375018]Gram-positive bacterium: Bacillus subtilis (MIC=70 µM);##Gram-negative bacterium: Escherichia coli (MIC=15.5 µM).	[Ref.18375018]IC50=45 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP03020	INWKKIFEKVKNLV	14	Mastoparan PDD-A	No entry found	Belongs to the mastoparan family	Not found	Polistes dorsalis dorsolis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial activity. PDD-A shows little hemolytic activity.	[Ref.18375018]Gram-positive bacterium: Bacillus subtilis (MIC=11.8 µM);##Gram-negative bacterium: Escherichia coli (MIC=7.5 µM).	[Ref.18375018]IC50>100 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP03021	INWKKIASIGKEVLKAL	17	Mastoparan PMM	No entry found	Belongs to the mastoparan family	Not found	Polistes major major	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial activity. Shows hemolytic activity.	[Ref.18375018]Gram-positive bacterium: Bacillus subtilis (MIC=7.3 µM);##Gram-negative bacterium: Escherichia coli (MIC=25.8 µM).	[Ref.18375018]IC50=80 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP03022	INWLKLGKKMMSAL	14	Mastoparan MP	No entry found	Belongs to the mastoparan family	Not found	Mischocyttarus phthisicus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Has antibacterial activity. Has hemolytic activity.	[Ref.18375018]Gram-positive bacterium: Bacillus subtilis (MIC=9 µM);##Gram-negative bacterium: Escherichia coli (MIC=65 µM).	[Ref.18375018]IC50=100 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP01739	LLPIVGNLLKSLL	13	Temporin-B (Frogs, amphibians, animals)	P79874 	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found	6GIL resolved by NMR.	"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has hemolytic activity.
PTM: Leucine amide at position 13.
Tissue specificity: Expressed by the skin glands."	[Ref.9022710] Gram-positive bacteria: Bacillus megaterium BM11 (LC=2.8 µM), Staphylococcus aureus Cowanl (LC=6.0 µM), Streptococcus pyogenes betahemolytic group A (LC=7.0 µM);##Gram-negative bacteria: Escherichia coli D21(LC=21.0 µM), Escherichia coli D21e7 (LC=13.2 µM), Escherichia coli D21f1 (LC=10.0 µM), Escherichia coli D21f2 (LC=3.3 µM), Escherichia coli D22 (LC=11.2 µM),Yersinia pseudotuberculosis (LC=7.0 µM), Pseudomonas aeruginosa ATCC15692 (LC>360 µM);##Yeast: Candida albicans (LC=4.0 µM).(LC: Lethal concentration).##[Ref.28443279] Gram-positive bacterium: S.aureus ATCC 33591 (MIC=12μM), Staphylococcus epidermidis (MIC=6μM);##Gram-negative bacterium: Klebsiella pneumoniae ATCC BAA-1706 (MIC=48μM), Pseudomonas aeruginosa ATCC 27853 (MIC=48μM)	[Ref.9022710] LC>120 µM against Human red blood cells. (LC: Lethal concentration)##[Ref.28443279] 1% hemolysis at 96μM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9022710##28443279	Eur J Biochem. 1996 Dec 15;242(3):788-792.##Front Chem. 2017 Apr 11;5:24.	Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.##Grassi L, Maisetta G, Maccari G, Esin S, Batoni G.	Temporins, antimicrobial peptides from the European red frog Rana temporaria.##Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide	
DRAMP03033	INWKGIAAMAKKLL	14	Mastoparan-like peptide 12a (Insects, animals)	P0C1M4	Not found	Not found	Vespa magnifica (Hornet)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Mast cell degranulating peptide. Has little hemolytic activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14). "	[Ref.17046111]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=7.5 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.7 µg/ml);##Fungi: Candida albicans ATCC 2002 (MIC=3.7 µg/ml).	[Ref.16330062]Little hemolytic activity at 50 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16330062##17046111	Toxicon. 2006 Feb;47(2):249-253.##Peptides. 2006 Dec;27(12):3053-3057.	Xu X, Li J, Lu Q, Yang H, Zhang Y, Lai R.##Xu X, Yang H, Yu H, Li J, Lai R.	Two families of antimicrobial peptides from wasp (Vespa magnifica) venom.##The mastoparanogen from wasp.	
DRAMP03034	INWKGIAAMKKLL	13	Mastoparan-like peptide 12b (Insects, animals)	P0C1M5	Not found	Not found	Vespa magnifica (Hornet)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Mast cell degranulating peptide. Has little hemolytic activity. Shows antimicrobial activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L13)."	[Ref.16330062]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.7 µg/ml);##Fungi: Candida albicans ATCC 2002 (MIC=7.5 µg/ml).	[Ref.16330062]Little hemolytic activity at 50 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16330062	Toxicon. 2006 Feb;47(2):249-53. Epub 2005 Dec 5. Peptides. 2006 Dec;27(12):3053-7. Epub 2006 Oct 13.	Xu X, Li J, Lu Q, Yang H, Zhang Y, Lai R.Xu X, Yang H, Yu H, Li J, Lai R.	Two families of antimicrobial peptides from wasp (Vespa magnifica) venomThe mastoparanogen from wasp.	
DRAMP03035	INLKAIAALAKKLLG	15	Mastoparan-like peptide 12c (Insects, animals)	A0SPI0	Not found	Not found	Vespa magnifica (Hornet)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Shows mast cell degranulation and antimicrobial activities.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14). "	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.0 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.0 µg/ml).##Fungi: Candida albicans ATCC 2002 (MIC=12.0 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17046111	Peptides. 2006 Dec;27(12):3053-3057.	Xu X, Yang H, Yu H, Li J, Lai R.	The mastoparanogen from wasp.	
DRAMP03036	INLKAIAAMAKKLL	14	Mastoparan-like peptide 12d (Insects, animals)	P0C5G7	Not found	Not found	Vespa magnifica (Hornet)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Shows mast cell degranulation and antimicrobial activities.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14). "	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.0 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=1.5 µg/ml).##Fungi: Candida albicans ATCC 2002 (MIC=12.0 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17046111	Peptides. 2006 Dec;27(12):3053-3057.	Xu X, Yang H, Yu H, Li J, Lai R.	The mastoparanogen from wasp.	
DRAMP03037	LNLKGIFKKVASLLT	15	Eumenitin (Er-12; Insects, animals)	P0C931	Not found	Not found	Eumenes rubronotatus (Solitary wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Cationic linear alpha-helical antimicrobial peptide that binds preferentially to charged lipid membranes as compared with zwitterionic ones. It exhibits inhibitory activity against both Gram-positive and Gram-negative bacteria, and moderately stimulates degranulation from the rat peritoneal mast cells. Does not show hemolytic activity. May play a role in preventing infection by microorganisms during prey consumption by their larvae.
Tissue specificity: Expressed by the venom gland."	[Ref.16762455]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC>60 µM), Staphylococcus aureus ATCC 25923 (MIC=6 µM), Staphylococcus saprophytius (CS) (MIC=6 µM), Staphylococcus epidermius (CS) (MIC>60 µM), Bacillus subtilis CCT 2471 (MIC=60 µM), Bacillus thuringiensis (WT) (MIC>60 µM);##Gram-negative bacteria: Escherichia coli CCT 1371 (MIC=6 µM), Escherichia coli ATCC 25922 (MIC=6 µM), Escherichia cloacae ATCC 23355 (MIC>60 µM), Proteus mirabilis (CS) (MIC>60 µM), Pseudomonas aeruginosa ATCC 15442 (MIC=30 µM).	[Ref.16762455]Non-hemolytic activity against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen	16762455##18206199	Peptides. 2006 Nov;27(11):2624-2631.##Toxicon. 2008 Apr;51(5):736-745.	Konno K, Hisada M, Naoki H, Itagaki Y, Fontana R, Rangel M, Oliveira JS, Cabrera MP, Neto JR, Hide I, Nakata Y, Yasuhara T, Nakajima T.##Arcisio-Miranda M, dos Santos Cabrera MP, Konno K, Rangel M, Procopio J.	Eumenitin, a novel antimicrobial peptide from the venom of the solitary eumenine wasp Eumenes rubronotatus.##Effects of the cationic antimicrobial peptide eumenitin from the venom of solitary wasp Eumenes rubronotatus in planar lipid bilayers: surface charge and pore formation activity.	
DRAMP03038	LNLKGLIKKVASLLN	15	Eumenitin-R (Insects, animals)	P0CJ36	Not found	Not found	Eumenes rubrofemoratus (Solitary wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Linear cationic alpha-helical peptide that acts as antimicrobial peptide by forming pore in membrane. Has antibacterial activities against both Gram-positive and Gram-negative strains. Has more potent activities against the yeast C.albicans. Shows moderate mast cell degranulation and leishmanicidal activities. Has a very low hemolytic activity against mice erythrocytes.
Tissue specificity: Expressed by the venom sac."	[Ref.21549739]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=60 µM), Staphylococcus epidermidis (clinical sample) (MIC=30 µM), Micrococcus luteus ATCC 10240 (MIC=15 µM), Streptococcus pyogenes (clinical sample) (MIC=15 µM), Bacillus subtilis ATCC 6633 (MIC=7.5 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 µM), Proteus mirabilis (clinical sample) (MIC=60 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=30 µM), Stenotrophomonas maltophilia ATCC 13637 (MIC=15 µM);##Fungi: Candida albicans ATCC 90112 (MIC<7.5 µM).	[Ref.21549739]EC50=530.3 μM against mice erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen	21549739	Toxicon. 2011 Jun;57(7-8):1081-1092.	Rangel M, Cabrera MP, Kazuma K, Ando K, Wang X, Kato M, Nihei K, Hirata IY, Cross TJ, Garcia AN, Faquim-Mauro EL, Franzolin MR, Fuchino H, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.	Chemical and biological characterization of four new linear cationic Î±-helical peptides from the venoms of two solitary eumenine wasps.	
DRAMP03039	LNLKGLFKKVASLLT	15	Eumenitin-F (Insects, animals)	P0CJ37	Not found	Not found	Eumenes fraterculus (Solitary wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Linear cationic alpha-helical peptide that acts as antimicrobial peptide by forming pore in membrane. Has antibacterial activities against both Gram-positive and Gram-negative strains. Has more potent activities against the yeast C.albicans. Shows moderate mast cell degranulation and leishmanicidal activities. Has a very low hemolytic activity against mice erythrocytes.
Tissue specificity: Expressed by the venom sac."	[Ref.21549739]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>60 µM), Staphylococcus epidermidis (clinical sample) (MIC=30 µM), Micrococcus luteus ATCC 10240 (MIC=30 µM), Streptococcus pyogenes (clinical sample) (MIC=30 µM), Bacillus subtilis ATCC 6633 (MIC=30 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 µM), Proteus mirabilis (clinical sample) (MIC>60 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=30 µM), Stenotrophomonas maltophilia ATCC 13637 (MIC=15 µM);##Fungi: Candida albicans ATCC 90112 (MIC=7.5 µM).	[Ref.21549739]EC50=353.4 μM against mice erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen	21549739	Toxicon. 2011 Jun;57(7-8):1081-1092.	Rangel M, Cabrera MP, Kazuma K, Ando K, Wang X, Kato M, Nihei K, Hirata IY, Cross TJ, Garcia AN, Faquim-Mauro EL, Franzolin MR, Fuchino H, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.	Chemical and biological characterization of four new linear cationic Î±-helical peptides from the venoms of two solitary eumenine wasps.	
DRAMP03040	FDVMGIIKKIAGAL	14	Eumenine mastoparan-EF (EMP-EF; Insects, animals)	P0CJ39	Not found	Not found	Eumenes fraterculus (Solitary wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Linear cationic alpha-helical peptide that acts as antimicrobial peptide by forming pore in membrane. Has antibacterial activities against both Gram-positive and Gram-negative strains. Has more potent activities against the yeast C.albicans. Shows moderate mast cell degranulation and leishmanicidal activities. Has a very low hemolytic activity against mice erythrocytes.
Tissue specificity: Expressed by the venom sac.
PTM: C-terminal amidation (Leucine amide: L14)."	[Ref.21549739]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=30 µM), Staphylococcus epidermidis (clinical sample) (MIC=30 µM), Micrococcus luteus ATCC 10240 (MIC=30 µM), Streptococcus pyogenes (clinical sample) (MIC>30 µM), Bacillus subtilis ATCC 6633 (MIC=30 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 µM), Proteus mirabilis (clinical sample) (MIC=60 µM), Pseudomonas aeruginosa ATCC 27853 (MIC>30 µM), Stenotrophomonas maltophilia ATCC 13637 (MIC>30 µM);##Fungi: Candida albicans ATCC 90112 (MIC=7.5 µM).	[Ref.21549739]EC50=181.1 μM against mice erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen	21549739	Toxicon. 2011 Jun;57(7-8):1081-1092.	Rangel M, Cabrera MP, Kazuma K, Ando K, Wang X, Kato M, Nihei K, Hirata IY, Cross TJ, Garcia AN, Faquim-Mauro EL, Franzolin MR, Fuchino H, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.	Chemical and biological characterization of four new linear cationic Î±-helical peptides from the venoms of two solitary eumenine wasps.	
DRAMP03041	FDIMGLIKKVAGAL	14	Eumenine mastoparan-ER (EMP-ER; Insects, animals)	P0CJ38	Not found	Not found	Eumenes rubrofemoratus (Solitary wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Linear cationic alpha-helical peptide that acts as antimicrobial peptide by forming pore in membrane. Has antibacterial activities against both Gram-positive and Gram-negative strains. Has more potent activities against the yeast C.albicans. Shows moderate mast cell degranulation and leishmanicidal activities. Has a very low hemolytic activity against mice erythrocytes.
Tissue specificity: Expressed by the venom sac.
PTM: C-terminal amidation (Leucine amide: L14)."	[Ref.21549739]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=30 µM), Staphylococcus epidermidis (clinical sample) (MIC=30 µM), Micrococcus luteus ATCC 10240 (MIC>30 µM), Streptococcus pyogenes (clinical sample) (MIC>30 µM), Bacillus subtilis ATCC 6633 (MIC=30 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 µM), Proteus mirabilis (clinical sample) (MIC=60 µM), Pseudomonas aeruginosa ATCC 27853 (MIC>30 µM), Stenotrophomonas maltophilia ATCC 13637 (MIC>30 µM);##Fungi: Candida albicans ATCC 90112 (MIC=7.5 µM).	[Ref.21549739]EC50=200 μM against mice erythrocytes	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen	21549739	Toxicon. 2011 Jun;57(7-8):1081-1092.	Rangel M, Cabrera MP, Kazuma K, Ando K, Wang X, Kato M, Nihei K, Hirata IY, Cross TJ, Garcia AN, Faquim-Mauro EL, Franzolin MR, Fuchino H, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.	Chemical and biological characterization of four new linear cationic Î±-helical peptides from the venoms of two solitary eumenine wasps.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)[C@H](C)CC
DRAMP03042	INLLKIAKGIIKSL	14	Eumenine mastoparan-AF (EMP-AF; Af-113; Insects, animals)	P0C022	Not found	Not found	Anterhynchium flavomarginatum micado (Solitary wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix 	Not found		"Function: Mast cell degranulating peptide. Also permeates anionic liposomes. Has hemolytic activity. Has an amphiphilic alpha-helix conformation. Shows broad-spectrum antimicrobial activity. Blocks the lobster neuromuscular transmission. Induces the depolarization of the muscle membrane.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14)."	[Ref.15317499]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC=5 µg/ml), S. saprophyticus CS (MIC=5 µg/ml), S. epidermidis CS (MIC=5 µg/ml), Bacillus subtilis CCT 2471 (MIC=40 µg/ml);##Gram-negative bacteria: Escherichia coli CCT 1371 (MIC=20 µg/ml), Escherichia coli ATCC 25922 (MIC=50 µg/ml), Pseudomonas aeruginosa ATCC 15442 (MIC=20 µg/ml).	[Ref.10775751]100% hemolytic activity against human erythrocytes at 10^-4 M	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen	15317499##11006592##10775751	J Pept Res. 2004 Sep;64(3):95-103.##Rapid Commun Mass Spectrom. 2000;14(19):1828-1834.##Toxicon. 2000 Nov;38(11):1505-1015.	dos Santos Cabrera M.P, de Souza B.M, Fontana R, Konno K, Palma M.S, de Azevedo W.F. Jr, Neto J.R.##Hisada M, Konno K, Itagaki Y, Naoki H, Nakajima T.##Konno K, Hisada M, Naoki H, Itagaki Y, Kawai N, Miwa A, Yasuhara T, Morimoto Y, Nakata Y.	Conformation and lytic activity of eumenine mastoparan: a new antimicrobial peptide from wasp venom.##Advantages of using nested collision induced dissociation/post-source decay with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: sequencing of novel peptides from wasp venom.##Structure and biological activities of eumenine mastoparan-AF (EMP-AF), a new mast cell degranulating peptide in the venom of the solitary wasp (Anterhynchium flavomarginatum micado).	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP03043	INWLKLGKAIIDAL	14	Agelaia-mastoparan (Agelaia-MP; Insects, animals)	P69436	Not found	Not found	Agelaia pallipes pallipes (Neotropical social wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Hemolytic mast cell degranulator, presenting no antimicrobial action and no chemotaxis for polymorphonucleated leukocytes (PMNL).
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14)."	[Ref.15225564]Gram-negative bacteria: Escherichia coli (MIC=382 µg/ml), Pseudomonas aeruginosa (MIC=257 µg/ml);##Gram-positive bacteria: Bacillus subtilis (MIC=237 µg/ml), Staphylococcus aureus (MIC=191 µg/ml).	[Ref.15225564]70% hemolytic activity at 156 ng/ml against rat erythrocytes	Linear	Free	Amidation	Free	L	Not included yet	Not found	15225564##15052574	Toxicon. 2004 Jul;44(1):67-74.##Rapid Commun Mass Spectrom. 2004;18(6):636-642.	Mendes MA, de Souza BM, Marques MR, Palma MS.##Mendes MA, Monson de Souza B, Delazari dos Santos L, Palma MS.	Structural and biological characterization of two novel peptides from the venom of the neotropical social wasp Agelaia pallipes pallipes.##Structural characterization of novel chemotactic and mastoparan peptides from the venom of the social wasp Agelaiapallipes pallipes by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP03044	ILGTILGLLKGL	12	Protonectin (Agelaia-chemotactic peptide, Agelaia-CP; Insects, animals)	P69437	Not found	Not found	Agelaia pallipes pallipes (Neotropical social wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Mast cell degranulator that induces a potent chemotaxis in polymorphonucleated leukocyte (PMNL) cells. Shows potent antimicrobial action against both Gram-positive and Gram-negative bacteria. Shows no hemolytic activity.	[Ref.15225564]Gram-negative bacteria: Escherichia coli (MIC=25 µg/ml), Pseudomonas aeruginosa (MIC=1.7 µg/ml);##Gram-positive bacteria: Bacillus subtilis (MIC=3.1 µg/ml), Staphylococcus aureus (MIC=12.5 µg/ml).	[Ref.15052574]Non-hemolytic activity against rat red blood cell	Linear	Free	Amidation	Free	L	Not included yet	Not found	15225564##15052574	Toxicon. 2004 Jul;44(1):67-74.##Rapid Commun Mass Spectrom. 2004;18(6):636-642.	Mendes MA, de Souza BM, Marques MR, Palma MS.##Mendes MA, Monson de Souza B, Delazari dos Santos L, Palma MS.	Structural and biological characterization of two novel peptides from the venom of the neotropical social wasp Agelaia pallipes pallipes.##Structural characterization of novel chemotactic and mastoparan peptides from the venom of the social wasp Agelaiapallipes pallipes by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@@H](C)O
DRAMP03045	VTCELLMFGGVVGDSACAANCLSMGKAGGSCNGGLCDCRKTTFKELWDKRFG	52	Defensin-NV (Insects, animals)	No entry found	Not found	Not found	Nasonia vitripennis (Ectoparasitic wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Bridge	Not found		Function: Defensin-NV had little hemolytic activity to rabbit red blood cells and has antimicrobial activity against Gram-positive, Gram-negative bacteria, and Fungi.	[Ref.20362606]Gram-positive bacteria: Staphylococcus aureus (MIC=0.93 µM), Bacillus cereus (MIC=0.93 µM), B. dysenteriae (MIC=0.46 µM);##Gram-negative bacteria: Escherichia coli (MIC=1.86 µM), Pseudomonas aeruginosa (MIC=9.3 µM).##Yeast: Candida albicans (MIC=1.86 µM).	[Ref.20362606]5% hemolytic activity at 200 μg/ml against rabbit red blood cells	Cyclic	Free	Free	There are three disulfide bonds(By similar).	Not included yet	Not included yet	Not found	20362606	Toxicon. 2010 Aug 1;56(1):101-106.	Ye J, Zhao H, Wang H, Bian J, Zheng R.	A defensin antimicrobial peptide from the venoms of Nasonia vitripennis.	
DRAMP03046	ILGIITSLLKSL	12	Orancis-protonectin (chain of Venom peptide 2-long; Venom peptide 2, OdVP2; Insects, animals)	P86147, C7DT08	Belongs to the MCD family (Protonectin subfamily)	VP2	Orancistrocerus drewseni (Solitary wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Function: Has potent hemolytic activity against ovine erythrocytes at micromolar concentrations. Also exhibits strong antimicrobial activity against fungi. Venom peptide 2-long has substantially lower antimicrobial activity against C. albicans and bacteria than Orancis-protonectin but has equivalent activity against Botrytis cinerea.	[Ref.19857508]Gram-positive bacteria: Staphylococcus aureus (MIC=25 μg/ml);##Fungi: Candida albicans (MIC<100 µg/ml), Botrytis cinerea (MIC=0.5 µg/ml).	[Ref.18695936]84% hemolytic activity at 50 μM against sheep blood cells.	Linear	Free	Amidation	Free	L	Not included yet	Not found	19857508##18695936	Toxicon. 2010 Apr 1;55(4):711-718.##Amino Acids. 2009 Jul;37(2):389-394.	Baek JH, Lee SH.##Murata K, Shinada T, Ohfune Y, Hisada M, Yasuda A, Naoki H, Nakajima T.	Isolation and molecular cloning of venom peptides from Orancistrocerus drewseni (Hymenoptera: Eumenidae).##Novel mastoparan and protonectin analogs isolated from a solitary wasp, Orancistrocerus drewseni drewseni.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC
DRAMP03047	EPILGIITSLLKSL	14	Venom peptide 2-long (OdVP2L; analog of OdVP2; Insects, animals)	P86147, C7DT08	Belongs to the MCD family (Protonectin subfamily)	VP2	Orancistrocerus drewseni (Solitary wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has potent hemolytic activity against ovine erythrocytes at micromolar concentrations.
Tissue specificity: Expressed by the venom gland."	[Swiss_Prot Entry P86147]Fungi: Botrytis cinerea (MIC=0.5 µg/ml), Candida albicans (MIC=100 µg/ml);##Gram-positive bacterium: S. aureus (MIC=25 µg/ml);##Gram-negative bacterium: Escherichia coli.	[Swiss_Prot Entry P86147]has potent hemolytic activity against ovine erythrocytes at micromolar concentrations	Linear	Free	Amidation	Free	L	Not included yet	Not found	19857508##18695936	Toxicon. 2010 Apr 1;55(4):711-718.##Amino Acids. 2009 Jul;37(2):389-394.	Baek JH, Lee SH.##Murata K, Shinada T, Ohfune Y, Hisada M, Yasuda A, Naoki H, Nakajima T.	Isolation and molecular cloning of venom peptides from Orancistrocerus drewseni (Hymenoptera: Eumenidae).##Novel mastoparan and protonectin analogs isolated from a solitary wasp, Orancistrocerus drewseni drewseni.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP03050	INWKKIAEVGGKILSSL	17	Dominulin-A (Insects, animals)	P0C1M6	Belongs to the MCD family (Mastoparan subfamily)	Not found	Polistes dominulus (European paper wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antimicrobial activity.	Gram-positive bacterium: Bacillus subtilis ATCC 6633 (MIC=2 µg/ml);##Gram-negative bacterium: Escherichia coli JM109 (MIC=8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16446098	J Am Soc Mass Spectrom. 2006 Mar;17(3):376-383.	Turillazzi S, Mastrobuoni G, Dani FR, Moneti G, Pieraccini G, la Marca G, Bartolucci G, Perito B, Lambardi D, Cavallini V, Dapporto L.	Dominulin A and B: two new antibacterial peptides identified on the cuticle and in the venom of the social paper wasp Polistes dominulus using MALDI-TOF, MALDI-TOF/TOF, and ESI-ion trap.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP03051	INWKKIAEIGKQVLSAL	17	Dominulin-B (Insects, animals)	P0C1M7	Belongs to the MCD family (Mastoparan subfamily)	Not found	Polistes dominulus (European paper wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antimicrobial activity.	Gram-positive bacterium: Bacillus subtilis ATCC 6633 (MIC=2 µg/ml);##Gram-negative bacterium: Escherichia coli JM109 (MIC=8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16446098	J Am Soc Mass Spectrom. 2006 Mar;17(3):376-383.	Turillazzi S, Mastrobuoni G, Dani FR, Moneti G, Pieraccini G, la Marca G, Bartolucci G, Perito B, Lambardi D, Cavallini V, Dapporto L.	Dominulin A and B: two new antibacterial peptides identified on the cuticle and in the venom of the social paper wasp Polistes dominulus using MALDI-TOF, MALDI-TOF/TOF, and ESI-ion trap.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP03052	GAARKSIRLHRLYTWKATIYTR	22	PP13 (Insects, animals)	No entry found	Not found	Not found	Pteromalus puparum (wasp)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Alpha helix (CD)	Not found		Function: These peptides have net positive charges and are active against both Gram-negative and -positive bacteria, but are not active against fungi tested.	Gram-positive bacteria: Staphylococcus aureus CVCC1882 (MIC=23.3 µM), Sarcina lutea CVCC1600 (MIC=8 µM), Bacillus pumilus CVCC709 (MIC=9 µM), Bacillus subtilis CVCC717 (MIC=13.3 µM).##Gram-positive bacterium: Escherichia coli CVCC1570 (MIC=16.7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Cell membrane	19950104	J Pept Sci. 2010 Jan;16(1):58-64.	Shen X, Ye G, Cheng X, Yu C, Yao H, Hu C.	Novel antimicrobial peptides identified from an endoparasitic wasp cDNA library.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O
DRAMP03053	GSCSCSGTISPYGLRTCRATKTKPSHPTTKETHPQTLPT	39	PP102 (Insects, animals)	No entry found	Not found	Not found	Pteromalus puparum (wasp)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: These peptides have net positive charges and are active against both Gram-negative and -positive bacteria, but are not active against fungi tested.	Gram-positive bacteria: Staphylococcus aureus CVCC1882 (MIC=13.3 µM), Sarcina lutea CVCC1600 (MIC=63.3 µM), Bacillus pumilus CVCC709 (MIC=23.3 µM), Bacillus subtilis CVCC717 (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Cell membrane	19950104	J Pept Sci. 2010 Jan;16(1):58-64.	Shen X, Ye G, Cheng X, Yu C, Yao H, Hu C.	Novel antimicrobial peptides identified from an endoparasitic wasp cDNA library.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP03054	GKWGWIYITILFADVGGFKSSRHPEERRVQERRFKRITRGPD	42	PP113 (Insects, animals)	No entry found	Not found	Not found	Pteromalus puparum (wasp)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: These peptides have net positive charges and are active against both Gram-negative and -positive bacteria, but are not active against fungi tested. Salt-dependency studies revealed that the biocidal activity of these peptides against E. coli decreased with increasing concentration of NaCl.	Gram-positive bacteria: Staphylococcus aureus CVCC1882 (MIC=13 µM), Sarcina lutea CVCC1600 (MIC=16.7 µM), Bacillus pumilus CVCC709 (MIC=23.3 µM), Bacillus subtilis CVCC717 (MIC=23.3 µM).##Gram-positive bacterium: Escherichia coli CVCC1570 (MIC=16.7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Cell membrane	19950104	J Pept Sci. 2010 Jan;16(1):58-64.	Shen X, Ye G, Cheng X, Yu C, Yao H, Hu C.	Novel antimicrobial peptides identified from an endoparasitic wasp cDNA library.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC
DRAMP03055	YVPPVQKPHPNGPKFPTFP	19	PP30 (Pro-rich; abaecin-like; Insects, animals)	No entry found	Not found	Not found	Pteromalus puparum (wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=23.3±2.1 µM);##Gram-positive bacteria: Bacillus subtilis (MIC=16.7±2.1 µM), Staphylococcus aureus (MIC=133.3±11.6 µM), Sarcina lutea (MIC=13.3±1.2 µM), Bacillus pumilu (MIC=13.3±2.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	20466006	J Invertebr Pathol. 2010 Sep;105(1):24-29.	Shen X, Ye G, Cheng X, Yu C, Altosaar I, Hu C.	Characterization of an abaecin-like antimicrobial peptide identified from a Pteromaluspuparum cDNA clone.	CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O
DRAMP03056	SLLSLIRKLIT	11	Decoralin (Insects, animals)	P85870	Not found	Not found	Oreumenes decoratus (Potter wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Linear cationic alpha-helical peptide that acts as antimicrobial peptide. At high concentrations exhibits activity in stimulating degranulation from rat peritoneal mast cells. Inhibits the growth of L.major promastigotes in vitro with an IC50 of 72 µM. Has hemolytic activity towards human and mouse erythrocytes.
Tissue specificity: Expressed by the venom gland."	[Ref.17981364]Gram-positive bacteria: Staphylococcus aureus CCT 6538 (MIC=40 µM), S. saprophyticus (MIC=40 µM), Bacillus subtilis CCT 2471 (MIC=40 µM), B. thuringiensis (MIC=40 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=80 µM), Escherichia coli CCT 1371 (MIC=160 µM), Klebsiella pneumoniae ATCC 13883 (MIC=80 µM), A. faecalis ATCC 8750 (MIC=40 µM);##Fungi: Candida albicans (MIC=40 µM), L. major promastigotes (IC50=72 µM).	[Ref.17981364]EC50=1 mM against mouse erythrocytes	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane	17981364	Peptides. 2007 Dec;28(12):2320-2327.	Konno K, Rangel M, Oliveira JS, Dos Santos Cabrera MP, Fontana R, Hirata IY, Hide I, Nakata Y, Mori K, Kawano M, Fuchino H, Sekita S, Neto JR.	Decoralin, a novel linear cationic alpha-helical peptide from the venom of the solitary eumenine wasp Oreumenes decoratus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP18493	FIHHIIGGLISVGKHIHGLIHGH	23	TP3	L0CMD2	Piscidin	TP3	Oreochromis niloticus (Nile tilapia) (Tilapia nilotica)	Antibacterial, wound healing, immunomodulatory, Anti-Gram+, Antimicrobial	Protein level	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive bacteria. Antifungal activity. Has hemolytic activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=256 μg/ml; MBC=256 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=256 μg/ml; MBC>256 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 2% hemolysis at 3.13 μg/ml, 5% hemolysis at 6.25 μg/ml, 10% hemolysis at 12.50 μg/ml, 55% hemolysis at 25.00 μg/ml, 85% hemolysis at 50.00 μg/ml, 100% hemolysis at 100.00 μg/ml against mouse red blood cell	Linear	Free	Free	Free	L	Not included yet	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP03819	RRWWRF	6	Cyclic hexapeptide CYC-(RRWWRF)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Anti-Gram+, Anti-Gram-	Synthetic	Non helix or strand structure (Turn)	Not found	1QVK,1QVL	Function: Antibacterial activity against Escherichia coli and Bacillus subtilis.  Has hemolytic activity.	[Ref.16075425] Gram-negative bacterium: Escherichia coli(MIC=6.3 μM);##Gram-positive bacterium: Bacillus subtilis(MIC=3.1 μM)	[Ref.16075425] It has 24% hemolysis at 100 μM against erythrocytes.	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Not found	16075425##7883644	Chembiochem. 2005 Sep;6(9):1654-1662.##J Appl Bacteriol. 1995 Jan;78(1):39-46.	Appelt C, Wessolowski A, S?derh??ll JA, Dathe M, Schmieder P.##Blondelle SE, Takahashi E, Dinh KT, Houghten RA.	Structure of the antimicrobial, cationic hexapeptide cyclo(RRWWRF) and its analogues in solution and bound to detergent micelles.##The antimicrobial activity of hexapeptides derived from synthetic combinatorial libraries.	
DRAMP03820	RRYYRF	6	Cyclic hexapeptide RRYYRF	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Anti-Gram+, Anti-Gram-	Synthetic	Non helix or strand structure (Turn)	Not found	1SKI	Function: Antibacterial activity against Escherichia coli and Bacillus subtilis. Has hemolytic activity.	[Ref.16075425] Gram-negative bacterium: Escherichia coli(MIC>100 μM);##Gram-positive bacterium: Bacillus subtilis(MIC>100 μM)	[Ref.16075425] It has 1% hemolysis at 100 μM against erythrocytes.	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Not found	16075425	Chembiochem. 2005 Sep;6(9):1654-1662.	Appelt C, Wessolowski A, S?derh??ll JA, Dathe M, Schmieder P.	Structure of the antimicrobial, cationic hexapeptide cyclo(RRWWRF) and its analogues in solution and bound to detergent micelles.	
DRAMP03821	KKWWKF	6	Cyclic hexapeptide KKWWKF	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Anti-Gram+, Anti-Gram-	Synthetic	Non helix or strand structure (Turn)	Not found	1SKK	Function: Antibacterial activity against Escherichia coli and Bacillus subtilis. Has hemolytic activity.	[Ref.16075425] Gram-negative bacterium: Escherichia coli(MIC=25 μM);##Gram-positive bacterium: Bacillus subtilis(MIC=25 μM)	[Ref.16075425] It has 10% hemolysis at 100 μM against erythrocytes.	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Not found	16075425	Chembiochem. 2005 Sep;6(9):1654-1662.	Appelt C, Wessolowski A, S?derh??ll JA, Dathe M, Schmieder P.	Structure of the antimicrobial, cationic hexapeptide cyclo(RRWWRF) and its analogues in solution and bound to detergent micelles.	
DRAMP03063	DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCET	44	Defensin ARD1 (Heliomicin analogs; Insects, animals)	P84156	Not found	Not found	Archaeoprepona demophon (One-spotted leafwing butterfly)	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	Not found	1OZZ, 1P00, 1P0A resolved by NMR.	"Function: Possesses potent anti-fungal activity.
PTM: Contains three disulfide bonds 7-32; 18-40; 22-42. "	Fungi: Candida albicans IHEM 8060 (MIC=6.25 µg/ml), Cryptococcus neoformans A (MIC=12.5 µg/ml), Aspergillus fumigatus GASP4707 (MIC=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic(CSαβ scaffold (an α-helix linked to a β-she	Free	Free	Disulfide bonds between Cys7 and Cys32; Cys18 and Cys40; Cys22 and Cys42.	L	No cytotoxicity information found	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](C(C)C)NC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC2=O
DRAMP03069	DLHIPPPDNKINWPQLSGGGGGSPKTGYDININAQQK	37	Diptericin (Insects, animals)	Q9TWW2	Belongs to the attacin/sarcotoxin-2 family	Not found	Sarcophaga peregrina (Flesh fly)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		By injury to the body wall of the larva. Expression peaks at 10 hours post-injury and is maintained at this level for at least 3 days.	Escherichia coli (MIC=6.25 µg/ml), Shigella sonnei (MIC=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	1445217	Biochem J. 1992 Oct 15;287 (Pt 2):573-578.	Ishikawa M, Kubo T, Natori S.	Purification and characterization of a diptericin homologue from Sarcophaga peregrina (flesh fly).	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)O
DRAMP03075	WNPFKELERAGQRVRDAIISAGPAVATVAQATALAK	36	Cecropin-D	P01511	Belongs to the cecropin family	Not found	Antheraea pernyi (Chinese oak silk moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
PTM: C-terminal amidation."	Gram-negative bacteria: Escherichia coli D21 (MIC=0.37 µM), E. coli D31 (MIC=0.21 µM), Serratia marsescens (MIC=6.1 µM), S. marsescens Strain 122 (MIC=75 µM), Pseudomonas aeruginosa OT97 (MIC>81 µM), Xenorhabdus nematophilus Xn21 (MIC=16 µM);##Gram-positive bacteria: Bacillus subtilis Bsll (MIC>81 µM), Bacillus megaterium Bmll (MIC=24 µM), Bacillus thuringiensis Btll (MIC>81 µM), Streptococcus fecalis Ds16 (MIC>81 µM), S. fecalis AD-4 (MIC>81 µM), Micrococcus luteus MI11 (MIC=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	6754375	Eur J Biochem. 1982 Sep;127(1):219-224.	Qu Z, Steiner H, Engström A, Bennich H, Boman HG.	Insect immunity: isolation and structure of cecropins B and D from pupae of the Chinese oak silk moth, Antheraea pernyi.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@H](C)CC
DRAMP03089	GWLKKIGKKIERVGQHTRDATIQGLGIAQQAANVAATAR	39	Drosophila cecropin-A1/A2 (Insects, animals)	P14954, B3DN02, B3DN08, O16815, O16816, O16817, O16818, O16819, O16820	Belongs to the cecropin family	CecA1 AND CecA2	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Strongly expressed in larval, pupal and adult fat body and hemocytes after injection of bacteria. Maximal expression in the adult involves fat body cells of the head, thorax and abdomen.
Induction: Induced as part of the humoral response to a bacterial invasion. Transcripts appear within one hour after injection of bacteria into the hemocoel, reach a maximum after 2-6 hours and have almost disappeared after 24 hours. Similar response is seen when flies ingest bacteria present in their food.
PTM: C-terminal amidation (By similarity)."	Gram-negative bacteria: Escherichia coli D21 (MIC=0.3 µM), Enterobacter cloacae β12 (MIC=0.4 µM), Pseudomonas aeruginosa OT97 (MIC=2.2 µM), Serratia marcescens Db11 (MIC=93 µM);##Gram-positive bacteria: Bacillus megatherium Bm11 (MIC=2.6 µM), Bacillus subtilis Bsll (MIC=16 µM), Micrococcus luteus MI11 (MIC=8.5 µM). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	2104802##2390977##9725836	EMBO J. 1990 Jan;9(1):217-224.##EMBO J. 1990 Sep;9(9):2969-2976.	Kylsten P, Samakovlis C, Hultmark D.##Samakovlis C, Kimbrell DA, Kylsten P, Engström A, Hultmark D.	The cecropin locus in Drosophila; a compact gene cluster involved in the response to infection.##The immune response in Drosophila: pattern of cecropin expression and biological activity.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O)C(C)C
DRAMP03090	GWLRKLGKKIERIGQHTRDASIQVLGIAQQAANVAATAR	39	Drosophila cecropin B (CecB; Insects, animals)	P14956, O16826, O16827, O16828, O18647, O61274, Q9V425	Belongs to the cecropin family	CecB	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		Induced as part of the humoral response to a bacterial invasion. Transcripts appear within one hour after injection of bacteria into the hemocoel, reach a maximum after 2-6 hours and have almost disappeared after 24 hours. Similar response is seen when flies ingest bacteria present in their food. [Ref.1]	Gram-negative bacteria: Escherichia coli D21 (MIC=1.8 µM), Enterobacter cloacae b12 (MIC=1.0 µM), Pseudomonas aeruginosa OT97 (MIC=4.2 µM);##Gram-positive bacteria: Bacillus megatherium Bm11 (MIC=3.7 µM), Bacillus subtilis Bsll (MIC=3.2 µM), Micrococcus luteus MI11 (MIC=59 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	2390977##2104802	EMBO J. 1990 Sep;9(9):2969-2976.##EMBO J. 1990 Jan;9(1):217-224.	Samakovlis C, Kimbrell DA, Kylsten P, Engström A, Hultmark D.##Kylsten P, Samakovlis C, Hultmark D.	The immune response in Drosophila: pattern of cecropin expression and biological activity.##The cecropin locus in Drosophila; a compact gene cluster involved in the response to infection.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O)C(C)C
DRAMP03095	VFIDILDKVENAIHNAAQVGIGFAKPFEKLINPK	34	Andropin (Insects, animals)	P21663, A9UNE4, O16822, O16823, O16824, Q6LAI1, Q9VA90	Not found	Anp	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Andropin is constitutively expressed in the adult male ejaculatory duct in response to mating not bacterial infection. Andropin is less fungicidal than the cecropins (Insect Biochem Mol Biol. 1999;29:965-72). Along with other antimicrobial proteins, this peptide sterilizes the reproduction system of insects and protects sperms from being infected by bacteria (J Insect Physiol. 2001 Jun;47(6):617-622). Similarly, ceratotoxins are expressed in the female reproductive accesary glands and expressed during mating.	Gram-negative bacteria: Escherichia coli D21 (MIC=140 µM), Enterobacter cloacae b312 (MIC>300 µM), Pseudomonas aeruginosa OT97 (MIC>300 µM), Serratia marcescens Db 11 (MIC>127 µM), Serratia marcescens Db 1140 (MIC>127 µM);##Gram-positive bacteria: Bacillus megatherium Bml1 (MIC=11 µM), Bacillus subtilis Bs11 (MIC=17 µM), Micrococcus luteus MIll (MIC=20 µM). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	1899226	EMBO J. 1991; 10:163-169.	Samakovlis, C, Kylsten, P, Kimbrell, DA, Engstroem, A, Hultmark, D.	The andropin gene and its product, a male-specific antibacterial peptide in Drosophila melanogaster.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)O
DRAMP03096	RRQGPIFDTRPSPFNPNQPRPGPIY	25	Metchnikowin-2 (Insects, animals)	No entry found	Not found	Not found	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Micrococcus luteus (MIC=0.5-1.0 µM).##Fungi: Neurospora crassa (MIC=0.5-1.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	7588819	Eur J Biochem. 1995 Oct 15;233(2):694-700.	Levashina EA, Ohresser S, Bulet P, Reichhart JM, Hetru C, Hoffmann JA.	Metchnikowin, a novel immune-inducible proline-rich peptide from Drosophila with antibacterial and antifungal properties.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP18495	QCRRLCYKQRCVTYCRGR	18	Gomesin (Gm; Spiders, arachnids, Chelicerata, arthropods, invertebrates, animals)	P82358 	Belongs to the tachyplesin family	Not found	Acanthoscurria gomesiana (Tarantula spider) (Phormictopus pheopygus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiparasitic, Antimalarial, Antic	Protein level	Beta sheet	Not found	1KFP resolved by NMR.	"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi. It shows hemolytic activity.
Tissue specificity: In hemocytes only, but not in all hemocytes observed."	[Ref.10942757] Gram-positive bacteria: Aerococcus viridans (MIC=0.8-1.6 μM), Bacillus cereus (MIC=6.25-12.5 μM), Bacillus megaterium (MIC=0.2-0.4 μM), Bacillus thuringiensis (MIC=1.6-3.15 μM), Enterococcus faecalis (MIC=6.2-12.5 μM), Listeria monocytogenes (MIC=0.8-1.6 μM), Micrococcus luteus (MIC=0.4-0.8 μM), Pediococcus acidolacrici (MIC=3.15-6.25 μM), Staphylococcus aureus (MIC=1.6-3.15 μM), Staphylococcus epidermidis (MIC=0.8-1.6 μM), Staphylococcus haemolyticus (MIC=0.8-1.6 μM), Staphylococcus saprophyticus (MIC=0.8-1.6 μM), Streptococcus pyogenes (MIC=1.6-3.15 μM), Nocardia asteroides (MIC=1.6-3.15 μM);##Gram-negative bacteria: Escherichia coli 1106 (MIC=0.8-1.6 μM), Escherichia coli D22 (MIC=0.4-0.8 μM), Escherichia coli D31 (MIC=0.8-1.6 μM), Escherichia coli SBS363 (MIC=0.4-0.8 μM), Erwinia carolovora (MIC=3.15-6.25 μM), Enterobacter cloacae β12 (MIC=3.15-6.25 μM), Klebsiella pneumoniae (MIC=3.15-6.25 μM), Pseudomonas aeruginosa (MIC=1.6-3.15 μM), Salmonella thyphinurium (MIC=0.8-1.6 μM), Xhantomonas campestris pv. orizae (MIC=3.15-6.25 μM);##Fungi: Alternaria brassicola (MIC=0.4-0.8 μM), Aspergillus fumigatus (MIC=1.6-3.15 μM), Beauveria bassiana (MIC=12.5-25 μM), Fusarium culmorum (MIC=0.4-0.8 μM), Fusarium oxysporum (MIC=0.4-0.8 μM), Neurospora crassa (MIC=0.4-0.8 μM), Nectria haematococca (MIC=0.2-0.4 μM), Tricoderma viridae (MIC=0.4-0.8 μM), Tricophvton mentagrophytes (MIC=0.8-1.6 μM);##Yeasts: Candida albicans (MIC=0.15-0.3 μM), Candida glabrata (MIC=12.5-25 μM), Candida tropicalis (MIC=3.15-6.25 μM), Cryptococcus neoformans (MIC=0.8-1.6 μM), Saccharomyces cerevisiae (MIC=1.6-3.15 μM).	[Ref.10942757] It exhibits 16% hemolysis at 1 μM and 100 μM against human erythrocytes	Cyclic	pyroglutamic acid	Amidation	Disulfide bond between Cys2 and Cys15,Cys6 and Cys11.	L	No cytotoxicity information found	Not found	10942757	J Biol Chem. 2000 Oct 27;275(43):33464-70.	Silva PI Jr, Daffre S, Bulet P.	Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family.	
DRAMP03098	HRHQGPIFDTRPSPFNPNQPRPGPIY	26	Metchnikowin (Pro-rich; Insects, animals)	Q24395, Q24396, Q86BV8, Q9V7B9	Not found	Mtk	Drosophila melanogaster (Common fruit fly)	Antimicrobial, Antibacterial, Antifungal	Protein level	Rich in Proline	Not found		Transgenic plants: Insect peptide metchnikowin confers on barley a selective capacity for resistance to fungal ascomycetes pathogens (J Exp Bot. 2009;60(14):4105-14). 	Micrococcus luteus (MIC=0.5-1.0 µg/ml), Neurospora crassa (MIC=0.5-1.0 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	7588819	Eur J Biochem. 1995 Oct 15;233(2):694-700.	Levashina E.A, Ohresser S, Bulet P, Reichhart JM, Hetru C, Hoffmann J.A.	Metchnikowin, a novel immune-inducible proline-rich peptide from Drosophila with antibacterial and antifungal properties.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP03104	ATCDLLSGTGINHSACAAHCLLRGNRGGYCNGKAVCVCRN	40	Sapecin (defensins; Insects, animals)	P18313	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Sarcophaga peregrina (Flesh fly)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Combine helix and strand structure	Not found	1L4V resolved by NMR.	"Function: Sapecins, which are potent bactericidal proteins, are produced in response to injury. Sapecin is cytotoxic to Gram-positive bacteria, and to a lesser extent against Gram-negative bacteria.
Tissue specificity: Hemocytes and fat body. Induction: By injury to the larval cell wall.
PTM: Contains three disulfide bonds 3-30; 16-36; 20-38."	Gram-positive bacteria: Staphylococcus aureus FDA209P (MIC=5.0 µg/ml), Staphylococcus smith (MIC=5.0 µg/ml), Micrococcus luteus FDA16 (MIC=1.2 µg/ml), Micrococcus luteus IF03333 (MIC=1.2 µg/ml), Micrococcus luteus PC11001 (MIC=10.0 µg/ml), Bacillus subtilis NRRI B-558 (MIC=39.0 µg/ml), Bacillus subtilis PC1219 (MIC=20.0 µg/ml), Mycobacterium smegmatis ATCC607 (MIC=78.0 µg/ml), Corynebacterium bouis 1810 (MIC=2.5 µg/ml), Corynebacterium michiganense (MIC=2.5 µg/ml).##Gram-negative bacteria: Xantbmonas oryzae (MIC=20.0 µg/ml), Pseudomonas lachrymans (MIC=78.0 µg/ml), Escherichia coli NIHJ (MIC>78.0 µg/ml), Shigella sonnei JS11746 (MIC>78.0 µg/ml), Proteus vulgaris O X19 (MIC>78.0 µg/ml) 	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys30; Cys16 and Cys36; Cys20 and Cys38.	L	No cytotoxicity information found	Not found	3182836##3182836##2358424	J Biol Chem. 1988 Nov 15;263(32):17117-17121.##J Biol Chem. 1988 Nov 15;263(32):17112-17116.##J Biochem. 1990 Apr;107(4):514-518.	Matsuyama K, Natori S.##Matsuyama K, Natori S.##Kuzuhara T, Nakajima Y, Matsuyama K, Natori S.	Molecular cloning of cDNA for sapecin and unique expression of the sapecin gene during the development of Sarcophaga peregrina.##Purification of three antibacterial proteins from the culture medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina.##Determination of the disulfide array in sapecin, an antibacterial peptide of Sarcophaga peregrina (flesh fly).	CC[C@@H](C)[C@@H]1NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)CSSC[C@@H]2NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(N)=O)NC2=O
DRAMP03113	SQLGDLGSGAGQGGGGGGSIRAAGGAFGKLEAAREEEFFYKKQKEQLERLKNDQIHQAEFHHQQIKEHEEAIQRHKDFLNNLHK	84	SK84 (Gly-rich; Insects, animals)	No entry found	Not found	Not found	Drosophila virilis (Fruit fly)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal, Antiviral	Not found	Not found	Not found		Function: SK84 displays antibacterial activity against the tested Gram-positive bacteria (B. subtilis, Bacillus thuringiensis and Staphylococcus aureus), but had no effect on Gram-negative bacteria (Pseudomonas aeruginosa, Escherichia coli) and fungi (Saccharomyces cerevisiae, Candida albicans). Has weak hemolytic activity.	[Ref.19799950]Gram-positive bacteria: Bacillus thuringiensis ATCC 1041 (MIC=4 µM), B. subtilis ATCC 9372 (MIC=8 µM), Staphylococcus aureus ATCC 6538 (MIC=8 µM).	[Ref.19799950]0.01% hemolytic activity at 100 μM against human red blood cells	Linear	Free	Free	Free	L	Not included yet	Not found	19799950	Peptides. 2010 Jan;31(1):44-50.	Lu J, Chen ZW.	Isolation, characterization and anti-cancer activity of SK84, a novel glycine-rich antimicrobial peptide from Drosophila virilis.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP03116	SLGGVISGAKKVAKVAIPIGKAVLPVVAKLVG	32	Ceratotoxin-C (Insects, animals)	Q17313	Not found	CTXC1 AND CTCX2	Ceratitis capitata (Mediterranean Fruit fly)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Has hemolytic activity.Temperature dependence: Thermostable. Still active at 100 degrees Celsius.	[Ref.9569644]Gram-negative bacteria: Escherichia coli 23739 (MIC=13.6 µM), Escherichia coli LE 392 (MIC=5 µM), Pseudomonas aeruginosa 27853 (MIC>50 µM), P. vulgaris 6380 (MIC>50 µM), S. typhymurium 23853 (MIC>5 µM);##Gram-positive bacteria: E. cloacae 13047 (MIC>5 µM), E. jaecalis 29212 (MIC>50 µM), Staphylococcus aureus 25923 (MIC>50 µM), B. cereus 9634 (MIC>5 µM), Bacillus subtilis 6633 (MIC=5.9 µM).	[Swiss_Prot Entry Q17313]has hemolytic activity	Linear	Free	Free	Free	L	Not included yet	Not found	9569644	Eur. J. Biochem. 1996; 241:330-337.	Rosetto M, Manetti AGO, Giordano PC, Marri L, Amons R, Baldari CT, Marchini D, Dallai R.	Molecular characterization of ceratotoxin C, a novel antibacterial female-specific peptide of the ceratotoxin family from the medfly Ceratitis capitata.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C
DRAMP03117	QSEAGWLKKIGKKIERVGQHTRDATIQGLGVAQQAPNVAATAR	43	Drosophila cecropin-A1 (Insects, animals)	O61272	Belongs to the cecropin family	CecA1	Drosophila simulans (Fruit fly)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Homology	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
PTM: C-terminal amidation (By similarity)."	Gram-negative bacteria: Alcaligenes faecalis (MIC=10-25 µM), Escherichia coli 1106 (MIC=0.25-0.5 µM), Escherichia coli D22 (MIC=0.1-0.25 µM), Escherichia coli D31 (MIC=0.1-0.25 µM), Escherichia coli SBS363 (MIC=0.1-0.25 µM), Enterobacter cloacae β12 (MIC=0.5-1 µM), Erwinia carotovora (MIC=0.5-1 µM), Klebsiella pneumoniae (MIC=1-2.5 µM), Pseudomonas aeruginosa (MIC=1-2.5 µM), Salmonella typhimurium (MIC=0.5-1 µM), Xanthomonas campestris (MIC=0.5-1 µM); ##Gram-positive bacteria: Aerococcus viridans (MIC=5-10 µM), Bacillus megaterium (MIC=1-2.5 µM), Micrococcus luteus (MIC=5-10 µM).##Fungi: Botrytis cinerea (MIC=5-10 µM), Fusarium culmorum (MIC=1-2.5 µM), Fusarium oxysporum (MIC=1-2.5 µM), Neurospora crassa (MIC=2.5-10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9553148##9725836	Immunogenetics. 1998 May;47(6):417-429.##Genetics. 1998 Sep;150(1):157-171.##Insect Mol Biol. 2000 Feb;9(1):75-84.	Date A, Satta Y, Takahata N, Chigusa S.I.##Ramos-Onsins S, Aguade M.##Vizioli J, Bulet P, Charlet M, Lowenberger C, Blass C, Müller HM, Dimopoulos G, Hoffmann J, Kafatos FC, Richman A.	Evolutionary history and mechanism of the Drosophila cecropin gene family.##Molecular evolution of the Cecropin multigene family in Drosophila: functional genes vs pseudogenes.##Cloning and analysis of a cecropin gene from the malaria vector mosquito, Anopheles gambiae.	
DRAMP03137	ATCDLLSGFGVGDSACAAHCIARGNRGGYCNSKKVCVCRN	40	Defensin-A (AaeDefA; Insects, animals)	P91793, O77250, P91794, P91795, P91796, Q17EE3, Q6ITZ2, Q963E9	Belongs to the invertebrate defensin family (Type 1 subfamily)	DEFA	Aedes aegypti (Yellowfever mosquito)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Bridge	Not found		Function: Antibacterial peptide mostly active against Gram-positive bacteria. Has activity against the bacteria Gram-negative E. cloacae beta12.	Gram-positive bacteria: Enterobacter cloacae beta12 (MIC=1.2-2.4 µM), Aerococcus viridans (MIC=0.6-1.2 µM), Micrococcus luteus (MIC=0.6-1.2 µM), Bacillus rnegaterium (MIC=0.6-1.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Has three disulfide bonds	L	No cytotoxicity information found	Not found	7633471##7568275	Insect Biochem Mol Biol. 1995 Jul;25(7):867-873.##Proc Biol Sci. 1995 Aug 22;261(1361):217-221.	Lowenberger C, Bulet P, Charlet M, Hetru C, Hodgeman B, Christensen BM, Hoffmann JA.##Chalk R, Albuquerque CM, Ham PJ, Townson H.	Insect immunity: isolation of three novel inducible antibacterial defensins from the vector mosquito, Aedes aegypti.##Full sequence and characterization of two insect defensins: immune peptides from the mosquito Aedes aegypti.	
DRAMP03138	GGLKKLGKKLEGAGKRVFNAAEKALPVVAGAKAL	34	Cecropin-A (Insects, animals)	P82592, Q17NR3, Q95PI9	Belongs to the cecropin family	CECA	Aedes aegypti (Yellowfever mosquito)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli D22 (MIC=0.25-0.5 µg/ml), E. coli D31 (MIC=0.25-0.5 µg/ml), E. coli SBS363 (MIC=0.1-0.25 µg/ml), E. coli 1106 (MIC=0.25-0.5 µg/ml), Enterobacter cloacae b12 (MIC=50-100 µg/ml), E. carotovora (MIC=0.25-0.5 µg/ml), Klebsiella pneumoniae (MIC=1-2.5 µg/ml), Pseudomonas aeruginosa (MIC=10-25 µg/ml), Salmonella typhimurium (MIC=1-2.5 µg/ml), X. campestris (MIC=0.5-1 µg/ml);##Gram-positive bacteria: Aerococcus viridans (MIC=2.5-5 µg/ml), Bacillus megaterium (MIC=1-2.5 µg/ml), Micrococcus luteus (MIC=10-25 µg/ml), Streptococcus pyogenes (MIC=10-25 µg/ml).##Fungi: Fusarium culmorum (MIC=1-2.5 µg/ml), Fusarium oxysporum (MIC=2.5-5 µg/ml), Neurospora crassa (MIC=5-10 µg/ml), Candida albicans (MIC=25-50 µg/ml), Cryptococcus neoformans (MIC=25-50 µg/ml), Saccharomyces cerevisiae (MIC=50-100 µg/ml) 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Linear	L	Not included yet	Not found	10400619	J Biol Chem. 1999 Jul 16;274(29):20092-20097.	Lowenberger C, Charlet M, Vizioli J, Kamal S, Richman A, Christensen BM, Bulet P.	Antimicrobial activity spectrum, cDNA cloning, and mRNA expression of a newly isolated member of the cecropin family from the mosquito vector Aedes aegypti.	
DRAMP03140	GRLKKLGKKIEGAGKRVFKAAEKALPVVAGVKALG	35	Anopheles cecropin-A amidated isoform (Insects, animals)	P82290, A7XAX5, A7XAX7, A7XAY1, A7XAY8, A7XAZ7, A7XB12, A7XB23, Q7QEE3	Belongs to the cecropin family	CecA	Anopheles gambiae (African malaria mosquito)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antibacterial activity against several Gram-positive and Gram-negative bacteria. Also has antifungal activity.
Tissue specificity: Relatively abundant in head, thorax and to a lesser extent in abdominal carcass and anterior midgut.
Developmental stage: In young pupae, expressed within 2 hours of infection and continued to accumulate over 16 hours.
Induction: By bacterial infection.
PTM: C-terminal amidation."	Gram-negative bacteria: Alcaligenes faecalis (MIC=1-2.5 µM), Escherichia coli 1106 (MIC=0.5-1 µM), E. coli D22 (MIC=0.1-0.25 µM), E. coli D31 (MIC=0.1-0.25 µM), E. coli SBS363 (MIC=0.05-0.1 µM), Enterobacter cloacae β12 (MIC=0.5-1 µM), Erwinia carotovora (MIC=0.5-1 µM), Klebsiella pneumoniae (MIC=1-2.5 µM), Pseudomonas aeruginosa (MIC=1-2.5 µM), Salmonella typhimurium (MIC=0.1-0.25 µM), Xanthomonas campestris (MIC=0.5-1 µM); ##Gram-positive bacteria: Aerococcus viridans (MIC=0.5-1 µM), Bacillus cereus (MIC=50-100 µM), Bacillus megaterium (MIC=0.5-1 µM), Listeria monocytogenes (MIC=50-100 µM), Micrococcus luteus (MIC=0.5-1 µM), Staphylococcus aureus (MIC=50-100 µM), Staphylococcus epidermidis (MIC=10-25 µM), Staphylococcus haemolyticus (MIC=1-2.5 µM), Staphylococcus saprophyticus (MIC=1-2.5 µM), Streptococcus pyogenes (MIC=0.1-0.25 µM).##Fungi: Aspergillus fumigatus (MIC=5-10 µM), Botrytis cinerea (MIC=1-2.5 µM), Fusarium culmorum (MIC=0.5-1 µM), Fusarium oxysporum (MIC=1-2.5 µM), Neurospora crassa (MIC=1-2.5 µM), Candida albicans (MIC=1-2.5 µM), Cryptococcus neoformans (MIC=5-10 µM), Saccharomyces cerevisiae (MIC=25-50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Linear	L	Not included yet	Not found	10672074##12421409	Insect Mol Biol. 2000 Feb;9(1):75-84.##Insect Mol Biol. 2002 Dec;11(6):517-525.	Vizioli J, Bulet P, Charlet M, Lowenberger C, Blass C, Müller HM, Dimopoulos G, Hoffmann J, Kafatos FC, Richman A.##Zheng XL, Zheng AL.	Cloning and analysis of a cecropin gene from the malaria vector mosquito, Anopheles gambiae.##Genomic organization and regulation of three cecropin genes in Anopheles gambiae.	
DRAMP03150	MVFAYAPTCARCKSIGARYCGYGYLNRKGVSCDGQTTINSCEDCKRKFGRCSDGFITECFL	61	Gambicin (Insects, animals)	No entry found	Not found	Not found	Anopheles albimanus (mosquito)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiparasitic	Not found	Bridge	Not found		"Function: In vitro experiments showed that the 6.8-kDa mature peptide can kill both Gram-positive and Gram-negative bacteria, has a morphogenic effect on a filamentous fungus, and is marginally lethal to Plasmodium berghei ookinetes.
Induction: Predominantly expressed in the anterior part.
PTM: Contains four disulfide bridges."	Gram-negative bacterium: E. coli (MIC=6.25-12.5 µM);##Gram-positive bacterium: M. luteus (MIC=25-50 µM).##Fungus: N. crassa.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys9 and Cys20; Cys12 and Cys32; Cys41 and Cys51,Cys44 and Cys59.	L	No cytotoxicity information found	Not found	11606751	Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12630-5.	Vizioli J, Bulet P, Hoffmann JA, Kafatos FC, Müller HM, Dimopoulos G.	Gambicin: a novel immune responsive antimicrobial peptide from the malaria vector Anopheles gambiae.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H]3CSSC[C@@H]4NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](Cc5ccccc5)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](Cc5ccccc5)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC4=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC3=O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](C)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC1=O
DRAMP03153	GIGGKPVQTAFVDNDGIYD	19	27 kDa antibacterial protein	P81925	Not found	Not found	Cyprinus carpio (common carp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has antibacterial activity. Forms large ion channels responsible for disrupting the cellular envelope of bacteria leading to cell lysis.	Gram-positive bacteria: Staphylococcus aureus (MIC=5 µg/ml), Micrococcus luteus (MIC=0. 5 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=5 µg/ml), Pseudomonas fluorescens (MIC=10 µg/ml), Aeromonas hydrophila (MIC=5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	8797847	Eur J Biochem. 1996 Aug 15;240(1):143-149.	LemaÃ®tre C, Orange N, Saglio P, Saint N, Gagnon J, Molle G.	Characterization and ion channel activities of novel antibacterial proteins from the skin mucosa of carp (Cyprinus carpio).	
DRAMP03162	ATCDLLSAFGVGHAACAAHCIGHGYRGGYCNSKAVCTCRR	40	Phlebotomus duboscqi defensin (PduDef; defensins; Insects, animals)	P83404	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Phlebotomus duboscqi	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal, Antiparasitic	Protein level	Bridge	Not found		"Function: Has antiparasitic and antifungal activity.
Tissue specificity: Is synthesized by the fat body and eventually secreted into the hemolymph.
Induction: By bacterial and parasitic hemolymph and gut infections. Expression peaks at 24 hours post infection by bacterium P. carotovorum, and at day four post infection by the parasite L. major. 
PTM: Problely contains three disulfide bonds 3-30; 16-36; 20-36."	Gram-positive bacteria: Staphylococcus aureus (MIC=0.78-1.56 µM), Aspergillus fumigatus (MIC=12.5-25 µM).##Fungi: Fusarium culmorum (MIC=1.56-3.12 µM), Fusarium oxysporum (MIC=3.12-6.25 µM), Neurospora crassa (MIC=6.25-12.5 µM), Trichoderma viride (MIC=3.12-6.25 µM), Trichophyton mentagrophytes (MIC=25-50 µM), Candida albicans (MIC=6.25-12.5 µM), Saccharomyces cerevisiae (MIC=25-50 µM).##Parasite: Leishmania major promastigote forms (IC50=68-85 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys30; Cys16 and Cys36; Cys20 and Cys36.	L	No cytotoxicity information found	Not found	15557638	Infect Immun. 2004 Dec;72(12):7140-7146.	Boulanger N, Lowenberger C, Volf P, Ursic R, Sigutova L, Sabatier L, Svobodova M, Beverley SM, Späth G, Brun R, Pesson B, Bulet P.	Characterization of a defensin from the sand fly Phlebotomus duboscqi induced by challenge with bacteria or the protozoan parasite Leishmania major.	CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CS[SH]3C[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc4ccccc4)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](Cc4c[nH]cn4)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS3)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@H](Cc2c[nH]cn2)NC(=O)CNC1=O
DRAMP03166	IRNSLTCRFNFGICLPKRCPGRMRQIGTCF	30	P15 (deer beta-defensin; ruminant, animals)	No entry found	Not found	Not found	Cervus elaphus (New Zealand deer)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		"Function: It shows strong activity against Gram-negative bacteria, but lesser activity against Gram-positive bacteria and yeast.
Caution: the sequence displayed is N-terminal sequence of P15. "	Gram-negative bacterium: Escherichia coli O111 (MIC=0.3 µg/mL);##Gram-positive bacterium: Staphylococcus aureus NCTC 4163 (MIC=1 µg/mL).##Fungi: Candida albicans 3135A (MIC=3 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There are two disulfide bonds(By similar).	Not included yet	Not included yet	Not found	16011891	Int J Antimicrob Agents. 2005 Aug;26(2):165-169.	Treffers C, Chen L, Anderson RC, Yu PL.	Isolation and characterisation of antimicrobial peptides from deer neutrophils.	
DRAMP03169	RARAPHKAWYNCMTDAGISGAIAGAVAGCAATIEIGCVEGAIAGIGPSGIASMIAALWTCRSKY	64	Protease-activated antimicrobial peptide	No entry found	Not found	Not found	Propionibacterium jensenii	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Propionibacterium acidipropionici ATCC 4965 (MIC=3.6 nM), P. acidipropionici ATCC 4875 (MIC=7.2 nM), P. acidipropionici (MIC=3.6 nM), P. freudenreichii subsp. freudenreichii ATCC 6207T (MIC=7.2 nM), P. freudenreichii INF-P203 (MIC=116 nM), P. freudenreichii INF-P205 (MIC=58 nM), P. jensenii LMG 2820 (MIC=116 nM), P. jensenii LMG 3032 (MIC=116 nM), P. thoenii INF-P410 (MIC=116 nM), P. thoenii INF-P414 (MIC=0.9 nM), Lactobacillus delbrueckii subsp. lactis ATCC 4797 (MIC=0.5 nM), L. delbrueckii subsp. lactis DSM 20072T (MIC=0.2 nM), L. delbrueckii subsp. bulgaricus DSM 20081T (MIC=7.2 nM), L. helveticus DSM 20075T (MIC=0.9 nM), Lactobacillus plantarum LMG 2003 (MIC=116 nM), L. sakei NCDO 2714 (MIC=0.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	12057960	J Bacteriol. 2002 Jul;184(13):3649-3656.	Faye T, Brede DA, Langsrud T, Nes IF, Holo H.	An antimicrobial peptide is produced by extracellular processing of a protein from Propionibacterium jensenii.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP03173	RWCVYAYVRVRGVLVRYRRCW	21	Arenicin-1 (Ar-1; marine polychaeta, animals)	Q5SC60, P84105	Not found	Not found	Arenicola marina (Lugworm) (Lumbricus marinus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Cytotoxic	Protein level	Beta strand (2 strands; 16 residues)	Arenicin-1 is a two-stranded antiparallel β-sheet (Cys3-Val10 and Val13-Cys20) stabilized by nine intra-backbone hydrogen bonds and a disulfide bond between Cys3 and Cys20. The strands of the β-sheet are connected by a type I´ β-turn. The surface of arenicin is amphiphilic, with distinct hydrophobic and hydrophilic areas (ref.2).	2JSB resolved by NMR.	"Function: Has antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteriua as well as yeast C. albicans. Bacterial killing occurs within minutes and is accompanied by membrane permeabilization, membrane detachment and release of cytoplasm. Interaction of arenicin with reconstituted membranes that mimic the lipopolysaccharide-containing outer membrane or the phospholipid-containing plasma membrane of Gram-negative bacteria exhibited no pronounced lipid specificity.
PTM: Contains one disulfide bond 3-20.
Domian: Contains 1 BRICHOS domain."	Gram-positive bacterium: Listeria monocytogenes EGD (MIC=0.6 µg/ml);##Gram-negative bacteria: Escherichia coli ML-35p (MIC=4 µg/ml), E. coli WBB01 (MIC=0.3 mM), E. coli ATCC 23716 (MIC=0.6 mM), Salmonella enterica R595 (MIC=0.3 mM), S. enterica R60 (MIC=1.25 mM), Proteus mirabilis R45 (MIC=0.6 mM).##Yeast: Candida albicans 820 (MIC=20 µg/ml).##Human Jurkat T-cells: LD50>40 mM (35.5% lysis at 30 mM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys3 and Cys20.	L	[Ref.27940358] Cytotoxicity: human embryonic fibroblasts (HEF) and human red blood cells (hRBC)(IC50 for arenicin-1 in the presence or absence of 10% FBS were of 35 and 8 μM,HC50 indicating 50% hemolysis after 24 h incubation, equaled to 16μM).	Anionic lipid vesicles	15527787##17935487	FEBS Lett. 2004 Nov 5;577(1-2):209-214.##Biochem J. 2008 Feb 15;410(1):113-122.	Ovchinnikova TV, Aleshina GM, Balandin SV, Krasnosdembskaya AD, Markelov ML, Frolova EI, Leonova YF, Tagaev AA, Krasnodembsky EG, Kokryakov VN.##Andrä J, Jakovkin I, Grötzinger J, Hecht O, Krasnosdembskaya AD, Goldmann T, Gutsmann T, Leippe M.	Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina.##Structure and mode of action of the antimicrobial peptide arenicin.	CC(C)C[C@@H]1NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](N)CCCNC(=N)N)CSSC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC1=O
DRAMP03176	SWLSKTAKKLENSAKKRISEGIAIAIQGGPR	31	Cecropin-P1 (CP1; nematodes, animals)	P14661, Q5H7N7	Belongs to the cecropin family	ASCEC-1	Ascaris suum (Pig roundworm) (Ascaris lumbricoides)	Antimicrobial, Antibacterial, Antifungal	Protein level	Alpha helix 	Not found	2N92##7DEH##7VOZ	"Function: Has antibacterial activity against several Gram-positive and Gram-negative bacteria. Is weakly active against yeasts. Acts by a nonpore mechanism.
Induction: By bacterial infection."	P1-NH2 (amidated cecropin P1): [E. coli K-12/ D21 (MIC=0.3 µM), E. coli 853/67/0149/K88 (MIC=0.9 µM), E. coli Bd2221/75/08/K88 (MIC=0.6 µM), E. coli Bd4462/84/0101/K99 (MIC=0.7 µM), E. coli Bd4466/84/064/K99 (MIC=0.3 µM), Salmonella typhimurium LT2 (MIC=0.9 µM), A. calcoaceticus Ac1l (MIC=0.2 µM), Proteus vulgaris Pvll (MIC=5.7 µM), Pseudomonas aeruginosa OT97 (MIC=5.9 µM), Bacillus megaterium Bmll (MIC=1.8 µM), Streptococcus pyogenes (MIC=19 µM)].##P1-OH (non-amidated cecropin P1): [E. coli K-12/ D21 (MIC=0.4 µM), E. coli 853/67/0149/K88 (MIC=0.6 µM), E. coli Bd2221/75/08/K88 (MIC=0.7 µM), E. coli Bd4462/84/0101/K99 (MIC=0.8 µM), E. coli Bd4466/84/064/K99 (MIC=0.6 µM), Salmonella typhimurium LT2 (MIC=1.7 µM), A. calcoaceticus Ac1l (MIC=0.5 µM), Proteus vulgaris Pvll (MIC=12 µM), Pseudomonas aeruginosa OT97 (MIC=13 µM), Bacillus megaterium Bmll (MIC=5.3 µM), Streptococcus pyogenes (MIC=44 µM)].	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	15850460##1396696	Biochem J. 2005 Aug 15;390(Pt 1):207-214.##Eur J Biochem. 1992 Oct 1;209(1):163-169.	llai A, Ueno S, Zhang H, Lee JM, Kato Y.##Sipos D, Andersson M, Ehrenberg A.	Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode Ascaris suum.##The structure of the mammalian antibacterial peptide cecropin P1 in solution, determined by proton-NMR.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP03181	HVDKKVADKVLLLKQLRIMRLLTRL	25	Spinigerin (Insects, animals)	P82357	Not found	Not found	Pseudacanthotermes spiniger (Termite)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found	1ZRW, 1ZRV resolved by NMR.	Function: Active against Gram-positive bacteria and Gram-negative bacteria and fungi.	Gram-positive bacteria: Bacillus megaterium (MIC=0.8-1.5 µM), Micrococcus luteus (MIC=0.8-1.5 µM);##Gram-negative bacteria: Escherichia coli SBS363 (MIC=3-6 µM), E. coli D22 (MIC=3-6 µM), Klebsiella pneumoniae (MIC=50-100 µM), Salmonella typhimurium (MIC=3-6 µM), Pseudomonas aeruginosa (MIC=50-100 µM).##Fungi: Trichoderma viride (MIC=1.5-3 µM), Neurospora crassa (MIC=3-6 µM), Fusarium culmorum (MIC=1.5-3 µM), Nectria haematococca (MIC=0.4-0.8 µM), Candida albicans (MIC=3-6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	11053427##16170803	J Biol Chem. 2001 Feb 9;276(6):4085-4092.##Biopolymers. 2006 Feb 5;81(2):92-103. 	Lamberty M, Zachary D, Lanot R, Bordereau C, Robert A, Hoffmann JA, Bulet P.##Landon C, Meudal H, Boulanger N, Bulet P, Vovelle F.	Insect immunity. Constitutive expression of a cysteine-rich antifungal and a linear antibacterial peptide in a termite insect.##Solution structures of stomoxyn and spinigerin, two insect antimicrobial peptides with an alpha-helical conformation.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP03186	SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW	38	Spheniscin-2 (Sphe-2; penguin avian beta-defensin 103b; birds ,animals)	P83430	Belongs to the beta-defensin family	Not found	Aptenodytes patagonicus (King penguin)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Beta strand (3 strands; 14 residues)	The overall fold of Sphe-2 includes a three-stranded antiparallel beta-sheet stabilized by three disulfide bridges with a pairing typical of beta-defensins. In addition, the N-terminal segment shows helical features on most structures.(Ref.2)	1UT3 resolved by NMR.	"Function: Has antimicrobial activity. Has insecticidal and hemolytic activities. Probably acts by disturbing membrane Function: with its amphipathic structure.
PTM: Contains three disulfide bond: 5-33; 12-27; 17-34.
Preserving food in the bird somach for several weeks during egg incubation. The disulfide bond pattern is identical to canonical beta-defensins from mammals. The high potency is related to its high cationicity as well as a hydrophobic patch, which is not observed in mammalian defensins. "	[Ref.14525994]Gram-positive bacteria: Micrococcus luteus (MIC=1.5-3.0 µM), Bacillus subtilis (MIC=0.8-1.5 µM), Bacillus cereus ATCC 11778 (MIC=3-6 µM), Bacillus megaterium (MIC=0.4-0.8 µM), Staphylococcus aureus (MIC=1.5-3.0 µM), Staphylococcus saprophyticus (MIC=1.5-3.0 µM), Staphylococcus haemolyticus (MIC=1.5-3.0 µM), Nocardia asteroides (MIC=0.8-1.5 µM), Aerococcus viridans (MIC=0.4-0.8 µM), Listeria monocytogenes (MIC=6-12 µM);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=0.8-1.5 µM), Escherichia coli 1106 (MIC=1.5-3.0 µM), Salmonella typhimurium (MIC=6-12 µM), Klebsiella pneumoniae (MIC=50-100 µM), Pseudomonas aeruginosa ATCC 82118 (MIC=6-12 µM), Vibrio metschnikovii NCTC 8483 (MIC=25-50 µM), Vibrio anguillarum ATCC 19264 (MIC=25-50 µM);##Fungi: Candida glabrata (MIC>100 µM), Candida albicans IHEM 8060 (MIC=50-100 µM), Candida tropicalis (MIC=1.5-3.0 µM), Neurospora crassa (MIC=3-6 µM),Aspergillus fumigatus (MIC=3-6 µM).	It has hemolytic activity	Cyclic	Free	Free	Disulfide bonds between Cys5 and Cys33; Cys12 and Cys27; Cys17 and Cys34.	L	No cytotoxicity information found	Not found	14525994##15123713	J Biol Chem. 2003 Dec 19;278(51):51053-51058.##J Biol Chem. 2004 Jul 16;279(29):30433-30439.	Thouzeau C, Le Maho Y, Froget G, Sabatier L, Le Bohec C, Hoffmann JA, Bulet P.##Landon C, Thouzeau C, Labbé H, Bulet P, Vovelle F.	Spheniscins, avian beta-defensins in preserved stomach contents of the king penguin, Aptenodytes patagonicus.##Solution structure of spheniscin, a beta-defensin from the penguin stomach.	CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)C(C)C)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N3)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2
DRAMP03187	QRYFCRVRGGRCAALTCLPRETQIGRCSVKGRKCCR	36	Beta defensin 1(BD-1; mammals, animals)	P83943	Belongs to the beta-defensin family	DEFB1	Chinchilla lanigera (Long-tailed chinchilla) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has antibacterial and antifungal activity. May have a role in maintaining sterility in the middle ear.	Gram-negative bacterium: Moraxella catarrhalis (MIC=5 µg/ml);##Gram-positive bacterium: Streptococcus pneumoniae (MIC=5 µg/ml).##Fungi: Candida albicans (MIC=12.5-20 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There are three disulfide bonds.	Not included yet	Not included yet	Not found	14996845	J Biol Chem. 2004 May 7;279(19):20250-20256.	Harris RH, Wilk D, Bevins CL, Munson RS Jr, Bakaletz LO.	Identification and characterization of a mucosal antimicrobial peptide expressed by the chinchilla (Chinchilla lanigera) airway.	
DRAMP03190	RLGNFFRKAKKKIGRGLKKIGQKIKDFLGNLVPRTES	37	PobRL-37 (cathelicidin; primates, mammals, animals)	No entry found	Not found	Not found	Cercopithecidae	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Function: Has antibacterial activity.	In 20% TSB in SPB medium: Escherichia coli (MIC=0.5 µM), Pseudomonas aeruginosa (MIC=0.5-1 µM), Staphylococcus aureus (MIC=2 µM), Enterococcus faecalis (MIC=2-4 µM).##In 20% SAB in SPB: Candida albicans (MIC=8-16 µM). In 5% TSB in SPB: Escherichia coli (MIC=0.5 µM). In 5% SAB in SPB: Candida albicans (MIC=4-8 µM).##In 20% TSB in PIL: Escherichia coli (MIC=1 µM), Pseudomonas aeruginosa (MIC=1-2 µM); Staphylococcus aureus (MIC=0.5 µM), Enterococcus faecalis (MIC=1-2 µM).##In 20% SAB in PIL: Candida albicans (MIC=16 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@H](C)CC
DRAMP03196	RCVCRRGVCRCVCTRGFC	18	PhTD-1 (PhTD1; primates, mammals, animals)	P86722, P86723	Not found	Not found	Papio hamadryas (Hamadryas baboon)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	In low salt conditions: Escherichia coli ML35p (MIC=1.5 µM), Listeria monocytogenes EGD (MIC=1.6 µM) and methicillin-resistant Staphylococcus aureus ATCC 33591 (MIC=2.5 µM),.##Fungi: Candida albicans 820 (MIC=1.6 µM);##At high physiological salt concentrations: Escherichia coli ML35p (MIC=2.0 µM), Listeria monocytogenes EGD (MIC=1.7 µM), Staphylococcus aureus ATCC 33591 (MIC=3.6 µM), Candida albicans 820 (MIC=6.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys2 and Cys11; Cys4 and Cys9; Cys13 and Cys18.	L	No cytotoxicity information found	Not found	20155756	Rapid Commun Mass Spectrom. 2010 Mar 15;24(5):599-604.	Stegemann C, Tsvetkova EV, Aleshina GM, Lehrer RI, Kokryakov VN, Hoffmann R.	De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.	
DRAMP03197	RCVCTRGFCRCVCTRGFC	18	PhTD-3 (PhTD3; primates, mammals, animals)	P86722, P86723	Not found	Not found	Papio hamadryas (Hamadryas baboon)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	In low salt conditions: Escherichia coli ML35p (MIC=1.7 µM), Listeria monocytogenes EGD (MIC=1.5 µM), Staphylococcus aureus ATCC 33591 (MIC=1.7 µM), Candida albicans 820 (MIC=1.4 µM);##At high physiological salt concentrations: Escherichia coli ML35p (MIC=2.2 µM), Listeria monocytogenes EGD (MIC=1.9 µM), Staphylococcus aureus ATCC 33591 (MIC=4.5 µM), Candida albicans 820 (MIC=7.4 µM). 	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys2 and Cys11; Cys4 and Cys9; Cys13 and Cys18.	L	No cytotoxicity information found	Not found	20155756	Rapid Commun Mass Spectrom. 2010 Mar 15;24(5):599-604.	Stegemann C, Tsvetkova EV, Aleshina GM, Lehrer RI, Kokryakov VN, Hoffmann R.	De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.	
DRAMP03198	ACYCRIPACFAGERRYGTCFYLGRVWAFCC	30	Alpha-defensin PhD-4 (primates, mammals, animals)	P86724	Belongs to the alpha-defensin family	Not found	Papio hamadryas (Hamadryas baboon)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antibacterial activity in low salt conditions, and the antimicrobial activity decreases significantly at high physiological salt concentrations.
PTM: Contains three disulfide bonds (By similarity)."	In low salt conditions: Gram-negative bacterium: E. coli ML35p (MIC=2.4 µM),;##Gram-positive bacteria: Listeria monocytogenes EGD (MIC=2.2 µM), methicillin-resistant S. aureus ATCC 33591 (MIC=3.5 µM).##Fungi: Candida albicans 820 (MIC=3.9 µM).##At high physiological salt concentrations: E. coli ML35p (MIC=7.1 µM), L. monocytogenes EGD (MIC=1.8 µM), S. aureus ATCC 33591 (MIC>50 µM), Candida albicans 820 (MIC>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization(Cys2 and Cys30).	Disulfide bonds between Cys2 and Cys30; Cys4 and Cys19; Cys9 and Cys29.	L	Not included yet	Not found	20155756	Rapid Commun Mass Spectrom. 2010 Mar 15;24(5):599-604.	Stegemann C, Tsvetkova EV, Aleshina GM, Lehrer RI, Kokryakov VN, Hoffmann R.	De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.	
DRAMP03215	ZCRRLCYKQRCVTYCRGR	18	Gomesin (Gm; spiders, Arthropods, animals)	P82358, Q86RA2	Not found	Not found	Acanthoscurria gomesiana (Tarantula spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor	Protein level	Beta strand	Gm adopts a well-defined β-hairpin-like struc ture, and the disulfide bonds have been reported to be important for the maintenance of this structure.	1KFP resolved by NMR.	[Ref.10942757]Function: Gomesin bound to the cell surface of cryptococci neoformans, which resulted in cell death associated with membrane permeabilization (FEMS Microbiol Lett. 2007 Sep;274(2):279-86). Also, this peptide triggers SH-SY5Y cell death through L-type channel calcium influx, MAPK/ERK, PKC and PI3K signaling and generation of reactive oxygen species (Soletti RC et al 2010 Chem Biol Interact 186: 135-43). Although represented by E, the N-terminal residue is a pyroglutamate. In hemocytes only, but not in all hemocytes observed.##[Ref.28741926]Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.10942757]Gram-positive bacteria: Aerococcus viridans (MIC=0.8-1.6 µM), Bacillus cereus (MIC=6.25-12.5 µM), Bacillus megaterium (MIC=0.2-0.4 µM), Bacillus thuringiensis (MIC=1.6-3.15 µM), Enterococcus faecalis (MIC=6.2-12.5 µM), Listeria monocytogenes (MIC=0.8-1.6 µM), Micrococcus luteus (MIC=0.4-0.8 µM), Pediococcus acidolacrici (MIC=3.15-6.25 µM), Staphylococcus aureus (MIC=1.6-3.15 µM), S. epidermidis (MIC=0.8-1.6 µM), S. haemolyticus (MIC=0.8-1.6 µM), S. saprophyticus (MIC=0.8-1.6 µM), Streptococcus pyogenes (MIC=1.6-3.15 µM), Nocardia asteroides (MIC=1.6-3.15 µM);##Gram-negative bacteria: Alcaligenes faecalis (MIC>100 µM), Escherichia coli 1106 (MIC=0.8-1.6 µM), E. coli D22 (MIC=0.4-0.8 µM), E. coli D31 (MIC=0.8-1.6 µM), E. coli SBS363 (MIC=0.4-0.8 µM), Erwinia carolovora carolovora (MIC=3.15-6.25 µM), Enterobacter cloacae beta 12 (MIC=3.15-6.25 µM), Klebsiella pneumoniae (MIC=3.15-6.25 µM), Pseudomonas aeruginosa (MIC=1.6-3.15 µM), Salmonella typhimurium (MIC=0.8-1.6 µM), Xhantomonas campestris pv. orizae (MIC=3.15-6.25 µM).##Fungi: Alternaria brassicola (MIC=0.4-0.8 µM), Aspergillus fumigatus (MIC=1.6-3.15 µM), Beauveria bassiana (MIC=12.5-25 µM), Fusarium culmorum (MIC=0.4-0.8 µM), F. oxysporum (MIC=0.4-0.8 µM), Neurospora crassa (MIC=0.4-0.8 µM), Nectria haematococca (MIC=0.2-0.4 µM), Tricoderma viridae (MIC=0.4-0.8 µM), Tricophvton mentagrophytes (MIC=0.8-1.6 µM), C. albicans (MIC=0.15-0.3 µM), C. glabrata (MIC=12.5-25 µM), C. tropicalis (MIC=3.15-6.25 µM), C. neoformans (MIC=0.8-1.6 µM), Saccharomyces cerevisiae (MIC=1.6-3.15 µM).##[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=32 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=4 μM), Klebsiella pneumoniae ATCC 700603 (MIC=32 μM), Acinetobacter baumannii ATCC 19606 (MIC=4-8 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=8-16 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)	[Ref.28741926] It has 0% hemolysis at 6 μM , 3% hemolysis at 10 μM , 10% hemolysis at 5 μM , 41.2-53.2% hemolysis at 64 μM , 50% hemolysis at 100 μM against human red blood cells	Cyclic	pyroglutamic acid	Amidation 	Disulfide bond between Cys2 and Cys15,Cys6 and Cys11.	L	[Ref.28741926] CC50 = 67.0 ± 5.0 μM against CRL-1739, CC50 = 3.7 ± 0.2 μM against MM96L, CC50 = 49.9 ±16.6μM against HFF-1, CC50 =54.1±5.0 μM against HeLa, CC50 = 3.8 ± 0.3 μM against K-562.	Not found	10942757##28741926	J Biol Chem. 2000 Oct 27;275(43):33464-33470.##ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459. 	Silva PI Jr, Daffre S, Bulet P.##Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family.##Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP03216	GIRCPKSWKCKAFKQRVLKRLLAMLRQHAF	30	Oxyopinin-4a (Oxt-4a; spiders, Arthropods, animals)	F8J4S0, P86350	Not found	Not found	Oxyopes takobius (Lynx spider) (Oxyopes foliiformis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found	2L3I resolved by NMR.	"Function: Disrupts cell membranes through the formation of pores Probable. Has antibacterial activity. Has hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: Contains one disulfide bond 4-10."	[Ref.21933345]Gram-positive bacteria: S. aureus (MIC=10 µM) and Bacillus subtilis (MIC=0.5 µM);##Gram-negative bacteria: P. fluorescens (MIC=1 µM) and E. coli (MIC=0.5 µM).	[Ref.21933345] EC50=7 μM against human erythrocytes	Cyclic	Free	Free	Disulfide bond between Cys4 and Cys10.	L	No cytotoxicity information found	Cell membrane (Probable)	21933345	FEBS J. 2011 Nov;278(22):4382-4393.	Dubovskii PV, Vassilevski AA, Samsonova OV, Egorova NS, Kozlov SA, Feofanov AV, Arseniev AS, Grishin EV.	Novel lynx spider toxin shares common molecular architecture with defense peptides from frog skin.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C1=O
DRAMP03217	FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ	48	M-oxotoxin-Ot1a (Oxyopinin-1, Oxki1; spiders, Arthropods, animals)	P83247	Not found	Not found	Oxyopes takobius (Lynx spider) (Oxyopes foliiformis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal	Protein level	Alpha helix 	Not found		Function: Disrupts cell membranes, particularly those rich in phosphocholine, through formation of pores. Has antimicrobial activity against Gram-negative bacterium E. coli, Gram-positive bacteria B. subtilis and S. aureus, and hemolytic activity against sheep erythrocytes. Has insecticidal activity against S. frugiperda ovarian cells by opening non-selective ion channels. Enhances the insecticidal activity of spider venom neurotoxic peptides.	[Ref.11976325]Gram-negative bacterium: Escherichia coli (MIC=1.6 µM);##Gram-positive bacteria: Bacillus subtilis, Staphylococcus aureus (MIC=6.2 µM).	[Ref.11976325]100% hemolytic activity at 50 µM against sheep red blood cells	Linear	Free	Free	Free	L	Not included yet	Cell membrane	11976325##15328050	J Biol Chem. 2002 Jun 28;277(26):23627-23637.##Biochim Biophys Acta. 2004 Aug 30;1664(2):182-188.	Corzo G, Villegas E, Gómez-Lagunas F, Possani LD, Belokoneva OS, Nakajima T.##Belokoneva OS, Satake H, Mal'tseva EL, Pal'mina NP, Villegas E, Nakajima T, Corzo G.	Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins.##Pore formation of phospholipid membranes by the action of two hemolytic arachnid peptides of different size.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP03222	GFGALFKFLAKKVAKTVAKQAAKQGAKYVVNKQME	35	M-ctenitoxin-Cs1a (M-CNTX-Cs1a; Cupiennin-1a; spiders, Arthropods, animals)	P83619	Belongs to the cupiennin family	Not found	Cupiennius salei (Wandering spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal	Protein level	Alpha helix (3 helices; 11 residues)	The peptide adopts a helix-hinge-helix structure in a membrane mimicking solvent. The hinge may play a role in allowing the amphipathic N-terminal helix and polar C-terminal helix to orient independently upon membrane binding, in order to achieve maximal antibacterial efficacy.(Ref.2)	2K38 resolved by NMR.	Function: Has antimicrobial activity. Has insecticidal and hemolytic activities. Probably acts by disturbing membrane Function: with its amphipathic structure. Synergistically increases the insecticidal activity of CSTX-1, CSTX-9, and CSTX-13 by up to 65%. Also inhibits the formation of nitric oxide by neuronal nitric oxide synthase. LD50 is 5.9 pmol/mg on Drosophila. 	[Ref.11792701]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=0.31-0.63 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=0.31-0.63 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=0.31-0.63 µM), Enterococcus faecalis ATCC 29212 (MIC=2.50-5.00 µM).	[Ref.11792701]EC50=24.4 μM against human red blood cells.	Linear	Free	Amidation 	Free	L	Not included yet	calcium calmodulin	11792701##17319697	J Biol Chem. 2002 Mar 29;277(13):11208-11216.##Biochemistry. 2007 Mar 20;46(11):3576-3585.	Kuhn-Nentwig L, Muller J, Schaller J, Walz A, Dathe M, Nentwig W.##Pukala TL, Boland MP, Gehman JD, Kuhn-Nentwig L, Separovic F, Bowie JH.	Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae).##Solution structure and interaction of cupiennin 1a, a spider venom peptide, with phospholipid bilayers.	CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP03225	GFGSLFKFLAKKVAKTVAKQAAKQGAKYVANKHME	35	M-ctenitoxin-Cs1d (M-CNTX-Cs1d; Cupiennin-1d; spiders, Arthropods, animals)	P83622	Belongs to the cupiennin family	Not found	Cupiennius salei (Wandering spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antimicrobial activity. Has insecticidal activity. Probably acts by disturbing membrane Function: with its amphipathic structure.
Tissue specificity: Expressed by the venom gland.
Toxic dose: LD50 is 6.4 pmol/mg on Drosophila."	[Ref.11792701]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=0.08-0.16 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=0.16-0.31 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=0.63-1.25 µM), Enterococcus faecalis ATCC 29212 (MIC=1.25-2.50 µM).	[Ref.11792701]Not determined	Linear	Free	Amidation 	Free	L	Not included yet	Not found	11792701##10669026	J Biol Chem. 2002 Mar 29;277(13):11208-11216.##Toxicon. 2000 Mar;38(3):373-380.	Kuhn-Nentwig L, Muller J, Schaller J, Walz A, Dathe M, Nentwig W.##Haeberli S, Kuhn-Nentwig L, Schaller J, Nentwig W.	Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae).##Characterisation of antibacterial activity of peptides isolated from the venom of the spider Cupiennius salei (Araneae: Ctenidae).	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP03226	SMWSGMWRRKLKKLRNALKKKLKGE	25	M-zodatoxin-Lt1a (M-ZDTX-Lt1a; Latarcin-1, Ltc-1, Ltc1; spiders, Arthropods, animals)	Q1ELT9	Belongs to the latarcin family	Not found	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix (1 helices; 16 residues)	The Ltc1 molecule is found to form a straight uninterrupted amphiphilic helix comprising 8-23 residues. The hydrophobic surface of the Ltc1 helix is narrow-shaped and extends with no gradient along the axis. (Ref.2)	2PCO resolved by NMR.	Function: Has hemolytic activity against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.	[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.5 µM), Bacillus subtilis VKM B-501 (MIC=1.0 µM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=1.0 µM), Escherichia coli MH1 (MIC=0.7µM), Pseudomonas aeruginosa PAO1 (MIC=4.1 µM);##Fungi: Pichia pastoris GS115 (MIC=17 µM), Saccharomyces cerevisiae Y190 (MIC>33 µM).	[Ref.16735513]20% hemolytic activity at 80 μM against rabbit erythrocytes 	Linear	Free	Free	Free	L	Not included yet	Not found	16735513##18293934	J Biol Chem. 2006 Jul 28;281(30):20983-20992.##Biochemistry. 2008 Mar 18;47(11):3525-3533.	Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.##Dubovskii PV, Volynsky PE, Polyansky AA, Karpunin DV, Chupin VV, Efremov RG, Arseniev AS.	Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.##Three-dimensional structure/hydrophobicity of latarcins specifies their mode of membrane activity.	CSCC[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP03227	GLFGKLIKKFGRKAISYAVKKARGKH	26	M-zodatoxin-Lt2a (M-ZDTX-Lt2a; Latarcin-2a, Ltc-2a, Ltc2a; spiders, Arthropods, animals)	Q1ELU1	Belongs to the latarcin family	Not found	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix (2 helices; 18 residues)	The molecule of Ltc2a is found to consist of two helical regions (residues 3-9 and 13-21) connected via a poorly ordered fragment.	2G9P resolved by NMR.	Function: Has hemolytic activity against Rabbit erythrocytes and has toxicity to ovarian insect Sf9 cells (EC50=20 µM). Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae. 	[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.7 µM), Bacillus subtilis VKM B-501 (MIC=0.4 µM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=1.0 µM), Escherichia coli MH1 (MIC=0.7 µM), Pseudomonas aeruginosa PAO1 (MIC=6.7 µM);##Fungi: Pichia pastoris GS115 (MIC=6.7 µM), Saccharomyces cerevisiae Y190 (MIC=54 µM).	[Ref.16735513]20% hemolytic activity at 6 μM against rabbit erythrocytes 	Linear	Free	Free	Free	L	Not included yet	Not found	16735513##16939228	J Biol Chem. 2006 Jul 28;281(30):20983-20992.##Biochemistry. 2006 Sep 5;45(35):10759-10767.	Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.##Dubovskii PV, Volynsky PE, Polyansky AA, Chupin VV, Efremov RG, Arseniev AS.	Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.##Spatial structure and activity mechanism of a novel spider antimicrobial peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP03229	SWKSMAKKLKEYMEKLKQRA	20	M-zodatoxin-Lt3a (M-ZDTX-Lt3a; Latarcin-3a, Ltc-3a; spiders, Arthropods, animals)	Q1ELU3	Belongs to the latarcin family	Not found	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Has hemolytic activity against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland."	[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.3 µM), Bacillus subtilis VKM B-501 MIC=1.2 µM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=2.5 µM), Escherichia coli MH1 (MIC=6.0 µM), Pseudomonas aeruginosa PAO1 (MIC>40 µM);##Fungi: Pichia pastoris GS115 (MIC=20 µM), Saccharomyces cerevisiae Y190 (MIC=20 µM).	[Ref.16735513]20% hemolytic activity at >120 μM against rabbit erythrocytes 	Linear	Free	Amidation 	Free	L	Not included yet	Not found	16735513	J Biol Chem. 2006 Jul 28;281(30):20983-209892.	Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.	Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.	CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(N)=O
DRAMP03230	SWASMAKKLKEYMEKLKQRA	20	M-zodatoxin-Lt3b (M-ZDTX-Lt3b; Latarcin-3b, Ltc-3b; spiders, Arthropods, animals)	Q1ELU2	Belongs to the latarcin family	Not found	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Has hemolytic against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland."	[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.7 µM), Bacillus subtilis VKM B-501 (MIC=2.9 µM);Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=23 µM), Escherichia coli MH1 (MIC=28 µM), Pseudomonas aeruginosa PAO1 (MIC>45 µM);##Fungi: Pichia pastoris GS115 (MIC=23 µM), Saccharomyces cerevisiae Y190 (MIC=23 µM).	[Ref.16735513]20% hemolytic activity at >120 μM against rabbit erythrocytes 	Linear	Free	Amidation 	Free	L	Not included yet	Not found	16735513	J Biol Chem. 2006 Jul 28;281(30):20983-209892.	Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.	Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.	CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(N)=O
DRAMP03231	GLKDKFKSMGEKLKQYIQTWKAKF	24	M-zodatoxin-Lt4a (M-ZDTX-Lt4a; Latarcin-4a, Ltc-4a; spiders, Arthropods, animals)	Q1ELU5	Belongs to the latarcin family	Not found	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Has hemolytic activity against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland."	[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.3 µM), Bacillus subtilis VKM B-501 (MIC=1.1 µM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=4.5 µM), Escherichia coli MH1 (MIC=3.2 µM), Pseudomonas aeruginosa PAO1 (MIC>35 µM);##Fungi: Pichia pastoris GS115 (MIC=36 µM), Saccharomyces cerevisiae Y190 (MIC=18 µM).	[Ref.16735513]20% hemolytic activity at >120 μM against rabbit erythrocytes 	Linear	Free	Amidation 	Free	L	Not included yet	Not found	16735513	J Biol Chem. 2006 Jul 28;281(30):20983-209892.	Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.	Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)O
DRAMP03232	SLKDKVKSMGEKLKQYIQTWKAKF	24	M-zodatoxin-Lt4b (M-ZDTX-Lt4b; Latarcin-4b, Ltc-4b; spiders, Arthropods, animals)	Q1ELU4	Belongs to the latarcin family	Not found	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Has hemolytic activity against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland."	[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.3 µM), Bacillus subtilis VKM B-501 (MIC=1.1 µM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=4.4 µM), Escherichia coli MH1 (MIC=4.4 µM), Pseudomonas aeruginosa PAO1 (MIC>35 µM);##Fungi: Pichia pastoris GS115 (MIC>35 µM), Saccharomyces cerevisiae Y190 (MIC=35 µM).	[Ref.16735513]20% hemolytic activity at >120 μM against rabbit erythrocytes 	Linear	Free	Amidation 	Free	L	Not included yet	Not found	16735513	J Biol Chem. 2006 Jul 28;281(30):20983-209892.	Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.	Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)O
DRAMP03233	GFFGKMKEYFKKFGASFKRRFANLKKRL	28	M-zodatoxin-Lt5a (M-ZDTX-Lt5a; Latarcin-5, Ltc-5; spiders, Arthropods, animals)	Q1ELU9	Belongs to the latarcin family	Not found	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Has antimicrobial activity against Gram-positive bacteria and Gram-negative bacteria and and yeasts. Also has hemolytic activity against rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland. PTM: Leucine amide at L28."	[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=1.1 µM), Bacillus subtilis VKM B-501 (MIC=0.6 µM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=0.6 µM), Escherichia coli MH1 (MIC=0.6 µM), Pseudomonas aeruginosa PAO1 (MIC=18 µM);##Fungi: Pichia pastoris GS115 (MIC>37 µM), Saccharomyces cerevisiae Y190 (MIC>37 µM).	[Ref.16735513]20% hemolytic activity at 40 μM against rabbit erythrocytes 	Linear	Free	Amidation 	Free	L	Not included yet	Not found	16735513	J Biol Chem. 2006 Jul 28;281(30):20983-20992. 	Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV. 	Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.	CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP03236	GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYLLKYYGKKALQKASEKL	69	M-zodatoxin-Lt8a (M-ZDTX-Lt8a; Cytoinsectotoxin-1a, CIT-1a; spiders, Arthropods, animals)	P85253, B3W6H9	Belongs to the cytoinsectotoxin family	cit 1-1	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal	Protein level	Not found	Not found		"Function: Insecticidal, cytolytic and antimicrobial peptide. Has insecticidal activity against the flesh fly S. carnaria, and against the cockroach N. cinerea. CIT 1a Has hemolytic activity against human erythrocytes, and cytolytic activity against insect Sf9 cells in the same concentration range. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland.
Toxic dose: LD50 is 5 µg/g for adult and 20 µg/g for larvae of flesh fly S. carnaria. LD50 is 500 µg/g for cockroach N. cinerea."	[Ref.18215128]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.5 µM), Bacillus subtilis VKM B-501 (MIC=0.9 µM), Micrococcus luteus (MIC>30 µM), Staphylococcus aureus (MIC>30 µM);##Gram-negative bacteria: Escherichia coli C600 (MIC=0.5 µM), E. coli DH5alpha (MIC=0.9 µM), E. coli MH1 (MIC=0.5 µM), Pseudomonas aeruginosa PAO1 (MIC=1.9 µM), Pseudomonas fluorescens VKM B-894 (MIC=3.8 µM).	[Ref.18215128]EC50=6 μM against human erythrocytes 	Linear	Free	Free	Free	L	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)C(C)C)[C@H](C)CC)C(C)C
DRAMP03253	GKLQAFLAKMKEIAAQTL	18	M-lycotoxin-Ls3a (M-LCTX-Ls3a; Lycocitin-1; spiders, Arthropods, animals)	P0C2U6	Not found	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Inhibits growth of Gram-positive and Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation."	Gram-positive bacteria: Staphylococcus aureus, Bacillus subtilis ATCC6633 (MIC=1.6-3.2 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=3.2-6.4 µM), Pseudomonas aeruginosa.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation 	Free	L	Not included yet	Not found	14991689	J Mass Spectrom. 2004 Feb;39(2):193-201.	Budnik BA, Olsen JV, Egorov TA, Anisimova VE, Galkina TG, Musolyamov AK, Grishin EV, Zubarev RA.	De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP03254	GRLQAFLAKMKEIAAQTL	18	M-lycotoxin-Ls3b (M-LCTX-Ls3b; Lycocitin-2; spiders, Arthropods, animals)	P0C2U7	Not found	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Inhibits growth of Gram-positive and Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation."	Gram-positive bacteria: Staphylococcus aureus 209P, Bacillus subtilis ATCC 6633 (MIC=1.57-3.14 µM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=3.14-6.29 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=5.02-10.05 µM).##Fungi: Candida albicans. 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation 	Free	L	Not included yet	Not found	14991689	J Mass Spectrom. 2004 Feb;39(2):193-201.	Budnik BA, Olsen JV, Egorov TA, Anisimova VE, Galkina TG, Musolyamov AK, Grishin EV, Zubarev RA.	De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP03278	IWLTALKFLGKHAAKHLAKQQLSKL	25	M-lycotoxin-Hc1a (M-LCTX-Hc1a; Lycotoxin I; spiders, Arthropods, animals)	P61507	Not found	Not found	Hogna carolinensis (Carolina wolf spider) (Lycosa carolinensis) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		Function: Forms pore that permeabilize the cell membrane. Promotes efflux of calcium from synaptosomes, causes hemolysis, and dissipates voltage gradients across muscle membrane. Potently inhibits the growth of bacteria, yeast and Leishmania. Is lethal to lepidopteran larvae. May Function: both in the prey capture strategy as well as protection from infectious organisms arising from prey ingestion.	Gram-positive bacteria: Bacillus thuringiensis subsp. Israelensis (MIC<5.0 µM);##Gram-negative bacteria: Escherichia coli D31 (MIC=10-20 µM), Escherichia coli DH5 (MIC=80-150 µM).##Fungi: Candida glabrata ATCC 2001 (MIC=100-150 µM), Candida albicans clinical isolate (MIC=100-200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation 	Free	L	Not included yet	Cell membrane	9442044##18098329 	J Biol Chem. 1998 Jan 23;273(4):2059-2066.##J Pept Sci. 2008 Apr;14(4):528-534.	Yan L, Adams ME.##Adão R, Seixas R, Gomes P, Pessoa JC, Bastos M.	Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis.##Membrane structure and interactions of a short Lycotoxin I analogue.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP03279	KIKWFKTMKSIAKFIAKEQMKKHLGGE	27	M-lycotoxin-Hc2a (M-LCTX-Hc2a; Lycotoxin-2; Lycotoxin II; spiders, Arthropods, animals)	P61508	Not found	Not found	Hogna carolinensis (Carolina wolf spider) (Lycosa carolinensis) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		Function: Forms pore that permeabilize the cell membrane. Promotes efflux of calcium from synaptosomes, causes hemolysis, and dissipates voltage gradients across muscle membrane. Potently inhibits the growth of bacteria, yeast and Leishmania. May Function: both in the prey capture strategy as well as protection from infectious organisms arising from prey ingestion.	Gram-positive bacteria: Bacillus thuringiensis subsp. Israelensis (MIC=10-60 µM);##Gram-negative bacteria: Escherichia coli D31 (MIC<10 µM), Escherichia coli DH5 (MIC<40 µM).##Fungi: Candida glabrata ATCC 2001 (MIC=100-150 µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Cell membrane	9442044##18098329	J Biol Chem. 1998 Jan 23;273(4):2059-2066.##J Pept Sci. 2008 Apr;14(4):528-534.	Yan L, Adams ME.##Adão R, Seixas R, Gomes P, Pessoa JC, Bastos M.	Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis.##Membrane structure and interactions of a short Lycotoxin I analogue.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP03280	ATYDGKCYKKDNICKYKAQSGKTAICKCYVKVCPRDGAKCEFDSYKGKCYC	51	AcAMP (A. clavatus antimicrobial peptide)	No entry found	Not found	Not found	Aspergillus clavatus ES1	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral, Antifungal	Not found	Not found	Not found		This basic, Cys-rich antifungal peptide is also active against bacteria. AcAMP was sensitive to proteolytic enzymes, stable between pH 5.0 and 10.0, and heat resistant (15 min at 100 degrees C). 	Gram-positive bacteria: Staphylococcus aureus (MIC=20 µg/ml), Bacillus cereus (MIC=10 µg/ml), Micrococcus luteus (MIC=10 µg/ml), Enterococcus faecalis (MIC=50 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=30 µg/ml), Pseudomonas aeruginosa (MIC=50 µg/ml).##Fungi: Aspergillus niger, Fusarium solani, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization(Cys33 and Cys51).	Disulfide bonds between Cys7 and Cys26,Cys14 and Cys40,Cys28 and Cys49,Cys33 and Cys51.	L	Not included yet	Not found	20440534	J Ind Microbiol Biotechnol. 2010 Aug;37(8):805-813.	Hajji M, Jellouli K, Hmidet N, Balti R, Sellami-Kamoun A, Nasri M.	A highly thermostable antimicrobial peptide from Aspergillus clavatus ES1: biochemical and molecular characterization.	
DRAMP03285	LFCRKGTCHFGGCPAHLVKVGSCFGFRACCKWPWDV	36	Ostricacin-1 (Beta-defensin 2; Birds, animals)	P85113	Belongs to the beta-defensin family	Not found	Struthio camelus (Ostrich)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		PTM: Contains three disulfide bonds 3-29; 8-23; 13-30.	Gram-positive bacteria: Staphylococcus aureus 1056-MRSA (MIC=1.25 µg/ml), S. aureus NCTC 4163 (MIC=6.7 µg/ml);##Gram-negative bacteria: Escherichia coli O157:H7 (MIC=0.96 µg/ml), E. coli 0111 (MIC=6.7 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys29,Cys8 and Cys23,Cys13 and Cys30.	L	No cytotoxicity information found	Not found	16459058	Biotechnol Lett 2001; 23: 207-210.##Int J Antimicrob Agents. 2006 Mar;27(3):229-235.	Yu, PL, Choudhury SD, Ahrens K.##Sugiarto H, Yu PL.	Purification and characterization of the antimicrobial peptide, ostricacin.##Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.	CC(C)C[C@@H]1NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N3)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N2
DRAMP03286	APGNKAECEREKGYCGFLKCSFPFVVSGKCSRFFFCCKNIW	41	Ostricacin-2 (Beta-defensin 1; Birds, animals)	P85114	Belongs to the beta-defensin family	Not found	Struthio camelus (Ostrich)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		PTM: Contains three disulfide bonds 8-36; 15-30; 20-37.	Gram-positive bacterium: Staphylococcus aureus 1056-MRSA (MIC=1.25 µg/ml);##Gram-negative bacterium: Escherichia coli O157:H7 (MIC=0.96 µg/ml);##Yeast: Candida albicans 3153A (MIC=6.2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys8 and Cys36,Cys15 and Cys30,Cys20 and Cys37.	L	No cytotoxicity information found	Not found	16459058	Int J Antimicrob Agents. 2006 Mar;27(3):229-235.	Sugiarto H, Yu PL.	Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc3ccccc3)NC(=O)CNC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N3)C(=O)N1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP03287	IPRPLDPCIAQNGRCFTGICRYPYFWIGTCRNGKSCCRRR	40	Ostricacin-3 (Beta-defensin 7; Birds, animals)	P85115	Belongs to the beta-defensin family	Not found	Struthio camelus (Ostrich)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		PTM: Contains three disulfide bonds 8-36; 15-30; 20-37.	Gram-positive bacterium: Staphylococcus aureus 1056-MRSA (MIC=2.78 µg/ml);##Gram-negative bacterium: Escherichia coli O157:H7 (MIC=2.41 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys8 and Cys36,Cys15 and Cys30,Cys20 and Cys37.	L	No cytotoxicity information found	Not found	16459058	Int J Antimicrob Agents. 2006 Mar;27(3):229-235.	Sugiarto H, Yu PL.	Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.	CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H]([C@H](C)CC)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H]([C@H](C)CC)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC2=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H]([C@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N3
DRAMP03288	LPVNEAQCRQVGGYCGLRICNFPSRFLGLCTRNHPCCSRVWV	42	Ostricacin-4 (Beta-defensin 8; Birds, animals)	P85116	Belongs to the beta-defensin family	Not found	Struthio camelus (Ostrich)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		PTM: Contains three disulfide bonds 8-36; 15-30; 20-37.	Gram-positive bacterium: Staphylococcus aureus 1056-MRSA (MIC=11.48 µg/ml);##Gram-negative bacterium: Escherichia coli O157:H7 (MIC=12.03 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys8 and Cys36,Cys15 and Cys30,Cys20 and Cys37.	L	No cytotoxicity information found	Not found	16459058	Int J Antimicrob Agents. 2006 Mar;27(3):229-235.	Sugiarto H, Yu PL.	Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H]4CCCN4C(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)N2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC3=O)NC1=O
DRAMP03311	RGFRKHFNKLVKKVKHTISETAHVAKDTAVIAGSGAAVVAAT	42	Stomoxyn (Insects, animals)	Q8T9R8	Not found	Not found	Stomoxys calcitrans (Stable fly)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix (4 helices; 32 residues)	Stomoxyn adoptS a flexible random coil structure in water while both assume a stable helical structure in the presence of TFE. In 50% TFE, the structure of stomoxyn is typical of cecropins, including an amphipathic helix at the N-terminus and a hydrophobic C-terminus with helical features that probably fold in a helical conformation at higher TFE concentration. (Ref.2)	1ZRX resolved by NMR.	"Function: Has antimicrobial activity against most Gram-positive and Gram-negative bacteria, filamentous fungi and yeasts tested. Has trypanolytic effect on T.b.rhodesiense and hemolytic activity against bovine red blood cells. May play an important role in protecting the stored blood in the anterior midgut from microorganisms prior to digestion. Adopts an amphipathic alpha-helical structure only in the presence of an organic solvent that mimics a phospholipid membrane.
Tissue specificity: Constitutively expressed in the adult anterior midgut; proventriculus, thoracic and reservoir regions."	[Ref.12372834]Gram-negative bacteria: Escherichia coli K12 RM148 (MIC=0.19-0.39 µM), E. coli D22 (MIC=0.19-0.39 µM), E. coli D31(MIC=0.19-0.39 µM), E. coli SBS363 (MIC<0.19 µM), E. coli 1106 (MIC=0.19-0.39 µM), Enterobacter cloacae b12 (MIC=3.12-6.25 µM), Erwinia carotovora (MIC=0.78-1.56 µM), Klebsiella pneumoniae (MIC=0.78-1.56 µM), Pseudomonas aeruginosa (MIC=0.39-0.78 µM), Salmonella typhimurium (MIC=0.39-0.78 µM), Xanthomonas campestris ( MIC=0.39-0.78 µM);##Gram-positive bacteria: Aerococcus viridans (MIC=0.78-1.56 µM), Bacillus megaterium (MIC=0.78-1.56 µM), Bacillus subtilis (MIC=6.25-12.5 µM), Enterococcus faecalis (MIC=0.78-1.56 µM), Micrococcus luteus (MIC=0.78-1.56 µM), Streptococcus pyogenes (MIC=1.56-3.12 µM);##Fungi: Aspergillus fumigatus (MIC=50-100 µM), Fusarium culmorum (MIC=0.39-0.78 µM), Fusarium oxysporum (MIC=0.78-1.56 µM), Nectria haematococca (MIC=0.39-0.78 µM), N. crassa (MIC=3.12-6.25 µM), Trichoderma viride (MIC=1.56-3.12 µM), Trichophyton mentagrophytes (MIC=3.12-6.25 µM), Candida albicans (MIC=25-50 µM), C. glabrata (MIC=25-50 µM), C. neoformans (MIC=0.78-1.56 µM).	[Ref.12372834]2% hemolytic activity at 10 μM, 9% hemolytic activity at 100 μM against bovine red blood cells	Linear	Free	Amidation	Free	L	Not included yet	Not found	12372834##16170803	J. Biol. Chem. 2002; 277: 49921-49926.##Biopolymers. 2006 Feb 5;81(2):92-103.	Nathalie Boulanger, Rebecca J. L. Munks, Joanne V. Hamilton, Françoise Vovelle, Reto Brun, Mike J. Lehane, and Philippe Bulet.##Landon C, Meudal H, Boulanger N, Bulet P, Vovelle F.	Epithelial innate immunity. A novel antimicrobial peptide with antiparasitic activity in the blood-sucking insect Stomoxys calcitrans.##Solution structures of stomoxyn and spinigerin, two insect antimicrobial peptides with an alpha-helical conformation.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)[C@@H](C)O)C(C)C)C(C)C
DRAMP03312	VDKPDYRPRPRPPNM	15	Metalnikowin-1 (Metalnikowin I; Insects, animals)	P80408	Not found	Not found	Palomena prasina (Green shield bug) (Cimex prasinus)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Rich	Not found		"Function: Antibacterial peptide active against Gram-negative bacteria.
Induction: By bacterial infection."	Gram-negative bacteria: Escherichia coli D22 (MIC=50-100 µM), Salmonella typhimurium (MIC=50-100 µM), Alcaligenes faecalis (MIC=50-100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	PubMed ID is not available	J. Insect Physiol. 1996; 42: 81-89.	Chernysh S, Cociancich S, Briand JP, Hetru C, Bulet P.	The inducible antibacterial peptides of the hemipteran insect Palomena prasina: identification of a unique family of proline-rich peptides and of a novel insect defensin.	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)O
DRAMP03320	GEILCNLCTGLINTLENLLTTKGADKVKDYISSLCNKASGFIATLCTKVLDFGIDKLIQLIEDKVDANAICAKIHAC	77	Pore-forming peptide ameobapore A (EH-APP; saposin-like protein)	P34095, Q24839	Not found	Not found	Entamoeba histolytica (protozoan parasite)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix (5 helices; 53 residues)	Amoebapore A belongs to the superfamily of saposin-like proteins that are characterized by a conserved disulfide bond pattern and a fold consisting of five helices.(Ref.3)	1OF9 resolved by NMR.	Forms pores in the cytoplasmic membrane of host cells. Implicated in the cytolytic activity of the parasite.	Gram-positive bacteria: Micrococcus luteus (MIC=1.9 µM), Bacillus megaterium (MIC=13 µM), Bacillus subtilis (MIC=27 µM), Staphylococcus aureus (MIC>15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization(Cys5 and Cys77).	Disulfide bonds between Cys5 and Cys77,Cys8 and Cys71,Cys35 and Cys46.	L	No cytotoxicity information found	Cell membrane	7715451##8146160##14970207	Mol Microbiol. 1994 Dec;14(5):895-904.##Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2602-2606.##J Biol Chem. 2004 Apr 23;279(17):17834-41.	Leippe M, Andrä J, Nickel R, Tannich E, Müller-Eberhard HJ.##Leippe M, Andrä J, Müller-Eberhard HJ.##Hecht O, Van Nuland NA, Schleinkofer K, Dingley AJ, Bruhn H, Leippe M, Grötzinger J.	Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes.##Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.##Solution structure of the pore-forming protein of Entamoeba histolytica.	
DRAMP03321	VISIIPV	7	Colutellin-A	P86168	Not found	Not found	Colletotrichum dematium (Anthracnose fungus)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Fungi: Sclerotinia sclerotiorum (MIC=32.4 µg/ml after 288 hours), Botrytis cinerea (MIC=10.8 µg/ml after 288 hours),Fusarium solani, Aspergillus fumigatus, Geotrichum candidum.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Free	L	[Ref.18599825] It has less cytotoxicity against human PBMCs.	Not found	18599825	Microbiology. 2008 Jul;154(Pt 7):1973-1979.	Ren Y, Strobel GA, Graff JC, Jutila M, Park SG, Gosh S, Teplow D, Condron M, Pang E, Hess WM, Moore E.	Colutellin A, an immunosuppressive peptide from Colletotrichum dematium.	
DRAMP03370	QLINSPVTCMSYGGSCQRSCNGGFRLGGHCGHPKIRCCRRK	41	Beta-defensin 6 (BD-6, mBD-6; Defensin, beta 6; Rodents, mammals, animals)	Q91VD6	Belongs to the beta-defensin family	Defb6	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram-	Transcript level	Bridge	Not found		"PTM: Contains three disulfide bonds 9-37; 16-30; 20-38.
Predominantly expressed in skeletal muscle, also expressed in esophagus, tongue, and trachea. Also expressed in lung when induced by lipopolysaccharide. Expressed constitutively and induced by lipopolysaccharide (LPS)."	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=20 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys9 and Cys37,Cys16 and Cys30,Cys20 and Cys38.	L	No cytotoxicity information found	Not found	11408484	J Biol Chem. 2001 Aug 24;276(34):31510-31514.	Yamaguchi Y, Fukuhara S, Nagase T, Tomita T, Hitomi S, Kimura S, Kurihara H, Ouchi Y.	A novel mouse beta-defensin, mBD-6, predominantly expressed in skeletal muscle.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)CNC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]4CCCN4C(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(C)C)[C@@H](C)O)CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC1=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC3=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N2
DRAMP03405	GLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE	33	mCRAMP-1 (mouse cathelin-related antimicrobial peptide 1; cathelicidin; Rodents, mammals, animals	P51437, Q0VB78	Not found	Camp	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Alpha helix (CD)	The spectra of 10-25 µm synthetic CRAMP-1 in buffer suggest that the peptide is in a random coil configuration and that it will assume a helical structure in the presence of 15–45% (v/v) trifluoroethanol.		"Function: Acts as a potent antimicrobial peptide.
Tissue specificity: Expressed in testis, spleen, stomach, and intestine. Very low expression found in heart, lung and skeletal muscle. No expression in brain, kidney or liver."	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 µM), Escherichia coli ML35 (MIC=2 µM), Escherichia coli D21 (MIC=8 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=4 µM), Serratia marcescens ATCC 8100 (MIC=4 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=32 µM), Staphylococcus aureus Cowan I (MIC=32 µM), Staphylococcus aureus (MRSA) (MIC>64 µM), Staphylococcus aureus (MRSA) (MIC=64 µM), Staphylococcus epidermidis ATCC 12228 (MIC=16 µM), Streptococcus faecalis ATCC 29212 (MIC=16 µM), Bacillus megaterium Bm11 (MIC=4 µM).##Fungi: Candida albicans (MIC>64 µM), Cryptococcus neoformans (MIC=16 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	9148921##8706928	J Biol Chem. 1997 May 16;272(20):13088-13093.##FEBS Lett. 1996 Aug 5;391(1-2):5-8.	Gallo RL, Kim KJ, Bernfield M, Kozak CA, Zanetti M, Merluzzi L, Gennaro R.##Popsueva AE, Zinovjeva MV, Visser JW, Zijlmans JM, Fibbe WE, Belyavsky AV.	Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse.##A novel murine cathelin-like protein expressed in bone marrow.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP03406	ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE	38	mCRAMP-2 (mouse cathelin-related antimicrobial peptide 2; cathelicidin; Rodents, mammals, animals	P51437, Q0VB78	Not found	Camp	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Alpha helix (CD)	The CD spectra of CRAMP-2 (not shown) were similar to CRAMP-1.		"Function: Acts as a potent antimicrobial peptide.
Tissue specificity: Expressed in testis, spleen, stomach, and intestine. Very low expression found in heart, lung and skeletal muscle. No expression in brain, kidney or liver."	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 µM), Escherichia coli ML35 (MIC=2 µM), Escherichia coli D21 (MIC=8 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=4 µM), Serratia marcescens ATCC 8100 (MIC=4 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=32 µM), Staphylococcus aureus Cowan I (MIC=32 µM), Staphylococcus aureus (MRSA) (MIC>64 µM), Staphylococcus aureus (MRSA) (MIC=64 µM), Staphylococcus epidermidis ATCC 12228 (MIC=16 µM), Streptococcus faecalis ATCC 29212 (MIC=32 µM), Bacillus megaterium Bm11 (MIC=4 µM).##Fungi: Candida albicans (MIC>64 µM), Cryptococcus neoformans (MIC=16 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	9148921##8706928	J Biol Chem. 1997 May 16;272(20):13088-13093.##FEBS Lett. 1996 Aug 5;391(1-2):5-8.	Gallo RL, Kim KJ, Bernfield M, Kozak CA, Zanetti M, Merluzzi L, Gennaro R.##Popsueva AE, Zinovjeva MV, Visser JW, Zijlmans JM, Fibbe WE, Belyavsky AV.	Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse.##A novel murine cathelin-like protein expressed in bone marrow.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP03419	VTCYCRRTRCGFRERLSGACGYRGRIYRLCCR	32	Neutrophil antibiotic peptide NP-1 (RatNP-1; Rodents, mammals, animals)	Q62716	Belongs to the alpha-defensin family	Not found	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		Comment: Active in vitro against S. aureus, fungi, Gram-positive and Gram-negative bacteria and to a lesser extent against an enveloped virus.	Gram-positive bacterium: Staphylococcus aureus 502A [18 h] (MIC<100 cfu/ml);##Gram-negative bacterium: Escherichia coli ML-35 [18 h] (MIC<100 cfu/ml).##Fungi: Candida albicans 820 [18 h] (MIC<100 cfu/ml), Cryptococcus neoformans A-383 [18 h] (MIC=1.7 x 102 cfu/ml). 	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.	L	No cytotoxicity information found	Not found	2543629##7594610	Infect. Immun. 1989;57:2021-2027.##J. Immunol. 1995;155:4476-4484.	Eisenhauer P.B, Harwig S.S.S.L, Szklarek D, Ganz T, Selsted M.E, Lehrer R.I.##Yount N.Y, Wang MS.C, Yuan J, Banaiee N, Ouellette A.J, Selsted M.E.	Purification and antimicrobial properties of three defensins from rat neutrophils.##Rat neutrophil defensins. Precursor structures and expression during neutrophilic myelopoiesis.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)NCC(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
DRAMP03422	ACYCRIGACVSGERLTGACGLNGRIYRLCCR	31	Neutrophil antibiotic peptide NP-4 (RatNP-4; Rodents, mammals, animals)	Q62714	Belongs to the alpha-defensin family	Np4	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral, Antifungal	Protein level	Bridge	Not found		Active in vitro against S. aureus, fungi, Gram-positive and Gram-negative bacteria and to a lesser extent against an enveloped virus.	Gram-positive bacterium: Staphylococcus aureus 502A (MIC=50 µg/ml);##Gram-negative bacteria: Escherichia coli ML-35, Acinetobacter calcoaceticus (MIC=50 µg/ml).Fungi: Cryptococcus neoformans (MIC=10 µg/ml), Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys2 and Cys30,Cys4 and Cys19,Cys9 and Cys29.	L	No cytotoxicity information found	Not found	2543629##7594610	Infect. Immun. 1989;57:2021-2027.##J. Immunol. 1995;155:4476-4484.	Eisenhauer P.B, Harwig S.S.S.L, Szklarek D, Ganz T, Selsted M.E, Lehrer R.I.##Yount N.Y, Wang MS.C, Yuan J, Banaiee N, Ouellette A.J, Selsted M.E.	Purification and antimicrobial properties of three defensins from rat neutrophils.##Rat neutrophil defensins. Precursor structures and expression during neutrophilic myelopoiesis.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC3=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)CSSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N2)NC(=O)[C@H](C)NC(=O)CNC1=O
DRAMP03463	GLVRKGGEKFGEKLRKIGQKIKEFFQKLALEIEQ	34	rCRAMP (rat cathelin-related antimicrobial peptide; Rodents, mammals, animals)	No entry found	Not found	Not found	Rattus norvegicus (Norway rat)	Antimicrobial, Antibacterial	Not found	Alpha helix 	Not found		Function: Has antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[No NaCl]: Escherichia coli DH5a (MIC=0.54 µM), E. coli ML-35p (MIC=1.55 µM), Pseudomonas aeruginosa PAO1 (MIC=0.69 µM), Pseudomonas aeruginosa MR3007 (MIC=2.01 µM); Staphylococcus aureus ATCC (MRSA) 33591 (MIC=3.19 µM), Staphylococcus aureus 93918 (MIC=2.14 µM).##[100 mM NaCl]: Escherichia coli DH5a (MIC=0.61 µM), Escherichia coli ML-35p (MIC=0.66 µM), Pseudomonas aeruginosa PAO1 (MIC=1.17 µM), Pseudomonas aeruginosa MR3007 (MIC=1.78 µM), Staphylococcus aureus ATCC (MRSA) 33591 (MIC>20.1 µM), Staphylococcus aureus 93918 (MIC=2.16 µM). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	10768969	Infect Immun. 2000 May;68(5):2748-2755.	Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray PB Jr, Lehrer RI, Welsh MJ, Tack BF.	Bactericidal activity of mammalian cathelicidin-derived peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP03464	GLLNGLALRLGKRALKKIIKRLCR	24	Cryptonin (Insects, animals)	P85028	Not found	Not found	Cryptotympana dubia (Korean horse cicada)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		Function: Has very low hemolytic activity on rat erythrocytes. 	[Ref.18000874]Gram-positive bacteria: Bacillus subtilis KCTC 3086 (MIC=3.12 µg/ml), Staphylococcus aureus KCTC 1928 (MIC=25 µg/ml), Micrococcus luteus KCTC 3063 (MIC=1.56 µg/ml), Staphylococcus aureus (MRSA) (MIC=25 µg/ml), VRE (MIC=25 µg/ml);##Gram-negative bacteria: Escherichia coli K12-594 (MIC=3.12 µg/ml);##Fungi: Candida albicans KCTC 7965 (MIC=50 µg/ml), Candida tropicalis KCTC 1925 (MIC=3.12 µg/ml).	[Ref.18000874]<5% hemolytic activity at 25-200 µg/ml against rat erythrocytes	Linear	Free	Free	Free	L	Not included yet	Not found	18000874	Arch Insect Biochem Physiol. 2007 Dec;66(4):204-213.	Leem JY, Park DS, Suh EY, Hur JH, Oh HW, Park HY.	Isolation and functional analysis of a 24-residue linear alpha-helical antimicrobial peptide from Korean blackish cicada, Cryptotympana dubia (Homoptera).	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP03465	NEYHGFVDKANNENKRKKQQGRDDFVVKPNNFANRRRKDDYNENYYDDVDAADVV	55	Cicadin (Insects, animals)	P83282	Not found	Not found	Cicada flammata 	Antimicrobial, Antifungal, Antiviral	Protein level	Not found	Not found		Function: Possesses antifungal activity against B.cinerea, M.arachidicola, F.oxysporum, R.solani and C.comatus. Suppresses the activity of HIV-1 reverse transcriptase and stimulates the proliferation of murine splenocytes.	Fungi: Botrytis cinerea (MIC=100 nM), Mycosphaerella arachidicola (MIC=70 nM), Fusarium oxysporum (MIC=180 nM), Physalospora piricola (MIC=60 nM), Rhizoctonia solani, Coprinus comatus, HIV-1 reverse transcriptase.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	11814612	Peptides. 2002;23:7-11.	Wang H, Ng TB.	Isolation of cicadin, a novel and potent antifungal peptide from dried juvenile cicadas.	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)O
DRAMP03467	PAQPFRFPKHPQGPQTRPPI	20	Antibacterial napin (Plants)	P84529	Belongs to the 2S seed storage albumins family	Not found	Brassica rapa subsp. chinensis (Pak-choi)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: The small, basic, water-soluble napins are one of the two major kinds of storage proteins synthesized in the seed during its maturation. Inhibits cell-free protein synthesis. Has antibacterial activity against Gram-negative bacterium P. fluorescens, and the Gram-positive bacteria B. subtilis, B. cereus, B. megaterium and M. phei. No antibacterial activity against the Gram-positive bacterium S. aureus or the Gram-negative bacteria E. coli, E. aerogenes and P. aeruginosa.
Subunit structure: The mature protein consists of a small and a large chain linked by disulfide bonds."	Gram-negative bacterium: Pseudomonas fluorescens (MIC=66±3.7 µM);##Gram-positive bacteria: Bacillus subtilis (MIC=236±10.2 µM), Bacillus cereus (MIC=222±9.1 µM), Bacillus megaterium (MIC=215±6.8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	15062997	Peptides. 2004 Feb;25(2):171-176.	Ngai PH, Ng TB.	A napin-like polypeptide from dwarf Chinese white cabbage seeds with translation-inhibitory, trypsin-inhibitory, and antibacterial activities.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)O
DRAMP03471	GFGCPGNQLKCNNHCKSISCRAGYCDAATLWLRCTCTDCNGKK	43	Recombinant Crassostrea Gigas Defensin (Cg-Def; molluscs, animals)	Q4GWV4	Not found	def	Crassostrea gigas (Pacific oyster)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Combine helix and strand structure	Not found	2B68 resolved by NMR.	Function: Has antibacterial activity (By similarity).	Gram-positive bacteria: Micrococcus lysodeikticus (MIC=0.005-0.01 µM), Staphylococcus aureus (MIC=1.25-2.5 µM), Microbacterium maritypicum (MIC=0.5-1 µM), Bacillus megaterium (MIC>20 µM);##Gram-negative bacteria: Escherichia coli 363 (MIC=35-20 µM), Vibrio alginolyticus (MIC>20 µM), Salmonella typhimurium (MIC>20 µM).##Fungi: Fusarium oxysporum (MIC=9-4.5 µM), Botrytis cinerea (MIC>20 µM), Penicillium crustosum (MIC>20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys4 and Cys25,Cys11 and Cys34,Cys15 and Cys36,Cys20 and Cys39.	Not included yet	Not included yet	Lipid II	16246846	J Biol Chem. 2006 Jan 6;281(1):313-323.	Gueguen Y, Herpin A, Aumelas A, Garnier J, Fievet J, Escoubas JM, Bulet P, Gonzalez M, Lelong C, Favrel P, Bachère E.	Characterization of a defensin from the oyster Crassostrea gigas. Recombinant production, folding, solution structure, antimicrobial activities, and gene expression.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H]5CCCN5C(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc5ccccc5)NC(=O)CN)CSSC[C@H](NC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC3=O)NC(=O)[C@H](CO)NC1=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N2
DRAMP03472	MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLR	74	cgUbiquitin	No entry found	Not found	Not found	Crassostrea gigas (Pacific oyster)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Combine helix and strand structure	According to the homology modeling, this peptide is composed of three secondary structural motifs including three α-helices and four β-strands separated by 7 loops regions.	1AAR##1CMX##1D3Z####2AYO	Function: cgUbiquitin shows broad potent antimicrobial activity against Gram-positive and -negative bacteria, without hemolytic activity.	[Ref.22858580]Gram-positive bacteria: B. subtilis KCTC1021 (MIC=0.4 µM), S. aureus RM4220 (MIC=4.7 µM), S. iniae FP5229 (MIC=0.9 µM);##Gram-negative bacteria: E. coli D31 (MIC=0.2 µM), E. coli ML35p (MIC=1.4 µM), P. aeruginosa KCTC2004 (MIC=0.6 µM), S. flexneri KCTC2517 (MIC=0.7 µM), S. sonnei KCTC2009 (MIC=1.2 µM), A. hydrophila KCTC2358 (MIC=0.7 µM), V. parahemolyticus KCCM41664 (MIC=1.1 µM);##Yeast: C. albicans KCTC7965 (MIC=9.4 µM).	[Ref.22858580]Non-hemolytic against human red blood cells up to 100 μg/mL	Linear	Free	Free	Free	L	Not included yet	Not found	22858580	Mol Immunol. 2013 Jan;53(1-2):88-98.	Seo JK, Lee MJ, Go HJ, Kim GD, Jeong HD, Nam BH, Park NG.	Purification and antimicrobial function of ubiquitin isolated from the gill of Pacific oyster, Crassostrea gigas.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)[C@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O
DRAMP03474	VRPYLVAF	8	Pleurostatin (Fungus)	P84866	Not found	Not found	Pleurotus ostreatus (Oyster mushroom)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	20% growth inhibition Fusarium oxysporum (MIC=15.6 µM).##45% growth inhibition Mycosphaerella arachidicola (MIC=15.6 µM).##63% growth inhibition Physalospora piricola (MIC=15.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	15941607	Peptides. 2005 Nov;26(11):2098-103. Epub 2005 Jun 6.	Chu K.T, Xia L, Ng T.B. 	Pleurostrin, an antifungal peptide from the oyster mushroom	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP03477	ILGTILGLLKSL	12	Polybia-CP (Polybia chemotactic peptide; Venom protein CP; Insects, animals)	P0C1R0, P84879	Not found	Not found	Polybia paulista (Neotropical social wasp) (Swarm-founding polistine wasp)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix 	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis CCT 2576 (MIC=15 µg/ml), Staphylococcus aureus ATCC 6538 (MIC=15 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16129513##28981608	Peptides. 2005 Nov;26(11):2157-2164.##Acta Biochim Biophys Sin (Shanghai). 2017 Oct 1;49(10):916-925.	Souza BM, Mendes MA, Santos LD, Marques MR, César LM, Almeida RN, Pagnocca FC, Konno K, Palma MS.##Jia F, Wang J, Peng J, Zhao P, Kong Z, Wang K, Yan W, Wang R.	Structural and functional characterization of two novel peptide toxins isolated from the venom of the social wasp Polybia paulista.##D-amino acid substitution enhances the stability of antimicrobial peptide polybia-CP.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@@H](C)O
DRAMP03486	GKIPVKAIKQAGKVIGKGLRAINIAGTTHDVVSFFRPKKKKH	42	Manduca Sexta Moricin (MS moricin; Insects, animals)	Q86MA1	Not found	Not found	Manduca sexta (Tobacco hornworm)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix (1 helices; 31 residues)	The tertiary structure is composed of an eight-turn alpha-helix spanning almost the entire peptide. Insights of relationships between the structure and function are also presented. (Ref.1)	2JR8 resolved by NMR.	"Function: Exhibits potent antimicrobial activities against a broad spectrum of Gram-positive and Gram-negative bacteria with a minimum inhibitory concentration of 1.4 microM.
Tissue specificity: expressed in Manduca sexta fat body."	Gram-negative bacteria: Klebsiella pneumoniae (MIC=6.25 µg/ml), Salmonella typhimurium (MIC=6.25 µg/ml), S. typhimurium DT104 (MIC=6.25 µg/ml), Escherichia coli O157:H7 (MIC=6.25 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25 923 (MIC=6.25 µg/ml), Methicillin-resistant S. aureus ATCC 43 300 (MIC=6.25 µg/ml), Methicillin-resistant S. aureus ATCC BAA-39 (MIC=12.5 µg/ml), Listeria monocytogenes (MIC=6.25 µg/ml).##NOTE: MIC is deï¬ned as the lowest peptide concentration that gives no visible growth after overnight incubation in 100% Muller-Hinton broth.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	18265434##12706633	J Pept Sci. 2008 Jul;14(7):855-863.##Insect Biochem Mol Biol. 2003 May;33(5):541-59.	Dai H, Rayaprolu S, Gong Y, Huang R, Prakash O, Jiang H.##Zhu Y, Johnson TJ, Myers AA, Kanost MR.	Solution structure, antibacterial activity, and expression profile of Manduca sexta moricin.##Identification by subtractive suppression hybridization of bacteria-induced genes expressed in Manduca sexta fat body.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C
DRAMP03493	DKLIGSCVWGAVNYTSDCNGECKRRGYKGGHCGSFANVNCWCET	44	Defensin heliomicin (Insects, animals)	P81544	Not found	Not found	Heliothis virescens (Tobacco budworm moth)	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	Not found	1I2U,1I2V resolved by NMR. 	Similar to plant defensin RsAFP2 (also in structure), it interacts with glucosylceramide isolated from the membranes of yeast and soybean but not humans (J Biol Chem 2004; 279: 3900-3905). Transgenic plants: expression of this peptide in tobacco improves resistance to pathogens (Montesinos E 2007 FEMS Microbiol Lett 270, 1-11).	Fungi: Neurospora crassa (MIC=0.1-0.2 µM), Fusarium culmorum (MIC=0.2-0.4 µM), Fusarium oxysporum (MIC=1.5-3 µM), Nectria haematococca (MIC=0.4-0.8 µM), Aspergillus fumigatus (MIC=6-12 µM), Trichoderma viride (MIC=1.5-3 µM), Candida albicans (MIC=2.5-5 µM), Cryptococcus neoformans (MIC=2.5-5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys7 and Cys32,Cys18 and Cys40, Cys22 and Cys42.	Not included yet	Not included yet	Not found	10092609##11580275	J Biol Chem. 1999 Apr 2;274(14):9320-9326.##Biochemistry. 2001 Oct 9;40(40):11995-2003.	Lamberty M, Ades S, Uttenweiler-Joseph S, Brookhart G, Bushey D, Hoffmann JA, Bulet P.##Lamberty M, Caille A, Landon C, Tassin-Moindrot S, Hetru C, Bulet P, Vovelle F.	Insect immunity. Isolation from the lepidopteran Heliothis virescens of a novel insect defensin with potent antifungal activity.##Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](C(C)C)NC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC2=O
DRAMP03507	KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL	35	Cecropin-B (Insects, animals)	P01509	Belongs to the cecropin family	Not found	Antheraea pernyi (Chinese oak silkmoth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli D21 (MIC=0.36 µM), Escherichia coli D31 (MIC=0.30 µM), Serratia marsescens (MIC=2.6 µM), Serratia marsescens Strain 122 (MIC=12 µM), Pseudomonas aeruginosa OT97 (MIC=2.9 µM), Xenorhabdus nematophilus Xn21 (MIC=1.6 µM);##Gram-positive bacteria: Bacillus subtilis Bsll (MIC=17 µM), Bacillus megaterium Bmll (MIC=0.64 µM), Bacillus thuringiensis Btll (MIC>88 µM), Streptococcus fecalis Ds16 (MIC>88 µM), Streptococcus fecalis AD-4 (MIC>88 µM), Micrococcus luteus MI11 (MIC=0.29 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	6754375##2962676	Eur J Biochem. 1982 Sep;127(1):219-224.##Biomed Environ Mass Spectrom. 1987 Nov;14(11):669-673.	Qu Z, Steiner H, Engström A, Bennich H, Boman HG.##Craig AG, Engström A, Bennich H, Kamensky I.	Insect immunity: isolation and structure of cecropins B and D from pupae of the Chinese oak silk moth, Antheraea pernyi.##Plasma desorption mass spectrometry coupled with conventional peptide sequencing techniques.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@H](C)CC
DRAMP03513	KVNVNAIKKGGKAIGKGFKVISAASTAHDVYEHIKNRRH	39	G. mellonella moricin-like peptide A (Gm-mlpA; Insects, animals; Predicted)	A5JSU5	Not found	mor	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=10 µM);##Gram-positive bacterium: Micrococcus luteus (MIC=10 µM).##Fungi: Fusarium graminearum mycelia (MIC=70 µM), F;##Graminearum spores (MIC=0.7 µM), Fusarium oxysporum mycelia (MIC=7 µM), F. oxysporum spores (MIC=10 µM), Ascochyta rabiei spores (MIC=7 µM), Leptosphaeria maculans spores (MIC=7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	18207081	Insect Biochem Mol Biol. 2008;38:201-212.	Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.	The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O)[C@H](C)CC)C(C)C
DRAMP03514	GKIPVKAIKKGGQIIGKALRGINIASTAHDIISQFKPKKKKNH	43	G. mellonella moricin-like peptide B (Gm-mlpB; Insects, animals; Predicted)	A5JSU6	Not found	mor	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacterium: Micrococcus luteus (MIC=100 µM).##Fungi: Fusarium graminearum spores (MIC=10 µM), F;##Graminearum mycelia (MIC=280 µM), Fusarium oxysporum spores (MIC=100 µM), F. oxysporum mycelia (MIC=280 µM), Leptosphaeria maculans spores (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	18207081	Insect Biochem Mol Biol. 2008;38:201-212.	Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.	The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP03515	KVPIGAIKKGGKIIKKGLGVIGAAGTAHEVYSHVKNRH	38	Moricin-like peptide C1 (Gm-mlpC1; Insects, animals; Predicted)	A5JSU7	Not found	mor	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=10 µM);##Gram-positive bacterium: Micrococcus luteus (MIC=100 µM).##Fungi: Fusarium graminearum spores (MIC=1 µM), Fusarium oxysporum spores (MIC=10 µM), Ascochyta rabiei spores (MIC=100 µM), Leptosphaeria maculans spores (MIC=6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	18207081	Insect Biochem Mol Biol. 2008;38:201-212.	Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.	The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP03516	KVPIGAIKKGGKIIKKGLGVLGAAGTAHEVYNHVRNRQ	38	Moricin-like peptide C2 (Gm-mlpC2; Insects, animals; Predicted)	A5JSU8	Not found	mor	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=10 µM);##Gram-positive bacterium: Micrococcus luteus (MIC=100 µM).##Fungi: Fusarium graminearum spores (MIC=1 µM), Fusarium oxysporum spores (MIC=10 µM), Ascochyta rabiei spores (MIC=100 µM), Leptosphaeria maculans spores (MIC=8 µM), Fusarium graminearum mycelia (MIC=8 µM), Fusarium oxysporum mycelia (MIC=8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	18207081	Insect Biochem Mol Biol. 2008;38:201-212.	Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.	The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP03517	KVPIGAIKKGGKIIKKGLGVIGAAGTAHEVYSHVKNRQ	38	Moricin-like peptide C3 (Gm-mlpC3; Insects, animals; Predicted)	A5JSU9	Not found	mor	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacterium: Micrococcus luteus (MIC=100 µM).##Fungi: Fusarium graminearum spores (MIC=10 µM), Fusarium oxysporum spores (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	18207081	Insect Biochem Mol Biol. 2008;38:201-212.	Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.	The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP03518	KVPVGAIKKGGKAIKTGLGVVGAAGTAHEVYSHIRNRH	38	Moricin-like peptide C4/C5 (Gm-mlpC4/C5; Insects, animals; Predicted)	A5JSV1	Not found	mor	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=100 µM).##Fungi: Fusarium graminearum spores (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	18207081	Insect Biochem Mol Biol. 2008;38:201-212.	Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.	The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@H](C)CC
DRAMP03519	KGIGSALKKGGKIIKGGLGALGAIGTGQQVYEHVQNRQ	38	Moricin-like peptide D (Gm-mlpD; Insects, animals; Predicted)	A5JSV2	Not found	mor	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=10 µM).##Fungi: Fusarium graminearum spores (MIC=10 µM), Fusarium oxysporum spores (MIC=100 µM), Ascochyta rabiei spores(MIC=100 µM), Leptosphaeria maculans spores (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	18207081	Insect Biochem Mol Biol. 2008;38:201-212.	Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.	The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP03520	ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD	39	Cecropin-D-like peptide (Insects, animals)	P85210	Not found	Not found	Galleria mellonella (greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Micrococcus luteus, Listeria monocytogenes, Sarcina Lutea, Escherichia coli D31(MIC=6.9-8.6 µM), Aspergillus niger.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	11995991##17194500	Acta Biochim Pol. 2001;48(4):1191-1195.##Peptides. 2007 Mar;28(3):533-546.	Mak P, Chmiel D, Gacek GJ.##Cytrynska M, Mak P, Zdybicka-Barabas A, Suder P, Jakubowicz T.	Antibacterial peptides of the moth Galleria mellonella.##Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP03521	DIQIPGIKKPTHRDIIIPNWNPNVRTQPWQRFGGNKS	37	Proline-rich antimicrobial peptide 1 (Insects, animals)	P85214	Not found	Not found	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Micrococcus luteus(MIC=55.0 µM).##Fungi: Pichia pastoris (MIC=16.5 µM), Zygosaccharomyces marxianus (MIC=16.5 µM), Schizosaccharomyces pombe (MIC=11 µM), candida wickerhamii (MIC=16.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	11995991##17194500	Acta Biochim Pol. 2001;48(4):1191-1195.##Peptides. 2007 Mar;28(3):533-546.	Mak P, Chmiel D, Gacek GJ.##Cytrynska M, Mak P, Zdybicka-Barabas A, Suder P, Jakubowicz T.	Antibacterial peptides of the moth Galleria mellonella.##Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)O
DRAMP03523	ETESTPDYLKNIQQQLEEYTKNFNTQVQNAFDSDKIKSEVNNFIESLGKILNTEKKEAPK	60	Anionic antimicrobial peptide 2 (Insects, animals)	P85216	Not found	Not found	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Micrococcus luteus(MIC=43.3-86.6 µM), Listeria monocytogenes (MIC=86.6 µM), Sarcina Lutea (MIC=86.6 µM).##Fungi: Pichia pastoris (MIC=43.3-86.6 µM), P. stipitis (MIC=43.3-86.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	17194500	Peptides. 2007;28:533-546.	Cytrynska M, Mak P, Zdybicka-Barabas A, Suder P, Jakubowicz T.	Purification and characterization of eight peptides from Galleria mellonella immune hemolymph	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)NC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
DRAMP03524	EADEPLWLYKGDNIERAPTTADHPILPSIIDDVKLDPNRRYA	42	Lebocin-like anionic peptide 1 (Insects, animals)	P85211	Not found	Not found	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Micrococcus luteus(MIC=22.7 µM), Listeria monocytogenes (MIC=90.9 µM).##Fungi: Aspergillus niger (MIC=90.9 µM), Trichoderma harzianum (MIC=90.9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	17194500	Peptides. 2007;28:533-546.	Cytrynska M, Mak P, Zdybicka-Barabas A, Suder P, Jakubowicz T.	Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP03525	VQETQKLAKTVGANLEETNKKLAPQIKSAYDDFVKQAQEVQKKLHEAASKQ	51	Apolipophorin-3 (Apolipophorin-III; Insects, animals)	P80703, O76946	Not found	Not found	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Listeria monocytogenes (MIC=6.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	17194500	Peptides. 2007 Mar;28(3):533-46.	CytryÅ„ska M, Mak P, Zdybicka-Barabas A, Suder P, Jakubowicz T.	Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP03526	EIRLPEPFRFPSPTVPKPIDIDPILPHPWSPRQTYPIIARRS	42	Proline-rich antimicrobial peptide 2 (Insects, animals)	P85212	Not found	Not found	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Micrococcus luteus (MIC=8.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	17194500	Peptides. 2007 Mar;28(3):533-546.	CytryÅ„ska M, Mak P, Zdybicka-Barabas A, Suder P, Jakubowicz T.	Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)C(=O)O
DRAMP03527	DKLIGSCVWGATNYTSDCNAECKRRGYKGGHCGSFWNVNCWCEE	44	Gm defensin-like peptide (Insects, animals)	P85215	Not found	Not found	Galleria mellonella (Greater wax moth)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Bridge	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Sarcina Lutea (MIC=1.9 µM).##Fungi: Aspergillus niger (MIC=2.9 µM), Candida albicans (MIC=2.9 µM), C. fructus (MIC=2.9 µM), Candida wickerhamii (MIC=2.9 µM), Pichia pastoris (MIC=2.9 µM), P. stiptis (MIC=2.9 µM), Pachysolen tannophilus (MIC=2.9 µM), Trichoderma harzianum (MIC=2.9 µM), Zygosaccharomyces marxianus (MIC=2.9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys7 and Cys32,Cys18 and Cys40, Cys22 and Cys42.	L	No cytotoxicity information found	Not found	17194500	Peptides. 2007 Mar;28(3):533-546.	CytryÅ„ska M, Mak P, Zdybicka-Barabas A, Suder P, Jakubowicz T.	Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](C(C)C)NC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c3ccccc13)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC2=O
DRAMP03528	DTLIGSCVWGATNYTSDCNAECKRRGYKGGHCGSFLNVNCWCE	43	Defensin (Galiomicin; Insects, animals)	P85213, Q6QR79	Not found	Not found	Galleria mellonella (Greater wax moth)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Fungi: Aspergillus niger (MIC=2.1 µM), Candida albicans (MIC=8.5 µM), C. fructus (MIC=8.5 µM), Fusarium oxysporum (MIC=16.9 µM), Pichia pastoris (MIC=16.9 µM), Pachysolen tannophilus (MIC=8.5 µM), Trichoderma harzianum (MIC=4.2 µM), Zygosaccharomyces Marxianus (MIC=8.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys7 and Cys32,Cys18 and Cys40, Cys22 and Cys42.	L	Not included yet	Not found	17194500##14728668	Peptides. 2007 Mar;28(3):533-546.##Insect Mol Biol 2004; 13: 65-72.	Cytrynska M, Mak P, Zdybicka-Barabas A, Suder P, Jakubowicz T.##Lee Y.S, Yun E.K, Jang W.S, Kim I, Lee J.H, Park S.Y, Ryu K.S, Seo S.J, Kim C.H, Lee I.H.	Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.##Purification, cDNA cloning and expression of an insect defensin from the great wax moth, Galleria mellonella.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](C(C)C)NC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC2=O
DRAMP03532	AKIPIKAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKH	42	Moricin-1 (Insects, animals)	P82818	Belongs to the moricin family	MOR1	Bombyx mori (Silk moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix (1 helices; 30 residues)	The solution structure reveals an unique structure comprising of a long alpha-helix containing eight turns along nearly the full length of the peptide except for four N-terminal residues and six C-terminal residues. The electrostatic surface map shows that the N-terminal segment of the alpha-helix, residues 5-22, is an amphipathic alpha-helix with a clear separation of hydrophobic and hydrophilic faces, and that the C-terminal segment o	1KV4 resolved by NMR.	Function: Has antibacterial activity against Gram-positive and Gram-negative bacteria. Probably acts by disturbing membrane functions with its amphipathic structure.	Gram-negative bacteria: Escherichia coli JM109 (MIC=0.31 µM), Acinetobacter sp. NISL B-4653 (MIC=0.27 µM), Pseudomonas fluorescens IAM1179 (MIC=0.53 µM), Pseudomonas aeruginosa IAM15140 (MIC=0.81 µM);##Gram-positive bacteria: Bacillus subtilis IAM1107 (MIC=0.19 µM), Bacillus megaterium IAM1030 (MI=0.09 µM), Bacillus cereus IFO3457 (MIC=0.38 µM), Staphylococcus aureus ATCC6538P (MIC=0.21 µM), Staphylococcus aureus ATCC6538P (MIC=0.22 µM), Staphylococcus aureus IFO3083 (MIC=0.46 µM), Staphylococcus xylosus IAM1312 (MIC=0.27 µM), Staphylococcus epidermidis IFO12993 (MIC=0.18 µM), Streptococcus pyogenes ATCC21547 (MIC=0.25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	8530391##11997013	J Biol Chem. 1995 Dec 15;270(50):29923-29927.##FEBS Lett. 2002 May 8;518(1-3):33-38.	Hara S, Yamakawa M.##Hemmi H, Ishibashi J, Hara S, Yamakawa M.	Moricin, a novel type of antibacterial peptide isolated from the silkworm, Bombyx mori.##Solution structure of moricin, an antibacterial peptide, isolated from the silkworm Bombyx mori.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)[C@H](C)CC
DRAMP03539	EWEPVQNGGSSYYMVPRIWA	20	Antifungal protein (Psc-AFP)	No entry found	Not found	Not found	Cullen corylifolium	Antimicrobial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Fungi: Alternaria brassicae (MIC=10 µM), Aspergillus niger (MIC=10 µM), Fusarium oxysporum (MIC=10 µM), Rhizoctonia cerealis (MIC=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	16530884	Peptides. 27:1726-1731(2006)	Yang X, Li J, Wang X, Fang W, Bidochka M.J, She R, Xiao Y, Pei Y.	Psc-AFP, an antifungal protein with trypsin inhibitor activity from Psoralea corylifolia seeds	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)O
DRAMP03540	CLAGRLDKQCTCRRSQPSRRSGHEVGRPSPHCGPSRQCGCHMD	43	Human drosomycin-like defensin (DLD; Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antifungal	Not found	Bridge 	Not found		Function: This is the first indication of an endogenous human peptide with specific antifungal activity, which is probably central in the defense against infections with molds.	Filamentous fungi: Aspergillus fumigatus (MIC=6.25 µM), A. nidulans (MIC=6.25 µM), A. ustus (MIC=12.5 µM), Fusarium solani (MIC=25 µM), F. oxysporum (MIC=6.25 µM), R. oryzae (MIC=6.25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Has three disulfide bonds	L	No cytotoxicity information found	Not found	18212107	Antimicrob Agents Chemother 2008; 52: 1407-1412.	Simon A et al Netea MG.	Drosomycin-like defensin, a human homologue of Drosophila melanogaster drosomycin with antifungal activity.	
DRAMP03562	FLAKAVAKAAAKALAKAL	18	P1 (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antifungal	Not found	Not found	Not found		Function: Presentes antifungal activity against Candida albicans. 	Yeast: Candida albicans (MIC=82 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	22884922	Peptides. 2012 Oct;37(2):301-308.	Amaral AC, Silva ON, Mundim NC, de Carvalho MJ, Migliolo L, Leite JR, Prates MV, Bocca AL, Franco OL, Felipe MS.	Predicting antimicrobial peptides from eukaryotic genomes: In silico strategies to develop antibiotics.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(N)=O
DRAMP03563	KAGLAFPVGRVHRLLRK	17	P2 (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antifungal	Not found	Not found	Not found		Function: Presentes antifungal activity against Candida albicans. 	Yeast: Candida albicans (MIC=133 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	22884922	Peptides. 2012 Oct;37(2):301-308.	Amaral AC, Silva ON, Mundim NC, de Carvalho MJ, Migliolo L, Leite JR, Prates MV, Bocca AL, Franco OL, Felipe MS.	Predicting antimicrobial peptides from eukaryotic genomes: In silico strategies to develop antibiotics.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP03567	KRIVQRIKDFLRNLVPRTES	20	KR-20 (Derived from LL-37)	No entry found	Not found	Not found	Homo sapiens (Human sweat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix 	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus mprF (MIC=16 µM), Staphylococcus aureus ATCC 25923 (MIC>64 µM), Staphylococcus aureus (GAS) (MIC=4 µM);##Gram-negative bacterium: Escherichia coli O29 (MIC>64 µM).##Yeast: Candida albicans ATCC 14053 (MIC=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Lipopolysaccharide (LPS)-binding	14978112	J Immunol 2004; 172: 3070-3077.	Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL.	Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP03568	RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	31	RK-31 (Derived from LL-37)	No entry found	Not found	Not found	Homo sapiens (Human sweat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix 	Not found	2K6O##5NMN##5NNK##5NNM##5NNT##7PDC##7SAY	Function: Has hemolytic activity against human erythrocytes .	[Ref.14978112]Gram-positive bacteria: Staphylococcus aureus mprF (MIC=8 µM), Staphylococcus aureus ATCC 25923 (MIC=16 µM), Group A Staphylococcus aureus (GAS) (MIC=8 µM);##Gram-negative bacterium: Escherichia coli O29 (MIC=8 µM);##Yeast: Candida albicans ATCC 14053 (MIC=4 µM).	[Ref.14978112]6% hemolytic activity at 44 μM against human erythrocytes	Linear	Free	Free	Free	L	Not included yet	Lipopolysaccharide (LPS)-binding	14978112	J Immunol 2004; 172: 3070-3077.	Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL.	Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP03569	KSKEKIGKEFKRIVQRIKDFLRNLVPRTES	30	KS-30 (Derived from LL-37)	No entry found	Not found	Not found	Homo sapiens (Human sweat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix 	Not found	2K6O##5NMN##5NNK##5NNM##5NNT##7PDC##7SAY##2FCG##2LMF	Function:Has hemolytic activity against human erythrocytes.	[Ref.14978112]Gram-positive bacteria: Staphylococcus aureus mprF (MIC=8 µM), Staphylococcus aureus ATCC 25923 (MIC=16 µM), Group A Staphylococcus aureus (GAS) (MIC=4 µM);##Gram-negative bacterium: Escherichia coli O29 (MIC=8 µM);##Yeast: Candida albicans ATCC 14053 (MIC=2 µM)	[Ref.14978112]23% hemolytic activity at 88 μM against human erythrocytes	Linear	Free	Free	Free	L	Not included yet	Lipopolysaccharide (LPS)-binding	14978112	J Immunol 2004; 172: 3070-3077.	Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL.	Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP03570	LLGDFFRKSKEKIGKEFKRIVQR	23	LL-23 (Derived from LL-37)	P49913, Q71SN9	Not found	Not found	Homo sapiens (Human sweat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix (1 helices; 19 residues)	The Ser9 site splits the hydrophobic surface of the amphipathic helix into two domains, which explains its poor antimicrobial activity (active against only susceptible bacterial strains). 	2LMF resolved by NMR.	Its structure, dynamics, and antimicrobial and immune modulating activities have been characterized (Biochemistry 2012).	Gram-negative bacterium: Escherichia coli DC2 (MIC=9 µM);##Gram-positive bacteria: Staphylococcus aureus mprF (presence of carbonate) (MIC=3 µM), S. aureu mprF (absence of carbonate) (MIC=24 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	17012259##22185690	FASEB J 2006; 20, 2068-2080.##Biochemistry. 2012 Jan 17;51(2):653-664. 	Yamasaki K et al. Gallo RL.##Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.	Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin.##Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)CNC(=O)CC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP01877	GLMSVLKGVLKTAGKHIFKNVGGSLLDQAKCKITGQC	37	Brevinin-2PRd (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana pirica (Hokkaido frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: activity against reference strains of Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella pneumoniae) and Gram-positive (Staphlococcus aureus) bacteria but displayed relatively low hemolytic activity. 	[Ref.15003829] Gram-negative bacterium: Escherichia coli(MIC=3μM), Pseudemonas aeruginosa(MIC=3μM), Enterobacter cloacae(MIC=6μM), Klebsiella pneumoniae(MIC=6μM);## Gram-positive bacterium: Staphylococcus aureus(MIC=25μM);## Yeast: Candida albicans(MIC=100μM)	[Ref.15003829] HC50=100 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	15003829	Regul Pept. 2004 May 15;118(3):135-141.	Conlon JM, Sonnevend A, Patel M, Al-Dhaheri K, Nielsen PF, Kolodziejek J, Nowotny N, Iwamuro S, P	A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.	
DRAMP01878	GLLSVLKGVLKTAGKHIFKNVGGSLLDQAKCKISGQC	37	Brevinin-2PRe (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana pirica (Hokkaido frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: activity against reference strains of Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella pneumoniae) and Gram-positive (Staphlococcus aureus) bacteria but displayed relatively low hemolytic activity. 	[Ref.15003829] Gram-negative bacterium: Escherichia coli(MIC=3μM), Pseudemonas aeruginosa(MIC=3μM), Enterobacter cloacae(MIC=3μM), Klebsiella pneumoniae(MIC=6μM);## Gram-positive bacterium: Staphylococcus aureus(MIC=25μM);## Yeast: Candida albicans(MIC>100μM)	[Ref.15003829] HC50=80 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	15003829	Regul Pept. 2004 May 15;118(3):135-141.	Conlon JM, Sonnevend A, Patel M, Al-Dhaheri K, Nielsen PF, Kolodziejek J, Nowotny N, Iwamuro S, P	A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.	
DRAMP03573	IGKEFKRIVQRIKDFLRNLVPRTES	25	LL-37(13-37)(C-terminal fragment of LL-37; Human, mammals, animals)	P49913, Q71SN9	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram-, Anticancer	Protein level	Alpha helix (1 helices; 14 residues)	Residues 17-29 of LL-37(13-37) are helical.	2FCG resolved by NMR.	The slightly lower activity of LL-37(13-37) may result from the interference of the disordered regions with membrane binding of the peptide.	Gram-negative bacterium: Escherichia coli K12 (MIC=80 µM).##Drug-resistant KBv cancer cells (LC50=39 µM), Drug-sensitive KB cancer cells (LC50=40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation	Disulfide bonds	L	Not included yet	Not found	16637646	J Am Chem Soc. 2006 May 3;128(17):5776-5785.	Li X, Li Y, Han H, Miller DW, Wang G. 	Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. 	
DRAMP03574	FKRIVQRIKDFLRNLV	16	LL-37(17-32)(C-terminal fragment of LL-37; Human, mammals, animals)	P49913, Q71SN9	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram-, Anticancer	Protein level	Not found	To achieve selective membrane targeting, D-amino acids were incorporated into LL-37(17-32). The D-peptide showed similar antibacterial activity to the L-diastereomer, it lost toxicity to human cells. 		Antibacterial and anticancer assays found that LL-37(17-32) was more active than LL-37(13-37). 	Gram-negative bacteria: Escherichia coli K12(MIC=20 µM).##Drug-resistant KBv cancer cells (LC50=30 µM), Drug-sensitive KB cancer cells (LC50=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation	Disulfide bonds	L	Not included yet	Not found	16637646	J Am Chem Soc. 2006 May 3;128(17):5776-5785.	Li X, Li Y, Han H, Miller DW, Wang G. 	Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. 	
DRAMP03598	GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP	41	Human beta-defensin 2 (hBD-2; Defensin, beta 2; Beta-defensin 4A; Human, mammals, animals)	O15263, Q52LC0	Belongs to the beta-defensin family	DEFB4A AND DEFB4B	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral	Protein level	Combine helix and strand structure	The structure (one N-terminal helix and 3 beta strands) was found to be monomer in solution (PDB ID: 1E4Q) but a dimer in the crystal (PDB ID: 1FD3). 	1FD4, 1FD3 resolved by X-ray.##1FQQ resolved by NMR.	"Function: Has anti-HIV and antibacterial activity.
Tissue specificity: Expressed in the skin and respiratory tract.
Induction: By inflammation.
PTM: Contains three disulfide bonds 8-37, 15-30, 20-38.
Transgenic plants: expression of this peptide in Arabidopsis thaliana reduced fungal infection."	Gram-negative bacteria: Escherichia coli D31(MIC=62 µg/ml), Escherichia coli ATCC (MIC=62 µg/ml), Pseudomonas aeruginosa ATCC (MIC=62 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC (MIC=62 µg/ml), Enterococcus faecalis ATCC (MIC=15 µg/ml).	[Ref.15625724] It is slightly hemolytic (<12%) against human erythrocytes at the highest concentration of 500 μg/ml.	Cyclic	Free	Free	Disulfide bonds between Cys8 and Cys37,Cys15 and Cys30,Cys20 and Cys38.	L	No cytotoxicity information found	Not found	9202117##10906336##17340092	Nature. 1997 Jun 26;387(6636):861.##J Biol Chem. 2000 Oct 20;275(42):32911-32918.##Plant Cell Rep. 2007 Aug;26(8):1391-1398.	Harder J, Bartels J, Christophers E, Schröder JM.##Hoover DM, Rajashankar KR, Blumenthal R, Puri A, Oppenheim JJ, Chertov O, Lubkowski J.##Aerts AM, Thevissen K, Bresseleers SM, Sels J, Wouters P, Cammue BP, François IE.	A peptide antibiotic from human skin.##The structure of human beta-defensin-2 shows evidence of higher order oligomerization.##Arabidopsis thaliana plants expressing human beta-defensin-2 are more resistant to fungal attack: functional homology between plant and human defensins.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)NC2=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N3)[C@@H](C)O)C(C)C
DRAMP03599	GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK	45	Human beta-defensin 3 (BD-3, hBD-3; Hbd3; Beta-defensin 103; Human, mammals, animals)	P81534, Q8NFG6, Q9NPF6	Belongs to the beta-defensin family	DEFB103A AND DEFB103	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Combine helix and strand structure	Contains three disulfide bonds and a short helical segment preceding a three-stranded antiparallel beta-sheet. 	1KJ6 resolved by NMR.	"Function: Exhibits antimicrobial activity against Gram-positive bacteria and the Gram-negative bacteria and the yeast C.albicans. Kills multiresistant S. aureus and vancomycin-resistant E. faecium. Has hemolytic activity.
Tissue specificity: Highly expressed in skin and tonsils, and to a lesser extent in trachea, uterus, kidney, thymus, adenoid, pharynx and tongue. Low expression in salivary gland, bone marrow, colon, stomach, polyp and larynx. No expression in small intestine.
Induction: By bacterial infection and by IFNG/IFN-gamma.
PTM: Contains three disulfide bonds 11-40; 18-33; 23-41."	[Ref.11085990]Gram-negative bacteria: Escherichia coli DSM1103 (MIC=9.4 µg/ml), Klebsiella pneumoniae DSM681 (MIC=25 µg/ml), Pseudomonas aeruginosa DSM1128 (MIC=18.75 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=4.7 µg/ml), Streptococcus pneumoniae DSM11865 (MIC=4.7 µg/ml).	[Ref.11085990] It has 9% hemolysis at 250 µg/ml, 15% hemolysis at 500 µg/ml against human erythrocytes.	Cyclic	Free	Free	Disulfide bonds between Cys11 and Cys40,Cys18 and Cys33,Cys23 and Cys41.	L	No cytotoxicity information found	Not found	15625724##11085990	Biopolymers. 2005;80(1):34-49.##J Biol Chem. 2001 Feb 23;276(8):5707-5713.	Schulz A, Klüver E, Schulz-Maronde S, Adermann K.##Harder J, Bartels J, Christophers E, Schroder JM.	Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins.##Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC2=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N3)[C@@H](C)O)[C@H](C)CC
DRAMP03600	EFELDRICGYGTARCRKKCRSQEYRIGRCPNTYACCLRKWDESLLNRTKP	50	Human beta-defensin 4 (hBD-4, BD-4; Beta-defensin 104; Human, mammals, animals)	Q8WTQ1, Q496I2, Q496I3, Q496I4	Belongs to the beta-defensin family	DEFB104A	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Bridge 	Not found	5KI9	"Function: Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103.
Tissue specificity: High expression in the testis. Gastric antrum exhibited relatively high levels. A lower expression is observed in uterus and neutrophils thyroid gland, lung, and kidney. No detectable expression in other tissues tested.
Induction: Antimicrobial activity is decreased when the sodium chloride concentration is increased.
PTM: Contains three disulfide bonds (By similarity)."	Gram-positive bacterium: Staphylococcus carnosus TM300 (MIC=4.5 µg/ml);##Gram-negative bacteria: Escherichia coli BL21 (MIC>100 µg/ml), Pseudomonas aeruginosa (MIC=4.1 µg/ml).##Yeast: Saccharomyces cerevisiae ATCC9763 (MIC>100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys8 and Cys36,Cys15 and Cys29,Cys19 and Cys37.	L	No cytotoxicity information found	Not found	11481241	FASEB J. 2001 Aug;15(10):1819-1821.	García JR, Krause A, Schulz S, Rodríguez-Jiménez FJ, Klüver E, Adermann K, Forssmann U, Frimpong-Boateng A, Bals R, Forssmann WG.	Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity.	
DRAMP03603	ARLKKCFNKVTGYCRKKCKVGERYEIGCLSGKLCCAN	37	Human beta-defensin 28 (hBD-28; hBD28; Human, mammals, animals)	No entry found	Belongs to the beta-defensin family	Not found	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Bridge 	Not found		Function: Has antibacterial activity gaginst Gram-positive and the Gram-negative bacteria. 	Gram-negative bacteria: Escherichia coli DSM1103 (MIC=37.5 µg/ml), Klebsiella pneumoniae DSM681 (MIC=50 µg/ml), Pseudomonas aeruginosa DSM1128 (MIC=37.5 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=25 µg/ml), Streptococcus pneumoniae DSM11865 (MIC=37.5 µg/ml).	[Ref.15625724] It is slightly hemolytic (<12%) against human erythrocytes at the highest concentration of 500 μg/ml.	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys14 and Cys28,Cys18 and Cys35	L	No cytotoxicity information found	Not found	15625724	Biopolymers. 2005;80(1):34-49.	Schulz A, Klüver E, Schulz-Maronde S, Adermann K.	Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)N[C@@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N2
DRAMP03638	LCLDQKPEMEPFRKDAQQALEPSRQRRWLHRRCLSGRGFCRAICSIFEEPVRGNIDCYFGYNCCRRMFSHYRTS	74	VpBD (V.philippinarum beta defensin; big defensin)	No entry found	Not found	Not found	Venerupis philippinarum (The manila clam)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: The rVpBD displays broad-spectrum inhibitory activity towards all tested bacteria with the highest activity against Staphyloccocus aureus and Pseudomonas putida.	Gram-positive bacteria: Staphyloccocus aureus (MIC=1.64-3.28 µM), Micrococcus luteus (MIC>26.26 µM), Bacillus sp. (MIC=13.13-26.26 µM);##Gram-negative bacteria: Vibrio anguillarum (MIC=13.13-26.26 µM), Entherobacter cloacae (MIC>26.26 µM), Vibrio ichthyoenteri (MIC=3.28-6.56 µM), Pseudomonas putida (MIC=1.64-3.28 µM), Proteus mirabilis (MIC>26.26 µM), Enterobacter sp. (MIC=13.13-26.26 µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys33 and Cys63,Cys40 and Cys57,Cys44 and Cys64.	L	No cytotoxicity information found	Not found	20975988	PLoS One. 2010 Oct 20;5(10):e13480.	Zhao J, Li C, Chen A, Li L, Su X, Li T.	Molecular characterization of a novel big defensin from clam Venerupis philippinarum.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc4c[nH]cn4)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC3=O)NC1=O
DRAMP03642	GRKSDCFRKSGFCAFLKCPSLTLISGKCSRFYLCCKRIR	39	Chicken heterophil peptides 1 (Antimicrobial peptide CHP1; Birds, animals)	P80389	Belongs to the beta-defensin family	Not found	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge 	Not found		"Function: Bactericidal activity; inhibits S. aureus and E. coli.
PTM: Contains three disulfide bonds 6-28; 13-34; 18-35."	Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=2.7 µg/ml);##Gram-positive bacterium: Staphylococcus aureus (MIC=0.7 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys28,Cys13 and Cys34,Cys18 and Cys35.	L	No cytotoxicity information found	Not found	7964174	J Leukoc Biol. 1994 Nov;56(5):661-665.	Evans EW, Beach GG, Wunderlich J, Harmon BG.	Isolation of antimicrobial peptides from avian heterophils.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N3)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]3CCCN3C2=O)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP01376	GFMDTAKNAAKNVAVTLLDNLKCKITKAC	29	Odorranain-F1 (OdF1; Frogs, amphibians, animals)	A6MBL3	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Odorranain-F1 adopts 55% 		Function: Odorranain-F1 exhibites antimicrobial activities against the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Also has hemolytic activity against rabbiit red cell.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=4.20 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=2.10 μg/ml), Bacillus subtilis (MIC=8.40 μg/ml).##Yeast: Candida albicans (MIC=1.05 μg/ml).	[Ref.17272268] RCH=15.4 ± 3.5% against rabbit red blood cells at 50 μg/ml. RCH, red cell hemolysis.	Cyclic	Free	Cyclization (Cys23 and Cys29)	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01378	GIFGKILGVGKKVLCGLSGVC	21	Odorranain-H1 (OdH1; Frogs, amphibians, animals)	A6MBN4	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Odorranain-H1 adopts 50.3 β-sheet structure in water solution.		Function: Odorranain-H1 exhibites antimicrobial activities against Gram-positive and Gram-negative bacteria and fungi. Also has hemolytic activity against rabbit red cell.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=23.60 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=5.90 μg/ml), Bacillus subtilis (MIC=5.90 μg/ml).##Yeast: Candida albicans (MIC=11.80 μg/ml).	[Ref.17272268] RCH=21.6 ± 7.3% against rabbit red blood cells. RCH, red cell hemolysis.	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01386	VIPFVASVAAEMMQHVYCAASKKC	24	Odorranain-P1a (OdP1a; Brevinin-1HS1; Brevinin-1-OA2; Frogs, amphibians, animals)	A6MBQ8, A6MBQ6	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		Function: Odorranain-P1a exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Also has hemolytic activity against rabbit red cell. 	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=3.50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.50 μg/ml), Bacillus subtilis (MIC=1.75 μg/ml).##Yeast: Candida albicans (MIC=1.75 μg/ml).	[Ref.17272268] RCH=11.2 ± 2.9% against rabbit red blood cells. RCH, red cell hemolysis.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP03646	RVKRFWPLVPVAINTVAAGINLYKAIRRK	29	Cathelicidin-3 (CATH-3; Fowlicidin-3; Birds, animals)	Q2IAL6	Not found	CATHL3	Gallus gallus (Chicken) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix (1 helices; 9 residues)	NMR spectroscopy reveales that fowlicidin-3 comprises 27 amino-acid residues and adopts a predominantly alpha-helical structure extending from residue 9 to 25 with a slight kink induced by a glycine at position 17..	2HFR resolved by NMR.	"Function: May have antimicrobial activity and play a role in the innate immune response.
Tissue specificity: Detected in bone marrow, liver and lung."	Gram-negative bacteria: Escherichia coli 25922 (MIC=2 µM), Salmonella typhimurium 14028 (MIC=2 µM), S. typhimurium DT104 700408 (MIC=2 µM), Salmonella enteritidis 13076 (MIC=2 µM), Klebsiella pneumoniae 13883 (MIC=1 µM);##Gram-positive bacteria: Listeria monocytogenes 19115 (MIC=2 µM), Staphylococcus aureus 25923 (MIC=1 µM), S. aureus (MRSA) 43300 (MIC=1 µM), S. aureus (MRSA) BAA-39 (MIC=1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Lipopolysaccharide (LPS)-binding	17827276##16326712##17229147	Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15063-15068.##J Biol Chem. 2006 Feb 3;281(5):2858-2867.##FEBS J. 2007 Jan;274(2):418-428.	Goitsuka R, Chen CL, Benyon L, Asano Y, Kitamura D, Cooper MD.##Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, Zhang G.##Bommineni YR, Dai H, Gong YX, Soulages JL, Fernando SC, Desilva U, Prakash O, Zhang G.	Chicken cathelicidin-B1, an antimicrobial guardian at the mucosal M cell gateway.##Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity.##Fowlicidin-3 is an alpha-helical cationic host defense peptide with potent antibacterial and lipopolysaccharide-neutralizing activities.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC
DRAMP03647	PIRNWWIRIWEWLNGIRKRLRQRSPFYVRGHLNVTSTPQP	40	Cathelicidin-B1 (CATH-B1; cathelicidin; Birds, animals)	Q5F378, A7M6V2	Not found	CATHB1	Gallus gallus (Chicken) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli (MIC=2.5 µM), Pseudomonas aeruginosa (MIC=0.63 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=1.25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	17827276##15642098	Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15063-15068.##Genome Biol. 2005;6(1):R6.	Goitsuka R, Chen CL, Benyon L, Asano Y, Kitamura D, Cooper MD.##Caldwell RB, Kierzek AM, Arakawa H, Bezzubov Y, Zaim J, Fiedler P, Kutter S, Blagodatski A, Kostovska D, Koter M, Plachy J, Carninci P, Hayashizaki Y, Buerstedde JM.	Chicken cathelicidin-B1, an antimicrobial guardian at the mucosal M cell gateway.##Full-length cDNAs from chicken bursal lymphocytes to facilitate gene function analysis.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP03659	LPRDTSRCVGYHGYCIRSKVCPKPFAAFGTCSWRQKTCCVDTTSDFHTCQDKGGHCVSPKIRCLEEQLGLCPLKRWTCCKEI	82	Gallinacin-11 (Gal-11; Beta-defensin 11; Birds, animals)	Q6IV20, A0A1W6, Q09MT4, Q9PS49	Belongs to the beta-defensin family	GAL11	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Bridge	Not found	6QEU##6QET##6QES	Tissue specificity: Detected in outer membrane of the vitelline layer of the egg (at protein level). Expressed in the liver, gall bladder, kidney, testis, ovary and male and female reproductive tracts. Expressed in the ovarian stroma, but not in the ovarian follicles. No expression is detected in bone marrow. PTM: Contains three disulfide bonds 8-38; 15-31; 21-39.	Gram-negative bacterium: Escherichia coli (MIC=50 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys8 and Cys38,Cys15 and Cys31, Cys21 and Cys39.	L	Not included yet	Not found	17244739##1520265	Reproduction. 2007 Jan;133(1):127-133.##Biochem J. 1992 Aug 15;286 (Pt 1):17-22.	Subedi K, Isobe N, Nishibori M, Yoshimura Y.##Kido S, Morimoto A, Kim F, Doi Y.	Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).##Isolation of a novel protein from the outer layer of the vitelline membrane.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C2=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2c[nH]c4ccccc24)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N3)C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)O
DRAMP03676	APRKNVRWCAISLPEWSKCYQWQRRMRKLGAPSITCIRRTS	41	GLFcin (Lactoferrin fragment)	Q29477, Q29479	Belongs to the transferrin family	LTF	Capra hircus (Goat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: GLFcin is thermal-stable and with high antibacterial activity.	Gram-negative bacteria: Escherichia coli (MIC=4.07 µg/ml), Propioni bacterium acnes (MIC=12.32 µg/ml), Pseudemonas aeruginosa (MIC=4.07 µg/ml);##Gram-positive bacteria: Bacillus cereus (MIC=12.32 µg/ml), Staphylococcus aureus (MIC=4.07 µg/ml), Listeria monocytogene (MIC=4.07 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	19780544	J Agric Food Chem. 2009 Oct 28;57(20):9509-9515.	Chen GH, Chen WM, Huang GT, Chen YW, Jiang ST.	Expression of recombinant antibacterial lactoferricin-related peptides from Pichia pastoris expression system.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC
DRAMP03677	SKCYQWQRRMRKLGAPSITCIRRTS	25	GLFcin II (Lactoferrin fragment)	Q29477, Q29479	Belongs to the transferrin family	LTF	Capra hircus (Goat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: GLFcin is thermal-stable and with high antibacterial activity.	Gram-negative bacteria: Escherichia coli (MIC=6.80 µg/ml), Propioni bacterium acnes (MIC=10.50 µg/ml), Pseudemonas aeruginosa (MIC=14.50 µg/ml);##Gram-positive bacteria: Bacillus cereus (MIC=16.00 µg/ml), Staphylococcus aureus (MIC=6.80 µg/ml), Listeria monocytogene (MIC=9.92 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	19780544	J Agric Food Chem. 2009 Oct 28;57(20):9509-9515.	Chen GH, Chen WM, Huang GT, Chen YW, Jiang ST.	Expression of recombinant antibacterial lactoferricin-related peptides from Pichia pastoris expression system.	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP03679	RFRPPIRRPPIRPPFNPPFRPPVRPPFRPPFRPPFRPPIGPFP	43	Cathelicidin-2 (Bactenecin-5, Bac5; ChBac5; ruminant, animals)	P82018, Q4JFB9	Not found	CATHL2	Capra hircus (Goat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli (MIC=1 µg/ml), Salmonella typhimurium (MIC=1 µg/ml), Pseudomonas aeruginosa (MIC=1 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC<2 µg/ml), Listeria monocytogenes (MIC<2 µg/ml) and Bacillus subtilis (MIC<2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Lipopolysaccharide (LPS)-binding	10417180	nfect Immun. 1999 Aug;67(8):4106-4111.	Shamova O, Brogden KA, Zhao C, Nguyen T, Kokryakov VN, Lehrer RI.	Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(N)=O
DRAMP03682	FLPIIAKLLGGLL	13	Vespid chemotactic peptide 5e (VCP 5e; Insects, animals)	P0C1M1	Belongs to the MCD family (Crabrolin subfamily)	Not found	Vespa magnifica 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Mast cell degranulating peptide (By similarity). Has little hemolytic activity. Shows antimicrobial activity against the Gram-negative bacteria and the Gram-positive bacteria. Also has antifungal activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (By similarity)."	[Ref.16330062]Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=30 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=5 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=25 µg/ml).	[Ref.16330062]Little hemolytic activity up to 50 μg/ml against rabbit red blood cells	Linear	Free	Amidation	Free	L	Not included yet	Not found	16330062	Toxicon. 2006 Feb;47(2):249-53.	Xu X, Li J, Lu Q, Yang H, Zhang Y, Lai R.	Two families of antimicrobial peptides from wasp (Vespa magnifica) venom.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP03683	FLIIRRPIVLGLL	13	Vespid chemotactic peptide 5g (VCP 5g; Insects, animals)	P0C1M3	Belongs to the MCD family (Crabrolin subfamily)	Not found	Vespa magnifica 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Mast cell degranulating peptide (By similarity). Has little hemolytic activity. Shows antimicrobial activity against the Gram-negative bacteria and the Gram-positive bacteria. Also has antifungal activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (By similarity)."	[Ref.16330062]Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=30 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=10 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=12.5 µg/ml).	[Ref.16330062]Little hemolytic activity up to 50 μg/ml against rabbit red blood cells	Linear	Free	Amidation	Free	L	Not included yet	Not found	16330062	Toxicon. 2006 Feb;47(2):249-53.	Xu X, Li J, Lu Q, Yang H, Zhang Y, Lai R.	Two families of antimicrobial peptides from wasp (Vespa magnifica) venom.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP03684	FLPIPRPILLGLL	13	Vespid chemotactic peptide 5f (VCP 5f; Insects, animals)	P0C1M2	Belongs to the MCD family (Crabrolin subfamily)	Not found	Vespa magnifica 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Mast cell degranulating peptide (By similarity). Has little hemolytic activity. Shows antimicrobial activity against the Gram-negative bacteria and the Gram-positive bacteria. Also has antifungal activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (By similarity)."	[Ref.16330062]Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=30 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=5 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=25 µg/ml).	[Ref.16330062]Little hemolytic activity up to 50 μg/ml against rabbit red blood cells	Linear	Free	Amidation	Free	L	Not included yet	Not found	16330062	Toxicon. 2006 Feb;47(2):249-53. 	Xu X, Li J, Lu Q, Yang H, Zhang Y, Lai R.	Two families of antimicrobial peptides from wasp (Vespa magnifica) venom.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP18366	GFGSKPIDSFGLSWL	15	Sungsanpin (a class 2 lasso peptide; bacteriocins)	No entry found	Not found	Not found	a Marine Streptomyces species	Anti-cancer		Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Form a lactam bond at position 1 and 8(Gly1, Asp8)	L	Not included yet	Not found	23662937	J Nat Prod. 2013 May 24;76(5):873-9	Um S, Kim YJ, Kwon H, Wen H, Kim SH, Kwon HC, Park S, Shin J, Oh DC.	Sungsanpin, a lasso peptide from a deep-sea streptomycete	
DRAMP03687	FLSLIPSLVGGSISAFK	17	TsAP-1 (T. serrulatus antimicrobial peptide 1; scorpions, arachnids, invertebrates, animals)	S6CWV8	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short antimicrobial peptide (group 4) family.	Not found	Tityus serrulatus (Brazilian yellow scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Protein level	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Anticancer activity against HI57 and H838.	[Ref.23770440] Gram-positive bacteria : Staphylococcus aureus(MIC=120 μM, MBC>160 μM);##Gram-negative bacteria : Escherichia coli(MIC=160 μM, MBC>160 μM);##Fungi : Candida albicans(MIC=160 μM, MBC>160 μM)	[Ref.23770440] 0% hemolysis at 40 μM , 2% hemolysis at 80 μM , 5% hemolysis at 120 μM , 7% hemolysis at 160 μM against horse red blood cells	Linear	Free	Amidation	Free	L	Not included yet	Not found	23770440	Biochimie. 2013 Jun 14. doi: 10.1016/j.biochi.2013.06.003.	Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, Chen T, Shaw C.	Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP03688	FLGMIPGLIGGLISAFK	17	TsAP-2 (T. serrulatus antimicrobial peptide 2; scorpions, arachnids, invertebrates, animals)	No entry found	Not found	Not found	Tityus serrulatus (Brazilian yellow scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal, Anti-cancer	Not found	Not found	Not found		Function: TsAP-2 was of high potency against the Gram-positive bacterium, Staphylococcus aureus and the yeast Candida albicans.	Gram-positive bacterium: Staphylococcus aureus (MIC=5 µM).##Yeast: Candida albicans (MIC=10 µM). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	23770440	Biochimie. 2013 Jun 14. pii: S0300-9084(13)00164-8.	Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, Chen T, Shaw C.	Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP03691	FSFKRLKGFAKKLWNSKLARKIRTKGLKYVKNFAKDMLSEGEEAPPAAEPPVEAPQ	56	Im-1 (Arthropods, animals)	P0CF38	Belongs to the scorpion BPP family	Not found	Isometrus maculatus (Lesser brown scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Causes cytolysis by the formation of pores in the membrane. Causes rapid and reversible paralysis in crickets. Has antibacterial activity.
Tissue specificity: Expressed by the venom gland.
Toxic dose: PD50 is 38 mg/kg into the insect A. domestica."	Gram-negative bacterium: Escherichia coli NBRC 3972 (MIC=0.4-0.8 µM);##Gram-positive bacteria: Staphylococcus aureus NBRC 13276 (MIC=13-25 µM), Bacillus subtilis NBRC 3009 (MIC=0.8-1.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linera	Free	Free	Free	L	Not included yet	Cell membrane	20139620	Biosci Biotechnol Biochem. 2010;74(2):364-369. 	Miyashita M, Sakai A, Matsushita N, Hanai Y, Nakagawa Y, Miyagawa H.	A novel amphipathic linear peptide with both insect toxicity and antimicrobial activity from the venom of the scorpion Isometrus maculatus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP03693	KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC	61	Bactridin-1 (Bact1; Bactridine 1; Arthropods, animals)	P0CF39	Belongs to the long (4 C-C) scorpion toxin superfamily Sodiu	Not found	Tityus discrepans (Venezuelan scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Shows antibacterial activity. Modifies membrane sodium permeability on Y.enterocolitica. Is toxic to cockroaches and crabs, but is not to mice. Does not induce haemolysis in human erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity) and C- terminal amidation."	Gram-positive bacteria: Bacillus subtillis ICTA-07 (MIC=22 µM), Microccocus luteus ATCC 4698 (MIC=43 µM), Enterococcus faecalis WHO14 (MIC=34 µM);##Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=77 µM), Yersinia enterocolitica ATCC 9610 (MIC=49 µM), Acinetobacter calcoaceticus ATCC 2305-5 (MIC=43 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation(Cyclization with a disulfide bond(Cys11 and Cys61))	Disulfide bond between Cys11 and Cys61,Cys15 and Cys37, Cys23 and Cys42, Cys27 and Cys44.	L	Not included yet	Not found	19540868##22355312	Toxicon. 2009 Nov;54(6):802-817.##PLoS One. 2012;7(2):e30478.	Díaz P, D'Suze G, Salazar V, Sevcik C, Shannon JD, Sherman NE, Fox JW.##Guerrero-Vargas JA, Mourão CB, Quintero-Hernández V, Possani LD, Schwartz EF.	Antibacterial activity of six novel peptides from Tityus discrepans scorpion venom. A fluorescent probe study of microbial membrane Na+ permeability changes.##Identification and phylogenetic analysis of Tityus pachyurus and Tityus obscurus novel putative Na+-channel scorpion toxins.	
DRAMP03694	KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR	64	Bactridin-2 (Bact2, Bactridine 2; P-Mice-Antm-beta* NaTx14.8; Arthropods, animals)	P0CF37	Belongs to the long (4 C-C) scorpion toxin superfamily Sodiu	Not found	Tityus discrepans (Venezuelan scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Shows antibacterial activity against both Gram-positive bacteria (B.subtilis, M.luteus, E.faecalis) and Gram-negative bacteria (P.aeruginosa, Y.enterocolitica, A.calcoaceticus). Modifies membrane sodium permeability on Y.enterocolitica. Is toxic to mice, but is not to crabs. Induces concentration dependent haemolysis in human erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity) and C-terminal amidation."	Gram-positive bacteria: Bacillus subtillis ICTA-07 (MIC=30 µM), Microccocus luteus ATCC 4698 (MIC=27 µM), Enterococcus faecalis WHO14 (MIC=65 µM);##Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=54 µM), Yersinia enterocolitica ATCC 9610 (MIC=46 µM), Acinetobacter calcoaceticus ATCC 2305-5 (MIC=27 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation	Disulfide bond between Cys11 and Cys62,Cys15 and Cys37, Cys23 and Cys43, Cys27 and Cys45.	L	Not included yet	Not found	19540868##22355312	Toxicon. 2009 Nov;54(6):802-817.##PLoS One. 2012;7(2):e30478.	Díaz P, D'Suze G, Salazar V, Sevcik C, Shannon JD, Sherman NE, Fox JW.##Guerrero-Vargas JA, Mourão CB, Quintero-Hernández V, Possani LD, Schwartz EF.	Antibacterial activity of six novel peptides from Tityus discrepans scorpion venom. A fluorescent probe study of microbial membrane Na+ permeability changes.##Identification and phylogenetic analysis of Tityus pachyurus and Tityus obscurus novel putative Na+-channel scorpion toxins.	
DRAMP03700	FLWGLIPGAISAVTSLIKK	19	Antimicrobial peptide ctriporin (Riporin; Arthropods, animals)	G1FE62	Not found	Not found	Chaerilus tricostatus (Scorpion)	Antimicrobial, Antibacterial, Anti-Gram+	Transcript level	Not found	Not found		"Function: Antimicrobial peptide that acts by breaking the cell wall. Has antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Is efficient in curing staphylococcal skin infection in mice, when externally applied.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: Has no activity against Gram-negative bacteria (E.coli and P.aeruginosa)."	Gram-positive bacteria: Staphylococcus aureus (MIC=5 µg/ml), Micrococcus luteus (MIC=5 µg/ml), Bacillus thuringiensis (MIC=10 µg/ml), B. subtilis (MIC=10 µg/ml).##Fungi: Candida albicans (MIC=20 µg/ml).##Antibiotic-resistant pathogens: methicillin-resistant Staphylococcus aureus (MIC=5-10 µg/ml), penicillin-resistant S. epidermidis (MIC=10 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane	21876042	Antimicrob Agents Chemother. 2011 Nov;55(11):5220-9.	Fan Z, Cao L, He Y, Hu J, Di Z, Wu Y, Li W, Cao Z.	Ctriporin, a new anti-methicillin-resistant Staphylococcus aureus peptide from the venom of the scorpion Chaerilus tricostatus.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@@H](C)O)C(C)C
DRAMP03702	LFGLIPSLIGGLVSAFK	17	Mucroporin (Antimicrobial peptide 36.21; Arthropods, animals)	B9UIY3	Belongs to the short cationic antimicrobial peptide family	Not found	Lychas mucronatus (Chinese swimming scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Function: Cationic host defense peptide that have antibacterial activity by breaking membranes. Is more effective on Gram-positive than on Gram-negative bacteria. Its synthetic analog mucroporin-M1 is more effective.
Tissue specificity: Expressed by the venom gland. 
Miscellaneous: Minimum inhibitory concentrations (MIC) for Mucroporin-1 analog are the following: MIC=12.5 µg/ml against E.coli AB94012, MIC=100 µg/ml against P.aeruginosa AB93066, MIC=25 µg/ml against B.thuringiensis AB92037, MIC=25 µg/ml against B.subtilis AB91021, MIC=5 µg/ml against S.aureus AB94004, and MIC=5 µg/ml against the methicillin-resistant coagulase-negative Staphylococcus. Furthermore, this analog is as effective against antibiotic-resistant pathogens as it is against antibiotic-sensitive pathogens."	Gram-negative bacteria: Escherichia coli AB94012 (MIC>100 µg/ml), Pseudomonas aeruginosa AB93066 (MIC>100 µg/ml);##Gram-positive bacteria: Bacillus thuringiensis AB92037 (MIC=25 µg/ml), Bacillus subtilis AB91021 (MIC=50 µg/ml), Staphylococcus aureus AB94004 (MIC=25 µg/ml), Methicillin-resistant coagulase-negative S. aureus (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane	20663230##18779362	BMC Genomics. 2010 Jul 28;11:452.##Antimicrob Agents Chemother. 2008 Nov;52(11):3967-3972.	Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.##Dai C, Ma Y, Zhao Z, Zhao R, Wang Q, Wu Y, Cao Z, Li W.	Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.##Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP03706	FLFSLIPHAIGGLISAFK	18	Antimicrobial peptide 1 (AamAP1; Arthropods, animals)	G8YYA5	Not found	ap1	Androctonus amoreuxi (African fattail scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antibacterial and antifungal activity. Causes hemolysis on horse erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: C-termianal amidation."	Gram-positive bacterium: Staphylococcus aureus (MIC=20 µM);##Gram-negative bacterium: Escherichia coli (MIC=150 µM).##Yeast: Candida albicans (MIC=64 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane	22484288	Peptides. 2012 Jun;35(2):291-299.	Almaaytah A, Zhou M, Wang L, Chen T, Walker B, Shaw C.	Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP03707	FPFSLIPHAIGGLISAIK	18	Antimicrobial peptide 2 (AamAP2; Arthropods, animals)	G8YYA6	Not found	ap2	Androctonus amoreuxi (African fattail scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antibacterial and antifungal activity. Causes hemolysis on horse erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: C-termianal amidation."	Gram-positive bacterium: Staphylococcus aureus (MIC=48 µM);##Gram-negative bacterium: Escherichia coli (MIC=120 µM).##Yeast: Candida albicans (MIC=64 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane	22484288	Peptides. 2012 Jun;35(2):291-299.	Almaaytah A, Zhou M, Wang L, Chen T, Walker B, Shaw C.	Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP01392	GLLSGTSVRGSI	12	Odorranain-V1 (OdV1; Frogs, amphibians, animals)	A6MBS7	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		Function: Odorranain-V1 exhibites moderate antimicrobial activities against all of the tested microbes. Also has hemolytic activity against rabbit red cells	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=36.00 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=18.00 μg/ml), Bacillus subtilis (MIC=18.00 μg/ml).##Yeast: Candida albicans (MIC=9.00 μg/ml).	[Ref.17272268] RCH=23.9 ± 4.7% against rabbit red blood cells. RCH, red cell hemolysis.	Linear	Free	Free	Free	L	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)O
DRAMP01393	GLFGKSSVWGRKYYVDLAGCAKA	23	Odorranain-W1 (OdW1; Frogs, amphibians, animals)	A6MBS8	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		Function: Odorranain-W1 has hemolytic activity against rabbit red cell.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=12.60 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.30 μg/ml), Bacillus subtilis (MIC=6.30 μg/ml).##Yeast: Candida albicans (MIC=3.15 μg/ml).	[Ref.17272268] RCH=17.6 ± 2.2% against rabbit red blood cells. RCH, red cell hemolysis.	Linear	Free	Free	Free	L	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
DRAMP03715	FLSTLWNAAKSIF	13	Amphiphatic peptide CT2 (VmCT2; Non-disulfide-bridged peptide 5.14, NDBP-5.14; Arthropods, animal	I0DEB4	Belongs to the scorpion NDBP 5 family	Not found	Vaejovis mexicanus smithi (Scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		"Function: Amphipatic peptide that shows antibacterial activities against both Gram-positive and Gram-negative bacteria. Has hemolytic at its MIC range, but shows a strong cytotoxic activity at higher concentrations, reaching 84% lysis at 50 µM.
Tissue specificity: Expressed by the venom gland."	[Ref.22342498]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=10 uM), Bacillus subtilis ATCC 6633 (MIC=20 µM), Streptococcus agalactiae (clinical isolate) (MIC=20 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20 µM), Salmonella typhi ATCC 6399 (MIC=10 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=10 µM).	[Ref.22342498]25% hemolytic activity at 25 μM, 84% hemolytic activity at 50 μM against human erythrocytes	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane	22342498	Peptides. 2012 Apr;34(2):290-295.	RamÃ­rez-Carreto S, Quintero-HernÃ¡ndez V, JimÃ©nez-Vargas JM, Corzo G, Possani LD, Becerril B, Ortiz E.	Gene cloning and functional characterization of four novel antimicrobial-like peptides from scorpions of the family Vaejovidae.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP01730	FLPLIGRVLSGIL	13	Temporin-A (Frogs, amphibians, animals)	P56917 	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix	Not found	2MAA resolved by NMR.	"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has hemolytic activity.
PTM: Leucine amide at position 13.
Tissue specificity: Expressed by the skin glands."	[Ref.9022710] Gram-positive bacteria: Bacillus megaterium BM11 (LC=1.2 µM), Staphylococcus aureus Cowan 1 (LC=2.3 µM), Streptococcus pyogenes betahemolytic group A (LC=2.0 µM);##Gram-negative bacteria: Escherichia coli D21 (LC=11.9 µM), Escherichia coli D21e7 (LC=1.4 µM), Escherichia coli D21f1 (LC=0.9 µM), Escherichia coli D21f2 (LC=4.8 µM), Escherichia coli D22 (LC=3.4 µM), Yersinia pseudotuberculosis (LC=2.0 µM), Pseudomonas aeruginosa ATCC 15692 (LC>360 µM);##Yeast: Candida albicans ATCC 10261 (LC=3.4 µM).(LC: Lethal concentration)	[Ref.9022710] LC>120 µM against Human red blood cells. (LC: Lethal concentration)	Linear	Free	Amidation	Free	L	Not included yet	Not found	9022710	Eur J Biochem. 1996 Dec 15;242(3):788-792.	Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.	Temporins, antimicrobial peptides from the European red frog Rana temporaria.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP03723	GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT	44	Pandinin-1 (Pin1; Arthropods, animals)	P83239	Belongs to the Scorpion family	Not found	Pandinus imperator (Emperor scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix 	Not found		MOA: Disrupts cell membranes through formation of pores.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC>20.8 µM), Escherichia coli (MIC=20.8 µM);##Gram-positive bacteria: Enterococcus faecalis (MIC=1.3 µM), Bacillus subtilis (MIC=5.2 µM), Staphylococcus epidermidis (MIC=5.2 µM), Staphylococcus aureus (MIC=2.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Cell membrane	11563967##16199510	Biochem J. 2001 Oct 1;359(Pt 1):35-45.##Biophys J. 2005 Dec;89(6):4067-4080. 	Corzo G, Escoubas P, Villegas E, Barnham KJ, He W, Norton RS, Nakajima T.##Nomura K, Ferrat G, Nakajima T, Darbon H, Iwashita T, Corzo G.	Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator.##Induction of morphological changes in model lipid membranes and the mechanism of membrane disruption by a large scorpion-derived pore-forming peptide.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O
DRAMP03724	FWGALAKGALKLIPSLFSSFSKKD	24	Pandinin-2 (Pin2; Arthropods, animals)	P83240	Belongs to the scorpion NDBP 4 family	Not found	Pandinus imperator (Emperor scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Hemolytic	Protein level	Alpha helix 	Not found		"Function: Disrupts cell membranes through formation of pores. Has strong antimicrobial activity against Gram-positive bacteria and less active against Gram-negative bacteria. Possesses antifungal activity against C. albicans and hemolytic activity against sheep and pig erythrocytes.
Tissue specificity: Expressed by the venom gland."	[Ref.11563967]Gram-negative bacteria: Pseudomonas aeruginosa (MIC=38.2 µM), Escherichia coli (MIC=19.1 µM);#Gram-positive bacteria: Enterococcus faecalis (MIC=2.4 µM), Bacillus subtilis (MIC=4.8 µM), Staphylococcus epidermidis (MIC=4.8 µM), Staphylococcus aureus (MIC=2.4 µM);##Yeast: Candida albicans (MIC=19.1 µM).	[Ref.11563967]Strong hemolytic activity (11.1-44.5 microM) against sheep erythrocytes	Linear	Free	Free	Free	L	Not included yet	Cell membrane	11563967##15328050##15298871	Biochem J. 2001 Oct 1;359(Pt 1):35-45.##Biochim Biophys Acta. 2004 Aug 30;1664(2):182-188.##Biophys J. 2004 Oct;87(4):2497-507. 	Corzo G, Escoubas P, Villegas E, Barnham KJ, He W, Norton RS, Nakajima T.##Belokoneva OS, Satake H, Mal'tseva EL, Pal'mina NP, Villegas E, Nakajima T, Corzo G.##Nomura K, Corzo G, Nakajima T, Iwashita T.	Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator.##Pore formation of phospholipid membranes by the action of two hemolytic arachnid peptides of different size.##Orientation and pore-forming mechanism of a scorpion pore-forming peptide bound to magnetically oriented lipid bilayers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP03729	KWFNEKSIQNKIDEKIGKNFLGGMAKAVVHKLAKNEFMCVANVDMTKSCDTHCQKASGEKGYCHGTKCKCGVPLSY	76	Opiscorpine-1 (Arthropods, animals)	Q5WR03, Q5WQZ8	Belongs to the long chain scorpion toxin family (Class 3 subfamily)	Not found	Opistophthalmus carinatus (African yellow leg scorpion)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		"Function: The short amino-terminal segment of opiscorpine 1 (residues 1–35), named Jan-f3, has antimicrobial activity against fungi and the Gram-negative bacteria.
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity)."	Fungi: Fusarium culmorum IMI180420 (IC50=8.8 µM), Fusarium oxysporum MUCL39789 (IC50=10.04 µM).##Gram-negative bacterium: Escherichia coli JM109 (MIC=12 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15241551	Cell Mol Life Sci. 2004 Jul;61(14):1751-1763.	Zhu S, Tytgat J.	The scorpine family of defensins: gene structure, alternative polyadenylation and fold recognition.	
DRAMP03734	FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ	45	Parabutoporin (PP; Non-disulfide-bridged peptide 3.2, NDBP-3.2; Arthropods, animals)	P83312	Belongs to the scorpion BPP family	Not found	Parabuthus schlechteri (Scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: At high concentrations, acts as pore former in cellular membranes and causes the leakage of the cells. At submicromolar concentrations, degranulates granulocytes and has hemolytic activity against human red blood cells. Also strongly inhibits the production of superoxide anions. Has a strong antibacterial activity against Gram-negative bacteria but is less active against Gram-positive bacteria. Also has antifungal activity. Induces reversible G-protein dependent Ca2+ release from intracellular stores and increase Ca2+ influx in HL-60 cells. Induces the activation of the Rac pathway in granulocytes. Synergistically enhances the excitatory effects of short and long chain ion-channel-specific neurotoxins by interaction with the neuronal membranes.
Tissue specificity: Expressed by the venom gland.
NOTE: residue 11, 44, 55 are uncertainty."	[Ref.12354111]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.1 µM), Escherichia coli DH5a (MIC=3.1 µM), Pseudomonas aeruginosa ATCC 257853 (MIC=6.3 µM), Klebsiella pneumoniae ATCC 13833 (MIC=1.6 µM), Salmonella choleraesuis ATCC 13311 (MIC=3.1 µM), Haemophilus influenzae ATCC 19418 (MIC=3.1 µM);##Gram-positive bacteria: Bacillus subtilis ATCC 6051 (MIC=6.3 µM), Listeria monocytogenes NCTC 11994 (MIC=6.3 µM), Micrococcus luteus ATCC 9341 (MIC=25 µM);##Fungi: Neurospora crassa (MIC=2.5 µM), Botrytis cinerea (MIC=3.5 µM), Fusarium culmorum (MIC=0.3 µM), Saccharomyces cerevisiae (MIC=2 µM).	[Ref.12354111]50% hemolysis is induced by about 38 µM against human red blood cells	Linear	Free	Free	Free	L	Not included yet	Cell membrane	12354111##12457879##14575699##15245865	Eur J Biochem. 2002 Oct;269(19):4799-4810.##Toxicon. 2002 Dec;40(12):1679-1683.##iochem Biophys Res Commun. 2003 Nov 7;311(1):90-97.##Peptides. 2004 Jul;25(7):1079-1084.	Moerman L, Bosteels S, Noppe W, Willems J, Clynen E, Schoofs L, Thevissen K, Tytgat J, Van Eldere J, Van Der Walt J, Verdonck F.Willems J, Noppe W, Moerman L, van der Walt J, Verdonck F.##Moerman L, Verdonck F, Willems J, Tytgat J, Bosteels S.##Willems J, Moerman L, Bosteels S, Bruyneel E, Ryniers F, Verdonck F.	Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa.##Cationic peptides from scorpion venom can stimulate and inhibit polymorphonuclear granulocytes.##Antimicrobial peptides from scorpion venom induce Ca(2+) signaling in HL-60 cells.##Parabutoporin--an antibiotic peptide from scorpion venom--can both induce activation and inhibition of granulocyte cell functions.	CSCC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP03735	GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNLVAEKIGATPS	44	Opistoporin-1 (OP1; Non-disulfide-bridged peptide 3.5; Opistoporin-3, OP3; Arthropods, animals)	P83313, Q5VJS8, Q5VJT0	Belongs to the antimicrobial peptide scorpion family	Not found	Opistophthalmus carinatus (African yellow leg scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found		"Function: At high concentrations, acts as pore former in cellular membranes and causes the leakage of the cells. At submicromolar concentrations, degranulates granulocytes and has hemolytic activity against human red blood cells. Also strongly inhibits the production of superoxide anions. Has a strong antibacterial activity against Gram-negative bacteria but is less active against Gram-positive bacteria. Also has antifungal activity.
Tissue specificity: Expressed by the venom gland."	[Ref.12354111]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.5 µM), Escherichia coli DH5a (MIC=6.3 µM), Serratia marcescens ATCC 133880 (MIC=50 µM), Pseudomonas aeruginosa ATCC 257853 (MIC=12.5 µM), Klebsiella pneumoniae ATCC 13833 (MIC=6.3 µM), Salmonella choleraesuis ATCC 13311 (MIC=25 µM), Haemophilus influenzae ATCC 19418 (MIC=1.6 µM);##Gram-positive bacteria: Bacillus subtilis ATCC 6051 (MIC=12.5 µM), Bacillus subtilis IP 5832 (MIC=12.5 µM), Listeria monocytogenes NCTC 11994 (MIC=12.5 µM), Micrococcus luteus ATCC 9341 (MIC>50 µM), Enterococcus faecalis ATCC 19433 (MIC=12.5 µM), Staphylococcus aureus ATCC 292136.3 (MIC>50 µM), Streptococcus pneumoniae ATCC 33400 (MIC=12.5 µM), Nocardia asteroides ATCC 3308 (MIC>50 µM);##Fungi: Neurospora crassa (IC50=0.8 µM), Botrytis cinerea (IC50=3.1 µM), Fusarium culmorum (IC50=0.8 µM), Saccharomyces cerevisiae (IC50=2 µM).	[Ref.12354111]10% hemolytic activity at 10 µM, 30% hemolytic activity at 100 µM against human red blood cells	Linear	Free	Free	Free	L	Not included yet	Cell membrane	12354111##12457879##14575699	Eur J Biochem. 2002 Oct;269(19):4799-4810.##Toxicon. 2002 Dec;40(12):1679-1683.##iochem Biophys Res Commun. 2003 Nov 7;311(1):90-97.	Moerman L, Bosteels S, Noppe W, Willems J, Clynen E, Schoofs L, Thevissen K, Tytgat J, Van Eldere J, Van Der Walt J, Verdonck F.Willems J, Noppe W, Moerman L, van der Walt J, Verdonck F.##Moerman L, Verdonck F, Willems J, Tytgat J, Bosteels S.	Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa.##Cationic peptides from scorpion venom can stimulate and inhibit polymorphonuclear granulocytes.##Antimicrobial peptides from scorpion venom induce Ca(2+) signaling in HL-60 cells.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O
DRAMP03738	GWINEEKIQKKIDERMGNTVLGGMAKAIVHKMAKNEFQCMANMDMLGNCEKHCQTSGEKGYCHGTKCKCGTPLSY	75	Scorpine (defensins; Arthropods, animals)	P56972	Belongs to the long chain scorpion toxin family (Class 3 subfamily)	Not found	Pandinus imperator (Emperor scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found	7M1D##7M1E	Function: Has antibacterial activity and a potent inhibitory effect on the ookinete (ED(50) 0.7 uM) and gamete (ED(50) 10 uM) stages of Plasmodium berghei development.	Gram-positive bacterium: Bacillus subtilis (MIC=1.0 µM);##Gram-negative bacterium: Klebsiella pneumoniae (MIC=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys39 and Cys62,Cys49 and Cys67, Cys53 and Cys69.	L	Not included yet	Not found	10767415	FEBS Lett. 2000 Apr 14;471(2-3):165-168.	Conde R, Zamudio FZ, RodrÃ­guez MH, Possani LD.	Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]3CSSC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N4CCC[C@H]4C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC1=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N3)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC2=O)C(C)C
DRAMP02828	GLFRRLRDSIRRGQQKILEKARRIGERIKDIFRG	34	BMAP-34 (BMAP 34, bovine cathelicidin, cattle, ruminant, mammals, animals)	P56425	Belongs to the cathelicidin family.	CATHL7	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found		"Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. 
Tissue specificity: Expressed in bone marrow myeloid cells, spleen and testis."	[Ref.9795251] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=3 μM), Staphylococcus aureus Cowan 1 (MIC=3 μM), Staphylococcus aureus (MRSA, clinical isolate) (MIC=6 μM), Staphylococcus epidermidis ATCC 12228 (MIC=1.5 μM), Bacillus megaterium Bm 11 (MIC=3 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1.5 μM), Escherichia coli ML-35 (MIC=1.5 μM), Escherichia coli D21 (MIC=1.5 μM), Escherichia coli D22 (MIC=1.5 μM), Salmonella typhimurium ATCC 14028 (MIC=3 μM), Salmonella enteritidis (clinical isolate) (MIC=3 μM), Serratia marcescens ATCC 8100 (MIC=1.5 μM), Pseudomonas aeruginosa ATCC 27853 (MIC≥48 μM);##Fungus: Candida albicans (clinical isolate) (MIC>96 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	9409740##9795251	FEBS Lett. 1997 Nov 17;417(3):311-5.##Biochim Biophys Acta. 1998 Oct 23;1425(2):361-368.	Scocchi M, Wang S, Zanetti M.##Gennaro R, Scocchi M, Merluzzi L, Zanetti M.	Structural organization of the bovine cathelicidin gene family and identification of a novel member.##Biological characterization of a novel mammalian antimicrobial peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP02926	KWCFRVCYRGICYRRCR	17	Tachyplesin I (Tac; TP1; Horseshoe Crab, arachnids, Chelicerata, arthropods, invertebrates, animals)	P14213	Belongs to the tachyplesin/polyphemusin family.	Not found	Tachypleus tridentatus (Japanese horseshoe crab)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral, Anti-HIV, Anti-cancer	Protein level	Beta strand	This stability is due to the rigid structure imposed by the two disulfide linkages. Its amphipathic nature is closely associated with biological activity. A 	1MA2, 1MA5, 6PIN, 1WO0, 1WO1, 2MDB, 2RTV resolved by NMR.	"Function:  Significantly inhibits the growth of Gram-negative and Gram-positive bacteria, also anti-HIV activity may be due to the inhibition of virual adsorption to cells.
PTM: Contains two disulfide bonds 3-16; 7-12 and Arginine amide at R17."	No MICs found in DRAMP database	[Ref.29870123] 9.6% hemolytic activity at 8 μg/mL and 72.8% hemolytic activity at 512 μg/mL against human red blood cells.	Cyclic	Free	Amidation (Arg17)	Disulfide bond between Cys3 and Cys16,Cys7 and Cys12.	L	[Ref.28429216]It possessed a cytotoxic effect on HL-60 cells (acutehuman promyelocytic leukemia cells) , K562 cells(myelogenous leukemia cells) , TSU cells (prostatecancer cells) .	Cell membrane	12369825##2229025##31455019	Biochemistry 2002; 41: 12359.##J Biochem. 1990 Aug;108(2):261-266.##Int J Mol Sci. 2019 Aug 26;20(17):4184.	Laederach A, Andreotti AH, Fulton, DB.##Muta T, Fujimoto T, Nakajima H, Iwanaga S.##Vernen F, Harvey PJ, Dias SA, Veiga AS, Huang YH, Craik DJ, Lawrence N, Troeira Henriques S.	Solution and Micelle-Bound Structures of Tachyplesin I and its Active Aromatic Linear Derivatives.##Tachyplesins isolated from hemocytes of Southeast Asian horseshoe crabs (Carcinoscorpius rotundicauda and Tachypleus gigas): identification of a new tachyplesin, tachyplesin III, and a processing intermediate of its precursor.##Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties.	
DRAMP03746	FIGAIARLLSKIF	13	Peptide BmKn2 (Biologically active peptide 4; NDBP-5.1; Arthropods, animals)	Q6JQN2	Not found	Kn2	Mesobuthus martensii (Buthus martensii)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation."	Gram-positive bacteria: Staphylococcus aureus (MIC=0.6 µg/ml), Micrococcus luteus(MIC=8 µg/ml), Bacillus subtilis (MIC=5 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=1.5 µg/ml), Pseudomonas aeruginosa (MIC=21.3 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	15062994	Peptides. 2004 Feb;25(2):143-150.	Zeng XC, Wang SX, Zhu Y, Zhu SY, Li WX.	Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP03748	FRFGSFLKKVWKSKLAKKLRSKGKQLLKDYANKVLNGPEEEAAAPAE	47	Bradykinin-potentiating peptide BmK3 (Bpp BmK3; NDBP-3.3; Arthropods, animals)	Q9Y0X4	Belongs to the scorpion BPP family	Not found	Mesobuthus martensii (Manchurian scorpion) (Buthus martensii)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Alpha helix (predict)	The secondary structure prediction for BmKbpp reveals that BmKbpp is composed of an α-helical structure from amino residues 3-35, followed by a coil-coiled region of three residues (NGP), and ended with an α-helical region of 9 residues (ref.2).		"Function: Amphipathic peptide that shows bradykinin potentiating activity and antimicrobial activities against bacteria and fungi. Has higher antibacterial activities against Gram-negative than against Gram-positive bacteria. Also inhibits NADPH oxidase-dependent superoxide production (IC50 is 0.4 µM on granulocytes stimulated with PMA, IC50 is 0.51 µM on HL-60 cells undifferentiated and IC50 is 0.53 µM on HL-60 cells treated with DMSO). The C-terminal peptide shows a higher bradykinin potentiating activity than the complete peptide.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: Shows hemolytic activity. Shows a alpha-helical structure. The genomic DNA coding for this protein is not a continuous sequence in the genome. The transcript of this protein may be generated by trans-splicing, by which exons from two independently transcribed pre-mRNAs are joined to form a single mature transcript."	[Ref.22115565]Gram-negative bacteria: Escherichia coli DH 5-α (MIC=2.3 µM), Haemophilus inﬂuenzae ATCC 31517 (MIC=3.2 µM), Klebsiella pneumoniae ATCC 13882 (MIC=2.8 µM), Salmonella enterica ATCC 8090 (MIC=2.3 µM), Pseudomonas aeruginosa ATCC 9229 (MIC=4.7 µM), Serratia marcescens ATCC 13880 (MIC=68.2 µM);##Gram-positive bacteria: Bacillus subtilis ATCC 6051 (MIC=24.4 µM), Listeria monocytogenes ATCC 35152 (MIC=5.7 µM), Micrococcus luteus ATCC 9341 (MIC=20.3 µM), Enterococcus faecalis ATCC 14508 (MIC=57.1 µM), Nocardia asteroides ATCC 3308 (MIC>70 µM), Staphylococcus aureus ATCC 14458 (MIC>70 µM);##Fungi: Neurospora crassa FGSC 2489 (IC50=2 µM), Botrytis cinerea ATCC 28387 (IC50=3.1 µM), Fusarium culmorum ATCC 32973 (IC50=0.2 µM).	[Ref.22115565]3.5% hemolytic activity at 6 μM, 11.2% hemolytic activity at 10 μM, 22.5% hemolytic activity at 30 μM, 33.9% hemolytic activity at 50 μM against human red blood cells	Linear	Free	Free	Free	L	Not included yet	Not found	10868911##22115565	IUBMB Life. 2000 Mar;49(3):207-210.##Peptides. 2012 Jan;33(1):44-51.	Zeng XC, Li WX, Peng F, Zhu ZH.##Zeng XC, Wang S, Nie Y, Zhang L, Luo X.	Cloning and characterization of a novel cDNA sequence encoding the precursor of a novel venom peptide (BmKbpp) related to a bradykinin-potentiating peptide from Chinese scorpion Buthus martensii Karsch.##Characterization of BmKbpp, a multifunctional peptide from the Chinese scorpion Mesobuthus martensii Karsch: gaining insight into a new mechanism for the functional diversification of scorpion venom peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP03750	IFGAIAGLLKNIF	13	Venom antimicrobial peptide-6 (Meucin-13; NDBP-5; Arthropods, animals)	E4VP07, E4VP35	Belongs to the scorpion NDBP 5 family	Not found	Mesobuthus eupeus (Lesser Asian scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found		"Function: Amphipathic peptide that exhibits extensive cytolytic activities against both prokaryotic and eukaryotic cells. Is more potent against Gram-positive bacteria (lethal concentration (LC=0.25-2.9 µM) than against Gram-negative bacteria (LC=6.2->50 µM), and fungi (LC=14.1->50 µM). Shows hemolytic activity against rabbit erythrocytes and cytolysis against rat dorsal root ganglions. In vivo, intravenous injection into mice tail provokes uncomfortable symptoms with a death rate of 12.5%.
Tissue specificity: Expressed by the venom gland."	[Ref.19088182]Gram-positive bacteria: Bacillus sp. DM-1 (MIC=2 µM), Micrococcus luteus (MIC=2.9 µM), Bacillus megaterium (MIC=0.25 µM);##Gram-negative bacteria: Agrobacterium tumefaciens (MIC=11.8 µM), Escherichia coli (MIC=7.90 µM), Shewanella oneidensis (MIC=6.20 µM), Stenotrophomonus sp. YC-1 (MIC=6.20 µM);##Fungi: Beauveria spp. (MIC=14.1 µM), Neurospora crassa (MIC=18.3 µM), Candida albicans (MIC=42.8 µM), Saccharomyces cerevisiae (MIC=18.3 µM).	[Ref.19088182]37.7% hemolytic activity at 6.25 M, 59.2% hemolytic activity at 12.5 M against rabbit red blood cells	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane	19088182	FASEB J. 2009 Apr;23(4):1230-1245.	Gao B, Sherman P, Luo L, Bowie J, Zhu S.	Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP03751	FFGHLFKLATKIIPSLFQ	18	Venom antimicrobial peptide-9 (Meucin-18; NDBP-5; Arthropods, animals)	E4VP50	Belongs to the ponericin-W family	Not found	Mesobuthus eupeus (Lesser Asian scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found		"Function: Amphipathic peptide that exhibits extensive cytolytic activities against both prokaryotic and eukaryotic cells. Is more potent against Gram-positive bacteria (lethal concentration (LC=1.5-10.9 µM) than against Gram-negative bacteria (LC=6.2-50 µM), and fungi (LC=25.1-8.3 µM). Is lethal to the fungus Beauveria sp (LC=1.9 µM), a highly lethal pathogenic fungus to insects and resistant to many AMPs. Shows hemolytic activity against rabbit erythrocytes and cytolysis against rat dorsal root ganglions. In vivo, intravenous injection into mice tail provokes uncomfortable symptoms with a death rate of 12.5%.
Tissue specificity: Expressed by the venom gland."	[Ref.19088182]Gram-positive bacteria: Bacillus sp. DM-1 (MIC=0.60 µM), Micrococcus luteus (MIC=0.60 µM), Bacillus megaterium (MIC=0.25 µM);##Gram-negative bacteria: Agrobacterium tumefaciens (MIC=6.00 µM), Escherichia coli (MIC=2.40 µM), Shewanella oneidensis (MIC=1.50 µM), Stenotrophomonus sp. YC-1(MIC=2.60 µM), Salmonella typhimurium (MIC=10.9 µM);##Fungi: Beauveria spp.(MIC=1.9 µM), Neurospora crassa (MIC=5.2 µM), Candida albicans (MIC=25.1 µM), Saccharomyces cerevisiae (MIC=25.1 µM), Aspergillus fumigatus (MIC=8.3 µM), Geotrichum candidum (MIC=3.5 µM).	[Ref.19088182]74% hemolytic activity at 6.25 M, 100% hemolytic activity at 12.5 M against rabbit red blood cells	Linear	Free	Free	Free	L	Not included yet	Cell membrane	19088182	FASEB J. 2009 Apr;23(4):1230-1245.	Gao B, Sherman P, Luo L, Bowie J, Zhu S.	Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC
DRAMP03752	FLFSLIPSAISGLISAFK	18	Peptide BmKb1 (Non-disulfide-bridged peptide 4.2, NDBP-4.2; Arthropods, animals)	Q718F4, Q2M5D6 Q95P85	Not found	Kb1	Mesobuthus martensii (Manchurian scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation."	Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), Micrococcus luteus(MIC=81.5 µg/ml), Bacillus subtilis (MIC=48.8 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=18.1 µg/ml), Pseudomonas aeruginosa (MIC=90.8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane (Forms a helical membrane channel in the prey)	15062994##16040157	Peptides. 2004 Feb;25(2):143-150.##Peptides. 2005 Dec;26(12):2427-2433.	Zeng XC, Wang SX, Zhu Y, Zhu SY, Li WX.##Luo F, Zeng XC, Hahin R, Cao ZJ, Liu H, Li WX.	Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch.##Genomic organization of four novel nondisulfide-bridged peptides from scorpion Mesobuthus martensii Karsch: gaining insight into evolutionary mechanism.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP03753	GFWGSLWEGVKSVV	14	Amphipathic peptide CT1 (StCT1; Non-disulfide-bridged peptide 5, NDBP-5; Arthropods, animals)	P0DJO3	Not found	Not found	Scorpiops tibetanus (Scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antimicrobial peptide that is rapidly bactericidal against Gram-positive bacteria (MIC=12.5 µg/ml against S.aureus, and MIC=100 µg/ml against M. luteus). Is also active against clinical antibiotics-resistant bacterial strains.
PTM: C-terminal amidation and Cleavage on pair of basic residues.
Miscellaneous: Is highly capable of inhibiting antibiotic-resistant pathogen growth, including methicillin-resistant S.aureus. In vivo, shows high antimicrobial activity on a S.aureus-infected mouse model."	Gram-positive bacteria: Staphylococcus aureus AB94004 (MIC=12.5 µg/ml), Bacillus thuringensis AB92037 (MIC>100 µg/ml), Bacillus subtilis AB91021 (MIC>100 µg/ml), Micrococcus luteus AB93113 (MIC=100 µg/ml), MRSA P1374 (MIC=200 µg/ml), MRSA P1386 (MIC=250 µg/ml);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=100 µg/ml), Pseudomonas aeruginosa AB93066 (MIC=100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane	19854232	Peptides. 2010 Jan;31(1):22-26.	Yuan W, Cao L, Ma Y, Mao P, Wang W, Zhao R, Wu Y, Cao Z, Li W.	Cloning and functional characterization of a new antimicrobial peptide gene StCT1 from the venom of the scorpion Scorpiops tibetanus.	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)C(C)C
DRAMP03754	GFWGKLWEGVKSAI	14	Amphipathic peptide CT2 (StCT2; Non-disulfide-bridged peptide 5, NDBP-5; Arthropods, animals)	P0DJO4	Not found	Not found	Scorpiops tibetanus (Scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		"PTM: C-terminal amidation and Cleavage on pair of basic residues.
Miscellaneous: Is highly capable of inhibiting antibiotic-resistant pathogen growth, including methicillin-resistant S.aureus. In vivo, shows high antimicrobial activity on a S.aureus-infected mouse model."	Gram-positive bacteria: Staphylococcus aureus AB94004 (MIC=6.25 µg/ml), Bacillus thuringensis AB92037 (MIC=50 µg/ml), Bacillus subtilis AB91021 (MIC=25 µg/ml), Micrococcus luteus AB93113 (MIC=25 µg/ml), PRSA P1383 (MIC=12.5 µg/ml), PRSE P1389 (MIC=12.5 µg/ml), MRCNS P1369 (MIC=6.25 µg/ml), MRSA P1374 (MIC=6.25 µg/ml), MRSA P1386 (MIC=12.5 µg/ml), MRSA P1381 (MIC=25 µg/ml), MSSE P1111 (MIC=6.25 µg/ml);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=50 µg/ml), Pseudomonas aeruginosa AB93066 (MIC>100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane	22542475	Peptides. 2012 Aug;36(2):213-220.	Cao L, Li Z, Zhang R, Wu Y, Li W, Cao Z.	StCT2, a new antibacterial peptide characterized from the venom of the scorpion Scorpiops tibetanus.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(N)=O
DRAMP03774	GFWGKLWEGVKNAI	14	UyCT1 (Arthropods, animals)	No entry found	Not found	Not found	Urodacus yaschenkoi (Scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Shows minimum inhibitory concentration against Gram-positive and Gram-negative bacteria. Has hemolytic activity.	[Ref.23182832]Gram-positive bacterium: Staphylococcus aureus ATCC 25953 (MIC=15 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=10 µM).	[Ref.23182832]20% hemolytic activity at 12.5 μM, 45% hemolytic activity at 25 μM, 80% hemolytic activity at 50 μM, 90% hemolytic activity at 100 μM against human erythrocytes	Linear	Free	Amidation	Free	L	Not included yet	Not found	23182832	Toxicon. 2013 Mar 1;63:44-54.	Luna-Ramírez K, Quintero-Hernández V, Vargas-Jaimes L, Batista CV, Winkel KD, Possani LD.	Characterization of the venom from the Australian scorpion Urodacus yaschenkoi: Molecular mass analysis of components, cDNA sequences and peptides with antimicrobial activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(N)=O
DRAMP03775	FWGKLWEGVKNAI	13	UyCT2 (Arthropods, animals)	No entry found	Not found	Not found	Urodacus yaschenkoi (Scorpion)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Shows minimum inhibitory concentration against Gram-positive and Gram-negative bacteria. Has hemolytic activity.	[Ref.23182832]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=25 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=40 µM).	[Ref.23182832]3% hemolytic activity at 12.5 μM, 6% hemolytic activity at 25 μM, 5% hemolytic activity at 50 μM, 35% hemolytic activity at 100 μM against human erythrocytes	Linear	Free	Amidation	Free	L	Not included yet	Not found	23182832	Toxicon. 2013 Mar 1;63:44-54.	Luna-Ramírez K, Quintero-Hernández V, Vargas-Jaimes L, Batista CV, Winkel KD, Possani LD.	Characterization of the venom from the Australian scorpion Urodacus yaschenkoi: Molecular mass analysis of components, cDNA sequences and peptides with antimicrobial activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(N)=O
DRAMP03776	ILSAIWSGIKSLF	13	UyCT3 (Arthropods, animals)	No entry found	Not found	Not found	Urodacus yaschenkoi (Scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Shows minimum inhibitory concentration against Gram-positive and Gram-negative bacteria. Has hemolytic activity.	[Ref.23182832]Gram-positive bacterium: Staphylococcus aureus ATCC 25953 (MIC=10 µM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=6 µM).	[Ref.23182832]30% hemolytic activity at 12.5 μM, 90% hemolytic activity at 25 μM, 92% hemolytic activity at 50 μM, 90% hemolytic activity at 100 μM against human erythrocytes	Linear	Free	Amidation	Free	L	Not included yet	Not found	23182832	Toxicon. 2013 Mar 1;63:44-54.	Luna-Ramírez K, Quintero-Hernández V, Vargas-Jaimes L, Batista CV, Winkel KD, Possani LD.	Characterization of the venom from the Australian scorpion Urodacus yaschenkoi: Molecular mass analysis of components, cDNA sequences and peptides with antimicrobial activity.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP03777	IWSAIWSGIKGLL	13	UyCT5 (Arthropods, animals)	No entry found	Not found	Not found	Urodacus yaschenkoi (Scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Shows minimum inhibitory concentration against Gram-positive and Gram-negative bacteria. Has hemolytic activity.	[Ref.23182832]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15 µM), Pseudomonas aeruginosa ATCC 9027 (MIC=2 µM).##Gram-positive bacterium: Staphylococcus aureus ATCC 25953 (MIC=1 µM).	[Ref.23182832]27% hemolytic activity at 12.5 μM, 65% hemolytic activity at 25 μM, 95% hemolytic activity at 50 μM, 90% hemolytic activity at 100 μM against human erythrocytes	Linear	Free	Amidation	Free	L	Not included yet	Not found	23182832	Toxicon. 2013 Mar 1;63:44-54.	Luna-Ramírez K, Quintero-Hernández V, Vargas-Jaimes L, Batista CV, Winkel KD, Possani LD.	Characterization of the venom from the Australian scorpion Urodacus yaschenkoi: Molecular mass analysis of components, cDNA sequences and peptides with antimicrobial activity.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP03797	GLRKRLRKFRNKIKEKLKKIGQKIQGFVPKLAPRTDY	37	CAP7 (C-terminal fragment of CAP18; lagomorphs, mammals, animals)	P25230	Belongs to the cathelicidin family	CAP18	Oryctolagus cuniculus (Rabbit)	Antimicrobial, Antibacterial	Protein level	Alpha helix (1 helices; 30 residues)	Not found	1LYP resolved by NMR.	"Function: CAP18 binds to the lipid A moiety of bacterial lipopolysaccharides (LPS), a glycolipid present in the outer membrane of all Gram-negative bacteria. Has antibiotic activity.
Tissue specificity: Neutrophils.
PTM: Contains two disulfide bonds (By similarity)."	[No NaCl]: Escherichia coli DH5a (MIC=0.19 µM), Escherichia coli ML-35p (MIC=0.05 µM), Pseudomonas aeruginosa PAO1 (MIC=0.2 µM), Pseudomonas aeruginosa MR3007 (MIC=0.05 µM), Staphylococcus aureus ATCC (MRSA) 33591 (MIC=1.24 µM), Staphylococcus aureus 93918 (MIC=0.41 µM).##[100 mM NaCl]: Escherichia coli DH5a (MIC=0.21 µM), Escherichia coli ML-35p (MIC=0.09 µM), Pseudomonas aeruginosa PAO1 (MIC=0.62 µM), Pseudomonas aeruginosa MR3007 (MIC=0.36 µM), Staphylococcus aureus ATCC (MRSA) 33591 (MIC=1.36 µM), Staphylococcus aureus 93918 (MIC=0.63 µM). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Lipopolysaccharides (LPS)-binding	8132348##10768969##7649303	Antimicrob Agents Chemother. 1993 Dec;37(12):2534-2539.##Infect Immun. 2000 May;68(5):2748-2755.##FEBS Lett. 1995 Aug 14;370(1-2):46-52.	Larrick JW, Hirata M, Shimomoura Y, Yoshida M, Zheng H, Zhong J, Wright SC.##Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray PB Jr, Lehrer RI, Welsh MJ, Tack BF.##Chen C, Brock R, Luh F, Chou PJ, Larrick JW, Huang RF, Huang TH.	Antimicrobial activity of rabbit CAP18-derived peptides.##Bactericidal activity of mammalian cathelicidin-derived peptides.##The solution structure of the active domain of CAP18--a lipopolysaccharide binding protein from rabbit leukocytes.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
DRAMP03814	GILDTLKQFAKGVGKWLVKGAAQGVLSTVSCKLAKTC	37	D16W (GGN4 analogue peptide with single substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Single substitution of aspartic acid 16 by tryptophan (D16W) in the native GGN4. Has hemolytic activity as well as the antimicrobial activity.	[Ref.12199716]Gram-positive bacteria: Micrococcus luteus (MIC=25 µg/ml), Bacillus subtilis (MIC=2.5 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=10 µg/ml), Shigella dysentariae (MIC=10 µg/ml), Pseudomonas putida (MIC=100 µg/ml), Pseudomonas aeruginosa (MIC=50 µg/ml), Eshchericia coli (MIC=10 µg/ml), Salmonella typhimurium (MIC=50 µg/ml).	[Ref.12199716] 1.97% hemolytic activity at 10 µg/mL, 52.9% hemolytic activity at 100 µg/mL against human red blood cells.	Cyclic	Free	Cyclization(Cys31 and Cys37).	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	12199716	Eur J Biochem. 2002 Sep;269(17):4367-4374.	Won HS, Park SH, Kim HE, Hyun B, Kim M, Lee BJ, Lee BJ.	Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.	
DRAMP03815	GILDTLKQFAKGVGKWLVKGAAQ	23	D16W-N23 (single amino acid substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Comment: Single substitution of aspartic acid 16 by tryptophan (D16W) in the Delta24-37 GGN4, which is a peptide analogue with 14 residues truncated from the C-terminus of GGN4.	Gram-positive bacteria: Micrococcus luteus (MIC=2.5 µg/ml), Bacillus subtilis (MIC=25 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=25 µg/ml), Shigella dysentariae (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=125 µg/ml), Eshchericia coli (MIC=25 µg/ml), Salmonella typhimurium (MIC=125 µg/ml).	[Ref.12199716] 0.02% hemolytic activity at 10 µg/mL, 0.38% hemolytic activity at 100 µg/mL against human red blood cells.	Linear	Free	Free	Free	L	Not included yet	Not found	12199716	Eur J Biochem. 2002 Sep;269(17):4367-4374.	Won HS, Park SH, Kim HE, Hyun B, Kim M, Lee BJ, Lee BJ.	Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O
DRAMP03816	GILDTLKQFAKGVGKFLVKGAAQ	23	D16F-N23 (single amino acid substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Comment: Single substitution of aspartic acid 16 by phenylalanine (D16F) in the Delta24-37 GGN4, which is a peptide analogue with 14 residues truncated from the C-terminus of GGN4.	Gram-positive bacterium: Bacillus subtilis (MIC=25 µg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=100 µg/ml), Shigella dysentariae (MIC=50 µg/ml), Pseudomonas aeruginosa (MIC=200 µg/ml), Eshchericia coli (MIC=25 µg/ml).	[Ref.12199716] 0.06% hemolytic activity at 10 µg/mL, 0.32% hemolytic activity at 100 µg/mL against human red blood cells.	Linear	Free	Free	Free	L	Not included yet	Not found	12199716	Eur J Biochem. 2002 Sep;269(17):4367-4374.	Won HS, Park SH, Kim HE, Hyun B, Kim M, Lee BJ, Lee BJ.	Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O
DRAMP03823	ALWKTLLKKVLKA	13	Dermaseptin derivative K4-S4-(1-13)	P80280	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix (1 helices; 5 residues)	The Ramachandran plot of P showes that residues 2 and 4-13 are all in α-helix regions of the plot; the residues in all of the structures are in the core α-helix region for residues 2, 3, and 6-11, and both residue 5 and 12 had over 60% in the core and the rest in allowed α-helix regions.	2DD6 resolved by NMR.	Function: Has antibacterial activity. Also has hemolytic activity against red blood cells (RBCs).	[Ref.15917541]Gram-negative bacterium: Escherichia coli U16318 (MIC=9-3 µM);##Gram-positive bacterium: Staphylococcus aureus B38302 (MIC=4.5-1.5 µM).	[Ref.15917541]LC50=50 μM against human red blood cells	Linear	Free	Amidation	Free	L	Not included yet	Cell membrane	16407175##15917541	J Biol Chem. 2006 Apr 7;281(14):9432-9438.##Antimicrob Agents Chemother. 2005 Jun;49(6):2412-2420.	Shalev DE, Rotem S, Fish A, Mor A.##Radzishevsky IS, Rotem S, Zaknoon F, Gaidukov L, Dagan A, Mor A.	Consequences of N-acylation on structure and membrane binding properties of dermaseptin derivative K4-S4-(1-13).##Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides.	CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(N)=O)C(C)C)[C@@H](C)O
DRAMP03824	FKCRRWQWR	9	CNBr-cleaved lactoferricin Subfragment 1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: The antibacterial activity of this subfragment 1 is not as potent as that of intact lactoferricin, having an MIC of 10 to 50 µM for most of the bacteria tested.	Gram-negative bacteria: Escherichia coli L361 (MIC=10 µM), Pseudomonas fluorescens (MIC=50 µM), Salmonella Salford (MIC>50 µM), Escherichia coli O:9 (MIC=15 µM);##Gram-positive bacteria: Bacillus cereus (MIC=20 µM), Listeria monocytogenes (MIC=10 µM), Staphylococcus aureus (MIC>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Linked with a homoserine lactone	Free	L	Not included yet	Not found	8980754	Antimicrob Agents Chemother. 1997 Jan;41(1):54-59.	Hoek KS, Milne JM, Grieve PA, Dionysius DA, Smith R.	Antibacterial activity in bovine lactoferrin-derived peptides.	
DRAMP03825	KKLGAPSITCVRRAFA	16	CNBr-cleaved lactoferricin Subfragment 2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Subfragment 2 had weak antibacterial activity against L. monocytogenes and both E. coli isolates, being effective in the range of 40 to 60 µM.	Gram-negative bacteria: Escherichia coli L361 (MIC=50 µM), Pseudomonas fluorescens (MIC>100 µM), Salmonella Salford (MIC>100 µM), Escherichia coli O:9 (MIC=60 µM);##Gram-positive bacteria: Bacillus cereus (MIC>100 µM), Listeria monocytogenes (MIC=40 µM), Staphylococcus aureus (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	8980754	Antimicrob Agents Chemother. 1997 Jan;41(1):54-59.	Hoek KS, Milne JM, Grieve PA, Dionysius DA, Smith R.	Antibacterial activity in bovine lactoferrin-derived peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O
DRAMP03826	KNLRRIIRKIIHIIKKYG	18	Ovispirin-1 (OV-1; N-terminal 18 amino acids of SMAP-29)	No entry found	Not found	Not found	Synthetic construct	Antibacterial, Cytotoxic, Anti-Gram+, Anti-Gram-, Antimicrobial	Synthetic	Alpha helix (1 helices; 13 residues)	Ovispirin-1 is a uniform α-helix over residues 4-16. 	1HU5 resolved by NMR.	Function: Possess potently antimicrobial activity. It is also highly cytotoxic to human epithelial cells (ME-180 cervical cells: 100% at 200 µg/ml, 93.6% at 50 µg/ml, 55.3% at 25 µg/ml) and A-549 pulmonary cells: 99.7% at 200 µg/ml, 99.4% at 50 µg/ml, 90.9% at 25 µg/ml) and hemolytic for human Human red blood cells.	[Ref.11932493]Gram-negative bacteria: Pseudomonas aeruginosa 9 strains (MIC=0.7-5.6 µg/ml), Stenotrophomonas maltophilia 5 strains (MIC=0.5-2.2 µg/ml);##Gram-positive bacteria: Listeria monocytogenes EGD [n=3] (MIC=1.5±0.3 µg/ml), Staphylococcus aureus 930918 [n=3] (MIC=1.0±0.13 µg/ml).	[Ref.11932493]55% hemolytic at 40 µg/mL, 70.2% hemolytic activity at 80 µg/mL against human red blood cells	Linear	Free	Free	Free	L	Not included yet	Not found	11932493	Protein Eng. 2002 Mar;15(3):225-232.	Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF.	Impact of single-residue mutations on the structure and Function: of ovispirin/novispirin antimicrobial peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP03827	KNLRRIIRKGIHIIKKYG	18	Novispirin G-10 (mutation of Ovispirin-1)	No entry found	Not found	Not found	Synthetic construct	Antibacterial, Cytotoxic, Anti-Gram+, Anti-Gram-, Antimicrobial	Synthetic	Alpha helix (2 helices; 11 residues)	Novispirin G-10 shows an α-helix-hinge-310 helix structural motif with residues 4-11 forming the α-helix, residues 12 and 13 forming the hinge and residues 14-16 forming the 310 helix.	1HU6 resolved by NMR.	Function: Possess potently antimicrobial activity. Also has hemolytic activity against Human red blood cells, and has cytotoxicity activity against ME-180 cervical cells (33.2% at 200 µg/ml, 5.0% at 50 µg/ml, 7.1% at 25 µg/ml) and A-549 pulmonary cells (33.2% at 200 µg/ml, 14.6% at 50 µg/ml, 10.0% at 25 µg/ml).	[Ref.11932493]Gram-negative bacteria: Pseudomonas aeruginosa 9 strains (MIC=0.11-12.7 µg/ml), Stenotrophomonas maltophilia 5 strains (MIC=0.29-3.6 µg/ml);##Gram-positive bacteria: Listeria monocytogenes EGD [n=3] (MIC=1.4±0.4 µg/ml), Staphylococcus aureus 930918 [n=3] (MIC=4.6±1.7 µg/ml).	[Ref.11932493]1.8% hemolytic at 40 µg/mL, 2.5% hemolytic activity at 80 µg/mL against human red blood cells	Linear	Free	Free	Free	L	Not included yet	Not found	11932493	Protein Eng. 2002 Mar;15(3):225-232.	Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF.	Impact of single-residue mutations on the structure and Function: of ovispirin/novispirin antimicrobial peptides.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)[C@H](C)CC)[C@H](C)CC
DRAMP03828	KNLRRITRKIIHIIKKYG	18	Novispirin T-7 (mutation of Ovispirin-1)	No entry found	Not found	Not found	Synthetic construct	Antibacterial, Cytotoxic, Anti-Gram+, Anti-Gram-, Antimicrobial	Synthetic	Alpha helix (1 helices; 11 residues)	Novispirin T-7 is a well-defined α-helix over residues 7-17 with residues 3-6 forming a type IV turn.	1HU7 resolved by NMR.	Function: Possess potently antimicrobial activity. Also has hemolytic activity against Human red blood cells, and has cytotoxicity activity against ME-180 cervical cells (81.5% at 200 µg/ml, 28.4% at 50 µg/ml, 15.6% at 25 µg/ml) and A-549 pulmonary cells (81.5% at 200 µg/ml, 22.9% at 50 µg/ml, 15.4% at 25 µg/ml).	[Ref.11932493]Gram-negative bacteria: Pseudomonas aeruginosa 9 strains (MIC=0.26-27.8 µg/ml), Stenotrophomonas maltophilia 5 strains (MIC=0.32-1.75 µg/ml);##Gram-positive bacteria: Listeria monocytogenes EGD (MIC=2.4±1.5 [n=3] µg/ml), Staphylococcus aureus 930918 (MIC=3.3±1.5 [n=3] µg/ml).	[Ref.11932493]3% hemolytic at 40 µg/mL, 10% hemolytic activity at 80 µg/mL against human red blood cells	Linear	Free	Free	Free	L	Not included yet	Not found	11932493	Protein Eng. 2002 Mar;15(3):225-232.	Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF.	Impact of single-residue mutations on the structure and Function: of ovispirin/novispirin antimicrobial peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)[C@H](C)CC
DRAMP03829	GLKKLLGKLLKKLGKLLLK	19	GLK-19	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Anticancer	Synthetic	Not found	Not found		Function: GLK-19 showed a higher activity against Escherichia coli than human LL-37.	Gram-negative bacterium: Escherichia coli K12 (MIC=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	18957441	Nucleic Acids Res. 2009 Jan;37(Database issue):D933-937.	Wang G, Li X, Wang Z.	APD2: the updated antimicrobial peptide database and its application in peptide design.	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP03830	GLWNSIKIAGKKLFVNVLDKIRCKVAGGCKTSPDVEYHK	39	Palustrin-2ISb + 3aa	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=6.3 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.3 µM), S. aureus (MRSA) (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys23 and Cys29.	L	Not included yet	Not found	21911019	Peptides. 2011 Oct;32(10):2052-2057.	Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.	Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-3 family isolated from the skin of the endangered frog Odorrana ishikawae.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC1=O)[C@H](C)CC)C(C)C)C(C)C
DRAMP03831	GLWNSIKIAGKKLFVNVLDKIRCKVAGGC	29	Palustrin-2ISb-des-C7	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=6.3 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=1.6 µM), S. aureus (MRSA) (MIC=12.5 µM).##Yeast: Candida albicans (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization(Cys23 and Cys29).	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	21911019	Peptides. 2011 Oct;32(10):2052-2057.	Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.	Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-4 family isolated from the skin of the endangered frog Odorrana ishikawae.	
DRAMP03832	GLWDSIKIAGKKLFVNVLDKIRCKVAGGC	29	Palustrin-2ISb-des-C7-4D	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=12.5 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 µM), S. aureus (MRSA) (MIC=12.5 µM);##yeast Candida albicans (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization(Cys23 and Cys29).	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	21911019	Peptides. 2011 Oct;32(10):2052-2057.	Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.	Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-5 family isolated from the skin of the endangered frog Odorrana ishikawae.	
DRAMP03833	GLWNSIKIAGKNLFVNVLDKIRCKVAGGC	29	Palustrin-2ISb-des-C7-12N	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=12.5 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 µM), S. aureus (MRSA) (MIC=12.5 µM);##yeast Candida albicans (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization(Cys23 and Cys29).	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	21911019	Peptides. 2011 Oct;32(10):2052-2057.	Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.	Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-6 family isolated from the skin of the endangered frog Odorrana ishikawae.	
DRAMP03834	GLWNSIKIAGKKLFVNVLDKIRSKVAGGS	29	Palustrin-2ISb-des-C7-23,29S	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=3.1 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.3 µM), S. aureus (MRSA) (MIC=25 µM);##yeast Candida albicans (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Free	L	Not included yet	Not found	21911019	Peptides. 2011 Oct;32(10):2052-2057.	Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.	Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-7 family isolated from the skin of the endangered frog Odorrana ishikawae.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)O)C(C)C
DRAMP03835	GKKLFVNVLDKIRCKVAGGC	20	Palustrin-2ISb-des-C7-des-N9	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Yeast: Candida albicans (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization(Cys14 and Cys20).	Disulfide bond between Cys14 and Cys20.	L	No cytotoxicity information found	Not found	21911019	Peptides. 2011 Oct;32(10):2052-2057.	Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.	Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-8 family isolated from the skin of the endangered frog Odorrana ishikawae.	
DRAMP03852	GLARIVVIRVAR	12	G1 (Bac2A variant through single amino acid substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=125 µg/ml), Escherichia coli (MIC=16 µg/ml), Salmonella typhimurium (MIC=63 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=63 µg/ml), Staphylococcus epidermidis (MIC=16 µg/ml), Enterococcus faecalis (MIC=31 µg/ml).##Yeast: Candida albicans (MIC=125 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP03853	RGARIVVIRVAR	12	G2 (Bac2A variant through single amino acid substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=31 µg/ml), Escherichia coli (MIC=8 µg/ml), Salmonella typhimurium (MIC=31 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=31 µg/ml), Staphylococcus epidermidis (MIC=16 µg/ml), Enterococcus faecalis (MIC=31 µg/ml).##Yeast: Candida albicans (MIC=16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP03854	RRARIVVIRVAR	12	R2 (Bac2A variant through single amino acid substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=8 µg/ml), Escherichia coli (MIC=4 µg/ml), Salmonella typhimurium (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), Staphylococcus epidermidis (MIC=2 µg/ml), Enterococcus faecalis (MIC=16 µg/ml).##Yeast: Candida albicans (MIC=8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP03855	RLRRIVVIRVAR	12	R3 (Bac2A variant through single amino acid substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=8 µg/ml), Escherichia coli (MIC=4 µg/ml), Salmonella typhimurium (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=8 µg/ml), Staphylococcus epidermidis (MIC=2 µg/ml), Enterococcus faecalis (MIC=8 µg/ml).##Yeast: Candida albicans (MIC=16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP03856	RLWRIVVIRVAR	12	W3 (Bac2A variant through single amino acid substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=8 µg/ml), Escherichia coli (MIC=2 µg/ml), Salmonella typhimurium (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=2 µg/ml), Staphylococcus epidermidis (MIC=0.5 µg/ml), Enterococcus faecalis (MIC=2 µg/ml).##Yeast: Candida albicans (MIC=8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP03857	RLARRVVIRVAR	12	R5 (Bac2A variant through single amino acid substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=63 µg/ml), Escherichia coli (MIC=16 µg/ml), Salmonella typhimurium (MIC=31 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=63 µg/ml), Staphylococcus epidermidis (MIC=16 µg/ml), Enterococcus faecalis (MIC=125 µg/ml).##Yeast: Candida albicans (MIC=125 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP03858	RLARIVKIRVAR	12	K7 (Bac2A variant through single amino acid substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=31 µg/ml), Escherichia coli (MIC=16 µg/ml), Salmonella typhimurium (MIC=63 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=125 µg/ml), Staphylococcus epidermidis (MIC=31 µg/ml), Enterococcus faecalis (MIC=125 µg/ml).##Yeast: Candida albicans (MIC=31 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP03859	RLARIVVIRWAR	12	W10 (Bac2A variant through single amino acid substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=16 µg/ml), Escherichia coli (MIC=4 µg/ml), Salmonella typhimurium (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=8 µg/ml), Staphylococcus epidermidis (MIC=2 µg/ml), Enterococcus faecalis (MIC=4 µg/ml).##Yeast: Candida albicans (MIC=8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)C(C)C)C(C)C
DRAMP03860	RLARIVVIRVRR	12	R11 (Bac2A variant through single amino acid substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=16 µg/ml), Escherichia coli (MIC=8 µg/ml), Salmonella typhimurium (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=8 µg/ml), Staphylococcus epidermidis (MIC=2 µg/ml), Enterococcus faecalis (MIC=8 µg/ml).##Yeast: Candida albicans (MIC=8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP03861	RLARIVVIRVAG	12	G12 (Bac2A variant through single amino acid substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=63 µg/ml), Escherichia coli (MIC=16 µg/ml), Salmonella typhimurium (MIC=63 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=63 µg/ml), Staphylococcus epidermidis (MIC=31 µg/ml), Enterococcus faecalis (MIC=31 µg/ml).##Yeast: Candida albicans (MIC=63 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(N)=O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP03862	RLRRIVVIRVRR	12	Sub2 (Bac2A variant through two amino acids substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=8 µg/ml), Escherichia coli (MIC=2 µg/ml), Salmonella typhimurium (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=8 µg/ml), Staphylococcus epidermidis (MIC=2 µg/ml), Enterococcus faecalis (MIC=4 µg/ml).##Yeast: Candida albicans (MIC=31 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP03863	RRWRIVVIRVRR	12	Sub3 (Bac2A variant through three amino acids substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Half Life: With a half-life of approximately 1h in 25% aqueous mouse serum,Sub3 was relatively stable for a medium-sized peptide.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=2 µg/ml), Escherichia coli (MIC=2.5 µg/ml), Salmonella typhimurium (MIC=4 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=2 µg/ml), Staphylococcus epidermidis (MIC=0.2 µg/ml), Enterococcus faecalis (MIC=4 µg/ml).##Yeast: Candida albicans (MIC=4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP03864	RRWKIVVIRWRR	12	Sub5 (Bac2A variant through five amino acids substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=2 µg/ml), Escherichia coli (MIC=4 µg/ml), Salmonella typhimurium (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=2 µg/ml), Staphylococcus epidermidis (MIC=0.5 µg/ml), Enterococcus faecalis (MIC=2 µg/ml).##Yeast: Candida albicans (MIC=4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)C(C)C)C(C)C
DRAMP03865	RWWKIWVIRWWR	12	Sub6 (Bac2A variant through six amino acids substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=31 µg/ml), Escherichia coli (MIC=4 µg/ml), Salmonella typhimurium (MIC=16 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=8 µg/ml), Staphylococcus epidermidis (MIC=1 µg/ml), Enterococcus faecalis (MIC=8 µg/ml).##Yeast: Candida albicans (MIC=31 µg/ml)..	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)C(C)C
DRAMP03866	KIWVIRWR	8	Bac8a (Bac2A variant)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: 8-mer substituted peptide that showes broad spectrum activity against bacteria and the yeast C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=16 µg/ml), Escherichia coli (MIC=8 µg/ml), Salmonella typhimurium (MIC=31 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), Staphylococcus epidermidis (MIC=4 µg/ml), Enterococcus faecalis (MIC=16 µg/ml).##Yeast: Candida albicans (MIC=16 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	
DRAMP03867	RIWVIRWR	8	Bac8b (Bac2A variant)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: 8-mer substituted peptide that showes broad spectrum activity against bacteria and the yeast C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=16 µg/ml), Escherichia coli (MIC=4 µg/ml), Salmonella typhimurium (MIC=16 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=4 µg/ml), Staphylococcus epidermidis (MIC=4 µg/ml), Enterococcus faecalis (MIC=8 µg/ml).##Yeast: Candida albicans (MIC=16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	
DRAMP03868	RIWVIWRR	8	Bac8c (Bac2A variant)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: 8-mer substituted peptide that showes broad spectrum activity against bacteria and the yeast C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=8 µg/ml), Escherichia coli (MIC=2 µg/ml), Salmonella typhimurium (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=2 µg/ml), Staphylococcus epidermidis (MIC=2 µg/ml), Enterococcus faecalis (MIC=2 µg/ml).##Yeast: Candida albicans (MIC=8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	
DRAMP03869	RRWVIWRR	8	Bac8d (Bac2A variant)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		"Function: 8-mer substituted peptide that showes broad spectrum activity against bacteria and the yeast C. albicans.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=250 µg/ml), Escherichia coli (MIC=16 µg/ml), Salmonella typhimurium (MIC=31 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), Staphylococcus epidermidis (MIC=8 µg/ml), Enterococcus faecalis (MIC=32 µg/ml).##Yeast: Candida albicans (MIC=63 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16041366	Nat Biotechnol. 2005 Aug;23(8):1008-1012.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.	
DRAMP03870	RLARIVVIRVAR	12	Bac2A (a linear variant of bovine dodecapeptide)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=50 µg/ml), Escherichia coli (MIC=17 µg/ml), Salmonella (MIC=34 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=17 µg/ml), Staphylococcus epidermidis (MIC=4 µg/ml), Enterococcus faecalis (MIC=17 µg/ml).##Yeast: Candida albicans (MIC=9 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16041366##17052614	Nat Biotechnol. 2005 Aug;23(8):1008-1012.Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Volkmer-Engert R, Walter T, Hancock RE. Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	High-throughput generation of small antibacterial peptides with improved activity.Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP03871	YQWQRRMRKL	10	cLf 20-29 (fragment of caprine lalctoferricin, residues 20-29)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=308 µM), Escherichia coli (wild strain) (MIC>300 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=308 µM), Enterococcus faecalis ATCC 29212 (MIC>300 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	13677384	Am J Vet Res. 2003 Sep;64(9):1088-1092.	Chen PW, Shyu CL, Mao FC.	Antibacterial activity of short hydrophobic and basic-rich peptides.	
DRAMP03875	RRWQWRMKKL	10	bLf 20-29 (fragment of bovine lactoferricin, residues 20-29)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.25 µM), Escherichia coli (wild strain) (MIC=5.63 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=11.25 µM), Enterococcus faecalis ATCC 29212 (MIC=15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	13677384	Am J Vet Res. 2003 Sep;64(9):1088-1092.	Chen PW, Shyu CL, Mao FC.	Antibacterial activity of short hydrophobic and basic-rich peptides.	
DRAMP03876	RRWWWRWRRW	10	LFB-RW (derivative of bovine lactoferrin with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15 µM), Escherichia coli (wild strain) (MIC=5.63 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=7.5 µM), Enterococcus faecalis ATCC 29212 (MIC=11.25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	13677384	Am J Vet Res. 2003 Sep;64(9):1088-1092.	Chen PW, Shyu CL, Mao FC.	Antibacterial activity of short hydrophobic and basic-rich peptides.	
DRAMP03877	KKWWWKWKKW	10	LFB-KW (derivative of bovine lactoferrin with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.25 µM), Escherichia coli (wild strain) (MIC=7.50 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=11.25 µM), Enterococcus faecalis ATCC 29212 (MIC=22.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	13677384	Am J Vet Res. 2003 Sep;64(9):1088-1092.	Chen PW, Shyu CL, Mao FC.	Antibacterial activity of short hydrophobic and basic-rich peptides.	
DRAMP03878	RRWWRRWRRW	10	LFB-Rwa (derivative of bovine lactoferrin with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15 µM), Escherichia coli (wild strain) (MIC=5.63 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=7.5 µM), Enterococcus faecalis ATCC 29212 (MIC=22.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	13677384	Am J Vet Res. 2003 Sep;64(9):1088-1092.	Chen PW, Shyu CL, Mao FC.	Antibacterial activity of short hydrophobic and basic-rich peptides.	
DRAMP03879	RRFFFRFRRF	10	LFB-RF (derivative of bovine lactoferrin with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=22.5 µM), Escherichia coli (wild strain) (MIC=15 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=15 µM), Enterococcus faecalis ATCC 29212 (MIC=22.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	13677384	Am J Vet Res. 2003 Sep;64(9):1088-1092.	Chen PW, Shyu CL, Mao FC.	Antibacterial activity of short hydrophobic and basic-rich peptides.	
DRAMP03880	RRIIIRWRRI	10	LFB-RI (derivative of bovine lactoferrin with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.63 µM), Escherichia coli (wild strain) (MIC=3.75 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=11.25 µM), Enterococcus faecalis ATCC 29212 (MIC=15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	13677384	Am J Vet Res. 2003 Sep;64(9):1088-1092.	Chen PW, Shyu CL, Mao FC.	Antibacterial activity of short hydrophobic and basic-rich peptides.	
DRAMP03881	RRWWWR	6	LFB-6RW (derivative of bovine lactoferrin with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=22.5 µM), Escherichia coli (wild strain) (MIC=22.5 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=11.25 µM), Enterococcus faecalis ATCC 29212 (MIC=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	13677384	Am J Vet Res. 2003 Sep;64(9):1088-1092.	Chen PW, Shyu CL, Mao FC.	Antibacterial activity of short hydrophobic and basic-rich peptides.	
DRAMP03882	SKCYQWQRRMRKLGA	15	LFC (fragment of mature caprine lactoferrin, residues 17 to 31)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=252 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>500 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03883	TKCFQWQWNMRKVRG	15	LFH W8 (tryptophan-modified human lactoferricin derivative)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=74 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>500 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03884	SKCYQWQWRMRKLGA	15	LFC W8 (tryptophan-modified caprine lactoferricin derivative)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=174 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>500 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03885	SKCRQWQWKIRRTNP	15	LFP W8 (tryptophan-modified porcine lactoferricin derivative)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=219 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>500 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03886	FKCRRWQWRMKKLGA	15	LFB (fragment of bovine lalctoferricin, residues 17 to 31)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=24 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=48 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives.	
DRAMP03887	AKCRRWQWRMKKLGA	15	LFB A1 (derivative of LFB, residue substitution with alanine at position 1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=35 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03888	FACRRWQWRMKKLGA	15	LFB A2 (derivative of LFB, residue substitution with alanine at position 2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=40 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03889	FKARRWQWRMKKLGA	15	LFB A3 (derivative of LFB, residue substitution with alanine at position 3)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=51 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03890	FKCARWQWRMKKLGA	15	LFB A4 (derivative of LFB, residue substitution with alanine at position 4)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=35 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03891	FKCRAWQWRMKKLGA	15	LFB A5 (derivative of LFB, residue substitution with alanine at position 5)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=61 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03892	FKCRRWAWRMKKLGA	15	LFB A7 (derivative of LFB, residue substitution with alanine at position 7)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=15 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=75 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03893	FKCRRWQWAMKKLGA	15	LFB A9 (derivative of LFB, residue substitution with alanine at position 9)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=28 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03894	FKCRRWQWRAKKLGA	15	LFB A10 (derivative of LFB, residue substitution with alanine at position 10)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=70 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03895	FKCRRWQWRMAKLGA	15	LFB A11 (derivative of LFB, residue substitution with alanine at position 11)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=35 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03896	FKCRRWQWRMKALGA	15	LFB A12 (derivative of LFB, residue substitution with alanine at position 12)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03897	FKCRRWQWRMKKAGA	15	LFB A13 (derivative of LFB, residue substitution with alanine at position 13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03898	FKCRRWQWRMKKLAA	15	LFB A14 (derivative of LFB, residue substitution with alanine at position 14)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=12 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=77 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11095180	J Pept Res. 2000 Nov;56(5):265-274.	StrÃ¸m MB, Rekdal O, Svendsen JS.	Antibacterial activity of 15-residue lactoferricin derivatives	
DRAMP03899	AKCLRWQWEMRKVGG	15	LFM A1 W8 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=391 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03900	AKCLRWQWAMRKVGG	15	LFM A1,9 W8 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=134 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03901	RKCLRWQWEMRKVGG	15	LFM R1 W8 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=37 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=374 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03902	EKCLRWQWRMRKVGG	15	LFM R9 W8 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03903	AKCLRWQWRMRKVGG	15	LFM A1 R9 W8 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=31 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=257 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03904	RKCLRWQWAMRKVGG	15	LFM A9 R1 W8 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=31 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=257 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03905	RKCLRWQWRMRKVGG	15	LFM R1,9 W8 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=10 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=37 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03906	AKCLRWQWEMRKYGG	15	LFM A1 W8 Y13 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=151 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03907	AKCLRWQWAMRKYGG	15	LFM A1,9 W8 Y13 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=88 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03908	RKCLRWQWEMRKYGG	15	LFM R1 W8 Y13 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=19 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=73 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03909	EKCLRWQWRMRKYGG	15	LFM R9 W8 Y13 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=63 µM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03910	AKCLRWQWRMRKYGG	15	LFM A1 R9 W8 Y13 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03911	RKCLRWQWAMRKYGG	15	LFM A9 R1 W8 Y13 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=12 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03912	RKCLRWQWRMRKYGG	15	LFM R1,9 W8 Y13 (LFM W8 derivative with residues substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.	Gram-negative bacterium: Escherichia coli (MIC=10 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11168896	J Pept Res. 2001 Feb;57(2):127-139.	StrÃ¸m MB, Rekdal O, Stensen W, Svendsen JS.	Increased antibacterial activity of 15-residue murine lactoferricin derivatives.	
DRAMP03920	KWKLFKKIEKVGQGIGAVLKVLTTGL	26	Cecropin A (1-8)-melittin (1-13)hybrid peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.7 µM), Staphylococcus aureus Cowan 1 (MIC=2 µM), Streptococcus pyogenes (MIC=1 µM);##Gram-negative bacteria: Escherichia coli D21 (MIC=0.5 µM), Pseudomonas aeruginosa OT97 (MIC=1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1733777	FEBS Lett. 1992 Jan 20;296(2):190-194.	Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.	Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.	
DRAMP03921	KWKLFKKIGIGAVLKVLTTGLPALIS	26	Cecropin A (1-8)-melittin (1-18)hybrid peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found	1BH1##2MLT##2MW6##3QRX##6DST##6O4M##8AHS##8AHT	Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli D21 (MIC=0.3 µM), Pseudomonas aeruginosa OT97 (MIC=0.7 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.4 µM), Bacillus megaterium Bm11 (MIC=0.4 µM), Staphylococcus aureus Cowan 1 (MIC=1 µM), Streptococcus pyogenes (MIC=2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1733777	FEBS Lett. 1992 Jan 20;296(2):190-194.	Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.	Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.	
DRAMP03922	KWKLFKKIGIGAVLKVLTTG	20	Cecropin A (1-8)-melittin (1-12)hybrid peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli D21 (MIC=0.4 µM), Pseudomonas aeruginosa OT97 (MIC=0.9 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.3 µM), Bacillus megaterium Bm11 (MIC=0.2 µM), Staphylococcus aureus Cowan 1 (MIC=2 µM), Streptococcus pyogenes (MIC=0.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1733777	FEBS Lett. 1992 Jan 20;296(2):190-194.	Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.	Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.	
DRAMP03923	KWKLFKKIGIGAVLKVLT	18	Cecropin A (1-8)-melittin (1-10)hybrid peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli D21 (MIC=0.5 µM), Pseudomonas aeruginosa OT97 (MIC=3 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.3 µM), Bacillus megaterium Bm11 (MIC=0.5 µM), Staphylococcus aureus Cowan 1 (MIC=7 µM), Streptococcus pyogenes (MIC=0.8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1733777	FEBS Lett. 1992 Jan 20;296(2):190-194.	Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.	Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.	
DRAMP03924	KWKLFKKGIGAVLKV	15	Cecropin A (1-7)-melittin (1-8)hybrid peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli D21 (MIC=4 µM), Pseudomonas aeruginosa OT97 (MIC=15 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=1.4 µM), Bacillus megaterium Bm11 (MIC=0.8 µM), Staphylococcus aureus Cowan 1 (MIC=29 µM), Streptococcus pyogenes (MIC=0.7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1733777	FEBS Lett. 1992 Jan 20;296(2):190-194.	Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.	Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.	
DRAMP03925	KWKLFKKGAVLKVLT	15	Cecropin A (1-7)-melittin (3-10)hybrid peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli D21 (MIC=3 µM), Pseudomonas aeruginosa OT97 (MIC=15 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=3 µM), Bacillus megaterium Bm11 (MIC=0.9 µM), Staphylococcus aureus Cowan 1 (MIC>200 µM), Streptococcus pyogenes (MIC=1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1733777	FEBS Lett. 1992 Jan 20;296(2):190-194.	Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.	Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.	
DRAMP03927	KWKLFKKIGAVLKVL	15	Cecropin A (1-7)-melittin (2-9)hybrid peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix (1 helices; 10 residues)	Adopts an amphipathic helix almost parallel to the surface of the micelle.	2JMY resolved by NMR.	CAMEL is also a hybrid peptide obtained by combining residues 1-7 of cecropin (CA) and residues 2-9 of melittin (M).	Gram-negative bacteria: Escherichia coli D21 (MIC=1 µM), Pseudomonas aeruginosa OT97 (MIC=4 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.5 µM), Bacillus megaterium Bm11 (MIC=0.7 µM), Staphylococcus aureus Cowan 1 (MIC=2 µM), Streptococcus pyogenes (MIC=0.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1733777##17397158	FEBS Lett. 1992 Jan 20;296(2):190-194.##J Am Chem Soc. 2007 Apr 25;129(16):5228-5234.	Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.##Respondek M, Madl T, Göbl C, Golser R, Zangger K.	Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.##Mapping the orientation of helices in micelle-bound peptides by paramagnetic relaxation waves.	
DRAMP03928	KWKLFKKAVLKVLTT	15	Cecropin A (1-7)-melittin (4-11)hybrid peptide (CAM)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli D21 (MIC=0.6 µM), Pseudomonas aeruginosa OT97 (MIC=4 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.6 µM), Bacillus megaterium Bm11 (MIC=0.5 µM), Staphylococcus aureus Cowan 1 (MIC=8 µM), Streptococcus pyogenes (MIC=0.7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1733777##20111863	FEBS Lett. 1992 Jan 20;296(2):190-194.##Curr Microbiol. 2010 Sep;61(3):169-175.	Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.##Cao Y, Yu RQ, Liu Y, Zhou HX, Song LL, Cao Y, Qiao DR.	Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.##Design, recombinant expression, and antibacterial activity of the cecropins-melittin hybrid antimicrobial peptides.	
DRAMP03929	KWKLFKKVLKVLTTG	15	Cecropin A (1-7)-melittin (5-12)hybrid peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli D21 (MIC=0.5 µM), Pseudomonas aeruginosa OT97 (MIC=2 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.3 µM), Bacillus megaterium Bm11 (MIC=0.5 µM), Staphylococcus aureus Cowan 1 (MIC=8 µM), Streptococcus pyogenes (MIC=0.4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1733777	FEBS Lett. 1992 Jan 20;296(2):190-194.	Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.	Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.	
DRAMP03930	KWKLFKKLKVLTTGL	15	Cecropin A (1-7)-melittin (6-13)hybrid peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli D21 (MIC=2 µM), Pseudomonas aeruginosa OT97 (MIC=8 µM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=1 µM), Bacillus megaterium Bm11 (MIC=0.5 µM), Staphylococcus aureus Cowan 1 (MIC=51 µM), Streptococcus pyogenes (MIC=0.4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1733777	FEBS Lett. 1992 Jan 20;296(2):190-194.	Andreu D, Ubach J, Boman A, WÃ¥hlin B, Wade D, Merrifield RB, Boman HG.	Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.	
DRAMP03931	DPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKPN	39	hPAB-beta (a hBD-2 variant; beta-defensins)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found	1FD3##1FD4##1FQQ##6CS9##1E4Q	Comment: No comments found on DRAMP database	Type strains: Staphylococcus aureus ATCC25923 (MIC=62.5 µg/ml), Staphylococcus aureus ATCC29215 (MIC=62.5 µg/ml), Escherichia coli ATCC29213 (MIC=125 µg/ml), Enterococcus feces ATCC29212 (MIC=250 µg/ml).##Clinical strains: Salmonella typhoid (MIC=62.5 µg/ml), Salmonella typhoid A (MIC=62.5 µg/ml), Shigella dysentery (MIC=62.5 µg/ml), Escherichia coli (MIC=62.5 µg/ml), Staphylococcus aureus (MIC=31.25 µg/ml), Staphylococcus epidermis (MIC=62.5 µg/ml), Enterobacter cloacae (MIC=62.5 µg/ml), Bacillus proteus curious (MIC=62.5 µg/ml), Acinetobacter lwoffii (MIC=62.5 µg/ml), Pseudomonas aeruginosa Pa6 (MIC=125 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15808901	Peptides. 2005 May;26(5):721-729.	Rao X, Hu J, Li S, Jin X, Zhang C, Cong Y, Hu X, Tan Y, Huang J, Chen Z, Zhu J, Hu F.	Design and expression of peptide antibiotic hPAB-beta as tandem multimers in Escherichia coli.	
DRAMP03933	IIYCNRRTGKCQRM	14	I14M (truncated isoform of thanatin, residue 8-21)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-positive bacteria: Aerococcus viridans (MIC=1.2-2.5 µM), Micrococcus luteus (MIC=5-10 µM), Bacillus megaterium (MIC=10-20 µM);##Gram-negative bacteria: Escherichia coli D22 (MIC=20-40 µM), Escherichia coli D31 (MIC=20-40 µM), Klebsiella pneumoniae (MIC=20-40 µM).##Fungi: Neurospora crassa (MIC=20-40 µM), Botrytis cinerea (MIC=10-20 µM), Alternaria brassicicola (MIC=5-10 µM), Fusarium culmorum (MIC=20-40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8577744	Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.	Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.	Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.	
DRAMP03934	YCNRRTGKCQRM	12	Y12M (truncated isoform of thanatin, residue 10-21)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-positive bacteria: Aerococcus viridans (MIC=20-40 µM), Micrococcus luteus (MIC=20-40 µM), Bacillus megaterium (MIC=20-40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8577744	Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.	Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.	Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.	
DRAMP03935	VPIIYCNRRTGKCQRM	16	V16M (truncated isoform of thanatin, residue 6-21)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-positive bacteria: Aerococcus viridans (MIC=1.2-2.5 µM), Micrococcus luteus (MIC=2.5-5 µM), Bacillus megaterium (MIC=5-10 µM), Bacillus subtilis (MIC=20-40 µM), Pediococcus acidilactici (MIC=20-40 µM);##Gram-negative bacteria: Escherichia coli D22 (MIC=0.6-1.2 µM), Escherichia coli D31 (MIC=0.6-1.2 µM), Klebsiella pneumoniae (MIC=2.5-5 µM), Enterobacter cloacae (MIC=5-10 µM), E. carotovora (MIC=20-40 µM).##Fungi: Neurospora crassa (MIC=10-20 µM), Botrytis cinerea (MIC=10-20 µM), Nectria haematococca (MIC=5-10 µM), Trichoderma viride (MIC=20-40 µM), Alternaria brassicicola (MIC=5-10 µM), Fusarium culmorum (MIC=10-20 µM), A. pisi (MIC=20-40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8577744	Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.	Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.	Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.	
DRAMP03936	KPVPIIYCNRRTGKCQRM	18	K18M (truncated isoform of thanatin, residue 4-21)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-positive bacteria: Aerococcus viridans (MIC=0.6-1.2 µM), Micrococcus luteus (MIC=1.2-2.5 µM), Bacillus megaterium (MIC=2.5-5 µM), Bacillus subtilis (MIC=20-40 µM), Pediococcus acidilactici (MIC=20-40 µM);##Gram-negative bacteria: Escherichia coli D22 (MIC=0.3-0.6 µM), Escherichia coli D31 (MIC=0.3-0.6 µM), Escherichia coli 1106 (MIC=0.6-1.2 µM), Salmonella typhimuriumn (MIC=1.2-2.5 µM), Klebsiella pneumoniae (MIC=1.2-2.5 µM), Enterobacter cloacae (MIC1.2-2.5 µM), E. carotovora (MIC=20-40 µM), Pseudomonas aeruginosa (MIC=20-40 µM).##Fungi: Neurospora crassa (MIC=2.5-5 µM), Botrytis cinerea (MIC=1.2-2.5 µM), Nectria haematococca (MIC=5-10 µM), Trichoderma viride (MIC=2.5-5 µM), Alternaria brassicicola (MIC=2.5-5 µM), Fusarium culmorum (MIC=5-10 µM), A. pisi (MIC=10-20 µM), Fusarium oxysporumn (MIC=20-40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8577744	Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.	Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.	Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.	
DRAMP03937	GSKKPVPIIYCNRRTGKC	18	G18C (truncated isoform of thanatin, residue 1-18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-positive bacteria: Aerococcus viridans (MIC=2.5-5 µM), Micrococcus luteus (MIC=1.2-2.5 µM), Bacillus megaterium (MIC=5-10 µM), Bacillus subtilis (MIC=5-10 µM), Pediococcus acidilactici (MIC=20-40 µM).##Fungi: Neurospora crassa (MIC=10-20 µM), Botrytis cinerea (MIC=5-10 µM), Nectria haematococca (MIC=5-10 µM), Trichoderma viride (MIC=20-40 µM), Alternaria brassicicola (MIC=5-10 µM), Fusarium culmorum (MIC=10-20 µM), A. pisi (MIC=20-40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8577744	Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.	Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.	Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.	
DRAMP03938	GSKKPVPIIYCNRRTGKCQ	19	G19Q (truncated isoform of thanatin, residue 1-19)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-positive bacteria: Aerococcus viridans (MIC=2.5-5 µM), Micrococcus luteus (MIC=5-10 µM), Bacillus megaterium (MIC=5-10 µM), Pediococcus acidilactici (MIC=20-40 µM).##Fungi: Neurospora crassa (MIC=10-20 µM), Botrytis cinerea (MIC=5-10 µM), Nectria haematococca (MIC=5-10 µM), Trichoderma viride (MIC=10-20 µM), Alternaria brassicicola (MIC=5-10 µM), Fusarium culmorum (MIC=10-20 µM), A. pisi (MIC=20-40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8577744	Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.	Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.	Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.	
DRAMP03939	GSKKPVPIIYCNRRTGKCQR	20	G20R (truncated isoform of thanatin, residue 1-20)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-positive bacteria: Aerococcus viridans (MIC=2.5-5 µM), Micrococcus luteus (MIC=2.5-5 µM), Bacillus megaterium (MIC=2.5-5 µM), Bacillus subtilis (MIC20-40 µM), Pediococcus acidilactici (MIC=20-40 µM).##Fungi: Neurospora crassa (MIC=5-10 µM), Botrytis cinerea (MIC=5-10 µM), Nectria haematococca (MIC=2.5-5 µM), Trichoderma viride (MIC=10-20 µM), Alternaria brassicicola (MIC=5-10 µM), Fusarium culmorum (MIC=10-20 µM), A. pisi (MIC=10-20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8577744	Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.	Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.	Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.	
DRAMP03945	LIKIVPAMICAVTKKC	16	Del 1-4 (Ranalexin analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacterium: Staphylococcus aureus (MIC=256 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=256 µg/ml), Pseudomonas aeruginosa (MIC=256 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8144672	J Biol Chem. 1994 Apr 8;269(14):10849-10855.	Clark DP, Durell S, Maloy WL, Zasloff M.	Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.	
DRAMP03947	GGLIKIVPAMICAVTKKC	18	Del 1-2 (Ranalexin analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacterium: Staphylococcus aureus (MIC=256 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC>256 µg/ml), Pseudomonas aeruginosa (MIC>256 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8144672	J Biol Chem. 1994 Apr 8;269(14):10849-10855.	Clark DP, Durell S, Maloy WL, Zasloff M.	Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.	
DRAMP03948	LGGLIKIVPAMICAVTKKC	19	Del 1 (Ranalexin analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacterium: Staphylococcus aureus (MIC=256 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=256 µg/ml), Pseudomonas aeruginosa (MIC>256 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8144672	J Biol Chem. 1994 Apr 8;269(14):10849-10855.	Clark DP, Durell S, Maloy WL, Zasloff M.	Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.	
DRAMP03949	FLGGLIKIVPAMICAVTKK	19	Del 20 (Ranalexin analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacterium: Staphylococcus aureus (MIC=128 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=256 µg/ml), Pseudomonas aeruginosa (MIC=128 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8144672	J Biol Chem. 1994 Apr 8;269(14):10849-10855.	Clark DP, Durell S, Maloy WL, Zasloff M.	Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.	
DRAMP03954	MTKGDTKVMKCVLEVISDSLSKPSPMPVSPECLETLQGDERILSVLRHQNL	51	Rat CGA7â€“57 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Fungi: Neurospora crassa (MIC=10 µg/ml), Alternaria brassicicola (MIC=20 µg/ml), Nectria haematococca (MIC=10 µg/ml), Fusarium culmorum (MIC=20 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10753865	J Biol Chem. 2000 Apr 14;275(15):10745-10753.	Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, Aunis D, Metz-Boutigue MH.	Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.	
DRAMP03955	STALPVNSPMNKGDTEVMKCIVEVISDTLSKPSPMPVSQECFETLRGDERILSILRHQNLLKELQDLALQGAKERAHQQKK	81	Human recombinant Ser-Thr-Ala-CGA1-78 peptide (hrVS-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Synthetic	Not found	Not found	6R2X	Comment: No comments found on DRAMP database	Gram-positive bacteria: Micrococcus luteus (MIC=30 µM), Bacillus megaterium (MIC=30 µM).##Fungi: Neurospora crassa (MIC=10 µM), Alternaria brassicicola (MIC=1 µM), Nectria haematococca (MIC=3 µM), Fusarium culmorum (MIC=5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10753865	J Biol Chem. 2000 Apr 14;275(15):10745-10753.	Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, Aunis D, Metz-Boutigue MH.	Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.	
DRAMP03957	RILSILRHQNLLKE	14	CGA47-60 (hrVS-1-derived peptide)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Fungi: Neurospora crassa (MIC=7 µM), Aspergillus fumigatus (MIC=50 µM), Alternaria brassicicola (MIC=10 µM), Nectria haematococca (MIC=7 µM), Fusarium culmorum (MIC=20 µM), F. oxyporum (MIC=50 µM), Trichophyton mentagrophytes (MIC=50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10753865	J Biol Chem. 2000 Apr 14;275(15):10745-10753.	Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, Aunis D, Metz-Boutigue MH.	Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.	
DRAMP03958	TLRGDERILSILRHQNLLKE	20	CGA41-60 (hrVS-1-derived peptide)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Fungi: Neurospora crassa (MIC=100 µM), Nectria haematococca (MIC=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10753865	J Biol Chem. 2000 Apr 14;275(15):10745-10753.	Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, Aunis D, Metz-Boutigue MH.	Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.	
DRAMP03959	TLRGDERILSILRHQNLLKELQDLALQGAK	30	CGA41-70 (hrVS-1-derived peptide)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found	6R2X	Comment: No comments found on DRAMP database	Fungi: Neurospora crassa (MIC=7 µM), Alternaria brassicicola (MIC=7 µM), Nectria haematococca (MIC=7 µM), Fusarium culmorum (MIC=10 µM), F. oxyporum (MIC=30 µM), Trichophyton mentagrophytes (MIC=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10753865	J Biol Chem. 2000 Apr 14;275(15):10745-10753.	Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, Aunis D, Metz-Boutigue MH.	Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.	
DRAMP03960	RILSILRHQNLLKELQDLALQGAK	24	CGA47-70 (hrVS-1-derived peptide)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Fungi: Neurospora crassa (MIC=5 µM), Aspergillus fumigatus (MIC=30 µM), Alternaria brassicicola (MIC=10 µM), Nectria haematococca (MIC=7 µM), Fusarium culmorum (MIC=10 µM), F. oxyporum (MIC=30 µM), Trichophyton mentagrophytes (MIC=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10753865	J Biol Chem. 2000 Apr 14;275(15):10745-10753.	Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, Aunis D, Metz-Boutigue MH.	Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.	
DRAMP03967	KWKLFKKIPKFLHLAKKF	18	P18 (Cecropin A(1-8)-Magainin 2(1−12) hybrid peptide analogue)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Alpha helix 	Not found		MOA: P18 kills cancer cells by disrupting membranes (Tang C et al 2010 Org Biomol Che 8:984-7). 	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=1.56 µM), Bacillus megaterium KCTC 1096 (MIC=0.78 µM).##Tumor cells: MDA-MB-361 (IC50=8.0 µM), Jurkat (IC50=4.0 µM), K-562 (IC50=3.5 µM), Normal cells NIH 3T3 (IC50=75.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	12005420##12370027	J Pept Res. 2001 Dec;58(6):504-514.##Protein Pept Lett. 2002 Oct;9(5):395-402.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.##Lee SH, Lee DG, Yang ST, Kim Y, Kim JI, Hahm KS, Shin SY.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.##Antibiotic activity of reversed peptides of alpha-helical antimicrobial peptide, P18.	
DRAMP03968	KWKLFKKILKFLHLAKKF	18	[L9]-P18 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=3.125 µM), Proteus vulgaris (MIC=6.25 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=3.0 µM), Jurkat (IC50=9.0 µM), K-562 (IC50=3.0 µM), Normal cells NIH 3T3 (IC50=70.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03969	KWKLFKKISKFLHLAKKF	18	[S9]-P18 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=25.0 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=6.25 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=6.25 µM), Bacillus megaterium KCTC 1096 (MIC=3.125 µM).##Tumor cells: MDA-MB-361 (IC50=4.0 µM), Jurkat (IC50=7.0 µM), K-562 (IC50=3.0 µM), Normal cells NIH 3T3 (IC50=50.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03970	WKLFKKIPKFLHLAKKF	17	N-1 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=9.5 µM), Jurkat (IC50=12.0 µM), K-562 (IC50=6.0 µM), Normal cells NIH 3T3 (IC50=75.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03971	FKLFKKIPKFLHLAKKF	17	N-2 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=0.78 µM).##Tumor cells: MDA-MB-361 (IC50=11.0 µM), Jurkat (IC50=11.0 µM), K-562 (IC50=7.0 µM), Normal cells NIH 3T3 (IC50=70.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03972	KWFKKIPKFLHLAKKF	16	N-3 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=17.0 µM), Jurkat (IC50=17.0 µM), K-562 (IC50=11.0 µM), Normal cells NIH 3T3 (IC50=50.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03973	WFKKIPKFLHLAKKF	15	N-4 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=32.0 µM), Jurkat (IC50=23.0 µM), K-562 (IC50=24.0 µM), Normal cells NIH 3T3 (IC50=100.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03974	WKKIPKFLHLAKKF	14	N-5 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=3.125 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03975	KWFKKIPKFLHLLKKF	16	N-3L (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=3.125 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=3.125 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=1.56 µM), Bacillus megaterium KCTC 1096 (MIC=0.78 µM).##Tumor cells: MDA-MB-361 (IC50=5.0 µM), Jurkat (IC50=4.0 µM), K-562 (IC50=4.2 µM), Normal cells NIH 3T3 (IC50=50.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03976	WFKKIPKFLHLLKKF	15	N-4L (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=3.125 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 µM), Proteus vulgaris (MIC=12.5 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=0.78 µM).##Tumor cells: MDA-MB-361 (IC50=5.0 µM), Jurkat (IC50=6.0 µM), K-562 (IC50=3.0 µM), Normal cells NIH 3T3 (IC50=50.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03977	WKKIPKFLHLLKKF	14	N-5L (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=3.125 µM), Proteus vulgaris (MIC=12.5 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=17.0 µM), Jurkat (IC50=14.0 µM), K-562 (IC50=10.0 µM), Normal cells NIH 3T3 (IC50=50.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03978	KWKLFKKIPFLHLAKKF	17	C-1 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=26.0 µM), Jurkat (IC50=32.0 µM), K-562 (IC50=31.0 µM), Normal cells NIH 3T3 (IC50=100.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03979	KWKLFKKIPKFLHLAKK	17	C-2 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=38.0 µM), Jurkat (IC50=26.0 µM), K-562 (IC50=23.0 µM), Normal cells NIH 3T3 (IC50=100.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03980	KWKLFKKIPLHLAKKF	16	C-3 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25-12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78-1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=3.125 µM).##Tumor cells: MDA-MB-361 (IC50=79.0 µM), Jurkat (IC50=74.0 µM), K-562 (IC50=62.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03981	KWKLFKKIPKFLHLAK	16	C-4 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=3.125-6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=3.125 µM), Bacillus megaterium KCTC 1096 (MIC=3.125 µM).##Tumor cells: MDA-MB-361 (IC50=54.0 µM), Jurkat (IC50=31.0 µM), K-562 (IC50=25.0 µM), Normal cells NIH 3T3 (IC50=50.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03982	KWKLFKKIPHLAKKF	15	C-5 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=12.5 µM), Proteus vulgaris (MIC=1.56 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=6.25 µM), Bacillus megaterium KCTC 1096 (MIC=1.56 µM).##Tumor cells: MDA-MB-361 (IC50=100.0 µM), Jurkat (IC50=81.0 µM), K-562 (IC50=67.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03983	KWKLFKKIPKFLHLA	15	C-6 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25-12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 µM), Staphylococcus aureus KCTC 1621 (MIC=6.25 µM), Bacillus megaterium KCTC 1096 (MIC=3.125 µM).##Tumor cells: MDA-MB-361 (IC50=47.0 µM), Jurkat (IC50=21.0 µM), K-562 (IC50=27.0 µM), Normal cells NIH 3T3 (IC50=100.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03984	KWKLFKKIPLAKKF	14	C-7 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25-12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=12.5 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=6.25 µM), Bacillus megaterium KCTC 1096 (MIC=3.125 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03985	KWKLFKKIPKFLHL	14	C-8 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=6.25 µM), Bacillus megaterium KCTC 1096 (MIC=3.125 µM).##Tumor cells: MDA-MB-361 (IC50=83.0 µM), Jurkat (IC50=54.0 µM), K-562 (IC50=30.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03986	KWKLFKKIPLKKF	13	C-9 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=12.5 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=12.5 µM), Bacillus megaterium KCTC 1096 (MIC=3.125 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03987	KWKLFKKIPKFLH	13	C-10 (analog of P18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25-12.5 µM), Proteus vulgaris (MIC=3.125 µM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 µM), Staphylococcus aureus KCTC 1621 (MIC=6.25 µM), Bacillus megaterium KCTC 1096 (MIC=3.125 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005420	J Pept Res. 2001 Dec;58(6):504-514.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.	
DRAMP03988	LLKWLKK	7	L3K3W4 (LlKmWn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-positive bacteria.	Gram-positive bacterium: Micrococcus luteus ATCC 10240 (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19544481	J Pept Sci. 2009 Sep;15(9):583-588.	Kang SJ, Won HS, Choi WS, Lee BJ.	De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.	
DRAMP03989	LLKWLLK	7	L4K2W4 (LlKmWn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-positive bacteria.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=25 µg/ml), Staphylococcus aureus ATCC 6538p (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19544481	J Pept Sci. 2009 Sep;15(9):583-588.	Kang SJ, Won HS, Choi WS, Lee BJ.	De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.	
DRAMP03990	LLKWLKKL	8	L4K3W4 (LlKmWn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=50 µg/ml), Staphylococcus aureus ATCC 6538p (MIC=25 µg/ml);##Gram-negative bacterium: Pseudomonas aeruginosa ATCC 27853 (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19544481	J Pept Sci. 2009 Sep;15(9):583-588.	Kang SJ, Won HS, Choi WS, Lee BJ.	De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.	
DRAMP03991	KLLKWLLK	8	L4K3W5 (LlKmWn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-positive bacteria.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=50 µg/ml), Staphylococcus aureus ATCC 6538p (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19544481	J Pept Sci. 2009 Sep;15(9):583-588.	Kang SJ, Won HS, Choi WS, Lee BJ.	De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.	
DRAMP03992	KLLKWLLKL	9	L5K3W5 (LlKmWn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=12.5 µg/ml), Staphylococcus aureus ATCC 6538p (MIC=3.1 µg/ml), Staphylococcus epidermis ATCC 12228 (MIC=12.5 µg/ml), Micrococcus luteus ATCC 10240 (MIC=25 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.5 µg/ml), Shigella dysentariae ATCC 9752 (MIC=12.5 µg/ml), Salmonella typhomurium ATCC 14028 (MIC=25 µg/ml), Klebsiella pneumoniae ATCC 10031 (MIC=6.3 µg/ml), Pseudomonas aeruginosa ATCC 27 853 (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19544481	J Pept Sci. 2009 Sep;15(9):583-588.	Kang SJ, Won HS, Choi WS, Lee BJ.	De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.	
DRAMP03993	KKLLKWLKKLL	11	L5K5W6 (LlKmWn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=6.3 µg/ml), Staphylococcus aureus ATCC 6538p (MIC=6.3 µg/ml), Staphylococcus epidermis ATCC 12228 (MIC=6.3 µg/ml), Micrococcus luteus ATCC 10240 (MIC=6.3 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.5 µg/ml), Shigella dysentariae ATCC 9752 (MIC=6.3 µg/ml), Salmonella typhomurium ATCC 14028 (MIC=25 µg/ml), Klebsiella pneumoniae ATCC 10031 (MIC=6.3 µg/ml), Pseudomonas aeruginosa ATCC 27 853 (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19544481	J Pept Sci. 2009 Sep;15(9):583-588.	Kang SJ, Won HS, Choi WS, Lee BJ.	De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.	
DRAMP03994	KKLLKWLLKLL	11	L6K4W6 (LlKmWn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=1.6 µg/ml), Staphylococcus aureus ATCC 6538p (MIC=1.6 µg/ml), Staphylococcus epidermis ATCC 12228 (MIC=1.6 µg/ml), Micrococcus luteus ATCC 10240 (MIC=1.6 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.3 µg/ml), Shigella dysentariae ATCC 9752 (MIC=3.1 µg/ml), Salmonella typhomurium ATCC 14028 (MIC=25 µg/ml), Klebsiella pneumoniae ATCC 10031 (MIC=3.1 µg/ml), Pseudomonas aeruginosa ATCC 27 853 (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19544481	J Pept Sci. 2009 Sep;15(9):583-588.	Kang SJ, Won HS, Choi WS, Lee BJ.	De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.	
DRAMP03995	LKLLKWLLKLL	11	L7K3W6 (LlKmWn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=1.6 µg/ml), Staphylococcus aureus ATCC 6538p (MIC=3.1 µg/ml), Staphylococcus epidermis ATCC 12228 (MIC=3.1 µg/ml), Micrococcus luteus ATCC 10240 (MIC=3.1 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=50 µg/ml), Shigella dysentariae ATCC 9752 (MIC=12.5 µg/ml), Klebsiella pneumoniae ATCC 10031 (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19544481	J Pept Sci. 2009 Sep;15(9):583-588.	Kang SJ, Won HS, Choi WS, Lee BJ.	De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.	
DRAMP03996	LKKLLKWLLKLLK	13	L7K5W7 (LlKmWn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-positive bacteria.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=3.1 µg/ml), Staphylococcus aureus ATCC 6538p (MIC=12.5 µg/ml), Staphylococcus epidermis ATCC 12228 (MIC=12.5 µg/ml), Micrococcus luteus ATCC 10240 (MIC=3.1 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19544481	J Pept Sci. 2009 Sep;15(9):583-588.	Kang SJ, Won HS, Choi WS, Lee BJ.	De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.	
DRAMP03997	LLKLLKWLLKLLK	13	L8K4W7 (LlKmWn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=6.3 µg/ml), Staphylococcus aureus ATCC 6538p (MIC=25 µg/ml), Staphylococcus epidermis ATCC 12228 (MIC=50 µg/ml), Micrococcus luteus ATCC 10240 (MIC=6.3 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19544481	J Pept Sci. 2009 Sep;15(9):583-588.	Kang SJ, Won HS, Choi WS, Lee BJ.	De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.	
DRAMP03999	ILGKIAEGIKSLF	13	[A6]-IsCT (Mutant: W6A; IsCT analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: [A6]-IsCT did not cause any hemolysis at peptide concentrations as high as 100 µM, indicating that Trp6 is important for both the hemolytic activity and antibacterial activity of IsCT.
Chemical modification: C-terminal amidation."	[Ref.15369808]Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=64 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=32 µM), Salmonella typhimurium KCTC 1926 (MIC>64 µM);##Gram-positive bacteria: Staphylococcus epidermidis KCTC 1917 (MIC>64 µM), Staphylococcus aureus KCTC 1621 (MIC>64 µM).	[Ref.15369808]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15369808	Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-719.	Lee K, Shin SY, Kim K, Lim SS, Hahm KS, Kim Y.	Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs.	
DRAMP04000	ILGKILEGIKSLF	13	[L6]-IsCT (Mutant: W6L; IsCT analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Drastic reduction in antibacterial activity against both Gram-positive and Gram-negative bacteria, and big loss of hemolysis activity.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=16 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=16 µM), Salmonella typhimurium KCTC 1926 (MIC=16 µM);##Gram-positive bacteria: Staphylococcus epidermidis KCTC 1917 (MIC=32 µM), Staphylococcus aureus KCTC 1621 (MIC=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15369808	Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-719.	Lee K, Shin SY, Kim K, Lim SS, Hahm KS, Kim Y.	Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs.	
DRAMP04001	ILGKIWKGIKSLF	13	[K7]-IsCT (Mutant: E7K; IsCT analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: [K7]-IsCT displays a similar or 2-fold increase in antibacterial activity against both Gram-positive and Gram-negative bacteria, and complete loss of hemolysis activity.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=2 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=2 µM), Salmonella typhimurium KCTC 1926 (MIC=1 µM);##Gram-positive bacteria: Staphylococcus epidermidis KCTC 1917 (MIC=1 µM), Staphylococcus aureus KCTC 1621 (MIC=1 µM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15369808	Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-719.	Lee K, Shin SY, Kim K, Lim SS, Hahm KS, Kim Y.	Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs.	
DRAMP04002	ILGKILKGIKKLF	13	[L6, K11]-IsCT (IsCT analog through amino acids substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: [L6, K11]-IsCT displays a similar or 2-fold higher antibacterial activity relative to that of native IsCT.
Chemical modification: C-terminal amidation."	Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=2 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=2 µM), Salmonella typhimurium KCTC 1926 (MIC=1 µM);##Gram-positive bacteria: Staphylococcus epidermidis KCTC 1917 (MIC=1 µM), Staphylococcus aureus KCTC 1621 (MIC=2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15369808	Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-719.	Lee K, Shin SY, Kim K, Lim SS, Hahm KS, Kim Y.	Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs.	
DRAMP04003	ILGKIWKIKKLF	12	[K7, P8, K11]-IsCT (IsCT analog through amino acids substitution)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: [K7, P8, K11]-IsCT exhibited more potent antibacterial activity than native IsCT but no hemolytic activity, even at concentrations as high as 100 µM. [K7, P8, K11]-IsCT displays a similar or 2-fold higher antibacterial activity relative to that of native IsCT.
Chemical modification: C-terminal amidation."	[Ref.15369808]Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=2 µM), Pseudomonas aeruginosa KCTC 1637 (MIC=2 µM), Salmonella typhimurium KCTC 1926 (MIC=1 µM);##Gram-positive bacteria: Staphylococcus epidermidis KCTC 1917 (MIC=1 µM), Staphylococcus aureus KCTC 1621 (MIC=2 µM);##Antibiotic-resistant bacteria: Methicillin-resistant Staphylococcus aureus (MRSA) CCARM 3001 (MIC=1 µM), multidrug-resistant Pseudomonas aeruginosa (MDRPA) (CCARM 3543) (MIC=1 µM) and multidrug-resistant Pseudomonas aeruginosa (MDRPA) CCARM 2095 (MIC=1 µM).	[Ref.15369808]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15369808	Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-719.	Lee K, Shin SY, Kim K, Lim SS, Hahm KS, Kim Y.	Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs.	
DRAMP04004	VSLFPVXLFP	10	Gramicidin analogue ([Scr2]-GS)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Staphylococcus aureus ATCC 6538 P(MIC=25 µg/ml), Streptococcus pyogenes N.Y.5 (MIC=25 µg/ml), Myotis flavus ATCC 10240 (MIC=3.1 µg/ml), Bacillus subtilis ATCC 6633 (MIC=6.3 µg/ml);##Gram-negative bacteria: Corynebacterium diphtheriae P.W.8 (MIC=3.1 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8791160	Int J Pept Protein Res. 1996 May;47(5):369-375.	Tamaki M, Akabori S, Muramatsu I.	Properties of synthetic analogs of gramicidin S containing L-serine or L-glutamic acid residue in place of L-ornithine residue.	
DRAMP04005	VSLFPVSLFP	10	Gramicidin analogue ([Ser2,2']-GS)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Streptococcus pyogenes N.Y.5 (MIC=25 µg/ml), Myotis flavus ATCC 10240 (MIC=12.5 µg/ml);##Gram-negative bacteria: Corynebacterium diphtheriae P.W.8 (MIC=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8791160	Int J Pept Protein Res. 1996 May;47(5):369-375.	Tamaki M, Akabori S, Muramatsu I.	Properties of synthetic analogs of gramicidin S containing L-serine or L-glutamic acid residue in place of L-ornithine residue.	
DRAMP04011	GVVTDLLKTAGKLLGNLFGSLSG	23	Plasticin PD36 KF (analog of PD36)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy. The hemolytic activity of the peptides was determined using fresh rat erythrocytes.	[Ref.17128968]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=6.5 µM), Bacillus megaterium ATCC 9885 (MIC=50.25 µM);##Gram-negative bacteria: Escherichia coli ATCC 11775 (MIC=6.5 µM), Salmonella typhimurium CIP 6062 (MIC=25.25 µM), Enterobacter cloacae ATCC 11775 (MIC=12.5 µM).	[Ref.17128968]25% hemolytic at 50 μM, 50% hemolytic activity at 100 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17128968	Biochemistry 2006; 45: 14285-14297.	Amri CE et al Bruston F.	The plasticins: membrane adsortpion, lipid disorders, and biological activity.	
DRAMP04012	GVVTDLLKTAGKLLGNLVGSLSG	23	Plasticin PD36 K (analog of PD36)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy. The hemolytic activity of the peptides was determined using fresh rat erythrocytes.	[Ref.17128968]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=50.5 µM), Bacillus megaterium ATCC 9885 (MIC=12.5 µM);##Gram-negative bacteria: Escherichia coli ATCC 11775 (MIC=12.5 µM).	[Ref.17128968]35% hemolytic at 50 μM, 71% hemolytic activity at 100 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17128968	Biochemistry 2006; 45: 14285-14297.	Amri CE et al Bruston F.	The plasticins: membrane adsortpion, lipid disorders, and biological activity.	
DRAMP04013	GLVTGLLKTAGKLLGDLFGSLTG	23	Plasticin ANC KF (analog of natural peptide ANC)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy. The hemolytic activity of the peptides was determined using fresh rat erythrocytes.	[Ref.17128968]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=12.5 µM), Bacillus megaterium ATCC 9885 (MIC=12.5 µM);##Gram-negative bacteria: Escherichia coli ATCC 11775 (MIC=25 µM).	[Ref.17128968]22% hemolytic at 50 μM, 48% hemolytic activity at 100 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17128968	Biochemistry 2006; 45: 14285-14297.	Amri CE et al Bruston F.	The plasticins: membrane adsortpion, lipid disorders, and biological activity.	
DRAMP04014	LLGDFFRKAKEKIGKEFKRIVQRIKDFLRNLVPRTES	37	LL-37A9 (LL-37 variants)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against the Gram-negative bacterium E. coli.	Gram-negative bacteria: Escherichia coli DC2 (MIC=6 µM), Escherichia coli K12 (MIC=15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22185690	Biochemistry. 2012 Jan 17;51(2):653-664. 	Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.	Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.	
DRAMP04015	LLGDFFRKVKEKIGKEFKRIVQRIKDFLRNLVPRTES	37	LL-37V9 (LL-37 variants)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against the Gram-negative bacterium E. coli.	Gram-negative bacteria: Escherichia coli DC2 (MIC=12 µM), Escherichia coli K12 (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22185690	Biochemistry. 2012 Jan 17;51(2):653-664. 	Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.	Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.	
DRAMP04016	LLGDFFRKAKEKIGKEFKRIVQR	23	LL-23A9 (LL-23 variants)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negagtive bacteria: Escherichia coli DC2 (MIC=9 µM), Escherichia coli K12 (MIC=80 µM);##Gram-positive bacteria: Staphylococcus aureus mprF (presence of carbonate) (MIC=0.35-0.7 µM), S. aureus mprF (absence of carbonate) (MIC=6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22185690	Biochemistry. 2012 Jan 17;51(2):653-664. 	Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.	Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.	
DRAMP04017	LLGDFFRKVKEKIGKEFKRIVQR	23	LL-23V9 (LL-23 variants)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli DC2 (MIC=2 µM), Escherichia coli K12 (MIC=40 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 µM), S. aureus mprF (presence of carbonate) (MIC=0.35-0.7 µM), S. aureus mprF (absence of carbonate) (MIC=6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22185690	Biochemistry. 2012 Jan 17;51(2):653-664. 	Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.	Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.	
DRAMP04019	RAVAVIIRLRRV	12	Bac014 (Scrambled Variants of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=23 µg/ml), Escherichia coli (MIC=11 µg/ml), Salmonella (MIC=11 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=23 µg/ml), Staphylococcus epidermidis (MIC=6 µg/ml).##Yeast: Candida albicans (MIC=6 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04020	RRAAVVLIVIRR	12	Bac020 (Scrambled Variants of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=11 µg/ml), Escherichia coli (MIC=6 µg/ml), Salmonella (MIC=23 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=11 µg/ml), Staphylococcus epidermidis (MIC=1.5 µg/ml).##Yeast: Candida albicans (MIC=11 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04021	VRLRIRVAVIRA	12	Bac034 (Scrambled Variants of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=25 µg/ml), Escherichia coli (MIC=3 µg/ml), Salmonella (MIC=12 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=25 µg/ml), Staphylococcus epidermidis (MIC=3 µg/ml).##Yeast: Candida albicans (MIC=12 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04022	VRFRIRVAVIRA	12	F3 (single amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=6 µg/ml), Escherichia coli (MIC=1.6 µg/ml), Salmonella (MIC=6 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 µg/ml), Staphylococcus epidermidis (MIC=1.6 µg/ml).##Yeast: Candida albicans (MIC=6 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04023	VRWRIRVAVIRA	12	W3 (single amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=6 µg/ml), Escherichia coli (MIC=1.6 µg/ml), Salmonella (MIC=6 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 µg/ml), Staphylococcus epidermidis (MIC=1.6 µg/ml).##Yeast: Candida albicans (MIC=12 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04024	VRLWIRVAVIRA	12	W4 (single amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC>50 µg/ml), Escherichia coli (MIC=6 µg/ml), Salmonella (MIC>50 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=50 µg/ml), Staphylococcus epidermidis (MIC=3 µg/ml).##Yeast: Candida albicans (MIC=50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04025	VRLRIRVAVRRA	12	R10 (single amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=12 µg/ml), Escherichia coli (MIC=6 µg/ml), Salmonella (MIC=6 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 µg/ml), Staphylococcus epidermidis (MIC=1.6 µg/ml).##Yeast: Candida albicans (MIC=6 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04026	VRLRIRVAVIRK	12	K12 (single amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=6 µg/ml), Escherichia coli (MIC=3 µg/ml), Salmonella (MIC=6 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6 µg/ml), Staphylococcus epidermidis (MIC=1.6 µg/ml).##Yeast: Candida albicans (MIC=3 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04027	VQLRIRVRVIRK	12	opt1 (multiple amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=6 µg/ml), Escherichia coli (MIC=3 µg/ml), Salmonella (MIC=6 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 µg/ml), Staphylococcus epidermidis (MIC=1.6 µg/ml).##Yeast: Candida albicans (MIC=6 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04028	VRLRIRVRVIRK	12	opt2 (multiple amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=3 µg/ml), Escherichia coli (MIC=1.6 µg/ml), Salmonella (MIC=6 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6 µg/ml), Staphylococcus epidermidis (MIC=0.8 µg/ml).##Yeast: Candida albicans (MIC=3 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04029	KQFRIRVRVIRK	12	opt3 (multiple amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=6 µg/ml), Escherichia coli (MIC=3 µg/ml), Salmonella (MIC=6 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 µg/ml), Staphylococcus epidermidis (MIC=1.6 µg/ml).##Yeast: Candida albicans (MIC=6 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04030	KRFRIRVRVIRK	12	opt4 (multiple amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=6 µg/ml), Escherichia coli (MIC=1.6 µg/ml), Salmonella (MIC=3 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6 µg/ml), Staphylococcus epidermidis (MIC=0.8 µg/ml).##Yeast: Candida albicans (MIC=12 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04031	KRWRIRVRVIRK	12	opt5 (multiple amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (MIC=3 µg/ml), Escherichia coli (MIC=1.6 µg/ml), Salmonella (MIC=3 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=3 µg/ml), Staphylococcus epidermidis (MIC=0.8 µg/ml).##Yeast: Candida albicans (MIC=6 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17052614	Chem Biol. 2006 Oct;13(10):1101-1107.	Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.	Sequence requirements and an optimization strategy for short antimicrobial peptides.	
DRAMP04032	ALRLAIRKR	9	Modified defensin	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Staphylococcus aureus (MIC=5 µg/ml), Staphylococcus aureus (MRSA) (MIC>48 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=4 µg/ml), Pseudomonas aeruginosa (MIC=15 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10561605	Eur J Biochem. 1999 Dec;266(2):616-623.	Ishibashi J, Saido-Sakanaka H, Yang J, Sagisaka A, Yamakawa M.	Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros.	
DRAMP04033	ALLLAIRKR	9	Modified defensin	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Staphylococcus aureus (MIC=4 µg/ml), Staphylococcus aureus (MRSA) (MIC=40 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=6 µg/ml), Pseudomonas aeruginosa (MIC=4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10561605	Eur J Biochem. 1999 Dec;266(2):616-623.	Ishibashi J, Saido-Sakanaka H, Yang J, Sagisaka A, Yamakawa M.	Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros.	
DRAMP04034	AWLLAIRKR	9	Modified defensin	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Staphylococcus aureus (MIC=3 µg/ml), Staphylococcus aureus (MRSA) (MIC=25 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=5 µg/ml), Pseudomonas aeruginosa (MIC=4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10561605	Eur J Biochem. 1999 Dec;266(2):616-623.	Ishibashi J, Saido-Sakanaka H, Yang J, Sagisaka A, Yamakawa M.	Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros.	
DRAMP04035	ALYLAIRKR	9	Modified defensin	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Staphylococcus aureus (MIC=3 µg/ml), Staphylococcus aureus (MRSA) (MIC=30 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=4 µg/ml), Pseudomonas aeruginosa (MIC=4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10561605	Eur J Biochem. 1999 Dec;266(2):616-623.	Ishibashi J, Saido-Sakanaka H, Yang J, Sagisaka A, Yamakawa M.	Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros.	
DRAMP04036	ALWLAIRKR	9	Modified defensin	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacteria: Staphylococcus aureus (MIC=4 µg/ml), Staphylococcus aureus (MRSA) (MIC=40 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=10 µg/ml), Pseudomonas aeruginosa (MIC=10 µg/ml). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10561605	Eur J Biochem. 1999 Dec;266(2):616-623.	Ishibashi J, Saido-Sakanaka H, Yang J, Sagisaka A, Yamakawa M.	Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros.	
DRAMP04048	RRLCRIVVIRVCRR	14	BacR (cyclic derivative of bactenecin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli K-12 (MIC=2 µg/ml), Pseudomonas aeruginosa K799 (MIC=4 µg/ml), Salmonella typhimurium 14028s (MIC=4 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=64 µg/ml), Staphylococcus epidermidis C621 (MIC=8 µg/ml), Enterococcus faecalis ATCC 29212 (MIC=32 µg/ml), Listeria monocytogenes (MIC<0.125 µg/ml), Corynebacterium xerosis (MIC=1 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=8 µg/ml), S. mitis (MIC=0.5 µg/ml), Streptococcus pneumoniae ATCC 49619 (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys4 and Cys12.	L	No cytotoxicity information found	Not found	10223951	Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.	Wu M, Hancock RE.	Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC1=O
DRAMP04049	RRRCPIVVIRVCRR	14	BacP3R (cyclic derivative of bactenecin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli K-12 (MIC=2 µg/ml), Pseudomonas aeruginosa K799 (MIC=8 µg/ml), Salmonella typhimurium 14028s (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>64 µg/ml), Staphylococcus epidermidis C621 (MIC=16 µg/ml), Enterococcus faecalis ATCC 29212 (MIC=32 µg/ml), Listeria monocytogenes (MIC+0.5 µg/ml), Corynebacterium xerosis (MIC=4 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=8 µg/ml), S. mitis (MIC=1 µg/ml), Streptococcus pneumoniae ATCC 49619 (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys4 and Cys12.	L	No cytotoxicity information found	Not found	10223951	Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.	Wu M, Hancock RE.	Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC1=O
DRAMP04050	RRRLCPIVIRVCRR	14	BacP3R-V (cyclic derivative of bactenecin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli K-12 (MIC=2 µg/ml), Pseudomonas aeruginosa K799 (MIC=8 µg/ml), Salmonella typhimurium 14028s (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>64 µg/ml), Staphylococcus epidermidis C621 (MIC=16 µg/ml), Enterococcus faecalis ATCC 29212 (MIC>64 µg/ml), Listeria monocytogenes (MIC=1 µg/ml), Corynebacterium xerosis (MIC=4 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=4 µg/ml), S. mitis (MIC=1 µg/ml), Streptococcus pneumoniae ATCC 49619 (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys5 and Cys12.	L	No cytotoxicity information found	Not found	10223951	Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.	Wu M, Hancock RE.	Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC1=O
DRAMP04051	RICRIVVIRCIR	12	Bac2I-NH2 (cyclic derivative of bactenecin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli K-12 (MIC=4 µg/ml), Pseudomonas aeruginosa K799 (MIC=16 µg/ml), Salmonella typhimurium 14028s (MIC=8 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=32 µg/ml), Staphylococcus epidermidis C621 (MIC=8 µg/ml), Enterococcus faecalis ATCC 29212 (MIC>32 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation 	Disulfide bond between Cys3 and Cys10.	L	No cytotoxicity information found	Not found	10223951	Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.	Wu M, Hancock RE.	Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.	
DRAMP04052	RLCPRVRIRVCR	12	BacP2R-NH2 (cyclic derivative of bactenecin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli K-12 (MIC=4 µg/ml), Pseudomonas aeruginosa K799 (MIC=16 µg/ml), Salmonella typhimurium 14028s (MIC=32 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>32 µg/ml), Staphylococcus epidermidis C621 (MIC=16 µg/ml), Enterococcus faecalis ATCC 29212 (MIC>32 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation 	Disulfide bond between Cys3 and Cys11.	L	No cytotoxicity information found	Not found	10223951	Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.	Wu M, Hancock RE.	Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.	
DRAMP04053	RLCRIVPVIRVCR	13	BacP1 (cyclic derivative of bactenecin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli K-12 (MIC=32 µg/ml), Pseudomonas aeruginosa K799 (MIC>64 µg/ml), Salmonella typhimurium 14028s (MIC>64 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=64 µg/ml), Staphylococcus epidermidis C621 (MIC=64 µg/ml), Enterococcus faecalis ATCC 29212 (MIC>64 µg/ml), Listeria monocytogenes (MIC=2 µg/ml), Corynebacterium xerosis (MIC=8 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=64 µg/ml), S. mitis (MIC=4 µg/ml), Streptococcus pneumoniae ATCC 49619 (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys3 and Cys12.	L	No cytotoxicity information found	Not found	10223951	Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.	Wu M, Hancock RE.	Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC1=O
DRAMP04054	RLCRIVWVIRVCR	13	BacW (cyclic derivative of bactenecin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli K-12 (MIC=8 µg/ml), Pseudomonas aeruginosa K799 (MIC=4 µg/ml), Salmonella typhimurium 14028s (MIC=4 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4 µg/ml), Staphylococcus epidermidis C621 (MIC=2 µg/ml), Enterococcus faecalis ATCC 29212 (MIC=8 µg/ml), Listeria monocytogenes (MIC=0.5 µg/ml), Corynebacterium xerosis (MIC=1 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=2 µg/ml), S. mitis (MIC=1 µg/ml), Streptococcus pneumoniae ATCC 49619 (MIC=16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10223951	Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.	Wu M, Hancock RE.	Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.	
DRAMP04055	RRLCRIVWVIRVCRR	15	BacW2R (cyclic derivative of bactenecin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli K-12 (MIC=2 µg/ml), Pseudomonas aeruginosa K799 (MIC=2 µg/ml), Salmonella typhimurium 14028s (MIC=2 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 µg/ml), Staphylococcus epidermidis C621 (MIC=1 µg/ml), Enterococcus faecalis ATCC 29212 (MIC=2 µg/ml), Listeria monocytogenes (MIC=0.25 µg/ml), Corynebacterium xerosis (MIC=0.25 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=1 µg/ml), S. mitis (MIC=0.25 µg/ml), Streptococcus pneumoniae ATCC 49619 (MIC=8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10223951	Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.	Wu M, Hancock RE.	Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.	
DRAMP04056	RLSRIVVIRVSR	12	Lin Bac2S-NH2 (linear derivative of bactenecin)	No entry found	Not found	Not found	Synthetic construct 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli K-12 (MIC=2 µg/ml), Pseudomonas aeruginosa K799 (MIC=16 µg/ml), Salmonella typhimurium 14028s (MIC=32 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4 µg/ml), Staphylococcus epidermidis C621 (MIC=1 µg/ml), Enterococcus faecalis ATCC 29212 (MIC=4 µg/ml), Listeria monocytogenes (MIC=0.25 µg/ml), Corynebacterium xerosis (MIC=0.25 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=2 µg/ml), S. mitis (MIC=0.125 µg/ml), Streptococcus pneumoniae ATCC 49619 (MIC=16 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10223951	Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.	Wu M, Hancock RE.	Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.	
DRAMP04057	RLSRIVVIRVCR	12	Lin BacS-NH2 (linear derivative of bactenecin)	No entry found	Not found	Not found	Synthetic construct 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli K-12 (MIC=4 µg/ml), Pseudomonas aeruginosa K799 (MIC=16 µg/ml), Salmonella typhimurium 14028s (MIC>64 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=16 µg/ml), Staphylococcus epidermidis C621 (MIC=2 µg/ml), Enterococcus faecalis ATCC 29212 (MIC=16 µg/ml), Listeria monocytogenes (MIC=0.5 µg/ml), Corynebacterium xerosis (MIC=0.5 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=8 µg/ml), S. mitis (MIC=0.5 µg/ml), Streptococcus pneumoniae ATCC 49619 (MIC=8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10223951	Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.	Wu M, Hancock RE.	Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.	
DRAMP18364	WTTIVKVSKAVCKTGTCICTTSCSNCK	27	Thuricin 4A-4 (bacteriocin)	No entry found	Belongs to the lantibiotic family.	Not found	Bacillus thuringiensis serovar thuringiensis T01001 	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against B. cereus, B. firmus, B. thuringiensis, B. subtilis, B. pumilus, E. faecalis, M. Paenibacillus, S. aureus, and S. sciuri.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25548056	Appl Environ Microbiol. 2015 Mar;81(5):1765-74.		The Bacillus cereus group is an excellent reservoir of novel lanthipeptides.	
DRAMP18365	INTWNTTATSTSIIISETFGNKGKVCTYTVECVNNCRG	38	Thusin (ThsA1, ThsA2; a two-chain lantibiotic, type 2, class 1 bacteriocins)	No entry found	Belongs to the lantibiotic family (class I bacteriocins)	Not found	Bacillus thuringiensis strain BGSC 4BT1, serovar rongseni	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against S. pneumoniae ATCC 49619, B. cereus ATCC 14579, B. thuringiensis BMB171, B. pumilus SCG I , B. subtilis Bsn5, L. monocytogenes LM201 (MIC 6.25 uM), L. monocytogenes LM605, S. aureus ATCC 43300, S. sciuri Bom1, B. amyloliquefaciens X1 (MIC 12.5 uM), S. aureus CMCC 26003, MRSA (MIC 25 uM), and E. faecalis ATCC 29212 (MIC 50 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27486447	Front Microbiol. 2016 Jul 19;7:1115.	Xin B, Zheng J, Liu H, Li J, Ruan L, Peng D, Sajid M, Sun M	Thusin, a Novel Two-Component Lantibiotic with Potent Antimicrobial Activity against Several Gram-Positive Pathogens.	
DRAMP18363	CVWGGDCTDFLGCGTAWICV	20	Sviceucin (bacteriocin)	No entry found	Not found	Not found	Streptomyces sviceus	Antimicrobial, Antibacterial, Anti-Gram+		Beta	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: B. megaterium, L. bulgaricus 340, S. aureus subsp. aureus ATCC 6538, L. sakei subsp. sakei DSM 20017.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid II	26343290	ACS Chem Biol. 2015 Nov 20;10(11):2641-9.	Li Y, Ducasse R, Zirah S, Blond A, Goulard C, Lescop E, Giraud C, Hartke A, Guittet E, Pernodet JL, Rebuffat S.	Characterization of Sviceucin from Streptomyces Provides Insight into Enzyme Exchangeability and Disulfide Bond Formation in Lasso Peptides	
DRAMP18361	APKGVQGPNG	10	YD1 (bacteriocin)	No entry found	Not found	Not found	Bacillus amyloliquefaciens	Antimicrobial, Antibacterial		Not found	Not found		YD1 binds to the plasmid DNA of E. coli.	Active against Gram- S. typhimurium KCTC 1925 (MIC 32 ug/ml), E. coli KCTC 1923 (MIC 8 ug/ml), P. aeruginosa KCTC 1637 (MIC 16 ug/ml), Gram+ M. smegmatis ATCC 9341 (MIC 8 ug/ml), S. aureus KCTC 1928, MRSA B15 (MIC 32 ug/ml), E. faecalis ATCC 29212, B. subtilis ATCC 6633, M. luteus ATCC 9341, VRE 2, and VRE5 (MIC 64 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28050849	AMB Express. 2017 Dec;7(1):8	Rahman MS, Choi YH, Choi YS, Yoo JC.	Glycin-rich antimicrobial peptide YD1 from B. amyloliquefaciens, induced morphological alteration in and showed affinity for plasmid DNA of E. coli.	
DRAMP18362	CEWYNISCQLGNKGQWCTLTKECQRSCK	28	Formicin (bacteriocin)	No entry found	Belongs to the lantibiotic family.	Not found	Bacillus paralicheniformis APC 1576	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: L. s delbrueckii subsp. bulgaricus, L. amylophilus, L. lactis, M. luteus, S. smutans, including clinical strains S. aureus, C. difficile, and L. monocytogenes.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27450592	Microbiology. 2016 Sep;162(9):1662-1671.	Collins FW, O'Connor PM, O'Sullivan O, Rea MC, Hill C, Ross RP.	Formicin - a novel broad-spectrum two-component lantibiotic produced by Bacillus paralicheniformis APC 1576	
DRAMP18360	VLSIVACSSGCGSGKTAASCVATCGNKCFTNVGSLC	36	Paenicidin B (bacteriocin)	No entry found	Belongs to the lantibiotic family.	Not found	Paenibacillus terrae; old: Bacillus circulans NRRL B-30644	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against B. subtilis JH642 (MIC 50 uM), L. lactis subsp. cremoris HP (12.5 uM), L. monocytogenes ATCC 15313 (100 uM), and S. aureus ATCC 25923 (MIC 100 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24382692	Chembiochem. 2014 Jan 24;15(2):243-9.	Lohans CT1, van Belkum MJ, Cochrane SA, Huang Z, Sit CS, McMullen LM, Vederas JC.	Biochemical, structural, and genetic characterization of tridecaptin A?, an antagonist of Campylobacter jejuni.	
DRAMP18359	KCSWWNASCHLGNNGKICTVSHECAAGCNL	30	Sh-lantibiotic-alpha (bacteriocin)	No entry found	Belongs to the lantibiotic family.	Not found	human skin bacterium, Staphylococcus hominis A9	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		"Function: Active against S. aureus, but not commensal bacteria.
PTM: Three thioether bonds are proposed: S8-C18, T19-C24, S21-C28 and one S-S bond between C2-C9."	Gram-positive bacteria: S. aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28228596	Sci Transl Med. 2017 Feb 22;9(378)	Nakatsuji T, Chen TH, Narala S, Chun KA, Two AM, Yun T, Shafiq F, Kotol PF, Bouslimani A, Melnik AV, Latif H, Kim JN, Lockhart A, Artis K, David G, Taylor P, Streib J, Dorrestein PC, Grier A, Gill SR, Zengler K, Hata TR, Leung DY, Gallo RL.	Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis	
DRAMP18358	ATPTITTSSATCGGIIVAASAAQCPTLACSSRCGKRKK	38	Sh-lantibiotic-beta (bacteriocin)	No entry found	Belongs to the lantibiotic family.	Not found	human skin bacterium, Staphylococcus hominis A9	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		"Function: Active against S. aureus, but not commensal bacteria.
PTM: Four thioether bonds are proposed: S9-C12, S20-C24, T26-C29 and S30-C33. In addition, there are five dehydrated S/T at the N-terminus of the peptide."	Gram-positive bacteria: S. aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28228596	Sci Transl Med. 2017 Feb 22;9(378).	Nakatsuji T, Chen TH, Narala S, Chun KA, Two AM, Yun T, Shafiq F, Kotol PF, Bouslimani A, Melnik AV, Latif H, Kim JN, Lockhart A, Artis K, David G, Taylor P, Streib J, Dorrestein PC, Grier A, Gill SR, Zengler K, Hata TR, Leung DY, Gallo RL	Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis	
DRAMP04064	CVKCKCKCGSGVKVKVKVC	19	Cyclic cationic V1 peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy. Has hemolytic activity against human erythrocytes, and also Cytotoxic activity against THP-1 cells (EC50=0.045 mM).	[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=5 nM), Pseudomonas aeruginosa ATTC 27853 (MIC>619 nM), Klebsiella pneumoniae ATTC 13883 (MIC=145 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=5 nM), Shigella sonnei ATTC 25931 (MIC=5 nM).	[Ref.15328096]EC50=880000 nM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15328096	Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.	Frecer V, Ho B, Ding JL.	De Novo Design of Potent Antimicrobial Peptides.	
DRAMP04065	CVKVSVKVGSGVKVSVKVC	19	Cyclic cationic V2 peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=5.6 mM).	[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=5 nM), Pseudomonas aeruginosa ATTC 27853 (MIC>643 nM), Klebsiella pneumoniae ATTC 13883 (MIC=643 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=5 nM), Shigella sonnei ATTC 25931 (MIC=5 nM).	[Ref.15328096]EC50=589000 nM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15328096	Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.	Frecer V, Ho B, Ding JL.	De Novo Design of Potent Antimicrobial Peptides.	
DRAMP04066	CVKVRVKVGSGVKVRVKVC	19	Cyclic cationic V3 peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.042 mM).	[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=300 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=5 nM), Klebsiella pneumoniae ATTC 13883 (MIC=10 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=300 nM), Shigella sonnei ATTC 25931 (MIC=5 nM).	[Ref.15328096]EC50=590000 nM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15328096	Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.	Frecer V, Ho B, Ding JL.	De Novo Design of Potent Antimicrobial Peptides.	
DRAMP04067	CVKVQVKVGSGVKVQVKVC	19	Cyclic cationic V4 peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.047 mM).	[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=10 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=5 nM), Klebsiella pneumoniae ATTC 13883 (MIC<5 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=5 nM), Shigella sonnei ATTC 25931 (MIC=10 nM).	[Ref.15328096]EC50=3226000 nM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15328096	Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.	Frecer V, Ho B, Ding JL.	De Novo Design of Potent Antimicrobial Peptides.	
DRAMP04068	CAKAKAKAGSGAKAKAKAC	19	Cyclic cationic V5 peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.14 mM).	[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=173 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=5 nM), Klebsiella pneumoniae ATTC 13883 (MIC>692 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=5 nM), Shigella sonnei ATTC 25931 (MIC=692 nM).	[Ref.15328096]EC50=1055000 nM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15328096	Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.	Frecer V, Ho B, Ding JL.	De Novo Design of Potent Antimicrobial Peptides.	
DRAMP04069	CFKFKFKFGSGFKFKFKFC	19	Cyclic cationic V6 peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.045 mM).	[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=518 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=4 nM), Klebsiella pneumoniae ATTC 13883 (MIC=4 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=528 nM), Shigella sonnei ATTC 25931 (MIC=4 nM).	[Ref.15328096]EC50=35000 nM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15328096	Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.	Frecer V, Ho B, Ding JL.	De Novo Design of Potent Antimicrobial Peptides.	
DRAMP04070	CWKWKWKWGSGWKWKWKWC	19	Cyclic cationic V7 peptide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.085 mM).	[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=114 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=4 nM), Klebsiella pneumoniae ATTC 13883 (MIC=458 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=4 nM), Shigella sonnei ATTC 25931 (MIC=7 nM).	[Ref.15328096]EC50=45000 nM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15328096	Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.	Frecer V, Ho B, Ding JL.	De Novo Design of Potent Antimicrobial Peptides.	
DRAMP04075	AKKVFKRLEKLFSKIQNDK	19	Antimicrobial peptide HP (2-20)	P56029	Not found	rplA	Synthetic construct (amino acid substitution)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix (1 helices; 11 residues)	Not found	1P0G resolved by NMR.	Function: Peptides originating from the N-terminal end of L1 have antibacterial activity against bacteria such as E. coli and Bacillus megaterium and modest antifungal activities. Has no effect on H. pylori itself. Peptides are not hemolytic against mammalian cells. These peptides may be released in the stomach during altruistic lysis to kill other fast growing bacteria.	[Ref.16255716]Gram-positive bacteria: Bacillus subtilis (MIC=3.13 µg/ml), Staphylococcus epidermidis (MIC=6.25 µg/ml), Staphylococcus aureus (MIC=12.5 µg/ml), Listeria monocytogenes (MIC=6.25 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=3.13 µg/ml), Salmonella typhimurium (MIC=1.56 µg/ml), Proteus vulgaris (MIC=6.25 µg/ml), Pseudomonas aeruginosa (MIC=6.25 µg/ml), Escherichia coli O157 (MIC=12.5 µg/ml);##Fungi: Trichosporon beigelii (MIC=3.13 µg/ml), Candida albicans (MIC>25 µg/ml), Saccharomyces cerevisiae (MIC>25 µg/ml), Aspergillus flavus (MIC=50 µg/ml), Aspergillus fumigatus (MIC>50 µg/ml), Botrytis cinerea (MIC=12.5 µg/ml), Fusarium moniliforme (MIC=25 µg/ml).	[Swiss_Prot Entry P56029]Non-hemolytic against mammalian cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Phospholipids	16255716##PubMed ID is not available##PubMed ID is not available	Biochem J. 2006 Feb 15;394(Pt 1):105-114.##Submitted (SEP-2004) to the PDB data bank.##To be published	Lee KH, Lee DG, Park YK, Harm KS, Kim YM.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.	Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Structure of antimicrobial peptide, HP (2-20) and its analogues derived from Helicobacter pylori, as determined by 1H NMR spectroscopy.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.	
DRAMP04076	AKKVFKRLEKLFSKIQNWK	19	Anal 1 (antimicrobial peptide HP (2-20)analogue)	P56029	Not found	Not found	Synthetic construct (amino acid substitution)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix (1 helices; 14 residues)	Not found	1P0J resolved by NMR.	Function: Has antibacterial and antifungal activiy. 	Gram-positive bacteria: Bacillus subtilis (MIC=1.56 µg/ml), Staphylococcus epidermidis (MIC=3.13 µg/ml), Staphylococcus aureus (MIC=3.13 µg/ml), Listeria monocytogenes (MIC=0.78 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=0.78 µg/ml), Salmonella typhimurium (MIC=0.39 µg/ml), Proteus vulgaris (MIC=3.13 µg/ml), Pseudomonas aeruginosa (MIC=3.13 µg/ml), Escherichia coli O157 (MIC=6.25 µg/ml).##Fungi: Trichosporon beigelii (MIC=1.56 µg/ml), Candida albicans (MIC=25 µg/ml), Saccharomyces cerevisiae (MIC=25 µg/ml), Aspergillus flavus (MIC=50 µg/ml), Aspergillus fumigatus (MIC>50 µg/ml), Botrytis cinerea (MIC=6.25 µg/ml), Fusarium moniliforme (MIC=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16255716##PubMed ID is not available	Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published	Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.	Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.	
DRAMP04077	AKKVFKRLEKLFSKIWNDK	19	Anal 2 (antimicrobial peptide HP (2-20)analogue)	P56029	Not found	Not found	Synthetic construct (amino acid substitution)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix (1 helices; 14 residues)	Not found	1P0L resolved by NMR.	Function: Has antibacterial and antifungal activiy. 	Gram-positive bacteria: Bacillus subtilis (MIC=1.56 µg/ml), Staphylococcus epidermidis (MIC=3.13 µg/ml), Staphylococcus aureus (MIC=6.25 µg/ml), Listeria monocytogenes (MIC=1.56 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=3.13 µg/ml), Salmonella typhimurium (MIC=0.78 µg/ml), Proteus vulgaris (MIC=3.13 µg/ml), Pseudomonas aeruginosa (MIC=6.25 µg/ml), Escherichia coli O157 (MIC=6.25 µg/ml).##Fungi: Trichosporon beigelii (MIC=1.56 µg/ml), Candida albicans (MIC=25 µg/ml), Saccharomyces cerevisiae (MIC=25 µg/ml), Aspergillus flavus (MIC=50 µg/ml), Aspergillus fumigatus (MIC>50 µg/ml), Botrytis cinerea (MIC=6.25 µg/ml), Fusarium moniliforme (MIC=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16255716##PubMed ID is not available	Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published	Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.	Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.	
DRAMP04078	AKKVFKRLEKLFSKIWNWK	19	Anal 3 (antimicrobial peptide HP (2-20)analogue)	P56029	Not found	Not found	Synthetic construct (amino acid substitution)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix (1 helices; 14 residues)	Not found	1P0O resolved by NMR.	Function: Has antibacterial and antifungal activiy. 	Gram-positive bacteria: Bacillus subtilis (MIC=1.56 µg/ml), Staphylococcus epidermidis (MIC=3.13 µg/ml), Staphylococcus aureus (MIC=1.56 µg/ml), Listeria monocytogenes (MIC=0.39 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=1.56 µg/ml), Salmonella typhimurium (MIC=0.39 µg/ml), Proteus vulgaris (MIC=3.13 µg/ml), Pseudomonas aeruginosa (MIC=3.13 µg/ml), Escherichia coli O157 (MIC=3.13 µg/ml).##Fungi: Trichosporon beigelii (MIC=1.56 µg/ml), Candida albicans (MIC=12.5 µg/ml), Saccharomyces cerevisiae (MIC=25 µg/ml), Aspergillus flavus (MIC=25 µg/ml), Aspergillus fumigatus (MIC=25 µg/ml), Botrytis cinerea (MIC=3.13 µg/ml), Fusarium moniliforme (MIC=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16255716##PubMed ID is not available	Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published	Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.	Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.	
DRAMP04079	AKKVFKRLEKSFSKIQNDK	19	Anal 4 (antimicrobial peptide HP (2-20)analogue)	P56029	Not found	Not found	Synthetic construct (amino acid substitution)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix (1 helices; 13 residues)	Not found	1P5K resolved by NMR.	Function: Has antibacterial and antifungal activiy. 	Gram-positive bacteria: Bacillus subtilis (MIC=6.25 µg/ml), Staphylococcus epidermidis (MIC>12.5 µg/ml), Staphylococcus aureus (MIC>12.5 µg/ml), Listeria monocytogenes (MIC>12.5 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=12.5 µg/ml), Salmonella typhimurium (MIC=12.5 µg/ml), Proteus vulgaris (MIC>12.5 µg/ml), Pseudomonas aeruginosa (MIC=12.5 µg/ml), Escherichia coli O157 (MIC>12.5 µg/ml).##Fungi: Trichosporon beigelii (MIC=12.5 µg/ml), Candida albicans (MIC>25 µg/ml), Saccharomyces cerevisiae (MIC>25 µg/ml), Aspergillus flavus (MIC>50 µg/ml), Aspergillus fumigatus (MIC>50 µg/ml), Botrytis cinerea (MIC>50 µg/ml), Fusarium moniliforme (MIC>50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16255716##PubMed ID is not available	Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published	Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.	Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.	
DRAMP04080	AKKVSKRLEKLFSKIQNDK	19	Anal 5 (antimicrobial peptide HP (2-20)analogue)	P56029	Not found	Not found	Synthetic construct (amino acid substitution)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix (1 helices; 12 residues)	Not found	1P5L resolved by NMR.	Function: Has antibacterial and antifungal activiy. 	Gram-positive bacteria: Bacillus subtilis (MIC=3.13 µg/ml), Staphylococcus epidermidis (MIC=12.5 µg/ml), Staphylococcus aureus (MIC>12.5 µg/ml), Listeria monocytogenes (MIC>12.5 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=6.25 µg/ml), Salmonella typhimurium (MIC=12.5 µg/ml), Proteus vulgaris (MIC>12.5 µg/ml), Pseudomonas aeruginosa (MIC=12.5 µg/ml), Escherichia coli O157 (MIC=6.25 µg/ml).##Fungi: Trichosporon beigelii (MIC=12.5 µg/ml), Candida albicans (MIC>25 µg/ml), Saccharomyces cerevisiae (MIC>25 µg/ml), Aspergillus flavus (MIC>50 µg/ml), Aspergillus fumigatus (MIC>50 µg/ml), Botrytis cinerea (MIC>50 µg/ml), Fusarium moniliforme (MIC>50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16255716##PubMed ID is not available	Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published	Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.	Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.	
DRAMP04081	AKKVFKRLEKLFSKIFNFK	19	Anal 6 (antimicrobial peptide HP (2-20)analogue)	P56029	Not found	Not found	Synthetic construct (amino acid substitution)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix 	Not found		Function: Has antibacterial and antifungal activiy. 	Gram-positive bacteria: Bacillus subtilis (MIC=1.56 µg/ml), Staphylococcus epidermidis (MIC=6.25 µg/ml), Staphylococcus aureus (MIC=3.13 µg/ml), Listeria monocytogenes (MIC=0.78 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=3.13 µg/ml), Salmonella typhimurium (MIC=0.39 µg/ml), Proteus vulgaris (MIC=3.125 µg/ml), Pseudomonas aeruginosa (MIC=6.25 µg/ml), Escherichia coli O157 (MIC=6.25 µg/ml).##Fungi: Trichosporon beigelii (MIC=3.13 µg/ml), Candida albicans (MIC>25 µg/ml), Saccharomyces cerevisiae (MIC=25 µg/ml), Aspergillus flavus (MIC=50 µg/ml), Aspergillus fumigatus (MIC=50-25 µg/ml), Botrytis cinerea (MIC=12.5 µg/ml), Fusarium moniliforme (MIC=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16255716##PubMed ID is not available	Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published	Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.	Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.	
DRAMP04082	AKKVFKRLEKLFSKIYNYK	19	Anal 7 (antimicrobial peptide HP (2-20)analogue)	P56029	Not found	Not found	Synthetic construct (amino acid substitution)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix 	Not found		Function: Has antibacterial and antifungal activiy. 	Gram-positive bacteria: Bacillus subtilis (MIC=1.56 µg/ml), Staphylococcus epidermidis (MIC=3.13 µg/ml), Staphylococcus aureus (MIC=3.13 µg/ml), Listeria monocytogenes (MIC=0.78 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC=3.13 µg/ml), Salmonella typhimurium (MIC=0.39 µg/ml), Proteus vulgaris (MIC=6.25-3.13 µg/ml), Pseudomonas aeruginosa (MIC=3.13 µg/ml), Escherichia coli O157 (MIC=3.13 µg/ml).##Fungi: Trichosporon beigelii (MIC=1.56 µg/ml), Candida albicans (MIC=12.5 µg/ml), Saccharomyces cerevisiae (MIC=25 µg/ml), Aspergillus flavus (MIC=50 µg/ml), Aspergillus fumigatus (MIC=50-25 µg/ml), Botrytis cinerea (MIC=6.25 µg/ml), Fusarium moniliforme (MIC=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16255716##PubMed ID is not available	Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published	Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.	Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.	
DRAMP04083	GIGKFLKKAKKFGKAFVKILKK	22	D-amino-acid pexiganan (MSI-214)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		MSI-214 is a peptide identical in sequence to pexiganan but comprising all D-amino acids.	Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=16 µg/ml), Enterococcus faecium ATCC 51559 (vancomycin resistant) (MIC=4 µg/ml), Enterococcus faecalis ATCC 29212 (MIC=16 µg/ml), Streptococcus bovis ATCC 49133 (MIC=4 µg/ml), Micrococcus luteus ATCC 4698 (MIC=2-4 µg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8-16 µg/ml), Proteus mirabilis ATCC 29245 (MIC>256 µg/ml), Serratia marcescens ATCC 8100 (MIC>256 µg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16-32 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10103181	Antimicrob Agents Chemother. 1999 Apr;43(4):782-788.	Ge Y, MacDonald DL, Holroyd KJ, Thornsberry C, Wexler H, Zasloff M.	In vitro antibacterial properties of pexiganan, an analog of magainin.	
DRAMP04095	GFGSLFKFLAKKVAKTVAKQAAKQGAKYVANKHMQ	35	Cupiennin-1D (spiders, Arthropods, animals)	P83622	Belongs to the cupiennin family	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity. Has insecticidal and hemolytic activities. Probably acts by disturbing membrane Function: with its amphipathic structure.
Tissue specificity: Expressed by the venom gland.
Toxic dose: LD50 is 6.4 pmol/mg on Drosophila."	[Ref.11792701]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=0.31-0.63 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=0.31-0.63 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=0.31-0.63 µM), Enterococcus faecalis ATCC 29212 (MIC=1.25-2.50 µM).	[Swiss_Prot Entry P83622]has hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11792701##10669026	J Biol Chem. 2002 Mar 29;277(13):11208-11216.##Toxicon. 2000 Mar;38(3):373-380.	Kuhn-Nentwig L, Muller J, Schaller J, Walz A, Dathe M, Nentwig W.##Haeberli S, Kuhn-Nentwig L, Schaller J, Nentwig W.	Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae).##Characterisation of antibacterial activity of peptides isolated from the venom of the spider Cupiennius salei (Araneae: Ctenidae).	
DRAMP04096	EQEENVVKIQAFWKGYKQRKEYM	23	2IQ2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Displays antimicrobial activity against bacteria and yeast C. albicans.	Gram-negative bacterium: Escherichia coli (MIC=2.1 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=32 µM).##Yeast: Candida albicans (MIC=28 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23238369	Biochimie. 2013 Apr;95(4):875-880.	McLean DT, Lundy FT, Timson DJ.	IQ-motif peptides as novel anti-microbial agents.	
DRAMP04097	DNTDSVVKIQSWFRMATARKSYL	23	2IQ3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Displays antimicrobial activity against bacteria and yeast C. albicans.	Gram-negative bacterium: Escherichia coli (MIC=1.2 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=26 µM).##Yeast: Candida albicans (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23238369	Biochimie. 2013 Apr;95(4):875-880.	McLean DT, Lundy FT, Timson DJ.	IQ-motif peptides as novel anti-microbial agents.	
DRAMP04098	ANVGFVIQLQARLRGFLVRQKFA	23	3IQ1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Displays antimicrobial activity against bacteria and yeast C. albicans.	Gram-negative bacterium: Escherichia coli (MIC=1.7 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=1.7 µM).##Yeast: Candida albicans (MIC>94 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23238369	Biochimie. 2013 Apr;95(4):875-880.	McLean DT, Lundy FT, Timson DJ.	IQ-motif peptides as novel anti-microbial agents.	
DRAMP04099	TWLPAVIKIQAHWRGYRQRKIYL	23	3IQ2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Displays antimicrobial activity against bacteria and yeast C. albicans.	Gram-negative bacterium: Escherichia coli (MIC=1.9 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=1.6 µM).##Yeast: Candida albicans (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23238369	Biochimie. 2013 Apr;95(4):875-880.	McLean DT, Lundy FT, Timson DJ.	IQ-motif peptides as novel anti-microbial agents.	
DRAMP04100	ANLDAIIKIQAWARMWAARRQYL	23	3IQ3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Displays antimicrobial activity against bacteria and yeast C. albicans.	Gram-negative bacterium: Escherichia coli (MIC=2 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=11 µM).##Yeast: Candida albicans (MIC>89 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23238369	Biochimie. 2013 Apr;95(4):875-880.	McLean DT, Lundy FT, Timson DJ.	IQ-motif peptides as novel anti-microbial agents.	
DRAMP04101	KNVNSIVKIQAFFRARKAQDDYR	23	3IQ4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Displays antimicrobial activity against bacteria and yeast C. albicans.	Gram-negative bacterium: Escherichia coli (MIC=3.5 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC=4.6 µM).##Yeast: Candida albicans (MIC=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23238369	Biochimie. 2013 Apr;95(4):875-880.	McLean DT, Lundy FT, Timson DJ.	IQ-motif peptides as novel anti-microbial agents.	
DRAMP04102	KWKSFIKKLTSKFLHLAKKF	20	CP-P	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity. Also has hemolytic activity against human erythrocytes.	[Ref.22518150]Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 µg/ml).	[Ref.22518150]MHC=250 µg/mL against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Not found	Not found	Not found	Not found	
DRAMP04103	KWKSFIKKLTSKFLHSAKKF	20	S16 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=3.125 µg/ml).##Clinical isolates: Acinetobacter baumannii b-01 (MIC=3.125 µg/mL), Acinetobacter baumannii b-02 (MIC=6.25 µg/mL), Acinetobacter baumannii b-03 (MIC=6.25 µg/mL), Acinetobacter baumannii b-04 (MIC=3.125 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04104	KFKSFIKKLTSKFLHSAKKF	20	F2 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity. Also has hemolytic activity against human erythrocytes.	[Ref.22518150]Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 µg/ml).	[Ref.22518150]MHC=250 µg/mL against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04105	KWNSFIKKLTSKFLHSAKKF	20	N3 (derivative of CP-P)	No entry found	Derived from the peptide CP-P	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04106	KWKSFKKKLTSKFLHSAKKF	20	K6 (derivative of CP-P)	No entry found	Derived from the peptide CP-P	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04107	KWKSFINKLTSKFLHSAKKF	20	N7 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04108	KWKSFIKKAKTSFLHSAKKF	20	A9 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=25 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04111	KWKSFIKKSTSKFLHSAKKF	20	S9 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=50 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04112	KWKSFIKKLLSKFLHSAKKF	20	L10 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity. Also has hemolytic activity against human erythrocytes.	[Ref.22518150]Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 µg/ml).	[Ref.22518150]MHC<125 µg/mL against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04113	KWKSFIKKLASKFLHSAKKF	20	A10 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity. Also has hemolytic activity against human erythrocytes.	[Ref.22518150]Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 µg/ml).	[Ref.22518150]MHC=250 µg/mL against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04114	KWKSFIKKLTDKFLHSAKKF	20	D11 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=25 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04115	KWKSFIKKLTKKFLHSAKKF	20	K11 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix (CD)	Not found		Function: Has antibacterial activity.	Gram-positive bacteria: Staphylococcus aureus CMCC26003 (MIC=0.5 µg/mL), Bacillus subtilis DB430 (MIC=2 µg/mL), Bacillus pumilus CMCC63202 (MIC=0.5 µg/mL), Soluble wall Micrococcus S1.634 (MIC=1 µg/mL), Micrococcus luteus CMCC28001 (MIC=2 µg/mL).##Gram-negative bacteria: E. coli ATCC8099 (MIC=0.5 µg/mL), Klebsiella pneumoniae CMCC46117 (MIC=2 µg/mL), Salmonella paratyphi BCMCC50094 (MIC=2 µg/mL), Pseudomonas aeruginosa CMCC10104 (MIC=4 µg/mL).##Clinical isolates: Acinetobacter baumannii b-01 (MIC=0.8 µg/mL), Acinetobacter baumannii b-02 (MIC=3.125 µg/mL), Acinetobacter baumannii b-03 (MIC=3.25 µg/mL), Acinetobacter baumannii b-04 (MIC=1.6 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04117	KWKSFIKKLTSKALHSAKKF	20	A13 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=6.25 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04119	KWKSFIKKLTSKFLHSKKKF	20	K17 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04120	KWKSFIKKLTSKFLHSADKF	20	D18 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=25 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04121	KWKSFIKKLTSKFLHSANKF	20	N18 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=6.25 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04122	KWKSFIKKLTSKFLHSAKKN	20	N20 (derivative of CP-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Pseudomonas aeruginosa (MIC=6.25 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150	Int J Microbiol. 2012;2012:764834.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.	
DRAMP04123	SGKLCCRRKK	10	D0-NH2(Derived from HBD-28 variant)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
Chemical modification: C-terminal amidation."	[Ref.22518150] Gram-negative bacteria: Escherichia coli (MIC=12±0.17 µM), Pseudomonas aeruginosa ATCC 27853 (MIC>100 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>100 µM).	[Ref.23860860] 2.2% hemolysis at 100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150##23860860	Int J Microbiol. 2012;2012:764834. ##Biotechnol Bioeng. 2014 Jan;111(1):37-49. doi: 10.1002/bit.25003.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.##Saravanan R, Li X, Lim K, Mohanram H, Peng L, Mishra B, Basu A, Lee JM, Bhattacharjya S, Leong SS.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.##Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility	
DRAMP04124	SGKLYYRRKK	10	D1-NH2 (Derived from D0)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
Chemical modification: C-terminal amidation."	[Ref.22518150] Gram-negative bacteria: Escherichia coli (MIC=12±0.01 µM), Pseudomonas aeruginosa ATCC 27853 (MIC>100 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>100 µM).	[Ref.23860860] 2.0% hemolysis at 100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150##23860860	Int J Microbiol. 2012;2012:764834. ##Biotechnol Bioeng. 2014 Jan;111(1):37-49. doi: 10.1002/bit.25003.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.##Saravanan R, Li X, Lim K, Mohanram H, Peng L, Mishra B, Basu A, Lee JM, Bhattacharjya S, Leong SS.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.##Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility	
DRAMP04125	SGKLWWRRKK	10	D2-NH2 (Derived from D0)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
Chemical modification: C-terminal amidation."	[Ref.22518150]Gram-negative bacteria: Escherichia coli (MIC=6±0.012 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=12±0.01 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12±0.01 µM).	[Ref.23860860] 2.5% hemolysis at 100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150##23860860	Int J Microbiol. 2012;2012:764834. ##Biotechnol Bioeng. 2014 Jan;111(1):37-49. doi: 10.1002/bit.25003.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.##Saravanan R, Li X, Lim K, Mohanram H, Peng L, Mishra B, Basu A, Lee JM, Bhattacharjya S, Leong SS.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.##Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility	
DRAMP04126	SGKRWWRRKK	10	D3-NH2 (Derived from D0)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
Chemical modification: C-terminal amidation."	[Ref.22518150] Gram-negative bacteria: Escherichia coli (MIC=6±0.012 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=6±0.078 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=25±0.01 µM).	[Ref.23860860] 5.0% hemolysis at 100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150##23860860	Int J Microbiol. 2012;2012:764834. ##Biotechnol Bioeng. 2014 Jan;111(1):37-49. doi: 10.1002/bit.25003.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.##Saravanan R, Li X, Lim K, Mohanram H, Peng L, Mishra B, Basu A, Lee JM, Bhattacharjya S, Leong SS.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.##Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility	
DRAMP04127	RGKRWWRRKK	10	D4-NH2(Derived from D0)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
Chemical modification: C-terminal amidation."	[Ref.22518150] Gram-negative bacteria: Escherichia coli (MIC=3±0.012 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=6±0.04 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6±0.01 µM).	[Ref.23860860] 5.0% hemolysis at 100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150##23860860	Int J Microbiol. 2012;2012:764834. ##Biotechnol Bioeng. 2014 Jan;111(1):37-49. doi: 10.1002/bit.25003.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.##Saravanan R, Li X, Lim K, Mohanram H, Peng L, Mishra B, Basu A, Lee JM, Bhattacharjya S, Leong SS.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.##Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility	
DRAMP04128	RWKRWWRRKK	10	D5-NH2 (Derived from D0)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
Chemical modification: C-terminal amidation."	[Ref.22518150] Gram-negative bacteria: Escherichia coli (MIC=3±0.012 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=3±0.012 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6±0.012 µM).	[Ref.23860860] 6.5% hemolysis at 100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150##23860860	Int J Microbiol. 2012;2012:764834. ##Biotechnol Bioeng. 2014 Jan;111(1):37-49. doi: 10.1002/bit.25003.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.##Saravanan R, Li X, Lim K, Mohanram H, Peng L, Mishra B, Basu A, Lee JM, Bhattacharjya S, Leong SS.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.##Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility	
DRAMP04129	RKKRWWRRKK	10	D6-NH2 (Derived from D0)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
Chemical modification: C-terminal amidation."	[Ref.22518150] Gram-negative bacteria: Escherichia coli (MIC=3±0.07 µM), Pseudomonas aeruginosa ATCC 27853 (MIC=3±0.012 µM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6±0.012 µM).	[Ref.23860860] 6.5% hemolysis at 100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22518150##23860860	Int J Microbiol. 2012;2012:764834. ##Biotechnol Bioeng. 2014 Jan;111(1):37-49. doi: 10.1002/bit.25003.	Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.##Saravanan R, Li X, Lim K, Mohanram H, Peng L, Mishra B, Basu A, Lee JM, Bhattacharjya S, Leong SS.	The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.##Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility	
DRAMP04136	LRRLWLRANRL	11	LRR-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: E. coli ATCC 25922 (MIC=128 µM), P. aeruginosa ATCC 27853 (MIC>128 µM), S. typhimurium C7731 (MIC>128 µM);##Gram-positive bacteria: S. epidermidis ATCC12228 (MIC>128 µM), E. faecalis ATCC 29212 (MIC>128 µM), S. aureus ATCC 29213 (MIC=128 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23430306	Amino Acids. 2013 Apr;44(4):1215-1224.	Ma QQ, Lv YF, Gu Y, Dong N, Li DS, Shan AS.	Rational design of cationic antimicrobial peptides by the tandem of leucine-rich repeat.	
DRAMP04137	LRRLWLRANRLLRRLWLRANRL	22	LRR-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: E. coli ATCC 25922 (MIC=4 µM), P. aeruginosa ATCC 27853 (MIC=4 µM), S. typhimurium C7731 (MIC=2 µM);##Gram-positive bacteria: S. epidermidis ATCC12228 (MIC=2 µM), E. faecalis ATCC 29212 (MIC=2 µM), S. aureus ATCC 29213 (MIC=2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23430306	Amino Acids. 2013 Apr;44(4):1215-1224.	Ma QQ, Lv YF, Gu Y, Dong N, Li DS, Shan AS.	Rational design of cationic antimicrobial peptides by the tandem of leucine-rich repeat.	
DRAMP04138	APRKNVRW	8	L1 (first 8 N-terminal residues of bovine LF)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=62.36 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23026014	Biochim Biophys Acta. 2013 Feb;1828(2):677-686.	Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.	A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.	
DRAMP04139	APRKNVRF	8	L2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=129.66 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23026014	Biochim Biophys Acta. 2013 Feb;1828(2):677-686.	Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.	A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.	
DRAMP04140	APRKNVKW	8	L3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=64.11 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23026014	Biochim Biophys Acta. 2013 Feb;1828(2):677-686.	Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.	A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.	
DRAMP04141	APRKNLKW	8	L4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=31.61 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23026014	Biochim Biophys Acta. 2013 Feb;1828(2):677-686.	Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.	A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.	
DRAMP04142	APRKQLKW	8	L5	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=7.79 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23026014	Biochim Biophys Acta. 2013 Feb;1828(2):677-686.	Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.	A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.	
DRAMP04143	APRRQLKW	8	L6	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=15.17 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23026014	Biochim Biophys Acta. 2013 Feb;1828(2):677-686.	Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.	A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.	
DRAMP04144	APKKQLKW	8	L7	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=16.02 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23026014	Biochim Biophys Acta. 2013 Feb;1828(2):677-686.	Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.	A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.	
DRAMP04145	AFRKQLKW	8	L8	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=3.71 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23026014	Biochim Biophys Acta. 2013 Feb;1828(2):677-686.	Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.	A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.	
DRAMP04146	LFRKQLKW	8	L9	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=1.78 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23026014	Biochim Biophys Acta. 2013 Feb;1828(2):677-686.	Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.	A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.	
DRAMP04147	WFRKQLKW	8	L10	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-negative bacteria: Escherichia coli ATCC 25923 (MIC=0.8 µM), Klebsiella pneumoniae (MIC=3.35 µM), Acinetobacter sp. (MIC=3.35 µM), Psudomonas aruginosa (MIC=6.71 µM).##Fungi: Candida albicans ATCC SC5314 (MIC=10.49 µM), C. tropicalis ATCC 13803 (MIC=20.98 µM), C. parapsilosis ATCC 22019 (MIC=5.24 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	23026014	Biochim Biophys Acta. 2013 Feb;1828(2):677-686.	Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.	A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.	
DRAMP04159	RIKRFWPVVIRTVVAGYNLYRAIKK	25	LR2 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04160	RIKRFWPVVIRTVVAGYNLYRAIK	24	LR3 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=7.032 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=2.344 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=0.586 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04161	RIKRFWPVVIRTVVAGYNLYRAI	23	LR4 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis (MIC=37.5 µg/ml), Staphylococcus aureus ATCC25923 (MIC=37.5 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=9.375 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04162	RIKRFWPVVIRTVVAGYNLYRA	22	LR5 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus ATCC25923 (MIC=75 µg/ml);##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=4.688 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=4.688 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04163	RIKRFWPVVIRTVVAGYNLYR	21	LR6 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04164	RIKRFWPVVIRTVVAGYNLY	20	LR7 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04165	RIKRFWPVVIRTVVAGYNL	19	LR8 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04166	RIKRFWPVVIRTVVAGYN	18	LR9 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04167	RIKRFWPVVIRTVVAGY	17	LR10 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04168	RIKRFWPVVIRTVVAG	16	LR11 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04169	RIKRFWPVVIRTVV	14	LR13 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04170	RIKRFWPVVIRT	12	LR15 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04171	RIKRFWPVVIR	11	LR16 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis (MIC=4.688 µg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 µg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 µg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04174	KWLKKWL	7	L2K3W2 (LlKmW2 model peptides)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: B. subtilis (MIC=80 µg/ml), S. aureus (MIC=80 µg/ml), S. epidermis (MIC>80 µg/ml), M. luteus (MIC>80 µg/ml), S. aureus (MRSA) (MIC>80 µg/ml).##Gram-negative bacteria: E. coli (MIC>80 µg/ml), S. dysentariae (MIC>80 µg/ml), S. typhimorium (MIC>80 µg/ml), K. pneumoniae (MIC>80 µg/ml), P. aeruginosa (MIC>80 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20736034	Regul Pept. 2011 Jan 17;166(1-3):36-41.	Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.	De novo generation of short antimicrobial peptides with simple amino acid composition.	
DRAMP04175	KWLLKWL	7	L3K2W2 (LlKmW2 model peptides)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: B. subtilis (MIC=20 µg/ml), S. aureus (MIC=20 µg/ml), S. epidermis (MIC=80 µg/ml), M. luteus (MIC=80 µg/ml), S. aureus (MRSA) (MIC>80 µg/ml).##Gram-negative bacteria: E. coli (MIC=40 µg/ml), S. dysentariae (MIC>80 µg/ml), S. typhimorium (MIC>80 µg/ml), K. pneumoniae (MIC=80 µg/ml), P. aeruginosa (MIC=80 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20736034	Regul Pept. 2011 Jan 17;166(1-3):36-41.	Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.	De novo generation of short antimicrobial peptides with simple amino acid composition.	
DRAMP04176	KKWLKKWLK	9	L2K5W2 (LlKmW2 model peptides)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: B. subtilis (MIC=80 µg/ml), S. aureus (MIC=40 µg/ml), S. epidermis (MIC>80 µg/ml), M. luteus (MIC>80 µg/ml), S. aureus (MRSA) (MIC>80 µg/ml).##Gram-negative bacteria: E. coli (MIC=40 µg/ml), S. dysentariae (MIC>80 µg/ml), S. typhimorium (MIC>80 µg/ml), K. pneumoniae (MIC>80 µg/ml), P. aeruginosa (MIC=80 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20736034	Regul Pept. 2011 Jan 17;166(1-3):36-41.	Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.	De novo generation of short antimicrobial peptides with simple amino acid composition.	
DRAMP04177	LKWLKKWLK	9	L3K4W2 (LlKmW2 model peptides)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: B. subtilis (MIC=40 µg/ml), S. aureus (MIC=10 µg/ml), S. epidermis (MIC=40 µg/ml), M. luteus (MIC=80 µg/ml), S. aureus (MRSA) (MIC>80 µg/ml).##Gram-negative bacteria: E. coli (MIC=40 µg/ml), S. dysentariae (MIC>80 µg/ml), S. typhimorium (MIC>80 µg/ml), K. pneumoniae (MIC>80 µg/ml), P. aeruginosa (MIC=80 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20736034	Regul Pept. 2011 Jan 17;166(1-3):36-41.	Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.	De novo generation of short antimicrobial peptides with simple amino acid composition.	
DRAMP04178	LKWLLKWLK	9	L4K3W2 (LlKmW2 model peptides)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: B. subtilis (MIC=5 µg/ml), S. aureus (MIC=2.5 µg/ml), S. epidermis (MIC=5 µg/ml), M. luteus (MIC=10 µg/ml), S. aureus (MRSA) (MIC=20 µg/ml).##Gram-negative bacteria: E. coli (MIC=5 µg/ml), S. dysentariae (MIC=40 µg/ml), S. typhimorium (MIC=20 µg/ml), K. pneumoniae (MIC=20 µg/ml), P. aeruginosa (MIC=40 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20736034	Regul Pept. 2011 Jan 17;166(1-3):36-41.	Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.	De novo generation of short antimicrobial peptides with simple amino acid composition.	
DRAMP04179	LKWLLKWLL	9	L5K2W2 (LlKmW2 model peptides)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: B. subtilis (MIC<1.3 µg/ml), S. aureus (MIC<1.3 µg/ml), S. epidermis (MIC<1.3 µg/ml), M. luteus (MIC=2.5 µg/ml), S. aureus (MRSA) (MIC=2.5 µg/ml).##Gram-negative bacteria: E. coli (MIC=5 µg/ml), S. dysentariae (MIC=2.5 µg/ml), S. typhimorium (MIC=10 µg/ml), K. pneumoniae (MIC=5 µg/ml), P. aeruginosa (MIC=10 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20736034	Regul Pept. 2011 Jan 17;166(1-3):36-41.	Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.	De novo generation of short antimicrobial peptides with simple amino acid composition.	
DRAMP04180	LKKWLKKWLKK	11	L3K6W2 (LlKmW2 model peptides)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: B. subtilis (MIC=20 µg/ml), S. aureus (MIC=10 µg/ml), S. epidermis (MIC=40 µg/ml), M. luteus (MIC=40 µg/ml), S. aureus (MRSA) (MIC>80 µg/ml).##Gram-negative bacteria: E. coli (MIC=20 µg/ml), S. dysentariae (MIC=80 µg/ml), S. typhimorium (MIC>80 µg/ml), K. pneumoniae (MIC>80 µg/ml), P. aeruginosa (MIC=40 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20736034	Regul Pept. 2011 Jan 17;166(1-3):36-41.	Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.	De novo generation of short antimicrobial peptides with simple amino acid composition.	
DRAMP04181	LLKWLKKWLKK	11	L4K5W2 (LlKmW2 model peptides)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: B. subtilis (MIC=2.5 µg/ml), S. aureus (MIC=2.5 µg/ml), S. epidermis (MIC=2.5 µg/ml), M. luteus (MIC=2.5 µg/ml), S. aureus (MRSA) (MIC=40 µg/ml).##Gram-negative bacteria: E. coli (MIC=40 µg/ml), S. dysentariae (MIC=80 µg/ml), S. typhimorium (MIC=40 µg/ml), K. pneumoniae (MIC=40 µg/ml), P. aeruginosa (MIC=20 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20736034	Regul Pept. 2011 Jan 17;166(1-3):36-41.	Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.	De novo generation of short antimicrobial peptides with simple amino acid composition.	
DRAMP04182	LLKWLLKWLKK	11	L5K4W2 (LlKmW2 model peptides)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: B. subtilis (MIC<1.3 µg/ml), S. aureus (MIC<1.3 µg/ml), S. epidermis (MIC<1.3 µg/ml), M. luteus (MIC<1.3 µg/ml), S. aureus (MRSA) (MIC=5 µg/ml).##Gram-negative bacteria: E. coli (MIC=10 µg/ml), S. dysentariae (MIC=10 µg/ml), S. typhimorium (MIC=20 µg/ml), K. pneumoniae (MIC=20 µg/ml), P. aeruginosa (MIC=10 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20736034	Regul Pept. 2011 Jan 17;166(1-3):36-41.	Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.	De novo generation of short antimicrobial peptides with simple amino acid composition.	
DRAMP04183	LLKWLLKWLLK	11	L6K3W2 (LlKmW2 model peptides)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: B. subtilis (MIC<1.3 µg/ml), S. aureus (MIC=2.5 µg/ml), S. epidermis (MIC<1.3 µg/ml), M. luteus (MIC=2.5 µg/ml), S. aureus (MRSA) (MIC=5 µg/ml).##Gram-negative bacteria: E. coli (MIC>80 µg/ml), S. dysentariae (MIC>80 µg/ml), S. typhimorium (MIC>80 µg/ml), K. pneumoniae (MIC>80 µg/ml), P. aeruginosa (MIC>80 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20736034	Regul Pept. 2011 Jan 17;166(1-3):36-41.	Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.	De novo generation of short antimicrobial peptides with simple amino acid composition.	
DRAMP04184	GLLSLLSLLGKLL	13	DFTamP1	No entry found	Not found	Not found	Synthetic construct (Ab Initio Design)	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Has antimicrobial activities.	Gram-positive bacterium: S. aureus USA300 (MIC=3.12 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22803960	J Am Chem Soc. 2012 Aug 1;134(30):12426-9.	Mishra B, Wang G.	"Ab Initio Design of Potent Anti-MRSA Peptides Based on Database
Filtering Technology."	
DRAMP04185	GLLPLLSLLGKLL	13	DFTamP1-p	No entry found	Not found	Not found	Synthetic construct (Ab Initio Design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antimicrobial activities.	Gram-positive bacteria: S. aureus USA300 (MIC=1.56 µM), B. subtilis (MIC=3.12 µM).##Gram-negative bacteria: E. coli K12 (MIC=25 µM), P. aeruginosa (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22803960	J Am Chem Soc. 2012 Aug 1;134(30):12426-9.	Mishra B, Wang G.	"Ab Initio Design of Potent Anti-MRSA Peptides Based on Database
Filtering Technology."	
DRAMP04186	WLKKLLKKLLK	11	L5K5W1 (L5K5Wn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 µg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 µg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 µg/mL), Micrococcus luteus ATCC 10240 (MIC=4 µg/mL), MRSA-TK784 (MIC=8 µg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4 µg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 µg/mL), Salmonella typhimurium ATCC 14028 (MIC=2 µg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 µg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23344198	Molecules. 2013 Jan 11;18(1):859-876.	Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.	Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.	
DRAMP04187	KWLKKLLKKLL	11	L5K5W2 (L5K5Wn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 µg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 µg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 µg/mL), Micrococcus luteus ATCC 10240 (MIC=4 µg/mL), MRSA-TK784 (MIC=8 µg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 µg/mL), Shigella dysenteriae ATCC 9752 (MIC=1 µg/mL), Salmonella typhimurium ATCC 14028 (MIC=2 µg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 µg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23344198	Molecules. 2013 Jan 11;18(1):859-876.	Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.	Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.	
DRAMP04188	LKWLKKLLKKL	11	L5K5W3 (L5K5Wn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 µg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 µg/mL), Staphylococcus epidermis ATCC 12228 (MIC=4 µg/mL), Micrococcus luteus ATCC 10240 (MIC=4 µg/mL), MRSA-TK784 (MIC=8 µg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4 µg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 µg/mL), Salmonella typhimurium ATCC 14028 (MIC=4 µg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 µg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23344198	Molecules. 2013 Jan 11;18(1):859-876.	Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.	Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.	
DRAMP04189	LLKWLKKLLKK	11	L5K5W4 (L5K5Wn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 µg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 µg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 µg/mL), Micrococcus luteus ATCC 10240 (MIC=4 µg/mL), MRSA-TK784 (MIC=16 µg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4 µg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 µg/mL), Salmonella typhimurium ATCC 14028 (MIC=4 µg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=4 µg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=4 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23344198	Molecules. 2013 Jan 11;18(1):859-876.	Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.	Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.	
DRAMP04190	KLLKWLKKLLK	11	L5K5W5 (L5K5Wn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 µg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 µg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 µg/mL), Micrococcus luteus ATCC 10240 (MIC=2 µg/mL), MRSA-TK784 (MIC=8 µg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 µg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 µg/mL), Salmonella typhimurium ATCC 14028 (MIC=2 µg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 µg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23344198	Molecules. 2013 Jan 11;18(1):859-876.	Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.	Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.	
DRAMP18357	ASVVKTTIKASKKLCKGATLTCGCNITGKK	30	Warnerin (bacteriocin)	No entry found	Belongs to the lantibiotic family.	Not found	Staphylococcus warneri KL-1	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against S. epidermis (MIC <1 ug/ml), S. epidermis ATCC 700566 (MIC 8 ug/ml), S. epidermis ATCC 700567 (MIC 8 ug/ml), Staphylococcus sp. ATCC 700575 (MIC 32 ug/ml), S. aureus (VISA) CCUG 45315 (MIC 1.5 ug/ml), K. pneumoniae ATCC 700603 (MIC 96 ug/ml), E. faecium ATCC 51559 (MIC 64 ug/ml), and E. faecium (VRE) ATCC 700221 (MIC 32 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19361283	Biol Chem. 2009 May-Jun;390(5-6):437-44	Petersen J, Boysen A, Fogh L, Tabermann K, Kofoed T, King A, Schrotz-King P, Hansen MC	Identification and characterization of a bioactive lantibiotic produced by Staphylococcus warneri.	
DRAMP04192	LKKLLKWLKKL	11	L5K5W7 (L5K5Wn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 µg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 µg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 µg/mL), Micrococcus luteus ATCC 10240 (MIC=4 µg/mL), MRSA-TK784 (MIC=16 µg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 µg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 µg/mL), Salmonella typhimurium ATCC 14028 (MIC=4 µg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 µg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23344198	Molecules. 2013 Jan 11;18(1):859-876.	Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.	Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.	
DRAMP04193	LLKKLLKWLKK	11	L5K5W8 (L5K5Wn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=4 µg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 µg/mL), Staphylococcus epidermis ATCC 12228 (MIC=4 µg/mL), Micrococcus luteus ATCC 10240 (MIC=4 µg/mL), MRSA-TK784 (MIC=16 µg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4 µg/mL), Shigella dysenteriae ATCC 9752 (MIC=4 µg/mL), Salmonella typhimurium ATCC 14028 (MIC=4 µg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=4 µg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23344198	Molecules. 2013 Jan 11;18(1):859-876.	Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.	Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.	
DRAMP04194	KLLKKLLKWLK	11	L5K5W9 (L5K5Wn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 µg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 µg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 µg/mL), Micrococcus luteus ATCC 10240 (MIC=4 µg/mL), MRSA-TK784 (MIC=8 µg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 µg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 µg/mL), Salmonella typhimurium ATCC 14028 (MIC=2 µg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 µg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=4 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23344198	Molecules. 2013 Jan 11;18(1):859-876.	Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.	Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.	
DRAMP04195	KKLLKKLLKWL	11	L5K5W10 (L5K5Wn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=1 µg/mL), Staphylococcus aureus ATCC 6538p (MIC=1 µg/mL), Staphylococcus epidermis ATCC 12228 (MIC=1 µg/mL), Micrococcus luteus ATCC 10240 (MIC=2 µg/mL), MRSA-TK784 (MIC=4 µg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 µg/mL), Shigella dysenteriae ATCC 9752 (MIC=1 µg/mL), Salmonella typhimurium ATCC 14028 (MIC=1 µg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 µg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=4 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23344198	Molecules. 2013 Jan 11;18(1):859-876.	Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.	Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.	
DRAMP04196	LKKLLKKLLKW	11	L5K5W11 (L5K5Wn model peptide)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 µg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 µg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 µg/mL), Micrococcus luteus ATCC 10240 (MIC=4 µg/mL), MRSA-TK784 (MIC=16 µg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4 µg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 µg/mL), Salmonella typhimurium ATCC 14028 (MIC=4 µg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=4 µg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23344198	Molecules. 2013 Jan 11;18(1):859-876.	Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.	Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.	
DRAMP04233	FLGVVFKLASKVFPAVFGKV	20	D28 (Rational design peptide)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Has strong bacteriostatic activity against several species of bacteria, including Staphylococcus aureus and Bacillus anthracis.	Gram-positive bacteria: Staphylococcus aureus (MIC=8 µg/ml), Bacillus anthracis (MIC=16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17051220	Nature. 2006 Oct 19;443(7113):867-869.	Loose C, Jensen K, Rigoutsos I, Stephanopoulos G.	A linguistic model for the rational design of antimicrobial peptides.	
DRAMP04234	FLFRVASKVFPALIGKFKKK	20	D51 (Rational design peptide)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Has strong bacteriostatic activity against several species of bacteria, including Staphylococcus aureus and Bacillus anthracis.	Gram-positive bacteria: Staphylococcus aureus (MIC=16 µg/ml), Bacillus anthracis (MIC=16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17051220	Nature. 2006 Oct 19;443(7113):867-869.	Loose C, Jensen K, Rigoutsos I, Stephanopoulos G.	A linguistic model for the rational design of antimicrobial peptides.	
DRAMP04235	LGALFRVASKVFPAVISMVK	20	D22 (Rational design peptide)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Has strong bacteriostatic activity against several species of bacteria, including Staphylococcus aureus and Bacillus anthracis.	Gram-positive bacteria: Staphylococcus aureus (MIC=64 µg/ml), Bacillus anthracis (MIC=64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17051220	Nature. 2006 Oct 19;443(7113):867-869.	Loose C, Jensen K, Rigoutsos I, Stephanopoulos G.	A linguistic model for the rational design of antimicrobial peptides.	
DRAMP04237	GLFDIVKKLVSDF	13	Antibacterial peptide A4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix (1 helices; 8 residues)	Not found	1VM4 resolved by NMR.	Function: Has antibacterial activity against the Gram-negative bacterium E. coli.	Gram-negative bacterium: Escherichia coli (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15572363	J Biol Chem. 2005 Feb 18;280(7):5803-5811.	Wang G, Li Y, Li X.	Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor.	
DRAMP04240	KLKLLLLL	8	Synthetic 1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive and Gram-negative bacteria.	Gram-positive bacteria: Staphylococcus aureus (MIC=8 µg/ml), S. aureus (MRSA) (MIC>35 µg/ml).##Gram-negative bacterium: Escherichia coli (MIC=20 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8093007	Biochem J. 1994 Sep 1;302 ( Pt 2):535-538.	Alvarez-Bravo J, Kurata S, Natori S.	Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus.	
DRAMP04241	KLKLLLLLKLK	11	Synthetic 2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive and Gram-negative bacteria.	Gram-positive bacteria: Staphylococcus aureus (MIC=2 µg/ml), S. aureus (MRSA) (MIC=30 µg/ml).##Gram-negative bacterium: Escherichia coli (MIC=20 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8093007	Biochem J. 1994 Sep 1;302 ( Pt 2):535-538.	Alvarez-Bravo J, Kurata S, Natori S.	Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus.	
DRAMP04242	RLKLLLLLRLK	11	Synthetic 3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive and Gram-negative bacteria.	Gram-positive bacteria: Staphylococcus aureus (MIC=1 µg/ml), S. aureus (MRSA) (MIC=30 µg/ml).##Gram-negative bacterium: Escherichia coli (MIC=20 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8093007	Biochem J. 1994 Sep 1;302 ( Pt 2):535-538.	Alvarez-Bravo J, Kurata S, Natori S.	Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus.	
DRAMP04243	RLKLLLLRLK	10	Synthetic 4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive and Gram-negative bacteria.	Gram-positive bacteria: Staphylococcus aureus (MIC=2 µg/ml), S. aureus (MRSA) (MIC>35 µg/ml).##Gram-negative bacterium: Escherichia coli (MIC=20 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8093007	Biochem J. 1994 Sep 1;302 ( Pt 2):535-538.	Alvarez-Bravo J, Kurata S, Natori S.	Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus.	
DRAMP04244	RLKLLLRLK	9	Synthetic 5	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activity against the Gram-positive and Gram-negative bacteria.	Gram-positive bacteria: Staphylococcus aureus (MIC=2 µg/ml), S. aureus (MRSA) (MIC>35 µg/ml).##Gram-negative bacterium: Escherichia coli (MIC=20 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8093007	Biochem J. 1994 Sep 1;302 ( Pt 2):535-538.	Alvarez-Bravo J, Kurata S, Natori S.	Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus.	
DRAMP04264	KWKSFIKKLTSAAKKVVTTAKPLISS	26	CP26	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=1 μg/ml), Salmonella typhimurium (MIC=3 μg/ml), Pseudomonas aeruginosa K799 (MIC=1 μg/ml), Pseudomonas aeruginosa Z61 (MIC=1 μg/ml), Pseudomonas aeruginosa H744 (MIC=1 μg/ml), Pseudomonas aeruginosa H374 (MIC=1 μg/ml), Pseudomonas aeruginosa H547 (MIC=1 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04265	KWKSFIKKLTTAVKKVLTTGLPALIS	26	CP29	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=2 μg/ml), Pseudomonas aeruginosa K799 (MIC=6 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=2 μg/ml), Pseudomonas aeruginosa H374 (MIC=2 μg/ml), Pseudomonas aeruginosa H547 (MIC=2 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04279	ILKKWPWWPWRRK	13	CP11CN	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Chemical modification: C-terminal amidation.	Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=16 µg/ml), S. aureus SAP0017 MRSA (MIC=16 µg/ml), Staphylococcus haemolyticus Clinical isolate (MIC=2 µg/ml), S. haemolyticus Vancomycin-resistant isolate (MIC=1 µg/ml), Staphylococcus epidermidis Clinical isolate (MIC=8 µg/ml), Enterococcus faecalis ATCC 29212 (MIC>64 µg/ml), Listeria monocytogenes NCTC 7973 (MIC=16 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=8 µg/ml), Corynebacterium xerosis Lab strain (MIC=0.5 µg/ml).(Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11294848	Antimicrob. Agents Chemother. 1999,43:1542-1548.	Friedrich, C, M. G. Scott, N. Karunaratne, H. Yan, and R. E. Hancock.	"Salt-resistant alpha-helical cationic antimicrobial peptides.##Antibacterial Action of Structurally Diverse Cationic
Peptides on Gram-Positive Bacteria."	
DRAMP04359	INWKKIFQKVKNLV	14	PDD-A-1 (PDD-A analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli. PDD-A also shows hemolytic activity.	[Ref.18375018]Gram-negative bacterium: Escherichia coli (MIC=8 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=45 µM).	[Ref.18375018]IC50 = 100 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04360	INWKKIFEKVKDLV	14	PDD-A-2 (PDD-A analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=9 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04361	IDWKKIFEKVKNLV	14	PDD-A-3 (PDD-A analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=13 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=8.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04362	IDWKKIFEKVKDLV	14	PDD-A-4 (PDD-A analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=47.5 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=17.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04363	INWSKIFEKVKNLV	14	PDD-A-5 (PDD-A analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=12.5 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=17 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04364	INWSSIFEKVKNLV	14	PDD-A-6 (PDD-A analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=35 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04365	INWSSIFESVKNLV	14	PDD-A-7 (PDD-A analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=87.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04367	INWKKIFEKVSNLV	14	PDD-A-9 (PDD-A analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=12.5 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=22.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04368	INWKKIFESVKNLV	14	PDD-A-10 (PDD-A analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=10 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04369	INWKSIFEKVKNLV	14	PDD-A-11 (PDD-A analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=15 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04370	NIWKKIFEKVKNLV	14	PDD-A-12 (PDD-A analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04371	INWLKLGKKILGAI	14	PDD-B-1 (PDD-B analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=67.5 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04372	INWLRLGRRILGAL	14	PDD-B-2 (PDD-B analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC>100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=17.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04373	INFLKLGKKILGAL	14	PDD-B-3 (PDD-B analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC>100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=22.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04374	INWKKLGKKILGAL	14	PDD-B-4 (PDD-B analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=43 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=15.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04376	INWLKLGKKIISAL	14	MP-1 (MP analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04377	INWLKLGKKLLSAL	14	MP-2 (MP analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04378	INWLKLGKKMMSAI	14	MP-5 (MP analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=70 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=35 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04379	SNWLKLGKKMMSAL	14	MP-6 (MP analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04380	INWKKIASIGKEVLKAI	17	PMM-1 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=5.5 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=27.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04381	NWKKIASIGKEVLKAL	16	PMM-2 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=21 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=46 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04382	WKKIASIGKEVLKAL	15	PMM-3 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=62 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=125 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04383	KKIASIGKEVLKAL	14	PMM-4 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC>100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=75 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04385	INWKKIASIGKEVLKA	16	PMM-6 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=75 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=70 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04386	INWKKIASIGKEVLK	15	PMM-7 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04387	INWKKIASIGKEVL	14	PMM-8 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04389	IWNKIAKSIGKVLEKAL	17	PMM-10 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=15 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=35 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04390	INWKKGKEVLKAL	13	PMM-11 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC>100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04391	NIWKKIASIAKEVLKAL	17	PMM-12 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=6.25 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04392	KNWKKIASIGKEVLKAL	17	PMM-13 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=12.5 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=60 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04393	SNWKKIASIGKEVLKAL	17	PMM-14 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC=25 µM);##Gram-positive bacterium: Bacillus subtilis (MIC=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04528	TCRYWCKTPENQTYCCEDEREIPSKVGLKPGKCPPVRPVCPPTRGFFEPPKTCSNDGSCYGADKCCFDRCLGEHVCKPIQTRG	83	CrusEs (cDNA encoding crustin-like peptide)	No entry found	Not found	Not found	Chinese mitten crab, Eriocheir sinensis	Antibacterial, Antifungal, Antiviral, In, Anti-Gram+, Antimicrobial	Not found	Not found	Not found		Function: CrusEs is a potent antibacterial protein against Gram-positive bacteria infection.	Gram-positive bacteria: M. luteus (MIC=0.23 µM), B. subtilis (MIC=0.11 µM), B. thuringiensis (MIC=0.11 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20144896	Dev Comp Immunol. 2010 Jul;34(7):734-740.	Mu C, Zheng P, Zhao J, Wang L, Zhang H, Qiu L, Gai Y, Song L.	Molecular characterization and expression of a crustin-like gene from Chinese mitten crab, Eriocheir sinensis.	
DRAMP04542	IDWKKLLDAAKQIL	6	Polybia-MP-I (insects, vertebrates, animals)	No entry found	Not found	Not found	Polybia paulista (Neotropical social wasp)	Antimicrobial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli (MIC=5 µM), Pseudomonas aeruginosa (MIC=5 µM).##Gram-positive bacterium: Staphylococcus aureus (MIC=9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19463874	Peptides. 2009 Aug;30(8):1387-1395.	de Souza BM, da Silva AV, Resende VM, Arcuri HA, Dos Santos Cabrera MP, Ruggiero Neto J, Palma MS.	Characterization of two novel polyfunctional mastoparan peptides from the venom of the social wasp Polybia paulista.	
DRAMP04543	IDWLKLGKMVIDAL	14	Polybia-MP-II (insects, vertebrates, animals)	No entry found	Not found	Not found	Polybia paulista (Neotropical social wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Cytotoxic	Not found	Alpha helix	It forms amphipathic alpha-helical conformations under membrane-mimetic conditions.		"Function: Both peptides (Polybia-MP-II and -III) are polyfunctional, causing pronounced cell lysis of rat mast cells and erythrocytes, in addition to having antimicrobial activity against both Gram-positive and Gram-negative bacteria.
PTM: C-terminal amidation."	Gram-negative bacteria: Escherichia coli (MIC=5 µM), Pseudomonas aeruginosa (MIC=38 µM).##Gram-positive bacteria: Staphylococcus aureus (MIC=2 µM), Bacillus cereus (MIC=5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19463874	Peptides. 2009 Aug;30(8):1387-1395.	de Souza BM, da Silva AV, Resende VM, Arcuri HA, Dos Santos Cabrera MP, Ruggiero Neto J, Palma MS.	Characterization of two novel polyfunctional mastoparan peptides from the venom of the social wasp Polybia paulista.	
DRAMP04544	IDWLKLGKMVMDVL	14	Polybia-MP-III (insects, vertebrates, animals)	No entry found	Not found	Not found	Polybia paulista (Neotropical social wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Cytotoxic	Not found	Alpha helix	It forms amphipathic alpha-helical conformations under membrane-mimetic conditions.		"Function: Both peptides (Polybia-MP-II and -III) are polyfunctional, causing pronounced cell lysis of rat mast cells and erythrocytes, in addition to having antimicrobial activity against both Gram-positive and Gram-negative bacteria.
PTM: C-terminal amidation."	Gram-negative bacteria: Escherichia coli (MIC=38 µM), Pseudomonas aeruginosa (MIC=310 µM).##Gram-positive bacteria: Staphylococcus aureus (MIC=19 µM), Bacillus cereus (MIC=38 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19463874	Peptides. 2009 Aug;30(8):1387-1395.	de Souza BM, da Silva AV, Resende VM, Arcuri HA, Dos Santos Cabrera MP, Ruggiero Neto J, Palma MS.	Characterization of two novel polyfunctional mastoparan peptides from the venom of the social wasp Polybia paulista.	
DRAMP04545	SFPFFPPGICKRLKRC	16	Limnonectin-1Fa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Limnonectes fujianensis (Fujian large-headed frog)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Possesses relatively potent growth inhibitory activity against the Gram-negative bacterium E. coli. Ineffective against the Gram-positive bacterium S. aureus and the potentially pathogenic yeast C. albicans at concentrations up to 160 µM.	Gram-negative bacterium: Escherichia coli (MIC=35 µM)	[Ref.21396976] It exhibits no hemolytic activity at a concentration of up to 160 μM.	Cyclic	Free	Cyclization(Cys10 and Cys16).	Disulfide bond between Cys10 and Cys16.	L	No cytotoxicity information found	Not found	21396976	Biochimie. 2011 Jun;93(6):981-987.	Wu Y, Wang L, Zhou M, Ma C, Chen X, Bai B, Chen T, Shaw C.	Limnonectins: A new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis).	
DRAMP04546	SFHVFPPWMCKSLKKC	16	Limnonectin-1Fb (Frogs, amphibians, animals)	No entry found	Not found	Not found	Limnonectes fujianensis (Fujian large-headed frog)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Possesses relatively potent growth inhibitory activity against the Gram-negative bacterium E. coli. Ineffective against the Gram-positive bacterium S. aureus and the potentially pathogenic yeast C. albicans at concentrations up to 160 µM.	Gram-negative bacterium: Escherichia coli (MIC=70 µM)	[Ref.21396976] It exhibits no hemolytic activity at a concentration of up to 160 μM.	Cyclic	Free	Cyclization(Cys10 and Cys16).	Disulfide bond between Cys10 and Cys16.	L	No cytotoxicity information found	Not found	21396976	Biochimie. 2011 Jun;93(6):981-987.	Wu Y, Wang L, Zhou M, Ma C, Chen X, Bai B, Chen T, Shaw C.	Limnonectins: A new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis).	
DRAMP04553	GVIKSVLKGVAKTVALGML	19	H. erythraea B2RP	No entry found	Not found	Not found	Hylarana erythraea	Antimicrobial, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (MIC=12.5 microM);##Gram-poaitive bacteria: Staphylococcus aureus (MIC=12.5 microM), multidrug-resistant clinical isolates of Acetinobacter baumannii (MIC in the range 6-12.5 microM).##Yeast: Candida albicans (MIC=50 microM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20015460	Peptides. 2010 Apr;31(4):548-554.	Al-Ghaferi N, Kolodziejek J, Nowotny N, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD, Conlon JM.	Antimicrobial peptides from the skin secretions of the South-East Asian frog Hylarana erythraea (Ranidae).	
DRAMP04640	GMASKAGSVLGKLAKVAIGAL	21	PGLa-AN2	No entry found	Not found	Not found	Xenopus andrei	Antimicrobial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: E. coli (MIC=25 µM);##Gram-positive bacterium: S. aureus (MIC=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21498136	Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.	Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.	Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.	
DRAMP04665	KPFKKLEKVGRNIRDGIIKAGPAVAVIGQATSIARPTGK	39	Px-cec1	No entry found	Not found	Not found	Plutella xylostella (Diamondback moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix (CD)	A circular dichroism (CD) analysis revealed that the recombinant Px-cec1 mainly contained α-helixes.		Function: Recombinant Px-cec1 exhibites a broad spectrum of anti-microbial properties against fungi, Gram-positive and Gram-negative bacteria, but it does not exhibit hemolytic activity against human erythrocytes.	[Ref.22921836]Gram-positive bacterium: S. aureus (MIC=2 µM);##Gram-negative bacteria: E. coli (MIC=0.1 µM), Pseudomonas fluorescent (MIC=1.1 µM), Salmonella choleraesuis (MIC=2.1 µM);##Fungi: Aureobasidium pullulans (MIC=4.0 µM), Aspergillus flavus (MIC=14.5 µM), Aspergillus fumigatus (MIC=16.0 µM), Aspergillus niger (MIC=14.6 µM), Fusarium oxysporum (MIC=8.0 µM).	[Ref.22921836]Non-hemolytic activity against human erythrocytes.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22921836	Protein Expr Purif. 2012 Oct;85(2):230-238. 	Jin F, Sun Q, Xu X, Li L, Gao G, Xu Y, Yu X, Ren S.	cDNA cloning and characterization of the antibacterial peptide cecropin 1 from the diamondback moth, Plutella xylostella L.	
DRAMP04670	KNIGNSVSCLRNKGVCMPGKCAPKMKQIGTCGMPQVKCCKRK	42	PBD1-42	No entry found	Not found	Not found	Boletus edulis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: The recombinant pBD142 exhibited antimicrobial activity against both Gram-positive Staphylococcus aureus and Gram-negative E. coli including the multi-resistant E. coli. Shows hemolytic activity and high thermal stability. 	[Ref.23220638]Gram-negative bacterium: Escherichia coli (MIC=100 µg/mL);##Gram-positive bacterium: Staphylococcus aureus (MIC=80 µg/mL).	[Ref.23220638]5% hemolytic activity at 10 μg/mL, 10% hemolytic activity at 20 μg/mL, 10% hemolytic activity at 100 μg/mL against porcine fresh blood	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23220638	Protein Expr Purif. 2013 Mar;88(1):47-53.	Li CL, Xu TT, Chen RB, Huang XX, Zhao YC, Bao YY, Zhao WD, Zheng ZY.	Cloning, expression and characterization of antimicrobial porcine b defensin 1 in Escherichia coli.	
DRAMP04671	TDHQMAQSACIGVSQDNAYASAIPRDCHGG	30	Myticusin-1	No entry found	Not found	Not found	Mytilus coruscus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Myticusin-1 exhibites stronger anti-microbial properties against Gram-positive bacteria more than Gram-negative bacteria and fungus.	Gram-negative bacteria: Escherichia coli (MIC=6.7-12.5 µM), Vibrio Parahaemolyticus (MIC>25.0 µM), Pseudomonas aeruginosa (MIC>25.0 µM), Vibrio.harveyi (MIC=12.5-25.0 µM).##Gram-positive bacteria: Bacillus subtilis (MIC=1.2-2.5 µM), Staphylococcus aureus (MIC=2.5-5.0 µM), Sarcina luteus (MIC=1.2-2.5 µM), Bacillus megaterium (MIC=2.5-5.0 µM).##Fungi: Candida albicans (MIC=6.7-12.5 µM), Monilia albican (MIC=12.5-25.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23247103	Fish Shellfish Immunol. 2013 Feb;34(2):610-616.	Liao Z, Wang XC, Liu HH, Fan MH, Sun JJ, Shen W.	Molecular characterization of a novel antimicrobial peptide from Mytilus coruscus.	
DRAMP04676	MFTLKKPLLLLFFLGTISLSLCQEERDADEEEGEMIEEEVKRSLLGTVKDLLIGAGKSAAQSVLKGLSCKLSKDC	75	Brevinin-2HS2A	E7EKE0	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana hainanensis (Odor frog) (Rana hainanensis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		"Function: Has antimicrobial activity against some Gram-positive bacteria and fungi but has no activity against a range of Gram- negative bacteria except P.faecalis. Has extremely low hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands."	[Ref.22450466]Gram-positive bacteria: S.aureus ATCC 25923 (MIC=19 µM), B.licheniformis X39 (MIC=37.5 µM) and R.rhodochrous X15 (MIC=9.5 µM);##Gram-negative bacterium: P. faecalis X29 (MIC=9.5 µM);##Fungi: C. albicans ATCC 2002 (MIC=19 µM), slime mold 090223 (MIC=37.5 µM).	[Ref.22450466]LC50=300 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22450466	Peptides. 2012 Jun;35(2):285-290.	Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.	Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.	
DRAMP04677	MFTMKKPLLLIVLLGIISLSLCEQERAADEEEGEMIEEEVKRSLLGTVKDLLIGAGKSAAQSVLKGLSCKLSKDC	75	Brevinin-2HS2B	E7EKE1	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana hainanensis (Odor frog) (Rana hainanensis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		"Function: Has antimicrobial activity against some Gram-positive bacteria and fungi but has no activity against a range of Gram- negative bacteria except P. faecalis. Has low hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands."	[Ref.22450466]Gram-positive bacteria: S.aureus ATCC 25923 (MIC=19 µM), B. licheniformis X39 (MIC=37.5 µM) and R. rhodochrous X15 (MIC=9.5 µM);##Gram-negative bacterium: P. faecalis X29 (MIC=9.5 µM);##Fungi: C. albicans ATCC 2002 (MIC=19 µM), slime mold 090223 (MIC=37.5 µM).	[Ref.22450466]LC50=300 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22450466	Peptides. 2012 Jun;35(2):285-290.	Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.	Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.	
DRAMP04679	FLPFLIPALTSLISSL	16	Senegalin	L0P323	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Kassina senegalensis (Senegal running frog)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial peptide with activity against the Gram-positive bacterium S. aureus NCTC 10788 and the yeast C. albicans NCPF 1467. Ineffective against the Gram-negative bacterium E. coli NCTC 10418. Induces a dose-dependent contraction of rat urinary bladder smooth muscle (EC50=2.9 nM) and a dose-dependent relaxation of rat tail artery smooth muscle (EC50=37.7 nM).	Gram-positive bacterium: S. aureus NCTC 10788 (MIC=50 µM). Yeast: C. albicans NCPF 1467 (MIC=150 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23430307	Amino Acids. 2013 May;44(5):1347-1355. 	Wang H, Li R, Xi X, Meng T, Zhou M, Wang L, Zhang Y, Chen T, Shaw C.	Senegalin: a novel antimicrobial/myotropic hexadecapeptide from the skin secretion of the African running frog, Kassina senegalensis.	
DRAMP00001	GSGVIPTISHECHMNSFQFVFTCCS	25	Variacin (Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Micrococcus varians (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has a broad host range of inhibition against Gram-positive food spoilage bacteria. Variacin is resistant to heat and pH conditions from 2 to 10.
Biophysicochemical properties: Variacin is resistant to heat and pH conditions from 2 to 10."	Gram-positive bacteria: Lactobacillus helveticus (+++), L. bulgaricus (+++), Lactobacillus lactis (++), Lactobacillus delbrueckii (+++), Lactobacillus acidophilus (++), Lactobacillus plantarum (+), Lactobacillus sake (LSK) (++), Lactobacillus curvatus (++), Leuconostoc mesenteroides (+), Streptococcus thermophilus (++), Lactococcus lactis (SL2) (++), Enterococcus faecalis (++), Enterococcus faecium (++), Listeria innocua (++), Listeria monocytogenes (++++), Listeria welhia (++).##Note: Inhibitory activity tested with supernatant adjusted to pH 7.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	Not included yet	L	Not found	Not found	8633879	Appl Environ Microbiol. 1996 May;62(5):1799-1802.	Pridmore D, Rekhif N, Pittet AC, Suri B, Mollet B.	Variacin, a new lanthionine-containing bacteriocin produced by Micrococcus varians: comparison to lacticin 481 of Lactococcus lactis.	
DRAMP00002	WKSESVCTPGCVTGLLQTCFLQTITCNCKISK	32	Entianin (Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Bacillus subtilis subsp. spizizenii DSM 15029(T) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Entianin is very active against several Gram-positive pathogens, such as Staphylococcus aureus and Enterococcus faecalis. 	[Ref.21239550] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC = 4-8 μg/ml),Staphylococcus aureus ATCC 43300 (MRSA)(MIC = 8 μg/ml), Enterococcus faecalis ATCC 29212(MIC = 16μg/ml), Micrococcus luteus ATCC 9341(MIC = 4-8μg/ml), Enterococcus faecalis ATCC 51299 (VRE) (MIC = 8-16 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Succinylation	Free	There are two dehydroalanines (S5; S31),one dehydrobutyrine (T18),one lanthionine (S3-C7) and four β-methyllanthionines (T8-C11; T13-C19; T23-C26; T25-C28).	L	No cytotoxicity information found	Not found	21239550	Appl Environ Microbiol. 2011 Mar;77(5):1698-1707.	Fuchs SW, Jaskolla TW, Bochmann S, Kötter P, Wichelhaus T, Karas M, Stein T, Entian KD.	Entianin, a Novel Subtilin-Like Lantibiotic from Bacillus subtilis DSM 15029T with High Antimicrobial Activity.	
DRAMP00003	ADRGWIKTLTKDCPNVISSICAGTIITACKNCA	33	Bovicin HJ50 (Bacteriocin; Predicted)	Q83ZN8	Belongs to the lantibiotic family (Class I bacteriocin)	bovA	Streptococcus bovis HJ50 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found	2M8V	PTM: There are two thioether rings (T8-C13 and T10-C32) and one unique disulfide bridge between C21-C29.	Gram-positive bacteria: Bacillus megaterium AS1.941 (IZ=14 mm), Bacillus subtilis AS1.1087 (IZ=12 mm), Lactobacillus curvatus LTH1174 (IZ=13 mm), Leuconostoc mesenteroides AS1.2 (IZ=10 mm), Leuconostoc dextranicum 181 (IZ=13 mm), Micrococcus flavus NCIB8166 (IZ=21 mm).##NOTE: IZ = zone of inhibition.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14702402##19202107	Microbiology. 2004 Jan;150(Pt 1):103-108.##Microbiology. 2009 Feb;155(Pt 2):584-593.	Xiao H, Chen X, Chen M, Tang S, Zhao X, Huan L.##Liu G, Zhong J, Ni J, Chen M, Xiao H, Huan L.	Bovicin HJ50, a novel lantibiotic produced by Streptococcus bovis HJ50.##Characteristics of the bovicin HJ50 gene cluster in Streptococcus bovis HJ50.	
DRAMP00004	MNNTIKDFDLDLKTNKKDTATPYVGSRYLCTPGSCWKLVCFTTTVK	46	Lantibiotic (Bacteriocin)	Q48TR2	Belongs to the lantibiotic family (Class I bacteriocin)	srtA	Streptococcus pyogenes serotype M28 (strain MGAS6180) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Function: Active on certain Gram-positive bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16088825	J Infect Dis. 2005 Sep 1;192(5):760-770.	Green NM, Zhang S, Porcella SF, Nagiec MJ, Barbian KD, Beres SB, LeFebvre RB, Musser JM.	Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity.	
DRAMP00006	GNGVIKTISHECHMNTWQFIFTCCS	25	Butyrivibriocin OR79 (Bacteriocin)	O85355	Belongs to the lantibiotic family (Class I bacteriocin)	bvi79	Butyrivibrio fibrisolvens (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic). The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor."	Gram-positive bacteria: Fibrisolvens, Butyrivibrio crossotus, Clostridium clostridiforme, Lachnospira multiparus, Ruminococcus flavefaciens.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	10224011	Appl Environ Microbiol. 1999 May;65(5):2128-2135.	Kalmokoff ML, Lu D, Whitford MF, Teather RM.	Evidence for production of a new lantibiotic (butyrivibriocin OR79A) by the ruminal anaerobe Butyrivibrio fibrisolvens OR79: characterization of the structural gene encoding butyrivibriocin OR79A.	
DRAMP18350	CLGIGSCNDFAGCGYAIVCFW	21	Siamycin II(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Streptomyces strains AA3891	Antiviral, Anti-HIV, Antimicrobial		Beta strand	It differs from Siamycin I only by one amino acid. Siamycin I has a valine residue at position 4. In both peptides, disulfide bonds link Cys1 with Cys13 and Cys7 with Cys19, and the side chain of Asp9 forms an amide bond with the N-terminus (XXJ). The original has been replaced since antimicrobial assays revealed no activity.		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7787424	J Biomol NMR. 1995 Apr;5(3):271-86.	Constantine KL, Friedrichs MS, Detlefsen D, Nishio M, Tsunakawa M, Furumai T, Ohkuma H, Oki T, Hill S, Bruccoleri RE, et al.	High-resolution solution structure of siamycin II: novel amphipathic character of a 21-residue peptide that inhibits HIV fusion.	
DRAMP18351	EDGLHPRLCSC	11	Trichamide(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Trichodesmium erythraeum	Unknown		Not found	Trichamide consists of 11 amino acids, including two cysteine-derived thiazole groups, and is cyclized by an N-C terminal amide bond.		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16751554	Appl Environ Microbiol. 2006 Jun;72(6):4382-7.	Sudek S, Haygood MG, Youssef DT, Schmidt EW.	Structure of trichamide, a cyclic peptide from the bloom-forming cyanobacterium Trichodesmium erythraeum, predicted from the genome sequence.	
DRAMP00008	CSTNTFSLSDYWGNNGAWCTLTHECMAWCK	30	Lacticin 3147 A1 (LtnA1; Bacteriocin; Preclinical)	O87236	Belongs to the lantibiotic family (Class I bacteriocin)	ltnA1	Lactococcus lactis subsp. lactis (Streptococcus lactis) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. When present individually lacticin 3147 A1 exhibits strong activity towards L.lactis strain AM2, weak activity towards L.lactis strain HP and no activity towards L.lactis strain IFPL359, but when combined with lacticin 3147 A2 it displays strong activity towards all three strains.
PTM: There are two 2,3-dehydrobutyrines (T3; T5), one 2,3-didehydroalanine (S7), two Lanthionines (C1-S2; S9-C19) and two Beta-methyllanthionines (T20-C25; T22-C29)."	Gram-positive bacteria: Enterococcus, Lactobacillus, Lactococcus, Leuconostoc.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There are two 2,3-dehydrobutyrines (T3; T5), one 2,3-didehydroalanine (S7), two Lanthionines (C1-S2; S9-C19) and two Beta-methyllanthionines (T20-C25; T22-C29).	Mixed(D-Ala)	No cytotoxicity information found	Lipid II	10971756##15023056##10608807	J Appl Microbiol. 2000 Aug;89(2):249-260.##Biochemistry. 2004 Mar 23;43(11):3049-3056.##J Biol Chem. 1999 Dec 31;274(53):37544-37550.	Mart­nez-Cuesta MC, Buist G, Kok J, Hauge HH, Nissen-Meyer J, Pel¡ez C, Requena T.##Martin NI, Sprules T, Carpenter MR, Cotter PD, Hill C, Ross RP, Vederas JC.##Ryan MP, Jack RW, Josten M, Sahl HG, Jung G, Ross RP, Hill C.	Biological and molecular characterization of a two-peptide lantibiotic produced by Lactococcus lactis IFPL105.##Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.##Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147.	
DRAMP00009	TTPATPAISILSAYISTNTCPTTKCTRAC	29	Bacteriocin lacticin 3147 A2 (LtnA2; Bacteriocin; Preclinical)	O87237	Belongs to the lantibiotic family (Class I bacteriocin)	ltnA2	Lactococcus lactis subsp. lactis (Streptococcus lactis) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. When present individually lacticin 3147 A2 exhibits weak activity towards L.lactis strain AM2 and L.lactis strain HP, and no activity towards L.lactis strain IFPL359, but when combined with lacticin 3147 A1 it displays strong activity towards all three strains.
PTM: There are one 2-oxobutanoic acid (T1), two 2,3-dehydrobutyrines (T2; T5), two 2,3-dehydroalanines (S9; S12), one Lanthionine (S16-C20) and two Beta-methyllanthionines (T22-C24; T26-C29)."	Gram-positive bacteria: Enterococcus, Lactobacillus, Lactococcus, Leuconostoc.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Amidation 	Free	There are one 2-oxobutanoic acid (T1), two 2,3-dehydrobutyrines (T2; T5), two 2,3-dehydroalanines (S9; S12), one Lanthionine (S16-C20) and two Beta-methyllanthionines (T22-C24; T26-C29).	Mixed(D-Ala)	No cytotoxicity information found	Lipid II	10971756##15023056##10608807	J Appl Microbiol. 2000 Aug;89(2):249-260.##Biochemistry. 2004 Mar 23;43(11):3049-3056.##J Biol Chem. 1999 Dec 31;274(53):37544-37550.	Mart­nez-Cuesta MC, Buist G, Kok J, Hauge HH, Nissen-Meyer J, Pel¡ez C, Requena T.##Martin NI, Sprules T, Carpenter MR, Cotter PD, Hill C, Ross RP, Vederas JC.##Ryan MP, Jack RW, Josten M, Sahl HG, Jung G, Ross RP, Hill C.	Biological and molecular characterization of a two-peptide lantibiotic produced by Lactococcus lactis IFPL105.##Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.##Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147.	
DRAMP00010	KCKWWNISCDLGNNGHVCTLSHECQVSCN	29	Plantaricin W alpha (Plw-alpha; Bacteriocin)	Q9AF67, D2KR94	Belongs to the lantibiotic family (Class I bacteriocin)	plWalpha	Lactobacillus plantarum (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		"Function: Plantaricin W (Plw) is a new two-peptide bacteriocin, from Lactobacillus plantarum, which inhibits a large number of Gram-positive bacteria. The two individual peptides, Plwalpha (comprising 29 residues) and Plwbeta (comprising 32 residues), had low antimicrobial activity but acted synergistically. The data indicate that the two peptides work in a 1:1 ratio.
PTM: Chemical analyses showed that both peptides are lantibiotics, but two unmodified cysteines and one serine residue were present in Plwa, and Plwb contained one cysteine residue."	Gram-positive bacteria: Lactobacillus spp, Lactococcus lactis, Listeria innocua, Listeria monocytogenes, Oenococcus oeni, Leuconostoc mesenteroides, Pediococcus acidilactici, Pediococcus pentosaceus, Enterococcus faecalis, Propionibacterium freudenreichii, Staphylococcus aureus. 	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys9,two lanthionines (S8-C18,S21-C28),one β-methyllanthionine(T19-C24).	L	No cytotoxicity information found	Not found	11238971	Microbiology. 2001 Mar;147(Pt 3):643-651.	Holo H, Jeknic Z, Daeschel M, Stevanovic S, Nes IF.	Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)CSSC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)NC(=O)[C@H](CO)NC1=O
DRAMP00011	SGIPCTIGAAVAASIAVCPTTKCSKRCGKRKK	32	Plantaricin W beta (Plw-beta; Bacteriocin)	Q9AF68	Belongs to the lantibiotic family (Class I bacteriocin)	plWbeta	Lactobacillus plantarum (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		"Function: Plantaricin W (Plw) is a new two-peptide bacteriocin, from Lactobacillus plantarum, which inhibits a large number of Gram-positive bacteria. The two individual peptides, Plwalpha (comprising 29 residues) and Plwbeta (comprising 32 residues), had low antimicrobial activity but acted synergistically. The data indicate that the two peptides work in a 1:1 ratio.
PTM: Chemical analyses showed that both peptides are lantibiotics, but two unmodified cysteines and one serine residue were present in Plwa, and Plwb contained one cysteine residue. Plwbeta is synthesized with a 29 aa leader, processed by an ABC transporter and then subjected to further proteolytic attack, resulting in the removal of the six Nterminal residues."	Gram-positive bacteria: Lactobacillus spp, Lactococcus lactis, Listeria innocua, Listeria monocytogenes, Oenococcus oeni, Leuconostoc mesenteroides, Pediococcus acidilactici, Pediococcus pentosaceus, Enterococcus faecalis, Propionibacterium freudenreichii, Staphylococcus aureus. 	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Deaminated	Free	one lanthionine (S14-C18),two β-methyllanthionines(T20-C23,T21-C27).	L	No cytotoxicity information found	Not found	11238971	Microbiology. 2001 Mar;147(Pt 3):643-651.	Holo H, Jeknic Z, Daeschel M, Stevanovic S, Nes IF.	Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics.	
DRAMP00012	TITLSTCAILSKPLGNNGYLCTVTKECMPSCN	32	Lantibiotic lichenicidin VK21 A1 (LchA1; Lchalpha; Bacteriocin)	P86475, E0YCK1, Q65DC4, Q62NU5	Belongs to the lantibiotic family (Class I bacteriocin)	lchA1	Bacillus licheniformis (strain ATCC 14580/VK21/DSM 13) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Alpha helix (1 helices; 3 residues)	The Lchalpha peptide displays structural homology with mersacidin-like lantibiotics and involves relatively well-structured N- and C-terminal domains connected by a flexible loop stabilized by a thioether bridge Ala11-S-Ala21. 	2KTN resolved by NMR.	"Function: The mature peptides, Lchalpha and Lchbeta, interact synergistically to possess antibiotic activity against Gram-positive bacteria within a nanomolar concentration range, though the individual peptides were shown to be active at micromolar concentrations. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. Combined LchA1 and LchA2 peptides also inhibit Bacillus sp. HIL-Y85/54728, L.lactis DPC3417 and B.halodurans C-125, which produce lantibiotics themselves. Inactivated by proteinase K and pronase E, but not by trypsin and chymotrypsin.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor."	Only Lchalpha: Bacillus megaterium VKM41 (IC50=1.8 uM), Bacillus subtilis L1 (IC50=9 uM), Rhodococcus sp. SS2 (IC50=9 uM), Micrococcus luteus B1314 (IC50=1.2 uM), Staphylococcus aureus 209p (IC50=3.1 uM).##Lchalpha+Lchbeta: Bacillus megaterium VKM41 (IC50=0.12 uM), Bacillus subtilis L1 (IC50=0.64 uM), Rhodococcus sp. SS2 (IC50=0.64 uM), Micrococcus luteus B1314 (IC50=0.09 uM), Staphylococcus aureus 209p (IC50=0.64 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	19561184##19707558##20578714	Appl Environ Microbiol. 2009 Sep;75(17):5451-5460.##PLoS One. 2009 Aug 26;4(8):e6788.##Biochemistry. 2010 Aug 3;49(30):6462-6472.	Begley M, Cotter PD, Hill C, Ross RP.##Dischinger J, Josten M, Szekat C, Sahl HG, Bierbaum G.##Shenkarev ZO, Finkina EI, Nurmukhamedova EK, Balandin SV, Mineev KS, Nadezhdin KD, Yakimenko ZA, Tagaev AA, Temirov YV, Arseniev AS, Ovchinnikova TV.	Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.##Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13.##Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21.	
DRAMP00013	TTPATTSSWTCITAGVTVSASLCPTTKCTSRC	32	Lantibiotic lichenicidin VK21 A2 (LchA2; Lchbeta; Bacteriocin)	P86476, P86720, E0YCK0	Belongs to the lantibiotic family (Class I bacteriocin)	lchA2	Bacillus licheniformis (strain ATCC 14580/VK21/DSM 13) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Alpha helix (1 helices; 14 residues)	The Lchbeta peptide represents a prolonged hydrophobic alpha-helix flanked with more flexible N- and C-terminal domains. 	2KTO resolved by NMR.	"Function: The mature peptides, Lchalpha and Lchbeta, interact synergistically to possess antibiotic activity against Gram-positive bacteria within a nanomolar concentration range, though the individual peptides were shown to be active at micromolar concentrations. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. Combined LchA1 and LchA2 peptides also inhibit Bacillus sp. HIL-Y85/54728, L.lactis DPC3417 and B.halodurans C-125, which produce lantibiotics themselves. Inactivated by proteinase K and pronase E, but not by trypsin and chymotrypsin.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor."	Only Lchbeta: Bacillus megaterium VKM41 (IC50=2 uM), Bacillus subtilis L1 (IC50=30 uM), Rhodococcus sp. SS2 (IC50=16.6 uM), Micrococcus luteus B1314 (IC50=2.6 uM), Staphylococcus aureus 209p (IC50=20 uM).##Lchalpha+Lchbeta: Bacillus megaterium VKM41 (IC50=0.12 uM), Bacillus subtilis L1 (IC50=0.64 uM), Rhodococcus sp. SS2 (IC50=0.64 uM), Micrococcus luteus B1314 (IC50=0.09 uM), Staphylococcus aureus 209p (IC50=0.64 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	19561184##19707558##20578714	Appl Environ Microbiol. 2009 Sep;75(17):5451-5460.##PLoS One. 2009 Aug 26;4(8):e6788.##Biochemistry. 2010 Aug 3;49(30):6462-6472.	Begley M, Cotter PD, Hill C, Ross RP.##Dischinger J, Josten M, Szekat C, Sahl HG, Bierbaum G.##Shenkarev ZO, Finkina EI, Nurmukhamedova EK, Balandin SV, Mineev KS, Nadezhdin KD, Yakimenko ZA, Tagaev AA, Temirov YV, Arseniev AS, Ovchinnikova TV.	Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.##Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13.##Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21.	
DRAMP00014	VTSKSLCTPGCITGVLMCLTQNSCVSCNSCIRC	33	Geobacillin I (nisin analog; Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	sunA	Geobacillus thermodenitrificans NG80-2 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Extensive NMR characterization demonstrated that geobacillin I contains seven thioether cross-links, two more than the five cross-links found in nisin and the most cross-links found in any lantibiotic to date.		"Function: Geobacillin I is active against a wide range of Gram positive bacteria but it not active against Gram-negative bacterium E. coli.
PTM: Contains seven thioether cross-links.
Biophysicochemical properties: Geobacillin I is more stable than nisin at pH 7 and 8 at 37 and at 60 °C."	Gram-positive bacteria: Streptococcus dysgalatiae subsp dysgalactiae ATCC 27957 (IC50=0.69±0.05 µM), Vancomycin-resistant Enterococcusfaecium CNRZ 481 (IC50=0.84±0.05 µM), Methicillin-resistant Staphylococcus aureus C5 (IC50=2.23±0.03 µM), Bacillus anthracis Sterne 7702 (IC50=0.49±0.02 µM), Bacillus subtilis ATCC 6633 (IC50=0.55±0.01 µM), Lactococcus lactis HP ATCC 11602 (IC50=0.12±0.09 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization  between S29 and C33	Four lanthionines (S3-C7,S23-C27,S26-C30,S29-C33) and three β-methyllanthionines (T8-C11; T13-C18; T20-C24),S5 is dehydroalanines.	L	No cytotoxicity information found	Not found	22431611	Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5241-5246.	Garg N, Tang W, Goto Y, Nair SK, van der Donk WA.	Lantibiotics from Geobacillus thermodenitrificans.	
DRAMP00015	STIVCVSLRICNWSLRFCPSFKVRCPM	27	Geobacillin II (nisin analog; Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Geobacillus thermodenitrificans NG80-2 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Geobacillin II only demonstrated antimicrobial activity against Bacillus strains.	Gram-positive bacteria: Bacillus cereus Z4222, Bacillus subtilis ATCC 6633.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization  between S29 and C33	Four lanthionines (S3-C7,S23-C27,S26-C30,S29-C33) and three β-methyllanthionines (T8-C11; T13-C18; T20-C24),S5 is dehydroalanines.	L	No cytotoxicity information found	Not found	22431611	Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5241-5246.	Garg N, Tang W, Goto Y, Nair SK, van der Donk WA.	Lantibiotics from Geobacillus thermodenitrificans.	
DRAMP00016	GNGVVLTLTHECNLATWTKKLKCC	24	Salivaricin 9 (Sal9; Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	sivA	Streptococcus salivarius (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Note: The Sal9 genetic determinants appear generally (but not always) to be megaplasmid-associated, and production seems often to occur in strains that also produce SalA. As is the case for SalA, the production of Sal9 appears to be autoinducible.	Gram-positive bacteria: Streptococcus pyogenes and some Enterococci.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21310787	Microbiology. 2011 May;157(Pt 5):1290-1299.	Wescombe PA, Upton M, Renault P, Wirawan RE, Power D, Burton JP, Chilcott CN, Tagg JR.	Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius.	
DRAMP00018	GTTVVNSTFSIVLGNKGYICTVTVECMRNCSK	32	SmbA1 (Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Streptococcus mutans GS5 (Gram-negative bacteria)	Antimicrobial, Antibacterial	Not found	Rich	Not found		The two peptides (SmbA and SmbB) are encoded by two chromosomal DNA genes in the same operon.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15673730	Antimicrob Agents Chemother. 2005 Feb;49(2):541-548.	Yonezawa H, Kuramitsu HK.	Genetic analysis of a unique bacteriocin, Smb, produced by Streptococcus mutans GS5.	
DRAMP00019	STPACAIGVVGITVAVTGISTACTSRCINK	30	SmbA2 (Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Streptococcus mutans GS5 (Gram-negative bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		The two peptides (SmbA and SmbB) are encoded by two chromosomal DNA genes in the same operon.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15673730	Antimicrob Agents Chemother. 2005 Feb;49(2):541-548.	Yonezawa H, Kuramitsu HK.	Genetic analysis of a unique bacteriocin, Smb, produced by Streptococcus mutans GS5.	
DRAMP00020	CAWYNISCRLGNKGAYCTLTVECMPSCN	28	HalA1 (one chain of haloduracin; Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Bacillus halodurans C-125 (Gram-positive bacteria) 	Antimicrobial, Antibacterial	Not found	Rich	Not found		Function: Active on certain Gram-positive bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Surface of a bacterial target	17085596	Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17243-17248. 	McClerren AL, Cooper LE, Quan C, Thomas PM, Kelleher NL, van der Donk WA.	Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic.	
DRAMP00021	TTWPCATVGVSVALCPTTKCTSQC	24	HalA2 (one chain of haloduracin; Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Bacillus halodurans C-125 (Gram-positive bacteria) 	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: Active on certain Gram-positive bacteria. HalA2 causes pore formation and K+ efflux.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17085596	Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17243-17248. 	McClerren AL, Cooper LE, Quan C, Thomas PM, Kelleher NL, van der Donk WA.	Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic.	
DRAMP00022	CSTNTFSLSDYWGNKGNWCTATHECMSWCK	30	Staphylococcin C55alpha (SacAalpha; chain alpha of Staphylococcin C55; Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Staphylococcus aureus C55 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Active on certain Gram-positive bacteria.	Gram-positive bacteria: Staphylococcus aureus and Micrococcus luteus (C55alpha and C55beta work synergistically at a ratio of 1:1).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9835565##10417203	Appl Environ Microbiol. 1998 Dec;64(12):4803-4808.##Infect Immun. 1999 Aug;67(8):4268-4271.	Navaratna MA, Sahl HG, Tagg JR.##Navaratna MA, Sahl HG, Tagg JR.	Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55.##Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II Staphylococcus aureus strains and demonstration of an association with the exfoliative toxin B gene.	
DRAMP00023	GTPLALLGGAATGVIGYISNQTCPTTACTRAC	32	Staphylococcin C55beta (SacAbeta; chain beta of Staphylococcin C55; Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Staphylococcus aureus C55 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Active on certain Gram-positive bacteria.	Gram-positive bacteria: Staphylococcus aureus, Micrococcus luteus (C55alpha and C55beta work synergistically at a ratio of 1:1).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9835565##10417203	Appl Environ Microbiol. 1998 Dec;64(12):4803-4808.##Infect Immun. 1999 Aug;67(8):4268-4271.	Navaratna MA, Sahl HG, Tagg JR.##Navaratna MA, Sahl HG, Tagg JR.	Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55.##Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II Staphylococcus aureus strains and demonstration of an association with the exfoliative toxin B gene.	
DRAMP00024	TTPACFTIGLGVGALFSAKFC	21	CylLS (a structural subunit of cytolysin; Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Enterococcus faecalis (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		CylLL and CylLS are activated by an extracellular protease, CylA.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8898386	Mol Microbiol. 1996 Sep;21(6):1175-1184.	Booth MC, Bogie CP, Sahl HG, Siezen RJ, Hatter KL, Gilmore MS.	Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic.	
DRAMP00025	TTPVCAVAATAAASSAACGWVGGGIFTGVTVVVSLKHC	38	CylLL (a structural subunit of cytolysin; Bacteriocin)	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Enterococcus faecalis (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		CylLL and CylLS are activated by an extracellular protease, CylA.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8898386	Mol Microbiol. 1996 Sep;21(6):1175-1184.	Booth MC, Bogie CP, Sahl HG, Siezen RJ, Hatter KL, Gilmore MS.	Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic.	
DRAMP00026	KRGSGWIATITDDCPNSVFVCC	22	Salivaricin A (SalA; Bacteriocin; Preclinical)	P36500	Belongs to the type A lantibiotic family (Class I bacteriocin)	salA	Streptococcus salivarius 20P3 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Rich	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: Contains one lanthionine (S17-C22) and two Beta-methyllanthionines (T9-C14; T11-C21), which is followed by membrane translocation and cleavage of the modified precursor. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8357242	Appl Environ Microbiol. 1993 Jul;59(7):2014-2021.	Ross KF, Ronson CW, Tagg JR.	Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3.	
DRAMP00027	GGGVIQTISHECRMNSWQFLFTCCS	25	Salivaricin B (SboB; Bacteriocin; Preclinical)	No entry found	Belongs to the type A lantibiotic family (Class I bacteriocin)	Not found	Streptococcus salivarius K12 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		PTM: Thioether bonds are predicted between 7-12; 9-23; 16-24.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17194838	Appl Environ Microbiol. 2007 Feb;73(4):1107-1113.	Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, Tagg JR.	Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.	
DRAMP00028	IASKFICTPGCAKTGSFNSYCC	22	Lantibiotic epidermin (Bacteriocin)	P08136, Q54093	Belongs to the type A lantibiotic family (Class I bacteriocin)	epiA	Staphylococcus epidermidis TU 3298 / DSM 3095 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Rich	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are one didehydrobutyrine (T14), two lanthionines (S3-C7; S16-C21) and one Beta-methyllanthionine (T8-C11) and one S-(2-aminovinyl)-D-cysteine (S19-C22)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid II	2835685##3769923	Nature. 1988 May 19;333(6170):276-268.##Eur J Biochem. 1986 Oct 1;160(1):9-22.	Schnell N, Entian KD, Schneider U, Götz F, Zähner H, Kellner R, Jung G.##Allgaier H, Jung G, Werner RG, Schneider U, Zähner H.	Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings.##Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic.	
DRAMP00029	GKNGVFKTISHECHLNTWAFLATCCS	26	Streptococcin A-FF22 (Antibacterial peptide SA-FF22; Bacteriocin)	P36501	Belongs to the type A lantibiotic family (Class I bacteriocin)	scnA	Streptococcus pyogenes FF22 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function Lanthionine-containing peptide antibiotic (lantibiotic) active on certain Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are one 2,3-didehydrobutyrine at T23, two Beta-methyllanthionine (T8-C13; T17-C25), and one Lanthionine (S10-C24)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	8328813##8125103	Appl Environ Microbiol. 1993 Jun;59(6):1969-1971.##Eur J Biochem. 1994 Mar 1;220(2):455-462.	Hynes WL, Ferretti JJ, Tagg JR.##Jack RW, Carne A, Metzger J, StefanoviÄ‡ S, Sahl HG, Jung G, Tagg J.	Cloning of the gene encoding Streptococcin A-FF22, a novel lantibiotic produced by Streptococcus pyogenes, and determination of its nucleotide sequence.##Elucidation of the structure of SA-FF22, a lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22.	
DRAMP18349	CLGVGSCNDFAGCGYAVVCFW	21	Siamycin I (Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Streptomyces strain AA6532	Antiviral, Anti-HIV, Antimicrobial		Beta strand	It differs from Siamycin I only by one amino acid. Siamycin I has a valine residue at position 4. In both peptides, disulfide bonds link Cys1 with Cys13 and Cys7 with Cys19, and the side chain of Asp9 forms an amide bond with the N-terminus (XXJ). The original has been replaced since antimicrobial assays revealed no activity.		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8557614	J Antibiot (Tokyo). 1995 Dec;48(12):1515-7.	Detlefsen DJ, Hill SE, Volk KJ, Klohr SE, Tsunakawa M, Furumai T, Lin PF, Nishio M, Kawano K, Oki T, et al.	Siamycins I and II, new anti-HIV-1 peptides: II. Sequence analysis and structure determination of siamycin I.	
DRAMP00031	GSEIQPR	7	Lantibiotic carnocin-UI49 (Bacteriocin)	P36960	Belongs to the type A lantibiotic family (Class I bacteriocin)	Not found	Carnobacterium sp. (strain UI49) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Rich 	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic). Active on Gram-positive bacteria.
Biophysicochemical properties: Bacteriocin activity is very stable below pH 8 and is moderately heat stable in the crude extract."	Gram-positive bacteria: Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus sakei, L. lactis, Pediococcus acidilactici, all Carnobacterium species (six NCDO strains).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1622206	Appl Environ Microbiol. 1992;58(5):1417-1422.	Stoffels G, Nissen-Meyer J, Gudmundsdottir A, Sletten K, Holo H, Nes IF.	Purification and characterization of a new bacteriocin isolated from a Carnobacterium sp.	
DRAMP00033	ASIVKTTIKASKKLCRGFTLTCGCHFTGKK	30	Lantibiotic epilancin 15X (Bacteriocin)	P86047	Belongs to the type A lantibiotic family (Class I bacteriocin)	Not found	Staphylococcus epidermidis 15X154 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Non helix or strand structure	The molecule contains ten post-translationally modified amino acids, three lanthionine ring structures and a hydroxy-propionyl N-terminal moiety.	1W9N resolved by NMR.	"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria: such as staphylococci, enterococci and streptococci. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are one Lactic acid (S1), one 2,3-didehydroalanine (S3) and three 2,3-dehydrobutyrines (T7; T8; T28); also one Lanthionine (S12-C16) and two Beta-methyllanthionines (T20-C23; T22-C25)."	Gram-positive bacteria: resistant bacterial strains Staphylococcus aureus (MRSA) and VRE.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15792796	FEBS Lett. 2005 Mar 28;579(9):1917-1922.	Ekkelenkamp MB, Hanssen M, Danny Hsu ST, de Jong A, Milatovic D, Verhoef J, van Nuland NA.	Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.	
DRAMP00034	SASVLKTSIKVSKKYCKGVTLTCGCNITGGK	31	Lantibiotic epilancin K7 (Bacteriocin)	Q57312	Belongs to the type A lantibiotic family (Class I bacteriocin)	elkA	Staphylococcus epidermidis K7 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Rich	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are two dihydroalanines (Dha): S3 and S8; two dehydrobutyrines (Dhb): T7, T28; one lanthionine: S12-C16; and two Beta-methyllanthionine: T20-C23, T22-C25."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	7607233	Eur J Biochem. 1995 Jun 1;230(2):587-600.	van de Kamp M, van den Hooven HW, Konings RN, Bierbaum G, Sahl HG, Kuipers OP, Siezen RJ, de Vos WM, Hilbers CW, van de Ven FJ.	Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7.	
DRAMP00035	ASIIKTTIKVSKAVCKTLTCICTGSCSNCK	30	Lantibiotic paenibacillin (Bacteriocin)	P86013	Belongs to the type A lantibiotic family (Class I bacteriocin)	Not found	Paenibacillus polymyxa (Bacillus polymyxa) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Rich 	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. Lacks antibacterial activity against Gram-negative bacteria.
Physicochemical properties: water solubility, thermal resistance, and stability against acid/alkali (pH 2.0 to 9.0) treatment."	Gram-positive bacteria: Bacillus spp, Clostridium sporogenes, Lactobacillus spp, Lactococcus lactis, Leuconostoc mesenteroides, Listeria spp, Pediococcus cerevisiae, Staphylococcus aureus, Streptococcus agalactiae 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17071789##18625234	Appl Environ Microbiol. 2007 Jan;73(1):168-178.##FEBS Lett. 2008 Aug 6;582(18):2787-2792.	He Z, Kisla D, Zhang L, Yuan C, Green-Church KB, Yousef AE.##He Z, Yuan C, Zhang L, Yousef AE.	Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin.##N-terminal acetylation in paenibacillin, a novel lantibiotic.	
DRAMP00036	ITSISLCTPGCKTGALMGCNMKTATCHCSIHVSK	34	Nisin A (Bacteriocin; Preclinical)	P13068	Belongs to the type A lantibiotic family (Class I bacteriocin)	spaN	Lactococcus lactis subsp. lactis (Streptococcus lactis) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Non helix or strand structure	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are two dehydroalanines (S5; S33), one dehydrobutyrine (T2), which form one lanthionine (S3-C7) and four Beta-methyllanthionines (T8-C11; T13-C19; T23-C26; T25-C28).
Medical use: Urogenital tract infections and spermicidal activity in-vivo; animal model: rabbit (Reproduction. 2004 Jul;128(1):117-126)."	Gram-positive bacteria: Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, Listeria, clostridium.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There are two dehydroalanines (S5; S33), one dehydrobutyrine (T2), which form one lanthionine (S3-C7) and four β-methyllanthionines (T8-C11; T13-C19; T23-C26; T25-C28).	L	No cytotoxicity information found	Lipid II	3141403##5131162##1575686	J Biol Chem. 1988 Nov 5;263(31):16260-16266.##J Am Chem Soc. 1971 Sep 8;93(18):4634-4635.##Biochem J. 1992 Apr 15;283 (Pt 2):413-420.	Buchman GW, Banerjee S, Hansen JN.##Gross E, Morell JL.##Lian LY, Chan WC, Morley SD, Roberts GC, Bycroft BW, Jackson D.	Structure, expression, and evolution of a gene encoding the precursor of nisin, a small protein antibiotic.##The structure of nisin.##Solution structures of nisin A and its two major degradation products determined by n.m.r.	
DRAMP00037	ITSISLCTPGCKTGALMGCNMKTATCNCSIHVSK	34	Nisin Z (Bacteriocin; Preclinical)	P29559	Belongs to the type A lantibiotic family (Class I bacteriocin)	nisZ	Lactococcus lactis subsp. lactis (Streptococcus lactis) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix (1 helices; 4 residues)	The structure shows a novel lipid II-binding motif in which the pyrophosphate moiety of lipid II is primarily coordinated by the N-terminal backbone amides of nisin via intermolecular hydrogen bonds. This cage structure provides a rationale for the conservation of the lanthionine rings among several lipid II-binding lantibiotics.	1WCO resolved by NMR.	"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are two dehydroalanines (Dha): S5, S33; one didehydrobutyrine (Dhb): T2; one lanthionine: S3-C7; and four methyllanthionines: T8-C11, T13-C19, T23-C26, and T25-C28."	Gram-positive bacteria: Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, Listeria, clostridium.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There are two dehydroalanines (S5; S33), one dehydrobutyrine (T2), which form one lanthionine (S3-C7) and four β-methyllanthionines (T8-C11; T13-C19; T23-C26; T25-C28).	L	No cytotoxicity information found	Lipid II	1935953##7626780##15361862	Eur J Biochem. 1991 Nov 1;201(3):581-584.##DNA Seq. 1995;5(4):203-218.##Nat Struct Mol Biol. 2004 Oct;11(10):963-967.	Mulders JW, Boerrigter IJ, Rollema HS, Siezen RJ, de Vos WM.##Immonen T, Ye S, Ra R, Qiao M, Paulin L, Saris PE.##Hsu ST, Breukink E, Tischenko E, Lutters MA, de Kruijff B, Kaptein R, Bonvin AM, van Nuland NA.	Identification and characterization of the lantibiotic nisin Z, a natural nisin variant.##The codon usage of the nisZ operon in Lactococcus lactis N8 suggests a non-lactococcal origin of the conjugative nisin-sucrose transposon.##The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics.	
DRAMP00038	ITSKSLCTPGCKTGILMTCPLKTATCGCHFG	31	Nisin U (Bacteriocin)	Q2QBT0	Belongs to the type A lantibiotic family (Class I bacteriocin)	nsuA	Lactococcus uberis ATCC 27958	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are two dihydroalanines (Dha)(S5; T18), one didehydrobutyrine (Dhb)(T2), one lanthionine (S3-C7) and four methyllanthionines (T8-C11; T13-C19; T23-C26; T25-C28).
Biotechnological use: Used as a food preservative."	Gram-positive bacteria: Streptococcus pyogenes, Streptococcus uberis, Streptococcus agalactiae, Streptococcus dysgalactiae, Staphylococcus simulans, Staphylococcus cohnii, Lactococcus lactis, Lactobacillus acidophilus, Streptococcus mitis.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There are two dihydroalanines (Dha)(S5; T18), one didehydrobutyrine (Dhb)(T2), one lanthionine (S3-C7) and four methyllanthionines (T8-C11; T13-C19; T23-C26; T25-C28).	L	No cytotoxicity information found	Lipid II	16461661	Appl Environ Microbiol. 2006 Feb;72(2):1148-1156.	Wirawan RE, Klesse NA, Jack RW, Tagg JR.	Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis.	
DRAMP00039	TAGPAIRASVKQCQKTLKATRLFTVSCKGKNGCK	34	Pep5 (Bacteriocin)	P19578	Belongs to the type A lantibiotic family (Class I bacteriocin)	pepA	Staphylococcus epidermidis (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Rich 	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor.After proteolysis of the propeptide, the N-terminal 2,3-didehydrobutyrine hydrolyzes to 2-oxobutanoic acid, possibly spontaneously."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid II	2764678##7556197	Arch Microbiol. 1989;152(1):16-19.##Eur J Biochem. 1995 Sep 1;232(2):478-489.	Kaletta C, Entian KD, Kellner R, Jung G, Reis M, Sahl HG.##Meyer C, Bierbaum G, Heidrich C, Reis M, S¼ling J, Iglesias-Wind MI, Kempter C, Molitor E, Sahl HG.	Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence.##Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation.	
DRAMP00040	IASKFLCTPGCAKTGSFNSYCC	22	Gallidermin (Bacteriocin; Preclinical)	P21838	Belongs to the type A lantibiotic family (Class I bacteriocin)	gdmA	Staphylococcus gallinarum TU 3928 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Rich	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are one didehydrobutyrine (Dhb): T14; two lanthionines: S3-C7, S16-C21; one Beta-methyllanthionine: T8-C11; and S-(2-aminovinyl)-D-cysteine (Ser-Cys): S19-C22."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	3181159	Eur J Biochem. 1988 Oct 15;177(1):53-59.	Kellner R, Jung G, Hörner T, Zähner H, Schnell N, Entian KD, Götz F.	Gallidermin: a new lanthionine-containing polypeptide antibiotic.	
DRAMP00041	FKSWSLCTPGCARTGSFNSYCC	22	Mutacin-1140 (Mutacin III; Bacteriocin)	O68586	Belongs to the type A lantibiotic family (Class I bacteriocin)	lanA	Streptococcus mutans (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are one dihydroalanine (Dha): S5; one didehydrobutyrine (Dhb): T14; two lanthionines: S3-C7, S16-C21; one Beta-methyllanthionine: T8-C11; and S-(2-aminovinyl)-D-cysteine (Ser-Cys): S19-C22."	Gram-positive bacteria: Streptococcus cricetus E49, Streptococcus rattus BHT-2, Streptococcus mutans NG8, S. mutans OMZ175, S. mutans V100, Streptococcus sobrinus SL1, S. sobrinus ATCC 27352, Streptococcus downeii ATCC 33748, Streptococcus salivarius ATCC 25975, Streptococcus salivariusATCC 27945, Streptococcus mitis ATCC 19950, Streptococcus sanguinis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	11082191	Eur J Biochem. 2000 Dec;267(23):6810-6816.	Smith L, Nov¡k J, Rocca J, McClung S, Hillman JD, Edison AS.	Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics.	
DRAMP00042	FKSWSFCTPGCAKTGSFNSYCC	22	Bacteriocin mutacin B-Ny266 (Preclinical)	P80666	Belongs to the type A lantibiotic family (Class I bacteriocin)	Not found	Streptococcus mutans Ny266 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Rich	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: There are one dihydroalanines (Dha): S5; one didehydrobutyrine (Dhb): T14; two lanthionines: S3-C7, S16-C21; one Beta-methyllanthionine: T8-C11; and S-(2-aminovinyl)-D-cysteine (Ser-Cys): S19-C22."	Gram-positive bacterium: Micrococcus luteus ATCC 272.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	9237644	FEBS Lett. 1997 Jun 30;410(2-3):275-279.	Mota-Meira M, Lacroix C, LaPointe G, Lavoie MC.	Purification and structure of mutacin B-Ny266: a new lantibiotic produced by Streptococcus mutans.	
DRAMP00043	KKKSGVIPTVSHDCHMNTFQFMFTCCS	27	Bacteriocin nukacin (Nukacin KQ-1; Nukacin KQU-131)	B5MFD0	Belongs to the type A lantibiotic family (Class I bacteriocin)	nukA	Staphylococcus hominis KQU-131 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores (By similarity).
Biophysicochemical properties: Temperature dependence (Retains 50% of its antimicrobial activity after heating at 100 degrees Celsius for 100 minutes, and retains 25% antimicrobial activity after heating at 121 Celsius for 15 minutes)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18685189	Biosci Biotechnol Biochem. 2008 Aug;72(8):2232-2235.	Wilaipun P, Zendo T, Okuda K, Nakayama J, Sonomoto K.	Identification of the nukacin KQU-131, a new type-A(II) lantibiotic produced by Staphylococcus hominis KQU-131 isolated from Thai fermented fish product (Pla-ra).	
DRAMP00044	KKKSGVIPTVSHDCHMNSFQFVFTCCS	27	Bacteriocin nukacin (Nukacin 3299; Simulancin 3299)	E0WX65	Belongs to the type A lantibiotic family (Class I bacteriocin)	nukA	Staphylococcus simulans	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores (By similarity).
Biophysicochemical properties: pH dependence (Optimum pHs for antimicrobial activity are 3.0 and 6.0. Activity is reduced by 50% at alkaline pHs 9.0 and 11.0); Temperature dependence (No change in antimicrobial activity between 80 or 100 degrees Celsius after 15 minutes, but reduction in 50% antimicrobial activity at 121 degrees Celsius after 15 minutes).
ptm: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20627619	Vet Microbiol. 2010 Nov 20;146(1-2):124-131.	Ceotto H, Holo H, da Costa KF, Nascimento Jdos S, Salehian Z, Nes IF, Bastos Mdo C.	Nukacin 3299, a lantibiotic produced by Staphylococcus simulans 3299 identical to nukacin ISK-1.	
DRAMP18346	ITPLATLATPEATPVGFAATSATAAAVNMITHDVTRH	37	Legonaridin(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	legA	Streptomyces sp. CT34	Unknown		Not found	Despite the same chemical features as those observed in cypemycin and grisemycin, legonaridin 1 has a structurally different C-terminus with a free carboxylic acid.		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26256511	Org Biomol Chem. 2015 Oct 7;13(37):9585-92. 	Rateb ME, Zhai Y, Ehrner E, Rath CM, Wang X, Tabudravu J, Ebel R, Bibb M, Kyeremeh K, Dorrestein PC, Hong K, Jaspars M, Deng H.	Legonaridin, a new member of linaridin RiPP from a Ghanaian Streptomyces isolate.	
DRAMP18347	CLGVGSCNDFAGCGYAIVCFW	21	Siamycin(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Streptomyces sp. No. 73264	Antiviral, Anti-HIV, Antimicrobial		Not found	It differs from siamycin I only at position 17 (V to I).		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8619594	Antimicrob Agents Chemother. 1995 Oct;39(10):2345-7.	Chokekijchai S, Kojima E, Anderson S, Nomizu M, Tanaka M, Machida M, Date T, Toyota K, Ishida S, Watanabe K, et al.	NP-06: a novel anti-human immunodeficiency virus polypeptide produced by a Streptomyces species.	
DRAMP18348	GNWHGTAPDWFFNYYW	16	RES-701-1(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Streptomyces spp.	Unknown		Not found	Not found		RES-701-1 is an endothelin B receptor (ET) selective peptidic antagonist.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Letters in Peptide Science. 1997 Jun;4(3):167-170.	Shibata K,Yano K,Tanaka T,Matsuda Y,Yamasaki M.	C-terminal modifications of an endothelin antagonist RES-701-1: Production of ETA/ETB dual selective analogs. 	
DRAMP00046	GSRYLCTPGSCWKLVCFTTTVK	22	Lantibiotic streptin (Bacteriocin)	P0C0H8, Q9FDV1, P0C0H9, Q48YZ4, Q9FDV1	Belongs to the type A lantibiotic family (Class I bacteriocin)	srtA	Streptococcus pyogenes & Streptococcus pyogenes serotype M1 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on certain Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
Induction: Induces its own expression in at least strain M25.
Miscellaneous: A longer form (streptin 2, with three more amino acids at the N-terminus) is probably due to incomplete processing. Other forms also exist, some of which are due to differing levels of dehydration.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor."	Active on certain Gram-positive bacteria.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	11328600##12732544##11296296##16088826	J Biochem. 2001 May;129(5):769-775.##Appl Environ Microbiol. 2003 May;69(5):2737-2747.##Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4658-4663.##J Infect Dis. 2005 Sep 1;192(5):771-782.	Karaya K, Shimizu T, Taketo A.##Wescombe PA, Tagg JR.##Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, Primeaux C, Sezate S, Suvorov AN, Kenton S, Lai HS, Lin SP, Qian Y, Jia HG, Najar FZ, Ren Q, Zhu H, Song L, White J, Yuan X, Clifton SW, Roe BA, McLaughlin R.##Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, Sturdevant DE, Graham MR, Vuopio-Varkila J, Hoe NP, Musser JM.	New gene cluster for lantibiotic streptin possibly involved in streptolysin S formation.##Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes.##Complete genome sequence of an M1 strain of Streptococcus pyogenes.##Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events.	
DRAMP00047	VGSRYLCTPGSCWKLVCFTTTVK	23	Streptin 1 (Bacteriocin)	No entry found	Belongs to the type A lantibiotic family (Class I bacteriocin)	Not found	Bacillus subtilis A1/3 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Rich 	Not found		Two possible structures have been proposed for streptin 1 due to insufficient info. The first lanthionine S3-C7 and the second methyllanthionine T8-C12 are identical in the two proposed structures. A third intra-bond is either S11-C17 or C17-T19 (or C17-T20 or C17-T21). Compared to Streptin 1, Streptin 2 contains 3 additional residues TPY at the N-terminus. Small quantities of peptides at various degrees of dehydration were also detected.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12732544	Appl Environ Microbiol. 2003 May;69(5):2737-2747.	Wescombe PA, Tagg JR.	Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes.	
DRAMP00048	WKSESLCTPGCVTGALQTCFLQTLTCNCKISK	32	Lantibiotic subtilin (Bacteriocin)	P10946	Belongs to the type A lantibiotic family (Class I bacteriocin)	spaS	Bacillus subtilis (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Rich 	Not found		"Function Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor.Succinylated subtilin is 10-20 times less active than subtilin. The ratio subtilin/succinylated subtilin is about 1:2 after 24 hours growth.The 2,3-didehydrobutyrine is determined to be the Z-isomer."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Succinylation	Free	There are two dehydroalanines (S5; S31),one dehydrobutyrine (T18),one lanthionine (S3-C7) and four β-methyllanthionines (T8-C11; T13-C19; T23-C26; T25-C28).	L	No cytotoxicity information found	Lipid II	4154277##21239550	"Hoppe Seylers Z Physiol Chem. 1973 Jul;354(7):810-812.##Appl Environ Microbiol
. 2011 Mar;77(5):1698-707."	Gross E, Kiltz HH, Nebelin E.##Sebastian W Fuchs, Thorsten W Jaskolla, Sophie Bochmann, Peter Kötter, Thomas Wichelhaus, Michael Karas, Torsten Stein, Karl-Dieter Entian	Subtilin, VI: the structure of subtilin (author's transl).##Entianin, a novel subtilin-like lantibiotic from Bacillus subtilis subsp. spizizenii DSM 15029T with high antimicrobial activity	
DRAMP00049	KGGSGVIHTISHECNMNSWQFVFTCCS	27	Bacteriocin lacticin-481 (Lactococcin-DR)	P36499	Belongs to the type A lantibiotic family (Class I bacteriocin)	lctA	Lactococcus lactis CNRZ 481 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor."	Gram-positive bacteria: Lactic acid bacteria, Clostridium tyrobutyricum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	16348628##8344922##8764998	Appl Environ Microbiol. 1992 Jan;58(1):279-284.##J Biol Chem. 1993 Aug 5;268(22):16361-16368.##FEBS Lett. 1996 Aug 12;391(3):317-322.	Piard JC, Muriana PM, Desmazeaud MJ, Klaenhammer TR.##Piard JC, Kuipers OP, Rollema HS, Desmazeaud MJ, de Vos WM.##van den Hooven HW, Lagerwerf FM, Heerma W, Haverkamp J, Piard JC, Hilbers CW, Siezen RJ, Kuipers OP, Rollema HS.	Purification and Partial Characterization of Lacticin 481, a Lanthionine-Containing Bacteriocin Produced by Lactococcus lactis subsp. lactis CNRZ 481.##Structure, organization, and expression of the lct gene for lacticin 481, a novel lantibiotic produced by Lactococcus lactis.##The structure of the lantibiotic lacticin 481 produced by Lactococcus lactis: location of the thioether bridges.	
DRAMP18345	CLGIGSCNNFAGCGYAVVCFW	21	Tricyclic peptide RP 71955 (Bacteriocin)	P37046	Not found	Not found	Streptomyces sp. (strain SP9440)	Antiviral, Anti-HIV, Antimicrobial		Beta strand	An internal amide bond between the NH2 of C1 and the gamma-COOH of D9 was observed, as well as two disulfide bridges, one between C1 and C13 and one between C7 and C19.	1RPB, 1RPC resolved by NMR	Caution:The isopeptide linked residue 9 is shown as Asn rather than Asp as mentioned in PubMed:8286361, because it is not known whether Asp or Asn is encoded and the isopeptide bonds are almost always formed between the amides Asn or Gln and N6-lysine or alpha amino groups, with the liberation of an ammonia that makes the reaction essentially irreversible.(From Swiss-prot)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8270499	J Antibiot (Tokyo). 1993 Nov;46(11):1756-7.	Helynck G, Dubertret C, Mayaux JF, Leboul J.	Isolation of RP 71955, a new anti-HIV-1 peptide secondary metabolite.	
DRAMP00051	FSSLSLCSLGCTGVKNPSFNSYCC	24	Mutacin I (Bacteriocin)	No entry found	Belongs to the type A lantibiotic family (Class I bacteriocin)	Not found	Streptococcus mutans CH43); also Streptococcus mutans UA140 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus, Staphylococcus epidermidis, enterococci, pneumococci, group A streptococci.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10919773##11133423	Appl Environ Microbiol. 2000 Aug;66(8):3221-3229.##Appl Environ Microbiol. 2001 Jan;67(1):15-21. 	Qi F, Chen P, Caufield PW.##Qi F, Chen P, Caufield PW.	Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans, CH43, and genetic analysis of mutacin I biosynthesis genes.##The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV.	
DRAMP00052	NRWWQGVVPTVSYECRMNSWQHVFTCC	27	Mutacin-2 (Mutacin II mutacin H-29B; Bacteriocin)	O54329, P84110	Belongs to the type A lantibiotic family (Class I bacteriocin)	mutA	Streptococcus mutans (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Rich	Not found		"Function: Mutacin-2 inhibits other mutans streptococci as well as many gram-positive exogenous pathogens. Transiently and partially depolarizes the transmembrane electrical potential and pH gradient of susceptible cells, inhibits the uptake of amino acids and depletes the intracellular ATP pool.
Biophysicochemical properties: pH dependence (Stable from pH 4.0 to 10.0); Temperature dependence (Thermostable).
PTM: There are one didehydrobutyrine (T25), two lanthionines (S12-C26; S19-C27) and one Beta-methyllanthionine (T10-C15)."	Gram-positive bacteria: Micrococcus luteus, Staphylococcus aureus, Peptostreptococcus micros, Pediococcus acidilactici, Clostridium sporogenes, Corynebacterium diphtheriae, Actinomyces viscosus, Gardnerella vaginalis, Propionibacterium acnes, Listeria monocytogenes, Mycobacterium smegmatis.##Gram-negative bacteria: Campylobacter jejuni, Helicobacter pylori, Neisseria gonorrhoeae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10821848##8592997##16626493##8021218	J Biol Chem. 2000 May 26;275(21):15845-15850.##Antimicrob Agents Chemother. 1995 Dec;39(12):2656-2660.##BMC Microbiol. 2006 Apr 20;6:36.##J Bacteriol. 1994 Jul;176(14):4316-4320.	Krull RE, Chen P, Novak J, Kirk M, Barnes S, Baker J, Krishna NR, Caufield PW.##Chikindas ML, Nov¡k J, Driessen AJ, Konings WN, Schilling KM, Caufield PW.##Nicolas G, Morency H, LaPointe G, Lavoie MC.##Nov¡k J, Caufield PW, Miller EJ.	Biochemical structural analysis of the lantibiotic mutacin II.##Mutacin II, a bactericidal antibiotic from Streptococcus mutans.##Mutacin H-29B is identical to mutacin II (J-T8).##Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans.	
DRAMP00053	ITSISLCTPGCKTGALMGCNMKTATCNCSVHVSK	34	Nisin F (Bacteriocin; Perclinical)	No entry found	Belongs to the type A lantibiotic family (Class I bacteriocin)	Not found	Lactococcus lactis F10 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: defense response to Gram-positive bacteria.	Gram-positive bacteria: Staphylococcus aureus, Staphylococcus carnosus, Lactobacillus curvatus N1902, Lactobacillus plantarum, Lactobacillus reuteri.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There are two dehydroalanines (S5; S33), one dehydrobutyrine (T2), which form one lanthionine (S3-C7) and four β-methyllanthionines (T8-C11; T13-C19; T23-C26; T25-C28).	L	No cytotoxicity information found	Lipid II	18039827	Appl Environ Microbiol. 2008 Jan;74(2):547-549.	de Kwaadsteniet M, Ten Doeschate K, Dicks LM.	Characterization of the structural gene encoding nisin F, a new lantibiotic produced by a Lactococcus lactis subsp. lactis isolate from freshwater catfish (Clarias gariepinus).	
DRAMP00054	ITSISLCTPGCKTGVLMGCNLKTATCNCSVHVSK	34	Nisin Q (Bacteriocin)	No entry found	Belongs to the type A lantibiotic family (Class I bacteriocin)	nisQ	Lactococcus lactis 61-14 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: defense response to Gram-positive bacteria.	Gram-positive bacteria: LAB, Bacillus sp, Listeria sp, Micrococcus sp.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There are two dehydroalanines (S5; S33), one dehydrobutyrine (T2), which form one lanthionine (S3-C7) and four β-methyllanthionines (T8-C11; T13-C19; T23-C26; T25-C28).	L	No cytotoxicity information found	Not found	12913315	Biosci Biotechnol Biochem. 2003 Jul;67(7):1616-1619.	Zendo T, Fukao M, Ueda K, Higuchi T, Nakayama J, Sonomoto K.	Identification of the lantibiotic nisin Q, a new natural nisin variant produced by Lactococcus lactis 61-14 isolated from a river in Japan.	
DRAMP00055	ITSVSWCTPGCTSEGGGSGCSHCC	24	Bacteriocin 97518	No entry found	Belongs to the type A lantibiotic family (Class I bacteriocin)	Not found	Planomonospora sp. (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Rich 	Not found		Function: It inhibits cell wall synthesis of Gram-positive bacteria, including Staphylococcus aureus (MRSA).	Gram-negative bacteria: Escherichia coli, Moraxella catarrhalis.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17469849	Biochemistry. 2007 May 22;46(20):5884-5895.	Castiglione F, Cavaletti L, Losi D, Lazzarini A, Carrano L, Feroggio M, Ciciliato I, Corti E, Candiani G, Marinelli F, Selva E.	A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.	
DRAMP00056	CVQSCSFGPLTWSCDGNTK	19	Bacteriocin ancovenin	P38655	Belongs to the type B lantibiotic family (Class I bacteriocin)	Not found	Streptomyces sp. A647P-2 (Gram-positive bacteria)	Antimicrobial	Protein level	Not found	Not found		"MOA: Acts as an inhibitor of angiotensin I converting enzyme.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine or the formation of dialkylamine bonds with lysine. This is followed by membrane translocation and cleavage of the modified precursor."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Tetrahedron Lett. 1985;26:665-668.	Wakamiya T, Ueki Y, Shiba T, Kido Y, Motoki Y.	The structure of ancovenin, a new peptide inhibitor of angiotensin I converting enzyme.	
DRAMP00057	CKQSCSFGPFTFVCDGNTK	19	Bacteriocin duramycin (Leucopeptin; Bacteriocin)	P36504	Belongs to the type B lantibiotic family (Class I bacteriocin)	Not found	Streptoverticillium griseoverticillatum (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Rich 	Not found		"Function: Acts as inhibitor of human phospholipase A2.
PTM: Methyllanthionine rings between residues 1 and18 as well as between residues 5 and 11; a lanthionine occurs between Cys14 and residue 4. In addition, addition of Lys19 to dehydralanine at position 6 forms a lysinoalanine bridge. The Asp residue at position 15 is hydroxylated. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	phosphatidylethanolamine	2272918##2125590	J Antibiot (Tokyo). 1990 Nov;43(11):1421-1430.##J Antibiot (Tokyo). 1990 Nov;43(11):1403-1412.	Hayashi F, Nagashima K, Terui Y, Kawamura Y, Matsumoto K, Itazaki H.##Fredenhagen A, Fendrich G, Märki F, Märki W, Gruner J, Raschdorf F, Peter HH.	The structure of PA48009: the revised structure of duramycin.##Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin.	
DRAMP00058	CRQSCSFGPLTFVCDGNTK	19	Lantibiotic duramycin B (Bacteriocin)	P36502	Belongs to the type B lantibiotic family (Class I bacteriocin)	Not found	Streptoverticillium strain R2075 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Rich	Not found		Methyllanthionine rings between residues 1 and18 as well as between residues 5 and 11; a lanthionine occurs between Cys14 and residue 4. In addition, addition of Lys19 to dehydralanine at position 6 forms a lysinoalanine bridge. The Asp residue at position 15 is hydroxylated. Duramycins and cinnamycin specifically binds to phosphatidylethanolamine, thereby indirectly inhibiting the activity of phospholipase A2.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Phosphatidylethanolamine	2125590	J Antibiot (Tokyo). 1990 Nov;43(11):1403-1412.	Fredenhagen A, Fendrich G, Märki F, Märki W, Gruner J, Raschdorf F, Peter HH.	Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin.	
DRAMP00059	CANSCSYGPLTWSCDGNTK	19	Lantibiotic duramycin C (Bacteriocin)	P36503	Belongs to the type B lantibiotic family (Class I bacteriocin)	Not found	Streptomyces griseoluteus R2107 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Rich	Not found		"Function: Acts as inhibitor of phospholipase A2.
PTM: Methyllanthionine rings between residues 1 and 18 as well as between residues 5 and 11; a lanthionine occurs between Cys14 and residue 4. In addition, addition of Lys19 to dehydralanine at position 6 forms a lysinoalanine bridge. The Asp residue at position 15 is hydroxylated."	Bacillus 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	phosphatidylethanolamine	2125590##8375380	J Antibiot (Tokyo). 1990 Nov;43(11):1403-1412.##Eur J Biochem. 1993 Sep 1;216(2):419-428.	Fredenhagen A, Fendrich G, Märki F, Märki W, Gruner J, Raschdorf F, Peter HH. Zimmermann N, Freund S, Fredenhagen A, Jung G.	Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A3. Structural revision of duramycin and cinnamycin.Solution structures of the lantibiotics duramycin B and C.	
DRAMP00060	CRQSCSFGPFTFVCDGNTK	19	Bacteriocin cinnamycin (Lanthiopeptin Ro 09-0198)	P29827	Belongs to the type B lantibiotic family (Class I bacteriocin)	cinA	Streptomyces cinnamoneus cinnamoneus DSM 40005 (Gram-positive bacteria)	Antimicrobial, Antbacterial, Antiviral	Protein level	Beta strand (2 strands; 2 residues)	The peptide has a hydrophobic pocket surrounded by residues Phe-7 through Ala(S)-14 to bind to the head group of the ligand. Fitting of the head group to the hydrophobic pocket was so good that other than a glycerophosphoethanolamine head group would be unable to fit the pocket.	2DDE resolved by NMR.	"Function: Can act as inhibitor of the enzyme phospholipase A2, and of the angiotensin-converting enzyme. Shows inhibitory activities against herpes simplex virus and immunopotentiating activities. Its antimicrobial activities are not very pronounced.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine or the formation of dialkylamine bonds with lysine. This is followed by membrane translocation and cleavage of the modified precursor."	Bacillus, herpes simplex virus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	phosphatidylethanolamine	2125590##2544544##8882709	J Antibiot (Tokyo). 1990 Nov;43(11):1403-1412.##J Antibiot (Tokyo). 1989 Jun;42(6):837-845.##J Biochem. 1996 Feb;119(2):226-230.	Fredenhagen A, Fendrich G, Märki F, Märki W, Gruner J, Raschdorf F, Peter HH.##Naruse N, Tenmyo O, Tomita K, Konishi M, Miyaki T, Kawaguchi H, Fukase K, Wakamiya T, Shiba T.##Hosoda K, Ohya M, Kohno T, Maeda T, Endo S, Wakamatsu K.	Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin.##Lanthiopeptin, a new peptide antibiotic. Production, isolation and properties of lanthiopeptin.##Structure determination of an immunopotentiator peptide, cinnamycin, complexed with lysophosphatidylethanolamine by 1H-NMR1.	
DRAMP00061	ASGWVCTLTIECGTVICAC	19	Actagardine (Gardimycin; Bacteriocin)	P56650	Belongs to the type B lantibiotic family (Class I bacteriocin)	Not found	Actinoplanes liguriae (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Non helix or strand structure	Actagardine shows a rigid compact globular shape based on the constraining bridging pattern, which is composed of an N-terminal lanthionine ring from residues 1-6 and three intertwined C-terminal methyllanthionine rings comprising residues 7-12, 9-17 and 14-19. In addition, this C-terminal ring system is stabilised by a short antiparallel beta sheet. A feature of the actagardine structure is the presence of two putative binding pockets.	1AJ1 resolved by NMR.	"Function: The molecule has a compact shape. Like mersacidin, this peptide inhibits cell wall biosynthesis by binding to lipid II.
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. The 14-19 beta-methyllanthionine thioether bond is oxidized to a sulfoxide. This is followed by membrane translocation and cleavage of the modified precursor."	Gram-positive bacteria: streptococci, Streptococcus pyogenes.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid II	2211371##9219543	J Antibiot (Tokyo). 1990 Sep;43(9):1082-1088.##Eur J Biochem. 1997 Jun 15;246(3):809-819.	Kettenring JK, Malabarba A, V©key K, Cavalleri B.##Zimmermann N, Jung G.	Sequence determination of actagardine, a novel lantibiotic, by homonuclear 2D NMR spectroscopy.##The three-dimensional solution structure of the lantibiotic murein-biosynthesis-inhibitor actagardine determined by NMR.	
DRAMP00062	CTFTLPGGGGVCTLTSECIC	20	Mersacidin (Bacteriocin; Preclinical)	P43683	Belongs to the type B lantibiotic family (Class I bacteriocin)	mrsA	Bacillus sp. HIL-Y85/54728 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Non helix or strand structure (Turn)	Not found	1QOW resolved by NMR. 	"Function: Kills a number of Gram-positive bacteria. Acts at the level of cell wall biosynthesis by interfering with bacterial peptidoglycan biosynthesis. Specifically inhibits the conversion of the lipid II intermediate into polymeric nascent glycan strands by transglycosylation. May interact with the peptidoglycan precursor rather than with the enzyme.
PTM: There are one dihydroalanine (Dha): S16; three Beta-methyllanthionines: C1-T2, T4-C12, T13-C18; and S-(2-aminovinyl)-3-methyl-D-cysteine: T15-C20."	Gram-positive bacteria: Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococcus, Clostridium difficile.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	The sugar phosphate head group of the peptidoglycan precursorLipid II	7737474##9119018##10831439##10818347	FEMS Microbiol Lett. 1995 Mar 15;127(1-2):121-126.##Eur J Biochem. 1997 Mar 1;244(2):501-512.##Appl Environ Microbiol. 2000 Jun;66(6):2565-2571.##Acta Crystallogr D Biol Crystallogr. 2000 Jun;56(Pt 6):705-713.	Bierbaum G, Brötz H, Koller KP, Sahl HG.##Prasch T, Naumann T, Markert RL, Sattler M, Schubert W, Schaal S, Bauch M, Kogler H, Griesinger C.##Altena K, Guder A, Cramer C, Bierbaum G.##Schneider TR, Kärcher J, Pohl E, Lubini P, Sheldrick GM.	Cloning, sequencing and production of the lantibiotic mersacidin.##Constitution and solution conformation of the antibiotic mersacidin determined by NMR and molecular dynamics.##Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster.##Ab initio structure determination of the lantibiotic mersacidin.	
DRAMP00064	MSKRDCNLMKACCAGQAVTYAIHSLLNRLGGDSSDPAGCNDIVRKYCK	48	Enterocin 96 (Bacteriocin)	Q82YI9	Belongs to the class II bacteriocin	Not found	Enterococcus faecalis (strain ATCC 700802 / V583) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Predicted	Not found	Not found		Search in protein databases revealed that enterocin 96 was identical to the C-terminal part of a putative uncharacterized protein from Enterococcus faecalis V583 (accession number EF_B0056) identified after complete genome sequencing of this strain. The amino acid sequence of this protein contains an N-terminal extension of 26 amino acids with two C-terminal 1 glycyl residues. The likely presence of such an extension for enterocin 96 was investigated by sequencing its structural gene.	Gram-positive bacteria: Enterococcus faecalis, E. faecium WHE, E. hirae, E. pseudoavium, E. sulfureus, E. saccharolyticus, E. columbae, Lactobacillus plantarum, L. acidophilus, Lactobacillus sakeii subsp. sakei, L. paracasei subsp. paracasei, Lactococcus lactis, Lactococcus lactis subsp. cremoris, Leuconostoc mesenteroides, Bacillus subtilis, Bacillus cereus, Listeria innocua, Listeria monocytogenes, Staphylococcus xylosus, Staphylococcus aureus;##Gram-negative bacteria: Salmonella enterica serovar Typhimurium, S. enterica serovar Infantis, Klebsiella pneumoniae, Serratia liquefaciens, Proteus vulgaris, Enterobacter cloacae, Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12663927	Science. 2003 Mar 28;299(5615):2071-2074.	Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, Fouts DE, Eisen JA, Gill SR, Heidelberg JF, Tettelin H, Dodson RJ, Umayam L, Brinkac L, Beanan M, Daugherty S, DeBoy RT, Durkin S, Kolonay J, Madupu R, Nelson W, Vamathevan J, Tran B, Upton J, Hansen T, Shetty J, Khouri H, Utterback T, Radune D, Ketchum KA, Dougherty BA, Fraser CM.	Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis.	
DRAMP00065	KKKKKKVACTWGNAATAAASGAVXGILGGPTGALAGAIWGVSQCASNNLHGMH	53	Plantaricin 1.25 beta (thermostable Bacteriocin)	Q9ZEU9	Belongs to the class II bacteriocin	plnB	Lactobacillus plantarum TMW1.25 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Lactobacillus plantarum TMW1.25 produces two bacteriocins plantaricin 1.25a and plantaricin 1.25b.	Plantarum, Plantarum sp, Plantarum coryniformis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10684981	Biochim Biophys Acta. 2000 Feb 29;1490(3):355-361.	Ehrmann MA, Remiger A, Eijsink VG, Vogel RF.	A gene cluster encoding plantaricin 1.25beta and other bacteriocin-like peptides in Lactobacillus plantarum TMW1.25.	
DRAMP00066	AGFLKVVQLLAKYGSKAVQWAWANKGKILDWLNAGQAIDWVVSKIKQILGIK	52	Lacticin Q (Bacteriocin)	A4UVR2	Belongs to the class II bacteriocin	lnqQ	Lactococcus lactis QU 5 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found	2N8P##7P5R	Lacticin Q was very stable against heat treatment and changes in pH; in particular, it was stable at alkaline pH values, while nisin A was inactivated. Moreover, lacticin Q induced ATP efflux from a Listeria sp. strain in a shorter time and at a lower concentration than nisin A, indicating that the former affected indicator cells in a different manner from that of the latter. 	Gram-positive bacteria: Bacillus cereus JCM 2152, Bacillus circulans JCM 2504, Bacillus coagulans JCM 2257, Bacillus subtilis JCM 1465, Enterococcus faecalis JCM 5803, Enterococcus faecium JCM 5804, Enterococcus mundtii QU 2, Enterococcus hirae ATCC 10541, Lactococcus lactis ATCC 19435, Lactococcus lactis NCDO 497, Lactobacillus acidophilus JCM 1132, Lactobacillus alimentarius JCM 1095, Lactobacillus brevis JCM 1059, Lactobacillus casei JCM 1134, Lactobacillus coryniformis JCM 1164, Lactobacillus sakeii JCM 1157, Leuconostoc mesenteroides JCM 6124, Listeria innocua ATCC 33090, Micrococcus luteus IFO 12708, Pediococcus pentosaceus JCM 5885.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17351096	Appl Environ Microbiol. 2007 May;73(9):2871-2877.	Fujita K, Ichimasa S, Zendo T, Koga S, Yoneyama F, Nakayama J, Sonomoto K.	Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria.	
DRAMP00067	KNYGNGVHCTKKGCSVDWGYAATNIANNSVMNGLTG	36	Leucocin C-TA33a (Bacteriocin)	No entry found	Belongs to the class II bacteriocin	Not found	Leuconostoc mesenteroides TA33a (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9611809	Microbiology. 1998 May;144 (Pt 5):1343-1348.	Papathanasopoulos MA, Dykes GA, Revol-Junelles AM, Delfour A, von Holy A, Hastings JW.	Sequence and structural relationships of leucocins A-, B- and C-TA33a from Leuconostoc mesenteroides TA33a.	
DRAMP00070	ACQCPDAISGWTHTDYQCHGLENKMYRHVYAICMNGTQVYCRTEWGSSC	49	Laterosporulin (Bacteriocin)	No entry found	Belongs to the class II bacteriocin	Not found	Brevibacillus sp. Strain GI-9 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found	4OZK	The bacteriocin was produced after 12 hours in the lag phase and the use of Diaion HP-20 hydrophobic resin increased yield. Partial sequence was determined and the entire sequence was deduced. This peptide is thermal stable, pH tolerant, and resistant to proteases. Reducing agent DTT had no effect on peptide activity or migration on gel.	Gram-positive bacteria: Bacillus subtilis, Staphylococcus aureus, Listeria monocytogenesa;##Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22403615	PLoS One. 2012;7(3):e31498. 	Singh PK, Chittpurna, Ashish, Sharma V, Patil PB, Korpole S.	Identification, Purification and Characterization of Laterosporulin, a Novel Bacteriocin Produced by Brevibacillus sp. Strain GI-9.	
DRAMP00071	KTVNYGNGLYCNQKKCWVNWSETATTIVNNSIMNGLTGGNAGWHSGGRA	49	Ubericin-A (Bacteriocin)	A9Q0M7	Belongs to the class IIa bacteriocin	ubaA	Streptococcus uberis (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Heat-stable antibiotic	Gram-positive bacteria: Listeria spp., Enterococcus hirae, Enterococcus faecalis ATCC 19433, Streptococcus bovis 83, Streptococcus uberis 42 and Lactococcus lactis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17933926	Appl Environ Microbiol. 2007 Dec;73(23):7763-7766.	Heng NC, Burtenshaw GA, Jack RW, Tagg JR.	Ubericin A, a class IIa bacteriocin produced by Streptococcus uberis.	
DRAMP00072	AYPGNGVHCGKYSCTVDKQTAIGNIGNNAA	30	Bacteriocin curvaticin	P84886	Belongs to the class IIa bacteriocin	Not found	Lactobacillus curvatus L442 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity.
PTM: Problely contains one disulfide bond 9-14.
Biophysicochemical properties: pH dependence (Stable below pH 6) and Temperature dependence (Stable below 60 degrees Celsius. Activity decreases sharply at temperatures above 60 degrees Celsius)."	Gram-positive bacteria: Listeria monocytogenes, Lactobacillus sakeii, Lactobacillus plantarum, Lactobacillus farciminis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16244793	Antonie Van Leeuwenhoek. 2006 Jan;89(1):19-26.	Xiraphi N, Georgalaki M, Driessche GV, Devreese B, Beeumen JV, Tsakalidou E, Metaxopoulos J, Drosinos EH.	Purification and characterization of curvaticin L442, a bacteriocin produced by Lactobacillus curvatus L442.	
DRAMP00073	KNYGNGVYCNKHKCSVDWATFSANIANNSVAMAGLTGGNAGNK	43	Weissellin-A (Bacteriocin)	B3A0N4	Belongs to the class IIa bacteriocin	Not found	Weissella paramesenteroides DX (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: The mode of action appears to be non-lytic. Inactivated by proteinase K, but insensitive to trypsin, alpha-chymotrypsin, pepsin and papain.
Biophysicochemical properties: pH dependence (Remains active between pH 2 and 10); Temperature dependence (Remains active after incubation at 121 degrees Celsius for 1 hour).
PTM: Contains one disulfide bond 9-14. "	Gram-positive bacteria: Myotis flavus strain ATCC 400, Micrococcus luteus strain CECT241, C. soprogenes strain NCTC533, Listeria monocytogenes strain ATCC 19111, L.inocua strain ATCC BAA-680D and Staphylococcus carnosus strain LMG13564 (+++); Bacillus cereus strain LMG13569, C. thiaminolyticum strain ATCC 15579, Enterococcus faecalis strain NCTC8176, Lactococcus lactis strain LM0230, Lactobacillus casei strain ATCC 344, Lactococcus lactis strain IL1403, L. jensenii strain ATCC 25258, Lactobacillus plantarum strain CECT220, L. brevis strain ATCC 8287, L. bulgaricus strain LMG13551, Pediococcus acidilactici strain ATCC 25740, P. pentosaceus strain ATCC 33316 and P. pentosaceus strain LMG13560 (+). Leuconostoc mesenteroides strain ATCC 19254, Lactococcus lactis strain ATCC 1454, L. sakei strain CECT906T, Lactococcus lactis subsp. cremoris strain MC1363 and L. curvatus strain ATCC 51436 (++).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21511463	Bioresour Technol. 2011 Jun;102(12):6730-6734.	Papagianni M, Papamichael EM.	Purification, amino acid sequence and characterization of the class IIa bacteriocin weissellin A, produced by Weissella paramesenteroides DX.	
DRAMP00075	ATRSYGNGVYCNNSKCWNVGEAKENIAGIVISGKASGL	38	Enterocin M (Bacteriocin)	P85876	Belongs to the class IIa bacteriocin	Not found	Enterococcus faecium AL 41 (Streptococcus faecium) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Bacteriocin that inhibits the growth of closely related Enterococcus species and a wide range of Gram-positive bacterial species. Inhibits the growth of several strains of the Gram-negative bacterium E.coli, but not the growth of Gram-negative Pseudomonas species.
Biophysicochemical properties: pH dependence (Stable at pH 5.0); Temperature dependence (Thermostable, retains activity after heating at 60, 80 and 100 degrees Celsius for 1 hour. Long-term storage at 4 degrees Celsius or -20 degrees Celsius does not affect activity). "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17551760	J Ind Microbiol Biotechnol. 2007 Aug;34(8):533-537.	Marekov¡ M, Laukov¡ A, Skaugen M, Nes I.	Isolation and characterization of a new bacteriocin, termed enterocin M, produced by environmental isolate Enterococcus faecium AL41.	
DRAMP00076	KYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWSK	43	Mundticin ATO6 (Bacteriocin)	P80925	Belongs to the class IIa bacteriocin	Not found	Enterococcus mundtii ATO6 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: This bacteriocin inhibits the growth of a wide range of Gram-positive bacteria at nanomolar concentrations, especially pathogenic L. monocytogenes and C. botulinum but has no effect on the growth of a number of yeasts and Gram-negative bacteria.
Biophysicochemical properties: pH dependence (Stable from pH 1 to 10); Temperature dependence (Thermostable; Retains 100% of its maximal activity after heating at 100 degrees Celsius for 15 min, but only 50% of activity after heating 1 hour at this same temperature)."	Gram-positive bacteria: Listeria monocytogenes, Lactobacillus salivarius, L. sake, Leuconostoc paramesenteroides, Leuconostoc mesenteroides, Carnobacterium piscicola, Pediococcus dextrinicus, P. pentosaseus, Enterococcus faecalis, E. hirae, Listeria inocua, Clostridium botulinum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9733915	Biochim Biiophys Acta 1998; 1373: 47-58.	Bennik MHJ et al Smid EJ.	A novel bacteriocin with a YGNGV motif from vegetable-associated Enterococcus mundtii: full characterization and interaction with target organisms.	
DRAMP00077	KYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWKS	43	Mundticin KS (Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	Enterococcus mundtii NFRI 7393 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		"Function: Mundticin KS is active against closely related lactic acid bacteria and the food-borne pathogen Listeria monocytogenes.
Sequence similarity: Mundticin KS comprises a 43-amino-acid peptide with an amino acid sequence similar to that of mundticin ATO6 produced by E. mundtii ATO6. Mundticin KS and mundticin ATO6 are distinguished by the inversion of the last two amino acids at their respective C termini."	Gram-positive bacteria: Enterococcus faecium IFO13712 (+++), Enterococcus faecalis IFO12964 (+++), Enterococcus mundtii JCM 8731 (+++), Lactobacillus plantarum ATCC 8041 (+), Lactobacillus lactis NFRI 7307 (+), Lactobacillus curvatus JCM 1096 (+), Listeria monocytogenes ATCC 15313 and ATCC 49594 (++).##Note: Symbols: +, sensitive to mundticin KS (+, ++, and +++ reflect the degree of sensitivity).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12147478	Appl Environ Microbiol. 2002 Aug;68(8):3830-3840.	Kawamoto S, Shima J, Sato R, Eguchi T, Ohmomo S, Shibato J, Horikoshi N, Takeshita K, Sameshima T.	Biochemical and genetic characterization of munddticin KS, an antilisterial peptide produced by Enterococcus mundtii NFRI 7397.	
DRAMP00078	KNYGNGVHCTKKGCSVDWGYAWTNIANNSVMNGLTGGNAGWHN	43	Leucocin C (Leu C; Pediocin-like peptide; Bacteriocin)	P81053	Belongs to the class IIa bacteriocin	Not found	Leuconostoc mesenteroides (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Inhibits a wide spectrum of lactic acid bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12127968##9611809	Biochem Biophys Res Commun. 2002 Jul 26;295(4):826-827.##Microbiology. 1998 May;144 (Pt 5):1343-1348.	Fimland G, Sletten K, Nissen-Meyer J.##Papathanasopoulos MA, Dykes GA, Revol-Junelles AM, Delfour A, von Holy A, Hastings JW.	The complete amino acid sequence of the pediocin-like antimicrobial peptide leucocin C.##Sequence and structural relationships of leucocins A-, B- and C-TA33a from Leuconostoc mesenteroides TA33a.	
DRAMP00079	ATYYGNGLYCNKEKCWVDWNQAKGEIGKIIVNGWVNHGPWAPRR	44	Bacteriocin hiracin-JM79 (HirJM79; Bacteriocin)	Q0Z8B6	Belongs to the class IIa bacteriocin	hirJM79	Enterococcus hirae DCH5 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Has antibacterial activity. Lacks antibacterial activity against Gram-negative bacteria.	Gram-positive bacteria: Lactobacillus helveticus, Lactobacillus curvatus, Lactobacillus bulgaricus, Lactobacillus sakeii, Pediococcus pentosaceus, Enterococcus faecium, Enterococcus faecalis, Propionibacterium sp, Propionibacterium acidipropionici, Clostridium tyrobutiricum, Listeria monocytogenes, Listeria ivanovii, Listeria seeligeri, Listeria welshimeri, Listeria grayi, Staphylococcus aureus, Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17326750	FEMS Microbiol Lett. 2007 May;270(2):227-236.	S¡nchez J, Diep DB, Herranz C, Nes IF, Cintas LM, Hern¡ndez PE.	Amino acid and nucleotide sequence, adjacent genes, and heterologous expression of hiracin JM79, a sec-dependent bacteriocin produced by Enterococcus hirae DCH5, isolated from Mallard ducks (Anas platyrhynchos).	
DRAMP00080	ARSYGNGVYCNNKKCWVNRGEATQSIIGGMISGWASGLAGM	41	Curvacin A (Bacteriocin)	P0A311, P35619, P80097	Belongs to the class IIa bacteriocin	curA	Lactobacillus curvatus LTH1174 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix (2 helices; 17 residues)	In DPC micelles, the cationic and hydrophilic N-terminal half of the peptide forms an S-shaped beta-sheet-like domain stabilized by a disulfide bridge and a few hydrogen bonds. This domain is followed by a helix-hinge-helix motif: a hydrophilic 6-mer helix (residues 19-24) and an amphiphilic/hydrophobic 11-mer helix (residues 29-39).	2A2B resolved by NMR.	PTM: Contains one disulfide bond 10-15. 	Gram-positive bacteria: Closely related Lactobacilli, Listeria monocytogenes and ivanovvi, Enterococcus faecalis, Carnobacterium sp and Brocothrix thermosphacta.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7694558##16331975	Arch Microbiol. 1993;160(4):279-283.##Biochemistry. 2005 Dec 13;44(49):16149-16157.	Tichaczek PS, Vogel RF, Hammes WP.##Haugen HS, Fimland G, Nissen-Meyer J, Kristiansen PE.	Cloning and sequencing of curA encoding curvacin A, the bacteriocin produced by Lactobacillus curvatus LTH1174.##Three-dimensional structure in lipid micelles of the pediocin-like antimicrobial peptide curvacin A.	
DRAMP00081	KYYGNGVHCTKSGCSVNWGEAFSAGVHRLANGGNGFW	37	Leucocin-A (Leucocin A-UAL 187; Leu A; Bacteriocin)	P34034	Belongs to the class IIa bacteriocin	lcnA	Leuconostoc gelidum (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Combine helix and strand structure	In both TFE and DPC micelle, The region encompassing residues 17-31 assumes an essentially identical amphiphilic alpha-helix conformation. A three-strand antiparallel beta-sheet domain (residues 2-16), anchored by the disulfide bridge. In TFE, these two regions have a more defined relationship relative to each other, while, in DPC micelles, the C-terminus is folded back onto the alpha-helix. 	1CW6 resolved by NMR.	"Function: Inhibits a wide spectrum of lactic acid bacteria.
PTM: Contains one disulfide bond 9-14."	Gram-positive bacteria: Lactic acid bacteria, Listeria monocytogenes.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1840587##8418850##9398233	J Bacteriol. 1991 Dec;173(23):7491-7500.##Biochemistry. 1993 Jan 12;32(1):310-318.##Biochemistry. 1997 Dec 9;36(49):15062-15072.	Hastings JW, Sailer M, Johnson K, Roy KL, Vederas JC, Stiles ME.##Sailer M, Helms GL, Henkel T, Niemczura WP, Stiles ME, Vederas JC.####Fregeau Gallagher NL, Sailer M, Niemczura WP, Nakashima TT, Stiles ME, Vederas JC.	Characterization of leucocin A-UAL 187 and cloning of the bacteriocin gene from Leuconostoc gelidum.##15N- and 13C-labeled media from Anabaena sp. for universal isotopic labeling of bacteriocins: NMR resonance assignments of leucocin A from Leuconostoc gelidum and nisin A from Lactococcus lactis.##Three-dimensional structure of leucocin A in trifluoroethanol and dodecylphosphocholine micelles: spatial location of residues critical for biological activity in type IIa bacteriocins from lactic acid	
DRAMP00082	TKYYGNGVYCNSKKCWVDWGQAAGGIGQTVVXGWLGGAIPGK	42	Bavaricin-MN (Bacteriocin)	P80493	Belongs to the class IIa bacteriocin	Not found	Lactobacillus sakeii (Gram-positive bacteria)	Antimicrobial, Anti-Gram+	Protein level	Not found	Not found		PTM: contains one disulfide bond 10-15.	Gram-positive bacterium: Listeria monocytogenes Scott A.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8953724	Appl Environ Microbiol. 1996 Dec;62(12):4529-4535.	Kaiser AL, Montville TJ.	Purification of the bacteriocin bavaricin MN and characterization of its mode of action against Listeria monocytogenes Scott A cells and lipid vesicles.	
DRAMP00083	KYYGNGVHXGKHSXTVDWGTAIGNIGNNAAANXATGXNAGG	41	Bavaricin-A (Bacteriocin)	P80953	Belongs to the class IIa bacteriocin	Not found	Lactobacillus sakeii (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Lactobacillus, Listeria monocytogenes, Pediococcus, Enterococcus, Leuconostoc, Lactococcus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8407671	J Appl Bacteriol. 1993 Aug;75(2):113-122.	Larsen AG, Vogensen FK, Josephsen J.	Antimicrobial activity of lactic acid bacteria isolated from sour doughs: purification and characterization of bavaricin A, a bacteriocin produced by Lactobacillus bavaricus MI401.	
DRAMP00084	KYYGNGVTCGKHSXSVDWXKXT	22	Mutacin F-59.1 (Bacteriocin)	P86386	Belongs to the class IIa bacteriocin	Not found	Streptococcus mutans (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Bactericidal activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2009) to UniProtKB	Nicolas GG, Lavoie MC, Lapointe G, Mota-Meira M.	Characterization of mutacin F-59.1, a pediocin-like bacteriocin produced by Streptococcus mutans 59.1.	
DRAMP00085	TSYGNGVHCNKSKCWIDVSELETYKAGTVSNPKDILWSLKE	41	Bacteriocin	P86291	Belongs to the class IIa bacteriocin	Not found	Lactococcus sp	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has bacteriocin active.	Gram-positive bacteria: Streptococcus aureus, Bacillus thuringiensis;##Gram-negative bacteria: Salmonella typhi, Klebsiella sp., Escherichia coli KL16 and Escherichia coli Gj137.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2009) to UniProtKB	Ingale A.G.	Molecular characterisation of bacteriocin from microflora associated with radish and ginger.	
DRAMP00086	TKYYGNGVYCNSKKCWVDWGTAQGCIDVVIGQLGGGIPGKGKC	43	Divergicin M35 (Pediocin-like peptide; Bacteriocin)	P84962	Belongs to the class IIa bacteriocin	Not found	Carnobacterium divergens M35 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Bacteriocin with antibacterial activity against Gram-positive bacteria.
Biophysicochemical properties: Displays a high degree of stability when incubated at temperatures of up to 121 degrees Celsius for 60 minutes. 
Biotechnological use: Has potential for use as a biopreservative for inhibiting Listeria monocytogenes in seafood products that do not usually undergo an adequate heat treatment."	Gram-positive bacteria: Many strains of Listeria monocytogenes, L. seeligeri, L. welshimeri, L. grayi, L. murayi, L. ivanovii, L. innocus, Ceanothus divergens and Carnobacterium piscicola.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15541799	Int J Food Microbiol. 2004 Dec 15;97(2):123-136.	Tahiri I, Desbiens M, Benech R, Kheadr E, Lacroix C, Thibault S, Ouellet D, Fliss I.	Purification, characterization and amino acid sequencing of divergicin M35: a novel class IIa bacteriocin produced by Carnobacterium divergens M35.	
DRAMP18344	CLGIGSCNNFAGCGYAVVCFW	21	Tricyclic peptide RP 71955 (Bacteriocin)	P37046	Belongs to the class I bacteriocin	Not found	Streptomyces sp. (strain SP9440)	Antiviral, Anti-HIV, Antimicrobial		Beta strand	An internal amide bond between the NH2 of C1 and the gamma-COOH of D9 was observed, as well as two disulfide bridges, one between C1 and C13 and one between C7 and C19. In contrast. Class 2 lassos do not have disulfide bonds.	1RPB, 1RPC resolved by NMR	Caution:The isopeptide linked residue 9 is shown as Asn rather than Asp as mentioned in PubMed:8286361, because it is not known whether Asp or Asn is encoded and the isopeptide bonds are almost always formed between the amides Asn or Gln and N6-lysine or alpha amino groups, with the liberation of an ammonia that makes the reaction essentially irreversible.(From Swiss-prot)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8270499	J Antibiot (Tokyo). 1993 Nov;46(11):1756-7.	Helynck G, Dubertret C, Mayaux JF, Leboul J.	Isolation of RP 71955, a new anti-HIV-1 peptide secondary metabolite.	
DRAMP00088	KYYGNGVSCNKKGCSVDWGKAIGIIGNNAAANLTTGGKAAWAC	43	Enterocin-HF (Bacteriocin)	P86183	Belongs to the class IIa bacteriocin	Not found	Enterococcus faecium (Streptococcus faecium) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Bacteriocin.
PTM: Contains one disulfide bond 9-14."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JAN-2009) to UniProtKB.	Almeida T, Brandao A, Campanero C, Igrejas G, Torres C, Herandez P.E, Poeta P, Cintas L.M, Herranz C.	Amino acid sequence of Enterocin-HF, a new pediocin-like bacteriocin produced by E. faecium HS and E. faecium TA29 isolated from humans and fish (thin-lipped grey mullet; Liza ramada) in Portugal.	
DRAMP00091	AISYGNGVYCNKEKCWVNKAENKQAITGIVIGGWASSLAGMGH	43	Carnobacteriocin BM1 (Carnobacteriocin B1; Bacteriocin)	P38579	Belongs to the class IIa bacteriocin	cbnBM1	Carnobacterium piscicola LV17B (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Bridge 	Not found		"Function: Has antibacterial activity.
PTM: Probablely contains one disulfide bond 10-15."	Listeria and Enterococcus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163526	J Biol Chem 1994; 269: 12204-12211.	Quadri LE et al Stiles ME	Chemical and genetic characterization of bacteriocins produced by Carnobacterium piscicola LV17B	
DRAMP00092	ATYYGNGLYCNKQKHYTWVDWNKASREIGKIIVNGWVQH	39	Bacteriocin SRCAM 602 (Preclinical)	P86393	Belongs to the class IIa bacteriocin	Not found	Paenibacillus polymyxa (Bacillus polymyxa) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Bacteriocin with antibacterial activity.
Miscellaneous: Antimicrobial activity is lost upon treatment with beta-chymotrypsin, proteinase K and papain, but not when treated with lysozyme or lipase.
Biophysicochemical properties: pH dependence (Stable from pH 3.0-9.0, inactivated at pH 10.0); Temperature dependence (Thermostable, activity is retained after incubation at 100 degrees Celsius for 15 minutes)."	Gram-positive bacteria: Clostridium jejuni.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15690798	J Food Prot. 2005 Jan;68(1):11-17.	Svetoch EA, Stern NJ, Eruslanov BV, Kovalev YN, Volodina LI, Perelygin VV, Mitsevich EV, Mitsevich IP, Pokhilenko VD, Borzenkov VN, Levchuk VP, Svetoch OE, Kudriavtseva TY.	Isolation of Bacillus circulans and Paenibacillus polymyxa strains inhibitory to Campylobacter jejuni and characterization of associated bacteriocins.	
DRAMP00093	FVYGNGVTSILVQAQFLVNGQRRFFYTPDK	30	Bacteriocin SRCAM 37	P86395	Belongs to the class IIa bacteriocin	Not found	Paenibacillus polymyxa (Bacillus polymyxa) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Bacteriocin with antibacterial activity.
Biophysicochemical properties: pH dependence (Stable from pH 3.0-9.0, inactivated at pH 10.0); Temperature dependence (Thermostable, activity is retained after incubation at 100 degrees Celsius for 15 minutes).
Miscellaneous: Antimicrobial activity is lost upon treatment with beta-chymotrypsin, proteinase K and papain, but not when treated with lysozyme or lipase. "	Gram-positive bacteria: Clostridium jejuni.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15690798##16977842	J Food Prot. 2005 Jan;68(1):11-17.##Poult Sci. 2006 Sep;85(9):1570-1575.	Svetoch EA, Stern NJ, Eruslanov BV, Kovalev YN, Volodina LI, Perelygin VV, Mitsevich EV, Mitsevich IP, Pokhilenko VD, Borzenkov VN, Levchuk VP, Svetoch OE, Kudriavtseva TY.##Cole K, Farnell MB, Donoghue AM, Stern NJ, Svetoch EA, Eruslanov BN, Volodina LI, Kovalev YN, Perelygin VV, Mitsevich EV, Mitsevich IP, Levchuk VP, Pokhilenko VD, Borzenkov VN, Svetoch OE, Kudryavtseva TY, Reyes-Herrera I, Blore PJ, Solis de los Santos F, Donoghue DJ.	Isolation of Bacillus circulans and Paenibacillus polymyxa strains inhibitory to Campylobacter jejuni and characterization of associated bacteriocins.##Bacteriocins reduce Campylobacter colonization and alter gut morphology in turkey poults.	
DRAMP00094	VNYGNGVSCSKTKCSVNWGIITHQAFRVTSGVASG	35	Bacteriocin SRCAM 1580	P86394	Belongs to the class IIa bacteriocin	Not found	Bacillus circulans (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Bacteriocin with antibacterial activity.
Biophysicochemical properties: pH dependence (Stable from pH 3.0-9.0, inactivated at pH 10.0); Temperature dependence (Thermostable, activity is retained after incubation at 100 degrees Celsius for 15 minutes).
Miscellaneous: Antimicrobial activity is lost upon treatment with beta-chymotrypsin, proteinase K and papain, but not when treated with lysozyme or lipase. "	Gram-positive bacteria: Clostridium jejuni.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15690798##16977842	J Food Prot. 2005 Jan;68(1):11-17.##Poult Sci. 2006 Sep;85(9):1570-1575.	Svetoch EA, Stern NJ, Eruslanov BV, Kovalev YN, Volodina LI, Perelygin VV, Mitsevich EV, Mitsevich IP, Pokhilenko VD, Borzenkov VN, Levchuk VP, Svetoch OE, Kudriavtseva TY.##Cole K, Farnell MB, Donoghue AM, Stern NJ, Svetoch EA, Eruslanov BN, Volodina LI, Kovalev YN, Perelygin VV, Mitsevich EV, Mitsevich IP, Levchuk VP, Pokhilenko VD, Borzenkov VN, Svetoch OE, Kudryavtseva TY, Reyes-Herrera I, Blore PJ, Solis de los Santos F, Donoghue DJ.	Isolation of Bacillus circulans and Paenibacillus polymyxa strains inhibitory to Campylobacter jejuni and characterization of associated bacteriocins.##Bacteriocins reduce Campylobacter colonization and alter gut morphology in turkey poults.	
DRAMP00095	KYYGNGVHCTKSGCSVNWGEAASAGIHRLANGGNGFW	37	Mesentericin Y105 (MesY105; Bacteriocin)	P38577	Belongs to the class IIa bacteriocin	mesY	Leuconostoc mesenteroides (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has bacteriocin activity.
PTM: Probablely contains one disulfide bond 9-14."	Lactobacillus, Leuconostoc, Pediococcus, Listeria monocytogenes, Listeria innocua, Listeria ivanovii.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1487737##7551032	J Gen Microbiol. 1992 Dec;138(12):2725-2731.##Microbiology. 1995 Jul;141 (Pt 7):1637-1645.	H©chard Y, D©rijard B, Letellier F, Cenatiempo Y.##Fremaux C, H©chard Y, Cenatiempo Y.	Characterization and purification of mesentericin Y105, an anti-Listeria bacteriocin from Leuconostoc mesenteroides.##Mesentericin Y105 gene clusters in Leuconostoc mesenteroides Y105.	
DRAMP00096	KYYGNGVTCGKHSCSVDWGKATTCIINNGAMAWATGGHQGNHKC	44	Pediocin PA-1 (Pediocin ACH; Bacteriocin)	P29430, P34912	Belongs to the class IIa bacteriocin	pedA	Pediococcus acidilactici PAC-1.0 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Bridge 	Not found		"Function: Has bacteriocin activity.
PTM: Probablely contains one disulfide bond 9-14."	Gram-positive bacteria: Listeria monocytogenes ATCC 19115, L. seeligeri ATCC 35967, Pediococcus pentosaceus JCM2026, P. pentosaceus JCM5890, Pediococcus acidilactici IAM1233, Lactobacillus plantarum JCM1149, Lactobacillus sakei IAM1900.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1514784##1575516	Appl Environ Microbiol. 1992 Aug;58(8):2360-2367.##Arch Biochem Biophys. 1992 May 15;295(1):5-12.	Marugg JD, Gonzalez CF, Kunka BS, Ledeboer AM, Pucci MJ, Toonen MY, Walker SA, Zoetmulder LC, Vandenbergh PA.##Henderson JT, Chopko AL, van Wassenaar PD.	Cloning, expression, and nucleotide sequence of genes involved in production of pediocin PA-1, and bacteriocin from Pediococcus acidilactici PAC1.0.##Purification and primary structure of pediocin PA-1 produced by Pediococcus acidilactici PAC-1.0.	
DRAMP00097	TSYGNGVHCNKSKCWIDVSELETYKAGTVSNPKDILW	37	Lactococcin MMFII (Pediocin-like peptide; Bacteriocin)	P83002	Belongs to the class IIa bacteriocin	Not found	Lactococcus lactis subsp. lactis (Streptococcus lactis) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		Function: Bacteriocin active against Listeria monocytogenes and Lactococcus cremoris.	Lactococcus cremoris, Listeria ivanovii.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11728715##11708769	FEMS Microbiol Lett. 2001 Nov 27;205(1):49-55.##Biochem Biophys Res Commun. 2001 Nov 23;289(1):13-18.	Ferchichi M, Fr¨re J, Mabrouk K, Manai M.##Ferchichi M, Fathallah M, Mansuelle P, Rochat H, Sabatier JM, Manai M, Mabrouk K.	Lactococcin MMFII, a novel class IIa bacteriocin produced by Lactococcus lactis MMFII, isolated from a Tunisian dairy product.##Chemical synthesis, molecular modeling, and antimicrobial activity of a novel bacteriocin, MMFII.	
DRAMP18343	GLPWGCPSDIPGWNTPWAC	19	BI-32169(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Streptomyces sp. (DSM 14996)	Antidiabetic		Not found	BI-32169 consists exclusively of protein amino acids and is cyclized from the side chain of Asp9 to the N-terminus of Gly1. One disulfide bond between Cys6 and Cys19 forms a bicyclic structure.		BI-32169 and its methyl ester derivative (2) showed potent inhibitory activity against the human glucagon receptor (IC50 440 and 320 nM, respectively) in a functional cell-based assay.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15387654	J Nat Prod. 2004 Sep;67(9):1528-31.	Potterat O, Wagner K, Gemmecker G, Mack J, Puder C, Vettermann R, Streicher R.	BI-32169, a bicyclic 19-peptide with strong glucagon receptor antagonist activity from Streptomyces sp.	
DRAMP00099	KYYGNGLSCNKSGCSVDWSKAISIIGNNAVANLTTGGAAGWKS	43	Sakacin 5X (Sak5X; Pediocin-like peptide; Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	lactic acid bacteria (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Bridge 	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Lactobacillus lactis 105, L. collinoides 110, L. brevis 111, L. brevis 112, Pediococcus damnosus 113, P. damnosus 114, Enterococcus faecalis 109.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11442722	J Appl Microbiol. 2001 Jul;91(1):131-138.	Vaughan A, Eijsink VG, O'Sullivan TF, O'Hanlon K, van Sinderen D.	An analysis of bacteriocins produced by lactic acid bacteria isolated from malted barley	
DRAMP00100	KYYGNGVSCNSHGCSVNWGQAWTCGVNHLANGGHGVC	37	Sakacin G (SakG; Pediocin-like peptide; Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	skgA2	Lactobacillus sakei 2512 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		MOA: The mode of activity against Listeria innocua 2030C and L. ivanovii subsp. ivanovii ATCC 19119 was bactericidal, resulting in cell lysis and enzyme- and DNA-leakage. 	Gram-positive bacteria: Streptococcus caprinus, S. macedonicus, Listeria innocua, L. sakei, L. ivanovii subsp. ivanovii and Listeria monocytogenes, Lactococcus lactis subsp. Lactis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12450870##20152920	Appl Environ Microbiol 2002; 68: 6416-6420.##Anaerobe. 2011 Feb;17(1):23-31.	Simon L, Fremaux C, Cenatiempo Y, Berjeaud JM.##Todorov SD, Rachman C, Fourrier A, Dicks LM, van Reenen CA, Pr©vost H, Dousset X.	Sakacin G, a new type of antilisterial bacteriocin.##Characterization of a bacteriocin produced by Lactobacillus sakeii R1333 isolated from smoked salmon.	
DRAMP00101	KYYGNGVHCGKHSCTVDWGTAIGNIGNNAAANWATGGNAGWNK	43	Sakacin P (Sakacin 674; Pediocin-like peptide; Bacteriocin)	P35618, Q57121	Belongs to the class IIa bacteriocin	sakP	Lactobacillus sakei Lb674 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Combine helix and strand structure	Structures in TFE and DPC were determined (Uteng M et al 2003 Biochemistry 42: 11417-26). The N-terminal region formed a 3-stranded beta sheet-like structure, while a well defined helical region was found between residues 18-33. The beta-like structure and the helical region are not packed together.	1OG7, 1OHM, 1OHN resolved by NMR.	"Function: Has bactericidal activity.
PTM: Contains one disulfide bond 9-14."	Gram-positive bacteria: Listeria monocytogenes and ivanovvi, Enterococcus faecalis, Carnobacterium sp and Brocothrix thermosphacta.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8138128##14516192	FEMS Microbiol Lett. 1994 Jan 15;115(2-3):143-149.##Biochemistry. 2003 Oct 7;42(39):11417-11426.	Holck AL, Axelsson L, H¼hne K, Kröckel L.##Uteng M, Hauge HH, Markwick PR, Fimland G, Mantzilas D, Nissen-Meyer J, Muhle-Goll C.	Purification and cloning of sakacin 674, a bacteriocin from Lactobacillus sakei Lb674.##Three-dimensional structure in lipid micelles of the pediocin-like antimicrobial peptide sakacin P and a sakacin P variant that is structurally stabilized by an inserted C-terminal disulfide bridge.	
DRAMP00102	KYYGNGVSCNKNGCTVDWSKAIGIIGNNAAANLTTGGAAGWNKG	44	Piscicolin-126 (Pisc126; Bacteriocin)	P80569, Q934J2	Belongs to the class IIa bacteriocin	pisA	Carnobacterium piscicola JG126 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Inhibits the growth of several Gram-positive bacteria, especially the food-borne pathogen Listeria monocytogenes, but has no effect on the growth of a number of yeasts and Gram-negative bacteria.
PTM: Contains one disulfide bond 9-14 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8702282	Appl Environ Microbiol. 1996 Aug;62(8):2897-2903.	Jack RW, Wan J, Gordon J, Harmark K, Davidson BE, Hillier AJ, Wettenhall RE, Hickey MW, Coventry MJ.	Characterization of the chemical and antimicrobial properties of piscicolin 126, a bacteriocin produced by Carnobacterium piscicola JG126.	
DRAMP00103	KTYYGTNGVHCTKNSLWGKVRLKNMKYDQNTTYMGRLQDILLGWATGAFGKTFH	54	Bacteriocin OR-7 (Preclinical)	No entry found	Belongs to the class IIa bacteriocin	Not found	Lactobacillus salivarius NRRL B-30514 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		"Function: OR-7 had activity to a gram-negative bacterium.
Biophysicochemical properties: Temperature dependence (Remains active after exposure to 90 degrees C for 15 min), pH dependence (Stable from pH 3.0 to 9.1)."	Campylobacter jejuni NCTC 11168.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16940109	Antimicrob. Agents Chemother. 2006 50 (9):3111-3116.	Stern NJ, Svetoch EA, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, Pokhilenko VD, Levchuk VP, Svetoch OE, Seal BS.	Isolation of a Lactobacillus salivarius Strain and Purification of Its Bacteriocin, Which Is Inhibitory to Campylobacter jejuni in the Chicken Gastrointestinal System	
DRAMP00108	KNYGNGVHCTKKGCSVDWGYAWANIANNSVMNGLTGGNAGWHN	43	Leucocin C (Pediocin-like peptide; Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	Lactococcus lactis MMFI (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Bridge 	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12127968	Biochem Biophys Res Commun 2002; 295: 826-827.	Fimland G, Sletten K, Nissen-Meyer J.	The complete amino acid sequence of the pediocin-like antimicrobial peptide leucocin C.	
DRAMP00109	KYYGNGLSCSKKGCTVNWGQAFSCGVNRVATAGHGK	36	Plantaricin C19 (Pediocin-like peptide; Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	Lactobacillus plantarum C19 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		MOA: Plantaricin C19 exerts a bacteriostatic action on sensitive cells of Listeria grayi IP 6818 in BHI broth.	Gram-positive bacterium: Listeria grayi.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11545225	Int J Food Microbiol. 2001 Aug 15;68(1-2):93-104.	Atrih A, Rekhif N, Moir AJ, Lebrihi A, Lefebvre G.	Mode of action, purification and amino acid sequence of plantaricin C19, an anti-Listeria bacteriocin produced by Lactobacillus plantarum C19.	
DRAMP00110	KYYGNGVTCGKHSCSVNWGQAFSCSVSHLANFGHGKC	37	Plantaricin 423 (Pediocin-like peptide; Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	plaA	Lactobacillus plantarum 423 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Bridge 	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Listeria spp., Staphylococcus spp., Pediococcus spp., Lactobacillus spp.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12423916##17056693	Int J Food Microbiol. 2003 Feb 25;81(1):29-40.##Appl Environ Microbiol. 2006 Dec;72(12):7644-7651.	Van Reenen CA, Chikindas ML, Van Zyl WH, Dicks LM.##Van Reenen CA, Van Zyl WH, Dicks LM.	Characterization and heterologous expression of a class IIa bacteriocin, plantaricin 423 from Lactobacillus plantarum 423, in Saccharomyces cerevisiae.##Expression of the immunity protein of plantaricin 423, produced by Lactobacillus plantarum 423, and analysis of the plasmid encoding the bacteriocin.isiae.	
DRAMP00111	KYYGNGVHCGKKTCYVDWGQATASIGKIIVNGWTQHGPWAHR	42	Penocin A (PenA; Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	Pediococcus pentosaceus (strain ATCC 25745/183-1w) (Gram-positive bacteria) 	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Piscicola, Clostridia butyricum, Enterococcus faecium, Enterococcus faecalis, Lactobacillus curvatus, Lactobacillus casei, Lactobacillus sakeii, L. raffinolactis, Leuconostoc mesenteroides, Listeria innocua, Listeria monocytogenes, Pediococcus acidilactici, P. pentosaceus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17030793##16735728	Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15611-15616.##Microbiology. 2006 Jun;152(Pt 6):1649-1659.	Makarova K. et al Mills D.##Diep DB, Godager L, Brede D, Nes IF.	Comparative genomics of the lactic acid bacteria.##Data mining and characterization of a novel pediocin-like bacteriocin system from the genome of Pediococcus pentosaceus ATCC 25745.	
DRAMP18342	GLPWGCPSDIPGWNTPWAC	19	BI-32169(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Streptomyces sp. (DSM 14996)	Unknown		Not found	Its structure has been established by amino acid analysis, mass spectrometry, and 2D NMR analysis. BI-32169 consists exclusively of protein amino acids and is cyclized from the side chain of Asp9 to the N-terminus of Gly1. One disulfide bond between Cys6 and Cys19 forms a bicyclic structure.		BI-32169 showed potent inhibitory activity against the human glucagon receptor (IC50 440 nM) in a functional cell-based assay. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2004391##15387654 	Cas Lek Cesk. 1991 Jan 18;130(3):76-8.##J Nat Prod. 2004 Sep;67(9):1528-31.	Marel M, Mel	"[Pleural exudates in patients with lung cancer. Comparative study].
##BI-32169, a bicyclic 19-peptide with strong glucagon receptor antagonist activity from Streptomyces sp."	
DRAMP00113	TTHSGKYYGNGVYCTKNKCTVDWAKATTCIAGMSIGGFLGGAIPGKC	47	Enterocin A (EntA; Pediocin-like peptide; Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	Enterococcus faecium (Streptococcus faecium) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Bridge 	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8633865	Appl Environ Microbiol 1996; 62: 1676-1682.	erich T et al Nes IF.	Biochemical and genetic characterization of enterocin A from Enterococcus faecium, a new antilisterial bacteriocin in the pediocin family of bacteriocins.	
DRAMP00114	KSYGNGVHCNKKKCWVDWGSAISTIGNNSAANWATGGAAGWKS	43	Listeriocin 743A (Pediocin-like peptide; Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	Listeria innocua 743 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Bridge 	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11526003	Appl Environ Microbiol 2001; 67: 4041-4047.	Kalmokoff ML, Banerjee SK, Cyr T, Hefford MA, Gleeson T.	Identification of a new plasmid-encoded sec-dependent bacteriocin produced by Listeria innocua 743.	
DRAMP00116	FTPSVSFSQNGGVVEAAAQRGYIYKKYPKGAKVPNKVKMLVNIRGKQTMRTCYLMSWTASSRTAKYYYYI	70	Bacteriocin 32 (Bac 32; Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	Enterococcus faecium (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Enterococcus faecium, E. hirae, E. durans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16569830	Antimicrob Agents Chemother. 2006 Apr;50(4):1202-1212.	Inoue T, Tomita H, Ike Y.	Bac 32, a novel bacteriocin widely disseminated among clinical isolates of Enterococcus faecium.	
DRAMP18341	WNDTGKDADGSEY	13	Daptomycin(Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Streptomyces roseosporus NRRL11379	Unknown		Not found	the sequence is a close mimic of the natural counterpart. The natural form is cyclic due to the ester bond between the hydroxyl of T4 and the carboxyl of kynurenine-13 (represented by Y here). The N-terminus is lipidated with n-decanoyl fatty acid chain. Other nonstandard amino acids include ornithine-6 (represented with K), (2S,3R)-3-methyl-glutamic acid-12 (represented with E), and three D-amino acids at positions N2, A8, and S11. 		In 2003,  FDA approved daptomycin as a new peptide antibiotic. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3024560	Antimicrob Agents Chemother. 1986 Oct;30(4):532-5.	Eliopoulos GM, Willey S, Reiszner E, Spitzer PG, Caputo G, Moellering RC Jr.	In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.	
DRAMP18340	WNDTGKDADGSEY	13	Daptomycin(Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Streptomyces roseosporus NRRL11379	Antimicrobial, Antibacterial, Anti-Gram+		Not found	the sequence is a close mimic of the natural counterpart. The natural form is cyclic due to the ester bond between the hydroxyl of T4 and the carboxyl of kynurenine-13 (represented by Y here). The N-terminus is lipidated with n-decanoyl fatty acid chain. Other nonstandard amino acids include ornithine-6 (represented with K), (2S,3R)-3-methyl-glutamic acid-12 (represented with E), and three D-amino acids at positions N2, A8, and S11. 		In 2003,  FDA approved daptomycin as a new peptide antibiotic. Active against various Gram-positive bacteria such as S. aureus. This is another anionic peptide that is distinct from many of the cationic AMPs. Its activity requires the presence of Ca2+ (calcium) that causes the aggregation of the peptide. 	Gram-positive 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3024560	Antimicrob Agents Chemother. 1986 Oct;30(4):532-5.	Eliopoulos GM, Willey S, Reiszner E, Spitzer PG, Caputo G, Moellering RC Jr.	In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.	
DRAMP00119	KSYGNGVQCNKKKCWVDWGSAISTIGNNSAANWATGGAAGWKS	43	Listeriocin 743A	No entry found	Not found	Not found	Listeria innocua	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Listeria monocytogenes.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11526003	Appl Environ Microbiol. 2001 Sep;67(9):4041-4047.	Kalmokoff ML, Banerjee SK, Cyr T, Hefford MA, Gleeson T.	Identification of a new plasmid-encoded sec-dependent bacteriocin produced by Listeria innocua 743.	
DRAMP00121	ATYYGNGVYCNKQKCWVDWSRARSEIIDRGVKAYVNGFTKVLGGIGGR	48	Enterocin SE-K4 	Q8GR39	Not found	orf6	Enterococcus faecalis (Streptococcus faecalis)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases	Doi K, Eguchi T, Iwatake A, Shima J, Ohmomo S, Ogata S.	High production of enterocin SE-K4 from Enterococcus faecalis strain K-4.	
DRAMP00122	TYYGNGVSCNKKGCSVDWGKAISIIGNNSAANLATGGAAGWKS	43	Avicin A 	D2DXK5	Not found	avcA	Enterococcus avium (Streptococcus avium)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19933345	Appl Environ Microbiol. 2010 Jan;76(2):483-492.	Birri DJ, Brede DA, Forberg T, Holo H, Nes IF.	Molecular and genetic characterization of a novel bacteriocin locus in Enterococcus avium isolates from infants.	
DRAMP00123	TKYYGNGVYCNSKKCWVDWGQASGCIGQTVVGGWLGGAIPGKC	43	Divercin V41 (Bacteriocin)	No entry found	Not found	Not found	Carnobacterium divergens V41	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9802025	Microbiology. 1998 Oct;144 ( Pt 10):2837-2844.	Métivier A, Pilet MF, Dousset X, Sorokine O, Anglade P, Zagorec M, Piard JC, Marion D, Cenatiempo Y, Fremaux C.	Divercin V41, a new bacteriocin with two disulfide bonds produced by Carnobacterium divergens V41: primary structure and genetic organization.	
DRAMP00124	KYYGNGVTCGKHSCSVDWGKATTCIINNGAMAWATGGHQGTHKC	44	Coagulin (Bacteriocin)	No entry found	Not found	Not found	Bacillus coagulans I-4	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11097892	Appl Environ Microbiol. 2000 Dec;66(12):5213-5220.	Le Marrec C, Hyronimus B, Bressollier P, Verneuil B, Urdaci MC.	Biochemical and genetic characterization of coagulin, a new antilisterial bacteriocin in the pediocin family of bacteriocins, produced by Bacillus coagulans I(4).	
DRAMP00125	KYYGNGVTCGLHDCRVDRGKATCGIINNGGMWGDIG	36	Bifidocin B (Bacteriocin)	No entry found	Not found	Not found	Bifidobacterium bifidum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23384878	Biotechnol Adv. 2013 Jul;31(4):482-488.	Martinez FA, Balciunas EM, Converti A, Cotter PD, de Souza Oliveira RP.	Bacteriocin production by Bifidobacterium spp. A review.	
DRAMP00130	SIWGDIGQGVGKAAYWVGKAMGNMSDVNQASRINRKKKH	39	Lactococcin Q alpha (Qalpha; Bacteriocin)	Q1JV79	Belongs to the class IIb bacteriocin	laqA	Lactococcus lactis QU 4 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Lactococcus lactis subsp. lactis ATCC 19435 (MIC>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16672481	Appl Environ Microbiol. 2006 May;72(5):3383-3389.	Zendo T, Koga S, Shigeri Y, Nakayama J, Sonomoto K.	Lactococcin Q, a novel two-peptide bacteriocin produced by Lactococcus lactis QU 4.	
DRAMP00131	KKWGWLAWVEPAGEFLKGFGKGAIKEGNKDKWKNI	35	Lactococcin Q beta (Qbeta; Bacteriocin)	Q1JV78	Belongs to the class IIb bacteriocin	laqB	Lactococcus lactis QU 4 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Lactococcus lactis subsp. lactis ATCC 19435 (MIC>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16672481	Appl Environ Microbiol. 2006 May;72(5):3383-3389.	Zendo T, Koga S, Shigeri Y, Nakayama J, Sonomoto K.	Lactococcin Q, a novel two-peptide bacteriocin produced by Lactococcus lactis QU 4.	
DRAMP00132	GTWDDIGQGIGRVAYWVGKALGNLSDVNQASRINRKKKH	39	Lactococcin G subunit alpha (Galpha; Bacteriocin)	P36961	Belongs to the class IIb bacteriocin	Not found	Lactococcus lactis subsp. lactis (Streptococcus lactis) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Alpha helix	In DPC, LcnG-alpha has an N-terminal alpha-helix (residues 3-21) that contains a GxxxG helix-helix interaction motif (residues 7-11) and a less well defined C-terminal alpha-helix (residues 24-34), and in between (residues 18-22) there is a second somewhat flexible GxxxG-motif. Its structure in TFE was similar.	2JPJ, 2JPL resolved by NMR.	"MOA: The N-terminal halves of both the alpha and beta peptides may form amphiphilic alpha-helices, suggesting that the peptides are pore-forming toxins that create cell membrane channels through a ""barrel-stave"" mechanism. Bacteriocin activity requires interaction of alpha and beta peptides in a molar ratio of 7:1 or 8:1 respectively."	Lactococcus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1512201##18187052	J Bacteriol. 1992 Sep;174(17):5686-5692.##Biochim Biophys Acta. 2008 Mar;1784(3):543-554.	Nissen-Meyer J, Holo H, H¥varstein LS, Sletten K, Nes IF.##Rogne P, Fimland G, Nissen-Meyer J, Kristiansen PE.	A novel lactococcal bacteriocin whose activity depends on the complementary action of two peptides.##Three-dimensional structure of the two peptides that constitute the two-peptide bacteriocin lactococcin G. 	
DRAMP00133	KKWGWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNI	35	Lactococcin G subunit beta (Gbeta ; Bacteriocin)	P36962	Belongs to the class IIb bacteriocin	Not found	Lactococcus lactis subsp. lactis (Streptococcus lactis) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Alpha helix	In DPC, LcnG-beta has an N-terminal alpha-helix (residues 6-19). The region from residues 20 to 35, which also contains a flexible GxxxG-motif (residues 18-22), appeared to be fairly unstructured in DPC.	2JPK, 2JPM resolved by NMR.	"MOA: The N-terminal halves of both the alpha and beta peptides may form amphiphilic alpha-helices, suggesting that the peptides are pore-forming toxins that create cell membrane channels through a ""barrel-stave"" mechanism. Bacteriocin activity requires interaction of alpha and beta peptides in a molar ratio of 7:1 or 8:1 respectively."	Lactococcus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1512201##18187052	J Bacteriol. 1992 Sep;174(17):5686-5692.##Biochim Biophys Acta. 2008 Mar;1784(3):543-554.	Nissen-Meyer J, Holo H, H¥varstein LS, Sletten K, Nes IF.##Rogne P, Fimland G, Nissen-Meyer J, Kristiansen PE.	A novel lactococcal bacteriocin whose activity depends on the complementary action of two peptides.##Three-dimensional structure of the two peptides that constitute the two-peptide bacteriocin lactococcin G. 	
DRAMP00134	SVPTSVYTLGIKILWSAYKHRKTIEKSFNKGFYH	34	Plantaricin NC8 beta peptide (PLNC8 beta; Bacteriocin)	Q84HW1	Belongs to the class IIb bacteriocin	plnc8B	Lactobacillus plantarum NC8 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12514019##14973042##18819721	Appl Environ Microbiol. 2003 Jan;69(1):383-339.##J Bacteriol. 2004 Mar;186(5):1556-1564.##Int J Food Microbiol. 2008 Dec 10;128(2):390-394.	Maldonado A, Ruiz-Barba JL, Jim©nez-D­az R.##Maldonado A, Jim©nez-D­az R, Ruiz-Barba JL.##Navarro L, Rojo-Bezares B, S¡enz Y, D­ez L, Zarazaga M, Ruiz-Larrea F, Torres C.	Purification and genetic characterization of plantaricin NC8, a novel coculture-inducible two-peptide bacteriocin from Lactobacillus plantarum NC8.##Induction of plantaricin production in Lactobacillus plantarum NC8 after coculture with specific Gram-positive bacteria: is mediated by an autoinduction mechanism.##Comparative study of the pln locus of the quorum-sensing regulated bacteriocin-producing Lactobacillus plantarum J51 strain.	
DRAMP00135	LTTKLWSSWGYYLGKKARWNLKHPYVQF	28	Plantaricin NC8 alpha peptide (PLNC8 alpha; Bacteriocin)	Q84HW0	Belongs to the class IIb bacteriocin	plnc8A	Lactobacillus plantarum NC8 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12514019	Appl Environ Microbiol. 2003 Jan;69(1):383-389.	Maldonado A, Ruiz-Barba JL, Jim©nez-D­az R.	Purification and genetic characterization of plantaricin NC8, a novel coculture-inducible two-peptide bacteriocin from Lactobacillus plantarum NC8.	
DRAMP00137	KKKKQSWYAAAGDAIVSFGEGFLNAW	26	Plantaricin S beta (Bacteriocin)	O32830	Belongs to the class IIb bacteriocin	plsB	Lactobacillus plantarum LPCO10 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Predicted	Not found	Not found	6GO0	Although beta alone appeared to retain a trace of inhibitory activity, the complementary action of both the alpha and beta peptides was required for full bacteriocin activity.	Enterococcus, Lactobacillus, Lactococcus, Leuconostoc.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8534111##9572965	Appl Environ Microbiol. 1995 Dec;61(12):4459-4463.##Appl. Environ. Microbiol. 1998;64 (5):1871-1877.	Jim©nez-D­az R, Ruiz-Barba JL, Cathcart DP, Holo H, Nes IF, Sletten KH, Warner PJ.##Stephens SK, Floriano B, Cathcart DP, Bayley SA, Witt VF, Jim©nez-D­az R, Warner PJ, Ruiz-Barba JL.	Purification and partial amino acid sequence of plantaricin S, a bacteriocin produced by Lactobacillus plantarum LPCO10, the activity of which depends on the complementary action of two peptides.##Molecular analysis of the locus responsible for production of plantaricin S, a two-peptide bacteriocin produced by Lactobacillus plantarum LPCO10.	
DRAMP00138	NPKVAHCASQIGRSTAWGAVSGA	23	Acidocin J1132 alpha peptide (Bacteriocin)	Q9R4A0	Belongs to the class IIb bacteriocin	Not found	Lactobacillus acidophilus JCM 1132 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Comment: Acidocin J1132 is a pore-forming bacteriocin that creates cell membrane channels through the ""barrel-stave"" mechanism. Both alpha and beta had inhibitory activity, and an increase in activity by the complementary action of the two components was observed."	Lactobacillus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8975617	Appl Environ Microbiol. 1996 Mar;62(3):892-897.	Tahara T, Oshimura M, Umezawa C, Kanatani K.	Isolation, partial characterization, and mode of action of Acidocin J1132, a two-component bacteriocin produced by Lactobacillus acidophilus JCM 1132.	
DRAMP00139	GNPKVAHCASQIGRSTAWGAVSGA	24	Acidocin J1132 beta peptide (Bacteriocin)	Q9R499	Belongs to the class IIb bacteriocin	Not found	Lactobacillus acidophilus JCM 1132 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Comment: Acidocin J1132 is a pore-forming bacteriocin that creates cell membrane channels through the ""barrel-stave"" mechanism. Both alpha and beta had inhibitory activity, and an increase in activity by the complementary action of the two components was observed."	Lactobacillus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8975617	Appl Environ Microbiol. 1996 Mar;62(3):892-897.	Tahara T, Oshimura M, Umezawa C, Kanatani K.	Isolation, partial characterization, and mode of action of Acidocin J1132, a two-component bacteriocin produced by Lactobacillus acidophilus JCM 1132.	
DRAMP00140	RNNWQTNVGGAVGSAMIGATVGGTICGPACAVAGAHYLPILWTAVTAATGGFGKIRK	57	Lactacin-F subunit LafA (Bacteriocin)	P24022	Belongs to the class IIb bacteriocin	lafA	Lactobacillus johnsonii (strain CNCM I-12250 / La1 / NCC 533) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Heat stable bacteriocin. peptides for activity: lafA and lafX. Associated with a 180 kDa bacteriocin complex.	Enterococcus faecalis and other Lactobacilli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1903624##14983040	Appl Environ Microbiol. 1991 Jan;57(1):114-121.##Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2512-2517.	Fremaux C, Ahn C, Klaenhammer TR.##Pridmore RD, Berger B, Desiere F, Vilanova D, Barretto C, Pittet AC, Zwahlen MC, Rouvet M, Altermann E, Barrangou R, Mollet B, Mercenier A, Klaenhammer T, Arigoni F, Schell MA.	Purification and partial characterization of lactacin F, a bacteriocin produced by Lactobacillus acidophilus 11088.##The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533.	
DRAMP00141	NRWGDTVLSAASGAGTGIKACKSFGPWGMAICGVGGAAIGGYFGYTHN	48	Lactacin-F subunit LafX (Bacteriocin)	Q48509	Belongs to the class IIb bacteriocin	lafX	Lactobacillus johnsonii (strain CNCM I-12250 / La1 / NCC 533) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Heat stable bacteriocin. peptides for activity: lafA and lafX. Associated with a 180 kDa bacteriocin complex.	Enterococcus faecalis and other Lactobacilli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8285694##14983040	Appl Environ Microbiol. 1993 Nov;59(11):3906-3915.##Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2512-2517.	Fremaux C, Ahn C, Klaenhammer TR.##Pridmore RD, Berger B, Desiere F, Vilanova D, Barretto C, Pittet AC, Zwahlen MC, Rouvet M, Altermann E, Barrangou R, Mollet B, Mercenier A, Klaenhammer T, Arigoni F, Schell MA.	Molecular analysis of the lactacin F operon.##The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533.	
DRAMP00142	RNNWAANIGGVGGATVAGWALGNAVCGPACGFVGAHYVPIAWAGVTAATGGFGKIRK	57	Gassericin T (gassericin K7 B; Bacteriocin)	Q9XDR7	Belongs to the class IIb bacteriocin	gatA	Lactobacillus gasseri LA158 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11129595	Biosci Biotechnol Biochem. 2000 Oct;64(10):2201-2208.##DNA Sequence and HPLC Purification of Gassericin T, a Class IIb Bacteriocin Produced by Lactobacillus gasseri LA158, from Cheese Whey-based Medium.	Kawai Y, Saitoh B, Takahashi O, Kitazawa H, Saito T, Nakajima H, Itoh T.##Yasuta N, Chujo T, Nakamura K, Arakawa K, Kawai Y, Ito Y, Ishikawa J, Itoh M, Sakai A, Nishimura J, Makino Y, Shigenobu S, Kitazawa H, Saito T.	Primary amino acid and DNA sequences of gassericin T, a lactacin F-family bacteriocin produced by Lactobacillus gasseri SBT2055.##Submitted (APR-2012) to the EMBL/GenBank/DDBJ databases.	
DRAMP00143	KSSAYSLQMGATAIKQVKKLFKKWGW	26	Plantaricin-A (PlnA; Bacteriocin)	P80214, F9UU02	Belongs to the class IIb bacteriocin	plnA	Lactobacillus plantarum (strain ATCC BAA-793 / NCIMB 8826 / WCFS1) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Alpha helix 	Active plantaricin A is composed of an alpha chain and a beta chain. The sequence of alpha chain and beta chain, however, are essential identical with the only difference being one additional Ala at the N-terminus of chain b. The 3D structure of chain a in DPC micelles has been determined by NMR spectroscopy (J Biol Chem. 2005 Jun 17;280(24):22945-50). 	1YTR resolved by NMR.	"Function: This heat stable bacteriocin inhibits the growth of closely related Lactobacillus species. It may act as a pore-forming protein, creating a channel in the cell membrane through a ""barrel stave"" mechanism. Antibacterial activity requires both chain a (PlnA) and chain b (PlnB). The sequence of chain a and chain b, however, are essential identical with the only difference being one additional Ala at the N-terminus of chain b.
Subunit structure: Active plantaricin A is composed of an alpha chain and a beta chain.
Miscellaneous: The beta chain sequence is shown."	Closely related Lactobacillus 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	8245827	J Gen Microbiol. 1993 Sep;139(9):1973-1978.	Nissen-Meyer J, Larsen AG, Sletten K, Daeschel M, Nes IF.	Purification and characterization of plantaricin A, a Lactobacillus plantarum bacteriocin whose activity depends on the action of two peptides.	
DRAMP00144	NRWTNAYSAALGCAVPGVKYGKKLGGVWGAVIGGVGGAAVCGLAGYVRKG	50	Amylovorin-L (Lactobin-A; Amylovorin-L471; Bacteriocin)	P80696	Belongs to the class IIb bacteriocin	amyL	Lactobacillus amylovorus (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: This heat stable bacteriocin inhibits the growth of closely related Lactobacillus species. It may act as a pore-forming protein, creating a channel in the cell membrane.
Subunit structure: Active lactobin is composed of two different peptides, one which is lactobin A.
Regions: Contains a transmembrane helix region."	Lactobacillus helveticus ATCC 15009.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	10517609##14672834##8979334	Microbiology. 1999 Sep;145 (Pt 9):2559-2568.##Int J Food Microbiol. 2004 Jan 1;90(1):93-106.##Appl Environ Microbiol. 1997 Jan;63(1):13-20.	Callewaert R, Holo H, Devreese B, Van Beeumen J, Nes I, De Vuyst L.##De Vuyst L, Avonts L, Neysens P, Hoste B, Vancanneyt M, Swings J, Callewaert R.##Contreras BG, De Vuyst L, Devreese B, Busanyova K, Raymaeckers J, Bosman F, Sablon E, Vandamme EJ.	Characterization and production of amylovorin L471, a bacteriocin purified from Lactobacillus amylovorus DCE 471 by a novel three-step method.##The lactobin A and amylovorin L471 encoding genes are identical, and their distribution seems to be restricted to the species Lactobacillus amylovorus that is of interest for cereal fermentations.##Isolation, purification, and amino acid sequence of lactobin A, one of the two bacteriocins produced by Lactobacillus amylovorus LMG P-13139.	
DRAMP00145	GMSGYIQGIPDFLKGYLHGISAANKHKKGRL	31	Lactocin-705 (Bacteriocin)	P80959	Belongs to the class IIb bacteriocin	Not found	Lactobacillus plantarum (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Potentially useful to control food-borne pathogens in ground meat.	several lactic acid bacteria, Listeria, Streptococci, etc.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8796440	Int J Food Microbiol. 1996 Apr;29(2-3):397-402.	Vignolo G, Fadda S, de Kairuz MN, de Ruiz Holgado AA, Oliver G.	Control of Listeria monocytogenes in ground beef by 'Lactocin 705', a bacteriocin produced by Lactobacillus casei CRL 705).	
DRAMP00146	KRGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL	45	Abp118 alpha (Salivaricin CRL1328 alpha peptide)	Q8KWI0	Belongs to the class IIb bacteriocin	abp118alpha	Lactobacillus salivarius (Gram-positive bacteria)	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Function: Abp118alpha alone exhibits the antimicrobial activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11932444##19591924	Microbiology. 2002 Apr;148(Pt 4):973-984.##Res Microbiol. 2009 Jul-Aug;160(6):401-408.	Flynn S, van Sinderen D, Thornton GM, Holo H, Nes IF, Collins JK.##Vera Pingitore E, Hebert E.M, Nader-Macias M.E, Sesma F.	Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118.##Characterization of salivaricin CRL 1328, a two-peptide bacteriocin produced by Lactobacillus salivarius CRL 1328 isolated from the human vagina.	
DRAMP00147	KNGYGGSGNRWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFTSCR	46	Abp118 beta (Salivaricin CRL1328 beta peptide)	Q8KWH9	Belongs to the class IIb bacteriocin	abp118beta	Lactobacillus salivarius (Gram-positive bacteria)	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Function: Abp118beta can enhanced the antimicrobial activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11932444##19591924	Microbiology. 2002 Apr;148(Pt 4):973-984.##Res Microbiol. 2009 Jul-Aug;160(6):401-408.	Flynn S, van Sinderen D, Thornton GM, Holo H, Nes IF, Collins JK.##Vera Pingitore E, Hebert E.M, Nader-Macias M.E, Sesma F.	Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118.##Characterization of salivaricin CRL 1328, a two-peptide bacteriocin produced by Lactobacillus salivarius CRL 1328 isolated from the human vagina.	
DRAMP00148	LSCDEGMLAVGGLGAVGGPWGAAVGVLVGAALYCF	35	Thermophilin 9 (BlpDst; Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Streptococcus thermophilus LMD-9 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18156339	Appl Environ Microbiol. 2008 Feb;74(4):1102-1110.	Fontaine L, Hols P.	The inhibitory spectrum of thermophilin 9 from Streptococcus thermophilus LMD-9 depends on the production of multiple peptides and the activity of BlpG(St), a thiol-disulfide oxidase.	
DRAMP18339	GFIGWGNNIFGHYSGDF	17	Anantin(Bacteriocin)	Q7M0J9	Not found	Not found	Streptomyces coerulescens	Unknown		Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##PubMed ID is not available	The Journal of antibiotics. 1991 Feb;44(2):164-71.##The Journal of antibiotics. 1991 Feb;44(2):172-80.	Weber W,Fischli W,Hochuli E,Kupfer E,Weibel E K.##Wyss D F,Lahm H W,Manneberg M,Labhardt A M.	Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). I. Producing organism, fermentation, isolation and biological activity.##Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). II. Determination of the primary sequence by NMR on the basis of proton assignments.	
DRAMP00150	KNGYGGSGNRWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH	46	Sln2 (chain b of Salivaricin P; Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Lactobacillus salivarius DPC6005 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17416691	Appl Environ Microbiol. 2007 Jun;73(11):3719-3723.	Barrett E, Hayes M, O'Connor P, Gardiner G, Fitzgerald GF, Stanton C, Ross RP, Hill C.	Salivaricin P, one of a family of two-component antilisterial bacteriocins produced by intestinal isolates of Lactobacillus salivarius.	
DRAMP00151	ESVFSKIGNAVGPAAYWILKGLGNMSDVNQADRINRKKH	39	Enterocin 1071A (Ent1071A; Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Enterococcus faecalis BFE 1071 (Gram-positive bacteria) 	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11976133	Appl Environ Microbiol. 2002 May;68(5):2550-2554.	Franz CM, Grube A, Herrmann A, Abriouel H, Stärke J, Lombardi A, Tauscher B, Holzapfel WH.	Biochemical and genetic characterization of the two-peptide bacteriocin enterocin 1071 produced by Enterococcus faecalis FAIR-E 309.	
DRAMP00152	GPGKWLPWLQPAYDFVTGLAKGIGKEGNKNKWKNV	35	Enterocin 1071B (Ent1071B; Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Enterococcus faecalis BFE 1071 (Gram-positive bacteria) 	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11976133	Appl Environ Microbiol. 2002 May;68(5):2550-2554.	Franz CM, Grube A, Herrmann A, Abriouel H, Stärke J, Lombardi A, Tauscher B, Holzapfel WH.	Biochemical and genetic characterization of the two-peptide bacteriocin enterocin 1071 produced by Enterococcus faecalis FAIR-E 309.	
DRAMP00153	KVSGGEAVAAIGICATASAAIGGLAGATLVTPYCVGTWGLIRSH	44	NlmA (chain a of Mutacin IV; Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Streptococcus mutans UA140 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Streptococci sanguinis NY101, S. sanguinis ATCC 10556, Streptococcus parasanguinis ATCC 15911, S. oralis TCC 10557, S. mitis ATCC 903, S. mitis ATCC 33399, S. gordonii ATCC 10558, S. crista ATCC 49999, S. sobrinus OMZ176.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11133423	Appl Environ Microbiol. 2001 Jan;67(1):15-21.	Qi F, Chen P, Caufield PW.	The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV.	
DRAMP00154	DKQAADTFLSAVGGAASGFTYCASNGVWHPYILAGCAGVGAVGSVVFPH	49	NlmB (chain b of Mutacin IV; Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Streptococcus mutans UA140 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Streptococci sanguinis NY101, S. sanguinis ATCC 10556, Streptococcus parasanguinis ATCC 15911, S. oralis TCC 10557, S. mitis ATCC 903, S. mitis ATCC 33399, S. gordonii ATCC 10558, S. crista ATCC 49999, S. sobrinus OMZ176.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11133423	Appl Environ Microbiol. 2001 Jan;67(1):15-21.	Qi F, Chen P, Caufield PW.	The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV.	
DRAMP00155	YSSKDCLKDIGKGIGAGTVAGAAGGGLAAGLGAIPGAFVGAHFGVIGGSAACIGGLLGN	59	BrcA (chain a of Brochocin C; Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Brochothrix campestris ATCC 43754 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Chain A has an identical sequence to NKR-5-3A from E. faecium NKR-5-3 (Ishbashi N et al 2012 Biosci Biotechnol Biochem 76: 947-953).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9835559	Appl Environ Microbiol. 1998 Dec;64(12):4757-4766.	McCormick JK, Poon A, Sailer M, Gao Y, Roy KL, McMullen LM, Vederas JC, Stiles ME, Van Belkum MJ.	Genetic characterization and heterologous expression of brochocin-C, an antibotulinal, two-peptide bacteriocin produced by Brochothrix campestris ATCC 43754.	
DRAMP00156	KINWGNVGGSCVGGAVIGGALGGLGGAGGGCITGAIGSIWDQW	43	BrcB (NKR-5-3A; chain b of Brochocin C; Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Brochothrix campestris ATCC 43754 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9835559	Appl Environ Microbiol. 1998 Dec;64(12):4757-4766.	McCormick JK, Poon A, Sailer M, Gao Y, Roy KL, McMullen LM, Vederas JC, Stiles ME, Van Belkum MJ.	Genetic characterization and heterologous expression of brochocin-C, an antibotulinal, two-peptide bacteriocin produced by Brochothrix campestris ATCC 43754.	
DRAMP00157	RNKLAYNMGHYAGKATIFGLAAWALLA	27	Plantaricin S alpha (Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Lactobacillus plantarum LPCO10 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found	6GNZ	Although beta alone appeared to retain a trace of inhibitory activity, the complementary action of both the alpha and beta peptides was required for full bacteriocin activity.	Gram-positive bacteria: Enterococcus, Lactobacillus, Lactococcus, Leuconostoc.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8534111##9572965	Appl Environ Microbiol. 1995 Dec;61(12):4459-4463.##Appl. Environ. Microbiol. 1998;64 (5):1871-1877.	Jim©nez-D­az R, Ruiz-Barba JL, Cathcart DP, Holo H, Nes IF, Sletten KH, Warner PJ.##Stephens SK, Floriano B, Cathcart DP, Bayley SA, Witt VF, Jim©nez-D­az R, Warner PJ, Ruiz-Barba JL.	Purification and partial amino acid sequence of plantaricin S, a bacteriocin produced by Lactobacillus plantarum LPCO10, the activity of which depends on the complementary action of two peptides.##Molecular analysis of the locus responsible for production of plantaricin S, a two-peptide bacteriocin produced by Lactobacillus plantarum LPCO10.	
DRAMP00158	GMSGYIQGIPDFLKGYLHGISAANKHKKGRLGY	33	Lactocin 705alpha (lac705alpha; chain a of Lactocin 705; Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Lactobacillus casei CRL 705 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Several lactic acid bacteria, Listeria, Streptococci, etc.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10754241	FEMS Microbiol Lett. 2000 Apr 15;185(2):157-161.	Cuozzo SA, Sesma F, Palacios JM, de Ru­z Holgado AP, Raya RR.	Identification and nucleotide sequence of genes involved in the synthesis of lactocin 705, a two-peptide bacteriocin from Lactobacillus casei CRL 705.	
DRAMP00159	GFWGGLGYIAGRVGAAYGHAQASANNHHSPING	33	Lactocin 705beta (lac705beta; chain b of Lactocin 705; Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Lactobacillus casei CRL 705 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Several lactic acid bacteria, Listeria, Streptococci, etc.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10754241	FEMS Microbiol Lett. 2000 Apr 15;185(2):157-161.	Cuozzo SA, Sesma F, Palacios JM, de Ru­z Holgado AP, Raya RR.	Identification and nucleotide sequence of genes involved in the synthesis of lactocin 705, a two-peptide bacteriocin from Lactobacillus casei CRL 705.	
DRAMP00160	YSGKDXLKDMGGYALAGAGSGALXGAPAGXVGALPGAFVGAHVGAIAG	48	ThmA (chain a of Thermophilin 13; Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Streptococcus thermophilus (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Streptococcus thermophilus SFi3, Clostridium botulinum, Listeria monocytogenes, Bacillus cereus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9162062	J Biol Chem. 1997 May 30;272(22):14277-14284.	Marciset O, Jeronimus-Stratingh MC, Mollet B, Poolman B.	Thermophilin 13, a nontypical antilisterial poration complex bacteriocin, that functions without a receptor.	
DRAMP00161	QINWGSVVGHCIGGAIIGGAFSGGAAAGVGCLVGSGKAIINGL	43	ThmB (chain b of Thermophilin 13; Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Streptococcus thermophilus (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		ThmB, by itself, is not bactericidal. An equal amount of ThmB can increase the activity of ThmA by 40 fold, however, an excess of ThmB inhibits the activity of ThmA. Disulfide bonds are not required for activity. 	Gram-positive bacteria: Streptococcus thermophilus SFi3, Clostridium botulinum, Listeria monocytogenes, Bacillus cereus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9162062	J Biol Chem. 1997 May 30;272(22):14277-14284.	Marciset O, Jeronimus-Stratingh MC, Mollet B, Poolman B.	Thermophilin 13, a nontypical antilisterial poration complex bacteriocin, that functions without a receptor.	
DRAMP00162	GNAACVIGCIGSCVISEGIGSLVGTAFTLG	30	Thuricin CDalpha (Trn-alpha; one peptide of Thuricin CD; Bacteriocin)	F5AT07	Belongs to the class IIb bacteriocin	Not found	Bacillus thuringiensis DPC 6431 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Alpha helix (3 helices; 16 residues)	Trn-α has L-stereochemistry at Ser21 (alpha-R), L-stereochemistry at Thr25 (alpha-R), and D-stereochemistry at Thr28 (alpha-S) (an LLD isomer).	2L9X resolved by NMR.	"Function: Thuricin CD is produced by Bacillus thuringiensis DPC 6431, a bacterial strain isolated from a human fecal sample, and it consists of two distinct peptides, Trn-alpha and Trn-beta, that act synergistically to kill a wide range of clinical C. difficile isolates. Thuricin CD showes no activity against any Gram-negative organisms tested, including Escherichia coli, Pseudomonas sp., Salmonella sp., and Bacteroides fragilis. 
Biophysicochemical properties: Cell-free supernatants of thuricin were active throughout the pH range of 2-9 and heat stable up to 85 °C. There was, however, a reduction in activity at 90 °C and a complete loss of activity at 100 °C after 15 min."	Gram-positive bacteria: Clinical Clostridium difficile isolates (MIC in the range of nM) and Listeria monocytogenes, Lactobacillus fermentum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20435915##21526839	Proc Natl Acad Sci U S A. 2010 May 18;107(20):9352-9357.##J Am Chem Soc. 2011 May 25;133(20):7680-7683.	Rea MC, Sit CS, Clayton E, O'Connor PM, Whittal RM, Zheng J, Vederas JC, Ross RP, Hill C.##Sit CS, McKay RT, Hill C, Ross RP, Vederas JC.	Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.##The 3D structure of thuricin CD, a two-component bacteriocin with cysteine sulfur to alpha-carbon cross-links.	
DRAMP00163	GWVACVGACGTVCLASGGVGTEFAAASYFL	30	Thuricin CDdbeta (Trn-beta; one peptide of Thuricin CD; Bacteriocin)	F5AT06	Belongs to the class IIb bacteriocin	Not found	Bacillus thuringiensis DPC 6431 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Alpha helix (3 helices; 22 residues)	Trn-β was also found to be the LLD isomer, with L-stereochemistry at Thr21 (alpha-R), L-stereochemistry at Ala25 (alpha-R), and D-stereochemistry at Tyr28 (alpha-S).	2LA0 resolved by NMR.	"Function: Thuricin CD is produced by Bacillus thuringiensis DPC 6431, a bacterial strain isolated from a human fecal sample, and it consists of two distinct peptides, Trn-alpha and Trn-beta, that act synergistically to kill a wide range of clinical C. difficile isolates. Thuricin CD showes no activity against any Gram-negative organisms tested, including Escherichia coli, Pseudomonas sp., Salmonella sp., and Bacteroides fragilis. 
Biophysicochemical properties: Cell-free supernatants of thuricin were active throughout the pH range of 2-9 and heat stable up to 85 °C. There was, however, a reduction in activity at 90 °C and a complete loss of activity at 100 °C after 15 min."	Gram-positive bacteria: Clinical Clostridium difficile isolates (MIC in the range of nM) and Listeria monocytogenes, Lactobacillus fermentum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20435915##21526839	Proc Natl Acad Sci U S A. 2010 May 18;107(20):9352-9357.##J Am Chem Soc. 2011 May 25;133(20):7680-7683.	Rea MC, Sit CS, Clayton E, O'Connor PM, Whittal RM, Zheng J, Vederas JC, Ross RP, Hill C.##Sit CS, McKay RT, Hill C, Ross RP, Vederas JC.	Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.##The 3D structure of thuricin CD, a two-component bacteriocin with cysteine sulfur to alpha-carbon cross-links.	
DRAMP00164	LAGYTGIASGTAKKVVDAIDKGAAAFVIISIISTVISAGALGAVSASADFIILTVKNYISRNLKAQAVIW	70	Bacteriocin uberolysin (Bacteriocin)	A5H1G9	Belongs to the class IIc bacteriocin	ublA	Streptococcus uberis strain 42 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Most streptococci (except S.rattus and S. mutans), Listeria spp., enterococci and staphylococci.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Not found	17464077	Microbiology. 2007 May;153(Pt 5):1619-1630.	Wirawan RE, Swanson KM, Kleffmann T, Jack RW, Tagg JR.	Uberolysin: a novel cyclic bacteriocin produced by Streptococcus uberis.	
DRAMP00165	IYWIADQFGIHLATGTARKLLDAMASGASLGTAFAAILGVTLPAWALAAAGALGATAA	58	Gassericin A (GaaA; Bacteriocin)	O24790	Belongs to the class IIc bacteriocin	gaaA	Lactobacillus gasseri LA39 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Alpha helix	Not found		It causes K+ ion efflux from indicator cells and liposome.Circularized by forming a peptide bond between the N- and C-ends. Initially, it was thought to differ from Reutericin 6 only by the number of D-amino acids (Kawai et al., 2004). A re-study corrected this and concluded that gassericin A and reutericin 6 are identical bacteriocins (Arakawa et al. 2010 Lett Appl. Microbiol 50:406-411). However, reutericin 6 was isolated from Lactobacillus reuteri LA6.	Gram-positive bacterium: L. reuteri LA6.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Not found	9648219##19666732	Biosci Biotechnol Biochem. 1998 May;62(5):887-892.##Appl Environ Microbiol. 2009 Oct;75(19):6340-6351.	Kawai Y, Saito T, Suzuki M, Itoh T.##Ito Y, Kawai Y, Arakawa K, Honme Y, Sasaki T, Saito T.	Sequence analysis by cloning of the structural gene of gassericin A, a hydrophobic bacteriocin produced by Lactobacillus gasseri LA39.##Conjugative plasmid from Lactobacillus gasseri LA39 that carries genes for production of and immunity to the circular bacteriocin gassericin A.	
DRAMP00166	IYFIADKMGIQLAPAWYQDIVNWVSAGGTLTTGFAIIVGVTVPAWIAEAAAAFGIASA	58	Butyrivibriocin AR10 (Bacteriocin)	Q9ZGP5	Belongs to the class IIc bacteriocin	bviA	Butyrivibrium fibrisolvens AR10 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Clostridium clostridiforme ATCC25537, C. perfringens, Eubacterium ruminentium ATCC17233, Lachnospira multiperus ATCC19207, L. vitulinus ATCC27783, Lactobacillus ruminis ATCC27780, Ruminococcus albus SY3, Streptococcus bovis ATCC33317, Listeria ivanovii 80, L. gray 83.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Not found	9023920##15162201	Appl Environ Microbiol. 1997 Feb;63(2):394-402.##Can J Microbiol. 2003 Dec;49(12):763-773.	Kalmokoff ML, Teather RM.##Kalmokoff ML, Cyr TD, Hefford MA, Whitford MF, Teather RM.	Isolation and characterization of a bacteriocin (Butyrivibriocin AR10) from the ruminal anaerobe Butyrivibrio fibrisolvens AR10: evidence in support of the widespread occurrence of bacteriocin-like activity among ruminal isolates of B. fibrisolvens.##Butyrivibriocin AR10, a new cyclic bacteriocin produced by the ruminal anaerobe Butyrivibrio fibrisolvens AR10: characterization of the gene and peptide.	
DRAMP00167	NKGCATCSIGAACLVDGPIPDFEIAGATGLFGLWG	35	Subtilosin A (Antilisterial bacteriocin subtilosin; D-amino acid; Bacteriocin; Preclinical)	O07623	Belongs to the class IIc bacteriocin	sboA	Bacillus subtilis (strain 168) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix (1 helices; 6 residues)	The NMR study results demonstrate that in addition to having a cyclized peptide backbone (amide between N and C termini), three cross-links are formed between the sulfurs of Cys13, Cys7, and Cys4 and the alpha-positions of Phe22, Thr28, and Phe31, respectively.	1PXQ resolved by NMR.	PTM: This peptide undergoes unique processing steps that include proteolytic cleavage after Glu-8, and covalent linkage of the alpha-amino of Asn-9 with the carboxyl of Gly-43 to form a cyclopeptide. Thioether cross-links are formed between cysteines and the alpha-carbons of other amino acids, Cys-12 to Phe-39, Cys- 15 to Thr-36, and Cys-21 to Phe-30. In forming these cross-links, Thr-36 and Phe-39 are converted to D-amino-acids. and 39 probably due to their modification, and reports a cyclic permutation of the peptide sequence.	[Ref.17213266] MICs between 1 and 12.5 mg/L: E. faecalis OGX-1, L. monocytogenes ATCC 19115, P. gingivalis ATCC 33277, K. rhizophila ATCC 9341, Enterobacter aerogenes ATCC 13408, Streptococcus pyogenes ATCC 19615 and Shigella sonnei ATCC 25931. ##MICs between 25 and 100 mg/L: Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 9027, S. gordonii Challis ATCC 49818 and Staphylococcus aureus ATCC 6538. ##MICs over 100mg/L: B. subtilis ATCC 6633,Fusobacterium nucleatum ATCC 25586,P. gingivalis W83 ,K. pneumoniae ATCC 4352 ,K. pneumoniae UMN1, Bacillus cereus ATCC 10876, Staphylococcus epidermidis ATCC 12228,Proteus mirabilis ATCC 25933 ,Salmonella enterica Typhi ATCC 12048.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Thioether bridges between Cys4 and Phe31,Cys7 and Thr28,Cys13 and Phe22.	Mixed(D-Thr28,D-Phe31)	No cytotoxicity information found	Not found	3936839##15035610	J Biochem. 1985 Sep;98(3):585-603.##Biochemistry. 2004 Mar 30;43(12):3385-3395.	Babasaki K, Takao T, Shimonishi Y, Kurahashi K.##Kawulka KE, Sprules T, Diaper CM, Whittal RM, McKay RT, Mercier P, Zuber P, Vederas JC.	Subtilosin A, a new antibiotic peptide produced by Bacillus subtilis 168: isolation, structural analysis, and biogenesis.##Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives.	
DRAMP00168	AAPKITQKQKNCVNGQLGGMLAGALGGPGGVVLGGIGGAIAGGCFN	46	Divergicin A (Bacteriocin)	Q3SAX6	Belongs to the class IIc bacteriocin	Not found	Carnobacterium divergens (Gram-positive bacteria)	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7768812##16385127	J Bacteriol. 1995 Jun;177(11):3143-3149.##Microbiology. 2006 Jan;152(Pt 1):171-178.	Worobo RW, Van Belkum MJ, Sailer M, Roy KL, Vederas JC, Stiles ME.##van Belkum MJ, Stiles ME.	A signal peptide secretion-dependent bacteriocin from Carnobacterium divergens.##Characterization of the theta-type plasmid pCD3.4 from Carnobacterium divergens, and modulation of its host range by RepA mutation.	
DRAMP00169	MAKEFGIPAAVAGTVINVVEAGGWVTTIVSILTAVGSGGLSLLAAAGRESIKAYLKKEIKKKGKRAVIAW	70	Enterocin AS-48 (AS-48; Bacteriocin)	Q47765	Belongs to the class IIc bacteriocin	as-48	Enterococcus faecalis S-48 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix (6 helices; 54 residues)	The NMR structure of AS-48 at pH 3 showed that AS-48 is a monomer consisting of a bundle of five helices arranged with the topology of the saposin fold.	1E68 resolved by NMR.##1O82,1O83,1O84 resolved by X-ray.	Function: The bacteriocin AS-48 is a membrane-interacting peptide, which displays a broad anti-microbial spectrum against Gram-positive and Gram-negative bacteria. The antimicrobial effect of AS-48 is due to its ability to form pores in the membranes of sensitive bacteria, leading to the efflux of small molecules and the depletion of the membrane electrical potential and ultimately leading to cell death.	Gram-positive bacteria: Bacillus subtilus, Bacillus cereus, Bacillus circulans, Bacillus megaterium, Corynebacterium glutamicum, Corynebacterium bovis, Mycobacterium phlei, Nocardia corrallina, Micrococcus luteus, Micrococcus lysodeikticus, Staphylococcus aureus, Streptococcus faecalis, Streptococcus faecium;##Gram-negative bacteria: Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Proteus inconstans, Salmonella typhimurium, Shigella sonnei, Pseudomonas fluorescens, Pseudomonas aeruginosa, Pseudomonas reptilivora.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Hydrogen bonds between Ala-2 and Ile-7, Val-18 and Gly-23,  Thr-33 and Gly-36, the backbone carbonyl oxygen of Phe-5 and the side-chain hydroxylic proton of Ser-50	L	No cytotoxicity information found	Cell membrane	2501837##14623193##11005847	Res Microbiol. 1989 Jan;140(1):57-68.##J Mol Biol. 2003 Nov 28;334(3):541-549.##Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11221-6.	G¡lvez A, Maqueda M, Mart­nez-Bueno M, Valdivia E.##S¡nchez-Barrena MJ, Mart­nez-Ripoll M, G¡lvez A, Valdivia E, Maqueda M, Cruz V, Albert A.##Gonz¡lez C, Langdon GM, Bruix M, G¡lvez A, Valdivia E, Maqueda M, Rico M.	Bactericidal and bacteriolytic action of peptide antibiotic AS-48 against gram-positive and Gram-negative bacteria and other organisms.##Structure of bacteriocin AS-48: from soluble state to membrane bound state.##Bacteriocin AS-48, a microbial cyclic polypeptide structurally and functionally related to mammalian NK-lysin.	
DRAMP00170	LVAYGIAQGTAEKVVSLINAGLTVGSIISILGGVTVGLSGVFTAVKAAIAKQGIKKAIQL	60	Carnocyclin A (CclA; Bacteriocin)	B2MVM5	Belongs to the class IIc bacteriocin	cclA	Carnobacterium maltaromaticum UAL307 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix (4 helices; 38 residues)	The NMR study results reveal that CclA preferentially binds halide anions and has a structure that is surprisingly similar to that of AS-48 despite low sequence identity, different oligomeric state, and disparate function. CclA folds into a compact globular bundle, comprised of four helices surrounding a hydrophobic core.	2KJF resolved by NMR.	"Function: Carnocyclin A (CclA) is a potent antimicrobial peptide from Carnobacterium maltaromaticum UAL307 that displays a broad spectrum of activity against numerous Gram-positive organisms.
Biophysicochemical properties: pH dependence (Stable from pH 2 to 12); Temperature dependence (Displays a high degree of stability when incubated at temperatures between -80 and 75 degrees Celsius for 60 minutes. Autoclaving the peptide at 121 degrees Celsius for 15 minutes had no effect but incubation at 100 degrees Celsius for 60 minutes caused a 32-fold reduction in activity)."	Gram-positive bacteria: Carnobacterium maltaromaticum UAL26, C. maltaromaticum LV17A, C. divergens LV13, Brochothrix campestris ATCC 43754, B. thermosphacta ATCC 11509, Enterococcus faecalis ATCC 7080, E. faecium ATCC 19434, E. faecium BFE900, Lactococcus lactis subsp. lactis ATCC 11454, Lactococcus lactis subsp. cremoris ATCC 11602, Lactococcus lactis subsp. lactis DPC3147, Lactobacillus sakeii 706, L. sakei UAL1218, Leuconostoc mesenteroides Y105, Pediococcus acidilactici PAC1.0, Listeria monocytogenes ATCC 15313, Listeria monocytogenes H7762, Listeria monocytogenes ATCC 43256, Listeria monocytogenes HPB 642, Listeria monocytogenes UAFM 1, Listeria monocytogenes UAFM 15, Staphylococcus aureus ATCC 25923, Staphylococcus aureus ATCC 6538, Staphylococcus aureus ATCC 29213.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Lipid II	18552180##19692336	Appl Environ Microbiol. 2008 Aug;74(15):4756-4763.##J Biol Chem. 2009 Oct 16;284(42):28674-81.	Martin-Visscher LA, van Belkum MJ, Garneau-Tsodikova S, Whittal RM, Zheng J, McMullen LM, Vederas JC.##Martin-Visscher LA, Gong X, Duszyk M, Vederas JC.	Isolation and characterization of carnocyclin a, a novel circular bacteriocin produced by Carnobacterium maltaromaticum UAL307.##The three-dimensional structure of carnocyclin A reveals that many circular bacteriocins share a common structural motif.	
DRAMP00172	LVATGMAAGVAKTIVNAVSAGMDIATALSLFSGAFTAAGGIMALIKKYAQKKLWKQLIAA	60	Garvicin ML (Bacteriocin)	D2KC49	Belongs to the class IIc bacteriocin	garML	Lactococcus garvieae DCC43 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		The peptide is expressed as a 63mer precursor. The leader sequence was removed and covalent link of the N and C-termini leading to the mature peptide. This bacteriocin inhibits other Gram-positive bacteria. The cyclic structure of the peptide confers stability to heat (80-100oC), pH (2-10) and proteases (trypsin, pepsin, papain and proteinase K). 	Gram-positive bacteria: Lactobacillus reuteri 20016 (378), L. helveticus 15009 (492), L. curvatus 2739 (177), L. casei 334 (1-174), L. acidophilus 4356 (236), L. sakei 2714 (1-445), Lactococcus lactis BB24 (928), L. lactis NZ9000 (163), L. lactis DPC5598 (1-541)ï¼ŒL. garvieae 5274 (617), L. garvieae 5806 (2-807), L. garvieae 5807 (2-705), L. raffinolactis 988 (228), Pediococcus acidilactici 347 (1-398), P. pentosaceus FBB61 (1-131), Enterococcus faecium P13 (1-291), E. faecium L50 (719), E. faecialis DBH18 (25), E. faecalis P4 (123), Propionibacterium sp.P6 (190), P. acidipropionici 563 (864), Clostridium tyrobutiricum 3.5CT (651), C. tyrobutiricum 1754 (839), C. perfringens 376 (352), C. botulinum 551 (574), Listeria monocytogenes 4032 (662), L. ivanovii 913 (1-020), L. seeligeri 917 (684), L. grayi 931 (742), L. welshimeri 919 (452), Brochothrix thermosphacta 847 (283), Streptococcus pneumoniae FQ26 (590), S. pneumoniae 67620 (596), S. pneumoniae 15M-1047 (790).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Not found	21057028	Appl Environ Microbiol. 2011 Jan;77(1):369-373.	Borrero J, Brede DA, Skaugen M, Diep DB, Herranz C, Nes IF, Cintas LM, Hern¡ndez PE.	Characterization of Garvicin ML, a Novel Circular Bacteriocin Produced by Lactococcus garvieae DCC43, Isolated from Mallard Ducks (Anas platyrhynchos).	
DRAMP18337	ATQSHQ	6	S. amritsarensis lipopeptide (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Streptomyces amritsarensis	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25006539	AMB Express. 2014 Jun 28;4:50. 	Sharma D, Mandal SM, Manhas RK.	Purification and characterization of a novel lipopeptide from Streptomyces amritsarensis sp. nov. active against methicillin-resistant Staphylococcus aureus.	
DRAMP18338	STNCFCYICCSCSS	14	Thiocillin GE37468 (Bacteriocin)	P0C8P9	Belongs to the class I bacteriocin	getA	Streptomyces ATCC 55365	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Not found		Has bacteriocidal activity against both aerobic and anaerobic Gram-positive bacteria. Has poor activity against Gram-negative bacteria, with the exception of B.fragilis. Inhibits bacterial protein biosynthesis by acting on elongation factor Tu. Full antibiotic activity depends on the presence of the modified residue Ile-50.	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Elongation Factor Tu  (EF-Tu)	21788474	Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13053-8. 	Young TS, Walsh CT.	Identification of the thiazolyl peptide GE37468 gene cluster from Streptomyces ATCC 55365 and heterologous expression in Streptomyces lividans.	
DRAMP00175	MGAIAKLVAKFGWPIVKKYYKQIMQFIGEGWAINKIIEWIKKHI	44	Enterocin L50A (EntL50A; Bacteriocin)	D4QP39	Belongs to the class IId bacteriocin	Not found	Enterococcus faecium E980/L50 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		Function: Expression in vivo and in vitro transcription/translation experiments demonstrated that entL50A and entL50B are the only genes required to obtain antimicrobial activity, strongly indicating that their bacteriocin products are not posttranslationally modified. Both bacteriocins possess antimicrobial activity on their own, with EntL50A being the most active. In addition, when the two bacteriocins were combined, a considerable synergism was observed, especially with some indicator strains. Non-hemolytic activity	[Ref.9555877]Gram-positive bacteria: Pediococcus acidilactici 347(2400AU/ml), Enterococcus faecium T136(1200AU/ml), Lactococcus lactis subsp.cremoris CNRZ 177(4800AU/ml), Lactobacillus sake 148(600AU/ml).	[Ref:9555877]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9555877##20398277	Bacteriol. 1998 Apr;180(8):1988-1994.##BMC Genomics. 2010 Apr 14;11:239.	Cintas LM, Casaus P, Holo H, Hernandez PE, Nes IF, H¥varstein LS.##van Schaik W, Top J, Riley DR, Boekhorst J, Vrijenhoek JE, Schapendonk CM, Hendrickx AP, Nijman IJ, Bonten MJ, Tettelin H, Willems RJ.	Enterocins L50A and L50B, two novel bacteriocins from Enterococcus faecium L50, are related to staphylococcal hemolysins.##Pyrosequencing-based comparative genome analysis of the nosocomial pathogen Enterococcus faecium and identification of a large transferable pathogenicity island.	
DRAMP00176	MGAIAKLVTKFGWPLIKKFYKQIMQFIGQGWTIDQIEKWLKRH	43	Enterocin L50B (EntL51B; Bacteriocin)	D4QP38	Belongs to the class IId bacteriocin	Not found	Enterococcus faecium E980/L50 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		Function: Expression in vivo and in vitro transcription/translation experiments demonstrated that entL50A and entL50B are the only genes required to obtain antimicrobial activity, strongly indicating that their bacteriocin products are not posttranslationally modified. Both bacteriocins possess antimicrobial activity on their own, with EntL50A being the most active. In addition, when the two bacteriocins were combined, a considerable synergism was observed, especially with some indicator strains. Non-hemolytic activity.	[Ref.9555877]Gram-positive bacteria: Pediococcus acidilactici 347(200AU/ml), Enterococcus faecium T136(100AU/ml), Lactococcus lactis subsp.cremoris CNRZ 177(1200AU/ml), Lactobacillus sake 148(100AU/ml).	[Ref:9555877]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9555877##20398277	Bacteriol. 1998 Apr;180(8):1988-1994.##BMC Genomics. 2010 Apr 14;11:239.	Cintas LM, Casaus P, Holo H, Hernandez PE, Nes IF, H¥varstein LS.##van Schaik W, Top J, Riley DR, Boekhorst J, Vrijenhoek JE, Schapendonk CM, Hendrickx AP, Nijman IJ, Bonten MJ, Tettelin H, Willems RJ.	Enterocins L50A and L50B, two novel bacteriocins from Enterococcus faecium L50, are related to staphylococcal hemolysins.##Pyrosequencing-based comparative genome analysis of the nosocomial pathogen Enterococcus faecium and identification of a large transferable pathogenicity island.	
DRAMP00179	MNFLKNGIAKWMTGAELQAYKKKYGCLPWEKISC	34	Enterocin Q (EntQ; Bacteriocin)	Q7WYZ9	Belongs to the class IId bacteriocin	entqA	Enterococcus faecium L50 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Enterococcus faecium L50 produces, in addition to EntL50, the sec-dependent pediocin-like enterocin P (EntP), and an unmodified non-pediocin-like bacteriocin, termed enterocin Q (EntQ), synthesized without an N-terminal leader sequence or signal peptide. (Ref.1)	A broad antimicrobial spectrum against the most relevant beer-spoilage lactic acid bacteria (LAB) (i.e., Lactobacillus brevis and Pediococcus damnosus).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11073927##17021217	J Bacteriol. 2000 Dec;182(23):6806-6814.##Appl Environ Microbiol. 2006 Oct;72(10):6653-6666.	Cintas LM, Casaus P, Herranz C, H¢varstein LS, Holo H, Hern¡ndez PE, Nes IF.##Criado R, Diep DB, Aakra A, Guti©rrez J, Nes IF, Hern¡ndez PE, Cintas LM.	Biochemical and genetic evidence that Enterococcus faecium L50 produces enterocins L50A and L50B, the sec-dependent enterocin P, and a novel bacteriocin secreted without an N-terminal extension termed enterocin Q.##Complete sequence of the enterocin Q-encoding plasmid pCIZ2 from the multiple bacteriocin producer Enterococcus faecium L50 and genetic characterization of enterocin Q production and immunity.	
DRAMP00180	SLQYVMSAGPYTWYKDTRTGKTICKQTIDTASYTFGVMAEGWGKTFH	47	Lactococcin-B (LCN-B; Bacteriocin)	P35518	Belongs to the class IId bacteriocin	lcnB	Lactococcus lactis subsp (Streptococcus cremoris) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		MOA: Kills Lactococci by dissipating the membrane potential of the cells.	Lactococcus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	1610182##8885398	Appl Environ Microbiol. 1992 Feb;58(2):572-577.##Microbiology. 1996 Oct;142 (Pt 10):2825-2830.	van Belkum MJ, Kok J, Venema G.##Venema K, Dost MH, Venema G, Kok J.	Cloning, sequencing, and expression in Escherichia coli of lcnB, a third bacteriocin determinant from the lactococcal bacteriocin plasmid p9B4-6.##Mutational analysis and chemical modification of Cys24 of lactococcin B, a bacteriocin produced by Lactococcus lactis.	
DRAMP00181	KLTFIQSTAAGDLYYNTNTHKYVYQQTQNAFGAAANTIVNGWMGGAAGGFGLHH	54	Lactococcin-A (LCN-A; Bacteriocin)	P0A313, Q00563	Belongs to the class IId bacteriocin	lcnA	Lactococcus lactis subsp (Streptococcus cremoris) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Domain: Contains one Transmembrane helix at position 9-31 (Potential).	Lactococcus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1901707##1904860	Appl Environ Microbiol. 1991 Feb;57(2):492-498.##J Bacteriol. 1991 Jun;173(12):3879-3887.	van Belkum MJ, Hayema BJ, Jeeninga RE, Kok J, Venema G.##Holo H, Nilssen O, Nes IF.	Organization and nucleotide sequences of two lactococcal bacteriocin operons.##Lactococcin A, a new bacteriocin from Lactococcus lactis subsp. cremoris: isolation and characterization of the protein and its gene.	
DRAMP00182	DWTXWSXLVXAACSVELL	18	Thuricin-S (Bacteriocin)	P84763	Belongs to the class IId bacteriocin	Not found	Bacillus thuringiensis subsp. entomocidus (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Thuricin S has the same N-terminal sequence (DWTXWSXL) as bacthuricin F4 and thuricin 17, produced by Bacillus thuringiensis strains BUPM4 and NEB17, respectively, and could therefore be classified as a new subBelongs to the class IId bacteriocin.	Gram-positive bacteria: Listeria monocytogenes, Bacillus subtilis and other Bacillus, Enterobacter cloacae, L. acidophilus, Lactococcus lactis, Pediococcus acidilactici, S. thermophilus;##Gram-negative bacteria: S. cholerae, Shigella flexneri and Pseudomonas aeruginosa.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17496978	Can J Microbiol. 2007 Feb;53(2):284-290.	Chehimi S, Delalande F, Sabl© S, Hajlaoui MR, Van Dorsselaer A, Limam F, Pons AM.	Purification and partial amino acid sequence of thuricin S, a new anti-Listeria bacteriocin from Bacillus thuringiensis.	
DRAMP00183	DWTCWSCLVCAACSVELLNLVTAATGASTAS	31	Thuricin-17 (Thurincin H; Bacteriocin)	B5U2V4	Belongs to the class IId bacteriocin	tucA1	Bacillus thuringiensis (strain SF361/NEB17) (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix (2 helices; 18 residues)	Not found	2LBZ resolved by NMR.	Function: The bacteriocin thurincin H, which is produced by Bacillus thuringiensis SF361, exhibits strong activity against a spectrum of Bacillus and Listeria spp. , including the human pathogen Listeria monocytogenes. The application of this bacteriocin to leaves (spray) or roots (drench) directly stimulates the growth of both a C(3) dicot (soybean) and a C(4) monocot (corn). This growth stimulation is similar in nature to that previously seen when plants are treated with Nod factors. Strain NEB17 contains three copies of the gene for thuricin 17 that code for identical amino acid sequences. These two lines of evidence suggest that the dual functions of these proteins may have constrained their evolution. This is the first report of direct plant growth enhancement by a bacteriocin.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (++), Bacillus subtilis ATCC 6537 (+), Bacillus subtilis CU1065 5(WT) (+++), Bacillus subtilis LRB90 (+), Bacillus subtilis LRB91 (+), Bacillus cereus F4552 (+++++), Bacillus cereus F4810 (+++++), Bacillus cereus Northview P2E018 (+++++), Geobacillus stearothermophilus ATCC 12980 (+++++), Bacillus thuringiensis EG10368 (+++++), Bacillus megaterium LRB89 (+++++), Listeria mo nocytogenes F2 586 1053 (++++), Listeria monocytogenes 2289 (++++), Listeria innocua ATCC 2283 (+++++), Listeria ivanovii ATCC 19119 (+++++), Micrococcus luteus (+), Staphylococcus aureus ATCC 9144 (+), Staphylococcus aureus ATCC 8095 (+), Carnobacterium piscicola CU216 (+++++) [NOTE: + (weakly activity) to +++++ (highest activity)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1908301##216478494##19732155##21786372	Planta. 2009 Mar;229(4):747-755.##J Appl Microbiol. 2006 Mar;100(3):545-554.##FEMS Microbiol Lett. 2009 Oct;299(2):205-213.##Angew Chem Int Ed Engl. 2011 Sep 5;50(37):8718-8721.	Lee KD, Gray EJ, Mabood F, Jung WJ, Charles T, Clark SR, Ly A, Souleimanov A, Zhou X, Smith DL.##Gray EJ, Lee KD, Souleimanov AM, Di Falco MR, Zhou X, Ly A, Charles TC, Driscoll BT, Smith DL.##Lee H, Churey JJ, Worobo RW.##Sit CS, van Belkum MJ, McKay RT, Worobo RW, Vederas JC.	The Belongs to the class IId bacteriocin thuricin-17 increases plant growth.##A novel bacteriocin, thuricin 17, produced by plant growth promoting rhizobacteria strain Bacillus thuringiensis NEB17: isolation and classification.##Biosynthesis and transcriptional analysis of thurincin H, a tandem repeated bacteriocin genetic locus, produced by Bacillus thuringiensis SF361.##The 3D solution structure of thurincin H, a bacteriocin with four sulfur to alpha-carbon crosslinks.	
DRAMP00184	EGTWQHGYGVSSAYSNYHHGSKTHSATVVNNNTGRQGKDTQRAGVWAKATVGRNLTEKASFYYNFW	66	Lactococcin 972 (Lcn972; homodimer; Bacteriocin)	O86283	Belongs to the class IId bacteriocin	lcn972	Lactococcus lactis subsp. lactis IPLA 972 (Streptococcus lactis) (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Beta strand (6 strands; 45 residues)	Not found	2LGN resolved by NMR.	Comment: No comments found on DRAMP database	Lactococcus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid II	10589723##21818877##PubMed ID is not available	Microbiology. 1999 Nov;145 (Pt 11):3155-3161.##Microbiology. 1996 Sep;142 (Pt 9):2393-2398.##Submitted (JUL-2011) to the PDB data bank.	Mart­nez B, Fern¡ndez M, Su¡rez JE, Rodr­guez A.##Mart­nez B, Su¡rez JE, Rodr­guez A.##Turner D.L, Lamosa P, Martinez B.	Synthesis of lactococcin 972, a bacteriocin produced by Lactococcus lactis IPLA 972, depends on the expression of a plasmid-encoded bicistronic operon.##Lactococcin 972: a homodimeric lactococcal bacteriocin whose primary target is not the plasma membrane.##Structure and properties of lactococcin 972 from Lactococcus lactis.	
DRAMP00185	KGKGFWSWASKATSWLTGPQQPGSPLLKKHR	31	Leucocin-B (Leu B; Leucocin B-TA33a; Bacteriocin)	P81052	Belongs to the class IId bacteriocin	Not found	Leuconostoc mesenteroides TA33a (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Inhibits a wide spectrum of lactic acid bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9611809	Microbiology. 1998 May;144 (Pt 5):1343-1348.	Papathanasopoulos MA, Dykes GA, Revol-Junelles AM, Delfour A, von Holy A, Hastings JW.	Sequence and structural relationships of leucocins A-, B- and C-TA33a from Leuconostoc mesenteroides TA33a.	
DRAMP00186	KRKCPKTPFDNTPGAWFAHLILGC	24	LSEI_2163 (m2163; Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	Not found	Lactobacillus casei ATCC 334 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: mature LSEI_2163 peptide was a class IId bacteriocin that exhibited antimicrobial activity against some lactobacilli and several Listeria species. The activities of both peptides tolerat 121°C for 30 min but not treatment with proteinase K or trypsin.	Gram-negative bacteria: Lactobacillus casei ATCC 393 (++), L. casei ATCC 27139 (++), Lactobacillus rhamnosus ATCC 21052 (+++++), L. rhamnosus ATCC 14957 (+), Lactobacillus plantarum ATCC 8014 (+), Listeria innocua ATCC 33091 (++), L. innocua CIP 78.44 (++), Listeria monocytogens ATCC 19112 (+++), Listeria welshimeri ATCC 43551 (++), Listeria seeligeri CIP79.46 (++++).##Note: + indistinct inhibit zone with diameter 8-12 mm, ++ indistinct inhibit zone with diameter ≥12 mm, +++ clear inhibit zone with diameter 12-16 mm, ++++ clear inhibit zone with diameter 16-20 mm, and +++++ clear inhibit zone with diameter ≥20 mm.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22688903	Appl Microbiol Biotechnol. 2012 Jun 12.	Kuo YC, Liu CF, Lin JF, Li AC, Lo TC, Lin TH.	Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.	
DRAMP00187	DSIRDVSPTFNKIRRWFDGLFK	22	LSEI_2386 (m2386; Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	Not found	Lactobacillus casei ATCC 334 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: mature LSEI_2386 was a putative pheromone peptide that also had significant bacteriocin activity against several Listeria species. The activities of both peptides tolerat 121°C for 30 min but not treatment with proteinase K or trypsin.	Gram-negative bacteria: Listeria innocua ATCC 33091 (++++), L. innocua CIP 78.44 (++++), Listeria monocytogens ATCC 19112 (+++++), Listeria welshimeri ATCC 43551 (+++++), Listeria seeligeri CIP79.46 (+++++).##Note: ++++ clear inhibit zone with diameter 16-20 mm, and +++++ clear inhibit zone with diameter ≥20 mm.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22688903	Appl Microbiol Biotechnol. 2012 Jun 12.	Kuo YC, Liu CF, Lin JF, Li AC, Lo TC, Lin TH.	Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.	
DRAMP00188	APAGLVAKFGRPIVKKYYKQIMQFIGEGSAINKIIPWIARMWRT	44	Enterocin RJ-11 (EntRJ-11; Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	Not found	Enterococcus faecalis RJ-11 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Enterococcus faecalis RJ-11, Enterococcus sp. strain RB-3, Enterococcus sp. strain RJ-10, Enterococcus sp. strain SJ-16, Enterococcus sp. strain YJ-35, Enterococcus durans KB-60, Lactococcus lactis IFO12007, Leuconostoc mesenteroides IFO3426, Bacillus subtilis JCM1465, Bacillus amyloliquefaciens B1, Bacillus cereus B3, Listeria monocytogenes SUB635, Staphylococcus aureus SUB511.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14532021	Appl Environ Microbiol. 2003 Oct;69(10):5746-5753.	Yamamoto Y, Togawa Y, Shimosaka M, Okazaki M.	Purification and characterization of a novel bacteriocin produced by Enterococcus faecalis strain RJ-11.	
DRAMP00192	MRTGNAN	7	Microcin C7 (MccC7; Microcin C51, MccC51; Bacteriocin)	Q47505	Belongs to the class I microcin	mccA	Escherichia coli (Gram-negative bacteria)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Beta strand	Not found	3H5R, 3H9J, 3H9Q, 3H9G resolved by X-ray.	Function: Inhibits protein translation by blocking aspartyl-tRNA synthetase Function: and inhibiting production of aminoacetylated tRNA-Asp. PTM: The peptide moiety allows entry into the bacterial cell, where it undergoes proteolytic cleavage to release the aspartyl adenylate analog, which is responsible for aspartyl-tRNA synthetase inhibition. Can be processed by the non-specific oligopeptidases pepA, pepB and pepN.	Gram-negative bacteria: Enterobacteria including species of Klebsiella, Salmonella, Shigella, Yersinia and Proteus, strains of Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	It targets the aspartyl-tRNA synthetase 	17827970##17711420##19494832	J Mol Microbiol Biotechnol. 2007;13(4):200-209.##Mol Microbiol. 2007 Sep;65(6):1380-1394.##EMBO J. 2009 Jul 8;28(13):1953-1964.	Duquesne S, Petit V, Peduzzi J, Rebuffat S.##Severinov K, Semenova E, Kazakov A, Kazakov T, Gelfand MS.##Regni CA, Roush RF, Miller DJ, Nourse A, Walsh CT, Schulman BA.	Structural and functional diversity of microcins, gene-encoded antibacterial peptides from enterobacteria.##Low-molecular-weight post-translationally modified microcins.##How the MccB bacterial ancestor of ubiquitin E1 initiates biosynthesis of the microcin C7 antibiotic.	
DRAMP00193	VGIGGGGGGGGGGSCGGQGGGCGGCSNGCSGGNGGSGGSGSHI	43	Microcin B17 (MccB17; Bacteriocin)	P05834, Q7M024	Belongs to the class I microcin	mcbA	Escherichia coli (Gram-negative bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: This glycine-rich peptide antibiotic inhibits DNA replication in many enteric bacteria, that leads to induction of the SOS repair system, massive DNA degradation and cell death. B17 inhibits type II topoisomerase by trapping an enzyme - DNA cleavable complex.
PTM: Maturation of thiazole and oxazole containing antibiotics involves the enzymic condensation of a Cys, Ser or Thr with the alpha-carbonyl of the preceding amino acid to form a thioether or ether bond, then dehydration to form a double bond with the alpha-amino nitrogen. Thiazoline or oxazoline rings are dehydrogenated to form thiazole or oxazole rings."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1846808##3329729	EMBO J. 1991 Feb;10(2):467-476.##Proteins. 1986 Nov;1(3):230-238.	Viz¡n JL, Hern¡ndez-Chico C, del Castillo I, Moreno F.##Davagnino J, Herrero M, Furlong D, Moreno F, Kolter R.	The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by Escherichia coli DNA gyrase.##The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine.	
DRAMP00194	GTPGFQTPDARVISRFGFN	19	Capistruin (Bacteriocin)	No entry found	Belongs to the class I microcin	Not found	Burkholderia thailandensis E264 (Gram-negative bacteria)	Antimicrobial, Antibacterial	Not found	Beta strand	Not found		Discovered by genome mining based on the known MccJ25-gene coding cluster McjABCD. Capistruin is endoded by the capABCD gene cluster, where capA encodes the precursor polypeptide, capB cleaves the presursor and is likely to promote the cyclization, capC encodes an enzyme that activates the side chain of Asp9 for cyclization, and capD encodes a immunity protein. Showed activity against closely related Burkholderia and Pseudomonas strains. Different from the lasso structure of MccJ25, where the N-terminal Gly forms an amide bond with the carboxyl group of Glu8, capistruin forms a 9-residue macrolactam ring formed between NH of Gly1 and the carboxylic side chain of Asp9. In addition, Arg15 is reponsible for the trapping of the tail in the ring structure. 	Burkholderia and Pseudomonas strains	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18671394	J Am Chem Soc. 2008 Aug 27;130(34):11446-11454.	Knappe TA, Linne U, Zirah S, Rebuffat S, Xie X, Marahiel MA.	Isolation and structural characterization of capistruin, a lasso peptide predicted from the genome sequence of Burkholderia thailandensis E264.	
DRAMP00195	ASGRDIAMAIGTLSGQFVAGGIGAAAGGVAGGAIYDYASTHKPNPAMSPSGLGGTIKQKPEGIPSEAWNYAAGRLCNWSPNNLSDVCL	88	Colicin-V (Microcin-V; Bacteriocin)	P22522	Belongs to the class IIa microcin	cvaC	Escherichia coli (Gram-negative bacteria)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Colicin V kills sensitive cells by disrupting the membrane potential. It targets bacterial membranes and induces ion channel formation, leading to the disruption of the proton-motive force and hence ATP production.
PTM: Contains one disulfide bond between 76-87."	Gram-negative bacteria: Escherichia coli (also closely related bacteria), Enterobacteriaceae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	8204625##7952189##2249654	Biochemistry. 1994 Jun 7;33(22):6911-6917.##Microbiology. 1994 Sep;140 (Pt 9):2383-2389.##EMBO J. 1990 Dec;9(12):3875-3884.	Fath MJ, Zhang LH, Rush J, Kolter R.##H¥varstein LS, Holo H, Nes IF.##Gilson L, Mahanty HK, Kolter R.	Purification and characterization of colicin V from Escherichia coli culture supernatants.##The leader peptide of colicin V shares consensus sequences with leader peptides that are common among peptide bacteriocins produced by Gram-positive bacteria.##Genetic analysis of an MDR-like export system: the secretion of colicin V.	
DRAMP00196	GDVNWVDVGKTVATNGAGVIGGAFGAGLCGPVCAGAFAVGSSAAVAALYDAAGNSNSAKQKPEGLPPEAWNYAEGRMCNWSPNNLSDVCL	90	Microcin L (MccL; Bacteriocin)	Q841V4	Belongs to the class IIa microcin	mclC	Escherichia coli (Gram-negative bacteria)	Antimicrobial, Antibacterial, Anti-Gram-	Predicted	Not found	Not found		It targets bacterial membranes and induces ion channel formation, leading to the disruption of the proton-motive force and hence ATP production.	Gram-negative bacteria: Escherichia coli, Klebsiella oxytoca CIP666, Salmonella enterica serovar Agon, S. enterica serovar Braenderup, S. enterica serovar Brandenburg, S. enterica serovar Bredeney, S. enterica serovar Derby, S. enterica serovar Dublin, S. enterica serovar Enteritidis ATCC 13076, S. enterica serovar Hadar, S. enterica serovar Heildeberg, S. enterica serovar Indiana, S. enterica serovar Kottbus, S. enterica serovar Newport, S. enterica serovar St.Paul, S. enterica serovar Typhimurium CIP5858, S. enterica serovar Virchow, Shigella sonnei CIP5236, Shigella flexneri CIP5236, Pseudomonas aeruginosa CIP100720T, Pseudomonas aeruginosa ATCC 27853.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	14742202##12897830	Antimicrob Agents Chemother. 2004 Feb;48(2):505-513.##Can J Microbiol. 2003 May;49(5):357-361.	Pons AM, Delalande F, Duarte M, Benoit S, Lanneluc I, Sabl© S, Van Dorsselaer A, Cottenceau G.##Sabl© S, Duarte M, Bravo D, Lanneluc I, Pons AM, Cottenceau G, Moreno F.	Genetic analysis and complete primary structure of microcin L.##Wild-type Escherichia coli producing microcins B17, D93, J25, and L; cloning of genes for microcin L production and immunity.	
DRAMP00197	AGDPLADPNSQIVRQIMSNAAWGPPLVPERFRGMAVGAAGGVTQTVLQGAAAHMPVNVPIPKVPMGPSWNGSKG	74	Microcin 24 (Mcc24; Bacteriocin)	Q46971	Belongs to the class IIa microcin	mtfS	Escherichia coli (Gram-negative bacteria)	Antimicrobial, Antibacterial, Anti-Gram-	Homology	Not found	Not found		MOA: It targets bacterial membranes and induces ion channel formation, leading to the disruption of the proton-motive force and hence ATP production.	Gram-negative bacteria: Escherichia coli, Salmonella typhimurium.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases.	O'Brien G.J, Mahanty H.K.	Complete nucleotide sequence of microcin 24 genetic region and analysis of a new ABC transporter.	
DRAMP00198	GGAPATSANAAGAAAIVGALAGIPGGPLGVVVGAVSAGLTTGIGSTVGSGSASSSAGGGS	60	Microcin H47 (MccH47; Bacteriocin)	P62530, P62531, Q9RM53	Belongs to the class IIb microcin	mchB	Escherichia coli (Gram-negative bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Bactericidal antibiotic. Active on bacteria phylogenetically related to the producing strain.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10471561##11181394	Antimicrob Agents Chemother. 1999 Sep;43(9):2176-2182.##Antimicrob Agents Chemother. 2001 Mar;45(3):969-972.	Rodr­guez E, Gaggero C, Lavi±a M.##Azpiroz MF, Rodr­guez E, Lavi±a M.	The structural gene for microcin H47 encodes a peptide precursor with antibiotic activity.##The structure, function, and origin of the microcin H47 ATP-binding cassette exporter indicate its relatedness to that of colicin V.	
DRAMP00199	MNLNGLPASTNVIDLRGKDMGTYIDANGACWAPDTPSIIMYPGGSGPSYSMSSSTSSANSGS	62	Microcin I47 (MccI47; Bacteriocin)	No entry found	Belongs to the class IIb microcin	Not found	Escherichia coli H47 (Gram-negative bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16569859	Antimicrob Agents Chemother. 2006 Apr;50(4):1411-1418.	Poey ME, Azpiroz MF, Lavi±a M.	Comparative analysis of chromosome-encoded microcins.	
DRAMP00200	DGNDGQAELIAIGSLAGTFISPGFGSIAGAYIGDKVHSWATTATVSPSMSPSGIGLSSQFGSGRGTSSASSSAGSGS	77	Microcin M (MccM; Bacteriocin)	No entry found	Belongs to the class IIb microcin	Not found	Escherichia coli MC4100 (Gram-negative bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		All Belongs to the class IIb microcins such as MccE492 have a Ser-rich C-terminal region and they may carry a siderophore-type PTM.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Nat Prod Rep. 2007 Aug;24(4):708-734.	Duquesne S, Destoumieux-Garz³n D, Peduzzi J, Rebuffat S.	Microcins, gene-encoded antibacterial peptides from enterobacteria.	
DRAMP00202	SCTTCVCTCSCCTT	14	Thiocillin (Bacteriocin)	P0C8P7, P0C8P6, Q812G9	Belongs to the thiocillin family	Not found	Bacillus cereus); also Bacillus badius	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has bacteriocidal activity against Gram-positive bacteria, but not against Gram-negative bacteria. Inhibits bacterial protein biosynthesis by acting on the elongation factor Tu (EF-Tu).
PTM: Maturation of thiazole and oxazole containing antibiot"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	819410##7328054	J Antibiot (Tokyo). 1976 Apr;29(4):366-374.##J Antibiot (Tokyo). 1981 Sep;34(9):1126-1136.	Shoji J, Kato T, Yoshimura Y, Tori K.##Shoji J, Hinoo H, Wakisaka Y, Koizumi K, Mayama M.	Structural studies on thiocillins I, II and III (studies on antibiotics from the genus Bacillus XXIX).##Isolation of three new antibiotics, thiocillins I, II and III, related to micrococcin P. Studies on antibiotics from the genus Bacillus. VIII.	
DRAMP00203	SCNCVCGFCCSCSP	14	Thiocillin GE2270 (Antibiotic GE2270; Bacteriocin)	Q7M0J8	Belongs to the thiocillin family	Not found	Planobispora rosea (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: inhibits bacterial protein biosynthesis by preventing the formation of a stable complex between the elongation factor Tu (EF-Tu), GTP and tRNA, hindering the activation of EF-Tu.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1908853	J Antibiot (Tokyo). 1991 Jul;44(7):693-701.	Selva E, Beretta G, Montanini N, Saddler G.S, Gastaldo L, Ferrari P, Lorenzetti R, Landini P, Ripamonti F, Goldstein B.P, Berti M, Montanaro L, Denaro M.	Antibiotic GE2270 A: a novel inhibitor of bacterial protein synthesis. I. Isolation and characterization.	
DRAMP00205	CLGIGSCNDFAGCGYAVVCFW	21	Tricyclic peptide RP 71955 (Bacteriocin)	P37046, Q7M104	Belongs to the class 1 lasso peptide	Not found	Streptomyces sp. (strain SP9440) (Gram-positive bacteria)	Antimicrobial, Antiviral	Protein level	Beta strand	Not found	1RPB, 1RPC resolved by NMR.	Function: Active against HIV-1 virus in vitro.	Virus: HIV-1	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization of a N-terminal between Cys1 and Asp9	Free	Disulfide bonds between Cys1 and Cys 13,Cys 7 and Cys19.	L	No cytotoxicity information found	Not found	8270499##8286361	J Antibiot (Tokyo). 1993 Nov;46(11):1756-1757.##Biochemistry. 1994 Jan 11;33(1):42-50.	Helynck G, Dubertret C, Mayaux JF, Leboul J.##Fréchet D, Guitton JD, Herman F, Faucher D, Helynck G, Monegier du Sorbier B, Ridoux JP, James-Surcouf E, Vuilhorgne M.	Isolation of RP 71955, a new anti-HIV-1 peptide secondary metabolite.##Solution structure of RP 71955, a new 21 amino acid tricyclic peptide active against HIV-1 virus.	
DRAMP00206	KTYYGTNGVHCTKKSLWGKVRLKNVIPGTLCRKQSLPIKQDLKILLGWATGAFGKTFH	58	Acidocin A (Bacteriocin)	Q48496	Not found	acdA	Lactobacillus acidophilus TK9201 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found		Function: Acidocin A is active against closely related lactic acid bacteria and food-borne pathogens including Listeria monocytogenes.	Gram-positive bacteria: Listeria monocytogenes, Clostridium sporogenes, Brochothrix thermosphacta, Lactobacillus fermentum, Lactobacillus delbrueckii subsp. Bulgaricus. Inmost other Lactobacillus species. 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7793908	Appl Environ Microbiol. 1995 Mar;61(3):1061-1067.	Kanatani K, Oshimura M, Sano K.	Isolation and characterization of acidocin A and cloning of the bacteriocin gene from Lactobacillus acidophilus.	
DRAMP00207	IYWIADQFGIHLATGTARKLLDAVASGASLGTAFAAILGVTLPAWALAAAGALGATAA	58	Acidocin B (Bacteriocin)	Q48499	Not found	acdB	Lactobacillus acidophilus M46 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Predicted	Not found	Not found	2MWR	Function: Acidocin B is active against Listeria monocytogenes, Clostridium sporogenes, Brochothrix thermosphacta, Lactobacillus fermentum and Lactobacillus delbrueckii subsp. bulgaricus, but inactive against most other Lactobacillus species.	Gram-positive bacteria: Listeria monocytogenes, Clostridium sporogenes, Brochothrix thermosphacta, Lactobacillus fermentum, Lactobacillus delbrueckii subsp. Bulgaricus. Inmost other Lactobacillus species. 	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Not found	7551031	Microbiology. 1995 Jul;141 (Pt 7):1629-1635.	Leer RJ, van der Vossen JM, van Giezen M, van Noort JM, Pouwels PH.	Genetic analysis of acidocin B, a novel bacteriocin produced by Lactobacillus acidophilus.	
DRAMP00208	KTHYPTNAWKSLWKGFWESLRYTDGF	26	Acidocin 8912 (Bacteriocin)	Q48501, Q9R5H2	Not found	acdT	Lactobacillus acidophilus TK8912 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Has a bactericidal effect on sensitive cells but not a bacteriolytic effect.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8554765##1368836	Lett Appl Microbiol. 1995 Dec;21(6):384-386.##Biosci Biotechnol Biochem. 1992 Aug;56(8):1212-1215.	Kanatani K, Tahara T, Oshimura M, Sano K, Umezawa C.##Tahara T, Kanatani K, Yoshida K, Miura H, Sakamoto M, Oshimura M.	Cloning and nucleotide sequence of the gene for acidocin 8912, a bacteriocin from Lactobacillus acidophilus TK8912.##Purification and some properties of acidocin 8912, a novel bacteriocin produced by Lactobacillus acidophilus TK8912.	
DRAMP00209	ANCSCSTASDYCPILTFCTTGTACSYTPTGCGTGWVYCACNGNFY	45	Fulvocin C (Bacteriocin)	P01547	Not found	Not found	Myxococcus fulvus (Gram-negative bacteria)	Unknown	Protein level	Not found	Not found		Function: Bacteriocin.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	6783114	Biochim Biophys Acta. 1981 Jan 30;667(1):213-217.	Tsai H, Hirsch HJ.	The primary structure of fulvocin C from Myxococcus fulvus.	
DRAMP18336	ADRGWIKTLTKDCPNVISSICAGTIITACKNCA	33	Thermophilin 1277 (Bacteriocin)	A7M695	Belongs to the lantibiotics family (Class I bacteriocin)	tepA	Streptococcus thermophilus SBT1277	Antimicrobial, Antibacterial, Anti-Gram+		Rich 	Peptide sequence analysis following chemical modification of thermophilin 1277 revealed that the Cys21 and Cys29 residues form a disulfide bridge and that Thr8 or Thr10 forms two 3-methyllanthionines with Cys13 or Cys32 via thioether bridges. Antimicrobial activity was disrupted by ethanethiol or reductive agent treatments, indicating that the internal amino acid modifications are crucial for the activity.		It shares the same sequence with bovicin HJ50 prior to post-translational modifications. A followup study concluded at two rings and one disulfide bond .	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17381740	J Appl Microbiol. 2007 Apr;102(4):971-80.	Kabuki T, Uenishi H, Watanabe M, Seto Y, Nakajima H.	Characterization of a bacteriocin, Thermophilin 1277, produced by Streptococcus thermophilus SBT1277.	
DRAMP00211	GLGKAQCAALWLQCASGGTIGCGGGAVACQNYRQFCR	37	Sublancin-168 (Bacteriocin)	P68578, O34781, O64033	Not found	sunA	Bacillus phage SPbeta (Bacillus phage SPBc2) (Bacteriophage SP-beta)	Unknown	Homology	Not found	Not found	2MIJ	"Function: Bacteriocin active against Gram-positive bacteria. Inhibits B. cereus spore outgrowth, after the germination stage, approximately 1000-fold better than it inhibits exponential growth of the same cells. Inhibits B.subtilis strain ATCC 6633 (By similarity).
PTM: Production of active sublancin-168 requires at least one thiol-disulfide oxidoreductase (BdbB or, in its absence, BdbC). Membrane translocation and cleavage of the precursor are probably performed by SunT (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10376821	Microbiology. 1999 May;145 ( Pt 5):1055-1067.	Lazarevic V, Düsterhöft A, Soldo B, Hilbert H, Mauël C, Karamata D.	Nucleotide sequence of the Bacillus subtilis temperate bacteriophage SPbetac2.	
DRAMP00212	AVPAVRKTNETLD	13	Rhamnosin A (Bacteriocin)	P86526 	Not found	Not found	Lactobacillus rhamnosus strain 68 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against the Gram-positive bacterium: M. lysodeikticus, but not against Lactobacillus plantarum 8014 or Lact. plantarum 39268. It may act as a pore-forming protein, creating a channel in the cell membrane.
Classification: Being a small, heat-stable, nonlanthionine-containing peptide, rhamnosin A should be categorized as a class II bacteriocin."	Gram-positive bacterium: Micrococcus lysodeikticus ATCC 4698.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	 Cell membrane	19796123	J Appl Microbiol. 2009 Dec 1;107(6):2108-2015.	DimitrijeviÄ‡ R, StojanoviÄ‡ M, ZivkoviÄ‡ I, Petersen A, Jankov RM, DimitrijeviÄ‡ L, GavroviÄ‡-JankuloviÄ‡ M.	The identification of a low molecular mass bacteriocin, rhamnosin A, produced by Lactobacillus rhamnosus strain 68.	
DRAMP00213	STPVLASVAVSMELLPTASVLYSDVAGCFKYSAKHHC	37	Lactocin S (Bacteriocin)	P23826, Q48848, Q48858	Not found	lasA	Lactobacillus sakei L45 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"MOA: The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. 
PTM: Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor."	Leuconostoc, Carnobacteria, Lactobacilli, Pediococci, Lactococci, Listeria monocytogenes, Listeria innocua, Staphylococcus, Bacillus cereus, Clostridium spp.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Deaminated	Cyclization  between S32 and C37	Two lanthionines(S32-C37,S23-C28)	Mixed(D-Ala)	No cytotoxicity information found	Cell membrane	1872611##7961627	Appl Environ Microbiol. 1991 Jun;57(6):1829-1834.##J Biol Chem. 1994 Nov 4;269(44):27183-27185.	M¸rtvedt CI, Nissen-Meyer J, Sletten K, Nes IF.##Skaugen M, Nissen-Meyer J, Jung G, Stevanovic S, Sletten K, Inger C, Abildgaard M, Nes IF.	Purification and amino acid sequence of lactocin S, a bacteriocin produced by Lactobacillus sake L45.##In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide.	
DRAMP00214	MVPTTFTLTTNNFLSDYQQLFI	22	Lactococcin K (Bacteriocin)	No entry found	Not found	Not found	Lactococcus lactis subsp. lactis MY23 	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16614924	Biotechnol Lett. 2006 Mar;28(5):357-362.	Kim YS, Kim MJ, Kim P, Kim JH.	Cloning and production of a novel bacteriocin, lactococcin K, from Lactococcus lactis subsp. lactis MY23.	
DRAMP00215	NRWYCNSAAGGVGGAAGCVLAGYVGEAKENIAGEVRKGWGMAGGFTHNKACKSFPGSGWASG	62	Enterocin E-760 (Bacteriocin)	No entry found	Not found	Not found	Enterococcus durans/faecium/hirae NRRL B-30745 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		The enterocin demonstrated thermostability by retaining activity after 5 min at 100 degrees C and was stable at pH values between 5.0 and 8.7. However, activity was lost below pH 3.0 and above pH 9.5.	Gram-positive bacteria: Salmonella enterica serovar Enteritidis, S. enterica serovar Choleraesuis, S. enterica serovar Typhimurium, S. enterica serovar Gallinarum, Escherichia coli O157:H7, Yersinia enterocolitica, Citrobacter freundii, Klebsiella pneumoniae, Shigella dysenteriae, Pseudomonas aeruginosa, Proteus mirabilis, Morganella morganii, Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, Campylobacter jejuni, 20 other Campylobacter species isolates. 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18086839	Antimic Agents Chemother 2008 Mar;52(3):1094-1100.	Line JE, Svetoch EA, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, Levchuk VP, Svetoch OE, Seal BS, Siragusa GR, Stern NJ.	Isolation and purification of enterocin E-760 with broad antimicrobial activity against gram-positive and gram-negative bacteria	
DRAMP00216	AIKLVQSPNGNFAASFVLDGTKWIFKSKYYDSSKGYWVGIYEVWDRK	47	Antimicrobial peptide LCI (Bacteriocin)	P82243	Not found	Not found	Bacillus subtilis (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Beta strand (4 strands; 27 residues)	The solution structure of LCI has a novel topology, containing a four-strand antiparallel beta-sheet as the dominant secondary structure.	2B9K resolved by NMR.	"Function: Has antibacterial activity against X.oryzae pv oryzae and R.solanacearum. May bind DNA or mRNA.
Miscellaneous: Heat stable. Resistant to proteolysis by tryspin and pepsin, but susceptible to pronase E and proteinase K."	X. oryzae pv oryzae, R. solanacearum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	DNA or mRNA	PubMed ID is not available##21449609	Rice Genet. Newsl. 1990;7:151-154.##iochemistry. 2011 May 10;50(18):3621-3627.	Liu JY, Pan NS, Chen ZL.##Xia, B, Gong, W, Lu, G.	Characterization of an anti-rice bacterial blight polypeptide LCI.##Solution structure of LCI, an AMP from Bacillus subtilis.	
DRAMP00217	ASILTNAS	8	Bacteriocin	P84703	Not found	Not found	Rhizobium leguminosarum bv. Viciae (Gram-negative bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Narrow spectrum bacteriocin, active against closely related bacterial species.	Closely related bacterial species.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2005) to UniProtKB.	Naeem F.I, Khan S.A, Mukhtar Z, Zafar Y, Malik K.A, Hafeez F.Y.	Isolation and characterization of bacteriocin like protein from Rhizobium leguminosarum bv. viciae.	
DRAMP00219	YSLQMGATAIKQVKKLFKKWGW	22	PlnA-22 (Bacteriocin)	No entry found	Not found	Not found	Lactobacillus plantarum (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Lactobacillus sake NCDO 2714 (IC50=40 nM), Lactobacillus plantarum 965 (IC50=300 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15805109	J Biol Chem. 2005 Jun 17;280(24):22945-22950.	Kristiansen PE, Fimland G, Mantzilas D, Nissen-Meyer J.	Structure and mode of action of the membrane-permeabilizing antimicrobial peptide pheromone plantaricin A.	
DRAMP00220	GATAIKQVKKLFKKWGW	17	PlnA-17 (Bacteriocin)	No entry found	Not found	Not found	Lactobacillus plantarum (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Lactobacillus sake NCDO 2714 (IC50=15 nM), Lactobacillus plantarum 965 (IC50=400 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15805109	J Biol Chem. 2005 Jun 17;280(24):22945-22950.	Kristiansen PE, Fimland G, Mantzilas D, Nissen-Meyer J.	Structure and mode of action of the membrane-permeabilizing antimicrobial peptide pheromone plantaricin A.	
DRAMP00221	DQMSDGVNYGKGSSLSKGGAKCGLGIVGGLATIPSGPLGWLAGAAGVINSCMK	53	Carnobacteriocin-A (Piscicolin-61; Bacteriocin)	P38578	Not found	cbnBA	Carnobacterium piscicola (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity.
PTM: Contains one disulfide bond 22-51."	Gram-positive bacteria: Carnobacterium, Enterococcus, Listeria monocytogenes, Clostridium perfringens.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8012574##7764997	Microbiology. 1994 Mar;140 (Pt 3):517-526.##Curr Microbiol. 1994 Aug;29(2):63-68.	Worobo RW, Henkel T, Sailer M, Roy KL, Vederas JC, Stiles ME.##Holck AL, Axelsson L, Schillinger U.	Characteristics and genetic determinant of a hydrophobic peptide bacteriocin, carnobacteriocin A, produced by Carnobacterium piscicola LV17A.##Purification and cloning of piscicolin 61, a bacteriocin from Carnobacterium piscicola LV61.	
DRAMP18335	GNGVFKTISHECHLNTWAFLATCCS	25	Salivaricin G32(Bacteriocin)	H6VLK4	Belongs to the lantibiotics family (Class I bacteriocin)	slnA	Streptococcus salivarius strain G32	Antimicrobial, Antibacterial, Anti-Gram+		Not found	The first modified amino acid was found to be a dehydrobutyrine (Dhb) at position 8 that could form a beta-methyl-lanthionine bond with Cys13. A second beta-methyl-lanthionine formation between Dhb and Cys was found at positions 10 and 32, respectively. A disulfide bridge was between the two Cys residues at positions 21 and 29. The data is in accordance with the sequence analysis of bovicin HJ50 and thermophilin 1277.		The inhibitory peptide differs from the Streptococcus pyogenes-produced SA-FF22 in the absence of lysine in position 2.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22567013##23122510 	Int J Microbiol. 2012;2012:738503.##Food Microbiol. 2013 Feb;33(1):124-30.	Wescombe PA, Dyet KH, Dierksen KP, Power DA, Jack RW, Burton JP, Inglis MA, Wescombe AL, Tagg JR.##Georgalaki M, Papadimitriou K, Anastasiou R, Pot B, Van Driessche G, Devreese B, Tsakalidou E.	Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.##Macedovicin, the second food-grade lantibiotic produced by Streptococcus macedonicus ACA-DC 198.	
DRAMP00224	KQQLATEAESAGPIL	15	BTL (Bacteriocin)	No entry found	Not found	Not found	Bacillus subtilis B-TL2 (Gram-positive bacteria)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: The peptide exhibits strong inhibitory activity against mycelial growth of Bipolaris maydis, Alternaria brassicae, Aspergillus niger, Cercospora personata.
Biophysicochemical properties: The purified BTL displays thermostability, almost retaining 100% activity at 100 degrees C for 15 min."	Fungi: Bipolaris maydis, Alternaria brassicae, Aspergillus niger, Cercospora personata.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18241956	Peptides. 2008 Mar;29(3):350-355.	Zhang B, Xie C, Yang X.	A novel small antifungal peptide from Bacillus strain B-TL2 isolated from tobacco stems.	
DRAMP00225	ILFSYLLFYVLKENSKREDKYQNIIEELTELLPKIKEDVEDIKEKLNK	48	Bacteriocin UviB	P15936	Not found	uviB	Clostridium perfringens (Gram-positive bacteria)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Function: May have a role in bacteriocin secretion or immunity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2901768##2460717	Plasmid. 1988 Mar;19(2):134-150.##Mol Microbiol. 1988 Sep;2(5):607-614.	Garnier T, Cole ST.##Garnier T, Cole ST.	Complete nucleotide sequence and genetic organization of the bacteriocinogenic plasmid, pIP404, from Clostridium perfringens.##Studies of UV-inducible promoters from Clostridium perfringens in vivo and in vitro.	
DRAMP00226	NIPQLTPTP	9	Bioactive peptide 3 (BAP3; Curvalicin-28c; Bacteriocin)	P84711	Not found	Not found	Lactobacillus curvatus (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive bacteria and the Gram-positive bacteria. Has no antifungal activity against S.cerevisiae, Penicillium sp BKS-TAN2 or A.niger.
PTM: Contains one disulfide bond."	Gram-positive bacteria: Listeria monocytogenes, Lactococcus lactis subsp lactis and Lactobacillus curvatus H28.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Food Res. Intern. 2010;43:33-39.	Ghalfi H, Benkerroum N, Ongena M, Bensaid M, Thonart P.	Production of three anti-listerial peptides by Lactobacillus curvatus in MRS broth.	
DRAMP00227	VAPFPEQFLX	10	Bioactive peptide 2 (BAP2;Curvalicin-28b; Bacteriocin)	P84710	Not found	Not found	Lactobacillus curvatus (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Has antibacterial activity. Has no antifungal activity against S. cerevisiae, Penicillium sp BKS-TAN2 or A. niger.	Gram-positive bacteria: Listeria monocytogenes, Lactococcus lactis subsp lactis and Lactobacillus curvatus H28.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Food Res. Intern. 2010;43:33-39.	Ghalfi H, Benkerroum N, Ongena M, Bensaid M, Thonart P.	Production of three anti-listerial peptides by Lactobacillus curvatus in MRS broth.	
DRAMP00228	TPVVNPPFLQQT	12	Bioactive peptide 1 (BAP1; Curvalicin-28a; Bacteriocin)	P84709	Not found	Not found	Lactobacillus curvatus (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Has antibacterial activity. Has no antifungal activity against S. cerevisiae, Penicillium sp BKS-TAN2 or A. niger.	Gram-positive bacteria: Listeria monocytogenes, Lactococcus lactis subsp lactis and Lactobacillus curvatus H28.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Food Res. Intern. 2010;43:33-39.	Ghalfi H, Benkerroum N, Ongena M, Bensaid M, Thonart P.	Production of three anti-listerial peptides by Lactobacillus curvatus in MRS broth.	
DRAMP00229	KPAWCWYTLAMCGAGYDSGTCDYMYSHCFGVKHSSGGGGSYHC	43	Bacteriocin plantarican ASM1 (PASM1; Bacteriocin)	C7G1H4	Not found	bactA1	Lactobacillus plantarum A-1 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found	2MVI	"Function: Bacteriocin with a narrow antibacterial spectrum. Has Antibacterial activity.
Biophysicochemical properties: pH dependence (Stable from pH 5.5-8.5); Temperature dependence (Thermostable, activity is retained after incubation at 90degrees Celsius for 15 minutes).
PTM: Contains two disulfide bonds."	Gram-positive bacteria: Lactobacillus plantarum, L. pentosus, L. curvatus, L. lindneri, Leuconostoc mesenteroides and Enterococcus faecalis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19939484	Int J Food Microbiol. 2010 Jan 31;137(1):94-99.	Hata T, Tanaka R, Ohmomo S.	Isolation and characterization of plantaricin ASM1: a new bacteriocin produced by Lactobacillus plantarum A-1.	
DRAMP00230	GSQLVYREWVGHSNVIKP	18	Lariatins A (lasso peptide; Bacteriocin)	No entry found	Not found	Not found	Rhodococcus jostii K01-B0171 (Gram-positive bacteria) 	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Mycobacterium smegmatis and Mycobacterium tuberculosis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16756302	J Am Chem Soc. 2006 Jun 14;128(23):7486-7891.	Iwatsuki M, Tomoda H, Uchida R, Gouda H, Hirono S, Omura S.	Lariatins, antimycobacterial peptides produced by Rhodococcus sp. K01-B0171, have a lasso structure.	
DRAMP00231	GSQLVYREWVGHSNVIKGPP	20	Lariatins B (lasso peptide; Bacteriocin)	No entry found	Not found	Not found	Rhodococcus jostii K01-B0171 (Gram-positive bacteria) 	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Mycobacterium smegmatis and Mycobacterium tuberculosis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16756302	J Am Chem Soc. 2006 Jun 14;128(23):7486-7891.	Iwatsuki M, Tomoda H, Uchida R, Gouda H, Hirono S, Omura S.	Lariatins, antimycobacterial peptides produced by Rhodococcus sp. K01-B0171, have a lasso structure.	
DRAMP00233	ISLEICXIFHDN	12	Lichenin (Bacteriocin-like)	P82907	Not found	Not found	Bacillus licheniformis (Gram-positive bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Residue A7 is uncertain. Has antibacterial activity only against strictly anaerobic rumen bacteria.
Biophysicochemical properties: pH dependence (Optimum pH is 6.8); Temperature dependence (Optimum temperature is 39 degrees Celsius)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11576300##15881839	J Appl Microbiol. 2001 Oct;91(4):636-645.##Microbiol Res. 2005;160(2):213-218.	Pattnaik P, Kaushik JK, Grover S, Batish VK.##Pattnaik P, Grover S, Batish VK.	Purification and characterization of a bacteriocin-like compound (Lichenin) produced anaerobically by Bacillus licheniformis isolated from water buffalo.##Effect of environmental factors on production of lichenin, a chromosomally encoded bacteriocin-like compound produced by Bacillus licheniformis 26L-10/3RA.	
DRAMP00234	DIGGSRQGCVA	11	Trifolitoxin (TFX; Bacteriocin)	P42723	Not found	tfxA	Rhizobium leguminosarum bv. Trifolii T24 (Gram-negative bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antibiotic whose production provides the bacteria a mechanism of host root nodule competitiveness with other invading inefficient strains.
PTM: Synthesized ribosomally as a prepeptide that is post-translationally modified to the active peptide. TfxB, TfxD and TfxF are all required for this processing.The chromophore is probably a six-membered ring derived from the cyclization of Gln-38.
Maturation of thiazole and oxazole containing antibiotics involves the enzymic condensation of a Cys, Ser or Thr with the alpha-carbonyl of the preceding amino acid to form a thioether or ether bond, then dehydration to form a double bond with the alpha-amino nitrogen. Thiazoline or oxazoline rings are dehydrogenated to form thiazole or oxazole rings.
Biophysicochemical properties: pH dependence (Sensitive to extremes of pH); Temperature dependence (Thermostable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8509324	J Bacteriol. 1993 Jun;175(12):3693-3702.	Breil BT, Ludden PW, Triplett EW.	DNA sequence and mutational analysis of genes involved in the production and resistance of the antibiotic peptide trifolitoxin.	
DRAMP00235	MINRTDCNENSYLEIHNNEGRDTLCFANAGTMPVAIYGVNWVESGNNVVTLQFQRNLSDPRLETITLQKWGSWNPGHIHEILSIRIY	87	AFP1 (Bacteriocin)	No entry found	Not found	Not found	Streptomyces tendae Tu901 (Gram-positive bacteria)	Antimicrobial, Antifungal	Not found	Combine helix and strand structure	Mature AFP1 comprises 86 residues and contains two antiparallel beta-sheets (five and four beta-strands each), that pack against each other in a parallel beta-sandwich.	1G6E resolved by NMR.	Function: AFP1 is a recently discovered anti-fungal, chitin-binding protein.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	10601197##11350173	J Bacteriol. 1999 Dec;181(24):7421-7429.##J Mol Biol. 2001 May 11;308(4):765-782.	Bormann C, Baier D, Hörr I, Raps C, Berger J, Jung G, Schwarz H.##Campos-Olivas R, Hörr I, Bormann C, Jung G, Gronenborn AM.	Characterization of a novel, antifungal, chitin-binding protein from Streptomyces tendae T¼901 that interferes with growth polarity.##Solution structure, backbone dynamics and chitin binding of the anti-fungal protein from Streptomyces tendae TU901.	
DRAMP00236	SDCNINSNTAADVILCFNQVGSCALCSPTLVGGPVP	36	Halocin-S8 (HalS8; Bacteriocin)	Q9HHA8	Not found	halS8	Haloarchaeon S8a 	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Miscellaneous: Halocin-S8 is quite robust, as it can be desalted, boiled, subjected to organic solvents, and stored at 4 degrees Celsius for extended periods without losing activity."	Gram-positive bacteria: Halobacterium salinarum NRC817, Halobacterium GRB and Haloferax gibbonsii.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10940040	J Bacteriol. 2000 Sep;182(17):4951-4958.	Price LB, Shand RF.	Halocin S8: a 36-amino-acid microhalocin from the haloarchaeal strain S8a.	
DRAMP00237	DIDITGCSACKYAAG	15	Halocin-C8 (HalC8; Bacteriocin)	P83716	Not found	Not found	Halobacterium sp. (strain AS7092)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		MOA: Causes cell lysis and death, possibly by disrupting the cell wall. boiled, subjected to organic solvents, and stored at 4 degrees Celsius for extended periods without losing activity.	A wide variety of haloarchaeons.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell wall	12811620	Extremophiles. 2003 Oct;7(5):401-407.	Li Y, Xiang H, Liu J, Zhou M, Tan H.	Purification and biological characterization of halocin C8, a novel peptide antibiotic from Halobacterium strain AS7092.	
DRAMP00238	YTAKQCLQAIGSCGIAGTGAGAAGGPAGAFVGAXVVXI	38	Curvaticin FS47 (Bacteriocin)	P80323	Not found	Not found	Lactobacillus curvatus FS47 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Has bacteriocin activity.	Gram-positive bacteria: Listeria monocytogenes, Pediococcus, Enterococcus, Lactobacilli and Bacilli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8031103	Appl Environ Microbiol. 1994 Jun;60(6):2191-2195.	Garver KI, Muriana PM.	Purification and partial amino acid sequence of curvaticin FS47, a heat-stable bacteriocin produced by Lactobacillus curvatus FS47.	
DRAMP00239	TPGGIDFISGGPHVAQDVLNAIKNFFK	27	Enterocin NKR-5-3D (Bacteriocin)	No entry found	Not found	Not found	Enterococcus faecium NKR-5-3 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22738965	Biosci Biotechnol Biochem. 2012 May 23;76(5):947-953.	Ishibashi N, Himeno K, Fujita K, Masuda Y, Perez RH, Zendo T, Wilaipun P, Leelawatcharamas V, Nakayama J, Sonomoto K.	Purification and characterization of multiple bacteriocins and an inducing peptide produced by Enterococcus faecium NKR-5-3 from Thai fermented fish.	
DRAMP00240	MRKEFHNVLSSGQLLADKRPARDYNRK	27	Pep27 (Bacteriocin)	No entry found	Not found	Not found	Streptococcus pneumoniae (Gram-negative bacteria)	Antibacterial, Anti-cancer, Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16004618	Cancer Cell Int. 2005 Jul 11;5:21.	Lee DG, Hahm KS, Park Y, Kim HY, Lee W, Lim SC, Seo YK, Choi CH.	Functional and structural characteristics of Anti-cancer peptide Pep27 analogues.	
DRAMP00241	KKXXKKVAXTWGNAATAAASGAVKGILG	28	Brevicin 27 (Bacteriocin)	No entry found	Not found	Not found	Lactobacillus brevis SB27 (Gram-positive bacteria) 	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9009071	Curr Microbiol. 1997 Mar;34(3):173-179.	Benoit V, Lebrihi A, Milli¨re JB, Lefebvre G.	Purification and partial amino acid sequence of brevicin 27, a bacteriocin produced by Lactobacillus brevis SB27.	
DRAMP00242	XXKEIXHIFHDN	12	Subpeptin JM4-B (Bacteriocin)	P83879	Not found	Not found	Bacillus subtilis JM4 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity against Gram-positive and Gram-negative bacteria.
Developmental stage: Expressed from the mid-exponential phase, maximum activity is reached at the stationary phase."	Gram-positive bacteria: Salmonella, Bacillus cereus, Bacillus megaterium, Lactobacillus casei, Leptostylus viridescens, Myotis flavus, Corynebacterium glutamicum, Corynebacterium crenatum, Leuconostoc mesenteroides, Enterococcus faecalis, Shigella flexneri, Staphylococcus aureus and Bacillus thuringiensis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16211432	Curr Microbiol. 2005 Nov;51(5):292-296.	Wu S, Jia S, Sun D, Chen M, Chen X, Zhong J, Huan L.	Purification and characterization of two novel antimicrobial peptides Subpeptin JM4-A and Subpeptin JM4-B produced by Bacillus subtilis JM4.	
DRAMP00243	XXKEIXWIFHDN	12	Subpeptin JM4-A (Bacteriocin)	P83878	Not found	Not found	Bacillus subtilis JM4 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity against Gram-positive and Gram-negative bacteria.
Developmental stage: Expressed from the mid-exponential phase, maximum activity is reached at the stationary phase.
Biophysicochemical properties: pH dependence (Active from pH 2.0 to 8.0. Retains some activity up to pH 12.0); Temperature dependence (Active from 20 to 100 degrees Celsius)."	Gram-positive bacteria: Salmonella, Bacillus cereus, Bacillus megaterium, Lactobacillus casei, Leptostylus viridescens, Lactobacillus plantarum CGMCC 1.3, Myotis flavus, Corynebacterium glutamicum, Corynebacterium crenatum, Leuconostoc mesenteroides, Bacillus thuringiensis, Streptococcus faecalis CGMCC.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16211432	Curr Microbiol. 2005 Nov;51(5):292-296. 	Wu S, Jia S, Sun D, Chen M, Chen X, Zhong J, Huan L.	Purification and characterization of two novel antimicrobial peptides Subpeptin JM4-A and Subpeptin JM4-B produced by Bacillus subtilis JM4.	
DRAMP00245	VGALAVVVWLWLWLW	15	Gramicidin A (GA; Nonribosomally synthesized bacteriocin)	No entry found	Not found	Not found	Bacillus brevis (soil bacterium) (Gram-positive bacteria)	Antimicrobial, Antbacterial, Antiviral	Not found	Beta strand (1 strands; 13 residues)	Amino acids 4, 6, 8, 10, and 12 are D-amino acids, allowing the formation of a special helical structure that head-to-head dimerizes into a cation channel in lipid bilayer with the C-terminus exposed. Structures solved in organic solvents by x-ray diffraction are believed to be non-channel forms. 	1MAG resolved by NMR.	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19870884##8810522	J Exp Med. 1939 Jun 30;70(1):1-10.##J Biomol NMR. 1996 Jul;8(1):1-14.	Dubos RJ.##Ketchem RR, Lee KC, Huo S, Cross TA.	STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS : I. PREPARATION OF THE AGENT. ITS ACTIVITY IN VIT.##Macromolecular structural elucidation with solid-state NMR-derived orientational constraints.	
DRAMP00246	VGALAVVVWLFLWLW	15	Gramicidin B (GB; Bacteriocin)	No entry found	Not found	Not found	Bacillus brevis (soil bacterium) (Gram-positive bacteria)	Antimicrobial, Antbacterial, Antiviral	Not found	Beta strand (1 strands; 13 residues)	Not found	1JO3 resolved by NMR.	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11570868	Biochemistry 2001; 40: 11676-11686.	Townsley, L.E, Tucker, W.A, Sham, S, Hinton, J.F.	Structures of gramicidins A, B, and C incorporated into sodium dodecyl sulfate micelles.	
DRAMP00247	VGALAVVVWLYLWLW	15	Gramicidin C (GC; Bacteriocin)	No entry found	Not found	Not found	Bacillus brevis (soil bacterium) (Gram-positive bacteria)	Antimicrobial, Antbacterial, Antiviral	Not found	Beta strand (1 strands; 13 residues)	Not found	1JO4 resolved by NMR.	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11570868	Biochemistry 2001; 40: 11676-11686.	Townsley, L.E, Tucker, W.A, Sham, S, Hinton, J.F.	Structures of gramicidins A, B, and C incorporated into sodium dodecyl sulfate micelles.	
DRAMP00248	KPAWCWYTLAMCGAGYDSGTCDYMYSHCFGIKHHSSGSSSYHC	43	Glycocin F (GccF; S-glycosylated bacteriocin)	E9K9Z1	Not found	gccF	Lactobacillus plantarum KW30 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix (2 helices; 16 residues)	Glycocin F is a 43-amino acid bacteriocin, which contains two beta-linked N-acetylglucosamine moieties, attached via side chain linkages to a serine via oxygen, and to a cysteine via S-linked sugar. The peptide conformation consists primarily of two alpha-helices held together by a pair of nested disulfide bonds.	2KUY resolved by NMR.	"Function: Has antibacterial activity.
PTM: Contains two disulfide bonds 5-28; 12-21."	Gram-positive bacterium: Lactobacillus plantarum ATCC 8014 (IC50=2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21395300##21251913	Biochemistry. 2011 Apr 12;50(14):2748-2755.##FEBS Lett. 2011 Feb 18;585(4):645-650.	Venugopal H, Edwards PJ, Schwalbe M, Claridge JK, Libich DS, Stepper J, Loo T, Patchett ML, Norris GE, Pascal SM.##Stepper J, Shastri S, Loo TS, Preston JC, Novak P, Man P, Moore CH, Havl­?ek V, Patchett ML, Norris GE.	Structural, dynamic, and chemical characterization of a novel S-glycosylated bacteriocin.##Cysteine S-glycosylation, a new post-translational modification found in glycopeptide bacteriocins.	
DRAMP00249	YSLQMGATAIKQVKKLFKKKGG	22	Pln149 (Plantaricin 149; Bacteriocin; Derivatives: Pln149a)	No entry found	Not found	Not found	Lactobacillus plantarum NRIC 149 (Gram-positive bacteria)	Antimicrobial, Antibacterial, Antifungal	Not found	Alpha helix	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrance	17266050	J. Fermentation Bioeng. 1994;77(3):277-282.	Kato T, Matsuda T, Ogawa E, Ogawa H, Kato H, Doi U.	Plantaricin-149, a bacteriocin produced by Lactobacillus plantarum NRIC 149.	
DRAMP00250	DYHHGVRVL	9	Bacteriocin serracin-P 43 kDa subunit (Bacteriocin)	P83375	Not found	Not found	Serratia plymuthica (Gram-negative bacteria)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Function: Major component of a prophage tail sheath. Antibacterial activity against Gram-negative bacteria E.amylovora.	Gram-negative bacterium: Erwinia amylovora.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12406768	Appl Environ Microbiol. 2002 Nov;68(11):5704-5710.	Jabrane A, Sabri A, Comp¨re P, Jacques P, Vandenberghe I, Van Beeumen J, Thonart P.	Characterization of serracin P, a phage-tail-like bacteriocin, and its activity against Erwinia amylovora, the fire blight pathogen.	
DRAMP00251	ALPKKLKYLNLFNDGFNYMGVV	22	Bacteriocin serracin-P 23 kDa subunit (Bacteriocin)	P83378	Not found	Not found	Serratia plymuthica J7 (Gram-negative bacteria)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Function: Major component of a prophage tail tube. Antibacterial activity against Gram-negative bacteria E.amylovora.	Gram-negative bacterium: Erwinia amylovora.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12406768	Appl Environ Microbiol. 2002 Nov;68(11):5704-5710.	Jabrane A, Sabri A, Comp¨re P, Jacques P, Vandenberghe I, Van Beeumen J, Thonart P.	Characterization of serracin P, a phage-tail-like bacteriocin, and its activity against Erwinia amylovora, the fire blight pathogen.	
DRAMP00252	VNPSYRLDPESRPQCEAHCGQLGMRLGAIVIMGTATGCVCEPKEAATPESR	51	AdDLP (A. dehalogenans defensin-like peptide; Bacteriocin)	No entry found	Not found	Not found	Anaeromyxobacter dehalogenans (Gram-negative bacteria)	Antibacterial, Antifungal, Antiparasitic, Antimicrobial	Not found	Not found	Circular dichroism (CD) analysis indicates that recombinant AdDLP adopts a typical structural feature of eukaryotic defensins, which is also consistent with an ab initio structure model predicted using I-TASSER algorithm.		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19615342	Biochem Biophys Res Commun. 2009 Sep 18;387(2):393-398.	Gao B, Rodriguez MD, Lanz-Mendoza H, Zhu S.	AdDLP, a bacterial defensin-like peptide, exhibits anti-Plasmodium activity.	
DRAMP00253	DAPGHPGKHYLQVNVPSDVRTIGVAGGGVQQCFRVTPGAWNDTRALVSNGAQVEVWGYTVADCANRTTANQKYYDKAAAPSDSSTYFWFTLKNLRV	96	Ipomicin (Bacteriocin)	No entry found	Not found	Not found	sweet potato pathogen); also Streptomyces ipomoeae (Gram-negative bacteria)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12676701	Appl Environ Microbiol. 2003 Apr;69(4):2201-2208.	Zhang X, Clark CA, Pettis GS.	Interstrain inhibition in the sweet potato pathogen Streptomyces ipomoeae: purification and characterization of a highly specific bacteriocin and cloning of its structural gene.	
DRAMP00256	KGILGKLGVVQAGVDFVSGVWAGIKQSAKDHPNA	34	Divergicin 750 (Bacteriocin)	Q46597	Not found	dvn750	Carnobacterium divergens (Lactobacillus divergens)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8869500	FEMS Microbiol Lett. 1996 Feb 15;136(2):163-168.	Holck A, Axelsson L, Schillinger U.	Divergicin 750, a novel bacteriocin produced by Carnobacterium divergens 750.	
DRAMP00257	MAAFMKLIQFLATKGQKYVSLAWKHKGTILKWINAGQSFEWIYKQIKKLWA	51	Bacteriocin 	O85756	Not found	brcA	Brochothrix campestris	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9835559	Appl Environ Microbiol. 1998 Dec;64(12):4757-4766.	McCormick JK, Poon A, Sailer M, Gao Y, Roy KL, McMullen LM, Vederas JC, Stiles ME, Van Belkum MJ.	Genetic characterization and heterologous expression of brochocin-C, an antibotulinal, two-peptide bacteriocin produced by Brochothrix campestris ATCC 43754.	
DRAMP00258	MAGFLKVVQILAKYGSKAVQWAWANKGKILDWINAGQAIDWVVEKIKQILGIK	53	Lacticin Z (Bacteriocin)	A7M6Q0	Not found	lnqZ	Lactococcus lactis	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17690480	Biosci Biotechnol Biochem. 2007 Aug;71(8):1984-1992.	Iwatani S, Zendo T, Yoneyama F, Nakayama J, Sonomoto K.	Characterization and structure analysis of a novel bacteriocin, lacticin Z, produced by Lactococcus lactis QU 14.	
DRAMP00259	MQKPEIISADLGLCAVNEFVALAAIPGGAATFAVCQMPNLDEIVSNAAYV	50	Bacteriocin boticin B 	Q9KGZ4	Not found	btcB	Clostridium botulinum	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11097932	Appl Environ Microbiol. 2000 Dec;66(12):5480-5483.	Dineen SS, Bradshaw M, Johnson EA.	Cloning, nucleotide sequence, and expression of the gene encoding the bacteriocin boticin B from Clostridium botulinum strain 213B.	
DRAMP00260	TYYGNGLYCNKEKCWVDWNQAKGEIGKIIVNGWVNH	36	Bacteriocin (Class IIa sec-dependent bacteriocin)	Q27HG2	Belongs to the Class IIa sec-dependent bacteriocin	bacA	Enterococcus faecium (Streptococcus faecium)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16820469	Appl Environ Microbiol. 2006 Jul;72(7):4761-4766.	De Kwaadsteniet M, Fraser T, Van Reenen CA, Dicks LM.	Bacteriocin T8, a novel class IIa sec-dependent bacteriocin produced by Enterococcus faecium T8, isolated from vaginal secretions of children infected with human immunodeficiency virus.	
DRAMP00261	GSGPTYCWNEANNPGGPNRCSNNKQCDGARTCSSSGFCQGTSRKPDPGPKGPTYCWDEAKNPGGPNRCSNSKQCDGARTCSSSGFCQGTAGHAAA	95	Antiviral lectin scytovirin (SVN)	P86041	Not found	Not found	Scytonema varium (cyanobacterium)	Antimicrobial, Antiviral	Protein level	Combine helix and strand structure	Not found	2QT4 resolved by X-ray.	"Function: Has strong anti-HIV activity against T-tropic strains of HIV-1 and weaker activity against M-tropic strains of HIV-1. Inhibits HIV-1 fusion and infection of CD4 LTR beta-gal cells in vitro. Inhibits fusion of HIV infected CEM-SS cells with uninfected CEM-SS cells, and fusion of HIV-1 Env expressing HL2/3 cells with CD4 LTR beta-gal cells. Binds to HIV gp120, HIV gp160 and to a lesser extent HIV gp41. Binding to HIV gp120 is glycosylation dependent. Binds with high specificity to the tetrasaccharide Man-alpha-1,2-Man-alpha-1,6-Man-alpha-1,6-Man and also binds the higher-order oligosaccharides oligomannose 8 and oligomannose 9. Does not bind to monosaccharides, complex or hybrid N-linked oligosaccharides or chitin.
PTM: Contains five disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12614152##16647158##17965185	Biochemistry. 2003 Mar 11;42(9):2578-2584.##Peptides. 2006 Jul;27(7):1668-1675.##Protein Sci. 2007 Dec;16(12):2756-2760.	Bokesch HR, O'Keefe BR, McKee TC, Pannell LK, Patterson GM, Gardella RS, Sowder RC 2nd, Turpin J, Watson K, Buckheit RW Jr, Boyd MR.##Xiong C, O'Keefe BR, Byrd RA, McMahon JB.##Moulaei T, Botos I, Ziółkowska NE, Bokesch HR, Krumpe LR, McKee TC, O'Keefe BR, Dauter Z, Wlodawer A.	A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium.##Potent anti-HIV activity of scytovirin domain 1 peptide.##Atomic-resolution crystal structure of the antiviral lectin scytovirin.	
DRAMP00262	LGKFSQTCYNSAIQGSVLTSTCERTNGGYNTSSIDLNSVIENVDGSLKWQPSNFIETCRNTQLAGSSELAAECKTRAQQFVSTKINLDDHIANIDGTLKYE	101	Cyanovirin-N (CV-N)	P81180	Belongs to the cyanovirin-N family	Not found	Nostoc ellipsosporum (cyanobacterium)	Antimicrobial, Antiviral	Protein level	Combine helix and strand structure	Not found	2EZM resolved by NMR.	"Function: Mannose-binding lectin.
Biotechnological use: Overexpression of this protein to provide quantities adequate for medical use as a topical microbiocide has been attempted in a number of systems including E.coli, Lactobacillus jensenii, the yeast Pichia pastoris and Nicotiana tabacum. One fusion construct for overexpression of this protein can be found in entry AC D1WFZ2.
Miscellaneous: Its activity in situ is Not found, however it acts as a viral entry inhibitor, inhibiting HIV-1, HIV-2 and simian immunodeficiency virus (and some other viruses such as feline immunodeficiency virus, measles virus and human herpesvirus) infection and replication. It prevents essential interactions between the envelope glycoprotein and target cell receptors by binding to carbohydrates on viral protein gp120 and possibly by other mechanisms as well. Addition to cells must occur before or shortly after virus addition. It also inhibits cell-to-cell fusion, and virus-to-cell and cell-to-cell transmission of a viral infection. Is remarkably stabile; the protein can withstand multiple freeze-thaw cycles, dissolution in organic solvents, treatment with salt, detergent, H2O2 and boiling without significant loss of anti-HIV activity."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9210678##9665171	Antimicrob Agents Chemother. 1997 Jul;41(7):1521-1530.##Nat Struct Biol. 1998 Jul;5(7):571-578.	Boyd MR, Gustafson KR, McMahon JB, Shoemaker RH, O'Keefe BR, Mori T, Gulakowski RJ, Wu L, Rivera MI, Laurencot CM, Currens MJ, Cardellina JH 2nd, Buckheit RW Jr, Nara PL, Pannell LK, Sowder RC 2nd, Henderson LE.##Bewley CA, Gustafson KR, Boyd MR, Covell DG, Bax A, Clore GM, Gronenborn AM.	Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.##Solution structure of cyanovirin-N, a potent HIV-inactivating protein.	
DRAMP00263	GWWNSWGKCVAGTIGGAGTGGLGGAAAGSAVPVIGTGIGGAIGGVSGGLTGAATFC	56	Bacteriocin cerein 7B 	Q2MDB2	Not found	cer7B	Bacillus cereus	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16451187	FEMS Microbiol Lett. 2006 Jan;254(1):108-115.	Oscáriz JC, Cintas L, Holo H, Lasa I, Nes IF, Pisabarro AG.	Purification and sequencing of cerein 7B, a novel bacteriocin produced by Bacillus cereus Bc7.	
DRAMP00264	EQCREEEDDR	10	Coconut antifungal peptide (Plants)	No entry found	Not found	Not found	Cocos nucifera	Antimicrobial, Antifungal, Antiviral	Not found	Not found	Not found		Function: Also has HIV-1 reverse transcriptase activity (IC50=52.5 µM)	Fungi: Fusarium oxysporum, Mycosphaerella arachidicola (IC50=1.2 µM), Physalospora piricola.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16308082	Peptides. 2005 Dec;26(12):2392-2396.	Wang HX, Ng TB.	An antifungal peptide from the coconut.	
DRAMP00265	EALYNSEDLYEETSDSDD	18	Putative antimicrobial protein 1 (Ls-AMP1; Plant defensin)	P86895	Not found	Not found	Lippia sidoides (Pepper-rosmarin)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: May possess antifungal activity.
Caution: Antifungal activity was tested using a fraction containing a number of different peptides. It is not clear which peptide actually has antifungal activity."	Fungi: Botrytis cinerea.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21210197	Protein J. 2011 Jan;30(1):32-38.	Moreira JS, Almeida RG, Tavares LS, Santos MO, Viccini LF, Vasconcelos IM, Oliveira JT, Raposo NR, Dias SC, Franco OL.	Identification of botryticidal proteins with similarity to NBS-LRR proteins in rosemary pepper (Lippia sidoides Cham.) flowers.	
DRAMP00266	SPPEAAYGPGNTNSDSGDK	19	Putative antimicrobial protein 2 (Ls-AMP2; Plant defensin)	P86896	Not found	Not found	Lippia sidoides (Pepper-rosmarin)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: May possess antifungal activity.
Caution: Antifungal activity was tested using a fraction containing a number of different peptides. It is not clear which peptide actually has antifungal activity."	Fungi: Botrytis cinerea.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21210197	Protein J. 2011 Jan;30(1):32-38.	Moreira JS, Almeida RG, Tavares LS, Santos MO, Viccini LF, Vasconcelos IM, Oliveira JT, Raposo NR, Dias SC, Franco OL.	Identification of botryticidal proteins with similarity to NBS-LRR proteins in rosemary pepper (Lippia sidoides Cham.) flowers.	
DRAMP00267	ESGINLQGDATLANN	15	Antifungal lectin AMML (AMML; Plant defensin)	P85004	Not found	Not found	Astragalus mongholicus (Huang qi) (Astragalus membranaceus varmongholicus)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Lectin that binds strongly to galactose, lactose, D-raffinose, L-rhamnose and cellobiose, and less strongly to D-glucose, D-xylose and L-arabinose. Does not bind D-galacturonic acid, D-fructose, D-mannose, D-ribose, L-sorbose, maltose and sucrose. Has hemagglutinating activity towards human type O and rabbit erythrocytes. Has strong antifungal activity against B. cinera, and weaker antifungal activity against D. turcia, F. oxysporum and Colletorichum sp. but not against Rhizoctonia solani and Mycosphaerella arachidicola.
Miscellaneous: Hemagglutinating activity stable when incubated at 65 degrees Celsius for 30 minutes. Hemagglutinating activity is reduced by 50% when incubated at 75 degrees Celsius for 30 minutes and is abolished by incubation at 85 degrees Celsius for 30 minutes. Hemagglutinating activity is stable between pH 4.5 and 7.5, but is completely inhibited by incubation below pH 3.0 or above pH 10."	Fungi: Botrytis cinerea (IC50=1.2 µM), Drechslera turcia, Fusarium oxysporum and Colletorichum sp.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Galactose and Glucose	16140255	Arch Biochem Biophys. 2005 Oct 1;442(1):72-81.	Yan Q, Jiang Z, Yang S, Deng W, Han L.	A novel homodimeric lectin from Astragalus mongholicus with antifungal activity.	
DRAMP00268	QGIGVGDNDGKRGKR	15	Antifungal protein Pr-2 (Pr-2; Plant defensin)	P86796	Not found	Not found	Cucurbita maxima (Pumpkin) (Winter squash)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Has strong antifungal activity. Lacks antifungal activity against P.verrucosum var. verrucosum. Lacks antibacterial activity against the Gram-negative bacterium E.coli and against the Gram-positive bacterium S.aureus. Has very low hemolytic activity against human erythrocytes. Increases fungal cell membrane permeability, probably by disrupting the membrane structure.	[Ref.19807165]Fungi: Botrytis cinerea (EC50=20 µM), Candida albicans (EC50=20 µM), Colletotrichum coccodes (EC50=10 µM), Fusarium oxysporum (EC50=10 µM), Fusarium solani (EC50=10 µM), Trichoderma harzianum (EC50=20 µM), Trichoderma viride (EC50=20 µM), Aspergillus fumigatus EC50=40 µM), Aspergillus parasiticus (EC50=80 µM), Didymella bryoniae (EC50=40 µM).	[Ref:19807165]0% hemolytic activity at 80 µM and 8% hemolytic activity at 160 µM against huamn red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19807165	J Agric Food Chem. 2009 Oct 14;57(19):9299-9304.	Park SC, Kim JY, Lee JK, Hwang I, Cheong H, Nah JW, Hahm KS, Park Y.	Antifungal mechanism of a novel antifungal protein from Pumpkin rinds against various fungal pathogens.	
DRAMP00269	LDSLSFSYNNFEEDD	15	Antifungal protein 1 (GAFP-1; Plant defensin)	P86920	Not found	Not found	Arachis hypogaea (Peanut)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Has strong antifungal activity against fungal phytopathogens.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAY-2011) to UniProtKB	Indira S.	GAFP-1 from roots of Arachis hypogeae L.	
DRAMP00270	ATFTIRNNCPYTIWAAAVPGGGRRLNSGGTWTINVAPGTA	40	Osmotin (CpOsm; Plant defensin)	P86363	Belongs to the thaumatin family	Not found	Calotropis procera (Roostertree) (Asclepias procera)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity.
Miscellaneous: On the 2D-gel the determined pI of isoform 1 is: 8.9, its MW is: 22 kDa. On the 2D-gel the determined pI of isoform 2 is: 9.1, its MW is: 22 kDa."	Fungi: Fusarium solani (IC50=67.0 µg/ml), Colletotrichum gloeosporioides (IC50=32.1 µg/ml), Neurospora isolate (IC50=57.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21334906	Plant Physiol Biochem. 2011 Jul;49(7):738-743. 	de Freitas CD, Nogueira FC, Vasconcelos IM, Oliveira JT, Domont GB, Ramos MV.	Osmotin purified from the latex of Calotropis procera: Biochemical characterization, biological activity and role in plant defense.	
DRAMP00271	ATFTIRNNXPYTVWAAASPGGGRRLDMARIWGRTNXNFD	39	Osmotin-like protein (Thaumatin-like protein; Plant defensin)	P83491	Belongs to the thaumatin family	Not found	Hevea brasiliensis (Para rubber tree) (Siphonia brasiliensis)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: May be an important antifungal protein.
PTM: Contains intrachain disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Plant Physiol. Biochem. 2001;39:1047-1055.	Subroto T, de Vries H, Schuringa J.J, Soedjanaatmadja U.M.S, Hofsteenge J, Jekel P.A, Beintema J.J.	Enzymic and structural studies on processed proteins from the vacuolar (lutoid-body) fraction of latex of Hevea brasiliensis.	
DRAMP00272	AKITFTNNHPRTIWP	15	Thaumatin-like protein (Plants)	P83957	Belongs to the thaumatin family	Not found	Castanopsis chinensis (Chinese chinquapin) (Kweilin chestnut)	Antimicrobial, Antifungal, Antiviral	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Fungi: Botrytis cinerea, Fusarium oxysporum (IC50=0.5 µM), Mycosphaerella arachidicola, Psylla piricola.##HIV-1 reverse transcriptase (IC50=1.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12565869	Biochem Biophys Res Commun. 2003 Feb 7;301(2):364-370.	Chu KT, Ng TB.	Isolation of a large thaumatin-like antifungal protein from seeds of the Kweilin chestnut Castanopsis chinensis.	
DRAMP00273	ANFEIVNNCPYTVWAAASPGGGRRLDRGQT	30	Thaumatin-like protein (Plants)	P83959	Belongs to the thaumatin family	Not found	Phaseolus vulgaris (Kidney bean) (French bean)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Fungi: Coprinus comatus, Fusarium oxysporum, Pleurotus ostreatus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10486265	Biochem Biophys Res Commun. 1999 Sep 16;263(1):130-134.	Ye XY, Wang HX, Ng TB.	First chromatographic isolation of an antifungal thaumatin-like protein from French bean legumes and demonstration of its antifungal activity.	
DRAMP00274	QKIQEIDLQTYLQPQ	15	Amaryllin (Plant defensin)	P86781	Not found	Not found	Amaryllis belladonna (Naked lady lily)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Has antifungal activity.	Fungi: Aspergillus flavus and Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19478451	Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jun 1;65(Pt 6):635-637.	Kumar S, Singh N, Sinha M, Kaur P, Srinivasan A, Sharma S, Singh TP.	Isolation, purification, crystallization and preliminary crystallographic studies of amaryllin, a plant pathogenesis-related protein from Amaryllis belladonna.	
DRAMP00276	YSYKKIDCGGACAARCRLSSRPRLCNRACGTCCARCNCVPPGTSGNTETCPCYASLTTHGNKRKCP	66	Snakin-2 (StSN2; Cys-rich; Plant defensin)	Q93X17, A1YN11, Q948Z5	Not found	SN2	Solanum tuberosum (Potato)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Bridge	Not found		"Function: Has an antimicrobial activity. Causes a rapid aggregation of both Gram-positive and Gram-negative bacteria, but the antimicrobial activity is not correlated with the capacity to aggregate bacteria.
Tissue specificity: Expressed in tubers, stems, flowers, shoot apex and leaves, but not in roots or stolons.
Induction: Locally up-regulated by abscisic acid, wounding and infection with compatible fungus. Down-regulated by gibberellic acid or infection with virulent bacteria. No responses to ethylene or abiotic stresses.
PTM: Six disulfide bonds may be present."	Gram-positive bacteria: Clavibacter michiganensis (EC50=4 µM), Ralstonia solanacearum (EC50=15 µM).##Fungi: pathogens Rhizobium meliloti (EC50=8 µM), Botrytis cinerea (EC50=2 µM), Fusarium solani (EC50=2 µM), Fusarium culmorum (EC50=2 µM), Fusarium oxysporum f.sp. conglutinans (EC50=10 µM), Fusarium oxysporum f.sp.lycopersici (EC50=20 µM), Plectosphaerella cucumerina (EC50=10 µM), Colletotrichum graminicola (EC50=10 µM), Colletotrichum lagenarium (EC50=10 µM), Bipolaris maydis (EC50=20 µM), Aspergillus flavus (EC50=20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11891250	Plant Physiol. 2002 Mar;128(3):951-961.	Marta Berrocal-Lobo, Ana Segura, Manuel Moreno, Gemma López, Francisco García-Olmedo, Antonio Molina	Snakin-2, an antimicrobial peptide from potato whose gene is locally induced by wounding and responds to pathogen infection.	
DRAMP00277	DICTNCCAGTKGCNTTSANGAFICEGQSDPKKPKACPLNCDPHIAYA	47	Potamin-1 (PT-1; Plants)	P84813	Belongs to the protease inhibitor I20	Not found	Solanum tuberosum (Potato)	Antimicrobial, Antifungal, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Inhibitor of serine proteases chymotrypsin, papain and trypsin. Has strong antifungal activity against C. albicans and R.solani. Has antibacterial activity against the Gram-positive bacterium C.michiganense, but Non-antibacterial activity against the Gram-positive bacterium S. aureus. Lacks hemolytic activity against human erythrocytes.
PTM: Contains four disulfide bonds (By similarity)."	[Ref.15809084]Fungi: Candida albicans(MIC =100μM) and Rhizoctonia solani(MIC =100μM);##Gram-positive bacterium: Clavibacter michiganensis(MIC =50μM)	[Ref:15809084]Non-hemolytic activity against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15809084	Biochem Biophys Res Commun. 2005 May 13;330(3):921-927.	Kim JY, Park SC, Kim MH, Lim HT, Park Y, Hahm KS.	Antimicrobial activity studies on a trypsin-chymotrypsin protease inhibitor obtained from potato.	
DRAMP00278	LPSDATLVLDQTGKELDARL	20	Antifungal protein J (AFP-J; Plants)	P84794	Belongs to the protease inhibitor I3	Not found	Solanum tuberosum (Potato)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Inhibitor of serine proteases chymotrypsin, pepsin and trypsin. Has strong antifungal activity. Non-hemolytic activity against human erythrocytes.	[Ref.16076139]Fungi: Candida albicans TIMM 1768(MIC=6.25μg/mL)), Saccharomyces cerevisiae KCTC 7296(MIC=6.25μg/mL)), Trichosporon beigelii KCTC 7707(MIC=6.25μg/mL))	[Ref:16076139]Non-hemolytic activity against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16076139	J Agric Food Chem. 2005 Aug 10;53(16):6491-6496.	Park Y, Choi BH, Kwak JS, Kang CW, Lim HT, Cheong HS, Hahm KS.	Kunitz-type serine protease inhibitor from potato (Solanum tuberosum L. cv. Jopung).	
DRAMP00279	AQIVKLGGDDGSLAFVPSKISVAAGEAIEFVNNAGFPHNIVFDEDAVPAGVDADAISYDDYLNSKGETVVRKLSTPGVYGVYCEPHAGAGMKMTITVQ	98	Plastocyanin (Plants)	P56274	Not found	PETE	Ulva pertusa (Sea lettuce)	Antimicrobial, Antiviral	Protein level	Combine helix and strand structure	Not found	1IUZ resolved by X-ray.	"Function: Participates in electron transfer between P700 and the cytochrome b6-f complex in photosystem I. Has antiviral activity against Potato virus Y (strain N).
Domain: Contains 1 plastocyanin-like domain."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9933621##PubMed ID is not availbale	J Biol Chem. 1999 Feb 12;274(7):4225-4230.##Submitted (JUN-2003) to UniProtKB.	Shibata N, Inoue T, Nagano C, Nishio N, Kohzuma T, Onodera K, Yoshizaki F, Sugimura Y, Kai Y.##	Novel insight into the copper-ligand geometry in the crystal structure of Ulva pertusa plastocyanin at 1.6-A resolution. Structural basis for regulation of the copper site by residue 88.##	
DRAMP00280	LIYAKVECLTTGVRTYVGKQSWPELVGTKGKTAAATIDKENTHVTAVLCPPLTTLAACRTFDFRCDRVRVLINRIGGVVTKTPTVG	86	Trypsin inhibitor (FtTI; Plant defensin)	P86971	Not found	Not found	Fagopyrum tataricum (Tartarian buckwheat) (Polygonum tataricum)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Serine protease inhibitor which is active against trypsin. Displays strong antifungal activity against a number of phytopathogenic fungi.
Biophysicochemical properties: pH dependence (Optimum pH is 8.0 at 37 degrees Celsius. Maintains over 90% of its inhibitory activity from pH 3 to 10); Temperature dependence (Active between 10 and 60 degrees Celsius. 84% activity retained when heated for 30 minutes at 80 degrees Celsius. Incubation at temperatures above 80 degrees Celsius rapidly decreases inhibitory activity).
PTM: Contains two disulfide bonds 8-65; 49-58."	Fungi: M. melonis, A. cucumerina, A. solani, C. glaeosporioides and P. capsici.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21544554	Appl Biochem Biotechnol. 2011 May 5.	Ruan JJ, Zhou ML, Chen H, Shao JR.	Identification and Characterization of a Trypsin Inhibitor from Fagopyrum tataricum Seeds.	
DRAMP00281	NTCENLAGSYKGVCFGGCDRHCRTQEGAISGRCRDDFRCWCTKNC	45	Defensin-like protein 230 (Disease resistance response protein 230; Plant defensin)	Q01783	Belongs to the DEFL family	PI230	Pisum sativum (Garden pea)	Unknown	Transcript level	Not found	Not found		"Function: Has antifungal activity (By similarity).
Induction: Upon contact with the plant pathogen fungus Fusarium solani.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1799696	Mol Plant Microbe Interact. 1991 Jul-Aug;4(4):324-331.	Chiang CC, Hadwiger LA.	The Fusarium solani-induced expression of a pea gene family encoding high cysteine content proteins.	
DRAMP00282	GPMRIAEARHCESLSHRFKGPCTRDSNCASVCETERFSGGNCHGFRRRCFCTKPC	55	Defensin-like protein P322 (Probable protease inhibitor P322; Plant defensin)	P20346	Belongs to the DEFL family	Not found	Solanum tuberosum (Potato)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Plant Molecular Biology. 1988, 11(3):255-269.	Stiekema WJ, Heidekamp F, Dirkse WG, van Beckum J, de Haan P, ten Bosch C, Louwerse JD.	Molecular cloning and analysis of four potato tuber mRNAs.	
DRAMP00283	RECQSQSHRYKGACVHDTNCASVCQTEGFSGGKCVGFRGRCFCTKAC	47	Defensin Ec-AMP-D1 (Plant defensin)	P86518	Belongs to the DEFL family	Not found	Echinochloa crus-galli (Barnyard grass) (Panicum crus-galli)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity. Inhibits hyphal development in P. infestans (IC50=25.5 µg/ml), but not release of zoospores. At concentrations above 100 µg/ml, induces morphological changes such as lysis of hyphae and sporangia in P. infestans.
PTM: Contains four disulfide bonds (By similarity)."	Fungi: Fusarium graminearum (IC50=15 µg/ml), Fusarium oxysporum (IC50=102 µg/ml), F. verticillioides (IC50=8.5 µg/ml), Diplodia maydis (IC50=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18625284	Biochimie. 2008 Nov-Dec;90(11-12):1667-1673. 	Odintsova TI, Rogozhin EA, Baranov Y, Musolyamov AKh, Yalpani N, Egorov TA, Grishin EV.	Seed defensins of barnyard grass Echinochloa crusgalli (L.) Beauv.	
DRAMP00284	RVCMGKSQHHSFPCISDRLCSNECVKEEGGWTAGYCHLRYCRCQKAC	47	Defensin-like protein 1 (SI alpha-1; Plant defensin)	P21923	Belongs to the DEFL family	Not found	Sorghum bicolor (Sorghum) (Sorghum vulgare)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity (By similarity).
PTM: Contains four disulfide bonds 3-47; 14-36; 20-41; 24-43."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1995329##7705336	FEBS Lett. 1991 Feb 11;279(1):101-104.##Eur J Biochem. 1995 Mar 1;228(2):250-256.	Bloch C Jr, Richardson M.##Nitti G, Orrù S, Bloch C Jr, Morhy L, Marino G, Pucci P.	A new family of small (5 kDa) protein inhibitors of insect alpha-amylases from seeds or sorghum (Sorghum bicolar (L) Moench) have sequence homologies with wheat gamma-purothionins.##Amino acid sequence and disulphide-bridge pattern of three gamma-thionins from Sorghum bicolor.	
DRAMP00285	RVCMGKSAGFKGLCMRDQNCAQVCLQEGWGGGNCDGVMRQCKCIRQCW	48	Defensin-like protein 2 (SI alpha-2; Plant defensin)	P21924	Belongs to the DEFL family	Not found	Sorghum bicolor (Sorghum) (Sorghum vulgare)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity (By similarity).
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1995329	FEBS Lett. 1991 Feb 11;279(1):101-104.	Bloch C Jr, Richardson M.	A new family of small (5 kDa) protein inhibitors of insect alpha-amylases from seeds or sorghum (Sorghum bicolar (L) Moench) have sequence homologies with wheat gamma-purothionins.	
DRAMP00286	RVCRRRSAGFKGLCMSDHNCAQVCLQEGWGGGNCDGVIRQCKCIRQC	47	Defensin-like protein 3 (SI alpha-3; Plant defensin)	P21925	Belongs to the DEFL family	Not found	Sorghum bicolor (Sorghum) (Sorghum vulgare)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity (By similarity).
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1995329##7705336	FEBS Lett. 1991 Feb 11;279(1):101-104.##Eur J Biochem. 1995 Mar 1;228(2):250-256.	Bloch C Jr, Richardson M.##Nitti G, Orrù S, Bloch C Jr, Morhy L, Marino G, Pucci P.	A new family of small (5 kDa) protein inhibitors of insect alpha-amylases from seeds or sorghum (Sorghum bicolar (L) Moench) have sequence homologies with wheat gamma-purothionins.##Amino acid sequence and disulphide-bridge pattern of three gamma-thionins from Sorghum bicolor.	
DRAMP00287	RVCRRRSAGFKGLCMSDHNCAQVCLQEGWGGGNCDGVMRQCKCIRQC	47	Defensin-like protein 21 (SI alpha-2.1; Plant defensin)	Q09198	Belongs to the DEFL family	Not found	Sorghum bicolor (Sorghum) (Sorghum vulgare)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity (By similarity).
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7705336	Eur J Biochem. 1995 Mar 1;228(2):250-256.	Nitti G, Orrù S, Bloch C Jr, Morhy L, Marino G, Pucci P.	Amino acid sequence and disulphide-bridge pattern of three gamma-thionins from Sorghum bicolor.	
DRAMP00288	RECQSQSHRYKGACVHDTNCASVCQTEGFSGGKCVGFRGRCFCTKHC	47	Defensin Ec-AMP-D2 (Plant defensin)	P86519	Belongs to the DEFL family	Not found	Echinochloa crus-galli (Barnyard grass) (Panicum crus-galli)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity. Inhibits spore germination in Fusarium oxysporum (IC(50)=102 Î¼g/ml). Inhibits hyphal development in P. infestans (IC(50)=50 Î¼g/ml). Does not induce morphological changes such as lysis of hyphae and sporangia in P. infestans.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18625284	Biochimie. 2008 Nov-Dec;90(11-12):1667-1673.	Odintsova TI, Rogozhin EA, Baranov Y, Musolyamov AKh, Yalpani N, Egorov TA, Grishin EV.	Seed defensins of barnyard grass Echinochloa crusgalli (L.) Beauv.	
DRAMP00289	RLCRVRGTRGHCFNDHGCDKVCTREGFVRGKCNGILRRCICDRQC	45	Defensin-like protein (Gamma-thionin; Plant defensin)	B5LZ79	Belongs to the DEFL family	Not found	Gymnadenia conopsea (Fragrant orchid) (Orchis conopsea)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity (By similarity).
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##PubMed ID is not available	Submitted (JUL-2008) to the EMBL/GenBank/DDBJ databases.##Submitted (JUL-2008) to UniProtKB.	Not found##Mukherjee G, Sen SK.	Not found##Purification, characterization, and antifungal activity of chitinase from Streptomyces venezuelae P(10).	
DRAMP00290	KTCENLSDSFKGPCIPDGNCNKHCKEKEHLLSGRCRDDFRCWCTRNC	47	Defensin Lc-def (Plant defensin)	B3F051, P85530	Belongs to the DEFL family	Not found	Lens culinaris subsp. culinaris (Cultivated lentil) (Lens esculenta)	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	Not found	2LJ7 resolved by NMR.	"Function: Has antifungal activity against the phytopathogenic fungus Aspergillus niger VKM F-2259, but not against A.alternatia VKM F- 3047. Does not inhibit trypsin or chymotrypsin.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18468512##PubMed ID is not available	Biochem Biophys Res Commun. 2008 Jul 11;371(4):860-865.##To be Published.	Finkina EI, Shramova EI, Tagaev AA, Ovchinnikova TV.##Shenkarev Z, Mineev K, Gizatullina A, Finkina E, Arseniev A, Ovchinnikova T.	A novel defensin from the lentil Lens culinaris seeds.##Solution structure of defensin Lc-def from germinated lentil (Lens Culinaris) seeds.	
DRAMP00291	RTCESQSHRFKGACLSDTNCASVCQTEGFPAGDCKGARRRCFCVKPC	47	Defensin-like protein (Gamma-thionin homolog; Plant defensin)	A3FPF2	Belongs to the DEFL family	Not found	Nelumbo nucifera (Sacred lotus)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Has antifungal activity (By similarity).
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##16972135	Submitted (FEB-2007) to the EMBL/GenBank/DDBJ database##Curr Microbiol. 2006 Oct;53(4):265-269.	Not found##Mukherjee G, Sen SK.	Not found##Purification, characterization, and antifungal activity of chitinase from Streptomyces venezuelae P(10).	
DRAMP00292	RVCESQSHGFHGLCNRDHNCALVCRNEGFSGGRCKRSRRCFCTRIC	46	Defensin-like protein (8.4 kDa sulfur-rich protein; Plant defensin)	Q07502	Belongs to the DEFL family	Not found	Glycine max (Soybean) (Glycine hispida)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Has antifungal activity (By similarity).
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8278516	Plant Physiol. 1993 Feb;101(2):699-700.	Choi Y, Choi YD, Lee JS.	Nucleotide sequence of a cDNA encoding a low molecular weight sulfur-rich protein in soybean seeds.	
DRAMP00293	RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC	47	Gamma1-hordothionin (Gamma 1-H; Plant defensin)	P20230	Belongs to the DEFL family	Not found	Hordeum vulgare (Barley)	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	Gamma 1-H adopts a well-defined triple-stranded antiparallel beta-sheet (residues 1-6, 31-34, and 39-47), an alpha-helix (residues 16-28), and the corresponding connecting loops. Three disulfide bridges are located in the hydrophobic core holding together the alpha-helix and the beta-sheet and forming a cysteine-stabilized alpha-helical (CSH) motif.	1GPT resolved by NMR.	"Function: Inhibits protein translation in cell-free systems.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-21; 24-43.
Caution: Was initially thought to be a thionin."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2176600##8380707	Eur I Biochem 1990;194:533-539.##Biochemistry. 1993 Jan 19;32(2):715-724.	Mendez E, Moreno A, Colilla F.J, Pelaez F, Limas G.G, Mendez R, Soriano F, Salinas M, de Haro C.##Bruix M, Jim©nez MA, Santoro J, Gonz¡lez C, Colilla FJ, M©ndez E, Rico M.	Primary structure and inhibition of protein synthesis in eukaryotic cell-free system of a novel thionin, gamma-hordothionin, from barley endosperm.##Solution structure of gamma 1-H and gamma 1-P thionins from barley and wheat endosperm determined by 1H-NMR: a structural motif common to toxic arthropod proteins.	
DRAMP00294	YKRGGGGWGGGGGWKGGGGGGGGWKGGGGGGKGGGG	36	Glycine-rich protein GWK (Plants)	P84064	Not found	Not found	Cucumis melo (Muskmelon)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Possesses antifungal activity against a number of phytopathogenic fungi.	Fungi: Hordeum sativum and F. culmorum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2004) to UniProtKB	Vassilevski AA, Egorov TA, Grishin EV.	Unknown	
DRAMP00295	ADPTFGFTPLGLSEKANLQIMKAYD	25	Soybean toxin 27 kDa chain (SBTX 27 kDa chain; Plant defensin)	P86520	Not found	Not found	Glycine max (Soybean) (Glycine hispida)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Involved in plant defense. Has antifungal activity against C. sojina but not A. niger and F. solani. Does not have urease or hemagglutination activities. Does not inhibit trypsin. Injection into mice produces toxic effects such as dyspnea, tonic-clonic convulsion and death.
Subunit structure Heterodimer of a 27 kDa subunit and a 17 kDa subunit; disulfide-linked.
Tissue specificity: Expressed in seeds, leaves, roots and stem (at protein level).
Induction: In seeds, induced by jasmonate.
Post-translational modification: SBTX is known to be glycosylated but it is not known which one of its two subunits is modified; contains 5% carbohydrates.
Toxic dose: LD50 is 5.6 mg/kg by intraperitoneal injection into mice.
Miscellaneous: On the 2D-gel the determined pI of SBTX is: 8.2, its MW is: 44 kDa.
Biophysicochemical properties: pH dependence (Activity decreases below pH 5.5 and above pH 8.0)."	Fungi: C. sojina.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18328522	Toxicon. 2008 May;51(6):952-963.	Vasconcelos IM, Morais JK, Siebra EA, Carlini CR, Sousa DO, Beltramini LM, Melo VM, Oliveira JT.	SBTX, a new toxic protein distinct from soyatoxin and other toxic soybean [Glycine max] proteins, and its inhibitory effect on Cercospora sojina growth.	
DRAMP00296	PNPKVFFDMTIGGQSAGRIVMEEYA	25	Soybean toxin 17 kDa chain (SBTX 17 kDa chain; Plant defensin)	P86548	Not found	Not found	Glycine max (Soybean) (Glycine hispida)	Antimicrobial, Antifungal, Cytotoxic	Protein level	Not found	Not found		"Function: Involved in plant defense. Has antifungal activity against C.sojina but not A.niger and F.solani. Does not have urease or hemagglutination activities. Does not inhibit trypsin. Injection into mice produces toxic effects such as dyspnea, tonic-clonic convulsion and death.
Subunit structure: Heterodimer of a 27 kDa subunit and a 17 kDa subunit; disulfide-linked.
Tissue specificity: Expressed in seeds, leaves, roots and stem (at protein level).
Induction: In seeds, induced by jasmonate.
Post-translational modification: SBTX is known to be glycosylated but it is not known which one of its two subunits is modified; contains 5% carbohydrates.
Toxic dose: LD50 is 5.6 mg/kg by intraperitoneal injection into mice.
Miscellaneous: On the 2D-gel the determined pI of SBTX is: 8.2, its MW is: 44 kDa.
Biophysicochemical properties: pH dependence (Activity decreases below pH 5.5 and above pH 8.0). "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18328522	Toxicon. 2008 May;51(6):952-963.	Vasconcelos IM, Morais JK, Siebra EA, Carlini CR, Sousa DO, Beltramini LM, Melo VM, Oliveira JT.	SBTX, a new toxic protein distinct from soyatoxin and other toxic soybean [Glycine max] proteins, and its inhibitory effect on Cercospora sojina growth.	
DRAMP00297	ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV	33	U1-theraphotoxin-Pc1a (U1-TRTX-Pc1a; Psalmopeotoxin-1; PcFK1; Plants)	P0C201	Not found	Not found	Psalmopoeus cambridgei (Trinidad chevron tarantula)	Antiplasmodial, Cytotoxic	Protein level	Combine helix and strand structure	Not found	1X5V resolved by NMR.	"Function: Possess strong antiplasmodial activity against the intra-erythrocyte stage of Plasmodium falciparum in vitro. Interacts with infected and healthy erythrocytes. Does not lyse erythrocytes, is not cytotoxic to nucleated mammalian cells, and does not inhibit neuromuscular function. Has neither antibacterial nor antifungal activity.
Tissue specificity: Expressed by the venom gland.
Domain: The presence of a 'disulfide through disulfide knot' structurally defines this protein as a knottin.
PTM: Contains three disulfide bonds and C-terminal amidation."	Plasmodium falciparum (IC50=1.59 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15304333##16452619	FEBS Lett. 2004 Aug 13;572(1-3):109-117.##Protein Sci. 2006 Mar;15(3):628-634.	Choi SJ, Parent R, Guillaume C, Deregnaucourt C, Delarbre C, Ojcius DM, Montagne JJ, C©l©rier ML, Phelipot A, Amiche M, Molgo J, Camadro JM, Guette C.##Pimentel C, Choi SJ, Chagot B, Guette C, Camadro JM, Darbon H.	Isolation and characterization of Psalmopeotoxin I and II: two novel antimalarial peptides from the venom of the tarantula Psalmopoeus cambridgei.##Solution structure of PcFK1, a spider peptide active against Plasmodium falciparum.	
DRAMP00298	RCLPAGKTCVRGPMRVPCCGSCSQNKCT	28	U1-theraphotoxin-Pc1a (U2-TRTX-Pc1a; Psalmopeotoxin-2; PcFK2; Plants)	P0C202	Not found	Not found	Psalmopoeus cambridgei (Trinidad chevron tarantula)	Antiplasmodial, Cytotoxic	Protein level	Not found	Not found		"Function: Possess strong antiplasmodial activity against the intra-erythrocyte stage of P.falciparum in vitro. Specifically interacts with infected erythrocytes. Does not lyse erythrocytes, is not cytotoxic to nucleated mammalian cells, and does not inhibit neuromuscular function. Has neither antibacterial nor antifungal activity.
Tissue specificity: Expressed by the venom gland.
Domain: The presence of a 'disulfide through disulfide knot' structurally defines this protein as a knottin By similarity.
Miscellaneous: Usually endopeptidases cleave the propeptide at the C-terminus of the basic doublet (Arg-37-38-Arg), but here, it seems that the endopeptidase cleaves the precursor within the doublet.
PTM: Contains three disulfide bonds (By similarity)."	Plasmodium falciparum (IC50=1.15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15304333	FEBS Lett. 2004 Aug 13;572(1-3):109-117.	Choi SJ, Parent R, Guillaume C, Deregnaucourt C, Delarbre C, Ojcius DM, Montagne JJ, C©l©rier ML, Phelipot A, Amiche M, Molgo J, Camadro JM, Guette C.	Isolation and characterization of Psalmopeotoxin I and II: two novel antimalarial peptides from the venom of the tarantula Psalmopoeus cambridgei.	
DRAMP00299	DADIAVWAPPVNAQN	15	Ribonuclease (Plants)	P84784	Not found	Not found	Thelephora ganbajun (Mushroom)	Antimicrobial, Antiviral	Protein level	Not found	Not found		"Function: Inhibits HIV-1 reverse transcriptase.
Miscellaneous: Inhibits HIV-1 reverse transcriptase with an IC50 of 300 nM.
Biophysicochemical properties: pH dependence (Optimum pH is 6-7); Temperature dependence (Optimum temperature is 45 degrees Celsius. Activity decreases sharply above 50 degrees Celsius and below 40 degrees Celsius)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15474506	Biochem Biophys Res Commun. 2004 Nov 12;324(2):855-859.	Wang HX, Ng TB.	Purification of a novel ribonuclease from dried fruiting bodies of the edible wild mushroom Thelephora ganbajun.	
DRAMP00300	PGAGSQEERMQGQMEGQDFSHEERFLSMVRE	31	Antifungal protein 1 (Pa-AFP1; Plant defensin)	B3EWF0	Not found	Not found	Passiflora alata (Winged-stem passion flower) (Fragrant granadilla)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity against C. gloeosporioides but not against Botrytis cinerea and Fusarium sp. or against various yeasts. Has no antibacterial activity.
Subunit structure: Heterodimer; disulfide-linked.
PTM: Disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20955745	Peptides. 2011 May;32(5):868-874.	Ribeiro SM, Almeida RG, Pereira CA, Moreira JS, Pinto MF, Oliveira AC, Vasconcelos IM, Oliveira JT, Santos MO, Dias SC, Franco OL.	Identification of a Passiflora alata Curtis dimeric peptide showing identity with 2S albumins.	
DRAMP00301	DYPKLTFTTS	10	Malanin chain A (Plant defensin)	P86600	Not found	Not found	Malania oleifera	Anti-cancer, Cytotoxic	Protein level	Not found	Not found		"Function: Significantly inhibits growth and induces an apoptotic response in HeLa cells through cell-cycle arrest at S-phase. Exhibits highly cytotoxic activities against cancer cell and non-cancer cell lines.
Subunit structure: Heterodimer of an A chain and a B chain, which are crosslinked by one or more disulfide bonds.
Toxic dose: LD50 values are 26.22 µg/kg by intraperitoneal injection and 43.11 mg/kg by intragingival injection into IRC strain mice."	Cancer cell lines: HeLa (IC50=0.15±0.08 nM), PC-12 (IC50=7.71±0.24 nM), MCF-7 (IC50=11.20±0.02 nM), K562 (IC50=15.80±0.09 nM).##Non-cancer cell lines: Vero (IC50=2.79±0.05 nM) and Madin-Darby canine kidney cells (IC50=3.92±0.01 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19341757	Toxicon. 2009 Aug;54(2):121-127.	Yuan Y, Dai X, Wang D, Zeng X.	Purification, characterization and cytotoxicity of malanin, a novel plant toxin from the seeds of Malania oleifera.	
DRAMP00302	DETXTDEEFN	10	Malanin chain B (Plant defensin)	P86601	Not found	Not found	Malania oleifera	Anti-cancer, Cytotoxic	Protein level	Not found	Not found		"Function: Significantly inhibits growth and induces an apoptotic response in HeLa cells through cell-cycle arrest at S-phase. Exhibits highly cytotoxic activities against cancer cell and non-cancer cell lines.
Subunit structure: Heterodimer of an A chain and a B chain, which are crosslinked by one or more disulfide bonds.
Toxic dose: LD50 values are 26.22 µg/kg by intraperitoneal injection and 43.11 mg/kg by intragingival injection into IRC strain mice."	Cancer cell lines: HeLa (IC50=0.15±0.08 nM), PC-12 (IC50=7.71±0.24 nM), MCF-7 (IC50=11.20±0.02 nM), K562 (IC50=15.80±0.09 nM).##Non-cancer cell lines: Vero (IC50=2.79±0.05 nM) and Madin-Darby canine kidney cells (IC50=3.92±0.01 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19341757	Toxicon. 2009 Aug;54(2):121-127.	Yuan Y, Dai X, Wang D, Zeng X.	Purification, characterization and cytotoxicity of malanin, a novel plant toxin from the seeds of Malania oleifera.	
DRAMP00303	ACGGGGGDVGSLISASLFDQMLKYRNDPRCCXXGF	35	Basic endochitinase CH1 (Plant defensin)	P29137	Belongs to the glycosyl hydrolase 19 family (Chitinase class I subfamily)	Not found	Castanea sativa (Sweet chestnut)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16653058	Plant Physiol. 1992 Oct;100(2):778-783.	Collada C, Casado R, Fraile A, Aragoncillo C.	Basic Endochitinases Are Major Proteins in Castanea sativa Cotyledons.	
DRAMP00304	SIGFDGLNDPDIVAR	15	Endochitinase 1 (Plant defensin)	P86078	Belongs to the glycosyl hydrolase 20 family (Chitinase class I subfamily)	Not found	Capsicum annuum var. annuum (Red pepper)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Defense against chitin containing fungal pathogens. 
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	Submitted (JUL-2008) to UniProtKB	Belchi-Navarro S, Almagro L, Pedreno M.A.	Not found	
DRAMP00305	NNFYSYNAFITAAKSFPGFGTTGDTAVRGPIQISYNYNYGPCGR	44	Endochitinase 1 (Plant defensin)	P86081	Belongs to the glycosyl hydrolase 21 family (Chitinase class I subfamily)	Not found	Capsicum chinense (Scotch bonnet) (Bonnet pepper)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Defense against chitin containing fungal pathogens. 
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	Submitted (JUL-2008) to UniProtKB	Gomez Ros L.V, Almagro L, Ros Barcelo A, Pedreno M.A.	Not found	
DRAMP00306	GPLQLSWNYNYGAAGK	16	Endochitinase 1 (Plant defensin)	P85343	Belongs to the glycosyl hydrolase 22 family (Chitinase class I subfamily)	Not found	Ginkgo biloba (Ginkgo) (Maidenhair tree)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19157640	J Plant Physiol. 2009 May 15;166(8):831-843.	Uzal EN, Gómez-Ros LV, Hernández JA, Pedreño MA, Cuello J, Ros Barceló A.	Analysis of the soluble cell wall proteome of gymnosperms.	
DRAMP00307	EQCGNQAGGXVPPNG	15	Endochitinase A1 (Plant defensin)	P21225	Belongs to the glycosyl hydrolase 23 family (Chitinase class I subfamily)	Not found	Pisum sativum (Garden pea)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
Induction: By infection with the fungal pathogen Ascochyta pisi."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	Planta 184:24-29(1991).	Vad K, Mikkelsen JD, Collinge DB.	Induction, purification and characterization of chitinase isolated from pea leaves inoculated with Ascochyta pisi.	
DRAMP00308	AIGFDGLNDPDIVAR	15	Endochitinase 1 (Plant defensin)	P85337	Belongs to the glycosyl hydrolase 24 family (Chitinase class I subfamily)	Not found	Taxus baccata (English yew)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19157640	J Plant Physiol. 2009 May 15;166(8):831-843.	Uzal EN, Gómez-Ros LV, Hernández JA, Pedreño MA, Cuello J, Ros Barceló A.	Analysis of the soluble cell wall proteome of gymnosperms.	
DRAMP00309	MTEQKPKPSCHNVMVGNYVPTASDRAANRTLGFGLVTNIINGGLDC	46	Endochitinase 2 (CHIT 2; Plant defensin)	Q06014	Belongs to the glycosyl hydrolase 25 family (Chitinase class I subfamily)	Not found	Arachis hypogaea (Peanut)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense against chitin containing fungal and bacterial pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
Induction: By glucan and Phytophthora megasperma elicitors."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1980004	Mol Gen Genet. 1990 Dec;224(3):469-476.	Herget T, Schell J, Schreier PH.	Elicitor-specific induction of one member of the chitinase gene family in Arachis hypogaea.	
DRAMP00310	SAIWFWMTPQSPK	13	Endochitinase 2 (Plant defensin)	P86079	Belongs to the glycosyl hydrolase 26 family (Chitinase class I subfamily)	Not found	Capsicum annuum var. annuum (Red pepper)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	Submitted (JUL-2008) to UniProtKB	Gomez Ros L.V, Almagro L, Ros Barcelo A, Pedreno M.A.	Not found	
DRAMP00311	GPIQISYNYNYGPCGRYCGILGVSPGDNLDCGNQR	35	Endochitinase 2 (Plant defensin)	P86082	Belongs to the glycosyl hydrolase 27 family (Chitinase class I subfamily)	Not found	Capsicum chinense (Scotch bonnet) (Bonnet pepper)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	Submitted (JUL-2008) to UniProtKB	Sabater Jara A.B, Almagro L, Pedreno M.A.	Not found	
DRAMP00312	TAGFGVFTNIINGGLECGK	19	Endochitinase 2 (Plant defensin)	P85338	Belongs to the glycosyl hydrolase 28 family (Chitinase class I subfamily)	Not found	Taxus baccata (English yew)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
PTM: Contians one disulfide bond (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19157640	J Plant Physiol. 2009 May 15;166(8):831-843.	Uzal EN, Gómez-Ros LV, Hernández JA, Pedreño MA, Cuello J, Ros Barceló A.	Analysis of the soluble cell wall proteome of gymnosperms.	
DRAMP00313	MTPQGNKPSSHDVITGRWTPSDADRAAGRVSGFGVITNIINGGLDC	46	Endochitinase 3 (CHIT 3; Plant defensin)	Q06015	Belongs to the glycosyl hydrolase 29 family (Chitinase class I subfamily)	Not found	Arachis hypogaea (Peanut)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Defense against chitin containing fungal and bacterial pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
Induction: Constitutively expressed at low levels."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	1980004	Mol Gen Genet. 1990 Dec;224(3):469-476.	Herget T, Schell J, Schreier PH.	Elicitor-specific induction of one member of the chitinase gene family in Arachis hypogaea.	
DRAMP00314	MYDESTGYSSALK	13	Endochitinase 3 (Plant defensin)	P85355	Belongs to the glycosyl hydrolase 30 family (Chitinase class I subfamily)	Not found	Taxus baccata (English yew)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19157640	J Plant Physiol. 2009 May 15;166(8):831-843.	Uzal EN, Gómez-Ros LV, Hernández JA, Pedreño MA, Cuello J, Ros Barceló A.	Analysis of the soluble cell wall proteome of gymnosperms.	
DRAMP00315	MTPQGNKPSCHDVITNAWRPTATDSAAGRAPGYGVITNIINGGLDC	46	Endochitinase 4 (CHIT 4; Plant defensin)	Q06016	Belongs to the glycosyl hydrolase 31 family (Chitinase class I subfamily)	Not found	Arachis hypogaea (Peanut)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Defense against chitin containing fungal and bacterial pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
Induction: By glucan elicitor, and to a lesser extent by yeast extract, Phytophthora megasperma elicitor, UV light and dilution."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	1980004	Mol Gen Genet. 1990 Dec;224(3):469-476.	Herget T, Schell J, Schreier PH.	Elicitor-specific induction of one member of the chitinase gene family in Arachis hypogaea.	
DRAMP00316	MTAQGNKPSSHDVITGRWTPSAADRAAGRVSGFGVITNIINGGLDC	46	Endochitinase 1A (CHIT 1A; Plant defensin)	Q06012	Belongs to the glycosyl hydrolase 32 family (Chitinase class I subfamily)	Not found	Arachis hypogaea (Peanut)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Defense against chitin containing fungal and bacterial pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
Induction: By yeast extract and dilution. Slight induction by glucan elicitor."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	1980004	Mol Gen Genet. 1990 Dec;224(3):469-476.	Herget T, Schell J, Schreier PH.	Elicitor-specific induction of one member of the chitinase gene family in Arachis hypogaea.	
DRAMP00317	MTAQGNKPSSHDVITGRWTPSAADKAAGRVSGFGVITNIINGGLDC	46	Endochitinase 1B (CHIT 1B; Plant defensin)	Q06013	Belongs to the glycosyl hydrolase 33 family (Chitinase class I subfamily)	Not found	Arachis hypogaea (Peanut)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Defense against chitin containing fungal and bacterial pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
Induction: By yeast extract and dilution. Slight induction by glucan elicitor."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	1980004	Mol Gen Genet. 1990 Dec;224(3):469-476.	Herget T, Schell J, Schreier PH.	Elicitor-specific induction of one member of the chitinase gene family in Arachis hypogaea.	
DRAMP00318	EQCGRQAGGATCPNNLCCSQYGY	23	Endochitinase B (Plant defensin)	P21227	Belongs to the glycosyl hydrolase 34 family (Chitinase class I subfamily)	Not found	Pisum sativum (Garden pea)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Defense against chitin containing fungal pathogens.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
Induction: By infection with the fungal pathogen Ascochyta pisi."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	PubMed ID is not availbale	Planta 184:24-29(1991).	Vad K, Mikkelsen JD, Collinge DB.	Induction, purification and characterization of chitinase isolated from pea leaves inoculated with Ascochyta pisi.	
DRAMP00319	ENCGRQAG	8	Endochitinase (Plant defensin)	P86473	Belongs to the glycosyl hydrolase 35 family (Chitinase class I subfamily)	Not found	Actinidia chinensis (Kiwi) (Yangtao)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Defense against chitin containing fungal pathogens (By similarity).
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
Allergenic properties: Causes an allergic reaction in human.
Domian: Contains 1 chitin-binding type-1 domain."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	IgE	1553642	Tidsskr Nor Laegeforen. 1992 Jan 10;112(1):38-42.	Rygnestad T.	Suicide in Norway. Changes in the 20th century with special emphasis on the development during the last 20 years.	
DRAMP00320	MARVNSLKCALCFIVLILFVQLNCIPETRVMAVELSRVFLQTSSTDCGEPCVYIPCTITALLGCSCLNKVCVRP	74	Acyclotide phyb-K (Plant defensin)	B3EWH6	Belongs to the cyclotide family (Bracelet subfamily)	Not found	Petunia hybrida (Petunia)	Unknown	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism (By similarity).
Tissue specificity: Expressed in midvein, lamina and periphery of leaves (at protein level).
Domain: The presence of a 'disulfide through disulfide knot' structurally defines this protein as a knottin.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21143680##22700981	Plant J. 2010 Dec;64(6):1002-1017.##J Biol Chem. 2012 Aug 3;287(32):27033-46.	Breuillin F, Schramm J, Hajirezaei M, Ahkami A, Favre P, Druege U, Hause B, Bucher M, Kretzschmar T, Bossolini E, Kuhlemeier C, Martinoia E, Franken P, Scholz U, Reinhardt D.##Poth AG, Mylne JS, Grassl J, Lyons RE, Millar AH, Colgrave ML, Craik DJ.	Phosphate systemically inhibits development of arbuscular mycorrhiza in Petunia hybrida and represses genes involved in mycorrhizal functioning.##Cyclotides associate with leaf vasculature and are the products of a novel precursor in petunia (Solanaceae).	
DRAMP00321	QSISCAESCVWIPCATSLIGCSCVNSRCIYSK	32	Acyclotide phyb-M (Plant defensin)	B3EWH7	Belongs to the cyclotide family (Bracelet subfamily)	Not found	Petunia hybrida (Petunia)	Unknown	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism (By similarity).
Tissue specificity: Expressed in midvein, lamina and periphery of leaves (at protein level).
Domain: The presence of a 'disulfide through disulfide knot' structurally defines this protein as a knottin.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22700981	J Biol Chem. 2012 Aug 3;287(32):27033-46.	Poth AG, Mylne JS, Grassl J, Lyons RE, Millar AH, Colgrave ML, Craik DJ.	Cyclotides associate with leaf vasculature and are the products of a novel precursor in petunia (Solanaceae).	
DRAMP00322	SEPQXGRDAGGAL	13	Insecticidal protein LA-a (Latex abundant protein a; Plant defensin)	P86799	Not found	Not found	Morus alba (White mulberry)	Insecticidal	Protein level	Not found	Not found		"Function: Has insecticidal activity when consumed by D. melanogaster larvae. Has low chitinase and chitosanase activity.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins. Endohydrolysis of beta-(1->4)-linkages between D-glucosamine residues in a partly acetylated chitosan.
PTM: Glycosylated; contains galactose."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	20109180	BMC Biochem. 2010 Jan 28;11:6.	Kitajima S, Kamei K, Taketani S, Yamaguchi M, Kawai F, Komatsu A, Inukai Y.	Two chitinase-like proteins abundantly accumulated in latex of mulberry show insecticidal activity.	
DRAMP00323	SEQQXGRDVGGAL	13	Insecticidal protein LA-b (Latex abundant protein b; Plant defensin)	P86800	Not found	Not found	Morus alba (White mulberry)	Insecticidal	Protein level	Not found	Not found		"Function: Has insecticidal activity when consumed by D.melanogaster larvae. Has low chitinase and chitosanase activity.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins. Endohydrolysis of beta-(1->4)-linkages between D-glucosamine residues in a partly acetylated chitosan.
PTM: Glycosylated; contains galactose."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20109180	BMC Biochem. 2010 Jan 28;11:6.	Kitajima S, Kamei K, Taketani S, Yamaguchi M, Kawai F, Komatsu A, Inukai Y.	Two chitinase-like proteins abundantly accumulated in latex of mulberry show insecticidal activity.	
DRAMP00324	GIFTFEDESTSTVAPAKLYK	20	Protein PR-L1 (Plant defensin)	P83363	Belongs to the BetVI family	Not found	Lupinus luteus (European yellow lupin)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Pathogenesis-related protein. May have antifungal or antibacterial activity.
Induction: By heavy metal ions."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	J. Plant Physiol. 1999;154:703-708.	Przymusinski R, Gwozdz E.A.	Heavy metal-induced polypeptides in lupin roots are similar to pathogenesis-related proteins.	
DRAMP00325	SVFAFENEQSSTIAPARLYK	20	Protein PR-L2 (Plant defensin)	P83364	Belongs to the BetVI family	Not found	Lupinus luteus (European yellow lupin)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Pathogenesis-related protein. May have antifungal or antibacterial activity.
Induction: By heavy metal ions."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	J. Plant Physiol. 1999;154:703-708.	Przymusinski R, Gwozdz E.A.	Heavy metal-induced polypeptides in lupin roots are similar to pathogenesis-related proteins.	
DRAMP00326	GIFTFEDESTTTVAPAKLYK	20	Protein PR-L3 (Plant defensin)	P83365	Belongs to the BetVI family	Not found	Lupinus luteus (European yellow lupin)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Pathogenesis-related protein. May have antifungal or antibacterial activity.
Induction: By heavy metal ions."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	J. Plant Physiol. 1999;154:703-708.	Przymusinski R, Gwozdz E.A.	Heavy metal-induced polypeptides in lupin roots are similar to pathogenesis-related proteins.	
DRAMP00327	SVFAFQDESTSTIAQARLFI	20	Protein PR-L4 (Plant defensin)	P83366	Belongs to the BetVI family	Not found	Lupinus luteus (European yellow lupin)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Pathogenesis-related protein. May have antifungal or antibacterial activity.
Induction: By heavy metal ions."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	J. Plant Physiol. 1999;154:703-708.	Przymusinski R, Gwozdz E.A.	Heavy metal-induced polypeptides in lupin roots are similar to pathogenesis-related proteins.	
DRAMP00328	SIFAFQDESPSAIAQAKLFK	20	Protein PR-L5 (Plant defensin)	P83367	Belongs to the BetVI family	Not found	Lupinus luteus (European yellow lupin)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Pathogenesis-related protein. May have antifungal or antibacterial activity.
Induction: By heavy metal ions."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	J. Plant Physiol. 1999;154:703-708.	Przymusinski R, Gwozdz E.A.	Heavy metal-induced polypeptides in lupin roots are similar to pathogenesis-related proteins.	
DRAMP00329	GVFTFEDESTSTVAPAKLYK	20	Protein PR-L6 (Plant defensin)	P83368	Belongs to the BetVI family	Not found	Lupinus luteus (European yellow lupin)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Pathogenesis-related protein. May have antifungal or antibacterial activity.
Induction: By heavy metal ions."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	J. Plant Physiol. 1999;154:703-708.	Przymusinski R, Gwozdz E.A.	Heavy metal-induced polypeptides in lupin roots are similar to pathogenesis-related proteins.	
DRAMP00330	DFVDAHNAARAQVGVGPVHWTVDAYARQYANDRNLVHSATR	41	Pathogenesis-related protein (PR-1; Plant defensin)	P83834	Belongs to the CRISP family	Not found	Cucumis melo (Muskmelon)	Unknown	Protein level	Not found	Not found		Function: Probably involved in the defense reaction of plants against pathogens (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15480331	J Allergy Clin Immunol. 2004 Oct;114(4):896-899.	Asensio T, Crespo JF, Sanchez-Monge R, Lopez-Torrejon G, Somoza ML, Rodriguez J, Salcedo G.	Novel plant pathogenesis-related protein family involved in food allergy.	
DRAMP00331	GVQKSEVVITSA	12	Pathogenesis-related protein (PRP; Plant defensin)	C0HJB6	Belongs to the BetVI family	Not found	Foeniculum vulgare (Fennel)	Unknown	Protein level	Not found	Not found		"Function: Probably involved in the defense reaction of plants against pathogens (By similarity).
Allergenic properties: Causes an allergic reaction in human."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	IgE	23210484	J Agric Food Chem. 2013 Jan 23;61(3):740-746.	Pastorello EA, Farioli L, Stafylaraki C, Scibilia J, Giuffrida MG, Mascheri A, Piantanida M, Baro C, Primavesi L, Nichelatti M, Schroeder JW, Pravettoni V.	Fennel allergy is a lipid-transfer protein (LTP)-related food hypersensitivity associated with peach allergy.	
DRAMP00332	DLDVNVFNR	9	Pathogenesis-related protein (Plant defensin)	P85494	Not found	Not found	Ephedra distachya (Joint-fir) (Ephedra vulgaris)	Antimicrobial	Protein level	Not found	Not found		"Function: Probably involved in the defense reaction of plants against pathogens.
Domain: Contains 1 barwin domain."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19157640	J Plant Physiol. 2009 May 15;166(8):831-843.	Uzal EN, Gómez-Ros LV, Hernández JA, Pedreño MA, Cuello J, Ros Barceló A.	Analysis of the soluble cell wall proteome of gymnosperms.	
DRAMP00333	AVKTITLNLVSPSANRYATFLTEIRDNVRXRSLDYSHSGIDVIGAPSSRDSXLNINFQSP	60	Antiviral protein DAP-32 (Ribosome-inactivating protein; Plant defensin)	P24477	Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily)	Not found	Dianthus caryophyllus (Carnation) (Clove pink)	Antimicrobial, Antiviral	Protein level	Not found	Not found		"Function: Single-chain ribosome-inactivating protein, possessing high antiviral potency and low toxicity to normal cells in culture and to intact animals. Capable of inhibiting HIV-1 infection and replication.
Catalytic activity: Endohydrolysis of the N-glycosidic bond at one specific adenosine on the 28S rRNA."	Syncytkia (IC50=0.76 nM), viral coreprotein P24 (IC50=0.71 nM), HIV-RT (IC50=0.76 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1936243	FEBS Lett. 1991 Oct 7;291(1):139-144.	Lee-Huang S, Kung HF, Huang PL, Huang PL, Li BQ, Huang P, Huang HI, Chen HC.	A new class of anti-HIV agents: GAP31, DAPs 30 and 32.	
DRAMP00334	GLDTVSFSTKGATYITYVNFLNELRVKTKPEGNSHGIPSLRKSSDDPGSSFVVAG	55	Antiviral protein GAP-31 (Ribosome-inactivating protein; Plant defensin)	P24475	Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily)	Not found	Suregada multiflora (False lime) (Gelonium multiflorum)	Antimicrobial, Antiviral	Protein level	Not found	Not found		"Function: Single-chain ribosome-inactivating protein, possessing high antiviral potency and low toxicity to normal cells in culture and to intact animals. Capable of inhibiting HIV-1 infection and replication.
Catalytic activity: Endohydrolysis of the N-glycosidic bond at one specific adenosine on the 28S rRNA."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1936243	FEBS Lett. 1991 Oct 7;291(1):139-144.	Lee-Huang S, Kung HF, Huang PL, Huang PL, Li BQ, Huang P, Huang HI, Chen HC.	A new class of anti-HIV agents: GAP31, DAPs 30 and 32.	
DRAMP00335	NVRFDLSGATSSSYKTFIKN	20	Ribosome-inactivating protein (rRNA N-glycosidase; Plant defensin)	P80750	Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily)	Not found	Cucurbita pepo (Vegetable marrow) (Summer squash)	Unknown	Protein level	Not found	Not found		Catalytic activity: Endohydrolysis of the N-glycosidic bond at one specific adenosine on the 28S Rrna.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9022685	Eur J Biochem. 1996 Dec 15;242(3):585-591.	Yoshinari S, Yokota S, Sawamoto H, Koresawa S, Tamura M, Endo Y.	Purification, characterization and subcellular localization of a type-1 ribosome-inactivating protein from the sarcocarp of Cucurbita pepo.	
DRAMP00339	GADFQECMKEHSQKQHQHQG	20	Alpha-basrubrin (Fragment; Plants)	P83186	Not found	Not found	Basella alba (Malabar spinach) (Basella rubra)	Antimicrobial, Antifungal, Antiviral	Protein level	Not found	Not found		Function: Inhibits HIV-1 reverse transcriptase and cell-free translation.	Fungi: Botrytis cinerea, Mycosphaerella arachidicola, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11688973	Biochem Biophys Res Commun. 2001 Nov 9;288(4):765-770.	Wang H, Ng T.B.	Novel antifungal peptides from ceylon spinach seeds.	
DRAMP00340	KIMAKPSKFYEQLRGR	16	Beta-basrubin (Plants)	P83187	Not found	Not found	Basella alba (Malabar spinach) (Basella rubra)	Antimicrobial, Antifungal, Antiviral	Protein level	Not found	Not found		Function: Possesses antifungal activity. Inhibits HIV-1 reverse transcriptase and cell-free translation.	Fungi: Botrytis cinerea, Mycosphaerella arachidicola, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11688973	Biochem Biophys Res Commun. 2001 Nov 9;288(4):765-770.	Wang H, Ng T.B.	Novel antifungal peptides from ceylon spinach seeds.	
DRAMP00341	ANTAFVSSAHNTQKIPAGAPFNRNLRAMLADLRQNAAFAG	40	Antifungal protein ginkbilobin-1 (Ginkbilobin, GNL; Plants)	P83171	Not found	GNK1	Ginkgo biloba (Ginkgo) (Maidenhair tree)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral, Antifungal	Protein level	Not found	Not found		Function: Also inhibits HIV-1 reverse transcriptase and proliferation of murine splenocytes.	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacteria: Pseudomonas aeruginosa, Escherichia coli.##Fuungi: Botrytis cinerea, Mycosphaerella arachidicola, Fusarium oxysporum, Rhizoctonia solani, Coprinus comatus,	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11118300	Biochem Biophys Res Commun. 2000 Dec 20;279(2):407-411.	Wang H, Ng T.B.	Ginkbilobin, a novel antifungal protein from Ginkgo biloba seeds with sequence similarity to embryo-abundant protein.	
DRAMP00342	ATITVVNRCSYTVWPGALPGGGVRLDPGQRWALNMPAGTAGAAV	44	Antifungal protein R (Plant defensin)	P33044	Not found	Not found	Hordeum vulgare (Barley)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Has antifungal activity. Inhibits the growth of Trichoderma viridae and Candida albicans.	Fungi: Trichoderma viridae, Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1936240	FEBS Lett. 1991 Oct 7;291(1):127-131.	Hejgaard J, Jacobsen S, Svendsen I.	Two antifungal thaumatin-like proteins from barley grain.	
DRAMP00343	ATFTVINKCQYTVWAAAVPAGGGQKLDAGQTWSIXXP	37	Antifungal protein S (Plant defensin)	P33045	Not found	Not found	Hordeum vulgare (Barley)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Has antifungal activity. Inhibits the growth of Trichoderma viridae and Candida albicans.	Fungi: Trichoderma viridae, Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1936240	FEBS Lett. 1991 Oct 7;291(1):127-131.	Hejgaard J, Jacobsen S, Svendsen I.	Two antifungal thaumatin-like proteins from barley grain.	
DRAMP00344	AISYDQVKSSLLPCVGYVRGNNARPAPPNYCKGIRSLKSAARIRLDRQAACKCIKSLAADISDINYGVAAGLPGQCNVHIPYKISPSIDCKRVK	94	Non-specific lipid-transfer protein 6 (LTP; Plants)	O24418	Belongs to the plant LTP family	LTP6	Gossypium hirsutum (Upland cotton) (Gossypium mexicanum)	Not found	Transcript level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).
Tissue specificity: Specifically expressed in fiber cells."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	9030188	Biochim Biophys Acta. 1997 Jan 21;1344(2):111-114.	Ma DP, Liu HC, Tan H, Creech RG, Jenkins JN, Chang YF.	Cloning and characterization of a cotton lipid transfer protein gene specifically expressed in fiber cells.	
DRAMP00345	ACEPAQLAVCASAILGGTKPSGECCGNLRAQQGCLCQYVKDPNYGHYVSSPHARDTLNLCGIPVPHC	67	Probable non-specific lipid-transfer protein (LTP; B-FABP; Plants)	P20145	Belongs to the plant LTP family	LTP2	Hordeum vulgare (Barley)	Not found	Transcript level	Not found	Not found		"Function: Potential phospholipid transfer protein.
Tissue specificity: Aleurone.
Developmental stage: Maximum mRNA abundance around mid-phase of grain development.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	7849757	Plant J. 1994 Dec;6(6):849-860.	Kalla R, Shimamoto K, Potter R, Nielsen PS, Linnestad C, Olsen OA.	The promoter of the barley aleurone-specific gene encoding a putative 7 kDa lipid transfer protein confers aleurone cell-specific expression in transgenic rice.	
DRAMP00346	AITCGQVSSALGPCAAYAKGSGTSPSAGCCSGVKRLAGLARSTADKQATCRCLKSVAGAYNAGRAAGIPSRCGVSVPYTISASVDCSKIH	90	Non-specific lipid-transfer protein Cw18 (LTP Cw-18; PKG2316; Plants)	Q43871	Belongs to the plant LTP family	CW18	Hordeum vulgare (Barley)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
Tissue specificity: Highly expressed in leaves and coleoptiles. No expression in roots.
Induction: By NaCl, abscisic acid and inoculation with the fungal pathogen E. graminis.
PTM: Contains four disulfide bonds 4-52; 14-29; 30-72; 50-86."	Fungi: Fusarim solani (EC50=3-20×10-6 M), Pseudomonas solanacearum (EC50=3-6×10-7 M), Pythium aphanidermatum, Clavibacter michiganensis subsp. Sepedonicus (EC50=l-3×10-7 M).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	8420795##8281190	FEBS Lett. 1993 Jan 25;316(2):119-122.##Plant J. 1993 Dec;4(6):983-991.	Molina A, Segura A, García-Olmedo F.##Molina A, Garc­a-Olmedo F.	Lipid transfer proteins (nsLTPs) from barley and maize leaves are potent inhibitors of bacterial and fungal plant pathogens.##Developmental and pathogen-induced expression of three barley genes encoding lipid transfer proteins.	
DRAMP00347	AISCGQVSSALSPCISYARGNGAKPPVACCSGVKRLAGAAQSTADKQAACRCLKSLATSIKGINMGKVSGVPGKCGVSVPFPISMSTDCNKVH	93	Non-specific lipid-transfer protein 3 (LTP 3; CW-19; CW-20; Plants)	Q43766	Belongs to the plant LTP family	LTP3	Hordeum vulgare (Barley)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds (By similarity)."	Fungi: Fusarim solani (EC50=3-20×10-6 M), Pseudomonas solanacearum (EC50=3-6×10-7 M), Pythium aphanidermatum, Clavibacter michiganensis subsp. Sepedonicus (EC50=l-3×10-7 M).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	8420795##8281190	FEBS Lett. 1993 Jan 25;316(2):119-122.##Plant J. 1993 Dec;4(6):983-991.	Molina A, Segura A, García-Olmedo F.##Molina A, Garc­a-Olmedo F.	Lipid transfer proteins (nsLTPs) from barley and maize leaves are potent inhibitors of bacterial and fungal plant pathogens.##Developmental and pathogen-induced expression of three barley genes encoding lipid transfer proteins.	
DRAMP00348	AISCGQVSSALSPCISYARGNGAKPPAACCSGVKRLAGAAQSTADKQAACKCIKSAAGGLNAGKAAGIPSMCGVSVPYAISASVDCSKIR	90	Non-specific lipid-transfer protein 4.1 (LTP 4.1; CW-21; Plants)	Q43767	Belongs to the plant LTP family	LTP4.1	Hordeum vulgare (Barley)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds 4-52; 14-29; 30-72; 50-86."	Fungi: Fusarim solani (EC50=3-20×10-6 M), Pseudomonas solanacearum (EC50=3-6×10-7 M), Pythium aphanidermatum, Clavibacter michiganensis subsp. Sepedonicus (EC50=l-3×10-7 M).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	8420795##8281190	FEBS Lett. 1993 Jan 25;316(2):119-122.##Plant J. 1993 Dec;4(6):983-991.	Molina A, Segura A, García-Olmedo F.##Molina A, Garc­a-Olmedo F.	Lipid transfer proteins (nsLTPs) from barley and maize leaves are potent inhibitors of bacterial and fungal plant pathogens.##Developmental and pathogen-induced expression of three barley genes encoding lipid transfer proteins.	
DRAMP00349	AISCGQVSSALSPCISYARGNGAKPPVACCSGVKRLAGAAQSTADKQAACKCIKSAAGGLNAGKAAGIPSMCGVSVPYAISASVDCSKIR	90	Non-specific lipid-transfer protein 4.2 (LTP 4.2; Low-temperature-responsive protein 4.9; Plants)	Q43875	Belongs to the plant LTP family	LTP4.2	Hordeum vulgare (Barley)	Not found	Transcript level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
Induction: By cold.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	8804389	Mol Gen Genet. 1996 Aug 27;252(1-2):162-168.	Molina A, Diaz I, Vasil IK, Carbonero P, Garc­a-Olmedo F.	Two cold-inducible genes encoding lipid transfer protein LTP4 from barley show differential responses to bacterial pathogens.	
DRAMP18333	STPACAIGVVGITVAVTGISTACTSRCINK	30	BHT-Ab(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Streptococcus rattus BHT	Antimicrobial, Antibacterial, Anti-Gram+		Not found	The amino acid sequence is identical to SmbA. 		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16194596##18220976	FEMS Microbiol Lett. 2005 Nov 15;252(2):235-41.##Mini Rev Med Chem. 2007 Dec;7(12):1236-47.	Hyink O, Balakrishnan M, Tagg JR.##Lawton EM, Ross RP, Hill C, Cotter PD.	Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin.##Two-peptide lantibiotics: a medical perspective.	
DRAMP18334	MWGRILAFVAKYGTKAVQWAWKNKWFLLSLGEAVFDYIRSIWGG	44	BHT-B (Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	bht-b	Streptococcus rattus BHT	Antimicrobial, Antibacterial, Anti-Gram+		Not found	BHT-B is a non-modi?ed 5195 Da peptide with some similarity to the tryptophan-rich Staphylococcus aureus bacteriocin, aureocin A53.		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16194596	FEMS Microbiol Lett. 2005 Nov 15;252(2):235-41.##Mini Rev Med Chem. 2007 Dec;7(12):1236-47.	Hyink O, Balakrishnan M, Tagg JR.	Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin.	
DRAMP00351	AITCGQVTSNLAPCLAYLRNTGPLGRCCGGVKALVNSARTTEDRQIACTCLKSAAGAISGINLGKAAGLPSTCGVNIPYKISPSTDCSKVQ	91	Non-specific lipid-transfer protein 1 (LTP 1; PR-14; Plant defensin)	Q42952	Belongs to the plant LTP family	LTP1	Nicotiana tabacum (Common tobacco)	Not found	Protein level	Alpha helix (5 helices; 50 residues)	The overall fold of tobacco LTP 1 includes four α-helices: H1 (Cys4-Leu18), H2 (Cys27-Val37), H3 (Glu42-Ala55) and H4 (Leu63-Thr72), followed by a C-terminal segment involving three γ-turns.	1T12 resolved by NMR.	"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. Binds cis-unsaturated fatty acids and jasmonic acid with a higher affinity than linear chain fatty acids. Formation of the complex with jasmonic acid results in a conformational change facilitating the LPT1 binding on the elicitin plasma membrane receptor that is known to be involved in plant defense induction. May also play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
Tissue specificity: High expression in leaf epidermis and shoot apex, and also in root epidermis during seedling germination.
PTM: Contains four disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	8883375##15726627	Plant Physiol. 1996 Oct;112(2):513-524.##Proteins. 2005 May 1;59(2):356-367.	Canevascini S, Caderas D, Mandel T, Fleming AJ, Dupuis I, Kuhlemeier C.##Da Silva P, Landon C, Industri B, Marais A, Marion D, Ponchet M, Vovelle F.	Tissue-specific expression and promoter analysis of the tobacco Itp1 gene.##Solution structure of a tobacco lipid transfer protein exhibiting new biophysical and biological features.	
DRAMP00352	VDCGQVNSSLASCIPFLTGGVASPSASCCAGVQNLKTLAPTSADRRAACECIKAAAARFPTIKQDAASSLPKKCGVDINIPISKTTNCQAIN	92	Non-specific lipid-transfer protein A (NS-LTP A; PLTP; Plants)	P10973	Belongs to the plant LTP family	Not found	Ricinus communis (Castor bean)	Not found	Protein level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	PubMed ID is not available	Biochim. Biophys. Acta 1986;870:248-255.	Takishima K, Watanabe S, Yamada M, Mamiya G.	The amino-acid sequence of the nonspecific lipid transfer protein from germinated castor bean endosperms.	
DRAMP00353	VNCGQVNKALSSCVPFLTGFDTTPSLTCCAGVMELKRLAPTVKDKRIACECVKTAAARYPNIREDAASSLPYKCGVVINVPISKTTNCHEIN	92	Non-specific lipid-transfer protein B (NS-LTP B; PLTP; Plants)	P10974	Belongs to the plant LTP family	Not found	Ricinus communis (Castor bean)	Not found	Protein level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	3191918	Eur J Biochem. 1988 Nov 1;177(2):241-249.	Takishima K, Watanabe S, Yamada M, Suga T, Mamiya G.	Amino acid sequences of two nonspecific lipid-transfer proteins from germinated castor bean.	
DRAMP00354	AVPCSTVDMKAAACVGFATGKDSKPSQACCTGLQQLAQTVKTVDDKKAICRCLKASSKSLGIKDQFLSKIPAACNIKVGFPVSTNTNCETIH	92	Non-specific lipid-transfer protein C, cotyledon-specific isoform (NS-LTP C; PLTP; Plants)	P10975, Q43120	Belongs to the plant LTP family	Not found	Ricinus communis (Castor bean)	Not found	Protein level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	1783615	J Biochem. 1991 Nov;110(5):823-831.	Tsuboi S, Suga T, Takishima K, Mamiya G, Matsui K, Ozeki Y, Yamada M.	Organ-specific occurrence and expression of the isoforms of nonspecific lipid transfer protein in castor bean seedlings, and molecular cloning of a full-length cDNA for a cotyledon-specific isoform.	
DRAMP00355	AVPCSTVDMKAAACVGFATGKDSKPSSACCTGLQQLAQTVKSVDDKKAICRCLKASSKSLGIKDQFLSKIPAACNIKVGFPVSTATNCETIH	92	Non-specific lipid-transfer protein D, cotyledon-specific isoform (NS-LTP D; Plants)	Q43119	Belongs to the plant LTP family	Not found	Ricinus communis (Castor bean)	Not found	Homology	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	PubMed ID is not available	Planta 1992;187:367-371.	Weig A, Komor E.	The lipid-transfer protein C of Ricinus communis L.: isolation of two cDNA sequences which are strongly and exclusively expressed in cotyledons after germination.	
DRAMP00356	GITCGMVSSKLAPCIGYLKGGPLGGGCCGGIKALNAAAATTPDRKTACNCLKSAANAIKGINYGKAAGLPGMCGVHIPYAISPSTNCNAVH	91	Non-specific lipid-transfer protein (LTP; PLTP; Plants)	P10976	Belongs to the plant LTP family	Not found	Spinacia oleracea (Spinach)	Not found	Protein level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	16667945##3609015	Plant Physiol. 1991 Jan;95(1):164-170.##Eur J Biochem. 1987 Jul 15;166(2):387-391.	Bernhard WR, Thoma S, Botella J, Somerville CR.##Bouillon P, Drischel C, Vergnolle C, Duranton H, Kader JC.	Isolation of a cDNA Clone for Spinach Lipid Transfer Protein and Evidence that the Protein Is Synthesized by the Secretory Pathway.##The primary structure of spinach-leaf phospholipid-transfer protein.	
DRAMP00357	TTSEAAISCGQVSSAIALCLSYARGQGFAPSAGCCSGVRSLNSAARTTADRRAACNCLKNAARGISGLNAGNAASIPSKCGVSVPYTISTSTDCSRVS	98	Non-specific lipid-transfer protein 1 (LTP 1; Plants)	Q43193, Q43195	Belongs to the plant LTP family	LTP1	Sorghum bicolor (Sorghum) (Sorghum vulgare)	Not found	Homology	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	7958959	Gene. 1994 Oct 21;148(2):305-308.	Pel¨se-Siebenbourg F, Caelles C, Kader JC, Delseny M, Puigdom¨nech P.	A pair of genes coding for lipid-transfer proteins in Sorghum vulgare.	
DRAMP00358	ATTSEAAVTCGQVSSAIGPCLSYARGQGSGPSAGCCSGVRSLNSAARTTADRRAACNCLKNAARGIRGLNVGKAASIPSKCGVSIPYTISTSTDCSRVS	99	Non-specific lipid-transfer protein 2 (LTP 2; Plants)	Q43194	Belongs to the plant LTP family	LTP2	Sorghum bicolor (Sorghum) (Sorghum vulgare)	Not found	Homology	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	7958959	Gene. 1994 Oct 21;148(2):305-308.	Pel¨se-Siebenbourg F, Caelles C, Kader JC, Delseny M, Puigdom¨nech P.	A pair of genes coding for lipid-transfer proteins in Sorghum vulgare.	
DRAMP00359	AISCGQVASAIAPCISYARGQGSGPSAGCCSGVRSLNNAARTTADRRAACNCLKNAAAGVSGLNAGNAASIPSKCGVSIPYTISTSTDCSRVN	93	Non-specific lipid-transfer protein (LTP; PLTP; Plants)	P19656	Belongs to the plant LTP family	Not found	Zea mays (Maize)	Not found	Protein level	Alpha helix (6 helices; 53 residues)	The global fold involving four helical fragments connected by three loops and a C-terminal tail without regular secondary structures is stabilized by four disulfide bridges. The most striking feature of this structure is the existence of an internal hydrophobic cavity running through the whole molecule. (Ref.3)	1AFH resolved by NMR.##1FK0, 1FK1, 1FK2, 1FK3 resolved by X-ray	"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
Allergenic properties: Causes an allergic reaction in human.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	2022320##7735835##8845747	Gene. 1991 Mar 1;99(1):133-136.##Structure. 1995 Feb 15;3(2):189-199.##Protein Sci. 1996 Apr;5(4):565-577.	Arondel V, Tchang F, Baillet B, Vignols F, Grellet F, Delseny M, Kader JC, Puigdom¨nech P.##Shin DH, Lee JY, Hwang KY, Kim KK, Suh SW.##Gomar J, Petit MC, Sodano P, Sy D, Marion D, Kader JC, Vovelle F, Ptak M.	Multiple mRNA coding for phospholipid-transfer protein from Zea mays arise from alternative splicing.##High-resolution crystal structure of the non-specific lipid-transfer protein from maize seedlings.##Solution structure and lipid binding of a nonspecific lipid transfer protein extracted from maize seeds.	
DRAMP00360	ISCQDVKQSLAPCLPYVTGRAPKPA	25	Non-specific lipid-transfer protein 1 (LTP 1; Plants)	P86527	Belongs to the plant LTP family	Not found	Nigella sativa (Black cumin)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.	Fungi: Fusarium oxysporum and Phytophthora infestans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	19621049	Bioorg Khim. 2009 May-Jun;35(3):344-349.	Oshchepkova IuI, Veshkurova ON, Rogozhin EA, Musoliamov AKh, Smirnov AN, Odintsova TI, Egorov TsA, Grishin EV, Salikhov ShI.	Isolation of the lipid-transporting protein Ns-LTP1 from seeds of the garden fennel flower (Nigella sativa).	
DRAMP00361	ITCPQVTQSLAPCVPYLISG	20	Non-specific lipid-transfer protein (LTP; Harmalin; Plants)	B3EWH4	Belongs to the plant LTP family	Not found	Peganum harmala (Syrian rue) (Harmal peganum)	Antimicrobial, Antifungal, Antiviral, Anti-cancer	Protein level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues. Inhibits cell proliferation of cervical carcinoma cell line HeLa (IC50=2.74 µM), gastric carcinoma cell line MGC-7 (IC50=3.13 µM), esophageal carcinoma cell line Eca-109 (IC50=0.7 µM) and melanoma B16 cells (IC50=1.47 µM). Has antifungal activity. Induces caspase-dependent apoptosis in cell line Eca-109. Demonstrates inhibitory effect on HIV-1 reverse transcriptase (IC50=1.26 µM).
Biophysicochemical properties: pH dependence (Stable between pH 4 and 10); Temperature dependence (Thermostable. Retains antifungal activity between 4 degrees Celsius and 60 degrees Celsius. Activity reduced after 30 min at 80 degrees Celsius)."	Fungi: Penicillium digitatum (IC50=37.5 µM), Alternaria alternata (IC50=1.5 µM), Rhizopus stolonifer (IC50=8.44 µM) and Magnaporthe grisea (IC50=12.19 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	PubMed ID is not available	Submitted (MAR-2012) to UniProtKB	Ma XJ, Liu DL, Tang HS, Wang Y, Sun SR.	Purification and characterization of a novel protein from Peganum harmala seeds with antifungal, antiproliferation and anti-HIV-1 reverse transcriptase activities.	
DRAMP00362	AISCGTVSGALVPCLTYLKGGPGPSPQCCGGVKRLNGAARTTIDRRAACNCLKSSAGSISGLKPGNVATLPGKCGVRLPYTISTSTNCNTIRF	93	Non-specific lipid-transfer protein 1 (Lc-LTP1; Plants)	A0AT28	Belongs to the plant LTP family	Not found	Lens culinaris (Lentil) (Cicer lens)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds 4-51; 14-28; 29-74; 49-88."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	17511608	Biochemistry (Mosc). 2007 Apr;72(4):430-438.	Finkina EI, Balandin SV, Serebryakova MV, Potapenko NA, Tagaev AA, Ovchinnikova TV.	Purification and primary structure of novel lipid transfer proteins from germinated lentil (Lens culinaris) seeds.	
DRAMP00363	AISCGAVTSDLSPCLTYLTGGPGPSPQCCGGVKKLLAAANTTPDRQAACNCLKSAAGSITKLNTNNAAALPGKCGVNIPYKISTTTNCNTVKF	93	Non-specific lipid-transfer protein 2 (Lc-LTP2; Plants)	A0AT29, P84255	Belongs to the plant LTP family	Not found	Lens culinaris (Lentil) (Cicer lens)	Antimicrobial, Antibacterial	Protein level	Alpha helix (6 helices; 57 residues)	Not found	2LJO resolved by NMR.	"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds 4-51; 14-28; 29-74; 49-88."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	17511608##17511608##PubMed ID is not available	Biochemistry (Mosc). 2007 Apr;72(4):430-438.##Biochemistry (Mosc). 2007 Apr;72(4):430-438.##To be Published.	Finkina EI, Balandin SV, Serebryakova MV, Potapenko NA, Tagaev AA, Ovchinnikova TV.##Finkina EI, Balandin SV, Serebryakova MV, Potapenko NA, Tagaev AA, Ovchinnikova TV.##Shenkarev, Z, Mineev, K, Gizatullina, A, Finkina, E, Arseniev, A, Ovchinnikova, T.	Purification and primary structure of novel lipid transfer proteins from germinated lentil (Lens culinaris) seeds.##Purification and primary structure of novel lipid transfer proteins from germinated lentil (Lens culinaris) seeds.##Solution structure of lipid transport protein Lc-LTP2 from germinated lentil (Lens Culinaris) seeds.	
DRAMP00364	AISCGAVTSDLSPCLTYLTGGPGPSPQCCGGVKKLLAAANTTPDRQAACNCLKSAAGSITKLNTNNAAALPGKCGVNIPYKISTSTNCNTVKF	93	Non-specific lipid-transfer protein 4 (Lc-LTP4; Plants)	A0AT33, P84255	Belongs to the plant LTP family	Not found	Lens culinaris (Lentil) (Cicer lens)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds 4-51; 14-28; 29-74; 49-88."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	17511608	Biochemistry (Mosc). 2007 Apr;72(4):430-438.	Finkina EI, Balandin SV, Serebryakova MV, Potapenko NA, Tagaev AA, Ovchinnikova TV.	Purification and primary structure of novel lipid transfer proteins from germinated lentil (Lens culinaris) seeds.	
DRAMP00365	AISCGAVTGDLSPCLTYLTGGPGPSPQCCGGVKKLLAAANTTPDRQAACNCMKSAASSITKLNTNNAAALPGKCGVNIPYKISTSTNCNTVK	92	Non-specific lipid-transfer protein 5 (Lc-LTP5; Plants)	A0AT31	Belongs to the plant LTP family	Not found	Lens culinaris (Lentil) (Cicer lens)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds 4-51; 14-28; 29-74; 49-88."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	17511608	Biochemistry (Mosc). 2007 Apr;72(4):430-438.	Finkina EI, Balandin SV, Serebryakova MV, Potapenko NA, Tagaev AA, Ovchinnikova TV.	Purification and primary structure of novel lipid transfer proteins from germinated lentil (Lens culinaris) seeds.	
DRAMP00366	AISCGAVTSDLSPCLTYLTGGPGPSPQCCGGVKKLLAAANTTPDRQAACNCLKSAAGSITKLNTNNAAALPGKCGVDIPYKISTSTNCNTVKF	93	Non-specific lipid-transfer protein 6 (Lc-LTP6; Plants)	A0AT32	Belongs to the plant LTP family	Not found	Lens culinaris (Lentil) (Cicer lens)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds 4-51; 14-28; 29-74; 49-88."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	17511608	Biochemistry (Mosc). 2007 Apr;72(4):430-438.	Finkina EI, Balandin SV, Serebryakova MV, Potapenko NA, Tagaev AA, Ovchinnikova TV.	Purification and primary structure of novel lipid transfer proteins from germinated lentil (Lens culinaris) seeds.	
DRAMP00367	AISCGAVTSDLSPCLTYLTGGPGPSPQCCGGVKKLLAAANTTPDRQAACNCLKSAAGSITKLNTNNAAALPGKCGVNIPYKISTTTNCNTVK	92	Non-specific lipid-transfer protein 7 (Lc-LTP7; Plants)	A0AT29, P84255	Belongs to the plant LTP family	Not found	Lens culinaris (Lentil) (Cicer lens)	Antimicrobial, Antibacterial	Protein level	Not found	Not found	2MAL##5LQV	"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds 4-51; 14-28; 29-74; 49-88."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	17511608	Biochemistry (Mosc). 2007 Apr;72(4):430-438.	Finkina EI, Balandin SV, Serebryakova MV, Potapenko NA, Tagaev AA, Ovchinnikova TV.	Purification and primary structure of novel lipid transfer proteins from germinated lentil (Lens culinaris) seeds.	
DRAMP00368	AISCGAVTSDLSPCLTYLTGGPGPSPQCCGGVKKLLAAANTTPDRQAACNCLKSAAGSITKLNTNNAAALPGKCGVNIPYKISTSTNCNTVK	92	Non-specific lipid-transfer protein 8 (Lc-LTP8; Plants)	A0AT33, P84255	Belongs to the plant LTP family	Not found	Lens culinaris (Lentil) (Cicer lens)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds 4-51; 14-28; 29-74; 49-88."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	17511608	Biochemistry (Mosc). 2007 Apr;72(4):430-438.	Finkina EI, Balandin SV, Serebryakova MV, Potapenko NA, Tagaev AA, Ovchinnikova TV.	Purification and primary structure of novel lipid transfer proteins from germinated lentil (Lens culinaris) seeds.	
DRAMP00369	ITCGLVASKLAPCIGYLQGAPGPSAACCGGIKSLNSAAASPADRKTACTCLKSAATSIKGINYGKAASLPRQCGVSVPYAISPNTNCNAIH	91	IWF1 (Bv-LTP1; Plant defensin)	Q43748	Belongs to the plant LTP family	IWF1'	Beta vulgaris (Sugar beet)	Antimicrobial, Antifungal	Homology	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues. Also has fungicide activity.	Fungi: Cercospora beticola.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	8790287	Plant Mol Biol. 1996 Jun;31(3):539-552.	Nielsen KK, Nielsen JE, Madrid SM, Mikkelsen JD.	New antifungal proteins from sugar beet (Beta vulgaris L.) showing homology to non-specific lipid transfer proteins.	
DRAMP00370	ITCGQVTSQVAGCLSYLQRGGAPAPXXXXGIRNLXXMA	38	Antifungal protein 5 (CW-5; Plants)	P83139	Belongs to the plant LTP family	Not found	Malva parviflora (Little mallow) (Cheeseweed mallow)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Possesses potent antifungal activity against F. graminearum but not P. infestans.
Miscellaneous: Under low salt conditions, possesses potent antifungal activity but activity is drastically reduced under high salt conditions."	Fungi: Fusarium graminearum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11302747	Biochem Biophys Res Commun. 2001 Apr 20;282(5):1224-1228.	Wang X, Bunkers GJ, Walters MR, Thoma RS.	Purification and characterization of three antifungal proteins from cheeseweed (Malva parviflora).	
DRAMP00371	GPLGGCCGGIKKSAAAGISGINYGIAAGLPGKCGVNIPYKISPSTDCSKVQ	51	Non-specific lipid-transfer protein (LTP; Plant defensin)	B3A0N2	Belongs to the plant LTP family	Not found	Lycium barbarum (Matrimony vine)	Unknown	Protein level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).
Miscellaneous: Causes an allergic reaction."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	PubMed ID is not availbale	Submitted (SEP-2011) to UniProtKB	Carnes J, Lopez-matas M.A, Saez R.	Allergic sensitization to Goji berries is mediated by a 7 kDa band (LTP).	
DRAMP00372	AVSCGDVTSSIAPCLSYVMGRESSPSSSCCSGVRTLNGKASSSADRRTACSCLKNMASSFRNLNMGNAASIPSKCGVSVAFPISTSVDCSKIN	93	Non-specific lipid-transfer protein 3 (Os-LTP3)	Q2QYL3, Q42976, Q8GZV1	Belongs to the plant LTP family	LTP110-A	Oryza sativa Japonica Group	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues. May possess an antifungal activity and protect the plant against pathogens.
PTM: Problely contains four disulfide bonds 4-52; 14-29; 30-75; 50-89. "	Pyricularia oryzae, Xanthomonas oryzae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14659081	J Biochem Mol Biol. 2003 Nov 30;36(6):603-607.	Ge X, Chen J, Li N, Lin Y, Sun C, Cao K.	Resistance Function: of rice lipid transfer protein LTP110.	
DRAMP00373	ALSCGTVNSNLAACIGYLTQNAPLARGCCTGVTNLNNMAXTTP	43	Seed non-specific lipid transfer protein-like (ns-LTP; Plants)	P29420	Belongs to the plant LTP family	Not found	Raphanus sativus (Radish)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues. This isoform inhibits the hyphal growth of several fungi in vitro.	Fungi: Alternaria brassicola (MUCL 20297) (IC50=48 µg/mL), Ascochyta pisi (MUCL 20164) (IC50=41 µg/mL), Botrytis cinerea (MUCL 30158) (IC50=45 µg/mL), Colletotrichum lindemuthianum (MUCL 9577) (IC50=25 µg/mL), Fusarium culmorum (IMI 180420) (IC50=20 µg/mL), Fusarium oxysporum f. sp. lycopersici (MUCL 909) (IC50=54 µg/mL), Fusarium oxysporum f. sp. pisi (IMI 236441) (IC50=58 µg/mL), Nectria haematococca (Collection Van Etten 26022) (IC50=100 µg/mL), Phoma betae (MUCL 9916) (IC50=18 µg/mL), Pyricularia oryzae (MUCL 30166) (IC50=10 µg/mL), Trichoderma hamatum (MUCL 29736) (IC50=30 µg/mL), Verticillium dahliae (MUCL 6963) (IC50=7 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	16653017	Plant Physiol. 1992 Oct;100(2):1055-1058.	Terras FR, Goderis IJ, Van Leuven F, Vanderleyden J, Cammue BP, Broekaert WF.	In vitro antifungal activity of a radish (Raphanus sativus L.) seed protein homologous to non-specific lipid transfer proteins.	
DRAMP00374	AVSCNTVIADLYPCLSYVTQGGPVPTLCCNGLTTLKSQAQTSVDRQGVCRCIKSAIGGLTLSPRTIQNALELPSKCGVDLPYKFSPSTDCDSIQ	94	Non-specific lipid-transfer protein 6 (LTP 6; Plants)	Q9LDB4	Belongs to the plant LTP family	LTP6	Arabidopsis thaliana (Mouse-ear cress)	Not found	Transcript level	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity). Their biological Function: is presently Comment: No comments found on DRAMP databasen.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	10940464	Plant Sci. 2000 Aug 8;157(1):1-12.	Arondel12 V V, Vergnolle2 C, Cantrel C, Kader J.	Lipid transfer proteins are encoded by a small multigene family in Arabidopsis thaliana.	
DRAMP00375	PAGPFRIPPRXRXEFQ	16	Antifungal protein 1 small subunit (CW-1; Plants)	P83140	Not found	Not found	Malva parviflora (Little mallow) (Cheeseweed mallow)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Possesses very potent antifungal activity against F. graminearum.
Subunit structure: Heterodimer of a large and a small subunit.
Miscellaneous: Antimicrobial activity is not affected by salt concentration."	Fungi:##At low salt condition: Fusarium graminearum (IC50=2.5 ppm).##At high salt condition: Fusarium graminearum (IC50=10 ppm).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11118343	Biochem Biophys Res Commun. 2000 Dec 20;279(2):669-673.	Wang X, Bunkers GJ.	Potent heterologous antifungal proteins from cheeseweed (Malva parviflora).	
DRAMP00376	VAGPFRIPPLRREFQ	15	Antifungal protein 1 large subunit (CW-1; Plants)	P83141	Not found	Not found	Malva parviflora (Little mallow) (Cheeseweed mallow)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Possesses antifungal activity against P. infestans but not F. graminearum.
Subunit structure: Heterodimer of a large and a small subunit.
Miscellaneous: Antimicrobial activity is not affected by salt concentration."	Fungi: Phytophthora infestans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11118343	Biochem Biophys Res Commun. 2000 Dec 20;279(2):669-673.	Wang X, Bunkers GJ.	Potent heterologous antifungal proteins from cheeseweed (Malva parviflora).	
DRAMP00377	SDYSRKRDPPQKYEEE	16	Antifungal protein 2 small subunit (CW-2; Plants)	P83142	Not found	Not found	Malva parviflora (Little mallow) (Cheeseweed mallow)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Possesses antifungal activity against P. infestans but not F. graminearum.
Subunit structure: Heterodimer of a large and a small subunit. 
Miscellaneous: Antimicrobial activity is not affected by salt concentration."	Fungi: Phytophthora infestans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11118343	Biochem Biophys Res Commun. 2000 Dec 20;279(2):669-673.	Wang X, Bunkers GJ.	Potent heterologous antifungal proteins from cheeseweed (Malva parviflora).	
DRAMP00378	PEDPQRRYQEXQREXRXQQE	20	Antifungal protein 2 large subunit (CW-2; Plants)	P83143	Not found	Not found	Malva parviflora (Little mallow) (Cheeseweed mallow)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Possesses antifungal activity against P. infestans but not F. graminearum.
Subunit structure: Heterodimer of a large and a small subunit.
Miscellaneous: Antimicrobial activity is not affected by salt concentration."	Fungi: Phytophthora infestans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11118343	Biochem Biophys Res Commun. 2000 Dec 20;279(2):669-673.	Wang X, Bunkers GJ.	Potent heterologous antifungal proteins from cheeseweed (Malva parviflora).	
DRAMP00379	PEDPQRRYQEEQRRE	15	Antifungal protein 3 (CW-3; Plants)	P83137	Not found	Not found	Malva parviflora (Little mallow) (Cheeseweed mallow)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Possesses antifungal activity.
Miscellaneous: Antimicrobial activity is not affected by salt concentration."	Fungi: Phytophthora infestans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11302747	Biochem Biophys Res Commun. 2001 Apr 20;282(5):1224-1228.	Wang X, Bunkers GJ, Walters MR, Thoma RS.	Purification and characterization of three antifungal proteins from cheeseweed (Malva parviflora).	
DRAMP00380	DRQIDMEEQQLEKLNKQDRXPGLRYAAKQQMXTXRMG	37	Antifungal protein 4 (CW-4; Plants)	P83138	Not found	Not found	Malva parviflora (Little mallow) (Cheeseweed mallow)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Possesses antifungal activity.
Miscellaneous: Antimicrobial activity is not affected by salt concentration.
Biophysicochemical properties: Temperature dependence (Thermostable). Still active after heating at 100 degrees Celsius for 20 minutes."	Fungi: Phytophthora infestans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11302747	Biochem Biophys Res Commun. 2001 Apr 20;282(5):1224-1228.	Wang X, Bunkers GJ, Walters MR, Thoma RS.	Purification and characterization of three antifungal proteins from cheeseweed (Malva parviflora).	
DRAMP00381	SGECNMYGRCPPGYCCSKFGYCGGVRAYCG	30	IWF4 (Plants)	No entry found	Not found	Not found	Beta vulgaris (Sugar beet)	Antimicrobial, Antifungal	Not found	Not found	Not found		Tissue specificity: IWF4 mRNA is expressed in the aerial parts of the plant only, with a constitutive expression in young and mature leaves and in young flowers.	Fungi: Cercospora beticola (IC50<2 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	9008390	Plant Physiol. 1997 Jan;113(1):83-91.	Nielsen KK, Nielsen JE, Madrid SM, Mikkelsen JD.	Characterization of a new antifungal chitin-binding peptide from sugar beet leaves.	
DRAMP00382	TFPKCAPTRPPGPKPCDINNFKSKFWHIWRA	31	Datucin (Glycopeptide; Plants)	No entry found	Not found	Not found	Datura stramonium	Antimicrobial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23193597	Biopolymers 2012; 98(4):332-337.	Mandal SM.	A Novel Hydroxyproline Rich Glycopeptide from Pericarp of Datura stramonium: Proficiently Eradicate the Biofilm of Antifungals Resistant Candida albicans.	
DRAMP00383	AKCIKNGKGCREDQGPPFCCSGFCYRQVGWARGYCKNR	38	Antimicrobial peptide 1 (Mc-AMP1; knottin-type peptide; Plant defensin)	O81338	Belongs to the AMP family	Not found	Mesembryanthemum crystallinum (Common ice plant) (Cryophytum crystallinum)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Homology	Bridge	Not found		"Function: Possesses antifungal and antibacterial activity.
Domain: The presence of a 'disulfide through disulfide knot' structurally defines this protein as a knottin.
PTM: Contains three disulfide bonds 3-20; 10-24; 18-35."	Gram-positive bacteria: Bacillus megaterium (IC50=2 µg/mL), Sarcina lutea (IC50=50 µg/mL).##Fungi: Alternaria brassicola (IC50=6 µg/mL), Ascochyta pisi (IC50=6 µg/mL), Botrytis cinerea (IC50=2 µg/mL), Cercospora beticola (IC50=2 µg/mL), Colletotrichum lindemuthianum (IC50=1 µg/mL), Fusarium culmorum (IC50=3 µg/mL), Fusarium oxysporum f. sp. Pisi (IC50=5 µg/mL), Fusarium oxysporum f. sp. Lycopersici (IC50=10 µg/mL), Nectria haematococca (IC50=0.5 µg/mL), Phoma betae (IC50=6 µg/mL), Pyrenophora tritici-repentis (IC50=20 µg/mL), Pyricularia oryzae (IC50=0.5 µg/mL), Rhizoctonia solani (IC50=15 µg/mL), Verticiliium dahliae (IC50=0.5 µg/mL), Venturia inaequalis (IC50=1 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.	Michalowski C.B, Bohnert H.J.	Antimicrobial peptide 1 from the common ice plant.	
DRAMP00386	AISCGQVSSAIGPCLSYARGQGSAPSAGCC	30	EcLTP (E. crus-galli lipid transfer protein; Plants)	No entry found	Not found	Not found	Echinochloa crusgalli L. (seeds of weed cereal barnyard grass)	Antimicrobial, Antifungal	Not found	Not found	Not found		Function: Possesses antifungal activity.	Fungi: Phytophthora infestans (IC50=6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22940285	Peptides. 2012 Nov;38(1):33-40.	Rogozhin EA, Ryazantsev DY, Grishin EV, Egorov TA, Zavriev SK.	Defense peptides from barnyard grass (Echinochloa crusgalli L.) seeds.	
DRAMP00387	GSGRGSCRSQCMRRHEDEPWRVQECVSQCRRRRGGGD	37	Antimicrobial peptide 1 (EcAMP1; hairpin-like peptides; Plants)	P86698	Not found	Not found	Echinochloa crus-galli (Barnyard grass) (Panicum crus-galli)	Antimicrobial, Antifungal	Protein level	Alpha helix (3 helices; 20 residues)	The peptide adopts a disulfide-stabilized alpha-helical hairpin structure in aqueous solution and thus represents a novel fold among naturally occurring antimicrobial peptides.	2L2R resolved by NMR.	"Function: EcAMP1 can inhibit growth of several fungal phytopathogens. Does not destroy spores but rather inhibits hyphal growth during germination. Does not affect spore germination in A. niger, C. graminicola, D. maydis and T. album. Does not inhibit trypsin. Confocal microscopy revealed intensive EcAMP1 binding to the surface of fungal conidia followed by internalization and accumulation in the cytoplasm without disturbance of membrane integrity.
Tissue specificity: Seed."	Fungi: Alternaria alternata (EC50=16.0±2.3 µM), A. solani (EC50=14.0±2.1 µM), Aspergillus niger (EC50>32 µM), Bipolaris sorokiniana (EC50=18.2±2.7 µM), Colletotrichum graminicola (EC50>10 µM), Diplodia maydis (EC50>10 µM), Fusarium graminearum (EC50=4.5±1.4 µM), Fusarium oxysporum (EC50=8.5±1.6 µM), F. solani (EC50=4.0±1.2 µM), F. verticillioides (EC50=8.1±2.3 µM), Phoma betae (EC50=6.0±1.5 µM), Phytophthora infestans (EC50=16.3±2.5 µM), Pythium debaryanum (EC50=12.0±1.7 µM), P. ultimum (EC50=14.4±2.1 µM), Tritirachium album (EC50>32 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22940285##21561864	Peptides. 2012 Nov;38(1):33-40.##J Biol Chem. 2011 Jul 15;286(28):25145-25153.	Rogozhin EA, Ryazantsev DY, Grishin EV, Egorov TA, Zavriev SK.##Nolde SB, Vassilevski AA, Rogozhin EA, Barinov NA, Balashova TA, Samsonova OV, Baranov YV, Feofanov AV, Egorov TA, Arseniev AS, Grishin EV.	Defense peptides from barnyard grass (Echinochloa crusgalli L.) seeds.##Disulfide-stabilized helical hairpin structure and activity of a novel antifungal peptide EcAMP1 from seeds of barnyard grass (Echinochloa crus-galli).	
DRAMP00388	DRCSQQCQHHRDPDRKQQCMRECRRHQGRSD	31	Antimicrobial peptide 2 (EcAMP2; Plants)	B3EWR4	Not found	Not found	Echinochloa crus-galli (Barnyard grass) (Panicum crus-galli)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: EcAMP2 inhibits spore germination of P. infestans with an IC50 of 24 µM but have no antibacterial activity.
PTM: Contains two disulfide bonds (By similarity)."	Fungi: Phytophthora infestans (IC50=24 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22940285	Peptides. 2012 Nov;38(1):33-40.	Rogozhin EA, Ryazantsev DY, Grishin EV, Egorov TA, Zavriev SK.	Defense peptides from barnyard grass (Echinochloa crusgalli L.) seeds.	
DRAMP00389	DRCSQQCQHHRDPDRKQQCMRECRRH	26	EcAMP2.1 (truncated EcAMP2 without five C-terminal residues)	B3EWR4	Not found	Not found	Echinochloa crus-galli (Barnyard grass) (Panicum crus-galli)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: EcAMP2.1 inhibits spore germination of P. infestans with an IC50 of 24 µM but have no antibacterial activity.
PTM: Contains two disulfide bonds (By similarity)."	Fungi: Phytophthora infestans (IC50=24 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22940285	Peptides. 2012 Nov;38(1):33-40.	Rogozhin EA, Ryazantsev DY, Grishin EV, Egorov TA, Zavriev SK.	Defense peptides from barnyard grass (Echinochloa crusgalli L.) seeds.	
DRAMP00390	ANKCIIDCMKVKTTCGDECKGAGFKTGGCALPPDIMKCCHNC	42	Antimicrobial peptide 3 (ToAMP3; Cys-rich; Plant defensin)	B3EWQ3	Not found	Not found	Taraxacum officinale (Common dandelion) (Leontodon taraxacum)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Possesses antifungal activity. Also active against bacterial species P. syringae, B. subtilis and X. campestris.
Tissue specificity: Expressed in flowers but not in leaves, seeds or roots (at protein level)."	Fungi: Aspergillus niger (IC50=1.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22640720	Peptides. 2012 Aug;36(2):266-271.	Astafieva AA, Rogozhin EA, Odintsova TI, Khadeeva NV, Grishin EV, Egorov TsA.	Discovery of novel antimicrobial peptides with unusual cysteine motifs in dandelion Taraxacum officinale Wigg. flowers.	
DRAMP00391	GGKCTVDWGGQGGGRRLPSPLFCCYKPTRICYLNQETCETETCP	44	Antimicrobial peptide 2 (ToAMP2; Cys-rich; Plant defensin)	B3EWQ2	Not found	Not found	Taraxacum officinale (Common dandelion) (Leontodon taraxacum)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Possesses antifungal activity. Also active against bacterial species P. syringae, B. subtilis and X. campestris.
Tissue specificity: Expressed in flowers but not in leaves, seeds or roots (at protein level)."	Fungi: Botrytis cinerea (IC50=5.2 µM), Aspergillus niger (IC50=2.6 µM), Bipolaris sorokiniana (IC50=5.2 µM), Pythium debaryanum (IC50=2.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22640720	Peptides. 2012 Aug;36(2):266-271.	Astafieva AA, Rogozhin EA, Odintsova TI, Khadeeva NV, Grishin EV, Egorov TsA.	Discovery of novel antimicrobial peptides with unusual cysteine motifs in dandelion Taraxacum officinale Wigg. flowers.	
DRAMP00392	VAKCTEESGGKYFVFCCYKPTRICYMNEQKCESTCIGK	38	Antimicrobial peptide 1 (ToAMP1; Cys-rich; Plant defensin)	B3EWQ1	Not found	Not found	Taraxacum officinale (Common dandelion) (Leontodon taraxacum)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Possesses antifungal activity. Also active against bacterial species P. syringae, B. subtilis and X. campestris.
Tissue specificity: Expressed in flowers but not in leaves, seeds or roots (at protein level)."	Fungi: Botrytis cinerea (IC50=5.8 µM), Aspergillus niger (IC50=5.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22640720	Peptides. 2012 Aug;36(2):266-271.	Astafieva AA, Rogozhin EA, Odintsova TI, Khadeeva NV, Grishin EV, Egorov TsA.	Discovery of novel antimicrobial peptides with unusual cysteine motifs in dandelion Taraxacum officinale Wigg. flowers.	
DRAMP00393	IQCGESCVWIPCISSAWGCSCKNKICSS	28	Hedyotide B2 (hB2; Uncyclotides; Plants)	No entry found	Not found	Not found	Hedyotis biflora (aerial tissues)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Possesses antifungal activity.	Gram-negative bacterium: Escherichia coli (MIC>80 µM);##Gram-positive bacteria: Streptococcus salivarius(MIC>80 µM), Staphylococcus epidermidis (MIC>80 µM), Streptococcus aureus (MIC>80 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21979955	J Biol Chem. 2011 Dec 30;286(52):44833-44844.	Nguyen GK, Zhang S, Wang W, Wong CT, Nguyen NT, Tam JP.	Discovery of a linear cyclotide from the bracelet subfamily and its disulfide mapping by top-down mass spectrometry.	
DRAMP00394	FSGSVNQACSGFGWK	15	Antimicrobial peptide1 (Plant defensin)	P85484	Not found	Not found	Pinus halepensis (Aleppo pine)	Antimicrobial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19157640	J Plant Physiol. 2009 May 15;166(8):831-143.	Uzal EN, G³mez-Ros LV, Hern¡ndez JA, Pedre±o MA, Cuello J, Ros Barcel³ A.	Analysis of the soluble cell wall proteome of gymnosperms.	
DRAMP00395	GIPCGESCVWIPCITSAIGCSCKSKVCYRN	30	Cyclotide vitri-A (Vbc6; Plant defensin)	B1NRR3	Not found	Not found	Viola biflora (Yellow wood violet)	Antimicrobial	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Problely contains three disulfide bonds 4-20; 8-22; 13-27. This is a cyclic peptide."	No MICs found in DRAMP database	[Ref.20580652] HD50=8.91 µM against human type O red blood cells.	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys 4 and Cys20, Cys8 and Cys22,  Cys13 and Cys27 .	L	[Ref.14987049] Cytotoxicity: U-937 GTB (lymphoma)(IC50 = 0.6 µM) and RPMI-8226/s (myeloma)(IC50 = 1 µM).##[Ref.20580652] Cytotoxicity: U251(IC50 = 6.03 μg/mL), MDA-MB-231(IC50 = 3.69 μg/mL), A549(IC50 = 3.90 μg/mL), DU145(IC50 = 3.07 μg/mL), BEL-7402(IC50 = 4.94 μg/mL).	Not found	18191970	Phytochemistry. 2008 Feb;69(4):939-952.	Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00396	NLCERASLTWTGNCGNTGHCDTQCRNWESAKHGACHKRGNWKCFCYFDC	49	Ct-AMP1 (CtAMP1, C. ternatea-antimicrobial peptide 1; Plant defensin)	No entry found	Not found	Not found	Clitoria ternatea	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Bacillus subtilis (IC50=15 µg/mL).##Medium A: Botrytis cinerea (IC50=20 µg/ml), Cladosporium sphaerospermum (IC50=6 µg/ml), Fusarium culmorum (IC50=10 µg/ml), Leptosphaeria maculans (IC50=6 µg/ml), Penicillium digitatum (IC50=20 µg/ml), Trichoderma viride (IC50>100 µg/ml), Septoria tritiei (IC50=2 µg/ml), Verticilium albo-atrum (IC50=2 µg/ml). NOTE: Medium B = 1/2 strength potato dextrose broth.##Medium B: Botrytis cinerea (IC50>100 µg/ml), Cladosporium sphaerospermum (IC50=100 µg/ml), Fusarium culmorum (IC50=50 µg/ml), Leptosphaeria maculans (IC50=20 µg/ml), Penicillium digitatum (IC50=80 µg/ml), Trichoderma viride (IC50>100 µg/ml), Septoria tritiei (IC50=80 µg/ml), Verticilium albo-atrum (IC50>100 µg/ml).##NOTE: Medium B = Medium A supplemented with 1 mM CaCl2 and 50 mM KCI.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7628617	FEBS Lett. 1995 Jul 17;368(2):257-262.	Osborn RW, De Samblanx GW, Thevissen K, Goderis I, Torrekens S, Van Leuven F, Attenborough S, Rees SB, Broekaert WF.	Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae.	
DRAMP00397	KFCEKPSGTWSGVCGNSGACKDQCIRLEGAKHGSCNYKPPAHRCICYYEC	50	Defensin D1 (Ns-D1; Plant defensin)	P86972	Belongs to the DEFL family	Not found	Nigella sativa (Black cumin)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		"Function: Antimicrobial peptide active against fungi, Gram-positive and Gram-negative bacteria. Has no effect on spore germination. Destroys spores in germinated conidia by disruption of cell walls and membranes in A. niger and B. sorokiniana. Causes vacuolization of germinated macro- and microconidia in F. oxysporum, F. graminearum and F. culmorum. Strongly inhibits growth of P. infestans on potato tubers above concentrations of 13.6 µg/ml.
PTM: Contains four disulfide bonds."	Fungi: Aspergillus niger (IC50=3.5 µg/ml), Bipolaris sorokiniana (IC50=3.0 µg/ml), Fusarium oxysporum (IC50=9.5 µg/ml), Fusarium graminearum (IC50=6.9 µg/ml), Fusarium culmorum (IC50=6.9 µg/ml) and Botrytis cinerea (IC50=27.4 µg/ml).##Gram-positive bacteria: Clavibacter michiganensis (1.4 cm) and Bacillus subtilis (1.3 cm);##Gram-negative bacteria: Pseudomonas syringae (0.9 cm), Erwinia carotovora (0.7 cm) and Escherichia coli (1.2 cm).##NOTE: Inhibition zone; Defensin concentration (11 µg in 50 Î¼l).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21144761	Plant Physiol Biochem. 2011 Feb;49(2):131-137.	Rogozhin EA, Oshchepkova YI, Odintsova TI, Khadeeva NV, Veshkurova ON, Egorov TA, Grishin EV, Salikhov SI.	Novel antifungal defensins from Nigella sativa L. seeds.	
DRAMP00398	KFCEKPSGTWSGVCGNSGACKDQCIRLEGAKHGSCNYKLPAHRCICYYEC	50	Defensin D2 (Ns-D2; Plant defensin)	P86973	Belongs to the DEFL family	Not found	Nigella sativa (Black cumin)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		"Function: Antimicrobial peptide active against fungi, Gram-positive and Gram-negative bacteria. Has no effect on spore germination. Destroys spores in germinated conidia by disruption of cell walls and membranes in Aspergillus niger and B.sorokiniana. Causes vacuolization of germinated macro- and microconidia in Fusarium oxysporum, F.graminearum and F.culmorum. Strongly inhibits growth of P.infestans on potato tubers above concentrations of 3.4 µg/ml.
PTM: Contains four disulfide bonds."	Fungi: Aspergillus niger (IC50=3.5 µg/ml), Bipolaris sorokiniana (IC50=1.8 µg/ml), Fusarium oxysporum (IC50=5.3 µg/ml), Fusarium graminearum (IC50=6.9 µg/ml), Fusarium culmorum (IC50=6.9 µg/ml) and Botrytis cinerea (IC50=13.7 µg/ml).##Gram-positive bacteria: Clavibacter michiganensis (1.5 cm) and Bacillus subtilis (1.3 cm);##Gram-negative bacteria: Pseudomonas syringae (1.3 cm), Erwinia carotovora (0.7 cm) and Escherichia coli (1.4 cm).##NOTE: Inhibition zone; Defensin concentration (11 µg in 50 Î¼l).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21144761	Plant Physiol Biochem. 2011 Feb;49(2):131-137.	Rogozhin EA, Oshchepkova YI, Odintsova TI, Khadeeva NV, Veshkurova ON, Egorov TA, Grishin EV, Salikhov SI.	Novel antifungal defensins from Nigella sativa L. seeds.	
DRAMP00399	NTCEHLADTYRGVCFTNASCDDHCKNKAHLISGTCHDWKCFCTQNC	46	Defensin-like protein 39 (Disease resistance response protein 39; Plant defensin)	Q01784	Belongs to the DEFL family	PI39	Pisum sativum (Garden pea)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Possesses antifungal activity (By similarity).
Tissue specificity: Pods.
Induction: Upon contact with the plant pathogen fungus Fusarium solani.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1799696	Mol Plant Microbe Interact. 1991 Jul-Aug;4(4):324-331.	Chiang CC, Hadwiger LA.	The Fusarium solani-induced expression of a pea gene family encoding high cysteine content proteins.	
DRAMP00400	NLCERASLTWTGNCGNTGHCDTQCRNWESAKHGACHKRGNWKCFCYFNC	49	Defensin-like protein 1 (Defensin AMP1, CtAMP1; Plant defensin)	Q7M1F2	Belongs to the DEFL family	Not found	Clitoria ternatea (Butterfly pea)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Possesses antimicrobial activity sensitive to inorganic cations. Binds specifically to the fungal plasma membrane. Has no inhibitory effect on insect gut alpha-amylase.
PTM: Contains four disulfide bonds (By similarity)."	Fungi: Botrytis cinerea (IC50=20 µg/ml), Cladosporium sphaerospermum (IC50=6 µg/ml), Fusarium culmorum (IC50=10 µg/ml), Leptosphaeria maculans (IC50=6 µg/ml), Penicillium digitatum (IC50=20 µg/ml), Trichoderma viride (IC50>100 µg/ml), Septoria tritiei (IC50=2 µg/ml), Verticilium albo-atrum (IC50=2 µg/ml), Neurospora crassa (IC50<0.3 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	fungal plasma membrane	7628617##10656585	FEBS Lett. 1995 Jul 17;368(2):257-262.##Mol Plant Microbe Interact. 2000 Jan;13(1):54-61.	Osborn RW, De Samblanx GW, Thevissen K, Goderis I, Torrekens S, Van Leuven F, Attenborough S, Rees SB, Broekaert WF.##Thevissen K, Osborn RW, Acland DP, Broekaert WF.	Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae.##Specific binding sites for an antifungal plant defensin from Dahlia (Dahlia merckii) on fungal cells are required for antifungal activity.	
DRAMP00401	DSECLKEYGGDVGFPFCAPRIFPTICYTRCRENKGAKGGRCIWGEGTNVKCLCDYCNDSPFDQ	63	Defensin-like protein 2 (MTI-2; Trypsin inhibitor 2; Plant defensin)	P26780	Belongs to the DEFL family	Not found	Sinapis alba (White mustard) (Brassica hirta)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Inhibits bovine beta-trypsin and alpha-chymotrypsin on a 1:1 molar basis.
PTM: Problely contains four disulfide bonds 4-56; 17-41; 26-51; 30-53."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7750566##1451776	FEBS Lett. 1995 May 8;364(2):179-181.##FEBS Lett. 1992 Apr 13;301(1):10-14.	Ceci LR, Spoto N, de Virgilio M, Gallerani R.##Menegatti E, Tedeschi G, Ronchi S, Bortolotti F, Ascenzi P, Thomas RM, Bolognesi M, Palmieri S.	The gene coding for the mustard trypsin inhibitor-2 is discontinuous and wound-inducible.##Purification, inhibitory properties and amino acid sequence of a new serine proteinase inhibitor from white mustard (Sinapis alba L.) seed.	
DRAMP00402	XTCESPSHKFKGPCATNRNCES	22	Defensin D1 (So-D1; Antimicrobial peptide D1; Plant defensin)	P81572	Belongs to the DEFL family	Not found	Spinacia oleracea (Spinach)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antimicrobial peptide. Active against Gram-positive and Gram-negative bacterial pathogens.	Gram-positive bacterium: Clavibacter michiganensis;##Gram-negative bacterium: Ralstonia solanacearum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9762899	FEBS Lett. 1998; 435: 159-162.	Segura A, Moreno M, Molina A, Garc­a-Olmedo F.	Novel defensin subfamily from spinach (Spinacia oleracea).	
DRAMP00403	GIFSSRKCKTPSKTFKGICTRDSNCDTSCRYEGYPAGDCKGIRRRCMCSKPC	52	Defensin D2 (So-D2; Antimicrobial peptide D2; Plant defensin)	P81571	Belongs to the DEFL family	Not found	Spinacia oleracea (Spinach)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf.
PTM: Contains four disulfide bonds (By similarity)."	Gram-positive bacterium: Clavibacter michiganensis;##Gram-negative bacterium: Ralstonia solanacearum.##Fungi: Fusarium culmorum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9762899	FEBS Lett. 1998; 435: 159-162.	Segura A, Moreno M, Molina A, Garc­a-Olmedo F.	Novel defensin subfamily from spinach (Spinacia oleracea).	
DRAMP00404	GIFSSRKCKTVSKTFRGICTRNANC	25	Defensin D3 (So-D3; Antimicrobial peptide D3; Plant defensin)	P81570	Belongs to the DEFL family	Not found	Spinacia oleracea (Spinach)	Antimicrobial, Antibacterial, Antifungal	Protein level	Bridge	Not found		"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf."	Fungi: Fusarium spp.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9762899	FEBS Lett. 1998; 435: 159-162.	Segura A, Moreno M, Molina A, Garcia-Olmedo F.	Novel defensin subfamily from spinach (Spinacia oleracea).	
DRAMP00405	MFFSSKKCKTVSKTFRGPCVRNA	23	Defensin D4 (So-D4; Antimicrobial peptide D4; Plant defensin)	P81569	Belongs to the DEFL family	Not found	Spinacia oleracea (Spinach)	Antimicrobial, Antibacterial, Antifungal	Protein level	Bridge	Not found		"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf."	Fungi: Fusarium spp.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9762899	FEBS Lett. 1998; 435: 159-162.	Segura A, Moreno M, Molina A, Garcia-Olmedo F.	Novel defensin subfamily from spinach (Spinacia oleracea).	
DRAMP00406	MFFSSKKCKTVXKTFRGPCVRNAN	24	Defensin D5 (So-D5; Antimicrobial peptide D5; Plant defensin)	P81568	Belongs to the DEFL family	Not found	Spinacia oleracea (Spinach)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf."	Gram-positive bacterium: Clavibacter michiganensis;##Gram-negative bacterium: Ralstonia solanacearum.##Fungi: Fusarium culmorum, Fusarium solani, Bipolaris maydis and Colletotrichum lagenarium.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9762899	FEBS Lett. 1998; 435: 159-162.	Segura A, Moreno M, Molina A, Garcia-Olmedo F.	Novel defensin subfamily from spinach (Spinacia oleracea).	
DRAMP00407	GIFSNMYXRTPAGYFRGPXGYXXN	24	Defensin D6 (So-D6; Antimicrobial peptide D6; Plant defensin)	P81567	Belongs to the DEFL family	Not found	Spinacia oleracea (Spinach)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf."	Gram-positive bacterium: Clavibacter michiganensis (EC50=1 µM);##Gram-negative bacterium: Ralstonia solanacearum (EC50=6 µM).##Fungi: Fusarium solani (EC50=11 µM). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9762899	FEBS Lett. 1998; 435: 159-162.	Segura A, Moreno M, Molina A, Garcia-Olmedo F.	Novel defensin subfamily from spinach (Spinacia oleracea).	
DRAMP00408	GIFSSRKCKTPSKTFKGYCTRDSNCDTSCRYEGYPAGD	38	Defensin D7 (So-D7; Antimicrobial peptide D7; Plant defensin)	P81573	Belongs to the DEFL family	Not found	Spinacia oleracea (Spinach)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf."	Fusarium spp.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9762899	FEBS Lett. 1998; 435: 159-162.	Segura A, Moreno M, Molina A, Garcia-Olmedo F.	Novel defensin subfamily from spinach (Spinacia oleracea).	
DRAMP00409	KTCENLADTY	10	Defensin-like protein (Sesquin; Plant defensin)	P84868	Belongs to the DEFL family	Not found	Vigna unguiculata subsp. sesquipedalis (Yard-Long bean) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral, Antifungal	Protein level	Not found	Not found		Function: Has antifungal and antibacterial activity. Has mitogenic activity towards murine splenocytes. Inhibits the proliferation of M1 leukemia and MCF-7 breast cancer cells in vitro. Inhibits human immunodeficiency virus-1 (HIV-1) reverse transcriptase.	Fungi: Botrytis cinerea (IC50=2.5±0.01 µM), Fusarium oxysporum (IC50=1.4±0.02 µM), Mycosphaerella arachidicola (IC50=0.15±0.002 µM).##Gram-positive bacteria: Bacillus megaterium, Mycobacterium phlei;##Gram-negative bacteria: Escherichia coli, Proteus vulgaris.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15949629	Peptides. 2005 Jul;26(7):1120-1126.	Wong JH, Ng TB	Sesquin, a potent defensin-like antimicrobial peptide from ground beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase.	
DRAMP00410	QKLCERPSGTWSGVCGNNNACKNQCINLEKARHGSCNYVFPAHK	44	Defensin-like protein 1 (Bn-AFP1; Plant defensin)	P69240, P30225, Q41163	Belongs to the DEFL family	AFP1	Brassica napus (Rape)	Antimicrobial, Antifungal	Protein level	Rich	Not found	1AYJ	"Function: Possesses antifungal activity sensitive to inorganic cations.
Subunit structure: Forms oligomers in its native state.
PTM: Problely contains one disulfide bond."	Fungi: Alternaria brassicola (IC50=3 µg/ml), Botrytis cinerea (IC50=1.50 µg/ml), Fusarium culmorum (IC50=2 µg/ml), Fusarium oxysporum f.sp.lycopersici (IC50=1.80 µg/ml), Pyricularia oryzae (IC50=0.25 µg/ml), Verticiliium dahliae (IC50=0.80 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8422949	FEBS Lett. 1993 Feb 1;316(3):233-240.	Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.	A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.	
DRAMP00411	QKLCERPSGTWSGVCGNNNACKN	23	Defensin-like protein 2 (Bn-AFP2; Plant defensin)	P30226	Belongs to the DEFL family	Not found	Brassica napus (Rape)	Antimicrobial, Antifungal	Protein level	Rich	Not found		"Function: Possesses antifungal activity sensitive to inorganic cations.
Subunit structure: Forms oligomers in its native state."	Fungi: Alternaria brassicola (IC50=75 µg/ml), Botrytis cinerea(IC50> 100 µg/ml), Fusarium culmorum (IC50=38 µg/ml), Fusarium oxysporum f.sp.lycopersici (IC50=42 µg/ml), Pyricularia oryzae (IC50=3 µg/ml), Verticiliium dahliae (IC50=15 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8422949	FEBS Lett. 1993 Feb 1;316(3):233-240.	Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.	A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.	
DRAMP00412	QKLCERPSGTWSGVCGNNNACKNQCIN	27	Defensin-like protein 1 (Br-AFP1; Plant defensin)	P30227	Belongs to the DEFL family	Not found	Brassica rapa (Turnip)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Possesses antifungal activity sensitive to inorganic cations.
Subunit structure: Forms oligomers in its native state."	Fungi: Alternaria brassicola (IC50=3 µg/ml), Botrytis cinerea(IC50=1.5 µg/ml), Fusarium culmorum (IC50=2 µg/ml), Fusarium oxysporum f.sp. lycopersici (IC50=1.8 µg/ml), Pyricularia oryzae (IC50=0.25 µg/ml), Verticiliium dahliae (IC50=0.8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8422949	FEBS Lett. 1993 Feb 1;316(3):233-240.	Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.	A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.	
DRAMP00413	QKLCERPSGTXSGVCGNNNACKNQCIR	27	Defensin-like protein 2 (Br-AFP2; Plant defensin)	P30228	Belongs to the DEFL family	Not found	Brassica rapa (Turnip)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Function: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	Fungi: Alternaria brassicola (IC50=75 µg/ml), Botrytis cinerea(IC50>100 µg/ml), Fusarium culmorum (IC50=38 µg/ml), Fusarium oxysporum f.sp. lycopersici (IC50=42 µg/ml), Pyricularia oryzae (IC50=3 µg/ml), Verticiliium dahliae (IC50=15 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8422949	FEBS Lett. 1993 Feb 1;316(3):233-240.	Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.	A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.	
DRAMP18331	GKNGVFKTISHECHLNTWAFLATCCS	26	Antibacterial peptide A-M49 (Bacteriocin)	Q54957	Belongs to the lantibiotics family (Class I bacteriocin)	scnA' AND scnA''	Streptococcus pyogenes serotype M49	Antimicrobial, Antibacterial, Anti-Gram+		Not found	There are one 2,3-didehydrobutyrine at T23, two Beta-methyllanthionines (T8-C13; T17-C25) and one Lanthionine (S10-C24).		There are two genes coding for lantibiotic streptococcin A-M49, their coding sequences only differ in the propeptide region.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	7993103	Appl Environ Microbiol. 1994 Nov;60(11):4207-9.	Hynes WL, Friend VL, Ferretti JJ.	Duplication of the lantibiotic structural gene in M-type 49 group A streptococcus strains producing streptococcin A-M49.	
DRAMP18332	GTTVVNSTFSIVLGNKGYICTVTVECMRNCQ	31	BHT-Aa(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	bht-a	Streptococcus rattus BHT	Antimicrobial, Antibacterial, Anti-Gram+		tryptophan rich	A variant of Smb, as evidenced by the fact that the two operons share 95% identity.		The amino acid sequence of another chain (BhtA2) is STPACAIGVVGITVAVTGISTACTSRCINK, which is identical to SmbA. 	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16194596##18220976	FEMS Microbiol Lett. 2005 Nov 15;252(2):235-41.##Mini Rev Med Chem. 2007 Dec;7(12):1236-47.	Hyink O, Balakrishnan M, Tagg JR.##Lawton EM, Ross RP, Hill C, Cotter PD.	Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin.##Two-peptide lantibiotics: a medical perspective.	
DRAMP00415	QKLCQRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNYVFPAHKCICYFPC	51	Raphanus sativus Antifungal Protein 2 (Rs-AFP2; Plant defensin)	P30230, Q003I2	Belongs to the DEFL family	AFP2	Raphanus sativus (Radish)	Antimicrobial, Antifungal	Protein level	Bridge	Not found	2N2R	PTM: Contains four disulfide bonds 4-51;15-36;21-45;25-47, and Pyrrolidone carboxylic acid at position 1.	Fungi: Alternaria brassicola (IC50=2 µg/ml), Ascochyta pisi (IC50=4 µg/ml), Botrytis cinerea (IC50=2 µg/ml), Cercospora beticola (IC50=2 µg/ml), Colletotrichum lindemuthianum (IC50=3 µg/ml), Fusarium culmorum (IC50=2 µg/ml), Fusarium oxysporum f.sp.lycopersici (IC50=2 µg/ml), Fusarium oxysporum f.sp.pisi (IC50=2 µg/ml), Mycosphaerella fijiensis var.fijiensis (IC50=1.5 µg/ml), Nectria haematococca (IC50=2 µg/ml), Phoma betae (IC50=1 µg/ml), Phytophthora infestans (IC50=25 µg/ml), Pyrenophora tritici-repentis (IC50=1.5 µg/ml), Pyricularia oryzae (IC50=0.4 µg/ml), Rhizoctonia solani (IC50>100 µg/ml), Sclerotinia sclerotiorum (IC50>100 µg/ml), Septoria nodorum (IC50=15 µg/ml), Trichoderma hamatum (IC50=2 µg/ml), Verticillium dahliae (IC50=1.5 µg/ml), Venturia inaequalis (IC50=25 µg/ml). [NOTE: Synthetic low ionic strength growth medium]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7780308	Plant Cell. 1995 May;7(5):573-588.	Terras FR, Eggermont K, Kovaleva V, Raikhel NV, Osborn RW, Kester A, Rees SB, Torrekens S, Van Leuven F, Vanderleyden J, et al.	Small cysteine-rich antifungal proteins from radish: their role in host defense.	
DRAMP00418	QKLCERPSGTWSGVCGNNGACRNQCIRLERARHGSCNYVFPAHKCICYFPC	51	Hc-AFP4 (Plant defensin)	No entry found	Not found	Hc-AFP4	Heliophila coronopifolia (South African Brassicaceae species)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: Has antifungal activity. 
PTM: Contains four disulfide bonds."	Fungi: Botrytis cinerea (IC50=15-20 µg/ml), Fusarium solani (IC50=5-10 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22032337	BMC Res Notes. 2011 Oct 28;4:459.	de Beer A, Vivier MA.	Four plant defensins from an indigenous South African Brassicaceae species display divergent activities against two test pathogens despite high sequence similarity in the encoding genes.	
DRAMP00419	RYCERSSGTWSGVCGNTDKCSSQCQRLEGAAHGSCNYVFPAHKCICYYPC	50	Hc-AFP3 (Plant defensin)	No entry found	Not found	Hc-AFP3	Heliophila coronopifolia (South African Brassicaceae species)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: Has antifungal activity. 
PTM: Contains four disulfide bonds."	Fungi: Botrytis cinerea (IC50=20-25 µg/ml), Fusarium solani (IC50>25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22032337	BMC Res Notes. 2011 Oct 28;4:459.	de Beer A, Vivier MA.	Four plant defensins from an indigenous South African Brassicaceae species display divergent activities against two test pathogens despite high sequence similarity in the encoding genes.	
DRAMP00420	QKLCERPSGTWSGVCGNNNACRNQCINLEKARHGSCNYVFPAHKCICYFPC	51	Hc-AFP2 (Plant defensin)	No entry found	Not found	Hc-AFP2	Heliophila coronopifolia (South African Brassicaceae species)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: Has antifungal activity. 
PTM: Contains four disulfide bonds."	Fungi: Botrytis cinerea (IC50=10-15 µg/ml), Fusarium solani (IC50=10-15 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22032337	BMC Res Notes. 2011 Oct 28;4:459.	de Beer A, Vivier MA.	Four plant defensins from an indigenous South African Brassicaceae species display divergent activities against two test pathogens despite high sequence similarity in the encoding genes.	
DRAMP00421	RYCERSSGTWSGVCGNSGKCSNQCQRLEGAAHGSCNYVFPAHKCICYYPC	50	Hc-AFP1 (Plant defensin)	No entry found	Not found	Hc-AFP1	Heliophila coronopifolia (South African Brassicaceae species)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: Has antifungal activity. 
PTM: Contains four disulfide bonds."	Fungi: Botrytis cinerea (IC50>25 µg/ml), Fusarium solani (IC50>25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22032337	BMC Res Notes. 2011 Oct 28;4:459.	de Beer A, Vivier MA.	Four plant defensins from an indigenous South African Brassicaceae species display divergent activities against two test pathogens despite high sequence similarity in the encoding genes.	
DRAMP00424	QKLCERSSGTWSGVCGNNNACKNQCINLEGARHGSCNYVFPYHRCICYFPC	50	Br-AFP1 (Defensin 1.2; Plant defensin)	No entry found	Not found	Not found	Brassica rapa subsp. Chinensis	Antimicrobial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8422949##7628617	FEBS Lett. 1993 Feb 1;316(3):233-240.##FEBS Lett. 1995 Jul 17;368(2):257-262.	Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.##Osborn RW, De Samblanx GW, Thevissen K, Goderis I, Torrekens S, Van Leuven F, Attenborough S, Rees SB, Broekaert WF.	A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.##Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae.	
DRAMP00426	DGVKLCDVPSGTWSGHCGSSSKCSQQCKDREHFAYGGACHYQFPSVKCFCKRQC	54	Defensin-like protein 1 (Hs-AFP1; Plant defensin)	Q7M1F4, P0C8Y5	Belongs to the DEFL family	Not found	Heuchera sanguinea (Coralbells)	Antimicrobial, Antifungal	Protein level	Bridge	Not found	2N2Q	"Function: Possesses antifungal activity insensitive to inorganic cations. Causes germ tubes and hyphae to swell and form multiple hyphal buds. Binds to the plasma membrane of the fungus. Has no inhibitory effect on insect gut alpha-amylase.
PTM: Contains four disulfide bonds (By similarity)."	Fungi: Botrytis cinerea (IC50=6 µg/ml), Cladosporium sphaerospermum (IC50=1 µg/ml), Fusarium culmorum (IC50=1 µg/ml), Leptosphaeria maculans (IC50=25 µg/ml), Penicillium digitatum (IC50=1µg/ml), Trichoderma viride (IC50=15 µg/ml), Septoria tritiei (IC50=0.5 µg/ml), Verticillium albo-atrum (IC50=0.5 µg/ml), Neurospora crassa (IC50=12 µg/ml). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	chitin, mannan, galactocerebrosides, and sphingomyelin (Mycopathologia. 1998-1999;144:87-91)	7628617##9405418##16284838	FEBS Lett. 1995 Jul 17;368(2):257-262.##J Biol Chem. 1997 Dec 19;272(51):32176-32181.##Mycopathologia. 1998-1999;144(2):87-91.	Osborn RW, De Samblanx GW, Thevissen K, Goderis I, Torrekens S, Van Leuven F, Attenborough S, Rees SB, Broekaert WF.##Thevissen K, Osborn RW, Acland DP, Broekaert WF.##De Lucca AJ, Jacks TJ, Broekaert WJ.	Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae.##Specific, high affinity binding sites for an antifungal plant defensin on Neurospora crassa hyphae and microsomal membranes.##Fungicidal and binding properties of three plant peptides.	
DRAMP00427	AICKKPSKFFKGACGRDADCEKACDQENWPGGVCVPFLRCECQRSC	46	Defensin-like protein AX1 (Antifungal protein AX1; Plant defensin)	P81493	Belongs to the DEFL family	Not found	Beta vulgaris (Sugar beet)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Protein level	Not found	Not found		"Function: Strong inhibiting activity against C. beticola and other filamentous fungi. Little or no effect against bacteria.
Tissue specificity: Leaves and flowers.
PTM: Contains four disulfide bonds 3-46; 14-34; 20-40; 24-42 (By similarity)."	Fungi: Cercospora beticola, Botrytis cinerea, Fusarium graminearum, Bipolaris maydis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7655063	Mol Plant Microbe Interact. 1995 May-Jun;8(3):424-434.	Kragh KM, Nielsen JE, Nielsen KK, Dreboldt S, Mikkelsen JD.	Characterization and localization of new antifungal cysteine-rich proteins from Beta vulgaris.	
DRAMP00428	ATCRKPSMYFSGACFSDTNCQKACNREDWPNGKCLVGFKCECQRPC	46	Defensin-like protein AX2 (Antifungal protein AX2; Cys-rich; Plant defensin)	P82010, P81510	Belongs to the DEFL family	Not found	Beta vulgaris (Sugar beet)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Protein level	Not found	Not found		"Function: Strong inhibiting activity against C. beticola and other filamentous fungi. Little or no effect against bacteria.
Tissue specificity: Leaves and flowers.
PTM: Contains four disulfide bonds 3-46; 14-34; 20-40; 24-42 (By similarity)."	Fungi: Cercospora beticola, Botrytis cinerea, Fusarium graminearum, Bipolaris maydis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7655063	Mol Plant Microbe Interact. 1995 May-Jun;8(3):424-434.	Kragh KM, Nielsen JE, Nielsen KK, Dreboldt S, Mikkelsen JD.	Characterization and localization of new antifungal cysteine-rich proteins from Beta vulgaris.	
DRAMP00429	LCNERPSQTWSGNCGNTAHCDKQCQDWEKASHGACHKRENHWKCFCYFNC	50	Aesculus hippocastanum antimicrobial protein 1 (Ah-AMP1; Cys-rich; Plant defensin)	Q7M1F3	Belongs to the DEFL family	Not found	Aesculus hippocastanum (Horse chestnut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Combine helix and strand structure	Not found	1BK8 resolved by NMR.	"Function: Possesses antimicrobial activity sensitive to inorganic cations. Binds specifically to the fungal plasma membrane. Has no inhibitory effect on insect gut alpha-amylase.
PTM: Contains four disulfide bonds 2-50; 14-35; 20-44; 24-46 (By similarity)."	Gram-positive bacterium: Bacillus subtilis (IC50=100 µg/mL).##Fungi: [MA: Botrytis cinerea (IC50=25 µg/mL), Cladosporium sphaerospermum (IC50=0.5 µg/mL), Fusarium culmorum (IC50=12 µg/mL), Leptosphaeria maculans (IC50=0.5 µg/mL), Penicillium digitatum (IC50=6 µg/mL), Trichoderma viride (IC50>100 µg/mL), Septoria tritiei (IC50=0.5 µg/mL), Verticilium albo-atrum (IC50=6 µg/mL). MA+: Botrytis cinerea (IC50>100 µg/mL), Cladosporium sphaerospermum (IC50=12 µg/mL), Fusarium culmorum (IC50>100 µg/mL), Leptosphaeria maculans (IC50=6 µg/mL), Penicillium digitatum (IC50=25 µg/mL), Trichoderma viride (IC50>100 µg/mL), Septoria tritiei (IC50=1.5 µg/mL), Verticilium albo-atrum (IC50>100 µg/mL)].##NOTE: MA+ = MA supplemented with 1 mM CaCl2 and 50 mM KCl.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Binds specifically to the fungal plasma membrane.	7628617##10591099##10656585	FEBS Lett. 1995 Jul 17;368(2):257-262.##Proteins. 1999 Nov 15;37(3):388-403.##Mol Plant Microbe Interact. 2000 Jan;13(1):54-61.	Osborn RW, De Samblanx GW, Thevissen K, Goderis I, Torrekens S, Van Leuven F, Attenborough S, Rees SB, Broekaert WF.##Fant F, Vranken WF, Borremans FA.##Thevissen K, Osborn RW, Acland DP, Broekaert WF.	Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae.##The three-dimensional solution structure of Aesculus hippocastanum antimicrobial protein 1 determined by 1H nuclear magnetic resonance.##Specific binding sites for an antifungal plant defensin from Dahlia (Dahlia merckii) on fungal cells are required for antifungal activity.	
DRAMP00430	RVCESQSHGFKGACTGDHNCALVCRNEGFSGGNCRGFRRRCFCTLKC	47	Defensin-like protein 1 (Cp-thionin I; Cp-thionin-1; Gamma-thionin I; Plant defensin)	P83399	Belongs to the DEFL family	Not found	Vigna unguiculata (Cowpea)	Not found	Protein level	Bridge	Not found		"Function: Inhibits trypsin but not chymotrypsin.
Subunit structure: Monomer and homodimer.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12112698	Proteins. 2002 Aug 1;48(2):311-319.	Melo FR, Rigden DJ, Franco OL, Mello LV, Ary MB, Grossi de S¡ MF, Bloch C Jr.	Inhibition of trypsin by cowpea thionin: characterization, molecular modeling, and docking.	
DRAMP00432	RVCRRRSAGFKGVCMSDHNCAQVCLQEGYGGGNCDGIMRQCKCIRQC	47	Defensin-like protein 1 (Gamma-zeathionin-1; Plant defensin)	P81008	Belongs to the DEFL family	Not found	Zea mays (Maize)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Sodium channel blocker.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Protein Pept. Lett. 1996;3:267-274.	Castro M.S, Fontes W, Morhy L, Bloch C. Jr.	Complete amino acid sequences of two gamma-thionins from maize (Zea mays L.) seeds.	
DRAMP00433	RVCMGKSQHHSFPCISDRLCSNECVKEDGGWTAGYCHLRYCRCQKAC	47	Defensin-like protein 2 (Gamma-zeathionin-2; Plant defensin)	P81009	Belongs to the DEFL family	Not found	Zea mays (Maize)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Sodium channel blocker.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Protein Pept. Lett. 1996;3:267-274.	Castro M.S, Fontes W, Morhy L, Bloch C. Jr.	Complete amino acid sequences of two gamma-thionins from maize (Zea mays L.) seeds.	
DRAMP00434	KICRRRSAGFKGPCMSNKNCAQVCQQEGWGGGNCDGPFRRCKCIRQC	47	Defensin-like protein 1 (Gamma-1-purothionin; Plant defensin)	P20158	Belongs to the DEFL family	Not found	Triticum aestivum (Wheat)	Antimicrobial, Antifungal	Protein level	Bridge	Gamma 1-P has a well-defined triple-stranded antiparallel beta-sheet (residues 1-6, 31-34, and 39-47), an alpha-helix (residues 16-28), and the corresponding connecting loops. Three disulfide bridges are located in the hydrophobic core holding together the alpha-helix and the beta-sheet and forming a cysteine-stabilized alpha-helical (CSH) motif.	1GPS	PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2226781##8380707	FEBS Lett. 1990 Sep 17;270(1-2):191-194.##Biochemistry. 1993 Jan 19;32(2):715-724.	Colilla FJ, Rocher A, Mendez E.##Bruix M, Jim©nez MA, Santoro J, Gonz¡lez C, Colilla FJ, M©ndez E, Rico M. 	Gamma-Purothionins: amino acid sequence of two polypeptides of a new family of thionins from wheat endosperm.##Solution structure of gamma 1-H and gamma 1-P thionins from barley and wheat endosperm determined by 1H-NMR: a structural motif common to toxic arthropod proteins.	
DRAMP00435	KVCRQRSAGFKGPCVSDKNCAQVCLQEGWGGGNCDGPFRRCKCIRQC	47	Defensin-like protein 2 (Gamma-2-purothionin; Plant defensin)	P20159	Belongs to the DEFL family	Not found	Triticum aestivum (Wheat)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2226781	FEBS Lett. 1990 Sep 17;270(1-2):191-194. 	Colilla FJ, Rocher A, Mendez E. 	Gamma-Purothionins: amino acid sequence of two polypeptides of a new family of thionins from wheat endosperm. 	
DRAMP00438	KSTCKAESNTFPGLCITKPPCRKACLSEKFTDGKCSKILRRCICYKPCVFDGKMIQTGAENLAEEAETLAAALLEEEMMDN	81	Defensin-like protein 1 (Gamma-thionin 1; Plant defensin)	O24115	Belongs to the DEFL family	THIO1	Nicotiana paniculata	Antimicrobial, Antifungal	Transcript level	Bridge	Not found		PTM: Contains four disulfide bonds 4-48; 15-35; 21-42; 25-44.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Plant Gene Register PGR97-132.	Komori T, Yamada S, Imaseki H.	A cDNA clone for gamma-thionin from Nicotiana paniculata.	
DRAMP00439	RTCESQSHRFHGTCVRESNCASVCQTEGFIGGNCRAFRRRCFCTRNC	47	Defensin-like protein (Gamma-thionin homolog PPT; Plant defensin)	Q40901	Belongs to the DEFL family	Not found	Petunia integrifolia (Violet-flowered petunia)	Antimicrobial, Antifungal	Transcript level	Bridge	Not found		"Function: May be involved in the defense of the pistil against pathogen infection.
Tissue specificity: Predominantly expressed in the pistil during all stages of flower development.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-21; 24-43 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7948892	Plant Mol Biol. 1994 Oct;26(1):459-464.	Karunanandaa B, Singh A, Kao TH.	Characterization of a predominantly pistil-expressed gene encoding a gamma-thionin-like protein of Petunia inflata.	
DRAMP00440	NEMGGPLVVEARTCESQSHKFKGTCLSDTNCANVCHSERFSGGKCRGFRRRCFCTTHC	58	Defensin SD2 (Plant defensin)	P82659	Belongs to the DEFL family	SD2	Helianthus annuus (Common sunflower)	Antimicrobial, Antifungal	Transcript level	Bridge	Not found		"Function:May play a protective role in flowers by protecting the reproductive organs from potential pathogen attack.
Tissue specificity: Highest expression in flowers and to a lesser extent in leaves. Lower levels in hypocotyls. No expression in roots and cotyledons.
Developmental stage:Expressed progressively during flower development reaching the highest level in the mature fertilized flower stage.
PTM: Problely contains four disulfide bonds 14-57; 25-44; 31-52; 35-54."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Plant Physiol. Biochem. 2000;38:253-258.	Urdangarin M.C, de la Canal L.	A defensin gene expressed in sunflower inflorescence.	
DRAMP00441	RTCQSQSHKFKGACFSDTNCDSVCRTENFPRGQCNQHHVERKCYCERDC	49	Defensin Tk-AMP-D1 (Plant defensin)	P84963	Belongs to the DEFL family	Not found	Triticum kiharae (Wheat)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Has weak antifungal activity, but not against A. consortiale Botrytis cinerea, H. sativum, F. culmorum, C. graminicola and D. maydis.
PTM: Contains four disulfide bonds 3-49; 14-34; 20-43; 24-45 (By similarity)."	Fungi: Fusarium graminearum and Fusarium verticillioides (MIC<30 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17321030##18625284	Biochimie. 2007 May;89(5):605-612.##Biochimie. 2008 Nov-Dec;90(11-12):1667-1673.	Odintsova TI, Egorov TA, Musolyamov AKh, Odintsova MS, Pukhalsky VA, Grishin EV.##Odintsova TI, Rogozhin EA, Baranov Y, Musolyamov AKh, Yalpani N, Egorov TA, Grishin EV.	Seed defensins from T. kiharae and related species: genome localization of defensin-encoding genes.##Seed defensins of barnyard grass Echinochloa crusgalli (L.) Beauv.	
DRAMP00442	RDCESDSHKFHGACFSDTNCANVCQTEGFTAGKCVGVQRHCHCTKDC	47	Defensin Tk-AMP-D1.1 (Plant defensin)	P84965	Belongs to the DEFL family	Not found	Triticum kiharae (Wheat)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Plant defense peptide (By similarity).
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17321030	Biochimie. 2007 May;89(5):605-612.	Odintsova TI, Egorov TA, Musolyamov AKh, Odintsova MS, Pukhalsky VA, Grishin EV.	Seed defensins from T. kiharae and related species: genome localization of defensin-encoding genes. 	
DRAMP00443	RTCESQSHKFKGPCFSDSNCATVCRTENFPRGQCNQHHVERKCYCERSC	49	Defensin Tk-AMP-D2 (Plant defensin)	P84968	Belongs to the DEFL family	Not found	Triticum kiharae (Wheat)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Plant defense peptide (By similarity).
PTM: Contains four disulfide bonds 3-49; 14-34; 20-43; 24-45 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17321030	Biochimie. 2007 May;89(5):605-612.	Odintsova TI, Egorov TA, Musolyamov AKh, Odintsova MS, Pukhalsky VA, Grishin EV.	Seed defensins from T. kiharae and related species: genome localization of defensin-encoding genes. 	
DRAMP00444	RDCKSDSHKFHGACFSDTNCANVCQTEGFTRGKCDGIHCHCIKDC	45	Defensin Tk-AMP-D3 (Plant defensin)	P84970	Belongs to the DEFL family	Not found	Triticum kiharae (Wheat)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Plant defense peptide (By similarity).
PTM: Contains four disulfide bonds 3-45; 14-34; 20-39; 24-41 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17321030	Biochimie. 2007 May;89(5):605-612.	Odintsova TI, Egorov TA, Musolyamov AKh, Odintsova MS, Pukhalsky VA, Grishin EV.	Seed defensins from T. kiharae and related species: genome localization of defensin-encoding genes. 	
DRAMP00445	RDCTSQSHKFVGLCLSDRNCASVCLTEYFTGGKCDHRRCVCTKGC	45	Defensin Tk-AMP-D4 (Plant defensin)	P84971	Belongs to the DEFL family	Not found	Triticum kiharae (Wheat)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Plant defense peptide (By similarity).
PTM: Contains four disulfide bonds 3-45; 14-34; 20-39; 24-41 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17321030	Biochimie. 2007 May;89(5):605-612.	Odintsova TI, Egorov TA, Musolyamov AKh, Odintsova MS, Pukhalsky VA, Grishin EV.	Seed defensins from T. kiharae and related species: genome localization of defensin-encoding genes. 	
DRAMP00446	RECRSESKKFVGLCVSDTNCASVCLTERFPGGKCDGYRRCFCTKDC	46	Defensin Tk-AMP-D5 (Plant defensin)	P84966	Belongs to the DEFL family	Not found	Triticum kiharae (Wheat)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Plant defense peptide (By similarity).
PTM: Contains four disulfide bonds 3-46; 14-34; 20-40; 24-42 (By similarity). "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17321030	Biochimie. 2007 May;89(5):605-612.	Odintsova TI, Egorov TA, Musolyamov AKh, Odintsova MS, Pukhalsky VA, Grishin EV.	Seed defensins from T. kiharae and related species: genome localization of defensin-encoding genes. 	
DRAMP00447	RDCRSQSKTFVGLCVSDTNCASVCLTEHFPGGKCDGYRRCFCTKDC	46	Defensin Tk-AMP-D6 (Plant defensin)	P84967	Belongs to the DEFL family	Not found	Triticum kiharae (Wheat)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Plant defense peptide (By similarity).
PTM: Contains four disulfide bonds 3-46; 14-34; 20-40; 24-42 (By similarity). "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17321030	Biochimie. 2007 May;89(5):605-612.	Odintsova TI, Egorov TA, Musolyamov AKh, Odintsova MS, Pukhalsky VA, Grishin EV.	Seed defensins from T. kiharae and related species: genome localization of defensin-encoding genes. 	
DRAMP00448	RECRSQSKQFVGLCVSDTNCASVCLTEHFPGGKCDGYRRCFCTKDC	46	Defensin Tk-AMP-D6.1 (Plant defensin)	P84969	Belongs to the DEFL family	Not found	Triticum kiharae (Wheat)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Plant defense peptide (By similarity).
PTM: Contains four disulfide bonds 3-46; 14-34; 20-40; 24-42 (By similarity). "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17321030	Biochimie. 2007 May;89(5):605-612.	Odintsova TI, Egorov TA, Musolyamov AKh, Odintsova MS, Pukhalsky VA, Grishin EV.	Seed defensins from T. kiharae and related species: genome localization of defensin-encoding genes. 	
DRAMP00449	RTCQSQSHKFKGACFSDTNCASVCRTENFPRGQCNQHHVERKCYCERDC	49	Defensin Tm-AMP-D1.2 (Plant defensin)	P84964	Belongs to the DEFL family	Not found	Triticum monococcum (Einkorn wheat)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Plant defense peptide (By similarity).
PTM: Contains four disulfide bonds 3-49; 14-34; 20-43; 24-45 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17321030	Biochimie. 2007 May;89(5):605-612.	Odintsova TI, Egorov TA, Musolyamov AKh, Odintsova MS, Pukhalsky VA, Grishin EV.	Seed defensins from T. kiharae and related species: genome localization of defensin-encoding genes. 	
DRAMP00451	QKLCARPSGTWSSGNCRNNNACRNFCIKLEKSRHGSCNIPFPSNKCICYFPC	52	Defensin-like protein 2B (AFP2b; M2B; Plant defensin)	Q10989	Belongs to the DEFL family	Not found	Sinapis alba (White mustard)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Possesses antifungal activity sensitive to inorganic cations. 
Subunit structure: Forms oligomers in its native state.
PTM: Contains four disulfide bonds 4-52; 16-37; 22-46; 26-48 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8836771	Int J Pept Protein Res. 1996 Jun;47(6):437-446.	Neumann GM, Condron R, Polya GM.	Purification and mass spectrometry-based sequencing of yellow mustard (Sinapis alba L.) 6 kDa proteins. Identification as antifungal proteins.	
DRAMP00452	KICEALSGNFKGLCLSSRDCGNVCRREGFTDGSCIGFRLQCFCTKPCA	48	Defensin J1-1 (Plant defensin)	Q43413	Belongs to the DEFL family	Not found	Capsicum annuum (Bell pepper)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Tissue specificity: Expressed in orange and red ripe fruit and to a lesser extent in mature, green fruit. Present in trace in young, green fruit.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43."	Fungi: Fusarium oxysporum, Botrytis cinerea.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8883377	Plant Physiol. 1996 Oct;112(2):615-622.	Meyer B, Houln© G, Pozueta-Romero J, Schantz ML, Schantz R.	Fruit-specific expression of a defensin-type gene family in bell pepper. Upregulation during ripening and upon wounding.	
DRAMP00453	RTCESQSHRFKGLCFSKSNCGSVCHTEGFNGGHCRGFRRRCFCTRHC	47	Defensin J1-2 (Plant defensin)	O65740	Belongs to the DEFL family	Not found	Capsicum annuum (Bell pepper)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Tissue specificity: Expressed in flowers and in young fruits.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43."	Fungi: Fusarium oxysporum, Botrytis cinerea.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8883377##9790581	Plant Physiol. 1996 Oct;112(2):615-622.##Mol Gen Genet. 1998 Sep;259(5):504-510.	Meyer B, Houln© G, Pozueta-Romero J, Schantz ML, Schantz R.##Houln© G, Meyer B, Schantz R.	Fruit-specific expression of a defensin-type gene family in bell pepper. Upregulation during ripening and upon wounding.##Alteration of the expression of a plant defensin gene by exon shuffling in bell pepper (Capsicum annuum L.).	
DRAMP00455	LLGRCKVKSNRFNGPCLTDTHCSTVCRGEGYKGGDCHGLRRRCMCLC	47	Defensin-like protein 2 (Fabatin-2; Plant defensin)	P81457	Belongs to the DEFL family	Not found	Vicia faba (Broad bean)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Fabatins have antibacterial activity against Gram-positive and Gram-negative bacteria, but were inactive against the yeasts Saccharomyces cerevisiae and Candida albicans. High activity against P. aeruginosa.
PTM: Contains four disulfide bonds 5-47; 16-36; 22-43; 26-45."	Gram-positive bacteria: Bacillus subtilis, Enterococcus hirae;##Gram-negative bacterium: Pseudomonas aeruginosa.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	9103978	FEMS Microbiol Lett. 1997 Apr 1;149(1):59-64.	Zhang Y, Lewis K.	Fabatins: new antimicrobial plant peptides.	
DRAMP00456	LLGRCKVKSNRFHGPCLTDTHCSTVCRGEGYKGGDCHGLRRRCMCLC	47	Defensin-like protein 1 (Fabatin-1; Plant defensin)	P81456	Belongs to the DEFL family	Not found	Vicia faba (Broad bean)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Fabatins have antibacterial activity against Gram-positive and Gram-negative bacteria, but were inactive against the yeasts Saccharomyces cerevisiae and Candida albicans. High activity against P. aeruginosa.
PTM: Contains four disulfide bonds 5-47; 16-36; 22-43; 26-45."	Gram-positive bacteria: Bacillus subtilis, Enterococcus hirae;##Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa. 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	9103978	FEMS Microbiol Lett. 1997 Apr 1;149(1):59-64.	Zhang Y, Lewis K.	Fabatins: new antimicrobial plant peptides.	
DRAMP00457	RTCESKSHRFKGPCVSTHNCANVCHNEGFGGGKCRGFRRRCYCTRHC	47	Defensin-like protein 1 (LCR68; Plant defensin 2.3; Plant defensin)	Q9ZUL7, Q4VP02	Belongs to the DEFL family	PDF2.3	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Bridge	Not found		"Tissue specificity: Expressed in the whole plant except roots.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147637	Plant Biotechnol J. 2006 May;4(3):317-324.	Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.	Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.	
DRAMP00458	RTCESQSHRFKGTCVSASNCANVCHNEGFVGGNCRGFRRRCFCTRHC	47	Defensin-like protein 2 (LCR69; Plant defensin 2.2; Plant defensin)	Q39182, Q42011, Q4VP00, Q4VP03	Belongs to the DEFL family	PDF2.2	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Bridge	Not found		"Function: Confers broad-spectrum resistance to pathogens.
Tissue specificity: Broadly expressed.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##8281187	Plant Mol Biol. 2001 May;46(1):17-34.##Plant J. 1993 Dec;4(6):1051-1061.##Plant Physiol. Biochem. 1998;36:533-537.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Höfte H, Desprez T, Amselem J, Chiapello H, Rouz© P, Caboche M, Moisan A, Jourjon MF, Charpenteau JL, Berthomieu P, et al.##Thomma B.P.H.J, Broekaert W.F.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##An inventory of 1152 expressed sequence tags obtained by partial sequencing of cDNAs from Arabidopsis thaliana.##Tissue-specific expression of plant defensin genes PDF2.1 and PDF2.2 in Arabidopsis thaliana.	
DRAMP00459	RICKSRSQKFKGPCVSEDNCANVCHTEGFPDGDCDGLLRRCYCNTHC	47	Defensin-like protein 3 (Protein LCR71; Plant defensin)	P82781	Belongs to the DEFL family	LCR71	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Bridge	Not found		PTM: Contains four disulfide bonds 3-47;14-34;20-41;24-43.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247	Plant Mol Biol. 2001 May;46(1):17-34.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.	
DRAMP00460	RTCASQSQRFKGKCVSDTNCENVCHNEGFPGGDCRGFRRRCFCTRNC	47	Defensin-like protein 4 (Protein LCR70; Plant defensin 2.1; Plant defensin)	Q41914, Q541X5, Q9ZUL6	Belongs to the DEFL family	PDF2.1	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Bridge	Not found		"Function: Confers broad-spectrum resistance to pathogens.
Tissue specificity: Expressed in roots, siliques and seeds.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##8281187	Plant Mol Biol. 2001 May;46(1):17-34.##Plant J. 1993 Dec;4(6):1051-1061.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Höfte H, Desprez T, Amselem J, Chiapello H, Rouz© P, Caboche M, Moisan A, Jourjon MF, Charpenteau JL, Berthomieu P, et al.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##An inventory of 1152 expressed sequence tags obtained by partial sequencing of cDNAs from Arabidopsis thaliana.	
DRAMP00461	RTCETSSNLFNGPCLSSSNCANVCHNEGFSDGDCRGFRRRCLCTRPC	47	Defensin-like protein 5 (Protein LCR66; Plant defensin 2.4; Plant defensin)	Q9C947, A0MED6, Q1PFI2, Q8LEG6	Belongs to the DEFL family	PDF2.4	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Bridge	Not found		PTM: Contains four disulfide bonds 4-51; 15-36; 21-45; 25-47, and Pyrrolidone carboxylic acid at position 1.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147637	Plant Biotechnol J. 2006 May;4(3):317-324.	Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.	Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.	
DRAMP00462	RTCQSKSHHFKYMCTSNHNCAIVCRNEGFSGGRCHGFHRRCYCTRLC	47	Defensin-like protein 6 (Protein LCR74; Plant defensin 2.5; Plant defensin)	Q9FFP8, P82783	Belongs to the DEFL family	PDF2.5	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Bridge	Not found		PTM: Contains four disulfide bonds 4-47; 14-34; 20-41; 24-43.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247	Plant Mol Biol. 2001 May;46(1):17-34.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.	
DRAMP00463	QQMCEAKSLDWKGMCLKWRNCRQVCISEGFTDGRCKGFTRKCICSKPCFVLPN	53	Defensin-like protein 7 (Protein LCR75; LCR79; Plant defensin)	P82784, P82788	Belongs to the DEFL family	LCR75	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Bridge	Not found		"Tissue specificity: Expressed in stems, roots, rosette leaves and flower buds.
PTM: Contains four disulfide bonds 4-48;15-35;21-42;25-44."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247	Plant Mol Biol. 2001 May;46(1):17-34.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.	
DRAMP00464	EVSPLDNKICKTRSDRFSGVCISTNNCAIICQQFEHFDGGHCEFDGAFRRCMCTKQC	57	Defensin-like protein 8 (Protein LCR73; Plant defensin)	P82782, Q4VP01	Belongs to the DEFL family	LCR73	Arabidopsis thaliana (Mouse-ear cress)	Not found	Homology	Bridge	Not found		PTM: Contains four disulfide bonds 10-57; 21-42; 27-51; 31-53.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247	Plant Mol Biol. 2001 May;46(1):17-34.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.	
DRAMP00465	QPQLCETKSLNYRGLCLKWRSCKRVCISEGFPDGRCKGFFNNKCVCRKPCALLSTEN	57	Defensin-like protein 9 (Protein LCR76; Plant defensin)	P82785	Belongs to the DEFL family	LCR76	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Bridge	Not found		PTM: Contains four disulfide bonds 5-50;16-36;22-44;26-46.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247	Plant Mol Biol. 2001 May;46(1):17-34.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.	
DRAMP00466	RTCESPSNKFQGVCLNSQSCAKACPSEGFSGGRCSSLRCYCSKAC	45	Defensin-like protein 10 (Protein LCR72; Plant defensin 2.6; Plant defensin)	Q9ZUL8, Q0IGN8	Belongs to the DEFL family	PDF2.6	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Bridge	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247	Plant Mol Biol. 2001 May;46(1):17-34.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.	
DRAMP00467	QKCEWECKLLPNFPCWLKGAGEGLCDNLCKYEGAISGVCVSDPHRCLCRNRKPGCS	56	Defensin-like protein 11 (Plant defensin)	Q9M1V4, A0MF42	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Bridge	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147637##15955924	Plant Biotechnol J. 2006 May;4(3):317-324.##Plant Physiol. 2005 Jun;138(2):600-610.	Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00468	QMNDCDCDHDHRCGEWEDESHGNCKQHHLRVVCTCTLDCLDISSTSNA	48	Putative defensin-like protein 12 (Plant defensin)	Q2V477	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Bridge	Not found		Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00469	QKLCERPSGTWSGVCGNSNACKNQCINLEKARHGSCNYVFPAHKCICYFPC	51	Defensin-like protein 13 (At-AFP1; Protein LCR67; Plant defensin)	P30224, Q42179	Belongs to the DEFL family	PDF1.1	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Protein level	Rich	Not found		"Function: Confers broad-spectrum resistance to pathogens. Possesses antifungal activity sensitive to inorganic cations in vitro.
Tissue specificity: Expressed predominantly in siliques and dry seeds.
PTM: Contains four disulfide bonds 4-51; 15-36; 21-45; 25-47, and pyrrolidone carboxylic acid at Q1."	Fungi: Alternaria brassicola (IC50=10 µg/ml), Botrytis cinerea (IC50=3.90 µg/ml), Fusarium culmorum (IC50=3 µg/ml), Fusarium oxysporum f.sp. lycopersici (IC50=3 µg/ml), Pyricularia oryzae (IC50=0.25 µg/ml), Verticiliium dahliae (IC50=1.50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8422949##17180735##8989885	FEBS Lett. 1993 Feb 1;316(3):233-240.##Transgenic Res. 2007 Aug;16(4):531-538.##Plant Cell. 1996 Dec;8(12):2309-2323.	Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.##Sels J, Delaur© SL, Aerts AM, Proost P, Cammue BP, De Bolle MF.##Penninckx IA, Eggermont K, Terras FR, Thomma BP, De Samblanx GW, Buchala A, M©traux JP, Manners JM, Broekaert WF.	A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.##Use of a PTGS-MAR expression system for efficient in planta production of bioactive Arabidopsis thaliana plant defensins.##Pathogen-induced systemic activation of a plant defensin gene in Arabidopsis follows a salicylic acid-independent pathway.	
DRAMP00470	QKLCEKPSGTWSGVCGNSNACKNQCINLEGAKHGSCNYVFPAHKCICYFPC	51	Defensin-like protein 14 (Plant defensin 1.3; Plant defensin)	O80995	Belongs to the DEFL family	PDF1.3	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		PTM: Contains four disulfide bonds 4-51;15-36;21-45;25-47, and Pyrrolidone carboxylic acid at position 1.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10617197	Nature. 1999 Dec 16;402(6763):761-768.	Lin X, Kaul S, Rounsley S, Shea TP, Benito MI, Town CD, Fujii CY, Mason T, Bowman CL, Barnstead M, Feldblyum TV, Buell CR, Ketchum KA, Lee J, Ronning CM, Koo HL, Moffat KS, Cronin LA, Shen M, Pai G, Van Aken S, Umayam L, Tallon LJ, Gill JE, Adams MD, Carr	Sequence and analysis of chromosome 2 of the plant Arabidopsis thaliana.	
DRAMP00471	QKLCEKPSGTWSGVCGNSNACKNQCINLEGAKHGSCNYVFPAHKCICYVPC	51	Defensin-like protein 15 (Putative plant defensin 1.2b; Plant defensin)	O80994	Belongs to the DEFL family	PDF1.2B	Arabidopsis thaliana (Mouse-ear cress)	Not found	Homology	Not found	Not found		"Function: Confers broad-spectrum resistance to pathogens.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924##12447532	Plant Physiol. 2005 Jun;138(2):600-610.##Planta. 2002 Dec;216(2):193-202.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Thomma BP, Cammue BP, Thevissen K.	Genome organization of more than 300 defensin-like genes in Arabidopsis.##Plant defensins.	
DRAMP18329	NSGGAAVVAALGCAAGGVKYGRLLGPWGAAIG	32	Pneumococin N(Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	blpN	Streptococcus pneumoniae?TIGR4	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comparison of the TIGR4 BlpM and -N amino acid sequences demonstrated that only ?ve amino acid differences were suf?cient to target the heterologous strain.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17074857	Infect Immun. 2007 Jan;75(1):443-51. 	Dawid S, Roche AM, Weiser JN.	The blp bacteriocins of Streptococcus pneumoniae mediate intraspecies competition both in vitro and in vivo.	
DRAMP18330	CCCCCTTCCFSIATGSGNSQGGSGSYTPGK	30	streptolysin S(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	sagA	Streptococcus pyogenes MGAS 8232	Unknown		Not found	Not found		Streptolysin S (SLS) is a bacteriocin-like haemolytic and cytotoxic virulence factor that plays a key role in the virulence of Group A Streptococcus(GAS). The peptide contributes to the cytotoxicity, inflammatory activation and polymorphonuclear neutrophil (PMN) resistance of GAS, thereby playing a role in necrosis and systemic spread. It is also responsible for the associated characteristic beta-haemolytic activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18787690	PLoS Pathog. 2008 Sep 12;4(9):e1000144. 	Cotter PD, Draper LA, Lawton EM, Daly KM, Groeger DS, Casey PG, Ross RP, Hill C.	Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes.	
DRAMP18328	KNNWQTNVLEGGGAAFGGWGLGTAICAASGVGAPFMGACGYIGAKFGVDLWAGVTGATGGF	61	Pneumococin M(Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	blpM	Streptococcus pneumoniae?TIGR4	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comparison of the TIGR4 BlpM and -N amino acid sequences demonstrated that only ?ve amino acid differences were suf?cient to target the heterologous strain.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17074857	Infect Immun. 2007 Jan;75(1):443-51. 	Dawid S, Roche AM, Weiser JN.	The blp bacteriocins of Streptococcus pneumoniae mediate intraspecies competition both in vitro and in vivo.	
DRAMP00474	LCKRESETWSGRCVNDYQCRDHCINNDRGNDGYCAGGYPWYRSCFCFFSC	50	Defensin-like protein 18 (Plant defensin 1.5; Plant defensin)	Q9FZ31	Belongs to the DEFL family	PDF1.5	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Confers broad-spectrum resistance to pathogens.
PTM: Contains four disulfide bonds 3-51; 14-35; 20-45; 24-47."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924##12447532	Plant Physiol. 2005 Jun;138(2):600-610.##Planta. 2002 Dec;216(2):193-202.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Thomma BP, Cammue BP, Thevissen K.	Genome organization of more than 300 defensin-like genes in Arabidopsis.##Plant defensins.	
DRAMP00475	TEMMAVEGRICERRSKTWTGFCGNTRGCDSQCKRWERASHGACHAQFPGFACFCYFNC	58	Defensin-like protein 19 (Protein LCR78; Plant defensin 1.4; Plant defensin)	P82787, Q8VZQ7, Q9FWR6	Belongs to the DEFL family	PDF1.4	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Bridge	Not found		PTM: Contains four disulfide bonds 11-58;22-43;28-52;32-54.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247	Plant Mol Biol. 2001 May;46(1):17-34.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.	
DRAMP00476	QKHIAPWIFEDKSICCKEHPSVGRCLPGIDDDAEKDGKCWKFCIEGCETGGFCKLFEHKHICHCNCSG	68	Putative defensin-like protein 20 (Plant defensin)	Q2V2S1	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00477	QKHTAPWIPEDNSICCKEHPSVGRCLPNIDDSAEKGGKCWKFCIEGCETGGFCKLFGHKHICHCNCSG	68	Defensin-like protein 21 (Plant defensin)	P0CAX9, O23285, Q2V3I6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Bridge	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00478	YNVENGGSLCCNNHPKFGKCNTKNDDQRCNSWCLNGCDNGKGGYCKSMSHGGQCHCYC	58	Defensin-like protein 22 (Plant defensin)	Q2V391	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00479	SGSSLCCNTHAKFGACNTYQDRKRCNKWCLDGCDNKKGGFCKRFAGGAKKCHCYC	55	Putative defensin-like protein 23 (Plant defensin)	Q2V364	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00480	RKTVWPSSELDPKCCSNQPEFGICDSKEDDERCAQMCLDGCPTNKGGGCQPITEAPGAVCSCYCA	65	Defensin-like protein 24 (Plant defensin)	Q2V371	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00481	YNVESGGSLCCNNHPKFGKCNTNNDNQRCNRWCHNGCGNGKGDYCKAMSHGGLCHCYC	58	Putative defensin-like protein 25 (Plant defensin)	Q2V392	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00482	MIYNVESGGSLCCNSHPKFGKCNTNNDEQRCNRWCHNGCGNGKGGYYKSMSHGGQCHYYC	60	Putative defensin-like protein 26 (Plant defensin)	Q2V4J2	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		PTM: Problely contains two disulfide bonds.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00483	VMNEDSILSSNKGDSLCCNDHPEFGICTNKSCNKWCLQGCTRGGFCKRKICHCYC	55	Putative defensin-like protein 27 (Plant defensin)	Q2L6T3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00484	KENITPWIYSMKQPVSCNREHSEIGICLSGIDDDIQNDGKCWKFCLMVAKSGGYNADK	58	Putative defensin-like protein 28 (Plant defensin)	P0CAY0, F4JUP3, O23285	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00485	KSMVEVNAAHKWYIVEGLCSKFPDCNKHCKEQKFPGGTCLKLGVNMMCTCIYS	53	Putative defensin-like protein 29 (Plant defensin)	Q2V3R9	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924##10907853	Plant Physiol. 2005 Jun;138(2):600-610.##DNA Res. 2000 Jun 30;7(3):217-221.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Kaneko T, Katoh T, Sato S, Nakamura A, Asamizu E, Tabata S.	Genome organization of more than 300 defensin-like genes in Arabidopsis.##Structural analysis of Arabidopsis thaliana chromosome 3. II. Sequence features of the 4,251,695 bp regions covered by 90 P1, TAC and BAC clones.	
DRAMP00486	KSMAKAQGGWYLVEGLCSKFPDCNKHCKEQGFLGGQCLKLGVNMLCFCIHT	51	Putative defensin-like protein 30 (Plant defensin)	Q2V3S0	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		Caution: Could be the product of a pseudogene. Lacks the signal peptide, which is a conserved features of the family.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924##10907853	Plant Physiol. 2005 Jun;138(2):600-610.##DNA Res. 2000 Jun 30;7(3):217-221.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Kaneko T, Katoh T, Sato S, Nakamura A, Asamizu E, Tabata S.	Genome organization of more than 300 defensin-like genes in Arabidopsis.##Structural analysis of Arabidopsis thaliana chromosome 3. II. Sequence features of the 4,251,695 bp regions covered by 90 P1, TAC and BAC clones.	
DRAMP00487	EDRSKLIPIGPCSKIANCNQTCIESQFLGGKCIKWYPDSIKETCACLVKPSITHV	55	Putative defensin-like protein 31 (Plant defensin)	Q2V3D7	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00488	KDIDGRKPLLIGTCIEFPTEKCNKTCIESNFAGGKCVHIGQSLDFVCVCFPKYYI	55	Defensin-like protein 32 (Plant defensin)	Q2V4I8	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found	2MZ0	"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00489	QNPRGRKCEDPNGVDQKAKCYIYCNEQGFLGGSCQGYTNHYMCECYVG	48	Putative defensin-like protein 33 (Plant defensin)	Q2V4D6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00490	QILTGIKCPDPNGHDKEDKCNIYCLNQNYMGGSCQGYKNHYMCECYVG	48	Defensin-like protein 34 (Plant defensin)	Q2V4D7	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00491	KSMNPTGRRCPDPNGVEKKSMCYSSCKTQGFMGGSCQGHKGNYMCECYEG	50	Defensin-like protein 35 (Plant defensin)	Q2V4F3, Q9SH70	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00492	IESPIFTGNKCSDPTGMDKDGKCLDYCHAQGYPGGSCIGFIDQGYMCVCKVG	52	Putative defensin-like protein 36 (Plant defensin)	Q2V4D5	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00493	TTAGRRDGKSGRTEWLYVAGECAKLPRCNKYCVSNGFHLGGFCEKLSPQASYLSCVCKYT	60	Defensin-like protein 37 (Plant defensin)	Q56XC2, F4JSA4, Q9SVQ4	Belongs to the DEFL family	EDA21	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00494	YCERVRSRSAPHDICKKKNGNAVCKEKCWTIEKYQNGRCLILPKTTKLDCYCYHFDQC	58	Putative defensin-like protein 38 (Plant defensin)	Q2V462	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00495	YCEKVRSKTAPRDVCKKSNGNALCKKTCWTIEKYVNGKCLILPKTTNLDCYCYHYDNGSACRA	63	Putative defensin-like protein 39 (Plant defensin)	Q2V460	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00496	LGTSPYCEKVLSRFAPPGNCLKKNGNALCKESCANEQFREGVCLHLPKPQSKLNCYCSVLKCP	63	Putative defensin-like protein 40 (Plant defensin)	Q2V325	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00497	MTQGKRKHPCDLKNPSKRAPPATCNKPNGAILCGDFCLHEGYNIGKCVMRRTGKACICSQCEGW	64	Defensin-like protein 41 (Plant defensin)	Q3E8B0	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00498	MNWELCDDYPSKAPPETCNKVDGARRCRTSCNNEGYGGANCNLKGKVKVCECTILRVCLPHHKRPPHVPKPPK	73	Putative defensin-like protein 42 (Plant defensin)	P0CAY1	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"PTM: Contains four disulfide bonds (By similarity).
Caution: Could be the product of a pseudogene. Lacks the signal peptide, which is a conserved feature of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924##10907853	Plant Physiol. 2005 Jun;138(2):600-610.##DNA Res. 2000 Jun 30;7(3):217-221.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Kaneko T, Katoh T, Sato S, Nakamura A, Asamizu E, Tabata S.	Genome organization of more than 300 defensin-like genes in Arabidopsis.##Structural analysis of Arabidopsis thaliana chromosome 3. II. Sequence features of the 4,251,695 bp regions covered by 90 P1, TAC and BAC clones.	
DRAMP00499	SEIKPTGRIDDQCKQMCSATYGDGKCASDCRKAGFSSGRCLTSSPFGNKCCCTK	54	Defensin-like protein 43 (Plant defensin)	Q2V4J5	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00500	SEIKPTGRVDNQCKEMCSATFGDGKCAADCRKAGFSSGRCLTSSPFGNKCCCT	53	Defensin-like protein 44 (Plant defensin)	Q9M833	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00501	SDIKPTGRIDNQCKRMCSATYGNGKCAADCRSDGFSSGQCFTSPPFDNRCCCNN	54	Defensin-like protein 45 (Plant defensin)	Q2V3Y8	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00502	IDAGIKGFDTDHCDTRCYGRDECMNYCIKAGFPKGGQCGSLCIPCGFKCCCQK	53	Defensin-like protein 46 (Plant defensin)	Q2V3V1, A0ME04	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00503	SDARIEGFSFDNCNIRCSEDYWNDECNKDCLRAGFQKGGQCGSPCIPCPVKCCCQK	56	Defensin-like protein 47 (Plant defensin)	Q3E7C7	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00504	AEIKKFSYDHCFHLCVAGEYGSNECFVDCAQKGFWHGDCANRTEKDPIRCCCYN	54	Putative defensin-like protein 48 (Plant defensin)	Q2V365	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00505	AETTKFSYDHCFHLCVEGEYGSRECFVDCTQKGFWHGVCANKTTAKDPIHCCCYN	55	Defensin-like protein 49 (Plant defensin)	Q2V366	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924##14993207	Plant Physiol. 2005 Jun;138(2):600-610.##Genome Res. 2004 Mar;14(3):406-413.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Castelli V, Aury JM, Jaillon O, Wincker P, Clepet C, Menard M, Cruaud C, Qu©tier F, Scarpelli C, Schächter V, Temple G, Caboche M, Weissenbach J, Salanoubat M.	Genome organization of more than 300 defensin-like genes in Arabidopsis.##Whole genome sequence comparisons and full-length cDNA sequences: a combined approach to evaluate and improve Arabidopsis genome annotation.	
DRAMP00506	SEIKAKINGLECFNTCTPYYDDYKCNVDCLSSGYPAGDCHIVSPSQPKKCCCY	53	Defensin-like protein 50 (Protein LCR49; Plant defensin)	P82764	Belongs to the DEFL family	LCR49	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17229318##11437247##15955924	BMC Genomics. 2007 Jan 17;8:18.##Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Moskal WA Jr, Wu HC, Underwood BA, Wang W, Town CD, Xiao Y.##Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Experimental validation of novel genes predicted in the un-annotated regions of the Arabidopsis genome.##Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00507	SEIKAKINGLECFNTCTSYYDDHKCNVDCLSSGYPAGECYTVSPSQPKKCCCY	53	Defensin-like protein 51 (Protein LCR48; Plant defensin)	P82763, A0MJW7, A7REH1	Belongs to the DEFL family	LCR48	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17565583##11437247##15955924	Plant J. 2007 Jul;51(2):262-280.##Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Moskal WA Jr, Wu HC, Underwood BA, Graham MA, Town CD, VandenBosch KA.##Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants.##Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00508	VSGPPKCIALCRPGYYERFECFHDCITEGYDDGSCVPGPTTAKCGIITKTTNKICYSFAFE	61	Putative defensin-like protein 52 (Plant defensin)	Q2V433	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"PTM: Problely contains two disulfide bonds.
Caution: Could be the product of a pseudogene. Lacks 2 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00509	MFSQNICMWRDCFARCSPGYYERFECFHDCITKGYDDGNCVPGPKTGRCCCTR	53	Putative defensin-like protein 53 (Plant defensin)	P0CAY2	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"PTM: Contains four disulfide bonds (By similarity).
Caution: Could be the product of a pseudogene. Lacks the signal peptide, which is a conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00510	ESVIEPAKYGACLFLCDARRDDHACFYDCTNVAIYRTGHCVGNPPRCCCIRG	52	Defensin-like protein 54 (Plant defensin)	Q8GY39	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11910074##15955924##14993207	Science. 2002 Apr 5;296(5565):141-145.##Plant Physiol. 2005 Jun;138(2):600-610.##Genome Res. 2004 Mar;14(3):406-413.	Seki M, Narusaka M, Kamiya A, Ishida J, Satou M, Sakurai T, Nakajima M, Enju A, Akiyama K, Oono Y, Muramatsu M, Hayashizaki Y, Kawai J, Carninci P, Itoh M, Ishii Y, Arakawa T, Shibata K, Shinagawa A, Shinozaki K.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Castelli V, Aury JM, Jaillon O, Wincker P, Clepet C, Menard M, Cruaud C, Qu©tier F, Scarpelli C, Schächter V, Temple G, Caboche M, Weissenbach J, Salanoubat M.	Functional annotation of a full-length Arabidopsis cDNA collection.##Genome organization of more than 300 defensin-like genes in Arabidopsis.##Whole genome sequence comparisons and full-length cDNA sequences: a combined approach to evaluate and improve Arabidopsis genome annotation.	
DRAMP00511	LSNSDALASSVIETTKNDVCSTPCTIRYGTFECFQDCILDHFRDGNCINGRCCCKY	56	Putative defensin-like protein 55 (Plant defensin)	Q2V2Q4	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00512	DVLASSDIYICVTVIETTKNDVCSTPCTIRYGTFECFHDCILEHYRDGNCINGRCCCK	58	Putative defensin-like protein 56 (Plant defensin)	Q2V4A6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00513	SSVIETTKNDVCSTPCTRRYGTYECWHDCLHERYNDGGCVDGRCCCKK	48	Putative defensin-like protein 57 (Plant defensin)	Q2V4A8	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00514	DVLVSSVIETSKNDVCFIPCTRRYGDWECYDDCLGKNFNDGGCVDGRCCCKK	52	Defensin-like protein 58 (Plant defensin)	Q4VNZ9, F4IU82, F4IU83	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00515	LSNSDILVSSVIETSKYDVCFIPCTRRYEDRECNDDCLAKDFNDGGCVDGRCCCKY	56	Defensin-like protein 59 (Plant defensin)	Q4VNZ8	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00516	EVLVAPVIETAQNDVCFVPCTSRYGHYECAFDCMHKRYKDGGCVHGRCCCKT	52	Putative defensin-like protein 60 (Plant defensin)	Q2V4A5	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00517	YDRCIGPCLRFYGNHQCYKNCRKAKYDGGQCDFVKKGEKLPECCCYYNKN	50	Putative defensin-like protein 62 (Plant defensin)	Q2V485	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00518	SYNIGQTRLVVIQEQEPHCIGPCEIAFGNRPCNEECTSQQYAYGFCDYQTKGEDNPQCCCYTS	63	Putative defensin-like protein 63 (Plant defensin)	Q2V4G1	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00519	ERIDICFIPCTRRYGDYECWFDCTYNRYKEGGCVEDVVVKHNRNRPTFRAVELCFFSIKFMYDFSMK	67	Putative defensin-like protein 64 (Plant defensin)	Q2V4A7	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		Caution: Could be the product of a pseudogene. Lacks 2 of the 4 disulfide bonds, which are conserved features of the family.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00520	FSVQIGISVQAAPPTCGRDCTEKFLTQDCDKYCVGLSYKKGVCILSEGLPPKTSTYRCCCS	61	Putative defensin-like protein 66 (Plant defensin)	Q2V2Y6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00521	VEMGISVQALPPTCGPDCTGRFMNQDCSKYCAALSYKHGVCILFRGLPPRTSTLRCCCG	59	Putative defensin-like protein 67 (Plant defensin)	Q3EBU2	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00522	YDLFSEIGISAATLVIPTCFENCNATFQDPECNKWCALLAYKDGSCLYPPSEVDDLPPIKRPYIPRCCCNPITLSPPSP	79	Defensin-like protein 68 (Plant defensin)	Q2V4L5, A0MJT8, Q9LR89	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924##17147637##17229318	Plant Physiol. 2005 Jun;138(2):600-610.##Plant Biotechnol J. 2006 May;4(3):317-324.##BMC Genomics. 2007 Jan 17;8:18.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.##Moskal WA Jr, Wu HC, Underwood BA, Wang W, Town CD, Xiao Y.	Genome organization of more than 300 defensin-like genes in Arabidopsis.##Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.##Experimental validation of novel genes predicted in the un-annotated regions of the Arabidopsis genome.	
DRAMP00523	YDLFTGIGIDARTVPPTCYESCNATFQNPECNKMCVGLAYKDGSCIYPPPEVDGLPPKRPYFPRCCCNPIILSPPSP	77	Defensin-like protein 69 (Plant defensin)	Q9FL73, A0MFP1	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9679202##15955924##17147637	DNA Res. 1998 Apr 30;5(2):131-145.##Plant Physiol. 2005 Jun;138(2):600-610.##Plant Biotechnol J. 2006 May;4(3):317-324.	Kaneko T, Kotani H, Nakamura Y, Sato S, Asamizu E, Miyajima N, Tabata S.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.	Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence features of the regions of 1,381,565 bp covered by twenty one physically assigned P1 and TAC clones.##Genome organization of more than 300 defensin-like genes in Arabidopsis.##Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.	
DRAMP00524	NFASGEASSQLCFNPCTPQLGNNECNTICMNKKYKEGSCVGFGIPPTSKYCCCKT	55	Putative defensin-like protein 70 (Protein LCR83; Plant defensin)	P82792	Belongs to the DEFL family	LCR83	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00525	LPSSVINGFGYDYCIVECSITFLDDACKPLCIDRGYSDGGCIGLSPHFKCCCKK	54	Defensin-like protein 71 (Plant defensin)	P82793	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00526	MKLSILVKAMKRNNGFRYDYCIAECSEHFLDDVCKPVCIDKGYSDGGCIGLAPNFKCCCKK	61	Putative defensin-like protein 72 (Plant defensin)	Q2V2S9	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"PTM: Contains four disulfide bonds (By similarity).
Caution: Could be the product of a pseudogene. Lacks the signal peptide, which is a conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00527	EPQCIGSCEMLADCNTACIRMGYLFGQCVGWKTPDMCCCNH	41	Putative defensin-like protein 73 (Protein LCR44; Plant defensin)	P82759	Belongs to the DEFL family	LCR44	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00528	QKECIGPCDMFTDCQAACVGIRKGYNYGQCVAWKPKDDDPFTCCCYKLTP	50	Defensin-like protein 74 (Protein LCR43; Plant defensin)	P82758	Belongs to the DEFL family	LCR43	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00529	ITVQADCIGPCNDDCQQLCKSKGYTDWTCASFRTKSSCCCKPPRHQIFEQNAQLNN	56	Defensin-like protein 75 (Protein LCR45; Plant defensin)	P82760	Belongs to the DEFL family	LCR45	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247	Plant Mol Biol. 2001 May;46(1):17-34.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.	
DRAMP00530	IDVHDAMCYRSECTSVCDQICLSHGYTNGWYCGTFRLHTGCCCLKKKELNQIISPSKN	58	Defensin-like protein 76 (Protein LCR86; Plant defensin)	P82795	Belongs to the DEFL family	LCR86	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10470850##11437247	DNA Res. 1999 Jun 30;6(3):183-195.##Plant Mol Biol. 2001 May;46(1):17-34.	Kaneko T, Katoh T, Sato S, Nakamura Y, Asamizu E, Kotani H, Miyajima N, Tabata S.##Vanoosthuyse V, Miege C, Dumas C, Cock JM.	Structural analysis of Arabidopsis thaliana chromosome 5. IX. Sequence features of the regions of 1,011,550 bp covered by seventeen P1 and TAC clones.##Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.	
DRAMP00531	RSNGIYDPMCPGVCGNLVKPDCNGLCHELGFPAGGYCKPGNTCCCKKKDSGPVDVPPTA	59	Defensin-like protein 78 (Plant defensin)	Q9SL74, A0MJT1	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147637##15955924##17565583	Plant Biotechnol J. 2006 May;4(3):317-324.##Plant Physiol. 2005 Jun;138(2):600-610.##Plant J. 2007 Jul;51(2):262-280.	Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Silverstein KA, Moskal WA Jr, Wu HC, Underwood BA, Graham MA, Town CD, VandenBosch KA.	Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.##Genome organization of more than 300 defensin-like genes in Arabidopsis.##Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants.	
DRAMP00532	YQMLICLDLNISCADCQKQCDETSYGGMCLNGGRTCCCKKSPPPSYYDPRPPSS	54	Putative defensin-like protein 79 (Plant defensin)	Q2V470	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00533	EVRDICPGVCHAGIEPDCDTLCISMGFTGGYCQGLTCCCNPKSSKSSIINRPI	53	Putative defensin-like protein 80 (Protein LCR81; Plant defensin)	P82790	Belongs to the DEFL family	LCR81	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00534	KSPVSCDGACTSTPQCNKICTSKGYKKGICHGSAHLFYICCCYAKFESQYDPSISSPPNY	60	Defensin-like protein 81 (Plant defensin)	Q2V4G6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147637##15955924##17565583	Plant Biotechnol J. 2006 May;4(3):317-324.##Plant Physiol. 2005 Jun;138(2):600-610.##Plant J. 2007 Jul;51(2):262-280.	Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Silverstein KA, Moskal WA Jr, Wu HC, Underwood BA, Graham MA, Town CD, VandenBosch KA.	Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.##Genome organization of more than 300 defensin-like genes in Arabidopsis.##Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants.	
DRAMP00535	RTQEHPCQDYRLGCKSRDVCNAKCLSLGYVKGGDCVTFAFPICCCKINFGFQDDSPISSPIFTD	64	Defensin-like protein 82 (Plant defensin)	Q2V334	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14993207	Genome Res. 2004 Mar;14(3):406-413.	Castelli V, Aury JM, Jaillon O, Wincker P, Clepet C, Menard M, Cruaud C, Qu©tier F, Scarpelli C, Schächter V, Temple G, Caboche M, Weissenbach J, Salanoubat M.	Whole genome sequence comparisons and full-length cDNA sequences: a combined approach to evaluate and improve Arabidopsis genome annotation.	
DRAMP00536	QIITCLPGECTNPSECNAACKSNGYKGGACVSMSIGSTTGACCCKPNFKSQDSFKSNDIIINNN	64	Putative defensin-like protein 83 (Protein LCR46; Plant defensin)	P82761	Belongs to the DEFL family	LCR46	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10470850##11437247	DNA Res. 1999 Jun 30;6(3):183-195.##Plant Mol Biol. 2001 May;46(1):17-34	Kaneko T, Katoh T, Sato S, Nakamura Y, Asamizu E, Kotani H, Miyajima N, Tabata S.##Vanoosthuyse V, Miege C, Dumas C, Cock JM.	Structural analysis of Arabidopsis thaliana chromosome 5. IX. Sequence features of the regions of 1,011,550 bp covered by seventeen P1 and TAC clones.##Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.	
DRAMP00537	QSSKCTKGCTSTPECNIKCMKKGGGHCQAYIGRSHGRLAIENYCCCNNYSNSPISSPVMN	60	Putative defensin-like protein 84 (Plant defensin)	Q2V2Y3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00538	LISDKCTEGCKSTIGCNTRCMMRGGGYCESAKIHGAVKIFCCCNNYSNSPISSPVIN	57	Defensin-like protein 85 (Plant defensin)	Q8GXV6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11910074##9628582	Science. 2002 Apr 5;296(5565):141-145.##DNA Res. 1998 Feb 28;5(1):41-54.	Seki M, Narusaka M, Kamiya A, Ishida J, Satou M, Sakurai T, Nakajima M, Enju A, Akiyama K, Oono Y, Muramatsu M, Hayashizaki Y, Kawai J, Carninci P, Itoh M, Ishii Y, Arakawa T, Shibata K, Shinagawa A, Shinozaki K.##Sato S, Kaneko T, Kotani H, Nakamura Y, Asamizu E, Miyajima N, Tabata S.	Functional annotation of a full-length Arabidopsis cDNA collection.##Structural analysis of Arabidopsis thaliana chromosome 5. IV. Sequence features of the regions of 1,456,315 bp covered by nineteen physically assigned P1 and TAC clones.	
DRAMP00539	QFRGIKQCEMKCYSTPECNATCLHEGYEEGKCLKSWDGGVECCCLGLLASSHQDSSPISSPHYIIFHGICILNI	74	Putative defensin-like protein 86 (Protein LCR82; Plant defensin)	P82791	Belongs to the DEFL family	LCR82	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		PTM: Contains four disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00540	QLKSTCRIAEAWKGAKECNAKCAALGTTRGGVCQKFLGDLYCCCWD	46	Defensin-like protein 87 (Plant defensin)	Q3E7S1	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Caution: Could be the product of a pseudogene. Lacks 1 of the 4 disulfide bonds, which are conserved features of the family.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00541	VEVIPCIAGSKCTNDMTYNELCRFKGFSKGGFCQKYVHQTIGRCCCHPTGLESQESSISGDTNVVITN	68	Putative defensin-like protein 88 (Plant defensin)	Q2V3J1	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00542	QTMQCYSGIACTDDGTCNDYCNPRNNNLGGVCLRRANCCCCYVSVVKSQESSLSKDTNNVFITN	64	Putative defensin-like protein 89 (Plant defensin)	Q2V3J0	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00543	SPEKYYDCKQDGCITTPPCWRKCVSMGYPKGGECRIYSYGGVCCCDLTSKPPN	53	Defensin-like protein 90 (Plant defensin)	Q2V4G9	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00544	FTIAEPYIHPCMKGFCSFKSECANKCIFMGHHKGGDCIGGLDGIYCCCLA	50	Defensin-like protein 91 (Protein LCR47; Plant defensin)	P82762	Belongs to the DEFL family	LCR47	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14993207##11437247##15955924	Genome Res. 2004 Mar;14(3):406-413.##Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Castelli V, Aury JM, Jaillon O, Wincker P, Clepet C, Menard M, Cruaud C, Qu©tier F, Scarpelli C, Schächter V, Temple G, Caboche M, Weissenbach J, Salanoubat M.##Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Whole genome sequence comparisons and full-length cDNA sequences: a combined approach to evaluate and improve Arabidopsis genome annotation.##Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00545	WGKCDLRKGLCRLADTISTCDVPCRAVDSKYHGGECLNVGGGQGICWCCRDYDAAKSGAEKESM	64	Defensin-like protein 95 (Plant defensin)	Q6NMS3, O49628	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00546	RQVCDYDKGECNSYEKSSTCIEPCKQLDSKFIGGRCIPVGGITGMGLCVCCRDVQRGAEKESM	63	Defensin-like protein 96 (Plant defensin)	Q8L7G7, O49628, Q8H0Y6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Confers broad-spectrum resistance to pathogens.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00547	RRVCDSAAGLCSMLFSCNTQCNSLGRNFTGGECSDARFPGLSVCYCCHNVESSAEMESM	59	Defensin-like protein 97 (Protein LCR85; Plant defensin)	P82794, O49626, Q1PE59	Belongs to the DEFL family	LCR85	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147637##15955924##17565583	Plant Biotechnol J. 2006 May;4(3):317-324.##Plant Physiol. 2005 Jun;138(2):600-610.##Plant J. 2007 Jul;51(2):262-280.	Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Silverstein KA, Moskal WA Jr, Wu HC, Underwood BA, Graham MA, Town CD, VandenBosch KA.	Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.##Genome organization of more than 300 defensin-like genes in Arabidopsis.##Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants.	
DRAMP00548	RLVCDTPAGTCTSSSTCNDQCNTWGGNYSGGECADSSFPGLSICYCCHYVGSSAEMESM	59	Defensin-like protein 98 (Plant defensin)	Q94AZ8, O49626	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00549	SCDFPLGACTPFRDCKESCIKFKTRAGQTFFDGKCRPRDRPSVWTACFCCYYDSIGAQ	58	Defensin-like protein 100 (Plant defensin)	Q3E6U0, A0MJT5, O49626	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147637##15955924##17565583	Plant Biotechnol J. 2006 May;4(3):317-324.##Plant Physiol. 2005 Jun;138(2):600-610.##Plant J. 2007 Jul;51(2):262-280.	Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Silverstein KA, Moskal WA Jr, Wu HC, Underwood BA, Graham MA, Town CD, VandenBosch KA.	Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.##Genome organization of more than 300 defensin-like genes in Arabidopsis.##Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants.	
DRAMP00550	FPASDQSIYARCIGPCPRYAVPHWCENECLSRKYMAGGECAFIEGEGPTPRCCCINL	57	Putative defensin-like protein 101 (Plant defensin)	Q2V337	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00551	RTTTGGSPGYGIGGRTKTCFTPALCIYRGVHGCDSYCKTKNFDYGYCRQEHCCCVNY	57	Putative defensin-like protein 102 (Plant defensin)	Q2V3L0	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00552	LPTTARSPGYEIGPQRRRRVTCFSFSFCKPARGLASCDLFCKRLKFESGLCTGDLEKCCCIDYIN	65	Defensin-like protein 103 (Plant defensin)	Q8GXR4	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11910074##15955924	Science. 2002 Apr 5;296(5565):141-145.##Plant Physiol. 2005 Jun;138(2):600-610.	Seki M, Narusaka M, Kamiya A, Ishida J, Satou M, Sakurai T, Nakajima M, Enju A, Akiyama K, Oono Y, Muramatsu M, Hayashizaki Y, Kawai J, Carninci P, Itoh M, Ishii Y, Arakawa T, Shibata K, Shinagawa A, Shinozaki K.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Functional annotation of a full-length Arabidopsis cDNA collection.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00553	LPMTHGGKPGYGIERTIIRPEWRCYVDEGCPKGQGAPCEKNCKNVADYGICIGIKCCCFDVIPVPPT	67	Putative defensin-like protein 104 (Plant defensin)	Q2V476	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00554	MLMACYSAGQLGCLVFCNEAEYSYGKCIGRGRCCCYDL	38	Putative defensin-like protein 105 (Plant defensin)	P0CAY3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00555	HTTIASAPSSGEPTTYATGPALSKHSHDNDGICFVTPACFAPGQYEIGCIVYCHESHYKHYKCVNRSCCCYNTDKNASELK	81	Defensin-like protein 106 (Plant defensin)	Q1G3Y1, A0MDJ9, Q9SYA4	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147637##15955924##17565583	Plant Biotechnol J. 2006 May;4(3):317-324.##Plant Physiol. 2005 Jun;138(2):600-610.##Plant J. 2007 Jul;51(2):262-280.	Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Silverstein KA, Moskal WA Jr, Wu HC, Underwood BA, Graham MA, Town CD, VandenBosch KA.	Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.##Genome organization of more than 300 defensin-like genes in Arabidopsis.##Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants.	
DRAMP00556	RMTTTTSPGFGIKQQDRQCFEHAPYLCRGGEGDCRMYCRDLDFSFGTCFSGVCCCQI	57	Defensin-like protein 107 (Plant defensin)	Q2V413	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00557	RMTTASTPGYGIKQEDRLCIQGQEGTKLCSSGTSRDCLNFCLIRGYAGGSCYAYTLDQCCCRIPPPKLK	69	Defensin-like protein 108 (Protein LCR51; Plant defensin)	A8MQN0, O80684	Belongs to the DEFL family	LCR51	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00558	RPSFKPIPLFGEKLTQCFDTRPCLQGMLKCIEFCSSMGTADGQCNNENLCCCTHE	55	Defensin-like protein 109 (Plant defensin)	Q2V390	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9679202##15955924	DNA Res. 1998 Apr 30;5(2):131-145.##Plant Physiol. 2005 Jun;138(2):600-610.	Kaneko T, Kotani H, Nakamura Y, Sato S, Asamizu E, Miyajima N, Tabata S.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence features of the regions of 1,381,565 bp covered by twenty one physically assigned P1 and TAC clones.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00559	RSTSDIVSGSGIKEDEHVCFKTSPCLPEVGGEKGCIAFCSRMKFTTGLCLGSVVCCCYT	59	Putative defensin-like protein 110 (Plant defensin)	Q2V4N0	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00560	SDDTQGFGIKQEYKQCYTPDPCRKGGNDECERFCVAKSGLLYGKCINDGSKDVCCCLTK	59	Putative defensin-like protein 111 (Protein LCR50; Plant defensin)	P82765	Belongs to the DEFL family	LCR50	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00561	SDRTSGVGINQEYAKCYDLADCQKPKVDDAACERFCGAKSFLLYGKCDTATNKCCCKSKTK	61	Defensin-like protein 112 (Plant defensin)	Q2V488	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00562	SDSFPGLGLKKQAHKQCYSPDLCTGGDSKCDICCVLISGVYYGKCIQSKCHCLNKTK	57	Defensin-like protein 113 (Plant defensin)	Q2V342	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00563	SELDNTSGFEIKQEDKCYGPEPCKNGYEGCLFFCVRIAYYLYGECTMKPDHQKHCCCVTK	60	Putative defensin-like protein 114 (Plant defensin)	Q2V322	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00564	SDSTLGIGINQDWKKCFSPDPCKKAGTQGCMEFCRTISFLLFGECTSKPDQCCCVTK	57	Defensin-like protein 115 (Plant defensin)	Q2V321	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00565	SDSALGIGIKEDWEVCFSIDPCLTGEGTLGCTKWCRNHINLSLVGYCRTDPEHCCCVAEK	60	Defensin-like protein 116 (Plant defensin)	Q3E8I8	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9679202##15955924##14993207	DNA Res. 1998 Apr 30;5(2):131-145.##Plant Physiol. 2005 Jun;138(2):600-610.##Genome Res. 2004 Mar;14(3):406-413.	Kaneko T, Kotani H, Nakamura Y, Sato S, Asamizu E, Miyajima N, Tabata S.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Castelli V, Aury JM, Jaillon O, Wincker P, Clepet C, Menard M, Cruaud C, Qu©tier F, Scarpelli C, Schächter V, Temple G, Caboche M, Weissenbach J, Salanoubat M.	Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence features of the regions of 1,381,565 bp covered by twenty one physically assigned P1 and TAC clones.##Genome organization of more than 300 defensin-like genes in Arabidopsis.##Whole genome sequence comparisons and full-length cDNA sequences: a combined approach to evaluate and improve Arabidopsis genome annotation.	
DRAMP00566	SDGTSGYGITEATKRCFTPAPCTRGLFYCQTFCSSLSAVLIGVCESGICCCILNQ	55	Defensin-like protein 117 (Plant defensin)	Q2V4G3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147637##15955924##17565583	Plant Biotechnol J. 2006 May;4(3):317-324.##Plant Physiol. 2005 Jun;138(2):600-610.##Plant J. 2007 Jul;51(2):262-280.	Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Silverstein KA, Moskal WA Jr, Wu HC, Underwood BA, Graham MA, Town CD, VandenBosch KA.	Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.##Genome organization of more than 300 defensin-like genes in Arabidopsis.##Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants.	
DRAMP00567	QEMCRDILMKAKNCDEGTCDTLCKQKWKGNGSCFPNVYTYRKSCLCTFPCKT	52	Putative defensin-like protein 118 (Protein LCR52; Plant defensin)	P82766	Belongs to the DEFL family	LCR52	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00568	QEMCRDLLMRAKNCDDSTCATLCKQKWKGNGSCFPNVYRKSCLCTFPCKT	50	Putative defensin-like protein 119 (Protein LCR53; Plant defensin)	P82767	Belongs to the DEFL family	LCR53	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00569	QEMCHDLIKKTDCDDATCVTLCKQKWNGNGGGSCFQIVNLKSCLCAFPCQV	51	Putative defensin-like protein 120 (Protein LCR56; Plant defensin)	P82770	Belongs to the DEFL family	LCR56	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00570	QETCHDLIMKRDCDEATCVNMCQQKWKGSGGSCFQNFNVMSCICNFPCQV	50	Putative defensin-like protein 121 (Protein LCR55; Plant defensin)	P82769	Belongs to the DEFL family	LCR55	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00571	QELCHDYMSGTELCEEDKCVAKCIWMHGTAAKGTCMPKPSKQCVCTYSCNA	51	Defensin-like protein 122 (Protein LCR30; Plant defensin)	P82745	Belongs to the DEFL family	LCR30	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
Tissue specificity: Expressed in flower buds, but not in stems, roots or rosette leaves.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00572	MRPRSRAGDKFMSQGQELCHEYFQLTAPCEKQPCIDMCSSKYKTGKGVCGPAVHQCFCTFSCTV	64	Defensin-like protein 123 (Plant defensin; Uncertain)	Q0WN71	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924##17565583	Plant Physiol. 2005 Jun;138(2):600-610.##Plant J. 2007 Jul;51(2):262-280.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Silverstein KA, Moskal WA Jr, Wu HC, Underwood BA, Graham MA, Town CD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.##Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants.	
DRAMP00573	ANCVNYFEITFPEVCEANWCAAECLKAYKNGKGTCWQKFCQCVYDC	46	Defensin-like protein 124 (Protein LCR16; Plant defensin)	P82731, A0MJV4	Belongs to the DEFL family	LCR16	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147637##15955924##17565583	Plant Biotechnol J. 2006 May;4(3):317-324.##Plant Physiol. 2005 Jun;138(2):600-610.##Plant J. 2007 Jul;51(2):262-280.	Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Silverstein KA, Moskal WA Jr, Wu HC, Underwood BA, Graham MA, Town CD, VandenBosch KA.	Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.##Genome organization of more than 300 defensin-like genes in Arabidopsis.##Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants.	
DRAMP00574	EEKQCYDYLLTPQENCEGLICAHECTMQHGGNGVCVDTTSTVCICTYDCTS	51	Defensin-like protein 125 (Protein LCR54; Plant defensin)	P82768	Belongs to the DEFL family	LCR54	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00575	QHAMCHEILPETDCGAGSCTALCLQLWRGTGKCVRTNDQKLICLCNFECIV	51	Putative defensin-like protein 126 (Protein LCR6; Plant defensin)	P82721	Belongs to the DEFL family	LCR6	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9679202##11437247##15955924	DNA Res. 1998 Apr 30;5(2):131-145.##Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence features of the regions of 1,381,565 bp covered by twenty one physically assigned P1 and TAC clones.##Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence features of the regions of 1,381,565 bp covered by twenty one physically assigned P1 and TAC clones.##Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00576	QNAICQKFLSETDCGAGSCTALCLQLWKGIGKCIKTDDHKLLCLCKYECIV	51	Defensin-like protein 127 (Protein LCR20; Plant defensin)	P82734, Q4VP05, Q4VP06	Belongs to the DEFL family	LCR20	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9679202##11437247##15955924	DNA Res. 1998 Apr 30;5(2):131-145.##Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence features of the regions of 1,381,565 bp covered by twenty one physically assigned P1 and TAC clones.##Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence features of the regions of 1,381,565 bp covered by twenty one physically assigned P1 and TAC clones.##Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00577	QHICHQILLNNNCDGATCTSLCDKQLQGTGQCYKTVDKRFICLCNYLCRT	50	Putative defensin-like protein 128 (Protein LCR8; Plant defensin)	P82723	Belongs to the DEFL family	LCR8	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00578	DTCHEYLYPEKCENNQCNSECATKFKEVGVFGFCVPPRSEPTEQFCICSYNC	52	Putative defensin-like protein 129 (Protein LCR13; Plant defensin)	P82728	Belongs to the DEFL family	LCR13	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00579	SIFIKYSDRTCHVYIKAENCEIDQCNWECGTKYKRVGVQGLCVPPGFDPIDQACLCSFNC	60	Defensin-like protein 130 (Protein LCR28; Plant defensin)	P82743, Q2V320	Belongs to the DEFL family	LCR28	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9679202##11437247##15955924	DNA Res. 1998 Apr 30;5(2):131-145.##Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence features of the regions of 1,381,565 bp covered by twenty one physically assigned P1 and TAC clones.##Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence features of the regions of 1,381,565 bp covered by twenty one physically assigned P1 and TAC clones.##Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00580	HICHDYLEGDHCDPKDCNLDCRDKWKGTGTCEPPTGTPLTRTCYCTYDC	49	Putative defensin-like protein 131 (Protein LCR29; Plant defensin)	P82744	Belongs to the DEFL family	LCR29	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00581	NDEQLRGNRCFQIKFKTGKCVPKECQTACQEKLRKPKLKGEGFCMKECTCCFYT	54	Putative defensin-like protein 133 (Protein LCR33; Plant defensin)	P82748	Belongs to the DEFL family	LCR33	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00582	FSPEDCLDDVGWILICTKPTCKFSCWTSRSVNKGRKMQDYWCSDSNTCHCVFCTGD	56	Putative defensin-like protein 134 (Plant defensin)	P0CAY4	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00583	QRRKCDEKIVLQFCNGRNRCYEYCDTKECVAACKKKRNGEGICNGDVFSVSAQCLCLYKC	60	Putative defensin-like protein 135 (Plant defensin)	Q2V3K1	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00584	NMSVDQKRCWATLKENNCVHDECRSMCLKKNPKGHGRCIKSSKGRIICLCGYDCP	55	Putative defensin-like protein 137 (Protein LCR14; Plant defensin)	P82729	Belongs to the DEFL family	LCR14	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00585	QPLGTMERCYDMLTWGECVPDNCAFSCALKRHGKGGCIKAYDNRPACVCYYTCLRS	56	Putative defensin-like protein 139 (Protein LCR7; Plant defensin)	P82722	Belongs to the DEFL family	LCR7	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00586	QPLEEMVECKEVLWPEECKYDACAFACALKRHGKGGCLEGPDYRSACICQYACKRS	56	Defensin-like protein 140 (Protein LCR15; Plant defensin)	P82730	Belongs to the DEFL family	LCR15	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00587	QQQQQRCEEALTEIDCGAGNCNALCLQKRKGLGRCVQRTPCDKLKCMCYYPCSS	54	Defensin-like protein 141 (Protein LCR3; Plant defensin)	P82718	Belongs to the DEFL family	LCR3	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9679202##11437247##15955924	DNA Res. 1998 Apr 30;5(2):131-145.##Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence features of the regions of 1,381,565 bp covered by twenty one physically assigned P1 and TAC clones.##Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence features of the regions of 1,381,565 bp covered by twenty one physically assigned P1 and TAC clones.##Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00588	EKLTTCSRFLSQKSGKCVKEDCDRMCKQKWPGKYTVGHCYGQFKDAKRCLCSVCGPDRQPP	61	Putative defensin-like protein 142 (Protein LCR34; Plant defensin)	P82749	Belongs to the DEFL family	LCR34	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00589	MVNGQCSFPQPVGPNGKCVPKDCKSLCHKKYKGGSICTTGKPNICMCLVCRRRSPEV	57	Defensin-like protein 144 (Protein LCR10; Plant defensin)	Q8S8H9, A0MJT0, P82725, Q1PF66	Belongs to the DEFL family	LCR10	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147637##15955924##17565583##11437247	Plant Biotechnol J. 2006 May;4(3):317-324.##Plant Physiol. 2005 Jun;138(2):600-610.##Plant J. 2007 Jul;51(2):262-280.##Plant Mol Biol. 2001 May;46(1):17-34.	Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Silverstein KA, Moskal WA Jr, Wu HC, Underwood BA, Graham MA, Town CD, VandenBosch KA.##Vanoosthuyse V, Miege C, Dumas C, Cock JM.	Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.##Genome organization of more than 300 defensin-like genes in Arabidopsis.##Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants.##Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.	
DRAMP00590	NLQQRRQMNQTWCSRPLLTHKQTGKCVIEDCESKCRQKWKGNGTQATCRNQCNCHFRCPWIQGQP	65	Putative defensin-like protein 145 (Protein LCR2; Plant defensin)	P82717	Belongs to the DEFL family	LCR2	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00591	NVQQVKREQCHTVIPNKSGKCIFTECKSACEKLKKPVASLCLPPKTCRCYHFCS	54	Putative defensin-like protein 146 (Protein LCR9; Plant defensin)	P82724	Belongs to the DEFL family	LCR9	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00592	NVQQKRSNRCIDFPVNPKTGLCVLKDCESVCKKTSKGLEGICWKFNAKGKDPKQCKCCGLWPPLY	65	Defensin-like protein 147 (Protein LCR1; Plant defensin)	P82716	Belongs to the DEFL family	LCR1	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00593	NVEQKSQDWCWSIVNKDRCLQKECESLCSKKHPKGKFMCIPSTPGGPFQCHCRHPCR	57	Putative defensin-like protein 148 (Protein LCR4; Plant defensin)	P82719	Belongs to the DEFL family	LCR4	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00594	NEGLGKPKKQCNEILKQSNCVAAECDSMCVKKRGKGAGYCSPSKKCYCYYHCP	53	Defensin-like protein 149 (Protein LCR5; Plant defensin)	Q8S8H3, P82720, Q8LGD4	Belongs to the DEFL family	LCR5	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00595	DVDQGYKQQCYKTIDVNLCVTGECKKMCVRRFKQAAGMCIKSVPSAPAPNRCRCIYHC	58	Putative defensin-like protein 150 (Protein LCR32; Plant defensin)	P82747	Belongs to the DEFL family	LCR32	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00596	QAPSTCFEALKDASKGASCDSELCASLCKKKSGGGVGTCRTKTTQPSKGQPECHCRFWCKSDGTPYK	67	Defensin-like protein 151 (Protein LCR17; Plant defensin)	Q9T0E3, Q6GKX9	Belongs to the DEFL family	LCR17	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00597	KQRLCIKVLTNASHVSKGASTCDSKLCTSLCEKISPQGVSFCKPIATTGQSKKGNPVCNCRYWCRSDGTPHTT	73	Putative defensin-like protein 152 (Protein LCR11; Plant defensin)	P82726	Belongs to the DEFL family	LCR11	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00598	KVPCLSRMFNKNNTCSFLRCEANCARKYKGYGDCRPGDRPHDKKDSLFCFCNYPC	55	Defensin-like protein 153 (Protein LCR31; Plant defensin)	P82746, A0MJV0	Belongs to the DEFL family	LCR31	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00599	VVEKAKGDGSCTIIIDPKAPSCDIIQCRLSCITDYNGLAECIASRIGSPPNCVCTYDC	58	Putative defensin-like protein 154 (Protein LCR35; Plant defensin)	P82750	Belongs to the DEFL family	LCR35	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00600	DKRCSIIIDLSPCYPIECRLSCITERNGDGECVVSKVGSTPNCLCTYDC	49	Defensin-like protein 155 (Protein LCR36; Plant defensin)	P82751	Belongs to the DEFL family	LCR36	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00601	KRHCSTIILPESPCVPQDCVEYCFEEYNGGGTCIASKTGRTTNCMCTYNCHGNNL	55	Defensin-like protein 156 (Protein LCR21; Plant defensin)	P82735	Belongs to the DEFL family	LCR21	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00602	DERCTIIIHPGSPCDPSDCVQYCYAEYNGVGKCIASKPGRSANCMCTYNC	50	Putative defensin-like protein 157 (Protein LCR22; Plant defensin)	Q9M0F3	Belongs to the DEFL family	LCR22	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00603	DQTDKYCTIIIDPRTPCDLVDCRLSCYTGYNGVGKCIASKASRTPNCVCTYNC	53	Putative defensin-like protein 158 (Protein LCR23; Plant defensin)	P82737	Belongs to the DEFL family	LCR23	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00604	KRCHLTIDKATACSLSDCRLSCYSGYNGVGKCFDDPKVAGPSNCGCIYNC	50	Defensin-like protein 159 (Protein LCR25; Plant defensin)	P82739, A0MJW9	Belongs to the DEFL family	LCR25	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00605	DEGKRCHTTIDKGNFCDLVDCRLSCFSGYNGVGKCFDDPKVPGRSNCGCLYNC	53	Putative defensin-like protein 160 (Protein LCR26; Plant defensin)	Q9M0F2	Belongs to the DEFL family	LCR26	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00606	EECRLTIDKATPCHLSDCRLSCYTGYNGVGECFDDPNVPGPDNCGCRYNC	50	Defensin-like protein 161 (Protein LCR27; Plant defensin)	Q9M0F1	Belongs to the DEFL family	LCR27	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00607	GATIKKCVVDVKLSKPCTFQECQPLCLQKYNGNGLCPGDDNNICACVYNC	50	Putative defensin-like protein 162 (Protein LCR37; Plant defensin)	P82752	Belongs to the DEFL family	LCR37	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00608	ADIKRCVVDVKLSKPCTFQECIPLCFQRYNGNGVCTGKKNEICTCAYNC	49	Defensin-like protein 163 (Protein LCR24; Plant defensin)	Q8LFM0, P82738, Q0V821	Belongs to the DEFL family	LCR24	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00609	KQLKTCTSVIKLGHPCDIESCLNECFRVYNTGFATCRGDKYSQLCTCEYNC	51	Defensin-like protein 164 (Protein LCR38; Plant defensin)	P82753	Belongs to the DEFL family	LCR38	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00610	QKRCRQELEPGKQCVLAKCRELCFKQLKGFGSCIEKPPGSSKYTCNCFYNCGPPGFF	57	Putative defensin-like protein 165 (Protein LCR12; Plant defensin)	P82727	Belongs to the DEFL family	LCR12	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00611	LYMCVSSTCVIQWCAIQCKRKEANGIGTCKPRPNQGKIQYRKLKEECHCVYKCS	54	Defensin-like protein 166 (Plant defensin)	P0CAY5	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00612	RNRICRTSEKYYREFCGHAGNDDCLSKSTKKPKPFKCVCHDNRSQNITSINDRYNNCICTFYC	63	Putative defensin-like protein 168 (Plant defensin)	Q2V3Q1	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00613	LMDSMPQRHPVEGWCKRPLPNQKPGPCNNDRCSARCKEQKQFEFKGGKAMGICSSENRCLCTFRCR	66	Putative defensin-like protein 169 (Plant defensin)	Q2V3K0	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00614	NMGCMAVLGSCGVITDCSGSCKTKFGQDASGDCDRDGGQGTCMCGYPCPHDKLHM	55	Putative defensin-like protein 170 (Protein LCR62; Plant defensin)	P82776	Belongs to the DEFL family	LCR62	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00615	NMGCMAVLGSCGVITDCSGECISRFGPQARGYCDRDGGSGTCVCVYPCPADKPHM	55	Defensin-like protein 171 (Protein LCR61; Plant defensin)	P82775, Q4VNZ4	Belongs to the DEFL family	 LCR61 	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00616	NMGCTATMGPCEKDKSCSATCRATFGDRANGFCDYSTSTSPGGECTCVYHCPPVVPHESHL	61	Defensin-like protein 172 (Protein LCR60; Plant defensin)	P82774	Belongs to the DEFL family	LCR60	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00617	NMGCIQIIGRCIKIPDCSASCRKFLGPHASGYCDNDGAGGTCICTYPCQTKEIHM	55	Defensin-like protein 173 (Protein LCR63; Plant defensin)	P82777, Q4VNZ3	Belongs to the DEFL family	LCR63	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00618	NTGCFDYDVYQPCDHCRERCLKYYPVTRKAICRKNHCVCIGPCPNDKAIPNVKLFKNVKEQILS	64	Defensin-like protein 175 (Plant defensin)	Q2V4H7	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00619	NTGCFDYDVYQPCDHCRERCLKYYPVTRKAICRKNHCVCIGPCPDDKAIPDVKLFKNVKEQILS	64	Defensin-like protein 176 (Protein LCR65; Plant defensin)	P82779, A0MJW1	Belongs to the DEFL family	LCR65	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00620	NMGCNDYIVGDVCVHCRERCLRYYPVTRKAECYRNHCLCIGPCPDDRPHKRFQMLNSSKNVKAQILS	67	Defensin-like protein 178 (Protein LCR64; Plant defensin)	P82778, A0MJW0	Belongs to the DEFL family	LCR64	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00621	QTCDENLSSCENCDQRCKAKHGPSSVSKCNGPDGTCGCASFKPAKLCIGATDMCTDKCPTSCCDRQCAIKYKNGKGGCVDYAGYRMCICEYTC	93	Putative defensin-like protein 179 (Protein LCR57; Plant defensin)	P82771	Belongs to the DEFL family	LCR57	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains seven disulfide bonds (By similarity).
Caution: Contains 7 disulfide bonds instead of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00622	SICNDRLGLCDGCDQRCKAKHGPSCESKCDGPVGMLLCTCTYECGPTKLCNGGLGNCGESCNEQCCDRNCAQRYNGGHGYCNTLDDFSLCLCKYPC	96	Defensin-like protein 181 (Protein LCR80; Plant defensin 3.1; Plant defensin)	P82789, A0MJT6, Q1PDQ7	Belongs to the DEFL family	PDF3.1	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Confers broad-spectrum resistance to pathogens. 
PTM: Contains eight disulfide bonds (By similarity).
Caution: Contains 8 disulfide bonds instead of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00623	NTCIEGIGNCQQCDVRCKARHGPAAKGACDSKFQLCTCNYPCGQGPSPPQPKKCYGGAGICSDRCGAQCCNQNCAQKYNQGSGFCDSIGNTSLCKCQYNC	100	Defensin-like protein 183 (Protein LCR19; Plant defensin)	P82733, Q4VNZ2	Belongs to the DEFL family	LCR19	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains eight disulfide bonds (By similarity).
Caution: Contains 8 disulfide bonds instead of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00624	NKKMVGEAKKCDQTWTCEGEDKCREKCLTLHNGVGVCDLYTAPLVPKQCFCHYDC	55	Putative defensin-like protein 184 (Protein LCR18; Plant defensin)	P82732	Belongs to the DEFL family	LCR18	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00625	KTCSDGWTCLGPKEEDKCKENCMAKHKGVGTCNLYTIPEFPAPITYYMCDCMFDC	55	Putative defensin-like protein 185 (Protein LCR39; Plant defensin)	P82754	Belongs to the DEFL family	LCR39	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00626	KTCSDGWTCVGEDKCKVNCMAKHKGVGTCTLYIIPSFPAPITSYICDCMFDC	52	Putative defensin-like protein 186 (Protein LCR40; Plant defensin)	P82755	Belongs to the DEFL family	LCR40	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00627	ENQKMVGEAKQCKTGWACFGEDACKEKCMAKYKGVGTVTYFPFPPETIIIYCECLYDC	58	Putative defensin-like protein 187 (Protein LCR42; Plant defensin)	P82757	Belongs to the DEFL family	LCR42	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Could be the product of a pseudogene. Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00628	ENGIMIGEAKKCSNSWICEGDEKCKEKCMADYKGNGTCYYPSPPSKQHPEFFYPTCWCGFDC	62	Putative defensin-like protein 188 (Protein LCR41; Plant defensin)	P82756	Belongs to the DEFL family	LCR41	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00629	MSNGMPRTVPCIEGRILWNRTLPCSSILCGDHCVPHGYRAGTCDIVNDRAICKCSRCR	58	Putative defensin-like protein 189 (Plant defensin)	Q2V468	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00630	MRMTQKVSCIEGRTLWARPPKFFYCSSTLCEDNCINTGAYRGGTCDMEDEVAICRCHRCKKII	63	Putative defensin-like protein 190 (Plant defensin)	Q2V467	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00631	KKPPCLEGRTAYVSPGPCSNSLCTQDCRPAGYHTGKCKVEWSTPICKCYGCRKV	54	Putative defensin-like protein 191 (Plant defensin)	Q2V466	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00632	YDRKCLKEYGGDVGFSYCAPRIFPTFCDQNCRKNKGAKGGVCRWEENNAIGVKCLCNFCSEEPSDQTLSRI	71	Defensin-like protein 192 (Trypsin inhibitor ATTI-7; Plant defensin)	Q42330, Q9SX84	Belongs to the DEFL family	O22866	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00633	QGSKCLKEYGGNVGFSYCAPRIFPSFCYRNCRKNKGAKGGRCRSGGAGAGSMICLCDYCSDKP	63	Defensin-like protein 193 (Trypsin inhibitor ATTI-2; Plant defensin)	O22866, Q67YC6, Q6ZZT9	Belongs to the DEFL family	ATTI2	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00634	KDKECLKGYIDAPLSYCMARIYPSLCYRNCRFYKGAKGGKCDGLKCFCDFCSDKPF	56	Defensin-like protein 194 (Trypsin inhibitor ATTI-3; Plant defensin)	O22867, B9DGH7, F4IR67, Q6ZZP9, Q6ZZQ4, Q6ZZQ9, Q6ZZR4, Q6ZZR9, Q6ZZT8	Belongs to the DEFL family	ATTI3	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00635	QGNECLKEYGGDVGFGFCAPRIFPTICYTRCRENKGAKGGRCRWGQGSNVKCLCDFCDDTPQ	62	Defensin-like protein 195 (Trypsin inhibitor ATTI-1; diDi 4T-1; Plant defensin)	Q42328, O22865, Q6ZZP6	Belongs to the DEFL family	ATTI1	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	The protein contains one alpha-helix and two strands of antiparallel beta-sheet, with a type IV beta-turn connecting the two strands. The alpha-helix and the inhibitory loop are connected to the beta-sheet through three disulfide bridges; a fourth disulfide bridge connects the N- and C-termini. (Ref.3)	1JXC resolved by NMR.	"Function: Defense response to fungus.
PTM: Contains four disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924##12369816	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.##Biochemistry. 2002 Oct 15;41(41):12284-96.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.##Zhao Q, Chae YK, Markley JL.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.##NMR solution structure of ATTp, an Arabidopsis thaliana trypsin inhibitor.	
DRAMP00636	HDSECLKEYGGDVGFGFCAPKIFPTICYRNCQKDKGANGGKCLWGEGGKVKCLCDFCSNESFNQFISLT	69	Defensin-like protein 196 (Trypsin inhibitor ATTI-4; Plant defensin)	Q8RYE7, Q6ZZS3	Belongs to the DEFL family	ATTI4	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00637	KDDKFICVVEYGGDVGPTFCNPKFFPTLCRQNCRSFKGAKGGKCVKQPKHKHIKCFCDYCKDD	63	Defensin-like protein 197 (Trypsin inhibitor ATTI-6; Plant defensin)	O22869, F4IR70, Q6ZZS7, Q6ZZU1, Q8GWN0	Belongs to the DEFL family	ATTI6	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity).
Caution: Was initially thought (PubMed:15082560) to be a protease inhibitor."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00638	RTTTSGYGMLFDSVACEGGFEYCPRGGGNDKCTTFCRSLPNKYDFGVCDKIYACCCHINV	60	Defensin-like protein 199 (Plant defensin)	Q2V4G5	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00639	RETRMMEQTCPVFWPMVPCDANKCEQMCRDYYGSVPSYCNRIGTPIAECACSLTPC	56	Defensin-like protein 201 (Plant defensin)	Q2V4N2	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00640	KTCKLFRGECPVDPCEPEKCDECCKATFGKQICGKCEQESTELHCHCRR	49	Putative defensin-like protein 202 (Plant defensin)	Q2V3J6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00641	QTCFKGEAQEGVCVKVDGSKLCDLLCRATNTTWFGACEVEDNETHCHCYGPC	52	Putative defensin-like protein 203 (Plant defensin)	Q2V424	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00642	HCDHFLGEAPVYPCKEKACKSVCKEHYHHACKGECEYHGREVHCHCYGDYH	51	Defensin-like protein 204 (Plant defensin)	Q56XB0	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found	7JN6	"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00643	NCDTYLGEVTVYYPCRERDCEAQCYEHYPHSCKGECEHHDHVVHHDNEEEHCHCYGR	57	Defensin-like protein 205 (His-rich; Plant defensin)	Q9M9M3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00644	ACFTFLGECGPEPFTGSNADCLACCVALYKSPPVCAGRVEGVPAHCHCYKS	51	Defensin-like protein 206 (Plant defensin)	Q94JR6, Q9M1Y2	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP18327	ESISVAGGTWNYGYGVGQAYSHYKHDYNNHGAKVVNSNNGVKDYKNAGPGVWAKASIGTVWDPATFYYNPTGFYSN	76	Sil(Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	Not found	Streptococcus iniae SF1	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		SIL is secreted by S. iniae into the extracellular milieu. Although it displayed antibacterial activity against B. subtilis, SIL showed no effect on 22 other Gram+ and Gram- bacteria tested. It can attach to the B. subtilis surface without killing (bacteriostatic). Activity is lost by heating at 50oC (heat-sensitive). SIL may serve as a virulent factor for infection. This dual role as antimicrobial and immune modulator suggests that a good understanding of the functions of an AMP is essential.  	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24781647	PLoS One. 2014 Apr 29;9(4):e96222.	Li MF, Zhang BC, Li J, Sun L.	Sil: a Streptococcus iniae bacteriocin with dual role as an antimicrobial and an immunomodulator that inhibits innate immune response and promotes S. iniae infection.	
DRAMP00646	ACFKFLGECGAVPFPGTNADCTSCCVGNFGSAVCAGRVEVEGGVKHCHCYGTS	53	Defensin-like protein 208 (Plant defensin)	Q2V2Q8	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00647	IITKTMNSKETIYLDNPAVSPSIDQNLVDIHLGHSFVQGVMSFCYDCGKACFRRGKNLARCQKFVCRCTISKLR	74	Defensin-like protein 209 (Plant defensin)	Q2V3K2	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00648	IITKTMNSKETTYLDSPAVSPSIDQYLVDIHLGHSFLQGVMSFCYDCGKACFRRGKNLARCKKFVCRCTKSGIK	74	Defensin-like protein 210 (Plant defensin)	Q2V3K4	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00649	IVMKSSNSKERTYPVTPALNPLTGQHSLRQRQLIFCDECANACFRRKKPVRSCQRFICRCAIRDVGY	67	Putative defensin-like protein 211 (Plant defensin)	Q2V3K7	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00650	VLINGSSDEERTYSFSPRASPFDPRSLNQELKIGRIGYCFDCARACMRRGKYIRTCSFERKLCRYSISDIK	71	Defensin-like protein 212 (Plant defensin)	A8MRC6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains two disulfide bonds (By similarity).
Caution: Could be the product of a pseudogene. Lacks 2 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00651	TLINGSSDEERTYSFSPTTSPFDPRSLNQELKIGRIGYCFDCARACMRRGKYIRTCSFERKLCRCSISDIK	71	Defensin-like protein 213 (Plant defensin)	Q4VP08, Q9LSW1	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00652	ILINESSDEERTYSFSPTTSPFDPRSLNQELKIGRIGYCFDCARACMRRGKYIRTCSFERKLCRCSISGIK	71	Defensin-like protein 214 (Plant defensin)	Q4VP10	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00653	ILINESSDEQRIYSFSPTTSPFDPRSLNQELKIGRIGYCFDCARACMRRGKYIRTCSFERKLCRCSISGIK	71	Defensin-like protein 215 (Plant defensin)	Q4VP07	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00654	ILINESSDEQRIYSFSPTTSPFDPRSLNQELKIGRIGYCFDCARACMRRGKYIRTCSFERKLCRCSISDIK	71	Defensin-like protein 216 (Plant defensin)	P0CAY6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00655	ILIKESSEEERIYPFNPVASPFDPRSLNQILKIGKIGYCFDCARACMRRDRYIRTCSFERKLCRCSYSHIHHTHG	75	Defensin-like protein 217 (Plant defensin)	Q4VP09	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00656	KNKKVVIIPGPKGERPDIKVVEGPSTVEDDFCYDCVRRCMVKGVGFYFRSCKGFVCRCYYPFMGGYGP	68	Defensin-like protein 218 (Plant defensin)	Q2V370	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00657	FFKKLFLRASNIMIKSISEGKSQFSGPALSPNIDPADEHIGHSPEDMKIIFCQQCAFHCIEKKKNIAHCENSICRCTLEDIL	82	Defensin-like protein 219 (Plant defensin)	Q2V305	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00658	NIMTKSISQVKSQFFSPALSPNVDPADEHIGHSPDDMKIIFCQQCAFHCIEKKKNIGNCENSICRCTLEDIL	72	Defensin-like protein 220 (Plant defensin)	Q2V304	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00659	NIMTKSILEGKTQFSIPSLSSTIDPAYEHIGHFPDDMKIIFCQQCAFHCIEKKKNIPHCENSICRCTLENIL	72	Putative defensin-like protein 221 (Plant defensin)	Q2V306	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00660	TVKSYSEEKTHSFDLTANPPIDLNIVDELPRDEHLGVSHADNVIGFCQECAHHCLQRKRVLGECRWFTCHCSRITIGVGL	80	Defensin-like protein 222 (Plant defensin)	Q2V300	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00661	VVPSSFKRVEGPVTAASADFCYKCSRGCYRRYRRPVFCQGSICRCSSFIDDGY	53	Defensin-like protein 223 (Plant defensin)	Q2V369	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00662	MKKFGCNTTHPFPGKCGNNGKSSWVSDMKKLPSAPKNRDIRCECSDRPSLARGMPGERVCRCDYDC	66	Putative defensin-like protein 225 (Protein SCRL1; SCR-like protein 1; Plant defensin)	P82620	Belongs to the DEFL family	SCRL1	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Could be the product of a pseudogene. Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00663	KTKWGCDMNRPFPGKCGTNGKDTCISDIKKMPGAPKDLVVRCECSQRFVWKGYPPERLCKCQYDC	65	Defensin-like protein 226 (Protein SCRL2; SCR-like protein 2; Plant defensin)	P82621	Belongs to the DEFL family	SCRL2	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00664	IHVEQAGVCEFTGEFPGKCGNNGRKMCVEAMNKKNKGSPGENKKNLRCECFDNPVVILGRPKRICRCRNNC	71	Putative defensin-like protein 227 (Protein SCRL28; SCR-like protein 28; Plant defensin)	P82647	Belongs to the DEFL family	SCRL28	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00665	ANKRCHLNQMFTGKCGNDGNKACLGDFKNKRFRYDLCQCTDATQISPSLPPQRVCNCSRPC	61	Putative defensin-like protein 228 (Protein SCRL3; SCR-like protein 3; Plant defensin)	P82622	Belongs to the DEFL family	SCRL3	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00666	HVREVKSVETKAKRVKKVCEKAQVFEQNCGWDGNKTCIRGFNKIKEYPFHCECGIYDAPNSRRICKCKFPYSPC	74	Defensin-like protein 229 (Protein SCRL27; SCR-like protein 27; Plant defensin)	P82646	Belongs to the DEFL family	SCRL27	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity).
Tissue specificity: Flower buds. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00667	EKLCTTIGDLDGKCSQDGEKLCMRYMTDQSKKKFLSCTCNNVVMLHKYKHYCECQSHCTPKQT	63	Putative defensin-like protein 230 (Protein SCRL24; SCR-like protein 24; Plant defensin)	P82643	Belongs to the DEFL family	SCRL24	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00668	KELCNRIEDIDGNCDFEGEKGCLKFMTNKYKKERHVSCTCTNLYMLHKTKRFCDCKHRCSG	61	Putative defensin-like protein 231 (Protein SCRL25; SCR-like protein 25; Plant defensin)	P82644	Belongs to the DEFL family	SCRL25	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00669	GAPPVECWSEILFSGKCGFHGKKKCYKEMESKLKQRVLKCRCEDVKKDSNTSKDEHYCGCQRENPYECN	69	Defensin-like protein 232 (Protein SCRL23; SCR-like protein 23; Plant defensin)	P82642	Belongs to the DEFL family	SCRL23	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity).
Tissue specificity: Flower buds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00670	GAPPQDCWNLVTFPAKCGIHGKKKCFKEMESKYQQRFLQCTCKNLKPEPKSPKDEHDCTCQRANPYECNS	70	Putative defensin-like protein 233 (Protein SCRL22; SCR-like protein 22; Plant defensin)	P82641	Belongs to the DEFL family	SCRL22	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity).
Tissue specificity: Expressed at least in stem, root, rosette leaves and flower buds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00671	VLKPMDQCGRKDIFLGGCGSNGSKTCINDFVKKGGVAAKPSSCECDDFGEEHLCRCYVPC	60	Putative defensin-like protein 234 (Protein SCRL14; SCR-like protein 14; Plant defensin)	P82633	Belongs to the DEFL family	SCRL14	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00672	GLDPMAANLRVRKDIFIGGCGRDGNKTCMKDFVKKGGVMNKPISCECDNLGYEHLCRCNFS	61	Putative defensin-like protein 235 (Protein SCRL26; SCR-like protein 26; Plant defensin)	P82645	Belongs to the DEFL family	SCRL26	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: Defense response to fungus.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00673	QGKKKPPCPLGLSANGKCGHDGPKLCFSEMERKFNKDVVKTITHCKCWDDRRNNVDKHRCTCYLKHGFPCTNG	73	Putative defensin-like protein 236 (Protein SCRL20; SCR-like protein 20; Plant defensin)	P82639	Belongs to the DEFL family	SCRL20	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00674	QAKKKRCPIGLHTYGKCGTDRAKFCFSEIESKLSFSKQVLNTISSCRCDDDRQGNKDLYWCQCDRREGRPCPAN	74	Putative defensin-like protein 237 (Protein SCRL21; SCR-like protein 21; Plant defensin)	P82640, F4JMF8	Belongs to the DEFL family	SCRL21	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00675	QVKPTGCQGGQRYRGKCGTNGTKTCVKDMMLPKLFKTKRCDCQDMLGTFKGWHFCTCYSGRPGC	64	Putative defensin-like protein 238 (Protein SCRL16; SCR-like protein 16; Plant defensin)	P82635	Belongs to the DEFL family	SCRL16	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00676	GLIRECDYTMEGYGPCGPNGRSLCLDTFWKTPPSPGLSKNLEGCRCEDRGKRPPIFTGLSHTCRCCWSYGGGSDD	75	Putative defensin-like protein 239 (Protein SCRL17; SCR-like protein 17; Plant defensin)	P82636	Belongs to the DEFL family	SCRL17	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00677	GLVRICNHRIEGYGTCGPNGRKICLDAFWKNQPSPGLSKNLEGCQCEDRRKRPQFKGLSHSCSCCWSYQGNSDE	74	Putative defensin-like protein 240 (Protein SCRL18; SCR-like protein 18; Plant defensin)	P82637	Belongs to the DEFL family	SCRL18	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00678	RTIRICDRKVEGNGTCGPNSNNICLDEFWKNPPSPRLAKSLEGCTCEPRGKRPKFKGLSHVCWCCWSYNSSNPAG	75	Defensin-like protein 241 (Protein SCRL19; SCR-like protein 19; Plant defensin)	P82638	Belongs to the DEFL family	SCRL19	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00679	HEEPKVAPTEELMFAPSNQPRYCRSRQVFDGSCTDRGTPRTTCFLDFLGARSASEMPKNCDCTPQPNNKRLCECSVICTDCCVKN	85	Defensin-like protein 242 (Protein SCRL10; SCR-like protein 10; Plant defensin)	P82629, Q6GKW3	Belongs to the DEFL family	SCRL10	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00680	HLSHEEPMKEPEYCRWTNAFNGTCSDRGNPQTMCFFDFLDAHTARVMPKNCACNDLPGNKRYCECSFVCNS	71	Putative defensin-like protein 243 (Protein SCRL9; SCR-like protein 9; Plant defensin)	P82628	Belongs to the DEFL family	SCRL9	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00681	KELKWCPSKDVFNGSCTDTGSPSYTCFLDLLGSKSASAMPKNCKCTPLPHNRRQCDCFVVCDSN	64	Putative defensin-like protein 244 (Protein SCRL11; SCR-like protein 11; Plant defensin)	P82630	Belongs to the DEFL family	SCRL11	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00682	EESSMNIDAQRRPWCPSKKQVFGGSCGNDGAQQCLNNLLSTWDPSVRLSPVSCNCTPQPNNNILCSCPNMICP	73	Defensin-like protein 245 (Protein SCRL4; SCR-like protein 4; Plant defensin)	P82623, A0MJS7, A7RED2	Belongs to the DEFL family	SCRL4	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity).
Tissue specificity: Flower buds and roots."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00683	EESRMNINAERRPWCPSKIQMFDTNCEVDGAKQCLDLLISTWDPSVRLTRVSCICSDFPYRNMMCSCPNMICP	73	Defensin-like protein 246 (Protein SCRL5; SCR-like protein 5; Plant defensin)	P82624, Q1PFI3, Q5XVH8	Belongs to the DEFL family	SCRL5	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity).
Tissue specificity: Flower buds and stems."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00684	EKLSMDPTRRPWCPSKKQMFGGNCGNDGDSLCLMLLAASWDESLRHSSISCNCTTYPNYKILCSCPNMICP	71	Defensin-like protein 247 (Protein SCRL6; SCR-like protein 6; Plant defensin)	P82625, Q570C5, Q8L952	Belongs to the DEFL family	SCRL6	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00685	EAAGERRQWCPSKQQVFRGSCSDDGGQKCLNDLLWTWNPSVRLSPIYCDCTPKRHNKRLCDCPSMICL	68	Defensin-like protein 249 (Protein SCRL7; SCR-like protein 7; Plant defensin)	P82626, A7RED3	Belongs to the DEFL family	SCRL7	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00686	EKRPWCPTRKQIFDGSCNRTDYTQCFNDLRNTWDDIGDLCPTDCTCTPQPQNKRLCYCRYLPCPST	66	Defensin-like protein 250 (Protein SCRL8; CR-like protein 8; Plant defensin)	P82627	Belongs to the DEFL family	SCRL8	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00687	QRLVPLCKTIGYENPGKCPADGNKFCRRKLDDRYVKYKRCDCQDTKGRKQNHHRCICYMKLPCNQ	65	Putative defensin-like protein 251 (Protein SCRL12; SCR-like protein 12; Plant defensin)	P82631	Belongs to the DEFL family	SCRL12	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00688	QRRKPVCKLTGVLNPGKCPTAIHDASNLCSRKLASPNMTFKRCDCQNTEWRGKDHYQCTCYIKLPCNQ	68	Putative defensin-like protein 252 (Protein SCRL13; SCR-like protein 13; Plant defensin)	P82632	Belongs to the DEFL family	SCRL13	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00689	EVEPVPYCKVITWYDVKCGADGNKTCVDHLIKGHIYDVPVCDCSELTTSGILCTCQHRFPCKEPPPLHRISIRKQIRG	78	Putative defensin-like protein 253 (Protein SCRL15; SCR-like protein 15; Plant defensin)	P82634	Belongs to the DEFL family	SCRL15	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00690	VRHNLAVGDVCATNEECRINCQCDAAYCDLSCNMCVYMLHVMDTIDANIPNQPCISEYQNCGKKTSSLQ	69	Putative defensin-like protein 254 (Plant defensin)	Q2V318	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains two disulfide bonds (By similarity).
Caution: Could be the product of a pseudogene. Lacks 2 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00691	YEDSCSTDEECRRNCLCDVAYCDKSRDKCDYGFMNRVDVRFPKHPYISKNKDGSGR	56	Defensin-like protein 255 (Plant defensin)	Q2V3Q8	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains two disulfide bonds (By similarity).
Caution: Could be the product of a pseudogene. Lacks 2 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00692	VADYCNRDADCKRVCLRPYACNLTRHLCMCHPNDVSSSKQHCIPEHKGFGEGGPPPQRLKLYR	63	Putative defensin-like protein 256 (Plant defensin)	Q2V483	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00693	RELAGVNEIFEIAARSSNNAGTARALQQAPPCKRDVDCSFECPKGGFCNDRLGTCDCF	58	Putative defensin-like protein 257 (Plant defensin)	Q2V3S8	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00694	RELTGAGKKLEVATRSSNYAGTARTLLQARPCQRDVDCNFQCPRIQGGQCNNHHGTCDCF	60	Putative defensin-like protein 258 (Plant defensin)	Q2V3S7	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00695	RKLTGVADVIVEGEAASPQYGIIDENDTLNKSPSCKRDIDCTFQCRRGGFCNLILQKCECL	61	Defensin-like protein 259 (Plant defensin)	Q9LV55, A0MEY0	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00696	IQNSETSVNQNSCMPNEPRCTGCPGGGSGGYRGPPPPCCKNDSDCKAHCPEGGYCSNQCDCVCNLVKVMNNDVRCQVDTDCNMKCSKQGYCKLAS	95	Defensin-like protein 260 (Plant defensin)	Q9LMX3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00697	REMVKAEVNCIGGKCPEGKKNCNCMPPIAHVMDDIRPCNTDGDCYKFCPRECELGTCYCRCDYGCTCTC	69	Putative defensin-like protein 262 (Plant defensin)	Q2V4E0	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00698	REMAKEEVNCIGGHCPDGKKDCNCLPLIAPTMDIYETNESCRTDNECIKYCPKGCKIVDCNFGTCLCEYC	70	Putative defensin-like protein 263 (Plant defensin)	Q2V4D9	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00699	LEGESKVSGQVRDETPHTWYCKYDDNCRENCPGCTITKCNYGVCICSNCYHQQSDLGVESHM	62	Putative defensin-like protein 264 (Plant defensin)	Q2V2W3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00700	SKGEEKTSGELRDVTPQRGGPCSYDNLCHNHCPGCKITQCVNGECVCLICYTPPL	55	Putative defensin-like protein 265 (Plant defensin)	Q2V2W2	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00701	SEQRTRVSEVVREAEIHDGGQCTDDDICNKNCLDCIARQCIFQQCVCSKRFFPPNSQPNLRVKKH	65	Defensin-like protein 267 (Plant defensin)	Q2V354	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00702	IPRGWQEPCFCPSKNPYCDCGDDLQVPTTSVISPKPIIEQCARCERNSQCNKVCPATCKYKVCIFNRTCEFSTCHCYRC	79	Defensin-like protein 268 (Plant defensin)	Q2V4N6, A0MJU3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00703	RMSGDVTIQRGGSCNNDNTCHDTCPGCRITQCIFRQCVCTRCNTPRSSLRIESHM	55	Defensin-like protein 266 (Plant defensin)	Q2V4F0	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00704	RQMQRPQNVECVGGECQPKHPQQYFGSCFRDSDCRNSCFPYCRYQKCHHHECICSLCSSEVAPSPK	66	Defensin-like protein 269 (Plant defensin)	Q2V4F4	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00705	TRIMDDSSDCVFKGPCQRRSDCYERCGLKPPSRAALCQPMGLQGRVCCCL	50	Putative defensin-like protein 270 (Plant defensin)	Q2V2Z3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00706	TRIMDASSDCEFKGPCHKKEDCYDSCGVNKPPFNNAICVPGRDSFQCCCILS	52	Putative defensin-like protein 271 (Plant defensin)	Q2V352	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00707	TREILSAEICGWNDPAVHCKTKEDCFEKCGGRPAKKVFCVRPGDHSYDRLCCCRA	55	Defensin-like protein 272 (Plant defensin)	Q2V2W8	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00708	NSVEKDVMDGPCRLRGTCNNDGDCDKHCHRSTDAAAMDGHCLFDKPTGPVCCCLFD	56	Putative defensin-like protein 274 (Plant defensin)	Q2V2W7	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00709	KIVKRMQVGPSECVYRGRCRDSYECRSRCGPPEFSHETLGLCMFDYDDYEYFCCCTTNY	59	Defensin-like protein 275 (Plant defensin)	Q2V4I9	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00710	SGCNFKGSCRTDDQCKRICRGHGLDPSFQLCVPYSSKGGKCCCLHYEGAPLSSEVI	56	Defensin-like protein 276 (Plant defensin)	Q2V328	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00711	IVCNFEGHCVTSDDCINVCKSGEDPFLCVRSGPHKGMCCCLKTNGSVLE	49	Putative defensin-like protein 277 (Plant defensin)	Q2V329	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00712	ARIQESTNDILKPITCNTNADCAKFCKGPIHNCVYHTCQCVPGNPHCC	48	Defensin-like protein 278 (Plant defensin)	Q2V4F7	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00713	QESKKGILLKPKTCNTNADCAKFCKGPIQNCLYHTCACVPGNPHCC	46	Putative defensin-like protein 279 (Plant defensin)	Q2V4F6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00714	DYKFHVCDPSFDEKDCDFECKEFGHPGGYCRPDRVQPRIRMCYCTDR	47	Putative defensin-like protein 280 (Plant defensin)	Q2V4C4	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00715	TDPVPTPPGLHIPCGKGFTSKECNKYCTGVGYRRGYCAPDEEYPQISSCYCKWRI	55	Defensin-like protein 281 (Plant defensin)	Q2V4C3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00716	NRQCVQAMDCTNVCSHGGLCTKNGKCVCWSPNVVINSGPPCWSDEMCFSTCGGNGGYCNYDIGGCFCQ	68	Putative defensin-like protein 282 (Plant defensin)	Q2V2Y0	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00717	TAARENLHHQCFCESPSKCDCFPTTPTPPTSVNKSRKGGPLCTTDGDCKHFCRPKKGVCNIDFETCICQ	69	Putative defensin-like protein 283 (Plant defensin)	Q2L6T1	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00718	KEDKECNDSKCLPNPSRINLEEGNIKRIDVNHGGICDTYLECGGLACSDYRRACCVNGKCVCRKQGQTLPDCPN	74	Defensin-like protein 285 (Plant defensin)	Q2V315, F4KBR3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00719	LDEPNMDTISKSREYKCKIDLDCSNHIACRHCSYRNCKCDHGTCKCMP	48	Defensin-like protein 286 (Plant defensin)	Q2L6T6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00720	AEEMGKGEVTISLRCKTKTECLKNIACEACVDCRCDKGICKCHGFTAETNNPTV	54	Defensin-like protein 287 (Plant defensin)	Q2V4N4	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00721	KPRGKRPQSNFHAKRIRTVLQTLLVMLCTDYRCDKGLCKCHGFGGEKENPTAAPLTA	57	Putative defensin-like protein 288 (Plant defensin)	Q2V4N5	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00722	DASCLTTKECVVRCSDEDAQCIHGECHCPHLKVDIEPTKAIRCKTDLDCPDPHQCPKYDYYACLNNGECTCISV	74	Defensin-like protein 289 (Plant defensin)	Q2V4I2	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains six disulfide bonds (By similarity).
Caution: Contains 6 disulfide bonds instead of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00723	TSSTLKESLTAEIKPTKVDRCKTDRDCPQSHRCQKDFYYGCVVGECICRAV	51	Defensin-like protein 291 (Plant defensin)	Q2V472	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00724	MLLETDASRNKPSSYIPLCGSDNSCGGLWCPRKGGKYSCISMTCDIQEDCPKLVRCKDSPGPYCMEGFCTC	71	Defensin-like protein 292 (Plant defensin; Uncertain)	P0CAY8	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Could be the product of a pseudogene. Lacks the signal peptide and 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00725	SRNKLSSYIPLCGSNTYCGGLWCPKKGGKYSCISMSCDIQEDCPKLVRCKNSPGPYCMEGFCTC	64	Defensin-like protein 293 (Plant defensin)	Q2V4A3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00726	SKNKSRSDLPLCGFREHCDGLWCPGEGGKYSCINWSCNFIEDCEKRIRCEKTGPCCFDGLCDCTNF	66	Defensin-like protein 294 (Plant defensin)	Q2V4A4	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00727	HNFLPCVITNDCEYHHCSSGTVLCVNRQCHCSRSSTHQTKLDNLKKMDYAKKCKWTKDCDPRMRFTCVSGSYMCFDGLCTCTN	83	Defensin-like protein 295 (Plant defensin)	Q4VNZ6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains six disulfide bonds (By similarity).
Caution: Contains 6 disulfide bonds instead of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00728	ELVLPCKTTYDCVNLPCLGRPPLCINGQCKCTTTLTHQAKLDNLRTMNDAKTCKYTSDCDPRMRYSCVSGSYICLNGFCTCT	82	Defensin-like protein 296 (Plant defensin)	Q4VNZ5	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains six disulfide bonds (By similarity).
Caution: Contains 6 disulfide bonds instead of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00729	QLIVPCKTSEQCKSIRCSNGSAQCVNKQCQCPSLKQIYSVTDVSCKTVSDCVASHQCPTGLSACIEGKCICLP	73	Putative defensin-like protein 298 (Plant defensin)	Q2V459	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains six disulfide bonds (By similarity).
Caution: Contains 6 disulfide bonds instead of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00730	QFRCKSVAECDSRGCRVGTHVICNEHHICTCAHGSPIGGQCDGVEDCDLSGCPPNSHVICDRIGGNFCTCVPN	73	Defensin-like protein 301 (Plant defensin)	Q3E715	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains six disulfide bonds (By similarity).
Caution: Contains 6 disulfide bonds instead of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00731	MLRFVLVYIPVSVVSHTLCISLFIICSTRHTCFSKRYTCLLNICFCFFISSRIRNYF	57	Defensin-like protein 302 (Plant defensin)	Q2V3W5	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Could be the product of a pseudogene. Lacks the signal peptide and 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00732	RCYTNDDCKDGQPCPVPLACLFGSCICPWKSQSKLPICQIICANLD	46	Putative defensin-like protein 303 (Plant defensin)	Q2V311	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00733	VRLTENMCFKDDDCINQGEWCPVLRVCSYAECICPWGTRSKLPSCQIICAHLDKKSVNSYNPCGCNYK	68	Putative defensin-like protein 304 (Plant defensin)	Q2V309	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00734	KTNFDCVNLKCPTPFVTPKCVSGGCECPLKELLTLLSDTNYGVAACIDYCKAKGENAYTCILNHCYCRKPSM	72	Putative defensin-like protein 305 (Plant defensin)	Q2V493	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00735	QSCNNDSDCTNLKCATKNIKCEQNKCQCLDERYIRAISLNTRSPRCNVQSCIDHCKAIGEVIYVCFTYHCYCRKPPM	77	Defensin-like protein 306 (Plant defensin)	Q2V3H6	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00736	RTGYVSCKTNSDCVKLKCPTPFGGPKCISGSCECPFKELMTLPNDTNYGVAACIDYCKAKGEIVYACILNHCYSYKPPM	79	Putative defensin-like protein 307 (Plant defensin)	Q2V3H5	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00737	MIMGVSYHENRCHDWVDCAIWCKQWVPQPKCINRVCDCKPKSLPTNDEIPKSASSSSKN	59	Defensin-like protein 308 (Plant defensin)	Q4VP04	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00738	MIMGVHYHEYRCHDWVDCAIWCKQWVPQPKCINRVCDCKPKSLPTNEEVPQSAYSSNSNY	60	Putative defensin-like protein 309 (Plant defensin)	Q2V310	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00739	DICQTDRDCVEIGIPRCKRTGKMPICYNGYCCCICSAKRLPASTTRKPPSPSTSKLV	57	Defensin-like protein 311 (Plant defensin)	Q2V3X3	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00740	QSPLSQSSHEFTVVSPYLSCFGIEECLFYLYFKLYDLCVILLCTWFDLSE	50	Putative defensin-like protein 312 (Plant defensin)	Q2V3K9	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		Caution: Could be the product of a pseudogene. Lacks 3 of the 4 disulfide bonds, which are conserved features of the family.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00741	HVCLMSFGSSYRVGVHITHEKVAACPRQNQRLYSCDSLRILYHYSCLTTRDLLYICDCSDFENIICLIRLLLNLDFVEVKLV	82	Defensin-like protein 316 (Plant defensin)	Q2V4J8	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00742	FKIHEVPEPTGKWCGYSVPMKPCINDDRVKRCIAENTHGWLMATGMCTSIPSLKDCYCMHQCP	63	Putative defensin-like protein 317 (Plant defensin)	Q2V3Y5	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00743	DCKHPVGPYTDSCFTDCVSGKYGYNYESAFCSRDETGTCKICCCELINE	49	Defensin-like protein 313 (Plant defensin)	Q3E8K0, Q1PDQ0	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Homology	Not found	Not found		"Function: May have antifungal activity.
PTM: Contains three disulfide bonds (By similarity).
Caution: Lacks 1 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11437247##15955924	Plant Mol Biol. 2001 May;46(1):17-34.##Plant Physiol. 2005 Jun;138(2):600-610.	Vanoosthuyse V, Miege C, Dumas C, Cock JM.##Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Two large Arabidopsis thaliana gene families are homologous to the Brassica gene superfamily that encodes pollen coat proteins and the male component of the self-incompatibility response.##Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00744	MYLSSRTGSRLLFLVKASFNTFEKVATISSTLIYFVSHKLVSSRSCSHNFRNICGYIRHNCRKCIRFCFCTFSIKISLPLVIARRIEY	88	Putative defensin-like protein 315 (Plant defensin)	Q2V3R5	Belongs to the DEFL family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Not found	Not found	Not found		"PTM: Contains two disulfide bonds (By similarity).
Caution: Could be the product of a pseudogene. Lacks the signal peptide and 2 of the 4 disulfide bonds, which are conserved features of the family."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15955924	Plant Physiol. 2005 Jun;138(2):600-610.	Silverstein KA, Graham MA, Paape TD, VandenBosch KA.	Genome organization of more than 300 defensin-like genes in Arabidopsis.	
DRAMP00745	GTCKAECPTWEGICINKAPCVKCCKAQPEKFTDGHCSKILRRCLCTKPC	49	Floral defensin-like protein 2 (PhD2; Plant defensin)	Q8H6Q0	Belongs to the DEFL family	D2	Petunia hybrida (Petunia)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Plant defense peptide with antifungal activity against F. oxysporum and Botrytis cinerea.
Tissue specificity: Petals.
Domain: The presence of a 'disulfide through disulfide knot' structurally defines this protein as a knottin (By similarity).
Biophysicochemical properties: pH dependence (Stable under extremes of pH); Temperature dependence (Stable under extremes of temperature).
PTM: Contains five disulfide bonds 3-49; 7-23; 14-36; 20-43; 24-45 (By similarity)."	Fungi: Fusarium oxysporum (86% inhibition at 10 µg/ml), Botrytis cinerea (41% inhibition at 10 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12644678	Plant Physiol. 2003 Mar;131(3):1283-1293.	Lay FT, Brugliera F, Anderson MA.	Isolation and properties of floral defensins from ornamental tobacco and petunia.	
DRAMP00746	RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC	47	Flower-specific defensin (NaD1; Plant defensin)	Q8GTM0	Belongs to the DEFL family	D1	Nicotiana alata (Winged tobacco) (Persian tobacco)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Combine helix and strand structure	NaD1 adopts the cysteine-stabilized αβ (CSαβ) motif formed by a triple-stranded antiparallel β-sheet and a single α-helix that is tethered to the sheet via three disulfide bonds. The fourth disulfide bond reinforces the N- and C-terminal regions of the molecule. 	4AAZ, 4AB0 resolved by X-ray.	"Function: NaD1 is a member of a family of cationic peptides that displays growth inhibitory activity against several filamentous fungi, including Fusarium oxysporum.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43.
Tissue specificity: Most abundant in the epidermal cell layers of the petals and sepals, within the connective cells of the anthers, and the cortical cells of the style. Not detected in the tapetum, pollen mother cells, the transmitting tissue, the vascular bundles of the anther and style or in leaves. Expressed also in ovaries, but barley detectable in roots.
Biophysicochemical properties: pH dependence (Stable under extremes of pH); Temperature dependence (Stable under extremes of temperature."	Fungi: Fusarium oxysporum f. sp. Vasinfectum (IC50=1 µM), Thielaviopsis basicola (IC50=0.80 µM), Verticillium dahliae (IC50=0.75 µM), Leptosphaeria maculans (IC50=0.80 µM), Aspergillus nidulans (IC50=0.80 µM), Candida albicans (IC50>10 µM), Pichia pastoris (IC50>10 µM), Saccharomyces cerevisiae (IC50>10 µM).##Gram-negative bacteria: Escherichia coli (IC50>10 µM), Pseudomonas aeruginosa (IC50>10 µM);##Gram-positive bacteria: Staphylococcus aureus (IC50>10 µM), Bacillus cereus (IC50>10 µM).##HeLa cells (IC50>10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12644678##12473460##22511788##18339623	Plant Physiol. 2003 Mar;131(3):1283-1293.##J Mol Biol. 2003 Jan 3;325(1):175-188.##J Biol Chem. 2012 Jun 8;287(24):19961-72.##J Biol Chem. 2008 May 23;283(21):14445-52.	Lay FT, Brugliera F, Anderson MA.##Lay FT, Schirra HJ, Scanlon MJ, Anderson MA, Craik DJ.##Lay FT, Mills GD, Poon IK, Cowieson NP, Kirby N, Baxter AA, van der Weerden NL, Dogovski C, Perugini MA, Anderson MA, Kvansakul M, Hulett MD.##van der Weerden NL, Lay FT, Anderson MA.	Isolation and properties of floral defensins from ornamental tobacco and petunia.##The three-dimensional solution structure of NaD1, a new floral defensin from Nicotiana alata and its application to a homology model of the crop defense protein alfAFP.##Dimerization of plant defensin NaD1 enhances its antifungal activity.##The plant defensin, NaD1, enters the cytoplasm of Fusarium oxysporum hyphae.	
DRAMP00747	RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKLLRRCLCTKPCVFDEKMIKTGAETLVEEAKTLAAALLEEEIMDN	80	Defensin-like protein (Flower-specific gamma-thionin; Plant defensin)	P32026	Belongs to the DEFL family	FST	Nicotiana tabacum (Common tobacco)	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	Not found	1MR4 resolved by NMR.	"Function: Involved in floral organogenesis. May play a protective role in flowers by protecting the reproductive organs from potential pathogen attack.
Tissue specificity: Found in petals, stamen and pistils, but not in sepals. In particular, accumulation in a configuration surrounding the inner reproductive whorls.
Developmental stage: Accumulates in developing flowers and its level drops as flowers mature.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43."	Fungi: Fusarium oxysporum and Botrytis cinerea.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1495489##12473460	Mol Gen Genet. 1992 Jul;234(1):89-96.##J Mol Biol. 2003 Jan 3;325(1):175-188.	Gu Q, Kawata EE, Morse MJ, Wu HM, Cheung AY.##Lay FT, Schirra HJ, Scanlon MJ, Anderson MA, Craik DJ.	A flower-specific cDNA encoding a novel thionin in tobacco.##The three-dimensional solution structure of NaD1, a new floral defensin from Nicotiana alata and its application to a homology model of the crop defense protein alfAFP.	
DRAMP00748	QDKCKKVYENYPVSKCQLANQCNYDCKLDKHARSGECFYDEKRNLQCICDYCEY	54	Defensin-like protein(Brazzein; Plants)	P56552	Belongs to the DEFL family	Not found	Pentadiplandra brazzeana	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Combine helix and strand structure	The brazzein fold, which contains one alpha-helix and three strands of antiparallel beta-sheet.	1BRZ resolved by NMR.##4HE7 resolved by X-ray.	"Function: Taste-modifying protein; sweet-tasting. It is 2000 sweeter than sucrose on a molar basis. Has a pH-specific antimicrobial activity against bacteria and fungi. 
PTM: Contains four disulfide bonds 4-52; 16-37; 22-47; 26-49."	Gram-positive bacteria: Bacillus subtilis, Staphylococcus aureus.##Gram-positive bacterium: Escherichia coli.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15118082##9628478	Proc Natl Acad Sci U S A. 2004 May 11;101(19):7363-7368.##Nat Struct Biol. 1998 Jun;5(6):427-431.	Yount NY, Yeaman MR.##Caldwell JE, Abildgaard F, Dzakula Z, Ming D, Hellekant G, Markley JL.	Multidimensional signatures in antimicrobial peptides.##Solution structure of the thermostable sweet-tasting protein brazzein.	
DRAMP00749	ELCEKASKTWSGNCGNTGHCDNQCKSWEGAAHGACHVRNGKHMCFCYFNC	50	Defensin-like protein 1 (Dm-AMP1; Plant defensin)	P0C8Y4	Belongs to the DEFL family	Not found	Dahlia merckii (Bedding dahlia)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Bridge	Not found		"Function: Possesses antimicrobial activity sensitive to inorganic cations. Has no inhibitory effect on insect gut alpha-amylase. Induces potential changes in fungal membranes and increased K+ efflux and Ca2+ uptake. Interacts with sphingolipids and ergosterols found in fungal plasma membranes. 
Biotechnological use: DmAMP1 expression in heterologous plants such as rice or papaya may provide a broad-spectrum disease resistance.
PTM: Problely contains four disulfide bonds 3-50;14-35;20-44;24-46."	Gram-positive bacterium: Bacillus subtilis (IC50=150 µg/mL).##Medium A: Botrytis cinerea (IC50=12 µg/ml), Cladosporium sphaerospermum (IC50=3 µg/ml), Fusarium culmorum (IC50=5 µg/ml), Leptosphaeria maculans (IC50=1.5 µg/ml), Penicillium digitatum (IC50=2 µg/ml), Trichoderma viride (IC50>100 µg/ml), Septoria tritiei (IC50=1 µg/ml), Verticilium albo-atrum (IC50=4 µg/ml). NOTE: Medium B = 1/2 strength potato dextrose broth.##Medium B: Botrytis cinerea (IC50>100 µg/ml), Cladosporium sphaerospermum (IC50=12 µg/ml), Fusarium culmorum (IC50=8 µg/ml), Leptosphaeria maculans (IC50=15 µg/ml), Penicillium digitatum (IC50=70 µg/ml), Trichoderma viride (IC50>100 µg/ml), Septoria tritiei (IC50=4 µg/ml), Verticilium albo-atrum (IC50>100 µg/ml).##NOTE: Medium B = Medium A supplemented with 1 mM CaCl2 and 50 mM KCI.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	cell membrabce	13129623##7628617##8663029##17216480	FEMS Microbiol Lett. 2003 Sep 12;226(1):169-173.##FEBS Lett. 1995 Jul 17;368(2):257-262.##Plant Physiol. 2002 Apr;128(4):1346-1358.##J Biol Chem. 1996 Jun 21;271(25):15018-15025.##Planta. 2007 Jun;226(1):87-97	Thevissen K, Fran§ois IE, Takemoto JY, Ferket KK, Meert EM, Cammue BP.##Osborn RW, De Samblanx GW, Thevissen K, Goderis I, Torrekens S, Van Leuven F, Attenborough S, Rees SB, Broekaert WF.##Fran§ois IE, De Bolle MF, Dwyer G, Goderis IJ, Woutors PF, Verhaert PD, Proost P, Schaaper WM, Cammue BP, Broekaert WF.##Thevissen K, Ghazi A, De Samblanx GW, Brownlee C, Osborn RW, Broekaert WF.##Zhu YJ, Agbayani R, Moore PH.	DmAMP1, an antifungal plant defensin from dahlia (Dahlia merckii), interacts with sphingolipids from Saccharomyces cerevisiae.##Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae.##Fungal membrane responses induced by plant defensins and thionins.##Ectopic expression of Dahlia merckii defensin DmAMP1 improves papaya resistance to Phytophthora palmivora by reducing pathogen vigor.	
DRAMP00750	EVCEKASKTWSGNCGNTGHC	20	Defensin-like protein 2 (Dm-AMP2; Plant defensin)	No entry found	Belongs to the DEFL family	Not found	Dahlia merckii (Bedding dahlia)	Antimicrobial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Medium A: Botrytis cinerea (IC50=10 µg/ml), Cladosporium sphaerospermum (IC50=3 µg/ml), Fusarium culmorum (IC50=5 µg/ml), Leptosphaeria maculans (IC50=1 µg/ml), Penicillium digitatum (IC50=2 µg/ml), Trichoderma viride (IC50>100 µg/ml), Septoria tritiei (IC50=1 µg/ml), Verticilium albo-atrum (IC50=2 µg/ml). NOTE: Medium A = 1/2 strength potato dextrose broth.##Medium B: Botrytis cinerea (IC50>100 µg/ml), Cladosporium sphaerospermum (IC50=12 µg/ml), Fusarium culmorum (IC50=12 µg/ml), Leptosphaeria maculans (IC50=20 µg/ml), Penicillium digitatum (IC50=50 µg/ml), Trichoderma viride (IC50>100 µg/ml), Septoria tritiei (IC50=2 µg/ml), Verticilium albo-atrum (IC50>100 µg/ml).##NOTE: Medium B = Medium A supplemented with 1 mM CaCl2 and 50 mM KCI.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	cell membrabce	8422949##7628617	FEBS Lett. 1993 Feb 1;316(3):233-240.##FEBS Lett. 1995 Jul 17;368(2):257-262.	Terras FR, Torrekens S, Van Leuven F, Osborn RW, Vanderleyden J, Cammue BP, Broekaert WF.##Osborn RW, De Samblanx GW, Thevissen K, Goderis I, Torrekens S, Van Leuven F, Attenborough S, Rees SB, Broekaert WF.	A new family of basic cysteine-rich plant antifungal proteins from Brassicaceae species.##Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae.	
DRAMP00751	RMCKTPSAKFKGYCVSSTNCKNVCRTEGFPTGSCDFHITSRKCYCYKPCP	50	Defensin-2 (Plant defensin)	A4L7R8	Belongs to the DEFL family	Def2	Pinus sylvestris (Scots pine)	Antimicrobial, Antifungal	Homology	Not found	Not found	7LNS	"Function: Plant defense peptide. Has antifungal activity.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19253756	Tsitol Genet. 2008 Nov-Dec;42(6):55-60.	Koval'ova VA, Hut RT.	Molecular cloning and characterization of Scotch pine Defensin-2.	
DRAMP00752	RMCKTPSGKFKGYCVNNTNCKNVCRTEGFPTGSCDFHVAGRKCYCYKPCP	50	PsDef1 (P. sylvestris defensin 1, p1; Plant defensin)	A4L7R7	Belongs to the DEFL family	Def1	Pinus sylvestris (Scots pine)	Antimicrobial, Antifungal	Protein level	Not found	Not found	5NCE	"Function: Plant defense peptide. Has antifungal activity.
PTM: Contains four disulfide bonds (By similarity)."	Fungi: Botrytis cinerea (IC50=0.4 µg/ml), Fusarium oxysporum (IC50=2.9 µg/ml), Fusarium solani (IC50=0.9 µg/ml), Heterobasidion annosum (IC50=1.4 µg/ml), Candida albicans and Trichoderma reesei.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19683554	Peptides. 2009 Dec;30(12):2136-2143.	Kovaleva V, Kiyamova R, Cramer R, Krynytskyy H, Gout I, Filonenko V, Gout R.	Purification and molecular cloning of antimicrobial peptides from Scots pine seedlings.	
DRAMP00753	ATKVKAKQRGKEKVSSGRPGQHN	23	Elicitor peptide 1 (AtPep1; Plant defensin)	Q9LV87, Q8LCK9	Belongs to the brassicaceae elicitor peptide family	PEP1	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Protein level	Not found	Sequential removal of N-terminal amino acids has little effect on activity. Activity is completely abolished when nine C-terminal amino acids remained. Removal of the C-terminal asparagine from AtPep1(9-23), resultes in a decrease in activity (12 max approximately 100 nM).		"Function: Elicitor of plant defense. Induces the production of plant defensin (PDF1.2) and of H2O2. Promotes resistance to the root fungal pathogen P. irregulare.
Subunit structure: Interacts with its receptor PEPR1.
Induction: By wounding, methyl jasmonate (MeJA), ethylene. The expression of the peptide PEP1 precursor is induced by the mature peptide PEP1."	Pythium irregulare	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16785434##16785433##18824048	Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10098-103.##Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10104-9.##Peptides. 2008 Dec;29(12):2083-9.	Huffaker A, Pearce G, Ryan CA.##The cell surface leucine-rich repeat receptor for AtPep1, an endogenous peptide elicitor in Arabidopsis, is functional in transgenic tobacco cells.##Pearce G, Yamaguchi Y, Munske G, Ryan CA.	An endogenous peptide signal in Arabidopsis activates components of the innate immune response.##The cell surface leucine-rich repeat receptor for AtPep1, an endogenous peptide elicitor in Arabidopsis, is functional in transgenic tobacco cells.##Structure-activity studies of AtPep1, a plant peptide signal involved in the innate immune response.	
DRAMP00754	DNKAKSKKRDKEKPSSGRPGQTNSVPNAAIQVYKED	36	Elicitor peptide 2 (AtPep2; Plant defensin)	Q9LV88, Q8L902	Belongs to the brassicaceae elicitor peptide family	PEP2	Arabidopsis thaliana (Mouse-ear cress)	Not found	Homology	Not found	Not found		Function: Elicitor of plant defense (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16785434##10718197	Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10098-103.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.	Huffaker A, Pearce G, Ryan CA.##Sato S, Nakamura Y, Kaneko T, Katoh T, Asamizu E, Kotani H, Tabata S.	An endogenous peptide signal in Arabidopsis activates components of the innate immune response.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.	
DRAMP00755	EIKARGKNKTKPTPSSGKGGKHN	23	Elicitor peptide 3 (AtPep3; Plant defensin)	Q8LAX3	Belongs to the brassicaceae elicitor peptide family	PEP3	Arabidopsis thaliana (Mouse-ear cress)	Not found	Homology	Not found	Not found		Function: Elicitor of plant defense (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16785434##10718197	Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10098-103.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.	Huffaker A, Pearce G, Ryan CA.##Sato S, Nakamura Y, Kaneko T, Katoh T, Asamizu E, Kotani H, Tabata S.	An endogenous peptide signal in Arabidopsis activates components of the innate immune response.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.	
DRAMP00756	GLPGKKNVLKKSRESSGKPGGTNKKPF	27	Elicitor peptide 4 (AtPep4; Plant defensin)	Q9FIA9, Q8L9J1	Belongs to the brassicaceae elicitor peptide family	PEP4	Arabidopsis thaliana (Mouse-ear cress)	Not found	Homology	Not found	Not found		Function: Elicitor of plant defense (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16785434##10718197	Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10098-103.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.	Huffaker A, Pearce G, Ryan CA.##Sato S, Nakamura Y, Kaneko T, Katoh T, Asamizu E, Kotani H, Tabata S.	An endogenous peptide signal in Arabidopsis activates components of the innate immune response.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.	
DRAMP00757	SLNVMRKGIRKQPVSSGKRGGVNDYDM	27	Elicitor peptide 5 (AtPep5; Plant defensin)	Q8LD63, Q9FIA8	Belongs to the brassicaceae elicitor peptide family	PEP5	Arabidopsis thaliana (Mouse-ear cress)	Not found	Homology	Not found	Not found		Function: Elicitor of plant defense (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16785434##10718197	Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10098-103.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.	Huffaker A, Pearce G, Ryan CA.##Sato S, Nakamura Y, Kaneko T, Katoh T, Asamizu E, Kotani H, Tabata S.	An endogenous peptide signal in Arabidopsis activates components of the innate immune response.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.	
DRAMP00758	ITAVLRRRPRPPPYSSGRPGQNN	23	Elicitor peptide 6 (AtPep6; Plant defensin)	Q9SIZ9	Belongs to the brassicaceae elicitor peptide family	PEP6	Arabidopsis thaliana (Mouse-ear cress)	Not found	Homology	Not found	Not found		Function: Elicitor of plant defense (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16785434##10718197	Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10098-103.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.	Huffaker A, Pearce G, Ryan CA.##Sato S, Nakamura Y, Kaneko T, Katoh T, Asamizu E, Kotani H, Tabata S.	An endogenous peptide signal in Arabidopsis activates components of the innate immune response.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.	
DRAMP00759	VSGNVAARKGKQQTSSGKGGGTN	23	Elicitor peptide 7 (AtPep7; Plant defensin)	P0C1T5, Q1G3G0	Belongs to the brassicaceae elicitor peptide family	PEP7	Arabidopsis thaliana (Mouse-ear cress)	Not found	Homology	Not found	Not found		Function: Elicitor of plant defense (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16785434##10718197##17147637	Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10098-103.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.##Plan	Huffaker A, Pearce G, Ryan CA.##Sato S, Nakamura Y, Kaneko T, Katoh T, Asamizu E, Kotani H, Tabata S.##Underwood BA, Vanderhaeghen R, Whitford R, Town CD, Hilson P.	An endogenous peptide signal in Arabidopsis activates components of the innate immune response.##Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence features of the regions of 3,076,755 bp covered by sixty P1 and TAC clones.##Simultaneous high-throughput recombinational cloning of open reading frames in closed and open configurations.	
DRAMP00760	RECKAQGRHGTCFRDANCVQVCEKQAGWSHGDCRAQFKCKCIFEC	45	NmDef02 (Plants)	No entry found	Belongs to the defensin family	Not found	Nicotiana megalosiphon	Antimicrobial, Antifungal	Not found	Not found	Not found		Transgenic plants: Constitutive expression of NmDef02 gene in transgenic tobacco and potato plants enhanced resistance against various plant microbial pathogens, including the oomycete Phytophthora infestans, causal agent of the economically important pot	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20626828	Plant Biotechnol J. 2010 Aug;8(6):678-690.	Portieles R, Ayra C, Gonzalez E, Gallo A, Rodriguez R, Chac³n O, L³pez Y, Rodriguez M, Castillo J, Pujol M, Enriquez G, Borroto C, Trujillo L, Thomma BP, Borr¡s-Hidalgo O.	NmDef02, a novel antimicrobial gene isolated from Nicotiana megalosiphon confers high-level pathogen resistance under greenhouse and field conditions.	
DRAMP00762	GLPVCGETCFGGTCNTPGCTCDPWPVCTRN	30	Vaby D (Plant defensin)	No entry found	Not found	Not found	Viola abyssinica (Ethiopian highlands)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Not found	Bridge	Not found		PTM: Contains three disulfide bonds	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21434649	J Nat Prod. 2011 Apr 25;74(4):727-731.	Yeshak MY, Burman R, Asres K, Göransson U.	Cyclotides from an extreme habitat: characterization of cyclic peptides from Viola abyssinica of the Ethiopian highlands.	
DRAMP00763	GLPVCGETCAGGTCNTPGCSCSWPICTRN	29	Vaby A (Plant defensin)	No entry found	Not found	Not found	Viola abyssinica (Ethiopian highlands)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Not found	Bridge	Not found		PTM: Contains three disulfide bonds	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21434649	J Nat Prod. 2011 Apr 25;74(4):727-731.	Yeshak MY, Burman R, Asres K, Göransson U.	Cyclotides from an extreme habitat: characterization of cyclic peptides from Viola abyssinica of the Ethiopian highlands.	
DRAMP00767	GDACGETCFTGICFTAGCSCNPWPTCTRN	29	ChaC1 (Chassatide C1; Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Chassalia chartacea	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Not found	Not found	Not found		IC50=9.8 µM, HD50=51.9 µM.##Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).	Gram-negative bacterium: Escherichia coli (MIC>80 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 µM), Staphylococcus epidermidis (MIC>80 µM).	[Ref.22467870] HD50=51.9 µM against human type A red blood cells.	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys 4 and Cys18, Cys8 and Cys20,  Cys13 and Cys26 .	L	[Ref.22467870] Cytotoxicity: HeLa cells (IC50=9.8 µM).	Not found	22467870	J Biol Chem. 2012 May 18;287(21):17598-17607.	Nguyen GK, Lim WH, Nguyen PQ, Tam JP.	Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.	
DRAMP00768	GIPCAESCVWIPPCTITALMGCSCKNNVCYNN	32	ChaC2 (Chassatide C2; Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Chassalia chartacea	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Not found	Not found	Not found		IC50=2.4 µM, HD50>25 µM.##Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).	Gram-negative bacterium: Escherichia coli (MIC>80 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 µM), Staphylococcus epidermidis (MIC>80 µM).	[Ref.22467870] HD50>25 µM against human type A red blood cells.	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys 4 and Cys21, Cys8 and Cys23,  Cys13 and Cys28.	L	[Ref.22467870] Cytotoxicity: HeLa cells (IC50=2.4 µM).	Not found	22467870	J Biol Chem. 2012 May 18;287(21):17598-17607.	Nguyen GK, Lim WH, Nguyen PQ, Tam JP.	Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.	
DRAMP00769	GASCGETCFTGICFTAGCSCNPWPTCTRN	29	ChaC4 (Chassatide C4; Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Chassalia chartacea	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Not found	Not found	Not found		IC50=9.8 µM, HD50=51.9 µM.##Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).	Gram-negative bacterium: Escherichia coli (MIC>80 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 µM), Staphylococcus epidermidis (MIC>80 µM).	[Ref.22467870] HD50=51.9 µM against human type A red blood cells.	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys 4 and Cys18, Cys8 and Cys20,  Cys13 and Cys26 .	L	[Ref.22467870] Cytotoxicity: HeLa cells (IC50=9.8 µM).	Not found	22467870	J Biol Chem. 2012 May 18;287(21):17598-17607.	Nguyen GK, Lim WH, Nguyen PQ, Tam JP.	Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.	
DRAMP00770	GEYCGESCYLIPCFTPGCYCVSRQCVNKN	29	ChaC10 (Chassatide C10; Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Chassalia chartacea	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Not found	Not found	Not found		IC50=5.0 µM, HD50>25 µM.##Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).	Gram-negative bacterium: Escherichia coli (MIC>80 µM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 µM), Staphylococcus epidermidis (MIC>80 µM).	[Ref.22467870] HD50>25 µM against human type A red blood cells.	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys 4 and Cys18, Cys8 and Cys20,  Cys13 and Cys25 .	L	[Ref.22467870] Cytotoxicity: HeLa cells (IC50=5.0 µM).	Not found	22467870	J Biol Chem. 2012 May 18;287(21):17598-17607.	Nguyen GK, Lim WH, Nguyen PQ, Tam JP.	Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.	
DRAMP00771	GIACGESCVFLGCFIPGCSCKSKVCYFN	28	Psyle A (Cyclotides; Plants)	No entry found	Belongs to the cyclotide family	Not found	Psychotria leptothyrsa	Antimicrobial, Anti-HIV, Anti-cancer	Not found	Not found	Not found		Function: Cyclotide cytotoxicity on the human lymphoma cell line U-937 GTB (IC50=26 µM).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys I and CysIV, CysII and CysV,  CysIII and CysVI .	L	[Ref.20575512] Cytotoxicity: the human lymphoma cell line U-937 GTB (IC50 = 26 µM).	Not found	20575512	J Nat Prod. 2010 Jul 23;73(7):1207-1213.	Gerlach SL, Burman R, Bohlin L, Mondal D, Göransson U.	Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa.	
DRAMP00772	KLCGETCFKFKCYTPGCSCSYPFCK	25	Psyle C (uncyclotides; Plants)	No entry found	Not found	Not found	Psychotria leptothyrsa	Anti-cancer	Not found	Not found	Not found		Cyclotide cytotoxicity on the human lymphoma cell line U-937 GTB (IC50=3.5 µM).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20575512	J Nat Prod. 2010 Jul 23;73(7):1207-1213.	Gerlach SL, Burman R, Bohlin L, Mondal D, Göransson U.	Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa.	
DRAMP00773	GVIPCGESCVFIPCISSVLGCSCKNKVCYRD	31	Psyle E (Cyclotides; Plants)	No entry found	Belongs to the cyclotide family	Not found	Psychotria leptothyrsa	Anti-cancer	Not found	Not found	Not found		Function: Cyclotide cytotoxicity on the human lymphoma cell line U-937 GTB (IC50=0.76 µM).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys I and CysIV, CysII and CysV,  CysIII and CysVI .	L	[Ref.20575512] Cytotoxicity: the human lymphoma cell line U-937 GTB (IC50=0.76 µM).	Not found	20575512	J Nat Prod. 2010 Jul 23;73(7):1207-1213.	Gerlach SL, Burman R, Bohlin L, Mondal D, Göransson U.	Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa.	
DRAMP00775	GIPCGESCVFIPCLTSAIDCSCKSKVCYRN	30	Mram 8 (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola philippica	Anti-cancer	Not found	Not found	Not found		Function: The novel cyclotides show cytotoxic activity against several cancer cell lines.	Cancer cell lines: BGC-823 (IC50=1.75±0.05 µM), MM96L (IC50=4.91±0.04 µM), HeLa (IC50=15.5±0.06 µM).##Non-cancer cell line: HFF-1 (IC50=3.19±0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21723349	Peptides. 2011 Aug;32(8):1719-1723. 	He W, Chan LY, Zeng G, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola philippica.	
DRAMP00776	GSIPCEGSCVFIPCISAIIGCSCSNKVCYKN	31	Viphi G (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola philippica	Anti-cancer	Not found	Not found	Not found		Function: The novel cyclotides show cytotoxic activity against several cancer cell lines. Note: Activity tested together with Viphi F.	Cancer cell lines: BGC-823 (IC50=2.91±0.06 µM), MM96L (IC50=1.03±0.03 µM), HeLa (IC50=6.35±0.31 µM).##Non-Cancer cell line: HFF-1 (IC50=1.76±0.12 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21723349	Peptides. 2011 Aug;32(8):1719-1723.	He W, Chan LY, Zeng G, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola philippica.	
DRAMP00777	GSIPCGESCVFIPCISAIIGCSCSSKVCYKN	31	Viphi F (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola philippica	Anti-cancer	Not found	Not found	Not found		Function: The novel cyclotides show cytotoxic activity against several cancer cell lines. Note: Activity tested together with Viphi G.	Cancer cell lines: BGC-823 (IC50=2.91±0.06 µM), MM96L (IC50=1.03±0.03 µM), HeLa (IC50=6.35±0.31 µM)##Non-Cancer cell line: HFF-1 (IC50=1.76±0.12 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21723349	Peptides. 2011 Aug;32(8):1719-1723.	He W, Chan LY, Zeng G, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola philippica.	
DRAMP00778	GSIPCGESCVFIPCISAVIGCSCSNKVCYKN	31	Viphi E (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola philippica	Anti-cancer	Not found	Not found	Not found		Function: The novel cyclotides show cytotoxic activity against several cancer cell lines. Note: Activity tested together with Viphi D.	Cancer cell lines: MM96L (IC50=2.51±0.03 µM), HeLa (IC50=5.24±0.40 µM).##Non-Cancer cell line: HFF-1 (IC50=1.55±0.09 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21723349	Peptides. 2011 Aug;32(8):1719-1723.	He W, Chan LY, Zeng G, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola philippica.	
DRAMP00779	GIPCGESCVFIPCISSVIGCSCSSKVCYRN	30	Viphi D (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola philippica	Anti-cancer	Not found	Not found	Not found		Function: The novel cyclotides show cytotoxic activity against several cancer cell lines. Note: Activity tested together with Viphi E.	Cancer cell lines: MM96L (IC50=2.51±0.03 µM), HeLa (IC50=5.24±0.40 µM).##Non-Cancer cell line: HFF-1 (IC50=1.55±0.09 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21723349	Peptides. 2011 Aug;32(8):1719-1723.	He W, Chan LY, Zeng G, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola philippica.	
DRAMP00780	GSIPCGESCVFIPCISSVIGCACKSKVCYKN	31	Viphi A (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola philippica	Anti-cancer	Not found	Not found	Not found		Function: The novel cyclotides show cytotoxic activity against several cancer cell lines.	Cancer cell lines: BGC-823 (IC50=1.75±0.05 µM), MM96L (IC50=4.91±0.04 µM), HeLa (IC50=15.5±0.06 µM).##Non-cancer cell line: HFF-1 (IC50=3.19±0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21723349	Peptides. 2011 Aug;32(8):1719-1723.	He W, Chan LY, Zeng G, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola philippica.	
DRAMP00781	GLPVCGETCVGGTCNTPGCGCSWPVCTRN	29	Viba 17 (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola philippica	Anti-cancer	Not found	Not found	Not found		Function: The novel cyclotides show cytotoxic activity against several cancer cell lines. Note: Activity tested together with Viba 15.	Cancer cell lines: BGC-823 (IC50=1.32±0.15 µM), MM96L (IC50=3.10±0.06 µM), HeLa (IC50=10.21±0.43 µM).##Non-Cancer cell line: HFF-1 (IC50=2.38±0.09 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21723349	Peptides. 2011 Aug;32(8):1719-1723.	He W, Chan LY, Zeng G, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola philippica.	
DRAMP00782	GLPVCGETCVGGTCNTPGCACSWPVCTRN	29	Viba 15 (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola philippica	Anti-cancer	Not found	Not found	Not found		Function: The novel cyclotides show cytotoxic activity against several cancer cell lines. Activity tested together with Viba 17.	Cancer cell lines: BGC-823 (IC50=1.32±0.15 µM), MM96L (IC50=3.10±0.06 µM), HeLa (IC50=10.21±0.43 µM).##Non-Cancer cell line: HFF-1 (IC50=2.38±0.09 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21723349	Peptides. 2011 Aug;32(8):1719-1723.	He W, Chan LY, Zeng G, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola philippica.	
DRAMP18326	NGEWGYVVTKGAFQATTDVIANGWVSSLGGGYFGKP	36	Bovicin 255(Bacteriocin)	No entry found	Belongs to the class II bacteriocin	Not found	Streptococcus bovis	Antimicrobial, Antibacterial, Anti-Gram+		Not found	The prepeptide shares homology with the nonlantibiotic bacteriocins lactococcin A of Lactobacillus lactis (identities, 29%; positives, 48%) and thermophilin A of Streptococcus thermophilus (identities, 35%; positives, 42%). However, the homology with thermophilin A seems to reside primarily in the leader sequence (identities, 65%; positives, 73%), whereas homology with lactococcin A is distributed along the length of the prepeptide.		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11157218	Appl Environ Microbiol. 2001 Feb;67(2):569-74.	Whitford MF, McPherson MA, Forster RJ, Teather RM.	Identification of bacteriocin-like inhibitors from rumen Streptococcus spp. and isolation and characterization of bovicin 255.	
DRAMP00784	GLPVCGETCVGGTCNTPGCSCSWPVCTRN	29	Varv peptide A (Varv A; Plant defensin)	Q5USN7, P58446	Belongs to the cyclotide family	Not found	Viola arvensis (European field pansy) (Field violet)	Anti-cancer	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism. Has cytotoxic activity against a variety of drug-resistant and drug-sensitive human tumor cell lines, and against primary chronic lymphocytic leukemia cells. Has weak cytotoxic activity against primary ovarian carcinoma cells or normal lymphocytes.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26."	Human tumor cell lines: RPMI-8226/s (IC50=3.24 µM), RPMI-8226/Dox40 (IC50=2.73 µM), RPMI-8226/LR-5 (IC50=3.19 µM), U-937GTB (IC50=6.35 µM), U-937Vcr (IC50=4.84 µM), ACHN (IC50=4.19 µM), CCRF-CEM (IC50=3.56 µM), CCRF-CEM/VM-1 (IC50=4.97 µM), NCI-H69 (IC50=4.88 µM), NCI-H69AR (IC50=4.89 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.	L	[Ref.20580652] Cytotoxicity: U251(IC50 = 37.8μg/mL), MDA-MB-231(IC50>10μg/mL), A549(IC50>10μg/mL), DU145(IC50>10μg/mL), BEL-7402(IC50>10μg/mL).##[Ref.14987049] Cytotoxicity: U-937 GTB (lymphoma)(IC50 = 6µM) and RPMI-8226/s (myeloma)(IC50 = 3µM).	Not found	20580652##14987049##12477048	"Peptides
. 2010 Aug;31(8):1434-1440.##J Nat Prod. 2004 Feb;67(2):144-147.##Mol Cancer Ther
. 2002 Apr;1(6):365-9."	Jun Tang, Conan K Wang, Xulin Pan, He Yan, Guangzhi Zeng, Wenyan Xu, Wenjun He, Norelle L Daly, David J Craik, Ninghua Tan. ##Erika Svangård, Ulf Göransson, Zozan Hocaoglu, Joachim Gullbo, Rolf Larsson, Per Claeson, Lars Bohlin. ##Petra Lindholm, Ulf Göransson, Senia Johansson, Per Claeson, Joachim Gullbo, Rolf Larsson, Lars Bohlin, Anders Backlund	Isolation and characterization of cytotoxic cyclotides from Viola tricolor. ##Cytotoxic cyclotides from Viola tricolor.##Cyclotides: a novel type of cytotoxic agents.	
DRAMP00785	GLPVCGETCFGGTCNTPGCSCDPWPMCSRN	30	Varv peptide B (Varv B; Plant defensin)	P58447	Belongs to the cyclotide family	Not found	Viola arvensis (European field pansy) (Field violet)	Anti-cancer	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.	L	No Cytotoxicity information found	Not found	10075760	J Nat Prod. 1999 Feb;62(2):283-286.	Göransson U, Luijendijk T, Johansson S, Bohlin L, Claeson P.	Seven novel macrocyclic polypeptides from Viola arvensis.	
DRAMP00786	GVPICGETCVGGTCNTPGCSCSWPVCTRN	29	Varv peptide C (Varv C; Plant defensin)	P58448	Belongs to the cyclotide family	Not found	Viola arvensis (European field pansy) (Field violet)	Anti-cancer	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10075760	J Nat Prod. 1999 Feb;62(2):283-286.	Göransson U, Luijendijk T, Johansson S, Bohlin L, Claeson P.	Seven novel macrocyclic polypeptides from Viola arvensis.	
DRAMP00787	GLPICGETCVGGSCNTPGCSCSWPVCTRN	29	Varv peptide D (Varv D; Plant defensin)	P58449	Belongs to the cyclotide family	Not found	Viola arvensis (European field pansy) (Field violet)	Anti-cancer	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10075760	J Nat Prod. 1999 Feb;62(2):283-286.	Göransson U, Luijendijk T, Johansson S, Bohlin L, Claeson P.	Seven novel macrocyclic polypeptides from Viola arvensis.	
DRAMP00788	GLPICGETCVGGTCNTPGCSCSWPVCTRN	29	Varv peptide E (Varv E; Plant defensin)	P83835	Belongs to the cyclotide family	Not found	Viola arvensis (European field pansy) (Field violet)	Anti-cancer, Antiviral	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism. Has cytotoxic activity against human lymphoma U-937 GTB and human myeloma RPMI-8226/s cell lines.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26."	[Ref.14987049]Human cancer cell lines: U-937 GTB (lymphoma) (IC50=4 µM), RPMI-8226/s (myeloma) (IC50=4 µM).##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=350 nM).	[Ref.20580652] HD50=6.96µM against human type O red blood cells.	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.	L	[Ref.20580652] Cytotoxicity: U251(IC50=38.84μg/mL), MDA-MB-231(IC50>10μg/mL), A549(IC50>10μg/mL), DU145(IC50>10μg/mL), BEL-7402(IC50>10μg/mL).##[Ref.14987049] Cytotoxicity: U-937 GTB (lymphoma)(IC50 = 4 µM) and RPMI-8226/s (myeloma)(IC50 = 4 µM).##[Ref.18008336]CEM-SS cells:IC50=3980 nM.	Not found	18008336##10075760##14987049##20580652	Biopolymers. 2008;90(1):51-60.##J Nat Prod. 1999 Feb;62(2):283-286.##J Nat Prod. 2004 Feb;67(2):144-147.##Peptides. 2010 Aug;31(8):1434-40.	Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. ##Göransson U, Luijendijk T, Johansson S, Bohlin L, Claeson P.Svang.##Svangård E, Göransson U, Hocaoglu Z, Gullbo J, Larsson R, Claeson P, Bohlin L.##Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, He W, Daly NL, Craik DJ, Tan N.	Cyclotides as natural anti-HIV agents.##Seven novel macrocyclic polypeptides from Viola arvensis.##Cytotoxic cyclotides from Viola tricolor.##Isolation and characterization of cytotoxic cyclotides from Viola tricolor.	CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N4)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC3=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N2
DRAMP00789	GVPICGETCTLGTCYTAGCSCSWPVCTRN	29	Varv peptide F (Varv F; Plant defensin)	P58451	Belongs to the cyclotide family	Not found	Viola arvensis (European field pansy) (Field violet)	Anti-cancer	Protein level	Combine helix and strand structure	Not found	2K7G resolved by NMR.	"Function: Probably participates in a plant defense mechanism. Has cytotoxic activity against a variety of drug-resistant and drug-sensitive human tumor cell lines.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26."	Human tumor cell lines: RPMI-8226/s (IC50=5.90 µM), RPMI-8226/Dox40 (IC50=3.14 µM), RPMI-8226/LR-5 (IC50=6.31 µM), U-937GTB (IC50=7.07 µM), U-937Vcr (IC50=7.45 µM), ACHN (IC50=2.63 µM), CCRF-CEM (IC50=7.13 µM), CCRF-CEM/VM-1 (IC50=7.15 µM), NCI-H69 (IC50=7.49 µM), NCI-H69AR (IC50=7.12 µM).	[Ref.20580652] HD50=33.04µM against human type O red blood cells.	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.	L	[Ref.20580652] Cytotoxicity: U251(IC50=44.49μg/mL), MDA-MB-231(IC50>10μg/mL), A549(IC50>10μg/mL), DU145(IC50>10μg/mL), BEL-7402(IC50>10μg/mL).	Not found	10075760##12477048##19211551	J Nat Prod. 1999 Feb;62(2):283-286.##Mol Cancer Ther. 2002 Apr;1(6):365-369.##J Biol Chem. 2009 Apr 17;284(16):10672-83.	Göransson U, Luijendijk T, Johansson S, Bohlin L, Claeson P.##Lindholm P, Göransson , Johansson S, Claeson P, Gullbo J, Larsson R, Bohlin L, Backlund A.##Wang CK, Hu SH, Martin JL, Sjögren T, Hajdu J, Bohlin L, Claeson P, Göransson U, Rosengren KJ, Tang J, Tan NH, Craik DJ.	Seven novel macrocyclic polypeptides from Viola arvensis.##Cyclotides: a novel type of cytotoxic agents.##Combined X-ray and NMR analysis of the stability of the cyclotide cystine knot fold that underpins its insecticidal activity and potential use as a drug scaffold.	
DRAMP00790	GVPVCGETCFGGTCNTPGCSCDPWPVCSRN	30	Varv peptide G (Varv G; Plant defensin)	P58452	Belongs to the cyclotide family	Not found	Viola arvensis (European field pansy) (Field violet)	Anti-cancer	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10075760	J Nat Prod. 1999 Feb;62(2):283-286.	Göransson U, Luijendijk T, Johansson S, Bohlin L, Claeson P.	Seven novel macrocyclic polypeptides from Viola arvensis.	
DRAMP00791	GLPVCGETCFGGTCNTPGCSCETWPVCSRN	30	Varv peptide H (Varv H; Plant defensin)	P58453	Belongs to the cyclotide family	Not found	Viola arvensis (European field pansy) (Field violet)	Anti-cancer	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-27."	No MICs found in DRAMP database	[Ref.20580652] HD50=7.52µM against human type O red blood cells.	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys27.	L	[Ref.20580652] Cytotoxicity: U251(IC50=44.70μg/mL), MDA-MB-231(IC50>10μg/mL), A549(IC50>10μg/mL), DU145(IC50>10μg/mL), BEL-7402(IC50>10μg/mL).	Not found	10075760	J Nat Prod. 1999 Feb;62(2):283-286.	Göransson U, Luijendijk T, Johansson S, Bohlin L, Claeson P.	Seven novel macrocyclic polypeptides from Viola arvensis.	
DRAMP00792	GLPVCGETCTLGKCYTAGCSCSWPVCYRN	29	Vodo peptide N (Plant defensin)	P83838	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Not found	Protein level	Not found	Forms a head-to-tail cyclic backbone and that six cysteine residues are involved in three disulphide bonds.	2AKS	"Function: Probably participates in a plant defense mechanism.
PTM: Problely contains three disulfide bonds 5-19; 9-21; 14-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12946412	Phytochemistry. 2003 Sep;64(1):135-142.	Svang¥rd E, Göransson , Smith D, Verma C, Backlund A, Bohlin L, Claeson P.	Primary and 3-D modelled structures of two cyclotides from Viola odorata.	
DRAMP00793	GAPICGESCFTGKCYTVQCSCSWPVCTRN	29	Vodo peptide M (Plant defensin)	P83839	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Not found	Protein level	Not found	Forms a head-to-tail cyclic backbone and that six cysteine residues are involved in three disulphide bonds.	1ZLO	"Function: Probably participates in a plant defense mechanism.
PTM: Problely contains three disulfide bonds 5-19; 9-21; 14-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12946412	Phytochemistry. 2003 Sep;64(1):135-142.	Svang¥rd E, Göransson , Smith D, Verma C, Backlund A, Bohlin L, Claeson P.	Primary and 3-D modelled structures of two cyclotides from Viola odorata.	
DRAMP18325	MAADIISTIGDLVKLIINTVKKFQK	25	delta-lysin I (Bacteriocin)	No entry found	Not found	Not found	Staphylococcus warneri RK	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Warnericin RK and delta-lysin I displayed the same antibacterial spectrum, which is almost restricted to the Legionella genus. Also, both peptides have a hemolytic activity.	[Ref.18339450]Gram-positive bacteria: Bacillus megaterium F04(+), Bacillus subtilis(–), Enterococcus faecalis V583(–), Listeria monocytogenes EGDe(–), Micrococcus luteus(–), Pediococcus acidilactici 583(–), Staphylococcus aureus 971(–), Staphylococcus chromogenes(–), Staphylococcus cohnii 898(–), Staphylococcus epidermidis 567(-), Staphylococcus haemolyticus 694(-), Staphylococcus hominis 373(-), Staphylococcus lentus 982(-), Staphylococcus lugdunensis 967(-), Staphylococcus saprophyticus 715(-), Staphylococcus warneri 447(-), Staphylococcus warneri RK(-);## Gram-negative bacteria:  Enterobacter cloacae D03(-), Escherichia coli MG1655(-), Hafnia alvei(-), Klebsiella pneumoniae 0502083(-), Legionella bozemanii ATCC 33217(+),  Legionella dumofii ATCC 33279(+), Legionella feeleii ATCC 35072(+), Legionella like bacteria (LLAP10)(+), Legionella longbeachae ATCC 33484(+), Legionella micdadei ATCC 33218(+), Legionella oakridgensis ATCC 33761(+), Legionella pneumophila Corby (sg1)(+), Legionella pneumophila Lens (sg1)(+), Legionella pneumophila Paris (sg1)(+), Legionella pneumophila ATCC 33155 (sg3)(+), Legionella pneumophila ATCC 33216 (sg5)(+), Legionella pneumophila ATCC 33215 (sg6)(+), Proteus mirabilis ATCC 35659(-), Pseudomonas aeruginosa DSMZ1128(-), Pseudomonas aeruginosa 910704(-), Salmonella typhimurium(-)	[Ref.18339450]10% hemolytic activity at 1.56 μM, 40% hemolytic activity at 6.25 μM, 62% hemolytic activity at 25 μM, 80% hemolytic activity at 50 μM against human erythrocytes 	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18339450	Peptides. 2008 Jun;29(6):978-84. 	Verdon J, Berjeaud JM, Lacombe C, H	Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri.	
DRAMP00796	GEFLKCGESCVQGECYTPGCSCDWPICKKN	30	Cliotide T2 (cT2; Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Not found	Not found	Not found		Function: Cliotide T2 shows stronger antimicrobial activity against the Gram-negative bacteria than the Gram-positive bacteria. Cliotide T2 was relatively nonhemolytic (HD50>100 µM) .	[Ref.21596752]Gram-positive bacteria: Staphylococcus aureus ATCC12600, Enterococcus faecalis ATCC 47077 (less active);##Gram-negative bacteria: Escherichia coli ATCC 700926 (MIC>100 µM), Pseudomonas aeruginosa ATCC 39018 (MIC>100 µM), Klebsiella pneumonia ATCC 13883 (MIC>100 µM).	[Ref:21596752] HD50>100 µM against human type A erythrocytes	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys I and CysIV, CysII and CysV,  CysIII and CysVI.	L	[Ref.21596752] Cytotoxicity: HeLa Cells (IC50=8.0 µM).	Not found	21596752	J Biol Chem. 2011 Jul 8;286(27):24275-24287.	Nguyen GK, Zhang S, Nguyen NT, Nguyen PQ, Chiu MS, Hardjojo A, Tam JP.	Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.	
DRAMP00797	GLPTCGETCTLGTCYVPDCSCSWPICMKN	29	Cliotide T3 (cT3; Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Not found	Not found	Not found	2LAM	"Function: Cliotide T3 shows stronger antimicrobial activity against the Gram-negative bacteria than the Gram-positive bacteria. It also has hemolytic activity against human type A erythrocytes (HD50=13.1 µM) and cytotoxicity against HeLa Cells (IC50=2.0 µM).
[Note: HD50 refers to the peptide concentration that causes 50% lysis of red blood cells; IC50 refers to the peptide concentration that causes 50% death of HeLa cells]. "	[Ref.21596752]Gram-positive bacteria: Staphylococcus aureus ATCC12600, Enterococcus faecalis ATCC 47077 (less active);##Gram-negative bacteria: Escherichia coli ATCC 700926 (MIC>100 µM), Pseudomonas aeruginosa ATCC 39018 (MIC>100 µM), Klebsiella pneumonia ATCC 13883 (MIC>100 µM).	[Ref:21596752] HD50=13.1 µM against human type A erythrocytes	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys I and CysIV, CysII and CysV,  CysIII and CysVI.	L	[Ref.21596752] Cytotoxicity: HeLa Cells (IC50=2.0 µM).	Not found	21596752	J Biol Chem. 2011 Jul 8;286(27):24275-24287.	Nguyen GK, Zhang S, Nguyen NT, Nguyen PQ, Chiu MS, Hardjojo A, Tam JP.	Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.	
DRAMP00799	GVIPCGESCVFIPCISAAIGCSCKNKVCYRN	31	Cycloviolin-A (Plant defensin)	P84637	Belongs to the cyclotide family	Not found	Leonia cymosa (Sacha uba)	Antimicrobial, Antiviral	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Has anti-HIV activity.
PTM: This is a cyclic peptide which may contain three disulfide bonds 5-21;9-23;14-28."	[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=130 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys5 and Cys21, Cys9 and Cys23,Cys14 and Cys28.	L	[Ref.18008336]CEM-SS cells:IC50=560 nM.	Not found	10813905##18008336	J Org Chem. 2000 Jan 14;65(1):124-128.##Biopolymers. 2008;90(1):51-60.	Hallock YF, Sowder RC 2nd, Pannell LK, Hughes CB, Johnson DG, Gulakowski R, Cardellina JH 2nd, Boyd MR.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. 	Cycloviolins A-D, anti-HIV macrocyclic peptides from Leonia cymosa.##Cyclotides as natural anti-HIV agents.	
DRAMP00800	GTACGESCYVLPCFTVGCTCTSSQCFKN	28	Cycloviolin-B (Plant defensin)	P84638	Belongs to the cyclotide family	Not found	Leonia cymosa (Sacha uba)	Antimicrobial, Antiviral	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Has anti-HIV activity.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-18;8-20;13-25."	[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=130 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys18, Cys8 and Cys20,Cys13 and Cys25.	L	[Ref.18008336]CEM-SS cells:IC50=560 nM.	Not found	10813905##18008336	J Org Chem. 2000 Jan 14;65(1):124-128.##Biopolymers. 2008;90(1):51-60.	Hallock YF, Sowder RC 2nd, Pannell LK, Hughes CB, Johnson DG, Gulakowski R, Cardellina JH 2nd, Boyd MR.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. 	Cycloviolins A-D, anti-HIV macrocyclic peptides from Leonia cymosa.##Cyclotides as natural anti-HIV agents.	
DRAMP00801	GIPCGESCVFIPCLTTVAGCSCKNKVCYRN	30	Cycloviolin-C (Plant defensin)	P84639	Belongs to the cyclotide family	Not found	Leonia cymosa (Sacha uba)	Antimicrobial, Antiviral	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Has anti-HIV activity.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20;8-22;13-27."	[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=130 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27.	L	[Ref.18008336]CEM-SS cells:IC50=560 nM.	Not found	10813905##18008336	J Org Chem. 2000 Jan 14;65(1):124-128.##Biopolymers. 2008;90(1):51-60.	Hallock YF, Sowder RC 2nd, Pannell LK, Hughes CB, Johnson DG, Gulakowski R, Cardellina JH 2nd, Boyd MR.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. 	Cycloviolins A-D, anti-HIV macrocyclic peptides from Leonia cymosa.##Cyclotides as natural anti-HIV agents.	
DRAMP00802	GFPCGESCVFIPCISAAIGCSCKNKVCYRN	30	Cycloviolin-D (Plant defensin)	P84640	Belongs to the cyclotide family	Not found	Leonia cymosa (Sacha uba)	Antimicrobial, Antiviral	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Has anti-HIV activity.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27."	[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=130 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27.	L	[Ref.18008336]CEM-SS cells:IC50=560 nM.	Not found	10813905##18008336	J Org Chem. 2000 Jan 14;65(1):124-128.##Biopolymers. 2008;90(1):51-60.	Hallock YF, Sowder RC 2nd, Pannell LK, Hughes CB, Johnson DG, Gulakowski R, Cardellina JH 2nd, Boyd MR.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. 	Cycloviolins A-D, anti-HIV macrocyclic peptides from Leonia cymosa.##Cyclotides as natural anti-HIV agents.	
DRAMP00803	GDPTFCGETCRVIPVCTYSAALGCTCDDRSDGLCKRN	37	Palicourein (Cyclotides; Plants)	P84645	Belongs to the cyclotide family	Not found	Palicourea condensata (Cappel)	Antimicrobial, Antiviral	Protein level	Combine helix and strand structure	Palicourein has an atypical size and composition within one of the surface-exposed loops.	1R1F resolved by NMR.	"Function: Probably participates in a plant defense mechanism. Inhibits the cytopathic effects of the human immunodeficiency virus.
In vitro activity: Palicourein inhibits the cytopathic effects of HIV-1RF infection of CEM-SS cells with an EC50 value of 0.1 µM and an IC50 value of 1.5 µM.
PTM: This is a cyclic peptide which may contain three disulfide bonds 6-24; 10-26; 16-34."	[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=100 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys1 and Cys19; Cys5 and Cys21; Cys11 and Cys28;hydrogen bonds between the oxygen atoms of the Glu3 carboxyl group and the backbone amides of residues Thr12, Thr13, and Ser14, and the side chain of Ser14. 	L	[Ref.11430013] Cytotoxicity: human T-lymphoblastoid cell line (CEM-SS)(EC50=0.10 Μm, IC50=1.5 μM) . ##[Ref.18008336]CEM-SS cells:IC50=1500 nM.	Not found	11430013##14725768##18008336	J Nat Prod. 2001 Feb;64(2):249-250.##Structure. 2004 Jan;12(1):85-94.##Biopolymers. 2008;90(1):51-60.	Bokesch HR, Pannell LK, Cochran PK, Sowder RC 2nd, McKee TC, Boyd MR.##Barry DG, Daly NL, Bokesch HR, Gustafson KR, Craik DJ.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. 	A novel anti-HIV macrocyclic peptide from Palicourea condensata.##Solution structure of the cyclotide palicourein: implications for the development of a pharmaceutical framework.##Cyclotides as natural anti-HIV agents.	
DRAMP00804	GIPCAESCVYIPCTVTALLGCSCSNRVCYN	30	Cycloviolacin-O1 (Plant defensin)	P82230	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Combine helix and strand structure	Not found	1NBJ resolved by NMR.	"Function: Probably participates in a plant defense mechanism. It shows haemolytic activity.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-21; 8-23; 13-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys21; Cys8 and Cys23; Cys13 and Cys28.	L	[Ref.20575512] Cytotoxicity on the human lymphoma cell line U-937 GTB(IC50 around 1 µM).	Not found	16872274##10600388##12482868	Biochem J. 2006 Nov 15;400(1):1-12.##J Mol Biol. 1999 Dec 17;294(5):1327-1336.##J Biol Chem. 2003 Mar 7;278(10):8606-8616.	Ireland DC, Colgrave ML, Craik DJ.##Craik DJ, Daly NL, Bond T, Waine C.##Rosengren KJ, Daly NL, Plan MR, Waine C, Craik DJ.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability..##Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.##Twists, knots, and rings in proteins. Structural definition of the cyclotide framework.	
DRAMP00805	GIPCGESCVWIPCISSAIGCSCKSKVCYRN	30	Cycloviolacin-O2 (Plant defensin)	P58434, P85526	Belongs to the cyclotide family	Not found	Viola biflora (Yellow wood violet) & Viola odorata (Sweet violet)	Insecticidal 	Protein level	Combine helix and strand structure	Not found	2KCG, 2KNM, 2KNN resolved by NMR.	"Function: Probably participates in a plant defense mechanism. Has strong cytotoxic activity against a variety of drug-resistant and drug-sensitive human tumor cell lines, and against primary chronic lymphocytic leukemia and ovarian carcinoma cells. Has weaker cytotoxic activity against normal lymphocytes. Has hemolytic activity.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-20; 8-22; 13-27."	[Ref.16872274]Human tumor cell lines: RPMI-8226/s (IC50=0.12 µM), RPMI-8226/Dox40 (IC50=0.12 µM), RPMI-8226/LR-5 (IC50=0.12 µM), U-937GTB (IC50=0.26 µM), U-937Vcr (IC50=0.20 µM), ACHN (IC50=0.22 µM), CCRF-CEM (IC50=0.11 µM), CCRF-CEM/VM-1 (IC50=0.14 µM), NCI-H69 (IC50=0.12 µM), NCI-H69AR (IC50=0.26 µM).	[Ref:16872274] It has 35% hemolytic activity at 1.0 μM and 60% hemolytic activity at 1.5 μM against human type A red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	[Ref.20580652] Cytotoxicity: U251(IC50=17.05μg/mL), MDA-MB-231(IC50=4.81μg/mL), A549(IC50=5.99μg/mL), DU145(IC50=5.08μg/mL), BEL-7402(IC5=6.07μg/mL).	Not found	16872274##10600388##16872274	"Biochem J. 2006 Nov 15;400(1):1-12.##J Mol Biol. 1999 Dec 17;294(5):1327-1336.##Biochem J
. 2006 Nov 15;400(1):1-12. "	Ireland DC, Colgrave ML, Craik DJ.##Craik DJ, Daly NL, Bond T, Waine C.##David C Ireland 1, Michelle L Colgrave, David J Craik	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability..##Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.##A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability	
DRAMP00806	GIPCGESCVWIPCLTSAIGCSCKSKVCYRN	30	Cycloviolacin-O3 (Plant defensin)	P58435	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-20; 8-22; 13-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	No cytotoxicity information found	Not found	16872274##10600388	Biochem J. 2006 Nov 15;400(1):1-12.##J Mol Biol. 1999 Dec 17;294(5):1327-1336.	Ireland DC, Colgrave ML, Craik DJ.##Craik DJ, Daly NL, Bond T, Waine C.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability..##Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	
DRAMP00807	GIPCGESCVWIPCISSAIGCSCKNKVCYRN	30	Cycloviolacin-O4 (Plant defensin)	P58436	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-20; 8-22; 13-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	No cytotoxicity information found	Not found	16872274##10600388	Biochem J. 2006 Nov 15;400(1):1-12.##J Mol Biol. 1999 Dec 17;294(5):1327-1336.	Ireland DC, Colgrave ML, Craik DJ.##Craik DJ, Daly NL, Bond T, Waine C.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability..##Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	
DRAMP00808	GTPCGESCVWIPCISSAVGCSCKNKVCYKN	30	Cycloviolacin-O5 (Plant defensin)	P58437	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-20; 8-22; 13-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	No cytotoxicity information found	Not found	16872274##10600388	Biochem J. 2006 Nov 15;400(1):1-12.##J Mol Biol. 1999 Dec 17;294(5):1327-1336.	Ireland DC, Colgrave ML, Craik DJ.##Craik DJ, Daly NL, Bond T, Waine C.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability..##Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	
DRAMP00809	GTLPCGESCVWIPCISAVGCSCKSKVCYKN	30	Cycloviolacin-O6 (Plant defensin)	P58438	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 5-21; 9-23; 14-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys21; Cys9 and Cys23; Cys14 and Cys28.	L	No cytotoxicity information found	Not found	16872274##10600388	Biochem J. 2006 Nov 15;400(1):1-12.##J Mol Biol. 1999 Dec 17;294(5):1327-1336.	Ireland DC, Colgrave ML, Craik DJ.##Craik DJ, Daly NL, Bond T, Waine C.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability..##Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	
DRAMP00810	SIPCGESCVWIPCTITALAGCKCKSKVCYN	30	Cycloviolacin-O7 (Plant defensin)	P58439	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-21; 8-23; 13-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys21; Cys8 and Cys23; Cys13 and Cys28.	L	No cytotoxicity information found	Not found	16872274##10600388	Biochem J. 2006 Nov 15;400(1):1-12.##J Mol Biol. 1999 Dec 17;294(5):1327-1336.	Ireland DC, Colgrave ML, Craik DJ.##Craik DJ, Daly NL, Bond T, Waine C.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability..##Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	
DRAMP00811	GTLPCESCVWIPCISSVVGCSCKSKVCYKN	30	Cycloviolacin-O8 (Cyclotide c1; Plant defensin)	P58440, Q5USN9	Belongs to the cyclotide family	Voc1	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 5-21; 9-23; 14-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys21; Cys9 and Cys23; Cys14 and Cys28.	L	[Ref.29734037] Cytotoxicity against three cancer cell lines: MDA-MB-231 breast (IC50=1.15 μM), PC-3 prostate (IC50=1.05 μM), and OVCAR-3 ovarian (IC50=0.80 μM). Cytotoxicity against non-cancerous human dermal fibroblast cells was determined to be ∼3× less (3.13 μM) than cancer cell lines 	Not found	16872274##10600388	Biochem J. 2006 Nov 15;400(1):1-12.##J Mol Biol. 1999 Dec 17;294(5):1327-1336.	Ireland DC, Colgrave ML, Craik DJ.##Craik DJ, Daly NL, Bond T, Waine C.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability..##Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	
DRAMP00812	GIPCGESCVWIPCLTSAVGCSCKSKVCYRN	30	Cycloviolacin-O9 (Vbc5; Plant defensin)	P58441, B1NRR2	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet) & Viola biflora (Yellow wood violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-20; 8-22; 13-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	No cytotoxicity information found	Not found	16872274##10600388##18191970	Biochem J. 2006 Nov 15;400(1):1-12.##J Mol Biol. 1999 Dec 17;294(5):1327-1336.##Phytochemistry. 2008 Feb;69(4):939-952.	Ireland DC, Colgrave ML, Craik DJ.##Craik DJ, Daly NL, Bond T, Waine C.##Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability..##Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.##The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00813	GIPCGESCVYIPCLTSAVGCSCKSKVCYRN	30	Cycloviolacin-O10 (Plant defensin)	P58442	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-20; 8-22; 13-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	No cytotoxicity information found	Not found	16872274##10600388	Biochem J. 2006 Nov 15;400(1):1-12.	Ireland DC, Colgrave ML, Craik DJ.##Craik DJ, Daly NL, Bond T, Waine C.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability..##Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	
DRAMP00814	GTLPCGESCVWIPCISAVVGCSCKSKVCYKN	31	Cycloviolacin-O11 (Cyclotide c2; Plant defensin)	P58443, Q5USP0	Belongs to the cyclotide family	Voc2	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 5-21; 9-23; 14-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys21; Cys9 and Cys23; Cys14 and Cys28.	L	No cytotoxicity information found	Not found	16872274##10600388	Biochem J. 2006 Nov 15;400(1):1-12.	Ireland DC, Colgrave ML, Craik DJ.##Craik DJ, Daly NL, Bond T, Waine C.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability..##Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	
DRAMP18324	MQFITDLIKKAVDFFKGLFGNK	22	Warnericin RK (Bacteriocin)	No entry found	Not found	Not found	Staphylococcus warneri RK	Antimicrobial, Antibacterial, Anti-Gram-		Alpha Helix	Not found		Warnericin RK acts as a specific anti-Legionella AMP by permeabilizing the bacterial membrane.	Gram-negative(Narrow)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18339450##19804724 	Peptides. 2008 Jun;29(6):978-84.##Biophys J. 2009 Oct 7;97(7):1933-40. 	Verdon J, Berjeaud JM, Lacombe C, H	Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri.##Detergent-like activity and alpha-helical structure of warnericin RK, an anti-Legionella peptide.	
DRAMP00816	GIPCGESCVWIPCISAAIGCSCKSKVCYRN	30	Cycloviolacin-O13 (Cyclotide c3; Plant defensin)	Q5USN8	Belongs to the cyclotide family	Voc3	Viola odorata (Sweet violet)	Antiviral,Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Has hemolytic activity.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27."	[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=320 nM).	[Ref:16872274] It has 50% hemolytic activity at 1.0 μM and 75% hemolytic activity at 1.5 μM against human type A red blood cells	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	[Ref.18008336]CEM-SS cells:IC50=6400 nM.	Not found	16872274##18008336	Biochem J. 2006 Nov 15;400(1):1-12.##Biopolymers. 2008;90(1):51-60.	Ireland DC, Colgrave ML, Craik DJ.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. 	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability.##Cyclotides as natural anti-HIV agents.	
DRAMP00817	GSIPACGESCFKGKCYTPGCSCSKYPLCAKN	31	Cycloviolacin-O14 (Plant defensin)	P85177	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Antiviral,Insecticidal 	Protein level	Combine helix and strand structure	Cycloviolacin O14 is shown to contain the CCK motif.	2GJ0 resolved by NMR.	"Function: Probably participates in a plant defense mechanism. Has hemolytic activity.
PTM: This is a cyclic peptide which may contain three disulfide bonds 6-20; 10-22; 15-27."	[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=440 nM).	[Ref:16872274] It has 3% hemolytic activity at 1.0 μM and 13% hemolytic activity at 1.5 μM against human type A red blood cells	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys6 and Cys20; Cys10 and Cys22; Cys15 and Cys27.	L	[Ref.18008336]CEM-SS cells:IC50=4800 nM.	Not found	16872274##18008336	Biochem J. 2006 Nov 15;400(1):1-12.##Biopolymers. 2008;90(1):51-60.	Ireland DC, Colgrave ML, Craik DJ.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. 	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability.##Cyclotides as natural anti-HIV agents.	
DRAMP00818	GLVPCGETCFTGKCYTPGCSCSYPICKKN	29	Cycloviolacin-O15 (Plant defensin)	P85178	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Has hemolytic activity.
PTM: This is a cyclic peptide which may contain three disulfide bonds 5-19; 9-21; 14-26."	No MICs found in DRAMP database	[Ref:16872274] It has 6% hemolytic activity at 1.0 μM and 26% hemolytic activity at 1.5 μM against human type A red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.	L	No cytotoxicity information found	Not found	16872274	Biochem J. 2006 Nov 15;400(1):1-12.	Ireland DC, Colgrave ML, Craik DJ.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability.	
DRAMP00819	GLPCGETTCFTGKCYTPGCSCSYPICKKIN	30	Cycloviolacin-O16 (Plant defensin)	P85179	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-18; 8-20; 13-25."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys18; Cys8 and Cys20; Cys13 and Cys25.	L	No cytotoxicity information found	Not found	16872274	Biochem J. 2006 Nov 15;400(1):1-12.	Ireland DC, Colgrave ML, Craik DJ.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability.	
DRAMP00820	GIPCGESCVWIPGISAAIGCSCKNKVCYRN	30	Cycloviolacin-O17 (Plant defensin)	P85180	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-20; 8-22; 13-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	No cytotoxicity information found	Not found	16872274	Biochem J. 2006 Nov 15;400(1):1-12.	Ireland DC, Colgrave ML, Craik DJ.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability.	
DRAMP00821	GIPCGESCVYIIPCTVTALAQCKCKSKVCYN	31	Cycloviolacin-O18 (Plant defensin)	P85181	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-21; 8-23; 13-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys21; Cys8 and Cys23; Cys13 and Cys28.	L	No cytotoxicity information found	Not found	16872274	Biochem J. 2006 Nov 15;400(1):1-12.	Ireland DC, Colgrave ML, Craik DJ.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability.	
DRAMP00822	GTLPCGESCVWIPCISSVVGCSCKSKVCYKD	31	Cycloviolacin-O19 (Plant defensin)	P85182	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 5-21; 9-23; 14-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys21; Cys9 and Cys23; Cys14 and Cys28.	L	No cytotoxicity information found	Not found	16872274	Biochem J. 2006 Nov 15;400(1):1-12.	Ireland DC, Colgrave ML, Craik DJ.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability.	
DRAMP00823	GIPCGESCVWIPCLTSAIGCSCKSKVCYKD	30	Cycloviolacin-O20 (Plant defensin)	P85183	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	No cytotoxicity information found	Not found	16872274	Biochem J. 2006 Nov 15;400(1):1-12.	Ireland DC, Colgrave ML, Craik DJ.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability.	
DRAMP00824	GLPVCGETCVTGSCYTPGCTCSWPVCTRN	29	Cycloviolacin-O21 (Plant defensin)	P85184	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 5-19; 9-21; 14-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.	L	No cytotoxicity information found	Not found	16872274	Biochem J. 2006 Nov 15;400(1):1-12.	Ireland DC, Colgrave ML, Craik DJ.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability.	
DRAMP00825	GLPICGETCVGGTCNTPGCTCSWPVCTRN	29	Cycloviolacin-O22 (Plant defensin)	P85185	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 5-19; 9-21; 14-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.	L	No cytotoxicity information found	Not found	16872274	Biochem J. 2006 Nov 15;400(1):1-12.	Ireland DC, Colgrave ML, Craik DJ.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability.	
DRAMP00826	GLPTCGETCFGGTCNTPGCTCDSSWPICTHN	31	Cycloviolacin-O23 (Plant defensin)	P85186	Belongs to the cyclotide family	Not found	Viola odorata (Sweet violet)	Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 5-19; 9-21; 14-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.	L	No cytotoxicity information found	Not found	16872274	Biochem J. 2006 Nov 15;400(1):1-12.	Ireland DC, Colgrave ML, Craik DJ.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability.	
DRAMP18197	INNWVRVPPCDQVCSRSNPEKDECCRAHGHAFHAHCNGGMNCYRR	45	Diapausin-1	No entry found	Belongs to the diapausin family of peptides	Not found	hemolymph, tobacco hornworm, Manduca sexta	Antimicrobial, Antifungal		Not found	Not found		Function: Active against FUNGI such as S. cerevisiae (IC50 12 uM) but not bacteria.	S. cerevisiae(IC50 12 uM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26976231	Dev Comp Immunol.61:258-68(2016)	Al Souhail Q, Hiromasa Y, Rahnamaeian M, Giraldo MC, Takahashi D, Valent B, Vilcinskas A, Kanost MR.	Characterization and regulation of expression of an antifungal peptide from hemolymph of an insect, Manduca sexta.	
DRAMP18196	GIFSKLAGKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC	46	Esculentin-1A	P40843	Belongs to the frog skin active peptide (FSAP) family	Not found	Pelophylax esculentus (Edible frog) (Rana esculenta)	Antimicrobial, Antibacterial, Antibiotic		Not found	Not found	2N6M	Function: Antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.	No MICs found in DRAMP database	[Swiss_Prot Entry P40843]has hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163497	J. Biol. Chem. 269:11956-11961(1994)	Simmaco M., Mignogna G., Barra D., Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta.Molecular cloning of cDNAs encoding esculentin and brevinins andisolation of new active peptides.	
DRAMP00829	GIPCGESCVYIPCLTSAIGCSCKSKVCYRN	30	Cycloviolacin-H1 (Plant defensin)	P58433	Belongs to the cyclotide family	Not found	Viola hederacea (Australian violet)	Antimicrobial	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-20; 8-22; 13-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	No cytotoxicity information found	Not found	10600388	J Mol Biol. 1999 Dec 17;294(5):1327-1336.	Craik DJ, Daly NL, Bond T, Waine C.	Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	
DRAMP00830	SAIACGESCVYIPCFIPGCSCRNRVCYLN	29	Cycloviolacin-H2 (Plant defensin)	P85233	Belongs to the cyclotide family	Not found	Viola hederacea (Australian violet)	Antimicrobial	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 5-19; 9-21; 14-26."	Virus: HIV.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.	L	No cytotoxicity information found	Not found	10600388	J Mol Biol. 1999 Dec 17;294(5):1327-1336.	Craik DJ, Daly NL, Bond T, Waine C.	Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	
DRAMP00831	GLPVCGETCFGGTCNTPGCICDPWPVCTRN	30	Cycloviolacin-H3 (Plant defensin)	P85232	Belongs to the cyclotide family	Not found	Viola hederacea (Australian violet)	Antimicrobial, Antiviral	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-20; 8-22; 13-27."	Virus: HIV.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	No cytotoxicity information found	Not found	10600388	J Mol Biol. 1999 Dec 17;294(5):1327-1336.	Craik DJ, Daly NL, Bond T, Waine C.	Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	
DRAMP00832	GIPCAESCVWIPCTVTALLGCSCSNNVCYN	30	Cycloviolacin-H4 (Plant defensin)	P85234	Belongs to the cyclotide family	Not found	Viola hederacea (Australian violet)	Antimicrobial, Antiviral	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-20; 8-22; 13-27."	No MICs found in DRAMP database	[Ref.16441062] HD50=5.5 µM against human type A red blood cells.	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	No cytotoxicity information found	Not found	10600388	J Mol Biol. 1999 Dec 17;294(5):1327-1336.	Craik DJ, Daly NL, Bond T, Waine C.	Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	
DRAMP00833	GGTIFDCGETCFLGTCYTPGCSCGNYGFCYGTN	33	Cycloviolacin-Y1 (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola yedoensis (Chinese herb)	Antimicrobial, Antiviral	Not found	Bridge	Not found		Function: Has anti-HIV activity. PTM: Contains three disulfide bonds.	[Ref.18081258] Anti-HIV activity:EC50=1.2μM, IC50>4.5μM. ##NOTE:EC50 refers to the values for HIV-infected cell cultures, IC50 refers to the values for uninfected cell cultures.##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=1210 nM).	[Ref.18081258] It has hemolytic activity.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys7 and Cys21; Cys11 and Cys23; Cys16 and Cys29.	L	[Ref.18008336]CEM-SS cells:IC50>4470 nM.	Not found	18081258##18008336	J Nat Prod. 2008 Jan;71(1):47-52.##Biopolymers. 2008;90(1):51-60. 	Wang CK, Colgrave ML, Gustafson KR, Ireland DC, Goransson U, Craik DJ.##David C Ireland, Conan K L Wang, Jennifer A Wilson, Kirk R Gustafson, David J Craik	Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis.##Cyclotides as natural anti-HIV agents	
DRAMP00834	GGTIFDCGESCFLGTCYTAGCSCGNWGLCYGTN	33	Cycloviolacin-Y2 (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola yedoensis (Chinese herb)	Antimicrobial, Antiviral	Not found	Bridge	Not found		Function: Has anti-HIV activity. PTM: Contains three disulfide bonds.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys7 and Cys21; Cys11 and Cys23; Cys16 and Cys29.	L	No cytotoxicity information found	Not found	18081258	J Nat Prod. 2008 Jan;71(1):47-52.	Wang CK, Colgrave ML, Gustafson KR, Ireland DC, Goransson U, Craik DJ.	Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis.	
DRAMP00835	GGTIFDCGETCFLGTCYTAGCSCGNWGLCYGTN	33	Cycloviolacin-Y3 (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola yedoensis (Chinese herb)	Antimicrobial, Antiviral	Not found	Bridge	Not found		Function: Has anti-HIV activity. PTM: Contains three disulfide bonds.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys7 and Cys21; Cys11 and Cys23; Cys16 and Cys29.	L	No cytotoxicity information found	Not found	18081258	J Nat Prod. 2008 Jan;71(1):47-52.	Wang CK, Colgrave ML, Gustafson KR, Ireland DC, Goransson U, Craik DJ.	Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis.	
DRAMP00836	GVPCGESCVFIPCITGVIGCSCSSNVCYLN	30	Cycloviolacin-Y4 (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola yedoensis (Chinese herb)	Antimicrobial, Antiviral	Not found	Bridge	Not found		Function: Has anti-HIV activity. Cycloviolacins Y4 is more hemolytic than cycloviolacin Y1. PTM: Contains three disulfide bonds.	[Ref.18618891]Effects: H. contortus( IC50=2.01μM, IC99=6.73μM) and T. colubriformis(IC50=2.27μM, IC99=5.26μM).##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=120 nM).	[Ref:18081258] HD50=9.3 μM against human type A red blood cells.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	[Ref.18008336]CEM-SS cells:IC50=1720 nM.	Not found	18081258##18008336##18618891	J Nat Prod. 2008 Jan;71(1):47-52.##Biopolymers. 2008;90(1):51-60.##Chembiochem. 2008 Aug 11;9(12):1939-45. doi: 10.1002/cbic.200800174.	Wang CK, Colgrave ML, Gustafson KR, Ireland DC, Goransson U, Craik DJ.##David C Ireland, Conan K L Wang, Jennifer A Wilson, Kirk R Gustafson, David J Craik##Michelle L Colgrave, Andrew C Kotze, David C Ireland, Conan K Wang, David J Craik	Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis.##Cyclotides as natural anti-HIV agents##The anthelmintic activity of the cyclotides: natural variants with enhanced activity	
DRAMP00837	GIPCAESCVWIPCTVTALVGCSCSDKVCYN	30	Cycloviolacin-Y5 (Plants)	No entry found	Belongs to the cyclotide family	Not found	Viola yedoensis (Chinese herb)	Antimicrobial, Antiviral	Not found	Bridge	Not found		"Function: Has anti-HIV activity. Cycloviolacin Y5 is the most hydrophobic of the cyclotides from V. yedoensis, and is more hemolytic than cycloviolacin Y1.
PTM: Contains three disulfide bonds. "	[Ref.18618891]Effects: H. contortus( IC50=2.28μM, IC99=22.24μM) and T. colubriformis(IC50=2.40μM, IC99=10.97μM).##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=40 nM).	[Ref:18081258] HD50=8.7 μM against human type A red blood cells.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys21; Cys8 and Cys23; Cys13 and Cys28.	L	[Ref.18008336]CEM-SS cells:IC50=1760 nM.	Not found	18081258##18008336##18618891	J Nat Prod. 2008 Jan;71(1):47-52.##Biopolymers. 2008;90(1):51-60.##Chembiochem. 2008 Aug 11;9(12):1939-45. doi: 10.1002/cbic.200800174.	Wang CK, Colgrave ML, Gustafson KR, Ireland DC, Goransson U, Craik DJ.##David C Ireland, Conan K L Wang, Jennifer A Wilson, Kirk R Gustafson, David J Craik##Michelle L Colgrave, Andrew C Kotze, David C Ireland, Conan K Wang, David J Craik	Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis.##Cyclotides as natural anti-HIV agents##The anthelmintic activity of the cyclotides: natural variants with enhanced activity	
DRAMP00838	GIGCGESCVWIPCVSAAIGCSCSNKICYRN	30	Cyclotide phyb-A (Plant defensin)	B3EWH5	Belongs to the cyclotide family	Not found	Petunia hybrida (Petunia)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism (By similarity).
Tissue specificity: Expressed in midvein, lamina and periphery of leaves (at protein level).
Domain: The presence of a 'disulfide through disulfide knot' structurally defines this protein as a knottin.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-2; 8-22; 13-27. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	No cytotoxicity information found	Not found	PubMed ID is not available	J. Biol. Chem. 2012;287:27033-27046.	Poth A.G, Mylne J.S, Grassl J, Lyons R.E, Millar A.H, Colgrave M.L, Craik D.J.	Cyclotides associate with leaf vasculature and are the products of a novel precursor in Petunia (Solanaceae).	
DRAMP00839	GVIPCGESCVFIPCISTVIGCSCKNKVCYRN	31	Cyclotide cter-A (Plant defensin)	P86841	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 5-21; 9-23; 14-28. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00840	GVPCAESCVWIPCTVTALLGCSCKDKVCYLN	31	Cyclotide cter-B (Plant defensin)	P86842	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-21; 8-23; 13-28. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00841	GVPCAESCVWIPCTVTALLGCSCKDKVCYLD	31	Cyclotide cter-C (Plant defensin)	P86843	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-21; 8-23; 13-28. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00842	GIPCAESCVWIPCTVTALLGCSCKDKVCYLN	31	Cyclotide cter-D (Plant defensin)	P86844	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-21; 8-23; 13-28. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00843	GIPCAESCVWIPCTVTALLGCSCKDKVCYLD	31	Cyclotide cter-E (Plant defensin)	P86845	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-21; 8-23; 13-28. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys21; Cys8 and Cys23; Cys13 and Cys28.	L	No cytotoxicity information found	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00844	GIPCGESCVFIPCISSVVGCSCKSKVCYLD	30	Cyclotide cter-F (Plant defensin)	P86846	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00845	GLPCGESCVFIPCITTVVGCSCKNKVCYNN	30	Cyclotide cter-G (Plant defensin)	P86847	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00846	GLPCGESCVFIPCITTVVGCSCKNKVCYND	30	Cyclotide cter-H (Plant defensin)	P86848	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00847	GTVPCGESCVFIPCITGIAGCSCKNKVCYIN	31	Cyclotide cter-I (Plant defensin)	P86849	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 5-21; 9-23; 14-28. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00848	GTVPCGESCVFIPCITGIAGCSCKNKVCYID	31	Cyclotide cter-J (Plant defensin)	P86850	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 5-21; 9-23; 14-28. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00849	HEPCGESCVFIPCITTVVGCSCKNKVCYN	29	Cyclotide cter-K (Plant defensin)	P86851	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00850	HEPCGESCVFIPCITTVVGCSCKNKVCYD	29	Cyclotide cter-L (Plant defensin)	P86852	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00851	GIPCGESCVFIPCITGIAGCSCKSKVCYRN	30	Cyclotide cter-O (Plant defensin)	P86901	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21593408	Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10127-32.	Poth AG, Colgrave ML, Lyons RE, Daly NL, Craik DJ.	Discovery of an unusual biosynthetic origin for circular proteins in legumes.	
DRAMP18323	KKKSGVIPTVSHDCHMNSFQFVFTCCS	27	Nukacin ISK-1(Bacteriocin)	Q9KWM4	Belongs to the lantibiotics family (Class I bacteriocin)	nukA	Staphylococcus warneri ISK-1	Antimicrobial, Antibacterial, Anti-Gram+		Not found	There are one didehydrobutyrine (Dhb): T24; two lanthionines: S11-C25, S18-C26; and one Beta-methyllanthionine: T9-C14.		Nukacin 3299, produced by Staphylococcus simulans 3299, is identical to nukacin ISK-1.Partial known sequence of Warnericin RB4 matches nukacin ISK-1, suggesting a possible identical peptide also produced by Staphylococcus warneri RB4.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid II 	11193411##20627619 	Biosci Biotechnol Biochem. 2000 Nov;64(11):2420-8.##Vet Microbiol. 2010 Nov 20;146(1-2):124-31.	Sashihara T, Kimura H, Higuchi T, Adachi A, Matsusaki H, Sonomoto K, Ishizaki A.##Ceotto H, Holo H, da Costa KF, Nascimento Jdos S, Salehian Z, Nes IF, Bastos Mdo C.	A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure.##Nukacin 3299, a lantibiotic produced by Staphylococcus simulans 3299 identical to nukacin ISK-1.	
DRAMP00853	GIPCGESCVFIPCISTVIGCSCKNKVCYRN	30	Cyclotide cter-Q (Plant defensin)	P86904	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00854	GIPCGESCVFIPCTVTALLGCSCKDKVCYKN	31	Cyclotide cter-R (Plant defensin)	P86903	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00855	GSAFCGETCVLGTCYTPDCSCTALVCLKN	29	Cyclotide cter-N (Plant defensin)	P86900	Belongs to the cyclotide family	Not found	Clitoria ternatea (Butterfly pea)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 5-19; 9-21; 14-26. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21194241	ACS Chem Biol. 2011 Apr 15;6(4):345-355.	Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, Craik DJ.	Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins.	
DRAMP00857	GLPVCGETCFGGTCNTPGCSCTWPICTRD	29	Kalata-B2 (Plant defensin)	P58454	Belongs to the cyclotide family	OAK4	Oldenlandia affinis	Insecticidal	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Inhibitory effect on the growth and development of Helicoverpa armigera larvae suggests a role for the cyclotides in plant defense. Has hemolytic activity.
PTM: Kalata-B2 is a cyclic peptide which contains three disulfide bonds 5-19; 9-21; 14-26."	[Ref.17534989]Insects: Helicoverpa armigera	[Ref.20564013] HD50=3.3±1.9 μM against Human red blood cells .	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19,Cys9 and Cys21,Cys14 and Cys26.	L	No cytotoxicity information found	Not found	10600388##15654741##17534989##20564013	"J Mol Biol. 1999 Dec 17;294(5):1327-1336.##Biochemistry. 2005 Jan 25;44(3):851-860.##Chembiochem. 2007 Jun 18;8(9):1001-1011.##Biopolymers
. 2010;94(5):647-58."	Craik DJ, Daly NL, Bond T, Waine C.##Jennings CV, Rosengren KJ, Daly NL, Plan M, Stevens J, Scanlon MJ, Waine C, Norman DG, Anderson MA, Craik DJ.##Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.##Manuel R Plan, K Johan Rosengren, Lillian Sando, Norelle L Daly, David J Craik	Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.##Isolation, solution structure, and insecticidal activity of kalata B2, a circular protein with a twist: do Möbius strips exist in nature?##The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.##Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis	
DRAMP00858	GLPTCGETCFGGTCNTPGCTCDPWPICTRD	30	Kalata-B3 (Plant defensin)	P58455	Belongs to the cyclotide family	OAK2	Oldenlandia affinis	Insecticidal	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Has hemolytic activity.
PTM: Kalata-B3 are cyclic peptides which may contain three disulfide bonds 5-19; 9-21; 14-27."	No MICs found in DRAMP database	[Ref:11535828] It has hemolytic activity	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys27.	L	No cytotoxicity information found	Not found	11535828	Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10614-9.	Jennings C, West J, Waine C, Craik D, Anderson M.	Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis.	
DRAMP00859	GLPVCGETCVGGTCNTPGCTCSWPVCTRD	29	Kalata-B4 (Plant defensin)	P83938	Belongs to the cyclotide family	Not found	Oldenlandia affinis	Not found	Protein level	Beta strand (4 strands; 10 residues)	The charged residues (Glu3 and Arg24), along with the cation-binding site (near Glu3) are segregated on the other side of the molecule and in contact with polar head groups of detergent. The spatial structure of kalata B1 is only slightly changed during incorporation into micelles and represents a distorted triple-stranded beta-sheet cross-linked by a cystine knot. Detailed structural analysis and comparison with other knottins revealed	1ZNU resolved by NMR.	"Function: Probably participates in a plant defense mechanism.
PTM: Kalata-B4 is a cyclic peptide which may contain three disulfide bonds 5-19; 9-21; 14-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.	L	No cytotoxicity information found	Binds to the micelle surface	10600388##16817894	J Mol Biol. 1999 Dec 17;294(5):1327-1336.##FEBS J. 2006 Jun;273(12):2658-2672.	Craik DJ, Daly NL, Bond T, Waine C.##Shenkarev ZO, Nadezhdin KD, Sobol VA, Sobol AG, Skjeldal L, Arseniev AS.	Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.##Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle.	
DRAMP00860	TPCGESCVYIPCISGVIGCSCTDKVCYLN	29	Kalata-B5 (Plant defensin)	P58456	Belongs to the cyclotide family	Not found	Oldenlandia affinis	Not found	Protein level	Combine helix and strand structure	It displays a typical tightly folded cyclic Scystine knot structure. A range of pH and temperature titrations reveal that a conserved glutamic acid in loop 1 Sof the structure forms a key hydrogen bond network, similar to that reported previously for other cyclotides.	2KUX resolved by NMR.	"Function: Probably participates in a plant defense mechanism.
PTM: Kalata-B5 is a cyclic peptide which contains three disulfide bonds 4-20; 8-22; 13-27."	No MICs found in DRAMP database	[Ref.20564013] HD50=27.4±1.2 μM against Human red blood cells .	Cyclic	No specific N-terminal	No specific C-terminal	"Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.Hydrogen bonds between the side chain carboxyl group of Glu6 and the backbone amide protons of Ile14 and Ser15, as well as the side
chain hydroxyl proton of Ser15. "	L	No cytotoxicity information found	Not found	10600388##17534989##20564013	J Mol Biol. 1999 Dec 17;294(5):1327-1336.##Chembiochem. 2007 Jun 18;8(9):1001-1011.##Biopolymers. 2010;94(5):647-658.	Craik DJ, Daly NL, Bond T, Waine C.##Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.##Plan MR, Rosengren KJ, Sando L, Daly NL, Craik DJ.	Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.##The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.##Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.	
DRAMP00861	GLPVCGETCFGGTCNTPGCSCSSWPICTRN	30	Kalata-B6 (Plant defensin)	P58455	Belongs to the cyclotide family	OAK2	Oldenlandia affinis	Insecticidal	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Has hemolytic activity.
PTM: Kalata-B6 are cyclic peptides which may contain three disulfide bonds 5-19; 9-21; 14-27."	No MICs found in DRAMP database	[Ref.20564013] HD50=7.7±1.3 μM against Human red blood cells.	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19,Cys9 and Cys21,Cys14 and Cys27.	L	No cytotoxicity information found	cell membrabce	17534989	Chembiochem. 2007 Jun 18;8(9):1001-1011.	Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.	The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.	
DRAMP00862	GLPVCGETCTLGTCYTQGCTCSWPICKRN	29	Kalata-B7 (Plant defensin)	P58457	Belongs to the cyclotide family	OAK3	Oldenlandia affinis	Not found	Protein level	Bridge	Not found	2M9O##2JWM	"Function: Probably participates in a plant defense mechanism. Has hemolytic activity.
PTM: Kalata-B7 are cyclic peptides which may contain three disulfide bonds 5-19; 9-21; 14-27."	No MICs found in DRAMP database	[Ref.20564013] HD50=55.2±1.3 μM against Human red blood cells .	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19,Cys9 and Cys21,Cys14 and Cys27.	L	No cytotoxicity information found	cell membrabce	17534989	Chembiochem. 2007 Jun 18;8(9):1001-1011.	Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.	The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.	
DRAMP00863	GSVLNCGETCLLGTCYTTGCTCNKYRVCTKD	31	Kalata-B8 (Plant defensin)	P85175	Belongs to the cyclotide family	Not found	Oldenlandia affinis	Antimicrobial, Antiviral	Protein level	Beta strand (3 strands; 7 residues)	Not found	2B38 resolved by NMR.	"Function: Probably participates in a plant defense mechanism. Inhibits the cytopathic effects of the human immunodeficiency virus. Has no hemolytic activity.
PTM: Kalata-B8 is a cyclic peptide which contains three disulfide bonds 6-20; 10-22; 15-28."	[Ref.16207177]Virus: Human T-lymphoblast (CEM-SS) cells (EC50=2.5 µM).##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=2500 nM).	[Ref.20564013] It produced 7% hemolysis at the 62μM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Disulfide bonds between Cys6 and Cys20; Cys10 and Cys22; Cys15 and Cys28.	L	[Ref.16207177] Kalata B8 inhibited the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells with an antiviral cytoprotective concentration (EC50) of approx. 2.5 μM, while the cytotoxic concentration (IC50) was >11 μM. ##[Ref.18008336]CEM-SS cells:IC50>11000 nM.	Not found	18008336##16207177##17534989	Biopolymers. 2008;90(1):51-60.##Biochem J. 2006 Feb 1;393(Pt 3):619-626.##Chembiochem. 2007 Jun 18;8(9):1001-1011.	Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. ##Daly NL, Clark RJ, Plan MR, Craik DJ.##Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.	Cyclotides as natural anti-HIV agents.##Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif.##The cyclotide fingerprint in Oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.	CC(C)C[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N4)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC3=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2
DRAMP00864	GSVFNCGETCVLGTCYTPGCTCNTYRVCTKD	31	Kalata-B9 (Plant defensin)	P85127	Belongs to the cyclotide family	Not found	Oldenlandia affinis	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Kalata-B9 is a cyclic peptide which contains three disulfide bonds 6-20; 10-22; 15-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys6 and Cys20; Cys10 and Cys22; Cys15 and Cys28.	L	No cytotoxicity information found	Not found	17534989	Chembiochem. 2007 Jun 18;8(9):1001-1011.	Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.	The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.	
DRAMP00865	ESEFDRQEYEECKRQCMQLETSGQMRRCVSQCDKRFEEDIDWSKYDNQE	49	Vicilin-like Antimicrobial peptide 2a (MiAMP2a; Plant defensin)	Q9SPL5	Belongs to the vicilin-like family	AMP2-1	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database.	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml).##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP00866	GLPTCGETCFGGTCNTPGCSCSSWPICTRD	30	Kalata-B10 (Plant defensin)	P85128	Belongs to the cyclotide family	Not found	Oldenlandia affinis	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Kalata-B10 are cyclic peptides which may contain three disulfide bonds 5-19; 9-21; 14-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19,Cys9 and Cys21,Cys14 and Cys27.	L	No cytotoxicity information found	Not found	17534989	Chembiochem. 2007 Jun 18;8(9):1001-1011.	Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.	The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.	
DRAMP00867	GLPVCGETCFGGTCNTPGCSCTDPICTRD	29	Kalata-B11 (Plant defensin)	P85129	Belongs to the cyclotide family	Not found	Oldenlandia affinis	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Kalata-B11 are cyclic peptides which may contain three disulfide bonds 5-19; 9-21; 14-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19,Cys9 and Cys21,Cys14 and Cys26.	L	No cytotoxicity information found	Not found	17534989	Chembiochem. 2007 Jun 18;8(9):1001-1011.	Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.	The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.	
DRAMP00868	GSLCGDTCFVLGCNDSSCSCNYPICVKD	28	Kalata-B12 (Plant defensin)	P85130	Belongs to the cyclotide family	Not found	Oldenlandia affinis	Not found	Protein level	Beta strand (3 strands; 11 residues)	Not found	2KVX resolved by NMR.	"Function: Probably participates in a plant defense mechanism.
PTM: Kalata-B12 are cyclic peptides which may contain three disulfide bonds 4-18; 8-20; 13-25."	No MICs found in DRAMP database	[Ref.21466163] It has almost negligible hemolytic activity.	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys18,Cys8 and Cys20,Cys13 and Cys25.	L	No cytotoxicity information found	Not found	17534989##21466163	Chembiochem. 2007 Jun 18;8(9):1001-1011.##Biochemistry. 2011 May 17;50(19):4077-4086.	Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.##Wang CK, Clark RJ, Harvey PJ, Rosengren KJ, Cemazar M, Craik DJ.	The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.##The role of conserved Glu residue on cyclotide stability and activity: a structural and functional study of kalata B12, a naturally occurring Glu to Asp mutant.	
DRAMP00869	GLPVCGETCFGGTCNTPGCACDPWPVCTRD	30	Kalata-B13 (Plant defensin)	P85131	Belongs to the cyclotide family	Not found	Oldenlandia affinis	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Kalata-B13 are cyclic peptides which may contain three disulfide bonds 5-19; 9-21; 14-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19,Cys9 and Cys21,Cys14 and Cys27.	L	No cytotoxicity information found	Not found	17534989	Chembiochem. 2007 Jun 18;8(9):1001-1011.	Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.	The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.	
DRAMP00870	GLPVCGESCFGGTCNTPGCACDPWPVCTRD	30	Kalata-B14 (Plant defensin)	P85132	Belongs to the cyclotide family	Not found	Oldenlandia affinis	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Kalata-B14 are cyclic peptides which may contain three disulfide bonds 5-19; 9-21; 14-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19,Cys9 and Cys21,Cys14 and Cys27.	L	No cytotoxicity information found	Not found	17534989	Chembiochem. 2007 Jun 18;8(9):1001-1011.	Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.	The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.	
DRAMP00871	GLPVCGESCFGGSCYTPGCSCTWPICTRD	29	Kalata-B15 (Plant defensin)	P85133	Belongs to the cyclotide family	Not found	Oldenlandia affinis	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Kalata-B15 are cyclic peptides which may contain three disulfide bonds 5-19; 9-21; 14-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19,Cys9 and Cys21,Cys14 and Cys27.	L	No cytotoxicity information found	Not found	17534989	Chembiochem. 2007 Jun 18;8(9):1001-1011.	Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.	The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.	
DRAMP00872	GIPCAESCVYIPCTITALLGCKCQDKVCYD	30	Kalata-B16 (Plant defensin)	P85134	Belongs to the cyclotide family	Not found	Oldenlandia affinis	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Kalata-B16 are cyclic peptides which may contain three disulfide bonds 4-21; 8-23; 13-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys21,Cys8 and Cys23,Cys13 and Cys28.	L	No cytotoxicity information found	Not found	17534989	Chembiochem. 2007 Jun 18;8(9):1001-1011.	Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.	The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.	
DRAMP00873	GIPCAESCVYIPCTITALLGCKCKDQVCYN	30	Kalata-B17 (Plant defensin)	P85135	Belongs to the cyclotide family	Not found	Oldenlandia affinis	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Kalata-B16 are cyclic peptides which may contain three disulfide bonds 4-21; 8-23; 13-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys21,Cys8 and Cys23,Cys13 and Cys28.	L	No cytotoxicity information found	Not found	17534989	Chembiochem. 2007 Jun 18;8(9):1001-1011.	Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.	The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.	
DRAMP00875	SISCGESCAMISFCFTEVIGCSCKNKVCYLN	31	Leaf cyclotide 1 (Vhl-1; Plant defensin)	P84522	Belongs to the cyclotide family	Not found	Viola hederacea (Australian violet)	Antimicrobial, Antiviral	Protein level	Combine helix and strand structure	Vhl-1 adopts a compact and well defined structure including a distorted triple-stranded beta-sheet, a short 3(10) helical segment and several turns. It is stabilized by three disulfide bonds, which, together with backbone segments, form a cyclic cystine knot motif. The three-disulfide bonds are almost completely buried into the protein core, and the six cysteines contribute only 3.8% to the molecular surface.	1ZA8 resolved by NMR.	"Function: Probably participates in a plant defense mechanism. Has anti-human immunodeficiency virus activity.
Tissue specificity: Expressed in leaves.
PTM: Vhl-1 is a cyclic peptide which contains three disulfide bonds 4-21; 8-23; 14-28."	[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=870 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys21; Cys8 and Cys23; Cys13 and Cys28.	L	No cytotoxicity information found in the reference(s) presented	Not found	18008336##15824119	Biopolymers. 2008;90(1):51-60.##J Biol Chem. 2005 Jun 10;280(23):22395-22405.	Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. ##Chen B, Colgrave ML, Daly NL, Rosengren KJ, Gustafson KR, Craik DJ.	Cyclotides as natural anti-HIV agents.##Isolation and characterization of novel cyclotides from Viola hederaceae: solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide.	
DRAMP00876	GLPVCGETCFTGTCYTNGCTCDPWPVCTRN	30	Leaf cyclotide 2 (Vhl-2; Plant defensin)	P85231	Belongs to the cyclotide family	Not found	Viola hederacea (Australian violet)	Antimicrobial, Antiviral	Protein level	Beta strand (5 strands; 6 residues)	Analysis of surface hydrophobicity and haemolytic activity for a range of cyclotides indicates a correlation between them, with increasing hydrophobicity resulting in increased haemolytic activity.	2KUK resolved by NMR.	"Function: Probably participates in a plant defense mechanism. Has hemolytic activity.
Tissue specificity: Expressed in leaves.
PTM: This is a cyclic peptide which contains three disulfide bonds 5-19; 9-21; 14-27."	[Ref.15824119]Virus: HIV(EC50= 0.87 μM)	[Ref:15824119]Has hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	cell membrabce	15824119##Pubmed ID is not available	J Biol Chem. 2005 Jun 10;280(23):22395-22405.##Aust. J. Chem. 2010;63:771-778.	Chen B, Colgrave ML, Daly NL, Rosengren KJ, Gustafson KR, Craik DJ.##Daly NL, Chen B, Nguyencong P, Craik DJ.	Isolation and characterization of novel cyclotides from Viola hederaceae: solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide.##Structure and activity of the leaf-specific cyclotide vhl-2.	
DRAMP00879	GIPCGESCVFIPCITSVAGCSCKSKVCYRN	30	Circulin-C (CIRC; Plant defensin)	P84641	Belongs to the cyclotide family	Not found	Chassalia parviflora 	Antimicrobial, Antiviral	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Inhibits the cytopathic effects of the human immunodeficiency virus.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27."	[Ref.10691702]Virus: HIV-1 (EC50= 50-275 nM).##NOTE: EC50 = concentration that is 50% effective.##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=50-275 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27.	L	No cytotoxicity information found in the reference(s) presented	Not found	10691702##18008336	J Nat Prod. 2000 Feb;63(2):176-178.##Biopolymers. 2008;90(1):51-60.	Gustafson KR, Walton LK, Sowder RC Jr, Johnson DG, Pannell LK, Cardellina JH Jr, Boyd MR.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. 	New circulin macrocyclic polypeptides from Chassalia parvifolia.##Cyclotides as natural anti-HIV agents.	
DRAMP00880	KIPCGESCVWIPCVTSIFNCKCKENKVCYHD	31	Circulin-D (CIRD; Plant defensin)	P84642	Belongs to the cyclotide family	Not found	Chassalia parviflora 	Antimicrobial, Antiviral	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Inhibits the cytopathic effects of the human immunodeficiency virus.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27."	[Ref.10691702]Virus: HIV-1 (EC50= 50-275 nM).##NOTE: EC50 = concentration that is 50% effective.##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=50-275 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27.	L	No cytotoxicity information found in the reference(s) presented	Not found	10691702##18008336	J Nat Prod. 2000 Feb;63(2):176-178.##Biopolymers. 2008;90(1):51-60.	Gustafson KR, Walton LK, Sowder RC Jr, Johnson DG, Pannell LK, Cardellina JH Jr, Boyd MR.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. 	New circulin macrocyclic polypeptides from Chassalia parvifolia.##Cyclotides as natural anti-HIV agents.	
DRAMP00881	KIPCGESCVWIPCLTSVFNCKCENKVCYHD	30	Circulin-E (CIRE; Plant defensin)	P84643	Belongs to the cyclotide family	Not found	Chassalia parviflora 	Antimicrobial, Antiviral	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Inhibits the cytopathic effects of the human immunodeficiency virus.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27."	[Ref.10691702]Virus: HIV-1 (EC50= 50-275 nM).##NOTE: EC50 = concentration that is 50% effective.##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=50-275 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27.	L	No cytotoxicity information found in the reference(s) presented	Not found	10691702##18008336	J Nat Prod. 2000 Feb;63(2):176-178.##Biopolymers. 2008;90(1):51-60.	Gustafson KR, Walton LK, Sowder RC Jr, Johnson DG, Pannell LK, Cardellina JH Jr, Boyd MR.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. 	New circulin macrocyclic polypeptides from Chassalia parvifolia.##Cyclotides as natural anti-HIV agents.	
DRAMP00882	KVCYRAIPCGESCVWIPCISAAIGCSCKN	29	Circulin-F (CIRF; Plant defensin)	P84644	Belongs to the cyclotide family	Not found	Chassalia parviflora	Antimicrobial, Antiviral	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Inhibits the cytopathic effects of the human immunodeficiency virus.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-20; 8-22; 13-27."	[Ref.10691702]Virus: HIV-1 (EC50= 50-275 nM).##NOTE: EC50 = concentration that is 50% effective.##[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=50-275 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27.	L	No cytotoxicity information found in the reference(s) presented	Not found	10691702##18008336	J Nat Prod. 2000 Feb;63(2):176-178.##Biopolymers. 2008;90(1):51-60.	Gustafson KR, Walton LK, Sowder RC Jr, Johnson DG, Pannell LK, Cardellina JH Jr, Boyd MR.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. 	New circulin macrocyclic polypeptides from Chassalia parvifolia.##Cyclotides as natural anti-HIV agents.	
DRAMP00883	SCVYIPCTITALLGCSCKNKVCYNGIPCAE	30	Cyclotide hypa-A (hypa-A; Plant defensin)	P58445	Belongs to the cyclotide family	Not found	Hybanthus parviflorus (Violetilla) (Viola parvifloria)	Not found	Protein level	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		"Function: Probably participates in a plant defense mechanism.
Domain: The presence of a 'disulfide through disulfide knot' structurally defines this protein as a knottin.
PTM: This is a cyclic peptide which contains three disulfide bonds 4-21; 8-23; 13-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11524112	Phytochemistry. 2001 Sep;58(1):47-51.	Broussalis AM, Göransson U, Coussio JD, Ferraro G, Martino V, Claeson P.	First cyclotide from Hybanthus (Violaceae).	
DRAMP00884	SISCGESCVYIPCTVTALVGCTCKDKVCYLN	31	Cyclotide hyfl-A (Plant defensin)	P84647	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Protein level	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		"Function: Probably participates in a plant defense mechanism.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-21; 8-23; 13-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00885	GSPIQCAETCFIGKCYTEELGCTCTAFLCMKN	32	Cyclotide hyfl-B (Plant defensin)	P84648	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Protein level	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		"Function: Probably participates in a plant defense mechanism.
PTM: This is is a cyclic peptide which may contain three disulfide bonds 6-22; 10-24; 15-29."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00886	GSPRQCAETCFIGKCYTEELGCTCTAFLCMKN	32	Cyclotide hyfl-C (Plant defensin)	P84649	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Protein level	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		"Function: Probably participates in a plant defense mechanism.
PTM: This is is a cyclic peptide which may contain three disulfide bonds 4-21; 8-23; 13-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00887	GSVPCGESCVYIPCFTGIAGCSCKSKVCYYN	31	Cyclotide hyfl-D (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00888	GEIPCGESCVYLPCFLPNCYCRNHVCYLN	29	Cyclotide hyfl-E (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00889	SISCGETCTTFNCWIPNCKCNHHDKVCYWN	30	Cyclotide hyfl-F (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00890	CAETCVVLPCFIVPGCSCKSSVCYFN	26	Cyclotide hyfl-G (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00891	CAETCIYIPCFTEAVGCKCKDKVCYKN	27	Cyclotide hyfl-H (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00892	GIPCGESCVFIPCISGVIGCSCKSKVCYRN	30	Cyclotide hyfl-I (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00893	GIACGESCAYFGCWIPGCSCRNKVCYFN	28	Cyclotide hyfl-J (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00894	GTPCGESCVYIPCFTAVVGCTCKDKVCYLN	30	Cyclotide hyfl-K (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00895	GTPCAESCVYLPCFTGVIGCTCKDKVCYLN	30	Cyclotide hyfl-L (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00896	GNIPCGESCIFFPCFNPGCSCKDNLCYYN	29	Cyclotide hyfl-M (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00897	CGETCVILPCISAALGCSCKDTVCYKN	27	Cyclotide hyfl-N (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00898	CGETCVIFPCISAAFGCSCKDTVCYKN	27	Cyclotide hyfl-O (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00899	CVWIPCISGIAGCSCKNKVCYLN	23	Cyclotide hyfl-P (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus floribundus (Greenviolet)	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Function: Probably participates in a plant defense mechanism.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00900	CGETCLFIPCIFSVVGCSCSSKVCYRN	27	Hymo A (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus monopetalus	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Caution: The sequence is incomplete!	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00901	CGETCVTGTCYTPGCACDWPVCKRD	25	Hymo B (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Hybanthus monopetalus	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Caution: The sequence is incomplete!	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00902	CGETCIWGRCYSENIGCHCGFGICTLN	27	Hyst A (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Australian Hybanthusstellarioides	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Caution: The sequence is incomplete!	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00903	RGCYKICGETCLFIPCLTSVFGCSCKN	27	Hyve A (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Australian Hybanthus vernonii	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Caution: The sequence is incomplete!	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00904	CGETCVVDTRCYTKKCSCAWPVCMRN	26	Hyca A (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Australian Hybanthus calycinus	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Caution: The sequence is incomplete!	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00905	CVWIPCISAAIGCSCKSKVCYRN	23	Hyde A (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Australian Hybanthus debilissimus	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Caution: The sequence is incomplete!	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00906	CGESCVYIPCTVTALLGCSCKDKVCYKN	28	Hyen A (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Australian Hybanthus enneaspermus	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 	7S55	Caution: The sequence is incomplete!	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00907	CGETCKVTKRCSGQGCSCLKGRSCYD	26	Hyen B (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Australian Hybanthus enneaspermus	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Caution: The sequence is incomplete!	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00908	CGETCVVLPCFIVPGCSCKSSVCYFN	26	Hyep A (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Australian Hybanthus epacroides	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Caution: The sequence is incomplete!	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00909	CGETCIYIPCFTEAVGCKCKDKVCYKN	27	Hyep B (Plant defensin)	No entry found	Belongs to the cyclotide family	Not found	Australian Hybanthus epacroides	Not found	Not found	Bridge	Cyclotides are plant-derived miniproteins that have the unusual features of a head-to-tail cyclized peptide backbone and a knotted arrangement of disulfide bonds. 		Caution: The sequence is incomplete!	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16199617	Plant Cell. 2005 Nov;17(11):3176-3189.	Simonsen SM, Sando L, Ireland DC, Colgrave ML, Bharathi R, Göransson U, Craik DJ.	A continent of plant defense peptide diversity: cyclotides in Australian Hybanthus (Violaceae).	
DRAMP00910	GGTIFDCGESCFLGTCYTKGCSCGEWKLCYGTN	33	Tricyclon-A (Cyclotides; Plant defensin)	P0C589	Belongs to the cyclotide family	Not found	Viola arvensis (European field pansy) (Field violet)	Not found	Protein level	Beta strand (3 strands; 13 residues)	Not found	1YP8 resolved by NMR.	"Function: Probably participates in a plant defense mechanism. Has a weak hemolytic activity.
PTM: Contains three disulfide bonds 7-21; 11-23; 16-29. Proteolytically processed in two steps to yield first two linear precursors, and then two cyclic peptides after removal of the N-terminal repeats (NTR) and short tails."	Cytolysis	[Ref:15893660] It has 2% hemolytic activity at 500 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys7 and Cys21, Cys11 and Cys23, Cys16 and Cys29.	L	No cytotoxicity information found	Not found	15893660	Structure. 2005 May;13(5):691-701.	Mulvenna JP, Sando L, Craik DJ.	Processing of a 22 kDa precursor protein to produce the circular protein tricyclon A.	
DRAMP00911	GGTIFDCGESCFLGTCYTKGCSCGEWKLCYGEN	33	Tricyclon-B (Plant defensin)	P0C589	Belongs to the cyclotide family	Not found	Viola arvensis (European field pansy) (Field violet)	Not found	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Problely contains three disulfide bonds 7-21; 11-23; 16-29. Proteolytically processed in two steps to yield first two linear precursors, and then two cyclic peptides after removal of the N-terminal repeats (NTR) and short tails."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys7 and Cys21, Cys11 and Cys23, Cys16 and Cys29.	L	No cytotoxicity information found	Not found	15893660	Structure. 2005 May;13(5):691-701.	Mulvenna JP, Sando L, Craik DJ.	Processing of a 22 kDa precursor protein to produce the circular protein tricyclon A.	
DRAMP00912	GIPCAESCVWIPCTVTALLGCSCSNKVCYN	30	Root cyclotide 1 (Vhr1; Plant defensin)	P83937	Belongs to the cyclotide family	Not found	Viola hederacea (Australian violet)	Not found	Protein level	Combine helix and strand structure	Not found	1VB8 resolved by NMR.	"Function: Probably participates in a plant defense mechanism.
Tissue specificity: Expressed in roots.
PTM: Contains three disulfide bonds 4-21; 8-23; 13-28. This is a cyclic peptide (cross-link at G1-N30)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys21, Cys8 and Cys23,Cys13 and Cys28.	L	No cytotoxicity information found	Not found	15295104	Plant Cell. 2004 Aug;16(8):2204-2216.	Trabi M, Craik DJ.	Tissue-specific expression of head-to-tail cyclized miniproteins in Violaceae and structure determination of the root cyclotide Viola hederacea root cyclotide1.	
DRAMP00913	GLPVCGETCFGGTCNTPGCSCSYPICTRN	29	Cyclotide vibi-A (Plant defensin)	P85239	Belongs to the cyclotide family	Not found	Viola biflora (Yellow wood violet)	Cytotoxic	Protein level	Bridge	The cyclotides are head-to-tail macrocyclic and they have three disulfides arranged in a cystine knot, in which two disulfide bonds and their connecting backbone segments form an embedded ring that is penetrated by the third disulfide bond. Cyclotides exhibit a broad range of biological effects, including insecticidal, haemolytic, and cytotoxic effects.		"Function: Probably participates in a plant defense mechanism and shows potent cytotoxic activity.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26. This is a cyclic peptide (cross-link between G1-N29)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19,Cys9 and Cys21,Cys14 and Cys26.	L	No cytotoxicity information found	Not found	18191970	Phytochemistry. 2008 Feb;69(4):939-952.	Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00914	GLPVCGETCFGGTCNTPGCTCSYPICTRN	29	Cyclotide vibi-B (Plant defensin)	P85240	Belongs to the cyclotide family	Not found	Viola biflora (Yellow wood violet)	Cytotoxic	Protein level	Bridge	The cyclotides are head-to-tail macrocyclic and they have three disulfides arranged in a cystine knot, in which two disulfide bonds and their connecting backbone segments form an embedded ring that is penetrated by the third disulfide bond. Cyclotides exhibit a broad range of biological effects, including insecticidal, haemolytic, and cytotoxic effects.		"Function: Probably participates in a plant defense mechanism and shows potent cytotoxic activity.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26. This is a cyclic peptide (cross-link between G1-N29).
Note: Sequence uncertainty at position 2 (L or I)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19,Cys9 and Cys21,Cys14 and Cys26.	L	No cytotoxicity information found	Not found	18191970	Phytochemistry. 2008 Feb;69(4):939-952.	Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00915	GLPVCGETCAFGSCYTPGCSCSWPVCTRN	29	Cyclotide vibi-C (Plant defensin)	P85241	Belongs to the cyclotide family	Not found	Viola biflora (Yellow wood violet)	Cytotoxic	Protein level	Bridge	The cyclotides are head-to-tail macrocyclic and they have three disulfides arranged in a cystine knot, in which two disulfide bonds and their connecting backbone segments form an embedded ring that is penetrated by the third disulfide bond. Cyclotides exhibit a broad range of biological effects, including insecticidal, haemolytic, and cytotoxic effects.		"Function: Probably participates in a plant defense mechanism and shows potent cytotoxic activity.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26. This is a cyclic peptide (cross-link between G1-N29)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys19,Cys9 and Cys21,Cys14 and Cys26.	L	No cytotoxicity information found	Not found	18191970	Phytochemistry. 2008 Feb;69(4):939-952.	Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00916	GLPVCGETCFGGRCNTPGCTCSYPICTRN	29	Cyclotide vibi-D (Plant defensin)	P85242	Belongs to the cyclotide family	Not found	Viola biflora (Yellow wood violet)	Cytotoxic	Protein level	Bridge	The cyclotides are head-to-tail macrocyclic and they have three disulfides arranged in a cystine knot, in which two disulfide bonds and their connecting backbone segments form an embedded ring that is penetrated by the third disulfide bond. Cyclotides exhibit a broad range of biological effects, including insecticidal, haemolytic, and cytotoxic effects.		"Function: Probably participates in a plant defense mechanism. Has moderate levels of cytotoxic activity.
PTM: Contains three disulfide bonds 5-21; 9-23; 14-28. This is a cyclic peptide (cross-link at G1-N29)."	Human lymphoma cell line U-937 GTB (IC50>30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys21; Cys9 and Cys23; Cys14 and Cys28.	L	[Ref.18191970] Cytotoxicity: Human lymphoma cell line U-937 GTB (IC50>30 µM).	Not found	18191970	Phytochemistry. 2008 Feb;69(4):939-952.	Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00917	GIPCAESCVWIPCTVTALIGCGCSNKVCYN	30	Cyclotide vibi-E (Vbc1; Plant defensin)	B1NRQ8, P85243	Belongs to the cyclotide family	Not found	Viola biflora (Yellow wood violet)	Cytotoxic	Protein level	Bridge	The cyclotides are head-to-tail macrocyclic and they have three disulfides arranged in a cystine knot, in which two disulfide bonds and their connecting backbone segments form an embedded ring that is penetrated by the third disulfide bond. Cyclotides exhibit a broad range of biological effects, including insecticidal, haemolytic, and cytotoxic effects.		"Function: Probably participates in a plant defense mechanism. Has cytotoxic activity.
PTM: Contains three disulfide bonds 4-21; 8-23; 13-28. This is a cyclic peptide (cross-link at G1-N3)."	Human lymphoma cell line U-937 GTB (IC50=3.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys4 and Cys21, Cys8 and Cys23,Cys13 and Cys28.	L	[Ref.18191970] Cytotoxicity: Human lymphoma cell line U-937 GTB (IC50=3.2 µM).	Not found	18191970	Phytochemistry. 2008 Feb;69(4):939-952.	Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00918	GTIPCGESCVFIPCLTSALGCSCKSKVCYKN	31	Cyclotide vibi-F (Plant defensin)	P85244	Belongs to the cyclotide family	Not found	Viola biflora (Yellow wood violet)	Cytotoxic	Protein level	Bridge	The cyclotides are head-to-tail macrocyclic and they have three disulfides arranged in a cystine knot, in which two disulfide bonds and their connecting backbone segments form an embedded ring that is penetrated by the third disulfide bond. Cyclotides exhibit a broad range of biological effects, including insecticidal, haemolytic, and cytotoxic effects.		"Function: Probably participates in a plant defense mechanism and shows potent cytotoxic activity.
PTM: Contains three disulfide bonds 5-21; 9-23; 14-28. This is a cyclic peptide (cross-link at G1-N31)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys21; Cys9 and Cys23; Cys14 and Cys28.	L	No cytotoxicity information found	Not found	18191970	Phytochemistry. 2008 Feb;69(4):939-952.	Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00919	GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN	31	Cyclotide vibi-G (Plant defensin)	P85245	Belongs to the cyclotide family	Not found	Viola biflora (Yellow wood violet)	Cytotoxic	Protein level	Bridge	The cyclotides are head-to-tail macrocyclic and they have three disulfides arranged in a cystine knot, in which two disulfide bonds and their connecting backbone segments form an embedded ring that is penetrated by the third disulfide bond. Cyclotides exhibit a broad range of biological effects, including insecticidal, haemolytic, and cytotoxic effects.		"Function: Probably participates in a plant defense mechanism. Has cytotoxic activity.
PTM: Contains three disulfide bonds 5-21; 9-23; 14-28. This is a cyclic peptide (cross-link at G1-N31)."	Human lymphoma cell line U-937 GTB (IC50=0.96 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys21; Cys9 and Cys23; Cys14 and Cys28.	L	[Ref.18191970] Cytotoxicity: Human lymphoma cell line U-937 GTB (IC50=0.96 µM).	Not found	18191970	Phytochemistry. 2008 Feb;69(4):939-952.	Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00920	GLLPCAESCVYIPCLTTVIGCSCKSKVCYKN	31	Cyclotide vibi-H (Plant defensin)	P85246	Belongs to the cyclotide family	Not found	Viola biflora (Yellow wood violet)	Cytotoxic	Protein level	Bridge	The cyclotides are head-to-tail macrocyclic and they have three disulfides arranged in a cystine knot, in which two disulfide bonds and their connecting backbone segments form an embedded ring that is penetrated by the third disulfide bond. Cyclotides exhibit a broad range of biological effects, including insecticidal, haemolytic, and cytotoxic effects.		"Function: Probably participates in a plant defense mechanism. Has cytotoxic activity.
PTM: Contains three disulfide bonds 5-21; 9-23; 14-28. This is a cyclic peptide (cross-link at G1-N31)."	Human lymphoma cell line U-937 GTB (IC50=1.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys5 and Cys21; Cys9 and Cys23; Cys14 and Cys28.	L	[Ref.18191970] Cytotoxicity: Human lymphoma cell line U-937 GTB (IC50=1.6 µM).	Not found	18191970	Phytochemistry. 2008 Feb;69(4):939-952.	Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00921	GIPCGESCVWIPCLTSTVGCSCKSKVCYRN	30	Cyclotide vibi-I (Vbc2; Plant defensin)	B1NRQ9	Belongs to the cyclotide family	Not found	Viola biflora (Yellow wood violet)	Cytotoxic	Protein level	Bridge	The cyclotides are head-to-tail macrocyclic and they have three disulfides arranged in a cystine knot, in which two disulfide bonds and their connecting backbone segments form an embedded ring that is penetrated by the third disulfide bond. Cyclotides exhibit a broad range of biological effects, including insecticidal, haemolytic, and cytotoxic effects.		"Function: Probably participates in a plant defense mechanism.
PTM: Contains three disulfide bonds 4-20; 8-22; 13-27. This is a cyclic peptide (cross-link at G1-N30)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18191970	Phytochemistry. 2008 Feb;69(4):939-952.	Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00922	GTFPCGESCVWIPCISKVIGCACKSKVCYKN	31	Cyclotide vibi-J (Vbc3; Plant defensin)	B1NRR0	Belongs to the cyclotide family	Not found	Viola biflora (Yellow wood violet)	Cytotoxic	Protein level	Bridge	The cyclotides are head-to-tail macrocyclic and they have three disulfides arranged in a cystine knot, in which two disulfide bonds and their connecting backbone segments form an embedded ring that is penetrated by the third disulfide bond. Cyclotides exhibit a broad range of biological effects, including insecticidal, haemolytic, and cytotoxic effects.		"Function: Probably participates in a plant defense mechanism and shows potent cytotoxic activity.
PTM: Contains three disulfide bonds 5-21; 9-23; 14-28. This is a cyclic peptide (cross-link at G1-N31)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18191970	Phytochemistry. 2008 Feb;69(4):939-952.	Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00923	GIPCGESCVWIPCLTSAVGCPCKSKVCYRN	30	Cyclotide vibi-K (Vbc4; Plant defensin)	B1NRR1	Belongs to the cyclotide family	Not found	Viola biflora (Yellow wood violet)	Cytotoxic	Protein level	Bridge	The cyclotides are head-to-tail macrocyclic and they have three disulfides arranged in a cystine knot, in which two disulfide bonds and their connecting backbone segments form an embedded ring that is penetrated by the third disulfide bond. Cyclotides exhibit a broad range of biological effects, including insecticidal, haemolytic, and cytotoxic effects.		"Function: Probably participates in a plant defense mechanism and shows potent cytotoxic activity.
PTM: Contains three disulfide bonds 4-20; 8-22; 13-27. This is a cyclic peptide (cross-link at G1-N31)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18191970	Phytochemistry. 2008 Feb;69(4):939-952.	Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, Clark RJ, Göransson U.	The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity.	
DRAMP00924	PGLGFY	6	Cyclopeptide E (Plant defensin)	P85003	Not found	Not found	Annona cherimola (Custard apple) (Cherimoya)	Anti-cancer, Cytotoxic	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism. Has cytotoxic activity against human nasopharyngeal carcinoma.
PTM: This is a cyclic peptide."	Human nasopharyngeal carcinoma (IC50=17 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16040066	Phytochemistry. 2005 Oct;66(19):2376-2380.	Wélé A, Zhang Y, Brouard JP, Pousset JL, Bodo B.	Two cyclopeptides from the seeds of Annona cherimola.	
DRAMP00925	PGMGIYLPM	9	Cyclopeptide F (Plant defensin)	P85002	Not found	Not found	Annona cherimola (Custard apple) (Cherimoya)	Cytotoxic	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism. Has cytotoxic activity.
PTM: This is a cyclic peptide."	Human nasopharyngeal carcinoma (IC50=60 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16040066	Phytochemistry. 2005 Oct;66(19):2376-2380.	W©l© A, Zhang Y, Brouard JP, Pousset JL, Bodo B.	Two cyclopeptides from the seeds of Annona cherimola.	
DRAMP00926	SAISCGETCFKFKCYTPRCSCSYPVCK	27	Violacin-A (Violacin-1; linearized uncyclotides; Plant defensin)	Q2HY54	Not found	Not found	Viola odorata (Sweet violet)	Antimicrobial	Protein level	Beta strand (4 strands; 9 residues)	The three-dimensional solution structure of violacin A is determined and found to adopt the cystine knot fold of native cyclotides. (Ref.2)	2FQA resolved by NMR.	"Function: Probably participates in a plant defense mechanism. Has low hemolytic activity.
Miscellaneous: The presence of a premature stop codon inhibits the translation of a key Asn residue that is thought to be required for cyclization.
PTM: Contains three disulfide bonds 5-19; 9-21; 14-26."	[Ref.16488428]show insecticidal, anti-HIV, antimicrobial, antineurotensive, cytotoxic and haemolytic activity	[Ref:16488428]10% hemolytic activity at 1.0μM and 35% hemolytic activity at 1.5μM against human type A red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16872274##16488428	Biochem J. 2006 Nov 15;400(1):1-12.##J Mol Biol. 2006 Apr 14;357(5):1522-1535.	Ireland DC, Colgrave ML, Craik DJ.##Ireland DC, Colgrave ML, Nguyencong P, Daly NL, Craik DJ.	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability..##Discovery and characterization of a linear cyclotide from Viola odorata: implications for the processing of circular proteins.	
DRAMP00927	GSIPCAESCVYIPCFTGIAGCSCKNKVCYYN	31	Cyclotide vico-A (Plant defensin)	P84635	Not found	Not found	Viola cotyledon (Violeta)	Antimicrobial	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Problely contains three disulfide bonds 5-21; 9-23; 14-28. This is a cyclic peptide (cross-link at G1-N31)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12782038	Anal Biochem. 2003 Jul 1;318(1):107-117.	Göransson U, Broussalis AM, Claeson P.	Expression of Viola cyclotides by liquid chromatography-mass spectrometry and tandem mass spectrometry sequencing of intercysteine loops after introduction of charges and cleavage sites by aminoethylation.	
DRAMP00928	GSIPCAESCVYIPCITGIAGCSCKNKVCYYN	31	Cyclotide vico-B (Plant defensin)	P84636	Not found	Not found	Viola cotyledon (Violeta)	Antimicrobial	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism.
PTM: Problely contains three disulfide bonds 5-21; 9-23; 14-28. This is a cyclic peptide (cross-link at G1-N31)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12782038	Anal Biochem. 2003 Jul 1;318(1):107-117.	Göransson U, Broussalis AM, Claeson P.	Expression of Viola cyclotides by liquid chromatography-mass spectrometry and tandem mass spectrometry sequencing of intercysteine loops after introduction of charges and cleavage sites by aminoethylation.	
DRAMP00932	SYFSAWAGPGCNNHNARYSKCGCSNIGHNVHGGYEFVYQGQTAAAYNTDNCKGVAQTRFSSSVNQACSNFGWKSVFIQC	79	Antimicrobial peptide 1 (PMAP1; Plant defensin)	P83880	Not found	Not found	Pinus monticola (Western white pine) (Strobus monticola)	Antimicrobial, Antibacterial, Antifungal	Protein level	Bridge 	Not found		"Tissue specificity: Detected at higher levels in needles and twigs from canker-resistant seedlings than in needles from canker-susceptible plants. During summer, detected on cankered, healthy and marginal bark. During winter, detected at lower levels in cankered bark and bark from the canker margin than in healthy bark (at protein level).
Developmental stage: In summer, present at higher levels in older needles and twigs than in tissues from the current year. In winter, detected at high levels in both older and current-year needles and twigs. Induction: By wounding and by methyl jasmonate.
PTM: Problely contains three disulfide bonds 11-67; 21-79; 23-51."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18943919##14759906 	Phytopathology. 2006 Feb;96(2):164-170.##Tree Physiol. 1997 Oct;17(10):663-669.	Ekramoddoullah AK, Liu JJ, Zamani A.##Davidson J, Ekramoddoullah AK.	Cloning and Characterization of a Putative Antifungal Peptide Gene (Pm-AMP1) in Pinus monticola.##Analysis of bark proteins in blister rust-resistant and susceptible western white pine (Pinus monticola).	
DRAMP00934	RTCESQSHRFKGTCVRQSNCAAVCQTEGFHGGNCRGFRRRCFCTKHC	47	Vv-AMP1 (Vitis vinifera antimicrobial peptide 1; Plant defensin)	No entry found	Not found	Not found	Vitis vinifera (Berry)	Antimicrobial, Antifungal	Not found	Not found	Not found		MOA: the inhibitory activity of Vv-AMP1 might be associated with altering the membrane permeability of the fungal membranes.	Fungi: Fusarium oxysporum and Verticillium dahliae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18611251	BMC Plant Biol. 2008 Jul 8;8:75.	de Beer A, Vivier MA.	Vv-AMP1, a ripening induced peptide from Vitis vinifera shows strong antifungal activity.	
DRAMP00935	DVSFSLSGGGTASYEK	16	Ribosome-inactivating protein trichokirin (rRNA N-glycosidase; Plant defensin)	P16093	Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily)	Not found	Trichosanthes kirilowii (Chinese snake gourd) (Chinese cucumber)	Cytotoxic	Protein level	Not found	Not found		"Catalytic activity: Endohydrolysis of the N-glycosidic bond at one specific adenosine on the 28S rRNA.
PTM: Glycosylated."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3262509	Eur J Biochem. 1988 Oct 1;176(3):581-588.	Casellas P, Dussossoy D, Falasca AI, Barbieri L, Guillemot JC, Ferrara P, Bolognesi A, Cenini P, Stirpe F.	Trichokirin, a ribosome-inactivating protein from the seeds of Trichosanthes kirilowii Maximowicz. Purification, partial characterization and use for preparation of immunotoxins.	
DRAMP00936	DVSFRLSGATSKKKVYFISNLRKALPNEKKLYDIPLVRSSXSGSK	45	Ribosome-inactivating protein TAP-29 (rRNA N-glycosidase; Plant defensin)	P23029	Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily)	Not found	Trichosanthes kirilowii (Chinese snake gourd) (Chinese cucumber)	Antiviral, Cytotoxic, Antimicrobial	Protein level	Not found	Not found		"Function: Capable of inhibiting HIV-1 infection and replication. It inactivates eukaryotic 60S ribosomal subunits.
Catalytic activity: Endohydrolysis of the N-glycosidic bond at one specific adenosine on the 28S rRNA."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1713684	Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6570-4.	Lee-Huang S, Huang PL, Kung HF, Li BQ, Huang PL, Huang P, Huang HI, Chen HC.	TAP 29: an anti-human immunodeficiency virus protein from Trichosanthes kirilowii that is nontoxic to intact cells.	
DRAMP00937	KSCCRNTVARNCYNVCRIPGTPRPVCAATCDCKLITGTKCPPGYEK	46	Tu-AMP1 (Plant defensin)	No entry found	Belongs to the thionin family	Not found	Tulipa gesneriana L. 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Bacteria: Erwinia carotovora (IC50=11 µg/ml), Agrobacterium radiobacter (IC50=15 µg/ml), Agrobacterium rhizogenes (IC50=20 µg/ml);##Gram-positive bacteria: Clavibacter michiganensis (IC50=14 µg/ml), Curtobacterium flaccumfaciens (IC50=13 µg/ml).##Fungi: Fusarium oxysporum (IC50=2 µg/ml), Geotrichum candidum (IC50=2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	15056889	Biosci Biotechnol Biochem. 2004 Mar;68(3):571-577.	Fujimura M, Ideguchi M, Minami Y, Watanabe K, Tadera K.	Purification, characterization, and sequencing of novel antimicrobial peptides, Tu-AMP 1 and Tu-AMP 2, from bulbs of tulip (Tulipa gesneriana L.).	
DRAMP00938	KSCCRNTTARNCYNVCRIPG	20	Tu-AMP2 (Plant defensin)	No entry found	Belongs to the thionin family	Not found	Tulipa gesneriana L. 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Erwinia carotovora (IC50=15 µg/ml), Agrobacterium radiobacter (IC50=17 µg/ml), Agrobacterium rhizogenes (IC50=20 µg/ml);##Gram-positive bacteria: Clavibacter michiganensis (IC50=17 µg/ml), Curtobacterium flaccumfaciens (IC50=15 µg/ml).##Fungi: Fusarium oxysporum (IC50=2 µg/ml), Geotrichum candidum (IC50=2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15056889	Biosci Biotechnol Biochem. 2004 Mar;68(3):571-577.	Fujimura M, Ideguchi M, Minami Y, Watanabe K, Tadera K.	Purification, characterization, and sequencing of novel antimicrobial peptides, Tu-AMP 1 and Tu-AMP 2, from bulbs of tulip (Tulipa gesneriana L.).	
DRAMP00939	VDCGANPFKVACFNSCLLGPSTVFQCADFCACRLPAG	37	Type-5 thionin (Type V thionin; Plant defensin)	Q05806	Belongs to the thionin family	TTHV	Triticum aestivum (Wheat)	Cytotoxic	Transcript level	Not found	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Contains three disulfide bonds 3-40; 12-30; 16-26. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1569564	J Mol Biol. 1992 Apr 20;224(4):1003-1009.	Castagnaro A, Mara±a C, Carbonero P, Garc­a-Olmedo F.	Extreme divergence of a novel wheat thionin generated by a mutational burst specifically affecting the mature protein domain of the precursor.	
DRAMP00940	TTCCPSIVARSNFNVCRLPGTPEALCATYTGCIIIPGATCPGDYAN	46	Crambin (Plant defensin)	P01542	Belongs to the thionin family	THI2	Crambe hispanica subsp. abyssinica (Abyssinian kale) (Crambe abyssinica)	Cytotoxic	Protein level	Combine helix and strand structure	Not found	3NIR resolved by X-ray.	"Function: The Function: of this hydrophobic plant seed protein is not known.
Miscellaneous: Two isoforms exists, a major form PL (shown here) and a minor form SI.
PTM: Contains three disulfide bonds 3-40; 4-32; 16-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	6895315##21505232	Biochemistry. 1981 Sep 15;20(19):5437-5443.##Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Apr 1;67(Pt 4):424-428.	Teeter MM, Mazer JA, L'Italien JJ.##Schmidt A, Teeter M, Weckert E, Lamzin VS.	Primary structure of the hydrophobic plant protein crambin.##Crystal structure of small protein crambin at 0.48Å resolution.	
DRAMP00941	KSCCRNTLARNCYNACRFTGGSQPTCGILCDCIHVTTTTCPSSHPS	46	Hellethionin-D (Plant defensin)	P60057	Belongs to the thionin family	Not found	Helleborus purpurascens (Purple hellebore)	Cytotoxic	Protein level	Combine helix and strand structure	Not found	1NBL resolved by NMR. 	"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Contains four disulfide bonds 3-40; 4-32; 12-30; 16-26. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12600207	Biochemistry. 2003 Mar 4;42(8):2404-2411.	Milbradt AG, Kerek F, Moroder L, Renner C.	Structural characterization of hellethionins from Helleborus purpurascens.	
DRAMP00942	KSCCRTTLGRNCYNLCRSRGAQKLCSTVCRCKLTSGLSCPKGFPK	45	Alpha-2-purothionin (Plant defensin)	P32032	Belongs to the thionin family	THI1.2	Triticum aestivum (Wheat)	Cytotoxic	Transcript level	Bridge	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Problely contains four disulfide bonds 3-39; 5-31; 12-29; 16-25. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7824649	Plant Physiol. 1994 Nov;106(3):1221-1222.	Castagnaro A, Mara±a C, Carbonero P, Garc­a-Olmedo F.	cDNA cloning and nucleotide sequences of alpha 1 and alpha 2 thionins from hexaploid wheat endosperm.	
DRAMP00943	KSCCRSTLGRNCYNLCRARGAQKLCAGVCRCKISSGLSCPKGFPK	45	Alpha-1-purothionin (Plant defensin)	P01544	Belongs to the thionin family	THI1.1	Triticum aestivum (Wheat)	Cytotoxic	Protein level	Combine helix and strand structure	Not found	2PLH resolved by X-ray.	"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane. Their precise Function: is not known.
PTM: Contains four disulfide bonds 3-39; 4-31; 12-29; 16-25. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7824649##2235992	Plant Physiol. 1994 Nov;106(3):1221-1222.##Proteins. 1990;8(2):118-132.	Castagnaro A, Mara±a C, Carbonero P, Garc­a-Olmedo F.##Teeter MM, Ma XQ, Rao U, Whitlow M.	cDNA cloning and nucleotide sequences of alpha 1 and alpha 2 thionins from hexaploid wheat endosperm.##Crystal structure of a protein-toxin alpha 1-purothionin at 2.5A and a comparison with predicted models.	
DRAMP00944	KSCCKSTLGRNCYNLCRARGAQKLCANVCRCKLTSGLSCPKDFPK	45	Purothionin A-1 (Plant defensin)	P01543	Belongs to the thionin family	THI1.3	Triticum aestivum (Wheat)	Cytotoxic	Protein level	Combine helix and strand structure	Not found	1BHP resolved by X-ray.	Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15299761	Acta Crystallogr D Biol Crystallogr. 1995 Nov 1;51(Pt 6):914-924.	Stec B, Rao U, Teeter MM.	Refinement of purothionins reveals solute particles important for lattice formation and toxicity. Part 2: structure of beta-purothionin at 1.7 A resolution.	
DRAMP00945	KSCCPTTTARNIYNTCRFGGGSRPVCAKLSGCKIISGTKCDSGWNH	46	Phoratoxin (Plant defensin)	P01539	Belongs to the thionin family	Not found	Phoradendron tomentosum (California mistletoe)	Cytotoxic	Protein level	Not found	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane. Their precise function is not known.
PTM: Contains three disulfide bonds 3-40; 4-32; 16-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	4606908	Acta Pharm Suec. 1974 Sep;11(4):367-374.	Mellstrand ST, Samuelsson G.	Phoratoxin, a toxic protein from the mistletoe Pharoadendron tomentosum subsp. macrophyllum (Loranthaceae). The disulphide bonds.	
DRAMP00946	QKIPFKECYPACLVECKAGSKFPKYLKCPFTCTKECLQQPSPPSVSSNNIDESDYFCKLGCATYHCVSLSSIQNPNVERVSACVDSCSNKCTKKN	95	Thionin-like protein 2 (Plant defensin)	A8MRP4	Belongs to the thionin family	Not found	Arabidopsis thaliana (Mouse-ear cress)	Not found	Homology	Not found	Not found		Function: May be involved in plant defense.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11130712	Nature. 2000 Dec 14;408(6814):816-820.	Theologis A, Ecker JR, Palm CJ, et al.	Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana.	
DRAMP00947	KSCCPTTAARNQYNICRLPGTPRPVCAALSGCKIISGTGCPPGYRH	46	Denclatoxin-B (Plant defensin)	P01541	Belongs to the thionin family	Not found	Dendrophthora clavata (Columbian mistletoe)	Cytotoxic	Protein level	Not found	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Problely contains three disulfide bonds 3-40; 4-32; 16-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	906843	Acta Pharm Suec. 1977;14(3):245-254.	Samuelsson G, Pettersson B.	Toxic proteins from the mistletoe Dendrophtora clavata. II. The amino acid sequence of denclatoxin B.	
DRAMP00948	KSCCPSTTARNIYNTCRLTGTSRPTCASLSGCKIISGSTCBSGWBH	46	Ligatoxin-A (Plant defensin)	P01540	Belongs to the thionin family	Not found	Phoradendron liga (Argentine mistletoe)	Cytotoxic	Protein level	Not found	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Contains three disulfide bonds 3-40; 4-32; 16-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7136736	Acta Pharm Suec. 1982;19(4):285-292.	Thunberg E, Samuelsson G.	Isolation and properties of ligatoxin A, a toxic protein from the mistletoe Phoradendron liga.	
DRAMP00949	KSCCPSTTARNIYNTCRLTGASRSVCASLSGCKIISGSTCDSGWNH	46	Ligatoxin-B (Plant defensin)	P59358	Belongs to the thionin family	Not found	Phoradendron liga (Argentine mistletoe)	Cytotoxic	Protein level	Not found	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Contains three disulfide bonds 3-40;4-32;16-26."	Human lymphoma cell line U-937-GTB (IC50=1.8 µM);##primary multidrug-resistant renal adenocarcinoma cell line ACHN (IC50=3.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12049612	Biochem J. 2002 Sep 1;366(Pt 2):405-413.	Li SS, Gullbo J, Lindholm P, Larsson R, Thunberg E, Samuelsson G, Bohlin L, Claeson P.	Ligatoxin B, a new cytotoxic protein with a novel helix-turn-helix DNA-binding domain from the mistletoe Phoradendron liga.	
DRAMP00950	KSCCPBTTGRBIYBTCRFGGGSRZVCARISGCKIISASTCPSYPBK	46	Viscotoxin-1-PS (Vt1-PS; Plant defensin)	P01537	Belongs to the thionin family	THI2.4	Viscum album (European mistletoe)	Cytotoxic	Protein level	Bridge 	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Contains three disulfide bonds 3-40; 4-32; 16-26. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	4417993	Acta Pharm Suec. 1974 May;11(2):175-184.	Samuelsson G, Jayawardene AL.	Isolation and characterization of viscotoxin 1-Ps from Viscum album L. ssp. austriacum (Wiesb.) vollmann, growing on Pinus silvestris.	
DRAMP00951	KSCCPNTTGRNIYNACRLTGAPCPTCAKLSGCKIISGSTCPSDYPK	46	Viscotoxin A (Plants)	Q9S9A2	Not found	Not found	Viscum album (European mistletoe)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8292787	Plant Mol Biol. 1993 Dec;23(6):1233-1242.	Schrader-Fischer G, Apel K.	cDNA-derived identification of novel thionin precursors in Viscum album that contain highly divergent thionin domains but conserved signal and acidic polypeptide domains.	
DRAMP00952	KSCCPNTTGRNIYNTCRLTGSSRETCAKLSGCKIISASTCPSNYPK	46	Viscotoxin A1 (Plant defensin)	D0VWT3	Not found	Not found	Viscum album (European mistletoe)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Protein level	Combine helix and strand structure	Not found	3C8P resolved by X-ray.	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18703848	Acta Crystallogr D Biol Crystallogr. 2008 Sep;64(Pt 9):985-992.	Pal A, Debreczeni JE, Sevvana M, Gruene T, Kahle B, Zeeck A, Sheldrick GM.	Structures of viscotoxins A1 and B2 from European mistletoe solved using native data alone.	
DRAMP00953	KSCCPNTTGRNIYNTCRFGGGSREVCASLSGCKIISASTCPSYPDK	46	Viscotoxin-A2 (VtA2; Plant defensin)	P32880, P01536	Belongs to the thionin family	THI2.3	Viscum album (European mistletoe)	Cytotoxic	Protein level	Combine helix and strand structure	Not found	1JMN resolved by NMR.	"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Contains three disulfide bonds 3-40; 4-32; 16-26. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	4607177##12733989	Acta Pharm Suec. 1974 Sep;11(4):381-386.##Biochem J. 2003 Aug 15;374(Pt 1):71-78.	Olson T, Samuelsson G.##Coulon A, Mosbah A, Lopez A, Sautereau AM, Schaller G, Urech K, Roug© P, Darbon H.	The disulphide bonds of viscotoxin A2 from the European mistletoe (Viscum album L. Loranthaceae).##Comparative membrane interaction study of viscotoxins A3, A2 and B from mistletoe (Viscum album) and connections with their structures.	
DRAMP00954	KSCCPNTTGRNIYNACRLTGAPRPTCAKLSGCKIISGSTCPSDYPK	46	Viscotoxin-A3 (Plant defensin)	P01538	Belongs to the thionin family	THI2.1	Viscum album (European mistletoe)	Antimicrobial, Antifungal, Cytotoxic	Protein level	Combine helix and strand structure	Not found	1OKH resolved by X-ray.	"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Contains three disulfide bonds 3-40; 4-32; 16-26. "	Fungi: Fusarium solani, Sclerotinia sclerotiorum, Phytophtora infestans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrance	1710983##4941626##10947973	Eur J Biochem. 1991 Jun 15;198(3):549-553.##Acta Chem Scand. 1971;25(6):2048-2054.##Biochem J. 2000 Sep 1;350 Pt 2:569-577.	Schrader G, Apel K.##Samuelsson G, Pettersson B.##Romagnoli S, Ugolini R, Fogolari F, Schaller G, Urech K, Giannattasio M, Ragona L, Molinari H.	Isolation and characterization of cDNAs encoding viscotoxins of mistletoe (Viscum album).##The disulfide bonds of viscotoxin A3 from the European mistletoe (Viscum album L., Loranthaceae).##NMR structural determination of viscotoxin A3 from Viscum album L.	
DRAMP00955	KSCCPNTTGRNIYNTCRLGGGSRERCASLSGCKIISASTCPSDYPK	46	Viscotoxin-B (VtB; Plant defensin)	P08943, P01536, P84186	Belongs to the thionin family	THI2.2	Viscum album (European mistletoe)	Antimicrobial, Antifungal, Cytotoxic	Protein level	Combine helix and strand structure	Not found	1JMP resolved by NMR.##2V9B resolved by X-ray.	"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane. Their precise Function: is not known.
PTM: Contains three disulfide bonds 3-40; 4-32; 16-26."	Fungi: Fusarium solani, Sclerotinia sclerotiorum, Phytophtora infestans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1710983##12733989	Eur J Biochem. 1991 Jun 15;198(3):549-553.##Biochem J. 2003 Aug 15;374(Pt 1):71-78.	Schrader G, Apel K.##Coulon A, Mosbah A, Lopez A, Sautereau AM, Schaller G, Urech K, Roug© P, Darbon H.	Isolation and characterization of cDNAs encoding viscotoxins of mistletoe (Viscum album).##Comparative membrane interaction study of viscotoxins A3, A2 and B from mistletoe (Viscum album) and connections with their structures.	
DRAMP00956	KSCCPNTTGRNIYNTCRFAGGSRERCAKLSGCKIISASTCPSDYPK	46	Viscotoxin-C1 (VtC1; Plant defensin)	P83554	Belongs to the thionin family	Not found	Viscum album (European mistletoe)	Cytotoxic	Protein level	Combine helix and strand structure	Not found	1ORL resolved by NMR.##3C8P resolved by X-ray.	"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane. Their precise Function: is not known.
PTM: Contains three disulfide bonds 3-40; 4-32; 16-26."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9348108##14580196	Biol Chem. 1997 Sep;378(9):989-996.##Biochemistry. 2003 Nov 4;42(43):12503-10.	Orr¹ S, Scaloni A, Giannattasio M, Urech K, Pucci P, Schaller G.##Romagnoli S, Fogolari F, Catalano M, Zetta L, Schaller G, Urech K, Giannattasio M, Ragona L, Molinari H.	Amino acid sequence, S-S bridge arrangement and distribution in plant tissues of thionins from Viscum album.##NMR solution structure of viscotoxin C1 from Viscum album species Coloratum ohwi: toward a structure-Function: analysis of viscotoxins.	
DRAMP00957	KSCCRSTQARNIYNAPRFAGGSRPLCALGSGCKIVDDKKTPPND	44	Pp-AMP1 (P. pubescens AMP1; Plant defensin)	No entry found	Belongs to the thionin family	Not found	Phyllostachys pubescens (Japanese bamboo shoots)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Bridge 	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Erwinia carotovora (IC50=22 µg/ml), Agrobacterium radiobacter (IC50=15 µg/ml), Agrobacterium rhizogenes (IC50=15 µg/ml);##Gram-positive bacteria: Clavibacter michiganensis (IC50=14 µg/ml), Curtobacterium flaccumfaciens (IC50=25 µg/ml).##Fungi: Fusarium oxysporum (IC50=2 µg/ml), Geotrichum candidum (IC50=2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	15784998	Biosci Biotechnol Biochem. 2005 Mar;69(3):642-645.	Fujimura M, Ideguchi M, Minami Y, Watanabe K, Tadera K.	Amino acid sequence and antimicrobial activity of chitin-binding peptides, Pp-AMP 1 and Pp-AMP 2, from Japanese bamboo shoots (Phyllostachys pubescens).	
DRAMP00958	KSCCRSTTARNIYNGCRVPGTARPVCAKKSGCKIQEAKKCEPPYD	45	Pp-AMP2 (P. pubescens AMP2; Plant defensin)	No entry found	Belongs to the thionin family	Not found	Phyllostachys pubescens (Japanese bamboo shoots)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Bridge 	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Erwinia carotovora (IC50=20 µg/ml), Agrobacterium radiobacter (IC50=13 µg/ml), Agrobacterium rhizogenes (IC50=15 µg/ml);##Gram-positive bacteria: Clavibacter michiganensis (IC50=18 µg/ml), Curtobacterium flaccumfaciens (IC50=20 µg/ml).##Fungi: Fusarium oxysporum (IC50=2 µg/ml), Geotrichum candidum (IC50=2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	15784998	Biosci Biotechnol Biochem. 2005 Mar;69(3):642-645.	Fujimura M, Ideguchi M, Minami Y, Watanabe K, Tadera K.	Amino acid sequence and antimicrobial activity of chitin-binding peptides, Pp-AMP 1 and Pp-AMP 2, from Japanese bamboo shoots (Phyllostachys pubescens).	
DRAMP00959	KICRRRSAGFKGPCMSNKNCAQVCQQEQWQQQNCDQPFRRCKCIRQC	47	Gamma1-purothionin (gamma1-P; thionin-like polypeptides; Plant defensin)	No entry found	Belongs to the thionin family	Not found	Triticum turgidum L cv Senatore Capelli (wheat endosperm)	Not found	Not found	Beta strand	Not found		PTM: Contains four disulfide bonds.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2226781	FEBS Lett 1990; 270: 191-194.	Colilla FJ, Rocher A, Mensez E.	Gamma-purothionins: amino acid sequence of two polypeptides of a new family of thionins from wheat endosperm.	
DRAMP00960	KVCRQRSAQFKGPCVSDKNCAQVCLQEQWQQQNCDQPFRRCKCIRQC	47	Gamma2-purothionin (gamma2-P; thionin-like polypeptides; Plant defensin)	No entry found	Belongs to the thionin family	Not found	Triticum turgidum L cv Senatore Capelli (wheat endosperm)	Not found	Not found	Not found	Not found		PTM: Contains four disulfide bonds.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2226781	FEBS Lett 1990; 270: 191-194.	Colilla FJ, Rocher A, Mensez E.	Gamma-purothionins: amino acid sequence of two polypeptides of a new family of thionins from wheat endosperm.	
DRAMP00961	KSCCRNTWARNCYNVCRLPGTISREICAKKCDCKIISGTTCPSDYPK	47	Thionin (Plant defensin)	P07504	Belongs to the thionin family	THI1	Pyrularia pubera (Buffalo nut) (Oil nut)	Cytotoxic	Protein level	Bridge	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
Toxic dose: At concentrations of 0.04 mg/ml the protein causes visible disruption of cultured mouse B16 melanoma cells.
PTM: Contains three disulfide bonds 3-41; 4-31; 16-27 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3985614	Arch Biochem Biophys. 1985 Apr;238(1):18-29.	Vernon LP, Evett GE, Zeikus RD, Gray WR.	A toxic thionin from Pyrularia pubera: purification, properties, and amino acid sequence.	
DRAMP00962	RNCESLSHRFKGPCTRDSNC	20	Pseudothionin Solanum tuberosum 1 (Pth-St1; Plant defensin)	No entry found	Belongs to the thionin family	Not found	Solanum tuberosum (potato)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Clavibacter michiganensis subspecies sepedonicus, Pseudomonas solanacearum and Fusarium solani.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8033886	Eur J Biochem. 1994 Jul 1;223(1):135-139.	Moreno M, Segura A, Garc­a-Olmedo F.	 Pseudothionin-St1, a potato peptide active against potato pathogens.	
DRAMP00963	KSCCKNTTGRNCYNACRFAGGSRPVCATACGCKIISGPTCPRDYPK	46	Thionin BTH7 (Plant defensin)	Q42838	Belongs to the thionin family	Not found	Hordeum vulgare (Barley)	Cytotoxic	Transcript level	Bridge	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Contains four disulfide bonds 3-40;4-32;12-30;16-26. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases	Holtorf S, Schuetz C, Apel K, Bohlmann H.	Specific and distinct expression patterns of two members of the thionin multigene family of barley in transgenic tobacco.	
DRAMP00964	KICCPRTIDRNIYNACRLTGASMTNCANLSGCKIVSGTTCPPGYTH	46	Thionin (Plant defensin)	Q9SBK8	Belongs to the thionin family	THI2	Brassica rapa subsp. pekinensis (Chinese cabbage) (Brassica pekinensis)	Cytotoxic	Transcript level	Not found	Not found		Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases	Lee S.Y, Cho M.J, Choi Y.O.	Molecular cloning and characterization of flower specific thionin in Chinese cabbage.	
DRAMP00965	KSCCKNTTGRNCYNACHFAGGSRPVCATACGCKIISGPTCPRDYPK	46	Probable leaf thionin (Plant defensin)	Q8H0Q5	Belongs to the thionin family	Not found	Hordeum vulgare (Barley)	Cytotoxic	Transcript level	Bridge	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Problely contains four disulfide bonds 3-40; 4-32; 12-30; 16-26. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases	Kah B, Kogel K.H, Langen G.	ORF of a leaf expressed barley thionin.	
DRAMP00966	KSCCKDTLARNCYNTCHFAGGSRPVCAGACRCKIISGPKCPSDYPK	46	Leaf-specific thionin DB4 (Hv-THDB4; Plant defensin)	P08772	Belongs to the thionin family	THI1.3	Hordeum vulgare (Barley)	Cytotoxic	Transcript level	Not found	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Problely contains four disulfide bonds 3-40; 4-32; 12-30; 16-26. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Mol. Gen. Genet. 207:446-454(1987)	Bohlmann H, Apel K.	Isolation and characterization of cDNAs coding for leaf-specific thionins closely related to the endosperm-specific hordothionin of barley (Hordeum vulgare L.).	
DRAMP18321	MAAFMKLIQFLATKGQKYVSLAWKRKGTILKWINAGQSFEWIYKQIKKLWA	51	Epidermicin NI01(Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	Not found	Staphylococcus epidermidisstrain 224	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Epidermicin NI01 contains 51 residues with four tryptophan and nine lysine residues, and the sequence showed approximately 50% identity to peptides lacticin Z, lacticin Q, and aureocin A53.		Comment: No comments found on DRAMP database	Gram-positive 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22155816	Antimicrob Agents Chemother. 2012 Mar;56(3):1539-47.	Sandiford S, Upton M.	Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci.	
DRAMP01380	GLFTLIKCAYQLIAPTVACN	20	Odorranain-J1 (OdJ1; Frogs, amphibians, animals)	A6MBN6	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Odorranain-J1 adopts 50.1% β-sheet and 13.7% turn structure in water solution.		Function: Odorranain-J1 exhibites moderate antimicrobial activities against Gram-positive and Gram-negative bacteria and fungi.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=35.60 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=17.80 μg/ml), Bacillus subtilis (MIC=35.60 μg/ml).##Yeast: Candida albicans (MIC=8.90 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP00968	KSCCKDTLARNCYNTCRFAGGSRPVCAGACRCKIISGPKCPSDYPK	46	Leaf-specific thionin BTH6 (Plant defensin)	P09618	Belongs to the thionin family	Not found	Hordeum vulgare (Barley)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Contains four disulfide bonds 3-40; 4-30; 12-26; 16-26."	Fungi: Thievaliopsis paradoxa, Drechslera teres.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16453847##PubMed ID is not available	EMBO J. 1988 Jun;7(6):1559-1565.##Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases	Bohlmann H, Clausen S, Behnke S, Giese H, Hiller C, Reimann-Philipp U, Schrader G, Barkholt V, Apel K.##Holtorf S, Schuetz C, Apel K, Bohlmann H.	Leaf-specific thionins of barley-a novel class of cell wall proteins toxic to plant-pathogenic fungi and possibly involved in the defence mechanism of plants.##Specific and distinct expression patterns of two members of the thionin multigene family of barley in transgenic tobacco.	
DRAMP00969	KSCCRSTLGRNCYNLCRVRGAQKLCAGVCRCKLTSSGKCPTGFPK	45	Alpha-hordothionin (alpha-HT; Plant defensin)	P01545	Belongs to the thionin family	THI1.1	Hordeum vulgare (Barley)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3082629##2850969	Eur J Biochem. 1986 Apr 1;156(1):131-135.##Gene. 1988 Oct 30;70(2):271-281.	Ponz F, Paz-Ares J, Hern¡ndez-Lucas C, Garc­a-Olmedo F, Carbonero P.##Rodr­guez-Palenzuela P, Pintor-Toro JA, Carbonero P, Garc­a-Olmedo F.	Cloning and nucleotide sequence of a cDNA encoding the precursor of the barley toxin alpha-hordothionin.##Nucleotide sequence and endosperm-specific expression of the structural gene for the toxin alpha-hordothionin in barley (Hordeum vulgare L.).	
DRAMP00970	KSCCRSTLGRNCYNLCRVRGAQKLCANACRCKLTSGLKCPSSFPK	45	Beta-hordothionin (beta-HT; Plant defensin)	P21742	Belongs to the thionin family	THI1.2	Hordeum vulgare (Barley)	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	Not found	1WUW resolved by X-ray.	Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15848162	FEBS Lett. 2005 Apr 25;579(11):2301-2306.	Johnson KA, Kim E, Teeter MM, Suh SW, Stec B.	Crystal structure of alpha-hordothionin at 1.9 Angstrom resolution.	
DRAMP00971	QKTCCPSQSTRKEFEDCISEGNLQILCSAESGCRDTYVGYCPSGFPY	47	Probable thionin-2.3 (Plant defensin)	Q8VZK8, Q56XM5, Q6AWT2, Q9ZUL0	Belongs to the thionin family	At2g15010	Arabidopsis thaliana (Mouse-ear cress)	Cytotoxic	Transcript level	Not found	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Problely contains three disulfide bonds 5-41; 5-33; 17-27."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10617197##14593172	Nature. 1999 Dec 16;402(6763):761-768.##Science. 2003 Oct 31;302(5646):842-846.	Lin X, Kaul S, Rounsley S, Shea TP, et al.##Yamada K, Lim J, Dale JM, Chen H, et al.	Sequence and analysis of chromosome 2 of the plant Arabidopsis thaliana.##Empirical analysis of transcriptional activity in the Arabidopsis genome.	
DRAMP00972	NICCPSIQARTFYNACLFAVGSPSSCIRNSSCLDISESTCPRGYTN	46	Probable thionin-2.4 (Plant defensin)	Q9C8D6	Uncertain	At1g66100	Arabidopsis thaliana (Mouse-ear cress)	Cytotoxic	Transcript level	Not found	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Contains four disulfide bonds 3-40;4-32;16-26. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11130712##14593172	Nature. 2000 Dec 14;408(6814):816-820.##Science. 2003 Oct 31;302(5646):842-846.	Theologis A, Ecker JR, Palm CJ, et al.##Yamada K, Lim J, Dale JM, et al.	Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana.##Empirical analysis of transcriptional activity in the Arabidopsis genome.	
DRAMP00973	KICCPSNQARNGYSVCRIRFSKGRCMQVSGCQNSDTCPRGWVN	43	Thionin-2.1 (Plant defensin)	Q42596, Q8LCH6, Q9C7S9	Belongs to the thionin family	THI2.1	Arabidopsis thaliana (Mouse-ear cress)	Cytotoxic	Transcript level	Not found	Not found		"Function: Seems to function as a defense factor. Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
Tissue specificity: Detected in rosette leaves and at a very high "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11130712##14593172##8552715	Nature. 2000 Dec 14;408(6814):816-820.##Science. 2003 Oct 31;302(5646):842-846.##Plant Physiol. 1995 Nov;109(3):813-820.	Theologis A, Ecker JR, Palm CJ, et al.##Yamada K, Lim J, Dale JM, et al.##Epple P, Apel K, Bohlmann H.	Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana.##Empirical analysis of transcriptional activity in the Arabidopsis genome.##An Arabidopsis thaliana thionin gene is inducible via a signal transduction pathway different from that for pathogenesis-related proteins.	
DRAMP00974	KICCPTKDDRSVYFVCMLSVSSQFYCLLKSKCKNTSQTICPPGYTN	46	Thionin-2.2 (Plant defensin)	Q42597, Q8LEF0, Q9FIW2	Belongs to the thionin family	THI2.2	Arabidopsis thaliana (Mouse-ear cress)	Cytotoxic	Transcript level	Bridge	Not found		"Function: Thionins are small plant proteins which are toxic to animal cells. They seem to exert their toxic effect at the level of the cell membrane.
PTM: Contains three disulfide bonds 3-40;4-32;16-26.
Tissue specificity: Low basal expression in seedlings. Also detected in rosette leaves."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8552715##10048488	Plant Physiol. 1995 Nov;109(3):813-820.##DNA Res. 1998 Dec 31;5(6):379-391.	Epple P, Apel K, Bohlmann H.##Asamizu E, Sato S, Kaneko T, Nakamura Y, Kotani H, Miyajima N, Tabata S.	An Arabidopsis thaliana thionin gene is inducible via a signal transduction pathway different from that for pathogenesis-related proteins.##Structural analysis of Arabidopsis thaliana chromosome 5. VIII. Sequence features of the regions of 1,081,958 bp covered by seventeen physically assigned P1 and TAC clones.	
DRAMP00975	RVCMKGSAGFKGLCMRDQNCAQVCLQEGWGGGNCDGVMRQCKCIRQC	47	SI alpha-2 (SIa2; Plant defensin)	No entry found	Not found	Not found	Sorghum bicolor (Seeds)	Antimicrobial, Antifungal	Not found	Bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1995329	FEBS Lett. 1991 Feb 11;279(1):101-104.	Bloch C Jr, Richardson M.	A new family of small (5 kDa) protein inhibitors of insect alpha-amylases from seeds or sorghum (Sorghum bicolar (L) Moench) have sequence homologies with wheat gamma-purothionins.	
DRAMP00976	VGECVRGRCPSGMCCSQFGYCGKGPKYCG	29	Antimicrobial peptide 1 (AC-AMP1; Plant defensin)	P27275	Not found	Not found	Amaranthus caudatus (Love-lies-bleeding) (Inca-wheat)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Bridge	Not found	1MMC	"Function: Chitin-binding protein with a defensive Function: against numerous chitin containing fungal pathogens. It is also a potent inhibitor of Gram-positive bacteria.
Miscellaneous: Its chitin-binding activity is strongly inhibited by divalent cations.
PTM: Contains three disulfide bonds 4-15; 9-21; 14-28."	Gram-positive bacteria: Bacillus megaterium (IC50=40 µg/ml), Sarcina lutea (IC50=250 µg/ml).##Fungi: Alternaria brassicola (IC50=7 µg/ml), Ascochyta pisi (IC50=8 µg/ml), Botrytis cinera (IC50=10 µg/ml), Colletotrichum lindemuthianum (IC50=8 µg/ml), Fusarium culmorum (IC50=2 µg/ml), Trichoderma hamatum (IC50=7 µg/ml), Verticillium dahliae (IC50=6 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	1567877##9176817	Biochemistry. 1992 May 5;31(17):4308-4314.##J Pept Res. 1997 Apr;49(4):336-340.	Broekaert W.F, Marien W, Terras F.R.G, de Bolle M.F.C, Proost P, van Damme J, Dillen L, Claeys M, Rees S.B, Vanderleyden J, Cammue B.P.A.##el Bouyoussfi M, Laus G, Verheyden P, Wyns L, Tourwe D, Van Binst G.	Antimicrobial peptides from Amaranthus caudatus seeds with sequence homology to the cysteine/glycine-rich domain of chitin-binding proteins.##Location of the three disulfide bonds in an antimicrobial peptide from Amaranthus caudatus using mass spectrometry.	
DRAMP00977	VGECVRGRCPSGMCCSQFGYCGKGPKYCGR	30	Antimicrobial peptide 2 (AC-AMP2; Plant defensin)	P27275	Not found	Not found	Amaranthus caudatus (Love-lies-bleeding) (Inca-wheat)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Beta strand	The main structural element is an antiparallel beta-sheet from Met13 to Lys23 including a betaI-turn over Gln17-Phel8 with a beta bulge at Gly19. In addition, a beta'I turn over Arg6-Gly7, a beta'III turn over Ser11-Gly12 and a helical turn from Gly24 to Cys28 are identified.	1MMC, 1ZNT, 1ZUV, 1ZWU resolved by NMR.	"Function: Chitin-binding protein with a defensive Function: against numerous chitin containing fungal pathogens. It is also a potent inhibitor of Gram-positive bacteria.
Miscellaneous: Its chitin-binding activity is strongly inhibited by divalent cations.
PTM: Contains three disulfide bonds 4-15; 9-21; 14-28."	Gram-positive bacteria: Bacillus megaterium (IC50=40 µg/ml), Sarcina lutea (IC50=250 µg/ml).##Fungi: Alternaria brassicola (IC50=7 µg/ml), Ascochyta pisi (IC50=8 µg/ml), Botrytis cinera (IC50=10 µg/ml), Colletotrichum lindemuthianum (IC50=8 µg/ml), Fusarium culmorum (IC50=2 µg/ml), Trichoderma hamatum (IC50=7 µg/ml), Verticillium dahliae (IC50=6 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	1567877##8627629##9176817	Biochemistry. 1992 May 5;31(17):4308-4314.##J Mol Biol. 1996 May 3;258(2):322-333.##J Pept Res. 1997 Apr;49(4):336-340.	Broekaert W.F, Marien W, Terras F.R.G, de Bolle M.F.C, Proost P, van Damme J, Dillen L, Claeys M, Rees S.B, Vanderleyden J, Cammue B.P.A.##Martins JC, Maes D, Loris R, Pepermans HA, Wyns L, Willem R, Verheyden P.##el Bouyoussfi M, Laus G, Verhey	Antimicrobial peptides from Amaranthus caudatus seeds with sequence homology to the cysteine/glycine-rich domain of chitin-binding proteins.##H NMR study of the solution structure of Ac-AMP2, a sugar binding antimicrobial protein isolated from Amaranthus caudatus.	
DRAMP00978	QTCASRCPRPCNAGLCCSIYGYCGSGNAYCGAGNCRCQCRG	41	Antifungal peptide 1 (EAFP1; Plant defensin)	P83596	Belongs to the hevein-like family	Not found	Eucommia ulmoides (Hardy rubber tree)	Antimicrobial, Antifungal	Protein level	Bridge 	Not found		Function: Has antifungal activity. PTM: Contain five disulfide bonds 3-17; 7-37; 11-23; 16-30; 35-39, and Pyrrolidone carboxylic acid at position 1.	Fungi: Phytophthora infestans, Ascochyta lycopersici (IC50=155 µg/ml), Verticillium dahliae, Gibberella zeae, Alternaria nicotianae, Fusarium moniliforme (IC50=56 µg/ml), Fusarium oxysporum (IC50=46 µg/ml) and Colletotrichum gossypii (IC50=35 µg/ml). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12067732	FEBS Lett. 2002 Jun 19;521(1-3):87-90.	Huang R.-H, Xiang Y, Liu X.-Z, Zhang Y, Hu Z, Wang D.-C.	Two novel antifungal peptides distinct with a five-disulfide motif from the bark of Eucommia ulmoides Oliv.	
DRAMP00979	QTCASRCPRPCNAGLCCSIYGYCGSGAAYCGAGNCRCQCRG	41	Antifungal peptide 2 (EAFP2; Plant defensin)	P83597	Belongs to the hevein-like family	Not found	Eucommia ulmoides (Hardy rubber tree)	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	EAFP2 adopts a compact global fold composed of a 3(10) helix (Cys3-Arg6), an alpha-helix (Ala27-Cys31) and a three-stranded antiparallel beta-sheet (Cys16-Ser18, Cys23-Ser25, and Cys35-Cys37) and cross-linked by five disulfide bridges. The tertiary structure of EAFP2 shows a chitin-binding domain.	1P9G resolved by X-ray.	"Function: Has antifungal activity.
PTM: Contains five disulfide bonds 3-17; 7-37; 11-23; 16-30; 35-39, and Pyrrolidone carboxylic acid at position 1."	Fungi: Phytophthora infestans, Ascochyta lycopersici (IC50=109 µg/ml), Verticillium dahliae, Gibberella zeae, Alternaria nicotianae, Fusarium moniliforme (IC50=18 µg/ml), Fusarium oxysporum (IC50=94 µg/ml) and Colletotrichum gossypii (IC50=56 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12067732##15363789##15147184	FEBS Lett. 2002 Jun 19;521(1-3):87-90.##J Struct Biol. 2004 Oct;148(1):86-97.##Biochemistry. 2004 May 25;43(20):6005-6012.	Huang R.-H, Xiang Y, Liu X.-Z, Zhang Y, Hu Z, Wang D.-C.##Xiang Y, Huang RH, Liu XZ, Zhang Y, Wang DC.##Huang RH, Xiang Y, Tu GZ, Zhang Y, Wang DC.	Two novel antifungal peptides distinct with a five-disulfide motif from the bark of Eucommia ulmoides Oliv.##Crystal structure of a novel antifungal protein distinct with five disulfide bridges from Eucommia ulmoides Oliver at an atomic resolution.##Solution structure of Eucommia antifungal peptide: a novel structural model distinct with a five-disulfide motif.	
DRAMP00980	AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGAGSCQSQCRGC	44	Antimicrobial peptide 1a (WAMP-1a; Plant defensin)	P85966	Belongs to the hevein-like family	Not found	Triticum kiharae (wheat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Combine helix and strand structure	Not found	2LB7 resolved by NMR.	PTM: Contains five disulfide bonds 4-19; 13-25; 16-44; 18-32; 37-41.	Fungi: Bipolaris sorokiniana (IC50=5 µg/ml), Botrytis cinerea (IC50=20 µg/ml), Fusarium oxysporum (IC50=5 µg/ml), Fusarium solani (IC50=5 µg/ml), Fusarium verticillioides (IC50=30 µg/ml), Neurospora crassa (IC50=10 µg/ml);##Gram-positive bacterium: Clavibacter michiganensis (1.3cm inhibition for 2.5 µg/50µl);##Gram-negative bacteria: Erwinia carotovora (1.1cm for 2.5 µg/50µl), Pseudomonas syringae (0.9cm for 2.5 µg/50µl).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	19583772##16269343	FEBS J. 2009 Aug;276(15):4266-4275.##Peptides. 2005 Nov;26(11):2064-2073.	Odintsova TI, Vassilevski AA, Slavokhotova AA, Musolyamov AK, Finkina EI, Khadeeva NV, Rogozhin EA, Korostyleva TV, Pukhalsky VA, Grishin EV, Egorov TA.##Egorov TA, Odintsova TI, Pukhalsky VA, Grishin EV.	A novel antifungal hevein-type peptide from Triticum kiharae seeds with a unique 10-cysteine motif.##Diversity of wheat anti-microbial peptides.	
DRAMP00981	AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGAGSCQSQCRGCR	45	Antimicrobial peptide 1b (WAMP-1b; Plant defensin)	P85966	Belongs to the hevein-like family	Not found	Triticum kiharae (wheat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found	2LB7	PTM: Contains five disulfide bonds 4-19; 13-25; 16-44; 18-32; 37-41.	Fungi: Bipolaris sorokiniana (IC50=5 µg/ml), Botrytis cinerea (IC50=20 µg/ml), Fusarium oxysporum (IC50=5 µg/ml), F. solani (IC50=5 µg/ml), F. verticillioides (IC50=30 µg/ml), Neurospora crassa (IC50=10 µg/ml);##Gram-positive bacterium: Clavibacter michiganensis (1.3cm inhibition for 2.5 µg/50µl);##Gram-negative bacteria: Erwinia carotovora (1.1cm for 2.5 µg/50µl), Pseudomonas syringae (0.9cm for 2.5 µg/50µl).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	19583772##16269343	FEBS J. 2009 Aug;276(15):4266-4275.##Peptides. 2005 Nov;26(11):2064-2073.	Odintsova TI, Vassilevski AA, Slavokhotova AA, Musolyamov AK, Finkina EI, Khadeeva NV, Rogozhin EA, Korostyleva TV, Pukhalsky VA, Grishin EV, Egorov TA.##Egorov TA, Odintsova TI, Pukhalsky VA, Grishin EV.	A novel antifungal hevein-type peptide from Triticum kiharae seeds with a unique 10-cysteine motif.##Diversity of wheat anti-microbial peptides.	
DRAMP00982	AQCGAQGGGATCPGGLCCSQWGWCGSTPKYCGAGCQSNCK	40	Fa-AMP1 (Fagopyrum antimicrobial peptide 1; hevein-type; Plant defensin)	No entry found	Belongs to the hevein-like family	Not found	Fagopyrum esculentum Moench (buckwheat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial avtivity against Gram-positive bacteria and Gram-negative bacteria, also has antifungal activity.	Gram-positive bacteria: Clavibacter michiganensis (IC50=14 µg/ml), Curtobacterium accumfaciens (IC50=13 µg/ml);##Gram-negative bacteria: Erwinia carotovora (IC50=11 µg/ml), Agrobacterium radiobacter (IC50=24 µg/ml), Agrobacterium rhizogenes (IC50=20 µg/ml).##Fungi: Fusarium oxysporum (IC50=19 µg/ml), Geotrichum candidum (IC50=36 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12951494	Biosci Biotechnol Biochem. 2003 Aug;67(8):1636-1642.	Fujimura M, Minami Y, Watanabe K, Tadera K.	Purification, characterization, and sequencing of a novel type of antimicrobial peptides, Fa-AMP1 and Fa-AMP2, from seeds of buckwheat (Fagopyrum esculentum Moench.).	
DRAMP00983	AQCGAQGGGATCPGGLCCSQWGWCGSTPKYCGAGCQSNCR	40	Fa-AMP2 (Fagopyrum antimicrobial peptide 2; hevein-type; Plant defensin)	No entry found	Belongs to the hevein-like family	Not found	Fagopyrum esculentum Moench (buckwheat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antibacterial avtivity against Gram-positive bacteria and Gram-negative bacteria, also has antifungal activity.	Gram-positive bacteria: Clavibacter michiganensis (IC50=17 µg/ml), Curtobacterium accumfaciens (IC50=15 µg/ml);##Gram-negative bacteria: Erwinia carotovora (IC50=15 µg/ml), Agrobacterium radiobacter (IC50=17 µg/ml), Agrobacterium rhizogenes (IC50=24 µg/ml).##Fungi: Fusarium oxysporum (IC50=29 µg/ml), Geotrichum candidum (IC50=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12951494	Biosci Biotechnol Biochem. 2003 Aug;67(8):1636-1642.	Fujimura M, Minami Y, Watanabe K, Tadera K.	Purification, characterization, and sequencing of a novel type of antimicrobial peptides, Fa-AMP1 and Fa-AMP2, from seeds of buckwheat (Fagopyrum esculentum Moench.).	
DRAMP00984	AGECVQGRCPSGMCCSQFGYCGRGPKYCGR	30	Antimicrobial peptide Ar-AMP (Ar-AMP; hevin-like peptides; Plant defensin)	Q5I2B2	Belongs to the hevein-like family	Not found	Amaranthus retroflexus (Redroot amaranth) (Redroot pigweed)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Bridge	Not found		PTM: Contains three disulfide bonds 4-15; 9-21; 14-28.	Fungi: Botrytis cinerea, Fusarium culmorum, Helminthosporium sativum and Alternaria consortiale.##Gram-positive bacterium: Bacillus subtilis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	16126239	Phytochemistry. 2005 Oct;66(20):2426-2431.	Lipkin A, Anisimova V, Nikonorova A, Babakov A, Krause E, Bienert M, Grishin E, Egorov T.	An antimicrobial peptide Ar-AMP from amaranth (Amaranthus retroflexus L.) seeds.	
DRAMP00985	QQCGRQASGRLCGNRLCCSQWGYCGSTASYCGAGCQSQCRS	41	Pn-AMP1 (PnAMP1; Plant defensin)	P81591	Belongs to the hevein-like family	Not found	Ipomoea nil (Japanese morning glory) (Pharbitis nil)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Bridge	Not found		"Miscellaneous: Its antimicrobial activity is strongly inhibited by divalent cations.
PTM: Contains four disulfide bonds 3-18; 12-24; 17-31; 35-39, and Pyrrolidone carboxylic acid at position 1."	Gram-positive Bacterium: Bacillus subtilis (IC50=38 µg/ml).##Fungi (Medium A, Medium A+): Botrytis cinerea (IC50=16, 150 µg/ml), Colletotrichum langenarium (IC50=10, >200 µg/ml), Sclerotinia sclerotiorum (IC50=11, >200 µg/ml), Fusarium oxysporum (IC50=10, >200 µg/ml), Rhizoctonia solani (IC50=26, >200 µg/ml), Phytophthora capsici (IC50=5, 130 µg/ml), Phytophthora parasitica (IC50=3, 90 µg/ml), Saccharomyces cerevisiae (IC50=14, >200 µg/ml).##NOTE! Medium A+ = Medium A supplemented with 5 mM CaCl2.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	9507071	Biochim Biophys Acta. 1998 Jan 15;1382(1):80-90.	Koo JC, Lee SY, Chun HJ, Cheong YH, Choi JS, Kawabata S, Miyagi M, Tsunasawa S, Ha KS, Bae DW, Han CD, Lee BL, Cho MJ.	Two hevein homologs isolated from the seed of Pharbitis nil L. exhibit potent antifungal activity.	
DRAMP00986	QQCGRQASGRLCGNRLCCSQWGYCGSTASYCGAGCQSQCR	40	Pn-AMP2 (PnAMP2; Plant defensin)	P81591	Belongs to the hevein-like family	Not found	Ipomoea nil (Japanese morning glory) (Pharbitis nil)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Bridge	Not found		"Miscellaneous: Its antimicrobial activity is strongly inhibited by divalent cations.
PTM: Contains four disulfide bonds 3-18; 12-24; 17-31; 35-39, and Pyrrolidone carboxylic acid at position 1."	Gram-positive bacterium: Bacillus subtilis (IC50=20 µg/ml).##Fungi (Medium A, Medium A+): Botrytis cinerea (IC50=2, 95 µg/ml), Colletotrichum langenarium (IC50=4, ND µg/ml), Sclerotinia sclerotiorum (IC50=3, >200 µg/ml), Fusarium oxysporum (IC50=2.5, >200 µg/ml), Rhizoctonia solani (IC50=75, >200 µg/ml), Phytophthora capsici (IC50=0.6, 150 µg/ml), Phytophthora parasitica (IC50=2, >200 µg/ml), Pythium spp. (IC50=2.5, ND µg/ml), Saccharomyces cerevisiae (IC50=8, >200 µg/ml).##NOTE! Medium A+ = Medium A supplemented with 5 mM CaCl2.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	9507071	Biochim Biophys Acta. 1998 Jan 15;1382(1):80-90.	Koo JC, Lee SY, Chun HJ, Cheong YH, Choi JS, Kawabata S, Miyagi M, Tsunasawa S, Ha KS, Bae DW, Han CD, Lee BL, Cho MJ.	Two hevein homologs isolated from the seed of Pharbitis nil L. exhibit potent antifungal activity.	
DRAMP00987	QQCGRQAGNRRCANNLCCSQYGYCGRTNEYCCTSQGCQSQCRRCG	45	Ee-CBPb (Hevein-like antimicrobial peptide; Plants)	No entry found	Belongs to the hevein-like family	Not found	Euonymus europaeus (European spindle tree)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Not found	Not found	Not found		"Function: Ee-CBPb possesses a very strong antifungal activity. Besides fungi, Ee-CBP1 also inhibits the growth of Gram-positive bacteria but not that of Gram-negative bacteria and yeasts.
PTM: Contains five disulfide bonds."	Fungi: Alternaria brassicicola (IC50=3 µg/ml), Botrytis cinerea (IC50=1 µg/ml), Fusarium culmorum (IC50=3 µg/ml), Fusarium oxysporum f.sp.cubense (IC50=15 µg/ml), Fusarium oxysporum f.sp. Matthiolae (IC50=5 µg/ml), Mycosphaerella eumusae (IC50=6 µg/ml), Neurospora crassa (IC50=2 µg/ml), Phoma exigua (IC50=33 µg/ml), Phytophthora cryptogea (IC50=25 µg/ml), Pythium ultimum (IC50=33 µg/ml), Rhizoctonia solani (IC50=25 µg/ml).##Gram-positive bacteria: Bacillus megaterium (IC50=2 µg/ml), Sarcina lutea (IC50=7 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	15048569##12387889	Planta. 2004 Jun;219(2):221-232.##FEBS Lett. 2002 Oct 23;530(1-3):181-185.	Van den Bergh KP, Roug© P, Proost P, Coosemans J, Krouglova T, Engelborghs Y, Peumans WJ, Van Damme EJ.##Van den Bergh KP, Proost P, Van Damme J, Coosemans J, Van Damme EJ, Peumans WJ.	Synergistic antifungal activity of two chitin-binding proteins from spindle tree (Euonymus europaeus L.).##Five disulfide bridges stabilize a hevein-type antimicrobial peptide from the bark of spindle tree (Euonymus europaeus L.).	
DRAMP00988	QQCGRQAGNRRCPNNLCCSQFGYCGRTNEYCCTGFGCQSNCRRCG	45	Ee-CBPl (Hevein-like antimicrobial peptide; Plants)	No entry found	Belongs to the hevein-like family	Not found	Euonymus europaeus (European spindle tree)	Antimicrobial, Antifungal	Not found	Not found	Not found		"Function: Ee-CBP1 possesses a very strong antifungal activity. 
PTM: Contains Disulfide bond."	Fungi: Alternaria brassicicola (IC50=0.6 µM), Botrytis cinerea (IC50=0.2 µM), Fusarium culmorum (IC50=0.6 µM), Fusarium oxysporum f. sp. cubense (IC50=3 µM), Fusarium oxysporum f. sp. matthiolae (IC50=1 µM), Mycosphaerella eumusae (IC50=1.2 µM), Neurospora crassa (IC50=0.4 µM), Phoma exigua (IC50=6.6 µM),Phytophthora cryptogea (IC50=5 µM), Pythium ultimum (IC50=6.6 µM), Rhizoctonia solani (IC50=5 µM), Trichoderma hamatum (IC50=20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	15048569	Planta. 2004 Jun;219(2):221-232.	Van den Bergh KP, Roug© P, Proost P, Coosemans J, Krouglova T, Engelborghs Y, Peumans WJ, Van Damme EJ.	Synergistic antifungal activity of two chitin-binding proteins from spindle tree (Euonymus europaeus L.).	
DRAMP00989	EQCGRQAGGKLCPNNLCCSQWGWCGSTDEYCSPDHNCQSNCKD	43	Hevein (Hev b 6; Plants)	P02877	Belongs to the hevein-like family	HEV1	Hevea brasiliensis (Para rubber tree) (Siphonia brasiliensis)	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	The first high-resolution solution-state structure of a member of the toxin-agglutinin folding motif with the WGA disulfide linkage is presented.	1HEV resolved by NMR.##1Q9B, 1WKX resolved by X-ray.	"Function: N-acetyl-D-glucosamine / N-acetyl-D-neuraminic acid binding lectin. Can inhibit fungal growth.
PTM: Proteolytically processed to yield the two chains of the mature protein, and it Contains four disulfide bonds 3-18; 12-24; 17-31; 37-41.
Allergenic properties: Causes an allergic reaction in human."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	2217194##8431421	Proc Natl Acad Sci U S A. 1990 Oct;87(19):7633-7637.##Biochemistry. 1993 Feb 16;32(6):1407-1422.	Broekaert I, Lee HI, Kush A, Chua NH, Raikhel N.##Andersen NH, Cao B, Rodríguez-Romero A, Arreguin B.	Wound-induced accumulation of mRNA containing a hevein sequence in laticifers of rubber tree (Hevea brasiliensis).##Hevein: NMR assignment and assessment of solution-state folding for the agglutinin-toxin motif.	
DRAMP00990	KICERASGTWKGICIHSNDCNNQCVKWENAGSGSCHYQFPNYMCFCYFDC	50	Sm-AMP-D1 (Plant defensin)	No entry found	Not found	Not found	Stellaria media L (Common chickweed seeds)	Antimicrobial, Antifungal	Not found	Not found	Not found		Function: Sm-AMP-D defensins displays strong antifungal activity against important plant pathogens being active at very low concentrations (IC50=1 M).	Fungi: Fusarium oxysporum 16/10 (IC50=0.5 µM), Botrytis cinerea SGR-1 (IC50=0.35 µM), Bipolaris sorokiniana 6/10 (IC50=0.52 µM), Fusarium graminearum VKM F-1668 (IC50=0.52 µM), Fusarium avenaceum VKM F-2303 (IC50=1 µM), Phoma betae VKM F-2532 (IC50=0.52 µM), Pythium debaryanum VKMF-1505 (IC50=1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21056078	Biochimie. 2011 Mar;93(3):450-456.	Slavokhotova AA, Odintsova TI, Rogozhin EA, Musolyamov AK, Andreev YA, Grishin EV, Egorov TA.	Isolation, molecular cloning and antimicrobial activity of novel defensins from common chickweed (Stellaria media L.) seeds.	
DRAMP00991	EQCGRQAGGKLCPNNLCCSQYGWCGSSDDYCSPSKNCQSNCKGGG	45	Pseudo-hevein (Minor hevein; hevein-like peptides; Plants)	P80359	Not found	Not found	Hevea brasiliensis (Para rubber tree) 	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: N-acetyl-D-glucosamine / N-acetyl-D-neuraminic acid binding lectin. Can inhibit fungal growth.
PTM: Problely Contains four disulfide bonds 3-18; 12-24; 17-31; 37-41."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	7947977	Biochim Biophys Acta. 1994 Nov 16;1209(1):144-148.	Soedjanaatmadja UM, Hofsteenge J, Jeronimus-Stratingh CM, Bruins AP, Beintema JJ.	Demonstration by mass spectrometry that pseudo-hevein and hevein have ragged C-terminal sequences.	
DRAMP00992	KICERASGTWKGICIHSNDCNNQCVKWENAGSGSCHYQFPNYMCFCYFNC	50	Sm-AMP-D2 (Plant defensin)	No entry found	Not found	Not found	Stellaria media L (Common chickweed seeds)	Antimicrobial, Antifungal	Not found	Not found	Not found		Function: Sm-AMP-D defensins displays strong antifungal activity against important plant pathogens being active at very low concentrations (IC50=1 M).	Fungi: Fusarium oxysporum 16/10 (IC50=0.5 µM), Botrytis cinerea SGR-1 (IC50=0.35 µM), Bipolaris sorokiniana 6/10 (IC50=0.52 µM), Fusarium graminearum VKM F-1668 (IC50=0.52 µM), Fusarium avenaceum VKM F-2303 (IC50=1 µM), Phoma betae VKM F-2532 (IC50=0.52 µM), Pythium debaryanum VKMF-1505 (IC50=1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21056078	Biochimie. 2011 Mar;93(3):450-456.	Slavokhotova AA, Odintsova TI, Rogozhin EA, Musolyamov AK, Andreev YA, Grishin EV, Egorov TA.	Isolation, molecular cloning and antimicrobial activity of novel defensins from common chickweed (Stellaria media L.) seeds.	
DRAMP00993	QAGGQTCPGGICCSQWGYCGTTADYCSPNNNCQSNCWASG	40	WjAMP-1 (C-terminal domain of hevein; Plant defensin)	No entry found	Not found	WjAMP-1	Wasabia japonica L. (Wasabi plant) (Wasabia japonica) 	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: WjAMP-1 showed antimicrobial activity against both fungi and bacteria.	Gram-negative bacteria: Escherichia coli (IC50=27.5 µg/ml), Pseudomonas cichorii (IC50=13.8 µg/ml), Pseudomonas glumae (IC50=20 µg/ml), Pseudomonas plantarii (IC50=22.5 µg/ml), Agrobacterium tumefaciens (IC50=12.5 µg/ml).##Fungi: Alternaria alternata (IC50=5.8 µg/ml), Botrytis cinerea (IC50=15 µg/ml), Fusarium solani (IC50=8.4 µg/ml), Magnaporte grisea (IC50=80 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12668776	Plant Cell Physiol. 2003 Mar;44(3):296-303.	Kiba A, Saitoh H, Nishihara M, Omiya K, Yamamura S.	C-terminal domain of a hevein-like protein from Wasabia japonica has potent antimicrobial activity.	
DRAMP00994	QWGRRCCGWGPGRRYCVRWC	20	IB-AMP1 (IBAMP1; Basic peptide AMP1; Plants)	O24006	Not found	AMP	Impatiens balsamina (Balsam)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Bridge	Not found		"Developmental stage: Highly expressed in dry mature seed and by the stages 2-5 of developing seed. The peptide IB-AMP1 is also detected at early stages of germination (24 hours and 48 hours postgermination).
PTM: Contains two disulfide bonds C6-C16; C7-C2"	Gram-positive bacteria: Bacillus subtilis (IC50=10 µg/ml), Micrococcus luteus (IC50=10 µg/ml), Staphylococcus aureus (IC50=30 µg/ml), Streptococcus faecalis (IC50=6 µg/ml).##Fungi: Alternaria longipes (IC50=3 µg/ml), Botrytis cinerea (IC50=12 µg/ml), Cladosporium sphaerospermum (IC50=1 µg/ml), Fusarium culmorum (IC50=1 µg/ml), Penicillium digitatum (IC50=3 µg/ml), Trichoderma viride (IC50=6 µg/ml), Verticillium alboatrum (IC50=3 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9305910##9454588	J Biol Chem. 1997 Sep 26;272(39):24480-24487.##Biochemistry. 1998 Jan 27;37(4):983-990.	Tailor RH, Acland DP, Attenborough S, Cammue BP, Evans IJ, Osborn RW, Ray JA, Rees SB, Broekaert WF.##Patel SU, Osborn R, Rees S, Thornton JM.	A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein.##Structural studies of Impatiens balsamina antimicrobial protein (Ib-AMP1).	
DRAMP00995	QYGRRCCNWGPGRRYCKRWC	20	IB-AMP2 (IBAMP2; Basic peptide AMP2; Plants)	O24006	Not found	Not found	Impatiens balsamina (Balsam)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Developmental stage: Highly expressed in dry mature seed and by the stages 2-5 of developing seed.
PTM: Contains two disulfide bonds C6-C16; C7-C20 and Pyrrolidone carboxylic acid at position 1 (Probable)."	Fungi: Alternaria longipes (IC50=12 µg/ml), Botrytis cinerea (IC50=25 µg/ml), Cladosporium sphaerospermum (IC50=6 µg/ml), Fusarium culmorum (IC50=6 µg/ml), Penicillium digitatum (IC50=6 µg/ml), Trichoderma viride (IC50=12 µg/ml), Verticillium alboatrum (IC50=12 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9305910	J Biol Chem. 1997 Sep 26;272(39):24480-24487.	Tailor RH, Acland DP, Attenborough S, Cammue BP, Evans IJ, Osborn RW, Ray JA, Rees SB, Broekaert WF.	A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein.	
DRAMP00996	QYRHRCCAWGPGRKYCKRWC	20	IB-AMP3 (IBAMP3; Basic peptide AMP3; Plants)	O24006	Not found	Not found	Impatiens balsamina (Balsam)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Developmental stage: Highly expressed in dry mature seed and by the stages 2-5 of developing seed.
PTM: Contains two disulfide bonds C6-C16; C7-C20 and Pyrrolidone carboxylic acid at position 1 (Probable)."	Fungi: Alternaria longipes (IC50=6 µg/ml), Botrytis cinerea (IC50=6 µg/ml), Cladosporium sphaerospermum (IC50=3 µg/ml), Fusarium culmorum (IC50=6 µg/ml), Penicillium digitatum (IC50=3 µg/ml), Trichoderma viride (IC50=12 µg/ml), Verticillium alboatrum (IC50=6 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9305910	J Biol Chem. 1997 Sep 26;272(39):24480-24487.	Tailor RH, Acland DP, Attenborough S, Cammue BP, Evans IJ, Osborn RW, Ray JA, Rees SB, Broekaert WF.	A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein.	
DRAMP00997	QWGRRCCGWGPGRRYCRRWC	20	IB-AMP4 (IBAMP4; Basic peptide AMP4; Plants)	O24006	Not found	Not found	Impatiens balsamina (Balsam)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		Developmental stage: Highly expressed in dry mature seed and by the stages 2-5 of developing seed. PTM: Contains two disulfide bonds C6-C16; C7-C20 and Pyrrolidone carboxylic acid at position 1 (Probable). Note: Peptide IB-AMP4 has a higher antifungal act	Gram-positive bacteria: Bacillus subtilis (IC50=5 µg/ml), Micrococcus luteus (IC50=5 µg/ml), Staphylococcus aureus (IC50=20 µg/ml), Streptococcus faecalis (IC50=5 µg/ml);##Gram-negative bacteria: Xanthomonas campestris (IC50=6 µg/ml), Xanthomonas oryzae (IC50=15 µg/ml).##Fungi: Alternaria longipes (IC50=3 µg/ml), Botrytis cinerea (IC50=6 µg/ml), Cladosporium sphaerospermum (IC50=1 µg/ml), Fusarium culmorum (IC50=1 µg/ml), Penicillium digitatum (IC50=3 µg/ml), Trichoderma viride (IC50=6 µg/ml), Verticillium alboatrum (IC50=6 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9305910##9454588	J Biol Chem. 1997 Sep 26;272(39):24480-24487.##Biochemistry. 1998 Jan 27;37(4):983-990.	Tailor RH, Acland DP, Attenborough S, Cammue BP, Evans IJ, Osborn RW, Ray JA, Rees SB, Broekaert WF.##Patel SU, Osborn R, Rees S, Thornton JM.	A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein.##Structural studies of Impatiens balsamina antimicrobial protein (Ib-AMP1).	
DRAMP00998	RSGRGECRRQCLRRHEGQPWETQECMRRCRRRG	33	Antimicrobial peptide MBP-1 (Maize Basic Peptide 1; Plant defensin)	P28794	Not found	Not found	Zea mays (Maize)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Inhibitor of both bacterial and fungal growth in vitro.	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Corynebacterium nebraskense ssp.##Fungi: Fusarium graminearum, Fusarium moniliforme, Aspergillus flavus, Alonina longipes, Sclerotinia sclerotiorum, Sclerotinia trifoliorum. 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1527010	J. Biol. Chem. 1992; 267:18814-18820	Duvick JP, Rood T, Rao AG, Marshak DR.1992	Purification and characterization of a novel antimicrobial peptide from maize (Zea mays L.) kernels.	
DRAMP00999	GFGCNGPWDEDDMQCHNHCKSIKGYKGGYCAKGGFVCKCY	40	Plectasin (fungal defensin)	Q53I06	Not found	DEF	Pseudoplectania nigrella (Ebony cup)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Combine helix and strand structure	Not found	1ZFU resolved by NMR.	Function: Recombinant peptide is especially active against Streptococcus pneumoniae, including strains resistant to conventional antibiotics. Plectasin showes extremely low toxicity in mice, and cured them of experimental peritonitis and pneumonia caused by S. pneumoniae as efficaciously as vancomycin and penicillin.	Gram-positive bacterium: Streptococcus pneumoniae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid II 	16222292	Nature. 2005 Oct 13;437(7061):975-780.	Mygind PH, Fischer RL, Schnorr KM, Hansen MT, Sönksen CP, Ludvigsen S, Ravent³s D, Buskov S, Christensen B, De Maria L, Taboureau O, Yaver D, Elvig-J¸rgensen SG, S¸rensen MV, Christensen BE, Kjaerulff S, Frimodt-Moller N, Lehrer RI, Zasloff M, Kristensen 	Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus.	
DRAMP01000	YQCGQGG	7	Ascalin (Plants)	P84071	Not found	Not found	 Allium cepa var. aggregatum (shallot)	Antimicrobial, Antifungal, Antiviral	Protein level	Not found	Not found		"Function: Has antifungal activity against Botrytis cinerea. Inhibits HIV-1 reverse transcriptase.
Miscellaneous: Inhibits HIV-1 reverse transcriptase with an IC50 of 10 µM."	Botrytis cinerea, HIV-1 reverse transcriptase (IC50=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12126728	Peptides. 2002 Jun;23(6):1025-1029.	Wang HX, Ng TB.	Ascalin, a new anti-fungal peptide with human immunodeficiency virus type 1 reverse transcriptase-inhibiting activity from shallot bulbs.	
DRAMP01001	GVGYKVVVTTTAAADDDDVV	20	Arietin (Plants)	P83988	Not found	Not found	Cicer arietinum (chickpea)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Has antifungal activity. Inhibits cell-free translation in rabbit reticulocyte lysate system. Does not have mitogenic and anti-HIV-1 reverse transcriptase activities.	Fungi: Botrytis cinerea, Fusarium oxysporum, Mycosphaerella arachidicola.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12084511	Peptides. 2002 May;23(5):817-822.	Ye XY, Ng TB, Rao PF.	Cicerin and arietin, novel chickpea peptides with different antifungal potencies.	
DRAMP01002	RDWERREFERRQNELRREQEQRREELL	27	Alpha-benincasin (Plants)	P83960	Not found	Not found	Benincasa hispida 	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has weak antifungal activity toward C. comatus and P. piricola but not toward M. arachidicola. Inhibits cell-free translation in rabbit reticulocyte lysate system.
Miscellaneous: IC50 of 20 pM in rabbit reticulocyte."	Fungi: Coprinus comatus, Pseudocercospora piricola.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12576080	Peptides. 2003 Jan;24(1):11-16.	Ng TB, Parkash A, Tso WW.	Purification and characterization of alpha- and beta-benincasins, arginine/glutamate-rich peptides with translation-inhibiting activity from wax gourd seeds.	
DRAMP01003	KTCENLADDY	10	Gymnin (Plants)	P84200	Not found	Not found	Gymnocladus chinensis 	Antimicrobial, Antifungal, Antiviral	Protein level	Not found	Not found		Function: Exerts antifungal activity. Has weak mitogenic activity against murine splenocytes. Displays antiproliferative activity on a human hepatoma cell line and mouse leukemia cell lines. Inhibits human immunodeficiency virus-1 (HIV-1) reverse transcriptase.	Fungi: Fusarium oxysporum (IC50=2 µM), Mycosphaerella arachidicola (IC50=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14499273	Peptides. 2003 Jul;24(7):963-968.	Wong JH, Ng TB.	Gymnin, a potent defensin-like antifungal peptide from the Yunnan bean (Gymnocladus chinensis Baill).	
DRAMP01005	VKSTGRADDDLAVKTKYLPP	20	Cicerarin (Plant defensin)	P83986	Not found	Not found	Cicer arietinum (chickpea)	Antimicrobial, Antifungal, Antiviral	Protein level	Not found	Not found		Function: Has antifungal activity. Also inhibits HIV-1 reverse transcriptase.	Fungi: Botrytis cinerea (IC50=20.6 µM), Mycosphaerella arachidicola (IC50=15.3 µM), Pseudocercospora piricola (IC50=8.2 µM).##Virus: HIV-1 RT (IC50=87.5 µM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12895650	Peptides. 2003 May;24(5):659-663.	Chu KT, Liu KH, Ng TB.	Cicerarin, a novel antifungal peptide from the green chickpea.	
DRAMP01006	ARCENFADSYRQPPISSSQT	20	Cicerin (Plant defensin)	P83987	Not found	Not found	Cicer arietinum (chickpea)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Has antifungal activity. Inhibits cell-free translation in rabbit reticulocyte lysate system.	Fungi: Mycosphaerella arachidicola, Fusarium oxysporum, Botrytis cinerea (IC50=12 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12084511	Peptides. 2003 May;24(5):665-669.	Cai YD, Liu XJ, Li YX, Xu XB, Chou KC.	Cicerin and arietin, novel chickpea peptides with different antifungal potencies.	
DRAMP01007	MTCGQVQGNLAQCIGFLQKGGVVPPSCCTGVKNILNSSRTTADRRAVCSCLKAAAGAVRGINPNNAEALPGKCGVNIPYKISTSTNCNSIN	91	Non-specific lipid transfer peptide (LTP 1; nsLTP; Plants)	P83434	Not found	Not found	Vigna radiata var. radiata (Mung bean) (Phaseolus aureus)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Alpha helix (4 helices; 46 residues)	The global fold of mung bean nsLTP1 is similar to those of the monocotyledonous nsLTP1 structures and consists of four alpha-helices stabilized by four disulfide bonds.	1SIY resolved by NMR.	"Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues.
PTM: Contains four disulfide bonds 3-50; 13-27; 28-73; 48-87."	Fungi: Fusarium solani, Fusarium oxysporum, Pythium aphanidermatum, Sclerotium rolfsii.##Gram-positive Bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	15350690##15823028	Peptides. 2004 Aug;25(8):1235-1242.##Biochemistry. 2005 Apr 19;44(15):5703-5712.	Wang SY, Wu JH, Ng TB, Ye XY, Rao PF.##Lin KF, Liu YN, Hsu ST, Samuel D, Cheng CS, Bonvin AM, Lyu PC.	A non-specific lipid transfer protein with antifungal and antibacterial activities from the mung bean.## Characterization and structural analyses of nonspecific lipid transfer protein 1 from mung bean.	
DRAMP01008	SNDIYFNFQR	10	Antifungal lectin PVAP (Plant defensin)	P84869	Not found	Not found	Phaseolus vulgaris (Kidney bean)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has hemagglutinating activity towards rabbit erythrocytes. Has antiproliferative activity towards L1210 tumor cell line with an IC50 of 3.6 µM. 
Miscellaneous: Antifungal, antiproliferative and hemagglutinating activity is abolished by incubatio"	Fungi: Mycophaerella arachidicola (IC50=9.8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16026901	Peptides. 2005 Dec;26(12):2397-2403.	Xia L, Ng T.B.	An antifungal protein from flageolet beans	
DRAMP01009	DDFLCAGGCL	10	Alliumin (Plants)	P84796	Not found	Not found	Allium sativum (Garlic)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has antifungal activity against M.arachidicola with an IC50 of 1.3 µM. Has antibacterial activity against the Gram-negative bacteria P. fluorescens. Has antiproliferative activity towards L1210 leukemia cells with an IC50 of 8.33 µM.	Fungi: Mycosphaerella arachidicola (IC50=1.3 µM).##Gram-negative bacterium: Pseudomonas fluorescens.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15629528	Peptides. 2005 Feb;26(2):177-183.	Xia L, Ng TB.	Isolation of alliumin, a novel protein with antimicrobial and antiproliferative activities from multiple-cloved garlic bulbs.	
DRAMP01010	KTCENLADTFRGPCFATSNC	20	Lunatusin (Plants)	No entry found	Not found	Not found	Phaseolus lunatus L.(Chinese lima bean)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral, Antifungal	Not found	Not found	Not found		Function: It also inhibited proliferation in the breast cancer cell line MCF-7. Lunatusin reduced the activity of HIV-1 reverse transcriptase and it also inhibited translation in a cell-free rabbit reticulocyte lysate system. Its anti-fungal activity was 	Fungi: Fusarium oxysporum, Mycosphaerella arachidicola and Botrytis cinerea.##Gram-positive bacteria: Bacillus megaterium, Bacillus subtilis;##Gram-negative bacteria: Proteus vulgaris, Mycobacterium phlei.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16269344	Peptides. 2005 Nov;26(11):2086-2092.	Wong JH, Ng TB.	Lunatusin, a trypsin-stable antimicrobial peptide from lima beans (Phaseolus lunatus L.).	
DRAMP01011	KTCENLADTFRGPCFATSNCDDHCKNKEHLLSGRCRDDFRCWCTRNC	47	White cloud bean defensin (Plant defensin)	No entry found	Not found	Not found	Phaseolus vulgaris cv. white cloud beans	Antimicrobial, Antibacterial, Antifungal	Not found	Bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16687191	Peptides. 2006 Sep;27(9):2075-2081.	Wong JH, Zhang XQ, Wang HX, Ng TB.	A mitogenic defensin from white cloud beans (Phaseolus vulgaris).	
DRAMP01013	KTCENLADTYKGPCFTTGSCD	21	PvD1 (P. vulgaris defensin 1; Plants)	F8QXP9	Not found	Not found	Phaseolus vulgaris (Seeds)	Antimicrobial, Antifungal	Predicted	Bridge	Not found		Its activity involves membrane permeabilization, inhibition of medium acifification, and induction of ROS in fungi cells (Curr Microbiol. 2010 Dec 19. 62: 1209-1217). 	Fungi: Candida albicans, C. parapsilosis, Candida tropicalis, Candida guilliermondii, K. marxiannus, Saccharomyces cerevisiae, Fusarium oxysporum, F. solani, F. lateritium and R. solani.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18786582	Peptides. 2008 Dec;29(12):2090-2100.	Games PD, Dos Santos IS, Mello EO, Diz MS, Carvalho AO, de Souza-Filho GA, Da Cunha M, Vasconcelos IM, Ferreira Bdos S, Gomes VM.	Isolation, characterization and cloning of a cDNA encoding a new antifungal defensin from Phaseolus vulgaris L. seeds.	
DRAMP01014	RTCMIKKEGWGKCLIDTTCAHSCKNRGYIGGNCKGMTRTCYCLVNC	46	VrD1 (V.radiata defensin 1; Plants)	No entry found	Not found	Not found	Vigna radiata	Antimicrobial, Antifungal	Not found	Combine helix and strand structure	Not found	1TI5 resolved by NMR.	Comment: No comments found on DRAMP database	Fungi: Fusarium oxysporum, Pyricularia oryza, Rhizoctonia solani, Trichophyton rubrum, bruchid larva.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15080630	J Agric Food Chem 2004; 52: 2256-2261.	Chen JJ et al Chen CS.	Cloning and functional expression of a mungbean defensin VrD1 in Pichia pastoris.	
DRAMP01015	RTCMKKEGWGKCLIDTTCAHSCKNRGYIGGNCKGMTRTCYCLVNC	45	VaD1 (Plant defensin)	No entry found	Not found	Not found	Vigna angularis Kao Hsiung No.6 (Seeds)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found	1TI5	Comment: No comments found on DRAMP database	Fungi: Fusarium oxysporum, Fusarium oxysporum f. sp. Pisi.##Gram-positive bacterium: Staphylococcus epidermidis;##Gram-negative bacterium: Salmonella typhimurium.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15713009	J Agric Food Chem 2005; 53: 982-988.	Chen G.-H. et al. Chen, C.-S.	Cloning and characterization of a plant defensin VaD1 from Azuki Bean.	
DRAMP01019	KTCENLANTYRGPCFTTGSCDDHCKNKEHLRSGRCRDDFRCWCTRNC	47	VrD2 (Vigna radiata defensin 2; plant defensin)	No entry found	Not found	Not found	Vigna radiata	Antimicrobial, Antibacterial, Antifungal	Not found	Combine helix and strand structure	Not found	2GL1 resolved by NMR.	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Proteins 2007; 68: 530-540.	Lin KF, Lee TR, Tsai PH, Hsu MP, Chen CS, Lyu PC.	NMR solution structure of Vigna radiata Defensin 2 (VrD2).	
DRAMP01020	RVCMKGSQHHSFPCISDRLCSNECVKEEGGWTAGYCHLRYCRCQKAC	47	SIalpha1 (Plant defensin)	No entry found	Not found	Not found	Sorghum bicolor	Antimicrobial, Antibacterial	Not found	Combine helix and strand structure	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9715910	Proteins. 1998 Aug 15;32(3):334-349.	Bloch C Jr, Patel SU, Baud F, Zvelebil MJ, Carr MD, Sadler PJ, Thornton JM.	1H NMR structure of an antifungal gamma-thionin protein SIalpha1: similarity to scorpion toxins.	
DRAMP01021	AQKCGEQGRGAKCPNCLCCGRYGFCGSTPDYCGVGCQSQCRGC	43	Antimicrobial peptide 1a (LAMP-1a; Plant defensin)	P86521	Not found	Not found	Leymus arenarius (Lyme grass) (Elymus arenarius)	Antimicrobial	Protein level	Bridge	Not found		PTM: Contains five disulfide bonds 4-19; 13-25; 16-43; 18-32; 36-40.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	PubMed ID is not available	Submitted (APR-2010) to UniProtKB	Odintsova TI.	Unknown	
DRAMP01022	KGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGFCGSGPQYCG	44	Cy-AMP1 (Plant defensin)	No entry found	Not found	Not found	Cycas revoluta (cycad seeds)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Cy-AMP1 has antimicrobial activity against various plant-pathogenic fungi and bacteria.	Gram-positive bacteria: Clavibacterium michiganensis (IC50=7.3 µg/ml), Curtobacterium ï¬‚accumfaciens (IC50=8.9 µg/ml);##Gram-negative bacteria: Agrobacterium radiobacter (IC50=8.3 µg/ml), Agrobacterium rhizogenes (IC50=8.5 µg/ml), Erwinia carobora (IC50=8.0 µg/ml).##Fungi: Fusarium oxysporum (IC50=6.0 µg/ml), Geotrichum candidum (IC50=7.4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	18778743	Peptides. 2008 Dec;29(12):2110-2117.	Yokoyama S, Kato K, Koba A, Minami Y, Watanabe K, Yagi F.	Purification, characterization, and sequencing of antimicrobial peptides, Cy-AMP1, Cy-AMP2, and Cy-AMP3, from the Cycad (Cycas revoluta) seeds.	
DRAMP01023	KGGPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGFCGSGPQYCG	44	Cy-AMP2 (Plant defensin)	No entry found	Not found	Not found	Cycas revoluta (cycad seeds)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Cy-AMP2 has antimicrobial activity against various plant-pathogenic fungi and bacteria.	Gram-positive bacteria: Clavibacterium michiganensis (IC50=7.6 µg/ml), Curtobacterium ï¬‚accumfaciens (IC50=8.3 µg/ml);##Gram-negative bacteria: Agrobacterium radiobacter (IC50=7.8 µg/ml), Agrobacterium rhizogenes (IC50=8.2 µg/ml), Erwinia carobora (IC50=8.1 µg/ml).##Fungi: Fusarium oxysporum (IC50=7.1 µg/ml), Geotrichum candidum (IC50=7.0 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	18778743	Peptides. 2008 Dec;29(12):2110-2117.	Yokoyama S, Kato K, Koba A, Minami Y, Watanabe K, Yagi F.	Purification, characterization, and sequencing of antimicrobial peptides, Cy-AMP1, Cy-AMP2, and Cy-AMP3, from the Cycad (Cycas revoluta) seeds.	
DRAMP01024	AVTCNTVVSSLAPCVPFFAGSAAQPTAACCNGVRSLNSAARTTPDRRTACNCIKSSASSIGLNYNKAAKLPSRCTVNVTVPISPSVNCAT	90	Cy-AMP3 (Plant defensin)	No entry found	Not found	Not found	Cycas revoluta (cycad seeds)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Cy-AMP3 has weak antimicrobial activity against various plant-pathogenic fungi and bacteria.	Gram-positive bacteria: Clavibacterium michiganensis (IC50=235 µg/ml), Curtobacterium ï¬‚accumfaciens (IC50=195 µg/ml);##Gram-negative bacteria: Agrobacterium radiobacter (IC50=260 µg/ml), Agrobacterium rhizogenes (IC50=235 µg/ml), Erwinia carobora (IC50=230 µg/ml).##Fungi: Fusarium oxysporum (IC50=250 µg/ml), Geotrichum candidum (IC50=200 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	18778743	Peptides. 2008 Dec;29(12):2110-2117.	Yokoyama S, Kato K, Koba A, Minami Y, Watanabe K, Yagi F.	Purification, characterization, and sequencing of antimicrobial peptides, Cy-AMP1, Cy-AMP2, and Cy-AMP3, from the Cycad (Cycas revoluta) seeds.	
DRAMP01025	ESEFDRQEYEECKRQCMQLETSGQMRRCVSQCDKRFEEDIDWSKYDNQD	49	Vicilin-like Antimicrobial peptide 2a (MiAMP2a; Plant defensin)	Q9SPL4	Belongs to the vicilin-like family	AMP2-2	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml).##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01026	DPQTDCQQCQRRCRQQESGPRQQQYCQRRCKEICEEEEEYN	41	Vicilin-like Antimicrobial peptide 2b (MiAMP2b; Plant defensin)	Q9SPL4	Belongs to the vicilin-like family	AMP2-2	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antimicrobial peptides 2b has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01027	RQRDPQQQYEQCQKHCQRRETEPRHMQTCQQRCERRYEKEKRKQQKRYEEQQREDEEKYEERMKEEDN	68	MiAMP2c (Gln- and Glu-rich; Plant defensin)	No entry found	Belongs to the vicilin-like family	Not found	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antifungal	Not found	Rich	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01028	RQRDPQQQYEQCQERCQRHETEPRHMQTCQQRCERRYEKEKRKQQKRYEEQQREDEEKYEERMKEED	67	Vicilin-like Antimicrobial peptide 2c-3 (MiAMP2c-3; Plant defensin)	Q9SPL4	Belongs to the vicilin-like family	AMP2-2	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antimicrobial peptides 2c has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01029	RQRDPQQQYEQCQERCQRHETEPRHMQTCQQRCERRYEKEKRKQQKR	47	Vicilin-like Antimicrobial peptide 2c-2 (MiAMP2c-2; Plant defensin)	Q9SPL4	Belongs to the vicilin-like family	AMP2-2	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antimicrobial peptides 2c has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01030	RQRDPQQQYEQCQERCQRHETEPRHMQTCQQRCERRYEKEKRKQQ	45	Vicilin-like Antimicrobial peptide 2c-1 (MiAMP2c-1; Plant defensin)	Q9SPL4	Belongs to the vicilin-like family	AMP2-2	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antimicrobial peptides 2c has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01031	KRDPQQREYEDCRRRCEQQEPRQQYQCQRRCREQQ	35	Vicilin-like Antimicrobial peptide 2d (MiAMP2d; Plant defensin)fens	Q9SPL4	Belongs to the vicilin-like family	AMP2-2	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antimicrobial peptides 2d has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01032	DPQTECQQCQRRCRQQESDPRQQQYCQRRCKEICEEEEEYN	41	Vicilin-like Antimicrobial peptide 2b (MiAMP2b; Plant defensin)	Q9SPL3	Belongs to the vicilin-like family	AMP2-3	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial peptides 2b has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01033	RQRDPQQQYEQCQKRCQRRETEPRHMQICQQRCERRYEKEKRKQQKRYEEQQREDEEKYEERMKEGD	67	Vicilin-like Antimicrobial peptide 2c-3 (MiAMP2c-3; Plant defensin)	Q9SPL3	Belongs to the vicilin-like family	AMP2-3	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial peptides 2c has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01034	RQRDPQQQYEQCQKRCQRRETEPRHMQICQQRCERRYEKEKRKQQKR	47	Vicilin-like Antimicrobial peptide 2c-2 (MiAMP2c-2; Plant defensin)	Q9SPL3	Belongs to the vicilin-like family	AMP2-3	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial peptides 2c has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01035	RQRDPQQQYEQCQKRCQRRETEPRHMQICQQRCERRYEKEKRKQQ	45	Vicilin-like Antimicrobial peptide 2c-1 (MiAMP2c-1; Plant defensin)	Q9SPL3	Belongs to the vicilin-like family	AMP2-3	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial peptides 2c has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01036	KRDPQQREYEDCRRHCEQQEPRLQYQCQRRCQEQQ	35	Vicilin-like Antimicrobial peptide 2d (MiAMP2d; Plant defensin)	Q9SPL3	Belongs to the vicilin-like family	AMP2-3	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial peptides 2d has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01037	DPQTECQQCQRRCRQQESGPRQQQYCQRRCKEICEEEEEYN	41	Vicilin-like Antimicrobial peptide 2b (MiAMP2b; Plant defensin)	Q9SPL5	Belongs to the vicilin-like family	AMP2-1	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antimicrobial peptides 2b has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01038	RQRDPQQQYEQCQKHCQRRETEPRHMQTCQQRCERRYEKEKRKQQKRYEEQQREDEEKYEERMKEED	67	Vicilin-like Antimicrobial peptide 2c-3 (MiAMP2c-3; Plant defensin)	Q9SPL5	Belongs to the vicilin-like family	AMP2-1	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antimicrobial peptides 2c has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01039	RQRDPQQQYEQCQKHCQRRETEPRHMQTCQQRCERRYEKEKRKQQKR	47	Vicilin-like Antimicrobial peptide 2c-2 (MiAMP2c-2; Plant defensin)	Q9SPL5	Belongs to the vicilin-like family	AMP2-1	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antimicrobial peptides 2c has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01040	RQRDPQQQYEQCQKHCQRRETEPRHMQTCQQRCERRYEKEKRKQQ	45	Vicilin-like Antimicrobial peptide 2c-1 (MiAMP2c-1; Plant defensin)	Q9SPL5	Belongs to the vicilin-like family	AMP2-1	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antimicrobial peptides 2c has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01041	KRDPQQREYEDCRRRCEQQEPRQQHQCQLRCREQQ	35	Vicilin-like Antimicrobial peptide 2d (MiAMP2d; Plant defensin)	Q9SPL5	Belongs to the vicilin-like family	AMP2-1	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antimicrobial peptides 2d has antibacterial and antifungal activity against a range of species (By similarity).	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml);##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml)##NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP01042	RHCESLSHRFKGPCTRDSNCASVCETERFSGGNCHGFRRRCFCTKPC	47	P322 (Plant defensin)	No entry found	Not found	Not found	Solanum tuberosum (potato tuber)	Unknown	Not found	Bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Plant Mol Biol 1988; 11:255-269.	Stiekema WJ et al Louwerse JD.	Molecular cloning and analysis of four potato tuber mRNAs.	
DRAMP01043	QICKAPSQTFPGLCFMDSSCRKYCIKEKFTGGHCSKLQRKCLCTKPC	47	TPP3 (Plant defensin)	No entry found	Not found	Not found	Lycopersicon esculentum	Antimicrobial, Antifungal	Not found	Not found	Not found	4UJ0	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7647301	Plant Mol Biol 1995; 28:691-711.	Milligan SB, Gasser CS.	Nature and regulation of pistil-expressed genes in tomato.	
DRAMP01044	KTCENLVDTYRGPCFTTGSCDDHCKNKEHLLSGRCRDDVRCWCTRNC	47	Defensin-like protein (Clone PSAS10; Plant defensin)	P18646	Not found	Not found	Vigna unguiculata (cowpea seeds)	Antimicrobial, Antifungal	Homology	Bridge	Not found		This protein is required for germination.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2103443	Plant Mol Biol. 1990 Jul;15(1):59-64.	Ishibashi N, Yamauchi D, Minamikawa T.	Stored mRNA in cotyledons of Vigna unguiculata seeds: nucleotide sequence of cloned cDNA for a stored mRNA and induction of its synthesis by precocious germination.	
DRAMP01045	ITCGLVASKLAPCIGYLQGAPGPSAACCGGIKSLNSAAASPADRKTACTCLKSAATSMKGINYGKAASLPRQCGVSIPYAISPNTNCNAIH	91	IWF2 (Bv-LTP2; Plant defensin)	No entry found	Not found	IWF1	Beta vulgaris (Sugar beet)	Antimicrobial, Antifungal	Not found	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues. Also has fungicide activity.	Fungi: Cercospora beticola.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	8790287	Plant Mol Biol. 1996 Jun;31(3):539-552.	Nielsen KK, Nielsen JE, Madrid SM, Mikkelsen JD.	New antifungal proteins from sugar beet (Beta vulgaris L.) showing homology to non-specific lipid transfer proteins.	
DRAMP01046	GYGGHGGHGGHGGHGGHGGHGHGGGGHG	28	Shepherin I (fragement of shep-GRP; Plants)	No entry found	Not found	GRP	Capsella bursa-pastoris (shepherd's purse)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Not found	Not found	Circular dichroism (CD) spectra of shepherin I showes that shepherin I in 50% trifluoroethanol has 66.7% random coils, without any alpha-helices.		"Function: These antimicrobial peptides exhibit antimicrobial activity against Gram-negative bacteria and fungi.
Tissue specificity: Expressed in roots but not in leaves and stems."	Gram-negative bacteria: Erwinia herbicola (IC50=62 µg/ml), Escherichia coli (IC50<2.5 µg/ml), Pseudomonas putida (IC50<2.5 µg/ml), Pseudomonas syringae (IC50<2.5 µg/ml), Salmonella typhimurium (IC50<2.5 µg/ml), Serratia sp. (IC50=8 µg/ml).##Fungi: Candida albicans (IC50=8 µg/ml), Cryptococcus neoformans (IC50<2.5 µg/ml), Saccharomyces cerevisiae (IC50<7 µg/ml), Alternaria alternata (IC50<7 µg/ml), Aspergillus flavus (IC50=65 µg/ml), Fusarium culmorum (IC50=72 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11117262	Plant Mol Biol. 2000 Sep;44(2):187-197.	Park CJ, Park CB, Hong SS, Lee HS, Lee SY, Kim SC.	Characterization and cDNA cloning of two glycine- and histidine-rich antimicrobial peptides from the roots of shepherd's purse, Capsella bursa-pastoris.	
DRAMP01047	GYHGGHGGHGGGYNGGGGHGGHGGGYNGGGHHGGGGHG	38	shepherin II (fragement of shep-GRP; Plants)	No entry found	Not found	GRP	Capsella bursa-pastoris (shepherd's purse)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Not found	Not found	Circular dichroism (CD) spectra of shepherin II showes that shepherin II in 50% trifluoroethanol has 75% random coils, without any alpha-helices.		"Function: These antimicrobial peptides exhibit antimicrobial activity against Gram-negative bacteria and fungi.
Tissue specificity: Expressed in roots but not in leaves and stems."	Gram-negative bacteria: Erwinia herbicola (IC50=25 µg/ml), Escherichia coli (IC50<2.5 µg/ml), Pseudomonas putida (IC50<2.5 µg/ml), Pseudomonas syringae (IC50<2.5 µg/ml), Salmonella typhimurium (IC50=65 µg/ml), Serratia sp. (IC50<2.5 µg/ml).##Fungi: Candida albicans (IC50=5 µg/ml), Cryptococcus neoformans (IC50<2.5 µg/ml), Saccharomyces cerevisiae (IC50=3 µg/ml), Aspergillus flavus (IC50=60 µg/ml), Fusarium culmorum (IC50=68 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11117262	Plant Mol Biol. 2000 Sep;44(2):187-197.	Park CJ, Park CB, Hong SS, Lee HS, Lee SY, Kim SC.	Characterization and cDNA cloning of two glycine- and histidine-rich antimicrobial peptides from the roots of shepherd's purse, Capsella bursa-pastoris.	
DRAMP01048	HTPTPTPICKSRSHEYKGRCIQDMDCNAACVKESESYTGGFCNGRPPFKQCFCTKPCKRERAAATLRWPGL	71	Sd5 (sugarcane defensin 5; Plant defensin)	No entry found	Not found	Not found	Saccharum officinarum (Sugarcane)	Antimicrobial, Antifungal	Not found	Combine helix and strand structure	Based on circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy showed that the structures of these Sds were compatible with alpha/beta proteins, a feature expected for plant defensins.	2KSK resolved by NMR.	Function: Sd5 is active against fungi, but not against bacteria.	Fungi: Neurospora crassa and Fusarium solani (IC50=10-15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18618271	Plant Mol Biol. 2008 Nov;68(4-5):321-335.	De-Paula VS, Razzera G, Medeiros L, Miyamoto CA, Almeida MS, Kurtenbach E, Almeida FC, Valente AP.	Evolutionary relationship between defensins in the Poaceae family strengthened by the characterization of new sugarcane defensins.	
DRAMP01049	RHRHCFSQSHKFVGACLRESNCENVCKTEGFPSGECKWHGIVSKCHCKRIC	51	Sd3 (sugarcane defensin 3; Plant defensin)	No entry found	Not found	Not found	Saccharum officinarum (Sugarcane)	Antimicrobial, Antifungal	Not found	Combine helix and strand structure	Based on circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy showed that the structures of these Sds were compatible with alpha/beta proteins, a feature expected for plant defensins.		Function: Sd3 is active against fungi, but not against bacteria.	Fungi: Neurospora crassa and Aspergillus niger (IC50=1-3.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18618271	Plant Mol Biol. 2008 Nov;68(4-5):321-335.	De-Paula VS, Razzera G, Medeiros L, Miyamoto CA, Almeida MS, Kurtenbach E, Almeida FC, Valente AP.	Evolutionary relationship between defensins in the Poaceae family strengthened by the characterization of new sugarcane defensins.	
DRAMP01050	RYCLSQSHRFKGLCMSSSNCANVCQTENFPGGECKADGATRKCFCKKIC	49	Sd1 (sugarcane defensin 1; Plant defensin)	B2CNV2	Not found	PDEF	Saccharum officinarum (Sugarcane)	Antimicrobial, Antifungal	Predicted	Combine helix and strand structure	Based on circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy showed that the structures of these Sds were compatible with alpha/beta proteins, a feature expected for plant defensins.		Function: Sd1 is active against fungi, but not against bacteria.	Fungi: Neurospora crassa, Aspergillus niger, Fusarium solani (IC50=1-2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18618271##PubMed ID is not available	Plant Mol Biol. 2008 Nov;68(4-5):321-335.##Submitted (FEB-2008) to the EMBL/GenBank/DDBJ databases.	De-Paula VS, Razzera G, Medeiros L, Miyamoto CA, Almeida MS, Kurtenbach E, Almeida FC, Valente AP.##Padovan L, Segat L, Tossi A, Crovella S.	Evolutionary relationship between defensins in the Poaceae family strengthened by the characterization of new sugarcane defensins.##Novel plant-defensin from sugarcane (Saccharum officinarum).	
DRAMP01051	KSTCKAESNTFPGLCITKPPCRKACLSEKFTDGKCSKILRRCICYKPC	48	NpThio1 (Plant defensin)	No entry found	Not found	Not found	Nicotiana excelsior	Antimicrobial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Plant Physiol 1997; 115:314.	Yamada S, Komori T, Imaseki H.	Unknown	
DRAMP01052	KDCKTESNTFPGICITKPPCRKACIKEKFTDGHCSKILRRCLCTKPC	47	NeThio2 (Plant defensin)	No entry found	Not found	Not found	Nicotiana excelsior	Antimicrobial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Plant Physiol 1997; 115:314.	Yamada S, Komori T, Imaseki H.	Unknown	
DRAMP01053	ATITFTNKCTRTVWPGG	17	Thaumatin-like protein (CdTLP; Plants)	P84334	Not found	Not found	Cassia didymobotrya (Popcorn cassia)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity.
Induction: By salicylic acid and by laminarin oligosaccharides.
PTM: Contains one disulfide bond (By similarity)."	Fungi: Candida albicans 586 (EC50=6.2 µM), Candida parapsilosis ATCC 22019 (EC50=2.2 µM), Candida krusei ATCC 14243 (EC50=2.5 µM), C. krusei 80 (EC50=5.4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17056265	Plant Physiol Biochem. 2006 Oct;44(10):604-610.	Vitali A, Pacini L, Bordi E, De Mori P, Pucillo L, Maras B, Botta B, Brancaccio A, Giardina B.	Purification and characterization of an antifungal thaumatin-like protein from Cassia didymobotrya cell culture.	
DRAMP01054	QNICPRVNRIVTPCVAYGLGRAPIAPCCRALNDLRFVNTRNLRRAACRCLVGVVNRNPGLRRNPRFQNIPRDCRNTFVRPFWWRPRIQCGRINLTDKLIYL	105	Antimicrobial protein Ace-AMP1 (Ace-AMP1; Plant defensin)	Q41258	Not found	Not found	Allium cepa (onion)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Bridge	Not found		"Function: Antifungal and antibacterial activity against the Gram-positive bacteria: B. megaterium and S. lutea.
PTM: Contains four disulfide bonds 4-49; 14-26; 28-73; 47-89."	Gram-positive bacteria: Bacillus megaterium, Sarcina Lutea.##Fungi (SMF-, SMF+): Alternaria brassicola (IC50=2.5, 1.5 µg/ml), Ascockyta pisi (IC50=1, 10 µg/ml), Botrytis cinerea (IC50=3, 7 µg/ml), Colletotrickum lindemutkianum (IC50=1.5, 1.5 µg/ml), Fusarium culmorum (IC50=6, 10 µg/ml), Fusarium oxysporum fsp. pisi (IC50=3.5, 4 µg/ml), Fusarium oxysporum fsp. lycopersici (IC50=3, 10 µg/ml),Nectria haematococca (IC50=3.5, 7 µg/ml),Phoma betae (IC50=1.5, 7 µg/ml), Pyrenopkora tritici-repentis (IC50=3, 3.5 µg/ml), Pyricularia oryzae (IC50=3, 7 µg/ml), Verticillium dahliae (IC50=0.25, 0.5 µg/ml).##[NOTE: SMF- = Synthetic growth Medium with low ionic strength; SMF+ = Synthetic growth Medium supplemented with with 1 mM CaCl2, 50 mM KC1]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7480341##9521681	Plant Physiol. 1995 Oct;109(2):445-455.##Biochemistry. 1998 Mar 17;37(11):3623-3637.	Cammue BP, Thevissen K, Hendriks M, Eggermont K, Goderis IJ, Proost P, Van Damme J, Osborn RW, Guerbette F, Kader JC, et al.##Tassin S, Broekaert WF, Marion D, Acland DP, Ptak M, Vovelle F, Sodano P.	A potent antimicrobial protein from onion seeds showing sequence homology to plant lipid transfer proteins.##Solution structure of Ace-AMP1, a potent antimicrobial protein extracted from onion seeds. Structural analogies with plant nonspecific lipid transfer proteins.	
DRAMP01055	AGCIKNGGRCNASAGPPYCCSSYCFQIAGQSYGVCKNR	38	P. americana AMP (Pa-AMP-1; PAFP-S; Cys-rich; Plant defensin)	P81418, O82728	Belongs to the AMP family	Not found	Phytolacca americana (American pokeweed) (Phytolacca decandra)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Beta strand (3 strands; 13 residues)	The global fold involves a cystine-knotted three-stranded antiparallel beta-sheet (residues 8-10, 23-27, 32-36), a flexible loop (residues 14-19), and four beta-reverse turns (residues 4-8, 11-14, 19-22, 28-32). This structure features all the characteristics of the knottin fold. It is the first structural model of an antifungal peptide that adopts a knottin-type structure. 	1DKC resolved by NMR.	"Function: Possesses antifungal activity.
Tissue specificity: Seed specific.
Domain: The presence of a 'disulfide through disulfide knot' structurally defines this protein as a knottin.
PTM: Contains three disulfide bonds: 3-20; 10-24; 19-35. "	Gram-positive bacteria: Bacillus megaterium (IC50=8 µg/ml), Staphyanococcus sp. (IC50=11 µg/ml).##Fungi: Alternaria panax, Fusarium sp., Rhizoctonia solani.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10759497##11551192	Plant Physiol. 2000 Apr;122(4):1015-1024.##Biochemistry. 2001 Sep 18;40(37):10973-10978.	Liu Y, Luo J, Xu C, Ren F, Peng C, Wu G, Zhao J.##Gao GH, Liu W, Dai JX, Wang JF, Hu Z, Zhang Y, Wang DC.	Purification, characterization, and molecular cloning of the gene of a seed-specific antimicrobial protein from pokeweed.##Solution structure of PAFP-S: a new knottin-type antifungal peptide from the seeds of Phytolacca americana.	
DRAMP01056	ELCEKASQTWSGTCGKTKHCDDQCKSWEGAAHGACHVRDGKHMCFCYFNC	50	Ha-DEF1 (H. annuus defensin 1; Plants)	No entry found	Not found	Not found	Helianthus annuus (sunflower)	Antimicrobial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Fungi: Saccharomyces cerevisiae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17375322	Planta. 2007 Aug;226(3):591-600.	de Z©licourt A, Letousey P, Thoiron S, Campion C, Simoneau P, Elmorjani K, Marion D, Simier P, Delavault P.	Ha-DEF1, a sunflower defensin, induces cell death in Orobanche parasitic plants.	
DRAMP01057	XXTKFDFFTLALQXPAXF	18	30 kDa antifungal protein (Plants)	Q10722	Not found	Not found	Engelmannia peristenia (Engelmann's daisy) (Engelmannia pinnatifida)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity against the plant fungal pathogens. Does not have antifungal activity against the human pathogen C. albicans. Does not have ribonuclease activity.
Tissue specificity: Leaves.
Developmental stage: Expressed in young plants, no expression in mature plants.
Miscellaneous: Resistant to heat and proteolysis.
Biophysicochemical properties: Temperature dependence (Thermostable)."	Fungi: Gaeumannomyces graminis, Phytophthora infestans, Phytophthora megasperma, Sclerotinia sclerotiorum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8670144	Biochem J. 1996 Jun 15;316 ( Pt 3):723-727.	Huynh QK, Borgmeyer JR, Smith CE, Bell LD, Shah DM.	Isolation and characterization of a 30 kDa protein with antifungal activity from leaves of Engelmannia pinnatifida.	
DRAMP01058	ATFDIQNKXTYTVWAAAWAPSYPGGXKQLD	30	Antifungal protein (Plants)	P84061	Not found	Not found	Diospyros texana (Texas persimmon)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity against P. infestans.
Tissue specificity: Expressed in the skin and the flesh but not the seed of the fruit.
Developmental stage: Overripe fruit."	Phytophthora infestans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8048935	Biochem Biophys Res Commun. 1994 Jul 29;202(2):666-672.	Vu L, Huynh QK.	Isolation and characterization of a 27-kDa antifungal protein from the fruits of Diospyros texana.	
DRAMP01059	VLSHNNESSYSDTSSCTSQ	19	Putative antimicrobial protein 1 (Plants)	B3EWI5	Not found	Not found	Cenchritis muricatus (Beaded periwinkle)	Antimicrobial	Protein level	Not found	Not found		Function: May have antimicrobial activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22367403	Curr Microbiol. 2012 May;64(5):501-505.	López-Abarrategui C, Alba A, Lima LA, Maria-Neto S, Vasconcelos IM, Oliveira JT, Dias SC, Otero-Gonzalez AJ, Franco OL.	Screening of antimicrobials from Caribbean sea animals and isolation of bactericidal proteins from the littoral mollusk Cenchritis muricatus.	
DRAMP01060	DLPECCSATELELDSGKQTS	20	Putative antimicrobial protein 2 (Plants)	B3EWI6	Not found	Not found	Cenchritis muricatus (Beaded periwinkle)	Antimicrobial	Protein level	Not found	Not found		Function: May have antimicrobial activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22367403	Curr Microbiol. 2012 May;64(5):501-505.	López-Abarrategui C, Alba A, Lima LA, Maria-Neto S, Vasconcelos IM, Oliveira JT, Dias SC, Otero-Gonzalez AJ, Franco OL.	Screening of antimicrobials from Caribbean sea animals and isolation of bactericidal proteins from the littoral mollusk Cenchritis muricatus.	
DRAMP01062	SESILIVHQQQSRSSGS	17	Putative antimicrobial protein 3 (Cm-p2; Plants)	B3EWI8	Not found	Not found	Cenchritis muricatus (Beaded periwinkle)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: This peptide demonstrated the capacity to prevent the development of yeasts and filamentous fungi. Otherwise, Cm-p1 displayed no toxic effects against mammalian cells.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22210491	Biochimie. 2012 Apr;94(4):968-974.	L³pez-Abarrategui C, Alba A, Silva ON, Reyes-Acosta O, Vasconcelos IM, Oliveira JT, Migliolo L, Costa MP, Costa CR, Silva MR, Garay HE, Dias SC, Franco OL, Otero-Gonz¡lez AJ.	Functional characterization of a synthetic hydrophilic antifungal peptide derived from the marine snail Cenchritis muricatus.	
DRAMP01065	NSMERVEELRKKLQD	15	Chitin-binding protein HM30 (Plants)	P83630	Belongs to the parathyroid hormone family	Not found	Hydrangea macrophylla (Bigleaf hydrangea)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Has antifungal activity against phytopathogenic fungi. Has no chitinase or agglutination activities.	Fungi: Alternria alternate, Alternaria cucumerina, Aspergillus niger, Collectotrichum gossypii, Fusarium oxysporum, F. oxysporum subsp melonis, Fusarium moniliforme, Thanatephorus cucumeris, Verticillium dahliae, Pyricularia oryzae Cav..	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	11812226	Protein Expr Purif. 2002 Feb;24(1):76-82.	Yang Q, Gong ZZ.	Purification and characterization of an ethylene-induced antifungal protein from leaves of Guilder rose (Hydrangea macrophylla).	
DRAMP01067	KQTENLADTY	10	Coccinin (Plant defensin)	P84785	 Belongs to the DEFL family	Not found	Phaseolus coccineus (Scarlet runner bean) (Phaseolus multiflorus)	Antimicrobial, Antifungal, Antiviral	Protein level	Not found	Not found		Function: Has strong antifungal activity. Inhibits the proliferation of leukemia cells in vitro. Inhibits human immunodeficiency virus-1 (HIV-1) reverse transcriptase (IC50=41 µM). Lacks mitogenic activity towards murine splenocytes.	Fungi: Fusarium oxysporum (IC50=81±7 µM), Mycosphaerella arachidicola (IC50=75±5 µM), Physalospora piricola (IC50=89±4 µM), Rhizoctomia solani (IC50=134±2 µM), Botrytis cinerea (IC50=109±5 µM), Coprinus comatus (IC50=122±7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15572193	Peptides. 2004 Dec;25(12):2063-2068.	Ngai PH, Ng TB.	Coccinin, an antifungal peptide with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from large scarlet runner beans.	
DRAMP01068	LNCGQVDSKMKPCLTYVQGGPGPSGECCNGVRDLHNQAQSSGDRQTVCNCLKGIARGIHNLNLNNAASIPSKCNVNVPYTISPDIDCSRIY	91	Non-specific lipid-transfer protein (Plant defensin)	A8YPK3	Belongs to the plant LTP family	ltp1	Hordeum vulgare (Barley)	Antimicrobial	Homology	Not found	Not found	1BE2##1JTB##1LIP##1MID##3GSH	Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	PubMed ID is not available	Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases	Niessen L.	Behaviour of foam components in gushing beer.	
DRAMP01069	MADKGVGSRLSALFLLVLLVISIGMMQLEPAEGRTCKTPSGKFKGVCASRNNCKNVCQTEGFPSGSCDFHVANRKCYCSKPCP	83	Putative plant defensin SPI1B (Plants)	Q8GTL2	Not found	Not found	Picea abies (Norway spruce) (Picea excelsa)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases	Fossdal CG.	The putative gymnosperm plant defensin (SPI1) accumulates after seed germination and a related SPI1B cDNA is found in needles.	
DRAMP01070	AIPCGQVNSALASCVSYAKGSGASPPGACCSGVRRLAGLARSTADKQAACRCIKSAAGGLNPGKAASIPSKCGVSIPYSISASVDCSKIH	90	Non-specific lipid-transfer protein (Plants)	Q1KMV1	Belongs to the plant LTP family	Not found	Triticum aestivum (Wheat)	Antimicrobial, Antifungal	Homology	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	18257684	Mol Plant Microbe Interact. 2008 Mar;21(3):346-360.	Sun JY, Gaudet DA, Lu ZX, Frick M, Puchalski B, Laroche A.	Characterization and antifungal properties of wheat nonspecific lipid transfer proteins.	
DRAMP01071	AISCGQVASAIAPCISYARGQGSAPSAGCCSGVRSLNNAARTTADRRAACNCLKNAAAGVSGLNAGNAASIPSKCGVSIPYTISTSTDCSRVN	93	Non-specific lipid-transfer protein (Plants)	Q2XX14	Belongs to the plant LTP family	plt1	Zea mays subsp. parviglumis (Balsas teosinte)	Antimicrobial	Homology	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	16120802	Mol Biol Evol. 2005 Dec;22(12):2480-2490.	Moeller DA, Tiffin P.	Genetic diversity and the evolutionary history of plant immunity genes in two species of Zea.	
DRAMP01072	AISCGQVASAIAPCISYARGQGSGPSAGCCSGVKSLNNAARTTADRRAACNCLKNAAAGVSGLNAGNAASIPSKCGVSIPYTISTSTDCSRVN	93	Non-specific lipid-transfer protein (Plants)	Q2XX25	Belongs to the plant LTP family	plt1	Zea mays subsp. parviglumis (Balsas teosinte)	Antimicrobial	Homology	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	16120802	Mol Biol Evol. 2005 Dec;22(12):2480-2490.	Moeller DA, Tiffin P.	Genetic diversity and the evolutionary history of plant immunity genes in two species of Zea.	
DRAMP01073	AISCGQVNSALASCVSYAKGSGASPPGACCSGVRRLAGLARSTADKQAACRCIKSAAGGLNPGKAASIPSKCGVSIPYSISASVDCSKIH	90	Non-specific lipid-transfer protein (Plants)	Q9FUK0	Belongs to the plant LTP family	LTP1	Triticum aestivum (Wheat)	Antimicrobial	Homology	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	PubMed ID is not available	Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases	Seo Y.W, Jang C.S.	Isolation and characterization of lipid transfer protein in wheat.	
DRAMP01074	AISCGQVNSALGPCISYARGSGANTSAACCSGVKRLAGSVRTSDDKKAACLCIKRAAGGLNPGKAADIPTKCRVTIPYKISSNVNCNNLH	90	Non-specific lipid-transfer protein (Plants)	Q155V0	Belongs to the plant LTP family	Not found	Secale cereale (Rye)	Antimicrobial	Homology	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	16823370	Nat Biotechnol. 2006 Jul;24(7):852-855.	Doxey AC, Yaish MW, Griffith M, McConkey BJ.	Ordered surface carbons distinguish antifreeze proteins and their ice-binding regions.	
DRAMP01075	AISCGQVSSALSPCISYARGSGSSPPAACCSGVRSLAGAARSTADKQAACKCIKSAAGGLNAGKAAGIPSKCGVSIPYAISSSVDCSKIR	90	Non-specific lipid-transfer protein (Plants)	Q1KMU9	Belongs to the plant LTP family	LTP	Triticum aestivum (Wheat)	Antimicrobial	Homology	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	18257684	Mol Plant Microbe Interact. 2008 Mar;21(3):346-360.	Sun JY, Gaudet DA, Lu ZX, Frick M, Puchalski B, Laroche A.	Characterization and antifungal properties of wheat nonspecific lipid transfer proteins.	
DRAMP01076	AISCGQVSSALTPCVAYAKGSGTSPSGACCSGVRKLAGLARSTADKQATCRCLKSVAGGLNPNKAAGIPSKCGVSVPYTISASVDCSKIH	90	Non-specific lipid-transfer protein (Plants)	Q9ATG4	Belongs to the plant LTP family	LTP2	Triticum aestivum (Wheat)	Antimicrobial	Homology	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	PubMed ID is not available	Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases	Seo Y.W, Jang C.S, Bu S.Y, Kim J.B.	Isolation and characterization of lipid transfer protein in wheat.	
DRAMP01077	AITCGQVNSAVGPCLTYARGGAGPSAACCSGVRSLKAAASSTADRRTACNCLKNAARGIKGLNAGNAASIPSKCGVSVPYTISASIDCSRVS	92	Non-specific lipid-transfer protein (Plants)	Q2RBD2	Belongs to the plant LTP family	Not found	Oryza sativa subsp. japonica (Rice)	Antimicrobial	Transcript level	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	16188032	BMC Biol. 2005 Sep 27;3:20.	Rice Chromosomes 11 and 12 Sequencing Consortia.	The sequence of rice chromosomes 11 and 12, rich in disease resistance genes and recent gene duplications.	
DRAMP01078	AITCGQVSSAIAPCLSYARGTGSGPSASCCSGVRNLKSAASTAADRRAACNCLKNAARGVSGLNAGNAASIPSKCGVSIPYTISTSTDCSRVN	93	Non-specific lipid-transfer protein (Plants)	O24583	Belongs to the plant LTP family	Not found	Zea mays (Maize)	Antimicrobial	Transcript level	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	19936069	PLoS Genet. 2009 Nov;5(11):e1000740.	Soderlund C, Descour A, Kudrna D, Bomhoff M, Boyd L, Currie J, Angelova A, Collura K, Wissotski M, Ashley E, Morrow D, Fernandes J, Walbot V, Yu Y.	Sequencing, mapping, and analysis of 27,455 maize full-length cDNAs.	
DRAMP01079	AITCGQVSSALSPCIPYARGNGANPSAACCSGVRRIAGAVQSTADKKTACNCIKRAAGGLNAGKAADIPSKCSVSIPYAINPSVDCSTIR	90	Non-specific lipid-transfer protein (Plants)	Q155V1	Belongs to the plant LTP family	Not found	Secale cereale (Rye)	Antimicrobial	Homology	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	16823370	Nat Biotechnol. 2006 Jul;24(7):852-855.	Doxey AC, Yaish MW, Griffith M, McConkey BJ.	Ordered surface carbons distinguish antifreeze proteins and their ice-binding regions.	
DRAMP01080	AITCGQVTHNVAPCFNYVKSGGAVPAACCKGVSNLNSMAKTTADRQQTCNCLKSAAGSIKGLNANLAAGLPGKCGVNVPYKISTSTNCNNVK	92	Non-specific lipid-transfer protein (Plants)	Q4PLT5	Belongs to the plant LTP family	LTP6	Fragaria ananassa (Strawberry)	Antimicrobial	Homology	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	PubMed ID is not available	Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases	Zuidmeer L, Salentijn EMJ.	Cross-reactivity of a recombinant non-specific lipid transfer protein from strawberry.	
DRAMP01084	ILGAILPLVSGLLSNKL	17	Alyteserin-2b (toads, amphibians, animals)	No entry found	Not found	Not found	Alytes obstetricans (European midwife toad)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Function: Amtimicrobial peptide. (By similarity)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19463738	Peptides. 2009 Jun;30(6):1069-1073.	Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.	The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).	
DRAMP01086	ILGAILPLVSGLLSSKL	17	Alyteserin-2c (toads, amphibians, animals)	No entry found	Not found	Not found	Alytes obstetricans (European midwife toad)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Function: Amtimicrobial peptide. (By similarity)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19463738	Peptides. 2009 Jun;30(6):1069-1073.	Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.	The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).	
DRAMP01087	GLKDIFKAGLGSLVKNIAAHVAN	23	Alyteserin-1d (toads, amphibians, animals)	No entry found	Not found	Not found	Alytes obstetricans (European midwife toad)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Function: Amtimicrobial peptide. (By similarity)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19463738	Peptides. 2009 Jun;30(6):1069-1073.	Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.	The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).	
DRAMP01092	QGRLGTQWAVGHLM	14	Alytesin (toads, amphibians, animals)	P08944	Belongs to the bombesin/neuromedin-B/ranatensin family	Not found	Alytes obstetricans (Common midwife toad) (Bufo obstetricans)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	6141890	Comp Biochem Physiol C. 1984;77(1):99-108.	Erspamer V, Erspamer GF, Mazzanti G, Endean R.	Active peptides in the skins of one hundred amphibian species from Australia and Papua New Guinea.	
DRAMP01093	IIGPVLGLVGKPLESLLE	18	Bombinin GH-1L (bombinin H isomers; toads, amphibians, animals)	No entry found	Belongs to the bombinin family	Not found	Bombina orientalis (Oriental fire-bellied toad) 	Antimicrobial, Antibacterial	Predicted	Not found	Not found		"Function: Bombinins GH-1D showes only 2.5% hemolysis at 30 µM concentration.
PTM: C-terminal amidation."	GH-1L does not display any microbicidal activity against all the microorganisms tested.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11090921	Peptides. 2000 Nov;21(11):1673-1679.	Mangoni ML, Grovale N, Giorgi A, Mignogna G, Simmaco M, Barra D.	Structure-Function: relationships in bombinins H, antimicrobial peptides from Bombina skin secretions.	
DRAMP01095	GIGASILSAGKSALKGFAKGLAEHFAN	27	Bombinin-like peptide 2 (Contains: Bombinin H2; toads, amphibians, animals)	P82286	Belongs to the bombinin family	Not found	Bombina variegata (Yellow-bellied toad)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Bombinin-like peptide 2 has antimicrobial activity, but no hemolytic activity. Preliminary evidence indicates that this peptide does not lyse and thus kill the bacteria by its antimicrobial activity. Bombinin H2 has antibacterial and hemolytic activity.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	[Ref:10333736]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10333736##223491	Biopolymers. 1998;47(6):435-450.##EMBO J. 1993 Dec;12(12):4829-4832.	Simmaco M, Mignogna G, Barra D.##Mignogna G, Simmaco M, Kreil G, Barra D.	Antimicrobial peptides from amphibian skin: what do they tell us?##Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.	
DRAMP01099	GIGAAILSAGKSIIKGLANGLAEHF	25	Bombinin-like peptide 4 (BLP-4; toads, amphibians, animals)	P29005	Belongs to the bombinin family	Not found	Bombina orientalis (Oriental fire-bellied toad)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Alpha helix	Not found		"Function: Has antimicrobial activity, but no hemolytic activity. Preference on killing Gram-negative non-enteric bacteria.
Tissue specificity: Expressed by the skin glands."	[Ref.1744108]Gram-negative bacteria: Neisseria meningitidis, Neisseria gonorrhoeoe, Neisseria Iactamica, Neisseria cinerea.	[Ref:1744108]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1744108	J Biol Chem. 1991 Dec 5;266(34):23103-23111.	Gibson BW, Tang DZ, Mandrell R, Kelly M, Spindel ER.	Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis.	
DRAMP01100	GIGGALLSAAKVGLKGLAKGLAEHFAN	27	Bombinin-like peptide 1 (Contains: Bombinin H; toads, amphibians, animals)	P29006	Belongs to the bombinin family	Not found	Bombina variegata (Yellow-bellied toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antimicrobial activity, but low hemolytic activity. Preliminary evidence indicates that this peptide does not lyse and thus kill the bacteria by its antimicrobial activity. Bombinin H has antibacterial and hemolytic activity.
Tissue specificity: Expressed by the skin glands."	[Ref.1712299]Gram-positive bacteria: Staphylococcus species;##Gram-negative bacteria: Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Pseudomonas aeruginosa, Pseudomonas maltophilia, Alcaligenes denitrificans.	[Ref:8223491]Has low hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1712299##8223491	Eur J Biochem. 1991 Jul 1;199(1):217-222.##EMBO J. 1993 Dec;12(12):4829-4832.	Simmaco M, Barra D, Chiarini F, Noviello L, Melchiorri P, Kreil G, Richter K.##Mignogna G, Simmaco M, Kreil G, Barra D.	A family of bombinin-related peptides from the skin of Bombina variegata.##Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.	
DRAMP01101	ILGPVLGLVGNALGGLIKNE	20	Maximin-Ht (Maximin-7; toads, amphibians, animals)	P83086 	Belongs to the bombinin family	Not found	Bombina maxima (Chinese large-webbed bell toad)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUN-2001) to UniProtKB	Chen TB, McClean S, Orr DF, Bjourson AJ, Rao PF, Shaw C.	Isolation and structural characterisation of antimicrobial peptides from the venom of the Chinese large-webbed bell toad (Bombina maxima).	
DRAMP01102	ILGPVLSLVGNALGGLLKNE	20	Maximin-Hu (Maximin-8; toads, amphibians, animals)	P83087	Belongs to the bombinin family	Not found	Bombina maxima (Chinese large-webbed bell toad)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11835991##PubMed ID is not available	Peptides 2002; 23:427-435.##Submitted (JUL-2001) to UniProtKB.	Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.##Chen TB, McClean S, Orr DF, Bjourson AJ, Rao PF, Shaw C.	Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.##Isolation and structural characterisation of antimicrobial peptides from the venom of the Chinese large-webbed bell toad (Bombina maxima).	
DRAMP01103	GSNKGFNFMVDMIQALSN	18	Maximin-S2 (chain of Maximins-S type B/C; toads, amphibians, animals)	Q5GC92	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Maximin-S2 has an activity against mycoplasma but has no activity against common Gram-positive and Gram-negative bacteria nor fungi. Has no hemolytic activity. Tissue specificity: Expressed by the skin dorsal glands. PTM: Asparagine amide at position 18.	No MICs found in DRAMP database	[Ref:15649437]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15649437	Biochem Biophys Res Commun. 2005 Feb 18;327(3):945-951.	Wang T, Zhang J, Shen JH, Jin Y, Lee WH, Zhang Y.	Maximins S, a novel group of antimicrobial peptides from toad Bombina maxima.	
DRAMP01104	GSNKGFNFMVDMINALSN	18	Maximin-S3 (chain of Maximins-S type B/C; toads, amphibians, animals)	Q5GC92	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Maximin-S3 has an activity against mycoplasma but has no activity against common Gram-positive and Gram-negative bacteria nor fungi. Has no hemolytic activity. Tissue specificity: Expressed by the skin dorsal glands. PTM: Asparagine amide at position 18.	No MICs found in DRAMP database	[Ref:15649437]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15649437	Biochem Biophys Res Commun. 2005 Feb 18;327(3):945-951.	Wang T, Zhang J, Shen JH, Jin Y, Lee WH, Zhang Y.	Maximins S, a novel group of antimicrobial peptides from toad Bombina maxima.	
DRAMP01106	GSNKGFNFMVDMIQALSK	18	Maximin-S5 (chain of Maximins-S type B/C; toads, amphibians, animals)	Q5GC92	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Maximin-S3 has an activity against mycoplasma but has no activity against common Gram-positive and Gram-negative bacteria nor fungi. Has no hemolytic activity. Tissue specificity: Expressed by the skin dorsal glands. PTM: Lysine amide at position 18.	Mycoplasma	[Ref:15649437]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15649437	Biochem Biophys Res Commun. 2005 Feb 18;327(3):945-951.	Wang T, Zhang J, Shen JH, Jin Y, Lee WH, Zhang Y.	Maximins S, a novel group of antimicrobial peptides from toad Bombina maxima.	
DRAMP01112	GIGGALLSAGKSALKGLAKGLAEHFAN	27	Maximin-11 (Maximin-6; toads, amphibians, animals)	Q58T41, P83085	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Function: It has little hemolytic activity 	Yeast: Candida albicans.	[Ref:11835991]Little hemolytic activity at 50 μg/ml against red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01113	GIGAKILGGVKTALKGALKELASTYVN	27	Maximin-7 (toads, amphibians, animals)	Q58T58, Q58T74	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Function: It has little hemolytic activity. 	[Swiss_Prot Entry Q58T58]Yeast: Candida albicans	[Ref:15770703]Little hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703	Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01114	GIGTKILGGLKTAVKGALKELASTYVN	27	Maximin-8 (toads, amphibians, animals)	Q58T56	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Function: It has little hemolytic activity. 	[Ref.15770703]Yeast: Candida albicans	[Ref:15770703]Little hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703	Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01115	GIGRKFLGGVKTTFRCGVKDFASKHLY	27	Maximin-9 (toads, amphibians, animals)	Q58T55	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11835991	FEBS Lett. 2005 Aug 15;579(20):4443-4448	Wen-Hui Lee, Jie Zhang, Ying-Xia Zhang, Yang Jin, Ren Lai and Yun Zhang.	Maximin 9, a novel free thiol containing antimicrobial peptide with antimycoplasma activity from frog Bombina maxima	
DRAMP01116	GIGGALLSAGKSALKGLAKGLAEHFAS	27	Maximin-10 (toads, amphibians, animals)	Q58T45, Q58T39	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Function: Maximin-10 shows antimicrobial activity against bacteria and against the fungus C. albicans. It has little hemolytic activity (By similarity).	[Swiss_Prot Entry Q58T45]Yeast: Candida albicans	[Ref:11835991]Little hemolytic activity at 50 μg/ml against red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01117	GIGTKIIGGLKTAVKGALKELASTYVN	27	Maximin-11 (toads, amphibians, animals)	Q58T51	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703	Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01118	GIGGALLSAGKAALKGLAKGFAEHF	25	Maximin y type 2 (toads, amphibians, animals)	Q58T94	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703	Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01119	GIGGALLSAGKSALKGLAKGFAEHF	25	Maximin-y (toads, amphibians, animals)	Q58T91	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703	Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01120	ILGPVLSLVGSALGGLIKKI	20	Maximin-Hv (toads, amphibians, animals)	Q58T91 , Q58T89 , Q58T94	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703	Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01121	ILGPVLGLVSNAIGGLIKKI	20	Maximin-Hw (toads, amphibians, animals)	Q58T92	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703	Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01122	GIGGALLSAGKSALKGLAKGLVEHFAN	27	Maximin-z (toads, amphibians, animals)	Q58T90	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703	Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01127	ILGPVLGLVSDTLDDVLGIL	20	Maximin-H5 (toads, amphibians, animals)	Q8JHE1, Q58T54	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Comment: A arginine mutant (i.e. 3D to 3R) was found to be HIV inhibitory (Wang G et al. 2010 Antimicrob. Agents Chemother. 54: 1343-1346).	Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12127963	Biochem Biophys Res Commun 2002 Jul 26;295(4):796-799.	Lai R, Liu H, Hui Lee W, Zhang Y.	An anionic antimicrobial peptide from toad Bombina maxima.	
DRAMP01128	ILGPVIGTIGNVLGGLLKNL	20	Maximin-H6 (toads, amphibians, animals)	Q58T72	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703	Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01129	ILGPVIKTIGGVIGGLLKNL	20	Maximin-H7 (toads, amphibians, animals)	Q58T56	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703	Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01130	ILGPVLGLVSNALGGLLKNI	20	Maximin-H8 (toads, amphibians, animals)	Q58T86, Q58T49	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01131	ILGPVLGLVSNALGGLIKKI	20	Maximin-H9 (toads, amphibians, animals)	Q58T80, Q58T69	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01132	ILGPVLGLVSNALGGLLKNL	20	Maximin-H10 (toads, amphibians, animals)	Q58T59	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Function: Shows strong hemolytic activity.	[Swiss_Prot Entry Q58T59]Yeast: Candida albicans	[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703	Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01133	ILGPVLGLVGSALGGLIKKI	20	Maximin-H11 (toads, amphibians, animals)	Q58T95, Q58T65, Q58T64, Q58T48	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Function: Shows strong hemolytic activity.	[Swiss_Prot Entry Q58T95]Yeast: Candida albicans	[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01134	ILGPVIKTIGGVLGGLLKNL	20	Maximin-H13 (toads, amphibians, animals)	Q58T58	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703	Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lee W.-H, Li Y, Lai R, Li S, Zhang Y, Wang W.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01135	LLGPVLGLVSNALGGLLKNI	20	Maximin-H12 (toads, amphibians, animals)	Q58T87	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11835991##15770703	Peptides. 2002 Mar;23(3):427-435.##Eur J Immunol. 2005 Apr;35(4):1220-1229.	Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.##Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.	Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.##Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.	
DRAMP01136	ILGPVLGLVGEPLGGLIKKI	20	Maximin-H14 (toads, amphibians, animals)	Q58T46	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01137	ILGPVLGLVGNALGGLLKNL	20	Maximin-H15 (toads, amphibians, animals)	Q58T43, Q58T39	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01138	ILGPVLSLVGNALGGLIKKI	20	Maximin-H16 (toads, amphibians, animals)	Q58T93, Q58T40	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Shows strong hemolytic activity. 	[Swiss_Prot Entry Q58T93]Yeast: Candida albicans	[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-1229.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01139	GIVDFAKKVVGGIRNALGI	19	Uperin-2.1 (toads, amphibians, animals)	P82027	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Shows a medium antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands."	Leuconostoc mesenteroides, Micrococcus luteus, Streptococcus uberis (medium antibacterial activity).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01140	GFVDLAKKVVGGIRNALGI	19	Uperin-2.2 (toads, amphibians, animals)	P82028	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Shows a weak antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Bacillus cereus, Leuconostoc mesenteroides, L. innocua, Micrococcus luteus, Staphylococcus aureus and Streptococcus uberis.##Gram-negative bacteria: Pasteurella haemolytica, Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01141	GFFDLAKKVVGGIRNALGI	19	Uperin-2.3 (toads, amphibians, animals)	P82029	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Shows a medium antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Bacillus cereus, Leuconostoc mesenteroides, Streptococcus uberis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01142	GILDFAKTVVGGIRNALGI	19	Uperin-2.4 (toads, amphibians, animals)	P82030	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Shows a weak antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Bacillus cereus, Escherichia coli, Leuconostoc mesenteroides, L. innocua, Micrococcus luteus, Pasteurella haemolytica, Staphylococcus aureus and Streptococcus uberis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01143	GIVDFAKGVLGKIKNVLGI	19	Uperin-2.5 (toads, amphibians, animals)	P82031	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Shows a medium antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Micrococcus luteus, Leuconostoc mesenteroides, Streptococcus uberis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01144	GILDIAKKLVGGIRNVLGI	19	Uperin-2.6 (toads, amphibians, animals)	P82095	Not found	Not found	Uperoleia mjobergii (Australian toadlet)	Unknown	Protein level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996;49:1325-1331.	Bradford A.M, Bowie J.H, Tyler M.J, Wallace J.C.	New antibiotic uperin peptides from the dorsal glands of the australian toadlet Uperoleia mjobergii.	
DRAMP01145	GIIDIAKKLVGGIRNVLGI	19	Uperin-2.7 (toads, amphibians, animals)	P82039	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01146	GILDVAKTLVGKLRNVLGI	19	Uperin-2.8 (toads, amphibians, animals)	P82040	Not found	Not found	Uperoleia mjobergii (Australian toadlet)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Shows antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Bacillus cereus, Lactococcus lactis, Staphylococcus epidermidis, Streptococcus uberis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01147	GVLDAFRKIATVVKNVV	17	Uperin-3.1 (toads, amphibians, animals)	P82032	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Shows a medium antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Staphylococcus aureus, Leuconostoc mesenteroides.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01148	GVLDAFRKIATVVKNLV	17	Uperin-3.2 (toads, amphibians, animals)	P82033	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01149	GVLDAFKKIATVVKNLV	17	Uperin-3.3 (toads, amphibians, animals)	P82034	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01150	GVGDLIRKAVAAIKNIV	17	Uperin-3.4 (toads, amphibians, animals)	P82041	Not found	Not found	Uperoleia mjobergii (Australian toadlet)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01156	GVGDIFRKIVSTIKNVV	17	Uperin-3.7 (toads, amphibians, animals)	P82044	Not found	Not found	Uperoleia mjobergii (Australian toadlet)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01157	GVGSFIHKVVSAIKNVA	17	Uperin-4.1 (toads, amphibians, animals)	P82035	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Shows a medium antibacterial activity against L. mesenteriodes.
PTM: Alanine amide at position 17."	Gram-positive bacterium: Leuconostoc mesenteroides.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01158	FQFVNPSDIVFGS	13	Uperin-5.1 (toads, amphibians, animals)	P82036	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defense peptide.
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01159	GLAGAISSALDKLKQSQLIKNYAKKLGYPR	30	Uperin-6.1 (toads, amphibians, animals)	P82037	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defense peptide.
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01160	GLAGAISSVLDKLKQSQLIKNYAKKLGYPR	30	Uperin-6.2 (toads, amphibians, animals)	P82038	Not found	Not found	Uperoleia inundata (Floodplain toadlet)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defense peptide.
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1996; 49:475-484.	Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.	Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.	
DRAMP01161	GWFDVVKHIASAV	13	Uperin-7.1 (Frogs, amphibians, animals)	P82050	Not found	Not found	Litoria ewingi (Brown tree frog) (Ewing's tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Antiviral	Protein level	Not found	Not found		"Function: Uperin 7.1 shows antibacterial activity against L. lactis. Uperin 7.1.1 is inactive.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Streptococcus uberis, Lactococcus lactis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Aust. J. Chem. 1997; 50:889-894.	Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.	An unusual combination of peptides from the skin glands of Ewing's tree frog, Litoria ewingi. Sequence determination and antimicrobial activity.	
DRAMP01166	FLPMLAKLLSGFLGK	15	Preprotemporin-1SKd (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana sakuraii (Japanese brown frog)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17174009	Peptides. 2007 Mar;28(3):505-514.	Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.	Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.	
DRAMP01168	RAEAVPPGFTPFRKP	15	Ranakinin-N (bradykinin-like peptide; Frogs, amphibians, animals)	P86093	Belongs to the bradykinin family	Not found	Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17994619	J Pept Sci. 2008 May;14(5):626-630.	Liu X, You D, Chen L, Wang X, Zhang K, Lai R.	A novel bradykinin-like peptide from skin secretions of the frog, Rana nigrovittata.	
DRAMP01169	ENREVPPGFTALIKTLRKCKII	22	Distinctin 1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Phyllomedusa distincta (Tree frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Note: Distinctin chain 1 links to Distinctin chain 2 to form a heterodimeric peptide to exert antibacterial function. ##Gram-positive bacteria: Enterococcus faecalis (MIC=14.5 µM), Staphylococcus aureus (MIC=28.0 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=28.0 µM), Escherichia coli (MIC=14.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	"There is an intermolecular disulphide bridge between Distinctin chain 1 (Cys19) and Distinctin chain 2 (Cys22). 
There is an intermolecular disulphide bridge between Distinctin chain 1 (Cys19) and Distinctin chain 2 (Cys22)."	L	No cytotoxicity information found	Not found	19189273	J Pept Sci. 2009 Apr;15(4):278-284.	Vidovic V, Prongidi-Fix L, Bechinger B, Werten S.	Production and isotope labeling of antimicrobial peptides in Escherichia coli by means of a novel fusion partner that enables high-yield insoluble expression and fast purification.	
DRAMP01171	GVVDILKGAGKDLLAHLVGKISEKV	25	Ocellatin-1 (Frogs, amphibians, animals)	P83951	Not found	Not found	Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Has hemolytic activity against human erythrocytes and antibacterial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin dorsal glands."	[Swiss_Prot Entry P83951]Gram-negative bacterium: Escherichia coli	[Ref:15648972]Show hemolytic activity against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15648972	Protein J. 2004 Nov;23(8):501-508.	Nascimento AC, Zanotta LC, Kyaw CM, Schwartz EN, Schwartz CA, Sebben A, Sousa MV, Fontes W, Castro MS.	Ocellatins: new antimicrobial peptides from the skin secretion of the South American frog Leptodactylus ocellatus (Anura: Leptodactylidae).	
DRAMP01172	GVLDIFKDAAKQILAHAAEKQI	22	Ocellatin-2 (Frogs, amphibians, animals)	P83866	Not found	Not found	Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Has hemolytic activity against human erythrocytes and antibacterial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin dorsal glands."	[Swiss_Prot Entry P83866]Gram-negative bacterium: Escherichia coli	[Ref:15648972]Show hemolytic activity against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15648972	Protein J. 2004 Nov;23(8):501-508.	Nascimento AC, Zanotta LC, Kyaw CM, Schwartz EN, Schwartz CA, Sebben A, Sousa MV, Fontes W, Castro MS.	Ocellatins: new antimicrobial peptides from the skin secretion of the South American frog Leptodactylus ocellatus (Anura: Leptodactylidae).	
DRAMP01173	GVLDILKNAAKNILAHAAEQI	21	Ocellatin-3 (Frogs, amphibians, animals)	P83867	Not found	Not found	Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Has hemolytic activity against human erythrocytes and antibacterial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation."	[Swiss_Prot Entry P83867]Gram-negative bacterium: Escherichia coli	[Ref:15648972]Show hemolytic activity against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15648972	Protein J. 2004 Nov;23(8):501-508.	Nascimento AC, Zanotta LC, Kyaw CM, Schwartz EN, Schwartz CA, Sebben A, Sousa MV, Fontes W, Castro MS.	Ocellatins: new antimicrobial peptides from the skin secretion of the South American frog Leptodactylus ocellatus (Anura: Leptodactylidae).	
DRAMP01175	AVLDILKDVGKGLLSHFMEKV	21	Ocellatin-5 (Frogs, amphibians, animals)	P85443	Not found	Not found	Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Has hemolytic and antibacterial activities.
Tissue specificity: Expressed by the skin dorsal glands."	[Ref.19739090]Gram-postive bacterium: Staphylococcus aureus(100% inhibition at 64μg/mL);##Gram-negative bacterium: Escherichia coli(100% inhibition at 32μg/mL).	[Ref:19739090]Show hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19739090##	J Exp Zool A Ecol Genet Physiol. 2010 Jan 1;313(1):1-8.##Thesis (2007), University of Brasilia, Brazil	Leite JM Jr, Silva LP, Silva-Leite RR, Ferrari AS, Noronha SE, Silva HR, Bloch C Jr, Leite JR.##Nascimento A.C.C.	Leptodactylus ocellatus (Amphibia): mechanism of defense in the skin and molecular phylogenetic relationships.##Cytolytic peptides and proteases from the skin secretion of the frog Leptodactylus ocellatus).	
DRAMP01176	AVLDFIKAAGKGLVTNIMEKVG	22	Ocellatin-6 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19739090	J Exp Zool A Ecol Genet Physiol. 2010 Jan 1;313(1):1-8.	Leite JM Jr, Silva LP, Silva-Leite RR, Ferrari AS, Noronha SE, Silva HR, Bloch C Jr, Leite JR.	Leptodactylus ocellatus (Amphibia): mechanism of defense in the skin and molecular phylogenetic relationships.	
DRAMP01178	GVVDILKGAAKDLAGHLASKVMNKI	25	Ocellatin-K1 (Frogs, amphibians, animals)	P86711	Not found	Not found	Leptodactylus knudseni (Knudsen's thin-toed frog) (Amazonian toad-frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Has antibacterial activity. Tissue specificity: Expressed by the skin glands. PTM: Isoleucine amide at position 25.	[Swiss_Prot Entry P86711]show antibacterial activity	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2010) to UniProtKB	Cardozo-Filho J.L, Soares A.A, Bloch C. Jr, Silva L.P, Stabeli R.G, Calderon L.A.	Identification of peptides from Amazonian Leptodactylus knudseni skin secretion by MALDI TOF/TOF.	
DRAMP01179	GVVDILKGAGKDLLAHALSKLSEKV	25	Ocellatin-V1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Leptodactylus validus Garman (Caribbean frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: The very low antimicrobial potency (MIC>200 µM) against Escherichia coli and Staphylococcus aureus associated with the peptides is probably a consequence of their lack of amphipathicity and reduced cationicity compared with active members of the ocellatin family from related species.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18501993	Peptides. 2008 Aug;29(8):1287-1292.	King JD, Leprince J, Vaudry H, Coquet L, Jouenne T, Conlon JM.	Purification and characterization of antimicrobial peptides from the Caribbean frog, Leptodactylus validus (Anura: Leptodactylidae).	
DRAMP01180	GVLDILKGAGKDLLAHALSKISEKV	25	Ocellatin-V2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Leptodactylus validus Garman (Caribbean frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: The very low antimicrobial potency (MIC>200 µM) against Escherichia coli and Staphylococcus aureus associated with the peptides is probably a consequence of their lack of amphipathicity and reduced cationicity compared with active members of the ocellatin family from related species.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18501993	Peptides. 2008 Aug;29(8):1287-1292.	King JD, Leprince J, Vaudry H, Coquet L, Jouenne T, Conlon JM.	Purification and characterization of antimicrobial peptides from the Caribbean frog, Leptodactylus validus (Anura: Leptodactylidae).	
DRAMP01181	GVLDILTGAGKDLLAHALSKLSEKV	25	Ocellatin-V3 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Leptodactylus validus Garman (Caribbean frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: The very low antimicrobial potency (MIC>200 µM) against Escherichia coli and Staphylococcus aureus associated with the peptides is probably a consequence of their lack of amphipathicity and reduced cationicity compared with active members of the ocellatin family from related species.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18501993	Peptides. 2008 Aug;29(8):1287-1292.	King JD, Leprince J, Vaudry H, Coquet L, Jouenne T, Conlon JM.	Purification and characterization of antimicrobial peptides from the Caribbean frog, Leptodactylus validus (Anura: Leptodactylidae).	
DRAMP01183	GVLDILKGAAKDLAGHVATKVINKI	25	Syphaxin (SPX; Frogs, amphibians, animals)	P85279	Not found	Not found	Leptodactylus syphax (Burgundy thin-toed frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Has hemolytic and antibacterial activity. PTM: Isoleucine amide at position 25. Tissue specificity: Expressed by the skin dorsal glands.	[Swiss_Prot Entry P85279]show antibacterial activity	[Ref:17628627]Show hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17628627	Toxicon. 2007 Sep 15;50(4):572-580.	Dourado F.S, Leite J.R.S.A, Silva L.P, Melo J.A.T, Bloch C. Jr, Schwartz E.F.	Antimicrobial peptide from the skin secretion of the frog Leptodactylus syphax.	
DRAMP01186	IGVIKLSLCEEERNADEEKRRDDPDEMDVEVEKR	34	Chensinin-1CEb (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana chensinensis (Chinese brown frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: Has moderate antimicrobial activity against microorganisms.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21303203	Zoolog Sci. 2011 Feb;28(2):112-117.	Zhao J, Sun Y, Li Z, Su Q.	Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.	
DRAMP01187	FTLKKSQLLLFFLGTINFSLCEEERNAEEERRDYPEEKDVEVEKR	45	Chensinin-3CE (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana chensinensis (Chinese brown frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: Has moderate antimicrobial activity against microorganisms.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21303203	Zoolog Sci. 2011 Feb;28(2):112-117.	Zhao J, Sun Y, Li Z, Su Q.	Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.	
DRAMP01193	FLPKLFAGIISKNF	14	Andersonin-Y2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Golden crossband frog)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Function: Weakly active against bacteria and fungi.	No MICs found in DRAMP database	[Ref:22029824]Not found	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01196	KEKLKLKCKAPKCYNDKLACT	21	Andersonin-G1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Golden crossband frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Weakly active against bacteria and fungi and has no hemolytic activity under the test conditions.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>200 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC>200 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>200 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC>200 µg/ml).	[Ref:22029824]Non-hemolytic activity against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01197	ENMFNIKSSVESDSFWG	17	Andersonin-N1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Golden crossband frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Weakly active against bacteria and fungi and has no hemolytic activity under the test conditions.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>200 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC>200 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>200 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC>200 µg/ml).	[Ref:22029824]Non-hemolytic activity against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01198	EMLKKKKEVKMERKT	15	Andersonin-Q1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana andersonii (Golden crossband frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Weakly active against bacteria and fungi and has no hemolytic activity under the test conditions.	[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>200 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC>200 µg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>200 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC>200 µg/ml).	[Ref:22029824]Non-hemolytic activity against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01205	GLFDIIKNIVSTL	13	Dahlein-1.1 (Frogs, amphibians, animals)	P84273	Not found	Not found	Litoria dahlii (Dahl's aquatic frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Weak wide spectrum antimicrobial activity against Gram-positive bacteria.
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11555873	Rapid Commun Mass Spectrom. 2001;15(18):1726-1734.	Wegener KL, Brinkworth CS, Bowie JH, Wallace JC, Tyler MJ.	Bioactive dahlein peptides from the skin secretions of the Australian aquatic frog Litoria dahlii: sequence determination by electrospray mass spectrometry.	
DRAMP01206	GLFDIIKNIFSGL	13	Dahlein-1.2 (Frogs, amphibians, animals)	P84263	Not found	Not found	Litoria dahlii (Dahl's aquatic frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Weak wide spectrum antimicrobial activity against Gram-positive bacteria.
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11555873	Rapid Commun Mass Spectrom. 2001;15(18):1726-1734.	Wegener KL, Brinkworth CS, Bowie JH, Wallace JC, Tyler MJ.	Bioactive dahlein peptides from the skin secretions of the Australian aquatic frog Litoria dahlii: sequence determination by electrospray mass spectrometry.	
DRAMP01207	CYSAAKYPGFQEFINRKYKSSRF	23	Galensin (Frogs, amphibians, animals)	Q90W78	Not found	Not found	Kassina senegalensis (Senegal running frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial activity against the Gram-positive bacteria: M. luteus and the Gram-negative bacteria E. coli. 
Tissue specificity: Expressed by the skin dorsal glands."	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases	Reid C.N, Bjourson A.J, Shaw C.	Galensin, a novel homodimeric antimicrobial peptide from the defensive skin secretion of Kassina senegalensis: isolation, structural characterisation and cloning of precursor cDNA.	
DRAMP01210	MFTLKKTLLLLFFLGTINLSLCKEERDADEERRDDPDKRDVEVEKRFLSGILKLAFKIPSVLCAVLKNC	69	Pleurain-D1 antimicrobial peptide (Frogs, amphibians, animals)	B5L1C2	Not found	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-583.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	
DRAMP01211	MFTLKKTLLLLFFLGTINLSLCKEERDADEERRDDPDKRDVEVEKRFLSGILKLASKIPSVLCAVLKNC	69	Pleurain-D2 antimicrobial peptide (Frogs, amphibians, animals)	B5L1D6	Not found	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-583.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	
DRAMP01212	SIITMTREAKLPQLWKQIACRLYNTC	26	Pleurain-A3 (Pleurain A3; Frogs, amphibians, animals)	A8B5P7	Not found	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		"Function: Has little hemolytic activity on red blood cells.
Tissue specificity: Expressed by the skin dorsal glands."	[Swiss_Prot Entry A8B5P7]has activity against Gram-positive and -negative bacteria, and fungi	[Ref:17764786]Little hemolytic activity on red blood cells even with peptide concentration up to 200 μg/ml	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17764786	Peptides. 2007 Oct;28(10):2069-2074.	Wang X, Song Y, Li J, Liu H, Xu X, Lai R, Zhang K.	A new family of antimicrobial peptides from skin secretions of Rana pleuraden.	
DRAMP01213	SIITTTKEAKLPQLWKQIACRLYNTC	26	Pleurain-A4 (Pleurain A4; Frogs, amphibians, animals)	A8B5Q0	Not found	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		"Function: Has little hemolytic activity on red blood cells.
Tissue specificity: Expressed by the skin dorsal glands."	[Swiss_Prot Entry A8B5Q0]has activity against Gram-positive and -negative bacteria, and fungi	[Ref:17764786]Little hemolytic activity on red blood cells even with peptide concentration up to 200 μg/ml	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17764786	Peptides. 2007 Oct;28(10):2069-2074.	Wang X, Song Y, Li J, Liu H, Xu X, Lai R, Zhang K.	A new family of antimicrobial peptides from skin secretions of Rana pleuraden.	
DRAMP01215	FFGAIAAALPHVISAIKNAL	20	Kassinatuerin-2Mb (Frogs, amphibians, animals)	No entry found	Not found	Not found	Kassina maculata (African hyperoliid frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Alpha helix	Secondary structure prediction analysis revealed that virtually the entire structure of each kassinatuerin-2 related peptide is composed of alpha-helix, the helix was not amphipathic like many other amphibian skin antimicrobial peptides, in which there is a hydrophobic face and a positively charged faces the latter presumably interacting with the negatively charged glycocalyx of cell membranes.		Function: Has relatively potent growth inhibitory activity against the Gram-positive bacterium, S. aureus, but were ineffective against the Gram-negative bacterium, E. coli and were relatively ineffective against the pathogenic yeast, C. albicans. Has hemolytic activity as demonstrated using horse erythrocytes.	[Ref.19427345]Gram-positive bacterium: Staphylococcus aureus	[Ref:19427345]18% hemolytic activity at 16 μM, 45–50% hemolytic activity at 120 μM against horse erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19427345	Peptides. 2009 Aug;30(8):1428-1433.	Wang L, Zhou M, McGrath S, Chen T, Gorman SP, Walker B, Shaw C.	A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.	
DRAMP01216	FVGAIAAALPHVISAIKNAL	20	Kassinatuerin-2Mc (Frogs, amphibians, animals)	No entry found	Not found	Not found	Kassina maculata (African hyperoliid frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Alpha helix	Secondary structure prediction analysis revealed that virtually the entire structure of each kassinatuerin-2 related peptide is composed of alpha-helix, the helix was not amphipathic like many other amphibian skin antimicrobial peptides, in which there is a hydrophobic face and a positively charged faces the latter presumably interacting with the negatively charged glycocalyx of cell membranes.		Function: Has relatively potent growth inhibitory activity against the Gram-positive bacterium, S. aureus, but were ineffective against the Gram-negative bacterium, E. coli and were relatively ineffective against the pathogenic yeast, C. albicans. Has hemolytic activity as demonstrated using horse erythrocytes.	[Ref.19427345]Gram-positive bacterium: Staphylococcus aureus	[Ref:19427345]18% hemolytic activity at 16 μM, 45–50% hemolytic activity at 120 μM against horse erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19427345	Peptides. 2009 Aug;30(8):1428-1433.	Wang L, Zhou M, McGrath S, Chen T, Gorman SP, Walker B, Shaw C.	A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.	
DRAMP01217	IIGAIAAALPHVINAIKNTF	20	Kassinatuerin-2Md (Frogs, amphibians, animals)	No entry found	Not found	Not found	Kassina maculata (African hyperoliid frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Alpha helix	Secondary structure prediction analysis revealed that virtually the entire structure of each kassinatuerin-2 related peptide is composed of alpha-helix, the helix was not amphipathic like many other amphibian skin antimicrobial peptides, in which there is a hydrophobic face and a positively charged faces the latter presumably interacting with the negatively charged glycocalyx of cell membranes.		Function: Has relatively potent growth inhibitory activity against the Gram-positive bacterium, S. aureus, but were ineffective against the Gram-negative bacterium, E. coli and were relatively ineffective against the pathogenic yeast, C. albicans. Has hemolytic activity as demonstrated using horse erythrocytes.	[Ref.19427345]Gram-positive bacterium: Staphylococcus aureus	[Ref:19427345]18% hemolytic activity at 16 μM, 45–50% hemolytic activity at 120 μM against horse erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19427345	Peptides. 2009 Aug;30(8):1428-1433.	Wang L, Zhou M, McGrath S, Chen T, Gorman SP, Walker B, Shaw C.	A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.	
DRAMP18320	SASIVKTTIKASKKLCRGFTLTCGCHFTGKK	31	Epilancin 15X(Bacteriocin)	P86047	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Staphylococcus epidermidis 15X154	Antimicrobial, Antibacterial, Anti-Gram+		Non helix or strand structure	The peptide was found to highly resemble the previously identified epilancin K7 with 68% sequence identity, three nearly identical lanthionine rings and a modified amino acid at the N-terminus. The C-terminal B and C rings of epilancin 15X are structurally similar to the D and E rings of nisin A that are believed to be involved in pore formation.	1W9N resolved by NMR	The compound contains an unusual N-terminal D-lactate group that could be essential for biological activity. This study demonstrates that this moiety confers stability against proteolytic degradation by aminopeptidases. 	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15792796##21802007 	FEBS Lett. 2005 Mar 28;579(9):1917-22.##Chem Biol. 2011 Jul 29;18(7):857-67.	Ekkelenkamp MB, Hanssen M, Danny Hsu ST, de Jong A, Milatovic D, Verhoef J, van Nuland NA.##Vel	Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.##Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate.	
DRAMP01223	GFMDTAKQVAKNVAVTLIDKLRCKVTGGC	29	Palustrin-2AJ2 (PL2AJ12; Frogs, amphibians, animals)	G3F828	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Displays broad-spectrum antibacterial activity against a range of Gram-positive and Gram-negative bacteria. Has low hemolytic activity, low cytotoxicity and low antioxidant activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 23-29 and Cleavage on pair of basic residues."	[Swiss_Prot Entry G3F828]broad-spectrum antibacterial activity against a range of Gram-positive and Gram-negative bacteria	[Ref:21816202]Show slight hemolytic activity against human and rabbit erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21816202	Biochimie. 2012 Feb;94(2):328-334.	Chen Z, Yang X, Liu Z, Zeng L, Lee W, Zhang Y.	Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis.	
DRAMP01225	GIFPKIIGKGIVNGIKSLAKGVGMKVFKAGLNNIGNTGCNNRDEC	45	Palustrin-3AR (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana areolata (North American crawfish frog)	Antimicrobial, Antibacterial, Antiviral	Not found	Not found	Not found		This peptide could inhibit HIV infection at a concentration that is also toxic to T cells (J Virol 2005; 79:11598-11606).	No MICs found in DRAMP database	[Ref:12429503] HC50=200 µM against human erythrocytes	Cyclic	Free	Cyclization (Cys39 and Cys45)	Disulfide bond between Cys39 and Cys45.	L	No cytotoxicity information found	Not found	12429503	Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.	Ali MF, Lips KR, Knoop FC, Fritzsch B, Miller C, Conlon JM.	Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.	
DRAMP01226	ALFSILRGLKKLGKMGQAFVNCEIYKKC	28	Palustrin-1a (Frogs, amphibians, animals)	P84274	Not found	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Tissue specificity: Expressed by the skin glands.	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP01230	GFLSTVKNLATNVAGTVLDTIRCKVTGGCRP	31	Palustrin-2a (Frogs, amphibians, animals)	P84278	Not found	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Tissue specificity: Expressed by the skin glands.	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Basir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP01236	GLWDSIKNFGKTIALNVMDKIKCKIGGGCPP	31	Palustrin-2CE (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana chensinensis (Chinese brown frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21303203	Zoolog Sci. 2011 Feb;28(2):112-117.	Zhao J, Sun Y, Li Z, Su Q.	Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.	
DRAMP01239	GLWNTIKEAGKKFAINVLDKIRCGIAGGCKT	31	Palustrin-2CG1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Amolops chunganensis	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22951323	Peptides. 2012 Aug 19.	Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.	Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.	
DRAMP01240	MFTMKKSPLVLFFLGIVSLSLCQEERSADDEEGEVIEEEVKRGFWDTIKQAGKKFFLNVLDKIRCKVAGGCRT	73	Palustrin-OG1 antimicrobial peptide (Frogs, amphibians, animals)	A6MBT7	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Unknown	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01241	IGTISLSLCEQERDADEDEGETLEE	25	Palustrin-RA2 antimicrobial peptide (Frogs, amphibians, animals)	D2K8I5	Not found	Not found	Rana andersonii (golden crossband frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2009) to the EMBL/GenBank/DDBJ databases	Yang X, Liang X, Zhang Y, Lee WH.	The highest antimicrobial peptide diversity, skin antimicrobial peptide peptidomics of amphibian, Rana andersonii.	
DRAMP01242	MFTLKKTLFLVFFLGMVSLSLCEQERHAHEETSNDPTEEENAAGNEESGEEGDMEKRFLLFPLMCKIQGKC	71	Japonicin-1Npa (Frogs, amphibians, animals)	D0ES73	Not found	Not found	Nanorana parkeri	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20153801	Biochimie. 2010 May;92(5):475-481.	Lu Z, Zhai L, Wang H, Che Q, Wang D, Feng F, Zhao Z, Yu H.	Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri.	
DRAMP01243	MFTLKKSLFLVFFLGMVSLALCRHERHAHEESSNDPTEEENAAGNEESGEEGDMEKRFVLPLVMCKILRKC	71	Japonicin-1Npb (Frogs, amphibians, animals)	D0ES74	Not found	Not found	Nanorana parkeri	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20153801	Biochimie. 2010 May;92(5):475-481.	Lu Z, Zhai L, Wang H, Che Q, Wang D, Feng F, Zhao Z, Yu H.	Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri.	
DRAMP01247	MFTLKKPLLLLFFLGTINLSLCQDETNAEEERRDEEVAKMEEIKRGLLSGILGAGKHIVCGLTGCAKA	68	OGG1 antimicrobial peptide (Frogs, amphibians, animals)	B5L181	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ databases	Wang X, Lai R.	Odorrana grahmi antimicrobial peptide cDNA sequences.	
DRAMP01256	SAVGRHSRRFGLRKHRKH	18	Dybowskin-2CDYb (Frogs, amphibians, animals)	B5A9T0	Not found	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antimicrobial active against Gram-negative bacteria and Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19539775	Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.	Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.	Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.	
DRAMP01262	RPPGFSPFR	9	Bradykinin (Frogs, amphibians, animals)	P86627	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Produces in vitro relaxation of rat arterial smooth muscle and constriction of intestinal smooth muscle. Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	May target bradykinin receptors (BDKRB)	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01263	RPPGFSPF	8	Des-Arg-bradykinin (Frogs, amphibians, animals)	P86628	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Produces in vitro relaxation of rat arterial smooth muscle and constriction of intestinal smooth muscle. Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01264	RPPGFTPFR	9	[Thr6]-bradykinin (Frogs, amphibians, animals)	P86629	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Produces in vitro relaxation of rat arterial smooth muscle and constriction of intestinal smooth muscle. Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01265	RPPGFTPF	8	Des-Arg-[Thr6]-bradykinin (Frogs, amphibians, animals)	P86630	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Produces in vitro relaxation of rat arterial smooth muscle and constriction of intestinal smooth muscle. Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01266	RPPGFSPFRIY	11	Phyllokinin (Frogs, amphibians, animals)	P86631	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Produces in vitro relaxation of rat arterial smooth muscle and constriction of intestinal smooth muscle. Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01267	RPPGFTPFRIY	11	[Thr6]-Phyllokinin (Frogs, amphibians, animals)	P86632	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Produces in vitro relaxation of rat arterial smooth muscle and constriction of intestinal smooth muscle, Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands.
Note: Sequence uncertainty at position 10 (I or L)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01268	QEYRGWMDF	9	[Arg4]-Phyllocaerulein (Frogs, amphibians, animals)	P86625	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defense peptide. May have antimicriobial activity.
PTM: Pyrrolidone carboxylic acid at Q1 and Phenylalanine amide at F9."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01269	YAFGYPS	7	Dermorphin (Frogs, amphibians, animals)	P86633	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defense peptide. May have antimicriobial activity.
PTM: D-amino acid (D-alanine) at A2 and Amidation (Serine amide) at S7. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01270	YMFHLMD	7	[D-Met2]-deltorphin (Frogs, amphibians, animals)	P86634	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defense peptide. May have antimicriobial activity.
PTM: D-amino acid (D-methionine) at M2 and Amidation (Aspartic acid 1-amide) at D7. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP18404	INWLKLGKMVIDAL	14	Polybia-MPII (mastoparan; insects, arthropods, invertebrates, animals)	No entry found	Not found	Not found	venom, the social wasp, Pseudopolybia vespiceps testacea	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal		Not found	Not found		Fuction: It demonstrated a potent ability to suppress endotoxin lipopolysaccharide (LPS)-mediated induction of the pro-inflammatory cytokine TNF-a in human peripheral blood mononuclear cells by 94%. It also completely protected mice against an invasive S. aureus infection when given I.P. to mice at 8 mg/kg 4 hr prior to initiation of the infection. Surface immobilization led to enhanced antimicrobial activity against P. aeruginosa.	Gram-positive bacteria: S. aureus(MIC 2.3 ug/ml);##Gram-negative bacteria: P. aeruginosa (MIC 9 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28108242	Int J Antimicrob Agents. 2017 Feb;49(2):167-175. 2017	Silva JC, Neto LM, Neves RC, Gon?alves JC, Trentini MM, Mucury-Filho R, Smidt KS, Fensterseifer IC, Silva ON, Lima LD, Clissa PB, Vilela N, Guilhelmelli F, Silva LP, Rangel M, Kipnis A, Silva-Pereira I, Franco OL, Junqueira-Kipnis AP, Bocca AL, Mortari MR.	Evaluation of the antimicrobial activity of the mastoparan Polybia-MPII isolated from venom of the social wasp Pseudopolybia vespiceps testacea (Vespidae, Hymenoptera)	
DRAMP18403	VKGSWSKKFEVIA	13	Tridecaptin A1 (TriA1; lipopeptides; nonribosomally synthesized peptide antibiotic)	No entry found	Not found	Not found	Paenibacillus terrae; old: Bacillus circulans NRRL B-30644	Antimicrobial, Antibacterial		Nonhelixbeta	Not found	2N5Y	There are three D-type 2,4-diaminobutyrate (Dab), represented by K's here. In addition, residue V1, S4, W5, and I12 are also D-amino acids.	Active against Gram+ B. subtilis JH642 (MIC 50 uM), S. aureus ATCC 25923 (100 uM), Gram- food pathogens C. jejuni NCTC 11168 (MIC 100 uM), E. coli DH5alpha (MIC 50 uM), and Salmonella enterica serovar Typhimurium (25 uM). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24382692	Chembiochem. 2014 Jan 24;15(2):243-9.	Lohans CT1, van Belkum MJ, Cochrane SA, Huang Z, Sit CS, McMullen LM, Vederas JC. 	Biochemical, structural, and genetic characterization of tridecaptin A?, an antagonist of Campylobacter jejuni.	
DRAMP18402	GKGSWSKKIEVIA	13	Tridecaptin B1 (TriB1; lipopeptides; nonribosomally synthesized peptide antibiotic, Gram-positive	No entry found	Not found	Not found	Paenibacillus polymyxa NRRL B-30507	Antimicrobial, Antibacterial, Anti-Gram-		Not found	Not found		Comment: No comments found on DRAMP database	Active against multidrug resistant Gram-negative bacteria.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25959079	Org Biomol Chem. 2015 Jun 7;13(21):6073-81. doi: 10.1039/c5ob00780a.	Cochrane SA, Lohans CT, van Belkum MJ, Bels MA, Vederas JC.	Studies on tridecaptin B(1), a lipopeptide with activity against multidrug resistant Gram-negative bacteria	
DRAMP18401	ILSAIWSGIKGLL	13	Uy17 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Urodacus yaschenkoi	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against M. luteus (MIC 15 uM), S. aureus (30 uM), and L. monocytogenes (MIC 15 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28067810	Toxins (Basel). 2017 Jan 6;9, 22. doi: 10.3390/toxins9010022.	Luna-Ramirez K, Tonk M, Rahnamaeian M, Vilcinskas A.	Bioactivity of Natural and Engineered Antimicrobial Peptides from Venom of the Scorpions Urodacus yaschenkoi and U. manicatus	
DRAMP01275	FLSLIPHIVSGVASIAKHFG	20	Phylloseptin-s1 (Frogs, amphibians, animals)	F7UI84	Not found	preproPLS-S1	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial 	Homology	Not found	Not found		"Function: Amphibian defense peptide. May have antimicriobial activity.
PTM: Pyrrolidone carboxylic acid at Q1."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases	Abbassi F, Galanth C, Piesse C, Nicolas P, Amiche M, Ladram A.	Phylloseptins from phyllomedusa sauvagei.	
DRAMP01276	FLSLIPHIVSGVASLAKHFG	20	Phylloseptin-s2 (Frogs, amphibians, animals)	F7UI85	Not found	preproPLS-S2	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial 	Homology	Not found	Not found		"Function: Amphibian defense peptide. May have antimicriobial activity.
PTM: Pyrrolidone carboxylic acid at Q1."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases	Abbassi F, Galanth C, Piesse C, Nicolas P, Amiche M, Ladram A.	Phylloseptins from phyllomedusa sauvagei.	
DRAMP01277	FLSLIPHIVSGVASLAIHFG	20	Phylloseptin-s3 (Frogs, amphibians, animals)	F7UI86	Not found	preproPLS-S3	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial 	Homology	Not found	Not found		"Function: Amphibian defense peptide. May have antimicriobial activity.
PTM: Pyrrolidone carboxylic acid at Q1."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases	Abbassi F, Galanth C, Piesse C, Nicolas P, Amiche M, Ladram A.	Phylloseptins from phyllomedusa sauvagei.	
DRAMP18319	ITSHSLCTPGCAKTGSFNSFCC	22	BsaA2(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Staphylococcus aureus strain 26	Antimicrobial, Antibacterial, Anti-Gram+		Bridge	Tandem MS analysis identified two sequence tags (Dhb-PGCAK/Q-Dhb-G and I/L-Dhb-Dha-H [due to the use of CID, Dha/Dhb represents either a dehydrated amino acid or a site of thioether bridge cleavage]) that matched the deduced amino acid sequence of BsaA2.Thioether bonds between residues 3 and 7, 8-11, 16-21, and 19-22.		This bacteriocin is identical to staphylococcin Au-26 initially reported in 1992.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20023032	J Bacteriol. 2010 Feb;192(4):1131-42.	Daly KM, Upton M, Sandiford SK, Draper LA, Wescombe PA, Jack RW, O'Connor PM, Rossney A, G?tz F, Hill C, Cotter PD, Ross RP, Tagg JR.	Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.	
DRAMP01279	FLISIPYSASIGGTATLTGTA	21	Phylloseptin Bu-1 (Frogs, amphibians, animals)	P86282	Not found	Not found	Phyllomedusa burmeisteri (Brazilian common walking leaf frog) 	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defense peptide. May have antimicriobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Alanine amide at A21."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2009) to UniProtKB	Conceicao K, Klitzke C.F, Brito R.C, Andrade D.F, Junca F.A, Biondi I, Lopes-Ferreira M.	Identification of peptides from Phyllomedusa burmesteri skin secretomics by nano LC MS/MS.	
DRAMP01280	FLLSLPHLASGLASLVLSK	19	Phylloseptin Bu-2 (Frogs, amphibians, animals)	P86283	Not found	Not found	Phyllomedusa burmeisteri (Brazilian common walking leaf frog) 	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defense peptide. May have antimicriobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Lysine amide at L19."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2009) to UniProtKB	Conceicao K, Klitzke C.F, Brito R.C, Andrade D.F, Junca F.A, Biondi I, Lopes-Ferreira M.	Identification of peptides from Phyllomedusa burmesteri skin secretomics by nano LC MS/MS.	
DRAMP01281	FLSLIPHAINAISAIANHF	19	Phylloseptin-J1 (PLS-J1; PS-J1; Frogs, amphibians, animals)	P86614	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01282	FLSLIPHAINAISAIADHF	19	Phylloseptin-J2 (PLS-J2; PS-J2; Frogs, amphibians, animals)	P86615	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01283	FLSLIPHAINAISAIANHL	19	Phylloseptin-J3 (PLS-J3; PS-J3; Frogs, amphibians, animals)	P86616	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1979) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01284	FLSLIPHAINAISAIAHHL	19	Phylloseptin-J4 (PLS-J4; PS-J4; Frogs, amphibians, animals)	P86617	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1980) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01285	FLSLIPHAISAISAIAHHL	19	Phylloseptin-J5 (PLS-J5; PS-J5; Frogs, amphibians, animals)	P86618	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1980) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01286	FLSLIPHAISAISAIANHL	19	Phylloseptin-J6 (PLS-J6; PS-J6; Frogs, amphibians, animals)	P86619	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1980) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01287	FLSLIPHAISAISAIADHL	19	Phylloseptin-J7 (PLS-J7; PS-J7; Frogs, amphibians, animals)	P86620	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1980) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01289	FLSLIPKIAGGIASLVKNL	19	Phylloseptin-1 (PStar 01; Frogs, amphibians, animals)	P84929	Not found	Not found	Phyllomedusa tarsius (Brownbelly leaf frog) (Phyllomedusa tarsia)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2006) to UniProtKB	Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.	Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).	
DRAMP01290	FLSLIPHIATGIAALAKHL	19	Phylloseptin-2 (PStar 02; Frogs, amphibians, animals)	P84930	Not found	Not found	Phyllomedusa tarsius (Brownbelly leaf frog) (Phyllomedusa tarsia)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2006) to UniProtKB	Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.	Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).	
DRAMP01291	FFSMIPKIATGIASLVKNL	19	Phylloseptin-3 (PStar 03; Frogs, amphibians, animals)	P84931	Not found	Not found	Phyllomedusa tarsius (Brownbelly leaf frog) (Phyllomedusa tarsia)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2006) to UniProtKB	Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.	Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).	
DRAMP01292	FLSLIPHAINAVSTLVHHSG	20	Phylloseptin-4 (PS-4; Frogs, amphibians, animals)	P84569	Not found	psn4	Phyllomedusa oreades (Orange-legged leaf frog) (Monkey frog)	Antiprotozoal 	Protein level	Not found	Not found		"Function: Has antiprotozoal activity against Trypanosoma cruzi.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	Trypanosoma cruzi (IC50=5.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15752569	Peptides. 2005 Apr;26(4):565-573.	Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr. 	Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.	
DRAMP01293	FLSLIPHAINAVSAIAKHS	19	Phylloseptin-5 (PS-5; Frogs, amphibians, animals)	P84570	Not found	psn5	Phyllomedusa oreades (Orange-legged leaf frog) (Monkey frog)	Antiprotozoal 	Protein level	Not found	Not found		"Function: Has antiprotozoal activity against Trypanosoma cruzi.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	Trypanosoma cruzi (IC50=4.9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15752569	Peptides. 2005 Apr;26(4):565-573.	Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr. 	Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.	
DRAMP01294	FPPWL	5	Tryptophyllin-5.1 (Frogs, amphibians, animals)	P84573	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defense peptide. May have antimicriobial activity.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Nat. Chem. Biol. 0:0-0(2007)	Silva LP, Brand GD, Bloch C Jr.	High-throughput imaging co-localization of peptides and proteins.	
DRAMP01295	NLVSALIEGRKYLKNVLKKLNRLKEKNKAKNSKENN	36	Distinctin-like peptide (Frogs, amphibians, animals)	Q17UZ0	Belongs to the frog skin active peptide family	ppdis-H1	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial	Protein level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Thesis (2006), University of Ulster Coleraine, United Kingdom	Thompson AH.	A genomic/proteomic approach to isolating and identifying bioactive peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.	
DRAMP18400	FLSTIWNGIKGLL	13	Uy192 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Urodacus yaschenkoi	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against M. luteus (MIC 15 uM), E. coli (15 uM), S. aureus (15 uM), L. grayi (15 uM), L. fleischmannii (MIC 4 uM), and L. monocytogenes (MIC 4 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28067810	Toxins (Basel). 2017 Jan 6;9, 22. doi: 10.3390/toxins9010022.	Luna-Ramirez K, Tonk M, Rahnamaeian M, Vilcinskas A.	Bioactivity of Natural and Engineered Antimicrobial Peptides from Venom of the Scorpions Urodacus yaschenkoi and U. manicatus	
DRAMP18399	FPFLLSLIPSAISAIKRL	18	Uy234 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Urodacus yaschenkoi	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against M. luteus (MIC 2 uM), L. grayi (MIC 4 uM), and L. monocytogenes (MIC 8 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28067810	Toxins (Basel). 2017 Jan 6;9, 22. doi: 10.3390/toxins9010022.	Luna-Ramirez K, Tonk M, Rahnamaeian M, Vilcinskas A.	Bioactivity of Natural and Engineered Antimicrobial Peptides from Venom of the Scorpions Urodacus yaschenkoi and U. manicatus	
DRAMP01298	FRPALIVRTKGK	12	Hyposin-J1 (HPS-J1; Frogs, amphibians, animals)	P86613	Not found	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
PTM: Lysine amide at K12."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01299	FRPALIVRTKGTRL	14	Hyposin-HA4 (Hyposin-4; Frogs, amphibians, animals)	P84957	Not found	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-3613.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP01300	LRPAVIVRTKGK	12	Hyposin-HA3 (Hyposin-3; Frogs, amphibians, animals)	P84956	Not found	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-3613.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP01304	SLIPHAINAVSAIAKHF	17	Phylloseptin-6 (PS-6; Frogs, amphibians, animals)	P84571	Not found	psn6	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15752569	Peptides. 2005 Apr;26(4):565-573.	Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr. 	Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.	
DRAMP01307	FLSLIPTAINAVSALAKHF	19	Phylloseptin-8 (PS-8; Frogs, amphibians, animals)	P85883	Not found	psn-8	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17553595	Peptides. 2007 Jul;28(7):1331-1343.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.	
DRAMP01308	FLSLIPHAINAVSALAKHF	19	Phylloseptin-8 (PS-8; Frogs, amphibians, animals)	P85447	Not found	Not found	Phyllomedusa tomopterna (Tiger-striped leaf frog) (Pithecopus tomopternus)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (FEB-2008) to UniProtKB	de sa Mandel S.M, Mundim N.C.C.R, Freitas T, Silva L.P, Bloch C. Jr.	Dermaseptins and phylloseptins of Phyllomedusa (Hylidae) secretion.	
DRAMP18318	ITSFIGCTPGCGKTGSFNSFCC	22	BacCH91(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	bacCH91	Staphylococcus aureus CH-91	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Similar to Gallidermin and epidermin. The fourth residue was phenylalanine in BacCH91 but lysine in both epidermin and gallidermin, which explains the more hydrophobic character of BacCH91. 		The bacteriocin was not affected by any of the staphylococcal peptidases tested, particularly StpC. BacCH91 was unaffected by trypsin and proteinase K.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23196985	Appl Microbiol Biotechnol. 2013 Aug;97(16):7229-39.	Wladyka B, Wielebska K, Wloka M, Bochenska O, Dubin G, Dubin A, Mak P.	Isolation, biochemical characterization, and cloning of a bacteriocin from the poultry-associated Staphylococcus aureus strain CH-91.	
DRAMP01310	FLGLLPSIVSGAVSLVKKL	19	Phylloseptin-9 (PS-9; Frogs, amphibians, animals)	Q0VZ38, P84905	Not found	psn-9	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16713656	Peptides. 2006 Sep;27(9):2129-2136.	Chen T, Zhou M, Gagliardo R, Walker B, Shaw C.	Elements of the granular gland peptidome and transcriptome persist in air-dried skin of the South American orange-legged leaf frog, Phyllomedusa hypocondrialis.	
DRAMP01311	FLSLLPSLVSGAVSLVKKL	19	Phylloseptin-10 (PS-10; Frogs, amphibians, animals)	Q0VZ39, P84906	Not found	psn-10	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16713656	Peptides. 2006 Sep;27(9):2129-2136.	Chen T, Zhou M, Gagliardo R, Walker B, Shaw C.	Elements of the granular gland peptidome and transcriptome persist in air-dried skin of the South American orange-legged leaf frog, Phyllomedusa hypocondrialis.	
DRAMP01312	FLSLLPSLVSGAVSLVKIL	19	Phylloseptin-11 (PS-11; Frogs, amphibians, animals)	Q0VZ40	Not found	psn-11	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16713656	Peptides. 2006 Sep;27(9):2129-2136.	Chen T, Zhou M, Gagliardo R, Walker B, Shaw C.	Elements of the granular gland peptidome and transcriptome persist in air-dried skin of the South American orange-legged leaf frog, Phyllomedusa hypocondrialis.	
DRAMP01313	FLSLIPHAINAVSALVHHF	19	Phylloseptin-12 (PS-12; Frogs, amphibians, animals)	P84904	Not found	Not found	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2006) to UniProtKB	Silva L.P, Brand G.D, Bloch C. Jr.	High-throughput co-localization of peptides and proteins by imaging mass spectrometry.	
DRAMP01315	FLSLIPHAINAVGVHAKHF	19	Phylloseptin 13 (PS-13; Frogs, amphibians, animals)	P84938	Not found	psn13	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17553595	Peptides. 2007 Jul;28(7):1331-1343.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.	
DRAMP01316	FLSLIPAAISAVSALADHF	19	Phylloseptin 14 (PS-14; Frogs, amphibians, animals)	P84939	Not found	psn14	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial 	Protein level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17553595	Peptides. 2007 Jul;28(7):1331-1343.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.	
DRAMP01317	LLSLVPHAINAVSAIAKHF	19	Phylloseptin 15 (PS-15; Frogs, amphibians, animals)	Q0VKG9, P84940	Not found	psn15	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial 	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17553595	Peptides. 2007 Jul;28(7):1331-1343.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.	
DRAMP01318	LRPAVIVRTKAL	12	Antimicrobial peptide 1 (Frogs, amphibians, animals)	P84524	Not found	Not found	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium M. luteus.
Tissue specificity: Expressed by the venom gland."	Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2005) to UniProtKB.	Thompson A.H.	Antimicrobial peptides derived from the venom of the South American tree frog, Phyllomedusa hypochondrialis.	
DRAMP01321	MFTLKKSLLLLFFLGTINLSLCEQERNAEEERRDDLGERQAEVEKRFFPIVGKLLSG	57	Amolopin-n1 antimicrobial peptide (Frogs, amphibians, animals)	C5H0E2	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	
DRAMP01322	FTMKKSLLLLFFLGTINLSLCEQERNAEEERRDDLGERQAEVEKR	45	Amolopin-n2 antimicrobial peptide (Frogs, amphibians, animals)	C5H3Z4	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Transcript level	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2008) to the EMBL/GenBank/DDBJ databases	Wang A, Lai R.	cDNA Cloning of a Novel Antimicrobial Peptide from Amolops loloensis.	
DRAMP01323	MFTMKKSLLLLFFLGTIHLSLCEQERNAEEERRDDLGERQAEVEKRFLPIAGKLLSGLSGLLGK	64	Amolopin-2e antimicrobial peptide (Frogs, amphibians, animals)	C5H0D6	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	
DRAMP01324	MFTLKKSLLLLFFLGTINLSLCEQERNAEEERRDEPDERNAEVEKRFFPIVGKLLFGLSGLLGK	64	Amolopin-2f antimicrobial peptide (Frogs, amphibians, animals)	C5H0D7	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	
DRAMP01325	MFTLKKSLLLLFFLGTINLSLCEQERNAEEERRDEPDERNAEVEKRFFPIVGKLLSGLSGLLGK	64	Amolopin-2g antimicrobial peptide (Frogs, amphibians, animals)	C5H0D8	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	
DRAMP01326	MFTLKKSLLLLFFLGTINLSLCEQERNAEEERRDDLGERQAEVEKRFFPIVGKLLFGLFGLLGK	64	Amolopin-2h antimicrobial peptide (Frogs, amphibians, animals)	C5H0D9	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	
DRAMP01327	MFPLKKSLLLLFFLATINLSLCEQERNAEEERRDEPDERNAEVEKRFFPIVGKLLSGLLGK	61	Amolopin-2i antimicrobial peptide (Frogs, amphibians, animals)	C5H0E0	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	
DRAMP01328	MFTLKKSLLLLFFLATINLSFCEQERNAEEERRDEPDERNAEVEKRFFPIVGKLLFGLLGK	61	Amolopin-2k antimicrobial peptide (Frogs, amphibians, animals)	C5H0E1	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Wang A, Lai R.	cDNA Cloning of a Novel Antimicrobial Peptide From the Skin of Amolops loloensis.	
DRAMP01329	MFTMKKSLLLLFFLGAISLSLCEQERDADEEETEGGAKVETVKRASVPPGFTPFRVAPEIV	61	Amolopin-5a antimicrobial peptide (Frogs, amphibians, animals)	C5H0C9	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Wang A, Lai R.	cDNA Cloning of a Novel Antimicrobial Peptide From the Skin of Amolops loloensis.	
DRAMP01330	MFTMKKSLLLLFFLGMISLSLCKQERDANEERRDDPDENEENGGEAKVEEIKRAARPPLGCKAAFC	66	Amolopin-6a antimicrobial peptide (Frogs, amphibians, animals)	C5H0D0	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Wang A, Lai R.	cDNA Cloning of a Novel Antimicrobial Peptide From the Skin of Amolops loloensis.	
DRAMP01331	MFTMKKSLLLLFFLGMISLSLCKQERDANEERRDDPDENEENGGEAKVEEIKRAARPPLRCKAAFC	66	Amolopin-6b antimicrobial peptide (Frogs, amphibians, animals)	C5H0D1	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Wang A, Lai R.	cDNA Cloning of a Novel Antimicrobial Peptide From the Skin of Amolops loloensis.	
DRAMP01332	MFTMKKSLLLLFFLGAISLSLCEQERDADEEDGGEVTEEEVKRAAFRGCWTKNYSPKPCLGKR	63	Amolopin-7a antimicrobial peptide (Frogs, amphibians, animals)	C5H0D2	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Wang A, Lai R.	cDNA Cloning of a Novel Antimicrobial Peptide From the Skin of Amolops loloensis.	
DRAMP01333	MFTMKKSLLLLFFLGMISLSLCKQERDANEERRDDPDENEENGGEAKVEEIQRGARPPLRCKAALC	66	Amolopin-8a antimicrobial peptide (Frogs, amphibians, animals)	C5H0D3	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Wang A, Lai R.	cDNA Cloning of a Novel Antimicrobial Peptide From the Skin of Amolops loloensis.	
DRAMP01334	MFTLKKSMLLLFFLGTISLSLCEEERNADEDDGEKEVKRGIFALIKTAAKFVGKNLLKQAGKAGLEHLACKANNQC	76	Amolopin-9a antimicrobial peptide (Frogs, amphibians, animals)	C5H0D4	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	
DRAMP01335	MFTMKKSLLLLFFLGTISLSLCEEERSADEDDGEKGVKRGIFSLIKTAAKFVGKNLLKQAGKAGVEHLACKANNQC	76	Amolopin-9b antimicrobial peptide (Frogs, amphibians, animals)	C5H0D5	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19843479	Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.	Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.	Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.	
DRAMP01336	NILSSIVNGINRALSFFG	18	Amolopin-p1	C5H0C7	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: defense response to bacterium.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Pubmed ID is not available	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.	Wang A, Lai R.	cDNA Cloning of a Novel Antimicrobial Peptide From the Skin of Amolops loloensis.	
DRAMP01337	NVLSSVANGINRALSFFG	18	Amolopin-p2	C5H0C8	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Pubmed ID is not available	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.	Wang A, Lai R.	cDNA Cloning of a Novel Antimicrobial Peptide From the Skin of Amolops loloensis.	
DRAMP01338	FLPMLAGLAANFLPKLFCKITKKC	24	Amolopin-1a (Frogs, amphibians, animals)	A0SN41, A0SN38, A0SN39	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17000029	Peptides. 2006 Dec;27(12):3085-3091. 	Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.	Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.	
DRAMP01340	FLPPSPWKETFRTT	14	Amolopin-3a (Frogs, amphibians, animals)	A6XFB5	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Pubmed ID is not available	Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases.	Lai R, Liang J.	No title found	
DRAMP01342	FLPIVGKLLSGLL	13	Amolopin-2b (Frogs, amphibians, animals)	A0SN47, A0SN48	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17000029	Peptides. 2006 Dec;27(12):3085-3091. 	Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.	Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.	
DRAMP01343	FLPMLAGLAANLLPKLFCKITKKC	24	Amolopin-1c (Frogs, amphibians, animals)	A0SN43	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17000029	Peptides. 2006 Dec;27(12):3085-3091. 	Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.	Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.	
DRAMP01344	LLPIVGKLLSGLL	13	Amolopin-2c (Frogs, amphibians, animals)	A0SN50	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17000029	Peptides 2006; 27: 3085-3091.	Lu Y et al Lai R2006	Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis	
DRAMP01345	FLPMLAGLAANFLPELFCKITKKC	24	Amolopin-1d (Frogs, amphibians, animals)	A0SN44	Not found	Not found	Amolops loloensis (Rufous-spotted torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.	Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17000029	Peptides. 2006 Dec;27(12):3085-3091. 	Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.	Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.	
DRAMP01348	RVCSAIPLPICH	12	Tigerinin-RC1 (Frogs, amphibians, animals)	C7ENH5	Not found	Not found	Fejervarya cancrivora (crab-eating frog)	Not found	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Pubmed ID is not available	Submitted (JUN-2009) to the EMBL/GenBank/DDBJ databases.	Lu Y, Song Y, Wang L, Yang H, Zhang K, Lai R.	Purification, characterization and cloning of two novel tigerinin-like peptides from skin secretions of Fejervarya cancrivora.	
DRAMP01349	RVCMAIPLPLCH	12	Tigerinin-RC2 (Frogs, amphibians, animals)	C7ENH6	Not found	Not found	Fejervarya cancrivora (crab-eating frog)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Pubmed ID is not available	Submitted (JUN-2009) to the EMBL/GenBank/DDBJ databases.	Lu Y, Song Y, Wang L, Yang H, Zhang K, Lai R.	Purification, characterization and cloning of two novel tigerinin-like peptides from skin secretions of Fejervarya cancrivora.	
DRAMP01388	GFSPNLPGKGLRIS	14	Odorranain-R1 (OdR1; Frogs, amphibians, animals)	A6MBR8 	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		Function: Odorranain-R1 appears to be narrowly antifungal with low potency against Candida albicans.	[Ref.17272268] Yeast: Candida albicans (MIC=50 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01363	GFLDKLKKGASDFANALVNSIKGT	24	Frenatin-4 (Frogs, amphibians, animals)	P82023	Not found	Not found	Litoria infrafrenata (Giant tree frog) (White-lipped tree frog)	Antimicrobial	Protein level	Not found	Not found		"Function: Wide spectrum antimicrobial peptide. Considered to interact with the outer lipid layer of the bacterial cell, penetrate the bacterial membrane, form ion channels, and ultimately kill the cell.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands."	Wide spectrum antimicrobial peptide.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9225251	J Pept Sci. 1996 Mar-Apr;2(2):117-124.	Raftery MJ, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata.	
DRAMP01365	GLFGVLAKVASHVVPAIAEHFQA	23	Maculatin-1.2 (Frogs, amphibians, animals)	P82067	Not found	Not found	Litoria genimaculata (Green-eyed tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Shows antibacterial activity against S. aureus and S. uberis.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation."	Gram-positive bacteria: Staphylococcus aureus, Streptococcus uberis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9620615	J Pept Sci. 1998 Apr;4(2):111-115.	Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.	The maculatin peptides from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1.	
DRAMP01366	GLLGLLGSVVSHVVPAIVGHF	21	Maculatin-1.3 (frog, amphibia, animals)	No entry found	Not found	Not found	Litoria eucnemis (Australian anurans)	Antimicrobial, Antibacterial, Antiviral	Not found	Not found	Not found		Function: Has antiviral activity. The peptide is HIV inhibitory (EC50=4 µM).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15203252	Peptides. 2004; 25: 1035-1054.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	
DRAMP01369	GLLQTIKEKLESLESLAKGIVSGIQA	26	Maculatin-3.1 (Frogs, amphibians, animals)	P82069	Not found	Not found	Litoria genimaculata (brown-spotted treefrog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Shows antibacterial activity against S. uberis.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation."	Gram-positive bacterium: Streptococcus uberis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9620615	J Pept Sci. 1998 Apr;4(2):111-115.	Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.	The maculatin peptides from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1.	
DRAMP01379	GFFTLIKAANKLINKTVNKEAGKGGLEIMA	30	Odorranain-I1 (OdI1; Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana grahami (Yunnanfu frog) (Huia grahami)	Antimicrobial	Homology	Not found	Not found		Function: Found no antimicrobial activity against the tested microbes and also has no hemolytic activity against red cell.	[Ref.17272268]Not detectable activity	[Ref:17272268]Non-hemolytic activity against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01382	VEVQVRDKGKGIYGLSPLRQPAP	23	Odorranain-L1 (OdL1; Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial	Homology	Not found	Not found		Function: Found no antimicrobial activity against the tested microbes and also has no hemolytic activity against red cell.	[Ref.17272268]Not detectable activity	[Ref:17272268]Non-hemolytic activity against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01385	AVPLIYNRPGIYVTKRPKGK	20	Odorranain-O1 (OdO1; Frogs, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial	Homology	Not found	Not found		Function: Found no antimicrobial activity against the tested microbes and also has no hemolytic activity against red cell.	[Ref.17272268]Not detectable activity	[Ref:17272268]Non-hemolytic activity against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01404	GLFTFIKCAYKLRAPAVAC	19	Odorranain-J2 antimicrobial peptide (Frogs, amphibians, animals)	A6MBN7	Not found	Not found	Odorrana grahami (Yunnanfu frog )	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01405	GVLGTVKNLLIGAGKSAAQSVLKTLSCKLFNDC	33	Odorranain-C6 antimicrobial peptide (Frogs, amphibians, animals)	A6MBF3, A6MBK2	Not found	Not found	Odorrana grahami (Yunnanfu frog )	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01406	AVPLIYNRPGIYAPKRPKGK	20	Antimicrobial peptide odorranain-O3 (Frogs, amphibians, animals)	C3RTI0	Not found	Not found	Rana grahami (Yunnanfu frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Ma Y, Lai R, Wu J, Li J.	Antimicrobial peptide from skin of Odorrana grahami.	
DRAMP01407	MFTLKKSLFVLFFLGIVSLSVCEHNRDADEEDGGEAIGGEVRRAALKGCWTKSIPPKPCSGKR	63	Antimicrobial peptide odorranain B4 (Frogs, amphibians, animals)	D0PRC0	Not found	Not found	Rana grahami (Yunnanfu frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2008) to the EMBL/GenBank/DDBJ databases	Ma Y, Li J.	No title found on DRAMP	
DRAMP01408	MFTLKKSLLVLFFLGIVSLSVCEHNRDADEEDGGEVTGEEVKRAALKGCWTNSIPPKPCSGKR	63	Antimicrobial peptide odorranain B5 (Frogs, amphibians, animals)	D0PRC1	Not found	Not found	Rana grahami (Yunnanfu frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2008) to the EMBL/GenBank/DDBJ databases	Ma Y, Li J.	No title found on DRAMP	
DRAMP18317	MGAVIKVGAKVIGWGAASGAGLYGLEKILKK	31	Aureocin A70 (AurD)(Bacteriocin)	Q93GF8	Belongs to the class II bacteriocin	aurD	Staphylococcus aureus A70	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Aureocin A70 is a multipeptide bacteriocin composed of four related peptides that are small (30-31 amino acid residues), strongly cationic (pI of 9.85 to 10.04) and highly hydrophobic. These peptides also have a high content of small amino acid residues like glycine (23	Gram-positive 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11531330	J Mol Biol. 2001 Aug 31;311(5):939-49.	Netz DJ, Sahl HG, Marcelino R, dos Santos Nascimento J, de Oliveira SS, Soares MB, do Carmo de Freire Bastos M.	Molecular characterisation of aureocin A70, a multi-peptide bacteriocin isolated from Staphylococcus aureus.	
DRAMP01425	GLLSGVLGVGKKVDCGLSGLC	21	Nigrocin-OG21 (frog, amphibians, animals)	No entry found	Not found	Not found	Odorrana grahami (Yunnanfu frog)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Function: Showes an effect on HIV when applied in combination with OdK1.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01444	GLLDSIKGMAISAGKGALQNLLKVASCKLDKTC	33	Nigrocin-1 (Frogs, amphibians, animals)	P0C008	Not found	Not found	Pelophylax nigromaculatus (Black-spotted frog) (Rana nigromaculata) (frog skin active peptide)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. Has weak hemolytic activity.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: Contains one disulfide bond 27-33. (By similarity)"	[Ref.11682065]Gram-positive bacterium: Micrococcus luteus(MIC=2.5μg/ml);##Gram-negative bacteria: Shigella dysenteriae(MIC=10μg/ml), Klebsiella pneumoniae(MIC=10μg/ml), Pseudomonas aeruginosa(MIC=75μg/ml), Salmonella typhimurium(MIC=22.5μg/ml), Proteus mirabilis(MIC>200μg/ml), Serratia marcescens(MIC>200μg/ml);##Yeast: Candida albicans(MIC=100μg/ml).	[Ref:11682065]1.1% hemolytic activity at 100μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11682065	FEBS Lett. 2001 Oct 19;507(1):95-100.	Park S, Park SH, Ahn HC, Kim S, Kim SS, Lee BJ, Lee BJ.	Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata.	
DRAMP01445	GLLSKVLGVGKKVLCGVSGLC	21	Nigrocin-2 (Nigrocin-2LVa; Frogs, amphibians, animals)	P0C009	Not found	Not found	Rana nigromaculata (Black-spotted frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found		"Function: Thanks to its single linear amphipathic alpha-helix, may integrate into membrane phospholipids, leading to lysis of the membrane. Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. Has weak hemolytic activity.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: Contains one disulfide bond 15-21. (By similarity)"	[Ref.11682065]Gram-positive bacterium: Micrococcus luteus(MIC=2.5μg/ml);##Gram-negative bacteria: Shigella dysenteriae(MIC=10μg/ml), Klebsiella pneumoniae(MIC=10μg/ml), Pseudomonas aeruginosa(MIC=100μg/ml), Salmonella typhimurium(MIC=22.5μg/ml), Proteus mirabilis(MIC>200μg/ml), Serratia marcescens(MIC>200μg/ml);##Yeast: Candida albicans(MIC=150μg/ml).	[Ref:11682065] It has 0.9% hemolytic activity at 100μg/ml against human red blood cells	Cyclic	Free	Cyclization (Cys15 and Cys21)	Disulfide bond between Cys15 and Cys21.	L	No cytotoxicity information found	Cell membrane	11682065	FEBS Lett. 2001 Oct 19;507(1):95-100.	Park S, Park SH, Ahn HC, Kim S, Kim SS, Lee BJ, Lee BJ.	Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata.	
DRAMP01446	VIEPKCYKYEGKKCPPDINPVCGTDKRTYYNECALCVFIRQSTKKADKAIKIKKWGKC	58	Proteinase inhibitor PSKP-1 (Frogs, amphibians, animals)	P83578	Not found	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Function: Shows hemagglutinating activity, inhibits prolyl endopeptidase. May have a role in mucosal defense against microbes by interacting directly with their membranes.	Gram-negative bacterium: Escherichia coli (EC50=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15153102	Eur J Biochem. 2004 Jun;271(11):2117-2126.	Gebhard L.G, Carrizo F.U, Stern A.L, Burgardt N.I, Faivovich J, Lavilla E, Ermacora M.R.	A Kazal prolyl endopeptidase inhibitor isolated from the skin of Phyllomedusa sauvagii.	
DRAMP01448	SLFSIFKTAAKFVGKNLLKQAGKAGLETLACKAKNEC	37	Esculentin-2-CG1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Not found	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Not found	Not found	Not found	Not found	
DRAMP01449	IKDAAKLIGKTVAKEAGKTGLELMACKITNQC	32	Esculentin-2-OG3 antimicrobial peptide (Frogs, amphibians, animals)	A6MAX1	Not found	Not found	Rana grahami (Yunnanfu frog)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01450	GLFTLIKGAAKLIGRTVAKEAGKTGLELMACKITNQC	37	Esculentin-2-OG5 antimicrobial peptide (Frogs, amphibians, animals)	A6MAX6	Not found	Not found	Rana grahami (Yunnanfu frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01451	FTLKKSLLVLFFLGTISLSLCQEERAADEEDNGEVEE	37	Esculentin-2-OG11 antimicrobial peptide (Frogs, amphibians, animals)	B5L1A6	Not found	Not found	Rana grahami (Yunnanfu frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP18316	MGALIKTGAKIIGSGAAGGLGTYIGHKILGK	31	Aureocin A70 (AurC)(Bacteriocin)	Q93GF7	Belongs to the class II bacteriocin	aurC	Staphylococcus aureus A70	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Aureocin A70 is a multipeptide bacteriocin composed of four related peptides that are small (30-31 amino acid residues), strongly cationic (pI of 9.85 to 10.04) and highly hydrophobic. These peptides also have a high content of small amino acid residues like glycine (23	Gram-positive 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11531330	J Mol Biol. 2001 Aug 31;311(5):939-49.	Netz DJ, Sahl HG, Marcelino R, dos Santos Nascimento J, de Oliveira SS, Soares MB, do Carmo de Freire Bastos M.	Molecular characterisation of aureocin A70, a multi-peptide bacteriocin isolated from Staphylococcus aureus.	
DRAMP18315	MGAVAKFLGKAALGGAAGGATYAGLKKIFG	30	Aureocin A70 (AurB)(Bacteriocin)	Q93GF6	Belongs to the class II bacteriocin	aurB	Staphylococcus aureus A70	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Aureocin A70 is a multipeptide bacteriocin composed of four related peptides that are small (30-31 amino acid residues), strongly cationic (pI of 9.85 to 10.04) and highly hydrophobic. These peptides also have a high content of small amino acid residues like glycine (23	Gram-positive 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11531330	J Mol Biol. 2001 Aug 31;311(5):939-49.	Netz DJ, Sahl HG, Marcelino R, dos Santos Nascimento J, de Oliveira SS, Soares MB, do Carmo de Freire Bastos M.	Molecular characterisation of aureocin A70, a multi-peptide bacteriocin isolated from Staphylococcus aureus.	
DRAMP01460	GLFSILKGVGKIAIKGLGKNLGKMGLDLVSCKISKEC	37	Esculentin-2Vb (2VEb; Frogs, amphibians, animals)	Q1JS89	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana versabilis (Chinese bamboo leaf odorous frog) (Rana versabilis)	Antimicrobial	Protein level	Not found	Not found		"Function: Antimicrobial peptide (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 31-37."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16621152	Peptides. 2006 Jul;27(7):1738-1744.	Chen T, Zhou M, Rao P, Walker B, Shaw C.	The Chinese bamboo leaf odorous frog (Rana (Odorrana) versabilis) and North American Rana frogs share the same families of skin antimicrobial peptides.	
DRAMP01463	GLFSKFNKKKIKSGLIKIIKTAGKEAGLEALRTGIDVIGCKIKGEC	46	Esculentin-1SEa (Frogs, amphibians, animals)	P85059	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sevosa (Dusky gopher frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Mast cell degranulating peptide. Causes histamine release from rat peritoneal mast cells in vitro. Has antibacterial activity.
Tissue specificity: Expressed by the skin glands. 
PTM: Problely contains one dislfide bond 40-46."	Gram-negative bacterium: Escherichia coli K12;##Gram-positive bacterium: Micrococcus luteus NCT C2665.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16386333	Peptides. 2006 Jun;27(6):1313-1319.	Graham C, Richter SC, McClean S, O'Kane E, Flatt PR, Shaw C.	Histamine-releasing and antimicrobial peptides from the skin secretions of the dusky gopher frog, Rana sevosa.	
DRAMP01464	GLFSKFNKKKIKSGLFKIIKTAGKEAGLEALRTGIDVIGCKIKGEC	46	Esculentin-1SEb (Frogs, amphibians, animals)	P85054	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sevosa (Dusky gopher frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Mast cell degranulating peptide. Causes histamine release from rat peritoneal mast cells in vitro. Has antibacterial activity.
Tissue specificity: Expressed by the skin glands. 
PTM: Problely contains one dislfide bond 40-46."	Gram-negative bacterium: Escherichia coli K12;##Gram-positive bacterium: Micrococcus luteus NCT C2665.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16386333	Peptides. 2006 Jun;27(6):1313-1319.	Graham C, Richter SC, McClean S, O'Kane E, Flatt PR, Shaw C.	Histamine-releasing and antimicrobial peptides from the skin secretions of the dusky gopher frog, Rana sevosa.	
DRAMP01465	GIFSKLAGKKLKNLLISGLKSVGKEVGMDVVRTGIDIAGCKIKGEC	46	Esculentin-1R (Frogs, amphibians, animals)	P86018	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana ridibunda (Laughing frog) (Marsh frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 40-46."	[Swiss_Prot Entry P86018]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref:18855342]Low hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP01466	GILSLVKVAKLAGKTFAKEGGKFGLEFIACKVTNQC	36	Esculentin-2R (Frogs, amphibians, animals)	P86016	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana ridibunda (Laughing frog) (Marsh frog)	Antimicrobial	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 30-36."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP01467	GIFSLVKGVAKLAGKTLAKEGGKFGLELAMCKIAKQC	37	Esculentin-2Rb (Frogs, amphibians, animals)	P86021	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana ridibunda (Laughing frog) (Marsh frog)	Antimicrobial	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 31-37."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP01468	GILSLVKGAAKLLGKGLAKEGGKVGLEFIACKVTNQC	37	Esculentin-2Ra (Frogs, amphibians, animals)	P86017	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana ridibunda (Laughing frog) (Marsh frog)	Antimicrobial	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 31-37."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP18314	MGKLAIKAGKIIGGGIASALGWAAGEKAVGK	31	Aureocin A70 (AurA)(Bacteriocin)	Q93GF5	Belongs to the class II bacteriocin	aurA	Staphylococcus aureus A70	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Aureocin A70 is a multipeptide bacteriocin composed of four related peptides that are small (30-31 amino acid residues), strongly cationic (pI of 9.85 to 10.04) and highly hydrophobic. These peptides also have a high content of small amino acid residues like glycine (23	Gram-positive 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11531330	J Mol Biol. 2001 Aug 31;311(5):939-49.	Netz DJ, Sahl HG, Marcelino R, dos Santos Nascimento J, de Oliveira SS, Soares MB, do Carmo de Freire Bastos M.	Molecular characterisation of aureocin A70, a multi-peptide bacteriocin isolated from Staphylococcus aureus.	
DRAMP01481	NIFSLLSLGAKVLGKTLLKSAGKAGAEQLACKATNQC	37	Esculentin-2Wa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates capito (North American New World frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19635516	Peptides. 2009 Oct;30(10):1775-1781.	Conlon JM, Meetani MA, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.	Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae).	
DRAMP18313	TPALAVVTTVLPAAAVTTAKSV	22	Sclerosin(Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Pseudomonas sp. strain DF41 	Antimicrobial, Antibacterial		Not found	Warning: this peptide contains non-natural amino acids although they are represented using the closest standard 20 amino acids. Specifically, T1, T8, T17, and T18 are dehydrated into Dhb.  P12 is 3,4-dehydrated (Dhp). In total, five residues are dehydrated. Residue K20 is Dab (2,4-diaminobutyric acid). Finally, the acyl chain CH(3)-(CH(2))(6)-CH(OH)-CH(2)-CO is attached to the N-terminus. Thus, the entire sequence is CH(3)-(CH(2))(6)-CH		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22838838	Can J Microbiol. 2012 Aug;58(8):1027-34. 	Berry CL, Brassinga AK, Donald LJ, Fernando WG, Loewen PC, de Kievit TR.	Chemical and biological characterization of sclerosin, an antifungal lipopeptide.	
DRAMP01488	GIFSKLAGKKIKNLISGLKNIGKEVGMDVVRTGIDIAGCKIKGEC	45	Esculentin-1C (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Unknown	Antimicrobial, Antibacterial	Not found	Alpha helix 	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15232222	Mol Cells. 2004 Jun 30;17(3):469-476.	Won HS, Kim SS, Jung SJ, Son WS, Lee B, Lee BJ.	Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea.	
DRAMP01489	GIFSKLAGKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC	46	Esculentin-1A (Frogs, amphibians, animals)	P40843	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (European Edible frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found	2N6M##5XDJ	"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 40-46."	[Swiss_Prot Entry P40843]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref:8163497]Not found	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163497	J Biol Chem. 1994 Apr 22;269(16):11956-11961.	Simmaco M, Mignogna G, Barra D, Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP01492	GIFSLVKGAAKLAGKGLAKEGGKFGLELIACKIAKQC	37	Esculentin-IIb (Frogs, amphibians, animals)	P40846	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (European Edible frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species.	[Swiss_Prot Entry P40846]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref:8163497]Not found	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163497	J Biol Chem. 1994 Apr 22;269(16):11956-11961.	Simmaco M, Mignogna G, Barra D, Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP01498	GLFSKFAGKGIKNFLNKGVKHIGKE	25	Esculentin-1-OA6 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01500	KISGKAIKNLFIKGAKNVGKEVGMDVVRTGIDVVGCKIKGEC	42	Esculentin-1-OR2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana andersonii (Chinese odorous frog)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01512	QVFTLIKGATQLIRKTLGEQ	20	Esculentin-2-OR6 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana rotodora (Chinese odorous frog)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22029824	J Proteome Res. 2012 Jan 1;11(1):306-319.	Yang X, Lee WH, Zhang Y.	Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.	
DRAMP01514	GIFSKFGRKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC	46	Esculentin-1 (Frogs, amphibians, animals)	P84840	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Pelophylax saharicus (Sahara frog) (Rana saharica)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antimicrobial peptide (By similarity). Stimulates insulin secretion by BRIN-BD11 cells in vitro.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	[Ref.8163497] MHC>100 µM against human red blood cell.	Cyclic	Free	Cyclization (Cys40 and Cys46)	Disulfide bond between Cys40 and Cys46.	L	No cytotoxicity information found	Not found	16394170	J Endocrinol. 2006 Jan;188(1):1-9.	Marenah L, Flatt PR, Orr DF, Shaw C, Abdel-Wahab YH.	Skin secretions of Rana saharica frogs reveal antimicrobial peptides esculentins-1 and -1B and brevinins-1E and -2EC with novel insulin releasing activity.	
DRAMP18312	MTDANVDARRARAPHGISGAIAGVVAGCAATIEIGCVEGAIAGIGPSGIASMIAALWTCRSKYRRFSSGSGYVMLLSWSAEFVFGYFIGCRCGFLLSQK	99	Propionicin PLG-1(Bacteriocin)	I2HA02	Not found	plg-1	Propionibacterium thoeniiP127	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal		Not found	Not found		Propionicin PLG-1 is active against a variety of microorganisms such as propionibacteria, as well as many other gram-positive and gram-negative bacteria and even fungi.Propionicin PLG-1 is stable after long-term storage in a dry or frozen state and rapidly kills sensitive cells upon exposure in culture medium or skim milk.	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11010864	Appl Environ Microbiol. 2000 Oct;66(10):4230-6.	Faye T, Langsrud T, Nes IF, Holo H.	Biochemical and genetic characterization of propionicin T1, a new bacteriocin from Propionibacterium thoenii.	
DRAMP01744	FLPLIGKVLSGIL	13	Temporin-G (Frogs, amphibians, animals)	P79875 	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.
PTM: Leucine amide at position 13.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9022710	Eur J Biochem. 1996 Dec 15;242(3):788-792.	Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.	Temporins, antimicrobial peptides from the European red frog Rana temporaria.	
DRAMP01743	FLPLIGKVLSGIL	13	Temporin-F (Frogs, amphibians, animals)	P56921	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiparasitic	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-negative and Gram-positive  bacteria.
PTM: Leucine amide at position 13.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9022710	Eur J Biochem. 1996 Dec 15;242(3):788-792.	Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.	Temporins, antimicrobial peptides from the European red frog Rana temporaria.	
DRAMP01742	VLPIIGNLLNSLL	13	Temporin-E (Frogs, amphibians, animals)	P56920 	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacteria.
PTM: Leucine amide at position 13.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9022710	Eur J Biochem. 1996 Dec 15;242(3):788-792.	Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.	Temporins, antimicrobial peptides from the European red frog Rana temporaria.	
DRAMP01519	GVFSFLKTGAKLLGSTLLKMAGKAGAEHLACKATNQC	37	Esculentin-2PRa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pretiosa (North American oregon spotted frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. 	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	21295070	Dev Comp Immunol. 2011 Jun;35(6):644-649.	Conlon JM, Mechkarska M, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, Hayes MP, Padgett-Flohr G.	Host defense peptides in skin secretions of the Oregon spotted frog Ranapretiosa: implications for species resistance to chytridiomycosis.	
DRAMP01522	GILDSFKQFAKGVGKDLIKGAAQGVLSTMSCKLAKTC	37	Rugosin-C (Frogs, amphibians, animals)	P80956	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity against Gram-positive bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 31-37."	Gram-positive bacterium: Staphylococcus aureus 209P.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7612013	Biochem. Biophys. Res. Commun. 1995; 212: 249-254.	Suzuki S, Ohe Y, Kagegawa T, Tatemoto K.	Isolation and characterization of novel antimicrobial peptides, rugosins A, B and C, from the skin of the frog, Rana rugosa.	
DRAMP01523	KGAAKGLLEVASCKLSKSC	19	Rugosin A-like peptide (Frogs, amphibians, animals)	P84912	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana saharica (Sahara frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Stimulates insulin secretion by BRIN-BD11 cells in vitro. Has antibacterial activity.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16269346	Peptides. 2005 Nov;26(11):2117-2123.	Marenah L, Flatt P.R, Orr D.F, Shaw C, Abdel-Wahab Y.H.A.	Isolation and structural characterization of novel Rugosin A-like insulinotropic peptide from the skin secretions of Rana saharica frog.	
DRAMP01527	FTMKKSLFLILFLGAIPLSMC	21	Nigroain-L antimicrobial peptide (Frogs, amphibians, animals)	C0ILB3	Not found	Not found	Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defensive peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01528	FTMKKSLLFIFFLGTISLSLC	21	Nigroain-H antimicrobial peptide (Frogs, amphibians, animals)	C0ILB0	Not found	Not found	Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defensive peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01529	FTMKKSLLLIFFLGTISLSLC	21	Nigroain-H antimicrobial peptide (Frogs, amphibians, animals)	C0ILA9	Not found	Not found	Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defensive peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01530	FTMKKSPLLLFFLGTISLSLC	21	Nigroain-E antimicrobial peptide (Frogs, amphibians, animals)	C0ILA0, C0ILA2	Not found	Not found	Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defensive peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01531	FTMKKSLLLIFFLGTISLSLCEQER	25	Nigroain-D antimicrobial peptide (Frogs, amphibians, animals)	C0IL92, C0IL99, C0IL98	Not found	Not found	Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defensive peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01532	FTMKKSLFLLFFLGTISLSLC	21	Nigroain-B antimicrobial peptide (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata)	Antimicrobial	Predicted	Not found	Not found		Function: Amphibian defensive peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01534	CVISAGWDHKVRCKLTGNC	19	Nigroain-B2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial	Not found	Bridge	Not found		PTM: Contains one disulfide bridge.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01535	CKIALPYHMRCRVLGRC	17	Nigroain-B3 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial	Not found	Bridge	Not found		PTM: Contains one disulfide bridge.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01536	CVISAGWNHKIR	12	Nigroain-B4 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial	Not found	Bridge	Not found		PTM: Contains one disulfide bridge.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01537	MFTMKKSLLLLFFLGVISLSLCKQKRHADEEGNEVSGGEAKVEEVKRFKTWKRPPFQTSCSGIIKE	66	Nigroain-C antimicrobial peptide  (Frogs, amphibians, animals)	C0IL83	Not found	Not found	Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Genomics. 2010,95:66-71.	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP01538	FKTWKRPPFQTSCSGIIKE	19	Nigroain-C1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01540	CVHWQTNPARTSCIGP	16	Nigroain-D1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial	Not found	Not found	Not found		PTM: Contains one disulfide bridge.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01541	CVHWQTNPARTSRIGP	16	Nigroain-D2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial	Not found	Not found	Not found		PTM: Contains one disulfide bridge.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01544	GCTQWINNIHGRICVRN	17	Nigroain-E2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01545	SFLSKFKDIALDVPRMRARVY	21	Nigroain-I (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana nigrovittata (Black-striped frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71. 	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.	
DRAMP01548	MEIKYLLTVFLVLLIVSDHCQAFLFSLIPSAISGLISAFKGRRKRDLNGQIDHFKNFRKRDAELEELLSKLPIY	74	Caerin-1 	A9NJH7	Not found	Not found	Mesobuthus martensii (Manchurian scorpion) (Buthus martensii)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Pubmed ID is not available	Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases.	Zhu S, Gao B.	Scorpion venom gland caerin-like antibacterial peptide gene: inducible expression and RNA editing.	
DRAMP01551	GLLGVLGSVAKHVLPHVVPVIAEHL	25	Caerin-1.2 (Frogs, amphibians, animals)	P56227	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria caerulea (Australian frog)	Antimicrobial, Antibacterial,Antiviral	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation."	[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	"[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 22	µM."	Not found	26026377##PubMed ID is not available	Peptides. 2015 Sep;71:296-303. ##J. Chem. Res. 1993; 138: 910-936.	VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01554	GLLSSLSSVA	10	Caerin-1.4.1 (Chain of Caerin-1.4)	P62545, P56229, P62544	Belongs to the frog skin active peptide (FSAP) family (Caerin subfamily)	Not found	Litoria caerulea (Green tree frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Pubmed ID is not available	J. Chem. Res. 1993,138:910-936.	Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	
DRAMP01556	GLFSVLGAVAKHVLPHVVPVIAEKL	25	Caerin-1.6 (Frogs, amphibians, animals)	P62546, P56231, P81249, P62547	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria xanthomera (Orange-thighed frog) (Litoria chloris)	Antimicrobial, Antibacterial,Antiviral	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin dorsal glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility By similarity.
PTM: C-terminal amidation."	[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	"[Ref.26026377]Human endocervical cells End1/E6E7:50% cell death at 10	µM."	Cell membrane	26026377##9230483##9204574##9516047	Peptides. 2015 Sep;71:296-303. ##J Pept Sci. 1997 May-Jun;3(3):181-185.##Rapid Commun Mass Spectrom. 1997;11(9):997-1000.##J Pept Res. 1998 Feb;51(2):121-126.	VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Steinborner ST, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ, Ramsay SL.##Steinborner ST, Waugh RJ, Bowie JH, Tyler MJ.##Steinborner ST, Currie GJ, Bowie JH, Wallace JC, Tyler MJ.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##New caerin antibacterial peptides from the skin glands of the Australian tree frog Litoria xanthomera.##New caerin antibacterial peptides from the skin glands of the Australian tree frog Litoria xanthomera. Part 2. Sequence determination using mass spectrometry and associated techniques.##New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01557	GLFKVLGSVAKHLLPHVAPVIAEKL	25	Caerin-1.7 (Frogs, amphibians, animals)	P62548, P62549, P56232, P81250	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria xanthomera (Orange-thighed frog) (Litoria chloris)	Antimicrobial, Antibacterial,Antiviral	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity. 
Tissue specificity: Expressed by the skin dorsal glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility By similarity.
PTM: C-terminal amidation."	[Ref.26026377]Virus:HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Free	L	[Ref.26026377]Human endocervical cells End1/E6E7:50% cell death at 12.5 µM.	Cell membrane	26026377##9230483##9204574##9516047	Peptides. 2015 Sep;71:296-303. ##J Pept Sci. 1997 May-Jun;3(3):181-185.##Rapid Commun Mass Spectrom. 1997;11(9):997-1000.##J Pept Res. 1998 Feb;51(2):121-126.	VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Steinborner ST, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ, Ramsay SL.##Steinborner ST, Waugh RJ, Bowie JH, Tyler MJ.##Steinborner ST, Currie GJ, Bowie JH, Wallace JC, Tyler MJ.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##New caerin antibacterial peptides from the skin glands of the Australian tree frog Litoria xanthomera.##New caerin antibacterial peptides from the skin glands of the Australian tree frog Litoria xanthomera. Part 2. Sequence determination using mass spectrometry and associated techniques.##New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP01558	FKVLGSVAKHLLPHVAPVIAEK	22	Caerin-1.7.1 (Chain of Caerin-1.7)	P62549, P56232, P81250	Belongs to the frog skin active peptide (FSAP) family (Caerin subfamily)	Not found	Litoria chloris (Blue-thighed frog)	Not found	Protein level	Not found	Not found		PTM: Caerin-1.7.1 does not have any antibacterial activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9516047	J Pept Res. 1998 Feb;51(2):121-126.	Steinborner ST, Currie GJ, Bowie JH, Wallace JC, Tyler MJ.	New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria.	
DRAMP01559	GLFKVLGSVAKHLLPHVVPVIAEKL	25	Caerin-1.8 (Frogs, amphibians, animals)	P81251	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria chloris (Blue-thighed frog)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Protein level	Alpha helix 	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin dorsal glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation."	Litoria chloris	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9516047	J Pept Res. 1998 Feb;51(2):121-126.	Steinborner ST, Currie GJ, Bowie JH, Wallace JC, Tyler MJ.	New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria.	
DRAMP01561	MEIKYLLTVFLVLLIVSDHCQAFLFSLIPSAISGLISAFKGKRRRDLNAQIDQFKNFRKRDAELEELLSKLPIY	74	Caerin-2 (Venom antimicrobial peptide-10)	A9NJH6	Not found	Not found	Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Pubmed ID is not available##Pubmed ID is not available	Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases.##Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.	Zhu S, Gao B.##Zhu S, Gao B.	Scorpion venom gland caerin-like antibacterial peptide gene: inducible expression and RNA editing.##Genomic organization of the MeVAMP-10, a venom antimicrobial peptide from Mesobuthus eupeus.	
DRAMP01564	ALGGLLADVVKSKEQPA	17	Caerin-2.2.1 (Chain of Caerin-2.2)	P62570, P62571, P56234	Belongs to the frog skin active peptide (FSAP) family (Caerin subfamily)	Not found	Litoria caerulea (Green tree frog) (Litoria gilleni)	Antimicrobial	Protein level	Not found	Not found		Function: Antimicrobial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Pubmed ID is not available	J. Chem. Res. 1993,138:910-936.	Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	
DRAMP01565	GLVSSIGKALGGLLADVVKTKEQPA	25	Caerin-2.4 (Frogs, amphibians, animals)	P56236	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria caerulea (Green tree frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antimicrobial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J. Chem. Res. 1993; 138: 910-936.	Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	
DRAMP01566	GLVASIGRALGGLLADVVKSKEQPA	25	Caerin-2.5 (Frogs, amphibians, animals)	P56237	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria gilleni (Centralian tree frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antimicrobial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J. Chem. Res. 1993; 138: 910-936.	Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	
DRAMP01569	GLWQKIKDKASELVSGIVEGVK	22	Caerin-3.1 (Frogs, amphibians, animals)	P62562, P56238, P62563, P86505	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria gilleni (Centralian tree frog) (Litoria splendida) (Litoria rothii)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation."	Gram-positive bacterium: Micrococcus luteus (MIC<0.4 µg/ml). (Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##15203252##16124032##195396	J. Chem. Res. 1993; 138: 910-936.##Peptides. 2004 Jun;25(6):1035-1054.##Rapid Commun Mass Spectrom. 2005;19(18):2716-2724.##Toxicon. 2009 Nov;54(6):828-835. 	Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.##Brinkworth CS, Bowie JH, Bilusich D, Tyler MJ.##Sherman PJ, Jackway RJ, Nicholson E, Musgrave IF, Boontheung P, Bowie JH.	Peptides from Australian frogs. The structures of the caerins from Litoria caerula.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.##The rothein peptides from the skin secretion of Roth's tree frog Litoria rothii. Sequence determination using positive and negative ion electrospray mass spectrometry.##Activities of seasonably variable caerulein and rothein skin peptides from the tree frogs Litoria splendida and Litoria rothii.	
DRAMP01571	GLWEKIKEKANELVSGIVEGVK	22	Caerin-3.3 (Frogs, amphibians, animals)	P56240	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria caerulea (Green tree frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J. Chem. Res. 1993; 138: 910-936.	Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	
DRAMP01572	GLWEKIREKANELVSGIVEGVK	22	Caerin-3.4 (Frogs, amphibians, animals)	P56241	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria caerulea (Green tree frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J. Chem. Res. 1993; 138: 910-936.	Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	
DRAMP01575	GLWQKIKSAAGDLASGIVEAIKS	23	Caerin-4.2 (Frogs, amphibians, animals)	P56243	Belongs to the frog skin active peptide family (Caerin subfamily)	Not found	Litoria caerulea (Green tree frog); also L.caerulea/L.splendida hybrid	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J. Chem. Res. 1993; 138: 910-936.	Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.	Peptides from Australian frogs. The structures of the caerins from Litoria caerula.	
DRAMP01579	GLFGILGSVAKHVLPHVVPVIAEHS	25	Caerin 1.12 (Frogs, amphibians, animals)	Q800R8	Not found	Not found	Litoria caerulea (Green tree frog)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12709067	Eur J Biochem. 2003 May;270(9):2068-2081.	Vanhoye D, Bruston F, Nicolas P, Amiche M.	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.	
DRAMP01580	GLLSVLGSLKLIVPHVVPLIAEHL	24	Caerin 1.13 (Frogs, amphibians, animals)	Q800R7	Not found	Not found	Litoria caerulea (Green tree frog)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12709067	Eur J Biochem. 2003 May;270(9):2068-2081.	Vanhoye D, Bruston F, Nicolas P, Amiche M.	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.	
DRAMP01581	SVLGKSVAKHLPHVVPVIAEKT	22	Caerin 1.14 (Frogs, amphibians, animals)	Q800R6	Not found	Not found	Litoria caerulea (Green tree frog)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12709067	Eur J Biochem. 2003 May;270(9):2068-2081.	Vanhoye D, Bruston F, Nicolas P, Amiche M.	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.	
DRAMP01582	GLFGLAKGSVAKPHVVPVISQLV	23	Caerin 1.15 (Frogs, amphibians, animals)	Q800R5	Not found	Not found	Litoria caerulea (Green tree frog)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12709067	Eur J Biochem. 2003 May;270(9):2068-2081.	Vanhoye D, Bruston F, Nicolas P, Amiche M.	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.	
DRAMP18310	ITVCISVC	8	Patellamide A(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	patE	Prochloron didemni	Unknown		Not found	Not found		Before both peptides, there is a 5-aa conserved region consisting of the consensus G(LV)E(AP)S. The sequence AYDGE terminates the patellamide A sequence and directly precedes the stop codon. Between the two patellamides, the 8-aa sequence AYDGVEPS seems to encode for both a start and stop cyclization sequence, with the consensus stop sequence being AYDG(EV).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15883371	Proc Natl Acad Sci U S A. 2005 May 17;102(20):7315-20.	Schmidt EW, Nelson JT, Rasko DA, Sudek S, Eisen JA, Haygood MG, Ravel J.	Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella.	
DRAMP18311	VTACITFC	8	Patellamide C(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	patE	Prochloron didemni	Unknown		Not found	Not found		Before both peptides, there is a 5-aa conserved region consisting of the consensus G(LV)E(AP)S. The sequence AYDGE terminates the patellamide A sequence and directly precedes the stop codon. Between the two patellamides, the 8-aa sequence AYDGVEPS seems to encode for both a start and stop cyclization sequence, with the consensus stop sequence being AYDG(EV).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15883371	Proc Natl Acad Sci U S A. 2005 May 17;102(20):7315-20.	Schmidt EW, Nelson JT, Rasko DA, Sudek S, Eisen JA, Haygood MG, Ravel J.	Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella.	
DRAMP01592	FDVIKKVASVIGGL	14	Citropin-1.1.1 (Frogs, amphibians, animals)	P81835, P81836, P81837	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Bacteriostatic action for Gram-positive bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	
DRAMP01593	DVIKKVASVIGGL	13	Citropin-1.1.2 (Frogs, amphibians, animals)	P81835, P81836, P81837	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Bacteriostatic action for Gram-positive bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	
DRAMP01595	FDIIKKVASVVG	12	Citropin-1.2.1 (Frogs, amphibians, animals)	P81840, P81841, P81842, P81843	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Bacteriostatic action for Gram-positive bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	
DRAMP01596	DIIKKVASVVG	11	Citropin-1.2.2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Litoria citropa (Blue Mountains tree-frog)	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1 .	
DRAMP01597	GLFDIIKKVAS	11	Citropin-1.2.3 (Frogs, amphibians, animals)	P81840	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	
DRAMP01598	GLFDIIKKVASVVGLASP	18	Citropin-1.2.4 (Frogs, amphibians, animals)	P81844	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	
DRAMP01599	GLFDIIKKVASVVGLASQ	18	Citropin-1.2.5 (Frogs, amphibians, animals)	P81845	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	
DRAMP01604	GLFDVIKKVASVIGLASQ	18	Citropin-1.1.4 (Frogs, amphibians, animals)	P81839	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	
DRAMP01605	DLFQVIKEKLKELTGGVIEGIQGV	24	Citropin-3.1.2 (Frogs, amphibians, animals)	P81851, P81852, P81853	Not found	Not found	Litoria citropa (Australian blue mountains tree frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the dorsal and submental skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10504394	Eur J Biochem. 1999 Oct;265(2):627-637.	Wegener KL, Wabnitz PA, Carver JA, Bowie JH, Chia BC, Wallace JC, Tyler MJ.	Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.	
DRAMP01609	GLFDIVKKVVGALGSL	16	Aurein-2.2 (Frogs, amphibians, animals)	P82389	Not found	Not found	Litoria aurea (Green; also golden bell frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer	Protein level	Alpha helix	Not found		"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin dorsal glands."	Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=12 μg/ml), Micrococcus luteus (MIC=25 μg/ml), , Staphylococcus epidermidis (MIC=25 μg/ml), Streptococcus uberis (MIC=100 μg/ml), Staphylococcus aureus (MIC=25 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	10951191##15203252	Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	
DRAMP01610	GLFDIVKKVVGAIGSL	16	Aurein-2.3 (Frogs, amphibians, animals)	P82390	Not found	Not found	Litoria aurea (Green; also golden bell frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer	Protein level	Alpha helix	Not found		"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin dorsal glands."	[Ref.10951191]Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=25 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=25 μg/ml), Staphylococcus aureus (MIC=100 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	10951191##15203252	Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	
DRAMP01611	GLFDIVKKVVGTLAGL	16	Aurein-2.4 (Frogs, amphibians, animals)	P82391	Not found	Not found	Litoria aurea (Green; also golden bell frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer	Protein level	Not found	Not found		"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands."	[Ref.10951191]Gram-positive bacteria: Bacillus cereus (MIC=25 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=25 μg/ml), Staphylococcus epidermidis (MIC=25 μg/ml), Streptococcus uberis (MIC=25 μg/ml), Staphylococcus aureus (MIC=25 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	10951191##15203252	Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	
DRAMP01615	GLFDIVKKIAGHIA	14	Aurein-3.1.1 (Frogs, amphibians, animals)	P69021	Not found	Not found	Litoria aurea (Green and golden bell frog)	Antimicrobial, Antibacterial, Anti-cancer	Protein level	Not found	Not found		"Function: 	  Has antimicrobial activity against L.lactis, L.innocua, M.luteus, S.aureus, S.epidermidis and S.uberis. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10951191	Eur J Biochem. 2000 Sep;267(17):5330-5341.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.	The antibiotic and anticancer active aurein peptides from the australian bell frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.	
DRAMP01616	FDIVKKIAGHIAGSI	15	Aurein-3.1.2 (Frogs, amphibians, animals)	P69021	Not found	Not found	Litoria aurea (Green and golden bell frog)	Antimicrobial, Antibacterial, Anti-cancer	Protein level	Not found	Not found		"Function: 	  Has antimicrobial activity against L.lactis, L.innocua, M.luteus, S.aureus, S.epidermidis and S.uberis. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10951191	Eur J Biochem. 2000 Sep;267(17):5330-5341.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.	The antibiotic and anticancer active aurein peptides from the australian bell frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.	
DRAMP01619	FDIVKKIAGHIVSSI	15	Aurein-3.3.1 (Frogs, amphibians, animals)	P82396	Not found	Not found	Litoria raniformis (Southern bell frog)	Antimicrobial, Antibacterial, Anti-cancer	Protein level	Not found	Not found		"Function: 	  Antimicrobial activity against L.lactis, M.luteus, P.multocida, S.aureus, S.epidermidis and S.uberis. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10951191	Eur J Biochem. 2000 Sep;267(17):5330-5341.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.	The antibiotic and anticancer active aurein peptides from the australian bell frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.	
DRAMP18309	WAIVLL	6	Baceridin(Bacteriocin)	No entry found	Not found	Not found	plant-associated Bacillus strain	Antimicrobial, Antibacterial, Anti-Gram+		Not found	A circular peptide where residues 2, 3, and 5 are D-amino acids. 		Baceridin was tested for antimicrobial and cytotoxic activity and displayed moderate cytotoxicity (1	Gram-positive(weakly)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24692199	Chembiochem. 2014 May 5;15(7):1021-9. 	Niggemann J, Bozko P, Bruns N, Wodtke A, Gieseler MT, Thomas K, Jahns C, Nimtz M, Reupke I, Br	Baceridin, a cyclic hexapeptide from an epiphytic bacillus strain, inhibits the proteasome.	
DRAMP01624	ILGPILGLVSNAGGLL	16	Bombinin-H6 (bombinin H isomers; Frogs, amphibians, animals)	No entry found	Belongs to the bombinin family	Not found	Not found	Antimicrobial, Antibacterial	Not found	Not found	Not found		"Function: H6 shows the greatest activity, causing 60% hemolysis at a very low peptide concentration (4 µM).
PTM: C-terminal amidation."	H6 does not display any microbicidal activity against all the microorganisms tested.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11090921	Peptides. 2000 Nov;21(11):1673-1679.	Mangoni ML, Grovale N, Giorgi A, Mignogna G, Simmaco M, Barra D.	Structure-Function: relationships in bombinins H, antimicrobial peptides from Bombina skin secretions.	
DRAMP18308	MGISSPALPQNTADLFQLDLEIGVEQSLASPAITSVSWCTPGCTSEGGGSGCSHCC	56	Planosporicin(Bacteriocin)	R4ZCJ5	Belongs to the lantibiotics family (Class I bacteriocin)	pspA	Planomonospora alba	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	broad-spectrum	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17469849	Biochemistry. 2007 May 22;46(20):5884-95. 	Castiglione F, Cavaletti L, Losi D, Lazzarini A, Carrano L, Feroggio M, Ciciliato I, Corti E, Candiani G, Marinelli F, Selva E.	A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.	
DRAMP01629	GWMSKIASGIGTFLSGVQQG	20	Phylloxin-S1 (Frogs, amphibians, animals)	No entry found	Belongs to the Phyllomedusinae subfamily	Not found	Phyllomedusa sauvagii (Waxy Monkey Leaf Frog)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18644413	Peptides. 2008 Nov;29(11):2074-2082.	Amiche M, Ladram A, Nicolas P.	A consistent nomenclature of antimicrobial peptides isolated from frogs of the subfamily Phyllomedusinae.	
DRAMP01630	AVWKDFLKNIGKAAGKAVLNSVTDMVNE	28	Dermaseptin-LI1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Phyllomedusa hypochondrialis (Orange legged leaf frog)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18644413	Peptides. 2008 Nov;29(11):2074-2082.	Amiche M, Ladram A, Nicolas P.	A consistent nomenclature of antimicrobial peptides isolated from frogs of the subfamily Phyllomedusinae.	
DRAMP01631	GLWKSLLKNVGKAAGKAALNAVTDMVNQ	28	Dermaseptin-S7 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14599725	Regul Pept. 2003 Nov 15;116(1-3):139-146.	Chen T, Tang L, Shaw C.	Identification of three novel Phyllomedusa sauvagei dermaseptins (sVI-sVIII) by cloning from a skin secretion-derived cDNA library.	
DRAMP01632	ALWKTMLKKLGTVALHAGKAALGAAADTISQ	31	Dermaseptin-S8 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Alpha helix	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14599725	Regul Pept. 2003 Nov 15;116(1-3):139-146.	Chen T, Tang L, Shaw C.	Identification of three novel Phyllomedusa sauvagei dermaseptins (sVI-sVIII) by cloning from a skin secretion-derived cDNA library.	
DRAMP01633	DEEKRENEDEENQEDDEQSEMRRGLRSKIWLWVLLMIWQESNKFKKM	47	Dermaseptin S9 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Phyllomedusa sauvagii (Painted-belly leaf frog)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Not found	Not found	Not found	Not found	
DRAMP01634	EEEKREGENEKEQEDDNQSEEKRGLVSDLLSTVTGLLGNLGGGGLKKI	48	Preprodermaseptin S10 (Frogs, amphibians, animals)	Q1EN14	Not found	drsS10	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial	Homology	Not found	Not found		Function: Defense response to bacterium	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.	Amiche M., Lequin O., Vanhoye D., Bruston F., Ladram A., Convert O., Nicolas P.	A new structural motif of alpha-helical antimicrobial peptides with a nonamphipathic hydrophobic core and cationic termini.	
DRAMP01635	EEEKRENEDEEEQEDDEQSEEKRALWKTLLKGAGKVFGHVAKQFLGSQGQPES	53	Preprodermaseptin S11 (Frogs, amphibians, animals)	Q1EN13	Not found	drsS11	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial	Homology	Not found	Not found		Function: Defense response to bacterium	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.	Amiche M., Lequin O., Vanhoye D., Bruston F., Ladram A., Convert O., Nicolas P.	A new structural motif of alpha-helical antimicrobial peptides with a nonamphipathic hydrophobic core and cationic termini.	
DRAMP01636	EEEKRENEDEENQEDDEQSEMRRGLWSKIKEAAKTAGKMAMGFVNDMVGEQ	51	Preprodermaseptin S12 (Frogs, amphibians, animals)	Q1EN12	Not found	drsS12	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial	Homology	Not found	Not found		Function: Defense response to bacterium	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.	Amiche M., Lequin O., Vanhoye D., Bruston F., Ladram A., Convert O., Nicolas P.	A new structural motif of alpha-helical antimicrobial peptides with a nonamphipathic hydrophobic core and cationic termini.	
DRAMP01637	DEEKRENEDEENQEDDEQSEMRRGLRSKIKEAAKTAGKMALGFVNDMAGEQ	51	Dermaseptin S13 (Frogs, amphibians, animals)	Q1EN11	Not found	drsS13	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial	Homology	Not found	Not found		Function: Defense response to bacterium	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.	Amiche M., Lequin O., Vanhoye D., Bruston F., Ladram A., Convert O., Nicolas P.	A new structural motif of alpha-helical antimicrobial peptides with a nonamphipathic hydrophobic core and cationic termini.	
DRAMP01640	GLWKSLLKNVGVAAGKAALNAVTDMVNQ	28	Dermaseptin-2 (DShypo02; Frogs, amphibians, animals)	P84597	Not found	Not found	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16844081	Biochem Biophys Res Commun. 2006 Sep 1;347(3):739-746. 	Brand GD, Leite JR, de SÃ¡ Mandel SM, Mesquita DA, Silva LP, Prates MV, Barbosa EA, Vinecky F, Martins GR, Galasso JH, Kuckelhaus SA, Sampaio RN, Furtado JR Jr, Andrade AC, Bloch C Jr.	Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia).	
DRAMP01641	ALWKDVLKKIGTVALHAGKAAFGAAADTISQGGS	34	Dermaseptin-3 (DShypo03; Frogs, amphibians, animals)	P84598	Not found	Not found	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial	Protein level	Not found	Not found		Function: May have antimicrobial activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16844081	Biochem Biophys Res Commun. 2006 Sep 1;347(3):739-746. 	Brand GD, Leite JR, de SÃ¡ Mandel SM, Mesquita DA, Silva LP, Prates MV, Barbosa EA, Vinecky F, Martins GR, Galasso JH, Kuckelhaus SA, Sampaio RN, Furtado JR Jr, Andrade AC, Bloch C Jr.	Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia).	
DRAMP01642	GLWSTIKQKGKEAAIAAAKAAGKAVLNAASEAL	33	Dermaseptin-4 (DShypo04; Frogs, amphibians, animals)	P84599	Not found	Not found	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial	Protein level	Not found	Not found		Function: May have antimicrobial activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16844081	Biochem Biophys Res Commun. 2006 Sep 1;347(3):739-746. 	Brand GD, Leite JR, de SÃ¡ Mandel SM, Mesquita DA, Silva LP, Prates MV, Barbosa EA, Vinecky F, Martins GR, Galasso JH, Kuckelhaus SA, Sampaio RN, Furtado JR Jr, Andrade AC, Bloch C Jr.	Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia).	
DRAMP01644	GLWSTIKQKGKEAAIAAAKAAGQAVLNSASEAL	33	Dermaseptin-6 (DShypo06; Frogs, amphibians, animals)	P84601	Not found	Not found	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16844081	Biochem Biophys Res Commun. 2006 Sep 1;347(3):739-746. 	Brand GD, Leite JR, de SÃ¡ Mandel SM, Mesquita DA, Silva LP, Prates MV, Barbosa EA, Vinecky F, Martins GR, Galasso JH, Kuckelhaus SA, Sampaio RN, Furtado JR Jr, Andrade AC, Bloch C Jr.	Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia).	
DRAMP01645	GLWSTIKQKGKEAAIAAAKAAGQAALNAASEAL	33	Dermaseptin-7 (DShypo07; Frogs, amphibians, animals)	P84880	Not found	Not found	Phyllomedusa hypochondrialis (Orange-legged leaf frog)	Antimicrobial	Protein level	Not found	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16844081	Biochem Biophys Res Commun. 2006 Sep 1;347(3):739-746. 	Brand GD, Leite JR, de SÃ¡ Mandel SM, Mesquita DA, Silva LP, Prates MV, Barbosa EA, Vinecky F, Martins GR, Galasso JH, Kuckelhaus SA, Sampaio RN, Furtado JR Jr, Andrade AC, Bloch C Jr.	Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia).	
DRAMP01652	GLWNKIKEAASKAAGKAALGFVNEMV	26	Dermaseptin-B5 (Dermaseptin BV; Frogs, amphibians, animals)	P81487	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor)	Antimicrobial, Antibacterial	Protein level	Alpha helix	Not found		"Function: Possesses a potent antimicrobial activity against Gram-positive and Gram-negative bacteria. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation (Potential)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9614066	J Biol Chem. 1998 Jun 12;273(24):14690-7.	Charpentier S, Amiche M, Mester J, Vouille V, Le Caer JP, Nicolas P, Delfour A.	Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics.	
DRAMP01653	ALWKDILKNAGKAALNEINQLVNQ	24	Dermaseptin-B6 (Dermaseptin BVI; Frogs, amphibians, animals)	P81490, Q98TQ1	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Possesses a potent antimicrobial activity against Gram-positive and Gram-negative bacteria. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9614066	J Biol Chem. 1998 Jun 12;273(24):14690-7.	Charpentier S, Amiche M, Mester J, Vouille V, Le Caer JP, Nicolas P, Delfour A.	Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics.	
DRAMP01654	GLWSKIKEAGKAVLTAAGKAALGAVSDAV	29	Dermaseptin-B8 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Phyllomedusa bicolor (Two-colored leaf frog)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9305726	FEBS Lett. 1997 Sep 1;414(1):27-32.	Vouille V, Amiche M, Nicolas P.	Structure of genes for dermaseptins B, antimicrobial peptides from frog skin. Exon 1-encoded prepropeptide is conserved in genes for peptides of highly different structures and activities.	
DRAMP01655	GLWSNIKTAGKEAAKAALKAAGKAALGAVTDAV	33	Dermaseptin DRG1 (Dermaseptin-1; Dermaseptin-B7, DRS-B7; Frogs, amphibians, animals)	Q90ZK3	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	DRG1	Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor)	Antimicrobial	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (Potential).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases	Amiche M.	Unknown	
DRAMP01656	RGLWSKIKEAGKAALTAAGKAALGAVSDAV	30	Dermaseptin DRG2 (Dermaseptin-2; Frogs, amphibians, animals)	Q90ZK5	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	DRG2	Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor)	Antimicrobial	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (Potential).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases	Amiche M.	Unknown	
DRAMP01658	GLWKNMLSGIGKLAGQAALGAVKTLV	26	Dermaseptin-J1 (DRS-J1; Frogs, amphibians, animals)	P86635	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01659	GLWKNMLSGIGKLAGEAALGAVKTLV	26	Dermaseptin-J2 (DRS-J2; Frogs, amphibians, animals)	P86636	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01660	ALWKNMLSGIGKLAGQAALGAVKTLV	26	Dermaseptin-J3 (DRS-J3; Frogs, amphibians, animals)	P86637	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01661	ALWKDMLSGIGKLAGQAALGAVKTLV	26	Dermaseptin-J4 (DRS-J4; Frogs, amphibians, animals)	P86638	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01662	GLWSKIKEAGKAAVKAAGKAALGAVANSV	29	Dermaseptin-J5 (DRS-J5; Frogs, amphibians, animals)	P86683	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01663	GLWSKIKEAGKAAVKAAGKAALGAVADSV	29	Dermaseptin-J6 (DRS-J6; Frogs, amphibians, animals)	P86684	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP18307	APVPFSCTRGCLTHLV	16	LMW peptide (Bacteriocin)	No entry found	Not found	Not found	Pediococcus pentosaceus IE-3	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Unlike pediocin-like bacteriocins, the low molecular weight peptide (LMW) showed resistance to different proteases. Moreover, peptide treated with reducing agent like dithiothreitol (DTT) exhibited increased activity against both Gram-positive and Gram-negative test strains in comparison to native peptide. However, peptide treated with oxidizing agent such as hydrogen peroxide (H2O2) did not show any antimicrobial activity.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25158757	BMC Microbiol. 2014 Aug 27;14:226. 	Singh PK, Sharma S, Kumari A, Korpole S.	A non-pediocin low molecular weight antimicrobial peptide produced by Pediococcus pentosaceus strain IE-3 shows increased activity under reducing environment.	
DRAMP01665	GLWKSLLKNVGKAAGKAALNAVTDMVNQA	29	Dermaseptin-J8 (DRS-J8; Frogs, amphibians, animals)	P86640	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01666	GLWKSLLKNVGKAAGKAALNAVTDMVNQS	29	Dermaseptin-J9 (DRS-J9; Frogs, amphibians, animals)	P86641	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01667	ALWKSLLKGAGQLVGGVVQHFMGSQGQPES	30	Dermaseptin-J10 (DRS-J10; Frogs, amphibians, animals)	P86642	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01669	ALWFTMLKKLGTMALHAGKAALGAAANTISQGTQ	34	Dermaseptin-2 (DS II; Dermaseptin-S2, DS2; Frogs, amphibians, animals)	P80278	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial, Antifungal, Antiprotozoal	Protein level	Alpha helix	Not found		"Function: Possesses a potent antimicrobial activity against bacteria, fungi and protozoa. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin glands."	Aspergillus fumigatus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8306981	Eur J Biochem. 1994 Jan 15;219(1-2):145-154.	Mor A, Nicolas P.	Isolation and structure of novel defensive peptides from frog skin.	
DRAMP01670	ALWKNMLKGIGKLAGKAALGAVKKLVGAES	30	Dermaseptin-3 (DS III; Dermaseptin-S3, DS3; Frogs, amphibians, animals)	P80279	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial, Antifungal, Antiprotozoal	Protein level	Alpha helix	Not found		"Function: Possesses a potent antimicrobial activity against bacteria, fungi and protozoa. Probably acts by disturbing membrane functions with its amphipathic structure. Binds to healthy erythrocytes (this binding is receptor independent), but has no significant hemolytic activity. Does not bind to P. falciparum infected erythrocytes, but accumulates within the parasite. Kills the parasite, but has no hemolytic activity on the host cell.
Tissue specificity: Expressed by the skin glands."	[Ref.9395500]Fungi: Aspergillus fumigatus;##Protozoa: Malarial parasite strain H (IC50=0.8 µg/ml), Malarial parasite strain NF54 (IC50=0.26 µg/ml).	[Ref:8306981]No significant hemolytic activity against rabbit red blood cells;##[Ref:9395500]Non-hemolytic activity against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Binds to healthy erythrocytes (this binding is receptor independent).	8306981##9395500	Eur J Biochem. 1994 Jan 15;219(1-2):145-155.##J Biol Chem. 1997 Dec 12;272(50):31609-31616.	Mor A, Nicolas P.##Ghosh JK, Shaool D, Guillaud P, CicÃ©ron L, Mazier D, Kustanovich I, Shai Y, Mor A.	Isolation and structure of novel defensive peptides from frog skin.##Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis.	
DRAMP01671	ALWMTLLKKVLKAAAKALNAVLVGANA	27	Dermaseptin-4 (DS IV; Dermaseptin-S4, DS4; Frogs, amphibians, animals)	P80280	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral	Protein level	Combine strand and Turn structure	Not found		"Function: Possesses a potent antimicrobial activity against Gram-negative and Gram-positive bacteria, fungi, protozoa, and the enveloped herpes simplex virus type 1. Probably acts by disturbing membrane functions with its amphipathic structure. Has strong hemolytic activity. Does not bind to P. falciparum infected erythrocytes, but accumulates within the parasite.
Tissue specificity: Expressed by the skin glands.
Pharmaceutical use: Derivatives of this peptide may be used as therapeutic agents to treat bacterial infections and malaria, and to prevent infection by herpes simplex virus type 1 and HIV-1."	[Swiss_Prot Entry P80280]Possesses a potent antimicrobial activity against Gram-negative and Gram-positive bacteria, fungi, protozoa, and the enveloped herpes simplex virus type 1	[Ref:11850249]IC50=20 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	healthy erythrocytes (this binding is receptor independent).	8306981##11850249##9395500	Eur J Biochem. 1994 Jan 15;219(1-2):145-154.##Antimicrob Agents Chemother. 2002 Mar;46(3):689-694.##J Biol Chem. 1997 Dec 12;272(50):31609-31616.	Mor A, Nicolas P.##Navon-Venezia S, Feder R, Gaidukov L, Carmeli Y, Mor A.##Ghosh JK, Shaool D, Guillaud P, CicÃ©ron L, Mazier D, Kustanovich I, Shai Y, Mor A.	Isolation and structure of novel defensive peptides from frog skin.##Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.##Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis.	
DRAMP01672	GLWSKIKTAGKSVAKAAAKAAVKAVTNAV	29	Dermaseptin-5 (DS V; Dermaseptin-S5, DS5; Frogs, amphibians, animals)	P80281	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"MOA: Probably acts by disturbing membrane functions with its amphipathic structure. Binds to healthy erythrocytes (this binding is receptor independent), and has strong hemolytic activity. Does not bind to P.falciparum infected erythrocytes, but accumulates within the parasite.
Pharmaceutical use: Derivatives of this peptide may be used as therapeutic agents to treat bacterial infections and malaria, and to prevent infection by herpes simplex virus type 1 and HIV-1."	[Swiss_Prot Entry P80281]Possesses a potent antimicrobial activity against bacteria, fungi and protozoa	[Ref:8306981]Show strong hemolytic activity against rabbit healthy erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8306981	Eur J Biochem. 1994 Jan 15;219(1-2):145-154.	Mor A, Nicolas P.	Isolation and structure of novel defensive peptides from frog skin.	
DRAMP01673	GLWSKIKETGKEAAKAAGKAALNKIAEAV	29	Dermaseptin-1 (DStar 01; Frogs, amphibians, animals)	P84921	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa tarsius (Brownbelly leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial peptide, active against the Gram-positive bacterium S. aureus, the Gram-negative bacteria E. coli and P. aeruginosa, and the yeasts C. albicans and P. brasiliensis. Has hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	[Swiss_Prot Entry P84921]Gram-positive bacteria: Staphylococcus aureus, Enterococcus faecalis;##Gram-neagtive bacterium: Pseudomonas aeruginosa.;##Fungi: Candida albicans and Paracoccidioides brasiliensis.	[Ref:PubMed ID is not available]40% hemolytic activity at 128 µg/ml	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2006) to UniProtKB.	Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.	Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).	
DRAMP18306	KYYGNGVTXGKHSXXVDXG	19	Pediocin ACCEL(Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	Pediococcus pentosaceus ACCEL	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		It was inactivated by various proteases and stable at pH 2.0-6.0 and <100  Celsius degree. More than 80% activity was left even after 15 min of heating at 121  Celsius degree and pH 2.0-4.0.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14995112	J Agric Food Chem. 2004 Mar 10;52(5):1146-51.	Wu CW, Yin LJ, Jiang ST.	Purification and characterization of bacteriocin from Pediococcus pentosaceus ACCEL.	
DRAMP01675	GLFKTLIKGAGKMLGHVAKQFLGSQGQPES	30	Dermaseptin-3 (DStar 03; Frogs, amphibians, animals)	P84923	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa tarsius (Brownbelly leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial peptide, active against the Gram-positive bacterium S. aureus, the Gram-negative bacteria E. coli and P. aeruginosa, and the yeasts C. albicans and P. brasiliensis. Has hemolytic activity.
Tissue specificity: Expressed by the skin glands."	[Swiss_Prot Entry P84923]Gram-positive bacteria: Staphylococcus aureus, Enterococcus faecalis;##Gram-neagtive bacterium: Pseudomonas aeruginosa;##Fungi: Candida albicans and Paracoccidioides brasiliensis.	[Ref:PubMed ID is not available]100% hemolytic activity at 128 µg/ml	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2006) to UniProtKB.	Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.	Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).	
DRAMP01676	ALWKDILKNAGKAALNEINQIVQ	23	Dermaseptin-4 (DStar 04; Frogs, amphibians, animals)	P84924	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa tarsius (Brownbelly leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antimicrobial peptide, active against the Gram-positive bacterium S. aureus, the Gram-negative bacteria E. coli and P. aeruginosa. Has hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	[Swiss_Prot Entry P84924]Gram-positive bacteria: Staphylococcus aureus, Enterococcus faecalis;##Gram-neagtive bacterium: Pseudomonas aeruginosa.	[Ref:PubMed ID is not available]5% hemolytic activity at 128 µg/ml	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2006) to UniProtKB.	Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.	Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).	
DRAMP01677	GLWSKIKEAAKTAGKAAMGFVNEMV	25	Dermaseptin-5 (DStar 05; Frogs, amphibians, animals)	P84925	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa tarsius (Brownbelly leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial peptide, active against the Gram-positive bacterium S. aureus, the Gram-negative bacteria E. coli and P. aeruginosa, and the yeasts C. albicans and P. brasiliensis. Has hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	[Swiss_Prot Entry P84925]Gram-positive bacteria: Staphylococcus aureus, Enterococcus faecalis;##Gram-neagtive bacterium: Pseudomonas aeruginosa;##Fungi: Candida albicans and Paracoccidioides brasiliensis.	[Ref:PubMed ID is not available]15% hemolytic activity at 128 µg/ml	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2006) to UniProtKB.	Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.	Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).	
DRAMP01678	ALWKNMLKGIGKLAGQAALGAVKTLVGA	28	Dermaseptin-6 (DStar 06; Frogs, amphibians, animals)	P84926	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa tarsius (Brownbelly leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antimicrobial peptide, active against the Gram-positive bacterium S. aureus, and the Gram-negative bacteria E. coli and P. aeruginosa. Has hemolytic activity.
Tissue specificity: Expressed by the skin glands."	[Swiss_Prot Entry P84926]Gram-positive bacteria: Staphylococcus aureus, Enterococcus faecalis;##Gram-neagtive bacterium: Pseudomonas aeruginosa.	[Ref:PubMed ID is not available]Show hemolytic activity at 612 µM	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2006) to UniProtKB.	Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.	Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).	
DRAMP01679	ALWKDVLKKIGTVALHAGKAALGAVADTISQ	31	Dermaseptin-7 (DStar 07; Frogs, amphibians, animals)	P84927	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa tarsius (Brownbelly leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antimicrobial peptide, active against the Gram-positive bacterium S. aureus, and the Gram-negative bacteria E. coli and P. aeruginosa. Has hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	[Swiss_Prot Entry P84927]Gram-positive bacteria: Staphylococcus aureus, Enterococcus faecalis;##Gram-neagtive bacterium: Pseudomonas aeruginosa.	[Ref:PubMed ID is not available]Show hemolytic activity at 286 µM	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2006) to UniProtKB.	Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.	Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).	
DRAMP01680	SLRGFLKGVGTALAGVGKVVADQFDKLLQAGQ	32	Dermaseptin-8 (DStar 08; Frogs, amphibians, animals)	P84928	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa tarsius (Brownbelly leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive bacterium S. aureus, and the Gram-negative bacteriun E. coli. Has hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	[Swiss_Prot Entry P84928]Gram-positive bacteria: Staphylococcus aureus;##Gram-neagtive bacterium:  Escherichia coli.	[Ref:PubMed ID is not available]Show hemolytic activity at 432 µM	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2006) to UniProtKB.	Prates M.V, Jardim D.P, Silva L.P, Gordo M, Leite J.R.S.A, Figueredo R.C.R, Amaral A.C, Felipe M.S.S, Bloch C. Jr.	Dermaseptins and phylloseptins from Phyllomedusa tarsius (Amphibia).	
DRAMP01681	GLWSKIKTAGKEAAKAAAKAAGKAALNAVSEAI	33	Dermaseptin-S6 (DS6; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14599726	Regul Pept. 2003 Nov 15;116(1-3):147-154.	Chen T, O'Rourke M, Orr DF, Coulter DJ, Hirst DG, Rao P, Shaw C.	Kinestatin: a novel bradykinin B2 receptor antagonist peptide from the skin secretion of the Chinese toad, Bombina maxima.	
DRAMP01682	GLRSKIWLWVLLMIWQESNKFKKM	24	Dermaseptin-S9 (DS9; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa sauvagei (South American hylid frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16401077	Biochemistry. 2006 Jan 17;45(2):468-480.	Lequin O, Ladram A, Chabbert L, Bruston F, Convert O, Vanhoye D, Chassaing G, Nicolas P, Amiche M.	Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.	
DRAMP01683	ALWKTLLKGAGKVFGHVAKQFLGSQGQPES	30	Dermaseptin-S11 (DS11; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16401077	Biochemistry. 2006 Jan 17;45(2):468-480.	Lequin O, Ladram A, Chabbert L, Bruston F, Convert O, Vanhoye D, Chassaing G, Nicolas P, Amiche M.	Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.	
DRAMP01684	GLWSKIKEAAKTAGKMAMGFVNDMV	25	Dermaseptin-S12 (DS12; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16401077	Biochemistry. 2006 Jan 17;45(2):468-480.	Lequin O, Ladram A, Chabbert L, Bruston F, Convert O, Vanhoye D, Chassaing G, Nicolas P, Amiche M.	Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.	
DRAMP01685	GLRSKIKEAAKTAGKMALGFVNDMA	25	Dermaseptin-S13 (DS13; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16401077	Biochemistry. 2006 Jan 17;45(2):468-480.	Lequin O, Ladram A, Chabbert L, Bruston F, Convert O, Vanhoye D, Chassaing G, Nicolas P, Amiche M.	Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.	
DRAMP01686	SLGSFMKGVGKGLATVGKIVADQFGKLLEA	30	Dermaseptin AA-1-1 (Frogs, amphibians, animals)	O93221	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Agalychnis annae (Blue-sided leaf frog)	Antimicrobial	Transcript level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9774745	Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.	Wechselberger C.	Cloning of cDNAs encoding new peptides of the dermaseptin-family.	
DRAMP01687	SLWSKIKEMAATAGKAALNAVTGMVNQ	27	Dermaseptin AA-3-1 (Frogs, amphibians, animals)	O93223	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Agalychnis annae (Blue-sided leaf frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9774745	Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.	Wechselberger C.	Cloning of cDNAs encoding new peptides of the dermaseptin-family.	
DRAMP01688	GMFTNMLKGIGKLAGQAALGAVKTLA	26	Dermaseptin AA-3-3 (Frogs, amphibians, animals)	O93224	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Agalychnis annae (Blue-sided leaf frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9774745	Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.	Wechselberger C.	Cloning of cDNAs encoding new peptides of the dermaseptin-family.	
DRAMP01689	GMWGSLLKGVATVVKHVLPHALSSQQS	27	Dermaseptin AA-3-4 (Frogs, amphibians, animals)	O93225	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Agalychnis annae (Blue-sided leaf frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9774745	Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.	Wechselberger C.	Cloning of cDNAs encoding new peptides of the dermaseptin-family.	
DRAMP01690	GMWSTIRNVGKSAAKAANLPAKAALGAISEAV	32	Dermaseptin AA-3-6 (Frogs, amphibians, animals)	O93226	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Agalychnis annae (Blue-sided leaf frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9774745	Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.	Wechselberger C.	Cloning of cDNAs encoding new peptides of the dermaseptin-family.	
DRAMP01691	GLVSGLLNTAGGLLGDLLGSLGSLSG	26	Dermaseptin AA-2-5 (Frogs, amphibians, animals)	O93222	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Agalychnis annae (Blue-sided leaf frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9774745	Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.	Wechselberger C.	Cloning of cDNAs encoding new peptides of the dermaseptin-family.	
DRAMP01692	ALWKTLLKKVGKVAGKAVLNAVTNMANQNEQ	31	Dermaseptin PD-2-2 (Frogs, amphibians, animals)	O93452	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Pachymedusa dacnicolor (Giant mexican leaf frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9774745	Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.	Wechselberger C.	Cloning of cDNAs encoding new peptides of the dermaseptin-family.	
DRAMP01693	GMWSKIKNAGKAAAKASKKAAGKAALGAVSEAL	33	Dermaseptin PD-3-3 (DRS-DA3; Frogs, amphibians, animals)	O93453	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Pachymedusa dacnicolor (Giant mexican leaf frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9774745	Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.	Wechselberger C.	Cloning of cDNAs encoding new peptides of the dermaseptin-family.	
DRAMP18305	KVTKSVKSIPVKI	13	Paenibacterin (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Paenibacillus thiaminolyticus OSY-SE	Antimicrobial, Antibacterial		Not found	A C15 fatty acid chain is attahced to the N-terminus of the peptide (XXL). The carboxyl-terminal Ile is connected to Thr by ester linkage (XXJ). In addition, the first and fourth K's are ornithine (represented with K). 		Comment: No comments found on DRAMP database	Broad-spectrum	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22367082	Appl Environ Microbiol. 2012 May;78(9):3156-65.	Guo Y, Huang E, Yuan C, Zhang L, Yousef AE.	Isolation of a Paenibacillus sp. strain and structural elucidation of its broad-spectrum lipopeptide antibiotic.	
DRAMP01695	GVVTDLLNTAGGLLGNLVGSLSG	23	Dermaseptin PD-3-6 (Plasticin-DA1; Frogs, amphibians, animals)	O93454	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Pachymedusa dacnicolor (Giant mexican leaf frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9774745	Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.	Wechselberger C.	Cloning of cDNAs encoding new peptides of the dermaseptin-family.	
DRAMP01696	LLGDLLGQTSKLVNDLTDTVGSIV	24	Dermaseptin PD-3-7 (Frogs, amphibians, animals)	O93455	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Pachymedusa dacnicolor (Giant mexican leaf frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9774745	Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.	Wechselberger C.	Cloning of cDNAs encoding new peptides of the dermaseptin-family.	
DRAMP01697	GMWSKIKNAGKAAKAAAKAAGKAALGAVSEAM	32	Dermaseptin-DA4 (DRS-DA4; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Pachymedusa dacnicolor (Mexican frog)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		It shows selective activity against gram-negative bacteria and not toxic to fresh rat erythrocytes. DRS-DA4 is a potent chemoattractant for human leukocytes and is devoid of hemolytic activity.	[Ref.FEBS J. 2009 Nov;276(22):6773-6786.]Gram-negative bacteria:Escherichia coli ML35p(MIC=5 µM), Escherichia coli 363 ATCC 11775(MIC=5 µM), Peudomonas aeruginosa ATCC 27853(MIC=40 µM).	[Ref. FEBS J. 2009 Nov;276(22):6773-6786.]Show no hemolytic activity against rat blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	FEBS J. 2009 Nov;276(22):6773-6786.	Auvynet C, Joanne P, Bourdais J, Nicolas P, Lacombe C, Rosenstein Y.	Dermaseptin DA4, although closely related to dermaseptin B2, presents chemotactic and Gram-negative selective bactericidal activities.	
DRAMP01699	GLWSKIKDVAAAAGKAALGAVNEALGEQ	28	Dermaseptin-H2 (Dermaseptin-like peptide 2, DMS2; Frogs, amphibians, animals)	P84937	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Thesis (2006), University of Ulster Coleraine, United Kingdom.	Thompson A.H.	A genomic/proteomic approach to isolating and identifying bioactive peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.	
DRAMP01700	GLWSTIKNVAAAAGKAALGAL	21	Dermaseptin-H3 (Dermaseptin-like peptide 3, DMS3; Frogs, amphibians, animals)	Q17UY8	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	dpp-H3	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Staphylococcus aureus, Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17553595	Peptides. 2007 Jul;28(7):1331-43.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.	
DRAMP18304	VLSIVACSSGCGSGKTAASCVETCGNRCFTNVGSLC	36	Paenicidin A (Bacteriocin)	K7TS19	Belongs to the lantibiotics family (Class I bacteriocin)	paeA	Paenibacillus polymyxa NRRL B-30509	Antimicrobial, Antibacterial, Anti-Gram+		Not found	There are three lanthionines (between residues 3-7; 8-11; 19-24) and three methyllanthionines rings (between residues 16-20; 23-28; 30-36).		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23167271	J Am Chem Soc. 2012 Dec 5;134(48):19540-3.	Lohans CT, Huang Z, van Belkum MJ, Giroud M, Sit CS, Steels EM, Zheng J, Whittal RM, McMullen LM, Vederas JC.	Structural characterization of the highly cyclized lantibiotic paenicidin A via a partial desulfurization/reduction strategy.	
DRAMP01704	SVLSTITDMAKAAGRAALNAITGLVNQ	27	Dermaseptin-C3 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Unknown	Antimicrobial 	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18644413	Peptides. 2008 Nov;29(11):2074-2082.	Amiche M, Ladram A, Nicolas P.	A consistent nomenclature of antimicrobial peptides isolated from frogs of the subfamily Phyllomedusinae.	
DRAMP01705	DLWNSIKDMAAAAGRAALNAVTGMVNQ	27	Dermaseptin-like peptide (SmDLP; Frogs, amphibians, animals)	P83914	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Schistosoma mansoni (Blood fluke)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Has hemolytic activity on human and duck erythrocytes. 	[Swiss_Prot Entry P83914]Gram-positive bacterium: Micrococcus luteus;##Yeast: Candida albicans.	[Ref:6539015]Show hemolytic activity on human and duck erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	6539015	J Parasitol. 2005 Dec;91(6):1340-1351.	Quinn GA, Heymans R, Rondaj F, Shaw C, de Jong-Brink M.	Schistosoma mansoni dermaseptin-like peptide: structural and functional characterization.	
DRAMP01706	GLLSGILNTAGGLLGNLIGSLSNGES	26	Dermaseptin-like DRP-AC-1 (Frogs, amphibians, animals)	Q800S2	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Agalychnis callidryas (Red-eyed tree frog) (Phyllomedusa callidryas)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12709067	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.	Vanhoye D, Bruston F, Nicolas P, Amiche M.	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.	
DRAMP01707	GLLSGILNSAGGLLGNLIGSLSNGES	26	Dermaseptin-like DRP-AC-2 (Frogs, amphibians, animals)	Q800S1	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Agalychnis callidryas (Red-eyed tree frog) (Phyllomedusa callidryas)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12709067	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.	Vanhoye D, Bruston F, Nicolas P, Amiche M.	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.	
DRAMP01708	SVLSTITDMAKAAGRAALNAITGLVNQGEQ	30	Dermaseptin-like DRP-AC-3 (Frogs, amphibians, animals)	Q800S0	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Agalychnis callidryas (Red-eyed tree frog) (Phyllomedusa callidryas)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12709067	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.	Vanhoye D, Bruston F, Nicolas P, Amiche M.	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.	
DRAMP01709	ALWKDLLKNVGIAAGKAVLNKVTDMVNQ	28	Dermaseptin-1 (DStomo01; Frogs, amphibians, animals)	P85523	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa tomopterna (Tiger-striped leaf frogï¼ŒPithecopus tomopternus)	Antimicrobial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2008) to UniProtKB.	de Sa Mandel S.M, Mundim N.C.C.R, Silva L.P, Prates M.V, Bloch C. Jr.	Dermaseptins and phylloseptins of Phyllomedusa (Hylidae) secretion.	
DRAMP01710	ALWKTMLKKLGTVALHAGKAALGAAADTISQGA	33	Dermaseptin DS VIII-like peptide (Frogs, amphibians, animals)	P86280	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa burmeisteri (Brazilian common walking leaf frog)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2009) to UniProtKB	Conceicao K, Klitzke C.F, Brito R.C, Andrade D.F, Junca F.A, Biondi I, Lopes-Ferreira M.	Identification of peptides from Phyllomedusa burmesteri skin secretomics by nano LC MS/MS.	
DRAMP01711	ALWKNMLKGIGKLAGKAALGAVK	23	Dermaseptin III-like peptide (Frogs, amphibians, animals)	P86281	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phyllomedusa burmeisteri (Brazilian common walking leaf frog)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2009) to UniProtKB.	Conceicao K, Klitzke C.F, Brito R.C, Andrade D.F, Junca F.A, Biondi I, Lopes-Ferreira M.	Identification of peptides from Phyllomedusa burmesteri skin secretomics by nano LC MS/MS.	
DRAMP18303	VLSIVACSSGCGSGKTAASCVETCGNRCFTNVGSLC	36	Paenicidin A (Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	paeA	Paenibacillus polymyxa NRRL B-30509	Antimicrobial, Antibacterial, Anti-Gram+		Not found	There are three lanthionines (between residues 3-7; 8-11; 19-24) and three methyllanthionines rings (between residues 16-20; 23-28; 30-36).		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23167271##24382692 	J Am Chem Soc. 2012 Dec 5;134(48):19540-3.##Chembiochem. 2014 Jan 24;15(2):243-9.  	Lohans CT, Huang Z, van Belkum MJ, Giroud M, Sit CS, Steels EM, Zheng J, Whittal RM, McMullen LM, Vederas JC.##Lohans CT, van Belkum MJ, Cochrane SA, Huang Z, Sit CS, McMullen LM, Vederas JC.	Structural characterization of the highly cyclized lantibiotic paenicidin A via a partial desulfurization/reduction strategy.##Biochemical, structural, and genetic characterization of tridecaptin A?, an antagonist of Campylobacter jejuni.	
DRAMP01713	VHLEEILLLLFFLGTISLSLCEEERDADEEENEVSGYAANVNVKRCGYKHGRANCGRG	58	OGA1 antimicrobial peptide (Frogs, amphibians, animals)	B5L172	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ databases	Wang X, Lai R.	Odorrana grahmi antimicrobial peptide cDNA sequences.	
DRAMP01714	MFTMKKSLLLLFFLGTINLSFCQEETNAEEERRDEEVAKMEEIKRGLLSGPRCGEESTMWT	61	OGF2 antimicrobial peptide (Frogs, amphibians, animals)	B5L190	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ databases	Wang X, Lai R.	Odorrana grahmi antimicrobial peptide cDNA sequences.	
DRAMP01715	MFTLKKPLLLLFFLGTINLSLCQDETNAEEERRDEEVVKMEEIKRGLLSGILGAGKHIVCGLTGCAKA	68	OGG1 antimicrobial peptide (Frogs, amphibians, animals)	B5L183	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ databases	Wang X, Lai R.	Odorrana grahmi antimicrobial peptide cDNA sequences.	
DRAMP01716	MFTLKKSLLLLFFLGTINLSLCQDVTNAEEERRDEEVAKMEEIKRGLLRPPRCGEAYSMWT	61	OGF1 antimicrobial peptide (Frogs, amphibians, animals)	B5L180	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ databases	Wang X, Lai R.	Odorrana grahmi antimicrobial peptide cDNA sequences.	
DRAMP01717	SLGSFLKGVGTTLASVGKVVSDQFGKLLQAGQ	32	Dermatoxin (Frogs, amphibians, animals)	Q9PT75, P81566	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	DRT	Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Possesses a potent antimicrobial activity against Gram-positive bacteria and less active against Gram-negative bacteria. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Highest expression in skin and to a lesser extent in brain and intestine.
Miscellaneous: The sequence shown corresponds to the dermatoxin isolated from frog skin. A variant of it is present in frog brain."	Gram-positive bacteria: Bacillus megaterium, Corynebacterium glutamicumm, Staphylococcus aureus (++);##Gram-negative bacteria: mollicutes Acholeplasma laidlawii, Spiroplasma melliferum (++); Burkholderia cepacia, Pseudomonas aeruginosa, Salmonella typhimurium and S. meliloti (+).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10880984	Eur J Biochem. 2000 Jul;267(14):4583-4592.	Amiche M, Seon AA, Wroblewski H, Nicolas P.	Isolation of dermatoxin from frog skin, an antibacterial peptide encoded by a novel member of the dermaseptin genes family.	
DRAMP01718	SLGGFLKGVGKALAGVGKVVADQFGNLLQAGQ	32	Dermatoxin-J1 (DRT-J1; Frogs, amphibians, animals)	P86621	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01719	SLGGFLKGVGKALAGVGKMVADQFGNLLQAGQ	32	Dermatoxin-J2 (DRT-J2; Frogs, amphibians, animals)	P86622	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01720	SLGGFLKGVGKVLAGVGKVVADQFGNLLEAGQ	32	Dermatoxin-J3 (DRT-J3; Frogs, amphibians, animals)	P86623	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP01722	FLAGLIGGLAKML	13	Temporin-LTe antimicrobial peptide (Frogs, amphibians, animals)	G5CKS1	Not found	Not found	Hylarana latouchii (broad-folded frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22426384	Biochimie. 2012 Jun;94(6):1317-1326.	Wang H, Yu Z, Hu Y, Yu H, Ran R, Xia J, Wang D, Yang S, Yang X, Liu J.	Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.	
DRAMP01723	FLPILGKLLSGFL	13	Temporin-TOa (Frogs, amphibians, animals)	D5MTH4	Not found	Not found	Rana tagoi okiensis (Oki brown frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Peptides. 2010,0:0-0.	Tazato S, Conlon JM, Iwamuro S.	Cloning and expression of genes enocoding antimicrobial peptides and bradykinin from the skin and brain of Oki Tago's brown frog, Rana tagoi okiensis.	
DRAMP01724	FLPILGKLLSGLL	13	Temporin-TOb (Frogs, amphibians, animals)	D5MTH5	Not found	Not found	Rana tagoi okiensis (Oki brown frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Peptides. 2010,0:0-0.	Tazato S, Conlon JM, Iwamuro S.	Cloning and expression of genes enocoding antimicrobial peptides and bradykinin from the skin and brain of Oki Tago's brown frog, Rana tagoi okiensis.	
DRAMP01725	FLPFVGNLLKGLL	13	Temporin-CG1 antimicrobial peptide (Frogs, amphibians, animals)	E1AWD7	Not found	Not found	Amolops chunganensis (Chungan torrent frog)	Antimicrobial 	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22951323	Peptides. 2012 Nov;38(1):41-53.	Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.	Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.	
DRAMP01726	FFPIVGKLLSGLF	13	Temporin-CG2 antimicrobial peptide (Frogs, amphibians, animals)	E1AWD8	Not found	Not found	Amolops chunganensis (Chungan torrent frog)	Antimicrobial 	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22951323	Peptides. 2012 Nov;38(1):41-53.	Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.	Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.	
DRAMP01727	FLPIVGKLLSGLF	13	Temporin-CG3 antimicrobial peptide (Frogs, amphibians, animals)	E1AWE0	Not found	Not found	Amolops chunganensis (Chungan torrent frog)	Antimicrobial 	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22951323	Peptides. 2012 Nov;38(1):41-53.	Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.	Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.	
DRAMP01728	FLPILGNLLNGLL	13	Temporin-CG4 antimicrobial peptide (Frogs, amphibians, animals)	E1AWE1	Not found	Not found	Amolops chunganensis (Chungan torrent frog)	Antimicrobial 	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22951323	Peptides. 2012 Nov;38(1):41-53.	Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.	Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.	
DRAMP01729	FLPFVGNLLNGLL	13	Temporin-CG5 antimicrobial peptide (Frogs, amphibians, animals)	E1B232	Not found	Not found	Amolops chunganensis (Chungan torrent frog)	Antimicrobial 	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22951323	Peptides. 2012 Nov;38(1):41-53.	Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.	Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.	
DRAMP02857	ILPWKWPWWPWRR	13	Indolicidin (Cathelicidin-4; mammals, animals)	P33046, A3KN14	Belongs to the cathelicidin family	CATHL4	Bos taurus (Bovine) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	No secondary structure	The backbone structure in DPC, well defined between residues 3 and 11, is extended, with two half-turns at residues Lys-5 and Trp-8. The backbone structure in SDS, well defined between residues 5 and 11, is also extended, but lackes the bend in the C-terminal half. Indolicidin in complexes with DPC has a central hydrophobic core composed of proline and tryptophan, which is bracketed by positively charged regions near the peptide termini	1G8C, 1G89 resolved by NMR.	"Function: Potent microbicidal activity; active against Staphylococcus aureus, Escherichia coli and Candida albicans.
Tissue specificity: Large granules of neutrophils.
PTM: Contains two disulfide bonds and C-terminal amidation."	[Ref.12074933] Gram-positive bacterium: Staphylococcus aureus (MIC=0.003%);##Gram-negative bacterium: Escherichia coli (MIC=0.007%);##Fungus: Candida albicans (MIC=0.015%)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1537821##11123901##12074933	J Biol Chem. 1992 Mar 5;267(7):4292-4295.##Biochemistry. 2000 Dec 26;39(51):15765-74.##Life Sci. 2002 Jul 5;71(7):747-50.	Selsted ME, Novotny MJ, Morris WL, Tang YQ, Smith W, Cullor JS.##Rozek A, Friedrich CL, Hancock RE.##Kowalska K, Carr DB, Lipkowski AW.	Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils.##Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles.##Direct antimicrobial properties of substance P.	
DRAMP01741	LLPIVGNLLNSLL	13	Temporin-D (Frogs, amphibians, animals)	P56919	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix	Not found		Relative to Temporins A, B, and H, temporin D showed the greatest hemolytic activity. Thus, although it lacks antibacterial activity, this peptide may also plays a role in host defense by showing toxicity to eukaryotes) (Eur. J Biochem 2000; 267: 1447-1454). 	[Ref.9022710]Gram-positive bacterium: Bacillus megaterium	[Ref.10691983]55% hemolysis at 10 μM, 90% hemolysis at 20 μM, 95% hemolysis at 40μM, 100% hemolysis at 60 μM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9022710##10691983	Eur J Biochem. 1996 Dec 15;242(3):788-792.##Eur J Biochem. 2000 Mar;267(5):1447-54.	Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.##Mangoni ML, Rinaldi AC, Di Giulio A, Mignogna G, Bozzi A, Barra D, Simmaco M.	Temporins, antimicrobial peptides from the European red frog Rana temporaria.##Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin.	
DRAMP02819	GLLKRIKTLL	10	Anoplin (Insects, arthropods, invertebrates, animals)	P0C005	Not found	Not found	Anoplius samariensis (Solitary wasp)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	The peptide adopts a random coil structure in water and tends to fold into an 	2MJQ,2MJR,2MJS,2MJT	[Ref.29614317]Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.##[Ref.25316570]Function: Exhibits potent activity in stimulating degranulation from rat peritoneal mast cells but not from RBL-2H3 cells. Exhibits broad-spectrum antimicrobial activity against both Gram-negative bacteriapositive and Gram-negative bacterianegative bacteria. Has no hemolytic activity towards human erythrocytes.	[Ref.29614317]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=26 μg/mL);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=13 μg/mL);##Fungi: Candida albicans ATCC 10231 (MIC=19.5 μg/mL).##[Ref.25316570]Gram-positive bacteria : Staphylococcus aureus (MIC=64 μg/ml), bacillus subtilis (MIC=32 μg/ml);##Gram-negative bacteria : Escherichia coli (MIC=64 μg/ml), Peudomonas eruginosa (MIC=32 μg/ml).##[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=200 μg/ml), Bacillus subtilis DELTA (MIC=300 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=200 μg/ml), Pseudomonas aeruginosa PAO (MIC=100 μg/ml), Zymomonas mobilis 10988 (MIC=40 μg/ml);##Fungi : Candida parapsilosis (MIC=15 μg/ml)	[Ref.25316570] 1% hemolysis at 12.5 μg/ml , 2% hemolysis at 25 μg/ml , 1% hemolysis at 50 μg/ml , 1.5% hemolysis at 100 μg/ml , 1.5% hemolysis at 200 μg/ml against mice red blood cells.##[Ref.27862650]3% hemolysis at  100μg/ml , 6% hemolysis at 200μg/ml , 10% hemolysis at 300μg/ml , 12% hemolysis at 500μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29614317##25316570#27862650	Peptides. 2018 Jun;104:7-14.##J Pept Sci. 2014 Dec;20(12):945-51. doi: 10.1002/psc.2705.##J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.	Salas RL, Garcia JKDL, Miranda ACR, Rivera WL, Nellas RB, Sabido PMG.##Yang Wang, Jianbo Chen, Xin Zheng, Xiaoli Yang, Panpan Ma,Ying Cai,Bangzhi Zhangb,and Yuan Chen##Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis	Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin.##Design of novel analogues of short antimicrobial peptide anoplin with improved antimicrobial activity##Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin	
DRAMP04395	AMVGT	5	EP3 (Earthworm,animals)	No entry found	Belongs to the antibacterial vermipeptides family (AVPF)	Not found	Eisenia foetida (Common brandling worm)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.	[Ref.European Journal of Soil Biology, 2007, 43 S127-S134] Gram-negative bacteria: Pseudomonas pyocyanea (IC=12.58 μg/ml), Acinetobacter baumanii (IC=12.58 μg/ml), Klebsiella terrigena (IC=12.58 μg/ml);## Gram-positive bacteria: Enterococcus gallinarum (IC=12.58 μg/ml), Enterococcus faecalis (IC=25.68 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	European Journal of Soil Biology, 2007, 43:S127-S134	C Wang, Z Suna, X Zhang, G Xu## Ito Y, Yoshikawa A, Hotani T, Fukuda S, Sugimura K, Imoto T.	A novel antimicrobial vermipeptide family from earthworm Eisenia fetida.	
DRAMP04394	AMVSS	5	EP2 (Earthworm,animals)	No entry found	Belongs to the antibacterial vermipeptides family (AVPF)	Not found	Eisenia foetida (Common brandling worm)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.	[Ref.European Journal of Soil Biology, 2007, 43 S127-S134] Gram-negative bacteria: Pseudomonas pyocyanea (IC=11.4 μg/ml), Acinetobacter baumanii (IC=11.4 μg/ml), Klebsiella terrigena (IC=11.4 μg/ml);##Gram-positive bacteria: Enterococcus gallinarum (IC=11.4 μg/ml), Enterococcus faecalis (IC=22.8 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	European Journal of Soil Biology, 2007, 43:S127-S134.	C Wang, Z Suna, X Zhang, G Xu## Ito Y, Yoshikawa A, Hotani T, Fukuda S, Sugimura K, Imoto T.	A novel antimicrobial vermipeptide family from earthworm Eisenia fetida.	
DRAMP02396	ACSAG	5	OEP3121 (EP5-1;earthworm,animals)	P84182	Not found	Not found	Eisenia foetida (Common brandling worm) (Common dung-worm)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Protein level	Not found	Not found		Function: Displays antimicrobial activity. The effects of EP5 on HeLa cells lead to the cancer cell's apoptosis and break down. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15253156##PubMed ID is not available	Acta Biochim Biophys Sin (Shanghai). 2004 Apr;36(4):297-302.##European Journal of Soil Biology, 2007, 43:S127-S134.	Liu YQ, Sun ZJ, Wang C, Li SJ, Liu YZ.##C Wang, Z Suna, X Zhang, G Xu.	Purification of a novel antibacterial short peptide in earthworm Eisenia foetida.##A novel antimicrobial vermipeptide family from earthworm Eisenia fetida.	
DRAMP01747	ILPIIGKILSTIF	13	Temporin-1CEe (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana chensinensis (Chinese brown frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Temporin-1CEe showed higher antimicrobial activity against Gram-positive bacteria: than Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21303203	Zoolog Sci. 2011 Feb;28(2):112-117.	Zhao J, Sun Y, Li Z, Su Q.	Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.	
DRAMP02242	GLMDVFKGAAKNLLASALDKIRCKVTKC	28	Ranatuerin-2PRa (frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pirica (Hokkaido frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: activity against reference strains of Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella pneumoniae) and Gram-positive (Staphlococcus aureus) bacteria but displayed relatively low hemolytic activity. 	[Ref.15003829] Gram-negative bacterium: Escherichia coli(MIC=13μM);## Gram-positive bacterium: Staphylococcus aureus(MIC>100μM);## Yeast: Candida albicans(MIC=100μM)	[Ref.15003829] HC50=150μM against human erythrocytes	Cyclic	Free	Cyclization (Cys23 and Cys28)	Disulfide bond between Cys23 and Cys28.	L	No cytotoxicity information found	Not found	15003829	Regul Pept. 2004 May 15;118(3):135-141.	Conlon JM, Sonnevend A, Patel M, Al-Dhaheri K, Nielsen PF, Kolodziejek J, Nowotny N, Iwamuro S, P	A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.	
DRAMP01749	FLPIVGRLISGLL	13	Temporin-1ARa (Temporin 1ARa; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana areolata (crawfish frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12429503	Biochim Biophys Acta 2002; 1601: 55-63.	Ali M et al Conlon JM.	Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata	
DRAMP01756	MFTLKKSLLLLFFLGTNISLSLCEEERDADQEERRDDPEERDVEVEKRFLFPIASMLGKVLGK	65	Temporin-2-RA2 peptide (Frogs, amphibians, animals)	E3SZL6	Not found	Not found	Odorrana andersonii (golden crossband frog)	Antimicrobial 	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2009) to the EMBL/GenBank/DDBJ databases	Yang X, Liang X, Zhang Y, Lee WH.	The highest antimicrobial peptides diversity, skin antimicrobial peptides peptidomics of Amphibian, Rana andersonii.	
DRAMP01757	MFTLKKPLLLLFFLGTINLSLCEEEERDIDQEERRDDPEERDVEVEKRFLFPLAKASFLGKVLGK	65	Temporin-1-RA1 peptide (Frogs, amphibians, animals)	E3SZL5	Not found	Not found	Odorrana andersonii (golden crossband frog)	Antimicrobial 	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2009) to the EMBL/GenBank/DDBJ databases	Yang X, Liang X, Zhang Y, Lee WH.	The highest antimicrobial peptides diversity, skin antimicrobial peptides peptidomics of Amphibian, Rana andersonii.	
DRAMP01758	FLSAITSILGKFF	13	Temporin-1SPa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana septentrionalis (mink frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15556063	Comp. Biochem. Physiol. C 2004; 139: 31-38.	Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog Rana septentrionalis.	
DRAMP01760	FLPIIGQLLSGLL	13	Temporin-1AUa (Temporin 1AUa; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana aurora (Northern red-legged frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: It lacks basic residues and only showed weak activity against bacteria or very weak effect on erythrocytes. Therefore, other functions other than antimicrobial should be sought.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15325526	Dev Comp Immunol 2005; 29: 83-90.	Conlon JM et al Jouenne T.	host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.	
DRAMP01761	FLPILGNLLSGLL	13	Temporin-PRa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pretiosa (Oregon spotted frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21295070	Dev Comp Immunol. 2011 Jun;35(6):644-649.	Conlon JM, Mechkarska M, Emanahmed, Coquet L, Jouenne T, JÃ©rÃ´meleprince, Vaudry H, Hayes MP, Padgett-Flohr G.	Host defense peptides in skin secretions of the Oregon spotted frog Ranapretiosa: implications for species resistance to chytridiomycosis.	
DRAMP01762	FLPIITNLLGKLL	13	Temporin-PRb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pretiosa (Oregon spotted frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21295070	Dev Comp Immunol. 2011 Jun;35(6):644-649.	Conlon JM, Mechkarska M, Emanahmed, Coquet L, Jouenne T, JÃ©rÃ´meleprince, Vaudry H, Hayes MP, Padgett-Flohr G.	Host defense peptides in skin secretions of the Oregon spotted frog Ranapretiosa: implications for species resistance to chytridiomycosis.	
DRAMP01763	NFLDTLINLAKKFI	14	Temporin-PRc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pretiosa (Oregon spotted frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21295070	Dev Comp Immunol. 2011 Jun;35(6):644-649.	Conlon JM, Mechkarska M, Emanahmed, Coquet L, Jouenne T, JÃ©rÃ´meleprince, Vaudry H, Hayes MP, Padgett-Flohr G.	Host defense peptides in skin secretions of the Oregon spotted frog Ranapretiosa: implications for species resistance to chytridiomycosis.	
DRAMP01767	FLPALAGIAGLLGKIFGK	18	Temporin-She (Frogs, amphibians, animals)	D5GRW4	Belongs to the frog skin active peptide family (Brevinin subfamily)	preproTemp-She	Pelophylax saharicus (Sahara frog) (Rana saharica)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J. Biol. Chem. 0:0-0(2010).	Abbassi F, Lequin O, Piesse C, Goasdoue N, Foulon T, Nicolas P, Ladram A.	A. Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide.	
DRAMP01770	AVDLAKIANIANKVLSSLFGK	21	Temporin-1SKc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sakuraii (Japanese brown frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17174009	Peptides. 2007 Mar;28(3):505-514.	Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.	Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.	
DRAMP01772	FLPLIGKILGTILGK	15	Temporin-1Ob (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana ornativentris (Japanese mountain brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147973	Peptides. 2007 Mar;28(3):524-532.	Ohnuma A, Conlon JM, Yamaguchi K, Kawasaki H, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.	Antimicrobial peptides from the skin of the Japanese mountain brown frog Rana ornativentris: evidence for polymorphism among preprotemporin mRNAs.	
DRAMP01774	FLPLLASLFSGLF	13	Temporin-1Od (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana ornativentris (Japanese mountain brown frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17147973	Peptides. 2007 Mar;28(3):524-532.	Ohnuma A, Conlon JM, Yamaguchi K, Kawasaki H, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.	Antimicrobial peptides from the skin of the Japanese mountain brown frog Rana ornativentris: evidence for polymorphism among preprotemporin mRNAs.	
DRAMP01778	FLPAALAGIGGILGKLFGK	19	Temporin-1Sd (Frogs, amphibians, animals)	D4YWD0	Belongs to the frog skin active peptide family (Brevinin subfamily)	preproTemp-1Sd	Pelophylax saharicus (Sahara frog) (Rana saharica)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J. Biol. Chem. 2010;0:0-0.	Abbassi F, Lequin O, Piesse C, Goasdoue N, Foulon T, Nicolas P, Ladram A.	A. Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide.	
DRAMP18302	SCNCVCGFCCSCSPSA	16	GE2270A(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Nonomuraea	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Elongation Factor Tu  (EF-Tu)	PubMed ID is not available	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1997 JAN 13;230(2):320-326.	Mohrle VG,Tieleman LN,Kraal B.	Elongation Factor Tu1 of the Antibiotic GE2270A Producer Planobispora rosea Has an Unexpected Resistance Profile against EF-Tu Targeted Antibiotics.	
DRAMP01786	FLPIVGRLISGIL	13	Temporin-CPb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates capito (New World frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19635516	Peptides. 2009 Oct;30(10):1775-1781.	Conlon JM, Meetani MA, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.	Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae).	
DRAMP01792	SIFPAIVSFLSKFL	14	Temporin 1HKa (Temporin-1HKa; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana heckscheri 	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17005262	Regul Pept 2007; 138: 87-93.	Conlon JM et al Moler PE.	Peptidomic analysis of skin secretions from Rana heckscheri and Rana okaloosae provides insight into phylogenetic relationships among frogs of the Aquarana species group. 	
DRAMP01793	FLPFLKSILGKIL	13	Temporin-1OLa (Temporin 1OLa; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana okaloosae (Florida bog frog)	Antimicrobial 	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17005262	Regul Pept 2007; 138: 87-93.	Conlon JM et al Moler PE.	Peptidomic analysis of skin secretions from Rana heckscheri and Rana okaloosae provides insight into phylogenetic relationships among frogs of the Aquarana species group. 	
DRAMP01794	FLPFFASLLGKLL	13	Temporin-1OLb (Temporin 1OLb; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana okaloosae (Florida bog frog)	Antimicrobial 	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17005262	Regul Pept 2007; 138: 87-93.	Conlon JM et al Moler PE.	Peptidomic analysis of skin secretions from Rana heckscheri and Rana okaloosae provides insight into phylogenetic relationships among frogs of the Aquarana species group. 	
DRAMP01795	SILPTIVSFLSKVF	14	Temporin-1Ga (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grylio (North American pig frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10828493	Regul Pept. 2000 Jun 30;90(1-3):53-60.	Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.	Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.	
DRAMP01796	SILPTIVSFLSKFL	14	Temporin-1Gb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grylio (North American pig frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10828493	Regul Pept. 2000 Jun 30;90(1-3):53-60.	Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.	Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.	
DRAMP01797	SILPTIVSFLTKFL	14	Temporin-1Gc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grylio (North American pig frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10828493	Regul Pept. 2000 Jun 30;90(1-3):53-60.	Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.	Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.	
DRAMP01798	FILPLIASFLSKFL	14	Temporin-1Gd (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grylio (North American pig frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10828493	Regul Pept. 2000 Jun 30;90(1-3):53-60.	Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.	Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.	
DRAMP01799	ILPILGNLLNGLL	13	Temporin-1PRa (Temporin 1PRa; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pirica (Hokkaido frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: It shows only very weak antimicrobial and hemolytic activity.	[Ref.15003829]Gram-positive bacteria: Staphylococcus aureus (MIC>100 µM);##Gram-negative bacteria:Escherichia coli (MIC>100 µM);##Fungi:Candida albicans (MIC>100 µM)	[Ref:15003829]HC50>300 μM against washed human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15003829	Regul. Pept 2004; 118: 135-141.	Conlon JM et al Pal T.	A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.	
DRAMP01800	ILPILGNLLNSLL	13	Temporin-1PRb (Temporin 1PRb; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pirica (Hokkaido frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15003829	Regul. Pept 2004; 118: 135-141.	Conlon JM et al Pal T.	A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.	
DRAMP01801	FIGPIISALASLFG	14	Temporin-1DYa (Frogs, amphibians, animals)	P0C5X6	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Active against the Gram-positive bacteria: S. aureus and Gram-negative bacteria E.coli. Tissue specificity: Expressed by the skin glands. PTM: Glycine amide at position 14.	Gram-positive bacterium: Staphylococcus aureus (MIC>60 µM);##Gram-negative bacterium: Escherichia coli (MIC>60 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17688900	Toxicon. 2007 Nov;50(6):746-756.	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.	Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.	
DRAMP01802	FFGSVLKLIPKIL	13	Temporin-PTa (Frogs, amphibians, animals)	P0C8U2	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana picturata (Malaysian fire frog) (Hylarana picturata)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix	Not found		Function: Has antibacterial activity against the Gram-positive bacteria: S. aureus ATCC 25923 and the Gram-negative bacteria E.coli ATCC 25726. Tissue specificity: Expressed by the skin glands. PTM: Leucine amide at position 13.	Gram-positive bacterium: Staphylococcus aureus ATCC 25923;##Gram-negative bacterium: Escherichia coli ATCC 25726	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473.	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01803	VLPLVGNLLNDLL	13	Temporin-CDYa (Frogs, amphibians, animals)	B3VZU3	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Function: Antimicrobial activity againist Gram-negative bacteria and Gram-positive bacteria. Tissue specificity: Expressed by the skin glands. PTM: Leucine amide at position 13.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19539775	Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178. 	Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.	Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.	
DRAMP01804	ILPILAPLIGGLL	13	Temporin-CDYb (Brevinin-1CDYb; Frogs, amphibians, animals)	B3VZU4	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Has low activity against the Gram-positive bacteria: S. aureus and Gram-negative bacteria E.coli. Has weak hemolytic activity against human erythrocytes. Tissue specificity: Expressed by the skin glands. PTM: Leucine amide at position 13.	[Swiss_Prot Entry B3VZU4]Gram-positive bacterium: Staphylococcus aureus (MIC>100 µM);##Gram-negative bacterium: Escherichia coli (MIC>100 µM).	[Ref:19539775]HC50=180 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19539775	Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178. 	Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.	Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.	
DRAMP01805	FIGPLISALASLFKG	15	Temporin-CDYd (Frogs, amphibians, animals)	B3VZU5	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Function: Antimicrobial activity againist Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19539775	Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178. 	Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.	Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.	
DRAMP01806	FIGPIISALASLFGG	15	Temporin-CDYe (Frogs, amphibians, animals)	B3VZU6	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Function: Antimicrobial activity againist Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19539775	Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178. 	Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.	Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.	
DRAMP01810	FLPIIAKVLSGLL	13	Temporin-1BYa (Frogs, amphibians, animals)	P84116	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana boylii (Foothill yellow-legged frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Antibacterial activity against the Gram-positive bacteria: S. aureus. Tissue specificity: Expressed by the skin glands. PTM: Leucine amide at position 13.	Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14531844	J Pept Res. 2003 Nov;62(5):207-213.	Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, PÃ¡l T, Rollins-Smith LA.	Isolation of peptides of the brevinin-3 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.	
DRAMP01813	FLPVIAGLLSKLF	13	Temporin 1Ec (Temporin-1Ec; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta 	Unknown	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14499272	Peptides 2003; 24: 955-961.	Ali MF et al Conlon JM.	Characterization of novel antimicrobial peptides fromthe skins of frogs of the Rana esculenta complex.	
DRAMP18352	ATYYGNGVYCNKQECWVDWNKASKEIGKIIVNGWVQHGPWAPR	43	Durancin GL (bacteriocin)	No entry found	Belongs to the class IIa bacteriocin.	Not found	Enterococcus durans	Antimicrobial, Antibacterial		Not found	Not found		Fuction: Plasmid-encoded bacteriocin is active against the indicator strain E. durans 41D-S1, L. monocytogenes strains, including nisin-resistant L. monocytogenes NR30.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22493306	Microbiology. 2012 Jun;158(Pt 6):1523-32.	Du L, Somkuti GA, Renye JA Jr.	Molecular analysis of the bacteriocin-encoding plasmid pDGL1 from Enterococcus durans and genetic characterization of the durancin GL locus.	
DRAMP18301	SCTTCECSCSCSS	13	nocathiacin I(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Nocardia sp. ATCC202099	Antimicrobial, Antibacterial		Not found	NOC-I shares the overall similarity in structure to the naturally occurring but un-glycosylated analogue, nosiheptide (NOS). NOC-I is further functionalized by the methoxylation of a dehydrothreonine in the macrocyclic core,N-hydroxylation ofthe indole moiety, rigid constraining of these two systems viaan etherbondinadditiontotwoesterlinkages,andappendingofa rare sugar moiety, 2,4,6-tri-deoxy-3-methyl-4-N,N-dimethylaminoL-hexose.		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20473441	Mol Biosyst. 2010 Jul;6(7):1180-5. 	Ding Y, Yu Y, Pan H, Guo H, Li Y, Liu W.	Moving posttranslational modifications forward to biosynthesize the glycosylated thiopeptide nocathiacin I in Nocardia sp. ATCC202099.	
DRAMP01387	GLLSGILGAGKHIVCGLSGPCQSLNRKSSDVEYHLAKC	38	Odorranain-P2a (OdP2a; Frogs, amphibians, animals)	A6MBR1	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Odorranain-P2a exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Has no hemolytic activity against red cell.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=6.25 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.12 μg/ml), Bacillus subtilis (MIC=12.5 μg/ml).##Yeast: Candida albicans (MIC=3.12 μg/ml).	[Ref:17272268]Non-hemolytic activity against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04210	GIGKHVGKALKGLKGLLKGLGES	24	Adepantin-1 (Automatically Designed Peptide antibacterial 1; synthetic)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Helix	Not found		Function: Antibacterial activity against Gram negative bacteria. Has hemolytic activity.	[Ref.19947578] Gram-negative bacteria: Escherichia coli ATCC (MIC=2-4 μM), Pseudomonas aeruginosa (MIC=16 μM).	[Ref.19947578] HC50>800 μM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membranes	19947578	J Chem Inf Model. 2009 Dec;49(12):2873-82	Juretić D, Vukicević D, Ilić N, Antcheva N, Tossi A.	Computational design of highly selective antimicrobial peptides.	
DRAMP01824	ILPLVGNLLNDLL	13	Temporin-1Ja (Frogs, amphibians, animals)	P83307	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana japonica (Japanese reddish frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antibacterial activity against the Gram-negative bacteria E. coli and the Gram-positive bacteria: S. aureus. Tissue specificity: Expressed by the skin glands. PTM: Leucine amide at position 13. 	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11835990	Peptides. 2002 Mar;23(3):419-425.	Isaacson T, Soto A, Iwamuro S, Knoop FC, Conlon JM.	Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica.	
DRAMP01825	HFLGTLVNLAKKIL	14	Temporin-1DRa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana aurora draytonii (California red-legged frog)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16307827	Peptides. 2006 Jun;27(6):1305-1312.	Conlon JM, Al-Ghafari N, Coquet L, Leprince J, Jouenne T, Vaudry H, Davidson C.	Evidence from peptidomic analysis of skin secretions that the red-legged frogs, Rana aurora draytonii and Rana aurora aurora, are distinct species.	
DRAMP01826	RIGVLLARLPKLFSLFKLMGKKV	23	RV-23 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana aurora draytonii (California red-legged frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Alpha helix	Not found		[Ref.27271216]Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=12.5 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=6.25 μM), Klebsiella pneumoniae (MIC=6.25 μM)	[Ref.27271216] 60% hemolysis at 20 μM , 90% hemolysis at 40 μM , 100% hemolysis at 60 μM , 100% hemolysis at 100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16307827##27271216	Peptides. 2006 Jun;27(6):1305-1312.##Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.	Conlon JM, Al-Ghafari N, Coquet L, Leprince J, Jouenne T, Vaudry H, Davidson C.##Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji	Evidence from peptidomic analysis of skin secretions that the red-legged frogs, Rana aurora draytonii and Rana aurora aurora, are distinct species.##Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity	
DRAMP01740	LLPILGNLLNGLL	13	Temporin-C (Frogs, amphibians, animals)	P56918	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacteria.
PTM: Leucine amide at position 13.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9022710	Eur J Biochem. 1996 Dec 15;242(3):788-792.	Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.	Temporins, antimicrobial peptides from the European red frog Rana temporaria.	
DRAMP01126	ILGPVISKIGGVLGGLLKNL	20	Maximin-H4 (Toads, amphibians, animals)	P83084, Q58T61, Q58T60	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Shows strong hemolytic activity. 	[Ref.11835991] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=12 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=6 μg/ml), Bacillus pyocyaneus CMCCB 1010 (MIC=12 μg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=6 μg/ml).	[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.	Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01125	ILGPVLGLVGNALGGLIKKI	20	Maximin-H3 (Toads, amphibians, animals)	P83083, Q58T42, Q58T44, Q58T45, Q58T52, Q58T55, Q58T62, Q58T68, Q58T70	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Shows strong hemolytic activity.	[Ref.11835991] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=20 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=10 μg/ml), Bacillus pyocyaneus CMCCB 1010 (MIC=20 μg/ml);##Fungi: Candida albicans ATCC 2002 (MIC=5 μg/ml).	[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP18299	WNDTGKDADGAEY	13	Taromycin A (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	marine actinomycete Saccharomonospora sp. CNQ-490 	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Taromycin A differs from Daptomycin only in serveal places: 1) residue T11 is an D-Ala; 2) W is chlorinated at position 6; 3)  Kny is also chlorinated at position 4; and 4) it carried an octa-2,4-dienoyl lipid side chain. Warning: the sequence is a close mimic of the natural counterpart.  For example, kynurenine-13 (Kyn) is represented by Y here.		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24449899	Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1957-62.	Yamanaka K, Reynolds KA, Kersten RD, Ryan KS, Gonzalez DJ, Nizet V, Dorrestein PC, Moore BS.	Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A.	
DRAMP18298	CCSCSCSTCTCTCTCASSAATKM	23	Listeriolysin S(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Listeria monocytogenes F2365	Unknown		Not found	Not found		Comment: A haemolytic and cytotoxic factor, designated Listeriolysin S, which contributes to virulence of the pathogen. This haemolysin is only induced under oxidative stress conditions and contributes to murine virulence and in survival in polymorphonuclear neutrophils.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18787690	PLoS Pathog. 2008 Sep 12;4(9):e1000144.	Cotter PD, Draper LA, Lawton EM, Daly KM, Groeger DS, Casey PG, Ross RP, Hill C.	Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes.	
DRAMP01835	GFRDVLKGAAKEFVKTVAGHIAN	23	Ascaphin-1M (Frogs, amphibians, animals)	No entry found	Not found	Not found	A. montanus (North America inland frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18983817	Biochim Biophys Acta. 2009 Aug;1788(8):1556-1563.	Conlon JM, Kolodziejek J, Nowotny N.	Antimicrobial peptides from the skins of North American frogs.	
DRAMP01836	GFREVLKGAAKAFVKTVAGHIANI	24	Ascaphin-3M (Frogs, amphibians, animals)	No entry found	Not found	Not found	A. montanus (North America inland frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18983817	Biochim Biophys Acta. 2009 Aug;1788(8):1556-1563.	Conlon JM, Kolodziejek J, Nowotny N.	Antimicrobial peptides from the skins of North American frogs.	
DRAMP01837	GFKDWIKGAAKKLIKTVASNIANQ	24	Ascaphin-4M (Frogs, amphibians, animals)	No entry found	Not found	Not found	A. montanus (North America inland frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18983817	Biochim Biophys Acta. 2009 Aug;1788(8):1556-1563.	Conlon JM, Kolodziejek J, Nowotny N.	Antimicrobial peptides from the skins of North American frogs.	
DRAMP01838	GIKDWIKGAAKTLIKTVASHIANQ	24	Ascaphin-5M (Frogs, amphibians, animals)	No entry found	Not found	Not found	A. montanus (North America inland frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18983817	Biochim Biophys Acta. 2009 Aug;1788(8):1556-1563.	Conlon JM, Kolodziejek J, Nowotny N.	Antimicrobial peptides from the skins of North American frogs.	
DRAMP01839	GFKDWIKSAAKKLIKTVASNIANQ	24	Ascaphin-7M (Frogs, amphibians, animals)	No entry found	Not found	Not found	A. montanus (North America inland frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18983817	Biochim Biophys Acta. 2009 Aug;1788(8):1556-1563.	Conlon JM, Kolodziejek J, Nowotny N.	Antimicrobial peptides from the skins of North American frogs.	
DRAMP01841	GFRDVLKGAAKQFVKTVAGHIANI	24	Ascaphin-2 (Frogs, amphibians, animals)	P0CJ26	Belongs to the ascaphin family	Not found	Ascaphus truei (Coastal tailed frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.	[Ref.15207717]Gram-negative bacterium: Escherichia coli	[Ref.15207717]Not found	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15207717	Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.	Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.	The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.	
DRAMP01843	GFKDWIKGAAKKLIKTVAANIANQ	24	Ascaphin-4 (Frogs, amphibians, animals)	P0CJ28	Belongs to the ascaphin family	Not found	Ascaphus truei (Coastal tailed frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.	[Ref.15207717]Gram-negative bacterium: Escherichia coli	[Ref.15207717]Not found	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15207717	Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.	Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.	The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.	
DRAMP01845	GFKDWIKGAAKKLIKTVASSIANE	24	Ascaphin-6 (Frogs, amphibians, animals)	P0CJ30	Belongs to the ascaphin family	Not found	Ascaphus truei (Coastal tailed frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Tissue specificity: Expressed by the skin glands. 
Caution: May represent an artifactually modified form of ascaphin-7 arising from hydrolysis during the purification procedure."	[Ref.15207717]Gram-negative bacterium: Escherichia coli	[Ref.15207717]Not found	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15207717	Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.	Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.	The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.	
DRAMP01848	GFKKLLKGAAKALVKTVLF	19	[D4k]ascaphin-8	No entry found	Not found	Not found	Ascaphus truei (Coastal tailed frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22374306	Peptides. 2012 Apr;34(2):275-282.	Popovic S, Urbán E, Lukic M, Conlon JM.	Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.	
DRAMP01850	RGFMDTAKNVAKNMAVTLLDNLKCKITKAC	30	Odorranain-F-RA1 antimicrobial peptide (Frogs, amphibians, animals)	D2K8I2, D2K8E4	Not found	Not found	Rana andersonii (Golden crossband frog)	Not found	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Submitted (NOV-2009) to the EMBL/GenBank/DDBJ database	Yang X, Liang X, Zhang Y, Lee W.-H.	The highest antimicrobial peptide diversity, skin antimicrobialpeptide peptidomics of amphibian, Rana andersonii.	
DRAMP18297	ISVCITVC	8	Patellamide D(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Lissoclinum patella	Unknown		Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2724305	J Med Chem. 1989 Jun;32(6):1349-54.	Degnan BM, Hawkins CJ, Lavin MF, McCaffrey EJ, Parry DL, van den Brenk AL, Watters DJ.	New cyclic peptides with cytotoxic activity from the ascidian Lissoclinum patella.	
DRAMP18296	WXAVFXNMAKYMFKSQSKXVVIGFLVAS	28	Leucocin H beta(Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Leuconostoc MF215B	Antimicrobial, Antibacterial, Anti-Gram+		Not found	No sequence homology to other known bacteriocins could be demonstrated. It also appeared that the two peptides themselves shared little or no sequence homology.		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10387116	Curr Microbiol. 1999 Jul;39(1):43-8.	Blom H, Katla T, Holck A, Sletten K, Axelsson L, Holo H.	Characterization, production, and purification of leucocin H, a two-peptide bacteriocin from Leuconostoc MF215B.	
DRAMP01853	FLPLIAGLAANFLPKLFCKITKKC	24	Brevinin-1-RAB2 antimicrobial peptide (Frogs, amphibians, animals)	D2K8D2, D2K8G7	Not found	Not found	Rana andersonii (golden crossband frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Submitted (OCT-2009) to the EMBL/GenBank/DDBJ databases.	Yang X, Liang X, Zhang Y, Lee W.-H.	The highest antimicrobial peptide diversity, skin antimicrobialpeptides peptidomics of Amphibian, Rana andersonii.	
DRAMP01854	GFLDTLKNMALNAAKGAGGSVLKALFCKLFKTC	33	Brevinin-2-RA21 antimicrobial peptide (Frogs, amphibians, animals)	D2K8J5	Not found	Not found	Rana andersonii (golden crossband frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Submitted (NOV-2009) to the EMBL/GenBank/DDBJ database	Yang X, Liang X, Zhang Y, Lee W.-H.	The highest antimicrobial peptide diversity, skin antimicrobialpeptide peptidomics of amphibian, Rana andersonii.	
DRAMP01855	GLLDTFKNLALNAAKSAGVSVLNSLSCKLFKTC	33	Brevinin-2E-OG4 antimicrobial peptide (Frogs, amphibians, animals)	A6MAT9, A6MAU0	Not found	Not found	Odorrana grahami (Yunnanfu frog )	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP18295	WXIGVTGAALGTGKGVKNVI	20	Leucocin H alpha(Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Leuconostoc MF215B	Antimicrobial, Antibacterial, Anti-Gram+		Not found	No sequence homology to other known bacteriocins could be demonstrated. It also appeared that the two peptides themselves shared little or no sequence homology.		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10387116	Curr Microbiol. 1999 Jul;39(1):43-8.	Blom H, Katla T, Holck A, Sletten K, Axelsson L, Holo H.	Characterization, production, and purification of leucocin H, a two-peptide bacteriocin from Leuconostoc MF215B.	
DRAMP01857	GLLDTLKNMAINAAKDAGVSVLNTLSCKLSKTC	33	Brevinin-2-RA20 antimicrobial peptide (Frogs, amphibians, animals)	D2K8J4	Not found	Not found	Rana andersonii (golden crossband frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Submitted (NOV-2009) to the EMBL/GenBank/DDBJ database	Not found	The highest antimicrobial peptide diversity, skin antimicrobialpeptide peptidomics of amphibian, Rana andersonii.	
DRAMP01858	GLLDTLKNMAINAAKGAGVSVLNALSCKLSKTC	33	Brevinin-2-RA6 antimicrobial peptide (Frogs, amphibians, animals)	D2K8C6, D2K8D4, D2K8D8	Not found	Not found	Odorrana andersonii (golden crossband frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Submitted (OCT-2009) to the EMBL/GenBank/DDBJ databases	Not found	The highest antimicrobial peptide diversity, skin antimicrobialpeptide peptidomics of amphibian, Rana andersonii.	
DRAMP01859	GLLDTLKNMATNAAKGAGVSVLKALSCKLFKTC	33	Brevinin-2-RA22 antimicrobial peptide (Frogs, amphibians, animals)	D2K8J6	Not found	Not found	Odorrana andersonii (golden crossband frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Submitted (NOV-2009) to the EMBL/GenBank/DDBJ database	Not found	The highest antimicrobial peptide diversity, skin antimicrobialpeptide peptidomics of amphibian, Rana andersonii.	
DRAMP01860	MFTFKKSMLLLFFLGTINLSLCEQERNADEEERRDDEDKRDVEVEKRFLGSLLGLVGKIVPTLICKISKKC	71	Brevinin-1RTa antimicrobial peptide (Frogs, amphibians, animals)	D1MIZ4	Not found	Not found	Amolops ricketti (Chinese sucker frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22100518	Peptides. 2012 Jan;33(1):27-34.	Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.	ntification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).	
DRAMP01861	MFTSKKSLLVLFFLGTISLSFCEEERNADEDDGEMTEEVKRGILDTLKEFGKTAAKGIAQSLLSTASCKLAKTC	74	Brevinin-2RTb antimicrobial peptide (Frogs, amphibians, animals)	D1MIZ8	Not found	Not found	Amolops ricketti (Chinese sucker frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22100518	Peptides. 2012 Jan;33(1):27-34.	Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.	ntification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).	
DRAMP01862	MFTSKKSMLLLFFLGTINLSLCEQERNADEEERRDDEDKRDVEVEKRFLGSLLGLVGKVVPTLFCKISKKC	71	Brevinin-1RTb antimicrobial peptide (Frogs, amphibians, animals)	D1MIZ6	Not found	Not found	Amolops ricketti (Chinese sucker frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22100518	Peptides. 2012 Jan;33(1):27-34.	Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.	ntification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).	
DRAMP01863	MFTTKKSLLVLFFLGTISLSFCEEERNADEDDGEMTEEEKRGLMSTLKDFGKTAAKEIAQSLLSTASCKLAKTC	74	Brevinin-2RTa antimicrobial peptide (Frogs, amphibians, animals)	D1MIZ7	Not found	Not found	Amolops ricketti (Chinese sucker frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22100518	Peptides. 2012 Jan;33(1):27-34.	Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.	ntification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).	
DRAMP01864	SFLTSFKDMAIKVAKDAGVNILNTISCKIFKTC	33	Brevinin-2-RA13 antimicrobial peptide (Frogs, amphibians, animals)	D2K8C8	Not found	Not found	Rana andersonii (golden crossband frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Submitted (NOV-2009) to the EMBL/GenBank/DDBJ database	Not found	The highest antimicrobial peptide diversity, skin antimicrobialpeptide peptidomics of amphibian, Rana andersonii.	
DRAMP01865	MFTMKKSLLLLFFLGTISLSLCEQERDAEEEEGSENGAEDIKLNRVVKCSYRLGSPDSRCN	61	Odorranain-A-RA1 antimicrobial peptide (Frogs, amphibians, animals)	D2K8C3	Not found	Not found	Odorrana andersonii (golden crossband frog)	Antibiotic	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Submitted (OCT-2009) to the EMBL/GenBank/DDBJ databases	Yang X, Liang X, Zhang Y, Lee WH.	The highest antimicrobial peptides diversity, skin antimicrobial peptides peptidomics of Amphibian, Rana andersonii.	
DRAMP01866	MFTLKKSLLLLFFLGTINLSLCEQERDADEEERRDDDEMDVEVEKRFLPLFLPKIICAITKKC	63	Mantzorumin-D1 antimicrobial peptide (Frogs, amphibians, animals)	E1B245	Not found	Not found	Amolops mantzorum	Antibiotic	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Submitted (AUG-2010) to the EMBL/GenBank/DDBJ databases	Wang H, Liu J.	Antimicrobial peptides from amphibian skin of Amolops mantzorum.	
DRAMP01867	MFTLKKSMLLLFFLGTINLSLCEQERDAEEERRDDEDKRDVEVEKRFVLGVVTKLLPSLFCMITKKC	67	Hainanensisin-A4 antimicrobial peptide (Frogs, amphibians, animals)	E7EKF2	Not found	Not found	Amolops hainanensis (Hainan sucker frog) 	Antibiotic	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Submitted (DEC-2010) to the EMBL/GenBank/DDBJ databases	Wang H, Liu J.	Antimicrobial peptides from amphibian skin of Amolops hainanensis.	
DRAMP01868	MFTFKKSMLLLFFLGTINLSLCEQERNADEEERRDDPDETNVEVEKRFLPLLAGVVANFLPQIICKIARKC	71	Brevinin-1E-RTa antimicrobial peptide (Frogs, amphibians, animals)	D1MIZ4	Not found	Not found	Amolops ricketti (Chinese sucker frog)	Antimicrobial, Antibiotic	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22100518	Peptides. 2012 Jan;33(1):27-34.	Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.	Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).	
DRAMP01871	FLPIIASVAAKLIPSIVCRITKKC	24	Brevinin-1SPc (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana septentrionalis (mink frog)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes.	No MICs found in DRAMP database	[Ref.15556063]HC50=3 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15556063	Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.	Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).	
DRAMP01874	VIPFVASVAAEMMPHVYCAASRKC	24	Brevinin-1Eba (Frogs, amphibians, animals)	No entry found	Not found	Transcript level	Rana esculenta	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163497	J Biol Chem. 1994 Apr 22;269(16):11956-61.	Simmaco M, Mignogna G, Barra D, Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP01882	MFTLKKTLLLIFVLGTISLSLCEQERGADEDEGEAVEEIKRGLLDSVKEGLKKVAGQLLDTLKCKISGCTPA	72	Pleurain-M1 antimicrobial peptide (Frogs, amphibians, animals)	B5L1L3	Not found	Not found	Rana pleuraden (Yunnan pond frog) 	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-583.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	
DRAMP01883	MRMSIKCFAVIFVAFAFFLGQISRAEACIPDGGRCHESDPGPGCCSGFCYRERNWKDGDCRKRP	64	Salivary gland antimicrobial peptide 1 	Q3LTD6	Not found	Not found	Bradysia hygida	Antimicrobial	Predicted	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases	da Silva JAC, Zanarotti GM, Gallina AP, de Almeida JC.	The innate immune system of larvae and pupae of Bradysia hygida (Diptera, Sciaridae) is provided with an additional external preventive mechanism of defense, which is regulated in development.	
DRAMP01884	MFTMKKSLLLLFFLGMISLSLCQDERGADEDDGGEMTEEEKRGAFGNFLKGVAKKAGLKILSIAQCKLSGTC	72	Nigroain-F antimicrobial peptide  (Frogs, amphibians, animals)	C0ILA3	Not found	Not found	Rana nigrovittata (Black-striped frog) (Hylarana nigrovittata)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Genomics. 2010,95:66-71.	Ma Y., Liu C., Liu X., Wu J., Yang H., Wang Y., Li J., Yu H., Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP01894	FFPIVAGVAGQVLKKIFCTISKKC	24	Brevinin 1Pg (Frogs, amphibians, animals)	A9CBI5	Not found	Not found	Rana pipiens (Northern leopard frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17938991	J Mol Evol. 2007 Nov;65(5):605-615.	Tennessen JA, Blouin MS.	Selection for antimicrobial peptide diversity in frogs leads to gene duplication and low allelic variation.	
DRAMP01895	FTSKKSMLLFFFLGTISLSLCQ	22	Brevinin-2CE (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana chensinensis (Chinese brown frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21303203	Zoolog Sci. 2011 Feb;28(2):112-117.	Zhao J, Sun Y, Li Z, Su Q.	Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.	
DRAMP01901	GILDKLKEFGISAARGVAQSLLNTASCKLAKTC	33	Brevinin-2CG1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Amolops chunganensis	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Primarily active against Gram-positive bacteria. Also highly active against Gram-negative P. faecalis X29 and S. rubidaea.	Gram-negative bacteria: P. faecalis X29, S. rubidaea.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22951323	Peptides. 2012 Nov;38(1):41-53.	Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.	Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.	
DRAMP01902	GLLDTFKNMALNAAKSAGVSVLNSLSCKLSKTC	33	Brevinin-2E-OG7 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grahami (Yunnanfu frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01903	FLPLLAGLAANFLPKLFCKITKKC	24	Brevinin-1E-OG1 (brevinin-1E-OG3; Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grahami (Yunnanfu frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01904	GLLDTFKNLALNAPKSAGVSVLNSLSCKLSKTC	33	Brevinin-2E-OG2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grahami (Yunnanfu frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01905	FLPLLAGLAANFLPKLFCKITRKC	24	Brevinin-1E-OG5 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grahami (Yunnanfu frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01906	FLPFLAGLAANFLPKLFCKITRKC	24	Brevinin-1E-OG4 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grahami (Yunnanfu frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP01907	FFPLIAGLAANFLPQILCKIARKC	24	Antimicrobial peptide brevinin-1E-OG7 (Frogs, amphibians, animals)	C3RTH8	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grahami (Yunnanfu frog)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Ma Y, Lai R, Wu J, Li J.	Antimicrobial peptide from skin of Odorrana grahami.	
DRAMP01908	GILDTLKNLAKTAGKGILKSLVNTASCKLSGQC	33	Brevinin 2Ta (Frogs, amphibians, animals)	P82268	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana temporaria (European common frog)	Antimicrobial	Transcript level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Problely contains one disulfide bond 27-33. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.	Simmaco M, Miele R, Mangoni M.L, Barra D.	A cDNA clone encoding brevinin 2Ta from Rana temporaria.	
DRAMP01915	GVLGTVKNLLIGAGKSAAQSVLKTLSCKLSNDC	33	Brevinin-2GRb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grahami (Asian frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	[Ref.16621155] LC50=180 μM against human erythrocytes. 	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	16621155##17272268	Peptides. 2006 Sep;27(9):2111-2117.##Mol Cell Proteomics. 2007 May;6(5):882-894. 	Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.##Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.##Anti-infection peptidomics of amphibian skin.	
DRAMP01916	GVIIDTLKGAAKTVAAELLRKAHCKLTNSC	30	Brevinin-2GU (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana guntheri (Asian frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19332309	J Biosci Bioeng. 2009 Apr;107(4):460-463.	Zhou QF, Li MY, Li CW.	Cloning and expression of a novel insulin-releasing peptide, brevinin-2GU from Escherichia coli.	
DRAMP01917	FFPNVASVPGQVLKKIFCAISKKC	24	Brevinin-1PLa (Frogs, amphibians, animals)	B6CPR5	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (Pickerel frog)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Inhibit the growth of Batrachochytrium dendrobatidis (Bd) (MIC=50 µM), a fungus that might have played a role in killing many frogs.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18799711##11087945	Mol Biol Evol. 2008 Dec;25(12):2669-2680.##Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	Tennessen JA, Blouin MS.##Basir YJ, Knoop FC, Dulka J, Conlon JM.	Balancing selection at a frog antimicrobial peptide locus: fluctuating immune effector alleles? ##Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP01923	FFPAIFRLVAKVVPSIICSVTKKC	24	Brevinin-1R (Frogs, amphibians, animals)	P86027	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Pelophylax ridibundus (Marsh frog) (Rana ridibunda)	Antimicrobial 	Protein level	Not found	Not found		Function: Antimicrobial peptide. Tissue specificity: Expressed by the skin glands. PTM: Contains one disulfide bond 18-24.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342##18855342	Mass Spectrom. 2007;4:79-88.##Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Artemenko K.A, Samgina T.Y, Lebedev A.T, Doyle J.R, Llewellyn L.E, Bilusich D, Bowie J.H.##Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	Host-defence peptides from the skin secretion of the European marsh frog Rana ridibunda.##De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP01924	FLPAIFRMAAKVVPTIICSITKKC	24	Brevinin-1Ea (Frogs, amphibians, animals)	P40835	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (European frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.	[Swiss_Prot Entry P40835]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref.8163497]LC50=0.5 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163497	J Biol Chem. 1994 Apr 22;269(16):11956-11961.	Simmaco M, Mignogna G, Barra D, Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP01925	VIPFVASVAAEMQHVYCAASRKC	23	Brevinin-1Eb (Frogs, amphibians, animals)	P40836	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (European frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.	[Swiss_Prot Entry P40836]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref.8163497]LC50=0.5 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163497	J Biol Chem. 1994 Apr 22;269(16):11956-11961.	Simmaco M, Mignogna G, Barra D, Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP01926	FLPLLAGLAANFFPKIFCKITRKC	24	Brevinin-1Ec (Frogs, amphibians, animals)	P86150	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana ridibunda (Laughing frog) (Marsh frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.	[Swiss_Prot Entry P86150]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref.18855342]show hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP01927	GILDTLKNLAISAAKGAAQGLVNKASCKLSGQC	33	Brevinin-2Ea (Frogs, amphibians, animals)	P40837	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (Edible frog) (Pelophylax esculentus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity 	[Swiss_Prot Entry P40837]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref.8163497]LC50>100 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163497	J Biol Chem. 1994 Apr 22;269(16):11956-11961.	Simmaco M, Mignogna G, Barra D, Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP01928	GILDTLKNLAKTAGKGALQGLVKMASCKLSGQC	33	Brevinin-2Eb (Frogs, amphibians, animals)	P40838	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (Edible frog) (Pelophylax esculentus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity 	[Swiss_Prot Entry P40838]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref.8163497]LC50>100 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163497	J Biol Chem. 1994 Apr 22;269(16):11956-11961.	Simmaco M, Mignogna G, Barra D, Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP01929	GILLDKLKNFAKTAGKGVLQSLLNTASCKLSGQC	34	Brevinin-2Ec (Frogs, amphibians, animals)	P40839, P84842	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (Edible frog) (Pelophylax esculentus) (Rana saharica (Sahara frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity 	[Swiss_Prot Entry P40839]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref.8163497]LC50>100 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163497##16394170	J Biol Chem. 1994 Apr 22;269(16):11956-11961.##J Endocrinol. 2006 Jan;188(1):1-9.	Simmaco M, Mignogna G, Barra D, Bossa F.##Marenah L, Flatt PR, Orr DF, Shaw C, Abdel-Wahab YH.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.##Skin secretions of Rana saharica frogs reveal antimicrobial peptides esculentins-1 and -1B and brevinins-1E and -2EC with novel insulin releasing activity.	
DRAMP01930	VIPFVASVAAEMMHHVYCAASKRC	24	Brevinin-1Ed (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (Korea)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Alpha helix 	Not found		This is a narrow spectrum AMP from the frog.	Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15232222	Mol Cells. 2004 Jun 30;17(3):469-476.	Won HS, Kim SS, Jung SJ, Son WS, Lee B, Lee BJ.	Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea.	
DRAMP01931	GILDSLKNLAKNAGQILLNKASCKLSGQC	29	Brevinin-2Ed (Frogs, amphibians, animals)	P40840	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (Edible frog) (Pelophylax esculentus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity 	[Swiss_Prot Entry P40840]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref.8163497]LC50>100 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163497	J Biol Chem. 1994 Apr 22;269(16):11956-11961.	Simmaco M, Mignogna G, Barra D, Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP01932	GIFDKLKNFAKGVAQSLLNKASCKLSGQC	29	Brevinin-2Ee (Frogs, amphibians, animals)	P40841	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (Edible frog) (Pelophylax esculentus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity 	[Swiss_Prot Entry P40841]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref.8163497]LC50>100 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8163497	J Biol Chem. 1994 Apr 22;269(16):11956-11961.	Simmaco M, Mignogna G, Barra D, Bossa F.	Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP01936	GLWNTKLEAGLLFAMGKLDLKRCLKAGGC	29	Brevinin-2Ek (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta complex	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		"Function: Potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli (By similarity).
Sequence similarity: This peptide shows limited amino acid sequence similarity to the homologous exon gene products that encode the N-terminal flanking peptides of preprocaerulein, preproxenopsin, and preprolevitide."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14499272	Peptides. 2003 Jul;24(7):955-961.	Ali MF, Knoop FC, Vaudry H, Conlon JM.	Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.	
DRAMP01945	FLPLVRGAAKLIPSVVCAISKRC	23	Brevinin-1SE (Frogs, amphibians, animals)	P85056	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sevosa (Dusky gopher frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Mast cell degranulating peptide. Causes histamine release from rat peritoneal mast cells in vitro.	Gram-negative bacterium: Escherichia coli K12;##Gram-positive bacterium: Micrococcus luteus NCT C2665.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16386333	Peptides. 2006 Jun;27(6):1313-1319.	Graham C, Richter SC, McClean S, O'Kane E, Flatt PR, Shaw C.	Histamine-releasing and antimicrobial peptides from the skin secretions of the dusky gopher frog, Rana sevosa.	
DRAMP01946	GLFNVFKGLKTAGKHVAGSLLNQLKCKVSGGC	32	Brevinin-20a (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana Ornativentris (Japanese mountain brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11892844	J Pept Res. 2001 Nov;58(5):349-356.	Kim JB et al Conlon JM.	Antimicrobial peptides from the skin of the Japanese mountain brown frog, Rana ornativentris.	
DRAMP01947	GIFNVFKGALKTAGKHVAGSLLNQLKCKVSGEC	33	Brevinin-20b (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana Ornativentris (Japanese mountain brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11892844	J Pept Res. 2001 Nov;58(5):349-356.	Kim JB et al Conlon JM.	Antimicrobial peptides from the skin of the Japanese mountain brown frog, Rana ornativentris.	
DRAMP18293	KGGSGVIHTISHEVIYNSWNFVFTCCS	27	Bacteriocin J46 (Bacteriocin)	P71449	Belongs to the lantibiotics family (Class I bacteriocin)	lcp J	Lactococcus lactis J46	Unknown		Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8588891	Lett Appl Microbiol. 1996 Jan;22(1):76-9.	Huot E, Barrena-Gonzalez C, Petitdemange H.	Comparative effectiveness of nisin and bacteriocin J46 at different pH values.	
DRAMP18294	ALQFIQNTASGALYYNTKTHKYQYQQTSGA	30	lactococcin Z(Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	lczA	Lactococcus lactis QU 7	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Lactococcin Z showed homology to lactococcins A, B and M.		Comment: No comments found on DRAMP database	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26093857	Probiotics Antimicrob Proteins. 2015 Sep;7(3):222-31. 	Ishibashi N, Seto H, Koga S, Zendo T, Sonomoto K.	Identification of Lactococcus-Specific Bacteriocins Produced by Lactococcal Isolates, and the Discovery of a Novel Bacteriocin, Lactococcin Z.	
DRAMP01952	FMGGLIKAATKALPAAFCAITKKC	24	Brevinin-1PTb (Frogs, amphibians, animals)	P0C8T2	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana picturata (Malaysian fire frog) (Hylarana picturata)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923;##Gram-negative bacterium: Escherichia coli ATCC 25726.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01954	GLLDTLKNMAINAAKGAGQSVLNTLSCKLSKTC	33	Brevinin-2HSb (Frogs, amphibians, animals)	P0C8T0	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana hosii (Hose's rock frog) (Rana hosii)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923;##Gram-negative bacterium: Escherichia coli ATCC 25726.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01958	GFLDSFKNAMIGVAKSAGKTALNTLACKIDKTC	33	Brevinin-2PTd (Frogs, amphibians, animals)	P0C8T6	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana picturata (Malaysian fire frog) (Hylarana picturata)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33."	Gram-positive bacterium: Staphylococcus aureus ATCC 25923;##Gram-negative bacterium: Escherichia coli ATCC 25726.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys27 and Cys33)	Disulfide bond between Cys27 and Cys33.	L	No cytotoxicity information found	Not found	18621071	Toxicon. 2008 Sep 1;52(3):465-473. 	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.	Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).	
DRAMP01960	FLPILASLAAKFGPKLFCLVTKKC	24	Brevinin-1BYa (Frogs, amphibians, animals)	P84111	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana boylii (Foothill yellow-legged frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has hemolytic activity.	[Ref.14531844]Gram-positive bacterium: Staphylococcus aureus(MIC=2 µM);##Gram-negative bacterium: Escherichia coli(MIC=17 µM);##Yeast: Candida albicans(MIC=3 µM)	[Ref.14531844]HC50=4 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14531844	J Pept Res. 2003 Nov;62(5):207-213.	Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, PÃ¡l T, Rollins-Smith LA.	Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.	
DRAMP01961	FLPILASLAAKLGPKLFCLVTKKC	24	Brevinin-1BYb (Frogs, amphibians, animals)	P84112	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana boylii (Foothill yellow-legged frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has hemolytic activity.	[Ref.14531844]Gram-positive bacterium: Staphylococcus aureus(MIC=4 µM);##Gram-negative bacterium: Escherichia coli(MIC=16 µM);##Yeast: Candida albicans(MIC=16 µM).	[Ref.14531844]HC50=4 µM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14531844	J Pept Res. 2003 Nov;62(5):207-213.	Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, PÃ¡l T, Rollins-Smith LA.	Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.	
DRAMP01962	FLPILASLAATLGPKLLCLITKKC	24	Brevinin-1BYc (Frogs, amphibians, animals)	P84113	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana boylii (Foothill yellow-legged frog)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans (weak activity).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14531844	J Pept Res. 2003 Nov;62(5):207-213.	Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, PÃ¡l T, Rollins-Smith LA.	Isolation of peptides of the brevinin-3 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.	
DRAMP01964	FLPIIAGVAAKVLPKIFCAISKKC	24	Brevinin-1BLb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates blairi (leopard frog)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19254736	Toxicon. 2009 Jun;53(7-8):699-705.	Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.	Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.	
DRAMP01966	FLPVIAGVAANFLPKLFCAISKKC	24	Brevinin-1Ya (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates yavapaiensis (North America leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.19254736] Gram-positive bacteria : Staphylococcus aureus(MIC=3 μM);##Gram-negative bacteria : Escherichia coli(MIC=50 μM);##Fungi : Candida albicans(MIC=12 μM)	[Ref.19254736] LC50=18 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19254736	Toxicon. 2009 Jun;53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.	Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.	Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.	
DRAMP01967	FLPIIAGAAAKVVQKIFCAISKKC	24	Brevinin-1Yb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates yavapaiensis (North America leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.19254736] Gram-positive bacteria : Staphylococcus aureus(MIC=3 μM);##Gram-negative bacteria : Escherichia coli(MIC=25 μM);##Fungi : Candida albicans(MIC=3 μM)	[Ref.19254736] LC50=16 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19254736	Toxicon. 2009 Jun;53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.	Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.	Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.	
DRAMP01972	FLPLLPSALPSFLCLVFKKC	20	Brevinin-1ZHc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana zhenhaiensis (Chinese brown frog)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22943778	Zoolog Sci. 2012 Sep;29(9):553-558.	Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.	Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.	
DRAMP01973	FLPLLLSALPSFSCLVFKKC	20	Brevinin-1ZHd (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana zhenhaiensis (Chinese brown frog)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22943778	Zoolog Sci. 2012 Sep;29(9):553-558.	Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.	Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.	
DRAMP01975	VIPFVASVAAEMMQHVYCAASRRC	24	Brevinin-1Ra (Frogs, amphibians, animals)	P86028	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Pelophylax ridibundus (Marsh frog) (Rana ridibunda)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342##18280749	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.##J Am Soc Mass Spectrom. 2008 Apr;19(4):479-487.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.##Samgina TY, Artemenko KA, Gorshkov VA, Poljakov NB, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.##Oxidation versus carboxamidomethylation of S-S bond in ranid frog peptides: pro and contra for de novo MALDI-MS sequencing.	
DRAMP01976	GIMDTLKNLAKTAGKGALQSLLNHASCKLSGQC	33	Brevinin-2Eg (Frogs, amphibians, animals)	P86154	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Pelophylax ridibundus (Marsh frog) (Rana ridibunda)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.	[Swiss_Prot Entry P86154]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species	[Ref.18855342]show hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP18292	FKKKKRNIGTFVFFAIALFCTVMFAYLLLTNQYVPIDYNVPRYA	44	LsbA(Bacteriocin)	O68888	Belongs to the class IId bacteriocin	lsbA	Lactococcus lactis 	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive(narrow)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12801935	J Biol Chem. 2003 Sep 5;278(36):34291-8.	Gajic O, Buist G, Kojic M, Topisirovic L, Kuipers OP, Kok J.	Novel mechanism of bacteriocin secretion and immunity carried out by lactococcal multidrug resistance proteins.	
DRAMP01978	KLKNFAIGVAQSLLNKASCKLSGQC	25	Brevinin-2R (Frogs, amphibians, animals)	P85095	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Pelophylax ridibundus (Marsh frog) (Rana ridibunda)	Antimicrobial, Antibacterial, Anti-cancer	Protein level	Not found	Not found		Function: Cytotoxicity towards malignant cells, including Jurkat (T-cell leukemia), BJAB (B-cell lymphoma), HT29/219, SW742 (colon carcinomas), L929 (fibrosarcoma), MCF-7 (breast adenocarcinoma), A549 (lung carcinoma), acts via the activation of the lysosomal-mitochondrial death pathway and autophagy-like cell death. Does not show significant hemolytic activity. Tissue specificity: Expressed by the skin glands. PTM: contains one disulfide bond 19-25.	[Swiss_Prot Entry P85095]Cytotoxic to cancer cells, acts via the activation of the lysosomal-mitochondrial death pathway and autophagy-like cell death	[Ref.18494941]2.5% hemolytic activity at 200 μg/ml against sheep erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18494941	Cell Mol Med. 2008 Jun;12(3):1005-1022.	Ghavami S, Asoodeh A, Klonisch T, Halayko AJ, Kadkhoda K, Kroczak TJ, Gibson SB, Booy EP, Naderi-Manesh H, Los M.	Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway.	
DRAMP01979	GILDSLKNFAKDAAGILLKKASCKLSGQC	29	Brevinin-2Ra (Frogs, amphibians, animals)	P86022	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Pelophylax ridibundus (Marsh frog) (Rana ridibunda)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide. (By similarity)
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 23-29."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP01980	GLMSTLKGAATNAAVTLLNKLQCKLTGTC	29	Brevinin-2Rb (Frogs, amphibians, animals)	P86023	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Pelophylax ridibundus (Marsh frog) (Rana ridibunda)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide. (By similarity)
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 23-29."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP01981	GLMSTLKGAATNVAVTLLNKLQCKLTGTC	29	Brevinin-2Rc (Frogs, amphibians, animals)	P86024	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Pelophylax ridibundus (Marsh frog) (Rana ridibunda)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide. (By similarity)
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 23-29."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP01982	GILDSLKNLAKNAAQILLNKASCKLSGQC	29	Brevinin-2Rd (Frogs, amphibians, animals)	P86025	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Pelophylax ridibundus (Marsh frog) (Rana ridibunda)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide. (By similarity)
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 23-29."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP18291	LAMVKYYGNGVSCNWRKHSCKKGLSVDWVYFGLLHNLGALRWYQHR	46	Garviecin LG34(Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	Lactococcus garvieae LG34	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Not found		Garviecin LG34 showed resistance to heat and low pH, and was sensitive to proteolytic enzymes but not to lipase and amylase.	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Food Control. 2015 Apr;50:896-900.	Gao YR,Li DP,Liu S,Zhang LY.	Garviecin LG34, a novel bacteriocin produced by Lactococcus garvieae isolated from traditional Chinese fermented cucumber.	
DRAMP01984	FLPLIASVAANLAPKIICKITKTC	24	Brevinin-1HS2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Huia schmackeri (Chinese piebald odorous frog)	Antimicrobial 	Not found	Not found	Not found		"Function: Antimicrobial peptide homologs.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18423796	Peptides. 2008 Aug;29(8):1456-1460.	Quan Z, Zhou M, Chen W, Chen T, Walker B, Shaw C.	Novel brevinins from Chinese piebald odorous frog (Huia schmackeri) skin deduced from cloned biosynthetic precursors.	
DRAMP01985	GLWDTIKQAGKKIFLSVLDKIRCKVAGGC	29	Brevinin-2HS1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Huia schmackeri (Chinese piebald odorous frog)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Not found	Not found	Not found		"Function: Antimicrobial peptide homologs.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18423796	Peptides. 2008 Aug;29(8):1456-1460.	Quan Z, Zhou M, Chen W, Chen T, Walker B, Shaw C.	Novel brevinins from Chinese piebald odorous frog (Huia schmackeri) skin deduced from cloned biosynthetic precursors.	
DRAMP01987	SILGTVKDLLIGAGKSAALSVLKGLSCKLSKDC	33	Brevinin-2HS3 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Huia schmackeri (Chinese piebald odorous frog)	Antimicrobial 	Not found	Not found	Not found		"Function: Antimicrobial peptide homologs.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18423796	Peptides. 2008 Aug;29(8):1456-1460.	Quan Z, Zhou M, Chen W, Chen T, Walker B, Shaw C.	Novel brevinins from Chinese piebald odorous frog (Huia schmackeri) skin deduced from cloned biosynthetic precursors.	
DRAMP01988	FFGTALKIAANVLPTAICKILKKC	24	Brevinin-1LTa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana latouchii (Chinese frog fauna)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Tissue specificity: Expressed by the skin glands.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrance	19022312	Peptides. 2009 Feb;30(2):273-282.	Wang H, Lu Y, Zhang X, Hu Y, Yu H, Liu J, Sun J.	The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae).	
DRAMP01989	FFGTALKIAANILPTAICKILKKC	24	Brevinin-1LTb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana latouchii (Chinese frog fauna)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		"This peptide differs from Brevinin-1LTa by only one residue (I vs. V). This conservative change allows to predict that this peptide has all the activities of Brevinin-1LTa.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrance	19022312	Peptides. 2009 Feb;30(2):273-282.	Wang H, Lu Y, Zhang X, Hu Y, Yu H, Liu J, Sun J.	The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae).	
DRAMP01991	FFGSVLKVAAKVLPAALCQIFKKC	24	Brevinin-1LT2 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Hylarana latouchii (Chinese broad-folded frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19340924	Biochimie. 2009 Apr;91(4):540-547.	Wang H, Yan X, Yu H, Hu Y, Yu Z, Zheng H, Chen Z, Zhang Z, Liu J.	Isolation, characterization and molecular cloning of new antimicrobial peptides belonging to the brevinin-1 and temporin families from the skin of Hylarana latouchii (Anura: Ranidae).	
DRAMP01992	FLPLVRVAAKLIPSVVCAISKRC	23	Brevinin-1CPa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates capito (North American frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: Antimicrobial peptides.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19635516	Peptides. 2009 Oct;30(10):1775-1781.	Conlon JM, Meetani MA, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.	Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae).	
DRAMP01993	FLPVLARLAVKFLPSIVCAATKKC	24	Brevinin-1Wa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates capito (the New World frog)	Antimicrobial 	Not found	Not found	Not found		Function: Antimicrobial peptides.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19635516	Peptides. 2009 Oct;30(10):1775-1781. 	Conlon JM, Meetani MA, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.	Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae).	
DRAMP18289	KRKKHRCRVYNNGMPTGMYRWC	22	Bactofencin A (Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	Not found	Lactobacillus salivarius DPC6502	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24169573	MBio. 2013 Oct 29;4(6):e00498-13. 	O'Shea EF, O'Connor PM, O'Sullivan O, Cotter PD, Ross RP, Hill C.	Bactofencin A, a new type of cationic bacteriocin with unusual immunity.	
DRAMP18290	IGGALGNALNGLGTWANMMNGGGFVNQWQVYANKGKINQYRPY	43	Garvicin A (Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	Not found	Lactococcus garvieae 21881	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive(certain)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23666326	Appl Environ Microbiol. 2013 Jul;79(14):4336-46.	Maldonado-Barrag	Garvicin A, a novel class IId bacteriocin from Lactococcus garvieae that inhibits septum formation in L. garvieae strains.	
DRAMP18287	MSYEKLNNEELSKILGGNGINWGAVAGSCASGAVIGAAFGNPLTGCVANSAFSFSWQAFKNRPRPKKIA	69	Blp1b(Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Lactobacillus salivarius BGHO1	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22739096	Int J Antimicrob Agents. 2012 Aug;40(2):127-34. 	Busarcevic M, Dalgalarrondo M.	Purification and genetic characterisation of the novel bacteriocin LS2 produced by the human oral strain Lactobacillus salivarius BGHO1.	
DRAMP18288	KRGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL	45	Sln1 (Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Lactobacillus salivarius DPC6005	Antimicrobial, Antibacterial		Not found	Not found		Shown is the sequence for chain a, which is identical at the amino acid level to the chain a of ABP-118. The peptide sequence for chain b is also similar to chain b of ABP-118 with only two changes: T43 to Ala and Arg46 to His.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17416691	Appl Environ Microbiol. 2007 Jun;73(11):3719-23.	Barrett E, Hayes M, O'Connor P, Gardiner G, Fitzgerald GF, Stanton C, Ross RP, Hill C.	Salivaricin P, one of a family of two-component antilisterial bacteriocins produced by intestinal isolates of Lactobacillus salivarius.	
DRAMP18286	ECELAKVDGGYTPKNCAMAVGGGMLSGAIRGGMSGTVFGVGTGNLAGAFAGAHIGLVAGGLACIGGYLGSH	71	Blp1a(Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Lactobacillus salivarius BGHO1	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22739096	Int J Antimicrob Agents. 2012 Aug;40(2):127-34. 	Busarcevic M, Dalgalarrondo M.	Purification and genetic characterisation of the novel bacteriocin LS2 produced by the human oral strain Lactobacillus salivarius BGHO1.	
DRAMP02002	FLPALIGIAAKALPSLLCKITKKC	24	Brevinin-1P (Frogs, amphibians, animals)	Q2UXW0	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana fukienensis (Fukien gold-striped pond frog) (Rana plancyi fukienensis)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Antimicrobial peptide.(By similarity). It shows hemolytic activity against host erythrocytes.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16139929	Peptides. 2006 Jan;27(1):42-48. 	Chen T, Li L, Zhou M, Rao P, Walker B, Shaw C.	Amphibian skin peptides and their corresponding cDNAs from single lyophilized secretion samples: identification of novel brevinins from three species of Chinese frogs.	
DRAMP02003	FFPAILRVAAKVGPAVLCAITKKC	24	Brevinin-1S (Frogs, amphibians, animals)	Q2UXV9	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana schmackeri (Schmacker's frog) (Huia schmackeri)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Antimicrobial peptide.(By similarity)
Tissue specificity: Expressed by the skin glands.
PTM: Problely contains one disulfide bond 18-24."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16139929	Peptides. 2006 Jan;27(1):42-48. 	Chen T, Li L, Zhou M, Rao P, Walker B, Shaw C.	Amphibian skin peptides and their corresponding cDNAs from single lyophilized secretion samples: identification of novel brevinins from three species of Chinese frogs.	
DRAMP18285	TNWKKIGKCYAGTLGSAVLGFGAMGPVGYWAGAGVGYASFC	41	Bacteriocin LS2 (Bacteriocin)	I0B594	Belongs to the class IId bacteriocin	bacls2	Lactobacillus salivarius BGHO1	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Note that the strain Lactobacillus salivarius BGHO1 exhibits a wide antimicrobial spectrum against S. flexneri, S. sonnei, S. dysenteriae, S. boydii, Y. enterocolitica, S. enteritidis, L. innocua, S. aureus, E. faecalis, M. flavus, S. pneumoniae and S. mutans. However, this broad spectrum could result from synergistic effect of its bacteriocins and the lactic acid which, in addition to the general antimicrobial effects exhibited by lowering the pH, can permeabilise the outer membrane of Gram-negative bacteria and make them more vulnerable to the effects of bacteriocins.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22739096	Int J Antimicrob Agents. 2012 Aug;40(2):127-34. 	Busarcevic M, Dalgalarrondo M.	Purification and genetic characterisation of the novel bacteriocin LS2 produced by the human oral strain Lactobacillus salivarius BGHO1.	
DRAMP18284	IYWIADQFGIHLATGTARKLLDAMASGASLGTAFAAILGVTLPAWALAAAGALGATAA	58	Reutericin 6 (Bacteriocin)	No entry found	Belongs to the class IIc bacteriocin	Not found	Lactobacillus reuteri LA6	Antimicrobial, Antibacterial, Anti-Gram+		Alpha helix	Not found		L.reuteri LA6 has the structural gene for gassericin A with no variations among those primers. These results indicate that a bacteriocin of the same structure has been produced by different lactobacilli species isolated from the same infant.	Gram-positive(certain)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Not found	PubMed ID is not available	Letters in Applied Microbiology. 1991 Dec;13(6):281	T. Toba, S.K. Samant, E. Yoshioka and T. Itoh	Reutericin 6, a new bacteriocin produced by Lactobacillus reuteri LA 6.	
DRAMP18283	KTKQQFLIKAQTQLFKVFGYTL	22	Plantaricin ZJ5 (Bacteriocin)	T1WIT7	Belongs to the class IId bacteriocin	Not found	Lactobacillus plantarum ZJ5	Antimicrobial, Antibacterial		Not found	Not found		Comment: 37% similar to Warnericin RK.The peptide activity was lost by treatment with pepsin and proteinase K (62%) but not affected by lipase or alpha-amylase. 	broad-spectrum	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25147943	PLoS One. 2014 Aug 22;9(8):e105549. 	Song DF, Zhu MY, Gu Q.	Purification and characterization of Plantaricin ZJ5, a new bacteriocin produced by Lactobacillus plantarum ZJ5.	
DRAMP02011	GILDTLKHLAKTAGKGALQSLLNHASCKLSGQC	33	Brevinin-2Tb (Frogs, amphibians, animals)	P82269	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antimicrobial peptide.(By similarity)
Tissue specificity: Expressed by the skin glands.
PTM: Problely contains one disulfide bond 27-33."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10333736	Biopolymers. 1998;47(6):435-450.	Simmaco M, Mignogna G, Barra D.	Antimicrobial peptides from amphibian skin: what do they tell us?	
DRAMP02012	VNPIILGVLPKFVCLITKKC	20	Brevinin-1T (Brevinin-2T; Frogs, amphibians, animals)	P82232	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antibacterial activity against representative Gram-negative and Gram-positive bacteria: and exhibits a very high hemolytic activity.	[Swiss_Prot Entry P82232]Antibacterial activity against representative Gram-negative and Gram-positive bacteria	[Ref.10333736]Not found	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	10333736	Biopolymers. 1998;47(6):435-450.	Simmaco M, Mignogna G, Barra D.	Antimicrobial peptides from amphibian skin: what do they tell us?	
DRAMP02013	FITLLLRKFICSITKKC	17	Brevinin-1Ta (Frogs, amphibians, animals)	P82233	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antibacterial activity against representative Gram-negative and Gram-positive bacteria: and exhibits no hemolytic activity.	[Swiss_Prot Entry P82233]Antibacterial activity against representative Gram-negative and Gram-positive bacteria	[Ref.10333736]Non-hemolytic	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	10333736	Biopolymers. 1998;47(6):435-450.	Simmaco M, Mignogna G, Barra D.	Antimicrobial peptides from amphibian skin: what do they tell us?	
DRAMP02014	GLWETIKNFGKKFTLNILHKLKCKIGGGC	29	Brevinin-2Tc (Frogs, amphibians, animals)	P82234	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Antibacterial activity against representative Gram-negative and Gram-positive bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	10333736	Biopolymers. 1998;47(6):435-450.	Simmaco M, Mignogna G, Barra D.	Antimicrobial peptides from amphibian skin: what do they tell us?	
DRAMP02015	GLWETIKNFGKKFTLNILHNLKCKIGGGC	29	Brevinin-2Td (Frogs, amphibians, animals)	P82235	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Antibacterial activity against representative Gram-negative and Gram-positive bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	10333736	Biopolymers. 1998;47(6):435-450.	Simmaco M, Mignogna G, Barra D.	Antimicrobial peptides from amphibian skin: what do they tell us?	
DRAMP02016	FLSLALAALPKFLCLVFKKC	20	Brevinin-1DYa (Frogs, amphibians, animals)	P0C5W6	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antimicrobial peptide. Has hemolytic activity. Tissue specificity: Expressed by the skin glands. PTM: contains one disulfide bond 14-20.	[Swiss_Prot Entry P0C5W6]Gram-positive bacterium: Staphylococcus aureus (low activity);##Gram-negative bacterium: Escherichia coli (MIC<15 µM).	[Ref.17688900]LC50<5 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17688900	Toxicon. 2007 Nov;50(6):746-756.	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.	Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.	
DRAMP02017	GLLSAVKGVLKGAGKNVAGSLMDKLKCKLFGGC	33	Brevinin-2DYa (Frogs, amphibians, animals)	P0C5X1	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 27-33."	Gram-negative bacterium: Escherichia coli (MIC<15 µM);##Gram-positive bacterium: Staphylococcus aureus (MIC<15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17688900	Toxicon. 2007 Nov;50(6):746-756.	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.	Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.	
DRAMP02018	FLSLALAALPKLFCLIFKKC	20	Brevinin-1DYb (Brevinin-1CDYb; Frogs, amphibians, animals)	P0C5W7	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has low activity against the Gram-positive bacteria: S. aureus and the Gram-negative bacteria E. coli. Has hemolytic activity. Has a strong hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 14-20."	[Swiss_Prot Entry P0C5W7]Gram-positive bacterium: Staphylococcus aureus (low activity);##Gram-negative bacterium: Escherichia coli (MIC<15 µM).	[Ref.17688900]LC50<6 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19539775##17688900	Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.##Toxicon. 2007 Nov;50(6):746-756. 	Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.##Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.	Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.##Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.	
DRAMP02020	FLPLLLAGLPKLLCLFFKKC	20	Brevinin-1DYc (Frogs, amphibians, animals)	P0C5W8	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antimicrobial peptide. Has low activity against the Gram-positive bacteria: S. aureus and the Gram-negative bacteria E.coli (MIC<15 µM). Has hemolytic activity. 
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 14-20."	[Swiss_Prot Entry P0C5W8]Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli (MIC<15 µM).	[Ref.17688900]LC50<7 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17688900	Toxicon. 2007 Nov;50(6):746-756.	Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.	Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.	
DRAMP18282	QWGGG	5	Plantaricin ZJ008 (Bacteriocin)	No entry found	Not found	Not found	Lactobacillus plantarum ZJ008	Antimicrobial, Antibacterial		Not found	The sequence showed no homology with known bacteriocins.		Warning: only the N-terminal amino acid sequence has been elucidated for this 20-residue bacteriocin. This bacteriocin was highly thermostable (121  Celsius degree, 30 min) and exhibited narrow pH stability (pH 4.0	broad-spectrum	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	25038669	Food Chem. 2014 Dec 15;165:216-23.	Zhu X, Zhao Y, Sun Y, Gu Q.	Purification and characterisation of plantaricin ZJ008, a novel bacteriocin against Staphylococcus spp. from Lactobacillus plantarum ZJ008.	
DRAMP02027	GLFSVVTGVLKAVGKNVAGSLLEQLKCKISGGC	33	Brevinin-2CDYb (Frogs, amphibians, animals)	P86042	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 27-33."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19539775	Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.	Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.	Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.	
DRAMP18281	GRADYNFGYGLGRGTRKFFNGIGRWVRKTF	30	Plantaricin KL-1Y (Bacteriocin)	No entry found	Belongs to the class IIb bacteriocin	Not found	Lactobacillus plantarum KL-1	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Not found		It showed synergistic effects with KL-1X and KL-1Z, two additional peptides whose sequences have not been established.	Gram-positive, Gram-negative (broad-spectrum)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25862353	World J Microbiol Biotechnol. 2015 Jun;31(6):983-94. 	Rumjuankiat K, Perez RH, Pilasombut K, Keawsompong S, Zendo T, Sonomoto K, Nitisinprasert S.	Purification and characterization of a novel plantaricin, KL-1Y, from Lactobacillus plantarum KL-1.	
DRAMP02029	FLPLLLAGLPKLLCFLFKKC	20	Brevinin-1CDYd (Frogs, amphibians, animals)	B3VZU1	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Antibacterial activity againist Gram-negative bacteria and Gram-positive bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 14-20."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19539775	Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178. 	Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.	Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.	
DRAMP18280	VFHAYSARGNYYGNCPANWPSCRNNYKSAGGK	32	Plantaricin 163 (Bacteriocin)	No entry found	Not found	Not found	Lactobacillus plantarum 163 	Antimicrobial, Antibacterial		Not found	Not found		Plantaricin 163 was highly thermostable (20 min, 121 degrees C), active in the presence of acidic pH (3-5), sensitive to protease, and exhibited broad-spectrum antimicrobial activity against LAB and other tested Gram-positive and Gram-negative bacteria.	broad-spectrum	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24228753	J Agric Food Chem. 2013 Nov 27;61(47):11676-82. 	Hu M, Zhao H, Zhang C, Yu J, Lu Z.	Purification and characterization of plantaricin 163, a novel bacteriocin produced by Lactobacillus plantarum 163 isolated from traditional Chinese fermented vegetables.	
DRAMP02079	FLPLLAASFACTVTKKC	17	Brevinin-1AVa (Frogs, amphibians, animals)	P86159	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana arvalis (Moor frog)	Antimicrobial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18280749##19308951	J Am Soc Mass Spectrom. 2008 Apr;19(4):479-487.##Rapid Commun Mass Spectrom. 2009 May;23(9):1241-1248.	Samgina TY, Artemenko KA, Gorshkov VA, Poljakov NB, Lebedev AT.##Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	Oxidation versus carboxamidomethylation of S-S bond in ranid frog peptides: pro and contra for de novo MALDI-MS sequencing.##Mass spectrometric study of peptides secreted by the skin glands of the brown frog Rana arvalis from the Moscow region.	
DRAMP02080	FVPLLVSKLVCVVTKKC	17	Brevinin-1AVb (Frogs, amphibians, animals)	P86160	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana arvalis (Moor frog)	Antimicrobial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18280749##19308951	J Am Soc Mass Spectrom. 2008 Apr;19(4):479-487.##Rapid Commun Mass Spectrom. 2009 May;23(9):1241-1248.	Samgina TY, Artemenko KA, Gorshkov VA, Poljakov NB, Lebedev AT.##Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	Oxidation versus carboxamidomethylation of S-S bond in ranid frog peptides: pro and contra for de novo MALDI-MS sequencing.##Mass spectrometric study of peptides secreted by the skin glands of the brown frog Rana arvalis from the Moscow region.	
DRAMP18279	AYSLQMGATAIKQVKKLFKKWGW	23	Plantaricin A(Bacteriocin)	P80214	Belongs to the class IIb bacteriocin	plnA	Lactobacillus plantarum (strain ATCC BAA-793 / NCIMB 8826 / WCFS1)	Antimicrobial, Antibacterial, Anti-Gram+		Alpha helix 	Active plantaricin A is composed of an alpha chain and a beta chain. The sequence of alpha chain and beta chain, however, are essential identical with the only difference being one additional Ala at the N-terminus of chain b. The 3D structure of chain a in DPC micelles has been determined by NMR spectroscopy (J Biol Chem. 2005 Jun 17;280(24):22945-50). The helical region (residues 12-21) are good for membrane targeting as well as the ph	1YTR resolved by NMR	Active plantaricin A is composed of an alpha chain and a beta chain.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8245827	J Gen Microbiol. 1993 Sep;139(9):1973-8.	Nissen-Meyer J, Larsen AG, Sletten K, Daeschel M, Nes IF.	Purification and characterization of plantaricin A, a Lactobacillus plantarum bacteriocin whose activity depends on the action of two peptides.	
DRAMP18278	YSYFGGSNGYSWRDKRGHWHYTVTKGGFETVIGIIGDGWGSAGAPGPGQH	50	BacSJ(Bacteriocin)	No entry found	Belongs to the class II bacteriocin	Not found	Lactobacillus paracasei subsp. paracasei BGSJ2-8	Unknown		Not found	BLAST protein sequence homology search revealed that BacSJ showed a very high homology with acidocin M from L. acidophilus TK8912.		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	ARCHIVES OF BIOLOGICAL SCIENCES. 2010;62(2):231-243.	Kojic M,Lozo J,Jovcic B,Strahinic I,Fira D,Topisirovic L.	A SUCCESSFUL USE OF A NEW SHUTTLE CLONING VECTOR PA13 FOR THE CLONING OF THE BACTERIOCINS BACSJ and ACIDOCIN 8912	
DRAMP18277	DIDITGCSACKYAAGQVCTIGCSAAGGFICGLLGITIPVAGLSCLGFVEIVCTVADEYSGCGDAVAKEACNRAGLC	76	Halocin C8 (Bacteriocin)	P83716	Not found	proC8	Halobacterium sp. (strain AS7092)	Antimicrobial, Antibacterial		disulphide bridges	HalC8 contains 10 cysteines that could form disulphide bridges, leading to a little decrease in molecular weight.		quite stable, can be desalted, boiled, frozen, subjected to organic solvents, and stored in culture supernatant at 4	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell wall	12811620##15978083 	Extremophiles. 2003 Oct;7(5):401-7.##Mol Microbiol. 2005 Jul;57(2):537-49.	Li Y, Xiang H, Liu J, Zhou M, Tan H.##Sun C, Li Y, Mei S, Lu Q, Zhou L, Xiang H.	Purification and biological characterization of halocin C8, a novel peptide antibiotic from Halobacterium strain AS7092.##A single gene directs both production and immunity of halocin C8 in a haloarchaeal strain AS7092.	
DRAMP02087	FLPVLAGLTPSIVPKLVCLLTKKC	24	Brevinin-1PRb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pretiosa (North oregon spotted frog)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		The MIC of Ranatuerin-2PRe is >50 µM.	No MICs found in DRAMP database	[Ref.21295070] LC50=80μM against human erythrocytes.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	21295070	Dev Comp Immunol. 2011 Jun;35(6):644-649. 	Conlon JM, Mechkarska M, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, Hayes MP, Padgett-Flohr G.	Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.	
DRAMP02088	FFPMLAGVAARVVPKVICLITKKC	24	Brevinin-1PRc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pretiosa (North oregon spotted frog)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	21295070	Dev Comp Immunol. 2011 Jun;35(6):644-649. 	Conlon JM, Mechkarska M, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, Hayes MP, Padgett-Flohr G.	Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.	
DRAMP02089	FLPMLAGLAASMVPKLVCLITKKC	24	Brevinin-1La (Brevinin-1PRd; Frogs, amphibians, animals)	P82825	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana luteiventris (Spotted frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Brevinin-1PRd isolated from the Oregon spotted frog shares the same sequence with this entry.	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP01124	ILGPVLSMVGSALGGLIKKI	20	Maximin-H2 (Toads, amphibians, animals)	P83082	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi.Shows strong hemolytic activity. 	[Ref.11835991] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=20 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=2 μg/ml), Bacillus pyocyaneus CMCCB 1010 (MIC=4 μg/ml);##Fungi: Candida albicans ATCC 2002 (MIC=2 μg/ml).	[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01123	ILGPVISTIGGVLGGLLKNL	20	Maximin-H1 (Toads, amphibians, animals)	P83080, P83081, Q58T74, Q58T41	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Shows strong hemolytic activity. 	[Ref.11835991] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=9 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=4.5 μg/ml), Bacillus pyocyaneus CMCCB 1010 (MIC=9 μg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=4.5 μg/ml).	[Ref:11835991]90–100% hemolytic activity at 50 μg/ml against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01111	SIGAKILGGVKTFFKGALKELASTYLQ	27	Maximin-5 (Toads, amphibians, animals)	P83084, Q58T60, Q58T61	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral, Anti-cancer	Protein level	Not found	Maximins are linear cationic peptides and easy to form membrane pore and they may induce a detergent-type disruption of sperm membrane like in the case of magainins.		"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. No amidation at the C-terminus.
Tissue specificity: Expressed by the skin glands."	[Ref.11835991] Gram-negative bacterium: Klebsiella pneumoniae (MIC=3.6 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.6 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=7.2 μg/ml), Bacillus megatherium (MIC=12 μg/ml), Bacillus dysenteriae (MIC=12 μg/ml).##Fungi: Candida albicans ATCC 2002 (MIC=1.2 μg/ml), Aspergillus flavus IFFI 4015 (MIC=12 μg/ml), Penicillium uticale IFFI 2001 (MIC=12 μg/ml);##Virus: HIV-1 (IC50=34.4 μg/ml, EC50=39.8 μg/ml);##Cancer cell lines: C8166 (IC50=34.4 μg/ml).	[Ref:11835991]Little hemolytic activity at 50 μg/ml against red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01110	GIGGVLLSAGKAALKGLAKVLAEKYAN	27	Maximin-4 (Toads, amphibians, animals)	P83083, Q58T42, Q58T44, Q58T52, Q58T62, Q58T77, Q58T79	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral, Anti-cancer	Protein level	Not found	Maximins are linear cationic peptides and easy to form membrane pore and they may induce a detergent-type disruption of sperm membrane like in the case of magainins.	2MHW resolved by NMR	Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. Possess a significant cytotoxicity against tumor cell lines. Possess a significant anti-HIV activity. High spermicidal activity.	[Ref.11835991] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2.7 µg/ml), Klebsiella pneumoniae (MIC=15 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=2.7 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=2.7 µg/ml), Bacillus megatherium (MIC=1.5 µg/ml), Bacillus dysenteriae (MIC=2.7 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=15 µg/ml);##Virus: HIV-1 (IC50=24.2 µg/ml, EC50=21.9 µg/ml);##Cancer cell lines: C8166 (IC50=24.2 µg/ml), Molt-4 (IC50=35.4 µg/ml).	[Ref:11835991]Little hemolytic activity at 50 μg/ml against red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP01109	GIGGKILSGLKTALKGAAKELASTYLH	27	Maximin-3 (Toads, amphibians, animals)	P83082, Q58T40, Q58T43, Q58T46, Q58T48, Q58T64, Q58T65, Q58T68, Q58T69	Belongs to the bombinin family	Not found	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral, Anti-cancer	Protein level	Not found	Maximins are linear cationic peptides and easy to form membrane pore and they may induce a detergent-type disruption of sperm membrane like in the case of magainins.	6HZ2	"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. Possess a significant cytotoxicity against tumor cell lines. Possess a significant anti-HIV activity. High spermicidal activity. No amidation at the C-terminus.
Toxic dose: LD50 is 4.3 mg/kg by intraperitoneal injection into mice.
Tissue specificity: Expressed by the skin glands."	[Ref.11835991] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=0.9 µg/ml), Klebsiella pneumoniae (MIC=3.1 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.1 µg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=1.5 µg/ml), Bacillus megatherium (MIC=0.9 µg/ml), Bacillus dysenteriae (MIC=0.9 µg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=15 µg/ml);##Virus: HIV-1 (IC50=11.4 µg/ml, EC50=1.5 µg/ml);##Cancer cell lines: C8166 (IC50=11.4 µg/ml), Molt-4 (IC50=25.2 µg/ml), BIU-87 (IC50=28 µg/ml), T24 (IC50=18 µg/ml).	[Ref:11835991]Little hemolytic activity at 50 μg/ml against red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	15770703##11835991	Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.	Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAMP02100	FLPIIASVAAKVFPKIFCAISKKC	24	Brevinin-1Pe (Frogs, amphibians, animals)	P82845	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pipiens (Northern leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02103	FLGSLLGLVGKIVPTLICKISKKC	24	Brevinin-1RTc (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Amolops ricketti (Chinese sucker frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		"Function: Brevinin-2RTc has antibacterial activity.
PTM: Contains one disulfide bond 27-33."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	[Ref.22100518]Not found	22100518	Peptides. 2012 Jan;33(1):27-34.	Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.	Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).	
DRAMP18353	ENDHRMPYELNRPNNLSKGGAKCGAAIA	28	Durancin L28-1A (bacteriocin)	No entry found	Belongs to the class IIa bacteriocin.	Not found	Enterococcus durans L28-1	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against Gram+ bacteria: L. sakei ssp. sakei JCM 1157T, L. sanfranciscensis JCM 5668, L. coryniformis ssp.coryniformis JCM 1164, L. plantarum NRIC 1067, L. animalis JCM 5670, L. pentosus JCM 1558, L. gasseri JCM 5344 , L. helveticus JCM 1554, L. lactis JCM 6123, L. lactis ssp. lactis C101910, L. lactis ssp. lactis IFO 12007 , E. faecium MR006 , E. durans MY411, C. divergens JCM 5816, W. paramesenteroides NRIC 1542, W. kandleri JCM 5817, W. halotolerans JCM 1114, and W. minor JCM 1168T.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15892738	Lett Appl Microbiol. 2005;40(6):430-5	Yanagida F, Chen Y, Onda T, Shinohara T.	Durancin L28-1A, a new bacteriocin from Enterococcus durans L28-1, isolated from soil.	
DRAMP18276	LQSNININTAAAVILIFNQVQVGALCAPTPVSGGGPPP	38	HalR1(Bacteriocin)	No entry found	Not found	Not found	Halobacterium salinarum GN101	Archaeolytic		Not found	HalR1 is 63% identical and 71% similar to HalS8.		Unlike HalH6, HalR1 does not appear to be archaeolytic, since it causes no change in the optical density or cell morphology of stationary phase Hbt. salinarum, nor can it form zones of inhibition on fully grown lawns. HalR1 has a dose-dependent, archaeostatic effect on growing Hbt. salinarum.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11938468	J Ind Microbiol Biotechnol. 2002 Jan;28(1):23-31.	O'Connor EM, Shand RF.	Halocins and sulfolobicins: the emerging story of archaeal protein and peptide antibiotics.	
DRAMP02107	MFTLKKSLLLLFFLGTINLSLCEQERDADEEERRDDPDERDVEVEKRFLPLLAGLAANFLPKLFCKITRKG	71	Brevinin-1E-OG2 antimicrobial peptide (Frogs, amphibians, animals)	A6MAR9	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP18354	ITSFSLCTPGCAKTGSFNSYCC	22	Hyicin 3682 (bacteriocin)	No entry found	Belongs to the lantibiotic family.	Not found	Staphylococcus hyicus 3682	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28285660	Microbiol Res. 2017 May;198:36-46.	Carlin Fagundes P, Nascimento de Sousa Santos I, Silva Francisco M, Mattos Albano R, de Freire Bastos MD.	Genetic and biochemical characterization of hyicin 3682, the first bacteriocin reported for Staphylococcus hyicus.	
DRAMP18273	KYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWKS	43	Enterocin CRL35 (Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	munA	Enterococcus mundtii CRL35	Antibacterial, Antiviral, Anti-Gram+, Antimicrobial		Bridge 	Not found		Both biological activities, antibacterial and antiviral, were destroyed after incubation of the enterocin with protease IV or by raising the pH.	Gram-positive, virus(certain)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	10493605##11040432	Int J Antimicrob Agents. 1999 Aug;12(4):293-9.##FEMS Microbiol Lett. 2000 Nov 1;192(1):79-83.	Wachsman MB, Far	Antiviral activity of enterocin CRL35 against herpesviruses.##Effect of enterocin CRL35 on Listeria monocytogenes cell membrane.	
DRAMP18272	MAKEFGIPAAVAGTVINVVVAGGWVTTIVSILTAVGSGGLSLLAAAGRESIKAYLKKEIKKKGKRAVIAW	70	Enterocin AS-48RJ (Bacteriocin)	No entry found	Belongs to the class IIc bacteriocin	Not found	Enterococcus faecium RJ16	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Not found	1E68 resolved by NMR	This is a natural variant of AS-48, where residue 20 is a Glu (Val in As-48RJ). It has the same activity spectrum as  AS-48 . 	Gram-positive, Gram-negative (broad-spectrum)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16094865	Syst Appl Microbiol. 2005 Jul;28(5):383-97.	Abriouel H, Lucas R, Ben Omar N, Valdivia E, Maqueda M, Mart	Enterocin AS-48RJ: a variant of enterocin AS-48 chromosomally encoded by Enterococcus faecium RJ16 isolated from food.	
DRAMP02115	AWLDKLKSLGKVVGKVAIGVAQHYLNPQQ	29	Raniseptin-2 (Rsp-2; Frogs, amphibians, animals)	P86185	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Hypsiboas raniceps (Chaco tree frog) (Hyla roeschmanni)	Unknown	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18976634	Biochem Biophys Res Commun. 2008 Dec 26;377(4):1057-1061.	Magalhães BS, Melo JA, Leite JR, Silva LP, Prates MV, Vinecky F, Barbosa EA, Verly RM, Mehta A, Nicoli JR, Bemquerer MP, Andrade AC, Bloch C Jr.	Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.	
DRAMP02116	AWLDKLKSIGKVVGKVAIGVAKNLLNPQ	28	Raniseptin-3 (Rsp-3; Frogs, amphibians, animals)	P86038	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Hypsiboas raniceps (Chaco tree frog) (Hyla roeschmanni)	Unknown	Protein level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18976634	Biochem Biophys Res Commun. 2008 Dec 26;377(4):1057-1061.	Magalhães BS, Melo JA, Leite JR, Silva LP, Prates MV, Vinecky F, Barbosa EA, Verly RM, Mehta A, Nicoli JR, Bemquerer MP, Andrade AC, Bloch C Jr.	Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.	
DRAMP02117	AWLDKLKSLGKVVGKVGLGVVQNYLNPRQ	29	Raniseptin-4 (Rsp-4; Frogs, amphibians, animals)	P86186	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Hypsiboas raniceps (Chaco tree frog) (Hyla roeschmanni)	Unknown	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18976634	Biochem Biophys Res Commun. 2008 Dec 26;377(4):1057-1061.	Magalhães BS, Melo JA, Leite JR, Silva LP, Prates MV, Vinecky F, Barbosa EA, Verly RM, Mehta A, Nicoli JR, Bemquerer MP, Andrade AC, Bloch C Jr.	Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.	
DRAMP02118	AWLDKLKNLGKVVGKVALGVVQNYLNPRQ	29	Raniseptin-5 (Rsp-5; Frogs, amphibians, animals)	P86187	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Hypsiboas raniceps (Chaco tree frog) (Hyla roeschmanni)	Unknown	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18976634	Biochem Biophys Res Commun. 2008 Dec 26;377(4):1057-1061.	Magalhães BS, Melo JA, Leite JR, Silva LP, Prates MV, Vinecky F, Barbosa EA, Verly RM, Mehta A, Nicoli JR, Bemquerer MP, Andrade AC, Bloch C Jr.	Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.	
DRAMP02119	ALLDKLKSLGKVVGKVALGVVQNYLNPRQ	29	Raniseptin-6 (Rsp-6; Frogs, amphibians, animals)	P86039	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Hypsiboas raniceps (Chaco tree frog) (Hyla roeschmanni)	Unknown	Protein level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18976634	Biochem Biophys Res Commun. 2008 Dec 26;377(4):1057-1061.	Magalhães BS, Melo JA, Leite JR, Silva LP, Prates MV, Vinecky F, Barbosa EA, Verly RM, Mehta A, Nicoli JR, Bemquerer MP, Andrade AC, Bloch C Jr.	Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.	
DRAMP02120	ALLDKLKSLGKVVGKVALGVAQHYLNPQQ	29	Raniseptin-7 (Rsp-7; Frogs, amphibians, animals)	P86040	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Hypsiboas raniceps (Chaco tree frog) (Hyla roeschmanni)	Unknown	Protein level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18976634	Biochem Biophys Res Commun. 2008 Dec 26;377(4):1057-1061.	Magalhães BS, Melo JA, Leite JR, Silva LP, Prates MV, Vinecky F, Barbosa EA, Verly RM, Mehta A, Nicoli JR, Bemquerer MP, Andrade AC, Bloch C Jr.	Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.	
DRAMP02121	ALLDKLKSLGKVVGKVAIGVAQHYLNPQQ	29	Raniseptin-8 (Rsp-8; Frogs, amphibians, animals)	P86188	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Hypsiboas raniceps (Chaco tree frog) (Hyla roeschmanni)	Unknown	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18976634	Biochem Biophys Res Commun. 2008 Dec 26;377(4):1057-1061.	Magalhães BS, Melo JA, Leite JR, Silva LP, Prates MV, Vinecky F, Barbosa EA, Verly RM, Mehta A, Nicoli JR, Bemquerer MP, Andrade AC, Bloch C Jr.	Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.	
DRAMP02122	ALLDKLKSLGKVVGKVAIGVAQHYLNPQ	28	Raniseptin-9 (Rsp-9; Frogs, amphibians, animals)	P86189	Belongs to the frog skin active peptide family (Dermaseptin subfamily)	Not found	Hypsiboas raniceps (Chaco tree frog) (Hyla roeschmanni)	Unknown	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18976634	Biochem Biophys Res Commun. 2008 Dec 26;377(4):1057-1061.	Magalhães BS, Melo JA, Leite JR, Silva LP, Prates MV, Vinecky F, Barbosa EA, Verly RM, Mehta A, Nicoli JR, Bemquerer MP, Andrade AC, Bloch C Jr.	Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.	
DRAMP02123	FIGAILPAIAGLVHGLINR	19	Hylin-b1 (Hy-b1; Frogs, amphibians, animals)	P84002	Not found	Not found	Hyla biobeba (Brazilian tree frog)	Antimicrobial	Protein level	Not found	Not found		"Function: Has hemolytic activity against human erythrocytes. May have antimicrobial activity.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	[Ref.15638808]Show hemolytic activity against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15638808	Protein Pept Lett. 2005 Jan;12(1):89-93.	Castro MS, Matsushita RH, Sebben A, Sousa MV, Fontes W.	Hylins: bombinins H structurally related peptides from the skin secretion of the Brazilian tree-frog Hyla biobeba.	
DRAMP02124	FIGAILPAIAGLVGGLINR	19	Hylin-b2 (Hy-b2; Frogs, amphibians, animals)	P84003	Not found	Not found	Hyla biobeba (Brazilian tree frog)	Antimicrobial	Protein level	Not found	Not found		"Function: Has hemolytic activity against human erythrocytes. May have antimicrobial activity.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	[Ref.15638808]Show hemolytic activity against human red blood cells 	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15638808	Protein Pept Lett. 2005 Jan;12(1):89-93.	Castro MS, Matsushita RH, Sebben A, Sousa MV, Fontes W.	Hylins: bombinins H structurally related peptides from the skin secretion of the Brazilian tree-frog Hyla biobeba.	
DRAMP02132	GLASTLGSFLGKFAKGGAQAFLQPK	25	Antimicrobial peptide 3 (XT-3; Levitide-like peptide; Frogs, amphibians, animals)	P84383	Belongs to the gastrin/cholecystokinin family (Magainin subfamily)	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has antibacterial activity against Gram-positive bacterium S.aureus and Gram-negative bacterium E.coli, when in combination with XT1 and XT6.	Gram-positive bacteria: Staphylococcus aureus;##Gram-negative bacteria: E.coli (Combination with XT1 and XT6).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	11738090	Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.	Ali MF, Soto A, Knoop FC, Conlon JM.	Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).	
DRAMP02134	GMATKAGTALGKVAKAVIGAAL	22	Antimicrobial peptide 5 (XT-5; PGLa-like peptide; Frogs, amphibians, animals)	P84385	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity against Gram-positive bacterium S. aureus, Gram-negative bacterium E.coli and yeast C. albicans. Has strong hemolytic activity against human red blood cells.
Tissue specificity: Skin."	[Ref.11738090]Gram-positive bacteria: Staphylococcus aureus (MIC>100 µM);##Gram-negative bacteria: Escherichia coli (MIC>100 µM);##Fungi: Candida albicans (MIC>100 µM)	[Ref.11738090]HC50>150 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	11738090	Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.	Ali MF, Soto A, Knoop FC, Conlon JM.	Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).	
DRAMP02137	GLLKPLLKIAAKVGSNLL	18	[G4K]XT-7 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22374306	Peptides. 2012 Apr;34(2):275-282.	Popovic S, Urbán E, Lukic M, Conlon JM.	Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.	
DRAMP02138	GWGDTFGKVLKNFAKVAGVKAAK	23	XTG1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22188679	FEBS J. 2012 Mar;279(5):724-736.	Tessera V, Guida F, Juretić D, Tossi A.	Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.	
DRAMP02139	GWGDTFLKTMAKIAKVGPKLLHS	23	XTG2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22188679	FEBS J. 2012 Mar;279(5):724-736.	Tessera V, Guida F, Juretić D, Tossi A.	Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.	
DRAMP02140	GFWSSALEGLKKFAKGGLEALTNPK	25	XPF-SP1 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21498136	Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.	Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.	Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.	
DRAMP02141	GLASTIGSLLGKFAKGGAQAFLQPK	25	XPF-SP2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21498136	Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.	Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.	Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.	
DRAMP02143	GFLGPLLKLGLKGAAKLLPQLLPSRQQ	27	CPF-SP2 (Frogs, amphibians, animals)	No entry found	Not found	Not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21498136	Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.	Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.	Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.	
DRAMP02144	MPVAVGPYGQSQPSCFDRVKMGFMMGFAVGMAAGALFGTFSCLRFGMRGRELMGGVGKTMMQSGGTFGTFMAIGMGIRC	79	Reactive oxygen species modulator 1 (ROS modulator 1; Frogs, amphibians, animals)	A4QNF3	Belongs to the MGR2 family	romo1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Has antibacterial activity against a variety of bacteria. Acts by inducing bacterial membrane breakage (By similarity).
Induces production of reactive oxygen species (ROS) which are necessary for cell proliferation. May play a role in inducing oxidative DNA damage and replicative senescence. May play a role in the coordination of mitochondrial morphology and cell proliferation.
Domain: Contains a transmembrane helix domian."	S. aureus, Pseudomonas aeruginosa and M. tuberculosis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases	Unknown	NIH - Xenopus Gene Collection (XGC) project	
DRAMP02145	FVPIWM	6	Electrin-1 (Frogs, amphibians, animals)	P82096	Not found	Not found	Litoria rubella (Desert tree frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	Aust. J. Chem. 1999;52:639-645.	Wabnitz PA, Bowie JH, Tyler MJ, Wallace JC.	Peptides from the skin glands of the Australian buzzing tree frog Litori electrica. Comparison with the skin peptides from Litoria rubella.	
DRAMP02146	FVHPM	5	Electrin-3 (Frogs, amphibians, animals)	P82099	Not found	Not found	Litoria rubella (Desert tree frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	Aust. J. Chem. 1999;52:639-645.	Wabnitz PA, Bowie JH, Tyler MJ, Wallace JC.	Peptides from the skin glands of the Australian buzzing tree frog Litori electrica. Comparison with the skin peptides from Litoria rubella.	
DRAMP02147	FITVH	5	Electrin-4 (Frogs, amphibians, animals)	P82100	Not found	Not found	Litoria rubella (Desert tree frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	Aust. J. Chem. 1999;52:639-645.	Wabnitz PA, Bowie JH, Tyler MJ, Wallace JC.	Peptides from the skin glands of the Australian buzzing tree frog Litori electrica. Comparison with the skin peptides from Litoria rubella.	
DRAMP02148	IYEPEIA	7	Electrin-5 (Frogs, amphibians, animals)	P82101	Not found	Not found	Litoria rubella (Desert tree frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	Aust. J. Chem. 1999;52:639-645.	Wabnitz PA, Bowie JH, Tyler MJ, Wallace JC.	Peptides from the skin glands of the Australian buzzing tree frog Litori electrica. Comparison with the skin peptides from Litoria rubella.	
DRAMP02149	NEEEKVKWEPDVP	13	Electrin-2.1 (Frogs, amphibians, animals)	P82097	Not found	Not found	Litoria rubella (Desert tree frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	Aust. J. Chem. 1999;52:639-645.	Wabnitz PA, Bowie JH, Tyler MJ, Wallace JC.	Peptides from the skin glands of the Australian buzzing tree frog Litori electrica. Comparison with the skin peptides from Litoria rubella.	
DRAMP02150	NEEEKVKWQPDVP	13	Electrin-2.2 (Frogs, amphibians, animals)	P82098	Not found	Not found	Litoria rubella (Desert tree frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	Aust. J. Chem. 1999;52:639-645.	Wabnitz PA, Bowie JH, Tyler MJ, Wallace JC.	Peptides from the skin glands of the Australian buzzing tree frog Litori electrica. Comparison with the skin peptides from Litoria rubella.	
DRAMP02151	MASLKKFLFLVLFLGMVSLSICDKEKREGENEEEEEEHEEESEEKRGLFSFLPKVIGVIGPLIHPPS	67	Preprofallaxidin-4 (Frogs, amphibians, animals)	B5LUQ5	Belongs to the frog skin active peptide family Dermas	Not found	Litoria fallax (Eastern dwarf tree frog)	Unknown	Transcript level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18803332	Rapid Commun Mass Spectrom. 2008 Oct;22(20):3207-3216.	Jackway RJ, Bowie JH, Bilusich D, Musgrave IF, Surinya-Johnson KH, Tyler MJ, Eichinger PC.	The fallaxidin peptides from the skin secretion of the Eastern Dwarf Tree Frog Litoria fallax. Sequence determination by positive and negative ion electrospray mass spectrometry: antimicrobial activity and cDNA cloning of the fallaxidins.	
DRAMP02152	MASLKKSLFLVLFLGFVSLSICEEEKREDKEDEGENEEAEENHEERSEEKRFLPLLASLVGGLLGKRS	68	Preprofallaxidin-5 (Frogs, amphibians, animals)	B5LUQ6	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Litoria fallax (Eastern dwarf tree frog)	Unknown	Transcript level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18803332	Rapid Commun Mass Spectrom. 2008 Oct;22(20):3207-3216.	Jackway RJ, Bowie JH, Bilusich D, Musgrave IF, Surinya-Johnson KH, Tyler MJ, Eichinger PC.	The fallaxidin peptides from the skin secretion of the Eastern Dwarf Tree Frog Litoria fallax. Sequence determination by positive and negative ion electrospray mass spectrometry: antimicrobial activity and cDNA cloning of the fallaxidins.	
DRAMP02153	FLPAIAGILSQLF	13	Hemolytic protein A1 (Frogs, amphibians, animals)	P32415	Not found	Not found	Rana esculenta (Edible frog) (Pelophylax esculentus)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide. Shows hemolytic activity.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	[Ref.11738090]5% hemolytic activity at 1 nmol/ml, 20% hemolytic activity at 1.5nmol/ml, 30% hemolytic activity at 2nmol/ml, 60% hemolytic activity at 2.5nmol/ml, 88% hemolytic activity at 3nmol/ml, 95% hemolytic activity at 3.5nmol/ml against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2317508	Biochim Biophys Acta. 1990 Mar 26;1033(3):318-323.	Simmaco M, De Biase D, Severini C, Aita M, Erspamer GF, Barra D, Bossa F.	Purification and characterization of bioactive peptides from skin extracts of Rana esculenta.	
DRAMP02154	FLPLIAGLLGKLF	13	Hemolytic protein B9 (Frogs, amphibians, animals)	P32416	Not found	Not found	Rana esculenta (Edible frog) (Pelophylax esculentus)	Unknown	Protein level	Not found	Not found		"Function: Shows hemolytic activity.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	[Ref.11738090]4% hemolytic activity at 1 nmol/ml, 5% hemolytic activity at 1.5nmol/ml, 17% hemolytic activity at 2nmol/ml, 20% hemolytic activity at 2.5nmol/ml, 35% hemolytic activity at 3nmol/ml, 90% hemolytic activity at 3.5nmol/ml against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2317508	Biochim Biophys Acta. 1990 Mar 26;1033(3):318-323.	Simmaco M, De Biase D, Severini C, Aita M, Erspamer GF, Barra D, Bossa F.	Purification and characterization of bioactive peptides from skin extracts of Rana esculenta.	
DRAMP02155	MSAVPFTRVLLISGFLAHLLLSTFVTLTVCKEVTEESDDLSKRNVLQRQLWAVGSLMGKKSLENTNRRSDEDMEISALFRGSPLKVKRSD	90	[Leu8]-phyllolitorin (Frogs, amphibians, animals)	P08948	Belongs to the bombesin/neuromedin-B/ranatensin family	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7997236	Mol Endocrinol. 1994 Aug;8(8):943-951.	Nagalla SR, Barry BJ, Spindel ER.	Cloning of complementary DNAs encoding the amphibian bombesin-like peptides Phe8 and Leu8 phyllolitorin from Phyllomedusa sauvagei: potential role of U to C RNA editing in generating neuropeptide diversity.	
DRAMP02156	QQWAVGHFM	9	Litorin (Frogs, amphibians, animals)	P08945	Belongs to the bombesin/neuromedin-B/ranatensin family	Not found	Litoria aurea (Green; also golden bell frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1140241	Experientia. 1975 May 15;31(5):510-511.	Anastasi A, Erspamer V, Endean R.	Aminoacid composition and sequence of litorin, a bombesin-like nonapeptide from the skin of the Australian leptodactylid frog Litoria aurea.	
DRAMP02157	MSAVPFTRVLLISGFLAHLLLSTFVTLTVCKEVTEESDDLSKRNVLQRQLWAVGSFMGKKSLENTNRRSDEDMEISALFRGSPLKVKRSD	90	[Phe8]-phyllolitorin (Frogs, amphibians, animals)	P08947	Belongs to the bombesin/neuromedin-B/ranatensin family	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7997236##3868775	Mol Endocrinol. 1994 Aug;8(8):943-951.##Peptides. 1985;6 Suppl 3:7-12.	Nagalla SR, Barry BJ, Spindel ER.##Erspamer V, Melchiorri P, Falconieri Erspamer G, Montecucchi PC, de Castiglione R.	Cloning of complementary DNAs encoding the amphibian bombesin-like peptides Phe8 and Leu8 phyllolitorin from Phyllomedusa sauvagei: potential role of U to C RNA editing in generating neuropeptide diversity.##Phyllomedusa skin: a huge factory and store-house of a variety of active peptides.	
DRAMP02158	QLWATGHFM	9	Rhodei-litorin (Frogs, amphibians, animals)	P08946	Belongs to the bombesin/neuromedin-B/ranatensin family	Not found	Phyllomedusa rohdei (Rohde's leaf frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3838283	FEBS Lett. 1985 Mar 11;182(1):53-56.	Barra D, Falconieri Erspamer G, Simmaco M, Bossa F, Melchiorri P, Erspamer V.	Rohdei-litorin: a new peptide from the skin of Phyllomedusa rohdei.	
DRAMP02159	FVGAALKVLANVLPPVISWIKQ	22	Melittin-related peptide (Frogs, amphibians, animals)	P86158	Not found	Not found	Rana arvalis (Moor frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19308951	Rapid Commun Mass Spectrom. 2009 May;23(9):1241-1248. 	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	Mass spectrometric study of peptides secreted by the skin glands of the brown frog Rana arvalis from the Moscow region.	
DRAMP02160	SEEEKRQPWLPFG	13	Peroniin-1.1b (Frogs, amphibians, animals)	P86495	Belongs to the frog skin active peptide family (Peroniin subfamily)	Not found	Litoria peronii (Emerald spotted tree frog) (Hyla peronii)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19642086	Rapid Commun Mass Spectrom. 2009 Sep;23(17):2628-2636.	Bilusich D, Jackway RJ, Musgrave IF, Tyler MJ, Bowie JH.	The host-defence skin peptide profiles of Peron's Tree Frog Litoria peronii in winter and summer. Sequence determination by electrospray mass spectrometry and activities of the peptides.	
DRAMP02161	DAQEKRQPWIPFV	13	Peroniin-1.2a (Frogs, amphibians, animals)	P86490	Belongs to the frog skin active peptide family (Peroniin subfamily)	Not found	Litoria peronii (Emerald spotted tree frog) (Hyla peronii)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19642086	Rapid Commun Mass Spectrom. 2009 Sep;23(17):2628-2636.	Bilusich D, Jackway RJ, Musgrave IF, Tyler MJ, Bowie JH.	The host-defence skin peptide profiles of Peron's Tree Frog Litoria peronii in winter and summer. Sequence determination by electrospray mass spectrometry and activities of the peptides.	
DRAMP02162	DAQEKRQPWLPFV	13	Peroniin-1.3a (Frogs, amphibians, animals)	P86493	Belongs to the frog skin active peptide family (Peroniin subfamily)	Not found	Litoria peronii (Emerald spotted tree frog) (Hyla peronii)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19642086	Rapid Commun Mass Spectrom. 2009 Sep;23(17):2628-2636.	Bilusich D, Jackway RJ, Musgrave IF, Tyler MJ, Bowie JH.	The host-defence skin peptide profiles of Peron's Tree Frog Litoria peronii in winter and summer. Sequence determination by electrospray mass spectrometry and activities of the peptides.	
DRAMP02163	QPWLPFR	7	Peroniin-1.5 (Frogs, amphibians, animals)	P86482	Belongs to the frog skin active peptide family (Peroniin subfamily)	Not found	Litoria peronii (Emerald spotted tree frog) (Hyla peronii)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19642086	Rapid Commun Mass Spectrom. 2009 Sep;23(17):2628-2636.	Bilusich D, Jackway RJ, Musgrave IF, Tyler MJ, Bowie JH.	The host-defence skin peptide profiles of Peron's Tree Frog Litoria peronii in winter and summer. Sequence determination by electrospray mass spectrometry and activities of the peptides.	
DRAMP02164	QVPQWAVGHFM	11	Ranatensin (Frogs, amphibians, animals)	P08950	Belongs to the bombesin/neuromedin-B/ranatensin family	Not found	Rana pipiens (Northern leopard frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2458345	J Biol Chem. 1988 Sep 15;263(26):13317-23.	Krane IM, Naylor SL, Helin-Davis D, Chin WW, Spindel ER.	Molecular cloning of cDNAs encoding the human bombesin-like peptide neuromedin B. Chromosomal localization and comparison to cDNAs encoding its amphibian homolog ranatensin.	
DRAMP02165	QTPQWATGHFM	11	Ranatensin-C (Frogs, amphibians, animals)	P08951	Belongs to the bombesin/neuromedin-B/ranatensin family	Not found	Rana pipiens (Northern leopard frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	6141890	Comp Biochem Physiol C. 1984;77(1):99-108.	Erspamer V, Erspamer GF, Mazzanti G, Endean R.	Active peptides in the skins of one hundred amphibian species from Australia and Papua New Guinea.	
DRAMP02166	SNTALRRYNQWATGHFM	17	Ranatensin-R (Frogs, amphibians, animals)	P08952	Belongs to the bombesin/neuromedin-B/ranatensin family	Not found	Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	445685	Chem Pharm Bull (Tokyo). 1979 Feb;27(2):492-498.	Yasuhara T, Ishikawa O, Nakajima T.	The studies on the active peptide in the skin of Rana rugosa. II. The structure of ranatensin-R, the new ranatensin analogue, and granuliberin-R, the new mast cell degranulating peptide.	
DRAMP02167	FPPWF	5	Tryptophyllin-T2-1 (Pha-T2-1; Tryptophyllin-11; Frogs, amphibians, animals)	P84952	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusahypochondrialis azurea)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-3613.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP02168	FPPWE	5	Tryptophyllin-T2-2 (Pha-T2-2; Tryptophyllin-3; Frogs, amphibians, animals)	P84943	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusahypochondrialis azurea)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-3613.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP18397	FFSALLSGIKSLF	13	Um4 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Urodacus manicatus	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against M. luteus (MIC 8 uM), E. coli (8 uM), S. aureus (15 uM), L. grayi (15 uM), L. fleischmannii (MIC 4 uM), and L. monocytogenes (MIC 8 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28067810	Toxins (Basel). 2017 Jan 6;9, 22. doi: 10.3390/toxins9010022.	Luna-Ramirez K, Tonk M, Rahnamaeian M, Vilcinskas A.	Bioactivity of Natural and Engineered Antimicrobial Peptides from Venom of the Scorpions Urodacus yaschenkoi and U. manicatus	
DRAMP02170	FPPWM	5	Tryptophyllin-T2-4 (Pha-T2-4; Tryptophyllin-8; Frogs, amphibians, animals)	P84948	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusahypochondrialis azurea)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-3613.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP02171	LPPWIG	6	Tryptophyllin-T2-5 (Pha-T2-5; Tryptophyllin-1; Frogs, amphibians, animals)	P84941	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusahypochondrialis azurea)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-3613. 	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP02172	KPPWRL	6	Tryptophyllin-T2-6 (Pha-T2-6; Tryptophyllin-6; Frogs, amphibians, animals)	P84946	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusahypochondrialis azurea)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-3613. 	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP02173	KPWERL	6	Tryptophyllin-T2-7 (Pha-T2-7; Tryptophyllin-7; Frogs, amphibians, animals)	P84947	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusahypochondrialis azurea)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-3613. 	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP02174	KPWERE	6	Tryptophyllin-T2-8 (Pha-T2-8; Tryptophyllin-12; Frogs, amphibians, animals)	P84953	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusahypochondrialis azurea)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-3613. 	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP02175	VPPIGWF	7	Tryptophyllin-T2-9 (Pha-T2-9; Tryptophyllin-4; Frogs, amphibians, animals)	P84944	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusahypochondrialis azurea)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-3613. 	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP02176	QDKPFWSPPIYPV	13	Tryptophyllin-T3-1 (Pj-T3-1; Frogs, amphibians, animals)	P86610	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
PTM: Pyrrolidone carboxylic acid at Q1.
Note: Sequence uncertainty at position 3 (K or Q) and 10 (I or L)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP02177	QDKPFWSPPIYPH	13	Tryptophyllin-T3-2 (Pj-T3-2; Frogs, amphibians, animals)	P86611	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
PTM: Pyrrolidone carboxylic acid at Q1.
Note: Sequence uncertainty at position 3 (K or Q) and 10 (I or L)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP02178	QDKPFWDPPIYPV	13	Tryptophyllin-T3-3 (Pj-T3-3; Frogs, amphibians, animals)	P86612	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phasmahyla jandaia (Jandaia leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
PTM: Pyrrolidone carboxylic acid at Q1.
Note: Sequence uncertainty at position 3 (K or Q) and 10 (I or L)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20932854	Toxicon. 2011 Jan;57(1):35-52.	Rates B, Silva LP, Ireno IC, Leite FS, Borges MH, Bloch C Jr, De Lima ME, Pimenta AM.	Peptidomic dissection of the skin secretion of Phasmahyla jandaia (Bokermann and Sazima, 1978) (Anura, Hylidae, Phyllomedusinae).	
DRAMP02179	QDKPFWPPPIYIM	13	Tryptophyllin-T3-1 (Pha-T3-1; Tryptophyllin-9; Frogs, amphibians, animals)	P84949	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
PTM: Pyrrolidone carboxylic acid at Q1."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-3613.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP02180	QDKPFWPPPIYPM	13	Tryptophyllin-T3-2 (Pha-T3-2; Tryptophyllin-10; Frogs, amphibians, animals)	P84950	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
PTM: Pyrrolidone carboxylic acid at Q1."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-3613.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP02181	GPIPWQR	7	Tryptophyllin-1 (Frogs, amphibians, animals)	P84831	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Ascaphus truei (Coastal tailed frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15922344	Gen Comp Endocrinol. 2005 Sep 1;143(2):193-199.	Conlon JM, Jouenne T, Cosette P, Cosquer D, Vaudry H, Taylor CK, Abel PW.	Bradykinin-related peptides and tryptophyllins in the skin secretions of the most primitive extant frog, Ascaphus truei.	
DRAMP02182	GPIPWQRRI	9	Tryptophyllin-2 (Frogs, amphibians, animals)	P84834	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Ascaphus truei (Coastal tailed frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15922344	Gen Comp Endocrinol. 2005 Sep 1;143(2):193-199.	Conlon JM, Jouenne T, Cosette P, Cosquer D, Vaudry H, Taylor CK, Abel PW.	Bradykinin-related peptides and tryptophyllins in the skin secretions of the most primitive extant frog, Ascaphus truei.	
DRAMP02183	DPWDWV	6	Tryptophyllin-3 (Frogs, amphibians, animals)	P84833	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Ascaphus truei (Coastal tailed frog)	Unknown	Protein level	Not found	Not found		"Fuunction: Putative defense peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15922344	Gen Comp Endocrinol. 2005 Sep 1;143(2):193-199. 	Conlon JM, Jouenne T, Cosette P, Cosquer D, Vaudry H, Taylor CK, Abel PW.	Bradykinin-related peptides and tryptophyllins in the skin secretions of the most primitive extant frog, Ascaphus truei.	
DRAMP02184	EPRTPWDWV	9	Tryptophyllin-4 (Frogs, amphibians, animals)	P84822	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Ascaphus truei (Coastal tailed frog)	Antimicrobial 	Protein level	Not found	Not found		"Fuunction: Putative defense peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15922344	Gen Comp Endocrinol. 2005 Sep 1;143(2):193-199.	Conlon JM, Jouenne T, Cosette P, Cosquer D, Vaudry H, Taylor CK, Abel PW.	Bradykinin-related peptides and tryptophyllins in the skin secretions of the most primitive extant frog, Ascaphus truei.	
DRAMP02185	QEKPYWPPPIYPM	13	Tryptophyllin-13 (Frogs, amphibians, animals)	P04096	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa rohdei (Rohde's leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
PTM: Pyrrolidone carboxylic acid at Q1."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Int. J. Pept. Protein Res. 1986;27:175-182.	Montecucchi PC, Gozzini L, Erspamer V.	Primary structure determination of a tryptophan-containing tridecapeptide from Phyllomedusa rohdei.	
DRAMP02186	FPPWVL	6	Tryptophyllin-14 (Frogs, amphibians, animals)	P85877	Belongs to the frog skin active peptide family (Tryptophillin subfamily)	Not found	Phyllomedusa centralis (Mato Grosso leaf frog)	Antimicrobial 	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15922344	Submitted (JUN-2008) to UniProtKB	Silva LP, Bonatto CC, Bloch C Jr.	Not found	
DRAMP02187	GLLDVVKGAAKNLLASALDKLKCKVTGC	28	Ranatuerin-2AVa (Frogs, amphibians, animals)	P86161	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana arvalis (Moor frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity against the Gram-positive bacterium L. lactis.
PTM: Contains one disulfide bond 23-28."	Gram-positive bacterium: L. lactis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19308951	Rapid Commun Mass Spectrom. 2009 May;23(9):1241-1248.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	Mass spectrometric study of peptides secreted by the skin glands of the brown frog Rana arvalis from the Moscow region.	
DRAMP02188	GLMDMVKGAAKNLFASALDTLKCKITGC	28	Ranatuerin-2AVb (Frogs, amphibians, animals)	P86162	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana arvalis (Moor frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
PTM: Contains one disulfide bond 23-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19308951	Rapid Commun Mass Spectrom. 2009 May;23(9):1241-1248.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	Mass spectrometric study of peptides secreted by the skin glands of the brown frog Rana arvalis from the Moscow region.	
DRAMP02189	GIMDTVKNAAKDLAGQLLDKLKCKITAC	28	Ranatuerin-2PLg (Frogs, amphibians, animals)	D3UA80	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana palustris (Pickerel frog)	Antimicrobial	Homology	Not found	Not found		"Function: Antimicrobial peptide (By similarity).
PTM: Contains one disulfide bond (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20179920	Immunogenetics. 2010 May;62(5):333-343.	Tennessen JA, Blouin MS.	A revised leopard frog phylogeny allows a more detailed examination of adaptive evolution at ranatuerin-2 antimicrobial peptide loci.	
DRAMP02190	GIMDTVKGVAKTVAASLLDKLKCKITGC	28	Ranatuerin-2Vb (ranat2Vb; 2VEb; Frogs, amphibians, animals)	Q1JS90	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Odorrana versabilis (Chinese bamboo leaf odorous frog) (Rana versabilis)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 23-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16621152	Peptides. 2006 Jul;27(7):1738-1744.	Chen T, Zhou M, Rao P, Walker B, Shaw C.	The Chinese bamboo leaf odorous frog (Rana (Odorrana) versabilis) and North American Rana frogs share the same families of skin antimicrobial peptides.	
DRAMP18271	LTANLGISSYAAKKVIDIINTGSAVATIIALVTAVVGGGLITAGIVATAKSLIKKYGAKYAAAW	64	NKR-5-3B(Bacteriocin)	No entry found	Belongs to the class IIc bacteriocin	Not found	Enterococcus faecium NKR-5-3	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found	2MP8	APD analysis reveals that the sequence of NKR-5-3B most resembles (62.1% similarity) bacterial Amylocyclicin. Structurally, it is highly similar to carnocyclin A,. In addition, the charge distribution of enterocin NKR-5-3B, carnocyclin A and enterocin AS-48 are also highly conserved.	Gram-positive (broad)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26174911	Biochemistry. 2015 Aug 11;54(31):4863-76. 	Himeno K, Rosengren KJ, Inoue T, Perez RH, Colgrave ML, Lee HS, Chan LY, Henriques ST, Fujita K, Ishibashi N, Zendo T, Wilaipun P, Nakayama J, Leelawatcharamas V, Jikuya H, Craik DJ, Sonomoto K.	Identification, Characterization, and Three-Dimensional Structure of the Novel Circular Bacteriocin, Enterocin NKR-5-3B, from Enterococcus faecium.	
DRAMP02192	DDGIEMTEEEVKRGILDLVTHVAKNLAAQLLDKLKCKMTGC	41	Ranatuerin-2PTa (Frogs, amphibians, animals)	D3UA81	Not found	Not found	Rana pretiosa	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20179920	Immunogenetics. 2010 May;62(5):333-343.	Tennessen JA, Blouin MS.	A revised leopard frog phylogeny allows a more detailed examination of adaptive evolution at ranatuerin-2 antimicrobial peptide loci.	
DRAMP02193	AFFTTVKNLVTNVAGTVIDKMKCKLTGEC	29	Ranatuerin-2PTb (Frogs, amphibians, animals)	D3UA86	Not found	Not found	Rana pretiosa	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20179920	Immunogenetics. 2010 May;62(5):333-343.	Tennessen JA, Blouin MS.	A revised leopard frog phylogeny allows a more detailed examination of adaptive evolution at ranatuerin-2 antimicrobial peptide loci.	
DRAMP02194	DDGVEITEEEVKRGLMDTVKNVAKNLAGHMLDKLKCKITGSC	42	Ranatuerin-2BLa (Frogs, amphibians, animals)	D3UA78	Not found	Not found	Rana blairi	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20179920	Immunogenetics. 2010 May;62(5):333-343.	Tennessen JA, Blouin MS.	A revised leopard frog phylogeny allows a more detailed examination of adaptive evolution at ranatuerin-2 antimicrobial peptide loci.	
DRAMP02195	SFLTTVKKLVTNVAALAGTVIDTIKCKITGGCRT	34	Ranatuerin-2BLc (Frogs, amphibians, animals)	D3UA84	Not found	Not found	Rana blairi	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20179920	Immunogenetics. 2010 May;62(5):333-343.	Tennessen JA, Blouin MS.	A revised leopard frog phylogeny allows a more detailed examination of adaptive evolution at ranatuerin-2 antimicrobial peptide loci.	
DRAMP02196	DDGVEITEEEVKRGLMDTVKNAAKNLAGQMLDKLKCKITGSC	42	Ranatuerin-2BLb (Frogs, amphibians, animals)	D3UA79	Not found	Not found	Rana blairi	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20179920	Immunogenetics. 2010 May;62(5):333-343.	Tennessen JA, Blouin MS.	A revised leopard frog phylogeny allows a more detailed examination of adaptive evolution at ranatuerin-2 antimicrobial peptide loci.	
DRAMP02197	MFTMKKSLLLFFFLGTISLSLCEEERGADEDDGVELTEEEVKRGLLSSFKGVAKGVAKDLAGKLLEKLKCKITGC	75	Ranatuerin-2SRa (Frogs, amphibians, animals)	J9RZ39	Not found	Not found	Rana sierrae (Nevada yellow-legged frog)	Antimicrobial 	Homology	Not found	Not found		Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Dis. Aquat. Organ. 2013,0:0-0.	Robertson LS, Fellers GM, Marranca JM, Kleeman PM.	Non-lethal collection of skin secretions for expression analysis and identification of antimicrobial peptide transcripts from six North American frog species.	
DRAMP02198	MFTLKKSLLLFFFLGTISLSLCEEERGADEDDDVEMTEEEVKRGIMDSVKGVAKNLAAKLLEKLKCKITGC	71	Ranatuerin-2SRb (Frogs, amphibians, animals)	J9RWR2	Not found	Not found	Rana sierrae (Nevada yellow-legged frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Dis. Aquat. Organ. 2013,0:0-0.	Robertson LS, Fellers GM, Marranca JM, Kleeman PM.	Non-lethal collection of skin secretions for expression analysis and identification of antimicrobial peptide transcripts from six North American frog species.	
DRAMP02199	MFTLKKSMLLLFFLGTISFSLCEEERGADKDDGGEITEEVKRGFLDVIKDTAQNLFATVLDKIKCKVTKC	70	Ranatuerin-2TGa (Frogs, amphibians, animals)	D5MTI4	Not found	Not found	Rana tagoi (Tago frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Peptides 0:0-0(2010	Tazato S, Conlon JM, Iwamuro S.	Cloning and expression of genes enocoding antimicrobial peptides andbradykinin from the skin and brain of Oki Tago's brown frog, Ranatagoi okiensis.	
DRAMP02200	MFTVKKSLLLLFFLGTITLSLCEQERGADEDNGGEMTEEEVKRGLFLDTLKGAAKDVAGKLLEGLKCKITGCKP	74	Ranatuerin-2RC antimicrobial peptide (Frogs, amphibians, animals)	C5IAZ1	Not found	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAR-2009) to the EMBL/GenBank/DDBJ database	Zhao R, Han W, Han J, Lei L, Feng X, Sun C, Jiang L.	Identification and characterization of a novel antimicrobial peptidefrom Rana catesbeiana.	
DRAMP02201	MFTLKKSLLLLFFLGTINLSLCEEERDAGDDQGEVVKQEVKRAFFTTFKNLVTNVAGTVIDKMKCKLTGEC	71	Ranatuerin-2BYa (Frogs, amphibians, animals)	J9RRZ4	Not found	Not found	Rana boylii (Foothill yellow-legged frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Dis. Aquat. Organ. 2013,0:0-0.	Robertson LS, Fellers GM, Marranca JM, Kleeman PM.	Non-lethal collection of skin secretions for expression analysis and identification of antimicrobial peptide transcripts from six North American frog species.	
DRAMP02202	MFTLKKSLLLFFFLGTISLSLCEEERGADEDDGVELTEEEVKRGILSTFKGLAKGVAKDLAGKLLDKFKCKITGC	75	Ranatuerin-2BYb (Frogs, amphibians, animals)	J9RWR8	Not found	Not found	Rana boylii (Foothill yellow-legged frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Dis. Aquat. Organ. 2013,0:0-0.	Robertson LS, Fellers GM, Marranca JM, Kleeman PM.	Non-lethal collection of skin secretions for expression analysis and identification of antimicrobial peptide transcripts from six North American frog species.	
DRAMP02203	MFTMKKSLLLLFFLGTINLSLCEEERDADQEERRDDPGERDVQVEKRFLPIAPMLGKYLGK	61	Ranatuerin-5Ca antimicrobial peptide (Frogs, amphibians, animals)	C5IAZ8	Not found	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAR-2009) to the EMBL/GenBank/DDBJ database	Zhao R, Han W, Han J, Lei L, Feng X, Sun C, Jiang L.	Identification and characterization of a novel antimicrobial peptidefrom Rana catesbeiana.	
DRAMP02204	MFTLKKSLLLLFFLGTINLSLCEEERDADQEERRDDPGERDVQVEKRFLPIASMLGKYLGK	61	Ranatuerin-5Cb antimicrobial peptide (Frogs, amphibians, animals)	C5IB02	Not found	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAR-2009) to the EMBL/GenBank/DDBJ database	Zhao R, Han W, Han J, Lei L, Feng X, Sun C, Jiang L.	Identification and characterization of a novel antimicrobial peptidefrom Rana catesbeiana.	
DRAMP02205	MFTLKKSMLLLFFLGTISLSLCQDEGADEDHGGEMTTEEKRGLMDIFKVAVNKLLAAGMNKPRCKAAHC	69	Ranatuerin-2YJ (Frogs, amphibians, animals)	G1ERV9	Not found	Not found	Rana dybowskii (Dybovsky's frog) (Korean brown frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22702542	Can J Microbiol. 2012 Jul;58(7):848-855.	Yang SJ, Xiao XH, Xu YG, Li DD, Chai LH, Zhang JY.	Induction of antimicrobial peptides from Rana dybowskii under Rana grylio virus stress, and bioactivity analysis.	
DRAMP02206	RGADEDDGVEITEEEVKRGLMDTVKNAAKNLAGQLLDRLKCKITGC	46	Ranatuerin 2CHa (Frogs, amphibians, animals)	A9CBH4	Not found	Not found	Rana chiricahuensis	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	[Ref.21262304] LC50=135 µM against human erythrocytes	Cyclic	Free	Cyclization (Cys41 and Cys46)	Disulfide bond between Cys41 and Cys46.	L	No cytotoxicity information found	Not found	17938991	J Mol Evol. 2007 Nov;65(5):605-615.	Tennessen JA, Blouin MS.	Selection for antimicrobial peptide diversity in frogs leads to gene duplication and low allelic variation.	
DRAMP02207	DDDQVEVQQEVKRGFLSTVKNLATNVAGTVIDTLKCKVTGGCRT	44	Ranatuerin 2CHb (Frogs, amphibians, animals)	A9CBH6	Not found	Ranatuerin2b	Rana chiricahuensis	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	[Ref.21262304] LC50=120 µM against human erythrocytes	Cyclic	Free	Free	Disulfide bond between Cys36 and Cys42.	L	No cytotoxicity information found	Not found	17938991	J Mol Evol. 2007 Nov;65(5):605-615.	Tennessen JA, Blouin MS.	Selection for antimicrobial peptide diversity in frogs leads to gene duplication and low allelic variation.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O
DRAMP02208	MFPLKKSLLLLFFFGTIPLSFCEQERGADEEEGNGEKEIKRSMFSVLKDLGKVGLGFVACKVNKQC	66	Ranatuerin-1Ca antimicrobial peptide (Frogs, amphibians, animals)	C5IAZ2	Not found	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAR-2009) to the EMBL/GenBank/DDBJ database	Zhao R, Han W, Han J, Lei L, Feng X, Sun C, Jiang L.	Identification and characterization of a novel antimicrobial peptidefrom Rana catesbeiana.	
DRAMP02209	MFTLKKSLLLLFFLGTITLSLCEQERGADEEEGNGEKEIKRSMFSVLKNLGKVGLGFVACKVNKQC	66	Ranatuerin-1Cb antimicrobial peptide (Frogs, amphibians, animals)	C5IAZ4, C5IAZ5, C5IAZ3	Not found	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAR-2009) to the EMBL/GenBank/DDBJ database	Zhao R, Han W, Han J, Lei L, Feng X, Sun C, Jiang L.	Identification and characterization of a novel antimicrobial peptidefrom Rana catesbeiana.	
DRAMP02210	MFTSKKSMLLLFFLGTISLSLCEEERDEDEVIEEEVKRGLLSVFKGVLKGVGKNVAGSLLDQLKCKISGGC	71	Ranatuerin-2AMa protein (Frogs, amphibians, animals)	A0AAR9	Not found	ranatuerin-2AMa	Rana amurensis (Korean brown frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16790295	Peptides. 2006 Nov;27(11):2688-2694.	Zhou M, Liu Y, Chen T, Fang X, Walker B, Shaw C.	Components of the peptidome and transcriptome persist in lin wa pi: the dried skin of the Heilongjiang brown frog (Rana amurensis) as used in traditional Chinese medicine.	
DRAMP02211	MFTSKKSMLLLFFLGTISLSLCQEERDADEDEVIEEEVKRGLFSVVKGVLKGVGKNVAGSLLDQLKCKISGGC	73	Ranatuerin-2AMb protein (Frogs, amphibians, animals)	A0AAS0	Not found	ranatuerin-2AMb	Rana amurensis (Korean brown frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16790295	Peptides. 2006 Nov;27(11):2688-2694.	Zhou M, Liu Y, Chen T, Fang X, Walker B, Shaw C.	Components of the peptidome and transcriptome persist in lin wa pi: the dried skin of the Heilongjiang brown frog (Rana amurensis) as used in traditional Chinese medicine.	
DRAMP02212	MFTLKKSLLLFFFLGTISLSLCEQERGADEDDGVEMTEEEVKRGLADYWRTAFRANFANLGPGIRCKSARC	71	Antimicrobial peptide ranatuerin-2ZHa (Frogs, amphibians, animals)	J9R283	Not found	Not found	Rana zhenhaiensis	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22943778	Zoolog Sci. 2012 Sep;29(9):553-558.	Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.	Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis.	
DRAMP02213	MFTLKKSMLLLFFLGTISLSLCQEERGADEDDGGEMTEEVKRGLLNVIKDTAQNLFAAALDKLKCKVTKCN	71	Ranatuerin-2TOa (Frogs, amphibians, animals)	D5MTH6	Not found	Not found	Rana tagoi okiensis (Oki brown frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Peptides 2010,0:0-0.	Tazato S, Conlon J.M, Iwamuro S.	Cloning and expression of genes enocoding antimicrobial peptides andbradykinin from the skin and brain of Oki Tago's brown frog, Ranatagoi okiensis.	
DRAMP02214	MFTLKKSMLLLFFLGTISLSLCQEERGADEDDGGEMTEEVKRGLLNVIKDTAQNLFAAALEKLKCKVTKCN	71	Ranatuerin-2TOb (Frogs, amphibians, animals)	D5MTH7	Not found	Not found	Rana tagoi okiensis (Oki brown frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Peptides 2010,0:0-0.	Tazato S, Conlon J.M, Iwamuro S.	Cloning and expression of genes enocoding antimicrobial peptides andbradykinin from the skin and brain of Oki Tago's brown frog, Ranatagoi okiensis.	
DRAMP02215	MFTLKKSMLLLFFLGTISLSLCQEERGADEDDGGEMTEEVKRGLLNVIRDTAQNLFAAALEKLKCKVTKCN	71	Ranatuerin-2TOc (Frogs, amphibians, animals)	D5MTH8	Not found	Not found	Rana tagoi okiensis (Oki brown frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Peptides 2010,0:0-0.	Tazato S, Conlon J.M, Iwamuro S.	Cloning and expression of genes enocoding antimicrobial peptides andbradykinin from the skin and brain of Oki Tago's brown frog, Ranatagoi okiensis.	
DRAMP02216	MFTLKKSMLLLFFLGTISLSLCQEERGADEDDGGEMTEEVKRGLLNVIKDTAQNLFTAALEKLKCKVTKCN	71	Ranatuerin-2TOd (Frogs, amphibians, animals)	D5MTH9	Not found	Not found	Rana tagoi okiensis (Oki brown frog)	Antimicrobial 	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Peptides 2010,0:0-0.	Tazato S, Conlon J.M, Iwamuro S.	Cloning and expression of genes enocoding antimicrobial peptides andbradykinin from the skin and brain of Oki Tago's brown frog, Ranatagoi okiensis.	
DRAMP02217	AAKLLLNPKFRCKAAFC	17	Ranatuerin-2Ra (Frogs, amphibians, animals)	P86020	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Pelophylax ridibundus (Marsh frog) (Rana ridibunda)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 12-17."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP02218	AVNIPFKVKFRCKAAFC	17	Ranatuerin-2R (Frogs, amphibians, animals)	P86019	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Pelophylax ridibundus (Marsh frog) (Rana ridibunda)	Antimicrobial 	Protein level	Not found	Not found		"Function: Antimicrobial peptide (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 12-17."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18855342	Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.	Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.	De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.	
DRAMP02226	GLMDTVKNAAKNLAGQLLDTIKCKMTGC	28	Ranatuerin-2ARa (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana areolata (North American crawfish frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	[Ref:12429503] HC50=100 µM against human erythrocytes	Cyclic	Free	Cyclization (Cys23 and Cys28)	Disulfide bond between Cys23 and Cys28.	L	No cytotoxicity information found	Not found	PubMed ID is not available	Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.	Ali MF, Lips KR, Knoop FC, Fritzsch B, Miller C, Conlon JM.	Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.	
DRAMP02227	GFLSTVKNLATNVAGTVIDTIKCKVTGGC	29	Ranatuerin-2Pa (Frogs, amphibians, animals)	Q8QFQ3	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pipiens (Northern leopard frog)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12413397	Biochem J. 2003 Apr 1;371(Pt 1):125-130.	Chen T, Farragher S, Bjourson AJ, Orr DF, Rao P, Shaw C.	Granular gland transcriptomes in stimulated amphibian skin secretions.	
DRAMP02232	FLPIASLLGKYL	12	Ranatuerin-5 (Frogs, amphibians, animals)	P82820	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Function: Antimicrobial peptide (By similarity).
Tissue specificity: Expressed by the skin glands."	Gram-positive bacterium: Staphylococcus aureus (MIC>200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9784389	Biochem Biophys Res Commun. 1998 Sep 29;250(3):589-592.	Goraya J, Knoop FC, Conlon JM.	Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana.	
DRAMP02240	GMFSVLKNLGKVGLGFVACKINKQC	25	Ranatuerin-1Gb (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana grylio (North American pig frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10828493	Regul Pept. 2000 Jun 30;90(1-3):53-60.	Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.	Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.	
DRAMP02086	FLPVLTGLTPSIVPKLVCLLTKKC	24	Brevinin-1PRa (frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pretiosa (North oregon spotted frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: activity against reference strains of Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella pneumoniae) and Gram-positive (Staphlococcus aureus) bacteria but displayed relatively low hemolytic activity. 	[Ref.15003829] Gram-negative bacterium: Escherichia coli(MIC>100μM);## Gram-positive bacterium: Staphylococcus aureus(MIC=13μM);## Yeast: Candida albicans(MIC=100μM).[Ref.21295070] Gram-negative bacterium: Escherichia coli(MIC>100μM);## Gram-positive bacterium: Staphylococcus aureus(MIC=50μM);## Yeast: Candida albicans(MIC=100μM).	[Ref.15003829] HC50=7μM against human erythrocytes.##[Ref.21295070] LC50= 150μM against human erythrocytes.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	15003829##21295070	Regul Pept. 2004 May 15;118(3):135-141.## Dev Comp Immunol. 2011 Jun;35(6):644-649. 	Conlon JM, Sonnevend A, Patel M, Al-Dhaheri K, Nielsen PF, Kolodziejek J, Nowotny N, Iwamuro S, P	A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.## Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.	
DRAMP02243	GLLSGLKKVGKHVAKNVAVSLMDSLKCKISGDC	33	Ranatuerin-1T (Brevinin-2T; Frogs, amphibians, animals)	P82740, P82236	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10422869##10333736	Peptides. 1999;20(2):159-163.##Biopolymers. 1998;47(6):435-450.	Goraya J, Knoop FC, Conlon JM.##Simmaco M, Mignogna G, Barra D.	Ranatuerin 1T: an antimicrobial peptide isolated from the skin of the frog, Rana temporaria.##Antimicrobial peptides from amphibian skin: what do they tell us?	
DRAMP01384	DEKGPKWKR	9	Odorranain-N1 (OdN1; Frogs, amphibians, animals)	A6MBP9	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		Function: Odorranain-N1 appears to be narrowly antifungal with low potency against Candida albicans.	[Ref.17272268] Yeast: Candida albicans (MIC=35.20 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP18270	KINWGSVGGSCVGGAVIGGALGGLGGAGGGCLTGAIGSIWDQW	43	Enterocin NKR-5-3Z(Bacteriocin)	I4DXG1	Belongs to the class IIb bacteriocin	enkZ	Enterococcus faecium NKR-5-3	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Ent53A and Ent53Z, components of a class IIb bacteriocin, show synergistic antimicrobial activity.		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25149515	Appl Environ Microbiol. 2014 Nov;80(21):6647-55. 	Ishibashi N, Himeno K, Masuda Y, Perez RH, Iwatani S, Zendo T, Wilaipun P, Leelawatcharamas V, Nakayama J, Sonomoto K.	Gene cluster responsible for secretion of and immunity to multiple bacteriocins, the NKR-5-3 enterocins.	
DRAMP18269	YSSKDCLKDIGKGIGAGTVAGAAGGGLAAGLGAIPGAFVGAHFGVIGGSAACIGGLLGN	59	Enterocin NKR-5-3A(Bacteriocin)	I4DXG0	Belongs to the class IIb bacteriocin	enkA	Enterococcus faecium NKR-5-3	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Ent53A and Ent53Z, components of a class IIb bacteriocin, show synergistic antimicrobial activity.		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25149515	Appl Environ Microbiol. 2014 Nov;80(21):6647-55. 	Ishibashi N, Himeno K, Masuda Y, Perez RH, Iwatani S, Zendo T, Wilaipun P, Leelawatcharamas V, Nakayama J, Sonomoto K.	Gene cluster responsible for secretion of and immunity to multiple bacteriocins, the NKR-5-3 enterocins.	
DRAMP02249	AIMDTIKDTAKTVAVGLLNKLKCKITGC	28	Ranatuerin-2SEB (Frogs, amphibians, animals)	P85058	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sevosa (dusky gopher frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli K12;##Gram-positive bacterium: Micrococcus luteus NCT C2665.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16386333	Peptides. 2006 Jun;27(6):1313-1319.	Graham C, Richter SC, McClean S, O'Kane E, Flatt PR, Shaw C.	Histamine-releasing and antimicrobial peptides from the skin secretions of the dusky gopher frog, Rana sevosa.	
DRAMP02250	GIMDTIKDTAKTVAVGLLNKLKCKITGC	28	Ranatuerin-2SEC (Frogs, amphibians, animals)	P85053	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana sevosa (dusky gopher frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli K12;##Gram-positive bacterium: Micrococcus luteus NCT C2665.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16386333	Peptides. 2006 Jun;27(6):1313-1319.	Graham C, Richter SC, McClean S, O'Kane E, Flatt PR, Shaw C.	Histamine-releasing and antimicrobial peptides from the skin secretions of the dusky gopher frog, Rana sevosa.	
DRAMP02253	GIMDSVKGLAKNLAGKLLDSLKCKITGC	28	Ranatuerin-IIbYb (Ranatuerin-2bYa; Frogs, amphibians, animals)	P84115	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana boylii (Foothill yellow-legged frog)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14531844	J Pept Res. 2003 Nov;62(5):207-213.	Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, PÃ¡l T, Rollins-Smith LA.	Isolation of peptides of the brevinin-2 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.	
DRAMP02258	GILSTFKGLAKGVAKDLAGNLLDKFKCKITGC	32	Ranatuerin-IIbYa (Ranatuerin-2bYa; Frogs, amphibians, animals)	P84114	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana boylii (Foothill yellow-legged frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Show weak hemolytic activity.	[Ref.14531844]Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus	[Ref.14531844]HC50=120 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14531844	J Pept Res. 2003 Nov;62(5):207-213.	Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, PÃ¡l T, Rollins-Smith LA.	Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.	
DRAMP02259	GIGKYLHSAKKFGKAWVGEIMNS	23	Magainin 2 analogue (F5Y, F16W-MG2)	P11006	Belongs to the gastrin/cholecystokinin family (Magainin subfamily)	Not found	Xenopus laevis (African clawed frog)	Unknown	Protein level	Alpha helix (1 helices; 12 residues)	The peptide assumed α-helices in the lipid environment, as characterized by double minima around 208 and 222 nm. The [θ]222 value, a measure of helicity, of I (−17,900 deg cm2 dmol−1) was ca. 20% smaller than that of F16W-MG2 (−23,200 deg cm2 dmol−1).	1DUM resolved by NMR	Membrane Permeabilization: The peptide-induced membrane permeabilization was examined on the basis of the efflux of the fluorescent dye calcein from egg PG LUVs. The mutant I (F5Y, F16W-MG2) showed a slightly weaker but comparable leakage activity compared with F16W-MG2.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11180056	Biopolymers. 2001 Apr 5;58(4):437-446.	Hara T, Kodama H, Kondo M, Wakamatsu K, Takeda A, Tachi T, Matsuzaki K.	Effects of peptide dimerization on pore formation: Antiparallel disulfide-dimerized magainin 2 analogue.	
DRAMP02260	GMASKAGTIAGKIAKTAIKLAL	22	PGLa-B1	No entry found	Not found	Not found	Xenopus borealis	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22036891	Gen Comp Endocrinol. 2012 May 1;176(3):513-518.	Conlon JM, Mechkarska M, King JD.	Host-defense peptides in skin secretions of African clawed frogs (Xenopodinae, Pipidae).	
DRAMP02261	GMASKAGSIVGKIAKIALGAL	21	PGLa-B2	No entry found	Not found	Not found	Xenopus borealis	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22036891	Gen Comp Endocrinol. 2012 May 1;176(3):513-518.	Conlon JM, Mechkarska M, King JD.	Host-defense peptides in skin secretions of African clawed frogs (Xenopodinae, Pipidae).	
DRAMP02262	GLGSLLGKAFKIGLKTVGKMMGGAPREQ	28	CPF-B1	No entry found	Not found	Not found	Xenopus borealis	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20656059	Comp Biochem Physiol C Toxicol Pharmacol. 2010 Nov;152(4):467-472.	Mechkarska M, Ahmed E, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.	Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis.	
DRAMP02263	GMASKAGSVLGKVAKVALKAAL	22	PGLa-AM1	No entry found	Not found	Not found	Xenopus amieti	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22326566	Int J Antimicrob Agents. 2012 Apr;39(4):317-320.	Conlon JM, Sonnevend A, Pál T, Vila-Farrés X.	Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group.	
DRAMP02264	GIWKTIKSMGKVFAGKILQNL	21	[D4K]B2RP	No entry found	Not found	Not found	Lithobates septentrionalis	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22326566	Int J Antimicrob Agents. 2012 Apr;39(4):317-320.	Conlon JM, Sonnevend A, Pál T, Vila-Farrés X.	Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group.	
DRAMP02265	MPVAVGPYGQSQPNCFDRVKMGFMMGFAVGMAAGALFGTFSCLRFGMRGRELMGGVGKTMMQSGGTFGTFMAIGMGIRC	79	Reactive oxygen species modulator 1 (ROS modulator 1; Frogs, amphibians, animals)	Q4V7T9	Belongs to the MGR2 family	romo1	Xenopus laevis (African clawed frog)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Has antibacterial activity against a variety of bacteria. Acts by inducing bacterial membrane breakage (By similarity).
Induces production of reactive oxygen species (ROS) which are necessary for cell proliferation. May play a role in inducing oxidative DNA damage and replicative senescence. May play a role in the coordination of mitochondrial morphology and cell proliferation.
Domain: Contains a transmembrane helix domian."	S. aureus, Pseudomonas aeruginosa and M. tuberculosis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases	Unknown	NIH - Xenopus Gene Collection (XGC) project	
DRAMP02266	KPSSDADEDNDEVERYVRGWASKIGQTLGKIAKVGLQGLMQPKREAMLRSAEAQGMIGTLTSKRIKQG	68	Prolevitide (Frogs, amphibians, animals)	P13684	Belongs to the gastrin/cholecystokinin family	Not found	Xenopus laevis (African clawed frog)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2830279	J Biol Chem. 1988 Mar 5;263(7):3279-3283.	Poulter L, Terry AS, Williams DH, Giovannini MG, Moore CH, Gibson BW.	Levitide, a neurohormone-like peptide from the skin of Xenopus laevis. Peptide and peptide precursor cDNA sequences.	
DRAMP02267	LKCVNLQANGIKMTQECAKEDTKCLTLRSLKKTLKFCASGRTCTTMKIMSLPGEQITCCEGNMCNA	66	Antimicrobial amphipathic helix-forming peptide (Frogs, amphibians, animals)	No entry found	Not found	Not found	Xenopus laevis (African clawed frog)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8203742	Anal Biochem. 1994 Feb 15;217(1):84-90.	James S, Gibbs BF, Toney K, Bennett HP.	Purification of antimicrobial peptides from an extract of the skin of Xenopus laevis using heparin-affinity HPLC: characterization by ion-spray mass spectrometry.	
DRAMP02270	GIGKFLHSAGKFGKAFVGEIMKS	23	Magainin-1 (Magainin I; chain of Magainins; Frogs, amphibians, animals)	P11006	Belongs to the magainin family	magainins	Xenopus laevis (African clawed frog)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antimicrobial peptides that inhibit the growth of numerous species of bacteria and fungi and induce osmotic lysis of protozoa. Magainins are membrane lytic agents.
Tissue specificity: Synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. It is stored as active, processed peptides in large granules within the granular gland secretions of the skin."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3299384	Proc Natl Acad Sci U S A. 1987 Aug;84(15):5449-5453.	Zasloff M.	Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.	
DRAMP02284	GLNTLKKVFQGLHEAIKLINNHVQ	24	Pseudin-1 (Pseudin 1; Frogs, amphibians, animals)	P83188	Not found	Not found	Pseudis paradoxa (Paradoxical frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Possesses antifungal activity against C. albicans and is also active against E. coli and S. aureus.
Tissue specificity: Expressed by the skin glands."	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11689009	Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-1005.	Olson L 3rd, Soto AM, Knoop FC, Conlon JM.	Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.	
DRAMP02285	GLNALKKVFQGIHEAIKLINNHVQ	24	Pseudin-2 (Pseudin 2; Frogs, amphibians, animals)	P83189	Not found	Not found	Pseudis paradoxa (Paradoxical frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Possesses antifungal activity against C. albicans and is also active against E. coli and S. aureus. Has low hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands."	[Ref.11689009]Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus;##Yeast: Candida albicans	[Ref.11689009]50% hemolysis of human erythrocytes is >300 μM	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11689009	Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-1005.	Olson L 4rd, Soto AM, Knoop FC, Conlon JM.	Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.	
DRAMP02286	GINTLKKVIQGLHEVIKLVSNHE	23	Pseudin-3 (Pseudin 3; Frogs, amphibians, animals)	P83190	Not found	Not found	Pseudis paradoxa (Paradoxical frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Possesses antifungal activity against C. albicans and is also active against E. coli and S. aureus.
Tissue specificity: Expressed by the skin glands."	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus;##yeast Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11689009	Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-1005.	Olson L 5rd, Soto AM, Knoop FC, Conlon JM.	Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.	
DRAMP02287	GINTLKKVIQGLHEVIKLVSNHA	23	Pseudin-4 (Pseudin 4; Frogs, amphibians, animals)	P83191	Not found	Not found	Pseudis paradoxa (Paradoxical frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix 	Not found		"Function: Possesses antifungal activity against C. albicans and is also active against E. coli and S. aureus.
Tissue specificity: Expressed by the skin glands."	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus;##yeast Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11689009	Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-1005.	Olson L 6rd, Soto AM, Knoop FC, Conlon JM.	Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.	
DRAMP02297	FPMKKSLLLIFFLGTINLSFCEEERNAEEEKRDGDDEMDVEVQKR	45	Gaegurin-6-RN antimicrobial peptide (Frogs, amphibians, animals)	C0ILG5, C0ILJ5	Not found	Not found	Rana nigrovittata (black-striped frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Comment: No comments found on DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71.	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP02298	FTMKKSLLLIFFLGTINLSLCEEERNAEEEKRDGDDEMDVEVQKR	45	Gaegurin-6-RN antimicrobial peptide (Frogs, amphibians, animals)	C0ILJ3, C0ILH9, C0ILH1, C0ILG3, C0ILJ4	Not found	Not found	Rana nigrovittata (black-striped frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Comment: No comments found on DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71.	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP02299	FTMKKSLLLLFFLGTINLSLCEKERNAEEEKRDGDDETDVEVQK	44	Gaegurin-6-RN antimicrobial peptide (Frogs, amphibians, animals)	C0ILJ2	Not found	Not found	Rana nigrovittata (black-striped frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Comment: No comments found on DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19778602	Genomics. 2010 Jan;95(1):66-71.	Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.	Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.	
DRAMP02301	MKIIVVLAVLMLVSAQVCLVSAAEMGHSSDNELSSRDLVKRFFLPPCAHKGTCGKRSIESSEGANGGE	68	Riparin-1.5 amide (Frogs, amphibians, animals)	A6MWT0	Not found	Not found	Crinia riparia (Streambank froglet) (Flinders Ranges froglet)	Unknown	Transcript level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys47 and Cys53.	L	No cytotoxicity information found	Not found	18601958	Regul Pept. 2008 Nov 29;151(1-3):80-87.	Jackway RJ, Pukala TL, Maselli VM, Musgrave IF, Bowie JH, Liu Y, Surinya-Johnson KH, Donnellan SC, Doyle JR, Llewellyn LE, Tyler MJ.	Disulfide-containing peptides from the glandular skin secretions of froglets of the genus Crinia: structure, activity and evolutionary trends.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP02302	FPLPCAYKGTYC	12	Riparin-1.3 (Frogs, amphibians, animals)	P86126	Not found	Not found	Crinia riparia (Streambank froglet) (Flinders Ranges froglet)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 5-12."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys5 and Cys12)	Disulfide bond between Cys5 and Cys12.	L	No cytotoxicity information found	Not found	16470724##18601958	Rapid Commun Mass Spectrom. 2006;20(5):797-803.##Regul Pept. 2008 Nov 29;151(1-3):80-87.	Maselli VM, Bilusich D, Bowie JH, Tyler MJ.##Jackway RJ, Pukala TL, Maselli VM, Musgrave IF, Bowie JH, Liu Y, Surinya-Johnson KH, Donnellan SC, Doyle JR, Llewellyn LE, Tyler MJ.	Host-defence skin peptides of the Australian Streambank Froglet Crinia riparia: isolation and sequence determination by positive and negative ion electrospray mass spectrometry.##Disulfide-containing peptides from the glandular skin secretions of froglets of the genus Crinia: structure, activity and evolutionary trends.	
DRAMP02303	MKIIVVLAVLMLVSAQVCLVSAAEMGHSSDNELSSRDLVKRFFLPPCAYKGTCNH	55	Riparin-1.4 (Frogs, amphibians, animals)	A6MWS7	Not found	Not found	Crinia riparia (Streambank froglet) (Flinders Ranges froglet)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 6-12."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys47 and Cys53.	L	No cytotoxicity information found	Not found	16470724	Rapid Commun Mass Spectrom. 2006;20(5):797-803.	Maselli VM, Bilusich D, Bowie JH, Tyler MJ.	Host-defence skin peptides of the Australian Streambank Froglet Crinia riparia: isolation and sequence determination by positive and negative ion electrospray mass spectrometry.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@H](C)CC
DRAMP02304	MKIIVFLAVLMLVSAQVCLVSAAEMEHSSDNELSSRDLVKRFFLPPCAHKGTCNH	55	Riparin-1.5 acid (Frogs, amphibians, animals)	A6MWS9	Not found	Not found	Crinia riparia (Streambank froglet) (Flinders Ranges froglet)	Unknown	Protein level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 6-12."	Comment: No comments found on DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys47 and Cys53.	L	No cytotoxicity information found	Not found	16470724	Rapid Commun Mass Spectrom. 2006;20(5):797-803.	Maselli VM, Bilusich D, Bowie JH, Tyler MJ.	Host-defence skin peptides of the Australian Streambank Froglet Crinia riparia: isolation and sequence determination by positive and negative ion electrospray mass spectrometry.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](C)NC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@H](C)CC
DRAMP02305	MKIIVFLAVLMLVSAQVCLVSAAEMEHSSDNELSSRDLVKRFPLPSCVYTRTCGKRDIESSEGANGGE	68	Riparin-1.6 (Frogs, amphibians, animals)	A6MWS8	Not found	Not found	Crinia riparia (Streambank froglet) (Flinders Ranges froglet)	Unknown	Transcript level	Not found	Not found		"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys47 and Cys53.	L	No cytotoxicity information found	Not found	18601958	Regul Pept. 2008 Nov 29;151(1-3):80-87.	Jackway RJ, Pukala TL, Maselli VM, Musgrave IF, Bowie JH, Liu Y, Surinya-Johnson KH, Donnellan SC, Doyle JR, Llewellyn LE, Tyler MJ.	Disulfide-containing peptides from the glandular skin secretions of froglets of the genus Crinia: structure, activity and evolutionary trends.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP02309	IIGHLIKTALGFLGL	15	Signiferin-2.2 (Frogs, amphibians, animals)	P86132	Not found	Not found	Crinia signifera (Common eastern froglet)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity against a wide spectrum of Gram-positive bacteria. Lacks antibacterial activity against the Gram-negative bacteria E. cloacae and E. coli.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation."	Gram-negative bacteria: Enterobacter cloacae ATCC 13047 (MIC≤100 µM), Escherichia coli ATCC3 5218 (MIC≤100 µM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15317042##16470724##18601958	Rapid Commun Mass Spectrom. 2004;18(18):2155-2161.##Rapid Commun Mass Spectrom. 2006;20(5):797-803.##Regul Pept. 2008 Nov 29;151(1-3):80-87.	Maselli VM, Brinkworth CS, Bowie JH, Tyler MJ.##Maselli VM, Bilusich D, Bowie JH, Tyler MJ.##Jackway RJ, Pukala TL, Maselli VM, Musgrave IF, Bowie JH, Liu Y, Surinya-Johnson KH, Donnellan SC, Doyle JR, Llewellyn LE, Tyler MJ.	Host-defence skin peptides of the Australian Common Froglet Crinia signifera: sequence determination using positive and negative ion electrospray mass spectra.##Host-defence skin peptides of the Australian Streambank Froglet Crinia riparia: isolation and sequence determination by positive and negative ion electrospray mass spectrometry.##Disulfide-containing peptides from the glandular skin secretions of froglets of the genus Crinia: structure, activity and evolutionary trends.	
DRAMP02310	AANFGPSVFTPEVHETWQKFLNVVVAALGKQYH	33	HbbetaP-1 (fish, chordates, animals)	No entry found	Not found	Not found	Ictalurus punctatus (Catfish)	Antimicrobial, Antibacterial, Antiparasitic	Not found	Not found	Not found		Function: Showes moderate activity against Gram-negative bacteria, Aeromonas hydrophila and Vibrio alginolyticus, but no activity against Gram-positive bacteria such as S. aureus, Streptococcus faecalis S. iniae.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18538841	Dev Comp Immunol. 2008;32(11):1301-1312. 	Ullal AJ, Litaker RW, Noga EJ.	Antimicrobial peptides derived from hemoglobin are expressed in epithelium of channel catfish (Ictalurus punctatus, Rafinesque).	
DRAMP02311	SGPVPSGCLRCICVVESGXRMPNPV	25	Lysozyme (1,4-beta-N-acetylmuramidase; starfish, chordates, animals)	P37715	Belongs to the glycosyl hydrolase 22 family	Not found	Asterias rubens (Common European starfish) (Asterias vulgaris)	Antimicrobial	Protein level	Not found	Not found		Catalytic activity: Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1149747	Eur J Biochem. 1975 May;54(1):19-23.	Jolles J, Jolles P.	The losozyme from Asterias rubens.	
DRAMP02313	QIHLSLCGLCCNCCHNIGCGFCCKF	25	Hepcidin-1 (fish, chordates, animals)	Q801Y3	Belongs to the hepcidin family	hamp1	Salmo salar (Atlantic salmon)	Unknown	Homology	Not found	Not found		"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12697315	Dev Comp Immunol. 2003 Jun-Jul;27(6-7):589-601.	Douglas SE, Gallant JW, Liebscher RS, Dacanay A, Tsoi SC.	Identification and expression analysis of hepcidin-like antimicrobial peptides in bony fish.	
DRAMP02319	FIGGIISLIKKLF	13	Grammistin Pp2a (Group II grammistin; fish, chordates, animals)	P69843	Belongs to the grammistin family (Group 2 subfamily)	Not found	Pogonoperca punctata (Clown grouper) (Bearded grouper)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Has lytic, hemolytic and antibacterial activities.	No MICs found in DRAMP database	[Swiss_Prot Entry P69843]has lytic, hemolytic and antibacterial activities	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Phospholipids	PubMed ID is not available	Fish. Sci. 2001 Feb;67:163-169.	Shiomi K, Yokota H, Nagashima Y, Ishida M.	Primary and secondary structures of grammistins, peptide toxins isolated from the skin secretion of the soapfish Pogonoperca punctata.	
DRAMP18268	ATYYGNGLYCNSKKCWVEWGITGGCLAQYAIGGWLGGAVPGKC	43	Enterocin NKR-5-3C(Bacteriocin)	I7H7S7	Belongs to the class IIa bacteriocin	enkC	Enterococcus faecium NKR-5-3	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Ent53C is a novel class IIa bacteriocin that contains a YGNVL motif sequence and two disul?de bridges. 		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25149515	Appl Environ Microbiol. 2014 Nov;80(21):6647-55. 	Ishibashi N, Himeno K, Masuda Y, Perez RH, Iwatani S, Zendo T, Wilaipun P, Leelawatcharamas V, Nakayama J, Sonomoto K.	Gene cluster responsible for secretion of and immunity to multiple bacteriocins, the NKR-5-3 enterocins.	
DRAMP02323	LFGFLIPLLPHLIGAIPQVIGAIR	24	Grammistin Pp4b (Group I grammistin; fish, chordates, animals)	P69838	Belongs to the grammistin family (Group 1 subfamily)	Not found	Pogonoperca punctata (Clown grouper) (Bearded grouper)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		MOA: Thanks to its abundant amphiphilic alpha-helices, it may integrate into membrane phospholipids, leading to lysis of the membrane. Has also ichthyotoxic activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Phospholipids	PubMed ID is not available	Fish. Sci. 2001 Feb;67:163-169.	Shiomi K, Yokota H, Nagashima Y, Ishida M.	Primary and secondary structures of grammistins, peptide toxins isolated from the skin secretion of the soapfish Pogonoperca punctata.	
DRAMP02325	FFHHIFRGIVHVGKTIHKLVTGG	23	Moronecidin 1 (fish, chordates, animals)	No entry found	Belongs to the pleurocidin family	Not found	Morone chrysops (white bass)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: Exhibits antimicrobial activity against fish bacterial pathogens, especially against species of Aeromonas, which may to certain extent reflect the pathogenicity of these bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11739390	J Biol Chem. 2002 Feb 15;277(7):5030-5039.	Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.	Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.	
DRAMP02326	FFHHIFRGIVHVGKTIHRLVTGG	23	Moronecidin 2 (fish, chordates, animals)	No entry found	Belongs to the pleurocidin family	Not found	Morone chrysops (white bass)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: Exhibits antimicrobial activity against fish bacterial pathogens, especially against species of Aeromonas, which may to certain extent reflect the pathogenicity of these bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11739390	J Biol Chem. 2002 Feb 15;277(7):5030-5039.	Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.	Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.	
DRAMP02327	FFHHIFRGIVHVGRTIHKLVTGG	23	Moronecidin 3 (fish, chordates, animals)	No entry found	Belongs to the pleurocidin family	Not found	Morone chrysops (white bass)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: Exhibits antimicrobial activity against fish bacterial pathogens, especially against species of Aeromonas, which may to certain extent reflect the pathogenicity of these bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11739390	J Biol Chem. 2002 Feb 15;277(7):5030-5039.	Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.	Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.	
DRAMP02328	FFHHIFRGIVHVGRTIHRLVTGG	23	Moronecidin 4 (fish, chordates, animals)	No entry found	Belongs to the pleurocidin family	Not found	Morone chrysops (white bass)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: Exhibits antimicrobial activity against fish bacterial pathogens, especially against species of Aeromonas, which may to certain extent reflect the pathogenicity of these bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11739390	J Biol Chem. 2002 Feb 15;277(7):5030-5039.	Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.	Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.	
DRAMP02329	IFHHIFKGIVHVGKTIHRLVTG	22	Moronecidin 5 (fish, chordates, animals)	No entry found	Belongs to the pleurocidin family	Not found	Morone chrysops (white bass)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: Exhibits antimicrobial activity against fish bacterial pathogens, especially against species of Aeromonas, which may to certain extent reflect the pathogenicity of these bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11739390	J Biol Chem. 2002 Feb 15;277(7):5030-5039.	Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.	Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.	
DRAMP02332	FIHHIFRGIVHAGRSIGRFLTG	22	Piscidin-3 (Pis-3; fish, chordates, animals)	P0C006	Belongs to the pleurocidin family	Not found	Morone chrysops x Morone saxatilis (white bass x striped sea-bass)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral	Protein level	Not found	Not found		"Function: Exhibits broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria. Has hemolytic activity.
Tissue specificity: Mast cells in gill, skin and gut, and in lining blood vessels in the viscera."	[Swiss_Prot Entry P0C006]broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria	[Ref.11713517]5% hemolytic activity at 100 μg/mL against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11713517	Nature. 2001 Nov 15;414(6861):268-269.	Silphaduang U, Noga EJ.	Peptide antibiotics in mast cells of fish.	
DRAMP02333	FFRHLFRGAKAIFRGARQGWRAHKVVSRYRNRDVPETDNNQEEP	44	Piscidin-4 (Pis-4; fish, chordates, animals)	E3UVF6	Belongs to the pleurocidin family	Not found	Morone chrysops x Morone saxatilis (white bass x striped sea-bass)	Antimicrobial, Antibacterial, Antiviral	Predicted	Not found	Not found		"Function: Piscidin 4 demonstrates potent, broad-spectrum, antibacterial activity against a number of fish and human pathogens, including multi-drug resistant bacteria.
Sequence similarity: It has considerable (to >65%) N-terminal sequence homology to piscidins 1-3."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19266617	Comp Biochem Physiol B Biochem Mol Biol. 2009 Apr;152(4):299-305.	Noga EJ, Silphaduang U, Park NG, Seo JK, Stephenson J, Kozlowicz S.	Piscidin 4, a novel member of the piscidin family of antimicrobial peptides.	
DRAMP02334	XSHLSLCRWCCNCCHNKGXGFCCKF	25	Hepcidin (fish, chordates, animals)	Q9DFD6	Belongs to the hepcidin family	hamp	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	Antimicrobial	Homology	Not found	Not found		"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11164886	Dev Comp Immunol. 2001 Apr;25(3):205-217.	Bayne CJ, Gerwick L, Fujiki K, Nakao M, Yano T.	Immune-relevant (including acute phase) genes identified in the livers of rainbow trout, Oncorhynchus mykiss, by means of suppression subtractive hybridization.	
DRAMP02335	SKGKKANKDVELARG	15	Oncorhyncin I (Oncorhyncin 1; fish, chordates, animals)	P83287	Not found	Not found	Oncorhynchus mykiss (Rainbow trout)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Planococcus citreus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10938737	Fish Shellfish Immunol. 2000 Apr;10(3):243-260.	Smith VJ, Fernandes JM, Jones SJ, Kemp GD, Tatner MF.	Antibacterial proteins in rainbow trout, Oncorhynchus mykiss.	
DRAMP02338	MVTLVLLVFLLLNVVEDEAASFPFSCPTLSGVCRKLCLPTEMFFGPLGCGKGFLCCVSHF	60	Beta-defensin 1 (fish, chordates, animals)	A6YT28	Not found	Not found	Oncorhynchus mykiss (Rainbow trout)	Antimicrobial	Transcript level	Bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases	Falco A, Chico V, Marroqui L, Perez L, Coll J.M, Estepa A.	Expression and antiviral activity of a beta-defensin-like peptide identified in the rainbow trout (Oncorhynchus mykiss) EST sequences.	
DRAMP02339	PKRKSATKGDEPA	13	Histone H6-like protein (fish, chordates, animals)	P83338	Not found	Not found	Oncorhynchus mykiss (Rainbow trout)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted APR-2002 to the SWISS-PROT data bank.	Fernandes JMO, Smith VJ.	Antimicrobial properties of a histone H6-like peptide from skin secretions of rainbow trout, Oncorhynchus mykiss.	
DRAMP02340	XXSVPAFGHYLPAXP	15	Salmocidin-1 (fish, chordates, animals)	P81369	Not found	Not found	Oncorhynchus mykiss (Rainbow trout)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAY-1998) to UniProtKB.	Henry M.A, Siegert K.J, Davidson I, Dunbar B, Mordue W, Secombes C.J.	Isolation and N-terminal sequencing of an antibacterial peptide in rainbow trout, Oncorhynchus mykiss.	
DRAMP02341	SGFVLKGYTKTSQ	13	Salmocidin-2A (fish, chordates, animals)	P82238	Not found	Not found	Oncorhynchus mykiss (Rainbow trout)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted DEC-1999 to the SWISS-PROT data bank.	Henry MA, Secombes CJ.	Purification and partial characterization of antibacterial peptides from rainbow trout, Oncorhynchus mykiss.	
DRAMP02342	AGFVLKGYTKTSQ	13	Salmocidin-IIb (fish, chordates, animals)	P82239	Not found	Not found	Oncorhynchus mykiss (Rainbow trout)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted DEC-1999 to the SWISS-PROT data bank.	Henry MA, Secombes CJ.	Purification and partial characterization of antibacterial peptides from rainbow trout, Oncorhynchus mykiss.	
DRAMP02343	XXPQQLGHVKAAXSDY	16	Salmocidin-3 (fish, chordates, animals)	P82240	Not found	Not found	Oncorhynchus mykiss (Rainbow trout)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-1999) to UniProtKB.	Henry M.A, Secombes C.J.	Purification and partial characterization of antibacterial peptides from rainbow trout, Oncorhynchus mykiss.	
DRAMP01375	GLGGAKKNFIIAANKTAPQSVKKTFSCKLYNG	32	Odorranain-E1 (OdE1; Frogs, amphibians, animals)	A6MBK8	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Odorranain-E1 adopts 100% turn structure in water solution.		Function: Odorranain-E1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Has no hemolytic activity against red cell.	[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=9.37 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=4.68 μg/ml), Bacillus subtilis (MIC=4.68 μg/ml).##Yeast: Candida albicans (MIC=9.37 μg/ml).	[Ref:17272268]Non-hemolytic activity against rabbit red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP02345	PEGQRALKRMARMTPLWRTMGTKPYGAYCLNNYECSTGICRGGHCMFSQPIKS	53	Liver-expressed antimicrobial peptide 2A (LEAP-2A; fish, chordates, animals)	Q64KQ7	Not found	LEAP-2A	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	Antimicrobial	Predicted	Not found	Not found		LEAP-2 is a blood-derived peptide expressed predominantly in the liver.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15350756	Vet Immunol Immunopathol. 2004 Oct;101(3-4):259-269.	Zhang YA, Zou J, Chang CI, Secombes CJ.	Discovery and characterization of two types of liver-expressed antimicrobial peptide 2 (LEAP-2) genes in rainbow trout.	
DRAMP02346	GVCLVALILMHQVCASPIGSHDSRLSLQQGTKLLERRTRMTPLWRFMGTKPTGAYCRDHFECSTQICRRGHCALSGA	77	Liver-expressed antimicrobial peptide 2B	No entry found	Not found	Not found	Oncorhynchus mykiss (rainbow trout)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Not found	Not found	Not found	Not found	
DRAMP02353	RSTEDIIKSISGGGFLNAMNA	21	Pleurocidin-like peptide WFX (fish, chordates, animals; Predicted)	Q7T053	Not found	ple6	Pseudopleuronectes americanus (Winter flounder) (Pleuronectes americanus)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Predicted	Not found	Not found		Function: Has antibacterial and antifungal activity.	Gram-negative bacteria: Aeromonas salmonicida A449 field isolate (MIC>64 µg/ml), A. salmonicida 97-4 field isolate (MIC>64 µg/ml), Pseudomonas aeruginosa K799 (MIC>64 µg/ml), Pseudomonas aeruginosa Z61 (MIC>64 µg/ml), Escherichia coli (MIC>64 µg/ml), Salmonella typhimurium 14028s (MIC>64 µg/ml), S. typhimurium MS7953s (MIC>64 µg/ml);##Gram-positive bacteria: Staphylococcus epidermidis (human clinical isolates) (MIC>64 µg/ml), Staphylococcus aureus (MRSA) (MIC>64 µg/ml).##Fungi: Candida albica (MIC>64 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12950255	Eur J Biochem. 2003 Sep;270(18):3720-3730.	Douglas SE, Patrzykat A, Pytyck J, Gallant JW.	Identification, structure and differential expression of novel pleurocidins clustered on the genome of the winter flounder, Pseudopleuronectes americanus (Walbaum).	
DRAMP18267	GLEESPGHPGQPGPPGPPGAPGP	23	BacFL31(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Enterococcus faecium FL31	Antimicrobial, Antibacterial, Anti-Gram+, Antilisterial		Pro-rich	It is usual that even in the N-terminal 23 residues sequenced, six prolines at positions 6,9,12,15,18, and 21 are hydroxylated.  		To our knowledge, BacFL31 is the first bacteriocin described as encompassing hydroxyproline residues. BacFL31 exerted bactericidal effect against L. monocytogenes and proved useful for the inhibition of the growth of L. monocytogenes in minced beef meat during storage at 4  Celsius degree. 	Gram-positive(certain)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24583094	Anaerobe. 2014 Jun;27:1-6.	Chakchouk-Mtibaa A, Elleuch L, Smaoui S, Najah S, Sellem I, Abdelkafi S, Mellouli L.	An antilisterial bacteriocin BacFL31 produced by Enterococcus faecium FL31 with a novel structure containing hydroxyproline residues.	
DRAMP02356	FLGLIFHGLVHAGKLIHGLIHRNRG	25	HKPLP (pleurocidin-like peptide; glycine-rich; fish, chordates, animals)	No entry found	Not found	Not found	Hippocampus kuda Bleeker (Sea horse)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22252202	J Antibiot (Tokyo). 2012 Mar;65(3):117-121.	Sun D, Wu S, Jing C, Zhang N, Liang D, Xu A.	Identification, synthesis and characterization of a novel antimicrobial peptide HKPLP derived from Hippocampus kuda Bleeker.	
DRAMP02369	LLAWCLVFLVIVQQVTSSPVPQSDTPLTSVQEVQRSLKRTARMTPLWRIMGTKPHGAYCQNHYECSTGICRKGHCSYS	78	Liver-expressed antimicrobial peptide 2 (fish, chordates, animals)	D0Q093	Not found	LEAP-2	Ctenopharyngodon idella (Grass carp) (Leuciscus idella)	Antimicrobial, Antibacterial, Anti-Gram-	Predicted	Not found	Not found		Grass carp LEAP-2 gene is expressed in a wide range of tissues except blood, with the highest level of transcripts found in liver. 	Gram-negative bacteria: Escherichia coli XC-1 and Aeromonas hydrophila S2.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19716607	Vet Immunol Immunopathol. 2010 Feb 15;133(2-4):133-143.	Liu F, Li JL, Yue GH, Fu JJ, Zhou ZF.	Molecular cloning and expression analysis of the liver-expressed antimicrobial peptide 2 (LEAP-2) gene in grass carp.	
DRAMP02370	KCCKKGGPRKCPPEGMTXFYERIFRI	26	Mucus envelope protein (parrotfish, chordates, animals)	P81557	Not found	Not found	Scarus vetula (Queen parrotfish)	Antimicrobial	Protein level	Not found	Not found		"Function: May have antimicrobial activity.
Tissue specificity: Produced by the opercular gland in the gill cavity and secreted as part of the mucus cocoon."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-1998) to UniProtKB	Videler H, Geertjes G.J, Videler J.J.	Biochemical characteristics and antibiotic properties of the mucus envelope of the queen parrotfish (Scarus vetula).	
DRAMP02371	MPVSVGSYGQQAQPSCFDRVKMGFMMGFAVGMAAGAMFGTFSCLRIGMRGRELMGGVGKTMMQSGGTFGTFMAIGMGIRC	80	Reactive oxygen species modulator 1 (ROS modulator 1; zebrafish, chordates, animals)	Q6NYD1	Belongs to the MGR2 family	romo1	Danio rerio (Zebrafish) (Brachydanio rerio)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Has antibacterial activity against a variety of bacteria. Acts by inducing bacterial membrane breakage (By similarity).
Induces production of reactive oxygen species (ROS) which are necessary for cell proliferation. May play a role in inducing oxidative DNA damage and replicative senescence. May play a role in the coordination of mitochondrial morphology and cell proliferation."	S. aureus, Pseudomonas aeruginosa and M. tuberculosis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases	Unknown	NIH - Zebrafish Gene Collection (ZGC) project	
DRAMP02372	QSHLSLCRFCCKCCRNKGCGYCCKF	25	Hepcidin-1 (zebrafish, chordates, animals)	P61516	Belongs to the hepcidin family	hamp1	Danio rerio (Zebrafish) (Brachydanio rerio)	Antimicrobial 	Homology	Not found	Not found		"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15043943	Dev Comp Immunol. 2004 Jun;28(7-8):747-754.	Shike H, Shimizu C, Lauth X, Burns JC.	Organization and expression analysis of the zebrafish hepcidin gene, an antimicrobial peptide gene conserved among vertebrates.	
DRAMP18266	TYYGNGLYCNKEKCWVDWNQAKGEIGKIIVNGWVNH	36	Bacteriocin T8(Bacteriocin)	Q27HG2	Belongs to the class IIa bacteriocin	bacA	Enterococcus faecium (Streptococcus faecium)	Antimicrobial, Antibacterial, Anti-Gram+		Not found	The predicted mature BacA protein (44 amino acids) showed sequence homology with the membrane-active class IIa bacteriocins of lactic acid bacteria and showed 86% homology with bacteriocin 31 from E. faecalis YI717 and 98% homology with bacteriocin RC714.		Fuction: Bacteriocin T8 is active against E. faecalis isolated from patients diagnosed with vaginosis, against Lactobacillus sakei, and against a Propionibacterium sp. The peptide is heat stable (60 min at 100 degrees C) and remains active in phosphate buffer from pH 4.0 to 10.0.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16820469##17088377 	Appl Environ Microbiol. 2006 Jul;72(7):4761-6.##Appl Environ Microbiol. 2006 Nov;72(11):6955-64. 	De Kwaadsteniet M, Fraser T, Van Reenen CA, Dicks LM.##Todokoro D, Tomita H, Inoue T, Ike Y.	Bacteriocin T8, a novel class IIa sec-dependent bacteriocin produced by Enterococcus faecium T8, isolated from vaginal secretions of children infected with human immunodeficiency virus.##Genetic analysis of bacteriocin 43 of vancomycin-resistant Enterococcus faecium.	
DRAMP02375	RQRVEELSKFSKKGAAARRRK	21	Misgurin (weatherfish, chordates, animals)	P81474	Not found	Not found	Misgurnus anguillicaudatus (Oriental weatherfish) (Oriental weatherloach)	Antimicrobial, Antibacterial, Antifungal	Protein level	Alpha helix 	Not found		Comment: No comments found on DRAMP database	B.subtilus, Staphylococcus aureus, Streptococcus mutans, Streptococcus pneumoniae, Pseudomonas putida, Escherichia coli, Salmonella typhimurium, Serratia spps, Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9271200	FEBS Lett. 1997 Jul 14;411(2-3):173-178.	Park CB, Lee JH, Park IY, Kim MS, Kim SC.	A novel antimicrobial peptide from the loach, Misgurnus anguillicaudatus.	
DRAMP02383	ASFPWSCPSLSGVCRKVCLPTELFFGPLGCGKGFLCGVSHFL	42	saBD (seabream beta defensin; fish, chordates, animals)	No entry found	Not found	Not found	Sparus aurata (Teleost fish gilthead seabream)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Its gene is constitutively expressed and upregulated by CpG ODNs. It is also chemotactic activity to leukocytes.	Vibrio anguillarum (a seabream pathogenic bacterium), Bacillus subtilis (strong activity); Vibrio harvey and Photobacterium damselae (little activity).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21497909	Mol Immunol. 2011 Jul;48(12-13):1432-1438.	Cuesta A, Meseguer J, Esteban MÃ.	Molecular and functional characterization of the gilthead seabream ?-defensin demonstrate its chemotactic and antimicrobial activity.	
DRAMP02384	SPAGCRFCCGCCPNMRGCGVCCRF	24	Hepcidin AS-hepc2 (fish, chordates, animals)	Q68M56	Not found	Not found	Acanthopagrus schlegelii (Black porgy)	Not found	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21073978	Comp Biochem Physiol B Biochem Mol Biol. 2011 Feb;158(2):155-163.	Yang M, Chen B, Cai JJ, Peng H, Ling-Cai, Yuan JJ, Wang KJ.	Molecular characterization of hepcidin AS-hepc2 and AS-hepc6 in black porgy (Acanthopagrus schlegelii): expression pattern responded to bacterial challenge and in vitro antimicrobial activity.	
DRAMP02385	CRFCCRCCPRMRGCGLCCRF	20	Hepcidin AS-hepc6 (fish, chordates, animals)	Q68M52	Not found	Not found	Acanthopagrus schlegelii (Black porgy)	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Pdp11 (IC50=2.20 µM), 51M6 (IC50=14.61 µM), Bacillus subtilis CECT 35 (IC50=11.41 µM), Escherichia coli DH5Î± (IC50=18.66 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18164062	Mol Immunol. 2008 Apr;45(8):2333-2342.	Cuesta A, Meseguer J, Esteban MA.	The antimicrobial peptide hepcidin exerts an important role in the innate immunity against bacteria in the bony fish giltherad seabream.	
DRAMP02387	PDPAKTAPKKKSKKAVT	17	Histone HIIb-3 (Antibacterial histone-like protein 3, HLP-3; catfishes, chordates, animals)	P81904	Belongs to the histone H2B family	Not found	Ictalurus punctatus (Channel catfish)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.	Aeromonas hydrophila, Saprolegnia spp.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9645227	Cell Mol Life Sci. 1998 May;54(5):467-475.	Robinette D, Wada S, Arroll T, Levy MG, Miller WL, Noga EJ.	Antimicrobial activity in the skin of the channel catfish Ictalurus punctatus: characterization of broad-spectrum histone-like antimicrobial proteins.	
DRAMP02388	PDPAKTAPKKGSKKAVTKXA	20	Histone HIIb-1 (Antibacterial histone-like protein 1, HLP-1; catfishes, chordates, animals)	P81903	Belongs to the histone H2B family	Not found	Ictalurus punctatus (Channel catfish)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Function: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. 	Aeromonas hydrophila, vibrio alginolyticus, Escherichia coli D31, Saprolegnia spp.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9645227	Cell Mol Life Sci. 1998 May;54(5):467-475.	Robinette D, Wada S, Arroll T, Levy MG, Miller WL, Noga EJ.	Antimicrobial activity in the skin of the channel catfish Ictalurus punctatus: characterization of broad-spectrum histone-like antimicrobial proteins.	
DRAMP02389	FKVQNQHGQVVKIFHH	16	Astacidin 1 (crayfish, Arthropods, animals)	No entry found	Not found	Not found	Not found	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17049601	Dev Comp Immunol. 2007;31(5):441-455. 	Jiravanichpaisal P, Lee SY, Kim YA, Andrén T, Söderhäll I.	Antibacterial peptides in hemocytes and hematopoietic tissue from freshwater crayfish Pacifastacus leniusculus: characterization and expression pattern.	
DRAMP02392	GWFKKAWRKVKNAGRVLKGVGIHYGVGLIG	30	Hematopoietic antimicrobial peptide-29 (MgCath29; hagfishes, chordates, animals)	Q71MD5	Not found	CATH29	Myxine glutinosa (Atlantic hagfish)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15019197	Peptides. 2003 Nov;24(11):1655-1667.	Uzzell T, Stolzenberg ED, Shinnar AE, Zasloff M.	Hagfish intestinal antimicrobial peptides are ancient cathelicidins.	
DRAMP02245	GLFLDTLKGLAGKLLQGLKCIKAGCKP	27	Ranatuerin-2Cb (Ranatuerin 2Cb; Frogs, amphibians, animals)	P82879	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana clamitans (Green frog) (Lithobates clamitans)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. 
Tissue specificity: Expressed by the skin glands."	[Ref.10822101] Gram-positive bacterium: Staphylococcus aureus (MIC=40 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=2 μg/ml).##Yeast: Candida albicans (MIC=46 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10822101	Peptides. 2000 Apr;21(4):469-476.	Halverson T, Basir YJ, Knoop FC, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.	
DRAMP02398	GPVGLLSSPGSLPPVGGAP	19	Antimicrobial peptide GP-19 (GP-19)	B3A0L2	Not found	Not found	Xenorhabdus budapestensis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: GP-19 displays broad-spectrum antimicrobial activity against the tested bacteria and fungi.	Gram-positive bacteria: Bacillus subtilis (IZ=19.04±0.2 mm), Bacillus megaterium (IZ=7.3±0.28 mm), Prototheca wickerhamii (IZ=10.3±0.33 mm);##Gram-negative bacteria: Xanthomonas campestris pv. vesicatoria (IZ=16.47±0.35 mm), Pseudomonas solanacearum (IZ=10.75±0.41 mm).##fungi: Phytophthora capsici (CD=16.62±1.07 mm), Verticillium dahlia (EC50=17.54 µg/ml), Fusarium graminearum (CD=12.04±0.87 mm), Fusarium omysporum (CD=21.64±0.4 mm).##NOTE: IZ = Inhibition Zone and CD = Colony diameter.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22497806	Peptides. 2012 Jun;35(2):253-260.	Xiao Y, Meng F, Qiu D, Yang X.	Two novel antimicrobial peptides purified from the symbiotic bacteria Xenorhabdus budapestensis NMC-10.	
DRAMP02399	EGPVGLADPDGPASAPLGAP	20	Antimicrobial peptide EP-20 (EP-20)	B3A0L3	Not found	Not found	Xenorhabdus budapestensis	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: EP-20 showes high inhibition against P. capsici but lower antibacterial activity.	Fungi: Phytophthora capsici (EC50=3.14 µg/ml), Verticillium dahlia (CD=19.32±1.31 mm), Fusarium graminearum (CD=12.45±1.6 mm), Fusarium oxysporum (CD=21.29±1.1 mm).##NOTE: CD = Colony diameter.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22497806	Peptides. 2012 Jun;35(2):253-260.	Xiao Y, Meng F, Qiu D, Yang X.	Two novel antimicrobial peptides purified from the symbiotic bacteria Xenorhabdus budapestensis NMC-10.	
DRAMP02400	GCPQTPRCTNYAEKGQCPPN	20	Antimicrobial peptide AJN-10 (AJN-10)	P0DJ30	Not found	Not found	Anguilla japonica (Japanese eel)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Function: Displays antimicrobial activity against the Gram-negative bacterium A.hydrophila.	Gram-negative bacterium: Aeromonas hydrophila.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21796440	Protein J. 2011 Aug;30(6):413-421.	Liang Y, Guan R, Huang W, Xu T.	Isolation and identification of a novel inducible antibacterial peptide from the skin mucus of Japanese eel, Anguilla japonica.	
DRAMP18265	MAKEFGIPAAVAGTVLNVVEAGGWVTTIVSILTAVGSGGLSLLAAAGRESIKAYLKKEIKKKGKRAVIAW	70	Enterocin RM6 (Bacteriocin)	No entry found	Belongs to the class IIc bacteriocin	Not found	Enterococcus faecalis OSY-RM6	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Tandem mass spectrometry (MS/MS) analysis revealed that enterocin RM6 is a 70-residue cyclic peptide with a head-to-tail linkage between methionine and tryptophan residues.	1E68	Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23844357	Biomed Res Int. 2013;2013:206917.	Huang E, Zhang L, Chung YK, Zheng Z, Yousef AE.	Characterization and application of enterocin RM6, a bacteriocin from Enterococcus faecalis.	
DRAMP02404	CPAIQRCCQQLRNIQPPCRCCQ	22	Chitin-binding protein 3 (Mo-CBP3)	P86528	Not found	Not found	Moringa oleifera (Horseradish tree) (Moringa pterygosperma)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Chitin binding protein. Has antifungal activity against F. solani. Not toxic to mice. Acts as a flocculent.
PTM: Glycosylated; contains 2.5% carbohydrates.
Miscellaneous: On the 2D-gel the determined pI of this protein is: 10.8, its MW is: 14.34 kDa."	Fungi: Fusarium solani.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	PubMed ID is not available	Thesis (2010), Federal University of Ceara, Brazil	Gifoni J.M.	Isolation and biochemical characterization of a new thermostable antifungal chitin-binding protein from Moringa oleifera seeds.	
DRAMP02405	QSERFEQQMQGQDFSHDERFLSQAA	25	Antifungal protein 1 (Pf-AFP1; Plants)	P84884	Belongs to the 2S seed storage albumins family	Not found	Passiflora edulis (Passion fruit)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Function: Has strong antifungal activity against T. harzianum, F. oxysporum and A. fumigatus. Lacks antifungal activity against R. solani, P. brasiliensis and C. albicans.
Tissue specificity: Expressed in seed (at protein level). Not detected in pulp, stems and leaves.
Developmental stage: Expressed in dormant seed."	Fungi: Trichoderma harzianum (IC50=32 µg/ml), Fusarium oxysporum (IC50=34 µg/ml), Aspergillus fumigatus (IC50=40 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16766236	Biochim Biophys Acta. 2006 Jun;1764(6):1141-6.	Pelegrini PB, Noronha EF, Muniz MA, Vasconcelos IM, Chiarello MD, Oliveira JT, Franco OL.	An antifungal peptide from passion fruit (Passiflora edulis) seeds with similarities to 2S albumin proteins.	
DRAMP02406	QEGCEWESRPCNRGCWLPRQWESVHMRFGVLVLWRAPQFEHFRECCNELRCEALRCMMRMRMEYWPRGLQDQQVYQRARDLEPRKHCGMSYPVECRMPR	99	Antimicrobial protein 2 (Si-AMP2; Plants)	B3EWE9	Belongs to the 2S seed storage albumins family	Not found	Sesamum indicum (Oriental sesame) (Sesamum orientale)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Has antibacterial activity against Gram-negative Klebsiella sp. but not against E. coli, Proteus sp., Salmonella sp. and Xanthomonas sp. or against Gram-positive bacteria S.pyogenes, S. aureus and Rathayibacter sp. Has no antifungal activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21691771	Protein J. 2011 Jun;30(5):340-350.	Maria-Neto S, Honorato RV, Costa FT, Almeida RG, Amaro DS, Oliveira JT, Vasconcelos IM, Franco OL.	Bactericidal activity identified in 2S Albumin from sesame seeds and in silico studies of structure-function relations.	
DRAMP02407	PAQPFRIKKRQGPFERP	17	Napin-like polypeptide (Contains: Napin-like polypeptide small chain and large chain)	P84782	Belongs to the 2S seed storage albumins family	Not found	Brassica oleracea var. alboglabra (Chinese kale) (Brassicaalboglabra)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Inhibits cell-free protein synthesis. Inhibits trypsin and chymotrypsin. Does not inhibit ribonuclease of protease activity. Has antibacterial activity except Gram-positive bacterium S. aureus or the Gram-negative bacteria E. coli, E. aerogenes, P. aeruginosa and P. vulgaris. Inhibits the proliferation of leukemia cells in vitro.
Subunit structure: The mature protein consists of a small and a large chain linked by disulfide bonds (sequence shown is small chain).
Biophysicochemical properties: This activity is preserved between pH 5 and pH 11, and between 10 and 40 degrees C. It falls to a low level at pH 3 and pH 13 and at 70 degrees C."	Gram-negative bacterium: Pseudomonas fluorescens (IC50=89±6.1 µM);##Gram-positive bacteria: Bacillus subtilis (IC50=278±12.9 µM), B. cereus (IC50=145±83 µM), Bacillus megaterium (IC50=156±8.4 µM), Megabacterium phlei (IC50=104±27 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15485558	J Pept Res. 2004 Nov;64(5):202-208.	A napin-like polypeptide with translation-inhibitory, trypsin-inhibitory, antiproliferative and antibacterial activities from kale seeds.	A napin-like polypeptide with translation-inhibitory, trypsin-inhibitory, antiproliferative and antibacterial activities from kale seeds.	
DRAMP02408	PVSRQQCSQRIQGERFNQCRSQMQDGQLQSCCQELQNVEEQCQC	44	2S albumin (To-A1)	P86783	Belongs to the 2S seed storage albumins family	Not found	Taraxacum officinale (Common dandelion) (Leontodon taraxacum)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: This is a 2S seed storage protein. Has antifungal activity. Inhibits growth of H.sativum, V.albo-atrum and P. infestans.
Subunit structure: The sequence shown is the mature protein which consists of a small and a large chain linked by 2 disulfide bonds."	Fungi: Helminthosporium sativum (IC50=62.5 µg/ml), Pemphigus betae (IC50=62.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19594427	Protein Pept Lett. 2010 Apr;17(4):522-529.	Odintsova TI, Rogozhin EA, Sklyar IV, Musolyamov AK, Kudryavtsev AM, Pukhalsky VA, Smirnov AN, Grishin EV, Egorov TA.	Antifungal activity of storage 2S albumins from seeds of the invasive weed dandelion Taraxacum officinale Wigg.	
DRAMP02413	GYGCPFNQYQCHSHCRGIRGYKGGYCTGRFKQTCKCY	37	Ornithodoros defensin B (Ticks, Arthropods, animals)	Q9BLJ4	Not found	omdef-B	Ornithodoros moubata (Soft tick) (Argasid tick)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11378409	Insect Biochem Mol Biol. 2001 Jun 22;31(8):747-751.	Nakajima Y, van der Goes van Naters-Yasui A, Taylor D, Yamakawa M.	Two isoforms of a member of the arthropod defensin family from the soft tick, Ornithodoros moubata (Acari: Argasidae).	
DRAMP02414	GYGCPFNQYQCHSHCSGIRGYKGGYCKGLFKQTCNCY	37	Ornithodoros defensin C (Ticks, Arthropods, animals)	Q8MY08	Not found	omdef-C	Ornithodoros moubata (Soft tick) (Argasid tick)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11378409	Insect Biochem Mol Biol. 2001 Jun 22;31(8):747-751.	Nakajima Y, van der Goes van Naters-Yasui A, Taylor D, Yamakawa M.	Two isoforms of a member of the arthropod defensin family from the soft tick, Ornithodoros moubata (Acari: Argasidae).	
DRAMP02415	GFGCPFNQYECHAHCSGVPGYKGGYCKGLFKQTCNCY	37	Ornithodoros defensin D (Ticks, Arthropods, animals)	Q8MY07	Not found	omdef-D	Ornithodoros moubata (Soft tick) (Argasid tick)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11378409	Insect Biochem Mol Biol. 2001 Jun 22;31(8):747-751.	Nakajima Y, van der Goes van Naters-Yasui A, Taylor D, Yamakawa M.	Two isoforms of a member of the arthropod defensin family from the soft tick, Ornithodoros moubata (Acari: Argasidae).	
DRAMP02416	GYGCPFNQYQCHSHCSGIRGYKGGYCKGTFKQTCKCY	37	Orinthodoros defensin A (Ticks, Arthropods, animals)	Q9BLJ3	Not found	omdef-A	Ornithodoros moubata (Soft tick) (Argasid tick)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11378409	Insect Biochem Mol Biol. 2001 Jun 22;31(8):747-751.	Nakajima Y, van der Goes van Naters-Yasui A, Taylor D, Yamakawa M.	Two isoforms of a member of the arthropod defensin family from the soft tick, Ornithodoros moubata (Acari: Argasidae).	
DRAMP02417	MVRARRGCGCPLNQGACHRHCKSIGRRGGYCAGFLKQTCTCYRN	44	Defensin (Ticks, Arthropods, animals)	B2D2C0	Belongs to the invertebrate defensin family	Not found	Ornithodoros coriaceus (Soft tick) (Argasid tick)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Antibacterial peptide mostly active against Gram-positive bacteria (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18725333	J Proteomics. 2008 Dec 2;71(5):493-512.	Francischetti IM, Meng Z, Mans BJ, Gudderra N, Hall M, Veenstra TD, Pham VM, Kotsyfakis M, Ribeiro JM.	An insight into the salivary transcriptome and proteome of the soft tick and vector of epizootic bovine abortion, Ornithodoros coriaceus.	
DRAMP02418	GFGCPLNQGACHNHCRSIGRRGGYCAGIIKQTCTCYRK	38	Longicin (Ticks, Arthropods, animals)	No entry found	Not found	Not found	Haemaphysalis longicornis (Tick)	Antimicrobial, Antibacterial, Antifungal, Antiparasitic	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17485458	Infect Immun. 2007 Jul;75(7):3633-3640.	Tsuji N, Battsetseg B, Boldbaatar D, Miyoshi T, Xuan X, Oliver JH Jr, Fujisaki K.	Babesial vector tick defensin against Babesia sp. parasites.	
DRAMP02420	FDNPFGCPADEGKCFDHCNNKAYDIGYCGGSYRATCVCYRK	41	Amblyomma defensin peptide 1 (ADP-1; Ticks, Arthropods, animals)	No entry found	Not found	Not found	Amblyomma hebraeum (Tick)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14705963	Biochem J. 2004 May 1;379(Pt 3):681-685.	Lai R, Lomas LO, Jonczy J, Turner PC, Rees HH.	Two novel non-cationic defensin-like antimicrobial peptides from haemolymph of the female tick, Amblyomma hebraeum.	
DRAMP02424	GFGCPFNQGACHRHCRSIRRRGGYCAGLIKQTCTCYRN	38	Defensin (Ticks, Arthropods, animals)	Q86LE4	Belongs to the invertebrate defensin family (Type 2 subfamily)	Not found	Boophilus microplus (Cattle tick)	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14642886	Dev. Comp. Immunol. 2004;28:191-200.	Fogaca A.C, Lorenzini D.M, Kaku L.M, Esteves E, Bulet P, Daffre S.	Cysteine-rich antimicrobial peptides of the cattle tick Boophilus microplus: isolation, structural characterization and tissue expression profile.	
DRAMP02426	GFGCPLNQGACHNHCRSIRRRGGYCSGIIKQTCTCY	36	Defensin (Varisin A1; Ticks, Arthropods, animals)	Q86QI5	Belongs to the invertebrate defensin family (Type 2 subfamily)	VSNA1	Dermacentor variabilis (American dog tick)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Bridge	Not found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
PTM: Problely contains three disulfide bonds 4-25; 11-33; 15-35."	Gram-positive bacteria: Bacillus subtilis, Borrelia burgdorferi.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11439245##14563361	Insect Biochem Mol Biol. 2001 Jul 26;31(9):857-865.##Insect Biochem Mol Biol. 2003 Nov;33(11):1099-1103.	Johns R, Sonenshine D.E, Hynes W.L.##Ceraul SM, Sonenshine DE, Ratzlaff RE, Hynes WL.	Identification of a defensin from the hemolymph of the American dog tick, Dermacentor variabilis.##An arthropod defensin expressed by the hemocytes of the American dog tick, Dermacentor variabilis (Acari: Ixodidae).	
DRAMP02431	HHVELCKKNDAELKEALTCITSKLPAALGCNDKSCVFEKLCKEGDLDEALKKHFTEAEVQTLHTTATDCDHSHGHEHSHGHEHGHGHH	88	Antimicrobial peptide microplusin (Ticks, Arthropods, animals)	B7PCF6	Not found	Not found	Ixodes scapularis (Black-legged tick) (Deer tick)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Has bacteriostatic activity against Gram-positive bacteria, but not against Gram-negative bacteria. Has fungistatic activity against some but not all fungi. Binds and sequesters copper and iron ions. Copper-chelating is crucial for antimicrobial activity against M. luteus.
PTM: Contains three disulfide bonds 6-41; 19-69; 30-35."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAR-2008) to the EMBL/GenBank/DDBJ databases	Caler E, Hannick L I, Bidwell S. et al.	Annotation of Ixodes scapularis.	
DRAMP02435	LSKFGGECSLKHNTCTYLKGGKNHVVNCGSAANKKCKSDRHHCEYDEHHKRVDCQTPV	58	Antifungal protein (PgAFP; Cys-rich)	D0EXD3, B6GXZ8	Not found	afp	Penicillium chrysogenum (Penicillium notatum)	Antimicrobial, Antibacterial, Antifungal, Antiparasitic	Protein level	Not found	Not found	7BAD##7BAE##7BAF##2NC2	"Function: Has strong antifungal activity against the molds Polytrichum commune Pc332, Penicillium echinulatum Pe321, and Aspergillus niger An261.
PTM: Contains three disulfide bonds (By similarity)."	Fungi: Polytrichum commune Pc332, Penicillium echinulatum Pe321, Aspergillus niger An261.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19914321##19683356	Peptides. 2010 Apr;31(4):541-547.##Int J Food Microbiol. 2009 Sep 30;135(1):39-46.	Rodríguez-Martín A, Acosta R, Liddell S, Núñez F, Benito MJ, Asensio MA.##Acosta R, Rodríguez-Martín A, Martín A, Núñez F, Asensio MA.	Characterization of the novel antifungal protein PgAFP and the encoding gene of Penicillium chrysogenum.##Selection of antifungal protein-producing molds from dry-cured meat products.	
DRAMP02436	EQPGGDKVNLGYFTN	15	Chitinase	P84754	Belongs to the glycosyl hydrolase 18 family Chitinase (class	Not found	Streptomyces violaceus (Streptomyces venezuelae)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity.
Catalytic activity: Random hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins.
Enzyme regulation: Inhibited by divalent metal ions. Maximum inhibition observed with Ca2+ while the least inhibition was observed with Fe2+. Inhibited by high concentrations of GlcNAc.
Biophysicochemical properties: pH dependence (Optimum pH is 6-8. There is a 37.7% decrease in activity at pH 5 and a 39.8% decrease in activity at pH 9); Temperature dependence (Optimum temperature is 35 degrees Celsius)."	Fungi: Aspergillus niger, Alternaria alternata, Hordeum sativum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	PubMed ID is not available##16972135	Thesis (2005), Visva Bharati (Central University), India.##Curr Microbiol. 2006 Oct;53(4):265-269.	Mukherjee G.##Mukherjee G, Sen SK.	Extracellular production of chitinase by Streptomyces venezuelae.##Purification, characterization, and antifungal activity of chitinase from Streptomyces venezuelae P(10).	
DRAMP02437	GFWKKVGSAAWGGVKAAAKGAAVGGLNALAKHIQ	34	Papillosin	P86416	Not found	Not found	Halocynthia papillosa (Red sea-squirt)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has strong antibacterial activity against the Gram-positive bacteria M. luteus, S. aureus, B. megaterium, A. viridans and E. faecalis, and against the Gram-negative bacteria K. pneumoniae, E. coli DH5alpha, S. typhimurium, P. aeruginosa and E. aerogenes. Lacks hemolytic activity against sheep erythrocytes.	[Ref.19085906]Gram-positive bacteria (Native, Synthetic): Micrococcus luteus A270 (MBC=0.13-0.25, 0.19-0.39 µM), Aerococcus viridans 54.145 T (MBC=ND, 0.19-0.39 µM), Bacillus megaterium 66.20 T (MBC=ND, 0.05-0.10 µM), Staphylococcus aureus 65.8 T (MBC=0.5-1.00, 1.56-3.13 µM), Enterococcus faecalis 103015 T (MBC=ND, 0.78-1.56 µM);##Gram-negative bacteria (Native, Synthetic): Enterobacter aerogenes 30.86 T (MBC=ND, 0.78-1.56 µM), Pseudomonas aeruginosa 100720 T (MBC=ND, 3.13-6.25 µM), Salmonella thyphimurium 60.62 T (MBC=ND, 0.78-1.56 µM), Klebsiella pneumoniae 82.91 T (MBC=ND, 0.39-0.78 µM), Escherichia coli (MBC=0.25-0.50, 0.78-1.56 µM)	[Ref.19085906]0% hemolytic activity at 50 μM against sheep erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19085906	J Pept Sci. 2009 Jan;15(1):48-55.	Galinier R, Roger E, Sautiere PE, Aumelas A, Banaigs B, Mitta G.	Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa.	
DRAMP02438	FWGHIWNAVKRVGANALHGAVTGALS	26	Halocyntin	P86415	Not found	Not found	Halocynthia papillosa (Red sea-squirt)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has strong antibacterial activity against the Gram-positive bacteria M. luteus, S. aureus, B. megaterium, A. viridans and E. faecalis, and against the Gram-negative bacterium K. pneumoniae. Has less potent antibacterial activity against the Gram-negative bacteria E. coli DH5alpha, S. typhimurium, P. aeruginosa, E. aerogenes and N. gonorrhoeae. Has moderate hemolytic activity against sheep erythrocytes.	[Ref.19085906]Gram-positive bacteria (Native, Synthetic): Micrococcus luteus A270 (MBC=0.39-0.78, 0.39-0.78 µM), Aerococcus viridans 54.145 T (MBC=3.13-6.25, 0.78-1.56 µM), Bacillus megaterium 66.20 T (MBC=0.75-1.56, 0.39-0.78 µM), Staphylococcus aureus 65.8 T (MBC=6.25-12.50, 1.56-3.13 µM), Enterococcus faecalis 103015 T (MBC=6.25-12.50, 1.56-3.13 µM);##Gram-negative bacteria (Native, Synthetic): Enterobacter aerogenes 30.86 T (MBC=25-50, 6.25-12.50 µM), Pseudomonas aeruginosa 100720 T (MBC>100, 25-50 µM), Salmonella thyphimurium 60.62 T (MBC=50-100, 12.50-25 µM), Klebsiella pneumoniae 82.91 T (MBC=12.50-25, 1.56-3.13 µM), Neisseria gonorrhoeae 103711 (MBC=25-50, ND µM), Escherichia coli (MBC=6.25-12.50, 6.25-12.50 µM).	[Ref.19085906]8% hemolytic activity at 6.25 μM, 13% hemolytic activity at 12.5 μM, 14% hemolytic activity at 25 μM, 22% hemolytic activity at 50 μM against sheep erythrocytes 	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19085906	J Pept Sci. 2009 Jan;15(1):48-55.	Galinier R, Roger E, Sautiere PE, Aumelas A, Banaigs B, Mitta G.	Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa.	
DRAMP02440	MKRNQKEWESVSKKGLMKPGGTSIVKAAGCMGCWASKSIAMTRVCALPHPAMRAI	55	Sporulation-killing factor SkfA	O31422	Not found	Not found	Bacillus subtilis (strain 168)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Induces the lysis of other B. subtilis cells that have not entered the sporulation pathway, providing a source of nutrients to support sporulation. Can also inhibit growth of other bacteria at high concentrations. Has a role in protecting the secreted lipase LipA against proteolysis, either by modulating its folding or by acting as a protease inhibitor.
Induction: By Spo0A and PhoP, during nutrient starvation, especially phosphate starvation. Repressed by AbrB during normal growth when nutrients are plentiful, in association with the transcriptional repressor Abh."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12817086##15812018##16816204	Science. 2003 Jul 25;301(5632):510-513.##Appl Environ Microbiol. 2005 Apr;71(4):1899-1908.##J Bacteriol. 2006 Jul;188(14):5299-5303.	González-Pastor JE, Hobbs EC, Losick R.##Westers H, Braun PG, Westers L, Antelmann H, Hecker M, Jongbloed JD, Yoshikawa H, Tanaka T, van Dijl JM, Quax WJ.##Allenby NE, Watts CA, Homuth G, Prágai Z, Wipat A, Ward AC, Harwood CR.	Cannibalism by sporulating bacteria.##Genes involved in SkfA killing factor production protect a Bacillus subtilis lipase against proteolysis.##Phosphate starvation induces the sporulation killing factor of Bacillus subtilis.	
DRAMP02442	WKSESVCTPGCVTGVLQTCFLQTITCNCHISK	32	Ericin S (lantibiotic-like peptide)	No entry found	Not found	Not found	Bacillus subtilis A1/3 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Rich 	Not found		Comment: No comments found on DRAMP database	B. amyloliquefaciens ATCC 15841, B. brevis ATCC 7577, B. cereus ATCC 14579, B. firmus ATCC 14575, B. polymyxa ATCC 842, B. sphaericus ATCC 14577, Bacillus subtilis natto DSM 1088, Bacillus subtilis DSM 3256, Bacillus subtilis DSM 3258, L. lactis IL-1403.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11872722	J. Bacteriol. 2002; 184:1703-1711.	Stein T, Borchert S, Conrad B, Feesche J, Hofemeister B, Hofemeister J, Entian KD.	Two different lantibiotic-like peptides originate from the ericin gene cluster of Bacillus subtilis A1/3.	
DRAMP02443	VLSKSLCTPGCITGPLQTCYLCFPTFAKC	29	Ericin A (lantibiotic-like peptide)	No entry found	Not found	Not found	Bacillus subtilis A1/3 (Gram-positive bacteria)	Antimicrobial, Antibacterial	Not found	Rich 	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11872722	J. Bacteriol. 2002; 184:1703-1711.	Stein T, Borchert S, Conrad B, Feesche J, Hofemeister B, Hofemeister J, Entian KD.	Two different lantibiotic-like peptides originate from the ericin gene cluster of Bacillus subtilis A1/3.	
DRAMP18264	VTTSIPCTVMVSAAVCPTLVCSNKCGGRG	29	Enterocin W beta(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Enterococcus faecalis NKR-4-1	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Enterocin Wbeta was proven to have 3 dehydrated amino acids as well as 2 and 2 Lan and MeLan residues, respectively. The amino acid sequences of the prepeptides of enterocin W showed the highest identity with those of plantaricins Walpha and Wbeta (63.3 and 44.7%, respectively).		Comment: No comments found on DRAMP database	Gram-positive (Narrow)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	22138996	Appl Environ Microbiol. 2012 Feb;78(3):900-3. 	Sawa N, Wilaipun P, Kinoshita S, Zendo T, Leelawatcharamas V, Nakayama J, Sonomoto K.	Isolation and characterization of enterocin W, a novel two-peptide lantibiotic produced by Enterococcus faecalis NKR-4-1.	
DRAMP02447	FCKSLPLPLSVK	12	Antimicrobial protein 2 (Antimicrobial protein AN5-2)	B3EWQ7	Not found	Not found	Paenibacillus alvei (Bacillus alvei)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has antibacterial activity Gram-positive bacteria as well as against Gram-negative bacteria.	Gram-positive bacteria: Lactobacillus plantarum strain ATCC 8014 and Bacillus cereus strain ATCC 14579;##Gram-negative bacteria: Escherichia coli strain ATCC 25922 and Salmonella enteritidis strain ATCC 13076.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2012) to UniProtKB	Alkotaini B, Anuar N, Kadhum AAH.	Unknown	
DRAMP02448	ASGGTVGXYGAWMRSXSLVSXSTITTFS	28	Antibacterial protein LC3 (Antibacterial protein LCIII)	Q9R5C6	Not found	Not found	Bacillus subtilis	Antimicrobial, Antibacterial, Antifungal, Antiparasitic	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Miscellaneous: On a 2D-GEL the determined pI of this protein is: 9.12."	X. campestris strain G and P. solacearum PO1.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1295599	Chin J Biotechnol. 1992;8(3):187-193.	Liu J, Li Z, Pan N, Chen Z.	Purification and partial characterization of an antibacterial protein LCIII.	
DRAMP02450	KIFTKCELARKLRAEGMDGF	20	Lysozyme C (1,4-beta-N-acetylmuramidase C)	P37155	Belongs to the glycosyl hydrolase 22 family	LYZ	Felis catus (Cat) (Felis silvestris catus)	Antimicrobial	Protein level	Not found	Not found		"Function: Lysozymes have primarily a bacteriolytic function; those in tissues and body fluids are associated with the monocyte-macrophage system and enhance the activity of immunoagents By similarity.
Catalytic activity: Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins.
Miscellaneous: Lysozyme C is capable of both hydrolysis and transglycosylation; it shows also a slight esterase activity. It acts rapidly on both peptide-substituted and unsubstituted peptidoglycan, and slowly on chitin oligosaccharides By similarity."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2344734	Comp Biochem Physiol B. 1990;95(4):773-779.	Halliday JA, Bell K, McKenzie HA, Shaw DC.	Feline whey proteins: identification, isolation and initial characterization of alpha-lactalbumin, beta-lactoglobulin and lysozyme.	
DRAMP02451	SKMKKCEFAKIAKEQHMDGYHGVSLADWVCLVNNESDFNTKAINRNKGI	49	Lysozyme C (1,4-beta-N-acetylmuramidase C)	P21776	Belongs to the glycosyl hydrolase 22 family	LYZ	Pseudocheirus peregrinus (Common ring-tailed possum)	Antimicrobial	Protein level	Not found	Not found		"Function: Lysozymes have primarily a bacteriolytic function; those in tissues and body fluids are associated with the monocyte-macrophage system and enhance the activity of immunoagents By similarity.
Catalytic activity: Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins.
Miscellaneous: Lysozyme C is capable of both hydrolysis and transglycosylation; it shows also a slight esterase activity. It acts rapidly on both peptide-substituted and unsubstituted peptidoglycan, and slowly on chitin oligosaccharides By similarity."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2605916	Comp Biochem Physiol B. 1989;94(4):775-778.	Nicholas K, Loughnan M, Messer M, Munks S, Griffiths M, Shaw D.	Isolation, partial sequence and asynchronous appearance during lactation of lysozyme and alpha-lactalbumin in the milk of a marsupial, the common ringtail possum (Pseudocheirus peregrinus).	
DRAMP02452	KYFATRCDLVRELRKXGF	18	Lysozyme	P82175	Belongs to the glycosyl hydrolase 22 family	Not found	Estigmene acrea (Salt marsh moth)	Antimicrobial	Protein level	Not found	Not found		Function: Lysozymes have primarily a bacteriolytic function; those in tissues and body fluids are associated with the monocyte- macrophage system and enhance the activity of immunoagents (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9303271	Dev Comp Immunol. 1997 Jul-Aug;21(4):323-336.	Wittwer D, Weise C, Götz P, Wiesner A.	LPS (lipopolysaccharide)-activated immune responses in a hemocyte cell line from Estigmene acraea (Lepidoptera).	
DRAMP02453	GKIPVKAIKKAGAAIGKGLRAINIASTAHDVYSFFKPKHKKK	42	S. litura moricin (Sl moricin; Insects, animals)	Q7YZB4	Not found	Not found	Spodoptera litura (Lepidopteran insect)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix (1 helices; 31 residues)	The solution structure of Sl moricin is determined by two-dimensional (2D) 1H-nuclear magnetic resonance (NMR) spectroscopy and hybrid distance geometry-simulated annealing calculation. The tertiary structure reveales a long alpha-helix containing eight turns along nearly the full length of the peptide like that of moricin, confirming that Sl moricin is a new moricin-like antibacterial peptide.	1X22 resolved by NMR. 	Function: Sl moricin showes a broad antibacterial spectrum against Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa (LD50=67.4 µg/ml), Escherichia coli JM109 (LD50=5.2 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (LD50=2.7 µg/ml), Methicillin-resistant S. aureus (LD50=9.8 µg/ml), Micrococcus luteus (LD50=28.4 µg/ml), Bacillus thuringiensis HD-1 (LD50=0.5 µg/ml), Enterococcus faecium IFO3128 (LD50=6.2 µg/ml). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16115804	Biochim Biophys Acta. 2005 Aug 31;1752(1):83-92.	Oizumi Y, Hemmi H, Minami M, Asaoka A, Yamakawa M.	Isolation, gene expression and solution structure of a novel moricin analogue, antibacterial peptide from a lepidopteran insect, Spodoptera litura.	
DRAMP02454	GCFEDWSRCSPSTASATGVLWRSCDSYCKVCFKADRGECYDSPSLNCPHRLPNNKQCRCINARTAKDNRNPTCWA	75	Theromacin (Arthropods, animals)	A8I0L8, A8IK85	Not found	Not found	Hirudo medicinalis (Medicinal leech)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Combine helix and strand structure	Structural features of Theromacin: the characteristic additional N-terminal helix and two long flexible loops separating the two helices.	2LN8 resolved by NMR.	"Function: It showes antimicrobial activity against Gram-positive bacteria and Gram-negative bacteria in the low microgram concentration range.
PTM: Problely contains five disulfide bonds 2-9; 24-28; 31-73; 39-47; 57-59."	Gram-negative bacterium: Escherichia coli ATCC 35218 (LD90=6.25 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 12600 (LD90=25 µg/ml), Bacillus megaterium ATCC 14581 (MBC=0.2-0.39 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22396551##PubMed ID is not available	J Biol Chem. 2012 Apr 20;287(17):14246-58.##Submitted (SEP-2007) to the EMBL/GenBank/DDBJ databases	Jung S, Sönnichsen FD, Hung CW, Tholey A, Boidin-Wichlacz C, Haeusgen W, Gelhaus C, Desel C, Podschun R, Waetzig V, Tasiemski A, Leippe M, Grötzinger J.##Schikorski D, Salzet M, Tasiemski A.	Macin family of antimicrobial proteins combines antimicrobial and nerve repair activities.##Antimicrobial peptides isolated from the medicinal leech.	
DRAMP02455	ADSRNPLEEEFRETNYEEF	19	L-amino-acid oxidase (ACL-LAO; LAAO; LAO)	P0CC16	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Agkistrodon contortrix laticinctus (Broad-banded copperhead)(Agkistrodon mokasen laticinctus)	Antimicrobial, Antibacterial, Antiparasitic	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids (L-Ile followed by L-Phe, L-Met, L-Val, L-Arg, L-Leu), thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage (minimum hemorrhagic dose of 10 µg), and apoptosis. May also induce hemolysis, edema, antibacterial and antiparasitic activities. May also regulate platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10441379	Arch Biochem Biophys. 1999 Aug 15;368(2):285-290.	Souza DH, Eugenio LM, Fletcher JE, Jiang MS, Garratt RC, Oliva G, Selistre-de-Araujo HS.	Isolation and structural characterization of a cytotoxic L-amino acid oxidase from Agkistrodon contortrix laticinctus snake venom: preliminary crystallographic data.	
DRAMP02457	ADVRNPLEEFRETDYEVL	18	L-amino-acid oxidase (Balt-LAAO-I; LAAO; LAO; snakes, reptils, animals)	P0DI86	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Bothrops alternatus (Urutu)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as slight hemorrhage, Induction: of platelet aggregation, edema in the mouse paw and bactericidal activity against both Gram-positive (S.aureus) and Gram-negative (E.coli) bacteria. May also induce hemolysis, apoptosis of vascular endothelial cells or tumor cell lines, and may have antiparasitic activities. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. 
Tissue specificity: Expressed by the venom gland."	Gram-positive bacterium: S. aureus;##Gram-negative bacterium: E. coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15142548	Bioorg Med Chem. 2004 Jun 1;12(11):2881-2886.	Stábeli RG, Marcussi S, Carlos GB, Pietro RC, Selistre-de-Araújo HS, Giglio JR, Oliveira EB, Soares AM.	Platelet aggregation and antibacterial effects of an L-amino acid oxidase purified from Bothrops alternatus snake venom.	
DRAMP02458	ADDKNPLEECFREDDYEGFLEIAKNGLSTTSNPKRVVIVGAGMSGLAAY	49	L-amino-acid oxidase (BiLAO; LAAO; LAO; snakes, reptils, animals)	P0DI87	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Bothrops insularis (Golden lancehead) (Queimada jararaca)	Antimicrobial, Antibacterial, Antiparasitic	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). In addition, this protein induces apoptosis and necrosis and has inhibitory effects on rat kidney Function: (decrease of blood flow and glomerular filtration).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17983639	Toxicon. 2008 Feb;51(2):199-207.	Braga MD, Martins AM, Amora DN, de Menezes DB, Toyama MH, Toyama DO, Marangoni S, Alves CD, Barbosa PS, de Sousa Alves R, Fonteles MC, Monteiro HS.	Purification and biological effects of L-amino acid oxidase isolated from Bothrops insularis venom.	
DRAMP02459	ADDKNPLEECFRETDYEEFLEIARNGLKATSNPKRVV	37	L-amino-acid oxidase (BjarLAAO-I; LAAO; LAO; snakes, reptils, animals)	P0DI88	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Bothrops jararaca (Jararaca)	Antimicrobial, Antibacterial, Anti-Gram+, Antiparasitic, Antitumor	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids (L-Met, L-Leu, L-Phe, L-Ile), thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, edema, apoptosis of vascular endothelial cells or tumor cell lines, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions By similarity. This protein induce hemolysis and has antibacterial and antiparasitic activities (against the Gram-positive S.aureus). Tested in vivo, this protein significantly inhibits Ehrlich ascite tumors growth and induces an influx of polymorphonuclear cells, as well as spontaneous liberation of hydrogen peroxide from peritoneal macrophages.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: Has parasiticidal activities against both trypanosomes and leishmania, as a result of enzyme-catalyzed hydrogen peroxide production."	Gram-positive bacterium: S. aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18346051##19101583##20615423	Basic Clin Pharmacol Toxicol. 2008 Jun;102(6):533-542.##Toxicon. 2009 Mar 1;53(3):330-341.##Toxicon. 2010 Nov;56(6):944-955.	de Vieira Santos MM, Sant'Ana CD, Giglio JR, da Silva RJ, Sampaio SV, Soares AM, Fecchio D.##Ciscotto P, Machado de Avila RA, Coelho EA, Oliveira J, Diniz CG, Farías LM, de Carvalho MA, Maria WS, Sanchez EF, Borges A, Chávez-Olórtegui C.##olindo P, Teixeira-Ferreira AS, DaMatta RA, Alves EW.	Antitumoural effect of an L-amino acid oxidase isolated from Bothrops jararaca snake venom.##Antigenic, microbicidal and antiparasitic properties of an L-amino acid oxidase isolated from Bothrops jararaca snake venom.##L-amino acid oxidase activity present in fractions of Bothrops jararaca venom is responsible for the Induction: of programmed cell death in Trypanosoma cruzi.	
DRAMP02460	ADDRNPLEECFRETDYEEFLEIAKNGLSTT	30	L-amino-acid oxidase (LAAO; LAO; snakes, reptils, animals)	P0DI89	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Bothrops leucurus (White-tailed jararaca) (White-tailed lancehead)	Antimicrobial, Antibacterial, Antiparasitic	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids (high activity against L-Met, L-Leu, L-Nle, L-Trp, L-Phe and moderate activity against L-Tyr), thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, antibacterial and antiparasitic activities (By similarity). In addition, this protein induces apoptosis. It also interacts with endothelial cells, and inhibits collagen- and ADP-induced platelet aggregation. L-LAAO family effects on platelets are controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: Has parasiticidal activities against both trypanosomes and leishmania, as a result of enzyme-catalyzed hydrogen peroxide production.
Biophysicochemical properties: pH dependence (Optimum pH is 7.5-8.8 for L-Leu)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21539897	Biochim Biophys Acta. 2011 Jul;1810(7):683-694.	Naumann GB, Silva LF, Silva L, Faria G, Richardson M, Evangelista K, Kohlhoff M, Gontijo CM, Navdaev A, de Rezende FF, Eble JA, Sanchez EF.	Cytotoxicity and inhibition of platelet aggregation caused by an l-amino acid oxidase from Bothrops leucurus venom.	
DRAMP02461	AHDGNPLEECFREDDEEFFLEIAKNGLTATSNPKRVVIV	39	L-amino-acid oxidase (BmarLAAO; LAAO; LAO; snakes, reptils, animals)	P0CJ40	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Bothrops marajoensis (Marajo lancehead)	Antimicrobial, Antibacterial, Antifungal, Antiparasitic	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions By similarity. In addition, this protein inhibits dose-dependently the growth of Gram-positive, Gram-negative bacteria and yeast, probably by the generation of hydrogen peroxide.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: Has parasiticidal activities against leishmania, as a result of enzyme-catalyzed hydrogen peroxide production."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19944711	Toxicon. 2010 Apr 1;55(4):795-804.	Costa Torres AF, Dantas RT, Toyama MH, Diz Filho E, Zara FJ, Rodrigues de Queiroz MG, Pinto Nogueira NA, Rosa de Oliveira M, de Oliveira Toyama D, Monteiro HS, Martins AM.	Antibacterial and antiparasitic effects of Bothrops marajoensis venom and its fractions: phospholipase A2 and L-amino acid oxidase.	
DRAMP02462	DDRRSPLEECFQQNDYEEFLEIARNSQLYQESLREDSSYHLSFIESLKSDALFSYEKKFWEADGIHGGKVINDLSLIHDLPKREIQALCYPSIKK	95	L-amino-acid oxidase (LAAO; LAO; snakes, reptils, animals)	P0DI91	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Naja oxiana (Central Asian cobra) (Oxus cobra)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiparasitic	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as antibacterial activity against both Gram-positive (B.subtilis) and Gram-negative (E.coli) bacteria, and inhibition of ADP- or collagen-induced platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. This protein may also induce hemorrhage, hemolysis, edema, apoptosis, and have antiparasitic activities.
Tissue specificity: Expressed by the venom gland.
Biophysicochemical properties: Kinetic parameters (KM=0.885 mM for L-Met; KM=0.051 mM for L-Phe; KM=0.147 mM for L-Trp; KM=0.75 mM for L-Leu)"	Gram-positive bacterium: Bacillus subtilis;##Gram-negative bacterium: E. coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18294891	Comp Biochem Physiol B Biochem Mol Biol. 2008 Apr;149(4):572-580.	Samel M, Tõnismägi K, Rönnholm G, Vija H, Siigur J, Kalkkinen N, Siigur E.	L-Amino acid oxidase from Naja naja oxiana venom.	
DRAMP02463	ADDKNPLEEAFREADYEVFLEIAKNGL	27	L-amino-acid oxidase (LAAO, LAO, LN-AAO; Reptiles, animals)	P0C2D3	Not found	Not found	Eristocophis macmahoni (Leaf-nosed viper)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemolysis, edema, apoptosis, as well as induction of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. Unlike other snake venom L-amino acid oxidases, does not induce hemorrhage. This protein may also have antibacterial and antiparasitic activities.
Catalytic activity: An L-amino acid + H2O + O2 = a 2-oxo acid + NH3 + H2O2.
Subunit structure: Homodimer; non-covalently linked.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	FAD and Flavoprotein	11368308	Arch Biochem Biophys. 2000 Dec 15;384(2):216-226.	Ali SA, Stoeva S, Abbasi A, Alam JM, Kayed R, Faigle M, Neumeister B, Voelter W.	Isolation, structural, and functional characterization of an apoptosis-inducing L-amino acid oxidase from leaf-nosed viper (Eristocophis macmahoni) snake venom.	
DRAMP02464	GPMRIPEKHRIVREYIRKFGLQLNEFVQETENAWYYIKNIRKKVHEVKKDPGLLKYPVKP	60	L-amino-acid oxidase (LAAO, LAO; reptilia, animals)	Q6T627	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Bitis gabonica (Gaboon adder) (Gaboon viper)	Antimicrobial, Antibacterial, Antiparasitic	Transcript level	Not found	Not found		Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15276202	Gene. 2004 Aug 4;337:55-69.	Francischetti IM, My-Pham V, Harrison J, Garfield MK, Ribeiro JM.	Bitis gabonica (Gaboon viper) snake venom gland: toward a catalog for the full-length transcripts (cDNA) and proteins.	
DRAMP02465	ADDINPKEECFFEDDYYEFE	20	L-amino-acid oxidase L1 (LAAO; LAAO-L1; LAO; Reptiles, animals)	P86535	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Daboia russelii (Russel's viper) (Vipera russelii)	Antimicrobial, Antibacterial, Antitumor, Antiparasitic	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions By similarity.
Tissue specificity: Expressed by the venom gland.
Biophysicochemical properties: Kinetic parameters (KM=0.297 mM for L-Met; KM=1.44 mM for L-Ile; KM=0.750 mM for L-Leu; KM=0.066 mM for L-Phe; KM=0.210 mM for L-Trp; KM=0.052 mM for L-Tyr; Vmax=8.96 µmol/min/mg enzyme toward L-Phe)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18384385##20203422	FEBS J. 2008 May;275(9):2078-2095.##Biomed Res. 2010 Feb;31(1):71-81.	Mandal S, Bhattacharyya D.##Suzuki M, Itoh T, Anuruddhe BM, Bandaranayake IK, Shirani Ranasinghe JG, Athauda SB, Moriyama A.	Two L-amino acid oxidase isoenzymes from Russell's viper (Daboia russelli russelli) venom with different mechanisms of inhibition by substrate analogs.##Molecular diversity in venom proteins of the Russell's viper (Daboia russellii russellii) and the Indian cobra (Naja naja) in Sri Lanka.	
DRAMP02466	ADDKNPLEECFCEDDDYCEG	20	L-amino-acid oxidase L2 (LAAO; LAAO-L2; LAO; Reptiles, animals)	P0DI90	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Daboia russelii (Russel's viper) (Vipera russelii)	Antimicrobial, Antibacterial, Antitumor, Antiparasitic	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions By similarity.
Tissue specificity: Expressed by the venom gland.
Biophysicochemical properties: Kinetic parameters (KM=1.89 mM for L-Ile; KM=599.7 µM for L-Leu; KM=222.8 µM for L-Met; KM=49.3 µM for L-Phe; KM=235.1 µM for L-Trp; KM=538.2 µM for L-Tyr; Vmax=6.94 µmol/min/mg enzyme toward L-Phe)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18384385	FEBS J. 2008 May;275(9):2078-2095.	Mandal S, Bhattacharyya D.	Two L-amino acid oxidase isoenzymes from Russell's viper (Daboia russelli russelli) venom with different mechanisms of inhibition by substrate analogs.	
DRAMP02467	ADDKNPLEECFREDDYEEFLEIAKNGLKKTSNPKHIVYPVKPSEQLYEESLRDQLPTSMHRYPSMIQKIFFAGEYTANAHGWIDSTIK	88	L-amino-acid oxidase (LAAO; LAO; Reptiles, animals)	P0C2D7	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Vipera berus berus (Common viper)	Antimicrobial, Antibacterial, Antitumor, Antiparasitic	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids (the most specific substrate is L-Phe, followed by L-Met, L-Leu, L-Phe, L-Ile, L-Arg and L-His), thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities By similarity. In addition, this protein has an ability to induce apoptosis in cultured HeLa and K562 cells, and inhibits ADP-induced platelet aggregation dose-dependently. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions.
Tissue specificity: Expressed by the venom gland. 
Biophysicochemical properties: Kinetic parameters (KM=0.361 mM for L-Leu; KM=0.286 mM for L-Met; KM=0.058 mM for L-Phe)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16574513	Biochim Biophys Acta. 2006 Apr;1764(4):707-714.	Samel M, Vija H, Rönnholm G, Siigur J, Kalkkinen N, Siigur E.	Isolation and characterization of an apoptotic and platelet aggregation inhibiting L-amino acid oxidase from Vipera berus berus (common viper) venom.	
DRAMP02468	DLLQFXDMMK	10	Acidic phospholipase A2 PnPLA2 (svPLA2; Reptiles, animals)	B3EWG8	Belongs to the phospholipase A2 family (Group II subfamily)	Not found	Porthidium nasuta (Hognosed viper)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Snake venom phospholipase A2 (PLA2) that has antibacterial activity against S.aureus ATCC 25923 and ATCC 29213, acts by inducing bacterial membrane breakage. Displays a potent inhibitory effect on collagen-induced human platelet aggregation and has indirect hemolytic activity. Does not show cytotoxicity to murine skeletal muscle myoblasts. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: The determined pI of this protein is: 4.6."	[Ref.22251437]Gram-positive bacteria: S. aureus ATCC 25923 and S. aureus ATCC 29213.	[Ref.22251437]MHD=7.5 μg against agarose erythrocyte-egg yolk gels	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22251437	Comp Biochem Physiol B Biochem Mol Biol. 2012 Apr;161(4):341-347.	Vargas LJ, Londoño M, Quintana JC, Rua C, Segura C, Lomonte B, Núñez V.	An acidic phospholipase A(2) with antibacterial activity from Porthidium nasutum snake venom.	
DRAMP02469	VNVLGGIEYSINNATLCSVGFSVRVFNYAEGAVRGLTQGNACMGRGDSGGSWFTLFERQYGL	62	Alpha-lytic protease L1	P85142	Belongs to the peptidase S1 family	Not found	Lysobacter sp. (strain XL1)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has bacteriolytic activity.
Biophysicochemical properties: pH dependence (Optimum pH is 8.0. Active from pH 7.0 to 11.0); Temperature dependence (Optimum temperature is 70 degrees Celsius)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2007) to UniProtKB	Muranova T.A, Stepnaya O.A, Tsfasman I.M, Kulaev I.S.	Identification of extracellular bacteriolytic enzymes from Lysobacter sp. XL1.	
DRAMP02471	IASASCTTCICTCSCSS	17	Thiostrepton (Alaninamide; Bryamycin; Gargon; Thiactin)	P0C8P8, C4NCM0	Belongs to the thiocillin family	tpdA	Streptomyces azureus	Antimicrobial, Antibacterial	Protein level	No secondary structure	Not found	1E9W, 3CF5 resolved by X-ray.##1OLN, 2JQ7 resolved by NMR.	"Function: Has bacteriocidal activity. Inhibits bacterial protein biosynthesis by acting on the elongation factor Tu (EF-Tu) (By similarity).
PTM: Maturation of thiazole and oxazole containing antibiotics involves the enzymic condensation of a Cys, Ser or Thr with the alpha-carbonyl of the preceding amino acid to form a thioether or ether bond, then dehydration to form a double bond with the alpha-amino nitrogen. Thiazoline or oxazoline ring are dehydrogenated to form thiazole or oxazole rings. Maturation of pyridinyl containing antibiotics involves the cross-linking of a Ser and a Cys-Ser pair usually separated by 7 or 8 residues along the peptide chain. The Ser residues are dehydrated to didehydroalanines, then bonded between their beta carbons. The alpha carbonyl of the Cys condenses with alpha carbon of the first Ser to form a pyridinyl ring. The ring may be multiply dehydrogenated to form a pyridine ring with loss of the amino nitrogen of the first Ser.
Pharmaceutical use: Available under the names Animax (Dechra) and Panolog (Fort Dodge), that combine thiostrepton with nystatin (antifungal), neomycin (antibiotic) and triamcinolone (corticosteroid). Used to treat cat and dog skin and ear disorders caused by"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	13355325##11320328	Antibiot Annu. 1955-1956;3:554-559.##Acta Crystallogr D Biol Crystallogr. 2001 May;57(Pt 5):755-758.	DONOVICK R, PAGANO JF, STOUT HA, WEINSTEIN MJ.##Bond CS, Shaw MP, Alphey MS, Hunter WN.	Thiostrepton, a new antibiotic. I. In vitro studies.##Structure of the macrocycle thiostrepton solved using the anomalous dispersion contribution of sulfur.	
DRAMP02472	LCPLDVLQLSSELLDIDGNEVEASRILSDITAFGGIRCPLTVVQSRGIGTIISSPYRFIAEGHPLSLKDMDGWFRVSDDEFNNYK	85	Turmerin (Plants)	P85278	Not found	Not found	Curcuma longa (Turmeric) (Curcuma domestica)	Anti-cancer, Antiplasmodial	Protein level	Not found	Not found		"Function: Has anticarcinogenic activity, prevents transformation of DMBA-treated JB6 cells. Has antipromoter activity, prevents promotion by tetradecanoyl phorbal acetate (TPA) in JB6 cells. Prevents tertiary butyl hydroperoxide-induced mutagenesis. Protects AT base pairs and shows antimutagenesis activity in TA102 and TA104 S.typhimurium mutagenesis tests. Inhibits paw edema formation induced by phospholipase A2 in Swiss Wistar mice. Prevents the release of arachidonate, the parent compound for the synthesis of prostaglandins and prostacyclins. Has antimalarial activity, kills P. falciparum. Has antivenom activity, nullifies the lethal effects of N.naja venom and inhibits phospholipase A2 present in N.naja venom. Has antifungal activity, inhibits cilia formation by A.niger. Is not toxic or allergenic.
Sequence similarities: Belongs to the protease inhibitor I3 (leguminous Kunitz-type inhibitor) family. [View classification]
Biophysicochemical properties: Temperature dependence (Stable for 7 days at room temperature and for 30 days at 4 degrees Celsius. Remains active after incubation at 100 degrees Celsius for 3 hours).
Caution: The order of the first peptide shown is Not found."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1731625##18177267	Arch Biochem Biophys. 1992 Feb 1;292(2):617-623.##Biol Chem. 2008 Mar;389(3):299-303.	Srinivas L, Shalini VK, Shylaja M.##Chethankumar M, Srinivas L.	Turmerin: a water soluble antioxidant peptide from turmeric [Curcuma longa].##New biological activity against phospholipase A2 by Turmerin, a protein from Curcuma longa L.	
DRAMP02475	NEKSGSCPDMSMPIPPLGICKTLCNSDSGCPNVQKCCKNGCGFMTCTTPVP	51	Nawaprin (Snakes, reptiles, animals)	P60589, P83769	Belongs to the snake waprin family	Not found	Naja nigricollis (Black-necked spitting cobra)	Antimicrobial, Antibacterial	Protein level	Not found	Not found	1UDK	Function: Damages membranes of susceptible bacteria. Does not inhibit the proteinases elastase and cathepsin G (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	12878611	J Biol Chem. 2003 Oct 10;278(41):40097-104.	Torres AM, Wong HY, Desai M, Moochhala S, Kuchel PW, Kini RM.	Identification of a novel family of proteins in snake venoms. Purification and structural characterization of nawaprin from Naja nigricollis snake venom.	
DRAMP02476	KTTKQLRLPKVKPGECPKVKIPPDYPCNQYCVWDFDCEGNKKCCPVGCAKECFPPGPL	58	Waprin-Phi3 (Snakes, reptiles, animals)	A7X4M7	Belongs to the snake waprin family	Not found	Philodryas olfersii (Green snake)	Antimicrobial	Transcript level	Not found	Not found		"PTM: four disulfide bonds: 6-44; 27-48; 31-43; 37-52.
Damages membranes of susceptible bacteria. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	17855442	Mol Cell Proteomics. 2008 Feb;7(2):215-246.	Fry BG, Scheib H, van der Weerd L, Young B, McNaughtan J, Ramjan SF, Vidal N, Poelmann RE, Norman JA.	Evolution of an arsenal: structural and functional diversification of the venom system in the advanced snakes (Caenophidia).	
DRAMP02477	EQEKPGSCPNVDMPIPPLGLCKTTCSKDSDCSETKKCCKNGCGFMTCTTARP	52	Waprin-Phi2 (Snakes, reptiles, animals)	A7X4K7	Belongs to the snake waprin family	Not found	Philodryas olfersii (Green snake)	Antimicrobial	Transcript level	Not found	Not found		"PTM: four disulfide bonds 8-38; 21-42; 25-37; 31-47.
Damages membranes of susceptible bacteria. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	17855442	Mol Cell Proteomics. 2008 Feb;7(2):215-246.	Fry BG, Scheib H, van der Weerd L, Young B, McNaughtan J, Ramjan SF, Vidal N, Poelmann RE, Norman JA.	Evolution of an arsenal: structural and functional diversification of the venom system in the advanced snakes (Caenophidia).	
DRAMP02479	QDRPKKPGLCPPRPQKPPCVKECKNDWSCPGQQKCCSYGCIDECRDPIFVN	51	Scuwaprin-a (Snakes, reptiles, animals)	B5G6G8	Belongs to the snake waprin family	Not found	Oxyuranus scutellatus scutellatus (Australian taipan) (Coastaltaipan)	Antimicrobial, Antibacterial, Antimalarial	Transcript level	Not found	Not found		Function: Damages membranes of susceptible bacteria. Does not inhibit the proteinases elastase and cathepsin G (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP02480	KDRPKKPGLCPPRPQKPCVKECKNDWSCPGQQKCCNYGCIDECRDPIFVN	50	Omwaprin-b (Oxywaprin-b; Snakes, reptiles, animals)	B5G6G7	Belongs to the snake waprin family	Not found	Oxyuranus microlepidotus (Inland taipan)	Antimicrobial, Antibacterial, Antimalarial	Transcript level	Not found	Not found		"Function: Damages membranes of susceptible bacteria. Does not inhibit the proteinases elastase and cathepsin G (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP02481	QDRPKKPGLCPPRPQKPCVKECKNDWSCPGQQKCCNYGCIDECRDPIFVN	50	Omwaprin-c (Oxywaprin-c; Snakes, reptiles, animals)	B5L5M9	Belongs to the snake waprin family	Not found	Oxyuranus microlepidotus (Inland taipan)	Antimicrobial, Antibacterial, Antimalarial	Homology	Not found	Not found		"Function: Damages membranes of susceptible bacteria. Does not inhibit the proteinases elastase and cathepsin G (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP02482	KDRPKKPGLCPPRPQKPCVKECKNDDSCPGQQKCCNYGCKDECRDPIFVG	50	Omwaprin-a (Oxywaprin; Oxywaprin-a; Snakes, reptiles, animals)	P83952	Belongs to the snake waprin family	Not found	Oxyuranus microlepidotus (Inland taipan)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Combine helix and strand structure	Omwaprin is closest in structure to the 50 amino acid residue C-terminal WAP domain of the human protein secretory leukocyte protease inhibitor (SLPI) (PDB ID: 2Z7F). This domain of SLPI has eight Cys residues that align well with the Cys residues of omwaprin, suggesting a similar fold.	3NGG resolved by NMR.	"Function: Damages membranes of susceptible bacteria. Has antibacterial activity against the Gram-positive bacteria. Has no antibacterial activity against the Gram-positive bacteria.
Tissue specificity: Expressed by the venom gland.
Domain: Contains 1 WAP domain.
PTM: Contains four disulfide bonds 10-35; 18-39; 22-34; 28-43."	Gram-positive bacteria: Bacillus megaterium, Bacillus anthracis, Staphylococcus warneri.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	17044815##20669184	Biochem J. 2007 Feb 15;402(1):93-104.##Protein Sci. 2010 Oct;19(10):1840-1849.	Nair DG, Fry BG, Alewood P, Kumar PP, Kini RM.##Banigan JR, Mandal K, Sawaya MR, Thammavongsa V, Hendrickx AP, Schneewind O, Yeates TO, Kent SB.	Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins.##Determination of the X-ray structure of the snake venom protein omwaprin by total chemical synthesis and racemic protein crystallography.	
DRAMP02483	KFFKKLKNSVKKRAKKFFKKPKVIGVTFPF	30	Cathelicidin-NA (Cathelicidin-related protein; Snakes, reptiles, animals)	B6S2X0	Not found	Not found	Naja atra (Chinese cobra)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Alpha helix 	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli ATCC 25922, Escherichia coli ML-35P, Escherichia coli clinic strain, Pseudomonas aeruginosa ATCC 27853, Pseudomonas aeruginosa PA 01, Pseudomonas aeruginosa clinic strain, Enterobacter aerogenes clinic strain, Enterobacter cloacae clinic strain.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	18620012	Peptides. 2008 Oct;29(10):1685-91. 	Zhao H, Gan TX, Liu XD, Jin Y, Lee WH, Shen JH, Zhang Y.	Identification and characterization of novel reptile cathelicidins from elapid snakes.	
DRAMP02484	ENEKAGSCPDVNQPIPPLGLCRNMCESDSGCPNNEKCCKNGCGFMTCSRPR	51	Waprin-Thr1 (Snakes, reptiles, animals)	A7X4I7	Belongs to the snake waprin family	Not found	Thrasops jacksonii (Jackson's black tree snake)	Antimicrobial	Transcript level	Not found	Not found		"Function: Damages membranes of susceptible bacteria. Does not inhibit the proteinases elastase and cathepsin G (By similarity).
PTM: Contains four disulfide bonds 8-38; 21-42; 25-37; 31-47 (By similarity).
Tissue specificity: Expressed by the venom gland.
Domain: Contains 1 WAP domain."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	17855442	Mol Cell Proteomics. 2008 Feb;7(2):215-246.	Fry BG, Scheib H, van der Weerd L, Young B, McNaughtan J, Ramjan SF, Vidal N, Poelmann RE, Norman JA.	Evolution of an arsenal: structural and functional diversification of the venom system in the advanced snakes (Caenophidia).	
DRAMP02485	QDGKAGSCPDVNQPIPPLGVCKTTCATDSNCPDIQKCCKNGCGHMSCTRPST	52	Waprin-Rha1 (Snakes, reptiles, animals)	A7X4J4	Belongs to the snake waprin family	Not found	Rhabdophis tigrinus tigrinus (Tiger keelback snake)	Antimicrobial	Transcript level	Not found	Not found		"Function: Damages membranes of susceptible bacteria. Does not inhibit the proteinases elastase and cathepsin G (By similarity).
PTM: Contains four disulfide bonds 8-38; 21-42; 25-37; 31-47 (By similarity).
Tissue specificity: Expressed by the venom gland.
Domain: Contains 1 WAP domain."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	17855442	Mol Cell Proteomics. 2008 Feb;7(2):215-246.	Fry BG, Scheib H, van der Weerd L, Young B, McNaughtan J, Ramjan SF, Vidal N, Poelmann RE, Norman JA.	Evolution of an arsenal: structural and functional diversification of the venom system in the advanced snakes (Caenophidia).	
DRAMP02486	QVVRPGSCPNVDVPIPPLGLCRTTCQTDANCQEGRKCCKNGCGFMTCETARF	52	Waprin-Lio1 (Snakes, reptiles, animals)	A7X4L4	Belongs to the snake waprin family	Not found	Liophis poecilogyrus (Water snake)	Antimicrobial	Transcript level	Not found	Not found		"Function: Damages membranes of susceptible bacteria. Does not inhibit the proteinases elastase and cathepsin G (By similarity).
PTM: Contains four disulfide bonds 8-38; 21-42; 25-37; 31-47 (By similarity).
Tissue specificity: Expressed by the venom gland.
Domain: Contains 1 WAP domain."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	17855442	Mol Cell Proteomics. 2008 Feb;7(2):215-246.	Fry BG, Scheib H, van der Weerd L, Young B, McNaughtan J, Ramjan SF, Vidal N, Poelmann RE, Norman JA.	Evolution of an arsenal: structural and functional diversification of the venom system in the advanced snakes (Caenophidia).	
DRAMP02487	KILFGCGISPGNPFPCSLPGLTGNRCRRDYDCPQTLRCCNFRCSRSCRIPPVLPWSCPRNPFKCTIPGIDRCRYDYDCPGRQRCCYYSCSRICK	94	Waprin-Enh1 (Snakes, reptiles, animals)	A7X4M1	Belongs to the snake waprin family	Not found	Enhydris polylepis (Macleay's water snake)	Antimicrobial	Transcript level	Not found	Not found		"Function: Damages membranes of susceptible bacteria. Does not inhibit the proteinases elastase and cathepsin G (By similarity).
PTM: Contains eight disulfide bonds (By similarity).
Tissue specificity: Expressed by the venom gland.
Domain: Contains 2 WAP domain."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	17855442	Mol Cell Proteomics. 2008 Feb;7(2):215-246.	Fry BG, Scheib H, van der Weerd L, Young B, McNaughtan J, Ramjan SF, Vidal N, Poelmann RE, Norman JA.	Evolution of an arsenal: structural and functional diversification of the venom system in the advanced snakes (Caenophidia).	
DRAMP02488	ADDRNPLEEFRENNYEEFL	19	L-amino-acid oxidase ACTX-8 (LAAO; LAO; Snakes, reptiles, animals)	P0DI85	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Deinagkistrodon acutus (Hundred-pace snake) (Agkistrodon acutus)	Antimicrobial, Antibacterial, Antitumor, Antiparasitic	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity). Induces apoptosis in HeLa cervical cancer cells. Both the caspase-dependent and the mitochondrial pathways seem to be involved in apoptosis.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17275856	Life Sci. 2007 Mar 6;80(13):1189-1197.	Zhang L, Wei LJ.	ACTX-8, a cytotoxic L-amino acid oxidase isolated from Agkistrodon acutus snake venom, induces apoptosis in Hela cervical cancer cells.	
DRAMP02489	QDRPKKPGLCPPRPQKPPCVRECKNDWSCPGEQKCCRYGCIFECRDPIFVK	51	Supwaprin-a (Snakes, reptiles, animals)	B5KGY9	Belongs to the snake waprin family	Not found	Austrelaps superbus (Lowland copperhead snake) (Hoplocephalussuperbus)	Antimicrobial, Antibacterial, Antimalarial	Transcript level	Not found	Not found		"Function: Damages membranes of susceptible bacteria. Does not inhibit the proteinases elastase and cathepsin G (By similarity).
PTM: Contains four disulfide bonds (By similarity).
Domain: Contains 1 WAP domain."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAY-2007) to the EMBL/GenBank/DDBJ databases	St Pierre L.	Identification and characterization of Waprins from the venom of Australian elapid snakes.	
DRAMP18263	KCPWWNLSCHLGNDGKICTYSHECTAGCNA	30	Enterocin W alpha(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Enterococcus faecalis NKR-4-1	Antimicrobial, Antibacterial, Anti-Gram+		Not found	The cysteine, serine, and threonine residues in this peptide form a disulfide bridge and 3 dehydrated residues with or without monosulfide bridges. The amino acid sequences of the prepeptides of enterocin W showed the highest identity with those of plantaricins Walpha and Wbeta (63.3 and 44.7%, respectively).		The two peptides acted synergistically, and their order of binding to the cell membrane was important for their inhibitory activity.	Gram-positive (Narrow)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	22138996	Appl Environ Microbiol. 2012 Feb;78(3):900-3. 	Sawa N, Wilaipun P, Kinoshita S, Zendo T, Leelawatcharamas V, Nakayama J, Sonomoto K.	Isolation and characterization of enterocin W, a novel two-peptide lantibiotic produced by Enterococcus faecalis NKR-4-1.	
DRAMP02491	QDHPKKPGLCPPRPQKPPCVRECKNDWSCPGEQKCCRYGCIFECRDPIFVK	51	Stewaprin-a (Snakes, reptiles, animals)	B5G6H3	Belongs to the snake waprin family	Not found	Hoplocephalus stephensii (Stephens' banded snake)	Antimicrobial, Antibacterial, Antimalarial	Transcript level	Not found	Not found		Function: Damages membranes of susceptible bacteria. Does not inhibit the proteinases elastase and cathepsin G (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP02492	LDRPKKPGLCPPRPQKPPCVRECKNDWRCPGEQKCCRYGCIYECRDPIFVK	51	Notewaprin-a (Snakes, reptiles, animals)	B5G6H4	Belongs to the snake waprin family	Not found	Notechis scutatus scutatus (Mainland tiger snake) (Common tigersnake)	Antimicrobial, Antibacterial, Antimalarial	Transcript level	Not found	Not found		Function: Damages membranes of susceptible bacteria. Does not inhibit the proteinases elastase and cathepsin G (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP02493	KDRPKKPGLCPPRPQKPCVKECKNDWSCSGQQKCCNYGCIDECRDPIFVN	50	Auswaprin-a (Snakes, reptiles, animals)	B5G6G9	Belongs to the snake waprin family	Not found	Pseudechis australis (Mulga snake) (King brown snake)	Antimicrobial, Antibacterial, Antimalarial	Transcript level	Not found	Not found		Function: Damages membranes of susceptible bacteria. Has no hemolytic activity.  Does not inhibit the proteinases elastase and cathepsin G (By similarity).	No MICs found in DRAMP database	[Swiss_Prot Entry B5G6G9]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP02494	KDRPKKLGLCPPRPQKPCVKECKNDWSCPGQQKCCNYGCIDECRDPIFVN	50	Porwaprin-a (Snakes, reptiles, animals)	B5G6H0	Belongs to the snake waprin family	Not found	Pseudechis porphyriacus (Red-bellied black snake)	Antimicrobial, Antibacterial, Antimalarial	Transcript level	Not found	Not found		Function: Damages membranes of susceptible bacteria. Has no hemolytic activity. Does not inhibit the proteinases elastase and cathepsin G (By similarity).	No MICs found in DRAMP database	[Swiss_Prot Entry B5G6H0]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP02496	QDRPVKPGLCPPRPQKPPCVKECKNDWSCRGEQKCCRYGCIYECRDPIFVK	51	Nigwaprin-a (Snakes, reptiles, animals)	B5G6H1	Belongs to the snake waprin family	Not found	Rhinoplocephalus nigrescens (Eastern small-eyed snake)	Antimicrobial, Antibacterial, Antimalarial	Transcript level	Not found	Not found		Function: Damages membranes of susceptible bacteria. Has no hemolytic activity. Does not inhibit the proteinases elastase and cathepsin G (By similarity).	No MICs found in DRAMP database	[Swiss_Prot Entry B5G6H1]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP02497	QDRPKKPGLCPPRPQKPPCVRECKNDWRCPGEQKCCRYGCIYECRDPIFVK	51	Carwaprin-a (Snakes, reptiles, animals)	B5G6H2	Belongs to the snake waprin family	Not found	Tropidechis carinatus (Australian rough-scaled snake)	Antimicrobial, Antibacterial, Antimalarial	Transcript level	Not found	Not found		Function: Damages membranes of susceptible bacteria. Has no hemolytic activity. Does not inhibit the proteinases elastase and cathepsin G (By similarity).	No MICs found in DRAMP database	[Swiss_Prot Entry B5G6H2]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP18262	MGAIAKLVAKFGWPIVKKYYKQIMQFIGEGWAINKIIDWIKKHI	44	Enterocin 7A(Bacteriocin)	Q1A2D3	Belongs to the class IId bacteriocin	mr10A	Enterococcus faecalis MRR 10-3; Enterococcus faecalis 710C	Antimicrobial, Antibacterial, Anti-Gram+		Helix	Both peptides are primarily alpha-helical, adopting a similar overall fold. The structures can be divided into three separate alpha-helical regions: the N- and C-termini are both alpha-helical, separated by a central kinked alpha-helix. The overall structures bear an unexpected resemblance to carnocyclin A, a 60-residue peptide that is cyclized via an amide bond between the C- and N-termini and has a saposin fold.	2M5Z resolved by NMR	leaderless, i.e. no signal peptide. The amino acid sequence of enterocin 7A is identical to that of MR10A. However, enterocin 7A is N-terminally formylated. Remarkably, the peptide is helical in aqueous solution.Enterocins 7A and 7B each display strong activity by themselves without their partner. 	Gram-positive (broad-spectrum)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	16751538##23725536	Appl Environ Microbiol. 2006 Jun;72(6):4245-9.##Biochemistry. 2013 Jun 11;52(23):3987-94.	Mart	Characterization of antimicrobial substances produced by Enterococcus faecalis MRR 10-3, isolated from the uropygial gland of the hoopoe (Upupa epops).##Solution structures of the linear leaderless bacteriocins enterocin 7A and 7B resemble carnocyclin A, a circular antimicrobial peptide.	
DRAMP02499	QDRPKKPGLRPPRPQKPPCVRECKNDWRCPGEQKCCRYGCIYECRDPIFVK	51	Veswaprin-b (Snakes, reptiles, animals)	B5L5P5	Belongs to the snake waprin family	Not found	Demansia vestigiata (Lesser black whip snake) (Demansia atra)	Antimicrobial, Antibacterial, Antimalarial	Homology	Not found	Not found		"Function: Damages membranes of susceptible bacteria. Has no hemolytic activity. Does not inhibit the proteinases elastase and cathepsin G (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	[Swiss_Prot Entry B5L5P5]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP02500	QDRPKKPGLCPPRPQKPPCVRECKNDWICPGEQKCCRYGCIYECRDPIFVK	51	Notewaprin-b (Snakes, reptiles, animals)	B5G6H5	Belongs to the snake waprin family	Not found	Notechis scutatus scutatus (Mainland tiger snake) (Common tigersnake)	Antimicrobial, Antibacterial, Antimalarial	Transcript level	Not found	Not found		"Function: Damages membranes of susceptible bacteria. Has no hemolytic activity. Does not inhibit the proteinases elastase and cathepsin G (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	[Swiss_Prot Entry B5G6H5]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP02502	QDRPVKPGLCPPRPQKPPCVKECKNDWSCRGEQKCCHYGCIYECRDPIFVK	51	Porwaprin-b (Snakes, reptiles, animals)	B5L5N2	Belongs to the snake waprin family	Not found	Pseudechis porphyriacus (Red-bellied black snake)	Antimicrobial, Antibacterial, Antimalarial	Homology	Not found	Not found		"Function: Damages membranes of susceptible bacteria. Has no hemolytic activity. Does not inhibit the proteinases elastase and cathepsin G (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	[Swiss_Prot Entry B5L5N2]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP02503	QDRPIKPGLCPPRPQKPPCVKECKNDRSCPREQKCCRYGCIYECRDPIFVK	51	Nigwaprin-b (Snakes, reptiles, animals)	B5L5N6	Belongs to the snake waprin family	Not found	Rhinoplocephalus nigrescens (Eastern small-eyed snake)	Antimicrobial, Antibacterial, Antimalarial	Homology	Not found	Not found		"Function: Damages membranes of susceptible bacteria. Has no hemolytic activity. Does not inhibit the proteinases elastase and cathepsin G (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	[Swiss_Prot Entry B5L5N6]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP18261	MGAIAKLVAKFGWPFIKKFYKQIMQFIGQGWTIDQIEKWLKRH	43	Enterocin 7B (Bacteriocin)	Q1A2D2	Belongs to the class IId bacteriocin	mr10B	Enterococcus faecalis 710C; Enterococcus faecalis MRR 10-3	Antimicrobial, Antibacterial, Anti-Gram+		Helix	Both peptides are primarily alpha-helical, adopting a similar overall fold. The structures can be divided into three separate alpha-helical regions: the N- and C-termini are both alpha-helical, separated by a central kinked alpha-helix. The overall structures bear an unexpected resemblance to carnocyclin A, a 60-residue peptide that is cyclized via an amide bond between the C- and N-termini and has a saposin fold.	2M60	leaderless, i.e. no signal peptide. Although MR10B and Enterocin 7B share the same amino acid sequence, enterocin 7B is N-terminally formylated Met.  Remarkably, the peptides are helical in aqueous solution. Enterocins 7A and 7B each display strong activity by themselves without their partner.	broad-spectrum( mainly Gram-positive)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	21469734##23725536	J Agric Food Chem. 2011 May 25;59(10):5602-8.##Biochemistry. 2013 Jun 11;52(23):3987-94.	Liu X, Vederas JC, Whittal RM, Zheng J, Stiles ME, Carlson D, Franz CM, McMullen LM, van Belkum MJ.##Lohans CT, Towle KM, Miskolzie M, McKay RT, van Belkum MJ, McMullen LM, Vederas JC.	Identification of an N-terminal formylated, two-peptide bacteriocin from Enterococcus faecalis 710C.##Solution structures of the linear leaderless bacteriocins enterocin 7A and 7B resemble carnocyclin A, a circular antimicrobial peptide.	
DRAMP18260	ATYYGNGLYCNKQKCWVDWNKASREIGKIIVNGWVQHGPWAPR	43	Bacteriocin 31 (Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	Enterococcus faecalis  Y1717	Antimicrobial, Antibacterial, Anti-Gram+		Not found	These bacteriocins are heat-stable, nonlanthionine, membrane-active peptides characterized by a Gly (22)		The deduced amino acid sequence of the mature protein of BacA showed a high degree of homology of the identical residues with the class II bacteriocin of lactic acid bacteria.	Gram-positive(narrow)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	8655558	J Bacteriol. 1996 Jun;178(12):3585-93.	Tomita H, Fujimoto S, Tanimoto K, Ike Y.	Cloning and genetic organization of the bacteriocin 31 determinant encoded on the Enterococcus faecalis pheromone-responsive conjugative plasmid pYI17.	
DRAMP02506	LDRPKKPGLCPPRPQKPPCVRECKNDWRCPGERKCCRYGCIYECRDPIFVK	51	Veswaprin-c (Snakes, reptiles, animals)	B5L5P6	Belongs to the snake waprin family	Not found	Demansia vestigiata (Lesser black whip snake) (Demansia atra)	Antimicrobial, Antibacterial, Antimalarial	Homology	Not found	Not found		"Function: Damages membranes of susceptible bacteria. Has no hemolytic activity. Does not inhibit the proteinases elastase and cathepsin G (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	[Swiss_Prot Entry B5L5P6]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18979207	Cell Mol Life Sci. 2008 Dec;65(24):4039-4054. 	St Pierre L, Earl ST, Filippovich I, Sorokina N, Masci PP, De Jersey J, Lavin MF.	Common evolution of waprin and Kunitz-like toxin families in Australian venomous snakes.	
DRAMP18259	LGSCVANKIKDEFFAMISISAIVKAAQKKAWKELAVTVLRFAKANGLKTNAIIVAGQLALWAVQCGLS	68	Enterocin O16 (Bacteriocin)	No entry found	Not found	Not found	Enterococcus faecalis	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		the enterocin O16 antimicrobial peptide is translated as a large precursor pre-proprotein. The precursor is secreted via the general secretory pathway, and a 30-residues proprotein is released from the cells	Gram-positive(certain)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25733609	J Bacteriol. 2015 Jul;197(13):2112-21. 	Dundar H, Brede DA, La Rosa SL, El-Gendy AO, Diep DB, Nes IF.	The fsr Quorum-Sensing System and Cognate Gelatinase Orchestrate the Expression and Processing of Proprotein EF_1097 into the Mature Antimicrobial Peptide Enterocin O16.	
DRAMP18355	MAAFMKLIQFLATKGQKYVSLAWKHKGTILKWINAGQSFEWIYKQIKKLWA	51	Lacticin Z (bacteriocin)	No entry found	Belongs to the lantibiotic family.	Not found	Lactococcus lactis QU 14	Antimicrobial, Antibacterial		Not found	Not found	2N8P	PTM: N-terminal Met is formylated.	Active against S. saprophyticus (MIC 82.3-160 nM), S. hominis, S. warneri, E. faecalis (MIC 160 nM), including multidrug-resistant S. epidermidis strains causing biofilm-related infections (MIC 10-658 nM), S. aureus 1195 (MRSA), and vancomycin-resistant enterococci (VRE) (MIC 160-329 nM). THe recombinant peptide shows activity against M. luteus and S. aureus strains in lawn assays.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17690480	Biosci Biotechnol Biochem. 2007 Aug;71(8):1984-92. 	Iwatani S, Zendo T, Yoneyama F, Nakayama J, Sonomoto K.	Characterization and structure analysis of a novel bacteriocin, lacticin Z, produced by Lactococcus lactis QU 14.	
DRAMP18258	PNWTKIGKCAGSIAWAIGSGLFGGAKLIKIKKYIAELGGLQKAAKLLVGATTWEEKLHAGGYALINLAAELTGVAGIQANCF	82	Closticin 574(Bacteriocin)	Q8GCU9	Belongs to the class IIc bacteriocin	cloA	Clostridium tyrobutyricum ADRIAT 932	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Closticin 574 is, on the basis of the nucleotide sequence of its structural gene, produced as preproprotein of 309 amino acid residues. After secretion and processing, it gives rise to an antimicrobial peptide of 82 amino acid residues.	Gram-positive(narrow)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12620847	Appl Environ Microbiol. 2003 Mar;69(3):1589-97.##Appl Environ Microbiol. 2003 Oct;69(10):5839-48.	Kemperman R, Kuipers A, Karsens H, Nauta A, Kuipers O, Kok J.	Identification and characterization of two novel clostridial bacteriocins, circularin A and closticin 574.	
DRAMP18256	GLCAVNEFVALAAIPGGAATFAVCQMPNLDEIVSNAAYV	39	Boticin B (Bacteriocin)	Q9KGZ4	Not found	btcB	Clostridium botulinum	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Boticin B appears to be unique since it shows no detectable homology to other bacteriocins, including those from clostridial species.		Amino acid analysis of purified boticin B estimated that the active protein contained 39 amino acids. Boticin B is a heat-stable bacteriocin produced by Clostridium botulinum strain 213B that has inhibitory activity against various strains of C. botulinum and related clostridia.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11097932	Appl Environ Microbiol. 2000 Dec;66(12):5480-3.	Dineen SS, Bradshaw M, Johnson EA.	Cloning, nucleotide sequence, and expression of the gene encoding the bacteriocin boticin B from Clostridium botulinum strain 213B.	
DRAMP02511	YKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWKCCKKGSG	42	Crotamine (defensin-like toxin; Snakes, reptiles, animals)	Q9PWF3	Belongs to the crotamine-myotoxin family	CRO2	Crotalus durissus terrificus (South American rattlesnake)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Cytotoxic, Antifungal	Protein level	Combine helix and strand structure	Crotamine contains an alpha-helix with residues 1-7 and a two-stranded anti-parallel beta-sheet with residues 9-13 and 34-38 as the only regular secondary structures. These are connected with each other and the remainder of the polypeptide chain by the three disulfide bonds, which also form part of a central hydrophobic core (Ref.2).	1Z99 resolved by NMR.	"Function: It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. As a cell-penetrating peptide, crotamine has high specificity for actively proliferating cells, and interacts inside the cell with subcellular and subnuclear structures, like vesicular compartments, chromosomes and centrioles. Crotamine has marked activity against the eukaryotic pathogen Candida albicans at pH 7.5 or 5.5.
Tissue specificity: Expressed by the venom gland.
Toxic dose: LD50 is 1.5 mg/kg by intravenous injection. LD50 is 32.8 mg/kg by intraperitoneal injection into mice.(Ref.3)(Ref.4)
Pharmaceutical use: Has high potential for use as an anticancer agent. In vivo treatment with this protein significantly delays tumor implantation, inhibits tumor growth and prolongs the lifespan of the mice with melanoma tumors. It has also potent and specific toxicity against tumor cell lines of aggressive mouse and human tumors, but low cytotoxicity against non-tumoral cell lines. In addition, this protein can act as a carrier capable of delivering DNA into replicating cells with low cytotoxicity against normal proliferative cells.(Ref.5)(Ref.6)
Miscellaneous: Has no hemolytic activity ."	[Swiss_Prot Entry Q9PWF3]Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacteria: Escherichia coli;##Yeast: Candida albicans	[Ref.210622]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Eukaryotic ion channels	19706485##16185738##1176086##9839677##22142367##210622	Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14972-14977.##Toxicon. 2005 Dec 1;46(7):759-767.##Hoppe Seylers Z Physiol Chem. 1975 Feb;356(2):213-215.##Toxicon. 1998 Dec;36(12):1927-1937.##Mol Pharm. 2012 Feb 6	Yount NY, Kupferwasser D, Spisni A, Dutz SM, Ramjan ZH, Sharma S, Waring AJ, Yeaman MR.##Fadel V, Bettendorff P, Herrmann T, de Azevedo WF Jr, Oliveira EB, Yamane T, Wüthrich K.##Laure CJ.##Mancin AC, Soares AM, Andrião-Escarso SH, Faça VM, Greene LJ, Zuccolotto S, Pelá IR, Giglio JR.##Nascimento FD, Sancey L, Pereira A, Rome C, Oliveira V, Oliveira EB, Nader HB, Yamane T, Kerkis I, Tersariol IL, Coll JL, Hayashi MA.##Kerkis I, Silva 	Selective reciprocity in antimicrobial activity versus cytotoxicity of hBD-2 and crotamine.##Automated NMR structure determination and disulfide bond identification of the myotoxin crotamine from Crotalus durissus terrificus.##The primary structure of crotamine (author's transl).##he analgesic activity of crotamine, a neurotoxin from Crotalus durissus terrificus (South American rattlesnake) venom: a biochemical and pharmacological study.##The natural cell-penetrating peptide crotamine targets tu	
DRAMP02512	ADDRNPLEQCFRETDYEEFLEIARNNLKATSNPKHVVIVGAGMAGLSAAYVLSGGGHQVTV	61	L-amino-acid oxidase (Casca LAO, LAAO, LAO; Snakes, reptiles, animals)	P0C2D2	Not found	Not found	Crotalus durissus cascavella (Northeastern Brazilian rattlesnake)	Antimicrobial, Antibacterial, Antiparasitic, Cytotoxic	Protein level	Not found	Not found		Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. This protein may also induce hemorrhage, hemolysis, and edema. Also has parasiticidal activities against leishmania, as a result of enzyme-catalyzed hydrogen peroxide production, and the 50% inhibitory concentration was estimated in 2.39 microg/ml.	Xanthomonas axonopodis pv passiflorae, Streptococcus mutans, Leishmania amazonensis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16307769	Toxicon. 2006 Jan;47(1):47-57.	Toyama MH, Toyama Dde O, Passero LF, Laurenti MD, Corbett CE, Tomokane TY, Fonseca FV, Antunes E, Joazeiro PP, Beriam LO, Martins MA, Monteiro HS, Fonteles MC.	Isolation of a new L-amino acid oxidase from Crotalus durissus cascavella venom.	
DRAMP02513	KRRGSVTTRYQFLMIHLLRPKKLFA	25	EA-CATH1	No entry found	Not found	Not found	Equus asinus	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20423460	FEBS J. 2010 May;277(10):2329-2339.	Lu Z, Wang Y, Zhai L, Che Q, Wang H, Du S, Wang D, Feng F, Liu J, Lai R, Yu H.	Novel cathelicidin-derived antimicrobial peptides from Equus asinus.	
DRAMP02514	RIKRFWPVVIRTVVAGYNLYRAIKKK	26	Cathelicidin Pc-CATH1	No entry found	Not found	Not found	Phasianus colchicus	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Dong L, Yang JJ, Wang Y, Liu H, Mu LX, Lin DH, Lai R.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP18398	ISQSDAILSAIWSGIKSLF	19	Um2 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Urodacus manicatus	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against M. luteus (MIC 4 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28067810	Toxins (Basel). 2017 Jan 6;9, 22. doi: 10.3390/toxins9010022.	Luna-Ramirez K, Tonk M, Rahnamaeian M, Vilcinskas A.	Bioactivity of Natural and Engineered Antimicrobial Peptides from Venom of the Scorpions Urodacus yaschenkoi and U. manicatus	
DRAMP02516	LVQRGRFGRFLKKVRRFIPKVIIAAQIGSRFG	32	Cc-CATH2	No entry found	Not found	Not found	Coturnix coturnix	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21375690	FEBS J. 2011 May;278(9):1573-1584.	Feng F, Chen C, Zhu W, He W, Guang H, Li Z, Wang D, Liu J, Chen M, Wang Y, Yu H.	Gene cloning, expression, and characterization of avian cathelicidin orthologue, Cc-CATHs, from Coturnix coturnix.	
DRAMP02517	RVRRFWPLVPVAINTVAAGINLYKAIRRK	29	Cc-CATH3	No entry found	Not found	Not found	Coturnix coturnix	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21375690	FEBS J. 2011 May;278(9):1573-1584.	Feng F, Chen C, Zhu W, He W, Guang H, Li Z, Wang D, Liu J, Chen M, Wang Y, Yu H.	Gene cloning, expression, and characterization of avian cathelicidin orthologue, Cc-CATHs, from Coturnix coturnix.	
DRAMP04532	GIHDILKYGKPS	12	Myxinidin (Hagfish, animals)	No entry found	Not found	Not found	Myxine glutinosa (Atlantic hagfish)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Myxinidin showed activity against a broad range of bacteria and yeast pathogens at minimum bactericidal concentration (MBC) ranging from 1.0 to 10.0 	[Ref.19330556] Gram-negative bacteria: Escherichia coli D31 (MBC=2.0 μg/ml), Salmonella enterica serovar Typhimurium C610 (MBC=2.5 μg/mL), Pseudomonas aeruginosa Z61 (MBC=7.0μg/ml), Pseudomonas aeruginosa K799 (MBC=10.0 μg/ml), Aeromonas salmonicida sub sp. salmonicida A449 (MBC=2.0 μg/ml), Listonella anguillarum 02-11 (MBC=1.0 μg/ml), Yersinia ruckeri 96-4 (MBC=2.0 μg/ml);##Gram-positive bacterium: Staphylococcus epidermis C621(MBC=8.5 μg/ml);##Yeast: Candida albicans C627 (MBC=10.0 μg/ml).	[Ref.19330556] Non-hemolytic activity against rabbit red blood cells at concentrations 50-fold higher than its antimicrobial activity.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19330556	Mar Biotechnol (NY). 2009 Nov-Dec;11(6):748-757.	Subramanian S, Ross NW, MacKinnon SL.	Myxinidin, a novel antimicrobial peptide from the epidermal mucus of hagfish, Myxine glutinosa L.	
DRAMP02519	KRFKKFFKKLKKSVKKRAKKFFKKPRVIGVSIPF	34	BF-CATH	No entry found	Not found	Not found	Bungarus fasciatus	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18620012	Peptides. 2008 Oct;29(10):1685-1691.	Zhao H, Gan TX, Liu XD, Jin Y, Lee WH, Shen JH, Zhang Y.	Identification and characterization of novel reptile cathelicidins from elapid snakes.	
DRAMP02521	KFFKKLKNSVKKRAKKFFKKPRVIGVSIPF	30	Cathelicidin-OH (Cathelicidin-related protein; Snakes, reptiles, animals)	B6S2X2	Belongs to the cathelicidin family.	Not found	Ophiophagus hannah (King cobra) (Naja hannah)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram+, Antifungal	Transcript level	Alpha helix 	Not found	2mwt resolved by NMR	[Ref.22491685]Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans	[Ref.18620012]Gram-negative bacteria: Escherichia coli ATCC 25922, Escherichia coli ML-35P, Escherichia coli clinic strain, Pseudomonas aeruginosa ATCC 27853, Pseudomonas aeruginosa PA 01, Pseudomonas aeruginosa clinic strain, Enterobacter aerogenes clinic strain, Enterobacter cloacae clinic strain.##[Ref.22491685]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=3.125 μg/ml), Staphylococcuss aureus ATCC 43300 MRSA (MIC=6.25 μg/ml), Staphylococcuss aureus clinical strain 1 (MIC=3.125 μg/ml), Staphylococcuss aureus clinical strain 2 (MIC=6.25 μg/ml), Staphylococcuss aureus clinical strain 3 (MIC=6.25 μg/ml), Enterococcus faecalis ATCC 29212 (MIC=25 μg/ml) ;##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=6.25 μg/ml), Escherichia coli ML-35p (MIC=3.125 μg/ml), Escherichia coli clinical strain 1 (MIC=6.25 μg/ml), Escherichia coli clinical strain 2 (MIC=3.125 μg/ml), Escherichia coli clinical strain 3 (MIC=1.56 μg/ml), Escherichia coli clinical strain 4 (MIC=12.5 μg/ml), Escherichia coli clinical strain 5 (MIC=3.125 μg/ml), Escherichia coli clinical strain 6 (MIC=3.125 μg/ml), Enterobacter cloacae ATCC 13047 (MIC=25 μg/ml), Enterobacter cloacae clinical strain (MIC=3.125 μg/ml), Enterobacter aerogenes clinical strain (MIC=6.25 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=6.25 μg/ml), Pseudomonas aeruginosa PA 01 (MIC=6.25 μg/ml), Pseudomonas aeruginosa clinical strain 1 (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain 2 (MIC=6.25 μg/ml), Haemophilus influenzae ATCC 49247 (MIC=3.125 μg/ml), Haemophilus influenzae ATCC 49766 (MIC=3.125 μg/ml), Klebsiella pneumoniae ATCC 13883 (MIC=6.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=3.125 μg/ml) ;##Fungi : Candida albicans ATCC 2002 (MIC>200 μg/ml), Candida albicans clinical strain (MIC>200 μg/ml)	[Ref.22491685] 3% hemolysis at 100 μg/ml , 5% hemolysis at 200 μg/ml , 6% hemolysis at 300 μg/ml , 7% hemolysis at 400 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	18620012##22491685	Peptides. 2008 Oct;29(10):1685-91. ##Antimicrob Agents Chemother. 2012 Jun;56(6):3309-17. doi: 10.1128/AAC.06304-11.	Zhao H, Gan TX, Liu XD, Jin Y, Lee WH, Shen JH, Zhang Y.##Sheng-An Li, Wen-Hui Lee, and Yun Zhang	Identification and characterization of novel reptile cathelicidins from elapid snakes.##Efficacy of OH-CATH30 and Its Analogs against Drug-ResistantBacteria In Vitro and in Mouse Models	
DRAMP02523	MLHLVVYDISDDGSRARLAKLLEKFGLQRVQYSAFRGELNPNDREVLARQVGKFVRDDRDCIFIIPLCQRCSSTAIVISNTGVELVKEKGVEFV	94	CRISPR-associated endoribonuclease Cas2 1 (Antiviral defensin)	O28403	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas21	Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM9628 / NBRC 100126)	Antimicrobial, Antiviral	Protein level	Not found	Not found		Function: CRISPR is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	9389475##18482976	Nature. 1997 Nov 27;390(6658):364-370.##J Biol Chem. 2008 Jul 18;283(29):20361-71.	Klenk HP, Clayton RA, Tomb JF, White O, Nelson KE, Ketchum KA, Dodson RJ, Gwinn M, Hickey EK, Peterson JD, Richardson DL, Kerlavage AR, Graham DE, Kyrpides NC, Fleischmann RD, Quackenbush J, Lee NH, Sutton GG, Gill S, Kirkness EF, Dougherty BA, McKenney K, Adams MD, Loftus B, et al.##Beloglazova N, Brown G, Zimmerman MD, Proudfoot M, Makarova KS, Kudritska M, Kochinyan S, Wang S, Chruszcz M, Minor W, Koonin EV, Edwards AM, Savchenko A, Ya	The complete genome sequence of the hyperthermophilic, sulphate-reducing archaeon Archaeoglobus fulgidus.##A novel family of sequence-specific endoribonucleases associated with the clustered regularly interspaced short palindromic repeats.	
DRAMP02524	MFYLISYDISVDQRRLKIAKLLEGYGQRVLESVFECDLELPAYRQLRQKLNRLIKDEEGDRLRIYRLCASCREQIEIIGDGPPPETSQDIYII	93	CRISPR-associated endoribonuclease Cas2 1 (Antiviral defensin)	A9WEP1	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-1	Chloroflexus aurantiacus (strain ATCC 29366 / DSM 635 / J-10-fl)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	PubMed ID is not availbale	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Copeland A, Lucas S, Lapidus, Barry K, Glavina del Rio T, Hammon N, Israni S, Dalin E, Tice H, Pitluck S, Chertkov O, Brettin T, Bruce D, Detter JC, Han C, Schmutz J, Larimer F, Land M, Hauser L, Kyrpides N, Mikhailova N, Pierson BK, Blankenship RE, Richardson P.	Complete sequence of Chloroflexus aurantiacus J-10-fl.	
DRAMP02525	MTVKHLIVCYDVEKTKDRNKVIKVLEYYGLIRVQYSVFMGSLTETRLHQMNARIKREFTKPSIKILVIEVCNACMERALLVHEELPKVNRQFEVI	95	CRISPR-associated endoribonuclease Cas2 1 (Antiviral defensin)	Q2FL79	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-1	Methanospirillum hungatei JF-1 (strain ATCC 27890 / DSM 864 / NBRC100397 / JF-1)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	PubMed ID is not availbale	Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases	Copeland A, Lucas S, Lapidus A, Barry K, Detter JC, Glavina T, Hammon N, Israni S, Pitluck S, Brettin T, Bruce D, Han C, Tapia R, Gilna P, Kiss H, Schmutz J, Larimer F, Land M, Kyrpides N, Ivanova N, McInerney MJ, Brockman F, Culley D, Ferry JG, Gunsalus RP, Morrison M, Plugge C, Scholten J, Stams AJM, Boone DR, Richardson P.	Complete sequence of Methanospirillum hungatei JF-1.	
DRAMP02526	MIWLAVYDIEDDGERAKASAILQAWGFVRVQRSFYVGRMPRGKAADLLKILQRHVKSGHIALIPITDELLAKALELGRPPYAPLKPPKYAQIYVV	95	CRISPR-associated endoribonuclease Cas2 1 (Antiviral defensin)	Q8ZZU2	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-1	Pyrobaculum aerophilum (strain ATCC 51768 / IM2 / DSM 7523 / JCM 9630/ NBRC 100827)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	11792869	Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):984-989.	Fitz-Gibbon ST, Ladner H, Kim UJ, Stetter KO, Simon MI, Miller JH.	Genome sequence of the hyperthermophilic crenarchaeon Pyrobaculum aerophilum.	
DRAMP02527	MLYLIIYDVPATKAGNKRRTRLFDLLSGYGKWRQFSVFECFLSVKQFAKLQTAMEKLIKLDEDAVCIYVLDENTVQRTITYGTPQPEKPGSIII	94	CRISPR-associated endoribonuclease Cas2 1 (Antiviral defensin)	Q6ZEI1	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-1	Synechocystis sp. (strain PCC 6803 / Kazusa)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	14686584	DNA Res. 2003 Oct 31;10(5):221-228.	Kaneko T, Nakamura Y, Sasamoto S, Watanabe A, Kohara M, Matsumoto M, Shimpo S, Yamada M, Tabata S.	Structural analysis of four large plasmids harboring in a unicellular cyanobacterium, Synechocystis sp. PCC 6803.	
DRAMP02528	MRELYLVIAYDTPDDRRRARLAKLLKGFGERRQYSVFEARLTREQWAHLKGKLEALVNKEEDVLAVYFLPPEAVGRTWRIGHEGLKRLEDPDFV	94	CRISPR-associated endoribonuclease Cas2 1 (Antiviral defensin)	Q745W0	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2a	Thermus thermophilus (strain HB27 / ATCC BAA-163 / DSM 7039)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	15064768	Nat Biotechnol. 2004 May;22(5):547-553.	Henne A, Brüggemann H, Raasch C, Wiezer A, Hartsch T, Liesegang H, Johann A, Lienard T, Gohl O, Martinez-Arias R, Jacobi C, Starkuviene V, Schlenczeck S, Dencker S, Huber R, Klenk HP, Kramer W, Merkl R, Gottschalk G, Fritz HJ.	The genome sequence of the extreme thermophile Thermus thermophilus.	
DRAMP02529	MRVLYIIAYDITDARRLGQIRYFLKGYSTGGQKSVYECFLEREELKFIISKIKRLINPNEDRVHIFRIDGRSKVITLGIAVPPIDPEYFYIG	92	CRISPR-associated endoribonuclease Cas2 1 (Antiviral defensin)	B5YJS1	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-1	Thermodesulfovibrio yellowstonii (strain ATCC 51303 / DSM 11347 /YP87)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	PubMed ID is not availbale	Submitted (AUG-2008) to the EMBL/GenBank/DDBJ databases	Dodson R.J, Durkin A.S, Wu M, Eisen J, Sutton G.	The complete genome sequence of Thermodesulfovibrio yellowstonii strain ATCC 51303 / DSM 11347 / YP87.	
DRAMP02530	MVVIVYVIVAYDVNVERVNRVKKFLRRYLNWVQNSLFEGELSSADLEEVKMGLREIINEDEDMVVIYRFRSADAFKREVMGIEKGLGGEEVI	92	CRISPR-associated endoribonuclease Cas2 2 (Antiviral defensin)	O30237	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas22	Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM9628 / NBRC 100126)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	9389475	Nature. 1997 Nov 27;390(6658):364-370.	Klenk HP, Clayton RA, Tomb JF, White O, Nelson KE, Ketchum KA, Dodson RJ, Gwinn M, Hickey EK, Peterson JD, Richardson DL, Kerlavage AR, Graham DE, Kyrpides NC, Fleischmann RD, Quackenbush J, Lee NH, Sutton GG, Gill S, Kirkness EF, Dougherty BA, McKenney K, Adams MD, Loftus B, et al.	The complete genome sequence of the hyperthermophilic, sulphate-reducing archaeon Archaeoglobus fulgidus.	
DRAMP02531	MQCLVIYDIPNDRARQRVADACLDYGLQRIQYSAFAGNLSRTHQRALFGEITRRVKGHTANVQLFVFDSKTWSDRRILEQQYDDA	85	CRISPR-associated endoribonuclease Cas2 2 (Antiviral defensin)	A9WFZ7	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-2	Chloroflexus aurantiacus (strain ATCC 29366 / DSM 635 / J-10-fl)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	PubMed ID is not availbale	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Copeland A, Lucas S, Lapidus, Barry K, Glavina del Rio T, Hammon N, Israni S, Dalin E, Tice H, Pitluck S, Chertkov O, Brettin T, Bruce D, Detter JC, Han C, Schmutz J, Larimer F, Land M, Hauser L, Kyrpides N, Mikhailova N, Pierson BK, Blankenship RE, Richardson P.	Complete sequence of Chloroflexus aurantiacus J-10-fl.	
DRAMP02532	MVRLVITYDIRKDKIRNKLFRLLERYGAWKQYSVFELEINPVHKVELFHSIADLIEDTDRVRIYDLCERCQGKITELGEVSPDKMQVVI	89	CRISPR-associated endoribonuclease Cas2 2 (Antiviral defensin)	Q2FQQ4	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-2	Methanospirillum hungatei JF-1 (strain ATCC 27890 / DSM 864 / NBRC100397 / JF-1)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	PubMed ID is not availbale	Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases	Copeland A, Lucas S, Lapidus A, Barry K, Detter JC, Glavina T, Hammon N, Israni S, Pitluck S, Brettin T, Bruce D, Han C, Tapia R, Gilna P, Kiss H, Schmutz J, Larimer F, Land M, Kyrpides N, Ivanova N, McInerney MJ, Brockman F, Culley D, Ferry JG, Gunsalus RP, Morrison M, Plugge C, Scholten J, Stams AJM, Boone DR, Richardson P.	Complete sequence of Methanospirillum hungatei JF-1.	
DRAMP02533	MILIYDINTEDNDGKRRLVKIMKTSRKYLSHVQKSVFEGDITEGQISLLKKEIMAIVNMKKDFVIIYSLRDGVKLNREILTDTPDPTDNFL	91	CRISPR-associated endoribonuclease Cas2 2 (Antiviral defensin)	Q2RHR2	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-2	Moorella thermoacetica (strain ATCC 39073)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	18631365	Environ Microbiol. 2008 Oct;10(10):2550-2573.	Pierce E, Xie G, Barabote RD, Saunders E, Han CS, Detter JC, Richardson P, Brettin TS, Das A, Ljungdahl LG, Ragsdale SW.	The complete genome sequence of Moorella thermoacetica (f. Clostridium thermoaceticum).	
DRAMP02534	MYVVVAYDITEDEVRNKVADALKAYGLERIQRSVFVGRINPALLKDLVERLKRITKGANADITIFKVDRRAIDTAIRIGPPPPARKNVDLY	91	CRISPR-associated endoribonuclease Cas2 2 (Antiviral defensin)	Q8ZZL9	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-2	Pyrobaculum aerophilum (strain ATCC 51768 / IM2 / DSM 7523 / JCM 9630/ NBRC 100827)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	11792869	Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):984-989.	Fitz-Gibbon ST, Ladner H, Kim UJ, Stetter KO, Simon MI, Miller JH.	Genome sequence of the hyperthermophilic crenarchaeon Pyrobaculum aerophilum.	
DRAMP02535	MKLLVVYDVSDDSKRNKLANNLKKLGLERIQRSAFEGDIDSQRVKDLVRVVKLIVDTNTDIVHIIPLGIRDWERRIVIGREGLEEWLV	88	CRISPR-associated endoribonuclease Cas2 2 (Antiviral defensin)	Q97Y85	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas22	Sulfolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 /P2)	Antimicrobial, Antiviral	Protein level	Combine helix and strand structure	Not found	3EXC resolved by X-ray.	Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	11427726##18482976##PubMed ID is not availbale	Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7835-7840.##J Biol Chem. 2008 Jul 18;283(29):20361-71.##To be Published	She Q, Singh RK, Confalonieri F, Zivanovic Y, Allard G, Awayez MJ, Chan-Weiher CC, Clausen IG, Curtis BA, De Moors A, Erauso G, Fletcher C, Gordon PM, Heikamp-de Jong I, Jeffries AC, Kozera CJ, Medina N, Peng X, Thi-Ngoc HP, Redder P, Schenk ME, Theriault C, Tolstrup N, Charlebois RL, Doolittle WF, Duguet M, Gaasterland T, Garrett RA, Ragan MA, Sensen CW, Van der Oost J.##Beloglazova N, Brown G, Zimmerman MD, Proudfoot M, Makarova KS, Kud	The complete genome of the crenarchaeon Sulfolobus solfataricus P2.##A novel family of sequence-specific endoribonucleases associated with the clustered regularly interspaced short palindromic repeats.##Structure of the RNA'se SSO8090 from Sulfolobus solfataricus.	
DRAMP02536	MDFWLVCYDVRDDKRRRKLAKLLEQRCQRVQYSVFECPLPEKVLTDLLHRRWLKELNLKEDSLRAYPLQRQSRSQAKIFGSPDLYEPPDFLIL	93	CRISPR-associated endoribonuclease Cas2 2 (Antiviral defensin)	Q6ZEC6	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-2	Synechocystis sp. (strain PCC 6803 / Kazusa)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	14686584	DNA Res. 2003 Oct 31;10(5):221-228.	Kaneko T, Nakamura Y, Sasamoto S, Watanabe A, Kohara M, Matsumoto M, Shimpo S, Yamada M, Tabata S.	Structural analysis of four large plasmids harboring in a unicellular cyanobacterium, Synechocystis sp. PCC 6803.	
DRAMP02537	MGKRLYAVAYDIPDDTRRVKLANLLKSYGERVQLSVFECYLDERLLEDLRRRARRLLDLGQDALRIYPVAGQVEVLGVGPLPELREVQVL	90	CRISPR-associated endonuclease Cas2 2 (Antiviral defensin)	Q746F4	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2b	Thermus thermophilus (strain HB27 / ATCC BAA-163 / DSM 7039)	Antimicrobial, Antiviral	Protein level	Combine helix and strand structure	Not found	1ZPW resolved by X-ray.	Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	15064768##22942283##PubMed ID is not availbale	Nat Biotechnol. 2004 May;22(5):547-553.##J Biol Chem. 2012 Oct 19;287(43):35943-52.##To be Published	Henne A, Brüggemann H, Raasch C, Wiezer A, Hartsch T, Liesegang H, Johann A, Lienard T, Gohl O, Martinez-Arias R, Jacobi C, Starkuviene V, Schlenczeck S, Dencker S, Huber R, Klenk HP, Kramer W, Merkl R, Gottschalk G, Fritz HJ.##Nam KH, Ding F, Haitjema C, Huang Q, DeLisa MP, Ke A.##Ihsanawati, Murayama K, Shirouzu M, Yokoyama S.	The genome sequence of the extreme thermophile Thermus thermophilus.##Double-stranded endonuclease activity in Bacillus halodurans clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas2 protein.##Crystal structure of a hypothetical protein TT1823 from Thermus thermophilus.	
DRAMP02538	MRLPYLVCYDISDEGRLNRVYRFMKGKGFHIQYSVFYCILTDVELKEMKAEILKLIHSRYDDVRIYPLPNNSLVAVLGVGDRIPDGVEVFY	91	CRISPR-associated endoribonuclease Cas2 2 (Antiviral defensin)	B5YJS4	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-2	Thermodesulfovibrio yellowstonii (strain ATCC 51303 / DSM 11347 /YP87)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	PubMed ID is not availbale	Submitted (AUG-2008) to the EMBL/GenBank/DDBJ databases	Dodson R.J, Durkin A.S, Wu M, Eisen J, Sutton G.	The complete genome sequence of Thermodesulfovibrio yellowstonii strain ATCC 51303 / DSM 11347 / YP87.	
DRAMP02539	MKMFTVISYDIVDDQRRTSVMKVLKGYGVRVQYSVFEAILDAREFHDLSNQLRKIIDPGQDSIRCYRLDQVAAQRTVIYGIGLTTTDPTHYMV	93	CRISPR-associated endoribonuclease Cas2 3 (Antiviral defensin)	A9WJV5	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-3	Chloroflexus aurantiacus (strain ATCC 29366 / DSM 635 / J-10-fl)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	PubMed ID is not availbale	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Copeland A, Lucas S, Lapidus, Barry K, Glavina del Rio T, Hammon N, Israni S, Dalin E, Tice H, Pitluck S, Chertkov O, Brettin T, Bruce D, Detter JC, Han C, Schmutz J, Larimer F, Land M, Hauser L, Kyrpides N, Mikhailova N, Pierson BK, Blankenship RE, Richardson P.	Complete sequence of Chloroflexus aurantiacus J-10-fl.	
DRAMP02540	MLIIVTYDVSTETRAGRKRLRRVAKLCESIGQRVQKSVFECRINLMQYEELERRLLSEIDEQEDNLRLYRLTEPAELHVKEYGNFKAIDFEGPLTI	96	CRISPR-associated endoribonuclease Cas2 3 (Antiviral defensin)	Q82W51	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas23	Nitrosomonas europaea (strain ATCC 19718 / NBRC 14298)	Antimicrobial, Antiviral	Protein level	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	12700255##18482976	J Bacteriol. 2003 May;185(9):2759-2773.##J Biol Chem. 2008 Jul 18;283(29):20361-71.	Chain P, Lamerdin J, Larimer F, Regala W, Lao V, Land M, Hauser L, Hooper A, Klotz M, Norton J, Sayavedra-Soto L, Arciero D, Hommes N, Whittaker M, Arp D.##Beloglazova N, Brown G, Zimmerman MD, Proudfoot M, Makarova KS, Kudritska M, Kochinyan S, Wang S, Chruszcz M, Minor W, Koonin EV, Edwards AM, Savchenko A, Yakunin AF.	Complete genome sequence of the ammonia-oxidizing bacterium and obligate chemolithoautotroph Nitrosomonas europaea.##A novel family of sequence-specific endoribonucleases associated with the clustered regularly interspaced short palindromic repeats.	
DRAMP02541	MILVTYDVNTVEPGGRRRLRQVAKACQDYGQRVQNSVFEVEVDPARWVALKARLEAIIDPALDSLRYYDLGANWQRRVDHVGAKPAVDLHGPLIL	95	CRISPR-associated endoribonuclease Cas2 3 (Antiviral defensin)	Q2RW60	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-3	Rhodospirillum rubrum (strain ATCC 11170 / NCIB 8255)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	PubMed ID is not availbale	Submitted (DEC-2005) to the EMBL/GenBank/DDBJ database	Copeland A, Lucas S, Lapidus A, Barry K, Detter JC, Glavina T, Hammon N, Israni S, Pitluck S, Munk AC, Brettin T, Bruce D, Han C, Tapia R, Gilna P, Schmutz J, Larimer F, Land M, Kyrpides N, Mavrommatis K, Richardson P, Zhang Y, Roberts G, Reslewic S, Zhou S, Schwartz DC.	Complete sequence of the chromosome of Rhodospirillum rubrum ATCC 11170.	
DRAMP02542	MFLYVIAYDIPDDRRRKKMADLLEGYGQRVQYSVFECTLSKSKFNELQKRLRKIYQSEEDSLRFYPLSGHTLTQVDIWGEPPLTKPPGSVIV	92	CRISPR-associated endoribonuclease Cas2 3 (Antiviral defensin)	Q6ZEA5	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-3	Synechocystis sp. (strain PCC 6803 / Kazusa)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	14686584	DNA Res. 2003 Oct 31;10(5):221-228.	Kaneko T, Nakamura Y, Sasamoto S, Watanabe A, Kohara M, Matsumoto M, Shimpo S, Yamada M, Tabata S.	Structural analysis of four large plasmids harboring in a unicellular cyanobacterium, Synechocystis sp. PCC 6803.	
DRAMP02543	MPYLIVTYDIAEERVNKVRKILKKYFMWVQNSVFEGEITEGKLLKCKLELEKVIDKEVDSVYFYSLENRLNYRKTVLGIEKEITGNIL	88	CRISPR-associated endoribonuclease Cas2 3 (Antiviral defensin)	B5YIU7	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-3	Thermodesulfovibrio yellowstonii (strain ATCC 51303 / DSM 11347 /YP87)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	PubMed ID is not availbale	Submitted (AUG-2008) to the EMBL/GenBank/DDBJ databases	Dodson R.J, Durkin A.S, Wu M, Eisen J, Sutton G.	The complete genome sequence of Thermodesulfovibrio yellowstonii strain ATCC 51303 / DSM 11347 / YP87.	
DRAMP02544	MVYVLIAYDISNDSKRLKAAQKLLQMGFARVQKSVYIAKGGRSLAKEAYRALQRLADSGKDKIMVMVIPGDSVRDAYGLGGSLEDGKRVVVV	92	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	Q05E21	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC100138 / K1)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	10382966	DNA Res. 1999 Apr 30;6(2):83-101, 145-152.	Kawarabayasi Y, Hino Y, Horikawa H, Yamazaki S, Haikawa Y, Jin-no K, Takahashi M, Sekine M, Baba S, Ankai A, Kosugi H, Hosoyama A, Fukui S, Nagai Y, Nishijima K, Nakazawa H, Takamiya M, Masuda S, Funahashi T, Tanaka T, Kudoh Y, Yamazaki J, Kushida N, Oguchi A, Kikuchi H, et al.	Complete genome sequence of an aerobic hyper-thermophilic crenarchaeon, Aeropyrum pernix K1.	
DRAMP02545	MSSRLAVFAYDIRDDRVRRHALKTLREWRLDGQLSVHECQVDAIQARRLFEQLGDELDPATDAWLFTWVEGHRAVLARGKGRTTALQDGLLLAA	94	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	D3RW30	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / D)(Chromatium vinosum)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	PubMed ID is not availbale	Submitted (FEB-2010) to the EMBL/GenBank/DDBJ databases	Lucas S, Copeland A, Lapidus A, Cheng J-F, Bruce D, Goodwin L, Pitluck S, Munk AC, Detter JC, Han C, Tapia R, Larimer F, Land M, Hauser L, Kyrpides N, Ivanova N, Zigann R, Dahl C, Woyke T.	Complete sequence of plasmid 1 of Allochromatium vinosum DSM 180.	
DRAMP02546	MLVLITYDVQTSSMGGTKRLRKVAKACQNYGQRVQNSVFECIVDSTQLTSLKLELTSLIDEEKDSLRIYRLGNNYKTKVEHIGAKPSIDLEDPLIF	96	CRISPR-associated endonuclease Cas2 (Antiviral defensin)	Q9KFX8	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Bacillus halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM9153 / C-125)	Antimicrobial, Antiviral	Protein level	Combine helix and strand structure	Not found	4ES1, 4ES2, 4ES3 resolved by X-ray.	Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	11058132##22942283##PubMed ID is not availbale	Nucleic Acids Res. 2000 Nov 1;28(21):4317-4331.##J Biol Chem. 2012 Oct 19;287(43):35943-52.##To be Published	Takami H, Nakasone K, Takaki Y, Maeno G, Sasaki R, Masui N, Fuji F, Hirama C, Nakamura Y, Ogasawara N, Kuhara S, Horikoshi K.##Nam KH, Ding F, Haitjema C, Huang Q, DeLisa MP, Ke A.##Ke A, Nam KH.	Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans and genomic sequence comparison with Bacillus subtilis.##Double-stranded endonuclease activity in Bacillus halodurans clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas2 protein.##Crystal structure of BH0342 protein.	
DRAMP02547	MLVLVTYDVNTETPAGRRRLRRIAKTCQNYGQRVQFSVFECNVDPAQWVKLRSKLLNEMDPKLDSLRFYFLGSNWQGRVEHEGAKEPRDLEGTLIL	96	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	Q8KDC5	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Chlorobium tepidum (strain ATCC 49652 / DSM 12025 / TLS)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	12093901	Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9509-9514.	Eisen JA, Nelson KE, Paulsen IT, Heidelberg JF, Wu M, Dodson RJ, Deboy R, Gwinn ML, Nelson WC, Haft DH, Hickey EK, Peterson JD, Durkin AS, Kolonay JL, Yang F, Holt I, Umayam LA, Mason T, Brenner M, Shea TP, Parksey D, Nierman WC, Feldblyum TV, Hansen CL, Craven MB, Radune D, Vamathevan J, Khouri H, White O, Gruber TM, Ketchum KA, Venter JC, Tettelin H, Bryant DA, Fraser CM.	The complete genome sequence of Chlorobium tepidum TLS, a photosynthetic, anaerobic, green-sulfur bacterium.	
DRAMP02548	MYVIMVYDVNQRRINKVLNTARKYLEWIQNSVLEGEITEAKFEMLKREIEIIINEEEDSVIFYIMRTTKYSERQILGIEKNKREQIL	87	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	B8DZH3	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Dictyoglomus turgidum (strain Z-1310 / DSM 6724)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	PubMed ID is not availbale	Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases	Lucas S, Copeland A, Lapidus A, Glavina del Rio T, Tice H, Bruce D, Goodwin L, Pitluck S, Sims D, Brettin T, Detter J.C, Han C, Larimer F, Land M, Hauser L, Kyrpides N, Mikhailova N, Mead D.	Complete sequence of Dictyoglomus turgidum DSM 6724.	
DRAMP02549	MSMLVVVTENVPPRLRGRLAIWLLEVRAGVYVGDVSAKIREMIWEQIAGLAEEGNVVMAWATNTETGFEFQTFGLNRRTPVDLDGLRLVSFLPV	94	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	P45956, Q2MA75	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	ygbF	Escherichia coli (strain K12)	Antimicrobial, Antiviral	Protein level	Not found	Not found		"Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 
Induction: Repressed by H-NS, activated by LeuO. Activated by the BaeSR two-component regulatory system, possibly due to envelope stress. Part of the casABCDE-ygbT-ygbF operon."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	2656660##9278503##16738553	J Bacteriol. 1989 Jun;171(6):3553-6.##Science. 1997 Sep 5;277(5331):1453-1462.##Mol Syst Biol. 2006;2:2006.0007.	Nakata A, Amemura M, Makino K.##Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y.##Hayashi K, Morooka N, Yamamoto Y, Fujita K, Isono K, Choi S, Ohtsubo E, Baba T, Wanner BL, Mori H, Horiuchi T.	Unusual nucleotide arrangement with repeated sequences in the Escherichia coli K-12 chromosome.##The complete genome sequence of Escherichia coli K-12.##Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110.	
DRAMP02550	MFVVLVYDTAAERNPNALRTCRKYLHWVQRSVFEGELSAAQYRALMTTLRDQLDLTYDSIRVYRTRSPALVETEWLGVPLGNQDSVL	87	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	Q0RE94	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Frankia alni (strain ACN14a)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	17151343	Genome Res. 2007 Jan;17(1):7-15.	Normand P, Lapierre P, Tisa LS, Gogarten JP, Alloisio N, Bagnarol E, Bassi CA, Berry AM, Bickhart DM, Choisne N, Couloux A, Cournoyer B, Cruveiller S, Daubin V, Demange N, Francino MP, Goltsman E, Huang Y, Kopp OR, Labarre L, Lapidus A, Lavire C, Marechal J, Martinez M, Mastronunzio JE, Mullin BC, Niemann J, Pujic P, Rawnsley T, Rouy Z, Schenowitz C, Sellstedt A, Tavares F, Tomkins JP, Vallenet D, Valverde C, Wall LG, Wang Y, Medigue C, B	Genome characteristics of facultatively symbiotic Frankia sp. strains reflect host range and host plant biogeography.	
DRAMP02551	MEHLYIVSYDIRNQRRWRRLFKTMHGFGCWLQLSVFQCRLDRIRIIKMEAAINEIVNHAEDHVLILDLGPAENVKPKVSSIGKTFDPILRQAVIV	95	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	Q74H35	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Geobacter sulfurreducens (strain ATCC 51573 / DSM 12127 / PCA)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	14671304	Science. 2003 Dec 12;302(5652):1967-1969.	Methé BA, Nelson KE, Eisen JA, Paulsen IT, Nelson W, Heidelberg JF, Wu D, Wu M, Ward N, Beanan MJ, Dodson RJ, Madupu R, Brinkac LM, Daugherty SC, DeBoy RT, Durkin AS, Gwinn M, Kolonay JF, Sullivan SA, Haft DH, Selengut J, Davidsen TM, Zafar N, White O, Tran B, Romero C, Forberger HA, Weidman J, Khouri H, Feldblyum TV, Utterback TR, Van Aken SE, Lovley DR, Fraser CM.	Genome of Geobacter sulfurreducens: metal reduction in subsurface environments.	
DRAMP02552	MPYVVVFYDVSDNKRRDLLAKTLQSLGLVRVQRSVFMGRGGYTKAKEAIRAASRIVDARTDSVVALVVPEDYARRMLVYGGIMSDPKQKQAVRVV	95	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	A2BKJ6	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Hyperthermus butylicus (strain DSM 5456 / JCM 9403)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	17350933	Archaea. 2007 May;2(2):127-135.	Brügger K, Chen L, Stark M, Zibat A, Redder P, Ruepp A, Awayez M, She Q, Garrett RA, Klenk HP.	The genome of Hyperthermus butylicus: a sulfur-reducing, peptide fermenting, neutrophilic Crenarchaeote growing up to 108 degrees C.	
DRAMP02553	MRGGNLKVLVVYDITDDSLRLKVAEILKDLGLFRIQKSAFIGEMTSQERENMEEILRRQNLGPSDRIDVFPICDRDLKMHSQIGRGKFGRGPP	93	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	B1L402	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Korarchaeum cryptofilum (strain OPF8)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	18535141	Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8102-8107.	Elkins JG, Podar M, Graham DE, Makarova KS, Wolf Y, Randau L, Hedlund BP, Brochier-Armanet C, Kunin V, Anderson I, Lapidus A, Goltsman E, Barry K, Koonin EV, Hugenholtz P, Kyrpides N, Wanner G, Richardson P, Keller M, Stetter KO.	A korarchaeal genome reveals insights into the evolution of the Archaea.	
DRAMP02554	MKHWRLVSYDIREPKRLRRVAKIMEGFGERIQYSVFRIYSTDKELEKLRWKLAKVTEEEDNIFYLTLCTKCASGAHTQEKKSAWPEAPKTLKIL	94	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	Q8F1F4	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai(strain 56601)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	12712204	Nature. 2003 Apr 24;422(6934):888-893.	Ren SX, Fu G, Jiang XG, Zeng R, Miao YG, Xu H, Zhang YX, Xiong H, Lu G, Lu LF, Jiang HQ, Jia J, Tu YF, Jiang JX, Gu WY, Zhang YQ, Cai Z, Sheng HH, Yin HF, Zhang Y, Zhu GF, Wan M, Huang HL, Qian Z, Wang SY, Ma W, Yao ZJ, Shen Y, Qiang BQ, Xia QC, Guo XK, Danchin A, Saint Girons I, Somerville RL, Wen YM, Shi MH, Chen Z, Xu JG, Zhao GP.	Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing.	
DRAMP02555	MYVVIVYDVGVERVNKVRSFLREYMNWVQNSVFEGELTKAEFLKIKSRLKELIQESSDHIIFYSSRDRKYLGIEDLGTPKADTSNII	87	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	Q8TJV8	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Methanosarcina acetivorans (strain ATCC 35395 / DSM 2834 / JCM 12185 /C2A)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	11932238	Genome Res. 2002 Apr;12(4):532-542.	Galagan JE, Nusbaum C, Roy A, Endrizzi MG, Macdonald P, FitzHugh W, Calvo S, Engels R, Smirnov S, Atnoor D, Brown A, Allen N, Naylor J, Stange-Thomann N, DeArellano K, Johnson R, Linton L, McEwan P, McKernan K, Talamas J, Tirrell A, Ye W, Zimmer A, Barber RD, Cann I, Graham DE, et al.	The genome of M. acetivorans reveals extensive metabolic and physiological diversity.	
DRAMP02556	MAVFLIAYDLVNERRGTHDYQPLWDELKRLGAHRTQFSLWLVSANNTTAEVRQHFQQFVDSNDRIWVTRLRKSQYDYANAIGGTNNWLSNNPPEA	95	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	B7KNJ8	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Methylobacterium extorquens (strain CM4 / NCIMB 13688)(Methylobacterium chloromethanicum)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	PubMed ID is not availbale	Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases	Lucas S, Copeland A, Lapidus A, Glavina del Rio T, Dalin E, Tice H, Bruce D, Goodwin L, Pitluck S, Chertkov O, Brettin T, Detter J.C, Han C, Larimer F, Land M, Hauser L, Kyrpides N, Mikhailova N, Marx C, Richardson P.	Complete sequence of chromosome of Methylobacterium chloromethanicum CM4.	
DRAMP18356	MAGLLRFLLSKGRALYNWAKSHVGKVWEWLKSGATYEQIKEWIENALGWR	50	BacSP222 (bacteriocin)	No entry found	Not found	Not found	isolated from dog skin lesions, Staphylococcus pseudintermedius strain 222	Antibacterial, Mammalian cells, Antimicrobial		Not found	Not found	5LWC	Fuction: No acitivtiy against two Gram-negative bacteria tested (see the article). N-terminal formylation is not needed for antibacterial effects since a synthetic peptide without this modification works better.	Active against B. subtilis ATCC 6633 (MIC 0.16 uM), L. lactis subsp. lactis LOCK 0871 strain 239 (MIC 0.89 uM), M. luteus ATCC 4698 (MIC 0.11 uM), S. aureus DSM 26258 (CH91), S. aureus MRSA USA300 strain FPR3757, S. aureus KB/8658, S. aureus ATCC 25923 (MIC 0.89-1.3 uM), S. epidermidis ATCC 35547 (MIC 4.4 uM), S. intermedius ATCC 29663, S. intermedius R-2725 (MIC 1.2-2 uM), S. pseudintermedius 222, S. pseudintermedius LMG 22219 (MIC 2.1 and 0.16 uM), S. saprophyticus ATCC 15305 (MIC 0.93 uM), S. pyogenes PCM 465 (MIC 7.8 uM), S. sanguinis PCM 2335 (MIC 3.5 uM), and C. albicans ATCC 10231 (MIC 100 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26411997	Sci Rep. 2015 Sep 28;5:14569	Wladyka B, Piejko M, Bzowska M, Pieta P, Krzysik M, Mazurek ?, Guevara-Lora I, Bukowski M, Sabat AJ, Friedrich AW, Bonar E, Mi?dzobrodzki J, Dubin A, Mak P.2015	A peptide factor secreted by Staphylococcus pseudintermedius exhibits properties of both bacteriocins and virulence factors	
DRAMP18255	VAGALGVQTAAATTIVNVILNAGTLVTVLGIIASIASGGAGTLMTIGWATFKATVQKLAKQSMARAIAY	69	Circularin A(Bacteriocin)	Q8GB47	Belongs to the class IIc bacteriocin	cirA	Clostridium beijerinckii ATCC 25752	Antimicrobial, Antibacterial, Anti-Gram+		Not found	nonmodified, head-to-tail-ligated cyclic antibacterial peptides		digestion products of circularin A are not the cause of the residual antibacterial activity	Gram-positive(broad)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Not found	12620847##14532033	Appl Environ Microbiol. 2003 Mar;69(3):1589-97.##Appl Environ Microbiol. 2003 Oct;69(10):5839-48.	Kemperman R, Kuipers A, Karsens H, Nauta A, Kuipers O, Kok J.##Kemperman R, Jonker M, Nauta A, Kuipers OP, Kok J.	Identification and characterization of two novel clostridial bacteriocins, circularin A and closticin 574.##Functional analysis of the gene cluster involved in production of the bacteriocin circularin A by Clostridium beijerinckii ATCC 25752.	
DRAMP02558	MKVLVSFEIKFKTNKEKIISILKHFGFRRMQENLYFGDVEYDELYAMQSDIMENIREYDSILTIPICKSCYLKLNVFGRNLSFKDELYKIF	91	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	D3E4V5	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Methanobrevibacter ruminantium (strain ATCC 35063 / DSM 1093 / JCM13430 / M1) (Methanobacterium rumi	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	20126622	PLoS One. 2010 Jan 28;5(1):e8926.	Leahy SC, Kelly WJ, Altermann E, Ronimus RS, Yeoman CJ, Pacheco DM, Li D, Kong Z, McTavish S, Sang C, Lambie SC, Janssen PH, Dey D, Attwood GT.	The genome sequence of the rumen methanogen Methanobrevibacter ruminantium reveals new possibilities for controlling ruminant methane emissions.	
DRAMP02559	MVVTVYLLIVYDVGVERVNRVKSYLRTELHWVQNSVFEGEVTESQFRRIETNLERIIDRERDSVIIYSFRSERAMNRNVLGLEKSPLDVIL	91	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	O27155	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 /JCM 10044 / NBRC 100330 / Delt	Antimicrobial, Antiviral	Protein level	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	9371463##18482976	J Bacteriol. 1997 Nov;179(22):7135-7155.##J Biol Chem. 2008 Jul 18;283(29):20361-71.	Smith DR, Doucette-Stamm LA, Deloughery C, Lee H, Dubois J, Aldredge T, Bashirzadeh R, Blakely D, Cook R, Gilbert K, Harrison D, Hoang L, Keagle P, Lumm W, Pothier B, Qiu D, Spadafora R, Vicaire R, Wang Y, Wierzbowski J, Gibson R, Jiwani N, Caruso A, Bush D, Reeve JN, et al.##Beloglazova N, Brown G, Zimmerman MD, Proudfoot M, Makarova KS, Kudritska M, Kochinyan S, Wang S, Chruszcz M, Minor W, Koonin EV, Edwards AM, Savchenko A, Yakunin AF	Complete genome sequence of Methanobacterium thermoautotrophicum deltaH: functional analysis and comparative genomics.##A novel family of sequence-specific endoribonucleases associated with the clustered regularly interspaced short palindromic repeats.	
DRAMP02560	MAEPRRWYLITYDIRDPKRWRKVHALLKGYGEWLQLSVFRCSLTDRDREKLRWELSRRMDAVDTLLVIGLCGGCVERVRAINAKEDWPEEPAPFKVL	97	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	Q1CW51	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Myxococcus xanthus (strain DK 1622)	Antimicrobial, Antiviral	Transcript level	Not found	Not found		"Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity).
Induction: Part of an operon going from at least MXAN_7266 to MXAN_7259 that includes a CRISPR operon with transcription continuing into the pre-crRNA locus."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	17015832##17369305	Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15200-5.##J Bacteriol. 2007 May;189(10):3738-3750.	Goldman BS, Nierman WC, Kaiser D, Slater SC, Durkin AS, Eisen JA, Ronning CM, Barbazuk WB, Blanchard M, Field C, Halling C, Hinkle G, Iartchuk O, Kim HS, Mackenzie C, Madupu R, Miller N, Shvartsbeyn A, Sullivan SA, Vaudin M, Wiegand R, Kaplan HB.##Viswanathan P, Murphy K, Julien B, Garza AG, Kroos L.	Evolution of sensory complexity recorded in a myxobacterial genome.##Regulation of dev, an operon that includes genes essential for Myxococcus xanthus development and CRISPR-associated genes and repeats.	
DRAMP02561	MQYKINMYAIVVYDVNVSRQNQIREFLRKYLYHVQRSVFEGEISPSSLYYMKKILQSYIGETDSLIIYVLRDKSCLMDKIVLGEDKDLQIY	91	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	Q74N46	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Nanoarchaeum equitans (strain Kin4-M)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	14566062	Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12984-8.	Waters E, Hohn MJ, Ahel I, Graham DE, Adams MD, Barnstead M, Beeson KY, Bibbs L, Bolanos R, Keller M, Kretz K, Lin X, Mathur E, Ni J, Podar M, Richardson T, Sutton GG, Simon M, Soll D, Stetter KO, Short JM, Noordewier M.	The genome of Nanoarchaeum equitans: insights into early archaeal evolution and derived parasitism.	
DRAMP02562	MYIVVVYDVGVERVNKVKKFLRMHLNWVQNSVFEGEVTLAEFERIKEGLKKIIDENSDSVIIYKLRSMPPRETLGIEKNPIEEII	85	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	Q8U1T8	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1)	Antimicrobial, Antiviral	Protein level	Combine helix and strand structure	Not found	2I0X resolved by X-ray.	Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	10430560##PubMed ID is not availbale	Genetics. 1999 Aug;152(4):1299-1305.##Submitted (AUG-2006) to the PDB data bank.	Maeder DL, Weiss RB, Dunn DM, Cherry JL, González JM, DiRuggiero J, Robb FT.##Chen LQ, Fu ZQ, Hwang J, Chang J, Chen L, Wang Y, Zhang H, Liu ZJ, Rose JP, WangBC.	Divergence of the hyperthermophilic archaea Pyrococcus furiosus and P. horikoshii inferred from complete genomic sequences.##Crystal Structure of Hypothetical Protein Pf1117 from Pyrococcus furiosus.	
DRAMP02563	MYIIVVYDVSVERVNRVKKFLRQHLHWVQNSVFEGEVTLAEFERIKAGIGELIDGDEDSVVIYKLRSMPKREVMGVEKNPIEDII	85	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	Q5JD44	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Pyrococcus kodakaraensis (strain ATCC BAA-918 / JCM 12380 / KOD1)(Thermococcus kodakaraensis (strain	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	15710748	Genome Res. 2005 Mar;15(3):352-363.	Fukui T, Atomi H, Kanai T, Matsumi R, Fujiwara S, Imanaka T.	Complete genome sequence of the hyperthermophilic archaeon Thermococcus kodakaraensis KOD1 and comparison with Pyrococcus genomes.	
DRAMP02564	MYVIMVYDVNEKRVAKILKIARKYLKWVQNSVLEGELSPGKYEKLKLEVSRLIDEKEDSVRFYVMDSQKVFNLETLGVEKGEDGFIF	87	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	Q9X2B6	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)	Antimicrobial, Antiviral	Protein level	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	10360571	Nature. 1999 May 27;399(6734):323-329.	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM.	Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima.	
DRAMP02565	MIVIVAYDISDEDRRGRLRRYLRRLGLARVNRSVYAGPGTATTAELVAERAKEIVEEGDSVFVIVVREDEYQRAHVFDGRDYYIVSERKYEVY	93	CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)	A1RZT9	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2	Thermofilum pendens (strain Hrk 5)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	18263724	J Bacteriol. 2008 Apr;190(8):2957-2965.	Anderson I, Rodriguez J, Susanti D, Porat I, Reich C, Ulrich LE, Elkins JG, Mavromatis K, Lykidis A, Kim E, Thompson LS, Nolan M, Land M, Copeland A, Lapidus A, Lucas S, Detter C, Zhulin IB, Olsen GJ, Whitman W, Mukhopadhyay B, Bristow J, Kyrpides N.	Genome sequence of Thermofilum pendens reveals an exceptional loss of biosynthetic pathways without genome reduction.	
DRAMP18253	KYYGNGLSXNKKGXTVDWGTAIGIIGNNAAANXATGGAAGXNK	43	Piscicocin CS526(Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	Carnobacterium piscicola CS526	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	In this study, we found that piscicocin CS526, which possessed YGNGL sequence, had anti-Listeria activity typical of class IIa bacteriocins. Accordingly, the presence of Val7 within the YGNGV7 motif could not be a prerequisite for the antimicrobial activity of class IIa bacteriocins.		The bacteriocin piscicocin CS526 was inactivated by proteolytic enzymes, was stable at 100 Celsius degree for 30 min, had a pH range of 2 to 8, and was active against Enterococcus, Listeria, Pediococcus, and Leuconostoc. 	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15640235##15836484	Appl Environ Microbiol. 2005 Jan;71(1):554-7.##J Appl Microbiol. 2005;98(5):1146-51.	Yamazaki K, Suzuki M, Kawai Y, Inoue N, Montville TJ.##Suzuki M, Yamamoto T, Kawai Y, Inoue N, Yamazaki K.	Purification and characterization of a novel class IIa bacteriocin, piscicocin CS526, from surimi-associated Carnobacterium piscicola CS526.##Mode of action of piscicocin CS526 produced by Carnobacterium piscicola CS526.	
DRAMP02567	MYILITYDVSTETEAGKKRLRKVAQVCKDFGQRVQKSVFECSVNEAQFEQLKHRLLQCIDEKSDSLRIYRLREPAKKYIQEYGVNLTIDFDAPLVL	96	CRISPR-associated endoribonuclease Cas2 1 (Antiviral defensin)	Q2RL67	Belongs to the CRISPR-associated endoribonuclease Cas2 prote	cas2-1	Moorella thermoacetica (strain ATCC 39073)	Antimicrobial, Antiviral	Homology	Not found	Not found		Function: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	18631365	Environ Microbiol. 2008 Oct;10(10):2550-2573.	Pierce E, Xie G, Barabote RD, Saunders E, Han CS, Detter JC, Richardson P, Brettin TS, Das A, Ljungdahl LG, Ragsdale SW.	The complete genome sequence of Moorella thermoacetica (f. Clostridium thermoaceticum).	
DRAMP02568	KGGYTRPISRPPYGGGYGNVCTSCHVLTTSQARSCCSRFGRCCVPRRGYSG	51	Penaeidin 3-1 	Q7Z286	Not found	PEN3-1	Fenneropenaeus chinensis (Fleshy prawn) (Penaeus chinensis)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15123293	Fish Shellfish Immunol. 2004 Apr;16(4):513-525.	Kang CJ, Wang JX, Zhao XF, Yang XM, Shao HL, Xiang JH.	Molecular cloning and expression analysis of Ch-penaeidin, an antimicrobial peptide from Chinese shrimp, Fenneropenaeus chinensis.	
DRAMP02569	MRLVVCLVFLASFALVCQAQGYQGGYTRPFPRPPYGGGYHPVPVCTSCHRLSPLQARACCRQLGRCCDAKQTYG	74	Penaeidin 	Q6H2Z5	Not found	PEN3a	Penaeus monodon (Giant tiger prawn)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	20379756	Mar Biotechnol (NY). 2010 Oct;12(5):487-505.	Tassanakajon A, Amparyup P, Somboonwiwat K, Supungul P.	Cationic antimicrobial peptides in penaeid shrimp.	
DRAMP02570	YRGGYTGPIPRPPPIGRPPLRLVVCACYRLSVSDARNCCIKFGSCCHLVK	50	Penaeidin-1 (Pen-1; shrimps, Arthropods, animals)	P81056	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
Tissue specificity: Higher expression in hemocytes and to a lesser extent in heart, testis, gills, intestine, lymphonoid organ and hepatopancreas. Traces in eyes and subcuticular epithelium. Not present in the brain.
Developmental stage: Expression decreases 3 hours after microbial challenge to return to control levels after 12 hours and slightly increases after 24 hours.
PTM: Contains three disulfide bonds 25-38; 27-45; 39-46."	Gram-positive bacterium: Micrococcus luteus;##Gram-negative bacterium: Escherichia coli.##Fungi: Neurospora crassa, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	9353298##10639333	Biol Chem. 1997 Nov 7;272(45):28398-28406.##J Cell Sci. 2000 Feb;113 (Pt 3):461-469.	Destoumieux D, Bulet P, Loew D, Van Dorsselaer A, Rodriguez J, Bachère E.##Destoumieux D, Muñoz M, Cosseau C, Rodriguez J, Bulet P, Comps M, Bachère E.	Penaeidins, a new family of antimicrobial peptides isolated from the shrimp Penaeus vannamei (Decapoda).##Penaeidins, antimicrobial peptides with chitin-binding activity, are produced and stored in shrimp granulocytes and released after microbial challenge.	
DRAMP02571	YRGGYTGPIPRPPPIGRPPFRPVCNACYRLSVSDARNCCIKFGSCCHLVK	50	Penaeidin-2a (Pen-2a; shrimps, Arthropods, animals)	P81057	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
Tissue specificity: Higher expression in hemocytes and to a lesser extent in heart, testis, gills, intestine, lymphonoid organ and hepatopancreas. Traces in eyes and subcuticular epithelium. Not present in the brain.
Developmental stage: Expression decreases 3 hours after microbial challenge to return to control levels after 12 hours and slightly increases after 24 hours.
PTM: Contains three disulfide bonds 24-38; 27-45; 39-46 and Lysine amide at position 50."	Gram-positive bacterium: Micrococcus luteus;##Gram-negative bacterium: Escherichia coli.##Fungi: Neurospora crassa, Fusarium oxysporum, Saccharomyces cerevisiae TGY.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	11028917##9353298##10561573	Cell Mol Life Sci. 2000 Aug;57(8-9):1260-1271.##J Biol Chem. 1997 Nov 7;272(45):28398-28406.##Eur J Biochem. 1999 Dec;266(2):335-346.	Destoumieux D, Munoz M, Bulet P, Bachère E.##Destoumieux D, Bulet P, Loew D, Van Dorsselaer A, Rodriguez J, Bachère E.##Destoumieux D, Bulet P, Strub JM, Van Dorsselaer A, Bachère E.	Penaeidins, a family of antimicrobial peptides from penaeid shrimp (Crustacea, Decapoda).##Penaeidins, a new family of antimicrobial peptides isolated from the shrimp Penaeus vannamei (Decapoda).##Recombinant expression and range of activity of penaeidins, antimicrobial peptides from penaeid shrimp.	
DRAMP02572	YRGGYTGPIPRPPPIGRPPLRPVCNACYRLSVSDARNCCIKFGSCCHLVK	50	Penaeidin-2b (Pen-2b; shrimps, Arthropods, animals)	Q963C4	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
PTM: Contains three disulfide bonds 24-38; 27-45; 39-46 and lysine amide at K50."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595	Immunogenetics. 2002 Sep;54(6):442-445. 	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.	
DRAMP02575	QVYKGGYTRPVPRPPPFVRPLPGGPIGPYNGCPVSCRGISFSQARSCCSRLGRCCHVGKGYS	62	Penaeidin-3b (Pen-3b; shrimps, Arthropods, animals)	P81059	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
Tissue specificity: Higher expression in hemocytes and to a lesser extent in heart, testis, gills, intestine, lymphonoid organ and hepatopancreas. Traces in eyes and subcuticular epithelium. Not present in the brain.
Developmental stage: Expression decreases 3 hours after microbial challenge to return to control levels after 12 hours and slightly increases after 24 hours.
PTM: Contains three disulfide bonds 32-47; 36-54; 48-55, Pyrrolidone carboxylic acid and Lysine amide at position 1 and 62 respectively."	Gram-positive bacterium: Micrococcus luteus;##Gram-negative bacterium: Escherichia coli.##Fungi: Neurospora crassa, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	11028917##10639333	Cell Mol Life Sci. 2000 Aug;57(8-9):1260-1271.##J Cell Sci. 2000 Feb;113 (Pt 3):461-469.	Destoumieux D, Munoz M, Bulet P, Bachère E.##Destoumieux D, Muñoz M, Cosseau C, Rodriguez J, Bulet P, Comps M, Bachère E.	Penaeidins, a family of antimicrobial peptides from penaeid shrimp (Crustacea, Decapoda).##Penaeidins, antimicrobial peptides with chitin-binding activity, are produced and stored in shrimp granulocytes and released after microbial challenge.	
DRAMP02576	QVYKGGYTRPIPRPPFVRPVPGGPIGPYNGCPVSCRGISFSQARSCCSRLGRCCHVGKGYS	61	Penaeidin-3c (Pen-3c; shrimps, Arthropods, animals)	P81060	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
Tissue specificity: Higher expression in hemocytes and to a lesser extent in heart, testis, gills, intestine, lymphonoid organ and hepatopancreas. Traces in eyes and subcuticular epithelium. Not present in the brain.
Developmental stage: Expression decreases 3 hours after microbial challenge to return to control levels after 12 hours and slightly increases after 24 hours.
PTM: Contains three disulfide bonds 31-46; 35-53; 47-54, Pyrrolidone carboxylic acid and Lysine amide at position 1 and 62 respectively."	Gram-positive bacterium: Micrococcus luteus;##Gram-negative bacterium: Escherichia coli.##Fungi: Neurospora crassa, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	11028917##10639333	Cell Mol Life Sci. 2000 Aug;57(8-9):1260-1271.##J Cell Sci. 2000 Feb;113 (Pt 3):461-469.	Destoumieux D, Munoz M, Bulet P, Bachère E.##Destoumieux D, Muñoz M, Cosseau C, Rodriguez J, Bulet P, Comps M, Bachère E.	Penaeidins, a family of antimicrobial peptides from penaeid shrimp (Crustacea, Decapoda).##Penaeidins, antimicrobial peptides with chitin-binding activity, are produced and stored in shrimp granulocytes and released after microbial challenge.	
DRAMP02577	QVYKGGYTRPIPRPPPFVRPLPGGPIGPYNGCPISCRGISFSQARSCCSRLGRCCHVGKGYS	62	Penaeidin-3d (Pen-3d; shrimps, Arthropods, animals)	Q963D0	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
PTM: Contains three disulfide bonds 32-47; 36-54; 48-55, Pyrrolidone carboxylic acid and Serine amide at position 1 and 62 respectively."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595	Immunogenetics. 2002 Sep;54(6):442-445. 	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.	
DRAMP18252	GDVMPESTPICAGFATLMSSIGLVKTIKGKC	31	Carnolysin A2(Bacteriocin)	W0FGJ7	Belongs to the lantibiotics family (Class I bacteriocin)	crnA2	Carnobacterium maltaromaticum C2	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Altogether, there are six dehydrated ser or thr, and five thioether bonds in the two chains. For Carnolysin A1, residues 8, 10, and 25 are dehydrated; thioether bonds exist between residues 9, 13; 24,28; 41,45; residues 16, 21, 33, 36, are D-amino acids. For Carnolysin A2, residues 8, 16, and 20 are dehydrated; thioether bonds exist between 7, 11; 26, 31; residues 16 and 19 are D-amino acids, which is the first D-Abu in ribosomally synt		Comment: No comments found on DRAMP database	Gram-positive(broad)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24412962	Int J Food Microbiol. 2014 Mar 3;173:81-8.	Tulini FL, Lohans CT, Bordon KC, Zheng J, Arantes EC, Vederas JC, De Martinis EC.	Purification and characterization of antimicrobial peptides from fish isolate Carnobacterium maltaromaticum C2: Carnobacteriocin X and carnolysins A1 and A2.	
DRAMP02580	QVYKGGYTRPIPRPPPFVRPLPGGPISPYNGCPVSCRGISFSQARSCCSRLGRCCHVGKGYS	62	Penaeidin-3g (Pen-3g; shrimps, Arthropods, animals)	Q963C7	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
PTM: Contains three disulfide bonds 32-47; 36-54; 48-55, Pyrrolidone carboxylic acid and Serine amide at position 1 and 62 respectively."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595	Immunogenetics. 2002 Sep;54(6):442-445. 	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.	
DRAMP02581	QVYKGGYTRPIPRPPPFVRPLPGGPIGPYNGCPISCRGISFSQARSYCSRLGRCCHVGKGYS	62	Penaeidin-3h (Pen-3h; shrimps, Arthropods, animals)	Q963C6	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
PTM: Contains two disulfide bonds 36-54; 48-55, Pyrrolidone carboxylic acid and Serine amide at position 1 and 62 respectively."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595	Immunogenetics. 2002 Sep;54(6):442-445. 	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.	
DRAMP02582	QVYKGGYTRPIPRPPPFVRPLPGGPIGPYNGRPVSCRGISFSQARSCCSRLGRCCHVGKGYS	62	Penaeidin-3i (Pen-3i; shrimps, Arthropods, animals)	Q963C5	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
PTM: Contains two disulfide bonds 36-54; 48-55, Pyrrolidone carboxylic acid and Serine amide at position 1 and 62 respectively."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595	Immunogenetics. 2002 Sep;54(6):442-445. 	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.	
DRAMP02583	QVYKGGYTRPVPRPPFVRPLPGGPIGPYNGCPVSCRGISFSQARSCCSRLGRCCHVGKGYS	61	Penaeidin-3j (Pen-3j; shrimps, Arthropods, animals)	Q963D9	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
PTM: Contains three disulfide bonds 31-46; 35-53; 47-54, Pyrrolidone carboxylic acid and Serine amide at position 1 and 61 respectively."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595	Immunogenetics. 2002 Sep;54(6):442-445. 	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.	
DRAMP02585	YSSGYTRPLPKPSRPIFIRPIGCDVCYGIPSSTARLCCFRYGDCCHR	47	Penaeidin-4c (Pen-4c; shrimps, Arthropods, animals)	Q963C3	Belongs to the penaeidin family	Not found	Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity (By similarity).
PTM: Contains three disulfide bonds 23-37; 26-44; 38-45 and C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595	Immunogenetics. 2002 Sep;54(6):442-445.	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.	
DRAMP02587	QGYKGPYTRPILRPYVRPVVSYNACTLSCRGITTTQARSCCTRLGRCCHVAKGYS	55	Penaeidin-3k (Pen-3k; shrimps, Arthropods, animals)	Q962B2	Belongs to the penaeidin family	Not found	Litopenaeus setiferus (Atlantic white shrimp) (Penaeus setiferus)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
PTM: Contains three disulfide bonds 25-40; 29-47; 41-48, Pyrrolidone carboxylic acid and Serine amide at position 1 and 55 respectively."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595	Immunogenetics. 2002 Sep;54(6):442-445. 	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.	
DRAMP02588	QGYKGPYTRPILRPYVRPVVSYNVCTLSCRGITTTQARSCCTRLGRCCHVAKGYS	55	Penaeidin-3l (Pen-3l; shrimps, Arthropods, animals)	Q962A8	Belongs to the penaeidin family	Not found	Litopenaeus setiferus (Atlantic white shrimp) (Penaeus setiferus)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
PTM: Contains three disulfide bonds 25-40; 29-47; 41-48, Pyrrolidone carboxylic acid and Serine amide at position 1 and 55 respectively."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595	Immunogenetics. 2002 Sep;54(6):442-445. 	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.	
DRAMP02589	QGCKGPYTRPILRPYVRPVVSYNACTLSCRGITTTQARSCCTRLGRCCHVAKGYS	55	Penaeidin-3m (Pen-3m; shrimps, Arthropods, animals)	Q962B1	Belongs to the penaeidin family	Not found	Litopenaeus setiferus (Atlantic white shrimp) (Penaeus setiferus)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
PTM: Contains three disulfide bonds 25-40; 29-47; 41-48, Pyrrolidone carboxylic acid and Serine amide at position 1 and 55 respectively."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595	Immunogenetics. 2002 Sep;54(6):442-445. 	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.	
DRAMP02590	QGYKGPYTRPILRPYVRPVVSYNACTLSCRGITTTQARSCSTRLGRCCHVAKGYS	55	Penaeidin-3n (Pen-3n; shrimps, Arthropods, animals)	Q962B0	Belongs to the penaeidin family	Not found	Litopenaeus setiferus (Atlantic white shrimp) (Penaeus setiferus)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity (By similarity).
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
PTM: Contains two disulfide bonds 25-40; 29-47, Pyrrolidone carboxylic acid and Serine amide at position 1 and 55 respectively."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12242595	Immunogenetics. 2002 Sep;54(6):442-445. 	Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.	Diversity of the penaeidin antimicrobial peptides in two shrimp species.	
DRAMP02592	GXFGKAFXSVSNFAKKHKTA	20	Styelin-A (Styelin A; invertebrates, animals)	P81469	Not found	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Bactericidal against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemocytes and pharyngeal tissues."	Psychrobacter immobilis, Planococcus citreus	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9467865	Comp Biochem Physiol B Biochem Mol Biol. 1997 Nov;118(3):515-521.	Lee IH, Cho Y, Lehrer RI.	Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava.	
DRAMP02593	GXFGPAFHSVSNFAKKHKTA	20	Styelin-B (Styelin B; invertebrates, animals)	P81470	Not found	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Bactericidal against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemocytes and pharyngeal tissues."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9467865	Comp Biochem Physiol B Biochem Mol Biol. 1997 Nov;118(3):515-521.	Lee IH, Cho Y, Lehrer RI.	Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava.	
DRAMP02594	GWFGKAFRSVSNFYKKHKTYIHAGLSAATLL	31	Styelin-C (Styelin C; chordates, animals)	O18494	Not found	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial	Homology	Alpha helix	Not found		Function: Bactericidal against several Gram-positive and Gram- negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9257708	FEBS Lett. 1997 Jul 21;412(1):144-148.	Zhao C, Liaw L, Lee IH, Lehrer RI.	cDNA cloning of three cecropin-like antimicrobial peptides (Styelins) from the tunicate, Styela clava.	
DRAMP02596	GWLRKAAKSVGKFYYKHKYYIKAAWKIGRHAL	32	Styelin-E (Styelin E; chordates, animals)	O18496	Not found	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Bactericidal against several Gram-positive and Gram- negative bacteria (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9257708	FEBS Lett. 1997 Jul 21;412(1):144-148.	Zhao C, Liaw L, Lee IH, Lehrer RI.	cDNA cloning of three cecropin-like antimicrobial peptides (Styelins) from the tunicate, Styela clava.	
DRAMP02597	VFQFLGKIIHHVGNFVHGFSHVF	23	Clavanin-A (His-rich; chordates, animals)	P80710, O18490	Not found	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Alpha helix	Not found		Function: Has antimicrobial activity.	Gram-negative bacterium: Escherichia coli;##yeast Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9001389##9237689	FEBS Lett. 1997 Jun 30;410(2-3):490-492.##FEBS Lett. 1997 Jan 3;400(2):158-162.	Lee IH, Zhao C, Cho Y, Harwig SSL, Cooper EL, Lehrer RI.##Zhao C, Lian H, Lee I.H, Lehrer R.I.	Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.##cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemocytes.	
DRAMP02598	VFQFLGRIIHHVGNFVHGFSHVF	23	Clavanin-B (His-rich; chordates, animals)	P80711	Not found	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial, Antifungal	Protein level	Alpha helix 	Not found		"Function: Has antimicrobial activity.
PTM: C-terminal amidation."	Escherichia coli, L. monocytes, Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9001389	 FEBS Lett. 1997 Jan 3;400(2):158-162.	Lee IH, Zhao C, Cho Y, Harwig SS, Cooper EL, Lehrer RI.	Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.	
DRAMP02599	VFHLLGKIIHHVGNFVYGFSHVF	23	Clavanin-C (His-rich; chordates, animals)	O18493, P80712	Not found	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Alpha helix	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Hemocytes and pharyngeal tissues."	Gram-negative bacterium: Escherichia coli;##yeast Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9001389##9237689	FEBS Lett. 1997 Jun 30;410(2-3):490-492.##FEBS Lett. 1997 Jan 3;400(2):158-162.	Lee IH, Zhao C, Cho Y, Harwig SSL, Cooper EL, Lehrer RI.##Zhao C, Lian H, Lee I.H, Lehrer R.I.	Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.##cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemocytes.	
DRAMP02600	AFKLLGRIIHHVGNFVYGFSHVF	23	Clavanin-D (His-rich; chordates, animals)	P80713, O18491	Not found	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Alpha helix	Not found		"Function: Has antimicrobial activity.
Tissue specificity: Hemocytes and pharyngeal tissues."	Gram-negative bacterium: Escherichia coli;##yeast Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9237689##9001389	FEBS Lett. 1997 Jun 30;410(2-3):490-492.##FEBS Lett. 1997 Jan 3;400(2):158-162.	Zhao C, Liaw L, Lee IH, Lehrer RI.##Lee IH, Zhao C, Cho Y, Harwig SS, Cooper EL, Lehrer RI.	cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemocytes.##Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.	
DRAMP02601	LFKLLGKIIHHVGNFVHGFSHVF	23	Clavanin E (His-rich; chordates, animals)	O18492	Not found	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Function: Has antimicrobial activity.	Gram-negative bacterium: Escherichia coli;##yeast Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9237689	FEBS Lett. 1997 Jun 30;410(2-3):490-492. 	Zhao C, Liaw L, Lee IH, Lehrer RI.	cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemocytes. 	
DRAMP02602	FLRFIGSVIHGIGHLVHHIGVAL	23	Clavaspirin (chordates, animals)	O97395	Not found	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Alpha helix 	Not found		Function: Has potent hemolytic activity. 	[Swiss_Prot Entry O97395]Exhibits broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria	[Ref.12005415]has potent hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12005415	J Pept Res. 2001 Dec;58(6):445-456.	Lee IH, Zhao C, Nguyen T, Menzel L, Waring AJ, Sherman MA, Lehrer RI.	Clavaspirin, an antibacterial and haemolytic peptide from Styela clava.	
DRAMP18251	GDINGEFTTSPACVYSVMVVSKASSAKCAAGASAVSGAILSAIRC	45	Carnolysin A1(Bacteriocin)	W0FC94	Belongs to the lantibiotics family (Class I bacteriocin)	crnA1	Carnobacterium maltaromaticum C2	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Altogether, there are six dehydrated ser or thr, and five thioether bonds in the two chains. For Carnolysin A1, residues 8, 10, and 25 are dehydrated; thioether bonds exist between residues 9, 13; 24,28; 41,45; residues 16, 21, 33, 36, are D-amino acids. For Carnolysin A2, residues 8, 16, and 20 are dehydrated; thioether bonds exist between 7, 11; 26, 31; residues 16 and 19 are D-amino acids, which is the first D-Abu in ribosomally synt		Comment: No comments found on DRAMP database	Gram-positive(broad)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24412962	Int J Food Microbiol. 2014 Mar 3;173:81-8.	Tulini FL, Lohans CT, Bordon KC, Zheng J, Arantes EC, Vederas JC, De Martinis EC.	Purification and characterization of antimicrobial peptides from fish isolate Carnobacterium maltaromaticum C2: Carnobacteriocin X and carnolysins A1 and A2.	
DRAMP02606	RLGNFFRKAKEKIGRGLKKIGQKIKDFWGNLVPRTES	37	Antibacterial protein LL-37 (cathelicidin; primates, mammals, animals)	Q1KLX5	Belongs to the cathelicidin family	CAMP	Trachypithecus cristatus (Silvered leaf-monkey) (Presbytis cristata)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Has antibacterial activity. (By similarity)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP02607	QLGDVLQKAGEKIVRGLKNIGQRIKDFFGKLTPRTES	37	Antibacterial protein LL-37 (AFRLL-37; cathelicidin; primates, mammals, animals)	Q1KLY8, Q1KLY7	Belongs to the cathelicidin family	CAMP	Ateles fusciceps robustus (Colombian black-faced spider monkey) (Brown-headed spider monkey)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Has antibacterial activity. (By similarity)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP02608	RLGKFFRKVKKKIGGGLKKIGQKIKDFLGNLVPRTAS	37	Antibacterial protein LL-37 (cathelicidin; primates, mammals, animals)	Q1KLY6	Belongs to the cathelicidin family	CAMP	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Has antibacterial activity. (By similarity)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP02610	VKGGIEKAGVCPADNVRCFKSDPPQCHTDQDCLGERKCCYLHCGFKCVIPVKKLEEGGNKDEDVSGPCPEPGWEAKSPGSSSTGCPQK	88	WAP four-disulfide core domain protein 12 (primates, mammals, animals)	A4K2Y4	Not found	WFDC12	Cercopithecus aethiops (Green monkey)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Antibacterial protein. Putative acid-stable proteinase inhibitor (By similarity).
Doamin: Contains 3 WAP domain"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17267810	Genome Res. 2007 Mar;17(3):276-286.	Hurle B, Swanson W; NISC Comparative Sequencing Program, Green ED.	Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage.	
DRAMP02611	DHYNCVRSGGQCLYSACPIYTKIQGTCYHGKAKCCK	36	Beta-defensin 1 (BD-1; Defensin, beta 1; primates, mammals, animals)	Q95J24	Belongs to the beta-defensin family	DEFB1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	Unknown	Homology	Not found	Not found		Function: Has bactericidal activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11862391	Immunogenetics. 2002 Feb;53(10-11):907-913.	Del Pero M, Boniotto M, Zuccon D, Cervella P, Spano A,Amoroso A, Crovella S.	Beta-defensin 1 gene variability among non-human primates.	
DRAMP02613	DSHEERRQGRHGHHEYGRKFHEKHHSHRGY	30	Mfa-hst 5 (M.fascicularis histatin 5; primates, mammals, animals)	No entry found	Not found	Not found	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	Antimicrobial, Antifungal	Not found	Alpha helix (CD)	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20423320	Protein Pept Lett. 2010 Jul;17(7):909-918.	Padovan L, Segat L, Pontillo A, Antcheva N, Tossi A, Crovella S.	Histatins In Non-Human Primates: Gene Variations and Functional Effects.	
DRAMP02614	GLEFSEPFPSGRFAVCESCKLGRGKCRKECLENEKPDGSCRLNFLCCRPRM	51	Beta-defensin 105A (Defensin, beta 105; Defensin, beta 105A; primates, mammals, animals)	A4H209	Belongs to the beta-defensin family	DEFB105A	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	Antimicrobial	Homology	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02615	DHYNCVRSGGQCLYSACPIYTRIQGTCYHGKAKCCK	36	Beta-defensin 1 (BD-1; Defensin, beta 1; primates, mammals, animals)	P61261, A4H1Z6	Belongs to the beta-defensin family	DEFB1	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Has bactericidal activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16700051	Proteins. 2006 Aug 1;64(2):524-531.	Chattopadhyay S, Sinha NK, Banerjee S, Roy D, Chattopadhyay D, Roy S.	Small cationic protein from a marine turtle has beta-defensin-like fold and antibacterial and antiviral activity.	
DRAMP02616	NLYVKRCLNDIGICKKTCKPEEVRSEHGWVMCGKRKACCVPAD	43	Beta-defensin 126 (Defensin, beta 126; Epididymal secretory protein 13.2, ESP13.2; primates, mamm	Q9BEE3	Belongs to the beta-defensin family	DEFB126	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
Tissue specificity: High-level and epididymis-specific expression. Detected in epithelial cells lining the efferent ductules, initial segment, and cauda regions of the epididymis, but not on spermatozoa.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10491631	Biol Reprod. 1999 Oct;61(4):965-972.	Perry AC, Jones R, Moisyadi S, Coadwell J, Hall L.	The novel epididymal secretory protein ESP13.2 in Macaca fascicularis.	
DRAMP02617	AIHRALICKRMEGHCEAECLTFEVKIGGCRAELTPYCCKKRKKD	44	Beta-defensin 107A (Defensin, beta 107; Defensin, beta 107A; primates, mammals, animals)	A4H218	Belongs to the beta-defensin family	DEFB107A	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Problely contains two disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02618	AYGGEKKCWNRSGHCRKQCKDGEAVKETCKNHRACCVPSNEDH	43	Beta-defensin 118 (Defensin, beta 118; primates, mammals, animals)	A4H223	Belongs to the beta-defensin family	DEFB118	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02619	KRHNLRCMGNSGICRASCKKNEQPYLYCRNYQACCLQSYMRISISGKEENTDWSYEKQWPRLP	63	Beta-defensin 119 (Defensin, beta 119; Beta-defensin 120; Defensin, beta 120; primates, mammals, 	A4H228, A4H233	Belongs to the beta-defensin family	DEFB119	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02620	ARLKKCFNNVTGYCRKKCKVGEIHEIGCLSGKLCCVNDEENKKHVPFKKPHQQPVEKLSVQQDYVILPTITIFTV	75	Beta-defensin 128 (Defensin, beta 128; primates, mammals, animals)	A4H255	Belongs to the beta-defensin family	DEFB128	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02621	GGSKCVSDTPGYCRTHCHRGETALFMCSPFRKCCISYSFLPQPDLPQLIGNHWPSRSRNTQRKNKKQQTTVTP	73	Beta-defensin 132 (Defensin, beta 132; primates, mammals, animals)	A4H265	Belongs to the beta-defensin family	DEFB132	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02622	RLGNFFRKVKEKIGGGLKKVGQKIKDFLGNLVPRTAS	37	Antibacterial protein LL-37 (primates, mammals, animals)	Q1KLX7	Belongs to the cathelicidin family	CAMP	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Binds to bacterial lipopolysaccharides (LPS), has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP02623	DSHEERHHGRHGHHKYGRKFHEKHHSHRGYRSNYLYDN	38	Macaque histatin (His-rich; M-Histatin 1; primates, mammals, animals)	P34084	Belongs to the histatin family	HTN1	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Function: Histatins are salivary proteins that are considered to be major precursors of the protective proteinaceous structure on tooth surfaces (enamel pellicle). In addition, histatins exhibit antibacterial and antifungal activities.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2229609	J Dent Res. 1990 Nov;69(11):1717-1723.	Xu T, Telser E, Troxler RF, Oppenheim FG.	Primary structure and anticandidal activity of the major histatin from parotid secretion of the subhuman primate, Macaca fascicularis.	
DRAMP02624	VKGGIEKAGVCPADNVRCFKSNPPQCHTDQDCLGERKCCYLHCGFKCVIPVKKLEEGGNKDEDVSGPHPEPGWEAKSPGSSSTGCPQI	88	WAP four-disulfide core domain protein 12 (primates, mammals, animals)	A4K2P8	Not found	WFDC12	Colobus guereza (Black-and-white colobus monkey)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Antibacterial protein. Putative acid-stable proteinase inhibitor (By similarity).
Doamin: Contains 2 WAP domain"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17267810	Genome Res. 2007 Mar;17(3):276-286.	Hurle B, Swanson W; NISC Comparative Sequencing Program, Green ED.	Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage.	
DRAMP02625	VKGNIEKPEVCPADNVRCIKSDPPQCHTDQDCQGIRKCCYLHCGFKCVIPVKELEEGGNQDEDVSRPCP	69	WAP four-disulfide core domain protein 12 (primates, mammals, animals)	A4K2W8	Not found	WFDC12	Aotus nancymaae (Ma's night monkey)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Antibacterial protein. Putative acid-stable proteinase inhibitor (By similarity).
Doamin: Contains 5 WAP domain"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17267810	Genome Res. 2007 Mar;17(3):276-286.	Hurle B, Swanson W; NISC Comparative Sequencing Program, Green ED.	Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage.	
DRAMP02626	VKGNTEKPGVCPADNVRCIKSDPPQCHTDQDCQGIRKCCYLHCGFKCVIPVKELEEGGSKDEDVSRPCPESGWEVKPPGFFSTRCPQK	88	WAP four-disulfide core domain protein 12 (primates, mammals, animals)	A4K2X6	Not found	WFDC12	Saimiri boliviensis boliviensis (Bolivian squirrel monkey)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Antibacterial protein. Putative acid-stable proteinase inhibitor (By similarity).
Doamin: Contains 6 WAP domain"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17267810	Genome Res. 2007 Mar;17(3):276-286.	Hurle B, Swanson W; NISC Comparative Sequencing Program, Green ED.	Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage.	
DRAMP02627	DHYICVRSGGQCLYSACPIYTKIQGTCYHGKAKCCK	36	Beta-defensin 1 (BD-1; Defensin, beta 1; primates, mammals, animals)	Q95M67	Belongs to the beta-defensin family	DEFB1	Cercopithecus erythrogaster (Red-bellied monkey) (White-throated monkey)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		Function: Has bactericidal activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11862391	Immunogenetics. 2002 Feb;53(10-11):907-913.	Del Pero M, Boniotto M, Zuccon D, Cervella P, Spanò A, Amoroso A, Crovella S.	Beta-defensin 1 gene variability among non-human primates.	
DRAMP18250	MACQCPDAISGWTHTDYQCHGLENKMYRHVYAICMNGTQVYCRTEWGSSC	50	Laterosporulin (Bacteriocin)	H1ZZ98	Belongs to the class IId bacteriocin	laterosporulin	Brevibacillus sp. Strain GI-9	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Beta strand	The crystal structure of LS at 2.0 A resolution reveals an all-bconformation of this peptide, with four beta-strands forming a twisted b-sheet. All six intrinsic cysteines are intramolecularly disulfide-bonded, with two disulfides constraining the N terminus of the peptide and the third disulfide crosslinking the extreme C terminus, resulting in the formation of a closed structure. Despite a low overall sequence similarity, LS has disul	4OZK resolved by X-ray	This peptide is thermal stable, pH tolerant, and resistant to proteases. Reducing agent DTT had no effect on peptide activity or migration on gel.	Gram-positive, Gram-negative (broad spectrum)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22403615##25345978	PLoS One. 2012;7(3):e31498. doi: 10.1371/journal.pone.0031498.##FEBS J. 2015 Jan;282(2):203-14.	Singh PK, Chittpurna, Ashish, Sharma V, Patil PB, Korpole S.##Singh PK, Solanki V, Sharma S, Thakur KG, Krishnan B, Korpole S.	Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. strain GI-9.##The intramolecular disulfide-stapled structure of laterosporulin, a class IId bacteriocin, conceals a human defensin-like structural module.	
DRAMP02630	GIGDPVTCLKNGAICHPVFCPRRYKQIGTCGLPGTKCCKKP	41	Rhesus monkey beta-defensin 2 (RhBD-2; Defensin, beta 2; primates, mammals, animals)	Q9BDS9	Belongs to the beta-defensin family	DEFB4A	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has bactericidal activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11238224	Clin Diagn Lab Immunol. 2001 Mar;8(2):370-375.	Bals R, Lang C, Weiner DJ, Vogelmeier C, Welsch U, Wilson JM.	Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules.	
DRAMP18248	KYGDVPLY	8	Bifidin I(Bacteriocin)	No entry found	Belongs to the class IIa bacteriocin	Not found	Bifidobacterium infantis BCRC 14602	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Not found		The N-terminal sequencing may also be blocked partially or totally which could be due to the structure of the peptide (circular) or N terminal capping.	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Food Control. 2010 May;21(5):746-753.	Cheikhyoussef A,Cheikhyoussef N,Chen HQ,Zhao JX,Tang J,Zhang H,Chen W.	Bifidin I - A new bacteriocin produced by Bifidobacterium infantis BCRC 14602: Purification and partial amino acid sequence	
DRAMP18249	DWTFANWSCLVCDDCSVNLTV	21	Bac-GM100  (Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	Not found	Brevibacillus brevis strain GM100	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-		Not found	Not found		The 21 N-terminal residues of Bac-GM100 displayed 65% homology with thurincin H from Bacillus thuringiensis. Bac-GM100 was extremely heat-stable and was stable within a pH range of 3-10. It proved sensitive to various proteases.	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23291759	Biosci Biotechnol Biochem. 2013;77(1):151-60.	Ghadbane M, Harzallah D, Laribi AI, Jaouadi B, Belhadj H.	Purification and biochemical characterization of a highly thermostable bacteriocin isolated from Brevibacillus brevis strain GM100.	
DRAMP02632	QVTPVTKCWGKSGRCRTTCKKSEVYYILCKTEAKCCVDPKYVPVRSKLTDTNTSLESTSAV	61	Beta-defensin 121 (Defensin, beta 121; primates, mammals, animals)	Q5J600	Belongs to the beta-defensin family	DEFB121	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases	Yashwanth R, Hamil K.G, Yenugu S, French F.S, Hall S.H.	Differential expression of a primate beta defensin gene cluster specific to male reproductive tract.	
DRAMP02633	VGSIEKCWNFRGSCRDECLKNEKVYVFCMSGKLCCLKPKDQPHLPQRTKN	50	Beta-defensin 122 (Defensin, beta 122; primates, mammals, animals)	Q5J5Z9	Belongs to the beta-defensin family	DEFB122	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases	Yashwanth R, Hamil K.G, Yenugu S, French F.S, Hall S.H.	Differential expression of a primate beta defensin gene cluster specific to male reproductive tract.	
DRAMP02634	GTQRCWNLYGKCRHRCSKKERVYVYCLNNKMCCVKPKYQPKEKWWPF	47	Beta-defensin 123 (Defensin, beta 123; primates, mammals, animals)	Q5J5D0	Belongs to the beta-defensin family	DEFB123	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases	Yashwanth R, Hamil K.G, Yenugu S, French F.S, Hall S.H.	Differential expression of a primate beta defensin gene cluster specific to male reproductive tract.	
DRAMP02635	KRHILRCMGNSGICRASCKKNEQPYLYCRNYQACCLQSYMRISISGKEENTDWSYEKQWPRLP	63	Beta-defensin 119 (Defensin, beta 119; Beta-defensin 120; Defensin, beta 120; primates, mammals, 	Q5J602, Q5J601	Belongs to the beta-defensin family	DEFB119	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.	Yashwanth R, Hamil K.G, Yenugu S, French F.S, Hall S.H.	Differential expression of a primate beta defensin gene cluster specific to male reproductive tract.	
DRAMP18246	GWVAXVGAXGTAALASGGV	19	Thuricin 439A,439B(Bacteriocin)	No entry found	Not found	Not found	Bacillus thuringiensis strain B439	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Based on its unique physical and biological characteristics we can conclude that thuricin 439 is a novel bacteriocin.		The two active peptides are likely to be encoded by a single gene, whose product may undergo one or more post translational modifications that result in two active products of different molecular masses.	Gram-positive (Narrow)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12644238	FEMS Microbiol Lett. 2003 Mar 14;220(1):127-31.	Ahern M, Verschueren S, van Sinderen D.	Isolation and characterisation of a novel bacteriocin produced by Bacillus thuringiensis strain B439.	
DRAMP18247	DWTXWSXL	8	Bacthuricin F4(Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	Not found	Bacillus thuringiensis subsp. kurstaki strain BUPM4	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	No proteins were shown to have similar sequences in either their N-terminal regions or any other region.		This bacteriocin was heat-stable up to 70 degrees C and resisted up to pH 3.0. Bacthuricin F4 was sensitive to proteases demonstrating its proteinaceous nature. 	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15752334	J Appl Microbiol. 2005;98(4):881-8.	Kamoun F, Mejdoub H, Aouissaoui H, Reinbolt J, Hammami A, Jaoua S.	Purification, amino acid sequence and characterization of Bacthuricin F4, a new bacteriocin produced by Bacillus thuringiensis.	
DRAMP02637	SARLGNFFRKVKEKIGGGLKKVGQKIKDFLGNLVPRTAS	39	Antibacterial protein FALL-39 (FALL-39 peptide antibiotic; primates, mammals, animals)	Q9GLV5	Belongs to the histatin family	CAMP	Macaca mulatta (Rhesus macaque) 	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Tissue specificity: Expressed in epithelia of various organs. Most abundant peptide levels are found in organs lining outer or inner body surfaces, such as organs of the respiratory or gastrointestinal tract.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	11238224	Clin Diagn Lab Immunol. 2001 Mar;8(2):370-375.	Bals R, Lang C, Weiner DJ, Vogelmeier C, Welsch U, Wilson JM.	Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules.	
DRAMP02638	MTPFWRGVSLRPIGASCRDDSECITRLCRKRRCSLSVAQE	40	Liver-expressed antimicrobial peptide 2 (LEAP-2; primates, mammals, animals)	Q95M25	Not found	LEAP2	Macaca mulatta (Rhesus macaque)	Antimicrobial	Homology	Not found	Not found	2L1Q	PTM: Contains two disulfide bonds 17-28; 23-33.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12493837	Protein Sci. 2003 Jan;12(1):143-152.	Krause A, Sillard R, Kleemeier B, Klüver E, Maronde E, Conejo-García JR, Forssmann WG, Schulz-Knappe P, Nehls MC, Wattler F, Wattler S, Adermann K.	Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver.	
DRAMP02639	RCICVLGIC	9	Demidefensin-3 (primates, mammals, animals)	Q9GLR2	Belongs to the alpha-defensin family	Not found	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		"Function: Has antimicrobial activities against bacteria and fungi (By similarity).
Subunit structure: Forms a cyclic homodimer; disulfide-linked (By similarity).
PTM: This is a cyclic peptide (By similarity).
Caution: The mature 9-residue peptide is expected to be found in 18-residue cyclopeptides produced by combinatorial peptide splicing either with itself or with other demidefensins. However among cyclopeptides screened for antimicrobial activity, no peptides that would have been produced from this sequence were detected."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11527997	J Leukoc Biol. 2001 Sep;70(3):461-464.	Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.	Circular minidefensins and posttranslational generation of molecular diversity.	
DRAMP02640	RCLCRRGVC	9	Rhesus theta defensin-1/2 subunit B (RTD-1b; primates, mammals, animals)	P82271	Belongs to the alpha-defensin family (Theta subfamily)	RTD1B	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		PTM: contains one disulfide bond 4-9.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10521339##1152799##11675394	Science. 1999 Oct 15;286(5439):498-502.##J Leukoc Biol. 2001 Sep;70(3):461-464.##J Biol Chem. 2002 Feb 1;277(5):3079-3084.	Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME.##Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.##Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME.	A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.##Circular minidefensins and posttranslational generation of molecular diversity.##Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.	
DRAMP02641	RCICTRGFC	9	Rhesus theta defensin-1/3 subunit A (RTD-1a; primates, mammals, animals)	P82270, Q9TU01	Belongs to the alpha-defensin family (Theta subfamily)	RTD1A	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		PTM: contains one disulfide bond 4-9.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10521339##1152799##11675394	Science. 1999 Oct 15;286(5439):498-502.##J Leukoc Biol. 2001 Sep;70(3):461-464.##J Biol Chem. 2002 Feb 1;277(5):3079-3084.	Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME.##Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.##Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME.	A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.##Circular minidefensins and posttranslational generation of molecular diversity.##Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.	
DRAMP02642	GFCRCLCRRGVCRCICTR	18	Rhesus theta-defensin 1 (RTD-1; primates, mammals, animals)	P82271, P82270, Q9TU01	Belongs to the alpha-defensin family (Theta subfamily)	Not found	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral	Protein level	Beta strand (4 strands; 10 residues)	Not found	1HVZ resolved by NMR.	"Function: RTD-1 and RTD-2 have similar antimicrobial activities against the Gram-positive bacteria S. aureus 502A and L. monocytogenes, the Gram-negative bacterium S. typhimurium, and the fungi C. albicans 16820 and C. neoformans 271A. RTD-2 is 2-3-fold less active than RTD-1 against E. coli ML35.
Subunit structure: RTD-1 is a cyclic heterodimer composed of subunits A and B; disulfide-linked.
Tissue specificity: RTD-1 is expressed in bone marrow. Detected in promyelocytes, myelocytes and mature neutrophils and monocytes.
Developmental stage: RTD-1 expression begins early during granulocyte myelopoiesis.
PTM: Forms a cyclic peptide with 1 subunit B (RTD-2) or with 1 subunit A (RTD-1). An additional intersubunit disulfide bond is formed.
Miscellaneous: RTD-1 is 10-fold more present in cells than RTD-2."	Gram-positive bacteria: Staphylococcus aureus 502a and Listeria monocytogenes;##Gram-negative bacteria: Salmonella typhimurium, Escherichia coli ML35.##Fungi: Candida albicans 16820, Cryptococcus neoformans 271A (the activity of RTD-2 against Escherichia coli ML35 was 2-3-fold less than those of RTD-1 and RTD-3).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.	L	No cytotoxicity information found	Not found	10521339##1152799##11675394	Science. 1999 Oct 15;286(5439):498-502.##J Leukoc Biol. 2001 Sep;70(3):461-464.##J Biol Chem. 2002 Feb 1;277(5):3079-3084.	Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME.##Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.##Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME.	A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.##Circular minidefensins and posttranslational generation of molecular diversity.##Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.	
DRAMP02643	RCLCRRGVCRCLCRRGVC	18	Rhesus theta-defensin 2 (RTD-2; primates, mammals, animals)	P82271	Belongs to the alpha-defensin family (Theta subfamily)	Not found	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: RTD-1 and RTD-2 have similar antimicrobial activities against the Gram-positive bacteria S. aureus 502A and L. monocytogenes, the Gram-negative bacterium S. typhimurium, and the fungi C. albicans 16820 and C. neoformans 271A. RTD-2 is 2-3-fold less active than RTD-1 against E. coli ML35.
Subunit structure: RTD-2 is a cyclic homodimer composed of two subunits B; disulfide-linked.
PTM: Forms a cyclic peptide with 1 subunit B (RTD-2) or with 1 subunit A (RTD-1). An additional intersubunit disulfide bond is formed.
Miscellaneous: RTD-1 is 10-fold more present in cells than RTD-2."	Gram-positive bacteria: Staphylococcus aureus 502a, Listeria monocytogenes; ##Gram-negative bacteria: Salmonella typhimurium, Escherichia coli ML35.##Fungi: Candida albicans 16820, Cryptococcus neoformans 271A (the activity of RTD-2 against Escherichia coli ML35 was 2-3-fold less than those of RTD-1 and RTD-3).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10521339##1152799##11675394	Science. 1999 Oct 15;286(5439):498-502.##J Leukoc Biol. 2001 Sep;70(3):461-464.##J Biol Chem. 2002 Feb 1;277(5):3079-3084.	Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME.##Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.##Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME.	A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.##Circular minidefensins and posttranslational generation of molecular diversity.##Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.	
DRAMP02644	RCICTRGFCRCICTRGFC	18	Rhesus theta-defensin 3 (RTD-3; primates, mammals, animals)	P82270, Q9TU01	Belongs to the alpha-defensin family (Theta subfamily)	Not found	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral	Protein level	Bridge	Not found		"Function: RTD-1 and RTD-3 have similar antimicrobial activities against the Gram-positive bacteria, the Gram-negative bacteria and the fungi C. albicans 16820 and C. neoformans 271A.
Subunit structure RTD-1 is a cyclic heterodimer composed of subunits A and B; disulfide-linked. RTD-3 is a cyclic homodimer composed of two subunits A; disulfide-linked.
PTM: Forms a cyclic peptide with subunit A (RTD-3) or with subunit B (RTD-1). An additional intersubunit disulfide bond is formed.
Miscellaneous: RTD-1 is 10-fold more present in cells than RTD-3."	Gram-positive bacteria: Staphylococcus aureus 502a, Listeria monocytogenes;##Gram-negative bacteria: Salmonella typhimurium, Escherichia coli ML35.##Fungi: Candida albicans 16820, Cryptococcus neoformans 271A (the activity of RTD-2 against Escherichia coli ML35 was 2-3-fold less than those of RTD-1 and RTD-3).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10521339##1152799##11675394	Science. 1999 Oct 15;286(5439):498-502.##J Leukoc Biol. 2001 Sep;70(3):461-464.##J Biol Chem. 2002 Feb 1;277(5):3079-3084.	Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME.##Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.##Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME.	A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.##Circular minidefensins and posttranslational generation of molecular diversity.##Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.	
DRAMP02645	GICRCICTRGFCRCICVL	18	Rhesus theta-defensin 4 (RTD-4; primates, mammals, animals)	No entry found	Belongs to the alpha-defensin family (Theta subfamily)	Not found	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Function: RTD-1 and RTD-5 are 3-fold more active than RTD-4.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21084627	J Leukoc Biol. 2011 Feb;89(2):283-290.	Tongaonkar P, Tran P, Roberts K, Schaal J, Osapay G, Tran D, Ouellette AJ, Selsted ME.	Rhesus macaque {theta}-defensin isoforms: expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities.	
DRAMP02646	GICRCLCRRGVCRCICVL	18	Rhesus theta-defensin 5 (RTD-5; primates, mammals, animals)	No entry found	Belongs to the alpha-defensin family (Theta subfamily)	Not found	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Function: RTD-1 and RTD-5 are 3-fold more active than RTD-4. RTD-6 has not be collected due to the lack of activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21084627	J Leukoc Biol. 2011 Feb;89(2):283-290.	Tongaonkar P, Tran P, Roberts K, Schaal J, Osapay G, Tran D, Ouellette AJ, Selsted ME.	Rhesus macaque {theta}-defensin isoforms: expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities.	
DRAMP02647	DPVTCLKNGAICHPVFCPRRYKQIGTCGLPGTKCCK	36	Beta-defensin 2 	No entry found	Not found	Not found	Macaca mulatta (Rhesus monkey)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Not found	Not found	Not found	Not found	
DRAMP02648	GDFFRKSKEKIGKEFKRIVQRIKDFLRN	28	Cationic antimicrobial protein	No entry found	Not found	Not found	Macaca mulatta (Rhesus monkey)	Antimicrobial	Not found	Not found	Not found	2K6O	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Not found	Not found	Not found	Not found	
DRAMP02649	MKVFFLFAVLFCLVRRNSVHISHQEARGP	29	EP2B protein 	Q8SQD5	Not found	EP2	Macaca mulatta (Rhesus monkey)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12606416	Biol Reprod. 2003 Jul;69(1):294-300.	Fröhlich O, Ibrahim NM, Young LG.	EP2 splicing variants in rhesus monkey (Macaca mulatta) epididymis.	
DRAMP02651	GDVPPGIRNTICLMQQGTCRLFFCHSGEKKRDICSDPWNRCCVSNRDEEGKEKPKTDGRSGI	62	Sperm associated antigen 11 isoform E (primates, mammals, animals)	No entry found	Not found	Not found	Macaca mulatta (Rhesus monkey)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15229135	Biol Reprod. 2004 Nov;71(5):1453-1460. 	Avellar MC, Honda L, Hamil KG, Yenugu S, Grossman G, Petrusz P, French FS, Hall SH.	Differential expression and antibacterial activity of epididymis protein 2 isoforms in the male reproductive tract of human and rhesus monkey (Macaca mulatta).	
DRAMP02652	VKGGIEKAGVCPADNIRCFKSDPPQCHTDQDCLGERKCCYLHCGFKCVIPVKKLEEGGNKDEDVSGPCPEPGWEAKSPGSSSTGCPQK	88	WAP four-disulfide core domain protein 12 (primates, mammals, animals)	A4K2T3	Not found	WFDC12	Macaca mulatta (Rhesus monkey)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Antibacterial protein. Putative acid-stable proteinase inhibitor (By similarity).
Doamin: Contains 1 WAP domain"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17267810	Genome Res. 2007 Mar;17(3):276-286.	Hurle B, Swanson W; NISC Comparative Sequencing Program, Green ED.	Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage.	
DRAMP02653	ACYCRIPACLAGERRYGTCFYLGRVWAFCC	30	Neutrophil defensin 1 (RMAD-1; primates, mammals, animals)	P60030	Belongs to the alpha-defensin family	Not found	Macaca mulatta (Rhesus macaque) 	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		Function: Has antibacterial and antifungal activiy. 	Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacterium: Escherichia coli.##Fungi: Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10531277	Infect Immun. 1999 Nov;67(11):6139-6144.	Tang YQ, Yuan J, Miller CJ, Selsted ME.	Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.	
DRAMP02654	ACYCRIPACLAGERRYGTCFYMGRVWAFCC	30	Neutrophil defensin 2 (RMAD-2; primates, mammals, animals)	P82317	Belongs to the alpha-defensin family	Not found	Macaca mulatta (Rhesus macaque) 	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		Function: Has antibacterial and antifungal activiy. 	Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacterium: Escherichia coli.##Fungi: Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10531277	Infect Immun. 1999 Nov;67(11):6139-6144.	Tang YQ, Yuan J, Miller CJ, Selsted ME.	Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.	
DRAMP02655	MRTFALLTAVLLVALQAQAGPLQARCDEAAGQEQPGVDDQDISISFAWDKISALQASGERGQYEEPQSLQGWMGDRLWNRVSMVHVT	87	Alpha defensin (primates, mammals, animals)	Q6KFT8	Not found	DEFA1	Macaca mulatta (Rhesus macaque) 	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15019196	ptides. 2003 Nov;24(11):1647-1654.	Nguyen TX, Cole AM, Lehrer RI.	Evolution of primate theta-defensins: a serpentine path to a sweet tooth.	
DRAMP02656	MRTLAILAAILLFALLAQAKSLQETADDAATQEQPGEDDQDLAVSFEENGLSTLRASGSQARRTCRCRFGRCFRRESYSGSCNINGRIFSLCCR	94	Alpha-defensin 2 (primates, mammals, animals)	Q9TTZ8	Not found	MNP2	Macaca mulatta (Rhesus macaque) 	Antimicrobial	Predicted	Not found	Not found	6KRA	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15019196	Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases	Zhao C, Nguyen T, Lehrer RI.	cDNA cloning of three alpha-defensins and three demidefensins from rhesus monkey bone marrow.	
DRAMP02657	MRTIAILAAILLFALLAQAKSLQETADEAATQEQPGEDDQDLAVSFEENGLSTLRDSGSQARRTCRCRIRRCRGLESSFGNCILHGQFAKLCCR	94	Alpha-defensin 1 (primates, mammals, animals)	Q5I2Q2	Not found	Not found	Macaca mulatta (Rhesus macaque) 	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14977952	Infect Immun. 2004 Mar;72(3):1470-1478.	Tanabe H, Yuan J, Zaragoza MM, Dandekar S, Henschen-Edman A, Selsted ME, Ouellette AJ.	Paneth cell alpha-defensins from rhesus macaque small intestine.	
DRAMP02658	MRTLTILAAILLFALLAQAKSLQETADDAATQEQPGEDDQDLAVSFEENGLSTLRASGSQARRNCHCRIGHCRRPAAPMGVCIIHGQFGKLCCR	94	Alpha-defensin 6 (primates, mammals, animals)	Q5I2P7	Not found	Not found	Macaca mulatta (Rhesus macaque) 	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14977952	Infect Immun. 2004 Mar;72(3):1470-1478.	Tanabe H, Yuan J, Zaragoza MM, Dandekar S, Henschen-Edman A, Selsted ME, Ouellette AJ.	Paneth cell alpha-defensins from rhesus macaque small intestine.	
DRAMP02659	ACYCRIPACLAGERRYGTCFYRRRVWAFCC	30	Neutrophil defensin 3 (RMAD-3; primates, mammals, animals)	P60031, P82318	Belongs to the alpha-defensin family	Not found	Macaca mulatta (Rhesus monkey)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Has bacteriostatic and antifungal activity.
PTM: Contains three disulfide bonds: 2-30; 4-19; 9-29."	Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacteria: Escherichia coli.##Fungi: Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10531277	Infect Immun. 1999 Nov;67(11):6139-6144.	Tang YQ, Yuan J, Miller CJ, Selsted ME.	Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.	
DRAMP02660	RRTCRCRFGRCFRRESYSGSCNINGRIFSLCCR	33	Neutrophil defensin 4 (RMAD-4; primates, mammals, animals)	P82319	Belongs to the alpha-defensin family	Not found	Macaca mulatta (Rhesus monkey)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found	6KRA	"Function: Defensins 4 has bacteriostatic and antifungal activity.
PTM: Contains three disulfide bonds 4-32; 6-21; 11-31."	Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacteria: Escherichia coli.##Fungi: Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10531277	Infect Immun. 1999 Nov;67(11):6139-6144.	Tang YQ, Yuan J, Miller CJ, Selsted ME.	Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.	
DRAMP02661	RTCRCRFGRCFRRESYSGSCNINGRIFSLCCR	32	Neutrophil defensin 5 (RMAD-5; primates, mammals, animals)	P82319	Belongs to the alpha-defensin family	Not found	Macaca mulatta (Rhesus monkey)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found	6KRA	"Function: Defensins 5 has bacteriostatic and antifungal activity.
PTM: Contains three disulfide bonds 3-31; 5-20; 10-30."	Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacteria: Escherichia coli.##Fungi: Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10531277	Infect Immun. 1999 Nov;67(11):6139-6144.	Tang YQ, Yuan J, Miller CJ, Selsted ME.	Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.	
DRAMP02662	RRTCRCRFGRCFRRESYSGSCNINGRISSLCCR	33	Neutrophil defensin 6 (RMAD-6; primates, mammals, animals)	P82320	Belongs to the alpha-defensin family	Not found	Macaca mulatta (Rhesus monkey)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Defensins 6 has bacteriostatic and antifungal activity.
PTM: Contains three disulfide bonds 65-93; 67-82; 72-92."	Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacteria: Escherichia coli.##Fungi: Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10531277	Infect Immun. 1999 Nov;67(11):6139-6144.	Tang YQ, Yuan J, Miller CJ, Selsted ME.	Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.	
DRAMP02663	RTCRCRFGRCFRRESYSGSCNINGRISSLCCR	32	Neutrophil defensin 7 (RMAD-7; primates, mammals, animals)	P82320	Belongs to the alpha-defensin family	Not found	Macaca mulatta (Rhesus monkey)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Bridge 	Not found		"Function: Defensins 7 has bacteriostatic and antifungal activity.
PTM: Contains three disulfide bonds 65-93; 67-82; 72-93."	Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacteria: Escherichia coli.##Fungi: Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10531277	Infect Immun. 1999 Nov;67(11):6139-6144.	Tang YQ, Yuan J, Miller CJ, Selsted ME.	Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.	
DRAMP02664	ACYCRIPACLAGERRYGTCFYLRRVWAFCC	30	Neutrophil defensin 8 (RMAD-8; primates, mammals, animals)	P60032, P82318	Belongs to the alpha-defensin family	Not found	Macaca mulatta (Rhesus monkey)	Antimicrobial, Antibacterial, Antifungal	Homology	Bridge	Not found		"Function: Probable antibiotic and antifungal activity.
PTM: Contains three disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10531277	Infect Immun. 1999 Nov;67(11):6139-6144.	Tang YQ, Yuan J, Miller CJ, Selsted ME.	Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.	
DRAMP02665	EPLQARADEMPAQKQPPADDQDVVIYFSGDDSSSLQVPGSTKGLICHCRVLYCLFGEHLGGTSFIHGERYPICCY	75	Defensin-7 (Defensin, alpha 7; primates, mammals, animals)	Q5G859	Not found	DEFA7	Pan troglodytes (chimpanzee)	Antimicrobial	Homology	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Miscellaneous: The human orthologous protein seems not to exist, its coding region does not have a start codon.
PTM: Problely contains two disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15494476	Physiol Genomics. 2004 Dec 15;20(1):1-11.	Patil A, Hughes AL, Zhang G.	Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.	
DRAMP02666	VKEDIEKAGVCPADNVRCFKSDPPQCHTDQDCLGERKCCYLHCGFKCVIPVKELEEGGNKDEDVSRPYPEPGWEAKCPGSSSTRCPQK	88	WAP four-disulfide core domain protein 12 (primates, mammals, animals)	A4K2P0	Not found	WFDC12	Pan troglodytes (chimpanzee)	Antimicrobial, Antibacterial	Homology	Not found	Not found		PTM: Contains four disulfide bonds 11-39; 18-43; 26-38; 32-47.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17267810	Genome Res. 2007 Mar;17(3):276-286.	Hurle B, Swanson W; NISC Comparative Sequencing Program, Green ED.	Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage.	
DRAMP02668	STRAFTCHCRRSCYSTEYSYGTCTVMGINHRFCCL	35	Defensin-6 (Defensin, alpha 6; primates, mammals, animals)	Q5G860	Belongs to the alpha-defensin family	DEFA6	Pan troglodytes (chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		PTM: Contains three disulfide bonds 4-31; 6-20; 10-30.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15494476	Physiol Genomics. 2004 Dec 15;20(1):1-11.	Patil A, Hughes AL, Zhang G.	Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.	
DRAMP02669	ACYCRIPACLAGERRYGTCIYQGRLWAFCC	30	Neutrophil defensin 1 (Defensin, alpha 1; primates, mammals, animals)	Q5G863	Belongs to the alpha-defensin family	DEFA1	Pan troglodytes (chimpanzee)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Homology	Bridge	Not found		MOA: Defensins are thought to kill microbes by permeabilizing their plasma membrane.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15494476	Physiol Genomics. 2004 Dec 15;20(1):1-11. Epub 2004 Oct 19.	Patil A, Hughes AL, Zhang G.	Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.	
DRAMP02670	VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRVD	34	Neutrophil defensin 4 (Defensin, alpha 4; primates, mammals, animals)	Q5G862	Belongs to the alpha-defensin family	DEFA4	Pan troglodytes (chimpanzee)	Antimicrobial, Antibacterial, Antifungal	Homology	Bridge	Not found	1ZMM	Has antimicrobial activity against Gram-negative bacteria, and to a lesser extent also against Gram-positive bacteria and fungi. Inhibits corticotropin (ACTH)-stimulated corticosterone production.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15494476	Physiol Genomics. 2004 Dec 15;20(1):1-11. 	Patil A, Hughes AL, Zhang G.	Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.	
DRAMP02671	DHYNCVSSGGQCLYSACPIFTKIQGTCYGGKAKCCK	36	Beta-defensin 1 (BD-1; primates, mammals, animals)	P60023, A4H1Z2, Q09753, Q95M69, Q95M68	Belongs to the beta-defensin family	DEFB1	Pan troglodytes (Chimpanzee); also Gorilla gorilla gorilla (Lowland gorilla)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Problely has antimicrobial activity.
PTM: Problely contains three disulfide bonds 5-34; 12-27; 17-35. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11862391##11168821	Immunogenetics. 2002 Feb;53(10-11):907-913.##J Med Primatol. 2000 Oct;29(5):318-323.	Del Pero M, Boniotto M, Zuccon D, Cervella P, Spanò A, Amoroso A, Crovella S.##Duits LA, Langermans JA, Paltansing S, van der Straaten T, Vervenne RA, Frost PA, Hiemstra PS, Thomas AW, Nibbering PH.	Beta-defensin 1 gene variability among non-human primates.##Expression of beta-defensin-1 in chimpanzee (Pan troglodytes) airways.	
DRAMP02672	GISDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP	41	Beta-defensin 4A (Beta-defensin 2, BD-2; primates, mammals, animals)	Q9TT12	Belongs to the beta-defensin family	DEFB4A	Pan troglodytes (Chimpanzee)	Antimicrobial	Homology	Bridge	Not found		"Function: Problely has antimicrobial activity.
PTM: Problely contains three disulfide bonds 8-37; 15-30; 20-38."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases	Duits LA, Langermans JAM, van der Straaten T, Vervenne RAW, Paltansing S, Frost PA, Hiemstra PS, Thomas AW, Nibbering PH.	Expression of beta-defensin-2 in chimpanzee (Pan troglodytes).	
DRAMP02673	GIINTLQKYYCRVRGGRCAVLTCLPKEEQIGKCSTRGRKCCRRKK	45	Beta-defensin 103A (Beta-defensin 3, BD-3; primates, mammals, animals)	Q95JD2, A4H1Z8, Q30KM2, Q5IAC2	Belongs to the beta-defensin family	DEFB103A	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Exhibits antimicrobial activity against Gram-positive and Gram-negative bacteria.
PTM: Problely contains three disulfide bonds 11-40; 18-33; 23-41."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##15904491	Physiol Genomics. 2005 Sep 21;23(1):5-17.##BMC Evol Biol. 2005 May 18;5:32.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G. Semple CAM, Maxwell A, Gautier P, Kilanowski FM, Eastwood H, Barran PE, Dorin JR.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. The complexity of selection at the major primate beta-defensin locus.	
DRAMP18245	SLGVTLGAAGVYTATQTIATQIWKCGAVLTTSAECSRTGKSC	42	Ticin A4(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Bacillus thuringiensis BMB3201	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Comment: Active against the tested Gram-positive bacteria, including B. amyloliquefaciens, B. cereus, B. firmus, B. thuringiensis, B. subtilis, B. pumilus, E. faecalis, L. monocytogenes, Microbacterium, Paenibacillus, S. aureus, and S. sciuri. However, they are more active against food-borne pathogens such as B. cereus and L. monocytogenes. Chemical modifications such as dehydration are to be determined.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26231642	Appl Environ Microbiol. 2015 Oct;81(20):6964-72.	Xin B, Zheng J, Xu Z, Li C, Ruan L, Peng D, Sun M.	Three Novel Lantibiotics, Ticins A1, A3, and A4, Have Extremely Stable Properties and Are Promising Food Biopreservatives.	
DRAMP02675	GLDFSQPFPSGEFAVCESCKLGRGKCRKECLENEKPDGNCRLNFLCCRQRI	51	Beta-defensin 105A (Beta-defensin 5, BD-5; primates, mammals, animals)	Q5IAB6, A4H205, Q30KM0	Belongs to the beta-defensin family	DEFB105A	Pan troglodytes (Chimpanzee)	Antimicrobial	Homology	Bridge	Not found		"Function: Problely has antimicrobial activity.
PTM: Problely contains three disulfide bonds 16-47; 26-40; 30-46."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15904491##16033865	BMC Evol Biol. 2005 May 18;5:32.##Physiol Genomics. 2005 Sep 21;23(1):5-17.	Semple CA, Maxwell A, Gautier P, Kilanowski FM, Eastwood H, Barran PE, Dorin JR.##Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	The complexity of selection at the major primate beta-defensin locus.##Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP02676	FFDEKCNKLKGTCKNNCGKNEELIALCQKSLKCCRTIQPCGSIID	45	Beta-defensin 106A (Beta-defensin 6, BD-6; primates, mammals, animals)	Q5IAB3, A4H210, Q30KL9	Belongs to the beta-defensin family	DEFB106A	Pan troglodytes (Chimpanzee)	Antimicrobial	Homology	Bridge	Not found		"Function: Problely has antimicrobial activity.
PTM: Problely contains three disulfide bonds 6-33; 13-27; 17-34."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15904491##16033865	BMC Evol Biol. 2005 May 18;5:32.##Physiol Genomics. 2005 Sep 21;23(1):5-17.	Semple CA, Maxwell A, Gautier P, Kilanowski FM, Eastwood H, Barran PE, Dorin JR.##Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	The complexity of selection at the major primate beta-defensin locus.##Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP02677	AIHRALISKRMEGHCEAECLTFEVKTGGCRAELAPFCCKNRKKH	44	Beta-defensin 107A (Beta-defensin 7; BD-7, DEFB-7, cBD-7; primates, mammals, animals)	Q5IAA9, A4H214, Q30KL8	Belongs to the beta-defensin family	DEFB107A	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		PTM: Contains two disulfide bonds 15-29; 19-38.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##15904491	Physiol Genomics. 2005 Sep 21;23(1):5-17.##BMC Evol Biol. 2005 May 18;5:32.	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G. Semple C.A.M, Maxwell A, Gautier P, Kilanowski F.M, Eastwood H, Barran P.E, Dorin J.R.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. The complexity of selection at the major primate beta-defensin locus.	
DRAMP02678	KFKEICERPDGSCRDFCLETEIHVGRCLNSRPCCLPLGHQPRIESTTPKKD	51	Beta-defensin 108B (Beta-defensin 8; BD-8, DEFB-8, hBD-8; primates, mammals, animals)	Q5IAA6	Belongs to the beta-defensin family	DEFB108B	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		PTM: contains three disulfide bonds 6-33; 13-27; 17-34.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15904491	BMC Evol Biol. 2005 May 18;5:32.	Semple C.A.M, Maxwell A, Gautier P, Kilanowski F.M, Eastwood H, Barran P.E, Dorin J.R.	The complexity of selection at the major primate beta-defensin locus.	
DRAMP02679	GLGPAEGHCLNLSGVCRRDVCKVVEDQIGACRRRMKCCRAWWILMPIPTPLIMSDYQEPLKRKLK	65	Beta-defensin109 (Defensin, beta 109; Defensin, beta 109; primates, mammals, animals)	Q30KL7	Belongs to the beta-defensin family	DEFB109	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity (By similarity).
PYM: Problely contrains three disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. 	
DRAMP02680	KMKYPEYGSLDLRRECRMGNGRCKNQCHENEIRIAYCIRPGTHCCLQQ	48	Beta-defensin 110 (Defensin, beta 110; Beta-defensin 111; primates, mammals, animals)	Q30KL6	Belongs to the beta-defensin family	DEFB110	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		PTM: Contains three disulfide bonds 16-44; 23-37; 27-45.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. 	
DRAMP02681	GPSVPQKKTREVAEKKRECQLVRGACKPECNSWEYVYYYCNVNPCCVVQEYQKPIINKITSKLHQK	66	Beta-defensin 113 (Defensin, beta 113; primates, mammals, animals)	Q30KL4	Belongs to the beta-defensin family	DEFB113	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity.
PTM: Problely contains three disulfide bonds 19-45; 26-40; 30-46."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. 	
DRAMP02682	GLFRSHNGKSREPWNPCELYQGMCRNACREYEIQYLTCPNDQKCCLKLSVKITSSKNVKEDYDSNSNLSVTNSSSYSHI	79	Beta-defensin 116 (Defensin, beta 116; primates, mammals, animals)	Q30KL1	Belongs to the beta-defensin family	DEFB116	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity.
PTM: Problely contains three disulfide bonds 17-44; 24-38; 28-45."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. 	
DRAMP02683	QVTPVMKCWGKSGRCRTTCKESEVYYILCKTEAKCCVDPKYVPVKPKLTDRNTSLESTSAV	61	Beta-defensin 121 (Defensin, beta 121; primates, mammals, animals)	Q30KK6	Belongs to the beta-defensin family	DEFB121	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity.
PTM: Problely contains three disulfide bonds 8-35; 15-29; 19-36."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. 	
DRAMP02684	EFKRCWKGQGACRTYCTRQETYMHLCPDASLCCLSYALKPPPVPKHEYE	49	Beta-defensin 124 (Defensin, beta 124; Defensin, beta 126; primates, mammals, animals)	Q30KK4	Belongs to the beta-defensin family	DEFB124	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity.
PTM: Problely contains three disulfide bonds 5-32; 12-26; 16-33."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. 	
DRAMP02685	VKCAVKDTYSCFIVRGKCRHECHDFEKPIGFCTKLNANCYM	41	Beta-defensin 133 (Defensin, beta 133; primates, mammals, animals)	Q30KJ6	Belongs to the beta-defensin family	DEFB133	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity.
PTM: Problely contains two disulfide bonds 11-39; 18-32."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. 	
DRAMP02686	EMHKKCYKNGICRLECYESEMLVAYCMFQLECCVKGNPAP	40	Beta-defensin 134 (Defensin, beta 134; primates, mammals, animals)	Q30KJ5	Belongs to the beta-defensin family	DEFB134	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity.
PTM: Problely contains three disulfide bonds 6-32; 12-26; 16-33."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. 	
DRAMP02687	GPNVYIQKIFASCWRLQGTCRPKCLKNETISYFGVILYICGCVNPKYLPILTGK	54	Beta-defensin 135 (Defensin, beta 135; primates, mammals, animals)	Q30KJ4	Belongs to the beta-defensin family	DEFB135	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity.
PTM: Problely contains two disulfide bonds 13-40; 24-42."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. 	
DRAMP02688	MFGNDGVKVRTCTSQKAVCFFGCPPGYRWIAFCHNILSCCKNMTRFQPLQAKDPWVH	57	Beta-defensin 136 (Defensin, beta 136; primates, mammals, animals)	Q30KJ3	Belongs to the beta-defensin family	DEFB136	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has antibacterial activity.
PTM: Problely contains three disulfide bonds 12-39; 19-33; 23-40."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. 	
DRAMP02689	AYSGEKKCWNRSGHCRKQCKDGEAVKDTCKNLRACCVPSNEDH	43	Beta-defensin 118 (Defensin, beta 118; primates, mammals, animals)	Q30KK9, A4H219	Belongs to the beta-defensin family	DEFB118	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Contains three disulfide bonds 8-35; 15-29; 19-36."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##PubMed ID is not available	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Hollox EJ, Armour JAL.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Evolution and sequence variation of human beta-defensin genes.	
DRAMP02690	KRHILRRMGNSGICRASCKKNEQPYLYCRNYQSCCLQSYMRISISGKEENTDWSYEKQWPRLP	63	Beta-defensin 119 (Defensin, beta 119; Beta-defensin 120; primates, mammals, animals)	Q30KK8, A4H224, A4H229, Q30KK7	Belongs to the beta-defensin family	DEFB119	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Problely contains two disulfide bonds 14-28; 18-35."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##PubMed ID is not available	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Hollox EJ, Armour JAL.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Evolution and sequence variation of human beta-defensin genes.	
DRAMP02691	GTQRCWNLYGKCRYRCSKKERVYVYCINNKMCCVKPKYQPKERWWPF	47	Beta-defensin 123 (Defensin, beta 123; primates, mammals, animals)	Q30KK5, A4H234	Belongs to the beta-defensin family	DEFB123	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Contains three disulfide bonds 5-32; 12-26; 16-33."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##PubMed ID is not available	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Hollox EJ, Armour JAL.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Evolution and sequence variation of human beta-defensin genes.	
DRAMP02692	NWYVKKCLNDVGICKKKCKPGEMHIKNGWATCGKQRDCCVPAD	43	Beta-defensin 126 (Defensin, beta 126; primates, mammals, animals)	Q30KK2, A4H242	Belongs to the beta-defensin family	DEFB126	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Contains three disulfide bonds 7-37; 14-32; 18-39."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##PubMed ID is not available	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Hollox EJ, Armour JAL.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Evolution and sequence variation of human beta-defensin genes.	
DRAMP02693	LKKCWNNYVQGHCRKICRVNEVPEALCENGRYCCLNIKELEAC	43	Beta-defensin 127 (Defensin, beta 127; primates, mammals, animals)	Q30KK1	Belongs to the beta-defensin family	DEFB127	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Contains three disulfide bonds 5-33; 13-27; 17-34."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##PubMed ID is not available	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Hollox EJ, Armour JAL.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Evolution and sequence variation of human beta-defensin genes.	
DRAMP02694	GVIPGQKQCIALKGVCRDKLCSTLDDTIGICNEGKKCCRRWWILEPYPTPVPKGKSP	57	Beta-defensin 130 (Defensin, beta 130; primates, mammals, animals)	Q30KJ9	Belongs to the beta-defensin family	DEFB130	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Contains two disulfide bonds 16-31; 21-38."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##PubMed ID is not available	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Hollox EJ, Armour JAL.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Evolution and sequence variation of human beta-defensin genes.	
DRAMP02695	FISNDECPSEYYYHCRLKCNADEHAIRYCADFSICCKLKIIEIHGQKKW	49	Beta-defensin 131 (Defensin, beta 131; primates, mammals, animals)	Q30KJ8	Belongs to the beta-defensin family	DEFB131	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Contains three disulfide bonds 7-35; 15-29; 19-36."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##PubMed ID is not available	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Hollox EJ, Armour JAL.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Evolution and sequence variation of human beta-defensin genes.	
DRAMP02696	GGSKCVSNTPGYCRTYCHWGETALFMCNASRKCCVSYSFLPKADLPRLIGNHWQSRRRNTQRKDKKQQTTVTS	73	Beta-defensin 132 (Defensin, beta 132; primates, mammals, animals)	Q30KJ7, A4H261	Belongs to the beta-defensin family	DEFB132	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Contains three disulfide bonds 5-33; 13-27; 17-34."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##PubMed ID is not available	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Hollox EJ, Armour JAL.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Evolution and sequence variation of human beta-defensin genes.	
DRAMP02697	ESLQERADEATTQKQSGEDNQDLAISFAGNGLSALRTSGSQARATCYCRIGHCTILESLSGVCEISGRLYRLCCR	75	Defensin-5 (Defensin, alpha 5; primates, mammals, animals)	Q5G861	Not found	DEFA5	Pan troglodytes (Chimpanzee)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane. All DEFA5 peptides exert antimicrobial activities, but their potency is affected by peptide processing (By similarity).
Subcellular location: Secreted. Cytoplasmic vesicle › secretory vesicle (By similarity). Note: Peptides HD5(20-94), HD5(23-94) and HD5(29-94) are detected intracellularly. Peptides HD5(56-94) and HD5(63-94) are found in the extracellular milieu.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15494476	Physiol Genomics. 2004 Dec 15;20(1):1-11.	Patil A, Hughes AL, Zhang G.	Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.	
DRAMP02698	RRTCHCRSRCLRRESNSGSCNINGRIFSLCCR	32	Rhesus macaque oral alpha-defensins (ROADs; primates, mammals, animals)	B5AKV3	Belongs to the alpha-defensin family	Not found	Macaca mulatta (Rhesus monkey)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Beta strand (3 strands; 19 residues)	NMR spectroscopy shows that Synthetic ROAD-1 adopts the canonical disulfide pairing and alpha-defensin fold.	2K1I resolved by NMR.	"Function: ROAD-1 is active against Staphylococcus aureus, Escherichia coli, and Candida albicans in a concentration-dependent manner. The antimicrobial mechanism of defensins has been correlated with their ability to disrupt and permeabilize the cell envelope, activities that depend on the surface features of the folded peptide.
PTM: Contains three disulfide bonds."	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.##Fungi: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys4 and Cys31; Cys6 and Cys20; Cys10 and Cys30.	L	No cytotoxicity information found	Not found	18930922	J Biol Chem. 2008 Dec 19;283(51):35869-35877.	Vasudevan S, Yuan J, Osapay G, Tran P, Tai K, Liang W, Kumar V, Selsted ME, Cocco MJ.	Synthesis, structure, and activities of an oral mucosal alpha-defensin from rhesus macaque.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP02699	VKEGIEKAGVCPADNVRCFKSDPPQCHTDQDCLGERKCCYLHCGFKCVIPVKELEEGGNKDEDVSRP	67	WAP four-disulfide core domain protein 12 (primates, mammals,animals)	A4K2R5	Not found	WFDC12	Gorilla gorilla gorilla (Lowland gorilla)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Antibacterial protein. Putative acid-stable proteinase inhibitor.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17267810	Genome Res. 2007 Mar;17(3):276-286.	Hurle B, Swanson W; NISC Comparative Sequencing Program, Green ED.	Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage.	
DRAMP02700	AIHRALICKRMEGHCEAECLTFEAKIGGCRAELAPFCCKNRKKH	44	Beta-defensin 107A (Defensin, beta 107; Defensin, beta 107A; primates, mammals,animals)	A4H215	Belongs to the beta-defensin family	DEFB107A	Gorilla gorilla gorilla (Lowland gorilla)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		PTM: Contains two disulfide bonds 15-29; 19-38.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP18244	SLGVTLGAAGVYTATQTIATQIWKCGAVLTTSAECSRTGNSC	42	Ticin A3(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Bacillus thuringiensis BMB3201	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Activity spectrum is similar to Ticin A4. Chemical modifications such as dehydration are to be determined. Chemical modifications such as dehydration are to be determined.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26231642	Appl Environ Microbiol. 2015 Oct;81(20):6964-72.	Xin B, Zheng J, Xu Z, Li C, Ruan L, Peng D, Sun M.	Three Novel Lantibiotics, Ticins A1, A3, and A4, Have Extremely Stable Properties and Are Promising Food Biopreservatives.	
DRAMP02702	KRHILRCMGNSGICRASCKKNEQPYLYCRNYQSCCLQSYMRISISGKEEDTDWSYEKQWPRLP	63	Beta-defensin 119 (Defensin, beta 119; Beta-defensin 120; primates, mammals,animals)	A4H225, A4H230	Belongs to the beta-defensin family	DEFB119	Gorilla gorilla gorilla (Lowland gorilla)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Potentially has antibacterial activity.
PTM: Contains three disulfide bonds 7-34; 14-28; 18-35."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP18243	SLGVTLGAAGLYTATQTIATQIWKCGAVLTTSAECSRTGNSC	42	Ticin A1(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Bacillus thuringiensis BMB3201	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Activity spectrum is similar to Ticin A4. Chemical modifications such as dehydration are to be determined.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26231642	Appl Environ Microbiol. 2015 Oct;81(20):6964-72.	Xin B, Zheng J, Xu Z, Li C, Ruan L, Peng D, Sun M.	Three Novel Lantibiotics, Ticins A1, A3, and A4, Have Extremely Stable Properties and Are Promising Food Biopreservatives.	
DRAMP02704	NWYVKKCLNDVGICKKKCKPEEMHVKNGWAMCGKQRDCCVPAD	43	Beta-defensin 126 (Defensin, beta 126; primates, mammals,animals)	A4H243	Belongs to the beta-defensin family	DEFB126	Gorilla gorilla gorilla (Lowland gorilla)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Potentially has antibacterial activity.
PTM: Contains three disulfide bonds 7-38; 14-32; 18-39."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02705	GGSKCVSNTPAYCRTYCHWGETALFMFNASRKCCISYSFLPKPDLPQLIGNHWQSRRNTQRKDKKQQTTVTS	72	Beta-defensin 132 (Defensin, beta 132; primates, mammals,animals)	A4H262	Belongs to the beta-defensin family	DEFB132	Gorilla gorilla gorilla (Lowland gorilla)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Potentially has antibacterial activity.
PTM: Contains two disulfide bonds 5-33; 17-34."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02706	EFELDRICGYGTARCRKKCRSQEYRIGRCPNTFACCLRKWDESLLNRTKP	50	Beta-defensin 104A (Defensin, beta 104; Defensin, beta 104A; primates, mammals, animals)	A4H202	Belongs to the beta-defensin family	DEFB104A	Gorilla gorilla gorilla (Lowland gorilla)	Antimicrobial	Homology	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP18242	EKYTEVPEYV	10	Fengycin B2 (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus thuringiensis 	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-		Not found	K2 is Orn. The C-terminal V forms an ester bond with the side chain of Y3.		Fuction: Active against fungi C. Albicans and A.niger. 	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24312083##22847390 	Front Microbiol. 2013 Nov 21;4:332.##J Am Soc Mass Spectrom. 2012 Oct;23(10):1716-28. Epub 2012 Jul 31. 	Roy A, Mahata D, Paul D, Korpole S, Franco OL, Mandal SM.##Pathak KV, Keharia H, Gupta K, Thakur SS, Balaram P.	Purification, biochemical characterization and self-assembled structure of a fengycin-like antifungal peptide from Bacillus thuringiensis strain SM1.##Lipopeptides from the banyan endophyte, Bacillus subtilis K1: mass spectrometric characterization of a library of fengycins.	
DRAMP02709	LLGDFFRKAKEKIGKESKRIVQRIKDFLRNLVPRTES	37	Antibacterial protein LL-37 (cathelicidin; primates, mammals, animals)	Q1KLY3	Belongs to the cathelicidin family	CAMP	Gorilla gorilla gorilla (Lowland gorilla) 	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Has antibacterial activity. (By similarity)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP18240	EKYTEIPEYV	10	Fengycin C(Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis K1	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-		Not found	K2 is Orn.		Comment: No comments found on DRAMP database	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22847390	J Am Soc Mass Spectrom. 2012 Oct;23(10):1716-28. Epub 2012 Jul 31.	Pathak KV, Keharia H, Gupta K, Thakur SS, Balaram P.	Lipopeptides from the banyan endophyte, Bacillus subtilis K1: mass spectrometric characterization of a library of fengycins.	
DRAMP18241	TWATIGKTIVQSVKKCRTFTCGCSLGSCSNCN	32	Subtilomycin(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	subA	Bacillus subtilis MMA7 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	There are extensive post-translational modifications: T1, T4 and T8 are dehydrated into Dhb. The N-terminal Dhb was unstable and further oxidized by deamination into 2-oxo butyrate. In addition, thioether or methylthioether bonds occur between the following residue pairs: S11-C15, T17-C21, T20-C23, S24-C28, and S27-C31.		Therefore the most likely sequence for the lantibiotic is Dhb*-W-A-Dhb-I-G-K-Dhb-I-V-Q-Dha-V-K-K-C-R-Dhb-F-Dhb-C-G-C-Dha-L-G-Dha-C-Dha-N-C-N, where the underlined amino acids have been experimentally confirmed by mass spectrometric analysis and the subsequent sequence predicted from the genomic sequence of strain MMA7.	Gram-positive, Gram-negative (broad spectrum)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23736764	Mar Drugs. 2013 Jun 3;11(6):1878-98.	Phelan RW, Barret M, Cotter PD, O'Connor PM, Chen R, Morrissey JP, Dobson AD, O'Gara F, Barbosa TM.	Subtilomycin: a new lantibiotic from Bacillus subtilis strain MMA7 isolated from the marine sponge Haliclona simulans.	
DRAMP18239	EKYTEAPEYV	10	Fengycin A2(Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis K1	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-		Not found	K2 is Orn. The C-terminal V forms an ester bond with the side chain of Y3.		Comment: No comments found on DRAMP database	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22847390	J Am Soc Mass Spectrom. 2012 Oct;23(10):1716-28. Epub 2012 Jul 31.	Pathak KV, Keharia H, Gupta K, Thakur SS, Balaram P.	Lipopeptides from the banyan endophyte, Bacillus subtilis K1: mass spectrometric characterization of a library of fengycins.	
DRAMP18238	EKYTEVPEYI	10	Fengycin B(Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis K1	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-		Not found	K2 is Orn. The structure consists of a cyclic peptide lactone formed between the phenolic -OH of Tyr3 and the C-terminal -COOH of an amino acid at position 10. The N-terminus of the decapeptide segment is acylated with a beta-hydroxy fatty acid (beta-OH FA).		Comment: No comments found on DRAMP database	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22847390	J Am Soc Mass Spectrom. 2012 Oct;23(10):1716-28. Epub 2012 Jul 31.	Pathak KV, Keharia H, Gupta K, Thakur SS, Balaram P.	Lipopeptides from the banyan endophyte, Bacillus subtilis K1: mass spectrometric characterization of a library of fengycins.	
DRAMP02713	DTHFPIYIFCCGCCHRSKCGMCCKT	25	Hepcidin (primates, mammals, animals)	Q5NVR8	Belongs to the glycosyl hydrolase 22 family	HAMP	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	Antimicrobial 	Homology	Not found	Not found		"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains three disulfide bonds 10-13; 11-19; 14-22."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases	The German cDNA consortium	Unknown	
DRAMP02714	LLGDFFRKAREKIGEEFKRIVQRIKDFLRNLVPRTES	37	Antibacterial protein LL-37 (cathelicidin; primates, mammals,animals)	Q1KLX2	Belongs to the beta-defensin family	CAMP	Pongo pygmaeus (Bornean orangutan)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Problrly has antibacterial activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharides (LPS)	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP02715	FFDEKCGKLKGTCKNNCGKNEELIALCQKSLKCCRTIQPCGSIID	45	Beta-defensin 106A (Defensin, beta 106; Defensin, beta 106A; primates, mammals,animals)	A4H212	Belongs to the beta-defensin family	DEFB106A	Pongo pygmaeus (Bornean orangutan)	Antimicrobial	Homology	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02716	GLDFSQPFPSDEFAVCESCKLGRGKCRKECLENEKPDGNCRLNFLCCRERI	51	Beta-defensin 105A (Defensin, beta 105; Defensin, beta 105A; primates, mammals,animals)	A4H207	Belongs to the beta-defensin family	DEFB105A	Pongo pygmaeus (Bornean orangutan)	Antimicrobial	Homology	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ database	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02717	KRYILRCMGNSGICRASCKRNEQPYLYCKNYQSCCLQSYMRISISGKEENTDWSYEKQWPKLP	63	Beta-defensin 119 (Defensin, beta 119; Beta-defensin 120; Defensin, beta 120; primates, mammals, 	A4H226	Belongs to the beta-defensin family	DEFB119	Pongo pygmaeus (Bornean orangutan)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Problely contains three disulfide bonds 7-34; 14-28; 18-35."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02718	GTQRCWNLYGKCRHRCSKKERVYVYCVNNKMCCVKPKYQPKERWWRF	47	Beta-defensin 123 (Defensin, beta 123; primates, mammals, animals)	A4H236	Belongs to the beta-defensin family	DEFB123	Pongo pygmaeus (Bornean orangutan)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Problely contains three disulfide bonds 5-32; 12-26; 16-33."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02719	SWYVKKCLNDVGICKKKCKPEELHVKNGWAMCGKQRDCCVPAD	43	Beta-defensin 126 (Defensin, beta 126; primates, mammals, animals)	A4H244	Belongs to the beta-defensin family	DEFB126	Pongo pygmaeus (Bornean orangutan)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Problely contains three disulfide bonds 7-38; 14-32; 18-39."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02720	ARLKKCFNNVTGYCRKKCKVGERYEIGCLSGKLCCINYEEEKEHVSFKKPHQHSGEKLSVQQDYIILPTVTIFTV	75	Beta-defensin 128 (Defensin, beta 128; primates, mammals, animals)	A4H253	Belongs to the beta-defensin family	DEFB128	Pongo pygmaeus (Bornean orangutan)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Problely contains three disulfide bonds 6-34; 14-28; 18-35."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02721	GGSKCVSNTPGYCRTYCHQGETALFMCNASRKCCVSYSFLPKPDLPQLIGNHWQSRRRNTQRKDKKQQTTVTS	73	Beta-defensin 132 (Defensin, beta 132; primates, mammals, animals)	A4H263	Belongs to the beta-defensin family	DEFB132	Pongo pygmaeus (Bornean orangutan)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Potentially has antibacterial activity.
PTM: Problely contains three disulfide bonds 5-33; 13-27; 17-34."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox E.J, Armour J.A.L.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02722	DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK	36	Beta-defensin 1 (BD-1; Defensin, beta 1; primates, mammals,animals)	P61263, A4H1Z4	Belongs to the beta-defensin family	Not found	Pongo pygmaeus (Bornean orangutan)	Antimicrobial, Antibacterial	Homology	Bridge	Not found	1E4S	"Function: Has bactericidal activity (By similarity).
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11862391##PubMed ID is not available	Immunogenetics. 2002 Feb;53(10-11):907-913.##Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases.	Del Pero M, Boniotto M, Zuccon D, Cervella P, Spanò A, Amoroso A, Crovella S.##Hollox E.J, Armour J.A.L.	Beta-defensin 1 gene variability among non-human primates.##Evolution and sequence variation of human beta-defensin genes.	
DRAMP18237	EKYTEAPEYI	10	Fengycin A(Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis K1	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-		Not found	K2 is Orn. The structure consists of a cyclic peptide lactone formed between the phenolic -OH of Tyr3 and the C-terminal -COOH of an amino acid at position 10. The N-terminus of the decapeptide segment is acylated with a beta-hydroxy fatty acid (beta-OH FA).		Comment: No comments found on DRAMP database	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22847390	J Am Soc Mass Spectrom. 2012 Oct;23(10):1716-28. Epub 2012 Jul 31.	Pathak KV, Keharia H, Gupta K, Thakur SS, Balaram P.	Lipopeptides from the banyan endophyte, Bacillus subtilis K1: mass spectrometric characterization of a library of fengycins.	
DRAMP02724	LPGNFFRKAREKIGKEFKRIVQRIKDFLQHLVPRTEA	37	Antibacterial protein LL-37 (cathelicidin; primates, mammals, animals)	Q1KLY2	Belongs to the cathelicidin family	CAMP	Nomascus gabriellae (Red-cheeked gibbon)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Has antibacterial activity. (By similarity)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP02725	LLGNFFRKAREKIGKEFKRIVQRIKDFLQHLVPRTEA	37	Antibacterial protein LL-37 (cathelicidin; primates, mammals, animals)	No entry found	Not found	Not found	Nomascus leucogenys (White-cheeked Gibbon)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Function: Has antibacterial activity. (By similarity)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP02729	AIHRALICKRMEGHCEAECLTFEVKIGGCRAELAPFCCKNRKKH	44	Beta-defensin 107A (Defensin, beta 107; Defensin, beta 107A; primates, mammals, animals)	A4H216, A4H217	Belongs to the beta-defensin family	DEFB107A	Hylobates lar (Common gibbon) (White-handed gibbon); also Pongo pygmaeus (Bornean orangutan)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Potentially has antibacterial activity.
PTM: Problely contains two disulfide bonds 15-29; 19-38."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02730	EFEWDRICGYGTARCRNKCRSQEYRIGRCPNTFACCLRKWDESLLNSTKP	50	Beta-defensin 104A (Defensin, beta 104; Defensin, beta 104A; primates, mammals, animals)	A4H204	Belongs to the beta-defensin family	DEFB104A	Hylobates lar (Common gibbon) (White-handed gibbon)	Antimicrobial	Homology	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02731	GLDFSQPFPSGEFAVFESCKFSRGKCRKECLENEKPDGNCRLNFLCCRQSI	51	Beta-defensin 105A (Defensin, beta 105; Defensin, beta 105A; primates, mammals, animals)	A4H208	Belongs to the beta-defensin family	DEFB105A	Hylobates lar (Common gibbon) (White-handed gibbon)	Antimicrobial	Homology	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02732	FFDDKCDKLRGTCKNSCEKNEELTSFCQKSLKCCRTIQTCGNTTD	45	Beta-defensin 106A (Defensin, beta 106; Defensin, beta 106A; primates, mammals, animals)	A4H213	Belongs to the beta-defensin family	DEFB106A	Hylobates lar (Common gibbon) (White-handed gibbon)	Antimicrobial	Homology	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP18236	NRWCFAGDD	9	NRWC(Bacteriocin)	No entry found	Not found	Not found	Bacillus subtilis ATCC 6633	Antimicrobial, Antibacterial		Not found	The sequence showed no homology with other known antimicrobial peptides.		The antimicrobial activity was affected by the action of the proteases pronase E and proteinase K, but the absence of the inhibition zone against H. parasuis was only observed when the enzymes were used at 10 mg/ml.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23519163	Microbiology. 2013 May;159(Pt 5):980-8.	Teixeira ML, Dalla Rosa A, Brandelli A.	Characterization of an antimicrobial peptide produced by Bacillus subtilis subsp. spizezinii showing inhibitory activity towards Haemophilus parasuis.	
DRAMP02734	KHHILRCMGNSGICRASCKKNEQPYLYCRNYQHCCLQSYMRISISGEEENTDWSYEKQWPRLP	63	Beta-defensin 119 (Defensin, beta 119; Beta-defensin 120; primates, mammals, animals)	A4H227, A4H232	Belongs to the beta-defensin family	DEFB119	Hylobates lar (Common gibbon) (White-handed gibbon)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Potentially has antibacterial activity.
PTM: Problely contains three disulfide bonds 7-34; 14-28; 18-35."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02735	NWYVKKCLNDVGICKKKCKPEELHVKNGRAMCGKQRDCCVPAD	43	Beta-defensin 126 (Defensin, beta 126; primates, mammals, animals)	A4H245	Belongs to the beta-defensin family	DEFB126	Hylobates lar (Common gibbon) (White-handed gibbon)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Potentially has antibacterial activity.
PTM: Problely contains three disulfide bonds 7-38; 14-32; 18-39."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02736	ARLKKCFNNITGYCRKKCKVGERYEIGCLSGKLCCVNDEEEKKHVSFKKPHQHSGEKLSVQQDYIILPTITIFAV	75	Beta-defensin 128 (Defensin, beta 128; primates, mammals, animals)	A4H254	Belongs to the beta-defensin family	DEFB128	Hylobates lar (Common gibbon) (White-handed gibbon)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Potentially has antibacterial activity.
PTM: Problely contains three disulfide bonds 6-34; 14-28; 18-35."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02737	GGSKCVSDTQGYCRTYCHQGETALFMCNASRKCCASYSFLPKPDLPQLIGNHWQSRRRNTQRKDKKQQTTVTSS	74	Beta-defensin 132 (Defensin, beta 132; primates, mammals, animals)	A4H264	Belongs to the beta-defensin family	DEFB132	Hylobates lar (Common gibbon) (White-handed gibbon)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Potentially has antibacterial activity.
PTM: Problely contains three disulfide bonds 5-33; 13-27; 17-34."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hollox EJ, Armour JAL.	Evolution and sequence variation of human beta-defensin genes.	
DRAMP02738	DHYNCVRSGGQCLYSACPIYTKIQGTCYQGKAKCCK	36	Beta-defensin 1 (BD-1; Defensin, beta 1; primates, mammals, animals)	Q7JGM2, Q95J22, Q7JGM1, A4H1Z5	Belongs to the beta-defensin family	DEFB1	Nomascus concolor (Black crested gibbon) (Hylobates moloch) (Hylobates lar)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Has bactericidal activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16700051##11862391	Proteins. 2006 Aug 1;64(2):524-531.##Immunogenetics. 2002 Feb;53(10-11):907-913.	Chattopadhyay S, Sinha NK, Banerjee S, Roy D, Chattopadhyay D, Roy S.##Del Pero M, Boniotto M, Zuccon D, Cervella P, Spano A, Amoroso A, Crovella S.	Small cationic protein from a marine turtle has beta-defensin-like fold and antibacterial and antiviral activity.##Beta-defensin 1 gene variability among non-human primates.	
DRAMP02739	EKKCPGRCTLKCGKHERPTLPYNCGKYICCVPVKVK	36	TEWP (turtle egg-white protein; Reptiles, animals)	No entry found	Not found	Not found	Caretta caretta (Loggerhead turtle)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral	Not found	Beta strand (2 strands; 2 residues)	The protein has no α-helix and consists of two antiparallel β-sheets. 	2B5B resolved by NMR.	Function: The protein showes strong antibacterial activity against Escherichia coli and Salmonella typhimurium. The protein also showes significant antiviral activity against an enveloped rhabdovirus, Chandipura virus,	Gram-negative bacteria: Escherichia coli (IC50=2.3 µM), Salmonella typhimurium (IC50=2.8 µM);##Gram-positive bacterium: Staphylococcus aureus (IC50=5.1 µM).##Virus: enveloped rhabdovirus, Chandipura virus, Vesicular stomatitis virus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16700051	Proteins. 2006 Aug 1;64(2):524-531.	Chattopadhyay S, Sinha NK, Banerjee S, Roy D, Chattopadhyay D, Roy S.	Small cationic protein from a marine turtle has beta-defensin-like fold and antibacterial and antiviral activity.	
DRAMP02741	DDTPSSRCGSGGWGPCLPIVDLLCIVHVTVGCSGGFGCCRIG	42	Pelovaterin (defensin-like AMP; Gly-rich; Reptiles, animals)	P84818	Not found	Not found	Pelodiscus sinensis (Chinese softshell turtle) (Trionyx sinensis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Combine helix and strand structure	An analysis of the ensemble of pelovaterin structures reveals that hydrophilic residues Asp1 Arg7 begin with a random coil structure leading to a short 310 helix between Cys8 and Gly12, whereas antiparallel â-strands are formed by the residues Leu17 Val20 (β), His27 Val28 (â2), and Gly34 Cys39 (â3) arranged in a βâ2â3 topology. 	2JR3 resolved by NMR.	"Function: Induces the nucleation and stabilization of vaterite, one of the crystalline polymorphs of calcium carbonate. Exhibits strong antimicrobial activity against Pseudomonas aeruginosa and Proteus vulgaris.
PTM: Contains three disulfide bonds 8-38; 16-32; 24-39."	Gram-negative bacteria: Pseudomonas aeruginosa (EC50=0.42 µg/mL), Proteus vulgaris (EC50=0.37 µg/mL), Proteus mirabilis (EC50=8.4 µg/mL);##Gram-positive bacterium: Staphylococcus aureus (EC50=42 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15877362##18341335	Biomacromolecules. 2005 May-Jun;6(3):1429-37.##J Am Chem Soc. 2008 Apr 9;130(14):4660-8.	Lakshminarayanan R, Chi-Jin EO, Loh XJ, Kini RM, Valiyaveettil S.##minarayanan R, Vivekanandan S, Samy RP, Banerjee Y, Chi-Jin EO, Teo KW, Jois SD, Kini RM, Valiyaveettil S.	Purification and characterization of a vaterite-inducing peptide, pelovaterin, from the eggshells of Pelodiscus sinensis (Chinese soft-shelled turtle).##Structure, self-assembly, and dual role of a beta-defensin-like peptide from the Chinese soft-shelled turtle eggshell matrix.	
DRAMP02742	QKKCPGRCTLKCGKHERPTLPYNCGKYICCVPVKVK	36	Defensin-like turtle egg white protein TEWP (TEWP; Reptiles, animals)	P0CAP0	Belongs to the beta-defensin family	Not found	Caretta caretta (Loggerhead sea turtle)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral	Protein level	Beta strand (2 strands; 2 residues)	Three-dimensional structure of TEWP was determined by distance geometry and simulated annealing. The protein has no α-helix and consists of two antiparallel β-sheets. The secondary structure is consistent with the previously obtained circular dichroism spectra. 	2B5B resolved by NMR.	"Function: The protein showes strong antibacterial activity against Escherichia coli and Salmonella typhimurium and also showes significant antiviral activity against an enveloped rhabdovirus, Chandipura virus, which is an emerging human pathogen.
Tissue specificity: Detected in egg white (at protein level)."	Gram-negative bacteria: Escherichia coli (IC50=3.3 µM), Salmonella typhimurium (IC50=2.8 µM);##Gram-positive bacterium: Staphylococcus aureus (IC50=5. 1µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16700051	Proteins. 2006 Aug 1;64(2):524-531.	Chattopadhyay S, Sinha NK, Banerjee S, Roy D, Chattopadhyay D, Roy S.	Small cationic protein from a marine turtle has beta-defensin-like fold and antibacterial and antiviral activity.	
DRAMP02743	AVRIGPCDQVCPRIVPERHECCRAHGRSGYAYCSGGGMYCN	41	Diapause-specific peptide (Dsp)	Q8T0W8	Belongs to the diapausin family	Not found	Gastrophysa atrocyanea	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	Not found	2E2F resolved by NMR.	"Function: Has antifungal activity against Trichophyton rubrum. Blocks voltage-dependent N-type calcium channels (Cav2.2 / CACNA1B).
Tissue specificity: Highly expressed in the fat body.
Developmental stage: Produced throughout adult diapause, and to a minor extent in pupae, but not in eggs, larvae, or post-diapausing adults. Inhibition of DSP expression does not affect the onset or maintenance of diapause, indicating that the expression of DSP accompanies but does not play a direct role in the induction or maintenance of diapause."	Trichophyton rubrum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17994764	Appl. Entomol. Zool. 1998; 33: 535-543.	Tanaka H et al. Suzuki K	A specific peptide produced during adult diapause of the leaf beetle, Gastrophysa atrocyanea Moschulsky (Coleoptara: Chrysomelidae)	
DRAMP02744	FWGTLAKLALKAVPAVMGMIKKE	23	Dinoponeratoxin Da-2501 (ants, insects, animals)	P0CF01	Not found	Not found	Dinoponera australis (Giant neotropical hunting ant)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Dinoponeratoxin Da-2051 may have antibacterial activity.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19879289	Toxicon. 2010 Apr 1;55(4):702-710.	Johnson SR, Copello JA, Evans MS, Suarez AV.	A biochemical characterization of the major peptides from the venom of the giant Neotropical hunting ant Dinoponera australis.	
DRAMP02745	ALKAVPAVMGMIKKE	15	Dinoponeratoxin Da-1585 (ants, insects, animals)	P0CF01	Not found	Not found	Dinoponera australis (Giant neotropical hunting ant)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Dinoponeratoxin Da-1585 may have antibacterial activity.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19879289	Toxicon. 2010 Apr 1;55(4):702-710.	Johnson SR, Copello JA, Evans MS, Suarez AV.	A biochemical characterization of the major peptides from the venom of the giant Neotropical hunting ant Dinoponera australis.	
DRAMP02746	GLKDWWNKHKDKIIAVAKEMGKAGLQAA	28	Dinoponeratoxin Da-3105 (ants, insects, animals)	P0CF02	Not found	Not found	Dinoponera australis (Giant neotropical hunting ant)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: May have antibacterial activity.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19879289	Toxicon. 2010 Apr 1;55(4):702-710.	Johnson SR, Copello JA, Evans MS, Suarez AV.	A biochemical characterization of the major peptides from the venom of the giant Neotropical hunting ant Dinoponera australis.	
DRAMP02747	FLGGLIGPLMSLIPGLLK	18	Dinoponeratoxin Da-1837 (ants, insects, animals)	P0CF03	Not found	Not found	Dinoponera australis (Giant neotropical hunting ant)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: May have antibacterial activity.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19879289	Toxicon. 2010 Apr 1;55(4):702-710.	Johnson SR, Copello JA, Evans MS, Suarez AV.	A biochemical characterization of the major peptides from the venom of the giant Neotropical hunting ant Dinoponera australis.	
DRAMP02748	GVVPHDFRI	9	Dinoponeratoxin Da-1039 (ants, insects, animals)	P0CF04	Not found	Not found	Dinoponera australis (Giant neotropical hunting ant)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: May have antibacterial activity.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19879289	Toxicon. 2010 Apr 1;55(4):702-710.	Johnson SR, Copello JA, Evans MS, Suarez AV.	A biochemical characterization of the major peptides from the venom of the giant Neotropical hunting ant Dinoponera australis.	
DRAMP02749	GLKDWWNKHKDKIIDVVKEMGKAGLQAA	28	Dinoponeratoxin Da-3177 (ants, insects, animals)	P0CF05	Not found	Not found	Dinoponera australis (Giant neotropical hunting ant)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: May have antibacterial activity, since it is predicted to form an amphipathic alpha helix.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19879289	Toxicon. 2010 Apr 1;55(4):702-710.	Johnson SR, Copello JA, Evans MS, Suarez AV.	A biochemical characterization of the major peptides from the venom of the giant Neotropical hunting ant Dinoponera australis.	
DRAMP02750	FTCDLLSGAGVDHSACAAHCILRGKTGGRCNSDRVCVCRA	40	Defensin (ants, insects, animals)	Q5BU36	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Formica aquilonia (Red wood ant)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		Function: Antibacterial peptide mostly active against Gram-positive bacteria (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033427	Insect Mol Biol. 2005 Aug;14(4):335-338.	Viljakainen L, Pamilo P.	Identification and molecular characterization of defensin gene from the ant Formica aquilonia.	
DRAMP03743	RSVCRQIKICRRRGGCYYKCTNRPY	25	Androctonin (Arthropods, animals)	P56684	Not found	Not found	Androctonus australis (Sahara scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Beta strand (2 strands; 8 residues)	The structure of androctonin involves a well-defined highly twisted anti-parallel beta-sheet with strands connected by a more variable positively charged turn.	1CZ6 resolved by NMR.	"Function: Androctonin is a highly cationic antimicrobial peptide from scorpion exhibiting a broad spectrum of activities against bacteria (Gram-positive and Gram-negative) and filamentous fungi. Acts on the membrane of the bacterial cells. It destabilize a membrane by modifying its properties.
PTM: Contains two disulfide bonds 4-20; 10-16."	[Ref.10942757] Gram-positive bacteria: Micrococcus luteus (MIC=0.6-1.5 μM), Aerococcus viridans (MIC=0.3-0.6 μM), Staphylococcus aureus (MIC=15-30 μM);##Gram-negative bacteria: Escherichia coli D31 (MIC=3-6 μM),  Escherichia coli D22 (MIC=6-15 μM),  Escherichia coli 1106 (MIC=6-15 μM), Salmonella typhimurium (MIC=3-6 μM).##Fungi: Alternaria brassicola (MIC=3-6 μM), Fusarium culmorum (MIC=3-6 μM), Fusarium oxysporum (MIC=6-12 μM), Neurospora crassa (MIC=6-12 μM), Nectria haematococca (MIC=6-12 μM), Trichoderma viridae (MIC=6-12 μM);##Yeast: Candida albicans (MIC=1.6-3.15 μM).##[Ref.8939880] Gram-positive bacteria: Bacillus subtilis (MIC=1.5-3.0 μM);##Gram-negative bacteria: Escherichia coli D22 (MIC>30 μM), Pseudomonas syringae (MIC=1.5-3.0 μM), Pseudomonas syringae pv.syringae (MIC=15-22 μM), Pseudomonas syringae phaseoli (MIC=1.5-3.0 μM), Pseudomonas syringae pv.pisi (MIC=6-15 μM), Pseudomonas syringae pv. maculicola (MIC=3-6 μM), Phoma valerianella (MIC=15-22 μM), Xanthomonas compestris pv.compestris (MIC=3-6 μM), Xanthomonas vesicatoria 687.3 (MIC=1.5-3.0 μM), Xanthomonas vesicatoria B229RI (MIC=1.5-3.0 μM);##Fungi: Alternaria dauci (MIC=8-16 μM), Stemphylium (MIC=4-8 μM),  Fusarium oxysporum M. (MIC=2-4 μM), Fusarium oxysporum L. (MIC=2-4 μM), Botrytis cinerea (MIC=6-12 μM), B. petunia (MIC=4-8 μM), Verticilium toreilis (MIC=2-4 μM), Aspergillus fumigatus (MIC=25-50 μM).	[Ref.8939880] It exhibits no hemolytic activity on porcine or bovine erythrocytes at a concentration of up to 150 μM.	Cyclic	Free	Free	Disulfide bond between Cys4 and Cys20,Cys10 and Cys16.	L	No cytotoxicity information found	Cell membrane	8939880##10563585##10942757	J Biol Chem. 1996 Nov 22;271(47):29537-29544.##J Biomol Struct Dyn. 1999 Oct;17(2):367-380.##J Biol Chem. 2000 Oct 27;275(43):33464-70.	Ehret-Sabatier L, Loew D, Goyffon M, Fehlbaum P, Hoffmann JA, van Dorsselaer A, Bulet P.##Mandard N, Sy D, Maufrais C, Bonmatin JM, Bulet P, Hetru C, Vovelle F.##Silva PI Jr, Daffre S, Bulet P.	Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood.##Androctonin, a novel antimicrobial peptide from scorpion Androctonus australis: solution structure and molecular dynamics simulations in the presence of a lipid monolayer.##Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N2
DRAMP02753	GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ	30	Ponericin G1 (ants, insects, animals)	P82414	Not found	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		MOA: The comparison of ponericins with those well-studied peptides suggests that ponericins may adopt an amphipathic alpha-helical structure on cell membranes.	B. cereus CIP 6624a, Bacillus megaterium ATCC 9885b, B.stearothermophilus CIP 675, B.stearothermophilus CIP 675, Bacillus subtilis ATCC 6623, Enterococcus faecalis CIP 636, Lactococcus lactis ssp. cremoris I116, Streptococcus pyogenes CIP 561, S. sanguinis CIP 55128, Listeria ivanovii LMA 94d, Listeria monocytogenes ATCC 15313, Micrococcus luteus CIP 5345, Staphylococcus aureus CIP 677, Staphylococcus aureus LMA, S. epidermidis CIP 53134, Escherichia coli, Enterobacter cloacae CIP 6085, Klebsiella pneumoniae CIP 8291, Proteus mirabilis LMA TP, Salmonella enterica CIP 813, Serratia marcescens LMA TP, Alcaligenes faecalis CIP 6723, Pseudomonas aeruginosa CIP A22, Proteus mirabilis LMA TP, Flavobacterium meningosepticum CIP 6057, Pseudomonas aeruginosa CIP A22, Yersinia entericolitica CIP 6529, P. putida LMA, Saccharomyces cerevisiae LMA 720	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chafotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02754	GWKDWLKKGKEWLKAKGPGIVKAALQAATQ	30	Ponericin G2 (ants, insects, animals)	P82415	Not found	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		MOA: The comparison of ponericins with those well-studied peptides suggests that ponericins may adopt an amphipathic alpha-helical structure on cell membranes.	Saccharomyces cerevisae	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chafotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02755	GWKDWLNKGKEWLKKKGPGIMKAALKAATQ	30	Ponericin G3 (ants, insects, animals)	P82416	Not found	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		MOA: The comparison of ponericins with those well-studied peptides suggests that ponericins may adopt an amphipathic alpha-helical structure on cell membranes.	Gram-positive bacteria: Bacillus cereus CIP 6624a, B. megaterium ATCC 9885b, B. stearothermophilus CIP 675, B. stearothermophilus CIP 675, B. subtilis ATCC 6623, Enterococcus faecalis CIP 636, Lactococcus lactis ssp. cremoris I116, Streptococcus pyogenes CIP 561, S. sanguinis CIP 55128, Listeria ivanovii LMA 94d, Listeria monocytogenes ATCC 15313, Micrococcus luteus CIP 5345, Staphylococcus aureus CIP 677, Staphylococcus aureus LMA, S. epidermidis CIP 53134;##Gram-negative bacteria: Escherichia coli, Enterobacter cloacae CIP 6085, Klebsiella pneumoniae CIP 8291, Proteus mirabilis LMA TP, Salmonella enterica CIP 813, Serratia marcescens LMA TP, Alcaligenes faecalis CIP 6723, Pseudomonas aeruginosa CIP A22, Proteus mirabilis LMA TP, Flavobacterium meningosepticum CIP 6057, Pseudomonas aeruginosa CIP A22, Yersinia entericolitica CIP 6529, P. putida LMA, Saccharomyces cerevisiae LMA 720.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chafotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02756	DFKDWMKTAGEWLKKKGPGILKAAMAAAT	29	Ponericin G4 (ants, insects, animals)	P82417	Not found	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		MOA: The comparison of ponericins with those well-studied peptides suggests that ponericins may adopt an amphipathic alpha-helical structure on cell membranes.	Gram-positive bacteria: B. cereus CIP 6624a, Bacillus megaterium ATCC 9885b, B.stearothermophilus CIP 675, B.stearothermophilus CIP 675, Bacillus subtilis ATCC 6623, Lactococcus lactis ssp. cremoris I116, Streptococcus pyogenes CIP 561, S. sanguinis CIP 55128, Micrococcus luteus CIP 5345;##Gram-negative bacteria: Klebsiella pneumoniae CIP 8291, Pseudomonas aeruginosa CIP A22, Saccharomyces cerevisae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chafotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02757	GLKDWVKIAGGWLKKKGPGILKAAMAAATQ	30	Ponericin G5 (ants, insects, animals)	P82418	Not found	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the venom gland."	[Swiss_Prot Entry P82418]has antibacterial activity	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chafotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02758	GLVDVLGKVGGLIKKLLP	18	Ponericin G6 (ants, insects, animals)	P82419	Not found	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has activity against Gram-positive bacteria and S. cerevisiae. Has non-hemolytic activity.
Tissue specificity: Expressed by the venom gland."	[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a, B. megaterium ATCC 9885b, B. stearothermophilus CIP 675, B. stearothermophilus CIP 675, B. subtilis ATCC 6623, Lactococcus lactis ssp. cremoris I116, Streptococcus pyogenes CIP 561, S. sanguinis CIP 55128, Listeria monocytogenes ATCC 15313, Micrococcus luteus CIP 5345, Staphylococcus aureus CIP 677, S. epidermidis CIP 53134;##Gram-negative bacteria: Klebsiella pneumoniae CIP 8291, Pseudomonas aeruginosa CIP A22, Saccharomyces cerevisiae LMA 720.	[Ref.11279030]Non-hemolytic activity against horse and sheep erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chafotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02759	GLVDVLGKVGGLIKKLLPG	19	Ponericin G7 (ants, insects, animals)	P82420	Not found	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Function: Has activity against Gram-positive bacteria and S. cerevisiae. Tissue specificity: Expressed by the venom gland.	[Swiss_Prot Entry P82420]has activity against Gram-positive bacteria and S.cerevisiae	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chafotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02760	LLKELWTKMKGAGKAVLGKIKGLL	24	Ponericin-L1 (ants, insects, animals)	P82421	Not found	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the venom gland."	[Swiss_Prot Entry P82421]Broad spectrum of activity against both Gram-positive and Gram-negative bacteria	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02761	LLKELWTKIKGAGKAVLGKIKGLL	24	Ponericin-L2 (ants, insects, animals)	P82422	Not found	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiviral	Protein level	Alpha helix 	Not found		"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria. 
Tissue specificity: Expressed by the venom gland."	[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 6.5mm), B. megaterium ATCC 9885b(Inhibition zone = 14mm), B. stearothermophilus CIP 675(Inhibition zone = 21mm), B. subtilis ATCC 6623(Inhibition zone = 13.5mm), Enterococcus faecalis CIP 636(Inhibition zone = 4mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 15.5mm), Streptococcus pyogenes CIP 561(Inhibition zone = 12.5mm), S. sanguinis CIP 55128(Inhibition zone = 6mm), Listeria ivanovii LMA 94d(Inhibition zone = 9.5mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 9.5mm), Micrococcus luteus CIP 5345(Inhibition zone = 10.5mm), Staphylococcus aureus CIP 677(Inhibition zone = 4.5mm), Staphylococcus aureus LMA(Inhibition zone = 11mm), S. epidermidis CIP 53134(Inhibition zone = 11.5mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 4mm), Enterobacter cloacae CIP 6085(Inhibition zone = 5mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 3.5mm), Proteus mirabilis LMA TP(Inhibition zone = 9mm), Salmonella enterica CIP 813(Inhibition zone = 1.5mm), Serratia marcescens LMA TP(Inhibition zone = 9mm), Flavobacterium meningosepticum CIP 6057(Inhibition zone = 7mm), Pseudomonas aeruginosa CIP A22(Inhibition zone = 14mm).	[Ref.11279030]Not found	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02762	WLGSALKIGAKLLPSVVGLFKKKKQ	25	Ponericin-W1 (ants, insects, animals)	P82423	Belongs to the ponericin-W family	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal, Antifungal	Protein level	Not found	Not found		"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities. 
Tissue specificity: Expressed by the venom gland."	[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 10mm), B. megaterium ATCC 9885b(Inhibition zone = 12.5mm), B. stearothermophilus CIP 675(Inhibition zone = 17mm), B. subtilis ATCC 6623(Inhibition zone = 12mm), Enterococcus faecalis CIP 636(Inhibition zone = 6mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 15mm), Streptococcus pyogenes CIP 561(Inhibition zone = 10mm), S. sanguinis CIP 55128(Inhibition zone = 7.5mm), Listeria ivanovii LMA 94d(Inhibition zone = 11.5mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 9.5mm), Micrococcus luteus CIP 5345(Inhibition zone = 11.5mm), Staphylococcus aureus CIP 677(Inhibition zone = 10mm), Staphylococcus aureus LMA(Inhibition zone = 13.5mm), S. epidermidis CIP 53134(Inhibition zone = 13.5mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 8mm), Enterobacter cloacae CIP 6085(Inhibition zone = 3mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 6.5mm), Proteus mirabilis LMA TP(no detected), Salmonella enterica CIP 813(Inhibition zone = 3mm), Serratia marcescens LMA TP(no detected), Flavobacterium meningosepticum CIP 6057(Inhibition zone = 6mm), Pseudomonas aeruginosa CIP A22(Inhibition zone = 16mm).	[Ref.11279030]2mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent)	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02763	WLGSALKIGAKLLPSVVGLFQKKKK	25	Ponericin-W2 (ants, insects, animals)	P82424	Belongs to the ponericin-W family	Not found	Pachycondyla goeldii (Ponerine ant)	Antibacterial, Antifungal, Insecticidal, Antimicrobial	Protein level	Not found	Not found		"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria. Has insecticidal activities. 
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02764	GIWGTLAKIGIKAVPRVISMLKKKKQ	26	Ponericin-W3 (ants, insects, animals)	P82425	Not found	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal, Antifungal	Protein level	Not found	Not found		"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities. 
Tissue specificity: Expressed by the venom gland."	[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 10mm), B. megaterium ATCC 9885b(Inhibition zone = 13.5mm), B. stearothermophilus CIP 675(Inhibition zone = 17mm), B. subtilis ATCC 6623(Inhibition zone = 13mm), Enterococcus faecalis CIP 636(Inhibition zone = 8mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 17.5mm), Streptococcus pyogenes CIP 561(Inhibition zone = 11.5mm), S. sanguinis CIP 55128(Inhibition zone = 10mm), Listeria ivanovii LMA 94d(Inhibition zone = 14mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 11mm), Micrococcus luteus CIP 5345(Inhibition zone = 11mm), Staphylococcus aureus CIP 677(Inhibition zone = 13mm), Staphylococcus aureus LMA(Inhibition zone = 18mm), S. epidermidis CIP 53134(Inhibition zone = 15mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 10mm), Enterobacter cloacae CIP 6085(Inhibition zone = 4mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 7.5mm), Proteus mirabilis LMA TP(no detected), Salmonella enterica CIP 813(Inhibition zone = 4mm), Serratia marcescens LMA TP(Inhibition zone = 11mm), Flavobacterium meningosepticum CIP 6057(no detected), Pseudomonas aeruginosa CIP A22(Inhibition zone = 18.5mm).	[Ref.11279030]1mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent)	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02765	GIWGTALKWGVKLLPKLVGMAQTKKQ	26	Ponericin-W4 (ants, insects, animals)	P82426	Not found	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal, Antifungal	Protein level	Not found	Not found		"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities. 
Tissue specificity: Expressed by the venom gland."	[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 8.5mm), B. megaterium ATCC 9885b(Inhibition zone = 13.5mm), B. stearothermophilus CIP 675(Inhibition zone = 18mm), B. subtilis ATCC 6623(Inhibition zone = 13mm), Enterococcus faecalis CIP 636(Inhibition zone = 3mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 14mm), Streptococcus pyogenes CIP 561(Inhibition zone = 8mm), S. sanguinis CIP 55128(Inhibition zone = 7mm), Listeria ivanovii LMA 94d(Inhibition zone = 10mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 10mm), Micrococcus luteus CIP 5345(Inhibition zone = 12.5mm), Staphylococcus aureus CIP 677(Inhibition zone = 11.5mm), Staphylococcus aureus LMA(Inhibition zone = 13.5mm), S. epidermidis CIP 53134(Inhibition zone = 11.5mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 8.5mm), Enterobacter cloacae CIP 6085(Inhibition zone = 16.5mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 9mm), Proteus mirabilis LMA TP(no detected), Salmonella enterica CIP 813(no detected), Serratia marcescens LMA TP(Inhibition zone = 13mm), Flavobacterium meningosepticum CIP 6057(no detected), Pseudomonas aeruginosa CIP A22(Inhibition zone = 17mm).	[Ref.11279030]2mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent)	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02766	FWGALIKGAAKLIPSVVGLFKKKQ	24	Ponericin-W5 (ants, insects, animals)	P82427	Belongs to the ponericin-W family	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal, Antifungal	Protein level	Not found	Not found		"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities. 
Tissue specificity: Expressed by the venom gland."	[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 7mm), B. megaterium ATCC 9885b(Inhibition zone = 12mm), B. stearothermophilus CIP 675(Inhibition zone = 17mm), B. subtilis ATCC 6623(Inhibition zone = 13mm), Enterococcus faecalis CIP 636(Inhibition zone = 3mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 11mm), Streptococcus pyogenes CIP 561(Inhibition zone = 6.5mm), S. sanguinis CIP 55128(Inhibition zone = 4.5mm), Listeria ivanovii LMA 94d(Inhibition zone = 8mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 6.5mm), Micrococcus luteus CIP 5345(Inhibition zone = 11mm), Staphylococcus aureus CIP 677(Inhibition zone = 7.5mm), Staphylococcus aureus LMA(Inhibition zone = 9mm), S. epidermidis CIP 53134(Inhibition zone = 7.5mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 3mm), Enterobacter cloacae CIP 6085(Inhibition zone = 11mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 6.5mm), Proteus mirabilis LMA TP(no detected), Salmonella enterica CIP 813(no detected), Serratia marcescens LMA TP(Inhibition zone = 11mm), Flavobacterium meningosepticum CIP 6057(Inhibition zone = 5mm), Pseudomonas aeruginosa CIP A22(Inhibition zone = 14mm).	[Ref.11279030]4mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent)	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02767	FIGTALGIASAIPAIVKLFK	20	Ponericin-W6 (ants, insects, animals)	P82428	Not found	Not found	Pachycondyla goeldii (Ponerine ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Activity against Gram-positive bacteria. Has insecticidal and hemolytic activities.
Tissue specificity: Expressed by the venom gland."	[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 9.5mm), B. megaterium ATCC 9885b(Inhibition zone = 17mm), B. stearothermophilus CIP 675(Inhibition zone = 18mm), B. subtilis ATCC 6623(Inhibition zone = 15mm), Enterococcus faecalis CIP 636(Inhibition zone = 3mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 11mm), Streptococcus pyogenes CIP 561(Inhibition zone = 9.5mm), S. sanguinis CIP 55128(Inhibition zone = 4mm), Listeria ivanovii LMA 94d(Inhibition zone = 5mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 4mm), Micrococcus luteus CIP 5345(Inhibition zone = 11mm), Staphylococcus aureus CIP 677(Inhibition zone = 7mm), Staphylococcus aureus LMA(Inhibition zone = 10mm), S. epidermidis CIP 53134(Inhibition zone = 7mm);##Gram-negative bacteria: Serratia marcescens LMA TP(Inhibition zone = 13mm), Pseudomonas aeruginosa CIP A22(Inhibition zone = 14mm).	[Ref.11279030]3mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent)	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11279030	J. Biol. Chem. 2001; 276: 17823-17829.	Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.	Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.	
DRAMP02769	GLLSKFGRLARKLARVIPKV	20	Pilosulin 2 (ants, insects, animals)	No entry found	Not found	Not found	Not found	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9813247	Arch Biochem Biophys. 2005 Feb 15;434(2):358-364.	Zelezetsky I, Pag U, Antcheva N, Sahl HG, Tossi A.	Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin.	
DRAMP02770	IIGLVSKGTCVLVKTVCKKVLKQG	24	Pilosulin 3 (ants, insects, animals)	Q68Y23	Belongs to the pilosulin family	Not found	Myrmecia banksi (Jack jumper ant) (Australian jumper ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		"Function: Shows moderate activity against E. coli and S. aureus (MIC<25 µM), slight activity against B. subtilis (MIC<50 µM), and no activity against L. garvieae, P. aeruginosa, C. albicans, and S. cerevisiae. Has no hemolytic nor cytolytic activity. Causes an IgE-independent histamine release. 
Tissue specificity: Expressed by the venom gland."	[Ref.15246874]Gram-negative bacteria: Escherichia coli (MIC<25 µM);##Gram-positive bacteria: Staphylococcus aureus(MIC<25 µM), Bacillus subtilis (MIC<50 µM).	[Ref.15246874]Non-hemolytic activity at 50 μM against human whole blood	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	IgE	15246874	Arch Biochem Biophys. 2004 Aug 15;428(2):170-178.	Inagaki H, Akagi M, Imai HT, Taylor RW, Kubo T.	Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia.	
DRAMP02771	FDITKLNIKKLTKATCKVISKGASMCKVLFDKKKQE	36	Pilosulin 4 (ants, insects, animals)	Q68Y22	Belongs to the pilosulin family	Not found	Myrmecia banksi (Jack jumper ant) (Australian jumper ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		"Function: Shows activity against E.coli and S.aureus, moderate activity against P.aeruginosa, weak activity against B.subtilis, and has no effect against L.garvieae, C.albicans, and S.cerevisiae. Has no hemolytic nor cytolytic activity. Causes an IgE-independent histamine release. 
Tissue specificity: Expressed by the venom gland."	[Ref.15246874]Gram-positive bacteria: Staphylococcus aureus (MIC<6.25 µM), Bacillus subtilis (MIC<50 µM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC<25 µM), Escherichia coli (MIC<6.25 µM).	[Ref.15246874]Non-hemolytic activity at 50 μM against human whole blood	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	 IgE 	15246874	Arch Biochem Biophys. 2004 Aug 15;428(2):170-178.	Inagaki H, Akagi M, Imai HT, Taylor RW, Kubo T.	Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 5, from a species of the Australian ant genus Myrmecia.	
DRAMP02772	IDWKKVDWKKVSKKTCKVMLKACKFL	26	Pilosulin-3a (Allergen Myr p II; Pilosulin-2; ants, insects, animals)	Q26464	Not found	Not found	Myrmecia pilosula (Jack jumper ant) (Australian jumper ant)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Has hemolytic activity.
Tissue specificity: Expressed by the venom gland.
Allergenic properties: Causes an allergic reaction in human.
PTM: Contains one disulfide bond and C-terminal amidation."	No MICs found in DRAMP database	[Ref.15639237]15% hemolytic activity at 10 μM, 40% hemolytic activity at 100 μM against human erythrocytes.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	IgE	15639237##8866004	Toxicon. 2004 Feb;43(2):173-183.##Biochem Mol Biol Int. 1996 Aug;39(5):877-885.	Davies NW, Wiese MD, Brown SG.##Donovan GR, Street MD, Tetaz T, Smith AI, Alewood D, Alewood P, Sutherland SK, Baldo BA.	Characterisation of major peptides in 'jack jumper' ant venom by mass spectrometry.##Expression of jumper ant (Myrmecia pilosula) venom allergens: post-translational processing of allergen gene products.	
DRAMP02773	DVKGMKKAIKGILDCVIEKGYDKLAAKLKKVIQQLWE	37	Pilosulin 5 (Myr b III; ants, insects, animals)	A9CM07	Not found	Myrb5	Myrmecia banksi (Jack jumper ant) (Australian jumper ant)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Causes a significant and dose-dependent histamine release, probably by influencing the signal transduction of mast cells through a non-IgE-mediated pathway. This peptide does not have cytotoxic activities.
Subunit structure: Homodimer; disulfide-linked.
Tissue specificity: Expressed by the venom gland.
PTM: Contains one disulfide bond."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18544336##16376960	Arch Biochem Biophys. 2008 Sep 15;477(2):411-416.##Toxicon. 2006 Feb;47(2):208-217.	Inagaki H, Akagi M, Imai HT, Taylor RW, Wiese MD, Davies NW, Kubo T.##Wiese MD, Chataway TK, Davies NW, Milne RW, Brown SG, Gai WP, Heddle RJ.	Pilosulin 5, a novel histamine-releasing peptide of the Australian ant, Myrmecia pilosula (Jack Jumper Ant).##Proteomic analysis of Myrmecia pilosula (jack jumper) ant venom.	
DRAMP02775	CIANRNGCQPDGSQGNCCSGYCHKEPGWVAGYCR	34	Antimicrobial peptide Alo-2 (Alo-2; knottin-type peptide; Insects, animals)	P83652	Belongs to the AMP family	Not found	Acrocinus longimanus (Giant harlequin beetle)	Antimicrobial, Antifungal	Protein level	Bridge	Not found		"Function: Has antifungal activity against C. glabrata.
Domain: The presence of a disulfide through disulfide knot' structurally defines this protein as a knottin.
PTM: Contains three disulfide bonds 1-18; 8-22; 17-33."	Fungi: Candida glabrata patient 1 (MIC>64 µg/mL), C. albicans IHEM 8060 (MIC>64 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14661954	Biochemistry. 2003 Dec 16;42(49):14434-14442.	Barbault F, Landon C, Guenneugues M, Meyer JP, Schott V, Dimarcq JL, Vovelle F.	Solution structure of Alo-3: a new knottin-type antifungal peptide from the insect Acrocinus longimanus.	
DRAMP02781	SLQGGAPNFPQPSQQNGGWQVSPDLGRDDKGNTRGQIEIQNKGKDHDFNAGWGKVIRGPNKAKPTWHVGGTYRR	74	Coleoptericin (Insects, animals)	P80032	Belongs to the coleoptericin family	Not found	Zophobas atratus (Giant mealworm beetle) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Responsible for the anti Gram-negative activity of immune hemolymph of Z. atratus.	Gram-negative bacteria: Escherichia coli D31, E. coli D22 (highly activity), Acinetobacter baumannii, Pseudomonas maltophilia (lower activity);##Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1761552	J Biol Chem. 1991 Dec 25;266(36):24520-24525.	Bulet P, Cociancich S, Dimarcq JL, Lambert J, Reichhart JM, Hoffmann D, Hetru C, Hoffmann JA.	Insect immunity. Isolation from a coleopteran insect of a novel inducible antibacterial peptide and of new members of the insect defensin family.	
DRAMP02782	FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR	43	Defensin, isoforms B and C (Insects, animals)	P80033	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Zophobas atratus (Giant mealworm beetle) 	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		Function: Involved in anti Gram-positive activity of immune hemolymph of Z. atratus.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1761552	J Biol Chem. 1991 Dec 25;266(36):24520-24525.	Bulet P, Cociancich S, Dimarcq JL, Lambert J, Reichhart JM, Hoffmann D, Hetru C, Hoffmann JA.	Insect immunity. Isolation from a coleopteran insect of a novel inducible antibacterial peptide and of new members of the insect defensin family.	
DRAMP02783	FTCDVLGFEIAGTKLNSAACGAHCLALGRTGGYCNSKSVCVCR	43	Peptide C (Insects, animals)	No entry found	Not found	Not found	Zophobas atratus (Giant mealworm beetle) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli D22;##Gram-positive bacteria: Micrococcus luteus, Corynebacterium D2, Streptococcus pyogenes, Bacillus subtilis QB935.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1761552	J Biol Chem. 1991 Dec 25;266(36):24520-24525.	Bulet P, Cociancich S, Dimarcq JL, Lambert J, Reichhart JM, Hoffmann D, Hetru C, Hoffmann JA.	Insect immunity. Isolation from a coleopteran insect of a novel inducible antibacterial peptide and of new members of the insect defensin family.	
DRAMP02784	SLQPGAPNVNNKDQPWQVSPHISRDDSGNTRTDINVQRHGENNDFEAGWSKVVRGPNKAKPTWHIGGTHRW	71	Acaloleptin-A1 (chain of Acaloleptin A; Insects, animals)	P81592, Q76K70	Belongs to the coleoptericin family	Not found	Acalolepta luxuriosa (Udo longhorn beetle)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Acaloleptins A1 show antibacterial activity against Gram-negative bacteria but not against Gram-positive bacteria.
Tissue specificity: Hemolymph (at protein level). Larval fat body.
Induction: By bacterial infection. Expression detected 2 hours post-injection, with expression increasing until 48 hours post-injection and remaining considerably high at least until 72 hours post-injection."	Gram-negative bacteria: Escherichia coli, Aeromonas hydrophila, Erwinia persicinus, Serratia marcescens, Aeromonas hydrophila. 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10077828##19527748	Arch Insect Biochem Physiol. 1999;40(2):88-98.##Dev Comp Immunol. 2009 Oct;33(10):1120-1127. 	Imamura M, Wada S, Koizumi N, Kadotani T, Yaoi K, Sato R, Iwahana H.##Imamura M, Wada S, Ueda K, Saito A, Koizumi N, Iwahana H, Sato R.	Acaloleptins A: inducible antibacterial peptides from larvae of the beetle, Acalolepta luxuriosa.##Multipeptide precursor structure of acaloleptin A isoforms, antibacterial peptides from the Udo longicorn beetle, Acalolepta luxuriosa.	
DRAMP02785	SLQPGAPNINNKDQPWQVSPHISRDDNGNTRTNINVQRHGENNDFEAGWSKVVRGPNKAKPTWHIGGTHRW	71	Acaloleptin-A2 (chain of Acaloleptin A; Insects, animals)	P81592, Q76K70	Belongs to the coleoptericin family	Not found	Acalolepta luxuriosa (Udo longhorn beetle)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Acaloleptins A2 show antibacterial activity against Gram-negative bacteria but not against Gram-positive bacteria.
Induction: By bacterial infection. Expression detected 2 hours post-injection, with expression increasing until 48 hours post-injection and remaining considerably high at least until 72 hours post-injection."	Gram-negative bacteria: Escherichia coli, Aeromonas hydrophila, Erwinia persicinus, Serratia marcescens, Aeromonas hydrophila. 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10077828##19527748	Arch Insect Biochem Physiol. 1999;40(2):88-98.##Dev Comp Immunol. 2009 Oct;33(10):1120-1127. 	Imamura M, Wada S, Koizumi N, Kadotani T, Yaoi K, Sato R, Iwahana H.##Imamura M, Wada S, Ueda K, Saito A, Koizumi N, Iwahana H, Sato R.	Acaloleptins A: inducible antibacterial peptides from larvae of the beetle, Acalolepta luxuriosa.##Multipeptide precursor structure of acaloleptin A isoforms, antibacterial peptides from the Udo longicorn beetle, Acalolepta luxuriosa.	
DRAMP02786	SLQPGAPNVNNKDQPWQVSPHISRDDSGNTRTNINVQRHGENNDFEAGWSKVVRGPNKAKPTWHIGGTHRW	71	Acaloleptin-A3 (chain of Acaloleptin A; Insects, animals)	P81592, Q76K70	Belongs to the coleoptericin family	Not found	Acalolepta luxuriosa (Udo longhorn beetle)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Acaloleptins A3 show antibacterial activity against Gram-negative bacteria but not against Gram-positive bacteria.
Induction: By bacterial infection. Expression detected 2 hours post-injection, with expression increasing until 48 hours post-injection and remaining considerably high at least until 72 hours post-injection."	Gram-negative bacteria: Escherichia coli, Aeromonas hydrophila, Erwinia persicinus, Serratia marcescens, Aeromonas hydrophila. 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10077828##19527748	Arch Insect Biochem Physiol. 1999;40(2):88-98.##Dev Comp Immunol. 2009 Oct;33(10):1120-1127. 	Imamura M, Wada S, Koizumi N, Kadotani T, Yaoi K, Sato R, Iwahana H.##Imamura M, Wada S, Ueda K, Saito A, Koizumi N, Iwahana H, Sato R.	Acaloleptins A: inducible antibacterial peptides from larvae of the beetle, Acalolepta luxuriosa.##Multipeptide precursor structure of acaloleptin A isoforms, antibacterial peptides from the Udo longicorn beetle, Acalolepta luxuriosa.	
DRAMP02787	SLQPGAPNVNNKDQPWQVSPHISRDDSGNTNTDINLQRHGENHDFDAGWSKVVRGPNKAKPTWHVGGTYRW	71	Acaloleptin-A4 (chain of Acaloleptin A; Insects, animals)	P81592, Q76K70	Belongs to the coleoptericin family	Not found	Acalolepta luxuriosa (Udo longhorn beetle)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Acaloleptins A4 show antibacterial activity against Gram-negative bacteria but not against Gram-positive bacteria.
Induction: By bacterial infection. Expression detected 2 hours post-injection, with expression increasing until 48 hours post-injection and remaining considerably high at least until 72 hours post-injection."	Gram-negative bacteria: Escherichia coli, Aeromonas hydrophila, Erwinia persicinus, Serratia marcescens, Aeromonas hydrophila. 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10077828##19527748	Arch Insect Biochem Physiol. 1999;40(2):88-98.##Dev Comp Immunol. 2009 Oct;33(10):1120-1127. 	Imamura M, Wada S, Koizumi N, Kadotani T, Yaoi K, Sato R, Iwahana H.##Imamura M, Wada S, Ueda K, Saito A, Koizumi N, Iwahana H, Sato R.	Acaloleptins A: inducible antibacterial peptides from larvae of the beetle, Acalolepta luxuriosa.##Multipeptide precursor structure of acaloleptin A isoforms, antibacterial peptides from the Udo longicorn beetle, Acalolepta luxuriosa.	
DRAMP02788	SDDEDEEEEEDQPWQLNPNIARGDDGNTRADVNIKRRGENHDFEAGWSKVVDGPDRAKPTWHVGGTFRW	69	Acaloleptin-A5 (chain of Acaloleptin A; Insects, animals)	P81592, Q76K70	Belongs to the coleoptericin family	Not found	Acalolepta luxuriosa (Udo longhorn beetle)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		"Function: Acaloleptin A5 shows antibacterial activity against Gram-positive bacteria but not against Gram-negative bacteria, and may also have antifungal activity.
Induction: By bacterial infection. Expression detected 2 hours post-injection, with expression increasing until 48 hours post-injection and remaining considerably high at least until 72 hours post-injection."	Gram-negative bacteria: Escherichia coli, Aeromonas hydrophila, Erwinia persicinus, Serratia marcescens, Aeromonas hydrophila. 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10077828##19527748	Arch Insect Biochem Physiol. 1999;40(2):88-98.##Dev Comp Immunol. 2009 Oct;33(10):1120-1127. 	Imamura M, Wada S, Koizumi N, Kadotani T, Yaoi K, Sato R, Iwahana H.##Imamura M, Wada S, Ueda K, Saito A, Koizumi N, Iwahana H, Sato R.	Acaloleptins A: inducible antibacterial peptides from larvae of the beetle, Acalolepta luxuriosa.##Multipeptide precursor structure of acaloleptin A isoforms, antibacterial peptides from the Udo longicorn beetle, Acalolepta luxuriosa.	
DRAMP02789	VTCDILSVEAKGVKLNDAACAAHCLFRGRSGGYCNGKRVCVCR	43	Tenecin-1 (Insects, animals)	Q27023	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Tenebrio molitor (Yellow mealworm beetle)	Antimicrobial, Antibacterial	Protein level	Bridge 	Not found		"Function: Bactericidal protein produced in response to injury. It is cytotoxic to Gram-positive bacteria.
PTM: Contains three disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7798186	J. Biochem. 1994; 116:53-58	Moon HJ, Lee SY, Kurata S, Natori S, Lee BL.	Purification and molecular cloning of cDNA for an inducible antibacterial protein from larvae of the coleopteran, Tenebrio molitor.	
DRAMP02790	DHHDGHLGGHQTGHQGGQQGGHLGGQQGGHLGGHQGGQPGGHLGGHQGGIGGTGGQQHGQHGPGTGAGHQGGYKTHGH	78	Tenecin-3 (Insects, animals)	Q27270	Not found	Not found	Tenebrio molitor (Yellow mealworm beetle)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Antifungal heat stable protein produced in response to injury. It is active against C.albicans. No antibacterial activity against Gram-positive and Gram-negative bacteria.
Developmental stage: Highest expression in larvae and adult. To a much lesser extent in pupae."	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8573176##PubMed ID is not available	Biochem Biophys Res Commun. 1996 Jan 5;218(1):6-11.##Mol. Cells 1995;5:287-292.	Lee YJ, Chung TJ, Park CW, Hahn Y, Chung JH, Lee BL, Han DM, Jung YH, Kim S, Lee Y.##Jung HY, Park BY, Lee DK, Hahn Y, Chung JH, Han DM, Moon HJ, Lee BL, Lee Y.	Structure and expression of the tenecin 3 gene in Tenebrio molitor.##Biochemical and molecular characterization of an antifungal protein from Tenebrio molitor larvae.	
DRAMP02791	VTCDLLSFEAKGFAANHSLCAAHCLAIGRRGGSCERGVCICRR	43	A.dichotoma defensin (defensins; Insects, animals)	Q10745	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Allomyrina dichotoma (Japanese rhinoceros beetle)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Bridge	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus, Bacillus subtilis, Staphylococcus aureus (MRSA).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8607799	Biochem Biophys Res Commun. 1996 Mar 27;220(3):526-531.	Miyanoshita A, Hara S, Sugiyama M, Asaoka A, Taniai K, Yukuhiro F, Yamakawa M.	Isolation and characterization of a new member of the insect defensin family from a beetle, Allomyrina dichotoma.	
DRAMP02792	ELPKLPDDKVLIRSRSNCPKGKVWNGFDCKSPFAFS	36	Scarabaecin, major form (Insects, animals)	Q86SC0	Not found	scar	Oryctes rhinoceros (Coconut rhinoceros beetle)	Antimicrobial, Antibacterial, Antifungal	Protein level	Combine helix and strand structure	The solution structure consists of a two-stranded antiparallel beta-sheet connected by a type-I beta-turn after a short helical turn. All secondary structures and a conserved disulfide bond are located in the C-terminal half of the peptide, residues 18-36. Overall folding is stabilized by a combination of a disulfide bond, seven hydrogen bonds, and numerous hydrophobic interactions.(Ref.2)	1IYC resolved by NMR.	Comment: No comments found on DRAMP database	Fungi: P. oryzae (IC50=16 µM), R. solani (IC50=32 µM), Botrytis cinerea (IC50=4 µM), S.tritici (IC50=16 µM), P. syringae pv.mori S6804 (IC50=25 µM); And Staphylococcus aureus, B. bassiana (weak activity).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	12859949##12676931	Biochem Biophys Res Commun. 2003 Jul 25;307(2):261-266.##J Biol Chem. 2003 Jun 20;278(25):22820-22827.	Tomie T, Ishibashi J, Furukawa S, Kobayashi S, Sawahata R, Asaoka A, Tagawa M, Yamakawa M.##Hemmi H, Ishibashi J, Tomie T, Yamakawa M.	Scarabaecin, a novel cysteine-containing antifungal peptide from the rhinoceros beetle, Oryctes rhinoceros.##Structural basis for new pattern of conserved amino acid residues related to chitin-binding in the antifungal peptide from the coconut rhinoceros beetle Oryctes rhinoceros.	
DRAMP02793	MQKLAEAIAAAVSAGQDKDWGKMGTSIVGIVENGITVLGKIFGF	44	Antibacterial protein1 (Gonococcal growth inhibitor I)	P11697	Belongs to the staphylococcal hemolytic protein family	Not found	Staphylococcus haemolyticus	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Has haemolytic activity.	Gonococci	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3138972	Biochem J. 1988 May 15;252(1):87-93.	Watson DC, Yaguchi M, Bisaillon JG, Beaudet R, Morosoli R.	The amino acid sequence of a gonococcal growth inhibitor from Staphylococcus haemolyticus.	
DRAMP02794	MEKIANAVKSAIEAGQNQDWTKLGTSILDIVSNGVTELSKIFGF	44	Antibacterial protein 2 (Gonococcal growth inhibitor II)	P11698	Belongs to the staphylococcal hemolytic protein family	Not found	Staphylococcus haemolyticus	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Has haemolytic activity.	Gonococci	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3138972	Biochem J. 1988 May 15;252(1):87-93.	Watson DC, Yaguchi M, Bisaillon JG, Beaudet R, Morosoli R.	The amino acid sequence of a gonococcal growth inhibitor from Staphylococcus haemolyticus.	
DRAMP02795	MSKLVQAISDAVQAQQNQDWAKLGTSIVGIVENGVGILGKLFGF	44	Antibacterial protein 3 (Gonococcal growth inhibitor III)	P11699	Belongs to the staphylococcal hemolytic protein family	Not found	Staphylococcus haemolyticus (strain JCSC1435)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Has haemolytic activity.	Gonococci	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3138972	Biochem J. 1988 May 15;252(1):87-93.	Watson DC, Yaguchi M, Bisaillon JG, Beaudet R, Morosoli R.	The amino acid sequence of a gonococcal growth inhibitor from Staphylococcus haemolyticus.	
DRAMP02796	ATCDILSFQSQWVTPNHAGCALHCVIKGYKGGQCKITVCHCRR	43	Defensin (Type 1 invertebrate defensin; Insects, animals)	P37364, P80308	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Pyrrhocoris apterus (Sap sucking bug)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Bridge	Not found		"Function: Has antibacterial activity against Gram-positive bacteria and the Gram-negative bacterium E.coli D22.
PTM: Contains three disulfide bonds 3-34; 20-39; 24-41 (By similarity)."	Gram-positive bacteria: Micrococcus luteus, Bacillus megaterium, Aerococcus viridans, Staphylococcus aureus, S. saprophyticus, Pediococcus acidilactici, Bacillus subtilis QB935, Escherichia coli D22.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8002963	Biochem J. 1994 Jun 1;300 (Pt 2):567-575.	Cociancich S, Dupont A, Hegy G, Lanot R, Holder F, Hetru C, Hoffmann JA, Bulet P.	Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus.	
DRAMP02797	GIINMLQKSYCKIRKGRCALLGCLPKEEQIGSCSVSGRKCCRKKK	45	Beta-defensin 103A (Defensin, beta 103; Defensin, beta 103A; houses, mammals, animals)	Q0W9P9	Belongs to the beta-defensin family	DEFB103A	Equus caballus (Horse)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Exhibits antimicrobial activity against Gram-positive and Gram-negative bacteria (By similarity).
PTM: Contains three disulfide bonds 11-40; 18-33; 23-41."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16723195	Gene. 2006 Jul 19;376(2):192-198.	Looft C, Paul S, Philipp U, Regenhard P, Kuiper H, Distl O, Chowdhary BP, Leeb T.	Sequence analysis of a 212 kb defensin gene cluster on ECA 27q17.	
DRAMP02798	GIACWSCRKILQKLEDLVGEQPNEATINEAASRVCRNLGLLRGACKKIMRTCLRLISRDILAGKKPQEVCVDIKLCKH	78	Antimicrobial peptide NK-lysin (houses, mammals, animals)	Q8HZQ3	Not found	NKL	Equus caballus (Horse)	Antimicrobial	Transcript level	Not found	Not found		"Function: May be an effector molecule of cytotoxic activity. Has antimicrobial activity.
PTM: Contains three disulfide bonds 4-76; 7-70; 35-45."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases	Davis E.G, Zhang G, Sang Y, Rush B.R, Ross C, Blecha F.	cDNA sequence of equine NK-lysin.	
DRAMP02799	DVQCGEGHFCHDQTCCRASQGGACCPYSQGVCCADQRHCCPVGF	44	Antimicrobial peptide eNAP-1 (houses, mammals, animals)	P80930	Belongs to the granulin family	Not found	Equus caballus (Horse)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has antimicrobial activity against Gram-negative and Gram-positive bacteria.
PTM: Contains two disulfide bonds 4-16; 10-26."	Streptococcus zooepidemicus, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1639474	Infect Immun. 1992 Aug;60(8):3065-3071.	Couto MA, Harwig SS, Cullor JS, Hughes JP, Lehrer RI.	Identification of eNAP-1, an antimicrobial peptide from equine neutrophils.	
DRAMP02800	EVERKHPLGGSRPGRCPTVPPGTFGHCACLCTGDASEPKGQKCCSN	46	Antimicrobial peptide eNAP-2 (houses, mammals, animals)	P56928	Not found	Not found	Equus caballus (Horse)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Selectively inactivates microbial serine proteases (subtilisin A and proteinase K) without inhibiting mammalian serine proteases (human neutrophil elastase, human cathepsin G and bovine pancreatic trypsin).	Streptococcus zooepidemicus, Escherichia coli, Pseudomonas aeruginosa.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1452336##8514405	Infect Immun. 1992 Dec;60(12):5042-5047.##Infect Immun. 1993 Jul;61(7):2991-2994.	Couto MA, Harwig SS, Cullor JS, Hughes JP, Lehrer RI.##Couto MA, Harwig SS, Lehrer RI.	eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes.##Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils.	
DRAMP02801	KVFERXELARTLKRLGLDGFRGVSLPNXVXLAR	33	Lysozyme C, spleen isozyme (1,4-beta-N-acetylmuramidase C; houses, mammals, animals)	P81710	Belongs to the glycosyl hydrolase 22 family	Not found	Equus caballus (Horse)	Antimicrobial	Protein level	Not found	Not found		"Function: Lysozymes have primarily a bacteriolytic function; those in tissues and body fluids are associated with the monocyte-macrophage system and enhance the activity of immunoagents By similarity.
Catalytic activity: Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins.
Miscellaneous: Lysozyme C is capable of both hydrolysis and transglycosylation; it shows also a slight esterase activity. It acts rapidly on both peptide-substituted and unsubstituted peptidoglycan, and slowly on chitin oligosaccharides By similarity."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8080284	Arch Biochem Biophys. 1994 Sep;313(2):360-366.	Grobler JA, Rao KR, Pervaiz S, Brew K.	Sequences of two highly divergent canine type c lysozymes: implications for the evolutionary origins of the lysozyme/alpha-lactalbumin superfamily.	
DRAMP02803	GCASRCKAKCAGRRCKGWASASFRGRCYCKCFRC	34	Mytilin-A (molluscas, animals)	P81612	Not found	Not found	Mytilus edulis (Blue mussel)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has antibacterial activity. It is active against the marine species Alteromonas carrageenovora, Pseudomonas alginovora and Cytophaga drobachiensis.	Gram-positive bacteria: Aerococcus viridans, Bacillus megaterium, Micrococcus luteus, Enterococcus faecalis, Staphylococcus aureus;##Gram-negative bacteria: Escherichia coli, Alteromonas carrageenovora, Pseudomonas alginovora, Cytophaga drobachiensis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8702979	J Biol Chem. 1996 Sep 6;271(36):21808-21813.	Charlet M, Chernysh S, Philippe H, Hetru C, Hoffmann JA, Bulet P.	Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis.	
DRAMP02804	GFGCPNDYPCHRHCKSIPGRYGGYCGGXHRLRCTC	35	Mytilus defensin-B (molluscas, animals)	P81611	Belongs to the invertebrate defensin family (Type 2 subfamily)	Not found	Mytilus edulis (Blue mussel)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		Function: Has antibacterial activity.	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8702979	J Biol Chem. 1996 Sep 6;271(36):21808-21813.	Charlet M, Chernysh S, Philippe H, Hetru C, Hoffmann JA, Bulet P.	Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis.	
DRAMP02805	SCASRCKGHCRARRCGYYVSVLYRGRCYCKCLRC	34	Mytilin-B (molluscas, animals)	P81613	Not found	Not found	Mytilus edulis (Blue mussel)	Antimicrobial, Antibacterial, Antiviral	Protein level	Combine helix and strand structure	Not found	2EEM resolved by NMR.	Function: Has antibacterial and antiviral activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8702979##17628674	J Biol Chem. 1996 Sep 6;271(36):21808-21813.##Dev Comp Immunol. 2008;32(3):227-238. 	Charlet M, Chernysh S, Philippe H, Hetru C, Hoffmann JA, Bulet P.##Roch P, Yang Y, Toubiana M, Aumelas A.	Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis.##NMR structure of mussel mytilin, and antiviral-antibacterial activities of derived synthetic peptides.	
DRAMP02806	GFGCPNDYPCHRHCKSIPGRXGGYCGGXHRLRCTCYR	37	Mytilus defensin-A (molluscas, animals)	P81610	Belongs to the invertebrate defensin family (Type 2 subfamily)	Not found	Mytilus edulis (Blue mussel)	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		"Function: Has antibacterial activity.
PTM: Contains three disulfide bonds (By similarity)."	Micrococcus luteus, Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8702979	J Biol Chem. 1996 Sep 6;271(36):21808-21813.	Charlet M, Chernysh S, Philippe H, Hetru C, Hoffmann JA, Bulet P.	Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis.	
DRAMP02807	DCCRKPFRKHCWDCTAGTPYYGYSTRNIFGCTC	33	Mytimycin (molluscas, animals)	P81614	Not found	Not found	Mytilus edulis (Blue mussel)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Fungi: Neurospora crassa, Fusarium culmorum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8702979	J Biol Chem. 1996 Sep 6;271(36):21808-21813.	Charlet M, Chernysh S, Philippe H, Hetru C, Hoffmann JA, Bulet P.	Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis.	
DRAMP02808	HSHACTSYWCGKFCGTASCTHYLCRVLHPGKMCACVHCSR	40	Myticin-A (Myt A; Cys-rich; molluscas, animals)	P82103	Not found	Not found	Mytilus galloprovincialis (Mediterranean mussel)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Rich	Not found		"Function: Bacteriolytic activity against Gram-positive bacteria M. luteus, Bacillus megaterium and A. viridans.
PTM: contains four disulfide bonds."	Gram-positive bacteria: Micrococcus luteus (MBC=2.25-4.5 µM), Bacillus megaterium (MBC=2.25-4.5 µM), Aerococcus viridans (MBC=9-4.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10491159	Eur J Biochem. 1999 Oct 1;265(1):71-78.	Mitta G, Hubert F, Noël T, Roch P.	Myticin, a novel cysteine-rich antimicrobial peptide isolated from haemocytes and plasma of the mussel Mytilus galloprovincialis.	
DRAMP02810	QEAQSVACTSYYCSKFCGSAGCSLYGCYLLHPGKICYCLHCSR	43	Myticin C 	No entry found	Not found	Not found	Mytilus galloprovincialis (Mediterranean mussel)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17628673	Dev Comp Immunol. 2008;32(3):213-226.	Pallavicini A, Costa Mdel M, Gestal C, Dreos R, Figueras A, Venier P, Novoa B.	High sequence variability of myticin transcripts in hemocytes of immune-stimulated mussels suggests ancient host-pathogen interactions.	
DRAMP02812	AVVNGVNYVGETTAA	15	Endopeptidase L4	P85155	Not found	Not found	Lysobacter sp. strain XL1 (Gram-negative bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Biophysicochemical properties: Optimum pH is 8.0; Optimum temperature is 50-55 degrees Celsius. Retains 50% of its maximal activity after incubation at 52 degrees Celsius for 15 min.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16266276	Biochemistry (Mosc). 2005 Sep;70(9):1031.	Stepnaya OA, Tsfasman IM, Logvina IA, Ryazanova LP, Muranova TA, Kulaev IS.	Isolation and characterization of a new extracellular bacteriolytic endopeptidase of Lysobacter sp. XL1.	
DRAMP02814	FHPSLWVLIPQYIQLIRKILKS	22	Conolysin-Mt2	No entry found	Not found	Not found	Conus mustelinus (Weasel cone)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17927208	Biochemistry. 2007 Nov 6;46(44):12586-12593. 	Biggs J.S, Rosenfeld Y, Shai Y, Olivera B.M.	Conolysin-Mt: a conus peptide that disrupts cellular membranes.	
DRAMP18235	LLEL	4	Gageopeptide D(Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis	Antimicrobial, Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Leu-Leu-Glu-Leu-3-beta-hydroxy-9,11-dimethyltetradecanoic acid		Non-cytotoxic antifungal agents. It was revealed that compounds 1 and 2 exhibited stronger antifungal activity than 3 and 4. Compounds 1 and 2 were structurally different from compounds 3 and 4 in terms of having less side chains in the fatty acid units, suggesting that the side chain length and the additional methyl group in the aliphatic chain are important for antifungal activity. These compounds also showed potent antimicrobial activity against Gram positive and Gram negative bacteria with MIC values of 0.04?0.08 uM.	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2485741	Yan Ke Xue Bao. 1989 Jun;5(1-2):32-5.	Lin N, Gong XM, Xie QJ, Shao MR.	Study in cytotoxicity of gentamycin to corneal epithelium and endothelium in tissue culture.	
DRAMP02816	RQKDKRPYSERKNQYTGPQFLYPPERIPP	29	Lumbrican	No entry found	Not found	Not found	Lumbricus rubellus (humus earthworm)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis ATCC 62037, Staphylococcus aureus ATCC 15752, Streptococcus mutans ATCC 25175;##Gram-negative bacteria: Escherichia coli ATCC 27325, Pseudomonas putida ATCC 17426, Serratia sp. ATCC 21074.##Fungi: Candida albicans ATCC 10231, Cryptococcus neoformans ATCC 34881, Saccharomyces cerevisiae ATCC 44774.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9784609	Biochim Biophys Acta. 1998 Oct 22;1408(1):67-76.	Cho JH, Park CB, Yoon YG, Kim SC.	Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization.	
DRAMP02818	ILQKAVLDCLKAAGSSLSKAAITAIYNKIT	30	Dicynthaurin	P0C007	Not found	Not found	Halocynthia aurantium (Sea peach)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix (CD)	CD spectra of the cynthaurin monomer (Fig. 5A) and homodimer (Fig. 5B) in PBS showes properties characteristic of helical peptides. In structure-promoting environments, such as TFE:phosphate buffer or SDS micelles, the helical conformations are enhanced and accounted for the dominant structural component of both the monomeric and the homodimeric peptides.		"Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria. Its antimicrobial activity is optimal at NaCl concentrations below 100 mM, suggesting that the antimicrobial actions of this peptide may take place intracellularly rather than extracellularly. Has no activity against the fungus C.albicans. Has hemolytic activity.
PTM: Contians one disulfide bond and C-terminal amidation."	[Ref.11479030]Gram-positive bacteria: Micrococcus luteus, Staphylococcus aureus(50 units at 100ug/ml), Listeria monocytogenes(50 units at 40ug/ml);##Gram-negative bacteria: Escherichia coli(50 units at 10ug/ml), Pseudomonas aeruginosa(25 units at 20ug/ml).	[Ref.11479030]10% hemolytic activity at 50 μg/ml, 20% hemolytic activity at 100 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11479030	Biochim Biophys Acta. 2001 Aug 15;1527(3):141-148.	Lee IH, Lee YS, Kim CH, Kim CR, Hong T, Menzel L, Boo LM, Pohl J, Sherman MA, Waring A, Lehrer RI.	Dicynthaurin: an antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium.	
DRAMP01820	FLPLFASLIGKLL	13	Temporin-1Cb (Temporin 1Cb; Frogs, amphibians, animals)	P82881	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana clamitans (Green frog) (Lithobates clamitans)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacterium Staphylococcus aureus.
Tissue specificity: Expressed by the skin glands."	[Ref.10822101] Gram-positive bacterium: Staphylococcus aureus (MIC=140 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10822101	Peptides. 2000 Apr;21(4):469-476.	Halverson T, Basir YJ, Knoop FC, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.	
DRAMP01822	FLPFLASLLSKVL	13	Temporin-1Cd (Temporin 1Cd; Frogs, amphibians, animals)	P82883	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana clamitans (Green frog) (Lithobates clamitans)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacterium Staphylococcus aureus.
Tissue specificity: Expressed by the skin glands."	[Ref.10822101] Gram-positive bacterium: Staphylococcus aureus (MIC=80 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10822101	Peptides. 2000 Apr;21(4):469-476.	Halverson T, Basir YJ, Knoop FC, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.	
DRAMP02820	VTCDLLSLQIKGIAINDSACAAHCLAMRRKGGSCKQGVCVCRN	43	Holotricin-1 (Gly-rich; His-rich; invertebrate defensin; animals)	Q7M426	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Holotrichia diomphalia (Korean black chafer)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Shows potent antibacterial activity against Gram-positive bacteria.
PTM: Contians three disulfide bonds 3-34; 20-39; 24-41."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7550103	Biol Pharm Bull. 1995 Mar;18(3):457-459.	Lee S.Y, Moon H.J, Kawabata S, Kurata S, Natori S, Lee B.L.	A sapecin homologue of Holotrichia diomphalia: purification, sequencing and determination of disulfide pairs.	
DRAMP02821	SLQPGAPSFPMPGSQLPTSVSGNVEKQGRNTIATIDAQHKTDRYDVRGTWTKVVDGPGRSKPNFRIGGSYRW	72	Holotricin-2 (Gly-rich; His-rich; invertebrate defensin; animals)	Q25054	Belongs to the coleoptericin family	Not found	Holotrichia diomphalia (Korean black chafer)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria but not against Gram-positive bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8188641	J Biochem. 1994 Jan;115(1):82-86.	Lee SY, Moon HJ, Kurata S, Kurama T, Natori S, Lee BL.	Purification and molecular cloning of cDNA for an inducible antibacterial protein of larvae of a coleopteran insect, Holotrichia diomphalia.	
DRAMP02822	YGPGDGHGGGHGGGHGGGHGNGQGGGHGHGPGGGFGGGHGGGHGGGGRGGGGSGGGGSPGHGAGGGYPGGHGGGHHGGYQTHGY	84	Holotricin-3 (Gly-rich; His-rich; invertebrate defensin; animals)	Q25055	Not found	Not found	Holotrichia diomphalia (Korean black chafer)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Has antifungal activity against C. albicans.	Yeast: Candida ablicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8535393	Biol. Pharm. Bull. 1995; 18:1049-1052.	Lee S.Y, Moon H.J, Kurata S, Natori S, Lee B.L.	Purification and cDNA cloning of an antifungal protein from the hemolymph of Holotrichia diomphalia larvae.	
DRAMP02824	VRNSQSCRRNKGICVPIRCPGSMRQIGTCLGAQVKCCRRK	40	Lingual antimicrobial peptide (mammals, animals)	A3RJ36	Belongs to the beta-defensin family	Not found	Bubalus bubalis (Domestic water buffalo)	Antimicrobial, Antibacterial, Antiviral	Protein level	Bridge	Not found		"Function: Has bactericidal activity (By similarity).
PTM: Contains three disulfide bonds 7-36; 14-29; 19-37."	Escherichia coli, Staphylococcus aureus, Streptococcus pyogenes, Candida albicans, Rinderpest Virus (RPV) and Newcastle Disease Virus (NDV)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18826332	Altern Lab Anim. 2008 Sep;36(4):429-440.	Das H, Swamy N, Sahoo G, Ahmed S.U, More T.	Beta-defensin antibiotic peptides in the innate immunity of the buffalo: in vivo and in vitro studies.	
DRAMP02825	SSMKLSFRARAYGFRGPGPQL	21	Catestatin	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15723172	Cell Mol Life Sci. 2005 Feb;62(3):377-385.	Briolat J, Wu SD, Mahata SK, Gonthier B, Bagnard D, Chasserot-Golaz S, Helle KB, Aunis D, Metz-Boutigue MH.	New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.	
DRAMP02826	RPKHPIKHQGLPQEVLNENLLRF	23	Isracidin	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19054235	J Appl Microbiol. 2009 Jan;106(1):233-240.	Birkemo GA, O'Sullivan O, Ross RP, Hill C.	Antimicrobial activity of two peptides casecidin 15 and 17, found naturally in bovine colostrum.	
DRAMP02827	FLSFPTTKTYFPHFDLSHGSAQVKGHGAK	29	BHP (pepsin-derived bovine hemoglobin fragment)	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11226440	FEBS Lett. 2001 Feb 23;491(1-2):159-163.	Froidevaux R, Krier F, Nedjar-Arroume N, Vercaigne-Marko D, Kosciarz E, Ruckebusch C, Dhulster P, Guillochon D.	Antibacterial activity of a pepsin-derived bovine hemoglobin fragment.	
DRAMP02829	SDEKASPDKHHRFSLSRYAKLANRLANPKLLETFLSKWIGDRGNRSV	47	Seminalplasmin	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16453469	EMBO J. 1983;2(7):1159-1163.	Theil R, Scheit KH.	Amino acid sequence of seminalplasmin, an antimicrobial protein from bull semen.	
DRAMP02830	AAEFPDFYDSEEQMGPHQEAEDEKDRADQRVLTEEEKKELENLAAMDLELQKIAEKFSQR	60	Chrombacin	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18181560	J Proteome Res. 2008 Feb;7(2):795-802.	Taylor SW, Sun C, Hsieh A, Andon NL, Ghosh SS.	A sulfated, phosphorylated 7 kDa secreted peptide characterized by direct analysis of cell culture media.	
DRAMP02831	MLTDLECAINSLIDVYHKYSLKKGNYHAVYRDDLKQLLETECPKFMKKKDADTWFKELDINQDGGINFEEFLVLVIKVGLEAHEEIHKE	89	Protein S100-A8 (Calgranulin-A; MRP-8; mammals, animals)	P28782, Q2NKR8	Belongs to the S-100 family	S100A8	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity towards bacteria and fungi and exerts its antimicrobial activity probably via chelation of Zn2+ which is essential for microbial growth. Can induce cell death via autophagy and apoptosis and this occurs through the cross-talk of mitochondria and lysosomes via reactive oxygen species (ROS) and the process involves BNIP3. Can regulate neutrophil number and apoptosis by an anti-apoptotic effect.
Tissue specificity: Found essentially in phagocytic cells.
Miscellaneous: Binds two calcium ions per molecule with an affinity similar to that of the S100 proteins (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	1610833##8505358	Biochemistry. 1992 Jun 30;31(25):5898-5905.##J Cell Sci. 1993 Feb;104 ( Pt 2):237-247.	Dianoux AC, Stasia MJ, Garin J, Gagnon J, Vignais PV.##Tang TK, Hong TM, Lin CY, Lai ML, Liu CH, Lo HJ, Wang ME, Chen LB, Chen WT, Ip W, et al.	The 23-kilodalton protein, a substrate of protein kinase C, in bovine neutrophil cytosol is a member of the S100 family.##Nuclear proteins of the bovine esophageal epithelium. I. Monoclonal antibody W2 specifically reacts with condensed nuclei of differentiated superficial cells.	
DRAMP02832	MPVAVGPYGQSQPSCFDRVKMGFVMGCAVGMAAGALFGTFSCLRIGMRGRELMGGIGKTMMQSGGTFGTFMAIGMGIRC	79	Reactive oxygen species modulator 1 (ROS modulator 1; mammals, animals)	Q3SZV8	Belongs to the MGR2 family	ROMO1	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Homology	Not found	Not found		"Function: Has antibacterial activity against a variety of bacteria. Acts by inducing bacterial membrane breakage (By similarity).
Induces production of reactive oxygen species (ROS) which are necessary for cell proliferation. May play a role in inducing oxidative DNA damage and replicative senescence. May play a role in the coordination of mitochondrial morphology and cell proliferation."	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacteria: Pseudomonas aeruginosa, Mycobacterium tuberculosis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases	Unknown	NIH - Mammalian Gene Collection (MGC) project	
DRAMP02833	SALYALYDFSPPARKMRAYTVRAYVHGSYSRRGPWYDFEPVPGASMDGL	49	Glycolactin (Antiviral defensin; mammals, animals)	P59760	Belongs to the pancreatic ribonuclease family	Not found	Bos taurus (Bovine)	Antimicrobial, Antiviral	Protein level	Not found	Not found		"Function: MManifests poly C-specific RNase activity toward yeast tRNA, elicits a dose-dependent inhibition of cell-free translation, inhibits formation of superoxide ions in vitro and inhibits the hemagglutinating activities of soybean lectin and Ricinus communis agglutinin 120. Inhibits HIV-1 reverse transcriptase.
Tissue specificity: Milk."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10486275##11105990	Biochem Biophys Res Commun. 1999 Sep 16;263(1):187-191.##Life Sci. 2000 Oct 20;67(22):2745-2752.	Ye XY, Cheng KJ, Ng TB.##Wang H, Ye X, Ng TB.	Isolation and characterization of angiogenin-1 and a novel protein designated lactogenin from bovine milk.##First demonstration of an inhibitory activity of milk proteins against human immunodeficiency virus-1 reverse transcriptase and the effect of succinylation.	
DRAMP02834	SDEKASPDKHHRFSLSRYAKLANRLANPKLLETFLSKWIGDRGNRSVK	48	Seminalplasmin (Calcium transport inhibitor; Peptide YY-2; mammals, animals)	P06833 	Not found	PYY2	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Function: Inhibits calcium transport into spermatozoa; it does not bind directly to calcium. Binds to calmodulin. Inhibits the growth of microorganisms. Seem to act as an antibiotic by permeabilizing the bacterial membrane.	Gram-negative bacterium: Escherichia coli.##Fungi: Saccharomyces cerevisiae, Candida ablicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Does not bind directly to calcium. It binds to calmodulin in the presence of Ca2+.	16453469##2334517##3863108	EMBO J. 1983;2(7):1159-1163.##Biol Chem Hoppe Seyler. 1990 Feb;371(2):111-116.##Proc Natl Acad Sci U S A. 1985 Oct;82(19):6490-6491.	Theil R, Scheit KH.##Krauhs E, Preuss KD, Scheit KH.##Lewis RV, Agustin JS, Kruggel W, Lardy HA.	Amino acid sequence of seminalplasmin, an antimicrobial protein from bull semen.##Functional properties of peptides derived from seminalplasmin: binding to monospecific anti-seminalplasmin immunoglobulins G and calmodulin.##The structure of caltrin, the calcium-transport inhibitor of bovine seminal plasma.	
DRAMP02836	QCVGTITLDQSDDLFDLNCNELQSVR	26	Cathelicidin antimicrobial peptide (cathelicidin; mammals, animals)	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial, Antibacterial	Not found	Not found	Not found		One chain of Cathelicidin antimicrobial peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8706679	Eur J Biochem. 1996 Jun 15;238(3):769-776.	Storici P, Tossi A, Lenarcic B, Romeo D.	Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides.	
DRAMP02837	PLSCRRKGGICILIRCPGPMRQIGTCFGRPVKCCR	35	Beta-defensin C7 (BBD(C7); mammals, animals)	O18815	Belongs to the beta-defensin family	Not found	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram-	Homology	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9488394	Infect Immun. 1998 Mar;66(3):1045-1056.	Tarver AP, Clark DP, Diamond G, Russell JP, Erdjument-Bromage H, Tempst P, Cohen KS, Jones DE, Sweeney RW, Wines M, Hwang S, Bevins CL.	Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.	
DRAMP18233	LLLE	4	Gageopeptide B(Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis	Antimicrobial, Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Leu-Leu-Leu-OMeGlu-3-beta-hydroxy-12-methyltetradecanoic acid		Non-cytotoxic antifungal agents. It was revealed that compounds 1 and 2 exhibited stronger antifungal activity than 3 and 4. Compounds 1 and 2 were structurally different from compounds 3 and 4 in terms of having less side chains in the fatty acid units, suggesting that the side chain length and the additional methyl group in the aliphatic chain are important for antifungal activity. These compounds also showed potent antimicrobial activity against Gram positive and Gram negative bacteria with MIC values of 0.04?0.08 uM.	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2485741	Yan Ke Xue Bao. 1989 Jun;5(1-2):32-5.	Lin N, Gong XM, Xie QJ, Shao MR.	Study in cytotoxicity of gentamycin to corneal epithelium and endothelium in tissue culture.	
DRAMP18234	LLEL	4	Gageopeptide C(Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis	Antimicrobial, Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Leu-Leu-Glu-Leu-3-beta-hydroxy-9,11-dimethyltridecanoic acid		Non-cytotoxic antifungal agents. It was revealed that compounds 1 and 2 exhibited stronger antifungal activity than 3 and 4. Compounds 1 and 2 were structurally different from compounds 3 and 4 in terms of having less side chains in the fatty acid units, suggesting that the side chain length and the additional methyl group in the aliphatic chain are important for antifungal activity. These compounds also showed potent antimicrobial activity against Gram positive and Gram negative bacteria with MIC values of 0.04?0.08 uM.	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2485741	Yan Ke Xue Bao. 1989 Jun;5(1-2):32-5.	Lin N, Gong XM, Xie QJ, Shao MR.	Study in cytotoxicity of gentamycin to corneal epithelium and endothelium in tissue culture.	
DRAMP02839	NPLSCRLNRGICVPIRCPGNLRQIGTCFTPSVKCCRWR	38	Enteric Beta-defensin (mammals, animals)	O02775, Q1RMP8	Belongs to the beta-defensin family (LAP/TAP subfamily)	EBD	Bos taurus (Bovine)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Tissue specificity: Inducibly expressed in enteric epithelial cells.
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9488394##8589529 	Infect Immun. 1998 Mar;66(3):1045-1056.##Mamm Genome. 1995 Aug;6(8):554-556.	Tarver AP, Clark DP, Diamond G, Russell JP, Erdjument-Bromage H, Tempst P, Cohen KS, Jones DE, Sweeney RW, Wines M, Hwang S, Bevins CL.##Gallagher DS Jr, Ryan AM, Diamond G, Bevins CL, Womack JE.	Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.##Somatic cell mapping of beta-defensin genes to cattle syntenic group U25 and fluorescence in situ localization to chromosome 27.	
DRAMP02846	QKIAEKFSGTRRG	13	Secretolytin (mammals, animals)	P23389, O02707	Belongs to the chromogranin/secretogranin protein family	CHGB	Bos taurus (Bovine)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7744058##8603705	Eur J Biochem. 1995 Apr 15;229(2):356-368.##FEBS Lett. 1996 Feb 5;379(3):273-278.	Strub JM, Hubert P, Nullans G, Aunis D, Metz-Boutigue MH.##Strub JM, Garcia-Sablone P, Lonning K, Taupenot L, Hubert P, Van Dorsselaer A, Aunis D, Metz-Boutigue MH.	Antibacterial activity of secretolytin, a chromogranin B-derived peptide (614-626), is correlated with peptide structure.##Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity.	
DRAMP02847	QAEESNLQSLVSQYFQTVADYGKDLVEKAKGSELQTQAKAYFEKTQEELTPFFKKAGTDLLNFLSSFIDPKKQPATR	77	Apolipoprotein A-II (Antimicrobial peptide BAMP-1; mammals, animals)	P81644, Q2NKV9	Belongs to the apolipoprotein A2 family	APOA2	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Function:May stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism. Has antimicrobial activity.	Escherichia coli and yeasts.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9538260	J Biochem. 1998 Apr;123(4):675-679.	Motizuki M, Itoh T, Yamada M, Shimamura S, Tsurugi K.	Purification, primary structure, and antimicrobial activities of bovine apolipoprotein A-II.	
DRAMP02848	QAEESNLQSLVSQYFQTVADYGKDLVEKAKGSELQTQAKAYFEKTQEELTPFFKKAGTDLLNFLSSFIDPKKQPAT	76	Apolipoprotein A-II(1-76)(mammals, animals)	P81644, Q2NKV9	Belongs to the apolipoprotein A2 family	APOA2	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Function:May stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism. Has antimicrobial activity.	Escherichia coli and yeasts.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9538260	J Biochem. 1998 Apr;123(4):675-679.	Motizuki M, Itoh T, Yamada M, Shimamura S, Tsurugi K.	Purification, primary structure, and antimicrobial activities of bovine apolipoprotein A-II.	
DRAMP02850	KTKLTEEEKNRLNFLKKISQRYQKFALPQYLKTVYQHQK	39	Casocidin-1 (mammals, animals)	P02663, Q1RMQ6, Q9TR51	Belongs to the alpha-casein family	CSN1S2	Bos taurus (Bovine)	Antimicrobial, Antibacterial	Protein level	Not found	Not found	6FS5##6FS4	Comment: No comments found on DRAMP database	Staphylococcus carnosus, Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7556666	FEBS Lett. 1995 Sep 25;372(2-3):185-188.	Zucht HD, Raida M, Adermann K, Mägert HJ, Forssmann WG.	Casocidin-I: a casein-alpha s2 derived peptide exhibits antibacterial activity.	
DRAMP02852	RFRPPIRRPPIRPPFYPPFRPPIRPPIFPPIRPPFRPPLGPFP	43	Cathelicidin-2 (Bactenecin-5, Bac5; PR-42; mammals, animals)	P19660, A5PJA3, Q24JY5	Belongs to the cathelicidin family	CATHL2	Bos taurus (Bovine)	Antimicrobial, Antibacterial	Protein level	Not found	BAC5 sequence consists almost exclusively of X-P-P-Y repeats.		"Function: Exerts, in vitro, a potent antimicrobial activity. Probably due to an impairment of the function of the respiratory chain and of energy-dependent activities in the inner membrane of susceptible microorganisms.
Tissue specificity: Large granules of neutrophils.
Domain: BAC5 sequence consists almost exclusively of X-P-P-Y repeats.
PTM: Contains two disulfide bonds and C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2229048	J Biol Chem. 1990 Nov 5;265(31):18871-18874.	Frank RW, Gennaro R, Schneider K, Przybylski M, Romeo D.	Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils.	
DRAMP02853	RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRP	59	Cathelicidin-3 (Bactenecin-7, Bac7; PR-59; mammals, animals)	P19661, A5PJ95	Belongs to the cathelicidin family	CATHL3	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found	5HAU	"Function: Exerts, in vitro, a potent antimicrobial activity. Probably due to an impairment of the function of the respiratory chain and of energy-dependent activities in the inner membrane of susceptible microorganisms.
Tissue specificity: Large granules of neutrophils.
PTM: Contains two disulfide bonds."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2229048	J Biol Chem. 1990 Nov 5;265(31):18871-18874.	Frank RW, Gennaro R, Schneider K, Przybylski M, Romeo D.	Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils.	
DRAMP02856	AGLFRRLRDSIRRGQQKILEKARRIGERIKDIFR	34	Cathelicidin-7 (Antibacterial peptide BMAP-34; mammals, animals)	P56425, A6QPU1, B9TUC8	Belongs to the cathelicidin family	CATHL7	Bos taurus (Bovine)	Antimicrobial	Transcript level	Not found	Not found		"Function: Exerts a potent antimicrobial activity.
Tissue specificity: Expressed in bone marrow myeloid cells, spleen and testis."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9409740##19136450	FEBS Lett. 1997 Nov 17;417(3):311-315.##J Hered. 2009 Mar-Apr;100(2):241-245.	Scocchi M, Wang S, Zanetti M.##Gillenwaters EN, Seabury CM, Elliott JS, Womack JE.	Structural organization of the bovine cathelicidin gene family and identification of a novel member.##Sequence analysis and polymorphism discovery in 4 members of the bovine cathelicidin gene family.	
DRAMP01356	FLGGLMKAFPALICAVTKKC	20	Ranalexin-1Ca (Ranatuerin 1Ca; Frogs, amphibians, animals)	P82876	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana clamitans (Green frog) (Lithobates clamitans)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. 
Tissue specificity: Expressed by the skin glands."	[Ref.10822101] Gram-positive bacterium: Staphylococcus aureus (MIC=17 μM);##Gram-negative bacterium: Escherichia coli (MIC=4 μM).##Yeast: Candida albicans (MIC=14 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10822101	Peptides. 2000 Apr;21(4):469-476.	Halverson T, Basir YJ, Knoop FC, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.	
DRAMP02864	QGVRNFVTCRINRGFCVPIRCPGHRRQIGTCLGPRIKCCR	40	Bovine Beta-defensin 7 (bBD-7; BNBD-7; BNDB-7; mammals, animals)	P46165, Q32P80	Belongs to the beta-defensin family	DEFB7	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)"	Gram-positive bacterium: Staphylococcus aureus 502A;##Gram-negative bacterium: Escherichia coli ML35	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8454635	J Biol Chem. 1993 Mar 25;268(9):6641-6648.	Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.	Purification, primary structures, and antibacterial activities of Beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.	
DRAMP02871	RRHMLRCMGDLGICRPACRQSEEPYLYCRNYQPCCLPFYVRIDISGKEGKNDWSRENRWPKVS	63	Beta-defensin 119 (Defensin, beta 119; mammals, animals)	Q32P86, A7LM95	Belongs to the beta-defensin family	DEFB119	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Homology	Bridge	Not found		"Function Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	Gram-negative bacteria: Escherichia coli, Salmonella typhimurium;##Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2007) to the EMBL/GenBank/DDBJ databases	Cormican P, Meade K.G, Lloyd A.T, Cahalane S, Narciandi F, O'Farrelly C.	Novel bovine AMPs exhibit constitutive tissue-specific gene expression and significant in vitro antimicrobial efficacy against Escherichia coli, Salmonella typhimurium, Stapylococcus aureus and Listeria monocytogenes.	
DRAMP02874	YPGPQAKEDSEGPSQGPASREK	22	Chromacin (mammals, animals)	P05059, P79392, Q2KJ52	Belongs to the chromogranin/secretogranin protein family	CHGA	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Has antibacterial activity against the Gram-positive bacterium M. luteus.	Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Binds calcium with a low-affinity.	8910482	J Biol Chem. 1996 Nov 8;271(45):28533-28540.	Strub JM, Goumon Y, Lugardon K, Capon C, Lopez M, Moniatte M, van Dorsselaer A, Aunis D, Metz-Boutigue MH.	Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules.	
DRAMP02876	SYSMEHFRWGKPV	13	Alpha-melanocyte-stimulating hormone (Alpha-MSH; mammals, animals)	P01190, Q05B64, Q28166, Q28167, Q28168	Belongs to the POMC family	POMC	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	The last three residues KPV are antimicrobial.		"Function: Has antibacterial activity against Gram-positive bacterium S. aureus. Also has antifungl activity against yeast C. albicans.
Miscellaneous: Alpha-MSH has potent anti-inflammatory influences in models of acute, chronic, and systemic inflammation. Its wide spectrum of activity and low toxicity suggest that a-MSH may be useful for treatment of inflammation in human and veterinary disorders."	Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10670585	J Leukoc Biol 2000; 67(2): 233-239.	Cutuli M, Cristiani S, Lipton JM, Catania A.	Antimicrobial effects of alpha-MSH peptides.	
DRAMP02879	NPVSCVRNKGICVPIRCPGNMKQIGTCVGRAVKCCR	36	Tracheal antimicrobial peptide (mammals, animals)	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Yeast: Candida ablicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8506305	Proc Natl Acad Sci U S A. 1993 May 15;90(10):4596-600.	Diamond G, Jones DE, Bevins CL.	Airway epithelial cells are the site of expression of a mammalian antimicrobial peptide gene.	
DRAMP02881	NPVSCVRNKGICVPIRCPGSMKQIGTCVGRAVKCCR	36	Antimicrobial protein exons 1-2 (mammals, animals)	No entry found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Antifungal	Not found	dulsulfide-bond link	Not found		Comment: No comments found on DRAMP database	Yeast: Candida ablicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8506305	Proc Natl Acad Sci U S A. 1993 May 15;90(10):4596-600.	Diamond G, Jones DE, Bevins CL.	Airway epithelial cells are the site of expression of a mammalian antimicrobial peptide gene.	
DRAMP02882	MTPFWRAVSLRPIGASCRDDSECITRLCRKRRCSLSVAQE	40	Liver-expressed antimicrobial peptide 2 (LEAP-2; mammals, animals)	Q95JC3, Q32P98	Not found	LEAP2	Bos taurus (Bovine)	Antimicrobial	Homology	Not found	Not found		PTM: Contains two disulfide bonds 16-28; 23-33.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12493837	Protein Sci. 2003 Jan;12(1):143-152.	Krause A, Sillard R, Kleemeier B, Klüver E, Maronde E, Conejo-García JR, Forssmann WG, Schulz-Knappe P, Nehls MC, Wattler F, Wattler S, Adermann K.	Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver.	
DRAMP02883	MIQIKFLCLFLAIMTIVVLDSNVAEARDCLSGTFKGPCWAWSGEKCRRLCIEEGRVSGHCSGGSKCWCEGC	71	Drosomycin-like A (Predicted)	Q95NH5	Not found	Drsl-B	Drosophila triauraria	Antimicrobial, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11707335	Gene. 2001 Oct 31;278(1-2):177-184.	Daibo S, Kimura MT, Goto SG.	Upregulation of genes belonging to the drosomycin family in diapausing adults of Drosophila triauraria.	
DRAMP02884	DCLSGRYRGSCAVWHRKKCVDICQREGRTSGHCSPSLKCWCEGC	44	Drosomycin-like C	Q86GH7	Not found	Drsl1	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16824706	Gene. 2006 Sep 1;379:26-32.	Yang WY, Wen SY, Huang YD, Ye MQ, Deng XJ, Han D, Xia QY, Cao Y.	Functional divergence of six isoforms of antifungal peptide Drosomycin in Drosophila melanogaster.	
DRAMP02885	MVQMIFLFAILAVMTIVLMEANTVLARDCLSGTFGGPCWAWSGEKCRRLCIEEGHVSGHCSGAMKCWCEGC	71	Drosomycin-like 3 (Drosomycin-like E; Drosomycin-like G; Predicted)	Q8IRD7	Not found	Drsl3	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16824706	Gene. 2006 Sep 1;379:26-32.	Yang WY, Wen SY, Huang YD, Ye MQ, Deng XJ, Han D, Xia QY, Cao Y.	Functional divergence of six isoforms of antifungal peptide Drosomycin in Drosophila melanogaster.	
DRAMP02886	MQIKFLYLFLAVMTIFILGAKEADADCLSGRYGGPCAVWDNETCRRVCKEEGRSSGHCSPSLKCWCEGC	69	Drosomycin-like 5 (Drosomycin-like E; Drosomycin-like G; Predicted)	Q9VZR2	Not found	Drsl5	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16824706	Gene. 2006 Sep 1;379:26-32.	Yang WY, Wen SY, Huang YD, Ye MQ, Deng XJ, Han D, Xia QY, Cao Y.	Functional divergence of six isoforms of antifungal peptide Drosomycin in Drosophila melanogaster.	
DRAMP02887	MEIKFLIVLSAVLMIIFLGAEESHADCLSGRYRGSCAVWHRKKCVDICQREGRTSGHCSPSLKCWCEGC	69	Dro1 protein (Drosomycin-like 1; Drosomycin-like C1; Predicted)	Q9VZQ5, C9QPF6	Not found	Drsl1	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16824706	Gene. 2006 Sep 1;379:26-32.	Yang WY, Wen SY, Huang YD, Ye MQ, Deng XJ, Han D, Xia QY, Cao Y.	Functional divergence of six isoforms of antifungal peptide Drosomycin in Drosophila melanogaster.	
DRAMP02888	MVQIKFLFVFLAVMTIVVLAANMADADCLSGKYKGPCAVWDNEMCRRICKEEGHISGHCSPSLKCWCEGC	70	Dro2 protein (Drosomycin 2; Drosomycin-like 2; Drosomycin-like D; Drosomycin-like H; Predicted)	Q7YXH9, Q9VZR3	Not found	Drsl2	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16824706	Gene. 2006 Sep 1;379:26-32.	Yang WY, Wen SY, Huang YD, Ye MQ, Deng XJ, Han D, Xia QY, Cao Y.	Functional divergence of six isoforms of antifungal peptide Drosomycin in Drosophila melanogaster.	
DRAMP02889	MAQIKGLFALLAVVTIVLMVANSASAVDCPSGRFSGPCWAWDGEQCRRLCREEGRVSGHCSASLKCWCEQC	71	Dro4 protein (Drosomycin 4; Drosomycin-like 4; Drosomycin-like F; Predicted)	Q8IRD6	Not found	Drsl4	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16824706	Gene. 2006 Sep 1;379:26-32.	Yang WY, Wen SY, Huang YD, Ye MQ, Deng XJ, Han D, Xia QY, Cao Y.	Functional divergence of six isoforms of antifungal peptide Drosomycin in Drosophila melanogaster.	
DRAMP02890	MMQIKFLFTFLALLMMVILGAKEADADCLSGRYRGPCAVWDNETCRRVCREEGRGRVSGHCSARLQCWCEGC	72	Dro6 protein (Drosomycin-like 6; Drosomycin-like D; Drosomycin-like I; Predicted)	Q9VZQ4	Not found	Drsl6	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16824706	Gene. 2006 Sep 1;379:26-32.	Yang WY, Wen SY, Huang YD, Ye MQ, Deng XJ, Han D, Xia QY, Cao Y.	Functional divergence of six isoforms of antifungal peptide Drosomycin in Drosophila melanogaster.	
DRAMP02891	WSGFTQGVGNPVSCVRNKGICVPIRCPGNMKQIGTC	36	Tracheal antimicrobial peptide	B3VHN0	Not found	Not found	Bos taurus (Bovine)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19181355	Res Vet Sci. 2009 Aug;87(1):59-63.	López-Meza JE, Gutiérrez-Barroso A, Ochoa-Zarzosa A.	Expression of tracheal antimicrobial peptide in bovine mammary epithelial cells.	
DRAMP02892	MKAFSIAVAVTLVLAFICILESSAVPLNGVQELEEAGSNDTPVAAHQEMSMESWMMPSRVREKRQSHISMCYWCCNCCRANKGCGYCCKF	90	Hepcidin antimicrobial peptide 1 	B6ZJU9	Not found	HAMP1	Pagrus auriga	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##PubMed ID is not available	Fish Shellfish Immunol. 2009,26:483-491.	Martin-Antonio B, Jimenez-Cantizano RM, Salas-Leiton E, Infante C, Manchado M.	Genomic characterization and gene expression analysis of four hepcidin genes in the redbanded seabream (Pagrus auriga).	
DRAMP02893	MKTFSVAVAVAVVLTFICLQESSADSVTEVQELEEPMSIGSPVAAYEEMPEESWKMPYASRSSSDRRRRRWRCRTCCRCCPRMKGCGICCRRR	93	Hepcidin antimicrobial peptide 2 	B6ZJV0	Not found	HAMP2	Pagrus auriga	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##PubMed ID is not available	Fish Shellfish Immunol. 2009,26:483-491.	Martin-Antonio B, Jimenez-Cantizano RM, Salas-Leiton E, Infante C, Manchado M.	Genomic characterization and gene expression analysis of four hepcidin genes in the redbanded seabream (Pagrus auriga).	
DRAMP02894	MKTFSVAVAVAVVLTFICLQESSAVPVTEVPELEEEISNDDAAASYEETSVETWMMPFDIRQKPHSGLIKCSYCCDCCVLGVCGMCCQ	88	Hepcidin antimicrobial peptide 3 	B6ZJV1	Not found	HAMP3	Pagrus auriga	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##PubMed ID is not available	Fish Shellfish Immunol. 2009,26:483-491.	Martin-Antonio B, Jimenez-Cantizano RM, Salas-Leiton E, Infante C, Manchado M.	Genomic characterization and gene expression analysis of four hepcidin genes in the redbanded seabream (Pagrus auriga).	
DRAMP02895	MKTFSVAVAVAVVLTFICLQESSAVSFTEVQEQEEPMSNDSPVAAHEEMSEESWKMPYNNRHKRSPAGRNKRRRRCRFCCGCCPNMIGCGTCCKF	95	Hepcidin antimicrobial peptide 4 	B6ZJV2	Not found	HAMP4	Pagrus auriga	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##PubMed ID is not available	Fish Shellfish Immunol. 2009,26:483-491.	Martin-Antonio B, Jimenez-Cantizano RM, Salas-Leiton E, Infante C, Manchado M.	Genomic characterization and gene expression analysis of four hepcidin genes in the redbanded seabream (Pagrus auriga).	
DRAMP02896	MFTLKKSLLLLFFLGTINLSLCEQERNADEEERRDDSDKRDVEVEKRFLSTLLKVAFKVVPTLFCPITKKC	71	Brevinin-1-AJ1 antimicrobial peptide	K7Z430	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial, Antibacterial, Antifungal	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	[Ref.22828809] 7.62% hemolytic activity at 25 μg/ml,24.58% hemolytic activity at 50 μg/ml, 83.05% hemolytic activity at 100 μg/ml, 87.65% hemolytic activity at 200 μg/ml against rabbit red blood cells	Cyclic	Free	Cyclization (Cys65 and Cys71)	Disulfide bond between Cys65 and Cys71.	L	No cytotoxicity information found	Not found	22828809	Amino Acids. 2012 Jul 25	He X, Yang S, Wei L, Liu R, Lai R, Rong M.	Antimicrobial peptide diversity in the skin of the torrent frog, Amolops jingdongensis.	
DRAMP02897	MFTLKKSLLLLFFLGTINLFFCEQERDADEEERRDDDEMDVEVEKRFLPLAVSLAANFLPKLFCKITKKC	70	Brevinin-1-AJ2 antimicrobial peptide	K7ZJ55	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Amino Acids. 2012 Jul 25	He X, Yang S, Wei L, Liu R, Lai R, Rong M.	Antimicrobial peptide diversity in the skin of the torrent frog, Amolops jingdongensis.	
DRAMP02898	MFTLKKSLLLLFFLGTINLSLCEQERDADEEERRDDDEMDVEVEKRFLPLAVSLAANFLPKLFCKITKNVETLEMELEII	80	Brevinin-1-AJ3 antimicrobial peptide	K7Z8Z4	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Amino Acids. 2012 Jul 25	He X, Yang S, Wei L, Liu R, Lai R, Rong M.	Antimicrobial peptide diversity in the skin of the torrent frog, Amolops jingdongensis.	
DRAMP02899	MFTLKKSLLLLFFLGTINLSLCEQERDADEEERRDDDEMDVEVEKRFLPLVASLAANFLPKLFCKITKKC	70	Brevinin-1MT1 antimicrobial peptide	E1B240	Not found	Not found	Amolops mantzorum	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##PubMed ID is not available	Submitted (AUG-2010) to the EMBL/GenBank/DDBJ database	Wang H, Liu J.	Antimicrobial peptides from amphibian skin of Amolops mantzorum.	
DRAMP02900	MFTLKKSMLLLFFLGTINLSLCEQERNADEEERRDDDEMDVEVEKRFLPMLAGLAANFLPKLFCKITKKC	70	Brevinin-1MT2 antimicrobial peptide	E1B241	Not found	Not found	Amolops mantzorum	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##PubMed ID is not available	Submitted (AUG-2010) to the EMBL/GenBank/DDBJ database	Wang H, Liu J.	Antimicrobial peptides from amphibian skin of Amolops mantzorum.	
DRAMP02901	CLGVGSCNNFAGCGYAIVCFW	21	Tricyclic peptide MS-271	P85078	Not found	Not found	Streptomyces sp.	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Inhibits chicken myosin light chain kinase with an IC50 of 8 M. Antibacterial activity against the Gram-positive bacteria. No antibacterial activity against the Gram-negative bacteria E. coli, K. pneumoniae, P. aeruginosa, P. vulgaris, S. sonnei and S. typhosa. No antifungal activity against C. albicans.
Caution: The isopeptide linked residue 9 is shown as Asn rather than Asp as mentioned in Ref.1, because it is not known whether Asp or Asn is encoded and the isopeptide bonds are almost always formed between the amides Asn or Gln and N6-lysine or alpha amino groups, with the liberation of an ammonia that makes the reaction essentially irreversible.
PTM: Contains two disulfide bonds and D-amino acid at position 21."	Gram-positive bacteria: Bacillus subtilis, Staphylococcus aureus, Enterococcus faecium.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8689231	Bioorg Med Chem. 1996 Jan;4(1):115-120.	Yano K, Toki S, Nakanishi S, Ochiai K, Ando K, Yoshida M, Matsuda Y, Yamasaki M.	MS-271, a novel inhibitor of calmodulin-activated myosin light chain kinase from Streptomyces sp.--I. Isolation, structural determination and biological properties of MS-271.	
DRAMP02902	ADDKNPLEEFRETNYEVFLEIAKNGLKATSNPKRVVIVGAGMAGLSAAY	49	L-amino-acid oxidase (LAAO, LAO; BpirLAAO-I; reptilia, animals)	P0C2D1	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Bothrops pirajai (Piraja's lance head)	Antimicrobial, Antibacterial, Anti-Gram-, Antiparasitic	Protein level	Not found	Not found		"FunctionCatalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. This protein may also have activities in hemorrhage, hemolysis, and apoptosis.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: Has parasiticidal activities against leishmania, as a result of enzyme-catalyzed hydrogen peroxide production."	Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa. Leishmania sp..	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16809041	Bioorg Med Chem. 2006 Oct 15;14(20):7034-7043.	Izidoro LF, Ribeiro MC, Souza GR, Sant'Ana CD, Hamaguchi A, Homsi-Brandeburgo MI, Goulart LR, Beleboni RO, Nomizo A, Sampaio SV, Soares AM, Rodrigues VM.	Biochemical and functional characterization of an L-amino acid oxidase isolated from Bothrops pirajai snake venom.	
DRAMP02904	AAGNPSETGGAVATYSTAVGSFLDGTVKVVATGGASRVPGNCGTAAVLECDNPESFDGTRAWGDLSADQGTGEDAPPETASLIFAVN	87	Antibacterial substance A	P01548	Not found	Not found	Streptomyces carzinostaticus	Antimicrobial	Protein level	Not found	Not found		"Function: May have antibacterial activity.
PTM: Contains one disulfide bond 42-50."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	5353565	Chem Pharm Bull (Tokyo). 1969 Oct;17(10):2188-2191.	Sato H, Tanimura T, Nakajima T, Tamura Z.	The total amino acid sequence of substance A produced by Streptomyces carzinostaticus.	
DRAMP02905	KWKIFKKIEHMGQNIRDGLIKAGPAVQVVGQAATIYKG	38	Hinnavin II	Q68KS5	Not found	Not found	Artogeia rapae	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16616565	Comp Biochem Physiol B Biochem Mol Biol. 2006 Jun;144(2):199-205. 	Yoe SM, Kang CS, Han SS, Bang IS.	Characterization and cDNA cloning of hinnavin II, a cecropin family antibacterial peptide from the cabbage butterfly, Artogeia rapae.	
DRAMP02906	RRLRPRRPRLPRPRPRPRPRPRSLPLPRPQPRRIPRPILLPWRPPRPIPRPQIQPIPRWL	60	OaBac7.5 (mammals, animals)	No entry found	Not found	Not found	Ovis aries (Sheep)	Unknown	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14651991	Biochem Biophys Res Commun. 2003 Dec 26;312(4):1139-1146.	Anderson RC, Yu PL.	Isolation and characterisation of proline/arginine-rich cathelicidin peptides from ovine neutrophils.	
DRAMP02907	RRLRPRRPRLPRPRPRPRPRPRSLPLPRPKPRPIPRPLPLPRPRPKPIPRPLPLPRPRPRRIPRPLPLPRPRPRPIPRPLPLPQPQPSPIPRPL	94	OaBac11 (mammals, animals)	No entry found	Not found	Not found	Ovis aries (Sheep)	Unknown	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14651991	Biochem Biophys Res Commun. 2003 Dec 26;312(4):1139-1146.	Anderson RC, Yu PL.	Isolation and characterisation of proline/arginine-rich cathelicidin peptides from ovine neutrophils.	
DRAMP02908	QGVRNRLSCHRNKGVCVPSRCPRHMRQIGTCRGPPVKCCRKK	42	Beta-defensin 1 (BD-1; sBD-1; mammals, animals)	O19038	Belongs to the beta-defensin family	DEFB1	Ovis aries (Sheep)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		Function: Has bactericidal activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9478010##9461419	J Nutr. 1998 Feb;128(2 Suppl):297S-299S.##Gene. 1998 Jan 5;206(1):85-91.	Huttner K.M, Brezinski-Caliguri D.J, Mahoney M.M, Diamond G.##Huttner K.M, Lambeth M.R, Burkin H.R, Broad T.E.	Antimicrobial peptide expression is developmentally regulated in the ovine gastrointestinal tract.##Localization and genomic organization of sheep antimicrobial peptides genes.	
DRAMP02909	HGVTDSLSCRWKKGICVLTRCPGTMRQIGTCFGPPVKCCRLK	42	Beta-defensin 2 (BD-2; sBD-2; mammals, animals)	O19039	Belongs to the beta-defensin family	DEFB2	Ovis aries (Sheep)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		Function: Has bactericidal activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9478010##9461419	J Nutr. 1998 Feb;128(2 Suppl):297S-299S.##Gene. 1998 Jan 5;206(1):85-91.	Huttner K.M, Brezinski-Caliguri D.J, Mahoney M.M, Diamond G.##Huttner K.M, Lambeth M.R, Burkin H.R, Broad T.E.	Antimicrobial peptide expression is developmentally regulated in the ovine gastrointestinal tract.##Localization and genomic organization of sheep antimicrobial peptides genes.	
DRAMP02914	RICRIIFLRVCR	12	Cathelicidin-1 (Bactenecin-1, Bac1; Cyclic dodecapeptide; ma	P54230	Belongs to the cathelicidin family	CATHL1A	Ovis aries (Sheep)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Bridge	Not found		Function: Potent microbicidal activity; active against S. aureus and E. coli (By similarity).	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7498547##9461419	FEBS Lett. 1995 Dec 4;376(3):225-228.##Gene. 1998 Jan 5;206(1):85-91.	Bagella L, Scocchi M, Zanetti M.##Huttner KM, Lambeth MR, Burkin HR, Burkin DJ, Broad TE.	cDNA sequences of three sheep myeloid cathelicidins.##Localization and genomic organization of sheep antimicrobial peptide genes.	
DRAMP02915	RFRPPIRRPPIRPPFRPPFRPPVRPPIRPPFRPPFRPPIGPFP	43	Cathelicidin-2 (Bactenecin-5, Bac5; OaBac5; mammals, animals)	P79362, P79363	Belongs to the cathelicidin family	CATHL2	Ovis aries (Sheep)	Antimicrobial	Transcript level	Not found	Not found		Function: Has potent antimicrobial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipipolysaccharides (LPS)-binding	9461419	Gene. 1998 Jan 5;206(1):85-91.	Huttner KM, Lambeth MR, Burkin HR, Burkin DJ, Broad TE.	Localization and genomic organization of sheep antimicrobial peptide genes.	
DRAMP02916	RRLRPRHQHFPSERPWPKPLPLPLPRPGPRPWPKPLPLPLPRPGLRPWPKPL	52	OaBac6	No entry found	Not found	Not found	Ovis aries (Sheep)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14651991	Biochem Biophys Res Commun. 2003 Dec 26;312(4):1139-1146.	Anderson RC, Yu PL.	Isolation and characterisation of proline/arginine-rich cathelicidin peptides from ovine neutrophils.	
DRAMP02917	DTHFPICIFCCGCCKTPKCGLCCKT	25	Hepcidin (dogs, mammals, animals)	Q5U9D2, Q5EES0	Belongs to the glycosyl hydrolase 22 family	HAMP	Canis familiaris (Dog) (Canis lupus familiaris)	Antimicrobial	Homology	Not found	Not found		"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##PubMed ID is not available	Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases##Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases	Shi J, Wei Y, Boothe D.##Li XD, Zhao TZ, Sun M, Tian KG, Chen XZ.	Identification of dog hepcidin.##Identification of dog hepcidin in China.	
DRAMP02918	MRPLYLLLLLLCLLFSYLPPGAGFLTGIGQRSDQYICARKGGTCNFSPCPLFTRIDGTCYRGKAKCCMP	69	Beta-defensin 1 	Q30KV2	Not found	CBD1	Canis familiaris (Dog) (Canis lupus familiaris)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP02919	NFDPKYRFERCAKVKGICKTFCDDDEYDYGYCIKWRNQCCI	41	Beta-defensin 110 (Defensin, beta 110; dogs, mammals, animals)	Q30KU3	Belongs to the glycosyl hydrolase 22 family	DEFB110	Canis familiaris (Dog)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP02920	KHHILRCMGNTGICRPSCRKTEQPYLYCLNYQSCCLQSYMRISISGREEKDDWSQQNRWPKIS	63	Beta-defensin 119 (Defensin, beta 119; dogs, mammals, animals)	Q30KT5	Belongs to the glycosyl hydrolase 22 family	DEFB119	Canis familiaris (Dog)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP02921	MRLLFLLFLLLVCLVQMTSGREKRRKSLECERMGGVCKHQKTHGCSILPAECKSRNKHCCRV	62	Beta-defensin 138 	Q30KR8	Not found	CBD138	Canis familiaris (Dog) (Canis lupus familiaris)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP02927	NKDCKYWCKDNLGLNYCCGQPGVTYPPFTKKHLGRCPAVRDTCTGVRTQLPTYCPHDGACQFRSKCCYDTCLKHHVCKTAEYPY	84	Antibacterial 11.5 kDa protein (crabs, Arthropods, animals)	Q9Y099	Not found	11.5 kDa	Carcinus maenas (Common shore crab) (Green crab)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16712935	Mol Immunol. 2007 Feb;44(5):943-949.	Brockton V, Hammond JA, Smith VJ.	Gene characterisation, isoforms and recombinant expression of carcinin, an antibacterial protein from the shore crab, Carcinus maenas.	
DRAMP02928	XXVPYPRPFPRPPIGPRPLPFPGGGRPFQS	30	Antibacterial 6.5 kDa protein (crabs, Arthropods, animals)	P82964	Not found	Not found	Carcinus maenas (Common shore crab) (Green crab)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Strong antimicrobial activity against Psychrobacter immobilis and M. luteus, less active against E. coli D22. 	Psychrobacter immobilis, Micrococcus luteus, Escherichia coli D22.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8856051	Eur J Biochem. 1996 Sep 15;240(3):532-539.	Schnapp D, Kemp GD, Smith VJ.	Purification and characterization of a proline-rich antibacterial peptide, with sequence similarity to bactenecin-7, from the haemocytes of the shore crab, Carcinus maenas.	
DRAMP02929	GQALNKLMPKIVSAIIYMIGQPNAGVTFLGHQCLVESTRQPDGFYTAKMWCTSWTSDNPIVGEGRSRVELEALKGSIRNFVQTASDYKKFTIEEVEDWIAS	102	Antimicrobial protein 1	A1YV58	Not found	AP	Scylla serrata (Mud crab)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Tissue specificity: Strongly expressed in gills, hemocytes and reproductive tract, with weaker expression in muscle, heart and digestive tract. Not detected in eyes and hepatopancreas (at protein level).	Gram-positive bacteria: Escherichia coli (MIC<50 µg/ml), Pseudomonas aeruginosa (MIC<25 µg/ml);##Gram-negative bacteria: Staphylococcus aureus (MIC<100 µg/ml), Streptococcus pyogenes (MIC<50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19219229	Acta Biochim Pol. 2009;56(1):71-82.	Yedery RD, Reddy KV.	Purification and characterization of antibacterial proteins from granular hemocytes of Indian mud crab, Scylla serrata.	
DRAMP02930	HSPGGA	6	Antimicrobial protein 2 (crabs, Arthropods, animals)	B3A0L8	Not found	Not found	Scylla serrata (Mud crab)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has antibacterial activity.	Gram-positive bacterium: Bacillus flexus;##Gram-negative bacteria: Escherichia coli, Vibrio harveyi.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2011) to UniProtKB	Meiyalagan V, Arumugam M.	Antibacterial protein (Scylla serrata).	
DRAMP02935	RRWCFRVCYKGFCYRKCR	18	Polyphemusin-2 (Polyphemusin II; crabs, Arthropods, animals)	P14216	Belongs to the tachyplesin/polyphemusin family	Not found	Limulus polyphemus (Atlantic horseshoe crab)	Antimicrobial, Antibacterial, Antifungal	Protein level	Bridge	Not found		"Function: Significantly inhibits the growth of Gram-negative and Gram-positive bacteria.
Tissue specificity: Hemocytes.
PTM: Contains two disulfide bonds 4-17; 8-13."	Yeast: Candida albicans M9.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation	Disulfide bond between Cys4 and Cys17,Cys8 and Cys13.	L	No cytotoxicity information found	Not found	2514185##15134657	J Biochem. 1989 Oct;106(4):663-668.##Biochim Biophys Acta. 2004 May 6;1698(2):239-250.	Miyata T, Tokunaga F, Yonega T, Yoshikawa K, Iwanaga S, Niwa M, Takao T, Shimonishi Y.##Powers J.P, Rozek A, Hancock R.E.	Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity.##Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I.	
DRAMP02936	NPLIPAIYIGATVGPSVWAYLVALVGAAAVTAANIRRASSDNHSCAGNRGWCRSKCFRHEYVDTYYSAVCGRYFCCRSR	79	Big defensin (crabs, Arthropods, animals)	P80957	Belongs to the big defensin family	Not found	Tachypleus tridentatus (Japanese horseshoe crab)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Combine helix and strand structure	Not found	2RNG resolved by NMR.	"Function: Significantly inhibits the growth of Gram-negative and Gram-positive bacteria and fungi in vitro.
Tissue specificity: Expressed in all tissues examined, including hemocytes, heart, hepatopancreas, stomach, intestine and skeletal muscle.
PTM: Contains three disulfide bonds."	Gram-negative bacteria: Escherichia coli 09:K39 (IC50=5 µg/ml), Salmonella typhimurium LT2 (IC50=20 µg/ml), S. minnesota R595 (IC50=1.3 µg/ml), Klebsiella pneumoniae (IC50>10 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (IC50<2.5 µg/ml).##Yeast: Candida albicans (IC50>20 µg/ml)(Ref.1).##Note: Washed with a phosphate buffered saline (PBS, pH 7.0).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	8586631##18785751	J Biochem. 1995 May;117(5):1131-1137.##Biochemistry. 2008 Oct 7;47(40):10611-9.	Saito T, Kawabata S, Shigenaga T, Takayenoki Y, Cho J, Nakajima H, Hirata M, Iwanaga S.##Kouno T, Fujitani N, Mizuguchi M, Osaki T, Nishimura S, Kawabata S, Aizawa T, Demura M, Nitta K, Kawano K.	A novel big defensin identified in horseshoe crab hemocytes: isolation, amino acid sequence, and antibacterial activity.##A novel beta-defensin structure: a potential strategy of big defensin for overcoming resistance by Gram-positive bacteria.	
DRAMP02937	YLAFRCGRYSPCLDDGPNVNLYSCCSFYNCHKCLARLENCPKGLHYNAYLKVCDWPSKAGCTSVNKECHLWKT	73	Tachycitin (crabs, Arthropods, animals)	P91818	Not found	Not found	Tachypleus tridentatus (Japanese horseshoe crab)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Beta strand	Not found	1DQC resolved by NMR.	Comment: No comments found on DRAMP database	Gram-positive bacteria: Staphylococcus aureus (IC50=56 µg/ml);##Gram-negative bacteria: Escherichia coli 363 (IC50=33 µg/ml), Escherichia coli B (IC50=2 µg/ml), Salmonella typhimurium LT2 (IC50=44 µg/ml), S. minnesota R595 (IC50=41 µg/ml), Klebsiella pneumoniae (IC50=32 µg/ml).##Yeast: Candida albicans (IC50=52 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	9010778##10770921	J Biochem. 1996 Dec;120(6):1253-1260.##J Biol Chem. 2000 Jun 16;275(24):17929-17932.	Kawabata S, Nagayama R, Hirata M, Shigenaga T, Agarwala KL, Saito T, Cho J, Nakajima H, Takagi T, Iwanaga S.##Suetake T, Tsuda S, Kawabata S, Miura K, Iwanaga S, Hikichi K, Nitta K, Kawano K.	Tachycitin, a small granular component in horseshoe crab hemocytes, is an antimicrobial protein with chitin-binding activity.##Chitin-binding proteins in invertebrates and plants comprise a common chitin-binding structural motif.	
DRAMP18230	LLLE	4	Gageotetrin B  (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis	Antimicrobial, Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Leu-Leu-Leu-OMeGlu-3-hydroxy-11-methyltridecanoic acid (HTDA)		Noncytotoxic Antimicrobial Linear Lipopeptides	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24502521	Org Lett. 2014 Feb 7;16(3):928-31. 	Tareq FS, Lee MA, Lee HS, Lee YJ, Lee JS, Hasan CM, Islam MT, Shin HJ.	Gageotetrins A-C, noncytotoxic antimicrobial linear lipopeptides from a marine bacterium Bacillus subtilis.	
DRAMP18231	LLLE	4	Gageotetrin C (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis	Antimicrobial, Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Leu-Leu-Leu-Glu-3-hydroxy-8,10-dimethyldodecanoic acid (HDDA)		Noncytotoxic Antimicrobial Linear Lipopeptides	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24502521	Org Lett. 2014 Feb 7;16(3):928-31. 	Tareq FS, Lee MA, Lee HS, Lee YJ, Lee JS, Hasan CM, Islam MT, Shin HJ.	Gageotetrins A-C, noncytotoxic antimicrobial linear lipopeptides from a marine bacterium Bacillus subtilis.	
DRAMP18232	LLEL	4	Gageopeptide A(Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis	Antimicrobial, Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Leu-Leu-Glu-Leu-3-beta-hydroxy-11-methyltridecanoic acid		Non-cytotoxic antifungal agents. It was revealed that compounds 1 and 2 exhibited stronger antifungal activity than 3 and 4. Compounds 1 and 2 were structurally different from compounds 3 and 4 in terms of having less side chains in the fatty acid units, suggesting that the side chain length and the additional methyl group in the aliphatic chain are important for antifungal activity. These compounds also showed potent antimicrobial activity against Gram positive and Gram negative bacteria with MIC values of 0.04?0.08 uM.	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2485741	Yan Ke Xue Bao. 1989 Jun;5(1-2):32-5.	Lin N, Gong XM, Xie QJ, Shao MR.	Study in cytotoxicity of gentamycin to corneal epithelium and endothelium in tissue culture.	
DRAMP02939	RWCFRVCYRGICYRKCR	17	Tachyplesin-2 (Tachyplesin II; crabs, Arthropods, animals)	P14214	Belongs to the tachyplesin/polyphemusin family	Not found	Tachypleus tridentatus (Japanese horseshoe crab)	Antimicrobial, Antibacterial, Antifungal	Protein level	Bridge	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans M9.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation (Arg17)	Disulfide bond between Cys3 and Cys16,Cys7 and Cys12.	L	No cytotoxicity information found	Not found	2514185	J Biochem. 1989 Oct;106(4):663-668.	Miyata T, Tokunaga F, Yonega T, Yoshikawa K, Iwanaga S, Niwa M, Takao T, Shimonishi Y.	Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity.	
DRAMP02940	KWCFRVCYRGICYRKCR	17	Tachyplesin-3 (Tachyplesin III; crabs, Arthropods, animals)	P18252	Belongs to the tachyplesin/polyphemusin family	Not found	Tachypleus gigas (Southeast Asian horseshoe crab)	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		"Function: Significantly inhibits the growth of Gram-negative and Gram-positive bacteria.
Tissue specificity: Hemocytes.
PTM: Contains two disulfide bonds 3-16; 7-12, and Arginine amide at R17."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation (Arg17)	Disulfide bond between Cys3 and Cys16,Cys7 and Cys12.	L	No cytotoxicity information found	Not found	2229025	J Biochem. 1990 Aug;108(2):261-266.	Muta T, Fujimoto T, Nakajima H, Iwanaga S.	Tachyplesins isolated from hemocytes of Southeast Asian horseshoe crabs (Carcinoscorpius rotundicauda and Tachypleus gigas): identification of a new tachyplesin, tachyplesin III, and a processing intermediate of its precursor.	
DRAMP02941	YSRCQLQGFNCVVRSYGLPTIPCCRGLTCRSYFPGSTYGRCQRF	44	Tachystatin-A1 (crabs, Arthropods, animals)	P0C1Z7	Not found	Not found	Tachypleus tridentatus (Japanese horseshoe crab)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Exhibits stronger antimicrobial activity against the Gram-positive bacterium S. aureus and fungi C. albicans and P. pastoris than Gram-negative bacterium E. coli. Binds to chitin (8.4 µM are required to obtain 50% of binding). Does not cause hemolysis on sheep erythrocytes. Has no blocking activity on the P-type calcium channel.
Tissue specificity: Granular hemocytes, small secretory granules.
PTM: Contains three disulfide bonds (By similarity)."	Gram-negative bacterium: Escherichia coli (IC50=25 µg/ml);##Gram-positive bacterium: Staphylococcus aureus (IC50=4.2 µg/ml).##Fungi: Candida albicans (IC50=3.0 µg/ml), Pichia pastoris (IC50=0.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	10473569	J Biol Chem. 1999 Sep 10;274(37):26172-26178.	Osaki T, Omotezako M, Nagayama R, Hirata M, Iwanaga S, Kasahara J, Hattori J, Ito I, Sugiyama H, Kawabata S.	Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins.	
DRAMP02942	YSRCQLQGFNCVVRSYGLPTIPCCRGLTCRSYFPGSTYGRCQRY	44	Tachystatin-A2 (crabs, Arthropods, animals)	Q9U8X3	Not found	Not found	Tachypleus tridentatus (Japanese horseshoe crab)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Beta strand	Not found	1CIX resolved by NMR.	"Function: Exhibits stronger antimicrobial activity against the Gram-positive bacterium S. aureus and fungi C. albicans and P. pastoris than Gram-negative bacterium E. coli. Binds to chitin (8.4 µM are required to obtain 50% of binding). Does not cause hemolysis on sheep erythrocytes. Has no blocking activity on the P-type calcium channel.
Tissue specificity: Granular hemocytes, small secretory granules.
PTM: Contains three disulfide bonds."	Gram-positive bacterium: Staphylococcus aureus (IC50=4.2 µg/ml);##Gram-negative bacterium: Escherichia coli (IC50=25 µg/ml).##Fungi: Candida albicans (IC50=3.0 µg/ml), Pichia pastoris (IC50=0.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	10473569##11959852	J Biol Chem. 1999 Sep 10;274(37):26172-26178.##J Biol Chem. 2002 Jun 28;277(26):23651-23657.	Osaki T, Omotezako M, Nagayama R, Hirata M, Iwanaga S, Kasahara J, Hattori J, Ito I, Sugiyama H, Kawabata S.##Fujitani N, Kawabata S, Osaki T, Kumaki Y, Demura M, Nitta K, Kawano K.	Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins.##Structure of the antimicrobial peptide tachystatin A.	
DRAMP02943	YVSCLFRGARCRVYSGRSCCFGYYCRRDFPGSIFGTCSRRNF	42	Tachystatin-B1 (crabs, Arthropods, animals)	P0C1Z8	Not found	Not found	Tachypleus tridentatus (Japanese horseshoe crab)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Beta strand	Not found	2DCV resolved by NMR.	"Function: Exhibits stronger antimicrobial activity against the Gram-positive bacterium S. aureus and fungi C. albicans and P. pastoris than Gram-negative bacterium E. coli. Binds to chitin (4.3 µM are required to obtain 50% of binding). Does not cause hemolysis on sheep erythrocytes. Has no blocking activity on the P-type calcium channel.
Tissue specificity: Granular hemocytes, small secretory granules.
Domain: The presence of a 'disulfide through disulfide knot' structurally defines this protein as a knottin."	Gram-positive bacterium: Staphylococcus aureus (IC50=7.4 µg/ml).##Fungi: Candida albicans (IC50=3.0 µg/ml), Pichia pastoris (IC50=0.1 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	10473569##17394123	J Biol Chem. 1999 Sep 10;274(37):26172-26178.##J Pept Sci. 2007 Apr;13(4):269-279.	Osaki T, Omotezako M, Nagayama R, Hirata M, Iwanaga S, Kasahara J, Hattori J, Ito I, Sugiyama H, Kawabata S.##Fujitani N, Kouno T, Nakahara T, Takaya K, Osaki T, Kawabata S, Mizuguchi M, Aizawa T, Demura M, Nishimura S, Kawano K.	Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins.##The solution structure of horseshoe crab antimicrobial peptide tachystatin B with an inhibitory cystine-knot motif.	
DRAMP02944	YITCLFRGARCRVYSGRSCCFGYYCRRDFPGSIFGTCSRRNF	42	Tachystatin-B2 (crabs, Arthropods, animals)	P0C1Z9	Not found	Not found	Tachypleus tridentatus (Japanese horseshoe crab)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Beta strand	Not found	2DCW resolved by NMR.	"Function: Exhibits stronger antimicrobial activity against the Gram-positive bacterium S. aureus and fungi C. albicans and P. pastoris than Gram-negative bacterium E. coli. Binds to chitin (4.3 µM are required to obtain 50% of binding). Does not cause hemolysis on sheep erythrocytes. Has no blocking activity on the P-type calcium channel.
Tissue specificity: Granular hemocytes, small secretory granules.
Domain: The presence of a 'disulfide through disulfide knot' structurally defines this protein as a knottin."	Gram-positive bacterium: Staphylococcus aureus (IC50=7.4 µg/ml).##Fungi: Candida albicans (IC50=3.0 µg/ml), Pichia pastoris (IC50=0.1 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	10473569##17394123	J Biol Chem. 1999 Sep 10;274(37):26172-26178.##J Pept Sci. 2007 Apr;13(4):269-279.	Osaki T, Omotezako M, Nagayama R, Hirata M, Iwanaga S, Kasahara J, Hattori J, Ito I, Sugiyama H, Kawabata S.##Fujitani N, Kouno T, Nakahara T, Takaya K, Osaki T, Kawabata S, Mizuguchi M, Aizawa T, Demura M, Nishimura S, Kawano K.	Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins.##The solution structure of horseshoe crab antimicrobial peptide tachystatin B with an inhibitory cystine-knot motif.	
DRAMP02945	DYDWSLRGPPKCATYGQKCRTWSPPNCCWNLRCKAFRCRPR	41	Tachystatin-C (crabs, Arthropods, animals)	P0C200	Not found	Not found	Tachypleus tridentatus (Japanese horseshoe crab)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		Causes hemolysis on sheep erythrocytes, probably by forming ion-permeable pores.	Gram-negative bacterium: Escherichia coli (IC50=1.2 µg/ml);##Gram-positive bacterium: Staphylococcus aureus (IC50=0.8 µg/ml).##Fungi: Candida albicans (IC50=0.9 µg/ml), Pichia pastoris (IC50=0.3 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Chitin-binding	10473569	J Biol Chem. 1999 Sep 10;274(37):26172-26178.	Osaki T, Omotezako M, Nagayama R, Hirata M, Iwanaga S, Kasahara J, Hattori J, Ito I, Sugiyama H, Kawabata S.	Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins.	
DRAMP02946	YEALVTSILGKLTGLWHNDSVDFMGHICYFRRRPKIRRFKLYHEGKFWCPGWAPFEGRCKYCVVF	65	PtALF1 (Portunus trituberculatus anti-lipopolysaccharide factor isoform 1; crabs, Arthropods, ani	No entry found	Not found	Not found	Portunus trituberculatus (Swimming Crab)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Contains a signal peptide and an LPS-binding Domain: (CYFRRRPKIRRFKLYHEGKFWC) and two conserved cysteine residues which can form a disulfide bridge.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	21168510	Fish Shellfish Immunol. 2011 Feb;30(2):583-591.	Liu Y, Cui Z, Luan W, Song C, Nie Q, Wang S, Li Q.	Three isoforms of anti-lipopolysaccharide factor identified from eyestalk cDNA library of swimming crab Portunus trituberculatus.	
DRAMP02947	YEALVTSILGKLTGLWHNDSVDFMGHICYFRRRPKIRRFKLYHEGKFWCPGWAPFEGRSRTKSRSGSSREATKDFVRKALQNGLVTQQDASLWLN	95	PtALF2 (Portunus trituberculatus anti-lipopolysaccharide factor isoform 2; crabs, Arthropods, ani	No entry found	Not found	Not found	Portunus trituberculatus (Swimming Crab)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Contains a signal peptide and an LPS-binding Domain: (CYFRRRPKIRRFKLYHEGKFWC) and two conserved cysteine residues which can form a disulfide bridge.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	21168510	Fish Shellfish Immunol. 2011 Feb;30(2):583-591.	Liu Y, Cui Z, Luan W, Song C, Nie Q, Wang S, Li Q.	Three isoforms of anti-lipopolysaccharide factor identified from eyestalk cDNA library of swimming crab Portunus trituberculatus.	
DRAMP18228	LLDVLLE	7	Gageostatin C (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-		Not found	Leu-Leu-Asp-Val-Leu-Leu-Glu-(E)-7,9-dimethylundec-2-enoic acid		surfactin like heptapeptides, cytotoxic. It is noteworthy that these compounds 1	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85. 	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis.	
DRAMP18229	LE	2	Gageotetrin A (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis	Antimicrobial, Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Leu-Glu-3-hydroxy-11-methyltridecanoic acid (HTDA)		Noncytotoxic Antimicrobial Linear Lipopeptides	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24502521	Org Lett. 2014 Feb 7;16(3):928-31. 	Tareq FS, Lee MA, Lee HS, Lee YJ, Lee JS, Hasan CM, Islam MT, Shin HJ.	Gageotetrins A-C, noncytotoxic antimicrobial linear lipopeptides from a marine bacterium Bacillus subtilis.	
DRAMP02949	GWLDIVKAIVVPAARETIKTQEITLLDHYCTLSRSPYIKSLELHYRAEVTCPGWTIIRGRGSNHRNPTNSGKDALKDFMTQAVAAGLVTKEEAAPWLN	98	PtALF4 (Portunus trituberculatus anti-lipopolysaccharide factor isoform 4; crabs, Arthropods, ani	No entry found	Not found	Not found	Portunus trituberculatus (Swimming Crab)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Contains a signal peptide and an LPS-binding Domain: (CTLSRSPYIKSLELHYRAEVTC) and two conserved cysteine residues which can form a disulfide bridge.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	21362485##22333564	Fish Shellfish Immunol. 2011 Jul;31(1):29-42.##Fish Shellfish Immunol. 2012 May;32(5):724-731.	Liu Y, Cui Z, Song C, Wang S, Li Q.##Liu Y, Cui Z, Li X, Song C, Li Q, Wang S.	Multiple isoforms of immune-related genes from hemocytes and eyestalk cDNA libraries of swimming crab Portunus trituberculatus.##A new anti-lipopolysaccharide factor isoform (PtALF4) from the swimming crab Portunus trituberculatus exhibited structural and functional diversity of ALFs.	
DRAMP02954	SRWPSPGRPRPFPGRPNPIFRPRPCICVRQPCPCDTY	37	Arasin 2 (Pro-rich, Arg-rich; crabs, Arthropods, animals)	A6XMY1	Not found	Not found	Hyas araneus (Great spider crab) 	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17658600	Dev Comp Immunol. 2008;32(3):275-285.	StensvÃ¥g K, Haug T, Sperstad SV, Rekdal O, Indrevoll B, Styrvold OB.	Arasin 1, a proline-arginine-rich antimicrobial peptide isolated from the spider crab, Hyas araneus.	
DRAMP02955	LGAWLAGKVAGTVATYAWNRYV	22	Hedistin (marine annelid, Metazoa)	Q1PG44	Not found	Not found	Hediste diversicolor	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus (MRSA);##Gram-negative bacterium: Vibrio alginolyticus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17210178	Dev Comp Immunol. 2007;31(8):749-762. 	Tasiemski A, Schikorski D, Le Marrec-Croq F, Pontoire-Van Camp C, Boidin-Wichlacz C, Sautière PE.	Hedistin: A novel antimicrobial peptide containing bromotryptophan constitutively expressed in the NK cells-like of the marine annelid, Nereis diversicolor.	
DRAMP02957	MWHLKLFAVLVICLLLAVQVHGSPIPELSSAKRRPRRITPFWRAVSLRPIGASCRDDSECLTRLCRKRRCSLSVAQE	77	Liver-expressed antimicrobial protein 2 (pigs, mammals, animals)	Q8MJ79	Not found	Not found	Sus scrofa (Pig)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16051358	Dev Comp Immunol. 2006;30(4):357-366.	Sang Y, Ramanathan B, Minton JE, Ross CR, Blecha F.	Porcine liver-expressed antimicrobial peptides, hepcidin and LEAP-2: cloning and induction by bacterial infection.	
DRAMP02958	QLRYREAVLRAVDRLNEQSSEANLYRLLELDQPPKADEDPGTPKPVSFTVKETVCPRPTRQPPELCDFKEKQCVGTVTLNPSIHSLDISCNEIQSV	96	Cathelin (pigs, mammals, animals)	P15175	Belongs to the cathelicidin family	Not found	Sus scrofa (Pig)	Unknown	Protein level	Not found	Not found		"Function: Probably a microbicidal peptide.
PTM: contains two disulfide bonds 55-66; 73-90."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8262248	FEBS Lett. 1993 Dec 27;336(2):289-292.	Lenarcic B, Ritonja A, Dolenc I, Stoka V, Berbic S, Pungercar J, Strukelj B, Turk V.	Pig leukocyte cysteine proteinase inhibitor (PLCPI), a new member of the stefin family.	
DRAMP02967	RADTQTYQPYNKDWIKEKIYVLLRRQAQQAGK	32	Antibacterial peptide 3910 (AP 3910; pigs, mammals, animals)	P80230, P37110	Belongs to the E(R) family	ERH	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: May have a role in the cell cycle (By similarity). AP 3910 has antibacterial activity against B. megaterium.
Subunit structure: Homodimer (By similarity)."	Gram-positive bacterium: Bacillus megaterium.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8375398	Eur J Biochem. 1993 Sep 1;216(2):623-629.	Agerberth B, Boman A, Andersson M, Jörnvall H, Mutt V, Boman HG.	Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910.	
DRAMP02968	AFPPPNVPGPRFPPPNFPGPRFPPPNFPGPRFPPPNFPGPRFPPPNFPGPPFPPPIFPGPWFPPPPPFRPPPFGPPRFP	79	Prophenin-1 (C6, PF-1; Pro-rich; pigs, mammals, animals)	P51524	Belongs to the cathelicidin family	Not found	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Exerts antimicrobial activity. It is more effective against Gram-negative bacteria than Gram-positive bacteria.	Gram-positive bacterium: Listeria monocytogenes;##Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7698355##7576250	FEBS Lett. 1995 Mar 27;362(1):65-69.##Biol Chem Hoppe Seyler. 1995 Aug;376(8):507-510.	Harwig SS, Kokryakov VN, Swiderek KM, Aleshina GM, Zhao C, Lehrer RI.##Strukelj B, Pungercar J, Kopitar G, Renko M, Lenarcic B, Berbić S, Turk V.	Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes.##Molecular cloning and identification of a novel porcine cathelin-like antibacterial peptide precursor.	
DRAMP02969	AFPPPNVPGPRFPPPNVPGPRFPPPNFPGPRFPPPNFPGPRFPPPNFPGPPFPPPIFPGPWFPPPPPFRPPPFGPPRFP	79	Prophenin-2 (C12, PF-2, PR-2; Pro-rich; pigs, mammals, animals)	P51525	Belongs to the cathelicidin family	Not found	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Exerts antimicrobial activity. It is more effective against Gram-negative bacteria than Gram-positive bacteria.	Gram-positive bacterium: Listeria monocytogenes;##Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8262247##7498526	FEBS Lett. 1993 Dec 27;336(2):284-288.##FEBS Lett. 1995 Dec 4;376(3):130-134.	Pungercar J, Strukelj B, Kopitar G, Renko M, Lenarcic B, Gubensek F, Turk V.##Zhao C, Ganz T, Lehrer RI.	Molecular cloning of a putative homolog of proline/arginine-rich antibacterial peptides from porcine bone marrow.##Structures of genes for two cathelin-associated antimicrobial peptides: prophenin-2 and PR-39.	
DRAMP02971	RGGRLCYCRRRFCICV	16	Protegrin-2 (Protegrin 2; PG-2; pigs, mammals, animals)	P32195	Belongs to the cathelicidin family	NPG2	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found	2MUH resolved by NMR.	"Function: Microbicidal activity. Active against E.coli, Listeria monocytogenes and C.albicans, in vitro.
PTM: Contains two disulfide bonds 6-15; 8-13 and Valine amide at V16."	Gram-positive bacterium: Listeria moncyrogenes strain EGD (MIC>25 µg/ml);##Gram-negative bacterium: Escherichia coli ML-35 (MIC>25 µg/ml).##Yeast: Candida albicans strain 820 (MIC>25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8335113##8250892	FEBS Lett. 1993 Jul 26;327(2):231-236.##Biochem Biophys Res Commun. 1993 Nov 15;196(3):1363-1368.	Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, Korneva HA, Lehrer RI.##Storici P, Zanetti M.	Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.##A novel cDNA sequence encoding a pig leukocyte antimicrobial peptide with a cathelin-like pro-sequence.	
DRAMP02972	RGGGLCYCRRRFCVCVGR	18	Protegrin-3 (Protegrin 3; PG-3; pigs, mammals, animals)	P32196	Belongs to the cathelicidin family	NPG3	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found	2MZ6 resolved by NMR.	"Function: Microbicidal activity. Active against E.coli, Listeria monocytogenes and C.albicans, in vitro.
PTM: Probablely contains two disulfide bonds 6-15; 8-13 and Arginine amide at R18."	Gram-positive bacterium: Listeria moncyrogenes strain EGD;##Gram-negative bacterium: Escherichia coli ML-35.##Yeast: Candida albicans strain 820.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8335113	FEBS Lett. 1993 Jul 26;327(2):231-236.	Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, Korneva HA, Lehrer RI.	Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.	
DRAMP02973	RGGRLCYCRGWICFCVGR	18	Protegrin-4 (Protegrin 4; PG-4; pigs, mammals, animals)	P49933	Belongs to the cathelicidin family	NPG4	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Antifungal	Protein level	Bridge	Not found		"Function: Microbicidal activity (By similarity).
PTM: Contains two disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8013647##12705830	FEBS Lett. 1994; 346: 285-288.##ochemistry. 2003 Apr 29;42(16):4669-4680.	Zhao C, Liu L, Lehrer RI.##Yang Y, Sanchez JF, Strub MP, Brutscher B, Aumelas A.	Identification of a new member of the protegrin family by cDNA cloning.##NMR structure of the cathelin-like domain of the protegrin-3 precursor.	
DRAMP02974	RGGRLCYCRPRFCVCVGR	18	Protegrin-5 (Protegrin 5; PG-5; pigs, mammals, animals)	P49934	Belongs to the cathelicidin family	NPG5	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Antifungal	Homology	Bridge	Not found		"Function: Microbicidal activity (By similarity).
PTM: Contains two disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7628604	FEBS Lett. 1995 Jul 17;368(2):197-202.	Zhao C, Ganz T, Lehrer RI.	The structure of porcine protegrin genes.	
DRAMP02976	NIGNSVSCLRNKGVCMPGKCAPKMKQIGTCGMPQVKCCKRK	41	Beta-defensin 1 (BD-1; Defensin, beta 1; pigs, mammals, animals)	O62697	Belongs to the beta-defensin family	DEFB1	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Homology	Not found	Not found		"Function: Has bactericidal activity (By similarity).
PTM: Contains three disulfide bonds 8-37; 15-30; 20-38 (By similarity)."	Gram-positive bacteria: Listeria monocytogenes, Streptococcus suis, Actinobacillus pleuropneumoniae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16552064##9537511##10446172	Infect Immun. 2006 Apr;74(4):2338-2352.##FEBS Lett. 1998 Mar 6;424(1-2):37-40.## Biol Chem. 1999 Aug 20;274(34):24031-24037.	Elahi S, Buchanan RM, Attah-Poku S, Townsend HG, Babiuk LA, Gerdts V.##Zhang G, Wu H, Shi J, Ganz T, Ross CR, Blecha F.##Zhang G, Hiraiwa H, Yasue H, Wu H, Ross CR, Troyer D, Blecha F.	The host defense peptide Beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets.##Molecular cloning and tissue expression of porcine beta-defensin-1.##Cloning and characterization of the gene for a new epithelial beta-defensin. Genomic structure, chromosomal localization, and evidence for its constitutive expression.	
DRAMP02977	SVSCLRNKGVCMPGKCAPKMKQIGTCGMPQVKCCKRK	37	pBD-1 (porcine beta-defensin 1; pigs, mammals, animals)	No entry found	Not found	Not found	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17168333	Sheng Wu Gong Cheng Xue Bao. 2006 Nov;22(6):1036-9.	Jiang LH, Lu HR, Huang DX, Yi JB, Li LY, Lin F.	[Expression of porcine beta-defensin 1 gene in Pichia pastoris] In Chinese	
DRAMP02978	DHYICAKKGGTCNFSPCPLFNRIEGTCYSGKAKCCIR	37	pBD-2 (porcine beta-defensin 2; pigs, mammals, animals)	No entry found	Not found	Not found	Sus scrofa (Pig)	Antimicrobial, Antibacterial	Not found	Combine helix and strand structure	Not found		Thought to be orthologue of hBD-1. The native pBD-2 has NOT been purified yet, so it's unclear to what extent the synthetic peptide corresponds to the in vivo form. Also of note is that the synthetic peptide does not have S-S bonds. pBD-2 (4-8 microM) killed these pathogens within 3h. Antimicrobial activity of pBD-2 was decreased at higher ionic strengths with no residual activity at 150mM NaCl. 	Salmonella typhimurium, Listeria monocytogenes and Erysipelothrix rhusiopathiae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17658606	Mol Immunol. 2008 Jan;45(2):386-394.	Veldhuizen EJ, Rijnders M, Claassen EA, van Dijk A, Haagsman HP.	Porcine beta-defensin 2 displays broad antimicrobial activity against pathogenic intestinal bacteria.	
DRAMP02979	DTHFPICIFCCGCCRKAICGMCCKT	25	Hepcidin (pigs, mammals, animals)	Q8MJ80	Belongs to the hepcidin family	HAMP	Sus scrofa (Pig)	Antimicrobial	Homology	Not found	Not found		"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases	Sang Y, Ross C.R, Blecha F.	Cloning and characterization of porcine liver-expressed antimicrobial peptides, Hepcidin (pHAMP) and LEAP2.	
DRAMP02981	MTPFWRAVSLRPIGASCRDDSECLTRLCRKRRCSLSVAQE	40	Liver-expressed antimicrobial peptide 2 (LEAP-2; pigs, mammals, animals)	Q95JB4	Belongs to the LEAP2 family	LEAP2	Sus scrofa (Pig)	Antimicrobial 	Homology	Not found	Not found		PTM: Contains two disulfide bonds 17-28; 23-33.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12493837	Protein Sci. 2003 Jan;12(1):143-152.	Krause A, Sillard R, Kleemeier B, Klüver E, Maronde E, Conejo-García JR, Forssmann WG, Schulz-Knappe P, Nehls MC, Wattler F, Wattler S, Adermann K.	Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver.	
DRAMP02982	MPVAVGPYGQSQPSCFDRVKMGFVMGCAVGMAAGALFGPFSCLRIGMRGRELMGGIGKTMMQSGGTFGPFMAIGMGIRC	79	Reactive oxygen species modulator 1 (ROS modulator 1; pigs, mammals, animals)	A1XQR6	Belongs to the MGR2 family	romo1	Sus scrofa (Pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Homology	Not found	Not found		"Function: Has antibacterial activity against a variety of bacteria. Acts by inducing bacterial membrane breakage (By similarity).
Induces production of reactive oxygen species (ROS) which are necessary for cell proliferation. May play a role in inducing oxidative DNA damage and replicative senescence. May play a role in the coordination of mitochondrial morphology and cell proliferation (By similarity).
Domain: Contains a transmembrane helix."	Gram-positive bacteria: Staphylococcus aureus, Mycobacterium tuberculosis;##Gram-negative bacterium: Pseudomonas aeruginosa.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAY-2006) to the EMBL/GenBank/DDBJ databases	Cai G, Chen Y, Wang C, Li J, Peng G, Zhang H.	Generation and analysis of cDNA sequences derived from a porcine skeletal muscle library.	
DRAMP02983	MTPFWRGVSLRPIGASCRDDSECITRLCKKRRCSLSVAQE	40	Liver-expressed antimicrobial peptide 2 (LEAP-2; pigs, mammals, animals)	Q91X13	Not found	LEAP2	Cavia porcellus (Guinea pig)	Antimicrobial 	Homology	Not found	Not found		PTM: Contains two disulfide bonds 17-28; 23-33.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12493837	Protein Sci. 2003 Jan;12(1):143-152.	Krause A, Sillard R, Kleemeier B, Klüver E, Maronde E, Conejo-García JR, Forssmann WG, Schulz-Knappe P, Nehls MC, Wattler F, Wattler S, Adermann K.	Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver.	
DRAMP02984	GLRKKFRKTRKRIQKLGRKIGKTGRKVWKAWREYGQIPYPCRI	43	Neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11; pigs, mammals, animals)	Q91X12	Not found	CAP11	Cavia porcellus (Domestic guinea pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Shows antibacterial activity against the Gram-positive bacteium S. aureus and Gram-negative bacterium E. coli.	Gram-negative bacterium: Escherichia coli (ED50=30-35 nM);##Gram-positive bacterium: Staphylococcus aureus (ED50=90-120 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8644997	Arch Biochem Biophys. 1996 Apr 15;328(2):219-226.	Yomogida S, Nagaoka I, Yamashita T.	Purification of the 11- and 5-kDa antibacterial polypeptides from guinea pig neutrophils.	
DRAMP02985	RRCICTTRTCRFPYRRLGTCLFQNRVYTFCC	31	Neutrophil cationic peptide 2 (CP-2; GNCP-2; pigs, mammals, animals)	P49112, Q9R0Z5	Belongs to the alpha-defensin family	Not found	Cavia porcellus (Guinea pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral	Homology	Bridge	Not found		"Function: Has antibiotic, anti-fungi and antiviral activity.
PTM: Contains three disulfide bonds (By similarity)."	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8173076##10738945	DNA Seq. 1993;4(2):123-128.##Inflamm Res. 2000 Feb;49(2):73-79.	Nagaoka I, Nonoguchi A, Yamashita T.##Nagaoka I, Hirota S, Yomogida S, Ohwada A, Hirata M.	Cloning and characterization of the guinea pig neutrophil cationic peptide-1 and -2 genes.##Synergistic actions of antibacterial neutrophil defensins and cathelicidins.	
DRAMP02986	RRCICTTRTCRFPYRRLGTCIFQNRVYTFCC	31	Neutrophil cationic peptide 1 (GPNP; Antiviral defensin; pigs, mammals, animals)	Q64365, P11478	Belongs to the alpha-defensin family	Not found	Cavia porcellus (Guinea pig)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral	Protein level	Bridge	Not found		"Function: Has antibiotic, anti-fungi and antiviral activity.
Tissue specificity: Bone marrow."	Gram-positive bacteria: Staphylococcus aureus, Streptococcus;##Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2473036##3623703	Infect Immun. 1989 Aug;57(8):2405-2409.##Infect Immun. 1987 Sep;55(9):2281-2286.	Yamashita T, Saito K.##Selsted ME, Harwig SS.	Purification, primary structure, and biological activity of guinea pig neutrophil cationic peptides.##Purification, primary structure, and antimicrobial activities of a guinea pig neutrophil defensin.	
DRAMP02987	AGFAAQAAASLAPVAIQQL	19	Tricholongin BII (Fungi)	No entry found	Not found	Not found	Trichoderma longibrachiatum	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1935961	Eur J Biochem. 1991 Nov 1;201(3):661-674.	Rebuffat S, Prigent Y, Auvin-Guette C, Bodo B.	Tricholongins BI and BII, 19-residue peptaibols from Trichoderma longibrachiatum. Solution structure from two-dimensional NMR spectroscopy.	
DRAMP02988	AGFAAQAAASLAPVAAQQL	19	Tricholongin BI (Fungi)	No entry found	Not found	Not found	Trichoderma longibrachiatum	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1935961	Eur J Biochem. 1991 Nov 1;201(3):661-674.	Rebuffat S, Prigent Y, Auvin-Guette C, Bodo B.	Tricholongins BI and BII, 19-residue peptaibols from Trichoderma longibrachiatum. Solution structure from two-dimensional NMR spectroscopy.	
DRAMP02989	VNWKKVLGKIIKVAK	15	Lasioglossin LL-I (Insects, animals)	No entry found	Not found	Not found	Lasioglossum laticeps (Eusocial Bee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Not found	Not found	Not found		Function: Active against B. subtilis, S. aureus, P. aeruginosa, and E. coli. Low hemolytic toxicity.	[Ref.19591185]Gram-positive bacteria: B. subtilis(MIC=0.8 μM), S. aureus(MIC=14.3 μM);##Gram-negative bacteria: P. aeruginosa(MIC=15.8 μM), E. coli(MIC=1.7 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2099.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP02990	VNWKKILGKIIKVAK	15	Lasioglossin LL-II (Insects, animals)	No entry found	Not found	Not found	Lasioglossum laticeps (Eusocial Bee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Not found	Not found	Not found		Function: Active against B. subtilis, S. aureus, P. aeruginosa, and E. coli. Low hemolytic toxicity.	[Ref.19591185]Gram-positive bacteria: B. subtilis(MIC=0.7 μM), S. aureus(MIC=9.0 μM);##Gram-negative bacteria: P. aeruginosa(MIC=14.4 μM), E. coli(MIC=1.4 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2099.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP02991	VNWKKILGKIIKVVK	15	Lasioglossin LL-III (Insects, animals)	No entry found	Not found	Not found	Lasioglossum laticeps (Eusocial Bee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Not found	Not found	Not found		Function: Active against B. subtilis, S. aureus, P. aeruginosa, and E. coli. Low hemolytic toxicity.	[Ref.19591185]Gram-positive bacteria: B. subtilis(MIC=0.7 μM), S. aureus(MIC=3.9 μM);##Gram-negative bacteria: P. aeruginosa(MIC=18.7 μM), E. coli(MIC=1.4 μM).	[Ref.19591185]LC50>220 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2099.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP02992	GLPRKILCAIAKKKGKCKGPLKLVCKC	27	Lasiocepsin (Insects, animals)	No entry found	Not found	Not found	Lasioglossum laticeps (Eusocial Bee)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Not found	Not found	Not found	2MBD	Function: The synthetic lasiocepsin possessed antimicrobial activity against both Gram-positive and -negative bacteria, antifungal activity against Candida albicans, and weak hemolytic activity against human erythrocytes.	No MICs found in DRAMP database	[Ref.22038181]LC50>200 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22038181	Amino Acids. 2012 Aug;43(2):751-761.	Monincová L, Slaninová J, Fucík V, Hovorka O, Voburka Z, Bednárová L, Malon P, Stokrová J, Cerovský V.	Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae). 	
DRAMP02994	VTCDLLSFKGQVNDSACAANCLSLGKAGGHCEKVGCICRKTSFKDLWDKYF	51	Defensin-1 (Royalisin; Insects, animals)	P17722, C7AHT1, Q5MY57, Q9BMA5	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Apis mellifera (Honeybee)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Found in royal jelly and in hemolymph, potent antibacterial protein against Gram-positive bacteria at low concentration.
Tissue specificity: High expression in head, hypopharyngeal gland, and mandibular gland. Low expression in thorax and thoracic salivary gland.
PTM: Contains three disulfide bonds 3-31; 17-36; 21-38 and Phenylalanine amide at F51."	Bifidobacterium adolescentis ATCC15703, Bifidobacterium longum ATCC15707, Leuconostoc cremoris ATCC 19254, Lactobacillus spps, Staphylococcus aureus, Streptococcus spps	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2358464##15607651	J Biol Chem. 1990 Jul 5;265(19):11333-11337.##Insect Biochem Mol Biol. 2005 Jan;35(1):11-22.	Fujiwara S, Imai J, Fujiwara M, Yaeshima T, Kawashima T, Kobayashi K.##Klaudiny J, Albert S, Bachanová K, Kopernický J, Simúth J.	A potent antibacterial protein in royal jelly. Purification and determination of the primary structure of royalisin.##Two structurally different defensin genes, one of them encoding a novel defensin isoform, are expressed in honeybee Apis mellifera.	
DRAMP03004	FVPYNPPRPGQSKPFPSFPGHGPFNPKIQWPYPLPNPGH	39	Abaecin (Insects, animals)	P81463	Not found	Not found	Bombus pascuorum (Brown bumblebee)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial peptide against Gram-positive and Gram-negative bacteria.
Induction: By bacterial infection."	Gram-negative bacteria: Micrococcus luteus;##Gram-negative bacteria: Escherichia coli D22.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9219367	Insect Biochem Mol Biol. 1997 May;27(5):413-22.	Rees JA, Moniatte M, Bulet P.	Novel antibacterial peptides isolated from a European bumblebee, Bombus pascuorum (Hymenoptera, Apoidea).	
DRAMP03005	GNRPVYIPPPRPPHPRL	17	Apidaecin (Insects, animals)	P81464	Belongs to the apidaecin family	Not found	Bombus pascuorum (Brown bumblebee)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial peptide against Gram-positive and Gram-negative bacteria.
Induction: By bacterial infection."	Gram-negative bacteria: Micrococcus luteus;##Gram-negative bacteria: Escherichia coli D22.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9219367	Insect Biochem Mol Biol. 1997 May;27(5):413-422.	Rees JA, Moniatte M, Bulet P.	Novel antibacterial peptides isolated from a European bumblebee, Bombus pascuorum (Hymenoptera, Apoidea).	
DRAMP03006	VTCDLLSIKGVAEHSACAANCLSMGKAGGRCENGICLCRKTTFKELWDKRF	51	Defensin (Insects, animals)	P81462	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Bombus pascuorum (Brown bumblebee)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		"Function: Antibacterial peptide against Gram-positive and Gram-negative bacteria and fungi.
Induction: By bacterial infection."	Gram-negative bacteria: Micrococcus luteus;##Gram-negative bacteria: Escherichia coli D22.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9219367	Insect Biochem Mol Biol. 1997 May;27(5):413-422.	Rees JA, Moniatte M, Bulet P.	Novel antibacterial peptides isolated from a European bumblebee, Bombus pascuorum (Hymenoptera, Apoidea).	
DRAMP04531	AAGMGFFGAR	10	Urechistachykinin II (UII)	P40752	Not found	Not found	Urechis unicinctus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. Antifungal. Has no hemolytic activity.	[Ref.18570895] Gram-negative bacteria: Escherichia coli O-157 (MIC=12.7μM), Pseudomonas aeruginosa (MIC=12.7μM), Vibrio vulnificu (MIC=25.4μM) ;##Gram-positive bacteria: Streptococcus mutans (MIC=12.7μM), Staphylococcus aureus (MIC=25.4μM),Enterococcus faecium(MIC=25.4μM) ;##Fungi: Candida albicans(MIC=25.4μM), Trichosporon beigelii (MIC=12.7μM), Malassezia furfur (MIC=50.9μM).	[Ref.18570895] Has no hemolytic activities against human erythrocyte cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18570895	FEBS Lett. 2008 Jul 9;582(16):2463-2466.	Sung WS, Park SH, Lee DG.	"        Antimicrobial effect and membrane-active mechanism of Urechistachykinins, neuropeptides derived from Urechis unicinctus.

"	
DRAMP04530	LRQSQFVGSR	10	Urechistachykinins I (UI)	P40751	Not found	Not found	Urechis unicinctus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. Antifungal. Has no hemolytic activity.	[Ref.18570895] Gram-negative bacteria: Escherichia coli O-157 (MIC=10.6μM), Pseudomonas aeruginosa (MIC=21.3μM), Vibrio vulnificus (MIC=42.5μM) ;##Gram-positive bacteria: Streptococcus mutans(MIC=21.3μM), Staphylococcus aureus (MIC=42.5μM),Enterococcus faecium (MIC=21.3μM) ;##Fungi: Candida albicans (MIC=42.5μM), Trichosporon beigelii (MIC=21.3μM), Malassezia furfur (MIC=42.5μM).	[Ref.18570895] Has no hemolytic activities against human erythrocyte cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18570895	FEBS Lett. 2008 Jul 9;582(16):2463-2466.	Sung WS, Park SH, Lee DG.	"        Antimicrobial effect and membrane-active mechanism of Urechistachykinins, neuropeptides derived from Urechis unicinctus.

"	
DRAMP01224	GFISTVKNLATNVAGTVIDTIKCKVTGGC	29	Palustrin-2AR (Palustrin-2ARa; Ranatuerin-2SEa; Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana areolata (North American crawfish frog)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-negative bacterium Escherichia coli. Has hemolytic activity.	[Ref.12429503] Gram-negative bacterium: Escherichia coli (MIC=110 μM)	[Ref.12429503] HC50>300 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys23 and Cys29)	Disulfide bond between Cys23 and Cys29.	L	No cytotoxicity information found	Not found	12429503	Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.	Ali MF, Lips KR, Knoop FC, Fritzsch B, Miller C, Conlon JM.	Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.	
DRAMP03013	LNLTKWLGKLGVILSHLNK	19	Bombolitin-6 (Insects, animals)	P0CD67	Belongs to the MCD family Bombolitin subfamily	Not found	Bombus lapidarius (Red-tailed bumblebee) (Apis lapidaria)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Mast cell degranulating peptide. May also display antibacterial and antifungal activities (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16626777	Toxicon. 2006 May;47(6):676-687.	Favreau P, Menin L, Michalet S, Perret F, Cheneval O, Stöcklin M, Bulet P, Stöcklin R.	Mass spectrometry strategies for venom mapping and peptide sequencing from crude venoms: case applications with single arthropod specimen.	
DRAMP03014	LKLKDILGKIKVILSHLNK	19	Bombolitin-7 (Insects, animals)	P0CD68	Belongs to the MCD family Bombolitin subfamily	Not found	Bombus lapidarius (Red-tailed bumblebee) (Apis lapidaria)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Mast cell degranulating peptide. May also display antibacterial and antifungal activities (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16626777	Toxicon. 2006 May;47(6):676-687.	Favreau P, Menin L, Michalet S, Perret F, Cheneval O, Stöcklin M, Bulet P, Stöcklin R.	Mass spectrometry strategies for venom mapping and peptide sequencing from crude venoms: case applications with single arthropod specimen.	
DRAMP03015	LKLKSILGKLGVILSHLNK	19	Bombolitin-8 (Insects, animals)	P0CD69	Belongs to the MCD family Bombolitin subfamily	Not found	Bombus lapidarius (Red-tailed bumblebee) (Apis lapidaria)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Mast cell degranulating peptide. May also display antibacterial and antifungal activities (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16626777	Toxicon. 2006 May;47(6):676-687.	Favreau P, Menin L, Michalet S, Perret F, Cheneval O, Stöcklin M, Bulet P, Stöcklin R.	Mass spectrometry strategies for venom mapping and peptide sequencing from crude venoms: case applications with single arthropod specimen.	
DRAMP03016	VTCDLLSFKGQVNDSACAANCLSLGKAGGHCEKGVCICRKTSFKDLWDKRF	51	Defensin-1 (Insects, animals)	Q5J8R1	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Apis mellifera carnica (Carniolan bee)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Found in royal jelly and in hemolymph, potent antibacterial protein against Gram-positive bacteria at low concentration (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15607651	Insect Biochem Mol Biol. 2005 Jan;35(1):11-22.	Klaudiny J, Albert S, Bachanová K, Kopernický J, Simúth J.	Two structurally different defensin genes, one of them encoding a novel defensin isoform, are expressed in honeybee Apis mellifera.	
DRAMP18418	FIGMIPGLIGGLISAFK	17	ToAP1	A0A1D3IXR7	Derived from NDBP subfamily 4	Not found	Tityus obscurus	Antimicrobial, Antifungal, Antibiofilm	Transcript level	Alpha helix	The peptide adopts a structure with 64.71% alpha helix		Function: Antibacterial activity against the all Candida spp. Has hemolytic activity.	[Ref.27917162] Fungi:Candida albicans (SC5314)(MIC=50μM), Candida tropicalis (ATCC 750)(MIC=12.5μM), Candida parapsilosis (ATCC 22019)(MIC=200μM), Candida glabrata (ATCC 90030)(MIC>400μM), Candida neoformans (H99 serotype A)(MIC=25μM)	[Ref.27917162] 20% hemolysis at 1.58 μM, 22% hemolysis at 3.16 μM, 23% hemolysis at 6.31 μM, 24% hemolysis at 12.59 μM, 28% hemolysis at 25.12 μM, 45% hemolysis at 50.11 μM , 50% hemolysis at 100μM against human red blood cell	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27917162	Front Microbiol. 2016 Nov 18;7:1844. eCollection 2016.	Guilhelmelli F, Vilela N, Smidt KS, de Oliveira MA, da Cunha Morales ?lvares A, Rigonatto MC, da Silva Costa PH, Tavares AH, de Freitas SM, Nicola AM, Franco OL, Derengowski LD, Schwartz EF, Mortari MR, Bocca AL, Albuquerque P, Silva-Pereira I.	Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms.	
DRAMP03023	INWKALLDAAKKVL	14	Mastoparan (Protonectarina-MP; Insects, animals)	P0C1Q5	Not found	Not found	Protonectarina sylveirae (Brazilian wasp)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Shows potent antimicrobial action against both Gram-positive and Gram-negative bacteria By similarity. This peptide shows potent histamine releasing activities on rat peritoneal mast cells. Also Has hemolytic and cytolytic activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14)."	[Swiss_Prot Entry P0C1Q5]Potent antimicrobial peptide against both Gram-positive and Gram-negative bacteria (By similarity)	[Ref.20108158]ED50 =3.4 × 10−5 M against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7513243##19857508##20108158	Nat Toxins. 1993;1(5):271-276.##Toxicon. 2010 Apr 1;55(4):711-718.##Amino Acids. 2011 Jan;40(1):77-90.	Dohtsu K, Okumura K, Hagiwara K, Palma MS, Nakajima T.##Baek JH, Lee SH.##de Souza BM, Dos Santos Cabrera MP, Neto JR, Palma MS.	Isolation and sequence analysis of peptides from the venom of Protonectarina sylveirae (Hymenoptera-Vespidae).##Isolation and molecular cloning of venom peptides from Orancistrocerus drewseni (Hymenoptera: Eumenidae).##Investigating the effect of different positioning of lysine residues along the peptide chain of mastoparans for their secondary structures and biological activities.	
DRAMP02842	RRWQWR	6	LfcinB(20-25)	P24627	bovine LfcinB	LTF	bovine	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found	1LFC	Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity.	[Ref.29984236] Gram-positive bacterium: Staphylococcus aureus ATCC 33591 (MIC=100 μg/ml; MBC=199 μg/ml)	[Ref.29984236] 3% hemolysis at 5 μM, 5% hemolysis at 12 μM, 5% hemolysis at 22 μM, 0% hemolysis at 50 μM, 2% hemolysis at 100 μM against human red blood cell.##[Ref.29551999] 7.1% hemolysis at 25μM, 50% hemolysis at >100μM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29984236##29551999##20844765	Biomed Res Int. 2018 Jun 10;2018:5252891##Front Microbiol. 2018 Mar 2;9:329.##PLoS One. 2010 Sep 10;5(9):e12684. doi: 10.1371/journal.pone.0012684	Sandra C. Vega Chaparro, J. Tatiana Valencia Salguero, Diana A. Mart##Nguyen LT, Chau JK, Perry NA, de Boer L, Zaat SA, Vogel HJ	Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.##Design, Synthesis and Evaluation of Branched RRWQWR-Based Peptides as Antibacterial Agents against Clinically Relevant Gram-Positive and Gram-Negative Pathogens##Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs	
DRAMP03025	INLKAIAALAKKLL	14	Mastoparan M	No entry found	Not found	Not found	Vespa magnifica	Antimicrobial, Antibacterial, Anti-gram+, Anti-gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27591703] Gram-positive bacteria : Staphylococcus aureus isolates(MIC=6.0 ± 3.5 mg/L, MBC=6.0 ± 3.5 mg/L), Enterococcus faecalis isolates(MIC=5.3 ± 2.3 mg/L, MBC=6.7 ± 2.3 mg/L);##Gram-negative bacteria : Pseudomonas aeruginosa isolates(MIC=4.0 ± 3.5 mg/L, MBC=4.7 ± 3.0 mg/L), Acinetobacter baumannii isolates(MIC=2.7 ± 1.2 mg/L, MBC=3.3 ± 1.2 mg/L)	[Ref.27591703] 0% hemolysis at 64 μg/ml against human red blood cells; 0% hemolysis at 32 μg/ml , 6% hemolysis at 64 μg/ml against sheep red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15935330##27591703	Biochem Pharmacol. 2005 Jul 15;70(2):209-219. ##Chem Biol Drug Des. 2017 Mar;89(3):327-338. doi: 10.1111/cbdd.12864.	Yibin G, Jiang Z, Hong Z, Gengfa L, Liangxi W, Guo W, Yongling L.##Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K	A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro.##Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.	
DRAMP03026	INWKKMAATALKMI	14	Parapolybia-MP (Insects, animals)	No entry found	Not found	Not found	Protonectarina sylveirae (Brazilian wasp)	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20108158	Amino Acids. 2011 Jan;40(1):77-90.	de Souza BM, Dos Santos Cabrera MP, Neto JR, Palma MS.	Investigating the effect of different positioning of lysine residues along the peptide chain of mastoparans for their secondary structures and biological activities.	
DRAMP18227	LLDVLLE	7	Gageostatin B (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-		Not found	Leu-Leu-Asp-Val-Leu-Leu-Glu-3-beta-hydroxy-9, 11-dimethyltridecanoic acid		surfactin like heptapeptides, cytotoxic. It is noteworthy that these compounds 1	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85. 	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis.	
DRAMP03029	INWKKIKSIIKAAMN	15	Mastoparan-V1 (Insects, animals)	P0C1Q8	Not found	Not found	Vespula vulgaris (Yellow jacket) (Wasp)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Chemotactic peptide for polymorphonucleated leukocytes (PMNL), but causing no hemolysis to erythrocytes and no mast cell degranulation activity at physiological concentrations. Potent antimicrobial peptide against Gram-positive and Gram-negative bacteria.
Expressed by the venom gland.
PTM: C-terminal amidation (Asparagine amide: N15)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12759486	Int Arch Allergy Immunol. 2003 May;131(1):25-32.	King T.P, Jim S.Y, Wittkowski K.M.	Inflammatory role of two venom components of yellow jackets (Vespula vulgaris): a mast cell degranulating peptide mastoparan and phospholipase A1.	
DRAMP03030	INWKKIKSLIKAAMS	15	Mastoparan-V2 (Insects, animals)	P0C1Q9	Not found	Not found	Vespula vulgaris (Yellow jacket) (Wasp)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Chemotactic peptide for polymorphonucleated leukocytes (PMNL), but causing no hemolysis to erythrocytes and no mast cell degranulation activity at physiological concentrations. Potent antimicrobial peptide against Gram-positive and Gram-negative bacteria.
Expressed by the venom gland.
PTM: C-terminal amidation (Serine amide: S15)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12759486	Int Arch Allergy Immunol. 2003 May;131(1):25-32.	King T.P, Jim S.Y, Wittkowski K.M.	Inflammatory role of two venom components of yellow jackets (Vespula vulgaris): a mast cell degranulating peptide mastoparan and phospholipase A1.	
DRAMP03031	INLKAIAAFAKKLL	14	Mastoparan-T (Insects, animals)	P0C1Q7	Not found	Not found	Vespa tropica (Greater banded hornet) (Sphex tropica)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Chemotactic peptide for polymorphonucleated leukocytes (PMNL), but causing no hemolysis to rat erythrocytes and no mast cell degranulation activity at physiological concentrations.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14)"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12759486	Int Arch Allergy Immunol. 2003 May;131(1):25-32.	King T.P, Jim S.Y, Wittkowski K.M.	Inflammatory role of two venom components of yellow jackets (Vespula vulgaris): a mast cell degranulating peptide mastoparan and phospholipase A1.	
DRAMP03032	IKWKAILDAVKKVL	14	Mastoparan-A (Insects, animals)	P0C1Q6	Not found	Not found	Vespa analis (Yellow-vented hornet)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Chemotactic peptide for polymorphonucleated leukocytes (PMNL), but causing no hemolysis to erythrocytes and no mast cell degranulation activity at physiological concentrations. Potent antimicrobial peptide against both Gram-positive and Gram-negative bacteria.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12759486	Int Arch Allergy Immunol. 2003 May;131(1):25-32.	King T.P, Jim S.Y, Wittkowski K.M.	Inflammatory role of two venom components of yellow jackets (Vespula vulgaris): a mast cell degranulating peptide mastoparan and phospholipase A1.	
DRAMP03048	KDLHTVVSAILQAL	14	Venom peptide 3 (OdVP3; Insects, animals)	C7DT09	Belongs to the MCD family	VP3	Orancistrocerus drewseni (Solitary wasp)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Exhibits strong antimicrobial activity. 
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19857508	Toxicon. 2010 Apr 1;55(4):711-718.	Baek JH, Lee SH.	Isolation and molecular cloning of venom peptides from Orancistrocerus drewseni (Hymenoptera: Eumenidae).	
DRAMP03049	GRILSFIKGLAEHL	14	Eumenine mastoparan-OD (EMP-OD; Venom peptide 1, OdVP1; Insects, animals)	P86146, C7DT07	Belongs to the MCD family (Mastoparan subfamily)	VP1	Orancistrocerus drewseni (Solitary wasp)	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has hemolytic activity against ovine erythrocytes at micromolar concentrations. Also exhibits strong antimicrobial activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14)."	[Ref.19857508]Fungi: Candida albicans, Botrytis cinerea (++);##Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: S. aureus (+)	[Ref.18695936]42% hemolytic activity at 50 μM against sheep blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen	19857508##18695936	Toxicon. 2010 Apr 1;55(4):711-718.##Amino Acids. 2009 Jul;37(2):389-394.	Baek JH, Lee SH.##Murata K, Shinada T, Ohfune Y, Hisada M, Yasuda A, Naoki H, Nakajima T.	Isolation and molecular cloning of venom peptides from Orancistrocerus drewseni (Hymenoptera: Eumenidae).##Novel mastoparan and protonectin analogs isolated from a solitary wasp, Orancistrocerus drewseni drewseni.	
DRAMP03058	ATCDLLSGTGINHSACAAHCLLRGNRGGYCNGKGVCVCRN	40	Phormia defensin A (insect defensin A, Ptdefensin A; Insects, animals)	No entry found	Not found	Not found	Phormia terranovae (Black blowfly)	Antimicrobial, Antibacterial	Not found	Combine helix and strand structure	Not found	1ICA resolved by NMR.	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2911573	Proc Natl Acad Sci U S A. 1989 Jan;86(1):262-266.	Lambert J, Keppi E, Dimarcq JL, Wicker C, Reichhart JM, Dunbar B, Lepage P, Van Dorsselaer A, Hoffmann J, Fothergill J, et al.	Insect immunity: isolation from immune blood of the dipteran Phormia terranovae of two insect antibacterial peptides with sequence homology to Rabbit lung macrophage bactericidal peptides.	
DRAMP03059	ATCDLLSGTGINHSACAAHCLLRGNRGGYCNRKGVCVCRN	40	Phormia defensin B (insect defensin B; Insects, animals)	No entry found	Not found	Not found	Phormia terranovae (Black blowfly)	Antimicrobial, Antibacterial	Not found	Not found	Not found		It contains three intramolecular disulfide bridges and differ from one another by only a single amino acid. This peptide is neither functionally nor structurally related to any known insect immune response peptides but show significant homology to microbicidal cationic peptides from mammalian granulocytes (defensins).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2911573	Proc Natl Acad Sci U S A. 1989 Jan;86(1):262-266.	Lambert J, Keppi E, Dimarcq JL, Wicker C, Reichhart JM, Dunbar B, Lepage P, Van Dorsselaer A, Hoffmann J, Fothergill J, et al.	Insect immunity: isolation from immune blood of the dipteran Phormia terranovae of two insect antibacterial peptides with sequence homology to rabbit lung macrophage bactericidal peptides.	
DRAMP03060	ATCDLLSMWNVNHSACAAHCLLLGKSGGRCNDDAVCVCRK	40	S.calcitrans defensin 2 (Smd2; defensins; Insects, animals)	O16137	Belongs to the invertebrate defensin family (Type 1 subfamily)	SMD2	Stomoxys calcitrans (Stable fly) 	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antibacterial peptide active mostly against Gram-negative bacteria. Its activity is enhanced by lipopolysaccharide.
Tissue specificity: Constitutively expressed in the anterior midgut and is up-regulated by blood feeding. Not expressed in the fat body or hemocytes.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9326639	Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11502-11507.	Lehane MJ, Wu D, Lehane SM.	Midgut-specific immune molecules are produced by the blood-sucking insect Stomoxys calcitrans.	
DRAMP03061	AAKPMGITCDLLSLWKVGHAACAAHCLVLGDVGGYCTKEGLCVCKE	46	S.calcitrans defensin 1 (Smd1; defensins; Insects, animals)	O16136	Belongs to the invertebrate defensin family (Type 1 subfamily)	SMD1	Stomoxys calcitrans (Stable fly) 	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Antibacterial peptide active mostly against Gram-negative bacteria. Its activity is enhanced by lipopolysaccharide (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9326639##11903625	Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11502-11507.##Insect Mol Biol. 2001 Dec;10(6):561-571.	Lehane MJ, Wu D, Lehane SM.##Munks RJ, Hamilton JV, Lehane SM, Lehane MJ.	Midgut-specific immune molecules are produced by the blood-sucking insect Stomoxys calcitrans.##Regulation of midgut defensin production in the blood-sucking insect Stomoxys calcitrans.	
DRAMP03062	VTGELKRDKRVTCNIGEWVCVAHCNSKSKKSGYCSRGVCYCTN	43	Defensin-A (DefA; GmDefA; Insects, animals)	Q8WTD4	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Glossina morsitans morsitans (Savannah tsetse fly)	Antimicrobial, Antibacterial, Anti-Gram-, Antiprotozoal	Protein level	Not found	Not found		"Function: Antibacterial peptide mostly active against Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemolymph and fat body.
Induction: By bacterial infection. 
PTM: Contains three disulfide bonds (By similarity)."	Protozoan: Procyclic trypanosomes (IC50=10 µM).##Gram-negative bacteria: Sodalis (IC50=2 µM)，Escherichia coli DH5α (IC50=0.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11592981##11886771	Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12648-12653.##Insect Biochem Mol Biol. 2002 Apr;32(4):369-375.	Hao Z, Kasumba I, Lehane MJ, Gibson WC, Kwon J, Aksoy S.##Boulanger N, Brun R, Ehret-Sabatier L, Kunz C, Bulet P.	Tsetse immune responses and trypanosome transmission: implications for the development of tsetse-based strategies to reduce trypanosomiasis.##Immunopeptides in the defense reactions of Glossina morsitans to bacterial and Trypanosoma brucei brucei infections.	
DRAMP03064	HGVSGHGQHGVHG	13	Alloferon-1 (Insects, animals)	P83412	Not found	Not found	Calliphora vicina (Blue blowfly) (Calliphora erythrocephala)	Antimicrobial, Antiparasitic, Antiviral, Antitumor	Protein level	Not found	Not found		"Function: Antimicrobial peptide presumably with antiparasitic, antiviral and/or Antitumoral activities.
Tissue specificity: Hemolymph.
Induction: By bacterial infection.
Miscellaneous: Stimulates antiviral and antitumoral resistance when injected in mice. Enhances natural cytotoxicity of blood and spleen lymphocytes. Induces interferon production in mouse and human."	Human influenza viruses A and B.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12235362	Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12628-32.	Chernysh S, Kim SI, Bekker G, Pleskach VA, Filatova NA, Anikin VB, Platonov VG, Bulet P.	Antiviral and antitumor peptides from insects.	
DRAMP03065	GVSGHGQHGVHG	12	Alloferon-2 (Insects, animals)	No entry found	Not found	Not found	Calliphora vicina (Blue blowfly) (Calliphora erythrocephala)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Not found	Not found	Not found		Function: Alloferon can (i) stimulate natural cytotoxicity of human peripheral blood lymphocytes, (ii) induces IFN synthesis in mouse and human models, and (iii) enhances antiviral and antitumor resistance in mice. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12235362	Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12628-32.	Chernysh S, Kim SI, Bekker G, Pleskach VA, Filatova NA, Anikin VB, Platonov VG, Bulet P.	Antiviral and antitumor peptides from insects.	
DRAMP03066	ATCDLLSGTGIKHSACAAHCLLRGNRGGYCNGRAICVCRN	40	Lucifensin (Lucifensin II; Insects, animals)	B3EWY5	Belongs to the invertebrate defensin family (Type 1 subfamil	Not found	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: May have antibacterial activity.
Tissue specificity: Larval fat body, hemolymph and salivary glands (at protein level).
PTM: Contains three disulfide bonds 3-30; 16-36; 20-38."	Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2012) to UniProtKB	El Shazely B, Veverka V, Fucik V, Voburka Z, Zdarek J, Cerovsky V.	Lucifensin II, the defensin of medicinal maggots of the blowfly Lucilia cuprina.	
DRAMP03067	ATCDLLSGTGVKHSACAAHCLLRGNRGGYCNGRAICVCRN	40	Lucifensin (Lucilia defensin; Insects, animals)	P86471	Belongs to the invertebrate defensin family (Type 1 subfamil	Not found	Lucilia sericata (Green bottle fly) (Phaenicia sericata)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Combine helix and strand structure	Not found	2LLD resolved by NMR.	"Function: May have antibacterial activity.
Tissue specificity: Larval fat body, hemolymph and salivary glands (at protein level).
PTM: Contains three disulfide bonds 3-30; 16-36; 20-38 (By similarity)."	Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19921400##22322867	Cell Mol Life Sci. 2010 Feb;67(3):455-466.##J Biomol NMR. 2012 Mar;52(3):277-282.	Cerovský V, Zdárek J, Fucík V, Monincová L, Voburka Z, Bém R.##Nygaard MK, Andersen AS, Kristensen HH, Krogfelt KA, Fojan P, Wimmer R.	Lucifensin, the long-sought antimicrobial factor of medicinal maggots of the blowfly Lucilia sericata.##The insect defensin lucifensin from Lucilia sericata.	
DRAMP03068	ESAPAPEVSGDAVFSAIQNGXLKNLGNAFFW	31	Antifungal protein 1 (MAF-1; Insects, animals)	P86696	Not found	Not found	Musca domestica (House fly)	Antimicrobial	Protein level	Not found	Not found		Function: Antifungal activity against C.albicans ATCC 76615.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19728925	Cell Mol Immunol. 2009 Aug;6(4):245-251.	Fu P, Wu J, Guo G.	Purification and molecular identification of an antifungal peptide from the hemolymph of Musca domestica (housefly).	
DRAMP18226	LLDVLLE	7	Gageostatin A (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus subtilis	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-		Not found	Leu-Leu-Asp-Val-Leu-Leu-Glu-3-beta-hydroxy-11-methyltridecanoic acid		Fuction: Surfactin like heptapeptides, cytotoxic. It is noteworthy that these compounds 1	Gram-positive, Gram-negative	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85. 	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis.	
DRAMP03071	DEKPKLILPTPAPPNLPQLVGGGGGNRKDGFGVSVDAHQKVWTSDNGGHSIGVSPGYSQHLPGPYGNSRPDYRIGAGYSYNF	82	Diptericin-A (Insects, animals)	P10836	Belongs to the attacin/sarcotoxin-2 family	Not found	Protophormia terraenovae (Northern blowfly)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Has activity against E.coli.
Miscellaneous: There seems to be a family of diptericin in protophormia. Diptericin A is the predominant member."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3276515	Eur J Biochem. 1988 Jan 15;171(1-2):17-22.	Dimarcq JL, Keppi E, Dunbar B, Lambert J, Reichhart JM, Hoffmann D, Rankine SM, Fothergill JE, Hoffmann JA.	Insect immunity. Purification and characterization of a family of novel inducible antibacterial proteins from immunized larvae of the dipteran Phormia terranovae and complete amino-acid sequence of the predominant member, diptericin A.	
DRAMP03072	DEKPKLILPTPAPPNLPQLVGGGGGNRKDGFGVSVDAHQKVWTSDNGRHSIGVTPGYSQHLGGPYGNSRPDYRIGAGYSYNF	82	Diptericin-D (Insects, animals)	P18684	Belongs to the attacin/sarcotoxin-2 family	Not found	Protophormia terraenovae (Northern blowfly)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Has activity against E.coli.
Induction: By bacterial infection.
Miscellaneous: There seems to be a family of diptericin in protophormia. Diptericin A is the predominant member."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2544427	Eur J Biochem. 1989 Jun 15;182(2):423-437.	Reichhart JM, Essrich M, Dimarcq JL, Hoffmann D, Hoffmann JA, Lagueux M.	Insect immunity. Isolation of cDNA clones corresponding to diptericin, an inducible antibacterial peptide from Phormia terranovae (Diptera). Transcriptional profiles during immunization.	
DRAMP03073	ATCDLLSGIGVQHSACALHCVFRGNRGGYCTGKGICVCRN	40	Sapecin-C (Sapecin C; defensins; Insects, animals)	P31530	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		Function: Sapecins, which are potent bactericidal proteins, are produced in response to body injury. Thus, sapecin is probably a defense protein synthesized by Sarcophaga to prevent bacterial infection through the damaged body wall. This gene was also found to be activated in the embryonic and early pupal stages, suggesting that sapecin also plays a role in the ontogenetic processes of Sarcophaga.	Gram-negative bacteria: Escherichia coli, Proteus mirabilis, Klebsiella Pneumoniae;##Gram-positive bacteria: Staphylococcus spps., Streptococcus spps, Bacillus megaterium, Bacillus circulans, Corynebacterium glutamicum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8471044	Biochem J. 1993 Apr 1;291 (Pt 1):275-279.	Yamada K, Natori S.	Purification, sequence and antibacterial activity of two novel sapecin homologues from Sarcophaga embryonic cells: similarity of sapecin B to charybdotoxin.	
DRAMP03074	GWLKKIGKKIERVGQNTRDATVKGLEVAQQAANVAATVR	39	Cecropin (Insects, animals)	P83403	Belongs to the cecropin family	Not found	Glossina morsitans morsitans (Savannah tsetse fly)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-negative bacteria.
Tissue specificity: Hemolymph.
Induction: By bacterial and parasitic infection.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11886771	Insect Biochem. Mol. Biol. 2002; 32:369-375.	Boulanger N, Brun R, Ehret-Sabatier L, Kunz C, Bulet P.	Immunopeptides in the defense reactions of Glossina morsitans to bacterial and Trypanosoma brucei brucei infections.	
DRAMP03076	GWLKKIGKKIERVGQHTRDATIQTIAVAQQAANVAATAR	39	Cecropin-1 (Cecropin 1; Insects, animals)	Q06589	Belongs to the cecropin family	CEC1	Ceratitis capitata (Mediterranean Fruit fly)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
PTM: C-terminal amidation (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7916722	Gene. 1993 Dec 8;134(2):241-243.	Rosetto M, Manetti AG, Marchini D, Dallai R, Telford JL, Baldari CT.	Sequences of two cDNA clones from the medfly Ceratitis capitata encoding antibacterial peptides of the cecropin family.	
DRAMP03077	GWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLK	39	Cecropin-2 (Cecropin 2; Md-Cec, Mdc; Insects, animals)	Q06590	Belongs to the cecropin family	CEC2	Ceratitis capitata (Mediterranean fruit fly) (Musca domestica)	Antimicrobial, Antibacterial, Antifungal	Homology	Alpha helix 	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
PTM: C-terminal amidation (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7916722	Gene. 1993 Dec 8;134(2):241-243.	Rosetto M, Manetti AG, Marchini D, Dallai R, Telford JL, Baldari CT.	Sequences of two cDNA clones from the medfly Ceratitis capitata encoding antibacterial peptides of the cecropin family.	
DRAMP03078	VFVALILAIAIGQSEAGWLKKIGKKIERVGQHTRDATIQGLGIAQQAANVAATAR	55	Cecropin-A2 (Insects, animals)	O61281	Belongs to the cecropin family	CecA2	Drosophila yakuba (Fruit fly)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
PTM: C-terminal amidation (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9553148	Immunogenetics. 1998 May;47(6):417-429.	Date A, Satta Y, Takahata N, Chigusa SI.	Evolutionary history and mechanism of the Drosophila cecropin gene family.	
DRAMP03079	GWLKKIGKKIERVGQHTRDATIQGLGVAQQAANVAATAR	39	Cecropin-A1 (Insects, animals)	P81685, P81688, B4HZP1	Belongs to the cecropin family	CecA1	Drosophila mauritiana (Fruit fly)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria (By similarity).
PTM: C-terminal amidation (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	 9335607##9725836	Genetics. 1997 Oct;147(2):713-724.##Genetics. 1998 Sep;150(1):157-171.	Clark AG, Wang L.##Ramos-Onsins S, Aguadé M.	Molecular population genetics of Drosophila immune system genes.##Molecular evolution of the Cecropin multigene family in Drosophila. functional genes vs. pseudogenes.	
DRAMP03080	AGWLRKLGKKIERIGQHTRDASIQVLGIAQQAANVAATAR	40	Cecropin-B (Insects, animals)	P67791, P67792, B4R1K3, O61273, P81689, P81686	Belongs to the cecropin family	CecB	Drosophila sechellia (Fruit fly)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9335607##9725836	Genetics. 1997 Oct;147(2):713-724.##Genetics. 1998 Sep;150(1):157-171.	Clark AG, Wang L.##Ramos-Onsins S, Aguadé M.	Molecular population genetics of Drosophila immune system genes.##Molecular evolution of the Cecropin multigene family in Drosophila. functional genes vs. pseudogenes.	
DRAMP03081	GWLKKLGKRIERIGQHTRDATIQGLGIAQQAANVAATAR	39	Cecropin-C (Insects, animals)	P84222, P84223, P84224, P84225, P84226	Belongs to the cecropin family	CecC	Drosophila erecta (Drosophila orena) (Drosophila teissieri) (Drosophila takahashii) (Drosophila yaku	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
Developmental stage: Expressed during metamorphosis in pupae."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11965438	J Mol Evol. 2002 May;54(5):665-670.	Date-Ito A, Kasahara K, Sawai H, Chigusa SI.	Rapid evolution of the male-specific antibacterial protein andropin gene in Drosophila.	
DRAMP03082	GFGCPLDQMQCHRHCQTITGRSGGYCSGPLKLTCTCYR	38	Defensin (invertebrate defensin; Insects, animals)	P80154	Belongs to the invertebrate defensin family (Type 2 subfamily)	Not found	Aeshna cyanea (Southern hawker dragonfly)	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		Function: Mediates the inducible antibacterial activity in larvae of A. cyanea.	Micrococcus luteus, A. viriduns, P. acidiluctici, R. meguterium, Streptococcus pyogenes, A. faecalis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1425705	Eur J Biochem. 1992 Nov 1;209(3):977-984.	Bulet P, Cociancich S, Reuland M, Sauber F, Bischoff R, Hegy G, Van Dorsselaer A, Hetru C, Hoffmann JA.	A novel insect defensin mediates the inducible antibacterial activity in larvae of the dragonfly Aeschna cyanea (Paleoptera, Odonata).	
DRAMP03083	LTCEIDRSLCLLHCRLKGYLRAYCSQQKVCRCVQ	34	Sapecin-B (defensins; Insects, animals)	P31529	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Sarcophaga peregrina (Flesh fly)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		Function: Sapecins, which are potent bactericidal proteins, are produced in response to body injury. Thus, sapecin is probably a defense protein synthesized by Sarcophaga to prevent bacterial infection through the damaged body wall. This gene was also found to be activated in the embryonic and early pupal stages, suggesting that sapecin also plays a role in the ontogenetic processes of Sarcophaga.	Gram-negative bacteria: Escherichia coli, Proteus mirabilis, Klebsiella pneumoniae;##Gram-positive bacteria: Staphylococcus spps., Streptococcus spps, Bacillus megaterium, Bacillus circulans, Corynebacterium glutamicum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7635204##8471044	FEBS Lett. 1995 Jul 24;368(3):485-487.##Biochem J. 1993 Apr 1;291 (Pt 1):275-279.	Lee SR, Kurata S, Natori S.##Yamada K, Natori S.	Molecular cloning of cDNA for sapecin B, an antibacterial protein of Sarcophaga, and its detection in larval brain.##Purification, sequence and antibacterial activity of two novel sapecin homologues from Sarcophaga embryonic cells: similarity of sapecin B to charybdotoxin.	
DRAMP03084	SIGSAFKKALPVAKKIGKAALPIAKAALP	29	Ceratotoxin-B (Insects, animals)	P36191	Not found	CTXB	Ceratitis capitata (Mediterranean Fruit fly)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix 	Not found		"Function: Female-specific peptides with potent activity against Gram-positive and Gram-negative bacteria. They have as well hemolytic activity.
Temperature dependence: Thermostable. Still active at 100 degrees Celsius."	[Swiss_Prot Entry P36191]Female-specific peptides with potent activity against Gram-positive and Gram-negative bacteria	[Swiss_Prot Entry P36191]has hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8353519	Insect Biochem Mol Biol. 1993 Jul;23(5):591-598.	Marchini D, Giordano PC, Amons R, Bernini LF, Dallai R.	Purification and primary structure of ceratotoxin A and B, two antibacterial peptides from the female reproductive accessory glands of the medfly Ceratitis capitata (Insecta:Diptera).	
DRAMP03085	SIGSALKKALPVAKKIGKIALPIAKAALP	29	Ceratotoxin-A (Insects, animals)	P36190, O17512	Not found	CTXA1	Ceratitis capitata (Mediterranean Fruit fly)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix 	Not found		"Function: Female-specific peptides with potent activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.
Temperature dependence: Thermostable. Still active at 100 degrees Celsius."	[Swiss_Prot Entry P36190]Female-specific peptides with potent activity against Gram-positive and Gram-negative bacteria	[Swiss_Prot Entry P36190]has hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8353519##7890755	Insect Biochem Mol Biol. 1993 Jul;23(5):591-598.##J Biol Chem. 1995 Mar 17;270(11):6199-6204.	Marchini D, Giordano PC, Amons R, Bernini LF, Dallai R.##Marchini D, Manetti AG, Rosetto M, Bernini LF, Telford JL, Baldari CT, Dallai R. 	Purification and primary structure of ceratotoxin A and B, two antibacterial peptides from the female reproductive accessory glands of the medfly Ceratitis capitata (Insecta:Diptera).##cDNA sequence and expression of the ceratotoxin gene encoding an antibacterial sex-specific peptide from the medfly Ceratitis capitata (diptera).	
DRAMP03086	SIGTAVKKAVPIAKKVGKVAIPIAKAVLSVVGQLVG	36	Ceratotoxin-D (Insects, animals)	O17513	Not found	CTXD	Ceratitis capitata (Mediterranean Fruit fly) (Tephritis capitata)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Female-specific peptides with potent activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.
Biophysicochemical properties: Temperature dependence (Thermostable. Still active at 100 degrees Celsius)."	[Swiss_Prot Entry O17513]Female-specific peptides with potent activity against Gram-positive and Gram-negative bacteria	[Swiss_Prot Entry O17513]has hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9569644	Insect Biochem Mol Biol. 1997 Dec;27(12):1039-1046.	Rosetto M, De Filippis T, Manetti AG, Marchini D, Baldari CT, Dallai R.	The genes encoding the antibacterial sex-specific peptides ceratotoxins are clustered in the genome of the medfly Ceratitis capitata.	
DRAMP03087	DDMTMKPTPPPQYPLNLQGGGGGGSGDGFGFAVQGHQKVWTSDNGRHEIGLNGGYGQHLGGPYGNSEPSWKVGSTYTYRFPNF	83	Drosophila diptericin (Insects, animals)	No entry found	Not found	Not found	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2125051	J Biol Chem. 1990 Dec 25;265(36):22493-8.	Wicker C, Reichhart JM, Hoffmann D, Hultmark D, Samakovlis C, Hoffmann JA.	Insect immunity. Characterization of a Drosophila cDNA encoding a novel member of the diptericin family of immune peptides.	
DRAMP03088	DDMTMKPTPPPQYPLNLQGGGGGQSGDGFGFAVQGHQKVWTSDNGRHEIGLNGGYGQHLGGPYGNSEPSWKVGSTYTYRFPNF	83	Diptericin (Insects, animals)	P24492, O16838, O16839, O16840, O16841, O18669, Q9V8P5	Belongs to the attacin/sarcotoxin-2 family	Dpt	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Required to resist Gram-negative bacterial infections, regulated by Dredd.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2125051##11269502	J Biol Chem. 1990 Dec 25;265(36):22493-22498.##The Drosophila caspase Dredd is required to resist gram-negative bacterial infection.	Wicker C, Reichhart JM, Hoffmann D, Hultmark D, Samakovlis C, Hoffmann JA.##Leulier F, Rodriguez A, Khush RS, Abrams JM, Lemaitre B.	Insect immunity. Characterization of a Drosophila cDNA encoding a novel member of the diptericin family of immune peptides.##The Drosophila caspase Dredd is required to resist Gram-negative bacterial infection.	
DRAMP18225	NKGCAICSIGAACLVDGPIPDFEIAGATGLFGLWG	35	Subtilosin A1 (Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Bacillus subtilis	Antimicrobial, Antibacterial		Not found	A variant of Subtilosin A, where residue T6 in Subtilosin A has been mutated to isoleucine. Like Subtilosin A, it is an N- and C-circulated peptide with three rare cross-links between the sulfurs of Cys13, Cys7, and Cys 4 and the alpha-carbons of Phe22, THr28, and Phe31, respectively.  		Fuction: Active against B. anthracis, B. cereus, B. thuringiensis, E. faecalis, S. carnosus, L. monocytogenes, and S. pyogenes. In addition to the hemolytic activity, subtilosin A1 was found to exhibit enhanced antimicrobial activity against specific bacterial strains.	[Ref.19633086]Gram-postive bacterium:Bacillus subtilis(MIC= 250μM), Bacillus anthracis(MIC= 16μM), Bacillus cereus(MIC= 40μM), Bacillus thuringiensis(MIC= 40μM), Enterococcus faecalis(MIC= 100μM),  taphylococcus carnosus(MIC= 100μM), Listeria monocytogenes(MIC= 40μM), Streptococcus pyogenes (MIC= 100μM).	[Ref.19633086] MLC=16 μM against rabbit blood agar	Cyclic	No specific N-terminal	No specific C-terminal	Thioether bridges between Cys4 and Phe31,Cys7 and Thr28,Cys13 and Phe22.	Mixed(D-Thr28,D-Phe31)	No cytotoxicity information found	Not found	19633086	J Bacteriol. 2009 Sep;191(18):5690-6.	Huang T, Geng H, Miyyapuram VR, Sit CS, Vederas JC, Nakano MM.	Isolation of a variant of subtilosin A with hemolytic activity.	
DRAMP03092	ATCDLLSKWNWNHTACAGHCIAKGFKGGYCNDKAVCVCRN	40	Drosophila defensin (Insects, animals)	P36192, Q4V3H2, Q867E6, Q867G6, Q86BV6, Q86BV7, Q9V5F5	Not found	Def	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8168509	Eur J Biochem. 1994 Apr 1;221(1):201-219.	Dimarcq JL, Hoffmann D, Meister M, Bulet P, Lanot R, Reichhart JM, Hoffmann JA.	Characterization and transcriptional profiles of a Drosophila gene encoding an insect defensin. A study in insect immunity.	
DRAMP03093	DCLSGRYKGPCAVWDNETCRRVCKEEGRSSGHCSPSLKCWCEGC	44	Drosomycin (Cys-rich; insect defensins; Insects, animals)	P41964, Q2UYN5, Q9VZQ2	Not found	Drs	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antifungal	Protein level	Combine helix and strand structure	Not found	1MYN resolved by NMR.	"Function: Possesses antifungal activity and is active against a relatively broad spectrum of filamentous fungi. It inhibits spore germination at high concentrations and at low concentrations delays growth of hyphae which subsequently exhibit abnormal morphology. Spz C-106 in the hemolymph controls expression of the antifungal peptide by acting as a ligand of Tl and inducing an intracellular signaling pathway.
Tissue specificity: Synthesized in the fat body and is secreted into the blood. In hemolymph 6 hours after immune challenge, levels of expression increase for first 24 hours and persist for the following three weeks.
PTM: Contains four disulfide bonds 2-44; 11-33; 19-39; 23-41."	Fungi: Neurospora crassa (IC50=0.6 µM), Botrytis cinerea (IC50=1.2 µM), Fusarium culmorum (IC50=1.0 µM), Alternaria brassicicola (IC50=0.9 µM), A. longipes (IC50=1.4 µM), Nectria haematococca (IC50=1.8 µM), Fusarium oxysporum(IC50=4.2 µM), A. pisi (IC50=3.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization (Cys2 and Cys44)	Disulfide bonds between Cys2 and Cys44; Cys11 and Cys33; Cys19 and Cys39,Cys23 and Cys41.	L	No cytotoxicity information found	Not found	7806546##8808632##9736738##12872120	J Biol Chem 1994; 269: 33159-33163.##Cell. 1996 Sep 20;86(6):973-983.##Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11342-11347.##Nat Immunol. 2003 Aug;4(8):794-800.	Fehlbaum P et al Hoffmann JA.##Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA.##Uttenweiler-Joseph S, Moniatte M, Lagueux M, Van Dorsselaer A, Hoffmann JA, Bulet P.##Weber AN, Tauszig-Delamasure S, Hoffmann JA, Lelièvre E, Gascan H, Ray KP, Morse MA, Imler JL, Gay NJ.	Insect immunity. Septic injury of drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides.##The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults.##Differential display of peptides induced during the immune response of Drosophila: a matrix-assisted laser desorption ionization time-of-flight mass spectrometry study.##Binding of the Drosophila cytokine Spätzle to Toll is	
DRAMP03094	DCLSGKYKGPCAVWDNEMCRRICKEEGHISGHCSPSLKCWCEGC	44	Drosomycin-2 (Insects, animals)	No entry found	Not found	Not found	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antifungal, Antiparasitic	Not found	Not found	Not found		"Function: Drosomycin-2 is antiparasitic peptide which shows inhibitory effect on the ookinete development of the parasite Plasmodium berghei.
Induction: Expressed in larva, pupa and adult."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18657321	Mol Immunol. 2008 Sep;45(15):3909-3916.	Tian C, Gao B, Rodriguez Mdel C, Lanz-Mendoza H, Ma B, Zhu S.	Gene expression, antiparasitic activity, and functional evolution of the drosomycin family.	
DRAMP03099	QRPYTQPLIYYPPPPTPPRIYRA	23	Attacin-C (Insects, animals)	Q95NH6	Not found	AttC	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antibacterial, Antifungal	Protein level	Rich	Not found		Comment: No comments found on DRAMP database	Agrobacterium tumefaciens (MIC>200 µM), Enterobacter cloacae b12 (MIC>200 µM), Escherichia coli SBS 363 (MIC>200 µM), Escherichia coli D31 (MIC>=200 µM), Escherichia coli D22 (MIC>=200 µM), Erwinia carotovora carotovora (MIC>200 µM), Pseudomonas aeruginosa (MIC>200 µM), Salmonella typhimurium (MIC>200 µM), Serratia marcescens (MIC>200 µM), Bacillus megaterium (MIC>200 µM), Micrococcus luteus(MIC>200 µM), Staphylococcus aureus (MIC>200 µM), Streptococcus pyogenes (MIC>200 µM), Neurospora crassa (MIC>200 µM), Aspergillus fumigatus (MIC>200 µM), Candida albicans (MIC>200 µM), Candida glabrata (MIC>200 µM), Cryptococcus neoformans (MIC>200 µM), Saccharomyces cerevisiae (MIC>200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14744858	J Biol Chem. 2004 Apr 9;279(15):14853-9. Epub 2004 Jan 26.	Rabel D, Charlet M, Ehret-Sabatier L, Cavicchioli L, Cudic M, Otvos L Jr, Bulet P.	Primary structure and in vitro antibacterial properties of the Drosophila melanogaster attacin C Pro-domain.	
DRAMP18224	EKYTEAPEYI	10	Ala-6-fenycin (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus sp. strain P34	Antimicrobial, Antibacterial, Anti-Gram+, Antiviral		Not found	An acyl chain (C15 to C17 carbons) is attached to E1, residue 2 is an ornithine (represented as K), and the carboxylic group of C-terminal I10  forms an ester bond with the side chain of Y3. 		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25477947	Braz J Microbiol. 2014 Oct 9;45(3):1089-94. eCollection 2014.	Scopel e Silva D, de Castro CC, da Silva e Silva F, Sant'anna V, Vargas GD, de Lima M, Fischer G, Brandelli A, da Motta Ade S, H	Antiviral activity of a Bacillus sp. P34 peptide against pathogenic viruses of domestic animals.	
DRAMP03101	GWLRKIGKKIERVGQHTRDATIQVLGIAQQAANVAATAR	39	Sarcotoxin-1C (Sarcotoxin IC; Insects, animals)	P08377	Belongs to the cecropin family	Not found	Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Sarcotoxins, which are potent bactericidal proteins, are produced in response to injury. They are cytotoxic to both Gram-positive and Gram-negative bacteria.
PTM: Problely Arginine amide at R39."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3888997	J Biol Chem. 1985 Jun 25;260(12):7174-7177.	Okada M, Natori S.	Primary structure of sarcotoxin I, an antibacterial protein induced in the hemolymph of Sarcophaga peregrina (flesh fly) larvae.	
DRAMP03102	GWLKKIGKKIERVGQHTRDATIQVIGVAQQAANVAATAR	39	Sarcotoxin-1B (Sarcotoxin IB; Insects, animals)	P08376	Belongs to the cecropin family	Not found	Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Sarcotoxins, which are potent bactericidal proteins, are produced in response to injury. They are cytotoxic to both Gram-positive and Gram-negative bacteria.
PTM: Problely Arginine amide at R39."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3888997##2689214	J Biol Chem. 1985 Jun 25;260(12):7174-7177.##FEBS Lett. 1989 Dec 4;258(2):199-202.	Okada M, Natori S.##Kanai A, Natori S.	Primary structure of sarcotoxin I, an antibacterial protein induced in the hemolymph of Sarcophaga peregrina (flesh fly) larvae.##Cloning of gene cluster for sarcotoxin I, antibacterial proteins of Sarcophaga peregrina.	
DRAMP03103	GWIRDFGKRIERVGQHTRDATIQTIAVAQQAANVAATLKG	40	Sarcotoxin-1D (Sarcotoxin ID; Insects, animals)	P18312	Belongs to the cecropin family	Not found	Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Sarcotoxins, which are potent bactericidal proteins, are produced in response to injury. They are cytotoxic to both Gram-positive and Gram-negative bacteria.	Gram-positive bacteria: Staphylococcus aureus FDA209P, Staphylococcus smith, Micrococcus luteus, Bacillus subtilis, Mycobacterium smegmatis, Corynebacterium bouis, Corynebacterium michiganense.##Gram-negagtive bacteria: Xantbmonas oryzae, Pseudomonas lachrymans, Escherichia coli, Shigella sonnei, Proteus vulgaris.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3182836	J Biol Chem. 1988 Nov 15;263(32):17112-17116.	Matsuyama K, Natori S.	Purification of three antibacterial proteins from the culture medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina.	
DRAMP03105	QHGHGGQDQHGYGHGQQAVYGKGHEGHGVNNLGQDGHGQHGYAHGHSDQHGHGGQHGQHDGYKNRGY	67	Antifungal protein (AFP; Insects, animals)	Q08617	Not found	Not found	Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: This protein inhibits the growth of a variety of fungal species. The antifungal activity of this protein is enhanced by the presence of sarcotoxin IA.	Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8505329##8454635	J Biol Chem. 1993 Jun 5;268(16):12055-12061.##J Biol Chem. 1993 Mar 25;268(9):6641-6648.	Iijima R, Kurata S, Natori S.##Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.	Purification, characterization, and cDNA cloning of an antifungal protein from the hemolymph of Sarcophaga peregrina (flesh fly) larvae.##Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.	
DRAMP03106	VFIDILDKMENAIHKAAQAGIGIAKPIENMILPKLTK	37	Andropin (Insects, animals)	Q8WSV4, Q8WSV5	Not found	Anp	Drosophila simulans (Fruit fly)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11965438	J Mol Evol. 2002 May;54(5):665-670.	Date-Ito A, Kasahara K, Sawai H, Chigusa SI.	Rapid evolution of the male-specific antibacterial protein andropin gene in Drosophila.	
DRAMP03107	FINLLDKVEDALHTGAQAGFKLIRPVERGATPKKSEKPEK	40	Andropin (Insects, animals)	Q8WSV1	Not found	Anp	Drosophila teissieri (Fruit fly)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11965438	J Mol Evol. 2002 May;54(5):665-670.	Date-Ito A, Kasahara K, Sawai H, Chigusa SI.	Rapid evolution of the male-specific antibacterial protein andropin gene in Drosophila.	
DRAMP03108	IFVDVLDNVETALHNAAKAGFKLIKPIEKLIMPK	34	Andropin (Insects, animals)	Q8WPA1, B4PLU4, Q8WP55, Q8WSU9	Not found	Anp	Drosophila yakuba (Fruit fly)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11965438	J Mol Evol. 2002 May;54(5):665-670.	Date-Ito A, Kasahara K, Sawai H, Chigusa SI.	Rapid evolution of the male-specific antibacterial protein andropin gene in Drosophila.	
DRAMP03109	VFIDILDKMENAIHKAAQAGIGLAKPIENMILPK	34	Andropin (Insects, animals)	Q8WSV2, B4HZP0, P81687	Not found	Anp	Drosophila sechellia (Fruit fly) 	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11965438## 9725836	J Mol Evol. 2002 May;54(5):665-670.##Genetics. 1998 Sep;150(1):157-171.	Date-Ito A, Kasahara K, Sawai H, Chigusa SI.##Ramos-Onsins S, Aguade M.	Rapid evolution of the male-specific antibacterial protein andropin gene in Drosophila.##Molecular evolution of the Cecropin multigene family in Drosophila: functional genes vs pseudogenes.	
DRAMP03110	VFIDILDKMENAIHKAAQAGIGIAKPIEKMILPK	34	Andropin (Insects, animals)	O16825, Q8WSV3	Not found	Anp	Drosophila mauritiana (Fruit fly)	Antimicrobial, Antibacterial, Antiprotozoal	Transcript level	Not found	Not found		Andropin is constitutively expressed in the adult male ejaculatory duct in response to mating not bacterial infection. 	Leishmania panamensis (EC50=23.45 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11965438	J. Mol. Evol. 2002; 54:665-670.	Date-Ito A, Kasahara K, Sawai H, Chigusa SI.	Rapid evolution of the male-specific antibacterial protein andropin gene in Drosophila.	
DRAMP03111	QSDALFVDIIDNVENAIHKAAKTGIGMVKPIENIFIPNQQKKSTEASN	48	Andropin (Insects, animals)	Q8WSV0	Not found	Anp	Drosophila orena (Fruit fly)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11965438	J. Mol. Evol. 2002; 54:665-670.	Date-Ito A, Kasahara K, Sawai H, Chigusa SI.	Rapid evolution of the male-specific antibacterial protein andropin gene in Drosophila.	
DRAMP18223	CWSCMGHSCWSCMGHSCWSCAGHSCWSCMGHSCWSCMGHSCWSCAGHCCGSCWHGGM	57	Sonorensin(Bacteriocin)	X2CRH8	Belongs to the class I bacteriocin	Not found	Bacillus sonorensis MT93	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Not found		The Clustal W alignment of the N terminus of sonorensin revealed homology with the leader sequences of protoxins from various Bacillus strains. This indicated that sonorensin, produced initially as a protoxin, was posttransitionally modified to active bacteriocin. The purified sonorensin was also found to be heat stable, stable at low temperature, biologically active over a wide pH range, and not affected in the presence of organic solvents, surfactants, and reducing agents. However, sonoresin was protease-sensitive.	Gram-positive, Gram-negative (broad spectrum)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24610839	Appl Environ Microbiol. 2014 May;80(10):2981-90. 	Chopra L, Singh G, Choudhary V, Sahoo DK.	Sonorensin: an antimicrobial peptide, belonging to the heterocycloanthracin subfamily of bacteriocins, from a new marine isolate, Bacillus sonorensis MT93.	
DRAMP03114	GWLKKIGKKIERIGQHTRDATIQGLGIAQQAANVAATAR	39	Cecropin-1/3 (Insects, animals)	Q94557	Not found	Not found	Drosophila virilis (Fruit fly)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9060393##17994087	J Mol Evol. 1997 Mar;44(3):272-281.##Nature. 2007 Nov 8;450(7167):203-218.	Zhou X, Nguyen T, Kimbrell D.A.##Drosophila 12 genomes consortium.	Identification and characterization of the Cecropin antibacterial protein gene locus in Drosophila virilis.##Evolution of genes and genomes on the Drosophila phylogeny.	
DRAMP03118	RRFKKFLKKVEGAGRRVANAAQKGLPLAAGVKGLV	35	Cecropin-C (AgCecC; Insects, animals)	Q8MUF3, B2FVD8, Q7QEE4	Belongs to the cecropin family	CecC	Anopheles gambiae (African malaria mosquito)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12421409	Insect Mol Biol. 2002 Dec;11(6):517-525.	Zheng XL, Zheng AL.	Genomic organization and regulation of three cecropin genes in Anopheles gambiae.	
DRAMP03119	ATCDLASFSSQWVTPNDSLCAAHCIARRYRGGYCNGKRVCVCR	43	Def-BAT (hybrid defensins; Insects, animals)	Q17027	Not found	Not found	Anopheles gambiae (African malaria mosquito)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Alpha helix (1 helices; 7 residues)	For Def-BAT, the two extended strands do not form an anti-parallel β-sheet. The helix is separated from the β-sheet by a turn (T1) and the two strands of the b-sheet by turn T2.	2E3F resolved by NMR.	"Function: Responsible for the anti Gram-positive activity of immune hemolymph and proves to be efficient against sensitive
strains as against resistant and multi-resistant strains."	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=6.25 µg/mL), Staphylococcus aureus strain 4 (IC90=6.25 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP03120	ATCDLASFSSQWVTPNDSLCAAHCLVKGYRGGYCKNKICHCRDKF	45	Def-BBB (hybrid defensins; Insects, animals)	Q17027	Not found	Not found	Anopheles gambiae (African malaria mosquito)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Combine helix and strand structure	Global fold has a N-terminal loop L1, followed by a helix and a two-stranded antiparallel β-sheet forming the CSab motif.	2E3E resolved by NMR.	"Function: Responsible for the anti Gram-positive activity of immune hemolymph and proves to be efficient against sensitive
strains as against resistant and multi-resistant strains."	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=10 µg/mL), Staphylococcus aureus strain 4 (IC90>80 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP03121	ATCDLASGFGVGSSLCAAHCLVKGYRGGYCKNKICHCRDKF	41	Def-ABB (hybrid defensins; Insects, animals)	Q17027	Not found	Not found	Anopheles gambiae (African malaria mosquito)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Combine helix and strand structure	Global fold has a N-terminal loop L1, followed by a helix and a two-stranded antiparallel β-sheet forming the CSab motif.	2NY9 resolved by NMR.	"Function: Responsible for the anti Gram-positive activity of immune hemolymph and proves to be efficient against sensitive
strains as against resistant and multi-resistant strains."	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90>25 µg/mL), Staphylococcus aureus strain 4 (IC90>80 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP03122	ATCDLASGFGVGSSLCAAHCIARRYRGGYCNSKAVCVCRN	40	Anopheles gambiae defensin (DEF-AAA; Insects, animals)	Q17027, O61721, Q38L95, Q38L99, Q38LA3, Q38LA4, Q38LA6, Q38LB0, Q38LB2	Belongs to the invertebrate defensin family (Type 1 subfamily)	Def1	Anopheles gambiae (African malaria mosquito)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Combine helix and strand structure	Global fold has a N-terminal loop L1, followed by a helix and a two-stranded antiparallel β-sheet forming the CSab motif.	2NY8 resolved by NMR.	"Function: Responsible for the anti Gram-positive activity of immune hemolymph and proves to be efficient against sensitive
strains as against resistant and multi-resistant strains.
Developmental stage: In larvae, transcript is enhanced 4 hours after the bacterial infection, increases up to 12 hours post inoculation and declines by 24 hours and by 30 hours returns to background levels. In adult female, expression is evident by 18 hours after infection. Constitutively expressed in both early and late pupae.
Induction: By bacterial infection.
PTM: Contains three disulfide bonds 3-30; 16-36; 20-38."	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=6.25 µg/mL), Staphylococcus aureus strain 4 (IC90=6.25 µg/mL).##T1=100 mg/kg, T2>100 mg/kg.##T1, dose causing the first signs of toxicity on mice. T2, lethal dose.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8799739##18214975	Insect Mol Biol. 1996 Aug;5(3):203-210.##Proteins. 2008 Jul;72(1):229-239.	Richman AM, Bulet P, Hetru C, Barillas-Mury C, Hoffmann JA, Kafalos FC.##Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Inducible immune factors of the vector mosquito Anopheles gambiae: biochemical purification of a defensin antibacterial peptide and molecular cloning of preprodefensin cDNA.##Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP03123	APRWKFGKRLEKLGRNVFRAAKKALPVIAGYKAL	34	Cecropin-B (AgCecB; Insects, animals)	Q8MUF4, Q7QEE2	Belongs to the cecropin family	CecB	Anopheles gambiae (African malaria mosquito)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12421409	Insect Mol Biol. 2002 Dec;11(6):517-525.	Zheng XL, Zheng AL.	Genomic organization and regulation of three cecropin genes in Anopheles gambiae.	
DRAMP03124	ATCDLASIFNVNHALCAAHCIARRYRGGYCNSKAVCVCRN	40	Def-AcAA (hybrid defensins; Insects, animals)	Q17027	Not found	Not found	Anopheles gambiae (African malaria mosquito)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Combine helix and strand structure	Global fold has a N-terminal loop L1, followed by a helix and a two-stranded antiparallel β-sheet forming the CSab motif.	2NZ3 resolved by NMR.	Function: Among the five hybrid defensins tested, Def-AcAA appears to be more efficient than Def-AAA on the multi resistant and sensitive strains. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=1.56 µg/mL), Staphylococcus aureus strain 4 (IC90=3.125 µg/mL).##T1=100 mg/kg, T2>100 mg/kg.##T1, dose causing the first signs of toxicity on mice. T2, lethal dose.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP03125	ATCDLASKWNWNHTLCAAHCIARRYRGGYCNSKAVCVCR	39	Def-DAA (hybrid defensins; Insects, animals)	Q17027	Not found	Not found	Anopheles gambiae (African malaria mosquito)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Combine helix and strand structure	Global fold has a N-terminal loop L1, followed by a helix and a two-stranded antiparallel β-sheet forming the CSab motif.	2E3G resolved by NMR.	Function: Among the five hybrid defensins tested, Def-DAA appears to be more efficient than Def-AAA on the multi resistant and sensitive strains. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=0.75 µg/mL), Staphylococcus aureus strain 4 (IC90=1.5 µg/mL).##T1=8 mg/kg, T2=30 mg/kg.##T1, dose causing the first signs of toxicity on mice. T2, lethal dose.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP03126	QLKNLACVTNEGPKWANTYCAAVCHMSGRGAGSCNAKDECVCSMT	45	Antimicrobial peptide defensin 3 (AgDef3; Insects, animals)	Q5TWR9, Q2KM07	Not found	Def3	Anopheles gambiae (African malaria mosquito)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Antibacterial peptide mostly active against Gram-positive bacteria with atypical up-regulation of expression. Developmental stage: Basal levels of expression during all life stages, with higher levels during larval development peaking at larval instars 2/3.
Induction: Not induced in 4th instar larvae following a blood meal, an infected blood meal, sterile injection or bacterial injection (E.coli K12 RM148 and M.luteus).
PTM: Contains three disulfide bonds 7-34; 20-39; 24-42."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18353100##16835022	Insect Mol Biol. 2008 Apr;17(2):103-112.##Insect Biochem Mol Biol. 2006 Jul;36(7):570-575.	Meredith JM, Hurd H, Lehane MJ, Eggleston P.##Calvo E, Pham VM, Lombardo F, ArcÃ  B, Ribeiro JM.	The malaria vector mosquito Anopheles gambiae expresses a suite of larval-specific defensin genes.##The sialotranscriptome of adult male Anopheles gambiae mosquitoes.	
DRAMP03127	GGLKKFGKKLEGVGKRVFKASEKALPVVTGFKAL	34	Cecropin-A (Insects, animals)	Q86PR6	Not found	CECA	Culex pipiens pipiens (Northern house mosquito)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.	Bartholomay L.C, Farid H.A, Ramzy R.M, Christensen B.M.	Innate immunity in the Culex pipiens-Wuchereria bancrofti host-parasite relationship.	
DRAMP03128	GRLKKLGKKIEKAGKRVFNAVQKGLPVAAGVQAL	34	Cecropin-B1 (Insects, animals)	Q86PR5	Not found	CECB1	Culex pipiens pipiens (Northern house mosquito)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.	Bartholomay L.C, Farid H.A, Ramzy R.M, Christensen B.M.	Innate immunity in the Culex pipiens-Wuchereria bancrofti host-parasite relationship	
DRAMP03129	GRSKKLGKKIEKAGKRVFNAAQKGLPVAAGVQAL	34	Cecropin-B2 (Insects, animals)	Q86PR4	Not found	CECB2	Culex pipiens pipiens (Northern house mosquito)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.	Bartholomay L.C, Farid H.A, Ramzy R.M, Christensen B.M.	Innate immunity in the Culex pipiens-Wuchereria bancrofti host-parasite relationship	
DRAMP03130	GGLKKFGKKLEGVGKRVFKASEKALPVAVGIKALG	35	Cecropin-A2 (Insects, animals)	Q963B0	Belongs to the cecropin family	CECA2	Aedes albopictus (Asian tiger mosquito)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.	Sun D, Fallon A.M.	Characterization of genomic DNA encoding mosquito cecropins.	
DRAMP03131	GGLKKLGKKLEGVGKRVFKASEKALPVLTGYKAIG	35	Cecropin-B (Insects, animals)	Q9Y0Y0, Q963A9	Belongs to the cecropin family	CECB1 AND CECB2	Aedes albopictus (Asian tiger mosquito) 	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria (By similarity)
Developmental stage: Expressed within 2 hours after induction and continued to accumulate over 24 hours. 
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10413113	FEBS Lett. 1999; 454:147-151.	Sun D, Eccleston ED, Fallon AM.	Cloning and expression of three cecropin cDNAs from a mosquito cell line.	
DRAMP03132	GGLKKLGKKLEGAGKRVFNAAEKALPVVAGAKALG	35	Cecropin-C (Insects, animals)	Q963A8, Q9Y0X9	Belongs to the cecropin family	CECC1 AND CECC2	Aedes albopictus (Asian tiger mosquito)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11087945	Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.	sir YJ, Knoop FC, Dulka J, Conlon JM.	Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.	
DRAMP03133	GGLKKLGKKLEGVGKRVFKASEKALPVAVGIKALG	35	Cecropin-A1 (AalCecA; Cecropin-A; Insects, animals)	P81417, Q963B1	Belongs to the cecropin family	CECA1	Aedes albopictus (Asian tiger mosquito)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10413113##9712710	FEBS Lett. 1999 Jul 2;454(1-2):147-151.##Biochem Biophys Res Commun. 1998 Aug 19;249(2):410-415.	Sun D, Eccleston ED, Fallon AM.##Sun D, Eccleston ED, Fallon AM.	Cloning and expression of three cecropin cDNAs from a mosquito cell line.##Peptide sequence of an antibiotic cecropin from the vector mosquito, Aedes albopictus.	
DRAMP03134	ATCDLLSGFGVGDSACAAHCIARGNRGGYCNSKKVCVCPI	40	Defensin-D (AaeDefD; Insects, animals)	No entry found	Not found	Not found	Aedes aegypti (Yellowfever mosquito)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli D31;##Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10469248	Insect Mol Biol. 1999 Aug;8(3):311-318.	Gao Y, Hernandez VP, Fallon AM.	Immunity proteins from mosquito cell lines include three defensin A isoforms from Aedes aegypti and a defensin D from Aedes albopictus.	
DRAMP03135	ATCDLLSGFGVGDSACAAHCIARGNRGGYCNSQKVCVCRN	40	Defensin-B (AaeDefB; Insects, animals)	P81602, Q71U14, Q71U15	Belongs to the invertebrate defensin family (Type 1 subfamily)	DEFB	Aedes aegypti (Yellowfever mosquito)	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		Function: Antibacterial peptide mostly active against Gram-positive bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Has three disulfide bonds	L	No cytotoxicity information found	Not found	7633471	Insect Biochem Mol Biol. 1995 Jul;25(7):867-873.	Lowenberger C, Bulet P, Charlet M, Hetru C, Hodgeman B, Christensen BM, Hoffmann JA. 	Insect immunity: isolation of three novel inducible antibacterial defensins from the vector mosquito, Aedes aegypti.	
DRAMP03136	ATCDLLSGFGVGDSACAAHCIARRNRGGYCNAKKVCVCRN	40	Defensin-C (AaeDefC; Insects, animals)	P81603, Q17EE4, Q9Y0F0, Q9Y0F1	Belongs to the invertebrate defensin family (Type 1 subfamily)	DEFC	Aedes aegypti (Yellowfever mosquito)	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		Function: Antibacterial peptide mostly active against Gram-positive bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7633471	Insect Biochem Mol Biol. 1995 Jul;25(7):867-873.	Lowenberger C, Bulet P, Charlet M, Hetru C, Hodgeman B, Christensen BM, Hoffmann JA. 	Insect immunity: isolation of three novel inducible antibacterial defensins from the vector mosquito, Aedes aegypti.	
DRAMP03139	ISCDLLSGLGWGHSICAGHCLAISWRYRGGYCNDQGVCVCRT	42	AAEL003849-PA 	Q17EE5	Not found	DEFE	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17510324	Science. 2007 Jun 22;316(5832):1718-1723.	Nene V, Wortman JR, Lawson D, Haas B, Kodira C, Tu ZJ, et al.	Genome sequence of Aedes aegypti, a major arbovirus vector.	
DRAMP03141	QTPCSSAKKVRCNVHCRGYTKLGSCYDDNCSCVDKPAAMKASFAA	45	Putative defensin 5 	A9QVW3	Not found	DEF5	Anopheles gambiae (African malaria mosquito)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19328852	Insect Biochem Mol Biol. 2009 May-Jun;39(5-6):382-394.	Neira Oviedo M, Ribeiro JM, Heyland A, VanEkeris L, Moroz T, Linser PJ.	The salivary transcriptome of Anopheles gambiae (Diptera: Culicidae) larvae: A microarray-based analysis.	
DRAMP03142	STCKLFTADVVSSITCKMYCVIKGKTGGYCNSEGLCTCRAEDLHFLLKPIINKD	54	AGAP004632-PA (Defensin)	Q5TRV9, Q1X7M1, Q2EQ06	Not found	DEF2	Anopheles gambiae (African malaria mosquito)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12364791	Science. 2002 Oct 4;298(5591):129-149.	Holt RA, Subramanian GM, Halpern A, Sutton GG, Charlab R, et al, Collins FH, Hoffman SL.	The genome sequence of the malaria mosquito Anopheles gambiae.	
DRAMP03143	MKQVCILLAVLLCTAAVADAMVFAYAPTCARCKSIGARYCGYGYLNRKGVSCDGQTTINSCEDCKRKFGRCSDGFITECFF	81	AGAP008645-PA (Putative infection responsive short peptide)	Q9XZN6, Q7Q8G3	Not found	irsp	Anopheles gambiae (African malaria mosquito)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11606751	Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12630-5.	Vizioli J, Bulet P, Hoffmann JA, Kafatos FC, Müller HM, Dimopoulos G.	Gambicin: a novel immune responsive antimicrobial peptide from the malaria vector Anopheles gambiae.	
DRAMP03144	ATCDLASGFGVGSSLCAAHCIARRYRGGYCNSQQVCVCRN	40	Salivary defensin 	A2TJI3	Not found	Not found	Anopheles stephensi (Indo-Pakistan malaria mosquito)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18275930	Acta Trop. 2008 Apr;106(1):75-79.	Dixit R, Sharma A, Patole MS, Shouche YS.	Molecular and phylogenetic analysis of a novel salivary defensin cDNA from malaria vector Anopheles stephensi.	
DRAMP03145	ATCDLLSGFGVGDSACAAHCIARRNRGGYCNAKTVCVC	38	Defensin 	Q9GYU6	Not found	Not found	Aedes albopictus (Asian tiger mosquito) (Stegomyia albopicta)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases	Melinda PM, Kostas B, Scott OL.	Wolbachia neither induces nor suppresses transcripts encoding antimicrobial peptides.	
DRAMP03146	ATCDLLSGFGVNDSACAAHCILRGNRGGYCNGKKVCVCRN	40	Defensin	Q86PP9	Not found	Not found	Culex pipiens pipiens (Northern house mosquito)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14550895	Mol Biochem Parasitol. 2003 Aug 11;130(1):43-50.	tholomay LC, Farid HA, Ramzy RM, Christensen BM.	Culex pipiens pipiens: characterization of immune peptides and the influence of immune activation on development of Wuchereria bancrofti.	
DRAMP03147	ATCDLLSGLGVNDSACAAHCIARGNRGGYCNSKKVCVCRN	40	Defensin-A 	B0W2M6	Not found	Not found	Culex quinquefasciatus (Southern house mosquito) (Culex pungens)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases	The Broad Institute Genome Sequencing Platform.	Annotation of Culex pipiens quinquefasciatus.	
DRAMP03148	DELPEETYQAAVENYRRKRATCDLLSGFGVGDSACAAHCIARRNRGGYCNAKTVCVC	57	Defensin 	Q9GYU6	Not found	Not found	Aedes albopictus (Asian tiger mosquito) (Stegomyia albopicta)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases	Melinda PM, Kostas B, Scott OL.	Wolbachia neither induces nor suppresses transcripts encoding antimicrobial peptides.	
DRAMP03149	VPTVICFLAMCLVAITGAYPQEPVLADEAQSVANSLFDELPEESYQAAVENLRLKRATCDLLSGFGVGDSACAAHCIARGNRGGYCNSKKVCVCPI	96	Defensin D	O77217	Not found	DefD	Aedes albopictus (Asian tiger mosquito) (Stegomyia albopicta)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10469248	Insect Mol Biol. 1999 Aug;8(3):311-318.	Gao Y, Hernandez VP, Fallon AM.	Immunity proteins from mosquito cell lines include three defensin A isoforms from Aedes aegypti and a defensin D from Aedes albopictus.	
DRAMP03151	RWKVFKKIEKVGRNVRDGIIKAGPAIGVLGQAKALG	36	Spodoptera cecropins A (insects, invertebrates, animals)	Q9XZG9	Not found	CECA	Spodoptera litura larvae (Common cutworm)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: It retains antibacterial activities in all conditions tested (at pH 5.6-8.0 and in the presence of 50-150 mM NaCl) that was adapted to confirm the antibacterial properties of Spodoptera cecropins. Northern blot analysis with (32)P-labeled PCR product coding for Spodoptera cecropin A revealed that Spodoptera cecropin genes are expressed in immunized fat body, but not in normal fat body.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11790350	Comp Biochem Physiol C Toxicol Pharmacol. 2000 Mar;125(3):287-297.	Choi CS, Lee IH, Kim E, Kim SI, Kim HR.	Antibacterial properties and partial cDNA sequences of cecropin-like antibacterial peptides from the common cutworm, Spodoptera litura.	
DRAMP03152	RWKVFKKIEKMGRNIRDGIVKAGPAIEVLGSAKALGK	37	Spodoptera cecropins B (insects, invertebrates, animals)	Q9XZH0	Belongs to the cecropin family	CECB	Spodoptera litura larvae (Common cutworm)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria. 
Induction: Induced as part of the humoral response to a bacterial invasion. Transcripts appear within the immunized fat body.
Tissue specificity: Expressed in immunized fat body.
NOTE: It retains antibacterial activities in all conditions tested (at pH 5.6-8.0 and in the presence of 50-150 mM NaCl) that was adapted to confirm the antibacterial properties of Spodoptera cecropins. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11790350	Comp Biochem Physiol C Toxicol Pharmacol. 2000 Mar;125(3):287-297.	Choi CS, Lee IH, Kim E, Kim SI, Kim HR.	Antibacterial properties and partial cDNA sequences of cecropin-like antibacterial peptides from the common cutworm, Spodoptera litura.	
DRAMP03154	GILDTIKSIASKVWNSKTVQDLKRKGINWVANKLGVSPQAA	41	Hadrurin (Non-disulfide-bridged peptide 3.1)	P82656	Belongs to the antimicrobial peptide scorpion family	Not found	Hadrurus aztecus 	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Function: Has antimicrobial activity. Also shows cytolytic activity when tested in human erythrocytes.	Gram-negative bacteria: Salmonella typhimurium, Klebsiella pneumoniae, Enterobacter cloacae, Pseudomonas aeruginosa, Escherichia coli, Serratia marcescens.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10931184	Eur J Biochem. 2000 Aug;267(16):5023-5031.	Torres-Larios A, Gurrola GB, Zamudio FZ, Possani LD.	Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus.	
DRAMP03155	ACLPNSCVSKGCCCGBSGYWCRQCGIKYTC	30	Sillucin	P02885	Not found	Not found	Rhizomucor pusillus	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		"Function: Sillucin is an antimicrobial agent produced by the thermophilic fungus Rhizomucor pusillus in liquid culture; it is effective against Gram-positive bacteria at the level of RNA metabolism.
PTM: Contains four disulfide bonds 2-7; 12-24; 13-30; 14-21."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	761621##11294620	FEBS Lett. 1979 Jan 1;97(1):81-83.##Biochemistry. 2001 Apr 17;40(15):4531-4538.	Bradley WA, Somkuti GA.##Qi J, Wu J, Somkuti GA, Watson JT.	The primary structure of sillucin and antimicrobial peptide from Mucor pusillus.##Determination of the disulfide structure of sillucin, a highly knotted, cysteine-rich peptide, by cyanylation/cleavage mass mapping.	
DRAMP03156	RRLRPRRPRLPRPRPRPRPRPRSLPLPRPQPRRIPRPILLPWRPPRPIPRPQPQPIPRWL	60	Cathelicidin-3 (Bactenecin-7, Bac7; PR-59; mammals, animals)	P50415	Belongs to the cathelicidin family	CATHL3	Ovis aries (Sheep)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Exerts, in vitro, a potent antimicrobial activity. Probably due to an impairment of the function of the respiratory chain and of energy-dependent activities in the inner membrane of susceptible microorganisms.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7498547	FEBS Lett. 1995 Dec 4;376(3):225-228.	Bagella L, Scocchi M, Zanetti M.	cDNA sequences of three sheep myeloid cathelicidins.	
DRAMP03157	ALLHHGLNCAKGVLA	15	Halocidin subunit B	P83706	Not found	Not found	Halocynthia aurantium (Sea peach)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has antimicrobial activity, possibly by attacking the bacterial cell membrane.	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Pseudomonas aeruginosa.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12067731	FEBS Lett. 2002 Jun 19;521(1-3):81-86.	Jang WS, Kim KN, Lee YS, Nam MH, Lee IH.	Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium.	
DRAMP03158	WLNALLHHGLNCAKGVLA	18	Halocidin subunit A (invertebrates, animals; Preclinical)	P83705	Not found	Not found	Halocynthia aurantium (Sea peach)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antimicrobial activity against S.aureus and P.aeruginosa, possibly by attacking the bacterial cell membrane. Mouse model: A single intravenous injection of the modified chain A by itself into mice resulted in an significant therapeutic effect (Jang et al. 2007;51: 4148-4156).	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Pseudomonas aeruginosa.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12067731	FEBS Lett. 2002 Jun 19;521(1-3):81-86.	Jang WS, Kim KN, Lee YS, Nam MH, Lee IH.	Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium.	
DRAMP03159	VKKGIEKAGVCPADNVRCFKSDPPQCHTDQDCLGERKCCYLHCGFKCVIPVKELEEGGNKDEDVSRP	67	WAP four-disulfide core domain protein 12 (mammals, animals)	A4K2V4	Not found	WFDC12	Pongo abelii (Sumatran orangutan)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Antibacterial protein. Putative acid-stable proteinase inhibitor (By similarity).
Doamin: Contains 1 WAP domain"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17267810	Genome Res. 2007 Mar;17(3):276-286.	Hurle B, Swanson W; NISC Comparative Sequencing Program, Green ED.	Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage.	
DRAMP03160	VKVNIEKPGVCPADNIRCIKSDPPQCHTDQDCQGIRKCCYLHCGFKCVIPVKELEEGGNKDEDVSRPCPEPGWEAKPPGVFSTRCPQK	88	WAP four-disulfide core domain protein 12 (mammals, animals)	A4K2U1	Not found	WFDC12	Callithrix jacchus (white-tufted-ear-marmoset)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Antibacterial protein. Putative acid-stable proteinase inhibitor (By similarity).
Doamin: Contains 4 WAP domain"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17267810	Genome Res. 2007 Mar;17(3):276-286.	Hurle B, Swanson W; NISC Comparative Sequencing Program, Green ED.	Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage.	
DRAMP03161	DHYNCVKGGGQCLYSACPIYTKVQGTCYGGKAKCCK	36	Beta-defensin 1 (BD-1; Defensin, beta 1; mammals, animals), 	Q95M66	Belongs to the beta-defensin family	DEFB1	Saguinus oedipus (Cotton-top tamarin)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has bactericidal activity (By similarity).
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11862391	Immunogenetics. 2002 Feb;53(10-11):907-913.	Del Pero M, Boniotto M, Zuccon D, Cervella P, Spanò A, Amoroso A, Crovella S.	Beta-defensin 1 gene variability among non-human primates.	
DRAMP03163	ATCDLFSFRSKWVTPNHAACAAHCLLRGNRGGRCKGTICHCRK	43	R. prolixus defensin A (RprDefA; insect defensin; Insects, animals)	No entry found	Not found	Not found	Rhodnius prolixus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal	Not found	Combine helix and strand structure	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12650692	Insect Biochem Mol Biol. 2003 Apr;33(4):439-447.	Lopez L, Morales G, Ursic R, Wolff M, Lowenberger C.	Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease.	
DRAMP03164	ATCDLLSFRSKWVTPNHAGCAAHCLLRGNRGGHCKGTICHCRK	43	R. prolixus defensin B (RprDefB; insect defensin; Insects, animals)	No entry found	Not found	Not found	Rhodnius prolixus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal	Not found	Combine helix and strand structure	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12650692	Insect Biochem Mol Biol. 2003 Apr;33(4):439-447.	Lopez L, Morales G, Ursic R, Wolff M, Lowenberger C.	Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease.	
DRAMP03165	ATCDLFSFRSKWVTPNHAGCAAHCIFLGNRGGRCVGTVCHCRK	43	R. prolixus defensin C (RprDefC; insect defensin; Insects, animals)	No entry found	Not found	Not found	Rhodnius prolixus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal	Not found	Combine helix and strand structure	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12650692	Insect Biochem Mol Biol. 2003 Apr;33(4):439-447.	Lopez L, Morales G, Ursic R, Wolff M, Lowenberger C.	Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease.	
DRAMP03167	RFIPPILRPPVRPPFRPPFRPPFRPPPIIRFFGG	34	P9	No entry found	Not found	Not found	Cervus elaphus (New Zealand deer)	Not found	Not found	Not found	Not found		Function: showes good antimicrobial activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16011891	Int J Antimicrob Agents. 2005 Aug;26(2):165-169.	Treffers C, Chen L, Anderson RC, Yu PL.	Isolation and characterisation of antimicrobial peptides from deer neutrophils.	
DRAMP03168	DDRRSPLEECFQQNDYEEFLEIAKNGLKKTXNPKHVXV	38	L-amino-acid oxidase (K-LAO; LAAO; LAO; reptilia, animals)	P0C2D4	Belongs to the flavin monoamine oxidase family (FIG1 subfamily)	Not found	Naja naja kaouthia (Monocled cobra)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids (highly active against L- Phe and L-Tyr, and moderately active against L-Trp, L-Met, L-Leu, and L-Arg), thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities (By similarity). This protein inhibits both agonist- and shear stress-induced platelet aggregation (SIPA). Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	FAD, Flavoprotein	1612186##11600144	Int J Biochem. 1992 Jun;24(6):967-973.##Toxicon. 2001 Dec;39(12):1827-1833.	Tan NH, Swaminathan S.##Sakurai Y, Takatsuka H, Yoshioka A, Matsui T, Suzuki M, Titani K, Fujimura Y.	Purification and properties of the L-amino acid oxidase from monocellate cobra (Naja naja kaouthia) venom.##Inhibition of human platelet aggregation by L-amino acid oxidase purified from Naja naja kaouthia venom.	
DRAMP03170	MQKLAEAIAAAVQAGQDKDWGKMGTSIVGIVENGISVLGKIFGF	44	Antibacterial protein 1 homolog (Gram-positive bacteria)	Q4L5M5	Belongs to the staphylococcal hemolytic protein family	Not found	Staphylococcus haemolyticus (strain JCSC1435)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Has haemolytic activity and also inhibits the growth of gonococci (By similarity).	Gonococci	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16237012	J Bacteriol. 2005 Nov;187(21):7292-7308.	Takeuchi F, Watanabe S, Baba T, Yuzawa H, Ito T, Morimoto Y, Kuroda M, Cui L, Takahashi M, Ankai A, Baba S, Fukui S, Lee JC, Hiramatsu K.	Whole-genome sequencing of staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of human-colonizing staphylococcal species.	
DRAMP18222	GDCGGTCTWTKDCSICPSWSCWSWSC	26	PseA(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Bacillus pseudomycoides DSM 12442	Antimicrobial, Antibacterial, Anti-Gram+		Not found	This antibiotic with four thioether rings and a disulfide bond. The leader sequence shows highest (37%) similarity to the leader sequence of mersacidin.The N terminus of the corepeptide contains the conserved lipid II binding motif of class II lantibiotics (TxS/TxE/DC) and, interestingly, the C terminus of the core peptide contains two SWSC motifs. Such motifs also are found in the heterocycloanthracins.		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25769830	Appl Environ Microbiol. 2015 May 15;81(10):3419-29.	Basi-Chipalu S, Dischinger J, Josten M, Szekat C, Zweynert A, Sahl HG, Bierbaum G.	Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.	
DRAMP03172	MSKLVQAISDAVQAGQNQDWAKLGTSIVGIVENGVGILGKLFGF	44	Antibacterial protein 3 homolog (Gram-positive bacteria)	Q4L5M1	Belongs to the staphylococcal hemolytic protein family	Not found	Staphylococcus haemolyticus (strain JCSC1435)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Has haemolytic activity and also inhibits the growth of gonococci (By similarity).	Gonococci	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16237012	J Bacteriol. 2005 Nov;187(21):7292-7308.	Takeuchi F, Watanabe S, Baba T, Yuzawa H, Ito T, Morimoto Y, Kuroda M, Cui L, Takahashi M, Ankai A, Baba S, Fukui S, Lee JC, Hiramatsu K.	Whole-genome sequencing of staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of human-colonizing staphylococcal species.	
DRAMP03174	RWCVYAYVRIRGVLVRYRRCW	21	Arenicin-2 (Ar-2; marine polychaeta, animals)	Q5SC59, P84106	Not found	Not found	Arenicola marina (Lugworm) (Lumbricus marinus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Beta strand (2 strands; 16 residues)	NMR investigation shows that in water solution arenicin-2 displays a prolonged beta-hairpin, formed by two antiparallel beta-strands and stabilized by one disulfide and nine hydrogen bonds. A significant right-handed twist in the beta-sheet is deprived the peptide surface of amphipathicity. CD spectroscopic analysis indicates that arenicin-2 binds to the SDS and DPC micelles, and conformation of the peptide is significantly changed upon	2JNI, 2L8X resolved by NMR.	"Function: Has antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteriua as well as yeast C. albicans. Bacterial killing occurs within minutes and is accompanied by membrane permeabilization, membrane detachment and release of cytoplasm. Interaction of arenicin with reconstituted membranes that mimic the lipopolysaccharide-containing outer membrane or the phospholipid-containing plasma membrane of Gram-negative bacteria exhibited no pronounced lipid specificity.
PTM: Contains one disulfide bond 3-20.
Domian: Contains 1 BRICHOS domain."	Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacterium: Escherichia coli ML-35p.##Yeast: Candida albicans 820.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys3 and Cys20.	L	No cytotoxicity information found	Anionic lipid vesicles	15527787##17935487##17585874	FEBS Lett. 2004 Nov 5;577(1-2):209-214.##Biochem J. 2008 Feb 15;410(1):113-122.##Biochem Biophys Res Commun. 2007 Aug 17;360(1):156-162.	Ovchinnikova TV, Aleshina GM, Balandin SV, Krasnosdembskaya AD, Markelov ML, Frolova EI, Leonova YF, Tagaev AA, Krasnodembsky EG, Kokryakov VN.##Andrä J, Jakovkin I, Grötzinger J, Hecht O, Krasnosdembskaya AD, Goldmann T, Gutsmann T, Leippe M.##Ovchinnikova TV, Shenkarev ZO, Nadezhdin KD, Balandin SV, Zhmak MN, Kudelina IA, Finkina EI, Kokryakov VN, Arseniev AS.	Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina.##Structure and mode of action of the antimicrobial peptide arenicin.##Recombinant expression, synthesis, purification, and solution structure of arenicin.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](N)CCCNC(=N)N)CSSC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O
DRAMP03175	FNKLKQGSSKRTCAKCFRKIMPSVHELDERRRGANRWAAGFRKCVSSICRY	51	Perinerin	P84117, P83551	Not found	Not found	Nereis aibuhitensis (Clamworm) (Perinereis aibuhitensis)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Antibacterial activity against both Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas aeruginosa, Escherichia coli K-12, Proteus vulgaris;##Gram-positive bacteria: Bacillus megaterium, Aerococcus viridans, Staphylococcus aureus, Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15113828	J Biochem. 2004 Mar;135(3):297-304.	Pan W, Liu X, Ge F, Han J, Zheng T.	Perinerin, a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization.	
DRAMP03177	SWLSKTYKKLENSAKKRISEGIAIAIQGGPR	31	Cecropin-P2 (CP2; nematodes, animals)	Q5H7N6	Belongs to the cecropin family	ASCEC-2	Ascaris suum (Pig roundworm) (Ascaris lumbricoides)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Has antibacterial activity against several Gram-positive and Gram-negative bacteria. Is weakly active against yeasts. Acts by a nonpore mechanism.
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15850460	Biochem J. 2005 Aug 15;390(Pt 1):207-214.	Pillai A, Ueno S, Zhang H, Lee JM, Kato Y.	Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode Ascaris suum.	
DRAMP03178	SWLSKTAKKLENSAKKRISEGIAIAIKGGSR	31	Cecropin-P3 (CP3; nematodes, animals)	Q5H7N5	Belongs to the cecropin family	ASCEC-3	Ascaris suum (Pig roundworm) (Ascaris lumbricoides)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Has antibacterial activity against several Gram-positive and Gram-negative bacteria. Is weakly active against yeasts. Acts by a nonpore mechanism.
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15850460	Biochem J. 2005 Aug 15;390(Pt 1):207-214.	Pillai A, Ueno S, Zhang H, Lee JM, Kato Y.	Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode Ascaris suum.	
DRAMP03179	SWLSKTYKKLENSAKKRISEGVAIAILGGLR	31	Cecropin-P4 (CP4; nematodes, animals)	Q5H7N4	Belongs to the cecropin family	ASCEC-4	Ascaris suum (Pig roundworm) (Ascaris lumbricoides)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Has antibacterial activity against several Gram-positive and Gram-negative bacteria. Is weakly active against yeasts. Acts by a nonpore mechanism.
Tissue specificity: Expressed in the body wall, intestine, uterus and ovary.
Induction: Induced as part of the humoral response to a bacterial invasion. Transcripts appear within the immunized fat body."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15850460	Biochem J. 2005 Aug 15;390(Pt 1):207-214.	Pillai A, Ueno S, Zhang H, Lee JM, Kato Y.	Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode Ascaris suum.	
DRAMP03180	AVDFSSCARMDVPGLSKVAQGLCISSCKFQNCGTGHCEKRGGRPTCVCDRCGRGGGEWPSVPMPKGRSSRGRRHS	75	ASABF-alpha (ASABF; nematodes, animals)	P90683	Not found	asabf-alpha	Ascaris suum (Pig roundworm) (Ascaris lumbricoides)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Combine helix and strand structure	Not found	2D56 resolved by NMR.	Slight hemolytic activity against human erythrocytes. 	[Ref.10991847]Gram-negative bacteria: Escherichia coli JM109 (IC50=50 µg/ml), Proteus vulgaris ATCC 13315 (IC50=10 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC6538P (IC50=0.6 µg/ml), Bacillus subtilis ATCC6633 (IC50=1.2 µg/ml), Micrococcus luteus ATCC398 (IC50=0.8 µg/ml).	[Ref.10991847]4.5% hemolytic activity at 1000 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8940016##10991847	J Biol Chem. 1996 Nov 29;271(48):30493-30498.##Antimicrob Agents Chemother. 2000 Oct;44(10):2701-2715.	Kato Y, Komatsu S.##Zhang H, Yoshida S, Aizawa T, Murakami R, Suzuki M, Koganezawa N, Matsuura A, Miyazawa M, Kawano K, Nitta K, Kato Y.	ASABF, a novel cysteine-rich antibacterial peptide isolated from the nematode Ascaris suum. Purification, primary structure, and molecular cloning of cDNA.##In vitro antimicrobial properties of recombinant ASABF, an antimicrobial peptide isolated from the nematode Ascaris suum.	
DRAMP03182	ACNFQSCWATCQAQHSIYFRRAFCDRSQCKCVFVRG	36	Termicin (Termite defensin; Insects, animals)	P82321	Not found	Not found	Pseudacanthotermes spiniger 	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Combine helix and strand structure	Not found	1MM0 resolved by NMR.	Function: Has antibacterial activity.	Gram-positive bacteria: Bacillus megaterium, Micrococcus luteus, Streptococcus pyogenes(++).##Fungi: Fusarium culmorum, Fusarium oxysporum, Neurospora crassa, Nectria haematococca, Trichoderma viride(+); Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisiae(+++).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11053427##12592014	J Biol Chem. 2001 Feb 9;276(6):4085-4092.##Protein Sci. 2003 Mar;12(3):438-446.	Lamberty M, Zachary D, Lanot R, Bordereau C, Robert A, Hoffmann JA, Bulet P.##Da Silva P, Jouvensal L, Lamberty M, Bulet P, Caille A, Vovelle F.	Insect immunity. Constitutive expression of a cysteine-rich antifungal and a linear antibacterial peptide in a termite insect.##Solution structure of termicin, an antimicrobial peptide from the termite Pseudacanthotermes spiniger.	
DRAMP03183	DAECEICKFVIQQVEAFIESNHSQAEIQKELNKL	34	Naegleriapore A 	Q95X03	Not found	NP-A	Naegleria fowleri (Brain eating amoeba)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiprotozoal, Cytotoxic	Predicted	Alpha helix 	It is characterized by a structure of amphipathic α-helices and an invariant framework of cysteine residues involved in disulfide bonds.		Function: Posesses antibacterial, cytotoxicity and pore-forming activity. In concentrations up to 10 µm, naegleriapore A is inactive against the Gram-negative bacterium E. coli D31. The specific pore-forming activities of naegleriapore A and B are 3.1±1.7 units pmol−1 and 3.7±1.3 units pmol−1, respectively.	Gram-negative bacterium: Escherichia coli K-12 D31;##Gram-positive bacterium: Bacillus subtilis strain 60015.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11948186	J Biol Chem. 2002 Jun 21;277(25):22353-22360.	Herbst R, Ott C, Jacobs T, Marti T, Marciano-Cabral F, Leippe M.	Pore-forming polypeptides of the pathogenic protozoon Naegleria fowleri.	
DRAMP03184	SVIGCEICEWLVATAEGFVNKTKPQIEQELLQICAKLGPYEQICDQLVLMELPDIIDQIIAKEPPAIVCSQVKICNG	77	Naegleriapore B 	Q95X02	Not found	NP-B	Naegleria fowleri (Brain eating amoeba) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiprotozoal, Cytotoxic	Predicted	Alpha helix 	It is characterized by a structure of amphipathic α-helices and an invariant framework of cysteine residues involved in disulfide bonds.		Function: Posesses antibacterial, cytotoxicity and pore-forming activity. Naegleriapore B does not exert any antibacterial activity in concentration up to 10 µm against the bacteria tested. The specific pore-forming activities of naegleriapore A and B are 3.1±1.7 units pmol−1 and 3.7±1.3 units pmol−1, respectively.	Gram-negative bacterium: Escherichia coli K-12 D31;##Gram-positive bacterium: Bacillus subtilis strain 60015.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11948186	J Biol Chem. 2002 Jun 21;277(25):22353-22360.	Herbst R, Ott C, Jacobs T, Marti T, Marciano-Cabral F, Leippe M.	Pore-forming polypeptides of the pathogenic protozoon Naegleria fowleri.	
DRAMP03185	SFGLCRLRRGFCAHGRCRFPSIPIGRCSRFVQCCRRVW	38	Spheniscin-1 (Sphe-1; penguin avian beta-defensin 103a; birds ,animals)	P83429	Belongs to the beta-defensin family	Not found	Aptenodytes patagonicus (King penguin)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity and antibacterial activity against Gram-positive and Gram-negative bacteria. Involved in the process of food preservation in the stomach during the incubation fast. May also be present during infection.
PTM: Contains three disulfide bond: 5-33; 12-27; 17-34.
Tissue specificity: Secreted into the stomach cavity."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys5 and Cys33; Cys12 and Cys27; Cys17 and Cys34.	L	No cytotoxicity information found	Not found	14525994	J Biol Chem. 2003 Dec 19;278(51):51053-8. 	Thouzeau C, Le Maho Y, Froget G, Sabatier L, Le Bohec C, Hoffmann JA, Bulet P.	Spheniscins, avian beta-defensins in preserved stomach contents of the king penguin, Aptenodytes patagonicus.	CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)C(C)C)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N3)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2
DRAMP03188	RLGGILRKAGEKIGGGLKKIGQKIKDFFGKLAPRTES	37	Antibacterial protein LL-37 (primates, mammals, animals)	Q1KLX0	Belongs to the cathelicidin family	CAMP	Saguinus oedipus (Cotton-top tamarin)	Antimicrobial, Antibacterial, Anti-Gram-	Homology	Bridge	Not found		Function: Has antibacterial activity (By similarity).	Gram-negative bacteria: Escherichia coli ML-35, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus 710A, Enterococcus faecalis A16.##Yeast: Candida albicans clinical isolate.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP03189	VARLGGILRKAGEKIGGGLKKIGQKIKDFFGKLAPRTES	39	Antibacterial protein LL-39 (primates, mammals, animals)	Q1KLX0	Belongs to the cathelicidin family	CAMP	Saguinus oedipus (Cotton-top tamarin)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP18221	TVYTQA	6	Fusaricidin D (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus polymyxa KT-8	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal		Not found	The carboxylic end of Ala6 forms an ester bond with the hydroxyl group of T1. Val2, Gln5, Ala6 are D-amino acids and Thr4 is a D-allo-Thr. In addition, the N-terminus NH is lipidated with 15-guanidino-3-hydroxypentadecanoic acid (GHPD). 		Fusaricidin A was elucidated to be a cyclic depsipeptide containing a unique fatty acid, 15-guanidino-3-hydroxypentadecanoic acid. Fusaricidins B, C, and D are minor components from the culture broth of a bacterial strain Bacillus polymyxa KT-8.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9127193##23185515	J Antibiot (Tokyo). 1997 Mar;50(3):220-8.##PLoS One. 2012;7(11):e50003.	Kajimura Y, Kaneda M.##Yu WB, Yin CY, Zhou Y, Ye BC.	Fusaricidins B, C and D, new depsipeptide antibiotics produced by Bacillus polymyxa KT-8: isolation, structure elucidation and biological activity.##Prediction of the mechanism of action of fusaricidin on Bacillus subtilis.	
DRAMP03192	RLGGFLQKAREKIARGFKKIGQKINDFLGKLAPRTEA	37	Antibacterial protein LL-37 (cathelicidin; primates, mammals, animals)	Q1KLY5	Belongs to the cathelicidin family	CAMP	Cebus capucinus (white-faced-sapajou)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Has antibacterial activity. (By similarity)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	16720578	J Biol Chem. 2006 Jul 21;281(29):19861-19871.	Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.	Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.	
DRAMP03194	RCVCTRGFC	9	Theta defensin subunit A (primates, mammals, animals)	P86722	Belongs to the alpha-defensin family (Theta subfamily)	Not found	Papio hamadryas (Hamadryas baboon)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Forms a cyclic peptide with subunit A (PhTD-3) or with subunit B (PhTD-1). An additional intersubunit disulfide bond is formed. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20155756	Rapid Commun Mass Spectrom. 2010 Mar 15;24(5):599-604.	Stegemann C, Tsvetkova EV, Aleshina GM, Lehrer RI, Kokryakov VN, Hoffmann R.	De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.	
DRAMP03195	RCVCRRGVC	9	Theta defensin subunit B (primates, mammals, animals)	P86723	Belongs to the alpha-defensin family (Theta subfamily)	Not found	Papio hamadryas (Hamadryas baboon)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Forms a cyclic peptide with subunit A (PhTD-1). An additional intersubunit disulfide bond is formed. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20155756	Rapid Commun Mass Spectrom. 2010 Mar 15;24(5):599-604.	Stegemann C, Tsvetkova EV, Aleshina GM, Lehrer RI, Kokryakov VN, Hoffmann R.	De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.	
DRAMP03199	RRICRCRIGRCLGLEVYFGVCFLHGRLARRCCR	33	PhD1 (PhD-1; Defensin-1; primates, mammals, animals)	P84757	Not found	Not found	Papio hamadryas (Hamadryas baboon)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Listeria monocytogenes, Staphylococcus aureus.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16978151	Biochemistry (Mosc). 2006 Aug;71(8):879-883.	Tsvetkova EV, Aleshina GM, Shamova OV, Leonova LE, Lehrer RI, Kokryakov VN.	alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.	
DRAMP03200	RICRCRIGRCLGLEVYFGVCFLHGRLARRCCR	32	PhD2 (PhD-2; Defensin-2; primates, mammals, animals)	P84757	Belongs to the alpha-defensin family	Not found	Papio hamadryas (Hamadryas baboon)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Listeria monocytogenes, Staphylococcus aureus.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16978151	Biochemistry (Mosc). 2006 Aug;71(8):879-83.	Tsvetkova EV, Aleshina GM, Shamova OV, Leonova LE, Lehrer RI, Kokryakov VN.	alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.	
DRAMP03201	RTCRCRLGRCSRRESYSGSCNINGRIYSLCCR	32	PhD3 (PhD-3; Defensin-3; primates, mammals, animals)	P84758	Belongs to the alpha-defensin family	Not found	Papio hamadryas (Hamadryas baboon)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Listeria monocytogenes, Staphylococcus aureus.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16978151	Biochemistry (Mosc). 2006 Aug;71(8):879-883.	Tsvetkova EV, Aleshina GM, Shamova OV, Leonova LE, Lehrer RI, Kokryakov VN.	alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.	
DRAMP03202	VKGGIEKAGVCPADNVRCFKSDPPQCHTDQDCLGARKCCYLHCGFKCVIPVKKLEEGGNKDEDVSGPCPEPGWEAKSPGSSSTGCPQK	88	WAP four-disulfide core domain protein 12 (primates, mammals, animals)	A4K2M6	Not found	WFDC12	Papio anubis (Olive baboon)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Antibacterial protein. Putative acid-stable proteinase inhibitor (By similarity).
Doamin: Contains 1 WAP domain"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17267810	Genome Res. 2007 Mar;17(3):276-286.	Hurle B, Swanson W; NISC Comparative Sequencing Program, Green ED.	Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage.	
DRAMP18220	TVYTNA	6	Fusaricidin C (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus polymyxa KT-8	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal		Not found	The carboxylic end of Ala6 forms an ester bond with the hydroxyl group of T1. Val2, Asn5, Ala6 are D-amino acids and Thr4 is a D-allo-Thr. In addition, the N-terminus NH is lipidated with 15-guanidino-3-hydroxypentadecanoic acid (GHPD). 		Fusaricidin A was elucidated to be a cyclic depsipeptide containing a unique fatty acid, 15-guanidino-3-hydroxypentadecanoic acid. Fusaricidins B, C, and D are minor components from the culture broth of a bacterial strain Bacillus polymyxa KT-8.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9127193##23185515	J Antibiot (Tokyo). 1997 Mar;50(3):220-8.##PLoS One. 2012;7(11):e50003.	Kajimura Y, Kaneda M.##Yu WB, Yin CY, Zhou Y, Ye BC.	Fusaricidins B, C and D, new depsipeptide antibiotics produced by Bacillus polymyxa KT-8: isolation, structure elucidation and biological activity.##Prediction of the mechanism of action of fusaricidin on Bacillus subtilis.	
DRAMP18219	TVVTQA	6	Fusaricidin B (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus polymyxa KT-8	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal		Not found	The carboxylic end of Ala6 forms an ester bond with the hydroxyl group of T1. Val2, Gln5, Ala6 are D-amino acids and Thr4 is a D-allo-Thr. In addition, the N-terminus NH is lipidated with 15-guanidino-3-hydroxypentadecanoic acid (GHPD). 		Fusaricidin A was elucidated to be a cyclic depsipeptide containing a unique fatty acid, 15-guanidino-3-hydroxypentadecanoic acid. Fusaricidins B, C, and D are minor components from the culture broth of a bacterial strain Bacillus polymyxa KT-8.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9127193##23185515	J Antibiot (Tokyo). 1997 Mar;50(3):220-8.##PLoS One. 2012;7(11):e50003.	Kajimura Y, Kaneda M.##Yu WB, Yin CY, Zhou Y, Ye BC.	Fusaricidins B, C and D, new depsipeptide antibiotics produced by Bacillus polymyxa KT-8: isolation, structure elucidation and biological activity.##Prediction of the mechanism of action of fusaricidin on Bacillus subtilis.	
DRAMP03206	RCICLLGIC	9	Theta defensin subunit C (BTD-c; BTD-4 subunit 2; primates, mammals, animals)	B6ULW6, P86033	Belongs to the alpha-defensin family (Theta subfamily)	BTDC	Papio anubis (Olive baboon)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Forms a cyclic peptide with subunit A (BTD-4). An additional intersubunit disulfide bond is formed. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18852242	Infect Immun. 2008 Dec;76(12):5883-5891.	Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.	Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.	
DRAMP03207	RCFCRRGVC	9	Theta defensin subunit D (BTD-d; BTD-7 subunit 2; primates, mammals, animals)	B6ULW7, P86034	Belongs to the alpha-defensin family (Theta subfamily)	BTDD	Papio anubis (Olive baboon)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Forms a cyclic peptide with subunit A (BTD-7). An additional intersubunit disulfide bond is formed.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18852242	Infect Immun. 2008 Dec;76(12):5883-5891.	Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.	Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.	
DRAMP03208	RCVCTRGFCRCVCRRGVC	18	BTD-1 (theta-defensin; primates, mammals, animals)	B6ULW4, P86031, B6ULW5, P86032	Not found	Not found	Papio anubis (Olive baboon)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: BTD-1 has antimicrobial activity against the Gram-negative bacterium E. coli ML35 and the Gram-positive bacterium S. aureus 502a, and the fungus C. albicans 16820. 	Gram-positive bacterium: Staphylococcus aureus 502a;##Gram-negative bacterium: Escherichia coli ML35.##Fungi: Candida albicans 16820.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	18852242	Infect Immun. 2008 Dec;76(12):5883-5891.	Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.	Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.	
DRAMP03209	RCVCRRGVCRCVCRRGVC	18	BTD-2 (theta-defensin; primates, mammals, animals)	B6ULW5, P86032	Not found	Not found	Papio anubis (Olive baboon)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: BTD-2 has antimicrobial activity against the Gram-negative bacterium E. coli ML35 and the Gram-positive bacterium S. aureus 502a, and the fungus C. albicans 16820. Among the five BTDs detected, the most potent peptide is BTD-2. BTD-2 is more effective against E. coli than BTD-1.	Gram-positive bacterium: Staphylococcus aureus 502a;##Gram-negative bacterium: Escherichia coli ML35.##Fungi: Candida albicans 16820.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	18852242	Infect Immun. 2008 Dec;76(12):5883-5891.	Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.	Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.	
DRAMP18218	TVVTNA	6	Fusaricidin A (Bacteriocin)	No entry found	Belongs to the lipopeptides family	Not found	Bacillus polymyxa KT-8	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal		Not found	The carboxylic end of Ala6 forms an ester bond with the hydroxyl group of T1. Val2, Asn5, Ala6 are D-amino acids and Thr4 is a D-allo-Thr. In addition, the N-terminus NH is lipidated with 15-guanidino-3-hydroxypentadecanoic acid (GHPD). 		Fusaricidin A was elucidated to be a cyclic depsipeptide containing a unique fatty acid, 15-guanidino-3-hydroxypentadecanoic acid. Fusaricidins B, C, and D are minor components from the culture broth of a bacterial strain Bacillus polymyxa KT-8.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8621351##23185515 	J Antibiot (Tokyo). 1996 Feb;49(2):129-35.##PLoS One. 2012;7(11):e50003.	Kajimura Y, Kaneda M.##Yu WB, Yin CY, Zhou Y, Ye BC.	Fusaricidin A, a new depsipeptide antibiotic produced by Bacillus polymyxa KT-8. Taxonomy, fermentation, isolation, structure elucidation and biological activity.##Prediction of the mechanism of action of fusaricidin on Bacillus subtilis.	
DRAMP03211	RCVCTRGFCRCICLLGIC	18	BTD-4 (theta-defensin; primates, mammals, animals)	B6ULW4, B6ULW6	Not found	Not found	Papio anubis (Olive baboon)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: BTD-4 has antimicrobial activity against the Gram-negative bacterium E. coli ML35 and the Gram-positive bacterium S. aureus 502a, and the fungus C. albicans 16820. Among the five BTD detected, BTD-4 is least positively charged (net charge +2). This may be responsible for its weaker antimicrobial activity observed in vitro. It disrupts E. coli membranes.	Gram-positive bacterium: Staphylococcus aureus 502a;##Gram-negative bacterium: Escherichia coli ML35.##Fungi: Candida albicans 16820.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	18852242	Infect Immun. 2008 Dec;76(12):5883-5891.	Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.	Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.	
DRAMP03212	RCVCTRGFCRCFCRRGVC	18	BTD-7 (theta-defensin; primates, mammals, animals)	B6ULW4, B6ULW7	Not found	Not found	Papio anubis (Olive baboon)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: BTD-7 has antimicrobial activity against the Gram-negative bacterium E. coli ML35 and the Gram-positive bacterium S. aureus 502a, and the fungus C. albicans 16820. 	Gram-positive bacterium: Staphylococcus aureus 502a;##Gram-negative bacterium: Escherichia coli ML35.##Fungi: Candida albicans 16820.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	18852242	Infect Immun. 2008 Dec;76(12):5883-5891.	Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.	Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.	
DRAMP18217	WEEYNIIXQLGNKGQ	15	Licheniocin 50.2(Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	Not found	Bacillus licheniformis VPS50.2	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Fuction: The bacteriocin activity was insensitive to lysozyme and proteinase K, heat stable after incubation at 100 Celsius degree for 30 min and over wide range of pH (2	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2423832	Laryngol Rhinol Otol (Stuttg). 	Maier H, Adler D.	Treatment of chronic recurring parotitis with the protease inhibitor aprotinin (trasylol).	
DRAMP18216	GWGDVLCVAGTIGGAGTGGLGGAAAGSAVPVIGTGIGGAIGGVSGGLTGAATFC	54	Cerein 7A(Bacteriocin)	No entry found	Belongs to the class IId bacteriocin	Not found	Bacillus cereus Bc7	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		When the purified cerein 7A and 7B were combined at a 1 : 1 ratio, no synergistic activity was observed between the two bacteriocins.	Gram-positive (wide range)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	16451187##10971770	FEMS Microbiol Lett.##J Appl Microbiol.	Osc	Purification and sequencing of cerein 7B, a novel bacteriocin produced by Bacillus cereus Bc7.##Characterization and mechanism of action of cerein 7, a bacteriocin produced by Bacillus cereus Bc7.	
DRAMP03218	GKFSVFGKILRSIAKVFKGVGKVRKQFKTASDLDKNQ	37	M-oxotoxin-Ot2a (Oxyopinin-2a, Oxki2a; spiders, Arthropods, animals)	P83248	Belongs to the oxyopinin-2 family	Not found	Oxyopes takobius (Lynx spider) (Oxyopes foliiformis)	Antimicrobial, Antibacterial, Insecticidal	Protein level	Alpha helix 	Not found		Function: Disrupts biological membranes, particularly those rich in phosphocholine. Has antimicrobial activity against Gram- negative bacterium E. coli and the Gram-positive bacteria B. subtilis and S. aureus, and hemolytic activity against sheep red blood cells. Has insecticidal activity against S. frugiperda ovarian cells by opening non-selective ion channels. Enhances the insecticidal activity of spider venom neurotoxic peptides.	No MICs found in DRAMP database	[Ref.11976325]10% hemolytic activity at 50 µM against sheep red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	11976325	J Biol Chem. 2002 Jun 28;277(26):23627-23637.	Corzo G, Villegas E, Gómez-Lagunas F, Possani LD, Belokoneva OS, Nakajima T. 	Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins.	
DRAMP03219	GKFSGFAKILKSIAKFFKGVGKVRKQFKEASDLDKNQ	37	M-oxotoxin-OtIIb (Oxyopinin-IIb, OxkiIIb; spiders, Arthropods, animals)	P83249	Belongs to the oxyopinin-2 family	Not found	Oxyopes takobius (Lynx spider) (Oxyopes foliiformis)	Antimicrobial, Antibacterial, Insecticidal	Protein level	Not found	Not found		Function: Disrupts biological membranes, particularly those rich in phosphocholine. Has antimicrobial activity against Gram- negative bacterium E. coli and the Gram-positive bacteria B. subtilis and S. aureus, and hemolytic activity against sheep red blood cells. Has insecticidal activity against S. frugiperda ovarian cells by opening non-selective ion channels. Enhances the insecticidal activity of spider venom neurotoxic peptides.	No MICs found in DRAMP database	[Ref.11976325]10% hemolytic activity at 50 µM against sheep red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11976325	J Biol Chem. 2002 Jun 28;277(26):23627-23637.	Corzo G, Villegas E, Gómez-Lagunas F, Possani LD, Belokoneva OS, Nakajima T. 	Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins.	
DRAMP03220	GKLSGISKVLRAIAKFFKGVGKARKQFKEASDLDKNQ	37	M-oxotoxin-Ot2c (Oxyopinin-2c, Oxki2c; spiders, Arthropods, animals)	P83250	Belongs to the oxyopinin-2 family	Not found	Oxyopes takobius (Lynx spider) (Oxyopes foliiformis)	Antimicrobial, Antibacterial, Insecticidal	Protein level	Alpha helix 	Not found		Function: Disrupts biological membranes, particularly those rich in phosphocholine. Has antimicrobial activity against Gram- negative bacterium E. coli and the Gram-positive bacteria B. subtilis and S. aureus, and hemolytic activity against sheep red blood cells. Has insecticidal activity against S. frugiperda ovarian cells by opening non-selective ion channels. Enhances the insecticidal activity of spider venom neurotoxic peptides.	No MICs found in DRAMP database	[Ref.11976325]10% hemolytic activity at 50 µM against sheep red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	11976325	J Biol Chem. 2002 Jun 28;277(26):23627-23637.	Corzo G, Villegas E, Gómez-Lagunas F, Possani LD, Belokoneva OS, Nakajima T. 	Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins.	
DRAMP03221	GKFSVFSKILRSIAKVFKGVGKVRKQFKTASDLDKNQ	37	M-oxotoxin-Ot2d (Oxyopinin-2d, Oxki2d; spiders, Arthropods, animals)	P83251	Belongs to the oxyopinin-2 family	Not found	Oxyopes takobius (Lynx spider)	Antimicrobial, Antibacterial, Insecticidal	Protein level	Not found	Not found		Function: Disrupts biological membranes, particularly those rich in phosphocholine. Has antimicrobial activity against Gram- negative bacterium E. coli and the Gram-positive bacteria B. subtilis and S. aureus, and hemolytic activity against sheep red blood cells. Has insecticidal activity against S. frugiperda ovarian cells by opening non-selective ion channels. Enhances the insecticidal activity of spider venom neurotoxic peptides.	No MICs found in DRAMP database	[Ref.11976325]10% hemolytic activity at 50 µM against sheep red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11976325	J Biol Chem. 2002 Jun 28;277(26):23627-23637.	Corzo G, Villegas E, Gómez-Lagunas F, Possani LD, Belokoneva OS, Nakajima T. 	Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins.	
DRAMP03223	GFGSLFKFLAKKVAKTVAKQAAKQGAKYIANKQME	35	M-ctenitoxin-Cs1b (M-CNTX-Cs1b; Cupiennin-1b; spiders, Arthropods, animals)	P83620	Belongs to the cupiennin family	Not found	Cupiennius salei (Wandering spider)	Antimicrobial, Antibacterial, Insecticidal	Protein level	Not found	Not found		Function: Has antimicrobial activity. Has insecticidal activity. Probably acts by disturbing membrane Function: with its amphipathic structure. Synergistically increases the insecticidal activity of CSTX-1, CSTX-9, and CSTX-13 by up to 65%. Also inhibits the formation of nitric oxide by neuronal nitric oxide synthase. LD50 is 5.9 pmol/mg on Drosophila. 	No MICs found in DRAMP database	[Ref.11792701]Not determined	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11792701	J Biol Chem. 2002 Mar 29;277(13):11208-11216.	Kuhn-Nentwig L, Muller J, Schaller J, Walz A, Dathe M, Nentwig W.	Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae).	
DRAMP03224	GFGSLFKFLAKKVAKTVAKQAAKQGAKYIANKQTE	35	M-ctenitoxin-Cs1c (M-CNTX-Cs1c; Cupiennin-1c; spiders, Arthropods, animals)	P83621	Belongs to the cupiennin family	Not found	Cupiennius salei (Wandering spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has antimicrobial activity. Probably acts by disturbing membrane Function: with its amphipathic structure.	Gram-negative bacteria: Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853;##Gram-positive bacteria: Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11792701	J Biol Chem. 2002 Mar 29;277(13):11208-11216.	Kuhn-Nentwig L, Muller J, Schaller J, Walz A, Dathe M, Nentwig W.	Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae).	
DRAMP03228	GLFGKLIKKFGRKAISYAVKKARGKN	26	M-zodatoxin-Lt2b (M-ZDTX-Lt2b; Latarcin-2b, Ltc-2b; spiders, Arthropods, animals)	Q1ELU0	Belongs to the latarcin family	Not found	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Has antimicrobial activity against both Gram-positive and Gram-negative bacteria, and the yeasts. Also has a strong hemolytic activity against rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	[Swiss_Prot Entry Q1ELU0]has a strong hemolytic activity against rabbit erythrocytes 	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16735513	J Biol Chem. 2006 Jul 28;281(30):20983-209892.	Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.	Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.	
DRAMP03234	QAFQTFKPDWNKIRYDAMKMQTSLGQMKKRFNL	33	M-zodatoxin-Lt6a (M-ZDTX-Lt6a; Latarcin 6a, Ltc-6a; spiders, Arthropods, animals)	Q1ELU8	Belongs to the latarcin family	Not found	Lachesana tarabaevi (Spider)	Not found	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16735513	J Biol Chem. 2006 Jul 28;281(30):20983-20992. 	Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV. 	Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.	
DRAMP03235	QAFKTFTPDWNKIRNDAKRMQDNLEQMKKRFNLNL	35	M-zodatoxin-Lt6b (M-ZDTX-Lt6b; Latarcin 6b, Ltc-6b; spiders, Arthropods, animals)	Q1ELU8	Belongs to the latarcin family	Not found	Lachesana tarabaevi (Spider)	Antibacterial, Antimicrobial, Antifungal, Antiviral	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16735513	J Biol Chem. 2006 Jul 28;281(30):20983-20992. 	Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV. 	Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.	
DRAMP18215	TTPLCVGVIIGITASIKICK	20	Cerecidin A7(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Bacillus cereus	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Fuction: Active against Gram-positive bacteria B. cereus As 1.348, B. cereus As 1.352, B. thuringiensis 1.1013, B. thuringiensis 1.1014, B. subtilis 1.107, B. subtilis DB104, B. pumilus 1.1165, E. faecalis 1.14, E. faecalis V583, E. durans 1.2023, E. pernyi 1.1010, L. coprophilus 1.214, L. acidophilus 100-33, L. casei 1.575, L. rhamnosus 1.104, L. plantarum 1.551, L. brevis 1.2028, L. brevis 1.7, L. buchneri 1.40, L. lactis LM0230, L. lactis MG1363, L. curvatus LTH1.174, L. dextranicum 181 (zone inhibition 7-11 mm), M. flavus NCIB8166 (zone inhibition 18 mm), S. aureus 1-1, S. bovis LG42, S. gordonii 1.2496, S. salivarius 1.2498, S. thermophilus 1.1864 (Zone inhibition 7-11 mm), including resistant superbugs (MRSA and VRE).	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24532070	Appl Environ Microbiol. 2014 Apr;80(8):2633-43.	Wang J, Zhang L, Teng K, Sun S, Sun Z, Zhong J.	Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity.	
DRAMP03238	GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYVLKYYGKKALQKASEKL	69	M-zodatoxin-Lt8c (M-ZDTX-Lt8c; Cytoinsectotoxin-1c, CIT-1c; spiders, Arthropods, animals)	P85255, B3W6I1	Belongs to the cytoinsectotoxin family	cit 1-3	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Insecticidal	Protein level	Not found	Not found		"Function: Insecticidal, cytolytic and antimicrobial peptide. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis(By similarity).
Tissue specificity: Expressed by the venom gland."	Gram-positive bacteria: Micrococcus luteus VKM Ac-2230, Staphylococcus aureus 209P, Arthrobacter globiformis VKM Ac-1112, Bacillus subtilis VKM B-501;##Gram-negative bacteria: Escherichia coli C600, E. coli DH5Î±, E. coli MH1, Pseudomonas aeruginosa PAO1, Pseudomonas fluorescens VKM B-894, Serratia marcescens VKM B-1248.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03239	GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGITKEEAQAKVDAMSKKQIRLYLLKYYGKKALQKASEKL	69	M-zodatoxin-Lt8d (M-ZDTX-Lt8d; Cytoinsectotoxin-1d, CIT-1d; spiders, Arthropods, animals)	P85256, B3W6I2	Belongs to the cytoinsectotoxin family	cit 1-4	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Insecticidal	Protein level	Not found	Not found		"Function: Insecticidal, cytolytic and antimicrobial peptide. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03240	GFFGNTWKKIKGKSDKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYLLKYYGKKALQKASEKL	69	M-zodatoxin-Lt8e (M-ZDTX-Lt8e; Cytoinsectotoxin-1e, CIT-1e; spiders, Arthropods, animals)	P85256, B3W6I3	Belongs to the cytoinsectotoxin family	cit 1-5	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Insecticidal	Protein level	Not found	Not found		"Function: Insecticidal, cytolytic and antimicrobial peptide. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03241	GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYLLKHYGKKALQKASEKL	69	M-zodatoxin-Lt8f (M-ZDTX-Lt8f; Cytoinsectotoxin-1f, CIT-1f; spiders, Arthropods, animals)	P85258, B3W6I4	Belongs to the cytoinsectotoxin family	cit 1-7	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Anti-Gram-, Insecticidal	Protein level	Not found	Not found		"Function: Insecticidal, cytolytic and antimicrobial peptide. Has insecticidal activity against the flesh fly S. carnaria. Has antibacterial activity against the Gram-negative bacteria E.coli. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03242	GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYVLKHYGKKALQKASEKL	69	M-zodatoxin-Lt8g (M-ZDTX-Lt8g; Cytoinsectotoxin-1g, CIT-1g; spiders, Arthropods, animals)	P85259, B3W6I5	Belongs to the cytoinsectotoxin family	cit 1-8	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Anti-Gram-, Insecticidal	Protein level	Not found	Not found		"Function: Has insecticidal activity against the flesh fly S. carnaria. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03243	GFFGNAWKKIKGKAEKFFRKKAAKIIAKKEGITKEEAEAKVDTMSKKQIKVYLLKHYGKKALQKASEKL	69	M-zodatoxin-Lt8h (M-ZDTX-Lt8h; Cytoinsectotoxin-1h, CIT-1h; spiders, Arthropods, animals)	P85247, B3W6I6	Belongs to the cytoinsectotoxin family	cit 1-11	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Anti-Gram-, Insecticidal	Protein level	Not found	Not found		"Function: Has insecticidal activity against the flesh fly S. carnaria. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03244	GFFGNTWKKIKGKTDKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYLLKHYGKKALQKASEKL	69	M-zodatoxin-Lt8j (M-ZDTX-Lt8j; Cytoinsectotoxin 1-9; spiders, Arthropods, animals)	P0CAZ3	Belongs to the cytoinsectotoxin family	cit 1-9	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Insecticidal	Transcript level	Not found	Not found		Insecticidal, cytolytic and antimicrobial peptide. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski AA, Kozlov SA, Samsonova OV, Egorova NS, Karpunin DV, Pluzhnikov KA, Feofanov AV, Grishin EV.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03245	GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYVLKHYGKKALQKVSEKL	69	M-zodatoxin-Lt8k (M-ZDTX-Lt8k; Cytoinsectotoxin 1-10; spiders, Arthropods, animals)	P0CAZ4	Belongs to the cytoinsectotoxin family	cit 1-10	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Insecticidal	Transcript level	Not found	Not found		"Function: Insecticidal, cytolytic and antimicrobial peptide. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03246	GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGIFKEEAQAKVDAMSKKQIRLYLLKYYGKKALQKASEKL	69	M-zodatoxin-Lt8i (M-ZDTX-Lt8i; Cytoinsectotoxin 1-6; spiders, Arthropods, animals)	P0CAZ2	Belongs to the cytoinsectotoxin family	cit 1-6	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Insecticidal	Transcript level	Not found	Not found		"Function: Insecticidal, cytolytic and antimicrobial peptide. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski AA, Kozlov SA, Samsonova OV, Egorova NS, Karpunin DV, Pluzhnikov KA, Feofanov AV, Grishin EV.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03247	GFFGNAWKKIKGKAEKFFRKKAAKIIAKKEGITKEEAEAKVDPMSKKQIKVYLLKHYGKKALQKASEKL	69	M-zodatoxin-Lt8l (M-ZDTX-Lt8l; Cytoinsectotoxin 1-12; spiders, Arthropods, animals)	P0CAZ5	Belongs to the cytoinsectotoxin family	cit 1-12	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Insecticidal	Transcript level	Not found	Not found		"Function: Insecticidal, cytolytic and antimicrobial peptide. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03248	GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYLLKHYGKKLFKKRPKNCDQ	71	M-zodatoxin-Lt8m (M-ZDTX-Lt8m; Cytoinsectotoxin 1-13; spiders, Arthropods, animals)	P0CAZ6	Belongs to the cytoinsectotoxin family	cit 1-13	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Insecticidal	Transcript level	Not found	Not found		"Function: Insecticidal, cytolytic and antimicrobial peptide. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03249	GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYLLKYYGKKLFKKRPKNCDQ	71	M-zodatoxin-Lt8o (M-ZDTX-Lt8o; Cytoinsectotoxin 1-14; spiders, Arthropods, animals)	P0CAZ7	Belongs to the cytoinsectotoxin family	cit 1-14	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Insecticidal	Transcript level	Not found	Not found		"Function: Insecticidal, cytolytic and antimicrobial peptide. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03250	GFFGNTWKKIKGKADKIMLKKAVKLMVKKEGISKEEAQAKVDAMSKKQIRLYLLKYYGKKSSSKSVRKIVISKSF	75	M-zodatoxin-Lt8p (M-ZDTX-Lt8p; Cytoinsectotoxin 1-15; spiders, Arthropods, animals)	P0CAZ8	Belongs to the cytoinsectotoxin family	cit 1-15	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Insecticidal	Transcript level	Not found	Not found		"Function: Insecticidal, cytolytic and antimicrobial peptide. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03251	GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYVLKHYGKKSSSKSFRKIVISKSF	75	M-zodatoxin-Lt8q (M-ZDTX-Lt8q; Cytoinsectotoxin 1-16; spiders, Arthropods, animals)	P0CAZ9	Belongs to the cytoinsectotoxin family	cit 1-16	Lachesana tarabaevi (Spider)	Antimicrobial, Antibacterial, Insecticidal	Transcript level	Not found	Not found		"Function: Insecticidal, cytolytic and antimicrobial peptide. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18215128	Biochem J. 2008 May 1;411(3):687-696.	Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.	Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.	
DRAMP03252	KIKWFKTMKSLAKFLAKEQMKKHLGE	26	M-lycotoxin-Ls2a (M-LCTX-Ls2a; Lycocitin-3; spiders, Arthropods, animals)	P0C2U8	Not found	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Function: Forms pore that permeabilize the cell membrane. Promotes efflux of calcium from synaptosomes, causes hemolysis, and dissipates voltage gradients across muscle membrane. Potently inhibits the growth of bacteria and yeast. May Function: both in the prey capture strategy as well as protection from infectious organisms arising from prey ingestion.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	14991689	J Mass Spectrom. 2004 Feb;39(2):193-201.	Budnik BA, Olsen JV, Egorov TA, Anisimova VE, Galkina TG, Musolyamov AK, Grishin EV, Zubarev RA.	De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis.	
DRAMP03255	MIASHLAFEKLSKLGSKHTML	21	M-lycotoxin-Ls4a (M-LCTX-Ls4a; Peptide 2340; spiders, Arthropods, animals)	P0C2V0	Not found	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: May inhibit growth of bacteria.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14991689	J Mass Spectrom. 2004 Feb;39(2):193-201.	Budnik B.A, Olsen J.V, Egorov T.A, Anisimova V.E, Galkina T.G, Musolyamov A.K, Grishin E.V, Zubarev R.A.	De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis.	
DRAMP03256	AGIGKIGDFIKKAIAKYKN	19	U1-lycotoxin-Ls1a (U1-LCTX-Ls1a; Peptide 2034; spiders, Arthropods, animals)	P0C2U9	Not found	Not found	Lycosa singoriensis (Wolf spider)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: May inhibit growth of bacteria.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14991689	J Mass Spectrom. 2004 Feb;39(2):193-201.	Budnik B.A, Olsen J.V, Egorov T.A, Anisimova V.E, Galkina T.G, Musolyamov A.K, Grishin E.V, Zubarev R.A.	De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis.	
DRAMP03257	QPFSLERW	8	Oligoventin (spiders, Arthropods, animals)	B3EWR9	Not found	Not found	Phoneutria nigriventer (Brazilian armed spider) (Ctenus nigriventer)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Has antibacterial activity against Gram-positive bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2012) to UniProtKB	Ferreira I.L.C, Sayegh R.S.R, Batista I.F.C, Silva P.I. Jr.	Isolation and characterization a novel ultrashort antibacterial peptide from the eggs of the spider Phoneutria nigriventer (Ctenidae).	
DRAMP03258	IIIQYEGHKH	10	Rondonin (spiders, Arthropods, animals)	B3EWP8	Not found	Not found	Acanthoscurria rondoniae (Spider)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Exhibits antifungal activity against Candida sp. No hemolytic activity	No MICs found in DRAMP database	[Swiss_Prot Entry B3EWP8]Non-hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Results Immunol. 2012;2:66-71.	Riciluca K.C.T, Sayegh R.S.R, Melo R.L, Silva P.I. Jr.	Rondonin an antifungal peptide from spider (Acanthoscurria rondoniae) haemolymph.	
DRAMP03259	RTCMIKKEGWGKCLIDTTCAHSCKNRGYIGGDCKGMTRTCYCLVNC	46	VrCRP (Cyst-rich; Plant defensin)	No entry found	Not found	Not found	V. radiata (a bruchid-resistant mungbean)	Insecticidal	Not found	Not found	Not found		Function: VrCRP exhibits insecticidal activity in vitro against C. chinensis.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12452641	J Agric Food Chem. 2002 Dec 4;50(25):7258-7263.	Chen KC, Lin CY, Kuan CC, Sung HY, Chen CS.	A novel defensin encoded by a mungbean cDNA exhibits insecticidal activity against bruchid.	
DRAMP03260	EKYCPTPRNTSCKKMNIRNNCCRDSDCTSNAFCCAEPCGNFCHKASDKPGGRRVDPNASCQTGYVYW	67	U14-lycotoxin-Ls1a (Toxin-like structure LSTX-N1; spiders, Arthropods, animals)	B6DD34	"Spider wap-1 family
 (Contains 1 WAP domain)"	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity). 
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (Probable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19875276	Zoology (Jena). 2010 Jan;113(1):10-18.	hang Y, Chen J, Tang X, Wang F, Jiang L, Xiong X, Wang M, Rong M, Liu Z, Liang S.	Transcriptome analysis of the venom glands of the Chinese wolf spider Lycosa singoriensis.	
DRAMP03262	EKYCPTPRNTSCKKMNIRNNCCRDSDCTSNAFCCAEPCGNFCHKASDKPGGRRVDPNASCKTGYVYW	67	U14-lycotoxin-Ls1b (Toxin-like structure LSTX-N3; spiders, Arthropods, animals)	B6DD36	"Spider wap-1 family
 (Contains 1 WAP domain)"	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity). 
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (Probable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19875276	Zoology (Jena). 2010 Jan;113(1):10-18.	hang Y, Chen J, Tang X, Wang F, Jiang L, Xiong X, Wang M, Rong M, Liu Z, Liang S.	Transcriptome analysis of the venom glands of the Chinese wolf spider Lycosa singoriensis.	
DRAMP18214	TTPLCVGVIIGLTTSIKICK	20	Cerecidin A1(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Bacillus cereus	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Fuction: Active against multiple Gram-positive strains, B. cereus As 1.348, B. cereus As 1.352, B. thuringiensis 1.1013, B. thuringiensis 1.1014, B. subtilis 1.107, B. subtilis DB104, B. pumilus 1.1165, E. faecalis 1.14, E. faecalis V583, E. durans 1.2023, E. pernyi 1.1010, L. coprophilus 1.214, L. acidophilus 100-33, L. casei 1.575, L. rhamnosus 1.104, L. plantarum 1.551, L. brevis 1.2028, L. brevis 1.7, L. buchneri 1.40, L. lactis LM0230, L. lactis MG1363, L. curvatus LTH1.174, L. dextranicum 181 (zone inhibition 6-10 mm, M. flavus NCIB8166 (zone inhibition 15 mm), S. bovis LG42, S. gordonii 1.2496, S. salivarius 1.2498, and S. thermophilus 1.1864 (Zone inhibition 7-9 mm), including resistant superbugs (MRSA and VRE).	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24532070	Appl Environ Microbiol. 2014 Apr;80(8):2633-43.	Wang J, Zhang L, Teng K, Sun S, Sun Z, Zhong J.	Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity.	
DRAMP03265	EKYCPTPRNTSCKKMNIKNNCCRDSDCTSNAFCCAEPCGNFCHKASDKPGGRRVDPNASCQTGYVYW	67	U14-lycotoxin-Ls1c (Toxin-like structure LSTX-N6; spiders, Arthropods, animals)	B6DD39	"Spider wap-1 family
 (Contains 1 WAP domain)"	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity). 
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (Probable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19875276	Zoology (Jena). 2010 Jan;113(1):10-18.	hang Y, Chen J, Tang X, Wang F, Jiang L, Xiong X, Wang M, Rong M, Liu Z, Liang S.	Transcriptome analysis of the venom glands of the Chinese wolf spider Lycosa singoriensis.	
DRAMP03266	DQYCPKSSITACKKMNIRNDCCKDDDCTGGSWCCATPCGNFCKYPTDRPGGKRAAGGKSCKTGYVYY	67	U15-lycotoxin-Ls1f (Toxin-like structure LSTX-N7; spiders, Arthropods, animals)	B6DD40	"Spider wap-1 family
 (Contains 1 WAP domain)"	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity). 
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (Probable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19875276	Zoology (Jena). 2010 Jan;113(1):10-18.	hang Y, Chen J, Tang X, Wang F, Jiang L, Xiong X, Wang M, Rong M, Liu Z, Liang S.	Transcriptome analysis of the venom glands of the Chinese wolf spider Lycosa singoriensis.	
DRAMP03267	DQYCPKSSITACKKMNIRNDCCKDDDCTGGSWCCATPCGNFCKYPTDRPGGKRAAGGKSCKTGYVY	66	U15-lycotoxin-Ls1d (Toxin-like structure LSTX-N8; spiders, Arthropods, animals)	B6DD41	"Spider wap-1 family
 (Contains 1 WAP domain)"	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity). 
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (Probable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19875276	Zoology (Jena). 2010 Jan;113(1):10-18.	hang Y, Chen J, Tang X, Wang F, Jiang L, Xiong X, Wang M, Rong M, Liu Z, Liang S.	Transcriptome analysis of the venom glands of the Chinese wolf spider Lycosa singoriensis.	
DRAMP18213	VKLFPVKLFP	10	Gramicidin S(Bacteriocin)	No entry found	Not found	Not found	Bacillus brevis	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-		Beta sheet	The second and seventh residues of this cyclic peptide are Ornithines, an analog of lysine (one CH2 shorter). They are represented here with lysines. In addition, residue F is a D-amino acid.		Function: This is the first cyclic peptide antibiotic used clinically. For gram-negative bacteria, however,  activity  was strongly dependent on whether the assay was carried out in solution or in agar. It was found that GS was active against gram-negative microorganisms in the solution-based  assay, but inactive against these using an agar-based  assay. GS was also found to have antifungal activity when measured using a  liquid-broth assay. 	Gram-positive, Gram-negative (broad-spectrum)	It exhibits hemolytic activity at 25 μM and 45 μM against human red cells and sheep red cells.	Cyclic	No specific N-terminal	No specific C-terminal	The 'O' in sequence is Ornithine	Mixed(D-Phe)	No cytotoxicity information found	Cell membrane	8836773##24388950	Int J Pept Protein Res. 1996 Jun;47(6):460-6.##Biochim Biophys Acta. 2014 May;1838(5):1420-9. 	Kondejewski LH, Farmer SW, Wishart DS, Hancock RE, Hodges RS.##Abraham T, Prenner EJ, Lewis RN, Mant CT, Keller S, Hodges RS, McElhaney RN.	Gramicidin S is active against both gram-positive and gram-negative bacteria.##Structure-activity relationships of the antimicrobial peptide gramicidin S and its analogs: aqueous solubility, self-association, conformation, antimicrobial activity and interaction with model lipid membranes.	
DRAMP03269	DQYCPKSSITACKKMNIRNDCCKDDDCTGGSWCCATPCGNFCKYPTDRPGGKRAAGGKSCKTSYVY	66	U15-lycotoxin-Ls1a (Toxin-like structure LSTX-N10; spiders, Arthropods, animals)	B6DD43	"Spider wap-1 family
 (Contains 1 WAP domain)"	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity). 
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (Probable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19875276	Zoology (Jena). 2010 Jan;113(1):10-18.	hang Y, Chen J, Tang X, Wang F, Jiang L, Xiong X, Wang M, Rong M, Liu Z, Liang S.	Transcriptome analysis of the venom glands of the Chinese wolf spider Lycosa singoriensis.	
DRAMP03270	DQYCPKSSITACKKMNIRNDCCKDDDCTGGSWYCATPCGNFCKYPTDRPGGKRAAGGKSCKTGYVY	66	U15-lycotoxin-Ls1b (Toxin-like structure LSTX-N11; spiders, Arthropods, animals)	B6DD44	"Spider wap-1 family
 (Contains 1 WAP domain)"	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity). 
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (Probable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19875276	Zoology (Jena). 2010 Jan;113(1):10-18.	hang Y, Chen J, Tang X, Wang F, Jiang L, Xiong X, Wang M, Rong M, Liu Z, Liang S.	Transcriptome analysis of the venom glands of the Chinese wolf spider Lycosa singoriensis.	
DRAMP03271	DQYCPKSSITACKKMNIRNDCCKDDDCTGGSWCCATPCGNICKYPTDRPGGKRAAGGKSCKTGYVY	66	U15-lycotoxin-Ls1c (Toxin-like structure LSTX-N12; spiders, Arthropods, animals)	B6DD45	"Spider wap-1 family
 (Contains 1 WAP domain)"	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity). 
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (Probable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19875276	Zoology (Jena). 2010 Jan;113(1):10-18.	hang Y, Chen J, Tang X, Wang F, Jiang L, Xiong X, Wang M, Rong M, Liu Z, Liang S.	Transcriptome analysis of the venom glands of the Chinese wolf spider Lycosa singoriensis.	
DRAMP18211	TSQTWGSPVP	10	Anacyclamide A10(Bacteriocin)	No entry found	Belongs to the class I bacteriocin	Not found	Anabaena sp. 90	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 2010 Feb;76(3):701-709.	Leikoski N,Fewer DP,Jokela J,Wahlsten M,Rouhiainen L,Sivonen K.	Highly Diverse Cyanobactins in Strains of the Genus Anabaena.	
DRAMP18212	LASTLGISTAAAKKAIDIIDAASTIASIISLIGIVTGAGAISYAIVATAKTMIKKYGKKYAAAW	64	Amylocyclicin(Bacteriocin)	No entry found	Belongs to the class IIc bacteriocin	acnA	Bacillus amyloliquefaciens FZB42	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Most similar to circular Uberolysin (45.9%). 		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Not found	24610713	J Bacteriol. 2014 May;196(10):1842-52.	Scholz R, Vater J, Budiharjo A, Wang Z, He Y, Dietel K, Schwecke T, Herfort S, Lasch P, Borriss R.	Amylocyclicin, a Novel Circular Bacteriocin Produced by Bacillus amyloliquefaciens FZB42.	
DRAMP03273	DQYCPKSSITACKKMNIRNDCCKDDDCTGGSWCCATPCGNFCKYPTDRPGGRRAAGGKSCKTGYVY	66	U15-lycotoxin-Ls1e (Toxin-like structure LSTX-N14; spiders, Arthropods, animals)	B6DD47	"Spider wap-1 family
 (Contains 1 WAP domain)"	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity). 
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (Probable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19875276	Zoology (Jena). 2010 Jan;113(1):10-18.	hang Y, Chen J, Tang X, Wang F, Jiang L, Xiong X, Wang M, Rong M, Liu Z, Liang S.	Transcriptome analysis of the venom glands of the Chinese wolf spider Lycosa singoriensis.	
DRAMP18210	SCNCVCGVCCSC	12	Amythiamicin C/D(Bacteriocin)	P0C912	Belongs to the class I bacteriocin	Not found	Amycolatopsis sp. (strain MI481-42F4 / FERM P-12739)	Antimicrobial, Antibacterial, Anti-Gram+, Antiparasitic		Not found	The main frame from C-1 to C-41 of these antibiotics was the same as that of amythiamicin D. Amino acid autoanalyses of amythiamicins A, B and C showed that these have another one mole of serine and proline in comparison with amythiamicin D. Stereochemistries of both amino acids were determined to be L by chiral HPLC. These seryl-prolyl residues in amythiamicins A, B and C are attached at C-41 through an oxazoline ring, amide and ester 		Sequence uncertainty (position 4): C or T. Function: Has bacteriocidal activity against Gram-positive bacteria: including multi-drug resistant strains such as Staphylococcus aureus MS9610 and Methicillin-resistant S.aureus, but is not active against most Gram-negative bacteria and fungi.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Elongation Factor Tu  (EF-Tu)	8040071##7961166##16262432	J Antibiot (Tokyo). 1994 Jun;47(6):668-74.##J Antibiot (Tokyo). 1994 Oct;47(10):1153-9.##J Am Chem Soc. 2005 Nov 9;127(44):15644-51.	Shimanaka K, Kinoshita N, Iinuma H, Hamada M, Takeuchi T.##Shimanaka K, Takahashi Y, Iinuma H, Naganawa H, Takeuchi T.##Hughes RA, Thompson SP, Alcaraz L, Moody CJ.	Novel antibiotics, amythiamicins. I. Taxonomy, fermentation, isolation, physico-chemical properties, and antimicrobial activity.##Novel antibiotics, amythiamicins. III. Structure elucidations of amythiamicins A, B and C.##Total synthesis of the thiopeptide antibiotic amythiamicin D.	
DRAMP03276	DQYCPKSSITACKKMNIRNDCCKDDDCTGGSWCCATPCGNFCKYPADRPGGKRAAGGKSCKTGYVY	66	U15-lycotoxin-Ls1g (Toxin-like structure LSTX-N17; spiders, Arthropods, animals)	B6DD50	"Spider wap-1 family
 (Contains 1 WAP domain)"	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity). 
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (Probable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19875276	Zoology (Jena). 2010 Jan;113(1):10-18.	hang Y, Chen J, Tang X, Wang F, Jiang L, Xiong X, Wang M, Rong M, Liu Z, Liang S.	Transcriptome analysis of the venom glands of the Chinese wolf spider Lycosa singoriensis.	
DRAMP03277	DQYCPKSSITACKKMNTRNDCCKDDDCTGGSWCCATPCGNFCKYPTDRPGGKRAAGGKSCKTGYVYY	67	U15-lycotoxin-Ls1h (Toxin-like structure LSTX-N18; spiders, Arthropods, animals)	B6DD51	"Spider wap-1 family
 (Contains 1 WAP domain)"	Not found	Lycosa singoriensis (Wolf spider) (Aranea singoriensis)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity). 
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (Probable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19875276	Zoology (Jena). 2010 Jan;113(1):10-18.	hang Y, Chen J, Tang X, Wang F, Jiang L, Xiong X, Wang M, Rong M, Liu Z, Liang S.	Transcriptome analysis of the venom glands of the Chinese wolf spider Lycosa singoriensis.	
DRAMP03281	LSCKRGTCHFGRCPSHLIKGSCSGG	25	Turkey Heterophil Peptide 3 (Antimicrobial peptide THP3; Birds, animals)	P80393	Belongs to the beta-defensin family	Not found	Meleagris gallopavo (Common turkey)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Bridge	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7964174	J Leukoc Biol. 1994 Nov;56(5):661-665.	Evans EW, Beach GG, Wunderlich J, Harmon BG.	Isolation of antimicrobial peptides from avian heterophils.	
DRAMP03282	GKREKCLRRNGFCAFLKCPTLSVISGTCSRFQVCC	35	Turkey Heterophil Peptide 1 (Antimicrobial peptide THP1; Birds, animals)	P80391	Belongs to the beta-defensin family	Not found	Meleagris gallopavo (Common turkey)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge 	Not found		PTM: Contains two disulfide bonds 	Gram-negative bacterium: Escherichia coli ATCC 25922;##Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7964174	J Leukoc Biol. 1994 Nov;56(5):661-665.	Evans EW, Beach GG, Wunderlich J, Harmon BG.	Isolation of antimicrobial peptides from avian heterophils.	
DRAMP03283	LFCKRGTCHFGRCPSHLIKVGSCFGFRSCCKWPWDA	36	Turkey Heterophil Peptide 2 (Antimicrobial peptide THP2, THP2; Birds, animals)	P80392	Belongs to the beta-defensin family	Not found	Meleagris gallopavo (Common turkey)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Tissue specificity: Expressed in circulating heterophil granulocytes and bone marrow (at protein level).
PTM: Contains three disulfide bonds 3-29; 8-23; 13-30."	Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7964174##19151352	J Leukoc Biol. 1994 Nov;56(5):661-665.##Poult Sci. 2009 Feb;88(2):372-379.	Evans EW, Beach GG, Wunderlich J, Harmon BG.##Kannan L, Rath NC, Liyanage R, Lay JO Jr.	Isolation of antimicrobial peptides from avian heterophils.##Direct screening identifies mature beta-defensin 2 in avian heterophils.	
DRAMP03284	LPRHTLHCVAYHGYCFHSKV	20	Beta-defensin (Birds, animals)	P86385	Belongs to the beta-defensin family	Not found	Dromaius novaehollandiae (Emu)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Has bactericidal activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22044478	Gene. 2012 Jan 15;492(1):244-249.	Maehashi K, Matano M, Irisawa T, Uchino M, Kashiwagi Y, Watanabe T.	Molecular characterization of goose- and chicken-type lysozymes in emu (Dromaius novaehollandiae): evidence for extremely low lysozyme levels in emu egg white.	
DRAMP03289	FFLLFLQGAAGNSVLCRIRGGRCHVGSCHFPERHIGRCSGFQACCIRTWG	50	Apl-AvBD16 (Beta defensins; Ducks, birds, animals)	No entry found	Not found	Not found	Anas platyrhynchos (Peking duck)	Antimicrobial, Antibacterial, Antiviral	Not found	Bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23112840	PLoS One. 2012;7(10):e47743.	Ma D, Zhang K, Zhang M, Xin S, Liu X, Han Z, Shao Y, Liu S.	Ma D, Zhang K, Zhang M, Xin S, Liu X, Han Z, Shao Y, Liu S.	
DRAMP03290	MRILYLLFSVLFLVLQVSPGLSLPQRDMFLCRIGSCHFGRCPIHLVRVGSCFGFRSCCKSPWDV	64	Anas platyrhynchos avian beta-defensin 2 (Apl_AvBD2; Ducks, birds, animals)	Q4VSK2	Belongs to the beta-defensin family	BD2	Anas platyrhynchos (Domestic duck)	Antimicrobial, Antibacterial	Predicted	Bridge	Not found		The widespread tissue distribution and the potent bactericidal and chemotactic activity make Apl_AvBD2 an important molecule in the innate immune response in ducks. It may play a vital role in the immune response of these birds against bacterial and viral pathogens.	Micrococcus luteusNCIM 2871 (MBC=3.7 µM), Escherichia coli NCIM 2685, Riemerella anatipestifer (MBC=2.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19362739	Mol Immunol. 2009 Jun;46(10):2029-2038.	Soman SS, Arathy DS, Sreekumar E.	Discovery of Anas platyrhynchos avian beta-defensin 2 (Apl_AvBD2) with antibacterial and chemotactic functions	
DRAMP03291	DTLACRQSHGSCSFVACRAPSVDIGTCRGGKLKCCK	36	Beta defensin-6-like antimicrobial peptide (Ducks, birds, animals; Predicted)	A3FPG7	Not found	Not found	Anas platyrhynchos (Domestic duck) (Anas boschas)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19996700	J Microbiol Biotechnol. 2009 Nov;19(11):1447-1455.	Ma D, Liao W, Wang R, Han Z, Liu S.	Two novel duck antibacterial peptides, avian beta-defensins 9 and 10, with antimicrobial activity.	
DRAMP03292	GMKEKCVTMGGYCRKQCRVQDALSGYCRNENPCCV	35	Defensin-B1 (DefB1; OaDefB1; mammals, animals)	P0C8A5	Belongs to the beta-defensin family	Not found	Ornithorhynchus anatinus (Duckbill platypus)	Antimicrobial	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed at low levels in kidney, lung, and spleen.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18463304##18662710	Genome Res. 2008 Jun;18(6):986-994.##Toxicon. 2008 Sep 15;52(4):559-565.	Whittington CM, Papenfuss AT, Bansal P, Torres AM, Wong ES, Deakin JE, Graves T, Alsop A, Schatzkamer K, Kremitzki C, Ponting CP, Temple-Smith P, Warren WC, Kuchel PW, Belov K.##Whittington CM, Papenfuss AT, Kuchel PW, Belov K.	Defensins and the convergent evolution of platypus and reptile venom genes.##Expression patterns of platypus defensin and related venom genes across a range of tissue types reveal the possibility of broader functions for OvDLPs than previously suspected.	
DRAMP03293	GLNNKCAYFRGQCRRKCPQRDIFFGFCRNHDQCCLSSLHTRH	42	Defensin-B2 (DefB2; OaDefB2; mammals, animals)	P0C8A6	Belongs to the beta-defensin family	Not found	Ornithorhynchus anatinus (Duckbill platypus)	Antimicrobial	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Lowly expressed in spleen, and lung.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18463304##18662710	Genome Res. 2008 Jun;18(6):986-994.##Toxicon. 2008 Sep 15;52(4):559-565.	Whittington CM, Papenfuss AT, Bansal P, Torres AM, Wong ES, Deakin JE, Graves T, Alsop A, Schatzkamer K, Kremitzki C, Ponting CP, Temple-Smith P, Warren WC, Kuchel PW, Belov K.##Whittington CM, Papenfuss AT, Kuchel PW, Belov K.	Defensins and the convergent evolution of platypus and reptile venom genes.##Expression patterns of platypus defensin and related venom genes across a range of tissue types reveal the possibility of broader functions for OvDLPs than previously suspected.	
DRAMP03294	GISRVRICREKGGHCDADCHLEERHLGGCRAAYLTFCC	38	Defensin-B3 (DefB3; OaDefB3; mammals, animals)	P0C8A7	Belongs to the beta-defensin family	Not found	Ornithorhynchus anatinus (Duckbill platypus)	Antimicrobial	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Lowly expressed in spleen, and expressed at lower levels in kidney, lung and testis.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18463304##18662710	Genome Res. 2008 Jun;18(6):986-994.##Toxicon. 2008 Sep 15;52(4):559-565.	Whittington CM, Papenfuss AT, Bansal P, Torres AM, Wong ES, Deakin JE, Graves T, Alsop A, Schatzkamer K, Kremitzki C, Ponting CP, Temple-Smith P, Warren WC, Kuchel PW, Belov K.##Whittington CM, Papenfuss AT, Kuchel PW, Belov K.	Defensins and the convergent evolution of platypus and reptile venom genes.##Expression patterns of platypus defensin and related venom genes across a range of tissue types reveal the possibility of broader functions for OvDLPs than previously suspected.	
DRAMP03295	CKGKLGYCRSKCQSKQVELGKCSTKAICCGISTGTSSSQGSHEVPVINSEPALESKPEPQDTQEEEATMVSE	72	Defensin-B4 (DefB4; OaDefB4; mammals, animals)	P0C8A8	Belongs to the beta-defensin family	Not found	Ornithorhynchus anatinus (Duckbill platypus)	Antimicrobial	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Highly expressed in kidney, lowly expressed in spleen, and expressed at lower levels in lung.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18463304##18662710	Genome Res. 2008 Jun;18(6):986-994.##Toxicon. 2008 Sep 15;52(4):559-565.	Whittington CM, Papenfuss AT, Bansal P, Torres AM, Wong ES, Deakin JE, Graves T, Alsop A, Schatzkamer K, Kremitzki C, Ponting CP, Temple-Smith P, Warren WC, Kuchel PW, Belov K.##Whittington CM, Papenfuss AT, Kuchel PW, Belov K.	Defensins and the convergent evolution of platypus and reptile venom genes.##Expression patterns of platypus defensin and related venom genes across a range of tissue types reveal the possibility of broader functions for OvDLPs than previously suspected.	
DRAMP03296	KKCRERGGQCHSGVCSWNEKFIGFCSFARPCC	32	Defensin-B5 (DefB5; OaDefB5; mammals, animals)	P0C8A9	Belongs to the beta-defensin family	Not found	Ornithorhynchus anatinus (Duckbill platypus)	Antimicrobial	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Highly expressed in kidney, and expressed at lower levels in testis.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18463304##18662710	Genome Res. 2008 Jun;18(6):986-994.##Toxicon. 2008 Sep 15;52(4):559-565.	Whittington CM, Papenfuss AT, Bansal P, Torres AM, Wong ES, Deakin JE, Graves T, Alsop A, Schatzkamer K, Kremitzki C, Ponting CP, Temple-Smith P, Warren WC, Kuchel PW, Belov K.##Whittington CM, Papenfuss AT, Kuchel PW, Belov K.	Defensins and the convergent evolution of platypus and reptile venom genes.##Expression patterns of platypus defensin and related venom genes across a range of tissue types reveal the possibility of broader functions for OvDLPs than previously suspected.	
DRAMP03297	KMEILLGSNGGARCDINKKSFDCYHRNGRCRFNCRKREYNNGDCSQYQSCCLPTRNL	57	Defensin-B6 (DefB6; OaDefB6; mammals, animals)	P0C8B0	Belongs to the beta-defensin family	Not found	Ornithorhynchus anatinus (Duckbill platypus)	Antimicrobial	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Lowly expressed in spleen, kidney and lung.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18463304##18662710	Genome Res. 2008 Jun;18(6):986-994.##Toxicon. 2008 Sep 15;52(4):559-565.	Whittington CM, Papenfuss AT, Bansal P, Torres AM, Wong ES, Deakin JE, Graves T, Alsop A, Schatzkamer K, Kremitzki C, Ponting CP, Temple-Smith P, Warren WC, Kuchel PW, Belov K.##Whittington CM, Papenfuss AT, Kuchel PW, Belov K.	Defensins and the convergent evolution of platypus and reptile venom genes.##Expression patterns of platypus defensin and related venom genes across a range of tissue types reveal the possibility of broader functions for OvDLPs than previously suspected.	
DRAMP03298	DTTFCRCRVSCNILEKYSGKCELSGRTARICC	32	Defensin-A1 (DefA1; OaDefA1; mammals, animals)	P0C8A1	Belongs to the alpha-defensin family	Not found	Ornithorhynchus anatinus (Duckbill platypus)	Antimicrobial	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Highly expressed in intestine, expressed at lower levels in spleen, and at very low levels in kidney and lung.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18463304##18662710	Genome Res. 2008 Jun;18(6):986-994.##Toxicon. 2008 Sep 15;52(4):559-565.	Whittington CM, Papenfuss AT, Bansal P, Torres AM, Wong ES, Deakin JE, Graves T, Alsop A, Schatzkamer K, Kremitzki C, Ponting CP, Temple-Smith P, Warren WC, Kuchel PW, Belov K.##Whittington CM, Papenfuss AT, Kuchel PW, Belov K.	Defensins and the convergent evolution of platypus and reptile venom genes.##Expression patterns of platypus defensin and related venom genes across a range of tissue types reveal the possibility of broader functions for OvDLPs than previously suspected.	
DRAMP03299	STITCYCRSRCRMLEKNSGTCRSSNCTYTLCC	32	Defensin-A2 (DefA2; OaDefA2; mammals, animals)	P0C8A2	Belongs to the alpha-defensin family	Not found	Ornithorhynchus anatinus (Duckbill platypus)	Antimicrobial	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Highly expressed in intestine, expressed at lower levels in spleen, and at very low levels in kidney and lung.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18463304##18662710	Genome Res. 2008 Jun;18(6):986-994.##Toxicon. 2008 Sep 15;52(4):559-565.	Whittington CM, Papenfuss AT, Bansal P, Torres AM, Wong ES, Deakin JE, Graves T, Alsop A, Schatzkamer K, Kremitzki C, Ponting CP, Temple-Smith P, Warren WC, Kuchel PW, Belov K.##Whittington CM, Papenfuss AT, Kuchel PW, Belov K.	Defensins and the convergent evolution of platypus and reptile venom genes.##Expression patterns of platypus defensin and related venom genes across a range of tissue types reveal the possibility of broader functions for OvDLPs than previously suspected.	
DRAMP03300	RIITCSCRTFCFLGERISGRCYQSVFIYRLCCRG	34	Defensin-A3 (DefA3; OaDefA3; mammals, animals)	P0C8A3	Belongs to the alpha-defensin family	Not found	Ornithorhynchus anatinus (Duckbill platypus)	Antimicrobial	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Highly expressed in spleen, and expressed at lower levels in intestin and lung.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18463304##18662710	Genome Res. 2008 Jun;18(6):986-994.##Toxicon. 2008 Sep 15;52(4):559-565.	Whittington CM, Papenfuss AT, Bansal P, Torres AM, Wong ES, Deakin JE, Graves T, Alsop A, Schatzkamer K, Kremitzki C, Ponting CP, Temple-Smith P, Warren WC, Kuchel PW, Belov K.##Whittington CM, Papenfuss AT, Kuchel PW, Belov K.	Defensins and the convergent evolution of platypus and reptile venom genes.##Expression patterns of platypus defensin and related venom genes across a range of tissue types reveal the possibility of broader functions for OvDLPs than previously suspected.	
DRAMP03301	HSCVCRRICAARQVRKGRCSRRRRICCLY	29	Defensin-A4 (DefA4; OaDefA4; mammals, animals)	P0C8A4	Belongs to the alpha-defensin family	Not found	Ornithorhynchus anatinus (Duckbill platypus)	Antimicrobial	Transcript level	Not found	Not found		"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Lowly expressed in spleen, and expressed at lower levels in kidney and lung.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18463304##18662710	Genome Res. 2008 Jun;18(6):986-994.##Toxicon. 2008 Sep 15;52(4):559-565.	Whittington CM, Papenfuss AT, Bansal P, Torres AM, Wong ES, Deakin JE, Graves T, Alsop A, Schatzkamer K, Kremitzki C, Ponting CP, Temple-Smith P, Warren WC, Kuchel PW, Belov K.##Whittington CM, Papenfuss AT, Kuchel PW, Belov K.	Defensins and the convergent evolution of platypus and reptile venom genes.##Expression patterns of platypus defensin and related venom genes across a range of tissue types reveal the possibility of broader functions for OvDLPs than previously suspected.	
DRAMP03302	EVRRRRRRPPCEDVNGQCQPRGNPCLRLRGACPRGSRCCMPTVAAH	46	Defensin-BvL (DefB-vL; OaDefB-vL; mammals, animals)	P0C8B1	Not found	Not found	Ornithorhynchus anatinus (Duckbill platypus)	Antimicrobial	Transcript level	Not found	Not found	2MN3 resolved by NMR.	"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Highly expressed in intestine, liver and spleen and expressed at lower levels in brain, kidney, lung, testis and venom gland.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18463304##18662710	Genome Res. 2008 Jun;18(6):986-994.##Toxicon. 2008 Sep 15;52(4):559-565.	Whittington CM, Papenfuss AT, Bansal P, Torres AM, Wong ES, Deakin JE, Graves T, Alsop A, Schatzkamer K, Kremitzki C, Ponting CP, Temple-Smith P, Warren WC, Kuchel PW, Belov K.##Whittington CM, Papenfuss AT, Kuchel PW, Belov K.	Defensins and the convergent evolution of platypus and reptile venom genes.##Expression patterns of platypus defensin and related venom genes across a range of tissue types reveal the possibility of broader functions for OvDLPs than previously suspected.	
DRAMP03303	DHHHDHGHDDHEHEELTLEKIKEKIKDYADKTPVDQLTERVQAGRDYLLGKGARPSHLPARVDRHLSKLTAAEKQELADYLLTFLH	86	Theromyzin (Frogs, amphibians, animals)	Q6T6C1	Not found	Not found	Theromyzon tessulatum (Duck leech)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15102860	J Biol Chem. 2004 Jul 23;279(30):30973-30982.	Tasiemski A, Vandenbulcke F, Mitta G, Lemoine J, Lefebvre C, Sautière PE, Salzet M.	Molecular characterization of two novel antibacterial peptides inducible upon bacterial challenge in an annelid, the leech Theromyzon tessulatum.	
DRAMP03304	QIVDCWETWSRCTKWSQGGTGTLWKSCNDRCKELGRKRGQCEEKPSRCPLSKKAWTCICY	60	Hydramacin-1 (Hm-1; annelida, animals)	B3RFR8	Belongs to the macin family	Not found	Hydra vulgaris (Hydra) (Hydra attenuata)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Combine helix and strand structure	The molecule possesses two short α-helices (residues 10-14 and 27-33) at the N terminus which are separated by a long flexible loop. The C-terminal region contains two β-strands (residues 38-42 and 56-60) in an antiparallel arrangement separated by a long flexible loop. 	2K35 resolved by NMR.	"Function: Hydramacin-1 is potently active against Gram-positive and Gram-negative bacteria including multi-resistant human pathogenic strains. Is not active against the Gram-positive Coccus species, Gram-negative non-fermentation species and against the fungus C.albicans. It leads to aggregation of bacteria as an initial step of its bactericidal mechanism. Aggregated cells are connected via electron-dense contacts and adopt a thorn apple-like morphology. Hydramycin contains a belt of positively charged residues that separate two hydrophobic areas. This structure may explain the observed aggregation of bacteria, since each of these areas can immerse into the outer leaflets of the membranes of two individual bacteria. Is able to permeabilize membranes of viable bacteria at low and neutral pH values, but no pore-forming activity is not detected.
Tissue specificity: Expressed in the endodermal epithelium.
Induction: By bacterial lipopolysaccharides (LPS).
PTM: Contains four disulfide bonds."	Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MBC=7.1 µM), Burkholderia cepacia ATCC 25416 (MBC>14.3 μM),Burkholderia cepacia ATCC 17759 (MBC>14.3 μM), B. cepacia LMG 16654 (MBC>14.3 μM), Citrobacter freundii NCTC 9750 (MBC=7.1 μM), C. freundii C7 (MBC=0.9 μM), Enterobacter cloacae Va11263/03 (MBC>14.3 μM), E. cloacae Va12270/03 (MBC=0.9 μM), Escherichia coli ATCC 25922 (MBC=0.9 μM), Klebsiella pneumoniae ATCC 13883 (MBC=0.9 μM), Klebsiella oxytoca ATCC 13182 (MBC=0.9 μM), Proteus mirabilis ATCC 21100 (MBC=14.3 μM), P. vulgaris ATCC 13315 (MBC>14.3 μM), Providencia rettgeri NCTC 7475 (MBC>14.3 μM), Pseudomonas aeruginosa NCTC 11446 (MBC>14.3 μM), Salmonella typhimurium 10003442 (MBC=0.9 μM), S. typhimurium 10003630 (MBC=0.9 μM), Serratia marcescens Mero060/148 (MBC>14.3 µM), S. marcescens Mero103/013 (MBC>14.3 μM), S. marcescens NCTC 10211 (MBC>14.3 μM), Yersinia enterocolitica NCTC 11176 (MBC=0.9 µM).##Multi-resistant Gram-negative bacteria: Escherichia coli Co 86 ESBL (MBC=3.6 μM), Klebsiella oxytoca ESBL 33 (MBC=7.1 µM), K. oxytoca ESBL 37 (MBC=3.6 μM), Klebsiella pneumoniae ATCC 700603 (MBC=3.6 μM).##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MBC>14.3 μM), Staphylococcus haemolyticus ATCC 29970 (MBC=1.8 μM), Streptococcus pyogenes ATCC 12344 (MBC>14.3 μM).##Multi-resistant Gram-positive bacteria: Staphylococcus aureus ATCC 33593 (MRSA) (MBC>14.3 μM), Enterococcus faecalis ATCC 51299 (MBC>14.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	cell membrane	19013190##19019828	Dev Comp Immunol. 2009 Apr;33(4):559-569.##J Biol Chem. 2009 Jan 16;284(3):1896-1905.	Bosch TC, Augustin R, Anton-Erxleben F, Fraune S, Hemmrich G, Zill H, Rosenstiel P, Jacobs G, Schreiber S, Leippe M, Stanisak M, Grötzinger J, Jung S, Podschun R, Bartels J, Harder J, Schröder JM.##Jung S, Dingley AJ, Augustin R, Anton-Erxleben F, Stanisak M, Gelhaus C, Gutsmann T, Hammer MU, Podschun R, Bonvin AM, Leippe M, Bosch TC, Grötzinger J.	Uncovering the evolutionary history of innate immunity: the simple metazoan Hydra uses epithelial cells for host defence.##Hydramacin-1, structure and antibacterial activity of a protein from the basal metazoan Hydra.	
DRAMP03305	DCYEDWSRCTPGTSFLTGILWKDCHSRCKELGHRGGRCVDSPSKHCPGVLKNNKQCHCY	59	Neuromacin (Annelida, animals)	A8V0B3	Belongs to the macin family	Not found	Hirudo medicinalis (Medicinal leech)	Antimicrobial	Homology	Not found	Not found		"Function: May have antimicrobial activity.
PTM: Contains four disulfide bonds By similarity."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18606660	J Immunol. 2008 Jul 15;181(2):1083-1095.	Schikorski D, Cuvillier-Hot V, Leippe M, Boidin-Wichlacz C, Slomianny C, Macagno E, Salzet M, Tasiemski A.	Microbial challenge promotes the regenerative process of the injured central nervous system of the medicinal leech by inducing the synthesis of antimicrobial peptides in neurons and microglia.	
DRAMP03306	GCFEDWSRCSPSTSRGTGVLWRDCDSYCKVCFKADRGECFDSPSLNCPQRLPNNKQCRCINARTAKDNRNPTCWA	75	Theromacin (Annelida, animals)	Q6T6C2	Belongs to the macin family	Not found	Theromyzon tessulatum (Duck leech)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Function: Has a bactericidal activity.	Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15102860	J Biol Chem. 2004 Jul 23;279(30):30973-82.	Tasiemski A, Vandenbulcke F, Mitta G, Lemoine J, Lefebvre C, Sautière PE, Salzet M.	Molecular characterization of two novel antibacterial peptides inducible upon bacterial challenge in an annelid, the leech Theromyzon tessulatum.	
DRAMP03307	ADTLACRQSHQSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS	42	Duck AvBD9 (avian beta defensin 9; Birds, animals)	No entry found	Not found	Not found	Anas platyrhynchos (Peking duck)	Antimicrobial, Antibacterial	Not found	Bridge	Not found		Comment: No comments found on DRAMP database	Escherichia coli, Staphylococcus aureus, Pasteurella multocida, Salmonella choleraesuis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19996700	J Microbiol Biotechnol. 2009 Nov;19(11):1447-1455.	Ma D, Liao W, Wang R, Han Z, Liu S.	Two novel duck antibacterial peptides, avian beta-defensins 9 and 10, with antimicrobial activity.	
DRAMP03308	VLLFLFQAAPGSADAPFADTAACRSQGNFCRAGACPPTFAASGSCHGGLLNCCAK	55	Duck AvBD10 (avian beta defensin 10; Birds, animals)	No entry found	Not found	Not found	Anas platyrhynchos (Domestic duck)	Antimicrobial, Antibacterial	Not found	Bridge	Not found		Comment: No comments found on DRAMP database	Escherichia coli, Staphylococcus aureus, Pasteurella multocida, Salmonella choleraesuis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19996700	J Microbiol Biotechnol. 2009 Nov;19(11):1447-1455.	Ma D, Liao W, Wang R, Han Z, Liu S.	Two novel duck antibacterial peptides, avian beta-defensins 9 and 10, with antimicrobial activity.	
DRAMP18209	ASSGWVCTLTIECGTVICACR	21	NAI-802 (Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Actinoplanes strains ID104802 and ID104771	Antimicrobial, Antibacterial, Anti-Gram+		Not found	This peptide shares 19 residues with class II lantibiotic actagardine. In addition, it contains one extra Ala at the N-terminus and an extra Arg at the C-terminus. Actagardine, Ala(0)-actagardine, actagardine B, michiganin A, NAI-802 and Ala(0)-NAI-802 share three conserved thioether bridges within a core 19-aa peptide consisting of 14 invariant residues. 		As expected from the overall higher positive charge, NAI-802 was slightly more active than actagardine against staphylococci and streptococci. Further improvement of its antibacterial activity was achieved by adding one additional positive charge through conversion of the C-terminal carboxylate into the corresponding basic amide.	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid II	23168402	J Antibiot (Tokyo). 2013 Feb;66(2):73-8.	Simone M, Monciardini P, Gaspari E, Donadio S, Maffioli SI.	Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains.	
DRAMP03313	VDKPDYRPRPWPRPN	15	Metalnikowin-2A (Metalnikowin IIA; Insects, animals)	P80409	Not found	Not found	Palomena prasina (Green shield bug) (Cimex prasinus)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antibacterial peptide active against Gram-negative bacteria.
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J. Insect Physiol. 1996; 42: 81-89.	Chernysh S, Cociancich S, Briand JP, Hetru C, Bulet P.	The inducible antibacterial peptides of the hemipteran insect Palomena prasina: identification of a unique family of proline-rich peptides and of a novel insect defensin.	
DRAMP03314	VDKPDYRPRPWPRNMI	16	Metalnikowin-2B (Metalnikowin IIB; Insects, animals)	P80410	Not found	Not found	Palomena prasina (Green shield bug) (Cimex prasinus)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antibacterial peptide active against Gram-negative bacteria.
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J. Insect Physiol. 1996; 42: 81-89.	Chernysh S, Cociancich S, Briand JP, Hetru C, Bulet P.	The inducible antibacterial peptides of the hemipteran insect Palomena prasina: identification of a unique family of proline-rich peptides and of a novel insect defensin.	
DRAMP03315	VDKPDYRPRPWPRPNM	16	Metalnikowin-3 (Metalnikowin III; Insects, animals)	P80411	Not found	Not found	Palomena prasina (Green shield bug) (Cimex prasinus)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antibacterial peptide active against Gram-negative bacteria.
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J. Insect Physiol. 1996; 42: 81-89.	Chernysh S, Cociancich S, Briand JP, Hetru C, Bulet P.	The inducible antibacterial peptides of the hemipteran insect Palomena prasina: identification of a unique family of proline-rich peptides and of a novel insect defensin.	
DRAMP03316	ATCDALSFSSKWLTVNHSACAIHCLTKGYKGGRCVNTICNCRN	43	Defensin (Insects, animals)	P80407	Belongs to the invertebrate defensin family (Type 1 subfamily)	Not found	Palomena prasina (Green shield bug)	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		"Function: Antibacterial peptide active against Gram-negative bacteria.
Induction: By bacterial infection.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J. Insect Physiol. 1996;42:81-89.	Chernysh S, Cociancich S, Briand JP, Hetru C, Bulet P.	The inducible antibacterial peptides of the hemipteran insect Palomena prasina: identification of a unique family of proline-rich peptides and of a novel insect defensin	
DRAMP03317	AKRGGFWRKVGRKLGKGIRKIGKTIKSQLGKFRPRLQYRYQF	42	Cathelicidin-related antimicrobial peptide (AMPs)	Q0R5P1	Not found	CRAMP	Chinchilla lanigera (Long-tailed chinchilla) (Chinchilla villidera) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: Escherichia coli, Moraxella catarrhalis 1857;##Gram-positive bacterium: Streptococcus pneumoniae serotype 14.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17113647	Mol Immunol. 2007 Mar;44(9):2446-2458.	McGillivary G, Ray WC, Bevins CL, Munson RS Jr, Bakaletz LO.	A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media.	
DRAMP03318	GAILCNLCKDTVKLVENLLTVDGAQAVRQYIDNLCGKASGFLGTLCEKILSFGVDELVKLIENHVDPVVVCEKIHAC	77	Pore-forming peptide ameobapore B (EH-APP; saposin-like protein)	Q24824	Not found	Not found	Entamoeba histolytica (protozoan parasite)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Forms pores in the cytoplasmic membrane of host cells. Implicated in the cytolytic activity of the parasite.	Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	7715451	Mol Microbiol. 1994 Dec;14(5):895-904.	Leippe M, Andrä J, Nickel R, Tannich E, Müller-Eberhard HJ.	Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes.	
DRAMP03319	IPVLCPVCTSLVGKLIDLVLGGAVDKVTDYLETLCAKADGLVETLCTKIVSYGIDKLIEKILEGGSAKLICGLIHAC	77	Pore-forming peptide ameobapore C (EH-APP; saposin-like protein)	Q24825	Not found	Not found	Entamoeba histolytica (protozoan parasite)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		Forms pores in the cytoplasmic membrane of host cells. Implicated in the cytolytic activity of the parasite.	Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	7715451	Mol Microbiol. 1994 Dec;14(5):895-904.	Leippe M, Andrä J, Nickel R, Tannich E, Müller-Eberhard HJ.	Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes.	
DRAMP03322	HPLKQYWWRPSI	12	PW2	No entry found	Not found	Not found	Phage display peptide library	Antimicrobial, Antifungal	Not found	Non helix or strand structure	In the absence of an interface, PW2 is in random coil conformation. In micelles, structural calculation shows that Trp-7 forms the hydrophobic core that is important for the peptide folding. Lys-4, Tyr-6, Trp-8, and Arg-9 are in the same surface, possibly facing the micelle interface. (Ref.2)	1M02 resolved by NMR.	Function: Synthetic PW2 shows anticoccidial activity against E. acervulina and Eimeria tenella with very low hemolytic activity. It also displays antifungal activity but no activity against bacteria.(Ref.2)	Fungi: Eimeria acervulina sporozoites, E. tenella sporozoites, Toxoplasma gondii tachyzoites (low activity).	[Ref.11849705]1.60% hemolytic activity at 100 μM against human erythrocytes,1.57% hemolytic activity at 100 μM against rabbit erythrocytes,1.42% hemolytic activity at 100 μM against chicken erythrocytes,	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11849705##12130641	Mol Biochem Parasitol. 2002 Mar;120(1):53-60.## Biol Chem. 2002 Sep 27;277(39):36351-6.	da Silva A Jr, Kawazoe U, Freitas FF, Gatti MS, Dolder H, Schumacher RI, Juliano MA, da Silva MJ, Leite A.##co LW, Da Silva A Jr, Leite A, Valente AP, Almeida FC.	Avian anticoccidial activity of a novel membrane-interactive peptide selected from phage display libraries.##NMR structure of PW2 bound to SDS micelles. A tryptophan-rich anticoccidial peptide selected from phage display libraries.	
DRAMP03323	MKTLVLLSPSSCWPSRSRLILSKTQMKRLKLRSSQRKRTR	40	Testis defensin	P70438	Not found	Not found	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9369178	Biol Reprod. 1997 Nov;57(5):1115-1122.	Grandjean V, Vincent S, Martin L, Rassoulzadegan M, Cuzin F.	Antimicrobial protection of the mouse testis: synthesis of defensins of the cryptdin family.	
DRAMP03324	MKTLVLLSALFLLAFQVQADPIQNTDEETNTEVQPQEEDQA	41	Testis defensin	P70439	Not found	Defa26	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9369178	Biol Reprod. 1997 Nov;57(5):1115-1122.	Grandjean V, Vincent S, Martin L, Rassoulzadegan M, Cuzin F.	Antimicrobial protection of the mouse testis: synthesis of defensins of the cryptdin family.	
DRAMP03325	QMRQTTELQPLHGEESRADIAIPMQKRRKRDINFPICRFCCQCCNKPSCGICCE	54	Hepcidin antimicrobial peptide 2 	Q5M9M1	Not found	Hamp2	Mus musculus (Mouse)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19468303	PLoS Biol. 2009 May 5;7(5):e1000112.	Lineage-specific biology revealed by a finished genome assembly of the mouse.	Lineage-specific biology revealed by a finished genome assembly of the mouse.	
DRAMP18204	SNASVWECCSTGSWVPFTCC	20	Labyrinthopeptin A1(Bacteriocin)	C0MP59	Belongs to the lantibiotics family (Class I bacteriocin)	labA1	Actinomadura namibiensis DSM 6313	Antimicrobial, Antiviral, Anti-HIV, Anti-HSV		Not found	LabyA1 contains a special amino acid labionin at positions 1, 4, 8, 10, 13, and 19. Labs 1,4 and labs 10, 13 are connected via a carbon-carbon bond, while labs 4, 8 and labs 13, 19 form normal thioether bonds. In addition, a disulfide bond occurs between C9 and C20.		Function: LabyA1 also demonstrated additive to synergistic effects in its anti-HIV-1 and anti-HSV-2 activity with anti(retro)viral drugs in dual combinations such as tenofovir, acyclovir, saquinavir, raltegravir and enfuvirtide.	HSV(EC50: 0.29	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23724015	PLoS One. 2013 May 28;8(5):e64010.	F	The Lantibiotic Peptide Labyrinthopeptin A1 Demonstrates Broad Anti-HIV and Anti-HSV Activity with Potential for Microbicidal Applications	
DRAMP03327	PSELEKALSNLIDVYHNYSNIQGNHHALYKNDFKKMVTTECPQFVQNINIENLFRELDINSDNAINFEEFLAMVIKVGVASHKDSHKE	88	Protein S100-A8 (Calgranulin-A; MRP-8; Rodents, mammals, animals)	P27005, P31724	Belongs to the S-100 family	S100a8	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity towards bacteria and fungi and exerts its antimicrobial activity probably via chelation of Zn2+ which is essential for microbial growth. Can induce cell death via autophagy and apoptosis and this occurs through the cross-talk of mitochondria and lysosomes via reactive oxygen species (ROS) and the process involves BNIP3. Can regulate neutrophil number and apoptosis by an anti-apoptotic effect.
Disruption phenotype: Death at an early embryonic stage due to embryo resorption, starting about 8 days after fertilization.
Miscellaneous: Binds two calcium ions per molecule with an affinity similar to that of the S100 proteins (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	1373330##17767165##18403730	Blood. 1992 Apr 15;79(8):1907-15.##Nat Med. 2007 Sep;13(9):1042-9.##Circ Res. 2008 May 23;102(10):1239-46.	Lagasse E, Weissman IL.##Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, Roth J.##Boyd JH, Kan B, Roberts H, Wang Y, Walley KR.	Mouse MRP8 and MRP14, two intracellular calcium-binding proteins associated with the development of the myeloid lineage.##Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock.##S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.	
DRAMP18206	ASGWVCTLTIECGTLVCAC	19	Deoxyactagardine B(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	ligA	Actinoplanes liguriae NCIMB41362	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Actagardine, Ala(0)-actagardine, actagardine B, michiganin A, NAI-802 and Ala(0)-NAI-802 share three conserved thioether bridges within a core 19-aa peptide consisting of 14 invariant residues. 		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid II	23168402	J Antibiot (Tokyo). 2013 Feb;66(2):73-8.	Simone M, Monciardini P, Gaspari E, Donadio S, Maffioli SI.	Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains.	
DRAMP18205	SDWSLWECCSTGSLFACC	18	Labyrinthopeptin A2 (Bacteriocin)	C0MP60	Belongs to the lantibiotics family (Class I bacteriocin)	labA2	Actinomadura namibiensis DSM 6313	Antimicrobial, Antiviral		Not found	This peptide contains a special amino acid labionin at positions 1, 4, 8, 10, 13, and 17. Labs 1,4 and labs 10, 13 are connected via a carbon-carbon bond, while labs 4, 8 and labs 13, 17 form normal thioether bonds. In addition, a disulfide bond occurs between C9 and C18. 		Comment: No comments found on DRAMP database	HSV	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20191635	Angew Chem Int Ed Engl. 2010 Mar 22;49(13):2436-40.	M	In vitro biosynthesis of the prepeptide of type-III lantibiotic labyrinthopeptin A2 including formation of a C-C bond as a post-translational modification.	
DRAMP03329	LRDLVCYCRSRGCKGRERMNGTCRKGHLLYTLCCR	35	Alpha-defensin cryptdin-1 (Crp1; Rodents, mammals, animals)	P11477, Q61448	Belongs to the alpha-defensin family	Defa1	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa. Has antibacterial activity against attenuated mutants of S. typhimurium.
Tissue specificity: Paneth cells of the small bowel. 
Developmental stage: Accumulates to high levels in mouse intestinal crypt epithelium during postnatal development.
PTM: Contains three disulfide bonds (By similarity). "	Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacteria: Escherichia coli ML-35p, mouse-avirulent Salmonella typhimurium 7953.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	1500431	J Cell Biol. 1992 Aug;118(4):929-936.	Selsted ME, Miller SI, Henschen AH, Ouellette AJ.	Enteric defensins: antibiotic peptide components of intestinal host defense.	CSCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03330	LRDLVCYCRTRGCKRRERMNGTCRKGHLMYTLCCR	35	Alpha-defensin cryptdin-2 (Defensin-related cryptdin-2; Rodents, mammals, animals)	P28309, P82293, Q60616, Q62537	Belongs to the alpha-defensin family	Defa2	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge 	Not found		"Function: Has broad-spectrum antibacterial activity. Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel.
PTM: Contains three disulfide bonds 6-34; 8-23; 13-33 (By similarity)."	Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacteria: Escherichia coli ML-35p, mouse-avirulent Salmonella typhimurium 7953.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	1500431##1500163	J Cell Biol. 1992 Aug;118(4):929-936.##Infect Immun. 1992 Sep;60(9):3556-3565.	Selsted ME, Miller SI, Henschen AH, Ouellette AJ.##Eisenhauer PB, Harwig SS, Lehrer RI.	Enteric defensins: antibiotic peptide components of intestinal host defense.##Cryptdins: antimicrobial defensins of the murine small intestine.	CSCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03331	LRDLVCYCRKRGCKRRERMNGTCRKGHLMYTLCCR	35	Alpha-defensin cryptdin-3 (Defensin-related cryptdin-3; Rodents, mammals, animals)	P28310, Q499K7	Belongs to the alpha-defensin family	Defa3	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel.
PTM: Contains three disulfide bonds (By similarity). "	Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacteria: Escherichia coli ML-35p, mouse-avirulent Salmonella typhimurium 7953.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	1500431	J Cell Biol. 1992 Aug;118(4):929-936.	Selsted ME, Miller SI, Henschen AH, Ouellette AJ.	Enteric defensins: antibiotic peptide components of intestinal host defense.	CSCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03332	LRGLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR	34	Alpha-defensin cryptdin-4 (Defensin-related cryptdin4; Rodents, mammals, animals)	P28311, A3KPC1, Q9QZL4	Belongs to the alpha-defensin family	Defa4	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Beta strand (3 strands; 18 residues)	Not found	2GW9, 1TV0, 2GWP, 2LEW, 2LEY resolved by NMR.	"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel.
PTM: Contains three disulfide bonds. "	Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacteria: Escherichia coli ML-35p, mouse-avirulent Salmonella typhimurium 7953.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys31,Cys8 and Cys23,Cys13 and Cys30.	L	No cytotoxicity information found	Phospholipid	15595831##7927786##16857681	Biochemistry. 2004 Dec 21;43(50):15759-15766.##Infect Immun. 1994 Nov;62(11):5040-5047.##J Biol Chem. 2006 Sep 22;281(38):28068-78.	Jing W, Hunter HN, Tanabe H, Ouellette AJ, Vogel HJ.##Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Rosengren KJ, Daly NL, Fornander LM, Jönsson LM, Shirafuji Y, Qu X, Vogel HJ, Ouellette AJ, Craik DJ.	Solution structure of cryptdin-4, a mouse paneth cell alpha-defensin.##Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Structural and functional characterization of the conserved salt bridge in mammalian paneth cell alpha-defensins: solution structures of mouse CRYPTDIN-4 and (E15D)-CRYPTDIN-4.	CC[C@@H](C)[C@@H]1NC(=O)CNC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)CSSC[C@@H](C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O
DRAMP03333	SKKLICYCRIRGCKRRERVFGTCRNLFLTFVFCCS	35	Alpha-defensin cryptdin-5 (Defensin-related cryptdin5; Rodents, mammals, animals)	P28312, Q64382	Belongs to the alpha-defensin family	Defa5	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
PTM: Contains three disulfide bonds."	Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacteria: Escherichia coli ML-35p, mouse-avirulent Salmonella typhimurium 7953.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	1500431	J Cell Biol. 1992 Aug;118(4):929-936.	Selsted ME, Miller SI, Henschen AH, Ouellette AJ.	Enteric defensins: antibiotic peptide components of intestinal host defense.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N2)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O
DRAMP03334	DLVCYCRARGCKGRERMNGTCRKGHLLYMLCCR	33	Alpha-defensin cryptdin-6/12 (Defensin-related cryptdin-6/12; Rodents, mammals, animals)	P50704, P50710, P82294	Belongs to the alpha-defensin family	Defa6 AND Defa12	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		"Function: Has broad-spectrum antibacterial activity. Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel.
PTM: Contains three disulfide bondss 4-32; 6-21; 11-31. Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa."	Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacteria: Escherichia coli ML-35p, mouse-avirulent Salmonella typhimurium 7953.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys4 and Cys32,Cys6 and Cys21,Cys11 and Cys31.	L	No cytotoxicity information found	Not found	7927786##1500163	Infect. Immun. 1994;62:5040-5047.##Infect. Immun. 1992;60:3556-3565.	Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Eisenhauer P.B, Harwig S.S.S.L, Lehrer R.I.	Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Cryptdins: antimicrobial defensins of the murine small intestine.	CSCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03335	LRDLVCYCRTRGCKRREHMNGTCRKGHLMYTLCCR	35	Alpha-defensin cryptdin-7 (Defensin-related cryptdin-7; Rodents, mammals, animals)	P50705	Belongs to the alpha-defensin family	Defa7	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel.
PTM: Contains three disulfide bonds 6-34; 8-23; 13-33 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	7927786##8188287	Genomics. 1994;19:448-453.##Infect Immun. 1994 Nov;62(11):5040-5047.	Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Huttner KM, Selsted ME, Ouellette AJ.	Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Structure and diversity of the murine cryptdin gene family.	CSCC[C@@H]1NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03336	LRDLVCYCRKRGCKRREHMNGTCRKGHLMYTLCCR	35	Alpha-defensin cryptdin-8 (Defensin-related cryptdin-8; Rodents, mammals, animals)	P50706	Belongs to the alpha-defensin family	Defa8	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel.
PTM: Contains three disulfide bonds 6-34; 8-23; 13-33 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	7927786##8188287	Genomics. 1994;19:448-453.##Infect Immun. 1994 Nov;62(11):5040-5047.	Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Huttner KM, Selsted ME, Ouellette AJ.	Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Structure and diversity of the murine cryptdin gene family.	CSCC[C@@H]1NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03337	LRDLVCYCRKRGCKRREHMNGTCRKGHLLYMLCCR	35	Alpha-defensin cryptdin-9 (Defensin-related cryptdin-9; Rodents, mammals, animals)	P50707	Belongs to the alpha-defensin family	Defa9	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	7927786##8188287	Genomics. 1994;19:448-453.##Infect Immun. 1994 Nov;62(11):5040-5047.	Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Huttner KM, Selsted ME, Ouellette AJ.	Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Structure and diversity of the murine cryptdin gene family.	CSCC[C@@H]1NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03338	LRDLVCYCRKRGCKGRERMNGTCRKGHLLYTMCCR	35	Alpha-defensin cryptdin-10 (Defensin-related cryptdin-10; Rodents, mammals, animals)	P50708	Belongs to the alpha-defensin family	Defa10	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	7927786##8188287	Genomics. 1994;19:448-453.##Infect Immun. 1994 Nov;62(11):5040-5047.	Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Huttner KM, Selsted ME, Ouellette AJ.	Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Structure and diversity of the murine cryptdin gene family.	CSCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CCSC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03339	LRDLVCYCRSRGCKGRERMNGTCRKGHLLYMLCCR	35	Alpha-defensin cryptdin-11 (Defensin-related cryptdin-11; Rodents, mammals, animals)	P50709	Belongs to the alpha-defensin family	Defa11	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	7927786##8188287	Genomics. 1994;19:448-453.##Infect Immun. 1994 Nov;62(11):5040-5047.	Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Huttner KM, Selsted ME, Ouellette AJ.	Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Structure and diversity of the murine cryptdin gene family.	CSCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03340	LRDLVCYCRKRGCKRREHMNGTCRRGHLMYTLCCR	35	Alpha-defensin cryptdin-13 (Defensin-related cryptdin-13; Rodents, mammals, animals)	P50711	Belongs to the alpha-defensin family	Defa13	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	7927786##8188287	Genomics. 1994;19:448-453.##Infect Immun. 1994 Nov;62(11):5040-5047.	Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Huttner KM, Selsted ME, Ouellette AJ.	Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Structure and diversity of the murine cryptdin gene family.	CSCC[C@@H]1NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03341	LRDLVCYCRTRGCKRRERMNGTCRKGHLMHTLCCR	35	Alpha-defensin cryptdin-14 (Defensin-related cryptdin-14; Rodents, mammals, animals)	P50712	Belongs to the alpha-defensin family	Defa14	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found	7YOA	"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	7927786##8188287	Genomics. 1994;19:448-453.##Infect Immun. 1994 Nov;62(11):5040-5047.	Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Huttner KM, Selsted ME, Ouellette AJ.	Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Structure and diversity of the murine cryptdin gene family.	CSCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03342	LRDLVCYCRKRGCKRREHINGTCRKGHLLYMLCCR	35	Alpha-defensin cryptdin-15 (Defensin-related cryptdin-15; Rodents, mammals, animals)	P50713	Belongs to the alpha-defensin family	Defa15	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	7927786##8188287	Genomics. 1994;19:448-453.##Infect Immun. 1994 Nov;62(11):5040-5047.	Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Huttner KM, Selsted ME, Ouellette AJ.	Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Structure and diversity of the murine cryptdin gene family.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03343	LRDLVCYCRSRGCKGRERMNGTCRKGHLMYTLCCR	35	Alpha-defensin cryptdin-16 (Defensin-related cryptdin-16; Rodents, mammals, animals)	P50714	Belongs to the alpha-defensin family	Defa16	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	7927786##8188287	Genomics. 1994;19:448-453.##Infect Immun. 1994 Nov;62(11):5040-5047.	Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Huttner KM, Selsted ME, Ouellette AJ.	Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Structure and diversity of the murine cryptdin gene family.	CSCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03344	LRDLVCYCRKRGCKRREHMNGTCRKGHLLYTLCCR	35	Alpha-defensin cryptdin-17 (CRYP17; Rodents, mammals, animals)	Q64016	Belongs to the alpha-defensin family	Defa17	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys6 and Cys34,Cys8 and Cys23,Cys13 and Cys33.	L	No cytotoxicity information found	Not found	7927786	Genomics. 1994;19:448-453.	Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.	Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.	CSCC[C@@H]1NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03345	SRDLICYCRKGGCNRGEQVYGTCSGRLLYCCPRR	34	Alpha-defensin cryptdin-20 (Defensin-related cryptdin-20; Rodents, mammals, animals)	Q45VN2	Belongs to the alpha-defensin family	Defa20	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: May have microbicidal activities (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases	Chen B, Zha Y, Xu X, Deng X.	Unknown	
DRAMP03346	SRDLICLCRNRRCNRGELFYGTCAGPFLRCCRRRR	35	Alpha-defensin cryptdin-21 (Defensin-related cryptdin-21; Rodents, mammals, animals)	Q8C1P2	Belongs to the alpha-defensin family	Defa21	Mus musculus (Mouse)	Antimicrobial	Homology	Not found	Not found		"Function: May have microbicidal activities (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15494476	Physiol Genomics. 2004 Dec 15;20(1):1-11.	Patil A, Hughes AL, Zhang G.	Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.	
DRAMP03347	SRDLICLCRKRRCNRGELFYGTCAGPFLRCCRRRR	35	Alpha-defensin cryptdin-22 (Defensin-related cryptdin-22; Rodents, mammals, animals)	Q8C1N8	Belongs to the alpha-defensin family	Defa22	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: May have microbicidal activities (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15494476	Physiol Genomics. 2004 Dec 15;20(1):1-11.	Patil A, Hughes AL, Zhang G.	Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.	
DRAMP03348	LRDLVCYCRTRGCKRRERMNGTCRKGHLIYTLCC	34	Alpha-defensin cryptdin-23 (Defensin-related cryptdin-23; Rodents, mammals, animals)	Q5G866, Q059S0	Belongs to the alpha-defensin family	Defa23	Mus musculus (Mouse)	Antimicrobial	Homology	Not found	Not found		Function: May have microbicidal activities (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15494476##15489334	Physiol Genomics. 2004 Dec 15;20(1):1-11.##Genome Res. 2004 Oct;14(10B):2121-2127.	Patil A, Hughes AL, Zhang G.##The MGC Project Team.	Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.##The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).	
DRAMP03349	LRDLVCYCRARGCKGRERMNGTCSKGHLLYMLCC	34	Alpha-defensin cryptdin-24 (Defensin-related cryptdin-24; Rodents, mammals, animals)	Q5G865	Belongs to the alpha-defensin family	Defa24	Mus musculus (Mouse)	Antimicrobial	Homology	Not found	Not found		Function: May have microbicidal activities (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15494476	Physiol Genomics. 2004 Dec 15;20(1):1-11.	Patil A, Hughes AL, Zhang G.	Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.	
DRAMP03350	CEDLICYCRTRGCKRRERLNGTCRKGHLMYMLWCC	35	Alpha-defensin cryptdin-25 (Defensin-related cryptdin-25; Rodents, mammals, animals)	Q5G864	Belongs to the alpha-defensin family	Defa25	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		Function: May have microbicidal activities (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15494476	Physiol Genomics. 2004 Dec 15;20(1):1-11.	Patil A, Hughes AL, Zhang G.	Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.	
DRAMP03351	LRDLGCYCRKRGCTRRERINGTCRKGHLMYTLCCL	35	Alpha-defensin cryptdin-26 (Defensin-related cryptdin-26; Rodents, mammals, animals)	Q3L180	Belongs to the alpha-defensin family	Defa26	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		Function: May have microbicidal activities (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15494476	Physiol Genomics. 2004 Dec 15;20(1):1-11.	Patil A, Hughes AL, Zhang G.	Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.	
DRAMP03352	RFPWCRKCRVCQKCQVCQKCPVCPTCPQCPKQPLCEERQNKTAITTQAPNTQHKGC	56	Alpha-defensin-related sequence 1 (Defensin-related cryptdin 1; Rodents, mammals, animals)	P17533, Q9QVW7	Belongs to the alpha-defensin family	Defa-rs1	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: Apparent precursor of a secreted, cationic, proline- and cysteine-rich peptide that contains Cys-Pro-Xaa repeats. Unlike cryptdin, the proposed mature peptide region lacks the structural motif characteristic of defensins. It may have microbicidal activit.
Developmental stage: Accumulates to high levels in intestinal crypt epithelium during postnatal development."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2351676##8034619	J Biol Chem. 1990 Jun 15;265(17):9831-9837.##J Biol Chem. 1994 Jul 15;269(28):18702.	Ouellette AJ, Lualdi JC.##Ouellette AJ, Lauldi J.	A novel mouse gene family coding for cationic, cysteine-rich peptides. Regulation in small intestine and cells of myeloid origin.##A novel gene family coding for cationic, cysteine-rich peptides. Regulation in mouse small intestine and cells of myeloid origin.	
DRAMP03353	LGWGRRCPQCPRCPSCPSCPRCPRCPRCKCNPK	33	Alpha-defensin-related sequence 2 (Defensin-related cryptdin 2; Rodents, mammals, animals)	P17534, Q64111	Belongs to the alpha-defensin family	Defa-rs2	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: Apparent precursor of a secreted, cationic, proline- and cysteine-rich peptide that contains Cys-Pro-Xaa repeats. Unlike cryptdin, the proposed mature peptide region lacks the structural motif characteristic of defensins. It may have microbicidal activit.
Developmental stage: Accumulates to high levels in intestinal crypt epithelium during postnatal development.
Tissue specificity: Small bowel, spleen, colon, kidney, liver, stomach and femur marrow."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2351676##8034619##7896294	J. Biol. Chem. 1990;265:9831-9837.##J Biol Chem. 1994 Jul 15;269(28):18702.##Genomics 1994;24:99-109.	Ouellette A.J, Lauldi J.C.##	A novel mouse gene family coding for cationic, cysteine-richpeptides. Regulation in small intestine and cells of myeloid origin.##A novel gene family coding for cationic, cysteine-rich peptides. Regulation in mouse small intestine and cells of myeloid origin.##A family of defensin-like genes codes for diverse cysteine-rich peptides in mouse Paneth cells.	
DRAMP03354	PRCPPCPRCSWCPRCPTCPRCNCNPK	26	Alpha-defensin-related sequence 7 (Defensin-related cryptdin 3; Rodents, mammals, animals)	P50715, Q64109, Q68VH1	Belongs to the alpha-defensin family	Defa-rs7	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: Apparent precursor of a secreted, cationic, proline- and cysteine-rich peptide that contains Cys-Pro-Xaa repeats. Unlike cryptdin, the proposed mature peptide region lacks the structural motif characteristic of defensins. It may have microbicidal activit.
Tissue specificity: Paneth cells of the small bowel."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7896294##15235601	Genomics. 1994 Nov 1;24(1):99-109.##Nat. Immunol. 2004;5:836-843.	Huttner K.M, Ouellette A.J.##Hornef M.W, Putsep K, Karlsson J, Refai E, Andersson M.	A family of defensin-like genes codes for diverse cysteine-rich peptides in mouse Paneth cells.##Increased diversity of intestinal antimicrobial peptides by covalentdimer formation.	
DRAMP03355	PPCPSCPSCPWCPMCPRCPSCKCNPK	26	Alpha-defensin-related sequence 10 (CRS4C-4; Cryptdin-related protein 4C-4; Rodents, mammals, ani	Q64263, Q0VDL7	Belongs to the alpha-defensin family	Defa-rs10	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: Apparent precursor of a secreted, cationic, proline- and cysteine-rich peptide that contains Cys-Pro-Xaa repeats. Unlike cryptdin, the proposed mature peptide region lacks the structural motif characteristic of defensins. It may have microbicidal activities (By similarity).
Tissue specificity: Paneth cells of the small bowel."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7896294##15489334	Genomics. 1994 Nov 1;24(1):99-109.##Genome Res. 2004 Oct;14(10B):2121-2127.	Huttner KM, Ouellette AJ.##Feingold EA, et al, Malek J.	A family of defensin-like genes codes for diverse cysteine-rich peptides in mouse Paneth cells.##The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).	
DRAMP03356	PPCPSCLSCPWCPRCLRCPMCKCNPK	26	Alpha-defensin-related sequence 12 (Defensin-related cryptdin 12; Rodents, mammals, animals)	P50716, Q64110	Belongs to the alpha-defensin family	Defa-rs12	Mus musculus (Mouse)	Antimicrobial	Transcript level	Not found	Not found		"Function: Apparent precursor of a secreted, cationic, proline- and cysteine-rich peptide that contains Cys-Pro-Xaa repeats. Unlike cryptdin, the proposed mature peptide region lacks the structural motif characteristic of defensins. It may have microbicidal activities.
Tissue specificity: Paneth cells of the small bowel."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7896294	Genomics. 1994 Nov 1;24(1):99-109.	Huttner KM, Ouellette AJ.	A family of defensin-like genes codes for diverse cysteine-rich peptides in mouse Paneth cells.	
DRAMP03357	LQDAALGWGRRCPQCPRCPSCPSCPRCPRCPRCKCNPK	38	Cryptdin related sequence peptide (CRS4C-1a; Rodents, mammals, animals)	Q70LV2, Q70LV8, Q70LV7, Q70LV6, Q70LV4	Not found	Defa-rs2	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		"Function: Antimicrobial peptide that defense response to Gram-negative bacterium and Gram-positive bacterium.
MOA: CRS peptides were able to bind LPS and to reduce its immunostimulatory activity, leading to a substantial reduction in cellular activation."	Gram-positive bacteria: Enterococcus faecalis (LC=1.9 µM), Lactobacillus fermentum DSM 20052 (LC=1.1 µM), Strepococcus pyogenes clinical isolate (LC=0.4 µM), Listeria monocytogenes type 1 clinical isolate (LC=1.4 µM);##Gram-negative bacteria: Escherichia coli strain D21 (LC=2.4 µM), Salmonella typhimurium ATCC 14028 (LC=1.7 µM).##NOTE: Dimerized peptide was two- to fourfold more potent than monomeric peptide. LC, Lethal concentrations.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	15235601	Nat Immunol. 2004 Aug;5(8):836-843.	Hornef MW, Pütsep K, Karlsson J, Refai E, Andersson M.	Increased diversity of intestinal antimicrobial peptides by covalent dimer formation.	
DRAMP03358	LQDAAVGWGRRCPQCPRCPSCPSCPRCPRCPRCKCNPK	38	Cryptdin related sequence peptide (CRS4C-1d; Rodents, mammals, animals)	Q70LV9, Q70LV5, Q70LV3	Not found	Defa-rs4	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Predicted	Not found	Not found		"Function: Antimicrobial peptide that defense response to Gram-negative bacterium and Gram-positive bacterium.
MOA: CRS peptides were able to bind LPS and to reduce its immunostimulatory activity, leading to a substantial reduction in cellular activation."	Gram-negative bacterium: Salmonella typhimurium ATCC 14028;##Gram-positive bacteria: Enterococcus faecalis, Listeria monocytogenes type 1 clinical isolate, Streptococcus pyogenes clinical isolate.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	15235601	Nat Immunol. 2004 Aug;5(8):836-843.	Hornef MW, Pütsep K, Karlsson J, Refai E, Andersson M.	Increased diversity of intestinal antimicrobial peptides by covalent dimer formation.	
DRAMP03359	LQDAALGWGRRCPRCPPCPRCSWCPRCPTCPRCNCNPK	38	Cryptdin related sequence peptide (CRS4C-2; Rodents, mammals, animals)	Q70LV0, Q70LU3	Not found	Defa-rs7	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Predicted	Not found	Not found		"Function: Antimicrobial peptide that defense response to Gram-negative bacterium and Gram-positive bacterium.
MOA: CRS peptides were able to bind LPS and to reduce its immunostimulatory activity, leading to a substantial reduction in cellular activation."	Gram-negative bacterium: Salmonella typhimurium ATCC 14028;##Gram-positive bacteria: Enterococcus faecalis, Listeria monocytogenes type 1 clinical isolate, Streptococcus pyogenes clinical isolate.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	15235601	Nat Immunol. 2004 Aug;5(8):836-843.	Hornef MW, Pütsep K, Karlsson J, Refai E, Andersson M.	Increased diversity of intestinal antimicrobial peptides by covalent dimer formation.	
DRAMP03360	LQDAALGWGRRCPRCPPCPRCSWCPRCPTCPGCNCNPK	38	Cryptdin related sequence peptide (CRS4C-2b; Rodents, mammals, animals)	Q70LV1	Not found	Defa-rs7	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Predicted	Not found	Not found		"Function: Antimicrobial peptide that defense response to Gram-negative bacterium and Gram-positive bacterium.
MOA: CRS peptides were able to bind LPS and to reduce its immunostimulatory activity, leading to a substantial reduction in cellular activation."	Gram-negative bacterium: Salmonella typhimurium ATCC 14028;##Gram-positive bacteria: Enterococcus faecalis, Listeria monocytogenes type 1 clinical isolate, Streptococcus pyogenes clinical isolate.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	15235601	Nat Immunol. 2004 Aug;5(8):836-843.	Hornef MW, Pütsep K, Karlsson J, Refai E, Andersson M.	Increased diversity of intestinal antimicrobial peptides by covalent dimer formation.	
DRAMP03361	LQDAALGWGRRCPRCPRCPNCRRCPRCPTCPSCNCNPK	38	CRS4C-3a (Cryptdin related sequence peptide; Rodents, mammals, animals)	No entry found	Not found	Not found	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15235601	Nat Immunol. 2004 Aug;5(8):836-843.	Hornef M.W, Putsep K, Karlsson J, Refai E, Andersson M.	Increased diversity of intestinal antimicrobial peptides by covalent dimer formation.	
DRAMP03362	LQDAALGWSRRCPRCPPCPNCRRCPRCPTCPSCNCNPK	38	CRS4C-3c (Cryptdin related sequence peptide; Rodents, mammals, animals)	No entry found	Not found	Not found	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		"Function: Antimicrobial peptide that defense response to Gram-negative bacterium and Gram-positive bacterium.
MOA: CRS peptides were able to bind LPS and to reduce its immunostimulatory activity, leading to a substantial reduction in cellular activation."	Gram-negative bacterium: Salmonella typhimurium ATCC 14028;##Gram-positive bacteria: Enterococcus faecalis, Listeria monocytogenes type 1 clinical isolate, Streptococcus pyogenes clinical isolate.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	15235601	Nat Immunol. 2004 Aug;5(8):836-843.	Hornef M.W, Putsep K, Karlsson J, Refai E, Andersson M.	Increased diversity of intestinal antimicrobial peptides by covalent dimer formation.	
DRAMP03363	LQDAALGWGRRCPRCPRCPNCKRCPRCPTCPRCNCNPK	38	CRS4C-3d (Cryptdin related sequence peptide; Rodents, mammals, animals)	No entry found	Not found	Not found	Mus musculus (Mouse)	Antimicrobial 	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15235601	Nat Immunol. 2004 Aug;5(8):836-843.	Hornef M.W, Putsep K, Karlsson J, Refai E, Andersson M.	Increased diversity of intestinal antimicrobial peptides by covalent dimer formation.	
DRAMP03364	DTNFPICIFCCKCCNNSQCGICCKT	25	Hepcidin (mammals, rodents, animals)	Q9EQ21	Not found	Hamp	Mus musculus (Mouse)	Antimicrobial 	Protein level	Not found	Not found		"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
Tissue specificity: Highly expressed in the liver and to a much lesser extent in the heart.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11113132##11447267	J Biol Chem. 2001 Mar 16;276(11):7811-7819.##Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8780-8785.	Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loréal O.##Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S.	A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.##Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice.	
DRAMP03365	DINFPICRFCCQCCNKPSCGICCEE	25	Hepcidin-2 (mammals, rodents, animals)	Q80T19, Q8BFW2	Not found	Hamp2	Mus musculus (Mouse)	Antimicrobial 	Transcript level	Not found	Not found		"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis.
Tissue specificity: Highly expressed in the liver and to a much lesser extent in the heart. Also expressed in pancreas.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12729891##16141072	FEBS Lett. 2003 May 8;542(1-3):22-26.##Science. 2005 Sep 2;309(5740):1559-1563.	Ilyin G, Courselaud B, Troadec MB, Pigeon C, Alizadeh M, Leroyer P, Brissot P, Loréal O.##Carninci P, Kasukawa T, Katayama S, et al.	Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload.##The transcriptional landscape of the mammalian genome.	
DRAMP03366	DQYKCLQHGGFCLRSSCPSNTKLQGTCKPDKPNCCKS	37	Beta-defensin 1 (BD-1; mBD-1; Defensin, beta 1; Rodents, mammals, animals)	P56386	Belongs to the beta-defensin family	Not found	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 5-34; 12-27; 17-35.	Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa;##Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9287114	FEBS Lett. 1997 Aug 11;413(1):45-49.	Huttner KM, Kozak CA, Bevins CL.	The mouse genome encodes a single homolog of the antimicrobial peptide human beta-defensin 1.	
DRAMP03367	AVGSLKSIGYEAELDHCHTNGGYCVRAICPPSARRPGSCFPEKNPCCKYMK	51	Beta-defensin 2 (BD-2, mBD-2; Defensin, beta 2; Defb2; Rodents, mammals, animals)	P82020	Belongs to the beta-defensin family	Defb2	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		"PTM: Contains three disulfide bonds 17-46; 24-39; 29-47.
Tissue specificity: Kidney, uterus and to a lesser extent in heart.
Induction: In tracheal epithelium, by lipopolysaccharide or inflammation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9923615	FEBS Lett. 1999 Jan 8;442(1):112-116.	Morrison GM, Davidson DJ, Dorin JR.	A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide.	
DRAMP03368	KKINNPVSCLRKGGRCWNRCIGNTRQIGSCGVPFLKCCKRK	41	Beta-defensin 3 (BD-3, mBD-3; Defensin, beta 3; Rodents, mammals, animals)	Q9WTL0, Q29R78	Belongs to the beta-defensin family	Defb3	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram-	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 9-37; 17-30; 20-38. Highest expression in salivary glands, epididymis, ovary and pancreas and to a lesser extent in lung, liver and brain. Low or no expression in skeletal muscle and tongue. By bacterial infection.	Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys9 and Cys37,Cys17 and Cys30,Cys20 and Cys38.	L	No cytotoxicity information found	Not found	10377137	Infect Immun. 1999 Jul;67(7):3542-3547.	Bals R, Wang X, Meegalla R.L, Wattler S, Weiner D.J, Nehls M.C, Wilson J.M.	Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs.	
DRAMP03369	QIINNPITCMTNGAICWGPCPTAFRQIGNCGHFKVRCCKIR	41	Beta-defensin 4 (BD-4, mBD-4; Defensin, beta 4; Rodents, mammals, animals)	P82019	Belongs to the beta-defensin family	Defb4	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 9-37; 16-30; 20-38. When expressed as a fusion protein, mBD-4 showed activity against both E. coli and S. aureus at 1ug/ml as well as chemotactic activity via CCR6-expressing cells (Rohrl J et al. J Biol Chem. 2010 Mar 5;285(10):7028-34). 	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys9 and Cys37,Cys16 and Cys30,Cys20 and Cys38.	L	No cytotoxicity information found	Not found	10922379	J Biol Chem. 2000 Oct 27;275(43):33314-33320.	Jia HP, Wowk SA, Schutte BC, Lee SK, Vivado A, Tack BF, Bevins CL, McCray PB Jr.	A novel murine beta-defensin expressed in tongue, esophagus, and trachea.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)CSSC[C@@H]2NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)CNC(=O)[C@@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1c[nH]c4ccccc14)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)NC2=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N3
DRAMP03371	KTINNPVSCCMIGGICRYLCKGNILQNGNCGVTSLNCCKRK	41	Beta-defensin 5 (BD-5, mBD-5; Defensin, beta 5; Rodents, mammals, animals)	Q9EPV9	Belongs to the beta-defensin family	Defb5	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 9-37; 16-30; 20-38.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases	Adler D.A, Holloway J.L, Haldeman B.E, Rixon M, Jaspers S, Fox B, Gosink J, Sheppard P, Presnell S, Gao Z, Whitmore T, Stamm M, Laube D, Diamond G.	EST and genomic database mining yield novel human and mouse beta-defensins	
DRAMP03372	NSKRACYREGGECLQRCIGLFHKIGTCNFRFKCCKFQIPEKKTKIL	46	Beta-defensin 7 (BD-7, mBD-7; Defensin, beta 7; Rodents, mammals, animals)	Q91V70	Belongs to the beta-defensin family	Defb7	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Protein level	Combine helix and strand structure	Not found	1E4T resolved by NMR.	PTM: Contains three disulfide bonds 6-33; 13-27; 17-34.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##11714914	Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.##Protein Sci. 2001 Dec;10(12):2470-2479.	Conejo-Garcia JR, Nehls MC, Wattler S, Bals R, Heitland A, Kluever E, Liepke C, Adermann K, Forssmann WG.##Bauer F, Schweimer K, Klüver E, Conejo-Garcia JR, Forssmann WG, Rösch P, Adermann K, Sticht H.	Cloning and characterization of mBD-7 and mBD-8, two novel mouse beta-defensins.##Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity.	
DRAMP03373	NEPVSCIRNGGICQYRCIGLRHKIGTCGSPFKCCK	35	Beta-defensin 8 (BD-8, mBD-8; Defensin, beta 8; Rodents, mammals, animals)	Q91V82, Q8R556	Belongs to the beta-defensin family	Defb8	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Combine helix and strand structure	Not found	1E4R resolved by NMR.	"PTM: Contains three disulfide bonds 6-33; 13-27; 17-34.
Function: The antimicrobial activity against S. aureus, E. coli and B.cepacia is reduced in raised concentration of NaCl, but its action against Pseudomonas aeruginosa is independent of NaCl concentration."	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacteria: Pseudomonas aeruginosa, Escherichia coli, Burkholderia cepacia.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##11714914	Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.##Protein Sci. 2001 Dec;10(12):2470-2479.	Conejo-Garcia JR, Nehls MC, Wattler S, Bals R, Heitland A, Kluever E, Liepke C, Adermann K, Forssmann WG.##Bauer F, Schweimer K, Klüver E, Conejo-Garcia JR, Forssmann WG, Rösch P, Adermann K, Sticht H.	Cloning and characterization of mBD-7 and mBD-8, two novel mouse beta-defensins.##Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity.	
DRAMP03374	IIGVSEMERCHKKGGYCYFYCFSSHKKIGSCFPEWPRCCKNIK	43	Beta-defensin 9 (BD-9, mBD-9; Defensin, beta 9; Rodents, mammals, animals)	Q8R2I6	Belongs to the beta-defensin family	Defb9	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		"PTM: Contains three disulfide bonds 10-38; 17-31; 21-39.
Tissue specificity: Expressed in both adult and neonate brain, and very weakly in kidneys, epididymis, and testis."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12644567	Mol Biol Evol. 2003 Mar;20(3):460-470.	Morrison G.M, Semple C.A.M, Kilanowski F.M, Hill R.E, Dorin J.R.	Signal sequence conservation and mature peptide divergence within subgroups of the murine beta-defensin gene family.	
DRAMP03375	DLKHLILKAQLTRCYKFGGFCHYNICPGNSRFMSNCHPENLRCCKNIKQF	50	Beta-defensin 10 (BD-10, mBD-10; Defensin, beta 10; Rodents, mammals, animals)	Q8R2I8, A2A4E8	Belongs to the beta-defensin family	Defb10	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		"PTM: Contains three disulfide bonds 14-43; 21-36; 26-44.
Tissue specificity: Expressed in both adult and neonate brain, and very weakly in kidneys, epididymis, and testis. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12644567##19468303	Mol Biol Evol. 2003 Mar;20(3):460-470.##PLoS Biol. 2009 May 5;7(5):e1000112.	Morrison G.M, Semple C.A.M, Kilanowski F.M, Hill R.E, Dorin J.R.##Church D.M, Goodstadt L, Hillier L.W, Zody M.C, Goldstein S, et al, Ponting C.P. 	Signal sequence conservation and mature peptide divergence within subgroups of the murine beta-defensin gene family.##Lineage-specific biology revealed by a finished genome assembly of the mouse.	
DRAMP03376	DLKHLILKAQLARCYKFGGFCYNSMCPPHTKFIGNCHPDHLHCCINMKELEGST	54	Beta-defensin 11 (BD-11, mBD-11; Defensin, beta 11; Rodents, mammals, animals)	Q8R2I7, Q499L3	Belongs to the beta-defensin family	Defb11	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		"PTM: Contains three disulfide bonds 14-43; 21-36; 26-44.
Tissue specificity: Expressed in both adult and neonate brain, and very weakly in kidneys, epididymis, and testis. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12644567##19468303	Mol Biol Evol. 2003 Mar;20(3):460-470.##PLoS Biol. 2009 May 5;7(5):e1000112.	Morrison G.M, Semple C.A.M, Kilanowski F.M, Hill R.E, Dorin J.R.##Church D.M, Goodstadt L, Hillier L.W, Zody M.C, Goldstein S, et al, Ponting C.P. 	Signal sequence conservation and mature peptide divergence within subgroups of the murine beta-defensin gene family.##Lineage-specific biology revealed by a finished genome assembly of the mouse.	
DRAMP03377	GLEYSQSFPGGEIAVCETCRLGRGKCRRTCIESEKIAGWCKLNFFCCRERI	51	Beta-defensin 12 (BD-12, mBD-12; Defensin, beta 12; Rodents, mammals, animals)	Q8K4N3	Belongs to the beta-defensin family	Defb12	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		"PTM: Contains three disulfide bonds 19-46; 26-40; 30-47.
Tissue specificity: Only expressed in epididymis (caput, corpus and cauda). "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12193721##16141072##14718547	J Immunol. 2002 Sep 1;169(5):2516-2523.##Science. 2005 Sep 2;309(5740):1559-1563.##J Biol Chem. 2004 Mar 26;279(13):12421-12426.	Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T, Kurihara H, Ouchi Y.##Carninci P, Kasukawa T, Katayama S, et al.##Zaballos A, Villares R, Albar JP, Martínez-A C, Márquez G.	Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice.##The transcriptional landscape of the mammalian genome.##Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ.	
DRAMP03378	TLYRRFLCKKMNGQCEAECFTFEQKIGTCQANFLCCRKRKEH	42	Beta-defensin 13 (BD-13, mBD-13; Defensin, beta 13; Rodents, mammals, animals)	Q8R2I4, A2A4E3	Belongs to the beta-defensin family	Defb13	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		"PTM: Contains three disulfide bonds 8-35; 15-29; 19-36.
Tissue specificity: Expressed in testis and to a lesser extent in epididymis (caput, corpus and cauda). Also weakly expressed in kidneys."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12644567##19468303##14718547	Mol Biol Evol. 2003 Mar;20(3):460-470.##PLoS Biol. 2009 May 5;7(5):e1000112.##J Biol Chem. 2004 Mar 26;279(13):12421-6.	Morrison G.M, Semple C.A.M, Kilanowski F.M, Hill R.E, Dorin J.R.##Church D.M, Goodstadt L, Hillier L.W, Zody M.C, Goldstein S. et al, Ponting C.P.##Zaballos A, Villares R, Albar JP, Martínez-A C, Márquez G.	Signal sequence conservation and mature peptide divergence within subgroups of the murine beta-defensin gene family.##Lineage-specific biology revealed by a finished genome assembly of the mouse.##Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ.	
DRAMP03379	FLPKTLRKFFCRIRGGRCAVLNCLGKEEQIGRCSNSGRKCCRKKK	45	Beta-defensin 14 (BD-14, mBD-14; Defensin, beta 14; Rodents, mammals, animals)	Q7TNV9, Q14BD1	Belongs to the beta-defensin family	Not found	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 11-40; 18-33; 23-41.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15489334##18167348	Genome Res. 2004 Oct;14(10B):2121-2127.##J Biol Chem. 2008 Feb 29;283(9):5414-5419.	Gerhard DS, Wagner L, et al.##Röhrl J, Yang D, Oppenheim JJ, Hehlgans T.	The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).##Identification and Biological Characterization of Mouse beta-defensin 14, the orthologue of human beta-defensin 3.	
DRAMP03380	FFDEKCSRVNGRCTASCLKNEELVALCQKNLKCCVTVQPCGKSKSNQSDEGSGHMGTWG	59	Beta-defensin 15 (BD-15, mBD-15; Defensin, beta 15; Rodents, mammals, animals)	Q8R2I5, A2A4E5	Belongs to the beta-defensin family	Defb15	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		"PTM: Contains three disulfide bonds 6-33; 13-27; 17-34.
Tissue specificity: Expressed in testis and to a lesser extent in epididymis (caput, corpus and cauda). Also weakly expressed in kidneys and colon."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12644567##19468303##14718547	Mol Biol Evol. 2003 Mar;20(3):460-470.##PLoS Biol. 2009 May 5;7(5):e1000112.##J Biol Chem. 2004 Mar 26;279(13):12421-6.	Morrison G.M, Semple C.A.M, Kilanowski F.M, Hill R.E, Dorin J.R.##Church D.M, Goodstadt L, Hillier L.W, Zody M.C, Goldstein S. et al, Ponting C.P.##Zaballos A, Villares R, Albar JP, Martínez-A C, Márquez G.	Signal sequence conservation and mature peptide divergence within subgroups of the murine beta-defensin gene family.##Lineage-specific biology revealed by a finished genome assembly of the mouse.##Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ.	
DRAMP03381	KKSYPEYGSLDLRKECKMRRGHCKLQCSEKELRISFCIRPGTHCCM	46	Beta-defensin 17 (BD-17, mBD-17; Defensin, beta 17; Rodents, mammals, animals)	Q30KP6	Belongs to the beta-defensin family	Defb17	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 16-44; 23-37; 27-45.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03382	APQMKTREVAERTHKCSLVRGTCKSECNSWEYKYNYCHTEPCCVVREYKRMEKLLSTPKYTT	62	Beta-defensin 18 (BD-18, mBD-18; Defensin, beta 18; Rodents, mammals, animals)	Q30KP5	Belongs to the beta-defensin family	Defb18	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03383	GKNPILQCMGNRGFCRSSCKKSEQAYFYCRTFQMCCLQSYVRISLTGVDDNTNWSYEKHWPRIP	64	Beta-defensin 19 (BD-19, mBD-19; Defensin, beta 19; Rodents, mammals, animals)	Q8K3I8, Q3V0L7	Belongs to the beta-defensin family	Defb19	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		Specifically expressed in male gonads (Sertoli cells). Not detected at 11.5 dpc. Specific signals are observed within seminiferous cords in male gonads at 12.5, 13.5, 14.5, and 16.5 dpc and in newborn testes. In 16.5 and newborn testes, its expression is also found in epididymis. No specific signal is found in female gonads. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12128228	Mech Dev. 2002 Aug;116(1-2):217-221.	Yamamoto M, Matsui Y.	Testis-specific expression of a novel mouse defensin-like gene, Tdl.	
DRAMP03384	KRCFSNVEGYCRKKCRLVEISEMGCLHGKYCCVNELENKKHKKHSVVEETVKLQDKSKVQDYMILPTVTYYTISI	75	Beta-defensin 20 (BD-20, mBD-20; Defensin, beta 20; Rodents, mammals, animals)	Q30KP3, Q8C5A7	Belongs to the beta-defensin family	Defb20	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03385	EFKRCWNGQGACRTFCTRQETFMHLCPDASLCCLSYSFKPSRPSRVGDV	49	Beta-defensin 25 (BD-25, mBD-25; Defensin, beta 25; Rodents, mammals, animals)	Q30KN8	Belongs to the beta-defensin family	Defb25	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		PTM: Contains three disulfide bonds 5-32; 12-26; 16-33.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03386	GLFGFRSSKRQEPWIACELYQGLCRNACQKYEIQYLSCPKTRKCCLKYPRKITSF	55	Beta-defensin 29 (BD-29, mBD-29; Defensin, beta 29; Rodents, mammals, animals)	Q8BGW9	Belongs to the beta-defensin family	Defb29	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 17-44; 24-38; 28-45.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16141072	Science. 2005 Sep 2;309(5740):1559-1563.	Carninci P, Kasukawa T, Katayama S, Gough J, Frith M.C, et al, Hayashizaki Y.	The transcriptional landscape of the mammalian genome.	
DRAMP03387	GVNMYIKRIYDTCWKLKGICRNTCQKEEIYHIFCGIQSLCCLEKKEMPVLFVK	53	Beta-defensin 30 (BD-30, mBD-30; Defensin, beta 30; Rodents, mammals, animals)	Q30KN4	Belongs to the beta-defensin family	Defb30	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		PTM: Contains three disulfide bonds 13-40; 20-34; 24-41.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##15489334	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Genome Res. 2004 Oct;14(10B):2121-2127.	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Gerhard DS, Wagner L, et al.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).	
DRAMP03388	RKRNSKFRPCEKMGGICKSQKTHGCSILPAECKSRYKHCCRL	42	Beta-defensin 33 (BD-33, mBD-33; Defensin, beta 33; Rodents, mammals, animals)	Q30KN3	Belongs to the beta-defensin family	Defb33	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		PTM: Contains three disulfide bonds 12-39; 17-32; 25-40.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##15489334	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Genome Res. 2004 Oct;14(10B):2121-2127.	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Gerhard DS, Wagner L, et al.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).	
DRAMP03389	FFFFDEKCSRINGRCTASCLKNEELVALCWKNLKCCVTVQSCGRSKGNQSDEGSGHMGTRG	61	Beta-defensin 34 (BD-34, mBD-34; Defensin, beta 34; Rodents, mammals, animals)	Q7TNV8	Belongs to the beta-defensin family	Defb34	Mus musculus (House mouse)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Only expressed in epididymis (caput, corpus and cauda).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14718547	J Biol Chem. 2004 Mar 26;279(13):12421-6.	Zaballos A, Villares R, Albar JP, Martínez-A C, Márquez G.	Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ.	
DRAMP03390	EIAVCETCRLGRGKCRRACIESEKIVGWCKLNFFCCRERI	40	Beta-defensin 35 (BD-35, mBD-35; Defensin, beta 35; Rodents, mammals, animals)	Q8R2I3	Belongs to the beta-defensin family	Defb35	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 8-35; 15-29; 19-36.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12644567##14718547	J Biol Chem. 2004 Mar 26;279(13):12421-12426.##J Biol Chem. 2004 Mar 26;279(13):12421-12426.	Morrison G.M, Semple C.A.M, Kilanowski F.M, Hill R.E, Dorin J.R.##Zaballos A, Villares R, Albar J.P, Martinez-A C, Marquez G.	Signal sequence conservation and mature peptide divergence within subgroups of the murine beta-defensin gene family.##Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ.	
DRAMP03391	QKCWNLHGKCRHRCSRKESVYVYCTNGKMCCVKPKYQPKPKPWMF	45	Beta-defensin 36 (BD-36, mBD-36; Defensin, beta 36; Rodents, mammals, animals)	Q8K3U4, A3KGR4, Q3V491	Belongs to the beta-defensin family	Defb36	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 3-30; 10-24; 14-31.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##16141072	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Science. 2005 Sep 2;309(5740):1559-1563.	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Carninci P, Kasukawa T, Katayama S, Gough J, Frith M.C, et al, Hayashizaki Y.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##The transcriptional landscape of the mammalian genome.	
DRAMP03392	QNNPVAMLDTIACIENKDTCRLKNCPRLHNVVGTCYEGKGKCCHKN	46	Beta-defensin 37 (BD-37, mBD-37; Defensin, beta 37; Rodents, mammals, animals)	Q7TMD2	Belongs to the beta-defensin family	Defb37	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 13-42; 20-35; 25-43.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14718547	J Biol Chem. 2004 Mar 26;279(13):12421-12426.	Zaballos A, Villares R, Albar JP, Martínez-A C, Márquez G.	Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ.	
DRAMP03393	IGPDTKKCVQRKNACHYFECPWLYYSVGTCYKGKGKCCQKRY	42	Beta-defensin 38 (BD-38, mBD-38; Defensin, beta 38; Rodents, mammals, animals)	Q7TNV7	Belongs to the beta-defensin family	Defb38	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram-	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 8-37; 15-30; 20-38.	Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa, Enterococcus faecium.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14718547	J Biol Chem. 2004 Mar 26;279(13):12421-12426.	Zaballos A, Villares R, Albar JP, Martínez-A C, Márquez G.	Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ.	
DRAMP03394	DDSIQCFQKNNTCHTNQCPYFQDEIGTCYDKRGKCCQKRLLHIRVPRKKKV	51	Beta-defensin 39 (BD-39, mBD-39; Defensin, beta 39; Rodents, mammals, animals)	Q70KL3, Q7TNV6	Belongs to the beta-defensin family	Defb39	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 6-35; 13-28; 18-36.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14718547	J Biol Chem. 2004 Mar 26;279(13):12421-12426.	Zaballos A, Villares R, Albar JP, Martínez-A C, Márquez G.	Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ.	
DRAMP03395	LDTIKCLQGNNNCHIQKCPWFLLQVSTCYKGKGRCCQKRRWFARSHVYHV	50	Beta-defensin 40 (BD-40, mBD-40; Defensin, beta 40; Rodents, mammals, animals)	Q70KL2, Q7TNV5	Belongs to the beta-defensin family	Defb40	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 6-35; 13-28; 18-36.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14718547	J Biol Chem. 2004 Mar 26;279(13):12421-12426.	Zaballos A, Villares R, Albar JP, Martínez-A C, Márquez G.	Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ.	
DRAMP03396	RSHIDIKNGIERCEKVRGMCKTVCDIDEYDYGYCIRWRNQCCI	43	Beta-defensin 41 (BD-41, mBD-41; Defensin, beta 41; Rodents, mammals, animals)	Q8C1G4, Q4FZ55	Belongs to the beta-defensin family	Defb41	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		PTM: Contains three disulfide bonds 13-41; 20-34; 24-42.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##16023745	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Biochim. Biophys. 2005 Acta 1730:22-30.	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Jalkanen J, Huhtaniemi I, Poutanen M.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Discovery and characterization of new epididymis-specific beta-defensins in mice.	
DRAMP03397	FLENQDCSKHRHCRMKCKANEYAVRYCEDWTICCRVKKKESKKKKMW	47	Beta-defensin 43 (BD-43, mBD-43; Defensin, beta 43; Rodents, mammals, animals)	Q30KM9	Belongs to the beta-defensin family	Defb43	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		PTM: Contains two disulfide bonds: 7-34; 13-27.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##15489334	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Genome Res. 2004 Oct;14(10B):2121-2127.	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Gerhard DS, Wagner L, et al.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).	
DRAMP03398	HPGTFHVRIKCMPKMTAVFGDNCSFYSSMGDLCNNTKSVCCMVPVRMDNI	50	Beta-defensin 50 (BD-50, mBD-50; Defensin, beta 50; Prostate beta-defensin 1; Rodents, mammals, a	Q6TU36, Q30KM7	Belongs to the beta-defensin family	Defb50	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		PTM: Contains two disulfide bonds 11-40; 23-41.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14659016	Genome Biol. 2003;4(12):R79.	Abbott D.E, Pritchard C, Clegg N.J, Ferguson C, Dumpit R, Sikes R.A, Nelson P.S.	Expressed sequence tag profiling identifies developmental and anatomic partitioning of gene expression in the mouse prostate.	
DRAMP03399	PGDIPPGIRNTVCLMQQGHCRLFMCRSGERKGDICSDPWNRCCVPYSVKDRR	52	Sperm-associated antigen 11 (Rodents, mammals, animals)	Q8K4N2, Q2HPE4, Q30KM3	Belongs to the beta-defensin family	Spag11	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram-	Homology	Not found	Not found		Is also responsible for sperm maturation, storage, and protection. 	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##12193721	Physiol Genomics. 2005 Sep 21;23(1):5-17.##J Immunol. 2002 Sep 1;169(5):2516-2523.	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T, Kurihara H, Ouchi Y.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice.	
DRAMP03400	GGVKGEEKRVCPPDYVRCIRQDDPQCYSDNDCGDQEICCFWQCGFKCVLPVKDNSEEQIPQSKV	64	WAP four-disulfide core domain protein 12 (Rodents, mammals, animals)	Q9JHY3	Not found	Wfdc12	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (IC90=10 µM);##Gram-positive bacterium: Staphylococcus aureus (IC90=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12574366	J Immunol. 2003 Feb 15;170(4):1973-1979.	Hagiwara K, Kikuchi T, Endo Y, Huqun, Usui K, Takahashi M, Shibata N, Kusakabe T, Xin H, Hoshi S, Miki M, Inooka N, Tokue Y, Nukiwa T.	Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif.	
DRAMP03401	QPRATRKGVTPKQGYCPEFLLDCPFVLLPVCSRDKGCKGTKKCCFYYCQMRCVEPWTTLT	60	WAP four-disulfide core domain protein 15A (Rodents, mammals, animals)	Q8BH89	Not found	Wfdc15a	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16141072	Science. 2005 Sep 2;309(5740):1559-1563.	Carninci P, Kasukawa T, Katayama S, et al.	The transcriptional landscape of the mammalian genome.	
DRAMP03402	RPEIKKKNVFSKPGYCPEYRVPCPFVLIPKCRRDKGCKDALKCCFFYCQMRCVDPWESPE	60	WAP four-disulfide core domain protein 15B (Elafin-like protein I; Rodents, mammals, animals)	Q9JHY4, A2A5M6, Q8BVC0	Not found	Wfdc15b	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli (IC90=10 µM);##Gram-positive bacterium: Staphylococcus aureus (IC90=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12574366	J Immunol. 2003 Feb 15;170(4):1973-1979.	Hagiwara K, Kikuchi T, Endo Y, Huqun, Usui K, Takahashi M, Shibata N, Kusakabe T, Xin H, Hoshi S, Miki M, Inooka N, Tokue Y, Nukiwa T.	Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif.	
DRAMP03403	AGANDLCQECEDIVHLLTKMTKEDAFQDTIRKFLEQECDILPLKLLVPRCRQVLDVYLPLVIDYFQGQIKPKAICSHVGLC	81	SP-BN (N-terminal region of Surfactant Protein B; SAPLIP; Rodents, mammals, animals)	No entry found	Not found	Not found	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Transgenic mice overexpressing SP-BN has significantly decreased bacterial burden and increased survival following intranasal inoculation with bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20007532	J Immunol. 2010 Jan 15;184(2):975-983.	Yang L, Johansson J, Ridsdale R, Willander H, Fitzen M, Akinbi HT, Weaver TE.	Surfactant protein B propeptide contains a saposin-like protein domain with antimicrobial activity at low pH.	
DRAMP03404	GEKLKKIGQKIKNFFQKL	18	Cramp 18 (CRAMP analogue)	No entry found	Not found	Not found	Mus musculus (Mouse)	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10973820	Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-909.	Shin SY, Kang SW, Lee DG, Eom SH, Song WK, Kim JI.	CRAMP Analogues Having Potent Antibiotic Activity against Bacterial, Fungal, and Tumor Cells without Hemolytic Activity.	
DRAMP03407	DPVTYIRNGGICQYRCIGLRHKIGTCGSPFKCCK	34	Defr1 (Murine beta-defensin related peptide; Rodents, mammals, animals)	No entry found	Belongs to the beta-defensin family	Not found	Mus musculus (Mouse)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		The antimicrobial activity of Defr1 against S. aureus, E. coli, and B. cepacia was found to be reduced in raised concentration of NaCl, but its action against P. aeruginosa was independent of NaCl concentration. 	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacteria: Pseudomonas aeruginosa, Escherichia coli, Burkholderia cepacia.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12226710	Mamm Genome. 2002 Aug;13(8):445-451.	Morrison GM, Rolfe M, Kilanowski FM, Cross SH, Dorin JR.	Identification and characterization of a novel murine beta-defensin-related gene.	
DRAMP03408	VTCFCRRRGCASRERHIGYCRFGNTIYRLCCRR	33	Neutrophil defensin 1 (HANP-1; alpha-defensin; Rodents, mammals, animals)	P81465	Belongs to the alpha-defensin family	Not found	Mesocricetus auratus (Golden hamster)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		Function: Anti-fungal and bactericidal activity, greater against Gram-positive bacteria.	Gram-positive bacteria: Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecalis;##Gram-negative bacteria: Escherichia coli, Salmonella serotype krefeld, Klebsiella oxytoca, Pseudomonas aeruginosa.##Fungi: Candida albicans, Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.	L	No cytotoxicity information found	Not found	8890190	Infect Immun. 1996 Nov;64(11):4444-4449.	Mak P, Wójcik K, Thogersen IB, Dubin A.	Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC1=O
DRAMP03409	CFCKRPVCDSGETQIGYCRLGNTFYRLCCRQ	31	Neutrophil defensin 2 (HANP-2; alpha-defensin; Rodents, mammals, animals)	P81466	Belongs to the alpha-defensin family	Not found	Mesocricetus auratus (Golden hamster)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		Function: Bactericidal activity, greater against Gram-positive bacteria. Low anti-fungi activity	Gram-positive bacteria: Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecalis;##Gram-negative bacteria: Escherichia coli, Salmonella serotype krefeld, Klebsiella oxytoca, Pseudomonas aeruginosa.##Fungi: Candida albicans, Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization(Cys1 and Cys29).	Free	Disulfide bonds between Cys1 and Cys29,Cys3 and Cys18,Cys8 and Cys28.	L	No cytotoxicity information found	Not found	8890190	Infect Immun. 1996 Nov;64(11):4444-4449.	Mak P, Wójcik K, Thogersen IB, Dubin A.	Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins.	
DRAMP03410	VTCFCRRRGCASRERLIGYCRFGNTIYGLCCRR	33	Neutrophil defensin 3 (HANP-3; alpha-defensin; Rodents, mammals, animals)	P81467	Belongs to the alpha-defensin family	Not found	Mesocricetus auratus (Golden hamster)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		Function: Anti-fungal and bactericidal activity, greater against Gram-positive bacteria.	Gram-positive bacteria: Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecalis;##Gram-negative bacteria: Escherichia coli, Salmonella serotype krefeld, Klebsiella oxytoca, Pseudomonas aeruginosa.##Fungi: Candida albicans, Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.	L	No cytotoxicity information found	Not found	8890190	Infect Immun. 1996 Nov;64(11):4444-4449.	Mak P, Wójcik K, Thogersen IB, Dubin A.	Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC1=O
DRAMP03411	VTCFCKRPVCDSGETQIGYCRLGNTFYRLCCRQ	33	Neutrophil defensin 4 (HANP-4; alpha-defensin; Rodents, mammals, animals)	P81468	Belongs to the alpha-defensin family	Not found	Mesocricetus auratus (Golden hamster)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		Function: Bactericidal activity, greater against Gram-positive bacteria. Low anti-fungi activity.	Gram-positive bacteria: Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecalis;##Gram-negative bacteria: Escherichia coli, Salmonella serotype krefeld, Klebsiella oxytoca, Pseudomonas aeruginosa.##Fungi: Candida albicans, Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.	L	No cytotoxicity information found	Not found	8890190	Infect Immun. 1996 Nov;64(11):4444-4449.	Mak P, Wójcik K, Thogersen IB, Dubin A.	Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC3=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C(C)C)C(=O)N2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC1=O
DRAMP03412	MRTLCSLLLIGCLLFSYATPVAGILGPLRIQTDYHRCLREKGFCLNAVCPRSTLFVGTCFPYKFYCCKFKR	71	Beta-defensin 2 	Q32ZI5	Not found	Defb2	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03413	MKTLVLLSALVLLALQVQAEPTPKTDEGTKTDEQPGKEDQVVSVSIEGQGDPAFQDGVLRDLKCFCRAKSCNWGEGIMGICNKRYGMLILCCR	93	Defensin 7 	Q6B328	Not found	Defa24	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##10456937	Infect. Immun. 2004,0:0-0.	Viera A., Kurland A.R., Condon M.R., Diamond G.	Identification and expression of alpha-defensin genes in the rat small intestine.	
DRAMP03414	MKTLVLLSALVLVAYQVQADPIQGAEEETKTEEQPSDEDQDVSVSFEGPEASALQDFEIGRPVRRCRCRANCGPKEYATAFCAQGPFKQFKFCCT	95	Defensin alpha 6 (Protein Defa6)	Q4JEI8	Not found	Defa6	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##10456937	Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases	Patil A, Zhang G.	Rapid duplication and diversification of mammalian alpha-defensins as evidenced by comparative analysis of rodent and human defensin genes.	
DRAMP03415	MRTLTLLTTLLLLALHTQAESPQGSRSTEEALDQEQLVMEDQDISISFGGDKGTALQDADVKSGVTCYCRLLSCQFGERLAGSCRSGGVTYPLCCH	96	Defensin alpha 7 (Defensin)	Q4JEI7	Not found	Defa7	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##10456937	Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases	Patil A, Zhang G.	Rapid duplication and diversification of mammalian alpha-defensins as evidenced by comparative analysis of rodent and human defensin genes.	
DRAMP03416	MRTLTLLTALLLLALHTQAESPQGSPKEAPDQEQLDMEDQDISVFFGGDKGTALQDAAGSTCSCRIGTCVSGEWLSWVCRINGRIYRLCCR	91	Defensin alpha 10 (Defensin)	Q4JEI4	Not found	Defa10	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##10456937	Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases	Patil A, Zhang G.	Rapid duplication and diversification of mammalian alpha-defensins as evidenced by comparative analysis of rodent and human defensin genes.	
DRAMP03417	MKTLILLSALVLLALQVQADPIQEAEEETKTEEQPADEDQDVSVSFEGPEASAVQDLRVRRTLQCSCRRVCRNTCSCIRLSRSTYAS	87	Defensin alpha-related sequence 1 (Protein Defa-rs1)	Q4JEI2	Not found	Defa-rs1	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found	5GWG	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##10456937	Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases	Patil A, Zhang G.	Rapid duplication and diversification of mammalian alpha-defensins as evidenced by comparative analysis of rodent and human defensin genes.	
DRAMP03418	DTNFPICLFCCKCCKNSSCGLCCIT	25	Hepcidin (mammals, rodents, animals)	Q99MH3	Not found	Hamp	Rattus norvegicus (Rat)	Antimicrobial	Homology	Not found	Not found		"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. May also have antimicrobial activity.
PTM: Contains four disulfide bonds 7-23; 10-13; 11-19; 14-22."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11113132	J Biol Chem. 2001 Mar 16;276(11):7811-7819.	Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loréal O.	A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.	
DRAMP03420	VTCYCRSTRCGFRERLSGACGYRGRIYRLCCR	32	Neutrophil antibiotic peptide NP-2 (RatNP-2; Rodents, mammals, animals)	Q62715	Belongs to the alpha-defensin family	Defa	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		Active in vitro against S. aureus, fungi, Gram-positive and Gram-negative bacteria and to a lesser extent against an enveloped virus.	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Salmonella typhimurium.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.	L	No cytotoxicity information found	Not found	2254017##7594610	Infect. Immun. 1990;58:3899-3902.##J. Immunol. 1995;155:4476-4484. 	Eisenhauer P.B, Harwig S.S.S.L, Szklarek D, Ganz T, Lehrer R.I.##Yount N.Y, Wang MS.C, Yuan J, Banaiee N, Ouellette A.J, Selsted M.E.	Polymorphic expression of defensins in neutrophils from outbred rats.##Rat neutrophil defensins. Precursor structures and expression during neutrophilic myelopoiesis.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)NCC(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
DRAMP03421	CSCRTSSCRFGERLSGACRLNGRIYRLCC	29	Neutrophil antibiotic peptide NP-3 (RatNP-3a, RatNP-3b; Rodents, mammals, animals)	Q62713, Q9Z1F1	Belongs to the alpha-defensin family	Not found	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral	Protein level	Bridge	Not found		Active in vitro against S. aureus, fungi, Gram-positive and Gram-negative bacteria and to a lesser extent against an enveloped virus.	Gram-positive bacterium: Staphylococcus aureus 502A;##Gram-negative bacterium: Escherichia coli ML-35.##Fungi: Candida albicans 820, Cryptococcus neoformans A-383.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization(Cys1 and Cys29).	Cyclization(Cys1 and Cys29).	Disulfide bonds between Cys1 and Cys29,Cys3 and Cys18,Cys8 and Cys28.	L	No cytotoxicity information found	Not found	2254017##7594610	Infect. Immun. 1990;58:3899-3902.##J. Immunol. 1995;155:4476-4484. 	Eisenhauer P.B, Harwig S.S.S.L, Szklarek D, Ganz T, Lehrer R.I.##Yount N.Y, Wang MS.C, Yuan J, Banaiee N, Ouellette A.J, Selsted M.E.	Polymorphic expression of defensins in neutrophils from outbred rats.##Rat neutrophil defensins. Precursor structures and expression during neutrophilic myelopoiesis.	
DRAMP03423	DIPPGIRNTVCFMQRGHCRLFMCRSGERKGDICSDPWNRCCVSSSIKNR	49	BIN1b (Sperm-associated antigen 11; Antimicrobial-like protein Bin-1b; Rodents, mammals, animals)	Q8VBV2	Belongs to the beta-defensin family	Spag11	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial, Anti-Gram-	Transcript level	Not found	Not found		"Function: Antimicrobial peptide against E.coli. Is also responsible for sperm maturation, storage, and protection.
Tissue specificity: Only expressed in epididymis (middle part of the caput).
Developmental stage: Its expression starts at 30 days of age, reaches a maximum during the sexually mature period, and then decreased in old rats.
PTM: Contains three disulfide bonds 11-40; 18-33; 23-41."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11230693	J Biotechnol. 2009 Jan 1;139(1):33-37##Science. 2001 Mar 2;291(5509):1783-1785.	Guo C, Diao H, Lian Y, Yu H, Gao H, Zhang Y, Lin D.##Li P, Chan HC, He B, So SC, Chung YW, Shang Q, Zhang YD, Zhang YL.	Recombinant expression and characterization of an epididymis-specific antimicrobial peptide BIN1b/SPAG11E.##An antimicrobial peptide gene found in the male reproductive system of rats.	
DRAMP03424	DQYRCLQNGGFCLRSSCPSHTKLQGTCKPDKPNCCRS	37	Beta-defensin 1 (BD-1, RBD-1; Defensin, beta 1; Rodents, mammals, animals)	O89117	Belongs to the beta-defensin family	Defb1	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial, Anti-Gram-	Transcript level	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##10456937	Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.##Infect Immun. 1999 Sep;67(9):4827-4833.	Page R.A, Malik A.N.##Jia HP, Mills JN, Barahmand-Pour F, Nishimura D, Mallampali RK, Wang G, Wiles K, Tack BF, Bevins CL, McCray PB Jr.	Rat beta defensin-1 peptide: candidate marker for diabetic nephropathy.##Molecular cloning and characterization of rat genes encoding homologues of human beta-defensins.	
DRAMP03425	KKVYNAVSCMTNGGICWLKCSGTFREIGSCGTRQLKCCKKK	41	Beta-defensin 3 (BD-3, RBD-3; Defensin, beta 3; Rodents, mammals, animals)	Q32ZI4	Belongs to the beta-defensin family	Defb3	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 9-37; 16-30; 20-38."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03426	QSINNPITCLTKGGVCWGPCTGGFRQIGTCGLPRVRCCKKK	41	Beta-defensin 4 (BD-4, RBD-4; Defensin, beta 4; RBD-2; Rodents, mammals, animals)	O88514, Q32ZE9	Belongs to the beta-defensin family	Defb4	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 9-37; 16-30; 20-38."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03427	QSINNPVSCVTHGGICWGRCPGSFRQIGTCGLGKVRCCKKK	41	Beta-defensin 5 (BD-5, RBD-5; Defensin, beta 5; Rodents, mammals, animals)	Q32ZI3	Belongs to the beta-defensin family	Defb5	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 9-37; 16-30; 20-38."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03428	ELKHLGLKTEFEQCQRIRGYCLNTYCRFPTSHVGSCYPEKRYCCKNIR	48	Beta-defensin 9 (BD-9, RBD-9; Defensin, beta 9; Rodents, mammals, animals)	Q32ZI2	Belongs to the beta-defensin family	Defb9	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 14-43; 21-36; 26-44."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03429	ELKHLGMTAETEWCRLFEGFCHDKNCPPPTSHVGSCHPEKRSCCKDRR	48	Beta-defensin 10 (BD-10, RBD-10; Defensin, beta 10; Rodents, mammals, animals)	Q32ZI1	Belongs to the beta-defensin family	Defb10	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 14-43; 21-36; 26-44."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03430	FLRRSVSGFQECHSKGGYCYRYYCPRPHRRLGSCYPYAANCCRRRR	46	Beta-defensin 11 (BD-11, RBD-11; Defensin, beta 11; Rodents, mammals, animals)	Q32ZI0	Belongs to the beta-defensin family	Defb11	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 12-41; 19-34; 24-42."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03431	GLEYSQSFPGGEFAVCETCRLGRGKCRRTCLDSEKIAGKCKLNFFCCRERI	51	Beta-defensin 12 (BD-12, RBD-12; Defensin, beta 12; Rodents, mammals, animals)	Q32ZH9	Belongs to the beta-defensin family	Defb12	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 19-46; 26-39; 30-47."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03432	TLYRRFLCKKMKGRCETACLSFEKKIGTCRADLTPLCCKEKKKH	44	Beta-defensin 13 (BD-13, RBD-13; Defensin, beta 13; Rodents, mammals, animals)	Q32ZH8	Belongs to the beta-defensin family	Defb13	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 8-37; 15-29; 19-38."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03433	FIPKSLRRFFCRVRGGRCAILNCLGKEEQIGRCSNRGQKCCRKKK	45	Beta-defensin 14 (BD-14, RBD-14; Defensin, beta 14; Rodents, mammals, animals)	Q32ZH7	Belongs to the beta-defensin family	Defb14	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 11-40; 18-33; 23-41."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03434	FFDEKCSRINGRCTESCLKNEELIALCQKNLKCCVTVQPCGRDKGDELDEDSGYNRTRG	59	Beta-defensin 15 (BD-15, RBD-15; Defensin, beta 15; Rodents, mammals, animals)	Q32ZH6	Belongs to the beta-defensin family	Defb15	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 6-33; 13-27; 17-34."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03435	KRSYPEYGSLDLRKECRMSKGHCKLQCSENEIRIAFCIRPGTHCCI	46	Beta-defensin 17 (BD-17, RBD-17; Defensin, beta 17; Rodents, mammals, animals)	Q32ZH5	Belongs to the beta-defensin family	Defb17	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 16-44; 23-37; 27-45."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03436	APQMKTRDVLERTHKCFLVGGECKSECSSWEYEYVFCYTGPCCVMREYKRVEKFSNTPKYTT	62	Beta-defensin 18 (BD-18, RBD-18; Defensin, beta 18; Rodents, mammals, animals)	Q32ZH4	Belongs to the beta-defensin family	Defb18	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03437	CRKSCWVIRGHCRKHCRSGERVKKPCSNGDYCCIAKKINTVPQAPKNAFSRNFRVHSRTAPVAVLKNST	69	Beta-defensin 19 (Rodents, mammals, animals)	Q32ZH3	Belongs to the beta-defensin family	Defb19	Rattus norvegicus (Rat)	Antimicrobial	Transcript level	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03438	KRCFSNVAGYCRKRCRLVEISEMGCLHGKYCCVNELENKRHKKDTVVEQPMEPRDKSKVQDYMVLPTITYYTITI	75	Beta-defensin 20 (BD-20, RBD-20; Defensin, beta 20; Rodents, mammals, animals)	Q32ZH2	Belongs to the beta-defensin family	Defb20	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03439	MRLLLMALPLLALLPQVIPDYSAEKRCLNRLGHCKRKCKAGEMVMETCKYFQVCCVLDDNDYKQKASITRTMEKTSTIEYNLS	83	Beta-defensin 21 (DEFB21; Protein Defb21; rodents, mammals, animals)	Q32ZH1	Belongs to the beta-defensin family	Defb21	Rattus norvegicus (Rat)	Antimicrobial	Homology	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03440	MKLVLLLLAIFVTTELVMSGKNPTLQCMGNRGFCRPSCKKGEQAYFYCRTYQICCLQSHVRISLTGVEDNTNWSYEKHWPRIP	83	Beta-defensin 24 (DEFB24; Protein Defb24; rodents, mammals, animals)	Q32ZG8	Belongs to the beta-defensin family	Defb24	Rattus norvegicus (Rat)	Antimicrobial	Homology	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03441	EFKRCWNGQGACRTYCTRQEKFIHLCPDASLCCLSYSLKASPHSRAGGV	49	Beta-defensin 25 (BD-25, RBD-25; Defensin, beta 25; Rodents, mammals, animals)	Q32ZG7	Belongs to the beta-defensin family	Defb25	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 5-32; 12-26; 16-33."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03442	MKTAVLTMVLLLLLSQVIPGSPEKCWKSFGICREECLRKEKFYIFCWDGSLCCVKPKNVPQWSQSSE	67	Beta-defensin 27 (DEFB27; Protein Defb27; rodents, mammals, animals)	Q32ZG5	Belongs to the beta-defensin family	Defb27	Rattus norvegicus (Rat)	Antimicrobial	Homology	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03443	MLLTRSSTLSGHIKLWFLTLAVLVVLAQTSPEGWFRTCFYGMGKCRHVCRANEKKKERCGENSFCCLGETKSKLSNIPTNKGRKKD	86	Beta-defensin 28 (Rodents, mammals, animals)	Q32ZG4	Belongs to the beta-defensin family	Defb28	Rattus norvegicus (Rat)	Antimicrobial	Transcript level	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03444	GLFGLRSGKRREPWVSCELYQGSCRNACQKYEIQYLTCPKKRKCCLKFPMKITRV	55	Beta-defensin 29 (BD-29, RBD-29; Defensin, beta 29; Rodents, mammals, animals)	Q32ZG3	Belongs to the beta-defensin family	Defb29	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 17-44; 24-38; 28-45."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03445	GVNMYIRQIYDTCWKLKGHCRNVCGKKEIFHIFCGTQFLCCIERKEMPVLFVK	53	Beta-defensin 30 (BD-30, RBD-30; Defensin, beta 30; Rodents, mammals, animals)	Q32ZG2	Belongs to the beta-defensin family	Defb30	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial, Anti-Gram-	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 13-40; 20-34; 24-41."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03446	RKRNTKFRQCEKMGGICKYQKTHGCSILPAECKSRYKHCCRL	42	Beta-defensin 33 (BD-33, RBD-33; Defensin, beta 33; Rodents, mammals, animals)	Q32ZG1	Belongs to the beta-defensin family	Defb33	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 10-39; 17-32; 25-40."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03447	MKISCFLLLVLSLSCFQINPFAVLDTRVCIEKRNTCHILQCPLFRDVVGTCFEGIGKCCHKYF	63	Beta-defensin 37 (Rodents, mammals, animals)	Q32ZF9	Belongs to the beta-defensin family	Defb37	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03448	TDQDTAKCVQKKNVCYYFECPWLSISVSTCYKGKAKCCQKRY	42	Beta-defensin 38 (BD-38, RBD-38; Defensin, beta 38; Rodents, mammals, animals)	Q32ZF8	Belongs to the beta-defensin family	Defb38	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 8-37; 15-30; 20-38."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03449	IDSVKCFQKNNTCHTIRCPYFQDEVGTCYEGRGKCCQKRLLSIRVPKKKV	50	Beta-defensin 39 (BD-39, RBD-39; Defensin, beta 39; Rodents, mammals, animals)	Q32ZF7	Belongs to the beta-defensin family	Defb39	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 6-35; 13-28; 18-36."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03450	MKISCFLMLVLFLSCFQMNSGAGLDTMKCVRGKNNCHMHRCPWFFVLISTCYSGKGSCCQKRRWFTRSHVNNV	73	Beta-defensin 40 (Protein Defb40; rodents, mammals, animals)	Q32ZF6	Belongs to the beta-defensin family	Defb40	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03451	MRSHSFLSALFLLVMMMPRGKAGVVPGEKQCILLKGVCKDVSCTSTDDTIGVCNDEKKCCRRWWVFDPYPTPVPKGKSP	79	Beta-defensin 41 (Protein Defb41; rodents, mammals, animals)	Q32ZF5	Belongs to the beta-defensin family	Defb41	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03452	MRLYLLLSTLLFLLGLLPRVRSGLGAAETHCVNLQGICRRDICKLIEDEIGACRRRWKCCRLWWVLLPIPTPVIFSDYQEPLQTKMK	87	Beta-defensin 42 (Protein Defb42; rodents, mammals, animals)	Q32ZF4	Belongs to the beta-defensin family	Defb42	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03453	FLANQECFSEYRHCRMKCKANEYAIRYCADWTICCRVKKREAKKKIMW	48	Beta-defensin 43 (BD-43, RBD-43; Defensin, beta 43; Rodents, mammals, animals)	Q32ZF3	Belongs to the beta-defensin family	Defb43	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains two disulfide bonds 7-35; 14-28."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03454	MDLHLLCLLLFLVTSLPEGYCVIGNSGVSFKPCTSEGGYCFFGCKLGWIWITYCNNIMSCCKKDTKHSLPQTKGV	75	Beta-defensin 44 (Protein Defb44; rodents, mammals, animals)	Q32ZF2	Belongs to the beta-defensin family	Defb44	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03455	MKLPVLFLLFCFLDLLKTVKAEMKDTLFCFLKKGKCRHVCMNVEKRVGPCTKLNANCCIFVRDMRAIIPEDQRTVSIKIRNKQN	84	Beta-defensin 49 (Protein Defb49; rodents, mammals, animals)	Q32ZF1	Belongs to the beta-defensin family	Defb49	Rattus norvegicus (Rat)	Antimicrobial	Homology	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03456	HPGTVHVRFKCIPKIAAVFGDNCPFYGNVDGLCNDKKSVCCMVPVRLDNI	50	Beta-defensin 50 (BD-50, RBD-50; Defensin, beta 50; Rodents, mammals, animals)	Q30KJ2	Belongs to the beta-defensin family	Defb50	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function Has antibacterial activity (By similarity).
PTM: Contains two disulfide bonds 11-40; 23-41."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##15489334	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Genome Res. 2004 Oct;14(10B):2121-2127.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.##Gerhard DS, Wagner L, et al.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).	
DRAMP03457	MRIHAFLALLAIFQVLHAITSALNFQRPCYLRGGICLKQGTPNCEPFRGPCRAFTVCCKIRS	62	Beta-defensin 51 (Protein Defb51; rodents, mammals, animals)	Q32ZF0	Belongs to the beta-defensin family	Defb51	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03458	MKLLYLLISVVLLISQVMAAPEGCKQEGQTEWKDFVRTKGAFIHFFNNDYGHHYCDSPTSVCLRRRTNCTRMPGLCPGRSFCCVRT	86	Beta-defensin 52 (Protein Defb52; rodents, mammals, animals)	Q30KJ1	Belongs to the beta-defensin family	Defb52	Rattus norvegicus (Rat)	Antimicrobial	Predicted	Not found	Not found		Function Has antibacterial activity (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03459	GKNPTLQCMGNRGFCRPSCKKGEQAYFYCRTYQICCLQSHVRISLTGVEDNTNWSYEKHWPRIP	64	DEFB24 (defensin; Rodents, mammals, animals)	No entry found	Not found	Not found	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16457734	Reprod Biol Endocrinol. 2006 Feb 4;4:7.	Yenugu S, Chintalgattu V, Wingard CJ, Radhakrishnan Y, French FS, Hall SH.	Identification, cloning and functional characterization of novel beta-defensins in the rat (Rattus norvegicus).	
DRAMP03460	GGVKGAEKGVCPPDNVRCIRGEDPQCHNDNDCKDQKICCYWHCGFKCVQPVKDSWEQ	57	WAP four-disulfide core domain protein 12 (mammals, rodents, animals)	Q6IE40	Not found	Wfdc12	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial	Homology	Not found	Not found		PTM: Contains four disulfide bonds 11-39; 18-43; 26-38; 32-47 and one WAP Domain: (residue 4-51).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15057822##15060002	Genome sequence of the Brown Norway rat yields insights into mammalian evolution.##Genome Res. 2004 Apr;14(4):609-622.	Gibbs R.A, Weinstock G.M, Metzker M.L, Muzny D.M, Sodergren E.J, et al, Collins F.S.##Puente XS, López-Otín C.	Genome sequence of the Brown Norway rat yields insights into mammalian evolution.##A genomic analysis of rat proteases and protease inhibitors.	
DRAMP03461	LRDLKCFCRRKSCNWGEGIMGICKKRYGSPILCCR	35	Defensin 5 (Enteric defensin; RD-5; Rodents, mammals, animals)	P82106	Belongs to the alpha-defensin family	Not found	Rattus norvegicus (Rat)	Antimicrobial	Transcript level	Not found	Not found		"Function: Probably contributes to the antimicrobial barrier Function: of the small intestine.
Tissue specificity: Small intestine. Not present in heart, liver, spleen, kidney, large intestine and colon.
Induction: By hemorrhagic shock.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10456932	Infect Immun. 1999 Sep;67(9):4787-4793.	Condon MR, Viera A, D'Alessio M, Diamond G.	Induction of a rat enteric defensin gene by hemorrhagic shock.	
DRAMP03462	ATELEKALSNVIEVYHNYSGIKGNHHALYRDDFRKMVTTECPQFVQNKNTESLFKELDVNSDNAINFEEFLVLVIRVGVAAHKDSHKE	88	Protein S100-A8 (Calgranulin-A; MRP-8; Rodents, mammals, animals)	P50115	Belongs to the S-100 family	S100a8	Rattus norvegicus (Rat)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: S100A8 is a calcium- and zinc-binding protein which plays a prominent role in the regulation of inflammatory processes and immune response. It has antimicrobial activity towards bacteria and fungi and exerts its antimicrobial activity probably via chelation of Zn2+ which is essential for microbial growth. Can induce cell death via autophagy and apoptosis and this occurs through the cross-talk of mitochondria and lysosomes via reactive oxygen species (ROS) and the process involves BNIP3. Can regulate neutrophil number and apoptosis by an anti-apoptotic effect.
Miscellaneous: Binds two calcium ions per molecule with an affinity similar to that of the S100 proteins (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	21487906	Inflammation. 2012 Apr;35(2):409-419.	Koike A, Arai S, Yamada S, Nagae A, Saita N, Itoh H, Uemoto S, Totani M, Ikemoto M.	Dynamic mobility of immunological cells expressing S100A8 and S100A9 in vivo: a variety of functional roles of the two proteins as regulators in acute inflammatory reaction.	
DRAMP03466	PRGSPRTEYEAARR	14	Ribosome-inactivating protein luffacylin (rRNA N-glycosidase; Plants)	P84073	Not found	Not found	Luffa cylindrica (Smooth loofah) (Sponge gourd)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Has antifungal activity against F. oxysporum and M. arachidicola. Inhibits cell-free translation in rabbit reticulocyte lysate system. Has some N-glycosidase activity.
Catalytic activity: Endohydrolysis of the N-glycosidic bond at one specific adenosine on the 28S rRNA."	Fungi: Mycosphaerella arachidicola, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12126727	Peptides. 2002 Jun;23(6):1019-10124.	Parkash A, Ng TB, Tso WW.	Isolation and characterization of luffacylin, a ribosome inactivating peptide with anti-fungal activity from sponge gourd (Luffa cylindrica) seeds.	
DRAMP03468	GVCDMADLA	9	Alveolarin (Fungus)	P84760	Not found	Not found	Polyporus alveolaris (Hexagonal-pored polypore) (Favolus alveolaris)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Antifungal activity. Inhibits mycelial growth of F. cinera, F. oxysporum, M. arachidicola and P. piricola. Lacks protease, ribonuclease, deoxyribonuclease and hemagglutinating activity.	Fungi: Botrytis cinerea, Fusarium oxysporum, Mycosphaerella arachidicola and Physalospora piricola.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15165727	Peptides. 2004 Apr;25(4):693-696.	Wang H, Ng TB, Liu Q.	Alveolarin, a novel antifungal polypeptide from the wild mushroom Polyporus alveolaris.	
DRAMP03469	MDVVRTLILCVCLFGLTFA	19	Serine protease inhibitor Cvsi-1 (molluscs, animals)	Q30HU9, P84574	Not found	Not found	Crassostrea virginica (Eastern oyster)	Antimicrobial, Antibacterial, Antiparasitic	Protein level	Not found	Not found		"Function: Slow-binding inhibitor of serine proteases. The inhibitor rapidly binds to the protease forming a weak enzyme-inhibitor complex, and this is followed by a slow isomerization forming a tight-binding enzyme-inhibitor complex. Active against subtilisin A, perkinsin and trypsin with dissociation constants of 0.29 nM, 13.7 nM and 17.7 nM respectively. Not active against thermolysin, papain or pepsin. Has antiparasitic activity against the protozoan P. marinus.
Tissue specificity: Detected in hemolymph (at protein level). In oysters collected in the summer the expression level is highest in the digestive gland with low levels of expression in gill, mantle, labial palp, style-sac midgut, gonad, heart, and hemocyte. In winter expression levels are higher in all tissues with highest expression levels observed in the digestive gland. Within the digestive gland expression is limited to the basophil cells of the digestive diverticula."	Subtilisin A and Prochlorococcus marinus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16872855##19720077	Comp Biochem Physiol B Biochem Mol Biol. 2006 Sep;145(1):16-26.##Dev Comp Immunol. 2010 Jan;34(1):84-92.	Xue QG, Waldrop GL, Schey KL, Itoh N, Ogawa M, Cooper RK, Losso JN, La Peyre JF.##La Peyre JF, Xue QG, Itoh N, Li Y, Cooper RK.	A novel slow-tight binding serine protease inhibitor from eastern oyster (Crassostrea virginica) plasma inhibits perkinsin, the major extracellular protease of the oyster protozoan parasite Perkinsus marinus.##Serine protease inhibitor cvSI-1 potential role in the eastern oyster host defense against the protozoan parasite Perkinsus marinus.	
DRAMP03470	GFGCPWNRYQCHSHCRSIGRLGGYCAGSLRLTCTCYRS	38	Defensin-1 (American oyster defensin, AOD; molluscs, animals)	P85008	Belongs to the invertebrate defensin family (Type 2 subfamily)	Not found	Crassostrea virginica (American oyster) 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		PTM: Contains three disulfide bond: 4-25; 11-33; 15-35.	Gram-positive bacteria: Lactococcus lactis subsp. lactis (MECs=2.4 µg/ml), Staphylococcus aureus (MECs=3 µg/ml);##Gram-negative bacteria: Escherichia coli D31 (MECs=7.6 µg/ml), Vibrio parahaemolyticus (MECs=15 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16297885	Biochem Biophys Res Commun. 2005 Dec 30;338(4):1998-2004.	Seo JK, Crawford JM, Stone KL, Noga EJ.	Purification of a novel arthropod defensin from the American oyster, Crassostrea virginica.	
DRAMP03473	DNGEAGRAAR	10	Antimicrobial ribonuclease (Fungus)	P84528	Not found	Not found	Pleurotus sajor-caju (Oyster mushroom)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Has ribonuclease activity towards yeast tRNA and polyuracil and weak ribonuclease activity towards other polyhomoribonucleotides. Has weak deoxyribonuclease activity. Displays antimitogenic activity towards murine splenocytes and antiproliferative activity towards HepG2 hepatoma cells and L1210 leukemia cells.
Biophysicochemical properties: pH dependence (Optimum pH is from 5.5 to 6.0); Temperature dependence (Optimum temperature below 60 degrees Celsius. Active from 0 to 100 degrees Celsius)."	Bacteria: Pseudomonas aeruginosa, Pseudomonas fluorescens, Staphylococcus aureus.##Fungi: Fusarium oxysporum (IC50=95 µM), Mycosphaerella arachidicola (IC50=72 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15003351	Peptides. 2004 Jan;25(1):11-17.	Ngai PH, Ng TB.	A ribonuclease with antimicrobial, antimitogenic and antiproliferative activities from the edible mushroom Pleurotus sajor-caju.	
DRAMP03475	QCMQLETSGQMRRCVSQCDKRFEEDIDWSKYDNQE	35	Vicilin-like Antimicrobial peptide 2a (MiAMP2a; Plant defensin)	Q9SPL3	Belongs to the vicilin-like family	AMP2-3	Macadamia integrifolia (Macadamia nut)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: (- Ca2+, + Ca2+): Clavibacter michiganensis (IC50=50, >50 µg/ml).##Fungi (- Ca2+, + Ca2+): Alternaria helianthi (IC50=5-10, ND µg/ml), Ceratocystis paradoxa (IC50=20-50, >50 µg/ml), Cercospora nicotianae (IC50=5-10, 5-10 µg/ml), Chalara elegans (IC50=2-5, 10-20 µg/ml), Fusarium oxysporum (IC50=10, 20-50 µg/ml), Leptosphaeria maculans (IC50=25, >50 µg/ml), Sclerotinia sclerotiorum (IC50=20-50, >50 µg/ml), Verticillium dahliae (IC50=5-10, >50 µg/ml), Saccharomyces cerevisiae (IC50=20-50, >50 µg/ml), Phytophthora cryptogea (IC50=5-10, 10-25 µg/ml), Phytophthora parasitica nicotianae (IC50=10-20, >50 µg/ml).##[NOTE:, Ca2+ = Medium with low content of CaCl2 (50 µM); + Ca2+ = Medium supplemented with high concentration of CaCl2 (1 mM)]	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10571855	Plant J. 1999 Sep;19(6):699-710.	Marcus JP, Green JL, Goulter KC, Manners JM.	A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.	
DRAMP03476	ATRVVYCNRRSGSVVGGDDTVYYEG	25	Eryngin (mushroom, fungi)	P84525	Not found	Not found	Pleurotus eryngii 	Antimicrobial, Antifungal	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	Fungi: Fusarium oxysporum, Mycosphaerella arachidicola.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15003349	Peptides. 2004 Jan;25(1):1-5.	Wang H, Ng TB.	Eryngin, a novel antifungal peptide from fruiting bodies of the edible mushroom Pleurotus eryngii.	
DRAMP03478	AGETHTVMINHAGRGAPKLVVGGKKLS	27	Ganodermin (Fungus)	P84995	Not found	Not found	Ganoderma lucidum (Ling zhi medicinal fungus) (Bracket fungus)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Has antifungal activity. Lacks hemagglutinating activity towards rabbit erythrocytes. Lacks deoxyribonuclease, ribonuclease and protease inhibitory activities.	Fungi: Botrytis cinerea (IC50=15.2 µM), Fusarium oxysporum (IC50=12.4 µM), Physalospora piricola (IC50=18.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16039755	Peptides. 2006 Jan;27(1):27-30. Epub 2005 Jul 21.	Wang H, Ng TB.	Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum	
DRAMP03479	WNPFKELERAGQRVRDAVISAAPAVATVGQAAAIARG	37	Bactericidin B-2 (Cecropin-like peptide B-2; Insects, animals)	P14662	Belongs to the cecropin family	Not found	Manduca sexta (Tobacco hornworm)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3143727	J Biol Chem. 1988 Dec 25;263(36):19424-19429.	Dickinson L, Russell V, Dunn PE.	A family of bacteria-regulated, cecropin D-like peptides from Manduca sexta.	
DRAMP03480	WNPFKELERAGQRVRDAIISAGPAVATVGQAAAIARG	37	Bactericidin B-3 (Cecropin-like peptide B-3; Insects, animals)	P14663	Belongs to the cecropin family	Not found	Manduca sexta (Tobacco hornworm)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3143727	J Biol Chem. 1988 Dec 25;263(36):19424-19429.	Dickinson L, Russell V, Dunn PE.	A family of bacteria-regulated, cecropin D-like peptides from Manduca sexta.	
DRAMP03481	WNPFKELERAGQRVRDAIISAAPAVATVGQAAAIARG	37	Bactericidin B-4 (Cecropin-like peptide B-4; Insects, animals)	P14664	Belongs to the cecropin family	Not found	Manduca sexta (Tobacco hornworm)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3143727	J Biol Chem. 1988 Dec 25;263(36):19424-19429.	Dickinson L, Russell V, Dunn PE.	A family of bacteria-regulated, cecropin D-like peptides from Manduca sexta.	
DRAMP03482	MGSKVYYVLMLALSFYVVQLCAFPRNSVAFEKQHESLPHADYIVTQKTESHEKTTAEPKLPGRIWCQYEEVTEDAICQEHCIPKGYSYGLCISNTCSCI	99	Defensin-like protein 1 (Predicted; Insects, animals; Predicted)	D1KRL1	Not found	Def1	Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19909380	Insect Mol Biol. 2010 Feb;19(1):61-75.	Pauchet Y, Wilkinson P, Vogel H, Nelson DR, Reynolds SE, Heckel DG, ffrench-Constant RH.	Pyrosequencing the Manduca sexta larval midgut transcriptome: messages for digestion, detoxification and defence.	
DRAMP03483	MKSSMLLLVCVTFLVIVSSPQNGVLADKLIGSCVWGAVDYTSNCNAECVRRGLR	54	Defensin-like protein 2 (Predicted; Insects, animals)	D1KRL2	Not found	Def2	Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19909380	Insect Mol Biol. 2010 Feb;19(1):61-75.	Pauchet Y, Wilkinson P, Vogel H, Nelson DR, Reynolds SE, Heckel DG, ffrench-Constant RH.	Pyrosequencing the Manduca sexta larval midgut transcriptome: messages for digestion, detoxification and defence.	
DRAMP03484	MNTKLIIFLATLVILTDAYVVKSPKDLSSADSNALEKNSQSLLHATYDESLYIPMRVSSCSDGICDLGCKILGYPHGRCISANTCQCY	88	Defensin-like protein 3 (Predicted; Insects, animals; Predicted)	D1KRL3	Not found	Def3	Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19909380	Insect Mol Biol. 2010 Feb;19(1):61-75.	Pauchet Y, Wilkinson P, Vogel H, Nelson DR, Reynolds SE, Heckel DG, ffrench-Constant RH.	Pyrosequencing the Manduca sexta larval midgut transcriptome: messages for digestion, detoxification and defence.	
DRAMP03485	WNPFKELERAGQRVRDAVISAAAVATVGQAAAIARGG	37	Bactericidin B-5P (Cecropin-like peptide B-5; Insects, animals)	P14665	Belongs to the cecropin family	Not found	Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3143727	J Biol Chem. 1988 Dec 25;263(36):19424-19429.	Dickinson L, Russell V, Dunn PE.	A family of bacteria-regulated, cecropin D-like peptides from Manduca sexta.	
DRAMP03487	QRFSQPTFKLPQGRLTLSRKF	21	Lebocin Peptide 1A (LP1A; Insects, animals)	No entry found	Belongs to the cecropin family	Not found	Manduca sexta	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Dev Comp Immunol. 2010 Jun;34(6):638-647.	Rayaprolu S, Wang Y, Kanost MR, Hartson S, Jiang H.	Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.	
DRAMP03488	WDFLKELEGVGQRVRDSIISAGPAIDVLKKSQGPRRWSRP	40	Defense protein 4 (DFP-4; Insects, animals)	Q5MGD8	Belongs to the cecropin family	Not found	Lonomia obliqua (Moth)	Antimicrobial	Homology	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16023793	Gene. 2005 Aug 1;355:11-27.	Veiga AB, Ribeiro JM, Guimarães JA, Francischetti IM.	A catalog for the transcripts from the venomous structures of the caterpillar Lonomia obliqua: identification of the proteins potentially involved in the coagulation disorder and hemorrhagic syndrome.	
DRAMP03489	LTVRAAQSFGRCNQKQCDADCVKKGYFGGLCTLTSCFCTGSRS	43	Defense protein 6 (DFP-6; Insects, animals)	Q5MGC9	Belongs to the invertebrate defensin family	Not found	Lonomia obliqua (Moth)	Antimicrobial	Homology	Not found	Not found		"Function: Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16023793	Gene. 2005 Aug 1;355:11-27.	Veiga AB, Ribeiro JM, Guimarães JA, Francischetti IM.	A catalog for the transcripts from the venomous structures of the caterpillar Lonomia obliqua: identification of the proteins potentially involved in the coagulation disorder and hemorrhagic syndrome.	
DRAMP03490	VFGTLGSTDDSLFGRYKQDIFNDHRGHLQGQAYGSR	36	Gloverin (Insects, animals)	P86358	Not found	Not found	Heliothis virescens (Tobacco budworm moth)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Antibacterial protein (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2009) to UniProtKB	Shelby KS.	Unknown	
DRAMP03491	YDNVNLDEILANDRLLVPYIKCLLDEGKKAPDAKELKEHIRXAL	44	Viresin (Insects, animals)	P86354	Not found	Not found	Heliothis virescens (Tobacco budworm moth)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		Function: Has antibacterial activity against the Gram-negative bacteria E. coli and E. cloacae, but not against the Gram-negative bacteria P. aeruginosa, P. vulgaris, K. pneumoniae and S. enteritidis or the Gram-positive bacteria S. aureus, S. epidermidis and S. salivarius.	Gram-negative bacteria: E. coli K12 D31, E. coli and E. cloacae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651803	Eur J Biochem. 2000 Feb;267(3):677-683.	Viresin. A novel antibacterial protein from immune hemolymph of Heliothis virescens pupae.	Viresin. A novel antibacterial protein from immune hemolymph of Heliothis virescens pupae.	
DRAMP03492	DKLIGSCVWGAVNYTSDCNGECLLRGYKGGHCGSFANVNCWCET	44	Defensin heliomicin (Mutation: K23L, R24L)	P81544	Belongs to the invertebrate defensin family (Type 2 subfamily)	Not found	Heliothis virescens (tobacco budworm)	Antimicrobial, Antibacterial, Antifungal	Protein level	Combine helix and strand structure	Not found	1I2V resolved by NMR. 	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11580275	Biochemistry. 2001 Oct 9;40(40):11995-12003.	Lamberty M, Caille A, Landon C, Tassin-Moindrot S, Hetru C, Bulet P, Vovelle F.	Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.	
DRAMP03494	WKPFKKIEKAVRRVRDGVAKAGPAVAVVGQAT	32	Cecropin (Insects, animals)	P83420	Not found	Not found	Oiketicus kirbyi (Bagworm moth)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria. Has also activity against fungi	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2002) to UniProtKB	Bulet P.	Unknown	
DRAMP03495	INNWVRVPPCDQVCSRTNPEKDECCRAHGHAFHATCSGGMQCYRR	45	Psychimicin (Insects, animals)	P83421	Not found	Not found	Oiketicus kirbyi (Bagworm moth)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity. Is particularly active against fungi, and to a lesser extent against Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemolymph.
PTM: Contains three disulfide bonds 10-24; 14-36; 25-42."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2002) to UniProtKB	Bulet P.	Unknown	
DRAMP03496	RWKVFKKIEKVGRNIRDGVIKAAPAIEVLGQAKAL	35	Cecropin-A (Insects, animals)	P83413	Not found	Not found	Heliothis virescens (Tobacco budworm moth)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria. Has also activity against fungi.
Tissue specificity: Hemolymph. Induction: By bacterial infection.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted JUL-2002 to the SWISS-PROT data bank.	Bulet P, Lamberty M, Brookhart G, Bushey D.	Unknown	
DRAMP03497	KWKVFKKIEKVGRNIRDGIVKAGPAIAVLGQAN	33	Cecropin-B (Insects, animals)	P83414	Belongs to the cecropin family	Not found	Heliothis virescens (Tobacco budworm moth)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria. Has also activity against fungi.
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2002) to UniProtKB.	Bulet P, Lamberty M, Brookhart G, Bushey D.	Unknown	
DRAMP03498	RWKVFKKIEKMGRNIRDGVIKAAPAIEVLGQAK	33	Cecropin-C (Insects, animals)	P83415	Belongs to the cecropin family	Not found	Heliothis virescens (Tobacco budworm moth)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria. Has also activity against fungi.
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2002) to UniProtKB.	Bulet P, Lamberty M, Brookhart G, Bushey D.	Unknown	
DRAMP03499	QRFIHPTYRPPPQPRRPVIMRA	22	Heliocin (Pro-rich; Insects, animals)	P83427	Belongs to the lebocin family	Not found	Heliothis virescens (Tobacco budworm moth)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has antibacterial activity, preferentially against Gram-negative bacteria.
Tissue specificity: Hemolymph.
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2002) to UniProtKB.	Bulet P, Lamberty M, Charlet M, Sabatier L, Rabel D.	Unknown	
DRAMP03500	GKIPIGAIKKAGKAIGKGLRAVNIASTAHDVYTFFKPKKRH	41	Virescein (Insects, animals)	P83416	Belongs to the moricin family	Not found	Heliothis virescens (Tobacco budworm moth)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has antibacterial activity against Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemolymph.
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2002) to UniProtKB.	Bulet P, Lamberty M, Charlet M, Sabatier L, Rabel D.	Unknown	
DRAMP03501	AIGCNTVASKMAPCLPYVTGKGPLGGCCGGVKGLIDAARTTPDRQAVCNCLKTLAKSYSGINLGNAAGLPGKCGVSIPYQISPNTDCSKVH	91	La-LTP (LJAFP; Insects, animals)	Q52RN7	Not found	Afp	Leonurus japonicus (Chinese motherwort) (Leonurus artemisia)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	Gram-positive Bacteria: Bacillus subtilis (IC50>15 µM). ##Gram-negative Bacteria: Pseudomonas solanacearum (IC50=7.5-15 µM), Ralstonia solanacearum (IC50=15 µM).##Fungi: Alternaria alternate (IC50<7.5 µM), Alternaria brassicae (IC50<7.5 µM), Aspergillus niger (IC50<7.5 µM), Bipolaris maydis (IC50<7.5 µM), Botrytis cinerea (IC50=7.5-15 µM), Cerospora personata (IC50=7.5-15 µM), Colletotrichum gloeosporiodes (IC50<7.5 µM), Fusarium graminearum (IC50=7.5-15 µM), Fusarium oxysporum (IC50=7.5-15 µM), Penicillium digitatum (IC50>15 µM), Pyricularia grisea (IC50=7.5-15 µM), Rhizoctonia solani (IC50<7.5 µM), Rhizoctonia cerealis (IC50=7.5-15 µM), Saccharomyces cerevisiae (IC50>15 µM), Sclerotinia sclerotiorum (IC50>15 µM), Trichoderma harzianum (IC50=7.5-15 µM), Verticillium dahliae (IC50=7.5-15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	PubMed ID is not available	Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases	Yang X, Xiao Y, Pei Y, Zhen C.	LJAFP, a novel non-specific lipid transfer protein-like antimicrobial protein from motherwort (Leonurus japonicus) confers disease resistance against phytopathogenic fungi and bacterium in transgenic tobacco.	
DRAMP03502	RWKIFKKIERVGQNVRDGIIKAGPAIQVLGTAKAL	35	Hyphancin-3D (Hyphancin IIID; Cecropin-A; Insects, animals)	P50720	Not found	Not found	Hyphantria cunea (Fall webworm moth)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Has antibacterial activity.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted MAR-1995 to the EMBL GenBank DDBJ databases.	Park SS, Shin SW, Kim MK, Park DS, Oh HW, Park HY.	Differences in the skin peptides of the male and female Australian tree frog Litoria splendida. The discovery of the aquatic male sex pheromone splendipherin, together with Phe8 caerulein and the antibiotic peptide caerin 1.10.	
DRAMP03503	RWKFFKKIERVGQNVRDGLIKAGPAIQVLGAAKAL	35	Hyphancin-3E (Hyphancin IIIE; Cecropin-A1; Insects, animals)	P50721	Not found	Not found	Hyphantria cunea (Fall webworm moth)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Has antibacterial activity.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted MAR-1995 to the EMBL GenBank DDBJ databases.	Park SS, Shin SW, Kim MK, Park DS, Oh HW, Park HY.	Differences in the skin peptides of the male and female Australian tree frog Litoria splendida. The discovery of the aquatic male sex pheromone splendipherin, together with Phe8 caerulein and the antibiotic peptide caerin 1.10.	
DRAMP03504	RWKVFKKIEKVGRNIRDGVIKAGPAIAVVGQAKAL	35	Hyphancin-3F (Hyphancin IIIF; Cecropin-A2; Insects, animals)	P50722	Not found	Not found	Hyphantria cunea (Fall webworm moth)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Has antibacterial activity.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted MAR-1995 to the EMBL GenBank DDBJ databases.	Park SS, Shin SW, Kim MK, Park DS, Oh HW, Park HY.	Differences in the skin peptides of the male and female Australian tree frog Litoria splendida. The discovery of the aquatic male sex pheromone splendipherin, together with Phe8 caerulein and the antibiotic peptide caerin 1.10.	
DRAMP03505	RWKVFKKIEKVGRHIRDGVIKAGPAITVVGQATAL	35	Hyphancin-3G (Hyphancin IIIG; Cecropin-A3; Insects, animals)	P50723	Not found	Not found	Hyphantria cunea (Fall webworm moth)	Antimicrobial, Antibacterial	Homology	Not found	Not found		"Function: Has antibacterial activity.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted MAR-1995 to the EMBL GenBank DDBJ databases.	Park SS, Shin SW, Kim MK, Park DS, Oh HW, Park HY.	Differences in the skin peptides of the male and female Australian tree frog Litoria splendida. The discovery of the aquatic male sex pheromone splendipherin, together with Phe8 caerulein and the antibiotic peptide caerin 1.10.	
DRAMP03506	TPDHREVPSFSSRWEPNFGLTFSK	24	Attacin (Insects, animals)	P86359	Belongs to the attacin/sarcotoxin-2 family	Not found	Heliothis virescens (Tobacco budworm moth)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Hemolymph antibacterial protein (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2009) to UniProtKB	Shelby KS.	Unknown	
DRAMP03508	DILRG	5	Yamamarin (Growth-suppressing pentapeptide; Plant defensin; Insects, animals)	P84863	Not found	Not found	Antheraea yamamai (Japanese oak silkmoth)	Unknown	Protein level	Not found	Not found		"Function: Suppresses growth in rat hepatoma cells and maintains diapause in insects.
Developmental stage: Diapause.
PTM: Diapausing first instar larvae contain both amidated and non-amidated forms."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not availbale##PubMed ID is not availbale	J. Insect Biotechnol. Sericology. 2004;73:7-13.##J. Insect Biotechnol. Sericology. 2007;76:63-69.	Yang P, Abe S, Zhao Y, An Y, Suzuki K.##Yang P, Abe S, Sato Y, Yamashita T, Matsuda F, Hamayasu T, Imai K, Suzuki K.	Growth suppression of rat heptatoma cells by a pentapeptide from Antheraea yamamai.##A palmitonyl conjugate of an insect pentapeptide causes growth arrest in mammalian cells and mimics the action of diapause hormone.	
DRAMP03509	RWKFFKKIEKVGQNIRDGIIKAGPAVAVVGQAASIT	36	Cecropin-A (Insects, animals)	P50724	Belongs to the cecropin family	Not found	Trichoplusia ni (Cabbage looper)	Antimicrobial, Antibacterial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8882660	Insect Biochem Mol Biol. 1996 Feb;26(2):177-184.	Kang D, Liu G, Gunne H, Steiner H.	PCR differential display of immune gene expression in Trichoplusia ni.	
DRAMP02962	GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG	36	PMAP-36	P49931 	Belongs to the cathelicidin family	PMAP36	Sus scrofa 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Alpha helix	PMAP-36 contains a typical 		Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. Has hemolytic activity.	[Ref.27251456] Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=2 μM, MBC=4 μM), Staphylococcus aureus 25923 (MIC=2 μM, MBC=4 μM), Staphylococcus epidermidis 12228 (MIC=2 μM, MBC=4 μM), Bacillus subtilis 63501 (MIC=1 μM, MBC=1 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=1 μM, MBC=4 μM), Escherichia coli EC183 (MIC=1 μM, MBC=1 μM), Escherichia coli 1005 (MIC=2 μM, MBC=2 μM), Salmonella typhimurium C77-31 (MIC=1 μM, MBC=2 μM);##Fungi: Candida albicans 2.2086 (MIC=128 μM, MFC=128 μM), Candida albicans CA276 (MIC=128 μM, MFC=128 μM), Candida tropicalis 2.1975 (MIC=1 μM, MFC=2 μM), Candida krusei 2.1857 (MIC=8 μM, MFC=8 μM).	[Ref.27251456] 5% hemolysis at 4 µM, MHC=4 µM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27251456	Sci Rep. 2016 Jun 2;6:27258. 	Lyu Y, Yang Y, Lyu X, Dong N, Shan A.	Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida.	
DRAMP03511	KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL	35	Cecropin-B (Immune protein P9; Insects, animals)	P01508	Belongs to the cecropin family	Not found	Hyalophora cecropia (Cecropia moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli D21 (MLC=0.32 µM), Escherichia coli D31 (MLC=0.32 µM), Serratia marcescens Db11 (MLC=4.5 µM), Serratia marcescens Db1108 (MLC=2.4 µM), Serratia marcescens Db1121 (MLC=2.2 µM), Serratia marcescens Strain 122 (MLC=2.9 µM), Pseudomonas aeruginosa OT97 (MLC=1.9 µM), Xenorhabdus nematophilus Xn21 (MLC=1.6 µM);##Gram-positive bacteria: Bacillus megaterium Bmll (MLC=0.44 µM), Bacillus subtilis Bs11 (MLC=18 µM), B.thuringiensis Bt11 (MLC>133 µM), Streptococcus fecalis AD-4 (MLC=7.3 µM), Streptococcus fecalis DS16 (MLC>24 µM), Micrococcus luteus M111 (MLC=1.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7140755	Eur J Biochem. 1982 Sep;127(1):207-217.	Hultmark D, Engström A, Bennich H, Kapur R, Boman HG.	Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae.	
DRAMP03512	WNPFKELEKVGQRVRDAVISAGPAVATVAQATALAK	36	Cecropin-D (Cecropin D; Insects, animals)	P01510	Belongs to the cecropin family	Not found	Hyalophora cecropia (Cecropia moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli D21 (LC=0.43 µM), Escherichia coli D31 (LC=0.40 µM), Serratia marcescens Db11 (LC=14 µM), Serratia marcescens Db1108 (LC=12 µM), Serratia marcescens Db1121 (LC=12 µM), Strain 122 (LC=19 µM), Pseudomonas aeruginosa OT97 (LC=100 µM), Xenorhabdus nematophilus Xn21 (LC=19 µM);##Gram-positive bacteria: Bacillus megaterium Bmll (LC=41 µM), Bacillus subtilis Bs11 (LC>95 µM), B.thuringiensis Bt11 (LC>95 µM), Streptococcus fecalis AD-4 (LC>95 µM), Streptococcus fecalis DS16 (LC=88 µM), Micrococcus luteus M111 (LC=21 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7140755##1711035	Eur J Biochem. 1982 Sep;127(1):207-217.##J Biol Chem. 1991 Jun 25;266(18):11510-11517.	Hultmark D, Engström A, Bennich H, Kapur R, Boman HG.##Gudmundsson GH, Lidholm DA, Asling B, Gan R, Boman HG.	Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae.##The cecropin locus. Cloning and expression of a gene cluster encoding three antibacterial peptides in Hyalophora cecropia.	
DRAMP03522	MKIAFIVAISLAFLAVTSCIEFEKSTESHDIQKRGVTITVKPPFPGCVFYECIANCRSRGYKNGGYCTINGCQCLR	76	Gallerimycin (defensins; Insects, animals)	Q8MVY9	Not found	Not found	Galleria mellonella (Greater wax moth)	Antimicrobial, Antifungal	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	Metarhizium anisopliae	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12811766	Arch Insect Biochem Physiol. 2003 Jul;53(3):125-133.	Schuhmann B, Seitz V, Vilcinskas A, Podsiadlowski L.	Cloning and expression of gallerimycin, an antifungal peptide expressed in immune response of greater wax moth larvae, Galleria mellonella.	
DRAMP03529	RWKLFKKIEKVGRNVRDGLIKAGPAIAVIGQAKSL	35	Cecropin-A (Insects, animals)	Q27239	Belongs to the cecropin family	CECA	Bombyx mori (Silk moth)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Highest expression in fat body and hemocytes. Is also expressed in Malpighian tubules and to a much lesser extent in midgut. Not present in silk gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7765280	Biosci Biotechnol Biochem. 1994 Aug;58(8):1476-1478.	Yamano Y, Matsumoto M, Inoue K, Kawabata T, Morishima I.	Cloning of cDNAs for cecropins A and B, and expression of the genes in the silkworm, Bombyx mori.	
DRAMP03530	RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAI	35	Cecropin-B (Lepidopteran-A/B; Insects, animals)	P04142	Belongs to the cecropin family	CECB1 and CECB2	Bombyx mori (Silk moth)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Highest expression in fat body and hemocytes. Is also expressed in Malpighian tubules and to a much lesser extent in midgut. Not present in silk gland.
PTM: Lepidopteran-B differs from lepidopteran-A by its hydroxylated residue."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2184991##7765280	Comp. Biochem. Physiol. 1990; 95:551-554.##Biosci Biotechnol Biochem. 1994 Aug;58(8):1476-1478.	Morishima I, Suginaka S, Ueno T, Hirano H.##Yamano Y, Matsumoto M, Inoue K, Kawabata T, Morishima I.	Isolation and structure of cecropins, inducible antibacterial peptides, from the silkworm, Bombyx mori.##Cloning of cDNAs for cecropins A and B, and expression of the genes in the silkworm, Bombyx mori.	
DRAMP03531	GNFFKDLEKMGQRVRDAVISAAPAVDTLAKAKALGQ	36	Cecropin-D (Insects, animals)	O76146	Belongs to the cecropin family	CECD	Bombyx mori (Silk moth)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10392453	Comp Biochem Physiol B Biochem Mol Biol. 1999 Apr;122(4):409-414.	Yang J, Furukawa S, Sagisaka A, Ishibashi J, Taniai K, Shono T, Yamakawa M.	cDNA cloning and gene expression of cecropin D, an antibacterial protein in the silkworm, Bombyx mori.	
DRAMP18208	VSTLSVSSPCPGWPSSFTWSNC	22	NAI-112(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Actinoplanes sp.	Antimicrobial, Antibacterial, Antinociceptive, Antiallodynic, Anti-Gram+		Not found	The structural data indicate that NAI-112 is a 22-aa, neutrally charged, glycosylated lanthipeptide containing N-terminal Lab and C-terminal MeLab residues separated by a 4-aa linker. It carries a 6-deoxyhexose moiety N-linked to a tryptophan residue. NAI-112 represents the ?rst occurrence of a lanthipeptide containing a MeLab and an N-glycosylation. NAI-112 and labyrinthopeptin A2 share a similar ring topology.		Comment: No comments found on DRAMP database	Gram-positive (modest)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24191663	ACS Chem Biol. 2014 Feb 21;9(2):398-404.	Iorio M, Sasso O, Maffioli SI, Bertorelli R, Monciardini P, Sosio M, Bonezzi F, Summa M, Brunati C, Bordoni R, Corti G, Tarozzo G, Piomelli D, Reggiani A, Donadio S.	A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.	
DRAMP18207	ASGWVCTLTIECGTLVCAC	19	Actagardine B(Bacteriocin)	No entry found	Belongs to the lantibiotics family (Class I bacteriocin)	Not found	Actinoplanes liguriae NCIMB41362	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Actagardine, Ala(0)-actagardine, actagardine B, michiganin A, NAI-802 and Ala(0)-NAI-802 share three conserved thioether bridges within a core 19-aa peptide consisting of 14 invariant residues. 		Comment: No comments found on DRAMP database	Gram-positive	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid II	23168402	J Antibiot (Tokyo). 2013 Feb;66(2):73-8.	Simone M, Monciardini P, Gaspari E, Donadio S, Maffioli SI.	Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains.	
DRAMP03534	PWNIFKEIERAVARTRDAVISAGPAVRTVAAATSVAS	37	Antibacterial peptide enbocin (Moricin; Insects, animals)	P48821	Belongs to the cecropin family	Not found	Bombyx mori (Silk moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Homology	Not found	Not found		Function: Has antibacterial activity against Gram-positive and Gram-negative bacteria.	Gram-positive bacteria: Bacillus subtilis, Bacillus thuringiensis, Staphyllococcus aureus;##Gram-negative bacteria: Psedomonas solanacearum, Salmonellar typhimurium, Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9610369	Biochem Biophys Res Commun. 1998 May 19;246(2):388-392.	Kim SH, Park BS, Yun EY, Je YH, Woo SD, Kang SW, Kim KY, Kang SK.	Cloning and expression of a novel gene encoding a new antibacterial peptide from silkworm, Bombyx mori.	
DRAMP03535	DLRFLYPRGKLPVPTPPPFNPKPIYIDMGNRY	32	Lebocin-1/2 (Pro-rich; Insects, animals)	P54684	Belongs to the lebocin family	Not found	Bombyx mori (Silk moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Rich	Not found		"Function: Antibacterial peptide.
Tissue specificity: Hemolymph. Produced in fat body.
Induction: By bacterial infection.
PTM: O-glycosylation is important for the antibacterial activity of lebocin, O-linked glycan structure is a disaccharide (Gal-GalNAc) in case of lebocin 1 and a monosaccharide (GalNAc) in case of lebocin 2."	Gram-negative bacteria: Acinetobacter sp. NISL B-4653, Escherichia coli HB1ll, Pseudomonas fluorescens IAM1179;##Gram-positive bacterium: Staphylococcus aureus ATCC6538P.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7654207##7545395	Biochem J. 1995 Sep 1;310 (Pt 2):651-656.##Biochem Biophys Res Commun. 1995 Sep 5;214(1):271-278. 	Hara S, Yamakawa M.##Chowdhury S, Taniai K, Hara S, Kadono-Okuda K, Kato Y, Yamamoto M, Xu J, Choi SK, Debnath NC, Choi HK, et al.	A novel antibacterial peptide family isolated from the silkworm, Bombyx mori.##cDNA cloning and gene expression of lebocin, a novel member of antibacterial peptides from the silkworm, Bombyx mori.	
DRAMP03536	DLRFLYPRGKLPVPTLPPFNPKPIYIDMGNRY	32	Lebocin-3 (LEB 3; Insects, animals)	P55796	Belongs to the lebocin family	LEB3	Bombyx mori (Silk moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	A unique threonine residue in each peptide was O-glycosylated and the modification seemed to be important for expression of antibacterial activity. 		Function: Antibacterial peptide.	Gram-negative bacteria: Acinetobacter sp. NISL B-4653, Escherichia coli HB1ll, Pseudomonas fluorescens IAM1179;##Gram-positive bacterium: Staphylococcus aureus ATCC 6538P.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	7654207##9325165	Biochem J. 1995 Sep 1;310 (Pt 2):651-656.##Biochem Biophys Res Commun. 1997 Sep 29;238(3):769-774.	Hara S, Yamakawa M.##Furukawa S, Taniai K, Ishibashi J, Hara S, Shono T, Yamakawa M.	A novel antibacterial peptide family isolated from the silkworm, Bombyx mori.##A novel member of lebocin gene family from the silkworm, Bombyx mori.	
DRAMP03537	DLRFWNPREKLPLPTLPPFNPKPIYIDMGNRY	32	Lebocin-4 (Leb 4; Insects, animals)	O15946	Belongs to the lebocin family	LEB4	Bombyx mori (Silk moth) 	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Antibacterial peptide.
Tissue specificity: Hemolymph. Produced in fat body.
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9325165	Biochem. Biophys. Res. Commun. 1997; 238:769-774	Furukawa S, Taniai K, Ishibashi J, Hara S, Shono T, Yamakawa M.	A novel member of lebocin gene family from the silkworm, Bombyx mori.	
DRAMP03538	RWKIFKKIEKVGQNIRDGIVKAGPAVAVVGQAATI	35	Cecropin (Antibacterial peptide CM-IV; Insects, animals)	P14666	Belongs to the cecropin family	Not found	Bombyx mori (Silk moth)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3318666	Annu Rev Microbiol. 1987;41:103-126.	Boman HG, Hultmark D.	Cell-free immunity in insects.	
DRAMP03541	KSKEKIGKEFKRIVQRIKDFLRNLVPR	27	Human KS-27 (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17012259	FASEB J. 2006 Oct;20(12):2068-2080.	Yamasaki K, Schauber J, Coda A, Lin H, Dorschner RA, Schechter NM, Bonnart C, Descargues P, Hovnanian A, Gallo RL.	Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin.	
DRAMP03543	HSDAVFTDNYTRLRKQMAVKKYLNSILN	28	Vasoactive intestinal polypeptide (VIP; Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Not found	Not found	Not found	Not found	2RRH	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18603306	J Neuroimmunol. 2008 Aug 30;200(1-2):11-16.	El Karim IA, Linden GJ, Orr DF, Lundy FT.	Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites.	
DRAMP03544	ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF	37	Calcitonin gene-related peptide (CGRP; Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18603306	J Neuroimmunol. 2008 Aug 30;200(1-2):11-16.	El Karim IA, Linden GJ, Orr DF, Lundy FT.	Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites.	
DRAMP03545	RVIEVVQGACRAIRHIPRRIRQGLERIL	28	LLP Lentivirus lytic peptide (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9371339	Antimicrob Agents Chemother. 1997 Nov;41(11):2394-2398.	Tencza SB, Douglass JP, Creighton DJ Jr, Montelaro RC, Mietzner TA.	Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteins.	
DRAMP03546	KQEGRDHDKSKGHFHMIVIHHKGGQAHHG	29	SgII peptide A (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18714013	J Immunol. 2008 Sep 1;181(5):3413-3421.	Edström AM, Malm J, Frohm B, Martellini JA, Giwercman A, Mörgelin M, Cole AM, Sørensen OE.	The major bactericidal activity of human seminal plasma is zinc-dependent and derived from fragmentation of the semenogelins.	
DRAMP03547	HNKQEGRDHDKSKGHFHRVVIHHKGGKAH	29	SgI-29 (85-113) (SgI-derived peptide; Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18314226	Peptides. 2008 Apr;29(4):505-511.	Zhao H, Lee WH, Shen JH, Li H, Zhang Y.	Identification of novel semenogelin I-derived antimicrobial peptide from liquefied human seminal plasma.	
DRAMP03548	RIAGYGLRGLAVIIRICIRGLNLIFEIIR	29	ELP (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9371339	Antimicrob Agents Chemother. 1997 Nov;41(11):2394-2398.	Tencza SB, Douglass JP, Creighton DJ Jr, Montelaro RC, Mietzner TA.	Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteins.	
DRAMP03549	ALLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	38	ALL-38 (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Not found	Not found	Not found	Not found	2K6O	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12759353	J Biol Chem. 2003 Aug 1;278(31):28540-6.	Sørensen OE, Gram L, Johnsen AH, Andersson E, Bangsbøll S, Tjabringa GS, Hiemstra PS, Malm J, Egesten A, Borregaard N.	Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina.	
DRAMP03550	DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA	42	Beta-amyloid peptide 42 (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Not found	Not found	Not found	Not found	1IYT	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20209079	PLoS One. 2010 Mar 3;5(3):e9505.	Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD.	The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.	
DRAMP03551	YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY	52	Adrenomedullin (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Not found	Not found	Not found	Not found	2L7S	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10225288	FEMS Immunol Med Microbiol. 1999 Apr;23(4):289-293.	Allaker RP, Zihni C, Kapas S.	An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora.	
DRAMP03552	DIPEVVVSLAWDESLAPKHPGSRKNMDCYCRIPACIAGERRYGTCIYQGRLWAFCC	56	HP 3-56 (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15616305	Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.	Ericksen B, Wu Z, Lu W, Lehrer RI.	Antibacterial activity and specificity of the six human {alpha}-defensins.	
DRAMP03553	DIPEVVVSLAWDESLAPKHPGSRKNMACYCRIPACIAGERRYGTCIYQGRLWAFCC	56	HP 1-56 (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15616305	Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.	Ericksen B, Wu Z, Lu W, Lehrer RI.	Antibacterial activity and specificity of the six human {alpha}-defensins.	
DRAMP03554	ASNFDCCLGYTDRILHPKFIVGFTRQLANEGCDINAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKV	67	CCL20(1-67) (Human, mammals, animals)	P78556	Belongs to the intercrine beta (chemokine CC) family	CCL20	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge (2 disulfide bonds)	Not found		Function: Chemotactic factor that attracts lymphocytes and, slightly, neutrophils, but not monocytes. Inhibits proliferation of myeloid progenitors in colony formation assays. May be involved in formation and function of the mucosal lymphoid tissues by attracting lymphocytes and dendritic cells towards epithelial cells. C-terminal processed forms have been shown to be equally chemotactically active for leukocytes. Possesses antibacterial activity E. coli ATCC 25922 and S. aureus ATCC 29213.	Gram-negative bacterium: Escherichia coli ATCC 25922,##Gram-positive bacterium: Staphylococcus aureus ATCC 29213.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12149255	J Biol Chem. 2002 Oct 4;277(40):37647-54.	Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J.	The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins.	
DRAMP03555	SNFDCCLGYTDRILHPKFIVGFTRQLANEGCDINAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKVKNM	69	CCL20(2-70) (Human, mammals, animals)	P78556	Belongs to the intercrine beta (chemokine CC) family	CCL20	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge (2 disulfide bonds)	Not found		Function: Chemotactic factor that attracts lymphocytes and, slightly, neutrophils, but not monocytes. Inhibits proliferation of myeloid progenitors in colony formation assays. May be involved in formation and function of the mucosal lymphoid tissues by attracting lymphocytes and dendritic cells towards epithelial cells. C-terminal processed forms have been shown to be equally chemotactically active for leukocytes. Possesses antibacterial activity E. coli ATCC 25922 and S. aureus ATCC 29213.	Gram-negative bacterium: Escherichia coli ATCC 25922,##Gram-positive bacterium: Staphylococcus aureus ATCC 29213.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12149255	J Biol Chem. 2002 Oct 4;277(40):37647-54.	Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J.	The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins.	
DRAMP03556	ASNFDCCLGYTDRILHPKFIVGFTRQLANEGCDINAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKVKNM	70	C-C motif chemokine 20 (Human, mammals, animals)	P78556	Belongs to the intercrine beta (chemokine CC) family	CCL20	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: May be involved in formation and function of the mucosal lymphoid tissues by attracting lymphocytes and dendritic cells towards epithelial cells. C-terminal processed forms have been shown to be equally chemotactically active for leukocytes. Possesses antibacterial activity E. coli ATCC 25922 and S. aureus ATCC 29213.	Gram-negative bacterium: Escherichia coli ATCC 25922,##Gram-positive bacterium: Staphylococcus aureus ATCC 29213.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12149255	J Biol Chem. 2002 Oct 4;277(40):37647-54.	Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J.	The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins.	
DRAMP03557	GRDYRTCLTIVQKLKKMVDKPTQRSVSNAATRVCRTGRSRWRDVCRNFMRRYQSRVTQGLVAGETAQQICEDLRLCIPSTGPL	83	Granulysin (Lymphokine LAG-2; Human, mammals, animals)	P22749	Not found	GNLY	Homo sapiens (Human)	Antimicrobial, Antibacterial, Antifungal, Antiparasitic	Protein level	Alpha helix	Not found	1L9L resolved by X-ray.	"Function: Antimicrobial protein that kills intracellular pathogens. Active against a broad range of microbes, including Gram-positive and Gram-negative bacteria, fungi, and parasites. Kills Mycobacterium tuberculosis.
Tissue specificity: Expressed in natural killer and T-cells.
Induction: By T-cell growth factor and IL2/interleukin-2."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9756476##12488100	Science. 1998 Oct 2;282(5386):121-125.##J Mol Biol. 2003 Jan 10;325(2):355-365.	Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, Froelich CJ, Ganz T, Thoma-Uszynski S, Melián A, Bogdan C, Porcelli SA, Bloom BR, Krensky AM, Modlin RL.##Anderson DH, Sawaya MR, Cascio D, Ernst W, Modlin R, Krensky A, Eisenberg D.	An antimicrobial activity of cytolytic T cells mediated by granulysin.##Granulysin crystal structure and a structure-derived lytic mechanism.	
DRAMP03558	EAEEDGDLQCLCVKTTSQVRPRHITSLEVIKAGPHCPTAQLIATLKNGRKICLDLQAPLYKKIIKKLLES	70	human platelet factor 4 (hPF4; Human, mammals, animals)	No entry found	Belongs to the intercrine alpha (chemokine CxC) family	Not found	Homo sapiens (Human)	Antiparasitic	Not found	Not found	Not found		Function: human platelet factor 4 (hPF4) kills malaria parasites inside erythrocytes by selectively lysing the parasite digestive vacuole (DV). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23245326	Cell Host Microbe. 2012 Dec 13;12(6):815-823.	Love MS, Millholland MG, Mishra S, Kulkarni S, Freeman KB, Pan W, Kavash RW, Costanzo MJ, Jo H, Daly TM, Williams DR, Kowalska MA, Bergman LW, Poncz M, DeGrado WF, Sinnis P, Scott RW, Greenbaum DC.	Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.	
DRAMP03559	VPLSRTVRCTCISISNQPVNPRSLEKLEIIPASQFCPRVEIIATMKKKGEKRCLNPESKAIKNLLKAVSKERSKRSP	77	CXCL10 (Human, mammals, animals)	P02778, Q96QJ5	Belongs to the intercrine alpha (chemokine CxC) family	CXCL10	Homo sapiens (Human)	Antimicrobial, Antibacterial, Antiparasitic	Protein level	Combine helix and beta structure	Not found	1O80,1O7Z,1O7Y resolved by X-ray.##1LV9 resolved by NMR.	Function: Chemotactic for monocytes and T-lymphocytes.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Binds to CXCR3	12949249##12737818	J Leukoc Biol. 2003 Sep;74(3):448-455.##Structure. 2003 May;11(5):521-32.	Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ.##Swaminathan GJ, Holloway DE, Colvin RA, Campanella GK, Papageorgiou AC, Luster AD, Acharya KR.	Many chemokines including CCL20/MIP-3alpha display antimicrobial activity.##Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine.	
DRAMP03560	TELRCQCLQTLQGIHLKNIQSVKVKSPGPHCAQTEVIATLKNGQKACLNPASPMVKKIIEKMLKNGKSN	69	CXC chemokine GRObeta [5-73] (Human, mammals, animals)	P19875	Belongs to the intercrine alpha (chemokine CxC) family	CXCL2	Homo sapiens (Human)	Antimicrobial, Antibacterial, Antiparasitic, Chemotactic	Protein level	Combine helix and beta structure	GRObeta [5-73] forms a dimer in solution that is architectured by a six-stranded antiparallel beta-sheet (residues 25 to 29, 39 to 44, 49 to 52) and a pair of helices (residues 58 to 68) with 2-fold symmetry, while the C terminus of the protein is disordered.(Ref.2)	1QNK resolved by NMR.	"Function: Produced by activated monocytes and neutrophils and expressed at sites of inflammation. Hematoregulatory chemokine, which, in vitro, suppresses hematopoietic progenitor cell proliferation. GRO-beta(5-73) shows a highly enhanced hematopoietic activity.
PTM: The N-terminal processed form GRO-beta(5-73) is produced by proteolytic cleavage after secretion from bone marrow stromal cells.
Pharmaceutical use: GRO-beta(5-73) is available under the name Garnocestim as immunomodulator. It is used prior to hematopoietic transplantation for peripheral blood stem cell mobilization and reduction of incidence, duration, and/or severity of chemotherapy induced cytopenias."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12949249##10600366	J Leukoc Biol. 2003 Sep;74(3):448-455.##J Mol Biol. 1999 Dec 17;294(5):1065-1072.	Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ.##Qian YQ, Johanson KO, McDevitt P.	Many chemokines including CCL20/MIP-3alpha display antimicrobial activity.##Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8.	
DRAMP03561	GPVSAVLTELRCTCLRVTLRVNPKTIGKLQVFPAGPQCSKVEVVASLKNGKQVCLDPEAPFLKKVIQKILDSGNKKN	77	CXCL6 (C-X-C motif chemokine 6; Human, mammals, animals)	P80162	Belongs to the intercrine alpha (chemokine CxC) family	CXCL6	Homo sapiens (Human)	Antimicrobial, Antibacterial, Antiparasitic	Protein level	Not found	Not found		Function: Chemotactic for neutrophil granulocytes.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Heparin-binding	18443119	Antimicrob Agents Chemother. 2008 Jul;52(7):2599-2607.	Linge HM, Collin M, Nordenfelt P, Mörgelin M, Malmsten M, Egesten A.	The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial.	
DRAMP03564	ICIFCCGCCHRSKCGMCCKT	20	Human hepcidin-20 (Hepc20; one chain of Hepcidin; Human, mammals, animals)	P81172, Q1HE14, Q9BY68	Not found	HAMP	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Beta strand	Not found	1M4E resolved by NMR.	"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. Has strong antimicrobial activity against E.coli ML35P N.cinerea and weaker against S.epidermidis, S.aureus and group b streptococcus bacteria. Active against the fungus C.albicans. No activity against P.aeruginosa.
Tissue specificity: Highest expression in liver and to a lesser extent in heart and brain. Low levels in lung, tonsils, salivary gland, trachea, prostate gland, adrenal gland and thyroid gland. Secreted into the urine.
PTM: Contains four disulfide bonds 2-18; 5-17; 6-14; 8-9."	Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Staphylococcus aureus, S. epidermidis, group B Streptococcus.##Fungi: Candida albicans, Aspergillus fumigatus, Aspergillus niger.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11113131##12138110##11034317	J Biol Chem. 2001 Mar 16;276(11):7806-7810.##J Biol Chem. 2002 Oct 4;277(40):37597-37603.##FEBS Lett. 2000 Sep 1;480(2-3):147-150.	Park CH, Valore EV, Waring AJ, Ganz T.##Hunter HN, Fulton DB, Ganz T, Vogel HJ.##Krause A et al Adermann K.	Hepcidin, a urinary antimicrobial peptide synthesized in the liver.##The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis.##LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. ref2) Hepcidin, a rinary antimicrobial peptide synthesized in the liver.	
DRAMP03565	DTHFPICIFCCGCCHRSKCGMCCKT	25	Human hepcidin-25 (Hepc25; one chain of Hepcidin; Human, mammals, animals)	P81172, Q1HE14, Q9BY68	Not found	HAMP	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Beta strand	N-terminus is a metal-binding site. disulfide bonds are essential for antibacterial activity by probably binding to DNA.	1M4F, 2KEF resolved by NMR.##3H0T resolved by X-ray.	"PTM: Contains four disulfide bonds 7-22; 10-13; 11-19; 14-22.
Tissue specificity: Highest expression in liver and to a lesser extent in heart and brain. Low levels in lung, tonsils, salivary gland, trachea, prostate gland, adrenal gland and thyroid gland. Secreted into the urine.
Function: It showed antimicrobial activities in vitro, this peptide might be the long-sought hormone that regulates iron homeostasis in humans. A pathogen will survive if it can figure out a way to steal iron from the host."	Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Staphylococcus aureus, S. epidermidis, group B Streptococcus.##Fungi: Candida albicans, Aspergillus fumigatus, Aspergillus niger.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	DNA	11034317##11113131##12138110##19553669	FEBS Lett. 2000 Sep 1;480(2-3):147-150.##J Biol Chem. 2001 Mar 16;276(11):7806-7810.##J Biol Chem. 2002 Oct 4;277(40):37597-37603.##J Biol Chem. 2009 Sep 4;284(36):24155-24167.	Krause A et al Adermann K.##Park CH, Valore EV, Waring AJ, Ganz T.##Hunter HN, Fulton DB, Ganz T, Vogel HJ.##Jordan JB, Poppe L, Haniu M, Arvedson T, Syed R, Li V, Kohno H, Kim H, Schnier PD, Harvey TS, Miranda LP, Cheetham J, Sasu BJ.	LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. ref2) Hepcidin, a rinary antimicrobial peptide synthesized in the liver.##Hepcidin, a urinary antimicrobial peptide synthesized in the liver.##The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis.##Hepcidin revisited, disulfide connectivity, dynamics, and structure.	
DRAMP03566	MHDFWVLWVLLEYIYNSACSVLSATSSVSSRVLNRSLQVKVVKITN	46	Salvic (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J Hard Tissue Biol 2005; 14: 258-260.	Kim YS et al Chung SI.	Cloning and identification of a new antimicrobial peptide, salvic, from human salivary gland.	
DRAMP03572	FALLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	39	Antibacterial protein FALL-39 (one chain of hCAP-18; Human, mammals, animals)	P49913, Q71SN9	Belongs to the cathelicidin family	CAMP	Homo sapiens (Human)	Antimicrobial, Antibacterial	Protein level	Alpha helix 	Not found	2K6O	"Function: Has antibacterial activity.
Tissue specificity: Expressed in bone marrow and testis and neutrophils.
PTM: The N-terminus is blocked."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	7529412##8681941	Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):195-199.##Eur J Biochem. 1996 Jun 1;238(2):325-332.	Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH.##Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R.	FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.##The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes.	
DRAMP03576	DSHEKRHHGYRRKFHEKHHSHREFPFYGDYGSNYLYDN	38	Histatin-1 (His-rich; Human, mammals, animals)	P15515 	Not found	HTN1	Homo sapiens (Human)	Antimicrobial, Antifungal	Protein level	Rich	Not found		PTM: Phosphoserine at position 2; And Sulfotyrosine at position 27,30,34,36.	Yeast: Candida albicans (99.5±0.5 % inhibition at 54 nmol).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3286634	J Biol Chem. 1988 Jun 5;263(16):7472-7477	Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, Troxler RF.	Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans.	
DRAMP03577	RKFHEKHHSHREFPFYGDYGSNYLYDN	27	Histatin-2 (His-rich; Human, mammals, animals)	P15516, Q16243, Q502Z1	Not found	HTN3	Homo sapiens (Human)	Antimicrobial, Antifungal	Protein level	Rich	Not found		An autoproteolytic product from Histatin 1 but not phosphorylated (Lal et al. 1992 Arch Oral Bio 37: 7-13). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1528633	Oral Microbiol Immunol 1992; 7: 127-128.	Xu L, Lal K, Pollock JJ.	Histatins 2 and 4 are autoproteolytic degradation products of human parotid saliva.	
DRAMP03578	DSHAKRHHGYKRKFHEKHHSHRGYRSNYLYDN	32	Histatin-3 (His-rich; Human, mammals, animals)	P15516, Q16243, Q502Z1	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antibacterial, Antifungal	Protein level	Rich	Not found		Comment: No comments found on DRAMP database	Yeast: Candida albicans (98.5±0.5 % inhibition at 54 nmol)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3286634	J Biol Chem. 1988 Jun 5;263(16):7472-7477	Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, Troxler RF1988	Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans.	
DRAMP03579	RKFHEKHHSHRGYRSNYLYDN	21	Histatin-4 (His-rich; Human, mammals, animals)	P15516, Q16243, Q502Z1	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antifungal	Protein level	Rich	Not found		An autoproteolytic product from Histatin 3.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1528633	Oral Microbiol Immunol 1992; 7: 127-128.	Xu L, Lal K, Pollock JJ.	Histatins 2 and 4 are autoproteolytic degradation products of human parotid saliva.	
DRAMP03580	DSHAKRHHGYKRKFHEKHHSHRGY	24	His3-(20-43)-peptide (Histatin 5; derivatives: Dh-5; Clinical)	P15516, Q16243, Q502Z1	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antibacterial, Antifungal	Protein level	Alpha helix 	Not found		Histatin 5 is a proteolytic product of histatin 3. The active Domain: of histitin 5 (Dh-5) corresponding to residues 11-24 showed HIV inhibitory effects. However,the results with the Dh-5 mutants are mixed (Groot et al. 2006 J. Virol. 80: 9236-9243). The sequence of Dhvar4 is KRLFKKLLFSLRKY, a helical peptide which is active against bacteria and fungi. Dhvar5 has a sequence LLLFLLKKRKKRKY, which is active against bacteria and fungi (Ruissen AL et al 2002 Peptides 23:1391-9). P-113 is a 12-residue active peptide corresponding to residues 4-15 of histatin 5 (Rothstein DM et al. 2001 AAC 45: 1367). The His-His sequence is a good ligand for Cu2+ (Kulon K et al. 2008 J Inorg Biochem 102: 960-72). Derivatives were subjected to clinical trials.	Yeast: Candida albicans (100% inhibition at 54 nmol), Cryptococcus neoformans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding (Zinc)	3286634	J Biol Chem. 1988 Jun 5;263(16):7472-7477.	Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, Troxler RF.	Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans.	
DRAMP03581	DSHAKRHHGYKRKFHEKHHSHRGYR	25	Histatin 6 (His-rich; Human, mammals, animals)	P15516, Q16243, Q502Z1	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antifungal	Protein level	Rich	Not found		An autoproteolytic product from Histatin 3.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J Dent Res 1990; 69: 2-6.	Troxler RF et al Oppenheim FG.	Structural relation between human salivary histatins.	
DRAMP03582	RKFHEKHHSHRGY	13	Histatin 7 (His-rich; Human, mammals, animals)	P15516, Q16243, Q502Z1	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antifungal	Protein level	Rich	Not found		An autoproteolytic product from Histatin 3 (residues 12-24).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	J Dent Res 1990; 69: 2-6.	Troxler RF et al Oppenheim FG.	Structural relation between human salivary histatins.	
DRAMP03583	KFHEKHHSHRGY	12	Histatin 8 (His-rich; Human, mammals, animals)	P15516, Q16243, Q502Z1	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antibacterial, Antifungal	Protein level	Rich	Not found		It is the fragment of histatin 5.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12711380	Arch Oral Biol 2003 May;48(5):361-368.	Yin A, Margolis HC, Grogan J, Yao Y, Troxler RF, Oppenheim FG.	Physical parameters of hydroxyapatite adsorption and effect on candidacidal activity of histatins.	
DRAMP03584	RKFHEKHHSHRGYR	14	Histatin 9 (His-rich; Also detected are Histatin 10; Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antifungal	Not found	Rich	Not found		An autoproteolytic product from Histatin 3 (residues 12-25). Histatin 12=residues 5-10; histatin 11=residues 5-11; Histatin 10=residues 13-25. Antimicrobial activities of Histatins 10-12 are Comment: No comments found on DRAMP databasen. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Oral Microbiol Immunol 1992; 7: 127-128.	Xu L, Lal K, Pollock JJ.	Histatins 2 and 4 are autoproteolytic degradation products of human parotid saliva.	
DRAMP03585	AELRCMCIKTTSGIHPKNIQSLEVIGKGTHCNQVEVIATLKDGRKICLDPDAPRIKKIVQKKLAGDES	68	Human TC-1 (Chain of Platelet basic protein; Human, mammals, animals)	P02775, B2R5F3, Q6IBJ8	Not found	PPBP	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Combine helix and strand structure	Not found	1TVX resolved by X-ray.	PTM: Contains two disulfide bonds 5-31; 7-46.	Gram-positive bacteria: Bacillus subtilis (MBC=0.4 µM), Staphylococcus aureus (MBC=6.8 µM);##Gram-negative bacterium: Escherichia coli (MBC=3.4 µM).##Fungi: Cryptococcus neoformans (MFC=1.9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10877842##8034022	J Biol Chem. 2000 Jul 7;275(27):20374-20381.##FEBS Lett. 1994 Jun 27;347(2-3):300-303.	Krijgsveld J, Zaat SA, Meeldijk J, van Veelen PA, Fang G, Poolman B, Brandt E, Ehlert JE, Kuijpers AJ, Engbers GH, Feijen J, Dankert J.##Kungl AJ, Machius M, Huber R, Schwer C, Lam C, Aschauer H, Ehn G, Lindley IJ, Auer M.	Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines.##Purification, crystallization and preliminary X-ray diffraction analysis of recombinant human neutrophil-activating peptide 2 (rhNAP-2).	
DRAMP03586	NLAKGKEESLDSDLYAELRCMCIKTTSGIHPKNIQSLEVIGKGTHCNQVEVIATLKDGRKICLDPDAPRIKKIVQKKLAGDES	83	Human TC-2 (Chain of Platelet basic protein; Human, mammals, animals)	P02775, B2R5F3, Q6IBJ8	Not found	PPBP	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Combine helix and strand structure	Not found	1F9P resolved by X-ray.	PTM: Contains two disulfide bonds 19-46; 22-62.	Gram-positive bacteria: Bacillus subtilis ATCC6633 (MBC=0.7 µM), Staphylococcus aureus 42D (MBC=11 µM);##Gram-negative bacterium: Escherichia coli ML35 (MBC=2.7 µM).##Fungi: Cryptococcus neoformans (MFC=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10877842##8034022	J Biol Chem. 2000 Jul 7;275(27):20374-20381.##FEBS Lett. 1994 Jun 27;347(2-3):300-303.	Krijgsveld J, Zaat SA, Meeldijk J, van Veelen PA, Fang G, Poolman B, Brandt E, Ehlert JE, Kuijpers AJ, Engbers GH, Feijen J, Dankert J.##Kungl AJ, Machius M, Huber R, Schwer C, Lam C, Aschauer H, Ehn G, Lindley IJ, Auer M.	Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines.##Purification, crystallization and preliminary X-ray diffraction analysis of recombinant human neutrophil-activating peptide 2 (rhNAP-2).	
DRAMP03587	SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSV	47	DCD-1 (chain of Dermcidin; Human, mammals, animals)	P81605, A5JHP2, A5JHP3, P58461, Q53YJ2	Not found	DCD	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Proteolytic	Protein level	Alpha helix 	Structural analysis of dermcidin-1L in 50% TFE using an N15-labeled recombinant peptide reveals a long helix-hinge-helix motif, allowing it to associate with bacterial membranes (Jung et al. 2010 BMB Rep. 43: 362-8). 	2KSG resolved by NMR.##2YMK resolved by X-ray.	"Function: DCD-1 displays antimicrobial activity thereby limiting skin infection by potential pathogens in the first few hours after bacterial colonization. Highly effective against E.coli, E.faecalis, S.aureus and C.albicans. Optimal pH and salt concentration resemble the conditions in sweat. Also exhibits proteolytic activity. Survival-promoting peptide promotes survival of neurons and displays phosphatase activity.
Catalytic activity: Preferential cleavage: Arg-|-Xaa, Lys-|-Xaa.
Cofactor: Manganese. Required for survival-promoting peptide.
Tissue specificity: Specifically and constitutively expressed in eccrine sweat gland cells. Secreted into the sweat at a concentration of 1-10 micrograms/ml."	Gram-negative bacteria: Escherichia coli, Enterococcus faecalis;##Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	May bind IgG	11694882##17448443##20510021	Nat Immunol. 2001 Dec;2(12):1133-1137.##Biochem Biophys Res Commun. 2007 Jun 15;357(4):828-833.##BMB Rep. 2010 May;43(5):362-368.	Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, Schirle M, Schroeder K, Blin N, Meier F, Rassner G, Garbe C.##Lee Motoyama JP, Kim-Motoyama H, Kim P, Nakagama H, Miyagawa K, Suzuki K.##Jung HH, Yang ST, Sim JY, Lee S, Lee JY, Kim HH, Shin SY, Kim JI.	Dermcidin: a novel human antibiotic peptide secreted by sweat glands.##Identification of dermcidin in human gestational tissue and characterization of its proteolytic activity.##Analysis of the solution structure of the human antibiotic peptide dermcidin and its interaction with phospholipid vesicles.	
DRAMP03588	LAHQKPFIRKSYKCLHKRCR	20	Human MUC7 20-Mer (Human, mammals, animals)	No entry found	Not found	Not found	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix 	Not found		Function: MUC7 20-mer showes potent activity against a variety of fungi, including C. albicans, C. glabrata, C. krusei, C. neoformans, and S. cerevisae. In addition, it is also active against several drug-resistant strains, including azole-resistant C. albicans, fluconazole-resistant C. glabrata, and amphotericin B-resistant C. neoformans.	Gram-positive bacteria: Streptococcus mutans (EC50=1.39 µM), Streptococcus gordonii (EC50=2.43 µM);##Gram-negative bacteria: Escherichia coli (EC50=1.61 µM), Pseudomonas aeruginosa (EC50=4.41 µM), Porphyromonas gingivalis (EC50<1 µM).##Fungi: Candida albicans (DIS) (EC50=5.85 µM), C. albicans (azole resistant) (EC50=2.40 µM), Candida glabrata (EC50=5.02 µM), C. glabrata (fluconazole resistant) (EC50=12.3 µM), Candida krusei (EC50=5.16 µM), Cryptococcus neoformans (EC50=4.05 µM), Cryptococcus neoformans (amphotericin B resistant) (EC50=4.29 µM), Saccharomyces cerevisiae (EC50=5.23 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12543672	Antimicrob Agents Chemother 2003 Feb;47(2):643-652.	Bobek LA, Situ H.	MUC7 20-Mer: Investigation of Antimicrobial Activity, Secondary Structure, and Possible Mechanism of Antifungal Action.	
DRAMP03589	VKEGIEKAGVCPADNVRCFKSDPPQCHTDQDCLGERKCCYLHCGFKCVIPVKELEEGGNKDEDVSRPYPEPGWEAKCPGSSSTRCPQK	88	WAP four-disulfide core domain protein 12 (Putative protease inhibitor WAP12; Human, mammals, ani	Q8WWY7, Q5H980, Q9BR31	Not found	WFDC12	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11779191	Biochem Biophys Res Commun. 2002 Jan 11;290(1):452-456.	Lundwall A, Clauss A.	Identification of a novel protease inhibitor gene that is highly expressed in the prostate.	
DRAMP03590	VAIALKAAHYHTHKE	15	Calcitermin (Human, mammals, animals)	P80511, P83219, Q5SY66	Belongs to the S-101 family	S100A12	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Alpha helix 	Not found		"Function: S100A12 is a calcium-, zinc- and copper-binding protein which plays a prominent role in the regulation of inflammatory processes and immune response. Possesses antifungal activity against C. albicans and is also active against E. coli and P. aeruginosa but not L. monocytogenes and S. aureus.
Tissue specificity: Predominantly expressed by neutrophils, monocytes and activated macrophages. Expressed by eosinophils and macrophages in asthmatic airways in regions where mast cells accumulate. Found in high concentrations in the serum of patients suffering from various inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and Kawasaki disease.
Domain: The hinge Domain: contributes significantly to its chemotactic properties."	Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa.##Yeast: Candida albicans at pH 5.4.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11522286	FEBS Lett. 2001 Aug 24;504(1-2):5-10.	Cole AM, Kim YH, Tahk S, Hong T, Weis P, Waring AJ, Ganz T.	Calcitermin, a novel antimicrobial peptide isolated from human airway secretions.	
DRAMP03591	ACYCRIPACIAGERRYGTCIYQGRLWAFCC	30	Neutrophil defensin 1 (Defensin, alpha 1; HNP-1, HP-1; Human, mammals, animals)	P59665, P11479, Q14125, Q6EZF6	Belongs to the alpha-defensin family	DEFA1, DEFA1B	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral(SARS-CoV-2)	Protein level	Beta strand	Compared to HNP-2, HNP-1 contains one additional residue (Ala) at the N-terminus. It contains a long stretch of a double-stranded antiparallel beta-sheet in a hairpin conformation that contains a beta-bulge, a short region of triple-stranded beta-sheet, and several tight turns.	2KHT resolved by NMR	"Function: Defensin 1 and defensin 2 have antibacterial, fungicide and antiviral activities. Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane.
PTM: ADP-ribosylation drastically reduces cytotoxic and antibacterial activities, and enhances IL8 production. Phosphorylation at Tyr-85 has been found in some cancer cell lines, and interferes with ADP-rybosylation."	[Ref.34206990]Virus:SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(approximately 50% inbibition at 1 μg/mL (290 nM));SARS-CoV-2 variant P.1:inhibition of infection in HeLa-hACE2 cells(67% inbibition at 50 μg/mL);SARS-CoV-2 variant B.1.1.7:inhibition of infection in HeLa-hACE2 cells(58% inbibition at 50 μg/mL).##[Ref.15616305] Gram-negative bacteria: Escherichia coli ATCC 8739 (vLD50=3.6±0.3 μg/ml), E. coli ATCC 25922 (vLD50=3.7±0.4 μg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=10±0.5 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (vLD50=4.2±1.0 μg/ml), Staphylococcus aureus ATCC 29213 (vLD50=2.1±0.3 μg/ml), Bacillus cereus ATCC 10876 (vLD50=0.22±0.03 μg/ml).##NOTE: vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).##[Ref.15118082]Gram-positive bacteria: Bacillus subtilis (Inhibition zone=24 mm in PH5.5, Inhibition zone=20 mm in PH7.5 completely inhibit at 10 μg/well), Staphylococcus aureus  (Inhibition zone=1 mm in PH5.5, Inhibition zone=7 mm incompletely inhibit and Inhibition zone=2 mm completely inhibit in PH7.5 at 10 μg/well);##Gram-negative bacteria: Escherichia coli (Inhibition zone=5 mm incompletely inhibit and Inhibition zone=2 mm completely inhibit in PH7.5 at 10 μg/well);##Fungi: Candida albicans (Inhibition zone=13 mm in PH5.5, Inhibition zone=10 mm in PH7.5 completely inhibit at 10 μg/well).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization(Cys2 and Cys30).	Disulfide bonds between Cys2 and Cys30,Cys4 and Cys19,Cys9 and Cys29.	L	[Ref.34206990]No cytotoxicity on HEK293T cells up to 50 μg/mL.	Not found	34206990##19253295##15616305##15118082	Viruses. 2021 Jun 26;13(7):1246.##Proteomics. 2009 Mar;9(5):1364-1373.##Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.##Proc Natl Acad Sci U S A. 2004 May 11;101(19):7363-8.	Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL.##Stegemann C, Kolobov A Jr, Leonova YF, Knappe D, Shamova O, Ovchinnikova TV, Kokryakov VN, Hoffmann R.##Ericksen B, Wu Z, Lu W, Lehrer RI.##Yount NY, Yeaman MR.	Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.##Isolation, purification and de novo sequencing of TBD-1, the first beta-defensin from leukocytes of reptiles.##Antibacterial activity and specificity of the six human {alpha}-defensins.##Multidimensional signatures in antimicrobial peptides.	
DRAMP03592	CYCRIPACIAGERRYGTCIYQGRLWAFCC	29	Neutrophil defensin 2 (HNP-2, HP-2, HP2; Human, mammals, animals)	P59665, P11479, Q14125, Q6EZF6, P59666, P11479, Q14125	Belongs to the alpha-defensin family	DEFA1 AND DEFA1B	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral(SARS-CoV-2)	Protein level	Beta strand	Not found	1ZMH, 1ZMI, 1ZMK resolved by X-ray.	"Function: Defensin 2 have antibiotic, fungicide and antiviral activities. Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane.
PTM: Contains three disulfide bonds 1-29; 3-18; 8-28."	[Ref.34206990]Virus:SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(approximately 50% inbibition at 1 μg/mL (290 nM)).##Gram-negative bacteria: Escherichia coli ATCC 8739 (vLD50=3.5±0.79 µg/ml), E. coli ATCC 25922 (vLD50=3.5±0.6 µg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=16±4.0 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (vLD50=4.2±0.9 µg/ml), S. aureus ATCC 29213 (vLD50=2.4±0.3 µg/ml), Bacillus cereus ATCC 10876 (vLD50=0.22±0.04 µg/ml).(Ref.2)##NOTE: vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys1 and Cys29,Cys3 and Cys18,Cys8 and Cys28.	L	No cytotoxicity information found in the reference(s) presented	Not found	34206990##15616305##15894545	Viruses. 2021 Jun 26;13(7):1246.##Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.##J Biol Chem. 2005 Sep 23;280(38):32921-9.	Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL.##Ericksen B, Wu Z, Lu W, Lehrer RI.##Xie C, Prahl A, Ericksen B, Wu Z, Zeng P, Li X, Lu WY, Lubkowski J, Lu W.	Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.##Antibacterial activity and specificity of the six human {alpha}-defensins.##Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids.	
DRAMP03593	DCYCRIPACIAGERRYGTCIYQGRLWAFCC	30	Neutrophil defensin 3 (Defensin, alpha 3; HNP-3, HP-3, HP3; Human, mammals, animals)	P59666, P11479, Q14125	Belongs to the alpha-defensin family	DEFA3	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral(SARS-CoV-2)	Protein level	Beta strand	Compared to HNP-2, HNP-3 contains one additional residue (Asp) at the N-terminus. The 3D structures remain the same. 	1DFN, 2PM4, 2PM5 resolved by X-ray.	"Function: Defensin 3 have antibiotic, fungicide and antiviral activities. Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane.
PTM: Contains three disulfide bonds 2-30; 4-19; 9-29."	[Ref.34206990]Virus:SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(approximately 50% inbibition at 1 μg/mL (290 nM)).##Gram-negative bacteria: Escherichia coli ATCC 8739 (vLD50=6.2±0.9 µg/ml), E. coli ATCC 25922 (vLD50=5.9±2.1 µg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=41±9.2 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (vLD50=13±2.1 µg/ml), S. aureus ATCC 29213 (vLD50=2.2±0.4 µg/ml), Bacillus cereus ATCC 10876 (vLD50=0.37±0.08 µg/ml).(Ref.2)##NOTE: vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization(Cys2 and Cys30).	Disulfide bonds between Cys2 and Cys30,Cys4 and Cys19,Cys9 and Cys29.	L	No cytotoxicity information found in the reference(s) presented	Not found	34206990##4056036##15616305	Viruses. 2021 Jun 26;13(7):1246.##J Clin Invest. 1985 Oct;76(4):1436-1439.##Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.	Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL.##Selsted ME, Harwig SS, Ganz T, Schilling JW, Lehrer RI.##Ericksen B, Wu Z, Lu W, Lehrer RI.	Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.##Primary structures of three human neutrophil defensins.##Antibacterial activity and specificity of the six human {alpha}-defensins.	
DRAMP03594	VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRV	33	Neutrophil defensin 4 (Defensin, alpha 4; HNP-4, HP-4; Human, mammals, animals)	P12838	Belongs to the alpha-defensin family	DEFA4	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral(SARS-CoV-2)	Protein level	Beta strand	Compared to HNP-2, HNP-1 contains one additional residue (Ala) at the N-terminus. It contains a long stretch of a double-stranded antiparallel beta-sheet in a hairpin conformation that contains a beta-bulge, a short region of triple-stranded beta-sheet, and several tight turns.	1ZMM resolved by X-ray.	"Function: Has antimicrobial activity against Gram-negative bacteria, and to a lesser extent also against Gram-positive bacteria and fungi. Protects blood cells against infection with HIV-1 (in vitro). In comparison with HNP1-3, inhibition of both strains of HIV-1 by HNP4 was noticeably stronger as evidenced by lower IC50 values (2-5 µM) and steeper and more complete inhibition curves.
PTM: Contains three disulfide bonds 2-30; 4-19; 9-29."	[Ref.34206990]Virus:showed inhibition against SARS-CoV-2.Gram-negative bacteria: Escherichia coli ATCC 8739 (vLD50=3.3±0.4 µg/ml), E. coli ATCC 25922 (vLD50=3.0±0.7 µg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=6.6±0.2 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (vLD50=7.3±1.4 µg/ml), S. aureus ATCC 29213 (vLD50=7.2±0.2 µg/ml), Bacillus cereus ATCC 10876 (vLD50=0.87±0.08 µg/ml).(Ref.4)##NOTE: vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).##Yeast: Candida albicans ATCC 99788 amphotericin B resistant (IC90>100 µg/ml).(Ref.2)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys2 and Cys30,Cys4 and Cys19,Cys9 and Cys29.	L	No cytotoxicity information found in the reference(s) presented	Not found	34206990##17088326##15620707##15616305	Viruses. 2021 Jun 26;13(7):1246.##Protein Sci. 2006 Dec;15(12):2749-2760.##FEBS Lett. 2005 Jan 3;579(1):162-166.##Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.	Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL.##Szyk A, Wu Z, Tucker K, Yang D, Lu W, Lubkowski J.##Wu Z, Cocchi F, Gentles D, Ericksen B, Lubkowski J, Devico A, Lehrer RI, Lu W.##Ericksen B, Wu Z, Lu W, Lehrer RI.	Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.##Crystal structures of human alpha-defensins HNP4, HD5, and HD6.##Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.##Antibacterial activity and specificity of the six human {alpha}-defensins.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)CNC1=O
DRAMP03595	ATCYCRTGRCATRESLSGVCEISGRLYRLCCR	32	Human defensin-5 (HD-5; Defensin, alpha 5; Human, mammals, animals)	Q01523, A0JDY6, Q3KNV2	Belongs to the alpha-defensin family	DEFA5	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral(SARS-CoV-2)	Protein level	Beta strand	The L- and D-forms of HD-5 are equally active than E.coli but not S. aureus (Wei G et al 2009 JBC 284: 29180-92). 	1ZMP resolved by X-ray.	"Function: Antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane. All DEFA5 peptides exert antimicrobial activities, but their potency is affected by peptide processing.
Tissue specificity: Paneth cells of the small intestine (at protein level).
PTM: Contains three disulfide bonds."	[Ref.34206990]Virus:SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(60% inhibition at 12.5 μg/mL (3.45 μM));SARS-CoV-2 variant P.1:inhibition of infection in HeLa-hACE2 cells(72% inbibition at 50 μg/mL);SARS-CoV-2 variant B.1.1.7:inhibition of infection in HeLa-hACE2 cells(32% inbibition at 50 μg/mL).##Gram-negative bacteria: Escherichia coli ATCC 8739 (vLD50=2.5±0.3 µg/ml), E. coli ATCC 25922 (vLD50=2.1±0.9 µg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=5.5±0.5 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (vLD50=6.3±0.5 µg/ml), S. aureus ATCC 29213 (vLD50=3.2±0.3 µg/ml), Bacillus cereus ATCC 10876 (vLD50<0.31 µg/ml).(Ref.2)##NOTE: vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).	[Ref.26206286] It has 0% hemolysis at 100μM against human red blood cells.	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.	L	[Ref.34206990]No cytotoxicity on HEK293T cells up to 50 μg/mL.	Not found	34206990##12021776##15616305##26206286	Viruses. 2021 Jun 26;13(7):1246.##Nat Immunol. 2002 Jun;3(6):583-590.##Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.##Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.	Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL.##Ghosh D, Porter E, Shen B, Lee SK, Wilk D, Drazba J, Yadav SP, Crabb JW, Ganz T, Bevins CL.##Ericksen B, Wu Z, Lu W, Lehrer RI.##Basil Mathew Ramakrishnan Nagaraj	Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.##Paneth cell trypsin is the processing enzyme for human defensin-5.##Antibacterial activity and specificity of the six human {alpha}-defensins.##Antimicrobial activity of human  -defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC1=O
DRAMP03596	AFTCHCRRSCYSTEYSYGTCTVMGINHRFCCL	32	Human defensin-6 (HD-6; Defensin, alpha 6; Human, mammals, animals)	Q01524	Belongs to the alpha-defensin family	DEFA6	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral(SARS-CoV-2)	Protein level	Beta strand (3 strands; 19 residues)	Not found	1ZMQ, 3QTE resolved by X-ray.	"Function: Has very low antimicrobial activity against Gram-negative and Gram-positive bacteria. May protect cells against infection with HIV-1.
Subunit structure: Homodimer.
Tissue specificity: Paneth cells of the small intestine.
PTM: Contains three disulfide bonds."	[Ref.34206990]Virus:SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(HD6 only blocked SARS-CoV-2 infection at the highest concentration tested (50 μg/mL, 13 μM)).##Gram-negative bacteria: Escherichia coli ATCC 8739 (vLD50>256 µg/ml), E. coli ATCC 25922 (vLD50=103±14 µg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=156±11 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (vLD50>256 µg/ml), S. aureus ATCC 29213 (vLD50>256 µg/ml), Bacillus cereus ATCC 10876 (vLD50=25±13 µg/ml).(Ref.3)##NOTE: vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys4 and Cys31,Cys6 and Cys20,Cys10 and Cys30.	L	[Ref.34206990]No cytotoxicity on HEK293T cells up to 50 μg/mL.	Not found	34206990##8417977##17088326##15616305	Viruses. 2021 Jun 26;13(7):1246.##FEBS Lett. 1993; 315:187-192.##Protein Sci. 2006 Dec;15(12):2749-2760.##Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.	Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL.##Jones DE, Bevins CL.##Szyk A, Wu Z, Tucker K, Yang D, Lu W, Lubkowski J.##Ericksen B, Wu Z, Lu W, Lehrer RI.	Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.##Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel.##Crystal structures of human alpha-defensins HNP4, HD5, and HD6.##Antibacterial activity and specificity of the six human {alpha}-defensins.	CC[C@@H](C)[C@@H]1NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](C)N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(N)=O)NC1=O
DRAMP03601	WYVKKCLNDVGICKKKCKPEEMHVKNGWAMCGKGRDCCVPAD	42	Human beta-defensin 26 (hBD-26; hBD26; Human, mammals, animals)	No entry found	Belongs to the beta-defensin family	Not found	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Bridge 	Not found		Function: Both hBD26 and hBD27 showe salt-sensitive antimicrobial activity against gram-negative E. coli but not against gram-positive S. aureus and S. cerevisiae.	Gram-negative bacterium: Escherichia coli K12.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19373462	Appl Microbiol Biotechnol. 2009 Aug;84(2):301-308.	Huang L, Leong SS, Jiang R.	Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27.	
DRAMP03602	QLKKCWNNYVQGHCRKICRVNEVPEALCENGRYCCLNIKELEAC	44	Human beta-defensin 27 (hBD-27; hBD27; Human, mammals, animals)	No entry found	Belongs to the beta-defensin family	Not found	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Bridge 	Not found		Function: Both hBD26 and hBD27 showe salt-sensitive antimicrobial activity against gram-negative E. coli but not against gram-positive S. aureus and S. cerevisiae.	Gram-negative bacterium: Escherichia coli K12.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19373462	Appl Microbiol Biotechnol. 2009 Aug;84(2):301-308.	Huang L, Leong SS, Jiang R.	Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27.	
DRAMP18202	LIGSLFRGAKAIFRGARQGWRSHKAVSRYRARYVRRPVIYYHRVYP	46	WB Piscidin 5 (fish, animals)	E3UVF7(Precursor)	Belongs to the defensin family	Not found	Morone chrysops	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antiparasitic		Not found	Not found		No more comments	Staphylococcus aureus ATCC 29213(MIC 4.52uM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	27552222	PLoS One. 11(8):e0159423(2016)	Salger SA, Cassady KR, Reading BJ, Noga EJ	A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes.	
DRAMP18203	SYVGDCGSNGGSCVSSYCPYGNRLNYFCPLGRTCCRRSY	39	Panusin (beta defensins; crustaceans, arthropods, invertebrates, animals)	A0A0S2XGP2(Precursor)	Belongs to the beta-defensin family	Not found	the Caribbean spiny lobster, Panulirus genus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal		Not found	Not found		Function: Active against E. coli, K. pneumonia, S. aureus, B. subtilisspizizenii, and C. albicans.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	27616720	Dev Comp Immunol. pii: S0145-305X(16)30274-9(2016)	Montero-Alejo V, Corzo G, Porro-Suard	Panusin represents a new family of beta-defensin-like peptides in invertebrates.	
DRAMP18200	FFGRLKSMWRGARGGLKAYKYQKDMAKMNKRYGPNWQQGGGQEPPADAQANDQPP	55	SB Piscidin 6 (fish, animals)	No entry found	Belongs to the defensin family	Not found	Morone saxatilis	Antimicrobial, Antibacterial, Anti-Gram+, Antiparasitic		Not found	Not found		No more comments	Staphylococcus aureus ATCC 29213(MIC >32.11uM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	27552222	PLoS One. 11(8):e0159423(2016)	Salger SA, Cassady KR, Reading BJ, Noga EJ	A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes.	
DRAMP18201	LFGSVKAWFKGAKKGFQDYRYQKDMAKMNKRYGPNWQQRGGQEPPADAQANDQPP	55	WB Piscidin 6 (fish, animals)	No entry found	Belongs to the defensin family	Not found	Morone chrysops	Antimicrobial, Antibacterial, Anti-Gram+, Antiparasitic		Not found	Not found		No more comments	Staphylococcus aureus ATCC 29213(MIC >31.59uM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	27552222	PLoS One. 11(8):e0159423(2016)	Salger SA, Cassady KR, Reading BJ, Noga EJ	A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes.	
DRAMP03606	AIHRALISKRMEGHCEAECLTFEVKIGGCRAELAPFCCKNRKKH	44	Beta-defensin 107 (Defensin, beta 107; Beta-defensin 7, BD-7; Human, mammals, animals)	Q8IZN7, B2RPM1, Q30E75, Q8NET2	Belongs to the beta-defensin family	DEFB107A AND DEFB107	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity.
Tissue specificity: Specifically expressed in testis.
PTM: Problely contains two disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16421571##12734011##11854508	Nature. 2006 Jan 19;439(7074):331-335.##Genome Biol. 2003;4(5):R31.##Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2129-2133.	Nusbaum C, Mikkelsen TS, Zody MC, et al, Lander ES.##Semple CA, Rolfe M, Dorin JR.##Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray PB Jr.	DNA sequence and analysis of human chromosome 8.##Duplication and selection in the evolution of primate beta-defensin genes.##Discovery of five conserved beta-defensin gene clusters using a computational search strategy.	
DRAMP03607	KFKEICERPNGSCRDFCLETEIHVGRCLNSRPCCLPLGHQPRIESTTPKKD	51	Putative beta-defensin 108A (Defensin, beta 108A; Human, mammals, animals)	A8MXU0	Belongs to the beta-defensin family	DEFB108P1 AND DEFB10	Homo sapiens (Human)	Antimicrobial, Antibacterial	Not found	Bridge 	Not found		"Function: Has antibacterial activity.
PTM: Problely contains three disulfide bonds 6-33; 13-27; 17-34."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16421571##12734011	Nature. 2006 Jan 19;439(7074):331-335.##Genome Biol. 2003;4(5):R31.	Nusbaum C, Mikkelsen TS, Zody MC, et al, Lander ES.##Semple CA, Rolfe M, Dorin JR.	DNA sequence and analysis of human chromosome 8.##Duplication and selection in the evolution of primate beta-defensin genes.	
DRAMP03608	KFKEICERPNGSCRDFCLETEIHVGRCLNSQPCCLPLGHQPRIESTTPKKD	51	Beta-defensin 108B (Beta-defensin 8; hBD-8; Defensin, beta 108B; Human, mammals, animals)	Q8NET1	Belongs to the beta-defensin family	DEFB108B	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11854508	Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2129-2133.	Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray PB Jr.	Discovery of five conserved beta-defensin gene clusters using a computational search strategy.	
DRAMP03610	GLGPAEGHCLNLFGVCRTDVCNIVEDQIGACRRRMKCCRAWWILMPIPTPLIMSDYQEPLKPNLK	65	Beta-defensin 109 (Defensin, beta 109; Defensin, beta 109; Human, mammals, animals)	Q30KR1	Belongs to the beta-defensin family	DEFB109P1 AND DEFB10	Homo sapiens (Human)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Has antibacterial activity.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03611	KKKYPEYGSLDLRRECRIGNGQCKNQCHENEIRIAYCIRPGTHCCLQQ	48	Beta-defensin 110 (Beta-defensin 10, DEFB-10; Defensin, beta 110; Human, mammals, animals)	Q30KQ9, Q30KR0	Belongs to the beta-defensin family	DEFB110	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Antiparasitic	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03612	GPSVPQKKTREVAERKRECQLVRGACKPECNSWEYVYYYCNVNPCCAVWEYQKPIINKITSKLHQK	66	Beta-defensin 113 (Beta-defensin 13, DEFB-13; Defensin, beta 113; Human, mammals, animals)	Q30KQ7	Belongs to the beta-defensin family	DEFB113	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03613	DRCTKRYGRCKRDCLESEKQIDICSLPRKICCTEKLYEEDDMF	43	Beta-defensin 114 (Beta-defensin 14, DEFB-14; Defensin, beta 114; Human, mammals, animals)	Q30KQ6, Q8NES9	Belongs to the beta-defensin family	DEFB114	Homo sapiens (Human)	Antimicrobial, Antibacterial	Protein level	Bridge 	Not found		"Function: Has antibacterial activity.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##11854508	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2129-33.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.##Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray PB Jr.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Discovery of five conserved beta-defensin gene clusters using a computational search strategy.	
DRAMP03614	QTAPDGWIRRCYYGTGRCRKSCKEIERKKEKCGEKHICCVPKEKDKLSHIHDQKETSELYI	61	Beta-defensin 115 (Beta-defensin 15, DEFB-15; Defensin, beta 115; Human, mammals, animals)	Q30KQ5	Belongs to the beta-defensin family	DEFB115	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##11780052	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Nature. 2001 Dec 20-27;414(6866):865-871.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.##Deloukas P, Matthews LH, Ashurst J, Burton J, et al, Rogers J.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##The DNA sequence and comparative analysis of human chromosome 20.	
DRAMP18199	CEWYNISCQLGNKGQWCTLTKECQRSCK	28	Formicin (Bacteriocin;lantibiotic;Gram-positive bacteria, prokaryotes; U	No entry found	Belongs to the lantibiotic family (Class I bacteriocin)	Not found	Bacillus paralicheniformis APC 1576	Antimicrobial, Antibacterial, Anti-Gram+		Not found	Not found		Function: Active against a broad spectrum of Gram+ bacteria (e.g., L. s delbrueckii subsp. bulgaricus; L. amylophilus; L. lactis; M. luteus; S. smutans), including clinical strains S. aureus, C. difficile, and L. monocytogenes.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27450592	Microbiology. 162(9):1662-1671(2016)	Collins FW, O'Connor PM, O'Sullivan O, Rea MC, Hill C, Ross RP	Formicin - a novel broad-spectrum two-component lantibiotic produced by Bacillus paralicheniformis APC 1576.	
DRAMP03616	AYSGEKKCWNRSGHCRKQCKDGEAVKDTCKNLRACCIPSNEDH	43	Beta-defensin 118 (Beta-defensin 18, DEFB-18; Defensin, beta 118; Human, mammals, animals)	Q96PH6, Q17RC4, Q8N691, Q9NUH0	Belongs to the beta-defensin family	DEFB118	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity.
Tissue specificity: High-level and epididymis-specific expression. Most abundant in the epithelium of the caput and is also present in the lumen and bound to sperm. Expressed also in pancreas.
PTM: Contains three disulfide bonds 8-35; 15-29; 19-36."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11564719##12600824	Endocrinology. 2001 Oct;142(10):4529-4539.##Am J Respir Cell Mol Biol. 2003 Jul;29(1):71-80.	Liu Q, Hamil KG, Sivashanmugam P, Grossman G, Soundararajan R, Rao AJ, Richardson RT, Zhang YL, O'Rand MG, Petrusz P, French FS, Hall SH.##Kao CY, Chen Y, Zhao YH, Wu R.	Primate epididymis-specific proteins: characterization of ESC42, a novel protein containing a trefoil-like motif in monkey and human.##ORFeome-based search of airway epithelial cell-specific novel human [beta]-defensin genes.	
DRAMP03617	KRHILRCMGNSGICRASCKKNEQPYLYCRNCQSCCLQSYMRISISGKEENTDWSYEKQWPRLP	63	Beta-defensin 119 (Beta-defensin 19, DEFB-19; Defensin, beta 119; Human, mammals, animals)	Q8N690, Q5GRG1, Q5JWP1, Q5TH42, Q8N689	Belongs to the beta-defensin family	DEFB119	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11854508	Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2129-2133.	Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray PB Jr.	Discovery of five conserved beta-defensin gene clusters using a computational search strategy.	
DRAMP03618	QVTPVMKCWGKSGRCRTTCKESEVYYILCKTEAKCCVDPKYVPVKPKLTDTNTSLESTSAV	61	Beta-defensin 121 (Beta-defensin 21, DEFB-21; Defensin, beta 121; Human, mammals, animals)	Q5J5C9, A1L4N1	Belongs to the beta-defensin family	DEFB121	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11780052##15489334	Nature. 2001 Dec 20-27;414(6866):865-871.##Genome Res. 2004 Oct;14(10B):2121-2127. 	Deloukas P, Matthews LH, Ashurst J, Burton J, et al, Rogers J.##Gerhard DS, Wagner L, Feingold EA, Shenmen CM, et al, Malek J.	The DNA sequence and comparative analysis of human chromosome 20.##The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).	
DRAMP18120	PPTQNPSMAPPTQNPYGQPMTPPTQNPYGQPMAPP	35	BnPRP1 (Plant defensin)	No entry found		BnPRP1	Brassica napus	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-		Not found	Not found		BnPRP1 has 40.5% identity with a known proline-rich antimicrobial peptide SP-B from the pig. BnPRP1 isolated from B. napus was the first PR-AMP member that was characterized in plants, and its homology sequences were found in some other Brassicaceae plants by the genome sequences analysis. 	Gram-positive: M. luteus (MIC= 16.9 ± 2.7 uM );##Gram-negative: E. coli (MIC= 8.4 ± 1.4 uM);## Fungi:Sclerotinia sclerotiorum, Mucor sp., Magnaporthe oryzae and Botrytis cinerea	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26383098	PLoS One. 2015 Sep 18;10(9):e0137414.	Cao H, Ke T, Liu R, et al.	Identification of a Novel Proline-Rich Antimicrobial Peptide from Brassica napus.	
DRAMP18198	GFGSKPLDSFGLNFF	15	Chaxapeptin	A0A0F7VRL1	Not found	ls3A sle2_130	Streptomyces leeuwenhoekii Strain C58	Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer		Not found	Not found	2N5C resolved by NMR	Function: Active against Gram-positive strains, S. aureus and B. subtilis (MIC 30-35 ug/mL), and no activity against the Gram-negative bacteria. It also showed dose dependent inhibition of A549 cancer cells.	S. aureus and B. subtilis (MIC 30-35 ug/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26402731	J Org Chem.80(20):10252-60(2015)	Elsayed SS, Trusch F, Deng H, Raab A, Prokes I, Busarakam K, Asenjo JA, Andrews BA, van West P, Bull AT, Goodfellow M, Yi Y, Ebel R, Jaspars M, Rateb ME.	Chaxapeptin, a Lasso Peptide from Extremotolerant Streptomyces leeuwenhoekii Strain C58 from the Hyperarid Atacama Desert.	
DRAMP03620	EFKRCWKGQGACQTYCTRQETYMHLCPDASLCCLSYALKPPPVPKHEYE	49	Beta-defensin 124 (Beta-defensin 24, DEFB-24; Defensin, beta 124; Human, mammals, animals)	Q8NES8, Q30E74	Belongs to the beta-defensin family	DEFB124	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##11854508##11780052	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2129-2133.##Nature. 2001 Dec 20-27;414(6866):865-871. 	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.##Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray PB Jr.##Deloukas P, Matthews LH, Ashurst J, Burton J, et al, Rogers J. 	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Discovery of five conserved beta-defensin gene clusters using a computational search strategy.##The DNA sequence and comparative analysis of human chromosome 20. 	
DRAMP03621	SFEPQKCWKNNVGHCRRRCLDTERYILLCRNKLSCCISIISHEYTRR	47	Beta-defensin 125 (Beta-defensin 25, DEFB-25; Defensin, beta 125; Human, mammals, animals)	Q8N687, A1A502, Q7Z7B9	Belongs to the beta-defensin family	DEFB125	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11854508##11780052##12975309	Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2129-2133.##Nature. 2001 Dec 20-27;414(6866):865-871.##Genome Res. 2003 Oct;13(10):2265-2270.	Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray PB Jr.##Deloukas P, Matthews LH, Ashurst J, Burton J, et al, Rogers J.##Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, et al, Gray A.	Discovery of five conserved beta-defensin gene clusters using a computational search strategy.##The DNA sequence and comparative analysis of human chromosome 20.##The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	
DRAMP03624	ARLKKCFNKVTGYCRKKCKVGERYEIGCLSGKLCCANDEEEKKHVSFKKPHQHSGEKLSVLQDYIILPTITIFTV	75	Beta-defensin 128 (Beta-defensin 28, DEFB-28; Defensin, beta 128; Human, mammals, animals)	Q7Z7B8, B2RU29	Belongs to the beta-defensin family	DEFB128	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11780052##15489334	Nature. 2001 Dec 20-27;414(6866):865-871.##Genome Res. 2004 Oct;14(10B):2121-2127. 	Deloukas P, Matthews LH, Ashurst J, Burton J, et al, Rogers J.##Gerhard DS, Wagner L, Feingold EA, Shenmen CM, et al, Malek J.	The DNA sequence and comparative analysis of human chromosome 20.##The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).	
DRAMP03626	FISNDECPSEYYHCRLKCNADEHAIRYCADFSICCKLKIIEIDGQKKW	48	Beta-defensin 131 (Beta-defensin 31, DEFB-31; Defensin, beta 131; Human, mammals, animals)	P59861	Belongs to the beta-defensin family	DEFB131	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
Tissue specificity: Highly expressed in testis. Is moderately expressed in the prostate and small intestine.
PTM: Contains three disulfide bonds 7-34; 14-28; 18-35 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12600824##15815621	Am J Respir Cell Mol Biol. 2003 Jul;29(1):71-80.##Nature. 2005 Apr 7;434(7034):724-731.	Kao CY, Chen Y, Zhao YH, Wu R.##Kremitzki C, Oddy L, Du H, et al, Wilson R.K.	ORFeome-based search of airway epithelial cell-specific novel human [beta]-defensin genes.##Generation and annotation of the DNA sequences of human chromosomes 2 and 4.	
DRAMP03627	GGSKCVSNTPGYCRTCCHWGETALFMCNASRKCCISYSFLPKPDLPQLIGNHWQSRRRNTQRKDKKQQTTVTS	73	Beta-defensin 132 (Defensin, beta 132; Beta-defensin 32, BD-32; Human, mammals, animals)	Q7Z7B7, B2RP72, Q4QY40	Belongs to the beta-defensin family	DEFB132	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12620395	Genomics. 2003 Feb;81(2):175-183.	Rodriguez-Jimenez FJ, Krause A, Schulz S, Forssmann WG, Conejo-Garcia JR, Schreeb R, Motzkus D.	Distribution of new human beta-defensin genes clustered on chromosome 20 in functionally different segments of epididymis.	
DRAMP03628	AVKDTYSCFIMRGKCRHECHDFEKPIGFCTKLNANCYM	38	Beta-defensin 133 (Defensin, beta 133; Human, mammals, animals)	Q30KQ1, Q4QY39	Belongs to the beta-defensin family	DEFB133	Homo sapiens (Human)	Antimicrobial, Antibacterial	Transcript level	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains two disulfide bonds 8-36; 15-29."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03629	GINSLSSEMHKKCYKNGICRLECYESEMLVAYCMFQLECCVKGNPAP	47	Beta-defensin 134 (Defensin, beta 134; Human, mammals, animals)	Q4QY38, A1L4A4	Belongs to the beta-defensin family	DEFB134	Homo sapiens (Human)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##15489334	Physiol Genomics. 2005 Sep 21;23(1):5-17.##Genome Res. 2004 Oct;14(10B):2121-7.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.##Gerhard DS, Wagner L, Feingold EA, Shenmen CM, et al, Malek J.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).	
DRAMP03630	GPNVYIQKIFASCWRLQGTCRPKCLKNEQYRILCDTIHLCCVNPKYLPILTGK	53	Beta-defensin 135 (Defensin, beta 135; Human, mammals, animals)	Q30KP9, Q4QY37	Belongs to the beta-defensin family	DEFB135	Homo sapiens (Human)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP03631	MFGNDGVKVRTCTSQKAVCFFGCPPGYRWIAFCHNILSCCKNMTRFQPPQAKDPWVH	57	Beta-defensin 136 (Defensin, beta 136; Human, mammals, animals)	Q30KP8, Q4QY36	Belongs to the beta-defensin family	DEFB136	Homo sapiens (Human)	Antimicrobial, Antibacterial	Homology	Bridge 	Not found		"Function: Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865	Physiol Genomics. 2005 Sep 21;23(1):5-17.	Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.	Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.	
DRAMP18140	VARGWKRKCPLFGKGG	16	VG16KRKP	No entry found			Synthetic construct	Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-	Synthetic		The solution-NMR structure of VG16KRKP in lipopolysaccharide features a folded conformation with a centrally located turn-type structure stabilized by aromatic-aromatic packing interactions with extended N- and C-termini.	2MXG,2MXH resolved by NMR	VG16KRKP is capable of inhibiting bacterial disease progression in plants.	Gram-negative: E. coli (MIC=8 uM), X. campestris  (MIC=10 uM), X. oryzae  (MIC=15 uM);##Gram-positive: B. subtilis (MIC=50 uM);##Fungi: Candida albicans  (MIC=2 uM), Cryptococcus grubii  (MIC=5 uM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	cell membrane	26144972	Sci Rep. 2015 Jul 6;5:11951.	Datta A, Ghosh A, Airoldi C, etal.	Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control	
DRAMP18195	MKTILRFVAGYDIASHKKKTGGYPWERGKA	30	LsbB (Bacteriocin)	Q7X2B5	Not found	lsbB	Lactococcus lactis subsp. lactis (Streptococcus lactis)	Antimicrobial, Antibacterial		alpha helical	Structure determination by NMR spectroscopy showed that LsbB has an N-terminal alpha helix, whereas the C-terminal of the molecule remains unstructured.	2MLU, 2MLV resolved by NMR	The results indicate that the outmost eight-amino acid sequence at the C-terminal end is likely to contain the receptor binding domain. Alanine substitution revealed that the tryptophan in position 25 (Trp25) is crucial for the blocking activity of the truncated peptides, as well as for the antimicrobial activity of the full-length bacteriocin.Â 	targeting primarily lactococcal cells	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12801935##24993828	J. Biol. Chem. 278:34291-34298(2003).##J. Biol. Chem. 289:23838-23845(2014)	Gajic O., Buist G., Kojic M., Topisirovic L., Kuipers O.P., Kok J.##Ovchinnikov K.V., Kristiansen P.E., Uzelac G., Topisirovic L.,Kojic M., Nissen-Meyer J., Nes I.F., Diep D.B.	Novel mechanism of bacteriocin secretion and immunity carried out bylactococcal multidrug resistance proteins.##Defining the structure and receptor binding domain of the leaderlessbacteriocin LsbB.	
DRAMP03633	MLTELEKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETECPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMGVAAHKKSHEESHKE	93	Protein S100-A8 (Calgranulin-A; MRP-8; Human, mammals, animals)	P05109, A8K5L3, D3DV37, Q5SY70, Q9UC84, Q9UC92, Q9UCJ0, Q9UCM6	Belongs to the S-100 family	S100A8	Homo sapiens (Human)	Antimicrobial, Antibacterial, Antifungal	Protein level	Combine helix and strand structure	The dimeric form of MRP8 is stabilized by hydrophobic interactions between mutually wrapped helices. There are two EF-hand motifs per monomer and each EF-hand bound one Ca(2+) with a different affinity [the affinity of the C-terminal EF-hand (EF-2) for Ca(2+) is stronger than that of the N-terminal EF-hand (EF-1)]. 	1MR8 resolved by X-ray.	"Function: Has antimicrobial activity towards bacteria and fungi and exerts its antimicrobial activity probably via chelation of Zn2+ which is essential for microbial growth. Can induce cell death via autophagy and apoptosis and this occurs through the cross-talk of mitochondria and lysosomes via reactive oxygen species (ROS) and the process involves BNIP3. Can regulate neutrophil number and apoptosis by an anti-apoptotic effect.
Tissue specificity: Calprotectin (S100A8/9) is predominantly expressed in myeloid cells.
Miscellaneous: Binds two calcium ions per molecule with an affinity similar to that of the S100 proteins (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Metal-binding	3313057##10771424	Nature. 1987 Nov 5-11;330(6143):80-82.##Acta Crystallogr D Biol Crystallogr. 2000 May;56(Pt 5):559-566.	Odink K, Cerletti N, Brüggen J, Clerc RG, Tarcsay L, Zwadlo G, Gerhards G, Schlegel R, Sorg C.##Ishikawa K, Nakagawa A, Tanaka I, Suzuki M, Nishihira J.	Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis.##The structure of human MRP8, a member of the S100 calcium-binding protein family, by MAD phasing at 1.9 A resolution.	
DRAMP18194	GGLKKLGKKLEGAGKRVFKASEKALPVVVGIKAIGK	36	AAEL000598-PA	Q17NR1	Not found	CECD	Aedes aegypti (Yellowfever mosquito) (Culex aegypti)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		alpha helical (N-terminal)	The structure of Aedesin is depicted as a helix-bent-helix structure with good RMSD statistics for the N-terminal helix (helix 1) and for the C-terminal helix (helix 2) taken separately.The helical wheel diagram of Aedesin shows the amphipathic character of the first and second aloha helices, as well as the opposite localization of their hydrophobic and positively charged residues, respectively.	2MMM resolved by NMR.	The anti-bacterial activity of Aedesin was found to be salt-resistant, indicating that it is active under physiological conditions encountered in body fluids characterized by ionic salt concentrations.	Gram-negative (including drug-resistent): E. coli (MIC 2-4 ug/mL), P. aeruginosa (MIC 1-4 ug/mL), A. baumannii (MIC 1-2 ug/mL), K. pneunomiae (MIC 1-2 ug/mL).##No antibacterial effects of the peptide were observed against different isolates of Gram-positive S. aureus, E. faecalis and E. faecium strains showing MIC values over 32. (Pubmed:25162372)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17510324##25162372	Science 316:1718-1723(2007).##PLoS ONE 9:e105441-e105441(2014).	Nene V., Wortman J.R., Lawson D., et al.##Godreuil S., Leban N., Padilla A., et al.	Genome sequence of Aedes aegypti, a major arbovirus vector.##Aedesin: structure and antimicrobial activity against multidrugresistant bacterial strains.	
DRAMP03635	GRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCIQA	48	Human lactoferricin (LfcinH; one chain of Lactotransferrin; Human, mammals, animals)	P02788, B7Z4X2, E7EQH5, O00756, Q16780, Q16785, Q16786, Q16789, Q8IU92	Belongs to the transferrin family	LTF	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Alpha helix	LfcinH shows a helical content from Gln14 to Lys29 in the membrane mimetic solvent but a nonexistent beta-sheet character in either the N- or C-terminal regions of the peptide. The LfcinH structure determined in aqueous solution displays a nascent helix in the form of a coiled conformation in the region from Gln14 to Lys29.	1Z6V, 1Z6W resolved by NMR.	"Function: Lactoferricin binds to the bacterial surface and is crucial for the bactericidal functions. Has some antiviral activity against papillomavirus infection. N-terminal region shows strong antifungal activity against C.albicans. Contains two BBXB heparin-binding consensus sequences that appear to form the predominate functional GAG-binding site.
Tissue specificity: High levels are found in saliva and tears, intermediate levels in serum and plasma, and low levels in urine."	Gram-negative bacterium: Escherichia coli serotype O111.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15155221##16048952	Antimicrob Agents Chemother. 2004 Jun;48(6):2190-2198.##Antimicrob Agents Chemother. 2005 Aug;49(8):3387-3395.	Chapple DS, Hussain R, Joannou CL, Hancock RE, Odell E, Evans RW, Siligardi G.##Hunter HN, Demcoe AR, Jenssen H, Gutteberg TJ, Vogel HJ.	Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide.##Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent.	
DRAMP03636	FFSASCVPGADKGQFPNLCRLCAGTGENKCA	31	Kaliocin-1 (one chain of Lactotransferrin; Human, mammals, animals)	P02788, B7Z4X2, E7EQH5, O00756, Q16780, Q16785, Q16786, Q16789, Q8IU92	Belongs to the transferrin family	LTF	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Kaliocin-1 has antimicrobial activity and is able to permeabilize different ions through liposomal membranes without causing extensive damage to the outer and inner bacterial membranes.
Tissue specificity: High levels are found in saliva and tears, intermediate levels in serum and plasma, and low levels in urine."	Gram-negative bacterium: Escherichia coli serotype O111.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12693969	Biochemistry (Mosc). 2003 Feb;68(2):217-227.	Viejo-Díaz M, Andrés MT, Pérez-Gil J, Sánchez M, Fierro JF.	Potassium efflux induced by a new lactoferrin-derived peptide mimicking the effect of native human lactoferrin on the bacterial cytoplasmic membrane.	
DRAMP03637	ATFNFINNCPFTVWAAAVPG	20	Thaumatin-like protein (Actc2)	P83958	Belongs to the thaumatin family	tlp	Actinidia chinensis (Kiwi) (Yangtao)	Antimicrobial, Antifungal, Antiviral	Protein level	Not found	Not found		Function: Has antifungal activity. Inhibits HIV-1 reverse transcriptase.	Botrytis cinerea, Coprinus comatus, Mycosphaerella arachidicola, Physalospora piricola, Candida albicans, Saccharomyces carlsbergensis, HIV-1 reverse transcriptase.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12165295##12417892##15536427	Phytochemistry. 2002 Sep;61(1):1-6.##J Allergy Clin Immunol. 2002 Nov;110(5):805-810.##J Allergy Clin Immunol. 2004 Nov;114(5):1169-1175.	Wang H, Ng TB.##Gavrović-Jankulović M, ćIrković T, Vucković O, Atanasković-Marković M, Petersen A, Gojgić G, Burazer L, Jankov RM.##Bublin M, Mari A, Ebner C, Knulst A, Scheiner O, Hoffmann-Sommergruber K, Breiteneder H, Radauer C.	Isolation of an antifungal thaumatin-like protein from kiwi fruits.##Isolation and biochemical characterization of a thaumatin-like kiwi allergen.##IgE sensitization profiles toward green and gold kiwifruits differ among patients allergic to kiwifruit from 3 European countries.	
DRAMP03639	GLSQGVEPDIGQTYFEESRINQD	23	Astexin-1 (lasso peptide)	No entry found	Not found	Not found	Asticcacaulis excentricus CB 48 (Gram-negative bacteria)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Beta strand (2 strands; 3 residues)	The solution structure of astexin-1 was determined and found to have a nine-membered macrolactam ring followed by an 8-aa loop and a 6-aa tail. The extended length of the loop and tail regions allow for hydrogen-bonding interactions between the backbone and polar side chains of these regions of the peptide.	2LTI resolved by NMR.	"Function: Astexin-1 has weak antimicrobial activity against Caulobacter crescentus. No growth inhibition is observed
for any other strains of bacteria tested, and the growth inhibition of C. crescentus is quite modest."	Gram-negative bacterium: Caulobacter crescentus CB15.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22949633	Proc Natl Acad Sci U S A. 2012 Sep 4. 	Maksimov MO, Pelczer I, Link AJ.	Precursor-centric genome-mining approach for lasso peptide discovery.	
DRAMP03640	DSHEKRHHEHRRKFHEKHHSHRGY	24	Hcl-hst 5 (N.leucogenys histatin 5)	No entry found	Not found	Not found	Nomascus leucogenys	Antimicrobial, Antifungal	Not found	Alpha helix (CD)	Not found		Rich in histidines. Partial helical in 50% TFE.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20423320	Protein Pept Lett. 2010 Jul;17(7):909-918.	Padovan L, Segat L, Pontillo A, Antcheva N, Tossi A, Crovella S.	Histatins In Non-Human Primates: Gene Variations and Functional Effects.	
DRAMP03641	DFGCGQGMIFMCQRRCMRLYPGSTGFCRGFRCMCDTHIPLRPPFMVG	47	Longicornsin (defensin-like; Arthropods, invertebrates, animals)	B2MW54	Not found	sGDLP	Haemaphysalis longicornis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has antibacterial activity.	Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa, Helicobacter pylori.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20027626	Protein Sci. 2010 Mar;19(3):392-327.	Lu X, Che Q, Lv Y, Wang M, Lu Z, Feng F, Liu J, Yu H.	A novel defensin-like peptide from salivary glands of the hard tick, Haemaphysalis longicorn.	
DRAMP03643	RLKRMTPFWRGVSLRPVGASCRDNSECITMLCRKNRCFLRTASE	44	Liver-expressed antimicrobial peptide 2 (LEAP-2; Birds, animals)	Q6QLQ6	Not found	Not found	Gallus gallus (Chicken)	Antimicrobial 	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15148642	Immunogenetics. 2004 Jun;56(3):170-177.	Lynn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.	Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.	
DRAMP03644	RVKRVWPLVIRTVIAGYNLYRAIKKK	26	Cathelicidin-1 (CATH-1; Fowlicidin-1; Birds, animals)	Q6QLQ5, Q2IAM1	Not found	CATHL1	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Cytolytic	Protein level	Alpha helix (2 helices; 13 residues)	Fowlicidin-1 mainly adopts an alpha-helical conformation with a slight kink induced by glycine close to the center, in addition to a short flexible unstructured region near the N terminus. The short C-terminal helical segment after the kink, consisting of a stretch of eight amino acids (residues 16-23), may be required for the peptide to interact with LPS and lipid membranes and to permeabilize both prokaryotic and eukaryotic cells.	2AMN resolved by NMR.	"Function: Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response.
Animal model (mouse): It increased mice survival by 50% from a lethal dose of S. aureus (MRSA). This truncated peptide also reduced TNF-alpha and NO production in macrophage by 77% and 96%, respectively."	[Ref.16326712]Gram-negative bacteria: [No NaCl]Escherichia coli 25922 (MIC=1.59 µM), Escherichia coli O157:H7 700728 (MIC=0.80 µM), Salmonella typhimurium 14028 (MIC=0.80 µM), Salmonella typhimurium DT104 700408 (MIC=0.40 µM), Klebsiella pneumoniae 13883 (MIC=0.40 µM), Pseudomonas aeruginosa 27853 (MIC=3.18 µM);##[100mM NaCl]Escherichia coli 25922 (MIC=1.59 µM), Escherichia coli O157:H7 700728 (MIC=0.80 µM), Salmonella typhimurium 14028 (MIC=1.59 µM), Salmonella typhimurium DT104 700408 (MIC=1.59 µM), Klebsiella pneumoniae 13883 (MIC=0.80 µM), Pseudomonas aeruginosa 27853 (MIC=3.18 µM);##Gram-positive bacteria: Listeria monocytogenes 19115 (MIC=0.80 µM), Staphylococcus aureus 25923 (MIC=0.80 µM), Staphylococcus aureus (MRSA) BAA-39 (MIC=0.40 µM), Staphylococcus aureus (MRSA) 43300 (MIC=0.40 µM);##[100mM NaCl]Listeria monocytogenes 19115 (MIC=1.59 µM), Staphylococcus aureus 25923 (MIC=0.80 µM), Staphylococcus aureus (MRSA) BAA-39 (MIC=0.80 µM), Staphylococcus aureus (MRSA) 43300 (MIC=0.40 µM)	[Ref.16326712]80% hemolytic activity at 10 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	16326712##16817888	 Biol Chem. 2006 Feb 3;281(5):2858-2867.##FEBS J. 2006 Jun;273(12):2581-2593. 	Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, Zhang G.##Xiao Y, Dai H, Bommineni YR, Soulages JL, Gong YX, Prakash O, Zhang G.	Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity.##Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken.	
DRAMP03648	GRKSDCFRKSGFCAFLKCPSLTLISGKCSRFYLCCKRIWG	40	Gallinacin-1 (Gal-1; Beta-defensin 1; Birds, animals)	P46156, Q09MK1, Q6B9W7, Q6GXJ4	Belongs to the beta-defensin family	GAL1	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge 	Not found		"Tissue specificity: Strong expression in the bone marrow, lung, testis. Moderate expression in the bursa and intestine. Low expression in the cloaca, gall bladder, brain and pancreas. Expressed in the vagina, ovarian stroma and the theca and granulosa layers of the ovarian follicle.
Developmental stage: Detected in the theca layer of the ovarian follicle in the white follicle (WF) stage, but decreases throughout the F1, F3, F5, and postovulatory follicle stages. Detected in the granulosa layer of the ovarian follicle in the white follicle (WF) stage, F1, F3, F5, and postovulatory follicle stages. In the vagina expression is higher in laying hens than in non-laying hens, and is higher in older laying hens than in young laying hens.
Induction: Induced in the theca layer of the F3 stage ovarian follicle by intravenous injection of LPS. Repressed in the granulosa layer of the F3 stage ovarian follicle by intravenous injection of LPS. Expression in cultured vaginal cells is increased by LPS and S.enteritidis. Expression in the kidney and liver is not affected by intravenous injection of LPS.
PTM: Contains three disulfide bonds 6-34; 13-28; 18-35."	Gram-negative bacterium: Escherichia coli ML-35;##Gram-positive bacterium: Listeria monocytogenes.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8150085##16394622##17244739	FEBS Lett. 1994 Apr 11;342(3):281-285.##J Reprod Dev. 2006 Apr;52(2):211-218.##Reproduction. 2007 Jan;133(1):127-133.	Harwig SS, Swiderek KM, Kokryakov VN, Tan L, Lee TD, Panyutich EA, Aleshina GM, Shamova OV, Lehrer RI.##Yoshimura Y, Ohashi H, Subedi K, Nishibori M, Isobe N.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.	Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes.##Effects of age, egg-laying activity, and Salmonella-inoculation on the expressions of gallinacin mRNA in the vagina of the hen oviduct.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).	
DRAMP03649	GRKSDCFRKNGFCAFLKCPYLTLISGKCSRFHLCCKRIW	39	Gallinacin-1 alpha (Gal-1 alpha; Antimicrobial peptide CHP2; Birds, animals)	P46157, P80390, Q09MR8, Q9DG59	Belongs to the beta-defensin family	Not found	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		PTM: Contains three disulfide bonds 6-34; 13-28; 18-35.	Gram-negative bacterium: Escherichia coli ML-35;##Gram-positive bacteria: Staphylococcus aureus, Listeria monocytogenes.##Yeast: Candida albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7964174##8150085	J Leukoc Biol. 1994 Nov;56(5):661-665.##FEBS Lett. 1994 Apr 11;342(3):281-285.	Evans EW, Beach GG, Wunderlich J, Harmon BG.##Harwig SS, Swiderek KM, Kokryakov VN, Tan L, Lee TD, Panyutich EA, Aleshina GM, Shamova OV, Lehrer RI.	Isolation of antimicrobial peptides from avian heterophils.##Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes.	
DRAMP03650	LFCKGGSCHFGGCPSHLIKVGSCFGFRSCCKWPWNA	36	Gallinacin-2 (Gal-2; Beta-defensin 2; Birds, animals)	P46158, Q09MT0, Q0PWH3, Q6B9W8, Q6GXJ3	Belongs to the beta-defensin family	GAL2	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Beta strand (3 strands; 11 residues)	The three-dimensional NMR structure of chicken AvBD2 defensin displays the structural three-stranded antiparallel β-sheet characteristic of β-defensins. The surface of the molecule does not display any amphipathic character.	2LG5, 2LG6 resolved by NMR.	"Tissue specificity: Expressed in circulating heterophil granulocytes and bone marrow (at protein level). Strong expression in the bone marrow, lung and testis. Moderate expression in the bursa and intestine. Low expression in the cloaca, gall bladder, brain, pancreas, trachea, air sacs and spleen. Expressed in the vagina, ovarian stroma and the theca layer of the ovarian follicle, but not in the granulosa layer of the ovarian follicle.
Developmental stage: Detected in the theca layer of the ovarian follicle in the white follicle (WF), F1, F3, F5, and postovulatory follicle stages. In the vagina expression is higher in laying hens than in non-laying hens, and is higher in older laying hens than in young laying hens.
Induction: Not induced in the ovarian follicle by intravenous injection of LPS. Expression in cultured vaginal cells is increased by LPS and S.enteritidis.
PTM: Contains three disulfide bonds 3-29, 8-23, 13-30."	Gram-negative bacteria: Escherichia coli ML-35, Salmonella enteritidis;##Gram-positive bacteria: Bacillus cereus, Listeria monocytogenes.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	8150085##19151352##15148642##17244739##16394622##22205	FEBS Lett. 1994 Apr 11;342(3):281-285.##Poult Sci. 2009 Feb;88(2):372-379.##Immunogenetics. 2004 Jun;56(3):170-177.##Reproduction. 2007 Jan;133(1):127-133.##J Reprod Dev. 2006 Apr;52(2):211-218.##J Biol Chem. 	Harwig SS, Swiderek KM, Kokryakov VN, Tan L, Lee TD, Panyutich EA, Aleshina GM, Shamova OV, Lehrer RI.##Kannan L, Rath NC, Liyanage R, Lay JO Jr.##Lynn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.##Yoshimura Y, Ohashi H, Subedi K, Nishibori M, Isobe N.##Derache C, Meudal H, Aucagne V, Mark KJ, Cadène M, Delmas AF, Lalmanach AC, Landon C.	Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes.##Direct screening identifies mature beta-defensin 2 in avian heterophils.##Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).##Effects of age, egg-laying activity, and Salmonella-i	
DRAMP03651	IATQCRIRGGFCRVGSCRFPHIAIGKCATFISCCGRAY	38	Gallinacin-3 (Gal-3; Beta-defensin 3; Birds, animals)	Q9DG58, Q0PWH2, Q6GXJ2	Belongs to the beta-defensin family	GAL3	Gallus gallus (Chicken)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Tissue specificity: Strongly expressed in the tongue, bone marrow, bursa of Fabricius and trachea. Also expressed in skin, esophagus and air sacs. Weak expression in the large intestine, kidney and ovary. Expressed in the vagina and ovarian stroma, but not in the ovarian follicle.
Developmental stage: In the vagina expression is higher in laying hens than in non-laying hens, and is higher in older laying hens than in young laying hens. Induction: Expression in cultured vaginal cells is increased by LPS and S. enteritidis.
PTM: contains three disulfide bonds 3-31; 10-25; 15-33. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11254635##15148642##16394622	Infect Immun. 2001 Apr;69(4):2684-2691.##Immunogenetics. 2004 Jun;56(3):170-177.##J Reprod Dev. 2006 Apr;52(2):211-218.	Zhao C, Nguyen T, Liu L, Sacco RE, Brogden KA, Lehrer RI.##Lynn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Yoshimura Y, Ohashi H, Subedi K, Nishibori M, Isobe N.	Gallinacin-3, an inducible epithelial beta-defensin in the chicken.##Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##Effects of age, egg-laying activity, and Salmonella-inoculation on the expressions of gallinacin mRNA in the vagina of the hen oviduct.	
DRAMP03652	RYHMQCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL	38	Gallinacin-4 (Gal-4; Beta-defensin 4; Birds, animals)	Q6GXJ1, Q0PXU4, Q6QLR0	Belongs to the beta-defensin family	GAL4	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram-	Transcript level	Bridge	Not found		Tissue specificity: Strong expression in the bone marrow and testis. Widely expressed. Weak expression in the ovarian stroma, but not expressed in the ovarian follicles. PTM: Contains three disulfide bonds 6-34; 13-28; 18-35.	Gram-negative bacteria: Salmonella typhimurium, Salmonella entiriditis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17346671##15310403##15148642##17244739	Biochem Biophys Res Commun. 2007 Apr 27;356(1):169-174.##BMC Genomics. 2004 Aug 13;5(1):56.##Immunogenetics. 2004 Jun;56(3):170-177.##Reproduction. 2007 Jan;133(1):127-133.	Milona P, Townes CL, Bevan RM, Hall J.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Lynn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.	The chicken host peptides, gallinacins 4, 7, and 9 have antimicrobial activity against Salmonella serovars.##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response 	
DRAMP03653	GLPQDCERRGGFCSHKSCPPGIGRIGLCSKEDFCCRSRWYS	41	Gallinacin-5 (Gal-5; Beta-defensin 5; Birds, animals)	Q6IV26, Q09MS7, Q0PWH0, Q6QLQ8	Belongs to the beta-defensin family	GAL5	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram-	Transcript level	Not found	Not found		Tissue specificity: Strong expression in the tongue and bone marrow. Low expression in the esophagus, trachea, lung, brain and ovary. Expressed in the ovarian stroma, but not in the ovarian follicles. PTM: contains three disulfide bonds 6-34; 13-28; 18-35.	Gram-negative bacteria: Salmonella typhimurium, Salmonella entiriditis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17346671##15310403##15148642##17244739	Biochem Biophys Res Commun. 2007 Apr 27;356(1):169-174.##BMC Genomics. 2004 Aug 13;5(1):56.##Immunogenetics. 2004 Jun;56(3):170-177.##Reproduction. 2007 Jan;133(1):127-133.	Milona P, Townes CL, Bevan RM, Hall J.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Lynn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.	The chicken host peptides, gallinacins 4, 7, and 9 have antimicrobial activity against Salmonella serovars.##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response 	
DRAMP03654	SPIHACRYQRGVCIPGPCRWPYYRVGSCGSGLKSCCVRNRWA	42	Gallinacin-6 (Gal 6; Beta-defensin 6; Birds, animals)	Q6QLR3	Belongs to the beta-defensin family	GAL6	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram-	Transcript level	Bridge	Not found		Tissue specificity: Expressed in bone marrow, testis, ovary, lung and trachea. Expressed in the ovarian stroma, but not in the ovarian follicles. PTM: Contains three disulfide bonds 6-35; 13-28; 18-36.	Gram-negative bacteria: Salmonella typhimurium, Salmonella entiriditis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17346671##15310403##15148642##17244739	Biochem Biophys Res Commun. 2007 Apr 27;356(1):169-174.##BMC Genomics. 2004 Aug 13;5(1):56.##Immunogenetics. 2004 Jun;56(3):170-177.##Reproduction. 2007 Jan;133(1):127-133.	Milona P, Townes CL, Bevan RM, Hall J.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Lynn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.	The chicken host peptides, gallinacins 4, 7, and 9 have antimicrobial activity against Salmonella serovars.##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response 	
DRAMP03655	RPIDTCRLRNGICFPGICRRPYYWIGTCNNGIGSCCARGWRS	42	Gallinacin-7 (Gal 7; Beta-defensin 7; Birds, animals)	Q6QLR2, Q09MR1, Q09MV1	Belongs to the beta-defensin family	GAL7	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram-	Transcript level	Bridge	Not found	5LCS	"Tissue specificity: Strong expression in the bone marrow and testis. Expressed in the ovarian stroma and the theca layer of the ovarian follicles. Not expressed in the granulosa layer of the ovarian follicles.
Developmental stage: Detected in the theca and granulosa layers of the ovarian follicle in the white follicle (WF), F1, F3, F5, and postovulatory follicle stages. Induction: Induced in the theca layer of the F3 stage ovarian follicle by intravenous injection of LPS. Expression in the kidney and liver is not affected by intravenous injection of LPS.
PTM: Contains three disulfide bonds 6-35; 13-28; 18-36."	Gram-negative bacterium: Salmonella enteriditis.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15148642##15310403##17244739	Immunogenetics. 2004 Jun;56(3):170-177.##BMC Genomics. 2004 Aug 13;5(1):56.##Reproduction. 2007 Jan;133(1):127-133.	nn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.	Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).	
DRAMP03656	NNEAQCEQAGGICSKDHCFHLHTRAFGHCQRGVPCCRTVYD	41	Gallinacin-8 (Gal-8; Beta-defensin 8; Birds, animals)	Q6IV23, Q6GXI7	Belongs to the beta-defensin family	GAL8	Gallus gallus (Chicken)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		Tissue specificity: Expressed in the liver, kidney, gall bladder, testis, ovary and male and femae reproductive tracts. Expressed in the ovarian stroma and the theca and granulosa layers of the ovarian follicle. Detected in the theca and granulosa layers of the ovarian follicle in the white follicle (WF), F1, F3, F5, and postovulatory follicle stages. Induction: Induced in the theca layer of the F3 stage ovarian follicle by intravenous injection of LPS. Expression in the granulosa layer of the ovarian follicle is not affected by intravenous injection of LPS. PTM: Contains three disulfide bonds 6-35; 13-28; 18-36.	Escherichia coli, Listeria monocytogenes, Salmonella typhimurium, Streptococcus pyogenes	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17244739##15310403##15744537	Reproduction. 2007 Jan;133(1):127-133.##BMC Genomics. 2004 Aug 13;5(1):56.##Immunogenetics. 2005 Apr;57(1-2):90-98.	Subedi K, Isobe N, Nishibori M, Yoshimura Y.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Higgs R, Lynn DJ, Gaines S, McMahon J, Tierney J, James T, Lloyd AT, Mulcahy G, O'Farrelly C.	Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##The synthetic form of a novel chicken beta-defensin identified in silico is predominantly active against intestinal pathogens.	
DRAMP03657	ADTLACRQSHGSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS	42	Gallinacin-9 (Gal-9; Beta-defensin 9; Gallinacin-6, Gal-6; Birds, animals)	Q6QLR1, Q09MS3	Belongs to the beta-defensin family	GAL9	Gallus gallus (Chicken)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		Tissue specificity: Strong expression in the testis, liver, gall bladder, kidney, esophagus and crop. Also expressed in the glandular stomach, ovary and male and female reproductive tracts. Low expression in the intestinal tract. Expressed in the ovarian stroma, but not in the ovarian follicles. PTM: Contains three disulfide bonds 6-35; 13-28; 18-36.	C.jejuni, C.perfringens, Staphylococcus aureus, Candida albicans and Saccharomyces cerevisiae. Less potent against Salmonella typhimurium and Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15148642##15310403##17244739##17194828	Immunogenetics. 2004 Jun;56(3):170-177.##BMC Genomics. 2004 Aug 13;5(1):56.##Reproduction. 2007 Jan;133(1):127-133.##Antimicrob Agents Chemother. 2007 Mar;51(3):912-922.	nn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.##van Dijk A, Veldhuizen EJ, Kalkhove SI, Tjeerdsma-van Bokhoven JL, Romijn RA, Haagsman HP.	Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).##The beta-defensin gallinacin-6 is expressed in the	
DRAMP03658	FPDTVACRTQGNFCRAGACPPTFTISGQCHGGLLNCCAKIPAQ	43	Gallinacin-10 (Gal-10; Beta-defensin 10; Birds, animals)	Q6QLQ9	Belongs to the beta-defensin family	GAL10	Gallus gallus (Chicken)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		Tissue specificity: Strong expression in the testis, liver, gall bladder and kidney. Also expressed in the ovary and male and female reproductive tracts. Expressed in the ovarian stroma and the theca and granulosa layers of the ovarian follicle. Developmental stage: Detected in the theca and granulosa layers of the ovarian follicle in the white follicle (WF), F1, F3, F5, and postovulatory follicle stages. Induction: Expression in the theca and granulosa layers of the F3 stage ovarian follicle is not affected by intravenous injection of LPS. PTM: Contains three disulfide bonds 7-36; 14-29; 19-37.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15148642##15310403##17244739	Immunogenetics. 2004 Jun;56(3):170-177.##BMC Genomics. 2004 Aug 13;5(1):56.##Reproduction. 2007 Jan;133(1):127-133.	nn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.	Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).	
DRAMP03660	HGPDSCNHDRGLCRVGNCNPGEYLAKYCFEPVILCCKPLSPTPTKT	46	Gallinacin-12 (Gal-12; Beta-defensin 12; Birds, animals)	Q6QLQ7, A0MV42, Q0PWG3, Q6IV19	Belongs to the beta-defensin family	GAL12	Gallus gallus (Chicken)	Antimicrobial, Antibacterial	Transcript level	Bridge	Not found		Tissue specificity: Expressed in the large intestine, kidney liver, gall bladder, testis, ovary and male and female reproductive tracts. Expressed in the ovarian stroma and the theca and granulosa layers of the ovarian follicle. Developmental stage: Detected in the theca and granulosa layers of the ovarian follicle in the white follicle (WF), F1, F3, F5, and postovulatory follicle stages. Induction: Induced in the theca layer of the F3 stage ovarian follicle by intravenous injection of LPS. Repressed in the granulosa layer of the F3 stage ovarian follicle by intravenous injection of LPS. PTM: Contains three disulfide bonds 6-35; 13-28; 18-36.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17244739##15310403	Reproduction. 2007 Jan;133(1):127-33.	Subedi K, Isobe N, Nishibori M, Yoshimura Y.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.	Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.	
DRAMP03661	FSDSQLCRNNHGHCRRLCFHMESWAGSCMNGRLRCCRFSTKQPFSNPKHSVLHTAEQDPSPSLGGT	66	Gallinacin-13 (Gal-13; Beta-defensin 13; Birds, animals)	Q6IV18, Q66VU2	Belongs to the beta-defensin family	GAL13	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Tissue specificity: Expressed in the liver, gall bladder, kidney, small intestine, spleen, testis, ovary and male and female reproductive tracts. Not detected in the ovarian stroma and the theca and granulosa layers of the ovarian follicle. PTM: Contains three disulfide bonds 7-35; 14-28; 18-36.	Gram-negative bacteria: Escherichia coli, Salmonella typhimurium;##Gram-positive bacteria: Listeria monocytogenes, Streptococcus pyogenes.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17244739##15310403##15744537	Reproduction. 2007 Jan;133(1):127-133.##BMC Genomics. 2004 Aug 13;5(1):56.##Immunogenetics. 2005 Apr;57(1-2):90-98.	Subedi K, Isobe N, Nishibori M, Yoshimura Y.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Higgs R, Lynn DJ, Gaines S, McMahon J, Tierney J, James T, Lloyd AT, Mulcahy G, O'Farrelly C.	Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##The synthetic form of a novel chicken beta-defensin identified in silico is predominantly active against intestinal pathogens.	
DRAMP03662	ESDTVTCRKMKGKCSFLLCPFFKRSSGTCYNGLAKCCRPFW	41	Gallinacin-14 (Gal-14; Beta-defensin 14; Birds, animals)	Q0E4V3	Belongs to the beta-defensin family	GAL14	Gallus gallus (Chicken)	Antimicrobial, Antibacterial	Homology	Not found	Not found		PTM: Contains three disulfide bonds 7-36; 14-29; 19-37.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17244739##PubMed ID is not available	Reproduction. 2007 Jan;133(1):127-133.##Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases.	Subedi K, Isobe N, Nishibori M, Yoshimura Y.##Soulier A.J, Rothwell L, Lovell M.A, Bumstead N, Barrow P.A, Kaiser P.	Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).##A novel chicken beta-defensin, gallinacin 14.	
DRAMP03663	MTPFWRGVSLRPVGASCRDNSECITMLCRKNRCFLRTASE	40	cLEAP-2 (Chicken LEAP-2; Birds, animals)	No entry found	Not found	Not found	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: S. enterica serovar Typhimurium strain SL1344, mutant S. enterica serovar Typhimurium strain phoP.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	cell membrane	15557621	Infect Immun. 2004 Dec;72(12):6987-6893.	wnes CL, Michailidis G, Nile CJ, Hall J.	Induction of cationic chicken liver-expressed antimicrobial peptide 2 in response to Salmonella enterica infection.	
DRAMP03664	ADNKNPLEECFRETNYEEFLEIAR	24	L-amino-acid oxidase (LAAO, LAO, TM-LAO; reptilia, animals)	P0C2D6	Not found	Not found	Trimeresurus mucrosquamatus (Taiwan habu) (Protobothrops mucrosquamatus)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis, and antiparasitic activities By similarity. This protein has antibacterial activity abd cytotoxic activity, as well as an ability to induce platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions.
Tissue specificity: Expressed by the venom gland. PTM: Contains one disulfide bond."	Gram-negative bacterium: E. coli;##S. aureus, B. dysenteriae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12621545	Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Mar;35(3):219-224.	Wei JF, Wei Q, Lu QM, Tai H, Jin Y, Wang WY, Xiong YL.	Purification, characterization and biological activity of an L-amino acid oxidase from Trimeresurus mucrosquamatus venom.	
DRAMP03665	IAIQGGXGYLXQPGDGYKYA	20	Lysozyme	P85152	Not found	Not found	Lysobacter sp. (strain XL1)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Biophysicochemical properties: Optimum pH is 8.0; Optimum temperature is 60 degrees Celsius.
Also has Catalytic activity: Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2007) to UniProtKB.	Muranova T.A, Stepnaya O.A, Tsfasman I.M, Kulaev I.S.	Identification of extracellular bacteriolytic enzymes from Lysobacter sp. XL1.	
DRAMP03666	XNVVFLNXPXPQW	13	N-acetylmuramoyl-L-alanine amidase L2	P85143	Not found	Not found	Lysobacter sp.	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Biophysicochemical properties: Optimum pH is 8.0; Optimum temperature is 65 degrees Celsius.
Also has Catalytic activity: Hydrolyzes the link between N-acetylmuramoyl residues and L-amino acid residues in certain cell-wall glycopeptides."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2007) to UniProtKB.	Muranova T.A, Stepnaya O.A, Tsfasman I.M, Kulaev I.S.	Identification of extracellular bacteriolytic enzymes from Lysobacter sp. XL1.	
DRAMP03667	ATVQGGIXYRMP	12	Proteinase L5 	P85158	Not found	Not found	Lysobacter sp. strain XL1 (Gram-negative bacteria)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Biophysicochemical properties: Optimum pH is 7.5; Optimum temperature is 80 degrees Celsius. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-2007) to UniProtKB.	Muranova T.A, Stepnaya O.A, Tsfasman I.M, Kulaev I.S.	Identification of extracellular bacteriolytic enzymes from Lysobacter sp. XL1.	
DRAMP03668	YLDVKQLANYLLCIGNGQVFNGRKTCQIGCRAVCQQPGCSGYKECEQIPNIRLHKYRCHCNEA	63	Megourin-1 (arthropod; animals)	P83417	Not found	Not found	Megoura viciae (Vetch aphid)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity against Gram-positive bacteria and fungi.
Induction: By bacterial infection.
PTM: Contains four disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2002) to UniProtKB	Bulet P, Charlet M, Chernish S, Hetru C.	Unknown	
DRAMP03669	YLDVNQIASYLLCLGQGAVFNGRKTCQIGCRAACQQPGCGGYKECEQIPNIRLHKYRCHCNSG	63	Megourin-2 (arthropod; animals)	P83418	Not found	Not found	Megoura viciae (Vetch aphid)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity against Gram-positive bacteria and fungi.
Induction: By bacterial infection.
PTM: Contains four disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2002) to UniProtKB	Bulet P, Charlet M, Chernish S, Hetru C.	Unknown	
DRAMP03670	YLDVNQIASYLLCLGEGAVFNGRKTCQIGCRAACQQPGCGGYKECEQIPNIRLHKYRCHCISG	63	Megourin-3 (arthropod; animals)	P83419	Not found	Not found	Megoura viciae (Vetch aphid)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		"Function: Has antimicrobial activity against Gram-positive bacteria and fungi.
Induction: By bacterial infection.
PTM: Contains four disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2002) to UniProtKB	Bulet P, Charlet M, Chernish S, Hetru C.	Unknown	
DRAMP03671	ATTGCSCPQCIIFDPICASSYKNGRRGFSSGCHMRCYNRCHGTDYFQISKGSKCI	55	Locustin (Insects, animals)	P83428	Not found	Not found	Locusta migratoria (Migratory locust)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Stored in hemocyte granules and secreted into the hemolymph."	Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2002) to UniProtKB	Bulet P, Charlet M, Sabatier-Ehret L.	Unknown	
DRAMP03672	VHVGPCDQVCSRIDPEKDECCRAHGYRGHSSCYYGRMECY	40	Spodomicin (Insects, animals)	P83411	Belongs to the diapausin family	Not found	Spodoptera littoralis 	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Fungicide.
Tissue specificity: Hemolymph.
Induction: By bacterial infection.
PTM: Contains three disulfide bonds."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2003) to UniProtKB	Bulet P, Lamberty M, Brookhart G, Bushey D.	Unknown	
DRAMP03673	FFHHIFRGIVHVGKSIHKLVTG	22	Dicentracin (Dicentracine)	P59906	Belongs to the pleurocidin family	Not found	Dicentrarchus labrax (European seabass) (Morone labrax)	Antimicrobial	Homology	Not found	Not found		Function: May have antimicrobial activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases	Salerno G, Roch P, Sri Widada J.	Dicentracine, first antimicrobial peptide isolated from the fish Dicentrarchus labrax.	
DRAMP03674	DTHISEKIIDCNDIG	15	Cystatin-1 (Cystatin-I)	P84911	Belongs to the caerin subfamily	Not found	Capra hircus (Goat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Inhibits papain, ficin and bromelain with an IC50 of 0.09 µM, 0.115 µM and 0.113 µM respectively. Has antibacterial activity against Gram-positive bacteria and against the Gram-negative bacteria. Reduced antibacterial activity against Gram-positive bacterium B.subtilis. No antibacterial activity against the Gram-negative bacterium P.fluorescens.
Miscellaneous: Stable in the pH range 5.0-9.0 at 37 degrees Celsius. Stable when incubated in the temperature range 25-75 degrees Celsius and pH 7.5.
Sequence uncertainty: K or Y at position 7."	[Swiss_Prot Entry P84911]has antibacterial activity against Gram-positive bacteria S.aureus and S.hemolyticus, and against the Gram-negative bacterium E.coli. Reduced antibacterial activity against Gram-positive bacterium B.subtilis. No antibacterial activity against the Gram-negative bacterium P.fluorescens	[Swiss_Prot Entry P84911]Not found	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16257555	Comp Biochem Physiol B Biochem Mol Biol. 2005 Dec;142(4):361-368. 	Sadaf Z, Shahid PB, Bilqees B.	Isolation, characterization and kinetics of goat cystatins.	
DRAMP18192	FLFSLIPNAISGLLSAFK	18	Antimicrobial peptide AcrAP2	A0A0A1I6N9	 Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short an	Not found	Androctonus crassicauda (Arabian fat-tailed scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Has antimicrobial activity against the Gram-positive bacteria S.aureus and the yeast C.albicans. Causes hemolysis on horse erythrocytes (64 uM for 100% hemolysis).	Gram-positive bacteria: S.aureus (MIC=8 uM, MBC=32 uM);##Yeast: C.albicans (MIC=16 uM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	25332684	Int. J. Biol. Sci. 10:1097-1107(2014)	Du Q., Hou X., Ge L., Li R., Zhou M., Wang H., Wang L., Wei M.,Chen T., Shaw C.	Cationicity-enhanced analogues of the antimicrobial peptides, AcrAP1and AcrAP2, from the venom of the scorpion, Androctonus crassicauda,display potent growth modulation effects on human cancer cell lines.	
DRAMP03678	SRRSCHRNKGVCALTRCPRNMRQIGTCFGPPVKCCRKK	38	Beta-defensin 1 (GBD-1; Defensin, beta 1; ruminant, animals)	O97946	Belongs to the beta-defensin family	DEFB1	Capra hircus (Goat)	Antimicrobial, Antibacterial	Homology	Bridge	Not found		"Function: Has bactericidal activity (By similarity).
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10531296	Infect Immun. 1999 Nov;67(11):6221-6224.	Zhao C, Nguyen T, Liu L, Shamova O, Brogden K, Lehrer RI.	Differential expression of caprine beta-defensins in digestive and respiratory tissues.	
DRAMP03680	RFRLPFRRPPIRIHPPPFYPPFRRFL	26	Cathelicidin-3.4 (Bactenecin-3.4, Bac3.4; ChBac3.4; ruminant, animals)	P85170	Belongs to the cathelicidin family	Not found	Capra hircus (Goat)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Has low hemolytic activity towards human red blood cells. 	[Swiss_Prot Entry P85170]Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa;##Gram-positive bacteria: Staphylococcus aureus, Listeria monocytogenes	[Swiss_Prot Entry P85170]Low hemolytic activity against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAY-2007) to UniProtKB.	Shamova O, Orlov D, Stegemann C, Lehrer RI, Brogden KA, Kolodkin N, Hoffmann R, Kokryakov VN.	Unknown	
DRAMP03681	ADDRNPLEECFRETDYEEFLEIARNGLKKT	30	L-amino-acid oxidase (LAAO; OHAP-1)	P0C2D5	Not found	Not found	Trimeresurus flavoviridis (Habu) (Protobothrops flavoviridis)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. This protein has an ability to induce hemolysis and apoptosis.
Tissue specificity: Expressed by the venom gland.
PTM: Contains one disulfide bond and N-glycosylated."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Glycyrrhizin (GL)	12650671##9781840	Toxicol In Vitro. 2003 Apr;17(2):169-177.##Biol Pharm Bull. 1998 Sep;21(9):924-927.	Sun LK, Yoshii Y, Hyodo A, Tsurushima H, Saito A, Harakuni T, Li YP, Kariya K, Nozaki M, Morine N.##Abe Y, Shimoyama Y, Munakata H, Ito J, Nagata N, Ohtsuki K.	Apoptotic effect in the glioma cells induced by specific protein extracted from Okinawa Habu (Trimeresurus flavoviridis) venom in relation to oxidative stress.##Characterization of an apoptosis-inducing factor in Habu snake venom as a glycyrrhizin (GL)-binding protein potently inhibited by GL in vitro.	
DRAMP03689	GWINEEKIQKKIDEP	15	Scorpine-like (Arthropods, animals)	P86121	Belongs to the Belongs to the long chain scorpion toxin famiy	Not found	Opisthacanthus cayaporum (South American scorpion)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Has antimicrobial activity against S. aureus (78% growth inhibition at 1.8 µM).
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds."	Gram-positive bacterium: Staphylococcus aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18502464	Toxicon. 2008 Jun 15;51(8):1499-1508.	Schwartz EF, Camargos TS, Zamudio FZ, Silva LP, Bloch C Jr, Caixeta F, Schwartz CA, Possani LD.	Mass spectrometry analysis, amino acid sequence and biological activity of venom components from the Brazilian scorpion Opisthacanthus cayaporum.	
DRAMP03690	FWSFLVKAASKILPSLIGGGDDNKSSS	27	Probable antimicrobial peptide Con10 (Arthropods, animals)	C5J897	Not found	Not found	Opisthacanthus cayaporum (South American scorpion)	Antimicrobial	Transcript level	Not found	Not found		"Function: Probable antimicrobial peptide.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19379768	Toxicon. 2009 Sep 1;54(3):252-261.	Silva EC, Camargos TS, Maranhão AQ, Silva-Pereira I, Silva LP, Possani LD, Schwartz EF.	Cloning and characterization of cDNA sequences encoding for new venom peptides of the Brazilian scorpion Opisthacanthus cayaporum.	
DRAMP03692	ACQFWSCNSSCISRGYRQGYCWGIQYKYCQCQ	32	Defensin-1 (Cll-dlp; Arthropods, animals)	Q6GU94, P83738	Belongs to the invertebrate defensin family	Not found	Centruroides limpidus limpidus (Mexican scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found	6B9W	"Function: Antibacterial protein involved in the immune response to septic injury. When combined with 14.026 kDa and 14.059 kDa hemolymph antimicrobial peptides, it has a strong cooperative activity against bacteria. No detectable antibacterial activity when present alone. Has no hemolytic activity against human erythrocytes.
Induction: By septic injury.
PTM: Contains three disulfide bonds 2-21; 7-29; 11-31."	[Ref.15197474]Gram-positive bacteria: Bacillus subtilis (MIC>50 µg/ml), Staphylococcus aureus ATCC 25923 (MIC>50 µg/ml);##Gram-negative bacteria: Escherichia coli DH5a (MIC>50 µg/ml), Klebsiella pneumoniae ATCC 13883 (MIC>50 µg/ml).##NOTE: Liquid growth inhibition assay.	[Swiss_Prot Entry Q6GU94]Non-hemolytic activity against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15197474	Cell Mol Life Sci. 2004 Jun;61(12):1507-1519.	Rodríguez de la Vega RC, García BI, D'Ambrosio C, Diego-García E, Scaloni A, Possani LD.	Antimicrobial peptide induction in the haemolymph of the Mexican scorpion Centruroides limpidus limpidus in response to septic injury.	
DRAMP03695	GFWSKIKDFAKKAWNSPLANELKSKALNAAKNFVSEKIGATPS	43	Probable antimicrobial peptide Con13 (Arthropods, animals)	C7C1L2	Belongs to the antimicrobial peptide scorpion family	Not found	Opisthacanthus cayaporum (South American scorpion)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Hemolytic and antibacterial and antifungal peptide (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	[Swiss_Prot Entry C7C1L2]has hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	cell membrane	19379768	Toxicon. 2009 Sep 1;54(3):252-261.	Silva EC, Camargos TS, Maranhão AQ, Silva-Pereira I, Silva LP, Possani LD, Schwartz EF.	Cloning and characterization of cDNA sequences encoding for new venom peptides of the Brazilian scorpion Opisthacanthus cayaporum.	
DRAMP03696	GWWNAFKSIGKKLLKSKLAKDITKMAKQRAKEYVVKKLNGPPEEEVAAIDALMNSLDY	58	Bradykinin-potentiating peptide-like (BPP; Non-disulfide-bridged peptide 3.7; Arthropods, animals	P0C8L3	Belongs to the scorpion BPP family	Not found	Hadrurus gertschi (Scorpion)	Unknown	Transcript level	Not found	Not found		"Function: defense response to bacterium.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17506894	BMC Genomics. 2007 May 16;8:119.	Schwartz EF, Diego-Garcia E, Rodríguez de la Vega RC, Possani LD.	Transcriptome analysis of the venom gland of the Mexican scorpion Hadrurus gertschi (Arachnida: Scorpiones).	
DRAMP03697	ARDAYIANDRNCVYTCALNPYCDSECKKNGADSGYCQWFGRFGNACWCKNLPDKVPIRIPGECR	64	Neurotoxin MeuNaTx-2 (Arthropods, animals)	P86403	Belongs to the Sodium channel inhibitor family (Alpha subfamily)	Not found	Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Inhibits Nav1.4 and DmNav1 sodium channels. Has antibacterial activity.
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity). "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2009) to UniProtKB	Zhu S.Y, Gao B.	Characterization of a sodium channel toxin from the scorpion Mesobuthus eupeus venom.	
DRAMP03698	ARDAYIAKPHNCVYECFDAFSSYCNGVCTKNGAKSGYCQILGTYGNGCWCIALPDNVPIRIPGKCH	66	Neurotoxin MeuNaTx-5 (Arthropods, animals)	P86405	Belongs to the Sodium channel inhibitor family (Alpha subfamily)	Not found	Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus)	Antimicrobial	Protein level	Combine helix and strand structure	Not found	2LKB resolved by NMR.	"Function: Inhibits sodium channels (Nav). Has antimicrobial activity.
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##21969612	Submitted (NOV-2009) to UniProtKB##Mol Cell Proteomics. 2012 Jan;11(1):M111.012054.	Zhu SY, Gao B.##Zhu S, Peigneur S, Gao B, Lu X, Cao C, Tytgat J.	Characterization of a sodium channel toxin from the scorpion Mesobuthus eupeus venom.##Evolutionary diversification of Mesobuthus α-scorpion toxins affecting sodium channels.	
DRAMP03699	DNGYLLDKYTGCKVWCVINNESCNSECKIRRGNYGYCYFWKLACYCEGAPKSELWHYETNKCNGRM	66	Neurotoxin MeuNaTx-6 (Arthropods, animals)	P86406	Belongs to the Sodium channel inhibitor family (Alpha subfamily)	Not found	Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus)	Antimicrobial	Protein level	Not found	Not found		"Function: Inhibits sodium channels (Nav). Has antimicrobial activity.
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2009) to UniProtKB	Zhu S.Y, Gao B.	Characterization of a sodium channel toxin from the scorpion Mesobuthus eupeus venom.	
DRAMP03701	QLEARFEPKQRNFRKRELDFEKLFANMPDY	30	Imcroporin (Arthropods, animals)	C7B247	Belongs to the short cationic antimicrobial peptide family	Not found	Isometrus maculatus (Lesser brown scorpion)	Antimicrobial, Antibacterial, Anti-Gram+	Transcript level	Not found	Not found		"Function: Has potent antibacterial activity against Gram-positive bacteria, but not Gram-negative bacteria. Shows a weak cytotoxicity effect against mammalian cell lines and hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the venom gland."	[Ref.19451300]Gram-positive bacteria: Micrococcus luteus(MIC=20μg/ml), Bacillus thuringiensis(MIC=50μg/ml), Staphylococcus aureus(MIC=20μg/ml), Bacillus subtilis(MIC=50μg/ml).	[Ref.19451300]5% hemolytic activity at 40 μg/mL, 20% hemolytic at 50 μg/mL, 70% hemolytic aactivity at 100 μg/mL against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	19451300	Antimicrob Agents Chemother. 2009 Aug;53(8):3472-7.	Zhao Z, Ma Y, Dai C, Zhao R, Li S, Wu Y, Cao Z, Li W.	Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.	
DRAMP03703	LFFLPSLIGGLISAFK	16	Mucroporin-like peptide (NDBP13; Arthropods, animals)	D9U2B8	Belongs to the short cationic antimicrobial peptide family	Not found	Lychas mucronatus (Chinese swimming scorpion)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Cationic host defense peptide that have antibacterial activity by breaking membranes. Is more effective on Gram-positive than on Gram-negative bacteria (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	20663230	BMC Genomics. 2010 Jul 28;11:452.	Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.	Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.	
DRAMP03704	LFGLIPSMMGGLVSAFK	17	Antimicrobial peptide 36.4 (Arthropods, animals)	P0CI89	Belongs to the short cationic antimicrobial peptide family	Not found	Lychas mucronatus (Chinese swimming scorpion)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Cationic host defense peptide that have antibacterial activity by breaking membranes. Is more effective on Gram-positive than on Gram-negative bacteria (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	20663230	BMC Genomics. 2010 Jul 28;11:452.	Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.	Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.	
DRAMP03705	LFFLPSLIGGLISAIK	16	Antimicrobial peptide 143 (Arthropods, animals)	P0CI90	Belongs to the short cationic antimicrobial peptide family	Not found	Lychas mucronatus (Chinese swimming scorpion)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Cationic host defense peptide that have antibacterial activity by breaking membranes. Is more effective on Gram-positive than on Gram-negative bacteria (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	20663230	BMC Genomics. 2010 Jul 28;11:452.	Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.	Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.	
DRAMP03708	RYCPRNPEACYNYCLRTGRPGGYCGGRSRITCFCFR	36	Tddefensin (Arthropods, animals)	P0CF77	Belongs to the invertebrate defensin family	Not found	Tityus discrepans (Venezuelan scorpion)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Antibacterial peptide mostly active against Gram-positive bacteria (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19470401	Biochimie. 2009 Aug;91(8):1010-1019.	D'Suze G, Schwartz EF, García-Gómez BI, Sevcik C, Possani LD.	Molecular cloning and nucleotide sequence analysis of genes from a cDNA library of the scorpion Tityus discrepans.	
DRAMP03709	GFREKHFQRFVKYAVPESTLRTVLQTVVHKVGKTQFGCPAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF	72	Potassium channel toxin MeuTXK-beta-1 (MeuTXKbeta1; Arthropods, animals)	A9XE60	Belongs to the long chain scorpion toxin family (Class 1 subfamily)	Not found	Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Has a low affinity binding to potassium channels of rat brain synaptosomes. Displays weak antibacterial activity against Stenotrophomonas sp. Strongly inhibits the development of the Plasmodium berghei ookinetes. Displays hemolytic effect on mouse erythrocytes. Induces cytolysis on Xenopus oocytes at high concentrations. Is not toxic on mice and on the insect Tenebrio molitor.
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	[Ref.20045493]10.3% hemolytic activity at 10 μM, 14.8% hemolytic activity at 20 μM against mouse erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20045493	Biochim Biophys Acta. 2010 Apr;1804(4):872-883.	Zhu S, Gao B, Aumelas A, del Carmen RodrÃ­guez M, Lanz-Mendoza H, Peigneur S, Diego-Garcia E, Martin-Eauclaire MF, Tytgat J, Possani LD.	MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity.	
DRAMP03710	GFREKHFQRFVKYAVPESTLRTVLQTVVHKVGKTQFGCSAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF	72	Potassium channel toxin MeuTXK-beta-2 (MeuTXKbeta2; Arthropods, animals)	A9XE59	Belongs to the long chain scorpion toxin family (Class 1 subfamily)	Not found	Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has a low affinity binding to potassium channels of rat brain synaptosomes. Displays weak antibacterial activity against Stenotrophomonas sp. Strongly inhibits the development of the Plasmodium berghei ookinetes. Displays slight hemolytic effect on mouse erythrocytes. Induces cytolysis on Xenopus oocytes at high concentrations. Is not toxic on mice and on the insect Tenebrio molitor.
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	[Ref.20045493]Slight hemolytic activity against mouse erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20045493	Biochim Biophys Acta. 2010 Apr;1804(4):872-883.	Zhu S, Gao B, Aumelas A, del Carmen RodrÃ­guez M, Lanz-Mendoza H, Peigneur S, Diego-Garcia E, Martin-Eauclaire MF, Tytgat J, Possani LD.	MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity.	
DRAMP03711	GLIHKVTKVQQLCAFNQDMAGWCEKSCQAAEGKNGYCHGTKCKCGKPLSYRRK	53	Scorpine-like peptide (OcyC7; Arthropods, animals)	C5J891	Belongs to the long chain scorpion toxin family (Class 3 subfamily)	Not found	Opisthacanthus cayaporum (South American scorpion)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Has antibacterial activity (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19379768	Toxicon. 2009 Sep 1;54(3):252-561.	Silva EC, Camargos TS, MaranhÃ£o AQ, Silva-Pereira I, Silva LP, Possani LD, Schwartz EF.	Cloning and characterization of cDNA sequences encoding for new venom peptides of the Brazilian scorpion Opisthacanthus cayaporum.	
DRAMP03712	IFKAIWSGIKSLF	13	Peptide Hp1090 (Non-disulfide-bridged peptide 5.9, NDBP-5.9; Arthropods, animals)	P0DJ02	Belongs to the scorpion NDBP 5 family	Not found	Heterometrus petersii (Asian forest scorpion)	Antimicrobial, Antibacterial, Antiviral	Transcript level	Alpha helix (CD)	CD spectroscopy analysis indicates that Hp1090 is an amphipathic α-helical peptide that prevents the initiation of HCV infection by directly interactingwith viral particles and rapidly permeabilizing their phospholipid membranes.		"Function: The peptide showed antibacterial activity against both Gram-negative and Gram-positive bacteria.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: This peptide has a significant inhibitory effect on hepatitis C virus (HCV) infection (IC50=7.62 µg/ml). Furthermore, this peptide potently inhibits HCV before viral entry into cells and kills HCV rapidly in vitro.
PTM: C-terminal amidation (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Binding to HCV	20950663	Peptides. 2011 Jan;32(1):11-19. 	Yan R, Zhao Z, He Y, Wu L, Cai D, Hong W, Wu Y, Cao Z, Zheng C, Li W.	A new natural alpha-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV.	
DRAMP03713	IFSAIGGFLKSIF	13	Peptide Hp1035 (Non-disulfide-bridged peptide 5.10, NDBP-5.10; Arthropods, animals)	P0DJ03	Belongs to the scorpion NDBP 5 family	Not found	Heterometrus petersii (Asian forest scorpion)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Amphipathic peptide with probable antibacterial activities. Hp1035 peptide, showing high homology to Hp1090, exhibited no anti-HCV activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20950663	Peptides. 2011 Jan;32(1):11-19. 	Yan R, Zhao Z, He Y, Wu L, Cai D, Hong W, Wu Y, Cao Z, Zheng C, Li W.	A new natural alpha-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV.	
DRAMP03716	KSTVGQKLKKKLNQAVDKVKEVLNKSEYMCPVVSSFCKQHCARLGKSGQCDLLECICS	58	Potassium channel toxin Hge-beta-KTx (HgebetaKTx; Arthropods, animals)	Q0GY41	Long chain scorpion toxin family (Class 2 subfamily)	Not found	Hadrurus gertschi (Scorpion)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: The full peptide presents antibacterial and cytotoxic activities. The C-terminus (33-76aa) blocks potassium channels Kv1.1/KCNA1, Kv1.2/KCNA2, and Kv1.3/KCNA3.
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17506894##18030427	BMC Genomics. 2007 May 16;8:119.##Cell Mol Life Sci. 2008 Jan;65(1):187-200.	Schwartz EF, Diego-Garcia E, RodrÃ­guez de la Vega RC, Possani LD.##Diego-GarcÃ­a E, Abdel-Mottaleb Y, Schwartz EF, de la Vega RC, Tytgat J, Possani LD.	Transcriptome analysis of the venom gland of the Mexican scorpion Hadrurus gertschi (Arachnida: Scorpiones).##Cytolytic and K+ channel blocking activities of beta-KTx and scorpine-like peptides purified from scorpion venoms.	
DRAMP03717	GRGREFMSNLKEKLSGVKEKMKNS	24	Meucin-24 (Arthropods, animals)	P0CH57	Long chain scorpion toxin family (Class 2 subfamily)	Not found	Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus)	Antimalarial	Protein level	Alpha helix (1 helices; 17 residues)	Circular dichroism (CD) analysis of chemically synthesized peptides demonstrates that meucin-24 presents an essential random coil conformation in water, but its alpha-helical content largely increases in the presence of 50% trifluoroethanol, a membrane-mimicking environment.	2KFE resolved by NMR.	"Function: The synthetic meucin-24 inhibits the development of P. berghei ookinetes, kills intraerythrocytic P.falciparum, and is cytotoxic to the Drosophila S2 cell at micromolar concentrations. No hemolytic activities have been found at micromolar concentrations.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: The RNA coding for this protein is silently edited.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	[Ref.20097251]Non-hemolytic effect against mouse erythrocytes even at 100 μM 	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20097251	Biochimie. 2010 Apr;92(4):350-359.	Gao B, Xu J, Rodriguez Mdel C, Lanz-Mendoza H, HernÃ¡ndez-Rivas R, Du W, Zhu S.	Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus.	
DRAMP03718	VKLIQIRIWIQYVTVLQMFSMKTKQ	25	Meucin-25 (BeL-170; Arthropods, animals)	P0CH58	Not found	Not found	Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus)	Antimalarial	Transcript level	Not found	CD results indicate that meucin-25 mainly adopts a beta-sheet structure in water but TFE promotes its alpha-helical formation, suggesting its conformational flexibility.		"Function: This synthetic cationic peptide inhibits the development of Plasmodium berghei ookinetes, kills intraerythrocytic P. falciparum, and is cytotoxic to the Drosophila S2 cell at micromolar concentrations. No hemolytic activities have been found at micromolar concentrations.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	[Ref.20097251]Non-hemolytic effect against mouse erythrocytes even at 101 μM	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20097251	Biochimie. 2010 Apr;92(4):350-359.	Gao B, Xu J, Rodriguez Mdel C, Lanz-Mendoza H, HernÃ¡ndez-Rivas R, Du W, Zhu S.	Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus.	
DRAMP03719	GFGCPLNQGACHRHCRSIRRRGGYCAGFFKQTCCYRN	37	Scorpion defensin (Arthropods, animals)	No entry found	Not found	Not found	Leiurus quinquestriatus	Antimicrobial, Antibacterial	Not found	Bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8333834	Biochem Biophys Res Commun. 1993 Jul 15;194(1):17-22.	Cociancich S, et al Hoffmann J.	Purification and characterization of a scorpion defensin, a 4kDa antibacterial peptide presenting structural similarities with insect defensins and scorpion toxins.	
DRAMP03720	GFGCPLNQGACHRHCRSIRRRGGYCAGFFKQTCTCYRN	38	4 kDa defensin (Antibacterial 4 kDa peptide; Arthropods, animals)	P41965	Belongs to the invertebrate defensin family (Type 2 subfamily)	Not found	Leiurus quinquestriatus hebraeus (Yellow scorpion)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antibacterial protein against Gram-positive bacteria; may act via membrane-permeabilization of these cells.
PTM: Contains three disulfide bonds 4-25; 11-33; 15-35 (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8333834	Biochem Biophys Res Commun. 1993 Jul 15;194(1):17-22.	Cociancich S, Goyffon M, Bontems F, Bulet P, Bouet F, Menez A, Hoffmann J.	Purification and characterization of a scorpion defensin, a 4kDa antibacterial peptide presenting structural similarities with insect defensins and scorpion toxins.	
DRAMP18417	FFGTLFKLGSKLIPGVMKLFSKKKER	26	ToAP2	A0A1D3IXJ5	Derived from NDBP subfamily 3	Not found	Tityus obscurus	Antimicrobial, Antifungal, Antibiofilm	Transcript level	Alpha helix	The peptide adopts a structure with 57.69% alpha helix		Function: antifungal activity. Has hemolytic activity.	[Ref.27917162] Fungi:Candida albicans (SC5314)(MIC=12.5μM);Candida tropicalis (ATCC 750)(MIC=3.12μM);Candida parapsilosis (ATCC 22019)(MIC=50μM);Candida glabrata (ATCC 90030)(MIC=200μM);Candida neoformans (H99 serotype A)(MIC=12.5μM)	[Ref.27917162] 30% hemolysis at 1.58 μM, 37% hemolysis at 3.16 μM, 45% hemolysis at 6.31 μM, 46% hemolysis at 12.59 μM, 48% hemolysis at 25.12 μM, 47% hemolysis at 50.11 μM , 50% hemolysis at 100μM against human red blood cell	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27917162	Front Microbiol. 2016 Nov 18;7:1844. eCollection 2016.	Guilhelmelli F, Vilela N, Smidt KS, de Oliveira MA, da Cunha Morales ?lvares A, Rigonatto MC, da Silva Costa PH, Tavares AH, de Freitas SM, Nicola AM, Franco OL, Derengowski LD, Schwartz EF, Mortari MR, Bocca AL, Albuquerque P, Silva-Pereira I.	Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms.	
DRAMP03725	IFSAIAGLLSNLL	13	Non-disulfide-bridged peptide 5.5 (NDBP-5.5; Arthropods, animals)	P0C8W1	Belongs to the scorpion NDBP 5 family	Not found	Hadrurus gertschi (Scorpion)	Antimicrobial, Antibacterial	Transcript level	Alpha helix 	Not found		Function: Has weak hemolytic activity.	No MICs found in DRAMP database	[Ref.17506894]Weak hemolytic activity against sheep red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	17506894	BMC Genomics. 2007 May 16;8:119.	Schwartz E.F, Diego-Garcia E, Rodriguez de la Vega R.C, Possani L.D.	Transcriptome analysis of the venom gland of the Mexican scorpion Hadrurus gertschi (Arachnida: Scorpiones).	
DRAMP03726	FIFDLLKKLV	10	Non-disulfide-bridged peptide 5.6 (NDBP-5.6; Arthropods, animals)	P0C8W2	Belongs to the scorpion NDBP 5 family	Not found	Hadrurus gertschi (Scorpion)	Antimicrobial, Antibacterial	Transcript level	Alpha helix 	Not found		Function: Has weak hemolytic activity.	No MICs found in DRAMP database	[Ref.17506894]Weak hemolytic activity against sheep red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	17506894	BMC Genomics. 2007 May 16;8:119.	Schwartz E.F, Diego-Garcia E, Rodriguez de la Vega R.C, Possani L.D.	Transcriptome analysis of the venom gland of the Mexican scorpion Hadrurus gertschi (Arachnida: Scorpiones).	
DRAMP03727	GWMSEKKVQGILDKKLPEGIIRNAAKAIVHKMAKNQFGCFANVDVKGDCKRHCKAEDKEGICHGTKCKCGVPISYL	76	Hge-scorpine (Hg-scorpine-like 1, HgeScplp1, Hgscplike1; Arthropods, animals)	Q0GY40, A8SDT6	Belongs to the long chain scorpion toxin family (Class 3 subfamily)	Not found	Hadrurus gertschi (Scorpion)	Antimicrobial, Antibacterial	Protein level	Not found	Not found	5IPO##5JYH	"Function: Hge-scorpine has antibacterial activity against B. subtilis, but not against S. aureus. Also has hemolytic and cytolytic activities. Hge36 peptide blocks Kv1.1/KCNA1 (IC50=185 nM) potassium channels. Shows a weak hemolytic activity.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: The C-terminus (AA 52-95) blocks Kv1.1/KCNA1, Kv1.2/KCNA2, and Kv1.3/KCNA2 potassium channels, showing a potential important role of AA 48-51. Hge36 peptide does not block Kv1.2/KCNA2 and Kv1.3/KCNA3.
PTM: Contains three disulfide bonds (By similarity)."	[Ref.18030427]Gram-postive bacteria:Bacillus subtilis(++), Staphylococcus aureus(-)	[Swiss_Prot Entry Q0GY40]has hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18030427	Cell Mol Life Sci. 2008 Jan;65(1):187-200.	Diego-GarcÃ­a E, Abdel-Mottaleb Y, Schwartz EF, de la Vega RC, Tytgat J, Possani LD.	Cytolytic and K+ channel blocking activities of beta-KTx and scorpine-like peptides purified from scorpion venoms.	
DRAMP03728	GILREKYAHKAIDVLTPMIGVPVVSKIVNNAAKQLVHKIAKNQQLCMFNKDVAGWCEKSCQQSAHQKGYCHGTKCKCGIPLNYK	84	Hg-scorpine-like 2 (Arthropods, animals)	P0C8W5	Belongs to the long chain scorpion toxin family (Class 3 subfamily)	Not found	Hadrurus gertschi (Scorpion)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Has antimicrobial activity against yeasts and bacteria (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity)."	Yeasts	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17506894	BMC Genomics. 2007 May 16;8:119.	Schwartz EF, Diego-Garcia E, RodrÃ­guez de la Vega RC, Possani LD.	Transcriptome analysis of the venom gland of the Mexican scorpion Hadrurus gertschi (Arachnida: Scorpiones).	
DRAMP03730	KWLNEKSIQNKIDEKIGKNFLGGMAKAVVHKLAKNEFMCMANMDPTGSCETHCQKASGEKGYCHGTKCKCGVPLSY	76	Opiscorpine-2 (Arthropods, animals)	Q5WR01, Q5WR02	Belongs to the long chain scorpion toxin family (Class 3 subfamily)	Not found	Opistophthalmus carinatus (African yellow leg scorpion)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Has antimicrobial activity against yeasts and bacteria (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity)."	Yeasts	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15241551	Cell Mol Life Sci. 2004 Jul;61(14):1751-1763.	Zhu S, Tytgat J.	The scorpine family of defensins: gene structure, alternative polyadenylation and fold recognition.	
DRAMP03731	KWLNEKSIQNKIDEKIGKNFLGGMAKAVVHKLAKNEFMCVANVDMTKSCDTHCQKASGEKGYCHGTKCKCGVPLSY	76	Opiscorpine-3 (Arthropods, animals)	Q5WQZ7	Belongs to the long chain scorpion toxin family (Class 3 subfamily)	Not found	Opistophthalmus carinatus (African yellow leg scorpion)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Has antimicrobial activity against yeasts and bacteria (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity)."	Yeasts	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15241551	Cell Mol Life Sci. 2004 Jul;61(14):1751-1763.	Zhu S, Tytgat J.	The scorpine family of defensins: gene structure, alternative polyadenylation and fold recognition.	
DRAMP03732	KWLNEKSIQNKIDEKIGKNFLGGMAKAVVHKLAKNEFMCVANIDMTKSCDTHCQKASGEKGYCHGTKCKCGVPLSY	76	Opiscorpine-4 (Arthropods, animals)	Q5WQZ9	Belongs to the long chain scorpion toxin family (Class 3 subfamily)	Not found	Opistophthalmus carinatus (African yellow leg scorpion)	Antimicrobial, Antibacterial, Antifungal	Transcript level	Not found	Not found		"Function: Has antimicrobial activity against yeasts and bacteria (By similarity).
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity)."	Yeasts	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15241551	Cell Mol Life Sci. 2004 Jul;61(14):1751-1763.	Zhu S, Tytgat J.	The scorpine family of defensins: gene structure, alternative polyadenylation and fold recognition.	
DRAMP03733	SIYERCELARELINR	15	Lysozyme (Arthropods, animals)	P0C8X2	Belongs to the glycosyl hydrolase 22 family	Not found	Tityus stigmurus (Brazilian scorpion)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Lysozymes have primarily a bacteriolytic Function: (By similarity).
Catalytic activity: Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17270501	Comp Biochem Physiol C Toxicol Pharmacol. 2007 Jul-Aug;146(1-2):147-157.	Batista C.V.F, Roman-Gonzalez S.A, Salas-Castillo S.P, Zamudio F.Z, Gomez-Lagunas F, Possani L.D.	Proteomic analysis of the venom from the scorpion Tityus stigmurus: biochemical and physiological comparison with other Tityus species.	
DRAMP03736	GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNFVAEKIGATPS	44	Opistoporin-2 (OP2; Non-disulfide-bridged peptide 3.6, NDBP-3.6; Arthropods, animals)	P83314	Belongs to the antimicrobial peptide scorpion family	Not found	Opistophthalmus carinatus (African yellow leg scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found		"Function: At high concentrations, acts as pore former in cellular membranes and causes the leakage of the cells. At submicromolar concentrations, degranulates granulocytes and has weak hemolytic activity against human red blood cells. Also strongly inhibits the production of superoxide anions. Has a strong antibacterial activity against Gram-negative bacteria but is less active against Gram-positive bacteria. Also has antifungal activity. (By similarity)
Tissue specificity: Expressed by the venom gland."	[Swiss_Prot Entry P83314]strong antibacterial activity against Gram-negative bacteria but is less active against Gram-positive bacteria. Also has antifungal activity.	[Swiss_Prot Entry P83314]Weak hemolytic activity against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	12354111	Eur J Biochem. 2002 Oct;269(19):4799-4810.	Moerman L, Bosteels S, Noppe W, Willems J, Clynen E, Schoofs L, Thevissen K, Tytgat J, Van Eldere J, Van Der Walt J, Verdonck F.	Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa.	
DRAMP03737	GKVWDWIKKTAKDVLNSDVAKQLKNKALNAAKNFVAEKIGATPS	44	Opistoporin-4 (Non-disulfide-bridged peptides 3.7, NDBP-3.7; Arthropods, animals)	Q5VJS9	Belongs to the antimicrobial peptide scorpion family	Not found	Opistophthalmus carinatus (African yellow leg scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		"Function: At high concentrations, acts as pore former in cellular membranes and causes the leakage of the cells. At submicromolar concentrations, degranulates granulocytes and has weak hemolytic activity against human red blood cells. Also strongly inhibits the production of superoxide anions. Has a strong antibacterial activity against Gram-negative bacteria but is less active against Gram-positive bacteria. Also has antifungal activity. (By similarity)
Tissue specificity: Expressed by the venom gland."	[Swiss_Prot Entry Q5VJS9]strong antibacterial activity against Gram-negative bacteria but is less active against Gram-positive bacteria. Also has antifungal activity.	[Swiss_Prot Entry Q5VJS9]Weak hemolytic activity against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	PubMed ID is not available	Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases	Zhu S, Tytgat J.	Precursor organization and gene structure of scorpion venom antimicrobial peptides.	
DRAMP03739	SIVPIRCRSNRDCRRFCGFRGGRCTYARQCLCGY	34	Buthinin (Sahara scorpion; Arthropods, animals)	P56685, P81617	Not found	Not found	Androctonus australis (Sahara scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		Function: Active against both Gram-positive and Gram-negative bacteria.	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Has three disulfide bonds	L	No cytotoxicity information found	Not found	8939880	J Biol Chem. 1996 Nov 22;271(47):29537-29544.	Ehret-Sabatier L, Loew D, Goyffon M, Fehlbaum P, Hoffmann JA, van Dorsselaer A, Bulet P.	Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood.	
DRAMP03740	GFGCPFNQGACHRHCRSIRRRGGYCAGLFKQTCTCYR	37	Androctonus defensin (4 kDa defensin; Arthropods, animals)	P56686, P81618	Belongs to the invertebrate defensin family (Type 2 subfamily)	Not found	Androctonus australis (Sahara scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Bridge	Not found		Function: Active against both Gram-positive and Gram-negative bacteria.	Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8939880	J Biol Chem. 1996 Nov 22;271(47):29537-29544.	Ehret-Sabatier L, Loew D, Goyffon M, Fehlbaum P, Hoffmann JA, van Dorsselaer A, Bulet P.	Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood.	
DRAMP03741	IFGSLFSLGSKLLPSVFKLFSRKKQ	25	Ponericin-W-like 32.1 (Arthropods, animals)	P0CI91	Belongs to the ponericin-W family	Not found	Lychas mucronatus (Chinese swimming scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Insecticidal	Transcript level	Not found	Not found		"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities (By similarity).
Tissue specificity: Expressed by the venom gland."	[Swiss_Prot Entry P0CI91]Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae	[Swiss_Prot Entry P0CI91]has hemolytic activities	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20663230	BMC Genomics. 2010 Jul 28;11:452.	Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.	Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.	
DRAMP03742	IFGSLFSLGSKLLPTVFKLFSRKKQ	25	Ponericin-W-like 32.2 (Arthropods, animals)	P0CI92	Belongs to the ponericin-W family	Not found	Lychas mucronatus (Chinese swimming scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Insecticidal	Transcript level	Not found	Not found		"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities (By similarity).
Tissue specificity: Expressed by the venom gland."	[Swiss_Prot Entry P0CI92]Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae	[Swiss_Prot Entry P0CI92]has hemolytic activities	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20663230	BMC Genomics. 2010 Jul 28;11:452.	Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.	Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.	
DRAMP03744	DNGYLLDKYTGCKVWCVINNESCNSECKIRGGYYGYCYFWKLACFCQGARKSELWNYNTNKCNGKL	66	Beta-toxin BmKAS (BmK AS, BmK-AS; BmK-PL; Arthropods, animals)	Q9UAC9	Not found	Not found	Mesobuthus martensii (Manchurian scorpion) (Buthus martensii)	Unknown	Protein level	Not found	Not found		Function: Beta toxins bind voltage-independently at site-4 of sodium channels and shift the voltage of activation toward more negative potentials thereby affecting sodium channel activation and promoting spontaneous and repetitive firing. It binds to distinct receptor sites of mammal and insect voltage-gated sodium channels. It displays antinociceptive effect in rat models, which is due to its specific modulation of sodium channels of sensory neurons. It also significantly stimulates the binding of [3H]-ryanodine to ryanodine receptors on the sarcoplasmic reticulum of the skeletal muscle through an indirect mechanism. And it promotes noradrenaline release from the rat hippocampus slice. Tissue specificity: Expressed by the venom gland. PTM: Contains four disulfide bonds 12-62; 16-37; 23-44; 27-46.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10191265##12376194	Biochem J. 1999 Apr 15;339 (Pt 2):343-350.##Brain Res. 2002 Oct 18;952(2):322-326.	Kuniyasu A, Kawano S, Hirayama Y, Ji YH, Xu K, Ohkura M, Furukawa K, Ohizumi Y, Hiraoka M, Nakayama H.##Chen B, Ji Y.	A new scorpion toxin (BmK-PL) stimulates Ca2+-release channel activity of the skeletal-muscle ryanodine receptor by an indirect mechanism.##Antihyperalgesia effect of BmK AS, a scorpion toxin, in rat by intraplantar injection.	
DRAMP03745	FIGAVAGLLSKIF	13	Peptide BmKn1 (Biologically active peptide 4; NDBP-5.1; Arthropods, animals)	Q9GQW4	Belongs to the scorpion NDBP 5 family	Kn1	Mesobuthus martensii (Buthus martensii)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Function: Antibacterial peptide (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11463163##PubMed ID is not available	IUBMB Life. 2001 Feb;51(2):117-120.##Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.	Zeng XC, Li WX, Wang SX, Zhu SY, Luo F.##Li WX, Zhu SY.	Precursor of a novel scorpion venom peptide (BmKn1) with no disulfide bridge from Buthus martensii Karsch.##A full-length cDNA encoding a putative active peptide, peptide 4, from Buthus martensii Karsch.	
DRAMP03747	FLSSLIPSAISGLISAFK	18	Peptide BmKb2 (Arthropods, animals)	Q2M591	Not found	Kb2	Mesobuthus martensii (Manchurian scorpion) (Buthus martensii)	Antimicrobial	Homology	Not found	Not found		Function: May be an antimicrobial peptide (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	cell membrane	16040157	Peptides. 2005 Dec;26(12):2427-2433.	Luo F, Zeng XC, Hahin R, Cao ZJ, Liu H, Li WX.	Genomic organization of four novel nondisulfide-bridged peptides from scorpion Mesobuthus martensii Karsch: gaining insight into evolutionary mechanism.	
DRAMP03749	YPASMDNYDDALEELDNLDLDDYFDLEPADFVLLDMWANMLESSDFDDME	50	Peptide BmKa2 (Acidic venom peptide Ka2; NDBP-6.2; Arthropods, animals)	Q8N0N8	Not found	Ka2	Mesobuthus martensii (Manchurian scorpion) (Buthus martensii)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Highly acidic peptide that may have antibacterial activity.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15062994##16040157	Peptides. 2004 Feb;25(2):143-150.##Peptides. 2005 Dec;26(12):2427-2433.	Zeng XC, Wang SX, Zhu Y, Zhu SY, Li WX.##Luo F, Zeng XC, Hahin R, Cao ZJ, Liu H, Li WX.	Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch.##Genomic organization of four novel nondisulfide-bridged peptides from scorpion Mesobuthus martensii Karsch: gaining ins	
DRAMP03755	QFTNVSCTTSKECWSVCQRLHNTSRGKCMNKKCRCYS	37	Potassium channel toxin alpha-KTx 1.1 (ChTX-Lq1; charybdotoxin; Arthropods, animals)	P13487	Not found	Not found	Leiurus quinquestriatus hebraeus (Yellow scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiviral	Protein level	Combine helix and strand structure	These structures show that charybdotoxin is composed of a beta-sheet linked to an alpha-helix by two disulphide bridges and to an extended fragment by the third disulphide bridge. 	1BAH, 2CRD resolved by NMR.	"Function: Potent selective inhibitor of high conductance (maxi-K), different medium and small conductance calcium-activated potassium channels (KCa/KCNM), as well as a voltage-dependent potassium channel (Kv1.3/KCNA3). It appears to block channel activity by a simple bimolecular inhibition process.
Tissue specificity: Expressed by the venom gland.
Domain: Has the structural arrangement of an alpha-helix connected to a beta-sheet by disulfide bonds (CSalpha/beta).
PTM: Contains three disulfide bonds."	Gram-positive bacteria: B.subtilis, S.aureus;##Gram-negative bacterium: E.coli.##Yeast: Candida albicans. 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15118082##1705886##9092804##1380828	Proc Natl Acad Sci U S A. 2004 May 11;101(19):7363-7368.##Eur J Biochem. 1991 Feb 26;196(1):19-28.##Biochemistry. 1997 Apr 1;36(13):3760-3766.##Biochemistry. 1992 Sep 1;31(34):7756-7764.	Yount NY, Yeaman MR.##Bontems F, Roumestand C, Boyot P, Gilquin B, Doljansky Y, Menez A, Toma F.##Song J, Gilquin B, Jamin N, Drakopoulou E, Guenneugues M, Dauplais M, Vita C, Ménez A.##Bontems F, Gilquin B, Roumestand C, Ménez A, Toma F.	Multidimensional signatures in antimicrobial peptides.##Three-dimensional structure of natural charybdotoxin in aqueous solution by 1H-NMR. Charybdotoxin possesses a structural motif found in other scorpion toxins.##NMR solution structure of a two-disulfide derivative of charybdotoxin: structural evidence for conservation of scorpion toxin alpha/beta motif and its hydrophobic side chain packing.##Analysis of side-chain organization on a refined model of charybdotoxin: structural and functional i	
DRAMP03756	FLGGLWKAMSNLL	13	Cytotoxic linear peptide (Non-disulfide bridged protein family 5, NDBP-5; Arthropods, animals)	H2CYR5	Not found	Not found	Pandinus cavimanus (Tanzanian red clawed scorpion)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Function: Amphipathic peptide that has antibacterial activities.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	22121013	Proteomics. 2012 Jan;12(2):313-328.	Diego-GarcÃ­a E, Peigneur S, Clynen E, Marien T, Czech L, Schoofs L, Tytgat J.	Molecular diversity of the telson and venom components from Pandinus cavimanus (Scorpionidae Latreille 1802): transcriptome, venomics and function.	
DRAMP03757	FIMDLLGKIF	10	Amphipathic peptide Tx348 (BoiTx348; Arthropods, animals)	B8XH50	Not found	Not found	Buthus occitanus israelis (Common yellow scorpion)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"PTM: C-terminal amidation and Cleavage on pair of basic residues.
Function: Amphipathic peptide that shows antibacterial acitivities."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	PubMed ID is not available	Submitted (OCT-2008) to the EMBL/GenBank/DDBJ databases	Zilberberg N, Kozminsky-Atias A.	Buthus occitanus israelis scorpion toxin.	
DRAMP18191	FLFSLIPHAISGLISAFK	18	Antimicrobial peptide AcrAP1	A0A0A1I6E7	 Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short an	Not found	Androctonus crassicauda (Arabian fat-tailed scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		Has antimicrobial activity against the Gram-positive bacteria S.aureus and the yeast C.albicans. Causes hemolysis on horse erythrocytes (64 uM for 100% hemolysis).	Gram-positive bacteria: S.aureus (MIC=8 uM, MBC=32 uM);##Yeast: C.albicans (MIC=16 uM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	25332684	Int. J. Biol. Sci. 10:1097-1107(2014)	Du Q., Hou X., Ge L., Li R., Zhou M., Wang H., Wang L., Wei M.,Chen T., Shaw C.	Cationicity-enhanced analogues of the antimicrobial peptides, AcrAP1and AcrAP2, from the venom of the scorpion, Androctonus crassicauda,display potent growth modulation effects on human cancer cell lines.	
DRAMP03759	FFSLIPSLIGGLVFAIK	17	Putative antimicrobial peptide clone 5 (Arthropods, animals)	Q5G8B4	Not found	Not found	Tityus costatus (Brazilian scorpion)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Antibacterial peptide.(By similarity)
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15683865	Toxicon. 2005 Mar 1;45(3):273-283.	Diego-GarcÃ­a E, Batista CV, GarcÃ­a-GÃ³mez BI, Lucas S, Candido DM, GÃ³mez-Lagunas F, Possani LD.	The Brazilian scorpion Tityus costatus Karsch: genes, peptides and function.	
DRAMP03760	FFSLIPSLIGGLVSAIK	17	Putative antimicrobial peptide clone 6 (Arthropods, animals)	Q5G8B3	Not found	Not found	Tityus costatus (Brazilian scorpion)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Antibacterial peptide.(By similarity)
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15683865	Toxicon. 2005 Mar 1;45(3):273-283.	Diego-GarcÃ­a E, Batista CV, GarcÃ­a-GÃ³mez BI, Lucas S, Candido DM, GÃ³mez-Lagunas F, Possani LD.	The Brazilian scorpion Tityus costatus Karsch: genes, peptides and function.	
DRAMP03761	GLREKHVQKLVALIPNDQLRSILKAVVHKVAKTQFGCPAYEGYCNNHCQDIERKDGECHGFKCKCAKD	68	Scorpine-like peptide Tco 41.46-2 (Arthropods, animals)	Q5G8A6, Q5G8A7	Not found	Not found	Tityus costatus (Brazilian scorpion)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Scorpine-like peptide Tco 41.46-2 may have anti-bacterial activity.(By similarity)
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15683865	Toxicon. 2005 Mar 1;45(3):273-283.	Diego-GarcÃ­a E, Batista CV, GarcÃ­a-GÃ³mez BI, Lucas S, Candido DM, GÃ³mez-Lagunas F, Possani LD.	The Brazilian scorpion Tityus costatus Karsch: genes, peptides and function.	
DRAMP03762	YPTSYDDDFDALDDLDDLDLDDLLDLEPADLVLLDMWANMLDSQDFEDFE	50	Anionic peptide clone 7 (Asp-rich; Arthropods, animals)	Q5G8B2	Not found	Not found	Tityus costatus (Brazilian scorpion)	Antimicrobial	Transcript level	Not found	Not found		"Function: May be an antimicrobial peptide.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15683865	Toxicon. 2005 Mar 1;45(3):273-283.	Diego-GarcÃ­a E, Batista CV, GarcÃ­a-GÃ³mez BI, Lucas S, Candido DM, GÃ³mez-Lagunas F, Possani LD.	The Brazilian scorpion Tityus costatus Karsch: genes, peptides and function.	
DRAMP03763	YPASYDDDFDALDDLDDLDLDDLLDLEPADLVLLDMWANMLDSQDFEDFE	50	Anionic peptide clone 8 (Asp-rich; Arthropods, animals)	Q5G8B1	Not found	Not found	Tityus costatus (Brazilian scorpion)	Antimicrobial	Transcript level	Not found	Not found		"Function: May be an antimicrobial peptide.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15683865	Toxicon. 2005 Mar 1;45(3):273-283.	Diego-GarcÃ­a E, Batista CV, GarcÃ­a-GÃ³mez BI, Lucas S, Candido DM, GÃ³mez-Lagunas F, Possani LD.	The Brazilian scorpion Tityus costatus Karsch: genes, peptides and function.	
DRAMP03764	YPASYDDDFDALDDLDGLDLDDLLDSEPADLVLLDMWANMLDSQDFEDFE	50	Anionic peptide clone 9 (Asp-rich; Arthropods, animals)	Q5G8B0	Not found	Not found	Tityus costatus (Brazilian scorpion)	Antimicrobial	Transcript level	Not found	Not found		"Function: May be an antimicrobial peptide.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15683865	Toxicon. 2005 Mar 1;45(3):273-283.	Diego-GarcÃ­a E, Batista CV, GarcÃ­a-GÃ³mez BI, Lucas S, Candido DM, GÃ³mez-Lagunas F, Possani LD.	The Brazilian scorpion Tityus costatus Karsch: genes, peptides and function.	
DRAMP03765	YPASYDGDFDALDDLDDLDLDDLLDLEPADLVLLDMWANMLDSQDFEDFE	50	Anionic peptide clone 10 (Asp-rich; Arthropods, animals)	Q5G8A9	Not found	Not found	Tityus costatus (Brazilian scorpion)	Antimicrobial	Transcript level	Not found	Not found		"Function: May be an antimicrobial peptide.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15683865	Toxicon. 2005 Mar 1;45(3):273-283.	Diego-GarcÃ­a E, Batista CV, GarcÃ­a-GÃ³mez BI, Lucas S, Candido DM, GÃ³mez-Lagunas F, Possani LD.	The Brazilian scorpion Tityus costatus Karsch: genes, peptides and function.	
DRAMP03766	GWINEEKIQKKIDEKIGNNILGGMAKAVVHKLAKGEFQCVANIDTMGNCETHCQKTSGEKGFCHGTKCKCGKPLSY	76	Heteroscorpine-1 (HS-1; defensins; Arthropods, animals)	P0C2F4	Belongs to the long chain scorpion toxin family (Class 3 subfamily)	Not found	Heterometrus laoticus (Thai giant scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has antibacterial activity.
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity).
Toxic dose: PD50 is 80 ul to crickets (Gryllus sp)."	Gram-positive bacterium: Bacillus subtilis (5.2 mm);##Gram-negative bacteria: Klebsiella pneumoniae (10.57 mm), Pseudomonas aeruginosa (6.4 mm).##NOTE: Diameter of clear zone from disc diffusion assay. Total protein is 6.25 µmole.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17056081	Toxicon. 2007 Jan;49(1):19-29.	Uawonggul N, Thammasirirak S, Chaveerach A, Arkaravichien T, Bunyatratchata W, Ruangjirachuporn W, Jearranaiprepame P, Nakamura T, Matsuda M, Kobayashi M, Hattori S, Daduang S.	Purification and characterization of Heteroscorpine-1 (HS-1) toxin from Heterometrus laoticus scorpion venom.	
DRAMP03768	ILSAIWSGIKS	11	OcyC1f (one chain of Non-disulfide-bridged peptide 5.7; Arthropods, animals)	C5J886	Not found	Not found	isthacanthus cayaporum (South American scorpion)	Antimicrobial	Protein level	Not found	Not found		"PTM: C-terminal amidation.
Function: Amphipathic peptide with probable antimicrobial activity."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19857508##18695936	Toxicon. 2009 Sep 1;54(3):252-561.##Toxicon. 2008 Jun 15;51(8):1499-508.	Silva EC, Camargos TS, MaranhÃ£o AQ, Silva-Pereira I, Silva LP, Possani LD, Schwartz EF.##Schwartz EF, Camargos TS, Zamudio FZ, Silva LP, Bloch C Jr, Caixeta F, Schwartz CA, Possani LD.	Cloning and characterization of cDNA sequences encoding for new venom peptides of the Brazilian scorpion Opisthacanthus cayaporum.##Mass spectrometry analysis, amino acid sequence and biological activity of venom components from the Brazilian scorpion Opisthacanthus cayaporum.	
DRAMP03769	GILGKIWEGVKSLI	14	OcyC2 (one chain of Non-disulfide-bridged peptide 5.8; Arthropods, animals)	C5J887	Not found	Not found	isthacanthus cayaporum (South American scorpion)	Antimicrobial	Protein level	Not found	Not found		"PTM: C-terminal amidation.
Function: Amphipathic peptide with probable antimicrobial activity."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19379768	Toxicon. 2009 Sep 1;54(3):252-261.	Silva EC, Camargos TS, MaranhÃ£o AQ, Silva-Pereira I, Silva LP, Possani LD, Schwartz EF.	Cloning and characterization of cDNA sequences encoding for new venom peptides of the Brazilian scorpion Opisthacanthus cayaporum.	
DRAMP03770	GILGKIWEGVKS	12	OcyC2f (one chain of Non-disulfide-bridged peptide 5.8; Arthropods, animals)	C5J887	Not found	Not found	isthacanthus cayaporum (South American scorpion)	Antimicrobial	Protein level	Not found	Not found		"PTM: C-terminal amidation.
Function: Amphipathic peptide with probable antimicrobial activity."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19379768	Toxicon. 2009 Sep 1;54(3):252-261.	Silva EC, Camargos TS, MaranhÃ£o AQ, Silva-Pereira I, Silva LP, Possani LD, Schwartz EF.	Cloning and characterization of cDNA sequences encoding for new venom peptides of the Brazilian scorpion Opisthacanthus cayaporum.	
DRAMP03771	FWATLAKGALKLIPTIANAFSSKS	24	Non-disulfide-bridged peptide 4.3 (NDBP-4.3; OcyC3; Arthropods, animals)	C5J888	Not found	Not found	Opisthacanthus cayaporum (South American scorpion)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Amphipathic peptide with probable antimicrobial activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19379768##18502464	Toxicon. 2009 Sep 1;54(3):252-261.##Toxicon. 2008 Jun 15;51(8):1499-508.	Silva EC, Camargos TS, MaranhÃ£o AQ, Silva-Pereira I, Silva LP, Possani LD, Schwartz EF.##Schwartz EF, Camargos TS, Zamudio FZ, Silva LP, Bloch C Jr, Caixeta F, Schwartz CA, Possani LD.	Cloning and characterization of cDNA sequences encoding for new venom peptides of the Brazilian scorpion Opisthacanthus cayaporum.##Mass spectrometry analysis, amino acid sequence and biological activity of venom components from the Brazilian scorpion Opisthacanthus cayaporum.	
DRAMP03772	FLGALLSKIF	10	Amphipathic peptide Hj0164 (Non-disulfide bridged protein family 5, NDBP-5; Arthropods, animals)	F1CJ89	Not found	Not found	Buthotus judaicus (Scorpion) (Hottentotta judaica)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"PTM: C-terminal amidation and Cleavage on pair of basic residues.
Function: Amphipathic peptide that shows antibacterial acitivities."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	21329713	Toxicon. 2011 Apr;57(5):695-703.	Morgenstern D, Rohde BH, King GF, Tal T, Sher D, Zlotkin E.	The tale of a resting gland: transcriptome of a replete venom gland from the scorpion Hottentotta judaicus.	
DRAMP03773	FKFGSFIKRMWRSKLAKKLRAKGKELLRDYANRVLSPEEEAAAPAPVPA	49	Meucin-49 (Arthropods, animals)	P86407	Not found	Not found	Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus)	Antimicrobial	Protein level	Not found	Not found		"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2009) to UniProtKB	Zhu S.Y, Gao B.	Characterization of an antimicrobial peptide from the scorpion Mesobuthus eupeus venom.	
DRAMP03778	ANDPQCLYGNVAAKF	15	Agrocybin (Fungus)	P84797	Not found	Not found	Agrocybe cylindracea (Toadstool)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Protein level	Not found	Not found		Function: Has mitogenic activity towards murine splenocytes. Lacks antiproliferative activity towards HepG2 hepatoma cells. 	Mycosphaerella arachidicola (IC50=125 µM), HIV-1 reverse transcriptase (IC50=60 µM), Pseudomonas fluorescens.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15629530	Peptides. 2005 Feb;26(2):191-196.	Ngai PH, Zhao Z, Ng TB.	Agrocybin, an antifungal peptide from the edible mushroom Agrocybe cylindracea.	
DRAMP03779	XTYNGKCYKKDNICKYKAQSGKTAICKCYVKKCPRDGAKCEFDSYKGKCYC	51	Antifungal protein (AFP; Fungi)	P17737	Not found	afp	Aspergillus giganteus	Antimicrobial, Antifungal	Protein level	Beta strand (6 strands; 15 residues)	The folding of AFP consists of five antiparallel beta strands connected in a -1, -1, +3, +1 topology and highly twisted, defining a small and compact beta barrel stabilized by four internal disulfide bridges. A cationic site formed by up to three lysine side chains adjacent to a hydrophobic stretch, both at the protein surface, may constitute a potential binding site for phospholipids which would be the basis of its biological function.	1AFP resolved by NMR.	"Function: This protein inhibits the growth of a variety of fungal species.
PTM: Contains four disulfide bonds 7-33; 14-40; 26-28; 49-51."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Phospholipids	2226447##7893713	Eur J Biochem. 1990 Oct 5;193(1):31-38.##Biochemistry. 1995 Mar 7;34(9):3009-3021.	Nakaya K, Omata K, Okahashi I, Nakamura Y, Kolekenbrock H, Ulbrich N.##Campos-Olivas R, Bruix M, Santoro J, Lacadena J, Martinez del Pozo A, Gavilanes JG, Rico M.	Amino acid sequence and disulfide bridges of an antifungal protein isolated from Aspergillus giganteus.##NMR solution structure of the antifungal protein from Aspergillus giganteus: evidence for cysteine pairing isomerism.	
DRAMP03780	AIPIAYVGMAVAPQVFRWLVRAYGAAAVTAAGVTLRRVINRSRSNDNHSCYGNRGWCRSSCRSYEREYRGGNLGVCGSYKCCVT	84	Big defensin (AiBD)	Q0H293	Not found	Not found	Argopecten irradians (Bay scallop) (Aequipecten irradians)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: Significantly inhibits the growth of Gram-negative and Gram-positive bacteria and fungi in vitro.
Tissue specificity: Expressed in hemocytes.
PTM: Contains three disulfide bonds 50-81; 57-76; 61-82."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16597463	Mol Immunol. 2007 Jan;44(4):360-368.	Zhao J, Song L, Li C, Ni D, Wu L, Zhu L, Wang H, Xu W.	Molecular cloning, expression of a big defensin gene from bay scallop Argopecten irradians and the antimicrobial activity of its recombinant protein.	
DRAMP03781	MGWLKKIGKKIERVGQHTRDATIQGLGIAQQAANVAATARGGRATAAVNAAQQAIGLGQITADRTHQGVREIKKGIKKLWG	81	CECdir-CECret	No entry found	Not found	Not found	Unknown	Antimicrobial	Not found	Not found	Not found		CECdir-CECret displays an enhanced in vitro antimicrobial activity and action spectrum in comparison to the monomer Cecropin A.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18325631	Peptides. 2008 Apr;29(4):512-519.	Schmitt P, Mercado L, DÃ­az M, GuzmÃ¡n F, Arenas G, Marshall SH.	Characterization and functional recovery of a novel antimicrobial peptide (CECdir-CECret) from inclusion bodies after expression in Escherichia coli.	
DRAMP03782	CPCGRRRCCVRGLNVYCCF	19	Corticostatin-related peptide LCRP (alpha-defensin)	Q10996	Belongs to the alpha-defensin family	Not found	Petromyzon marinus (Sea lamprey)	Antimicrobial	Protein level	Not found	Not found		"Function: May have microbicidal activities. May inhibit corticotropin (ACTH) stimulated steroidogenesis and the microbial actions of the corticostatins.
PTM: Problely contains three disulfide bonds 1-18; 3-9; 8-17."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8759287	Comp Biochem Physiol B Biochem Mol Biol. 1996 Jun;114(2):133-137.	Conlon JM, Sower SA.	Isolation of a peptide structurally related to mammaliancorticostatins from the lamprey Petromyzon marinus.	
DRAMP03783	QWGYGGMPYGGYGGMGGYGMGGYGMGYRRRMWGSPYGGYGGYGGYGGWG	49	Neuropeptide-like protein 27 (NLP-27; Gly-rich, Tyr-rich; nematodes, animals; Predicted)	No entry found	Not found	Not found	Caenorhabditis elegans	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15048112	Nat Immunol. 2004 May;5(5):488-494.	Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.	TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.	
DRAMP03784	QWGYGGYGRGYGGYGGYGRGMYGGYGRGMYGGYGRGMYGGWGK	43	Neuropeptide-like protein 28 (NLP-28; Gly-rich, Tyr-rich; nematodes, animals; Predicted)	No entry found	Not found	Not found	Caenorhabditis elegans	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15048112	Nat Immunol. 2004 May;5(5):488-494.	Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.	TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.	
DRAMP03785	QWGYGGYGRGYGGYGGYGRGMYGGYGRGMYGGYGRGMYGGYGRGMYGGWGK	51	Neuropeptide-like protein 29 (NLP-29; nematodes, animals)	O44664	Not found	nlp-29	Caenorhabditis elegans	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		"Function: Antimicrobial peptides that have antibacterial and antifungal activity.
Tissue specificity: Weakly or not expressed in absence of infection. Upon infection by D. coniospora, it is expressed in hypoderm. Also expressed in perivulval cells when D. coniospora spores adhere to this region.
Induction: Upon D. coniospora and S. marcescens infection.
PTM: C-terminal amidation."	Gram-negative bacterium: S. marcescens.##Fungi: D. coniospora.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11717458##15048112	Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14000-14005.##Nat Immunol. 2004 May;5(5):488-494.	Nathoo AN, Moeller RA, Westlund BA, Hart AC.##Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.	Identification of neuropeptide-like protein gene families in Caenorhabditiselegans and other species.##TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.	
DRAMP03786	QWGYGGYGRGYGGYGGYGRGYGGYGRGYGGYGRGMWGRPYGGYGWGK	47	Neuropeptide-like protein 30 (NLP-30; Gly-rich, Tyr-rich; nematodes, animals; Predicted)	No entry found	Not found	Not found	Caenorhabditis elegans	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15048112	Nat Immunol. 2004 May;5(5):488-494.	Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.	TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.	
DRAMP03787	NAQWGYGGYGRGYGGYGGYGRGYGGYGGYGRGYGGYGRGMYGGYGRPYGGYGWGK	55	Neuropeptide-like protein 31 (NLP-31; nematodes, animals)	O44662	Belongs to the YARP family	nlp-31	Caenorhabditis elegans	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		"Function: Antimicrobial peptide that has antifungal and weak antibacterial activity.
Tissue specificity: Expressed in hypoderm.
Developmental stage: Expressed in precomma stasge embryos.
Induction: Strongly up-regulated upon D. coniospora infection.
PTM: C-terminal amidation."	Gram-positive bacterium: Micrococcus luteus;##Gram-negative bacterium: E.coli.##Fungi: D.coniospora.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11717458##15048112	Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14000-5.##Nat Immunol. 2004 May;5(5):488-494.	Nathoo AN, Moeller RA, Westlund BA, Hart AC.##Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.	Identification of neuropeptide-like protein gene families in Caenorhabditis elegans and other species.##TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.	
DRAMP03788	QWGYGGPYGGYGGGYGGGPWGYGGGWRRRHWGGYGGGPWGGYGGGPWGGYY	51	Neuropeptide-like protein 33 (NLP-33; nematodes, animals)	Q95ZN4	Not found	nlp-33	Caenorhabditis elegans	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		"Function: May have antifungic activity.
Tissue specificity: Expressed in hypoderm.
Induction: Strongly up-regulated upon D. coniospora infection. 
PTM: C-terminal amidation."	Fungi: Drechmeria coniospora.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9851916##15048112	Science. 1998 Dec 11;282(5396):2012-2018.##Nat Immunol. 2004 May;5(5):488-494.	C. elegans Sequencing Consortium.## Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.	Genome sequence of the nematode C. elegans: a platform for investigating biology.##TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.	
DRAMP03789	EASCARMDVPVMQRIAQGLCTSSCTAQKCMTGICKKVDSHPTCFCGGCSNANDVSLDTLISQLPHN	66	ABF-1 (nematodes, animals)	No entry found	Not found	abf-1	Caenorhabditis elegans	Antimicrobial, Antibacterial, Antifungal	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11772394	Biochem J. 2002 Jan 15;361(Pt 2):221-230.	Kato Y, Aizawa T, Hoshino H, Kawano K, Nitta K, Zhang H.	abf-1 and abf-2, ASABF-type antimicrobial peptide genes in Caenorhabditis elegans.	
DRAMP03790	DIDFSTCARMDVPILKKAAQGLCITSCSMQNCGTGSCKKRSGRPTCVCYRCANGGGDIPLGALIKRG	67	ABF-2 (nematodes, animals)	G5EC68	Not found	abf-2	Caenorhabditis elegans	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Predicted	Not found	Not found	5IX5	Comment: No comments found on DRAMP database	Gram-positive bacteria: Bacillus subtilis IFO3134 (BC50=0.09 µM), Kocuria varians MAFF118076 (BC50=0.008 µM), Staphylococcus aureus ATCC6538P (BC50=0.005 µM);##Gram-negative bacteria: Agrobacterium tumefaciens MAFF1001 (BC50=0.05 µM), Bdellovibrio bacteriovorus MAFF106101 (BC50=0.06 µM), Klebsiella pneumoniae MAFF519002 (BC50=0.9 µM), Escherichia coli JM109 (BC50>15 µM).##Fungi: Candida krusei MAFF114085 (BC50=0.3 µM), Debaryomyces hansenii MAFF113836 (BC50>15 µM), Kluyveromyces thermotolerans MAFF113848 (BC50=0.3 µM), Paeonia anomala MAFF113717 (BC50=0.08 µM), Saccharomyces cerevisiae MAFF113011 (BC50=0.6 µM), Torulaspora delbrueckiiMAFF113811 (BC50>15 µM). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11772394	Biochem J. 2002 Jan 15;361(Pt 2):221-230.	Kato Y, Aizawa T, Hoshino H, Kawano K, Nitta K, Zhang H.	abf-1 and abf-2, ASABF-type antimicrobial peptide genes in Caenorhabditis elegans.	
DRAMP03791	QWGYNSYGYGNYGGYGGYPMYGGYGMNGGYGGGGLLGMFLGKKK	44	Caenacin-1 (Gly-rich, Tyr-rich; CNC-1; nematode, invertebrate, animals)	No entry found	Not found	Not found	Caenorhabditis elegans	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15048112	Nat Immunol. 2004 May;5(5):488-494.	Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.	TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.	
DRAMP03792	QYGYGGYPGMMGGYGGYPGMMGGYGMRPYGMGYGMGMGGMGMYRPGLLGMLMGK	54	Caenacin-2 (Gly-rich, Tyr-rich; CNC-2, nematode, invertebrate, animals)	No entry found	Not found	Not found	Caenorhabditis elegans	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15048112	Nat Immunol. 2004 May;5(5):488-494.	Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.	TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.	
DRAMP03793	QYGYGPMMGGYGPGMMGGYGPGMMGGYGPGMMGGYGPGMMGGYGMSPMYGGYGMYRPGLLGMLLG	65	Caenacin-3 (Gly-rich, Tyr-rich; CNC-3, nematode, invertebrate, animals)	No entry found	Not found	Not found	Caenorhabditis elegans	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15048112	Nat Immunol. 2004 May;5(5):488-494.	Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.	TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.	
DRAMP03794	QWGYGPYGGYGGGYPGMYGGYGMRPYGMYGGYGMGMYRPGLLGMLIGK	48	Caenacin-4 (Gly-rich, Tyr-rich; CNC-4, nematode, invertebrate, animals)	No entry found	Not found	Not found	Caenorhabditis elegans	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15048112	Nat Immunol. 2004 May;5(5):488-494.	Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.	TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.	
DRAMP03795	QWGYNSYGGYNSYGNYGGYGGGYNNGYGVNANLGVGGRGG	40	Caenacin-5 (Gly-rich, Tyr-rich; CNC-5, nematode, invertebrate, animals)	No entry found	Not found	Not found	Caenorhabditis elegans	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15048112	Nat Immunol. 2004 May;5(5):488-494.	Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.	TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.	
DRAMP03796	NPANPLNLKKHHGVFCDVCKALVEGGEKVGDDDLDAWLDVNIGTLCWTMLLPLHHECEEELKKVKKELKKDIENKDSPDKACKDVDLC	88	T07C4.4 (SPP-1; saposin-like protein, SAPLIP; roundworm, nematoda, animals)	No entry found	Not found	Not found	Caenorhabditis elegans	Antimicrobial, Antibacterial	Not found	Alpha helix (CD)	The CD spectrum of recombinant DEL βgalSAP of T07C4.4 is found to have a minimum at 208 nm, a distinct shoulder at 222 nm and a maximum at about 193 nm, typical of alpha-helical proteins.		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9920402	Biochim Biophys Acta. 1998 Dec 8;1429(1):259-264.	Bányai L, Patthy L.	Amoebapore homologs of Caenorhabditis elegans.	
DRAMP03798	MPCSCKKYCDPWEVIDGSCGLFNSKYICCREK	32	Corticostatin-related peptide RK-1 (RK-1; lagomorphs, mammals, animals)	P81655	Belongs to the alpha-defensin family	Not found	Oryctolagus cuniculus (Rabbit) 	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Beta strand(3 strands; 13 residues)	RK-1 consists of 32 residues, including six cysteines arranged into three disulfide bonds. The three-dimensional solution structure, determined by NMR, consists of a triple-stranded antiparallel beta-sheet and a series of turns and is similar to the known structures of other alpha-defensins (Ref.3).	1EWS resolved by NMR.	"Function: Has antimicrobial activity against Escherichia coli and activates Ca(2+) channels in vitro.
PTM: Contains three disulfide bonds 3-29; 5-19; 9-28."	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys29,Cys5 and Cys19,Cys9 and Cys28.	L	No cytotoxicity information found	Not found	8631871##11123900	J Biol Chem. 1996 May 3;271(18):10654-10659.##Biochemistry. 2000 Dec 26;39(51):15757-15764.	Bateman A, MacLeod RJ, Lembessis P, Hu J, Esch F, Solomon S.##McManus AM, Dawson NF, Wade JD, Carrington LE, Winzor DJ, Craik DJ.	The isolation and characterization of a novel corticostatin/defensin-like peptide from the kidney.##Three-dimensional structure of RK-1: a novel alpha-defensin peptide.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]4CCCN4C(=O)[C@@H](N)CCSC)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC3=O)C(=O)N[C@@H](CC(=O)O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N2)NC1=O
DRAMP03799	KPYCSCKWRCGIGEEEKGICHKFPIVTYVCCRRP	34	Rabbit kidney defensin RK-2 (alpha-defensins; lagomorphs, mammals, animals)	No entry found	Belongs to the alpha-defensin family	Not found	Oryctolagus cuniculus (Rabbit)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Bridge 	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9663443	Peptides. 1998;19(5):793-799.	Wu ER, Daniel R, Bateman A.	RK-2: a novel rabbit kidney defensin and its implications for renal host defense.	
DRAMP03800	VFCTCRGFLCGSGERASGSCTINGVRHTLCCRR	33	Neutrophil antibiotic peptide NP-5 (Microbicidal peptide NP-5; lagomorphs, mammals, animals)	P07466	Belongs to the alpha-defensin family	Not found	Oryctolagus cuniculus (Rabbit)	Unknown	Protein level	Not found	Not found		Function: Microbicidal activity. PTM: Contains three disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8439302##2843652	Biochem Biophys Res Commun. 1993 Feb 15;190(3):1009-1016.##J Mol Biol. 1988 Jun 5;201(3):625-636.	Sadro LC, Tremblay A, Solomon S, Palfree RG.##Pardi A, Hare DR, Selsted ME, Morrison RD, Bassolino DA, Bach AC 2nd.	Differential expression of corticostatins/defensins: higher levels of CS-4 (NP-2) transcripts compared with CS-6 (NP-5) in rabbit lung.##Solution structures of the rabbit neutrophil defensin NP-5.	
DRAMP03801	VSCTCRRFSCGFGERASGSCTVNGVRHTLCCRR	33	Neutrophil antibiotic peptide NP-4 (Microbicidal peptide NP-4; lagomorphs, mammals, animals)	P07467	Belongs to the alpha-defensin family	Not found	Oryctolagus cuniculus (Rabbit)	Unknown	Protein level	Not found	Not found		Function: Microbicidal activity. PTM: Contains three disulfide bonds (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1613398##3988726	J Leukoc Biol. 1992 Jun;51(6):634-639.##J Biol Chem. 1985 Apr 25;260(8):4579-4584.	Michaelson D, Couto M, Rayner J.R, Ganz T.##Selsted ME, Brown DM, DeLange RJ, Harwig SS, Lehrer RI.	Cationic defensins arise from charge-neutralized propeptides: amechanism for avoiding leukocyte autocytotoxicity?##Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils.	
DRAMP03802	GICACRRRFCPNSERFSGYCRVNGARYVRCCSRR	34	Corticostatin 1 (Antiadrenocorticotropin peptide I; lagomorphs, mammals, animals)	P07469	Belongs to the alpha-defensin family	Not found	Oryctolagus cuniculus (Rabbit)	Antimicrobial, Antibacterial	Protein level	Bridge 	Not found		"Function: Microbicidal activity and inhibits corticotropin (ACTH) stimulated corticosterone production.
PTM: Problely contains three disulfide bonds 3-31; 5-20; 11-30."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3988726##2829194##1311240	J Biol Chem. 1985 Apr 25;260(8):4579-4584.##Proc Natl Acad Sci U S A. 1988 Jan;85(2):592-596.##Endocrinology. 1992 Mar;130(3):1413-1423.	Selsted ME, Brown DM, DeLange RJ, Harwig SS, Lehrer RI.##Zhu QZ, Hu J, Mulay S, Esch F, Shimasaki S, Solomon S.##Zhu Q, Solomon S.	Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils.##Isolation and structure of corticostatin peptides from rabbit fetal and adult lung.##Isolation and mode of action of rabbit corticostatic (antiadrenocorticotropin) peptide	
DRAMP03803	GRCVCRKQLLCSYRERRIGDCKIRGVRFPFCCPR	34	Corticostatin-2 (Antiadrenocorticotropin peptide II; Corticostatin II; lagomorphs, mammals, anima	P07468	Belongs to the alpha-defensin family	Not found	Oryctolagus cuniculus (Rabbit)	Unknown	Protein level	Not found	Not found		"Function: Microbicidal activity and inhibits corticotropin (ACTH) stimulated corticosterone production.
PTM: Problely contains three disulfide bonds 3-32; 5-21; 11-31."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3988726##1311240	J Biol Chem. 1985 Apr 25;260(8):4579-4584.##Endocrinology. 1992 Mar;130(3):1413-1423.	Selsted ME, Brown DM, DeLange RJ, Harwig SS, Lehrer RI.##Zhu Q, Solomon S.	Primary structures of six antimicrobial peptides of rabbit peritonealneutrophils.##Isolation and mode of action of rabbit corticostatic (antiadrenocorticotropin) peptides.	
DRAMP03804	VVCACRRALCLPRERRAGFCRIRGRIHPLCCRR	33	Corticostatin-3 (Corticostatin III; Macrophage antibiotic peptide MCP-1; lagomorphs, mammals, ani	P01376	Belongs to the alpha-defensin family	Not found	Oryctolagus cuniculus (Rabbit)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Protein level	Bridge 	Not found		"Function: This peptide has antibiotic, anti-fungi and antiviral activity. It also inhibits corticotropin (ACTH) stimulated corticosterone production.
PTM: Contains three disulfide bonds (By similarity)."	herpes simplex virus type I	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	6643497##3988726##1311240	J Immunol. 1989 Aug 15;143(4):1358-1365.##J Biol Chem. 1985 Apr 25;260(8):4579-4584.##Endocrinology. 1992 Mar;130(3):1413-1423.	Ganz T, Rayner JR, Valore EV, Tumolo A, Talmadge K, Fuller F.##Selsted ME, Brown DM, DeLange RJ, Harwig SS, Lehrer RI.##Zhu Q, Solomon S.	The structure of the Rabbit macrophage defensin genes and their organ-specific expression.##Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils.##Isolation and mode of action of rabbit corticostatic (antiadrenocorticotropin) peptides.	
DRAMP03805	VVCACRRALCLPLERRAGFCRIRGRIHPLCCRR	33	Corticostatin-4 (Corticostatin IV; Macrophage antibiotic peptide MCP-2; lagomorphs, mammals, anim	P01377	Belongs to the alpha-defensin family	Not found	Oryctolagus cuniculus (Rabbit)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Protein level	Bridge 	Not found		"Function: This peptide has antibiotic, anti-fungi and antiviral activity. It also inhibits corticotropin (ACTH) stimulated corticosterone production.
PTM: Problely contains three disulfide bonds 3-31; 5-20; 10-30."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	6643497##3988726##1311240	J Biol Chem. 1983 Dec 10;258(23):14485-14489.##J Biol Chem. 1985 Apr 25;260(8):4579-4584.##Endocrinology. 1992 Mar;130(3):1413-1423.	Selsted ME, Brown DM, DeLange RJ, Lehrer RI.##Selsted ME, Brown DM, DeLange RJ, Harwig SS, Lehrer RI.##Zhu Q, Solomon S.	Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of Rabbit lung macrophages.##Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils.##Isolation and mode of action of rabbit corticostatic (antiadrenocorticotrop	
DRAMP03806	GICACRRRFCLNFEQFSGYCRVNGARYVRCCSRR	34	Corticostatin-6 (Corticostatin VI; Neutrophil antibiotic peptide NP-6; lagomorphs, mammals, anima	P80223, P80224	Belongs to the alpha-defensin family	Not found	Oryctolagus cuniculus (Rabbit)	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		Function: Microbicidal activity and inhibits corticotropin (ACTH) stimulated corticosterone production.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8397087	Eur J Biochem. 1993 Sep 1;216(2):653-659.	Fuse N, Hayashi Y, Fukata J, Tominaga T, Ebisui O, Satoh Y, Isohara T, Uno I, Imura H.	Purification and characterization of new anti-adrenocorticotropin Rabbit neutrophil peptides (defensins).	
DRAMP03807	GFFALIPGIE	10	Pardaxin-1 (Pardaxin I)	P81863	Belongs to the pardaxin family	Not found	Pardachirus marmoratus (Finless sole) (Achirus marmoratus)	Cytotoxic	Protein level	Not found	Not found		Function: Exhibits unusual shark repellent and surfactant properties. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis. Shown to be 5-10 times more toxic, cytolytic and active in membrane pore formation than pardaxin-2.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	3782138	J Biol Chem. 1986 Dec 15;261(35):16704-13.	Lazarovici P, Primor N, Loew LM.	Purification and pore-forming activity of two hydrophobic polypeptides from the secretion of the Red sea moses sole (Pardachirus marmoratus).	
DRAMP03808	GFFFP	5	Pardaxin-2 (Pardaxin II)	P81864	Belongs to the pardaxin family	Not found	Pardachirus marmoratus (Finless sole) (Achirus marmoratus)	Cytotoxic	Protein level	Not found	Not found		Function: Exhibits unusual shark repellent and surfactant properties. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	3782138	J Biol Chem. 1986 Dec 15;261(35):16704-13.	Lazarovici P, Primor N, Loew LM.	Purification and pore-forming activity of two hydrophobic polypeptides from the secretion of the Red sea moses sole (Pardachirus marmoratus).	
DRAMP03809	GFFALIPKIISSPLFKTLLSAVGSALSSSGEQE	33	Pardaxin P-1 (Pardaxin Pa1)	P81865	Belongs to the pardaxin family	Not found	Pardachirus pavoninus (Peacock sole) (Achirus pavoninus)	Cytotoxic	Protein level	Not found	Not found		"Function: Exhibits unusual shark repellent and surfactant properties. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis. Causes death in killfish oryzias latipes in 30 minutes at a concentration of 25 micrograms/ml.
Subunit structure: In aqueous solution exists as a tetramer.
Domain: Consists of a C-terminal hydrophilic region and a predominantly hydrophobic remainder."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	17737623	Science. 1986 Jul 18;233(4761):341-343.	Thompson SA, Tachibana K, Nakanishi K, Kubota I.	Melittin-like peptides from the shark-repelling defense secretion of the sole Pardachirus pavoninus.	
DRAMP03810	GFFALIPKIISSPIFKTLLSAVGSALSSSGGQE	33	Pardaxin P-2 (Pardaxin Pa2)	P23067	Belongs to the pardaxin family	Not found	Pardachirus pavoninus (Peacock sole) (Achirus pavoninus)	Cytotoxic	Protein level	Alpha helix	Pardaxin P-2 adopts a novel amphiphilic helix (7-11)-bend (12-13)-helix (14-26) motif with Pro-13 forming the focal point of the turn or bend between the two helices.(Ref.2)		"Function: Exhibits unusual shark repellent and surfactant properties. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Subunit structure: In aqueous solution exists as a tetramer.
Domain: Consists of a C-terminal hydrophilic region and a predominantly hydrophobic remainder."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	17737623##1868074	Science. 1986 Jul 18;233(4761):341-343.##Biochemistry. 1991 Aug 13;30(32):8009-8017.	Thompson SA, Tachibana K, Nakanishi K, Kubota I.##Zagorski MG, Norman DG, Barrow CJ, Iwashita T, Tachibana K, Patel DJ.	Melittin-like peptides from the shark-repelling defense secretion of the sole Pardachirus pavoninus.##Solution structure of pardaxin P-2.	
DRAMP03811	GFFAFIPKIISSPLFKTLLSAVGSALSSSGEQE	33	Pardaxin P-3 (Pardaxin Pa3)	P81866, Q7LZJ4	Belongs to the pardaxin family	Not found	Pardachirus pavoninus (Peacock sole) (Achirus pavoninus)	Cytotoxic	Protein level	Not found	Not found		"Function: Exhibits unusual shark repellent and surfactant properties. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Subunit structure: In aqueous solution exists as a tetramer.
Domain: Consists of a C-terminal hydrophilic region and a predominantly hydrophobic remainder."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	17737623	Science. 1986 Jul 18;233(4761):341-343.	Thompson SA, Tachibana K, Nakanishi K, Kubota I.	Melittin-like peptides from the shark-repelling defense secretion of the sole Pardachirus pavoninus.	
DRAMP03812	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	33	Pardaxin P-4 (Pardaxin P1a; Pardaxin Pa4)	P81861	Belongs to the pardaxin family	Not found	Pardachirus marmoratus (Finless sole) (Achirus marmoratus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Cytotoxic	Protein level	Alpha helix (2 helices; 15 residues)	The peptide adopts a bend-helix-bend-helix motif with an angle between the two structure helices of 122 +/- 9 degrees, making this structure substantially different from the one previously determined in organic solvents.	1XC0, 2KNS resolved by NMR.	"Function: Exhibits unusual shark repellent and surfactant properties. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Domain: Consists of a C-terminal hydrophilic region and a predominantly hydrophobic remainder.  Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria"	[Ref.23598079] Gram-positive bacteria : Micrococcus luteus(MIC=100 mg/L), Staphylococcus aureus(MIC=50 mg/L), Streptococcus pneumoniae(MIC=100 mg/L), Streptococcus agalactiae(MIC=100 mg/L), Staphylococcus sp.(MIC=6.25 mg/L);##Gram-negative bacteria : Grouper Vibrio alginolyticus(MIC=50 mg/L), Vibrio harveyi(MIC=50 mg/L), Vibrio vulnificus(MIC=100 mg/L)	[Ref.23598079] 7% hemolysis at 12.5 mg/L , 10% hemolysis at 25 mg/L , 27% hemolysis at 50 mg/L , 55% hemolysis at 100 mg/L , 95% hemolysis at 200 mg/L , 90% hemolysis at 400 mg/L against sheep red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	12124282##19959835##15292173##23598079	Biophys J. 2002 Aug;83(2):1004-1013.##J Biol Chem. 2010 Feb 5;285(6):3883-3895.##J Biol Chem. 2004 Oct 29;279(44):45815-23.##Peptides. 2013 Jun;44:139-48.	Hallock KJ, Lee DK, Omnaas J, Mosberg HI, Ramamoorthy A.##Bhunia A, Domadia PN, Torres J, Hallock KJ, Ramamoorthy A, Bhattacharjya S.##Porcelli F, Buck B, Lee DK, Hallock KJ, Ramamoorthy A, Veglia G.##Lin MC, Hui CF, Chen JY, Wu JL	Membrane composition determines pardaxin's mechanism of lipid bilayer disruption.##NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: mechanism of outer membrane permeabilization.##Structure and orientation of pardaxin determined by NMR experiments in model membranes.##Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.	
DRAMP03813	GFFALIPKIISSPLFKTLLSAVGSALSSSGDQE	33	Pardaxin P-5 (Pardaxin P1a; Pardaxin Pa5)	P81862	Belongs to the pardaxin family	Not found	Pardachirus marmoratus (Finless sole) (Achirus marmoratus)	Cytotoxic	Protein level	Not found	Not found		"Function: Exhibits unusual shark repellent and surfactant properties. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Domain: Consists of a C-terminal hydrophilic region and a predominantly hydrophobic remainder."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	9762902	FEBS Lett. 1998 Sep 18;435(2-3):173-177.	Adermann K, Raida M, Paul Y, Abu-Raya S, Bloch-Shilderman E, Lazarovici P, Hochman J, Wellhöner H.	Isolation, characterization and synthesis of a novel paradaxin isoform.	
DRAMP03817	RRWWFR	6	cRW2 peptide	No entry found	Not found	Not found	synthetic construct	Antimicrobial	Synthetic	No secondary structure	Not found	2OX2 resolved by NMR.	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17985394	J Pept Sci. 2008 Apr;14(4):524-527.	Appelt C, Wessolowski A, Dathe M, Schmieder P.	Structures of cyclic, antimicrobial peptides in a membrane-mimicking environment define requirements for activity.	
DRAMP03818	RRWFWR	6	cRW3 cationic antimicrobial peptide	No entry found	Not found	Not found	synthetic construct	Antimicrobial	Synthetic	No secondary structure	Not found	2OTQ resolved by NMR.	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17985394	J Pept Sci. 2008 Apr;14(4):524-527.	Appelt C, Wessolowski A, Dathe M, Schmieder P.	Structures of cyclic, antimicrobial peptides in a membrane-mimicking environment define requirements for activity.	
DRAMP03010	IKIMDILAKLGKVLAHV	17	Bombolitin III (insects, arthropods, invertebrates, animals)	P07494	Not found	Not found	Megabombus pennsylvanicus (Bumblebee)	Antimicrobial, Antibacterial, Anti Mammalian Cells	Protein level	Not found	Not found		Function: Mast cell degranulating peptide. Has hemolytic activity.	No MICs found in DRAMP database	[Ref.2578459] Hemolysis: ED50=2.8±0.05 µg/ml. Histamine release: ED50=10.4±0.4 µg/ml against guinea pig erythrocytes.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2578459 	J Biol Chem. 1985 Feb 10;260(3):1437-144.	Argiolas A, Pisano JJ.	Bombolitins, a new class of mast cell degranulating peptides from the venom of the bumblebee Megabombus pennsylvanicus.	
DRAMP03009	SKITDILAKLGKVLAHV	17	Bombolitin II (insects, arthropods, invertebrates, animals)	P07493	Not found	Not found	Megabombus pennsylvanicus (Bumblebee)	Antimicrobial, Antibacterial, Anti Mammalian Cells	Protein level	Not found	Not found		Function: Mast cell degranulating peptide. Has hemolytic activity.	No MICs found in DRAMP database	[Ref.2578459] Hemolysis: ED50=3.9±0.06 µg/ml. Histamine release: ED50=15.8±0.5 µg/ml against guinea pig erythrocytes.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2578459 	J Biol Chem. 1985 Feb 10;260(3):1437-144.	Argiolas A, Pisano JJ.	Bombolitins, a new class of mast cell degranulating peptides from the venom of the bumblebee Megabombus pennsylvanicus.	
DRAMP03008	IKITTMLAKLGKVLAHV	17	Bombolitin I (insects, arthropods, invertebrates, animals)	P10521	Not found	Not found	Megabombus pennsylvanicus (Bumblebee)	Antimicrobial, Antibacterial, Anti Mammalian Cells	Protein level	Not found	Not found		Function: Mast cell degranulating peptide. Has hemolytic activity.	No MICs found in DRAMP database	[Ref.2578459] Hemolysis: ED50=4.0±0.05 µg/ml. Histamine release: ED50=16.3±0.5 µg/ml against guinea pig erythrocytes.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2578459 	J Biol Chem. 1985 Feb 10;260(3):1437-144.	Argiolas A, Pisano JJ.	Bombolitins, a new class of mast cell degranulating peptides from the venom of the bumblebee Megabombus pennsylvanicus.	
DRAMP03822	RRAARF	6	Cyclic hexapeptide RR(NAL)(NAL)RF 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial	Synthetic	No secondary structure	Not found	1SKL resolved by NMR.	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16075425	Chembiochem. 2005 Sep;6(9):1654-1662.	Appelt C, Wessolowski A, SöderhÃäll JA, Dathe M, Schmieder P.	Structure of the antimicrobial, cationic hexapeptide cyclo(RRWWRF) and its analogues in solution and bound to detergent micelles.	
DRAMP03836	DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFLNVNCWCET	44	ETD135 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found	1P0A	Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=1.56 µg/ml), Candida albicans No.245962 (MIC50=1.56 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=6.25 µg/ml), Cryptococcus neoformans A (MIC50=6.25 µg/ml), Fusarium solani FFUS 8591 (MIC50=1.56 µg/ml), Scedosporium prolificans FSSP 8591 (MIC50=0.2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP03837	DKLIGSCVWGAVNYTSNCRAECKRRGYKGGHCGSFLNVNCWCET	44	ETD179 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=1.56 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP03838	DKLIGSCVWGAVNYTSNCRAECKRRGYKGGHCGSFANVNCWCET	44	ETD151 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found	1P00	Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=3.125 µg/ml), Candida albicans No.245962 (MIC50=0.4 µg/ml), Aspergillus fumigatus GASP 4707 (MIC50=6.25 µg/ml), Cryptococcus neoformans A (MIC50=1.56 µg/ml), Fusarium solani FFUS 8591 (MIC50=0.4 µg/ml), Scedosporium prolificans FSSP 8591 (MIC50=0.1 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP03839	DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCQT	44	ETD131 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=3.125 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=3.125 µg/ml), Cryptococcus neoformans A (MIC50=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP03840	DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCER	44	ETD130 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found	1OZZ	Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=1.56 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP03841	NKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCET	44	ETD140 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=3.125 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP03842	DKLIGSCVWGAVNYTRNCNAECKRRGYKGGHCGSFANVNCWCET	44	ETD150 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=3.125 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=6.25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP03843	DKLIGSCVWGAVNYTSRCNAECKRRGYKGGHCGSFANVNCWCET	44	ETD152 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=3.125 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP03844	DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFINVNCWCET	44	ETD132 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=6.25 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=6.25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP03845	DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANINCWCET	44	ETD133 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=6.25 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP03846	DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFLNINCWCET	44	ETD134 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=1.56 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=3.125 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP03847	DKLIGSCVWLAVNYTSNCNAECKRRGYKGGHCGSFLNVNCWCET	44	ETD154 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=6.25 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=12.5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP18190	FLSTIWNGIKSLL	13	Pantinin-3 (Non-disulfide-bridged peptide 4.22, NDBP-4.22, Non-disulfide-bridged peptide 5.23, ND	R4JJN6	 Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short an	Not found	Pandinus imperator (Emperor scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Amphipathic peptide that possesses relatively strong activities against Gram-positive bacteria and a fungus, but has very weak antimicrobial activities against Gram-negative bacteria. Also exhibits hemolytic activities against human erythrocytes. Furthermore, this peptide potently inhibits the growth of vancomycin-resistant Enterococcus (VRE) S13, a pathogen that can cause a number of human infections.Forms an alpha-helical membrane channel in the prey.	[Ref.23624072]Gram-positive bacteria: S.aureus (MIC=16 μM), B.magaterium (MIC=6 μM), M.luteus (MIC=8 μM ), VRE (MIC=4 μM), MRSA (MIC=12 μM);##Gram-negative bacteria: E.coli (MIC=36 μM), P.putida (MIC >87 μM), K.oxytoca (MIC=87 μM), E.cloacae (MIC >87 μM), S.enterica (MIC=84 μM);##Fungus: C.tropicalis (MIC=17 μM).	[Ref.23624072]70% hemolytic activity at 16 μM, 100% hemolytic activity at 32 μM, 100% hemolytic activity at 64 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	23624072##24184590	Peptides 45:28-34(2013)##Peptides 51:35-45(2014	Zeng X.C., Zhou L., Shi W., Luo X., Zhang L., Nie Y., Wang J., Wu S.,Cao B., Cao H.##Almaaytah A., Albalas Q.	Three new antimicrobial peptides from the scorpion Pandinusimperator.##Scorpion venom peptides with no disulfide bridges: a review.	
DRAMP03849	DKLIGSCVWLAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCET	44	ETD156 (Mutant of ARD1; Heliomicin analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Candida albicans IHEM 8060 (MIC50=3.125 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=25 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14978308	Protein Sci. 2004 Mar;13(3):703-713.	Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.	Lead optimization of antifungal peptides with 3D NMR structures analysis.	
DRAMP03850	FALALKALKKALKKLKKALKKAL	23	Antibacterial peptide/melittin homolog	No entry found	Not found	Not found	Synthetic construct 	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8714745	Scanning Microsc. 1995 Jun;9(2):501-507.	Henk WG, Todd WJ, Enright FM, Mitchell PS.	The morphological effects of two antimicrobial peptides, hecate-1 and melittin, on Escherichia coli.	
DRAMP03851	TWLKKRRWKKAKPP	14	Cyclic L27-11 (protegrin-1-mimetic)	No entry found	Not found	Not found	Synthetic construct (peptide library screen)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Function: This circular peptide is designed as a mimic of PG-1. The peptidomimetics had a non-membrane-lytic mechanism of action and identified a homolog of the beta-barrel protein LptD (Imp/OstA), which functions in outer-membrane biogenesis, as a cellular target. Animal model (mouse): The peptide showed in vivo efficacy in a mouse septicemia infection model. The original LLP1 (lentivirus lytic peptide 1) has been replaced.	Pseudomonas aeruginosa (Remarkably).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Gram-negative bacterial outer membrane protein LptD 	20167788	Science. 2010 Feb 19;327(5968):1010-1013.	Srinivas N, Jetter P, Ueberbacher BJ, Werneburg M, Zerbe K, Steinmann J, Van der Meijden B, Bernardini F, Lederer A, Dias RL, Misson PE, Henze H, Zumbrunn J, Gombert FO, Obrecht D, Hunziker P, Schauer S, Ziegler U, KÃäch A, Eberl L, Riedel K, DeMarco SJ, Robinson JA.	Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa.	
DRAMP03872	FQWQRNMRKV	10	hLf 21-30 (fragment of human lalctoferricin, residues 21-30)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>300 µM), Escherichia coli (wild strain) (MIC>300 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>300 µM), Enterococcus faecalis ATCC 29212 (MIC>300 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	13677384	Am J Vet Res. 2003 Sep;64(9):1088-1092.	Chen PW, Shyu CL, Mao FC.	Antibacterial activity of short hydrophobic and basic-rich peptides.	
DRAMP03873	LRWQNEMRKV	10	mLf 20-29 (fragment of murine lalctoferricin, residues 20-29)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>300 µM), Escherichia coli (wild strain) (MIC>300 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>300 µM), Enterococcus faecalis ATCC 29212 (MIC>300 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	13677384	Am J Vet Res. 2003 Sep;64(9):1088-1092.	Chen PW, Shyu CL, Mao FC.	Antibacterial activity of short hydrophobic and basic-rich peptides.	
DRAMP03874	RQWQSKIRRT	10	pLf20-29 (fragment of porcine lactoferricin, residues 20-29)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>300 µM), Escherichia coli (wild strain) (MIC>300 µM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>300 µM), Enterococcus faecalis ATCC 29212 (MIC>300 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	13677384	Am J Vet Res. 2003 Sep;64(9):1088-1092.	Chen PW, Shyu CL, Mao FC.	Antibacterial activity of short hydrophobic and basic-rich peptides.	
DRAMP03913	KWKWKW	6	(KW)3	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Fusarium solani, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23203110	Int J Mol Sci. 2012; 13(11): 15042-15053.	Gopal R, Na H, Seo CH, Park Y.	Antifungal Activity of (KW)n or (RW)n Peptide against Fusarium solani and Fusarium oxysporum.	
DRAMP03914	KWKWKWKW	8	(KW)4	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Fusarium solani, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23203110	Int J Mol Sci. 2012; 13(11): 15042-15053.	Gopal R, Na H, Seo CH, Park Y.	Antifungal Activity of (KW)n or (RW)n Peptide against Fusarium solani and Fusarium oxysporum.	
DRAMP03915	KWKWKWKWKW	10	(KW)5	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Fusarium solani, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23203110	Int J Mol Sci. 2012; 13(11): 15042-15053.	Gopal R, Na H, Seo CH, Park Y.	Antifungal Activity of (KW)n or (RW)n Peptide against Fusarium solani and Fusarium oxysporum.	
DRAMP03916	RWRW	4	(RW)2	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Fusarium solani, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23203110	Int J Mol Sci. 2012; 13(11): 15042-15053.	Gopal R, Na H, Seo CH, Park Y.	Antifungal Activity of (KW)n or (RW)n Peptide against Fusarium solani and Fusarium oxysporum.	
DRAMP03917	RWRWRW	6	(RW)3	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Fusarium solani, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23203110	Int J Mol Sci. 2012; 13(11): 15042-15053.	Gopal R, Na H, Seo CH, Park Y.	Antifungal Activity of (KW)n or (RW)n Peptide against Fusarium solani and Fusarium oxysporum.	
DRAMP03918	RWRWRWRW	8	(RW)4	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Fusarium solani, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23203110	Int J Mol Sci. 2012; 13(11): 15042-15053.	Gopal R, Na H, Seo CH, Park Y.	Antifungal Activity of (KW)n or (RW)n Peptide against Fusarium solani and Fusarium oxysporum.	
DRAMP03919	RWRWRWRWRW	10	(RW)5	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Possess antifungal activity.	Fungi: Fusarium solani, Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23203110	Int J Mol Sci. 2012; 13(11): 15042-15053.	Gopal R, Na H, Seo CH, Park Y.	Antifungal Activity of (KW)n or (RW)n Peptide against Fusarium solani and Fusarium oxysporum.	
DRAMP03926	GWLRKLGAVLKVLTT	15	Cecropin B (1-7)-melittin (4-11)hybrid peptide (CBM)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Function: The hemolytic assays indicated CBM had no hemolytic in vivo and in vitro.	[Ref.20111863]Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Bacillus subtilis, Bacillus thuringiensis, Salmonella derby.	[Ref.20111863]0.05% hemolytic activity at 5 mg/kg, 0.14% hemolytic activity at 10 mg/kg in vivo	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20111863	Curr Microbiol. 2010 Sep;61(3):169-175.	Cao Y, Yu RQ, Liu Y, Zhou HX, Song LL, Cao Y, Qiao DR.	Design, recombinant expression, and antibacterial activity of the cecropins-melittin hybrid antimicrobial peptides.	
DRAMP03932	ILRWPWWPWRRKM	13	Indolicidin derivative 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15154847	Biotechnol Appl Biochem. 2004 Jun;39(Pt 3):339-345.	Metlitskaia L, Cabralda JE, Suleman D, Kerry C, Brinkman J, Bartfeld D, Guarna MM.	Recombinant antimicrobial peptides efficiently produced using novel cloning and purification processes.	
DRAMP03940	FPWWWPF	7	Peptide 4 (Trp- and Arg-rich; derivative of Tritrpticin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Antifungal	Synthetic	Rich	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8706838	FEBS Lett. 1996 Jul 15;390(1):95-98.	Lawyer C, Pai S, Watabe M, Borgia P, Mashimo T, Eagleton L, Watabe K.	Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides.	
DRAMP03941	RFPWWWPFLR	10	Peptide 3 (Trp- and Arg-rich; derivative of Tritrpticin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Rich	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Pseudomonas, Klebsiella, Proteus species;##Gram-positive bacteria: Streptococcus, Staphylococcus species. 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8706838	FEBS Lett. 1996 Jul 15;390(1):95-98.	Lawyer C, Pai S, Watabe M, Borgia P, Mashimo T, Eagleton L, Watabe K.	Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides.	
DRAMP03942	RRRFPWVCWPFLRRR	15	Peptide 2 (Trp- and Arg-rich; derivative of Tritrpticin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Rich	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia, Proteus mirabilis;##Gram-positive bacteria: Staphylococcus epidermidis, Streptococcus group D.##Fungi: Aspergillus fumigatus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8706838	FEBS Lett. 1996 Jul 15;390(1):95-98.	Lawyer C, Pai S, Watabe M, Borgia P, Mashimo T, Eagleton L, Watabe K.	Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides.	
DRAMP03943	VXLFPKKPFLXV	12	Gratisin analogue	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Its activity against Pseudomonas aeruginosa IFO 3080 was two times higher than gramicidin S.	Gram-negative bacterium: Pseudomonas aeruginosa IFO 3080.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18305357	J Antibiot (Tokyo). 2008 Jan;61(1):33-35.	Tamaki M, Kokuno M, Suzuki Y, Iwama M, Shindo M, Uchida Y.	A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.	
DRAMP18396	FFWHHIGHALDAAKRVHGMLSG	22	moroNC-NH2 (moronecidin-like peptide; fish, animals)	No entry found	Not found	Not found	Notothenia coriiceps	Antimicrobial, Antibacterial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against Gram- S. sonnei (ATCC 29930) (MIC 12.5 uM), Psychrobacter sp. (PAMC 25501) (MIC 5 uM), E. coli DH5alpha (MIC 12.5 uM), Gram+ S. pyogenes (ATCC 19615) (MIC 25 uM), S. aureus (ATCC 33591) (MIC 25 uM) , L. monocytogenes (ATCC 15313) (MIC 12.5 uM), and yeast C. tropicalis (ATCC 20115) (MIC 5 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28122029	PLoS One. 2017 Jan 25;12(1):e0170821.	Shin SC, Ahn IH, Ahn DH, Lee YM, Lee J, Lee JH, Kim HW, Park H.	Characterization of Two Antimicrobial Peptides from Antarctic Fishes (Notothenia coriiceps and Parachaenichthys charcoti)	
DRAMP03946	GLIKIVPAMICAVTKKC	17	Del 1-3 (Ranalexin analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-positive bacterium: Staphylococcus aureus (MIC>256 µg/ml);##Gram-negative bacteria: Escherichia coli (MIC>256 µg/ml), Pseudomonas aeruginosa (MIC>256 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8144672	J Biol Chem. 1994 Apr 8;269(14):10849-10855.	Clark DP, Durell S, Maloy WL, Zasloff M.	Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.	
DRAMP03950	QKLCMRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNYVFPAHKCICYFPC	51	Rs-AFP2 variant (Mutation: Q5M)	P30230, Q003I2	Not found	Not found	Synthetic construct (Mutation of Rs-AFP2)	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Compared to Rs-AFP2, the mutation Rs-AFP2(Q5M) has increased antifungal potency.	SMF- (synthetic low ionic strength medium): Fusarium culmorum (IC50=4.1±0.2); SMF+ (SMF +1 mM CaCl2 and 50 mM KCl): Fusarium culmorum (IC50=5.4±1.2)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8995418	J Biol Chem. 1997 Jan 10;272(2):1171-1179.	De Samblanx GW, Goderis IJ, Thevissen K, Raemaekers R, Fant F, Borremans F, Acland DP, Osborn RW, Patel S, Broekaert WF.	Mutational analysis of a plant defensin from radish (Raphanus sativus L.) reveals two adjacent sites important for antifungal activity.	
DRAMP03951	QKLCQRPSGTWSGVCMNNNACKNQCIRLEKARHGSCNYVFPAHKCICYFPC	51	Rs-AFP2 variant (Mutation: G16M)	P30230, Q003I2	Not found	Not found	Synthetic construct (Mutation of Rs-AFP2)	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Compared to Rs-AFP2, the mutation Rs-AFP2(G16M) has increased antifungal potency.	SMF- (synthetic low ionic strength medium): Fusarium culmorum (IC50=2.2±0.3);##SMF+ (SMF + 1 mM CaCl2 and 50 mM KCl): Fusarium culmorum (IC50=5.0±0.9).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8995418	J Biol Chem. 1997 Jan 10;272(2):1171-1179.	De Samblanx GW, Goderis IJ, Thevissen K, Raemaekers R, Fant F, Borremans F, Acland DP, Osborn RW, Patel S, Broekaert WF.	Mutational analysis of a plant defensin from radish (Raphanus sativus L.) reveals two adjacent sites important for antifungal activity.	
DRAMP03952	QKLCQRPSRTWSGVCGNNNACKNQCIRLEKARHGSCNYVFPAHKCICYFPC	51	Rs-AFP2 variant (Mutation: G9R)	P30230, Q003I2	Not found	Not found	Synthetic construct (Mutation of Rs-AFP2)	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Compared to Rs-AFP2, the mutation Rs-AFP2(G9R) has increased antifungal potency.	SMF- (synthetic low ionic strength medium): Fusarium culmorum (IC50=3±0.5);##SMF+ (SMF + 1 mM CaCl2 and 50 mM KCl): Fusarium culmorum (IC50=3.3±0.6).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8995418	J Biol Chem. 1997 Jan 10;272(2):1171-1179.	De Samblanx GW, Goderis IJ, Thevissen K, Raemaekers R, Fant F, Borremans F, Acland DP, Osborn RW, Patel S, Broekaert WF.	Mutational analysis of a plant defensin from radish (Raphanus sativus L.) reveals two adjacent sites important for antifungal activity.	
DRAMP03953	QKLCQRPSGTWSGVCGNNNACKNQCIRLEKARHGSCNYRFPAHKCICYFPC	51	Rs-AFP2 variant (Mutation: V39R)	P30230, Q003I2	Not found	Not found	Synthetic construct (Mutation of Rs-AFP2)	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Compared to Rs-AFP2, the mutation Rs-AFP2(V39R) has increased antifungal potency.	SMF- (synthetic low ionic strength medium): Fusarium culmorum (IC50=4.0±0.2);##SMF+ (SMF + 1 mM CaCl2 and 50 mM KCl): Fusarium culmorum (IC50=3.2±0.3).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8995418	J Biol Chem. 1997 Jan 10;272(2):1171-1179.	De Samblanx GW, Goderis IJ, Thevissen K, Raemaekers R, Fant F, Borremans F, Acland DP, Osborn RW, Patel S, Broekaert WF.	Mutational analysis of a plant defensin from radish (Raphanus sativus L.) reveals two adjacent sites important for antifungal activity.	
DRAMP03961	KRIVQRIKDFLR	12	KR-12	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacterium: Bacillus megaterium.##Gram-negative bacterium: Escherichia coli.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18818205	J Biol Chem. 2008 Nov 21;283(47):32637-32643.	Wang G.	Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.	
DRAMP03962	KWKLFKKIGIGKFLHSAKKF	20	Cecropin A(1-8)-Magainin 2(1-12)hybrid peptide (CAMA)	P01507	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Alpha helix 	Not found	1F0D, 1D9J resolved by NMR.	MOA: The partial insertion of the Trp2 of CA-MA into the membrane, as well as the electrostatic interactions between the positively charged Lys residues at the N-terminus of the CA-MA and the anionic phospholipid headgroups, leads to the primary binding to the cell membrane. Then, the flexibility or bending potential induced by the Gly-Ile-Gly hinge sequence or the Pro residue in the central part of the peptides may allow the alpha-helix in the C-terminus to span the lipid bilayer.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11009597	Biochemistry. 2000 Oct 3;39(39):11855-11864.	Oh D, Shin SY, Lee S, Kang JH, Kim SD, Ryu PD, Hahm KS, Kim Y.	Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.	
DRAMP03963	KWKLFKKIKFLHSAKKF	17	Cecropin A(1-8)-Magainin 2(1-12)hybrid peptide analogue (P1)	P01507	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Alpha helix (1 helices; 9 residues)	Not found	1F0F resolved by NMR.	P1 has significantly decreased lytic activities against bacterial and tumor cells and PC/PS vesicles (3:1, w/w), and reduced pore-forming activity on lipid bilayers.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11009597	Biochemistry. 2000 Oct 3;39(39):11855-11864.	Oh D, Shin SY, Lee S, Kang JH, Kim SD, Ryu PD, Hahm KS, Kim Y.	Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.	
DRAMP03964	KWKLFKKIPKFLHSAKKF	18	Cecropin A(1-8)-Magainin 2(1-12)hybrid peptide analogue (P2)	P01507	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Alpha helix 	Not found	1F0E, 1D9M resolved by NMR.	P2 retained effective lytic activities and pore-forming activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11009597	Biochemistry. 2000 Oct 3;39(39):11855-11864.	Oh D, Shin SY, Lee S, Kang JH, Kim SD, Ryu PD, Hahm KS, Kim Y.	Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.	
DRAMP03965	KAKLFKKIGIGKFLHSAKKF	20	Cecropin A(1-8)-Magainin 2(1-12)hybrid peptide analogue (P3)	P01507	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Alpha helix (1 helices; 10 residues)	Not found	1F0H resolved by NMR.	The N-terminal region of P3 has a flexible structure without any specific secondary structure. The P3 modification caused a drastic decrease in the antibiotic activities.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11009597	Biochemistry. 2000 Oct 3;39(39):11855-11864.	Oh D, Shin SY, Lee S, Kang JH, Kim SD, Ryu PD, Hahm KS, Kim Y.	Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.	
DRAMP03966	KLKLFKKIGIGKFLHSAKKF	20	Cecropin A(1-8)-Magainin 2(1-12)hybrid peptide analogue (P4)	P01507	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Alpha helix 	Not found	1F0G, 1D9P resolved by NMR.	The hydrophobic Leu side chain of P4 is at position 2, retained its activities.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11009597	Biochemistry. 2000 Oct 3;39(39):11855-11864.	Oh D, Shin SY, Lee S, Kang JH, Kim SD, Ryu PD, Hahm KS, Kim Y.	Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.	
DRAMP02092	FLPAIAGMAAKFLPKIFCAISKKC	24	Brevinin-1Bb (Frogs, amphibians, animals)	P82834	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana berlandieri (Rio Grande leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=1 μM);##Gram-negative bacterium: Escherichia coli (MIC=3 μM).##Yeast: Candida albicans (MIC=10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP04006	GLVSGLLNTAGGLLGDLLGSLGSLSGGES	29	Plasticin-A1 (PTC-A1; DRP-AA-2-5; frogs, amphibians, animals)	No entry found	Not found	Not found	Agalychnis annae (AA)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9774745	Biochim Biophys Acta. 1998 Oct 14;1388(1):279-283.	Wechselberger C.	Cloning of cDNAs encoding new peptides of the dermaseptin-family.	
DRAMP18189	IFGAIWKGISSLL	13	Pantinin-2 (Non-disulfide-bridged peptide 4.21, NDBP-4.21, Non-disulfide-bridged peptide 5.22, ND	R4JQZ0	 Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short an	Not found	Pandinus imperator (Emperor scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Amphipathic peptide that possesses relatively strong activities against Gram-positive bacteria and a fungus, but has very weak antimicrobial activities against Gram-negative bacteria. Also exhibits mild hemolytic activities against human erythrocytes.Forms an alpha-helical membrane channel in the prey.	[Ref.23624072]Gram-positive bacteria: S.aureus (MIC=48 μM), B.magaterium (MIC=36 μM), M.luteus (MIC=18 μM ), VRE (MIC=36 μM), MRSA (MIC=28 μM);##Gram-negative bacteria: E.coli (MIC=48 μM), P.putida (MIC >87 μM), K.oxytoca (MIC >87 μM), E.cloacae (MIC >87 μM), S.enterica (MIC=68 μM);##Fungus: C.tropicalis (MIC=16 μM).	[Ref.23624072]10% hemolytic activity at 16 μM, 80% hemolytic activity at 32 μM, 100% hemolytic activity at 64 μM against human red bood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	23624072##24184590	Peptides 45:28-34(2013)##Peptides 51:35-45(2014	Zeng X.C., Zhou L., Shi W., Luo X., Zhang L., Nie Y., Wang J., Wu S.,Cao B., Cao H.##Almaaytah A., Albalas Q.	Three new antimicrobial peptides from the scorpion Pandinusimperator.##Scorpion venom peptides with no disulfide bridges: a review.	
DRAMP04008	GLLSGILNTAGGLLGNLIGSLSN	23	Plasticin-C1 (PTC-C1; DRP-AC-1; frogs, amphibians, animals)	No entry found	Not found	Not found	Agalychnis callidryas	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12709067	Eur J Biochem. 2003 May;270(9):2068-2081.	Vanhoye D, Bruston F, Nicolas P, Amiche M.	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.	
DRAMP04009	GLLSGILNSAGGLLGNLIGSLSN	23	Plasticin-C2 (PTC-C2; DRP-AC-2; frogs, amphibians, animals)	No entry found	Not found	Not found	Agalychnis callidryas	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12709067	Eur J Biochem. 2003 May;270(9):2068-2081.	Vanhoye D, Bruston F, Nicolas P, Amiche M.	Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.	
DRAMP04010	GLVSDLLSTVTGLLGNLGGGGLKKI	25	Plasticin-S1 (PTC-S1; frogs, amphibians, animals)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Antifungal, Antiviral	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18644413	Peptides. 2008 Nov;29(11):2074-2082.	Amiche M, Ladram A, Nicolas P.	A consistent nomenclature of antimicrobial peptides isolated from frogs of the subfamily Phyllomedusinae.	
DRAMP04018	ALYKKFKKKLLKSLKRLG	18	Rp-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found	2RLH, 2RLG resolved by NMR.	Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria and the yeast candian 	Gram-positive bacteria: Staphylococcus, Streptococcus, Bacillus species;##Gram-negative bacteria: Escherichia, Salmonella, Pseudomonas species.##Fungi: Candida and Cryptococcus species.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18712851	Biopolymers. 2009 Jan;91(1):1-13.	Bourbigot S, Dodd E, Horwood C, Cumby N, Fardy L, Welch WH, Ramjan Z, Sharma S, Waring AJ, Yeaman MR, Booth V.	Antimicrobial peptide RP-1 structure and interactions with anionic versus zwitterionic micelles.	
DRAMP04037	LKLLKKL	7	Immobilized peptide E07LKK	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7726486	Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.	Haynie SL, Crum GA, Doele BA.	Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.	
DRAMP04038	LKLLKKLLKLLKKL	14	Immobilized peptide E14LKK/H14LKK	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922 (MBC=1496 µg/ml), Klebsiella pneumoniae ATCC 4352 (MBC=1496 µg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923 (MBC=1496 µg/ml), Bacillus subtilis ATCC 6051 (MBC=1995 µg/ml).##Yeast: Candida albicans ATCC 10231 (MBC=3200 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7726486	Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.	Haynie SL, Crum GA, Doele BA.	Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.	
DRAMP04039	LKLLKKLLKLLKKLGK	16	Immobilized peptige E16KGL/H16KGL	No entry found	Not found	Not found	Synthetic construct 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7726486	Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.	Haynie SL, Crum GA, Doele BA.	Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.	
DRAMP04040	LKLLKKLLKLLKKLGGK	17	Immobilized peptide E17KGG	No entry found	Not found	Not found	Synthetic construct 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7726486	Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.	Haynie SL, Crum GA, Doele BA.	Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.	
DRAMP04041	LKLLKKLLKLLKKLGGGK	18	Immobilized peptide E18KGG	No entry found	Not found	Not found	Synthetic construct 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7726486	Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.	Haynie SL, Crum GA, Doele BA.	Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.	
DRAMP04042	KGLKKLLKLLKKLLKL	16	Immobilized peptide E16LKL	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7726486	Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.	Haynie SL, Crum GA, Doele BA.	Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.	
DRAMP04043	LKKLLKKLKK	10	Immobilized peptid E10KKL	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7726486	Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.	Haynie SL, Crum GA, Doele BA.	Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.	
DRAMP04044	LKKLLKKLKKLL	12	Immobilized peptid E12LLK	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7726486	Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.	Haynie SL, Crum GA, Doele BA.	Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.	
DRAMP04045	LKKLLKKLKKLLKK	14	Immobilized peptid E14KKL	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7726486	Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.	Haynie SL, Crum GA, Doele BA.	Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.	
DRAMP04046	SNMIEGVFAKGFKKASHLFKGIG	23	Immobilized peptide E23GIG magainin2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7726486	Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.	Haynie SL, Crum GA, Doele BA.	Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.	
DRAMP04047	SNMIEGVFAKGFKKASH	17	Immobilized peptide E17HSA magainin 2 deletion	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.	Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7726486	Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.	Haynie SL, Crum GA, Doele BA.	Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.	
DRAMP04071	LLGNFFRKSKQKIGKQFKRIVQRIKNFFRNLVPRTQS	37	LL-37 pentamide	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Has antibacterial activiy against Gram-positive bacteria. 	Gram-positive bacteria: Staphylococcus aureus 930918-3, S. aureuss 710A, S. aureuss ATCC (MRSA) 33591, Staphylococcus epidermidis ATCC 49741.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11557457	Antimicrob Agents Chemother. 2001 Oct;45(10):2695-2702.	Zhao C, Nguyen T, Boo LM, Hong T, Espiritu C, Orlov D, Wang W, Waring A, Lehrer RI.	RL-37, an alpha-helical antimicrobial peptide of the rhesus monkey.	
DRAMP04072	KWKIFKKIEHMGQNIRDGLIKAGPAVQVVGQAATIYKGSYSMEHFRWGKPV	51	Hinnavin II/MSH hybrid (rhin/MSH)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Function: rhin/MSH has a broader spectrum of activity than did the parental hinnavin II or MSH against fungi and Gram-positive and Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20221725	J Microbiol. 2010 Feb;48(1):24-29.	Bang SK, Kang CS, Han MD, Bang IS.	Expression of recombinant hybrid peptide hinnavin II/alpha-melanocyte-stimulating hormone in Escherichia coli: purification and characterization.	
DRAMP04073	KTCENLADTYRGPCFTTGSCDDHCKNKEHLLSGRCRDDFRCWCTKRC	47	TvD1 (Recombinant peptide; alpha-defensin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial	Synthetic	Not found	Not found		Function: The purified peptide also showed significant inhibition of root elongation in Arabidopsis seedlings, subsequently affecting the extension of growing root hairs indicating that it has the potential to disturb the plant growth and development.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18726095	Appl Microbiol Biotechnol. 2008 Oct;80(6):1023-1032.	Vijayan S, Guruprasad L, Kirti PB.	Prokaryotic expression of a constitutively expressed Tephrosia villosa defensin and its potent antifungal activity.	
DRAMP04074	PFWRIRIRR	9	PFR peptide (Recombinant peptide)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19026609	Biochim Biophys Acta. 2009 Feb;1788(2):314-323.	Zorko M, Japelj B, Hafner-Bratkovic I, Jerala R.	Expression, purification and structural studies of a short antimicrobial peptide.	
DRAMP04084	ATCDLASKFNWNHTLCAAHCIARRYRGGYCNSKAVCVCR	39	W9F (mutant of Def-DAA defensin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Mutant of Def-DAA defensin (W9F) is active against sensitive and resistant strains of S. aureus. All the mutants are less toxic than Def-DAA except one (W11V) but are more toxic than Def-AcAA. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=4 µg/mL), Staphylococcus aureus strain 4 (IC90=4 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP04085	ATCDLASIFNWNHTLCAAHCIARRYRGGYCNSKAVCVCR	39	K8I,W9F (mutant of Def-DAA defensin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Mutant of Def-DAA defensin (K8I,W9F) is active against sensitive and resistant strains of S. aureus. All the mutants are less toxic than Def-DAA except one (W11V) but are more toxic than Def-AcAA. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=2-4 µg/mL), Staphylococcus aureus strain 4 (IC90=2-4 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP04086	ATCDLASKFNVNHTLCAAHCIARRYRGGYCNSKAVCVCR	39	W9F,W11V (mutant of Def-DAA defensin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Mutant of Def-DAA defensin (W9F,W11V) is active against sensitive and resistant strains of S. aureus. All the mutants are less toxic than Def-DAA except one (W11V) but are more toxic than Def-AcAA. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=4-8 µg/mL), Staphylococcus aureus strain 4 (IC90=8-16 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP04087	ATCDLASIFNVNHTLCAAHCIARRYRGGYCNSKAVCVCR	39	K8I,W9F,W11V (mutant of Def-DAA defensin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Mutant of Def-DAA defensin (K8I,W9F,W11V) is active against sensitive and resistant strains of S. aureus. All the mutants are less toxic than Def-DAA except one (W11V) but are more toxic than Def-AcAA. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=2-4 µg/mL), Staphylococcus aureus strain 4 (IC90=2-4 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP04088	ATCDLASKFNWNHALCAAHCIARRYRGGYCNSKAVCVCR	39	W9F,T14A (mutant of Def-DAA defensin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Mutant of Def-DAA defensin (W9F,T14A) is active against sensitive and resistant strains of S. aureus. All the mutants are less toxic than Def-DAA except one (W11V) but are more toxic than Def-AcAA. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=2-4 µg/mL), Staphylococcus aureus strain 4 (IC90=2-4 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP04089	ATCDLASIFNWNHALCAAHCIARRYRGGYCNSKAVCVCR	39	K8I,W9F,T14A (mutant of Def-DAA defensin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Mutant of Def-DAA defensin (K8I,W9F,T14A) is active against sensitive and resistant strains of S. aureus. All the mutants are less toxic than Def-DAA except one (W11V) but are more toxic than Def-AcAA. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=2-4 µg/mL), Staphylococcus aureus strain 4 (IC90=2-4 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP04090	ATCDLASKWNVNHALCAAHCIARRYRGGYCNSKAVCVCR	39	W11V,T14A (mutant of Def-DAA defensin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Mutant of Def-DAA defensin (W11V,T14A) is active against sensitive and resistant strains of S. aureus. All the mutants are less toxic than Def-DAA except one (W11V) but are more toxic than Def-AcAA. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=4 µg/mL), Staphylococcus aureus strain 4 (IC90=8-16 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP04091	ATCDLASIWNVNHALCAAHCIARRYRGGYCNSKAVCVCR	39	K8I,W11V,T14A (mutant of Def-DAA defensin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Mutant of Def-DAA defensin (K8I,W11V,T14A) is active against sensitive and resistant strains of S. aureus. All the mutants are less toxic than Def-DAA except one (W11V) but are more toxic than Def-AcAA. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=4 µg/mL), Staphylococcus aureus strain 4 (IC90=2-4 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP04092	ATCDLASKWNVNHTLCAAHCIARRYRGGYCNSKAVCVCR	39	W11V (mutant of Def-DAA defensin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Mutant of Def-DAA defensin (W11V) is active against sensitive and resistant strains of S. aureus. All the mutants are less toxic than Def-DAA except one (W11V) but are more toxic than Def-AcAA. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=2-4 µg/mL), Staphylococcus aureus strain 4 (IC90=4-8 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP04093	ATCDLASIWNVNHTLCAAHCIARRYRGGYCNSKAVCVCR	39	K8I,W11V (mutant of Def-DAA defensin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Mutant of Def-DAA defensin (K8I,W11V) is active against sensitive and resistant strains of S. aureus. All the mutants are less toxic than Def-DAA except one (W11V) but are more toxic than Def-AcAA. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=4 µg/mL), Staphylococcus aureus strain 4 (IC90=4 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP04094	ATCDLASIWNWNHTLCAAHCIARRYRGGYCNSKAVCVCR	39	K8I (mutant of Def-DAA defensin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Mutant of Def-DAA defensin (K8I) is active against sensitive and resistant strains of S. aureus. All the mutants are less toxic than Def-DAA except one (W11V) but are more toxic than Def-AcAA. 	Gram-positive bacteria: Staphylococcus aureus strain 21 (IC90=2 µg/mL), Staphylococcus aureus strain 4 (IC90=4 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18214975	Proteins. 2008 Jul;72(1):229-239.	Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.	Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.	
DRAMP04130	FVDLKKIANIINSIFKK	17	LK1 (Temporin-1CEa analog peptide)	No entry found	Not found	Not found	Synthetic construct	Anti-cancer	Synthetic	Not found	Not found		Function: Has anticancer activity.	Cancer cell lines: MCF-7 (IC50=20.97 µM), Bcap-37 (IC50=18.7 µM), MDA-MB-231 (IC50=66.4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23609760	Arch Pharm Res. 2013 Apr 23.	Yang QZ, Wang C, Lang L, Zhou Y, Wang H, Shang DJ.	Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.	
DRAMP04131	FKDLKKIANIINSIFKK	17	LK2(5) (Temporin-1CEa analog peptide)	No entry found	Not found	Not found	Synthetic construct	Anti-cancer	Synthetic	Not found	Not found		Function: Has anticancer activity.	Cancer cell lines: MCF-7 (IC50=44.7 µM), Bcap-37 (IC50=83.49 µM), MDA-MB-231 (IC50=894.7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23609760	Arch Pharm Res. 2013 Apr 23.	Yang QZ, Wang C, Lang L, Zhou Y, Wang H, Shang DJ.	Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.	
DRAMP04132	FVKLKKIANIINSIFKK	17	LK2(6) (Temporin-1CEa analog peptide)	No entry found	Not found	Not found	Synthetic construct	Anti-cancer	Synthetic	Not found	Not found		Function: Has anticancer activity.	Cancer cell lines: MCF-7 (IC50=15.54 µM), MDA-MB-231 (IC50=85.41 µM), Bcap-37 (IC50=18.9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23609760	Arch Pharm Res. 2013 Apr 23.	Yang QZ, Wang C, Lang L, Zhou Y, Wang H, Shang DJ.	Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.	
DRAMP04133	FKKLKKIANIINSIFKK	17	LK3 (Temporin-1CEa analog peptide)	No entry found	Not found	Not found	Synthetic construct	Anti-cancer	Synthetic	Not found	Not found		Function: Has anticancer activity.	Cancer cell lines: MCF-7 (IC50=27.72 µM), MDA-MB-231 (IC50=224.8 µM), Bcap-37 (IC50=25.04 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23609760	Arch Pharm Res. 2013 Apr 23.	Yang QZ, Wang C, Lang L, Zhou Y, Wang H, Shang DJ.	Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.	
DRAMP04134	FVKLKKILNIINSIFKK	17	LK2(6)A(L) (Temporin-1CEa analog peptide)	No entry found	Not found	Not found	Synthetic construct	Anti-cancer	Synthetic	Not found	Not found		Function: Has anticancer activity.	Cancer cell lines: MCF-7 (IC50=9.01 µM), MDA-MB-231 (IC50=34.74 µM), Bcap-37 (IC50=10.52 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23609760	Arch Pharm Res. 2013 Apr 23.	Yang QZ, Wang C, Lang L, Zhou Y, Wang H, Shang DJ.	Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.	
DRAMP04135	FVKLKKILNIILSIFKK	17	LK2(6)AN(2L) (Temporin-1CEa analog peptide)	No entry found	Not found	Not found	Synthetic construct	Anti-cancer	Synthetic	Not found	Not found		Function: Has anticancer activity.	Cancer cell lines: MCF-7 (IC50=11 µM), MDA-MB-231 (IC50=41.55 µM), Bcap-37 (IC50=9.39 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23609760	Arch Pharm Res. 2013 Apr 23.	Yang QZ, Wang C, Lang L, Zhou Y, Wang H, Shang DJ.	Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.	
DRAMP04148	VXLFPPFLXV	10	Gramicidin S	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	58	Biochemistry. 1975 Dec 16;14(25):5500-5511.	Balerna M, Fosset M, Chicheportiche R, Romey G, Lazdunski M.	Constitution and properties of axonal membranes of crustacean nerves.	
DRAMP04149	VXLPFFPLXV	10	Gramicidin Analogue	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	58	Biochemistry. 1975 Dec 16;14(25):5500-5511.	Balerna M, Fosset M, Chicheportiche R, Romey G, Lazdunski M.	Constitution and properties of axonal membranes of crustacean nerves.	
DRAMP04150	VXLPFPFLXV	10	Gramicidin Analogue 1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	58	Biochemistry. 1975 Dec 16;14(25):5500-5511.	Balerna M, Fosset M, Chicheportiche R, Romey G, Lazdunski M.	Constitution and properties of axonal membranes of crustacean nerves.	
DRAMP04151	IKRFWPVVIRTVVAGYNLYRAIKKK	25	RL1 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04152	KRFWPVVIRTVVAGYNLYRAIKKK	24	RL2 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04153	RFWPVVIRTVVAGYNLYRAIKKK	23	RL3 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04154	FWPVVIRTVVAGYNLYRAIKKK	22	RL4 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04155	WPVVIRTVVAGYNLYRAIKKK	21	RL5 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04156	PVVIRTVVAGYNLYRAIKKK	20	RL6 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04157	VVIRTVVAGYNLYRAIKKK	19	RL7 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04158	VIRTVVAGYNLYRAIKKK	18	RL8 (homologue of Pc-CATH1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.	Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.	Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.	
DRAMP04172	WLKKW	5	LK2W2 (LlKmW2 model peptides)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: B. subtilis (MIC>80 µg/ml), S. aureus (MIC>80 µg/ml), S. epidermis (MIC>80 µg/ml), M. luteus (MIC>80 µg/ml), S. aureus (MRSA) (MIC>80 µg/ml).##Gram-negative bacteria: E. coli (MIC>80 µg/ml), S. dysentariae (MIC>80 µg/ml), S. typhimorium (MIC>80 µg/ml), K. pneumoniae (MIC>80 µg/ml), P. aeruginosa (MIC>80 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20736034	Regul Pept. 2011 Jan 17;166(1-3):36-41.	Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.	De novo generation of short antimicrobial peptides with simple amino acid composition.	
DRAMP04173	WLLKW	5	L2KW2 (LlKmW2 model peptides)	No entry found	Not found	Not found	Synthetic construct (De novo design)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation."	Gram-positive bacteria: B. subtilis (MIC>80 µg/ml), S. aureus (MIC>80 µg/ml), S. epidermis (MIC>80 µg/ml), M. luteus (MIC>80 µg/ml), S. aureus (MRSA) (MIC>80 µg/ml).##Gram-negative bacteria: E. coli (MIC>80 µg/ml), S. dysentariae (MIC>80 µg/ml), S. typhimorium (MIC>80 µg/ml), K. pneumoniae (MIC>80 µg/ml), P. aeruginosa (MIC>80 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20736034	Regul Pept. 2011 Jan 17;166(1-3):36-41.	Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.	De novo generation of short antimicrobial peptides with simple amino acid composition.	
DRAMP04197	RQIKIWFQNRRMKWKK	16	Penetratin	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP04198	RQIRIWFQNRRMRWRR	16	PenArg	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=16 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=8 μM)	[Ref.23085001] HC50>128 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP04199	KQIKIWFQNKKMKWKK	16	PenLys	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Alpha helix		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=256 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=64 μM)	[Ref.23085001] HC50>128 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP04200	RQIKIWFQNRRLKWKK	16	PenLeu	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=64 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=32 μM)	[Ref.23085001] HC50>128 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP04201	KIWFQNRRMKWKK	13	Pen13	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=256 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=128 μM)	[Ref.23085001] HC50>128 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP04202	RIWFQNRRMRWRR	13	Pen13Arg	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=32 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=32 μM)	[Ref.23085001] HC50>128 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP04203	KIWFQNKKMKWKK	13	Pen13Lys	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=256 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=256 μM)	[Ref.23085001] HC50>128 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP04204	RWFKIQMQIRRWKNKK	16	PenShuf	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=64 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=32 μM)	[Ref.23085001] HC50>128 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP04205	RWFKIQLQIRRWKNKK	16	PenShufLeu	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=16 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=32 μM)	[Ref.23085001] HC50=65±2.5 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP04206	KWFKIQLQIKKWKNKK	16	PenShufLysLeu	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=32 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=32 μM)	[Ref.23085001] HC50=91±2.3 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP04207	RWFRIQLQIRRWRNRR	16	PenShufArgLeu	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=16 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=16 μM)	[Ref.23085001] HC50=39±1.4 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.  doi: 10.1016/j.bbamem.2012.10.010.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP04208	WRRRRRRR	8	WR8	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP04209	WGRKKRRQRRRPPQ	14	Tat13	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23085001##20845937	Biochim Biophys Acta. 2013 Feb;1828(2):223-232.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.	Antimicrobial and cell-penetrating properties of penetratin analogs: Effect of sequence and secondary structure.	
DRAMP02126	FIGSALKVLAGVLPSIVSWVKQ	22	Melittin-like peptide (MLP; Frogs, amphibians, animals)	P56924	Not found	Not found	Rana temporaria (European common frog)	Defense response, Anti-cancer, Protein kinase inhibitor activity	Protein level	Not found	Not found		"Function: Peptide has cellular defense response,  inflammatory response, behavioral defense response, defense response to tumor cell,  defense response by callose deposition,  clearance of foreign intracellular nucleic acids, innate immune response, defense response by cell wall thickening, defense response to other organism, protein serine/threonine kinase inhibitor activity, calcium-dependent protein kinase inhibitor activity, protein tyrosine kinase inhibitor activity in GO analysis. Has hemolytic activity.
PTM: Glutamine amide at position 22.
Tissue specificity: Expressed by the skin dorsal glands."	No MICs found in DRAMP database	[Ref.9022710] LC=0.5 µM against human red blood cells. (LC: Lethal concentration)	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9022710	Eur J Biochem. 1996 Dec 15;242(3):788-792.	Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.	Temporins, antimicrobial peptides from the European red frog Rana temporaria.	
DRAMP04211	GIGKHVGKALKGLKGLLKGLGEC	23	ADP2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23196344	Biochim Biophys Acta. 2013 Mar;1828(3):1004-1012.	Ilić N, Novković M, Guida F, Xhindoli D, Benincasa M, Tossi A, Juretić D.	Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences.	
DRAMP04212	GLKGLLGKALKGIGKHIGKAQGC	23	ADP3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23196344	Biochim Biophys Acta. 2013 Mar;1828(3):1004-1012.	Ilić N, Novković M, Guida F, Xhindoli D, Benincasa M, Tossi A, Juretić D.	Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences.	
DRAMP04214	RRLFRRILRYL	11	R-BP100	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23246973	Biochim Biophys Acta. 2013 Mar;1828(3):944-955.	Torcato IM, Huang YH, Franquelim HG, Gaspar D, Craik DJ, Castanho MA, Troeira Henriques S.	Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria.	
DRAMP04215	RRLFRRILRWL	11	RW-BP100	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23246973	Biochim Biophys Acta. 2013 Mar;1828(3):944-955.	Torcato IM, Huang YH, Franquelim HG, Gaspar D, Craik DJ, Castanho MA, Troeira Henriques S.	Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria.	
DRAMP04216	KQSHKKGGHSFPKEKIS	17	P1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23022146	Biochimie. 2013 Feb;95(2):231-240.	Yamane ES, Bizerra FC, Oliveira EB, Moreira JT, Rajabi M, Nunes GL, de Souza AO, da Silva ID, Yamane T, Karpel RL, Silva PI Jr, Hayashi MA.	Unraveling the antifungal activity of a South American rattlesnake toxin crotamine.	
DRAMP04217	KMDSRWRWKSSKK	13	P2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23022146	Biochimie. 2013 Feb;95(2):231-240.	Yamane ES, Bizerra FC, Oliveira EB, Moreira JT, Rajabi M, Nunes GL, de Souza AO, da Silva ID, Yamane T, Karpel RL, Silva PI Jr, Hayashi MA.	Unraveling the antifungal activity of a South American rattlesnake toxin crotamine.	
DRAMP04218	KIFGAIWPLALGALKNLIK	19	Lys-a1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23340019	Peptides. 2013 Apr;42:78-83.	da Silva BR, de Freitas VA, Carneiro VA, Arruda FV, Lorenzón EN, de Aguiar AS, Cilli EM, Cavada BS, Teixeira EH.	Antimicrobial activity of the synthetic peptide Lys-a1 against oral streptococci.	
DRAMP04219	KSSTRGRKSSRRKK	14	CHRG01 (hBD3 derivative)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12936977	Antimicrob Agents Chemother. 2003 Sep;47(9):2804-2809.	Hoover DM, Wu Z, Tucker K, Lu W, Lubkowski J.	Antimicrobial characterization of human beta-defensin 3 derivatives.	
DRAMP04220	RGRKSSRRKK	10	CHRG02 (hBD3 derivative)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12936977	Antimicrob Agents Chemother. 2003 Sep;47(9):2804-2809.	Hoover DM, Wu Z, Tucker K, Lu W, Lubkowski J.	Antimicrobial characterization of human beta-defensin 3 derivatives.	
DRAMP04221	RGRKSSRRK	9	CHRG04 (hBD3 derivative)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12936977	Antimicrob Agents Chemother. 2003 Sep;47(9):2804-2809.	Hoover DM, Wu Z, Tucker K, Lu W, Lubkowski J.	Antimicrobial characterization of human beta-defensin 3 derivatives.	
DRAMP04222	KYYSRVRGGRSAVLSSLDK	19	CHRG06 (hBD3 derivative)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12936977	Antimicrob Agents Chemother. 2003 Sep;47(9):2804-2809.	Hoover DM, Wu Z, Tucker K, Lu W, Lubkowski J.	Antimicrobial characterization of human beta-defensin 3 derivatives.	
DRAMP04223	GIINTLQKYYSRVRGGR	17	CHRG07 (hBD3 derivative)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12936977	Antimicrob Agents Chemother. 2003 Sep;47(9):2804-2809.	Hoover DM, Wu Z, Tucker K, Lu W, Lubkowski J.	Antimicrobial characterization of human beta-defensin 3 derivatives.	
DRAMP04224	RPDKPRPYLPRPRPPRPVR	19	A3-APO	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20031377	Int J Antimicrob Agents. 2010 Apr;35(4):357-361.	Szabo D, Ostorhazi E, Binas A, Rozgonyi F, Kocsis B, Cassone M, Wade JD, Nolte O, Otvos L Jr.	The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models.	
DRAMP04225	GKPRPYLPRPTSHPRPIRV	19	Dros-Pyrr-Dros	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Letters in Peptide Science. 2001;8(3-5):201-209.	Bencivengo AM, Cudic M, Hoffmann R, Jr LO.	The efficacy of the antibacterial peptide, pyrrhocoricin, is finely regulated by its amino acid residues and active domains.	
DRAMP04226	VDKGSYLPRPTSHPRPIRV	19	Pyrr-Pyrr-Dros	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Letters in Peptide Science. 2001;8(3-5):201-209.	Bencivengo AM, Cudic M, Hoffmann R, Jr LO.	The efficacy of the antibacterial peptide, pyrrhocoricin, is finely regulated by its amino acid residues and active domains.	
DRAMP04227	GLLRRLRKKIGEIFKKYG	18	PGG	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9428709	Eur J Biochem. 1997 Dec 1;250(2):549-558.	Tossi A, Tarantino C, Romeo D.	Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.	
DRAMP04228	GRFRRLGRKFKKLFKKYGP	19	PGP	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9428709	Eur J Biochem. 1997 Dec 1;250(2):549-558.	Tossi A, Tarantino C, Romeo D.	Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.	
DRAMP04229	GLLRRLRDFLKKIGEKFKKIGY	22	PGYa	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9428709	Eur J Biochem. 1997 Dec 1;250(2):549-558.	Tossi A, Tarantino C, Romeo D.	Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.	
DRAMP04230	GILSKLGKALKKAAKHAAKA	20	PGAa	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9428709	Eur J Biochem. 1997 Dec 1;250(2):549-558.	Tossi A, Tarantino C, Romeo D.	Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.	
DRAMP04231	GLRKRLRKARNKIKEKLKKI	20	C18A	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8313956	FEBS Lett. 1994 Feb 14;339(1-2):108-112.	Tossi A, Scocchi M, Skerlavaj B, Gennaro R.	Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit Leukocytes.	
DRAMP04232	GLRKRLRKFRNKIKQKLKKI	20	C18Q	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8313956	FEBS Lett. 1994 Feb 14;339(1-2):108-112.	Tossi A, Scocchi M, Skerlavaj B, Gennaro R.	Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit Leukocytes.	
DRAMP04236	GLFDKLKSLVSDF	13	Antibacterial peptide A2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix (1 helices; 10 residues)	Not found	1VM2 resolved by NMR.	Function: Has antibacterial activity against the Gram-negative bacterium E. coli.	Gram-negative bacterium: Escherichia coli (MIC>250 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15572363	J Biol Chem. 2005 Feb 18;280(7):5803-5811.	Wang G, Li Y, Li X.	Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor.	
DRAMP04239	ERPPGFSPFR	10	Neurotensin	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12074933	Life Sci. 2002 Jul 5;71(7):747-750.	Kowalska K, Carr DB, Lipkowski AW.	Direct antimicrobial properties of substance P.	
DRAMP04245	LLLFLLKKRKKRKY	14	Dhvar5	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10518718	FEMS Microbiol Lett. 1999 Oct 15;179(2):217-222.	Groenink J, Walgreen-Weterings E, van 't Hof W, Veerman EC, Nieuw Amerongen AV.	Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens.	
DRAMP04246	KRLFKKLLFSLRKY	14	Dhvar4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10518718	FEMS Microbiol Lett. 1999 Oct 15;179(2):217-222.	Groenink J, Walgreen-Weterings E, van 't Hof W, Veerman EC, Nieuw Amerongen AV.	Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens.	
DRAMP04247	KEEQIGKSSTRGRKSSRRKK	20	STRO06	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12936977	Antimicrob Agents Chemother. 2003 Sep;47(9):2804-2809.	Hoover DM, Wu Z, Tucker K, Lu W, Lubkowski J.	Antimicrobial Characterization of Human -Defensin 3 Derivatives.	
DRAMP04248	KIGAKIKIGAKIKIGAKI	18	(KIGAKI)3-NH2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11352918	J Biol Chem. 2001 Jul 27;276(30):27899-27906.	Blazyk J, Wiegand R, Klein J, Hammer J, Epand RM, Epand RF, Maloy WL, Kari UP.	A Novel Linear Amphipathic b-Sheet Cationic Antimicrobial Peptide with Enhanced Selectivity for Bacterial Lipids.	
DRAMP04249	KIAGKIAKIAGKIAKIAGKIA	21	(KIAGKIA)3-NH2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11352918	J Biol Chem. 2001 Jul 27;276(30):27899-27906.	Blazyk J, Wiegand R, Klein J, Hammer J, Epand RM, Epand RF, Maloy WL, Kari UP.	A Novel Linear Amphipathic b-Sheet Cationic Antimicrobial Peptide with Enhanced Selectivity for Bacterial Lipids.	
DRAMP04250	KLAGLAKKLAGLAKKLAGLAK	21	(KLAGLAK)3-NH2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11352918	J Biol Chem. 2001 Jul 27;276(30):27899-27906.	Blazyk J, Wiegand R, Klein J, Hammer J, Epand RM, Epand RF, Maloy WL, Kari UP.	A Novel Linear Amphipathic b-Sheet Cationic Antimicrobial Peptide with Enhanced Selectivity for Bacterial Lipids.	
DRAMP04251	RRWVRRVRRWVRRVVRVVRRWVRR	24	WLBU2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15616311	Antimicrob Agents Chemother. 2005 Jan;49(1):316-322.	Deslouches B, Phadke SM, Lazarevic V, Cascio M, Islam K, Montelaro RC, Mietzner TA.	De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.	
DRAMP04252	GFKLKGMARISCLPNGQWSNFPPKCIRECAMVSS	34	Sushi peptide 1 (truncated fragment)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10973930	FASEB J. 2000 Sep;14(12):1801-1813.	Tan NS, Ng ML, Yau YH, Chong PK, Ho B, Ding JL.	Definition of endotoxin binding sites in horseshoe crab factor C recombinant sushi proteins and neutralization of endotoxin by sushi peptides.	
DRAMP04253	HAEHKVKIGVEQKYGQFPQGTEVTYTCSGNYFLM	34	Sushi peptide 3 (truncated fragment)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10973930	FASEB J. 2000 Sep;14(12):1801-1813.	Tan NS, Ng ML, Yau YH, Chong PK, Ho B, Ding JL.	Definition of endotoxin binding sites in horseshoe crab factor C recombinant sushi proteins and neutralization of endotoxin by sushi peptides.	
DRAMP04254	YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY	36	Neuropeptide Y (NPY)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found	1RON	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9756788	Antimicrob Agents Chemother. 1998 Oct;42(10):2745-2746.	Shimizu M, Shigeri Y, Tatsu Y, Yoshikawa S, Yumoto N.	Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncation.	
DRAMP04255	YPSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY	36	Neuropeptide Y (NPY)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found	1F8P	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9756788	Antimicrob Agents Chemother. 1998 Oct;42(10):2745-2746.	Shimizu M, Shigeri Y, Tatsu Y, Yoshikawa S, Yumoto N.	Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncation.	
DRAMP04256	DKLIGSCVWGAVNYTSDCNGECKRRGYKGGYCGSFANVNCWRT	43	R	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11580275	Biochemistry. 2001 Oct 9;40(40):11995-2003.	Lamberty M, Caille A, Landon C, Tassin-Moindrot S, Hetru C, Bulet P, Vovelle F.	Solution structures of the antigungal heliomicin and a selected variant whit both antibacterial and antifungal activities.	
DRAMP04257	AAAAGSVWGAVNYTSDCNGECKRRGYKGGYCGSFANVNCWCET	43	4A	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11580275	Biochemistry. 2001 Oct 9;40(40):11995-2003.	Lamberty M, Caille A, Landon C, Tassin-Moindrot S, Hetru C, Bulet P, Vovelle F.	Solution structures of the antigungal heliomicin and a selected variant whit both antibacterial and antifungal activities.	
DRAMP04258	DKLIGSCVWGAVNYTSDCAAEKRRGYKGGYCGSFANVNCWCET	43	AA	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11580275	Biochemistry. 2001 Oct 9;40(40):11995-2003.	Lamberty M, Caille A, Landon C, Tassin-Moindrot S, Hetru C, Bulet P, Vovelle F.	Solution structures of the antigungal heliomicin and a selected variant whit both antibacterial and antifungal activities.	
DRAMP04259	DKLIGSCVWGAVNYTSDCNGECLLRGYKGGYCSGFANVNCWCET	44	LL	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11580275	Biochemistry. 2001 Oct 9;40(40):11995-2003.	Lamberty M, Caille A, Landon C, Tassin-Moindrot S, Hetru C, Bulet P, Vovelle F.	Solution structures of the antigungal heliomicin and a selected variant whit both antibacterial and antifungal activities.	
DRAMP04260	LALLKVLLRKIKKAL	15	CM-1	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04261	LULLLKILLLKKLKA	15	CM-2	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04262	ALKAALLAILKIVRVIKK	18	CM-3	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04263	LLAILLLALLALRKKVLA	18	CM-4	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04266	KWKSFIKKLPSAAKKVTTAAKPLTK	25	CPα1	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=43 μg/ml), Pseudomonas aeruginosa K799 (MIC=64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=24 μg/ml), Pseudomonas aeruginosa H744 (MIC=8 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml), Pseudomonas aeruginosa H547 (MIC=16 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04267	KWKKFIKKIGIGAVLKVLTTGLPALKLTKK	30	CPα2	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=2 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=4 μg/ml), Pseudomonas aeruginosa H744 (MIC=2 μg/ml), Pseudomonas aeruginosa H374 (MIC=4 μg/ml), Pseudomonas aeruginosa H547 (MIC=2 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04268	KKWKKFIKKIGIGAVLTTPGAKK	23	CPα3	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=32 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml), Pseudomonas aeruginosa H547 (MIC=16 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04269	KWKSFIKNLTKGGSKILTTGLPALIS	26	CP201	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=43 μg/ml), Pseudomonas aeruginosa K799 (MIC=64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=32 μg/ml), Pseudomonas aeruginosa H744 (MIC=16 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml), Pseudomonas aeruginosa H547 (MIC=32 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04270	KWKKFIKNLTKGGSKILTTGLPALIS	26	CP202	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=16 μg/ml), Pseudomonas aeruginosa K799 (MIC=32 μg/ml), Pseudomonas aeruginosa Z61 (MIC=19 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H374 (MIC=4 μg/ml), Pseudomonas aeruginosa H547 (MIC=16 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04271	KWKSFIKKLTSAAKKVLTTGLPALIS	26	CP203	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=5 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H374 (MIC=4 μg/ml), Pseudomonas aeruginosa H547 (MIC=8 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04274	KKWWKFIKKAVNSGTTGLQTLAS	23	CP206	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=8 μg/ml), Pseudomonas aeruginosa H744 (MIC=16 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04275	KWKSFIKKLTSVLKKVVTTAKPLISS	26	CP207	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=3 μg/ml), Pseudomonas aeruginosa K799 (MIC=5 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml), Pseudomonas aeruginosa H547 (MIC=8 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04276	KKKSFIKLLTSAKVSVLTTAKPLISS	26	CP208	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=32 μg/ml), Pseudomonas aeruginosa H744 (MIC=64 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04277	WKVFKSFIKKASSFAQSVLD	20	CP209	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=11 μg/ml), Pseudomonas aeruginosa Z61 (MIC=64 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04280	KWKSFIKKLPSAAKKVVTTAKPLALIS	27	CM1	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=5 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=4 μg/ml), Pseudomonas aeruginosa H744 (MIC=2 μg/ml), Pseudomonas aeruginosa H547 (MIC=16 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04281	KWKSFIKKLPKAAKKVVTTAKKPLIV	26	CM2	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=3 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=1 μg/ml), Pseudomonas aeruginosa H547 (MIC=4 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04282	KWKKFIKSLTKSAAKTVVKTAKKPLIV	27	CM3	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=1 μg/ml), Salmonella typhimurium (MIC=3 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=2 μg/ml), Pseudomonas aeruginosa H374 (MIC=2 μg/ml), Pseudomonas aeruginosa H547 (MIC=2 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04283	KWKLFKKIGIGAVLKVLTTGLPALKLTLK	29	CM4	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=3 μg/ml), Salmonella typhimurium (MIC=3 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H547 (MIC=4 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04284	KLFKKIGIGAVLKVLTTGLPALKLTK	26	CM5	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=5 μg/ml), Salmonella typhimurium (MIC=29 μg/ml), Pseudomonas aeruginosa K799 (MIC=32 μg/ml), Pseudomonas aeruginosa Z61 (MIC=19 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H547 (MIC=32 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04285	KWKFKKIGIGAVLKVLTTGLPALKLTLK	28	CM6	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=6 μg/ml), Pseudomonas aeruginosa Z61 (MIC=5 μg/ml), Pseudomonas aeruginosa H744 (MIC=1 μg/ml), Pseudomonas aeruginosa H547 (MIC=2 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04286	KLWKLFKKIGIGAVLKVLTTGLPALKLTK	29	CM7	No entry found	Derived from the peptide CP26, CP29, CEME and CEMA	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=3 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=16 μg/ml), Pseudomonas aeruginosa H547 (MIC=32 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipopolysaccharide (LPS)-binding	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04287	AASKAAKTLAKLLSSLLKL	19	MC-03	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04288	LLKKLLRAASKALSLL	16	MC-04	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04289	AAKKLSKLLKTLLKLL	16	MC-05	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04290	KALKKLLKLASSLLTAL	17	MC-08	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04291	AASKALRTASRLARSLLT	18	MC-10	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04292	LKLLKKLLKKLKKLL	15	MB-00	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04293	VSSKYLSKVKVKAGK	15	MB-03	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04294	ARLAKKALRRLAKKD	15	MB-04	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04295	GESLASKAAKAAER	14	MB-10	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04296	ESLAKALSKEALKALK	16	MB-15	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04297	LKALKKLAKKLKKLA	15	MB-18	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04298	FASLLGKALKALAKQ	15	MB-21	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04299	GWLLLEYIPVIAAL	14	MB-22	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04300	LSSALSALSSALSSK	15	MB-25	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04301	EAALKAALDLAAKLA	15	MB-31	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04302	ERSAAKSAARSLARR	15	MB-32	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04303	EKTLARTAAKTALKK	15	MB-33	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04304	EKAAAKSAAAKTLARR	16	MB-34	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04305	VSSKYLSKALVKAGR	15	MB-35	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04306	FASLLGKALKALLAKLAKQ	19	MB-36	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04307	FASLLGKLAKKLAKKALK	18	MB-37	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04308	ESLKARSLKKSLKLKKLL	18	MB-38	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04309	ETELAKKALKALKLKKLA	18	MB-40	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04310	ELAKKALKALKKALKSAR	18	MB-41	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04311	ELAKKALRALKKALKSAK	18	MB-43	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04312	ETFAKKALKALEKLLKKG	18	MB-45	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04313	ESSLKKKALSKLSKLLKKG	19	MB-46	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04314	QKAASRLLRALSKLLEAF	18	MB-47	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04315	QKALAKLAKKALKALAKQ	18	MB-48	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04316	ESKAAKAAKKAAKAKASE	18	MB-50	No entry found	Not found	Not found	Synthetic construct (Computer-Aided Molecular Design)	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9879502	J Comput Aided Mol Des. 1998 Nov;12(6):543-556.	Patel S, Stott IP, Bhakoo M, Elliott P.	Patenting computer-designed peptides.	
DRAMP04317	FFGKVLKLIRKIF	13	DASamP1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22445495	Int J Antimicrob Agents. 2012 May;39(5):402-406.	Menousek J, Mishra B, Hanke ML, Heim CE, Kielian T, Wang G.	Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300.	
DRAMP04318	IKWKKLLRAAKRIL	14	DASamP2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22445495	Int J Antimicrob Agents. 2012 May;39(5):402-406.	Menousek J, Mishra B, Hanke ML, Heim CE, Kielian T, Wang G.	Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300.	
DRAMP04319	ALRLAIRRR	9	22A-30R-NH2 fragment 1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04320	ALLLAIRRR	9	22A-30R-NH2 fragment 2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04321	AWLLAIRRR	9	22A-30R-NH2 fragment 3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04322	ALYLAIRRR	9	22A-30R-NH2 fragment 4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04323	ALWLAIRRR	9	22A-30R-NH2 fragment 5	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04324	LCAAHCLAIGRR	12	19L-30R-NH2 fragment 1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04325	LCAAHCLAIRRR	12	19L-30R-NH2 fragment 2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04326	LCAAHCLAILRR	12	19L-30R-NH2 fragment 3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04327	LCAARCLAIGRR	12	19L-30R-NH2 fragment 4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04328	LCAALCLAIGRR	12	19L-30R-NH2 fragment 5	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04329	LRAAHRLAIGRR	12	19L-30R-NH2 fragment 6	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04330	LLAAHLLAIGRR	12	19L-30R-NH2 fragment 7	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04331	AAHCLAIGRR	10	19L-30R-NH2 fragment 8	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04332	AHCLAIGRR	9	19L-30R-NH2 fragment 9	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04333	HCLAIGRR	8	19L-30R-NH2 fragment 10	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04334	CLAIGRR	7	19L-30R-NH2 fragment 11	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9931294	Biochem J. 1999 Feb 15;338 ( Pt 1):29-33.	Saido-Sakanaka H, Ishibashi J, Sagisaka A, Momotani E, Yamakawa M.	Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.	
DRAMP04335	FLFSLIPKAIGGLISAFK	18	AamAP-S1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22484288	Peptides. 2012 Jun;35(2):291-299.	Almaaytah A, Zhou M, Wang L, Chen T, Walker B, Shaw C.	Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: Biochemical and functional characterization of natural peptides and a single site-substituted analog.	
DRAMP04336	IGKEFKRIVQRIKDFLRNL	19	IG-19 (residues 13-31 of LL-37)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=16 μM), Salmonella typhimurium (KCTC 1926)(MIC=8 μM)	[Ref.22521196] MHC10=21.6 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22521196	Peptides. 2012 Jun;35(2):239-247.	Nan YH, Bang JK, Jacob B, Park IS, Shin SY.	Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.	
DRAMP04337	IGKKFKRIVQRIKDFLRNL	19	a1 (IG-19 analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=2 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)	[Ref.22521196] MHC10=13.8 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22521196	Peptides. 2012 Jun;35(2):239-247.	Nan YH, Bang JK, Jacob B, Park IS, Shin SY.	Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.	
DRAMP04338	IGKKFKRIVQRIKKFLRNL	19	a2 (IG-19 analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=2 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=8 μM)	[Ref.22521196] MHC10=11.2 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22521196	Peptides. 2012 Jun;35(2):239-247.	Nan YH, Bang JK, Jacob B, Park IS, Shin SY.	Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.	
DRAMP04339	IGKKFKRIVQRIKKFLRKL	19	a3 (IG-19 analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=2 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)	[Ref.22521196] MHC10=23.7 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22521196	Peptides. 2012 Jun;35(2):239-247.	Nan YH, Bang JK, Jacob B, Park IS, Shin SY.	Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.	
DRAMP04340	IGKKFKRIVKRIKKFLRKL	19	a4 (IG-19 analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)	[Ref.22521196] MHC10=33.2 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22521196	Peptides. 2012 Jun;35(2):239-247.	Nan YH, Bang JK, Jacob B, Park IS, Shin SY.	Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.	
DRAMP04341	IGKLFKRIVQRIKKFLRNL	19	a5 (IG-19 analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=8 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)	[Ref.22521196] MHC10=3.0 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22521196	Peptides. 2012 Jun;35(2):239-247.	Nan YH, Bang JK, Jacob B, Park IS, Shin SY.	Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.	
DRAMP04342	IGKLFKRIVQRILKFLRNL	19	a6 (IG-19 analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=8 μM), Staphylococcus aureus (KCTC 1621)(MIC=8 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)	[Ref.22521196] MHC10=1.2 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22521196	Peptides. 2012 Jun;35(2):239-247.	Nan YH, Bang JK, Jacob B, Park IS, Shin SY.	Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.	
DRAMP04343	IGKLFKRIVKRILKFLRKL	19	a7 (IG-19 analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)	[Ref.22521196] MHC10=1.1 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22521196	Peptides. 2012 Jun;35(2):239-247.	Nan YH, Bang JK, Jacob B, Park IS, Shin SY.	Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.	
DRAMP04344	ILKLFKRIVKRILKFLRKL	19	a8 (IG-19 analogs)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=8 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=8 μM)	[Ref.22521196] MHC10=1.6 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22521196	Peptides. 2012 Jun;35(2):239-247.	Nan YH, Bang JK, Jacob B, Park IS, Shin SY.	Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.	
DRAMP04345	IGKKWKRIVKRIKKFLRKL	19	a4-W1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=4 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)	[Ref.22521196] MHC10=9.2 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22521196	Peptides. 2012 Jun;35(2):239-247.	Nan YH, Bang JK, Jacob B, Park IS, Shin SY.	Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.	
DRAMP04346	IGKKFKRIVKRIKKWLRKL	19	a4-W2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.22521196] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=4 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)	[Ref.22521196] MHC10=8.4 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22521196	Peptides. 2012 Jun;35(2):239-247.	Nan YH, Bang JK, Jacob B, Park IS, Shin SY.	Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.	
DRAMP04347	RAGLQFPVGRLLRRLLRRLLR	21	Buforin	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22306477	Peptides. 2012 Apr;34(2):283-289.	Jang SA, Kim H, Lee JY, Shin JR, Kim da J, Cho JH, Kim SC.	Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.	
DRAMP04348	RAGLQWPIGRLLRRLLRRLLR	21	Buf IIIa	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22306477	Peptides. 2012 Apr;34(2):283-289.	Jang SA, Kim H, Lee JY, Shin JR, Kim da J, Cho JH, Kim SC.	Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.	
DRAMP04349	RVVRQWPIGRVVRRVVRRVVR	21	Buf IIIb	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22306477	Peptides. 2012 Apr;34(2):283-289.	Jang SA, Kim H, Lee JY, Shin JR, Kim da J, Cho JH, Kim SC.	Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.	
DRAMP04350	KLLKQWPIGKLLKKLLKKLLK	21	Buf IIIc	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22306477	Peptides. 2012 Apr;34(2):283-289.	Jang SA, Kim H, Lee JY, Shin JR, Kim da J, Cho JH, Kim SC.	Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.	
DRAMP04351	KVVKQWPIGKVVKKVVKKVVK	21	Buf IIId	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22306477	Peptides. 2012 Apr;34(2):283-289.	Jang SA, Kim H, Lee JY, Shin JR, Kim da J, Cho JH, Kim SC.	Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.	
DRAMP04352	INWKKLLDAAKQIL	14	Asn-2-Polybia-MP	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20108158	Amino Acids. 2011 Jan;40(1):77-90.	de Souza BM, Dos Santos Cabrera MP, Neto JR, Palma MS.	Investigating the effect of different positioning of lysine residues along the peptide chain of mastoparans for their secondary structures and biological activities.	
DRAMP04353	INWLKAKKVAGMIL	14	MK-578	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20108158	Amino Acids. 2011 Jan;40(1):77-90.	de Souza BM, Dos Santos Cabrera MP, Neto JR, Palma MS.	Investigating the effect of different positioning of lysine residues along the peptide chain of mastoparans for their secondary structures and biological activities.	
DRAMP04354	GLFRALLRLLRSLWRLLLRA	20	PpTG20	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22819152	Int J Antimicrob Agents. 2012 Oct;40(4):337-343.	Li L, Shi Y, Su G, Le G.	Selectivity for and destruction of Salmonella typhimurium via a membrane damage mechanism of a cell-penetrating peptide ppTG20 analogue.	
DRAMP04355	GLRRALLRLLRSLRRLLLRA	20	P7	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22819152	Int J Antimicrob Agents. 2012 Oct;40(4):337-343.	Li L, Shi Y, Su G, Le G.	Selectivity for and destruction of Salmonella typhimurium via a membrane damage mechanism of a cell-penetrating peptide ppTG20 analogue.	
DRAMP04356	KWKLFKKIEKVGQRVDAVISAGPAVATVAQAATALAK	37	CAD	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22651919	Protein Expr Purif. 2012 Oct;85(2):200-203.	Yang K, Su Y, Li J, Sun J, Yang Y.	Expression and purification of the antimicrobial peptide cecropin AD by fusion with cationic elastin-like polypeptides.	
DRAMP04357	KWKLFKKIGIGAVLKVLTTGLIALIS	26	CEME(MBI-27)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=2 μg/ml), Pseudomonas aeruginosa K799 (MIC=5 μg/ml), Pseudomonas aeruginosa Z61 (MIC=4 μg/ml), Pseudomonas aeruginosa H744 (MIC=2 μg/ml), Pseudomonas aeruginosa H374 (MIC=2 μg/ml), Pseudomonas aeruginosa H547 (MIC=2 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04358	KWKLFKKIGIGAVLKVLTPGLPALKLTK	28	CEMA(MBI-28)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=3 μg/ml), Pseudomonas aeruginosa K799 (MIC=3 μg/ml), Pseudomonas aeruginosa Z61 (MIC=2 μg/ml), Pseudomonas aeruginosa H744 (MIC=2 μg/ml), Pseudomonas aeruginosa H374 (MIC=2 μg/ml), Pseudomonas aeruginosa H547 (MIC=4 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10085049	Infect Immun. 1999 Apr;67(4):2005-2009.	Scott MG, Yan H, Hancock RE.	Biological properties of structurally related alpha-helical cationic antimicrobial peptides.	
DRAMP04366	INWSSIFESVSNLV	14	PDD-A-8 (PDD-A analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC>100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04375	INSLKLGKKILGAL	14	PDD-B-5 (PDD-B analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC>100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04384	KIASIGKEVLKAL	13	PMM-5 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC>100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP04388	INWKKIASIGKEV	13	PMM-9 (PMM analog)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation."	Gram-negative bacterium: Escherichia coli (MIC>100 µM);##Gram-positive bacterium: Bacillus subtilis (MIC>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18375018	Peptides. 2008 Jun;29(6):992-1003.	Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.	New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.	
DRAMP01823	FLPFLATLLSKVL	13	Temporin-1Ce (Temporin 1Ce; Frogs, amphibians, animals)	P82884	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Rana clamitans (Green frog) (Lithobates clamitans)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacterium Staphylococcus aureus.
Tissue specificity: Expressed by the skin glands."	[Ref.10822101] Gram-positive bacterium: Staphylococcus aureus (MIC=100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10822101	Peptides. 2000 Apr;21(4):469-476.	Halverson T, Basir YJ, Knoop FC, Conlon JM.	Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.	
DRAMP04396	AIGNILKTLGNLAQKILGKQPKMLKLWKWNWKSSDVEYHLAKC	43	Antimicrobial peptide OGC1	C3RTH6	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Ma Y, Lai R, Wu J, Li J.	Antimicrobial peptide from skin of Odorrana grahami.	
DRAMP04397	AIGNILKTLGNLAQKILGK	19	Antimicrobial peptide OGC2	C3RTH7	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases	Ma Y, Lai R, Wu J, Li J.	Antimicrobial peptide from skin of Odorrana grahami.	
DRAMP04398	AKYTGKCTKSKNECKYKNDAGKDTFIKCPKFDNKKCTKDNNKCTVDTYNNAVDCD	55	Antifungal protein (PAF)	Q01701	Not found	paf	Penicillium chrysogenum (Penicillium notatum)	Antimicrobial, Antifungal, Antiviral	Protein level	Beta strand (5 strands; 24 residues)	PAF comprises five beta-strands forming two orthogonally packed beta-sheets that share a common interface.	2KCN resolved by NMR.	Function: It exhibits antifungal activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19459942##8566771	FEBS J. 2009 May;276(10):2875-2890.##Gene. 1995 Dec 29;167(1-2):167-171.	Batta G, Barna T, Gáspári Z, Sándor S, Kövér KE, Binder U, Sarg B, Kaiserer L, Chhillar AK, Eigentler A, Leiter E, Hegedüs N, Pócsi I, Lindner H, Marx F.##Marx F, Haas H, Reindl M, Stöffler G, Lottspeich F, Redl B.	Functional aspects of the solution structure and dynamics of PAF--a highly-stable antifungal protein from Penicillium chrysogenum.##oning, structural organization and regulation of expression of the Penicillium chrysogenum paf gene encoding an abundantly secreted protein with antifungal activity.	
DRAMP04399	MFTLKKSLLLLFFLGTINLSLCQEEERNADEEERRDERDVEVEKRVIPFVASVAAEMMQHVYCAASKKR	69	Odorranain-P1g antimicrobial peptide (Frogs, amphibians, animals)	B5L162	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ database	Wang X, Lai R.	Odorrana grahmi antimicrobial peptide cDNA sequences.	
DRAMP04400	MFTLKKPLLLLFFLGTINLSLCQEEERNADEEERRDERDVEVEKRVIPSVASVAAEMMQHVYCAASKKC	69	Odorranain-P1c antimicrobial peptide (Frogs, amphibians, animals)	B5L177	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ database	Wang X, Lai R.	Odorrana grahmi antimicrobial peptide cDNA sequences.	
DRAMP04401	MFTMKKSLLLLFFLGAINLSFCQEEERNADEEERRDERDVEVEKRVIPFVASVAAEKMQHVYCAASKKC	69	Odorranain-P1e antimicrobial peptide (Frogs, amphibians, animals)	B5L1A0	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ database	Wang X, Lai R.	Odorrana grahmi antimicrobial peptide cDNA sequences.	
DRAMP04402	MFTMKKSLLLLFFLGTINLSLCQEEERNADEEERRDERDVEVEKRVIPSVASVAAEMMQHVYCAASKKC	69	Odorranain-P1c antimicrobial peptide (Frogs, amphibians, animals)	B5L1A3	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ database	Wang X, Lai R.	Odorrana grahmi antimicrobial peptide cDNA sequences.	
DRAMP04403	MFTLKKSLLLLFFLGTINLSLCQEEERNADEEERRDERDIEVEKRVIPFVASVAAEMMQHVYCAASKKMLKLNWKSSDVENHLAKC	86	Odorranain-P1h antimicrobial peptide (Frogs, amphibians, animals)	B5L163	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ database	Wang X, Lai R.	Odorrana grahmi antimicrobial peptide cDNA sequences.	
DRAMP04404	MFTMKKSLLLLFFLGTINLSFCQEEERNADEEERRDERDVEVEKRVIPFVASVAAEMMQPVYCAASKKC	69	Odorranain-P1d antimicrobial peptide (Frogs, amphibians, animals)	B5L196	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ database	Wang X, Lai R.	Odorrana grahmi antimicrobial peptide cDNA sequences.	
DRAMP04405	MFTMKKSLLVLFFLGIVSLSLCEEERNADEDDGEMTEEVKRGILDTLKQLGKAAAQSLLSKAACKLAKTC	70	Granulosusin-E1 antimicrobial peptide (Frogs, amphibians, animals)	E1AXE7	Not found	Not found	Amolops granulosus (granular torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2010) to the EMBL/GenBank/DDBJ database	Wang H, Liu J.	Antimicrobial peptides from amphibian skin of Amolops granulosus.	
DRAMP04406	MFTLKKSMLLLLFLGTVSLSLCDQERAADEDEGEVIEEEVKRGFMDTAKNVFKNVAVTLLDKLKCKIAGGC	71	Granulosusin-D1 antimicrobial peptide (Frogs, amphibians, animals)	E1AXE5	Not found	Not found	Amolops granulosus (granular torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2010) to the EMBL/GenBank/DDBJ database	Wang H, Liu J.	Antimicrobial peptides from amphibian skin of Amolops granulosus.	
DRAMP04407	MFSKKSLLVLFFLGTISLSLCQEERGADEDEAVEFTEEEKRSILSTLKDVGISALKNAGSGVLKTLLCKLNKNCEK	76	Taipehensin-A1 antimicrobial peptide (Frogs, amphibians, animals)	E7EKG5	Not found	Not found	Hylarana taipehensis (Taipei frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (DEC-2010) to the EMBL/GenBank/DDBJ database	Wang H, Liu J.	Antimicrobial peptides from amphibian skin of Hylarana (Hylarana)taipehensis.	
DRAMP04408	GLFPNKDCKYWCKDNLGLNYCCGQPGVTYPPFTKKHLGRCPAVRDTCTGVRTQLPTYCPHDGACQFRSKCCYDTCLKHHVCKTAEYPY	88	Carcinin 	Q8WQ91	Not found	Not found	Carcinus maenas (Common shore crab) (Green crab)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16712935	Mol Immunol. 2007 Feb;44(5):943-949.	Brockton V, Hammond JA, Smith VJ.	Gene characterisation, isoforms and recombinant expression of carcinin, an antibacterial protein from the shore crab, Carcinus maenas.	
DRAMP04409	MFTLKKSLLLLFFLGIISLSLCEQERDANDEEDGGEVTKEVVKRSLRGCWTKSYPPQPCLGKR	63	Ranacyclin Ca antimicrobial peptide	C5IAX6	Not found	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAR-2009) to the EMBL/GenBank/DDBJ databases	Zhao R, Han W, Han J, Lei L, Feng X, Sun C, Jiang L.	Identification and characterization of a novel antimicrobial peptide from Rana catesbeiana.	
DRAMP04410	GDVHAQTTWPCATVGVSVALCPTTKCTSQC	30	Lantibiotic cytolysin 	Q9KFM6	Not found	Not found	Bacillus halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM9153 / C-125)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11058132	Nucleic Acids Res. 2000 Nov 1;28(21):4317-4331.	Takami H, Nakasone K, Takaki Y, Maeno G, Sasaki R, Masui N, Fuji F, Hirama C, Nakamura Y, Ogasawara N, Kuhara S, Horikoshi K.	Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans and genomic sequence comparison with Bacillus subtilis.	
DRAMP04411	ALPCAKKSCDSWCRRLDYPGGECVTKWKCSCNWMQIDK	38	Defensin like protein 2 (Predicted)	B5MF85	Not found	defensin2	Bombyx mori (Silk moth)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18776686	Biosci Biotechnol Biochem. 2008 Sep;72(9):2353-2361.	Kaneko Y, Tanaka H, Ishibashi J, Iwasaki T, Yamakawa M.	Gene expression of a novel defensin antimicrobial peptide in the silkworm, Bombyx mori.	
DRAMP04412	ASCYLLDGYAAGRDDCRAHCIAPRNRRLYCASYQVCVCRY	40	Defensin 	Q8WQZ3	Not found	Not found	Mamestra brassicae (Cabbage moth)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12753953	Biol Cell. 2003 Jan-Feb;95(1):53-57.	Mandrioli M, Bugli S, Saltini S, Genedani S, Ottaviani E.	Molecular characterization of a defensin in the IZD-MB-0503 cell line derived from immunocytes of the insect Mamestra brassicae (Lepidoptera).	
DRAMP04413	ASGCKADACKSYCKSLGSGGGYCDQGTWCVCN	32	Defensin-like protein (Predicted)	Q6YC89	Not found	Not found	Dermacentor variabilis (American dog tick)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17261604	Infect Immun. 2007 Apr;75(4):1973-1983.	Ceraul SM, Dreher-Lesnick SM, Gillespie JJ, Rahman MS, Azad AF.	New tick defensin isoform and antimicrobial gene expression in response to Rickettsia montanensis challenge.	
DRAMP04414	ATCDLFSFESKWFTPNHAACAAHCILLGNRGGHCVGTVCHCRK	43	Defensin 1 (Def1)	Q4VSI0	Not found	def1	Triatoma brasiliensis (Blood-sucking bug)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19505471	J Insect Physiol. 2009 Sep;55(9):840-848.	Waniek PJ, Castro HC, Sathler PC, Miceli L, Jansen AM, Araújo CA.	Two novel defensin-encoding genes of the Chagas disease vector Triatoma brasiliensis (Reduviidae, Triatominae): gene expression and peptide-structure modeling.	
DRAMP04415	ATCDLFSLQSKWVTPNHAACAAHCLLRGNRGGQCKGTICHCRK	43	Defensin 2 (Def2)	Q102J4	Not found	Def2	Triatoma brasiliensis (Blood-sucking bug)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19505471	J Insect Physiol. 2009 Sep;55(9):840-848.	Waniek PJ, Castro HC, Sathler PC, Miceli L, Jansen AM, Araújo CA.	Two novel defensin-encoding genes of the Chagas disease vector Triatoma brasiliensis (Reduviidae, Triatominae): gene expression and peptide-structure modeling.	
DRAMP04416	ATCDLFSFQSQWVTPNHAACAAHCLLRGNRGGECKGTICHCRK	43	Defensin 3 (Def3)	C6ZEC4	Not found	def3	Triatoma brasiliensis (Blood-sucking bug)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19505471	J Insect Physiol. 2009 Sep;55(9):840-848.	Waniek PJ, Castro HC, Sathler PC, Miceli L, Jansen AM, Araújo CA.	Two novel defensin-encoding genes of the Chagas disease vector Triatoma brasiliensis (Reduviidae, Triatominae): gene expression and peptide-structure modeling.	
DRAMP04417	ATCDLFSFQSKWVTPNHAACAAHCLLRGNRGGQCKGTICHCRK	43	Defensin 4 (Def4)	C6ZEC5	Not found	def4	Triatoma brasiliensis (Blood-sucking bug)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19505471	J Insect Physiol. 2009 Sep;55(9):840-848.	Waniek PJ, Castro HC, Sathler PC, Miceli L, Jansen AM, Araújo CA.	Two novel defensin-encoding genes of the Chagas disease vector Triatoma brasiliensis (Reduviidae, Triatominae): gene expression and peptide-structure modeling.	
DRAMP04418	ATCDLLSFEIKGFKLNDSACAAHCIQLGKRGGHCNNSKVCVCRR	44	Defensin 	B6RQP4	Not found	Not found	Sitophilus zeamais (Maize weevil)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18925938	BMC Biol. 2008 Oct 16;6:43.	Anselme C, Pérez-Brocal V, Vallier A, Vincent-Monegat C, Charif D, Latorre A, Moya A, Heddi A.	Identification of the weevil immune genes and their expression in the bacteriome tissue.	
DRAMP04419	ATCDLLSFLNVKDAACAAHCLAKGYRGGYCDGRKVCNCRR	40	Putative uncharacterized protein 	A4VBA2	Not found	Not found	Eristalis tenax (Drone fly) (Musca tenax)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17875201	BMC Genomics. 2007 Sep 17;8:326.	Altincicek B, Vilcinskas A.	Analysis of the immune-inducible transcriptome from microbial stress resistant, rat-tailed maggots of the drone fly Eristalis tenax.	
DRAMP04420	ATCDLLSFSSKWVTPNHAGCAAHCLLRGNRGGHCKGTICHCRK	43	Defensin B 	Q86MY2	Not found	DEFB	Rhodnius prolixus (Triatomid bug)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12650692	Insect Biochem Mol Biol. 2003 Apr;33(4):439-447.	Lopez L, Morales G, Ursic R, Wolff M, Lowenberger C.	Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease.	
DRAMP04421	ATCDLLSGFGVNDSACAAHCIARGNRGGYCNSKKVCVCRN	40	Defensin 	B9UKD3	Not found	Def	Apis cerana cerana (Oriental honeybee)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	PLoS ONE 2009, 4:E4239-E4239.	Xu P, Chen X.X.	Molecular cloning of antimicrobial peptide genes of Chinese honeybee (Apis cerana cerana Fabricius) and comparison with Italian honeybee (Apis mellifera L.).	
DRAMP04422	ATCDLLSGMGVNHSACAAHCVLRGNRGGYCNSKAVCVCR	39	Defensin 1	P82380	Not found	fbd1	Stomoxys calcitrans (Stable fly) (Conops calcitrans)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases	Munks R.J.L, Lehane S.M, Lehane M.J.	Expression and regulation of the genes, smd1 and smd2, which encode midgut-specific defensin molecules in Stomoxys calcitrans.	
DRAMP04423	ATCDLLSGTGVGHSACAAHCLLRGNRGGYCNGKGVCVCRN	40	Defensin 	Q86BU1	Not found	Not found	Musca domestica (House fly)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Dong Wu Xue Bao 2003, 49:0-0.	Wang LC, Wang JX, Wang LY, Zhao XF.	Cloning and sequence analysis of the full-length cDNA encoding defensin, an antimicrobial peptide from the housefly (Musca domestica).	
DRAMP04424	ATYYGNGLYCNKQKCWVDWNKASREIGKIIVNGNVQHGPWAPR	43	BacA protein 	Q47778	Not found	bacA	Enterococcus faecalis (Streptococcus faecalis)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8655558	J Bacteriol. 1996 Jun;178(12):3585-3593.	Tomita H, Fujimoto S, Tanimoto K, Ike Y.	Cloning and genetic organization of the bacteriocin 31 determinant encoded on the Enterococcus faecalis pheromone-responsive conjugative plasmid pYI17.	
DRAMP04425	DCNTKACWALCQREHGIYFRRAVCEGSRCKCILVNGR	37	Termicin 	Q5SDH7	Not found	Not found	Drepanotermes rubriceps	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15317879	Mol Biol Evol. 2004 Dec;21(12):2256-2264.	Bulmer MS, Crozier RH.	Duplication and diversifying selection among termite antifungal peptides.	
DRAMP04426	MKCILSLFTLFLVATLVYSYPAEWNSQHQLDDAQWEPAGELTEEHLSRMKRATCDLLSLTSKWFTPNHAGCAAHCIFLGNRGGRCVGTVCHCRK	94	Defensin C 	Q86MY1	Not found	DEFC	Rhodnius prolixus (Triatomid bug)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12650692	Insect Biochem Mol Biol. 2003 Apr;33(4):439-447.	Lopez L, Morales G, Ursic R, Wolff M, Lowenberger C.	Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease.	
DRAMP04427	NHRSCYRNKGVCAPARCPRNMRQIGTCHGPPVKCCRKK	38	Beta defensin-2 	O97942	Not found	Not found	Capra hircus (Goat)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10531296	Infect Immun. 1999 Nov;67(11):6221-6224.	Zhao C, Nguyen T, Liu L, Shamova O, Brogden K, Lehrer RI.	Differential expression of caprine beta-defensins in digestive and respiratory tissues.	
DRAMP04428	SFSCSQNGGFCISPKCLPGSKQIGTCILPGSKCCR	35	Beta defensin 1 (Beta-defensin-1)	Q865P6	Not found	Not found	Equus caballus (Horse)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15113660	Vet Immunol Immunopathol. 2004 May;99(1-2):127-132.	Davis EG, Sang Y, Blecha F.	Equine beta-defensin-1: full-length cDNA sequence and tissue expression.	
DRAMP04429	HSACAANCLSMGKAGGRCENGVCLCR	26	Defensin 	Q6TAX6	Not found	Not found	Bombus ignitus (Bumblebee) 	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases	Byeon G.M, Lee K.S, Choi Y.S, Jin B.R, Sohn H.D.	Molecular cloning and expression of defensin gene from Bee, Bombus ignitus.	
DRAMP04430	DKYCSENPLDCNEHCLKTKNQIGICHGANGNEKCSCMES	39	Putative potassium channel blocker TXKs2 	Q95P88	Not found	Not found	Mesobuthus martensii (Manchurian scorpion) (Buthus martensii)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11087122	IUBMB Life. 2000 Jul;50(1):57-61.	Zhu S, Li W, Jiang D, Zeng X.	Evidence for the existence of insect defensin-like peptide in scorpion venom.	
DRAMP04431	ENDHRMPYELNRPNNLSKGGAKCAAGILGAGLGAVGGGPGGFISAGISAVLGCM	54	Precursor of durancin TW-49M (Prepeptide of durancin TW-49M)	B3IUC6	Not found	durM	Enterococcus durans	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hu C, Zendo T, Nakayama J, Sonomoto K.	Characterization of durancin TW-49M and its atypical genetic locus: a novel bacteriocin produced by carrot-isolated Enterococcus durans QU 49.	
DRAMP04432	EPEPSYFNDCGSNGGSCTRGYCSYSNRLPYTCSLGRTCCRLAYV	44	Defensin 1 	B9UZC8	Not found	Not found	Panulirus japonicus (Japanese spiny lobster)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19073210	Dev Comp Immunol. 2009 Apr;33(4):434-438.	Pisuttharachai D, Yasuike M, Aono H, Yano Y, Murakami K, Kondo H, Aoki T, Hirono I.	Characterization of two isoforms of Japanese spiny lobster Panulirus japonicus defensin cDNA.	
DRAMP04433	EPEPSYILDCRTNGGRCVTGYCSNTLPYSCGGGAICCRHAYG	42	Defensin 2 	B9UZC9	Not found	Not found	Panulirus japonicus (Japanese spiny lobster)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19073210	Dev Comp Immunol. 2009 Apr;33(4):434-438.	Pisuttharachai D, Yasuike M, Aono H, Yano Y, Murakami K, Kondo H, Aoki T, Hirono I.	Characterization of two isoforms of Japanese spiny lobster Panulirus japonicus defensin cDNA.	
DRAMP04435	FCHNSISCMMGGDSTCNNVCVRQGNPNGGRCLPRDGCPGYDICACYPNN	49	Defensin domain protein	Q4WGI8	Not found	Not found	Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSCA1100) (Aspergillus fumigatus)	Antimicrobial	Predicted	Not found	Not found		Caution: The sequence shown here is derived from an EMBL/GenBank/DDBJ whole genome shotgun (WGS) entry which is preliminary data.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16372009	Nature. 2005 Dec 22;438(7071):1151-6.	Nierman WC, Pain A, Anderson MJ, Wortman JR, Kim HS, Arroyo J, et al.	Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus.	
DRAMP04436	FTAGIETSFSCSQNGGFCISPKCLPGSKQIGTCILPGSKCCRKK	44	Beta defensin 1 (Beta-defensin-1)	Q865P6	Not found	defb1	Equus caballus (Horse)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15113660	Vet Immunol Immunopathol. 2004 May;99(1-2):127-132.	Davis EG, Sang Y, Blecha F.	Equine beta-defensin-1: full-length cDNA sequence and tissue expression.	
DRAMP04437	GALWGAPAGGVGALPGAFVGAHVGAIAGGFACMGGMIGNKFN	42	Amphipathic pore-forming peptide 	O54454	Not found	thmA	Streptococcus thermophilus	Antimicrobial, Antibacterial, Antilisterial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9162062	J Biol Chem. 1997 May 30;272(22):14277-84.	Marciset O, Jeronimus-Stratingh MC, Mollet B, Poolman B.	Thermophilin 13, a nontypical antilisterial poration complex bacteriocin, that functions without a receptor.	
DRAMP04438	ITCGQVNSAVGPCLTYARGGGAGPSAACCNGVRSLKSAARTTADRRTACNCLKNAARGIKGLNAGNAASIPSKCGVSVPYTISASIDCSRVR	92	Non-specific lipid-transfer protein	A2ZDR8	Belongs to the plant LTP family	Not found	Oryza sativa subsp. indica (Rice)	Antimicrobial	Transcript level	Not found	Not found		Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	15685292	PLoS Biol. 2005 Feb;3(2):e38.	Yu J, Wang J, Lin W, Li S, Li H, Zhou J, Ni P, Dong W, et al.	The Genomes of Oryza sativa: A History of Duplications.	
DRAMP04439	IWCEFEEATETAICQEHCLPKGYSYGICVSNTCSCI	36	Defensin-like protein (Putative defensin; Predicted)	Q45RF8	Not found	Not found	Bombyx mori (Silk moth)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases	Kang SJ, Park KS, Park BR.	Defensin-like protein encoding cysteine-rich peptides in immune response of silkworm Bombyx mori.	
DRAMP04440	KSCCKDIMARNCYNVCRIPGTPRPVCATTCRCKIISGNKCPKDYPK	46	Leaf thionin Asthi1	Q8LT03	Not found	Asthi1	Avena sativa (Oat)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12059099	Mol Plant Microbe Interact. 2002 Jun;15(6):515-521.	Iwai T, Kaku H, Honkura R, Nakamura S, Ochiai H, Sasaki T, Ohashi Y.	Enhanced resistance to seed-transmitted bacterial diseases in transgenic rice plants overproducing an oat cell-wall-bound thionin.	
DRAMP04441	KSCCKDTTARNCYNVCRIPGTPRPVCATTCRCKIISGNKCPKDYPK	46	Leaf thionin Asthi2	Q8LT02	Not found	Asthi2	Avena sativa (Oat)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12059099	Mol Plant Microbe Interact. 2002 Jun;15(6):515-521.	Iwai T, Kaku H, Honkura R, Nakamura S, Ochiai H, Sasaki T, Ohashi Y.	Enhanced resistance to seed-transmitted bacterial diseases in transgenic rice plants overproducing an oat cell-wall-bound thionin.	
DRAMP04442	NTCCKDDIARNCYNVCRIPGTPTFICANMCRCIITRRNECPNDYPK	46	Leaf thionin Asthi3	Q8LT01	Not found	Asthi3	Avena sativa (Oat)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12059099	Mol Plant Microbe Interact. 2002 Jun;15(6):515-521.	Iwai T, Kaku H, Honkura R, Nakamura S, Ochiai H, Sasaki T, Ohashi Y.	Enhanced resistance to seed-transmitted bacterial diseases in transgenic rice plants overproducing an oat cell-wall-bound thionin.	
DRAMP04443	KSCCKSTTAINCYNVCRLAGAPRPVCAGPCGCKLLDVTTCPSDWPK	46	Thionin Asthi4	Q8LT00	Not found	Asthi4	Avena sativa (Oat)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12059099	Mol Plant Microbe Interact. 2002 Jun;15(6):515-521.	Iwai T, Kaku H, Honkura R, Nakamura S, Ochiai H, Sasaki T, Ohashi Y.	Enhanced resistance to seed-transmitted bacterial diseases in transgenic rice plants overproducing an oat cell-wall-bound thionin.	
DRAMP04444	KSCCPSTSARNCYNVCRLTGTSRPRCASLCGCKIVDGTCPDGYSK	45	Thionin Asthi5	Q8LSZ9	Not found	Asthi5	Avena sativa (Oat)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12059099	Mol Plant Microbe Interact. 2002 Jun;15(6):515-521.	Iwai T, Kaku H, Honkura R, Nakamura S, Ochiai H, Sasaki T, Ohashi Y.	Enhanced resistance to seed-transmitted bacterial diseases in transgenic rice plants overproducing an oat cell-wall-bound thionin.	
DRAMP04445	MALALRFFICFVLTVCIVSSVDAEISCGTVVSNLAPCANYLSKGGVVPDLCCEGVEKLNGVAQTMPMPTVHCKGHFWSQPKSSLWSS	87	Lipid binding protein 	Q1PDH3	Not found	Not found	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases	Silverstein K.A.T, Moskal W.A.Jr, Wu H.C, Underwood B.A, Graham M.A, Town C.D, VandenBosch K.A.	Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants.	
DRAMP04446	LSHSFKGTCLSDTNCANVCHSERFSGGKCRGFRRRCFCTTHC	42	Alcohol dehydrogenase 6	Q9M6B5	Not found	ADH6	Vitis vinifera (Grape)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Plant Physiol. 2000, 122:619-619.	Or E, Baybik J, Lavee S, Sadka A, Ogredovitch A.	Isolation and Characterization of Two cDNA Clones (Accession No. AF195866 and AF195867) Encoding Alcohol Dehydrogenase from Grape (Vitis vinifera cv. Perlette) Developing Fruits. (PGR00-022).	
DRAMP04447	MADKGVCSRLSALFLLVLLVISIGMMQLELAEARTCKTPSGKFKGVCASSNNCKNVCQTEGFPSGSCDFHVANRKCYCSKPCP	83	Defensin 	Q6RSS6	Not found	Not found	Picea glauca (White spruce) (Pinus glauca)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Physiol. Mol. Plant Pathol. 2004, 64:331-341.	Pervieux I, Bourassa M, Laurans F, Hamelin R, Seguin A.	A spruce defensin showing strong antifungal activity and increased transcript accumulation after wounding and jasmonate treatments.	
DRAMP04448	MADKGVGSRLSAIFLLVLLVISIGMMQLELAEGRTCKTPSGKFKGVCASSNNCKNVCQTEGFPSGSCDFHVANRKCYCSKPCP	83	Putative gamma-thionin protein 	Q40779	Not found	SPI1	Picea abies (Norway spruce) (Picea excelsa)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8790304	Plant Mol Biol. 1996 Jun;31(3):707-712.	Sharma P, Lönneborg A.	Isolation and characterization of a cDNA encoding a plant defensin-like protein from roots of Norway spruce.	
DRAMP04449	MAKFASIIALLFAALVLFSAFEAPSMVEAQKLCEKSSGTWSGVCGNNNACKNQCINLEGARHGSCNYIFPYHRCICYFPC	80	Gamma-thionin 1 	Q9FS38	Not found	Not found	Eutrema japonica (Wasabi plant) (Eutrema wasabi)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11204773	Mol Plant Microbe Interact. 2001 Feb;14(2):111-115.	Saitoh H, Kiba A, Nishihara M, Yamamura S, Suzuki K, Terauchi R.	Production of antimicrobial defensin in Nicotiana benthamiana with a potato virus X vector.	
DRAMP04450	MAKFVSIITLLFAALVLFAAFDAPTMVKAQKLCERSSGTWSGVCGNNNACKNQRINLEGARHGSCNYVFP	70	Defensin 	Q6TXV2	Not found	Not found	Brassica rapa subsp. pekinensis (Chinese cabbage) (Brassicapekinensis)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases	Park YS, Cho TJ.	Characterization of ethylene-inducible genes in Chinese cabbage.	
DRAMP04451	MAPSRRMVASAFLLLAILVATEMGTTKVAEARHCLSQSHRFKGMCVSSNNCANVCRTESFPDGECKSHGLERKCFCKKVC	80	Os02g0629800 protein (Putative defensin)	Q6K209	Not found	B1469H02.30	Oryza sativa subsp. japonica (Rice)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases	Sasaki T, Matsumoto T, Katayose Y.	Oryza sativa nipponbare(GA3) genomic DNA, chromosome 2, BAC clone:B1469H02.	
DRAMP04452	MATQRREISWTFGPLYTWRTTKGYGTTLETTNATSTSSKPSRRYENPYGCPTDEGKCFDRCNDSEFEGGYCGGSYRATCVCYRT	84	Defensin protein 2 	Q5VJF8	Not found	Not found	Amblyomma hebraeum (bont tick)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases	Lai R, Turner PC, Lomas LO, Jonczy J, Rees HH.	Two Novel Anionic Defensin-like antimicrobial proteins from Hemolymph of the Female Tick, Amblyomma hebraeum.	
DRAMP04453	MATVRNSRPEAAGEPSGVSSTEGDWRHIEKRDVSYQGEGNTRRFDNPFGCPADEGKCFDHCNNKAYDIGYCGGSYRATCVCYRK	84	Defensin protein 1 	Q5VJF9	Not found	Not found	Amblyomma hebraeum (bont tick)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases	Lai R, Turner PC, Lomas LO, Jonczy J, Rees HH.	Two Novel Anionic Defensin-like antimicrobial proteins from Hemolymph of the Female Tick, Amblyomma hebraeum.	
DRAMP04454	MEHSRRMLPAILLLLFLLMPSEMGTKVAEARTCESQSHKFQGTCLRESNCANVCQTEGFQGGVCRGVRRRCFCTRLC	77	Defensin EGAD1 	Q8H766	Not found	Not found	Elaeis guineensis var. tenera (Oil palm)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12021286	J Exp Bot. 2002 Jun;53(373):1387-1396.	Tregear JW, Morcillo F, Richaud F, Berger A, Singh R, Cheah SC, Hartmann C, Rival A, Duval Y.	Characterization of a defensin gene expressed in oil palm inflorescences: induction during tissue culture and possible association with epigenetic somaclonal variation events.	
DRAMP04455	MEKKSLAGLCFLFLVLFVAQEIVVTEAKTCENLADKYRGPCFSGCDTHCTTKEHAVSGRCRDDFRCWCTKRC	72	Antifungal protein defensin 	Q6Y4S5	Not found	Not found	Arachis diogoi	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases	Olli S, Kirthi PB.	RT-PCR based cloning of defensin cDNA from Arachis chacoense.	
DRAMP04456	MEKKSLAGLCFLFLVLFVAQEIVVTEAKTCENLADKYRGPCFSGCDTHCTTKENAVSGRCRDDFRCWCTKRC	72	Defensin 	Q5YLG8	Not found	Def1	Medicago truncatula (Barrel medic) (Medicago tribuloides)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16021402	Plant Mol Biol. 2005 Jun;58(3):385-399.	Hanks JN, Snyder AK, Graham MA, Shah RK, Blaylock LA, Harrison MJ, Shah DM.	Defensin gene family in Medicago truncatula: structure, expression and induction by signal molecules.	
DRAMP04457	MEKKSLAGLCFLFLVLFVAQEVMVQTEAKTCENLANTYRGPCFTTGSCDDHCKNKEHLRSGRCRDDFRCWCTRNC	75	PDF1	Q8W434	Not found	pDF1	Vigna radiata (Mung bean)	Antimicrobial	Protein level	Not found	Not found	2GL1	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17444520	Proteins. 2007 Aug 1;68(2):530-540.	Lin KF, Lee TR, Tsai PH, Hsu MP, Chen CS, Lyu PC.	Structure-based protein engineering for alpha-amylase inhibitory activity of plant defensin.	
DRAMP04458	MKCILSLVTLFLVAVLVHSHPAEWNTHQQLDDALWEPAGEVTEEHVARLKRATCDLFSFRSKWVTPNHAACAAHCLLRGNRGGRCKGTICHCRK	94	Defensin A 	Q86MY3	Not found	DEFA	Rhodnius prolixus (Triatomid bug)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12650692	Insect Biochem Mol Biol. 2003 Apr;33(4):439-447.	Lopez L, Morales G, Ursic R, Wolff M, Lowenberger C.	Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease.	
DRAMP04459	MKFFITFTFVLSLVVLTVYSAPREFAEPEEQDEGHFRVKRFTCDVLSVEAKGVKLNHAACGIHCLFRRRTGGYCNKKRVCICR	83	Defensin 1 	Q9BK52	Not found	Not found	Acalolepta luxuriosa (Udo longhorn beetle)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Appl. Entomol. Zool. (Jpn.) 2005, 40:335-345.	Ueda K, Imamura M, Saito A, Sato R.	Purification and cDNA cloning of an insect defensin from larvae of the longicorn beetle, Acalolepta luxuriosa.	
DRAMP04460	MKFFSLFPVILVVVACLTMRANAAPSAGDEVDHHPDYVDGVEALRQLEPELHGRYKRATCDLLSMWNVNHSACAAHCLLLGKSGGRCNDDAVCVCRK	97	Defensin 2a 	P82379	Not found	smd2a	Stomoxys calcitrans (Stable fly) (Conops calcitrans)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases	Munks R.J.L, Lehane S.M, Lehane M.J.	Expression and regulation of the genes, smd1 and smd2, which encode midgut-specific defensin molecules in Stomoxys calcitrans.	
DRAMP04461	MKFLNVVAIALLVVACLSVYSNAAPHEGVKEVAAAKPMGITCDLLSLWKVGHAACAAHCLVLGNVGGYCTKEGLCVCKE	79	Defensin 1a 	P82378	Not found	smd1a	Stomoxys calcitrans (Stable fly) (Conops calcitrans)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases	Munks R.J.L, Lehane S.M, Lehane M.J.	Expression and regulation of the genes, smd1 and smd2, which encode midgut-specific defensin molecules in Stomoxys calcitrans.	
DRAMP04462	MKFLQIFVLIATLWIAIVTANPVDDQKTAEIQENSNLIDETNNDEVIIQPRLSCQALGPIGCAANCKRLGFRGGWCTTGNTCRCFR	86	Putative uncharacterized protein 	Q5QBJ4	Not found	Not found	Culicoides sonorensis	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Not found	Insect Mol. Biol. 2005, 0:0-0.	Campbell C.L, VanDyke K.A, Letchworth G.J, Drolet B.S, Hanekamp T, Wilson W.C.	Midgut and salivary gland transcriptomes of the arbovirus vector Culicoides sonorensis (Diptera: Ceratopogonidae).	
DRAMP04463	MKQYKVLNEKEMKKPIGGESVFSKIGNAVGPAAYWILKGLGNMSDVNQADRINRKKH	57	Enterocin 1071A (Enterocin EntC1 peptide)	Q9L9U6	Not found	ent1071A	Enterococcus faecalis (Streptococcus faecalis)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10742203	Appl Environ Microbiol. 2000 Apr;66(4):1298-1304.	Balla E, Dicks LM, Du Toit M, Van Der Merwe MJ, Holzapfel WH.	Characterization and cloning of the genes encoding enterocin 1071A and enterocin 1071B, two antimicrobial peptides produced by Enterococcus faecalis BFE 1071.	
DRAMP04464	MKTFSVAVAVAIVLAFICTQESSALPVTGVEELVELVSSDDPVADHQELPVELGERLFNIRKKRASPKCTPYCYPTRDGV	80	Hepcidin 1 	D3Y2R5	Not found	Not found	Epinephelus coioides (Orange-spotted grouper) (Epinephelus nebulosus)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21145974	Fish Shellfish Immunol. 2011 Feb;30(2):559-568.	Zhou J.G, Wei J.G, Xu D, Cui H.C, Yan Y, Ou-Yang Z.L, Huang X.H, Huang Y.H, Qin Q.W.	Molecular cloning and characterization of two novel hepcidins from orange-spotted grouper, Epinephelus coioides.	
DRAMP04465	MKTFSVAVAVAVVLAFICTQESSALPVTGIEELVEPVSSDNNDNHQGLPVELRERLVNIRKKRAPTDCIPYCYPTGDGFH	80	Hepcidin 2 	D3Y2R6	Not found	Not found	Epinephelus coioides (Orange-spotted grouper) (Epinephelus nebulosus)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21145974	Fish Shellfish Immunol. 2011 Feb;30(2):559-568.	Zhou JG, Wei JG, Xu D, Cui HC, Yan Y, Ou-Yang ZL, Huang XH, Huang YH, Qin QW.	Molecular cloning and characterization of two novel hepcidins from orange-spotted grouper, Epinephelus coioides.	
DRAMP04466	MMKIAVPVFLILALFAMSQAAPSLALPGTVQVANVQPRGYCNLSNCLSQCYRRGFRWGWCDFFNTCHCS	69	Defensin TY 2 	C1IBY6	Not found	Not found	Tabanus yao (Horsefly)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ databases	Xu X, Ma D, Wu J, Lai R.	Cloning and characterization of defensin in horsefly (Tabanus Yao).	
DRAMP04467	MMNATENQIFVETVSDQELEMLIGGAGRGWIKTLTKDCPNVISSICAGTIITACKNCA	58	Columbicin A 	A0FL76	Not found	colA	Enterococcus columbae	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases	Martin M, Brede D.A, Herranz C, Nes I.F, Cintas L.M, Hernandez P.E.	Amino acid and nucleotide sequence of columbicin A, a novel lantibiotic variant produced by Enterococcus columbae PLCH2, isolated from wood pigeons (Columba palumbus).	
DRAMP04468	MNFKLLNLFAMVLFGVVVISNAAKPPSGFLTPDADNDENGNGVEEQTLERFTCDIWQNQAACAIHCIANGFRGGYCNAQKVCVCRR	86	Defensin I 	Q2QKD4	Not found	Not found	Mayetiola destructor (Hessian fly)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17070830	J Insect Physiol. 2006 Nov-Dec;52(11-12):1143-1152.	Mittapalli O, Shukle RH, Sardesai N, Giovanini MP, Williams CE.	Expression patterns of antibacterial genes in the Hessian fly.	
DRAMP04469	MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG	63	Cecropin (Cecropin 1 (Cecropin A)	Q95VE8	Not found	Cep 1	Musca domestica (House fly)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases	Wang J, Zhao X.	Molecular cloning and recombinant expression of a new gene encoding an antimicrobial peptide from house fly.	
DRAMP04470	MNNLNKFSTLGKSSLSQIEGGSVPTSVYTLGIKILWSAYKHRKTIEKSFNKGFYH	55	Plantaricin NC8 beta peptide 	Q84HW1	Not found	plnc8B	Lactobacillus plantarum	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12514019	Appl Environ Microbiol. 2003 Jan;69(1):383-389.	Maldonado A, Ruiz-Barba JL, Jiménez-Díaz R.	Purification and genetic characterization of plantaricin NC8, a novel coculture-inducible two-peptide bacteriocin from Lactobacillus plantarum NC8.	
DRAMP04471	MQTIKELNTMELQEIIGGENDHRMPYELNRPNNLSKGGAKCAAGILGAGLGAVGGGPGGFISAGISAVLGCM	72	Durancin Q prepeptide (Prepeptide of durancin Q)	B5BP43	Not found	duqQ	Enterococcus durans	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases	Hu C, Zendo T, Nakayama J, Sonomoto K.	Functional analysis and comparison of genes in the durM and the duqQ loci in durancin TW-49M and durancin Q biosynthesis and regulation.	
DRAMP04472	MRAIVFVLIFAIAFAATREGSILCNLCKDTVNLIENLLTVDGAQAVRQYIDNLCAKADGFLGTLCNKILSFGVDELVKLIENHVDPVVICEKIHAC	96	Pore-forming protein isoform B 	Q9U8G5	Not found	Dp-B	Entamoeba dispar	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10518795	Eur J Biochem. 1999 Nov;265(3):1002-1007.	Nickel R, Ott C, Dandekar T, Leippe M.	Pore-forming peptides of Entamoeba dispar. Similarity and divergence to amoebapores in structure, expression and activity.	
DRAMP04473	VPGGCTYTRSNRDVIGTCKTGSGQFRIRLDCNNAPDKTSVWAKPKVMVSVHCLVGQPRSISFETK	65	Propionicin T1 	Q9F6C4	Not found	pctA	Propionibacterium thoenii	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11010864	Appl Environ Microbiol. 2000 Oct;66(10):4230-4236.	Faye T, Langsrud T, Nes IF, Holo H.	Biochemical and genetic characterization of propionicin T1, a new bacteriocin from Propionibacterium thoenii.	
DRAMP04474	VSCDFEEANEDAVCQEHCLPKGYTYGICVSHTCSCI	36	Defensin (Spodoptericin)	Q7Z0G6	Not found	Def	Spodoptera frugiperda (Fall armyworm)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14597170	Gene. 2003 Nov 13;319:43-53.	Volkoff AN, Rocher J, d'Alençon E, Bouton M, Landais I, Quesada-Moraga E, Vey A, Fournier P, Mita K, Devauchelle G.	Characterization and transcriptional profiles of three Spodoptera frugiperda genes encoding cysteine-rich peptides. A new class of defensin-like genes from lepidopteran insects?	
DRAMP04475	VTCDLLGPTGWGDALCAAHCISKGYRGGYCNAQKVCVCR	39	Putative defensin 	A8CWF7	Not found	DEF	Lutzomyia longipalpis (Sand fly)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18194529	BMC Genomics. 2008 Jan 14;9:15.	Jochim RC, Teixeira CR, Laughinghouse A, Mu J, Oliveira F, Gomes RB, Elnaiem DE, Valenzuela JG.	The midgut transcriptome of Lutzomyia longipalpis: comparative analysis of cDNA libraries from sugar-fed, blood-fed, post-digested and Leishmania infantum chagasi-infected sand flies.	
DRAMP04476	MRILHFLLAFLIVFLLPVPGFTAGIETSFSCSQNGGFCISPKCLPGSKQIGTCILPGSKCCRKK	64	Beta defensin 1 (Beta-defensin-1)	Q865P6	Not found	defb1	Equus caballus (Horse)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15113660	Vet Immunol Immunopathol. 2004 May;99(1-2):127-132.	Davis EG, Sang Y, Blecha F.	Equine beta-defensin-1: full-length cDNA sequence and tissue expression.	
DRAMP04477	MRLHHLLLALFFLVLSAGSGFTQGIINHRSCYRNKGVCAPARCPRNMRQIGTCHGPPVKCCRKK	64	Beta defensin-2 	O97942	Not found	Not found	Capra hircus (Goat)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10531296	Infect Immun. 1999 Nov;67(11):6221-6224.	Zhao C, Nguyen T, Liu L, Shamova O, Brogden K, Lehrer RI.	Differential expression of caprine beta-defensins in digestive and respiratory tissues.	
DRAMP04478	MNFLKVFLVICAILATVWASPLGASEDREHHPEERAPCAQSEKDRCVAFCLTNGFSGGFCTSRGCKCEE	69	Defensin TY 1 	C1IBY5	Not found	Not found	Tabanus yao (Horsefly)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2007) to the EMBL/GenBank/DDBJ databases	Xu X, Ma D, Wu J, Lai R.	Cloning and characterization of defensin in horsefly (Tabanus Yao).	
DRAMP04479	MRLLFLLFLLLVCLIQMASGHEKTGRKHECQNMGGACKHQKTHGCAILPADCKSRNKHCCRV	62	Defensin like 3 (Predicted)	Q0W9Q3	Not found	defl3	Equus caballus (Horse)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16723195	Gene. 2006 Jul 19;376(2):192-198.	Looft C, Paul S, Philipp U, Regenhard P, Kuiper H, Distl O, Chowdhary BP, Leeb T.	Sequence analysis of a 212 kb defensin gene cluster on ECA 27q17.	
DRAMP04480	MRTFALLAATVLLVILQAQAEPVQARADEVAAQEQPGGHAQEASVSFVWDEGAAGQVSGERGQHAKLQSLEGQTGNGLWNRVSMVHVT	88	Alpha defensin 	Q6KFT8	Not found	DEFA1	Saguinus labiatus (Red-chested mustached tamarin)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15019196	ptides. 2003 Nov;24(11):1647-1654.	Nguyen TX, Cole AM, Lehrer RI.	Evolution of primate theta-defensins: a serpentine path to a sweet tooth.	
DRAMP04481	MSLLALVAGTLGVSQSIATTVVSIVLTGSTLISIILGITAILSGGVDAILEIGWSAFVATVKKIVAERGKAAAIAW	76	Circularin A 	Q5L226	Not found	Not found	Geobacillus kaustophilus (strain HTA426)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal		L	No cytotoxicity information found	Not found	15576355	Nucleic Acids Res. 2004 Dec 1;32(21):6292-303.	Takami H, Takaki Y, Chee GJ, Nishi S, Shimamura S, Suzuki H, Matsui S, Uchiyama I.	Thermoadaptation trait revealed by the genome sequence of thermophilic Geobacillus kaustophilus.	
DRAMP04482	MYSKYERQKDKRPYSERKDQYTGPQFLYPPDRIPPSKAIKWNEEGLPMYEVLPDGAGAKTAVEAAAE	67	Antimicrobial-like peptide PP-1 (Predicted)	Q867H2	Not found	Pp-1	Pheretima tschiliensis	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases	Wang X, Wang X.X.	cDNA cloning and molecular characterization of a new antimicrobial-like peptide from Pheretima tschiliensis.	
DRAMP04483	NKWGNAVIGAATGATRGVSWCRGFGPWGMTACALGGAAIGGYLGYKSN	48	Acidocin LF221B (Gassericin K7 B)	Q7WRX6	Not found	Not found	Lactobacillus gasseri	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14504837	Appl Microbiol Biotechnol. 2004 Feb;63(6):705-714.	Majhenic AC, Venema K, Allison GE, Matijasić BB, Rogelj I, Klaenhammer TR.	DNA analysis of the genes encoding acidocin LF221 A and acidocin LF221 B, two bacteriocins produced by Lactobacillus gasseri LF221.	
DRAMP04484	QNKDDTRFLGGVPGVGGGFVPGVPGHGGVAPVGGGLVPGGGGLIPGGGFECNYCRTRYGYVCCSDKCCYDVCLNDTVCKPIVLGSEG	87	Crustin-like protein fc-2 (Predicted)	Q102W4	Not found	Not found	Fenneropenaeus chinensis (Fleshy prawn) (Penaeus chinensis)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16987562	J Biotechnol. 2007 Jan 20;127(4):605-614.	Zhang J, Li F, Wang Z, Xiang J.	Cloning and recombinant expression of a crustin-like gene from Chinese shrimp, Fenneropenaeus chinensis.	
DRAMP04485	RCICGRGICRCICGRGIC	18	Retrocyclin 	Q8TEZ3	Not found	DEFQ1	Homo sapiens (Human)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11854483	Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1813-1818.	Cole AM, Hong T, Boo LM, Nguyen T, Zhao C, Bristol G, Zack JA, Waring AJ, Yang OO, Lehrer RI.	Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.	
DRAMP04486	SFPKKIDCGGACAARCQLSSRPHLCKRACGTCCARSRCVPPGTAGNQEMCPCYASLTTHGGKRKCP	66	Cold-regulated LTCOR12 	O65313	Not found	LtCor12	Lavatera thuringiaca	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases	Vazquez-Tello A.	Cloning and characterization of low temperature-regulated genes from Lavatera thuringiaca.	
DRAMP04487	SSPKKIDCGGACAARCQLSSRPHLCKRACGTCCARCACVPPGTAGNQEMCPKCYASLTTHGGKRKCP	67	LTCOR11 	O24040	Not found	LtCor11	Lavatera thuringiaca	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases	Vazquez-Tello A, Uozumi T.	LtCor11, a low-temperature-regulated gene from Lavatera thuringiaca homologous to the gibberellin-regulated GAS1 gene from Arabidopsis thaliana.	
DRAMP04488	SYFTAWAGPGCNNHAARYSKCGCSNIGNNVHGGYEFMYQGQTAAAYNTDNCKGVAQTRFSSSVNQACSSFGWKSFFIQC	79	Antimicrobial peptide 2 (Antimicrobial peptide 4)	Q71QD7	Not found	AMP4	Pinus sylvestris (Scots pine)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	14612232	FEMS Microbiol Lett. 2003 Nov 7;228(1):27-31.	Asiegbu FO, Choi W, Li G, Nahalkova J, Dean RA.	Isolation of a novel antimicrobial peptide gene (Sp-AMP) homologue from Pinus sylvestris (Scots pine) following infection with the root rot fungus Heterobasidion annosum.	
DRAMP04489	SYREAVLRAVDQFNERSAEANLYRLLELDPPPEQDAEDQGARKPVSFRVKETVCPRTSQQPVEQCD	66	MAP34-A protein (MAP34-B protein)	P82017, P82016	Not found	map34-A	Capra hircus (Goat)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases	Zhao C, Nguyen T, Brogden K, Lehrer R.	cDNA cloning of goat cathelin related peptides.	
DRAMP04490	SYREAVLRAVDQFNERSAEANLYRLLELDPPPEQDAEDRGARKPVSFKVKETVCPRTSQQPVEQCD	66	Myeloid antimicrobial peptide 	P79360	Not found	Map-34	Ovis aries (Sheep)	Antimicrobial, Antibacterial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8549789	FEBS Lett. 1995 Dec 27;377(3):519-522.	Mahoney MM, Lee AY, Brezinski-Caliguri DJ, Huttner KM.	Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide.	
DRAMP04491	VASCGQVVSYLAPCIGYAMGRERAPGGGCCTGVRSLNAAAATPADRQATCTCLKQQTSGMGGIKPDLVAGIPSKCGVNIPYAISPRTDCSKVR	93	Non-specific lipid-transfer protein	Q5UNP2	Not found	Ltp6	Hordeum vulgare var. distichum (Two-rowed barley)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Lipid-binding	15821867	Plant Mol Biol. 2005 Jan;57(1):35-51.	Federico ML, Kaeppler HF, Skadsen RW.	The complex developmental expression of a novel stress-responsive barley Ltp gene is determined by a shortened promoter sequence.	
DRAMP04492	GFGCPFNQGACHRHCRSIGRRGGYCAGLFKQTCTCYSR	38	Persulcatusin 	B7XFT1	Not found	Not found	Ixodes persulcatus (Taiga tick)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Insect Mol. Biol. 2009, 18:531-539.	Saito Y, Konnai S, Yamada S, Imamura S, Nishikado H, Ito T, Onuma M, Ohashi K.	Identification and characterization of antimicrobial peptide, defensin, in the taiga tick, Ixodes persulcatus.	
DRAMP04493	GFGCPFNQYQCHSHCLSIGRRGGYCGGSFKTTCTCYN	37	Amercin 	A0F088	Not found	amn	Amblyomma americanum (Lone star tick)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17550433	Med Vet Entomol. 2007 Jun;21(2):141-147.	Todd SM, Sonenshine DE, Hynes WL.	Tissue and life-stage distribution of a defensin gene in the Lone Star tick, Amblyomma americanum.	
DRAMP04494	GGYCSGIIKQTCTCYRN	17	Defensin 	B6UYK4	Not found	Not found	Dermacentor reticulatus	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases	Matejovska T, Golovchenko M, Rudenko N, Grubhoffer L.	Cloning and sequencing of defensins in hard and soft ticks.	
DRAMP04495	GGYYCPFFQDKCHRHCRSFGRKAGYCGGFLKKTCICVMK	39	Preprodefensin	Q7YXK5	Not found	Not found	Ixodes ricinus (Common tick)	Antimicrobial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15691006	J Med Entomol. 2005 Jan;42(1):36-41.	Rudenko N, Golovchenko M, Edwards MJ, Grubhoffer L.	Differential expression of Ixodes ricinus tick genes induced by blood feeding or Borrelia burgdorferi infection.	
DRAMP04496	GICYVLTCNSLCFPKLGRCSYNTCYCY	27	Cysteine-rich protein 	Q5DIE2	Not found	Not found	Apriona germari (Mulberry longhorn beetle)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases	Gui Z.-Z, Lu W, Sohn H.D, Jin B.R.	Molecular cloning a cDNA encoding the cysteine-rich protein from the mulberry longicorn beetle, Apriona germari.	
DRAMP04497	GSLKSSQCNPECTRRCSKTQYHKPCMFFCQKCCRKCLCVPPGFYGNKAVCPCYNNWKTQQGGPKCP	66	Gasa4-like protein (Predicted)	Q6V0P7	Not found	Not found	Pelargonium zonale	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases	Rosenwasser S, Granot D, Friedman H.	A homolog of gip-1 (gibberellic acid-induced gene).	
DRAMP04498	GSVSIEECPQKCDYRCSATKRQEPCLKYCNICCQKCLCVPSGTSGNKEECPCYNNLKSSQGNSKCP	66	GAST1 protein, putative 	Q10P25	Not found	Not found	Oryza sativa subsp. japonica (Rice)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16109971	Genome Res. 2005 Sep;15(9):1284-91.	Buell CR, Yuan Q, Ouyang S, Liu J, Zhu W, et al, Jiang J, Jackson S.	Sequence, annotation, and analysis of synteny between rice chromosome 3 and diverged grass species.	
DRAMP04499	HISHISMCRWCCNCCKAKGCGFCCKF	26	Hepcidin (Hepcidin type I)	Q49SH5	Not found	Not found	Paralichthys olivaceus (Bastard halibut) (Hippoglossus olivaceus)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16041149	Biosci Biotechnol Biochem. 2005 Jul;69(7):1411-1414.	Kim YO, Hong S, Nam BH, Lee JH, Kim KK, Lee SJ.	Molecular cloning and expression analysis of two hepcidin genes from olive flounder Paralichthys olivaceus.	
DRAMP04500	IAASKINCGAACKARCRLSSRPNLCHRACGTCCARCRCVPPGTSGNQKVCPCYYNMTTHGGRRKCP	66	GEG protein 	Q9XGJ3	Not found	geg	Gerbera hybrida (Daisy)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10368180	Plant Cell. 1999 Jun;11(6):1093-1104.	Kotilainen M, Helariutta Y, Mehto M, Pollanen E, Albert VA, Elomaa P, Teeri TH.	GEG participates in the regulation of cell and organ shape during corolla and carpel development in gerbera hybrida.	
DRAMP04501	VTCDLLSFGGKVGHSACAANCLSMGKAGGRCNGGVCQCRKTTFGDLWNKRF	51	Antimicrobial peptide Def1-2 	D0EZK5	Not found	Not found	Nasonia vitripennis (Parasitic wasp)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20097222	Dev Comp Immunol. 2010 Jun;34(6):659-668.	Gao B, Zhu S.	Identification and characterization of the parasitic wasp Nasonia defensins: positive selection targeting the functional region?	
DRAMP04502	VTCDLLSFGGVVGDSACAANCLSMGKAGGSCNGGICECRKTTFKELWDQRF	51	Antimicrobial peptide Def1-1 	D0EZK4	Not found	Not found	Nasonia vitripennis (Parasitic wasp)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20097222	Dev Comp Immunol. 2010 Jun;34(6):659-668.	Gao B, Zhu S.	Identification and characterization of the parasitic wasp Nasonia defensins: positive selection targeting the functional region?	
DRAMP04503	GILTDTLKGAAKNVAGVLLDKLKCKITGGC	30	Pelophylaxin-1 (Frogs, amphibians, animals)	Q2WCN8	Not found	pelophylaxin-1	Pelophylax plancyi fukienensis (Fukien gold-striped pond frog)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16139927	Peptides. 2006 Jan;27(1):36-41.	Zhou M, Chen T, Walker B, Shaw C.	"Pelophylaxins: novel antimicrobial peptide homologs from the skin secretion of the Fukien gold-striped pond frog, Pelophylax plancyi fukienensis: identification by ""shotgun"" cDNA cloning and sequence analysis."	
DRAMP04504	GILLNTLKGAAKNVAGVLLDKLKCKITGGC	30	Pelophylaxin-2 (Frogs, amphibians, animals)	Q2WCN7	Not found	pelophylaxin-2	Pelophylax plancyi fukienensis (Fukien gold-striped pond frog)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16139927	Peptides. 2006 Jan;27(1):36-41.	Zhou M, Chen T, Walker B, Shaw C.	"Pelophylaxins: novel antimicrobial peptide homologs from the skin secretion of the Fukien gold-striped pond frog, Pelophylax plancyi fukienensis: identification by ""shotgun"" cDNA cloning and sequence analysis."	
DRAMP04505	GLMDSLKGLAATAGKTVLQGLLKTASCKLEKTC	33	Pelophylaxin-3 (Frogs, amphibians, animals)	Q2WCN6	Not found	pelophylaxin-3	Pelophylax plancyi fukienensis (Fukien gold-striped pond frog)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16139927	Peptides. 2006 Jan;27(1):36-41.	Zhou M, Chen T, Walker B, Shaw C.	"Pelophylaxins: novel antimicrobial peptide homologs from the skin secretion of the Fukien gold-striped pond frog, Pelophylax plancyi fukienensis: identification by ""shotgun"" cDNA cloning and sequence analysis."	
DRAMP04506	ILPFLAGLFSKIL	13	Pelophylaxin-4 (Frogs, amphibians, animals)	Q2WCN5	Not found	pelophylaxin-4	Pelophylax plancyi fukienensis (Fukien gold-striped pond frog)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Homology	Not found	Not found		Function: Amphibian defense peptide.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16139927	Peptides. 2006 Jan;27(1):36-41.	Zhou M, Chen T, Walker B, Shaw C.	"Pelophylaxins: novel antimicrobial peptide homologs from the skin secretion of the Fukien gold-striped pond frog, Pelophylax plancyi fukienensis: identification by ""shotgun"" cDNA cloning and sequence analysis."	
DRAMP04507	MLTLKKSMLLLFFLGTISLSLCEEERSADEDDGEKEVKRGIFSLIKTAAKFVGKNLLKQAGKAGLEHLACKAKNEC	76	Esculentin-2-AJ2 antimicrobial peptide (Frogs, amphibians, animals)	K7Z8Z8	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04508	MLTLKKSMLLLFFLGTISLSLCEEERSADEDDGEKEVKRGIFSLIKTAAKFVGKNLLKQAGKAGLEHLACKAENEC	76	Esculentin-2-AJ3 antimicrobial peptide (Frogs, amphibians, animals)	K7ZGR7	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04509	MLTLKKSMLLLFFLGTISLSLCEEERSADEDDGEKEVKRGILSLIKNAAKFVGKNLHKQAGKGGLEHLACKAKNEC	76	Esculentin-2-AJ4 antimicrobial peptide (Frogs, amphibians, animals)	K7ZAL5	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04510	MFTMKKSLLVLFLLGIISLSFCEEERNADEDDGEMTEEEKRGILSTLKQFGKAAVKGVAQSLLNTASCKLAKTC	74	Esculentin-2-AJ5 antimicrobial peptide (Frogs, amphibians, animals)	K7Z8Z5	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04511	MFTMKKSLLVLFFLGIISLFFCEEERNADEDDGEMTEEEKRGILSTLKQFGKAAVKGVAQSFLNTASCKLAKTC	74	Esculentin-2-AJ6 antimicrobial peptide (Frogs, amphibians, animals)	K7ZGR5	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04512	MFTMKKSLLVLFFLGTISLSLCEEERNADEDDGEMTEEEKRGLMSTFKQVGISAIKGAAKNVLDVLSCKIAKTC	74	Brevinin-2-AJ2 antimicrobial peptide (Frogs, amphibians, animals)	K7ZAL2	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04513	MFTLKKSMLLLFFLGTISLSFCEEERSADEVDGEKEVKRGIFSIIKTAAKFLGKNLLKEAGKAGMEHLACKAKNEC	76	Esculentin-2-AJ1 antimicrobial peptide (Frogs, amphibians, animals)	K7ZJ57	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04514	MFTMKKSLLVLFFLGTISLSLCEEERNADEDDGEMTEEEKRGLVSTFKQVGISAIKGAAKNVLDVLSCKIAKTC	74	Brevinin-2-AJ7 antimicrobial peptide (Frogs, amphibians, animals)	K7ZAL3	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04515	MFTLKKSLLLLFFLATINLSLCEEERNADEDDGEMTEEEKRGFMSTFKQVGISAIKGAAKNVLDVLSCKIAKTC	74	Brevinin-2-AJ4 antimicrobial peptide (Frogs, amphibians, animals)	K7ZJ56	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04516	MFTMKKSLLVIFFLGTISLSLCEEERNADEDDGEMTEEEKRGLMSTFKRVGISAIKGAAKNVLDVLSCKIAKTC	74	Brevinin-2-AJ1 antimicrobial peptide (Frogs, amphibians, animals)	K7ZGR3	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04517	MFTMKKSLLVLFFLGTISLSLCEEERNADEDDGEMTEEEKRGLMSTFKQVGISAIKGAAQNVLGVLSCKLAKTC	74	Brevinin-2-AJ3 antimicrobial peptide (Frogs, amphibians, animals)	K7Z432	Not found	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22828809	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04518	MFTLKKSLLLLFFLGTINLFFCQEEERNADEEERRDERDVEVEKRVIPFVASVAAETMQHVYCAASKKMLKLNWKSSDVENHLAKC	86	Odorranain-P1a antimicrobial peptide (Frogs, amphibians, animals)	A6MBQ0	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04519	MFTMKKSLLLLFFLGTINLSLCQEEERNADEEERRDERDVEVEKRVIPFVASVAAEMMQHVYCAASKKC	69	Odorranain-P1b antimicrobial peptide (Frogs, amphibians, animals)	A6MBR0	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol Cell Proteomics. 2007 May;6(5):882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04520	MFTMKKPLLLLFFLGTISLSLCEEERNADEDDGEKEVKRGIFALIKTAAKFVGKNLLKQAGKAGLEHLACKANNQC	76	Esculentin-2MT1 antimicrobial peptide (Frogs, amphibians, animals)	E1AXF6	Not found	Not found	Amolops mantzorum	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2010) to the EMBL/GenBank/DDBJ database	Wang H, Liu J.	Antimicrobial peptides from amphibian skin of Amolops mantzorum.	
DRAMP04521	MFTLKKSMLLLFFLGTISLSLCEEERSADEDDGEKEVKRGIFSLIKTAAKFVGKNLLKQAGKAGMEHLACKANNQC	76	Esculentin-2MT2 antimicrobial peptide (Frogs, amphibians, animals)	E1B242	Not found	Not found	Amolops mantzorum	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2010) to the EMBL/GenBank/DDBJ database	Wang H, Liu J.	Antimicrobial peptides from amphibian skin of Amolops mantzorum.	
DRAMP04522	MFTMKKSMLLLFFLGMISLSLCQDERGADEDDGGEMTEEEKRGAFGDFLKGAAKKAGLKILSIAQCKLSGTC	72	Brevinin-2LT2 antimicrobial peptide (Frogs, amphibians, animals)	B9W1P5	Not found	Not found	Hylarana latouchii (broad-folded frog)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JAN-2009) to the EMBL/GenBank/DDBJ database	Wang H, Hu Y.	Construction of cDNA library of Hylarana latouchii skin tissue withcloning and sequence analysis of the cDNA encoding antimicrobialpeptides brevinin-2LTs.	
DRAMP04523	MFTMKKSLLLLFFLGTINLSFCQEEVRNADEEERRDERDVEVEKRVIPFVASVAAEMMQHVYCAASKKC	69	Odorranain-P1b antimicrobial peptide (Frogs, amphibians, animals)	A6MBQ7	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol. Cell. Proteomics. 2007,6:882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y,Rees H.H, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04524	MFTMKKSLLLLFFLGTINLSLCQEEVRNADEEERRDERDVEVEKRVIPFVASVAAEMMQHVYCAASKKC	69	Odorranain-P1b antimicrobial peptide (Frogs, amphibians, animals)	A6MBQ9	Not found	Not found	Odorrana grahami (Yunnanfu frog) (Rana grahami)	Antimicrobial	Homology	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17272268	Mol. Cell. Proteomics. 2007,6:882-894.	Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y,Rees H.H, Lai R, Yang D, Wu J.	Anti-infection peptidomics of amphibian skin.	
DRAMP04525	RSALSCQMCELVVKKYEGSADKDANVIKKDFDAECKKLFHTIPFGTRECDHYVNSKVDPIIHELEGGTAPKDVCTKLNECP	81	Caenopore-5	No entry found	Not found	Not found	Not found	Not found	Not found	Not found	The overall structure of the two caenopore-5 conformers consists of five amphiphatic helices connected by three disulfide bonds. The five helices are arranged in a folded leaf which is the characteristic signature of the SAPLIP family. 	2JS9	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19917307	Dev Comp Immunol. 2010 Mar;34(3):323-330.	Mysliwy J, Dingley AJ, Stanisak M, Jung S, Lorenzen I, Roeder T, Leippe M, Grötzinger J.	Caenopore-5: The three-dimensional structure of an antimicrobial protein from Caenorhabditis elegans.	
DRAMP04526	SCVFIPCITSLAGCSCKNKVCYYDGGSVPCGE	32	Parigidin-br1 (Cyclotides; Plants)	No entry found	Not found	Not found	Palicourea rigida (Rubiaceae)	Insecticidal	Not found	Not found	Not found		Function: Parigidin-br1 showes potent insecticidal activity against neonate larvae of Lepidoptera (Diatraea saccharalis), causing 60% mortality at a concentration of 1 µm but had no detectable antibacterial effects.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22074926	J Biol Chem. 2012 Jan 2;287(1):134-147.	Pinto MF, Fensterseifer IC, Migliolo L, Sousa DA, de Capdville G, Arboleda-Valencia JW, Colgrave ML, Craik DJ, Magalhães BS, Dias SC, Franco OL.	Identification and structural characterization of novel cyclotide with activity against an insect pest of sugar cane.	
DRAMP04527	SVRTQDNAVNRQIFGSNGPYRDFQLSDCYLPLETNPYCNEWQFAYHWNNALMDCERAIYHGCNRTRNNFITLTACKNQAGPICNRRRH	88	Luxuriosin	No entry found	Not found	Not found	Acalolepta luxuriosa (longicorn beetle)	Antimicrobial, Antibacterial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15716136	Biochim Biophys Acta. 2005 Feb 11;1722(1):36-42.	Ueda K, Saito A, Imamura M, Miura N, Atsumi S, Tabunoki H, Watanabe A, Kitami M, Sato R.	Purification and cDNA cloning of luxuriosin, a novel antibacterial peptide with Kunitz domain from the longicorn beetle, Acalolepta luxuriosa.	
DRAMP04529	FTQGVRNSQSCRRNKGICVPIRCPGSMRQIGTCLGAQVKCCRRK	44	LAP-like antimicrobial peptide (Bovine beta-defensins)	Q5W5H8	Not found	lap-like	Bos taurus (Bovine)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15520886	Mamm Genome. 2004 Oct;15(10):834-842.	Roosen S, Exner K, Paul S, Schröder JM, Kalm E, Looft C.	Bovine beta-defensins: identification and characterization of novel bovine beta-defensin genes and their expression in mammary gland tissue.	
DRAMP01097	GIGASILSAGKSALKGLAKGLAEHFAN	27	Bombinin-like peptide 1 (toads, amphibians, animals)	P29002?	Belongs to the bombinin family	Not found	Bombina orientalis (Oriental fire-bellied toad)	Antimicrobial	Protein level	Alpha helix	These peptides are cationic but otherwise differ considerably in such basic featuresa  st  heir size (Mr ~2300-4000), presence of disulfide bonds, and  structural motifs.		Function: Has antimicrobial activity, but no significant hemolytic activity. Preference on killing Gram-negative non-enteric bacteria.	[Ref.1744108] 82% inhibition Neisseria meningitidis 118V C (MIC=20 µg/ml), 98% inhibition Neisseria meningitidis 15240 IAI(MIC=20 µg/ml), 85% inhibition Neisseria meningitidis 126E IC1(MIC=20 µg/ml), 98% inhibition Neisseria gonorrhoeoe F62 (MIC=20 µg/ml), 96% inhibition Neisseria Iactamica 15323(MIC=20 µg/ml), 100% inhibition Neisseria Iactamica 15215A(MIC=20 µg/ml), 98% inhibition Neisseria cinerea 15461 (MIC=20 µg/ml), Bacillus megaterium BmII(MIC=0.3 µM), Staphylococcus aureus Cowan1 (MIC=3.4 µM), Escherichia coli D21 (MIC=1.7 µM), Escherichia coli D22(MIC=1.5 µM), Yersinia pseudotubercolosis (MIC=0.8 µM), Pseudomonas aeruginosa ATCC 15692(MIC=6.3 µM), Candida albicans(MIC=0.4 µM).	[Ref.1744108] No significant hemolytic activity against human red blood cell.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	1744108	J Biol Chem. 1991 Dec 5;266(34):23103-23111.	Gibson BW, Tang DZ, Mandrell R, Kelly M, Spindel ER.	Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis.	
DRAMP04533	AKRHHGYKRKFH	12	P-113D	No entry found	Not found	Not found	Homo sapiens	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11709321	Antimicrob Agents Chemother. 2001 Dec;45(12):3437-3444.	Sajjan US, Tran LT, Sole N, Rovaldi C, Akiyama A, Friden PM, Forstner JF, Rothstein DM.	P-113D, an Antimicrobial Peptide Active against Pseudomonas aeruginosa, Retains Activity in the Presence of putum from Cystic Fibrosis Patients.	
DRAMP04534	EPHPDEFVGLM	11	PG-KI	No entry found	Not found	Not found	Pseudophryne guntheri (Australian myobatrachid frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2356157	Peptides. 1990 Mar-Apr;11(2):299-304.	Simmaco M, Severini C, De Biase D, Barra D, Bossa F, Roberts JD, Melchiorri P, Erspamer V.	Six novel tachykinin- and bombesin-related peptides from the skin of the Australian frog Pseudophryne guntheri.	
DRAMP04535	EPNPDEFVGLM	11	PG-KII	No entry found	Not found	Not found	Pseudophryne guntheri (Australian myobatrachid frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2356157	Peptides. 1990 Mar-Apr;11(2):299-304.	Simmaco M, Severini C, De Biase D, Barra D, Bossa F, Roberts JD, Melchiorri P, Erspamer V.	Six novel tachykinin- and bombesin-related peptides from the skin of the Australian frog Pseudophryne guntheri.	
DRAMP04536	EPHPNEFVGLM	11	PG-KIII	No entry found	Not found	Not found	Pseudophryne guntheri (Australian myobatrachid frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2356157	Peptides. 1990 Mar-Apr;11(2):299-304.	Simmaco M, Severini C, De Biase D, Barra D, Bossa F, Roberts JD, Melchiorri P, Erspamer V.	Six novel tachykinin- and bombesin-related peptides from the skin of the Australian frog Pseudophryne guntheri.	
DRAMP04537	EPNPDEFFGLM	11	PG-SPI	No entry found	Not found	Not found	Pseudophryne guntheri (Australian myobatrachid frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2356157	Peptides. 1990 Mar-Apr;11(2):299-304.	Simmaco M, Severini C, De Biase D, Barra D, Bossa F, Roberts JD, Melchiorri P, Erspamer V.	Six novel tachykinin- and bombesin-related peptides from the skin of the Australian frog Pseudophryne guntheri.	
DRAMP04538	EPNPNEFFGLM	11	PG-SPII	No entry found	Not found	Not found	Pseudophryne guntheri (Australian myobatrachid frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2356157	Peptides. 1990 Mar-Apr;11(2):299-304.	Simmaco M, Severini C, De Biase D, Barra D, Bossa F, Roberts JD, Melchiorri P, Erspamer V.	Six novel tachykinin- and bombesin-related peptides from the skin of the Australian frog Pseudophryne guntheri.	
DRAMP04539	EGGGPQWAVGHFM	13	PG-L	No entry found	Not found	Not found	Pseudophryne guntheri (Australian myobatrachid frog)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2356157	Peptides. 1990 Mar-Apr;11(2):299-304.	Simmaco M, Severini C, De Biase D, Barra D, Bossa F, Roberts JD, Melchiorri P, Erspamer V.	Six novel tachykinin- and bombesin-related peptides from the skin of the Australian frog Pseudophryne guntheri.	
DRAMP04540	EKKPPRPPQWAVGHFM	16	PR-bombesin	No entry found	Not found	Not found	Bombina maxima (Chinese red belly toad)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11835992	Peptides. 2002 Mar;23(3):437-442.	Lai R, Liu H, Lee WH, Zhang Y.	A novel proline rich bombesin-related peptide (PR-bombesin) from toad Bombina maxima.	
DRAMP04541	PSCVCSGFETSGIHFC	16	Bb-AMP4	No entry found	Not found	Not found	Bellamya bengalensis	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21262297	Peptides. 2011 Apr;32(4):691-696.	Gauri SS, Mandal SM, Pati BR, Dey S.	Purification and structural characterization of a novel antibacterial peptide from Bellamya bengalensis: activity against ampicillin and chloramphenicol resistant Staphylococcus epidermidis.	
DRAMP04547	NALSMPRNKCNRALMCFG	18	Shuchin 1	No entry found	Not found	Not found	Rana shuchinae	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20553780	Peptides. 2010 Sep;31(9):1674-1677.	Zheng R, Yao B, Yu H, Wang H, Bian J, Feng F.	Novel family of antimicrobial peptides from the skin of Rana shuchinae.	
DRAMP04548	NALSSPRNKCDRASSCFG	18	Shuchin 2	No entry found	Not found	Not found	Rana shuchinae	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20553780	Peptides. 2010 Sep;31(9):1674-1677.	Zheng R, Yao B, Yu H, Wang H, Bian J, Feng F.	Novel family of antimicrobial peptides from the skin of Rana shuchinae.	
DRAMP04549	WLNALLHHGLNCAKGVL	17	17Hc	No entry found	Not found	Not found	Halocynthia aurantium	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878508	Antimicrob Agents Chemother. 2003 Aug;47(8):2481-2486.	Jang WS, Kim CH, Kim KN, Park SY, Lee JH, Son SM, Lee IH.	Biological Activities of Synthetic Analogs of Halocidin, an Antimicrobial Peptide from the Tunicate Halocynthia aurantium.	
DRAMP04550	WLNALLKKGLNCAKGVLA	18	18HcKK	No entry found	Not found	Not found	Halocynthia aurantium	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878508	Antimicrob Agents Chemother. 2003 Aug;47(8):2481-2486.	Jang WS, Kim CH, Kim KN, Park SY, Lee JH, Son SM, Lee IH.	Biological Activities of Synthetic Analogs of Halocidin, an Antimicrobial Peptide from the Tunicate Halocynthia aurantium.	
DRAMP04551	KWLNALLHHGLNCAKGVLA	19	K19Hc	No entry found	Not found	Not found	Halocynthia aurantium	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878508	Antimicrob Agents Chemother. 2003 Aug;47(8):2481-2486.	Jang WS, Kim CH, Kim KN, Park SY, Lee JH, Son SM, Lee IH.	Biological Activities of Synthetic Analogs of Halocidin, an Antimicrobial Peptide from the Tunicate Halocynthia aurantium.	
DRAMP04552	KWLNALLKKGLNCAKGVLA	19	K19HcKK	No entry found	Not found	Not found	Halocynthia aurantium	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12878508	Antimicrob Agents Chemother. 2003 Aug;47(8):2481-2486.	Jang WS, Kim CH, Kim KN, Park SY, Lee JH, Son SM, Lee IH.	Biological Activities of Synthetic Analogs of Halocidin, an Antimicrobial Peptide from the Tunicate Halocynthia aurantium.	
DRAMP04554	VDKPPYLPRPPPPRRIYNNR	20	Oncopeltus antibacterial peptide 4	No entry found	Not found	Not found	Oncopeltus fasciatus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11812116	J Invertebr Pathol. 2001 Oct;78(3):135-140.	Schneider M, Dorn A.	Differential infectivity of two Pseudomonas species and the immune response in the milkweed bug, Oncopeltus fasciatus (Insecta: Hemiptera).	
DRAMP04555	VGKTWIKVIRGIGKSKIKWQ	20	Bactrocerin-1	No entry found	Not found	Not found	Bactrocera dorsalis	Antimicrobial	Not found	Not found	Not found		Function: Shows a very broad spectrum of anti-microbial activity against Gram-positive bacteria, Gram-negative bacteria, and fungi. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19479741	Arch Insect Biochem Physiol. 2009 Jul;71(3):117-129.	Dang XL, Tian JH, Yang WY, Wang WX, Ishibashi J, Asaoka A, Yi HY, Li YF, Cao Y, Yamakawa M, Wen SY.	Bactrocerin-1: A novel inducible antimicrobial peptide from pupae of oriental fruit fly Bactrocera dorsalis Hendel.	
DRAMP04556	GWANTLKNVAGGLCKITGAA	20	Parkerin	No entry found	Not found	Not found	Nanorana parkeri	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20153801	Biochimie. 2010 May;92(5):475-481.	Lu Z, Zhai L, Wang H, Che Q, Wang D, Feng F, Zhao Z, Yu H.	Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri.	
DRAMP04557	GKLNLFLSRLEILKLFVGAL	20	Pelteobagrin	No entry found	Not found	Not found	Pelteobagrus fulvidraco (Yellow catfish)	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21073979	Comp Biochem Physiol B Biochem Mol Biol. 2011 Feb;158(2):149-154.	Su Y.	Isolation and identification of pelteobagrin, a novel antimicrobial peptide from the skin mucus of Yellow catfish (Pelteobagrus fulvidraco).	
DRAMP04558	GLRKRLRKFRNKIKEKLKKI	20	C18	No entry found	Not found	Not found	Oryctolagus cuniculus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8313956	FEBS Lett. 1994 Feb 14;339(1-2):108-112.	Tossi A, Scocchi M, Skerlavaj B, Gennaro R.	Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit Leukocytes.	
DRAMP04559	GLRKALRKFRNKIKEALKKI	20	C18AA	No entry found	Not found	Not found	Oryctolagus cuniculus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8313956	FEBS Lett. 1994 Feb 14;339(1-2):108-112.	Tossi A, Scocchi M, Skerlavaj B, Gennaro R.	Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit Leukocytes.	
DRAMP04560	HVDKKVADKVLLLKQLRIMRL	21	Spingerin C-4	No entry found	Not found	Not found	Pseudacanthotermes spiniger	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11053427	J Biol Chem. 2001 Feb 9;276(6):4085-4092.	Lamberty M, Zachary D, Lanot R, Bordereau C, Robert A, Hoffmann JA, Bulet P.	Insect immunity. Constitutive expression of a cysteine-rich antifungal and a linear antibacterial peptide in a termite insect.	
DRAMP04561	ALRSAVRTVARVGRAVLPHVAI	22	Ci-PAP-A2	No entry found	Not found	Not found	Ciona intestinalis	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17658598	Dev Comp Immunol. 2008;32(3):286-298.	Fedders H, Leippe M.	A reverse search for antimicrobial peptides in Ciona intestinalis: identification of a gene family expressed in hemocytes and evaluation of activity.	
DRAMP04562	WRSLGRTLLRLSHALKPLARRSGW	24	Ci-MAM-A24	No entry found	Not found	Not found	Ciona intestinalis	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18598239	Biochem J. 2008 Nov 15;416(1):65-75.	Fedders H, Michalek M, Grötzinger J, Leippe M.	An exceptional salt-tolerant antimicrobial peptide derived from a novel gene family of haemocytes of the marine invertebrate Ciona intestinalis.	
DRAMP04563	RSQMQDGQLQSCCQELQNVEEQCQC	25	2S albumin large chain 25 	No entry found	Not found	Not found	Taraxacum officinale	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19594427	Protein Pept Lett. 2010 Apr;17(4):522-529.	Odintsova TI, Rogozhin EA, Sklyar IV, Musolyamov AK, Kudryavtsev AM, Pukhalsky VA, Smirnov AN, Grishin EV, Egorov TA.	Antifungal activity of storage 2S albumins from seeds of the invasive weed dandelion Taraxacum officinale Wigg.	
DRAMP04564	FIFHIIKGLFHAGKMIHGLVTRRRH	25	Epinecidin-1 (Epi-1; fish, animals)	No entry found	Not found	Not found	Epinephelus coioides (Orange-spotted grouper) (Epinephelus nebulosus)	Antimicrobial, Antibacterial, Antifungal, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17570764	DNA Cell Biol. 2007 Jun;26(6):403-413.	Pan CY, Chen JY, Cheng YS, Chen CY, Ni IH, Sheen JF, Pan YL, Kuo CM.	Gene expression and localization of the epinecidin-1 antimicrobial peptide in the grouper (Epinephelus coioides), and its role in protecting fish against pathogenic infection.	
DRAMP04565	GVVDILKGAAKDLAGHLATKVMNKL	25	Laticeptin	No entry found	Not found	Not found	Leptodatylus laticeps	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16712520	Protein Pept Lett. 2006;13(4):411-415.	Conlon JM, Al-Ghaferi N, Abraham B, Sonnevend A, King JD, Nielsen PF.	Purification and properties of laticeptin, an antimicrobial peptide from skin secretions of the South American frog Leptodactylus laticeps.	
DRAMP04566	GKQYFPKVGGRLSGKAPLAAKTHRRLKP	28	Kenojeinin I	No entry found	Not found	Not found	Raja kenojei 	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15752571	Peptides. 2005 Apr;26(4):581-587.	Cho SH, Lee BD, An H, Eun JB.	Kenojeinin I, antimicrobial peptide isolated from the skin of the fermented skate, Raja kenojei.	
DRAMP04567	GWFKKTFHKVSHAVKSGIHAGQRGCSALGF	30	Centrocin 1	No entry found	Not found	Not found	Strongylocentrotus droebachiensis	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20438753	Dev Comp Immunol. 2010 Sep;34(9):959-968.	Li C, Haug T, Moe MK, Styrvold OB, Stensvåg K.	Centrocins: Isolation and characterization of novel dimeric antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.	
DRAMP04568	SWFSRTVHNVGNAVRKGIHAGQGVCSGLGL	30	Centrocin 2	No entry found	Not found	Not found	Strongylocentrotus droebachiensis	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20438753	Dev Comp Immunol. 2010 Sep;34(9):959-968.	Li C, Haug T, Moe MK, Styrvold OB, Stensvåg K.	Centrocins: Isolation and characterization of novel dimeric antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.	
DRAMP04569	KPWRFRRAIRRVRWRKVAPYIPFVVKTVGKK	31	Arminin-1a	No entry found	Not found	Not found	Hydra magnipapillata	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19770277	Antimicrob Agents Chemother. 2009 Dec;53(12):5245-5250.	Augustin R, Anton-Erxleben F, Jungnickel S, Hemmrich G, Spudy B, Podschun R, Bosch TC.	Activity of the novel peptide arminin against multiresistant human pathogens shows the considerable potential of phylogenetically ancient organisms as drug sources.	
DRAMP04570	WNSNRRFRVGRPPVVGRPGCVCFRAPCPCSNY	32	Callinectin	No entry found	Not found	Not found	Callinectes sapidus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21115038	Dev Comp Immunol. 2011 Apr;35(4):409-415.	Noga EJ, Stone KL, Wood A, Gordon WL, Robinette D.	Primary structure and cellular localization of callinectin; an antimicrobial peptide from the blue crab.	
DRAMP04571	IIKVPLKKFKSMREVMRDHGIKAPVVDPATKY	32	bullfrog pepsinogen C-derived antimicrobial peptide (bPcAP)	No entry found	Not found	Not found	Rana catesbeiana	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9639668	Biochim Biophys Acta. 1998 Jul 1;1407(1):31-39.	Minn I, Kim HS, Kim SC.	Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.	
DRAMP04572	GVVKVSRLKGESLRARL	17	bullfrog pepsinogen A-derived antimicrobial peptide (bPaAP)	No entry found	Not found	Not found	Rana catesbeiana	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9639668	Biochim Biophys Acta. 1998 Jul 1;1407(1):31-39.	Minn I, Kim HS, Kim SC.	Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.	
DRAMP04573	CIAKGNGCQPSGVQGNCCSGHCHKEPGWVAGYCK	34	Psacotheasin	No entry found	Not found	Not found	Psacothea hilaris	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20467242	J Microbiol Biotechnol. 2010 Apr;20(4):708-711.	Hwang JS, Lee J, Hwang B, Nam SH, Yun EY, Kim SR, Lee DG.	Isolation and Characterization of Psacotheasin, a Novel Knottin-Type Antimicrobial Peptide, from Psacothea hilaris.	
DRAMP04574	TTLTLHNLCPYPVWWLVTPNNGGFPIIDNTPVVLG	35	Dendrocin	No entry found	Not found	Not found	Dendrocalamus latiflorus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12893287	Biochem Biophys Res Commun. 2003 Aug 1;307(3):750-755.	Wang HX, Ng TB.	Dendrocin, a distinctive antifungal protein from bamboo shoots.	
DRAMP04575	LTCDILGSTPACAAHCIARGYRGGWCDGQSVCNCRR	36	Chironomus defensin	No entry found	Not found	Not found	Chironomus plumosus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9887520	Insect Biochem Mol Biol. 1998 Dec;28(12):1059-1066.	Lauth X, Nesin A, Briand JP, Roussel JP, Hetru C.	Isolation, characterization and chemical synthesis of a new insect defensin from Chironomus plumosus (Diptera).	
DRAMP04576	ILENLLARSTNEDREGSIFDTGPIRRPKPRPRPRPEG	37	Cg-Prp	No entry found	Not found	Not found	Crassostrea gigas	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18962895	Mol Immunol. 2009 Feb;46(4):516-522.	Gueguen Y, Bernard R, Julie F, Paulina S, Delphine DG, Franck V, Philippe B, Evelyne B.	Oyster hemocytes express a proline-rich peptide displaying synergistic antimicrobial activity with a defensin.	
DRAMP04577	RWKIFKKIEKVGRNVRDGIIKAGPAVAVVGQAATVVK	37	Papiliocin	No entry found	Not found	Not found	Papilio xuthus	Antimicrobial	Not found	Not found	Not found	2LA2	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20213310	Mol Cells. 2010 Apr;29(4):419-423.	Kim SR, Hong MY, Park SW, Choi KH, Yun EY, Goo TW, Kang SW, Suh HJ, Kim I, Hwang JS.	Characterization and cDNA cloning of a cecropin-like antimicrobial peptide, papiliocin, from the swallowtail butterfly, Papilio xuthus.	
DRAMP04578	KRFGRLAKSFLRMRILLPRRKILLAS	26	ECATH-1	No entry found	Not found	Not found	Equus asinus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10471829	FEBS Lett. 1999 Sep 3;457(3):459-464.	Scocchi M, Bontempo D, Boscolo S, Tomasinsig L, Giulotto E, Zanetti M.	Novel cathelicidins in horse leukocytes(1).	
DRAMP04579	KRRHWFPLSFQEFLEQLRRFRDQLPFP	27	ECATH-2	No entry found	Not found	Not found	Equus asinus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10471829	FEBS Lett. 1999 Sep 3;457(3):459-464.	Scocchi M, Bontempo D, Boscolo S, Tomasinsig L, Giulotto E, Zanetti M.	Novel cathelicidins in horse leukocytes(1).	
DRAMP04580	KRFHSVGSLIQRHQQMIRDKSEATRHGIRIITRPKLLLAS	40	ECATH-3	No entry found	Not found	Not found	Equus asinus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10471829	FEBS Lett. 1999 Sep 3;457(3):459-464.	Scocchi M, Bontempo D, Boscolo S, Tomasinsig L, Giulotto E, Zanetti M.	Novel cathelicidins in horse leukocytes(1).	
DRAMP04581	TYMPVEEGEYIVNISYADQPKKNSPFTAKKQPGPKVDLSGVKAYGPG	47	Ap	No entry found	Not found	Not found	Argopecten purpuratus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19481126	Peptides. 2009 Aug;30(8):1405-1411.	Arenas G, Guzmán F, Cárdenas C, Mercado L, Marshall SH.	A novel antifungal peptide designed from the primary structure of a natural antimicrobial peptide purified from Argopecten purpuratus hemocytes.	
DRAMP04582	IFGSIYHRKCVVKNRCETVSGHKTCKDLTCCRAVIFRHERPEVCRPQT	48	Strongylocin 1 (Cys-rich; sea urchin, Echinoidea, animals)	No entry found	Not found	Not found	Strongylocentrotus droebachiensis	Antimicrobial, Antibacterial, Antifungal, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18656496	Dev Comp Immunol. 2008;32(12):1430-1440. 	Li C, Haug T, Styrvold OB, Jørgensen TØ, Stensvåg K.	Strongylocins, novel antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.	
DRAMP04583	WNPFKKIANRNCYPKTTCETAGGKKTCKDFSCCQIVLFGKKTRAKCTVVTS	51	Strongylocin 2 (Cys-rich; sea urchin, Echinoidea, animals)	No entry found	Not found	Not found	Strongylocentrotus droebachiensis	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18656496	Dev Comp Immunol. 2008;32(12):1430-1440. 	Li C, Haug T, Styrvold OB, Jørgensen TØ, Stensvåg K.	Strongylocins, novel antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.	
DRAMP04584	IFNSIYHRKCVVKNRCETVSGHKTCKDLTCCRAVIFRHERPEVCRPST	48	SpStrongylocin 1 (S. purpuratus Strongylocin, sea urchin, Echinoidea, animals)	No entry found	Not found	Not found	Strongylocentrotus purpuratus	Antimicrobial, Antibacterial, Antifungal, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19852980	Dev Comp Immunol. 2010 Mar;34(3):286-292.	Li C, Blencke HM, Smith LC, Karp MT, Stensvåg K.	Two recombinant peptides, SpStrongylocins 1 and 2, from Strongylocentrotus purpuratus, show antimicrobial activity against Gram-positive and Gram-negative bacteria.	
DRAMP04585	WNPFRKLYRKECNDVTSCDTVSGVKTCTKKNCCHRKFFGKTILKAPECTVIS	52	SpStrongylocin 2 (S. purpuratus Strongylocin; sea urchin, Echinoidea, animals)	No entry found	Not found	Not found	Strongylocentrotus purpuratus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19852980	Dev Comp Immunol. 2010 Mar;34(3):286-292.	Li C, Blencke HM, Smith LC, Karp MT, Stensvåg K.	Two recombinant peptides, SpStrongylocins 1 and 2, from Strongylocentrotus purpuratus, show antimicrobial activity against Gram-positive and Gram-negative bacteria.	
DRAMP04586	GIWSSIKNLASKAWNSDIGQSLRNKAAGAINKFVADKIGVTPSQAASMTLDEIVDAMYYD	60	Vejovine	F1AWB0	Not found	Not found	Vaejovis mexicanus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20969885	Toxicon. 2011 Jan;57(1):84-92.	Hernández-Aponte CA, Silva-Sanchez J, Quintero-Hernández V, Rodríguez-Romero A, Balderas C, Possani LD, Gurrola GB.	Vejovine, a new antibiotic from the scorpion venom of Vaejovis mexicanus.	
DRAMP04587	RMRRSKSGKGSGGSKGSGSKGSKGSKGSGSKGSGSKGGSRPGGGSSIAGGGSKGKGGTQTA	61	aCATH	No entry found	Not found	Not found	Plecoglossus altivelis	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21397030	Fish Shellfish Immunol. 2011 Jul;31(1):52-57.	Lu XJ, Chen J, Huang ZA, Shi YH, Lv JN.	Identification and characterization of a novel cathelicidin from ayu, Plecoglossus altivelis.	
DRAMP04588	RICSRDKNCVSRPGVGSIIGRPGGGSLIGRPGGGSVIGRPGGGSPPGGGSFNDEFIRDHSDGNRFA	66	rtCATH 1 	No entry found	Not found	rtCATH_1	Oncorhynchus mykiss (rainbow trout)	Antimicrobial	Predicted	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16041021	Infect Immun. 2005 Aug;73(8):5053-5064.	Chang CI, Pleguezuelos O, Zhang YA, Zou J, Secombes CJ.	Identification of a novel cathelicidin gene in the rainbow trout, Oncorhynchus mykiss.	
DRAMP04589	SRSGRGSGKGGRGGSRGSSGSRGSKGPSGSRGSSGSRGSKGSRGGRSGRGSTIAGNGNRNNGGTRTA	67	Cod cathelicidin	No entry found	Not found	Not found	Gadus morhua	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20950641	Dev Comp Immunol. 2011 Mar;35(3):296-303.	Broekman DC, Frei DM, Gylfason GA, Steinarsson A, Jörnvall H, Agerberth B, Gudmundsson GH, Maier VH.	Cod cathelicidin: Isolation of the mature peptide, cleavage site characterisation and developmental expression.	
DRAMP04590	ERILDLRKTKKSCKNGEVLGCVSGHGPPGCSENECGMGPRPKACFFDCHYGCWCTGKLYRRKRDRKCVPKHECLL	75	Rhamp	No entry found	Not found	Not found	Rhipicephalus haemaphysaloides	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21168461	Peptides. 2011 Mar;32(3):441-446.	Zhang H, Zhang W, Wang X, Zhou Y, Wang N, Zhou J.	Identification of a cysteine-rich antimicrobial peptide from salivary glands of the tick Rhipicephalus haemaphysaloides.	
DRAMP04591	SKCKCSRKGPKIRYSDVKKLEMKPKYPHCEEKMVIITTKSVSRYRGQEHCLHPKLQSTKRFIKWYNAWNEKRRVYEE	77	CXCL14	No entry found	Not found	Not found	Homo sapiens	Antimicrobial	Not found	Not found	Not found	2HDL	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19109182	J Immunol. 2009 Jan 1;182(1):507-514.	Maerki C, Meuter S, Liebi M, Mühlemann K, Frederick MJ, Yawalkar N, Moser B, Wolf M.	Potent and broad-spectrum antimicrobial activity of CXCL14 suggests an immediate role in skin infections.	
DRAMP04592	SSFSPPRGPPGWGPPCVQQPCPKCPYDDYKCPTCDKFPECEECPHISIGCECGYFSCECPKPVCEPCESPIAELIKKGGYKG	82	Ls-Stylicin 1	No entry found	Not found	Not found	Litopenaeus stylirostris	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20061030	Mol Immunol. 2010 Mar;47(6):1269-1277.	Rolland JL, Abdelouahab M, Dupont J, Lefevre F, Bachère E, Romestand B.	Stylicins, a new family of antimicrobial peptides from the Pacific blue shrimp Litopenaeus stylirostris.	
DRAMP04593	RVPPYLGRDCKHWCRDNNQALYCCGPPGITYPPFIRKHPGKCPSVRSTCTGVRSSRPKFCPHDDACEFRSKCCYDACVKHHVCKTVEFY	89	CrusSp	No entry found	Not found	Not found	Scylla paramamosain	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18425600	Mol Biol Rep. 2009 May;36(5):841-850.	Imjongjirak C, Amparyup P, Tassanakajon A, Sittipraneed S.	Molecular cloning and characterization of crustin from mud crab Scylla paramamosain.	
DRAMP04594	NLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHV	80	TCP	No entry found	Not found	Not found	Homo sapiens	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20421939	PLoS Pathog. 2010 Apr 22;6(4):e1000857.	Papareddy P, Rydengård V, Pasupuleti M, Walse B, Mörgelin M, Chalupka A, Malmsten M, Schmidtchen A.	Proteolysis of human thrombin generates novel host defense peptides.	
DRAMP04595	SPRPDDKKNQGSASVDVQNERGEGTKVDARVRQELWRSDDGRTRAQAYGHWDRTYGGRNHGERSYGGGMRIEHTWGN	77	Prolixicin	No entry found	Not found	Not found	Rhodnius prolixus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21906194	Insect Mol Biol. 2011 Dec;20(6):775-786.	Ursic-Bedoya R, Buchhop J, Joy JB, Durvasula R, Lowenberger C.	Prolixicin: a novel antimicrobial peptide isolated from Rhodnius prolixus with differential activity against bacteria and Trypanosoma cruzi.	
DRAMP04596	FPVTWRWWKWWKG	13	PuroA	No entry found	Not found	Not found	Triticum aestivum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Journal of Cereal Science. 2012 Sep;56(2):171-180.	Ramalingam A, Palombo EA, Bhave M.	The Pinb-2 genes in wheat comprise a multigene family with great sequence diversity and important variants.	
DRAMP04597	FPVTWPTKWWKG	12	PuroB	No entry found	Not found	Not found	Triticum aestivum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Journal of Cereal Science. 2012 Sep;56(2):171-180.	Ramalingam A, Palombo EA, Bhave M.	The Pinb-2 genes in wheat comprise a multigene family with great sequence diversity and important variants.	
DRAMP04598	FSIARLLKWWKG	12	Pinb-2v1	No entry found	Not found	Not found	Triticum aestivum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Journal of Cereal Science. 2012 Sep;56(2):171-180.	Ramalingam A, Palombo EA, Bhave M.	The Pinb-2 genes in wheat comprise a multigene family with great sequence diversity and important variants.	
DRAMP04599	FPISTLLKWWKG	12	Pinb-2v3	No entry found	Not found	Not found	Triticum aestivum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Journal of Cereal Science. 2012 Sep;56(2):171-180.	Ramalingam A, Palombo EA, Bhave M.	The Pinb-2 genes in wheat comprise a multigene family with great sequence diversity and important variants.	
DRAMP04600	FPVTWPTKWWKS	12	Pinb-B	No entry found	Not found	Not found	Triticum aestivum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Journal of Cereal Science. 2011 Jan;53(1):112-117.	Phillipsa RL, Palomboa EA, Panozzob JF, Bhave M.	Puroindolines, Pin alleles, hordoindolines and grain softness proteins are sources of bactericidal and fungicidal peptides.	
DRAMP04601	FPVTWPTKWRKG	12	Pinb-D	No entry found	Not found	Not found	Triticum aestivum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Journal of Cereal Science. 2011 Jan;53(1):112-117.	Phillipsa RL, Palomboa EA, Panozzob JF, Bhave M.	Puroindolines, Pin alleles, hordoindolines and grain softness proteins are sources of bactericidal and fungicidal peptides.	
DRAMP04602	FPVTWPTKWLKG	12	Pinb-Q	No entry found	Not found	Not found	Triticum aestivum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Journal of Cereal Science. 2011 Jan;53(1):112-117.	Phillipsa RL, Palomboa EA, Panozzob JF, Bhave M.	Puroindolines, Pin alleles, hordoindolines and grain softness proteins are sources of bactericidal and fungicidal peptides.	
DRAMP04603	FSVTWRWWKWWKG	13	Pina-M	No entry found	Not found	Not found	Triticum aestivum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Journal of Cereal Science. 2011 Jan;53(1):112-117.	Phillipsa RL, Palomboa EA, Panozzob JF, Bhave M.	Puroindolines, Pin alleles, hordoindolines and grain softness proteins are sources of bactericidal and fungicidal peptides.	
DRAMP04604	FPVTWGWWKWWKG	13	Pina-R39 G	No entry found	Not found	Not found	Triticum aestivum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Journal of Cereal Science. 2011 Jan;53(1):112-117.	Phillipsa RL, Palomboa EA, Panozzob JF, Bhave M.	Puroindolines, Pin alleles, hordoindolines and grain softness proteins are sources of bactericidal and fungicidal peptides.	
DRAMP04605	FPVTFRFFKFFKG	13	Pina-W	No entry found	Not found	Not found	Triticum aestivum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Journal of Cereal Science. 2011 Jan;53(1):112-117.	Phillipsa RL, Palomboa EA, Panozzob JF, Bhave M.	Puroindolines, Pin alleles, hordoindolines and grain softness proteins are sources of bactericidal and fungicidal peptides.	
DRAMP04606	FPVTWRWWTWWKG	13	Hina	No entry found	Not found	Not found	Triticum aestivum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Journal of Cereal Science. 2011 Jan;53(1):112-117.	Phillipsa RL, Palomboa EA, Panozzob JF, Bhave M.	Puroindolines, Pin alleles, hordoindolines and grain softness proteins are sources of bactericidal and fungicidal peptides.	
DRAMP04607	MPLSWFFPRTWGKR	14	GSP-5D	No entry found	Not found	Not found	Triticum aestivum	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Journal of Cereal Science. 2011 Jan;53(1):112-117.	Phillipsa RL, Palomboa EA, Panozzob JF, Bhave M.	Puroindolines, Pin alleles, hordoindolines and grain softness proteins are sources of bactericidal and fungicidal peptides.	
DRAMP04608	AINXDAAYL	9	BCP61	No entry found	Not found	Not found	Bacillus sp. CS61	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22578764	Int J Antimicrob Agents. 2012 Jul;40(1):80-83.	Choi YH, Cho SS, Simkhada JR, Yoo JC.	A novel thermotolerant and acidotolerant peptide produced by a Bacillus strain newly isolated from a fermented food (kimchi) shows activity against multidrug-resistant bacteria.	
DRAMP04609	GPIRRPKPRPRPRPE	15	Cg-lgPrp	No entry found	Not found	Not found	Crassostrea gigas	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22327168	Dev Comp Immunol. 2012 Jul;37(3-4):363-370.	Schmitt P, de Lorgeril J, Gueguen Y, Destoumieux-Garzón D, Bachère E.	Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.	
DRAMP04610	GPIRRPKPRPRQRPE	15	Cg-lgPrp P/Q	No entry found	Not found	Not found	Crassostrea gigas	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22327168	Dev Comp Immunol. 2012 Jul;37(3-4):363-370.	Schmitt P, de Lorgeril J, Gueguen Y, Destoumieux-Garzón D, Bachère E.	Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.	
DRAMP04611	GFGCPRDQYKCNSHCQSIGCRAGYCDAVTLWLRCTCTDCNGKK	43	Cg-Defh1	No entry found	Not found	Not found	Crassostrea gigas	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22327168	Dev Comp Immunol. 2012 Jul;37(3-4):363-370.	Schmitt P, de Lorgeril J, Gueguen Y, Destoumieux-Garzón D, Bachère E.	Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.	
DRAMP04612	GFGCPGDQYECNRHCRSIGCRAGYCDAVTLWLRCTCTGCSGKK	43	Cg-Defh2	No entry found	Not found	Not found	Crassostrea gigas	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22327168	Dev Comp Immunol. 2012 Jul;37(3-4):363-370.	Schmitt P, de Lorgeril J, Gueguen Y, Destoumieux-Garzón D, Bachère E.	Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.	
DRAMP04613	IGCWTKSIPPRPCFVK	16	HV-BBI(3-18) (X)	No entry found	Not found	Not found	Odorrana grahami	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22516177	Peptides. 2012 Jun;35(2):276-284.	Dębowski D, Łukajtis R, Łęgowska A, Karna N, Pikuła M, Wysocka M, Maliszewska I, Sieńczyk M, Lesner A, Rolka K.	Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin.	
DRAMP04614	AVNIPFKVHFRCKSIFC	17	[Ser14,Ile15]OGTI (II)	No entry found	Not found	Not found	Odorrana grahami	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22516177	Peptides. 2012 Jun;35(2):276-284.	Dębowski D, Łukajtis R, Łęgowska A, Karna N, Pikuła M, Wysocka M, Maliszewska I, Sieńczyk M, Lesner A, Rolka K.	Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin.	
DRAMP04615	SVIGCWTKSIPPRPRCFVK	19	HV-BBI (IX)	No entry found	Not found	Not found	Odorrana grahami	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22516177	Peptides. 2012 Jun;35(2):276-284.	Dębowski D, Łukajtis R, Łęgowska A, Karna N, Pikuła M, Wysocka M, Maliszewska I, Sieńczyk M, Lesner A, Rolka K.	Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin.	
DRAMP04616	GSAQPYKQLHKVVNWDPYG	19	Cancrin	No entry found	Not found	Not found	Fejervarya cancrivora	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17707909	Mol Immunol. 2008 Feb;45(3):678-681.	Lu Y, Ma Y, Wang X, Liang J, Zhang C, Zhang K, Lin G, Lai R.	The first antimicrobial peptide from sea amphibian.	
DRAMP04617	SFKKFWGGVKAIFKGARKGWK	21	Hfp1	No entry found	Not found	Not found	Gasterosteus aculeatus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22188679	FEBS J. 2012 Mar;279(5):724-736.	Tessera V, Guida F, Juretić D, Tossi A.	Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.	
DRAMP04618	FFKKFWGGVKAIFKGARKGWK	21	Hfp2	No entry found	Not found	Not found	Gasterosteus aculeatus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22188679	FEBS J. 2012 Mar;279(5):724-736.	Tessera V, Guida F, Juretić D, Tossi A.	Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.	
DRAMP04619	SVKKFWGGVKAIFKGARKGLK	21	Hfp3	No entry found	Not found	Not found	Gasterosteus aculeatus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22188679	FEBS J. 2012 Mar;279(5):724-736.	Tessera V, Guida F, Juretić D, Tossi A.	Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.	
DRAMP04620	FVKKFWGGVKAIFKGARKGLK	21	Hfp4	No entry found	Not found	Not found	Gasterosteus aculeatus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22188679	FEBS J. 2012 Mar;279(5):724-736.	Tessera V, Guida F, Juretić D, Tossi A.	Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.	
DRAMP04621	FALGAVTKLLPSLLCMITRKC	21	Hainanenin-1	No entry found	Not found	Not found	Amolops hainanensis	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22306820	Peptides. 2012 Feb;33(2):251-257.	Zhang S, Guo H, Shi F, Wang H, Li L, Jiao X, Wang Y, Yu H.	Hainanenins: a novel family of�antimicrobial�peptides with strong activity from Hainan cascade-frog, Amolops hainanensis.	
DRAMP04622	FALGAVTKRLPSLFCLITRKC	21	Hainanenin-5	No entry found	Not found	Not found	Amolops hainanensis	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22306820	Peptides. 2012 Feb;33(2):251-257.	Zhang S, Guo H, Shi F, Wang H, Li L, Jiao X, Wang Y, Yu H.	Hainanenins: a novel family of�antimicrobial�peptides with strong activity from Hainan cascade-frog, Amolops hainanensis.	
DRAMP04623	GFGSLGKALRLGANVL	16	X. clivii-C1	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04624	GVGKFLHSAKKFGQALVSEIMKS	23	X. clivii-C2	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04625	GFKQFVHSMGKFGKAFVGEIINPK	24	X. borealis-B1	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04626	GIGKFLHSAGKFGKAFLGEVMKS	23	X. borealis-B2	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04627	GLGSLLGSLFKFIPKLLPSIQQ	22	X. borealis-B3	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04628	GLLTNVLGFLKKAGKGVLSGLLPL	24	X. borealis-B4	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04629	GIKEFAHSLGKFGKAFVGGILNQ	23	X. amieti-AM1	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04630	GLGSVLGKILKMGANLLGGAPKGA	24	X. amieti-AM3	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04631	GLGSLVGNALRIGAKLL	17	X. amieti-AM4	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04632	GWASKIGQALGKVAKVGLQQFIQPK	25	XPF-C1	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04633	GFGSLLGKALRLGANVL	17	CPF-C1	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04634	GLGSLLGKALKFGLKAAGKFMGGEPQQ	27	CPF-C2	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04635	GLASFLGKALKAGLKIGAHLLGGAPQQ	27	X. laevis 1	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04636	GFASFLGKALKAALKIGANMLGGTPQQ	27	X. laevis 2	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04637	GFGSFLGKALKAALKIGANALGGSPQQ	27	X. laevis 3	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04638	GLASLLGKALKAGLKIGTHFLGGAPQQ	27	X. laevis 4	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21199684	Comp Biochem Physiol C Toxicol Pharmacol. 2011 Apr;153(3):350-354.	Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, King JD, Takada K.	Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).	
DRAMP04639	GVSKILHSAGKFGKAFLGEIMKS	23	Magainin-AN2	No entry found	Not found	Not found	Xenopus clivii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21498136	Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.	Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.	Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.	
DRAMP04641	GWASKIGQTLGKMAKVGLQELIQPK	25	XPF-AN1	No entry found	Not found	Not found	Xenopus andrei	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21498136	Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.	Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.	Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.	
DRAMP04642	GIGKFLHSAGKFGKAFIGEIMKS	23	Magainin-M1	No entry found	Not found	Not found	Xenopus muelleri	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21664395	Peptides. 2011 Jul;32(7):1502-1508.	Mechkarska M, Ahmed E, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.	Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.	
DRAMP04643	GLGSLLGKAFKFGLKTVGKMMAGAPREQ	28	CPF-M1	No entry found	Not found	Not found	Xenopus muelleri	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21664395	Peptides. 2011 Jul;32(7):1502-1508.	Mechkarska M, Ahmed E, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.	Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.	
DRAMP04644	GMASKAGSVLGKITKIALGAL	21	PGLa-MW1	No entry found	Not found	Not found	Xenopus muelleri	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21664395	Peptides. 2011 Jul;32(7):1502-1508.	Mechkarska M, Ahmed E, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.	Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.	
DRAMP04645	GLGSLLGKAFKFGLKTVGKMMGGAPREQ	28	CPF-MW1	No entry found	Not found	Not found	Xenopus muelleri	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21664395	Peptides. 2011 Jul;32(7):1502-1508.	Mechkarska M, Ahmed E, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.	Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.	
DRAMP04646	GLGSLLGKAFKFGLKTVGKMMGGAPREE	28	CPF-MW2	No entry found	Not found	Not found	Xenopus muelleri	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21664395	Peptides. 2011 Jul;32(7):1502-1508.	Mechkarska M, Ahmed E, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.	Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.	
DRAMP04647	GIGSLLAKAAKLGANLL	17	CPF-L1	No entry found	Not found	Not found	Xenopus lenduensis	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22123629	Peptides. 2012 Jan;33(1):35-43.	King JD, Mechkarska M, Coquet L, Leprince J, Jouenne T, Vaudry H, Takada K, Conlon JM.	Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).	
DRAMP04648	GIGSALAKAAKLVAGIV	17	CPF-L2	No entry found	Not found	Not found	Xenopus lenduensis	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22123629	Peptides. 2012 Jan;33(1):35-43.	King JD, Mechkarska M, Coquet L, Leprince J, Jouenne T, Vaudry H, Takada K, Conlon JM.	Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).	
DRAMP04649	GLASFLGKALKAGLKIGSHLLGGAPQQ	27	CPF-P2	No entry found	Not found	Not found	Xenopus petersii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22123629	Peptides. 2012 Jan;33(1):35-43.	King JD, Mechkarska M, Coquet L, Leprince J, Jouenne T, Vaudry H, Takada K, Conlon JM.	Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).	
DRAMP04650	GFGSFLGKALKAALKIGANVLGGAPQQ	27	CPF-P3	No entry found	Not found	Not found	Xenopus petersii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22123629	Peptides. 2012 Jan;33(1):35-43.	King JD, Mechkarska M, Coquet L, Leprince J, Jouenne T, Vaudry H, Takada K, Conlon JM.	Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).	
DRAMP04651	GFGSFLGKALKAALKIGANVLGGAPEQ	27	CPF-P4	No entry found	Not found	Not found	Xenopus petersii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22123629	Peptides. 2012 Jan;33(1):35-43.	King JD, Mechkarska M, Coquet L, Leprince J, Jouenne T, Vaudry H, Takada K, Conlon JM.	Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).	
DRAMP04652	GFGSFLGKALKAALKIGADVLGGAPQQ	27	CPF-P5	No entry found	Not found	Not found	Xenopus petersii	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22123629	Peptides. 2012 Jan;33(1):35-43.	King JD, Mechkarska M, Coquet L, Leprince J, Jouenne T, Vaudry H, Takada K, Conlon JM.	Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).	
DRAMP04653	GFGSLLGKALKIGTNLL	17	CPF-PG1	No entry found	Not found	Not found	Xenopus pygmaeus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22123629	Peptides. 2012 Jan;33(1):35-43.	King JD, Mechkarska M, Coquet L, Leprince J, Jouenne T, Vaudry H, Takada K, Conlon JM.	Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).	
DRAMP04654	IKLSPETKDNLKKVLKGAIKGAIAVAKMV	29	H-0, Hymenochirin-1B	No entry found	Unknown	Not found	Hymenochirus boettgeri (Congo dwarf clawed frog)	Antimicrobial, Anticancer	Experimental evidence at transcript level	α-helical (most likely)	No detailed structure description found.		"Function: Antimicrobial, Anticancer, Immunomodulatory and Antidiabetic activity.
As a cationic, amphipathic, α-helical, 29-residue,host defense peptide,  Hymenochirin-1B is the predominant pharmacological active component of four hymenochirins, which showed a wide range of biological activities, such as antimicrobial, anticancer, immunomodulatory, and antidiabetic activities. Surprisingly, we don't find the entry introducing Hymenochirin-1B in UniProt (2021-3-29)."	[Ref.30789695] Cancer cell lines: A549 (IC50 = 15.22 ± 0.21 μM), HCT116 (IC50 = 12.76 ± 0.43 μM), HepG2 (IC50 = 8.07 ± 0.21 μM)	[Ref.30789695] It has 5%, 6.3%, 7.7%, 10%, 10.7%, 15.3%, 9%, 15% and 9.7% hemolysis against fresh rabbit blood cells at 0.010, 0.25, 0.5, 1.0, 2.0, 5.0, 10.0, 20.0, 25.0μM	Linear	Free	Amidation		L	No cytotoxicity information found in the reference	Not found	30789695	ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.	Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao	Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP04655	LKIPGFVKDTLKKVAKGIFSAVAGAMTPS	29	Hymenochirin-2B	No entry found	Not found	Not found	Hymenochirus boettgeri	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22497805	Peptides. 2012 Jun;35(2):269-275.	Mechkarska M, Prajeep M, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.	The hymenochirins: A family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).	
DRAMP04656	IKIPAVVKDTLKKVAKGVLSAVAGALTQ	28	Hymenochirin-3B	No entry found	Not found	Not found	Hymenochirus boettgeri	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22497805	Peptides. 2012 Jun;35(2):269-275.	Mechkarska M, Prajeep M, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.	The hymenochirins: A family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).	
DRAMP04657	IKIPAFVKDTLKKVAKGVISAVAGALTQ	28	Hymenochirin-4B	No entry found	Not found	Not found	Hymenochirus boettgeri	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22497805	Peptides. 2012 Jun;35(2):269-275.	Mechkarska M, Prajeep M, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.	The hymenochirins: A family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).	
DRAMP04658	IKIPPIVKDTLKKVAKGVLSTIAGALST	28	Hymenochirin-5B	No entry found	Not found	Not found	Hymenochirus boettgeri(Congo dwarf clawed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antimicrobial activity against both Gram-positive, Gram-negative bacteria and fungi.	Gram-positive bacterium: Staphylococcus aureus  (MIC=80 μM);##Gram-negative bacteria: Escherichia coli (MIC=40 μM);##Fungi: Candida albicans (MIC=160 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22497805	Peptides. 2012 Jun;35(2):269-275.	Mechkarska M, Prajeep M, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.	The hymenochirins: A family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).	
DRAMP04659	FKRLKKLFKKIWNWK	15	HPA3NT3(Derived from HP (2–20))	No entry found	Not found	Not found	Helicobacter pylori	Antimicrobial, Antibacterial, Anti-gram+, Anti-gram-, Antifungal	Not found	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli	[Ref.19642077] Gram-positive bacteria : Staphylococcus aureus(MIC=4 μM), Bacillus subtilis(MIC=4 μM), Listeria monocytogenes(MIC=22 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Salmonella typhimurium(MIC=2 μM), Pseudomonas aeruginosa(MIC=2 μM);##Fungi : Candida albicans(MIC=8 μM), Trichosporon beigelli(MIC=2-4 μM)	[Ref.19642077] 32% hemolysis at 50 μM , 46% hemolysis at 100 μM , 70% hemolysis at 200 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22982494##19642077	Biochim Biophys Acta. 2013 Feb;1828(2):443-454.##J Pept Sci. 2009 Sep;15(9):589-94. doi: 10.1002/psc.1155.	Lee JK, Park SC, Hahm KS, Park Y.##Gopal R, Park SC, Ha KJ, Cho SJ, Kim SW, Song PI, Nah JW, Park Y, Hahm KS	Antimicrobial HPA3NT3 peptide analogs: Placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.##Effect of Leucine and Lysine substitution on the antimicrobial activity and evaluation of the mechanism of the HPA3NT3 analog peptide.	
DRAMP04660	AKRLKKLFKKIWNWK	15	HPA3NT3-F1A (HPA3NT3 peptide analogs)	No entry found	Not found	Not found	Helicobacter pylori	Antimicrobial, Antibacterial, Anti-gram+, Anti-gram-, Antifungal	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli, Aspergillus awamori, Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus	[Ref.22982494] Gram-positive bacteria : Staphylococcus aureus(MIC=2 μM), Listeria monocytogenes(MIC=2 μM), Staphylococcus epidermidis(MIC=2-4 μM), Bacillus subtilis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Pseudomonas aeruginosa(MIC=1 μM), Primula vulgaris(MIC=4 μM), Salmonella typhimurium(MIC=1 μM);##Fungi : Candida albicans(MIC=8 μM), Trichosporon beigelii(MIC=16 μM), Aspergillus awamori(MIC=16 μM), Aspergillus flavus(MIC=16 μM), Aspergillus fumigatus(MIC=8 μM), Aspergillus parasiticus(MIC=8 μM)	[Ref.22982494] 7.1% hemolysis at 250 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22982494	Biochim Biophys Acta. 2013 Feb;1828(2):443-454. doi: 10.1016/j.bbamem.2012.09.005	Lee JK, Park SC, Hahm KS, Park Y.	Antimicrobial HPA3NT3 peptide analogs: Placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.	
DRAMP04661	FKRLKKLAKKIWNWK	15	HPA3NT3-F8A (HPA3NT3 peptide analogs)	No entry found	Not found	Not found	Helicobacter pylori	Antimicrobial, Antibacterial, Anti-gram+, Anti-gram-, Antifungal	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli, Aspergillus awamori, Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus	[Ref.22982494] Gram-positive bacteria : Staphylococcus aureus(MIC=4 μM), Listeria monocytogenes(MIC=2 μM), Staphylococcus epidermidis(MIC=2-4 μM), Bacillus subtilis(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Pseudomonas aeruginosa(MIC=2 μM), Primula vulgaris(MIC=4 μM), Salmonella typhimurium(MIC=2 μM);##Fungi : Candida albicans(MIC=8 μM), Trichosporon beigelii(MIC=16 μM), Aspergillus awamori(MIC=16 μM), Aspergillus flavus(MIC=16 μM), Aspergillus fumigatus(MIC=8 μM), Aspergillus parasiticus(MIC=8 μM)	[Ref.22982494] 4.6% hemolysis at 250 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22982494	Biochim Biophys Acta. 2013 Feb;1828(2):443-454. doi: 10.1016/j.bbamem.2012.09.005	Lee JK, Park SC, Hahm KS, Park Y.	Antimicrobial HPA3NT3 peptide analogs: Placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.	
DRAMP04662	AKRLKKLAKKIWNWK	15	HPA3NT3-F1AF8A (HPA3NT3 peptide analogs)	No entry found	Not found	Not found	Helicobacter pylori	Antimicrobial, Antibacterial, Anti-gram+, Anti-gram-, Antifungal	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli, Aspergillus awamori, Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus	[Ref.22982494] Gram-positive bacteria : Staphylococcus aureus(MIC=16 μM), Listeria monocytogenes(MIC=2 μM), Staphylococcus epidermidis(MIC=16 μM), Bacillus subtilis(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(MIC=32 μM), Pseudomonas aeruginosa(MIC=2 μM), Primula vulgaris(MIC=4 μM), Salmonella typhimurium(MIC=2 μM);##Fungi : Candida albicans(MIC=16 μM), Trichosporon beigelii(MIC=32 μM), Aspergillus awamori(MIC=16 μM), Aspergillus flavus(MIC=32 μM), Aspergillus fumigatus(MIC=4 μM), Aspergillus parasiticus(MIC=8 μM)	[Ref.22982494] 0% hemolysis at 250 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22982494	Biochim Biophys Acta. 2013 Feb;1828(2):443-454. doi: 10.1016/j.bbamem.2012.09.005	Lee JK, Park SC, Hahm KS, Park Y.	Antimicrobial HPA3NT3 peptide analogs: Placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.	
DRAMP04663	AKRLKKLAKKIWKWL	15	HPA3NT3-A1 (HPA3NT3 peptide analogs)	No entry found	Not found	Not found	Helicobacter pylori	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli, Aspergillus awamori, Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus	[Ref.22982494] Gram-positive bacteria : Staphylococcus aureus(MIC=16 μM), Listeria monocytogenes(MIC=16 μM), Staphylococcus epidermidis(MIC=8 μM), Bacillus subtilis(MIC=8 μM);##Gram-negative bacteria : Escherichia coli(MIC=32 μM), Pseudomonas aeruginosa(MIC=32 μM), Primula vulgaris(MIC=8-16 μM), Salmonella typhimurium(MIC=8 μM);##Fungi : Candida albicans(MIC=16 μM), Trichosporon beigelii(MIC>128 μM), Aspergillus awamori(MIC=64 μM), Aspergillus flavus(MIC=64 μM), Aspergillus fumigatus(MIC=16 μM), Aspergillus parasiticus(MIC=16 μM)	[Ref.22982494] 20.9% hemolysis at 250 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22982494	Biochim Biophys Acta. 2013 Feb;1828(2):443-454. doi: 10.1016/j.bbamem.2012.09.005	Lee JK, Park SC, Hahm KS, Park Y.	Antimicrobial HPA3NT3 peptide analogs: Placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.	
DRAMP04664	AKRLKKLAKKIWKWK	15	HPA3NT3-A2 (HPA3NT3 peptide analogs)	No entry found	Not found	Not found	Helicobacter pylori	Antimicrobial, Antibacterial, Anti-gram+, Anti-gram-, Antifungal	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli, Aspergillus awamori, Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus	[Ref.22982494] Gram-positive bacteria : Staphylococcus aureus(MIC=4 μM), Listeria monocytogenes(MIC=2 μM), Staphylococcus epidermidis(MIC=2-4 μM), Bacillus subtilis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Pseudomonas aeruginosa(MIC=2 μM), Primula vulgaris(MIC=2-4 μM), Salmonella typhimurium(MIC=2 μM);##Fungi : Candida albicans(MIC=8 μM), Trichosporon beigelii(MIC=16 μM), Aspergillus awamori(MIC=8 μM), Aspergillus flavus(MIC=8 μM), Aspergillus fumigatus(MIC=4 μM), Aspergillus parasiticus(MIC=8 μM)	[Ref.22982494] 0% hemolysis at 250 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22982494##32781586	Biochim Biophys Acta. 2013 Feb;1828(2):443-454.  doi: 10.1016/j.bbamem.2012.09.005##Int J Mol Sci. 2020 Aug 6;21(16):5632. doi: 10.3390/ijms21165632	Lee JK, Park SC, Hahm KS, Park Y.##Lee JK, Park Y.	Antimicrobial HPA3NT3 peptide analogs: Placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.##All d-Lysine Analogues of the Antimicrobial Peptide HPA3NT3-A2 Increased Serum Stability and without Drug Resistance.	
DRAMP04666	KKSLLAKAKNFGGKVITIFKA	21	LtTx-1a	No entry found	Not found	Not found	Lachesana tarabaevi	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23088912	Biochim Biophys Acta. 2013 Feb;1828(2):724-731.	Kuzmenkov AI, Fedorova IM, Vassilevski AA, Grishin EV.	Cysteine-rich toxins from Lachesana tarabaevi spider venom with amphiphilic C-terminal segments.	
DRAMP04667	GIGAILKVLSTGLPALISWIKRKRQQ	26	Melt	No entry found	Not found	Not found	Lachesana tarabaevi	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23088912	Biochim Biophys Acta. 2013 Feb;1828(2):724-731.	Kuzmenkov AI, Fedorova IM, Vassilevski AA, Grishin EV.	Cysteine-rich toxins from Lachesana tarabaevi spider venom with amphiphilic C-terminal segments.	
DRAMP04668	VTCDVLSFEAKGIAVNHSACALHCIALRKKGGSCQNGVCVCRN	43	Coprisin	No entry found	Not found	Not found	Copris tripartitus	Antimicrobial	Not found	Not found	Not found	2LN4	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23137439	Biochim Biophys Acta. 2013 Feb;1828(2):271-283.	Lee E, Kim JK, Shin S, Jeong KW, Shin A, Lee J, Lee DG, Hwang JS, Kim Y.	Insight into the antimicrobial activities of coprisin isolated from the dung beetle, Copris tripartitus, revealed by structure?activity relationships.	
DRAMP04669	ARRRRSSSRPIRRRRPRRRTTRRRRGARRRR	31	Protamine y1	No entry found	Not found	Not found	Thunnus thynnus	Antimicrobial	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23122778	Biochim Biophys Acta. 2013 Mar;1828(3):1143-1152.	Roberts JM, Graham LL, Quinn B, Pink DA.	Modeling the surface of campylobacter fetus: Protein surface layer stability and resistance to cationic antimicrobial peptides.	
DRAMP18188	GILGKLWEGFKSIV	14	Pantinin-1 (Non-disulfide-bridged peptide 4.20, NDBP-4.20, Non-disulfide-bridged peptide 5.21, ND	R4JNJ5	 Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short an	Not found	Pandinus imperator (Emperor scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Homology	Not found	Not found		Function: Amphipathic peptide that possesses relatively strong activities against Gram-positive bacteria and a fungus, but has very weak antimicrobial activities against Gram-negative bacteria. Also exhibits very low hemolytic activities against human erythrocytes.Forms an alpha-helical membrane channel in the prey.	[Ref.23624072]Gram-positive bacteria: S.aureus (MIC=8 μM), B.magaterium (MIC=32 μM), M.luteus (MIC=32 μM ), VRE (MIC=28 μM), MRSA (MIC=14 μM);##Gram-negative bacteria: E.coli (MIC=62 μM), P.putida (MIC >87 μM), K.oxytoca (MIC >87 μM), E.cloacae (MIC=76 μM), S.enterica (MIC=72 μM);##Fungus: C.tropicalis (MIC=16 μM).	[Ref.23624072]0% hemolytic activity at 16 μM, 0% hemolytic activity at 32 μM, 20% hemolytic activity at 64 μM against human red bood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	23624072##24184590	Peptides 45:28-34(2013)##Peptides 51:35-45(2014	Zeng X.C., Zhou L., Shi W., Luo X., Zhang L., Nie Y., Wang J., Wu S.,Cao B., Cao H.##Almaaytah A., Albalas Q.	Three new antimicrobial peptides from the scorpion Pandinusimperator.##Scorpion venom peptides with no disulfide bridges: a review.	
DRAMP04673	PAAAAQAVAGLAPVAAEQ	18	Alamethicin (ALM; fungi)	No entry found	Not found	Not found	Trichoderma viride	Antimicrobial, Antibacterial, Antifungal, Antiparasitic	Not found	Alpha helix	The molecular conformation of the three crystallographically independent molecules is largely alpha-helical with a bend in the helix axis at an internal proline residue. The helix structure is highly amphipathic as most of the solvent-accessible polar atoms lie on a narrow strip of surface parallel to the helix axis.(Ref.2)	1AMT resolved by X-ray.	Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Experientia, 1967; 23: 85-86.##Nature. 1982 Nov 25;300(5890):325-330.	Meyer CE, Reusser F.##Fox RO Jr, Richards FM.	Polypeptide anti-bacterial agent isolated from Trichoderma viride.##A voltage-gated ion channel model inferred from the crystal structure of alamethicin at 1.5-A resolution.	
DRAMP04674	VYINKLTPPCGTMYYACEAV	20	Antiviral protein Y3 (Fungi)	P83477	Not found	Not found	Pleurotus citrinopileatus (Golden oyster mushroom)	Antimicrobial, Antiviral	Protein level	Not found	Not found		Miscellaneous: Has antiviral activity against Tobacco mosaic virus and antitumor activity against stomach cancer cells in vitro.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Chinese J Biochem Mol Biol 2008; 24(7):597-603.	Wu LP, Wu ZJ, Lin D, Fang F, Lin QY, Xie LH.	Characterization and amino acid sequence of y3, an antiviral protein from mushroom Coprinus comatus.	
DRAMP04675	ALSFLFLFLFVAQEIVVTEANTCEHLADTYRGVCFTDASCDDHCKNKAHLISGTCHNFKC	60	Antimicrobial defensin peptide DRR230-c	Q8H6L2	Not found	DRR230-c	Pisum sativum (Garden pea) 	Antimicrobial, Antifungal	Transcript level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##6292726	Plant Sci. 2002, 163:855-864.	Lai FM, DeLong C, Mei K, Wignes T, Fobert PR.	Analysis of the DRR230 family of pea defensins: gene expression pattern and evidence of broad host-range antifungal activity.	
DRAMP04678	DSECLKEYGGDVGFGFCAPRIYPSFCVQRCRADKGALSGKCIWGQGSNVKCLCNFCRHEP	60	Defensin-like protein 4	P80301	Belongs to the DEFL family (RTI/MTI-2 subfamily)	Not found	Brassica napus (Rape)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Function: Inhibits trypsin and chymotrypsin.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8143882	FEBS Lett. 1994 Apr 4;342(2):221-224.	Ceciliani F, Bortolotti F, Menegatti E, Ronchi S, Ascenzi P, Palmieri S.	Purification, inhibitory properties, amino acid sequence and identification of the reactive site of a new serine proteinase inhibitor from oil-rape (Brassica napus) seed.	
DRAMP04681	VIAGGXAAIIG	11	Antiviral serine protease	P86931	Not found	Not found	Eisenia foetida (Common brandling worm) (Common dung-worm)	Antimicrobial, Antiviral	Protein level	Not found	Not found		Function: Serine protease which has antiviral activity against cucumber mosaic virus and tobacco mosaic virus.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18775500	Comp Biochem Physiol B Biochem Mol Biol. 2008 Dec;151(4):381-385.	Ueda M, Noda K, Nakazawa M, Miyatake K, Ohki S, Sakaguchi M, Inouye K.	A novel anti-plant viral protein from coelomic fluid of the earthworm Eisenia foetida: purification, characterization and its identification as a serine protease.	
DRAMP04682	QGRMYQRFLRQHVDPDETGGNDHYLNLSRRNIQCPNRHEGVRFNTDIHEDLTNRRPIDEHEGVVRVTDKTEEG	73	Lactogenin	P59761	Belongs to the pancreatic ribonuclease family	Not found	Bos taurus (Bovine)	Antimicrobial, Antiviral	Protein level	Not found	Not found		"Function: Secretory RNase specific towards pyrimidine bases, with higher activity towards poly C than poly U. Inhibits cell-free translation.
Miscellaneous: Inhibits HIV-1 reverse transcriptase in vitro."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10486275	Biochem Biophys Res Commun. 1999 Sep 16;263(1):187-191.	Ye XY, Cheng KJ, Ng TB.	Isolation and characterization of angiogenin-1 and a novel protein designated lactogenin from bovine milk.	
DRAMP04683	SMIGGVMSKG	10	NADPH oxidoreductase	P84517	Not found	Not found	Bombyx mori (Silk moth)	Antimicrobial, Antiviral	Protein level	Not found	Not found		"Function: NADPH oxidoreductase. Has antiviral activity against BmNPV.
Miscellaneous: Expressed at high levels in BmNPV-resistant strains. Expressed at lower levels in moderately resistant and susceptible strains. "	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17213661	Biosci Biotechnol Biochem. 2007 Jan;71(1):200-205.	Selot R, Kumar V, Shukla S, Chandrakuntal K, Brahmaraju M, Dandin SB, Laloraya M, Kumar PG.	Identification of a soluble NADPH oxidoreductase (BmNOX) with antiviral activities in the gut juice of Bombyx mori.	
DRAMP04684	NKPEALVDYTGVXNS	15	Bacteriocin BAC-IB17	C0HJE5	Not found	Not found	Bacillus subtilis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Has bactericidal activity.
Miscellaneous: On the 2D-gel the determined pI of this protein is: 7.0, its MW is: 10.7 kDa."	Gram-positive bacteria: M. luteus, methicillin-resistant S. aureus, methicillin-sensitive S. aureus and B. stearothermophilus;##Gram- negative bacteria: E. coli, S. typhi.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (AUG-2013) to UniProtKB	Ansari A, Siddiqui NN, Zohra RR, Aman A, Qader SA.	Isolation, purification and characterization of bacteriocin (BAC-IB17) produced from Bacillus subtilis KIBGE-IB17.	
DRAMP04685	VAAGGWRPIESLNSAEVQDV	20	Cysteine proteinase inhibitor 1 (KCPI1; Phytocystatin; Plant defensin)	P86472	"Belongs to the cystatin family (Phytocystatin subfamily
)"	Not found	Actinidia chinensis (Kiwi) (Yangtao)	Not found	Protein level	Not found	Not found		Function: Specific inhibitor of papain family cysteine proteinases (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	IgE	14697268##15536427	Phytochemistry. 2004 Jan;65(1):19-30.##J Allergy Clin Immunol. 2004 Nov;114(5):1169-1175.	Rassam M, Laing WA.##Bublin M, Mari A, Ebner C, Knulst A, Scheiner O, Hoffmann-Sommergruber K, Breiteneder H, Radauer C.	Purification and characterization of phytocystatins from kiwifruit cortex and seeds.##IgE sensitization profiles toward green and gold kiwifruits differ among patients allergic to kiwifruit from 3 European countries.	
DRAMP04686	LSAGPNGGSIAKLSVK	16	Disease resistance response protein (Plant defensin)	P85900	Belongs to the BetVI family	Not found	Pseudotsuga menziesii (Douglas-fir) (Abies menziesii)	Not found	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18602030	J Proteomics. 2008 Oct 7;71(4):425-438.	Islam MA, Sturrock RN, Ekramoddoullah AK.	A proteomics approach to identify proteins differentially expressed in Douglas-fir seedlings infected by Phellinus sulphurascens.	
DRAMP04687	GSNIEVMLGLPNSDVK	16	Glucan endo-1,3-beta-glucosidase, basic vacuolar isoform (Plant defensin)	P86080	Belongs to the glycosyl hydrolase 17 family	Not found	Capsicum annuum var. annuum (Red pepper)	Antimicrobial, Antibacterial, Antifungal	Protein level	Not found	Not found		Function: Implicated in the defense of plants against pathogens (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (JUL-2008) to UniProtKB	Belchi-Navarro S, Almagro L, Pedreno MA.	No title found	
DRAMP04688	NIFNAISAAGLGNQIKVSTAIDTGVLGTSYPPSK	34	Glucan endo-1,3-beta-glucosidase	P86102	Belongs to the glycosyl hydrolase 17 family	Not found	Vitis rotundifolia (Muscadine grape)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Is thought to be an important plant defense-related product against fungal pathogens.
Miscellaneous: On the 2D-gel the determined pI of this protein is: 6, its MW is: 25 kDa."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19412582	Appl Biochem Biotechnol. 2010 Mar;160(3):932-944.	Basha SM, Mazhar H, Vasanthaiah HK.	Proteomics approach to identify unique xylem sap proteins in Pierce's disease-tolerant Vitis species.	
DRAMP04689	AFVLDADNLIPKKITFGEGSQYGYVKVEGDALSDTLEKIDYETKLVSAPSSSTIIKTTSKYHTKGDVEIKEEHVKAGKEKAAHLFKLIEGYLKDHPSEYN	100	Allergen Fra a 1	Q5ULZ4	Belongs to the BetVI family	Not found	Fragaria ananassa (Strawberry)	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: May be involved in ripening of fruits.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15507096	Allergy. 2004 Dec;59(12):1277-1284.	Karlsson AL, Alm R, Ekstrand B, Fjelkner-Modig S, Schiött A, Bengtsson U, Björk L, Hjernø K, Roepstorff P, Emanuelsson CS.	Bet v 1 homologues in strawberry identified as IgE-binding proteins and presumptive allergens.	
DRAMP04690	MREETVVYEQEESVSHGGGKHRILAELARVEQEVAFLEKELKEVENTDIVSTVCEELLSVIEKGPDPLLPLTNGPLNLGWDRWFEGPNGGEGCRC	95	Guanine nucleotide-binding protein subunit gamma 1 (Ggamma-subunit 1;Heterotrimeric G protein gam	Q9FDX9, Q9LY73	Not found	GG1	Arabidopsis thaliana (Mouse-ear cress)	Antimicrobial, Antifungal	Protein level	Not found	Not found		"Function: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein- effector interaction. Involved in the abscisic acid (ABA) and ethylene signaling pathways. Regulates acropetal transport of auxin (IAA) in roots and hypocotyls, and thus modulates root architecture (e.g. lateral root formation). The heterotrimeric G- protein controls defense responses to necrotrophic and vascular fungi probably by modulating cell wall-related genes expression; involved in resistance to fungal pathogens such as Alternaria brassicicola, Plectosphaerella cucumerina and Fusarium oxysporum.
Tissue specificity: Mostly expressed in seedlings (especially at the hypocotyl/root junction), young cauline leaves, open flowers, and floral stems, and, to a lower extent, in roots (restricted to the stele), rosette leaves (restricted to veins), siliques, and unopened floral buds. Also present in hydathods.
Developmental stage: In seedlings, first observed at the hypocotyl/root junction but later confined to the hypocotyl. In flowers, restricted to the stigm"	Fungi: Alternaria brassicicola, Plectosphaerella cucumerina and Fusarium oxysporum.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21980142##17468261	Mol Plant. 2012 Jan;5(1):98-114.##Plant Cell. 2007 Apr;19(4):1235-1250.	Delgado-Cerezo M, Sánchez-Rodríguez C, Escudero V, Miedes E, Fernández PV, Jordá L, Hernández-Blanco C, Sánchez-Vallet A, Bednarek P, Schulze-Lefert P, Somerville S, Estevez JM, Persson S, Molina A.##Trusov Y, Rookes JE, Tilbrook K, Chakravorty D, Mason MG, Anderson D, Chen JG, Jones AM, Botella JR.	Arabidopsis heterotrimeric G-protein regulates cell wall defense and resistance to necrotrophic fungi.##Heterotrimeric G protein gamma subunits provide functional selectivity in Gbetagamma dimer signaling in Arabidopsis.	
DRAMP04691	GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD	32	Parigidin-br1	B3EWF1	Belongs to the cyclotide family (Bracelet subfamily)	Not found	Palicourea rigida	Toxin	Protein level	Not found	Not found		"Function: Probably participates in a plant defense mechanism. Reduces growth of and increases mortality in larvae of D.saccharalis. Kills cultured SF-9 cells of S.frugiperda probably by disrupting plasma membranes. Has hemolytic activity against human erythrocytes. Has no antibacterial activity against E.coli strain ATCC 8739 and S.aureus strain ATCC 25923.
Tissue specificity: Expressed in leaves, flowers, peduncles and seeds (at protein level).
PTM: This is a cyclic peptide."	[Swiss_Prot Entry B3EWF1]No antibacterial activity against E.coli strain ATCC 8739 and S.aureus strain ATCC 25923	[Ref.22074926] It has 28% and 41% hemolysis at 20 μM and 40 μM against human red blood cells.	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys6 and Cys22,Cys10 and Cys24,Cys15 and Cys29.	L	[Ref.22074926] It exhibited cytotoxic effects on SF-9 cells with CC50 values to be 1.7 μm at 24 h, 10.3 μm at 48 h and 73.1 μm at 72 h.	Not found	22074926	J Biol Chem. 2012 Jan 2;287(1):134-147.	Pinto MF, Fensterseifer IC, Migliolo L, Sousa DA, de Capdville G, Arboleda-Valencia JW, Colgrave ML, Craik DJ, Magalhães BS, Dias SC, Franco OL.	Identification and structural characterization of novel cyclotide with activity against an insect pest of sugar cane.	
DRAMP04692	GVFTHESQETSVIAPARLFKALFLDSDNLIQKVLPQAIKSTEIIEGNGGP	50	Major pollen allergen Que a 1 (Que a 1; Plant defensin)	P85126	Belongs to the BetVI family	Not found	Quercus alba (White oak)	Not found	Protein level	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	IgE	PubMed ID is not available	Allergy, 2008,146:203-211.	Moverare R., Everberg H., Carlsson R., Holtz A., Thunberg R., Olsson P., Brostedt P., Hoegbom E.	Purification and characterization of the major oak pollen allergenQue a 1 for use in component resolved diagnostics using ImmunoCAP.	
DRAMP04693	GSPRTEYEACRVRCQVAEHGVERQRRCQQVCEKRLREREGRRE	43	Luffin P1c (one chain of ribosome-inactivating protein luffin P1; Plant defensin)	P56568, Q8GRS9	Not found	Not found	Luffa aegyptiaca (Sponge gourd) (Luffa cylindrica)	Antimicrobial, Antiviral, Toxin	Protein level	Alpha helix	Nuclear magnetic resonance spectroscopy revealed that the Luffin P1 comprises a helix-loop-helix motif, with the two alpha helices tightly associated by two disulfide bonds.(Ref.2)	2L37 resolved by NMR.	Function: Inhibits protein synthesis in animal cells.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys10 and Cys31,Cys14 and Cys27.	L	[Ref.21195767] It exhibited ytotoxicity against uninfected C8166 cell line (IC50=235 μM). EC50 of the inhibition of syncytia formation and p24 antigen production were 50 μM (262 μg/ml) and 58 μM (306 μg/ml).	Not found	9214759##21195767	Biosci Biotechnol Biochem. 1997 Jun;61(6):984-988.##J Struct Biol. 2011 Apr;174(1):164-172.	Kimura M, Park SS, Sakai R, Yamasaki N, Funatsu G.##Ng YM, Yang Y, Sze KH, Zhang X, Zheng YT, Shaw PC.	Primary structure of 6.5k-arginine/glutamate-rich polypeptide from the seeds of sponge gourd (Luffa cylindrica).##Structural characterization and anti-HIV-1 activities of arginine/glutamate-rich polypeptide Luffin P1 from the seeds of sponge gourd (Luffa cylindrica).	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(N)=O)NC2=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP04694	VIIYELNLQGTTKAQYSTILKQLRDDIKDPNLXYGXXDYS	40	Ribosome-inactivating protein saporin-1 (SAP-1; SO-4; rRNA N-glycosidase; Plant defense)	P98185	Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily)	SAP1	Saponaria officinalis (Common soapwort) (Lychnis saponaria)	Toxin	Protein level	Not found	Not found		Function: Ribosome-inactivating protein of type 1, inhibits protein synthesis in animal cells (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2753596	Int J Pept Protein Res. 1989 Apr;33(4):263-267.	Montecucchi PC, Lazzarini AM, Barbieri L, Stirpe F, Soria M, Lappi D.	N-terminal sequence of some ribosome-inactivating proteins.	
DRAMP04695	ANIVFDVESATTGTYSTFLTSF	22	Dioicin-1 (Ribosome-inactivating protein; rRNA N-glycosidase; Plant defense)	P86144	Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily)	Not found	Phytolacca dioica (Bella sombra tree) (Phytolacca arborea)	Toxin	Protein level	Not found	Not found		Function: Nicks pBR322 dsDNA. Has adenine polynucleotide glycosidase activity on herring sperm ssDNA.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18704492	Planta. 2008 Nov;228(6):963-975.	Parente A, Conforto B, Di Maro A, Chambery A, De Luca P, Bolognesi A, Iriti M, Faoro F.	Type 1 ribosome-inactivating proteins from Phytolacca dioica L. leaves: differential seasonal and age expression, and cellular localization.	
DRAMP04696	DVTFSLLGANTKSYAAFITNFRKDVASEKK	30	Ribosome-inactivating protein momorcochin-S (rRNA N-glycosidase; Plant defense)	P20655	Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily)	Not found	Momordica cochinchinensis (Spiny bitter cucumber)	Toxin	Protein level	Not found	Not found		"Function: Inactivates eukaryotic 60S ribosomal subunits.
PTM: Glycosylated."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2597699	Biochim Biophys Acta. 1989 Dec 8;993(2-3):287-292.	Bolognesi A, Barbieri L, Carnicelli D, Abbondanza A, Cenini P, Falasca AI, Dinota A, Stirpe F.	Purification and properties of a new ribosome-inactivating protein with RNA N-glycosidase activity suitable for immunotoxin preparation from the seeds of Momordica cochinchinensis.	
DRAMP04697	DVTFSMLGANGATYYQFF	18	Ribosome-inactivating protein momorgrosvin (rRNA N-glycosidase; Plant defense)	P83323	Belongs to the ribosome-inactivating protein family (Type 1 RIP subfamily)	Not found	Siraitia grosvenorii (Monk's fruit) (Luo han guo)	Toxin	Protein level	Not found	Not found		"Function: Inhibits protein synthesis in the rabbit reticulocyte lysate system.
Catalytic activity: Endohydrolysis of the N-glycosidic bond at one specific adenosine on the 28S rRNA.
PTM: Glycosylated."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11205869	Life Sci. 2001 Jan 5;68(7):773-784.	Tsang KY, Ng TB.	Isolation and characterization of a new ribosome inactivating protein, momorgrosvin, from seeds of the monk's fruit Momordica grosvenorii.	
DRAMP04698	FLKGIIDTVSNWL	13	Amphipathic peptide CT1 (VsCT1; Non-disulfide-bridged peptide 5.11, NDBP-5.11)	I0DEB5	Belongs to the scorpion NDBP 5 family	Not found	Vaejovis subcristatus (Scorpion) (Thorellius subcristatus)	Antimicrobial	Transcript level	Not found	Not found		Function: Amphipatic peptide that shows no antibacterial activity even at 50 uM but shows hemolytic activity against human erythrocytes.	[Swiss_Prot Entry I0DEB5]No antibacterial activity even at 50 µM	[Ref.22342498]10% hemolytic activity at 10 μM and 50 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	22342498	Peptides. 2012 Apr;34(2):290-295.	Ramírez-Carreto S, Quintero-Hernández V, Jiménez-Vargas JM, Corzo G, Possani LD, Becerril B, Ortiz E.	Gene cloning and functional characterization of four novel antimicrobial-like peptides from scorpions of the family Vaejovidae.	
DRAMP04699	FLKGIIDTVSKLF	13	Amphipathic peptide CT2 (VsCT2; Non-disulfide-bridged peptide 5.12, NDBP-5.12)	I0DEB6	Belongs to the scorpion NDBP 5 family	Not found	Vaejovis subcristatus (Scorpion) (Thorellius subcristatus)	Antimicrobial	Transcript level	Not found	Not found		Function: Amphipatic peptide that shows no antibacterial activity even at 50 µM but shows hemolytic activity against human erythrocytes.	[Swiss_Prot Entry I0DEB6]No antibacterial activity even at 50 µM	[Ref.22342498]5% hemolytic activity at 12.5 μM, 25% hemolytic activity at 25 μM, 80% hemolytic activity at 50 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrane	22342498	Peptides. 2012 Apr;34(2):290-295.	Ramírez-Carreto S, Quintero-Hernández V, Jiménez-Vargas JM, Corzo G, Possani LD, Becerril B, Ortiz E.	Gene cloning and functional characterization of four novel antimicrobial-like peptides from scorpions of the family Vaejovidae.	
DRAMP04700	DLWQFGKMILKVAGKLPFPYYGAYGCYCGWGGRGKPKDPTDRCCFVHDCC	50	Basic phospholipase A2 BnpTX-1 (BnPTx-I, svPLA2; Phosphatidylcholine 2-acylhydrolase)	P0DM51	Belongs to the phospholipase A2 family (Group II subfamily D49 sub-subfami	Not found	Bothrops pauloensis (Neuwied's lancehead) (Bothrops neuwiedipauloensis)	Antimicrobial, Antibacterial, Antiparasitic, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Snake venom phospholipase A2 (PLA2). In vitro, shows anticoagulant activity and induces cytotoxicity when tested on C2C12 myoblasts/myotubes. In vivo, when tested on mice, induces myotoxicity (intramuscular injection), edema (injection in the subplantar region) and lethality. Also induces neurotoxic effect on mouse neuromuscular preparations and has bactericidal activity on the Gram-negative bacteria E.coli (ATCC29648) and the Gram- positive S.aureus (ATCC 25923). The catalytic and anticoagulant activities of BnpTX-I are higher than those of BnpTX-II. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.
Toxic Dose: LD(50) is 5.1 +/- 1.3 mg/kg by intraperitoneal injection into mice. LD(50) is 2.3 +/- 0.8 mg/kg by intravenous injection into mice.
Miscellaneous: Has a pI of approximately 7.8 and about 121 amino acids (PubMed:15302537).
PTM: Contains seven disulfide bonds."	Gram-negative bacterium: E. coli ATCC29648 and Gram-positive bacterium: S. aureus ATCC 25923.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15302537	Toxicon. 2004 Sep 1;44(3):305-314.	Rodrigues VM, Marcussi S, Cambraia RS, de Araújo AL, Malta-Neto NR, Hamaguchi A, Ferro EA, Homsi-Brandeburgo MI, Giglio JR, Soares AM.	Bactericidal and neurotoxic activities of two myotoxic phospholipases A2 from Bothrops neuwiedi pauloensis snake venom.	
DRAMP04701	SLLELGKMILQETGKMPSKSYGAYGCNCGVLGR	33	Phospholipase A2 homolog (BmarPLA2, svPLA2 homolog)	P0DI92	Belongs to the phospholipase A2 family (Group II subfamily)	Not found	Bothrops marajoensis (Marajo lancehead)	Antimicrobial, Antibacterial, Antiparasitic	Protein level	Not found	Not found		"Function: Snake phospholipase A2 homolog that lacks enzymatic activity. May display myotoxin activity. Does not show antimicrobial activity.
PTM: Contains seven disulfide bonds (By similarity)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19944711	Toxicon. 2010 Apr 1;55(4):795-804.	Costa Torres AF, Dantas RT, Toyama MH, Diz Filho E, Zara FJ, Rodrigues de Queiroz MG, Pinto Nogueira NA, Rosa de Oliveira M, de Oliveira Toyama D, Monteiro HS, Martins AM.	Antibacterial and antiparasitic effects of Bothrops marajoensis venom and its fractions: Phospholipase A2 and L-amino acid oxidase.	
DRAMP04702	VAVKATTTEEETEIPAK	17	38 kDa autolysin (Beta-glycosidase; Peptidoglycan hydrolase)	P81528	Not found	lytA	Mycobacterium phlei	Antimicrobial, Toxin	Protein level	Not found	Not found		"Function: Hydrolyzes the cell walls of mycobacteria. May play an important role in cell wall growth and cell separation.
Biophysicochemical properties: pH dependence (Optimum pH is 7.5).
PTM: The N-terminus is blocked (Probable)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10206696	Microbiology. 1999 Jan;145 ( Pt 1):169-176.	Li ZS, Beveridge TJ, Betts J, Clarke AJ.	Partial characterization of a major autolysin from Mycobacterium phlei.	
DRAMP04703	YKQCHKKGGHCFPKEKICIPPSSDFGKMDCRWRWKCCKKGSGK	43	Crotamine CRO1	O57540	Belongs to the crotamine-myotoxin family	CRO1	Crotalus durissus terrificus (South American rattlesnake)	Antimicrobial, Toxin	Transcript level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10484745	Toxicon. 1999 Jul;37(7):973-984.	Rádis-Baptista G, Oguiura N, Hayashi MA, Camargo ME, Grego KF, Oliveira EB, Yamane T.	Nucleotide sequence of crotamine isoform precursors from a single South American rattlesnake (Crotalus durissus terrificus).	
DRAMP04704	KQCHKKGGHCFPKEKICIPPSSDFGKMDCRWRWKCCKKGSGK	42	Crotamine CRO3	O73799	Belongs to the crotamine-myotoxin family	CRO3	Crotalus durissus terrificus (South American rattlesnake)	Antimicrobial, Toxin	Transcript level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10484745	Toxicon. 1999 Jul;37(7):973-984.	Rádis-Baptista G, Oguiura N, Hayashi MA, Camargo ME, Grego KF, Oliveira EB, Yamane T.	Nucleotide sequence of crotamine isoform precursors from a single South American rattlesnake (Crotalus durissus terrificus).	
DRAMP04705	YKRCHIKGGHCFPKEKICIPPSSDFGKMDCPWRRKCCKKGSG	42	Myotoxin-1 (Crotamine-1)	P24331	Belongs to the crotamine-myotoxin family	Not found	Crotalus durissus terrificus (South American rattlesnake)	Antimicrobial, Toxin	Transcript level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2389256	Toxicon. 1990;28(5):575-585.	Smith LA, Schmidt JJ.	Cloning and nucleotide sequences of crotamine genes.	
DRAMP04706	YKRCHKKEGHCFPKTVICLPPSSDFGKMDCRWKWKCCKKGSVN	43	Myotoxin-1 (Myotoxin I)	P12028	Belongs to the crotamine-myotoxin family	Not found	Crotalus oreganus concolor (Midget faded rattlesnake) (Crotalusviridis concolor)	Antimicrobial, Toxin	Protein level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3629618	Toxicon. 1987;25(6):677-680.	Bieber AL, McParland RH, Becker RR.	Amino acid sequences of myotoxins from Crotalus viridis concolor venom.	
DRAMP04707	YKQCHKKGGHCFPKEKICIPPSSDLGKMDCRWKWKCCKKGSG	42	Myotoxin-A (Myotoxin-1)	P01476	Belongs to the crotamine-myotoxin family	Not found	Crotalus viridis viridis (Prairie rattlesnake)	Antimicrobial, Toxin	Protein level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).(Ref.2)
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds.(Ref.1)
Toxic Dose: LD(50) is 3.0 mg/kg by intramuscular injection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Sarcoplasmic reticulum calcium-ATPase (Ref.3)	570412##2048143##1329655	Biochemistry. 1979 Feb 20;18(4):678-684.##Toxicon. 1991;29(2):265-268.##Arch Biochem Biophys. 1992 Nov 1;298(2):325-331.	Fox JW, Elzinga M, Tu AT.##Aird SD, Kruggel WG, Kaiser II.##Baker B, Utaisincharoen P, Tu AT.	Amino acid sequence and disulfide bond assignment of myotoxin a isolated from the venom of Prairie rattlesnake (Crotalus viridis viridis).##Multiple myotoxin sequences from the venom of a single prairie rattlesnake (Crotalus viridis viridis).##Structure-function relationship of myotoxin a using peptide fragments.	
DRAMP04708	YKRCHIKGGHCFPKEKICIPPSSDFGKMDCPWRRKSLKKGSG	42	Myotoxin-2 (Crotamine-2 Fragment)	P24332	Belongs to the crotamine-myotoxin family	Not found	Crotalus durissus terrificus (South American rattlesnake)	Antimicrobial, Toxin	Transcript level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2389256	Toxicon. 1990;28(5):575-585.	Smith LA, Schmidt JJ.	Cloning and nucleotide sequences of crotamine genes.	
DRAMP04709	YKRCHKKGGHCFPKEKICTPPSSDFGKMDCRWKWKCCKKGSVN	43	Myotoxin-2 (Myotoxin II)	P12029	Belongs to the crotamine-myotoxin family	Not found	Crotalus oreganus concolor (Midget faded rattlesnake) (Crotalusviridis concolor)	Antimicrobial, Toxin	Protein level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	3629618	Toxicon. 1987;25(6):677-680.	Bieber AL, McParland RH, Becker RR.	Amino acid sequences of myotoxins from Crotalus viridis concolor venom.	
DRAMP04710	YKRCHKKEGHCFPKTVICLPPSSDFGKMDCRWKWKCCKKGSVNNA	45	Myotoxin-2	P63175, P19861	Belongs to the crotamine-myotoxin family	Not found	Crotalus viridis viridis (Prairie rattlesnake)	Antimicrobial, Toxin	Protein level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2253781	FEBS Lett. 1990 Nov 12;274(1-2):43-47.	Griffin PR, Aird SD.	A new small myotoxin from the venom of the prairie rattlesnake (Crotalus viridis viridis).	
DRAMP04711	YKRCHIKGGHCFPKGKICIPPSSDFGKMDCPWRRKCCKKGSG	42	Myotoxin-3 (Crotamine-3)	P24333	Belongs to the crotamine-myotoxin family	Not found	Crotalus durissus terrificus (South American rattlesnake)	Antimicrobial, Toxin	Transcript level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2389256	Toxicon. 1990;28(5):575-585.	Smith LA, Schmidt JJ.	Cloning and nucleotide sequences of crotamine genes.	
DRAMP04712	YKRCHKKGGHCFPKTVICLPPSSDFGKMDCRWKWKCCKKGSVNNA	45	Myotoxin-3	P63176, P19861	Belongs to the crotamine-myotoxin family	Not found	Crotalus viridis viridis (Prairie rattlesnake)	Antimicrobial, Toxin	Protein level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2253781	FEBS Lett. 1990 Nov 12;274(1-2):43-47.	Griffin PR, Aird SD.	A new small myotoxin from the venom of the prairie rattlesnake (Crotalus viridis viridis).	
DRAMP04713	YKQCHKKGGHCFPKEKICIPPSSDFGKMDCRWRWKCCKKRSGK	43	Myotoxin-4 (Crotamine-4 Fragment)	P24334	Belongs to the crotamine-myotoxin family	Not found	Crotalus durissus terrificus (South American rattlesnake)	Antimicrobial, Toxin	Transcript level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2389256	Toxicon. 1990;28(5):575-585.	Smith LA, Schmidt JJ.	Cloning and nucleotide sequences of crotamine genes.	
DRAMP04714	YKRCHIKGGHCFPKEKLICIPPSSDIGKMDCPWKRKCCKKRS	42	Crotamine-IV-2	P86193	Belongs to the crotamine-myotoxin family	Not found	Crotalus durissus cumanensis (South American rattlesnake)	Antimicrobial, Toxin	Protein level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, and hind limb paralysis (By similarity). It also induces potent blockade of neuromuscular transmission in young chicken biventer cervicis preparation and potent myotoxic effect. In mice, it induces myonecrosis, upon intramuscular or subcutaneous injections.
Tissue specificity: Expressed by the venom gland.
Toxic Dose: LD(50) is 0.07 mg/kg by subcutaneous injection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17828447	Protein J. 2007 Dec;26(8):533-540.	Ponce-Soto LA, Martins-de-Souza D, Novello JC, Marangoni S.	Structural and biological characterization of two crotamine isoformsIV-2 and IV-3 isolated from the Crotalus durissus cumanensis venom.	
DRAMP04715	YKQCHKKGGHCFPKEVLICIPPSSDFGKMDCRWKRKCCKKRS	42	Crotamine-IV-3	P86194	Belongs to the crotamine-myotoxin family	Not found	Crotalus durissus cumanensis (South American rattlesnake)	Antimicrobial, Toxin	Protein level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, and hind limb paralysis (By similarity). It also induces potent blockade of neuromuscular transmission in young chicken biventer cervicis preparation and potent myotoxic effect. In mice, it induces myonecrosis, upon intramuscular or subcutaneous injections.
Tissue specificity: Expressed by the venom gland.
Toxic Dose: LD(50) is 0.06 mg/kg by subcutaneous injection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17828447	Protein J. 2007 Dec;26(8):533-540.	Ponce-Soto LA, Martins-de-Souza D, Novello JC, Marangoni S.	Structural and biological characterization of two crotamine isoformsIV-2 and IV-3 isolated from the Crotalus durissus cumanensis venom.	
DRAMP04716	YKRCHKKGGHCFPKTVICLPPSSDFGKMDCRWKWKCCKKGSVNNAISI	48	Myotoxin (Crotamine-4; Toxic peptide C)	P01477, G9DCI6	Belongs to the crotamine-myotoxin family	Not found	Crotalus oreganus helleri (Southern pacific rattlesnake) (Crotalusviridis helleri)	Antimicrobial, Toxin	Protein level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).
Tissue specificity: Expressed by the venom gland.
Toxic Dose: LD(50) is 1.96 mg/kg by subcutaneous injection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	694946	Toxicon. 1978;16(5):431-441.	Maeda N, Tamiya N, Pattabhiraman TR, Russell FE.	Some chemical properties of the venom of the rattlesnake, Crotalus viridis helleri.	
DRAMP04717	YKRCHKKGGHCFPKTVICLPPSSDFGKMDCRWRWKCCKKGSVNNAISI	48	Myotoxin (CAM-toxin)	P24330, F8S0Z6, J3RY57	Belongs to the crotamine-myotoxin family	Not found	Crotalus adamanteus (Eastern diamondback rattlesnake)	Antimicrobial, Toxin	Protein level	Not found	Not found		"Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor. It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism (By similarity).
Miscellaneous: This myotoxin is the most abundant transcript in the venom of the specimen analyzed (PubMed:23025625). Individuals of C. adamanteus from populations in southern and central Florida lack this toxin in their venoms (PubMed:23025625).
Tissue specificity: Expressed by the venom gland.(Ref.3)
Toxic Dose: LD(50) is 0.96 mg/kg by subcutaneous injection.(Ref.1)"	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23025625##1862521	BMC Genomics. 2012 Jul 16;13:312.##Toxicon. 1991;29(4-5):461-468.	Rokyta DR, Lemmon AR, Margres MJ, Aronow K.##Samejima Y, Aoki Y, Mebs D.	The venom-gland transcriptome of the eastern diamondback rattlesnake (Crotalus adamanteus).##Amino acid sequence of a myotoxin from venom of the eastern diamondback rattlesnake (Crotalus adamanteus).	
DRAMP04718	YKQCHKKGGHCFPKEKICIPPSSDFGKMDCRWRWKCCKKGSG	42	Crotamine Ile-19 (CRO_Ile-19)	P63327	Belongs to the crotamine-myotoxin family	Not found	Crotalus durissus ruruima (South American rattlesnake) (Mt. Roraimarattlesnake)	Antimicrobial, Toxin	Protein level	Combine helix and strand structure	The crystal structure of the myotoxic, cell-penetrating, basic polypeptide crotamine isolated from the venom of Crotalus durissus terrificus has been determined by single-wavelength anomalous dispersion techniques and refined at 1.7 Å resolution. The structure reveals distinct cationic and hydrophobic surface regions that are located on opposite sides of the molecule. (Ref.2)	4GV5 resolved by X-ray	Function: Cationic peptide that possess multiple functions. It acts as a cell-penetrating peptide (CPP), and as a potent voltage- gated potassium channel (Kv) inhibitor and exhibits antimicrobial activities (By similarity). It also elicts a short-lasting hyperextension of the hind limb. It does not causes observable tissue damage (whereas the whole venom causes severe myonecrosis accompanied by edema and hemorrhage).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available##24100315	Toxicon 1993,31:166-166.##Acta Crystallogr D Biol Crystallogr. 2013 Oct;69(Pt 10):1958-1964.	Dos Santos M.C., Morhy L., Ferreira L.C.L., Oliveira E.B.##Coronado MA, Gabdulkhakov A, Georgieva D, Sankaran B, Murakami MT, Arni RK, Betzel C.	Purification and properties of a crotamine analog from Crotalus durissus ruruima venom.##Structure of the polypeptide crotamine from the Brazilian rattlesnake Crotalus durissus terrificus.	
DRAMP18097	MPFHYFPKLNPITWIPGWIPGLGKDRCLLPKVTGPCKASLTRYYYDKDTKACVEFIYGGCRGNRNNFKRKDECEKACTDH	80	Kunitz-type serine protease inhibitor U1-aranetoxin-Av1a (U1-AATX-Av1a; Toxin 1; AvTox-1)	Q8T3S7	Belongs to the venom Kunitz-type family	Not found	Araneus ventricosus (Orbweaver spider) (Epeira ventricosa)	Insecticidal	Transcript level	Not found	Not found		Function: Putative insecticidal toxin that may inhibit trypsin.##Miscellaneous: Since this peptide has no sequence signal, its secretion is unsure.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Int. J. Ind. Entomol. 4:43-49 (2002)	Jung E.H., Lee K.S. , Han J.H., Je Y.H., Chang J.H., Roh J.Y., Sohn H.D., Jin B.R.	Molecular cloning of two cDNAs encoding an insecticidal toxin fromthe spider, Araneus ventricosus, and construction of a recombinantbaculovirus expressing a spider toxin.	
DRAMP18098	MALALLGLTIKPEHVPEGTGKAVADVEALACDPAQCMRSCPFNPFLNQYGGICKNGQCVCVKPS	64	U2-aranetoxin-Av1a (U2-AATX-Av1a; Toxin 2; AvTox-2)	Q8T3S6	Not found	Not found	Araneus ventricosus (Orbweaver spider) (Epeira ventricosa)	Insecticidal	Transcript level	Not found	Not found		Function: Putative insecticidal toxin.##Miscellaneous: Since this peptide has no sequence signal, its secretion is unsure.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Int. J. Ind. Entomol. 4:43-49 (2002).	Jung E.H., Lee K.S. , Han J.H., Je Y.H., Chang J.H., Roh J.Y., Sohn H.D., Jin B.R.	Molecular cloning of two cDNAs encoding an insecticidal toxin fromthe spider, Araneus ventricosus, and construction of a recombinantbaculovirus expressing a spider toxin.	
DRAMP18099	ECAAKNKRCADWAGPWCCEGLYCSCRSYPGCMCRPNS	37	Beta/delta-agatoxin-7 (Mu-2Aga_01; U3-agatoxin-Ao1a; U3-AGTX-Ao1a)	Q5Y4V8	Belongs to the beta/delta-agatoxin family	Not found	Agelena orientalis (Spider)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that modulates the insect Nav channel (DmNaV1/tipE (para/tipE)) in a unique manner, with both the activation and inactivation processes being affected. The voltage dependence of activation is shifted toward more hyperpolarized potentials (analogous to site 4 toxins) and a non- inactivating persistent sodium current is induced (site 3-like action). Interestingly, both effects take place in a voltage- dependent manner, producing a bell-shaped curve between -80 and 0 mV. Compared to beta/delta-agatoxin-1 to -3, this toxin appears to affect the insect sodium channel only weakly.##Miscellaneous: Does not affect mammalian sodium channels (Nav) (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15688451##20385552	Proteins 59:131-140 (2005).##J. Biol. CheM. 285:18545-18554 (2010).	Kozlov S. A., Malyavka A., McCutchen B., Lu A., Schepers E., Herrmann R., Grishin E.V.##Billen B., Vassilevski A., Nikolsky A., Debaveye S. , Tytgat J., Grishin E.	A novel strategy for the identification of toxinlike structures inspider venoM. ##Unique bell-shaped voltage-dependent modulation of Na+ channel gatingby novel insect-selective toxins from the spider Agelena orientaliS. 	
DRAMP18100	GCVGENQQCADWAGPHCCSGYYCTCRYFPKCICRKDS	37	Beta/delta-agatoxin-3 (Mu-2Aga_04; U3-agatoxin-Ao1c; U3-AGTX-Ao1c)	Q5Y4V6	Belongs to the beta/delta-agatoxin family	Not found	Agelena orientalis (Spider)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that modulates the insect Nav channel (DmNaV1/tipE (para/tipE)) in a unique manner, with both the activation and inactivation processes being affected. The voltage dependence of activation is shifted toward more hyperpolarized potentials (analogous to site 4 toxins) and a non- inactivating persistent sodium current is induced (site 3-like action). Interestingly, both effects take place in a voltage- dependent manner, producing a bell-shaped curve between -80 and 0 mV. Compared to beta/delta-agatoxin-1 to -3, this toxin appears to affect the insect sodium channel only weakly.##Miscellaneous: Does not affect mammalian sodium channels (Nav) (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15688451##20385552	Proteins 59:131-140 (2005).##J. Biol. CheM. 285:18545-18554 (2010).	Kozlov S. A., Malyavka A., McCutchen B., Lu A., Schepers E., Herrmann R., Grishin E.V.##Billen B., Vassilevski A., Nikolsky A., Debaveye S. , Tytgat J., Grishin E.	A novel strategy for the identification of toxinlike structures inspider venoM. ##Unique bell-shaped voltage-dependent modulation of Na+ channel gatingby novel insect-selective toxins from the spider Agelena orientaliS. 	
DRAMP18101	GDCVGESQQCADWSGPYCCKGYYCTCRYFPKCICVNDN	38	Beta/delta-agatoxin-1 (Mu-2Aga_07; U3-agatoxin-Ao1f; U3-AGTX-Ao1f)	Q5Y4V3	Belongs to the beta/delta-agatoxin family	Not found	Agelena orientalis (Spider)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that modulates the insect Nav channel (DmNaV1/tipE (para/tipE)) in a unique manner, with both the activation and inactivation processes being affected. The voltage dependence of activation is shifted toward more hyperpolarized potentials (analogous to site 4 toxins) and a non- inactivating persistent sodium current is induced (site 3-like action). Interestingly, both effects take place in a voltage- dependent manner, producing a bell-shaped curve between -80 and 0 mV. Compared to beta/delta-agatoxin-1 to -3, this toxin appears to affect the insect sodium channel only weakly.##Miscellaneous: Does not affect mammalian sodium channels (Nav) (By similarity).	Fly larvae (LD50=7 Î¼g/g).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15688451##20385552	Proteins 59:131-140 (2005).##J. Biol. CheM. 285:18545-18554 (2010).	Kozlov S. A., Malyavka A., McCutchen B., Lu A., Schepers E., Herrmann R., Grishin E.V.##Billen B., Vassilevski A., Nikolsky A., Debaveye S. , Tytgat J., Grishin E.	A novel strategy for the identification of toxinlike structures inspider venoM. ##Unique bell-shaped voltage-dependent modulation of Na+ channel gatingby novel insect-selective toxins from the spider Agelena orientaliS. 	
DRAMP18102	GGCVGESQQCADWSGPYCCKGYYCTCRYFPKCICVNDN	38	Beta/delta-agatoxin-2 (Mu-2Aga_08; U3-agatoxin-Ao1g; U3-AGTX-Ao1g)	Q5Y4V2	Belongs to the beta/delta-agatoxin family	Not found	Agelena orientalis (Spider)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that modulates the insect Nav channel (DmNaV1/tipE (para/tipE)) in a unique manner, with both the activation and inactivation processes being affected. The voltage dependence of activation is shifted toward more hyperpolarized potentials (analogous to site 4 toxins) and a non- inactivating persistent sodium current is induced (site 3-like action). Interestingly, both effects take place in a voltage- dependent manner, producing a bell-shaped curve between -80 and 0 mV. Compared to beta/delta-agatoxin-1 to -3, this toxin appears to affect the insect sodium channel only weakly.##Miscellaneous: Does not affect mammalian sodium channels (Nav) (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15688451##20385552	Proteins 59:131-140 (2005).##J. Biol. CheM. 285:18545-18554 (2010).	Kozlov S. A., Malyavka A., McCutchen B., Lu A., Schepers E., Herrmann R., Grishin E.V.##Billen B., Vassilevski A., Nikolsky A., Debaveye S. , Tytgat J., Grishin E.	A novel strategy for the identification of toxinlike structures inspider venoM. ##Unique bell-shaped voltage-dependent modulation of Na+ channel gatingby novel insect-selective toxins from the spider Agelena orientaliS. 	
DRAMP18103	GCVGENQQCADWAGLHCCSGYYCTCRYFPKCICRKDS	37	Beta/delta-agatoxin-4 (Mu-2Aaga_12; U3-agatoxin-Ao1k; U3-AGTX-Ao1k)	Q5Y4U8	Belongs to the beta/delta-agatoxin family	Not found	Agelena orientalis (Spider)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that modulates the insect Nav channel (DmNaV1/tipE (para/tipE)) in a unique manner, with both the activation and inactivation processes being affected. The voltage dependence of activation is shifted toward more hyperpolarized potentials (analogous to site 4 toxins) and a non- inactivating persistent sodium current is induced (site 3-like action). Interestingly, both effects take place in a voltage- dependent manner, producing a bell-shaped curve between -80 and 0 mV. Compared to beta/delta-agatoxin-1 to -3, this toxin appears to affect the insect sodium channel only weakly.##Miscellaneous: Does not affect mammalian sodium channels (Nav) (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15688451##20385552	Proteins 59:131-140 (2005).##J. Biol. CheM. 285:18545-18554 (2010).	Kozlov S. A., Malyavka A., McCutchen B., Lu A., Schepers E., Herrmann R., Grishin E.V.##Billen B., Vassilevski A., Nikolsky A., Debaveye S. , Tytgat J., Grishin E.	A novel strategy for the identification of toxinlike structures inspider venoM. ##Unique bell-shaped voltage-dependent modulation of Na+ channel gatingby novel insect-selective toxins from the spider Agelena orientaliS. 	
DRAMP18104	DCVGENGRCRDWYNDCCDGFYCSCRQPPYCICRNNN	36	Beta/delta-agatoxin-5 (Mu-2Aaga_13; U3-agatoxin-Ao1l; U3-AGTX-Ao1l)	Q5Y4U7	Belongs to the beta/delta-agatoxin family	Not found	Agelena orientalis (Spider)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that modulates the insect Nav channel (DmNaV1/tipE (para/tipE)) in a unique manner, with both the activation and inactivation processes being affected. The voltage dependence of activation is shifted toward more hyperpolarized potentials (analogous to site 4 toxins) and a non- inactivating persistent sodium current is induced (site 3-like action). Interestingly, both effects take place in a voltage- dependent manner, producing a bell-shaped curve between -80 and 0 mV. Compared to beta/delta-agatoxin-1 to -3, this toxin appears to affect the insect sodium channel only weakly.##Miscellaneous: Does not affect mammalian sodium channels (Nav) (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15688451##20385552	Proteins 59:131-140 (2005).##J. Biol. CheM. 285:18545-18554 (2010).	Kozlov S. A., Malyavka A., McCutchen B., Lu A., Schepers E., Herrmann R., Grishin E.V.##Billen B., Vassilevski A., Nikolsky A., Debaveye S. , Tytgat J., Grishin E.	A novel strategy for the identification of toxinlike structures inspider venoM. ##Unique bell-shaped voltage-dependent modulation of Na+ channel gatingby novel insect-selective toxins from the spider Agelena orientaliS. 	
DRAMP18105	ECVGENGHCRSWYNDCCDGYYCSCMQPPNCICRNNN	36	Beta/delta-agatoxin-6 (Mu-2Aaga_14; U3-agatoxin-Ao1m; U3-AGTX-Ao1m)	Q5Y4U6	Belongs to the beta/delta-agatoxin family	Not found	Agelena orientalis (Spider)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that modulates the insect Nav channel (DmNaV1/tipE (para/tipE)) in a unique manner, with both the activation and inactivation processes being affected. The voltage dependence of activation is shifted toward more hyperpolarized potentials (analogous to site 4 toxins) and a non- inactivating persistent sodium current is induced (site 3-like action). Interestingly, both effects take place in a voltage- dependent manner, producing a bell-shaped curve between -80 and 0 mV. Compared to beta/delta-agatoxin-1 to -3, this toxin appears to affect the insect sodium channel only weakly.##Miscellaneous: Does not affect mammalian sodium channels (Nav) (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15688451##20385552	Proteins 59:131-140 (2005).##J. Biol. CheM. 285:18545-18554 (2010).	Kozlov S. A., Malyavka A., McCutchen B., Lu A., Schepers E., Herrmann R., Grishin E.V.##Billen B., Vassilevski A., Nikolsky A., Debaveye S. , Tytgat J., Grishin E.	A novel strategy for the identification of toxinlike structures inspider venoM. ##Unique bell-shaped voltage-dependent modulation of Na+ channel gatingby novel insect-selective toxins from the spider Agelena orientaliS. 	
DRAMP18106	IFECVFSCDIKKEGKPCKPKGEKKCTGGWRCKIKLCLKI	39	U1-theraphotoxin-Ba1b (U1-TRTX-Ba1b; Venom peptide 2)	P85504	Belongs to the huwentoxin-2 family	Not found	Brachypelma ruhnaui (Mexican golden redrump tarantula) (Brachypelmaalbiceps)	Insecticidal	Protein level	Beta sheet (3 strands; 10 residues)	The three-dimensional conformation (Fig. 3B) of Ba2 consists in a three-stranded (residues 15â€“17, 29â€“32 and 35â€“38) anti-parallel beta-sheet. The first strand is connected with the second one by a large loop made of residues 19â€“28, whereas the second and third strands are connected by a Î²-turn.	2KGH resolved by NMR	Function: Has insecticidal activity.	Insect LD50=9.2 Â± 0.9 Î¼g/g	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19374957	BiochiM. BiophyS. Acta 1794:1190-1196 (2009).	Corzo G., Bernard C. , Clement H., Villegas E., Bosmans F., Tytgat J., Possani L.D., Darbon H., Alagon A.	Insecticidal peptides from the theraposid spider Brachypelmaalbiceps: an NMR-based model of Ba2.	
DRAMP18107	ILECVFSCDIKKEGKPCKPKGEKKCTGGWRCKIKLCLKI	39	U1-theraphotoxin-Ba1a (U1-TRTX-Ba1a; Venom peptide 1)	P85497	Belongs to the huwentoxin-2 family	Not found	Brachypelma ruhnaui (Mexican golden redrump tarantula) (Brachypelmaalbiceps)	Insecticidal	Protein level	Not found	Not found		Function: Has insecticidal activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (FEB-2008) to UniProtK	Corzo G., Clement H., Alagon A.	Primary structure of two insecticidal peptides from the theraposid Brachypelma ruhnaui.	
DRAMP18108	YCGLFGDLCTLDGTLACCIALELECIPLNDFVGICL	36	Asteropin-A (Asteropine-A)	P84702	Not found	Not found	Asteropus simplex (Marine sponge) (Stellettinopsis simplex)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Sialidase inhibitor. Competitively inhibits bacterial sialidases, but not viral sialidaseS. Does not inhibit glycosidases or proteaseS. Has no antitumor activity.	V. cholerae (Ki values of 340 nM), S. typhimurium (Ki values of 350 nM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16793514	CheM. Biol. 13:569-574 (2006).	Takada K., Hamada T., Hirota H., Nakao Y., Matsunaga S. , van Soest R.W.M. , Fusetani N.	Asteropine A, a sialidase-inhibiting conotoxin-like peptide from themarine sponge Asteropus simplex.	
DRAMP18109	SDCTLRNHDCTDDRHSCCRSKMFKDVCTCFYPSQAKKELCTCQQPKHLKYIEKGLQKAKDYAT	63	U2-ctenitoxin-Cs1a (U1-CNTX-Cs2a; Neurotoxic enhancer CSTX-13; U1-ctenitoxin-Cs2a; Fragments)	P83919, P83920	Belongs to the spider toxin CSTX superfamily	Not found	Cupiennius salei (Wandering spider)	Insecticidal	Protein level	Not found	Not found		Function: This toxin alone has very weak insecticidal activity, with an unknown molecular target. Acts as a neurotoxic enhancer, synergistically enhancing the neurotoxic action of omega-CNTX-Cs1a (CSTX-1) (AC P81694).	Fly (LD50=16.3 pmol/mg)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15272079##15914655	ProC. Natl. Acad. Sci. U.S. A. 101:11251-11256 (2004).##J. Exp. Biol. 208:2115-2121 (2005).	Wullschleger B., Kuhn-Nentwig L., Tromp J., Kaempfer U., Schaller J., Schuerch S. , Nentwig W.##Wullschleger B., Nentwig W., Kuhn-Nentwig L.	CSTX-13, a highly synergistically acting two-chain neurotoxicenhancer in the venom of the spider Cupiennius salei (Ctenidae).##Spider venom: enhancement of venom efficacy mediated by different synergistic strategies in Cupiennius salei.	
DRAMP18110	SSVCIPSGQPCPYNEHCCSGSCTYKENENGNTVQRCD	37	Omega-hexatoxin-Ar1a (Omega-HXTX-Ar1a; Omega-atracotoxin-Ar1a; Omega-AcTx-Ar1a)	P83580, A5A3H0	Belongs to the omega-atracotoxin type 1 family	Not found	Atrax robustus (Sydney funnel-web spider)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal toxin that reversibly and voltage- independently blocks both mid-low- (M-LVA) and high-voltage- activated (HVA) calcium channels (Cav) in cockroach DUM neuronS. Also causes a modest block of insect sodium channel currents (Nav). Induces potent excitatory symptoms, followed by flaccid paralysis leading to death in house cricketS. Miscellaneous: This toxin comes from a female specimen. It is observed that propeptide sequences coming from female specimen have only limited homology with the male paralogs, but the reason is unknown.Does not inhibit potassium channel currentS. Has no activity in vertebrate smooth and skeletal nerve-muscle preparations (PubMed: 17610847).	House crickets (LD50=236Â±28 pmol/g)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17610847	BiocheM. Pharmacol. 74:623-638 (2007).	Chong Y., Hayes J.L., Sollod B., Wen S. , Wilson D.T., Hains P.G., Hodgson W.C. , Broady K.W., King G.F., Nicholson G.M. 	The omega-atracotoxins: selective blockers of insect M-LVA and HVAcalcium channelS. 	
DRAMP18111	GGCIKWNHSCQTTTLKCCGKCVVCYCHTPWGTNCRCDRTRLFCTED	46	Mu-hexatoxin-Mg2a (Mu-HXTX-Mg2a; Neurotoxin magi-3)	P83559	Not found	Not found	Macrothele gigas (Spider)	Insecticidal	Protein level	Not found	Not found	6AX2	Function: Competes for binding at site 3 of the insect voltage- gated sodium channel (Nav). Insecticidal neurotoxin. Causes temporary paralysis to lepidopteran larvae when injected at 10.3 nmol/g. Is not toxic to mice when injected intracranially at 20 pmol/g.##PTM: Contains 5 disulfide bondS. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	site 3 of the insect voltage- gated sodium channel (Nav)	12860384	FEBS Lett. 547:43-50 (2003).	Corzo G., Gilles N., Satake H., Villegas E., Dai L., Nakajima T., Haupt J.	Distinct primary structures of the major peptide toxins from thevenom of the spider Macrothele gigas that bind to sites 3 and 4 in thesodium channel.	
DRAMP18112	CMGYDIHCTDRLPCCFGLECVKTSGYWWYKKTYCRRKS	38	Mu-hexatoxin-Mg1b (Mu-HXTX-Mg1b; Neurotoxin magi-1)	P83557	Belongs to the magi-1 family	Not found	Macrothele gigas (Spider)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin. Shows competition for site 3 of insect voltage-gated sodium channels (Nav). Has no effect on lepidopteran larvae when injected at 20 pmol/g, or on mice when injected intracranially at 32.8 nmol/g.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	site 4 of the insect voltage- gated sodium channel (Nav)	12860384	FEBS Lett. 547:43-50 (2003).	Corzo G., Gilles N., Satake H., Villegas E., Dai L., Nakajima T., Haupt J.	Distinct primary structures of the major peptide toxins from thevenom of the spider Macrothele gigas that bind to sites 3 and 4 in thesodium channel.	
DRAMP18113	ACVGDGQRCASWSGPYCCDGYYCSCRSMPYCRCRNNS	37	Delta-amaurobitoxin-Pl1b (Delta-AMATX-Pl1b; Delta-palutoxin IT2; Delta-paluIT2)	P83257	Belongs to the beta/delta-agatoxin family	Not found	Pireneitega luctuosa (Tangled nest spider) (Paracoelotes luctuosus)	Insecticidal	Protein level	beta sheet (5 strands; 10 residues)	The three-dimensional structure of Î´-paluIT2 consists of a compact disulfide-bonded core, from which four loops emerge.In Î´-paluIT2, the corresponding loops encompass residues 3â€“6 (loop I), 10â€“15 (loop II), 18â€“20 (loop III), and 25â€“31 (loop IV), and residues 7â€“9 are involved in an extended structure. The Î²-sheet structure is therefore made of three anti-parallel Î²-strands (Q7â€“R8, Y21â€“S24, and R32â€“N35 ).	1V91 resolved by NMR	Function: Insecticidal toxin. Lethal to lepidopteran larvae. No adverse affects when intracerebroventricularly injected in mice at a dose of 0.2 ug but causes reversible paralysis of legs when injected intracerebroventricularly in mice at a dose of 2.0 ug. Binds to site 4 of insect voltage-gated sodium channel (Nav) and inhibits channel inactivation.	Insect LD50=24.7 Â± 11.8 mg/g	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10971590##15683238##15726637	Eur. J. BiocheM. 267:5783-5795 (2000).##Biochemistry 44:1542-1549 (2005).##Proteins 59:368-379 (2005).	Corzo G., Escoubas P., Stankiewicz M. , Pelhate M. , Kristensen C. P., Nakajima T.##Corzo G., Escoubas P., Villegas E., Karbat I., Gordon D., Gurevitz M. , Nakajima T., Gilles N.##Ferrat G., Bosmans F., Tytgat J., Pimentel C. , Chagot B., Gilles N., Nakajima T., Darbon H., Corzo G.	Isolation, synthesis and pharmacological characterization of delta-palutoxins IT, novel insecticidal toxins from the spider Paracoelotesluctuosus (Amaurobiidae).##A spider toxin that induces a typical effect of scorpion alpha-toxinsbut competes with beta-toxins on binding to insect sodium channelS. ##Solution structure of two insect-specific spider toxins and their pharmacological interaction with the insect voltage-gated Na+channel.	
DRAMP18114	DAINSPVTCCYTLTSKKISMQRLMSYRRVTSSKCPKEAVIFKTIAGKEICAEPKXXWVQDSISHLDKKNQXPKP	74	Monocyte chemotactic protein 1B (MCP-1B; Fragment)	P80343	Belongs to the intercrine beta (chemokine CC) family	Not found	Bos taurus (Bovine)	Antitumor	Protein level	Not found	Not found		Function: Chemotactic factor that attracts monocytes, but not neutrophilS. Augments monocyte anti-tumor activity. Also induces the release of gelatinase B. This protein can bind heparin.##PTM: The N-terminus is blocked.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7947749	Biochemistry 33:13406-13412 (1994).	Proost P., Wuyts A., Lenaerts J.-P., van Damme J.	Purification, sequence analysis, and biological characterization of asecond bovine monocyte chemotactic protein-1 (Bo MCP-1B).	
DRAMP18115	QPVGINTSTTCCYRFINKKIPKQRLESYRRTTSSHCPREAVIFKTKLDKEICADPTQKWV	60	C-C motif chemokine 7 (Monocyte chemoattractant protein 3; Monocyte chemotactic protein 3; MCP-3;	P80098, Q569J6	Belongs to the intercrine beta (chemokine CC) family	CCL7	Homo sapiens (Human)	Antitumor	Protein level	14% helical (1 helices; 11 residues)	The shape of the MCP-3 monomer is that of an elongated tetrahedral. It consists of a three-stranded antiparallel Î² sheet and a three turn C-terminal Î± helix lying above the sheet floor. The N-terminal extremity is disordered up to residue 12, but located close to the helix; it consists of a long mobile loop, spatially stabilized because of the two disulfide bonds which link Cys 11 with Cys 36 and Cys 12 with Cys 52.	1BO0, 1NCV resolved by NMR	Function: Chemotactic factor that attracts monocytes and eosinophils, but not neutrophilS. Augments monocyte anti-tumor activity. Also induces the release of gelatinase B. This protein can bind heparin. Binds to CCR1, CCR2 and CCR3.##PTM: O-glycosylated.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8461011##7916328##8318676##15489334##1613466##15340161	BiocheM. BiophyS. ReS. Commun. 191:535-542 (1993).##Genomics 21:403-408 (1994).##Eur. Cytokine Netw. 4:99-110 (1993).##Genome ReS. 14:2121-2127 (2004).##J. Exp. Med. 176:59-65 (1992).##Protein Sci. 13:2819-282	Opdenakker G., Froyen G., Fiten P., Proost P., van Damme J.##Opdenakker G., Fiten P., Nys G., Froyen G., van Roy N., Speleman F., Laureys G., van Damme J.##Minty A., Chalon P., Guillemot J.-C. , Kaghad M. , Liauzun P., Magazin M. , Miloux B., Minty C. , Ramond P., Vita N., Lupker J., Shire D., Ferrara P., Caput D.##The MGC Project Team##van Damme J., Proost P., Lenaerts J.-P., Opdenakker G.##Zhang Z., Henzel W.J.##Kim K.-S. , Rajarathnam 	Human monocyte chemotactic protein-3 (MCP-3): molecular cloning ofthe cDNA and comparison with other chemokineS. ##The human MCP-3 gene (SCYA7): cloning, sequence analysis, andassignment to the C-C chemokine gene cluster on chromosome 17q11.2-q12.##Molecular cloning of the MCP-3 chemokine gene and regulation of its expression.##The status, quality, and expansion of the NIH full-length cDNAproject: the Mammalian Gene Collection (MGC).##Structural and functional identification of two human, tumor-	
DRAMP18116	QDFMKHLDKKTQTPKL	16	U2-segestritoxin-Sf1b (U2-SGTX-Sf1b; F5.7; Toxin SFI 2)	P61096	Belongs to the spider toxin SFI family	Not found	Segestria florentina (Tube-web spider) (Segestria gracilis)	Insecticidal	Protein level	Not found	Not found		Function: Causes flaccid paralysis followed by death when injected into Heliothis virescens larvae. Does not induce any toxic effects when injected intravenously into adult mice at a dose of 1.25 mg/kg body weight.	Heliothis virescens (LD50=7 Î¼g/g)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11689233	Toxicon 40:125-130 (2002).	Lipkin A., Kozlov S. , Nosyreva E., Blake A., Windass J.D., Grishin E.	Novel insecticidal toxins from the venom of the spider Segestriaflorentina.	
DRAMP18117	KECMTDGTVCYIHNHNDCCGSCLCSNGPIARPWEMMVGNCMCGPKA	46	U2-segestritoxin-Sf1a (U2-SGTX-Sf1a; F5.6; Toxin SFI 1)	P61095	Belongs to the spider toxin SFI family	Not found	Segestria florentina (Tube-web spider) (Segestria gracilis)	Insecticidal	Protein level	Not found	Not found	2MF3	Function: Causes flaccid paralysis followed by death when injected into Heliothis virescens larvae. Does not induce any toxic effects when injected intravenously into adult mice at a dose of 1.5 mg/kg body weight. Orally active against larvae of the tomato moth (Laconobia oleracea), the rice brown planthopper (Nilaparvata lugens), and the peach-potato aphid (Myzus persicae) when fused to snowdrop lectin.	Heliothis virescens (LD50=10 Î¼g/g)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11689233##15037094	Toxicon 40:125-130 (2002).##J. Insect Physiol. 50:61-71 (2004).	Lipkin A., Kozlov S. , Nosyreva E., Blake A., Windass J.D., Grishin E.##Fitches E., Edwards M. G., Mee C. , Grishin E., Gatehouse A.M. , Edwards J.P., Gatehouse J.A.	Novel insecticidal toxins from the venom of the spider Segestriaflorentina.##Fusion proteins containing insect-specific toxins as pest controlagents: snowdrop lectin delivers fused insecticidal spider venom toxinto insect haemolymph following oral ingestion.	
DRAMP18118	AECMVDETVCYIHNHNNC	18	U2-segestritoxin-Sf1i (U2-SGTX-Sf1i; Toxin F5.5; Fragment)	P61094	Belongs to the spider toxin SFI family	Not found	Segestria florentina (Tube-web spider) (Segestria gracilis)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal toxin. Causes flaccid paralysis followed by death when injected into Heliothis virescens larvae. Does not induce any toxic effects when injected intravenously into adult mice at a dose of 1.1 mg/kg body weight.	Heliothis virescens (LD50=4 Î¼g/g)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11689233	Toxicon 40:125-130 (2002).	Lipkin A., Kozlov S. , Nosyreva E., Blake A., Windass J.D., Grishin E.	Novel insecticidal toxins from the venom of the spider Segestriaflorentina.	
DRAMP18119	ADCVGDGQRCADWAGPYCCSGYYCSCRSMPYCRCRSDS	38	Mu-agatoxin-Aa1c (Mu-AGTX-Aa1c; Mu-agatoxin III; Mu-agatoxin-3)	P60178, P11059	Belongs to the beta/delta-agatoxin family	Not found	Agelenopsis aperta (North American funnel-web spider) (Agelenopsisgertschi)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that induces an irreversible spastic paralysis when injected into insectS. Modifies presynaptic voltage-gated sodium channels (Nav), causing them to open at the normal resting potential of the nerve. This leads to spontaneous release of neurotransmitter and repetitive action potentials in motor neuronS.	M. sexta (LD50=28Â±12 Î¼g/g)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2914898##15066410	J. Biol. CheM. 264:2150-2155 (1989).##Toxicon 43:509-525 (2004).	Skinner W.S. , Adams M. E., Quistad G.B., Kataoka H., Cesarin B.J., Enderlin F.E., Schooley D.A.##Adams M. E.	Purification and characterization of two classes of neurotoxins fromthe funnel web spider, Agelenopsis aperta.##Agatoxins: ion channel specific toxins from the American funnel webspider, Agelenopsis aperta.	
DRAMP18186	AKKPFVQRVKNAASKAYNKLKGLAMQSQYGCPIISNMCEDHCRRKKMEGQCDLLDCVCS	59	Beta-KTx-like peptide LaIT2	C7G3K3	 Belongs to the long chain scorpion toxin family. Class 2 subfamily.	Not found	Liocheles australasiae (Wood scorpion)	Antimicrobial, Antibacterial	Protein level	Not found	Not found	7WKF	Function:Amphipathic peptide that causes significant antimicrobial activity in the growth inhibition assay against E.coli. Causes paralysis or death to crickets within 48 hours after injection at a dose of 1.3 ug/insect (26 ug/g of body weight). 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19966481	Biosci. Biotechnol. Biochem. 73:2769-2772(2009)	Matsushita N., Miyashita M., Ichiki Y., Ogura T., Sakuradani E.,Nakagawa Y., Shimizu S., Miyagawa H.	Purification and cDNA cloning of LaIT2, a novel insecticidal toxinfrom venom of the scorpion Liocheles australasiae.	
DRAMP18187	IWLTALKFLGKNLGKHLAKQQLAKL	25	Toxin LyeTx 1	C0HJU9	Not found	Not found	Lycosa erythrognatha (Spider) (Scaptocosa raptoria)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found	7MMM	Function: Has hemolytic activity against rabbit erythrocytes. Forms pores in lipid bilayers in vitro; pore formation is reduced when cholesterol is present in the bilayers.	[Ref.19946788]Gram-positive bacterium: S.aureus (MIC=3.79 μM);##Gram-negative bacterium: E.coli (MIC=7.81 μM);##Yeasts: C.krusei (MIC=26.3 μM), C.neoformans (MIC=13.2 μM).	[Ref.19946788]ED50=1.3 × 10−4 M against rabbit erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19946788	Amino Acids 39:135-144(2010)	Santos D.M., Verly R.M., Pilo-Veloso D., de Maria M.,de Carvalho M.A., Cisalpino P.S., Soares B.M., Diniz C.G.,Farias L.M., Moreira D.F., Frezard F., Bemquerer M.P., Pimenta A.M.,de Lima M.E.	LyeTx I, a potent antimicrobial peptide from the venom of the spiderLycosa erythrognatha.	
DRAMP18121	ADCVGDGQKCADWFGPYCCSGYYCSCRSMPYCRCRSDS	38	Mu-agatoxin-Hc1c (Mu-AGTX-Hc1c; CT-III; Curtatoxin-3)	P15968	Belongs to the beta/delta-agatoxin family	Not found	Hololena curta (Funnel-web spider) (Agelena curta)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that induces irreversible neuromuscular blockade in the cricket A.domestica. Modifies presynaptic voltage-gated sodium channels (Nav), causing them to open at the normal resting potential of the nerve. This leads to spontaneous release of neurotransmitter and repetitive action potentials in motor neuronS.	A.domestica (LD50=4 Î¼g/g)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2298738##15066410	J. Biol. CheM. 265:2054-2059 (1990).##Toxicon 43:509-525 (2004).	Stapleton A., Blankenship D.T., Ackermann D.L., Chen T.-M. , Gorder G.W., Manley G.D., Palfreyman M. G., Coutant J.E., Cardin A.D.##Adams M. E.	CurtatoxinS. Neurotoxic insecticidal polypeptides isolated from thefunnel-web spider Hololena curta.##Agatoxins: ion channel specific toxins from the American funnel webspider, Agelenopsis aperta.	
DRAMP18122	SCVGEYGRCRSAYEDCCDGYYCNCSQPPYCLCRNNN	36	Mu-agatoxin-Hc1a (Mu-AGTX-Hc1a; Curtatoxin-1; CT-I)	P15967	Belongs to the beta/delta-agatoxin family	Not found	Hololena curta (Funnel-web spider) (Agelena curta)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that induces irreversible neuromuscular blockade in the cricket A.domestica. Modifies presynaptic voltage-gated sodium channels (Nav), causing them to open at the normal resting potential of the nerve. This leads to spontaneous release of neurotransmitter and repetitive action potentials in motor neuronS.	A.domestica (LD50=20 Î¼g/g)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2298738##15066410	J. Biol. CheM. 265:2054-2059 (1990).##Toxicon 43:509-525 (2004).	Stapleton A., Blankenship D.T., Ackermann D.L., Chen T.-M. , Gorder G.W., Manley G.D., Palfreyman M. G., Coutant J.E., Cardin A.D.##Adams M. E.	CurtatoxinS. Neurotoxic insecticidal polypeptides isolated from thefunnel-web spider Hololena curta.##Agatoxins: ion channel specific toxins from the American funnel webspider, Agelenopsis aperta.	
DRAMP18123	DCVGESQQCADWAGPHCCDGYYCTCRYFPKCICVNNN	37	Mu-agatoxin-Aa1f (Mu-AGTX-Aa1f; Mu-agatoxin VI; Mu-agatoxin-6)	P11062	Belongs to the beta/delta-agatoxin family	Not found	Agelenopsis aperta (North American funnel-web spider) (Agelenopsisgertschi)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that induces an irreversible spastic paralysis when injected into insectS. Modifies presynaptic voltage-gated sodium channels (Nav), causing them to open at the normal resting potential of the nerve. This leads to spontaneous release of neurotransmitter and repetitive action potentials in motor neuronS.	M. sexta (LD50=38Â±12 Î¼g/g)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2914898##15066410	J. Biol. CheM. 264:2150-2155 (1989).##Toxicon 43:509-525 (2004).	Skinner W.S. , Adams M. E., Quistad G.B., Kataoka H., Cesarin B.J., Enderlin F.E., Schooley D.A.##Adams M. E.	Purification and characterization of two classes of neurotoxins fromthe funnel web spider, Agelenopsis aperta.##Agatoxins: ion channel specific toxins from the American funnel webspider, Agelenopsis aperta.	
DRAMP18124	ACVGENKQCADWAGPHCCDGYYCTCRYFPKCICRNNN	37	Mu-agatoxin-Aa1e (Mu-AGTX-Aa1e; Mu-agatoxin V; Mu-agatoxin-5)	P11061	Belongs to the beta/delta-agatoxin family	Not found	Agelenopsis aperta (North American funnel-web spider) (Agelenopsisgertschi)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that induces an irreversible spastic paralysis when injected into insectS. Modifies presynaptic voltage-gated sodium channels (Nav), causing them to open at the normal resting potential of the nerve. This leads to spontaneous release of neurotransmitter and repetitive action potentials in motor neuronS.	M. sexta (LD50=48Â±11 Î¼g/g)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2914898##15066410	J. Biol. CheM. 264:2150-2155 (1989).##Toxicon 43:509-525 (2004).	Skinner W.S. , Adams M. E., Quistad G.B., Kataoka H., Cesarin B.J., Enderlin F.E., Schooley D.A.##Adams M. E.	Purification and characterization of two classes of neurotoxins fromthe funnel web spider, Agelenopsis aperta.##Agatoxins: ion channel specific toxins from the American funnel webspider, Agelenopsis aperta.	
DRAMP18125	ACVGENQQCADWAGPHCCDGYYCTCRYFPKCICRNNN	37	Mu-agatoxin-Aa1d (Mu-AGTX-Aa1d; Mu-agatoxin IV; Mu-agatoxin-4)	P11060	Belongs to the beta/delta-agatoxin family	Not found	Agelenopsis aperta (North American funnel-web spider) (Agelenopsisgertschi)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that induces an irreversible spastic paralysis when injected into insectS. Modifies presynaptic voltage-gated sodium channels (Nav), causing them to open at the normal resting potential of the nerve. This leads to spontaneous release of neurotransmitter and repetitive action potentials in motor neuronS.	M. sexta (LD50=40Â±9 Î¼g/g)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2914898##15066410##8608119	J. Biol. CheM. 264:2150-2155 (1989).##Toxicon 43:509-525 (2004).##Biochemistry 35:2836-2844 (1996).	Skinner W.S. , Adams M. E., Quistad G.B., Kataoka H., Cesarin B.J., Enderlin F.E., Schooley D.A.##Adams M. E.##Omecinsky D.O., Holub K.E., Adams M. E., Reily M. D.	Purification and characterization of two classes of neurotoxins fromthe funnel web spider, Agelenopsis aperta.##Agatoxins: ion channel specific toxins from the American funnel webspider, Agelenopsis aperta.##Three-dimensional structure analysis of mu-agatoxins: furtherevidence for common motifs among neurotoxins with diverse ion channelspecificitieS. 	
DRAMP18126	ECATKNKRCADWAGPWCCDGLYCSCRSYPGCMCRPSS	37	Mu-agatoxin-Aa1b (Mu-AGTX-Aa1b; Mu-agatoxin II; Mu-agatoxin-2)	P11058	Belongs to the beta/delta-agatoxin family	Not found	Agelenopsis aperta (North American funnel-web spider) (Agelenopsisgertschi)	Insecticidal	Protein level	Not found	Not found		Function: Insecticidal neurotoxin that induces an irreversible spastic paralysis when injected into insectS. Modifies presynaptic voltage-gated sodium channels (Nav), causing them to open at the normal resting potential of the nerve. This leads to spontaneous release of neurotransmitter and repetitive action potentials in motor neuronS.	M. sexta (LD50=75Â±27 Î¼g/g)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2914898##15066410	J. Biol. CheM. 264:2150-2155 (1989).##Toxicon 43:509-525 (2004).	Skinner W.S. , Adams M. E., Quistad G.B., Kataoka H., Cesarin B.J., Enderlin F.E., Schooley D.A.##Adams M. E.	Purification and characterization of two classes of neurotoxins fromthe funnel web spider, Agelenopsis aperta.##Agatoxins: ion channel specific toxins from the American funnel webspider, Agelenopsis aperta.	
DRAMP18127	ECVPENGHCRDWYDECCEGFYCSCRQPPKCICRNNN	36	Mu-agatoxin-Aa1a (Mu-AGTX-Aa1a; Mu-agatoxin I; Mu-agatoxin-1)	P11057	Belongs to the beta/delta-agatoxin family	Not found	Agelenopsis aperta (North American funnel-web spider) (Agelenopsisgertschi)	Insecticidal	Protein level	beta sheet (4 strands; 15 residues)	Not found	1EIT resolved by NMR	Function: Insecticidal neurotoxin that induces an irreversible spastic paralysis when injected into insectS. Modifies presynaptic voltage-gated sodium channels (Nav), causing them to open at the normal resting potential of the nerve. This leads to spontaneous release of neurotransmitter and repetitive action potentials in motor neuronS.	LD50 of 28Â±7 Î¼g/g in M. sexta	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2914898##15066410##8608119	J. Biol. CheM. 264:2150-2155 (1989).##Toxicon 43:509-525 (2004).##Biochemistry 35:2836-2844 (1996).	Skinner W.S. , Adams M. E., Quistad G.B., Kataoka H., Cesarin B.J., Enderlin F.E., Schooley D.A.##Adams M. E.##Omecinsky D.O., Holub K.E., Adams M. E., Reily M. D.	Purification and characterization of two classes of neurotoxins fromthe funnel web spider, Agelenopsis aperta.##Agatoxins: ion channel specific toxins from the American funnel webspider, Agelenopsis aperta.##Three-dimensional structure analysis of mu-agatoxins: furtherevidence for common motifs among neurotoxins with diverse ion channelspecificitieS. 	
DRAMP18128	SGTSEKERESGRLLGVVKRLIVGFRSPFR	29	Antimicrobial peptide HsAp4; 	P0DMJ0	Not found	Not found	Heterometrus spinifer (Asia giant forest scorpion) (Malaysian blackscorpion)	Antimicrobial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Possesses antimicrobial activity against both Gram- negative and Gram-positive bacteria, as well as against the fungus C. tropicaliS. Also possess a relatively high hemolytic activity (By similarity).	[Ref.23000095]Gram-positive bacteria: Staphylococcus aureus AB 94004 (MIC=23.6µM), Bacillus magaterium AB 90008 (MIC=11.8µM), Bacillus thuringiensis AB 93100 (MIC=46.5µM);##Gram-negative bacteria: Salmonella enterica AB 2010185 (MIC=25.0µM), E. coli DH5 (MIC=51.2µM), E. coli JM109 (MIC=50.4µM), Enterobacter cloacae subsp. cloacae AB 2010162 (MIC=47.9µM), Klebsiella oxytoca AB 2010143 (MIC=50.5µM);##Fungi: Candida tropicalis AY 91009 (MIC=48.6µM).	[Ref.23000095]5% hemolytic activity at 0.8 μM, 35% hemolytic activity at 1.6 μM, 95% hemolytic activity at 3.2 μM, 100% hemolytic activity against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23000095	Peptides 38:389-394 (2012).	Nie Y., Zeng X.C. , Yang Y., Luo F., Luo X., Wu S. , Zhang L., Zhou J.	A novel class of antimicrobial peptides from the scorpionHeterometrus spinifer.	
DRAMP18129	SGTPEKERESGRLLGVVKRYIVCVRNPCP	29	Antimicrobial peptide HsAp3; 	P0DMI9	Not found	Not found	Heterometrus spinifer (Asia giant forest scorpion) (Malaysian blackscorpion)	Antimicrobial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Possesses antimicrobial activity against both Gram- negative and Gram-positive bacteria, as well as against the fungus C. tropicali. Also possess a relatively high hemolytic activity (By similarity).	[Ref.23000095]Gram-positive bacteria: Staphylococcus aureus AB 94004 (MIC=23.6μM), Bacillus magaterium AB 90008 (MIC=11.8μM), Bacillus thuringiensis AB 93100 (MIC=46.5μM);##Gram-negative bacteria: Salmonella enterica AB 2010185 (MIC=25.0μM), E. coli DH5 (MIC=51.2μM), E. coli JM109 (MIC=50.4μM), Enterobacter cloacae subsp. cloacae AB 2010162 (MIC=47.9μM), Klebsiella oxytoca AB 2010143 (MIC=50.5μM);##Fungi: Candida tropicalis AY 91009 (MIC=48.6μM).	[Ref.23000095]5% hemolytic activity at 0.8 μM, 35% hemolytic activity at 1.6 μM, 95% hemolytic activity at 3.2 μM, 100% hemolytic activity against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23000095	Peptides 38:389-394 (2012).	Nie Y., Zeng X.C. , Yang Y., Luo F., Luo X., Wu S. , Zhang L., Zhou J.	A novel class of antimicrobial peptides from the scorpionHeterometrus spinifer.	
DRAMP18130	SGTSEKERESERLLGVVNPLIKCFRSPCP	29	Antimicrobial peptide HsAp2	P0DMI8	Not found	Not found	Heterometrus spinifer (Asia giant forest scorpion) (Malaysian blackscorpion)	Antimicrobial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Possesses antimicrobial activity against both Gram- negative and Gram-positive bacteria, as well as against the fungus C. tropicaliS. Also possess a relatively high hemolytic activity (By similarity).	[Ref.23000095]Gram-positive bacteria: Staphylococcus aureus AB 94004 (MIC=23.6μM), Bacillus magaterium AB 90008 (MIC=11.8μM), Bacillus thuringiensis AB 93100 (MIC=46.5μM);##Gram-negative bacteria: Salmonella enterica AB 2010185 (MIC=25.0μM), E. coli DH5 (MIC=51.2μM), E. coli JM109 (MIC=50.4μM), Enterobacter cloacae subsp. cloacae AB 2010162 (MIC=47.9μM), Klebsiella oxytoca AB 2010143 (MIC=50.5μM);##Fungi: Candida tropicalis AY 91009 (MIC=48.6μM).	[Ref.23000095]5% hemolytic activity at 0.8 μM, 35% hemolytic activity at 1.6 μM, 95% hemolytic activity at 3.2 μM, 100% hemolytic activity against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23000095	Peptides 38:389-394 (2012).	Nie Y., Zeng X.C. , Yang Y., Luo F., Luo X., Wu S. , Zhang L., Zhou J.	A novel class of antimicrobial peptides from the scorpionHeterometrus spinifer.	
DRAMP18131	SGTSEKERESGRLLGVVKRLIVCFRSPFP	29	Antimicrobial peptide HsAp1 (HsAp)	P0DMI7	Not found	Not found	Heterometrus spinifer (Asia giant forest scorpion) (Malaysian blackscorpion)	Antimicrobial, Antifungal, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Possesses antimicrobial activity against both Gram- negative and Gram-positive. Also possess a relatively high hemolytic activity.	[Ref.23000095]Gram-positive bacteria: Staphylococcus aureus AB 94004 (MIC=23.6μM), Bacillus magaterium AB 90008 (MIC=11.8μM), Bacillus thuringiensis AB 93100 (MIC=46.5μM);##Gram-negative bacteria: Salmonella enterica AB 2010185 (MIC=25.0μM), E. coli DH5 (MIC=51.2μM), E. coli JM109 (MIC=50.4μM), Enterobacter cloacae subsp. cloacae AB 2010162 (MIC=47.9μM), Klebsiella oxytoca AB 2010143 (MIC=50.5μM);##Fungi: Candida tropicalis AY 91009 (MIC=48.6μM).	[Ref.23000095]5% hemolytic activity at 0.8 μM, 35% hemolytic activity at 1.6 μM, 95% hemolytic activity at 3.2 μM, 100% hemolytic activity against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23000095	Peptides 38:389-394 (2012).	Nie Y., Zeng X.C. , Yang Y., Luo F., Luo X., Wu S. , Zhang L., Zhou J.	A novel class of antimicrobial peptides from the scorpionHeterometrus spinifer.	
DRAMP18132	ADPRNPLEECFRETD	15	L-amino-acid oxidase Bfon20 (LAAO; LAO)	P0DMG9	Belongs to the flavin monoamine oxidase family	Not found	Bothrops fonsecai (Fonseca's lancehead) (Rhinocerophis fonsecai)	Antimicrobial, Antitumor, Antibacterial, Antiparasitic	Protein level	Not found	Not found		Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis of vascular endothelial cells or tumor cell lines, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18760386	J. Proteomics 71:473-485 (2008).	Tashima A.K., Sanz L., Camargo A.C. , Serrano S. M. , Calvete J.J.	Snake venomics of the Brazilian pitvipers Bothrops cotiara andBothrops fonsecai. Identification of taxonomy markerS. 	
DRAMP18133	NRILPTLIGPL	11	Peptide Ctri9819	P0DMG0	Not found	Not found	Chaerilus tricostatus (Scorpion)	Antimicrobial, Antiviral	Transcript level	Not found	Not found		Function: Antimicrobial peptide (By similarity).##Miscellaneous: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells (PubMed: 23415044).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23415044	Biomaterials 34:3511-3522 (2013).	Hong W., Zhang R., Di Z., He Y., Zhao Z., Hu J., Wu Y., Li W., Cao Z.	Design of histidine-rich peptides with enhanced bioavailability andinhibitory activity against hepatitis C viruS. 	
DRAMP18134	INWDILIDTIKDKL	14	Peptide Ctri9677	P0DMF9	Not found	Not found	Chaerilus tricostatus (Scorpion)	Antimicrobial, Antiviral	Transcript level	Not found	Not found		Function: Antimicrobial peptide (By similarity).##Miscellaneous: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells (PubMed: 23415045).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23415044	Biomaterials 34:3511-3522 (2013).	Hong W., Zhang R., Di Z., He Y., Zhao Z., Hu J., Wu Y., Li W., Cao Z.	Design of histidine-rich peptides with enhanced bioavailability andinhibitory activity against hepatitis C viruS. 	
DRAMP18135	ILGKFCDEIKRIV	13	Peptide Hp1478 (Non-disulfide-bridged peptide 5; NDBP-5)	P0DMF0	Belongs to the scorpion NDBP 5 family	Not found	Heterometrus petersii (Asian forest scorpion)	Antimicrobial	Protein level	Not found	Not found		Function: Amphipathic peptide with antimicrobial activity (By similarity). Does not show antiviral activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24315793	Antiviral ReS. 102:1-10 (2014).	Hong W., Li T., Song Y., Zhang R., Zeng Z., Han S. , Zhang X., Wu Y., Li W., Cao Z.	Inhibitory activity and mechanism of two scorpion venom peptidesagainst herpes simplex virus type 1.	
DRAMP18136	IFKAIWSGIKRLC	13	Peptide Hp1412 (Non-disulfide-bridged peptide 5; NDBP-5)	P0DME9	Belongs to the scorpion NDBP 5 family	Not found	Heterometrus petersii (Asian forest scorpion)	Antimicrobial	Transcript level	Not found	Not found		Function: Amphipathic peptide with antimicrobial activity (By similarity). Does not show antiviral activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20443192##24315793	Proteomics 10:2471-2485 (2010).##Antiviral ReS. 102:1-10 (2014).	Ma Y., Zhao Y., Zhao R., Zhang W., He Y., Wu Y., Cao Z., Guo L., Li W.##Hong W., Li T., Song Y., Zhang R., Zeng Z., Han S. , Zhang X., Wu Y., Li W., Cao Z.	Molecular diversity of toxic components from the scorpionHeterometrus petersii venom revealed by proteomic and transcriptomeanalysiS. ##Inhibitory activity and mechanism of two scorpion venom peptidesagainst herpes simplex virus type 1.	
DRAMP18137	ILSYLWNGIKSIF	13	Peptide Hp1239 (Non-disulfide-bridged peptide 5; NDBP-5)	P0DME8	Belongs to the scorpion NDBP 5 family	Not found	Heterometrus petersii (Asian forest scorpion)	Antimicrobial, Antibacterial, Antiviral	Transcript level	Not found	Not found		Function: Amphipathic peptide with antibacterial activities (By similarity). Shows antiviral activities against the herpes simplex virus type-1. It potently inhibits the initial infection by provoking the rupture of viral envelop and the dissociation of proteins from the virions (EC (50) is 0.41 Î¼M). It also effectively inhibits viral attachment (EC (50) is 5.73 Î¼M), viral entry (EC (50) is 4.32 Î¼M) and viral proliferation after infection (EC (50) is 8.41 Î¼M). Morever, it enters mammalian tested cells (Vero) and reduces the intracellular infectivity.	CC50=26.15 Â± 1.91 Î¼M; HC50= 33.32 Â± 0.96 Î¼M; EC50=0.41 Â± 0.06 Î¼M	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20443192##24315793	Proteomics 10:2471-2485 (2010).##Antiviral ReS. 102:1-10 (2014).	Ma Y., Zhao Y., Zhao R., Zhang W., He Y., Wu Y., Cao Z., Guo L., Li W.##Hong W., Li T., Song Y., Zhang R., Zeng Z., Han S. , Zhang X., Wu Y., Li W., Cao Z.	Molecular diversity of toxic components from the scorpionHeterometrus petersii venom revealed by proteomic and transcriptomeanalysiS. ##Inhibitory activity and mechanism of two scorpion venom peptidesagainst herpes simplex virus type 1.	
DRAMP18138	ILGEIWKGIKDIL	13	Peptide Hp1165 (Non-disulfide-bridged peptide 5; NDBP-5)	P0DME7	Belongs to the scorpion NDBP 5 family	Not found	Heterometrus petersii (Asian forest scorpion)	Antimicrobial	Transcript level	Not found	Not found		Function: Amphipathic peptide with antimicrobial activity (By similarity). Does not show antiviral activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20443192##24315793	Proteomics 10:2471-2485 (2010).##Antiviral ReS. 102:1-10 (2014).	Ma Y., Zhao Y., Zhao R., Zhang W., He Y., Wu Y., Cao Z., Guo L., Li W.##Hong W., Li T., Song Y., Zhang R., Zeng Z., Han S. , Zhang X., Wu Y., Li W., Cao Z.	Molecular diversity of toxic components from the scorpionHeterometrus petersii venom revealed by proteomic and transcriptomeanalysiS. ##Inhibitory activity and mechanism of two scorpion venom peptidesagainst herpes simplex virus type 1.	
DRAMP18139	ILGKIWEGIKSIF	13	Peptide Hp1036 (Non-disulfide-bridged peptide 5; NDBP-5)	P0DME6	Belongs to the scorpion NDBP 5 family	Not found	Heterometrus petersii (Asian forest scorpion)	Antimicrobial, Antibacterial, Antiviral	Transcript level	Not found	Not found		Function: Amphipathic peptide with antibacterial activities (By similarity). Shows antiviral activities against the herpes simplex virus type-1. It potently inhibits the initial infection by provoking the rupture of viral envelop and the dissociation of proteins from the virions (EC (50) is 0.43 Î¼M). It also effectively inhibits viral attachment (EC (50) is 2.87 Î¼M), viral entry (EC (50) is 4.29 Î¼M) and viral proliferation after infection (EC (50) is 7.86). Morever, it enters mammalian tested cells (Vero) and reduces the intracellular infectivity.	CC50=46.71 Â± 3.80 Î¼M; HC50=34.91 Â± 0.47 Î¼M; EC50=0.43 Â± 0.09 Î¼M	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20443192##24315793	Proteomics 10:2471-2485 (2010).##Antiviral ReS. 102:1-10 (2014).	Ma Y., Zhao Y., Zhao R., Zhang W., He Y., Wu Y., Cao Z., Guo L., Li W.##Hong W., Li T., Song Y., Zhang R., Zeng Z., Han S. , Zhang X., Wu Y., Li W., Cao Z.	Molecular diversity of toxic components from the scorpionHeterometrus petersii venom revealed by proteomic and transcriptomeanalysiS. ##Inhibitory activity and mechanism of two scorpion venom peptidesagainst herpes simplex virus type 1.	
DRAMP18185	FLPLFLPKIICVITKKC	17	Jingdongin-1	K7ZGS2	 Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily	Not found	Amolops jingdongensis (Chinese torrent frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Has activity against Gram- negative bacterium and exhibits hemolytic activity. 	[Ref.22828809]Gram-negative bacterium: B.dysenteriae (MIC=35 μg/ml);##Gram-positive bacteria: S.aureus ATCC 2592 (MIC=4.7 μg/ml), B.subtilis ATCC 6633 (MIC=9.38 μg/ml);##Fungus: C.albicans (MIC=18.75 μg/ml)	[Ref.22828809] It exhibits hemolysis of 1.32%, 5.37%, 6.35%, 16.55% at 25 μg/ml, 50 μg/ml, 100 μg/ml, 200 μg/ml against rabbit red blood cells	Cyclic	Free	Cyclization(Cys11 and Cys17).	Disulfide bond between Cys11 and Cys17.	L	No cytotoxicity information found	Not found	22828809	Amino Acids 44:481-487(2013)	He X., Yang S., Wei L., Liu R., Lai R., Rong M.	Antimicrobial peptide diversity in the skin of the torrent frog,Amolops jingdongensis.	
DRAMP18141	PSPPGFSPFR	10	Nephilakinin-3 (Nephilakinin-III)	P0DM74	Belongs to the bradykinin-related peptide family	Not found	Nephila clavipes (Golden silk orbweaver)	Insecticidal	Protein level	Not found	Not found		Function: Causes constriction on isolated rat ileum preparations and relaxation on rat duodenum muscle preparations at amounts higher than bradykinin. Is a partial agonist bradykinin receptor B2 (BDKRB2). Has insecticidal propertieS. May be related to the predation of insects by the spider webS. ##Miscellaneous: Has been extracted from the spider web (PubMed: 16202476). Does not target bradykinin receptor B1 (BDKRB1) (PubMed: 16202476).	ED50=0.7Î¼M;LD50=70Â±17pmoles/mg honeybee	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16202476	Peptides 27:690-697 (2006).	Volsi E.C. , Mendes M. A., Marques M. R., dos Santos L.D., Santos K.S. , de Souza B.M. , Babieri E.F., Palma M. S. 	Multiple bradykinin-related peptides from the capture web of thespider Nephila clavipes (Araneae, Tetragnatidae).	
DRAMP18142	EAPPGFSPFR	10	Nephilakinin-2 (Nephilakinin-II)	P0DM73	Belongs to the bradykinin-related peptide family	Not found	Nephila clavipes (Golden silk orbweaver)	Insecticidal	Protein level	Not found	Not found		Function: Causes constriction on isolated rat ileum preparations and relaxation on rat duodenum muscle preparations at amounts higher than bradykinin. Is a partial agonist bradykinin receptor B2 (BDKRB3). Has insecticidal propertieS.	ED50=1.0Î¼M;LD50=72Â±18pmoles/mg honeybee	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16202476	Peptides 27:690-697 (2006).	Volsi E.C. , Mendes M. A., Marques M. R., dos Santos L.D., Santos K.S. , de Souza B.M. , Babieri E.F., Palma M. S. 	Multiple bradykinin-related peptides from the capture web of thespider Nephila clavipes (Araneae, Tetragnatidae).	
DRAMP18143	EELEAKDVIESKALATLDEER	21	Toxin OAIP 5	P0DM69	Belongs to the huwentoxin-2 family	Not found	Selenotypus plumipes (Australian featherleg tarantula)	Insecticidal	Protein level	Not found	Not found		Function: Probable ion channel inhibitor. Shows insecticidal activity when injected into mealwormS.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23894279	PLoS ONE 8:E66279-E66279 (2013)	Wong E.S. , Hardy M. C. , Wood D., Bailey T., King G.F.	SVM-based prediction of propeptide cleavage sites in spider toxinsidentifies toxin innovation in an australian tarantula.	
DRAMP18144	YCQKWMWTCDAERKCCEDMACELWCKKRL	29	Toxin OAIP 4	P0DM68	Belongs to the huwentoxin-1 family	Not found	Selenotypus plumipes (Australian featherleg tarantula)	Insecticidal	Protein level	Not found	Not found		Function: Probable ion channel inhibitor. Shows insecticidal activity when injected into mealwormS.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23894279	PLoS ONE 8:E66279-E66279 (2013)	Wong E.S. , Hardy M. C. , Wood D., Bailey T., King G.F.	SVM-based prediction of propeptide cleavage sites in spider toxinsidentifies toxin innovation in an australian tarantula.	
DRAMP18145	ECGGLMTRCDGKTTFCCSGMNCSPTWKWCVYAP	33	Toxin OAIP 3	P0DM67	Belongs to the huwentoxin-1 family	Not found	Selenotypus plumipes (Australian featherleg tarantula)	Insecticidal	Protein level	Not found	Not found		Function: Probable ion channel inhibitor. Shows insecticidal activity when injected into mealwormS.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23894279	PLoS ONE 8:E66279-E66279 (2013)	Wong E.S. , Hardy M. C. , Wood D., Bailey T., King G.F.	SVM-based prediction of propeptide cleavage sites in spider toxinsidentifies toxin innovation in an australian tarantula.	
DRAMP18146	DCLGQWASCEPKNSKCCPNYACTWKYPWCRYRA	33	Toxin OAIP 2	P0DM66	Belongs to the huwentoxin-1 family	Not found	Selenotypus plumipes (Australian featherleg tarantula)	Insecticidal	Protein level	Not found	Not found		Function: Probable ion channel inhibitor. Shows insecticidal activity when injected into mealwormS.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23894279	PLoS ONE 8:E66279-E66279 (2013)	Wong E.S. , Hardy M. C. , Wood D., Bailey T., King G.F.	SVM-based prediction of propeptide cleavage sites in spider toxinsidentifies toxin innovation in an australian tarantula.	
DRAMP18147	LKCNKLVPLFYKTCPAGKNL	20	Cytotoxin drCT-1 (drCT-I; Fragment)	P0C5H4	Belongs to the snake three-finger toxin family	Not found	Daboia russelii (Russel's viper) (Vipera russelii)	Anti-cancer, Cytotoxic	Protein level	Not found	Not found		Function: This three-finger cytotoxin has antiproliferative, cytotoxic and apoptotic activitieS. Both in vivo and in vitro experimental results suggests that this protein possess anticancer potential. Also shows neurotoxicity, cardiotoxicity and myotoxicity.	IC50=8.9 Î¼g/ml for U937 and 6.7 Î¼g/ml for K562	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17055549##16511326	Toxicon 49:46-56 (2007).##Acta Crystallogr. F 62:292-294 (2006).	Gomes A., Choudhury S. R., Saha A., Mishra R., Giri B., Biswas A.K., Debnath A., Gomes A.##Choudhury S. R., Gomes A., Gomes A., Dattagupta J.K., Sen U.	A heat stable protein toxin (drCT-I) from the Indian Viper (Daboiarusselli russelli) venom having antiproliferative, cytotoxic andapoptotic activitieS. ##Purification, crystallization and preliminary X-ray structuralstudies of a 7.2 kDa cytotoxin isolated from the venom of Daboiarusselli russelli of the Viperidae family.	
DRAMP18148	ATCAGQDQTCKVTCDCCGERGECVCGGPCICRQGNFLIAWYKLASCKK	48	Delta-ctenitoxin-Pn2c (Delta-CNTX-Pn2c; Neurotoxin Pn2-5A; Neurotoxin Tx2-5; PNTx2-5)	O76199, P29424	Belongs to the spider toxin Tx2 family	Not found	Phoneutria nigriventer (Brazilian armed spider) (Ctenus nigriventer)	Insecticidal	Protein level	Not found	Not found		Function: Reversible inhibitor of voltage-gated sodium channels (Nav). Delays the fast inactivation kinetics of neuronal-type sodium channelS. Causes scratching, lacrimation, hypersalivation, sweating and agitation followed by spastic paralysis of the anterior and posterior extremities and death at dose levels of 0.24 mg/mouse. Insecticidal to the larval and adult forms of the house fly.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9839668##1397265##19231838##16278100##1801316	Toxicon 36:1843-1850 (1998).##FEBS Lett. 310:153-156 (1992).##Biochemistry 48:3078-3088 (2009).##Comp. BiocheM. Physiol. 142:173-187 (2006).##Toxicon 29:1225-1233 (1991).	Kalapothakis E., Penaforte C. L., Beirao P.S. L., Romano-Silva M. A., Cruz J.S. , Prado M. A.M. , Guimaraes P.E.M. , Gomez M. V., Prado V.F.##Cordeiro M. N., Diniz C. R., Valentim A.D.C. , von Eickstedt V.R.D., Gilroy J., Richardson M. ##Matavel A., Fleury C. , Oliveira L.C. , Molina F., de Lima M. E., Cruz J.S. , Cordeiro M. N., Richardson M. , Ramos C. H., Beirao P.S. ##Richardson M. , Pimenta A.M. , Bemquerer M. P., Santoro M. M. , Bei	Cloning of cDNAS encoding neurotoxic peptides from the spiderPhoneutria nigriventer.##The purification and amino acid sequences of four Tx2 neurotoxinsfrom the venom of the Brazilian 'armed' spider Phoneutria nigriventer (Keys).##Structure and activity analysis of two spider toxins that alter sodium channel inactivation kineticS. ##Comparison of the partial proteomes of the venoms of Brazilianspiders of the genus Phoneutria.##Isolation of neurotoxic peptides from the venom of the 'armed' spider 	
DRAMP18149	DCGHLHDPCPNDRPGHRTCCIGLQCRYGKCLVRV	34	U1-TRTX-Sp1a (Orally active insecticidal peptide 1; OAIP-1)	K7N5K9	Not found	Not found	Selenotypus plumipes (Australian featherleg tarantula)	Insecticidal	Protein level	beta sheet (7 strands; 13 residues)	Not found	2LL1 resolved by NMR	Function: Probable ion channel inhibitor. Shows insecticidal activity. Acts synergistically with the neonicotinoid insecticide imidacloprid. Is neither a repellent that repels insects nor an attractant that is preferentially consumed by insectS. Is very stable.	Helicoverpa armigera (LD50=104.2Â±0.6 pmol/g)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23894279##24039872	PLoS ONE 8:E66279-E66279 (2013).##PLoS ONE 8:E73136-E73136 (2013).	Wong E.S. , Hardy M. C. , Wood D., Bailey T., King G.F.##Hardy M. C. , Daly N.L., Mobli M. , Morales R.A., King G.F.	SVM-based prediction of propeptide cleavage sites in spider toxinsidentifies toxin innovation in an australian tarantula.##Isolation of an orally active insecticidal toxin from the venom of anAustralian tarantula.	
DRAMP01274	QDRPKFCYLPADPAECNAYMPRFYYDSASNKCKEFIYGGCRGNANNFKNRAECRHTCVAS	60	Kunitz-type serine protease inhibitor PIVL; 	I2G9B4	Belongs to the venom Kunitz-type family	Not found	Macrovipera lebetina transmediterranea (Blunt-nosed viper) (Viperalebetina transmediterranea)	Antitumor	Protein level	Not found	Not found		Function: Serine protease inhibitor that inhibits trypsin. Exhibits an anti-tumor effect and displays integrin inhibitory activity without being cytotoxiC. Is able to dose-dependently inhibit the adhesion, migration and invasion of human glioblastoma U87 cellS. Also impairs the function of alphavbeta3 and to a lesser extent, the activity of alphavbeta6, alphavbeta5, alpha1beta1 and alpha5beta1 integrinS. ##Miscellaneous: Does not inhibit chymotrypsin (PubMed: 23262217).When intracerebroventricularly injected into mice, does not cause any toxic symptoms until a dose of 2 ug (PubMed: 23262217).	IC50=250 nM on fibrinogen and 300 nM on fibronectin of glioblastoma cell line U87	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23262217	Matrix Biol. 32:52-62 (2013).	Morjen M. , Kallech-Ziri O., Bazaa A., Othman H., Mabrouk K., Zouari-Kessentini R., Sanz L., Calvete J.J., Srairi-Abid N., El Ayeb M. , Luis J., Marrakchi N.	PIVL, a new serine protease inhibitor from Macrovipera lebetinatransmediterranea venom, impairs motility of human glioblastomacellS. 	
DRAMP01296	ASKCGRHGDSCVSSSDCCPGTWCHTYANRCQVRITEEELMKQREKILGRKGKDY	54	Omega-conotoxin-like protein 1 (OCLP1)	H9KQJ7	Not found	Not found	Apis mellifera (Honeybee)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Function: The impact of this protein on the neuronal activity of the honeybee brain is not known. It does not affect apparent movement or hatching of blowfly larvae. However, when injected into fish, it induces a strong reversible paralytic effect. In addition, the presence of this small peptide in the hemolymph of adult drones together with its induction after bacterial infection suggests that this peptide exhibits antibacterial activity. This peptide may act by inhibiting ion channelS. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17433819##22442369	J. Mol. Biol. 369:553-566 (2007).##J. Exp. Biol. 215:1313-1322 (2012).	Kaplan N., Morpurgo N., Linial M. ##Gatschenberger H., Gimple O., Tautz J., Beier H.	Novel families of toxin-like peptides in insects and mammals: acomputational approach.##Honey bee drones maintain humoral immune competence throughout alllife stages in the absence of vitellogenin production.	
DRAMP01297	SGYLPGKEYVYKYKGKVF	18	Longipin (Fragment)	C0HJF8	Not found	Not found	Acutisoma longipes (Neotropical harvestman) (Goniosoma longipes)	Antimicrobial, Antifungal, Anti-Gram+	Protein level	Not found	Not found		Function: Has moderate antifungal activity. Has weak antimicrobial activity against the Gram-positive bacterium M. luteus A270 (MIC=83 Î¼M) but not against S. aureus ATCC 29213 and S. epidermidis ATCC 12228. Inactive against the Gram-negative bacteria P.aeruginosa ATCC 14502, E.coli ATCC 25922 and E.coli SBS 363. Has no hemolytic activity against human erythrocytes at the highest concentration tested (125 μM).##Introduction: Constitutively expressed.	[Swiss_Prot Entry C0HJF8]Fungi: C. albicans MDM8 (MIC=35 μM), C. tropicalis IOC 4560 (MIC=63 μM), C. guilliermondii IOC 4557 (MIC=32 μM), C. albicans IOC 4558 (MIC=125 μM);##Gram-positive bacterium: M. luteus A270 (MIC=83 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	PubMed ID is not available	Submitted (OCT-2013) to the EMBL/GenBank/DDBJ database	Sayegh R.S. R.	Purification and characterization of antimicrobial peptides presentin the haemolymph of Acutisoma longipes (Gonyleptidae, Opiliones).	
DRAMP01272	ATCAGQDQPCKETCDCCGERGECVCGGPCICRQGYFWIAWYKLANCKK	48	Delta-ctenitoxin-Pn2a (Delta-CNTX-Pn2a; Neurotoxin Tx2-6; PnTx2-6)	P29425, Q95UF2	Belongs to the spider toxin Tx2 family	Not found	Phoneutria nigriventer (Brazilian armed spider) (Ctenus nigriventer)	Insecticidal	Protein level	Not found	Not found		Function: Irreversible inhibitor of voltage-gated sodium channels (Nav). Binds voltage-dependently to sodium channels and inhibits the inactivation of the activated channelS. Also shifts the voltage dependence of the sodium conductance to negative potentials and decrease the peak inward current. Causes scratching, lacrimation, hypersalivation, sweating and agitation followed by spastic paralysis of the anterior and posterior extremities and death at dose levels of 0.79 mg/mouse. Is insecticidal to the larval and adult forms of the house fly. Enhances rat erectile function by increasing NO release in the cavernosum tissue.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	sodium channels	12123835##1397265##16278100##19231838##18397797	FEBS Lett. 523:219-223 (2002).##FEBS Lett. 310:153-156 (1992).##Comp. BiocheM. Physiol. 142:173-187 (2006).##Biochemistry 48:3078-3088 (2009).##Toxicon 51:1197-1206 (2008).	Matavel A., Cruz J.S. , Penaforte C. L., Araujo D.A.M. , Kalapothakis E., Prado V.F., Diniz C. R., Cordeiro M. N., Beirao P.S. L.##;Cordeiro M. N., Diniz C. R., Valentim A.D.C. , von Eickstedt V.R.D., Gilroy J., Richardson M. ##Richardson M. , Pimenta A.M. , Bemquerer M. P., Santoro M. M. , Beirao P.S. , Lima M. E., Figueiredo S. G., Bloch C. Jr., Vasconcelos E.A., Campos F.A., Gomes P.C. , Cordeiro M. N.##Matavel A., Fleury C. , Oliveira	Electrophysiological characterization and molecular identification ofthe Phoneutria nigriventer peptide toxin PnTx2-6.##The purification and amino acid sequences of four Tx2 neurotoxinsfrom the venom of the Brazilian ‘armed' spider Phoneutria nigriventer (Keys).##Comparison of the partial proteomes of the venoms of Brazilianspiders of the genus Phoneutria.##Structure and activity analysis of two spider toxins that altersodium channel inactivation kineticS. ##Tx2-6 toxin of the Phoneutria nigrive	
DRAMP02595	GWLRKAAKSVGKFYYKHKYYIKAAWQIGKHAL	32	Styelin-D (Styelin D; chordates)	O18495	Not found	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: Bactericidal against several Gram-positive and Gram- negative bacteria.PTM:Contains L-DOPA (3',4'-dihydroxyphenylalanine)	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9257708##10978343	FEBS Lett. 412:144-148(1997).##J. Biol. Chem. 275:38417-38426(2000).	Zhao C., Liaw L., Lee I.H., Lehrer R.I.##Taylor S.W., Craig A.G., Fischer W.H., Park M., Lehrer R.I.	cDNA cloning of three cecropin-like antimicrobial peptides (Styelins)from the tunicate, Styela clava.##Styelin D, an extensively modified antimicrobial peptide fromascidian hemocytes.	
DRAMP02515	RVKRVLPLVIRTVIAGYNLYRAIKRK	26	Cc-CATH1	No entry found	Not found	Not found	Coturnix coturnix	Not found	Not found	Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21375690	FEBS J. 2011 May;278(9):1573-1584.	Feng F, Chen C, Zhu W, He W, Guang H, Li Z, Wang D, Liu J, Chen M, Wang Y, Yu H.	Gene cloning, expression, and characterization of avian cathelicidin orthologue, Cc-CATHs, from Coturnix coturnix.	
DRAMP18184	SIGNKGISFETCTAIEGLCFFGCKLGWVWIAYCNNIMSCCRKDTDFVLPQTKGI	54	Beta-defensin 42 (BD-42, mBD-42 )	Q8BVB5, Q4FZ54	Belongs to the beta-defensin family.	Defb42	Mus musculus (Mouse)	Antimicrobial, Antibacterial	Transcript level	Not found	Not found		Function: Has bactericidal activity (By similarity). May play a role in the antimicrobial protection of sperm and urogenital tract epithelia. Epididymis-specific, with highest levels in the initial segment and distal caput.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16033865##16141072##19468303##15489334##16023745	Physiol. Genomics 23:5-17(2005)##Science 309:1559-1563(2005)##PLoS Biol. 7:E1000112-E1000112(2009)##Genome Res. 14:2121-2127(2004)##Biochim. Biophys. Acta 1730:22-30(2005)	Patil A.A., Cai Y., Sang Y., Blecha F., Zhang G.##Carninci P., Kasukawa T., Katayama S. et al.##Church D.M., Goodstadt L., Hillier L.W. et al.##The MGC Project Team##Jalkanen J., Huhtaniemi I., Poutanen M.	Cross-species analysis of the mammalian beta-defensin gene family:presence of syntenic gene clusters and preferential expression in themale reproductive tract.##The transcriptional landscape of the mammalian genome.##Lineage-specific biology revealed by a finished genome assembly ofthe mouse.##The status, quality, and expansion of the NIH full-length cDNAproject: the Mammalian Gene Collection (MGC).##Discovery and characterization of new epididymis-specific beta-defensins in mice.	
DRAMP18405	VTQPLAPVHNPISV	14	PDC213 (beta-casein 213-224, human)	No entry found	Not found	Not found	milk, Homo sapiens	Antimicrobial, Antibacterial		Not found	Not found		It is a endogenous peptide with higher levels in preterm milk.	Active against S. aureus and Y. enterocolitica (80% inhibition at 15 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28093229	Biochem Biophys Res Commun. 2017 Feb 26;484(1):132-137.	Sun Y, Zhou Y, Liu X, Zhang F, Yan L, Chen L, Wang X, Ruan H, Ji C, Cui X, Wang J.	Antimicrobial activity and mechanism of PDC213, an endogenous peptide from human milk.	
DRAMP18406	KEICCKELTKPVKCSSDPLCQKLCMEKEKYEDGHCFTILSKCLCMKRCNAKTLATELLA	59	CaThi (thionin-like peptide 2; plants)	No entry found	Not found	Not found	Fruits, Capsicum annuum	Antimicrobial, Antifungal		Bridge	Not found		Comment: No comments found on DRAMP database	Active against C. albicans CE022, C. tropicalis CE017, C. parapsilosis CE002 (IC50 10 ug/ml), C. pelliculosa 3974 (IC50 40 ug/ml), and C. mogii 4674 (IC50 20 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23896704##26819228	Biopolymers. 2014 Jan;102(1):30-9.##BMC Microbiol. 2016 Jan 27;16:12.	Taveira GB, Mathias LS, da Motta OV, Machado OL, Rodrigues R, Carvalho AO, Teixeira-Ferreira A, Perales J, Vasconcelos IM, Gomes VM.##Taveira GB, Carvalho AO, Rodrigues R, Trindade FG, Da Cunha M, Gomes VM.	Thionin-like peptides from Capsicum annuum fruits with high activity against human pathogenic bacteria and yeasts.##Thionin-like peptide from Capsicum annuum fruits: mechanism of action and synergism with fluconazole against Candida species.	
DRAMP18407	KEICCKVPTTPFLCTNDPQCKTLCSKVNYEDGHCFDILSKCVCMNRCVQDAKTLAAELIEEEFLKQ	66	Thionin-like peptide 1 (plants)	No entry found	Not found	Not found	Fruits, Capsicum annuum	Antimicrobial, Antibacterial, Antifungal		Bridge	Not found		Comment: No comments found on DRAMP database	Active against S. cerevisiae, C. albicans, C. tropicalis, E. coli and P. aeruginosa.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23896704	Biopolymers. 2014 Jan;102(1):30-9.	Taveira GB, Mathias LS, da Motta OV, Machado OL, Rodrigues R, Carvalho AO, Teixeira-Ferreira A, Perales J, Vasconcelos IM, Gomes VM.	Thionin-like peptides from Capsicum annuum fruits with high activity against human pathogenic bacteria and yeasts	
DRAMP18408	EVCEKASKTWSGNCGNTGHC	20	Dm-AMP2 (Dahlia defensin, plants)	No entry found	Belongs to the defensin family.	Not found	seeds, Dahlia merckii	Antimicrobial, Antifungal		Bridge	Not found		Fuction: The sequence is not yet complete.In medium A supplemented with 1 mM CaCl2 and 50 mM KCl, the peptide is active against fungi B. cinerea (IC50 10 ug/ml), C. sphaerospermum (IC50 3 ug/ml), F. culmorum (IC50 3 ug/ml), L. maculans (IC50 1.0 ug/ml), P. digitatum (IC50 2 ug/ml), S. tritici (IC50 1 ug/ml), and V. albo-atrum (IC50 2 ug/ml).	Active against fungi B. cinerea (IC50 10 ug/ml), C. sphaerospermum (IC50 3 ug/ml), F. culmorum (IC50 3 ug/ml), L. maculans (IC50 1.0 ug/ml), P. digitatum (IC50 2 ug/ml), S. tritici (IC50 1 ug/ml), and V. albo-atrum (IC50 2 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7628617	FEBS Lett. 1995 Jul 17;368(2):257-62	Attenborough S, Rees SB, Broekaert WF. 	Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae	
DRAMP18409	INWKKIKSIIKAAMN	15	Mastoparan V1 (MP-V1, insects, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Venom; Social Wasp, Vespula vulgaris	Antimicrobial, Antibacterial, Antifungal		Helix	Not found		Weak hemolysis 6.6% at 50 uM (20% at 100 uM).	Active against S. mutans, S. enterica, and S. aureus (MIC 50 uM), and C. albicans, C. grabrata (MIC 50 uM), and C. neoformans (MIC 0.5 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27104500	Molecules. 2016 Apr 19;21(4):512.	Kim Y, Son M, Noh EY, Kim S, Kim C, Yeo JH, Park C, Lee KW, Bang WY.	MP-V1 from the Venom of Social Wasp Vespula vulgaris Is a de Novo Type of Mastoparan that Displays Superior Antimicrobial Activities.	
DRAMP18410	ITCQQVTXELEPCVPYLTQGIP	22	Cc-LTP2 (Coffea canephora lipid transfer protein 2, plants)	No entry found	Not found	Not found	seeds, Coffea canephora Pierre	Antimicrobial, Antibacterial, Antifungal		Not found	Not found		The sequence is not yet complete.	Active against Gram- bacteria X. euvesicatoria (inhibition zone of 0.25 mm at 75 ug/ml), and can permeate the memrbane of fungi F. solani at 200 ug/ml.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27813588	Genet Mol Res. 2016 Oct 24;15(4).	Bard GC, Zottich U, Souza TA, Ribeiro SF, Dias GB, Pireda S, Da Cunha M, Rodrigues R, Pereira LS, Machado OL, Carvalho AO, Gomes VM.	Purification, biochemical characterization, and antimicrobial activity of a new lipid transfer protein from Coffea canephora seeds.	
DRAMP18411	NGNLLGGLLRPVLGVVKGLTGGLGKK	26	Thaulin-1 (frog, amphibians, animals; Other sequences reported: Thaulin-2, Thaulin-3, Thaulin-4)	No entry found	Not found	Not found	skin, a Patagonian frog, Pleurodema thaul, South America	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against E. coli ATCC 25922 (MIC 62.5 ug/ml), K. pneumoniae (MIC 125 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28025119	Gene. 2017 Mar 20;605:70-80	Marani MM, Perez LO, de Araujo AR, Pl	Thaulin-1: The first antimicrobial peptide isolated from the skin of a Patagonian frog Pleurodema thaul (Anura: Leptodactylidae: Leiuperinae) with activity against Escherichia coli.	
DRAMP18412	SGYLPGKEYVYKYKGKVF	18	Longipin (arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	hemolymph, Acutisoma longipes	Antimicrobial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against M. luteus A270, Gram- P. aeruginosa ATCC27853, S. marcescens ATCC4112 (MIC 60-120 uM), fungi C. albicans MDM8 (MIC 15-30 uM), C. albicans IOC4558 (7.5-15 uM), C. guilliermondii and C. tropicalis (MIC 3.8-7.5 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27997568	PLoS One. 2016 Dec 20;11(12):e0167953.	Sayegh RS, Batista IF, Melo RL, Riske KA, Daffre S, Montich G, da Silva Junior PI	Longipin: An Amyloid Antimicrobial Peptide from the Harvestman Acutisoma longipes (Arachnida: Opiliones) with Preferential Affinity for Anionic Vesicles	
DRAMP18413	FFSMIPKIAGGIASLVKNLG	20	Phylloseptin-PBa (frog, amphibians, animals)	No entry found	Not found	Not found	the Peruvian Purple-Sided Leaf Frog, Phyllomedusa baltea , South America	Antimicrobial, Antibacterial, Antifungal		Not found	Not found		Fuction: It exhibited anti-proliferative activity against the human cancer cell lines, H460, PC3 and U251MG, but was less active against a normal human cell line (HMEC).	Active against S. aureus (MIC 8 ug/ml), E. coli (MIC 128 ug/ml) and C. albicans (MIC 8 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26633506	Toxins (Basel). 2015 Dec 1;7(12):5182-93	Wan Y, Ma C, Zhou M, Xi X, Li L, Wu D, Wang L, Lin C, Lopez JC, Chen T, Shaw C	Phylloseptin-PBa--A Novel Broad-Spectrum Antimicrobial Peptide from the Skin Secretion of the Peruvian Purple-Sided Leaf Frog (Phyllomedusa Baltea) Which Exhibits Cancer Cell Cytotoxicity.	
DRAMP18414	GILGKIWEGVKSLI	14	NDBP-5.8 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Opisthacanthus cayaporum	Antimicrobial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against C. albicans SC5314 (MIC 100 uM), C. tropicalis ATCC 750 (MIC 25 uM), C. parapsilosis ATCC 22019 (MIC 200 uM), C. neoformans H99 serotype A (MIC 100 uM), and C. neoformans B3501 serotype D (MIC 50 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27917162	Front Microbiol. 2016 Nov 18;7:1844. 	Guilhelmelli F, Vilela N, Smidt KS, de Oliveira MA, da Cunha Morales ?lvares A, Rigonatto MC, da Silva Costa PH, Tavares AH, de Freitas SM, Nicola AM, Franco OL, Derengowski LD, Schwartz EF, Mortari MR, Bocca AL, Albuquerque P, Silva-Pereira I.	Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms	
DRAMP18415	FWSFLVKAASKILPSLIGGGDDNKSSS	27	Con10 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Opisthacanthus cayaporum	Antimicrobial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against C. albicans SC5314 (MIC 100 uM), C. tropicalis ATCC 750 (MIC 12.5 uM), C. parapsilosis ATCC 22019 (MIC 200 uM), C. glabrata ATCC 90030 (MIC 200 uM), C. neoformans H99 serotype A (MIC 50 uM), and C. neoformans B3501 serotype D (MIC 25 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27917162	Front Microbiol. 2016 Nov 18;7:1844	Guilhelmelli F, Vilela N, Smidt KS, de Oliveira MA, da Cunha Morales ?lvares A, Rigonatto MC, da Silva Costa PH, Tavares AH, de Freitas SM, Nicola AM, Franco OL, Derengowski LD, Schwartz EF, Mortari MR, Bocca AL, Albuquerque P, Silva-Pereira I.	Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms	
DRAMP18416	FIGMIPGLIGGLISAIK	17	ToAP3 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Tityus obscurus	Antimicrobial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against C. albicans SC5314 (MIC 25 uM), C. tropicalis ATCC 750 (MIC 12.5 uM), C. parapsilosis ATCC 22019 (MIC 100 uM), C. neoformans H99 serotype A (MIC 100 uM), and C. neoformans B3501 serotype D (MIC 25 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27917162	Front Microbiol. 2016 Nov 18;7:1844	Guilhelmelli F, Vilela N, Smidt KS, de Oliveira MA, da Cunha Morales ?lvares A, Rigonatto MC, da Silva Costa PH, Tavares AH, de Freitas SM, Nicola AM, Franco OL, Derengowski LD, Schwartz EF, Mortari MR, Bocca AL, Albuquerque P, Silva-Pereira I.	Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms	
DRAMP03018	INMKASAAVAKKLL	14	MP-VB1 (Insects, animals)	No entry found	Not found	Not found	vespine wasps Vespa bicolor	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Has antimicrobial activities against standard strains and strong antimicrobial ability against drug-resistant strains. Among the tested drug-resistant strains, Pseudemonas aeruginosa and Staphylococcus aureus were the most sensitive for this kind of antimicrobial peptide. Has a little hemolytic activity.	[Ref.18723059] Gram-negative bacterium: Escherichia coli ATCC25922(MIC=15.0μg/ml), Escherichia coli 23A(MIC=15.0μg/ml), Escherichia coli 27A(MIC=60.0μg/ml), Pseudemonas aeruginosa 3A(MIC=15.0μg/ml), Pseudemonas aeruginosa 7A(MIC=120.0μg/ml), ;## Gram-positive bacterium: Staphylococcus aureus ATCC2592(MIC=3.75μg/ml), Staphylococcus aureus 6A(MIC=1.9μg/ml), Staphylococcus aureus 15A(MIC=3.75μg/ml);## Fungus: Candida albicans ATCC2002(MIC=15.0μg/ml)	[Ref.18723059] MP-VB1 had almost no hemolytic activity of 1.7% and 2.7% against rabbit and human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18723059	Peptides. 2008 Nov;29(11):1887-1892.	Chen W, Yang X, Yang X, Zhai L, Lu Z, Liu J, Yu H.	Antimicrobial peptides from the venoms of Vespa bicolor Fabricius.	
DRAMP01875	GLMSLFRGVLKTAGKHIFKNVGGSLLDQAKCKITGEC	37	Brevinin-2PRa (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana pirica (Hokkaido frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: activity against reference strains of Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella pneumoniae) and Gram-positive (Staphlococcus aureus) bacteria but displayed relatively low hemolytic activity. 	[Ref.15003829] Gram-negative bacterium: Escherichia coli(MIC=6μM), Pseudemonas aeruginosa(MIC=3μM), Enterobacter cloacae(MIC=6μM), Klebsiella pneumoniae(MIC=6μM);## Gram-positive bacterium: Staphylococcus aureus(MIC=25μM);## Yeast: Candida albicans(MIC>100μM)	[Ref.15003829] HC50=55 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	15003829	Regul Pept. 2004 May 15;118(3):135-141.	Conlon JM, Sonnevend A, Patel M, Al-Dhaheri K, Nielsen PF, Kolodziejek J, Nowotny N, Iwamuro S, P	A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.	
DRAMP01876	GLMSLFRGGVLKTAGKHIFKNVGGSLLDQAKCKITGEC	38	Brevinin-2PRb (Frogs, amphibians, animals)	No entry found	Not found	Not found	Rana pirica (Hokkaido frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: activity against reference strains of Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella pneumoniae) and Gram-positive (Staphlococcus aureus) bacteria but displayed relatively low hemolytic activity. 	[Ref.15003829] Gram-negative bacterium: Escherichia coli(MIC=3μM), Pseudemonas aeruginosa(MIC=3μM), Enterobacter cloacae(MIC=6μM), Klebsiella pneumoniae(MIC=6μM);## Gram-positive bacterium: Staphylococcus aureus(MIC=25μM);## Yeast: Candida albicans(MIC>100μM)	[Ref.15003829] HC50=65 μM against human erythrocytes	Cyclic	Free	Cyclization (Cys31 and Cys37)	Disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found	Not found	15003829	Regul Pept. 2004 May 15;118(3):135-141.	Conlon JM, Sonnevend A, Patel M, Al-Dhaheri K, Nielsen PF, Kolodziejek J, Nowotny N, Iwamuro S, P	A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.	
DRAMP18421	GFGCPKSALSCSQQCRENNTHSGGYCNGPFNIVCSCY	37	DefMT7 (defensin MT7; hard ticks, arachnids, arthropods, invertebrates, animals)	No entry found	Belongs to the defensin family.	Not found	Ixodes ricinus	Antiparasitic, Antimalarial		Bridge	Not found		Fuction: The peptide showed no activity against bacteria. It showed antimalarial activity. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27822206##26255244	Front Microbiol. 2016 Oct 24;7:1682. ##Dev Comp Immunol. 2015 Dec;53(2):358-65.	Cabezas-Cruz A, Tonk M, Bouchut A, Pierrot C, Pierce RJ, Kotsyfakis M, Rahnamaeian M, Vilcinskas A, Khalife J, Vald	Antiplasmodial Activity Is an Ancient and Conserved Feature of Tick Defensins.##Ixodes ricinus defensins attack distantly-related pathogens.	
DRAMP18422	GYFCPYNGYCDHHCRKKLRWRGGYCGGRWKLTCICVRG	38	DefMT2 (defensin MT2;hard ticks, arachnids, arthropods, invertebrates, animals)	No entry found	Belongs to the defensin family.	Not found	Ixodes ricinus	Antiparasitic, Antimalarial		Bridge	Not found		Fuction: The peptide showed no activity against bacteria. It showed antimalarial activity. 	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27822206##26255244	Front Microbiol. 2016 Oct 24;7:1682. ##Dev Comp Immunol. 2015 Dec;53(2):358-65.	Cabezas-Cruz A, Tonk M, Bouchut A, Pierrot C, Pierce RJ, Kotsyfakis M, Rahnamaeian M, Vilcinskas A, Khalife J, Vald	Antiplasmodial Activity Is an Ancient and Conserved Feature of Tick Defensins.##Ixodes ricinus defensins attack distantly-related pathogens.	
DRAMP18423	EEESEVAHLRVRRGFGCPLNQGACHRHCRSIRRRGGYCSGIIKQTCTCYRN	51	HEdefensin (arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	hemolymph, Haemaphysalis longicornis	Antimicrobial, Antiviral		Bridge	Not found		Fuction: The synthetic peptide showed virucidal activity against Langat virus (LGTV).	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27871830	Dev Comp Immunol. 2017 Mar;68:98-107	Talactac MR, Yada Y, Yoshii K, Hernandez EP, Kusakisako K, Hiroki M, Galay RL, Fujisaki K, Mochizuki M, Tanaka T	Characterization and antiviral activity of a newly identified defensin-like peptide, HEdefensin, in the hard tick Haemaphysalis longicornis	
DRAMP18424	TLNQARGSFDISCDKDNKRFALLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	58	TLN-58 (TLN58; human cathelicidin)	No entry found	Not found	Not found	the lesion vesicle, skin, Homo sapiens	Antimicrobial, Antibacterial		Not found	Not found	2K6O##2FCG##2LMF##4EYC	TLN-58 is an alternative processed form of hCAP-18, the precursor of human LL-37 and ALL-38. TLN-58 upregulated IL-17C, IL-8, IL-23, IL-1alpha, and IL-1beta mRNA and protein expression in normal human keratinocytes, similar to LL-37.	Active against S. aureus, S. epidermidis, and Group A Streptococcus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27771329	J Invest Dermatol. 2017 Feb;137(2):322-331	Murakami M, Kameda K, Tsumoto H, Tsuda T, Masuda K, Utsunomiya R, Mori H, Miura Y, Sayama K.	TLN-58, an additional hCAP18 processing form, found in the lesion vesicle of palmoplantar pustulosis in the skin.	
DRAMP18425	GVFDIIKGAGKQLIAHAMEKIAEKVGLNKDGN	32	Ocellatin-PT6 (frog, amphibians, animals)	No entry found	Not found	Not found	Skin Secretion, dorsal, Leptodactylus pustulatus	Not found		Helix	Not found		Fuction: It has leishmanicidal activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26107622##27463422	J Nat Prod. 2015 Jul 24;78(7):1495-504. ##Biopolymers. 2016 Dec;105(12):873-86.	Marani MM, Dourado FS, Quelemes PV, de Araujo AR, Perfeito ML, Barbosa EA, V	Characterization and Biological Activities of Ocellatin Peptides from the Skin Secretion of the Frog Leptodactylus pustulatus.  ##Ocellatin-PT antimicrobial peptides: High-resolution microscopy studies in antileishmania models and interactions with mimetic membrane systems.	
DRAMP18426	GVIDIIKGAGKDLIAHAIGKLAEKV	25	Ocellatin-PT3 (frog, amphibians, animals)	No entry found	Not found	Not found	Skin Secretion, dorsal, Leptodactylus pustulatus	Antiparasitic		Helix	Not found		Fuction: It has leishmanicidal activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26107622##27463422	J Nat Prod. 2015 Jul 24;78(7):1495-504. ##Biopolymers. 2016 Dec;105(12):873-86.	Marani MM, Dourado FS, Quelemes PV, de Araujo AR, Perfeito ML, Barbosa EA, V	Characterization and Biological Activities of Ocellatin Peptides from the Skin Secretion of the Frog Leptodactylus pustulatus.  ##Ocellatin-PT antimicrobial peptides: High-resolution microscopy studies in antileishmania models and interactions with mimetic membrane systems.	
DRAMP18427	DKGRRRSKFVLHRRQCAN	18	MrDN (pellino-1 derived, Crustaceans, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Giant freshwater prawn, Macrobrachium rosenbergii	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27648859	Mol Immunol. 2016 Oct;78:171-182.	Ravichandran G, Kumaresan V, Arasu MV, Al-Dhabi NA, Ganesh MR, Mahesh A, Dhayalan A, Pasupuleti M, Arockiaraj J	Pellino-1 derived cationic antimicrobial prawn peptide: Bactericidal activity, toxicity and mode of action	
DRAMP18428	KRIRFFERIRDRLRDLGNRIKNRIRDFFS	29	Saha-CATH6 (cathelicidins; mammals, animals)  	No entry found	Not found	Not found	Tasmanian devil, Sarcophilus harrisii	Antimicrobial, Antibacterial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27725697	Sci Rep. 2016 Oct 11;6:35019	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K	Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).	
DRAMP18429	KRIGLIRLIGKILRGLRRLG	20	Saha-CATH5 (cathelicidins; mammals, animals)	No entry found	Not found	Not found	Tasmanian devil, Sarcophilus harrisii	Antimicrobial, Antibacterial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against E. coli ATCC 25922, P. aeruginosa, E. faecalis, S. aureus ATCC 29213 (MRSA), S. pneumoniae ATCC 49619, S. pyogenes ATCC 19615, S. agalactiae ATCC 12386, S. agalactiae, S. anginosus, S. equi, and C. neoformans (MIC 32-64 ug/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27725697	Sci Rep. 2016 Oct 11;6:35019	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K	Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).	
DRAMP18430	KRMGIFHLFWAGLRKLGNLIKNKIQQGIENFLG	33	Saha-CATH3 (cathelicidins; mammals, animals)	No entry found	Not found	Not found	Tasmanian devil, Sarcophilus harrisii	Antimicrobial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against C. neoformans (MIC 16 ug/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27725697	Sci Rep. 2016 Oct 11;6:35019	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K	Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).	
DRAMP18431	GHLGRPYIGGGGGFNRGGGFHRGGGFHRGGGFQSGGGFHRGGGFHSGGSFGYR	53	Armadillidin Q (Gly-rich; Terrestrial Isopod, Crustaceans, arthropods, invertebrates, animals)	No entry found	Not found	Not found	haemocytes, Armadillidium vulgare	Antimicrobial, Antibacterial, Antifungal		Rich	Not found		Comment: No comments found on DRAMP database	Active against B. megaterium F04 (MBC 4.75 uM) and P. syringae DC3000 (MBC 1.18 uM). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrance	27713732	Front Microbiol. 2016 Sep 22;7:1484.	Verdon J, Coutos-Thevenot P, Rodier MH, Landon C, Depayras S, Noel C, La Camera S, Moumen B, Greve P, Bouchon D, Berjeaud JM, Braquart-Varnier C	Armadillidin H, a Glycine-Rich Peptide from the Terrestrial Crustacean Armadillidium vulgare, Displays an Unexpected Wide Antimicrobial Spectrum with Membranolytic Activity	
DRAMP18432	GLLSALRKMIPHILSHIKK	19	Antapin (ANTP; insects, arthropods, invertebrates, animals)	No entry found	Not found	Not found	wild bee, Anthophora plumipes	Antimicrobial, Antibacterial		Helix	Not found		It became more helical in the presence of TFE, SDS, or anionic lipids.	Active against B. subtilis, E. coli, S. aureus, and P. aeruginosa.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Not found	J. Pept. Sci., 2014; 20:S263	S. Cujov	Structural study of a novel antimicrobial peptide isolated from the venom of bee Anthophora plumipes	
DRAMP18433	GSEIRGPCIDRFCRVICRNNGYESGHCNRWARGCSCASWIGR	42	Cremycin-15 (nematode; invertebrates, animals)	No entry found	Not found	Not found	Caenorhabditis remanei	Antimicrobial, Antibacterial, Anti-Gram+		Bridge	Not found		Comment: No comments found on DRAMP database	Active against Gram-positive bacteria B. megaterium and S. marcescens (CL 14.1-17.7 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24434635	Nat Commun. 2014;5:3154.	Zhu S, Gao B. 	Nematode-derived drosomycin-type antifungal peptides provide evidence for plant-to-ecdysozoan horizontal transfer of a disease resistance gene	
DRAMP18434	VKSGHYKGPCYHDENCNGVCRDEGYKSGHCSRWGGACWCDT	41	Cremycin-5 (nematode; invertebrates, animals)	No entry found	Not found	Not found	Caenorhabditis remanei	Antimicrobial, Antifungal		Bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	24434635	Nat Commun. 2014;5:3154.	Zhu S, Gao B. 	Nematode-derived drosomycin-type antifungal peptides provide evidence for plant-to-ecdysozoan horizontal transfer of a disease resistance gene	
DRAMP18435	VWTVWGTIAG	10	Labaditin (plants)	No entry found	Not found	Not found	Not found	Antimicrobial, Antibacterial		Not found	Not found		The cyclic structure is critical for antimicrobial activity against S. aureus.	Active against S. mutans and S. aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20563613##27665378	Amino Acids. 2011 Jan;40(1):135-44.##Colloids Surf B Biointerfaces. 2016 Dec 1;148:453-459.	Barbosa SC, Cilli EM, Dias LG, Stabeli RG, Ciancaglini P.##Barbosa SC, Nobre TM, Volpati D, Ciancaglini P, Cilli EM, Lorenz	Labaditin, a cyclic peptide with rich biotechnological potential: preliminary toxicological studies and structural changes in water and lipid membrane environment. ##The importance of cyclic structure for Labaditin on its antimicrobial activity against Staphylococcus aureus.	
DRAMP18436	RTCESKSHRFKGPCVSTHNCANVCHNEGFGGGKCRGFRRRCYCTRHC	47	AtPDF2.3 (flowering plants)	No entry found	Not found	Not found	Arabidopsis thaliana	Antimicrobial, Antifungal		Bridge	Not found		Comment: No comments found on DRAMP database	Active against S. cerevisiae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27573545	Sci Rep. 2016 Aug 30;6:32121.	Vriens K, Peigneur S, De Coninck B, Tytgat J, Cammue BP, Thevissen K.	The antifungal plant defensin AtPDF2.3 from Arabidopsis thaliana blocks potassium channels. 	
DRAMP18437	LTCDLLSFEAKGFAANHSLCAAHCLAIGRKGGACQNGVCVCRR	43	Oryctes rhinoceros defensin (insects, arthropods, invertebrate, animals)  	No entry found	Belongs to the defensin family.	Not found	Coconut rhinoceros beetle, Oryctes rhinoceros	Antimicrobial, Antibacterial		Bridge	Not found		Comment: No comments found on DRAMP database	Active against S. aureus.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10561605	Eur J Biochem. 1999 Dec;266(2):616-23	Ishibashi J, Saido-Sakanaka H, Yang J, Sagisaka A, Yamakawa M.	Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros	
DRAMP18438	FFGRLKSMWRGARGGLKAYKYQKDMAKMNKRYGPNWQQGGGQEPPADAQANDQPP	55	SB Piscidin 6 (fish, animals)	No entry found	Not found	Not found	Morone saxatilis	Antimicrobial, Antibacterial, Antiparasitic		Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27552222	PLoS One. 2016 Aug 23;11(8):e0159423.	Salger SA, Cassady KR, Reading BJ, Noga EJ	A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes	
DRAMP18439	LFGSVKAWFKGAKKGFQDYRYQKDMAKMNKRYGPNWQQRGGQEPPADAQANDQPP	55	WB Piscidin 6 (fish, animals)	No entry found	Not found	Not found	Morone chrysops	Antimicrobial, Antibacterial, Antiparasitic		Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27552222	PLoS One. 2016 Aug 23;11(8):e0159423.	Salger SA, Cassady KR, Reading BJ, Noga EJ	A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes	
DRAMP18440	LIGSLFRGAKAIFRGARQGWRSHKAVSRYRARYVRRPVIYYHRVYP	46	WB Piscidin 5 (fish, animals)	No entry found	Not found	Not found	Morone chrysops	Antimicrobial, Antibacterial, Antiparasitic		Not found	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27552222	PLoS One. 2016 Aug 23;11(8):e0159423.	Salger SA, Cassady KR, Reading BJ, Noga EJ	A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes	
DRAMP18441	SYVGDCGSNGGSCVSSYCPYGNRLNYFCPLGRTCCRRSY	39	Panusin (beta defensins; crustaceans, arthropods, invertebrates, animals)	No entry found	Belongs to the beta-defensin family.	Not found	the Caribbean spiny lobster, Panulirus genus	Antimicrobial, Antibacterial, Antifungal		Bridge	Not found		Comment: No comments found on DRAMP database	Active against E. coli, K. pneumonia, S. aureus, B. subtilisspizizenii, and C. albicans.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27616720	Dev Comp Immunol. 2017 Feb;67:310-321	Montero-Alejo V, Corzo G, Porro-Suard	Panusin represents a new family of beta-defensin-like peptides in invertebrates.	
DRAMP18442	GVWDWIKKTAGKIWNSEPVKALKSQALNAAKNFVAEKIGATPS	43	Smp43 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	venom, Scorpio maurus palmatus	Antimicrobial, Antibacterial, Antifungal		Helix	Not found		Comment: No comments found on DRAMP database	Active against B. subtilis NCIMB 8024 (MIC 4 ug/ml), S. epidermidis sp., S. aureus SH100 (MIC 32-64 ug/ml), E. coli JM109, K. pneumoniae NCTC 13439, and C. albicans (MIC 64-128 ug/ml). 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrance	27019370	Toxicon. 2016 Jul;117:30-6. 	Harrison PL, Abdel-Rahman MA, Strong PN, Tawfik MM, Miller K.	Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus	
DRAMP18443	IWSFLIKAATKLLPSLFGGGKKDS	24	Smp24 (scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	venom, Scorpio maurus palmatus	Antimicrobial, Antibacterial, Antifungal		Helix	Not found		Removal of the N-terminal four residues increases peptide cell selectivity.	Active against B. subtilis NCIMB 8024, S. epidermidis sp., S. aureus SH100 (MIC 4-8 ug/ml), E. coli JM109 (MIC 64 ug/ml), and C. albicans (MIC 32 ug/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membrance	27019370	Toxicon. 2016 Jul;117:30-6. 	Harrison PL, Abdel-Rahman MA, Strong PN, Tawfik MM, Miller K.	Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus	
DRAMP18444	RYPAVGYT	8	Lacrain (myriapods, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Brazilian centipede, Scolopendra viridicornis	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria	[Ref.27451089]Gram-negative bacteria : Pseudomonas aeruginosa ATCC 27853 (MIC=5.8 μg/ml;MBC=11.6 μg/ml), Alcaligenes faecalis ATCC 8750 (MIC=5.8 μg/ml;MBC=5.8 μg/ml), Serratia marcescens ATCC 4112 (MIC=5.8 μg/ml;MBC=5.8 μg/ml), Enterobacter cloacae β-12 (MIC=2.9 μg/ml;MBC=2.9 μg/ml), Salmonella serovars (MIC=5.8 μg/ml;MBC=11.6 μg/ml), Salmonella enterica subsp. arizonae (MIC=5.8 μg/ml;MBC=5.8 μg/ml), Escherichia coli SBS363 (MIC=5.8 μg/ml;MBC=5.8 μg/ml), Escherichia coli D31 (MIC=5.8 μg/ml;MBC=5.8 μg/ml)	[Ref.27451089] 0% hemolysis at 0.5-500 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27451089	Int J Antimicrob Agents. 2016 Sep;48(3):277-85. doi: 10.1016/j.ijantimicag.2016.05.015.	E. Chaparro,P.I. da Silva Junior	Lacrain: the first antimicrobial peptide from the body extract of the Brazilian centipede Scolopendra viridicornis	
DRAMP18445	AATKPKKAGAEAAPKKPAKKQTKKKPAKKAGGKKKPKRAGAKKAKK	46	hdMolluscidin (mollusca/molluscs/mollusks, invertebrates, animals; Lys-rich; Ala-rich) 	No entry found	Not found	Not found	gill, the abalone, Haliotis discus	Antimicrobial, Antibacterial		Not found	Not found		No hemolysis at 100 ug/mL. May target an intracellular target.	Active against B. subtilis KCTC1021, B. subtilis RM125, S. aureus RM4220, E. coli D31, E. coli KCTC1116, P. aeruginosa KCTC2004, S. enterica KCTC2514, S. flexneri KCTC2517 (MIC 0.2-3.9 uM), fish pathogen A. hydrophila KCTC2358, and V. parahemolyticus KCCM41664 (MIC 0.4-0.7 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27033467	Fish Shellfish Immunol. 2016 May;52:289-97.	Seo JK, Go HJ, Kim CH, Nam BH, Park NG.		
DRAMP18446	HKMDLHWYLRTLEEVVIRALQRFQFR	26	Gm0026x00785(77	No entry found	Not found	Not found	soybean, Glycine max	Antimicrobial, Antibacterial		Not found	Not found		It inhibited the in vitro growth of X. axonopodis pv. glycines, the causative agent of the bacterial pustule disease, at 10 uM. Also active ex vivo and in vivo after vector transformation.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23029273	PLoS One. 2012;7(9):e45848.	Brand GD, Magalh?es MT, Tinoco ML, Arag?o FJ, Nicoli J, Kelly SM, Cooper A, Bloch C Jr.	Probing protein sequences as sources for encrypted antimicrobial peptides.	
DRAMP18447	RWRFLRKISSVHMFSVKALDDFRQL	25	Gm0025x00667(75	No entry found	Not found	Not found	soybean, Glycine max	Antimicrobial, Antibacterial		Not found	Not found		It inhibited the in vitro growth of X. axonopodis pv. glycines, the causative agent of the bacterial pustule disease, at 5 uM. Also active ex vivo and in vivo after vector transformation.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23029273	PLoS One. 2012;7(9):e45848.	Brand GD, Magalh?es MT, Tinoco ML, Arag?o FJ, Nicoli J, Kelly SM, Cooper A, Bloch C Jr.	Probing protein sequences as sources for encrypted antimicrobial peptides.	
DRAMP18448	INNWVRVPPCDQVCSRSNPEKDECCRAHGHAFHAHCNGGMNCYRR	45	Diapausin-1 (insects, arthropods, invertebrates, animals)	No entry found	Not found	Not found	hemolymph, tobacco hornworm, Manduca sexta	Antimicrobial, Antifungal		Bridge	Not found		Fuction: Active against FUNGI such as S. cerevisiae (IC50 12 uM) but not bacteria. The peptide is inducible since mRNA level in fact body increased after yeast challege of larvae.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26976231	Dev Comp Immunol. 2016 Aug;61:258-68.	Al Souhail Q, Hiromasa Y, Rahnamaeian M, Giraldo MC, Takahashi D, Valent B, Vilcinskas A, Kanost MR.	Characterization and regulation of expression of an antifungal peptide from hemolymph of an insect, Manduca sexta.	
DRAMP18449	AVNIPFKVHLRCKAAFC	17	Kunitzin-OS (amphibians, animals)	No entry found	Not found	Not found	Chinese frog, Odorrana schmackeri	Antibacterial, Enzyme inhibitor, Anti-Gram-, Antimicrobial		Not found	Not found		Comment: No comments found on DRAMP database	Gram-negative bacteria: E. coli (MIC 20 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27311856	Biochem Biophys Res Commun. 2016 Aug 19;477(2):302-9.	Chen X, Wang H, Shen Y, Wang L, Zhou M, Chen T, Shaw C.	Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs	
DRAMP18450	AAKIILNPKFRCKAAFC	17	Kunitzin-RE (amphibians, animals)	No entry found	Not found	Not found	European frog, Rana esculenta	Antibacterial, Enzyme inhibitor, Anti-Gram-, Antimicrobial		Not found	Not found		Fuction: A change of the last K to F reduced activity (MIC 160 uM). 	Gram-negative bacteria: E. coli (MIC 30 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27311856	Biochem Biophys Res Commun. 2016 Aug 19;477(2):302-9.	Chen X, Wang H, Shen Y, Wang L, Zhou M, Chen T, Shaw C.	Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs	
DRAMP18451	GFLDVVKHIGKAALGAVTHLINQ	23	CZS-3 (cruzioseptin-3; frog, amphibians, animals)	No entry found	Not found	Not found	the splendid leaf frog, Cruziohyla calcarifer, South America	Antimicrobial, Antibacterial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against E. coli (13.3 uM), S. aureus (13.3 uM), and C. albicans (13.3 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27321580	J Proteomics. 2016 Sep 2;146:1-13. 	Proa?o-Bola?os C, Zhou M, Wang L, Coloma LA, Chen T, Shaw C.	Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer.	
DRAMP18452	GFLDVIKHVGKAALGVVTHLINQ	23	CZS-2 (cruzioseptin-2; frog, amphibians, animals)	No entry found	Not found	Not found	the splendid leaf frog, Cruziohyla calcarifer, South America	Antimicrobial, Antibacterial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against E. coli (26.3 uM), S. aureus (6.6 uM), and C. albicans (13.2 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27321580	J Proteomics. 2016 Sep 2;146:1-13. 	Proa?o-Bola?os C, Zhou M, Wang L, Coloma LA, Chen T, Shaw C.	Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer.	
DRAMP18453	GFLDIVKGVGKVALGAVSKLF	21	CZS-1 (cruzioseptin-1; frog, amphibians, animals)	No entry found	Not found	Not found	the splendid leaf frog, Cruziohyla calcarifer, South America	Antimicrobial, Antibacterial, Antifungal		Not found	Not found		Comment: No comments found on DRAMP database	Active against E. coli (15.1 uM), S. aureus (3.8 uM), and C. albicans (3.8 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27321580	J Proteomics. 2016 Sep 2;146:1-13. 	Proa?o-Bola?os C, Zhou M, Wang L, Coloma LA, Chen T, Shaw C.	Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer.	
DRAMP18454	FLPVIAGVLSKLF	13	Tepmporin-1Ee (frog, amphibians, animals)	No entry found	Not found	Not found	skin secretion, the European edible frog, Pelophylax kl. esculentus, Europe.	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Not found		Fuction: It showed no hemolytic activity at 10 μM.	[Ref.27255993]Gram-positive bacteria: S. aureus (MIC= 10 μM);##Gram-negative bacteria: E. coli (MIC= 40 μM)	[Ref.27255993]Non-hemolytic activity at 10 μM	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27255993	Biochem Biophys Res Commun. 2016 Aug 5;476(4):566-73.	Chen X, Wang H, Yang M, Wang L, Zhou M, Chen T, Shaw C.	Identification and bioactivity evaluation of two novel temporins from the skin secretion of the European edible frog, Pelophylax kl. esculentus.	
DRAMP18455	DSYKKIDCGGACAARCRLSSRPRLCHRACGTCCARCNCVPPGTSGNTETCPCYASLTTHGNKRKCP	66	Tomato Snakin-2 (plants)	No entry found	Not found	Not found	Solanum lycopersicum	Antimicrobial, Antibacterial, Antifungal		Bridge	Not found		Comment: No comments found on DRAMP database	Active against E. coli, B. subtilis, and S. cerevisiae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21479554##27190708 	Transgenic Res. 2012 Feb;21(1):23-37.##PeerJ. 2016 May 10;4:e1987.	Balaji V, Smart CD.##Herbel V, Wink M.	Over-expression of snakin-2 and extensin-like protein genes restricts pathogen invasiveness and enhances tolerance to Clavibacter michiganensis subsp. michiganensis in transgenic tomato (Solanum lycopersicum).##Mode of action and membrane specificity of the antimicrobial peptide snakin-2.	
DRAMP18456	FSLIPSAIGGLISA	18	Pepcon (peptide consensus sequence, synthetic)	No entry found	Not found	Not found	Designed based on sequence alignment with scorpion linear peptides	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-		Not found	Not found		Comment: No comments found on DRAMP database	Gram-positive bacteria: S. epidermidis ATCC 12228 (MIC 7.5 uM),S. aureus (5 uM);##Gram-negative bacteria: E. coli ATCC 25922 (MIC 50 uM), S. enterica ATCC 10708 (60 uM), P. aeruginosa ATCC 27853 (40uM), A. baumannii ATCC 19606 (MIC 20 uM),K. pneumoniae (60 uM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28096686	Infect Drug Resist. 2016 Dec 29;10:1-17.	Almaaytah A, Ajingi Y, Abualhaijaa A, Tarazi S, Alshar'i N, Al-Balas Q	Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides.	
DRAMP18457	KRWWKWWRRC	10	Tet213 (synthetic, Trp-rich, Arg-rich)	No entry found	Not found	Not found	Synthetic	Antimicrobial, Antibacterial		Not found	Not found		Comment: No comments found on DRAMP database	Active against S. aureus and P. aeruginosa.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	Not found	Biomaterials. 2010 Dec;31(36):9519-26.	Kazemzadeh-Narbat M, Kindrachuk J, Duan K, Jenssen H, Hancock RE, Wang R	Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections	
DRAMP18458	TLISWIKNKRKQRPRVSRRRRRRGGRRRR	29	Melimine (a hybrid peptide of melittin and protamine, synthetic)	No entry found	Not found	Not found	Synthetic	Antimicrobial, Antibacterial		Not found	Not found		This peptide, consisting of the C-terminal regions of melittin and protamine, has been covalently immobilized 2008 via the N-terminus. Melimine coated contact lens reduced bacterial colonization (S. aureus and P. aeruginosa) by~70%.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19016975	J Appl Microbiol. 2008 Dec;105(6):1817-25.	Willcox MD, Hume EB, Aliwarga Y, Kumar N, Cole N.	A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses.	
DRAMP18459	GRRRRSVQWCA	11	hLF(1-11) (hLF1-11, first 11 residues, human lactoferrin; synthetic)	No entry found	Not found	Not found	Synthetic fragment	Antimicrobial, Antibacterial		Not found	Not found	1Z6V,1Z6W,1EH3	Fuction: hLF(1	Active against S. aureus, L. monocytogenes, E. coli, and K. pneumoniae.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11179314##24704699	Infect Immun. 2001 Mar;69(3):1469-76. ##Acta Biomater. 2014 Aug;10(8):3522-34.	Nibbering PH, Ravensbergen E, Welling MM, van Berkel LA, van Berkel PH, Pauwels EK, Nuijens JH.##Godoy-Gallardo M, Mas-Moruno C, Fern	Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria.##Covalent immobilization of hLf1-11 peptide on a titanium surface reduces bacterial adhesion and biofilm formation.	
DRAMP18419	GGFGCPFNIDNQGNCHNHCQSIRGRKGGYCHGIPKQTCKCYKPMGYKARPPFILG	55	STiDA-2	No entry found	Belongs to the defensin family.	Not found	Deduced; synthetic	Antiparasitic		Bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27822206	Front Microbiol. 2016 Oct 24;7:1682	Cabezas-Cruz A, Tonk M, Bouchut A, Pierrot C, Pierce RJ, Kotsyfakis M, Rahnamaeian M, Vilcinskas A, Khalife J, Vald	Antiplasmodial Activity Is an Ancient and Conserved Feature of Tick Defensins.	
DRAMP18420	GGFGCPFNIDNQGNCHNHCQSIRGRKGGYCHGIPKQTCKCYKPMGYKTRPPFILG	55	STiDA-1 	No entry found	Belongs to the defensin family.	Not found	Deduced; synthetic	Antiparasitic, Antimalarial		Bridge	Not found		Comment: No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27822206	Front Microbiol. 2016 Oct 24;7:1682	Cabezas-Cruz A, Tonk M, Bouchut A, Pierrot C, Pierce RJ, Kotsyfakis M, Rahnamaeian M, Vilcinskas A, Khalife J, Vald	Antiplasmodial Activity Is an Ancient and Conserved Feature of Tick Defensins.	
DRAMP20762	SDCNINSNTAADVILCFNQVGSCALCSPTLVGGPVP	36	Halocin S8 (HalS8, Halocin-S8; Microhalocin, Archaeocin, Bacteriocin, Archaea, Euryarchaeota, Prokaryotes)	Q9HHA8	Not found	halS8	Haloarchaeon S8a	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antibacterial activity against the haloarchaeons H.salinarium NRC817, Halobacterium GRB and H.gibbonsii.
Miscellaneous: Halocin-S8 is quite robust, as it can be desalted, boiled, subjected to organic solvents, and stored at 4 degrees Celsius for extended periods without losing activity."	[Ref.11114928] Archaea: Sulfolobus solfataricus (Inhibition Zone=4mm)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10940040##11114928	J Bacteriol. 2000 Sep;182(17):4951-8.##J Bacteriol. 2001 Jan;183(1):287-91.	Lance B. Price and Richard F. Shand##Haseltine C, Hill T, Montalvo-Rodriguez R, Kemper SK, Shand RF, Blum P.	Halocin S8, a 36-Amino-Acid Microhalocin from the Haloarchaeal Strain S8a.##Secreted euryarchaeal microhalocins kill hyperthermophilic crenarchaea.	
DRAMP18471	KKLALKALLLWLKALLKLAKLALKK	25	D-LAK60	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC>22.62 μM), Escherichia coli Top 10 (MIC=7.07±2.04 M), Pseudomonas aeruginosa (MIC>22.62 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18472	KKLALKALKLWLLALLKLAKLALKK	25	D-LAK80	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC>22.62 μM), Escherichia coli Top 10 (MIC=5.40±1.01 μM), Pseudomonas aeruginosa (MIC>22.62 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18473	KKLALKALKLWLLALKKLALLALKK	25	D-LAK100	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=4.14±1.03 μM), Escherichia coli Top 10 (MIC=1.51±0.23 M), Pseudomonas aeruginosa (MIC=7.92±2.06 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18474	KKLAKLALLKWLLALKKLALLALKK	25	D-LAK140	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=3.14±1.28 μM), Escherichia coli Top 10 (MIC=0.76±0.18 M), Pseudomonas aeruginosa (MIC=4.69±0.67 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18475	KKLAKLALLKWLLALKLLALKALKK	25	D-LAK160	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=3.85±0.64 μM), Escherichia coli Top 10 (MIC=1.49±0.56 μM), Pseudomonas aeruginosa (MIC=6.23±0.71 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18476	KKLAKALKLLALLWLKLAKALKKA	24	LAK80	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=13.05±0.13 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18477	KKLAKAPKLLALLWLKLAKALKKA	24	LAK80-P7	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=2.97±0.15 μM), Escherichia coli Top 10 (MIC=1.26±0.49 μM), Pseudomonas aeruginosa (MIC=2.13±0.77 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18478	KKLAKALKLPALLWLKLAKALKKA	24	LAK80-P10	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.62±0.17 μM), Escherichia coli Top 10 (MIC=0.82±0.03 μM), Pseudomonas aeruginosa (MIC=1.18±0.53 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18479	KKLAKALKLLAPLWLKLAKALKKA	24	LAK80-P12	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.80±0.27 μM), Escherichia coli Top 10 (MIC=0.80±0.01 μM), Pseudomonas aeruginosa (MIC=0.86±0.09 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18480	KKLALALKKLALLWKKLALALKKA	24	LAK120	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=2.95±0.06 μM), Escherichia coli Top 10 (MIC=1.47±0.64 μM), Pseudomonas aeruginosa (MIC=4.20±0.92 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18481	KKLALAPKKLALLWKKLALALKKA	24	LAK120-P7	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.80±0.03 μM), Escherichia coli Top 10 (MIC=0.45±0.10 μM), Pseudomonas aeruginosa (MIC=4.45±0.19 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18482	KKLALALKKPALLWKKLALALKKA	24	LAK120-P10	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.78±0.01 μM), Escherichia coli Top 10 (MIC=0.47±0.15 μM), Pseudomonas aeruginosa (MIC=9.16±1.43 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18483	KKLALALKKLAPLWKKLALALKKA	24	LAK120-P12	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.97±0.06 μM), Escherichia coli Top 10 (MIC=0.68±0.14 μM), Pseudomonas aeruginosa (MIC=2.14±0.53 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18484	KKLKLALAKLALLWKALALKLKKA	24	LAK160	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.11±0.48 μM), Escherichia coli Top 10 (MIC=0.73±0.40 μM), Pseudomonas aeruginosa (MIC=2.23±0.41 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18485	KKLKLAPAKLALLWKALALKLKKA	24	LAK160-P7	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.79±0.41 μM), Escherichia coli Top 10 (MIC=0.46±0.11 μM), Pseudomonas aeruginosa (MIC=2.98±0.21 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18486	KKLKLALAKPALLWKALALKLKKA	24	LAK160-P10	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=2.22±0.63 μM), Escherichia coli Top 10 (MIC=0.45±0.24 μM), Pseudomonas aeruginosa (MIC=4.14±0.23 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18487	KKLKLALAKLAPLWKALALKLKKA	24	LAK160-P12	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria.	Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.48±0.20 μM), Escherichia coli Top 10 (MIC=0.38±0.08 μM), Pseudomonas aeruginosa (MIC=1.69±0.09 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.	
DRAMP18488	FFGSLLSLGSKLLPSVFKLFQRKKE	25	Css54 (Css from the species name below; scorpions, arachnids, Chelicerata, arthropods, invertebra	P0DL41	Not found	Not found	Centruroides suffusus (Mexican scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Cytolysis, Hemolytic	Not found	Not found	Not found		Function: Amphipathic peptide that shows antibacterial activity against Escherichia coli and Staphylococcus aureus. Increases efficacy of antibiotics when tested against S.aureus, probably by facilitating their incorporation into the bacteria. Has hemolytic activity against human erythrocytes.	[Ref.23093034]Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=12.5 μg/ml).	[Ref.23093034]30% hemolytic activity at 9 μM, 67% hemolytic activity at 17 μM against human erythrocytes	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23093034	J Antibiot (Tokyo). 2013 Jan;66(1):3-10.	Garcia F, Villegas E, Espino-Solis GP, Rodriguez A, Paniagua-Solis JF, Sandoval-Lopez G, Possani LD, Corzo G.	Antimicrobial peptides from arachnid venoms and their microbicidal activity in the presence of commercial antibiotics.	
DRAMP18489	RKCNFLCKLKEKLRTVITSHIDKVLRPQG	29	Cathelicidin-PY (Frog, amphibians, animals; BBL)	No entry found	Belongs to the cathelicidin family	Not found	Paa yunnanensis(Chinese Yunnan frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-inflammatory	Not found	Helix	cathelicidin-PY adopts a tertiary structure with a mostly positively charged surface containing a helix (Thr15	2LR7	Function: Cathelicidin-PY exerted strong antimicrobial abilities and induced little hemolytic activity in a dose-dependent manner.	[Ref.23594231]Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=2.74 µM).	[Ref.23594231]2.5% hemolytic activity at 12.5 μg/mL, 3.5 hemolytic activity at 25 μg/mL, 5.5% hemolytic activity at 50 μg/mL against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23594231	J Med Chem. 2013 May 9;56(9):3546-56.	Wei L, Yang J, He X, Mo G, Hong J, Yan X, Lin D, Lai R.	Structure and function of a potent lipopolysaccharide-binding antimicrobial and anti-inflammatory peptide.	
DRAMP18491	RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK	37	CecropinXJ (Insects, arthropods, invertebrates, animals)	No entry found	Belongs to the cecropin family 	Not found	Bombyx mori	Antimicrobial, Antibacterial, Anti-Gram+, Anti-cancer	Not found	Not found	Not found		Function: Antimicrobial activity against Gram-positive and Gram-negative bacteria.	Gram-positive bacteria: Staphylococcus aureus (MIC= 1.81 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23500722	Protein Expr Purif. 2013 Jul;90(1):47-54.	Xia L, Liu Z, Ma J, Sun S, Yang J, Zhang F.	Expression, purification and characterization of cecropin antibacterial peptide from Bombyx mori in Saccharomyces cerevisiae.	
DRAMP18492	MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLR	74	cgUbiquitin (Oyster, mollusca/molluscs/mollusks, invertebrates, animals)	No entry found	Not found	Not found	Pacific oyster(Crassostrea gigas)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Helix and Beta	Not found		Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and Yeast. 	Gram-positive bacteria: Bacillus subtilis KCTC1021 (MIC=0.4 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22858580	Mol Immunol. 2013 Jan;53(1-2):88-98.	Seo JK, Lee MJ, Go HJ, Kim GD, Jeong HD, Nam BH, Park NG.	Purification and antimicrobial function of ubiquitin isolated from the gill of Pacific oyster, Crassostrea gigas.	
DRAMP03011	INIKDILAKLVKVLGHV	17	Bombolitin IV (insects, arthropods, invertebrates, animals)	P07495	Not found	Not found	Megabombus pennsylvanicus (Bumblebee)	Antimicrobial, Antibacterial, Anti Mammalian Cells	Protein level	Not found	Not found		Function: Mast cell degranulating peptide. Has hemolytic activity.	No MICs found in DRAMP database	[Ref.2578459] Hemolysis: ED50=1.8±0.05 µg/ml. Histamine release: ED50=12.5±0.7 µg/ml against guinea pig erythrocytes.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2578459 	J Biol Chem. 1985 Feb 10;260(3):1437-144.	Argiolas A, Pisano JJ.	Bombolitins, a new class of mast cell degranulating peptides from the venom of the bumblebee Megabombus pennsylvanicus.	
DRAMP03012	INVLGILGLLGKALSHL	17	Bombolitin V (insects, arthropods, invertebrates, animals)	P07496	Not found	Not found	Megabombus pennsylvanicus (Bumblebee)	Antimicrobial, Antibacterial, Anti Mammalian Cells	Protein level	Not found	Not found		Function: Mast cell degranulating peptide. Has hemolytic activity.	No MICs found in DRAMP database	[Ref.2578459] Hemolysis: ED50=0.7±0.05 µg/ml. Histamine release: ED50=2.0±0.3 µg/ml against guinea pig erythrocytes.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2578459 	J Biol Chem. 1985 Feb 10;260(3):1437-144.	Argiolas A, Pisano JJ.	Bombolitins, a new class of mast cell degranulating peptides from the venom of the bumblebee Megabombus pennsylvanicus.	
DRAMP02081	FLPLLAGLAANFLPKIFCKITRKC	24	Brevinin-1E (Frogs, amphibians, animals)	P32412 	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana esculenta (Edible frog) (Pelophylax esculentus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Anti Mammalian Cells	Protein level	Alpha helix	Possess an intramo-lecular disulfide bridge located at the  carboxyl-terminal end.		Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and a very high hemolytic activity.	[Ref.8163497] Gram-negative bacteria: Escherichia coliD21 (MIC=1.8 µM), Pseudomonas aeruginosa ATCC15692 (MIC=30.6 µM);##Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.4 µM), Staphylococcus aureus Cowan1 (MIC=0.6 µM);##Fungi: Candida albicans (MIC=4.7 µM);##Yeast: Saccharomyces cerevisiae (MIC=3.8 µM).	[Ref.8163497] LC50=0.5 µM against human red blood cell.	Cyclic	Free	Cyclization (Cys18 and Cys24)	Disulfide bond between Cys18 and Cys24.	L	No cytotoxicity information found	Not found	8508915##8163497	FEBS Lett. 1993 Jun 14;324(2):159-161.##J Biol Chem. 1994 Apr 22;269(16):11956-11961. 	Simmaco M, Mignogna G, Barra D, Bossa F.##Simmaco M, Mignogna G, Barra D, Bossa F.	Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta.##Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.	
DRAMP02751	GRPNPVNNKPTPHPRL	16	Formaecin-1 (Pro-rich; ants, insects, animals)	P81438	Not found	Not found	Myrmecia gulosa (Red bulldog ant)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Rich	Not found		"Function: Antibacterial activity against E.coli but none against other Gram-negative bacteria and Gram-positive bacteria.
Induction: By bacterial infection.
PTM: O-linked glycan consists of a Gal-GalNAc disaccharide, O-glycosylation is essential for full biological activity."	[Ref.9497332] Gram-negative bacteria: Escherichia coli NCTC 8196, Escherichia coli BLR.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9497332	J Biol Chem. 1998 Mar 13;273(11):6139-6143.	Mackintosh JA, Veal DA, Beattie AJ, Gooley AA.	Isolation from an ant Myrmecia gulosa of two inducible O-glycosylated proline-rich antibacterial peptides.	
DRAMP02752	GRPNPVNTKPTPYPRL	16	Formaecin-2 (Pro-rich; ants, insects, animals)	P81437 	Not found	Not found	Myrmecia gulosa (Red bulldog ant)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Rich	Not found		"Function: Antibacterial activity against E.coli but none against other Gram-negative bacteria and Gram-positive bacteria.
Induction: By bacterial infection.
PTM: O-linked glycan consists of a Gal-GalNAc disaccharide, O-glycosylation is essential for full biological activity."	[Ref.9497332] Gram-negative bacteria: Escherichia coli NCTC 8196, Escherichia coli BLR.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9497332	J Biol Chem. 1998 Mar 13;273(11):6139-6143.	Mackintosh JA, Veal DA, Beattie AJ, Gooley AA.	Isolation from an ant Myrmecia gulosa of two inducible O-glycosylated proline-rich antibacterial peptides.	
DRAMP03097	GKPRPYSPRPTSHPRPIRV	19	Drosocin (Glycopeptide,insects, arthropods, invertebrates, animals)	P36193	Belongs to the drosocin family	Dro	Drosophila melanogaster (Fruit fly)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Beta turns	The NMR data clearly indicate a difference between the glycosylated and nonglycosylated forms, i.e., in the perturbation of a turn directly adjacent to the glycosylation site.	4EZR resolved by X-ray.	"Function: Antibacterial peptide with strong anti-Gram-negative bacteria activity.
PTM: O-glycosylation is essential for full biological activity.
Tissue specificity: In hemolymph 6 hours after immune challenge, levels of expression increase for first 24 hours and persist for the following two weeks.
Developmental stage: Expressed in larvae and in adults.
Induction: By bacterial infection."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9888811##8325867##9497332	"Biochemistry. 1999 Jan 12;38(2):705-14.##
J Biol Chem. 1993 Jul 15;268(20):14893-7.##J Biol Chem. 1998 Mar 13;273(11):6139-6143."	"McManus AM, Otvos L Jr, Hoffmann R, Craik DJ.##
Bulet P, Dimarcq JL, Hetru C, Lagueux M, Charlet M, Hegy G, Van Dorsselaer A, Hoffmann JA.##Mackintosh JA, Veal DA, Beattie AJ, Gooley AA."	Conformational studies by NMR of the antimicrobial peptide, drosocin, and its non-glycosylated derivative: effects of glycosylation on solution conformation.##A novel inducible antibacterial peptide of Drosophila carries an O-glycosylated substitution.##Isolation from an ant Myrmecia gulosa of two inducible O-glycosylated proline-rich antibacterial peptides.	
DRAMP03575	FKRIVQRIKDFLR	13	LL-37(17-29) (C-terminal fragment of LL-37, LL; Human, mammals, animals)	P49913	Belongs to truncated LL-37.	Not found	Homo sapiens	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti-cancer	Protein level	Alpha helix##Random coil	Not found	2FBS resolved by NMR.	Function: LL-37(17-29) became slightly less active than the longer ones, indicating that the truncated hydrophobic residues L31 and V32 also play a role in interaction with human cells. Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.	[Ref.16637646] Gram-negative bacterium: Escherichia coli K12(MIC=40 μM);##Drug-resistant KBv cancer cells (LC50=60 μM), Drug-sensitive KB cancer cells (LC50=57 μM).##[Ref.28178190]Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=16 μM), S. faecalis ATCC 29212 (MIC=32 μM), Bacillus subtilis CMCC 63501 (MIC=16 μM), Staphylococcus epidermidis ATCC 12228 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16 μM), Escherichia coli UB 1005 (MIC=16 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Pseudomonas aeruginosa PAO1 (MIC=16 μM), Salmonella typhimurium ATCC 14028 (MIC=32 μM), Salmonella typhimurium ATCC 7731 (MIC=16 μM). [Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.28161291] HC50>256 μM against human red blood cells. [Ref.23894079] MHC10=160 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16637646##28178190##28161291##23894079	J Am Chem Soc. 2006 May 3;128(17):5776-5785.##Int J Mol Sci. 2017 Feb 6;18(2). pii: E339. ##Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733.##ChemMedChem. 2013 Oct;8(10):1638-42.	Li X, Li Y, Han H, Miller DW, Wang G. ##Tan T, Wu D, Li W, Zheng X, Li W, Shan A.##Rajasekaran G, Kim EY, Shin SY##Son M, Lee Y, Hwang H, Hyun S, Yu J	Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. ##High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7.##LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity. ##Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	
DRAMP02093	FLPFIAGVAAKFLPKIFCAISKKC	24	Brevinin-1Bc (Frogs, amphibians, animals)	P82835	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana berlandieri (Rio Grande leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacteria. 
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=13 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02094	FLPAIAGVAAKFLPKIFCAISKKC	24	Brevinin-1Bd (Frogs, amphibians, animals)	P82836	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana berlandieri (Rio Grande leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=3 μM);##Gram-negative bacterium: Escherichia coli (MIC=7 μM).##Yeast: Candida albicans (MIC=7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02095	FLPAIVGAAAKFLPKIFCVISKKC	24	Brevinin-1Be (Frogs, amphibians, animals)	P82837	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana berlandieri (Rio Grande leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial activity against  Gram-positive and Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=3 μM);##Gram-negative bacterium: Escherichia coli (MIC=15 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02096	FLPFIAGMAANFLPKIFCAISKKC	24	Brevinin-1Bf (Frogs, amphibians, animals)	P82838	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana berlandieri (Rio Grande leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		"Function: Antibacterial activity against  Gram-positive and Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=8 μM);##Gram-negative bacterium: Escherichia coli (MIC=19 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02097	FLPIIAGVAAKVFPKIFCAISKKC	24	Brevinin-1Pa (Frogs, amphibians, animals)	P82841	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pipiens (Northern leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=7 μM);##Gram-negative bacterium: Escherichia coli (MIC=14 μM).##Yeast: Candida albicans (MIC=5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02098	FLPIIASVAAKVFSKIFCAISKKC	24	Brevinin-1Pc (Frogs, amphibians, animals)	P82843	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pipiens (Northern leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=7 μM);##Gram-negative bacterium: Escherichia coli (MIC=5 μM).##Yeast: Candida albicans (MIC=7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02099	FLPIIASVAANVFSKIFCAISKKC	24	Brevinin-1Pd (Frogs, amphibians, animals)	P82844	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pipiens (Northern leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands."	[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=27 μM);##Gram-negative bacterium: Escherichia coli (MIC=78 μM).##Yeast: Candida albicans (MIC=29 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02255	GILSSIKGVAKGVAKNVAAQLLDTLKCKITGC	32	Ranatuerin-2Lb (Ranatuerin 2Lb; Ranaturin-2PRd; Frogs, amphibians, animals)	P82829	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana luteiventris (Spotted frog) (Rana pretiosa)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.10651828] Gram-positive bacterium: Staphylococcus aureus (MIC=4 µM);##Gram-negative bacterium: Escherichia coli (MIC=4 µM);##Yeast: Candida albicans (MIC=62 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02254	GILDSFKGVAKGVAKDLAGKLLDKLKCKITGC	32	Ranatuerin-2La (Ranatuerin 2La; Ranatuerin-2PRa; Frogs, amphibians, animals)	P82828	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana luteiventris (Spotted frog) (Rana pretiosa)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	[Ref.10651828] Gram-positive bacterium: Staphylococcus aureus (MIC=11 µM);##Gram-negative bacterium: Escherichia coli (MIC=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02256	GLLDTIKGVAKTVAASMLDKLKCKISGC	28	Ranatuerin-2B (Ranatuerin 2B, Frog, amphibians, animals)	P82840 	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana berlandieri (Rio Grande leopard frog) (Rana luteiventris)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.10651828] Gram-positive bacterium: Staphylococcus aureus (MIC=2 µM);##Gram-negative bacterium: Escherichia coli (MIC=2 µM);##Yeast: Candida albicans (MIC=35 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10651828	Eur J Biochem. 2000 Feb;267(3):894-900.	Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP02257	LMDTVKNVAKNLAGHMLDKLKCKITGC	27	Ranatuerin-2P (Ranatuerin 2P; Frogs, amphibians, animals)	Q8QFQ4, P82847	Belongs to the frog skin active peptide family (Brevinin subfamily)	Not found	Rana pipiens (Northern leopard frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal,Antiviral	Protein level	Not found	Not found		Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.10651828] Gram-positive bacteria: Staphylococcus aureus (MIC=50 µM);##Gram-negative bacterium: Escherichia coli (MIC=13 µM);##Yeast: Candida albicans (MIC=67 µM).##[Ref.11601906]Virus:##Frog Virus 3: 90% inhibition at 500 µM;##Channel Catfish Virus: 99% inhibition at 50 µM.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	There is a disulfide bond between Cys22 and Cys27.	L	No cytotoxicity information found in the reference(s) presented	Not found	11601906##10651828	Virology. 2001 Sep 30;288(2):351-7.##Eur J Biochem. 2000 Feb;267(3):894-900.	Chinchar VG, Wang J, Murti G, Carey C, Rollins-Smith L.##Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.	Inactivation of frog virus 3 and channel catfish virus by esculentin-2P and ranatuerin-2P, two antimicrobial peptides isolated from frog skin.##Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.	
DRAMP18496	KRGFGCNGPWNEDDLRCHNHCKSIKGYKGGYCAKGGFVCKCY	42	rNZ2114	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found	6K50	Function: Antibacterial activity against Gram-positive bacteria. Weak hemolytic activity.	[Ref.23624708]Gram-positive bacteria: Staphylococcus aureus(MSSA MIC=0.028 μM;MRSA MIC=0.90μM)	[Ref.23624708]<0.1% hemolysis upto 128μg/ml against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23624708	Appl Microbiol Biotechnol	Yong ZhangDa TengRuoyu MaoXiumin WangDi XiXiaoyuan HuJianhua Wang	High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus.	
DRAMP18497	WKSDVRRWRSRY	12	TSG-6 (Ixosin-B peptide derivative)	No entry found	Derived from Ixosin-B	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity,	[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC>100 μM);##Gram-negative bacteria: Escherichia coli (MIC=64 μM), Pseudomonas aeruginosa (MIC>100 μM)	[Ref.23570790]0.3±0.9% hemolysis at 100μM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23570790	Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.	Wu YS, Liao ZJ, Wang KS, Lung FD.	Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.	
DRAMP18498	WKSYVRRWRSRY	12	TSG-7 (Ixosin-B peptide derivative)	No entry found	Derived from Ixosin-B	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive  and Gram-negative bacteria. Has hemolytic activity	[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC=32 μM);##Gram-negative bacteria: Escherichia coli (MIC=16 μM), Pseudomonas aeruginosa (MIC=100 μM)	[Ref.23570790]1.5±1.4% hemolysis at 100μM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23570790	Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.	Wu YS, Liao ZJ, Wang KS, Lung FD.	Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.	
DRAMP18499	WKSYVRRWRSR	11	TSG-8 (Ixosin-B peptide derivative)	No entry found	Derived from Ixosin-B	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.	[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC=32 μM);##Gram-negative bacteria: Escherichia coli (MIC=16 μM), Pseudomonas aeruginosa (MIC>100 μM)	[Ref.23570790]-1.2±2.6% hemolysis at 100μM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23570790	Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.	Wu YS, Liao ZJ, Wang KS, Lung FD.	Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.	
DRAMP18500	WWSYVRRWRSR	11	TSG-8-1 (Ixosin-B peptide derivative)	No entry found	Derived from Ixosin-B	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.	[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC=8 μM);##Gram-negative bacteria: Escherichia coli (MIC=16 μM), Pseudomonas aeruginosa (MIC>100 μM)	[Ref.23570790]3.4±1.3% hemolysis at 100μM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23570790	Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.	Wu YS, Liao ZJ, Wang KS, Lung FD.	Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.	
DRAMP18501	WKSYVRRWRS	10	TSG-9 (Ixosin-B peptide derivative)	No entry found	Derived from Ixosin-B	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.	[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC>100 μM);##Gram-negative bacteria: Escherichia coli (MIC=64 μM), Pseudomonas aeruginosa (MIC>100 μM)	[Ref.23570790]-0.4±0.5% hemolysis at 100μM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23570790	Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.	Wu YS, Liao ZJ, Wang KS, Lung FD.	Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.	
DRAMP18502	WKSYVRRWR	9	TSG-10 (Ixosin-B peptide derivative)	No entry found	Derived from Ixosin-B	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.	[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC=64 μM);##Gram-negative bacteria: Escherichia coli (MIC=64 μM), Pseudomonas aeruginosa (MIC>100 μM)	[Ref.23570790]1.1±1.3% hemolysis at 100μM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23570790	Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.	Wu YS, Liao ZJ, Wang KS, Lung FD.	Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.	
DRAMP18503	WKSYVRRW	8	TSG-11 (Ixosin-B peptide derivative)	No entry found	Derived from Ixosin-B	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.	[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC=100 μM);##Gram-negative bacteria: Escherichia coli (MIC=64 μM), Pseudomonas aeruginosa (MIC>100 μM)	[Ref.23570790]2.0±0.3% hemolysis at 100μM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23570790	Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.	Wu YS, Liao ZJ, Wang KS, Lung FD.	Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.	
DRAMP18504	FSEAIKKIIDFLGEGLFDIIKKIAESF	27	E(AU)2 (Aurein 1.2 peptide derivative)	No entry found	Derived from Aurein 1.2	Not found	Litoria raniformis (Southern bell frog)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Coiled coil	Not found		Function: Antibacterial activity against Gram-negative bacteria, E(AU)2 has no hemolytic activity	[Ref.23519707]Gram-negative bacterium: Escherichia coli (MIC=128 μmol/L)	[Ref.23519707]~5% hemolysis at 128μmol/L, 0% hemolysis at 4 -32μmol/L against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23519707	Amino Acids. 2013 Jun;44(6):1521-8.	Lorenzón EN, Sanches PR, Nogueira LG, Bauab TM, Cilli EM.	Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of C?ndida albicans cells	
DRAMP18505	GLFDIIKKIAESFKFSEAIKKIIDFLG	27	(AU)2K (Aurein 1.2 peptide derivative)	No entry found	Derived from Aurein 1.2	Not found	Litoria raniformis (Southern bell frog)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria, Has hemolytic activity.	[Ref.23519707]Gram-negative bacterium: Escherichia coli (MIC=128 μmol/L)	[Ref.23519707]~30% hemolysis at 32μmol/L, 10% hemolysis at 4 μmol/L against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23519707	Amino Acids. 2013 Jun;44(6):1521-8.	Lorenzón EN, Sanches PR, Nogueira LG, Bauab TM, Cilli EM	Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of C?ndida albicans cells	
DRAMP18506	KKFFLKVLTKIRCKVAGGCRT	21	OG2 (Palustrin-OG1 peptide derivative)	No entry found	Derived from Palustrin-OG1	Not found	Synthetic construct (Modified Palustrin-OG1)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive, Gram-negative bacteria, and lower hemolytic activity than OG1.	[Ref.22670762]Gram-positive bacteria: Bacillus subtilis 1A751 (MIC=128 μg/mL), Staphylococcus aureus ATCC25923 (MIC=8 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=8 μg/mL),Salmonella choleraesuis CMCC50020 (MIC=16 μg/mL)	[Ref.22670762]7%±2% hemolysis at 2-256 μg/mL against porcine red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22670762	Protein Pept Lett. 2013 Jan;20(1):54-60.	Xie YG, Luan C, Zhang HW, Han FF, Feng J, Choi YJ, Groleau D, Wang YZ.	Effects of thioredoxin: SUMO and intein on soluble fusion expression of an antimicrobial peptide OG2 in Escherichia coli.	
DRAMP18508	KFAKKFKWFAKAAFKFFKK	19	gp41w-FKA (gp41 peptide derivative)	No entry found	Derived from the HIV glycoprotein, gp41	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	gp41w-FKA peptide to adopt a helical conformation in the cosolvent mixture of chloroform, methanol and water. The peptide formed a very well defined 		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.	[Ref.23019445]Gram-positive bacterium: Staphylococcus aureus (MIC<10 μg/ml, MBC=20-30 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=10-30 μg/ml, MBC=40-50 μg/ml)	[Ref.23019445]EC50=195 μg/mL against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	gp41w-FKA binds at the interfacial region of a phospholipid bilayer.	23019445	Beilstein J Org Chem. 2012;8:1172-84. Epub 2012 Jul 24.	Haney EF, Nguyen LT, Schibli DJ, Vogel HJ.	Design of a novel tryptophan-rich membrane-active antimicrobial peptide from the membrane-proximal region of the HIV glycoprotein, gp41.	
DRAMP18509	MAFKKLEKVGRNIRDGIIKAGPAVAVIGQATSIARPTGK	39	Px-cec1 (cecropin1 peptide derivative)	No entry found	Derived from the cecropin1	cecropin1	Diamondback moth(Plutella xylostella)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. No hemolytic activity.	"[Ref.22921836]Gram-positive bacteria: Staphylococcus aureus
 (MIC=2.1 μg/mL), Bacillus cereus (MIC=2.6 μg/mL);##Gram-negative bacteria: Escherichia coli K12D31 (MIC=0.1 μg/mL), Escherichia coli K12 (MIC=0.23 μg/mL), Pseudomonas fluorescent (MIC=1.1 μg/mL), Salmonella choleraesuis (MIC=2.1 μg/mL);##Fungi: Aureobasidium pullulans (MIC=4.0 μg/mL), Aspergillus flavus (MIC=14.5 μg/mL), Aspergillus fumigatus (MIC=16.0 μg/mL), Aspergillus niger (MIC=14.6 μg/mL), Fusarium oxysporum (MIC=8.0 μg/mL)"	[Ref.22921836]Non-hemolytic against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22921836	Protein Expr Purif. 2012 Oct;85(2):230-8.	Jin F, Sun Q, Xu X, Li L, Gao G, Xu Y, Yu X, Ren S.	cDNA cloning and characterization of the antibacterial peptide cecropin 1 from the diamondback moth, Plutella xylostella L.	
DRAMP18510	KKLALLALKKWLLALKKLALLALKK	25	D-LAK120	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.	[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.48±0.53 μM), Escherichia coli Top 10 (MIC=0.62±0.15 μM), Pseudomonas aeruginosa (MIC=2.71±1.07 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=1.95±0.08 μM)	[Ref.22869378]HC50=4.06±1.30 μM against Not found (The literature does not mention)	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic 	
DRAMP18511	KKLALLALKKWLPALKKLALLALKK	25	D-LAK120-P13	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.	[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.54±0.97 μM), Escherichia coli Top 10 (MIC=0.58±0.18 μM), Pseudomonas aeruginosa (MIC=1.42±0.41 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=0.88±0.08 μM), Plasmodium falciparum C10 (EC50=2.18±0.41 μM), A549 (EC50=2.44±0.43 μM), RAW264.7 (EC50=3.80±0.34 μM)	[Ref.22869378]HC50=11.66±0.03 μM against Not found (The literature does not mention)	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic 	
DRAMP18512	KKLALALAKKWLALAKKLALALAKK	25	D-LAK120-A	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.	[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.23±0.47 μM), Escherichia coli Top 10 (MIC=0.38±0.21 μM), Pseudomonas aeruginosa (MIC=1.83±0.63 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=1.45±0.12 μM), Plasmodium falciparum C10 (EC50=2.13±0.14 μM), A549 (EC50=5.23±0.35 μM), RAW264.7 (EC50=7.31±2.13 μM)	[Ref.22869378]HC50=17.42±2.17 μM against Not found (The literature does not mention)	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic 	
DRAMP18513	KKLALALAKKWLPLAKKLALALAKK	25	D-LAK120-AP13	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.	[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.08±0.62 μM), Escherichia coli Top 10 (MIC=0.29±0.09 μM), Pseudomonas aeruginosa (MIC=1.22±0.19 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=0.88±0.06 μM), Plasmodium falciparum C10 (EC50=2.36±0.10 μM), A549 (EC50=3.11±0.57 μM), RAW264.7 (EC50=3.42±0.16 μM)	[Ref.22869378]HC50=58.61±10.41 μM against Not found (The literature does not mention)	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic 	
DRAMP18514	KKLALHALKKWLHALKKLAHLALKK	25	D-LAK120-H 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.	[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.54±0.01 μM), Escherichia coli Top 10 (MIC=0.40±0.01 μM), Pseudomonas aeruginosa (MIC=1.35±0.07 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=1.26±0.14 μM), Plasmodium falciparum C10 (EC50=4.43±0.33 μM), A549 (EC50=4.54±0.30 μM), RAW264.7 (EC50=5.21±0.57 μM)	[Ref.22869378]HC50=20.29±2.42 μM against Not found (The literature does not mention)	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33.	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic 	
DRAMP18515	KWKSFLkTFKSLKKTVLHTLLKAISS	26	A12L/A20L (V13KL peptide derivative)	No entry found	Derived from the framework peptide V13KL	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. A12L/A20L against HeLa cells. Leucine to replace Alanine at the position 12 and 20 on the peptide V13KL. Has hemolytic activity.	[Ref.17158938]Gram-negative bacteria: Pseudomonas aeruginosa PAO1(MIC=62.5 μg/ml), Pseudomonas aeruginosa WR5 (MIC=125 μg/ml), Pseudomonas aeruginosa PAK (MIC=62.5 μg/ml), Pseudomonas aeruginosa PA14 (MIC=125 μg/ml), Pseudomonas aeruginosa M2 (MIC=62.5 μg/ml), Pseudomonas aeruginosa CP204 (MIC=62.5 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=78.7 μg/ml).##[Ref.22837667]Cancer cell: HeLa cell (IC50=1.71±0.07 μmol/L).	[Ref.22837667]MHC=8.0 μg/ml, MHC=5.20±0.02 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17158938##22837667	Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.##Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.##Huang YB, He LY, Jiang HY, Chen YX.	Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.##Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18516	KWKSFLKTFKSLKkTVLHTLLKAISS	26	K7D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial	Synthetic	Alpha helix 	Not found		Function: K7D against HeLa cells. D-Lysine replace L-Lysine at the position 7 on the polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=1.29±0.03 μmol/L)	[Ref.22837667]MHC=10.4±0.04 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18517	KWKSFLKTFKSLKKTVLHTLLkAISS	26	K14D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: K14D against HeLa cells. D-Lysine replace L-Lysine at the position 14 on the polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=1.52±0.05 μmol/L)	[Ref.22837667]MHC=5.20±0.02 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18518	KWKSFLkTFKSLKkTVLHTLLKAISS	26	K22D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: K22D against HeLa cells. D-Lysine replace L-Lysine at the position 22 on the polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=1.39±0.02 μmol/L)	[Ref.22837667]MHC=20.81±0.10 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18519	KWKSFLKTFKSLKkTVLHTLLkAISS	26	K7D/K14D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: K7D/K14D against HeLa cells. D-lysine replace L-Lysine at the position 7 and 14 on the polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=2.06±0.01 μmol/L)	[Ref.22837667]MHC=20.81±0.15 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18520	KWKSFLkTFKSLKkTVLHTLLkAISS	26	K14D/K22D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: K14D/K22D against HeLa cells. D-Lysine replace L-Lysine at the position 14 and 22 on the polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=1.40±0.09 μmol/L)	[Ref.22837667]MHC=20.81±0.06 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18521	KWKSFLkTFkSLKkTVLHTLLkAISS	26	K7D/K14D/K22D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: K7D/K14D/K22D against HeLa cells. D-Lysine replace L-Lysine at the position 7,14 and 22 on the polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=4.45±0.19 μmol/L)	[Ref.22837667]MHC=81.31±0.17 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18522	KWKSFLkTFkSLKkTVLHTLLkAISS	26	K7D/K10D/K14D/K22D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: K7D/K10D/K14D/K22D against HeLa cells. D-Lysine replace L-Lysine at the position 7,10,14 and 22 on the polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=4.79±0.23 μmol/L)	[Ref.22837667]MHC=325.20±0.82 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18523	KWkSFLkTFkSLKkTVLHTLLkAISS	26	K3D/K7D/K10D/K14D/K22D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: K3D/K7D/K10D/K14D/K22D against HeLa cells. D-Lysine replace L-Lysine at the position 3,7,10,14 and 22 on the polar face of peptide A12L/A20L. Weak hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=20.41±0.64 μmol/L)	[Ref.22837667]MHC>325.20 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18524	kWkSFLkTFkSLKkTVLHTLLkAISS	26	K1D/K3D/K7D/K10D/K14D/K22D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: K1D/K3D/K7D/K10D/K14D/K22D against HeLa cells. D-Lysine replace L-Lysine at the position 1,3,7,10,14 and 22 on the polar face of peptide A12L/A20L. Weak hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=18.07±0.48 μmol/L)	[Ref.22837667]MHC>325.20 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18525	KWKSFLKTFKSLKKTVLHTLLKAISS	26	L6D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: L6D against HeLa cells. D-Leucine replace L-Leucine at the position 6 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=2.23±0.10 μmol/L)	[Ref.22837667]MHC=10.40±0.08 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18526	KWKSFLKTFKSLKKTVLHTLLKAISS	26	L12D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: L12D against HeLa cells. D-Leucine replace L-Leucine at the position 12 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=2.63±0.07 μmol/L)	[Ref.22837667]MHC=20.81±0.03 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18527	KWKSFLKTFKSLKKTVLHTLLKAISS	26	L20D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: L20D against HeLa cells. D-Leucine replace L-Leucine at the position 20 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=2.33±0.06 μmol/L)	[Ref.22837667]MHC=20.81±0.13 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18528	KWKSFlKTFKSlKKTVLHTLLKAISS	26	L6D/L12D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: L6D/L12D against HeLa cells. D-Leucine replace L-Leucine at the position 6 and 12 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=3.01±0.08 μmol/L)	[Ref.22837667]MHC=20.81±0.10 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18529	KWKSFLKTFKSlKKTVLHTlLKAISS	26	L12D/L20D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: L12D/L20D against HeLa cells. D-Leucine replace L-Leucine at the position 12 and 20 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=3.14±0.06 μmol/L)	[Ref.22837667]MHC=81.31±0.43 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18530	KWKSFlKTFKSlKKTVLHTlLKAISS	26	L6D/L12D/L20D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: L6D/L12D/L20D against HeLa cells. D-Leucine replace L-Leucine at the position 6,12 and 20 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=7.80±0.26 μmol/L)	[Ref.22837667]MHC=162.61±0.19 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18531	KWKSFlKTFKSlKKTVlHTlLKAISS	26	L6D/L12D/L17D/L20D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: L6D/L12D/L17D/L20D against HeLa cells. D-Leucine replace L-Leucine at the position 6,12,17 and 20 on the non-polar face of peptide A12L/A20L. Has hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=9.69±0.38 μmol/L)	[Ref.22837667]MHC=81.31±1.05 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18532	KWKSFlKTFKSlKKTVlHTllKAISS	26	L6D/L12D/L17D/L20D/L21D (A12L/A20L peptide derivative)	No entry found	Derived from the framework peptide A12L/A20L	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix 	Not found		Function: L6D/L12D/L17D/L20D/L21D against HeLa cells. D-Leucine replace L-Leucine at the position 6,12,17,20 and 21 on the non-polar face of peptide A12L/A20L. Weak hemolytic activity.	[Ref.22837667]Cancer cell: HeLa cell (IC50=12.88 ± 0.15 μmol/L)	[Ref.22837667]MHC>325.20 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22837667	Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides.	
DRAMP18533	KWKSFLKTFKSAKKTVLHTALKAISS	26	V13KL (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Lysine replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=64.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=64.0 μg/ml), Staphylococcus epidermidis C621 (MIC=5.0 μg/ml), Bacillus subtilis C971 (MIC=1.6 μg/ml), Enterococcus faecalis C625 (MIC=64.0 μg/ml), Corynebacterium xerosis C875 (MIC=1.3 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=11.8 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=2.5 μg/ml), Escherichia coli DC2 (MIC=1.6 μg/ml), Salmonella typhimurium C587 (MIC=4.0 μg/ml), Salmonella typhimurium C610 (MIC=1.3 μg/ml), Pseudomonas aeruginosa H187 (MIC=8.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=5.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=3.1 μg/ml).##[Ref.17158938]Gram-negative bacteria: Pseudomonas aeruginosa PAO1(MIC=31.3 μg/ml), Pseudomonas aeruginosa WR5 (MIC=250 μg/ml), Pseudomonas aeruginosa PAK (MIC=125 μg/ml), Pseudomonas aeruginosa PA14 (MIC=62.5 μg/ml), Pseudomonas aeruginosa M2 (MIC=31.3 μg/ml), Pseudomonas aeruginosa CP204 (MIC=7.8 μg/ml), The geometric mean of MIC values above six Pseudomonas aeruginosa strains (MIC=49.6 μg/ml)	[Ref.17158938]MHC=250.0 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462##17158938	J Biol Chem. 2005 Apr 1;280(13):12316-29.##Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.##Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.##Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.	
DRAMP18534	KWKSFLKTFKSAKKTVLHTALKLISS	26	A23L (V13KL peptide derivative)	No entry found	Derived from the framework peptide V13KL	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Leucine to replace Alanine at the position 23 on the peptide V13KL. Has hemolytic activity.	[Ref.17158938]Gram-negative bacteria: Pseudomonas aeruginosa PAO1(MIC=31.3 μg/ml), Pseudomonas aeruginosa WR5 (MIC=62.5 μg/ml), Pseudomonas aeruginosa PAK (MIC=62.5 μg/ml), Pseudomonas aeruginosa PA14 (MIC=31.3 μg/ml), Pseudomonas aeruginosa M2 (MIC=31.3 μg/ml), Pseudomonas aeruginosa CP204 (MIC=15.6 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=35.1 μg/ml)	[Ref.17158938]MHC=62.5 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17158938	Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.	Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.	Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.	
DRAMP18535	KWKSFLKTFKSLKKTVLHTALKAISS	26	A12L (V13KL peptide derivative)	No entry found	Derived from the framework peptide V13KL	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Leucine to replace Alanine at the position 12 on the peptide V13KL. Has hemolytic activity.	[Ref.17158938]Gram-negative bacteria: Pseudomonas aeruginosa PAO1(MIC=15.6 μg/ml), Pseudomonas aeruginosa WR5 (MIC=62.5 μg/ml), Pseudomonas aeruginosa PAK (MIC=31.3 μg/ml), Pseudomonas aeruginosa PA14 (MIC=31.3 μg/ml), Pseudomonas aeruginosa M2 (MIC15.6= μg/ml), Pseudomonas aeruginosa CP204 (MIC=15.6 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=24.8 μg/ml)	[Ref.17158938]MHC=31.3 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17158938	Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.	Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.	Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.	
DRAMP18536	KWKSFLKTFKSAKKTVLHTLLKAISS	26	A20L (V13KL peptide derivative)	No entry found	Derived from the framework peptide V13KL	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Leucine to replace Alanine at the position 20 on the peptide V13KL. Has hemolytic activity.	[Ref.17158938]Gram-negative bacteria: Pseudomonas aeruginosa PAO1(MIC=7.8 μg/ml), Pseudomonas aeruginosa WR5 (MIC=31.3 μg/ml), Pseudomonas aeruginosa PAK (MIC=31.3 μg/ml), Pseudomonas aeruginosa PA14 (MIC=15.6 μg/ml), Pseudomonas aeruginosa M2 (MIC=15.6 μg/ml), Pseudomonas aeruginosa CP204 (MIC=7.7 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=15.6 μg/ml)	[Ref.17158938]MHC=31.3 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17158938	Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.	Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.	Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.	
DRAMP18537	KWKSFLKTFKSLKKTVLHTALKLISS	26	A12L/A23L (V13KL peptide derivative)	No entry found	Derived from the framework peptide V13KL	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-negative bacteria. Leucine to replace Alanine at the position 12 and 23 on the peptide V13KL. Has hemolytic activity.	[Ref.17158938]Gram-negative bacteria: Pseudomonas aeruginosa PAO1(MIC=15.6 μg/ml), Pseudomonas aeruginosa WR5 (MIC=250 μg/ml), Pseudomonas aeruginosa PAK (MIC=15.6 μg/ml), Pseudomonas aeruginosa PA14 (MIC=62.5 μg/ml), Pseudomonas aeruginosa M2 (MIC=31.3 μg/ml), Pseudomonas aeruginosa CP204 (MIC=7.8 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=31.2 μg/ml)	[Ref.17158938]MHC=15.6 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17158938	Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.	Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.	Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.	
DRAMP18538	KWKSFLKTFKSAVKTVLHTALKAISS	26	V681	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=16.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=9.0 μg/ml), Staphylococcus epidermidis C621 (MIC=5.0 μg/ml), Bacillus subtilis C971 (MIC=2.2 μg/ml), Enterococcus faecalis C625 (MIC=16.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.5 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=6.3 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=7.1 μg/ml), Escherichia coli DC2 (MIC=4.5 μg/ml), Salmonella typhimurium C587 (MIC=20.2 μg/ml), Salmonella typhimurium C610 (MIC=5.7 μg/ml), Pseudomonas aeruginosa H187 (MIC=6.4 μg/ml), Pseudomonas aeruginosa H188 (MIC=20.2 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=8.8 μg/ml)	[Ref.15677462]MHC=15.6 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18539	KWKSFLKTFKSALKTVLHTALKAISS	26	V13LL (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Leucine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=32.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=25.4 μg/ml), Staphylococcus epidermidis C621 (MIC=8.0 μg/ml), Bacillus subtilis C971 (MIC=3.2 μg/ml), Enterococcus faecalis C625 (MIC=32.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.5 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=10.9 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=6.4 μg/ml), Escherichia coli DC2 (MIC=5.0 μg/ml), Salmonella typhimurium C587 (MIC=32.0 μg/ml), Salmonella typhimurium C610 (MIC=10.1 μg/ml), Pseudomonas aeruginosa H187 (MIC=12.7 μg/ml), Pseudomonas aeruginosa H188 (MIC=32.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=12.7 μg/ml)	[Ref.15677462]MHC=7.8 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18540	KWKSFLKTFKSAAKTVLHTALKAISS	26	V13AL (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Alanine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=8.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=5.0 μg/ml), Staphylococcus epidermidis C621 (MIC=3.2 μg/ml), Bacillus subtilis C971 (MIC=2.0 μg/ml), Enterococcus faecalis C625 (MIC=16.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=4.5 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=2.5 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=6.4 μg/ml), Salmonella typhimurium C610 (MIC=2.5 μg/ml), Pseudomonas aeruginosa H187 (MIC=5.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=6.4 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=3.8 μg/ml)	[Ref.15677462]MHC=31.2 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18541	KWKSFLKTFKSAGKTVLHTALKAISS	26	V13G (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Glycine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=25.4 μg/ml), Staphylococcus aureus SAP0017 (MIC=10.1 μg/ml), Staphylococcus epidermidis C621 (MIC=3.2 μg/ml), Bacillus subtilis C971 (MIC=2.0 μg/ml), Enterococcus faecalis C625 (MIC=50.8 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=7.4 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=2.5 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=5.0 μg/ml), Salmonella typhimurium C610 (MIC=2.5 μg/ml), Pseudomonas aeruginosa H187 (MIC=6.4 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=4.1 μg/ml)	[Ref.15677462]MHC=125.0 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18542	KWKSFLKTFKSASKTVLHTALKAISS	26	V13SL (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Serine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=16.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=12.7 μg/ml), Staphylococcus epidermidis C621 (MIC=4.0 μg/ml), Bacillus subtilis C971 (MIC=2.5 μg/ml), Enterococcus faecalis C625 (MIC=50.8 μg/ml), Corynebacterium xerosis C875 (MIC=1.6 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=7.4 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=2.5 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=6.4 μg/ml), Salmonella typhimurium C610 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=6.4 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=4.2 μg/ml)	[Ref.15677462]MHC=125.0 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18543	KWKSFLKTFKSALKTVLHTALKAISS	26	V13LD (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Leucine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=5.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=4.0 μg/ml), Staphylococcus epidermidis C621 (MIC=2.5 μg/ml), Bacillus subtilis C971 (MIC=2.5 μg/ml), Enterococcus faecalis C625 (MIC=6.4 μg/ml), Corynebacterium xerosis C875 (MIC=1.6 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=3.3 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=3.2 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=16.0 μg/ml), Salmonella typhimurium C610 (MIC=3.2 μg/ml), Pseudomonas aeruginosa H187 (MIC=6.4 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=5.5 μg/ml)	[Ref.15677462]MHC=7.8 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18544	KWKSFLKTFKSAVKTVLHTALKAISS	26	V13VD (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Valine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=4.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=3.2 μg/ml), Staphylococcus epidermidis C621 (MIC=1.6 μg/ml), Bacillus subtilis C971 (MIC=1.3 μg/ml), Enterococcus faecalis C625 (MIC=12.7 μg/ml), Corynebacterium xerosis C875 (MIC=1.3 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=2.8 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=2.5 μg/ml), Escherichia coli DC2 (MIC=1.6 μg/ml), Salmonella typhimurium C587 (MIC=5.0 μg/ml), Salmonella typhimurium C610 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=4.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=8.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=3.3 μg/ml)	[Ref.15677462]MHC=62.5 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18545	KWKSFLKTFKSAAKTVLHTALKAISS	26	V13AD (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Alanine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=8.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=5.0 μg/ml), Staphylococcus epidermidis C621 (MIC=2.0 μg/ml), Bacillus subtilis C971 (MIC=1.6 μg/ml), Enterococcus faecalis C625 (MIC=32.0 μg/ml), Corynebacterium xerosis C875 (MIC=1.6 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=4.3 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=1.6 μg/ml), Escherichia coli DC2 (MIC=2.0 μg/ml), Salmonella typhimurium C587 (MIC=5.0 μg/ml), Salmonella typhimurium C610 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=4.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=3.3 μg/ml)	[Ref.15677462]MHC=250.0 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18546	KWKSFLKTFKSASKTVLHTALKAISS	26	V13SD (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Serine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Weak hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=64.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=64.0 μg/ml), Staphylococcus epidermidis C621 (MIC=12.7 μg/ml), Bacillus subtilis C971 (MIC=2.5 μg/ml), Enterococcus faecalis C625 (MIC=64.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=16.0 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=3.2 μg/ml), Escherichia coli DC2 (MIC=2.0 μg/ml), Salmonella typhimurium C587 (MIC=12.7 μg/ml), Salmonella typhimurium C610 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=18.3 μg/ml), Pseudomonas aeruginosa H188 (MIC=20.2 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=6.3 μg/ml)	[Ref.15677462]MHC>250.0 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18547	KWKSFLKTFKSAKKTVLHTALKAISS	26	V13KD (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Lysine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Weak hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=64.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=64.0 μg/ml), Staphylococcus epidermidis C621 (MIC=25.4 μg/ml), Bacillus subtilis C971 (MIC=3.2 μg/ml), Enterococcus faecalis C625 (MIC=64.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=18.7 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=3.2 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=32.0 μg/ml), Salmonella typhimurium C610 (MIC=1.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=32.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=25.4 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=7.7 μg/ml)	[Ref.15677462]MHC>250.0 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18548	KWKSFLKTFKLAVKTVLHTALKAISS	26	S11LL (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Leucine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=32.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=32.0 μg/ml), Staphylococcus epidermidis C621 (MIC=16.0 μg/ml), Bacillus subtilis C971 (MIC=5.0 μg/ml), Enterococcus faecalis C625 (MIC=50.8 μg/ml), Corynebacterium xerosis C875 (MIC=2.5 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=14.8 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=16.0 μg/ml), Escherichia coli DC2 (MIC=5.0 μg/ml), Salmonella typhimurium C587 (MIC=32.0 μg/ml), Salmonella typhimurium C610 (MIC=12.7 μg/ml), Pseudomonas aeruginosa H187 (MIC=20.2 μg/ml), Pseudomonas aeruginosa H188 (MIC=32.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=16.6 μg/ml)	[Ref.15677462]MHC=4.0 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18549	KWKSFLKTFKVAVKTVLHTALKAISS	26	S11VL (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Valine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=16.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=12.7 μg/ml), Staphylococcus epidermidis C621 (MIC=8.0 μg/ml), Bacillus subtilis C971 (MIC=2.5 μg/ml), Enterococcus faecalis C625 (MIC=20.2 μg/ml), Corynebacterium xerosis C875 (MIC=1.3 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=6.9 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=6.4 μg/ml), Escherichia coli DC2 (MIC=4.0 μg/ml), Salmonella typhimurium C587 (MIC=32.0 μg/ml), Salmonella typhimurium C610 (MIC=5.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=10.1 μg/ml), Pseudomonas aeruginosa H188 (MIC=20.2 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=9.7 μg/ml)	[Ref.15677462]MHC=7.8 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18550	KWKSFLKTFKAAVKTVLHTALKAISS	26	S11AL (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Alanine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=16.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=12.7 μg/ml), Staphylococcus epidermidis C621 (MIC=4.0 μg/ml), Bacillus subtilis C971 (MIC=2.5 μg/ml), Enterococcus faecalis C625 (MIC=20.2 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=6.6 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=6.4 μg/ml), Escherichia coli DC2 (MIC=4.0 μg/ml), Salmonella typhimurium C587 (MIC=20.2 μg/ml), Salmonella typhimurium C610 (MIC=4.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=10.1 μg/ml), Pseudomonas aeruginosa H188 (MIC=16.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=8.3 μg/ml)	[Ref.15677462]MHC=15.6 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18551	KWKSFLKTFKGAVKTVLHTALKAISS	26	S11G (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Glycine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=8.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=5.0 μg/ml), Staphylococcus epidermidis C621 (MIC=4.0 μg/ml), Bacillus subtilis C971 (MIC=2.0 μg/ml), Enterococcus faecalis C625 (MIC=12.7 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=4.5 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=5.0 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=12.7 μg/ml), Salmonella typhimurium C610 (MIC=3.2 μg/ml), Pseudomonas aeruginosa H187 (MIC=4.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=5.2 μg/ml)	[Ref.15677462]MHC=7.8 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18552	KWKSFLKTFKKAVKTVLHTALKAISS	26	S11KL (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Lysine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=32.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=16.0 μg/ml), Staphylococcus epidermidis C621 (MIC=6.4 μg/ml), Bacillus subtilis C971 (MIC=3.2 μg/ml), Enterococcus faecalis C625 (MIC=32.0 μg/ml), Corynebacterium xerosis C875 (MIC=4.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=10.5 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=10.1 μg/ml), Escherichia coli DC2 (MIC=4.0 μg/ml), Salmonella typhimurium C587 (MIC=25.4 μg/ml), Salmonella typhimurium C610 (MIC=8.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=25.4 μg/ml), Pseudomonas aeruginosa H188 (MIC=32.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=13.7 μg/ml)	[Ref.15677462]MHC=4.0 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18553	KWKSFLKTFKLAVKTVLHTALKAISS	26	S11LD (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Leucine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=8.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=5.0 μg/ml), Staphylococcus epidermidis C621 (MIC=4.0 μg/ml), Bacillus subtilis C971 (MIC=2.0 μg/ml), Enterococcus faecalis C625 (MIC=16.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=4.7 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=5.0 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=10.1 μg/ml), Salmonella typhimurium C610 (MIC=3.2 μg/ml), Pseudomonas aeruginosa H187 (MIC=4.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=5.0 μg/ml)	[Ref.15677462]MHC=31.2 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18554	KWKSFLKTFKVAVKTVLHTALKAISS	26	S11VD (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Valine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=16.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=8.0 μg/ml), Staphylococcus epidermidis C621 (MIC=4.0 μg/ml), Bacillus subtilis C971 (MIC=2.5 μg/ml), Enterococcus faecalis C625 (MIC=32.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=6.6 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=5.0 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=10.1 μg/ml), Salmonella typhimurium C610 (MIC=4.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=6.4 μg/ml), Pseudomonas aeruginosa H188 (MIC=16.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=6.1 μg/ml)	[Ref.15677462]MHC=125.0 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18555	KWKSFLKTFKAAVKTVLHTALKAISS	26	S11AD (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Alanine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=6.4 μg/ml), Staphylococcus aureus SAP0017 (MIC=5.0 μg/ml), Staphylococcus epidermidis C621 (MIC=2.5 μg/ml), Bacillus subtilis C971 (MIC=2.0 μg/ml), Enterococcus faecalis C625 (MIC=12.7 μg/ml), Corynebacterium xerosis C875 (MIC=1.6 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=3.8 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=4.0 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=8.0 μg/ml), Salmonella typhimurium C610 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=5.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=8.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=4.3 μg/ml)	[Ref.15677462]MHC=15.6 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18556	KWKSFLKTFKSAVKTVLHTALKAISS	26	S11SD (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Serine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=4.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=2.5 μg/ml), Staphylococcus epidermidis C621 (MIC=2.0 μg/ml), Bacillus subtilis C971 (MIC=1.3 μg/ml), Enterococcus faecalis C625 (MIC=6.4 μg/ml), Corynebacterium xerosis C875 (MIC=1.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=2.3 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=2.5 μg/ml), Escherichia coli DC2 (MIC=1.6 μg/ml), Salmonella typhimurium C587 (MIC=5.0 μg/ml), Salmonella typhimurium C610 (MIC=1.6 μg/ml), Pseudomonas aeruginosa H187 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=2.9 μg/ml)	[Ref.15677462]MHC=15.6 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18557	KWKSFLKTFKKAVKTVLHTALKAISS	26	S11KD (V681 peptide derivative)	No entry found	Derived from the framework peptide V681	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Lysine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.	[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=4.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=2.5 μg/ml), Staphylococcus epidermidis C621 (MIC=2.0 μg/ml), Bacillus subtilis C971 (MIC=2.0 μg/ml), Enterococcus faecalis C625 (MIC=12.7 μg/ml), Corynebacterium xerosis C875 (MIC=1.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=2.8 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=3.2 μg/ml), Escherichia coli DC2 (MIC=1.6 μg/ml), Salmonella typhimurium C587 (MIC=3.2 μg/ml), Salmonella typhimurium C610 (MIC=1.6 μg/ml), Pseudomonas aeruginosa H187 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=6.4 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=2.6 μg/ml)	[Ref.15677462]MHC=31.2 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15677462	J Biol Chem. 2005 Apr 1;280(13):12316-29.	Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.	Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.	
DRAMP18558	FIKRIARLLRKIF	13	Kn2-7 (BmKn2 peptide derivative)	No entry found	Derived from the peptide BmKn2	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.22792229]Gram-positive bacteria: Staphylococcus aureus AB94004 (MIC=3.13 μg/ml), Staphylococcus aureus ATCC 25923 (MIC=3.13 μg/ml), Bacillus subtilis AB91021 (MIC=6.25 μg/ml), Bacillus thuringiensis AB92037 (MIC=6.25 μg/ml), Micrococcus luteus AB93113 (MIC=6.25 μg/ml);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=6.25 μg/ml), Escherichia coli ATCC 25922 (MIC=25 μg/ml), Pseudomonas aeruginosa AB93066 (MIC=25 μg/ml), Pseudomonas aeruginosa A092994 (MIC=50 μg/ml), Pseudomonas aeruginosa A093052 (MIC=100 μg/ml), Pseudomonas aeruginosa A093056 (MIC=50 μg/ml), Pseudomonas aeruginosa A093085 (MIC=50 μg/ml), Pseudomonas aeruginosa A093115 (MIC=100 μg/ml).	[Ref.22792229]Non-hemolysis at 6.25 μg/ml, 5% hemolysis at 12.5 μg/ml,10% hemolysis at 25 μg/ml 15% hemolysis at 50 μg/ml, 40% hemolysis at 100 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22792229	PLoS One. 2012;7(7):e40135. doi: 10.1371/journal.pone.0040135.	Cao L, Dai C, Li Z, Fan Z, Song Y, Wu Y, Cao Z, Li W.	Antibacterial activity and mechanism of a scorpion venom peptide derivative in vitro and in vivo.	
DRAMP18559	IWRIFRRIF	9	HFU3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.22699557]Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=4 μM), Staphylococcus epidermidis ATCC 12228 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8 μM), Pseudomonas aeruginosa 27853 (MIC=4 μM)	[Ref.22699557]MHC=101.4 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22699557	Amino Acids. 2012 Dec;43(6):2527-36. doi: 10.1007/s00726-012-1334-7.	Ma QQ, Dong N, Shan AS, Lv YF, Li YZ, Chen ZH, Cheng BJ, Li ZY.	Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units.	
DRAMP18560	IWRIFRRIFRIF	12	HFU4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Has hemolytic activity.	[Ref.22699557]Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=1 μM), Staphylococcus epidermidis ATCC 12228 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4 μM), Pseudomonas aeruginosa 27853 (MIC=4 μM)	[Ref.22699557]MHC=19.6 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22699557	Amino Acids. 2012 Dec;43(6):2527-36. doi: 10.1007/s00726-012-1334-7.	Ma QQ, Dong N, Shan AS, Lv YF, Li YZ, Chen ZH, Cheng BJ, Li ZY.	Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units.	
DRAMP18561	IWRIFRRIFRIFIRF	15	HFU5	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.22699557]Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=8 μM), Staphylococcus epidermidis ATCC 12228 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16 μM), Pseudomonas aeruginosa 27853 (MIC=16 μM)	[Ref.22699557]MHC=15.0 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22699557	Amino Acids. 2012 Dec;43(6):2527-36. doi: 10.1007/s00726-012-1334-7.	Ma QQ, Dong N, Shan AS, Lv YF, Li YZ, Chen ZH, Cheng BJ, Li ZY.	Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units.	
DRAMP18562	KSLVRRWRSRW	11	MAP-04-01 (Ixosin-B peptide derivative)	No entry found	Derived from the peptide Ixosin-B	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. No hemolytic activity.	[Ref.22578463]Gram-positive bacterium: Staphylococcus aureus (MIC90=30 μM);##Gram-negative bacterium: Escherichia coli (MIC90=30 μM), Pseudomonas aeroginosa (MIC90=40 μM)	[Ref.22578463]Non-hemolysis at 100μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22578463	Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8.	Lung FD, Wang KS, Liao ZJ, Hsu SK, Song FY, Liou CC, Wu YS.	Discovery of potent antimicrobial peptide analogs of Ixosin-B.	
DRAMP18563	KSLRRVWRSWR	11	MAP-04-02 (Ixosin-B peptide derivative)	No entry found	Derived from the peptide Ixosin-B	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.No hemolytic activity.	[Ref.22578463]Gram-positive bacterium: Staphylococcus aureus (MIC90=60 μM);##Gram-negative bacterium: Escherichia coli (MIC90=30 μM), Pseudomonas aeroginosa (MIC90=40 μM)	[Ref.22578463]Non-hemolysis at 100μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22578463	Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8.	Lung FD, Wang KS, Liao ZJ, Hsu SK, Song FY, Liou CC, Wu YS.	Discovery of potent antimicrobial peptide analogs of Ixosin-B.	
DRAMP18564	KWLRRVWRWWR	11	MAP-04-03 (Ixosin-B peptide derivative)	No entry found	Derived from the peptide Ixosin-B	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Highly hemolytic activity.	[Ref.22578463]Gram-positive bacterium: Staphylococcus aureus (MIC90=2.5 μM);##Gram-negative bacterium: Escherichia coli (MIC90=15 μM), Pseudomonas aeroginosa (MIC90=20 μM)	[Ref.22578463]100% hemolysis at 100μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22578463	Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8.	Lung FD, Wang KS, Liao ZJ, Hsu SK, Song FY, Liou CC, Wu YS.	Discovery of potent antimicrobial peptide analogs of Ixosin-B.	
DRAMP18565	KRLRRVWRRWR	11	MAP-04-04 (Ixosin-B peptide derivative)	No entry found	Derived from the peptide Ixosin-B	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Weak hemolytic activity.	[Ref.22578463]Gram-positive bacterium: Staphylococcus aureus (MIC90=5 μM);##Gram-negative bacterium: Escherichia coli (MIC90=30 μM), Pseudomonas aeroginosa (MIC90=20 μM)	[Ref.22578463]3% hemolysis at 100μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22578463	Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8.	Lung FD, Wang KS, Liao ZJ, Hsu SK, Song FY, Liou CC, Wu YS.	Discovery of potent antimicrobial peptide analogs of Ixosin-B.	
DRAMP18566	VNWKKSLGKSIKVVK	15	LL-IIIs-1 (lasioglossin III peptide derivative)	No entry found	Derived from the peptide lasioglossin III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.7 μM), Bacillus cereus (MIC=0.8 μM), Staphylococcus aureus  (MIC=12.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=4.4 μM), Pseudomonas aeruginosa (MIC=78.7 μM);##Fungi: Candida albicans (MIC=100 μM)	[Ref.22526241]LC50=31.3 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18567	VNWKKILGKSIKVSK	15	LL-IIIs-2 (lasioglossin III peptide derivative)	No entry found	Derived from the peptide lasioglossin III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.9 μM), Bacillus cereus (MIC=1.2 μM), Staphylococcus aureus  (MIC=20.3 μM);##Gram-negative bacteria: Escherichia coli (MIC=8.8 μM), Pseudomonas aeruginosa (MIC=86.7 μM);##Fungi: Candida albicans (MIC=100 μM)	[Ref.22526241]LC50=69 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18568	VSWKKSLGKIIKVVK	15	LL-IIIs-3 (lasioglossin III peptide derivative)	No entry found	Derived from the peptide lasioglossin III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.4 μM), Bacillus cereus (MIC=1.1 μM), Staphylococcus aureus  (MIC=21.7 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.2 μM), Pseudomonas aeruginosa (MIC=76.3 μM);##Fungi: Candida albicans (MIC=93.3 μM)	[Ref.22526241]LC50=30 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18569	VNSKKISGKSIKVSK	15	LL-IIIs-4 (lasioglossin III peptide derivative)	No entry found	Derived from the peptide lasioglossin III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=2 μM), Bacillus cereus (MIC=1.1 μM), Staphylococcus aureus  (MIC=80 μM);##Gram-negative bacteria: Escherichia coli (MIC=20 μM).	[Ref.22526241]LC50>100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18570	VNRKKILGKSIKVVK	15	LL-IIIs-5 cis (lasioglossin III peptide derivative)	No entry found	Derived from the peptide lasioglossin III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.9 μM), Bacillus cereus (MIC=0.9 μM), Staphylococcus aureus  (MIC=45 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.5 μM), Pseudomonas aeruginosa (MIC=80 μM).	[Ref.22526241]LC50=100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18571	VNRKKILGKSIKVVK	15	LL-IIIs-5 trans (lasioglossin III peptide derivative)	No entry found	Derived from the peptide lasioglossin III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria .Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.1 μM), Bacillus cereus (MIC=1.3 μM), Staphylococcus aureus  (MIC=65 μM);##Gram-negative bacteria: Escherichia coli (MIC=5.5 μM), Pseudomonas aeruginosa (MIC=80 μM).	[Ref.22526241]LC50>100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18572	VNSKKISPKSIKVSK	15	LL-IIIs-6a (lasioglossin III peptide derivative)	No entry found	Derived from the peptide lasioglossin III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1 μM), Bacillus cereus (MIC=1.1 μM), Staphylococcus aureus  (MIC=93 μM);##Gram-negative bacteria: Escherichia coli (MIC=7.8 μM), Pseudomonas aeruginosa (MIC=93 μM).	[Ref.22526241]LC50>100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18573	VNSKKISPKSIKVSK	15	LL-IIIs-6b (lasioglossin III peptide derivative)	No entry found	Derived from the peptide lasioglossin III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.9 μM), Bacillus cereus (MIC=0.8 μM), Staphylococcus aureus  (MIC=50 μM);##Gram-negative bacteria: Escherichia coli (MIC=7.8 μM), Pseudomonas aeruginosa (MIC=63 μM).	[Ref.22526241]LC50=82 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18574	GFLSILKKVLPKVXAHXK	18	MEP-N (melectin peptide derivative)	No entry found	Derived from the peptide melectin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1 μM), Bacillus cereus (MIC=0.5 μM), Staphylococcus aureus (MIC=2.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.9 μM), Pseudomonas aeruginosa (MIC=17.3 μM);##Fungi: Candida albicans (MIC=15 μM)	[Ref.22526241]LC50=50 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18575	GFLSILKKVLPKSXAHSK	18	MEP-Ns-1 (melectin peptide derivative)	No entry found	Derived from the peptide melectin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.8 μM), Bacillus cereus (MIC=1.1 μM), Staphylococcus aureus (MIC=10.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.5 μM), Pseudomonas aeruginosa (MIC=77 μM);##Fungi: Candida albicans (MIC=30 μM)	[Ref.22526241]LC50=18.1 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18576	GFLSSLKKSLPKVXAHXK	18	MEP-Ns-2 (melectin peptide derivative)	No entry found	Derived from the peptide melectin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.5 μM), Bacillus cereus (MIC=1.2 μM), Staphylococcus aureus  (MIC=37 μM);##Gram-negative bacteria: Escherichia coli (MIC=7.8 μM).	[Ref.22526241]LC50=14.7 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18577	GFLSSLKKSLPKSXAHSK	18	MEP-Ns-3 (melectin peptide derivative)	No entry found	Derived from the peptide melectin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.3 μM), Bacillus cereus (MIC=1.2 μM) ;##Gram-negative bacteria: Escherichia coli (MIC=46.7 μM).	[Ref.22526241]LC50=13.9 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18578	GFRSILKKVSPKVXAHXK	18	MEP-Ns-4 cis (melectin peptide derivative)	No entry found	Derived from the peptide melectin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.5 μM), Bacillus cereus (MIC=1.3 μM), Staphylococcus aureus (MIC=37 μM);##Gram-negative bacteria: Escherichia coli (MIC=8.1 μM).	[Ref.22526241]LC50=11 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18579	GFRSILKKVSPKVXAHXK	18	MEP-Ns-4 trans (melectin peptide derivative)	No entry found	Derived from the peptide melectin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=2 μM), Bacillus cereus (MIC=1.7 μM), Staphylococcus aureus (MIC=63 μM);##Gram-negative bacteria: Escherichia coli (MIC=16.3 μM).	[Ref.22526241]LC50=20 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18580	GFLSSLKKSLGKSXAHSK	18	MEP-Ns-5 (melectin peptide derivative)	No entry found	Derived from the peptide melectin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.5 μM), Bacillus cereus (MIC=1.2 μM), Staphylococcus aureus (MIC=57 μM);##Gram-negative bacteria: Escherichia coli (MIC=5.6 μM).	[Ref.22526241]LC50=29 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18581	GFLSSLKKSLAKSXAHSK	18	MEP-Ns-6 (melectin peptide derivative)	No entry found	Derived from the peptide melectin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.5 μM), Bacillus cereus (MIC=1.2 μM), Staphylococcus aureus (MIC=43 μM);##Gram-negative bacteria: Escherichia coli (MIC=5.6 μM).	[Ref.22526241]LC50=39.5 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58.	Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.	Effect of hydrocarbon stapling on the properties of 	
DRAMP18582	KWFRVYRGIYRRR	13	CDT (Tachyplesin-1 peptide derivative)	No entry found	Derived from the peptide Tachyplesin-1 	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Beta strand	All of the four Cys residues were deleted from the primary structure of AMP.		Function: The MIC values of CDT were even found to be lower against Escherichia coli and Listeria monocytogenes in comparison to the native TP-1 peptide. No hemolytic activity.	No MICs found in DRAMP database	[Ref.22464970]Non-hemolysis at 200 μg/mL against Not found (The literature does not mention).	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22464970	Biochim Biophys Acta. 2012 Jul;1818(7):1613-24.	Saravanan R, Mohanram H, Joshi M, Domadia PN, Torres J, Ruedl C, Bhattacharjya S.	Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization.	
DRAMP18583	KWCFCVCYRGICYCRCRG	18	Tricystine cyclic cystine TP (ccTP, Tachyplesin-1 peptide derivative)	No entry found	Derived from the peptide Tachyplesin-1	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Beta tile	Although there is insufficient information to deconvolute these CD spectra of these two-b-strand cyclic cystine-knot structures due to the various contributions by β-turns, aromatic residues, disulfides and b-sheet structures, it is reasonable to conclude that all cyclic tachyplesins 2–6 as well as RTD display ordered structures in methanol.		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria.Antifungal activity agaist Candida albicans, Candida kefyr, Candida tropicalis	[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.0 μM in low-salt; MIC=0.8 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.4 μM in high-salt), Enterococcus faecalis (MIC=1.0 μM in low-salt; MIC=0.9 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=3.0 μM in low-salt; MIC=6.9 μM in high-salt), Pseudomonas aeruginosa (MIC=5.0 μM in low-salt; MIC=5.2 μM in high-salt), Primula vulgaris (MIC=6.0 μM in low-salt; MIC=14.4 μM in high-salt), Klebsiella oxytoca (MIC=2.1 μM in low-salt; MIC=7.8 μM in high-salt);##Fungi: Candida albicans (MIC=5.1 μM in low-salt; MIC=17.2 μM in high-salt), Candida kefyr (MIC=3.9 μM in low-salt; MIC=4.1 μM in high-salt), Candida tropicalis (MIC=5.2 μM in low-salt; MIC=1.1 μM in high-salt).	[Ref.10673369] EC25=3800 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.	L	No cytotoxicity information found	Not found	10673369	Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.	Tam JP, Lu YA, Yang JL.	Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.	
DRAMP18584	KWCFCVCYRGICRCRCRG	18	[Arg13]ccTP (ccTP peptide derivative)	No entry found	Derived from the peptide ccTP	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.3 μM in low-salt; MIC=0.9 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.5 μM in high-salt), Enterococcus faecalis (MIC=1.9 μM in low-salt; MIC=1.3 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=10.4 μM in low-salt; MIC=0.9 μM in high-salt), Pseudomonas aeruginosa (MIC=6.2 μM in low-salt; MIC=10.4 μM in high-salt), Primula vulgaris (MIC=16.4 μM in low-salt; MIC=28.9 μM in high-salt), Klebsiella oxytoca (MIC=4.0 μM in low-salt; MIC=7.6 μM in high-salt);##Fungi: Candida albicans (MIC=24.2 μM in low-salt; MIC=30.2 μM in high-salt), Candida kefyr (MIC=1.1 μM in low-salt; MIC=4.3 μM in high-salt), Candida tropicalis (MIC=12.4 μM in low-salt; MIC=3.9 μM in high-salt).	[Ref.10673369] EC25=590 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.	L	No cytotoxicity information found	Not found	10673369	Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.	Tam JP, Lu YA, Yang JL.	Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.	
DRAMP18585	KWCRCVCRRGICYCRCRG	18	[Arg4,8]ccTP (ccTP peptide derivative)	No entry found	Derived from the peptide ccTP	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Beta tile	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.3 μM in low-salt; MIC=0.3 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.7 μM in high-salt), Enterococcus faecalis (MIC=1.0 μM in low-salt; MIC=1.2 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=9.8 μM in low-salt; MIC=2.0 μM in high-salt), Pseudomonas aeruginosa (MIC=8.0 μM in low-salt; MIC=5.3 μM in high-salt), Primula vulgaris (MIC=26.7 μM in low-salt; MIC=56.2 μM in high-salt), Klebsiella oxytoca (MIC=6.1 μM in low-salt; MIC=7.8 μM in high-salt);##Fungi: Candida albicans (MIC=6.4 μM in low-salt; MIC=11.2 μM in high-salt), Candida kefyr (MIC=1.1 μM in low-salt; MIC=1.9 μM in high-salt), Candida tropicalis (MIC=2.8 μM in low-salt; MIC=4.2 μM in high-salt).	[Ref.10673369] EC25=910 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.	L	No cytotoxicity information found	Not found	10673369	Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.	Tam JP, Lu YA, Yang JL.	Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.	
DRAMP18586	KWCRCVCRRGICRCRCRG	18	[Arg4,8,13]ccTP (ccTP peptide derivative)	No entry found	Derived from the peptide ccTP	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.7 μM in low-salt; MIC=1.3 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.8 μM in high-salt), Enterococcus faecalis (MIC=0.7 μM in low-salt; MIC=0.5 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=5.5 μM in low-salt; MIC=1.2 μM in high-salt), Pseudomonas aeruginosa (MIC=3.9 μM in low-salt; MIC=4.7 μM in high-salt), Primula vulgaris (MIC=16.8 μM in low-salt; MIC=55.6 μM in high-salt), Klebsiella oxytoca (MIC=2.4 μM in low-salt; MIC=5.4 μM in high-salt);##Fungi: Candida albicans (MIC=7.1 μM in low-salt; MIC=5.1 μM in high-salt), Candida kefyr (MIC=4.2 μM in low-salt; MIC=0.7 μM in high-salt), Candida tropicalis (MIC=1.9 μM in low-salt; MIC=4.8 μM in high-salt).	[Ref.10673369] EC25=920 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.	L	No cytotoxicity information found	Not found	10673369	Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.	Tam JP, Lu YA, Yang JL.	Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.	
DRAMP18587	KWCRCVCRRGICRCRCRK	18	[Arg4,8,13][Lys18]ccTP (ccTP peptide derivative)	No entry found	Derived from the peptide ccTP	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.7 μM in low-salt; MIC=0.7 μM in high-salt), Micrococcus luteus (MIC=0.3 μM in low-salt; MIC=0.4 μM in high-salt), Enterococcus faecalis (MIC=1.4 μM in low-salt; MIC=1.2 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=6.1 μM in low-salt; MIC=1.2 μM in high-salt), Pseudomonas aeruginosa (MIC=2.0 μM in low-salt; MIC=4.7 μM in high-salt), Primula vulgaris (MIC=17.0 μM in low-salt; MIC=39.8 μM in high-salt), Klebsiella oxytoca (MIC=4.1 μM in low-salt; MIC=4.1 μM in high-salt);##Fungi: Candida albicans (MIC=10.5 μM in low-salt; MIC=5.2 μM in high-salt), Candida kefyr (MIC=1.1 μM in low-salt; MIC=0.7 μM in high-salt), Candida tropicalis (MIC=2.3 μM in low-salt; MIC=1.9 μM in high-salt).	[Ref.10673369] EC25=3900 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.	L	No cytotoxicity information found	Not found	10673369	Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.	Tam JP, Lu YA, Yang JL.	Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.	
DRAMP18588	GFCRCLCRRGVCRCICTK	18	RTD	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.1 μM in low-salt; MIC=0.9 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.4 μM in high-salt), Enterococcus faecalis (MIC=1.2 μM in low-salt; MIC=1.2 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=2.0 μM in low-salt; MIC=28.4 μM in high-salt), Pseudomonas aeruginosa (MIC=2.0 μM in low-salt; MIC=5.2 μM in high-salt), Primula vulgaris (MIC=10.2 μM in low-salt; MIC=50.4 μM in high-salt), Klebsiella oxytoca (MIC=2.0 μM in low-salt; MIC=12.8 μM in high-salt);##Fungi: Candida albicans (MIC=4.0 μM in low-salt; MIC=5.2 μM in high-salt), Candida kefyr (MIC=1.8 μM in low-salt; MIC=1.2 μM in high-salt), Candida tropicalis (MIC=2.8 μM in low-salt; MIC=1.0 μM in high-salt).	[Ref.10673369]EC25=2350 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	10673369	Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.	Tam JP, Lu YA, Yang JL.	Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.	
DRAMP18589	GWLDVAKKIGKAAFNVAKNFLFNKAVNFAAKGIKKAVDLWG	42	DSE (Ctx-Ha peptide derivative)	No entry found	Derived from the peptide Ctx-Ha	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.Has hemolytic activity.	[Ref.22391524]Gram-positive bacterium: Staphylococcus aureus (MIC=8.9 μmol/L; MMC=13.3 μmol/L);##Gram-negative bacterium: Escherichia coli (MIC=3.3 μmol/L; MMC=13.3 μmol/L);##Fungi: Candida albicans (MIC=53.3 μmol/L; MMC=53.3 μmol/L)	[Ref.22391524]HC50=0.6±0.1 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22391524	Antimicrob Agents Chemother. 2012 Jun;56(6):3004-10.	Lorenzón EN, Cespedes GF, Vicente EF, Nogueira LG, Bauab TM, Castro MS, Cilli EM.	Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.	
DRAMP18590	GWLDVAKKIGKAAFNVAKNFL-spacer-LFNKAVNFAAKGIKKAVDLWG	42	DEP (Ctx-Ha peptide derivative)	No entry found	Derived from the peptide Ctx-Ha	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.22391524]Gram-positive bacterium: Staphylococcus aureus (MIC=3.2 μmol/L; MMC=12.9 μmol/L);##Gram-negative bacterium: Escherichia coli (MIC=1.6 μmol/L; MMC=3.2 μmol/L);##Fungi: Candida albicans (MIC=51.7 μmol/L; MMC=51.7 μmol/L)	[Ref.22391524]HC50=0.7±0.1 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22391524	Antimicrob Agents Chemother. 2012 Jun;56(6):3004-10.	Lorenzón EN, Cespedes GF, Vicente EF, Nogueira LG, Bauab TM, Castro MS, Cilli EM.	Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.	
DRAMP18591	GWLDVAKKIGKAAFNVAKNFL-spacer-LFNKAVNFAAKGIKKAVDLWG	42	DEA (Ctx-Ha peptide derivative)	No entry found	Derived from the peptide Ctx-Ha	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.22391524]Gram-positive bacterium: Staphylococcus aureus (MIC=12.9 μmol/L; MMC=25.9 μmol/L);##Gram-negative bacterium: Escherichia coli (MIC=6.5 μmol/L; MMC=12.9 μmol/L);##Fungi: Candida albicans (MIC=100 μmol/L; MMC<100 μmol/L)	[Ref.22391524]HC50=0.8±0.1 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22391524	Antimicrob Agents Chemother. 2012 Jun;56(6):3004-10.	Lorenzón EN, Cespedes GF, Vicente EF, Nogueira LG, Bauab TM, Castro MS, Cilli EM.	Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.	
DRAMP18592	GWLDVAKKIGKAAFNVAKNFI	21	Ctx(Ile21)-Ha (Ctx-Ha peptide derivative)	No entry found	Derived from the peptide Ctx-Ha	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.22519531]Gram-positive bacterium: Staphylococcus aureus (MIC=1 μmol/L);##Gram-negative bacteria: Escherichia coli (MIC=4 μmol/L), Pseudomonas aeruginosa (MIC=8 μmol/L);##Fungi: Candida albicans (MIC=8 μmol/L), Candida krusei (MIC=8 μmol/L), Candida parapsilosis (MIC=4 μmol/L), Cryptococcus neoformans (MIC=8 μmol/L)	[Ref.22519531]HC50=26 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22519531	Protein Pept Lett. 2012 Jun 1;19(6):596-603.	Cespedes GF, Lorenzón EN, Vicente EF, Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM.	Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus.	
DRAMP18593	GWLDVAKKIGKAAFNVAKNFI	21	Ctx(Ile21)-Ha-VD16 (Ctx-Ha peptide derivative)	No entry found	Derived from the peptide Ctx-Ha	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. D-Valine to replace L-Valine at the position 16 on the peptide Ctx(Ile21)-Ha. Has hemolytic activity.	[Ref.22519531]Gram-positive bacterium: Staphylococcus aureus (MIC=2 μmol/L);##Gram-negative bacteria: Escherichia coli (MIC=4 μmol/L), Pseudomonas aeruginosa (MIC=16 μmol/L);##Fungi: Candida albicans (MIC=31 μmol/L), Candida krusei (MIC=16 μmol/L), Candida parapsilosis (MIC=31 μmol/L), Cryptococcus neoformans (MIC=31 μmol/L)	[Ref.22519531]HC50=18.7 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22519531	Protein Pept Lett. 2012 Jun 1;19(6):596-603.	Cespedes GF, Lorenzón EN, Vicente EF, Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM.	Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus.	
DRAMP18594	GWLDVAKKIGKAAFNVAKNFI	21	Ctx(Ile21)-Ha-VD5,16 (Ctx-Ha peptide derivative)	No entry found	Derived from the peptide Ctx-Ha	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. D-Valine to replace L-Valine at the position 5 and 16 on the peptide Ctx(Ile21)-Ha.Has hemolytic activity.	[Ref.22519531]Gram-positive bacterium: Staphylococcus aureus (MIC=64 μmol/L);##Gram-negative bacteria: Escherichia coli (MIC=16 μmol/L), Pseudomonas aeruginosa (MIC=128 μmol/L);##Fungi: Candida albicans (MIC=16 μmol/L), Candida krusei (MIC=16 μmol/L), Candida parapsilosis (MIC=31 μmol/L), Cryptococcus neoformans (MIC=31 μmol/L)	[Ref.22519531]HC50=43.1 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22519531	Protein Pept Lett. 2012 Jun 1;19(6):596-603.	Cespedes GF, Lorenzón EN, Vicente EF, Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM.	Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus.	
DRAMP18595	GWLDVAKKKGKAAFNVAKNFI	21	Ctx(Ile21)-Ha-I9K (Ctx-Ha peptide derivative)	No entry found	Derived from the peptide Ctx-Ha	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. L-Lysine to replace L-Isoleucine at the position 9 on the peptide Ctx(Ile21)-Ha.Has hemolytic activity.	[Ref.22519531]Gram-negative bacteria: Escherichia coli (MIC=8 μmol/L), Pseudomonas aeruginosa (MIC=32 μmol/L);##Fungi: Candida albicans (MIC=16 μmol/L), Candida krusei (MIC=31 μmol/L), Candida parapsilosis (MIC=31 μmol/L), Cryptococcus neoformans (MIC=31 μmol/L)	[Ref.22519531]HC50=24.9 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22519531	Protein Pept Lett. 2012 Jun 1;19(6):596-603.	Cespedes GF, Lorenzón EN, Vicente EF, Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM.	Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus.	
DRAMP18596	NVWKKVLGKIIKVAK	15	LL-I/1 (Lasioglossin LL-I peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-I	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity. 	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=1.3 μM), Staphylococcus aureus (MIC=71.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.5 μM), Pseudomonas aeruginosa (MIC=22.7 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2102.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18597	VNWKKVLAKIIKVAK	15	LL-I/2 (Lasioglossin LL-I peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-I	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.6 μM), Staphylococcus aureus (MIC=7.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=26.9 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2103.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18598	VNWKKVLKKIIKVAK	15	LL-I/3 (Lasioglossin LL-I peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-I	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=15.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=19.0 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2104.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18599	VNWKKVLPKIIKVAK	15	LL-I/4 (Lasioglossin LL-I peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-I	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.9 μM);##Gram-negative bacteria: Escherichia coli (MIC=5.0 μM), Pseudomonas aeruginosa (MIC=100 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2105.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18600	NVWKKILGKIIKVAK	15	LL-II/1 (Lasioglossin LL-II peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-II	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=19.7 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.1 μM), Pseudomonas aeruginosa (MIC=23.3 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2106.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18601	VNWKKILAKIIKVAK	15	LL-II/2 (Lasioglossin LL-II peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-II	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.Has hemolytic activity.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=4.3 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=22.5 μM).	[Ref.19591185]LC50=66.5 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2107.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18602	VNWKKILKKIIKVAK	15	LL-II/3 (Lasioglossin LL-II peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-II	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=15.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=26.1 μM).	[Ref.19591185]LC50=88.2 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2108.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18603	VNWKKILPKIIKVAK	15	LL-II/4 (Lasioglossin LL-II peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-II	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=80 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.5 μM), Pseudomonas aeruginosa (MIC=100 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2109.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18604	NVWKKILGKIIKVVK	15	LL-III/1 (Lasioglossin LL-III peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=9.0 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.4 μM), Pseudomonas aeruginosa (MIC=23.1 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2110.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18605	VNWKKILAKIIKVVK	15	LL-III/2 (Lasioglossin LL-III peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.6 μM), Staphylococcus aureus (MIC=2.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.4 μM), Pseudomonas aeruginosa (MIC=27.1 μM).	[Ref.19591185]LC50=55.1 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2111.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18606	VNWKKILKKIIKVVK	15	LL-III/3 (Lasioglossin LL-III peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.Has hemolytic activity.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=9.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=26.1 μM).	[Ref.19591185]LC50=72.2 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2112.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18607	VNWKKILPKIIKVVK	15	LL-III/4 (Lasioglossin LL-III peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.8 μM), Staphylococcus aureus (MIC=32.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.2 μM), Pseudomonas aeruginosa (MIC=100 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2113.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18608	VNWKKILGKIIKVVK	15	LL-III/5 (Lasioglossin LL-III peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-III	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.Weak hemolytic activity.
PTM: C-terminal hydroxyl modification"	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=1.2 μM), Staphylococcus aureus (MIC=40 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.5 μM), Pseudomonas aeruginosa (MIC=40 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2114.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18609	VNWKKILGKIIKVVK	15	LL-Ⅲ/6 (Lasioglossin LL-Ⅲ peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-Ⅲ	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
PTM: C-terminal methoxy modification"	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.5 μM), Staphylococcus aureus (MIC=2.1 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.0 μM), Pseudomonas aeruginosa (MIC=22.5 μM).	[Ref.19591185]LC50=79.3 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2115.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18610	VNWKKILGKI	10	LL-Ⅲ/7 (Lasioglossin LL-Ⅲ peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-Ⅲ	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=4.7 μM);##Gram-negative bacteria: Escherichia coli (MIC=23.3 μM), Pseudomonas aeruginosa (MIC=75 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2116.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18611	ILGKIIKVVK	10	LL-Ⅲ/8 (Lasioglossin LL-Ⅲ peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-Ⅲ 	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=40 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2117.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18612	KIIKVVK	7	LL-Ⅲ/10 (Lasioglossin LL-Ⅲ peptide derivative)	No entry found	Derived from the peptide Lasioglossin LL-Ⅲ	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria.	[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=100 μM).	[Ref.19591185]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19591185	Chembiochem. 2009 Aug 17;10(12):2089-2119.	Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.	Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.	
DRAMP18613	VRRFGWWWGFLRR	13	TPG (Tritrpticin peptide derivative)	No entry found	Derived from the peptide Tritrpticin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.12207877]Gram-positive bacteria: Bacillus subtilis (MIC=16 μg/ml), Staphylococcus aureus (MIC=16 μg/ml), Staphylococcus epidermidis (MIC=8 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=32 μg/ml), Salmonella typhimurium (MIC=32 μg/ml), Pseudomonas aeruginosa (MIC=64 μg/ml);##Fungus: Candida albicans (MIC=32 μg/ml).	[Ref.12207877]6% hemolysis at 25 μg/ml, 15% hemolysis at 50 μg/ml, 25% hemolysis at 100 μg/ml, 70% hemolysis at 200 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12207877	Biochem Biophys Res Commun. 2002 Sep 6;296(5):1044-50.	Yang ST, Yub Shin SY, Kim YC, Kim Y, Hahm KS, Kim JI.	Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide.	
DRAMP18627	KLKKLLKKWLKLLKKLLK	18	D4-K9L8W (D-amino acid substitution of K9L8W)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 12 and 16 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 4 and 8 on the peptide K9L8W. Weak hemolytic activity.	[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=1 μM), Staphylococcus epidermidis (MIC=2 μM), Staphylococcus aureus (MIC=2 μM);##Gram-negative bacteria: Escherichia coli (MIC=2 μM), Pseudomonas aeruginosa (MIC=2 μM), Salmonella typhimurium (MIC=2 μM).	[Ref.20363271]HC50>800 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20363271	Peptides. 2010 Jul;31(7):1251-61.	Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.	Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.	
DRAMP18507	FSGGNCRGFRRRCFCTK	17	SolyC (Plant defensin; tomato, plants)	No entry found	Belongs to the tomato defensin family	Not found	Tomato	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Beta sheet	Not found		Function: Antibacterial activity against a panel of human pathogens, including H.pylori, and displays anti-inflammatory activity in vitro. Weak hemolytic activity.	[Ref.23124812]Gram-positive bacteria: Staphylococcus aureus A170 (MIC=40 μg/mL), Staphylococcus epidermidis (MIC=40 μg/mL), Listeria monocytogenes (MIC=40 μg/mL);##Gram-negative bacteria: Salmonella enterica serovar Paratyphi (MIC=15 μg/mL), Escherichia coli (MIC=15 μg/mL), Helicobacter pylori VB1 (MIC=15 μg/mL), Helicobacter pylori VB2 (MIC=10 μg/mL), Helicobacter pylori VB3 (MIC=15 μg/mL), Helicobacter pylori VB4 (MIC=12 μg/mL), Helicobacter pylori VB5 (MIC=15 μg/mL), Helicobacter pylori VB6 (MIC=10 μg/mL), Helicobacter pylori VB7 (MIC=15 μg/mL), Helicobacter pylori VB8 (MIC=10 μg/mL), Helicobacter pylori VB9 (MIC=10 μg/mL), Helicobacter pylori VB10 (MIC=15 μg/mL).	[Ref.23124812]<5%  hemolysis at 50 μg/mL against mouse red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23124812	J Pept Sci. 2012 Dec;18(12):755-62.	Rigano MM, Romanelli A, Fulgione A, Nocerino N, D'Agostino N, Avitabile C, Frusciante L, Barone A, Capuano F, Capparelli R.	A novel synthetic peptide from a tomato defensin exhibits antibacterial activities against Helicobacter pylori.	
DRAMP20763	DIDITGCSACKYAAGQVCTIGCSAAGGFICGLLGITIPVAGLSCLGFVEIVCTVADEYSGCGDAVAKEACNRAGLC	76	Halocin C8 (HalC8, Halocin-C8; Microhalocins, Archaeocin, Bacteriocin, Archaea, Euryarchaeota, Prokaryotes)	P83716	Not found	proC8	Halobacterium sp. (strain AS7092)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: Antibacterial activity against a wide variety of haloarchaeons. Causes cell lysis and death, possibly by disrupting the cell wall. Immunity protein HalI: Acts as an immunity protein for halocin-C8. Able to block the halocin-C8 activity by sequestering the activity of halocin-C8 through specific and direct binding.
Miscellaneous: Is quite robust, as it can be desalted, boiled, subjected to organic solvents, and stored at 4 degrees Celsius for extended periods without losing activity.
Induction: Increases to maximal levels upon transition from exponential to stationary phase."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12811620	Extremophiles. 2003 Oct;7(5):401-7.	Li Y, Xiang H, Liu J, Zhou M, Tan H.	Purification and biological characterization of halocin C8, a novel peptide antibiotic from Halobacterium strain AS7092.	
DRAMP20764	LQSNININTAAAVILIFNQVQVGALCAPTPVSGGGPVP	38	Halocin R1 (HalR1, Halocin-R1; Microhalocins, Archaeocin, Bacteriocin, Archaea, Euryarchaeota, Prokaryotes)	No entry found	Not found	Not found	Halobacterium sp. GN101	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: HalR1 is a microhalocin ( 38 amino acids ), and even more intriguing, HalR1 is 63% identical and 71% similar to HalS8
(identical residues in capitals ) . HalR1 is not cationic like typical bacteriocins and eucaryocins, it will be interesting to discover their mechanisms of action."	[Ref.11114928] Archaea: Sulfolobus solfataricus (Inhibition Zone=7mm)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11938468##11114928	J Ind Microbiol Biotechnol. 2002 Jan;28(1):23-31.##J Bacteriol. 2001 Jan;183(1):287-91.	O'Connor EM, Shand RF.##Haseltine C, Hill T, Montalvo-Rodriguez R, Kemper SK, Shand RF, Blum P.	Halocins and sulfolobicins: the emerging story of archaeal protein and peptide antibiotics.##Secreted euryarchaeal microhalocins kill hyperthermophilic crenarchaea.	
DRAMP20765	DIDITGCSACKYAAGQVCTIGCSAAGGFICGLLGITIPVAGLSSLGFFVITCTTSADYYSIPDSNAAK	68	Halocin A4 (HalA4, Halocin-A4, Halocin U1; Microhalocins, Archaeocin, Bacteriocin, Archaea, Euryarchaeota, Prokaryotes)	No entry found	Not found	Not found	Haloarchaeon strain TuA4	Antimicrobial, Antibacterial	Protein level	Not found	Not found		Function: TuA4 cell lysates are not toxic for S. solfataricus, and protease (but not nuclease) treatment of the halocin A4 preparation inactivated toxicity, indicating that the A4 toxic factor must be a secreted protein.	[Ref.11114928] Archaea: Sulfolobus solfataricus (Inhibition Zone=12mm)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11114928	J Bacteriol. 2001 Jan;183(1):287-91.	Haseltine C, Hill T, Montalvo-Rodriguez R, Kemper SK, Shand RF, Blum P.	Secreted euryarchaeal microhalocins kill hyperthermophilic crenarchaea.	
DRAMP18614	VRRFAWWWAFLRR	13	TPA (Tritrpticin peptide derivative)	No entry found	Derived from the peptide Tritrpticin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.12207877]Gram-positive bacteria: Bacillus subtilis (MIC=16 μg/ml), Staphylococcus aureus (MIC=32 μg/ml), Staphylococcus epidermidis (MIC=16 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=32 μg/ml), Salmonella typhimurium (MIC=32 μg/ml), Pseudomonas aeruginosa (MIC=64 μg/ml);##Fungus: Candida albicans (MIC=32 μg/ml).	[Ref.12207877]18% hemolysis at 25 μg/ml, 30% hemolysis at 50 μg/ml, 62% hemolysis at 100 μg/ml, 95% hemolysis at 200 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12207877	Biochem Biophys Res Commun. 2002 Sep 6;296(5):1044-50.	Yang ST, Yub Shin SY, Kim YC, Kim Y, Hahm KS, Kim JI.	Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide.	
DRAMP18615	VRRFPFFFPFLRR	13	TWF (Tritrpticin peptide derivative)	No entry found	Derived from the peptide Tritrpticin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. No hemolytic activity.	[Ref.12207877]Gram-positive bacteria: Bacillus subtilis (MIC=8 μg/ml), Staphylococcus aureus (MIC=16 μg/ml), Staphylococcus epidermidis (MIC=8 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=8 μg/ml), Salmonella typhimurium (MIC=8 μg/ml), Pseudomonas aeruginosa (MIC=16 μg/ml);##Fungus: Candida albicans (MIC=16 μg/ml).	[Ref.12207877]Non-hemolysis at 200 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12207877	Biochem Biophys Res Commun. 2002 Sep 6;296(5):1044-50.	Yang ST, Yub Shin SY, Kim YC, Kim Y, Hahm KS, Kim JI.	Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide.	
DRAMP18616	RGLRRLGRKIAHGVKKYGPTVKRIKRKA	28	[K22,25,27]-SMAP-29 (SMAP-29 peptide derivative)	No entry found	Derived from the peptide SMAP-29	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. No hemolytic activity.	[Ref.11467858]Gram-positive bacteria: [No NaCl]: Bacillus subtilis (MIC=6.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=2.0 μM), Staphylococcus epidermidis (MIC=1.0 μM);##[100 mM NaCl]: Bacillus subtilis (MIC=4.0 μM), Staphylococcus aureus (MIC=1.0 μM), Micrococcus luteus (MIC=1.0 μM), Staphylococcus epidermidis (MIC=1.0 μM).##Gram-negative bacteria: [No NaCl]: Escherichia coli (MIC=6.0 μM), Salmonella typhimurium (MIC=2.0 μM), Pseudomonas aeruginosa (MIC=12.0 μM);[100 mM NaCl]: Escherichia coli (MIC=4.0 μM), Salmonella typhimurium (MIC=1.0 μM), Pseudomonas aeruginosa (MIC=4.0 μM).##Fungi: [No NaCl]: Candida albicans (MIC=2.0 μM);[100 mM NaCl]: Candida albicans (MIC=16.0 μM).	[Ref.11467858]Non-hemolysis at 100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11467858	Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.	Shin SY, Park EJ, Yang ST, Jung HJ, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide.	
DRAMP18617	RGLRRLGRKIAHGVKKYGATVLRIIRIA	28	[A19]-SMAP-29 (SMAP-29 peptide derivative)	No entry found	Derived from the peptide SMAP-29	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.11467858]Gram-positive bacteria: [No NaCl]: Bacillus subtilis (MIC=4.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=2.0 μM), Staphylococcus epidermidis (MIC=2.0 μM);##[100 mM NaCl]: Bacillus subtilis (MIC=2.0 μM), Staphylococcus aureus (MIC=1.0 μM), Micrococcus luteus (MIC=2.0 μM), Staphylococcus epidermidis (MIC=1.0 μM).##Gram-negative bacteria: [No NaCl]: Escherichia coli (MIC=4.0 μM), Salmonella typhimurium (MIC=2.0 μM), Pseudomonas aeruginosa (MIC=16.0 μM);[100 mM NaCl]: Escherichia coli (MIC=1.0 μM), Salmonella typhimurium (MIC=1.0 μM), Pseudomonas aeruginosa (MIC=4.0 μM).##Fungi: [No NaCl]: Candida albicans (MIC=2.0 μM);[100 mM NaCl]: Candida albicans (MIC=16.0 μM).	[Ref.11467858]7% hemolysis at 12.5 μM, 13% hemolysis at 25 μg/ml, 28% hemolysis at 50 μg/ml, 50.4% hemolysis at 100 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11467858	Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.	Shin SY, Park EJ, Yang ST, Jung HJ, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide.	
DRAMP18618	RGLRRLGRKIAHGVKKY	17	SMAP-29(1-17) (SMAP-29 peptide derivative)	No entry found	Derived from the peptide SMAP-29	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. No hemolytic activity.	[Ref.11467858]Gram-positive bacteria: [No NaCl]: Bacillus subtilis (MIC=8.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=2.0 μM), Staphylococcus epidermidis (MIC=1.0 μM);##[100 mM NaCl]: Bacillus subtilis (MIC=16.0 μM), Staphylococcus aureus (MIC=4.0 μM), Micrococcus luteus (MIC=4.0 μM), Staphylococcus epidermidis (MIC=2.0 μM).##Gram-negative bacteria: [No NaCl]: Escherichia coli (MIC=8.0 μM), Salmonella typhimurium (MIC=2.0 μM), Pseudomonas aeruginosa (MIC=8.0 μM);[100 mM NaCl]: Escherichia coli (MIC=16.0 μM), Salmonella typhimurium (MIC=8.0 μM), Pseudomonas aeruginosa (MIC=16.0 μM).##Fungi: [No NaCl]: Candida albicans (MIC=8.0 μM);[100 mM NaCl]: Candida albicans (MIC=16.0 μM).	[Ref.11467858]Non-hemolysis at 100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11467858	Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.	Shin SY, Park EJ, Yang ST, Jung HJ, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide.	
DRAMP18619	RKLRRLKRKIAHKVKKY	17	[K2,7,13]-SMAP-29(1-17) (SMAP-29 peptide derivative)	No entry found	Derived from the peptide SMAP-29	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. No hemolytic activity.	[Ref.11467858]Gram-positive bacteria: [No NaCl]: Bacillus subtilis (MIC=4.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=2.0 μM), Staphylococcus epidermidis (MIC=1.0 μM);[100 mM NaCl]: Bacillus subtilis (MIC=4.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=1.0 μM), Staphylococcus epidermidis (MIC=1.0 μM).##Gram-negative bacteria: [No NaCl]: Escherichia coli (MIC=3.0 μM), Salmonella typhimurium (MIC=2.0 μM), Pseudomonas aeruginosa (MIC=6.0 μM);[100 mM NaCl]: Escherichia coli (MIC=6.0 μM), Salmonella typhimurium (MIC=4.0 μM), Pseudomonas aeruginosa (MIC=3.0 μM).##Fungi: [No NaCl]: Candida albicans (MIC=8.0 μM);[100 mM NaCl]: Candida albicans (MIC=8.0 μM).	[Ref.11467858]Non-hemolysis at 100 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11467858	Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.	Shin SY, Park EJ, Yang ST, Jung HJ, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide.	
DRAMP18620	KKTWWKTWWTKWSQPKKKRKV	21	Pep-1-K (Pep-1 peptide derivative)	No entry found	Derived from the peptide Pep-1	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria. No hemolytic activity.	[Ref.16945333]Gram-positive bacteria: Bacillus subtilis (KCTC 3068) (MIC=2.0 μM), Staphylococcus aureus (KCTC 1621) (MIC=2.0 μM), Staphylococcus epidermidis (KCTC 1917) (MIC=1.0 μM);##Gram-negative bacteria: Escherichia coli (KCTC 1682) (MIC=2.0 μM), Salmonella typhimurium (KCTC 1926) (MIC=1.0 μM), Pseudomonas aeruginosa (KCTC 1637) (MIC=2.0 μM);##Antibiotic-resistant bacteria: MRSA 1 (CCARM 3001) (MIC=2.0 μM), MRSA 2 (CCARM 3089) (MIC=2.0 μM), MRSA 3 (CCARM 3543) (MIC=1.0 μM), MDRPA 1 (CCARM 2092) (MIC=8.0 μM), MDRPA 2 (CCARM 2095) (MIC=8.0 μM), MDRPA 3 (CCARM 2109) (MIC=8.0 μM).	[Ref.16945333]Non-hemolysis at 200 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16945333	Biochem Biophys Res Commun. 2006 Oct 20;349(2):769-74.	Zhu WL, Lan H, Park IS, Kim JI, Jin HZ, Hahm KS, Shin SY.	Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1.	
DRAMP18621	FLYIVAKLLSGLL	13	Temporin-PEa (Temporin-PE peptide derivative)	No entry found	Derived from the peptide Temporin-PE	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal	Synthetic	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria and fungi. Weak hemolytic activity.	[Ref.29191658]Gram-positive bacteria: Staphylococcus aureus (MIC=1.0 μM), Methicillin-resistant Staphylococcus aureus (MIC=2.0 μM), Enterococcus faecalis (MIC=2.0 μM);##Fungus: Candida albicans (MIC=2.0 μM).##Cancer cell lines: NCI-H157 (IC50=3.398 μM), U251MG (IC50=3.520 μM), PC-3 (IC50=27.62 μM), MDA-MB-435s (IC50=9.864 μM), HMEC-1 (IC50=40.30 μM).	[Ref.29191658]HC50=531.7 μM against horse red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29191658	Biochem Biophys Res Commun. 2018 Jan 22;495(4):2539-2546.	Sang M, Wu Q, Xi X, Ma C, Wang L, Zhou M, Burrows JF, Chen T.	Identification and target-modifications of temporin-PE: A novel antimicrobial peptide in the defensive skin secretions of the edible frog, Pelophylax kl. esculentus.	
DRAMP18622	FLPIVAKLLSGLLGRKKRRQRRR	23	Temporin-PEb (Temporin-PE peptide derivative)	No entry found	Derived from the peptide Temporin-PE	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.29191658]Gram-positive bacteria: Staphylococcus aureus (MIC=1.0 μM), Methicillin-resistant Staphylococcus aureus (MIC=2.0 μM), Enterococcus faecalis (MIC=2.0 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.0 μM);##Fungus: Candida albicans (MIC=1.0 μM).##Cancer cell lines: NCI-H157 (IC50=3.464 μM), U251MG (IC50=3.087 μM), PC-3 (IC50=3.051 μM), MDA-MB-435s (IC50=3.483 μM), HMEC-1 (IC50=9.976 μM).	[Ref.29191658]HC50=44.64 μM against horse red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29191658	Biochem Biophys Res Commun. 2018 Jan 22;495(4):2539-2546.	Sang M, Wu Q, Xi X, Ma C, Wang L, Zhou M, Burrows JF, Chen T.	Identification and target-modifications of temporin-PE: A novel antimicrobial peptide in the defensive skin secretions of the edible frog, Pelophylax kl. esculentus.	
DRAMP18623	INLKILARLAKKIL	14	[I5,R8] Mastoparan-L ([I5,R8] MP-L;Mastoparan-L peptide derivative)	No entry found	Derived from the peptide Mastoparan 	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anitifungal	Synthetic	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. [Ref.27423268]Cytotoxicity against THP-1-derived macrophages, Weak hemolytic activity.	[Ref.27423268]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=25 μM), Streptococcus pyogenes ATCC 19615 (MIC=6.25 μM), Listeria ivanovii Li 4pVS2 (MIC=50 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.5 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=6.25 μM), Klebsiella pneumoniae ATCC 13883 (MIC=6.25 μM), Acinetobacter baumannii ATCC 19606 (MIC=3 μM);##Fungi: Candida albicans ATCC 90028 (MIC=12.5 μM), Candida parapsilosis ATCC 22019 (MIC=25 μM).	[Ref.27423268]LC50>200 μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27423268	Biochim Biophys Acta. 2016 Nov;1858(11):2699-2708.	Irazazabal LN, Porto WF, Ribeiro SM, Casale S, Humblot V, Ladram A, Franco OL.	Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan.	
DRAMP18624	KLKKLLKKWLKLLKKLLK	18	K9L8W	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.	[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=4 μM), Staphylococcus epidermidis (MIC=8 μM), Staphylococcus aureus (MIC=8 μM);##Gram-negative bacteria: Escherichia coli (MIC=8 μM), Pseudomonas aeruginosa (MIC=8 μM), Salmonella typhimurium (MIC=4 μM).	[Ref.20363271]HC50=14 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20363271	Peptides. 2010 Jul;31(7):1251-61.	Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.	Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.	
DRAMP18625	KLKKLLKKWLKLLKKLLK	18	D3-K9L8W-1 (D-amino acid substitution of K9L8W)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 6 and 12 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 18 on the peptide K9L8W. Has hemolytic activity.	[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=2 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=4 μM), Salmonella typhimurium (MIC=2 μM).	[Ref.20363271]HC50=150 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20363271	Peptides. 2010 Jul;31(7):1251-61.	Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.	Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.	
DRAMP18626	KLKKLLKKWLKLLKKLLK	18	D3-K9L8W-2 (D-amino acid substitution of K9L8W)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 5 and 10 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 15 on the peptide K9L8W. Has hemolytic activity.	[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=1 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=4 μM), Salmonella typhimurium (MIC=2 μM).	[Ref.20363271]HC50=116 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20363271	Peptides. 2010 Jul;31(7):1251-61.	Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.	Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.	
DRAMP18628	KLKKLLKKWLKLLKKLLK	18	D6-K9L8W (D-amino acid substitution of K9L8W)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 6 and 12 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 3,15 and 18 on the peptide K9L8W, D-Tryptophan replace L-Tryptophan at the position 9 on the peptide K9L8W. Weak hemolytic activity.	[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=1 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=2 μM);##Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=2 μM), Salmonella typhimurium (MIC=2 μM).	[Ref.20363271]HC50>800 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20363271	Peptides. 2010 Jul;31(7):1251-61.	Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.	Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.	
DRAMP18629	KLKKLLKKWLKLLKKLLK	18	D9-K9L8W-1 (D-amino acid substitution of K9L8W)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 2,6,10,12 and 16 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 4,8,14 and 18 on the peptide K9L8W. Weak hemolytic activity.	[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=1 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=2 μM), Pseudomonas aeruginosa (MIC=2 μM), Salmonella typhimurium (MIC=2 μM).	[Ref.20363271]HC50>800 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20363271	Peptides. 2010 Jul;31(7):1251-61.	Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.	Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.	
DRAMP18630	KLKKLLKKWLKLLKKLLK	18	D9-K9L8W-2 (D-amino acid substitution of K9L8W)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 10,12,13,16 and 17 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 11,14,15 and 18 on the peptide K9L8W. Has hemolytic activity.	[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=2 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=4 μM), Salmonella typhimurium (MIC=2 μM).	[Ref.20363271]HC50=154 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	20363271	Peptides. 2010 Jul;31(7):1251-61.	Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.	Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.	
DRAMP18631	VGHNADLQIKLSIRRLLAAGVLKQTKGVGA	30	H5(61–90) V1 (Histone H5 peptide derivative)	No entry found	Derived from Histone H5	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix, Random coil	The peptide adopts a random coil structure in water and presented an orders alpha-helix structure with 84.2 % alpha-helices in 30?mM SDS		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria.  H5(61	[Ref.29402952] Gram-positive bacteria: Listeria monocytogenes (MIC=23.1±8.1 μg/mL);##Gram-negative bacterium: Pseudomonas aeruginosa (MIC=16±0 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29402952	Sci Rep. 2018 Feb 5;8(1):2411.	Jodoin J, Hincke MT.	Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.	
DRAMP18632	LSIRRLLAAGVLKQTKGVGA	20	Peptide H5 (71-90) (Histone H5 peptide derivative)	No entry found	Derived from Histone H5	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria. 	[Ref.29402952] Gram-negative bacterium: Pseudomonas aeruginosa (MIC=26.7±14.1 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29402952	Sci Rep. 2018 Feb 5;8(1):2411.	Jodoin J, Hincke MT.	Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.	
DRAMP18633	VGHNADLQIKLSIRRLLAAGVLKQTKGVGA	30	H5(61-90) V2 (Histone H5 peptide derivative)	No entry found	Derived from Histone H5	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix, Random coil	The peptide adopts a random coil structure in water and presented an orders alpha-helix structure with 75.5 % alpha-helices in 30?mM SDS		Function: Antibacterial activity against Gram-negative bacteria.  H5(61	[Ref.29402952] Gram-negative bacterium: Pseudomonas aeruginosa (MIC=33.8 ± 26.3 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29402952	Sci Rep. 2018 Feb 5;8(1):2411.	Jodoin J, Hincke MT.	Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.	
DRAMP18634	VGHNADLQIKLSIRRLLAAGVLKQTKGVGA	30	H5(61-90) V3 (Histone H5 peptide derivative)	No entry found	Derived from Histone H5	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix, Random coil	The peptide adopts a random coil structure in water and presented an orders alpha-helix structure with 84.7 % alpha-helices in 30?mM SDS		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. H5(61	[Ref.29402952] Gram-positive bacteria: Listeria monocytogenes (MIC=106.7 ± 37.0 μg/mL);##Gram-negative bacterium: Pseudomonas aeruginosa (MIC=48.0 ± 32.4 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29402952	Sci Rep. 2018 Feb 5;8(1):2411.	Jodoin J, Hincke MT.	Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.	
DRAMP18635	KLIPIASKTCPAGKNLCYKI	20	NCP-0	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Unordered structure	The peptide adopts overall content of unordered secondary structure that is 67% 		Function: Antibacterial activity against the Gram-negative bacteria.	[Ref.29364903] Gram-negative bacteria: Burkholderia cepacia ATCC 17759(MBC=50μg/ml);Moraxella catarrhalis ATCC 25238(MBC=1.6μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29364903	PLoS One. 2018 Jan 24;13(1):e0190778. 	Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.	Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.	
DRAMP18636	KLIFILSKTIPAGKNLFYKI	20	NCP-3a (CTX-1 peptide derivative)	No entry found	Derived from CTX-1	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29364903] Gram-positive bacteria: Methicillin-resistant Staphylococcus aureus ATCC 43300 (MBC=6.3 μg/ml), Staphylococcus aureus ATCC 22953 (MBC=12.5 μg/ml), Enterococcus hirae ATCC 10541 (MBC=6.3 μg/ml), Streptococcus agalactiae ATCC 13813 (MBC=3.1 μg/ml);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MBC=6.3 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MBC=25 μg/ml), Acinetobacter baumannii (ornithological, cloacal) (MBC=25 μg/ml), Acinetobacter baumannii (human, urinary) (MBC=25 μg/ml), Klebsiella pneumoniae subsp. pneumoniae (herpetological, cloacal) (MBC=50 μg/ml), Burkholderia cepacia ATCC 17759 (MBC=50 μg/ml), Moraxella catarrhalis ATCC 25238 (MBC=3.1 μg/ml);##Fungi: Candida albicans ATCC 10231 (MBC=6.3 μg/mL), Candida glabrata ATCC 90030 (MBC=25 μg/mL), Malassezia pachydermatis DSMZ 6172 (MBC=6.3 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29364903	PLoS One. 2018 Jan 24;13(1):e0190778. 	Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.	Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.	
DRAMP18637	KLILILSKTIPAGKNLFYKI	20	NCP-3b (CTX-1 peptide derivative)	No entry found	Derived from CTX-1	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29364903] Gram-positive bacteria: Methicillin-resistant Staphylococcus aureus ATCC 43300 (MBC=6.3 μg/ml), Staphylococcus aureus ATCC 22953 (MBC=50 μg/ml), Enterococcus hirae ATCC 10541 (MBC=12.5 μg/ml), Streptococcus agalactiae ATCC 13813 (MBC=12.5 μg/ml);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MBC=25 μg/ml), Acinetobacter baumannii (ornithological, cloacal) (MBC=25 μg/ml), Acinetobacter baumannii (human, urinary) (MBC=25 μg/ml), Klebsiella pneumoniae subsp. pneumoniae (herpetological, cloacal) (MBC=25 μg/ml), Burkholderia cepacia ATCC 17759 (MBC=25 μg/ml), Moraxella catarrhalis ATCC 25238 (MBC=12.5 μg/ml);##Fungi: Candida albicans ATCC 10231 (MBC=12.5 μg/mL), Candida glabrata ATCC 90030 (MBC=100 μg/mL), Malassezia pachydermatis DSMZ 6172 (MBC=25 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29364903	PLoS One. 2018 Jan 24;13(1):e0190778. 	Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.	Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.	
DRAMP18638	VYPFMWGGAYCFCDAELV	18	VT18-LV (VT18 peptide derivative)	No entry found	Derived from VT18	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Double-stranded 	Not found		Function: Antibacterial activity against the Gram-positive bacteria. 	[Ref.29277569] Gram-positive bacteria: Streptococcus pneumoniae ATCC 700669 (MIC=207 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29277569	Biochimie. 2018 Mar;146:139-147. 	Yang R, Zhang G, Zhang F, Li Z, Huang C.	Membrane permeabilization design of antimicrobial peptides based on chikungunya virus fusion domain scaffold and its antibacterial activity against gram-positive Streptococcus pneumoniae in respiratory infection.	
DRAMP18639	CKCRRRKVHGPMIRIRKK	18	CTO17 (TO17 peptide derivative)	No entry found	Derived from TO17	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-negative bacteria.	[Ref.29183811] Gram-negative bacterium: Vibrio vulnificus (MIC=20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29183811	Fish Shellfish Immunol. 2018 Jan;72:639-645. 	He SW, Wang GH, Yue B, Zhou S, Zhang M.	TO17: A teleost antimicrobial peptide that induces degradation of bacterial nucleic acids and inhibits bacterial infection in red drum, Sciaenops ocellatus.	
DRAMP18640	KCRRRKVHGPMIRIRKKNL	19	TO19 (TO17 peptide derivative)	No entry found	Derived from TO17	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-negative bacteria.	[Ref.29183811] Gram-negative bacterium: Vibrio vulnificus (MIC=20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29183811	Fish Shellfish Immunol. 2018 Jan;72:639-645.	He SW, Wang GH, Yue B, Zhou S, Zhang M.	TO17: A teleost antimicrobial peptide that induces degradation of bacterial nucleic acids and inhibits bacterial infection in red drum, Sciaenops ocellatus.	
DRAMP18641	TWWRWW	6	KCM11	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Low activity against the Gram-negative strains. High activity against the Gram-positive strains	[Ref.19734717] Gram-negative bacteria: Acidovorax konjaci(MEC=2.5 nM), Pseudomonas syringae pv. tomato DC3000 (MEC=5 nM), Pectobacterium carotovorum subsp. atrosepticum (MEC=5 nM), Xanthomonas albilineans (MEC=0.3 nM), Xanthomonas campestris pv. vesicatoria 833 (MEC=0.3 nM), Xanthomonas campestris pv. vesicatoria 833 pilA (MEC=0.3 nM), Xanthomonas oryzae pv. oryzae 599 (MEC=1.3 nM), Xanthomonas oryzae pv. oryzae 710 (MEC=1.3 nM), Xanthomonas oryzae pv. oryzae 090 (MEC=1.3 nM);##Gram-positive bacterium: Clavibacter michiganensis subsp. michiganensis (MEC=0.3 nM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19734717	J Microbiol Biotechnol. 2009 Aug;19(8):792-802.	Choi J, Moon E.	Identification of novel bioactive hexapeptides against phytopathogenic bacteria through rapid screening of a synthetic combinatorial library.	
DRAMP18642	KWRWIW	6	KCM12	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: High activity against E. coli DH5	[Ref.19734717] Gram-negative bacteria: Acidovorax konjaci (MEC=1.3 nM), Pseudomonas syringae pv. tomato DC3000 (MEC=0.3 nM), Escherichia coli DH5α (MEC=1.3 nM), Pseudomonas putida (MEC=0.6 nM), Pectobacterium carotovorum subsp. carotovorum (MEC=5 nM), Pectobacterium carotovorum subsp. atrosepticum (MEC=0.6 nM), Xanthomonas albilineans (MEC=1.3 nM), Xanthomonas campestris pv. vesicatoria 833 (MEC=0.3 nM), Xanthomonas campestris pv. vesicatoria 833 pilA (MEC=0.3 nM), Xanthomonas oryzae pv. oryzae 599 (MEC=0.2 nM), Xanthomonas oryzae pv. oryzae 710 (MEC=0.2 nM), Xanthomonas oryzae pv. oryzae 090 (MEC=0.2 nM);##Gram-positive bacterium: Clavibacter michiganensis subsp. michiganensis (MEC=0.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19734717	J Microbiol Biotechnol. 2009 Aug;19(8):792-802.	Choi J, Moon E.	Identification of novel bioactive hexapeptides against phytopathogenic bacteria through rapid screening of a synthetic combinatorial library.	
DRAMP18643	KWWWRW	6	KCM21	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: High activity against E. coli DH5	[Ref.19734717] Gram-negative bacteria: Acidovorax konjaci (MEC=0.6 nM), Pseudomonas syringae pv. tomato DC3000 (MEC=0.6 nM), Escherichia coli DH5α (MEC=1.3 nM), Pseudomonas putida (MEC=1.3 nM), Pectobacterium carotovorum subsp. carotovorum (MEC=5 nM), Pectobacterium carotovorum subsp. atrosepticum (MEC=0.6 nM), Xanthomonas albilineans (MEC=0.2 nM), Xanthomonas campestris pv. vesicatoria 833 (MEC=0.2 nM), Xanthomonas campestris pv. vesicatoria 833 pilA (MEC=0.2 nM), Xanthomonas oryzae pv. oryzae 599 (MEC=0.2 nM), Xanthomonas oryzae pv. oryzae 710 (MEC=0.3 nM), Xanthomonas oryzae pv. oryzae 090 (MEC=0.3 nM);##Gram-positive bacterium: Clavibacter michiganensis subsp. michiganensis (MEC=0.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19734717	J Microbiol Biotechnol. 2009 Aug;19(8):792-802.	Choi J, Moon E.	Identification of novel bioactive hexapeptides against phytopathogenic bacteria through rapid screening of a synthetic combinatorial library.	
DRAMP18644	WRWFIH	6	KRS22	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not foundn		Function: High activity against XCV833 and CM at the high concentration	[Ref.19734717] Gram-negative bacteria: Acidovorax konjaci (MEC=5 nM), Pseudomonas syringae pv. tomato DC3000 (MEC=2.5 nM), Escherichia coli DH5α (MEC=5 nM), Pectobacterium carotovorum subsp. atrosepticum (MEC=2.5 nM), Xanthomonas albilineans (MEC=2.5 nM), Xanthomonas campestris pv. vesicatoria 833 (MEC=2.5 nM), Xanthomonas campestris pv. vesicatoria 833 pilA (MEC=2.5 nM), Xanthomonas oryzae pv. oryzae 599 (MEC=0.6 nM), Xanthomonas oryzae pv. oryzae 710 (MEC=1.3 nM), Xanthomonas oryzae pv. oryzae 090 (MEC=0.3 nM);##Gram-positive bacterium: Clavibacter michiganensis subsp. michiganensis (MEC=1.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19734717	J Microbiol Biotechnol. 2009 Aug;19(8):792-802.	Choi J, Moon E.	Identification of novel bioactive hexapeptides against phytopathogenic bacteria through rapid screening of a synthetic combinatorial library.	
DRAMP18645	RKTWFW	6	PAF19	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Antifungal activity against Penicillium digitatum PHI-26, Penicillium italicum PHI-1, Botrytis cinerea CECT2100. All residues of PAF19 are D-animo acids.	[Ref.11976121] Fungi: Penicillium digitatum PHI-26 (MIC=60 μM, IC50=36 ± 6 μM), Penicillium italicum PHI-1 (MIC=80 μM, IC50=52 ± 5 μM), Botrytis cinerea CECT2100 (MIC=80 μM, IC50=43 ± 14 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11976121	Appl Environ Microbiol. 2002 May;68(5):2453-60.	López-García B, Pérez-Payá E, Marcos JF.	Identification of novel hexapeptides bioactive against phytopathogenic fungi through screening of a synthetic peptide combinatorial library.	
DRAMP18646	RKWHFW	6	PAF32	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Antifungal activity against Penicillium digitatum PHI-26, Penicillium italicum PHI-1, Botrytis cinerea CECT2100, Fusarium oxysporum CECT2866, Saccharomyces cerevisiae W303-1A. All residues of PAF32 are D-animo acids.	[Ref.11976121] Fungi: Penicillium digitatum PHI-26 (MIC=20 μM, IC50=7 ± 1 μM), Penicillium italicum PHI-1 (MIC=20 μM, IC50=15 ± 5 μM), Botrytis cinerea CECT2100 (MIC=40 μM, IC50=19 ± 8 μM), Fusarium oxysporum CECT2866 (MIC=80 μM, IC50=56 ± 11 μM), Saccharomyces cerevisiae W303-1A (MIC>160 μM, IC50=63 ± 10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11976121	Appl Environ Microbiol. 2002 May;68(5):2453-60.	López-García B, Pérez-Payá E, Marcos JF.	Identification of novel hexapeptides bioactive against phytopathogenic fungi through screening of a synthetic peptide combinatorial library.	
DRAMP18647	RKWLFW	6	PAF34	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Antifungal activity against Penicillium digitatum PHI-26, Penicillium italicum PHI-1, Penicillium expansum CMP-1, Botrytis cinerea CECT2100, Saccharomyces cerevisiae W303-1A . Antibacterial activity against Escherichia coli DH5	[Ref.11976121] Fungi: Penicillium digitatum PHI-26 (MIC=40 μM, IC50=15 ± 1 μM), Penicillium italicum PHI-1 (MIC=20 μM, IC50=12 ± 4 μM), Penicillium expansum CMP-1 (MIC=160 μM, IC50> 80 μM), Botrytis cinerea CECT2100 (MIC=60 μM), Saccharomyces cerevisiae W303-1A (MIC>160 μM, IC50=52 ± 22 μM);##Gram-negative bacterium: Escherichia coli DH5α(MIC=160 μM, IC50>80 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11976121	Appl Environ Microbiol. 2002 May;68(5):2453-60.	López-García B, Pérez-Payá E, Marcos JF.	Identification of novel hexapeptides bioactive against phytopathogenic fungi through screening of a synthetic peptide combinatorial library.	
DRAMP18648	FVPWFSKFLPRIL	13	[Pro3,DLeu9]TL(3) (Temporin L peptide derivative)	No entry found	Derived from Temporin L	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	The analogues bearing a D residue showed a reduction in the percentage of helicity compared to the corresponding L analogues in the MMs 		Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(3) is D-Leucine, D-Proline replace L-Proline at the position 10 on the  peptide [Pro3,DLeu9]TL(2).	[Ref.28863356] Gram-positive bacterium: Bacillus megaterium Bm11 (MIC=3.125μM), Staphylococcus epidermidis ATCC 12228 (MIC=25μM);##Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MIC=50μM), Escherichia coli D21 (MIC=50μM), Pseudomonas syringae pv tabaci 1918 (MIC=50μM);##Yeasts: Candida albicans ATCC 10231 (MIC=3.125μM), Candida crusei ATCC 6258 (MIC=3.125μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28863356	Eur J Med Chem. 2017 Oct 20;139:750-763.	Merlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.	Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities	
DRAMP18649	FQWQRNPRKVR	11	HLP6 (HLP2  peptide derivative)	No entry found	Derived from the peptide HLP 2	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria and Gram-positive bacteria.  HLP 6 had a proline substituted for methionine in HLP 2.	[Ref.9596699] Gram-negative bacteria: Escherichia coli NCTC 10418 (MIC=750 μM);##Gram-negative bacterium: Staphylococcus aureus (MIC=250 μM);##Clinical isolates: Acinetobacter sp.(MIC=10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9596699	Infect Immun. 1998 Jun;66(6):2434-40.	Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW.	Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.	
DRAMP18650	FQWQRNMRKVR	11	HLP7 (HLP2  peptide derivative)	No entry found	Derived from the peptide HLP 2	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. HLP 7 is the d form of HLP 2.	[Ref.9596699] Gram-negative bacteria: Escherichia coli NCTC 8007 (MIC=18 μM), Escherichia coli NCTC 10418 (MIC=40 μM);##Gram-negative bacterium: Staphylococcus aureus (MIC=14 μM);##Clinical isolates: Acinetobacter sp. (MIC=0.3 μM), Klebsiella sp. strain 3105 (MIC=80 μM), Providencia stuartii (MIC=110 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9596699	Infect Immun. 1998 Jun;66(6):2434-40.	Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW.	Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.	
DRAMP18651	SRSELIVHQRRC	12	Cm-p3 (Cm-p1  peptide derivative)	No entry found	Derived from the peptide Cm-p1	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Antifungal activity against Candida albicans and Trichophyton rubrum.	[Ref.25921828] Fungi: Candida albicans (01U) (MIC=128 μg/ml), Candida albicans (38U) (MIC=64 μg/ml), Trichophyton rubrum (MIC=128 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25921828	FASEB J. 2015 Aug;29(8):3315-25. 	López-Abarrategui C, McBeth C, Mandal SM, Sun ZJ, Heffron G, Alba-Menéndez A, Migliolo L, Reyes-Acosta O, García-Villarino M, Nolasco DO, Falcão R, Cherobim MD, Dias SC, Brandt W, Wessjohann L, Starnbach M, Franco OL, Otero-González AJ.	Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae).	
DRAMP18652	SRSELIVHQRMK	12	Cm-p4 (Cm-p1  peptide derivative)	No entry found	Derived from the peptide Cm-p1	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Antifungal activity against Candida albicans, Cryptococcus neoformans and Trichophyton rubrum.	[Ref.25921828] Fungi: Candida albicans (01U) (MIC=32 μg/ml), Candida albicans (38U) (MIC=32 μg/ml), Candida parapsilosis (MIC=256 μg/ml), Trichophyton rubrum (MIC=32 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25921828	FASEB J. 2015 Aug;29(8):3315-25. 	López-Abarrategui C, McBeth C, Mandal SM, Sun ZJ, Heffron G, Alba-Menéndez A, Migliolo L, Reyes-Acosta O, García-Villarino M, Nolasco DO, Falcão R, Cherobim MD, Dias SC, Brandt W, Wessjohann L, Starnbach M, Franco OL, Otero-González AJ.	Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae).	
DRAMP18653	SRSELIVHQRLF	12	Cm-p5 (Cm-p1  peptide derivative)	No entry found	Derived from the peptide Cm-p1	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Antifungal activity against Candida albicans, Candida parapsilosis, Cryptococcus neoformans, Trichophyton mentagrophytes and Trichophyton rubrum.	[Ref.25921828] Fungi: Candida albicans (01U) (MIC=10 μg/ml), Candida albicans (38U) (MIC=10 μg/ml), Candida parapsilosis (MIC=32 μg/ml), Cryptococcus neoformans (L26) (MIC=64 μg/ml), Cryptococcus neoformans (L30) (MIC=64 μg/ml), Trichophyton mentagrophytes (MIC=128 μg/ml), Trichophyton rubrum (MIC=10 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	25921828	FASEB J. 2015 Aug;29(8):3315-25. 	López-Abarrategui C, McBeth C, Mandal SM, Sun ZJ, Heffron G, Alba-Menéndez A, Migliolo L, Reyes-Acosta O, García-Villarino M, Nolasco DO, Falcão R, Cherobim MD, Dias SC, Brandt W, Wessjohann L, Starnbach M, Franco OL, Otero-González AJ.	Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae).	
DRAMP18654	GIIKVIKSLIEQFTGK	16	dPSMα1 (PSMα1 peptide derivative; bacteriocin; staphylococcus aureus, bacteria)	A9JX05, A8Z0V1, P0C7Y9, P0C7Y8, P0C7Y7, P0C7Y6, P0C7Y5, P0C7Y4, P0C7Y3	Belongs to the phenol-soluble modulin alpha peptides family.	psmA1	Truncated the peptide PSMα1 (from Staphylococcus aureus)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacteria. Peptide which can recruit, activate and subsequently lyse human neutrophils, thus eliminating the main cellular defense against infection. Stimulates the secretion of the chemotactic factor interleukin-8 (IL-8). The ensuing activation process triggers an inflammatory response in the host, thus contributing greatly to virulence. Also possesses hemolytic activity, which may contribute to the development of disease. Peptide production is higher in most prevalent community-associated MRSA strains than in hospital-associated MRSA strains.
Induction: Up-regulated by agr."	[Ref.22371493]Gram-positive bacteria: Staphylococcus epidermidis ATCC35984 (MIC=42 μM), Streptococcus serotype GAS M3 strain 4041-05 (MIC=11 μM).	[Ref.22371493]Non-hemolytic at 10μg/mL against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22371493	J Biol Chem. 2012 Apr 20;287(17):13889-98.	Gonzalez DJ, Okumura CY, Hollands A, Kersten R, Akong-Moore K, Pence MA, Malone CL, Derieux J, Moore BS, Horswill AR, Dixon JE, Dorrestein PC, Nizet V.	Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.	
DRAMP18655	VGTIIKIIKAIIDIFAK	17	dPSMα4 (PSMα4 peptide derivative; bacteriocin; staphylococcus aureus, bacteria)	A9JX08, P0C827, P0C826, P0C825, P0C824, P0C823, P0C822, P0C821, P0C820	Belongs to the phenol-soluble modulin alpha peptides family.	psmA4	Truncated the peptide PSMα4 (from Staphylococcus aureus)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Not found	Not found		"Function: Antibacterial activity against Gram-positive bacteria. Peptide which can recruit, activate and subsequently lyse human neutrophils, thus eliminating the main cellular defense against infection. Stimulates the secretion of the chemotactic factor interleukin-8 (IL-8). The ensuing activation process triggers an inflammatory response in the host, thus contributing greatly to virulence. Also possesses hemolytic activity, which may contribute to the development of disease. Peptide production is higher in most prevalent community-associated MRSA strains than in hospital-associated MRSA strains.
Induction: Up-regulated by agr."	[Ref.22371493]Gram-positive bacteria: Streptococcus serotype GAS M3 strain 4041-05 (MIC=10 μM).	[Ref.22371493]52% hemolysis at 10μg/mL against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22371493	J Biol Chem. 2012 Apr 20;287(17):13889-98.	Gonzalez DJ, Okumura CY, Hollands A, Kersten R, Akong-Moore K, Pence MA, Malone CL, Derieux J, Moore BS, Horswill AR, Dixon JE, Dorrestein PC, Nizet V.	Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.	
DRAMP18656	MRTGNAD	7	Microcin 7 (Bacteriocin; Escherichia coli, Bacteria)	No entry found	Bacteriocin	Not found	Escherichia coli	Antimicrobial, Antibacterial, Anti-Gram-	Natural	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.2861788] Gram-negative bacteria: Escherichia coli , Klebsiella pneumoniae, Salmonella typhi, Salmonella typhimurium, Salmonella sp., Shigella flexneri, Shigella sp., Proteus mirabilis	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2861788	Antimicrob Agents Chemother. 1985 May;27(5):791-7.	Garcia-Bustos JF, Pezzi N, Mendez E.	Structure and mode of action of microcin 7, an antibacterial peptide produced by Escherichia coli.	
DRAMP18657	GDGTGPGPGP	10	Chitinase (Bacteriocin; Streptomyces violaceusniger, Bacteria)	P86977	Bacteriocin	Not found	Streptomyces violaceusniger	Antimicrobial, Antifungal	Protein level	Not found	Not found		Function: Antifungal activity aginst mycelial growth of wood rotting fungi. 	[Ref.22915152] Inhibits mycelial growth of wood rotting fungi: Phanerochaete chrysosporium MTCC 787 (Inhibition Zone=32.60 mm), Schizophyllum commune ITCC 3751 (Inhibition Zone=27.60 mm), Gloeophyllum trabeum MTCC 355 (Inhibition Zone=30.70 mm), Polyporus agaricans ITCC 761 (Inhibition Zone=25.70 mm),Coriolus versicolor MTCC 138 (Inhibition Zone=20.60 mm), Polystictus versicolor ITCC 13 (Inhibition Zone=16.70 mm), Postia placenta MTCC 144 (Inhibition Zone=20.60 mm), Polyporus friabilis ITCC 335 (Inhibition Zone=22.60 mm).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22915152	J Basic Microbiol. 2013 May;53(5):429-39. doi: 10.1002/jobm.201100648. Epub 2012 Aug 23.	Nagpure A, Gupta RK.	Purification and characterization of an extracellular chitinase from antagonistic Streptomyces violaceusniger.	
DRAMP18658	FLPIVAKLLSGLL	13	Temporin-PE (Edible frogs, amphibians, animals)	A0A2H4WAJ8	Not found	Not found	Pelophylax kl.esculentus(Europe edible frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal, Anti-cancer, Anti-Gram-	Protein level	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.Has hemolytic activity.	[Ref.29191658]Gram-positive bacteria: Staphylococcus aureus (MIC=2.0 μM), Methicillin-resistant Staphylococcus aureus (MIC=4.0 μM), Enterococcus faecalis (MIC=8.0 μM);##Gram-negative bacteria: Escherichia coli (MIC=16.0 μM);##Fungus: Candida albicans (MIC=4.0 μM).##Cancer cell lines: NCI-H157 (IC50=34.56 μM), U251MG (IC50=25.13 μM), PC-3 (IC50=38.56 μM), MDA-MB-435s (IC50=33.23 μM), HMEC-1 (IC50=58.62 μM).	[Ref.29191658]HC50=39.64 μM against horse red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29191658	Biochem Biophys Res Commun. 2018 Jan 22;495(4):2539-2546.	Sang M, Wu Q, Xi X, Ma C, Wang L, Zhou M, Burrows JF, Chen T.	Identification and target-modifications of temporin-PE: A novel antimicrobial peptide in the defensive skin secretions of the edible frog, Pelophylax kl. esculentus.	
DRAMP18659	VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND	32	YFGAP-OH(Yellowfin tuna GAPDH-related antimicrobial peptide; fish, animals)	No entry found	Not found	Not found	Yellowfin tuna (Thunnus albacares)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Alpha helix and  Beta strands	One Alpha helix and two parallel Beta strands		"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacterial.Weak hemolytic activity.
YFGAP-OH is the C-terminus amidated modification of YFGAP."	[Ref.22771964]Gram-positive bacteria: Bacillus subtilis KCTC1021 (MIC=13.0 μg/ml), Bacillus subtilis RM125 (MIC=1.2 μg/ml), Micrococcus luteus ATCC9341 (MIC=6.5 μg/ml), Staphylococcus aureus RM4220 (MIC=125.0 μg/ml), Staphylococcus aureus KCTC1621 (MIC=11.0 μg/ml), Streptococcus iniae FP5229 (MIC=17.0 μg/ml);##Gram-negative bacteria: Escherichia coli D31 (MIC=6.2 μg/ml), Escherichia coli KCTC1116 (MIC=5.0 μg/ml), Escherichia coli ML35p (MIC=3.0 μg/ml), Enterobacter cloacae KCTC1685 (MIC=12.0 μg/ml), Pseudomonas aeroginosa KCTC2004 (MIC=3.7 μg/ml), Salmonella enterica KCTC2514 (MIC=3.1 μg/ml), Shigella flexneri KCTC2517 (MIC=5.0 μg/ml), Aeromonas hydrophila KCTC2358 (MIC=8.0 μg/ml), Vibrio parahemolyticus KCCM41664 (MIC=3.2 μg/ml)	[Ref.22771964]0.4% hemolysis at 100 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22771964	Fish Shellfish Immunol. 2012 Oct;33(4):743-52. doi: 10.1016/j.fsi.2012.06.023.	Seo JK, Lee MJ, Go HJ, Park TH, Park NG.	Purification and characterization of YFGAP, a GAPDH-related novel antimicrobial peptide, from the skin of yellowfin tuna, Thunnus albacares.	
DRAMP18660	VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND	32	YFGAP-NH2(Yellowfin tuna GAPDH-related antimicrobial peptide; fish, animals)	No entry found	Not found	Not found	Yellowfin tuna(Thunnus albacares)	Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal, Anti-Gram-	Not found	Alpha helix and  Beta strands	One Alpha helix and two parallel Beta strands		"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.
YFGAP-NH2 is the C-terminus free forms of YFGAP."	[Ref.22771964]Gram-positive bacteria: Bacillus subtilis KCTC1021 (MIC=5.4 μg/ml), Bacillus subtilis RM125 (MIC=0.7 μg/ml), Micrococcus luteus ATCC9341 (MIC=6.0 μg/ml), Staphylococcus aureus RM4220 (MIC=34.0 μg/ml), Staphylococcus aureus KCTC1621 (MIC=3.7 μg/ml);##Gram-negative bacteria: Escherichia coli D31 (MIC=1.9 μg/ml), Escherichia coli KCTC1116 (MIC=3.3 μg/ml), Escherichia coli ML35p (MIC=0.4 μg/ml), Enterobacter cloacae KCTC1685 (MIC=3.5 μg/ml), Pseudomonas aeroginosa KCTC2004 (MIC=1.7 μg/ml), Salmonella enterica KCTC2514 (MIC=0.9 μg/ml), Shigella flexneri KCTC2517 (MIC=2.0 μg/ml), Aeromonas hydrophila KCTC2358 (MIC=3.6 μg/ml), Vibrio parahemolyticus KCCM41664 (MIC=0.9 μg/ml);##Fungi: Candida albicans KCTC7965 (MIC=125.0 μg/ml)	[Ref.22771964]2.7% hemolysis at 100 μg/ml against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22771964	Fish Shellfish Immunol. 2012 Oct;33(4):743-52. doi: 10.1016/j.fsi.2012.06.023.	Seo JK, Lee MJ, Go HJ, Park TH, Park NG.	Purification and characterization of YFGAP, a GAPDH-related novel antimicrobial peptide, from the skin of yellowfin tuna, Thunnus albacares.	
DRAMP18661	GWLDVAKKIGKAAFNVAKNFL	21	Ctx-Ha (Frogs, amphibians, animals)	No entry found	Belongs to the Ceratotoxin family	Not found	Hypsiboas albopunctatus	Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal, Anti-Gram-	Not found	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.22391524]Gram-positive bacterium: Staphylococcus aureus (MIC=1.7 μmol/L; MMC=6.8 μmol/L);##Gram-negative bacterium: Escherichia coli (MIC=3.4 μmol/L; MMC=3.4 μmol/L);##Fungi: Candida albicans (MIC=54.6 μmol/L; MMC<100 μmol/L)	[Ref.22391524]HC50=37.3±1.4 μmol/L against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	22391524	Antimicrob Agents Chemother. 2012 Jun;56(6):3004-10.	Lorenzón EN, Cespedes GF, Vicente EF, Nogueira LG, Bauab TM, Castro MS, Cilli EM.	Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.	
DRAMP18662	LLAGLAANFLPKIFCKITRKC	21	Brevinin 21 (Brevinin-1E truncated peptide 21; Frogs, amphibians, animals)	No entry found	Derived from the peptide Brevinin-1E 	Not found	Rana esculenta	Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal, Anti-Gram-	Not found	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.9748603]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC=12.5 μg/ml), Methicillin resistant Staphylococcus aureus (MIC=25 μg/ml), Micrococcus luteus ATCC 9341 (MIC=6.25 μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 2592 (MIC=12.5 μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=12.5 μg/ml);##Fungus: Candida albicans ATCC 36232 (MIC=6.25 μg/ml).	[Ref.9748603]HD50=77 μg/ml(oxidized); HD50=110 μg/ml(reduced) against mouse red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9748603	Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.	Kwon MY, Hong SY, Lee KH.	Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta.	
DRAMP18663	GLAANFLPKIFCKITRKC	18	Brevinin 18 (Brevinin-1E truncated peptide 18; Frogs, amphibians, animals)	No entry found	Derived from the peptide Brevinin-1E 	Not found	Rana esculenta	Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal, Anti-Gram-	Not found	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.	[Ref.9748603]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC=25 μg/ml), Methicillin resistant Staphylococcus aureus (MIC=100 μg/ml), Micrococcus luteus ATCC 9341 (MIC=12.5 μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 2592 (MIC=25 μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=12.5 μg/ml);##Fungus: Candida albicans ATCC 36232 (MIC=25 μg/ml).	[Ref.9748603]HD50=146 μg/ml(oxidized); HD50=230 μg/ml(reduced) against mouse red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9748603	Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.	Kwon MY, Hong SY, Lee KH.	Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta.	
DRAMP18664	ANFLPKIFCKITRKC	15	Brevinin 15 (Brevinin-1E truncated peptide 15; Frogs, amphibians, animals)	No entry found	Derived from the peptide Brevinin-1E 	Not found	Rana esculenta	Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal, Anti-Gram-	Not found	Alpha helix 	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.9748603]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC=100 μg/ml), Micrococcus luteus ATCC 9341 (MIC=25 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 2592 (MIC=50 μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=50 μg/ml);##Fungus: Candida albicans ATCC 36232 (MIC=50 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9748603	Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.	Kwon MY, Hong SY, Lee KH.	Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta.	
DRAMP18665	INLKALAALAKKIL	14	Mastoparan-L (MP-L; insects, arthropods, invertebrates, animals)	P01514	Belongs to the tetradecapeptide family	Not found	Vespula lewisii (Korean yellow-jacket isp) (Vespula flaviceps lewisii)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix 	Not found	1D7N resolved by NMR.	"Function: Mast cell degranulating peptide. Activates G proteins that couple to phospholipase C. May be able to switch from an in-plane to a transmembrane orientation in lipid bilayers. Antibacterial activity against Gram-positive bacteria and  Gram-negative bacteria. Has hemolytic activity.
PTM: Leucine amide at the position 14.
Tissue specificity: Expressed by the venom gland."	[Ref.27423268]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=12.5 μM), Enterococcus faecalis ATCC 29212 (MIC=25 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=25 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=50 μM), Klebsiella pneumoniae ATCC 13883 (MIC=12.5 μM), Acinetobacter baumannii ATCC 19606 (MIC=2.7 μM)	[Ref.27423268]40% hemolysis at 10μM against rat red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27423268	Biochim Biophys Acta. 2016 Nov;1858(11):2699-2708.	Irazazabal LN, Porto WF, Ribeiro SM, Casale S, Humblot V, Ladram A, Franco OL.	Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan.	
DRAMP18666	GLGSVFGRLARILGRVIPKV	20	P1 (Pilosulin-1 1-20; Ant, insects, arthropods, invertebrates, animals)	Q07932	Derived from the peptide Pilosulin-1, Belongs to the pilosulin family.	Not found	Myrmecia pilosula (Jumper ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anitifungal, Anti-Gram-	Protein level	Alpha helix 	Not found	5X3L resolved by NMR.	"Function: Has strong cytotoxic and hemolytic activities. Is more potent against mononuclear leukocytes than against granulocytes. Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Adopts an alpha-helical structure.
Allergenic properties: Causes an allergic reaction in human. Binds to IgE."	[Ref.15639237]Gram-positive bacteria: Staphylococcus aureus 710A (MIC=4 μM), Bacillus megaterium BM11 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli ML-35 (MIC=2 μM), Pseudomonas aeruginosa ATCC27853 (MIC=8 μM), Salmonella typhimurium ATCC14028 (MIC=8 μM).##Drug resistant clinical isolates: Staphylococcus simulans 22 (MIC=2 μM), Micrococcus luteus (MIC=0.5 μM), Enterococcus spp. I-11305b (MIC=2 μM), Enterococcus spp. I-11054 (MIC=2 μM), Staphylococcus haemolyticus I-10925 (MIC=2 μM), Staphylococcus epidermidis LT1324 (MIC=2 μM), Staphylococcus aureus 5185 (MIC=2 μM), Staphylococcus aureus I-11574 (MIC=2 μM), Staphylococcus aureus LT1338 (MIC=3 μM), Staphylococcus aureus T1334 (MIC=1.5 μM), Citrobacter freundii I-11090 (MIC=2 μM), Klebsiella pneumoniae I-10910 (MIC=2 μM), Escherichia coli I-11276b (MIC=4 μM), Escherichia coli O-19592 (MIC=2 μM), Stenotrophomonas maltophilia O-16451 (MIC=2 μM), Stenotrophomonas maltophilia I-10717 (MIC=2 μM), Pseudomonas aeruginosa 4991 (MIC=4 μM), Pseudomonas aeruginosa I-10968 (MIC=4 μM), Candida albicans I-11301 (MIC=4 μM).	[Ref.15639237]20% hemolysis at 10μM, 100% hemolysis at 100μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15639237	Arch Biochem Biophys. 2005 Feb 15;434(2):358-64.	Zelezetsky I, Pag U, Antcheva N, Sahl HG, Tossi A.	Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin.	
DRAMP18667	KETWWETWWTEWSQPKKKRKV	21	Pep-1	No entry found	Not found	Not found	Derived from the nuclear localization sequence of simian virus 40 large T antigen and from reverse t	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria.No hemolytic activity.	[Ref.16945333]Gram-positive bacteria: Bacillus subtilis (KCTC 3068) (MIC=8.0 μM), Staphylococcus aureus (KCTC 1621) (MIC=64.0 μM), Staphylococcus epidermidis (KCTC 1917) (MIC=64.0 μM);##Gram-negative bacteria: Escherichia coli (KCTC 1682) (MIC=32.0 μM);##Antibiotic-resistant bacteria: MDRPA 1 (CCARM 2092) (MIC=32.0 μM), MDRPA 3 (CCARM 2109) (MIC=32.0 μM).	[Ref.16945333]Non-hemolysis at 200 μM against human red blood cells	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	16945333	Biochem Biophys Res Commun. 2006 Oct 20;349(2):769-74.	Zhu WL, Lan H, Park IS, Kim JI, Jin HZ, Hahm KS, Shin SY.	Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1.	
DRAMP18668	PSVQGAAAQLTADVKK	16	AI-hemocidins 1 (Hb-1  truncated peptide)	No entry found	Belongs to truncated Hb-1 	Not found	Arca inflata	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against the Gram-negative bacteria.	[Ref.28661457] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=47.35 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=47.35 μM), Pseudomonas aeruginosa clinical isolate (MIC=47.35 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28661457	Mar Drugs. 2017 Jun 29;15(7). pii: E205.	Li C, Zhu J, Wang Y, Chen Y, Song L, Zheng W, Li J, Yu R.	Antibacterial Activity of AI-Hemocidin 2, a Novel N-Terminal Peptide of Hemoglobin Purified from Arca inflata	
DRAMP18669	ISAAEFGKINGPIKK	15	AI-hemocidins 3 (Hb-1  truncated peptide)	No entry found	Belongs to truncated Hb-1 	Not found	Arca inflata	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against the Gram-negative bacteria.	[Ref.28661457] Gram-negative bacterium: Pseudomonas aeruginosa ATCC 27853 (MIC=95.37 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28661457	Mar Drugs. 2017 Jun 29;15(7). pii: E205.	Li C, Zhu J, Wang Y, Chen Y, Song L, Zheng W, Li J, Yu R.	Antibacterial Activity of AI-Hemocidin 2, a Novel N-Terminal Peptide of Hemoglobin Purified from Arca inflata	
DRAMP18670	VLASKNFGDK	10	AI-hemocidins 4 (Hb-1  truncated peptide)	No entry found	Belongs to truncated Hb-1 	Not found	Arca inflata	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Antibacterial activity against the Gram-positive bacteria.	[Ref.28661457] Gram-positive bacterium: Bacillus subtilis ATCC 6633 (MIC=69.55 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28661457	Mar Drugs. 2017 Jun 29;15(7). pii: E205.	Li C, Zhu J, Wang Y, Chen Y, Song L, Zheng W, Li J, Yu R.	Antibacterial Activity of AI-Hemocidin 2, a Novel N-Terminal Peptide of Hemoglobin Purified from Arca inflata	
DRAMP18671	KCRRRKVHGPMIRIRKK	17	TO17 (TFPI-1 C-terminal peptide)	No entry found	Belongs to the TFPI-1 C-terminal peptide	Not found	Red drum (Sciaenops ocellatus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria.	[Ref.29183811] Gram-positive bacteria: Micrococcus luteus (MIC=9 μM; MBC=18 μM), Staphylococcus aureus (MIC=4 μM; MBC=8 μM);##Gram-negative bacterium: Vibrio vulnificus (MIC= 80 μM; MBC=80 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	29183811	Fish Shellfish Immunol. 2018 Jan;72:639-645. 	He SW, Wang GH, Yue B, Zhou S, Zhang M.	TO17: A teleost antimicrobial peptide that induces degradation of bacterial nucleic acids and inhibits bacterial infection in red drum, Sciaenops ocellatus.	
DRAMP18672	APPPGLSAGV	10	Peptide 7 (Mollusca/molluscs/mollusks, invertebrates, animals)	No entry found	Not found	Not found	Marine snail Rapana venosa	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. 	[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21703315	Peptides. 2011 Jul;32(7):1477-83.	Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.	Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.	
DRAMP18673	ELVRKNVDHLSTPDVLELV	19	Peptide 3 (Mollusca/molluscs/mollusks, invertebrates, animals)	No entry found	Not found	Not found	Marine snail Rapana venosa	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. 	[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21703315	Peptides. 2011 Jul;32(7):1477-83.	Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.	Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.	
DRAMP18674	SPPNQPSIMTFDYAKTNK	18	Peptide 2 (Mollusca/molluscs/mollusks, invertebrates, animals)	No entry found	Not found	Not found	Marine snail Rapana venosa	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. 	[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21703315	Peptides. 2011 Jul;32(7):1477-83.	Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.	Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.	
DRAMP18675	SLPPTLEEEFNMKKMG	16	Peptide 4 (Mollusca/molluscs/mollusks, invertebrates, animals)	No entry found	Not found	Not found	Marine snail Rapana venosa	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. 	[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21703315	Peptides. 2011 Jul;32(7):1477-83.	Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.	Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.	
DRAMP18676	SPPSEQLGKSFNF	13	Peptide 5 (Mollusca/molluscs/mollusks, invertebrates, animals)	No entry found	Not found	Not found	Marine snail Rapana venosa	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. 	[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21703315	Peptides. 2011 Jul;32(7):1477-83.	Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.	Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.	
DRAMP18677	SPPPGESKVDMSFNYALSNPAQ	22	Peptide 6 (Mollusca/molluscs/mollusks, invertebrates, animals)	No entry found	Not found	Not found	Marine snail Rapana venosa	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. 	[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21703315	Peptides. 2011 Jul;32(7):1477-83.	Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.	Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.	
DRAMP18678	APPPGYAMESDSFS	14	Peptide 8 (Mollusca/molluscs/mollusks, invertebrates, animals)	No entry found	Not found	Not found	Marine snail Rapana venosa	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. 	[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21703315	Peptides. 2011 Jul;32(7):1477-83.	Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.	Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.	
DRAMP18679	FPPPGESAVDMSFFYALSNP	20	Peptide 9 (Mollusca/molluscs/mollusks, invertebrates, animals)	No entry found	Not found	Not found	Marine snail Rapana venosa	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. 	[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	21703315	Peptides. 2011 Jul;32(7):1477-83.	Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.	Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.	
DRAMP18680	GIADILKGLL	10	Ctry2146 (Scorpions, animals)	P0DMF1	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant	Not found	Chaerilus tryznai (Scorpion)	Antimicrobial, Antiviral	Not found	Not found	Not found		"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland."	[Ref.23415044] The HCV RNA level is screened that between 1.E+00% and 1.E+01% of control(IFNα.2a) in Huh7.5.1 cells.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	
DRAMP18681	LLGGLLQSLL	10	Ctry2346 (Scorpions, animals)	P0DMF2	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant	Not found	Chaerilus tryznai (Scorpion)	Antimicrobial, Antiviral	Not found	Not found	Not found		"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland."	[Ref.23415044] The HCV RNA level is screened that between 1.E-01% and 1.E+00% of control(IFNα.2a) in Huh7.5.1 cells.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	
DRAMP18682	GILDAITGLL	10	Ctry2606 (Scorpions, animals)	P0DMF4	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant	Not found	Chaerilus tryznai (Scorpion)	Antimicrobial, Antiviral	Not found	Not found	Not found		"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland."	[Ref.23415044] The HCV RNA level is screened that between 1.E-03% and 1.E-02% of control(IFNα.2a) in Huh7.5.1 cells.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	
DRAMP18683	YIRDFITRRPPFGNI	15	Ctri9194 (Scorpions, animals)	P0DMF5	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant	Not found	Chaerilus tricostatus (Scorpion)	Antimicrobial, Antiviral	Not found	Not found	Not found		"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland."	[Ref.23415044] The HCV RNA level is screened that between 1.E+00% and 1.E+01% of control(IFNα.2a) in Huh7.5.1 cells.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	
DRAMP18684	GILDALTGIL	10	Ctri9293 (Scorpions, animals)	P0DMF6	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant	Not found	Chaerilus tricostatus (Scorpion)	Antimicrobial, Antiviral	Not found	Not found	Not found		"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland."	[Ref.23415044] The HCV RNA level is screened that between 1.E+00% and 1.E+01% of control(IFNα.2a) in Huh7.5.1 cells.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	
DRAMP18685	GVVDTLKNLLMGLL	14	Ctri9594 (Scorpions, animals)	P0DMF7	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant	Not found	Chaerilus tricostatus (Scorpion)	Antimicrobial, Antiviral	Not found	Not found	Not found		"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland."	[Ref.23415044] The HCV RNA level is screened that between 1.E-01% and 1.E+00% of control(IFNα.2a) in Huh7.5.1 cells.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	
DRAMP18686	FLFNVIPHAINATASLIKK	19	Ctri9610 (Scorpions, animals)	P0DME2	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant	Not found	Chaerilus tricostatus (Scorpion)	Antimicrobial, Antiviral	Not found	Not found	Not found		"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland."	[Ref.23415044] The HCV RNA level is screened that between 1.E-01% and 1.E+00% of control(IFNα.2a) in Huh7.5.1 cells.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	
DRAMP18687	FLVGILPRMRGFITPFLKKVR	21	Ctri10033 (Scorpions, animals)	P0DME4	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant	Not found	Chaerilus tricostatus (Scorpion)	Antimicrobial, Antiviral	Not found	Not found	Not found		"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland."	[Ref.23415044] The HCV RNA level is screened that between 1.E+00% and 1.E+01% of control(IFNα.2a) in Huh7.5.1 cells.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	
DRAMP18688	FLWSLIPSAISAVTSLIKK	19	Ctri10036 (Scorpions, animals)	P0DME3	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant	Not found	Chaerilus tricostatus (Scorpion)	Antimicrobial, Antiviral	Not found	Not found	Not found		"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland."	[Ref.23415044] The HCV RNA level is screened that between 1.E+00% and 1.E+01% of control(IFNα.2a) in Huh7.5.1 cells.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	
DRAMP18689	FDLGGLIKGVVDLF	14	Ctri10261 (Scorpions, animals)	P0DMF8	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant	Not found	Chaerilus tricostatus (Scorpion)	Antimicrobial, Antiviral	Not found	Not found	Not found		"Function: Shows a low ability to inhibit hepatitis C virus (HCV) infection in Huh7.5.1 cells. 
Tissue specificity: Expressed by the venom gland."	[Ref.23415044] The HCV RNA level is screened that between 1.E+00% and 1.E+01% of control(IFNα.2a) in Huh7.5.1 cells.	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	
DRAMP18690	LRPAVIRPKGK	11	Hyposin-HA1 (Frogs, amphibians, animals)	P84954	Belongs to the Hyposins family	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial	Protein level	Not found	Not found		"Function: Has antimicrobial activity. 
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-13. 	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP18691	LRPAFIRPKGK	11	Hyposin-HA2 (Frogs, amphibians, animals)	P84955	Belongs to the Hyposins family	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial	Protein level	Not found	Not found		"Function: Has antimicrobial activity. 
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-13. 	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP18692	LGPALITRKPLKGKP	15	Hyposin-HA5 (Frogs, amphibians, animals)	P84958	Belongs to the Hyposins family	Not found	Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea)	Antimicrobial	Protein level	Not found	Not found		"Function: Has antimicrobial activity. 
Tissue specificity: Expressed by the skin glands."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	17696382	J Proteome Res. 2007 Sep;6(9):3604-13.	Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.	Amphibian skin secretomics: application of parallel quadrupole time-of-flight mass spectrometry and peptide precursor cDNA cloning to rapidly characterize the skin secretory peptidome of Phyllomedusa hypochondrialis azurea: discovery of a novel peptide family, the hyposins.	
DRAMP18693	RPKPQQFFGLM	11	Substance P (Mammals, animals)	P67932, P67933	Belongs to the tachykinin family.	TAC1	Not found	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Substance P possesses direct antimicrobial activity. Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.12074933]Gram-negative bacteria: Escherichia coli (MIC=0.06%), Proteus vulgaris (MIC=0.13%), Pseudomonas aeruginosa (MIC=0.13%) ;##Gram-positive bacteria: Staphylococcus aureus (MIC=0.007%), Enterococcus faecalis (MIC=0.13%);##Yeast: Candida albicans (MIC=0.25%)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12074933	Life Sci. 2002 Jul 5;71(7):747-50.	Kowalska K, Carr DB, Lipkowski AW.	Direct antimicrobial properties of substance P.	
DRAMP18694	RPKPQQWFWLM	11	substance P antagonist (Mammals, animals)	No entry found	Not found	Not found	Not found	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.12074933]Gram-negative bacteria: Escherichia coli (MIC=0.13%), Proteus vulgaris (MIC=0.13%), Pseudomonas aeruginosa (MIC=0.13%) ;##Gram-positive bacteria: Staphylococcus aureus (MIC=0.13%), Enterococcus faecalis (MIC=0.13%);##Yeast: Candida albicans (MIC=0.03%).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12074933	Life Sci. 2002 Jul 5;71(7):747-50.	Kowalska K, Carr DB, Lipkowski AW.	Direct antimicrobial properties of substance P.	
DRAMP18695	KHFGKDSNFPF	11	Venom peptide 1 (Scorpions, animals)	P86825	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short ant	Not found	Tityus serrulatus (Brazilian scorpion)	Antimicrobial, Antibacterial	Protein level	Not found	Not found		"Function: May be an antibacterial peptide. 
Tissue specificity: Expressed by the venom gland."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	18718845	Toxicon. 2008 Oct;52(5):611-8. 	Rates B, Ferraz KK, Borges MH, Richardson M, De Lima ME, Pimenta AM.	Tityus serrulatus venom peptidomics: assessing venom peptide diversity.	
DRAMP18696	FQWQRNMRKVRGPPVS	16	HLP1 (Lactotransferrin truncated peptide)	P02788, A0A161I202	Belongs to the Lactotransferrin	LTF	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Has antimicrobial activity, which depends on the extracellular cation concentration. Antimicrobial properties include bacteriostasis, which is related to its ability to sequester free iron and thus inhibit microbial growth, as well as direct bactericidal properties leading to the release of lipopolysaccharides from the bacterial outer membrane. Can also prevent bacterial biofilm development in P.aeruginosa infection. Has weak antifungal activity against C.albicans. HLP 1 corresponded to the loop region of human lactoferricin (residues 20 to 35).	[Ref.9596699] Gram-negative bacteria: Escherichia coli NCTC 8007 (MIC=500 μM), Escherichia coli NCTC 10418 (MIC=500μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=500 μM);##Clinical isolates: Acinetobacter sp.(MIC=2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9596699	Infect Immun. 1998 Jun;66(6):2434-40.	Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW.	Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.	
DRAMP18697	FQWQRNMRKVR	11	HLP2 (Lactotransferrin truncated peptide)	P02788, A0A161I202	Belongs to the Lactotransferrin	Not found	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. HLP 2 corresponded to the alpha-helical region of the loop in its native conformation (residues 20 to 30).	[Ref.9596699] Gram-negative bacteria: Escherichia coli NCTC 8007 (MIC=290 μM), Escherichia coli NCTC 10418 (MIC=579 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=14 μM);##Clinical isolates: Acinetobacter sp. (MIC=0.86 μM), Enterobacter aerogenes (MIC=290 μM), Klebsiella sp. strain 3105 (MIC=290 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9596699	Infect Immun. 1998 Jun;66(6):2434-40.	Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW.	Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.	
DRAMP18698	AERVGAGAPVYL	12	Histone H2A (Trouts, fish, animals)	P02264	Belongs to the histone H2A family.	Not found	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Protein level	Not found	Not found		"Function: The secreted form has antibacterial activity against Gram-positive bacteria and antifungal activity against Saccharomyces cerevisiae.
Tissue specificity: Expressed and secreted by skin epithelium."	[Ref.12164782] Gram positive bacteria: Aerococcus viridans (MIC=0.08-0.15 µM), Bacillus subtilis (MIC=0.6-1.2 µM), Micrococcus luteus (MIC=0.6-1.2 µM), Planococcus citreus (MIC=0.08-0.15 µM), Renibacterium salmoninarum (MIC=0.15-0.3 µM);##Fungi: Saccharomyces cerevisiae (MIC=0.3-0.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12164782	Biochem J. 2002 Dec 1;368(Pt 2):611-20.	Fernandes JMO., Kemp GD., Molle MG., Smith VJ.2002	Anti-microbial properties of histone H2A from skin secretions of rainbow trout, Oncorhynchus mykiss.	
DRAMP18699	FLGGLLASLLGKI	13	Pleurain-B1 (Frogs, amphibians, animals)	B5L1B2, B5L1B4, B5L1B6, B5L1B3	Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.19028675]Gram-negative bacterium: Escherichia coli(MIC=25 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 μg/ml), Bacillus subtilis (MIC=3.1 μg/ml);##Yeast: Candida albicans (MIC=1.6μg /ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-83.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	
DRAMP18700	YPELQQDLIARLL	13	Pleurain-C1 (Frogs, amphibians, animals)	B5L1A8	Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.3 μg/ml), Bacillus subtilis (MIC=3.1 μg/ml);##Yeast: Candida albicans(MIC=25 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-83.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	
DRAMP18701	FRSGILKLASKIPSVLCAVLKNC	23	Pleurain-D4 (Frogs, amphibians, animals)	B5L1I4	Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μg/ml), Bacillus subtilis (MIC=50 μg/ml);##Yeast: Candida albicans(MIC=25 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-83.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	
DRAMP18702	AKAWGIPPHVIPQIVPVRIRPLCGNV	26	Pleurain-E1 (Frogs, amphibians, animals)	B5L1I5	Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=25 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6..3 μg/ml)##Yeast: Candida albicans (MIC=25 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-83.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	
DRAMP18703	GFWDSVKEGLKNAAVTILNKIKCKISECPPA	31	Pleurain-G1 (Frogs, amphibians, animals)	B5L1I8	Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=50 μg/ml), Bacillus subtilis (MIC=100 μg/ml);##Yeast: Candida albicans(MIC=12.5 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-83.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	
DRAMP18704	FIPGLRRLFATVVPTVVCAINKLPPG	26	Pleurain-J1 (Frogs, amphibians, animals)	B5L1L0	Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=12.5 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μg/ml), Bacillus subtilis (MIC=50 μg/ml);##Yeast: Candida albicans(MIC=6.3 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-83.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	
DRAMP18705	GFFDRIKALTKNVTLELLNTITCKLPVTPP	30	Pleurain-N1 (Frogs, amphibians, animals)	B5L1L8	Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μg/ml);##Yeast: Candida albicans (MIC=12.5 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-83.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	
DRAMP18706	CVHWMTNTARTACIAP	16	Pleurain-R1 (Frogs, amphibians, animals)	No entry found	Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.	Not found	Rana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=100 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=25 μg/ml), Bacillus subtilis (MIC=100 μg/ml);##Yeast: Candida albicans(MIC=50 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-83.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	
DRAMP18707	RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPL	60	BACTENECIN 7 (bac 7, Pro-rich; bovine cathelicidin, cattle, ruminant, mammals, animals)	P19661	Belongs to the cathelicidin family.	CATHL3	Bos taurus (Bovine neutrophils)	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Not found	Rich	Not found	4JWC resolved by NMR	"Function: Antibacterial activity against an array of gram-negative and gram-positive bacteria.
PTM: Elastase is responsible for its maturation."	[Ref.2777377] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12 µg/ml in Murller-Hinton, MIC=50 µg/ml in Iso-Sensitest), Salmonella typhimurium LT2 (MIC=12 µg/ml in Murller-Hinton, MIC=200 µg/ml in Iso-Sensitest), Salmonella typhimurium ATCC 14028 (MIC=25 µg/ml in Murller-Hinton, MIC=100 µg/ml in Iso-Sensitest), Klebsiella pneumoniae ATCC 13883 (MIC=12 µg/ml in Murller-Hinton, MIC=200 µg/ml in Iso-Sensitest), Enterobacter cloacae ATCC 13047 (MIC=25 µg/ml in Murller-Hinton, MIC=200 µg/ml in Iso-Sensitest), Pseudomonas aeruginosa ATCC 7700 (MIC=50 µg/ml in Murller-Hinton);##Gram-positive bacterium: Staphylococcus epidermidis ATCC 12228 (MIC=200 µg/ml in Murller-Hinton, MIC=200 µg/ml in Iso-Sensitest).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2777377	Infect Immun. 1989 Oct;57(10): 3142-6.	Gennaro R, Skerlavaj B, Romeo D.	Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils.	
DRAMP18708	ALWMTLLKKVLKAAAKAALNAVLVGANA	28	Dermaseptin-S4 (DRS-S4, DS4; frog, amphibians, animals)	P80280	Belongs to the frog skin active peptide (FSAP) family. Dermaseptin subfami	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix 	Not found	2DD6 resolved by NMR	Function: Possesses a potent antimicrobial activity against Gram-negative and Gram-positive bacteria, fungi, protozoa, and the enveloped herpes simplex virus type 1. Probably acts by disturbing membrane functions with its amphipathic structure. Binds to healthy erythrocytes (this binding is receptor independent), and has strong hemolytic activity. Does not bind to P.falciparum infected erythrocytes, but accumulates within the parasite. Kills the parasite, and only at high concentrations has a hemolytic activity on the host cell.	[Swiss_Prot Entry P80280]Possesses a potent antimicrobial activity against Gram-negative and Gram-positive bacteria, fungi, protozoa, and the enveloped herpes simplex virus type 1	[Swiss_Prot Entry P80280]Strong hemolytic activity	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8306981	Eur. J. Biochem. 1994; 219:145-154.	Mor A, Nicolas P.	Isolation and structure of novel defensive peptides from frog skin.	
DRAMP18709	INLKALAALAKKIL	14	Mastoparan (MP; insects, arthropods, invertebrates, animals)	P01514	Not found	Not found	Vespula flaviceps lewisii (Korean yellow-jacket isp)	Antimicrobial, Antibacterial, Cell degranulating	Not found	Helix	Not found	1D7N resolved by NMR	Function: Antibacterial and cell degranulating activity.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	540362	Chem Pharm Bull (Tokyo). 1979 Aug;27(8):1942-4	Hirai Y, Yasuhara T, Yoshida H, Nakajima T, Fujino M, Kitada C.	A new mast cell degranulating peptide mastoparan in the venom of Vespula lewisii	
DRAMP18710	VTCDLLSFKGQVNDSACAANCLSLGKAGGHCEKVGCICRKTSFKDLWDKRF	51	Royalisin (Insects, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Apis mellifera L. (royal jelly honeybee)	Antimicrobial, Antibacterial, Anti-Gram+	Protein level	Bridge	High content of cysteine residues and a compact structure owing to intramolecular disulfide cross-linking. 		Function: Antibacteria activity against Gram-positive bacteria.	[Ref.2358464] Gram-positive bacteria: Bifidobacterium adolescentis ATCC15703 (MIC=15 µM at concentration of 1%, MIC=43 µM at concentration of 10%, MIC=59 µM at concentration of 100%), Bifidobacterium bifidum ATCC15606 (MIC=91 µM at concentration of 100%), Bifidobacterium breve ATCC15700 (MIC=67 µM at concentration of 10%, MIC=87 µM at concentration of 100%), Bifidobacterium infantis ATCC15697 (MIC=20 µM at concentration of 10%, MIC=71 µM at concentration of 100%), Bifidobacterium longum ATCC15707 (MIC=29 µM at concentration of 1%, MIC=81 µM at concentration of 10%, MIC=81 µM at concentration of 100%), Clostridium perfringens ATCC13124 (MIC=75 µM at concentration of 100%), Corynebacterium pyogenes (MIC=31 µM at concentration of 10%, MIC=96 µM at concentration of 100%), Eubacterium aerofacience (MIC=17 µM at concentration of 100%), Lactobacillus acidophilus ATCC314 (MIC=44 µM at concentration of 100%), Lactobacillus acidophilus ATCC4356 (MIC=47 µM at concentration of 100%), Lactobacillus bulgaricus ATCC11841 (MIC=21 µM at concentration of 1%, MIC=87 µM at concentration of 10%, MIC=84 µM at concentration of 100%), Lactobacillus helveticus ss. jugurti (MIC=33 µM at concentration of 1%, MIC=90 µM at concentration of 10%, MIC=72 µM at concentration of 100%), Lactobacillus lactis ATCC7830 (MIC=59 µM at concentration of 1%, MIC=90 µM at concentration of 10%, MIC=88 µM at concentration of 100%), Lactobacillus leichmannii ATCC7830 (MIC=14 µM at concentration of 1%, MIC=88 µM at concentration of 10%, MIC=89 µM at concentration of 100%), Leuconostoc cremoris ATCC19254 (MIC=16 µM at concentration of 1%, MIC=84 µM at concentration of 10%, MIC=88 µM at concentration of 100%), Stapjylococcus aureus SC-D (MIC=17 µM at concentration of 1%, MIC=22 µM at concentration of 10%, MIC=82 µM at concentration of 100%), Streptococcus cremoris SCR-812 (MIC=10 µM at concentration of 1%, MIC=18 µM at concentration of 10%, MIC=83 µM at concentration of 100%), Streptococcus thermophilus ATCC19258 (MIC=9 µM at concentration of 1%, MIC=14 µM at concentration of 10%, MIC=86 µM at concentration of 100%).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2358464	J. Biol. Chem. 1990; 265:11333-11337	Fujiwara S, Imai J, Fujiwara M, Yaeshima T, Kaishima T, Kobayashi K.	A potent antibacterial protein in royal jelly. Purification and determination of the primary structure of royalisin.	
DRAMP18711	GRKSDCFRKNGFCAFLKCPYLTLISGLCSFHLC	33	Chicken Heterophil Peptide 2 (CHP-2, avian beta-defensin, birds, animals)	P80390	Belongs to the beta-defensin family.	Not found	Gallus gallus (Chicken)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge	Not found		Function: Has bactericidal activity. Potent activity against E.coli ML-35, L.monocytogenes EGD and C.albicans.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	7964174	J. Leukoc. Biol. 1994; 56: 661-665.	Evans EW, Beach GG, Wunderlich J, Harmon BG.	Isolation of antimicrobial peptides from avian heterophils.	
DRAMP18712	GFGKAFHSVSNFAKKHKTA	19	Styelin A (Tunicate, invertebrates, animals)	P81469	Belongs to the Cecropins family.	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Helix 	Not found		"Function: Bactericidal against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemocytes and pharyngeal tissues."	[Ref.9467865] Gram positive bacteria: Listeria monocytogenes EGD (MIC=2 µg/ml), Staphylococcus aureus 930918-3 (MIC=6 µg/ml), Enterococcus faecalis 94.132 (MIC=2 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa MR 3007 (MIC=4 µg/ml), Escherichia coli ML-35p (MIC=2.7 µg/ml), Salmonella typhimurium 14028S (MIC=5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9467865	Comp. Biochem. Physiol. 1997; 118:515-521	Lee IH, Cho Y, Lehrer RI.	Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava.	
DRAMP18713	GFGPAFHSVSNFAKKHKTA	19	Styelin B (Tunicate, invertebrates, animals)	P81470	Belongs to the Cecropins family.	Not found	Styela clava (Sea squirt)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Helix 	Not found		"Function: Bactericidal against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemocytes and pharyngeal tissues."	[Ref.9467865] Gram positive bacteria: Listeria monocytogenes EGD (MIC=2 µg/ml), Staphylococcus aureus 930918-3 (MIC=6 µg/ml), Enterococcus faecalis 94.132 (MIC=2 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa MR 3007 (MIC=4.5 µg/ml), Escherichia coli ML-35p (MIC=2.7 µg/ml), Salmonella typhimurium 14028S (MIC=5 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9467865	Comp. Biochem. Physiol. 1997; 118:515-521	Lee IH, Cho Y, Lehrer RI.	Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava.	
DRAMP18714	IIGGR	5	Cathepsin G(1-5) (Human, primates, mammals, animals)	No entry found	Belongs to the Cathepsin G N-terminal 1-5 truncted peptide.	Not found	Homo sapiens	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Bactericidal activity against Gram-positive and Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2116408	J Biol Chem. 1990 Aug 15;265(23):13584-8. 	Bangalore N, Travis J, Onunka VC, Pohl J, Shafer WM.	Identification of the primary antimicrobial domains in human neutrophil cathepsin G.	
DRAMP18715	HPQYNQR	7	Cathepsin G(77-83) (Human, primates, mammals, animals)	No entry found	Belongs to the Cathepsin G 77-83 truncted peptide.	Not found	Homo sapiens	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Bactericidal activity against Gram-positive and Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	2116408	J Biol Chem. 1990 Aug 15;265(23):13584-8. 	Bangalore N, Travis J, Onunka VC, Pohl J, Shafer WM.	Identification of the primary antimicrobial domains in human neutrophil cathepsin G.	
DRAMP18716	PDPAKTAPKKGSKKAVTKA	19	Histone H2B-1(HLP-1) (fish, animals)	P81903	Belongs to the histone H2B family.	Not found	Ictalurus punctatus (Channel catfish) (Silurus punctatus)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	The nucleosome is a histone octamer 	Not found		"Function: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. Has broad-spectrum antimicrobial and antibacterial activity. It is important in the antimicrobial defenses of fish skin and possesses strong activity against saprolegnia, the most common fungal infection in fish. It is also inhibitory to fish bacterial pathogens, such as aeromonas hydrophila, vibrio alginolyticus and Escherichia coli D31.
PTM: Monoubiquitination at the C-terminal Lys gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation. Phosphorylated during apoptosis; which facilitates apoptotic chromatin condensation. "	[Ref.9645227] Gram negative bacteria: Escherichia coli (MIC=0.37±0.023 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	9645227	Cell. Mol. Life Sci. 1998; 54:467-475	Robinette D., Wada S., Arroll T., Levy MG., Miller WL., Noga EJ.	Antimicrobial activity in the skin of the channel catfish Ictalurus punctatus: characterization of broad-spectrum histone-like antimicrobial proteins.	
DRAMP18717	EFTNVSCTTSKECWSVCQRLHNTSRGKCMNKKCRCYS	37	Charybdotoxin (Yellow scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)	No entry found	Not found	Not found	Leiurus quinquestriatus hebraeus 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Combine Helix and Beta structure 	Not found	2CRD resolved by NMR	Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.15118082]Gram-positive bacteria: Bacillus subtilis (Inhibition zone=4 mm completely inhibit in PH5.5, Inhibition zone=7 mm incompletely inhibit and Inhibition zone=6 mm in PH7.5 completely inhibit at 10 μg/well), Staphylococcus aureus  (Inhibition zone=3 mm incompletely inhibit in PH5.5, Inhibition zone=6 mm incompletely inhibit and Inhibition zone=1 mm completely inhibit in PH7.5 at 10 μg/well);##Gram-negative bacteria: Escherichia coli (Inhibition zone=2 mm incompletely inhibit in PH5.5, Inhibition zone=8 mm incompletely inhibit in PH7.5 at 10 μg/well);##Fungi: Candida albicans (Inhibition zone=13 mm completely inhibit in PH5.5, Inhibition zone=15 mm in PH7.5 completely inhibit at 10 μg/well).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	15118082	Proc Natl Acad Sci U S A. 2004 May 11;101(19):7363-8.	Yount NY, Yeaman MR.	Multidimensional signatures in antimicrobial peptides.	
DRAMP18718	GDDDDDD	7	SAAP fraction 2 (Surfactant-associated anionic peptides; Asp-rich; sheep, ruminant, mammals, animals)	No entry found	Not found	Not found	Ovis aries	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Rich	Not found		Function: Antibacterial activity against negative bacteria.  No amidation at the C-terminus	[Ref.8552650] Gram-negative bacterium: Pasteurella haemolytica (MBC50=0.04 mM in Zn-saline, MBC50=11.49 mM in Test buffer; Peptide/surfactant mixture MBC50=0.05 mM in Zn-saline, MBC50=6.44 mM in Test buffer; Peptide/serum mixture MBC50=0.05 mM in Zn-saline, MBC50=10.38 mM in Test buffer; Peptide/surfactant/serum mixture MBC50=0.06 mM in Zn-saline, MBC50=5.93 mM in Test buffer).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8552650	Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):412-6.	Brogden KA, de Lucca AJ, Bland J, Elliott S.	Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica.	
DRAMP18719	DDDDDDD	7	SAAP fraction 3 (Surfactant-associated anionic peptides; Asp-rich; sheep, ruminant, mammals, animals)	No entry found	Not found	Not found	Ovis aries	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Rich	Not found		Function: Antibacterial activity against Gram positive and negative bacteria. No amidation at the C-terminus	[Ref.8552650] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MBC50=1.21 mM in Zn-saline), Streptococcus faecalis ATCC 29213 (MBC50=1.39 mM in Zn-saline);##Gram-negative bacteria: Escherichia coli ATCC 12795 (MBC50=0.64 mM in Zn-saline), Klebsiella pneumoniae ATCC 10031 (MBC50=0.62 mM in Zn-saline), Pasteurella haemolytica (MBC50=0.02 mM in Zn-saline, MBC50=8.52 mM in Test buffer; Peptide/surfactant mixture MBC50=0.01 mM in Zn-saline, MBC50=4.43 mM in Test buffer; Peptide/serum mixture MBC50=0.02 mM in Zn-saline, MBC50=4.95 mM in Test buffer; Peptide/surfactant/serum mixture MBC50=0.03 mM in Zn-saline, MBC50=2.79 mM in Test buffer).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8552650	Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):412-6.	Brogden KA, de Lucca AJ, Bland J, Elliott S.	Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica.	
DRAMP18720	GADDDDD	7	SAAP fraction 6 (Surfactant-associated anionic peptides; Asp-rich; sheep, ruminant, mammals, animals)	No entry found	Not found	Not found	Ovis aries	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Rich	Not found		Function: Antibacterial activity against negative bacteria. No amidation at the C-terminus	[Ref.8552650] Gram-negative bacterium: Pasteurella haemolytica (MBC50=0.02 mM in Zn-saline, MBC50=10.10 mM in Test buffer; Peptide/surfactant mixture MBC50=0.04 mM in Zn-saline, MBC50=5.18 mM in Test buffer; Peptide/serum mixture MBC50=0.04 mM in Zn-saline, MBC50=5.59 mM in Test buffer; Peptide/surfactant/serum mixture MBC50=0.04 mM in Zn-saline, MBC50=4.75 mM in Test buffer).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	8552650	Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):412-6.	Brogden KA, de Lucca AJ, Bland J, Elliott S.	Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica.	
DRAMP18721	GWKIGKKLEHHGQNIRDGLISAGPAVFAVGQAATIYAAAK	40	Hinnavin I (Hin I; insects, arthropods, invertebrates, animals)	No entry found	Belongs to the Cecropins family.	Not found	Artogeia rapae (cabbage butterfly)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Hinnavin 1 is heat stable; its activity is retained after 60 min incubation at 100 DC, being effective against Gram negative and/or Gram positive bacteria. Hinnavin I and lysozyme 2 showed a powerful synergistic effect on the inhibition of bacterial growth.	[Ref.9339895] Gram-positive bacteria: Bacillus subtilis (Inhibition zone=3.0 mm), Bacillus megaterium Bm11 (Inhibition zone=5.0 mm), Bacillus thuringiensis (Inhibition zone=3.0 mm);##Gram-negative bacteria: Escherichia coli (Inhibition zone=7.0 mm), Escherichia coli D21 (Inhibition zone=7.1 mm), Enterobacter cloacae (Inhibition zone=6.0 mm);##Fungi: Candida albicans (Inhibition zone=3.0 mm), Aspergillus niger (Inhibition zone=3.0 mm).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Cell membranes	9339895	Mol Cells. 1997 Aug 31;7(4):509-13	Bang IS, Son SY, Yoe SM.	Hinnavin I, an antibacterial peptide from cabbage butterfly, Artogeia rapae.	
DRAMP18722	AKKFGKAFVGEIM	13	MA (Magainin 2 (9-21) truncated peptide)	P11006	Belongs to truncated magainin 2.	magainins	Xenopus laevis (African clawed frog)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Alpha helix	Not found		Function: Antibacterial activity against the Gram-negative bacteria.	[Ref.28178190] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=32 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28178190	Int J Mol Sci. 2017 Feb 6;18(2). pii: E339. 	Tan T, Wu D, Li W, Zheng X, Li W, Shan A.	High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7	
DRAMP18723	KWKLFKKI	8	CE (Cecropin A (1	P01507	Belongs to truncated Cecropin A.	Not found	Hyalophora cecropia (Cecropia moth)	Antimicrobial, Antibacterial, Anti-Gram-	Not found	random coil	Not found		Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.	[Ref.28178190] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=64 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28178190	Int J Mol Sci. 2017 Feb 6;18(2). pii: E339. 	Tan T, Wu D, Li W, Zheng X, Li W, Shan A.	High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7	
DRAMP18724	PKRKSATKGDEPARRSARLSARPVPKPAAKPKKAAAPKKAVKGKKAAENGDAKAEAKVQAAGDGAGNAK	69	Oncorhyncin III (Oncorhyncin-3, histone-derived; fish, animals)	P02315	Belongs to the HMGN family.	Not found	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Oncorhyncin III has antibacterial activity against Gram-positive and Gram-negative bacteria at submicromolar concentrations. Non-histone protein that probably binds to the inner side of nucleosomal DNA, altering the association between the DNA and the nucleosome octamer. 	[Ref.12713443] Gram-positive bacteria: Aerococcus viridans (MIC=0.06-0.12 μM), Bacillus subtilis (MIC=0.25-0.5 μM), Micrococcus luteus (MIC=0.12-0.25 μM), Planococcus citerus (MIC=0.06-0.12 μM);##Gram-negative bacteria: Aeromonas hydrophila (MIC>0.5 μM), Aeromonas salmonicida (MIC>0.5 μM), Escherichia coli (MIC=0.25-0.5 μM), Listonella anguillarum (MIC=0.25-0.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	12713443	Biochem 2003; 373 (Pt 2): 621-628	Fernandes JM., Saint N, Kemp GD, Smith VJ. 	Oncorhyncin III: a potent antimicrobial peptide derived from the non-histone chromosomal protein H6 of rainbow trout, Oncorhynchus mykiss.	
DRAMP02518	KRFKKFFKKLKNSVKKRAKKFFKKPKVIGVTFPF	34	NA-CATH	No entry found	Not found	Not found	Naja atra	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Alpha helix, random coil	NA-CATH has previously been shown to be random coil in water or buffer and 		Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity.	[Ref.28089718] Gram-negative bacteria: Acinetobacter baumannii ATCC 9955 (MIC=10μg/ml), Acinetobacter baumannii ATCC BAA-1794 (MIC=10μg/ml), Escherichia coli ATCC 51659 (MIC=21μg/ml), K. pneumoniae ATCC 33495 (MIC=5.2μg/ml), K. pneumoniae ATCC BAA-1705 (MIC=5.2μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=10μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (MIC=10μg/ml)	[Ref.28089718] 0% hemolysis at 300μg/ml against sheep red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	28089718	Dev Comp Immunol. 2017 May;70:135-144. 	Barksdale SM, Hrifko EJ, van Hoek ML.	Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae	
DRAMP03714	FLGALWNVAKSVF	13	VmCT1	I0DEB3 	Belongs to the scorpion NDBP 5 family	Not found	Vaejovis mexicanus smithi (Scorpion)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Alpha helix, random coil	the peptide showed a coiled structure in water, zwitterionic lipid vesicles (POPC and POPC:DOPE) and negatively charge lipid vesicle (POPC:POPG) the analogs tend to adopt helical structures.		Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria, antifungal activity. Has hemolytic activity.	[Ref.27912176] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=3.12 μmol/L), Bacillus subtilis ATCC 6633 (MIC=25μmol/L), Staphylococcus epidermidis ATCC 12228 (MIC=3.12μmol/L);##Gram-negative bacterium: Pseudomonas aeruginosa ATCC 27853 (MIC=0.78μmol/L), Escherichia coli D31 (MIC=3.12μmol/L), Serratia marcescens ATCC 4112 (MIC=1.56μmol/L), Enterobacter cloacae β-12 (MIC=25μmol/L), Micrococcus luteus A270 (MIC=1.56μmol/L);##Fungi: Candida albicans MDM8 (MIC=12.5μmol/L), Candida tropicalis IOC 4560 (MIC=6.25μmol/L), Candida parapsilosis IOC 4564 (MIC=25μmol/L), Aspergillus niger (MIC=25μmol/L), Cladosporium herbarum ATCC 26362 (MIC=50μmol/L), Cryptococcus neoformans (MIC=3.12μmol/L)	[Ref.27912176] 10% hemolysis at 1.99μmol/L against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27912176	Eur J Med Chem. 2017 Jan 27;126:456-463. 	Pedron CN, Torres MT, Lima JADS, Silva PI, Silva FD, Oliveira VX.	Novel designed VmCT1 analogs with increased antimicrobial activity	
DRAMP03645	LVQRGRFGRFLRKIRRFRPKVTITIQGSARFG	32	fowlicidin-2	No entry found	Not found	CATHL2	Gallus gallus 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not foundn	2GDL	Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity.	[Ref.27698732] Gram-positive bacterium:Staphylococcus aureus ATCC 29213 (MIC=4µM);##Gram-negative bacterium:Escherichia coli ATCC 25922 (MIC=1µM), Pseudomonas aeruginosa ATCC 27853 (MIC=4µM), Salmonella typhimurium C77-31 (MIC=2µM)	[Ref.27698732] 15% hemolysis at 10µM,40% hemolysis at 80µM,60% hemolysis at 200µM against human red blood cells.	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	27698732	Exp Ther Med. 2016 Oct;12(4):2324-2330.	Xing LW, Tian SX, Gao W, Yang N, Qu P, Liu D, Jiao J, Wang J, Feng XJ.	Recombinant expression and biological characterization of the antimicrobial peptide fowlicidin-2 in Pichia pastoris.	
DRAMP20766	GEILCNLCTGLINTLENLLTTKGADKVKDYISSLCNKASGFIATLCTKVLDFGIDKLIQLIEDKVDANAICAKIHAC	77	Pore-forming peptide ameobapore A(Amoeba peptide, AP-A; Parasite, amoebozoa, protozoa, protists)	P34095	Belongs to the amoebapore (amoebapore) family	Not found	Entamoeba histolytica	Antimicrobial, Antibacterial, Anti-Gram+, Antibiotic	Protein level	Alpha helix	Not found	1OF9 resolved by NMR.	Function: Forms pores in the cytoplasmic membrane of host cells. Has antibacterial activity against M.luteus, no activity against E.coli. Implicated in the cytolytic activity of the parasite.	[Ref.7715451] Gram-positive bacterium: Micrococcus luteus (MIC=2 μM, MBC=5 μM).##[Ref.11948186]Gram-positive bacterium: B. subtilis (100% permeabilized bacteria: 5 nM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Disulfide bonds between Cys5 and Cys77, Cys8 and Cys71, Cys35 and Cys46	Not included yet	Not included yet	Not found	1881907##7715451##11948186	Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7659-63.##Mol Microbiol. 1994 Dec;14(5):895-904.##J Biol Chem. 2002 Jun 21;277(25):22353-60.	Leippe M, Ebel S, Schoenberger OL, Horstmann RD, üller-Eberhard HJ.##Leippe M, Andrä J, Nickel R, Tannich E, Müller-Eberhard HJ.##Herbst R, Ott C, Jacobs T, Marti T, Marciano-Cabral F, Leippe M.	Pore-forming peptide of pathogenic Entamoeba histolytica.##Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes.##Pore-forming polypeptides of the pathogenic protozoon Naegleria fowleri.	
DRAMP20767	GAILCNLCKDTVKLVENLLTVDGAQAVRQYIDNLCGKASGFLGTLCEKILSFGVDELVKLIENHVDPVVVCEKIHAC	77	Pore-forming peptide ameobapore B (Parasite, amoebozoa, protozoa, protists) 	Q24824	Belongs to the amoebapore (amoebapore) family	Not found	Entamoeba histolytica	Antimicrobial, Antibacterial, Anti-Gram+, Antibiotic	Protein level	Alpha helix	Not found		Function: Forms pores in the cytoplasmic membrane of host cells. Has antibacterial activity against M.luteus, no activity against E.coli. Implicated in the cytolytic activity of the parasite.	[Ref.7715451] Gram-positive bacterium: Micrococcus luteus (MIC=5 μM, MBC=5 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Disulfide bonds between Cys5 and Cys77, Cys8 and Cys71, Cys35 and Cys46	Not included yet	Not included yet	Not found	7715451	Mol Microbiol. 1994 Dec;14(5):895-904.	Leippe M, Andrä J, Nickel R, Tannich E, Müller-Eberhard HJ.	Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes.	
DRAMP20768	IPVLCPVCTSLVGKLIDLVLGGAVDKVTDYLETLCAKADGLVETLCTKIVSYGIDKLIEKILEGGSAKLICGLIHAC	77	Pore-forming peptide ameobapore C (EH-APP; Parasite, amoebozoa, protozoa, protists)	Q24825	Belongs to the amoebapore (amoebapore) family	Not found	Entamoeba histolytica	Antimicrobial, Antibacterial, Anti-Gram+, Antibiotic	Protein level	Alpha helix	Not found		Function: Forms pores in the cytoplasmic membrane of host cells. Has antibacterial activity against M.luteus, no activity against E.coli. Implicated in the cytolytic activity of the parasite.	[Ref.7715451] Gram-positive bacterium: Micrococcus luteus (MIC=5 μM, MBC=10 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Disulfide bonds between Cys5 and Cys77, Cys8 and Cys71, Cys35 and Cys46	Not included yet	Not included yet	Not found	7715451	Mol Microbiol. 1994 Dec;14(5):895-904.	Leippe M, Andrä J, Nickel R, Tannich E, Müller-Eberhard HJ.	Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes.	
DRAMP20769	DAECEICKFVIQQVEAFIESNHSQAEIQKELNKLCSSVPSIFTQTCLSIARMVPYIIKKLEEHNSPGQVCQGLHLCKSS	78	Naegleriapore A (NP-A; parasite, amoebozoa; protozoa, protists)	Q95X03	Not found	NP-A	Naegleria fowleri (Brain eating amoeba)	Antimicrobial, Antibacterial, Anti-Gram+	Protein predicted	Not found	Not found		No comments found on DRAMP database	[Ref.11948186] Gram-positive bacterium: B. subtilis (100% permeabilized bacteria: 158 nM)	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11948186	J Biol Chem. 2002 Jun 21;277(25):22353-60.	Herbst R, Ott C, Jacobs T, Marti T, Marciano-Cabral F, Leippe M.	Pore-forming polypeptides of the pathogenic protozoon Naegleria fowleri.	
DRAMP20770	SVIGCEICEWLVATAEGFVNKTKPQIEQELLQICAKLGPYEQICDQLVLMELPDIIDQIIAKEPPAIVCSQVKICNGSAMAVAA	84	Naegleriapore B (NP-B; parasite, amoebozoa, protozoa, protists)	Q95X02	Not found	NP-B	Naegleria fowleri (Brain eating amoeba)	Not found	Protein predicted	Not found	Not found		No comments found on DRAMP database	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	11948186	J Biol Chem. 2002 Jun 21;277(25):22353-60.	Herbst R, Ott C, Jacobs T, Marti T, Marciano-Cabral F, Leippe M.	Pore-forming polypeptides of the pathogenic protozoon Naegleria fowleri.	
DRAMP20771	GKCSVLKKVACAAAIAGAVAACGGIDLPCVLAALKAAEGCASCFCEDHCHGVCKDLHLC	59	Acanthaporin (parasite, amoebozoa, protozoa, protists)	I3NI56	Not found	Not found	Acanthamoeba culbertsoni	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix	Not found	2LRD, 2LRE resolved by NMR.	Function: Acanthaporin is antimicrobially active against several Gram-positive and Gram-negative bacteria at pH 5.2 but is inactive at pH 7.4, reflecting a pH-dependent activity of the protein.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	23143413	Nat Chem Biol. 2013 Jan;9(1):37-42.	Michalek M, Sönnichsen FD, Wechselberger R, Dingley AJ, Hung CW, Kopp A, Wienk H, Simanski M, Herbst R, Lorenzen I, Marciano-Cabral F, Gelhaus C, Gutsmann T, Tholey A, Grötzinger J, Leippe M.	Structure and function of a unique pore-forming protein from a pathogenic acanthamoeba.	
DRAMP20772	PPHKKKLAVYPVFLFYLFLSWFSLIV	26	cPcAMP1/26 (ciliate, Protists)	No entry found	Not found	Pcamp1	Paramecium caudatum	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: cPcAMP1/26 is capable of markedly killing A. hydrophila and S. aureus (p < 0.05)	[Ref.26883426] cPcAMP1/26 is capable of markedly killing A. hydrophila and S. aureus (p < 0.05), with the bactericidal rates being 27.7%, 31.7% and 40.1% as well as 34.4%, 47.4% and 49.2%, respectively	[Ref.26883426] cPcAMP1/26 showed little hemolytic activity towards human erythrocytes at 100 μg/ml	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	Not found	26883426	Dev Comp Immunol. 2016 Jul;60:53-65.	Cui P, Dong Y, Li Z, Zhang Y, Zhang S.	Identification and functional characterization of an uncharacterized antimicrobial peptide from a ciliate Paramecium caudatum.	
DRAMP20775	FLGFLKNLF	9	Ctry2459-WT (Ctry2459, scorpions,animals)	P0DMF3	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short antimicrobial peptide (group 4) family.	Not found	Chaerilus tryznai (Scorpion)	Antimicrobial, Antiviral	Protein level	Not found	Not found		Function: Inhibit hepatitis C virus(HCV) infection via inactivating infectious viral particle.  However, it cannot suppress established infection because of the poor cellular uptake and restriction of endosomes.	[Ref.23415044] Virus: Hepatitis C virus (EC50=1.84 μg/ml).##Cytotoxic: Huh7.5.1 cells (CC50=79.8 μg/ml)	[Ref.23415044] HC50 = 137.9 μg/ml  against human red blood cells.	Linear	Free	Free		L	[Ref.23415044] CC50=79.8 μg/ml against Huh7.5.1 cells.	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP20776	IGGYCSWLRL	10	HaA4 (beetles,insects,animals)	No entry found	Not found	Not found	Harmonia axyridis (Multicolored Asian lady beetle)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria. HaA4 is proved to have more potent activity against Staphylococcus epidermidis, M. luteus, and Pseudomonas syringae.	[Ref.23124352] Gram-negative bacteria: Escherichia coli KACC 13821 (MIC=32 microM), Klebsiella pneumoniae KACC 11402 (MIC<64 microM), Pseudomonas aeruginosa KACC 10259 (MIC<64 microM), Pseudomonas syringae KACC 10659 (MIC=2 microM)；## Gram-positive bacteria: Staphylococcus aureus KACC 13257 (MIC<64 microM),  MR Staphylococcus aureus CCARM 3001(MIC=32 microM), Enterococcus faecalis KACC 13807 (MIC=16 microM), Enterococcus hirae KACC 16328 ( MIC=32 microM), Staphylococcus epidermidis KACC 13234 (MIC=8 microM), Micrococcus luteus KACC 10488 (MIC = 4 microM), Streptococcus pyogenes KACC 11956 (MIC=32 microM)	[Ref.23124352] In the hemolytic assay, HaA4 peptide evidenced no hemolytic activity against mouse red blood cells, even at high concentrations, and thus suggesting that the peptide may not be detrimental to eukaryotic cells.	Linear	Free	Amidation		L	[Ref.23124352] The cytotoxicity is not found in a dose dependent manner.	Not found	23124352	J Microbiol Biotechnol. 2012 Nov;22(11):1588-90.	Kim IW, Lee JH, Park HY, Kwon YN, Yun EY, Nam SH, Kim SR, Ahn MY, Hwang JS.	Characterization and cDNA cloning of a defensin-like peptide, harmoniasin, from Harmonia axyridis.	CC[C@@H](C)[C@H](N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP20777	KRFKKFFRKLKKSVKKRAKEFFKKPRVIGVSIPF	34	Cath-BF	No entry found	Derived from three-finger toxin	Not found	Bungarus fasciatus (Banded krait)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.29392557] Gram-positive bacteria: MRSA PS-2 (MIC=64 μg/ml);##Gram-negative bacteria, MRSA PS-7 (MIC=64 μg/ml), MRSA PS-18 (MIC=64 μg/ml), MRSA PS-45 (MIC=64 μg/ml), MRSA PS-46 (MIC=128 μg/ml), MRSA PS-50 (MIC=64 μg/ml), MRSA PS-59 (MIC=128 μg/ml), MRSA PS-70 (MIC=32 μg/ml), MRSA PS-84 (MIC=128 μg/ml), MRSA PS-106 (MIC=128 μg/ml), MRSA PS-131 (MIC=64 μg/ml), MRSA PS-139 (MIC=64 μg/ml), MRSA PS-162 (MIC=64 μg/ml), MRSA PS-165 (MIC=32 μg/ml), Staphylococcus aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=256 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli ATCC 51446 (MIC=16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=32 μg/ml), Klebsiella pneumoniae ATCC 13883 (MIC=4 μg/ml)	[Ref.29392557] 5% haemolysis at 1.0 μg/ml, 5% haemolysis at 2.0 μg/ml, 5% haemolysis at 4.0 μg/ml, 5% haemolysis at 8.0 μg/ml, 7% haemolysis at 16.0 μg/ml, 9% haemolysis at 31.2 μg/ml, 13% haemolysis at 62.5 μg/ml, 17% haemolysis at 125.0 μg/ml, 19% haemolysis at 250.0 μg/ml, 23% haemolysis at 500.0 μg/ml, 24% haemolysis at 1000.0 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.29392557] The cell viability of HUVEC at the peptide concentration of 35.5 μg/ml, 71 μg/ml and 113 μg/ml  is 127%, 100% and 76%. ##The cell viability of H9c2 at the peptide concentration of 35.5, 71, and 113 μg/ml is 132, 100, and 80%.	Not found	29392557	J Microbiol. 2018 Feb;56(2):128-137.	Tajbakhsh M, Karimi A, Tohidpour A, Abbasi N, Fallah F, Akhavan MM.	The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)C(C)C
DRAMP20778	FFFLSRIF	8	Temporin-SHf (frogs,amphibians,animals)	No entry found	Belongs to the Temporin family	Not found	Pelophylax saharica(Sahara frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Once bound parallel to the microbial membrane surface, it folds into a non-amphipathic hydrophobic 		Function: Antibacterial activity against the Gram-negative bacteria (Escherichia coli ATCC 25922, Escherichia coli ATCC 35218, Escherichia coli D21, Escherichia coli ML-35p, Pseudomonas aeruginosa ATCC 27853) and Gram-positive bacteria (Staphylococcus aureus ATCC 25923, E. faecalis ATCC 29212, Bacillus megaterium. Antifungal activity)	[Ref.20308076] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=25 μM); Escherichia coli ATCC 35218(MIC>200 μM); Escherichia coli D21(MIC=100 μM); Escherichia coli ML-35p(MIC=30 μM); Pseudomonas aeruginosa ATCC 27853(MIC>200 μM);## Gram-positive bacteria: Staphylococcus aureus ATCC 25923(MIC=12.5 μM); E. faecalis ATCC 29212(MIC=50 μM); Bacillus megaterium(MIC=3 μM);## Yeasts: Candida albicans ATCC 90028(MIC=50 μM); C. parapsilosis ATCC 22019(MIC=50 μM); S. cerevisiae(MIC=12.5 μM);## Fungus(MIC>200 μM)	[Ref.20308076] Temporin-SHf is not cytotoxic against human erythrocytes (LC50 = 200 μm), with a hemolytic activity detected only at peptide concentration far above the MIC values determined for the sensitive strains (3–50 μm) 	Linear	Free	Amidation		L	[Ref.20308076] No cytotoxicity information found	Not found	20308076	J Biol Chem. 2010 May 28;285(22):16880-92. 	Abbassi F, Lequin O, Piesse C, Goasdou	Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP20779	GMWSKILGHLIR	12	Halictine 1 (bees,insects,animals)	No entry found	Not found	Not found	Halictus sexcinctus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Exhibits potent antimicrobial activity against the Gram-positive and Gram-negative bacteria as well as noticeable hemolytic activity. 	[Ref.20198492] Gram-negative bacteria: Escherichia coli(MIC=3.8 μM), Pseudomonas aeruginosa(MIC=45.0 μM);## Gram-positive bacteria: Bacillus subtilis(MIC=0.8 μM), Staphylococcus aureus(MIC=7.7 μM)	[Ref.20198492]  LC50=82μM against rat red blood cells	Linear	Free	Amidation		L	[Ref.20198492] No cytotoxicity information found	Not found	20198492	Amino Acids. 2010 Aug;39(3):763-75. 	Monincová L, Budesínskμ M, Slaninová J, Hovorka O, Cvacka J, Voburka Z, Fucík V, Borovicková L, Bednárová L, Straka J, Cerovskμ V.	Novel antimicrobial peptides from the venom of the eusocial bee Halictus sexcinctus (Hymenoptera: Halictidae) and their analogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP20780	GKWMSLLKHILK	12	Halictine 2 (bees,insects,animals)	No entry found	Not found	Not found	Halictus sexcinctus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Exhibits potent antimicrobial activity against the Gram-positive and Gram-negative bacteria as well as noticeable hemolytic activity. 	[Ref.20198492] Gram-negative bacteria: Escherichia coli(MIC=2.5μM), Pseudomonas aeruginosa(MIC=42.1);## Gram-positive bacteria: Bacillus subtilis(MIC=1.0μM), Staphylococcus aureus(MIC=8.1μM)	[Ref.20198492]  LC50=78.1μM against rat red blood cells	Linear	Free	Amidation		L	[Ref.20198492] No cytotoxicity information found	Not found	20198492	Amino Acids. 2010 Aug;39(3):763-75. 	Monincová L, Budesínskμ M, Slaninová J, Hovorka O, Cvacka J, Voburka Z, Fucík V, Borovicková L, Bednárová L, Straka J, Cerovskμ V.	Novel antimicrobial peptides from the venom of the eusocial bee Halictus sexcinctus (Hymenoptera: Halictidae) and their analogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP20781	LNWGAILKHIIK	12	Panurgine 1(bees,insects,animals)	C0HL84	Not found	Not found	Panurgus calcaratus(communal bee)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria, antifungal activity, and low hemolytic activity against human erythrocytes. 	[Ref.23483218] Gram-negative bacteria: Escherichia coli(MIC=3.7μM), Pseudomonas aeruginosa(MIC=51.7μM) ;## Gram-positive bacteria: Micrococcus luteus(MIC=1.5μM), Bacillus subtilis(MIC=1.3μM), Staphylococcus aureus(MIC=10.6μM) ;## Yeast: Candida albicans(MIC=7.3μM)	[Ref.23483218] LC50=119μM against rat red blood cells	Linear	Free	Amidation		L	[Ref.23483218] No cytotoxicity information found	Not found	23483218	Amino Acids. 2013 Jul;45(1):143-57. 	Čujová S, Slaninová J, Monincová L, Fuμík V, Bednárová L, μtokrová J, Hovorka O, Voburka Z, Straka J, μeμovskμ V.	Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae).	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP20782	FLSGILKLAFKIPSVLCAVLKNC	23	Pleurain-D1  (Frogs,amphibians,animals)	B5L1C5, B5L1D1, B5L1C3, B5L1C9, B5L1C2, B5L1D4	Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.	Not found	Nidirana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Not found	Not found		Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.19028675] Gram-negative bacteria: Escherichia coli (MIC=25 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μg/ml), Bacillus subtilis (MIC=50 μg/ml);##Yeast: Candida albicans(MIC=25 μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.19028675] No cytotoxicity information found	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-83.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C)[C@H](C)CC
DRAMP20783	GLLDSVKEGLKKVAGQLLDTLKCKISGCTPA	31	Pleurain-M1  (Frogs,amphibians,animals)	B5L1L3	Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.	Not found	Nidirana pleuraden (Yunnan pond frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.	[Ref.19028675] Gram-negative bacteria: Escherichia coli (MIC=6.3 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.3 μg/ml), Bacillus subtilis (MIC=25 μg/ml);##Yeast: Candida albicans(MIC=12.5 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.19028675] No cytotoxicity information found	Not found	19028675	Mol Cell Proteomics. 2009 Mar;8(3):571-83.	Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.	Antioxidant peptidomics reveals novel skin antioxidant system.	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O
DRAMP20784	FLKGCWTKWYSLKPKCPF	18	Megin 1	No entry found	Not found	Not found	Amphibian skin	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	The peptide contains an intra-molecular di-sulfide bridge		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27114317] Gram-negative bacteria: Escherichia coli (ATCC 25922)(MIC=25μg/mL);B. dysenteriae(MIC=3μg/mL);##Gram-positive bacteria:Staphylococcus aureus (ATCC 2592)(MIC=6.25μg/mL);Bacillus subtilis (ATCC 6633)(MIC=3μg/mL) ;##Fungi:C.albicans (ATCC 2002)(MIC=50μg/mL)	[Ref.27114317] Human red blood cells: 2.3% hemolysis at 25μg/ml; 5.6% hemolysis at 50μg/ml; 18.7% hemolysis at 100μg/ml; 29.5% hemolysis at 200μg/ml. Rabbit red blood cells :3.1% hemolysis at 25μg/ml; 7.3% hemolysis at 50μg/ml; 20.5% hemolysis at 100μg/ml; 32.9% hemolysis at 200μg/ml	Cyclic	Free	Amidation	Disulfide bond between Cys5 and Cys16	L	No cytotoxicity information found	Not found	27114317	Chin J Nat Med. 2016 Apr;14(4):294-298. 	Yang HL, Shen ZQ, Liu X, Kong Y.	Two novel antimicrobial peptides from skin venoms of spadefoot toad Megophrys minor.	
DRAMP20785	FFVLKFLLKWAGKVGLEHLACKFKNWC	27	Megin 2	No entry found	Not found	Not found	Amphibian skin	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	The peptide contains an intra-molecular di-sulfide bridge		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27114317] Gram-negative bacteria: Escherichia coli (ATCC 25922)(MIC=6.25μg/mL);B. dysenteriae(MIC=1.5μg/mL);##Gram-positive bacteria:Staphylococcus aureus (ATCC 2592)(MIC=12.5μg/mL);Bacillus subtilis (ATCC 6633)(MIC=1.5μg/mL) ;##Fungi:C.albicans (ATCC 2002)(MIC=12.5μg/mL)	[Ref.27114317] Human red blood cells: 3.9% hemolysis at 25μg/ml; 13.7% hemolysis at 50μg/ml; 27.7% hemolysis at 100μg/ml; 45.3% hemolysis at 200μg/ml;Rabbit red blood cells: 5.6% hemolysis at 25μg/ml; 15.2% hemolysis at 50μg/ml; 36.2% hemolysis at 100μg/ml; 50.3% hemolysis at 200 μg/ml	Cyclic	Free	Free	Disulfide bond between Cys21 and Cys27.	L	No cytotoxicity information found	Not found	27114317	Chin J Nat Med. 2016 Apr;14(4):294-298. 	Yang HL, Shen ZQ, Liu X, Kong Y.	Two novel antimicrobial peptides from skin venoms of spadefoot toad Megophrys minor.	CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)NC1=O
DRAMP20786	RRLRPRRPRLPRPRPRPRPRPR	22	mini-ChBac7.5N alpha	No entry found	Not found	Not found	Capra hircus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27795854] Gram-negative bacteria: E.coli (ML35p)(MIC=0.3 ± 0.1μM without NaCl;MIC=1.5 ± 0.2μM 100 mM NaCl;MIC=1μM Broth microdilution assay);E.coli (ATCC 25922)(MIC=0.6 ± 0.1μM without NaCl;MIC=0.9 ± 0.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);E.coli (M17)(MIC=0.5 ± 0.1μM without NaCl;MIC=0.8 ± 0.1μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Pseudomonas aeruginosa (ATCC 27853)(MIC=1.1 ± 0.4μM without NaCl;MIC=3.7 ± 1.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Pseudomonas aeruginosa clinical isolate(MIC=2μM Broth microdilution assay);Klebsiella spp. clinical isolate(MIC=4μM Broth microdilution assay);Acinetobacter baumannii clinical isolate(MIC=2μM Broth microdilution assay);##Gram-positive bacteria:Listeria monocytogenes (EGD)(MIC=0.2 ± 0.1μM without NaCl;MIC=1.0 ± 0.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Micrococcus luteus CIP A270(MIC=1μM Broth microdilution assay);Staphylococcus aureus (710A)(MIC=0.7 ± 0.2μM without NaCl;MIC> 50μM 100 mM NaCl;MIC>64μM Broth microdilution assay);Staphylococcus aureus (ATCC 25923)(MIC>64μM Broth microdilution assay);MRSA (ATCC 33591)(MIC=0.7 ± 0.2μM without NaCl;MIC> 50μM 100 mM NaCl;MIC>64μM Broth microdilution assay);Staphylococcus intermedius clin. isolate(MIC>64μM Broth microdilution assay);##Fungi:Candida albicans (820)(MIC=0.3 ± 0.1μM without NaCl;MIC> 50μM 100 mM NaCl;MIC=64μM Broth microdilution assay);Candida parapsilosis clinical isolate(MIC>64μM Broth microdilution assay)	[Ref.27818338] No hemolytic activity 	Linear	Free	Free		L	[Ref.27795854] The cytotoxicity values of the experimental samples are not significantly different from the values of the control samples over the entire range of concentrations:1-30 μM against various types of cultured human cells: namly, reythroleukemi	Not found	27795854	Acta Naturae. 2016 Jul-Sep;8(3):136-146.	Shamova OV, Orlov DS, Zharkova MS, Balandin SV, Yamschikova EV, Knappe D, Hoffmann R, Kokryakov VN, Ovchinnikova TV.	Minibactenecins ChBac7.N	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP20787	RRLRPRRPRLPRPRPRPRPRP	21	mini-ChBac7.5N beta	No entry found	Not found	Not found	Capra hircus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27795854] Gram-negative bacteria:E.coli (ML35p)(MIC=0.3 ± 0.1μM without NaCl;MIC=1.4 ± 0.2μM 100 mM NaCl;MIC=1μM Broth microdilution assay);E.coli (ATCC 25922)(MIC=0.5 ± 0.2μM without NaCl;MIC=0.8 ± 0.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);E.coli (M17)(MIC=0.5 ± 0.1μM without NaCl;MIC=0.9 ± 0.2μM 100 mM NaCl;MIC=1μM Broth microdilution assay);Pseudomonas aeruginosa (ATCC 27853)(MIC=1.0 ± 0.3μM without NaCl;MIC=3.2 ± 0.8μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Pseudomonas aeruginosa clinical isolate(MIC=2μM Broth microdilution assay);Klebsiella spp. clinical isolate(MIC=4μM Broth microdilution assay);Acinetobacter baumannii clinical isolate(MIC=4μM Broth microdilution assay);##Gram-positive bacteria:Listeria monocytogenes (EGD)(MIC=0.2 ± 0.1μM without NaCl;MIC=0.9 ± 0.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Micrococcus luteus CIP A270(MIC=1μM Broth microdilution assay);Staphylococcus aureus (710A)(MIC=0.6 ± 0.1μM without NaCl;MIC> 50μM 100 mM NaCl;MIC>64μM Broth microdilution assay);Staphylococcus aureus (ATCC 25923)(MIC>64μM Broth microdilution assay);MRSA (ATCC 33591)(MIC=0.5 ± 0.1μM without NaCl;MIC> 50μM 100 mM NaCl;MIC>64μM Broth microdilution assay);Staphylococcus intermedius clin. isolate(MIC>64μM Broth microdilution assay);##Fungi:Candida albicans (820)(MIC=0.3 ± 0.1μM without NaCl;MIC> 50μM 100 mM NaCl;MIC=64μM Broth microdilution assay);Candida parapsilosis clinical isolate(MIC>64μM Broth microdilution assay)	[Ref.27818338] No hemolytic activity 	Linear	Free	Free		L	[Ref.27795854] The cytotoxicity values of the experimental samples are not significantly different from the values of the control samples over the entire range of concentrations:1-30 μM against various types of cultured human cells: namly, reythroleukemi	Not found	27795854	Acta Naturae. 2016 Jul-Sep;8(3):136-146.	Shamova OV, Orlov DS, Zharkova MS, Balandin SV, Yamschikova EV, Knappe D, Hoffmann R, Kokryakov VN, Ovchinnikova TV.	Minibactenecins ChBac7.N	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O
DRAMP20788	QGVRNHVTCRINRGFCVPIRCPGRTRQIGTCFGPRIKCCRSW	42	Bovine neutrophil Beta-defensin 3 (BNBD-3; cattle, ruminant, mammals; animals)	P46161	Belongs to the beta-defensin family	DEFB3	Bos taurus (Bovine)	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		"Function: Antibacterial against Escherichia coli ML35 and Staphylococcus aureus 502A.
Tissue specificity: Neutrophilic granules."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization of a N-terminal glutamine	Free	Disulfide bonds between Cys24 and Cys53, Cys31 and Cys46, Cys36 and Cys54	L	No cytotoxicity information found	Not found	8454635	J. Biol. Chem. 1993; 268:6641-6648.	Selsted ME, Tang Y-Q, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.	Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.	
DRAMP20789	GPLSCGRNGGVCIPIRCPVPNRQIGTCFGRPVKCCRSW	38	Bovine neutrophil Beta-defensin 12 (BNBD-12; cattle, ruminant, mammals; animals)	P46170	Belongs to the beta-defensin family	DEFB12	Bos taurus (Bovine)	Antimicrobial, Antibacterial	Protein level	Bridge	Not found	1BNB resolved by NMR	"Function: Antibacterial against Escherichia coli ML35 and Staphylococcus aureus 511A.
Tissue specificity: Neutrophilic granules."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys5 and Cys34, Cys12 and Cys27, Cys17 and Cys35	L	No cytotoxicity information found	Not found	8454635	J. Biol. Chem. 1993; 268:6641-6648.	Selsted ME, Tang Y-Q, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.	Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]4CCCN4C(=O)CN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N3)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2
DRAMP20790	KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG	36	Cecropin B (Insects, arthropods, invertebrates, animals)	P01508	Belongs to the cecropin family.	Not found	Hyalophora cecropia (Cecropia moth)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antibacterial activity against several Gram-positive and Gram-negative bacteria.	[Ref.7019715] Gram-positive bacteria: Bacillus megaterium Bm11 (Inhibition zone=10.0 mm), Bacillus subtilis (Inhibition zone=7.2 mm);##Gram-negative bacteria: Escherichia coli K12 D31 (Inhibition zone=12.5 mm), Serratia marcescens Db1108 (Inhibition zone=7.2 mm), Pseudomonas aeruginosa OT97 (Inhibition zone=9.7 mm), Xenorhabdus nematophilus Xn21 (Inhibition zone=10.0 mm).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation (Leu35) PMID:3857578		L	[Ref.7019715] No cytotoxicity information found	Not found	7019715	Nature. 1981 Jul 16;292(5820):246-8.	Steiner H, Hultmark D, Engstr?m A, Bennich H, Boman HG.	Sequence and specificity of two antibacterial proteins involved in insect immunity	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)C)[C@H](C)CC)C(C)C
DRAMP20791	GGLKKLGKKLEGVGKRVFKASEKALPVAVGIKALGK	36	Cecropin A1 (insects, arthropods, invertebrates, animals)	P81417	Not found	CECA1	Aedes albopictus (Asian tiger mosquito)	Antimicrobial, Antibacterial	Protein level	Alpha helix	Not found		Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.9712710] No cytotoxicity information found	Not found	9712710	Biochem. Biophys. Res. Commun. 1998 Aug; 249(2):410-415.	Sun D, Eccleston ER, Fallon AM.	Peptide sequence of an antibiotic cecropin from the vector mosquito, Aedes albopictus.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP20792	GLFVGVLAKVAAHVVPAIAEHF	22	Maculatin 1.1 (Frog, amphibians, animals)	P82066	Not found	Not found	Litoria genimaculata (Green-eyed tree frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Helix	Not found	2MMJ resolved by NMR	"Function: Maculatin-1.1 shows significant antibacterial activity against Gram-positive bacteria, less against Gram-negative bacteria. Maculatin-1.1.1 is inactive.
Tissue specificity: Expressed by the skin dorsal glands."	[Ref.9620615] Gram positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=25 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=12.5 μg/ml), Staphylococcus aureus (MIC=6-12.5 μg/ml), Staphylococcus epidermidis (MIC=12.5 μg/ml), Streptococcus faecalis (MIC=25 μg/ml), Streptococcus uberis (MIC=3 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=100 μg/ml), Pasteurella multocida (MIC=100 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.9620615] No cytotoxicity information found	Not found	9620615	J. Pept. Sci. 1998 Apr; 4(2): 111-115. 	Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.	The maculatin peptide from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP20793	GLFVGLAKVAAHNNPAIAEHFQA	23	Maculatin 1.2 (Frog, amphibians, animals)	P82067	Not found	Not found	Litoria genimaculata (Green-eyed tree frog)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Helix	Not found		"Function: Antibacterial activity against Staphylococcus aureus and Streptococcus uberis.
Tissue specificity: Expressed by the skin dorsal glands."	[Ref.9620615] Gram positive bacteria: Staphylococcus aureus (MIC=50 μg/ml), Streptococcus uberis (MIC=6 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.9620615] No cytotoxicity information found	Not found	9620615	J. Pept. Sci. 1998 Apr; 4(2): 111-115. 	Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.	The maculatin peptide from the skin glands of the tree frog Litoria genimaculata. A comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(N)=O
DRAMP20794	LFCKRGTCHFGRCPSHLIKV	20	Turkey Heterophil Peptide 2 (THP-2; avian beta-defensin, birds, animals)	P80392	Belongs to the beta-defensin family.	Not found	Meleagris gallopavo (Wild turkey)	Antimicrobial, Antibacterial	Protein level	Bridge	Not found		"Function: Antibacterial activity against the Gram-positive bacterium Staphylococcus aureus. Lacks antibacterial activity against the Gram-negative bacterium Escherichia coli K-12.
Tissue specificity: Expressed in circulating heterophil granulocytes and bone marrow (at protein level)."	No MICs found in DRAMP database	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.7964174] No cytotoxicity information found	Not found	7964174	J. Leukoc. Biol. 1994 Nov; 56: 661-665.	Evans EW, Beach GG, Wunderlich J, Harmon BG.	Isolation of antimicrobial peptides from avian heterophils.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP20795	XTCESPSHKFKGPCATNRNCES	22	So-D1 (S. oleracea defensin 1; spinach defensins, plants)	P81572	Belongs to the DEFL family. Group II subfamily.	Not found	Spinacia oleracea (Spinach)	Antimicrobial, Antibacterial	Protein level	Bridge 	Not found		Function: Antimicrobial peptide. Active against Gram-positive and Gram-negative bacteria pathogens.	[Ref.9762899] Gram-positive bacterium: Clavibacter michiganensis (EC50=1 μM);##Gram-negative bacterium: Ralstonia solanacearum (EC50=15 μM). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.9762899] No cytotoxicity information found	Not found	9762899	FEBS Lett. 1998 Sep 18;435(2-3): 159-162. 	Segura A, Moreno M, Molina A, Garcia-Olmedo F	Novel defensin subfamily from spinach (Spinacia oleracea).	
DRAMP20796	GIFSNMYXRTPAGYFRGPXGYXXN	24	So-D6 (S. oleracea defensin 6, spinach defensins; plants)	P81567	Belongs to the DEFL family. Group II subfamily.	Not found	Spinacia oleracea (Spinach)	Antimicrobial, Antibacterial	Protein level	Bridge 	Not found		"Function: Antimicrobial activity against Fungi, Gram-positive and Gram-negative bacteria.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf."	[Ref.9762899] Gram-positive bacterium: Clavibacter michiganensis (EC50=1 μM);##Gram-negative bacterium: Ralstonia solanacearum (EC50=6 μM);##Fusarium solani (EC50=11 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.9762899] No cytotoxicity information found	Not found	9762899	FEBS Lett. 1998 Sep 18;435(2-3): 159-162. 	Segura A, Moreno M, Molina A, Garcia-Olmedo F	Novel defensin subfamily from spinach (Spinacia oleracea).	
DRAMP20797	GVIDAAKKVVNVLKNLF	17	Uperin 3.6 (Toad, amphibians, animals)	P82043	Belongs to the frog skin active peptide (FSAP) family. Uperin subfamily.	Not found	Uperoleia mjobergii (Australian toadlet)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix 	Not found		"Function: Antibacterial activity against B.cereus, L.lactis, L.innocua, M.luteus, S.aureus, S.epidermidis and S.uberis.
Tissue specificity: Expressed by the skin dorsal glands.
Mass spectrometry: Molecular mass is 1826 Da from positions 1 - 17. Determined by FAB."	[Ref.10461748] Gram positive bacteria: Bacillus cereus (MIC=25 μg/ml), Leuconostoc lactis  (MIC=3 μg/ml), Listeria innocua (MIC=50 μg/ml), Micrococcus luteus (MIC=50 μg/ml), Staphylococcus aureus (MIC=25 μg/ml), Staphylococcus epidermidis (MIC=12 μg/ml), Streptococcus uberis (MIC=12 μg/ml);##Gram-negative bacterium: Pasteurella haemolytica (MIC=25 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.10461748] No cytotoxicity information found	Not found	10461748	J Pept Res. 1999 Aug;54(2):137-45.	Chia BC, Carver JA, Mulhern TD, Bowie JH	The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)C(C)C
DRAMP20798	QGVRNSQSCRRNKGICVPIRCPGSMRQIGTCLGAQVKCCRRK	42	Lingual antimicrobial peptide (LAP, beta defensin, cattle, ruminant, animals)	Q28880	Belongs to the beta-defensin family. LAP/TAP subfamily.	LAP	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Bridge 	Not found		"Function: Shows a broad spectrum of antibacterial and antifungal activities.
Tissue specificity: In many of the exposed epithelial surfaces including conjunctivae, bronchi, colon, urinary tract and trachea.
Developmental stage: Not found in fetus."	[Ref.7886453] Gram-positive bacterium: Staphylococcus aureus 29213 (MIC=63-125 μg/ml);##Gram-negative bacteria: Escherichia coli D31 (MIC=16-32 μg/ml), Pseudomonas aeruginosa 27853  (MIC=63-125 μg/ml);##Fungi: Candida albicans 14053  (MIC=32-63 μg/ml), Candida tropicalis 13803 (MIC=16-32 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys9 and Cys38, Cys16 and Cys31, Cys21 and Cys39.	L	[Ref.7886453] No cytotoxicity information found	Not found	7886453	Science. 1995 Mar 17; 267(5204):1645-1648	Schonwetter BS., Stolzenberg ED., Zasloff MA.	Epithelial antibiotics induced at sites of inflammation.	CC[C@@H](C)[C@@H]1NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(C)C)CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)NC2=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N3
DRAMP20799	GCWSTVLGGLKKFAKGGLEAIVNPK	25	XT-2 (frog, amphibians, animals)	No entry found	Belongs to the Pipidae family.	Not found	Xenopus tropicalis (Diploid clawed frog, Africa)	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Alpha helix	Not found		Function: Antibacterial activity against the Gram-negative bacteria (Escherichia coli).	[Ref.11738090] Gram-negative bacteria: Escherichia coli (MIC=8μM).	[Ref.11738090] HC50 is not determined against human red blood cells.	Linear	Free	Free		L	[Ref.11738090] No cytotoxicity information found	Not found	11738090	Biochim Biophys Acta 2001 Nov 26;1550(1):81-9.	Ali MF, Soto A, Knoop FC, Conlon JM.	Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP20800	KKKKPLFGLFFGLF	14	the K4 peptide (synthetic; Phe-rich >25%)	No entry found	Not found	Not found	the APD database-aided design.	Antimicrobial, Antibacterial, Anti-Gram-	Not found	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Have Hemolytic activity against rabbit erythrocytes. Have Cytotoxicity activity on CHO-K1 cells, the peptide is slightly cytotoxic at 160 	[Ref.19573572] Gram-negative bacteria: Escherichia coli (MIC=40-80 μg/ml or 24-48 μM), Vibrio alginolyticus (MIC=10-20 μg/ml or 6-12 μM), Vibrio harveyi (MIC=5-10 μg/ml or 3-6 μM).	[Ref.19573572] No significant hemolytic activity is observed at 10 and 40 μg/ml. Slight hemolysis (6.65%) is shown at 160 μg/ml.	Linear	Free	Free		L	[Ref.19573572] The cell viability of CHO-K1 cells is 127%, 123%,78% and 10% at peptide concentrations of 10 μg/ml, 40 μg/ml, 160 μg/ml and 640 μg/ml	Not found	19573572	Peptides. 2009 Sep;30(9):1608-12	Duval E, Zatylny C, Laurencin M, Baudy-Floc'h M, Henry J.	KKKKPLFGLFFGLF: a cationic peptide designed to exert antibacterial activity	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP20801	GFGCPNNYQCHRHCKSIPGRCGGYCGGWHRLPCTCYRC	38	Mussel Defensin MGD-1 (Mediterranean mussel defensin 1; mollusca/molluscs/mollusks, invertebrates, animals)	P80571	Belongs to the invertebrate defensin family. Type 2 subfamily.	FH3	Mytilus galloprovincialis (Mediterranean mussel)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Combine Helix and Beta structure	The signature of MGD-1 is that of the arthropod defensins which range in length from 34 to 51 amino acid residues with 6 conserved cysteines engaged in three intramolecular disulfide bridges. They are characterized by the presence of a flexible amino-terminal loop, a central amphipathic 	1FJN resolved by NMR	Function: Active against both Gram-positive and Gram-negative bacteria but is not cytotoxic towards human erythrocytes or protozoa.	[Ref.8925841] Gram-positive bacteria: Micrococcus luteus (MIC=0.08 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=6.4 μg/ml), Vibrio alginolyticus (MIC=6.4 μg/ml), Vibrio splendidus (MIC=1.6 μg/ml), Vibrio P1 (MIC=6.4 μg/ml).	[Ref.8925841] The plasma is capable of causing 20% of the total hemolysis. 	Cyclic	Free	Amidation	Disulfide bonds between Cys4 and Cys25, Cys10 and Cys33, Cys14 and Cys35, Cys21 and Cys38.  Hydroxylation of Trp28 (3hydroxytryptophan)	L	[Ref.8925841] The protozoan P. marinus is not killed by pure peptide, even at a concentration of 16 μg/ml.	Cell membranes	8925841	Eur J Biochem. 1996 Aug 15;240(1):302-6.	Hubert F, Noel T, Roch P. 	A member of the arthropod defensin family from edible Mediterranean mussels (Mytilus galloprovincialis)	
DRAMP20802	GLGSVLGKALKIGANLL	17	CPF-AM1 (caerulein precursor fragment-AM1, frogs, amphibians, animals)	No entry found	Belongs to the CPF family.	Not found	Xenopus amieti (skin secretions, Africa)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.20226221] Gram-positive bacteria: Staphylococcus aureus (MIC>200μM) ;##Gram-negative bacteria: Escherichia coli (MIC>200μM).	[Ref.20226221] LC50>200μM against human red blood cells	Linear	Free	Amidation		L	[Ref.20226221] No cytotoxicity information found	Cell membranes	20226221	Peptides. 2010 Jun;31(6):989-94. 	Conlon JM, Al-Ghaferi N, Ahmed E, Meetani MA, Leprince J, Nielsen PF. 	Orthologs of magainin, PGLa, procaerulein-derived, and proxenopsin-derived peptides from skin secretions of the octoploid frog Xenopus amieti (Pipidae).	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP20803	FFRNLWKGAKAAFRAGHAAWRA	22	moronecidin-like peptide	No entry found	Not found	Not found	Hippocampus comes 	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix 	The peptide is Schiffer		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria; antifungal activity.	[Ref.30039186] Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (MIC=3.12 μg/ml),Staphylococcus epidermidis ATCC 1435 (MIC=1.56 μg/ml),Staphylococcus aureus MRSA (MIC=3.12 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.25 μg/ml), Pseudomonas aeruginosa ATCC10662 (MIC=50 μg/ml),Acinetobacter baumannii clinical isolate (MIC=6.25 μg/ml);##Fungi:Candida albicans clinical isolate (MIC=6.25 μg/ml), Candida tropicalis clinical isolate (MIC=6.25 μg/ml)	[Ref.30039186] 50% hemolysis at 87.5μg/ml,25% hemolysis at 50μg/ml,60% hemolysis at 100μg/ml against human red cells	Linear	Free	Amidation		L	[Ref.30039186] No cytotoxicity information found	Not found	30039186	Mar Biotechnol (NY). 2018 Dec;20(6):718-728.	Mohammadi M, Taheri B, Momenzadeh N, Salarinia R, Nabipour I, Farshadzadeh Z, Bargahi A.	Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(N)=O
DRAMP20804	DLRDSWKVIGSDKK	14	AI-hemocidins 2 (Hb-1  truncated peptide)	No entry found	Belongs to truncated Hb-1 	Not found	Arca inflata	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Alpha helix,random coil	Peptides displayed random coil conformations in PBS, the spectra of AI-hemocidin 2 featured an 		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria.	[Ref.28661457] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=45.54 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=91.08 μM), Pseudomonas aeruginosa clinical isolate (MIC=91.08 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=22.77 μM), Bacillus subtilis ATCC 6633 (MIC=182.16 μM).	[Ref.28661457] 10.27 ± 0.42% hemolysis at 500 μg/mL against murine red blood cells.	Linear	Free	Free		L	[Ref.28661457] The cell viability of HEK293 at the peptide concentration of 250 μg/ml is 88.18±9.48%. IC50 > 1000 μg/ml against HEK293 cells.	Not found	28661457	Mar Drugs. 2017 Jun 29;15(7). 	Li C, Zhu J, Wang Y, Chen Y, Song L, Zheng W, Li J, Yu R.	Antibacterial Activity of AI-Hemocidin 2, a Novel N-Terminal Peptide of Hemoglobin Purified from Arca inflata	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP20805	FSTKTRNWFSEHFKKVKEKLKDTFA	25	Apo5 APOC164-88 	No entry found	Not found	Not found	American alligator	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Alpha helix,beta-sheet,beta-turn,random coil	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.27542832] Gram-positive bacteria:Staphylococcus aureus ATCC BAA-1718 (EC50=4.96μg/ml), Staphylococcus aureus ATCC 33592 (EC50=0.0680μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 4157 (EC50=19.7μg/ml), Escherichia coli ATCC 51659 (EC50=13.9μg/ml), Pseudomonas aeruginosa PAO1 (EC50=0.0878μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (EC50=0.467μg/ml), Acinetobacter baumannii ATCC 9955 (EC50=0.644μg/ml), Acinetobacter baumannii ATCC BAA-1794 (EC50=0.234μg/ml)	[Ref.27542832] Not hemolytic to sheep red blood cells.	Linear	Free	Free		L	[Ref.27542832] The cell proliferation of A549 human lung epithelial cells is 175%, 170%, 145%, 173% and 120% at peptide concentrations of 1 μg/ml, 10 μg/ml, 25 μg/ml, 50 μg/ml, 100 μg/ml	Not found	27542832	BMC Microbiol. 2016 Aug 19;16(1):189. 	Barksdale SM, Hrifko EJ, Chung EM, van Hoek ML.	Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP20806	KTRNWFSEHFKKVKEKLKDTFA	22	Apo6 APOC167-88	No entry found	Not found	Not found	American alligator	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Alpha helix,beta-sheet,beta-turn,random coil	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.27542832] Gram-positive bacteria:Staphylococcus aureus ATCC BAA-1718 (EC50=2.31μg/ml), Staphylococcus aureus ATCC 33592 (EC50=0.883μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 4157 (EC50=3.85μg/ml), Escherichia coli ATCC 51659 (EC50=9.07μg/ml), Pseudomonas aeruginosa PAO1 (EC50=1.17μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (EC50=0.130μg/ml), Acinetobacter baumannii ATCC 9955 (EC50=0.233μg/ml), Acinetobacter baumannii ATCC BAA-1794 (EC50=0.126μg/ml)	[Ref.27542832] Not hemolytic to sheep red blood cells.	Linear	Free	Free		L	[Ref.27542832] The cell proliferation of A549 human lung epithelial cells is 190%, 167%, 150%, 135% and 144% at peptide concentrations of 1 μg/ml, 10 μg/ml, 25 μg/ml, 50 μg/ml, 100 μg/ml	Not found	27542832	BMC Microbiol. 2016 Aug 19;16(1):189. 	Barksdale SM, Hrifko EJ, Chung EM, van Hoek ML.	Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP20807	PPPVIKFNRPFLMWIVERDTRSILFMGKIVNPKAP	35	A1P394-428	No entry found	Not found	Not found	American alligator	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Alpha helix,beta-sheet,beta-turn,random coil	A1P is primarily random coil with two anti-parallel 		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.27542832] Gram-positive bacteria:Staphylococcus aureus ATCC BAA-1718 (EC50=36.5μg/ml), Staphylococcus aureus ATCC 33592 (EC50=2.68μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 4157 (EC50=9.2μg/ml), Escherichia coli ATCC 51659 (EC50=2.51μg/ml), Pseudomonas aeruginosa PAO1 (EC50=38.6μg/ml),  Acinetobacter baumannii ATCC 9955 (EC50=24.0μg/ml), Acinetobacter baumannii ATCC BAA-1794 (EC50=2.36μg/ml)	[Ref.27542832] Not hemolytic to sheep red blood cells.	Linear	Free	Free		L	[Ref.27542832] The cell proliferation of A549 human lung epithelial cells is 170%, 180%, 182%, 180% and 180% at peptide concentrations of 1 μg/ml, 10 μg/ml, 25 μg/ml, 50 μg/ml, 100 μg/ml	Not found	27542832	BMC Microbiol. 2016 Aug 19;16(1):189. 	Barksdale SM, Hrifko EJ, Chung EM, van Hoek ML.	Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP20808	RRLRKKTRKRLKKIGKVLKWI	21	RI21 (PMAP-36 peptide derivative)	No entry found	Derived from PMAP-36	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found		Function: Antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and Fungi..	[Ref.27251456] Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=4 μM, MBC=4 μM), Staphylococcus aureus 25923 (MIC=4 μM, MBC=4 μM), Staphylococcus epidermidis 12228 (MIC=4 μM, MBC=8 μM), Bacillus subtilis 63501 (MIC=1 μM, MBC=4 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM, MBC=8 μM), Escherichia coli EC183 (MIC=1 μM, MBC=2 μM), Escherichia coli 1005 (MIC=2 μM, MBC=2 μM), Salmonella typhimurium C77-31 (MIC=1 μM, MBC=2 μM);##Fungi: Candida albicans 2.2086 (MIC=8 μM, MFC=16 μM), Candida albicans CA276 (MIC=8 μM, MFC=32 μM), Candida tropicalis 2.1975 (MIC=1 μM, MFC=2 μM), Candida krusei 2.1857 (MIC=2 μM, MFC=4 μM).	[Ref.27251456] 5% hemolysis at 32 μM,  MHC=32 μM against human red blood cells.	Linear	Free	Amidation		L	[Ref.27251456] No cytotoxicity information found	Not found	27251456	Sci Rep. 2016 Jun 2;6:27258. 	Lyu Y, Yang Y, Lyu X, Dong N, Shan A.	Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@H](C)CC)C(C)C)C(N)=O
DRAMP20809	RKKTRKRLKKIGKVLKWI	18	RI18 (PMAP-36 peptide derivative)	No entry found	Derived from PMAP-36	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found		Function: Antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and Fungi..	[Ref.27251456] Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=4 μM, MBC=4 μM), Staphylococcus aureus 25923 (MIC=8 μM, MBC=8 μM), Staphylococcus epidermidis 12228 (MIC=4 μM, MBC=16 μM), Bacillus subtilis 63501 (MIC=1 μM, MBC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM, MBC=4 μM), Escherichia coli EC183 (MIC=1 μM, MBC=2 μM), Escherichia coli 1005 (MIC=2 μM, MBC=4 μM), Salmonella typhimurium C77-31 (MIC=2 μM, MBC=4 μM);##Fungi: Candida albicans 2.2086 (MIC=16 μM, MFC=32 μM), Candida albicans CA276 (MIC=8 μM, MFC=16 μM), Candida tropicalis 2.1975 (MIC=2 μM, MFC=4 μM), Candida krusei 2.1857 (MIC=4 μM, MFC=8 μM).	[Ref.27251456] 5% hemolysis at 128 μM, MHC=128 μM against human red blood cells.	Linear	Free	Amidation		L	[Ref.27251456] No cytotoxicity information found	Not found	27251456	Sci Rep. 2016 Jun 2;6:27258. 	Lyu Y, Yang Y, Lyu X, Dong N, Shan A.	Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@H](C)CC)C(C)C)C(N)=O
DRAMP20810	TRKRLKKIGKVLKWI	15	TI15 (PMAP-36 peptide derivative)	No entry found	Derived from PMAP-36	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found		Function: Antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and Fungi..	[Ref.27251456] Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=32 μM, MBC=128 μM), Staphylococcus aureus 25923 (MIC=32 μM, MBC=128 μM), Staphylococcus epidermidis 12228 (MIC=32 μM, MBC=64 μM), Bacillus subtilis 63501 (MIC=2 μM, MBC=4 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=8 μM, MBC=16 μM), Escherichia coli EC183 (MIC=2 μM, MBC=4 μM), Escherichia coli 1005 (MIC=4 μM, MBC=8 μM), Salmonella typhimurium C77-31 (MIC=8 μM, MBC=32 μM);##Fungi: Candida albicans 2.2086 (MIC=64 μM, MFC=64 μM), Candida albicans CA276 (MIC=128 μM, MFC=128 μM), Candida tropicalis 2.1975 (MIC=2 μM, MFC=4 μM), Candida krusei 2.1857 (MIC=8 μM, MFC=16 μM).	[Ref.27251456] Non-hemolysis upto 128 μM, MHC>128 μM against human red blood cells.	Linear	Free	Amidation		L	[Ref.27251456] No cytotoxicity information found	Not found	27251456	Sci Rep. 2016 Jun 2;6:27258. 	Lyu Y, Yang Y, Lyu X, Dong N, Shan A.	Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)[C@@H](C)O)[C@H](C)CC)C(C)C)C(N)=O
DRAMP20811	RLKKIGKVLKWI	12	RI12 (PMAP-36 peptide derivative)	No entry found	Derived from PMAP-36	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found		Function: Antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and Fungi..	[Ref.27251456] Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=64 μM, MBC=128 μM), Staphylococcus aureus 25923 (MIC=128 μM, MBC=128 μM), Staphylococcus epidermidis 12228 (MIC=64 μM, MBC=64 μM), Bacillus subtilis 63501 (MIC=2 μM, MBC=8 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=8 μM, MBC=32 μM), Escherichia coli EC183 (MIC=2 μM, MBC=4 μM), Escherichia coli 1005 (MIC=16 μM, MBC=32 μM), Salmonella typhimurium C77-31 (MIC=8 μM, MBC=32 μM);##Fungi: Candida albicans 2.2086 (MIC=128 μM, MFC=128 μM), Candida albicans CA276 (MIC=128 μM, MFC=128 μM), Candida tropicalis 2.1975 (MIC=8 μM, MFC=8 μM), Candida krusei 2.1857 (MIC=16 μM, MFC=16 μM).	[Ref.27251456] Non-hemolysis upto 128 μM, MHC>128 μM against human red blood cells.	Linear	Free	Amidation		L	[Ref.27251456] No cytotoxicity information found	Not found	27251456	Sci Rep. 2016 Jun 2;6:27258. 	Lyu Y, Yang Y, Lyu X, Dong N, Shan A.	Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(C)C)C(N)=O
DRAMP20812	GILGKLWKGVKSIF	14	K8	No entry found	Belongs to the Hp1404 family	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.26952110] Gram-positive bacteria:Staphylococcus aureus AB94004 (MIC=6.25μg/mL), Staphylococcus aureus ATCC6538 (MIC=6.25μg/mL), Staphylococcus aureus ATCC25923 (MIC=12.5μg/mL), Staphylococcus aureus MRSA P1381 (MIC=6.25μg/mL), Staphylococcus aureus MRSA P1374 (MIC=6.25μg/mL);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=25μg/mL), Escherichia coli ATCC25922 (MIC=100μg/mL), Pseudomonas aeruginosa AB93066 (MIC=50μg/mL), Pseudomonas aeruginosa ATCC9027 (MIC=25μg/mL)	[Ref.26952110] 2% hemolysis at 50μg/mL, 20% hemolysis at 100μg/mL, 45% hemolysis at 200μg/mL, 65% hemolysis at 400μg/mL against human red blood cells	Linear	Free	Amidation		L	[Ref.26952110] No cytotoxicity information found	Not found	26952110	Appl Microbiol Biotechnol. 2016 Jun;100(11):5069-77. 	Li Z, Liu G, Meng L, Yu W, Xu X, Li W, Wu Y, Cao Z.	K1K8: an Hp1404-derived antibacterial peptide	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)C(C)C
DRAMP20813	LILGKLWKGVKSIF	14	L1K8	No entry found	Belongs to the Hp1404 family	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.26952110] Gram-positive bacteria:Staphylococcus aureus AB94004 (MIC=12.5μg/mL), Staphylococcus aureus ATCC6538 (MIC=12.5μg/mL), Staphylococcus aureus ATCC25923 (MIC=12.5μg/mL), Staphylococcus aureus MRSA P1381 (MIC=25μg/mL), Staphylococcus aureus MRSA P1374 (MIC=6.25μg/mL);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=50μg/mL), Escherichia coli ATCC25922 (MIC=100μg/mL), Pseudomonas aeruginosa AB93066 (MIC=100μg/mL), Pseudomonas aeruginosa ATCC9027 (MIC=25μg/mL)	[Ref.26952110] 2% hemolysis at 200μg/mL, 10% hemolysis at 400μg/mL against human red blood cells	Linear	Free	Amidation		L	[Ref.26952110] No cytotoxicity information found	Not found	26952110	Appl Microbiol Biotechnol. 2016 Jun;100(11):5069-77. 	Li Z, Liu G, Meng L, Yu W, Xu X, Li W, Wu Y, Cao Z.	K1K8: an Hp1404-derived antibacterial peptide	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP20814	SILGKLWKGVKSIF	14	S1K8	No entry found	Belongs to the Hp1404 family	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.26952110] Gram-positive bacteria:Staphylococcus aureus AB94004 (MIC=6.25μg/mL), Staphylococcus aureus ATCC6538 (MIC=6.25μg/mL), Staphylococcus aureus ATCC25923 (MIC=6.25μg/mL), Staphylococcus aureus MRSA P1381 (MIC=12.5μg/mL), Staphylococcus aureus MRSA P1374 (MIC=6.25μg/mL);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=25μg/mL), Escherichia coli ATCC25922 (MIC=50μg/mL), Pseudomonas aeruginosa AB93066 (MIC=50μg/mL), Pseudomonas aeruginosa ATCC9027 (MIC=25μg/mL)	[Ref.26952110] 15% hemolysis at 200μg/mL, 45% hemolysis at 400μg/mL against human red blood cells	Linear	Free	Amidation		L	[Ref.26952110] No cytotoxicity information found	Not found	26952110	Appl Microbiol Biotechnol. 2016 Jun;100(11):5069-77. 	Li Z, Liu G, Meng L, Yu W, Xu X, Li W, Wu Y, Cao Z.	K1K8: an Hp1404-derived antibacterial peptide	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP20815	FILGKLWKGVKSIF	14	F1K8	No entry found	Belongs to the Hp1404 family	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.26952110] Gram-positive bacteria:Staphylococcus aureus AB94004 (MIC=6.25μg/mL), Staphylococcus aureus ATCC6538 (MIC=6.25μg/mL), Staphylococcus aureus ATCC25923 (MIC=6.25μg/mL), Staphylococcus aureus MRSA P1381 (MIC=12.5μg/mL), Staphylococcus aureus MRSA P1374 (MIC=12.5μg/mL);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=25μg/mL), Escherichia coli ATCC25922 (MIC=50μg/mL), Pseudomonas aeruginosa AB93066 (MIC=50μg/mL), Pseudomonas aeruginosa ATCC9027 (MIC=50μg/mL)	[Ref.26952110] 2% hemolysis at 100μg/mL, 35% hemolysis at 200μg/mL, 70% hemolysis at 400μg/mL against human red blood cells	Linear	Free	Amidation		L	[Ref.26952110] No cytotoxicity information found	Not found	26952110	Appl Microbiol Biotechnol. 2016 Jun;100(11):5069-77. 	Li Z, Liu G, Meng L, Yu W, Xu X, Li W, Wu Y, Cao Z.	K1K8: an Hp1404-derived antibacterial peptide	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP20816	KILGKLWKGVKSIF	14	K1K8	No entry found	Belongs to the Hp1404 family	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.26952110] Gram-positive bacteria:Staphylococcus aureus AB94004 (MIC=6.25μg/mL), Staphylococcus aureus ATCC6538 (MIC=12.5μg/mL), Staphylococcus aureus ATCC25923 (MIC=12.5μg/mL), Staphylococcus aureus MRSA P1381 (MIC=6.25μg/mL), Staphylococcus aureus MRSA P1374 (MIC=6.25μg/mL);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=25μg/mL), Escherichia coli ATCC25922 (MIC=50μg/mL), Pseudomonas aeruginosa AB93066 (MIC=50μg/mL), Pseudomonas aeruginosa ATCC9027 (MIC=50μg/mL)	[Ref.26952110] 10% hemolysis at 400μg/mL against human red blood cells	Linear	Free	Amidation		L	[Ref.26952110] The cell vaibility of HFF cell lines is 100%, 108%, 105%  and 38% at peptide concentrations of 0 μg/ml, 50 μg/ml, 100 μg/ml and 200 μg/ml. ##The cell viability of HEK293T cell lines is 105%, 125%, 101% and 21% at peptide concentrations of	Not found	26952110	Appl Microbiol Biotechnol. 2016 Jun;100(11):5069-77. 	Li Z, Liu G, Meng L, Yu W, Xu X, Li W, Wu Y, Cao Z.	K1K8: an Hp1404-derived antibacterial peptide	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP20817	RRLIRLILRLLR	12	RR12	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.26795535] Gram-positive bacteria:Bacillus subtilis lab strain (MIC=8μM), Staphylococcus aureus ATCC25923 (MIC=8μM), Streptococcus pyogenes ATCC19615 (MIC=12.5μM), Enterococcus feacalis ATCC29212 (MIC=10μM);##Gram-negative bacteria:Escherichia coli lab strain (MIC=8μM), Pseudomonas aeruginosa ATCC27853 (MIC=12.5μM), Klebsiella pneumoniae ATCC13883 (MIC=8μM), Salmonella enterica ATCC14028 (MIC=10μM)	[Ref.26795535] 4% hemolysis at 25μM, 10% hemolysis at 50μM, 32% hemolysis at 100μM against mice red cells	Linear	Free	Amidation		L	[Ref.26849911] No cytotoxicity information found	Not found	26849911	Biopolymers. 2016 May;106(3):345-56. 	Mohanram H, Bhattacharjya S.	Salt-resistant short antimicrobial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP20818	RRLIWLILRLLR	12	RR12Wpolar	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.26795535] Gram-positive bacteria:Bacillus subtilis lab strain (MIC=4μM), Staphylococcus aureus ATCC25923 (MIC=4μM), Streptococcus pyogenes ATCC19615 (MIC=4μM), Enterococcus feacalis ATCC29212 (MIC=8μM);##Gram-negative bacteria:Escherichia coli lab strain (MIC=8μM), Pseudomonas aeruginosa ATCC27853 (MIC=10μM), Klebsiella pneumoniae ATCC13883 (MIC=4μM), Salmonella enterica ATCC14028 (MIC=10μM)	[Ref.26795535] 5% hemolysis at 5 μM, 12% hemolysis at 10 μM, 32% hemolysis at 25 μM, 60% hemolysis at 50 μM, 78% hemolysis at 100 μM against mice red cells	Linear	Free	Amidation		L	[Ref.26849911] No cytotoxicity information found	Not found	26849911	Biopolymers. 2016 May;106(3):345-56. 	Mohanram H, Bhattacharjya S.	Salt-resistant short antimicrobial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP20819	RRLIRLWLRLLR	12	RR12Whydro	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.26795535] Gram-positive bacteria:Bacillus subtilis lab strain (MIC=4μM), Staphylococcus aureus ATCC25923 (MIC=8μM), Streptococcus pyogenes ATCC19615 (MIC=8μM), Enterococcus feacalis ATCC29212 (MIC=8μM);##Gram-negative bacteria:Escherichia coli lab strain (MIC=4μM), Pseudomonas aeruginosa ATCC27853 (MIC=10μM), Klebsiella pneumoniae ATCC13883 (MIC=4μM), Salmonella enterica ATCC14028 (MIC=8μM)	[Ref.26795535] 2% hemolysis at 25 μM, 5% hemolysis at 50μM, 18% hemolysis at 100μM against mice red cells	Linear	Free	Amidation		L	[Ref.26849911] No cytotoxicity information found	Not found	26849911	Biopolymers. 2016 May;106(3):345-56. 	Mohanram H, Bhattacharjya S.	Salt-resistant short antimicrobial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP20820	FRIRVRV	7	FV7	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.28178190] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=64 μM), Streptococcus Faecalis ATCC 29212 (MIC=32 μM), Bacillus subtilis CMCC 63501 (MIC=16 μM), Staphylococcus epidermidis ATCC 12228 (MIC=32 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16 μM), Escherichia coli UB 1005 (MIC=32 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μM), Pseudomonas aeruginosa PAO1 (MIC=32 μM), Salmonella typhimurium ATCC 14028 (MIC=16 μM), Salmonella typhimurium ATCC 7731 (MIC=32 μM).	[Ref.28178190] 3% hemolysis at 128 μM against human red cells	Linear	Free	Amidation		L	[Ref.28178190] No cytotoxicity information found	Not found	28178190	Int J Mol Sci. 2017 Feb 6;18(2). 	Tan T, Wu D, Li W, Zheng X, Li W, Shan A.	High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP20821	FRIRVRVFKRIVQRIKDFLR	20	FV-LL (FV7 and LL(LL-37,(17-29)) hybrid peptide)	No entry found	FV7 and LL(LL-37,(17-29)) hybrid peptide	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix, random coil	The hybrid peptide displayed an unordered conformation in phosphate buffer.		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.28178190] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=2 μM), Streptococcus Faecalis ATCC 29212 (MIC=4 μM), Bacillus subtilis CMCC 63501 (MIC=4 μM), Staphylococcus epidermidis ATCC 12228 (MIC=1 μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=1 μM), Escherichia coli UB 1005 (MIC=4 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=4 μM), Pseudomonas aeruginosa PAO1 (MIC=2 μM), Salmonella typhimurium ATCC 14028 (MIC=2 μM), Salmonella typhimurium ATCC 7731 (MIC=2 μM).	[Ref.28178190] 2% hemolysis at 128 μM against human red cells	Linear	Free	Amidation		L	[Ref.28178190] No cytotoxicity information found	Not found	28178190	Int J Mol Sci. 2017 Feb 6;18(2). 	Tan T, Wu D, Li W, Zheng X, Li W, Shan A.	High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP20822	FRIRVRVAKKFGKAFVGEIM	20	FV-MA (FV7 and MA(Magainin 2 (9-21))  hybrid peptide)	No entry found	FV7 and MA(Magainin 2 (9-21))  hybrid peptide	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix, random coil	The hybrid peptide displayed an unordered conformation in phosphate buffer.		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.28178190] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=8 μM), Streptococcus Faecalis ATCC 29212 (MIC=16 μM), Bacillus subtilis CMCC 63501 (MIC=4 μM), Staphylococcus epidermidis ATCC 12228 (MIC=8 μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=8 μM), Escherichia coli UB 1005 (MIC=8 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Pseudomonas aeruginosa PAO1 (MIC=2 μM), Salmonella typhimurium ATCC 14028 (MIC=4 μM), Salmonella typhimurium ATCC 7731 (MIC=4 μM).	[Ref.28178190] 1% hemolysis at 2 μM, 8% hemolysis at 4 μM, 10% hemolysis at 8 μM, 15% hemolysis at 16 μM, 20% hemolysis at 32 μM, 37% hemolysis at 64 μM, 55% hemolysis at 128 μM against human red cells	Linear	Free	Amidation		L	[Ref.28178190] No cytotoxicity information found	Not found	28178190	Int J Mol Sci. 2017 Feb 6;18(2). 	Tan T, Wu D, Li W, Zheng X, Li W, Shan A.	High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCSC)C(N)=O
DRAMP20823	FRIRVRVKWKLFKKI	15	FV-CE (FV7 and CE(Cecropin A (1	No entry found	FV7 and CE(Cecropin A (1	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Random coil	The hybrid peptide displayed an unordered conformation in phosphate buffer.		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.28178190] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=8 μM), Streptococcus Faecalis ATCC 29212 (MIC=1 μM), Bacillus subtilis CMCC 63501 (MIC=1 μM), Staphylococcus epidermidis ATCC 12228 (MIC=0.5 μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=2 μM), Escherichia coli UB 1005 (MIC=2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=2 μM), Pseudomonas aeruginosa PAO1 (MIC=2 μM), Salmonella typhimurium ATCC 14028 (MIC=4 μM), Salmonella typhimurium ATCC 7731 (MIC=4 μM).	[Ref.28178190] 1% hemolysis at 2 μM, 5% hemolysis at 128 μM against human red cells	Linear	Free	Amidation		L	[Ref.28178190] No cytotoxicity information found	Not found	28178190	Int J Mol Sci. 2017 Feb 6;18(2). 	Tan T, Wu D, Li W, Zheng X, Li W, Shan A.	High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(C)C)C(N)=O
DRAMP20824	GLFKKLRRKIKKGFKKIFKRLPPIGVGVSIPLAGKR	36	AM-CATH36	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix, random coil	NA-CATH has previously been shown to be random coil in water or buffer and 		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.28089718] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=21μg/ml), Staphylococcus aureus ATCC 33592 (MIC=21μg/ml);##Gram-negative bacteria:Acinetobacter baumannii ATCC 9955 (MIC=5.2μg/ml), Acinetobacter baumannii ATCC BAA-1794 (MIC=5.2μg/ml), Escherichia coli ATCC 4157 (MIC=140μg/ml), K. pneumoniae ATCC 33495 (MIC=5.2μg/ml), K. pneumoniae ATCC BAA-1705 (MIC=5.6μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=5.2μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (MIC=5.2μg/ml)	[Ref.28089718] 0% hemolysis at 300μg/ml against sheep red cells	Linear	Free	Free		L	[Ref.28089718] The survival rate of A549 human lung epithelial cells is 124% at a peptide concentration of 300 μg/ml	Not found	28089718	Dev Comp Immunol. 2017 May;70:135-144. 	Barksdale SM, Hrifko EJ, van Hoek ML.	Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP20825	KIKKGFKKIFKRLPPIGVGVSIPLAGKR	28	AM-CATH28	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix, random coil	NA-CATH has previously been shown to be random coil in water or buffer and 		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.28089718] Gram-negative bacteria:Acinetobacter baumannii ATCC 9955 (MIC=28μg/ml), Acinetobacter baumannii ATCC BAA-1794 (MIC=10μg/ml), K. pneumoniae ATCC 33495 (MIC=5.6μg/ml), K. pneumoniae ATCC BAA-1705 (MIC=28μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=21μg/ml)	[Ref.28089718] 1% hemolysis at 300μg/ml against sheep red cells	Linear	Free	Free		L	[Ref.28089718] The survival rate of A549 human lung epithelial cells is 122% at a peptide concentration of 300 μg/ml	Not found	28089718	Dev Comp Immunol. 2017 May;70:135-144. 	Barksdale SM, Hrifko EJ, van Hoek ML.	Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC
DRAMP20826	GLFKKLRRKIKKGFKKIFKRL	21	AM-CATH21	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix, random coil	NA-CATH has previously been shown to be random coil in water or buffer and 		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.28089718] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=28μg/ml), Staphylococcus aureus ATCC 33592 (MIC=28μg/ml);##Gram-negative bacteria:Acinetobacter baumannii ATCC 9955 (MIC=42μg/ml), Acinetobacter baumannii ATCC BAA-1794 (MIC=10μg/ml), Escherichia coli ATCC 4157 (MIC=21μg/ml), Escherichia coli ATCC 51659 (MIC=140μg/ml), K. pneumoniae ATCC 33495 (MIC=5.2μg/ml), K. pneumoniae ATCC BAA-1705 (MIC=28μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=10μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (MIC=42μg/ml)	[Ref.28089718] 0.5% hemolysis at 300μg/ml against sheep red cells	Linear	Free	Free		L	[Ref.28089718] The survival rate of A549 human lung epithelial cells is 113% at a peptide concentration of 300 μg/ml	Not found	28089718	Dev Comp Immunol. 2017 May;70:135-144. 	Barksdale SM, Hrifko EJ, van Hoek ML.	Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP20827	FLPIVGLLKSLLK	13	TB_L1FK	No entry found	Derived from TB	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,antifungal activity.	[Ref.28443279] Gram-positive bacteria: S.aureus ATCC 33591 (MIC=6μM), Staphylococcus epidermidis (MIC=1.5μM);##Gram-negative bacteria: Klebsiella pneumoniae ATCC BAA-1706 (MIC=6μM), Pseudomonas aeruginosa ATCC 27853 (MIC=6μM)	[Ref.28443279] 8% hemolysis at 48μM, 38% hemolysis at 96μM against human red cells	Linear	Free	Amidation		L	[Ref.28443279] IC50 = 52 μM against PBMCs. ##IC50 = 59 μM against A549 cells	Not found	28443279	Front Chem. 2017 Apr 11;5:24	Grassi L, Maisetta G, Maccari G, Esin S, Batoni G.	Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP20828	KKLLPIVANLLKSLL	15	TB_KKG6A	No entry found	Derived from TB	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,antifungal activity.	[Ref.28443279] Gram-positive bacteria: S.aureus ATCC 33591 (MIC=1.5μM), Staphylococcus epidermidis (MIC=1.5μM);##Gram-negative bacteria: Klebsiella pneumoniae ATCC BAA-1706 (MIC=3μM), Pseudomonas aeruginosa ATCC 27853 (MIC=3μM)	[Ref.28443279] 11% hemolysis at 48μM, 55% hemolysis at 96μM against human red cells	Linear	Free	Amidation		L	[Ref.28443279] IC50 = 49 μM against PBMCs. ##IC50 = 16 μM against A549 cells	Not found	28443279	Front Chem. 2017 Apr 11;5:24	Grassi L, Maisetta G, Maccari G, Esin S, Batoni G.	Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP20829	RWKIFKKIERVGQNVRDGIIKAGPAIQVLGTAKALGK	37	ABP-dHC-Cecropin A	No entry found	Derived from dHC	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix	ABP-dHC-Cecropin A and its analog adopt a well-defined 		Function: Anticancer activity against the human leukemia cells	[Ref.28347740] Cancer cell lines: Leukemia cell lines K562 (IC50=349.5μM), Leukemia cell lines U937 (IC50=303.2μM), Leukemia cell lines THP-1 (IC50=228.5μM)	[Ref.28347740] 0% hemolysis at 0μM, 1% hemolysis at 800μM against human red cells	Linear	Free	Free		L	[Ref.28347740] IC50 = 349.5 μM and CI = [304.0, 399.0] μM against K562 cells. ## IC50 = 303.2 μM and CI =[291.2, 315.3] μM against U937 cells. IC50 = 228.5 μM and CI = [199.1, 258.0] μM against THP-1 cells. The CI is the Confidence Interval of 90%.	Not found	28347740	Eur J Pharmacol. 2017 May 15;803:138-147. 	Sang M, Zhang J, Zhuge Q	Selective cytotoxicity of the antibacterial peptide ABP-dHC-Cecropin A and its analog towards leukemia cells	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(C)C)[C@H](C)CC
DRAMP20830	RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK	37	ABP-dHC-Cecropin A-K	No entry found	Derived from dHC	Not found	Synthetic construct	Anti-Cancer	Synthetic	Alpha helix	ABP-dHC-Cecropin A and its analog adopt a well-defined 		Function: Anticancer activity against the human leukemia cells	[Ref.28347740]  Cancer cell lines: Leukemia cell lines K562 (IC50=184.9μM), Leukemia cell lines U937 (IC50=223.9μM), Leukemia cell lines THP-1 (IC50=196.1μM)	[Ref.28347740] 0% hemolysis at 0μM, 1% hemolysis at 800μM against human red cells	Linear	Free	Free		L	[Ref.28347740] IC50 = 184.9 μM and CI = [185.3, 191.0] μM against K562 cells. ## IC50 = 223.9 μM and CI =[211.4, 236.5] μM against U937 cells. IC50 = 196.1 μM and CI = [170.2, 222.1] μM against THP-1 cells. The CI is the Confidence Interval of 90%.	Not found	28347740	Eur J Pharmacol. 2017 May 15;803:138-147. 	Sang M, Zhang J, Zhuge Q	Selective cytotoxicity of the antibacterial peptide ABP-dHC-Cecropin A and its analog towards leukemia cells	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(C)C)[C@H](C)CC
DRAMP20831	ILGKLWEGLKSLF	13	IsCT1L1	No entry found	Belongs to the scorpion NDBP 5 family	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.28657596] Gram-positive bacteria:Staphylococcus aureus (MIC=50μg/mL);##Gram-negative bacteria: S. typhimurium (MIC=100μg/mL), Escherichia coli (MIC=50μg/mL)	[Ref.28657596] 1% hemolysis at 10 μg/ml, 78% hemolysis at 50 μg/ml, 90% hemolysis at 100 μg/ml against human red cells	Linear	Free	Amidation		L	[Ref.28657596] No cytotoxicity information found	Not found	28657596	Antibiotics (Basel). 2017 Jun 28;6(3). 	de la Salud Bea R, Petraglia AF, Ascuitto MR, Buck QM.	Antibacterial Activity and Toxicity of Analogs of Scorpion Venom IsCT Peptides	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP20832	IDWKKLLNAAKQIL	14	Polybia-MP1S-D8N	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria, position 6 and 10 are cross-linked residues connected by the oct-4-enyl hydrocarbon staple	[Ref.29075946] Gram-positive bacteria: Bacillus subtilis (MIC=0.8μM), Staphylococcus aureus (MIC=0.8μM), Staphylococcus epidermidis (MIC=37.5μM);##Gram-negative bacteria:Escherichia coli (MIC=50μM), Shigella dysenteriae (MIC=100μM), Klebsiella pneumoniae (MIC=37.5μM)	[Ref.29075946] 16.3% hemolysis at 12.5μM, 37.8% hemolysis at 25μM against human red cells	Cyclic	Free	Amidation	The oct-4-enyl hydrocarbon staple between Leu6 and Ala10	L	[Ref.29075946] No cytotoxicity information found	Not found	29075946	Arch Pharm Res. 2017 Dec;40(12):1414-1421.	Luong HX, Kim DH, Lee BJ, Kim YW	Antimicrobial activity and stability of stapled helices of polybia-MP1	
DRAMP20833	FVPWFSKFLGRIL	13	[Pro3,DLeu9]TL(1) (Temporin L peptide derivative)	No entry found	Derived from Temporin L	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	The analogues bearing a D residue shows a reduction in the percentage of helicity compared to the corresponding L analogues in the MMs 		Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(1) is D-Leucine.	[Ref.28863356] Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3.125μM), Staphylococcus aureus Cowan I (MIC=12.5μM), Staphylococcus epidermidis ATCC 12228 (MIC=6.25μM);##Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MIC=12.5μM), Escherichia coli D21 (MIC=12.5μM), Pseudomonas syringae pv tabaci 1918 (MIC=12.5μM), Pseudomonas aeruginosa ATCC 2785 (MIC=50μM);##Yeasts: Candida albicans ATCC 10231 (MIC=3.125μM), Candida crusei ATCC 6258 (3.125μM).	[Ref.28863356] 21±4% hemolysis at 50μM, 7±3% hemolysis at 25μM, 6±3% hemolysis at 12.5μM, 3±2% hemolysis at 6.25μM, 1±1%  hemolysis at 3.125μM against human red blood cells.##20.63 ± 2.66% cytotoxic effect at 12.5μM, 57.52 ± 3.99%  cytotoxic effect at 25μM, 91.58 ± 3.85% cytotoxic effect at 50 μM on HaCaT cells.	Linear	Free	Amidation		Mixed (D-Leu9)	[Ref.28863356] The cytotoxic effects of the peptide are 20.63±2.66%, 57.52±3.99% and 91.58±3.85% at 12.5, 25 and 50 μM 	Not found	28863356	Eur J Med Chem. 2017 Oct 20;139:750-761.	Merlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.	Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP20834	RWQWRWQWR	9	PLS	No entry found	Not found	Not found	Not found	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria	[Ref.29551999] Gram-negative bacteria:E. faecalis-sensitive strain (MIC=25.6 μM),Staphylococcus aureus-sensitive strain (MIC=34.9 μM),,Staphylococcus aureus-resistant strain (MIC=25.0 μM);##Gram-positive bacteria:Klebsiella pneumoniaae-sensitive strain (MIC=30.7 μM),Klebsiella pneumoniaae-resistant strain (MIC=26.2 μM),Pseudomonas aeruginosa-sensitive strain (MIC=99.7 μM),Pseudomonas aeruginosa-resistant strain (MIC=107.2 μM)	[Ref.29551999] 24.8% hemolysis at 100μM,50% hemolysis at >100μM against human red cells	Linear	Free	Free		L	[Ref.29551999] No cytotoxicity information found	Not found	29551999	Front Microbiol. 2018 Mar 2;9:329.	Vega SC, Mart	Design, Synthesis and Evaluation of Branched RRWQWR-Based Peptides as Antibacterial Agents against Clinically Relevant Gram-Positive and Gram-Negative Pathogens	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP20835	ALAGTIIAGASLTFQVLDKVLEELGKVSRK	30	StII1-30 StII peptide derivative	No entry found	Not found	Not found	Synthetic construct	Candidacidal	Synthetic	Alpha helix	The peptide at low concentration exists in a random coil conformation.Increasing the peptide concentration up to 300 		Function: Antibacterial activity against the candida	No MICs found in DRAMP database	[Ref.29359791] HC50=42.5μM against human red blood cells	Linear	Free	Free		L	[Ref.29359791] No cytotoxicity information found	Not found	29359791	Biopolymers. 2018 Jan 23.	Lima de Oliveira A, Maffud Cilli E, Ros U, Crusca E Jr, Lanio ME, Alvarez C, Schreier S, Aguiar Pertinhez T, Spisni A.	Insights on the structure-activity relationship of peptides derived from Sticholysin II.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O
DRAMP20836	VLDKVLEELGKVSRKIAVGI	20	StII16-35 StII peptide derivative	No entry found	Not found	Not found	Synthetic construct	Candidacidal	Synthetic	Random coil conformation	The peptide displays a random coil conformation up to 1 mM and does not show any structure concentration		Function: Antibacterial activity against the candida	No MICs found in DRAMP database	[Ref.29359791] HC50=128μM against human red blood cells	Linear	Free	Free		L	[Ref.29359791] No cytotoxicity information found	Not found	29359791	Biopolymers. 2018 Jan 23.	Lima de Oliveira A, Maffud Cilli E, Ros U, Crusca E Jr, Lanio ME, Alvarez C, Schreier S, Aguiar Pertinhez T, Spisni A.	Insights on the structure-activity relationship of peptides derived from Sticholysin II.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)O
DRAMP20837	KRVKRFKKFFRKIKKGFRKIFKKTKIFIGGT	31	Pb-CATH1 Python bivittatus  antimicrobial peptides peptide derivative	No entry found	Derived from cathelicidin family	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive 	[Ref.28630199]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=2μg/ml);Pseudomonas aeruginosa (ATCC 27853)(MIC=3μg/ml);S. typhimurium (ATCC 14028)(MIC=1.5μg/ml);##Gram-positive bacteria:Staphylococcus aureus (ATCC 29213)(MIC>128μg/ml);B. cereus (ATCC 10876)(MIC=46μg/ml)	[Ref.28630199] 0% hemolysis at 4μg/ml against human red blood cell; 1.4 ± 0.4% hemolysis at 8μg/ml against human red blood cell; 5.1 ± 0.5% hemolysis at 16μg/ml against human red blood cell;7.3 ± 0.6% hemolysis at 32μg/ml against human red blood cell; 12.2 ± 0.7% hemolysis at 64μg/ml against human red blood cell	Linear	Free	Free		L	[Ref.28630199] No cytotoxicity information found	Not found	28630199	Antimicrob Agents Chemother. 2017 Aug 24;61(9). 	Kim D, Soundrarajan N, Lee J, Cho HS, Choi M, Cha SY, Ahn B, Jeon H, Le MT, Song H, Kim JH, Park C.	Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP20838	TRSRWRRFIRGAGRFARRYGWRIAL	25	Pb-CATH4 bivittatus  antimicrobial peptides peptide derivative 	No entry found	Derived from cathelicidin family	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	The peptide adopts arginine content of this peptide is 37.5%, and it contains two tryptophan residues (8.3%)		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria	[Ref.28630199]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=1μg/ml);Pseudomonas aeruginosa (ATCC 27853)(MIC=3μg/ml);S. typhimurium (ATCC 14028)(MIC=0.5μg/ml);##Gram-positive bacteria:Staphylococcus aureus (ATCC 29213)(MIC>128μg/ml);B. cereus (ATCC 10876)(MIC=10μg/ml);##Clinical isolates:Escherichia coli(MIC=4.7μg/ml);K. pneumoniae(MIC=1.18μg/ml)	[Ref.28630199] 0% hemolysis at 4μg/ml against human red blood cell; 1.4 ± 0.4% hemolysis at 8μg/ml against human red blood cell; 5.1 ± 0.5% hemolysis at 16μg/ml against human red blood cell;7.3 ± 0.6% hemolysis at 32μg/ml against human red blood cell; 12.2 ± 0.7% hemolysis at 64μg/ml against human red blood cell	Linear	Free	Free		L	[Ref.28630199] The cell viability of Pk15(pig kidney fibroblasts) is 103.8%, 124.6%, 94.7%,55.2% and 53.9% at peptide concentrations of 5, 10, 20, 30 and 64 μg/ml. ##The cell viability of HaCaT(human keratinocytes) is 106.9%, 94.6%, 66.2%, 58.1% and 51.	Not found	28630199	Antimicrob Agents Chemother. 2017 Aug 24;61(9). 	Kim D, Soundrarajan N, Lee J, Cho HS, Choi M, Cha SY, Ahn B, Jeon H, Le MT, Song H, Kim JH, Park C.	Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP20839	GFVALLKKLPLILKHLH	17	Xylopin 	C0HKQ5	Not found	Not found	Xylocopa appendiculata circumvolans	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Linear cationic alpha-helical	Not found		Function: Antimicrobial and mast cell degranulating peptide which probably acts by forming pores in membranes (PubMed:28546807, PubMed:28855917). Active against both Gram-negative and Gram-positive bacterial strains as well as against yeasts (PubMed:28546807, PubMed:28855917). Has leishmanicidal activity (IC50=25uM)(PubMed:28855917). Has little hemolytic activity (PubMed:28546807, PubMed:28855917)	[Ref.28855917]Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=15.0μM);Micrococcus luteus (ATCC 10240)(MIC=1.9μM);Bacillus subtilis (ATCC 6633)(MIC=3.75μM);Streptococcus pyogenes (CS)(MIC=3.75μM);Streptococcus agalactiae (CS)(MIC=3.75μM);Enterococcus. faecalis (CS)(MIC=15.0μM);##Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=3.75μM);Pseudomonas aeruginosa (ATCC 27853)(MIC=7.5μM);Stenotrophomonas maltophilia (ATCC 13637)(MIC=3.75μM);Shigella boydii (CS)(MIC=3.75μM);Klebsiella pneumoniae (CS)(MIC=7.5μM);Serratia marcescens (CS)(MIC=7.5μM);Enterobacter cloacae (CS)(MIC=7.5μM);Proteus mirabilis (CS)(MIC>30μM);Morganella morgannii (CS)(MIC=30μM);Acinetobacter baumanii/calcoaceticus (CS)(MIC=3.75μM) ;##Yeasts:Candida albicans (ATCC 90112)(MIC=7.5μM);Sacharomyces cerevisae(MIC=3.75μM)	[Ref.28855917]IC50=25uM against human red blood cells	Linear	Free	Amidation		L	[Ref.28855917] No cytotoxicity information found	Not found	28855917	J Venom Anim Toxins Incl Trop Dis. 2017 Aug 29;23:40.	Kazuma K, Ando K, Nihei KI, Wang X, Rangel M, Franzolin MR, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.	Peptidomic analysis of the venom of the solitary bee Xylocopa appendiculata circumvolans.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O
DRAMP20840	PDRAIDTYRTSPVADQRYNA	20	SLAY-C1	No entry found			Synthetic construct	Non-antibacterial	Synthetic form	Unknown	Not mentioned		Function: Non-antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC > 128 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC > 128 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).	[Ref.29307492] No hemolytic activity information found.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP20841	SKVWRHWRRFWHRAHRLH	18	C1b	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Random coil conformation	The peptide adopts an low alpha-helical content when dissolved in water.  However, the peptides displayed 3.23		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=6.25μM);Pseudomonas aeruginosa(MIC=1.56μM);##Gram-positive bacteria:Staphylococcus aureus(MIC=3.13μM);B. cereus(MIC=3.13μM);S. lactis(MIC=3.13μM);E. faecalis (MIC=1.56μM);E. faecium(MIC=3.13μM)	[Ref.27060618] HC50>500μM against human red blood cells	Linear	Free	Free		L	[Ref.27060618] No cytotoxicity information found	Not found	27060618	Acta Biomater. 2016 Jun;37:59-68.	Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.	Structure-activity analysis and biological studies of chensinin-1b analogues.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP20842	SKVWRHWRRFW	11	C1b(1-11)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Random coil conformation	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=12.5μM);Pseudomonas aeruginosa(MIC=3.13μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 6.25μM);B. cereus(MIC=6.25μM);S. lactis(MIC=6.25μM);E. faecalis (MIC=6.25μM);E. faecium(MIC=6.25μM)	[Ref.27060618] HC50>500μM against human red blood cells	Linear	Free	Free		L	[Ref.27060618] No cytotoxicity information found	Not found	27060618	Acta Biomater. 2016 Jun;37:59-68.	Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.	Structure-activity analysis and biological studies of chensinin-2b analogues.	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP20843	SKVWRHWRRFWHR	13	C1b(1-13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Random coil conformation	The peptide adopts 41.93% alpha-helical		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=6.25μM);Pseudomonas aeruginosa(MIC=3.13μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 3.13μM);B. cereus(MIC=1.56μM);S. lactis(MIC=3.13μM);E. faecalis (MIC=3.13μM);E. faecium(MIC=6.25μM)	[Ref.27060618] HC50>500μM against human red blood cells	Linear	Free	Free		L	[Ref.27060618] No cytotoxicity information found	Not found	27060618	Acta Biomater. 2016 Jun;37:59-68.	Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.	Structure-activity analysis and biological studies of chensinin-3b analogues.	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP20844	VWRHWRRFWHR	11	C1b(3-13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Random coil conformation	The peptide adopts 53.49% alpha-helical		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=6.25μM);Pseudomonas aeruginosa(MIC=3.13μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 3.13μM);B. cereus(MIC=3.13μM);S. lactis(MIC=6.25μM);E. faecalis (MIC=3.13μM);E. faecium(MIC=3.13μM)	[Ref.27060618] HC50>500μM against human red blood cells	Linear	Free	Free		L	[Ref.27060618] No cytotoxicity information found	Not found	27060618	Acta Biomater. 2016 Jun;37:59-68.	Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.	Structure-activity analysis and biological studies of chensinin-4b analogues.	CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP20845	VWRHWRRFW	9	C1b(3-11)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Random coil conformation	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=25μM);Pseudomonas aeruginosa(MIC=50μM);##Gram-positive bacteria:Staphylococcus aureus(MIC=25μM);B. cereus(MIC=50μM);S. lactis(MIC=100μM);E. faecalis (MIC=100μM);E. faecium(MIC=50μM)	[Ref.27060618] HC50>500μM against human red blood cells	Linear	Free	Free		L	[Ref.27060618] No cytotoxicity information found	Not found	27060618	Acta Biomater. 2016 Jun;37:59-68.	Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.	Structure-activity analysis and biological studies of chensinin-6b analogues.	CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP20846	VWRHWRRFWH	10	C1b(3-12)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Random coil conformation	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=50μM);Pseudomonas aeruginosa(MIC=12.5μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 12.25μM);B. cereus(MIC=6.25μM);S. lactis(MIC=12.25μM);E. faecalis (MIC=12.25μM);E. faecium(MIC=6.25μM)	[Ref.27060618] HC50>500μM against human red blood cells	Linear	Free	Free		L	[Ref.27060618] No cytotoxicity information found	Not found	27060618	Acta Biomater. 2016 Jun;37:59-68.	Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.	Structure-activity analysis and biological studies of chensinin-7b analogues.	CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP20847	WRHWRRFWHR	10	C1b(4-13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Random coil conformation	The peptide adopts 65.69% alpha-helical		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=25μM);Pseudomonas aeruginosa(MIC=3.13μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 50μM);B. cereus(MIC=6.25μM);S. lactis(MIC=6.25μM);E. faecalis (MIC=3.13μM);E. faecium(MIC=6.25μM)	[Ref.27060618] HC50>500μM against human red blood cells	Linear	Free	Free		L	[Ref.27060618] No cytotoxicity information found	Not found	27060618	Acta Biomater. 2016 Jun;37:59-68.	Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.	Structure-activity analysis and biological studies of chensinin-8b analogues.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP20848	VWRKWRRFW	9	[K4]C1b(3-11)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Random coil conformation	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=6.25μM);Pseudomonas aeruginosa(MIC=6.25μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 6.25μM);B. cereus(MIC=6.25μM);S. lactis(MIC=3.13μM);E. faecalis (MIC=3.13μM);E. faecium(MIC=3.13μM)	[Ref.27060618] HC50>500μM against human red blood cells	Linear	Free	Free		L	[Ref.27060618] No cytotoxicity information found	Not found	27060618	Acta Biomater. 2016 Jun;37:59-68.	Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.	Structure-activity analysis and biological studies of chensinin-9b analogues.	CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP20849	VWRRWRRFW	9	[R4]C1b(3-11)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Random coil conformation	The peptide adopts 3.23% alpha-helical		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=12.5μM);Pseudomonas aeruginosa(MIC=6.25μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 12.25μM);B. cereus(MIC=6.25μM);S. lactis(MIC=12.25μM);E. faecalis (MIC=12.25μM);E. faecium(MIC=12.5μM)	[Ref.27060618] HC50>500μM against human red blood cells	Linear	Free	Free		L	[Ref.27060618] No cytotoxicity information found	Not found	27060618	Acta Biomater. 2016 Jun;37:59-68.	Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.	Structure-activity analysis and biological studies of chensinin-10b analogues.	CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP20850	VWRKWRRFWKR	11	[K4,K10]C1b(3-13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Random coil conformation	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=3.13μM);Pseudomonas aeruginosa(MIC=1.56μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 6.25μM);B. cereus(MIC=3.13μM);S. lactis(MIC=6.25μM);E. faecalis (MIC=6.25μM);E. faecium(MIC=6.25μM)	[Ref.27060618] HC50>500μM against human red blood cells	Linear	Free	Free		L	[Ref.27060618] No cytotoxicity information found	Not found	27060618	Acta Biomater. 2016 Jun;37:59-68.	Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.	Structure-activity analysis and biological studies of chensinin-11b analogues.	CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP20851	VWRRWRRFWRR	11	[R4,R10]C1b(3-13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Random coil conformation	The peptide adopts 70.2% alpha-helical		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=3.13μM);Pseudomonas aeruginosa(MIC=3.13μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 3.13μM);B. cereus(MIC=3.13μM);S. lactis(MIC=3.13μM);E. faecalis (MIC=1.56μM);E. faecium(MIC=1.56μM)	[Ref.27060618] HC50>500μM against human red blood cells	Linear	Free	Free		L	[Ref.27060618] No cytotoxicity information found	Not found	27060618	Acta Biomater. 2016 Jun;37:59-68.	Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.	Structure-activity analysis and biological studies of chensinin-12b analogues.	CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP20852	ONNRPVYIPRPRPPHPRL	18	Api137 apidaecin petide derivative	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=2μg/mL);K. pneumoniae (DSM 681)(MIC=16μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=256μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>256μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>256μg/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50>0.6g/L);HeLa cells(IC50>0.6g/L)	[Ref.27243004] 0.4 ± 0.5% hemolysis at 0.1 g/L; 1.0 ± 0.2% hemolysis at 0.6 g/L against human red blood cells	Linear	Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)	Free	The 'O' in sequence is Ornithine	L	[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes. ##IC50 > 0.6g/L against HEK293. ##IC50 > 0.6g/L against HeLa.	Not found	27243004	Front Cell Dev Biol. 2016 May 10;4:39. 	Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.	N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.	
DRAMP20853	OIORPVYOPRPRPPHPRL	18	Api755 apidaecin petide derivative	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8μg/mL);K. pneumoniae (DSM 681)(MIC=8μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=16μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>64μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>16μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>128μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>128μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)	Free	The 'O' in sequence is Ornithine	L	[Ref.27243004] No cytotoxicity information found.	Not found	27243004	Front Cell Dev Biol. 2016 May 10;4:39. 	Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.	N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.	
DRAMP20854	OWORPVYOPRPRPPHPRL	18	Api760 apidaecin petide derivative	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8μg/mL);K. pneumoniae (DSM 681)(MIC=8μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=16μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>32μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>8μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>128μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>128μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)	Free	The 'O' in sequence is Ornithine	L	[Ref.27243004] No cytotoxicity information found.	Not found	27243004	Front Cell Dev Biol. 2016 May 10;4:39. 	Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.	N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.	
DRAMP20855	OWOWORPVYOPRPRPPHPRL	20	Api793 apidaecin petide derivative	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8μg/mL);K. pneumoniae (DSM 681)(MIC=16μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=16μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>16μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>8μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>64μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>64μg/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50=0.64 ± 0.05g/L);HeLa cells(IC50=0.64 ± 0.05g/L)	[Ref.27243004] 1.3 ± 0.4% hemolysis at 0.1 g/L; 1.6 ± 0.5% hemolysis at 0.6 g/L against human red blood cells	Linear	Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)	Free	The 'O' in sequence is Ornithine	L	[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes.## IC50 = 0.64 ± 0.05 g/L against HEK293. IC50 = 0.64 ± 0.15 g/L against HeLa.	Not found	27243004	Front Cell Dev Biol. 2016 May 10;4:39. 	Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.	N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.	
DRAMP20856	OWOWOWORPVYOPRPRPPHPRL	22	Api794 apidaecin petide derivative	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria; highly active against Pseudomonas aeruginosa in vitro	[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=16μg/mL);K. pneumoniae (DSM 681)(MIC=32μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=16μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>16μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>16μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>32μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>128μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>16μg/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50>0.6g/L);HeLa cells(IC50>0.6g/L)	[Ref.27243004] 1.7 ± 0.2% hemolysis at 0.1 g/L; 1.9 ± 0.3% hemolysis at 0.6 g/L against human red blood cells	Linear	Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)	Free	The 'O' in sequence is Ornithine	L	[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes.## IC50 = 0.28 ± 0.03 g/L against HEK293. IC50 = 0.23 ± 0.09 g/L against HeLa.	Not found	27243004	Front Cell Dev Biol. 2016 May 10;4:39. 	Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.	N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.	
DRAMP20857	OIOIORPVYOPRPRPPHPRL	20	Api795 apidaecin petide derivative	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria; highly active against Pseudomonas aeruginosa in vitro	[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8μg/mL);K. pneumoniae (DSM 681)(MIC=8μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=8μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>16μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>8μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>32μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>128μg/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50>0.6g/L);HeLa cells(IC50>0.6g/L)	[Ref.27243004] 0.8 ± 0.4% hemolysis at 0.1 g/L; 0.0 ± 0.7% hemolysis at 0.6 g/L against human red blood cells	Linear	Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)	Free	The 'O' in sequence is Ornithine	L	[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes.## IC50 > 0.6g/L against HEK293. IC50 > 0.6g/L against HeLa.	Not found	27243004	Front Cell Dev Biol. 2016 May 10;4:39. 	Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.	N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.	
DRAMP20858	OIOIOIORPVYOPRPRPPHPRL	22	Api796 apidaecin petide derivative	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8μg/mL);K. pneumoniae (DSM 681)(MIC=16μg/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=8μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>16μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>16μg/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>64μg/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>128μg/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>128μg/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50>0.6g/L);HeLa cells(IC50>0.6g/L)	[Ref.27243004] 0.8 ± 0.2% hemolysis at 0.1 g/L;μ0.1 ± 0.8 % hemolysis at 0.6 g/L against human red blood cells	Linear	Guanidation (Orn1 conjugated with N,N,N′,N′-tetramethylguanidino)	Free	The 'O' in sequence is Ornithine	L	[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes.## IC50 > 0.6g/L against HEK293. IC50 > 0.6g/L against HeLa.	Not found	27243004	Front Cell Dev Biol. 2016 May 10;4:39. 	Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.	N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.	
DRAMP20859	KFRTRRSKSSSNGGRKGSKG	20	TT(1-24)	No entry found	Derived from Cathelicidins	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Unconventional feature	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. TT(1	[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=32μM);A. salmonicida (ATCC 33658)(MIC=32-16μM);Y. ruckeri (NCIMB 1315)(MIC=32μM);V. anguillarum (ATCC 43305 With addition of 2% NaCl)(MIC>32μM);A. hydrophila (ATCC 7966)(MIC>32μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=64μM);L. garvieae (ATCC 49156)(MIC=16-8μM)	[Ref.27818338] No hemolytic activity to human	Linear	Free	Free		L	[Ref.27818338] No cytotoxicity information found	Not found	27818338	Fish Shellfish Immunol. 2016 Dec;59:456-468. 	D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.	Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins.	C[C@@H](O)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
DRAMP20860	KFRTRRSKSSSNGGRKGSKGGSKGRPGSGSSIAGA	35	TT(1-35)	No entry found	Derived from Cathelicidins	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Unconventional feature	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. TT(1	[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=4μM);A. salmonicida (ATCC 33658)(MIC=2μM);Y. ruckeri (NCIMB 1315)(MIC=8μM);V. anguillarum (ATCC 43305 With addition of 2% NaCl)(MIC>32μM);A. hydrophila (ATCC 7966)(MIC>32μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=16-8μM);L. garvieae (ATCC 49156)(MIC=1μM)	[Ref.27818338] No hemolytic activity to human;No hemolytic activity to trout	Linear	Free	Free		L	[Ref.27818338] The cell viability of RTG-2 cells is 106%,  117%, 126% and 121.5% at peptide concentrations of 0.25, 1, 4, and 8 μM.	Not found	27818338	Fish Shellfish Immunol. 2016 Dec;59:456-468. 	D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.	Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)O
DRAMP20861	KIRTRRSOARKOSRGNGGGIROPGGGIRLGGGSLIGR	37	STF(1-37)	No entry found	Derived from Cathelicidins	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Unconventional feature	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. The peptides inhibit the growth of V. anguillarum or A. hydrophila (MIC >32 	[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=2μM);A. salmonicida (ATCC 33658)(MIC=8-4μM);Y. ruckeri (NCIMB 1315)(MIC=16μM);V. anguillarum (ATCC 43305 With addition of 2% NaCl)(MIC>32μM);A. hydrophila (ATCC 7966)(MIC>32μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=16-8μM);L. garvieae (ATCC 49156)(MIC=8μM)	[Ref.27818338] No hemolytic activity to human;No hemolytic activity to trout	Cyclic	Free	Free	Disulfide bond between Cys12 and Cys22.	L	[Ref.27818338] The cell viability of RTG-2 cells is 108%,  112%, 117% and 118% at peptide concentrations of 0.25, 1, 4, and 8 μM.	Not found	27818338	Fish Shellfish Immunol. 2016 Dec;59:456-468. 	D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.	Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins.	
DRAMP20862	RRGKDSGGPKMGRKNSKGGWRGRPGSGRPGFGSGI	39	rtCATH2(5-40)	No entry found	Derived from Cathelicidins	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Unconventional feature	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria.The peptides inhibit the growth of V. anguillarum or A. hydrophila (MIC >32 	[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=16μM);A. salmonicida (ATCC 33658)(MIC=16μM);Y. ruckeri (NCIMB 1315)(MIC=16μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=64μM)	[Ref.27818338] No hemolytic activity to human	Linear	Free	Free		L	[Ref.27818338] No cytotoxicity information found	Not found	27818338	Fish Shellfish Immunol. 2016 Dec;59:456-468. 	D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.	Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)NCC(=O)O)C(=O)O
DRAMP20863	KIRTRRGKDSGGPKMGRKNSKGGWRGRPGSGSRPGFGSGI	42	rtCATH2(1-40)	No entry found	Derived from Cathelicidins	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Unconventional feature	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. The peptides inhibit the growth of V. anguillarum or A. hydrophila (MIC >32 	[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=4μM);A. salmonicida (ATCC 33658)(MIC=8-4μM);Y. ruckeri (NCIMB 1315)(MIC=16μM);V. anguillarum (ATCC 43305 With addition of 2% NaCl)(MIC>32μM);A. hydrophila (ATCC 7966)(MIC>32μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=16-8μM);L. garvieae (ATCC 49156)(MIC=16-8μM)	[Ref.27818338] No hemolytic activity to human;No hemolytic activity to trout	Linear	Free	Free		L	[Ref.27818338] The cell viability of RTG-2 cells is 112.5%, 105%, 107%, 94% at peptide concentrations of 0.25, 1, 4, and 8 μM.	Not found	27818338	Fish Shellfish Immunol. 2016 Dec;59:456-468. 	D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.	Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)NCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@@H](C)O)C(=O)O
DRAMP20864	KFRSNGRHGSGSRLGGGSLIGRPGGGS	27	SF(18-45)	No entry found	Derived from Cathelicidins	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Unconventional feature	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. SF(18	[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=16μM);A. salmonicida (ATCC 33658)(MIC=64μM);Y. ruckeri (NCIMB 1315)(MIC=32μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=64μM)	[Ref.27818338] No hemolytic activity to human	Linear	Free	Free		L	[Ref.27818338] No cytotoxicity information found	Not found	27818338	Fish Shellfish Immunol. 2016 Dec;59:456-468. 	D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.		CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)O
DRAMP20865	(RRWQWR)2-K-(Ahx)	14	the dimeric RRWQWR motif peptide molecule	No entry found	Derived from bovine LfcinB6	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.29984236] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=14 μg/ml; MBC=110 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=55 μg/ml; MBC=110 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae ATCC 13883 (MIC=27 μg/ml; MBC=55 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=27 μg/ml; MBC=220 μg/ml)	[Ref.29984236] 0% hemolysis at 5 μM, 1% hemolysis at 12 μM, 2% hemolysis at 22 μM, 2% hemolysis at 50 μM, 4% hemolysis at 100 μM against human red blood cells	Branched	Free	Amidation		L	[Ref.29984236] No cytotoxicity information found	Not found	29984236	Biomed Res Int. 2018 Jun 10;2018:5252891	Sandra C. Vega Chaparro, J. Tatiana Valencia Salguero, Diana A. Martínez Baquero, Jaiver E. Rosas Pérez.	Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.	
DRAMP20866	(RRWQWR)4-K2-(Ahx)2-C2	30	the tetrameric RRWQWR motif peptide molecule	No entry found	Derived from bovine LfcinB6	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.29984236] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=29 μg/ml; MBC=57 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=57 μg/ml; MBC=57 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae ATCC 13883 (MIC=29 μg/ml; MBC=115 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=57 μg/ml; MBC=115 μg/ml)	[Ref.29984236] 5% haemolysis at 5 μM, 10% haemolysis at 12 μM, 10% haemolysis at 22 μM, 0% haemolysis at 50 μM, 2% haemolysis at 100 μM against human red blood cells	Branched	Free	Amidation	Disulfide bond which links two dimeric motif peptides	L	[Ref.29984237] No cytotoxicity information found	Not found	29984236	Biomed Res Int. 2018 Jun 10;2018:5252891	Sandra C. Vega Chaparro, J. Tatiana Valencia Salguero, Diana A. Martínez Baquero, Jaiver E. Rosas Pérez.	Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.	
DRAMP20867	RWQWRWQWR	9	the palindromic RRWQWR motif peptide molecule	No entry found	Derived from bovine LfcinB6	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.29984236] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=74 μg/ml; MBC=148 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=9 μg/ml; MBC=74 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae ATCC 13883 (MIC=74 μg/ml; MBC=148 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=74 μg/ml; MBC=148 μg/ml)	[Ref.29984236] 0% haemolysis at 5 μM, 1% haemolysis at 12 μM, 0% haemolysis at 22 μM, 5% haemolysis at 50 μM, 25% haemolysis at 100 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.29984238] No cytotoxicity information found	Not found	29984236	Biomed Res Int. 2018 Jun 10;2018:5252891	Sandra C. Vega Chaparro, J. Tatiana Valencia Salguero, Diana A. Martínez Baquero, Jaiver E. Rosas Pérez.	Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP20868	KFKKLFKKLSPVIGKEFKRIVERIKRFLR	29	H4	No entry found	Derived from BMAP-27 and OP-145	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix 	The peptide adopts a conformational structure with 90 % alpha helix.		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.29910626] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=20 μM), Staphylococcus aureus ATCC 33591 (MIC=10 μM), Staphylococcus aureus ATCC 43300 (MIC=10 μM), Staphylococcus aureus ATCC BAA41 (MIC=10 μM), Enterococcus faecalis ATCC 19433 (MIC=15 μM), Enterococcus faecalis ATCC BAA2365 (MIC=5 μM), Staphylococcus epidermidis ATCC 12228 (MIC=10 μM), Enterococcus faecium ATCC BAA2316 (MIC=5 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=20 μM), Acinetobacter baumannii ATCC 19606 (MIC=10 μM), Klebsiella pneumoniae ATCC 13883 (MIC=2.5 μM), Pseudomonas aeruginosa ATCC BAA2114 (MIC=25 μM), Escherichia coli ATCC BAA2452 (MIC=10 μM)	[Ref.29910626] 0% haemolysis at 5 μM, 0% haemolysis at 10 μM, 0% haemolysis at 25 μM, 0% haemolysis at 40 μM, 0% haemolysis at 55 μM, 0% haemolysis at 75 μM, 0% haemolysis at 80 μM, 2.1% haemolysis at 100 μM against human red blood cells	Linear	Free	Free		L	[Ref.29910626] IC50 = 61.9±0.18 μM against HEK293.## IC50 = 64.9±1.01 μM against Vero.	Not found	29910626	Infect Drug Resist. 2018 Jun 1;11:835-847. 	Almaaytah A, Qaoud MT, Abualhaijaa A, Al-Balas Q, Alzoubi KH.	Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP20869	GLLKRIKTL	9	Pal-ano-9 (Pal-anoplin peptide derivative)	No entry found	Derived from the peptide Pal-anoplin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. The peptide is palmitoylated.	[Ref.29614317] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=0.406 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=0.406 μg/mL);##Fungi: Candida albicans ATCC 10231 (MIC=3.25 μg/mL).	[Ref.29614317] HC50=18.92μg/mL against human red blood cells	Linear	Acylation (Gly1 conjugated with a palmitoyl group)	Amidation		L	[Ref.29614317] No cytotoxicity information found	Not found	29614317	Peptides. 2018 Jun;104:7-14.	Salas RL, Garcia JKDL, Miranda ACR, Rivera WL, Nellas RB, Sabido PMG.	Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin.	CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP20870	GLLKRIKT	8	Pal-ano-8 (Pal-anoplin peptide derivative)	No entry found	Derived from the peptide Pal-anoplin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Random coil	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. The peptide is palmitoylated.	[Ref.29614317] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=1.63 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.25 μg/mL);##Fungi: Candida albicans ATCC 10231 (MIC=26 μg/mL).	[Ref.29614317] HC50=33.74μg/mL against human red blood cells	Linear	Acylation (Gly1 conjugated with a palmitoyl group)	Amidation		L	[Ref.29614318] No cytotoxicity information found	Not found	29614317	Peptides. 2018 Jun;104:7-14.	Salas RL, Garcia JKDL, Miranda ACR, Rivera WL, Nellas RB, Sabido PMG.	Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin.	CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP20871	GLLKRIK	7	Pal-ano-7 (Pal-anoplin peptide derivative)	No entry found	Derived from the peptide Pal-anoplin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Random coil	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. The peptide is palmitoylated.	[Ref.29614317] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=0.813 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1.63 μg/mL);##Fungi: Candida albicans ATCC 10231 (MIC=13 μg/mL).	[Ref.29614317] HC50=37.70μg/mL against human red blood cells	Linear	Acylation (Gly1 conjugated with a palmitoyl group)	Amidation		L	[Ref.29614319] No cytotoxicity information found	Not found	29614317	Peptides. 2018 Jun;104:7-14.	Salas RL, Garcia JKDL, Miranda ACR, Rivera WL, Nellas RB, Sabido PMG.	Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin.	CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP20872	GLLKRI	6	Pal-ano-6 (Pal-anoplin peptide derivative)	No entry found	Derived from the peptide Pal-anoplin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix 	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. The peptide is palmitoylated.	[Ref.29614317] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=0.61 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.25 μg/mL);##Fungi: Candida albicans ATCC 10231 (MIC=1.63 μg/mL).	[Ref.29614317] HC50=7.51μg/mL against human red blood cells	Linear	Acylation (Gly1 conjugated with a palmitoyl group)	Amidation		L	[Ref.29614320] No cytotoxicity information found	Not found	29614317	Peptides. 2018 Jun;104:7-14.	Salas RL, Garcia JKDL, Miranda ACR, Rivera WL, Nellas RB, Sabido PMG.	Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin.	CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)[C@H](C)CC
DRAMP20873	GLLKR	5	Pal-ano-5 (Pal-anoplin peptide derivative)	No entry found	Derived from the peptide Pal-anoplin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Random coil	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. The peptide is palmitoylated.	[Ref.29614317] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=3.25 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.5 μg/mL);##Fungi: Candida albicans ATCC 10231 (MIC=13 μg/mL).	[Ref.29614317] HC50= 66.12μg/mL against human red blood cells	Linear	Acylation (Gly1 conjugated with a palmitoyl group)	Amidation		L	[Ref.29614321] No cytotoxicity information found	Not found	29614317	Peptides. 2018 Jun;104:7-14.	Salas RL, Garcia JKDL, Miranda ACR, Rivera WL, Nellas RB, Sabido PMG.	Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin.	CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP20874	SKVWRHWRRFWHRAHRKL	18	Chensinin-1b	No entry found	Derived from chensinin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix, beta sheet and Random coil	The peptide adopts a random coil structure in water and presents an ordered alpha-helix structure with 11.96 % beta-strands and 28.06 % alpha-helices in TFE solution		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Anticancer activities against HeLa cervical carcinoma and MCF-7 breast carcinoma.	[Ref.29549839] Gram-positive bacteria: Staphylococcus aureus (MIC=3.13 μM), Bacillus cereus (MIC=3.13 μM), Streptococcus lactis (MIC=3.13 μM), Enterococcus faecalis (MIC=1.56 μM), Enterococcus faecium (MIC=3.13 μM);##Gram-negative bacteria: Escherichia coli (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=1.56 μM);##cancer cells: HeLa cervical carcinoma (IC50=113.10μ±μ4.10 μM), MCF-7 breast carcinoma (IC50=51.85μ±μ0.88 μM)	[Ref.29549839] HC50>500 μM against human red blood cells	Linear	Free	Free		L	[Ref.29549839] No cytotoxicity information found	Cell membrane (disrupted the bacterial cell membranes through a 	29549839	Eur J Med Chem. 2018 Apr 25;150:546-558.	Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D.	Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)C(=O)O
DRAMP20875	SKVWRHWRRFWHRAHRKL	18	OA-C1b	No entry found	Derived from Chensinin-1b	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix, Random coil	The peptide adopts a random coil structure in water and presents an ordered alpha-helix structure with 12.88 % beta-strands and 47.36 % alpha-helices in TFE solution		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Anticancer activities against HeLa cervical carcinoma, A375 melanoma and MCF-7 breast carcinoma. The peptide is a lipopeptide with CH3(CH2)6CO-.	[Ref.29549839] Gram-positive bacteria: Staphylococcus aureus (MIC=3.13 μM), Bacillus cereus (MIC=1.56 μM), Streptococcus lactis (MIC=1.56 μM), Enterococcus faecalis (MIC=1.56 μM), Enterococcus faecium (MIC=1.56 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.13 μM), Pseudomonas aeruginosa (MIC=1.56 μM);##cancer cells: HeLa cervical carcinoma (IC50=23.86μ±μ0.95 μM), A375 melanoma (IC50=50.97μ±μ1.45 μM), MCF-7 breast carcinoma (IC50=34.94μ±μ2.99 μM)	[Ref.29549839] HC50>500 μM against human red blood cells	Linear	Acylation (Ser1 conjugated with octanoic acid)	Free		L	[Ref.29549839] No cytotoxicity information found	Not found	29549839	Eur J Med Chem. 2018 Apr 25;150:546-558.	Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D.	Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.	CCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP20876	SKVWRHWRRFWHRAHRKL	18	LA-C1b	No entry found	Derived from Chensinin-1b	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix, Random coil	The peptide adopts a random coil structure in water and presents an ordered alpha-helix structure with 6.31 % beta-strands and 32.16 % alpha-helices in TFE solution		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Anticancer activities against HeLa cervical carcinoma, A375 melanoma and MCF-7 breast carcinoma. The peptide is a lipopeptide with CH3(CH2)6CO-.	[Ref.29549839] Gram-positive bacteria: Staphylococcus aureus (MIC=3.13 μM), Bacillus cereus (MIC=3.13 μM), Streptococcus lactis (MIC=3.13 μM), Enterococcus faecalis (MIC=1.56 μM), Enterococcus faecium (MIC=3.13 μM);##Gram-negative bacteria: Escherichia coli (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=1.56 μM);##cancer cells: HeLa cervical carcinoma (IC50=20.38μ±μ0.28 μM), A375 melanoma (IC50=21.25μ±μ1.51 μM), MCF-7 breast carcinoma (IC50=25.77μ±μ2.02 μM)	[Ref.29549839] HC50>500 μM against human red blood cells	Linear	Acylation (Ser1 conjugated with lauric acid)	Free		L	[Ref.29549839] No cytotoxicity information found	Not found	29549839	Eur J Med Chem. 2018 Apr 25;150:546-558.	Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D.	Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.	CCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP20877	SKVWRHWRRFWHRAHRKL	18	PA-C1b	No entry found	Derived from Chensinin-1b	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix, Random coil	The peptide adopts a random coil structure in water and presents an ordered alpha-helix structure with 12.88 % beta-strands and 22.67 % alpha-helices in TFE solution		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Anticancer activities against HeLa cervical carcinoma, A375 melanoma and MCF-7 breast carcinoma. The peptide is a lipopeptide with CH3(CH2)6CO-.	[Ref.29549839] Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μM), Bacillus cereus (MIC=6.25 μM), Streptococcus lactis (MIC=3.13 μM), Enterococcus faecalis (MIC= 3.13 μM), Enterococcus faecium (MIC= 6.25 μM);##Gram-negative bacteria: Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=6.25 μM);##cancer cells: HeLa cervical carcinoma (IC50=21.04μ±μ0.18 μM), A375 melanoma (IC50=18.15μ±μ0.21 μM), MCF-7 breast carcinoma (IC50=20.63μ±μ0.47 μM)	[Ref.29549839] HC50>500 μM against human red blood cells	Linear	Acylation (Ser1 conjugated with palmitic acid)	Free		L	[Ref.29549839] No cytotoxicity information found	Not found	29549839	Eur J Med Chem. 2018 Apr 25;150:546-558.	Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D.	Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.	CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP20878	MGFGCPEDEYECHNHCKNSVGCRGGYCDAGTLRQRCTCYGCNQKGRSIQE	50	rVpDef	No entry found	Derived from VpDef	ATGGGTTTTGGTTGTCCAGA	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.29524591] Gram-positive bacteria: Listeria monocytogenes ATCC 21633 (MIC=75 μg/ml), Bacillu subtilis Lzz-133 (MIC=95 μg/ml), Staphylococcus aureus ATCC 25923 (MIC=120 μg/ml);##Gram-negative bacteria: Escherichia coli O157 ATCC 35150 (MIC=50 μg/ml), Eschericha coli ATCC 10305 (MIC=75 μg/ml), Salmonella enterica ATCC 10467 (MIC=120 μg/ml)	[Ref.29524591] 0% haemolysis at 30 μg/ml, 0% haemolysis at 60 μg/ml, 0% haemolysis at 90 μg/ml, 0% haemolysis at 115 μg/ml, 0.2% haemolysis at 145 μg/ml, 1.5% haemolysis at 175 μg/ml against rabbit red blood cells	Linear	Free	Free		L	[Ref.29524591] No cytotoxicity information found	Not found	29524591	Protein Expr Purif. 2018 Jul;147:78-84. 	Meng DM, Lv YJ, Zhao JF, Liu QY, Shi LY, Wang JP, Yang YH, Fan ZC.	Efficient production of a recombinant Venerupis philippinarum defensin (VpDef) in Pichia pastoris and characterization of its antibacterial activity and stability.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP20879	KWKIFKKIEKVGRNVRDGIIKAGPAVQVVGQATSIAK	37	DAN1	A0A212EJN7	Belongs to the cecropin family.	KGM_210268	Danaus plexippus (monarch butterfly)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Random coil	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.29501691] Gram-positive bacteria: Bacillus subtilis (MIC=131.3μ±μ46.1 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC=4.9μ±μ2.3 μg/mL), Pseudomonas aeruginosa (MIC=7μ±μ0.8 μg/mL), Klebsiella pneumoniae (MIC=16.2μ±μ1.9 μg/mL)	[Ref.29501691] 0% haemolysis at 10 μg/ml, 0% haemolysis at 25 μg/ml, 0% haemolysis at 50 μg/ml, 0% haemolysis at 100 μg/ml, 0% haemolysis at 200 μg/ml against sheep red blood cells	Linear	Free	Amidation		L	[Ref.29501691] No cytotoxicity information found	Not found	29501691	Peptides. 2018 May;103:26-30. doi: 10.1016/j.peptides.2018.01.017.	Duwadi D, Shrestha A, Yilma B, Kozlovski I, Sa-Eed M, Dahal N, Jukosky J.	Identification and screening of potent antimicrobial peptides in arthropod genomes.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@H](C)CC
DRAMP20880	RWKFLKKIEKVGRKVRDGVIKAGPAVGVVGQATSIYK	37	DAN2	A0A212F3T6	Belongs to the cecropin family.	KGM_210265	Monarch butterfly (Danaus plexippus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Random coil	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29501691] Gram-positive bacteria: Bacillus subtilis (MIC=50μ±μ19 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC=2.1μ±μ0.7 μg/mL), Pseudomonas aeruginosa (MIC=5μ±μ2.5 μg/mL), Klebsiella pneumoniae (MIC=4.3μ±μ1.4 μg/mL);##Fungi: Candida albicans  (MIC=72.5μ±μ35.2 μg/mL)	[Ref.29501691] 0% haemolysis at 10 μg/ml, 0% haemolysis at 25 μg/ml, 0% haemolysis at 50 μg/ml, 0% haemolysis at 100 μg/ml, 0% haemolysis at 200 μg/ml against sheep red blood cells	Linear	Free	Amidation		L	[Ref.29501691] No cytotoxicity information found	Not found	29501691	Peptides. 2018 May;103:26-30. doi: 10.1016/j.peptides.2018.01.017.	Duwadi D, Shrestha A, Yilma B, Kozlovski I, Sa-Eed M, Dahal N, Jukosky J.	Identification and screening of potent antimicrobial peptides in arthropod genomes.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(C)C)C(C)C)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP20881	VTCDLLSAEAKGVKVNHAACAAHCLLKRKRGGYCNKRRICVCRN	44	HOLO1	D6X2G2	Derived from defensin-like peptides 	Not found	Red flour beetle (Tribolium castaneum)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antibacterial activity against the Gram-positive bacteria. Antifungal activity against Candida albicans.	[Ref.29501691] Gram-positive bacteria: Staphylococcus aureus (MIC=13.2μ±μ1.8 μg/mL), Bacillus subtilis (MIC=6μ±μ1.8 μg/mL);##Fungi: Candida albicans  (MIC=4.6μ±μ1.1 μg/mL)	[Ref.29501691] 0% haemolysis at 10 μg/ml, 0% haemolysis at 25 μg/ml, 0% haemolysis at 50 μg/ml,  0% haemolysis at 100 μg/ml, 0% haemolysis at 200 μg/ml against sheep red blood cells	Linear	Free	Amidation		L	[Ref.29501691] No cytotoxicity information found	Not found	29501691	Peptides. 2018 May;103:26-30. doi: 10.1016/j.peptides.2018.01.017.	Duwadi D, Shrestha A, Yilma B, Kozlovski I, Sa-Eed M, Dahal N, Jukosky J.	Identification and screening of potent antimicrobial peptides in arthropod genomes.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O)C(C)C
DRAMP20882	ATCDLLSASTPWGSLNHSACAAHCLTKRYKGGRCRNGICRCRR	43	LOUDEF1	E0VPU4	Derived from defensin-like peptides 	8233460 Phum_PHUM365	Human body louse (Pediculhumanus humanus)	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antibacterial activity against the Gram-positive bacteria. Antifungal activity Candida albicans.	[Ref.29501691] Gram-positive bacteria: Staphylococcus aureus (MIC=35μ±μ1.3 μg/mL), Bacillus subtilis (MIC=7μ±μ1.6 μg/mL);##Fungi: Candida albicans  (MIC= 19.1μ±μ9.6 μg/mL)	[Ref.29501691] 0% haemolysis at 10 μg/ml, 0% haemolysis at 25 μg/ml, 0% haemolysis at 50 μg/ml, 0% haemolysis at 100 μg/ml, 0% haemolysis at 200 μg/ml against sheep red blood cells	Linear	Free	Amidation		L	[Ref.29501691] No cytotoxicity information found	Not found	29501691	Peptides. 2018 May;103:26-30.	Duwadi D, Shrestha A, Yilma B, Kozlovski I, Sa-Eed M, Dahal N, Jukosky J.	Identification and screening of potent antimicrobial peptides in arthropod genomes.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP20883	KRFKKFFRKLKKSVKKRKKEFKKKPRVIKVSIPF	34	Cath-A	No entry found	Derived from three-finger toxin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.29392557] Gram-positive bacteria: MRSA PS-2 (MIC=64 μg/ml);##Gram-negative bacteria, MRSA PS-7 (MIC=64 μg/ml), MRSA PS-18 (MIC=32 μg/ml), MRSA PS-45 (MIC=32 μg/ml), MRSA PS-46 (MIC=32 μg/ml), MRSA PS-50 (MIC=32 μg/ml), MRSA PS-59 (MIC=64 μg/ml), MRSA PS-70 (MIC=32 μg/ml), MRSA PS-84 (MIC=128 μg/ml), MRSA PS-106 (MIC=32 μg/ml), MRSA PS-131 (MIC=128 μg/ml), MRSA PS-139 (MIC=32 μg/ml), MRSA PS-162 (MIC=128 μg/ml), MRSA PS-165 (MIC=32 μg/ml), Staphylococcus aureus ATCC 25923 (MIC=32 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=128 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli ATCC 51446 (MIC=16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=64 μg/ml), Klebsiella pneumoniae ATCC 13883 (MIC=16 μg/ml)	[Ref.29392557] 0% haemolysis at 1.0 μg/ml, 0% haemolysis at 2.0 μg/ml, 0% haemolysis at 4.0 μg/ml, 0% haemolysis at 8.0 μg/ml, 0% haemolysis at 16.0 μg/ml, 0% haemolysis at 31.2 μg/ml, 2% haemolysis at 62.5 μg/ml, 4% haemolysis at 125.0 μg/ml, 15% haemolysis at 250.0 μg/ml, 23% haemolysis at 500.0 μg/ml, 53% haemolysis  at 1000.0 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.29392557] The cell viability of HUVEC is 132%, 99% and 79%  at peptide concentrations of 35.5, 71 and 113 μg/ml .## The cell viability of H9c2is 129%, 97%, and 80% at peptide concentrations of 35.5, 71, and 113 μg/ml .	Not found	29392557	J Microbiol. 2018 Feb;56(2):128-137.	Tajbakhsh M, Karimi A, Tohidpour A, Abbasi N, Fallah F, Akhavan MM.	The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)C(C)C
DRAMP20884	KRFKKFFRKLKKSVKKRKKEFKKKPRVIGVSIPF	34	Cath-B	No entry found	Derived from three-finger toxin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.29392557] Gram-positive bacteria: MRSA PS-2 (MIC=256 μg/ml);##Gram-negative bacteria, MRSA PS-7 (MIC=32 μg/ml), MRSA PS-18 (MIC=128 μg/ml), MRSA PS-45 (MIC=64 μg/ml), MRSA PS-46 (MIC=128 μg/ml), MRSA PS-50 (MIC=128 μg/ml), MRSA PS-59 (MIC=32 μg/ml), MRSA PS-84 (MIC=128 μg/ml), MRSA PS-131 (MIC=64 μg/ml), MRSA PS-139 (MIC=64 μg/ml), MRSA PS-162 (MIC=256 μg/ml), MRSA PS-165 (MIC=128 μg/ml), Staphylococcus aureus ATCC 25923 (MIC=32 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=256 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 μg/ml), Escherichia coli ATCC 51446 (MIC=8 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=32 μg/ml), Klebsiella pneumoniae ATCC 13883 (MIC=8 μg/ml)	[Ref.29392557] 0% haemolysis at 1.0 μg/ml, 0% haemolysis at 2.0 μg/ml, 0% haemolysis at 4.0 μg/ml, 0% haemolysis at 8.0 μg/ml, 3% haemolysis at 16.0 μg/ml, 3% haemolysis at 31.2 μg/ml, 3% haemolysis at 62.5 μg/ml, 3% haemolysis at 125.0 μg/ml, 3% haemolysis at 250.0 μg/ml, 4% haemolysis at 500.0 μg/ml, 5% haemolysis at 1000.0 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.29392557] The cell viability of HUVEC is 118%, 100% and 75% at peptide concentrations of 35.5 μg/ml, 71 μg/ml and 113 μg/ml.## The cell viability of H9c2 is 123%, 97%, and 88% at peptide concentrations of 35.5, 71, and 113 μg/ml.	Not found	29392557	J Microbiol. 2018 Feb;56(2):128-137.	Tajbakhsh M, Karimi A, Tohidpour A, Abbasi N, Fallah F, Akhavan MM.	The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)C(C)C
DRAMP20885	ILKKLWEGVKSI	12	Hp1404-T1a	No entry found	Derived from Hp1404	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix	The peptide adopts an alpha-helical conformation in the membrane-mimicking environments and adopts a random coil conformation in the presence of all liposome types .		Function: Antibacterial activity against the Gram-negative bacteria. 	[Ref.29379033] Gram-negative bacteria: Pseudomonas aeruginosa 431 (MIC=25 μM), Pseudomonas aeruginosa 434 (MIC=25 μM), Pseudomonas aeruginosa 3399 (MIC=25 μM), Pseudomonas aeruginosa 3592 (MIC=12.5 μM), Pseudomonas aeruginosa 3904 (MIC=25 μM), Pseudomonas aeruginosa 4891 (MIC=25 μM), Pseudomonas aeruginosa 671973 (MIC=25 μM)	[Ref.29379033] Hp1404-T1a does not induce substantial hemolysis, even at the high tested concentration (200μμM) against mouse red blood cells	Linear	Free	Amidation		L	[Ref.29379033] No cytotoxicity information found	Lipopolysaccharide (LPS)-binding	29379033	Sci Rep. 2018 Jan 29;8(1):1763. 	Kim MK, Kang HK, Ko SJ, Hong MJ, Bang JK, Seo CH, Park Y.	Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@H](C)CC)C(C)C
DRAMP20886	ILKKLLEGVKSI	12	Hp1404-T1b	No entry found	Derived from Hp1404	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix	The peptide adopts an alpha-helical conformation in the membrane-mimicking environments and adopts a random coil conformation in the presence of all liposome types .		Function: Antibacterial activity against the Gram-negative bacteria. 	[Ref.29379033] Gram-negative bacteria: Pseudomonas aeruginosa 434 (MIC=25 μM), Pseudomonas aeruginosa 3592 (MIC=25 μM)	[Ref.29379033] Hp1404-T1b does not induce substantial hemolysis, even at the high tested concentration (200μμM) against mouse red blood cells	Linear	Free	Amidation		L	[Ref.29379033] No cytotoxicity information found	Lipopolysaccharide (LPS)-binding	29379033	Sci Rep. 2018 Jan 29;8(1):1763. 	Kim MK, Kang HK, Ko SJ, Hong MJ, Bang JK, Seo CH, Park Y.	Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@H](C)CC)C(C)C
DRAMP20887	KLIPILSKTIPAGKNLFYKI	20	NCP-2 (CTX-1 peptide derivative)	No entry found	Derived from CTX-1	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	The peptide adopts a conformational structure with 20 % alpha helix, 25 % beta sheet and 35 % random coil in the presence of DMPE-DMPG mixed vesicles.		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29364903] Gram-positive bacteria: Staphylococcus aureus ATCC 22953 (MBC=50 μg/ml), Streptococcus agalactiae ATCC 13813 (MBC=12.5 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MBC=12.5 μg/ml), Acinetobacter baumannii (herpetological, cloacal) (MBC=1.6 μg/ml), Acinetobacter baumannii (ornithological, cloacal) (MBC=50 μg/ml), Acinetobacter baumannii (human, urinary) (MBC=1.6 μg/ml), Moraxella catarrhalis ATCC 25238 (MBC=1.6 μg/ml);##Fungi: Candida albicans ATCC 10231 (MBC=50 μg/mL), Malassezia pachydermatis DSMZ 6172 (MBC=6.3 μg/mL)	[Ref.29364903] 2% haemolysis at 12.5 μg/ml, 8% haemolysis at 100.0 μg/ml against sheep red blood cells	Linear	Free	Free		L	[Ref.29364903] The cell death rate of Madin-Darby Bovine Kidney(MDBK) cells is 3 % and 5% at peptide concentrations of 12.5 and 100  μg/ml	Not found	29364903	PLoS One. 2018 Jan 24;13(1):e0190778. 	Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.	Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)O
DRAMP20888	KLIWILSKTIPAGKNLFYKI	20	NCP-3 (CTX-1 peptide derivative)	No entry found	Derived from CTX-1	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	The peptide adopts a conformational structure with 43 % beta sheet and 35 % random coil in the presence of DMPE-DMPG mixed vesicles.		Function: Antimicrobial activity against the Gram-positive bacteria, Gram-negative bacteria and fungi. NCP-3 completely inhibits the viral activity of BoHV-1 on MDBK cells at the concentration of 25 	[Ref.29364903] Gram-positive bacteria: Methicillin-resistant Staphylococcus aureus ATCC 43300 (MBC=6.3 μg/ml), Staphylococcus aureus ATCC 22953 (MBC=1.6 μg/ml), Enterococcus hirae ATCC 10541 (MBC=1.6 μg/ml), Streptococcus agalactiae ATCC 13813 (MBC=1.6 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MBC=12.5 μg/ml), Acinetobacter baumannii (herpetological, cloacal) (MBC=1.6 μg/ml), Acinetobacter baumannii (ornithological, cloacal) (MBC=6.3 μg/ml), Acinetobacter baumannii (human, urinary) (MBC=1.6 μg/ml), Klebsiella pneumoniae subsp. pneumoniae (herpetological, cloacal) (MBC=50 μg/ml), Enterobacter cloacae (herpetological, cloacal) (MBC=25 μg/ml), Burkholderia cepacia ATCC 17759 (MBC=50 μg/ml), Moraxella catarrhalis ATCC 25238 (MBC=1.6 μg/ml);##Fungi: Candida albicans ATCC 10231 (MBC=12.5 μg/mL), Candida glabrata ATCC 90030 (MBC=50 μg/mL), Malassezia pachydermatis DSMZ 6172 (MBC=6.3 μg/mL).	[Ref.29364903] 3% haemolysis at 12.5 μg/ml, 9% haemolysis at 100.0 μg/ml against sheep red blood cells	Linear	Free	Free		L	[Ref.29364903] The cell death rate of Madin-Darby Bovine Kidney(MDBK) cells is 3 % and 7% at peptide concentrations of 12.5 and 100  μg/ml	Not found	29364903	PLoS One. 2018 Jan 24;13(1):e0190778. 	Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.	Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)O
DRAMP20889	VYPFMWGGAYCFCKAKLV	18	VT18-KKLV (VT18 peptide derivative)	No entry found	Derived from VT18	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Double-stranded 	Not found		Function: Antibacterial activity against the Gram-positive bacteria. 	[Ref.29277569] Gram-positive bacteria: Streptococcus pneumoniae ATCC 700669 (MIC=52 μg/ml), Streptococcus pneumoniae ATCC 49619  (MIC=105 μg/ml), Streptococcus pneumoniae ATCC 700677 (MIC=76 μg/ml)	[Ref.29277569] 0.5% hemolysis at 5 μg/ml, 1.0% hemolysis at 10μg/ml, 2.0% hemolysis at 20 μg/ml, 2.5% hemolysis at 50 μg/ml, 3.0% hemolysis at 100 μg/ml, 5.0% hemolysis at 250 μg/ml, 7.0% hemolysis at 500 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.29277569] The cell viability of NL-20 normal lung cell line is not affected (<20%) below 50 μg/ml.## The cell viability of NL-20 is 82%, 44%, 17% and 13% at peptide concentrations of 50, 100, 250 and 500 μg/ml.	Not found	29277569	Biochimie. 2018 Mar;146:139-147.	Yang R, Zhang G, Zhang F, Li Z, Huang C.	Membrane permeabilization design of antimicrobial peptides based on chikungunya virus fusion domain scaffold and its antibacterial activity against gram-positive Streptococcus pneumoniae in respiratory infection.	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP20890	VYPFCWGGAYAFCKAKLV	18	VT18-CAKKLV (VT18 peptide derivative)	No entry found	Derived from VT18	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Double-stranded 	Not found		Function: Antibacterial activity against the Gram-positive bacteria. 	[Ref.29277569] Gram-positive bacteria: Streptococcus pneumoniae ATCC 700669 (MIC=58 μg/ml), Streptococcus pneumoniae ATCC 49619  (MIC=90 μg/ml), Streptococcus pneumoniae ATCC 700677 (MIC=72 μg/ml)	[Ref.29277569] 0.5% hemolysis at 5 μg/ml, 1.0% hemolysis at 10μg/ml, 1.5% hemolysis at 20 μg/ml, 2.0% hemolysis at 50 μg/ml, 3.8% hemolysis at 100 μg/ml, 4.5% hemolysis at 250 μg/ml, 6.8% hemolysis at 500 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.29277569] The cell viability of NL-20 normal lung cell line is not affected (<20%) below 50 μg/ml.## The cell viability of NL-20 is 86%, 48%, 19% and 11% at peptide concentrations of 50, 100, 250 and 500 μg/ml.	Not found	29277569	Biochimie. 2018 Mar;146:139-147.	Yang R, Zhang G, Zhang F, Li Z, Huang C.	Membrane permeabilization design of antimicrobial peptides based on chikungunya virus fusion domain scaffold and its antibacterial activity against gram-positive Streptococcus pneumoniae in respiratory infection.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP20891	VYPFCWGGAYAFCKAKLV	18	cVT18-CAKKLV (VT18 peptide derivative)	No entry found	Derived from VT18	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Double-stranded 	Not found		Function: Antibacterial activity against the Gram-positive bacteria. The positions 4 and 13 of cVT18-CAKKLV have a  disulfide bond to form a cyclic peptide.	[Ref.29277569] Gram-positive bacteria: Streptococcus pneumoniae ATCC 700669 (MIC=35 μg/ml), Streptococcus pneumoniae ATCC 49619  (MIC=67 μg/ml), Streptococcus pneumoniae ATCC 700677 (MIC=49 μg/ml)	[Ref.29277569] 0.5% hemolysis at 5 μg/ml, 0.5% hemolysis at 10 μg/ml, 0.6% hemolysis at 20 μg/ml, 1.0% hemolysis at 50 μg/ml, 1.9% hemolysis at 100 μg/ml, 2.5% hemolysis at 250 μg/ml, 3.5% hemolysis at 500 μg/ml against human red blood cell	Cyclic	Free	Amidation	Disulfide bond between Cys5 and Cys13.	L	[Ref.29277569] The cell viability of NL-20 normal lung cell line is not affected (<20%) below 50 μg/ml.## The cell viability of NL-20 is 81%, 73%, 34% and 19% at peptide concentrations of 50, 100, 250 and 500 μg/ml.	Not found	29277569	Biochimie. 2018 Mar;146:139-147.	Yang R, Zhang G, Zhang F, Li Z, Huang C.	Membrane permeabilization design of antimicrobial peptides based on chikungunya virus fusion domain scaffold and its antibacterial activity against gram-positive Streptococcus pneumoniae in respiratory infection.	
DRAMP20892	FIAAIIGGLFSAGKAIHRLIRRRRR	25	H3A/H4A	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive bacteria. Antifungal activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=32 μg/ml; MBC=32 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=128 μg/ml; MBC=256 μg/ml);##Fungi: Candida albicans (MIC=512 μg/ml; MBC=512 μg/ml)	[Ref.29040295] 7% haemolysis at 1.56 μg/ml, 10% haemolysis at 3.13 μg/ml, 70% haemolysis at 6.25 μg/ml, 95% haemolysis at 12.50 μg/ml, 98% haemolysis at 25.00 μg/ml, 100% haemolysis at 50.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP20893	FIHHIIGGLFSAGKAAHRLIRRRRR	25	I16A	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=64 μg/ml; MBC=128 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=64 μg/ml; MBC=512 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 10% haemolysis at 6.25 μg/ml, 20% haemolysis at 12.50 μg/ml, 35% haemolysis at 25.00 μg/ml, 80% haemolysis at 50.00 μg/ml, 95% haemolysis at 100.00 μg/ml, 100% haemolysis at 200.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP20894	FIHHIIGGLFSAGKAIHRHHRRRRR	25	L19H/I20H	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=128 μg/ml; MBC=512 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 10% haemolysis at 6.25 μg/ml, 13% haemolysis at 12.50 μg/ml, 16% haemolysis at 25.00 μg/ml, 40% haemolysis at 50.00 μg/ml, 85% haemolysis at 100.00 μg/ml, 100% haemolysis at 200.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP20895	AAHHIIGGLFSAGKAIHRLIRRRRR	25	F1A/I2A	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found	5H2S	Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=128 μg/ml; MBC=256 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC=256 μg/ml);##Fungi: Candida albicans (MIC=64 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 10% haemolysis at 12.50 μg/ml,  15% haemolysis at 25.00 μg/ml,  30% haemolysis at 50.00 μg/ml,  90% haemolysis at 100.00 μg/ml,  95% haemolysis at 200.00 μg/ml,  100% haemolysis at 400.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)N)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP20896	FIHHIIGGAASAGKAIHRLIRRRRR	25	L9A/F10A	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Antifungal activity.	[Ref.29040295] Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 5% haemolysis at 25.00 μg/ml,  10% haemolysis at 50.00 μg/ml,  30% haemolysis at 100.00 μg/ml,  95% haemolysis at 200.00 μg/ml,  100% haemolysis at 400.00 μg/ml,  100% haemolysis at 800.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP20897	FIHHIIGGLFSAGKARHRLIRRRRR	25	I16R	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Antifungal activity.	[Ref.29040295] Fungi: Candida albicans (MIC=128 μg/ml; MBC=256 μg/ml)	[Ref.29040295] 10% haemolysis at 25.00 μg/ml,  20% haemolysis at 50.00 μg/ml,  30% haemolysis at 100.00 μg/ml,  75% haemolysis at 200.00 μg/ml,  95% haemolysis at 400.00 μg/ml,  100% haemolysis at 800.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP20898	FIHHIIGGLFSAGKAEHRLIRRRRR	25	I16E	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic	Not found	Not found		Function: Antifungal activity.	[Ref.29040295] Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 5% haemolysis at 25.00 μg/ml,  15% haemolysis at 50.00 μg/ml,  40% haemolysis at 100.00 μg/ml,  65% haemolysis at 200.00 μg/ml,  85% haemolysis at 400.00 μg/ml,  90% haemolysis at 800.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP20899	FIHHAAGGLFSAGKAIHRLIRRRRR	25	I5A/I6A	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-negative bacteria. Antifungal activity.	[Ref.29040295] Gram-negative bacteria: Pseudomonas aeruginosa (MIC=512 μg/ml; MBC=512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 5% haemolysis at 25.00 μg/ml,  7% haemolysis at 50.00 μg/ml,  10% haemolysis at 100.00 μg/ml,  40% haemolysis at 200.00 μg/ml,  80% haemolysis at 400.00 μg/ml,  100% haemolysis at 800.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP20900	FIHHIIGGLFSIGKIIHRLIRRRRR	25	A12I/A15I	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml; MBC=64 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=64 μg/ml; MBC=256 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=512 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 0% haemolysis at 0.20 μg/ml,  5% haemolysis at 0.39 μg/ml,  25% haemolysis at 0.78 μg/ml,  85% haemolysis at 1.56 μg/ml,  95% haemolysis at 3.13 μg/ml,  100% haemolysis at 6.25 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP20901	FIHHIIGGLFSVGKHIHRLIRRRRR	25	A12V/A15H	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml; MBC=16 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=32 μg/ml; MBC=64 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=128 μg/ml; MBC=128 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 0% haemolysis at 0.78 μg/ml,  10% haemolysis at 1.56 μg/ml,  55% haemolysis at 3.13 μg/ml,  85% haemolysis at 6.25 μg/ml,  98% haemolysis at 12.50 μg/ml,  100% haemolysis at 25.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP20902	FIHHIIGGLFSVGKHIHSLIHRRRR	25	VHSH	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-positive bacteria. Antifungal activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml; MBC=16 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=16 μg/ml; MBC=32 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 5% haemolysis at 1.56 μg/ml,  5% haemolysis at 3.13 μg/ml,  10% haemolysis at 6.25 μg/ml,  35% haemolysis at 12.50 μg/ml,  55% haemolysis at 25.00 μg/ml,  85% haemolysis at 50.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP20903	FIHHIIGGLFSAGKAIHRLIRRR	23	dC2	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml; MBC=32 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=32 μg/ml; MBC=32 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=512 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 2% haemolysis at 3.13 μg/ml,  5% haemolysis at 6.25 μg/ml,  25% haemolysis at 12.50 μg/ml,  65% haemolysis at 25.00 μg/ml,  90% haemolysis at 50.00 μg/ml,  100% haemolysis at 100.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP20904	FIHHIIGGLFSAGKAIHSLIHRRRR	25	R18S/R21H	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=32 μg/ml; MBC=64 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=32 μg/ml; MBC=32 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC=512 μg/ml);##Fungi: Candida albicans (MIC=256 μg/ml; MBC=512 μg/ml)	[Ref.29040295] 8% haemolysis at 6.25 μg/ml,  10% haemolysis at 12.50 μg/ml,  15% haemolysis at 25.00 μg/ml,  40% haemolysis at 50.00 μg/ml,  80% haemolysis at 100.00 μg/ml,  100% haemolysis at 200.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP20905	FIHHIIGGLFSAGKAIHRLIR	21	dC4	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive bacteria. Antifungal activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=64 μg/ml; MBC=128 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=256 μg/ml; MBC=256 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=256 μg/ml)	[Ref.29040295] 5% haemolysis at 12.50 μg/ml,  10% haemolysis at 25.00 μg/ml,  45% haemolysis at 50.00 μg/ml,  80% haemolysis at 100.00 μg/ml,  100% haemolysis at 200.00 μg/ml,  100% haemolysis at 400.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP20906	HHIIGGLFSAGKAIHRLIRRRRR	23	dN2	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=512 μg/ml; MBC=512 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=512 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 5% haemolysis at 12.50 μg/ml,  5% haemolysis at 25.00 μg/ml,  20% haemolysis at 50.00 μg/ml,  65% haemolysis at 100.00 μg/ml,  90% haemolysis at 200.00 μg/ml,  100% haemolysis at 400.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP20907	IIGGLFSAGKAIHRLIRRRRR	21	dN4	No entry found	Derived from TP4	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=128 μg/ml; MBC=128 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=64 μg/ml; MBC=256 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=64 μg/ml; MBC=128 μg/ml)	[Ref.29040295] 10% haemolysis haemolysis at 12.50 μg/ml,  12% haemolysis haemolysis at 25.00 μg/ml,  20% haemolysis haemolysis at 50.00 μg/ml,  35% haemolysis haemolysis at 100.00 μg/ml,  75% haemolysis haemolysis at 200.00 μg/ml,  100% haemolysis haemolysis at 400.00 μg/ml,  100% haemolysis haemolysis at 800.00 μg/ml against mouse red blood cells	Linear	Free	Free		L	[Ref.29040295] No cytotoxicity information found	Not found	29040295	PLoS One. 2017 Oct 17;12(10):e0186442. 	Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.	Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP20908	FLHFLHHLF	9	Ctry2459-H3 (Ctry2459 peptide derivative, His-rich)	No entry found	Derived from the peptide Ctry2459	Not found	Synthetic construct(from a scorpion venom peptide library)	Antimicrobial, Antiviral	Synthetic	Not found	Not found		Function: Inhibits hepatitis C virus(HCV) infection via inactivating infectious viral particle.  However, it cannot suppress established infection because of the poor cellular uptake and restriction of endosomes.	[Ref.23415044] Virus: Hepatitis C virus ( EC50 = 0.85 μg/ml ).##Cytotoxic: Huh7.5.1 cells (CC50>500 μg/ml)	[Ref.23415044] HC50 = 416.4 μg/ml against human red blood cells.	Linear	Free	Amidation		L	[Ref.23415044] CC50>500 μg/ml against Huh7.5.1 cells 	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP20909	FLGFLHHLF	9	Ctry2459-H2 (Ctry2459 peptide derivative, His-rich)	No entry found	Derived from the peptide Ctry2460	Not found	Synthetic construct( from a scorpion venom peptide library)	Antimicrobial, Antiviral	Synthetic	Not found	Not found		Function: Inhibits hepatitis C virus(HCV) infection via inactivating infectious viral particle.  However, it cannot suppress established infection because of the poor cellular uptake and restriction of endosomes.	[Ref.23415044] Virus: Hepatitis C virus ( EC50 = 1.08 μg/ml ).##Cytotoxic: Huh7.5.1 cells (CC50>500 μg/ml)	[Ref.23415044] HC50 = 203.3 μg/ml against human red blood cells.	Linear	Free	Amidation		L	[Ref.23415044] CC50>500 μg/ml against Huh7.5.1 cells 	Not found	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP20910	FLGGLIKPWWPWRR	14	RN7-IN7(designed based on indolicidin and ranalexin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.	[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=31.25μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=62.5μg/ml), Acinetobacter baumanii ATCC 15308(MIC=125μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=31.25-62.5μg/ml), Staphylococcus aureus ATCC 25923(MIC=31.25μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=31.25μg/ml), Enterococcus cloacae(MIC>250μg/ml), 	[Ref.26046345] The hemolytic activities of RN7-IN7 is 0.0% at 15.62μg/ml against human RBCs.	Linear	Free	Amidation		L	[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 62.5 μg/ml. The cell viability of NL-20 is 95%, 92% and 6% at peptide concentrations of 62.5, 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected(	Not found	26046345	PLoS One. 2015 Jun 5;10(6):e0128532. 	Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.	Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP20911	CMSTRGDQARKICE	14	Sm-AMP-X2	U4N938	Belongs to the 	sm-amp-x	Stellaria media (Common chickweed) 	Antimicrobial, Antifungal	protein level	Not found	Not found		Function: The mature peptide has antifungal activities	[Ref.24081691] Fungus: Alternaria alternata(IC50>32.0μM), Aspergillus niger(IC50=16.9±1.9μM), Bipolaris sorokiniana(IC50>32.0μM), Botrytis cinerea(IC50>32.0μM), Fusarium oxysporum(IC50=25.0±3.0μM), Fusarium solani(IC50=22.5±3.1μM), Phytophthora infestans(IC50>32.0μM), Pythium ultimum(IC50>32.0μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys1 and Cys13	L	[Ref.24081691] No cytotoxicity information found	Not found	24081691	Plant Mol Biol. 2014 Jan;84(1-2):189-202. doi: 10.1007/s11103-013-0127-z. Epub 2013 Oct 1.	Slavokhotova AA, Rogozhin EA, Musolyamov AK, Andreev YA, Oparin PB, Berkut AA, Vassilevski AA, Egorov TA, Grishin EV, Odintsova TI.	Novel antifungal 	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC1=O
DRAMP20912	FLGGLIKKWPWWPWRR	16	RN7-IN9(designed based on indolicidin and ranalexin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.	[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=7.81μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=31.25μg/ml), Acinetobacter baumanii ATCC 15308(MIC=31.25μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=7.81–15.62μg/ml), Staphylococcus aureus ATCC 25923(MIC=7.81μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=7.81μg/ml), Enterococcus cloacae(MIC>250μg/ml), 	[Ref.26046345] The hemolytic activities of RN7-IN7 is 0.0% at 15.62μg/ml against human RBCs.	Linear	Free	Amidation		L	[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 31.25 μg/ml. The cell viability of NL-20 is 51%, 13% and 7% at peptide concentrations of 62.5, 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected	Not found	26046345	PLoS One. 2015 Jun 5;10(6):e0128532.	Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.	Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP20913	AIHDILKYGKPS	12	Myxinidin (G1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria.	[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC =10 microM), S. Salmonella typhimurium (MIC =3 microM), Klebsiella pneumoniae (MIC >50 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =10 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 3%, 5% and 10% at peptide concentrations of 1, 20, 50, 100 and 200 μM.	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. 	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC
DRAMP20914	GAHDILKYGKPS	12	Myxinidin (I2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.	[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC >50 microM), S. Salmonella typhimurium (MIC >50 microM), Klebsiella pneumoniae (MIC >50 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =30 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 6%, 6.6% and 15.5% at peptide concentrations of 1, 20, 50, 100 and 200 μM.	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. 	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O
DRAMP20915	GIADILKYGKPS	12	Myxinidin (H3)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.	[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC =15 microM), S. Salmonella typhimurium (MIC =10 microM), Klebsiella pneumoniae (MIC =30 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =20 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 4.9%,12%  and 20% at peptide concentrations of 1, 20, 50, 100 and 200 μM.	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. 	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC
DRAMP20916	GIHAILKYGKPS	12	Myxinidin (D4)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.	[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC >50 microM), S. Salmonella typhimurium (MIC >50 microM), Klebsiella pneumoniae (MIC =30 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =5 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 10%, 29.9%  and 34.9% at peptide concentrations of 1, 20, 50, 100 and 200 μM.	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. 	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC
DRAMP20917	GIHDALKYGKPS	12	Myxinidin (I5)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.	[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC =20 microM), Pseudomonas aeruginosa (MIC =10 microM), S. Salmonella typhimurium (MIC =4 microM), Klebsiella pneumoniae (MIC =20 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =20 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 4%, 11.7%  and 20% at peptide concentrations of 1, 20, 50, 100 and 200 μM.	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90.	Cantisani M1, Finamore E2, Mignogna E2, Falanga A3, Nicoletti GF4, Pedone C3, Morelli G3, Leone M5, Galdiero M6, Galdiero S7.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O
DRAMP20918	GIHDIAKYGKPS	12	Myxinidin (L6)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.	[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC >50 microM), S. Salmonella typhimurium (MIC >50 microM), Klebsiella pneumoniae (MIC =20 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =5 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 8%, 19.9%  and 29.9% at peptide concentrations of 1, 20, 50, 100 and 200 μM.	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90.	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC
DRAMP20919	GIHDILAYGKPS	12	Myxinidin (K7)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.	[Ref.2495783[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC =15 microM), Pseudomonas aeruginosa (MIC =15 microM), S. Salmonella typhimurium (MIC =15 microM), Klebsiella pneumoniae (MIC =20 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =10 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 2%, 5.7%  and 14% at peptide concentrations of 1, 20, 50, 100 and 200 μM.	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. 	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC
DRAMP20920	GIHDILKAGKPS	12	Myxinidin (Y8)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.	[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC =20 microM), Pseudomonas aeruginosa (MIC >50 microM), S. Salmonella typhimurium (MIC >50 microM), Klebsiella pneumoniae (MIC =20 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =10 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 3%  and 10% at peptide concentrations of 1, 20, 50, 100 and 200 μM.	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. 	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC
DRAMP20921	GIHDILKYAKPS	12	Myxinidin (G9)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.	[Ref.24957834] Gram-negative[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC =5 microM), Pseudomonas aeruginosa (MIC =15 microM), S. Salmonella typhimurium (MIC =10 microM), Klebsiella pneumoniae (MIC =10 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =10 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 0.7%, 4.9%  and 15% at peptide concentrations of 1, 20, 50, 100 and 200 μM.	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. 	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC
DRAMP20922	GIHDILKYGAPS	12	Myxinidin (K10)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.	[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC =15 microM), Pseudomonas aeruginosa (MIC >50 microM), S. Salmonella typhimurium (MIC >50 microM), Klebsiella pneumoniae (MIC =10 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =20 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 2%, 7%  and 12% at peptide concentrations of 1, 20, 50, 100 and 200 μM.	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. 	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC
DRAMP20923	GIHDILKYGKAS	12	Myxinidin (P11)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.	[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC =30 microM), S. Salmonella typhimurium (MIC =10 microM), Klebsiella pneumoniae (MIC =30 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =10 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 4.9%, 12%  and 9.9% at peptide concentrations of 1, 20, 50, 100 and 200 μM.	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. 	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC
DRAMP20924	GIHDILKYGKPA	12	Myxinidin (S12)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.	[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC >50 microM), S. Salmonella typhimurium (MIC >50 microM), Klebsiella pneumoniae (MIC =30 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC >50 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 7%, 14.9%  and 19.9% at peptide concentrations of 1, 20, 50, 100 and 200 μM.	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. 	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(N)=O)[C@H](C)CC
DRAMP20925	GIRDILKYGKPS	12	MH3R	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.	[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC =5 microM), Pseudomonas aeruginosa (MIC =20 microM), S. Salmonella typhimurium (MIC =5 microM), Klebsiella pneumoniae (MIC =5 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =10 microM)	[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.	Linear	Free	Amidation		L	[Ref.24957834] No cytotoxicity information found	Not found	24957834	Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90.	Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.	Structural insights into and activity analysis of the antimicrobial peptide myxinidin.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC
DRAMP20926	LLPWKWPWWKWRR	13	IN1(designed based on indolicidin and ranalexin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.	[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=31.25μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=31.25μg/ml), Acinetobacter baumanii ATCC 15308(MIC>250μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=31.25–62.5μg/ml), Staphylococcus aureus ATCC 25923(MIC=31.25μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=31.25μg/ml), Enterococcus cloacae(MIC>250μg/ml), 	[Ref.26046345] The hemolytic activities of IN1 is 3.6% at 250μg/ml against human RBCs.	Linear	Free	Amidation		L	[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 62.5 μg/ml. The cell viability of NL-20 is 37% and 17% at peptide concentrations of 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected (<10%) bel	Not found	26046345	PLoS One. 2015 Jun 5;10(6):e0128532. 	Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.	Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.	CC(C)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP20927	RRPWRWPWWPWRR	13	IN2(designed based on indolicidin and ranalexin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.	[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=31.25μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=31.25μg/ml), Acinetobacter baumanii ATCC 15308(MIC>250μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=31.25–62.5μg/ml), Staphylococcus aureus ATCC 25923(MIC=31.25μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=31.25μg/ml), Enterococcus cloacae(MIC>250μg/ml), 	[Ref.26046345] IN2 showed 15.39% hemolytic activity at concentration of 250μg/ml against human RBCs.	Linear	Free	Amidation		L	[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 62.5 μg/ml. The cell viability of NL-20 is 40% and 19% at peptide concentrations of 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected (<10%) bel	Not found	26046345	PLoS One. 2015 Jun 5;10(6):e0128532. 	Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.	Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP20928	RRPWRWPRWPWRR	13	IN3(designed based on indolicidin and ranalexin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.	[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=31.25μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=31.25μg/ml), Acinetobacter baumanii ATCC 15308(MIC>250μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=62.5μg/ml), Staphylococcus aureus ATCC 25923(MIC=31.25μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=62.5μg/ml), Enterococcus cloacae(MIC>250μg/ml), 	[Ref.26046345] The hemolytic activities of IN3 is 2.39% at 250μg/ml against human RBCs.	Linear	Free	Amidation		L	[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 62.5 μg/ml. The cell viability of NL-20 is 93% and 26% at peptide concentrations of 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected (<10%) bel	Not found	26046345	PLoS One. 2015 Jun 5;10(6):e0128532. 	Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.	Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP20929	FLGGLIKWWPWRR	13	RN7-IN6(designed based on indolicidin and ranalexin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.	[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=7.81μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=31.25μg/ml), Acinetobacter baumanii ATCC 15308(MIC>31.25μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=7.81–15.62μg/ml), Staphylococcus aureus ATCC 25923(MIC=7.81μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=7.81μg/ml), Enterococcus cloacae(MIC>250μg/ml), 	[Ref.26046345] The hemolytic activities of RN7-IN6 is 0.0% at 15.62μg/ml against human RBCs. 	Linear	Free	Amidation		L	[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 31.25 μg/ml. The cell viability of NL-20 is 70%, 6% and 8% at peptide concentrations of 62.5, 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected 	Not found	26046345	PLoS One. 2015 Jun 5;10(6):e0128532. 	Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.	Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP20930	KKLFKKILKYLA	12	BP100-Ala-NH-C16H33	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.29750913] Gram-negative bacteria:Escherichia coli(ATCC 25922)(MIC=16μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=8μM);Bacillus subtilis(PY79)(MIC=8μM)	[Ref.29750913] C50 =6.3μM against human red blood cells	Linear	Free	Amidation and Acylation (-NH-C₁₆H₃₃, conjugated with a n‑hexadecyl acyl chain)		L	[Ref.29750913] No cytotoxicity information found	Not found	29750913	Biochim Biophys Acta. 2018 Aug;1860(8):1502-1516. 	Carretero GPB, Saraiva GKV, Cauz ACG, Rodrigues MA, Kiyota S, Riske KA, Dos Santos AA, Pinatto-Botelho MF, Bemquerer MP, Gueiros-Filho FJ, Chaimovich H, Schreier S, Cuccovia IM.	Synthesis, biophysical and functional studies of two BP101 analogues modified by a hydrophobic chain and a cyclic peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O
DRAMP20932	GILGKLWEGVKSIF	14	Hp1404	No entry found	Melittin	Not found	Heterometrus petersii	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	Alpha helix	The peptide adopts an alpha-helical conformation in the membrane-mimicking environments and the presence of PE:PG and PC:CH liposomes, adopts a random coil conformation when mixed with PC:CH:SM liposomes. 		Function: Antibacterial activity against Gram-negative bacteria. 	[Ref.29379033] Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=12.5 μM), Pseudomonas aeruginosa 138 (MIC=12.5 μM), Pseudomonas aeruginosa 431 (MIC=12.5 μM), Pseudomonas aeruginosa 434 (MIC=12.5 μM), Pseudomonas aeruginosa 557 (MIC=6.25 μM), Pseudomonas aeruginosa 559 (MIC=25 μM), Pseudomonas aeruginosa 778 (MIC=12.5 μM), Pseudomonas aeruginosa 1034 (MIC=6.25 μM), Pseudomonas aeruginosa 1162 (MIC=12.5 μM), Pseudomonas aeruginosa 3290 (MIC=12.5 μM), Pseudomonas aeruginosa 3399 (MIC=6.25 μM), Pseudomonas aeruginosa 3543 (MIC=6.25 μM), Pseudomonas aeruginosa 3592 (MIC=6.25 μM), Pseudomonas aeruginosa 3904 (MIC=6.25 μM), Pseudomonas aeruginosa 4007 (MIC=25 μM), Pseudomonas aeruginosa 4319 (MIC=12.5 μM), Pseudomonas aeruginosa 4891 (MIC=6.25 μM), Pseudomonas aeruginosa 5018 (MIC=12.5 μM), Pseudomonas aeruginosa 671973 (MIC=3.13 μM)	[Ref.29379033]Hemolysis 2% at 12.5 μM against mouse red blood cell, hemolysis 11% at 25.0 μM against mouse red blood cell, hemolysis 55% at 50.0 μM against mouse red blood cell, hemolysis 92% at 100.0 μM against mouse red blood cell, hemolysis 100% at 200.0 μM against mouse red blood cell	Linear	Free	Amidation		L	[Ref.29379033] The cell survial  against HaCaT cells is 85%, 26%, 5% and 6% at peptide concentrations of 25, 50, 100 and 200 μM	Lipopolysaccharide (LPS)-binding	29379033	Sci Rep. 2018 Jan 29;8(1):1763. 	Kim MK, Kang HK, Ko SJ, Hong MJ, Bang JK, Seo CH, Park Y.	Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)C(C)C
DRAMP20933	FFSLIPSLVGGLISAFK	17	Stigmurin	No entry found	Derived from scorpion venom peptide	Not found	Tityus stigmurus	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal, Antiparasitic, Antiproliferative	Transcript level	Alpha helix 	Not found		Function: Antibacterial activity against the Gram-positive bacteria. Antifungal activity against yeasts.Antiparasitic Activity against epimastigote forms of Trypanosoma cruzi. Antiproliferative Activity against HeLa cells.	[Ref.29670004] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=9.38 μM), Staphylococcus epidermidis ATCC 122225 (MIC=9.38 μM);##yeasts: Candida albicans ATCC 90028 (MIC=37.5 μM);##Stigmurin inhibit 90% of the epimastigote forms of Trypanosoma cruzi growth at 25 ?M;##HeLa cell line: IC50=7.98 μM	[Ref.29670004]Hemolysis 0% at 1.17 μM, hemolysis 1% at 2.34 μM, hemolysis 1% at 4.69 μM, hemolysis 0% at 9.38 μM, hemolysis 1% at 18.75 μM, hemolysis 1% at 37.50 μM, hemolysis 3% at 75.00 μM against human red blood cell	Linear	Free	Amidation		L	[Ref.29670004] The cell viability of HeLa cell lines is 56%, 66%, 66%, 81%, 78%, 66% and 30% at peptide concentrations of 2, 4, 8, 10, 15,  20 and 40 μM. ##The cell viability of 3T3 cell lines is 81%, 63%, 51%, 29%, 27%, 19% and 15% at peptide concentra	Not found	29670004	Toxins (Basel). 2018 Apr 18;10(4). pii: E161.	Parente AMS, Daniele-Silva A, Furtado AA, Melo MA, Lacerda AF, Queiroz M, Moreno C, Santos E, Rocha HAO, Barbosa EG, Carvalho E, Silva-Júnior AA, Silva MS, Fernandes-Pedrosa MF.	Analogs of the Scorpion Venom Peptide Stigmurin: Structural Assessment, Toxicity, and Increased Antimicrobial Activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP20934	MNFNKFFVLFALIMVAVVGQSEAGWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKG	63	Lucilin Peptide	D7RT24	Cecropins	ATGAATTTTAATAAATTTTT	L. eximia maggots	Antimicrobial, Antibacterial, Anti-Gram-, Wound-healing	Transcript level	Alpha helix 	Not found		Function: Antibacterial activity against the Gram-negative bacteria. Immunomodulatory activity. Decreasing the TNF-alpha production in PBMCs and inducing cellular migration in human keratinocytes.	[Ref.29890152] Gram-negative bacteria: Escherichia coli DH10B (MIC=7.8 μg/ml; MBC=7.8 μg/ml), Escherichia coli ESBL (MIC=15.6 μg/ml; MBC=15.6 μg/ml), Enterobacter cloacae (MIC=125 μg/ml; MBC=125 μg/ml)	[Ref.29890152]Hemolysis 0% at 0.24 μg/ml, hemolysis 0% at 0.49 μg/ml, hemolysis 0% at 0.98 μg/ml, hemolysis 0% at 1.95 μg/ml, hemolysis 0% at 3.91 μg/ml, hemolysis 0% at 7.81 μg/ml, hemolysis 0% at 15.60 μg/ml, hemolysis 0% at 31.00 μg/ml, hemolysis 0% at 63.00 μg/ml, hemolysis 0% at 125.00 μg/ml, hemolysis 0% at 250.00 μg/ml against human red blood cell	Linear	Free	Free		L	[Ref.29890152] The peptide did not show cytotoxic activities against Vero cells. ##The peptide showed a toxic concentration from 62.5 μg/ml with IC50 of 58.30 μg/ml against PBMCs	Not found	29890152	Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8.	Téllez GA, Zapata JA, Toro LJ, Henao DC, Bedoya JP, Rivera JD, Trujillo JV, Rivas-Santiago B, Hoyos RO, Castano JC.	Identification, Characterization, Immunolocalization, and Biological Activity of Lucilin Peptide.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP20935	GFGMALKLLKKVL	13	Macropin 1(solitary bee, insects, animals)	C0HL98	Not found	Not found	Macropis fulvipes (Solitary bee) (Megilla fulvipes)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix,random coil	Not found		[Ref.24616110] Antimicrobial peptide active against Gram-positive bacteria like B.subtilis, S.aureus and L.monocytogenes as well as against Gram-negative bacteria like E.coli and P.aeruginosa with minimum inhibitory concentrations (MIC) between 1.3 ?M and 35 ?M.Active against fungus C.albicans (MIC=6.3 ?M).Has little hemolytic activity . Adopts an alpha-helical structure in a membrane mimic environment. [Ref.29185466] Acts by disrupting membranes and bacterial cell wall structures.Binds to peptidoglycan and lipopolysaccharide (LPS)	[Ref.24616110] Gram-negative bacteria: Escherichia coli(MIC=3.0 μM), Pseudomonas aeruginosa(MIC=35.0 μM);## Gram-positive bacteria: Bacillus subtilis (MIC=1.3 μM), Staphylococcus aureus(MIC=3.7 μM);## Fungus: Candida albicans (MIC=6.3 μM). ##[Ref.29185466]Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (MIC=3.13 μM), Staphylococcus aureus ATCC 29213 (MIC=3.13 μM), Listeria monocytogenes KCTC 3710 (MIC=25 μM);##Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=6.25 μM), Pseudomonas aeruginosa ATCC 15692 (MIC=6.25 μM), Escherichia coli ATCC 25922 (MIC=6.25 μM)	[Ref.24616110] LC50=160 μM against human red blood cells. ##[Ref.29185466]5% hemolysis at 25 μM against red blood cells, 93% hemolysis at 50 μM against red blood cells	Linear	Free	Amidation		L	[Ref.29185466] In HaCaT cells, Macropin produced cell survival rates of 82% and 41% at  peptide concentrations of 25 and 50 μM.## In Raw cells, Macropin produce cell survival rates of 41% and 0% at peptide concentrations of 25 and 50 μM.	Not found	24616110##29185466	J Pept Sci. 2014 Jun;20(6):375-84. doi: 10.1002/psc.2625. Epub 2014 Mar 11.## Sci Rep. 2017 Nov 29;7(1):16580. doi: 10.1038/s41598-017-16784-6.	Monincová L, Veverka V, Slaninová J, Buděšínský M, Fučík V, Bednárová L, Straka J, Ceřovský V.## Ko SJ, Kim MK, Bang JK, Seo CH, Luchian T, Park Y.	Structure-activity study of macropin, a novel antimicrobial peptide from the venom of solitary bee Macropis fulvipes (Hymenoptera: Melittidae).## Macropis fulvipes Venom component Macropin Exerts its Antibacterial and Anti-Biofilm Properties by Damaging the Plasma Membranes of Drug Resistant Bacteria.	CSCC[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP20936	RVKRFKKFFRKIKKGFRKIFKKTKIFIG	28	ΔPb-CATH1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.	[Ref.28630199] Gram-positive bacteria: Staphylococcus aureus (ATCC 29213)(MIC>128 μg/ml); B. cereus ATCC 10876 (MIC=46 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=3 μg/ml), S. typhimurium ATCC 14028 (MIC=1.5 μg/ml)	[Ref.28630199]1.4 ± 0.4% hemolysis at 8 μg/ml, 5.1 ± 0.5%  hemolysis at 16 μg/ml, 7.3 ± 0.6%  hemolysis at 32 μg/ml, 12.2 ± 0.7% hemolysis at 64 μg/ml against chicken red blood cells	Linear	Free	Free		L	[Ref.28630199] No cytotoxicity information found	Not found	28630199	Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00530-17.	Kim D, Soundrarajan N, Lee J, Cho HS, Choi M, Cha SY, Ahn B, Jeon H, Le MT, Song H, Kim JH, Park C.	Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)NCC(=O)O
DRAMP20937	HRVKRNGFRKFMRRLKKFFAGG	22	Pb-CATH3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.	[Ref.28630199] Gram-positive bacteria: B. cereus ATCC 10876 (MIC=32 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), S. typhimurium ATCC 14028 (MIC=2 μg/ml);##Clinical isolates: Escherichia coli (4.7 μg/ml), K. pneumoniae (1.18 μg/ml)	[Ref.28630199]0% hemolysis at 8 μg/ml, 1.7 ± 0.5%  hemolysis at 16 μg/ml, 3.1 ± 0.5%  hemolysis at 32 μg/ml, 4.0 ± 0.2% hemolysis at 64 μg/ml against chicken red blood cells	Linear	Free	Free		L	[Ref.28630199] No cytotoxicity information found	Not found	28630199	Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00530-17.	Kim D, Soundrarajan N, Lee J, Cho HS, Choi M, Cha SY, Ahn B, Jeon H, Le MT, Song H, Kim JH, Park C.	Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)O
DRAMP20938	RLLRKFFRKLKKSV	14	Cbf-14	No entry found	Belongs to cathelicidin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix,beta-sheet,beta-turn,random coil	The percentages of possible occurring conformations involved helix, beta, turn and random are also quantified in various solutions 		Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.	[Ref.28522372]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=64 μg/ml), Staphylococcus aureus (MIC=32 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=32 μg/ml), Escherichia coli (MIC=32 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa (MIC=32 μg/ml);##Yeasts: Candida albicans ATCC 10231 (MIC=64 μg/ml), Candida albicans (MIC=64 μg/ml)	[Ref.28522372]2% hemolysis at 800 μg/ml against mice red blood cells	Linear	Free	Free		L	The percentages of possible occurring conformations involved helix, beta, turn and random are also quantified in various solutions 	Not found	28522372	Eur J Pharm Sci. 2017 Jul 15;105:169-177.	Kang W, Liu H, Ma L, Wang M, Wei S, Sun P, Jiang M, Guo M, Zhou C, Dou J.	Effective antimicrobial activity of a peptide mutant Cbf-14-2 against penicillin-resistant bacteria based on its unnatural amino acids	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP20939	RLLRKFFRKLKKSV	14	D-Cbf-14	No entry found	Belongs to cathelicidin	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic	Alpha helix,beta-sheet,beta-turn,random coil	The percentages of possible occurring conformations involved helix, beta, turn and random are also quantified in various solutions 		Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. All amino acids in the sequence are D-type.	[Ref.28522372] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=64 μg/ml), Staphylococcus aureus (MIC=32 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=32 μg/ml), Escherichia coli (MIC=32 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Pseudomonas aeruginosa (MIC=64 μg/ml);##Yeasts: Candida albicans ATCC 10231 (MIC=64 μg/ml), Candida albicans (MIC=64 μg/ml)	[Ref.28522372]1% hemolysis at 800 μg/ml against mice red blood cells	Linear	Free	Free		D	[Ref.28522372] In mice spleen cells, the peptide produced cell viability of 97% at 800 μg/ml	Not found	28522372	Eur J Pharm Sci. 2017 Jul 15;105:169-182.	Kang W, Liu H, Ma L, Wang M, Wei S, Sun P, Jiang M, Guo M, Zhou C, Dou J.	Effective antimicrobial activity of a peptide mutant Cbf-14-3 against penicillin-resistant bacteria based on its unnatural amino acids	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP20940	IDWKKLLDAAKKIL	14	Polybia-MP1S-Q12K	No entry found	Derived from Polybia-MP1	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic	Alpha helix	The peptide adopts a conformational structure with 81.8% alpha helix in the aqueous solution.		Function: Antibacterial activity against the Gram-positive bacteria, position 6 and 10 are cross-linked residues connected by the oct-4-enyl hydrocarbon staple	[Ref.29075946] Gram-positive bacteria: Bacillus subtilis (MIC=0.8 μM), Staphylococcus aureus (MIC=1.2 μM), Staphylococcus epidermidis (MIC=50 μM)	[Ref.29075946]9.6% hemolysis at 12.5μM,13.9% hemolysis at 25μM against human red blood cells	Cyclic	Free	Amidation	The oct-4-enyl hydrocarbon staple between Leu6 and Ala10	L	[Ref.29075946] No cytotoxicity information found	Not found	29075946	Arch Pharm Res. 2017 Dec;40(12):1414-1422.	Luong HX, Kim DH, Lee BJ, Kim YW	Antimicrobial activity and stability of stapled helices of polybia-MP1	
DRAMP20941	FVPWFSKFLKRIL	13	[Pro3,DLeu9]TL(8) (Temporin L peptide derivative)	No entry found	Derived from Temporin L	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	The analogues bearing a D residue showed a reduction in the percentage of helicity compared to the corresponding L analogues in the MMs 		Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(8) is D-Leucine, L-Lysine replace L-Proline at the position 10 on the  peptide [Pro3,DLeu9]TL(2).	[Ref.28863356] Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3.125μM), Staphylococcus aureus Cowan I (MIC=6.25μM), Staphylococcus epidermidis ATCC 12228 (MIC=3.125μM);##Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MIC=3.125μM), Escherichia coli D21 (MIC=12.5μM), Pseudomonas syringae pv tabaci 1918 (MIC=6.25μM), Pseudomonas aeruginosa ATCC 2785 (MIC=12.5μM);##Yeasts: Candida albicans ATCC 10231 (MIC=1.56μM), Candida crusei ATCC 6258 (MIC=1.56μM)	[Ref.28863356]49.30 ± 2.88% cytotoxic effect at 12.5 μM, 66.86 ± 2.81%  cytotoxic effect at 25 μM, 96.79 ± 1.24% cytotoxic effect at 50 μM on HaCaT cells.	Linear	Free	Amidation		Mixed (D-Leu9)	[Ref.28863356] The cytotoxic effect is 49.30±2.88%, 66.86±2.81% and 96.79±1.24% at peptide concentrations of 12.5, 25 and 50 μM	Not found	28863356	Eur J Med Chem. 2017 Oct 20;139:750-761.	Merlino F, Carotenuto A, Casciaro B, MartorMerlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.	Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP20942	FVPWFSKFLKRIL	13	[Pro3,DLeu9]TL(9) (Temporin L peptide derivative)	No entry found	Derived from Temporin L	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	The analogues bearing a D residue showed a reduction in the percentage of helicity compared to the corresponding L analogues in the MMs 		Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(9) is D-Leucine, D-Lysine replace L-Proline at the position 10 on the  peptide [Pro3,DLeu9]TL(2).	[Ref.28863356] Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3.125 μM), Staphylococcus aureus Cowan I (MIC=12.5 μM), Staphylococcus epidermidis ATCC 12228 (MIC=3.125 μM);##Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MIC=6.25 μM), Escherichia coli D21 (MIC=12.5 μM), Pseudomonas syringae pv tabaci 1918 (MIC=12.5 μM), Pseudomonas aeruginosa ATCC 2785 (MIC=12.5 μM);##Yeasts: Candida albicans ATCC 10231 (MIC=1.56 μM), Candida crusei ATCC 6258 (MIC=1.56 μM)	[Ref.28863356]7±4% hemolysis at 50 μM, 5±3% hemolysis at 25 μM, 5±2% hemolysis at 12.5 μM, 1±2% hemolysis at 6.25 μM, 0±1%  hemolysis at 3.125 μM against human red blood cells. ##28.22 ± 3.52%  cytotoxic effect at 25 μM, 87.9 ± 1.07% cytotoxic effect at 50 μM on HaCaT cells.	Linear	Free	Amidation		Mixed (D-Leu9, D-Lys10)	[Ref.28863356] The cytotoxic effect is 0%, 28.22±3.52% and 87.9±1.07% at 12.5, 25 and 50 μM	Not found	28863356	Eur J Med Chem. 2017 Oct 20;139:750-761.	Merlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.	Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP20943	FVPWFSKFLWRIL	13	[Pro3,DLeu9]TL(10) (Temporin L peptide derivative)	No entry found	Derived from Temporin L	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	A distorted (type IV) 		Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(8) is D-Leucine, L-Tryptophan replace L-Proline at the position 10 on the  peptide [Pro3,DLeu9]TL(2).	[Ref.28863356] Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=1.56 μM), Staphylococcus aureus Cowan I (MIC=3.125 μM), Staphylococcus epidermidis ATCC 12228 (MIC=1.56 μM);##Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MIC=3.125 μM), Escherichia coli D21 (MIC=25 μM), Pseudomonas syringae pv tabaci 1918 (MIC=1.56 μM);##Yeasts: Candida albicans ATCC 10231 (MIC=3.125 μM), Candida crusei ATCC 6258 (MIC=3.125 μM)	[Ref.28863356]37±1% hemolysis at 50μM, 20±3% hemolysis at 25μM, 7±1% hemolysis at 12.5μM, 4±2% hemolysis at 6.25μM, 2±1%  hemolysis at 3.125μM against human red blood cells.##32.1 ± 2.21%  cytotoxic effect at 25μM, 89.3 ± 0.8% cytotoxic effect at 50 μM on HaCaT cells.	Linear	Free	Amidation		Mixed (D-Leu9)	[Ref.28863356] The cytotoxic effect is 0%, 32.1±2.21% and 89.3±0.8% at  12.5, 25 and 50 μM	Not found	28863356	Eur J Med Chem. 2017 Oct 20;139:750-761.	Merlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.	Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP20944	FVPWFSKFLWRIL	13	[Pro3,DLeu9]TL(11) (Temporin L peptide derivative)	No entry found	Derived from Temporin L	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix	The analogues bearing a D residue showed a reduction in the percentage of helicity compared to the corresponding L analogues in the MMs 		Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(10) is D-Leucine, D-Tryptophan replace L-Proline at the position 10 on the  peptide [Pro3,DLeu9]TL(2).	[Ref.28863356] Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3.125μM), Staphylococcus aureus Cowan I (MIC=3.125μM), Staphylococcus epidermidis ATCC 12228 (MIC=1.56μM);##Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MIC=3.125μM), Escherichia coli D21 (MIC=25μM), Pseudomonas syringae pv tabaci 1918 (MIC=3.125μM), Pseudomonas aeruginosa ATCC 2785 (MIC=50μM);##Yeasts: Candida albicans ATCC 10231 (MIC=3.125μM),Candida crusei ATCC 6258 (MIC=3.125μM)	[Ref.28863356]19.21 ± 1.44% cytotoxic effect at 12.5μM, 35.34 ± 5.99%  cytotoxic effect at 25μM, 96.77 ± 0.81% cytotoxic effect at 50 μM on HaCaT cells.	Linear	Free	Amidation		Mixed (D-Leu9, D-Trp10)	[Ref.28863356] The cytotoxic effect is 19.21±1.44%, 35.34±5.99% and 96.77±0.81% at 12.5, 25 and 50 μM	Not found	28863356	Eur J Med Chem. 2017 Oct 20;139:750-761.	Merlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.	Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP20945	KWKLFKKIFKRIVQRIKDFLRN	22	Recombinant  Cecropin A (1–8)–LL37 (17–30) (C–L)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria	[Ref.29925795] Gram-negative bacteria: Escherichia coli CVCC 245 (MIC=7.2 ± 0.14 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2.2 ± 0.05 μg/mL),L. mono. CVCC 1599 (MIC=2.1 ± 0.03 μg/mL)	[Ref.29925795] 50% hemolysis at 221 ± 3.45μg/ml against sheep red blood cells	Linear	Free	Free		L	[Ref.29925795] No cytotoxicity information found	Not found	29925795	Molecules. 2018 Jun 20;23(6). pii: E1491. 	Wei X, Wu R, Zhang L, Ahmad B, Si D, Zhang R.	Expression, Purification, and Characterization of a Novel Hybrid Peptide with Potent Antibacterial Activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP20946	TRSRWRRFIRGAGRFARRYGWRIA	24	ΔPb-CATH4 bivittatus  antimicrobial peptides peptide derivative	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Not found	Not found		Function: Antibacterial activity against the Gram-negative and Gram-negative bacteria. It is tested against the clinically isolated antibiotic resistance strains Escherichia coli and Klebsiella pneumoniae,which showed complete resistance particularly toward ampicillin and to a lesser extent with gentamicin	[Ref.28630199] Gram-negative bacteria: Escherichia coli (ATCC 25922)(MIC=1μg/ml);Pseudomonas aeruginosa (ATCC 27853)(MIC=3μg/ml);S. typhimurium (ATCC 14028)(MIC=0.5μg/ml);##Gram-positive bacteria: Staphylococcus aureus (ATCC 29213)(MIC>128μg/ml);B. cereus (ATCC 10876)(MIC=10μg/ml);##Clinical isolates:Escherichia coli(MIC=4.7μg/ml);K. pneumoniae(MIC=1.18μg/ml)	[Ref.28630199]Hemolysis 0% at 4μg/ml against human red blood cell;Hemolysis 1.2 ± 0.3% at 8μg/ml against human red blood cell;Hemolysis 3.2 ± 0.4% at 16μg/ml against human red blood cell;Hemolysis 6.5 ± 0.4% at 32μg/ml against human red blood cell;Hemolysis 10.7 ± 0.2% at 64μg/ml against human red blood cell	Linear	Free	Free		L	[Ref.28630199] No cytotoxicity information found	Not found	28630199	Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00530-17. 	Kim D, Soundrarajan N, Lee J, Cho HS, Choi M, Cha SY, Ahn B, Jeon H, Le MT, Song H, Kim JH, Park C.	Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)O
DRAMP20947	FLKALWNVAKSVF	13	[K]3-VmCT1-NH2 VmCT1 petide derivative	No entry found	Belongs to the scorpion NDBP 6 family	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Helical structures	The peptide adopts Helical fraction 0.10 in water;0.60 in TFE/Water;0.98 in POPC;0.52 in POPC:POPG;1 in POPC:DOPE;		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria and fungi.It presented higher or equivalent antimicrobial activity when compared to VmCT1.	[Ref.27912176] Gram-negative bacteria: Escherichia coli (SBS 363)(MIC=1.56μmol/L);Pseudomonas aeruginosa (ATCC 27853)(MIC=0.78μmol/L);Escherichia coli (D31)(MIC=1.56μmol/L);Serratia marcescens (ATCC 4112)(MIC=1.56μmol/L);Enterobacter cloacae (beta-12)(MIC=6.25μmol/L);##Gram-positive bacteria: Micrococcus luteus (A270)(MIC=0.78μmol/L);Staphylococcus aureus (ATCC 29213)(MIC=3.12μmol/L);Bacillus subtilis (ATCC 6633)(MIC=6.25μmol/L);Staphylococcus epidermidis (ATCC 12228)(MIC=3.12μmol/L);##Fungi: Candida albicans MDM8(MIC=3.12μmol/L);Candida tropicalis (IOC 4560)(MIC=3.12μmol/L);Candida parapsilosis (IOC 4564)(MIC=6.25μmol/L);##Aspergillus niger(MIC=12.5μmol/L);##Cladosporium herbarum (ATCC 26362)(MIC=25μmol/L);##Cryptococcus neoformans(MIC=3.12μmol/L)	[Ref.27912176] MHC=1.60 μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.27912176] No cytotoxicity information found	Not found	27912176	Eur J Med Chem. 2017 Jan 27;126:456-463. 	Pedron CN, Torres MT, Lima JADS, Silva PI, Silva FD, Oliveira VX.	Novel designed VmCT1 analogs with increased antimicrobial activity.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP20948	FLGALWKVAKSVF	13	[K]7-VmCT1-NH2 VmCT1 petide derivative	No entry found	Belongs to the scorpion NDBP 7 family	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Helical structures	The peptide adopts Helical fraction 0.04 in water;0.43 in TFE/Water;0.80 in POPC;0.63 in POPC:POPG;0.88 in POPC:DOPE;		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria and fungi.It presented higher or equivalent antimicrobial activity when compared to VmCT2.	[Ref.27912176] Gram-negative bacteria: Escherichia coli (SBS 363)(MIC=1.56μmol/L);Pseudomonas aeruginosa (ATCC 27853)(MIC=0.39μmol/L);Escherichia coli (D31)(MIC=1.56μmol/L);Serratia marcescens (ATCC 4112)(MIC=0.78μmol/L);Enterobacter cloacae (beta-12)(MIC=6.25μmol/L);##Gram-positive bacteria: Micrococcus luteus (A270)(MIC=1.56μmol/L);Staphylococcus aureus (ATCC 29213)(MIC=1.56μmol/L);Bacillus subtilis (ATCC 6633)(MIC=3.12μmol/L);Staphylococcus epidermidis (ATCC 12228)(MIC=1.56μmol/L);##Fungi: Candida albicans MDM8(MIC=1.56μmol/L);Candida tropicalis (IOC 4560)(MIC=1.56μmol/L);Candida parapsilosis (IOC 4564)(MIC=1.56μmol/L);##Aspergillus niger(MIC=6.25μmol/L);##Cladosporium herbarum (ATCC 26362)(MIC=12.5μmol/L);##Cryptococcus neoformans(MIC=1.56μmol/L)	[Ref.27912176] MHC=1.60μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.27912176] No cytotoxicity information found	Not found	27912176	Eur J Med Chem. 2017 Jan 27;126:456-463. 	Pedron CN, Torres MT, Lima JADS, Silva PI, Silva FD, Oliveira VX.	Novel designed VmCT1 analogs with increased antimicrobial activity.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP20949	FLGALWNVAKKVF	13	[K]11-VmCT1-NH2 VmCT1 petide derivative	No entry found	Belongs to the scorpion NDBP 8 family	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Helical structures	The peptide adopts Helical fraction 0.02 in water;0.27 in TFE/Water;0.56 in POPC;0.50 in POPC:POPG;0.76 in POPC:DOPE;		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria and fungi.It presented higher or equivalent antimicrobial activity when compared to VmCT3.	[Ref.27912176] Gram-negative bacteria: Escherichia coli (SBS 363)(MIC=1.56μmol/L);Pseudomonas aeruginosa (ATCC 27853)(MIC=0.39μmol/L);Escherichia coli (D31)(MIC=1.56μmol/L);Serratia marcescens (ATCC 4112)(MIC=0.78μmol/L);Enterobacter cloacae (beta-12)(MIC=6.25μmol/L);##Gram-positive bacteria: Micrococcus luteus (A270)(MIC=1.56μmol/L);Staphylococcus aureus (ATCC 29213)(MIC=1.56μmol/L);Bacillus subtilis (ATCC 6633)(MIC=6.25μmol/L);Staphylococcus epidermidis (ATCC 12228)(MIC=1.56μmol/L);##Fungi: Candida albicans MDM8(MIC=1.56μmol/L);Candida tropicalis (IOC 4560)(MIC=3.12μmol/L);Candida parapsilosis (IOC 4564)(MIC=6.25μmol/L);##Aspergillus niger(MIC=6.25μmol/L);##Cladosporium herbarum (ATCC 26362)(MIC=6.25μmol/L);##Cryptococcus neoformans(MIC=1.56μmol/L)	[Ref.27912176] MHC=1.60μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.27912176] No cytotoxicity information found	Not found	27912176	Eur J Med Chem. 2017 Jan 27;126:456-463. 	Pedron CN, Torres MT, Lima JADS, Silva PI, Silva FD, Oliveira VX.	Novel designed VmCT1 analogs with increased antimicrobial activity.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP20950	FLGELWNVAKSVF	13	[E]4-VmCT1-NH2 VmCT1 petide derivative	No entry found	Belongs to the scorpion NDBP 9 family	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Helical structures	The peptide adopts Helical fraction 0.02  in water;0.15 in TFE/Water;0.17 in POPC;0.20 in POPC:POPG;0.24 in POPC:DOPE;		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria and fungi. It showed a diminished antimicrobial activity against all the microorganisms tested, besides that it did not present activity at the range of concentrations analyzed against Escherichia coli SBS 363, E. cloacae, Bacillus subtilis, C. parapsilosis, A. niger and C. herbarum.	[Ref.27912176] Gram-negative bacteria: Pseudomonas aeruginosa (ATCC 27853)(MIC=3.12μmol/L);Escherichia coli (D31)(MIC=50μmol/L);Serratia marcescens (ATCC 4112)(MIC=3.12μmol/L);##Gram-positive bacteria: Micrococcus luteus (A270)(MIC=25μmol/L);Staphylococcus aureus (ATCC 29213)(MIC=50μmol/L);Staphylococcus epidermidis (ATCC 12228)(MIC=50μmol/L);##Fungi:Candida albicans MDM8(MIC=50μmol/L);Candida tropicalis (IOC 4560)(MIC=12.5μmol/L);##Cryptococcus neoformans(MIC=12.5μmol/L)	[Ref.27912176] MHC=25μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.27912176] No cytotoxicity information found	Not found	27912176	Eur J Med Chem. 2017 Jan 27;126:456-463. 	Pedron CN, Torres MT, Lima JADS, Silva PI, Silva FD, Oliveira VX.	Novel designed VmCT1 analogs with increased antimicrobial activity.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP20951	FLGALWEVAKSVF	13	[E]7-VmCT1-NH2 VmCT1 petide derivative	No entry found	Belongs to the scorpion NDBP 10 family	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Helical structures	The peptide adopts Helical fraction 0.04 in water;0.24 in TFE/Water;0.57 in POPC;0.44 in POPC:POPG;0.64 in POPC:DOPE;		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria and fungi.It analog presented a reduction or similar antimicrobial activity when compared to model molecule, this analog had an increase on activity against Escherichia coli SBS 363, Bacillus subtilis and C. herbarum.	[Ref.27912176] Gram-negative bacteria: Escherichia coli (SBS 363)(MIC=1.56μmol/L);Pseudomonas aeruginosa (ATCC 27853)(MIC=0.78μmol/L);Escherichia coli (D31)(MIC=1.56μmol/L);Serratia marcescens (ATCC 4112)(MIC=1.56μmol/L);Enterobacter cloacae (beta-12)(MIC=25μmol/L);##Gram-positive bacteria: Micrococcus luteus (A270)(MIC=1.56μmol/L);Staphylococcus aureus (ATCC 29213)(MIC=6.25μmol/L);Bacillus subtilis (ATCC 6633)(MIC=12.5μmol/L);Staphylococcus epidermidis (ATCC 12228)(MIC=6.25μmol/L);##Fungi: Candida albicans MDM8(MIC=12.5μmol/L);Candida tropicalis (IOC 4560)(MIC=12.5μmol/L);Candida parapsilosis (IOC 4564)(MIC=50μmol/L);##Aspergillus niger(MIC=25μmol/L);##Cladosporium herbarum (ATCC 26362)(MIC=25μmol/L);##Cryptococcus neoformans(MIC=6.25μmol/L)	[Ref.27912176] MHC=1.60μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.27912176] No cytotoxicity information found	Not found	27912176	Eur J Med Chem. 2017 Jan 27;126:456-463. 	Pedron CN, Torres MT, Lima JADS, Silva PI, Silva FD, Oliveira VX.	Novel designed VmCT1 analogs with increased antimicrobial activity.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP20952	FLGALWNVWKSVF	13	[W]9-VmCT1-NH2 VmCT1 petide derivative	No entry found	Belongs to the scorpion NDBP 11 family	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Helical structures	The peptide adopts Helical fraction 0.02 in water;0.11 in TFE/Water;0.30 in POPC;0.11 in POPC:POPG;0.24 in POPC:DOPE;		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria and fungi.It antimicrobial activities are increased or preserved when compared to VmCT1. 	[Ref.27912176] Gram-negative bacteria: Escherichia coli (SBS 363)(MIC=1.56μmol/L);Pseudomonas aeruginosa (ATCC 27853)(MIC=0.78μmol/L);Escherichia coli (D31)(MIC=1.56μmol/L);Serratia marcescens (ATCC 4112)(MIC=1.56μmol/L);Enterobacter cloacae (beta-12)(MIC=6.52μmol/L);##Gram-positive bacteria: Micrococcus luteus (A270)(MIC=1.56μmol/L);Staphylococcus aureus (ATCC 29213)(MIC=6.25μmol/L);Bacillus subtilis (ATCC 6633)(MIC=3.12μmol/L);Staphylococcus epidermidis (ATCC 12228)(MIC=1.56μmol/L);##Fungi: Candida albicans MDM8(MIC=6.25μmol/L);Candida tropicalis (IOC 4560)(MIC=50μmol/L);Candida parapsilosis (IOC 4564)(MIC=50μmol/L);##Aspergillus niger(MIC=50μmol/L);##Cladosporium herbarum (ATCC 26362)(MIC=50μmol/L);##Cryptococcus neoformans(MIC=3.12μmol/L)	[Ref.27912176]MHC=1.60μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.27912176] No cytotoxicity information found	Not found	27912176	Eur J Med Chem. 2017 Jan 27;126:456-463. 	Pedron CN, Torres MT, Lima JADS, Silva PI, Silva FD, Oliveira VX.	Novel designed VmCT1 analogs with increased antimicrobial activity.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP20953	FLGELWNVWKSVF	13	[E]4[W]9-VmCT1-NH2 VmCT1 petide derivative	No entry found	Belongs to the scorpion NDBP 12 family	Not found	Synthetic construct	Antimicrobial, Antibacterial	Synthetic	Helical structures	The peptide adopts Helical fraction 0.01 in water;0.11 in TFE/Water;0.24 in POPC;0.14 in POPC:POPG;0.23 in POPC:DOPE;		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria and fungi.It analog displayed a reduction in the antimicrobial activity, being the exceptions Escherichia coli SBS 363, Bacillus subtilis and Candida albicans.	[Ref.27912176] Gram-negative bacteria: Escherichia coli (SBS 363)(MIC=12.5μmol/L);Pseudomonas aeruginosa (ATCC 27853)(MIC=3.12μmol/L);Escherichia coli (D31)(MIC=6.25μmol/L);Serratia marcescens (ATCC 4112)(MIC=3.12μmol/L);Enterobacter cloacae (beta-12)(MIC=50μmol/L);##Gram-positive bacteria: Micrococcus luteus (A270)(MIC=3.12μmol/L);Staphylococcus aureus (ATCC 29213)(MIC=12.5μmol/L);Bacillus subtilis (ATCC 6633)(MIC=12.5μmol/L);Staphylococcus epidermidis (ATCC 12228)(MIC=6.25μmol/L);##Fungi: Candida albicans MDM8(MIC=6.25μmol/L);Candida tropicalis (IOC 4560)(MIC=12.5μmol/L);##Cryptococcus neoformans(MIC=6.25μmol/L)	[Ref.27912176] MHC=1.60μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.27912176] No cytotoxicity information found	Not found	27912176	Eur J Med Chem. 2017 Jan 27;126:456-463. 	Pedron CN, Torres MT, Lima JADS, Silva PI, Silva FD, Oliveira VX.	Novel designed VmCT1 analogs with increased antimicrobial activity.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP20955	LGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFH	42	L31-P113	No entry found	Derived from LL-37	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix 	The peptide adopts a conformational structure with 80 % alpha helix.		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29859288] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=25 ± 0 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16.6 ± 7.2 μM);##Fungi: Candida albicans ATCC 90028 (MIC=166.6 ± 57.7 μg/mL)	[Ref.29859288] Hemolysis 12.0 ± 0.7% at 500 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.29859288] No cytotoxicity information found	Not found	29859288	Gene. 2018 May 30. pii: S0378-1119(18)30617-6.	Wanmakok M, Orrapin S, Intorasoot A, Intorasoot S.	Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CNC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP20956	ALGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFHLEY	46	AL32-P113	No entry found	Derived from LL-37 and Hst-5	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic	Alpha helix 	The peptide adopts a conformational structure with 81 % alpha helix.		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.	[Ref.29859288] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=66.6 ± 28.8 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=41.6 ± 14.4 μM), Extended-spectrum beta-lactamase producing Escherichia coli (MIC=41.6 ± 14.4 μg/mL), New Delhi metallo-bata-lactamase-1 producing Acinetobacter baumannii  (MIC=20.8 ± 7.2 μg/mL);##Fungi: Candida albicans ATCC 90028 (MIC=166.6 ± 57.7 μg/mL)	[Ref.29859288] Hemolysis 10.4 ± 2.2% at 500 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.29859288] No cytotoxicity information found	Not found	29859288	Gene. 2018 May 30. pii: S0378-1119(18)30617-6.	Wanmakok M, Orrapin S, Intorasoot A, Intorasoot S.	Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP20957	FFSLIPKLVKGLISAFK	17	StigA6	No entry found	Derived from scorpion venom peptide	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiparasitic, Antiproliferative	Synthetic	Alpha helix 	The peptide adopts helical conformation with some random structure at the N- and C-terminals. In sodium phosphate buffer (PBS) and water they have a predominantly random structure, but in 20 mM sodium dodecyl sulfate (SDS) and 2,2,2-trifluoroethanol (TFE) they have a typical alpha-helix structure.		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity against yeasts.Antiparasitic Activity against epimastigote forms of Trypanosoma cruzi. Antiproliferative Activity against HeLa cells.	[Ref.29670004] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=2.34 μM), Staphylococcus epidermidis ATCC 122225 (MIC=9.38 μM), Enterococcus faecalis ATCC 4028 (MIC=1.17 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4.69 μM), Enterobacter cloacae ATCC 13047 (MIC=18.75 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=9.38 μM);##yeasts: Candida albicans ATCC 90028 (MIC=9.38 μM), Candida krusei ATCC 6258 (MIC=37.5 μM), Candida glabrata ATCC 90030 (MIC=18.75 μM);##StigA6 inhibit 100% of the epimastigote forms of Trypanosoma cruzi growth at 2.5 µM;##HeLa cell line: IC50=14.01 µM	[Ref.29670004] Hemolysis 0% at 1.17 μM, hemolysis 2% at 2.34 μM, hemolysis 15% at 4.69 μM, hemolysis 27% at 9.38 μM, hemolysis 30% at 18.75 μM, hemolysis 30% at 37.50 μM, hemolysis 27% at 75.00 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.29670004] The cell viability of HeLa cell lines is 19%, 15%, 11%, 29%, 9%, 13% and 8% at peptide concentrations of 2, 4, 8, 10, 15, 20 and 40 μM.  ##The cell viability of 3T3 cell lines is 81%, 73%, 69%, 61%, 51%, 20% and 15% at peptide concentrati	Not found	29670004	Toxins (Basel). 2018 Apr 18;10(4). pii: E161.	Parente AMS, Daniele-Silva A, Furtado AA, Melo MA, Lacerda AF, Queiroz M, Moreno C, Santos E, Rocha HAO, Barbosa EG, Carvalho E, Silva-Júnior AA, Silva MS, Fernandes-Pedrosa MF.	Analogs of the Scorpion Venom Peptide Stigmurin: Structural Assessment, Toxicity, and Increased Antimicrobial Activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP20958	FFKLIPKLVKGLISAFK	17	StigA16	No entry found	Derived from scorpion venom peptide	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiparasitic, Antiproliferative	Synthetic	Alpha helix 	The peptide adopts helical conformation with some random structure at the N- and C-terminals. In sodium phosphate buffer (PBS) and water they have a predominantly random structure, but in 20 mM sodium dodecyl sulfate (SDS) and 2,2,2-trifluoroethanol (TFE) they have a typical alpha-helix structure.		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity against yeasts.Antiparasitic Activity against epimastigote forms of Trypanosoma cruzi. Antiproliferative Activity against HeLa cells.	[Ref.29670004] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=2.34 μM), Staphylococcus epidermidis ATCC 122225 (MIC=9.38 μM), Enterococcus faecalis ATCC 4028 (MIC=1.17 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2.34 μM), Enterobacter cloacae ATCC 13047 (MIC=9.38 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1.17 μM);##yeasts: Candida albicans ATCC 90028 (MIC=4.69 μM), Candida krusei ATCC 6258 (MIC=9.38 μM), Candida glabrata ATCC 90030 (MIC=9.38 μM);##StigA16 inhibit 100% of the epimastigote forms of Trypanosoma cruzi growth at 2.5 µM;##HeLa cell line: IC50=13.01 µM	[Ref.29670004] Hemolysis 0% at 1.17 [Ref.29670004] Hemolysis 0% at 1.17 μM, hemolysis 2% at 2.34 μM, hemolysis 10% at 4.69 μM, hemolysis 20% at 9.38 μM, hemolysis 35% at 18.75 μM, hemolysis 37% at 37.50 μM, hemolysis 40% at 75.00 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.29670004] The cell viability of HeLa cell lines is 15%, 21%, 16%, 9%, 8%, 10% and 11% at peptide concentrations of 2, 4, 8, 10, 15, 20 and 40 μM. ##The cell viability of 3T3 cell lines is 69%, 77%, 62%, 47%, 21%, 15% and 15% at peptide concentratio	Not found	29670004	Toxins (Basel). 2018 Apr 18;10(4). pii: E161.	Parente AMS, Daniele-Silva A, Furtado AA, Melo MA, Lacerda AF, Queiroz M, Moreno C, Santos E, Rocha HAO, Barbosa EG, Carvalho E, Silva-Júnior AA, Silva MS, Fernandes-Pedrosa MF.	Analogs of the Scorpion Venom Peptide Stigmurin: Structural Assessment, Toxicity, and Increased Antimicrobial Activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP20959	ILKKLLKGVKSI	12	Hp1404-T1c	No entry found	Derived from Hp1404	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix	The peptide adopts an alpha-helical conformation in the membrane-mimicking environments and adopts a random coil conformation in the presence of all liposome types .		Function: Antibacterial activity against Gram-negative bacteria. 	[Ref.29379033] Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=3.13 μM), Pseudomonas aeruginosa 138 (MIC=25 μM), Pseudomonas aeruginosa 431 (MIC=12.5 μM), Pseudomonas aeruginosa 434 (MIC=6.25 μM), Pseudomonas aeruginosa 557 (MIC=25 μM), Pseudomonas aeruginosa 559 (MIC=25 μM), Pseudomonas aeruginosa 778 (MIC=6.25 μM), Pseudomonas aeruginosa 1034 (MIC=6.25 μM), Pseudomonas aeruginosa 1162 (MIC=3.13 μM), Pseudomonas aeruginosa 3399 (MIC=3.13 μM), Pseudomonas aeruginosa 3592 (MIC=6.25 μM), Pseudomonas aeruginosa 3904 (MIC=6.25 μM), Pseudomonas aeruginosa 4007 (MIC=12.5 μM), Pseudomonas aeruginosa 4319 (MIC=6.25 μM), Pseudomonas aeruginosa 4891 (MIC=6.25 μM), Pseudomonas aeruginosa 5018 (MIC=3.13 μM), Pseudomonas aeruginosa 671973 (MIC=6.25 μM)	[Ref.29379033] Hp1404-T1c does not induce substantial hemolysis, even at the high tested concentration (200 μM) against mouse red blood cells	Linear	Free	Amidation		L	[Ref.29379033] The cell survial  against HaCaT cells is 100%, 70%, 66% and 53% at peptide concentrations of 25, 50, 100 and 200 μM	Lipopolysaccharide (LPS)-binding and entering bacterial cells and interact with their DNA	29379033	Sci Rep. 2018 Jan 29;8(1):1763. 	Kim MK, Kang HK, Ko SJ, Hong MJ, Bang JK, Seo CH, Park Y.	Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@H](C)CC)C(C)C
DRAMP20960	ILKKLLKKVKSI	12	Hp1404-T1d	No entry found	Derived from Hp1404	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix	The peptide adopts an alpha-helical conformation in the membrane-mimicking environments and adopts a random coil conformation in the presence of all liposome types .		Function: Antibacterial activity against Gram-negative bacteria. 	[Ref.29379033] Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=1.56 μM), Pseudomonas aeruginosa 138 (MIC=12.5 μM), Pseudomonas aeruginosa 431 (MIC=3.13 μM), Pseudomonas aeruginosa 434 (MIC=3.13 μM), Pseudomonas aeruginosa 557 (MIC=3.13 μM), Pseudomonas aeruginosa 559 (MIC=12.5 μM), Pseudomonas aeruginosa 778 (MIC=3.13 μM), Pseudomonas aeruginosa 1034 (MIC=3.13 μM), Pseudomonas aeruginosa 1162 (MIC=1.56 μM), Pseudomonas aeruginosa 3290 (MIC=6.25 μM), Pseudomonas aeruginosa 3399 (MIC=1.56 μM), Pseudomonas aeruginosa 3543 (MIC=25 μM), Pseudomonas aeruginosa 3592 (MIC=3.13 μM), Pseudomonas aeruginosa 3904 (MIC=6.25 μM), Pseudomonas aeruginosa 4007 (MIC=6.25 μM), Pseudomonas aeruginosa 4319 (MIC=3.13 μM), Pseudomonas aeruginosa 4891 (MIC=3.13 μM), Pseudomonas aeruginosa 5018 (MIC=1.56 μM), Pseudomonas aeruginosa 671973 (MIC=1.56 μM)	[Ref.29379033] Hp1404-T1d does not induce substantial hemolysis, even at the high tested concentration (200 μM) against mouse red blood cells	Linear	Free	Amidation		L	[Ref.29379033] The cell survial  against HaCaT cells is 58%, 48%, 52% and 34% at peptide concentrations of 25, 50, 100 and 200 μM	Lipopolysaccharide (LPS)-binding	29379033	Sci Rep. 2018 Jan 29;8(1):1763. 	Kim MK, Kang HK, Ko SJ, Hong MJ, Bang JK, Seo CH, Park Y.	Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@H](C)CC)C(C)C
DRAMP20961	ILKKLLKKVKKI	12	Hp1404-T1e	No entry found	Derived from Hp1404	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic	Alpha helix	The peptide adopts an alpha-helical conformation in the membrane-mimicking environments and adopts a random coil conformation in the presence of all liposome types .		Function: Antibacterial activity against Gram-negative bacteria. 	[Ref.29379033] Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=1.56 μM), Pseudomonas aeruginosa 138 (MIC=6.25 μM), Pseudomonas aeruginosa 431 (MIC=3.13 μM), Pseudomonas aeruginosa 434 (MIC=3.13 μM), Pseudomonas aeruginosa 557 (MIC=3.13 μM), Pseudomonas aeruginosa 559 (MIC=6.25 μM), Pseudomonas aeruginosa 778 (MIC= 1.56 μM), Pseudomonas aeruginosa 1034 (MIC= 1.56 μM), Pseudomonas aeruginosa 1162 (MIC=1.56 μM), Pseudomonas aeruginosa 3290 (MIC=6.25 μM), Pseudomonas aeruginosa 3399 (MIC=0.78 μM), Pseudomonas aeruginosa 3543 (MIC=12.5 μM), Pseudomonas aeruginosa 3592 (MIC=1.56 μM), Pseudomonas aeruginosa 3904 (MIC=3.13 μM), Pseudomonas aeruginosa 4007 (MIC=3.13 μM), Pseudomonas aeruginosa 4319 (MIC=3.13 μM), Pseudomonas aeruginosa 4891 (MIC=1.56 μM), Pseudomonas aeruginosa 5018 (MIC=1.56 μM), Pseudomonas aeruginosa 671973 (MIC=1.56 μM)	[Ref.29379033] Hp1404-T1e does not induce substantial hemolysis, even at the high tested concentration (200 μM) against mouse red blood cells	Linear	Free	Amidation		L	[Ref.29379033] The cell survial  against HaCaT cells is 100%, 100%, 100%, 99% at peptide concentrations of 25, 50, 100 and 200 μM	Lipopolysaccharide (LPS)-binding and entering bacterial cells and interact with their DNA	29379033	Sci Rep. 2018 Jan 29;8(1):1763. 	Kim MK, Kang HK, Ko SJ, Hong MJ, Bang JK, Seo CH, Park Y.	Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)[C@H](C)CC)C(C)C
DRAMP20963	LRLKKYKVPQL	11	Cp1 alpha s1-casein peptide derivative	No entry found	Derived from bovine alpha S1-casein	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, low hemolytic and toxic effects	Synthetic	Unordered conformation	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.29783753] Gram-negative bacteria: Escherichia coli (ATCC 25922)(MIC=64μM);Escherichia coli (UB1005)(MIC=128μM);Salmonella pullorum (C7913)(MIC=256μM);Salmonella enterica subsp enterica (CMCC 50071)(MIC=256μM);##Gram-positive bacteria: Staphylococcus aureus (ATCC 29213)(MIC=640μM);L. monocytogenes (CMCC 54004)(MIC=64μM)	[Ref.2978375]Hemolysis 0% at 16μM;Hemolysis 23.54% at 512μM against human red blood cells	Linear	Free	Amidation		L	[Ref.29783753] In 293 cells, The peptide had no cytotoxic activity at concentrations of 1-512 μM. The cell survival rates are 100%, 96%, 98%, 105%, 104%, 112%, 116%, 114% and 103% at concentrations of 1, 2, 4, 8, 16, 32, 64, 128, 256, 512 μM	Not found	29783753	Molecules. 2018 May 19;23(5). pii: E1220.	Hou J, Liu Z, Cao S, Wang H, Jiang C, Hussain MA, Pang S	Broad-Spectrum Antimicrobial Activity and Low Cytotoxicity against Human Cells of a Peptide Derived from Bovine 	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(N)=O
DRAMP20964	KWKLFKKIFKRIVQRIKDFLRN	22	Synthesized Cecropin A (1–8)–LL37 (17–30) (C–L)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. 	[Ref.29920061] Gram-negative bacteria: Escherichia coli (CVCC 245)(MIC=7.0 ± 0.21μg/mL);##Gram-positive bacteria: Staphylococcus aureus (ATCC 25923)(MIC=2.0 ± 0.02μg/mL );L. mono. (CVCC 1599)(MIC=2.2 ± 0.05μg/mL)	[Ref.29920061]HC50 =219 ± 2.98μg/mL against sheep erythrocyte cells	Linear	Free	Free		L	[Ref.29925795] No cytotoxicity information found	Not found	29920061	Molecules. 2018 Jun 20;23(6). pii: E1491.	Wei X, Wu R, Zhang L, Ahmad B, Si D, Zhang R.	Expression, Purification, and Characterization of a Novel Hybrid Peptide with Potent Antibacterial Activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP20965	MNKVKEWIKYLKSLFSM	17	LPcin-YK3 (bovine cathelicidin, cattle, ruminant, mammals, animals)	No entry found	Not found	Not found	Bovine Lactophoricin	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Random coil, alpha helix	LPcin-YK3 peptide is a random coil in aqueous solution and forms an 		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans	[Ref.30021422] Gram-positive bacteria : Streptococcus mutans KCCM 40105 (MIC=1.25 μg/ml), Propionibacteria acnes KCCM 41747 (MIC=1.25 μg/ml), Staphylococcus aureus KCTC 1621 (MIC=0.62 μg/ml);##Gram-negative bacteria : Porphyromonas gingvalis KCTC 5352 (MIC=0.62 μg/ml), Escherichia coli KCCM 41290 (MIC=1.25 μg/ml);##Fungi : Candida albicans KCTC 17712 (MIC=10.0 μg/ml)	[Ref.30021422] 0% hemolysis  at 40 μg/ml against mouse red blood cell	Linear	Free	Free		L	[Ref.30021422] No cytotoxicity information found	Not found	30021422	J Microbiol Biotechnol.?2018 Aug 28;28(8):1299-1309. doi: 10.4014/jmb.1805.05001.	Ji-Sun Kim,Ji-Ho Jeong, Jang-Hee Cho,Dong-Hee Lee and Yongae Kim	Antimicrobial Activity of Antimicrobial Peptide LPcin-YK3 Derived from Bovine Lactophoricin	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O
DRAMP20966	GLTRLFSVIK	10	andricin B (Andrias davidianus, Amphibians, Animals)	No entry found	Not found	Not found	Andrias davidianus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Random coil	The residues Lys and Arg possess the positive charge, and charge-induced folding may influence the structure.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Saccharomyces cerevisiae, Aspergillus niger	[Ref.29130500]Gram-positive bacteria : Bacillus subtilis CICC 10034 (MIC=32 μg/ml, 33.4 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml), Staphylococcus aureus CICC10306 (MIC=16 μg/ml, 16.7 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml), Staphylococcus aureus CICC 10384 (MIC=16 μg/ml, 16.7 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml), Listeria innocua CICC 10417 (MIC=32 μg/ml, 33.4 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml);##Gram-negative bacteria : Escherichia coli CICC10293 (MIC=16 μg/ml, 16.7 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml), Pseudomonas aeruginosa CICC 21636 (MIC=8 μg/ml, 8.3 μMol/ml;MBC=16 μg/ml, 16.7 μMol/ml), Serratia marcescens ATCC 4112 (MIC=8 μg/ml, 8.3 μMol/ml;MBC=16 μg/ml, 16.7 μMol/ml), Enterobacter cloacae CICC 21539 (MIC=16 μg/ml, 16.7 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml), Salmonella paratyphi CICC 10437 (MIC=32 μg/ml, 33.4 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml);##Fungi : Aspergillus niger CICC 2124 (MIC=64 μg/ml, 66.8 μMol/ml;MBC=64 μg/ml, 66.8 μMol/ml), Candida albicans CICC 1965 (MIC=32 μg/ml, 33.4 μMol/ml;MBC=64 μg/ml, 66.8 μMol/ml), Saccharomyces cerevisiae CICC 1002 (MIC=64 μg/ml, 66.8 μMol/ml;MBC=64 μg/ml, 66.8 μMol/ml)	[Ref.29130500] 0% hemolysis  at 64 μg/ml , 0.5% hemolysis at 128 μg/ml , 2% hemolysis  at 256 μg/ml , 13% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.29130500] No cytotoxicity information found	Not found	29130500	Lett Appl Microbiol.?2018 Jan;66(1):38-43. doi: 10.1111/lam.12823.	J. Pei, Z. Feng,T. Ren,H. Sun,H. Han,W. Jin,J. Dang and Y. Tao	Purifification, characterization and application of a novel antimicrobial peptide from Andrias davidianus blood	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP20967	AIGHCLGATL	10	andricin 01 (Andrias davidianus, Amphibians, Animals)	No entry found	Not found	Not found	Andrias davidianus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Random coil	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28461043] Gram-positive bacteria : Bacillus subtilis CICC 10034 (MIC=32 μg/ml;MBC=32 μg/ml), Bacillus megaterium CICC 10448 (MIC=8 μg/ml;MBC=16 μg/ml), Staphylococcus aureus CICC 10306 (MIC=32 μg/ml;MBC=32 μg/ml), Staphylococcus aureus CICC 10384 (MIC=32 μg/ml;MBC=32 μg/ml), Listeria innocua CICC 10417 (MIC=32 μg/ml;MBC=32 μg/ml);##Gram-negative bacteria : Escherichia coli CICC 10293 (MIC=8 μg/ml;MBC=16 μg/ml), Escherichia coli CGMCC 3373 (MIC=8 μg/ml;MBC=16 μg/ml), Escherichia coli CICC 10302 (MIC=8 μg/ml;MBC=16 μg/ml), Escherichia coli CICC 10300 (MIC=8 μg/ml;MBC=16 μg/ml), Pseudomonas aeruginosa CICC 21636 (MIC=4 μg/ml;MBC=8 μg/ml), Alcaligenes faecalis ATCC 8750 (MIC=8 μg/ml;MBC=16 μg/ml), Serratia marcescens ATCC 4112 (MIC=8 μg/ml;MBC=8 μg/ml), Enterobacter cloacae CICC 21539 (MIC=4 μg/ml;MBC=8 μg/ml), Salmonella Paratyphi CICC 10437 (MIC=8 μg/ml;MBC=16 μg/ml)	[Ref.28461043] 0% hemolysis at 25 μg/ml , 0% hemolysis at 50 μg/ml , 4.3 ± 0.16% hemolysis at 100 μg/ml , 16.3 ± 2.16% hemolysis at 200 μg/ml against human hepatocyte cell line and human renal epithelial cells;0% hemolysis at 0–50 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.28461043] The cell viability of HL-7702 cells is 100.0±0.30%, 100.5±0.52%, 86.8±2.10% and 52.1±1.81% at peptide concentrations of 25, 50, 100 and 200 μg/ml. ##The cell viability of HREpiC cells is 100.1±0.20%, 103.1±1.20%, 82.3±1.84% and 50.3±2.05%	Not found	28461043	Int J Antimicrob Agents.?2017 Jul;50(1):41-46. doi: 10.1016/j.ijantimicag.2017.02.013.	Jinjin Pei, Lei Jiang	Antimicrobial peptide from mucus of Andrias davidianus: screening and purification by magnetic cell membrane separation technique	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
DRAMP20968	MMRVMRRKTKVIWEKKDFIGLYSID	25	Catesbeianin-1 (Ranidae, Anura, Amphibia, Animals)	C5IAX4	Not found	Not found	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Alpha helix	Catesbeianin-1 is an amphi pathic a-helix and that the helical wheel is divided into two parts, namely, a hydrophobic face and a hydro philic face.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28258530] Gram-positive bacteria : Staphylococcus aureus ATCC 25923 (MIC=3.1 μg/ml;MBC=6.3 μg/ml), B. subtilis ATCC6633 (MIC=25 μg/ml;MBC=50 μg/ml), Streptococcus suis CVCC606 (MIC=3.1 μg/ml;MBC=12.5 μg/ml), Listeria monocytogenes ATCC19115 (MIC=12.5 μg/ml;MBC=25 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=3.1 μg/ml;MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC227853 (MIC=12.5 μg/ml;MBC=25 μg/ml), Salmonella spp. CVCC 3377 (MIC=6.3 μg/ml;MBC=25 μg/ml), Klebsiella pneumoniae H507 (MIC=25 μg/ml;MBC=100 μg/ml)	[Ref.28258530] 0% hemolysis at 0 μg/ml , hemolysis 3% at 25 μg/ml , 7% hemolysis at 50 μg/ml , 8% hemolysis at 100 μg/ml , 35% hemolysis at 200 μg/ml , 50% hemolysis at 300 μg/ml , 85% hemolysis at 400 μg/ml , 95% hemolysis at 500 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.28258530] The cell viability of HEK293T cells is 102%, 103%, 103%, 100%, 98% and 85% at peptide concentrations of 0, 20, 40, 60, 80 and 100 μg/ml. ##The cell viability of HL-7200 cells is 107%, 106%, 99%, 95% and 88% at peptide concentrations of 0,	Not found	28258530	Biotechnol Lett. 2017 Jun;39(6):897-903. doi: 10.1007/s10529-017-2312-7.	Huihui Xu . Yang Zhang . Xin Feng . Kunyuan Tie . Yuan Cao . Wenyu Han	Catesbeianin-1, a novel antimicrobial peptide isolatedfrom the skin of Lithobates catesbeianus (American bullfrog)	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)O)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP20969	KLLKHKLLVTLA	12	HJH-1 (bovine cathelicidin, cattle, ruminant, mammals, animals)	No entry found	Not found	Not found	Bovine	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans	[Ref.30110916]Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=25 μg/ml), Clinical Staphylococcus aureus (MIC=25 μg/ml), ;##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=12.5 μg/ml), Clinical Escherichia coli (MIC=25 μg/ml), Salmonella pullorum CVCC3533 (MIC=6.25 μg/ml), Clinical Salmonella (MIC=6.25 μg/ml);##Fungi : Candida albicans ATCC 90029 (MIC=50 μg/ml)	[Ref.30110916] 8% hemolysis at 50 μg/ml , 12% hemolysis at 100 μg/ml , 16% hemolysis at 200 μg/ml , 17% hemolysis at 300 μg/ml , 18% hemolysis at 400 μg/ml against rabbit red blood cells	Linear	Free	Free		L	[Ref.30110916] No cytotoxicity information found	Not found	30110916	Molecules. 2018 Aug 14;23(8). pii: E2026. doi: 10.3390/molecules23082026.	Qing Wang, Yanzhao Xu, Mengmeng Dong, Bolin Hang, Yawei Sun, Lei Wang,Yongqiang Wang, Jianhe Hu, and Wenju Zhang 	HJH-1, a Broad-Spectrum Antimicrobial Activity and Low Cytotoxicity Antimicrobial Peptide	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
DRAMP20970	VNFKLLSHSLLVTLASHL	18	P3 (bovine cathelicidin, cattle, ruminant, mammals, animals)	P01966	Belongs to the globin family.	HBA	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans	[Ref.25753638] Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=25 μg/ml), Clinical Staphylococcus aureus (MIC=12.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=12.5 μg/ml), Clinical Escherichia coli (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=25 μg/ml);##Fungi : Candida albicans Clinical strain (MIC=25 μg/ml), Candida albicans ATCC 90029 (MIC=50 μg/ml)	[Ref.25753638] 3% hemolysis at 50 μg/ml , 5% hemolysis  at 100 μg/ml , 7% hemolysis at 200 μg/ml , 7.5% hemolysis at 300 μg/ml , 8% hemolysis at 400 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.25753638] The cell viability of HaCaT cell lines is 93% and 94% at peptide concentrations of 200 and 400 μg/ml. In kumning mice, the LD50 of P3 is 160 mg/kg for i.p. injection, while the LD50 of PMB(served as a control) is 50 mg/kg. No mortality w	Not found	25753638	Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.	Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu	Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP20971	KLLSHSLLVTLA	12	JH-0 (Derived from  P3)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25753638]Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=6.25 μg/ml), Clinical Staphylococcus aureus (MIC=6.25 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=6.25 μg/ml), Clinical Escherichia coli (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=6.25 μg/ml)	[Ref.25753638] 2.5% hemolysis at 50 μg/ml , 4% hemolysis at 100 μg/ml , 5% hemolysis at 200 μg/ml , 6% hemolysis at 300 μg/ml , 7% hemolysis at 400 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.25753638] The cell viability of HaCaT cell lines is 88% and 85% at peptide concentrations of 200 and 400 μg/ml. In Kunming mice,  the LD50 of JH-0 is 120 mg/kg for i.p. injection, while the LD50 of PMB(served as a control) is 50 mg/kg. No mortalit	Not found	25753638	Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.	Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu	Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
DRAMP20972	KLLRHRLLVTLA	12	JH-1 (Derived from  P3)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25753638] Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=6.25 μg/ml), Clinical Staphylococcus aureus (MIC=6.25 μg/ml), ;##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=3.125 μg/ml), Clinical Escherichia coli (MIC=6.25 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=12.5 μg/ml)	[Ref.25753638] 2% hemolysis at 50 μg/ml , 2.5% hemolysis at 100 μg/ml , 2.5% hemolysis at 200 μg/ml , 3% hemolysis at 300 μg/ml , 4% hemolysis at 400 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.25753638] The cell viability of HaCaT cell lines is 84% and 80% at peptide concentrations of 200 and 400 μg/ml. In Kunming mice, the LD50 of JH-1 is 94 mg/kg for i.p. injection, while the LD50 of PMB(served as a control) is 50 mg/kg. No mortality 	Not found	25753638	Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.	Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu	Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
DRAMP20973	VRFKLLSHSLLVTLASHL	18	JH-2 (Derived from  P3)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans	[Ref.25753638] Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=12.5 μg/ml), Clinical Staphylococcus aureus (MIC=6.25 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=6.25 μg/ml), Clinical Escherichia coli (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=6.25 μg/ml);##Fungi : Candida albicans ATCC 90029 (MIC=25 μg/ml), Candida albicans Clinical strain (MIC=25 μg/ml)	[Ref.25753638] 2% hemolysis at 50 [Ref.25753638] 2% hemolysis at 50 μg/ml , 2.5% hemolysis at 100 μg/ml , 3.5% hemolysis at 200 μg/ml , 4% hemolysis at 300 μg/ml , 4% hemolysis at 400 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.25753638] The cell viability of HaCaT cell lines is 88% and 84% at peptide concentrations of 200 and 400 μg/ml. In Kunming mice, the LD50 of JH-2 is 133 mg/kg for i.p. injection, while the LD50 of PMB(served as a control) is 50 mg/kg. no mortality	Not found	25753638	Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.	Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu	Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP20974	RRFKLLSHSLLVTLASHL	18	JH-3 (Derived from  P3)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans	[Ref.25753638]Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=6.25 μg/ml), Clinical Staphylococcus aureus (MIC=3.125 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=3.125 μg/ml), Clinical Escherichia coli (MIC=3.125 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=6.25 μg/ml);##Fungi : Candida albicans ATCC 90029 (MIC=12.5 μg/ml), Candida albicans Clinical strain (MIC=6.25 μg/ml)	[Ref.25753638] 8% hemolysis at 50 μg/ml , 13% hemolysis at 100 μg/ml , 17% hemolysis at 200 μg/ml , 18% hemolysis at 300 μg/ml , 18.5% hemolysis at 400 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.25753638] The cell viability of HaCaT cell lines is 86% and 86% at peptide concentrations of 200 and 400 μg/ml. In Kunming mice, the LD50 of JH-3 is 180 mg/kg for i.p. injection, , while the LD50 of PMB(served as a control) is 50 mg/kg. No mortali	Not found	25753638	Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.	Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu	Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)[C@@H](C)O)C(=O)O
DRAMP20975	KFFKKLKKAVKKGFKKFAKV	20	OH-CM6 (Derived from  OH-CATH30)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans	[Ref.22491685] Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=12.5 μg/ml), Staphylococcuss aureus ATCC 43300 MRSA (MIC=3.125 μg/ml), Staphylococcuss aureus clinical strain 1 (MIC=6.25 μg/ml), Staphylococcuss aureus clinical strain 2 (MIC=3.125 μg/ml), Staphylococcuss aureus clinical strain 3 (MIC=12.5 μg/ml), Enterococcus faecalis ATCC 29212 (MIC=25 μg/ml) ;##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=12.5 μg/ml), Escherichia coli ML-35p (MIC=6.25 μg/ml), Escherichia coli clinical strain 1 (MIC=12.5 μg/ml), Escherichia coli clinical strain 2 (MIC=3.125 μg/ml), Escherichia coli clinical strain 3 (MIC=1.56 μg/ml), Escherichia coli clinical strain 4 (MIC=12.5 μg/ml), Escherichia coli clinical strain 5 (MIC=6.25 μg/ml), Escherichia coli clinical strain 6 (MIC=3.125 μg/ml), Enterobacter cloacae ATCC 13047 (MIC>100 μg/ml), Enterobacter cloacae clinical strain (MIC>100 μg/ml), Enterobacter aerogenes clinical strain (MIC>100 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=12.5 μg/ml), Pseudomonas aeruginosa PA 01 (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain 1 (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain 2 (MIC=6.25 μg/ml), Haemophilus influenzae ATCC 49247 (MIC=3.125 μg/ml), Haemophilus influenzae ATCC 49766 (MIC=6.25 μg/ml), Klebsiella pneumoniae ATCC 13883 (MIC=6.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=3.125 μg/ml) ;##Fungi : Candida albicans ATCC 2002 (MIC>200 μg/ml), Candida albicans clinical strain (MIC>200 μg/ml)	[Ref.22491685] 13% hemolysis at 100 μg/ml , 17% hemolysis at 200 μg/ml , 18% hemolysis at 300 μg/ml , 18.5% hemolysis at 400 μg/ml against human red blood cells	Linear	Free	Free		L	[Ref.22491685] The cell viability of HaCaT cell lines is 76%, 62% and 53% at peptide concentrations of 50, 100, 200 μg/ml. In Kunming mice, the LD50 of OH-CATH30 is 120 mg/kg for i.p. injection, while those of pexiganan(control 1) and PMB(control 2) are	Not found	22491685	Antimicrob Agents Chemother. 2012 Jun;56(6):3309-17. doi: 10.1128/AAC.06304-11.	Sheng-An Li, Wen-Hui Lee, and Yun Zhang	Efficacy of OH-CATH30 and Its Analogs against Drug-ResistantBacteria In Vitro and in Mouse Models	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP20976	RKYVRFLHRWVKYFRAYL	18	"adevonin (Derived from Adenanthera pavonina trypsin inhibitor (ApTI))
inhibitor (ApTI))"	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Adevonin showed that its secondary structure varies according to the environment, acquiring 		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.30570384]Gram-positive bacteria : Staphylococcus aureus ATCC 80958 (MIC=7.35 μM);##Gram-negative bacteria : Escherichia coli ATCC 35218 (MIC=7.35 μM), Klebsiella oxytoca ATCC 13182 (MIC=1.84 μM), Klebsiella pneumoniae ATCC 70603 (MIC=3.67 μM), Serratia marcesens ATCC 13880 (MIC=1.84 μM), Klebsiella pneumoniae KpC+ 001825971 (MIC=25.6 μM)	[Ref.30570384] 0% hemolysis at 43.75 μM , 72.5% hemolysis at 175 μM , 77% hemolysis at 350 μg/ml against human type O erythrocytes	Linear	Free	Free		L	[Ref.30570384] In fibroblasts, a significant reduction of cell viability, of 25% on average, is observed in each time interval(24,48 and 72h) in the highest peptide concentration(10 μM)	Not found	30570384	Pathog Glob Health.?2018 Dec;112(8):438-447. doi: 10.1080/20477724.2018.1559489.	Mayara S. Rodrigues, Caio F. R. de Oliveira, Luís H. O. Almeida, Simone M.Neto, Ana Paula A. Boleti, Edson L. dos Santos, Marlon H. Cardoso, Suzana,M. Ribeiro, Octávio L. Franco, Fernando S. Rodrigues, Alexandre J. Macedo,Flávia R. Brust & Maria Lígia R. Macedo	Adevonin, a novel synthetic antimicrobial peptide designed from the Adenanthera pavonina trypsin inhibitor (ApTI) sequence	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)O
DRAMP20977	WLLKRWKKLL	10	Anoplin-1 (Derived from  Anoplin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25316570]Gram-positive bacteria : Staphylococcus aureus (MIC=32 μg/ml), bacillus subtilis (MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli (MIC=64 μg/ml), Peudomonas eruginosa (MIC=8 μg/ml)	[Ref.25316570] 0% hemolysis at 100 μg/ml , 1% hemolysis at 200 μg/ml against mice red blood cells	Linear	Free	Amidation		L	[Ref.25316570] No cytotoxicity information found	Not found	25316570	J Pept Sci. 2014 Dec;20(12):945-51. doi: 10.1002/psc.2705.	Yang Wang, Jianbo Chen, Xin Zheng, Xiaoli Yang, Panpan Ma,Ying Cai,Bangzhi Zhangb,and Yuan Chen	Design of novel analogues of short antimicrobial peptide anoplin with improved antimicrobial activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(N)=O
DRAMP20978	wllkrwkkll	10	Anoplin-2 (Derived from  Anoplin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25316570]Gram-positive bacteria : Staphylococcus aureus (MIC=16 μg/ml), bacillus subtilis (MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli (MIC=16 μg/ml), Peudomonas eruginosa (MIC=8 μg/ml)	[Ref.25316570] 0% hemolysis at 25 μg/ml , 1% hemolysis at 50 μg/ml , 0% hemolysis at 100 μg/ml , 0.5% hemolysis at 200 μg/ml against mice red blood cells	Linear	Free	Amidation		D	[Ref.25316570] No cytotoxicity information found	Not found	25316570	J Pept Sci. 2014 Dec;20(12):945-51. doi: 10.1002/psc.2705.	Yang Wang, Jianbo Chen, Xin Zheng, Xiaoli Yang, Panpan Ma,Ying Cai,Bangzhi Zhangb,and Yuan Chen	Design of novel analogues of short antimicrobial peptide anoplin with improved antimicrobial activity	CC(C)C[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](N)Cc1c[nH]c2ccccc12)C(N)=O
DRAMP20979	KLLKWWKKLL	10	Anoplin-3 (Derived from  Anoplin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25316570]Gram-positive bacteria : Staphylococcus aureus (MIC=16 μg/ml), bacillus subtilis (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli (MIC=16 μg/ml), Peudomonas eruginosa (MIC=8 μg/ml)	[Ref.25316570] 0% hemolysis at 12.5 μg/ml , 0.5% hemolysis at 25 μg/ml , 0.5% hemolysis at 50 μg/ml , 4% hemolysis at 100 μg/ml , 14% hemolysis at 200 μg/ml against mice red blood cells	Linear	Free	Amidation		L	[Ref.25316570] No cytotoxicity information found	Not found	25316570	J Pept Sci. 2014 Dec;20(12):945-51. doi: 10.1002/psc.2705.	Yang Wang, Jianbo Chen, Xin Zheng, Xiaoli Yang, Panpan Ma,Ying Cai,Bangzhi Zhangb,and Yuan Chen	Design of novel analogues of short antimicrobial peptide anoplin with improved antimicrobial activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP20980	kllkwwkkll	10	Anoplin-4 (Derived from  Anoplin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25316570]Gram-positive bacteria : Staphylococcus aureus (MIC=8 μg/ml), bacillus subtilis (MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli (MIC=8 μg/ml), Peudomonas eruginosa (MIC=8 μg/ml)	[Ref.25316570] 0.5% hemolysis at 12.5 μg/ml , 0.5% hemolysis at 25 μg/ml , 2% hemolysis at 50 μg/ml , 1% hemolysis at 100 μg/ml , 4% hemolysis at 200 μg/ml against mice red blood cells	Linear	Free	Amidation		D	[Ref.25316570] No cytotoxicity information found	Not found	25316570	J Pept Sci. 2014 Dec;20(12):945-51. doi: 10.1002/psc.2705.	Yang Wang, Jianbo Chen, Xin Zheng, Xiaoli Yang, Panpan Ma,Ying Cai,Bangzhi Zhangb,and Yuan Chen	Design of novel analogues of short antimicrobial peptide anoplin with improved antimicrobial activity	CC(C)C[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](N)CCCCN)C(N)=O
DRAMP20981	GFGSLLGKALRLGANVL	17	CPF-C1 (Frogs, Amphibians, Animals)	No entry found	Not found	Not found	Tetraploid frog Xenopus clivii	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Not found	Random coil, alpha helix	CPF-C1 revealed a random coil structure in PBS, displayed typical 		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=4 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=32 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=32 μg/ml), Pseudomonas aeruginosa 2760 (MIC=128 μg/ml), Pseudomonas aeruginosa 9132 (MIC=64 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=4 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)	[Ref.28371431] 0% hemolysis at 32 μg/ml , 5% hemolysis at 64 μg/ml , 7% hemolysis at 128 μg/ml , 15% hemolysis at 256 μg/ml , 57% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(N)=O
DRAMP20982	KFWSLLKKALRLWANVL	17	CPF-1 (Derived from  CPF-C1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	CPF-1 displayed typical 		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=32 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=32 μg/ml), Pseudomonas aeruginosa 2760 (MIC=32 μg/ml), Pseudomonas aeruginosa 9132 (MIC=64 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)	[Ref.28371431] 0% hemolysis at 0 μg/ml , 5% hemolysis at 4 μg/ml , 8% hemolysis at 8 μg/ml , 20% hemolysis at 16 μg/ml , 35% hemolysis at 32 μg/ml , 58% hemolysis at 64 μg/ml , 70% hemolysis at 128 μg/ml , 78% hemolysis at 256 μg/ml , 80% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(N)=O
DRAMP20983	kFwSLLkKALRLwANVL	17	CPF-2 (Derived from  CPF-C1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	CPF-2 displayed typical 		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)	[Ref.28371431] 0% hemolysis at 4 μg/ml , 5% hemolysis at 8 μg/ml , 8% hemolysis at 16 μg/ml , 24% hemolysis at 32 μg/ml , 48% hemolysis at 64 μg/ml , 68% hemolysis at 128 μg/ml , 85% hemolysis at 256 μg/ml , 90% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		Mixed(D-Lys1, D-Trp3, D-Lys7, D-Trp13)	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](N)CCCCN)C(C)C)C(N)=O
DRAMP20984	KFWKLLKKALRLWAKVL	17	CPF-3 (Derived from  CPF-C1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	CPF-3 displayed typical 		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)	[Ref.28371431] 0% hemolysis at 256 μg/ml , 5% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(N)=O
DRAMP20985	kFWKlLKkAlrLWAkVL	17	CPF-4 (Derived from  CPF-C1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=16 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=32 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)	[Ref.28371431] 0% hemolysis at 32 μg/ml , 5% hemolysis at 64 μg/ml , 8% hemolysis at 128 μg/ml , 10% hemolysis at 256 μg/ml , 25% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		Mixed(D-Lys1, D-Leu5, D-Lys8, D-Leu10, D-Arg11, D-Lys15)	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](N)CCCCN)C(C)C)C(N)=O
DRAMP20986	kFwKLLkKALrLwAkVL	17	CPF-5 (Derived from  CPF-C1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=8 μg/ml), Acinetobacter baumannii 4956 (MIC=8 μg/ml)	[Ref.28371431] 0% hemolysis at 16 μg/ml , 5% hemolysis at 32 μg/ml , 10% hemolysis at 64 μg/ml , 20% hemolysis at 128 μg/ml , 40% hemolysis at 256 μg/ml , 37% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		Mixed(D-Lys1, D-Trp3, D-Lys7, D-Arg11, D-Trp13, D-Lys15)	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](N)CCCCN)C(C)C)C(N)=O
DRAMP20987	lFwKLLlKAlrLwAkVL	17	CPF-6 (Derived from  CPF-C1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=16 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=64 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC8=μg/ml), Acinetobacter baumannii 2982 (MIC=8 μg/ml), Acinetobacter baumannii 4956 (MIC=8 μg/ml)	[Ref.28371431] 0% hemolysis at 4 μg/ml , 3% hemolysis at 8 μg/ml , 17.5% hemolysis at 16 μg/ml , 45% hemolysis at 32 μg/ml , 70% hemolysis at 64 μg/ml , 80% hemolysis at 128 μg/ml , 85% hemolysis at 256 μg/ml , 90% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		Mixed(D-Leu1, D-Trp3, D-Leu7, D-Leu10, D-Arg11, D-Trp13, D-Lys15)	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP20988	WFKKLLKKALRLWKKVL	17	CPF-7 (Derived from  CPF-C1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	CPF-7 displayed typical 		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=16 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=32 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)	[Ref.28371431] 0% hemolysis at 4 [Ref.28371431] 0% hemolysis at 4 μg/ml , 5% hemolysis at 8 μg/ml , 23% hemolysis at 16 μg/ml , 50% hemolysis at 32 μg/ml , 70% hemolysis at 64 μg/ml , 95% hemolysis at 128 μg/ml , 90% hemolysis at 256 μg/ml , 100% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(N)=O
DRAMP20989	wFKKlLKkAlrLWKkVL	17	CPF-8 (Derived from  CPF-C1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=8 μg/ml), Acinetobacter baumannii 4956 (MIC=8 μg/ml)	[Ref.28371431]13% hemolysis at 4 μg/ml , 5% hemolysis at 8 μg/ml , 0% hemolysis at 16 μg/ml , 0% hemolysis at 32 μg/ml , 0% hemolysis at 64 μg/ml , 0% hemolysis at 128 μg/ml , 0% hemolysis at 256 μg/ml , 0% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		Mixed(D-Trp1, D-Leu5, D-Lys8, D-Leu10, D-Arg11, D-Lys15)	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(N)=O
DRAMP20990	kFwKLLkKAlrLwKkVL	17	CPF-9 (Derived from  CPF-C1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=64 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=8 μg/ml), Acinetobacter baumannii 4956 (MIC=8 μg/ml)	[Ref.28371431]0% hemolysis at 256 μg/ml , 5% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		Mixed(D-Lys1, D-Trp3, D-Lys7, D-Leu10, D-Arg11, D-Trp13, D-Lys15)	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](N)CCCCN)C(C)C)C(N)=O
DRAMP20991	wFwKLLwKAlrLwWkVL	17	CPF-10 (Derived from  CPF-C1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=32 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=32 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=256 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=16 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)	[Ref.28371431]0% hemolysis at 4 μg/ml , 5% hemolysis at 8 μg/ml , 21% hemolysis at 16 μg/ml , 40% hemolysis at 32 μg/ml , 56% hemolysis at 64 μg/ml , 65% hemolysis at 128 μg/ml , 73% hemolysis at 256 μg/ml , 85% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		Mixed(D-Trp1, D-Trp3, D-Trp7, D-Leu10, D-Arg11, D-Trp13, D-Lys15)	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(N)=O
DRAMP20992	lLKkAlrLWKkVL	13	CPF-11 (Derived from  CPF-C1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=64 μg/ml), Staphylococcuss aureus 725 (MIC=32 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=64 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=32 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=16 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=128 μg/ml), Acinetobacter baumannii 1980 (MIC=64 μg/ml), Acinetobacter baumannii 2982 (MIC=64 μg/ml), Acinetobacter baumannii 4956 (MIC=32 μg/ml)	[Ref.28371431]2% hemolysis at 4 μg/ml , 3% hemolysis at 8 μg/ml , 1% hemolysis at 16 μg/ml , 0% hemolysis at 32 μg/ml , 0% hemolysis at 64 μg/ml , 0% hemolysis at 128 μg/ml , 10% hemolysis at 256 μg/ml , 20% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		Mixed(D-Leu1, D-Lys4, D-Leu6, D-Arg7, D-Lys11)	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP20993	LLwKAlrLwWkVL	13	CPF-12 (Derived from  CPF-C1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=32 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=64 μg/ml), Pseudomonas aeruginosa 2760 (MIC=64 μg/ml), Pseudomonas aeruginosa 9132 (MIC>256 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=16 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)	[Ref.28371431]0% hemolysis at 4 μg/ml , 3% hemolysis at 8 μg/ml , 0% hemolysis at 16 μg/ml , 0% hemolysis at 32 μg/ml , 0% hemolysis at 64 μg/ml , 3% hemolysis at 128 μg/ml , 8% hemolysis at 256 μg/ml , 38% hemolysis at 512 μg/ml against human red blood cells	Linear	Free	Amidation		Mixed(D-Trp3, D-Leu6, D-Arg7, D-Trp9, D-Lys11)	[Ref.28371431] No cytotoxicity information found	Not found	28371431	Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.	Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang	Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(N)=O
DRAMP20994	GLLKFIKKLL	10	anoplin analog 4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida parapsilosis	[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=15 μg/ml), Bacillus subtilis DELTA (MIC=30 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=300 μg/ml), Zymomonas mobilis 10988 (MIC=7 μg/ml);##Fungi : Candida parapsilosis (MIC=40 μg/ml)	[Ref.27862650]0% hemolysis at 55μg/ml , 7% hemolysis at 100μg/ml , 17% hemolysis at 200μg/ml , 24% hemolysis at 300 μg/ml , 33% hemolysis at 400μg/ml , 35% hemolysis at 500 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.27862650] No cytotoxicity information found	Not found	27862650	J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.	Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis	Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP20995	KLLKFIKKLL	10	anoplin analog 5	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida parapsilosis	[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=15 μg/ml), Bacillus subtilis DELTA (MIC=40 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=400 μg/ml), Zymomonas mobilis 10988 (MIC=10 μg/ml);##Fungi : Candida parapsilosis (MIC=30 μg/ml)	[Ref.27862650]0% hemolysis at 100 μg/ml , 4% hemolysis at 200 μg/ml , 11% hemolysis at 300 μg/ml , 13% hemolysis at 400 μg/ml , 15% hemolysis at 500 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.27862650] No cytotoxicity information found	Not found	27862650	J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.	Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis	Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP20996	RLLKFIKKLL	10	anoplin analog 6	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida parapsilosis	[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=20 μg/ml), Bacillus subtilis DELTA (MIC=40 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=400 μg/ml), Zymomonas mobilis 10988 (MIC=10 μg/ml);##Fungi : Candida parapsilosis (MIC=30 μg/ml)	[Ref.27862650]0% hemolysis at 300 μg/ml , 3% hemolysis at 400 μg/ml , 12% hemolysis at 500 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.27862650] No cytotoxicity information found	Not found	27862650	J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.	Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis	Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP20997	GLLKFIKKLL	10	anoplin analog 7	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=30 μg/ml), Pseudomonas aeruginosa PAO (MIC=5 μg/ml), Zymomonas mobilis 10988 (MIC=5 μg/ml)	[Ref.27862650]3% hemolysis at 100 μg/ml , 5% hemolysis at 200 μg/ml , 9% hemolysis at 300 μg/ml , 8% hemolysis at 400 μg/ml , 7% hemolysis at 500 μg/ml against human red blood cells	Linear	Acylation (Conjugated with octanoic acid)	Amidation		L	[Ref.27862650] No cytotoxicity information found	Not found	27862650	J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.	Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis	Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin	CCCCCCCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP20998	GLLKFIKKLL	10	anoplin analog 8	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=30 μg/ml), Pseudomonas aeruginosa PAO (MIC=5 μg/ml), Zymomonas mobilis 10988 (MIC=5 μg/ml)	[Ref.27862650]10% hemolysis at 50 μg/ml , 12% hemolysis at 100 μg/ml , 10% hemolysis at 400 μg/ml , 11% hemolysis at 500 μg/ml against human red blood cells	Linear	Acylation (Conjugated with decanoic acid) 	Amidation		L	[Ref.27862650] No cytotoxicity information found	Not found	27862650	J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.	Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis	Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin	CCCCCCCCCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP20999	GLLKFIKKLL	10	anoplin analog 9	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=40 μg/ml), Pseudomonas aeruginosa PAO (MIC=5 μg/ml), Zymomonas mobilis 10988 (MIC=30 μg/ml)	[Ref.27862650]10% hemolysis at 50 μg/ml , 12% hemolysis at 100 μg/ml , 10% hemolysis at 400 μg/ml , 11% hemolysis at 500 μg/ml against human red blood cells	Linear	Acylation (Conjugated with dodecanoic acid)	Amidation		L	[Ref.27862650] No cytotoxicity information found	Not found	27862650	J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.	Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis	Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin	CCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP21000	GCRRLCYKQRCVTYCRGR	18	cGm (Derived from Gm)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=32 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=4 μM), Escherichia coli CGSC 5167 (MIC=0.06 μM), Klebsiella pneumoniae ATCC 700603 (MIC=4-8 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1-4 μM), Helicobacter pylori ATCC 43504 (MIC= μM);##Fungi : Candida albicans ATCC 90028 (MIC=4-8 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)	[Ref.28741926] 5% hemolysis at 0.03 μM , 0% hemolysis at 1.1 μM , 10% hemolysis at 17 μM , 50% hemolysis at 100μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bond between Cys2 and Cys15,Cys6 and Cys11.	L	[Ref.28741926] CC50 = 39.8 ± 1.0 μM against CRL-1739, CC50 = 2.9 ± 0.1 μM against MM96L, CC50 = 71.7 ± 9.2 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 15.3 ± 1.4 μM against MCF-7, CC50 = 2.7 ± 0.1 μM against K-562, CC50 = 12.7 ± 1.1 μM PBMCs.	Not found	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?	Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP21001	GCRRLCWKQRCVTYCRGR	18	[Y7W]cGm (Derived from Gm)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1-2 μM)	[Ref.28741926] 35.1-55.5% hemolysis at 64 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.	L	[Ref.28741926] CC50 = 23.3 ± 0.4 μM against CRL-1739, CC50 = 5.1 ± 0.3 μM against MM96L, CC50 = 39.7 ± 3.8 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 3.9 ± 0.2 μM against K-562. 	Not found	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?	Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP21002	GCRRLCYKQRCVTWCRGR	18	[Y14W]cGm (Derived from Gm) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1-2 μM)	[Ref.28741926] 46.1-55.5% hemolysis at 64 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.	L	[Ref.28741926] CC50 = 30.3 ± 1.1 μM against CRL-1739, CC50 = 4.0 ± 0.1 μM against MM96L, CC50 = 68.4 ± 9.6 μM against HFF-1, CC50 = 50.4 ± 2.4 μM against HeLa, CC50 = 2.7 ± 0.1 μM against K-562. 	Not found	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?	Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP21003	GCRRLCYRQRCVTYCRGR	18	[K8R]cGm (Derived from Gm) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1-2 μM)	[Ref.28741926] 34.8-54.8% hemolysis at 64 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.	L	[Ref.28741926] CC50 = 29.4 ± 1.1 μM against CRL-1739, CC50 = 5.0 ± 0.3 μM against MM96L, CC50 = 34.5 ± 3.6 μM against HFF-1, CC50 = 39.4 ± 2.6 μM against HeLa, CC50 = 3.1 ± 0.1 μM against K-562.	Not found	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?	Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP21004	GCRRLCWRQRCVTWCRGR	18	[Y7W, K8R, Y14W]cGm (Derived from Gm) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1 μM)	[Ref.28741926] 42-49.8% hemolysis at 64 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.	L	[Ref.28741926] CC50 = 31.6 ± 1.3 μM against CRL-1739, CC50 = 5.4 ± 0.3 μM against MM96L, CC50 = 31.3 ± 2.6 μM against HFF-1, CC50 = 41.0 ± 4.2 μM against HeLa, CC50 = 15.1 ± 1.4 μM against MCF-7, CC50 = 3.9 ± 0.1 μM against K-562.	Not found	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?	Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP21005	GCRALCYKQRCVTYCRGA	18	[R4A, R18A]cGm (Derived from Gm) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=32 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μM), Escherichia coli CGSC 5167 (MIC=0.5-1 μM), Klebsiella pneumoniae ATCC 700603 (MIC=32 μM), Acinetobacter baumannii ATCC 19606 (MIC=8-16 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=32 μM), Cryptococcus neoformans ATCC 208821 (MIC=8-16 μM)	[Ref.28741926] 0% hemolysis at 17 μM , 3% hemolysis at 35 μM , 30-48.6% hemolysis at 64 μM , 40% hemolysis at 100 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.	L	[Ref.28741926] CC50 > 64 μM against CRL-1739, CC50 = 10.3 ± 1.1 μM against MM96L, CC50 = 51.2 ± 4.0 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 48.4 ± 0.7 μM against MCF-7, CC50 = 11.5 ± 0.6 μM against K-562, CC50 = 34.1 ± 3.9 μM against HL-60;CC50=30.8 ± 2.5μM against PBMCs.	Not found	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?	Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP21006	KCRRLCYRQRCVTYCRGR	18	[G1K, K8R]cGm (Derived from Gm) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=2 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=0.5-1 μM), Escherichia coli CGSC 5167 (MIC<0.015 μM), Klebsiella pneumoniae ATCC 700603 (MIC=8 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC<0.25 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=2 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.125-0.25 μM)	[Ref.28741926] 0% hemolysis at 0.5 μM , 2.5% hemolysis at 0.6 μM , 20% hemolysis at 8 μM , 43.3-56.9% hemolysis at 64 μM , 50% hemolysis at 100 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.	L	[Ref.28741926] CC50 = 19.5 ± 0.5 μM against CRL-1739, CC50 = 1.7 ± 0.1 μM against MM96L, CC50 = 9.0 ± 0.5 μM against HFF-1, CC50 = 44.2 ± 2.2μM against HeLa, CC50 = 6.7 ± 0.7 μM against MCF-7, CC50 = 2.1 ± 0.2 μM against K-562, CC50 = 9.0 ± 1.1μM against HL-60;CC50=5.1 ± 0.3μM against PBMCs.	Not found	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?	Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP21007	GURRLUYKQRUVTYURGR	18	[C/U]cGm (Derived from Gm) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=4-8 μM), Escherichia coli CGSC 5167 (MIC=0.03-0.06 μM), Klebsiella pneumoniae ATCC 700603 (MIC=8-16 μM), Acinetobacter baumannii ATCC 19606 (MIC=4 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=2-4 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=4-8 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)	[Ref.28741926] 32.3-33.3% hemolysis at 64 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between SeCys2 and SeCys15, SeCys6 and SeCys11. The 'U' in sequence is SelenoCys.	L	[Ref.28741926] CC50 = 51.0 ± 4.6 μM against CRL-1739, CC50 = 4.6 ± 0.2 μM against MM96L, CC50 = 15.6 ± 3.6 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 37.5 ± 3.3 μM against MCF-7, CC50 = 1.4 ± 0.2 μM against K-562, CC50 = 38.5 ± 4.8 μM against HL-60;CC50=15.5 ± 0.8μM against PBMCs.	Not found	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?	Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP21008	GCRRWCYKQRCVTYCRGR	18	[L5W]cGm (Derived from Gm) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria	[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8-16 μM)	[Ref.28741926] 36.8-43.4% hemolysis at 64 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.	L	[Ref.28741926] CC50 = 18.3 ± 1.4 μM against CRL-1739, CC50 = 4.0 ± 0.1 μM against MM96L, CC50 = 25.0 ± 2.9 μM against HFF-1, CC50 = 17.1 ± 0.7 μM against HeLa, CC50 = 1.0 ± 0.1 μM against K-562. 	Not found	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?	Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP21009	GCRRLCYKQRCVTYCRGpPR	20	[D-P L-P]cGm (Derived from Gm) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=4 μM), Klebsiella pneumoniae ATCC 700603 (MIC=1-4 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-4 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=4 μM);##Fungi : Candida albicans ATCC 90028 (MIC=8 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)	[Ref.28741926] 41.5-44.9% hemolysis at 64 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.	L	[Ref.28741926] CC50 = 22.5 ± 3.3 μM against CRL-1739, CC50 = 3.0 ± 0.1 μM against MM96L, CC50 = 14.9 ± 0.8 μM against HFF-1, CC50 = 51.5 ± 3.9 μM against HeLa, CC50 = 3.9 ± 0.2 μM against K-562, CC50 = 14.1 ± 0.9 μM against PBMCs	Not found	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?	Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP21010	KCRRYCYRQRCVTYCRGR	18	[G1K, L5Y, K8R]cGm (Derived from Gm) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=0.5-1 μM), Klebsiella pneumoniae ATCC 700603 (MIC=4-8 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC<0.25-0.5 μM);##Fungi : Candida albicans ATCC 90028 (MIC=4 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5 μM)	[Ref.28741926] 20.6-32% hemolysis at 64 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.	L	[Ref.28741926] CC50 = 26.5 ± 2.4 μM against CRL-1739, CC50 = 2.0 ± 0.1 μM against MM96L, CC50 = 14.7 ± 1.5 μM against HFF-1, CC50 = 20.9 ± 1.4 μM against HeLa, CC50 = 15.2 ± 1.9 μM against MCF-7, CC50 = 1.3 ± 0.1 μM against K-562, CC50 = 15.7 ±1.1μM against HL-60;CC50=10.4 ± 1.0μM against PBMCs.	Not found	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?	Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP21011	KURRYUYRQRUVTYURGR	18	[C/U, G1K, L5Y, K8R]cGm (Derived from Gm)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1-2 μM), Klebsiella pneumoniae ATCC 700603 (MIC=4-16 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1 μM);##Fungi : Candida albicans ATCC 90028 (MIC=4 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)	[Ref.28741926] 17.8-24% hemolysis at 64 μM against human red blood cells	Cyclic	No specific N-terminal	No specific C-terminal	Disulfide bonds between SeCys2 and SeCys15, SeCys6 and SeCys11. The 'U' in sequence is SelenoCys.	L	[Ref.28741926] CC50 = 46.2 ± 7.6 μM against CRL-1739, CC50 = 2.3 ± 0.2 μM against MM96L, CC50 = 30.8 ± 2.0 μM against HFF-1, CC50 = 36.2 ± 2.8 μM against HeLa, CC50 = 29.0 ± 3.7 μM against MCF-7, CC50 = 6.4 ± 0.6 μM against K-562, CC50 = 33.3 ±7.4μM against HL-60;CC50=9.5 ± 0.5μM against PBMCs.	Not found	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?	Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP21012	KILRGVCKKIMRTFLRRISKDILTGKK	27	NK-2 (Mammals, Animals)	No entry found	Not found	Not found	Mammal	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor	Not found	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.29043494]Gram-positive bacteria : Staphylococcus aureus (MIC=2 μM), Staphylococcus epidermidis (MIC=2 μM);##Gram-negative bacteria : Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=8 μM)	[Ref.29043494] 2.5% hemolysis at 10 μg/ml , 8% hemolysis at 25 μg/ml , 22% hemolysis at 50 μg/ml , 32.5% hemolysis at 75 μg/ml , 36% hemolysis at 150 μg/ml , 38% hemolysis at 300 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.29043494] IC50 = 25.1 μM against NK-2. ##IC50 = 8.4 μM against EJ. ##IC50 = 4.1 μM against PC-3. ##IC50 = 10.1 μM against T24. ##IC50 = 13.7  μM against HL-60. ##The proliferation inhibition activity on K562 is not significant.	Not found	29043494	Probiotics Antimicrob Proteins. 2018 Mar;10(1):118-127. doi: 10.1007/s12602-017-9335-1.	Jiexi Yan & Xiaolei Liang & Chang Liu & Yuemei Cheng & Lanxia Zhou & Kairong Wang & Li Zhao	Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP21013	KILRGVCKKIMRPFLRRISKDILTGKK	27	NK-pro (Derived from NK-2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.29043494]Gram-positive bacteria : Staphylococcus aureus (MIC=4 μM), Staphylococcus epidermidis (MIC=4 μM);##Gram-negative bacteria : Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=16 μM)	[Ref.29043494] 0.3% hemolysis at 10 μg/ml , 2% hemolysis at 25 μg/ml , 5.5% hemolysis at 50 μg/ml , 8% hemolysis at 75 μg/ml , 15% hemolysis at 150 μg/ml , 28% hemolysis at 300 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.29043494] IC50 = 43.7 μM against NK-2. ##IC50 = 23.3 μM against EJ. ##IC50 = 9.3 μM against PC-3. ##IC50 = 33.0 μM against T24. ##IC50 = 26.1  μM against HL-60. ####The proliferation inhibition activity on K562 is not significant.	Not found	29043494	Probiotics Antimicrob Proteins. 2018 Mar;10(1):118-127. doi: 10.1007/s12602-017-9335-1.	Jiexi Yan & Xiaolei Liang & Chang Liu & Yuemei Cheng & Lanxia Zhou & Kairong Wang & Li Zhao	Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP21014	KILPGVCKKIMRPFLRRISKDILTGKK	27	NK-dpro (Derived from NK-2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.29043494]Gram-positive bacteria : Staphylococcus aureus (MIC=8 μM), Staphylococcus epidermidis (MIC=8 μM);##Gram-negative bacteria : Escherichia coli (MIC=8 μM), Pseudomonas aeruginosa (MIC=32 μM)	[Ref.29043494] 0% hemolysis at 10 μg/ml , 2% hemolysis at 25 μg/ml , 3% hemolysis at 50 μg/ml , 4.5% hemolysis at 75 μg/ml , 10% hemolysis at 150 μg/ml , 20% hemolysis at 300 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.29043494] IC50 = 32.5 μM against NK-2. ##IC50 = 28.7 μM against EJ. ##IC50 = 9.6 μM against PC-3. ##IC50 = 39.6 μM against T24. ##IC50 = 48.4  μM against HL-60. ##The proliferation inhibition activity on K562 is not significant.	Not found	29043494	Probiotics Antimicrob Proteins. 2018 Mar;10(1):118-127. doi: 10.1007/s12602-017-9335-1.	Jiexi Yan & Xiaolei Liang & Chang Liu & Yuemei Cheng & Lanxia Zhou & Kairong Wang & Li Zhao	Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP21015	RIGSILGALAKGLPTLISWIKNR	23	A (A1R) (Derived from AR-23)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=6.25 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=6.25 μM), Klebsiella pneumoniae (MIC=12.5 μM)	[Ref.27271216] 100% hemolysis at  20μM against human red blood cells	Linear	Free	Amidation		L	[Ref.27271216] In L929 cells, the cell viability is 82%, 40%, 8%, 2% and almost 0% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.	Not found	27271216	Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.	Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji	Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP21016	AIGSILGRLAKGLPTLISWIKNR	23	A (A8R) (Derived from AR-23)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=3.13 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=12.5 μM)	[Ref.27271216] 80% hemolysis at 20 μM , 100% hemolysis at 40 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.27271216] In L929 cells, the cell viability is 97%, 58%, 10%, 2% and almost 0% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.	Not found	27271216	Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.	Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji	Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC
DRAMP21017	AIGSILGALAKGLPTLKSWIKNR	23	A (I17K) (Derived from AR-23)  	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=50 μM), Staphylococcus epidermidis (MIC=12.5 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (MIC=25 μM), Pseudomonas aeruginosa (MIC=25 μM), Klebsiella pneumoniae (MIC=50 μM)	[Ref.27271216] 5% hemolysis at 20 μM , 13% hemolysis at 40 μM , 20% hemolysis at 60 μM , 30% hemolysis at 80 μM , 35% hemolysis at 100 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.27271216] In L929 cells, the cell viability is 98%, 92%, 53%, 34% and 7.9% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.	Not found	27271216	Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.	Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji	Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC
DRAMP21018	AIGSILGALAKGLPTLRSWIKNR	23	A (I17R) (Derived from AR-23)  	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=25 μM), Staphylococcus epidermidis (MIC=6.25 μM), Bacillus subtilis (MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=25 μM)	[Ref.27271216] 10% hemolysis at 20 μM , 15% hemolysis at 40 μM , 20% hemolysis at 60 μM , 30% hemolysis at 80 μM , 35% hemolysis at 100 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.27271216] In L929 cells, the cell viability is 85%, 68%, 21% and 6.6% at peptide concentrations of 6.25, 12.5, 25 and 50 μM. 	Not found	27271216	Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.	Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji	Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC
DRAMP21019	RIGSILGRLAKGLPTLISWIKNR	23	A (A1R, A8R) (Derived from AR-23)  	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=12.5 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=6.25 μM), Klebsiella pneumoniae (MIC=6.25 μM)	[Ref.27271216] 58% hemolysis at 20 μM , 80% hemolysis at 40 μM , 100% hemolysis at 60 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.27271216] In L929 cells, the cell viability is 92%, 80%, 29%, 1% and almost 0% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.	Not found	27271216	Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.	Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji	Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP21020	RIGSILGALAKGLPTLKSWIKNR	23	A (A1R, I17K) (Derived from AR-23)  	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=100 μM), Staphylococcus epidermidis (MIC=6.25 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (MIC=25 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=25 μM)	[Ref.27271216] 2% hemolysis at 20 μM , 5% hemolysis at 40 μM , 10% hemolysis at  60 μM , 20% hemolysis at 80 μM , 30% hemolysis at 100 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.27271216] In L929 cells, the cell viability is 95%, 92%, 60%, 33% and 24% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.	Not found	27271216	Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.	Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji	Design of an Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@@H](C)O
DRAMP21021	AIGSILGRLAKGLPTLKSWIKNR	23	A (A8R, I17K) (Derived from AR-23)  	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=100 μM), Staphylococcus epidermidis (MIC=6.25 μM), Bacillus subtilis (MIC=12.5 μM);##Gram-negative bacteria : Escherichia coli (MIC=25 μM), Pseudomonas aeruginosa (MIC=25 μM), Klebsiella pneumoniae (MIC=25 μM)	[Ref.27271216] 2% hemolysis at 20 [Ref.27271216] 2% hemolysis at 20 μM , 5% hemolysis at 40 μM , 10% hemolysis at  60 μM , 20% hemolysis at 80 μM , 30% hemolysis at 100 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.27271216] In L929 cells, the cell viability is 100%, 99%, 92%, 64% and 21.1% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.	Not found	27271216	Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.	Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji	Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC
DRAMP21022	RIGSILGRLAKGLPTLKSWIKNR	23	A (A1R, A8R, I17K) (Derived from AR-23)  	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=100 μM), Staphylococcus epidermidis (MIC=6.25 μM), Bacillus subtilis (MIC=12.5 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=12.5 μM)	[Ref.27271216] 0% hemolysis at 40 μM , 1% hemolysis at 60 μM , 2% hemolysis at  80 μM , 2% hemolysis at 100 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.27271216] In L929 cells, the cell viability is 96%, 95%, 92%, 68% and 31.4% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM	Not found	27271216	Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.	Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji	Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@@H](C)O
DRAMP21023	RIGSILGRLAKGLPTLRSWIKNR	23	A (A1R, A8R, I17R) (Derived from AR-23) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=100 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=12.5 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=12.5 μM)	[Ref.27271216] 4% hemolysis at 40 μM , 10% hemolysis at 60 μM , 15% hemolysis at 80 μM , 20% hemolysis at 100 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.27271216] In L929 cells, the cell viability is 92%, 92%, 80%, 60% and 12% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM 	Not found	27271216	Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.	Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji	Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@@H](C)O
DRAMP21024	FFSLIPSLVGGLISAFK	17	Stigmurin (Tityus, Scorpionida, Arachnida)	No entry found	Not found	Not found	Scorpion Tityus stigmurus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida glabrata, Candida krusei	[Ref.30709056]Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=9.4 μM), Staphylococcus epidermidis (ATCC 12228)(MIC=9.4 μM), Enterococcus faecalis (ATCC 4028)(MIC>150 μM);##Gram-negative bacteria : Pseudomonas aeruginosa (ATCC 27853)(MIC>150 μM), Escherichia coli (ATCC 25922)(MIC>150 μM), Enterobacter cloacae (ATCC 13047)(MIC>150 μM);##Fungi : Candida albicans (ATCC 90028)(MIC=37.5 μM), Candida glabrata (ATCC 90030)(MIC>150 μM), Candida krusei (ATCC 6258)(MIC>150 μM)	[Ref.30709056] 7% hemolysis at 1.2 μg/ml , 4% hemolysis at 2.3 μg/ml , 2% hemolysis at 4.7 μg/ml , 0% hemolysis at 9.4 μg/ml , 3% hemolysis at 18.8 μg/ml , 2% hemolysis at 37.5 μg/ml , 3% hemolysis at 75 μg/ml , 5% hemolysis at 150 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.30709056] No cytotoxicity information found.	Not found	30709056	Int J Mol Sci. 2019 Jan 31;20(3). pii: E623. doi: 10.3390/ijms20030623.	Bruno Amorim-Carmo , Alessandra Daniele-Silva , Adriana M. S. Parente ,Allanny A. Furtado , Eneas Carvalho , Johny W. F. Oliveira , Elizabeth C. G. Santos , Marcelo S. Silva , Sérgio R. B. Silva , Arnóbio A. Silva-Júnior , Norberto K. Monteiro and Matheus F. Fernandes-Pedrosa	Potent and Broad-Spectrum Antimicrobial Activity of Analogs from the Scorpion Peptide Stigmurin	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21025	FFSLIPSLVKKLIKAFK	17	StigA25 (Derived from Stigmurin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida glabrata, Candida krusei	[Ref.30709056]Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=1.2 μM), Staphylococcus epidermidis (ATCC 12228)(MIC=2.3 μM), Enterococcus faecalis (ATCC 4028)(MIC=4.7 μM);##Gram-negative bacteria : Pseudomonas aeruginosa (ATCC 27853)(MIC=4.7 μM), Escherichia coli (ATCC 25922)(MIC=2.3 μM), Enterobacter cloacae (ATCC 13047)(MIC=18.8 μM);##Fungi : Candida albicans (ATCC 90028)(MIC=9.4 μM), Candida glabrata (ATCC 90030)(MIC=9.4 μM), Candida krusei (ATCC 6258)(MIC=9.4 μM)	[Ref.30709056] 1% hemolysis at 1.2 μg/ml , 5% hemolysis at 2.3 μg/ml , 9% hemolysis at 4.7 μg/ml , 19% hemolysis at 9.4 μg/ml , 33% hemolysis at 18.8 μg/ml , 60% hemolysis at 37.5 μg/ml , 78% hemolysis at 75 μg/ml , 93% hemolysis at 150 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.30709056] No cytotoxicity information found.	Not found	30709056	Int J Mol Sci. 2019 Jan 31;20(3). pii: E623. doi: 10.3390/ijms20030623.	Bruno Amorim-Carmo , Alessandra Daniele-Silva , Adriana M. S. Parente ,Allanny A. Furtado , Eneas Carvalho , Johny W. F. Oliveira , Elizabeth C. G. Santos , Marcelo S. Silva , Sérgio R. B. Silva , Arnóbio A. Silva-Júnior , Norberto K. Monteiro and Matheus F. Fernandes-Pedrosa	Potent and Broad-Spectrum Antimicrobial Activity of Analogs from the Scorpion Peptide Stigmurin	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21026	FFKLIPKLVKKLIKAFK	17	StigA31 (Derived from Stigmurin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida glabrata, Candida krusei	[Ref.30709056]Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=2.3 μM), Staphylococcus epidermidis (ATCC 12228)(MIC=2.3 μM), Enterococcus faecalis (ATCC 4028)(MIC=1.2 μM);##Gram-negative bacteria : Pseudomonas aeruginosa (ATCC 27853)(MIC=2.3 μM), Escherichia coli (ATCC 25922)(MIC=1.2 μM), Enterobacter cloacae (ATCC 13047)(MIC=4.7 μM);##Fungi : Candida albicans (ATCC 90028)(MIC=4.7 μM), Candida glabrata (ATCC 90030)(MIC=4.7 μM), Candida krusei (ATCC 6258)(MIC=4.7 μM)	[Ref.30709056] 1% hemolysis at 1.2 μg/ml , 6% hemolysis at 2.3 μg/ml , 10% hemolysis at 4.7 μg/ml , 12 % hemolysis at 9.4 μg/ml , 23% hemolysis at 18.8 μg/ml , 45% hemolysis at 37.5 μg/ml , 65% hemolysis at 75 μg/ml , 70% hemolysis at 150 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.30709056] No cytotoxicity information found.	Not found	30709056	Int J Mol Sci. 2019 Jan 31;20(3). pii: E623. doi: 10.3390/ijms20030623.	Bruno Amorim-Carmo , Alessandra Daniele-Silva , Adriana M. S. Parente ,Allanny A. Furtado , Eneas Carvalho , Johny W. F. Oliveira , Elizabeth C. G. Santos , Marcelo S. Silva , Sérgio R. B. Silva , Arnóbio A. Silva-Júnior , Norberto K. Monteiro and Matheus F. Fernandes-Pedrosa	Potent and Broad-Spectrum Antimicrobial Activity of Analogs from the Scorpion Peptide Stigmurin	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21027	ALWKKILKNAGKAALNKINQIVQ	23	K5, 17-DPS3 (Derived from dermaseptin-PS3 (DPS3))	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Random coil, alpha helix	These three peptides existed in random coils in aqueous solution, they all adopted 		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans	[Ref.30087268]Gram-positive bacteria : Staphylococcuss aureus (NCTC 10788)(MIC=8 μM);##Gram-negative bacteria : Escherichia coli (NCTC 10418)(MIC=8 μM);##Fungi : Candida albicans (NCYC 1467)(MIC=4 μM)	[Ref.30087268] 8% hemolysis at 0 μM , 40% hemolysis at 1 μM , 90% hemolysis at 2 μM against horse red blood cells	Linear	Free	Amidation		L	[Ref.30087268] IC50 = 18.20 μM for H157. ##IC50 = 18.20 μM for PC3. ##IC50 = 132.10 μM for HMEC-1	Not found	30087268	Toxins (Basel). 2018 Aug 7;10(8). pii: E320. doi: 10.3390/toxins10080320.	Yining Tan ,Xiaoling Chen , Chengbang Ma , Xinping Xi ,Lei Wang , Mei Zhou ,James F. Burrows ,Hang Fai Kwok 2 ID and Tianbao Chen	Biological Activities of Cationicity-Enhanced and Hydrophobicity-Optimized Analogues of an Antimicrobial Peptide, Dermaseptin-PS3, from the Skin Secretion of Phyllomedusa sauvagii	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(N)=O)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP21028	ALWKDILKNLLKAALNEINQIVQ	23	L10, 11-DPS3 (Derived from dermaseptin-PS3 (DPS3))	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Random coil, alpha helix	These three peptides existed in random coils in aqueous solution, they all adopted 		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans	[Ref.30087268]Gram-positive bacteria : Staphylococcuss aureus (NCTC 10788)(MIC=8 μM);##Gram-negative bacteria : Escherichia coli (NCTC 10418)(MIC=16 μM);##Fungi : Candida albicans (NCYC 1467)(MIC=16 μM)	[Ref.30087268] 20% hemolysis at 0 μM , 70% hemolysis at 1 μM , 95% hemolysis at 2 μM against horse red blood cells	Linear	Free	Amidation		L	[Ref.30087268] IC50 = 0.12 μM for H157. ##IC50 = 1.85 μM for PC3. ##IC50 = 8.76 μM for HMEC-1	Not found	30087268	Toxins (Basel). 2018 Aug 7;10(8). pii: E320. doi: 10.3390/toxins10080320.	Yining Tan ,Xiaoling Chen , Chengbang Ma , Xinping Xi ,Lei Wang , Mei Zhou ,James F. Burrows ,Hang Fai Kwok 2 ID and Tianbao Chen	Yining Tan ,Xiaoling Chen , Chengbang Ma , Xinping Xi ,Lei Wang , Mei Zhou ,James F. Burrows ,Hang Fai Kwok 2 ID and Tianbao Chen	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(N)=O)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP21029	ATYRTGRATRESLSGVEISGRLYRLR	26	D5R (Derived from HD5) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix, beta sheet, beta turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Saccharomyces cerevisiae	[Ref.26206286]Gram-positive bacteria : Staphylococcus aureus (NCTC 8530)(MIC=100 μM), Bacillus subtilis (NCIM 2162)(MIC=20 μM);##Gram-negative bacteria : Escherichia coli (MG 1655)(MIC=50 μM), Pseudomonas aeruginosa (NCTC 6750)(MIC=100 μM);##Fungi : Candida albicans (ATCC 18804)(MIC=20 μM), Saccharomyces cerevisiae (BY4741)(MIC=100 μM)	[Ref.26206286] 0% hemolysis at 100μM against human red blood cells	Linear	Free	Free		L	[Ref.26206286] No cytotoxic information found.	Not found	26206286	Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.	Basil Mathew Ramakrishnan Nagaraj	Antimicrobial activity of human-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)O
DRAMP21030	ATYrTGrATrESLSGVEISGrLYrLR	26	D5r (Derived from HD5) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix, beta sheet, beta turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans	[Ref.26206286]Gram-positive bacteria : Staphylococcus aureus (NCTC 8530)(MIC=100 μM), Bacillus subtilis (NCIM 2162)(MIC=50 μM);##Gram-negative bacteria : Escherichia coli (MG 1655)(MIC=50 μM), Pseudomonas aeruginosa (NCTC 6750)(MIC=200 μM);##Fungi : Candida albicans (ATCC 18804)(MIC=20 μM)	[Ref.26206286] 0% hemolysis at 100μM against human red blood cells	Linear	Free	Free		Mixed(D-Arg4, D-Arg7, D-Arg10, D-Arg21, D-Arg24)	[Ref.26206286] No cytotoxic information found.	Not found	26206286	Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.	Basil Mathew Ramakrishnan Nagaraj	Antimicrobial activity of human-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)O
DRAMP21031	ATYRTGRATRESLSGVEISGRLYRLR	26	MyD5R (Derived from HD5) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix, beta sheet, beta turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Saccharomyces cerevisiae	[Ref.26206286]Gram-positive bacteria : Staphylococcus aureus (NCTC 8530)(MIC=7.5 μM), Bacillus subtilis (NCIM 2162)(MIC=20 μM);##Gram-negative bacteria : Escherichia coli (MG 1655)(MIC=5 μM), Pseudomonas aeruginosa (NCTC 6750)(MIC=10 μM);##Fungi : Candida albicans (ATCC 18804)(MIC=10 μM), Saccharomyces cerevisiae (BY4741)(MIC=20 μM)	[Ref.26206286] 23% hemolysis at 10 μM , 50% hemolysis at 20 μM , 75% hemolysis at 50 μM , 87.5% hemolysis at 100 μM against human red blood cells	Linear	Acylation (Conjugated with myristic acid)	Free		L	[Ref.26206286] No cytotoxic information found.	Not found	26206286	Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.	Basil Mathew Ramakrishnan Nagaraj	Antimicrobial activity of human-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs	CCCCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP21032	ATYrTGrATrESLSGVEISGrLYrLR	26	MyD5r (Derived from HD5) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix, beta sheet, beta turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Saccharomyces cerevisiae	[Ref.26206286]Gram-positive bacteria : Staphylococcus aureus (NCTC 8530)(MIC=7.5 μM), Bacillus subtilis (NCIM 2162)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (MG 1655)(MIC=5 μM), Pseudomonas aeruginosa (NCTC 6750)(MIC=7.5 μM);##Fungi : Candida albicans (ATCC 18804)(MIC=10 μM), Saccharomyces cerevisiae (BY4741)(MIC=20 μM)	[Ref.26206286] 17% hemolysis at 10 μM , 25% hemolysis at 20 μM , 50% hemolysis at 50 μM , 70% hemolysis at 100 μM against human red blood cells	Linear	Acylation (Conjugated with myristic acid)	Free		Mixed(D-Arg4, D-Arg7, D-Arg10, D-Arg21, D-Arg24)	[Ref.26206286] No cytotoxic information found.	Not found	26206286	Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.	Basil Mathew Ramakrishnan Nagaraj	Antimicrobial activity of human-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs	CCCCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP21033	ATYRTGRATRESLSGVEISGRLYRLR	26	LaD5R (Derived from HD5) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix, beta sheet, beta turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Saccharomyces cerevisiae	[Ref.26206286]Gram-positive bacteria : Staphylococcus aureus (NCTC 8530)(MIC=2 μM), Bacillus subtilis (NCIM 2162)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (MG 1655)(MIC=20 μM), Pseudomonas aeruginosa (NCTC 6750)(MIC=10 μM);##Fungi : Candida albicans (ATCC 18804)(MIC=10 μM), Saccharomyces cerevisiae (BY4741)(MIC=10 μM)	[Ref.26206286] 0% hemolysis at 100μM against human red blood cells	Linear	Acylation (Conjugated with lauric acid)	Free		L	[Ref.26206286] No cytotoxic information found.	Not found	26206286	Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.	Basil Mathew Ramakrishnan Nagaraj	Antimicrobial activity of human-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs	CCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP21034	ATYrTGrATrESLSGVEISGrLYrLR	26	LaD5r (Derived from HD5) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix, beta sheet, beta turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Saccharomyces cerevisiae	[Ref.26206286]Gram-positive bacteria : Staphylococcus aureus (NCTC 8530)(MIC=20 μM), Bacillus subtilis (NCIM 2162)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (MG 1655)(MIC=10 μM), Pseudomonas aeruginosa (NCTC 6750)(MIC=50 μM);##Fungi : Candida albicans (ATCC 18804)(MIC=10 μM), Saccharomyces cerevisiae (BY4741)(MIC=10 μM)	[Ref.26206286] 0% hemolysis at 100μM against human red blood cells	Linear	Acylation (Conjugated with lauric acid)	Free		Mixed(D-Arg4, D-Arg7, D-Arg10, D-Arg21, D-Arg24)	[Ref.26206286] No cytotoxic information found.	Not found	26206286	Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.	Basil Mathew Ramakrishnan Nagaraj	Antimicrobial activity of human-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs	CCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP21035	KAAKAAKKAAKAAWK	15	AC-UM-14W (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26235946]Gram-positive bacteria : Bacillus subtilis (MIC>200 μg/ml), Staphylococcus aureus (MIC>200 μg/ml), Staphylococcus epidermis (MIC>200 μg/ml);##Gram-negative bacteria : Escherichia coli (MIC>200 μg/ml), Shigella dysentariae (MIC>200 μg/ml), Salmonella typhimurium (MIC>200 μg/ml), Klebsiella pneumonia (MIC>200 μg/ml), Pseudomonas aeruginosa (MIC>200 μg/ml)	[Ref.26235946] <1% hemolysis at 12.5 μM , <1% hemolysis at 25 μM against human red blood cells	Linear	Acylation (Conjugated with acetyl group)	Amidation		L	[Ref.26235946] No cytotoxic information found.	Not found	26235946	Bioorg Med Chem Lett. 2015 Sep 15;25(18):4016-9. doi: 10.1016/j.bmcl.2015.06.053.	Thuy T. T. Dinh , Do-Hee Kim , Huy X. Luong  , Bong-Jin Lee , Young-Woo Kim	Antimicrobial activity of doubly-stapled alanine/lysine-based peptides	CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21036	RWKIFKKIPKFLHSAKKF	18	PapMA (Derived from Papiliocin and Magainin 2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	PapMA and PapMA-k exhibited α-helical structures in 50 mM DPC micelles and 50% TFE/H2O but displayed unordered structures in aqueous solution.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26053120] Gram-positive bacteria : Bacillus subtilis(MIC=4.0 μM), Enterococcus faecalis(MIC=16 μM), Staphylococcus aureus(MIC=4.0 μM), ;##Gram-negative bacteria : Escherichia coli(MIC=2.0 μM), Pseudomonas aeruginosa(MIC=4.0 μM), Salmonella typhimurium(MIC=4.0 μM)	[Ref.26053120] MHC=100 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26053120] IC50 = 10 μM against mouse macrophage-derived RAW264.7 cells. ##IC50 = 9 μM for NIH3T3 fibroblasts.	Not found	26053120	Biochemistry. 2015 Jun 30;54(25):3921-31. doi: 10.1021/acs.biochem.5b00392.	Areum Shin, Eunjung Lee,  Dasom Jeon, Young-Guen Park, Jeong Kyu Bang, Yong-Sun Park, Song Yub Shin, and Yangmee Kim	Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP21037	RWKIFKKIkKFLHSAKKF	18	PapMA-k (Derived from Papiliocin and Magainin 2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	PapMA and PapMA-k exhibited α-helical structures in 50 mM DPC micelles and 50% TFE/H3O but displayed unordered structures in aqueous solution.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26053120] Gram-positive bacteria : Bacillus subtilis(MIC=4.0 μM), Enterococcus faecalis(MIC=16 μM), Staphylococcus aureus(MIC=4.0 μM), ;##Gram-negative bacteria : Escherichia coli(MIC=2.0 μM), Pseudomonas aeruginosa(MIC=4.0 μM), Salmonella typhimurium(MIC=2.0 μM)	[Ref.26053120] MHC=200 μM against human red blood cells	Linear	Free	Amidation	The 'k'  in sequence is lysine peptoid	L	[Ref.26053120] IC50 = 42 μM against mouse macrophage-derived RAW264.7 cells. ##IC50 = 39 μM for NIH3T3 fibroblasts.	Not found	26053120	Biochemistry. 2015 Jun 30;54(25):3921-31. doi: 10.1021/acs.biochem.5b00392.	Areum Shin, Eunjung Lee,  Dasom Jeon, Young-Guen Park, Jeong Kyu Bang, Yong-Sun Park, Song Yub Shin, and Yangmee Kim	Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity	
DRAMP21038	WGRRGWGPGRRYVRN	15	analog 1 (Derived from  Ib-AMP1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, beta turn	 In sodium phosphate buffer, the CD spectra of Ib-AMP1 and all linear analogs showed a large absorbance in the region of 190-200 nm, indicating a random coil structure. The spectra of Ib-AMP1 and analogs 1, 2, 3, and 4 became significantly more b-turn in 30 mM SDS micelles		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.19778562] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC 1621)(MIC=4 μM), Staphylococcus aureus (MRSA)(CCARM 3543)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=16 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM), Pseudomonas aeruginosa (MDRPA)(CCARM 2095)(MIC=16 μM) 	[Ref.19778562] MHC>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.19778562] No cytotoxicity information found.	Not found	19778562	Peptides. 2009 Dec;30(12):2144-9. doi: 10.1016/j.peptides.2009.09.020.	Peng Wang  , Jeong-Kyu Bang  , Hak Jun Kim  , Jin-Kyoung Kim  , Yangmee Kim , Song Yub Shin	Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O
DRAMP21039	WGRRGWGpGRRYVRN	15	analog 2 (Derived from  Ib-AMP2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, beta turn	 In sodium phosphate buffer, the CD spectra of Ib-AMP1 and all linear analogs showed a large absorbance in the region of 190-200 nm, indicating a random coil structure. The spectra of Ib-AMP1 and analogs 1, 2, 3, and 4 became significantly more b-turn in 30 mM SDS micelles		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.19778562] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 	[Ref.19778562] MHC>400 	Linear	Free	Amidation		Mixed(D-Pro8)	[Ref.19778562] No cytotoxicity information found.	Not found	19778562	Peptides.?2009 Dec;30(12):2144-9. doi: 10.1016/j.peptides.2009.09.020.	Peng Wang  , Jeong-Kyu Bang  , Hak Jun Kim  , Jin-Kyoung Kim  , Yangmee Kim , Song Yub Shin	Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O
DRAMP21040	WGRRGWGaGRRYVRW	15	analog 3 (Derived from  Ib-AMP2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, beta turn	 In sodium phosphate buffer, the CD spectra of Ib-AMP1 and all linear analogs showed a large absorbance in the region of 190–200 nm, indicating a random coil structure. The spectra of Ib-AMP1 and analogs 1, 2, 3, and 4 became significantly more b-turn in 30 mM SDS micelles		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.19778562] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC 1621)(MIC=4 μM), Staphylococcus aureus (MRSA)(CCARM 3543)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=16 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM), Pseudomonas aeruginosa (MDRPA)(CCARM 2095)(MIC=16 μM) 	[Ref.19778562] MHC>400 [Ref.19778562] MHC>400 μM against human red blood cells	Linear	Free	Amidation	The 'a' in sequence is Ala peptoid residue (Nala) (CH3–NH–CH2–COOH)	L	[Ref.19778562] No cytotoxicity information found.	Not found	19778562	Peptides. 2009 Dec;30(12):2144-9. doi: 10.1016/j.peptides.2009.09.020.	Peng Wang  , Jeong-Kyu Bang  , Hak Jun Kim  , Jin-Kyoung Kim  , Yangmee Kim , Song Yub Shin	Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1	
DRAMP21041	WGRRGWGkGRRYVRW	15	analog 4 (Derived from  Ib-AMP2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, beta turn	 In sodium phosphate buffer, the CD spectra of Ib-AMP1 and all linear analogs showed a large absorbance in the region of 190–200 nm, indicating a random coil structure. The spectra of Ib-AMP1 and analogs 1, 2, 3, and 4 became significantly more b-turn in 30 mM SDS micelles		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.19778562] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC 1621)(MIC=4 μM), Staphylococcus aureus (MRSA)(CCARM 3543)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM), Pseudomonas aeruginosa (MDRPA)(CCARM 2095)(MIC=16 μM)	[Ref.19778562] MHC>400 μM against human red blood cells	Linear	Free	Amidation	The 'k' in sequence is Lys peptoid residue (Nlys) (NH2–CH2–CH2–CH2–CH2–NH–CH2–COOH).	L	[Ref.19778562] No cytotoxicity information found.	Not found	19778562	Peptides. 2009 Dec;30(12):2144-9. doi: 10.1016/j.peptides.2009.09.020.	Peng Wang  , Jeong-Kyu Bang  , Hak Jun Kim  , Jin-Kyoung Kim  , Yangmee Kim , Song Yub Shin	Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1	
DRAMP21042	ILPWKWPWWKWRR	13	A2 (Derived from Indolicidin (IN))	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.19428758] Gram-positive bacteria : Bacillus subtilis(MIC=10 μg/ml), Staphylococcus epidermidis(MIC=10 μg/ml), Staphylococcus aureus(MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=20 μg/ml), Pseudomonas aeruginosa(MIC=20 μg/ml), Salmonella typhimurium(MIC=10 μg/ml)	[Ref.19428758] HC50=490 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.19428758] No cytotoxicity information found.	Not found	19428758	Peptides. 2009 May;30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.	Yong Hai Nan , Jeong-Kyu Bang , Song Yub Shin	Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21043	ILKWKWPWWPWRR	13	A3 (Derived from Indolicidin (IN))	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.19428758] Gram-positive bacteria : Bacillus subtilis(MIC=5 μg/ml), Staphylococcus epidermidis(MIC=10 μg/ml), Staphylococcus aureus(MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=10 μg/ml), Pseudomonas aeruginosa(MIC=20 μg/ml), Salmonella typhimurium(MIC=10 μg/ml)	[Ref.19428758] HC50=400 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.19428758] No cytotoxicity information found.	Not found	19428758	Peptides. 2009 May;30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.	Yong Hai Nan , Jeong-Kyu Bang , Song Yub Shin	Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21044	ILKWKWKWWPWRR	13	A4 (Derived from Indolicidin (IN))	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.19428758] Gram-positive bacteria : Bacillus subtilis(MIC=10 μg/ml), Staphylococcus epidermidis(MIC=10 μg/ml), Staphylococcus aureus(MIC=10 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=10 μg/ml), Pseudomonas aeruginosa(MIC=10 μg/ml), Salmonella typhimurium(MIC=10 μg/ml)	[Ref.19428758] HC50=560 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.19428758] No cytotoxicity information found.	Not found	19428758	Peptides. 2009 May;30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.	Yong Hai Nan , Jeong-Kyu Bang , Song Yub Shin	Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21045	ILPWKWKWWKWRR	13	A5 (Derived from Indolicidin (IN))	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.19428758] Gram-positive bacteria : Bacillus subtilis(MIC=5 μg/ml), Staphylococcus epidermidis(MIC=10 μg/ml), Staphylococcus aureus(MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=10 μg/ml), Pseudomonas aeruginosa(MIC=10 μg/ml), Salmonella typhimurium(MIC=10 μg/ml)	[Ref.19428758] HC50>800 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.19428758] No cytotoxicity information found.	Not found	19428758	Peptides. 2009 May;30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.	Yong Hai Nan , Jeong-Kyu Bang , Song Yub Shin	Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21046	ILKWKWPWWKWRR	13	A6 (Derived from Indolicidin (IN))	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.19428758] Gram-positive bacteria : Bacillus subtilis(MIC=5 μg/ml), Staphylococcus epidermidis(MIC=10 μg/ml), Staphylococcus aureus(MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=10 μg/ml), Pseudomonas aeruginosa(MIC=10 μg/ml), Salmonella typhimurium(MIC=10 μg/ml)	[Ref.19428758] HC50>800 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.19428758] No cytotoxicity information found.	Not found	19428758	Peptides. 2009 May;30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.	Yong Hai Nan , Jeong-Kyu Bang , Song Yub Shin	Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21047	ILKWKWKWWKWRR	13	A7 (Derived from Indolicidin (IN))	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.19428758] Gram-positive bacteria : Bacillus subtilis(MIC=5 μg/ml), Staphylococcus epidermidis(MIC=10 μg/ml), Staphylococcus aureus(MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=10 μg/ml), Pseudomonas aeruginosa(MIC=10 μg/ml), Salmonella typhimurium(MIC=5 μg/ml)	[Ref.19428758] HC50>800 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.19428758] No cytotoxicity information found.	Not found	19428758	Peptides. 2009 May;30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.	Yong Hai Nan , Jeong-Kyu Bang , Song Yub Shin	Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21048	GLLWKWGWKWKEFLRIVGY	19	peptide 6 (Derived from seq2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28236791] Gram-positive bacteria : Staphylococcus aureus(MIC>1024 μg/ml);##Gram-negative bacteria : Pseudomonas aeruginosa(MIC>1024 μg/ml)	[Ref.28236791] 51.36% hemolysis at 128 μg/ml	Linear	Free	Amidation		L	[Ref.28236791] No cytotoxicity information found.	Not found	28236791	Colloids Surf B Biointerfaces. 2017 May 1;153:152-159. doi: 10.1016/j.colsurfb.2017.02.003.	P. Maturanaa, M. Martinez , M.E. Noguerac, N.C. Santos , E.A. Disalvoa, L. Semorile , P.C. Maffia , A. Hollmann	Lipid selectivity in novel antimicrobial peptides: Implication on antimicrobial and hemolytic activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C
DRAMP21049	GLLRKWGKKWKEFLRRVWK	19	peptide 6.2 (Derived from seq2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	The spectra obtained confirmed an alpha-helix conversion in the presence of negatively charged micelles.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28236791] Gram-positive bacteria : Staphylococcus aureus(MIC=32 μg/ml);##Gram-negative bacteria : Pseudomonas aeruginosa(MIC=32 μg/ml)	[Ref.28236791] 34.46% hemolysis at 128 μg/ml	Linear	Free	Amidation		L	[Ref.28236791] No cytotoxicity information found.	Not found	28236791	Colloids Surf B Biointerfaces. 2017 May 1;153:152-159. doi: 10.1016/j.colsurfb.2017.02.003.	P. Maturanaa, M. Martinez , M.E. Noguerac, N.C. Santos , E.A. Disalvoa, L. Semorile , P.C. Maffia , A. Hollmann	Lipid selectivity in novel antimicrobial peptides: Implication on antimicrobial and hemolytic activity	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP21050	AWCFRVCYRGICYRRCR	17	TP1[K1A] (Derived from TP1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.03 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.03 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.125 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.125 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=2 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)	[Ref.28960954] MHC10=2.1 μg/ml against human red blood cells	Cyclic	Free	Amidation (Arg17)	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1	
DRAMP21051	KACFRVCYRGICYRRCR	17	TP1[W2A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=1 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)	[Ref.28960954] MHC10=8 μg/ml against human red blood cells	Cyclic	Free	Amidation (Arg17)	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-2	
DRAMP21052	KWAFRVCYRGICYRRSR	17	TP1[C3A, C16S] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=4 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC>16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC>16 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC>16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)	[Ref.28960954] MHC10=8 μg/ml against human red blood cells	Cyclic	Free	Amidation (Arg17)	Disulfide bond between Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-3	
DRAMP21053	KWCARVCYRGICYRRCR	17	TP1[F4A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)	[Ref.28960954] MHC10=40 μg/ml against human red blood cells	Cyclic	Free	Amidation (Arg17)	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-4	
DRAMP21054	KWCFAVCYRGICYRRCR	17	TP1[R5A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.03 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.06 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)	[Ref.28960954] MHC10=2 μg/ml against human red blood cells	Cyclic	Free	Amidation (Arg17)	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-5	
DRAMP21055	KWCFRACYRGICYRRCR	17	TP1[V6A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=1 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)	[Ref.28960954] MHC10=1.2 μg/ml against human red blood cells	Cyclic	Free	Amidation (Arg17)	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-6	
DRAMP21056	KWCFRVAYRGISYRRCR	17	TP1[C7A, C12S] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 [Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=2 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=4 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=2 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=2 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)	[Ref.28960954] MHC10=1 μg/ml against human red blood cells	Cyclic	Free	Amidation (Arg17)	Disulfide bond between Cys3 and Cys16.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis.2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-7	
DRAMP21057	KWCFRVCARGICYRRCR	17	TP1[Y8A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=8 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=0.125 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=1 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=2 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC= μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)	[Ref.28960954] MHC10=8 μg/ml against human red blood cells	Cyclic	Free	Amidation (Arg17)	Disulfide bond between Cys3 and Cys16, Cys7 and Cys12	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-8	
DRAMP21058	KWCFRVCYAGICYRRCR	17	TP1[R9A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=1 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.03 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.25 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.125 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=2 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.06 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=1 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)	[Ref.28960954] MHC10=2 μg/ml against human red blood cells	Cyclic	Free	Amidation (Arg17)	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-9	
DRAMP21059	KWCFRVCYRAICYRRCR	17	TP1[G10A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.03 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.03 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.25 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.6 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.6 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.06 μg/ml)	[Ref.28960954] MHC10=0.5 μg/ml against human red blood cells	Cyclic	Free	Amidation (Arg17)	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-10	
DRAMP21060	KWCFRVCYRGACYRRCR	17	TP1[I11A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=2 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=1 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)	[Ref.28960954] MHC10=32 μg/ml against human red blood cells	Cyclic	Free	Amidation (Arg17)	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-11	
DRAMP21061	KWCFRVSYRGIAYRRCR	17	TP1[C7S, C12A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=1 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=4 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=8 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=1 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=8 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)	[Ref.28960954] MHC10=0.6 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bond between Cys3 and Cys16.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-12	
DRAMP21062	KWCFRVCYRGICARRCR	17	TP1[Y13A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.06 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)	[Ref.28960954] MHC10=1 [Ref.28960954] MHC10=1 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bond between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-13	
DRAMP21063	KWCFRVCYRGICYARCR	17	TP1[R14A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=1 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.125 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.25 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)	[Ref.28960954] MHC10=0.5 [Ref.28960954] MHC10=0.5 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-14	
DRAMP21064	KWCFRVCYRGICYRACR	17	TP1[R15A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.03 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=2 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=4 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)	[Ref.28960954] MHC10=0.45 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-15	
DRAMP21065	KWSFRVCYRGICYRRAR	17	TP1[C3S, C16A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=1 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=2 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)	[Ref.28960954] MHC10=3 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bond between Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-16	
DRAMP21066	KWCFRVCYRGICYRRCA	17	TP1[R17A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.015 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.015 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.25 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)	[Ref.28960954] MHC10=0.45 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-17	
DRAMP21067	KWAFRVCYRGICYRRAR	17	TP1[C3A, C16A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=1 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=1 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=2 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=8 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)	[Ref.28960954] MHC10=40 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bond between Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-18	
DRAMP21068	KWCFRVAYRGIAYRRCR	17	TP1[C7A, C12A] (Derived from TP1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=2 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=2 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)	[Ref.28960954] MHC10=8 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bond between Cys3 and Cys16.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-19	
DRAMP21069	KWAFRVAYRGIAYRRAR	17	TP1[C3A, C7A, C12A, C16A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=1 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=8 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=4 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=4 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)	[Ref.28960954] MHC10=0.24 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-20	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21070	KWCFRRCYAGICYRRCR	17	TP1[V6R, R9A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC>16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC>16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=16 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC>16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)	[Ref.28960954] MHC10=11 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-21	
DRAMP21071	RWCFRVCYRGICYRRCR	17	TP1[K1R] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=1 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)	[Ref.28960954] MHC10=1 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-22	
DRAMP21072	KWCGRVCYRGICYRRCR	17	TP1[F4G] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=2 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=1 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=2 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=2 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=2 μg/ml)	[Ref.28960954] MHC10=0.47 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-23	
DRAMP21073	KWCSRVCYRGICYRRCR	17	TP1[F4S] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=2 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=4 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=4 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=2 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=4 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)	[Ref.28960954] MHC10=0.23 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-24	
DRAMP21074	KWCFRVCGRGICYRRCR	17	TP1[Y8G] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=2 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=8 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=8 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=2 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=4 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)	[Ref.28960954] MHC10=0.4 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-25	
DRAMP21075	KWCFRVCYRGGCYRRCR	17	TP1[I11G] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 [Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=2 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)	[Ref.28960954] MHC10=0.2 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-26	
DRAMP21076	KWCARVCARGACYRRCR	17	TP1[F4A, Y8A, I11A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC>16 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=8 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC>16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC>16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC>16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC>16 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC>16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC>16 μg/ml)	[Ref.28960954] MHC10=0.9 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis.2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-27	
DRAMP21077	KWCFVCYRGICYRRCG	16	TP1[-R5, R17G] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=1 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=8 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC>16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC>16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC>16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=16 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC>16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)	[Ref.28960954] MHC10=0.3 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis.2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-28	
DRAMP21078	AWCARVCYRGICYRRCR	17	TP1[K1A, F4A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=16 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=2 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=4 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=4 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=4 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=2 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=8 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC>16 μg/ml)	[Ref.28960954] MHC10=32 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-29	
DRAMP21079	AWCFRVCARGICYRRCR	17	TP1[K1A, Y8A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=2 μg/ml)	[Ref.28960954] MHC10=0.4 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-30	
DRAMP21080	AWCFRVCYRGACYRRCR	17	TP1[K1A, I11A] (Derived from TP1) 	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.25 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)	[Ref.28960954] MHC10=0.2 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-31	
DRAMP21081	KWCFRVCYAGICYRRCA	17	TP1[R9A, R17A] (Derived from TP1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans	[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.06 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=2 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.03 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)	[Ref.28960954] MHC10=0.2 μg/ml against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12	L	[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.	Not found	28960954	ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.	Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper	Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-32	
DRAMP21082	KWCFCVCYRGICRCRCRG	18	ccTP 3 (Derived from TP2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Beta tile	Although there is insufficient information to deconvolute these CD spectra of these two-b-strand cyclic cystine-knot structures due to the various contributions by 		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida kefyr, Candida tropicalis	[Ref.10673369] Gram-positive bacteria : Staphylococcus aureus(MIC=1.3 μM(low-salt);MIC=0.9 μM(high-salt)), Micrococcus luteus(MIC=0.5 μM(low-salt);MIC=0.5 μM(high-salt)), Enterococcus faecalis(MIC=1.9 μM(low-salt);MIC=1.3 μM(high-salt));##Gram-negative bacteria : Escherichia coli(MIC=10.4 μM(low-salt);MIC=0.9 μM(high-salt)), Pseudomonas aeruginosa(MIC=6.2 μM(low-salt);MIC=10.4 μM(high-salt)), Primula vulgaris(MIC=16.4 μM(low-salt);MIC=28.9 μM(high-salt)), Klebsiella oxytoca(MIC=4.0 μM(low-salt);MIC=7.6 μM(high-salt));##Fungi : Candida albicans(MIC=24.2 μM(low-salt);MIC=30.2 μM(high-salt)), Candida kefyr(MIC=1.1 μM(low-salt);MIC=4.3 μM(high-salt)), Candida tropicalis(MIC=12.4 μM(low-salt);MIC=3.9 μM(high-salt))	[Ref.10673369] EC25=590 μM against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys5 and Cys14, Cys7 and Cys12.	L	[Ref.10673369] No cytotoxicity information found.	Not found	10673369	Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.	James P. Tam, Yi-An Lu, and Jin-Long Yang	Marked Increase in Membranolytic Selectivity of Novel Cyclic Tachyplesins Constrained with an Antiparallel Two-b Strand Cystine Knot Framework	
DRAMP21083	KWCRCVCRRGICRCFCRG	18	ccTP 5 (Derived from TP2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Beta tile	Although there is insufficient information to deconvolute these CD spectra of these two-b-strand cyclic cystine-knot structures due to the various contributions by 		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida kefyr, Candida tropicalis	[Ref.10673369] Gram-positive bacteria : Staphylococcus aureus(MIC=1.7 μM(low-salt);MIC=1.3 μM(high-salt)), Micrococcus luteus(MIC=0.5 μM(low-salt);MIC=0.8 μM(high-salt)), Enterococcus faecalis(MIC=0.7 μM(low-salt);MIC=0.5 μM(high-salt));##Gram-negative bacteria : Escherichia coli(MIC=5.5 μM(low-salt);MIC=1.2 μM(high-salt)), Pseudomonas aeruginosa(MIC=3.9 μM(low-salt);MIC=4.7 μM(high-salt)), Primula vulgaris(MIC=16.8 μM(low-salt);MIC=55.6 μM(high-salt)), Klebsiella oxytoca(MIC=2.4 μM(low-salt);MIC=5.4 μM(high-salt));##Fungi : Candida albicans(MIC=7.1 μM(low-salt);MIC=5.1 μM(high-salt)), Candida kefyr(MIC=4.2 μM(low-salt);MIC=0.7 μM(high-salt)), Candida tropicalis(MIC=1.9 μM(low-salt);MIC=4.8 μM(high-salt))	[Ref.10673369] EC25=920 μM against human red blood cells	Cyclic	Free	Amidation	Disulfide bonds between Cys3 and Cys16, Cys5 and Cys14, Cys7 and Cys12.	L	[Ref.10673369] No cytotoxicity information found.	Not found	10673369	Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.	James P. Tam, Yi-An Lu, and Jin-Long Yang	Marked Increase in Membranolytic Selectivity of Novel Cyclic Tachyplesins Constrained with an Antiparallel Two-b Strand Cystine Knot Framework	
DRAMP21084	GWCRCVCRRGICRCFCRK	18	ccTP 6 (Derived from TP2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Beta tile	Although there is insufficient information to deconvolute these CD spectra of these two-b-strand cyclic cystine-knot structures due to the various contributions by 		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida kefyr, Candida tropicalis	[Ref.10673369] Gram-positive bacteria : Staphylococcus aureus(MIC=1.7 μM(low-salt);MIC=0.7 μM(high-salt)), Micrococcus luteus(MIC=0.3 μM(low-salt);MIC=0.4 μM(high-salt)), Enterococcus faecalis(MIC=1.4 μM(low-salt);MIC=1.2 μM(high-salt));##Gram-negative bacteria : Escherichia coli(MIC=6.1 μM(low-salt);MIC=1.2 μM(high-salt)), Pseudomonas aeruginosa(MIC=2.0 μM(low-salt);MIC=4.7 μM(high-salt)), Primula vulgaris(MIC=17.0 μM(low-salt);MIC=39.8 μM(high-salt)), Klebsiella oxytoca(MIC=4.1 μM(low-salt);MIC=4.1 μM(high-salt));##Fungi : Candida albicans(MIC=10.5 μM(low-salt);MIC=5.2 μM(high-salt)), Candida kefyr(MIC=1.1 μM(low-salt);MIC=0.7 μM(high-salt)), Candida tropicalis(MIC=2.3 μM(low-salt);MIC=1.9 μM(high-salt))	[Ref.10673369] EC25=3900 μM against human red blood cells	Cyclic	Free	Amidation (Gly18)	Disulfide bonds between Cys3 and Cys16, Cys5 and Cys14, Cys7 and Cys12.	L	No cytotoxicity information found	Not found	10673369	Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.	James P. Tam, Yi-An Lu, and Jin-Long Yang	Marked Increase in Membranolytic Selectivity of Novel Cyclic Tachyplesins Constrained with an Antiparallel Two-b Strand Cystine Knot Framework	
DRAMP21085	RFRRLRWKTRWRLKKI	16	PRW4 (PR) (Derived from PMAP-36)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix, beta Sheet	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25818457] Gram-positive bacteria : Staphylococcus aureus 25923(MIC=73.6 mg/L), Staphylococcus aureus 29213(MIC=9.2 mg/L), Staphylococcus epidermidis 12228(MIC=18.4 mg/L), Enterococcus faecalis 29212(MIC=9.2 mg/L), Bacillus subtilis 11060(MIC=18.4 mg/L);##Gram-negative bacteria : Escherichia coli 078(MIC=9.2 mg/L), Escherichia coli K88(MIC=9.2 mg/L), Escherichia coli ER2566(MIC=18.4 mg/L), Escherichia coli 44102(MIC=18.4 mg/L), Escherichia coli 1515(MIC=9.2 mg/L), Escherichia coli 25922(MIC=9.2 mg/L), Escherichia coli UB1005(MIC=9.2 mg/L), Salmonella typhimurium 7731(MIC=18.4 mg/L), Salmonella typhimurium 1402(MIC=18.4 mg/L), Pseudomonas aeruginosa 21625(MIC=73.6 mg/L), Pseudomonas aeruginosa 21630(MIC=36.8 mg/L), Pseudomonas aeruginosa 10419(MIC=36.8 mg/L), Pseudomonas aeruginosa 27853(MIC>294.3 mg/L), Salmonella pullorum 7913(MIC>294.3 mg/L)	[Ref.25818457] 0 % hemolysis at 294.3 mg/L against human red blood cells	Linear	Free	Amidation		L	[Ref.25818457] The cell viability of PRW4 is 100%, 96%, 92%, 86%, 85%, 83%, 82%, 80% and 80% at peptide concentrations of 1.1, 2.3, 4.6, 9.2, 18.4, 36.8, 73.6, 147.1 and 294.3 μg/ml	Not found	25818457	Biomaterials. 2015 Jun;52:517-30. doi: 10.1016/j.biomaterials.2015.02.063.	Zhi Ma, Dandan Wei, Ping Yan, Xin Zhu, Anshan Shan , Zhongpeng Bi	Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of a-helix-based peptide amphiphiles	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(N)=O
DRAMP21086	RFRRLRWKTRWRLKKIRFGRFLRKIRRFRPK	31	PR-FO (Derived from PRW4)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix, beta Sheet	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25818457] Gram-positive bacteria : Staphylococcus aureus 25923(MIC=8.6 mg/L), Staphylococcus aureus 29213(MIC=4.3 mg/L), Staphylococcus epidermidis 12228(MIC=2.2 mg/L), Enterococcus faecalis 29212(MIC=1.1 mg/L), Bacillus subtilis 11060(MIC=2.2 mg/L);##Gram-negative bacteria : Escherichia coli 078(MIC=2.2 mg/L), Escherichia coli K88(MIC=4.3 mg/L), Escherichia coli ER2566(MIC=2.2 mg/L), Escherichia coli 44102(MIC=8.6 mg/L), Escherichia coli 1515(MIC=2.2 mg/L), Escherichia coli 25922(MIC=2.2 mg/L), Escherichia coli UB1005(MIC=4.3 mg/L), Salmonella typhimurium 7731(MIC=0.5 mg/L), Salmonella typhimurium 1402(MIC=8.6 mg/L), Pseudomonas aeruginosa 21625(MIC=8.6 mg/L), Pseudomonas aeruginosa 21630(MIC=0.5 mg/L), Pseudomonas aeruginosa 10419(MIC=4.3 mg/L), Pseudomonas aeruginosa 27853(MIC=8.6 mg/L), Salmonella pullorum 7913(MIC=8.6 mg/L)	[Ref.25818457] 0% hemolysis at 9.2 mg/L , 1% hemolysis at 18.4 mg/L , 4% hemolysis at 36.8mg/L  , 5% hemolysis at 73.6 mg/L , 10% hemolysis at 147.1 mg/L , 13% hemolysis at 294.3 mg/L against human red blood cells	Linear	Free	Amidation		L	[Ref.25818457] The cell viability of PR-FO is 93%, 89%, 84%, 79%, 74%, 69%, 67%, 64% and 62% at peptide concentrations of 1.1, 2.3, 4.6, 9.2, 18.4, 36.8, 73.6, 147.1 and 294.3 μg/ml.	Not found	25818457	Biomaterials. 2015 Jun;52:517-30. doi: 10.1016/j.biomaterials.2015.02.063.	Zhi Ma, Dandan Wei, Ping Yan, Xin Zhu, Anshan Shan , Zhongpeng Bi	Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of a-helix-based peptide amphiphiles	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP21087	RFRRLRWKTRWRLKKICYCRRRFCVCV	27	PR-PG (Derived from PRW4)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix, beta Sheet	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25818457] Gram-positive bacteria : Staphylococcus aureus 25923(MIC=29.6 mg/L), Staphylococcus aureus 29213(MIC=7.4 mg/L), Staphylococcus epidermidis 12228(MIC=7.4 mg/L), Enterococcus faecalis 29212(MIC=3.7 mg/L), Bacillus subtilis 11060(MIC=7.4 mg/L);##Gram-negative bacteria : Escherichia coli 078(MIC=14.8 mg/L), Escherichia coli K88(MIC=1.9 mg/L), Escherichia coli ER2566(MIC=3.7 mg/L), Escherichia coli 44102(MIC=1.9 mg/L), Escherichia coli 1515(MIC=14.8 mg/L), Escherichia coli 25922(MIC=3.7 mg/L), Escherichia coli UB1005(MIC=7.4 mg/L), Salmonella typhimurium 7731(MIC=14.8 mg/L), Salmonella typhimurium 1402(MIC=7.4 mg/L), Pseudomonas aeruginosa 21625(MIC=14.8 mg/L), Pseudomonas aeruginosa 21630(MIC=7.4 mg/L), Pseudomonas aeruginosa 10419(MIC=14.8 mg/L), Pseudomonas aeruginosa 27853(MIC=14.8 mg/L), Salmonella pullorum 7913(MIC=14.8 mg/L)	[Ref.25818457] 0.5% hemolysis at 1.1 mg/L , 2% hemolysis at 2.3 mg/L , 10% hemolysis at 4.6 mg/L , 23% hemolysis at 9.2 mg/L , 30% hemolysis at 18.4 mg/L , 45% hemolysis at 36.8mg/L  , 46% hemolysis at 73.6 mg/L , 47% hemolysis at 147.1 mg/L , 50% hemolysis at 294.3 mg/L against human red blood cells	Linear	Free	Amidation		L	[Ref.25818457] The cell viability of PR-FG is 92.7%, 76%, 64%, 58%, 53%, 43%, 39%, 37% and 34% at peptide concentrations of 1.1, 2.3, 4.6, 9.2, 18.4, 36.8, 73.6, 147.1 and 294.3 μg/ml.	Not found	25818457	Biomaterials. 2015 Jun;52:517-30. doi: 10.1016/j.biomaterials.2015.02.063.	Zhi Ma, Dandan Wei, Ping Yan, Xin Zhu, Anshan Shan , Zhongpeng Bi	Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of a-helix-based peptide amphiphiles	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP21088	RFRRLRWKTRWRLKKIWWPFLRR	23	PR-TR (Derived from PRW4)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix, beta Sheet	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25818457] Gram-positive bacteria : Staphylococcus aureus 25923(MIC=26.7 mg/L), Staphylococcus aureus 29213(MIC=6.7 mg/L), Staphylococcus epidermidis 12228(MIC=13.4 mg/L), Enterococcus faecalis 29212(MIC=3.3 mg/L), Bacillus subtilis 11060(MIC=3.3 mg/L);##Gram-negative bacteria : Escherichia coli 078(MIC=13.4 mg/L), Escherichia coli K88(MIC=1.7 mg/L), Escherichia coli ER2566(MIC=3.3 mg/L), Escherichia coli 44102(MIC=6.7 mg/L), Escherichia coli 1515(MIC=1.7 mg/L), Escherichia coli 25922(MIC=6.7 mg/L), Escherichia coli UB1005(MIC=3.3 mg/L), Salmonella typhimurium 7731(MIC=6.7 mg/L), Salmonella typhimurium 1402(MIC=13.4 mg/L), Pseudomonas aeruginosa 21625(MIC=6.7 mg/L), Pseudomonas aeruginosa 21630(MIC=13.4 mg/L), Pseudomonas aeruginosa 10419(MIC=6.7 mg/L), Pseudomonas aeruginosa 27853(MIC=13.4 mg/L), Salmonella pullorum 7913(MIC=13.4 mg/L)	[Ref.25818457] 0% hemolysis at 9.2 mg/L , 1% hemolysis at 18.4 mg/L , 4% hemolysis at 36.8mg/L  , 10% hemolysis at 73.6 mg/L , 17% hemolysis at 147.1 mg/L , 22% hemolysis at 294.3 mg/L against human red blood cells	Linear	Free	Amidation		L	[Ref.25818457] The cell viability of PR-TR is 94%, 89%, 83%, 77%, 74%, 71%, 68%, 66% and 60% at peptide concentrations of 1.1, 2.3, 4.6, 9.2, 18.4, 36.8, 73.6, 147.1 and 294.3 μg/ml	Not found	25818457	Biomaterials. 2015 Jun;52:517-30. doi: 10.1016/j.biomaterials.2015.02.063.	Zhi Ma, Dandan Wei, Ping Yan, Xin Zhu, Anshan Shan , Zhongpeng Bi	Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of a-helix-based peptide amphiphiles	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21089	RFRRLRCKTRCRLKKI	16	C4 (Derived from PRW4)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>128 μM), Staphylococcus epidermidis 12228(MIC>128 μM), Enterococcus faecalis 29212(MIC>128 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=2 μM), Escherichia coli 1005(MIC>128 μM), Salmonella typhimurium 7731(MIC128 μM)	[Ref.25735802] MHC5>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.	Not found	25735802	Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.	Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan	Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(N)=O
DRAMP21090	RFRRLRDKTRDRLKKI	16	D4 (Derived from PRW4)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>128 μM), Staphylococcus epidermidis 12228(MIC>128 μM), Enterococcus faecalis 29212(MIC>128 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC>128 μM), Escherichia coli 1005(MIC>128 μM), Salmonella typhimurium 7731(MIC>128 μM)	[Ref.25735802] MHC5>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.	Not found	25735802	Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.	Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan	Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(N)=O
DRAMP21091	RFRRLRIKTRIRLKKI	16	I4 (Derived from PRW4)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=64 μM), Staphylococcus epidermidis 12228(MIC=16 μM), Enterococcus faecalis 29212(MIC=16 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=8 μM), Escherichia coli 1005(MIC=16 μM), Salmonella typhimurium 7731(MIC=16 μM)	[Ref.25735802] MHC5>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.	Not found	25735802	Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.	Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan	Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(N)=O
DRAMP21092	RFRRLRPKTRPRLKKI	16	P4 (Derived from PRW4)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>128 μM), Staphylococcus epidermidis 12228(MIC>128 μM), Enterococcus faecalis 29212(MIC>128 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=32 μM), Escherichia coli 1005(MIC=32 μM), Salmonella typhimurium 7731(MIC=32 μM)	[Ref.25735802] MHC5>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.	Not found	25735802	Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.	Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan	Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(N)=O
DRAMP21093	RFRRLRwKTRwRLKKI	16	PRW4-d (Derived from PRW4)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=8 μM), Staphylococcus epidermidis 12228(MIC=16 μM), Enterococcus faecalis 29212(MIC=4 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=4 μM), Escherichia coli 1005(MIC=8 μM), Salmonella typhimurium 7731(MIC=4 μM)	[Ref.25735802] MHC5>256 μM against human red blood cells	Linear	Free	Amidation		Mixed(D-Trp7, D-Trp11)	[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.	Not found	25735802	Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.	Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan	Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(N)=O
DRAMP21094	RFRRLRWRTRWRLRRI	16	PRW4-R (Derived from PRW4)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=4 μM), Staphylococcus epidermidis 12228(MIC=4 μM), Enterococcus faecalis 29212(MIC=2 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=4 μM), Escherichia coli 1005(MIC=2 μM), Salmonella typhimurium 7731(MIC=4 μM)	[Ref.25735802] MHC5>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.	Not found	25735802	Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.	Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan	Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(N)=O
DRAMP21095	IRCRRRFCRI	10	IR1 (Derived from PG-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC=64 μM), Staphylococcus epidermidis(MIC=64 μM), Streptococcus faecalis(MIC=64 μM), Bacillus subtilis(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(MIC=8 μM), Salmonella pullorum(MIC=16 μM), Salmonella typhimurium(MIC=128 μM), Bacteriump yocyaneum(MIC=64 μM)	[Ref.24621994] MHC10>128 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24621994] No cytotoxicity information found.	Not found	24621994	PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.	Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang	Antimicrobial potency and selectivity of simplified symmetric-end peptides	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)[C@H](C)CC
DRAMP21096	IRIRCRRRFCRIRI	14	IR2 (Derived from PG-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Beta sheet, beta hairpin	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC=4 μM), Staphylococcus epidermidis(MIC=4 μM), Streptococcus faecalis(MIC=4 μM), Bacillus subtilis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=1 μM), Salmonella pullorum(MIC=1 μM), Salmonella typhimurium(MIC=4 μM), Bacteriump yocyaneum(MIC=4 μM)	[Ref.24621994] MHC10=128 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24621994] No cytotoxicity information found.	Not found	24621994	PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.	Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang	Antimicrobial potency and selectivity of simplified symmetric-end peptides	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP21097	FRCRRRFCRF	10	FR1 (Derived from PG-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC=32 μM), Staphylococcus epidermidis(MIC=16 μM), Streptococcus faecalis(MIC=32 μM), Bacillus subtilis(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Salmonella pullorum(MIC=16 μM), Salmonella typhimurium(MIC=32 μM), Bacteriump yocyaneum(MIC>128 μM)	[Ref.24621994] MHC10>128 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24621994] No cytotoxicity information found.	Not found	24621994	PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.	Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang	Antimicrobial potency and selectivity of simplified symmetric-end peptides	N=C(N)NCCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP21098	FRFRCRRRFCRFRF	14	FR2 (Derived from PG-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC=2 μM), Staphylococcus epidermidis(MIC=2 μM), Streptococcus faecalis(MIC=4 μM), Bacillus subtilis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=1 μM), Salmonella pullorum(MIC=1 μM), Salmonella typhimurium(MIC=2 μM), Bacteriump yocyaneum(MIC=4 μM)	[Ref.24621994] MHC10=64 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24621994] No cytotoxicity information found.	Not found	24621994	PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.	Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang	Antimicrobial potency and selectivity of simplified symmetric-end peptides	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP21099	WRCRRRFCRW	10	WR1 (Derived from PG-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC=8 μM), Staphylococcus epidermidis(MIC=8 μM), Streptococcus faecalis(MIC=8 μM), Bacillus subtilis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=2 μM), Salmonella pullorum(MIC=4 μM), Salmonella typhimurium(MIC=16 μM), Bacteriump yocyaneum(MIC>128 μM)	[Ref.24621994] MHC10>128 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24621994] No cytotoxicity information found.	Not found	24621994	PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.	Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang	Antimicrobial potency and selectivity of simplified symmetric-end peptides	N=C(N)NCCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP21100	WRWRCRRRFCRWRW	14	WR2 (Derived from PG-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC=4 μM), Staphylococcus epidermidis(MIC=2 μM), Streptococcus faecalis(MIC=2 μM), Bacillus subtilis(MIC=1 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Salmonella pullorum(MIC=2 μM), Salmonella typhimurium(MIC=4 μM), Bacteriump yocyaneum(MIC=8 μM)	[Ref.24621994] MHC10=64 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24621994] No cytotoxicity information found.	Not found	24621994	PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.	Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang	Antimicrobial potency and selectivity of simplified symmetric-end peptides	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP21101	PRCRRRFCRP	10	PR1 (Derived from PG-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC>128 μM), Staphylococcus epidermidis(MIC>128 μM), Streptococcus faecalis(MIC>128 μM), Bacillus subtilis(MIC=16 μM);##Gram-negative bacteria : Escherichia coli(MIC=16 μM), Salmonella pullorum(MIC>128 μM), Salmonella typhimurium(MIC>128 μM), Bacteriump yocyaneum(MIC>128 μM)	[Ref.24621994] MHC10>128 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24621994] No cytotoxicity information found.	Not found	24621994	PLoS One.2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.	Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang	Antimicrobial potency and selectivity of simplified symmetric-end peptides	N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(N)=O
DRAMP21102	PRPRCRRRFCRPRP	14	PR2 (Derived from PG-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC>128 [Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC>128 μM), Staphylococcus epidermidis(MIC>128 μM), Streptococcus faecalis(MIC>128 μM), Bacillus subtilis(MIC=8 μM);##Gram-negative bacteria : Escherichia coli(MIC=16 μM), Salmonella pullorum(MIC>128 μM), Salmonella typhimurium(MIC>128 μM), Bacteriump yocyaneum(MIC>128 μM)	[Ref.24621994] MHC10>128 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24621994] No cytotoxicity information found.	Not found	24621994	PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.	Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang	Antimicrobial potency and selectivity of simplified symmetric-end peptides	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(N)=O
DRAMP21165	GIMSSLMKKLKKIIKK	16	HYL-11 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=54 μM), Staphylococcus epidermidis(MIC=1.7 μM);##Gram-negative bacteria : Escherichia coli(MIC=22 μM), Pseudomonas aeruginosa 5482(MIC=7.1 μM);##Fungi : Candida albicans(MIC=6.3 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21166	GILSSLLKKLKKIIAK	16	HYL-12 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=16 μM), Staphylococcus epidermidis(MIC=1.8 μM);##Gram-negative bacteria : Escherichia coli(MIC=8 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=10 μM)	[Ref.26998557] LC50=284 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21164	GIMSSLMKKLAKIIKK	16	HYL-10 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=33 μM), Staphylococcus epidermidis(MIC=2.9 μM);##Gram-negative bacteria : Escherichia coli(MIC=15 μM), Pseudomonas aeruginosa 5482(MIC=5.2 μM);##Fungi : Candida albicans(MIC=7.6 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21158	GIMSSLMKKLKKHIAK	16	HYL-4 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC>100 μM), Staphylococcus epidermidis(MIC=10 μM);##Gram-negative bacteria : Escherichia coli(MIC=26 μM), Pseudomonas aeruginosa 5482(MIC=6.4 μM);##Fungi : Candida albicans(MIC=12 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP21159	GIMISLMKKLAAHIAK	16	HYL-5 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=43 μM), Staphylococcus epidermidis(MIC=8.8 μM);##Gram-negative bacteria : Escherichia coli(MIC=12 μM), Pseudomonas aeruginosa 5482(MIC=47 μM);##Fungi : Candida albicans(MIC=12 μM)	[Ref.26998557] LC50=320 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21160	GIMSSLMKKLAAIIAK	16	HYL-6 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=7.2 μM), Staphylococcus epidermidis(MIC=5 μM);##Gram-negative bacteria : Escherichia coli(MIC=3.6 μM), Pseudomonas aeruginosa 5482(MIC=8 μM);##Fungi : Candida albicans(MIC=8.4 μM)	[Ref.26998557] LC50=93 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21161	GIMSSLMKKLAKIIAK	16	HYL-7 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=9 μM), Staphylococcus epidermidis(MIC=5 μM);##Gram-negative bacteria : Escherichia coli(MIC=3.7 μM), Pseudomonas aeruginosa 5482(MIC=4.5 μM);##Fungi : Candida albicans(MIC=11 μM)	[Ref.26998557] LC50=88 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21162	GIMSSLMKKLKKIIAK	16	HYL-8 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=32 μM), Staphylococcus epidermidis(MIC=1.9 μM);##Gram-negative bacteria : Escherichia coli(MIC=9 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=5.2 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21163	gimsslmkklkkiiak	16	HYL-9 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=13 μM), Staphylococcus epidermidis(MIC=2.2 μM);##Gram-negative bacteria : Escherichia coli(MIC=6.3 μM), Pseudomonas aeruginosa 5482(MIC=3.2 μM);##Fungi : Candida albicans(MIC=8 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		D	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@H](C)[C@@H](NC(=O)CN)C(=O)N[C@H](CCSC)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(N)=O)[C@@H](C)CC)[C@@H](C)CC
DRAMP21157	GIMSSLMKKLAAHIKK	16	HYL-3 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=85 μM), Staphylococcus epidermidis(MIC=11 μM);##Gram-negative bacteria : Escherichia coli(MIC=20 μM), Pseudomonas aeruginosa 5482(MIC=23 μM);##Fungi : Candida albicans(MIC=5 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP21156	GIMSSLMKKLAKHIAK	16	HYL-2 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=63 μM), Staphylococcus epidermidis(MIC=6.2 μM);##Gram-negative bacteria : Escherichia coli(MIC=15 μM), Pseudomonas aeruginosa 5482(MIC=7.9 μM);##Fungi : Candida albicans(MIC=14 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP21155	GIMSSLMKKLKAHIAK	16	HYL-1 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC>100 μM), Staphylococcus epidermidis(MIC=16 μM);##Gram-negative bacteria : Escherichia coli(MIC=30 μM), Pseudomonas aeruginosa 5482(MIC=26 μM);##Fungi : Candida albicans(MIC=23 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP21154	GIMSSLMKKLAAHIAK	16	HYL (Bee, Insecta, Animals)	No entry found	Not found	Not found	Solitary wild bee Hylaeus signatus	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=63 μM), Staphylococcus epidermidis(MIC=13 μM);##Gram-negative bacteria : Escherichia coli(MIC=15 μM), Pseudomonas aeruginosa 5482(MIC=20 μM);##Fungi : Candida albicans(MIC=18 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP21153	KRIRKRIKKWKR	12	KR-12-a8 (Derived from KR-12)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil	The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .Among these peptides, KR-12-a8 had shown the least α-helical structure.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=2 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=2 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)	[Ref.24105706] HC50>800 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 91.2%, 112.8%, 104.1%, 114.4%, 104.4%, 109.4%, 107.2% and 82.2% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.	Not found	24105706	J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.	Jacob B, Park IS, Bang JK, Shin SY	Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21151	LRIVKLILKWLR	12	KR-12-a6 (Derived from KR-12)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=2 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=16 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=16 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)	[Ref.24105706] HC50=22 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 100%, 99.1%, 100%, 98.8%, 99.9%, 85.3%, 5.9% and 0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.	Not found	24105706	J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.	Jacob B, Park IS, Bang JK, Shin SY	Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21150	KRIVKLILKWLR	12	KR-12-a5 (Derived from KR-12)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)	[Ref.24105706] HC50=96 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 96.6%, 100.1%, 96.6%, 96.8%, 81.2%, 3.1%, 0% and 0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.	Not found	24105706	J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.	Jacob B, Park IS, Bang JK, Shin SY	Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21152	KRIRKRIKKWLR	12	KR-12-a7 (Derived from KR-12)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=4 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)	[Ref.24105706] HC50>800 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 92.5%, 100.9%, 97.2%, 96.6%, 92.5%, 101.2%, 90.6% and 81.9% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.	Not found	24105706	J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.	Jacob B, Park IS, Bang JK, Shin SY	Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21149	KRIVKLIKKWLR	12	KR-12-a4 (Derived from KR-12)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=4 μM), Salmonella typhimurium (KCTC 1926)(MIC=1 μM)	[Ref.24105706] HC50>800 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 101.9%, 99.9%, 96.6%, 95.6%, 95.3%, 80.9%, 17.8% and 0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.	Not found	24105706	J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.	Jacob B, Park IS, Bang JK, Shin SY	Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21146	KRIVQRIKDWLR	12	KR-12-a1 (Derived from KR-12)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)	[Ref.24105706] HC50>800 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 108.7%, 111.2%, 107.5%, 107.5%, 103.1%, 111.2%, 107.2%, 98.1% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.	Not found	24105706	J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.	Jacob B, Park IS, Bang JK, Shin SY	Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21148	KRIVKRIKKWLR	12	KR-12-a3 (Derived from KR-12)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)	[Ref.24105706] HC50>800 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 104.7%, 111.6%, 105.3%, 108.4%, 111.2%, 104.4%, 108.8% and 95.0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.	Not found	24105706	J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.	Jacob B, Park IS, Bang JK, Shin SY	Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21147	KRIVQRIKKWLR	12	KR-12-a2 (Derived from KR-12)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=1 μM)	[Ref.24105706] HC50>800 μM against human red blood cells	Linear	Free	Amidation 		L	[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 111.9%, 103.4%, 102.2%, 102.2%, 100%, 101.2%, 112.5% and 95.0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.	Not found	24105706	J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.	Jacob B, Park IS, Bang JK, Shin SY	Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21145	RIRWILRYWRWS	12	Myxinidin3 (Derived from Myxinidin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Beta Sheet	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26450121] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=1 μM), Staphylococcus aureus CCARM 3114(MIC=8 μM), Staphylococcus aureus CCARM 3709(MIC=2 μM), Listeria monocytogenes (KCTC 3710)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2 μM), Escherichia coli CCARM 1229(MIC=1 μM), Escherichia coli CCARM 1238(MIC=2 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM), Salmonella typhimurium CCARM 8009(MIC=4 μM), Salmonella typhimurium CCARM 8013(MIC=4 μM), Pseudomonas aeruginosa (ATCC 27853)(MIC=4 μM), Pseudomonas aeruginosa 3592(MIC=8 μM), Pseudomonas aeruginosa 5018(MIC=8 μM)	[Ref.26450121] 27% hemolysis at 50 μM , 45% hemolysis at 100 μM , 63% hemolysis at 200 μM , 59% hemolysis at 400 μM against human red blood cells	Linear	Free	Free		L	[Ref.26450121] The cell survial rates of normal human keratinocytes (NHK) are 100%, 95.8%, 88.3%, 83.4%, 77.4% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50, 100 μM. Melittin, the control, induced 100% toxicity against NHKs at a concentration of	Not found	26450121	Amino Acids. 2016 Feb;48(2):505-22. doi: 10.1007/s00726-015-2104-0.	Han HM, Gopal R, Park Y	Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP21142	HKCAKIKWRGVHVKYCA	17	AMP2041 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix, beta sheet, beta turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23893489] Gram-positive bacteria : Staphylococcus aureus(MBC=3.71 μg/ml, 1.83 μM), MRSA(MBC=2.25 μg/ml, 1.11 μM), Streptococcus agalactiae(MBC>100 μg/ml, 55 μM);##Gram-negative bacteria : Pseudomonas aeruginosa(MBC=4.35 μg/ml, 2.14 μM), Escherichia coli(MBC=1.79 μg/ml, 0.88 μM), Salmonella enteritidis(MBC=10.41 μg/ml, 5.13 μM), Stenotrophomonas maltophilia(MBC=7.00 μg/ml, 3.45 μM)	[Ref.23893489] <1% hemolysis at 1 μg/ml , <1% hemolysis at 12.5 μg/ml , 5.73% hemolysis at 100 μg/ml , 6.4% hemolysis at 250 μg/ml , 9.4% hemolysis at 500 μg/ml against sheep red blood cells	Linear	Free	Free		L	[Ref.23893489] The cytotoxicity (vs control) of P2041 is 6% against HUVEC (endothelial) cells at a peptide concentration of 100 μg/ml. ##The cytotoxicity (vs control) of P2041 is 3% agaisnt WI-38 (fibroblast) cells at a peptide concentration of 100 μg/m	Not found	23893489	J Pept Sci. 2013 Sep;19(9):554-65. doi: 10.1002/psc.2532.	Romani AA, Baroni MC, Taddei S, Ghidini F, Sansoni P, Cavirani S, Cabassi CS	In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
DRAMP21141	KWCRKWQWRGVKFIKCV	17	AMP126 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix, beta sheet, beta turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23893489] Gram-positive bacteria : Staphylococcus aureus(MBC=46.5 μg/ml, 20.65 μM), MRSA(MBC>100 μg/ml, 55 μM), Streptococcus agalactiae(MBC=2.81 μg/ml, 1.24 μM);##Gram-negative bacteria : Pseudomonas aeruginosa(MBC=0.40 μg/ml, 0.17 μM), Escherichia coli(MBC=2.22 μg/ml, 0.98 μM), Salmonella enteritidis(MBC=10.8 μg/ml, 4.80 μM), Stenotrophomonas maltophilia(MBC=16.6 μg/ml, 7.37 μM)	[Ref.23893489] <1% hemolysis at 1 μg/ml , <1% hemolysis at 12.5 μg/ml , 5.30% hemolysis at 100 μg/ml , 6.9% hemolysis at 250 μg/ml , 12.5% hemolysis at 500 μg/ml against sheep red blood cells	Linear	Free	Free		L	[Ref.23893489] The cytotoxicity (vs control) of P126 is 5% against HUVEC (endothelial) cells at a peptide concentration of 100 μg/ml. ##The cytotoxicity (vs control) of P126 is 6% agaisnt WI-38 (fibroblast) cells at a peptide concentration of 100 μg/ml.	Not found	23893489	J Pept Sci. 2013 Sep;19(9):554-65. doi: 10.1002/psc.2532.	Romani AA, Baroni MC, Taddei S, Ghidini F, Sansoni P, Cavirani S, Cabassi CS	In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP21144	KIKWILKYWKWS	12	Myxinidin2 (Derived from Myxinidin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26450121] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=0.25 μM), Staphylococcus aureus CCARM 3114(MIC=16 μM), Staphylococcus aureus CCARM 3709(MIC=2 μM), Listeria monocytogenes (KCTC 3710)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=1 μM), Escherichia coli CCARM 1229(MIC=2 μM), Escherichia coli CCARM 1238(MIC=4 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM), Salmonella typhimurium CCARM 8009(MIC=8 μM), Salmonella typhimurium CCARM 8013(MIC=16 μM), Pseudomonas aeruginosa (ATCC 27853)(MIC=4 μM), Pseudomonas aeruginosa 3592(MIC=8 μM), Pseudomonas aeruginosa 5018(MIC=4 μM)	[Ref.26450121] 10% hemolysis at 50 μM , 28% hemolysis at 100 μM , 30% hemolysis at 200 μM , 50% hemolysis at 400 μM against human red blood cells	Linear	Free	Free		L	[Ref.26450121] The cell survial rates of normal human keratinocytes (NHK) are 100%, 95.8%, 88.3%, 83.4%, 77.4% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50, 100 μM. Melittin, the control, induced 100% toxicity against NHKs at a concentration of	Not found	26450121	Amino Acids. 2016 Feb;48(2):505-22. doi: 10.1007/s00726-015-2104-0.	Han HM, Gopal R, Park Y	Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP21143	GIHHILKYGKPS	12	Myxinidin1 (Derived from Myxinidin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26450121] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC>32 μM), Staphylococcus aureus CCARM 3114(MIC>32 μM), Staphylococcus aureus CCARM 3709(MIC>32 μM), Listeria monocytogenes (KCTC 3710)(MIC>32 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC>32 μM), Escherichia coli CCARM 1229(MIC>32 μM), Escherichia coli CCARM 1238(MIC>32 μM), Salmonella typhimurium (KCTC 1926)(MIC>32 μM), Salmonella typhimurium CCARM 8009(MIC>32 μM), Salmonella typhimurium CCARM 8013(MIC>32 μM), Pseudomonas aeruginosa (ATCC 27853)(MIC>32 μM), Pseudomonas aeruginosa 3592(MIC>32 μM), Pseudomonas aeruginosa 5018(MIC>32 μM)	[Ref.26450121] 0% hemolysis at 50 μM , 0% hemolysis at 100 μM , 0% hemolysis at 200 μM , 0% hemolysis at 400 μM against human red blood cells	Linear	Free	Free		L	[Ref.26450121] The cell survial rates of normal human keratinocytes (NHK) are 100%, 95.8%, 88.3%, 83.4%, 77.4% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50, 100 μM. Melittin, the control, induced 100% toxicity against NHKs at a concentration of	Not found	26450121	Amino Acids. 2016 Feb;48(2):505-22. doi: 10.1007/s00726-015-2104-0.	Han HM, Gopal R, Park Y	Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC
DRAMP21140	KGCALVKVRGLTLKVCK	17	AMP72 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix, beta sheet, beta turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23893489] Gram-positive bacteria : Staphylococcus aureus(MBC=6.88 μg/ml, 3.78 μM), MRSA(MBC=1.72 μg/ml, 0.94 μM), Streptococcus agalactiae(MBC>55 μg/ml, 100 μM);##Gram-negative bacteria : Pseudomonas aeruginosa(MBC=3.30 μg/ml, 1.81 μM), Escherichia coli(MBC=3.40 μg/ml, 1.87 μM), Salmonella enteritidis(MBC=3.20 μg/ml, 1.76 μM), Stenotrophomonas maltophilia(MBC=18.5 μg/ml, 10.19 μM)	[Ref.23893489] <1% hemolysis at 1 μg/ml , <1% hemolysis at 12.5 μg/ml , 1.5% hemolysis at 100 μg/ml , 4.2% hemolysis at 250 μg/ml , 12.0% hemolysis at 500 μg/ml against sheep red blood cells	Linear	Free	Free		L	[Ref.23893489] The cytotoxicity (vs control) of P72 is 3% against HUVEC (endothelial) cells at a peptide concentration of 100 μg/ml. ##The cytotoxicity (vs control) of P72 is 4% agaisnt WI-38 (fibroblast) cells at a peptide concentration of 100 μg/ml. #	Not found	23893489	J Pept Sci. 2013 Sep;19(9):554-65. doi: 10.1002/psc.2532.	Romani AA, Baroni MC, Taddei S, Ghidini F, Sansoni P, Cavirani S, Cabassi CS	In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O
DRAMP21139	RLLRPLLQLLKQKLR	15	GNU7 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisiae	[Ref.23946320] Gram-positive bacteria : Bacillus subtilis(MIC=2 mg/L), Enterococcus faecalis(MIC=2 mg/L), Micrococcus luteus(MIC=2 mg/L), Staphylococcus aureus(MIC=2 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=2 mg/L), Pseudomonas aeruginosa(MIC=2 mg/L), Salmonella typhimurium(MIC=2 mg/L);##Fungi : Candida albicans(MIC=2 mg/L), Cryptococcus neoformans(MIC=2 mg/L), Saccharomyces cerevisiae(MIC=4 mg/L)	[Ref.23946320] 0% hemolysis at 140 mg/L against human red blood cells	Linear	Free	Free		L	[Ref.23946320] The cell viability of hPBMCs is at peptide concentrations of 4, 8, 16, 32, 64 μg/ml	Not found	23946320	J Antimicrob Chemother. 2014 Jan;69(1):121-32. doi: 10.1093/jac/dkt322.	Hyun Kim, Ju Hye Jang, Sun Chang Kim and Ju Hyun Cho	De novo generation of short antimicrobial peptides with enhanced stability and cell specificity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21138	RIIRPIIQIIKQKIR	15	GNU6 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisiae	[Ref.23946320] Gram-positive bacteria : Bacillus subtilis(MIC=2 mg/L), Enterococcus faecalis(MIC=2 mg/L), Micrococcus luteus(MIC=2 mg/L), Staphylococcus aureus(MIC=2 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=4 mg/L), Pseudomonas aeruginosa(MIC=2 mg/L), Salmonella typhimurium(MIC=4 mg/L);##Fungi : Candida albicans(MIC=2 mg/L), Cryptococcus neoformans(MIC=2 mg/L), Saccharomyces cerevisiae(MIC=4 mg/L)	[Ref.23946320] 0% hemolysis at 140 mg/L against human red blood cells	Linear	Free	Free		L	[Ref.23946320] The cell viability of hPBMCs is 102.6%, 102.6%, 107.9%, 96.8% and 97.9% at peptide concentrations of 4, 8, 16, 32, 64 μg/ml	Not found	23946320	J Antimicrob Chemother. 2014 Jan;69(1):121-32. doi: 10.1093/jac/dkt322.	Hyun Kim, Ju Hye Jang, Sun Chang Kim and Ju Hyun Cho	De novo generation of short antimicrobial peptides with enhanced stability and cell specificity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21137	RVVRPVVQVVKQKVR	15	GNU5 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisiae	[Ref.23946320] Gram-positive bacteria : Bacillus subtilis(MIC=16 mg/L), Enterococcus faecalis(MIC=8 mg/L), Micrococcus luteus(MIC=2 mg/L), Staphylococcus aureus(MIC=4 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=32 mg/L), Pseudomonas aeruginosa(MIC=8 mg/L), Salmonella typhimurium(MIC>64 mg/L);##Fungi : Candida albicans(MIC=2 mg/L), Cryptococcus neoformans(MIC=2 mg/L), Saccharomyces cerevisiae(MIC=2 mg/L)	[Ref.23946320] 0% hemolysis at 140 mg/L against human red blood cells	Linear	Free	Free		L	[Ref.23946320] The cell viability of hPBMCs is at peptide concentrations of 4, 8, 16, 32, 64 μg/ml	Not found	23946320	J Antimicrob Chemother. 2014 Jan;69(1):121-32. doi: 10.1093/jac/dkt322.	Hyun Kim, Ju Hye Jang, Sun Chang Kim and Ju Hyun Cho	De novo generation of short antimicrobial peptides with enhanced stability and cell specificity	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21135	RRWWHWWRR	9	P7 (Derived from P5)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=4.33 μM, MBC=16 μM), Staphylococcus aureus(MIC=11.3 μM, MBC=128 μM);##Gram-negative bacteria : Escherichia coli(MIC=8.67 μM, MBC=128 μM)	[Ref.28372989] MHC5=86.67 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 102.4%, 99.2%, 112.8%, 107.2% and 85.2% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.	Not found	28372989	Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.	Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M	Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP21136	HRWWRWWRH	9	P8 (Derived from P5)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=1 μM, MBC=1 μM), Staphylococcus aureus(MIC=16 μM, MBC=32 μM);##Gram-negative bacteria : Escherichia coli(MIC=8 μM, MBC=32 μM)	[Ref.28372989] MHC5=86.67 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 96%, 98.4%, 86.8%, 84.8% and 88.8% and  at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.	Not found	28372989	Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.	Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M	Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O
DRAMP21134	HRWWRWWRR	9	P6 (Derived from P5)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=1 μM, MBC=1 μM), Staphylococcus aureus(MIC=8 μM, MBC=8 μM);##Gram-negative bacteria : Escherichia coli(MIC=8 μM, MBC=32 μM)	[Ref.28372989] MHC5=86.67 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 92.4%, 83.2%, 82.4%, 76% and 68% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.	Not found	28372989	Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.	Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M	Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(N)=O
DRAMP21133	RRWWRWWRR	9	P5 (Derived from Octa 2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=1 μM, MBC=1 μM), Staphylococcus aureus(MIC=5.6 μM, MBC=8 μM);##Gram-negative bacteria : Escherichia coli(MIC=3 μM, MBC=16 μM)	[Ref.28372989] MHC5=33.33 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28372989] IC50 = 86.67 μM for hPBMCs. The cell viability of hPBMCs is 98%, 96%, 89.6%, 78%, 92.8% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.	Not found	28372989	Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.	Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M	Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP21132	RRWHRHWRR	9	P4 (Derived from P5)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=2 μM, MBC=8 μM), Staphylococcus aureus(MIC=128 μM, MBC=128 μM);##Gram-negative bacteria : Escherichia coli(MIC=40 μM, MBC>128 μM)	[Ref.28372989] MHC5>86.67 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 90.8%, 94.1%, 92%, 95.6% and 86.5% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.	Not found	28372989	Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.	Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M	Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP21131	RRHWRWWRR	9	P3 (Derived from P5)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=7.3 μM, MBC=64 μM), Staphylococcus aureus(MIC=40 μM, MBC>128 μM);##Gram-negative bacteria : Escherichia coli(MIC=26 μM, MBC=128 μM)	[Ref.28372989] MHC5>86.67 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 99.6%, 97.6%, 100%, 99.6% and 93.2% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.	Not found	28372989	Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.	Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M	Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP21130	RRWHRWWRR	9	P2 (Derived from P5)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=5.2 μM, MBC=32 μM), Staphylococcus aureus(MIC=25.6 μM, MBC=128 μM);##Gram-negative bacteria : Escherichia coli(MIC=14.4 μM, MBC>128 μM)	[Ref.28372989] MHC5>86.67 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 99.6%, 98%, 95.6%, 98.8% and 90.4% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.	Not found	28372989	Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.	Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M	Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP21129	RRWWRHWRR	9	P1 (Derived from P5)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=10 μM, MBC=32 μM), Staphylococcus aureus(MIC=48 μM, MBC>128 μM);##Gram-negative bacteria : Escherichia coli(MIC=21.33 μM, MBC=128 μM)	[Ref.28372989] MHC5>86.67 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 104.0%, 107.6%, 112.4%, 101.6% and 93.2% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.	Not found	28372989	Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.	Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M	Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP21128	RFRRLRKKFRKRLKKI	16	T9F (Derived from RI16)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=128 μM), Staphylococcus epidermidis 12228(MIC=32 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=64 μM), Salmonella typhimurium 7731(MIC=128 μM), Pseudomonas aeruginosa 27853(MIC=256 μM), Pseudomonas aeruginosa 10419(MIC=256 μM), Pseudomonas aeruginosa 21625(MIC=256 μM), Pseudomonas aeruginosa 21630(MIC=256 μM), Pseudomonas aeruginosa LC(MIC=64 μM), Pseudomonas aeruginosa LCCI(MIC=256 μM), Pseudomonas aeruginosa LCGE(MIC=256 μM), Pseudomonas aeruginosa LCCE(MIC=256 μM)	[Ref.25494332] HC50>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM	Not found	25494332	PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.	Zhu X, Ma Z, Wang J, Chou S, Shan A	Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP21127	RFRRLRKKKRKRLKKI	16	T9K (Derived from RI16)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=128 μM), Staphylococcus epidermidis 12228(MIC=128 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=128 μM), Salmonella typhimurium 7731(MIC=256 μM), Pseudomonas aeruginosa 27853(MIC=128 μM), Pseudomonas aeruginosa 10419(MIC=256 μM), Pseudomonas aeruginosa 21625(MIC=256 μM), Pseudomonas aeruginosa 21630(MIC=256 μM), Pseudomonas aeruginosa LC(MIC=256 μM), Pseudomonas aeruginosa LCCI(MIC=256 μM), Pseudomonas aeruginosa LCGE(MIC=256 μM), Pseudomonas aeruginosa LCCE(MIC=256 μM)	[Ref.25494332] HC50>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM	Not found	25494332	PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.	Zhu X, Ma Z, Wang J, Chou S, Shan A	Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP21126	RFRRLRKKIRKRLKKI	16	T9I (Derived from RI16)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=256 μM), Staphylococcus epidermidis 12228(MIC=32 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=128 μM), Salmonella typhimurium 7731(MIC=256 μM), Pseudomonas aeruginosa 27853(MIC=256 μM), Pseudomonas aeruginosa 10419(MIC=256 μM), Pseudomonas aeruginosa 21625(MIC=256 μM), Pseudomonas aeruginosa 21630(MIC=256 μM), Pseudomonas aeruginosa LC(MIC=64 μM), Pseudomonas aeruginosa LCCI(MIC=256 μM), Pseudomonas aeruginosa LCGE(MIC=256 μM), Pseudomonas aeruginosa LCCE(MIC=256 μM)	[Ref.25494332] HC50>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM	Not found	25494332	PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.	Zhu X, Ma Z, Wang J, Chou S, Shan A	Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(N)=O
DRAMP21125	RFRRLRKKWRKRLKKI	16	T9W (Derived from RI16)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=128 μM), Staphylococcus epidermidis 12228(MIC=64 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=64 μM), Salmonella typhimurium 7731(MIC=128 μM), Pseudomonas aeruginosa 27853(MIC=2 μM), Pseudomonas aeruginosa 10419(MIC=4 μM), Pseudomonas aeruginosa 21625(MIC=4 μM), Pseudomonas aeruginosa 21630(MIC=4 μM), Pseudomonas aeruginosa LC(MIC=1 μM), Pseudomonas aeruginosa LCCI(MIC=2 μM), Pseudomonas aeruginosa LCGE(MIC=4 μM), Pseudomonas aeruginosa LCCE(MIC=4 μM)	[Ref.25494332] HC50>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM	Not found	25494332	PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.	Zhu X, Ma Z, Wang J, Chou S, Shan A	Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP21124	RFRRLRKKTRKRLKKI	16	RI16 (Derived from PMAP-36)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=128 μM), Staphylococcus epidermidis 12228(MIC=32 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=128 μM), Salmonella typhimurium 7731(MIC=128 μM), Pseudomonas aeruginosa 27853(MIC=256 μM), Pseudomonas aeruginosa 10419(MIC=256 μM), Pseudomonas aeruginosa 21625(MIC=256 μM), Pseudomonas aeruginosa 21630(MIC=256 μM), Pseudomonas aeruginosa LC(MIC=32 μM), Pseudomonas aeruginosa LCCI(MIC=256 μM), Pseudomonas aeruginosa LCGE(MIC=256 μM), Pseudomonas aeruginosa LCCE(MIC=256 μM)	[Ref.25494332] HC50>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM	Not found	25494332	PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.	Zhu X, Ma Z, Wang J, Chou S, Shan A	Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(N)=O
DRAMP21123	KRIVKLlLKWLR	12	KR-12-a5 (7-(D)L) (Derived from LL-37)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28525841] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)	[Ref.28525841] MHC10=111 μM against human red blood cells	Linear	Free	Amidation		Mixed(7 is D)	[Ref.28525841] The cell viability of mouse macrophage RAW264.7 cells is 100%, 97.4%, 98.1%, 93.6%, 100.8%, 104.5% and 104.5% at peptide concentrations of 0, 4, 8, 16, 32, 64, 128 and 256 μM	Not found	28525841	Eur J Med Chem. 2017 Aug 18;136:428-441. doi: 10.1016/j.ejmech.2017.05.028.	Kim EY, Rajasekaran G, Shin SY	LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP21122	KRIVKlILKWLR	12	KR-12-a5 (6-(D)L) (Derived from LL-37)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28525841] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=4 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)	[Ref.28525841] MHC10=202 μM against human red blood cells	Linear	Free	Amidation		Mixed(6 is D)	[Ref.28525841] The cell viability of mouse macrophage RAW264.7 cells is 100%, 101.9%, 118.9%, 107.5%, 111.3%, 110.6% and 110.6% at peptide concentrations of 0, 4, 8, 16, 32, 64, 128 and 256 μM	Not found	28525841	Eur J Med Chem. 2017 Aug 18;136:428-441. doi: 10.1016/j.ejmech.2017.05.028.	Kim EY, Rajasekaran G, Shin SY	LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)C(C)C
DRAMP21121	KRIVkLILKWLR	12	KR-12-a5 (5-(D)K) (Derived from LL-37)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28525841] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)	[Ref.28525841] MHC10=79 μM against human red blood cells	Linear	Free	Amidation		Mixed(5 is D)	[Ref.28525841] The cell viability of mouse macrophage RAW264.7 cells is 100%, 103.4%, 116.6%, 118.9%, 115.1%, 107.9% and 105.7% at peptide concentrations of 0, 4, 8, 16, 32, 64, 128 and 256 μM	Not found	28525841	Eur J Med Chem. 2017 Aug 18;136:428-441. doi: 10.1016/j.ejmech.2017.05.028.	Kim EY, Rajasekaran G, Shin SY	LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21119	KWCFRVCYRGRCYRRCR	17	I11R (Derived from tachyplesin I)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=1.56 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=1.56 μM), Pseudomonas aeruginosa PAO1(MIC=6.25 μM)	[Ref.26549611] MHC2=180 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26549611] No cytotoxicity information found.	Not found	26549611	Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.	Panteleev PV, Ovchinnikova TV	Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21120	KRIVKLILKWLR	12	KR-12-a5 (Derived from LL-37)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28525841] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)	[Ref.28525841] MHC10=25 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28525841] The cell viability of mouse macrophage RAW264.7 cells is 100%, 116.6%, 112.1%, 115.1%, 112.8%, 106.8% and 108.3% at peptide concentrations of 0, 4, 8, 16, 32, 64, 128 and 256 μM	Not found	28525841	Eur J Med Chem. 2017 Aug 18;136:428-441. doi: 10.1016/j.ejmech.2017.05.028.	Kim EY, Rajasekaran G, Shin SY	LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21118	KWCFRVCYRGSCYRRCR	17	I11S (Derived from tachyplesin I)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=0.8 μM), Pseudomonas aeruginosa PAO1(MIC=3.13 μM)	[Ref.26549611] MHC2=190 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26549611] The cell viability of human embryonic fibroblasts HEF is 90.6%, 92.9%, 84.1%, 70.6% and 34.1% at peptide concentrations of 6.25, 12.5, 25, 50 and 100 μM.	Not found	26549611	Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.	Panteleev PV, Ovchinnikova TV	Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21117	KWCFRVCRRGICYRRCR	17	Y8R (Derived from tachyplesin I)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=1.56 μM), Pseudomonas aeruginosa PAO1(MIC=6.25 μM)	[Ref.26549611] MHC2=195 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26549611] No cytotoxicity information found.	Not found	26549611	Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.	Panteleev PV, Ovchinnikova TV	Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21116	KWCFRVCSRGICYRRCR	17	Y8S (Derived from tachyplesin I)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=0.8 μM), Pseudomonas aeruginosa PAO1(MIC=3.13 μM)	[Ref.26549611] MHC2=310 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26549611] The cell viability of human embryonic fibroblasts HEF is 100%, 92.9%, 87.1%, 72.9%, 60.0% and 45.0% at peptide concentrations of 0, 6.25, 12.5, 25, 50 and 100 μM.	Not found	26549611	Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.	Panteleev PV, Ovchinnikova TV	Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21115	KWCFRRCYRGICYRRCR	17	V6R (Derived from tachyplesin I)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC>50 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=1.56 μM), Pseudomonas aeruginosa PAO1(MIC>50 μM)	[Ref.26549611] MHC2=200 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26549611] No cytotoxicity information found.	Not found	26549611	Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.	Panteleev PV, Ovchinnikova TV	Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21114	KWCFRSCYRGICYRRCR	17	V6S (Derived from tachyplesin I)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=1.56 μM), Pseudomonas aeruginosa PAO1(MIC=12.5 μM)	[Ref.26549611] MHC2=280 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26549611] No cytotoxicity information found.	Not found	26549611	Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.	Panteleev PV, Ovchinnikova TV	Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21111	LRRAARWARRLLRR	14	ASA (Derived from SLZP)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Sporothrix schenckii, Trichophyton mentagrophytes, Aspergillus fumigatus, Candida parapsilosis	[Ref.25069749] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=3.15 μg/ml), Bacillus cereus(MIC=3.15 μg/ml);##Gram-negative bacteria : E. coli (ATCC 9637)(MIC=25 μg/ml), Pseudomonas aeruginosa (ATCC BAA-427)(MIC=25 μg/ml), Klebsiella pneumoniae (ATCC 27736)(MIC=6.25 μg/ml);##Fungi : Sporothrix schenckii(MIC=12.5 μg/ml), Trichophyton mentagrophytes(MIC=100 μg/ml), Aspergillus fumigatus(MIC=50 μg/ml), Candida parapsilosis (ATCC 22019)(MIC=12.5 μg/ml)	[Ref.25069749] 3% hemolysis at 10 μg/ml , 5% hemolysis at 20 μg/ml , 7.5% hemolysis at 30 μg/ml , 10% hemolysis at 40 μg/ml , 12% hemolysis at 50 μg/ml , 13% hemolysis at 60 μg/ml , 15% hemolysis at 70 μg/ml , 19% hemolysis at 80 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.25069749] The cell viability of murine fibroblast cells (3T3) is 100%, 93.6%, 86.8%, 82.9%, 80% and 77.9% at peptide concentrations of 1.5, 3, 4.5, 6 and 9 μM.	Not found	25069749	Amino Acids. 2014 Nov;46(11):2531-43. doi: 10.1007/s00726-014-1802-3.	Ahmad A, Azmi S, Srivastava S, Kumar A, Tripathi JK, Mishra NN, Shukla PK, Ghosh JK	Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21112	LRRllRWlRRLLRR	14	DLSA (Derived from SLZP)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Sporothrix schenckii, Trichophyton mentagrophytes, Aspergillus fumigatus, Candida parapsilosis	[Ref.25069749] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=3.15 μg/ml), Bacillus cereus(MIC=3.15 μg/ml);##Gram-negative bacteria : E. coli (ATCC 9637)(MIC=12.5 μg/ml), Pseudomonas aeruginosa (ATCC BAA-427)(MIC=12.5 μg/ml), Klebsiella pneumoniae (ATCC 27736)(MIC=6.25 μg/ml);##Fungi : Sporothrix schenckii(MIC=6.25 μg/ml), Trichophyton mentagrophytes(MIC=12.5 μg/ml), Aspergillus fumigatus(MIC=6.25 μg/ml), Candida parapsilosis (ATCC 22019)(MIC=12.5 μg/ml)	[Ref.25069749] 0% hemolysis at 80 μg/ml against human red blood cells	Linear	Free	Amidation		Mixed(4, 5, 8 is D)	[Ref.25069749] The cell viability of murine fibroblast cells (3T3) is 84.8%, 83.4%, 76.9%, 72.1% and 62.8% at peptide concentrations of 1.5, 3, 4.5, 6 and 9 μM.	Not found	25069749	Amino Acids. 2014 Nov;46(11):2531-43. doi: 10.1007/s00726-014-1802-3.	Ahmad A, Azmi S, Srivastava S, Kumar A, Tripathi JK, Mishra NN, Shukla PK, Ghosh JK	Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21113	LRRPPRWPRRLLRR	14	PSA (Derived from SLZP)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Sporothrix schenckii, Trichophyton mentagrophytes, Aspergillus fumigatus, Candida parapsilosis	[Ref.25069749] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=12.5 μg/ml), Bacillus cereus(MIC>100 μg/ml);##Gram-negative bacteria : E. coli (ATCC 9637)(MIC=25 μg/ml), Pseudomonas aeruginosa (ATCC BAA-427)(MIC=100 μg/ml), Klebsiella pneumoniae (ATCC 27736)(MIC=12.5 μg/ml);##Fungi : Sporothrix schenckii(MIC=100 μg/ml), Trichophyton mentagrophytes(MIC>100 μg/ml), Aspergillus fumigatus(MIC>100 μg/ml), Candida parapsilosis (ATCC 22019)(MIC>100 μg/ml)	[Ref.25069749] 0% hemolysis at 80 μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.25069749] The cell viability of murine fibroblast cells (3T3) is 100%, 100%, 100%, 99.9%, 84.8% and 82.1% at peptide concentrations of 1.5, 3, 4.5, 6 and 9 μM.	Not found	25069749	Amino Acids. 2014 Nov;46(11):2531-43. doi: 10.1007/s00726-014-1802-3.	Ahmad A, Azmi S, Srivastava S, Kumar A, Tripathi JK, Mishra NN, Shukla PK, Ghosh JK	Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21103	RWTWRGSGRWTWR	13	L-RW (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.25683050] Gram-positive bacteria : Staphylococcus aureus(MIC=8 μg/ml), Micrococcus luteus(MIC=16 μg/ml), Bacillus subtilis(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=16 μg/ml), Pseudomonas aeruginosa(MIC=125 μg/ml), Acinetobacter baumannii(MIC=32 μg/ml), Stenotrophomonas maltophilia(MIC>500 μg/ml)	[Ref.25683050] 0% hemolysis at 8 mg/L , 3.25% hemolysis at 16 mg/L , 0% hemolysis at 32mg/L  , 0% hemolysis at 64 mg/L , 0% hemolysis at 125 mg/L , 0% hemolysis at  mg/L , 2.5%  hemolysis at 500 mg/L against rabbit red blood cells	Linear	Acylation (Conjugated with acetyl group)	Amidation		L	[Ref.25683050] The inhibition ratio of I-RW against human bronchial epithelial cell line BEAS-2B cells is 11.3%, 2.1%, 0.5%, 6.2%, 1.5%, 8.2%, 37.4% and 51.8% at peptide concentrations of 2.5, 5, 10, 20, 40, 80, 160 and 320 μg/ml	Not found	25683050	J Pept Sci. 2015 Apr;21(4):274-82. doi: 10.1002/psc.2728. 	Lanlan Yu, Qiannan Fan, Xiu Yue, Yexuan Maoa and Lingbo Qu	Activity of a novel-designed antimicrobial peptide and its interaction with lipids	CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O)[C@@H](C)O
DRAMP21110	LRRLLRWLRRLLRR	14	SLZP (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Sporothrix schenckii, Trichophyton mentagrophytes, Aspergillus fumigatus, Candida parapsilosis	[Ref.25069749] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=1.56 μg/ml), Bacillus cereus(MIC=3.15 μg/ml);##Gram-negative bacteria : E. coli (ATCC 9637)(MIC=25 μg/ml), Pseudomonas aeruginosa (ATCC BAA-427)(MIC=25 μg/ml), Klebsiella pneumoniae (ATCC 27736)(MIC=3.15 μg/ml);##Fungi : Sporothrix schenckii(MIC=3.15 μg/ml), Trichophyton mentagrophytes(MIC=6.25 μg/ml), Aspergillus fumigatus(MIC=6.25 μg/ml), Candida parapsilosis (ATCC 22019)(MIC=6.25 μg/ml)	[Ref.25069749] 15% hemolysis at 10 μg/ml , 25% hemolysis at 20 μg/ml , 30% hemolysis at 30 μg/ml , 40% hemolysis at 40 μg/ml , 50% hemolysis at 50 μg/ml , 55% hemolysis at 60 μg/ml , 70% hemolysis at 70 μg/ml , 80% hemolysis at 80μg/ml against human red blood cells	Linear	Free	Amidation		L	[Ref.25069749] The cell viability of murine fibroblast cells (3T3) is 85.9%, 77.5%, 73.7%, 50.0%, 23.7% and 0% at peptide concentrations of 1.5, 3, 4.5, 6 and 9 μM.	Not found	25069749	Amino Acids. 2014 Nov;46(11):2531-43. doi: 10.1007/s00726-014-1802-3.	Ahmad A, Azmi S, Srivastava S, Kumar A, Tripathi JK, Mishra NN, Shukla PK, Ghosh JK	Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21109	GIGGALLSAKAALGLAKGLAEHFAN	25	FPA-Bombinin-BO (toads, amphibians, animals)	No entry found	Not found	Not found	Asian bombinid toad species, Bombina orientalis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.25056849] Gram-positive bacteria : Staphylococcus aureus(MIC=7 μM, MBC=14 μM);##Gram-negative bacteria : Escherichia coli(MIC=14 μM, MBC=14 μM);##Fungi : Candida albicans(MIC=7 μM, MBC=14 μM)	[Ref.25056849] 100% hemolysis at 125 mg/L against horse red blood cells	Linear	Free	Amidation		L	[Ref.25056849] No cytotoxicity information found	Not found	25056849	Chem Biol Drug Des. 2015 Mar;85(3):259-67. doi: 10.1111/cbdd.12396.	Xiaojuan Hou, Qiang Du, Renjie Li, Mei Zhou, Hui Wang, Lei Wang, Can Guo, Tianbao Chen and Chris Shaw	Feleucin-BO1: A Novel Antimicrobial Non-Apeptide Amide from the Skin Secretion of the Toad, Bombina orientalis, and Design of a Potent Broad-Spectrum Synthetic Analogue, Feleucin-K3	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O
DRAMP21108	FLKLLKKLL	9	Feleucin-K3 (Derived from Feleucin-BO1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	In F-K3, these latter residues are substituted with Lys (K) residues, whose side-chains occupied the same positions, producing a model cationic amphipathic character in this analogue.		Function: Antibacterial activity against Gram-positive bacteria	[Ref.25056849] Gram-positive bacteria : Staphylococcus aureus(MIC=34 μM, MBC=128 μM)	[Ref.25056849] 100% hemolysis at >250 mg/L against horse red blood cells	Linear	Free	Amidation		L	[Ref.25056849] No cytotoxicity information found	Not found	25056849	Chem Biol Drug Des. 2015 Mar;85(3):259-67. doi: 10.1111/cbdd.12396.	Xiaojuan Hou, Qiang Du, Renjie Li, Mei Zhou, Hui Wang2, Lei Wang2, Can Guo, Tianbao Chen and Chris Shaw	Feleucin-BO1: A Novel Antimicrobial Non-Apeptide Amide from the Skin Secretion of the Toad, Bombina orientalis, and Design of a Potent Broad-Spectrum Synthetic Analogue, Feleucin-K3	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O
DRAMP21104	GIGGALLNVGKVALKGLAKGLAEHFAN	27	Feleucin-2 (toads, amphibians, animals)	X5JB11 	Belongs to the bombinin family.	feleucin-2	Bombina variegata (Yellow-bellied toad)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.25003126] Gram-positive bacteria : Staphylococcus aureus(MIC=8 mg/L, MBC=32 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=32 mg/L, MBC=32 mg/L);##Fungi : Candida albicans(MIC=32 mg/L, MBC=32 mg/L)	[Ref.25003126] 100% hemolysis at 64 mg/L against horse red blood cells	Linear	Free	Amidation		L	[Ref.25003126] No cytotoxicity information found	Not found	25003126	Biomed Res Int. 2014;2014:671362. doi: 10.1155/2014/671362.	Bing Bai, Xiaojuan Hou, Lei Wang, Lilin Ge, Yu Luo, Chengbang Ma, Mei Zhou, Jinao Duan, Tianbao Chen, and Chris Shaw	Feleucins: Novel Bombinin Precursor-Encoded Nonapeptide Amides from the Skin Secretion of Bombina variegata	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O)C(C)C)C(C)C
DRAMP21105	FLGLLGGLL	9	Feleucin-BV1 (toads, amphibians, animals)	No entry found	Not found	Not found	Bombina variegata	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria	[Ref.25003126] Gram-positive bacteria : Staphylococcus aureus(MIC=256 mg/L, MBC=256 mg/L)	[Ref.25003126] 100% hemolysis at >512 mg/L against horse red blood cells	Linear	Free	Amidation		L	[Ref.25003126] No cytotoxicity information found	Not found	25003126	Biomed Res Int. 2014;2014:671362. doi: 10.1155/2014/671362.	Bing Bai, Xiaojuan Hou, Lei Wang, Lilin Ge, Yu Luo, Chengbang Ma, Mei Zhou, Jinao Duan, Tianbao Chen, and Chris Shaw	Feleucins: Novel Bombinin Precursor-Encoded Nonapeptide Amides from the Skin Secretion of Bombina variegata	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O
DRAMP21106	FLGLIGSLL	9	Feleucin-BV2 (toads, amphibians, animals)	No entry found	Not found	Not found	Bombina variegata	Antimicrobial, Antibacterial, Anti-Gram+	Not found	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria	[Ref.25003126] Gram-positive bacteria : Staphylococcus aureus(MIC=128 mg/L, MBC=256 mg/L)	[Ref.25003126] 100% hemolysis at >512 mg/L against horse red blood cells	Linear	Free	Amidation		L	[Ref.25003126] No cytotoxicity information found	Not found	25003126	Biomed Res Int. 2014;2014:671362. doi: 10.1155/2014/671362.	Bing Bai, Xiaojuan Hou, Lei Wang, Lilin Ge, Yu Luo, Chengbang Ma, Mei Zhou, Jinao Duan, Tianbao Chen, and Chris Shaw	Feleucins: Novel Bombinin Precursor-Encoded Nonapeptide Amides from the Skin Secretion of Bombina variegata	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP21107	FLGLLGSLL	9	Feleucin-BO1 (toads, amphibians, animals)	No entry found	Not found	Not found	Asian bombinid toad species, Bombina orientalis	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix	The Phe (F) and Leu (L) residue side-chains are oriented on one side of the peptide In feleucin-BO1, while the short side-chains of the hydrophilic Gly (G) and Ser (S) residues are oriented on the other.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.25056849] Gram-positive bacteria : Staphylococcus aureus(MIC=3 μM, MBC=6 μM);##Gram-negative bacteria : Escherichia coli(MIC=12 μM, MBC=25 μM);##Fungi : Candida albicans(MIC=6 μM, MBC=12 μM)	[Ref.25056849] 100% hemolysis at 80 mg/L against horse red blood cells	Linear	Free	Amidation		L	[Ref.25056849] No cytotoxicity information found	Not found	25056849	Chem Biol Drug Des. 2015 Mar;85(3):259-67. doi: 10.1111/cbdd.12396.	Xiaojuan Hou, Qiang Du, Renjie Li, Mei Zhou, Hui Wang, Lei Wang, Can Guo, Tianbao Chen and Chris Shaw	Feleucin-BO1: A Novel Antimicrobial Non-Apeptide Amide from the Skin Secretion of the Toad, Bombina orientalis, and Design of a Potent Broad-Spectrum Synthetic Analogue, Feleucin-K3	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O
DRAMP21232	GIMDTVKNAAKNLAGQLLDKLKCKITAC	28	Ranatuerin-2PLx (R2PLx; Frogs, Amphibians, Animals)	A0A3P8MS06	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.	Not found	Lithobates palustris (Pickerel frog) (Rana palustris)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	Random coil, alpha helix	The CD spectra of both peptides shows the pattern of random coil in aqueous solution and a typical α-helix CD spectra in 50% of TFE solution.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.30279210] Gram-positive bacteria : Staphylococcus aureus(NCTC 10788)(MIC=32 μM, MBC=128 μM), MRSA (ATCC 12493)(MIC=256 μM, MBC=512 μM), Enterococcus faecalis(NCTC 12697)(MIC=128 μM, MBC=512 μM);##Gram-negative bacteria : Escherichia coli(NCTC 10418)(MIC=32 μM, MBC=64 μM), Pseudomonas aeruginosa(ATCC 27853)(MIC>512 μM, MBC>512 μM);##Fungi : Candida albicans(NCTC 1467)(MIC=256 μM, MBC=512 μM)	[Ref.30279210] 0% hemolysis at 4 μM , 1% hemolysis at 8 μM , 5% hemolysis at 16 μM , 10% hemolysis at 32 μM , 13% hemolysis at 64 μM , 20% hemolysis at 128 μM , 30% hemolysis at 256 μM , 44% hemolysis at 512 μM against human red blood cells	Linear	Free	Free		L	[Ref.30279210] No cytotoxicity information found	Not found	30279210	Biosci Rep. 2018 Nov 9;38(6). pii: BSR20180710. doi: 10.1042/BSR20180710.	Chen X, Zhang L, Ma C, Zhang Y, Xi X, Wang L, Zhou M, Burrows JF, Chen T	A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)[C@@H](C)O
DRAMP21231	KKKKKKNGFAAWGAFGA	17	S-6K-F17-3GN (Derived from S-6K-F17)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Not found	Substitutions with polar, known ‘helix-breaker’ Gly residues led to losses in helical character until finally the peptide containing 3 Gly and 1 Asn (S- 6K-F17-3GN) shows a severe loss in helical structure.		Function: Antibacterial activity against Gram-negative bacteria	[Ref.29275987] Gram-negative bacteria : Escherichia coli(MIC=4.2 μM)	[Ref.29275987] MHC2=587 μM against human red blood cells	Cyclic	Free	Amidation (Ala17)	The 'A' at position 10 and 14 are 2-(4'-pentenyl)alanine residues and there is a hydrocarbon staple crosslinking them.	L	No cytotoxicity information found	Not found	29275987	Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020.	Stone TA, Cole GB, Nguyen HQ, Sharpe S, Deber CM	Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides.	
DRAMP21230	KKKKKKAGFAAWGAFGA	17	S-6K-F17-3G (Derived from S-6K-F17)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria	[Ref.29275987] Gram-negative bacteria : Escherichia coli(MIC=4.2 μM)	[Ref.29275987] MHC2=128 μM against human red blood cells	Cyclic	Free	Amidation (Ala17)	The 'A' at position 10 and 14 are 2-(4'-pentenyl)alanine residues and there is a hydrocarbon staple crosslinking them.	L	No cytotoxicity information found	Not found	29275987	Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020.	Stone TA, Cole GB, Nguyen HQ, Sharpe S, Deber CM	Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides.	
DRAMP21229	KKKKKKAGFAAWAAFGA	17	S-6K-F17-2G (Derived from S-6K-F17)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-negative bacteria	[Ref.29275987] Gram-negative bacteria : Escherichia coli(MIC=1.6 μM)	[Ref.29275987] MHC2=15 μM against human red blood cells	Cyclic	Free	Amidation (Ala17)	The 'A' at position 10 and 14 are 2-(4'-pentenyl)alanine residues and there is a hydrocarbon staple crosslinking them.	L	No cytotoxicity information found	Not found	29275987	Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020.	Stone TA, Cole GB, Nguyen HQ, Sharpe S, Deber CM	Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides.	
DRAMP21227	ILKKIWKPIKKLF	13	IsCT-P (Derived from IsCT)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.16871429] Gram-positive bacteria : Staphylococcus aureus (KCTC 1621)(MIC=1 μM), Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), MRSA (CCARM 3001)(MIC=2 μM), MRSA (CCARM 3543)(MIC=1 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=1 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM), MDRPA (CCARM 2095)(MIC=1 μM)	[Ref.16871429] HC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.16871429] No cytotoxicity information found	Not found	16871429	Biotechnol Lett. 2006 Sep;28(18):1431-7. 	Lim SS, Yoon SP, Park Y, Zhu WL, Park IS, Hahm KS, Shin SY	Mechanism of antibacterial action of a synthetic peptide with an Ala-peptoid residue based on the scorpion-derived antimicrobial peptide IsCT.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21228	ILKKIWKaIKKLF	13	IsCT-a (Derived from IsCT-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.16871429] Gram-positive bacteria : Staphylococcus aureus (KCTC 1621)(MIC=1 μM), Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), MRSA (CCARM 3001)(MIC=2 μM), MRSA (CCARM 3543)(MIC=1 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=2 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM), MDRPA (CCARM 2095)(MIC=2 μM)	[Ref.16871429] HC50>400 μM against human red blood cells	Linear	Free	Amidation	The 'a' in sequence is Ala peptoid residue (N-methylglycine)	L	[Ref.16871429] No cytotoxicity information found	Not found	16871429	Biotechnol Lett. 2006 Sep;28(18):1431-7. 	Lim SS, Yoon SP, Park Y, Zhu WL, Park IS, Hahm KS, Shin SY	Mechanism of antibacterial action of a synthetic peptide with an Ala-peptoid residue based on the scorpion-derived antimicrobial peptide IsCT.	
DRAMP21225	KKFkWWWkFKK	11	STPk (Derived from STP)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.17604338] Gram-positive bacteria : Staphylococcus epidermidis(KCTC 1917)(MIC=1 μM), Staphylococcus aureus(KCTC 1621)(MIC=1 μM), MRSA1 (CCARM 3001)(MIC=2 μM), MRSA2 (CCARM 3543)(MIC=0.5 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=1 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=2 μM), MDRPA1 (CCARM 2095)(MIC=4 μM), MDRPA2 (CCARM 2109)(MIC=8 μM)	[Ref.17604338] MHC10>200 μM against human red blood cells	Linear	Free	Amidation	The 'k' in sequence is lysine peptoid residue [NH2-(CH2)4-NH-CH2-COOH]	L	[Ref.17604338] No cytotoxicity information found	Not found	17604338	J Pept Sci. 2007 Aug;13(8):529-35.	Zhu WL, Hahm KS, Shin SY	Cathelicidin-derived Trp/Pro-rich antimicrobial peptides with lysine peptoid residue (Nlys): therapeutic index and plausible mode of action.	
DRAMP21226	ILkWKWkWWkWRR	13	Ink (Derived from IN)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.17604338] Gram-positive bacteria : Staphylococcus epidermidis(KCTC 1917)(MIC=1 μM), Staphylococcus aureus(KCTC 1621)(MIC=1 μM), MRSA1 (CCARM 3001)(MIC=2 μM), MRSA2 (CCARM 3543)(MIC=1 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=2 μM), MDRPA1 (CCARM 2095)(MIC=4 μM), MDRPA2 (CCARM 2109)(MIC=8 μM)	[Ref.17604338] MHC10>200 μM against human red blood cells	Linear	Free	Amidation	The 'k' in sequence is lysine peptoid residue [NH2-(CH2)4-NH-CH2-COOH]	L	[Ref.17604338] No cytotoxicity information found	Not found	17604338	J Pept Sci. 2007 Aug;13(8):529-35.	Zhu WL, Hahm KS, Shin SY	Cathelicidin-derived Trp/Pro-rich antimicrobial peptides with lysine peptoid residue (Nlys): therapeutic index and plausible mode of action.	
DRAMP21223	ILKKIWKpIKKLF	13	IsCT-p (Derived from IsCT-P)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil	This result indicated that D-Pro in the central position of a short a-helical peptide provides more remarkable structural flexibility than L-Pro.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.16040002] Gram-positive bacteria : Staphylococcus aureus(KCTC 1621)(MIC=1 μM), MRSA (CCARM 3001)(MIC=2 μM), MRSA (CCARM 3543)(MIC=1 μM), Bacillus subtilis(KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=1 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=2 μM), MDRPA (CCARM 2095)(MIC=2 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)	[Ref.16040002] 0% hemolysis at 200 μM against human red blood cells	Linear	Free	Amidation		Mixed(D-Pro8)	[Ref.16040002] No cytotoxicity information found	Not found	16040002	Biochem Biophys Res Commun. 2005 Sep 9;334(4):1329-35.	Lim SS, Kim Y, Park Y, Kim JI, Park IS, Hahm KS, Shin SY	The role of the central L- or D-Pro residue on structure and mode of action of a cell-selective alpha-helical IsCT-derived antimicrobial peptide.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21224	VRRPkWWWkFLRR	13	TPk (Derived from TP)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.17604338] Gram-positive bacteria : Staphylococcus epidermidis(KCTC 1917)(MIC=1 μM), Staphylococcus aureus(KCTC 1621)(MIC=1 μM), MRSA1 (CCARM 3001)(MIC=1 μM), MRSA2 (CCARM 3543)(MIC=0.5 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=4 μM), MDRPA1 (CCARM 2095)(MIC=4 μM), MDRPA2 (CCARM 2109)(MIC=8 μM)	[Ref.17604338] MHC10>200 μM against human red blood cells	Linear	Free	Amidation	The 'k' in sequence is lysine peptoid residue [NH2-(CH2)4-NH-CH2-COOH]	L	[Ref.17604338] No cytotoxicity information found	Not found	17604338	J Pept Sci. 2007 Aug;13(8):529-35.	Zhu WL, Hahm KS, Shin SY	Cathelicidin-derived Trp/Pro-rich antimicrobial peptides with lysine peptoid residue (Nlys): therapeutic index and plausible mode of action.	
DRAMP21222	IirKIirK	8	Control-4D (Derived from IK12-all L)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=125 mg/L), Staphylococcus aureus(MIC>500 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=31.3 mg/L), Pseudomonas aeruginosa(MIC=125 mg/L);##Fungi : Candida albicans(MIC=62.5 mg/L)	[Ref.24211081] HC10>2000 mg/L against rabbit red blood cells	Linear	Free	Amidation		Mixed(D-Ile2, D-Arg3, D-Ile6, D-Arg7)	[Ref.24211081] No cytotoxicity information found	Not found	24211081	Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.	Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY	Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)CC)[C@H](C)CC)[C@@H](C)CC
DRAMP21221	iirkiirk	8	Control-all D (Derived from IK12-all L)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC>500 mg/L), Staphylococcus aureus(MIC>500 mg/L);##Gram-negative bacteria : Escherichia coli(MIC>500 mg/L), Pseudomonas aeruginosa(MIC>500 mg/L);##Fungi : Candida albicans(MIC=250 mg/L)	[Ref.24211081] HC10>2000 mg/L against rabbit red blood cells	Linear	Free	Amidation		D	[Ref.24211081] No cytotoxicity information found	Not found	24211081	Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.	Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY	Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.	CC[C@H](C)[C@@H](N)C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
DRAMP21219	irvkirvkirvk	12	IK12-all D (Derived from IK12-all L)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=1.0 mg/L), Staphylococcus aureus(MIC=7.8 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=7.8 mg/L), Pseudomonas aeruginosa(MIC=15.6 mg/L);##Fungi : Candida albicans(MIC=31.3 mg/L)	[Ref.24211081] HC10>125 mg/L against rabbit red blood cells	Linear	Free	Amidation		D	[Ref.24211081] No cytotoxicity information found	Not found	24211081	Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.	Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY	Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.	CC[C@H](C)[C@@H](N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(N)=O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C
DRAMP21220	IIRKIIRK	8	Control-all L (Derived from IK12-all L)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC>500 mg/L), Staphylococcus aureus(MIC>500 mg/L);##Gram-negative bacteria : Escherichia coli(MIC>500 mg/L), Pseudomonas aeruginosa(MIC>500 mg/L);##Fungi : Candida albicans(MIC=500 mg/L)	[Ref.24211081] HC10>2000 mg/L against rabbit red blood cells	Linear	Free	Amidation		L	[Ref.24211081] No cytotoxicity information found	Not found	24211081	Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.	Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY	Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP21218	IRVKIRVKIRVK	12	IK12-all L (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Beta sheet	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=2.0 mg/L), Staphylococcus aureus(MIC=31.3 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=15.6 mg/L), Pseudomonas aeruginosa(MIC=62.5 mg/L);##Fungi : Candida albicans(MIC=125 mg/L)	[Ref.24211081] HC10>125 mg/L against rabbit red blood cells	Linear	Free	Amidation		L	[Ref.24211081] No cytotoxicity information found	Not found	24211081	Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.	Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY	Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C
DRAMP21217	IRIkIrIK	8	IK8-2D (Derived from IK8-all L)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=3.9 mg/L), Staphylococcus aureus(MIC=31.3 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=15.6 mg/L), Pseudomonas aeruginosa(MIC=7.8 mg/L);##Fungi : Candida albicans(MIC=3.9 mg/L)	[Ref.24211081] HC10=1600 mg/L against rabbit red blood cells	Linear	Free	Amidation		Mixed (D-Lys4, D-Arg6)	[Ref.24211081] No cytotoxicity information found	Not found	24211081	Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.	Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY	Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP21215	irik	4	IK4-all D (Derived from IK8-all L)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC>500 mg/L), Staphylococcus aureus(MIC>500 mg/L);##Gram-negative bacteria : Escherichia coli(MIC>500 mg/L), Pseudomonas aeruginosa(MIC>500 mg/L);##Fungi : Candida albicans(MIC>500 mg/L)	[Ref.24211081] HC10>2000 mg/L against rabbit red blood cells	Linear	Free	Amidation		D	[Ref.24211081] No cytotoxicity information found	Not found	24211081	Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.	Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY	Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.	CC[C@H](C)[C@@H](N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(N)=O)[C@@H](C)CC
DRAMP21216	IrIkIrIk	8	IK8-4D (Derived from IK8-all L)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC>500 mg/L), Staphylococcus aureus(MIC>500 mg/L);##Gram-negative bacteria : Escherichia coli(MIC>500 mg/L), Pseudomonas aeruginosa(MIC>500 mg/L);##Fungi : Candida albicans(MIC>500 mg/L)	[Ref.24211081] HC10>2000 mg/L against rabbit red blood cells	Linear	Free	Amidation		Mixed (D-Arg2, D-Lys4, D-Arg6, D-Lys8)	[Ref.24211081] No cytotoxicity information found	Not found	24211081	Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.	Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY	Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.	CC[C@@H](C)[C@H](N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP21213	irikirik	8	IK8-all D (Derived from IK8-all L)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=2.0 mg/L), Staphylococcus aureus(MIC=3.9 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=3.9 mg/L), Pseudomonas aeruginosa(MIC=7.8 mg/L);##Fungi : Candida albicans(MIC=3.9 mg/L)	[Ref.24211081] HC10=1750 mg/L against rabbit red blood cells	Linear	Free	Amidation		D	[Ref.24211081] The cell viability of mouse alveolar macrophage RAW264.7 cells is 100%, 100%, 95%, 90%, 83.8%, 86.2%, 50%, 8.8% and 5% at peptide concentrations of 1, 2, 4, 8, 16, 31, 62, 100 and 125 mg/L. ##The cell viability of human fetatl lung fibrobl	Not found	24211081	Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.	Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY	Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.	CC[C@H](C)[C@@H](N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
DRAMP21214	irikir	6	IK6-all D (Derived from IK8-all L)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=31.3 mg/L), Staphylococcus aureus(MIC=250 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=125 mg/L), Pseudomonas aeruginosa(MIC=250 mg/L);##Fungi : Candida albicans(MIC=15.6 mg/L)	[Ref.24211081] HC10>2000 mg/L against rabbit red blood cells	Linear	Free	Amidation		D	[Ref.24211081] No cytotoxicity information found	Not found	24211081	Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.	Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY	Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.	CC[C@H](C)[C@@H](N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC
DRAMP21212	IRIKIRIK	8	IK8-all L (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Beta sheet	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=3.9 mg/L), Staphylococcus aureus(MIC=62.5 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=15.6 mg/L), Pseudomonas aeruginosa(MIC=31.3 mg/L);##Fungi : Candida albicans(MIC=3.9 mg/L)	[Ref.24211081] HC10=2000 mg/L against rabbit red blood cells	Linear	Free	Amidation		L	[Ref.24211081] No cytotoxicity information found	Not found	24211081	Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.	Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY	Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP21211	HLLKRVQRELIRWLDWLK	18	AmyI-1-18 (N3L, G12R) (Derived from AmyI-1-18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria	[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=2.9±0.2 μM)	[Ref.27478151] 14% hemolysis at 50 μM against human red blood cells	Linear	Free	Free		L	[Ref.27478151] No cytotoxicity information found	Not found	27478151	J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008.	Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T	Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP21208	HLNKRVQRLLIGWLDWLK	18	AmyI-1-18 (E9L) (Derived from AmyI-1-18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria	[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=3.7±1.5 μM). 	[Ref.27478151] 5% hemolysis at 50 μM against human red blood cells	Linear	Free	Free		L	[Ref.27478151] No cytotoxicity information found	Not found	27478151	J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008.	Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T	Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-23 and its amino acid-substituted analogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP21209	HLNKRVQRLLIRWLDWLK	18	AmyI-1-18 (E9L, G12R) (Derived from AmyI-1-18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria	[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=4.9±0.5 μM)	[Ref.27478151] 9% hemolysis at 50 μM against human red blood cells	Linear	Free	Free		L	[Ref.27478151] No cytotoxicity information found	Not found	27478151	J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008.	Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T	Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP21205	HLNKRVQRELIRWLDWLK	18	AmyI-1-18 (G12R) (Derived from AmyI-1-18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=4.6±1.1 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=61±8 μM)	[Ref.27478151] 2% hemolysis at 50 μM against human red blood cells	Linear	Free	Free		L	[Ref.27478151##26850840] No cytotoxicity information found	Not found	27478151##26850840	J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22819.	Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T	Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-20 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP21210	HLLKRVQRLLIGWLDWLK	18	AmyI-1-18 (N3L, E9L) (Derived from AmyI-1-18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria	[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=4.2±0.5 μM)	[Ref.27478151] 14% hemolysis at 50 μM against human red blood cells	Linear	Free	Free		L	[Ref.27478151] No cytotoxicity information found	Not found	27478151	J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008.	Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T	Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP21207	HLLKRVQRELIGWLDWLK	18	AmyI-1-18 (N3L) (Derived from AmyI-1-18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=2.5±0.7 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=58±22 μM)	[Ref.27478151] 3% hemolysis at 50 μM against human red blood cells	Linear	Free	Free		L	[Ref.27478151##26850842] No cytotoxicity information found	Not found	27478151##26850842	J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22821.	Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T	Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-22 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP21206	HLNKRVQRELIGWLRWLK	18	AmyI-1-18 (D15R) (Derived from AmyI-1-18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=11±1 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=31±4 μM)	[Ref.27478151] 2% hemolysis at 50 μM against human red blood cells	Linear	Free	Free		L	[Ref.27478151##26850841] No cytotoxicity information found	Not found	27478151##26850841	J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22820.	Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T	Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-21 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP21204	HLNKRVQRELRGWLDWLK	18	AmyI-1-18 (I11R) (Derived from AmyI-1-18)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=10±2 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=62±2 μM)	[Ref.27478151] 1% hemolysis at 50 μM against human red blood cells	Linear	Free	Free		L	[Ref.27478151##26850839] No cytotoxicity information found	Not found	27478151##26850839	J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22818.	Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T	Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-19 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)O
DRAMP21203	HLNKRVQRELIGWLDWLK	18	AmyI-1-18 (Oryza sativa L., Angiospermae, Plants)	P17654	Belongs to the glycosyl hydrolase 13 family.	AMY1.1	Oryza sativa subsp. japonica (Rice)	Antimicrobial, Antibacterial, Anti-Gram-, Antifungal	Protein level	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity gaginst Candida albicans. Important for breakdown of endosperm starch during germination.	[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=13±3 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=64±2 μM)	[Ref.27478151] 0.1% hemolysis at 100 μM against human red blood cells	Linear	Free	Free		L	[Ref.27478151##26850838] No cytotoxicity information found	Not found	27478151##26850838	J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22817.	Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T	Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP21202	FKKLKKLFKKILKLK	15	HPA3NT3-analog (Derived from HPA3NT3)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli	[Ref.19642077] Gram-positive bacteria : Staphylococcus aureus(MIC=8 μM), Bacillus subtilis(MIC=8 μM), Listeria monocytogenes(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(MIC=8 μM), Salmonella typhimurium(MIC=1 μM), Pseudomonas aeruginosa(MIC=2 μM);##Fungi : Candida albicans(MIC=4-8 μM), Trichosporon beigelli(MIC=1 μM)	[Ref.19642077] 0% hemolysis at 100 μM , 3% hemolysis at 200 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.19642077] No cytotoxicity information found.	Not found	19642077	J Pept Sci. 2009 Sep;15(9):589-94. doi: 10.1002/psc.1155.	Gopal R, Park SC, Ha KJ, Cho SJ, Kim SW, Song PI, Nah JW, Park Y, Hahm KS	Effect of Leucine and Lysine substitution on the antimicrobial activity and evaluation of the mechanism of the HPA3NT3 analog peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21201	GIGKFLHSAKKWGKAFVGEIMNS	23	Magainin 2a (M2a; Frogs, Amphibians, Animals)	No entry found	Belongs to the gastrin/cholecystokinin family. Magainin subfamily		From frog	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=128 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=32 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=64 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=64 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=128 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=32 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)	[Ref.18586467] MHC=128 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)C(C)C
DRAMP21200	GYKYINNIIKYINKFFKYIW	20	GW-M4 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=8 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=8 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=8 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=32 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=32 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=16 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=32 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)	[Ref.18586467] MHC=4 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP21199	GANAAKKFANLIKKIFNYIW	20	GW-M3 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=8 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=16 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=32 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=32 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=32 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)	[Ref.18586467] MHC=8 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP21198	GANAAKKLATFAKKIFTAYW	20	GW-M1 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=64 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=64 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=256 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=128 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=32 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=32 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=256 μg/ml)	[Ref.18586467] MHC=64 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
DRAMP21197	GLTFLKKILNFAKKIYTAIW	20	GW-H3 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=16 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=16 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=8 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=32 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=32 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=128 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=32 μg/ml), Escherichia coli (BCRC 10675)(MIC=32 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=64 μg/ml)	[Ref.18586467] MHC=8 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP21196	GYNYAKKLANLAKKFANALW	20	GW-H1 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=16 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=8 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=32 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=16 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=64 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=32 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=16 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=32 μg/ml), Escherichia coli (BCRC 10675)(MIC=8 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=8 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=32 μg/ml)	[Ref.18586467] MHC=128 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP21195	GATYAKKIIKTITKIATTAW	20	GW-A5 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=64 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=64 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=32 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)	[Ref.18586467] MHC=128 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP21194	GAKALTKAATAFTKFYKTIW	20	GW-A4 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=64 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=16 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)	[Ref.18586467] MHC=64 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP21193	GAKYAKIIYNYLKKIANALW	20	GW-A2 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=8 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=16 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=32 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=32 μg/ml), Streptococcus iniae (laboratory strain)(MIC=64 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=32 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=128 μg/ml), Escherichia coli (BCRC 10675)(MIC=64 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)	[Ref.18586467] MHC=8 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP21192	GAKYAKYIYNFYKYIAKYIW	20	GW-A1 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=256 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=128 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=64 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=64 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=64 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=256 μg/ml)	[Ref.18586467] MHC=8 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H](C)CC
DRAMP21191	GIKIAKKAITIAKKIAKIYW	20	GW-Q6 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=32 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=4 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=32 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=32 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=32 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=16 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=8 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=32 μg/ml)	[Ref.18586467] MHC=128 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC
DRAMP21190	GANALKKYFTILKKFFKLAW	20	GW-Q5 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=16 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=16 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=16 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=64 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=64 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=64 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=16 μg/ml), Escherichia coli (BCRC 10675)(MIC=8 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=8 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=32 μg/ml)	[Ref.18586467] MHC=4 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP21189	GANAAKKFATIAKKFINYLW	20	GW-Q4 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=16 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=8 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=8 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=32 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=16 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=8 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=8 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=64 μg/ml)	[Ref.18586467] MHC=128 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP21188	GANLAKKFYTYINKFINYAW	20	GW-Q3 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=256 μg/ml), Streptococcus iniae (laboratory strain)(MIC=256 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=256 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=128 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=128 μg/ml), Escherichia coli (BCRC 10675)(MIC=64 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=32 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=64 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)	[Ref.18586467] MHC=128 μM against human red blood cells	Linear	Free	Free		L	[Ref.18586467] No cytotoxicity information found.	Not found	18586467	Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.	Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ	Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP21187	WLRAFRRLVRRLARLLRR	18	WRL4 (Derived from leucocin A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Random coil, alpha helix, beta sheet, turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=6.65 μM), Staphylococcus aureus 1.160(MIC=1.66 μM), Listeria monocytogenes 21662(MIC=3.32 μM), Listeria monocytogenes 21633(MIC=3.32 μM), Bacillus cereus 63301(MIC=53.18 μM), Micrococcus luteus 28001(MIC=13.29 μM), Bacillus pumilus 63202(MIC=26.59 μM), Pseudomonas fluorescens 21620(MIC=53.18 μM), MRSA 43300(MIC=3.32 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=3.32 μM), Escherichia coli 25922(MIC=13.29 μM), Escherichia coli 35150(MIC=26.59 μM), Salmonella paratyphi-A 20501(MIC=6.65 μM), Salmonella paratyphi paratyphi-B 21495(MIC=3.32 μM), Salmonella paratyphi paratyphi-C 21512(MIC=6.65 μM), Shigella flexneri 51571(MIC=1.66 μM), Salmonella choleraesuis 13312(MIC=13.29 μM), Salmonella typhimurium 51005(MIC>53.18 μM), Salmonella enteritidis 21527(MIC>53.28 μM), Vibrio parahemolyticus 21617(MIC=6.65 μM);##Fungi : Candida albicans 10231(MIC=26.59 μM)	[Ref.28002968] MHC10=53.18 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28002968] The cell viability of RAW264.7 cells induced by WRL4 is 91.27%, 90.42%, 81.13%, 73.24%, 70.14%, 69.30%, 56.62%, 51.27% and 48.25% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.	Not found	28002968	J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.	Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X	Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21186	WLRAFRRLVRRLARGLRR	18	WRL3 (Derived from leucocin A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Random coil, alpha helix, beta sheet, turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=0.43 μM), Staphylococcus aureus 1.160(MIC=0.43 μM), Listeria monocytogenes 21662(MIC=0.21 μM), Listeria monocytogenes 21633(MIC=0.21 μM), Bacillus cereus 63301(MIC=0.85 μM), Micrococcus luteus 28001(MIC=0.43 μM), Bacillus pumilus 63202(MIC=0.85 μM), Pseudomonas fluorescens 21620(MIC=0.43 μM), MRSA 43300(MIC=0.85 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=0.85 μM), Escherichia coli 25922(MIC=1.70 μM), Escherichia coli 35150(MIC=1.70 μM), Salmonella paratyphi-A 20501(MIC=0.43 μM), Salmonella paratyphi paratyphi-B 21495(MIC=0.85 μM), Salmonella paratyphi paratyphi-C 21512(MIC=0.43 μM), Shigella flexneri 51571(MIC=0.43 μM), Salmonella choleraesuis 13312(MIC=1.70 μM), Salmonella typhimurium 51005(MIC=6.81 μM), Salmonella enteritidis 21527(MIC=6.81 μM), Vibrio parahemolyticus 21617(MIC=1.70 μM);##Fungi : Candida albicans 10231(MIC=3.40 μM)	[Ref.28002968] MHC10=27.22 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28002968] The cell viability of RAW264.7 cells induced by WRL3 is 98.31%, 95.21%, 92.96%, 90.70%, 89.30%, 89.01%, 76.90%, 48.45% and 40.73% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.	Not found	28002968	J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.	Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X	Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21185	WGRAFRRLVRRLARGLRR	18	WRL2 (Derived from leucocin A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Random coil, alpha helix, beta sheet, turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=3.49 μM), Staphylococcus aureus 1.160(MIC=1.74 μM), Listeria monocytogenes 21662(MIC=1.74 μM), Listeria monocytogenes 21633(MIC=1.74 μM), Bacillus cereus 63301(MIC=55.78 μM), Micrococcus luteus 28001(MIC=27.89 μM), Bacillus pumilus 63202(MIC=55.78 μM), Pseudomonas fluorescens 21620(MIC=55.78 μM), MRSA 43300(MIC=6.97 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=6.97 μM), Escherichia coli 25922(MIC=27.89 μM), Escherichia coli 35150(MIC=13.94 μM), Salmonella paratyphi-A 20501(MIC=3.49 μM), Salmonella paratyphi paratyphi-B 21495(MIC=6.97 μM), Salmonella paratyphi paratyphi-C 21512(MIC=3.49 μM), Shigella flexneri 51571(MIC=3.49 μM), Salmonella choleraesuis 13312(MIC=13.94 μM), Salmonella typhimurium 51005(MIC=13.94 μM), Salmonella enteritidis 21527(MIC>55.78 μM), Vibrio parahemolyticus 21617(MIC=13.94 μM);##Fungi : Candida albicans 10231(MIC=13.94 μM)	[Ref.28002968] MHC10>55.78 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28002968] The cell viability of RAW264.7 cells induced by WRL2 is 87.32%, 85.35%, 81.13%, 79.15%, 78.87%, 78.03%, 76.34%, 69.86% and 64.79% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.	Not found	28002968	J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.	Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X	Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21184	WGRAFRRGVRRLARGGRR	18	WR7 (Derived from leucocin A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Random coil, alpha helix, beta sheet, turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=14.66 μM), Staphylococcus aureus 1.160(MIC=7.33 μM), Listeria monocytogenes 21662(MIC=7.33 μM), Listeria monocytogenes 21633(MIC=7.33 μM), Bacillus cereus 63301(MIC=14.66 μM), Micrococcus luteus 28001(MIC=7.33 μM), Bacillus pumilus 63202(MIC>58.64 μM), Pseudomonas fluorescens 21620(MIC=29.32 μM), MRSA 43300(MIC=14.66 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=3.67 μM), Escherichia coli 25922(MIC=14.66 μM), Escherichia coli 35150(MIC=29.32 μM), Salmonella paratyphi-A 20501(MIC=7.33 μM), Salmonella paratyphi paratyphi-B 21495(MIC=3.67 μM), Salmonella paratyphi paratyphi-C 21512(MIC=7.33 μM), Shigella flexneri 51571(MIC=7.33 μM), Salmonella choleraesuis 13312(MIC=14.66 μM), Salmonella typhimurium 51005(MIC>58.64 μM), Salmonella enteritidis 21527(MIC>58.64 μM), Vibrio parahemolyticus 21617(MIC=29.32 μM);##Fungi : Candida albicans 10231(MIC=29.32 μM)	[Ref.28002968] MHC10>58.64 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28002968] The cell viability of RAW264.7 cells induced by WR7 is 97.46%, 94.65%, 89.01%, 82.25%, 81.41%, 80.85%, 78.59%, 76.06% and 74.80% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.	Not found	28002968	J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.	Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X	Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21183	WGRAFSRGVRRLARGGRG	18	WR5 (Derived from leucocin A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Random coil, alpha helix, beta sheet, turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=31.77 μM), Staphylococcus aureus 1.160(MIC=15.89 μM), Listeria monocytogenes 21662(MIC=15.89 μM), Listeria monocytogenes 21633(MIC=31.77 μM), Bacillus cereus 63301(MIC>63.54 μM), Micrococcus luteus 28001(MIC>63.54 μM), Bacillus pumilus 63202(MIC>63.54 μM), Pseudomonas fluorescens 21620(MIC>63.54 μM), MRSA 43300(MIC>63.54 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=7.94 μM), Escherichia coli 25922(MIC=31.77 μM), Escherichia coli 35150(MIC=31.77 μM), Salmonella paratyphi-A 20501(MIC=15.89 μM), Salmonella paratyphi paratyphi-B 21495(MIC=15.89 μM), Salmonella paratyphi paratyphi-C 21512(MIC=15.89 μM), Shigella flexneri 51571(MIC=15.89 μM), Salmonella choleraesuis 13312(MIC=15.89 μM), Salmonella typhimurium 51005(MIC>63.54 μM), Salmonella enteritidis 21527(MIC>63.54 μM), Vibrio parahemolyticus 21617(MIC>63.54 μM);##Fungi : Candida albicans 10231(MIC>63.54 μM)	[Ref.28002968] MHC10>63.54 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28002968] The cell viability of RAW264.7 cells induced by WR5 is 98.59%, 97.46%, 96.06%, 96.09%, 92.96%, 91.83%, 89.58%, 87.32% and 85.48% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.	Not found	28002968	J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.	Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X	Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O
DRAMP21182	WGRAFSAGVHRLARGGRG	18	WR3 (Derived from leucocin A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Random coil, alpha helix, beta sheet, turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>67.01 μM), Staphylococcus aureus 1.160(MIC>67.01 μM), Listeria monocytogenes 21662(MIC=33.50 μM), Listeria monocytogenes 21633(MIC=67.01 μM), Bacillus cereus 63301(MIC>67.01 μM), Micrococcus luteus 28001(MIC>67.01 μM), Bacillus pumilus 63202(MIC>67.01 μM), Pseudomonas fluorescens 21620(MIC>67.01 μM), MRSA 43300(MIC>67.01 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=16.75 μM), Escherichia coli 25922(MIC>67.01 μM), Escherichia coli 35150(MIC>67.01 μM), Salmonella paratyphi-A 20501(MIC=33.50 μM), Salmonella paratyphi paratyphi-B 21495(MIC>67.01 μM), Salmonella paratyphi paratyphi-C 21512(MIC>67.01 μM), Shigella flexneri 51571(MIC>67.01 μM), Salmonella choleraesuis 13312(MIC=33.50 μM), Salmonella typhimurium 51005(MIC>67.01 μM), Salmonella enteritidis 21527(MIC>67.01 μM), Vibrio parahemolyticus 21617(MIC>67.01 μM);##Fungi : Candida albicans 10231(MIC>67.01 μM)	[Ref.28002968] MHC10>67.01 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28002968] The cell viability of RAW264.7 cells induced by WR3 is 100%, 98.87%, 92.11%, 90.42%, 90.42%, 88.45%, 87.61%, 87.89% and 87.22% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.	Not found	28002968	J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.	Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X	Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O
DRAMP21181	WGRAFSAGVHRLANGGNG	18	WR1 (Derived from leucocin A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Random coil, alpha helix, beta sheet, turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>70.09s μM), Staphylococcus aureus 1.160(MIC=70.09 μM), Listeria monocytogenes 21662(MIC>70.09 μM), Listeria monocytogenes 21633(MIC>70.09 μM), Bacillus cereus 63301(MIC>70.09 μM), Micrococcus luteus 28001(MIC>70.09 μM), Bacillus pumilus 63202(MIC>70.09 μM), Pseudomonas fluorescens 21620(MIC>70.09 μM), MRSA 43300(MIC>70.09 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC>70.09 μM), Escherichia coli 25922(MIC>70.09 μM), Escherichia coli 35150(MIC>70.09 μM), Salmonella paratyphi-A 20501(MIC>70.09 μM), Salmonella paratyphi paratyphi-B 21495(MIC>70.09 μM), Salmonella paratyphi paratyphi-C 21512(MIC>70.09 μM), Shigella flexneri 51571(MIC>70.09 μM), Salmonella choleraesuis 13312(MIC>70.09 μM), Salmonella typhimurium 51005(MIC>70.09 μM), Salmonella enteritidis 21527(MIC>70.09 μM), Vibrio parahemolyticus 21617(MIC>70.09 μM);##Fungi : Candida albicans 10231(MIC>70.09 μM)	[Ref.28002968] MHC10>70.09 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28002968] The cell viability of RAW264.7 cells induced by WR1 is 99.44%, 96.62%, 95.21%, 94.08%, 92.96%, 92.99%, 92.68%, 87.04% and 77.58% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.	Not found	28002968	J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.	Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X	Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(N)=O
DRAMP21180	WGEAFSAGVHRLANGGNG	18	WG18 (Derived from leucocin A)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Random coil, alpha helix, beta sheet, turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>71.15 μM), Staphylococcus aureus 1.160(MIC>71.15 μM), Listeria monocytogenes 21662(MIC>71.15 μM), Listeria monocytogenes 21633(MIC>71.15 μM), Bacillus cereus 63301(MIC>71.15 μM), Micrococcus luteus 28001(MIC>71.15 μM), Bacillus pumilus 63202(MIC>71.15 μM), Pseudomonas fluorescens 21620(MIC>71.15 μM), MRSA 43300(MIC>71.15 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC>71.15 μM), Escherichia coli 25922(MIC>71.15 μM), Escherichia coli 35150(MIC>71.15 μM), Salmonella paratyphi-A 20501(MIC>71.15 μM), Salmonella paratyphi paratyphi-B 21495(MIC>71.15 μM), Salmonella paratyphi paratyphi-C 21512(MIC>71.15 μM), Shigella flexneri 51571(MIC>71.15 μM), Salmonella choleraesuis 13312(MIC>71.15 μM), Salmonella typhimurium 51005(MIC>71.15 μM), Salmonella enteritidis 21527(MIC>71.15 μM), Vibrio parahemolyticus 21617(MIC>71.15 μM);##Fungi : Candida albicans 10231(MIC>71.15 μM)	[Ref.28002968] MHC10>71.15 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28002968] The cell viability of RAW264.7 cells induced by WG18 is 98.87%, 94.93%, 93.52%, 90.14%, 85.35%, 83.10%, 80.56%, 75.77% and 73.62% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.	Not found	28002968	J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.	Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X	Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(N)=O
DRAMP21179	GILSSLWKKPKKIIAK	16	HYL-26 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC>100 μM), Staphylococcus epidermidis(MIC>100 μM);##Gram-negative bacteria : Escherichia coli(MIC>100μM), Pseudomonas aeruginosa 5482(MIC=98 μM);##Fungi : Candida albicans(MIC>100 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21178	GILSSLWKKLKKWIAK	16	HYL-25 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=2.5 μM), Staphylococcus epidermidis(MIC=1.6 μM);##Gram-negative bacteria : Escherichia coli(MIC=2.5 μM), Pseudomonas aeruginosa 5482(MIC=13 μM);##Fungi : Candida albicans(MIC=13 μM)	[Ref.26998557] LC50=57 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP21177	GILSSLLKKLKKWIAK	16	HYL-24 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=8 μM), Staphylococcus epidermidis(MIC=1.6 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Pseudomonas aeruginosa 5482(MIC=8 μM);##Fungi : Candida albicans(MIC=16 μM)	[Ref.26998557] LC50=115 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP21176	GILSSLLKKWKKIIAK	16	HYL-23 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=20 μM), Staphylococcus epidermidis(MIC=2.7 μM);##Gram-negative bacteria : Escherichia coli(MIC=7.5 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=11 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21175	GKLSSLWKKLKKIIAK	16	HYL-22 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=26 μM), Staphylococcus epidermidis(MIC=2.5 μM);##Gram-negative bacteria : Escherichia coli(MIC=20 μM), Pseudomonas aeruginosa 5482(MIC=6.8 μM);##Fungi : Candida albicans(MIC=34 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP21174	gilsslwkklkkiiak	16	HYL-21 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=6.3 μM), Staphylococcus epidermidis(MIC=1.7 μM);##Gram-negative bacteria : Escherichia coli(MIC=5 μM), Pseudomonas aeruginosa 5482(MIC=6.7 μM);##Fungi : Candida albicans(MIC=8 μM)	[Ref.26998557] LC50=191 μM against human red blood cells	Linear	Free	Amidation		D	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@H](C)[C@@H](NC(=O)CN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(N)=O)[C@@H](C)CC)[C@@H](C)CC
DRAMP21173	GILSSLWKKLKKIIAK	16	HYL-20 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=5.3 μM), Staphylococcus epidermidis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=3.4 μM), Pseudomonas aeruginosa 5482(MIC=5.3 μM);##Fungi : Candida albicans(MIC=11 μM)	[Ref.26998557] LC50=197 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21172	GILSSWLKKLKKIIAK	16	HYL-19 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=16 μM), Staphylococcus epidermidis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=11 μM), Pseudomonas aeruginosa 5482(MIC=4 μM);##Fungi : Candida albicans(MIC=17 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21168	GILKSLLKKLKKIIAK	16	HYL-15 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=17 μM), Staphylococcus epidermidis(MIC=2.2 μM);##Gram-negative bacteria : Escherichia coli(MIC=10 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=24 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21169	GILSKLLKKLKKIIAK	16	HYL-16 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=23 μM), Staphylococcus epidermidis(MIC=1.8 μM);##Gram-negative bacteria : Escherichia coli(MIC=18 μM), Pseudomonas aeruginosa 5482(MIC=4.5 μM);##Fungi : Candida albicans(MIC=45 μM)	[Ref.26998557] LC50>400 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21170	kILSSLLKKLKKIIAK	16	HYL-17 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=32 μM), Staphylococcus epidermidis(MIC=1.4 μM);##Gram-negative bacteria : Escherichia coli(MIC=16 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=25 μM)	[Ref.26998557] LC50=364 μM against human red blood cells	Linear	Free	Amidation		Mixed(1 is D)	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21171	GIWSSLLKKLKKIIAK	16	HYL-18 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=20 μM), Staphylococcus epidermidis(MIC=1.5 μM);##Gram-negative bacteria : Escherichia coli(MIC=1.6 μM), Pseudomonas aeruginosa 5482(MIC=6.3 μM);##Fungi : Candida albicans(MIC=16 μM)	[Ref.26998557] LC50=165 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21243	GFFALIPKIISSPLFKTLLSAVGSALS	27	pardaxin-6 (GE-6) (Derived from pardaxin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found	1XC0	Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23598079] Gram-positive bacteria : Micrococcus luteus(MIC=25 mg/L), Staphylococcus aureus(MIC=50 mg/L), Streptococcus pneumoniae(MIC=50 mg/L), Streptococcus agalactiae(MIC=50 mg/L), Staphylococcus sp.(MIC=6.25 mg/L);##Gram-negative bacteria : Grouper Vibrio alginolyticus(MIC=12.5 mg/L), Vibrio harveyi(MIC=12.5 mg/L), Vibrio vulnificus(MIC=50 mg/L)	[Ref.23598079] 8% hemolysis at 12.5 mg/L , 29% hemolysis at 25 mg/L , 38% hemolysis at 50 mg/L , 57.5% hemolysis at 100 mg/L , 99% hemolysis at 200 mg/L , 98% hemolysis at 400 mg/L against sheep red blood cells	Linear	Free	Free		L	[Ref.23598079] No cytotoxicity information found.	Not found	23598079	Peptides. 2013 Jun;44:139-48. doi: 10.1016/j.peptides.2013.04.004.	Lin MC, Hui CF, Chen JY, Wu JL	Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)O)[C@H](C)CC
DRAMP21242	FIFHIIKGLFHAGKMI	16	Epinecidin-8 (Derived from Epinecidin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23598079] Gram-positive bacteria : Staphylococcus aureus(MIC=6.25 mg/L), Staphylococcus sp.(MIC=12.5 mg/L);##Gram-negative bacteria : Grouper Vibrio alginolyticus(MIC=12.5 mg/L), Vibrio harveyi(MIC=6.25 mg/L)	[Ref.23598079] 0% hemolysis at 50 mg/L , 10% hemolysis at 100 mg/L , 20% hemolysis at 200 mg/L , 50% hemolysis at 400 mg/L against sheep red blood cells	Linear	Free	Free		L	[Ref.23598079] No cytotoxicity information found.	Not found	23598079	Peptides. 2013 Jun;44:139-48. doi: 10.1016/j.peptides.2013.04.004.	Lin MC, Hui CF, Chen JY, Wu JL	Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP21241	GFIFHIIKGLFHAGKMIHGLV	21	Epinecidin-1 (Derived from Epinecidin)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23598079] Gram-positive bacteria : Micrococcus luteus(MIC=6.25 mg/L), Staphylococcus aureus(MIC=50 mg/L), Streptococcus pneumoniae(MIC=50 mg/L), Streptococcus agalactiae(MIC>=100 mg/L), Staphylococcus sp.(MIC=6.25 mg/L);##Gram-negative bacteria : Grouper Vibrio alginolyticus(MIC=6.25 mg/L), Vibrio harveyi(MIC=6.25 mg/L), Vibrio vulnificus(MIC=50 mg/L)	[Ref.23598079] 0% hemolysis at 25 mg/L , 10% hemolysis at 50 mg/L , 15% hemolysis at 100 mg/L , 30% hemolysis at 200 mg/L , 50% hemolysis at 400 mg/L against sheep red blood cells	Linear	Free	Free		L	[Ref.23598079] No cytotoxicity information found.	Not found	23598079	Peptides. 2013 Jun;44:139-48. doi: 10.1016/j.peptides.2013.04.004.	Lin MC, Hui CF, Chen JY, Wu JL	Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP21240	WKRWVRRWKRWLR	13	FK13-a7 (Derived from FK13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)	[Ref.28161291] HC50=138.0 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a7 is 100.2%, 112.8%, 97.0%, 95.1%, 83.4% and 83.8% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by FK1	Not found	28161291	Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.	Rajasekaran G, Kim EY, Shin SY	LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21239	WKRWVQRWKRWLR	13	FK13-a6 (Derived from FK13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)	[Ref.28161291] HC50=167.5 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a6 is 91.3%, 94.6%, 103.0%, 96.6%, 61.9% and 28.7% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by FK13	Not found	28161291	Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.	Rajasekaran G, Kim EY, Shin SY	LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21238	WKRWVQRWKRFLR	13	FK13-a5 (Derived from FK13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)	[Ref.28161291] HC50=230.0 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a5 is 105.3%, 103.9%, 97.1%, 94.0%, 47.5% and 44.2% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by FK1	Not found	28161291	Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.	Rajasekaran G, Kim EY, Shin SY	LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21237	FKRWVQRWKRFLR	13	FK13-a4 (Derived from FK13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)	[Ref.28161291] HC50>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a4 is 94.0%, 95.7%, 108.7%, 93.2%, 52.8% and 10.6% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by FK13	Not found	28161291	Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.	Rajasekaran G, Kim EY, Shin SY	LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21236	WKRIVRRIWRWLR	13	FK13-a3 (Derived from FK13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM)	[Ref.28161291] HC50=12.5 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a3 is 102.3%, 112.1%, 104.5%, 103.8%, 74.3% and 70.2% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by F	Not found	28161291	Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.	Rajasekaran G, Kim EY, Shin SY	LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21235	WKRIVRWIKRWLR	13	FK13-a2 (Derived from FK13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=4 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM)	[Ref.28161291] HC50=14.0 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a2 is 104.5%, 101.7%, 100.4%, 77.0%, 58.9% and 15.8% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by FK	Not found	28161291	Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.	Rajasekaran G, Kim EY, Shin SY	LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21167	gilssllkklkkiiak	16	HYL-13 (Derived from HYL)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=5.7 μM), Staphylococcus epidermidis(MIC=3.2 μM);##Gram-negative bacteria : Escherichia coli(MIC=4.5 μM), Pseudomonas aeruginosa 5482(MIC=4.5 μM);##Fungi : Candida albicans(MIC=9 μM)	[Ref.26998557] LC50=333 μM against human red blood cells	Linear	Free	Amidation		D	[Ref.26998557] No cytotoxicity information found.	Not found	26998557	J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.	Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V	Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.	CC[C@H](C)[C@@H](NC(=O)CN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(N)=O)[C@@H](C)CC)[C@@H](C)CC
DRAMP21234	WKRIVRRIKRWLR	13	FK13-a1 (Derived from FK13)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)	[Ref.28161291] HC50>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a1 is 95.5%, 107.5%, 100.2%, 96.2%, 44.9% and 37.4% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by FK1	Not found	28161291	Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.	Rajasekaran G, Kim EY, Shin SY	LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21233	GIMDTVKNAAKNLAGQLLDKLK	22	R2PLx-22 (Derived from R2PLx)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	The CD spectra of both peptides shows the pattern of random coil in aqueous solution and a typical α-helix CD spectra in 50% of TFE solution.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.30279210] Gram-positive bacteria : Staphylococcus aureus(NCTC 10788)(MIC=256 μM, MBC=256 μM), MRSA (ATCC 12493)(MIC>512 μM, MBC>512 μM), Enterococcus faecalis(NCTC 12697)(MIC>512 μM, MBC>512 μM);##Gram-negative bacteria : Escherichia coli(NCTC 10418)(MIC=128 μM, MBC=256 μM), Pseudomonas aeruginosa(ATCC 27853)(MIC= μM, MBC= μM);##Fungi : Candida albicans(NCTC 1467)(MIC=512 μM, MBC>512 μM)	[Ref.30279210] 3% hemolysis at 1 μM , 4% hemolysis at 2 μM , 1% hemolysis at 4 μM , 0% hemolysis at 8 μM , 2% hemolysis at 16 μM , 0% hemolysis at 32 μM , 0% hemolysis at 128 μM , 3% hemolysis at 256 μM , 13% hemolysis at 512 μM against human red blood cells	Linear	Free	Free		L	[Ref.30279210] No cytotoxicity information found	Not found	30279210	Biosci Rep. 2018 Nov 9;38(6). pii: BSR20180710. doi: 10.1042/BSR20180710.	Chen X, Zhang L, Ma C, Zhang Y, Xi X, Wang L, Zhou M, Burrows JF, Chen T	A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
DRAMP21244	FLSLIPKLVKKIIKAFK	17	TsAP-S1 (Derived from TsAP-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Anticancer against H157, H838, MCF-7, PC3 and U251-MG	[Ref.23770440] Gram-positive bacteria : Staphylococcus aureus(MIC=2.5 μM, MBC=20 μM);##Gram-negative bacteria : Escherichia coli(MIC=5 μM, MBC=20 μM);##Fungi : Candida albicans(MIC=2.5 μM, MBC=5 μM)	[Ref.23770440] 30% hemolysis at 5 μM , 85% hemolysis at 10 μM , 100% hemolysis at 20 μM against horse red blood cells	Linear	Free	Amidation		L	[Ref.23770440] No cytotoxicity information found.	Not found	23770440	Biochimie. 2013 Sep;95(9):1784-94. doi: 10.1016/j.biochi.2013.06.003.	Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, Chen T, Shaw C	Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP21245	FLGMIPKLIKKLIKAFK	17	TsAP-S2 (Derived from TsAP-2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Anticancer against H157, H838, MCF-7, PC3 and U252-MG	[Ref.23770440] Gram-positive bacteria : Staphylococcus aureus(MIC=5 μM, MBC=20 μM);##Gram-negative bacteria : Escherichia coli(MIC=5 μM, MBC=40 μM);##Fungi : Candida albicans(MIC=2.5 μM, MBC=10 μM)	[Ref.23770440] 30% hemolysis at 5 μM , 85% hemolysis at 10 μM , 100% hemolysis at 20 μM against horse red blood cells	Linear	Free	Amidation		L	[Ref.23770440] No cytotoxicity information found.	Not found	23770440	Biochimie. 2013 Sep;95(9):1784-94. doi: 10.1016/j.biochi.2013.06.003.	Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, Chen T, Shaw C	Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21246	KKWRWWLKALAKK	13	pEM-2 (Derived from the venom of the snake Bothrops asper)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27591703] Gram-positive bacteria : Staphylococcus aureus isolates(MIC=5.3 ± 2.3 mg/L, MBC=6.7 ± 2.3 mg/L), Enterococcus faecalis isolates(MIC=6.7 ± 2.3 mg/L, MBC=8.0 ± 0.0 mg/L);##Gram-negative bacteria : Pseudomonas aeruginosa isolates(MIC=4.0 ± 3.5 mg/L, MBC=4.0 ± 3.5 mg/L), Acinetobacter baumannii isolates(MIC=4.0 ± 0.0 mg/L, MBC=5.3 ± 2.3 mg/L)	[Ref.27591703] 0% hemolysis at 2 μg/ml , 5% hemolysis at 4 μg/ml , 15% hemolysis at 8 μg/ml , 55% hemolysis at 16 μg/ml , 87% hemolysis at 32 μg/ml , 92% hemolysis at 64 μg/ml against human red blood cells; 0% hemolysis at 16 μg/ml , 2.5% hemolysis at 32 μg/ml , 10% hemolysis at 64 μg/ml against sheep red blood cells	Linear	Free	Amidation		L	[Ref.27591703] The cell viability of HEK293 cells induced by PV is 99.1%, 99.1%, 98.3%, 94.8%, 93.9%, 87.5% and 84.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μg/mL within 24h.	Not found	27591703	Chem Biol Drug Des. 2017 Mar;89(3):327-338. doi: 10.1111/cbdd.12864.	Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K	Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21247	KKWRWWLKALAKKLL	15	PV (Derived from pEM-2 and MP-VT1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27591703] Gram-positive bacteria : Staphylococcus aureus isolates(MIC=0.5 ± 0.0 mg/L, MBC=0.5 ± 0.0 mg/L), Enterococcus faecalis isolates(MIC=0.7 ± 0.3 mg/L, MBC=0.8 ± 0.3 mg/L);##Gram-negative bacteria : Pseudomonas aeruginosa isolates(MIC=1.2 ± 0.8 mg/L, MBC=1.3 ± 0.6 mg/L), Acinetobacter baumannii isolates(MIC=0.4 ± 0.1 mg/L, MBC=0.5 ± 0.0 mg/L)	[Ref.27591703] 0% hemolysis at 32 μg/ml , 5% hemolysis at 64 μg/ml against human red blood cells; 0% hemolysis at 32 μg/ml , 8% hemolysis at 64 μg/ml against sheep red blood cells	Linear	Free	Amidation		L	[Ref.27591703] The cell viability of HEK293 cells induced by PV is 98.8%, 97.4%, 85.8%, 56.2%, 22.8%, 12.2% and 2.3% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μg/mL within 24h.	Not found	27591703	Chem Biol Drug Des. 2017 Mar;89(3):327-338. doi: 10.1111/cbdd.12864.	Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K	Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP21248	LKLKAIAALAKKKW	14	BVP (Derived from pEM-2 and MP-VT1 and MP-B)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27591703] Gram-positive bacteria : Staphylococcus aureus isolates(MIC=24.0 ± 13.9 mg/L, MBC=37.3 ± 24.4 mg/L), Enterococcus faecalis isolates(MIC=12.0 ± 6.9 mg/L, MBC=18.7 ± 12.2 mg/L);##Gram-negative bacteria : Pseudomonas aeruginosa isolates(MIC=16.0 ± 13.9 mg/L, MBC=18.7 ± 12.2 mg/L), Acinetobacter baumannii isolates(MIC=8.0 ± 0.0 mg/L, MBC=10.7 ± 4.6 mg/L)	[Ref.27591703] 0% hemolysis at 64 μg/ml against human red blood cells; 0% hemolysis at 16 μg/ml , 2.5% hemolysis at 32 μg/ml , 10% hemolysis at 64 μg/ml against sheep red blood cells	Linear	Free	Amidation		L	[Ref.27591703] The cell viability of HEK293 cells induced by PV is 98.9%, 95.4%, 89.7%, 83.4%, 83.1%, 73.7% and 71.5% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μg/mL within 24h.	Not found	27591703	Chem Biol Drug Des. 2017 Mar;89(3):327-338. doi: 10.1111/cbdd.12864.	Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K	Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP21249	KKWRKLLKWLAKK	13	PVP (Derived from MP-B and MP-VT1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27591703] Gram-positive bacteria : Staphylococcus aureus isolates(MIC=4.3 ± 3.5 mg/L, MBC=6.0 ± 3.5 mg/L), Enterococcus faecalis isolates(MIC=2.7 ± 1.2 mg/L, MBC=3.3 ± 1.2 mg/L);##Gram-negative bacteria : Pseudomonas aeruginosa isolates(MIC=1.3 ± 0.6 mg/L, MBC=1.7 ± 0.6 mg/L), Acinetobacter baumannii isolates(MIC=2.3 ± 1.5 mg/L, MBC=2.7 ± 1.2 mg/L)	[Ref.27591703] 0% hemolysis at 64 μg/ml against human red blood cells; 0% hemolysis at 64 μg/ml against sheep red blood cells	Linear	Free	Amidation		L	[Ref.27591703] The cell viability of HEK293 cells induced by PV is 98.8%, 100%, 97.3%, 94.2%, 92.3%, 89.2% and 84.6% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μg/mL within 24h.	Not found	27591703	Chem Biol Drug Des. 2017 Mar;89(3):327-338. doi: 10.1111/cbdd.12864.	Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K	Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21250	KKWRKLLKKLKKLL	14	PV3 (Derived from pEM-2 and MP-VT1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.27591703] Gram-positive bacteria : Staphylococcus aureus isolates(MIC=2.0 ± 1.7 mg/L, MBC=2.3 ± 1.5 mg/L), Enterococcus faecalis isolates(MIC=1.2 ± 0.8 mg/L, MBC=1.3 ± 0.6 mg/L);##Gram-negative bacteria : Pseudomonas aeruginosa isolates(MIC=1.0 ± 0.0 mg/L, MBC=1.3 ± 0.6 mg/L), Acinetobacter baumannii isolates(MIC=1.0 ± 0.0 mg/L, MBC=1.7 ± 0.6 mg/L)	[Ref.27591703] 0% hemolysis at 64 μg/ml against human red blood cells; 10% hemolysis at 64 μg/ml against sheep red blood cells	Linear	Free	Amidation		L	[Ref.27591703] The cell viability of HEK293 cells induced by PV is 98.8%, 99.2%, 95.4%, 93.8%, 91.9%, 77.3% and 55.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μg/mL within 24h.	Not found	27591703	Chem Biol Drug Des. 2017 Mar;89(3):327-338. doi: 10.1111/cbdd.12864.	Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K	Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP21251	FLFSLIPSVIAGLVSAIRN	19	AaeAP1 (Scorpionida, Arachricla, Arthropoda)	A0A060QQ43 	Not found	AP1	Androctonus aeneas	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria. Antifungal activity against Candida albicans	[Ref.25626077] Gram-positive bacteria : Staphylococcus aureus(MIC=16 mg/L, MBC=32 mg/L);##Gram-negative bacteria : Escherichia coli(MIC>512 mg/L);##Fungi : Candida albicans(MIC=32 mg/L, MBC=64 mg/L)	[Ref.25626077] 100% hemolysis at 16 μg/ml against horse red blood cells	Linear	Free	Amidation		L	[Ref.25626077] No cytotoxicity information found.	Not found	25626077	Toxins (Basel). 2015 Jan 23;7(2):219-37. doi: 10.3390/toxins7020219.	Du Q, Hou X, Wang L, Zhang Y, Xi X, Wang H, Zhou M, Duan J, Wei M, Chen T, Shaw C	AaeAP1 and AaeAP2: novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O
DRAMP21252	FLFSLIPSAIAGLVSAIRN	19	AaeAP2 (Scorpionida, Arachricla, Arthropoda)	A0A060QMQ0 	Not found	AP2	Androctonus aeneas	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Transcript level	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria. Antifungal activity against Candida albicans	[Ref.25626077] Gram-positive bacteria : Staphylococcus aureus(MIC=16 mg/L, MBC=16 mg/L);##Gram-negative bacteria : Escherichia coli(MIC>512 mg/L);##Fungi : Candida albicans(MIC=32 mg/L, MBC=64 mg/L)	[Ref.25626077] 100% hemolysis at 64 μg/ml against horse red blood cells	Linear	Free	Amidation		L	[Ref.25626077] No cytotoxicity information found.	Not found	25626077	Toxins (Basel). 2015 Jan 23;7(2):219-37. doi: 10.3390/toxins7020219.	Du Q, Hou X, Wang L, Zhang Y, Xi X, Wang H, Zhou M, Duan J, Wei M, Chen T, Shaw C	AaeAP1 and AaeAP2: novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O)[C@H](C)CC)C(C)C
DRAMP21253	FLFKLIPKAIKGLVKAIRK	19	AaeAP1a (Derived from AaeAP1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.25626077] Gram-positive bacteria : Staphylococcus aureus(MIC=4 mg/L, MBC=32 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=16 mg/L, MBC=32 mg/L);##Fungi : Candida albicans(MIC=4 mg/L, MBC=16 mg/L)	[Ref.25626077] 100% hemolysis at 32 μg/ml against horse red blood cells	Linear	Free	Amidation		L	[Ref.25626077] No cytotoxicity information found.	Not found	25626077	Toxins (Basel). 2015 Jan 23;7(2):219-37. doi: 10.3390/toxins7020219.	Du Q, Hou X, Wang L, Zhang Y, Xi X, Wang H, Zhou M, Duan J, Wei M, Chen T, Shaw C	AaeAP1 and AaeAP2: novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)C(C)C
DRAMP21254	FLFKLIPKVIKGLVKAIRK	19	AaeAP2a (Derived from AaeAP2)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans	[Ref.25626077] Gram-positive bacteria : Staphylococcus aureus(MIC=4 mg/L, MBC=32 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=16 mg/L, MBC=32 mg/L);##Fungi : Candida albicans(MIC=4 mg/L, MBC=16 mg/L)	[Ref.25626077] 100% hemolysis at 64 μg/ml against horse red blood cells	Linear	Free	Amidation		L	[Ref.25626077] No cytotoxicity information found.	Not found	25626077	Toxins (Basel). 2015 Jan 23;7(2):219-37. doi: 10.3390/toxins7020219.	Du Q, Hou X, Wang L, Zhang Y, Xi X, Wang H, Zhou M, Duan J, Wei M, Chen T, Shaw C	AaeAP1 and AaeAP2: novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21255	WLSKTAKKL	9	WL1 (Derived from CP-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unordered conformation	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.29266746] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC>128 μM), Staphylococcus aureus ATCC 43300(MIC>128 μM), Staphylococcus epidermidis ATCC 12228(MIC>128 μM), Bacillus subtilis CMCC 63501(MIC>128 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC>128 μM), Escherichia coli UB1005(MIC>128 μM), Pseudomonas aeruginosa ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 7731(MIC>128 μM), Salmonella pullorum C79-13(MIC>128 μM)	[Ref.29266746] MHC5>128 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.29266746] The cell viability of IPEC-J2 cells induced by WL1 is 99.2%, 89.8%, 86.2%, 90.8%, 87.8%, 94.3% and 76.5% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of IPEC-J2 cells induced by the control Melittin is 7	Not found	29266746	Chem Biol Drug Des. 2018 May;91(5):1017-1029. doi: 10.1111/cbdd.13165.	Dong N, Wang Z, Chou S, Zhang L, Shan A, Jiang J	Antibacterial activities and molecular mechanism of amino-terminal fragments from pig nematode antimicrobial peptide CP-1.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(N)=O
DRAMP21256	WLSKTAKKLWLSKTAKKL	18	WL2 (Derived from CP-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.29266746] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC=128 μM), Staphylococcus aureus ATCC 43300(MIC=128 μM), Staphylococcus epidermidis ATCC 12228(MIC=128 μM), Bacillus subtilis CMCC 63501(MIC=64 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC=8 μM), Escherichia coli UB1005(MIC=8 μM), Pseudomonas aeruginosa ATCC 27853(MIC=16 μM), Salmonella typhimurium ATCC 7731(MIC=32 μM), Salmonella pullorum C79-13(MIC=16 μM)	[Ref.29266746] MHC5>128 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.29266746] The cell viability of IPEC-J2 cells induced by WL2 is 99.0%, 95.0%, 89%, 89.8%, 85.2%, 86.8% and 75.1% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of IPEC-J2 cells induced by the control Melittin is 77.	Not found	29266746	Chem Biol Drug Des. 2018 May;91(5):1017-1029. doi: 10.1111/cbdd.13165.	Dong N, Wang Z, Chou S, Zhang L, Shan A, Jiang J	Antibacterial activities and molecular mechanism of amino-terminal fragments from pig nematode antimicrobial peptide CP-1.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)[C@@H](C)O)C(N)=O
DRAMP21257	WLSKTAKKLWLSKTAKKLWLSKTAKKL	27	WL3 (Derived from CP-1)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil, alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.29266746] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC=32 μM), Staphylococcus aureus ATCC 43300(MIC=32 μM), Staphylococcus epidermidis ATCC 12228(MIC=32 μM), Bacillus subtilis CMCC 63501(MIC=8 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC=2 μM), Escherichia coli UB1005(MIC=2 μM), Pseudomonas aeruginosa ATCC 27853(MIC=2 μM), Salmonella typhimurium ATCC 7731(MIC=8 μM), Salmonella pullorum C79-13(MIC=2 μM)	[Ref.29266746] MHC5>128 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.29266746] The cell viability of IPEC-J2 cells induced by WL3 is 97.0%, 100.4%, 91.4%, 91.5%, 87.2%, 86.7% and 78.7% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of IPEC-J2 cells induced by the control Melittin is 	Not found	29266746	Chem Biol Drug Des. 2018 May;91(5):1017-1029. doi: 10.1111/cbdd.13165.	Dong N, Wang Z, Chou S, Zhang L, Shan A, Jiang J	Antibacterial activities and molecular mechanism of amino-terminal fragments from pig nematode antimicrobial peptide CP-1.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O
DRAMP21258	SWLSKTAKKLENSAKKRISEGIAIAIQGGPR	31	Cecropin P1 (CP-1) (nematodes, animals)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found	2N92 resolved by NMR	Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.29266746] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC>128 μM), Staphylococcus aureus ATCC 43300(MIC>128 μM), Staphylococcus epidermidis ATCC 12228(MIC>128 μM), Bacillus subtilis CMCC 63501(MIC=1 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC=0.5 μM), Escherichia coli UB1005(MIC=0.5 μM), Pseudomonas aeruginosa ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 7731(MIC=2 μM), Salmonella pullorum C79-13(MIC=0.5 μM)	[Ref.29266746] MHC5>128 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.29266746] The cell viability of IPEC-J2 cells induced by CP-1 is 87.9%, 100.4%, 93.5%, 88.5%, 91.8%, 84.2% and 86.3% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of IPEC-J2 cells induced by the control Melittin is	Not found	29266746	Chem Biol Drug Des. 2018 May;91(5):1017-1029. doi: 10.1111/cbdd.13165.	Dong N, Wang Z, Chou S, Zhang L, Shan A, Jiang J	Antibacterial activities and molecular mechanism of amino-terminal fragments from pig nematode antimicrobial peptide CP-1.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21259	MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA	48	Scolopendin 1 (Centipedes, Arthropoda, Animals)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Candida parapsilosis, Trichosporon beigelii	[Ref.25209888] Gram-positive bacteria : Staphylococcus aureus ATCC 25923(MIC=5.0 ± 4.3 μM), Enterococcus faecium ATCC 19434(MIC=10.0 ± 8.7 μM);##Gram-negative bacteria : Escherichia coli O-157 ATCC 43895(MIC=5.0 ± 4.3 μM), Pseudomonas aeruginosa ATCC 27853(MIC= 5.0 ± 4.3 μM);##Fungi : Candida albicans ATCC 90028(MIC=10.0 ± 8.7 μM), Candida parapsilosis ATCC 22019(MIC= 10.0 ± 8.7 μM), Trichosporon beigelii KCTC 7707(MIC=20.0 ± 17.3 μM)	[Ref.25209888] 0% hemolysis at 80 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.25209888] No cytotoxicity information found	Not found	25209888	Insect Mol Biol. 2014 Dec;23(6):788-99. doi: 10.1111/imb.12124.	Choi H, Hwang JS, Lee DG	Identification of a novel antimicrobial peptide, scolopendin 1, derived from centipede Scolopendra subspinipes mutilans and its antifungal mechanism.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCSC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O
DRAMP21260	AAKAAAKAAAKAA	13	KL0A10 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Uncertain antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.26385363] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC>128 μM), Staphylococcus epidermidis ATCC 12228(MIC>128 μM), Streptococcus faecalis ATCC 29212(MIC>128 μM), Bacillus subtilis CMCC 63501(MIC>128 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC>128 μM), Escherichia coli K88(MIC>128 μM), Escherichia coli CVCC 1515(MIC>128 μM), Escherichia coli UB1005(MIC>128 μM), Bacterium pyocyaneum ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 14028(MIC>128 μM), Salmonella pullorum C79–13(MIC>128 μM)	[Ref.26385363] MHC5>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26385363] The cell viability of HEK293 cells induced by KL0A10 is 103.9%, 110%, 110.6%, 107.8%, 110.3%, 110.1%, 107.2% and 106.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of HEK293 cells induced by control M	Not found	26385363	Amino Acids. 2016 Feb;48(2):403-17. doi: 10.1007/s00726-015-2094-y.	Li W, Tan T, Xu W, Xu L, Dong N, Ma D, Shan A	Rational design of mirror-like peptides with alanine regulation.	C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O
DRAMP21261	LLKAAAKAAAKLL	13	KL4A6 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26385363] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC>128 μM), Staphylococcus epidermidis ATCC 12228(MIC=128 μM), Streptococcus faecalis ATCC 29212(MIC=16 μM), Bacillus subtilis CMCC 63501(MIC=32 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC=2 μM), Escherichia coli K88(MIC=32 μM), Escherichia coli CVCC 1515(MIC=32 μM), Escherichia coli UB1005(MIC=32 μM), Bacterium pyocyaneum ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 14028(MIC=128 μM), Salmonella pullorum C79–13(MIC>128 μM)	[Ref.26385363] MHC5>256 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26385363] The cell viability of HEK293 cells induced by KL4A6 is 107.8%, 108.3%, 104.4%, 104.7%, 105.6%, 100%, 94.4% and 96.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of HEK293 cells induced by control Meli	Not found	26385363	Amino Acids. 2016 Feb;48(2):403-17. doi: 10.1007/s00726-015-2094-y.	Li W, Tan T, Xu W, Xu L, Dong N, Ma D, Shan A	Rational design of mirror-like peptides with alanine regulation.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(N)=O
DRAMP21262	AAKLLLKLLLKAA	13	KL6A4 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26385363] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC=32 μM), Staphylococcus epidermidis ATCC 12228(MIC=16 μM), Streptococcus faecalis ATCC 29212(MIC=16 μM), Bacillus subtilis CMCC 63501(MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC=1 μM), Escherichia coli K88(MIC=16 μM), Escherichia coli CVCC 1515(MIC=16 μM), Escherichia coli UB1005(MIC=32 μM), Bacterium pyocyaneum ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 14028(MIC>128 μM), Salmonella pullorum C79–13(MIC>128 μM)	[Ref.26385363] MHC5=8 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26385363] The cell viability of HEK293 cells induced by KL6A4 is 102.8%, 109.4%, 103.9%, 109.4%, 105.3%, 90.6%,  83.1% and 81.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of HEK293 cells induced by control Me	Not found	26385363	Amino Acids. 2016 Feb;48(2):403-17. doi: 10.1007/s00726-015-2094-y.	Li W, Tan T, Xu W, Xu L, Dong N, Ma D, Shan A	Rational design of mirror-like peptides with alanine regulation.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O
DRAMP21263	LLKLLLKLLLKLL	13	KL10A0 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Uncertain antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.26385363] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC>128 μM), Staphylococcus epidermidis ATCC 12228(MIC>128 μM), Streptococcus faecalis ATCC 29212(MIC>128 μM), Bacillus subtilis CMCC 63501(MIC>128 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC>128 μM), Escherichia coli K88(MIC>128 μM), Escherichia coli CVCC 1515(MIC>128 μM), Escherichia coli UB1005(MIC>128 μM), Bacterium pyocyaneum ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 14028(MIC>128 μM), Salmonella pullorum C79–13(MIC>128 μM)	[Ref.26385363] MHC5=2 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26385363] The cell viability of HEK293 cells induced by KL10A0 is 93.9%, 93.3%, 81.9%, 77.2%, 75.6%, 67.8%, 51.9% and 19.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of HEK293 cells induced by control Melitti	Not found	26385363	Amino Acids. 2016 Feb;48(2):403-17. doi: 10.1007/s00726-015-2094-y.	Li W, Tan T, Xu W, Xu L, Dong N, Ma D, Shan A	Rational design of mirror-like peptides with alanine regulation.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(N)=O
DRAMP21264	LKKLLKLLKKLLKLAG	16	LK (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=20 μM)	[Ref.23894079] MHC10=0.08 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21265	AKKLLKLLKKLLKLAG	16	LK-L1A (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10=1.25 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21266	LKKALKLLKKLLKLAG	16	LK-L4A (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10=1.25 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21267	LKKLAKLLKKLLKLAG	16	LK-L5A (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10=1.25 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21268	LKKLLKALKKLLKLAG	16	LK-L7A (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10=1.25 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21269	LKKLLKLAKKLLKLAG	16	LK-L8A (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10=1.25 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21270	LKKLLKLLKKALKLAG	16	LK-L11A (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10=1.25 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21271	LKKLLKLLKKLAKLAG	16	LK-L12A (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10=0.63 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21272	LKKLLKLLKKLLKAAG	16	LK-L14A (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10=1.25 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21273	LKKLLKLGKKLLKLAG	16	LK-L8G (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM)	[Ref.23894079] MHC10=10 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21274	LKKLLKLSKKLLKLAG	16	LK-L8S (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM)	[Ref.23894079] MHC10=20 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21275	LKKLLKLPKKLLKLAG	16	LK-L8P (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10=160 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21276	LKKLLKLNKKLLKLAG	16	LK-L8N (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM)	[Ref.23894079] MHC10=640 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21277	LKKLLKLQKKLLKLAG	16	LK-L8Q (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM)	[Ref.23894079] MHC10=320 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21278	LKKLLKLDKKLLKLAG	16	LK-L8D (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10=1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(=O)NCC(=O)O
DRAMP21279	LKKLLKLEKKLLKLAG	16	LK-L8E (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10=320 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(=O)NCC(=O)O
DRAMP21280	LKKLLKLKKKLLKLAG	16	LK-L8K (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10=160 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21281	LKKLLKLHKKLLKLAG	16	LK-L8H (Derived from LK)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM)	[Ref.23894079] MHC10=80 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP21282	AKRIVQRIKDFLR	13	Lt-F1A (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10>640 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21283	FKRAVQRIKDFLR	13	Lt-I4A (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10>640 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21284	FKRIAQRIKDFLR	13	Lt-V5A (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10=320 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP21285	FKRIVQRAKDFLR	13	Lt-I8A (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10>640 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP21286	FKRIVQRIKDALR	13	Lt-F11A (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10>640 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21287	FKRIVQRIKDFAR	13	Lt-F12A (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10>640 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21288	FKRGVQRIKDFLR	13	Lt-I4G (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21289	FKRSVQRIKDFLR	13	Lt-I4S (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21290	FKRNVQRIKDFLR	13	Lt-I4N (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=20 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21291	FKRQVQRIKDFLR	13	Lt-I4Q (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21292	FKRHVQRIKDFLR	13	Lt-I4H (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21293	FKRIGQRIKDFLR	13	Lt-V5G (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP21294	FKRISQRIKDFLR	13	Lt-V5S (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10=640 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21295	FKRINQRIKDFLR	13	Lt-V5N (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21296	FKRIQQRIKDFLR	13	Lt-V5Q (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10=1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21297	FKRIHQRIKDFLR	13	Lt-V5H (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21298	FKRIVQRIKDGLR	13	Lt-F11G (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=20 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21299	FKRIVQRIKDSLR	13	Lt-F11S (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21300	FKRIVQRIKDNLR	13	Lt-F11N (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=20 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21301	FKRIVQRIKDQLR	13	Lt-F11Q (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21302	FKRIVQRIKDHLR	13	Lt-F11H (Derived from Lt)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.	[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM)	[Ref.23894079] MHC10>1280 μM against human red blood cells	Linear	Free	Free		L	[Ref.23894079] No cytotoxicity information found.	Not found	23894079	ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.	Son M, Lee Y, Hwang H, Hyun S, Yu J	Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21303	RIIDLLARVRRPQKPKFVTVWVR	23	A7-PMAP-23 (Derived from PMAP-23)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix, beta turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.10527878] Gram-positive bacteria : Bacillus subtilis (KCTC 1918)(MIC=1.56 μM), Streptococcus pyogenes (KCTC 3096)(MIC=1.56 μM), Staphylococcus aureus (KCTC 1621)(MIC=3.125 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=3.125 μM), Salmonella typhimurium (KCTC 1926)(MIC=1.56 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=1.56 μM)	[Ref.10527878] 0% hemolysis at 100 μM against human red blood cells	Linear	Free	Free		L	[Ref.10527878] No cytotoxicity information found.	Not found	10527878	Biochem Biophys Res Commun. 1999 Oct 14;264(1):281-6.	Kang JH, Shin SY, Jang SY, Kim KL, Hahm KS.	Effects of tryptophan residues of porcine myeloid antibacterial peptide PMAP-23 on antibiotic activity.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C
DRAMP21304	RIIDLLWRVRRPQKPKFVTVAVR	23	A21-PMAP-23 (Derived from PMAP-23)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix, beta turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.10527878] Gram-positive bacteria : Bacillus subtilis (KCTC 1918)(MIC=3.125 μM), Streptococcus pyogenes (KCTC 3096)(MIC=3.125 μM), Staphylococcus aureus (KCTC 1621)(MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=6.25 μM), Salmonella typhimurium (KCTC 1926)(MIC=3.125 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=3.125 μM)	[Ref.10527878] 0% hemolysis at 100 μM against human red blood cells	Linear	Free	Free		L	[Ref.10527878] No cytotoxicity information found.	Not found	10527878	Biochem Biophys Res Commun. 1999 Oct 14;264(1):281-6.	Kang JH, Shin SY, Jang SY, Kim KL, Hahm KS.	Effects of tryptophan residues of porcine myeloid antibacterial peptide PMAP-23 on antibiotic activity.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C
DRAMP21305	RRRRRRRR	8	R8 (De novo synthesis)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Alpha helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=44 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=44 μM)	[Ref.23085001] HC50>128 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.23085001] No cytotoxicity information found.	Not found	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-32. doi: 10.1016/j.bbamem.2012.10.010.	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM	Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP21306	FVQWWSKWLGRIL	13	TL-1 (Derived from Temporin-1Tl (TL))	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26311041] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=32 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)	[Ref.26311041] HC50=21.4 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26311041] The cell viability of RAW264.7 macrophages cells induced by TL-1 is 112.2%, 109.3% and 109.3% at peptide concentrations of 2.5, 5 and 10 μM.	Not found	26311041	J Pept Sci. 2015 Oct;21(10):779-85. doi: 10.1002/psc.2807.	Rajasekaran G, Kamalakannan R, Shin SY	Enhancement of the anti-inflammatory activity of temporin-1Tl-derived antimicrobial peptides by tryptophan, arginine and lysine substitutions.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP21307	FVRWWSKWLRRIL	13	TL-2 (Derived from Temporin-2Tl (TL))	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26311041] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=8 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)	[Ref.26311041] HC50=8.5 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26311041] The cell viability of RAW264.7 macrophages cells induced by TL-2 is 111.8%, 112.5% and 81.0% at peptide concentrations of 2.5, 5 and 10 μM.	Not found	26311041	J Pept Sci. 2015 Oct;21(10):779-85. doi: 10.1002/psc.2807.	Rajasekaran G, Kamalakannan R, Shin SY	Enhancement of the anti-inflammatory activity of temporin-1Tl-derived antimicrobial peptides by tryptophan, arginine and lysine substitutions.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP21308	FVRWWSRWLRRIL	13	TL-3 (Derived from Temporin-3Tl (TL))	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26311041] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=8 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)	[Ref.26311041] HC50=8.0 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26311041] The cell viability of RAW264.7 macrophages cells induced by TL-3 is 117.4%, 111.5% and 110.5% at peptide concentrations of 2.5, 5 and 10 μM.	Not found	26311041	J Pept Sci. 2015 Oct;21(10):779-85. doi: 10.1002/psc.2807.	Rajasekaran G, Kamalakannan R, Shin SY	Enhancement of the anti-inflammatory activity of temporin-1Tl-derived antimicrobial peptides by tryptophan, arginine and lysine substitutions.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP21309	FVKWWSKWLKKIL	13	TL-4 (Derived from Temporin-4Tl (TL))	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.26311041] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=8 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=16 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)	[Ref.26311041] HC50=15.9 μM against human red blood cells	Linear	Free	Amidation		L	[Ref.26311041] The cell viability of RAW264.7 macrophages cells induced by TL-4 is 116.7%, 118.2% and 87.2% at peptide concentrations of 2.5, 5 and 10 μM.	Not found	26311041	J Pept Sci. 2015 Oct;21(10):779-85. doi: 10.1002/psc.2807.	Rajasekaran G, Kamalakannan R, Shin SY	Enhancement of the anti-inflammatory activity of temporin-1Tl-derived antimicrobial peptides by tryptophan, arginine and lysine substitutions.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP21311	RWLRKWTRKRLK	12	2W-1 (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=64 μM), Staphylococcus aureus 25923 (MIC=32 μM), Staphylococcus  epidermidis 12228 (MIC=16 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=16 μM), Escherichia coli 1005 (MIC=16 μM), Staphylococcus typhi (MIC=64 μM)	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 2W-1 is 95.9%, 92.4%, 89.0%, 86.4%, 85.7%, 94.1%, 91.9% and 98.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00289.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21312	RRLRWKTRWRLK	12	2W-2 (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=16 μM), Staphylococcus aureus 25923 (MIC=16 μM), Staphylococcus  epidermidis 12228 (MIC=16 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=16 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=32 μM)	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 2W-2 is 94.8%, 92.1%, 95.5%, 98.3%, 94.5%, 95%, 89.5% and  84.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00290.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21313	RRLRKKTWKRLW	12	2W-3 (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=64 μM), Staphylococcus aureus 25923 (MIC>128 μM), Staphylococcus  epidermidis 12228 (MIC=64 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=16 μM), Escherichia coli 1005 (MIC=32 μM), Staphylococcus typhi (MIC=64 μM)	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 2W-3 is 95.2%, 89.7%, 87.2%, 91.6%, 85%, 88.4%, 84.8% AND 89.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00291.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP21314	RWLRKWTRKWLK	12	3W-1 (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=8 μM), Staphylococcus aureus 25923 (MIC=16 μM), Staphylococcus  epidermidis 12228 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=16 μM)	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3W-1 is 99.5%, 96.2%, 95.7%, 90.9%, 69.1%, 6.4%, -1% and 0% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00292.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21315	WRLRWKTRWRLK	12	3W-2 (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=4 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=4 μM), Staphylococcus aureus 11011  (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=2 μM), Pseudomonas aeruginosa 25349 (MIC=8 μM),  Acinetobacter baumannii AB1901 (MIC=4 μM),  Acinetobacter baumannii AB1902 (MIC=4 μM).	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3W-2 is 100.9%, 96%, 103.4%, 97.2%, 104.7%, 103.6%, 97.6%, 90.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00293.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21316	RRLWKKTWKRLW	12	3W-3 (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=8 μM), Staphylococcus aureus 25923 (MIC=16 μM), Staphylococcus  epidermidis 12228 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=8 μM)	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3W-3 is 94.8%, 100.9%, 93.4%, 94.0%, 93.6%, 73.4%, 14.5% and -1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00294.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP21317	RWLRWKTRWRLK	12	3W-4 (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=4 μM), Staphylococcus aureus 25923 (MIC=16 μM), Staphylococcus  epidermidis 12228 (MIC=16 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=8 μM)	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3W-4 is 100.2%, 92.2%, 96.2%, 89.0%, 94.1%, 97.4%, 94.3% and 88.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00295.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21318	RRLRWWTRWRLK	12	3W-5 (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=4 μM), Staphylococcus aureus 25923 (MIC=8 μM), Staphylococcus  epidermidis 12228 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=8 μM)	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3W-5 is 96.4%, 99.1%, 100.2%, 101.4%, 97.8%, 99%, 102.6% and 82.6% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00296.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21319	VRLRVKTRVRLK	12	3V (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=16 μM), Staphylococcus aureus 25923 (MIC=64 μM), Staphylococcus  epidermidis 12228 (MIC=32 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=16 μM)	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3V is 98.6%, 101.4%, 103.4%, 92.4%, 101%, 101.9%, 93.6% and 97.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00297.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21320	LRLRLKTRLRLK	12	3L (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=32 μM), Staphylococcus aureus 25923 (MIC=32 μM), Staphylococcus  epidermidis 12228 (MIC=64 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=16 μM)	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3L is 95.9%, 92.4%, 91.6%, 82.1%, 104.3%, 97.1%, 99.5% and 96.6% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00298.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21321	RWLRWWTRWRLK	12	4W (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=4 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=4 μM)	[Ref.31276398] MHC=128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 4W is 95.3%, 88.3%, 89.7%, 97.9%, 91.2%, 77.6%, 32.8% and 0% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00299.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21322	WRVRWKTRWRVK	12	RTV (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=4 μM), Staphylococcus  epidermidis 12228 (MIC=4 μM), Staphylococcus aureus 11011 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=4 μM), Escherichia coli 20411 (MIC=4 μM), Acinetobacter baumannii AB1901 (MIC=8 μM),  Acinetobacter baumannii AB1902 (MIC=8 μM), Pseudomonas aeruginosa 25349 (MIC=32 μM)	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RTV is 106.6%, 103.1%, 94.0%, 106.4%, 96.4%, 104.8%, 95.5% and 96.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00300.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21323	WRIRWKTRWRIK	12	RTI (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=2 μM), Pseudomonas aeruginosa 25349 (MIC=8 μM).	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RTI is 103.1%, 97.4%, 103.8%, 106.4%, 96.4%, 104.8%, 95.7% and 96.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00301.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21324	WRFRWKTRWRFK	12	RTF (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=4 μM), Pseudomonas aeruginosa 25349 (MIC=8 μM).	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RTF is 100.7%, 101.6%, 97.8%, 99.0%, 100.9%, 97.4%, 95.3% and 90.3% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00302.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21325	WRLRWRTRWRLR	12	RTL (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=4 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=4 μM), Pseudomonas aeruginosa 25349 (MIC=16 μM).	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RTL is 102.2%, 104.5%, 94.8%, 103.1%, 103.6%, 103.6%, 105.5% and 105.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00303.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21326	WRLRWRLRWRLR	12	RLR (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=1 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=1 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=4 μM), Pseudomonas aeruginosa 25349 (MIC=4 μM).	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RLR is 100%, 91.4%, 104.8%, 94.5%, 98.6%, 99.8%, 98.8% and 82.6% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00304.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21327	WRVRWRVRWRVR	12	RVR  (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=1 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=1 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=4 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=2 μM), Pseudomonas aeruginosa 25349 (MIC=4 μM).	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RVR is 97.9%, 98.6%, 91.7%, 102.9%, 102.2%, 100.3%, 98.1% and 97.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00305.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21328	WRTRWRTRWRTR	12	RTR (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=4 μM), Staphylococcus aureus 25923 (MIC=8 μM), Staphylococcus  epidermidis 12228 (MIC=8 μM), Staphylococcus aureus 11011 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=4 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=32 μM), Acinetobacter baumannii AB1902 (MIC=32 μM), Pseudomonas aeruginosa 25349 (MIC>64 μM).	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RTR is 97.2%, 106.9%, 96.7%, 104.0%, 94.5%, 98.6%, 102.2% and 103.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00306.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	C[C@@H](O)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21329	WRFRWRFRWRFR	12	RFR (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=1 μM), Staphylococcus aureus 25923 (MIC=1 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=8 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=4 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=2 μM), Pseudomonas aeruginosa 25349 (MIC=8 μM).	[Ref.31276398] MHC=64μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RFR is 106.2%, 97.6%, 99.8%, 101.7%, 100.9%, 101.6%, 78.1% and 45.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00307.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(N)=O
DRAMP21330	WKVKWKVKWKVK	12	KVK (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=1 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM) ;##Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=1 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=1 μM), Pseudomonas aeruginosa 25349 (MIC=4 μM).	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by KVK is 101.2%, 98.3%, 98.3%, 99.1%, 95.2%, 101.9%, 96.6% and 100.5% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00308.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21331	WKLKWKLKWKLK	12	KLK (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=4 μM), Pseudomonas aeruginosa 25349 (MIC=4 μM).	[Ref.31276398] MHC=128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by KLK is 103.3%, 100.2%, 100.5%, 97.8%, 99.1%, 96.4%, 98.4% and 44.5% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00309.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21332	WKIKWKIKWKIK	12	KIK (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=1 μM), Acinetobacter baumannii AB1902 (MIC=2 μM), Pseudomonas aeruginosa 25349 (MIC=4 μM).	[Ref.31276398] MHC=64μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by KIK is 100.7%, 106.9%, 95.5%, 101.6%, 103.1%, 102.8%, 61.9% and 32.2% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00310.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21333	WRVRWKVRWRVK	12	RVK (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=1 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=1 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=4 μM), Pseudomonas aeruginosa 25349 (MIC=4 μM).	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RVK is 101.0%, 98.6%, 100.3%, 103.3%, 104.1%, 101.0%, 103.8% and 91.9% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00311.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21334	SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT	34	Ranatuerin-2Pb (Frogs, amphibians, animals)	A0A513ZTP5	Not found	Not found	Lithobates pipiens (Northern leopard frog) (Rana pipiens)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Transcript level	50% Helix, 7.8% antiparallel, 1.2% parallel, 10.9% turn and 29.8% others in 50% TFE/H2O. ##3.5% Helix, 26.6% antiparallel, 0% parallel, 18.3% turn and	Ranatuerin-2Pb might also possess two helical segments at respective N-terminus and C-terminus, and the last two residues are probably included in the helix domain.		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.	[Ref.31242693] Gram-positive bacteria:Staphylococcus aureus (MIC=8 μM; MBC=8 μM), MRSA (MIC=16 μM; MBC=32 μM), Enterococcus faecalis (MIC>256 μM; MBC>256 μM);##Gram-negative bacteria: Escherichia coli (MIC=8 μM; MBC=8 μM), Pseudomonas aeruginosa (MIC>256 μM; MBC>256 μM);##Fungi: Candida albicans (MIC=8 μM; MBC=16 μM)	[Ref.31242693] 7% hemolysis at 2 μM, 23% hemolysis at 8 μM, 50% hemolysis at 16 μM, 71% hemolysis at 32 μM, 100% hemolysis at 64 μM on horse erythrocytes.	Linear	Free	Free		L	[Ref.31242693] The IC50 values which represents the inhibitory effect of Ranatuerin-2Pb on the proliferation of NCI-H157, MCF-7, U251MG and PC-3 are 1.453 μM, 7.254 μM, 2.172 μM and 2.251 μM. In addtion, Ranatuerin-2Pb showed no inhibitory effect on the proliferation of MDA-MB-435s.  DETAILED DATA: ①The cell viabillity of NCI-H157 induced by Ranatuerin-2Pb is 96.2%, 96.9%, 85.6%, 60%, 5% and 4.4% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 100%, 95%, 89.4%, 41.2%, 16.2% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ②The cell viability of MCF-7 induced by Ranatuerin-2Pb is 100.6%, 92.5%, 90%, 99.4%, 36.2% and 11.2% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 100%, 98.1%, 92.5%, 7.5%, 8.7% and 8.7% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ③The cell viability of U251-MG induced by Ranatuerin-2Pb is 100%, 105.6%, 108.1%, 102.5%, 59.4% and 17.5% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 99.4%, 99.4%, 75.6%, 18.7%, 11.9% and 18.1% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ④The cell viability of PC-3 induced by Ranatuerin-2Pb is 108.7%, 112.5%, 84.4%, 80.6%, 28.1% and 16.2% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 110%, 113.1%, 109.4%, 33.1%, 16.9% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ⑤ The cell viability of MDA-MB-435S induced by Ranatuerin-2Pb is 96.9%, 88.8%, 96.9%, 88.1%, 100 and 25.6%, while the cell viability induced by Melittin is 100%, 93.1%, 82.5%, 18.8%, 18.8% and 18.1%.	Not found	31242693	Biomolecules. 2019 Jun 25;9(6):249. doi: 10.3390/biom9060249.	Zhou, XW; Shi, DN; Zhong, RM; Ye, ZM; Ma, CB; Zhou, M; Xi, XP; Wang, L; Chen, TB; Kwok, HF	Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C
DRAMP21335	SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC	32	RPa (Frogs, amphibians, animals)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	33.6% Helix, 18.1% antiparallel, 4.3% parallel, 11.4% turn and 32.5% others in 50% TFE/H2O. ##2.4% Helix, 30.6% antiparallel, 0% parallel, 17.3% turn 	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.	[Ref.31242693] Gram-positive bacteria:Staphylococcus aureus (MIC=16 μM; MBC=32 μM), MRSA (MIC=>256 μM; MBC>256 μM), Enterococcus faecalis (MIC>256 μM; MBC>256 μM);##Gram-negative bacteria: Escherichia coli (MIC=32 μM; MBC=64 μM), Pseudomonas aeruginosa (MIC>256 μM; MBC>256 μM);##Fungi: Candida albicans (MIC>256 μM; MBC>256 μM)	[Ref.31242693] 7% hemolysis at 16 μM, 23% hemolysis at 32 μM, 50% hemolysis at 64 μM, 76% hemolysis at 128 μM, 90% hemolysis at 256 μM, 100% hemolysis at 512 μM on horse erythrocytes.	Linear	Free	Free		L	[Ref.31242693] RPa only possessed inhibitory effect on the proliferation of H157 with the IC value of 5.841 μM, while showed no inhibitory effect on the proliferation of MCF-7, U251MG, PC-3 and MDA-MB-435s. DETAILED DATA: ①The cell viabillity of NCI-H157 induced by RPa is 97.5%, 94.4%, 92.5%, 71.2%, 40.6% and 4.4% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 100%, 95%, 89.4%, 41.2%, 16.2% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ②The cell viability of MCF-7 induced by RPa is 100.6%, 93.1%, 97.5%, 97.5%, 93.7% and 78.1% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM , while the cell viability induced by Melittin is 100%, 98.1%, 92.5%, 7.5%, 8.7% and 8.7% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ③The cell viability of U251-MG induced by RPa is 100%, 105.6%, 108.1%, 102.5%, 59.4% and 17.5% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 99.4%, 99.4%, 75.6%, 18.7%, 11.9% and 18.1% at 0.001, 0.01, 0.1, 1, 10, 100 μM.④The cell viability of PC-3 induced by RPb is 108.7%, 104.4%, 92.5%, 92.5%, 82.5% and 24.4% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 110%, 113.1%, 109.4%, 33.1%, 16.9% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ⑤The cell viability of MDA-MB-435S induced by RPa is 97.5%, 95%, 97.5%, 73.1%, 68.8% and 36.9%, while the cell viability induced by Melittin is 100%, 93.1%, 82.5%, 18.8%, 18.8% and 18.1%.	Not found	31242693	Biomolecules. 2019 Jun 25;9(6):249. doi: 10.3390/biom9060249.	Zhou, XW; Shi, DN; Zhong, RM; Ye, ZM; Ma, CB; Zhou, M; Xi, XP; Wang, L; Chen, TB; Kwok, HF	Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)C(C)C
DRAMP21336	SFLTTVKKLVTNLAAL	16	RPb (Frogs, amphibians, animals)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	49.6% Helix, 7.6% antiparallel, 0% parallel, 9.8% turn and 33% others in 50% TFE/H2O. ##0.3% Helix, 25.4% antiparallel, 0% parallel, 19.4% turn and 55	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.	[Ref.31242693] Gram-positive bacteria:Staphylococcus aureus (MIC=8 μM; MBC=8 μM), MRSA (MIC=16 μM; MBC=32 μM), Enterococcus faecalis (MIC=32 μM; MBC=128 μM);##Gram-negative bacteria: Escherichia coli (MIC=16 μM; MBC=16 μM), Pseudomonas aeruginosa (MIC=64 μM; MBC=256 μM);##Fungi: Candida albicans (MIC=16 μM; MBC=16 μM)	[Ref.31242693] 7% hemolysis at 16 μM, 18% hemolysis at 32 μM, 20% hemolysis at 64 μM, 40% hemolysis at 128 μM, 70% hemolysis at 256 μM, 100% hemolysis at 512 μM on horse erythrocytes. 	Linear	Free	Amidation		L	[Ref.31242693] RPb only possessed inhibitory effect on the proliferation of H157 with the IC value of 6.856 μM, while showed no inhibitory effect on the proliferation of MCF-7, U251MG, PC-3 and MDA-MB-435s. DETAILED DATA: ①The cell viabillity of NCI-H157 induced by RPb is 98.7%, 102.5%, 96.9%, 98.1%, 38.1%, 9.4% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 100%, 95%, 89.4%, 41.2%, 16.2% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ②The cell viability of MCF-7 induced by RPb is 100.6%, 92.5%, 90%, 99.4%, 36.2% and 11.2% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, , while the cell viability induced by Melittin is 100%, 98.1%, 92.5%, 7.5%, 8.7% and 8.7% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ③The cell viability of U251-MG induced by RPb is 105%, 103.1%, 109.4%, 102.5%, 105.6% and 13.1% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 99.4%, 99.4%, 75.6%, 18.7%, 11.9% and 18.1% at 0.001, 0.01, 0.1, 1, 10, 100 μM.④The cell viability of PC-3 induced by RPa is 108.8%, 103.8%, 118.1%, 125.6%, 116.9% and 68.8% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 110%, 113.1%, 109.4%, 33.1%, 16.9% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ⑤The cell viability of MDA-MB-435S induced by RPa is 98.1%, 95%, 100.6%, 97.5%, 80.6% and 43.1%, while the cell viability induced by Melittin is 100%, 93.1%, 82.5%, 18.8%, 18.8% and 18.1%.	Not found	31242693	Biomolecules. 2019 Jun 25;9(6):249. doi: 10.3390/biom9060249.	Zhou, XW; Shi, DN; Zhong, RM; Ye, ZM; Ma, CB; Zhou, M; Xi, XP; Wang, L; Chen, TB; Kwok, HF	Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(N)=O
DRAMP21337	GRFKRFRKKFKKLFKKLSPVIPLLHL	26	BMAP-27 (Bovine, mammals, animals)	P54228	Belongs to the cathelicidin family	CATHL6	Bos taurus (Bovine)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	73% α-helix in 50% TFE/H2O	An α-helix occurred from Arg2 to Leu17 in the N-terminal region and a short α-helix is observed from Leu23 to Leu26 in the Cterminal region; the two regions are connected with a flexible region containing two proline residues. 	2KET resolved by NMR	Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31226350] Gram-positive bacteria:Staphylococcus aureus (MIC=1-2 μM);##Gram-negative bacteria: Escherichia coli (MIC=2-4 μM)	[Ref.31226350] 50% hemolysis at 75 μM for human red blood cells	Linear	Free	Amidation		L	[Ref.31226350] The CC50 values which represent peptide concentration (μM) inducing 50% cytotoxicity to human cancer cell lines of BMAP-27 on MDA361 and A549 are 4.2 μM and 5.3 μM.  DETAILED DATA: ①The cell viability of MDA-361 induced by BMAP-27 is 100%, 100%, 98.9%, 97.7%, 87.6%, 59.8%, 34.7%, 12.4%, 10.3%, 8.3% and 9.4% at peptide concentrations of 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 6.4, 13, 25, 50 and 100 μM. ②The cell viability of A549 induced by BMAP-27 is 100%, 99.1%, 97.7%, 94.7%, 74.5%, 41.4%, 24.4%, 11.3%, 9.7%, 10.3% and 7.4% at peptide concentrations of 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 6.4, 13, 25, 50 and 100 μM.	Not found	31226350	Peptides. 2019 Jun 18;118:170106. doi: 10.1016/j.peptides.2019.170106.	Yang S, Lee CW, Kim HJ, Jung HH, Kim JI, Shin SY, Shin SH	Structural analysis and mode of action of BMAP-27, a cathelicidin-derived antimicrobial peptide	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP21338	FLRALWNVAKSVF	13	[Arg]3-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	23% α-helix in 60% TFE/Water. ## 0%α-helix in water.	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4560.	[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=1.6 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=1.6 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.8 μmol/L), Bacillus subtilis ATCC 6633 (MIC=0.8 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.4 μmol/L), Enterobacter cloacae β-12 (MIC=6.3 μmol/L), Pseudomonas aeruginosa ATCC 27853 (MIC=6.3 μmol/L);##Fungi: Candida albicans MDM8 (MIC=0.8 μmol/L), Candida tropicalis IOC 4560 (MIC=0.8 μmol/L)	[Ref.31212183] 25% hemolysis at 6.3 μmol/L, 65% hemolysis at 25 μmol/L, 75% hemolysis at 50 μmol/L, 100% hemolysis at 100 μmol/L for human red blood cells	Linear	Free	Amidation		L	[Ref.31212183] No cytotoxicity information found	Not found	31212183	Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.	Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX	Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP21339	FLGALWRVAKSVF	13	[Arg]7-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	22% α-helix in 60% TFE/Water. ## 0%α-helix in water.	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4561.	[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=1.6 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=1.6 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.4 μmol/L), Bacillus subtilis ATCC 6633 (MIC=0.8 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.2 μmol/L), Enterobacter cloacae β-12 (MIC=6.3 μmol/L), Pseudomonas aeruginosa ATCC 27853 (MIC=6.3 μmol/L);##Fungi: Candida albicans MDM8 (MIC=0.8 μmol/L), Candida tropicalis IOC 4560 (MIC=0.8 μmol/L)	[Ref.31212183] 10% hemolysis at 6.3 μmol/L, 50% hemolysis at 12.5 μmol/L, 60% hemolysis at 25 μmol/L, 90% hemolysis at 500 μmol/L for human red blood cells	Linear	Free	Amidation		L	[Ref.31212183] No cytotoxicity information found	Not found	31212183	Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.	Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX	Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP21340	FLGALWNVAKRVF	13	[Arg]11-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	25% α-helix in 60% TFE/Water. ## 2%α-helix in water.	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4562.	[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=1.6 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=1.6 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.8 μmol/L), Bacillus subtilis ATCC 6633 (MIC=0.8 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.2 μmol/L), Enterobacter cloacae β-12 (MIC=6.3 μmol/L), Pseudomonas aeruginosa ATCC 27853 (MIC=12.5 μmol/L);##Fungi: Candida albicans MDM8 (MIC=0.8 μmol/L), Candida tropicalis IOC 4560 (MIC=0.8 μmol/L)	[Ref.31212183] 25% hemolysis at 6.3 μmol/L, 50% hemolysis at 12.5 μmol/L, 70% hemolysis at 25 μmol/L, 90% hemolysis at 500 μmol/L for human red blood cells	Linear	Free	Amidation		L	[Ref.31212183] No cytotoxicity information found	Not found	31212183	Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.	Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX	Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP21341	GLGALWNVAKSVF	13	[Gly]1-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	37% α-helix in 60% TFE/Water. ## 2%α-helix in water.	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4563.	[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.8 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=25 μmol/L), Bacillus megaterium ATCC 10778 (MIC=3.1 μmol/L), Bacillus subtilis ATCC 6633 (MIC=3.1 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=50 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.4 μmol/L);##Fungi: Candida albicans MDM8 (MIC=25 μmol/L), Candida tropicalis IOC 4560 (MIC=6.3 μmol/L)	[Ref.31212183] 10% hemolysis at 50 μmol/L, 30% hemolysis at 100 μmol/L for human red blood cells	Linear	Free	Amidation		L	[Ref.31212183] No cytotoxicity information found	Not found	31212183	Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.	Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX	Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens	CC(C)C[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP21342	FLGALWNPAKSVF	13	[Pro]8-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	12% α-helix in 60% TFE/Water. ## 2%α-helix in water.	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida tropicalis IOC 4564.	[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=12.5 μmol/L), Bacillus subtilis ATCC 6633 (MIC=50 μmol/L);##Gram-negative bacteria: Serratia marcescens ATCC 4112 (MIC=12.5 μmol/L);##Fungi: Candida tropicalis IOC 4560 (MIC=50 μmol/L)	[Ref.31212183] 0% hemolysis at 100 μmol/L for human red blood cells	Linear	Free	Amidation		L	[Ref.31212183] No cytotoxicity information found	Not found	31212183	Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.	Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX	Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP21343	FLGALWNVLKSVF	13	[Leu]9-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	62% α-helix in 60% TFE/Water. ## 3%α-helix in water.	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4565.	[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.8 μmol/L), Bacillus megaterium ATCC 10778 (MIC=3.1 μmol/L), Bacillus subtilis ATCC 6633 (MIC=0.8 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=0.8 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.4 μmol/L), Pseudomonas aeruginosa ATCC 27853 (MIC=50 μmol/L);##Fungi: Candida albicans MDM8 (MIC=1.6 μmol/L), Candida tropicalis IOC 4560 (MIC=1.6 μmol/L)	[Ref.31212183] 20% hemolysis at 3.1 μmol/L, 70% hemolysis at 25 μmol/L, 100% hemolysis at 100 μmol/L for human red blood cells	Linear	Free	Amidation		L	[Ref.31212183] No cytotoxicity information found	Not found	31212183	Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.	Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX	Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP21344	FLGALWNVFKSVF	13	[Phe]9-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	32% α-helix in 60% TFE/Water. ## 1%α-helix in water.	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4566.	[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.2 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.8 μmol/L), Bacillus megaterium ATCC 10778 (MIC=1.6 μmol/L), Bacillus subtilis ATCC 6633 (MIC=0.8 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.2 μmol/L);##Fungi: Candida albicans MDM8 (MIC=6.3 μmol/L), Candida tropicalis IOC 4560 (MIC=0.8 μmol/L)	[Ref.31212183] 10% hemolysis at 1.6 μmol/L, 40% hemolysis at 3.1 μmol/L, 60% hemolysis at 6.3 μmol/L, 85% hemolysis at 25 μmol/L for human red blood cells	Linear	Free	Amidation		L	[Ref.31212183] No cytotoxicity information found	Not found	31212183	Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.	Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX	Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP21345	FLGALWNVAKSLF	13	[Leu]12-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	23% α-helix in 60% TFE/Water. ## 2%α-helix in water.	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4567.	[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.8 μmol/L), Bacillus megaterium ATCC 10778 (MIC=1.6μmol/L), Bacillus subtilis ATCC 6633 (MIC=0.8 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=0.8 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.4 μmol/L), Enterobacter cloacae β-12 (MIC=6.3 μmol/L), Pseudomonas aeruginosa ATCC 27853 (MIC=50 μmol/L);##Fungi: Candida albicans MDM8 (MIC=3.1 μmol/L), Candida tropicalis IOC 4560 (MIC=1.6 μmol/L)	[Ref.31212183] 20% hemolysis at 6.3 μmol/L, 60% hemolysis at 12.5 μmol/L, 75% hemolysis at 25 μmol/L, 90% hemolysis at 50 μmol/L for human red blood cells	Linear	Free	Amidation		L	[Ref.31212183] No cytotoxicity information found	Not found	31212183	Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.	Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX	Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP21346	FLGALWNVAKSYF	13	[Tyr]12-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	24% α-helix in 60% TFE/Water. ## 2%α-helix in water.	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4568.	[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.8 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=1.6 μmol/L), Bacillus megaterium ATCC 10778 (MIC=1.6 μmol/L), Bacillus subtilis ATCC 6633 (MIC=1.6 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=6.3 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.2 μmol/L);##Fungi: Candida albicans MDM8 (MIC=12.5 μmol/L), Candida tropicalis IOC 4560 (MIC=6.3 μmol/L)	[Ref.31212183] 25% hemolysis at 12.5 μmol/L, 60% hemolysis at 25 μmol/L, 85% hemolysis at 50 μmol/L, 100% hemolysis at 100 μmol/L for human red blood cells	Linear	Free	Amidation		L	[Ref.31212183] No cytotoxicity information found	Not found	31212183	Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.	Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX	Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP21347	IHHIHHH	7	2IH1 (De Novo Synthesis) 	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	18% α-helix in 50% TFE/H2O	The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC>64μM), Escherichia coli UB1005 (MIC>64μM), Escherichia coli K88 (MIC>64μM), Escherichia coli K99 (MIC>64μM), Escherichia coli 078 (MIC>64μM), Escherichia coli 987P (MIC>64μM), Pseudomonas aeruginosa 27853 (MIC>64μM), Pseudomonas aeruginosa PAO1 (MIC>64μM), Salmonella typhimurium 14028 (MIC>64μM), Salmonella typhimurium 7731 (MIC>64μM)	[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells	Linear	Free	Amidation		L	[Ref.31199117] ①The cell viability of HEK293T cells induced by 2IH1 is 103.6%, 102.2%, 101.7%, 103.9%, 103.6%, 106.1% and 103.3% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 2IH1 is 107.9%, 104.5%, 103.4%, 102.5%, 101.1%, 105.6% and 102.0% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	31199117	ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.	Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.	Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O)[C@H](C)CC
DRAMP21348	IHHIHHHIHHIHHH	14	2IH2 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	95% α-helix in 50% TFE/H2O	The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=64μM), Escherichia coli UB1005 (MIC=64μM), Escherichia coli K88 (MIC>64μM), Escherichia coli K99 (MIC=64μM), Escherichia coli 078 (MIC>64μM), Escherichia coli 987P (MIC=64μM), Pseudomonas aeruginosa 27853 (MIC=8μM), Pseudomonas aeruginosa PAO1 (MIC=64μM), Salmonella typhimurium 14028 (MIC>64μM), Salmonella typhimurium 7731 (MIC>64μM)	[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells	Linear	Free	Amidation		L	[Ref.31199117] ①The cell viability of HEK293T cells induced by 2IH2 is 104.7%, 104.7%, 102.8%, 103.6%, 105.3%, 102.2% and 102.5% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 2IH2 is 105.1%, 104.8%, 103.7%, 104.2%, 104.2%, 105.6%, 104.2% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	31199117	ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.	Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.	Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP21349	IHHIHHHIHHIHHHIHHIHHH	21	2IH3 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	95% α-helix in 50% TFE/H2O	The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=2μM), Escherichia coli UB1005 (MIC=2μM), Escherichia coli K88 (MIC=2μM), Escherichia coli K99 (MIC=2μM), Escherichia coli 078 (MIC=4μM), Escherichia coli 987P (MIC=2μM), Pseudomonas aeruginosa 27853 (MIC=0.5μM), Pseudomonas aeruginosa PAO1 (MIC=1μM), Salmonella typhimurium 14028 (MIC=16>64μM), Salmonella typhimurium 7731 (MIC=8μM)	[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells	Linear	Free	Amidation		L	[Ref.31199117] ①The cell viability of HEK293T cells induced by 2IH3 is 108.3%, 102.8%, 104.4%, 102.2%, 105%, 105.3% and 103.3% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 2IH3 is 102.5%, 104.5%, 105.6%, 103.7%, 102.0%, 103.1% and 103.1% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	31199117	ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.	Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.	Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP21350	IHHIHHHIHHIHHHIHHIHHHIHHIHHH	28	2IH4 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	95% α-helix in 50% TFE/H2O	The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=1μM), Escherichia coli UB1005 (MIC=2μM), Escherichia coli K88 (MIC=4>64μM), Escherichia coli K99 (MIC=1μM), Escherichia coli 078 (MIC=4>64μM), Escherichia coli 987P (MIC=1μM), Pseudomonas aeruginosa 27853 (MIC=1μM), Pseudomonas aeruginosa PAO1 (MIC=1μM), Salmonella typhimurium 14028 (MIC=64μM), Salmonella typhimurium 7731 (MIC>64μM)	[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells	Linear	Free	Amidation		L	[Ref.31199117] ①The cell viability of HEK293T cells induced by 2IH4 is  at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 2IH4 is 103.7%, 103.7%, 104.8%, 103.4%, 105.3%, 94.9% and 57.9% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	31199117	ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.	Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.	Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP21351	IHHIHHI	7	3IH1 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	53% α-helix in 50% TFE/H2O	The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC>64μM), Escherichia coli UB1005 (MIC>64μM), Escherichia coli K88 (MIC>64μM), Escherichia coli K99 (MIC>64μM), Escherichia coli 078 (MIC>64μM), Escherichia coli 987P (MIC>64μM), Pseudomonas aeruginosa 27853 (MIC>64μM), Pseudomonas aeruginosa PAO1 (MIC>64μM), Salmonella typhimurium 14028 (MIC>64μM), Salmonella typhimurium 7731 (MIC>64μM)	[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells	Linear	Free	Amidation		L	[Ref.31199117] ①The cell viability of HEK293T cells induced by 3IH1 is 105.6%, 101.1%, 100.6%, 102.5%, 100.3%, 101.4% and 101.1% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 3IH1 is 102.2%, 103.1%, 102.0%, 103.4%, 103.1%, 102.0% and 101.7% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	31199117	ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.	Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.	Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP21352	IHHIHHIIHHIHHI	14	3IH2 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	95% α-helix in 50% TFE/H2O	The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=4μM), Escherichia coli UB1005 (MIC=8μM), Escherichia coli K88 (MIC=4μM), Escherichia coli K99 (MIC=4μM), Escherichia coli 078 (MIC=8μM), Escherichia coli 987P (MIC=2μM), Pseudomonas aeruginosa 27853 (MIC=4μM), Pseudomonas aeruginosa PAO1 (MIC=4μM), Salmonella typhimurium 14028 (MIC=32μM), Salmonella typhimurium 7731 (MIC=16μM)	[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells	Linear	Free	Amidation		L	[Ref.31199117] ①The cell viability of HEK293T cells induced by 3IH2 is 105.8%, 105.8%, 105.2%, 104.2%, 101.1%, 101.7% and 100.8% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 3IH2 is 106.2%, 105.9%, 105.9%, 105.6%, 104.2%, 104.8% and 101.4% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	31199117	ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.	Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.	Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP21353	IHHIHHIIHHIHHIIHHIHHI	21	3IH3 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	95% α-helix in 50% TFE/H2O	The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=1μM), Escherichia coli UB1005 (MIC=1μM), Escherichia coli K88 (MIC=1μM), Escherichia coli K99 (MIC=1μM), Escherichia coli 078 (MIC=0.5μM), Escherichia coli 987P (MIC=0.5μM), Pseudomonas aeruginosa 27853 (MIC=1μM), Pseudomonas aeruginosa PAO1 (MIC=0.5μM), Salmonella typhimurium 14028 (MIC=2μM), Salmonella typhimurium 7731 (MIC=1μM)	[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells	Linear	Free	Amidation		L	[Ref.31199117] ①The cell viability of HEK293T cells induced by 3IH3 is 103.6%, 102.2%, 102.8%, 105%, 103.1%, 104.2% and 105.8% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 3IH3 is 103.9%, 103.1%, 103.9%, 102.2%, 104.2%, 103.1% and 101.7% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	31199117	ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.	Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.	Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP21354	IHHIHHIIHHIHHIIHHIHHIIHHIHHI	28	3IH4 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	95% α-helix in 50% TFE/H2O	The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=2μM), Escherichia coli UB1005 (MIC=4μM), Escherichia coli K88 (MIC=2μM), Escherichia coli K99 (MIC=4μM), Escherichia coli 078 (MIC=4μM), Escherichia coli 987P (MIC=4μM), Pseudomonas aeruginosa 27853 (MIC=8μM), Pseudomonas aeruginosa PAO1 (MIC=4μM), Salmonella typhimurium 14028 (MIC>64μM), Salmonella typhimurium 7731 (MIC>64μM)	[Ref.31199117] 8% hemolysis at 63μM, 15% hemolysis at 128μM against human red blood cells	Linear	Free	Amidation		L	[Ref.31199117] ①The cell viability of HEK293T cells induced by 3IH4 is 106.9%, 101.1%, 101.9%, 103.6%, 102.5%, 101.7% and 80.6% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 3IH4 is 104.2%, 105.3, 104.2%, 104.2%, 101.4%, 100.6%, 56.5% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	31199117	ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.	Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.	Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP21355	KKKKKAAFAKAWAAFAA	17	5Kamp (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.	Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=6.3μM), Pseudomonas aeruginosa PAO1(MIC=25μM), Pseudomonas aeruginosa PA214(MIC=25μM), Pseudomonas aeruginosa PA287(MIC=50μM), Pseudomonas aeruginosa PA330(MIC=50μM), Pseudomonas aeruginosa PA380(MIC=50μM)	[Ref.31194548] 0% hemolysis at 40μM against human blood cells.	Linear	Free	Amidation		L	[Ref.31194548] No cytotoxicity information found	Not found	31194548	J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.	Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM	Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP21356	KKKKAAFAKAWAKAFAA	17	4Kamp (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.	Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC=50μM), Pseudomonas aeruginosa PA214(MIC=50μM), Pseudomonas aeruginosa PA287(MIC>50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC=50μM)	[Ref.31194548] 0% hemolysis at 40μM against human blood cells.	Linear	Free	Amidation		L	[Ref.31194548] No cytotoxicity information found	Not found	31194548	J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.	Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM	Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP21357	KKKAAFAKAWAKAFKAA	17	3Kamp (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.	Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=25μM), Pseudomonas aeruginosa PAO1(MIC=50μM), Pseudomonas aeruginosa PA214(MIC=50μM), Pseudomonas aeruginosa PA287(MIC>50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)	[Ref.31194548] 0% hemolysis at 40μM against human blood cells.	Linear	Free	Amidation		L	[Ref.31194548] No cytotoxicity information found	Not found	31194548	J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.	Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM	Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP21358	KKAKAFAKAWAKAFKAA	17	2Kamp (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.	Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC=25μM), Pseudomonas aeruginosa PA214(MIC=50μM), Pseudomonas aeruginosa PA287(MIC=50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)	[Ref.31194548] 0% hemolysis at 40μM against human blood cells.	Linear	Free	Amidation		L	[Ref.31194548] No cytotoxicity information found	Not found	31194548	J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.	Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM	Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP21359	KAAKKFAKAWAKAFKAA	17	1Kamp (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.	Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC=50μM), Pseudomonas aeruginosa PA214(MIC>50μM), Pseudomonas aeruginosa PA287(MIC>50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)	[Ref.31194548] 0% hemolysis at 40μM against human blood cells.	Linear	Free	Amidation		L	[Ref.31194548] No cytotoxicity information found	Not found	31194548	J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.	Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM	Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP21360	KKKKKKALFALWLAFLA	17	6K-F17-4L (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.	Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC>50μM), Pseudomonas aeruginosa PA214(MIC=50μM), Pseudomonas aeruginosa PA287(MIC=25μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)	[Ref.31194548] 33% (± 22) hemolysis at 40μM against human blood cells.	Linear	Free	Amidation		L	[Ref.31194548] No cytotoxicity information found	Not found	31194548	J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.	Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM	Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O
DRAMP21361	KKKKKALFLKLWAAFLA	17	5Kamp-4L (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.	Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=3.1μM), Pseudomonas aeruginosa PAO1(MIC=12.5μM), Pseudomonas aeruginosa PA214(MIC=6.3μM), Pseudomonas aeruginosa PA287(MIC=6.3μM), Pseudomonas aeruginosa PA330(MIC=12.5μM), Pseudomonas aeruginosa PA380(MIC>50μM)	[Ref.31194548] 49% (± 22) hemolysis at 40μM against human blood cells.	Linear	Free	Amidation		L	[Ref.31194548] No cytotoxicity information found	Not found	31194548	J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.	Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM	Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O
DRAMP21362	KKKKAAFLKLWLKLFAA	17	4Kamp-4L (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.	Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC>50μM), Pseudomonas aeruginosa PA214(MIC>50μM), Pseudomonas aeruginosa PA287(MIC>50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)	[Ref.31194548] 8% (± 2.0) hemolysis at 40μM against human blood cells.	Linear	Free	Amidation		L	[Ref.31194548] No cytotoxicity information found	Not found	31194548	J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.	Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM	Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O
DRAMP21363	KKKAAFLKLWAKLFKAL	17	3Kamp-4L (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.	Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=3.1μM), Pseudomonas aeruginosa PAO1(MIC=3.1μM), Pseudomonas aeruginosa PA214(MIC=3.1μM), Pseudomonas aeruginosa PA287(MIC=3.1μM), Pseudomonas aeruginosa PA330(MIC=6.3μM), Pseudomonas aeruginosa PA380(MIC=3.1μM)	[Ref.31194548] 100% (± 4.5) hemolysis at 40μM against human blood cells.	Linear	Free	Amidation		L	[Ref.31194548] No cytotoxicity information found	Not found	31194548	J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.	Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM	Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP21364	KKLKAFLKAWAKLFKAL	17	2Kamp-4L (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.	Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=1.6μM), Pseudomonas aeruginosa PAO1(MIC=3.1μM), Pseudomonas aeruginosa PA214(MIC=3.1μM), Pseudomonas aeruginosa PA287(MIC=3.1μM), Pseudomonas aeruginosa PA330(MIC=6.3μM), Pseudomonas aeruginosa PA380(MIC=1.5μM)	[Ref.31194548] 89% (± 7.3) hemolysis at 40μM against human blood cells.	Linear	Free	Amidation		L	[Ref.31194548] No cytotoxicity information found	Not found	31194548	J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.	Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM	Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP21365	KALKKFLKAWAKLFKAL	17	1Kamp-4L (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.	Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=1.6μM), Pseudomonas aeruginosa PAO1(MIC=3.1μM), Pseudomonas aeruginosa PA214(MIC=3.1μM), Pseudomonas aeruginosa PA287(MIC=3.1μM), Pseudomonas aeruginosa PA330(MIC=6.3μM), Pseudomonas aeruginosa PA380(MIC=6.3μM)	[Ref.31194548] 81% (± 9.4) hemolysis at 40μM against human blood cells.	Linear	Free	Amidation		L	[Ref.31194548] No cytotoxicity information found	Not found	31194548	J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.	Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM	Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP21366	KLGALWNVAKSVF	13	[Lys]1-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	3% Helical content in water, 2% helical content in PBS (pH7.4), 30% helical content in SDS (20 mmol/L), 32% helical content in TFE/Water (3:2, v:v), 4	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans MDM8 and Candida tropicalis IOC 4560.	[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=25 μmol/L), Bacillus megaterium ATCC 10778 (MIC=3.1 μmol/L);##Gram-negative bacteria: Serratia marcescens ATCC 4112 (MIC=1.6 μmol/L), Enterobacter cloacae β-12 (MIC=25 μmol/L);##Fungi: Candida albicans MDM8 (MIC=3.1 μmol/L), Candida tropicalis IOC 4560 (MIC=0.8 μmol/L)	[Ref.31181304] 15% hemolysis at 25 μmol/L, 25% hemolysis at 50 μmol/L, 40% hemolysis at 100 μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.31181304] The cell viability of MCF-7 cells induced by [Lys1]-VmCT1-NH2 is 120%, 120%, 120%, 110%, 120%, 120%, 115% and 115% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. 	Not found	31181304	Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.	Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX	The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP21367	FLGALWNVKKSVF	13	[Lys]9-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Antifungal	Synthetic form	2% Helical content in water, 3% helical content in PBS (pH7.4), 21% helical content in SDS (20 mmol/L), 21% helical content in TFE/Water (3:2, v:v), 3	Not found		Function: Antibacterial activity against Gram-positive bacteria. Antifungal activity against Candida albicans MDM8.	[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L);##Fungi: Candida albicans MDM8 (MIC=50 μmol/L)	[Ref.31181304] 0% hemolysis at 100 μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.31181304] The cell viability of MCF-7 cells induced by [Lys9]-VmCT1-NH2 is 120%, 120%, 105%, 110%, 110%, 108%, 120% and 120% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. 	Not found	31181304	Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.	Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX	The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP21368	KLGALWNVAKSKF	13	[Lys]1[Lys]12-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	2% Helical content in water, 0% helical content in PBS (pH7.4), 19% helical content in SDS (20 mmol/L), 13% helical content in TFE/Water (3:2, v:v), 0	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans MDM8 and Candida tropicalis IOC 4560.	[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=12.5 μmol/L), Bacillus megaterium ATCC 10778 (MIC=6.3 μmol/L);##Gram-negative bacteria: Enterobacter cloacae β-12 (MIC=25μmol/L);##Fungi: Candida albicans MDM8 (MIC=6.3 μmol/L), Candida tropicalis IOC 4560 (MIC=3.1 μmol/L)	[Ref.31181304] 0% hemolysis at 100 μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.31181304] The cell viability of MCF-7 cells induced by [Lys1][Lys12]-VmCT1-NH2 is 105%, 110%, 95%, 100%, 110%, 120%, 120% and 120% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. 	Not found	31181304	Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.	Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX	The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP21369	FLKALWKVAKSVF	13	[Lys]3[Lys]7-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	0% Helical content in water, 5% helical content in PBS (pH7.4), 37% helical content in SDS (20 mmol/L), 52% helical content in TFE/Water (3:1, v:v), 0	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans MDM8 and Candida tropicalis IOC 4560.	[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.4 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.4 μmol/L), Staphylococcus epidermidis ATCC 12228 (MIC=3.1 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.1 μmol/L), Enterobacter cloacae β-12 (MIC=3.1 μmol/L);##Fungi: Candida albicans MDM8 (MIC=0.8 μmol/L), Candida tropicalis IOC 4560 (MIC=0.4 μmol/L)	[Ref.31181304] 15% hemolysis at 3.1 μmol/L, 45% hemolysis at 6.3 μmol/L, 65% hemolysis at 12.5 μmol/L, 85% hemolysis at 25 μmol/L, 90% hemolysis at 100 μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.31181304] ①The cell viability of MCF-7 cells induced by [Lys3][Lys7]-VmCT1-NH2 is 95%, 95%, 90%, 85%, 80%, 70%, 50%, 40% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. ②The cell viability of MCF-10A cells induced by [Lys3][Lys7]-VmCT1-NH2 is 120%, 120%, 120%,120%, 95% and 90% at peptide concentrations of 0.8, 1.6, 3.1, 6.3, 12.5 and 25 μM.	Not found	31181304	Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.	Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX	The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP21370	FLKALWNVAKKVF	13	[Lys]3[Lys]11-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	0% Helical content in water, 4% helical content in PBS (pH7.4), 28% helical content in SDS (20 mmol/L), 33% helical content in TFE/Water (3:2, v:v), 2	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans MDM8 and Candida tropicalis IOC 4560.	[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.8 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.4 μmol/L), Staphylococcus epidermidis ATCC 12228 (MIC=1.6 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.2 μmol/L), Enterobacter cloacae β-12 (MIC=3.1 μmol/L);##Fungi: Candida albicans MDM8 (MIC=1.6 μmol/L), Candida tropicalis IOC 4560 (MIC=0.4 μmol/L)	[Ref.31181304] 40% hemolysis at 12.5 μmol/L, 70% hemolysis at 25 μmol/L, 80% hemolysis at 50 μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.31181304] ①The cell viability of MCF-7 cells induced by [Lys3][Lys11]-VmCT1-NH2 is 95%, 100%, 80%, 80%, 55%, 45%, 20% and 20% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. ②The cell viability of MCF-10A cells induced by [Lys3][Lys11]-VmCT1-NH2 is 120%, 120%, 90%, 100%, 120% and 95%  at  peptide concentrations of 0.8, 1.6, 3.1, 6.3, 12.5 and 25 μM.	Not found	31181304	Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.	Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX	The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP21371	FLGALWKVAKKVF	13	[Lys]7[Lys]11-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	0% Helical content in water, 3% helical content in PBS (pH7.4), 27% helical content in SDS (20 mmol/L), 39% helical content in TFE/Water (3:2, v:v), 1	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans MDM8 and Candida tropicalis IOC 4560.	[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.8 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.4 μmol/L), Staphylococcus epidermidis ATCC 12228 (MIC=6.3 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=3.1 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.2 μmol/L), Enterobacter cloacae β-12 (MIC=3.1 μmol/L);##Fungi: Candida albicans MDM8 (MIC=1.6 μmol/L), Candida tropicalis IOC 4560 (MIC=0.4μmol/L)	[Ref.31181304] 45% hemolysis at 12.5 μmol/L, 100% hemolysis at 50 μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.31181304] ①The cell viability of MCF-7 cells induced by [Lys7][Lys11]-VmCT1-NH2 is 105%, 105%, 95%, 85%, 65%, 45%, 25% and 25% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. ②The cell viability of MCF-10A cells induced by [Lys7][Lys11]-VmCT1-NH2 is 120%, 120%, 85%, 90%, 120% and 120%at peptide concentrations of 0.8, 1.6, 3.1, 6.3, 12.5 and 25 μM.	Not found	31181304	Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.	Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX	The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP21372	FLKALWKVAKKVF	13	[Lys]3[Lys]7[Lys]11-VmCT1-NH2 (Derived from VmCT1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	0% Helical content in water, 3% helical content in PBS (pH7.4), 25% helical content in SDS (20 mmol/L), 23% helical content in TFE/Water (3:2, v:v), 2	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans MDM8 and Candida tropicalis IOC 4560.	[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.8 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.2 μmol/L), Staphylococcus epidermidis ATCC 12228 (MIC=3.1 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.1μmol/L), Enterobacter cloacae β-12 (MIC=3.1 μmol/L);##Fungi: Candida albicans MDM8 (MIC=0.8 μmol/L), Candida tropicalis IOC 4560 (MIC=0.4μmol/L)	[Ref.31181304] 40% hemolysis at 12.5 μmol/L, 60% hemolysis at 25 μmol/L, 80% hemolysis at 50 μmol/L, 100% hemolysis at 100 μmol/L against human red blood cells	Linear	Free	Amidation		L	[Ref.31181304] ①The cell viability of MCF-7 cells induced by [Lys3][Lys7][Lys11]-VmCT1-NH2 is 90%, 90%, 90%, 60%, 50%, 30%, 20% and 20% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. ②The cell viability of MCF-10A cells induced by [Lys3][Lys7][Lys11]-VmCT1-NH2 is 120%, 120%, 85%, 120%, 115% and 120%at peptide concentrations of 0.8, 1.6, 3.1, 6.3, 12.5 and 25 μM.	Not found	31181304	Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.	Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX	The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP21373	AIKIRKLFKKLLR	13	SP1 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=12.5–25 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP1 is 87.8%, 88.5%, 83.1%, 95.3%, 97.3% and 68.9% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC
DRAMP21374	GIKIRKLFKKLLR	13	SP2 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=6.25–12.5 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP2 is 108.8%, 110.1%, 116.9%, 104.7%, 108.8% and 83.1% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC
DRAMP21375	GWAKLITKAIKKI	13	SP3 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=25–50 µg/mL)	[Ref.31163671] 10% hemolysis at 50–100 μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP3 is 80.4%, 77.0%, 87.8%, 98.0%, 76.4% and 84.5% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(N)=O
DRAMP21376	GIKFFLKKLKKHI	13	SP4 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=25–50 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP4 is 102.0%, 114.2%, 100.7%, 93.2%, 108.1% and 83.1% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@H](C)CC)C(N)=O
DRAMP21377	IRPAKLRWFKKIK	13	SP5 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC >100 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP5 is 110.8%, 100.7%, 104.7%, 110.1%, 87.8% and 90.5% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP21378	RLFIKKLKFITRR	13	SP6 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=25–50 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP6 is 92.6%, 100%, 102.7%, 106.8%, 93.2% and 99.3% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP21379	NAMRGAKRVWRHI	13	SP7 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC >100 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP7 is 91.9%, 95.9%, 103.4%, 94.6%, 93.9% and 91.2% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(N)=O
DRAMP21380	KFRKFGKQVWVRL	13	SP8 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=12.5–25 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP8 is 98.0%, 104.7%, 98.0%, 103.4%, 93.2%, 92.6% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(N)=O
DRAMP21381	aikirklfkkllr	13	SP1D * (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=12.5–25 µg/mL)	[Ref.31163671] 10% hemolysis at 25–50 μg/mL against human blood cells.	Linear	Free	Amidation		D	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP1D is 80.4%, 102.0%, 81.8%, 81.8%, 74.3% and 66.2% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@H](C)[C@@H](NC(=O)[C@@H](C)N)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(N)=O)[C@@H](C)CC
DRAMP21382	KVWSRLRKIFSTR	13	SP9 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=6.25–12.5 µg/mL)	[Ref.31163671] 10% hemolysis at 50–100 μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP9 is 104.7%, 110.8%, 108.8%, 108.8%, 97.3% and 79.1% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O
DRAMP21383	AKVLKISRRAFRK	13	SP10 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC >100 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP10 is 114.2%, 82.4%, 94.6%, 98.6%, 103.4% and 98.6% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21384	IRRWRLHWFRRAI	13	SP11 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=12.5–25 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP11 is 95.3%, 109.5%, 108.1%, 89.2%, 112.8% and 81.1% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)[C@H](C)CC
DRAMP21385	IRRRIRLIVRRQI	13	SP12 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=12.5–25 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP12 is 98.0%, 99.3%, 95.9%, 92.6%, 100% and 89.2% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(N)=O)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP21386	HFKIRKRFVKKLV	13	SP13 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC >100 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP13 is 104.1%, 106.8%, 111.5%, 101.4%, 107.4%, 118.2% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP21387	RWIRWVWRKKLRI	13	SP14 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=12.5–25 µg/mL)	[Ref.31163671] 10% hemolysis at 50–100 μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP14 is 102.7%, 95.3%, 88.5%, 93.9%, 100% and 98.6% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(C)C)C(N)=O
DRAMP21388	RWIRWVWRKKLR	12	SP15 * (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC= 3.125–6.25 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		L	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP15 is 90.5%, 90.5%, 89.2%, 83.1%, 93.2% and 52.7% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP21389	rwirwvwrkklr	12	SP15D * (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix mainly	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=0.78–1.56 µg/mL)	[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.	Linear	Free	Amidation		D	[Ref.31163671] The cell viability of Hepa 1-6 induced by SP15D is 91.2%, 96.6%, 96.6%, 73.6%, 58.1% and 25% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.	Not found	31163671	Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.	Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava	De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.	CC[C@H](C)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP21390	RWKRHISEQLRRRDRLQR	18	K17 (Derived from ATG16)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.	[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=45.5-91 μM);##Gram-negative bacteria: Escherichia coli (MIC>120μM), Pseudomonas aeruginosa (MIC>120μM);##Fungi: Candida albicans (MIC>120μM)	[Ref.31145591] 2% hemolysis at 600 μM, 3% hemolysis at 700 μM, 4% hemolysis at 800 μM, 5% hemolysis at 900 μM, 6% hemolysis at 1000 μM, against mouse blood cells.	Linear	Free	Free		L	[Ref.31145591] No cytotoxicity information found	Not found	31145591	Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.	Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V	Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21391	RWKRHISEQLRRRDRLQRQAF	21	K18 (Derived from ATG16)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.	[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=28.8-57.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=60-120μM), Pseudomonas aeruginosa (MIC=60-120μM);##Fungi: Candida albicans (MIC>120μM)	[Ref.31145591] 3% hemolysis at 500μM, 16% hemolysis at 600 μM, 27% hemolysis at 700 μM, 38% hemolysis at 800 μM, 50% hemolysis at 900 μM, 62% hemolysis at 1000μM against mouse blood cells.	Linear	Free	Free		L	[Ref.31145591] No cytotoxicity information found	Not found	31145591	Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.	Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V	Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21392	RWKRHISEQLRRRDRLQRQAJ	21	K22 (Derived from ATG16)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.	[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=14.4-28.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=30-60μM), Pseudomonas aeruginosa (MIC=60-120μM);##Fungi: Candida albicans (MIC=60-120μM)	[Ref.31145591] 3% hemolysis at 500μM, 10% hemolysis at 600 μM, 13% hemolysis at 700 μM, 17% hemolysis at 800 μM, 20% hemolysis at 900 μM, 25% hemolysis at 1000μM against mouse blood cells.	Linear	Free	Free	The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.	L	[Ref.31145591] No cytotoxicity information found	Not found	31145591	Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.	Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V	Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.	
DRAMP21393	RWKRHISEQLRRRDRLQRQAJ	21	K22.2 (Derived from ATG16)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.	[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=4-8 μM);##Gram-negative bacteria: Escherichia coli (MIC=17.5-35μM), Pseudomonas aeruginosa (MIC=17.5-35μM);##Fungi: Candida albicans (MIC=60-120μM)	[Ref.31145591] 3% hemolysis at 500μM, 5% hemolysis at 600 μM, 10% hemolysis at 700 μM, 15% hemolysis at 800 μM, 17% hemolysis at 900 μM, 20% hemolysis at 1000μM against mouse blood cells.	Linear	Free	Amidation (2-Nal, position 21)	The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.	L	[Ref.31145591] No cytotoxicity information found	Not found	31145591	Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.	Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V	Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.	
DRAMP21394	RWKRHISEQLRRRDRLQRQAJ	21	K30 (Derived from ATG16)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Helix–loop–helix in the presence of anionic membrane lipids mimicking bacterial membranes.	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.	[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=0.9-1.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=6.4-12.8μM), Pseudomonas aeruginosa (MIC=13.5-27μM);##Fungi: Candida albicans (MIC=30-60μM)	[Ref.31145591] 3% hemolysis at 600μM, 4% hemolysis at 700 μM, 5% hemolysis at 800 μM, 6% hemolysis at 900 μM, 9% hemolysis at 1000 μM,against mouse blood cells.	Linear	Acylation (Arg1 conjugated with 4-methylhexanoyl group)	Amidation (2-Nal, position 21)	The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.	L	[Ref.31145591] No cytotoxicity information found	Not found	31145591	Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.	Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V	Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.	
DRAMP21395	RWKRHISEQLRRRDRLQRQAJ	21	K31 (Derived from ATG16)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.	[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=1.8-3.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.2-6.4μM), Pseudomonas aeruginosa (MIC=3.2-6.4μM);##Fungi: Candida albicans (MIC=3.2-6.4μM)	[Ref.31145591] 50% hemolysis at 10μM, 70% hemolysis at 61μM, 75% hemolysis at 100 μM, 80% hemolysis at 200 μM, 85% hemolysis at 300 μM, 90% hemolysis at 900 μM, 92% hemolysis at 500μM against mouse blood cells.	Linear	Acylation (Arg1 conjugated with myristoyl group)	Amidation (2-Nal, position 21)	The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.	L	[Ref.31145591] No cytotoxicity information found	Not found	31145591	Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.	Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V	Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.	
DRAMP21396	RWKRHISEQLRRRDRLQRQAJ	21	K33 (Derived from ATG16)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.	[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=1.8-3.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.2-6.4μM), Pseudomonas aeruginosa (MIC=6.4-12.8μM);##Fungi: Candida albicans (MIC=1.8-3.7μM)	[Ref.31145591] 75% hemolysis at 10μM, 97% hemolysis at 123μM, 100% hemolysis at 500μM against mouse blood cells.	Linear	Acylation (Arg1 conjugated with palmitoyl group)	Amidation (2-Nal, position 21)	The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.	L	[Ref.31145591] No cytotoxicity information found	Not found	31145591	Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.	Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V	Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.	
DRAMP21397	RWKRHISEQLRRRDRLQRQAJ	21	K36 (Derived from ATG16)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.	[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=0.9-1.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.2-6.4μM), Pseudomonas aeruginosa (MIC=6.4-12.8μM);##Fungi: Candida albicans (MIC=15-30μM)	[Ref.31145591] 5% hemolysis at 200μM, 10% hemolysis at 300 μM, 17% hemolysis at 400 μM, 23% hemolysis at 500 μM, 30% hemolysis at 600μM, 32% hemolysis at 700 μM, 35% hemolysis at 800 μM, 40% hemolysis at 900 μM, 42% hemolysis at 1000μM against mouse blood cells.	Linear	Acylation (Arg1 conjugated with Fmoc group)	Amidation (2-Nal, position 21)	The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.	L	[Ref.31145591] No cytotoxicity information found	Not found	31145591	Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.	Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V	Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.	
DRAMP21398	RWKRHISEQLRRRDRLQRQAJ	21	K46 (Derived from ATG16)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.	[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=1.8-3.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.2-6.4μM), Pseudomonas aeruginosa (MIC=6.4-12.8μM);##Fungi: Candida albicans (MIC=30-60μM)	[Ref.31145591] 10% hemolysis at 200μM, 15% hemolysis at 500μM, 17% hemolysis at 600 μM, 20% hemolysis at 700 μM, 25% hemolysis at 800 μM, 30% hemolysis at 900 μM, 42% hemolysis at 1000μM against mouse blood cells.	Linear	Acylation (Arg1 conjugated with capryl group)	Amidation (2-Nal, position 21)	The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.	L	[Ref.31145591] No cytotoxicity information found	Not found	31145591	Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.	Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V	Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.	
DRAMP21399	RRYGTCIYQGRLWAF	15	Pep-H  (Human, mammals, animals)	No entry found	Belongs to the alpha-defensin family.	Not found	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram+	Not found	β-strand mainly (according to PDB entry 3HJ2)	Not found		Function: Antibacterial activity against Gram-positive bacteria.	[Ref.31133658] Gram-positive bacteria:M.tb H37Rv (MIC=10 μg/ml)	[Ref.31133658] 2.7% hemolysis at 1μg/ml, 5% hemolysis at 5μg/ml, 6% hemolysis at 50μg/ml, 8% hemolysis at 100 μg/ml against human blood cells.	Linear	Free	Free		L	[Ref.31133658] The cell viability of MDMs induced by Pep-H is 94.2%, 91.5%, 90.4%, 88.0% and 84.1% at peptide concentrations of 1, 5, 25, 50, 100 μg/mL	Not found	31133658	Sci Rep. 2019; 9: 7866. Published online 2019 May 27. doi: 10.1038/s41598-019-44256-6	Richa Sharma， Ragini Raghav, Kumari Priyanka, Praveen Rishi, Sadhna Sharma, Sudha Srivastava, Indu Verma	Exploiting chitosan and gold nanoparticles for antimycobacterial activity of in silico identified antimicrobial motif of human neutrophil peptide-1	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP21400	CGIYRSLKLIKSLVLIK	17	NBC2253 (De Novo Synthesis) 	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31119600] Gram-positive bacteria:MRSA(MIC=6.7 ± 0.02µM);##Gram-negative bacteria:Escherichia coli O157:H7(MIC=25 ± 0.03µM)	[Ref.31119600] No hemolytic activity against bovine blood cells	Linear	The sulfhydryl side chain of the cysteine residue was conjugated to AuNC(previously modified with SPDP) via a disulfide bond.	Free		L	[Ref.31119600] The cell viability of Vero ATCC CCL 1-81 cells induced by NBC2253 is 87.8%, 66.4%, 62.2%, 69.1% and 68.8% at peptide concentrations of 1.2, 3.7, 11.1, 33.3 and 100 μM.	Not found	31119600	Protein J. 2019 May 22. doi: 10.1007/s10930-019-09840-9.	Prada YA, Guzmán F, Ortíz C, Cabanzo R, Torres R, Mejía-Ospino E	New Synthetic Peptides Conjugated to Gold Nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).	
DRAMP21401	CALKLTKAKRLVRKIGF	17	NBC2254 (De Novo Synthesis) 	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31119600] Gram-positive bacteria:MRSA(MIC=73 ± 0.02µM);##Gram-negative bacteria:Escherichia coli O157:H7(MIC=3.5 ± 0.05µM)	[Ref.31119600] No hemolytic activity against bovine blood cells	Linear	The sulfhydryl side chain of the cysteine residue was conjugated to AuNC(previously modified with SPDP) via a disulfide bond.	Free		L	[Ref.31119600] The cell viability of Vero ATCC CCL 1-81 cells induced by NBC2254 is 93.7%, 90.1%, 89.5%, 95.9% and 78.6% at peptide concentrations of 1.2, 3.7, 11.1, 33.3 and 100 μM.	Not found	31119600	Protein J. 2019 May 22. doi: 10.1007/s10930-019-09840-9.	Prada YA, Guzmán F, Ortíz C, Cabanzo R, Torres R, Mejía-Ospino E	New Synthetic Peptides Conjugated to Gold Nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).	
DRAMP21402	KFKKLFKKLSPVFKRIVQRIKDFLR	25	B1 (Derived from LL-37 and BMAP-27)	No entry found	Belongs to the cathelicidin family.	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	88 % of the α-helices and 12% of the random coil was predicted using HNN	The helicity percentages of the secondary structure of B1 are predicted using HNN		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31118709] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=20μM), Staphylococcus aureus ATCC 33591(MIC=20μM), Staphylococcus aureus ATCC 43300(MIC=20μM), Staphylococcus aureus ATCC BAA-41(MIC=20μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=20μM), Escherichia coli 35218 (MIC=20μM), Pseudomonas aeruginosa BAA-2114 (MIC=10μM)	[Ref.31118709] 0% hemolysis at 10μM, 8% hemolysis at 25μM, 19% hemolysis at 50μM, 23% hemolysis at 75μM, 30% hemolysis at 100μM, 38% hemolysis at 125μM, 40% hemolysis at 150μM, 43% hemolysis at 175μM, 50% hemolysis at 200μM against human blood cells.	Linear	Free	Free		L	[Ref.31118709] The cell viability of HEK293 mammalian cell line induced by B1 is 87.0%, 67.1%, 52.3%, 54.3%, 50.6% and 50% at peptide concentrations of 10, 20, 40, 60, 80 and 100 μM.	Not found	31118709	Infect Drug Resist. 2019; 12: 1035–1045. Published online 2019 Apr 30. doi: 10.2147/IDR.S199473	Yara Al Tall, Ahmad Abualhaijaa, Mohammad Alsaggar, Ammar Almaaytah, Majed Masadeh, and Karem H Alzoub	Design and characterization of a new hybrid peptide from LL-37 and BMAP-27	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21403	ITEVITILLNRLTDRLEK	18	peptide 1 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM phosphate buffer, pH7.4	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31117348] Gram-positive bacteria:Staphylococcus aureus ATCC 6538(MIC>100μM), Bacillus subtilis ATCC 6633(MIC>100μM);##Gram-negative bacteria:Escherichia coli ATCC 15597(MIC>100μM), Pseudomonas aeruginosa (MIC>100μM), Salmonella Typhimurium 6192(MIC>100μM), Klebsiella pneumoniae NCTC 5055(MIC>100μM)	[Ref.31117348] 5% hemolysis at 250 μM against human blood cells.	Linear	Free	Free		L	[Ref.31117348] No cytotoxicity information found	Not found	31117348	ACS Infect Dis. 2019 May 30. doi: 10.1021/acsinfecdis.9b00157.	Hammond K, Lewis H, Faruqui N, Russell C, Hoogenboom BW, Ryadnov MG	Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP21404	ITKVITKLLNRLTKILSK	18	peptide 2 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix mainly in 10 mM phosphate buffer, pH7.4	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31117348] Gram-positive bacteria:Staphylococcus aureus ATCC 6538(MIC=15 ± 2.5μM), Bacillus subtilis ATCC 6633(MIC=15 ± 2.5μM);##Gram-negative bacteria:Escherichia coli ATCC 15597(MIC=3.1μM), Pseudomonas aeruginosa (MIC=25μM), Salmonella Typhimurium 6192(MIC=40 ± 5μM), Klebsiella pneumoniae NCTC 5055(MIC=50μM)	[Ref.31117348] 5% hemolysis at 250 μM against human blood cells.	Linear	Free	Free		L	[Ref.31117348] ①The cell viability of MCF7 cells induced by peptide 2 is 94.2%, 88.6%, 82.0%, 55.0%, 44.0%, 32.4%, 15.3%, 15.8%, 12.8% and 1.2% at peptide concentrations of 1, 10, 15, 20, 25, 30, 35, 40, 50 and 100 μM. EC50=22.5±0.7 μM. ②The cell viability of Hela cells induced by peptide 2 is 96.1%, 95.4%, 83.8%, 64.2%, 57.7%, 49.5%, 31.5%, 30.2%, 7.8% and 0.2% at peptide concentrations of 1, 10, 15, 20, 25, 30, 35, 40, 50 and 100 μM. EC50=29.8±1 μM. ③The cell viabiity of HDF cells induced by peptide 2 is 96.3%, 89.7%, 89.9%, 92.7%, 95.0%, 93.4%, 93.1%, 96.1%, 88.6% and 67.4% at peptide concentrations of 1, 10, 15, 20, 25, 30, 35, 40, 50 and 100 μM.	Not found	31117348	ACS Infect Dis. 2019 May 30. doi: 10.1021/acsinfecdis.9b00157.	Hammond K, Lewis H, Faruqui N, Russell C, Hoogenboom BW, Ryadnov MG	Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP21405	GKIIKLKASLKLL	13	LGL13K (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31071184] Gram-positive bacteria:Staphylococcus aureus Xen36(MIC=83.3μg/ml), Staphylococcus aureus USA300(Uknow);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=10.4μg/ml)	[Ref.31071184] LD50=560μg/ml against human blood cells	Linear	Free	Amidation		L	[Ref.31071184] The cytotoxicity of L-GL13K on HEK cells is 2.1%, 3.3%, 2.4%, 1.2%24.3%, 51.7% and 73.6% at peptide concentrations of 1, 3.9, 15.6, 62.5, 250 and 1000 μg/mL, while the cytotoxicity of PMX on HEK cells (Control samples) is 1.2%, 1.2%, 6.6%, 3.6%, 39.6%, 47.1% and 68.5% at peptide concentrations of 1, 3.9, 15.6, 62.5, 250 and 1000 μg/mL.	Not found	31071184	PLoS One. 2019 May 9;14(5):e0216669. doi: 10.1371/journal.pone.0216669. eCollection 2019.	Gorr SU, Flory CM, Schumacher RJ	In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP21406	Gkiiklkaslkll	13	DGL13K (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31071184] Gram-positive bacteria:Staphylococcus aureus Xen36(MIC=2.6μg/ml), Staphylococcus aureus USA300(MIC=5.2μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=5.2μg/ml)	[Ref.31071184] LD50=950μg/ml against human blood cells	Linear	Free	Amidation		Mixed (L-Gly1)	[Ref.31071184] The cytotoxicity of D-GL13K on HEK cells is 1.5%, 0.9%, 2.1%, 1.5%, 34.2%, 32.4% and 41.1% at peptide concentrations of 1, 3.9, 15.6, 62.5, 250 and 1000 μg/mL, while the cytotoxicity of PMX on HEK cells (Control samples) is 1.2%, 1.2%, 6.6%, 3.6%, 39.6%, 47.1% and 68.5% at peptide concentrations of 1, 3.9, 15.6, 62.5, 250 and 1000 μg/mL.	Not found	31071184	PLoS One. 2019 May 9;14(5):e0216669. doi: 10.1371/journal.pone.0216669. eCollection 2019.	Gorr SU, Flory CM, Schumacher RJ	In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K.	CC[C@H](C)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(N)=O)[C@@H](C)CC
DRAMP21407	KLCKIVVIKVCK	12	Bac4K (Derived from CAMPs)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	β-turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC>64μM), Staphylococcus epidermidis (MIC=32μM), Bacillus subtilis (MIC>64μM), Enterococcus faecalis (MIC>64μM);##Gram-negative bacteria: Escherichia coli (MIC=8μM), Salmonella typhimurium (MIC>64μM), Pseudomonas aeruginosa (MIC>64μM), Acinetobacter baumannii (MIC>64μM)	[Ref.31056261] 0.6% hemolysis at 100 μM against human red blood cells.	Cyclic	Free	Free	Disulfide bond between Cys3 and Cys11.	L	[Ref.31056261] No cytotoxicity information found	Not found	31056261	Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2	Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI	A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC1=O
DRAMP21408	RLCRIWWIRWCR	12	Bac3W (Derived from CAMPs)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	β-turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC=16μM), Staphylococcus epidermidis (MIC=8μM), Bacillus subtilis (MIC=32μM), Enterococcus faecalis (MIC=32μM);##Gram-negative bacteria: Escherichia coli (MIC=2-4 μM), Salmonella typhimurium (MIC=8 μM), Pseudomonas aeruginosa (MIC=4μM), Acinetobacter baumannii (MIC=16-32μM)	[Ref.31056261] 0.9% hemolysis at 100 μM against human red blood cells	Cyclic	Free	Free	Disulfide bond between Cys3 and Cys11.	L	[Ref.31056261] No cytotoxicity information found	Not found	31056261	Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2	Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI	A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O
DRAMP21409	ricrivvirvcr	12	dBac (Derived from CAMPs)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	β-turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC=16μM), Staphylococcus epidermidis (MIC=4-8μM), Bacillus subtilis (MIC=16μM), Enterococcus faecalis (MIC>64μM);##Gram-negative bacteria: Escherichia coli (MIC=4-8μM), Salmonella typhimurium (MIC=32-64μM), Pseudomonas aeruginosa (MIC>64μM), Acinetobacter baumannii (MIC>64μM)	[Ref.31056261] 0.7% hemolysis at 100 μM against human red blood cells	Cyclic	Free	Free	Disulfide bond between Cys3 and Cys11.	D	[Ref.31056261] No cytotoxicity information found	Not found	31056261	Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2	Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI	A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.	CC[C@H](C)[C@@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@@H]1CSSC[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](CCCNC(=N)N)NC1=O
DRAMP21410	klckivvikvck	12	dBac4K (Derived from CAMPs)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	β-turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC>64μM), Staphylococcus epidermidis (MIC=8-16μM), Bacillus subtilis (MIC>64μM), Enterococcus faecalis (MIC>64μM);##Gram-negative bacteria: Escherichia coli (MIC=4-8μM), Salmonella typhimurium (MIC=32-64μM), Pseudomonas aeruginosa (MIC>64μM), Acinetobacter baumannii (MIC>64μM)	[Ref.31056261] 0.7% hemolysis at 100 μM against human red blood cells	Cyclic	Free	Free	Disulfide bond between Cys3 and Cys11.	D	[Ref.31056261] No cytotoxicity information found	Not found	31056261	Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2	Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI	A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.	CC[C@H](C)[C@H]1NC(=O)[C@@H](CCCCN)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](N)CCCCN)CSSC[C@H](C(=O)N[C@H](CCCCN)C(=O)O)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)NC1=O
DRAMP21411	ricriwwirwcr	12	dBac3W (Derived from CAMPs)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	β-turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC=16μM), Staphylococcus epidermidis (MIC=16μM), Bacillus subtilis (MIC=32μM), Enterococcus faecalis (MIC=16-32μM);##Gram-negative bacteria: Escherichia coli (MIC=4-8μM), Salmonella typhimurium (MIC=4-8μM), Pseudomonas aeruginosa (MIC=4-8μM), Acinetobacter baumannii (MIC=32μM)	[Ref.31056261] 1.0% hemolysis at 100 μM against human red blood cells	Cyclic	Free	Free	Disulfide bond between Cys3 and Cys11.	D	[Ref.31056261] No cytotoxicity information found	Not found	31056261	Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2	Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI	A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.	CC[C@H](C)[C@@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@@H]1CSSC[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](CCCNC(=N)N)NC1=O
DRAMP21412	rkcrivvirvcr	12	dBacK (Derived from CAMPs)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	β-turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC=4-8μM), Staphylococcus epidermidis (MIC=1-2μM), Bacillus subtilis (MIC=1-2μM), Enterococcus faecalis (MIC=4μM);##Gram-negative bacteria: Escherichia coli (MIC=1-2μM), Salmonella typhimurium (MIC=1-2μM), Pseudomonas aeruginosa (MIC=2-4μM), Acinetobacter baumannii (MIC=2-4μM)	[Ref.31056261] 0.6% hemolysis at 100 μM against human red blood cells	Cyclic	Free	Free	Disulfide bond between Cys3 and Cys11.	D	[Ref.31056261] No cytotoxicity information found	Not found	31056261	Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2	Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI	A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.	CC[C@H](C)[C@H]1NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCNC(=N)N)CSSC[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)NC1=O
DRAMP21413	rkcrivvirvcr	12	dBacK- (cap) (Derived from CAMPs)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	β-turn	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC=1-2μM), Staphylococcus epidermidis (MIC=2μM), Bacillus subtilis (MIC=2μM), Enterococcus faecalis (MIC=4-8μM);##Gram-negative bacteria: Escherichia coli (MIC=2-4μM), Salmonella typhimurium (MIC=2-4μM), Pseudomonas aeruginosa (MIC=4-8μM), Acinetobacter baumannii (MIC=1-2μM)	[Ref.31056261] 2.1% hemolysis at 100 μM against human red blood cells	Cyclic	Free	Free	Disulfide bond between Cys3 and Cys11. The lysine side-chain residue at position 2(Lys2) is conjugated to the capric acid 	D	[Ref.31056261] No cytotoxicity information found	Not found	31056261	Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2	Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI	A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.	CC[C@H](C)[C@H]1NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCNC(=N)N)CSSC[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)NC1=O
DRAMP21414	RWKIFKKIEKMGRNIRDGIVKAGPAIQVLGSAKAI	35	CecB Q53 (Derived from CecB E53)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Random coil in aqueous solution and amphipathic helix upon interaction with cell membranes	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria. Antifungal activity against Candida albicans ATCC 1023.	[Ref.31045339] Gram-positive bacteria: Staphylococcus aureus ATCC BAA-44(MIC>20μM), Staphylococcus epidermidis ATCC 700565(MIC=8μM);##Gram-negative bacteria:  Escherichia coli ATCC 25922 (MIC=0.15μM), Pseudomonas aeruginosa ATCC 27853(MIC=2.2μM), Pseudomonas aeruginosa ATCC 25668(MIC=2.2μM);##Fungi:Candida albicans ATCC 1023(MIC>20μM)	[Ref.31045339] 0.1% hemolysis at 20μM, 0.5% hemolysis at 30μM, 0.5% hemolysis at 200μM against human red blood cells	Linear	Free	Amidation		L	[Ref.31045339] ①The cell viability of Hela cells induced by CecB Q53 is 102.6%, 104.0%, 99.1% and 95.6% at peptide concentrations of 10, 20, 30 and 200 μM. ②The cell viability of CCD cells induced by CecB Q53 is 108.4%, 111.5%, 108.8% and 88.5% at peptide concentrations of 10, 20, 30 and 200 μM.	Not found	31045339	ACS Infect Dis. 2019 May 10. doi: 10.1021/acsinfecdis.9b00042.	Romoli O, Mukherjee S, Mohid SA, Dutta A, Montali A, Franzolin E, Brady D, Zito F, Bergantino E, Rampazzo C, Tettamanti G, Bhunia A, Sandrelli F	Enhanced Silkworm Cecropin B Antimicrobial Activity against Pseudomonas aeruginosa from Single Amino Acid Variation.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)C(N)=O
DRAMP21415	LKKWWKTSKGLLGGLLGKVTSVIK	24	α4-short (Derived from α4)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30967458] Gram-positive bacteria: Staphylococcus aureus 467-1 (MIC=2μM), Staphylococcus aureus 0154-17 (MIC=2μM), Staphylococcus aureus 187-10 (MIC=16μM), Staphylococcus aureus 0194-19 (MIC=2μM), Staphylococcus aureus US300 (MIC=8μM), Staphylococcus aureus 122-12 (MIC=2μM), Enterococcus faecium 23614 (MIC=1μM), Enterococcus faecium 14678 (MIC=1μM), Enterococcus faecium 26125 (MIC=1μM);##Gram-negative bacteria:Pseudomonas aeruginosa 16-21 (MIC=2μM), Pseudomonas aeruginosa 16-72 (MIC=2μM), Pseudomonas aeruginosa 16-73 (MIC=2μM), Pseudomonas aeruginosa 0038-13 (MIC=2μM), Pseudomonas aeruginosa 0038-14 (MIC=1μM), Pseudomonas aeruginosa 0040-21 (MIC=2μM), Pseudomonas aeruginosa 0046-106 (MIC=8μM), Pseudomonas aeruginosa 0068-37 (MIC=16μM), Pseudomonas aeruginosa 0071-75 (MIC=2μM), Pseudomonas aeruginosa 97-5 (MIC=2μM), Pseudomonas aeruginosa 109-10 (MIC=2μM), Pseudomonas aeruginosa 16-21 (MIC=2μM)Pseudomonas aeruginosa 132-37 (MIC=2μM), Pseudomonas aeruginosa 129-5 (MIC=2μM), Pseudomonas aeruginosa 152-19 (MIC=2μM), Pseudomonas aeruginosa 159-30 (MIC=2μM), Pseudomonas aeruginosa 474-1 (MIC=2μM), Acinetobacter baumannii C3 (MIC=1μM), Acinetobacter baumannii D4 (MIC=2μM), Acinetobacter baumannii A2 (MIC=4μM), Escherichia coli YDC518 (MIC=1μM), Escherichia coli YDC575 (MIC=2μM), Escherichia coli YDC596 (MIC=1μM), Escherichia coli YDC107 (MIC=1μM), Escherichia coli YDC337 (MIC=1μM), Escherichia coli YDC748 (MIC=1μM), Klebsiella pneumoniae A2 (MIC=4μM), Klebsiella pneumoniae D4 (MIC=2μM), Klebsiella pneumoniae 438-16 (MIC=4μM)	[Ref.30967458] 1% hemolysis at 17 μM, 2% hemolysis at 30 μM, 3% hemolysis at 63 μM against human red blood cells	Linear	Free	Free		L	[Ref.30967458] The white blood cell toxicity of α4-short is ~0%, ~0%, ~0%, ~0%, ~0%, 1.8% and 3.1% at peptide concentrations of 1, 2, 4, 8, 16, 32 and 64 μM.	Not found	30967458	mBio. 2019 Mar-Apr; 10(2): e00226-19. Published online 2019 Apr 9. doi: 10.1128/mBio.00226-19	Shasha Jiang, Berthony Deslouches, Chen Chen, Matthew E. Di, Y. Peter Di	Antibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, α6-Short, in a Murine Model of Respiratory Infection	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP21416	WVKAAAKAAAKVW	13	WV (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix predicted by I-TASSER, random coil in PBS, α-helix in SDS	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30897850] Gram-positive bacteria:Staphylococcus aureus ATCC 27853(MIC>128μM), Staphylococcus epidermidis ATCC 12228(MIC>128μM), Staphylococcus faecalis ATCC 29212(MIC=64μM), Bacillus subtilis CMCC 63501(MIC>128μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=32μM), Escherichia coli UB 1005 (MIC>128μM), Pseudomonas aeruginosa ATCC 27853(MIC>128μM), Salmonella typhimurium ATCC 14028(MIC>128μM)	[Ref.30897850] 1.5% hemolysis at 256μM against human red blood cells	Linear	Free	Amidaton		L	[Ref.30897850] ①The cell viability of RAW 264.7 induced by WV is 102.5%, 93.5%, 97.8%, 95.7%, 99.3%, 99.6%, 93.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on RAW 264.7 cells (Control samples) is 93.1%, 67.8%, 37.7%, 17.8%, 0%, 1.4% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.②The cell viability of HEK293T induced by WV is 115.2%, 104.3%, 114.5%, 107.6%, 105.8%, 108.0% and 93.8% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on HEK293T cells (Control samples) is 101.4%, 80.1%, 31.9%, 1.4%, 1.4%, 1.8% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.	Not found	30897850	Int J Mol Sci. 2019 Mar; 20(6): 1417. Published online 2019 Mar 20. doi: 10.3390/ijms20061417	Changxuan Shao, Weizhong Li, Peng Tan, Anshan Shan, Xiujing Dou, Deying Ma, Chunyu Liu	Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency	
DRAMP21417	WIKAAAKAAAKIW	13	WI (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix predicted by I-TASSER, random coil in PBS, α-helix in SDS	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30897850] Gram-positive bacteria:Staphylococcus aureus ATCC 27853(MIC=32μM), Staphylococcus epidermidis ATCC 12228(MIC=32μM), Staphylococcus faecalis ATCC 29212(MIC=32μM), Bacillus subtilis CMCC 63501(MIC=8μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=8μM), Escherichia coli UB 1005 (MIC=8μM), Pseudomonas aeruginosa ATCC 27853(MIC=32μM), Salmonella typhimurium ATCC 14028(MIC=32μM)	[Ref.30897850] 15% hemolysis at 256μM against human red blood cells	Linear	Free	Amidaton		L	[Ref.30897850] ①The cell viability of RAW 264.7 induced by WI is 104.0%, 98.2%, 98.6%, 106.5%, 103.6%, 101.8% and 100% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on RAW 264.7 cells (Control samples) is 93.1%, 67.8%, 37.7%, 17.8%, 0%, 1.4% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.②The cell viability of HEK293T induced by WV is 98.9%, 99.3%, 107.2%, 99.6%, 110.5%, 108.3%, 96.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on HEK293T cells (Control samples) is 101.4%, 80.1%, 31.9%, 1.4%, 1.4%, 1.8% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.	Not found	30897850	Int J Mol Sci. 2019 Mar; 20(6): 1417. Published online 2019 Mar 20. doi: 10.3390/ijms20061417	Changxuan Shao, Weizhong Li, Peng Tan, Anshan Shan, Xiujing Dou, Deying Ma, Chunyu Liu	Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency	
DRAMP21418	WFKAAAKAAAKFW	13	WF (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix predicted by I-TASSER, random coil in PBS, α-helix in SDS	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30897850] Gram-positive bacteria:Staphylococcus aureus ATCC 27853(MIC=8μM), Staphylococcus epidermidis ATCC 12228(MIC=16μM), Staphylococcus faecalis ATCC 29212(MIC=32μM), Bacillus subtilis CMCC 63501(MIC=8μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=4μM), Escherichia coli UB 1005 (MIC=4μM), Pseudomonas aeruginosa ATCC 27853(MIC=16μM), Salmonella typhimurium ATCC 14028(MIC=32μM)	[Ref.30897850] 12% hemolysis at 256μM against human red blood cells	Linear	Free	Amidaton		L	[Ref.30897850] ①The cell viability of RAW 264.7 induced by WF is 102.5%, 103.6%, 105.4%, 108.3%, 105.8%, 101.1% and 92.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on RAW 264.7 cells (Control samples) is 93.1%, 67.8%, 37.7%, 17.8%, 0%, 1.4% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.②The cell viability of HEK293T induced by WV is 101.8%, 101.4%, 93.5%, 97.1%, 93.8%, 107.6% and 92.0% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on HEK293T cells (Control samples) is 101.4%, 80.1%, 31.9%, 1.4%, 1.4%, 1.8% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.	Not found	30897850	Int J Mol Sci. 2019 Mar; 20(6): 1417. Published online 2019 Mar 20. doi: 10.3390/ijms20061417	Changxuan Shao, Weizhong Li, Peng Tan, Anshan Shan, Xiujing Dou, Deying Ma, Chunyu Liu	Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency	
DRAMP21419	WWKAAAKAAAKWW	13	WW (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix predicted by I-TASSER, random coil in PBS, α-helix in SDS	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30897850] Gram-positive bacteria:Staphylococcus aureus ATCC 27853(MIC=4μM), Staphylococcus epidermidis ATCC 12228(MIC=4μM), Staphylococcus faecalis ATCC 29212(MIC=4μM), Bacillus subtilis CMCC 63501(MIC=4μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=2μM), Escherichia coli UB 1005 (MIC=4μM), Pseudomonas aeruginosa ATCC 27853(MIC=8μM), Salmonella typhimurium ATCC 14028(MIC=8μM)	[Ref.30897850] 24% hemolysis at 256μM against human red blood cells	Linear	Free	Amidaton		L	[Ref.30897850] ①The cell viability of RAW 264.7 induced by WW is 104.3%, 103.6%, 109.4%, 103.6%, 97.5%, 89.9%, 63.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on RAW 264.7 cells (Control samples) is 93.1%, 67.8%, 37.7%, 17.8%, 0%, 1.4% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.②The cell viability of HEK293T induced by WV is 102.9%, 111.6%, 105.1%, 104.3%, 101.8%, 84.8%, 43.5% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on HEK293T cells (Control samples) is 101.4%, 80.1%, 31.9%, 1.4%, 1.4%, 1.8% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.	Not found	30897850	Int J Mol Sci. 2019 Mar; 20(6): 1417. Published online 2019 Mar 20. doi: 10.3390/ijms20061417	Changxuan Shao, Weizhong Li, Peng Tan, Anshan Shan, Xiujing Dou, Deying Ma, Chunyu Liu	Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency	
DRAMP21420	FLPKLFAKITKKNMAHIRC	19	AY1C (Derived from AY1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Helix-loop-helix derived from NMR	Not found	5YKL resolved by NMR	Function: Antibacterial activity against Gram-negative bacteria.	[Ref.30872680] Gram-negative bacteria:Pseudomonas aeruginosa (MIC=15μM), Escherichia coli  (MIC=17μM), Salmonella typhi(MIC=15μM), Klebsiella pneumoniae(MIC=12μM)	[Ref.30872680] 4% hemolysis at 10 μM, 9% hemolysis at 50 μM, 8% hemolysis at 100μM against human red blood cells	Linear	Free	Free		L	[Ref.30872680] No cytotoxicity information found.	Not found	30872680	Sci Rep. 2019; 9: 4485. Published online 2019 Mar 14. doi: 10.1038/s41598-019-41005-7	Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS	A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O
DRAMP21421	FLPKLFAKITKKNMAHIRC	19	AY1C-AgNP (Derived from AY1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Helix-loop-helix derived from NMR	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.30872680] Gram-negative bacteria:Pseudomonas aeruginosa (MIC=15μM), Escherichia coli  (MIC=12μM), Salmonella typhi(MIC=15μM), Klebsiella pneumoniae(MIC=10μM)	[Ref.30872680] 4% hemolysis at 10 μM, 6% hemolysis at 50 μM, 9% hemolysis at 100μM against human red blood cells	Linear	Free	Free	Conjugation with silver nanoparticles	L	[Ref.30872680] No cytotoxicity information found.	Not found	30872680	Sci Rep. 2019; 9: 4485. Published online 2019 Mar 14. doi: 10.1038/s41598-019-41005-7	Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS	A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria	
DRAMP21422	CFLPKLFAKITKKNMAHIR	19	CAY1 (Derived from AY1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Helix-loop-helix derived from NMR	Not found	5YKQ resolved by NMR	Function: Antibacterial activity against Gram-negative bacteria.	[Ref.30872680] Gram-negative bacteria:Pseudomonas aeruginosa (MIC=10μM), Escherichia coli  (MIC=10μM), Salmonella typhi(MIC=Not know), Klebsiella pneumoniae(MIC=7μM)	[Ref.30872680] 4% hemolysis at 10 μM, 9% hemolysis at 50 μM, 10% hemolysis at 100μM against human red blood cells	Linear	Free	Free		L	[Ref.30872680] No cytotoxicity information found.	Not found	30872680	Sci Rep. 2019; 9: 4485. Published online 2019 Mar 14. doi: 10.1038/s41598-019-41005-7	Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS	A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CS)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21423	CFLPKLFAKITKKNMAHIR	19	CAY1-AgNP (Derived from AY1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Helix-loop-helix derived from NMR	Not found		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.30872680] Gram-negative bacteria:Pseudomonas aeruginosa (MIC=10μM), Escherichia coli  (MIC=10μM), Salmonella typhi(MIC=15μM), Klebsiella pneumoniae(MIC=5μM)	[Ref.30872680] 3% hemolysis at 10 μM, 9% hemolysis at 50 μM, 9.5% hemolysis at 100μM against human red blood cells	Linear	Free	Free	Conjugation with silver nanoparticles	L	[Ref.30872680] No cytotoxicity information found.	Not found	30872680	Sci Rep. 2019; 9: 4485. Published online 2019 Mar 14. doi: 10.1038/s41598-019-41005-7	Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS	A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria	
DRAMP21424	KKGKGGG	7	B1 (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coils most likely	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=2-4µg/ml), MSSA ATCC 29213(MIC=8-16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=8-16µg/ml)	[Ref.30842436] EC10=64μM, EC50=230μM, 32% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	①Residue 3 is N-butylglycine. ②Residue 5 and residue 7 are  N-1-naphthylmethylglycine. ③Residue 6 is N-4-methylbenzylglycine. 	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21425	KKGKGGG	7	peptide 2 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=4µg/ml), MSSA ATCC 29213(MIC=8-16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)	[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	①Residue 3 is N-butylglycine. ②Residue 5 and residue 7 are N-1-naphthylmethylglycine. ③Residue 6 is N-benzylglycine resembling Phe.	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21426	KKKGGGG	7	peptide 3 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=4µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)	[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	①Residue 4 is N-butylglycine. ②Residue 5 and residue 7 are N-1-naphthylmethylglycine. ③Residue 6 is N-benzylglycine resembling Phe. 	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21427	GGGGKKK	7	peptide 4 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)	[Ref.30842436] EC10=54μM, 24% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	①Residue 1 and residue 3 are  N-1-naphthylmethylglycine.②Residue 2 is N-benzylglycine resembling Phe.③Residue 4 is N-butylglycine. 	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21428	GGGKGKK	7	peptide 5 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)	[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	①Residue 1 and residue 3 are  N-1-naphthylmethylglycine.②Residue 2 is N-benzylglycine resembling Phe.③Residue 5 is N-butylglycine. 	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21429	KKLKAFA	7	peptide 6 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=32µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=8µg/ml)	[Ref.30842436] EC10=5μM, EC50=58μM, 96% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 5 and residue 7 are 1-naphthylmethylglycine	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21430	KKKLAFA	7	peptide 7 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=16µg/ml)	[Ref.30842436] EC10=8μM, EC50=140μM, 55% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 5 and residue 7 are 1-naphthylmethylglycine	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21431	KKLKAFA	7	peptide 8 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)	[Ref.30842436] EC10=56μM, 34% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 5 and residue 7 are 2-naphthylmethylglycine	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21432	KKKLAFA	7	peptide 9 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=16µg/ml)	[Ref.30842436] EC10=46μM, 39% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 5 and residue 7 are 2-naphthylmethylglycine	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21433	AFAKLKK	7	peptide 10 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8-16µg/ml), MSSA ATCC 29213(MIC=16-32µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=64µg/ml)	[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 1 and residue 3 are 1-naphthylmethylglycine	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21434	AFAKLKK	7	peptide 11 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=4-8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=64µg/ml)	[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 1 and residue 3 are 2-naphthylmethylglycine	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21435	AFALKKK	7	peptide 12 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria. Antimicrobial activity against Gram-negative bacteria is uncertain.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=16µg/ml), MSSA ATCC 29213(MIC=32µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC>64µg/ml)	[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 1 and residue 3 are 1-naphthylmethylglycine	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21436	AFALKKK	7	peptide 13 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria. Antimicrobial activity against Gram-negative bacteria is uncertain.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=32µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC>64µg/ml)	[Ref.30842436] EC10=110μM, 15% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 1 and residue 3 are 2-naphthylmethylglycine	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21437	KKlKafa	7	peptide 14 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=4-8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=16-32µg/ml)	[Ref.30842436] EC10=28μM, EC50=128μM, 58% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 5 and residue 7 are 1-naphthylmethylglycine	Mixed (D-Leu3, D-Ala5, D-Phe6 and D-Ala7)	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21438	KKKlafa	7	peptide 15 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=2µg/ml), MSSA ATCC 29213(MIC=8µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=8µg/ml)	[Ref.30842436] EC10=8μM, EC50=40μM, 88% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 5 and residue 7 are 1-naphthylmethylglycine	Mixed (D-Leu4, D-Ala5, D-Phe6 and D-Ala7)	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21439	KKKlafa	7	peptide 16 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=2-4µg/ml), MSSA ATCC 29213(MIC=8-16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)	[Ref.30842436] EC10=18μM, EC50=118μM, 60% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 5 and residue 7 are 2-naphthylmethylglycine	Mixed (D-Leu4, D-Ala5, D-Phe6 and D-Ala7)	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21440	KKlKafa	7	peptide 17 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)	[Ref.30842436] EC10=8μM, 40% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 5 and residue 7 are 2-naphthylmethylglycine	Mixed (D-Leu3, D-Ala5, D-Phe6 and D-Ala7)	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21441	afaKlKK	7	peptide 18 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria. Antimicrobial activity against Gram-negative bacteria is uncertain.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=16µg/ml), MSSA ATCC 29213(MIC=32-64µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC>64µg/ml)	[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 1 and residue 3 are 2-naphthylmethylglycine	Mixed (D-Ala1, D-Phe2, D-Ala3, D-Leu5)	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21442	afalKKK	7	peptide 19 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria. Antimicrobial activity against Gram-negative bacteria is uncertain.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=16µg/ml), MSSA ATCC 29213(MIC=32µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC>64µg/ml)	[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 1 and residue 3 are 2-naphthylmethylglycine	Mixed (D-Ala1, D-Phe2, D-Ala3, D-Leu4)	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21443	afaKlKK	7	peptide 20 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria. Antimicrobial activity against Gram-negative bacteria is uncertain.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=16µg/ml), MSSA ATCC 29213(MIC=32µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC>64µg/ml)	[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 1 and residue 3 are 1-naphthylmethylglycine	Mixed (D-Ala1, D-Phe2, D-Ala3, D-Leu5)	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21444	afalKKK	7	peptide 21 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=16µg/ml), MSSA ATCC 29213(MIC=32µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)	[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 1 and residue 3 are 1-naphthylmethylglycine	Mixed (D-Ala1, D-Phe2, D-Ala3, D-Leu4)	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21445	KKKLAYA	7	peptide 22 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria. Antimicrobial activity against Gram-negative bacteria is uncertain.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=16µg/ml), MSSA ATCC 29213(MIC>64µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC>64µg/ml)	[Ref.30842436] EC10=117μM, 14% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 5 and residue 7 are 2-naphthylmethylglycine	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21446	KKKXAFA	7	peptide 23 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coils most likely	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria	[Ref.30842436] Gram-positive bacteria: MRSP C22963(MIC=2-4 µg/ml), MSSA ATCC 29213(MIC=32-64 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa(MIC= 8 µg/ml)	[Ref.30842436] EC10=14μM, EC50=104μM, 59% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Nle4 is norleucine. Residue 5 and residue 7 are 2-naphthylmethylglycine	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21447	KKKXAFA	7	peptide 24 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria. Antimicrobial activity against Gram-negative bacteria is uncertain.	[Ref.30842436] Gram-positive bacteria: MRSP C22963(MIC=16-32 µg/ml), MSSA ATCC 29213(MIC>64 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa(MIC= 16 µg/ml)	[Ref.30842436] EC10=3μM, EC50=41μM, 60% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Nle4 is norleucine. Residue 5 and residue 7 are 1-naphthylmethylglycine	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21448	KKKlaya	7	peptide 25 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=2-4µg/ml), MSSA ATCC 29213(MIC=32-64µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=8µg/ml)	[Ref.30842436] EC10=38μM, EC50=138μM, 53% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 5 and residue 7 are 1-naphthylmethylglycine	Mixed (D-Leu4, D-Ala5, D-Tyr6, D-Ala7)	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21449	KKKxafa	7	peptide 26 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Random coils most likely	Not found		Function: Antibacterial activity against Gram-positive bacteria. Antimicrobial activity against Gram-negative bacteria is uncertain.	[Ref.30842436] Gram-positive bacteria: MRSP C22963(MIC=4-8 µg/ml), MSSA ATCC 29213(MIC>64 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa(MIC=8 µg/ml)	[Ref.30842436] EC50=63μM, 56% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Nle4 is norleucine. Residue 5 and residue 7 are 1-naphthylmethylglycine	Mixed (D-Nle4, D-Ala5, D-Phe6, D-Ala7)	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21450	KKKxAYA	7	peptide 27 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria: MRSP C22963(MIC=2-4 µg/ml), MSSA ATCC 29213(MIC=64 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa(MIC=64 µg/ml)	[Ref.30842436] EC10=3μM, EC50=56μM, 54% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Nle4 is norleucine. Residue 5 and residue 7 are 2-naphthylmethylglycine.	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21451	KKKlaya	7	peptide 28 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=2-4µg/ml), MSSA ATCC 29213(MIC=32µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)	[Ref.30842436] EC10=6μM, EC50=50μM, 64% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 5 and residue 7 are 2-naphthylmethylglycine	Mixed (D-Leu4, D-Ala5, D-Tyr6, D-Ala7)	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21452	KKKLAFA	7	peptide 29 (Derived from B1)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Unknown	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30842436] Gram-positive bacteria: MRSP C22963(MIC=4-8 µg/ml), MSSA ATCC 29213(MIC=16-32 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa(MIC=32 µg/ml)	[Ref.30842436] EC10=9μM, 46% hemolysis at 150 µM against human red blood cells	Linear	Free	Amidation	Residue 5 and residue 7 are 2-naphthylmethylglycine. Residue 1, residue 2 and residue 3 are N-(4-aminobutyl)glycine	L	[Ref.30842436] No cytotoxicity information found.	Not found	30842436	Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3	Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen	Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections	
DRAMP21453	GLPLLISWIKRKRQQGSKKPVPIIYCNRRTGKCQRM	36	Hybrid (Derived from Melittin and thanatin)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	A combination of α-helix and β-lamellar	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30701481] Gram-positive bacteria:Staphylococcus aureus(MIC=0.9-1.5μmol/L), Bacillus subtilis(MIC=0.6-1.2μmol/L);##Gram-negative bacteria:Escherichia coli JM 109(MIC=0.6-1.2 μmol/L), Salmonella typhimurium(MIC=0.3-0.6μmol/L)	[Ref.30701481] 0% hemolysis at 45 μmol/L and >0% hemolysis at 60 μmol/L against sheep blood cells	Linear	Free	Free		L	[Ref.30701481] The average inhibitory rate of the hybrid peptide in the SMMC-7721 cells was 19.14%.	Not found	30701481	AMB Express. 2019; 9: 14. Published online 2019 Jan 30. doi: 10.1186/s13568-019-0739-z	Xiaofeng Jiang, Kun Qian, Guangping Liu, Laiyu Sun, Guoqing Zhou, Jingfen Li, Xinqiang Fang, Haixia Ge, Zhengbing Lv	Design and activity study of a melittin–thanatin hybrid peptide	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(C)C
DRAMP21454	GILDWGKKVMDWIKDKM	17	PLP1 (Insects, animals)	A0A348G6I7	Belongs to the formicidae venom precursor-01 superfamily.	Not found	Odontomachus monticola (Trap-jaw ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	α-helix predicted by Proteus	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria. Antifungal activity against Saccharomyces cerevisiae.	[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC<3.1μM);##Gram-negative bacteria:Escherichia coli (MIC<3.1μM);##Fungi:Saccharomyces cerevisiae (MIC<50μM)	[Ref.30658410] 0% hemolysis at 50 μM against rat blood cells	Linear	Free	Amidation		L	[Ref.30658410] No cytotoxicity information found.	Not found	30658410	Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050	Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki	Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(N)=O)[C@H](C)CC)C(C)C
DRAMP21455	GWGSIFKTVGKMIAKAAVKAAPEAISAMASQNE	33	PLP2 (Insects, animals)	A0A348G5V8	Belongs to the formicidae venom precursor-01 superfamily.	Not found	Odontomachus monticola (Trap-jaw ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	α-helix predicted by Proteus	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria. Antifungal activity against Saccharomyces cerevisiae.	[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC<6.2μM);##Gram-negative bacteria:Escherichia coli (MIC<6.2μM);##Fungi:Saccharomyces cerevisiae (MIC<50μM)	[Ref.30658410] 10.4% hemolysis at 50 μM against rat blood cells	Linear	Free	Free		L	[Ref.30658410] No cytotoxicity information found.	Not found	30658410	Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050	Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki	Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP21456	KIKWGKIFKKGGKLIGKTALEAAANAAASEAISAMASQNE	40	PLP3 (Insects, animals)	A0A348G5V9	Belongs to the formicidae venom precursor-01 superfamily.	Not found	Odontomachus monticola (Trap-jaw ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	α-helix predicted by Proteus	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria. Antifungal activity against Saccharomyces cerevisiae.	[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC<25μM);##Gram-negative bacteria:Escherichia coli (MIC<3.1μM);##Fungi:Saccharomyces cerevisiae (MIC<50μM)	[Ref.30658410] 0% hemolysis at 50 μM against rat blood cells	Linear	Free	Free		L	[Ref.30658410] No cytotoxicity information found.	Not found	30658410	Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050	Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki	Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)[C@@H](C)O
DRAMP21457	GVKELFGKAWGLVKKHLPKACGLLGYVKQ	29	PLP4 (Insects, animals)	A0A348G5W0	Belongs to the formicidae venom precursor-01 superfamily.	Not found	Odontomachus monticola (Trap-jaw ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	α-helix predicted by Proteus	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria. Antifungal activity against Saccharomyces cerevisiae.	[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC<3.1μM);##Gram-negative bacteria:Escherichia coli (MIC<3.1μM);##Fungi:Saccharomyces cerevisiae (MIC<3.1μM)	[Ref.30658410] 10.5% hemolysis at 50 μM against rat blood cells	Cyclic	Free	Free	Cys21 is S-(carbamoylmethyl)-L-cysteine and there is a interchain disulfide bond between two PLP4 peptide molecules.	L	[Ref.30658410] No cytotoxicity information found.	Not found	30658410	Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050	Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki	Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components	
DRAMP21458	IWGALLGTLIPAITSAIQ	18	PLP5 (Insects, animals)	A0A348G5W1	Belongs to the formicidae venom precursor-01 superfamily.	Not found	Odontomachus monticola (Trap-jaw ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	α-helix predicted by Proteus	Not found		Function: Antibacterial activity against Gram-nagetive bacteria. 	[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC Negative);##Gram-negative bacteria:Escherichia coli (MIC<50μM);##Fungi:Saccharomyces cerevisiae (MIC Negative)	[Ref.30658410] 6.9% hemolysis at 10μM and 94.8% at 50 μM against rat blood cells	Linear	Free	Amidation		L	[Ref.30658410] No cytotoxicity information found.	Not found	30658410	Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050	Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki	Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(N)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP21459	IKGKKIMKNMGKAMKIAGKVAKAMAPIVVPLIVSAA	36	PLP6 (Insects, animals)	A0A348G5W2	Belongs to the formicidae venom precursor-01 superfamily.	Not found	Odontomachus monticola (Trap-jaw ant)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Protein level	α-helix predicted by Proteus	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC<3.1μM);##Gram-negative bacteria:Escherichia coli (MIC<3.1μM);##Fungi:Saccharomyces cerevisiae (MIC Negative)	[Ref.30658410] 0% hemolysis at 50 μM against rat blood cells	Linear	Free	Amidation		L	[Ref.30658410] No cytotoxicity information found.	Not found	30658410	Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050	Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki	Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O)C(C)C)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP21460	IHKFWRCRRRFCRWFKHI	18	PQ (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix predicted by I-Tasser	In PBS, the α-helix content of PQ is 26.91% and the β-strand content of that is 11.16%. In SDS, the α-helix content of PQ is 32.02% and the β-strand of that is 6.15%. In TFE, the α-helix content of PQ is 36.82% and the β-strand of that is 4.28%.		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=8μM), Staphylococcus aureus ATCC 43300(MIC=8μM), Staphylococcus epidermidis ATCC 12228(MIC=8μM), Streptococci faecalis ATCC 29212(MIC=16μM), Bacillus subtilis CMCC 63501(MIC=16μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=16μM), Escherichia coli UB 1005(MIC=8μM), bacteria pyocyaneum ATCC 27853(MIC=8μM), Salmonella typhimurium ATCC 7731(MIC=8μM), Salmonella Pulloru C79-13(MIC=8μM)	[Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis.	Linear	Free	Amidation		L	[Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by PQ is 68.2%, 68.6%, 66.8%,63.6%, 69.1%, 62.2%, 55.8% and 28.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	30538681	Front Microbiol. 2018; 9: 2832. Published online 2018 Nov 27. doi: 10.3389/fmicb.2018.02832	Na Dong, Shuli Chou, Jiawei Li, Chenyu Xue, Xinran Li, Baojing Cheng, Anshan Shan, and Li Xu	Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(N)=O)[C@H](C)CC
DRAMP21461	IHKFWRPGRWFKHI	14	PP (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	A combination of α-helical and β-hairpin	In PBS, the α-helix content of PQ is 12.35% and the β-strand content of that is 16.30%. In SDS, the α-helix content of PQ is 9.86% and the β-strand of that is 11.56%. In TFE, the α-helix content of PQ is 37.54% and the β-strand of that is 2.54%.		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=16μM), Staphylococcus aureus ATCC 43300(MIC=16μM), Staphylococcus epidermidis ATCC 12228(MIC=16μM), Streptococci faecalis ATCC 29212(MIC=8μM), Bacillus subtilis CMCC 63501(MIC=8μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8μM), Escherichia coli UB 1005(MIC=4μM), bacteria pyocyaneum ATCC 27853(MIC=4μM), Salmonella typhimurium ATCC 7731(MIC=8μM), Salmonella Pulloru C79-13(MIC=4μM)	[Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis.	Linear	Free	Amidation		L	[Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by PP is 67.7%, 69.1%, 70.5%, 65.4%, 61.3%, 65.0%, 70.5% and 68.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	30538681	Front Microbiol. 2018; 9: 2832. Published online 2018 Nov 27. doi: 10.3389/fmicb.2018.02832	Na Dong, Shuli Chou, Jiawei Li, Chenyu Xue, Xinran Li, Baojing Cheng, Anshan Shan, and Li Xu	Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(N)=O)[C@H](C)CC
DRAMP21462	IHKFWRGGRWFKHI	14	GG (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	A combination of α-helical and β-hairpin	In PBS, the α-helix content of PQ is 1.49% and the β-strand content of that is 32.19%. In SDS, the α-helix content of PQ is 11.99% and the β-strand of that is 9.42%. In TFE, the α-helix content of PQ is 18.98% and the β-strand of that is 11.53%.		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=16μM), Staphylococcus aureus ATCC 43300(MIC=32μM), Staphylococcus epidermidis ATCC 12228(MIC=32μM), Streptococci faecalis ATCC 29212(MIC=32μM), Bacillus subtilis CMCC 63501(MIC=16μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8μM), Escherichia coli UB 1005(MIC=8μM), bacteria pyocyaneum ATCC 27853(MIC=16μM), Salmonella typhimurium ATCC 7731(MIC=64μM), Salmonella Pulloru C79-13(MIC=8μM)	[Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis.	Linear	Free	Amidation		L	[Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by GG is 67.7%, 74.2%, 76.5%, 72.4%, 72.8%, 69.1%, 65.9% and 59.9% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	30538681	Front Microbiol. 2018; 9: 2832. Published online 2018 Nov 27. doi: 10.3389/fmicb.2018.02832	Na Dong, Shuli Chou, Jiawei Li, Chenyu Xue, Xinran Li, Baojing Cheng, Anshan Shan, and Li Xu	Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(N)=O)[C@H](C)CC
DRAMP21463	IHKFWRRWFKHI	12	Qa (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix predicted by I-Tasser	In PBS, the α-helix content of PQ is 2.89% and the β-strand content of that is 19.89%. In SDS, the α-helix content of PQ is 5.54% and the β-strand of that is 14.12%. In TFE, the α-helix content of PQ is 3.08% and the β-strand of that is 18.1%.		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=8μM), Staphylococcus aureus ATCC 43300(MIC=16μM), Staphylococcus epidermidis ATCC 12228(MIC=16μM), Streptococci faecalis ATCC 29212(MIC=16μM), Bacillus subtilis CMCC 63501(MIC=32μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=16μM), Escherichia coli UB 1005(MIC=8μM), bacteria pyocyaneum ATCC 27853(MIC=16μM), Salmonella typhimurium ATCC 7731(MIC=16μM), Salmonella Pulloru C79-13(MIC=16μM)	[Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis.	Linear	Free	Amidation		L	[Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by Qa is 61.3%, 66.8%, 76.5%, 71.4%, 72.4%, 73.3%, 65.9% and 39.6% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	30538681	Front Microbiol. 2018; 9: 2832. Published online 2018 Nov 27. doi: 10.3389/fmicb.2018.02832	Na Dong, Shuli Chou, Jiawei Li, Chenyu Xue, Xinran Li, Baojing Cheng, Anshan Shan, and Li Xu	Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(N)=O)[C@H](C)CC
DRAMP21464	IHFKWRRWKFHI	12	Qna (De Novo Synthesis)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Linear and unordered conformation	In PBS, the α-helix content of PQ is 3.46% and the β-strand content of that is 17.46%. In SDS, the α-helix content of PQ is 1.29% and the β-strand of that is 21.49%. In TFE, the α-helix content of PQ is 0.73% and the β-strand of that is 18.82%.		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=32μM), Staphylococcus aureus ATCC 43300(MIC=32μM), Staphylococcus epidermidis ATCC 12228(MIC=32μM), Streptococci faecalis ATCC 29212(MIC=64μM), Bacillus subtilis CMCC 63501(MIC=64μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=32μM), Escherichia coli UB 1005(MIC=16μM), bacteria pyocyaneum ATCC 27853(MIC=32μM), Salmonella typhimurium ATCC 7731(MIC=32μM), Salmonella Pulloru C79-13(MIC=32μM)	[Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis.	Linear	Free	Amidation		L	[Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by Qna is 67.3%, 65.0%, 73.7%, 77.9%, 68.2%, 68.2%, 62.2% and 51.2% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM.	Not found	30538681	Front Microbiol. 2018; 9: 2832. Published online 2018 Nov 27. doi: 10.3389/fmicb.2018.02832	Na Dong, Shuli Chou, Jiawei Li, Chenyu Xue, Xinran Li, Baojing Cheng, Anshan Shan, and Li Xu	Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(N)=O)[C@H](C)CC
DRAMP21465	DEMKLDGFNMHLE	13	P1-Ll-1577 (De Novo Synthesis)	No entry found	Not found	Not found	 Leptodactylus latrans (Anura: Leptodactylidae)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil predicted by PSIPRED and GOR V	P1-Ll-1577, although presenting contributions of turn structure, is less ordered in the presence of TFE (percentage of an unordered structure higher than 40%).		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30423858] Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=40.5μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=20μM)	[Ref.30423858] 100% hemolysis MHC=640μM against human blood cells	Linear	Free	Amidation		L	[Ref.30423858] No cytotoxicity information found.	Not found	30423858	Molecules. 2018 Nov; 23(11): 2943. Published online 2018 Nov 11. doi: 10.3390/molecules23112943	Alvaro Siano, Maria Veronica Humpola, Eliandre de Oliveira, Fernando Albericio, Arturo C Simonetta, Rafael Lajmanovich, Georgina G Tonarelli	Leptodactylus latrans Amphibian Skin Secretions as a Novel Source for the Isolation of Antibacterial Peptides	CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP21466	AAGKGLVSNLLEK	13	P2-Ll-1298 (De Novo Synthesis)	No entry found	Not found	Not found	 Leptodactylus latrans (Anura: Leptodactylidae)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Helix(K4-E12) predicted by PSIPRED and helix(L6-L10) predicted by GOR V	P2-Ll-1298 showed contributions of α-helix.		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30423858] Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=49μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=24.6μM)	[Ref.30423858] 100% hemolysis MHC=320μM against human blood cells	Linear	Free	Amidation		L	[Ref.30423858] No cytotoxicity information found.	Not found	30423858	Molecules. 2018 Nov; 23(11): 2943. Published online 2018 Nov 11. doi: 10.3390/molecules23112943	Alvaro Siano, Maria Veronica Humpola, Eliandre de Oliveira, Fernando Albericio, Arturo C Simonetta, Rafael Lajmanovich, Georgina G Tonarelli	Leptodactylus latrans Amphibian Skin Secretions as a Novel Source for the Isolation of Antibacterial Peptides	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP21467	GLLDFLKAAGKGLVSNLLEK	20	P3-Ll-2085 (De Novo Synthesis)	No entry found	Not found	Not found	 Leptodactylus latrans (Anura: Leptodactylidae)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Helix(L2-E19) predicted by PSIPRED and Helix(L3-A9, L13-L17) predicted by GOR V	Deconvolution spectra by SELCON and CONTILL method indicated more than 70% helical structure for P3-Ll-2085		Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.	[Ref.30423858] Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=15μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=15μM)	[Ref.30423858] 100% hemolysis MHC=40μM against human blood cells	Linear	Free	Amidation		L	[Ref.30423858] No cytotoxicity information found.	Not found	30423858	Molecules. 2018 Nov; 23(11): 2943. Published online 2018 Nov 11. doi: 10.3390/molecules23112943	Alvaro Siano, Maria Veronica Humpola, Eliandre de Oliveira, Fernando Albericio, Arturo C Simonetta, Rafael Lajmanovich, Georgina G Tonarelli	Leptodactylus latrans Amphibian Skin Secretions as a Novel Source for the Isolation of Antibacterial Peptides	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP21310	RRLRKKTRKRLK	12	RK12 (Derived from PMAP-36)	No entry found	Not found	Not found	synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	No α-helix content in 50%TFE	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC>128 μM), Staphylococcus aureus 25923 (MIC>128 μM), Staphylococcus  epidermidis 12228 (MIC>128 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC>128 μM), Escherichia coli 1005 (MIC=64 μM), Staphylococcus typhi (MIC>128 μM)	[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).	Linear	Free	Amidation		L	[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RK12 is 91.7%, 96.2%, 95.2%, 95.3%, 96.2%, 94.7%, 98.8% and 99.3% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM	Not found	31276398	J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00288.	Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.	Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21577	WWVAARAARR	10	LP1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antifungal	Synthetic form	①Random-coil conformation. ②1.9% α-helix and 22.1% β-strand in 20 mM potassium phosphate buffer; 0.6% α-helix and 37.2% β-strand in 20 mM potassium ph	LP1 appears to adopt a random-coli conformation. 		Function: Potential antifungal activity against Candida albicans.	[Ref.28073163] Gram-positive bacteria: Bacillus megaterium ATCC 14581 (IC50 = 237 μM, MIC > 20 μM), Staphylococcus aureus ATCC 6538 (IC50 = 188 μM, MIC > 20 μM), Enterococcus faecalis ATCC 29212 (IC50 = 134 μM, MIC > 20 μM);##Gram-negative bacteria: Escherichia coli ATCC 700926 (IC50 = 805 μM, MIC > 20 μM);## Fungi: Candida albicans 002 ATCC 64385 (IC50 = 20 μM, MIC > 20 μM), C. albicans 004 ATCC MYA-2876 (IC50 = 20 μM, MIC > 20 μM).	[Ref.28073163] HC50 = 1810 μM against human red blood cells. Note:  HC50 is the half-maximal hemolytic concentration.	Linear 	Free	Amidation		L	No cytotoxicity information found in the reference	Not found	28073163	Biopolymers. 2017 May;108(3). doi: 10.1002/bip.23006.	Zachary B Jenner, Christopher M Crittenden, Martín Gonzalez, Jennifer S Brodbelt, Kerry A Bruns	Hydrocarbon-stapled lipopeptides exhibit selective antimicrobial activity	CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP21481	KKKKKKAAFAAWAAFAA	17	6K-F17	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	①Random coils in aqueous buffer. ②α-helix in SDS detergent micelles.	As previously reported, 6K-F17 adopts a random coil structure in aqueous buffer and an α helix in the presence of SDS detergent micelles.		Function: Antibacterial activity against Gram-negative bacteria. No experiments about antibacterial activity against Gram-positive bacteria are recorded.	[Ref.29275987] Gram-negative bacteria: E. coli (MIC= 1.6 μM)	[Ref.29275987] MHC = 320 μM against human red blood cells. Note: Minimum hemolytic concentration (MHC) is the minimum peptide concentration at which red blood cells undergo > 2% hemolysis.	Linear 	Free	Amidation		L	No cytotoxicity information found in the reference	Not found	29275987	Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020. Epub 2017 Oct 21.	Tracy A Stone, Gregory B Cole, Huong Q Nguyen, Simon Sharpe, Charles M Deber	Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP21494	GFLSILKKVLPKVJAHJK	18	MEP-N	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	①12% α-helical content in water.②43% α-helical content in 50% TFE. ③48% α-helical content in 8mM SDS.	No other descriptive information about the structure found in the literature		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria and Antifungal activity against Candida albicans.	[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 1 μM), Bacillus subtilis (MIC = 0.5 μM), Staphylococcus aureus (MIC = 2.5 μM);##Gram-negative bacteria: E.coli (MIC = 0.9 μM), Pseudomonas aeruginosa (MIC = 17.3 μM);##Fungi: Candida albicans (MIC = 15 μM).	[Ref.22526241] LC50 = 50 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.	Linear 	Free	Amidation	The J (position: 14 and 17) in sequence are norleucine. 	L	No cytotoxicity information found in the reference	Not found	22526241	Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 27.	Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský	Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera	
DRAMP21579	WWVXARAXRR	10	Val-nHSLP	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	0.7% α-helix and 33.4% β-strand in 20 mM potassium phosphate buffer; 0.8% α-helix and 35.8% β-strand in 20 mM potassium phosphate buffer made 30% in T	Overall, the peptides showed some β-strand secondary structural characteristics and little α-helical content.		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 20 μM.	[Ref.28073163] Gram-positive bacteria: Bacillus megaterium ATCC 14581 (IC50 = 2.25 μM, MIC = 5.00 μM), Staphylococcus aureus ATCC 6538 (IC50 = 0.63 μM, MIC = 10.0 μM), Enterococcus faecalis ATCC 29212 (IC50 = 0.66 μM, MIC = 5.00 μM);##Gram-negative bacteria: Escherichia coli ATCC 700926 (IC50 = 38.3 μM, MIC > 20 μM);## Fungi: Candida albicans 002 ATCC 64385 (IC50 > 20 μM, MIC > 20 μM), C. albicans 004 ATCC MYA-2876 (IC50 > 20 μM, MIC > 20 μM).	[Ref.28073163] HC50 = 13.4 μM against human red blood cells. Note:  HC50 is the half-maximal hemolytic concentration.	Linear 	Acylation (Valerylamide)	Amidation	①The X (position: 4 and 8) in sequence are (S)-2-(4'-pentenyl)-alanine. ②X (4) and X (8) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.	L	No cytotoxicity information found in the reference	Not found	28073163	Biopolymers. 2017 May;108(3). doi: 10.1002/bip.23006.	Zachary B Jenner, Christopher M Crittenden, Martín Gonzalez, Jennifer S Brodbelt, Kerry A Bruns	Hydrocarbon-stapled lipopeptides exhibit selective antimicrobial activity	
DRAMP21581	WWVXAFAXRRR	11	Cap-nHSLP	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	0.5% α-helix and 30.5% β-strand in 20 mM potassium phosphate buffer; 1.9% α-helix and 37.2% β-strand in 20 mM potassium phosphate buffer made 30% in T	Overall, the peptides showed some β-strand secondary structural characteristics and little α-helical content.		Function: Antibacterial activity against Gram-positive bacteria. Antibacterial activity against Gram-negative bacteria and antifungal activity against Candida albicans are not noteable under 20 μM.	[Ref.28073163] Gram-positive bacteria: Bacillus megaterium ATCC 14581 (IC50 = 2.03 μM, MIC = 10.0 μM), Staphylococcus aureus ATCC 6538 (IC50 = 0.63 μM, MIC = 5.00 μM), Enterococcus faecalis ATCC 29212 (IC50 = 0.64 μM, MIC = 5.00 μM);##Gram-negative bacteria: Escherichia coli ATCC 700926 (IC50 = 1.34 μM, MIC > 20 μM);## Fungi: Candida albicans 002 ATCC 64385 (IC50 > 20 μM, MIC > 20 μM), C. albicans 004 ATCC MYA-2876 (IC50 > 20 μM, MIC > 20 μM).	[Ref.28073163] HC50 = 3.59 μM against human red blood cells. Note:  HC50 is the half-maximal hemolytic concentration.	Linear 	Acylation (caproylamide)	Amidation	①The X (position: 4 and 8) in sequence are (S)-2-(4'-pentenyl)-alanine. ②X (4) and X (8) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.	L	No cytotoxicity information found in the reference	Not found	28073163	Biopolymers. 2017 May;108(3). doi: 10.1002/bip.23006.	Zachary B Jenner, Christopher M Crittenden, Martín Gonzalez, Jennifer S Brodbelt, Kerry A Bruns	Hydrocarbon-stapled lipopeptides exhibit selective antimicrobial activity	
DRAMP21596	KAAKAAKKAAKAAWK	15	Ac-UM-14W	No entry found	Not found	Not found	Synthetic construct	Non-antimicrobial	Synthetic form	Less α-helix content found in a 25mM potassium phosphate buffer solution at 20℃	Helix formation of unmodified analog Ac-UM-14W would be unfavorable due to the potential electrostatic repulsion among cationic side-chains of lysine residues in its helical conformation.		Function: Non-antibacterial activity against Gram-positive or Gram-negative bacteria. Antibacterial activity is not noteable under 200 μM.	[Ref.26235946] Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC > 200 μM), Staphylococcus aureus ATCC 6538p (MIC > 200 μM), Staphylococcus epidermis ATCC 12228 (MIC > 200 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC > 200 μM), Shigella dysentariae ATCC 9752 (MIC > 200 μM), Salmonella typhimurium ATCC 14028 (MIC > 200 μM), Klebsiella pneumonia ATCC 10031 (MIC > 200 μM), Pseudomonas aeruginosa ATCC 27853 (MIC > 200 μM).	[Ref.26235946] <1% hemolysis against human red blood cells at 12.5 μM and <1% hemolysis at 25 μM.	Linear 	Acetylation	Amidation		L	No cytotoxicity information found in the reference	Not found	26235946	Bioorg Med Chem Lett. 2015 Sep 15;25(18):4016-9. doi: 10.1016/j.bmcl.2015.06.053. Epub 2015 Jun 19.	Thuy T T Dinh, Do-Hee Kim, Huy X Luong, Bong-Jin Lee, Young-Woo Kim	Antimicrobial activity of doubly-stapled alanine/lysine-based peptides	CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP21604	KXWKAXK	7	U1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix in 25 mM potassium phosphate buffer solution (pH 6.5)	As expected, in the far ultraviolet circular dichroism (CD) experiment, the stapled heptapeptides displayed enhanced helical contents compared to their corresponding unstapled counterparts.		Function: Antibacterial activity against Gram-negative bacteria. Antibacterial activity against Gram-positive bacteria is not noteable under 100 μM.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC > 100 μM), Staphylococcus aureus ATCC 6538p (MIC > 100 μM), Staphylococcus epidermis ATCC 12228 (MIC > 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 100 μM), Shigella dysentariae ATCC 9752 (MIC > 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC > 100 μM), Pseudomonas aeruginosa ATCC 27853 (MIC > 100 μM).	0.91%, 0.76%, 0.70%, 0.91%, 0.88%, 0.90%, 0.75% and 0.99% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.	Linear	Acetylation	Amidation	①The X (position: 2 and 6) in sequence are (S)-α-methyl, α-pentenylglycine. Note: the Experimental section presenst that X is (S)-α-methyl, α-pentenylglycine, while the Results section presents that X is pentenylalanine. We incline to the former representation according to previous papers published by the research group which the author belonged. 	L	No cytotoxicity information found.	Not found	Not found	B KOREAN CHEM SOC	Thuy T.T. Dinh, Do-Hee Kim, Song-Jin Lee, Young-Woo Kim	De Novo Design and Their Antimicrobial Activity of Stapled Amphipathic Helices of Heptapeptides	
DRAMP21606	KXAKWXK	7	U2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-helix in 25 mM potassium phosphate buffer solution (pH 6.5)	As expected, in the far ultraviolet circular dichroism (CD) experiment, the stapled heptapeptides displayed enhanced helical contents compared to their corresponding unstapled counterparts.		Function: Antibacterial activity against Gram-negative bacteria. Antibacterial activity against Gram-positive bacteria is not noteable under 100 μM.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC > 100 μM), Staphylococcus aureus ATCC 6538p (MIC > 100 μM), Staphylococcus epidermis ATCC 12228 (MIC > 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC > 100 μM), Shigella dysentariae ATCC 9752 (MIC > 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 100 μM), Pseudomonas aeruginosa ATCC 27853 (MIC > 100 μM).	0.76%, 0.86%, 0.84%, 1.05%, 0.97%, 0.93%, 0.96% and 0.88% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.	Linear	Acetylation	Amidation	①The X (position: 2 and 6) in sequence are (S)-α-methyl, α-pentenylglycine. Note: the Experimental section presenst that X is (S)-α-methyl, α-pentenylglycine, while the Results section presents that X is pentenylalanine. We incline to the former representation according to previous papers published by the research group which the author belonged. 	L	No cytotoxicity information found.	Not found	Not found	B KOREAN CHEM SOC	Thuy T.T. Dinh, Do-Hee Kim, Song-Jin Lee, Young-Woo Kim	De Novo Design and Their Antimicrobial Activity of Stapled Amphipathic Helices of Heptapeptides	
DRAMP21608	KXWKLXK	7	U3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 25 mM potassium phosphate buffer solution (pH 6.5)	As expected, in the far ultraviolet circular dichroism (CD) experiment, the stapled heptapeptides displayed enhanced helical contents compared to their corresponding unstapled counterparts.		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 25 μM), Staphylococcus aureus ATCC 6538p (MIC = 25 μM), Staphylococcus epidermis ATCC 12228 (MIC = 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysentariae ATCC 9752 (MIC = 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 50 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 100 μM).	0.88%, 0.72%, 0.90%, 1.25%, 0.75%, 0.98%, 1.03% and 1.12% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.	Linear	Acetylation	Amidation	①The X (position: 2 and 6) in sequence are (S)-α-methyl, α-pentenylglycine. Note: the Experimental section presenst that X is (S)-α-methyl, α-pentenylglycine, while the Results section presents that X is pentenylalanine. We incline to the former representation according to previous papers published by the research group which the author belonged. 	L	No cytotoxicity information found.	Not found	Not found	B KOREAN CHEM SOC	Thuy T.T. Dinh, Do-Hee Kim, Song-Jin Lee, Young-Woo Kim	De Novo Design and Their Antimicrobial Activity of Stapled Amphipathic Helices of Heptapeptides	
DRAMP21610	KXLKWXK	7	U4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 25 mM potassium phosphate buffer solution (pH 6.5)	As expected, in the far ultraviolet circular dichroism (CD) experiment, the stapled heptapeptides displayed enhanced helical contents compared to their corresponding unstapled counterparts.		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC = 25 μM), Staphylococcus aureus ATCC 6538p (MIC = 25 μM), Staphylococcus epidermis ATCC 12228 (MIC = 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC = 25 μM), Shigella dysentariae ATCC 9752 (MIC > 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC = 50 μM), Pseudomonas aeruginosa ATCC 27853 (MIC = 100 μM).	0.80%, 1.98%, 1.28%, 0.81%, 0.97%, 1.19%, 1.19% and 1.22% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.	Linear	Acetylation	Amidation	①The X (position: 2 and 6) in sequence are (S)-α-methyl, α-pentenylglycine. Note: the Experimental section presenst that X is (S)-α-methyl, α-pentenylglycine, while the Results section presents that X is pentenylalanine. We incline to the former representation according to previous papers published by the research group which the author belonged. 	L	No cytotoxicity information found.	Not found	Not found	B KOREAN CHEM SOC	Thuy T.T. Dinh, Do-Hee Kim, Song-Jin Lee, Young-Woo Kim	De Novo Design and Their Antimicrobial Activity of Stapled Amphipathic Helices of Heptapeptides	
DRAMP21612	KXWAKXA	7	U5	No entry found	Not found	Not found	Synthetic construct	Non-antimicrobial	Synthetic form	α-helix in 25 mM potassium phosphate buffer solution (pH 6.5)	As expected, in the far ultraviolet circular dichroism (CD) experiment, the stapled heptapeptides displayed enhanced helical contents compared to their corresponding unstapled counterparts.		Function: Non-antibacterial activity against Gram-positive or Gram-negative bacteria. Antibacterial activity is not noteable under 100 μM. 	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC > 100 μM), Staphylococcus aureus ATCC 6538p (MIC > 100 μM), Staphylococcus epidermis ATCC 12228 (MIC > 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC > 100 μM), Shigella dysentariae ATCC 9752 (MIC > 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC > 100 μM), Pseudomonas aeruginosa ATCC 27853 (MIC > 100 μM).	0.86%, 0.78%, 0.75%, 0.82%, 0.94%, 0.87%, 1.03% and 1.10% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.	Linear	Acetylation	Amidation	①The X (position: 2 and 6) in sequence are (S)-α-methyl, α-pentenylglycine. Note: the Experimental section presenst that X is (S)-α-methyl, α-pentenylglycine, while the Results section presents that X is pentenylalanine. We incline to the former representation according to previous papers published by the research group which the author belonged. 	L	No cytotoxicity information found.	Not found	Not found	B KOREAN CHEM SOC	Thuy T.T. Dinh, Do-Hee Kim, Song-Jin Lee, Young-Woo Kim	De Novo Design and Their Antimicrobial Activity of Stapled Amphipathic Helices of Heptapeptides	
DRAMP21614	KXAWKXA	7	U6	No entry found	Not found	Not found	Synthetic construct	Non-antimicrobial	Synthetic form	α-helix in 25 mM potassium phosphate buffer solution (pH 6.5)	As expected, in the far ultraviolet circular dichroism (CD) experiment, the stapled heptapeptides displayed enhanced helical contents compared to their corresponding unstapled counterparts.		Function: Non-antibacterial activity against Gram-positive or Gram-negative bacteria. Antibacterial activity is not noteable under 100 μM. 	Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC > 100 μM), Staphylococcus aureus ATCC 6538p (MIC > 100 μM), Staphylococcus epidermis ATCC 12228 (MIC > 100 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC > 100 μM), Shigella dysentariae ATCC 9752 (MIC > 100 μM), Salmonella typhimurium ATCC 14028 (MIC > 100 μM), Klebsiella pneumonia ATCC 10031 (MIC > 100 μM), Pseudomonas aeruginosa ATCC 27853 (MIC > 100 μM).	0.60%, 0.67%, 0.73%, 0.70%, 0.72%, 1.01%, 0.91% and 1.23% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 μM.	Linear	Acetylation	Amidation	①The X (position: 2 and 6) in sequence are (S)-α-methyl, α-pentenylglycine. Note: the Experimental section presenst that X is (S)-α-methyl, α-pentenylglycine, while the Results section presents that X is pentenylalanine. We incline to the former representation according to previous papers published by the research group which the author belonged. 	L	No cytotoxicity information found.	Not found	Not found	B KOREAN CHEM SOC	Thuy T.T. Dinh, Do-Hee Kim, Song-Jin Lee, Young-Woo Kim	De Novo Design and Their Antimicrobial Activity of Stapled Amphipathic Helices of Heptapeptides	
DRAMP21616	qqrkrkiwsilaplgttlvklvagig	26	DRIM	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	①Disordered conformation in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②50	Our CD data show that all four linear peptides were generally disordered in aqueous solution, as expected, but prominent effects were seen regarding the impact of the staple.		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC = 32 μg/mL), Enterococcus faecalis (MIC = 32 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 32 μg/mL), Pseudomonas aeruginosa (MIC = 64 μg/mL)	[Ref.28921993] 60.5%, 98.0%, 95.1%, 99.0%, 97.9%, 96.3%, 98.8% and 98.2% hemolysis against human red blood cells at 5, 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.	Linear	Free	Amidation		D	[Ref.28921993] The toxicity of DRIM toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.	Not found	28921993	J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.	Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich	Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.	CC[C@H](C)[C@@H](NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CC(C)C)NC(=O)[C@H]1CCCN1C(=O)[C@@H](C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CCC(N)=O)[C@@H](C)CC)[C@@H](C)CC)[C@H](C)O)[C@H](C)O)C(C)C)C(C)C)C(=O)NCC(N)=O
DRAMP21618	PLILLRLLRGQF	12	WWSP	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	①Disordered conformation in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②Mi	Our CD data show that all four linear peptides were generally disordered in aqueous solution, as expected, but prominent effects were seen regarding the impact of the staple.		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC = 16 μg/mL), Enterococcus faecalis (MIC = 64 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 256 μg/mL), Pseudomonas aeruginosa (MIC > 256 μg/mL)	[Ref.28921993] 3.9%, 2.6%, 3.6%, 4.3%, 4.0%, 4.6%, 3.3% and 2.9% hemolysis against human red blood cells at 5, 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.	Linear	Free	Amidation		L	[Ref.28921993] The toxicity of WWSP toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.	Not found	28921993	J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.	Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich	Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP21620	AAVLLPVLLAAP	12	KFGF	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	①Disordered conformation in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②31	Our CD data show that all four linear peptides were generally disordered in aqueous solution, as expected, but prominent effects were seen regarding the impact of the staple.		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC > 256 μg/mL), Enterococcus faecalis (MIC > 256 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC > 256 μg/mL), Pseudomonas aeruginosa (MIC > 256 μg/mL)	[Ref.28921993] 0.4%, 0.2%, 0.3%, 0.2%, 1.5%, 0.2% and 0.1% hemolysis against human red blood cells at 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.	Linear	Free	Amidation		L	[Ref.28921993] The toxicity of KFGF toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.	Not found	28921993	J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.	Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich	Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(N)=O
DRAMP21622	KLALKALKALKAALKLA	17	MAP-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	①Disordered conformation in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②Ty	Our CD data show that all four linear peptides were generally disordered in aqueous solution, as expected, but prominent effects were seen regarding the impact of the staple.		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC = 16 μg/mL), Enterococcus faecalis (MIC = 256 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 16 μg/mL), Pseudomonas aeruginosa (MIC = 256 μg/mL)	[Ref.28921993] 1.6%, 0.8%, 0.6%, 0.4%, 0.7%, 1.8%, 0.4% and 0.1% hemolysis against human red blood cells at 5, 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.	Linear	Free	Amidation		L	[Ref.28921993] The toxicity of MAP-1 toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.	Not found	28921993	J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.	Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich	Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O
DRAMP21626	GILDTLKQFAKGVGKWLVKGAAQ	23	E2EM23W	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Typical random coil conformation with only 14% helical content in a 25 mM potassium phosphate buffer solution at 20 ℃.	E2EM23W showed circular dichroism spectra that are typical for a random coil, and its helical content was only 14%.		Function: Antibacterial activity against Gram-positive bacteria. Antibacterial activity against Gram-negative bacteria is not noteable under 200 μg/mL.	[Ref.24211019] Gram-positive bacteria: Bacillus subtilis (MIC = 50 μg/mL), Staphylococcus aureus (MIC = 100 μg/mL), Staphylococcus epidermis (MIC > 200 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC > 200 μg/mL), Shigella dysentariae (MIC > 200 μg/mL), Salmonella typhimurium (MIC > 200 μg/mL), Klebsiella pneumonia (MIC > 200 μg/mL), Proteus mirabilis (MIC > 200 μg/mL), Pseudomonas aeuginose (MIC > 200 μg/mL).	[Ref.24211019] No hemolytic activity information found.	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference	Not found	24211019	Bioorg Med Chem Lett. 2013 Dec 15;23(24):6717-20. doi: 10.1016/j.bmcl.2013.10.031. Epub 2013 Oct 26.	Thanh Kim Pham, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim	Truncated and constrained helical analogs of antimicrobial esculentin-2EM	CC[C@@H](C)[C@H](NC(=O)CNC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(N)=O)C(C)C)C(C)C)[C@@H](C)O
DRAMP21627	TLKQFAKGVGKWLVK	15	E2EM15W	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Random coil coformation with 4% helical content in a 25 mM potassium phosphate buffer solution at 20 ℃.	Circular dichroism also revealed that E2EM15W is even less structured under the same conditions, displaying a helical content of 4%; it is well established that the shorter a peptide is, the more difficult it is to form an α-helical conformation.		Function: Antibacterial activity against Gram-positive bacteria. Antibacterial activity against Gram-negative bacteria is not noteable under 200 μg/mL.	[Ref.24211019] Gram-positive bacteria: Bacillus subtilis (MIC = 200 μg/mL), Staphylococcus aureus (MIC = 100 μg/mL), Staphylococcus epidermis (MIC > 200 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 200 μg/mL), Shigella dysentariae (MIC > 200 μg/mL), Salmonella typhimurium (MIC > 200 μg/mL), Klebsiella pneumonia (MIC > 200 μg/mL), Proteus mirabilis (MIC > 200 μg/mL), Pseudomonas aeuginose (MIC > 200 μg/mL).	[Ref.24211019] No hemolytic activity information found.	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference	Not found	24211019	Bioorg Med Chem Lett. 2013 Dec 15;23(24):6717-20. doi: 10.1016/j.bmcl.2013.10.031. Epub 2013 Oct 26.	Thanh Kim Pham, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim	Truncated and constrained helical analogs of antimicrobial esculentin-2EM	CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)[C@@H](C)O
DRAMP21631	RLVRILVSKRPVAIKPYFRL	20	SLAY-P1	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 2 μM), Acinetobacter baumannii 5075 (MBC ≤ 2 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC ≤ 2 μM).	[Ref.29307492] The peptide showed 4.0% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP21632	TTSIRRRYQVSLIRRHRGKR	20	SLAY-P2	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC ≤ 2 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 4 μM).	[Ref.29307492] The peptide showed 3.1% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP21633	TCRTNRPCFYDLDLNVCRCS	20	SLAY-P3 cyclic	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC ≤ 2 μM), Acinetobacter baumannii 5075 (MBC = 4 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 4 μM).	[Ref.29307492] The peptide showed 0.9% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Cyclic	Free	Free	Disulfide bonds between Cys2 and Cys19, Cys8 and Cys17.	L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC(C)C[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)CSSC[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N2
DRAMP21634	SNGDGTLDAGSTCAPFYARA	20	SLAY-P4	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 2 μM), Acinetobacter baumannii 5075 (MBC = 16 μM), Pseudomonas aeruginosa 14 (MBC = 4 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 4 μM).	[Ref.29307492] The peptide showed 1.8% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)[C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)O
DRAMP21635	YYNPLPHDCGRDNNTDICSR	20	SLAY-P5 cyclic	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 4 μM), Acinetobacter baumannii 5075 (MBC = 8 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC ≤ 2 μM).	[Ref.29307492] The peptide showed 1.1% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Cyclic	Free	Free	Disulfide bonds between Cys9 and Cys18	L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)Cc2ccc(O)cc2)CSSC[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC1=O
DRAMP21636	LSVDKRPVLHPEHIYGHNHY	20	SLAY-P6	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 4 μM), Acinetobacter baumannii 5075 (MBC = 32 μM), Pseudomonas aeruginosa 14 (MBC = 8 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC ≤ 128 μM).	[Ref.29307492] The peptide showed 3.1% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP21637	IHRDQQHESFLDARPEPGLTE	21	SLAY-P7	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 4 μM), Acinetobacter baumannii 5075 (MBC = 16 μM), Pseudomonas aeruginosa 14 (MBC = 4 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 4 μM).	[Ref.29307492] The peptide showed 0.7% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)O
DRAMP21638	TIDFGVRNINQSNLVYDTER	20	SLAY-P8	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 8 μM), Acinetobacter baumannii 5075 (MBC = 16 μM), Pseudomonas aeruginosa 14 (MBC = 8 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC  > 128 μM).	[Ref.29307492] The peptide showed 10.8% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C
DRAMP21639	PCNPDHDYRPFGNFRIAFTT	20	SLAY-P9	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 8 μM), Acinetobacter baumannii 5075 (MBC = 16 μM), Pseudomonas aeruginosa 14 (MBC = 8 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 8 μM).	[Ref.29307492] The peptide showed 0% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP21640	TRDTNDLISSRTAAPSMV	18	SLAY-P10	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC = 64 μM), Pseudomonas aeruginosa 14 (MBC = 8 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 32 μM).	[Ref.29307492] The peptide showed 8.4% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP21641	LPLPSCSSHGGDADNTSQRN	20	SLAY-P11	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC = 128 μM), Pseudomonas aeruginosa 14 (MBC = 16 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 32 μM).	[Ref.29307492] The peptide showed 2.6% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP21642	PNDPDSPCVYRMPNARGCSI	20	SLAY-P12	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC = 128 μM), Pseudomonas aeruginosa 14 (MBC = 16 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 16 μM).	[Ref.29307492] The peptide showed 0.9% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)O
DRAMP21643	YDLSDSNCLPANRDKRYYVI	20	SLAY-P13	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 16 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).	[Ref.29307492] The peptide showed 3.1% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)O
DRAMP21644	SMLAYVDKNDHINPPHSPRS	20	SLAY-P14	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 32 μM), Acinetobacter baumannii 5075 (MBC = 128 μM), Pseudomonas aeruginosa 14 (MBC = 32 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 64 μM).	[Ref.29307492] The peptide showed 1.5% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O
DRAMP21645	DATPHAALFFTVKDHTAGDN	20	SLAY-P15	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 32 μM), Acinetobacter baumannii 5075 (MBC = 64 μM), Pseudomonas aeruginosa 14 (MBC = 32 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 64 μM).	[Ref.29307492] The peptide showed 0.6% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C
DRAMP21646	SDDAQRCYPHNRTPFTYTYI	20	SLAY-P16	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 32 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 16 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 32 μM).	[Ref.29307492] The peptide showed 3.3% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP21647	EPCSPKNNYHDLFYRT	16	SLAY-P17	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Slight antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 128 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 128 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).	[Ref.29307492] The peptide showed 1.7% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)O
DRAMP21648	CNPLNGADRRTDSFPRFTVI	20	SLAY-P18	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 128 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 64 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).	[Ref.29307492] The peptide showed 1.7% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP21649	TCRTNRPCFYDLDLNVCRCS	20	SLAY-P3	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Slight antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC > 128 μM), Acinetobacter baumannii 5075 (MBC = 128 μM), Pseudomonas aeruginosa 14 (MBC > 128 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).	[Ref.29307492] No hemolytic activity information found.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP21650	YYNPLPHDCGRDNNTDICSR	20	SLAY-P5	No entry found			Synthetic construct after SLAY screening and prediction	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Unknown	Not mentioned		Function: Slight antibacterial activity against Gram-negative bacteria.	[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC > 128 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 128 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).	[Ref.29307492] No hemolytic activity information found.	Linear	Free	Free		L	No cytotoxicity information found	Unknown	29307492	Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.	Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies	Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)O
	IKLSPETKDNLKKVLKGAIKGAIAVAKMV	29	Hymenochirin-1B	Not found	Unknown		Hymenochirus boettgeri (Congo dwarf clawed frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Experimental evidence at transcript level	α-helical (most likely)	No structure indentification experiment and detailed structure description found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 12.5 μM), S. aureus ATCC 25923 (MIC = 12.5 μM), S.epidermidis RP62A (MIC = 3.1 μM), S.epidermidis RP62A/1 (MIC = 1.6 μM), C.albicans ATCC 90028 (MIC = 100 μM);##Gram-negative bacteria: E.coli (MIC = 25 μM), A. baumannii (MIC = 6.25 μM), S. maltophilia (MIC = 6.25 μM), K. pneumoniae (MIC = 25 μM), P. aeruginosa (MIC = 50 μM), P.mirabilis (MIC > 100 μM).	[Ref.24172540] LC₅₀ = 213 ± 18 μM against freshly prepared human erythrocytes.												CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP28985	GIKKFLKSXKKFVKXFK	17	peptide 1 (Derived from Mag2)	No entry found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helix in 20 mM PBS solution (pH = 7.4) with 1% SDS at peptide concentrations of 100 μM	No detailed structure description		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria	"[Ref.33466998] Gram-positive bacteria: Staphylococcus aureus (MIC = 12.5 μM). 
##Gram-negative bacteria: Escherichia coli (MIC = 3.125 μM), Pseudomonas aeruginosa (MIC = 3.125 μM), 
multiple-drug resistant P.aeruginosa (MIC = 3.125 μM)"	[Ref.33466998] It has hemolysis against human red blood cells at 50 μM	Linear	Free	Amidation	The X (position: 9 and 15) in sequence indicate Aib residues (2-Aminoisobutyric acid)	L	No cytotoxicity information found in the reference		33466998	Molecules. 2021 Jan 16;26(2):444. doi: 10.3390/molecules26020444.	Motoharu Hirano, Chihiro Saito, Hidetomo Yokoo, Chihiro Goto, Ryuji Kawano, Takashi Misawa, Yosuke Demizu	Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence	
DRAMP28997	RWWWRWW	7	Unstapled heptapeptide 1	No entry found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Helicity = 22.7% in 10 mM sodium phosphate buffer (pH 7.4) at peptide concentrations of 100 μM	CD spectroscopy was used to characterize the secondary structure of five unstapled heptapeptides and their stapled counterparts in phosphate buffer, indicating a significant increase in peptide helical content upon the stapling, with helicity change from h = 14.1% - 33.7% (for unstapled peptides) to h = 58.9%-75.1% (for stapled peptides).		"Function: Antibacterial activity against Gram-positive bacteria.
It is a heptapeptide designed rationally."	Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC = 83 ± 18 μg/mL). Methicillin-resistant Staphylococcus aureus (MRSA) (MIC > 100 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference		PubMed ID is not available	Int J Pept Res Ther. 2019 Nov 14; 26(4):1711–1719. doi: 10.1007/s10989-019-09964-7.	Zhixia Chen, Xiuli Yu, Aiying Zhang, Fangfang Wang, Yankun Xing	De Novo Hydrocarbon-Stapling Design of Single-Turn α-Helical Antimicrobial Peptides	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP28999	WWKWWWK	7	Unstapled heptapeptide 3	No entry found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Helicity = 24.6% in 10 mM sodium phosphate buffer (pH 7.4) at peptide concentrations of 100 μM	CD spectroscopy was used to characterize the secondary structure of five unstapled heptapeptides and their stapled counterparts in phosphate buffer, indicating a significant increase in peptide helical content upon the stapling, with helicity change from h = 14.1% - 33.7% (for unstapled peptides) to h = 58.9%-75.1% (for stapled peptides).		"Function: Antibacterial activity against Gram-positive bacteria.
It is a heptapeptide designed rationally."	Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC = 76 ± 14 μg/mL). Methicillin-resistant Staphylococcus aureus (MRSA) (MIC = 62 ± 10 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference		PubMed ID is not available	Int J Pept Res Ther. 2019 Nov 14; 26(4):1711–1719. doi: 10.1007/s10989-019-09964-7.	Zhixia Chen, Xiuli Yu, Aiying Zhang, Fangfang Wang, Yankun Xing	De Novo Hydrocarbon-Stapling Design of Single-Turn α-Helical Antimicrobial Peptides	NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(N)=O
DRAMP29001	LLLRLLR	7	Unstapled heptapeptide 5	No entry found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Helicity = 30.2% in 10 mM sodium phosphate buffer (pH 7.4) at peptide concentrations of 100 μM	CD spectroscopy was used to characterize the secondary structure of five unstapled heptapeptides and their stapled counterparts in phosphate buffer, indicating a significant increase in peptide helical content upon the stapling, with helicity change from h = 14.1% - 33.7% (for unstapled peptides) to h = 58.9%-75.1% (for stapled peptides).		"Function: Antibacterial activity against Gram-positive bacteria.
It is a heptapeptide designed rationally."	Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC = 45 ± 9 μg/mL). Methicillin-resistant Staphylococcus aureus (MRSA) (MIC = 32 ± 5 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference		PubMed ID is not available	Int J Pept Res Ther. 2019 Nov 14; 26(4):1711–1719. doi: 10.1007/s10989-019-09964-7.	Zhixia Chen, Xiuli Yu, Aiying Zhang, Fangfang Wang, Yankun Xing	De Novo Hydrocarbon-Stapling Design of Single-Turn α-Helical Antimicrobial Peptides	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP29003	WWRRWWR	7	Unstapled heptapeptide 7	No entry found			Synthetic construct	Non-Antimicrobial	Synthetic form	Helicity = 14.1% in 10 mM sodium phosphate buffer (pH 7.4) at peptide concentrations of 100 μM	CD spectroscopy was used to characterize the secondary structure of five unstapled heptapeptides and their stapled counterparts in phosphate buffer, indicating a significant increase in peptide helical content upon the stapling, with helicity change from h = 14.1% - 33.7% (for unstapled peptides) to h = 58.9%-75.1% (for stapled peptides).		"Function: Antibacterial activity against Gram-positive bacteria is not significant under the concentration of 100 μg/mL.
It is a heptapeptide designed rationally."	Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC > 100 μg/mL). Methicillin-resistant Staphylococcus aureus (MRSA) (MIC > 100 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference		PubMed ID is not available	Int J Pept Res Ther. 2019 Nov 14; 26(4):1711–1719. doi: 10.1007/s10989-019-09964-7.	Zhixia Chen, Xiuli Yu, Aiying Zhang, Fangfang Wang, Yankun Xing	De Novo Hydrocarbon-Stapling Design of Single-Turn α-Helical Antimicrobial Peptides	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(N)=O
DRAMP29005	KLLKLLK	7	Unstapled heptapeptide 9	No entry found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Helicity = 33.7% in 10 mM sodium phosphate buffer (pH 7.4) at peptide concentrations of 100 μM	CD spectroscopy was used to characterize the secondary structure of five unstapled heptapeptides and their stapled counterparts in phosphate buffer, indicating a significant increase in peptide helical content upon the stapling, with helicity change from h = 14.1% - 33.7% (for unstapled peptides) to h = 58.9%-75.1% (for stapled peptides).		"Function: Antibacterial activity against Gram-positive bacteria.
It is a heptapeptide designed rationally."	Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC = 49 ± 11 μg/mL). Methicillin-resistant Staphylococcus aureus (MRSA) (MIC = 41 ± 9 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference		PubMed ID is not available	Int J Pept Res Ther. 2019 Nov 14; 26(4):1711–1719. doi: 10.1007/s10989-019-09964-7.	Zhixia Chen, Xiuli Yu, Aiying Zhang, Fangfang Wang, Yankun Xing	De Novo Hydrocarbon-Stapling Design of Single-Turn α-Helical Antimicrobial Peptides	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP29006	GLFAVIKKVASVIKGL	16	A4K14-citropin1.1	No entry found			Synthetic construct	Anticancer	Synthetic form	Helicity = 61.5% in 50% 2,2,2-trifluoroethanol (TFE) aqueous solution (0.1mg/mL)	[Ref.33363118] CD analysis indicates that the helicity of intial A4K14-citropin 1.1 was 61.5% and that of the stapled peptides ranged from 13.6 to 89.8%.		"Function: Antitumor activity against A549, HCT116 and HepG2 cancer cells.
A4K14-citropin 1.1 is a structurally optimized derivative of citropin-1.1 derived from amphibians' skin secreta peptide Citropin, which exhibits broad biological activities. Citropin-1.1 is Amphibian defense peptide with antibiotic and antimicrobial activity. Bowie and his team found that replacement of Asp4 and Gly14 with Ala and Lys (termed A4K14-CITROPIN 1.1) resulted in a more stable α-helix than Citropin on the C-terminal section, and it led to better biologicla activities"	[Ref.33363118] Cancer cell lines: C4-2B (IC50 = 29.05 μM), A549 (IC50 = 14.97 μM), U87 (IC50 = 14.8 μM), MCF-7 (14.16 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference		33363118	Front Chem. 2020 Dec 10;8:616147. doi: 10.3389/fchem.2020.616147. eCollection 2020.	Nan Wang, Gang Xie, Chao Liu, Wei Cong, Shipeng He, Yinghua Li, Li Fan, Hong-Gang Hu 	Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)C(C)C)C(C)C
DRAMP29018	IKLSKKTKKNLKKVLKGAIKGAIAVAKMV	29	H-14	No entry found			Synthetic construct	Anticancer	Synthetic form	α-helical (most likely)	No detailed structure description found.		"Function: Anticancer activity. 
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays"	[Ref.30789695] Cancer cell lines: A549 (IC50 = 0.98 ± 0.11 μM), HCT116 (IC50 = 1.841 ± 0.34 μM), HepG2 (IC50 = 4.54 ± 0.25 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference	Not found	30789695	ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.	Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao	Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP29028	KLLKKAGKLLKKAGKLLKKAG	21	Stripe	No entry found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-Helix content = 42% in 20 mM phosphate buffered saline (PBS) solution (pH 7.4), with 1% sodium dodecyl sulfate	No detailed structure description found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
The 'Stripe' is a rationally-designed amphipathic helical AMP comprising natural amino acids: the AMP has hydrophobic Ala/Leu on one side of the helix and cationic Lys residues on the other. It has great antimicrobial activity and weak hemolysis. However, Stripe was compeletely degraded within an hour after incubation with proteinase K at 37℃, which means a bad stability."	[Ref.33369262] Gram-positive bacteria: Staphylococcus aureus NBRC13276 (MIC = 12.5 μM) ;##Gram-negative bacteria: Escherichia coli DH5α (MIC = 3.125 μM), Pseudomonas aeruginosa NBRC13275 (MIC = 3.125 μM), multidrug-resistant Pseudomonas aeruginosa ATCCBAA-2111 (MDRP) (MIC = 3.125 μM)	[Ref.33369262] Stripe showed no hemolytic activity up to a concentration of 100 μM.	Linear	Free	Free		L	No cytotoxicity information found in the reference		33369262	Chempluschem. 2020 Dec;85(12):2731-2736. doi: 10.1002/cplu.202000749.	Motoharu Hirano, Chihiro Saito, Chihiro Goto, Hidetomo Yokoo, Ryuji Kawano, Takashi Misawa, Yosuke Demizu	Rational Design of Helix-Stabilized Antimicrobial Peptide Foldamers Containing α,α-Disubstituted Amino Acids or Side-Chain Stapling	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP29029	KLLKKGGKLLKKGGKLLKKGG	21	Stripe-based foldamer peptide 1	No entry found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	α-Helix content = 25% in 20 mM phosphate buffered saline (PBS) solution (pH 7.4), with 1% sodium dodecyl sulfate	[Ref.33369262] Conversely, the Gly-substitutde peptide 1 showed weaker spectral intensity than other peptides, which suggests a decrease in helicity.		"Function: Antibacterial activity against Gram-negative bacteria.
It is a helical foldmer peptide based on ""Stripe"" (an AMP  manually designed) by substituting Ala (position: 6, 13 and 20) with Gly. The peptide was less active than Stripe against four bacteria: S.aureus, E.coli, P.aeruginosa, MDRP. "	[Ref.33369262] Gram-positive bacteria: Staphylococcus aureus NBRC13276 (MIC > 50 μM) ;##Gram-negative bacteria: Escherichia coli DH5α (MIC = 12.5 μM), Pseudomonas aeruginosa NBRC13275 (MIC > 50 μM), multidrug-resistant Pseudomonas aeruginosa ATCCBAA-2111 (MDRP) (MIC > 50 μM)	[Ref.33369262] Peptide 1 showed no hemolytic activity up to a concentration of 100 μM.	Linear	Free	Free		L	No cytotoxicity information found in the reference		33369262	Chempluschem. 2020 Dec;85(12):2731-2736. doi: 10.1002/cplu.202000749.	Motoharu Hirano, Chihiro Saito, Chihiro Goto, Hidetomo Yokoo, Ryuji Kawano, Takashi Misawa, Yosuke Demizu	Rational Design of Helix-Stabilized Antimicrobial Peptide Foldamers Containing α,α-Disubstituted Amino Acids or Side-Chain Stapling	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)O
DRAMP29030	KLLKKXGKLLKKXGKLLKKXG	21	Stripe-based foldamer peptide 2	No entry found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-Helix content = 31% in 20 mM phosphate buffered saline (PBS) solution (pH 7.4), with 1% sodium dodecyl sulfate	[Ref.33369262] As shown in Figure 2, peptides 2, 3, 4 and 5 showed negative maxima at around 208 and 222nm, which suggests that they formed stable α-helical structures, similar to Stripe.		"Function: Antibacterial activity against Gram-negative bacteria.
It is a helical foldmer peptide based on ""Stripe"" (an AMP  manually designed) by introducing hydrophobic α,α-disubstituted amino acids (Aib). The peptide exhibited two to four times higher antimicrobial activity than Stripe. Besides, it is much more stable than Stripe against proteinase K."	[Ref.33369262] Gram-positive bacteria: Staphylococcus aureus NBRC13276 (MIC = 3.125 μM) ;##Gram-negative bacteria: Escherichia coli DH5α (MIC = 1.56 μM), Pseudomonas aeruginosa NBRC13275 (MIC = 1.56 μM), multidrug-resistant Pseudomonas aeruginosa ATCCBAA-2111 (MDRP) (MIC = 1.56 μM)	[Ref.33369262] Peptide 2 showed no hemolytic activity up to a concentration of 100 μM.	Linear	Free	Free	The X (position: 6, 13 and 20) in sequence denote Aib residue.	L	No cytotoxicity information found in the reference		33369262	Chempluschem. 2020 Dec;85(12):2731-2736. doi: 10.1002/cplu.202000749.	Motoharu Hirano, Chihiro Saito, Chihiro Goto, Hidetomo Yokoo, Ryuji Kawano, Takashi Misawa, Yosuke Demizu	Rational Design of Helix-Stabilized Antimicrobial Peptide Foldamers Containing α,α-Disubstituted Amino Acids or Side-Chain Stapling	
DRAMP29031	KLLKKZGKLLKKZGKLLKKZG	21	Stripe-based foldamer peptide 3	No entry found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-Helix content = 49% in 20 mM phosphate buffered saline (PBS) solution (pH 7.4), with 1% sodium dodecyl sulfate	[Ref.33369262] As shown in Figure 2, peptides 2, 3, 4 and 5 showed negative maxima at around 208 and 222nm, which suggests that they formed stable α-helical structures, similar to Stripe.		"Function: Antibacterial activity against Gram-negative bacteria.
It is a helical foldmer peptide based on ""Stripe"" (an AMP  manually designed) by introducing hydrophobic α,α-disubstituted amino acids (1-aminocyclohexanecarboxylic acid Ac₆c). The peptide showed similar or silightly weaker activity than Stripe."	[Ref.33369262] Gram-positive bacteria: Staphylococcus aureus NBRC13276 (MIC = 6.25 μM) ;##Gram-negative bacteria: Escherichia coli DH5α (MIC = 3.125 μM), Pseudomonas aeruginosa NBRC13275 (MIC = 6.25 μM), multidrug-resistant Pseudomonas aeruginosa ATCCBAA-2111 (MDRP) (MIC = 12.5 μM)	[Ref.33369262] It exhibits hemolysis at 1.56 μM agasint human red blood cells.	Linear	Free	Free	The Z (position: 6, 13 and 20) in sequence denote Ac₆c residue (1-Aminocyclohexanecarboxylic acid).	L	No cytotoxicity information found in the reference		33369262	Chempluschem. 2020 Dec;85(12):2731-2736. doi: 10.1002/cplu.202000749.	Motoharu Hirano, Chihiro Saito, Chihiro Goto, Hidetomo Yokoo, Ryuji Kawano, Takashi Misawa, Yosuke Demizu	Rational Design of Helix-Stabilized Antimicrobial Peptide Foldamers Containing α,α-Disubstituted Amino Acids or Side-Chain Stapling	
DRAMP29034	IKLSKETKDNLKKVLKGAIKGAIAVAKMV	29	[P5K]Hymenochirin-1B	Not found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anticancer	Synthetic form	α-helical (most likely)	No structure indentification experiment and detailed structure description found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria; Anticancer activity.
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays"	[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 6.25 μM), S. aureus ATCC 25923 (MIC = 6.25 μM), S.epidermidis RP62A (MIC = 1.6 μM), S.epidermidis RP62A/1 (MIC = 1.6 μM), C.albicans ATCC 90028 (MIC = 50 μM);##Gram-negative bacteria: E.coli (MIC = 12.5 μM), A. baumannii (MIC = 6.25 μM), S. maltophilia (MIC = 3.1 μM), K. pneumoniae (MIC = 12.5 μM), P. aeruginosa (MIC = 25 μM), P.mirabilis (MIC > 100 μM).##[Ref.30789695] Cancer cell lines: A549 (IC50 = 2.35 ± 0.31 μM), HCT116 (IC50 = 8.09 ± 0.40 μM), HepG2 (IC50 = 4.28 ± 0.38 μM)	[Ref.24172540] LC₅₀ = 205 ± 15 μM against freshly prepared human erythrocytes.	Linear	Free	Amidation		L	No cytotoxicity information found in the reference		24172540##30789695	Peptides. 2013 Dec;50:153-9. doi: 10.1016/j.peptides.2013.10.015. Epub 2013 Oct 27.##ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.	Milena Mechkarska, Manju Prajeep, Gordana D Radosavljevic, Ivan P Jovanovic, Amna Al Baloushi, Agnes Sonnevend, Miodrag L Lukic, J Michael Conlon##Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao	An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties##Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP29035	IKLSPKTKDNLKKVLKGAIKGAIAVAKMV	29	[E6K]Hymenochirin-1B	Not found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helical (most likely)	No structure indentification experiment and detailed structure description found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 3.1 μM), S. aureus ATCC 25923 (MIC = 1.6 μM), S.epidermidis RP62A (MIC = 0.8 μM), S.epidermidis RP62A/1 (MIC = 0.8 μM), C.albicans ATCC 90028 (MIC = 100 μM);##Gram-negative bacteria: E.coli (MIC = 6.25 μM), A. baumannii (MIC = 6.25 μM), S. maltophilia (MIC = 1.6 μM), K. pneumoniae (MIC = 6.25 μM), P. aeruginosa (MIC = 12.5 μM), P.mirabilis (MIC > 100 μM).	[Ref.24172540] LC₅₀ = 186 ± 4 μM against freshly prepared human erythrocytes.	Linear	Free	Amidation		L	No cytotoxicity information found in the reference		24172540	Peptides. 2013 Dec;50:153-9. doi: 10.1016/j.peptides.2013.10.015. Epub 2013 Oct 27.	Milena Mechkarska, Manju Prajeep, Gordana D Radosavljevic, Ivan P Jovanovic, Amna Al Baloushi, Agnes Sonnevend, Miodrag L Lukic, J Michael Conlon	An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP29036	IKLSPETKKNLKKVLKGAIKGAIAVAKMV	29	[D9K]Hymenochirin-1B	Not found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anticancer	Synthetic form	α-helical (most likely)	No structure indentification experiment and detailed structure description found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria; Anticancer activity.
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays"	[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 3.1 μM), S. aureus ATCC 25923 (MIC = 3.1 μM), S.epidermidis RP62A (MIC = 1.6 μM), S.epidermidis RP62A/1 (MIC = 0.8 μM), C.albicans ATCC 90028 (MIC = 50 μM);##Gram-negative bacteria: E.coli (MIC = 6.25 μM), A. baumannii (MIC = 3.1 μM), S. maltophilia (MIC = 3.1 μM), K. pneumoniae (MIC = 12.5 μM), P. aeruginosa (MIC = 25 μM), P.mirabilis (MIC > 100 μM).##[Ref.30789695] Cancer cell lines: A549 (IC50 = 1.82 ± 0.23 μM), HCT116 (IC50 = 6.50 ± 0.32 μM), HepG2 (IC50 = 4.96 ± 0.43 μM).	[Ref.24172540] LC₅₀ = 174 ± 12 μM against freshly prepared human erythrocytes.	Linear	Free	Amidation		L	No cytotoxicity information found in the reference		24172540##30789695	Peptides. 2013 Dec;50:153-9. doi: 10.1016/j.peptides.2013.10.015. Epub 2013 Oct 27.##ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.	Milena Mechkarska, Manju Prajeep, Gordana D Radosavljevic, Ivan P Jovanovic, Amna Al Baloushi, Agnes Sonnevend, Miodrag L Lukic, J Michael Conlon.##Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao.	An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties.##Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP29037	IKLSKKTKDNLKKVLKGAIKGAIAVAKMV	29	[P5K,E6K]Hymenochirin-1B	Not found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helical (most likely)	No structure indentification experiment and detailed structure description found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 3.1 μM), S. aureus ATCC 25923 (MIC = 3.1 μM), S.epidermidis RP62A (MIC = 1.6 μM), S.epidermidis RP62A/1 (MIC = 0.8 μM), C.albicans ATCC 90028 (MIC = 100 μM);##Gram-negative bacteria: E.coli (MIC = 3.1 μM), A. baumannii (MIC = 3.1 μM), S. maltophilia (MIC = 1.6 μM), K. pneumoniae (MIC = 6.25 μM), P. aeruginosa (MIC = 12.5 μM), P.mirabilis (MIC > 100 μM).	[Ref.24172540] LC₅₀ = 137 ± 11 μM against freshly prepared human erythrocytes.	Linear	Free	Amidation		L	No cytotoxicity information found in the reference		24172540	Peptides. 2013 Dec;50:153-9. doi: 10.1016/j.peptides.2013.10.015. Epub 2013 Oct 27.	Milena Mechkarska, Manju Prajeep, Gordana D Radosavljevic, Ivan P Jovanovic, Amna Al Baloushi, Agnes Sonnevend, Miodrag L Lukic, J Michael Conlon	An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP29038	IKLSKETKKNLKKVLKGAIKGAIAVAKMV	29	[P5K,D9K]Hymenochirin-1B	Not found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anticancer	Synthetic form	α-helical (most likely)	No structure indentification experiment and detailed structure description found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria; Anticancer activity.
Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays"	[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 6.25 μM), S. aureus ATCC 25923 (MIC = 3.1 μM), S.epidermidis RP62A (MIC = 1.6 μM), S.epidermidis RP62A/1 (MIC = 1.6 μM), C.albicans ATCC 90028 (MIC = 50 μM);##Gram-negative bacteria: E.coli (MIC = 6.25 μM), A. baumannii (MIC = 3.1 μM), S. maltophilia (MIC = 3.1 μM), K. pneumoniae (MIC = 6.25 μM), P. aeruginosa (MIC = 12.5 μM), P.mirabilis (MIC > 100 μM).##[Ref.30789695] Cancer cell lines: A549 (IC50 = 1.17 ± 0.23 μM), HCT116 (IC50 = 4.93 ± 0.51 μM), HepG2 (IC50 = 2.46 ± 0.32 μM).	[Ref.24172540] LC₅₀ = 127 ± 9 μM against freshly prepared human erythrocytes.	Linear	Free	Amidation		L	No cytotoxicity information found in the reference		24172540##30789695	Peptides. 2013 Dec;50:153-9. doi: 10.1016/j.peptides.2013.10.015. Epub 2013 Oct 27.##ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.	Milena Mechkarska, Manju Prajeep, Gordana D Radosavljevic, Ivan P Jovanovic, Amna Al Baloushi, Agnes Sonnevend, Miodrag L Lukic, J Michael Conlon.##Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao.	An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties.##Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Nov	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP29039	IKLSPKTKKNLKKVLKGAIKGAIAVAKMV	29	[E6K,D9K]Hymenochirin-1B	Not found			Synthetic construct	"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-,
Immunomodulatory, Anti-inflammatory"	Synthetic form	α-helical (most likely)	No structure indentification experiment and detailed structure description found		"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
The peptide, at a concentration of 2.5 μM, significantly (P<0.05) stimulates the production of the anti-inflammatory IL-4 and IL-10 but is without significant effect on production of the pro-inflammatory cytokines TNF-α and IL-17"	[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 3.1 μM), S. aureus ATCC 25923 (MIC = 1.6 μM), S.epidermidis RP62A (MIC = 1.6 μM), S.epidermidis RP62A/1 (MIC = 0.8 μM), C.albicans ATCC 90028 (MIC = 50 μM);##Gram-negative bacteria: E.coli (MIC = 3.1 μM), A. baumannii (MIC = 3.1 μM), S. maltophilia (MIC = 1.6 μM), K. pneumoniae (MIC = 3.1 μM), P. aeruginosa (MIC = 6.25 μM), P.mirabilis (MIC > 100 μM).	[Ref.24172540] LC₅₀ = 85 ± 5 μM against freshly prepared human erythrocytes.	Linear	Free	Amidation		L	No cytotoxicity information found in the reference		24172540	Peptides. 2013 Dec;50:153-9. doi: 10.1016/j.peptides.2013.10.015. Epub 2013 Oct 27.	Milena Mechkarska, Manju Prajeep, Gordana D Radosavljevic, Ivan P Jovanovic, Amna Al Baloushi, Agnes Sonnevend, Miodrag L Lukic, J Michael Conlon	An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP29040	IKLSPkTKDNLKKVLKGAIKGAIAVAKMV	29	[E6k]Hymenochirin-1B	Not found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helical (most likely)	No structure indentification experiment and detailed structure description found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 3.1 μM), S. aureus ATCC 25923 (MIC = 3.1 μM), S.epidermidis RP62A (MIC = 1.6 μM), S.epidermidis RP62A/1 (MIC = 0.8 μM), C.albicans ATCC 90028 (MIC = 100 μM);##Gram-negative bacteria: E.coli (MIC = 3.1 μM), A. baumannii (MIC = 3.1 μM), S. maltophilia (MIC = 3.1 μM), K. pneumoniae (MIC = 6.25 μM), P. aeruginosa (MIC = 12.5 μM), P.mirabilis (MIC > 100 μM).	[Ref.24172540] LC₅₀ = 188 ± 8 μM against freshly prepared human erythrocytes.	Linear	Free	Amidation	①Introduction of D-amino acid(s). (Look at 'Stereochemistry')	Mixed (D-Lys6)	No cytotoxicity information found in the reference		24172540	Peptides. 2013 Dec;50:153-9. doi: 10.1016/j.peptides.2013.10.015. Epub 2013 Oct 27.	Milena Mechkarska, Manju Prajeep, Gordana D Radosavljevic, Ivan P Jovanovic, Amna Al Baloushi, Agnes Sonnevend, Miodrag L Lukic, J Michael Conlon	An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties	
DRAMP29041	IKLSPETKkNLKKVLKGAIKGAIAVAKMV	29	[D9k]Hymenochirin-1B	Not found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helical (most likely)	No structure indentification experiment and detailed structure description found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 6.25 μM), S. aureus ATCC 25923 (MIC = 6.25 μM), S.epidermidis RP62A (MIC = 0.8 μM), S.epidermidis RP62A/1 (MIC = 0.8 μM), C.albicans ATCC 90028 (MIC = 100 μM);##Gram-negative bacteria: E.coli (MIC = 6.25 μM), A. baumannii (MIC = 3.1 μM), S. maltophilia (MIC = 3.1 μM), K. pneumoniae (MIC = 6.25 μM), P. aeruginosa (MIC = 25 μM), P.mirabilis (MIC > 100 μM).	[Ref.24172540] LC₅₀ > 400 μM against freshly prepared human erythrocytes.	Linear	Free	Amidation	①Introduction of D-amino acid(s). (Look at 'Stereochemistry')	Mixed (D-Lys9)	No cytotoxicity information found in the reference		24172540	Peptides. 2013 Dec;50:153-9. doi: 10.1016/j.peptides.2013.10.015. Epub 2013 Oct 27.	Milena Mechkarska, Manju Prajeep, Gordana D Radosavljevic, Ivan P Jovanovic, Amna Al Baloushi, Agnes Sonnevend, Miodrag L Lukic, J Michael Conlon	An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties	
DRAMP29042	IKLSPkTKkNLKKVLKGAIKGAIAVAKMV	29	[E6k,D9k]Hymenochirin-1B	Not found			Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helical (most likely)	No structure indentification experiment and detailed structure description found		Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.	[Ref.24172540] Gram-positive bacteria: S. aureus ATCC 29213 (MIC = 3.1 μM), S. aureus ATCC 25923 (MIC = 1.6 μM), S.epidermidis RP62A (MIC = 0.8 μM), S.epidermidis RP62A/1 (MIC = 0.8 μM), C.albicans ATCC 90028 (MIC = 100 μM);##Gram-negative bacteria: E.coli (MIC = 3.1 μM), A. baumannii (MIC = 1.6 μM), S. maltophilia (MIC = 1.6 μM), K. pneumoniae (MIC = 3.1 μM), P. aeruginosa (MIC = 6.25 μM), P.mirabilis (MIC > 100 μM).	[Ref.24172540] LC₅₀ = 302 ± 21 μM against freshly prepared human erythrocytes.	Linear	Free	Amidation	①Introduction of D-amino acid(s). (Look at 'Stereochemistry')	Mixed (D-Lys6 and D-Lys9)	No cytotoxicity information found in the reference		24172540	Peptides. 2013 Dec;50:153-9. doi: 10.1016/j.peptides.2013.10.015. Epub 2013 Oct 27.	Milena Mechkarska, Manju Prajeep, Gordana D Radosavljevic, Ivan P Jovanovic, Amna Al Baloushi, Agnes Sonnevend, Miodrag L Lukic, J Michael Conlon	An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties	
DRAMP29043	VDKPPYLPRPRPPRRIYNR	19	Oncocin (variant of Oncopeltus antibacterial peptide 4)	No entry found	Not found		Synthetic construct (Oncocin is a variant of the 2 kDa Oncopeltus antibacterial peptide 4, which was originally isolated from oncopeltus fasciatus (milkweed bug))	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Not found	Not found		Comment: Oncocin inhibits bacterial protein translation by targeting the ribosome.	[Ref.20565063] Gram-negative pathogens: P.aeruginosa DSM3227 (MIC = 4 μg/mL), P. aeruginosa Walter (MIC = 8 μg/mL), P. aeruginosa ATCC27853 (MIC = 4 μg/mL), P. aeruginosa PAO1 (MIC = 2 μg/mL), P. aeruginosa 60811001 (MIC = 2 μg/mL), P. aeruginosa 60909001 (MIC = 2 μg/mL), P. aeruginosa 61118003 (MIC = 2 μg/mL), P. aeruginosa 70108001 (MIC = 4 μg/mL), E. coli 70329001 (MIC = 1 μg/mL), E. coli 70430001 (MIC = 1 μg/mL), E. coli 70419002 (MIC = 8 μg/mL), E. coli 70502001 (MIC = 1 μg/mL), E. coli Neumann (MIC = 2 μg/mL), E. coli 205024 (MIC = 4 μg/mL), E. coli 455/7 (MIC = 0.5 μg/mL), E. coli 8474 (MIC = 0.5 μg/mL), K. pneumoniae DSM681 (MIC = 0.25 μg/mL), K. pneumoniae 57 USA (MIC = 0.25 μg/mL), K. pneumoniae 63 (MIC = 8 μg/mL), K. pneumoniae 8085 (MIC = 0.5 μg/mL), K. pneumoniae ATCC12657 (0.5 μg/mL), K. pneumoniae ATCC27799 (MIC = 1 μg/mL), A. baumannii ICB14067 (MIC = 1 μg/mL), A. baumannii ICB14072 (MIC = 1 μg/mL), A. baumannii ICB14073 (MIC = 2 μg/mL), A. baumannii ICB9250 (MIC = 0.5 μg/mL), A. baumannii M17 (MIC = 1 μg/mL), E. cloacae 34654 (MIC = 0.25 μg/mL), E. cloacae Ha088 (MIC = 0.125 μg/mL), E. cloacae Ha089 (0.125 μg/mL), E. cloacae Ha185 (MIC = 0.5 μg/mL), E. cloacae Ha89 (MIC = 0.25 μg/mL), P. vulgaris ICB9081 (MIC = 4 μg/mL), P. vulgaris ICB9095 (MIC = 4 μg/mL), Stenotrophomonas ICB308054 (MIC = 32 μg/mL), Stenotrophomonas ICB7569 (MIC = 8 μg/mL), Stenotrophomonas ICB7789 (MIC = 32 μg/mL)	[Ref.20565063]None of the tested peptides showed any hemolytic activity against human erythrocytes in the studied peptide concentration range up to 600 μg/mL.	Linear 	Free	Amidation		L	[Ref.20565063] Oncocin showed no toxic effects on HeLa- or neuronal-cell-like differentiated SH-SY5Y cells at a peptide concentration of 600 μg/mL, which was about 100-fold above their MIC-values against E.coli BL21 AI.	Bacterial ribosome	20565063##28575099	J Med Chem. 2010 Jul 22;53(14):5240-7. doi: 10.1021/jm100378b.##PLoS One. 2017 Jun 2;12(6):e0178943. doi: 10.1371/journal.pone.0178943.	Daniel Knappe, Stefania Piantavigna, Anne Hansen, Adam Mechler, Annegret Binas, Oliver Nolte, Lisandra L Martin, Ralf Hoffmann##Böttger R, Hoffmann R, Knappe D	Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): A Novel Antibacterial Peptide Optimized against Gram-Negative Human Pathogens##Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP29044	KFFRKLKKSVKKRAKKFFKKPRVIGVSIPF	30	Cbf-K-16 (variant of BF-30)	No entry found	Not found		Synthetic construct (Cbf-K16 is a variant of BF-30, which was found in the venom of the snake bungarus fasciatus)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Comment: Cbf-K16 possessed effective antimicrobial and anti-inflammatory activities and downregulated the expression of adhesion- and cytotoxin-associated genes of drug-resistant H. pylori SS1, making it a potential candidate for anti-infective therapy.	[Ref.31704464] Gram-negative drug-resistant clinical isolates: H. pylori SS1 (MIC = 16 μg/mL, MBC = 32 μg/mL); Gram -negative bacteria: H. pylori 26695 (MIC = 32 μg/mL, MBC = 64 μg/mL), H. pylori 11637 (MIC = 16 μg/mL, MBC = 64 μg/mL) ##[Ref.27287456] Gram-positive drug-resistant clinical isolates: MRSA strain no.1 (MIC = 32 μg/mL), MRSA strain no.2 (MIC = 16 μg/mL), S.aureus strain no.1 (MIC = 16 μg/mL), S.aureus strain no.2 (MIC = 64 μg/mL), S.aureus strain no.3 (MIC = 8 μg/mL), S.aureus strain no.4 (MIC = 16 μg/mL), S.aureus strain no.5 (MIC = 4 μg/mL), S.aureus strain no.6 (MIC = 8 μg/mL), S.aureus strain no.7 (MIC = 32 μg/mL), S.epidermidis strain no.1 (MIC = 16 μg/mL), S.epidermidis strain no.2 (MIC = 32 μg/mL);## Gram-positive bacteria: S.aureus ATCC 25923 (MIC = 8 μg/mL);## Gram-negative drug-resistant clinical isolates: E.coli strain no.1 (MIC = 4 μg/mL), E.coli strain no.2 (MIC = 8 μg/mL), E.coli strain no.3 (MIC = 8 μg/mL); ##Gram-negative bacteria: E.coli ATCC 25922 (MIC = 4 μg/mL)	[Ref.27287456]Cbf-K-16 has low hemolytic activity	Linear	Free	Free		L	[Ref.27287456] Cbf-K-16 has low cytotoxicity.	Genomic DNA	31704464##27287456	Microb Pathog. 2020 Jan;138:103847. doi: 10.1016/j.micpath.2019.103847. Epub 2019 Nov 5.##Arch Pharm Res. 2016 Jul;39(7):978-88. doi: 10.1007/s12272-016-0769-x. Epub 2016 Jun 10.	Jiang M, Ma L, Huang Y, Wu H, Dou J, Zhou C##Bo Li, Wei Kang, Hanhan Liu, Yanrong Wang, Changzhong Yu, Xinyi Zhu, Jie Dou, Haibo Cai, Changlin Zhou	Antimicrobial activities of peptide Cbf-K 16 against drug-resistant Helicobacter pylori infection in vitro and in vivo. ##The antimicrobial activity of Cbf-K16 against MRSA was enhanced by β-lactamantibiotics through cell wall non-integrity.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)C(C)C
DRAMP29045	SQRKLAAKLTSKGGGRLLRPLLQLLKQKLR	30	PA2-GNU7	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Helix-loop-helix structure	①Molecular modelling showed that the hybrid peptide was predicted to form a helix-loop-helix structure. ②The hybrid peptide PA2-GNU7 was constructed by joining the PA2 peptide (SQRKLAAKLTSK) to GNU7 (RLLRPLLQLLKQKLR) with a short linker (Gly × 3).		Comment: The specific binding activity of PA2-GNU7 against P. aeruginosa was derived from the binding activity of PA2 peptide.	[Ref.31704464] Gram-positive bacteria: S. aureus (MIC = 2 μM);##Gram-negative bacteria: P. aeruginosa (MIC = 2 μM), E. coli (MIC = 1 μM), S. typhimurium (MIC = 2 μM); ##Fungi: C.albicans (MIC = 8 μM)	[Ref.31678742]PA2-GNU7 was not toxic to human RBCs at the tested concentrations (0 - 65 μM).The haemolysis was less than 2.5 % up to the concentration of 65 μM.	Linear 	Free	Free		L	Not found	Outer membrane proteins (OMPs) like OprF, the major outer membrane porin of P.aeruginosa	31678742	Eur J Med Chem. 2020 Jan 1;185:111814. doi: 10.1016/j.ejmech.2019.111814. Epub 2019 Oct 25.	Kim H, Jang JH, Kim SC, Cho JH.	Development of a novel hybrid antimicrobial peptide for targeted killing of Pseudomonas aeruginosa 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP29046	FRKKWNKWALSR	12	PAMP(9-20) ( the C-terminal 12-residues of PAMP)	P53366, O62827, P43145, P35318	Belongs to the adrenomedullin family	ADM	Homo sapiens et.al	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	α-helical (most likely)	Not found		Function: Kuwasako et al. identified the C-terminal 12-residues of PAMP [PAMP(9–20)] in porcine adrenal medulla as a major endogenous active peptide of the AM precursor and demonstrated that its hypotensive activity is comparable to that of PAMP. PAMP(9-20) can acts as an potent antimicrobial peptide which is more selective than melittin, and antimicrobial action of PAMP(9-20) seems to exert via an intracellular target. 	[Ref.32439180] Gram-negative bacteria: E. coli (MIC = 4 μM), P. aeruginosa (MIC = 16 μM), S. typhimurium (MIC = 4 μM)##Gram-positive bacteria:B. subtilis (MIC = 8 μM), S. epidermidis (MIC = 8 μM), S. aureus(MIC = 16 μM)	[Ref.32439180]HC10 > 256 μM against sheep RBCs.Note: HC10 is the minimum peptide concentration that caused >10% hemolysis of sheep red blood cells.	Linear 	Free	Amidation		L	Not found	Bacterial DNA	32439180	Biochem Biophys Res Commun. 2020 Jun 30;527(3):744-750. doi: 10.1016/j.bbrc.2020.04.063. Epub 2020 May 18.	Ajish C, Yang S, Kumar SD, Shin SY. 	Proadrenomedullin N-terminal 20 peptide (PAMP) and its C-terminal 12-residue peptide, PAMP(9-20): Cell selectivity and antimicrobial mechanism	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP29047	ARLDVASEFRKKWNKWALSR	20	PAMP (Proadrenomedullin N-terminal 20 peptide)	P35318, E9PML4, L5L428	Belongs to the adrenomedullin family	ADM	Homo sapiens et.al	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Protein level	α-helical	Not found	2FLY	Introduction: Proadrenomedullin N-terminal 20 peptide (PAMP) is a biologically active molecule (20 amino acid residues) produced by post-translational enzymatic processing of the common precursor of adrenomedullin (AM), a 185-amino acid proadrenomedullin molecule. PMAP can bee found in various types.  Function: AM and PAMP are potent hypotensive and vasodilatator agents. Numerous actions have been reported most related to the physiologic control of fluid and electrolyte homeostasis. In the kidney, am is diuretic and natriuretic, and both am and pamp inhibit aldosterone secretion by direct adrenal actions. In pituitary gland, both peptides at physiologically relevant doses inhibit basal ACTH secretion. Both peptides appear to act in brain and pituitary gland to facilitate the loss of plasma volume, actions which complement their hypotensive effects in blood vessels. PAMP can acts as an potent antimicrobial peptide which is more selective than melittin, and antimicrobial action of PAMP seems to exert via an intracellular target.	[Ref.32439180] Gram-negative bacteria: E. coli (MIC = 8 μM), P. aeruginosa (MIC = 32 μM), S. typhimurium (MIC = 16 μM)##Gram-positive bacteria:B. subtilis (MIC = 8 μM), S. epidermidis (MIC = 8 μM), S. aureus(MIC = 16 μM)	[Ref.32439180]HC10 > 256 μM against sheep RBCs.Note: HC10 is the minimum peptide concentration that caused >10% hemolysis of sheep red blood cells.	Linear 	Free	Amidation		L	Not found	Bacterial DNA	32439180	Biochem Biophys Res Commun. 2020 Jun 30;527(3):744-750. doi: 10.1016/j.bbrc.2020.04.063. Epub 2020 May 18.	Ajish C, Yang S, Kumar SD, Shin SY. 	Proadrenomedullin N-terminal 20 peptide (PAMP) and its C-terminal 12-residue peptide, PAMP(9-20): Cell selectivity and antimicrobial mechanism	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP29048	KIAKRIWKILRRR	13	PA-13	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helical	Not found		Function: PA-13 exhibited potent antibacterial activity against P. aeruginosa, including multidrug resistant strains, via penetration through the bacteria’s membrane and causing depolarization, permeabilization and rupture of membranes, and subsequent leakage of intracellular contents and cell death. The peptide displayed low hemolytic and cytotoxic activities against mammalian cells suggesting a therapeutic potential. Furthermore, PA-13 showed anti-inflammatory activity via LPS neutralization. Note: It maintained antimicrobial activity in the presence of physiological salts and displayed rapid binding and penetration activity which resulted in membrane depolarization and permeabilization. 	"[Ref.32499514] Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC = 3.91 µg/ml), Escherichia coli ATCC 25922 (MIC = 31.25 µg/ml), Escherichia coli O157:H7 MT strain (MIC = 31.25 µg/ml), Shigella sonnei ATCC 11060 (MIC = 3.91 µg/ml), Salmonella Typhimurium ATCC 13311 (MIC = 1.95 µg/ml), Vibrio cholera O1 Inaba DMST 16261 (MIC = 31.25 µg/ml), Acinetobacter baumannii MT strain (MIC = 7.81 µg/ml). ##Clinically isolated MDR P. aeruginosa: P. aeruginosa No.1 (3.91 μg/mL), P. aeruginosa No.2	(7.81μg/mL), P. aeruginosa No.3 (7.81 μg/mL), P. aeruginosa No.4 (7.81 μg/mL), P. aeruginosa No.5 (7.81 μg/mL), P. aeruginosa No.6 (7.81 μg/mL), P. aeruginosa No.7 (7.81 μg/mL), P. aeruginosa No.8 (7.81 μg/mL), P. aeruginosa No.9 (7.81 μg/mL), P. aeruginosa No.10 (7.81 μg/mL), P. aeruginosa No.11 (7.81 μg/mL), P. aeruginosa No.12 (3.91 μg/mL), P. aeruginosa No.13 (15.63 μg/mL), P. aeruginosa No.14 (7.81 μg/mL),##Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (MIC = 62.5 µg/ml) Staphylococcus epidermidis ATCC 12228 (MIC = 3.91 µg/ml), Bacillus cereus ATCC 11778 (MIC = 15.63 µg/ml), Enterococcus faecalis ATCC 29212 (MIC = 250 µg/ml), Listeria monocytogenes 10403 s (MIC = 3.91 µg/ml)"	[Ref.32499514]MHC = 125 μg/mL. Note:MHC is the minimum concentration that caused 10% hemolysis of human red blood cells (hRBC). When no 10% hemolysis was observed at 250 µg/ml, a value of 500 µg/ml was used to calculate the therapeutic index.	Linear 	Free	Amidation		L	[Ref.32499514]Cytotoxic activity of PA-13 against the L929 mouse fibroblast cell line was determined by a colorimetric MTT viability assay. At the MIC (3.91 µg/ml), the cell survival was up to 90%. Even at the maximum concentration (250 µg/ml), the survival was common (81.29%). Melittin, used as a positive control, showed a strong and dose-dependent cytotoxic effect; no living cells were detected at 62.5 µg/ml. Peptide PA-13 displayed very little cytotoxicity on L929 cells when compared to melittin.	Membrane	32499514	Sci Rep. 2020 Jun 4;10(1):9117. doi: 10.1038/s41598-020-65688-5.	Klubthawee N, Adisakwattana P, Hanpithakpong W, Somsri S, Aunpad R	A novel, rationally designed, hybrid antimicrobial peptide, inspired by cathelicidin and aurein, exhibits membrane-active mechanisms against Pseudomonas aeruginosa 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC
DRAMP29049	ALLKRIKTLL	10	Ano-1β (variant of Anoplin)	No entry found	Not found		Synthetic construct (Ano-1β is a variant of Anoplin, which is a linear cationic α-helical AMPs isolated from the venom sac of anoplius samariensis(solitary spider wasps))	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	75.3% α-helical content in 30 mM SDS	As shown in Fig. 1, the new peptides displayed mostly unordered conformations in the aqueous environment as demonstrated by a negative peak at approximately 195 nm. However, in 30 mM SDS, the new peptides folded typical α-helical conformations, as evidenced by a characteristic positive peak at approximately 195 nm and double negative peaks at approximately 208 nm and 222 nm. 		Comment: the incorporation of β-Ala had significant influence on the antimicrobial activity of peptides mainly due to the changes of hydrophobicity and net positive charge. Ano-1β exhibited good antimicrobial potency, which was stable under physiological conditions and displayed preferable in vivo antimicrobial activity with less acute toxicity. In particular, Ano-1β showed low tendency to develop bacterial resistance in contrast to conventional antibiotics rifampicin and gentamicin, and they exhibited better anti-biofilm activity and synergistic or additive effects in combination with conventional antibiotics. Ano-1β might stands as a promising antimicrobial candidate to overcome increasing bacterial resistance, and the incorporation of β-Ala was a reasonable strategy for the development of promising antimicrobial agents.	[Ref.32654770] Gram-negative multidrug-resistant bacteria: P. aeruginosa 119 (MIC = 8 μM or 8.93 μg/mL), P. aeruginosa 124 (MIC = 8 μM or 8.93 μg/mL), P. aeruginosa 86 (MIC = 4 μM or 4.47 μg/mL); ##Gram-negative bacteria: P. aeruginosa ATCC 27853 (MIC = 8 μM or 8.93 μg/mL), P. aeruginosa ATCC 9027 (MIC = 8 μM or 8.93 μg/mL), E. coli ATCC 25922  (MIC = 32 μM or 35.72 μg/mL), K. pneumonia ATCC 700603 (MIC = 32 μM or 35.72 μg/mL), A. baumannii ATCC 19606 (MIC = 64 μM or 71.44 μg/mL); ##Gram-positive bacteria: S. aureus ATCC 25923 (MIC = 128 μM or 142.88 μg/mL), S. epidermidis ATCC 12228 (MIC = 8 μM or 8.93 μg/mL)	[Ref.32654770]Ano-1β induced inappreciable hemolytic activity with less than 5 % hemolysis at all the tested concentrations and HC > 256 μM. Note: Minimum hemolysis concentration (HC, μM) was defined as the minimal peptide concentration induced 10 % hemolysis.	Linear 	Free	Amidation	[Ref.32654770] The residue A at position 1 indicates the β-Ala	L	[Ref.32654770]After 1 h of incubation, Ano-1β, similar to their parent peptide anoplin, maintained more than 80 % cell viability of the two cells at all tested concentrations. After incubating for 24 h, Ano-1β still maintained more than 80 % cell viability of HEK 293 T cells at all tested concentrations but displayed cytotoxicity against Hela cells at the highest concentration (256 μM). The cell viability of Hela after 24 h of incubation is around 80%.	Membrane	32654770	Int J Med Microbiol. 2020 Jul;310(5):151433. doi: 10.1016/j.ijmm.2020.151433. Epub 2020 May 27.	Zhong C, Zhu Y, Zhu N, Liu T, Gou S, Zhang F, Yao J, Xie J, Ni J	Synthesis and anti-pseudomonal activity of new ß-Ala modified analogues of the antimicrobial peptide anoplin	
DRAMP29050	GLLKRIKALL	10	Ano-8β (variant of Anoplin)	No entry found	Not found		Synthetic construct (Ano-1β is a variant of Anoplin, which is a linear cationic α-helical AMPs isolated from the venom sac of anoplius samariensis(solitary spider wasps))	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	72.82% α-helical content in 30 mM SDS	As shown in Fig. 1, the new peptides displayed mostly unordered conformations in the aqueous environment as demonstrated by a negative peak at approximately 195 nm. However, in 30 mM SDS, the new peptides folded typical α-helical conformations, as evidenced by a characteristic positive peak at approximately 195 nm and double negative peaks at approximately 208 nm and 222 nm. 		Comment: the incorporation of β-Ala had significant influence on the antimicrobial activity of peptides mainly due to the changes of hydrophobicity and net positive charge. Ano-8β exhibited good antimicrobial potency, which was stable under physiological conditions and displayed preferable in vivo antimicrobial activity with less acute toxicity. In particular, Ano-8β showed low tendency to develop bacterial resistance in contrast to conventional antibiotics rifampicin and gentamicin, and they exhibited better anti-biofilm activity and synergistic or additive effects in combination with conventional antibiotics. Ano-8β might stands as a promising antimicrobial candidate to overcome increasing bacterial resistance, and the incorporation of β-Ala was a reasonable strategy for the development of promising antimicrobial agents.	[Ref.32654770] Gram-negative multidrug-resistant bacteria: P. aeruginosa 119 (MIC = 8 μM or 9.00 μg/mL), P. aeruginosa 124 (MIC = 16 μM or 17.98 μg/mL), P. aeruginosa 86 (MIC = 8 μM or 9.00 μg/mL); ##Gram-negative bacteria: P. aeruginosa ATCC 27853 (MIC = 4 μM or 4.50 μg/mL), P. aeruginosa ATCC 9027 (MIC = 8 μM or 9.00 μg/mL), E. coli ATCC 25922  (MIC = 32 μM or 36 μg/mL), K. pneumonia ATCC 700603 (MIC = 128 μM or 144 μg/mL), A. baumannii ATCC 19606 (MIC > 128 μM or 144 μg/mL); ##Gram-positive bacteria: S. aureus ATCC 25923 (MIC = 128 μM or 144 μg/mL), S. epidermidis ATCC 12228 (MIC = 16 μM or 18 μg/mL)	[Ref.32654770]Ano-8β induced inappreciable hemolytic activity with less than 5 % hemolysis at all the tested concentrations and HC > 256 μM. Note: Minimum hemolysis concentration (HC, μM) was defined as the minimal peptide concentration induced 10 % hemolysis.	Linear 	Free	Amidation	[Ref.32654770] The residue A at position 8 indicates the β-Ala	L	[Ref.32654770]After 1 h of incubation, Ano-8β, similar to their parent peptide anoplin, maintained more than 80 % cell viability of the two cells at all tested concentrations. After incubating for 24 h, Ano-8β still maintained more than 80 % cell viability of HEK 293 T cells at all tested concentrations but displayed cytotoxicity against Hela cells at the highest concentration (256 μM). The cell viability of Hela after 24 h of incubation is around 70%	Membrane	32654770	Int J Med Microbiol. 2020 Jul;310(5):151433. doi: 10.1016/j.ijmm.2020.151433. Epub 2020 May 27.	Zhong C, Zhu Y, Zhu N, Liu T, Gou S, Zhang F, Yao J, Xie J, Ni J	Synthesis and anti-pseudomonal activity of new ß-Ala modified analogues of the antimicrobial peptide anoplin	
DRAMP29051	KKRLKKIFKKPMVIGVTIPF	20	Ctn[15-34] (C-terminal fragment of crotalicidin)	U5KJM4	Belongs to the cathelicidin family.		Crotalus durissus terrificus (South American rattlesnake)	Antimicrobial, Antifungal	Protein level	α-helical	 preserves helicity		Comment: Ctn[15-34] showed to be an effective antifungal peptide, displaying antibiofilm activity and, importantly, interacting with and disrupting fungal plasma membrane. Function: Potent antimicrobial peptide against Gram-negative (P.aeruginosa, K.pneumoniae, E.coli, A.baumannii) (PubMed:25100358, PubMed:26465972). Shows moderate activities against Gram-positive bacteria (E.faecalis, S.aureus, S.pyogenes) (PubMed:25100358, PubMed:26465972). Also shows antifungal activity against standard and clinical isolates of yeasts (MIC=10-40 µM) and dermatophytes (MIC=1-5 µM) (PubMed:27876749). Adopts an amphipathic alpha helical conformation, that may allow to partition into the target membrane (PubMed:26465972). Shows high toxicity towards human fibroblasts (micromolar ranges) (PubMed:26465972). Shows low hemolytic activities on human erythrocytes (PubMed:25100358, PubMed:26465972). Also shows toxicity (micromolar ranges) when tested on many leukemia cell lines (PubMed:26465972). In addition, when tested in vitro on the parasite Trypanosoma cruzi (responsible of the Chagas disease), is able to reduce the number of the three forms (epimastigote, trypomastigote and amastigote) by inducing cell death through necrosis (PubMed:29208061).	[Ref.33172206] Fungi: Candida albicans ATCC 90028 (MIC = 10 µM or 23.7 µg/mL), Candida albicans LABMIC 0125 (MIC = 10 µM or 23.7 µg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Free		L	Not found	Fungal plasma membrane	33172206	Int J Mol Sci. 2020 Nov 6;21(21):8339. doi: 10.3390/ijms21218339.	Aguiar FLL, Santos NC, de Paula Cavalcante CS, Andreu D, Baptista GR, Gonçalves S. 	Antibiofilm Activity on Candida albicans and Mechanism of Action on Biomembrane Models of the Antimicrobial Peptide Ctn[15-34] 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C
DRAMP29052	FLGALFKVASKLVPAAICSISKKC	24	Brevinin-1GHd	A0A6M4CA40	Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily		Sylvirana guentheri (Gunther's frog) (Rana guentheri)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Transcript level	α-helical	The results of CD spectroscopy revealed that Brevinin-1GHd adopt a random coil structure in an aqueous environment, while forming an alpha-helix structure in a membrane-mimetic environment.		"Comment: Brevinin-1GHd with its excellent antimicrobial and anticancer activities is a promising candidate for a novel antibiotic agent, and study of its structure activity relationships also provided a rational template for further research and peptide analog design. In the reference, the example of Brevinin-1GHd is used to challenge the importance of ""Rana-Box"", which appears in many AMPs originating from frogs and contains an intermolecular disulfide bridge at the C-terminus of the peptide and seven to nine amino acid residues."	[Ref.32347293] Gram-positive bacteria: S. aureus (MIC = 2 μM/MBC= 4 µM), MRSA(MIC = 4 μM/MBC = 4µM); ##Gram-negative: E. coli(MIC = 8 μM/MBC = 8 µM), P. aeruginosa(MIC = 32 μM/MBC = 32µM); ##Fungi: C. albicans(MIC = 4 μM/MBC = 8µM）	[Ref.32347293] Brevinin-1GHd displayed 13% hemolysis on horse red blood cells at its highest MIC/MBC value of the tested bacteria P. aeruginosa (32 µM). However, when the concentration increased above 64 μM, the hemolytic activity of Brevinin-1GHd also gradually increased. At the concentration of 64, 128, 256 and 512 μM, it displayed about 36%, 64%, 83% and 108% hemolysis.	Cyclic 	Free	Free	Free	L	[Ref.32347293]Brevinin-1GHd showed significant cytotoxicity toward human HMEC-1 and HaCaT cells at concentrations of 0.00001 and 0.0001 M, respectively. Brevinin-1GHd induced one cell viability of 56% on HMEC-1 and the other cell viability of 75% on HaCat.	Cell membrane	32347293	Biosci Rep. 2020 May 29;40(5):BSR20200019. doi: 10.1042/BSR20200019.	Jiang Y, Wu Y, Wang T, Chen X, Zhou M, Ma C, Xi X, Zhang Y, Chen T, Shaw C, Wang L. 	Brevinin-1GHd: a novel Hylarana guentheri skin secretion-derived Brevinin-1 type peptide with antimicrobial and anticancer therapeutic potential 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@H](C)CC
DRAMP29053	AKLIPTIAL	9	RcAlb-PepI (designed in silico using as template the amino acid sequence of Rc-2S-Alb)	No entry found	Not found		Synthetic construct (Rc-2S-Alb comes from Ricinus communis (Castor bean))	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Partially ordered (non-regular) and α-helical	RcAlb-PepI and RcAlb-PepII in aqueous solution showed SRCD spectra typical of peptides that present major unordered content of secondary structure. The small (albeit significant) shift of the minimum for the RcAlb-PepII spectrum showed a more partially ordered peptide (although non-canonical) compared with RcAlb-PepI. The SRCD spectra of RcAlb-PepI and RcAlb-PepII in the film were characteristics of partially ordered (non-regular) and α-helix secondary structures.		Comment: RcAlb-PepI is safe and apparently effective for its intended use and has great potential for the future development of an antimicrobial agent with the ability to kill or inhibit K. pneumoniae and C. parapsilosis cells.	[Ref.31678367] Gram-negative bacteria: E. coli (MIC50 = 102 μM, MIC90 >  250 μM, MBC > 250 μM), K. pneumoniae(MIC50 = 121 μM, MIC90 > 250 μM, MBC > 250 μM)##Gram-positive bacteria: S. aureus (MIC50 = 123 μM, MIC90 > 250 μM, MBC > 250 μM)##Yeast: C. albicans (MIC50 = 62 μM, MIC90 > 250 μM, MFC > 250 μM), C. parapsilosis (MIC50 = 14 μM, MIC90 = 32 μM, MFC = 103 μM), C. tropicalis (MIC50 = 21 μM, MIC90 = 38 μM, MFC = 127 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Free		L	Not found	Not found	31678367	Biochim Biophys Acta Biomembr. 2020 Feb 1;1862(2):183092. doi: 10.1016/j.bbamem.2019.183092. Epub 2019 Oct 31.	Dias LP, Souza PFN, Oliveira JTA, Vasconcelos IM, Araújo NMS, Tilburg MFV, Guedes MIF, Carneiro RF, Lopes JLS, Sousa DOB	RcAlb-PepII, a synthetic small peptide bioinspired in the 2S albumin from the seed cake of Ricinus communis, is a potent antimicrobial agent against Klebsiella pneumoniae and Candida parapsilosis 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29054	SLRGCC	6	RcAlb-PepII (designed in silico using as template the amino acid sequence of Rc-2S-Alb)	No entry found	Not found		Synthetic construct (Rc-2S-Alb comes from Ricinus communis (Castor bean))	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Partially ordered (non-regular) and α-helical	RcAlb-PepI and RcAlb-PepII in aqueous solution showed SRCD spectra typical of peptides that present major unordered content of secondary structure. The small (albeit significant) shift of the minimum for the RcAlb-PepII spectrum showed a more partially ordered peptide (although non-canonical) compared with RcAlb-PepI. The SRCD spectra of RcAlb-PepI and RcAlb-PepII in the film were characteristics of partially ordered (non-regular) and α-helix secondary structures.		Comment: RcAlb-PepII is safe and apparently effective for its intended use and has great potential for the future development of an antimicrobial agent with the ability to kill or inhibit K. pneumoniae and C. parapsilosis cells.	[Ref.31678367] Gram-negative bacteria: E. coli (MIC50 = 31 μM, MIC90 = 29 μM, MBC > 250 μM), K. pneumoniae(MIC50 = 11 μM, MIC90 = 21 μM, MBC = 42 μM)##Gram-positive bacteria: S. aureus (MIC50 = 79 μM, MIC90 > 250 μM, MBC > 250 μM)##Yeast: C. albicans (MIC50 = 129 μM, MIC90 > 250 μM, MFC > 250 μM), C. parapsilosis (MIC50 = 9 μM, MIC90 = 17 μM, MFC = 25 μM), C. tropicalis (MIC50 = 29 μM, MIC90 = 28 μM, MFC = 67 μM)	[Ref.31678367] RcAlb-PepII was not harmful to human erythrocytes, even at a concentration 10 times higher than the MBC and MFC for K. pneumoniae and C. parapsilosis, respectively.	Linear 	Free	Free		L	[Ref.31678367] At 420 μM concentration (10 and 16.8 times higher than the MBC and MFC for K. pneumoniae and C. parapsilosis, respectively) RcAlb-PepII reduced only in 21.5% the Vero cell viability	Intracellular targets	31678367	Biochim Biophys Acta Biomembr. 2020 Feb 1;1862(2):183092. doi: 10.1016/j.bbamem.2019.183092. Epub 2019 Oct 31.	Dias LP, Souza PFN, Oliveira JTA, Vasconcelos IM, Araújo NMS, Tilburg MFV, Guedes MIF, Carneiro RF, Lopes JLS, Sousa DOB	RcAlb-PepII, a synthetic small peptide bioinspired in the 2S albumin from the seed cake of Ricinus communis, is a potent antimicrobial agent against Klebsiella pneumoniae and Candida parapsilosis 	CC(C)C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O
DRAMP29055	FFPVIGRILNGIL	13	temporin G	P79875	Belongs to the frog skin active peptide (FSAP) family. Temporin subfamily.		Rana temporaria (European common frog)	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antibiofilm	Protein level	Amphipathic alpha-helical (Uniprot:P79875)	Not found		Function: Amphipathic alpha-helical antimicrobial peptide with activity against Gram-positive bacteria (M.luteus), Gram-negative bacteria (E.coli), and fungi (S.cerevisiae) (PubMed:22439858). Stimulates insulin release from pancreatic beta-cells in a dose-dependent manner, without increasing intracellular calcium (PubMed:29349894). Does not protects BRIN-BD11 beta-cells against cytokine-induced apoptosis (PubMed:29349894). In vivo, intraperitoneal injection together with a glucose load into mice improves glucose tolerance with a concomitant increase in insulin secretion (PubMed:29349894).	[Ref.33321906] S. aureus ATCC 25923 biofilm: TG was capable of killing at least 39%, 78% and 87% at 3.12, 6.25, 12.5 and 25 µM. ##[Ref.22439858] Summary: TG had specific bactericidal activities against E. coli ATCC2592, M. luteus or S. cerevisiae.	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation		L	[Ref.33321906]TG was shown to be harmless against human keratinocytes at all concentrations tested with a slight cytotoxicity (~20% reduction of metabolically-active cells) at the highest active concentration	Not found	33321906##22439858	Int J Mol Sci. 2020 Dec 10;21(24):9410. doi: 10.3390/ijms21249410.##BMC Biotechnol. 2012 Mar 23;12:10. doi: 10.1186/1472-6750-12-10.	Casciaro B, Loffredo MR, Cappiello F, Fabiano G, Torrini L, Mangoni ML##Tao Ke, Su Liang, Jin Huang, Han Mao, Jibao Chen, Caihua Dong, Junyan Huang, Shengyi Liu, Jianxiong Kang, Dongqi Liu, Xiangdong Ma	The Antimicrobial Peptide Temporin G: Anti-Biofilm, Anti-Persister Activities, and Potentiator Effect of Tobramycin Efficacy Against Staphylococcus aureus.##A novel PCR-based method for high throughput prokaryotic expression of antimicrobial peptide genes	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29056	LRCMCIKWWSGKHPK	15	TC19 (derived from the human thrombocidin-1-derived peptide L3)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	Not found	Not found		Comment: TC19 combined low cytotoxicity towards human fibroblasts with efficient and rapid killing in human plasma of MDR strains of several bacterial species of the ESKAPE panel. However, the hemolytic activity data and secondary structure is missing.	[Ref.32376222] Gram-positive bacteria: E. coli ESBL (LC99.9 = 3.75 μM in PT buffer, LC99.9 = 15 μM in PBS buffer); ##Gram-negative bacteria: S. aureus JAR060131 (LC99.9 = 3.75 μM in PT buffer, LC99.9 = 7.5-15 μM in PBS buffer, LC99.9 = 15-30 μM in 50% plasma).##Multi-drug resistant (MDR) gram-positive bacteria:  E.faecium LUH10330 (LC99.9 = 1.6(1.6-3.2) μM in PBS buffer, LC99.9 =6.4 (3.2-6.4) μM in 50% plasma), S.aureus LUH14616 (LC99.9 = 3.2(3.2-6.4) μM in PBS buffer, LC99.9 = 12.8 (3.2-12.8) μM in 50% plasma).##Multi-drug resistant (MDR) and pan-drug resistant (PDR) gram-negative bacteria: K.pneumoniae LUH8995 (LC99.9 = 1.6(0.8-1.6) μM in PBS buffer, LC99.9 = 3.2 μM in 50% plasma), A.baumannii RUH875 (LC99.9 = 1.6(1.6-3.2) μM in PBS buffer, LC99.9 =6.4 (6.4-12.8) μM in 50% plasma), P.aeruginosa LUH15100 (LC99.9 = 4.8(3.2-6.4) μM in PBS buffer, LC99.9 > 204.8 μM in 50% plasma), E.cloacae LUH15114 (LC99.9 = 25.6 μM in PBS buffer, LC99.9 = 204.8 μM in 50% plasma)##Note: Results are expressed as the lethal concentration (LC) 99.9%, i.e. the lowest peptide concentration that resulted in >= 99.9% killing of bacteria after 2 h of incubation in PT buffer (10 mM phosphate buffer, pH 7.0, with 1% (v/v) TSB), phosphate buffered saline (PBS, pH 7.4) and in PBS with 50% (v/v) human plasma (one experiment, performed in duplicate). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation		L	[Ref.32891601]Up to 40 μM TC19 did not permeabilize human fibroblasts, whereas at 80 μM an increase in PI-positivity was recorded after 4 h of exposure. After 4h of incubation with TC19 at indicated concentration (80 μM), PI-uptake by normal human dermal fibroblasts (NHDF) had increased from 5% to 20% comparing to the result after 1h of incubation.	Bacterial membrane	32376222	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183282. doi: 10.1016/j.bbamem.2020.183282. Epub 2020 May 3.	Riool M, de Breij A, Kwakman PHS, Schonkeren-Ravensbergen E, de Boer L, Cordfunke RA, Malanovic N, Drijfhout JW, Nibbering PH, Zaat SAJ.	Thrombocidin-1-derived antimicrobial peptide TC19 combats superficial multi-drug resistant bacterial wound infections 	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP29057	RIVQRIKKWLLKWKKLGY	18	P5	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helical	Not found		Comment: This new peptide could be good candidates for future drug development for anti-biofilm and anti-infective therapy.	[Ref.31778756] Gram-negative bacteria: P. aeruginosa (MIC = 64 μg/mL, MBC = 128 μg/mL); ##Gram-positive bacteria: S. aureus (MIC = 16 µg/mL, MBC = 64 μg/mL)	[Ref.31778756]P5 displayed less than 10% hemolysis in all the range tested (0-1024 μg/mL)	Linear 	Free	Free		L	Not found	Bacterial cytoplasmic membranes	31778756	Microb Pathog. 2020 Feb;139:103886. doi: 10.1016/j.micpath.2019.103886. Epub 2019 Nov 25.	Martínez M, Polizzotto A, Flores N, Semorile L, Maffía PC	Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP29058	KGLLRKWGKKWKEFLRRVW	19	P6.2	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	Synthetic form	α-helical	Not found		Comment: This new peptide could be good candidates for future drug development for anti-biofilm and anti-infective therapy.	[Ref.31778756] Gram-negative bacteria: P. aeruginosa (MIC = 16 μg/mL, MBC = 32 μg/mL); ##Gram-positive bacteria: S. aureus (MIC = 32 µg/mL, MBC = 128 μg/mL)	[Ref.31778756]P6.2 exhibited a concentration dependent hemolytic activity, reaching values of 30% at the highest concentration(1024 μg/mL), but remaining below 5% until 128 μg/ml, which is fourfold or eightfold the MIC obtained for S.aureus or P.aeruginosa, respectively.	Linear 	Free	Free		L	Not found	Bacterial cytoplasmic membranes	31778756	Microb Pathog. 2020 Feb;139:103886. doi: 10.1016/j.micpath.2019.103886. Epub 2019 Nov 25.	Martínez M, Polizzotto A, Flores N, Semorile L, Maffía PC	Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2 	CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
DRAMP29059	FLQRIIGALGRLF	13	temporin-GHaR	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	α-helical	Not found		Comment: It showed potent antimicrobial activity with strong hemolytic toxicity	[Ref.33291521] Gram-positive bacteria: S. aureus(MIC / MBC = 1.6μM / 1.6μM), B. subtilis(MIC / MBC = 12.5μM / 25μM), S. mutans(MIC / MBC = 3.1μM / 6.2μM), MRSA(MIC / MBC = 3.1μM / 3.1μM), MRSA-1(MIC /MBC = 3.1μM / 25μM), MRSA-2(MIC / MBC = 6.2μM / 12.5μM), MRSA-3(MIC / MBC = 3.1μM /6.2μM)##Gram-negative bacteria: E. coli(MIC / MBC = 6.2μM / 6.2μM),  D31(MIC /MBC = 12.5μM / 25μM), P. aeruginosa(MIC / MBC = 6.2μM / 6.2μM), PAO1(MIC / MBC = 25μM / 50μM)##Fungi: C. albicans(MIC / MBC = 12.5μM / 50μM)	[Ref.33291521]HL50 = 48μM against human red blood cells (hRBCs)	Linear 	Free	Free		L	Not found	Cell membrane	33291521	Molecules. 2020 Dec 4;25(23):5724. doi: 10.3390/molecules25235724.	Wei H, Xie Z, Tan X, Guo R, Song Y, Xie X, Wang R, Li L, Wang M, Zhang Y	Temporin-Like Peptides Show Antimicrobial and Anti-Biofilm Activities against Streptococcus mutans with Reduced Hemolysis 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC
DRAMP29060	FLQRIRGALGRLF	13	GHaR6R (variant of temporin-GHaR)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	α-helical	Not found		Comment: GHaR6R not only exerted antimicrobial activity by destroying cell membranes of planktonic bacteria, but also exhibited anti-biofilm activity. The low-toxicity peptides of GHaR6R is expected to become promising antimicrobial candidate to develop anti-caries agents.	[Ref.33291521] Gram-positive bacteria: S. aureus(MIC / MBC = 3.1μM / 12.5μM), B. subtilis(MIC / MBC = 25μM / 50μM), S. mutans(MIC / MBC = 12.5μM /  12.5μM), MRSA(MIC / MBC = 6.2μM / 12.5μM), MRSA-1(MIC /MBC = 12.5μM / 25μM), MRSA-2(MIC / MBC = 12.5μM / 25μM), MRSA-3(MIC / MBC = 6.2μM / 25μM)##Gram-negative bacteria: E. coli(MIC / MBC = 12.5μM / 12.5μM),  D31(MIC /MBC = 25μM / 50μM), P. aeruginosa(MIC / MBC > 50μM / 50μM), PAO1(MIC / MBC = 3.1μM / 25μM)##Fungi: C. albicans(MIC / MBC = 50μM / 50μM)	[Ref.33291521]HL10 = 150μM against human red blood cells (hRBCs)	Linear 	Free	Free		L	[Ref.33291521]GHaR6R induced a cell viability of 98%, 95% and 83% to human oral epithelial cells at 3.1μM, 6.2μM and 12.5μM.	Cell membrane	33291521	Molecules. 2020 Dec 4;25(23):5724. doi: 10.3390/molecules25235724.	Wei H, Xie Z, Tan X, Guo R, Song Y, Xie X, Wang R, Li L, Wang M, Zhang Y	Temporin-Like Peptides Show Antimicrobial and Anti-Biofilm Activities against Streptococcus mutans with Reduced Hemolysis 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP29061	FLQRIIRALGRLF	13	GHaR7R (variant of temporin-GHaR)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	α-helical	Not found		Comment: GHaR6R not only exerted antimicrobial activity by destroying cell membranes of planktonic bacteria, but also exhibited anti-biofilm activity. However, the hemolysis and cytotoxicity to HOECs of GHaR7R is too strong to make it not suitable be a good antimicrobial candidate	[Ref.33291521] Gram-positive bacteria: S. aureus(MIC / MBC = 3.1μM / 3.1μM), B. subtilis(MIC / MBC > 50μM / 50μM), S. mutans(MIC / MBC = 6.2μM /  12.5μM), MRSA(MIC / MBC = 3.1μM / 6.2μM), MRSA-1(MIC /MBC = 6.2μM / 25μM), MRSA-2(MIC / MBC = 6.2μM / 50μM), MRSA-3(MIC / MBC = 6.2μM / 25μM)##Gram-negative bacteria: E. coli(MIC / MBC = 3.1μM / 12.5μM),  D31(MIC /MBC = 12.5μM / 50μM), P. aeruginosa(MIC / MBC > 50μM / 50μM), PAO1(MIC / MBC > 50μM / 50μM)##Fungi: C. albicans(MIC / MBC = 25μM / 25μM)	[Ref.33291521]HL50 = 10μM against human red blood cells (hRBCs)	Linear 	Free	Free		L	[Ref.33291521]GHaR6R induced a cell viability of 62%, 50% and 39% to human oral epithelial cells at 3.1μM, 6.2μM and 12.5μM.	Cell membrane	33291521	Molecules. 2020 Dec 4;25(23):5724. doi: 10.3390/molecules25235724.	Wei H, Xie Z, Tan X, Guo R, Song Y, Xie X, Wang R, Li L, Wang M, Zhang Y	Temporin-Like Peptides Show Antimicrobial and Anti-Biofilm Activities against Streptococcus mutans with Reduced Hemolysis 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC
DRAMP29062	FLQRIIGRLGRLF	13	GHaR8R (variant of temporin-GHaR)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	α-helical	Not found		Comment: GHaR6R not only exerted antimicrobial activity by destroying cell membranes of planktonic bacteria, but also exhibited anti-biofilm activity. The low-toxicity peptides of GHaR6R is expected to become promising antimicrobial candidate to develop anti-caries agents.	[Ref.33291521] Gram-positive bacteria: S. aureus(MIC / MBC = 1.6-3.1μM / 3.1μM), B. subtilis(MIC / MBC = 12.5μM / 12.5μM), S. mutans(MIC / MBC = 6.2μM /  6.2μM), MRSA(MIC / MBC = 3.1μM / 3.1μM), MRSA-1(MIC /MBC = 6.2μM / 6.2μM), MRSA-2(MIC / MBC = 3.1μM / 12.5μM), MRSA-3(MIC / MBC = 6.2μM / 12.5μM)##Gram-negative bacteria: E. coli(MIC / MBC = 3.1μM / 3.1μM),  D31(MIC /MBC = 12.5μM / 25μM), P. aeruginosa(MIC / MBC > 50μM / 50μM), PAO1(MIC / MBC = 6.2μM / 12.5μM)##Fungi: C. albicans(MIC / MBC = 12.5μM / 12.5μM)	[Ref.33291521]HL50 = 160μM against human red blood cells (hRBCs)	Linear 	Free	Free		L	[Ref.33291521]GHaR6R induced a cell viability of 83%, 64% and 50% to human oral epithelial cells at 3.1μM, 6.2μM and 12.5μM.	Cell membrane	33291521	Molecules. 2020 Dec 4;25(23):5724. doi: 10.3390/molecules25235724.	Wei H, Xie Z, Tan X, Guo R, Song Y, Xie X, Wang R, Li L, Wang M, Zhang Y	Temporin-Like Peptides Show Antimicrobial and Anti-Biofilm Activities against Streptococcus mutans with Reduced Hemolysis 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC
DRAMP29063	FLQRIIGARGRLF	13	GHaR9R (variant of temporin-GHaR)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	Not found	the α-helical structure of GHaR9R was destroyed		Comment: The antimicorbial activity of GHaR9R is bad comparing to other temporin-GHaR modified peptides.	[Ref.33291521] Gram-positive bacteria: S. aureus(MIC / MBC = 6.2μM / 12.5μM), B. subtilis(MIC / MBC > 50μM / 50μM), S. mutans(MIC / MBC > 50μM / 50μM), MRSA(MIC / MBC > 50μM / 50μM), MRSA-1(MIC / MBC > 50μM / 50μM), MRSA-2(MIC / MBC > 50μM / 50μM), MRSA-3(MIC / MBC > 50μM / 50μM)##Gram-negative bacteria: E. coli(MIC / MBC > 50μM / 50μM),  D31(MIC / MBC > 50μM / 50μM), P. aeruginosa(MIC / MBC > 50μM / 50μM), PAO1(MIC / MBC > 50μM / 50μM)##Fungi: C. albicans(MIC / MBC > 50μM / 50μM)	[Ref.33291521]GHaR9R didn t show hemolytic toxicity even when the concentration was raised up to 200 μM.	Linear 	Free	Free		L	Not found	Cell membrane	33291521	Molecules. 2020 Dec 4;25(23):5724. doi: 10.3390/molecules25235724.	Wei H, Xie Z, Tan X, Guo R, Song Y, Xie X, Wang R, Li L, Wang M, Zhang Y	Temporin-Like Peptides Show Antimicrobial and Anti-Biofilm Activities against Streptococcus mutans with Reduced Hemolysis 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC
DRAMP29064	FLQRIIGAWGRLL	13	GHaR9W (variant of temporin-GHaR)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	α-helical	Not found		Comment: GHaR6R not only exerted antimicrobial activity by destroying cell membranes of planktonic bacteria, but also exhibited anti-biofilm activity. The low-toxicity peptides of GHaR6R is expected to become promising antimicrobial candidate to develop anti-caries agents.	[Ref.33291521] Gram-positive bacteria: S. aureus(MIC / MBC = 3.1μM / 6.2μM), B. subtilis(MIC / MBC = 12.5μM / 50μM), S. mutans(MIC / MBC = 6.2μM /  6.2μM), MRSA(MIC / MBC = 6.2μM / 12.5μM), MRSA-1(MIC / MBC = 6.2μM / 12.5μM), MRSA-2(MIC / MBC = 6.2μM / 12.5μM), MRSA-3(MIC / MBC = 6.2μM / 12.5μM)##Gram-negative bacteria: E. coli(MIC / MBC = 12.5μM / 12.5μM),  D31(MIC /MBC = 12.5μM / 50μM), P. aeruginosa(MIC / MBC > 50μM / 50μM), PAO1(MIC / MBC = 25μM / 50μM)##Fungi: C. albicans(MIC / MBC = 25μM / 25μM)	[Ref.33291521]HL50 = 90μM against human red blood cells (hRBCs)	Linear 	Free	Free		L	[Ref.33291521]GHaR6R induced a cell viability of 74%, 63% and 60% to human oral epithelial cells at 3.1μM, 6.2μM and 12.5μM.	Cell membrane	33291521	Molecules. 2020 Dec 4;25(23):5724. doi: 10.3390/molecules25235724.	Wei H, Xie Z, Tan X, Guo R, Song Y, Xie X, Wang R, Li L, Wang M, Zhang Y	Temporin-Like Peptides Show Antimicrobial and Anti-Biofilm Activities against Streptococcus mutans with Reduced Hemolysis 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP29065	KTMMQSGGTFGTFMAIGMGIR	21	AMPR-11(derived from Romo1)	P60602	Belongs to the MGR2 family.	ROMO1	Homo sapiens (Human)	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Protein level	α-helical	AMPR-11 formed a random coil structure in distilled water but formed an ordered conformation in 50% hexafluoro-2-propanol (HFIP), which has been used for implementing a membrane-mimic environment 		Comment: AMP derived from Romo1 (AMPR-11) is a promising agent for treatment of sepsis caused by MDR bacteria, and AMPR-11 could be combined with other potential antibiotics for clinical treatment.	[Ref.33291307] Gram-positive bacteria: S. aureus(MBC=100 μg/mL), B. subtilis(MBC=90 μg/mL), E. faecium(MBC=85 μg/mL), S. sindenensis(MBC=95 μg/mL), E. faecalis(MBC=85 μg/mL), S. pneumoniae(MBC=100 μg/mL)##Gram-negative bacteria: E. coli(MBC=85 μg/mL), P. aeruginosa(MBC=100 μg/mL), K. pneumoniae(MBC=100 μg/mL), A. baumannii(MBC=100 μg/mL), E. aerogenes(MBC=90 μg/mL)##Multi-drug resistant bacteria: Methicillin-resistant S. aureus(MBC=100 μg/mL), Carbapenem-resistant P. aeruginosa(MBC=110 μg/mL), Carbapenem-resistant A. baumannii(MBC=110 μg/mL), Carbapenem-resistant K. pneumoniae(MBC=100 μg/mL), Vancomycin-resistant S. aureus(MBC=120 μg/mL), Vancomycin-resistant E. faecium(MBC=100 μg/mL )	[Ref.33291307]At the concentration of 32 μg/mL, AMPR-11 induced a hemolysis of 20% on mouse red blood cells; At the concentration of 256 μg/mL, AMPR-11 induced a hemolysis of 23%.	Linear 	Free	Free		L	[Ref.33291307] ①The cell viability of HeLa cells was 90%, 87%, 83% and 79% at the concentration of 32, 64, 128 and 256 μg/mL. ②The cell viability of HEK293 cells was 86%, 83%, 80% and 78% at the concentration of 32, 64, 128 and 256 μg/mL. ③The cell viability of HeLa cells was 89%, 86%, 83% and 80% at the concentration of 32, 64, 128 and 256 μg/mL. 	Bacterial membrane	32291307	mBio. 2020 Apr 14;11(2):e03258-19. doi: 10.1128/mBio.03258-19.	Lee HR, You DG, Kim HK, Sohn JW, Kim MJ, Park JK, Lee GY, Yoo YD	Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP29066	GFAWNVCVYRNGVRVCHRRAN	21	Marine peptide-N6	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	β-turn, coil and antiparallel sheet	①The structure analysis showed that N6  have one rigid disulfide bridge Cys7-Cys16, which links the two β-strands (Cys3-Asn10 and Arg13-Cys20) and forms an anti-parallel β-sheet. ②The secondary structures of N6NH2 and N6 in ddH2O were characterized by a coil and antiparallel strand or β-turn with a negative minimum at 200 nm. N6NH2 showed a more significant increase in α-helix and antiparallel strand in SDS solution than N6. Similarly, the CD spectrum of N6 and N6NH2 in 50% TFE showed one negative dichroic band at approximately 205 nm, and the positive maximum at 180 nm (strong) and at 230 nm 	5Y0H	Comment: N6NH2 and N6 are different from common antimicrobial peptides in the secondary structure. N6 has good antimicrobial activity.	[Ref.33348729] Gram-negative bacteria: Edwardsiella tarda(MIC = 6.4 μg/mL), Aeromonas veronii(MIC = 6.4 μg/mL), Escherichia coli CVCC195(MIC = 0.5 μg/mL), E. coli CVCC1515(MIC = 1 μg/mL), E. coli CVCC25922(MIC = 0.25 μg/mL), E. coli CVCCO157(MIC = 0.5 μg/mL), Salmonella typhimurium CVCC533(MIC = 1 μg/mL), S. typhimurium ATCC14028(MIC = 2 μg/mL), S. enteritidis CVCC3377(MIC = 0.25 μg/mL), S. pullorum CVCC1802(MIC = 0.5 μg/mL), S. pullorum CVCC1789(MIC = 0.5 μg/mL), Pseudomonas aeruginosa CICC21630(MIC = 4 μg/mL). ##Gram-positive bacteria: Staphylococcus aureus ATCC43300(MIC = 16 μg/mL), S. aureus ATCC546(MIC = 4 μg/mL), S. aureus ATCC25923(MIC = 0.25 μg/mL), S. hyicus 437-2(MIC = 64 μg/mL), S. hyicus 15095(MIC = 16 μg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free	There is a disulfide bond between Cys7 and Cys16	L	[Ref.33348729]Had very low cytotoxicity to mouse peritoneal RAW 264.7 macrophages (cell survival rate >93.35%)	Lipopolysaccharide (LPS) and genomic DNA	33348729	Mar Drugs. 2020 Dec 17;18(12):650. doi: 10.3390/md18120650.	Han H, Li T, Wang Z, Teng D, Mao R, Hao Y, Yang N, Wang X, Wang J.	Improved Stability and Activity of a Marine Peptide-N6NH2 against Edwardsiella tarda and Its Preliminary Application in Fish 	
DRAMP29067	GFAWNVCVYRNGVRVCHRRAN	21	N6NH2 (N6 amidated at its C-terminus)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	β-turn, coil and antiparallel sheet	①The structure analysis showed that N6  have one rigid disulfide bridge Cys7-Cys16, which links the two β-strands (Cys3-Asn10 and Arg13-Cys20) and forms an anti-parallel β-sheet. ②The secondary structures of N6NH2 and N6 in ddH2O were characterized by a coil and antiparallel strand or β-turn with a negative minimum at 200 nm. N6NH2 showed a more significant increase in α-helix and antiparallel strand in SDS solution than N6. Similarly, the CD spectrum of N6 and N6NH2 in 50% TFE showed one negative dichroic band at approximately 205 nm, and the positive maximum at 180 nm (strong) and at 230 nm 	5Y0H	Comment: In the model of fish peritonitis caused by E. tarda, superior to norfloxacin, N6NH2 improved the survival rate of fish, reduced the bacterial load on the organs, alleviated the organ injury and regulated the immunity of the liver and kidney. Amidation of the C-termini seems to be important in improving the lytic activity of the peptides against pathogenic bacteria. N6NH2 and N6 are different from common antimicrobial peptides in the secondary structure.	[Ref.33348729] Gram-negative bacteria: Edwardsiella tarda(MIC = 0.5 μg/mL), Aeromonas veronii(MIC = 2 μg/mL), Escherichia coli CVCC195(MIC = 0.06 μg/mL), E. coli CVCC1515(MIC = 0.06 μg/mL), E. coli CVCC25922(MIC = 0.06 μg/mL), E. coli CVCCO157(MIC = 0.06 μg/mL), Salmonella typhimurium CVCC533(MIC = 0.25 μg/mL), S. typhimurium ATCC14028(MIC = 0.06 μg/mL), S. enteritidis CVCC3377(MIC = 0.06 μg/mL), S. pullorum CVCC1802(MIC = 0.25 μg/mL), S. pullorum CVCC1789(MIC = 0.06 μg/mL), Pseudomonas aeruginosa CICC21630(MIC = 0.06 μg/mL). ##Gram-positive bacteria: Staphylococcus aureus ATCC43300(MIC = 1 μg/mL), S. aureus ATCC546(MIC = 1 μg/mL), S. aureus ATCC25923(MIC = 1 μg/mL), S. hyicus 437-2(MIC = 16 μg/mL), S. hyicus 15095 (MIC = 4 μg/mL).	[Ref.33348729]The hemolysis of N6NH2 towards mouse erythrocytes was 0.19% at a concentration of 256 μg/mL, lower than that of N6 (1.9%), indicating their low hemolytic activity 	Cyclic 	Free	Amidation	There is a disulfide bond between Cys7 and Cys16	L	[Ref.33348729]Had very low cytotoxicity to mouse peritoneal RAW 264.7 macrophages (cell survival rate >93.35%)	Lipopolysaccharide (LPS) and genomic DNA	33348729	Mar Drugs. 2020 Dec 17;18(12):650. doi: 10.3390/md18120650.	Han H, Li T, Wang Z, Teng D, Mao R, Hao Y, Yang N, Wang X, Wang J.	Improved Stability and Activity of a Marine Peptide-N6NH2 against Edwardsiella tarda and Its Preliminary Application in Fish 	
DRAMP29068	kFwSLLkKAlrLwKkVL	17	CPF-2-1 (Variant of CPF-C1)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	α-helical (most likely)	Not found		Comment: CPF-2 has potential as a lead compound to treat infections caused by S. aureus and MRSA, including the associated biofilms.	[Ref.32590058] Gram-positive: S. aureus ATCC 25923 (MIC = 16 μg/mL, MIC = 16 μg/mL in 10% serum, MIC = 32 μg/mL in 150 mM)	[Ref.32590058]It showed almost no hemolytic activity, even at concentrations up to 128 μg/ml.	Linear 	Free	Amidation	Introduction of D-amino acid(s). (Look at 'Stereochemistry')	Mixed (D-Lys1, D-Trp3, D-Lys7, D-Leu10, D-Arg11, D-Trp13 and D-Lys15)	Not found	Bacterial membrane	32590058	Biochimie. 2020 Sep;176:1-11. doi: 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.	Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.	CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA 	
DRAMP29069	kFwSLLkKAlrLwAkVL	17	CPF-2-2 (Variant of CPF-C1)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	α-helical (most likely)	Not found		Comment: CPF-2 has potential as a lead compound to treat infections caused by S. aureus and MRSA, including the associated biofilms.	[Ref.32590058] Gram-positive: S. aureus ATCC 25923 (MIC = 8 μg/mL, MIC = 128 μg/mL in 10% serum, MIC = 8 μg/mL in 150 mM, MBIC50 = 16 μg/mL, MBIC90 = 16 μg/mL, MBEC = 16 μg/mL), MRSA ATCC 33591 (MIC = 8 μg/mL), MRSA 054 isolated from clinics (MIC = 8 μg/mL), MRSA 023 isolated from clinics (MIC = 8 μg/mL), MRSA 113 isolated from clinics (MIC = 8 μg/mL), MRSA 048 isolated from clinics (MIC = 8 μg/mL), MRSA 002 isolated from clinics (MIC = 8 μg/mL), MRSA 074 isolated from clinics (MIC = 8 μg/mL), MRSA 051 isolated from clinics (MIC = 16 μg/mL), MRSA 052 isolated from clinics (MIC = 8 μg/mL), MRSA 075 isolated from clinics (MIC = 8 μg/mL), MRSA 071 isolated from clinics (MIC = 8 μg/mL), MRSA 936 isolated from clinics (MIC = 8 μg/mL), S. aureus 725 (MIC = 16 μg/mL), S. aureus 794 (MIC = 8 μg/mL)	[Ref.32590058]It showed almost no hemolytic activity, even at concentrations up to 128 μg/ml	Linear 	Free	Amidation	Introduction of D-amino acid(s). (Look at 'Stereochemistry')	Mixed (D-Lys1, D-Trp3, D-Lys7, D-Leu10, D-Arg11, D-Trp13 and D-Lys15)	Not found	Bacterial membrane	32590058	Biochimie. 2020 Sep;176:1-11. doi: 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.	Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.	CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA 	
DRAMP29070	GFGSLLGKALRLWKKVL	17	CPF-13 (Variant of CPF-C1)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	α-helical	Not found		Comment: CPF-13 showed improved antimicrobial activities against S. aureus and stabilities in serum and salt solution.	[Ref.32590058] Gram-positive: S. aureus ATCC 25923 (MIC = 4 μg/mL, MIC = 8 μg/mL in 10% serum, MIC = 4 μg/mL in 150 mM, MBIC50 = 4 μg/mL, MBIC90 = 8 μg/mL, MBEC = 8 μg/mL), MRSA ATCC 33591 (MIC = 8 μg/mL), MRSA 054 isolated from clinics (MIC = 8 μg/mL), MRSA 023 isolated from clinics (MIC = 8 μg/mL), MRSA 113 isolated from clinics (MIC = 8 μg/mL), MRSA 048 isolated from clinics (MIC = 8 μg/mL), MRSA 002 isolated from clinics (MIC = 8 μg/mL), MRSA 074 isolated from clinics (MIC = 8 μg/mL), MRSA 051 isolated from clinics (MIC = 8 μg/mL), MRSA 052 isolated from clinics (MIC = 8 μg/mL), MRSA 075 isolated from clinics (MIC = 8 μg/mL), MRSA 071 isolated from clinics (MIC = 8 μg/mL), MRSA 936 isolated from clinics (MIC = 8 μg/mL), S. aureus 725 (MIC = 8 μg/mL), S. aureus 794 (MIC = 8 μg/mL)	[Ref.32590058]It showed significant toxicity at high concentrations. At the concentration of 16, 32, 64 and 128 μg/mL, CPF-13 displayed 2%, 10%, 72% and 72% hemolysis, respectively.	Linear 	Free	Amidation		L	Not found	Bacterial membrane	32590058	Biochimie. 2020 Sep;176:1-11. doi: 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.	Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.	CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(N)=O
DRAMP29071	GFGSLLGKALRLwKkVL	17	CPF-14 (Variant of CPF-C1)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	α-helical	Not found		Comment: CPF-14 showed improved antimicrobial activities against S. aureus and stabilities in serum and salt solution.	[Ref.32590058] Gram-positive: S. aureus ATCC 25923 (MIC = 8 μg/mL, MIC = 4 μg/mL in 10% serum, MIC = 8 μg/mL in 150 mM, MBIC50 = 16 μg/mL, MBIC90 = 16 μg/mL, MBEC = 32 μg/mL), MRSA ATCC 33591 (MIC = 8 μg/mL), MRSA 054 isolated from clinics (MIC = 8 μg/mL), MRSA 023 isolated from clinics (MIC = 8 μg/mL), MRSA 113 isolated from clinics (MIC = 8 μg/mL), MRSA 048 isolated from clinics (MIC = 8 μg/mL), MRSA 002 isolated from clinics (MIC = 8 μg/mL), MRSA 074 isolated from clinics (MIC = 8 μg/mL), MRSA 051 isolated from clinics (MIC = 8 μg/mL), MRSA 052 isolated from clinics (MIC = 8 μg/mL), MRSA 075 isolated from clinics (MIC = 8 μg/mL), MRSA 071 isolated from clinics (MIC = 8 μg/mL), MRSA 936 isolated from clinics (MIC = 8 μg/mL), S. aureus 725 (MIC = 8 μg/mL), S. aureus 794 (MIC = 8 μg/mL)	[Ref.32590058]It exhibited low hemolytic activity against mouse RBCs. CPF-14 displayed 4% and 13% hemolysis at the concentration of 64 and 128 μg/mL	Linear 	Free	Amidation	Introduction of D-amino acid(s). (Look at 'Stereochemistry')	Mixed (D-Trp13 and D-Lys15)	Not found	Bacterial membrane	32590058	Biochimie. 2020 Sep;176:1-11. doi: 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.	Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.	CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA 	
DRAMP29072	GFGSLLGKAlrLwKkVL	17	CPF-15 (Variant of CPF-C1)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+	Synthetic form	α-helical (most likely)	Not found		Comment: CPF-15 had low antimicrobial activity.	[Ref.32590058] Gram-positive: S. aureus ATCC 25923 (MIC = 64 μg/mL)	[Ref.32590058]It showed significant toxicity at high concentrations. CPF-15 displayed 5%, 12%, 23%, 50% and 67% at the concentrations of 8, 16, 32, 64, 128 μg/mL	Linear 	Free	Amidation	Introduction of D-amino acid(s). (Look at 'Stereochemistry')	Mixed (D-Leu10, D-Arg11,D-Trp13 and D-Lys15)	Not found	Bacterial membrane	32590058	Biochimie. 2020 Sep;176:1-11. doi: 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.	Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.	CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA 	
DRAMP29073	RIVELTLPRVSVRL	14	CF-14	No entry found	Not found		Catfish skin mucus	Antimicrobial, Antibacterial, Anti-Gram-	Protein level	It formed α-helix in PBS with 2.5% SDS but exhibited low α-content in PBS only.	The CD spectra exhibited low α-helical content in PBS only. However, in PBS with 2.5% SDS, the CD spectra for CF-14 showed double-negative bands at 208 nm and 222 nm, indicating that CF-14 formed an α-helical structure under membrane-mimetic conditions.		Comment: These results strongly indicated that CF-14 could be a potential novel antibiotic agent against E.coli. Hence, understanding the antibacterial mechanism and analyzing the amino acid sequence of CF-14 can aid in designing effective antimicrobial agents.	[Ref.32205189] Gram-negative bacteria: E.coli (MIC = 31.3 μg/mL); ##[Ref.31291603]Gram-positive bacteria: S. putrefaciens (MIC = 62.5 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation		L	Not found	Bacterial DNA	32205189##31291603	Fish Shellfish Immunol. 2020 May;100:489-495. doi: 10.1016/j.fsi.2020.03.038. Epub 2020 Mar 20.##Fish Shellfish Immunol. 2019 Sep;92:881-888. doi: 10.1016/j.fsi.2019.07.015. Epub 2019 Jul 7.	Li T, Liu Q, Chen H, Li J##Tingting Li, Quanwei Liu, Dangfeng Wang, Jianrong Li	Antibacterial activity and mechanism of the cell-penetrating peptide CF-14 on the gram-negative bacteria, Escherichia coli.##Characterization and antimicrobial mechanism of CF-14, a new antimicrobial peptide from the epidermal mucus of catfish	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O)C(C)C
DRAMP29074	KRFWQLVPLAIKIYRAWKRR	20	dCATH (duck cathelicidin)	A0A493U1S6	Not found		Anas platyrhynchos platyrhynchos (Northern mallard)	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	Unknown	Initially, four analog peptides were designed by truncating two, four, six, and eight amino acids at the N-terminal ends of dCATH peptide. dCATH and its truncated analogs could not adopt the amphipathic α-helical structure since the hydrophobic and charged residues were dispersed all around the molecule. 		Comment: The peptide induces potent antimicrobial activity.	[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 8 μM), S. epidermidis KCTC 1917 (MIC = 8 μM), B. subtilis KCTC 3068 (MIC = 8 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 16 μM), MRSA CCARM 3090 (MIC = 16 μM), MRSA CCARM 3095 (MIC = 8 μM), VREF ATCC 51559(MIC = 16 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 8 μM), P. aeruginosa KCTC 1637(MIC = 16 μM), S. typhimurium KCTC 1926 (MIC = 4 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 16 μM), MDRPA CCARM 2109 (MIC = 16 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 8 μM), C. albicans KCTC 7121 (MIC = 16 μM).	[Ref.32698035] HC10 = 5.1 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).	Linear 	Free	Free		L	[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40 and 80 μM, the cell survival of dCATH against human bone marrow SH-SY5Y cells is 103%, 103%, 100%, 68%, 36%, 13% and 8%.	Not found	32698035	Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.	Kumar SD, Shin SY	Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP29075	FWQLVPLAIKIYRAWKRR	18	dCATH 18 (modified from dCATH)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	Unknown	Initially, four analog peptides were designed by truncating two, four, six, and eight amino acids at the N-terminal ends of dCATH peptide. dCATH and its truncated analogs could not adopt the amphipathic α-helical structure since the hydrophobic and charged residues were dispersed all around the molecule. 		Comment: The peptide induces potent antimicrobial activity.	[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 8 μM), S. epidermidis KCTC 1917 (MIC = 16 μM), B. subtilis KCTC 3068 (MIC = 8 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 32 μM), MRSA CCARM 3090 (MIC = 16 μM), MRSA CCARM 3095 (MIC = 32 μM), VREF ATCC 51559(MIC = 32 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 16 μM), P. aeruginosa KCTC 1637(MIC = 16 μM), S. typhimurium KCTC 1926 (MIC = 8 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 32 μM), MDRPA CCARM 2109 (MIC = 32 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 16 μM), C. albicans KCTC 7121 (MIC = 16 μM).	[Ref.32698035] HC10 = 1.3 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).	Linear 	Free	Amidation		L	[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 18 against human bone marrow SH-SY5Y cells is 102%, 83%, 75%, 52%, 23%, 9%, 7%.	Not found	32698035	Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.	Kumar SD, Shin SY	Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC
DRAMP29076	QLVPLAIKIYRAWKRR	16	dCATH 16 (modified from dCATH)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	Unknown	Initially, four analog peptides were designed by truncating two, four, six, and eight amino acids at the N-terminal ends of dCATH peptide. dCATH and its truncated analogs could not adopt the amphipathic α-helical structure since the hydrophobic and charged residues were dispersed all around the molecule. 		Comment: The peptide induces potent antimicrobial activity.	[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 8 μM), S. epidermidis KCTC 1917 (MIC = 16 μM), B. subtilis KCTC 3068 (MIC = 16 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 32 μM), MRSA CCARM 3090 (MIC = 16 μM), MRSA CCARM 3095 (MIC = 32 μM), VREF ATCC 51559(MIC = 32 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 32 μM), P. aeruginosa KCTC 1637(MIC = 16 μM), S. typhimurium KCTC 1926 (MIC = 16 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 32 μM), MDRPA CCARM 2109 (MIC = 32 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 8 μM), C. albicans KCTC 7121 (MIC = 16 μM).	[Ref.32698035] HC10 = 180 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).	Linear 	Free	Amidation		L	[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 16 against human bone marrow SH-SY5Y cells is 98%, 95%, 91%, 86%, 54%, 36%, 32%.	Not found	32698035	Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.	Kumar SD, Shin SY	Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC
DRAMP29077	VPLAIKIYRAWKRR	14	dCATH 14 (modified from dCATH)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	Unknown	Initially, four analog peptides were designed by truncating two, four, six, and eight amino acids at the N-terminal ends of dCATH peptide. dCATH and its truncated analogs could not adopt the amphipathic α-helical structure since the hydrophobic and charged residues were dispersed all around the molecule. 		Comment: The peptide induces potent antimicrobial activity.	[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 8 μM), S. epidermidis KCTC 1917 (MIC = 16 μM), B. subtilis KCTC 3068 (MIC = 4 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 32 μM), MRSA CCARM 3090 (MIC = 32 μM), MRSA CCARM 3095 (MIC = 32 μM), VREF ATCC 51559(MIC = 16 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 16 μM), P. aeruginosa KCTC 1637(MIC = 8 μM), S. typhimurium KCTC 1926 (MIC = 8 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 32  μM), MDRPA CCARM 2109 (MIC = 32 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 16 μM), C. albicans KCTC 7121 (MIC = 16 μM).	[Ref.32698035] HC10 > 256 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).	Linear 	Free	Amidation		L	[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 14 against human bone marrow SH-SY5Y cells is 103%, 101%, 100%, 100%, 91%, 74%, 70%	Not found	32698035	Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.	Kumar SD, Shin SY	Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC
DRAMP29078	LAIKIYRAWKRR	12	dCATH 12 (modified from dCATH)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	Random coil in buffer; 26.56% α-helix content in 50% TFE; 7.93% α-helix content in 30 mM SDS; 26.91% α-helix content in 0.1% LPS	Not found		Comment: Contribute to the design of short AMPs with bactericidal and immunomodulatory properties for combating bacterial infection and sepsis.	[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 8 μM), S. epidermidis KCTC 1917 (MIC = 4 μM), B. subtilis KCTC 3068 (MIC = 8 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 32 μM), MRSA CCARM 3090 (MIC = 32 μM), MRSA CCARM 3095 (MIC = 32 μM), VREF ATCC 51559(MIC = 32 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 16 μM), P. aeruginosa KCTC 1637(MIC = 4 μM), S. typhimurium KCTC 1926 (MIC = 8 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 32 μM), MDRPA CCARM 2109 (MIC = 16 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 8 μM), C. albicans KCTC 7121 (MIC = 16 μM).	[Ref.32698035] HC10 > 256 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).	Linear 	Free	Amidation		L	[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 12 against human bone marrow SH-SY5Y cells is 103%, 103%, 102%, 99%, 97%, 79%, 67%	Not found	32698035	Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.	Kumar SD, Shin SY	Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC
DRAMP29079	LAKKIYRAWKRR	12	dCATH 12-1 (modified from dCATH 12)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	Random coil in buffer; 6.24% α-helix content in 50% TFE; 7.52% α-helix content in 30 mM SDS; 8.73% α-helix content in 0.1% LPS	Not found		Comment: dCATH12-1 displayed high antimicrobial activity with minimal cytotoxicity	[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 4 μM), S. epidermidis KCTC 1917 (MIC = 8 μM), B. subtilis KCTC 3068 (MIC = 8 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 32 μM), MRSA CCARM 3090 (MIC = 16 μM), MRSA CCARM 3095 (MIC = 16 μM), VREF ATCC 51559(MIC = 16 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 8 μM), P. aeruginosa KCTC 1637(MIC = 4 μM), S. typhimurium KCTC 1926 (MIC = 4 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 32 μM), MDRPA CCARM 2109 (MIC = 32 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 8 μM), C. albicans KCTC 7121 (MIC = 8 μM).	[Ref.32698035] HC10 > 256 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).	Linear 	Free	Amidation		L	[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 12-1 against human bone marrow SH-SY5Y cells is 102%, 102%, 100%, 96%, 96%, 78%, 69%.	Not found	32698035	Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.	Kumar SD, Shin SY	Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP29080	LAKKIYRAWKRW	12	dCATH 12-2 (modified from dCATH 12)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	Random coil in buffer; 22.78% α-helix content in 50% TFE; 8.04% α-helix content in 30 mM SDS; 29.50% α-helix content in 0.1% LPS	Not found		Comment: dCATH12-2 displayed high antimicrobial activity with minimal cytotoxicity	[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 4 μM), S. epidermidis KCTC 1917 (MIC = 8 μM), B. subtilis KCTC 3068 (MIC = 4 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 32 μM), MRSA CCARM 3090 (MIC = 16 μM), MRSA CCARM 3095 (MIC = 16 μM), VREF ATCC 51559(MIC = 16 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 16 μM), P. aeruginosa KCTC 1637(MIC = 4 μM), S. typhimurium KCTC 1926 (MIC = 2 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 16 μM), MDRPA CCARM 2109 (MIC = 32 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 8 μM), C. albicans KCTC 7121 (MIC = 8 μM).	[Ref.32698035] HC10 > 256 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).	Linear 	Free	Amidation		L	[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 12-2 against human bone marrow SH-SY5Y cells is 102%, 101%, 100%, 100%, 97%, 92%, 85%.	Not found	32698035	Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.	Kumar SD, Shin SY	Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP29081	LAKKIYRKWKRW	12	dCATH 12-3 (modified from dCATH 12)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	Random coil in buffer; 27.42% α-helix content in 50% TFE; 23.60% α-helix content in 30 mM SDS; 23.51% α-helix content in 0.1% LPS	Not found		Comment: dCATH12-3 displayed high antimicrobial activity with minimal cytotoxicity	[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 4 μM), S. epidermidis KCTC 1917 (MIC = 4 μM), B. subtilis KCTC 3068 (MIC = 4 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 16 μM), MRSA CCARM 3090 (MIC = 16 μM), MRSA CCARM 3095 (MIC = 8 μM), VREF ATCC 51559(MIC = 8 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 8 μM), P. aeruginosa KCTC 1637(MIC = 4 μM), S. typhimurium KCTC 1926 (MIC = 2 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 16 μM), MDRPA CCARM 2109 (MIC = 8 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 8 μM), C. albicans KCTC 7121 (MIC = 8 μM).	[Ref.32698035] HC10 > 256 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).	Linear 	Free	Amidation		L	[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 12-3 against human bone marrow SH-SY5Y cells is 102%, 100%, 100%, 97%, 95%, 95%, 84%.	Not found	32698035	Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.	Kumar SD, Shin SY	Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP29082	LIKKIYRKWKRW	12	dCATH 12-4 (modified from dCATH 12)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	Random coil in buffer; 41.28% α-helix content in 50% TFE; 36.63% α-helix content in 30 mM SDS; 42.87% α-helix content in 0.1% LPS	Among the 12-meric analog AMPs, Trp rich dCATH 12–4 and dCATH 12-5 displayed high helicity in all membrane-mimetic environment with highest α-helical conformation observed (42.8% and 40.4% respectively) in 0.1% LPS		Comment: dCATH 12-4 demonstrated synergistic actions with various conventional antibiotics against antibiotic resistant pathogens, thus indicating their ability as promising adjuncts to combination therapy. 	[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 4 μM), S. epidermidis KCTC 1917 (MIC = 4 μM), B. subtilis KCTC 3068 (MIC = 2 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 16 μM), MRSA CCARM 3090 (MIC = 8 μM), MRSA CCARM 3095 (MIC = 8 μM), VREF ATCC 51559(MIC = 8 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 8 μM), P. aeruginosa KCTC 1637(MIC = 2 μM), S. typhimurium KCTC 1926 (MIC = 2 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 8 μM), MDRPA CCARM 2109 (MIC = 8 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 8 μM), C. albicans KCTC 7121 (MIC = 4 μM).	[Ref.32698035] HC10 > 256 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).	Linear 	Free	Amidation		L	[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 12-4 against human bone marrow SH-SY5Y cells is 102%, 102%, 100%, 100%, 100%, 91%, 83%.	Bacterial DNA	32698035	Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.	Kumar SD, Shin SY	Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP29083	LWKKIYRKWKRW	12	dCATH 12-5 (modified from dCATH 12)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	Random coil in buffer; 38.39% α-helix content in 50% TFE; 29.75% α-helix content in 30 mM SDS; 40.40% α-helix content in 0.1% LPS	Among the 12-meric analog AMPs, Trp rich dCATH 12–4 and dCATH 12-5 displayed high helicity in all membrane-mimetic environment with highest α-helical conformation observed (42.8% and 40.4% respectively) in 0.1% LPS		Comment: dCATH 12-5 demonstrated synergistic actions with various conventional antibiotics against antibiotic resistant pathogens, thus indicating their ability as promising adjuncts to combination therapy. 	[Ref.32698035] Gram-positive bacteria: S. aureus KCTC 1621 (MIC = 2 μM), S. epidermidis KCTC 1917 (MIC = 4 μM), B. subtilis KCTC 3068 (MIC = 2 μM);##Resistant Gram-positive bacteria: MRSA CCARM 3089 (MIC = 16 μM), MRSA CCARM 3090 (MIC = 8 μM), MRSA CCARM 3095 (MIC = 8 μM), VREF ATCC 51559(MIC = 8 μM);##Gram-negative bacteria: E. coli KCTC 1682 (MIC = 4 μM), P. aeruginosa KCTC 1637(MIC = 2 μM), S. typhimurium KCTC 1926 (MIC = 2 μM);##Resistant Gram-negative bacteria: MDRPAd CCARM 2095 (MIC = 8 μM), MDRPA CCARM 2109 (MIC = 4 μM); ##Yeast: C. albicans KCTC 7965 (MIC = 8 μM), C. albicans KCTC 7121 (MIC = 4 μM).	[Ref.32698035] HC10 > 256 μM. Note: HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).	Linear 	Free	Amidation		L	[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 12-5 against human bone marrow SH-SY5Y cells is 102%, 101%, 100%, 100%, 100%, 95%, 87%.	Bacterial DNA	32698035	Eur J Med Chem. 2020 Oct 15;204:112580. doi: 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.	Kumar SD, Shin SY	Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin: Plausible mechanism of bactericidal action and endotoxin neutralization 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP29084	GVTFNALKGVAKTVAAQLLKTAR	23	Brevinin-GR23	No entry found	Not found		Hylarana guentheri	Antimicrobial, Antibacterial, Anti-Gram-, Anti-Gram+	Synthetic form	α-helical	Not found		Comment: Although B-GR23 did not show a potent antimicrobial and antibiofilm activity, the outstanding characteristic is the low toxicity on human blood red cells, which makes it an ideal template peptide to derive more powerful antimicrobial peptides	[Ref.31549575] Gram-positive bacteria: Staphylococcus aureus (MIC = 16 μM), Streptococcus mutans(MIC > 100 μM);##Gram-negative bacteria: Escherichia coli (MIC = 64 μM), Pseudomonas aeruginosa(MIC > 100 μM);##Yeast: Canidia albican (MIC > 100 μM)	[Ref.31549575]B-GR23 induced a hemolysis of 0.13%, 0.23%, 0.38%, 0.75%, 0.83% and 1.60% on human blood red cells at the concentrations of 25, 50, 75, 100, 150 and 200 μM.	Linear 	Free	Amidation		L	Not found	Cell membrane	31549575	Biosci Biotechnol Biochem. 2020 Jan;84(1):143-153. doi: 10.1080/09168451.2019.1670045. Epub 2019 Sep 24.	Hengren Zhong, Zhipeng Xie, Shuxia Zhang, Hanqi Wei, Yanting Song, Yingxia Zhang, Manchuriga Wang	Brevinin-GR23 from frog Hylarana guentheri with antimicrobial and antibiofilm activities against Staphylococcus aureus	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP29085	GLVTDTLKGAAKTVAAELLRKAH	23	B-GH23-1 	No entry found	Not found		Hylarana guentheri	Antimicrobial, Antibacterial, Anti-Gram-	Synthetic form	Not found	Not found		Comment: B-GH23-1 had slight antibacterial activity on S.aureus	[Ref.31549575] Gram-positive bacteria: Staphylococcus aureus (MIC = 32-64 μM), Streptococcus mutans(MIC > 100 μM);##Gram-negative bacteria: Escherichia coli (MIC > 100 μM), Pseudomonas aeruginosa(MIC > 100 μM);##Yeast: Canidia albican (MIC > 100 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation		L	Not found	Cell membrane	31549575	Biosci Biotechnol Biochem. 2020 Jan;84(1):143-153. doi: 10.1080/09168451.2019.1670045. Epub 2019 Sep 24.	Hengren Zhong, Zhipeng Xie, Shuxia Zhang, Hanqi Wei, Yanting Song, Yingxia Zhang, Manchuriga Wang	Brevinin-GR23 from frog Hylarana guentheri with antimicrobial and antibiofilm activities against Staphylococcus aureus	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C
DRAMP29086	GVITDALKGAAKTVAAELPRKAH	23	B-GH23-2 	No entry found	Not found		Hylarana guentheri	Non-antimicrobial	Synthetic form	Not found	Not found		Comment: B-GH23-2 did not have any antimicrobial activity.	[Ref.31549575] Gram-positive bacteria: Staphylococcus aureus (MIC > 100 μM), Streptococcus mutans(MIC > 100 μM);##Gram-negative bacteria: Escherichia coli (MIC > 100 μM), Pseudomonas aeruginosa(MIC > 100 μM);##Yeast: Canidia albican (MIC > 100 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation		L	Not found	Cell membrane	31549575	Biosci Biotechnol Biochem. 2020 Jan;84(1):143-153. doi: 10.1080/09168451.2019.1670045. Epub 2019 Sep 24.	Hengren Zhong, Zhipeng Xie, Shuxia Zhang, Hanqi Wei, Yanting Song, Yingxia Zhang, Manchuriga Wang	Brevinin-GR23 from frog Hylarana guentheri with antimicrobial and antibiofilm activities against Staphylococcus aureus	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O)C(C)C)[C@@H](C)O)[C@@H](C)O
DRAMP29087	VRLIVKVRIWRR	12	RiLK1	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal	Synthetic form	Disordered structure in aqueous solution; β-sheet in the presence of SDS (3 mM)	Without SDS: 1.2% α-helix, 47.3% β-sheet, 51.5% random; t = 0 h with SDS:  7.4% α-helix, 51.4% β-sheet, 41.3% random; t = 5 min with SDS:  4.4% α-helix, 53.4% β-sheet, 42.2% random; t = 30 min with SDS: 11% α-helix, 48.7% β-sheet, 40.3% random; t = 1 h with SDS: 9.8% α-helix, 51.1% β-sheet, 39.1% random; t = 5 h with SDS: 6.7% α-helix, 54% β-sheet, 39.3% random; t = 6 h with SDS: 8% α-helix, 52% β-sheet, 40.1% random; t = 24 h with SDS: 8.4% α-helix, 53.6% β-sheet, 38% random		Comment: RiLK1 exerted potent killing effects against the clinical isolate (MBC = 1.25 M), two-fold lower than those observed against the strain isolated from food products and those determined with the parental peptide 1018-K6 against ACSSuT strain, thus, suggesting that RiLK1 might have a high potential also in the medical field.	"[Ref.32971824] Gram-negative bacteria: E.coli (IC50 = 1.20 ± 0.10 μM, MBC = 2.0 μM), S. Typhimurium (IC50 = 1.30 ± 0.14	μM, MBC = 2.5 μM);##Gram-positive bacteria: S. aureus (IC50 = 1.98 ± 0.25 μM, MBC = 16.0 μM), L. monocytogenes (IC50 = 0.46 ± 0.01 μM, MBC = 2.0 μM);##Fungi: C. albicans ATCC 14053, A. brasiliensis ATCC 9341. Susceptibility testing clearly showed that RiLK1 was very effective, being able to inhibit 100% growth of both fungi at 25 μM concentration (MFC)."	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation		L	[Ref.32971824] It was observed that the cell viability was recorded as 98%, 98.7%, and 98.9% at the concentrations of RiLK1 (10, 25, 50 μM)	Not found	32971824	Int J Mol Sci. 2020 Sep 22;21(18):6952. doi: 10.3390/ijms21186952.	Agrillo B, Proroga YTR, Gogliettino M, Balestrieri M, Tatè R, Nicolais L, Palmieri G	A Safe and Multitasking Antimicrobial Decapeptide: The Road from De Novo Design to Structural and Functional Characterization 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP29088	INWLKIAKKVKGML	14	MK58911 (a peptide analog from the mastoparan class of wasps)	No entry found	Not found		Galleria mellonella	Antimicrobial, Antifungal, Antitumor	Synthetic form	Not found	Not found		Comment: MK58911 is not toxic in two mammalian cells (lung fibroblasts and glioblastoma cells) and in the G. mellonella model and demonstrates both in vitro and in vivo antifungal efficacy. Moreover, the peptide acted on the membrane of fungal cells and induced necrosis.	[Ref.31867293] Fungi: C. neoformans (MIC = 31.2 μg/mL), C. gattii (MIC = 15.6 μg/mL), P. brasiliensis (MIC = 7.8 μg/mL), P. lutzii (MIC = 15.6 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation		L	[Ref.31867293]MK58911 was not toxic in lung fibroblasts (MRC5) and glioblastoma cells (U87) at tested concentrations, and a high IC50 of >500 μg/mL was observed in both mammalian cells.	Fungal cell membrane	31867293	Front Cell Infect Microbiol. 2019 Dec 6;9:419. doi: 10.3389/fcimb.2019.00419. eCollection 2019.	Singulani JL, Galeane MC, Ramos MD, Gomes PC, Dos Santos CT, de Souza BM, Palma MS, Fusco Almeida AM, Mendes Giannini MJS. 	Antifungal Activity, Toxicity, and Membranolytic Action of a Mastoparan Analog Peptide 	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)[C@H](C)CC
DRAMP29089	AFIQLSKPCISDKECSIVKNYRARCRKGYCVRRRIR	36	NCR044 (Putative Late nodulin)	A0A396GSL0	Not found	MtrunA17_Chr7g021623	Medicago truncatula (Barrel medic) (Medicago tribuloides)	Antimicrobial, Antifungal	Protein level	α-helix and β-sheet	NCR044 contains one short (A23 to R25, G28 to C30) antiparallel β-sheet and a whiff (S11 to E14) of an α-helix.	6U6G	Comment: The oxidized form of the NCR044 peptide exhibits potent broad-spectrum antifungal activity in vitro against four economically important fungal pathogens tested in this study. Many factors can strongly affect the efficacy of antifungal peptides. For example, disulfide bonds can help to increase potency of the oxidized form of NCR044. For deployment of NCR044 in crop protection, one could envisage further manipulating the cationicity/hydrophobicity of the oxidized or reduced NCR044 through site-directed mutagenesis and increase its antifungal potency on the surface of plant tissues without causing phytotoxicity.	[Ref.32571919] Fungi: Botrytis cinerea (IC50 = 1.55 ± 0.21 μM, IC90 = 2.72 ± 0.05 μM), Fusarium graminearum (IC50 = 1.93 ± 0.23 μM, IC90 = 2.80 ± 0.04 μM), F.virguliforme (IC50 = 1.68 ± 0.20 μM, IC90 = 2.70 ± 0.08 μM), F.oxysporum (IC50 = 0.52 ± 0.01 μM, IC90 = 0.71 ± 0.01 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free	There are two disulfide bond between Cys15 and Cys25, Cys9 and Cys30	L	Not found	Multiple membrane phospholipids	32571919	Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):16043-16054. doi: 10.1073/pnas.2003526117. Epub 2020 Jun 22.	Velivelli SLS, Czymmek KJ, Li H, Shaw JB, Buchko GW, Shah DM	Antifungal symbiotic peptide NCR044 exhibits unique structure and multifaceted mechanisms of action that confer plant protection 	
DRAMP29090	GIWKFLKKAKKFWK	14	MSI-1	No entry found	Not found		Synthetic construct	Antimicrobial, Antifungal, Anti-cryptococcal	Synthetic form	α-helical in hydrophobic environment	 Furthermore, the amphipathic structure of this peptide makes it adopt an alpha helical in hydrophobic environment which may lead to the insertion of MSI-1 into the lipid bilayer of the fungal membrane to exert antifungal activity.		Comment: The study had demonstrated the potent antifungal activity of MSI-1 against clinical isolated C. neoformans in vitro and in a murine model of cryptococcal meningoencephalitis. 	[Ref.32504765] Fungal strains: C. neoformans ATCC4906 (MIC = 8 μg/mL), C. neoformans 1201 (MIC = 8 μg/mL), C. neoformans 1768 (MIC = 16 μg/mL), C. neoformans 2011 (MIC = 8 μg/mL), C. neoformans 1386 (MIC = 16 μg/mL), C. neoformans 1965 (MIC = 16 μg/mL), C. gattii ATCC34877 (MIC = 4 μg/mL), C. albicans ATCC10231 (MIC = 32 μg/mL), C. albicans 2713 (MIC = 32 μg/mL), C. albicans 2144 (MIC = 64 μg/mL), C. albicans 1902 (MIC = 64 μg/mL), C. albicans 1869 (MIC = 32 μg/mL), C. albicans 2105 (MIC = 128 μg/mL )	No hemolysis information or data found in the reference(s) presented in this entry	Linear 	Free	Amidation		L	Not found	Fungal cell membrane	32504765	Peptides. 2020 Aug;130:170334. doi: 10.1016/j.peptides.2020.170334. Epub 2020 Jun 3.	Ma L, Wei S, Ye X, Xu P, Chen H, Liu Z, Zhou C	Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP29091	GRTSKQELCTWERGSVRQADKTIAG	25	Skh-AMP1	No entry found	Belongs to the Lamiaceae family, subfamily Nepetoideae.		Satureja khuzistanica	Antimicrobial, Antifungal	Natural peptide	α-helical	Evaluation of the peptide three-dimensional structure showed that, despite the unusual distribution of amino acids in the Wheel projection, Skh-AMP1 maybe forms a α-helix structure with more hydrophobic C-terminal than that of the N-terminal. 		Comment: The antifungal activity of Skh-AMP1 may be related to its ability to disrupt fungal cell membrane permeabilization and induce enhanced ROS production. Therefore, Skh-AMP1 can be introduced as a novel antifungal candidate for developing new therapeutic agents.	[Ref.31128493] Fungi: Candida albicans ATCC 10231 (MIC = 21.6 μM, MFC = 43.2 μM), Candida krusei DSM 70079 (MIC = 20.7 μM, MFC = 41.4 μM), Candida glabrata ATCC 90030 (MIC = 19.8 μM, MFC = 39.6 μM), Aspergillus niger ATCC 9029 (MIC = 22.5 μM, MFC = 45  μM), Aspergillus flavus PFCC 100 (MIC = 23.4 μM, MFC = 58.5 μM), Aspergillus fumigatus Af 293 (MIC = 20.7 μM, MFC = 41.4 μM)	[Ref.31128493] Using human erythrocytes, the hemolytic activity of Skh-AMP1 at concentrations from 3.6 μM to 72 μM was reported in the range of 0.19%–2.1%. At the MIC concentration of 25.2 μM, a very low hemolytic activity of 0.67% (SD = 0.02) was observed. Also, this peptide at MFC concentrations (36, 54 and 72 μM) showed 0.98%, 1.45% and 2.1% hemolytic activity for human erythrocytes.	Linear 	Free	Free		L	[Ref.31128493] Skh-AMP1 has about 3.6% cytotoxicity at the concentration of 25.2 μM in 48 h. Therefore, this peptide had no significant cytotoxic effect at the concentrations of 12.6 and 25.2 μM at 6, 24, and 48 h. However, Skh-AMP1 has about 12% and 27% cytotoxicity at the concentration of 50.4 μM and 63 μM, respectively	Fungal membrane	31704210##31128493	Peptides. 2020 Jan;123:170195. doi: 10.1016/j.peptides.2019.170195. Epub 2019 Nov 6.##Phytochemistry. 2019 Aug;164:136-143. doi: 10.1016/j.phytochem.2019.05.011. Epub 2019 May 23.	Khani S, Seyedjavadi SS, Hosseini HM, Goudarzi M, Valadbeigi S, Khatami S, Ajdary S, Eslamifar A, Amani J, Imani Fooladi AA, Razzaghi-Abyaneh M##Soghra Khani, Sima Sadat Seyedjavadi, Hadi Zare-Zardini, Hamideh Mahmoodzadeh Hosseini, Mehdi Goudarzi, Shohreh Khatami, Jafar Amani, Abbas Ali Imani Fooladi, Mehdi Razzaghi-Abyaneh	Effects of the antifungal peptide Skh-AMP1 derived from Satureja khuzistanica on cell membrane permeability, ROS production, and cell morphology of conidia and hyphae of Aspergillus fumigatus. ##Isolation and functional characterization of an antifungal hydrophilic peptide, Skh-AMP1, derived from Satureja khuzistanica leaves	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP29093	XTXXXfLXXT	10	polymyxin B (a mixture of polymyxin B1 to B4)	No entry found	Belongs to the Polymyxins family		Paenibacillus polymyxa	Antimicrobial, Antibacterial, Anti-Gram-, Anti-inflammatory	Natural peptide(s)	Ordered (the structure can not be described as α-helix, β-sheet or random coil simply)	[Ref2] According to the NMR data, there are eight structures fall into several groups, represented by the three structures. The overall structure is quite flat, with the aromatic ring oriented over the leucine methyl groups, and with a kink between residues 1−3 in the linear part of the peptide. However, differences in the ring pucker are evident, and changes in the ring pucker also affect other parts of the molecule. The peptide is interconverting among three possibilities. Changes in the ring pucker among the structures involves flipping residues 4, 8, and 9 while holding residues 6, 7, and 		Polymyxin B is an old antibiotic used to treat meningitis, pneumonia, sepsis, and urinary tract infections. While it is useful for many Gram-negative infections, it is not useful Gram-positive infections. It can be give by injection into a vein, muscle, or cerebrospinal fluid or inhaled. Polymyxin antibiotics are relatively neurotoxic and nephrotoxic, so are usually used only as a last resort if modern antibiotics are ineffective or are contraindicated. 	[Ref.16524407] Gram-negative bacteria: Acinetobacter spp. (MIC50 ≤ 1 μg/mL, MIC90 = 2 μg/mL), Aeromonas spp. (MIC50 ≤ 1 μg/mL, MIC90 ＞ 8 μg/mL), Alcaligenes spp. (MIC50 = 2 μg/mL, MIC90 > 8 μg/mL), Burkholderia cepacia (MIC50 > 8 μg/mL, MIC90 > 8 μg/mL), Pseudomonas aeruginosa (MIC50 ≤ 1 μg/mL, MIC90 = 2 μg/mL), Pseudomonas spp. (non-aeruginosa) (MIC50 ≤ 1μg/mL, MIC90 = 4 μg/mL), Stenotrophomonas maltophilia (MIC50 = 1 μg/mL, MIC90 = 8 μg/mL), other non-enteric bacilli (MIC50 = 4 μg/mL, MIC90 > 4 μg/mL); ##Enterobacteriaceae: Citrobacter spp. (MIC50 ≤ 1 μg/mL, MIC90 ≤ 1 μg/mL), Enterobacter spp. (MIC50 ≤ 1 μg/mL, MIC90 > 8 μg/mL), Escherichia coli (MIC50 ≤ 1 μg/mL, MIC90 ≤ 1 μg/mL), Klebsiella spp. (MIC50 ≤ 1μg/mL, MIC90 ≤ 1μg/mL), indole-positive Proteus spp. etc. (MIC50 > 8 μg/mL, MIC90 > 8 μg/mL), Proteus mirabilis (MIC50 > 8 μg/mL, MIC90 > 8 μg/mL), Salmonella spp. (MIC50 ≤ 1 μg/mL, MIC90 = 4 μg/mL), Shigella spp. (MIC50 ≤ 1 μg/mL, MIC90 ≤ 1 μg/mL), Serratia spp. (MIC50 > 8 μg/mL, MIC90 > 8 μg/mL), other enteric bacilli (MIC50 ≤ 1 μg/mL, MIC90 = 8 μg/mL). ##NOTE: indole-positive Proteus spp. etc. includes Morganella morganii, Proteus spp., Proteus vulgaris, Providencia alcalifaciens, Providencia rettgeri, Providencia spp. and Providencia stuartii.	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	[Ref.17878146] Acylation of fatty acid (6-methyloctanoic acid for polymyxin B1, 6-methylheptanoic acid for B2, octanoic acid for B3 and heptanoic acid for B4)	[Ref.17878146] Thr10 linking to Dab5 forming a cycle.	[Ref.17878146] ①The X in position 1, 3, 4, 5, 8 and 9 is α,γ-diaminobutyric acid (Dab). ②Dab4 links to Thr10 by amidation.	[Ref.17878146] L (mixed with D-Phe7)	Not found	Cell membrane	17878146##16524407	J Antimicrob Chemother. 2007 Dec;60(6):1206-15. doi: 10.1093/jac/dkm357. Epub 2007 Sep 17. ##Clin Microbiol Infect. 2006 Apr;12(4):315-21. doi: 10.1111/j.1469-0691.2005.01351.x.	Alexandre Prehn Zavascki, Luciano Zubaran Goldani, Jian Li, Roger L Nation ##A C Gales, R N Jones, H S Sader	Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.##Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).	
DRAMP29092	FKRLKKLISWIKRKRQQ	17	Hn-Mc (a chimeric peptide comprised of the N-terminus of HPA3NT3 and the C-terminus of melittin)	No entry found	Not found		Synthetic construct	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Anti-inflammatory	Synthetic construct	Random coil or α-helical structure	Hn-Mc adopted a random coil structure in the SUVs containing a mammalian membrane and in the buffer; however, it adopted an α-helical structure in SUVs containing a fungal membrane, indicating that it was not bound to the mammalian membrane but rather adhered to or inserted in the fungal membrane. 		Comment: Hn-Mc has a high affinity for the fungal plasma membrane and induces apoptosis in fungal cells, and provide guidance for the development of new antifungal agents. Hn-Mc is an excellent model peptide with potent antibacterial activity and non-cytotoxicity.	[Ref.32731574]Yeast: C. albicans (MIC = 16 μM), C. krusei (MIC = 8 μM), C. parapsilosis (MIC = 16 μM), C. tropicalis (MIC = 4 μM), T. beigellii (MIC = 1 μM);##Mold: T. rubrum (MIC = 1-2 μM), F. moniliforme(MIC = 1-2 μM), F. solani(MIC = 1 μM), F. oxysporum(MIC = 1-2 μM), A. flavus(MIC = 2-4 μM), A. fumigatus(MIC = 2-4 μM). ##[Ref.26028561] Drug-susceptible gram-negative bacteria: E. coli (MIC = 1 μM), P. aeruginosa (MIC = 2 μM); ##Drug-susceptible gram-positive bacteria: S. aureus (MIC = 2 μM), B. subtilis(MIC = 2 μM);##Drug-resistant bacteria:  P. aeruginosa DRPA-001 (MIC = 1 μM),  P. aeruginosa DRPA-002 (MIC = 1 μM),  P. aeruginosa DRPA-003 (MIC = 1 μM),  P. aeruginosa DRPA-004 (MIC = 1 μM),  P. aeruginosa DRPA-005 (MIC = 2 μM), S. aureus DRSA-001 (MIC = 2 μM), S. aureus DRSA-002 (MIC = 2 μM), S. aureus DRSA-003 (MIC = 1 μM), S. aureus DRSA-004 (MIC = 2 μM), S. aureus DRSA-005 (MIC = 2 μM).	[Ref.26028561] HPA3NT3 and melittin revealed the hemolysis of 68.2% and 100% at 250 μM, respectively, but Hn-Mc was 1.1% at the same concentration	Linear 	Free	Amidation		L	[Ref.26028561] The IC50 of HPA3NT3, melittin and Hn-Mc against HaCaT cells were 49.5, 2.8 and 357.5 μM, respectively	Mitochondria (possibily)	32731574##26028561	Antibiotics (Basel). 2020 Jul 28;9(8):454. doi: 10.3390/antibiotics9080454.##Biochem Biophys Res Commun. 2015 Jul 31;463(3):322-8. doi: 10.1016/j.bbrc.2015.05.063. Epub 2015 May 29.	Kim JY, Park SC, Noh G, Kim H, Yoo SH, Kim IR, Lee JR, Jang MK.##Young-Min Kim, Nam-Hong Kim, Jong-Wan Lee, Jin-Sun Jang, Yung-Hoon Park, Seong-Cheol Park, Mi-Kyeong Jang	Antifungal Effect of A Chimeric Peptide Hn-Mc against Pathogenic Fungal Strains. ##Novel chimeric peptide with enhanced cell specificity and anti-inflammatory activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)[C@H](C)CC
DRAMP29094	GPKTKAACKMACKLATCGKKPGGWKCKLCELGCDAV	36	Turgencin A	C0HLN5	Not found		Synoicum turgens	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-,Anti-cancer	Protein level	Random coil	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.32751755]Gram-positive bacteria:Bacillus megaterium(MIC=0.5 µg/mL); Bacillus subtilis(MIC=1.5 µg/mL); Corynebacterium glutamicum(MIC=1.5 µg/mL); Micrococcus luteus(MIC=8.0 µg/mL); Staphylococcus aureus(MIC=23.3 µg/mL);##Gram-negative bacteria:Escherichia coli(MIC=3.0 µg/mL); Pseudomonas aeruginosa(MIC=5.9 µg/mL);##Fungi: Rhodotorula sp(MIC=23.2 µg/mL);Aurobasidium pollulans(MIC=92.6 µg/mL); Candida albicans(MIC=46.3 µg/mL).##[Ref.31940927]Cancer:Human melanoma A2058(IC50=1.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation	Disulfide bond between Cys8 and Cys33, Cys12 and Cys29, Cys17 and Cys26; the 'Met' at position 10 is Methionine sulfoxide.	L	[Ref.31940927]Cytotoxicity: Human fibroblasts MRC-5(IC50=4.8 μM).	liposomes	32751755##31940927	Int J Mol Sci.2020 Jul 30;21(15):5460.##Mar Drugs. 2020 Jan 12;18(1):51.	Hansen IKØ, Lövdahl T, Simonovic D, Hansen KØ, Andersen AJC, Devold H, Richard CSM, Andersen JH, Strøm MB, Haug T.##Hansen IKØ, Isaksson J, Poth AG, Hansen KØ, Andersen AJC, Richard CSM, Blencke HM, Stensvåg K, Craik DJ, Haug T. 	Antimicrobial Activity of Small Synthetic Peptides Based on the Marine Peptide Turgencin A: Prediction of Antimicrobial Peptide Sequences in a Natural Peptide and Strategy for Optimization of Potency.##Isolation and Characterization of Antimicrobial Peptides with Unusual Disulfide Connectivity from the Colonial Ascidian Synoicum turgens.	
DRAMP29095	GIKEMLCNMACAQTVCKKSGGPLCDTCQAACKALG	35	Turgencin B	C0HLN6	Not found		Synoicum turgens	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-,Anti-cancer	Protein level	Alpha helix,random coil	Not found		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.31940927]Gram-positive bacteria:Corynebacterium glutamicum ATCC 13032(MIC=1.6 µM);Bacillus subtilis ATCC 23857(MIC=1.6 µM);Staphylococcus aureus ATCC 9144(MIC>100µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=12.5 µM);Pseudomonas aeruginosa ATCC 27853(MIC=25.0 µM);##Cancer:Human melanoma A2058(IC50=4.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation	Disulfide bond between Cys7 and Cys31, Cys11 and Cys27, Cys16 and Cys24; the 'Met' at position 5 and 9 is Methionine sulfoxide.	L	[Ref.31940927]Cytotoxicity: Human fibroblasts MRC-5(IC50=7.5 μM).	liposomes	31940927	Mar Drugs. 2020 Jan 12;18(1):51.	Hansen IKØ, Isaksson J, Poth AG, Hansen KØ, Andersen AJC, Richard CSM, Blencke HM, Stensvåg K, Craik DJ, Haug T. 		
DRAMP29096	GLPGPLGPAGPK	12	Collagencin	"S4R4C8,	S4R4C7,	S4R4C5"	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Predicted	Alpha helix,beta sheet,beta turn,random coil	The deconvolution of CD spectra in PBS buffer revealed that collagencin structure was organized as follow: 5.5% of α-helix, 19.3% of β-sheet, 36.3% of β-turn and 38.9% unordered. In methanol(organic buffers), a shift between β-sheet (36.4%) and β-turn (22.1%) was observed in collagencin structure while helix (4.9%) and unordered structure (36.6%) contents remained stables.In presence of DPPG phospholipids, a shift between β-sheet and β-turn was observed in collagencin structure. A maximal β-sheet content (49.7%) was observed at highest lipid: peptide ratio (100:1). In presence of POPG, α-helix		Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Collagencin highly interacts with both anionic and zwitterionic phospholipids but remains at membrane–water interface, which suggests a carpet mechanism of action of the peptide. Collagencin is probably antihypertensive according to its high similarity to peptide PGPLGLTGP, an ACE inhibitor that was previously isolated from skate skin hydrolysate.	[Ref.27038545]32.2% growth inhibition on Listeria innocua HPB29 at 235 µM; 31% growth inhibition on Lactococcus lactis ATCC 11454 at 235 µM ; 32.2% growth inhibition on Carnobacterium divergens M35 at 235 µM; 67% growth inhibition on Staphylococcus aureus ATCC 6538 at 235 µM; 62% growth inhibition on Streptococcus pyogenes ATCC19615 at 235 µM; 64% growth inhibition on Escherichia coli MC4100 at 235 µM; Escherichia coli O157:H7(NA); Aeromonas hydrophila ATCC 7966(NA); Pseudomonas aeruginosa ATCC 27853(NA).	[Ref.27038545]non-toxic to horse erythrocytes up to 470 μM; 25% hemolysis against horse erythrocytes at 940 µM.	Linear	Free	Free		L	[Ref.27038545]No cytotoxicity information found.	liposomes	27038545	Biochem Biophys Res Commun. 2016 Apr 29;473(2):642-7. 	Ennaas N, Hammami R, Gomaa A, Bédard F, Biron É, Subirade M, Beaulieu L, Fliss I.	Collagencin, an antibacterial peptide from fish collagen: Activity, structure and interaction dynamics with membrane.	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29097	TQQAFQKFLAAVTSALGKQYH	21	SHβAP	No entry found	Not found	Not found	Katsuwonus pelamis	Antimicrobial, Antibacterial,Anti-Gram+,Anti-Gram-,Antifungal	Not found	Alpha helix	Not found		Function:SHβAP showed broad spectrum antimicrobial activity without hemolytic activity.Antimicrobial activity of the peptide was heatstable and pH resistant but is sensitive to proteases and salt.The action mode of SHβAP is bacteriostatic process rather than bactericidal one.	[Ref.24495783]Gram-positive bacteria:B.subtilis KCTC1021(MEC=16.0 μg/mL); B.subtilis RM125(MEC=6.5 μg/mL); S.aureus KCTC1621(MEC=57.0 μg/mL);S.iniae FP5229(MEC=23.0 μg/mL);##Gram-negative bacteria:E.coli D31(MEC=15.0 μg/mL); E.coli KCTC1116(MEC=2.6 μg/mL); E.coli ML35p(MEC=6.2 μg/mL); P.aeruginosa KCTC2004(MEC=19.0 μg/mL); S.enterica KCTC2514(MEC=2.0 μg/mL); S.sonnei KCTC2009(MEC=6.0 μg/mL);A.hydrophila KCTC2358(MEC>125.0 μg/mL); V.parahaemolyticus HUFP91(MEC=1.9 μg/mL); V.parahaemolyticus KCCM41664(MEC=1.5 μg/mL);##Yeast:C.albicans KCTC7965(MEC=12.0 μg/mL).	[Ref.24495783]not cause hemolysis against RBCs up to 100 μg/mL concentration.	Linear	Free	Free		L	[Ref.24495783]No cytotoxicity information found.	liposomes	24495783	Fish Shellfish Immunol. 2014 Mar;37(1):173-83. 	Seo JK, Lee MJ, Jung HG, Go HJ, Kim YJ, Park NG. 	Antimicrobial function of SHβAP, a novel hemoglobin β chain-related antimicrobial peptide, isolated from the liver of skipjack tuna, Katsuwonus pelamis.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP29098	GLSRLFTALK	10	ACWWP1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Not found	Not found	Not found		Function:The change in cell surface hydrophobicity and membrane-permeable action of the purified ACWWP1 may have contributed to the antibacterial effect. 	[Ref.25172690]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=16 µg/ml); Bacillus subtilis ATCC 9372(MIC=16 µg/ml); Streptococcus pneumoniae ATCC 49619(MIC=64 µg/ml);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=32 µg/ml); Shigella dysenteriae ATCC 51302(MIC=256 µg/ml); Pseudomonas aeruginosa ATCC 27853 (MIC=64 µg/ml); Salmonella typhimurium ATCC 50013(MIC=32 µg/ml).	[Ref.25172690]non-toxic to mouse erythrocytes up to 512 µg/ml.	Linear	Free	Free		L	[Ref.25172690]No cytotoxicity information found.	liposomes	25172690	Food Chem. 2015 Feb 1;168:115-23.	Tang W, Zhang H, Wang L, Qian H, Qi X.	Targeted separation of antibacterial peptide from protein hydrolysate of anchovy cooking wastewater by equilibrium dialysis.	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
DRAMP29099	GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY	37	CAP18	G1T9L4	Not found	camp	Oryctolagus cuniculus	Antimicrobial, Antibacterial,Anti-Gram+,Anti-Gram-	Homology	Alpha helix	The peptide adopted an appreciable α-helical content in the presence of the organic cosolvent 40% trifluoroethanol and in the presence of 0.1% lipopolysaccharide.	1LYP	Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.CAP18 were active against P. aeruginosa, E. coli, S. aureus, and MRSA.	[Ref.11557478]Gram-negative bacteria:Pseudomonas aeruginosa(MIC=1-32 µg/ml); Pseudomonas aeruginosa(MIC50=4 µg/ml); Pseudomonas aeruginosa(MIC90=16 µg/ml); Stenotrophomonas maltophilia(MIC=2-16 µg/ml); Achromobacter xylosoxidans(MIC=2-32 µg/ml).##[Ref.10768969]Gram-positive bacteria:Staphylococcus aureus ATCC 33591(MIC=1.24 µM ); Staphylococcus aureus ATCC 33591(100 mM NaCl,MIC=1.36 µM); Staphylococcus aureus 930918-3(MIC=0.41 µM); Staphylococcus aureus 930918-3(100 mM NaCl,MIC=0.63 µM);##Gram-negative bacteria:Pseudomonas aeruginosa PAO1(25 mM NaCl,EC50=0.22±0.05 µM); Pseudomonas aeruginosa PAO1(175 mM NaCl, EC50=0.11±0.02 µM); Escherichia coli DH5α(MIC=0.19 µM); Escherichia coli DH5α(100 mM NaCl, MIC=0.21 µM); Escherichia coli ML-35p(MIC=0.05 µM); Escherichia coli ML-35p(100 mM NaCl, MIC=0.09 µM); Pseudomonas aeruginosa PAO1(MIC=0.20 µM); Pseudomonas aeruginosa PAO1(100 mM NaCl, MIC=0.62 µM); Pseudomonas aeruginosa MR3007(MIC=0.05 µM); Pseudomonas aeruginosa MR3007(100 mM NaCl, MIC=0.36 µM).##[Ref.26656394]Gram-negative bacteria:Yersinia ruckeri 392/2003(MIC=2-4 µg/ml); Aeromonas salmonicida ATCC 49385(MIC=2 µg/ml); Salmonella enterica serovar Typhimurium LT2(MIC=4-8 µg/ml); Campylobacter jejuni NCTC 11168(MIC=1 µg/ml); Escherichia coli ATCC 25922(MIC=4-8 µg/ml ); Pseudomonas aeruginosa ATCC 27853(MIC=4-8 µg/ml); Escherichia coli BW25113(MIC=4-8 µg/ml); Escherichia coli BW25113 del-rfaC(MIC=4 µg/ml); Escherichia coli ATCC 25922 del-rfaC(MIC=2 µg/ml);##Gram-positive bacterial:Flavobacterium psychrophilum 1947(MIC>>256 µg/ml); Staphylococcus aureus ATCC 29213(MIC>=32 µg/ml); Enterococcus faecalis ATCC 29212(MIC=8 µg/ml); Listeria monocytogenes N22-2(MIC=2-4 µg/ml).##[Ref.30245684]Gram-negative bacterial:Escherichia coli ATCC 25922 del-waaC(MIC=2-4 µg/ml); Escherichia coli ATCC 25922 del-waaE(MIC=4 µg/ml); Escherichia coli ATCC 25922 del-waaF(MIC=2-4 µg/ml); Escherichia coli ATCC 25922 del-waaG(MIC=4 µg/ml); Escherichia coli JW3596(MIC=4 µg/ml); Escherichia coli JW1667(MIC=2-4 µg/ml ).##[Ref.29852015]Gram-negative bacterial:Aeromonas salmonicida ATCC 33658(MIC=4 µg/ml);##Gram-positive bacterial:Lactococcus lactis IL1403(MIC=1-2 µg/ml).	[Ref.10768969]non-hemolysis against Human erythrocytes up to 500 µg/ml.##[Ref.26656394]1% hemolysis against Horse erythrocytes at 64 µg/ml.	Linear	Free	Free		L	Not found	liposomes	11557478##10768969##26656394##30245684##29852015	Antimicrob Agents Chemother. 2001 Oct;45(10):2838-2844.##Infect Immun. 2000 May;68(5):2748-2755.##PLoS One. 2015 Dec 11;10(12):e0144611.##Front Microbiol. 2018 Sep 7;9:2153.##PLoS One. 2018 May 31;13(5):e0197742.	Saiman L, Tabibi S, Starner TD, San Gabriel P, Winokur PL, Jia HP, McCray PB Jr, Tack BF.##Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray PB Jr, Lehrer RI, Welsh MJ, Tack BF.##Ebbensgaard A, Mordhorst H, Overgaard MT, Nielsen CG, Aarestrup FM, Hansen EB.##Ebbensgaard A, Mordhorst H, Aarestrup FM, Hansen EB.##Ebbensgaard A, Mordhorst H, Overgaard MT, Aarestrup FM, Hansen EB.	Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.##Bactericidal activity of mammalian cathelicidin-derived peptides.##Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria.##The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides. ##Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP29100	GIRDVLKGAAKAFVKTVAGHIAN	23	Ascaphin-1 [F2I]	P0CJ25	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram-	Protein level	Not found	Not found		Function:Antibacterial activity against Gram-positive bacteria	[Ref.19947578]Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=4 µM).	[Ref.19947578]25% hemolysis against human erythrocytes at 100 µM.	Linear	Free	Amidation		L	[Ref.19947578]No cytotoxicity information found.	liposomes	19947578	J Chem Inf Model. 2009 Dec;49(12):2873-82.	Juretić D, Vukicević D, Ilić N, Antcheva N, Tossi A.	Computational design of highly selective antimicrobial peptides.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP29101	GFKDLLKGAAKALVKAVLF	19	Ascaphin-8 [T16A]	P0CJ32	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Anti-cancer, Antifungal	Protein level	Alpha helix	45% α-helix was determined from the circular dichroism spectra recorded in 50% trifluoroethanol-water.		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.	[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=6 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=3 µM);##Fungi:Candida albicans ATCC 900280(MIC=6 µM).##Cancer:human hepatoma‐derived cells HepG2 (LC50=9 µM).	[Ref.18554256]Hemolysis against human erythrocytes (LC50=22 µM).	Linear	Free	Amidation		L	[Ref.18554256]Cytotoxicity:Mouse fibroblasts L929 (LC50=5 µM).	liposomes	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64. 	Conlon JM, Galadari S, Raza H, Condamine E.	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP29102	KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL	30	Hc-CATH	No entry found	Not found	Not found	Hydrophis cyanocinctus	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Anti-cancer, Antifungal	Not found	Alpha helix,β-sheet,random coil	The CD spectra in H2O adopts a random-coil conformation. In the membrane-mimetic environments of SDS/H2O solutions (30–120 mm), the secondary structure components of Hc-CATH dissolved in 60 mm SDS/H2O were calculated as 59.9% α-helix, 16% β-sheet, 0% β-turn, and 24% random coil.When dissolved in SDS/H2O solutions with serial concentrations of NaCl (at 0, 100, 200, and 400 mm), the α-helix contents decreased slightly from 59.9 to 33.8% as the NaCl concentration increased. Simultaneously, the contents of the β-turn (0 to 14.9%) and random coil (24 to 30.5%) increased slightly. 		Function:The microbial killing activity of Hc-CATH is executed through the disruption of cell membrane and lysis of bacterial cells. Antimicrobial activity of Hc-CATH in the presence of a high concentration of sodium chlorideIn addition is strong. Hc-CATH exhibited potent anti-inflammatory activity by inhibiting the LPS-induced production of nitric oxide (NO) and pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.	[Ref.26013823]Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=2.34 µg/ml); Escherichia coli ATCC 25922(400 Mm NaCl,MIC=4.69 µg/ml); Escherichia coli 1(MIC=2.34 µg/ml);Escherichia coli 2(MIC=2.34 µg/ml); Escherichia coli 3(MIC=2.34 µg/ml); Escherichia coli 4(MIC=9.38 µg/ml); Shigella dysenteriae(MIC=0.59 µg/ml); Klebsiella pneumoniae 1(MIC=37.50 µg/ml); Klebsiella pneumoniae 2(MIC=4.69 µg/ml); Klebsiella pneumoniae 3(MIC=9.38 µg/ml); Klebsiella pneumoniae 4(MIC=9.38 µg/ml); Klebsiella pneumoniae 5(MIC=18.75 µg/ml); Klebsiella pneumoniae 6(MIC=37.50 µg/ml); Klebsiella pneumoniae 7(MIC=37.50 µg/ml); Klebsiella pneumoniae 8(MIC=75.00 µg/ml); Serratia marcescens(MIC>200 µg/ml); Klebsiella oxytoca(MIC=4.69 µg/ml); Proteus vulgaris(MIC>200 µg/ml); Proteus mirabilis(MIC=4.69 µg/ml); Acinetobacter baumannii 1(MIC>200 µg/ml); Acinetobacter baumannii 2(MIC>200 µg/ml); Stenotrophomonas maltophilia(MIC>200 µg/ml); Stenotrophomonas maltophilia 2(MIC=9.38 µg/ml); Pseudomonas aeruginosa ATCC 27853(MIC=18.75 µg/ml); Pseudomonas aeruginosa 1 (MIC=37.50 µg/ml ); Pseudomonas aeruginosa(MIC>200 µg/ml); Salmonella paratyphi A(MIC=4.69 µg/ml);##Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=4.69 µg/ml); Staphylococcus aureus 1(MIC>200 µg/ml ); Staphylococcus aureus 2(MIC>200 µg/ml ); Staphylococcus aureus 3(MIC>200 µg/ml ); Staphylococcus aureus 4(MIC=4.69 µg/ml); Staphylococcus aureus 5(MIC=4.69 µg/ml); Bacillus cereus(MIC=9.38 µg/ml); Bacillus subtilis(MIC=75.00 µg/ml); Enterococcus faecium(MIC=37.50 µg/ml); Nocardia asteroides(MIC=9.38 µg/ml); Enterococcus faecalis(MIC>200 µg/ml); Staphylococcus epidermidis(MIC>200 µg/ml);##Fungi:Candida albicans 1(MIC=4.69 µg/ml); Candida albicans 2(MIC=4.69 µg/ml); Candida albicans 3(MIC=4.69 µg/ml); Candida albicans 4(MIC=4.69 µg/ml); Candida albicans 5(MIC=2.34 µg/ml); Candida albicans 6(MIC=2.34 µg/ml); Candida glabrata 1(MIC=2.34 µg/ml); Candida glabrata(MIC>200 µg/ml); Cryptococcus neoformans(MIC>200 µg/ml); Arcyria cinerea(MIC=9.38 µg/ml);##Pathogenic bacteria:Aeromonas sobria(MIC=2.34 µg/ml); Aeromonas hydrophila(MIC=2.34 µg/ml); Aeromonas veronii(MIC=2.34 µg/ml); Vibrio vulnificus(MIC=4.69 µg/ml ); Vibrio harveyi(MIC=9.38 µg/ml); Vibrio fluvialis(MIC=4.69 µg/ml); Vibrio alginolyticus(MIC=4.69 µg/ml); Vibrio parahaemolyticus(MIC=9.38 µg/ml); Vibrio splendidus(MIC=2.34 µg/ml); Vibrio anguillarum(MIC=18.75 µg/ml); Edwardsiella tarda(MIC=2.34 µg/ml).	[Ref.26013823]5.25% Hemolysis against Human erythrocytes at 200 µg/ml(55.12 μM).	Linear	Free	Free		L	[Ref.26013823]4.70% cell death at 200 µg/ml against Human hepatocellular carcinoma HepG2; 3.63% cell death at 200 µg/ml against Human prostate adenocarcinoma PC-3; 1.30% cell death at 200 µg/ml against Mouse fibroblasts L929.	liposomes	26013823	J Biol Chem. 2015 Jul 3;290(27):16633-52.	Wei L, Gao J, Zhang S, Wu S, Xie Z, Ling G, Kuang YQ, Yang Y, Yu H, Wang Y.	Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity and Special Mechanism.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
DRAMP29103	KWKLFKKIHKVGQNIRKGIIKAGPAVAVVGQAAQIAK	37	PEW300	P01507	Not found		Synthetic construct(Mutation of cecropin-A)	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix(Predicted)	Not found		Function:Purified PEW300 exhibited strong antibacterial activity against various Gram-positive and Gram-negative bacteria.PEW300 had no hemolytic activity toward mammalian cells even at high concentration (224 ng/μl).It showed good stability in neutral and alkaline solutions. PEW300 was thermally stable even at up to 100 °C and resistant to proteinase K, pepsin, snailase, and trypsin.The incubation with human serum had no effect on the antibacterial activity of PEW300.	[Ref.30607494]Gram-positive bacteria:Staphylococcus aureus ATCC 6538(MIC=14.18 µg/ml); Staphylococcus aureus ATCC 6538(MBC=28.36 µg/ml); Bacillus megaterium ATCC 14945(MIC=7.09 µg/ml); Bacillus megaterium ATCC 14945(MBC=14.18 µg/ml); Bacillus licheniformis ATCC 14580(MIC=14.18 µg/ml); Bacillus licheniformis ATCC 14580(MBC=14.18 µg/ml); Staphylococcus epidermidis ATCC 12228(MIC=7.09 µg/ml); Staphylococcus epidermidis ATCC 12228(MBC=7.09 µg/ml);Bacillus cereus ATCC 10876(MIC=14.18 µg/ml);Bacillus cereus ATCC 10876(MBC=28.36 µg/ml);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=7.09 µg/ml); Escherichia coli ATCC 25922(MBC=7.09 µg/ml); Pseudomonas aeruginosa ATCC 9027(MIC=14.18 µg/ml); Pseudomonas aeruginosa ATCC 9027(MBC=14.18 µg/ml); Stenotrophomonas maltophilia ATCC 51331(MIC=28.35 µg/ml); Stenotrophomonas maltophilia ATCC 51331(MBC=56.70 µg/ml); Pseudomonas otitidis MCC 10330(MIC=14.18 µg/ml); Pseudomonas otitidis MCC 10330(MBC=14.18 µg/ml); Klebsiella pneumoniae ATCC 35657(MIC=9.88 µg/ml); Klebsiella pneumoniae ATCC 35657(MBC=9.88 µg/ml); Salmonella enteritidis ATCC 9120(MIC=4.93 µg/ml); Salmonella enteritidis ATCC 9120(MBC=4.93 µg/ml).	[Ref.30607494]non-hemolysis to Sheep erythrocytes up to 224 µg/ml.	Linear	Free	Free		L	[Ref.30607494]No cytotoxicity information found.	liposomes	30607494	Appl Microbiol Biotechnol. 2019 Feb;103(4):1765-1775.	Wang M, Lin J, Sun Q, Zheng K, Ma Y, Wang J.	Design, expression, and characterization of a novel cecropin A-derived peptide with high antibacterial activity. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)C(C)C)C(C)C)[C@H](C)CC
DRAMP29104	LNLKALLAVAKKIL	14	Mastoparan-C(MP-C)	P01516	Not found		Vespa crabro	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Anti-cancer,Antifungal	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,24.85% α-helix was determined in 50% TFE.		Function:The peptide was tolerant in the presence of physiological salts.MP-C  lost antimicrobial activities after incubation with 20 μg/mL trypsin or chymotrypsin,indicating moderate protease resistance.	[Ref.29904274]Gram-positive bacteria:Staphylococcus aureus NCTC 10788(MIC=2 µM); Staphylococcus aureus NCTC 10788(MBC=2 µM); Staphylococcus aureus ATCC 12493(MRSA,MIC=4 µM); Staphylococcus aureus ATCC 12493(MRSA,MBC=4 µM); Enterococcus faecalis NCTC 12697(MIC=8 µM); Enterococcus faecalis NCTC 12697(MBC=8 µM);##Gram-negative bacteria:Escherichia coli NCTC 10418(MIC=4 µM); Escherichia coli NCTC 10418(MBC=8 µM); Pseudomonas aeruginosa ATCC 27853(MIC=8 µM); Pseudomonas aeruginosa ATCC 27853(MBC=16 µM);    Fungi:Candida albicans NCTC 1467(MIC=4 µM); Candida albicans NCTC 1467(MBC=4 µM);##Cancer:Human squamous lung carcinoma NCI-H157(IC50=13.57 µM);Human breast adenocarcinoma MDA-MB-435S(IC50=27.70 µM);Human prostate adenocarcinoma PC-3(IC50=6.29 µM);Human glioblastoma U251-MG(IC50=36.65 µM); Human breast adenocarcinoma MCF-7(IC50=25.27 µM).##[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=4 µM); Bacillus subtilis ATCC 23857(MIC=4 µM);##Gram-negative bacterial:Escherichia coli ATCC 25922(4.5 mM KCl and 0.004 mM FeCl3,MIC=4 µM); Pseudomonas aeruginosa ATCC 9027(4.5 mM KCl,MIC=8 µM); Klebsiella pneumoniae ATCC 700603(MIC=8 µM); Escherichia coli ATCC 25922(NaCl/MgCl2=150mM/1mM,MIC=4 µM); Pseudomonas aeruginosa ATCC 9027(NaCl/MgCl2=150mM/1mM,MIC=16 µM); Pseudomonas aeruginosa ATCC 9027(0.004mM FeCl3,MIC=4 µM);Escherichia coli(Rifampin-resistant strain,MIC=4 µM).	[Ref.29904274]50% hemolysis against horse erythrocytes at 40.11 µM.##[Ref.33285267]10% hemolysis against mouse erythrocytes at 64 µM; 60% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.29904274]Cytotoxicity:Human microvascular endothelial cells HMEC-1(IC50=57.15 µM).##[Ref.33285267]90% Killing against Human embryonic kidney HEK293T cells at 128 µM; Human embryonic kidney HEK293T cells(IC50=16 µM).	liposomes	33285267##29904274	Eur J Pharm Sci. 2021 Mar 1;158:105665.##Int J Biol Sci. 2018 Apr 25;14(6):599-607.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J. ##Chen X, Zhang L, Wu Y, Wang L, Ma C, Xi X, Bininda-Emonds ORP, Shaw C, Chen T, Zhou M.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.##Evaluation of the bioactivity of a mastoparan peptide from wasp venom and of its analogues designed through targeted engineering.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29105	CLNLKALLAVAKKILC	16	c Mastoparan-C(cMP-C)	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Anti-cancer,Antifungal	Protein level	Alpha helix,random coil	76% α-helix was determined from the circular dichroism spectra recorded in 50% TFE/10mM NH4AC solution,28% of the secondary structure  retained an α-helical domain in an aqueous environment.		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.29904274]Gram-positive bacteria:Staphylococcus aureus NCTC 10788(MIC=32 µM); Staphylococcus aureus NCTC 10788(MBC=64 µM); Staphylococcus aureus ATCC 12493(MRSA,MIC=128 µM); Staphylococcus aureus ATCC 12493(MRSA,MBC=128 µM); Enterococcus faecalis NCTC 12697(MIC=128 µM); Enterococcus faecalis NCTC 12697(MBC=128 µM);##Gram-negative bacteria:Escherichia coli NCTC 10418(MIC=32 µM); Escherichia coli NCTC 10418(MBC=128 µM); Pseudomonas aeruginosa ATCC 27853(MIC=32 µM); Pseudomonas aeruginosa ATCC 27853(MBC>512 µM);##Fungi:Candida albicans NCTC 1467(MIC=32 µM); Candida albicans NCTC 1467(MBC=128 µM);##Cancer:Human squamous lung carcinoma NCI-H157(IC50=7.02 µM);Human breast adenocarcinoma MDA-MB-435S(IC50=13.87 µM);Human prostate adenocarcinoma PC-3(IC50=13.87 µM);Human glioblastoma U251-MG(IC50=8.56 µM); Human breast adenocarcinoma MCF-7(IC50=13.66 µM).       	[Ref.29904274]50% hemolysis against horse erythrocytes at 9.19 µM.    	Cyclic	Free	Amidation	Disulfide bond (Cys1-Cys16)	L	[Ref.29904274]Cytotoxicity:Human microvascular endothelial cells HMEC-1(IC50=39.53 µM).  	liposomes	29904274	Int J Biol Sci. 2018 Apr 25;14(6):599-607.	Chen X, Zhang L, Wu Y, Wang L, Ma C, Xi X, Bininda-Emonds ORP, Shaw C, Chen T, Zhou M.	Evaluation of the bioactivity of a mastoparan peptide from wasp venom and of its analogues designed through targeted engineering.	
DRAMP29106	RKKRRQRRRLNLKALLAVAKKIL	23	t Mastoparan-C(tMP-C, Tat (49-57)-Mastoparan-C)	P01516,Q76PP9	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Anti-cancer,Antifungal	Protein level	Alpha helix,random coil	28% α-helix was determined from the circular dichroism spectra recorded in 50% TFE/10mM NH4AC solution,and it adopted a random coil structure in an aqueous environment.		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.29904274]Gram-positive bacteria:Staphylococcus aureus NCTC 10788(MIC=4 µM); Staphylococcus aureus NCTC 10788(MBC=4 µM); Staphylococcus aureus ATCC 12493(MRSA,MIC=4 µM); Staphylococcus aureus ATCC 12493(MRSA,MBC=8 µM); Enterococcus faecalis NCTC 12697(MIC=8 µM); Enterococcus faecalis NCTC 12697(MBC=16 µM);##Gram-negative bacteria:Escherichia coli NCTC 10418(MIC=2 µM); Escherichia coli NCTC 10418(MBC=2 µM); Pseudomonas aeruginosa ATCC 27853(MIC=4 µM); Pseudomonas aeruginosa ATCC 27853(MBC=4 µM);##Fungi:Candida albicans NCTC 1467(MIC=2 µM); Candida albicans NCTC 1467(MBC=2 µM);##Cancer:Human squamous lung carcinoma NCI-H157(IC50=2.79 µM);Human breast adenocarcinoma MDA-MB-435S(IC50=3.86 µM);Human prostate adenocarcinoma PC-3(IC50=3.86 µM);Human glioblastoma U251-MG(IC50=3.36 µM); Human breast adenocarcinoma MCF-7(IC50=3.70 µM).     	[Ref.29904274]50% hemolysis against horse erythrocytes at 77.94 µM.    	Linear	Free	Amidation		L	[Ref.29904274]Cytotoxicity:Human microvascular endothelial cells HMEC-1(IC50=9.18 µM).  	liposomes	29904274	Int J Biol Sci. 2018 Apr 25;14(6):599-607.	Chen X, Zhang L, Wu Y, Wang L, Ma C, Xi X, Bininda-Emonds ORP, Shaw C, Chen T, Zhou M.	Evaluation of the bioactivity of a mastoparan peptide from wasp venom and of its analogues designed through targeted engineering.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29107	ANLKALLAVAKKIL	14	Mastoparan-C [L1A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,43.88% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=32 µM); Bacillus subtilis ATCC 23857(MIC=4 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=4 µM); Pseudomonas aeruginosa ATCC 9027(MIC=16 µM); Klebsiella pneumoniae ATCC 700603(MIC=16 µM).	[Ref.33285267]2% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29108	LALKALLAVAKKIL	14	Mastoparan-C [N2A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,19.52% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=4 µM); Bacillus subtilis ATCC 23857(MIC=4 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=4 µM); Pseudomonas aeruginosa ATCC 9027(MIC=8 µM); Klebsiella pneumoniae ATCC 700603(MIC=8 µM).	[Ref.33285267]10% hemolysis against mouse erythrocytes at 128 µM,50% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29109	LNAKALLAVAKKIL	14	Mastoparan-C [L3A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,4.24% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=32 µM); Bacillus subtilis ATCC 23857(MIC=8 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(MIC=32 µM); Klebsiella pneumoniae ATCC 700603(MIC=32 µM).	[Ref.33285267]0% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29110	LNLAALLAVAKKIL	14	Mastoparan-C [K4A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,27.41% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=4 µM); Bacillus subtilis ATCC 23857(MIC=16 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(MIC=32 µM); Klebsiella pneumoniae ATCC 700603(MIC=32 µM).	[Ref.33285267]10% hemolysis against mouse erythrocytes at 128 µM,52% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29111	LNLKAALAVAKKIL	14	Mastoparan-C [L6A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,44.72% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=32 µM); Bacillus subtilis ATCC 23857(MIC=8 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(MIC=32 µM); Klebsiella pneumoniae ATCC 700603(MIC=16 µM).	[Ref.33285267]0% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29112	LNLKALAAVAKKIL	14	Mastoparan-C [L7A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,34.08% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=16 µM); Bacillus subtilis ATCC 23857(MIC=8 µM); ##Gram-negative bacteria:Escherichia coli ATCC 25922(4.5 mM KCl and 0.004 mM FeCl3,MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(4.5 mM KCl,MIC=16 µM); Klebsiella pneumoniae ATCC 700603(MIC=16 µM); Escherichia coli ATCC 25922(150mM NaCl,MIC=32 µM); Escherichia coli ATCC 25922(1mM MgCl2,MIC=16 µM); Pseudomonas aeruginosa ATCC 9027(150mM NaCl,MIC=32 µM); Pseudomonas aeruginosa ATCC 9027(1mM MgCl2,MIC=64 µM); Pseudomonas aeruginosa ATCC 9027(0.004mM FeCl3,MIC=8 µM);Escherichia coli(Rifampin-resistant strain,MIC=8 µM).	[Ref.33285267]8% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]45% Killing against Human embryonic kidney HEK293T cells at 128 µM; Human embryonic kidney HEK293T cells(IC50>128 µM).	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29113	LNLKALLAAAKKIL	14	Mastoparan-C [V9A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,7.45% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=16 µM); Bacillus subtilis ATCC 23857(MIC=8 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(MIC=16 µM); Klebsiella pneumoniae ATCC 700603(MIC=16 µM).	[Ref.33285267]20% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29114	LNLKALLAVAAKIL	14	Mastoparan-C [K11A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,16.69% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=4 µM); Bacillus subtilis ATCC 23857(MIC=16 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(MIC=32 µM); Klebsiella pneumoniae ATCC 700603(MIC=32 µM).	[Ref.33285267]18% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29115	LNLKALLAVAKAIL	14	Mastoparan-C [K12A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,37.54% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=4 µM); Bacillus subtilis ATCC 23857(MIC=8 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(MIC=16 µM); Klebsiella pneumoniae ATCC 700603(MIC=16 µM).	[Ref.33285267]10% hemolysis against mouse erythrocytes at 32 µM,90% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29116	LNLKALLAVAKKAL	14	Mastoparan-C [I13A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,8.91% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=32 µM); Bacillus subtilis ATCC 23857(MIC=8 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(MIC=32 µM); Klebsiella pneumoniae ATCC 700603(MIC=32 µM).	[Ref.33285267]5% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(N)=O
DRAMP29117	LNLKALLAVAKKIA	14	Mastoparan-C [L14A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,15.36% α-helix was determined in 60% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=32 µM); Bacillus subtilis ATCC 23857(MIC=8 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(MIC=16 µM); Klebsiella pneumoniae ATCC 700603(MIC=32 µM).	[Ref.33285267]5% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](C)C(N)=O
DRAMP29118	GNLKALLAVAKKIL	14	Mastoparan-C [L1G]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,16.12% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=32 µM); Bacillus subtilis ATCC 23857(MIC=4 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(4.5 mM KCl and 0.004 mM FeCl3,MIC=4 µM); Pseudomonas aeruginosa ATCC 9027(0.004 mM FeCl3,MIC=8 µM); Klebsiella pneumoniae ATCC 700603(MIC=16 µM); Escherichia coli ATCC 25922(150mM NaCl,MIC=8 µM); Escherichia coli ATCC 25922(1mM MgCl2,MIC=16 µM); Pseudomonas aeruginosa ATCC 9027(150mM NaCl,MIC=32 µM); Pseudomonas aeruginosa ATCC 9027(4.5mM KCl,MIC=16 µM); Pseudomonas aeruginosa ATCC 9027(1mM MgCl2,MIC=64 µM);Escherichia coli(Rifampin-resistant strain,MIC=8 µM).	[Ref.33285267]8% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]80% Killing against Human embryonic kidney HEK293T cells at 128 µM; Human embryonic kidney HEK293T cells(IC50=128 µM).	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29119	LNLKALGAVAKKIL	14	Mastoparan-C [L7G]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,7.26% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=128 µM); Bacillus subtilis ATCC 23857(MIC=32 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=32 µM); Pseudomonas aeruginosa ATCC 9027(MIC=32 µM); Klebsiella pneumoniae ATCC 700603(MIC=64 µM).	[Ref.33285267]0% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29120	KNLKALLAVAKKIL	14	Mastoparan-C [L1K]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,18.62% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=64 µM); Bacillus subtilis ATCC 23857(MIC=8 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(MIC=8 µM); Klebsiella pneumoniae ATCC 700603(MIC=16 µM).	[Ref.33285267]0% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29121	GNLKALAAVAKKIL	14	Mastoparan-C [L1G, L7A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,1.61% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC>128 µM); Bacillus subtilis ATCC 23857(MIC=8 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=64 µM); Pseudomonas aeruginosa ATCC 9027(MIC=64 µM); Klebsiella pneumoniae ATCC 700603(MIC=128 µM).	[Ref.33285267]0% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29122	LNLRALLAVARRIL	14	Mastoparan-C [K4,11,12R]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,24.8% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=4 µM); Bacillus subtilis ATCC 23857(MIC=4 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=4 µM); Pseudomonas aeruginosa ATCC 9027(MIC=8 µM); Klebsiella pneumoniae ATCC 700603(MIC=16 µM).	[Ref.33285267]10% hemolysis against mouse erythrocytes at 32 µM,87% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29123	LNLKKLLAVAKKIL	14	Mastoparan-C [A5K]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,25.08% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=8 µM); Bacillus subtilis ATCC 23857(MIC=2 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=4 µM); Pseudomonas aeruginosa ATCC 9027(MIC=4 µM); Klebsiella pneumoniae ATCC 700603(MIC=4 µM).	[Ref.33285267]10% hemolysis against mouse erythrocytes at 128 µM,30% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29124	LNLKKLLKVAKKIL	14	Mastoparan-C [A5,8K]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,3.56% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=16 µM); Bacillus subtilis ATCC 23857(MIC=4 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(MIC=4 µM); Klebsiella pneumoniae ATCC 700603(MIC=8 µM).	[Ref.33285267]15% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29125	LNLKALLAVAKKI	13	Mastoparan-C (1-13)	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,16.87% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=64 µM); Bacillus subtilis ATCC 23857(MIC=16 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=16 µM); Pseudomonas aeruginosa ATCC 9027(MIC=32 µM); Klebsiella pneumoniae ATCC 700603(MIC=64 µM).	[Ref.33285267]0% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(N)=O
DRAMP29126	LNLKALLAVAKK	12	Mastoparan-C (1-12)	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,8.04% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC>128 µM); Bacillus subtilis ATCC 23857(MIC>128 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC>128 µM); Pseudomonas aeruginosa ATCC 9027(MIC>128 µM); Klebsiella pneumoniae ATCC 700603(MIC>128 µM).	[Ref.33285267]0% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP29127	LNLKALLAVAK	11	Mastoparan-C (1-11)	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,24.68% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC>128 µM); Bacillus subtilis ATCC 23857(MIC>128 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC>128 µM); Pseudomonas aeruginosa ATCC 9027(MIC>128 µM); Klebsiella pneumoniae ATCC 700603(MIC>128 µM).	[Ref.33285267]0% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP29128	GNLKKLLAVAKKIL	14	Mastoparan-C [L1G, A5K]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,22.26% α-helix was determined in50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=16 µM); Bacillus subtilis ATCC 23857(MIC=4 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(4.5 mM KCl and 0.004 mM FeCl3,MIC=4 µM); Pseudomonas aeruginosa ATCC 9027(0.004 mM FeCl3,MIC=4 µM); Klebsiella pneumoniae ATCC 700603(MIC=16 µM); Escherichia coli ATCC 25922(150mM NaCl,MIC=16 µM); Escherichia coli ATCC 25922(1mM MgCl2,MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(NaCl/MgCl2=150mM/1mM,MIC=32 µM); Pseudomonas aeruginosa ATCC 9027(4.5mM KCl,MIC=16 µM); Escherichia coli(Rifampin-resistant strain,MIC=4 µM).	[Ref.33285267]0% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]65% Killing against Human embryonic kidney HEK293T cells at 128 µM; Human embryonic kidney HEK293T cells(IC50=128 µM).	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29129	LNLKKLAAVAKKIL	14	Mastoparan-C [A5K, L7A]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,8.55% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=32 µM); Bacillus subtilis ATCC 23857(MIC=4 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(MIC=4 µM); Klebsiella pneumoniae ATCC 700603(MIC=32 µM).	[Ref.33285267]0% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29130	LNLKKLLAVAKKI	13	Mastoparan-C (1-13) [A5K]	P01516	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Protein level	Alpha helix,random coil	The CD spectra in water adopts a random-coil conformation,4.42% α-helix was determined in 50% TFE.		Function:when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.	[Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=128 µM); Bacillus subtilis ATCC 23857(MIC=8 µM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=16 µM); Pseudomonas aeruginosa ATCC 9027(MIC=16 µM); Klebsiella pneumoniae ATCC 700603(MIC=64 µM).	[Ref.33285267]0% hemolysis against mouse erythrocytes at 256 µM.	Linear	Free	Amidation		L	[Ref.33285267]No cytotoxicity information found.	liposomes	33285267	Eur J Pharm Sci. 2021 Mar 1;158:105665.	Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.	Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(N)=O
DRAMP29131	KLLGPLLKIAAKVGSNLL	18	XT-7 [G1K]	P84381	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.	[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=25 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=12.5 µM);##Fungi:Candida albicans ATCC 900280(MIC=50 µM);##Cancer:human hepatoma‐derived cells HepG2 (LC50=230 µM).	[Ref.18554256]Hemolysis against human erythrocytes (LC50=400 µM).	Linear	Free	Amidation		L	[Ref.18554256]No cytotoxicity information found.	liposomes	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E.	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP29132	GLLGKLLKIAAKVGSNLL	18	XT-7 [P5K]	P84381	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Alpha helix	53% α-helix was determined from the circular dichroism spectra recorded in 50% trifluoroethanol-water.		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.	[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=12.5 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=3 µM);##Fungi:Candida albicans ATCC 900280(MIC=6 µM);##Cancer:human hepatoma‐derived cells HepG2 (LC50=14 µM).	[Ref.18554256]Hemolysis against human erythrocytes (LC50=15 µM).	Linear	Free	Amidation		L	[Ref.18554256]No cytotoxicity information found.	liposomes	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E.	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP29133	GLLGPLLKIAKKVGSNLL	18	XT-7 [A11K]	P84381	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.	[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=50 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=25 µM);##Fungi:Candida albicans ATCC 900280(MIC=25 µM);##Cancer:human hepatoma‐derived cells HepG2 (LC50=65 µM).	[Ref.18554256]Hemolysis against human erythrocytes (LC50=350 µM).	Linear	Free	Amidation		L	[Ref.18554256]No cytotoxicity information found.	liposomes	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E.	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP29134	GLLGPLLKIAAKVGKNLL	18	XT-7 [S15K]	P84381	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.	[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=12.5 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=3 µM);##Fungi:Candida albicans ATCC 900280(MIC=25 µM);##Cancer:human hepatoma‐derived cells HepG2 (LC50=24 µM).	[Ref.18554256]Hemolysis against human erythrocytes (LC50=110 µM).	Linear	Free	Amidation		L	[Ref.18554256]No cytotoxicity information found.	liposomes	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E.	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP29135	GLLGPLLKIAAKVGKKLL	18	XT-7 [S15K,N16K]	P84381	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.	[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=50 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=6 µM);##Fungi:Candida albicans ATCC 900280(MIC=6 µM);##Cancer:hepatoma‐derived cells HepG2 (LC50=10 µM).	[Ref.18554256]Hemolysis against human erythrocytes (LC50=60 µM).	Linear	Free	Amidation		L	[Ref.18554256]No cytotoxicity information found.	liposomes	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E.	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP29136	GLLGPLLKIAAKVGSKLL	18	XT-7 [N16K]	P84381	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.	[Ref.23094651]Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=6.3 µM).##[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=12.5 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=3 µM);##Fungi:Candida albicans ATCC 900280(MIC=12.5 µM);##Cancer: human hepatoma‐derived cells HepG2 (LC50=22 µM).	[Ref.23094651]50% hemolysis against rat erythrocytes at 142 µM.##[Ref.18554256]Hemolysis against human erythrocytes (LC50=80 µM).	Linear	Free	Amidation		L	[Ref.18554256]No cytotoxicity information found.	liposomes	23094651##18554256	 J Chem Inf Model. 2012 Dec 21;52(12):3341-51.##Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Kamech N, Vukičević D, Ladram A, Piesse C, Vasseur J, Bojović V, Simunić J, Juretić D.##Conlon JM, Galadari S, Raza H, Condamine E.	Improving the selectivity of antimicrobial peptides from anuran skin.##Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP29137	GLLGKLLKIAAKVGKKLL	18	XT-7 [P5K,S15K,N16K]	P84381	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.	[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=25 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=3 µM);##Fungi:Candida albicans ATCC 900280(MIC=3 µM);##Cancer:human hepatoma‐derived cells HepG2 (LC50=5 µM).	[Ref.18554256]Hemolysis against human erythrocytes (LC50=25 µM).	Linear	Free	Amidation		L	[Ref.18554256]No cytotoxicity information found.	liposomes	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E.	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP29138	GLLKKLLKIAAKVGKKLL	18	XT-7 [G4K,P5K,S15K,N16K]	P84381	Not found		Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Protein level	Not found	Not found		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Antifungal activity against Candida albicans.	[Ref.18554256]Gram-negative bacteria:Escherichia coli ATCC 25726(MIC=12.5 µM);##Gram-positive bactria:Staphylococcus aureus ATCC 25923(MIC=6 µM);##Fungi:Candida albicans ATCC 900280(MIC=3 µM);##Cancer: human hepatoma‐derived cells HepG2 (LC50=6 µM).	[Ref.18554256]Hemolysis against human erythrocytes (LC50=25 µM).	Linear	Free	Amidation		L	[Ref.18554256]No cytotoxicity information found.	liposomes	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E.	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP29139	IRPIPFIPRGGKT	13	Pxt‐1	No entry found	Not found	Not found	Xenopus tropicalis	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Not found	Alpha helix,random coil	10.9%,12.2%,12.7% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2).		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.25312021]Gram-negative bacteria:Escherichia coli DH5α(Not active up to 150 µg/ml);##Gram-positive bacteria:Staphylococcus aureus JCM 2151(Not active up to 150 µg/ml).	[Ref.25312021]0.1% Hemolysis against Rat erythrocytes at 20 µM.	Linear	Free	Amidation		L	[Ref.25312021]No cytotoxicity information found.	Not found	25312021	FEBS J. 2015 Jan;282(1):102-13.	Shigeri Y, Yasuda A, Hagihara Y, Nishi K, Watanabe K, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.	Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC
DRAMP29140	FIGALLRPALKLLA	14	Pxt‐2	No entry found	Not found	Not found	Xenopus tropicalis	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix,random coil	3.8%,4.0%,4.9% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2).		Function:showed growth inhibitory effects on both Escherichia coli (Gram-negative) and Staphylococcus aureus (Gram-positive).	[Ref.25312021]Gram-negative bacteria:Escherichia coli DH5α(MIC=50 µg/ml);##Gram-positive bacteria:Staphylococcus aureus JCM 2151(MIC=9.7 µg/ml).##[Ref.26802742]Gram-negative bacteria:Escherichia coli NBRC 14237(MIC<12.5 µM);Pseudomonas aeruginosa NBRC 12582(MIC<50 µM);##Gram-positive bacteria:Staphylococcus aureus NBRC 12732(MIC<12.5 µM);Micrococcus luteus NBRC 12708(MIC<25 µM);##Fungi:Saccharomyces cerevisiae NBRC 10217(ND);Candida albicans NBRC 1594(ND). 	[Ref.25312021]0.4% Hemolysis against Rat erythrocytes at 20 µM.##[Ref.26802742]2% Hemolysis against Rat erythrocytes at 50 µM.	Linear	Free	Amidation		L	[Ref.25312021]No cytotoxicity information found.	Not found	25312021##26802742	FEBS J. 2015 Jan;282(1):102-13.##J Biochem. 2016 Jun;159(6):619-29.	Shigeri Y, Yasuda A, Hagihara Y, Nishi K, Watanabe K, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.##Shigeri Y, Horie M, Yoshida T, Hagihara Y, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.	Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.##Physicochemical and biological characterizations of Pxt peptides from amphibian (Xenopus tropicalis) skin.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O
DRAMP29141	GLKEVAHSAKKFAKGFISGLTGS	23	Pxt‐3	No entry found	Not found	Not found	Xenopus tropicalis	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix,random coil	0.5%,1.2%,2.0% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2).		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.25312021]Gram-negative bacteria:Escherichia coli DH5α(Not active up to 150 µg/ml);##Gram-positive bacteria:Staphylococcus aureus JCM 2151(Not active up to 150 µg/ml).##[Ref.23935531]Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=64 µm);Pseudomonas aeruginosa ATCC 15692(MIC >256 µM);##Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC >256 µM);Micrococcus luteus(MIC=32 µM);##Fungi:Saccharomyces cerevisiae(MIC=128 µM);##Parasite:Trypanosoma brucei(LC95=8->256 µM).   	[Ref.25312021]0.2% Hemolysis against Rat erythrocytes at 20 µM.##[Ref.23935531] Hemolysis against Mouse erythrocytes (HC50>256 µm).	Linear	Free	Free		L	[Ref.23935531]Cytotoxicity against T-lymphocytes(IC50>256 µM).	Not found	25312021##23935531	FEBS J. 2015 Jan;282(1):102-13.##PLoS Genet. 2013;9(8):e1003662.	Shigeri Y, Yasuda A, Hagihara Y, Nishi K, Watanabe K, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.##Roelants K, Fry BG, Ye L, Stijlemans B, Brys L, Kok P, Clynen E, Schoofs L, Cornelis P, Bossuyt F.	Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.##Origin and functional diversification of an amphibian defense peptide arsenal.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP29142	LKGASKLIPHLLPSRQQ	17	Pxt‐4	No entry found	Not found	Not found	Xenopus tropicalis	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Not found	Alpha helix,random coil	1.8%,2.8%,3.9% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2).		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.25312021]Gram-negative bacteria:Escherichia coli DH5α(Not active up to 150 µg/ml);##Gram-positive bacteria:Staphylococcus aureus JCM 2151(Not active up to 150 µg/ml).	[Ref.25312021]0.1% Hemolysis against Rat erythrocytes at 20 µM.	Linear	Free	Free		L	[Ref.25312021]No cytotoxicity information found.	Not found	25312021	FEBS J. 2015 Jan;282(1):102-13.	Shigeri Y, Yasuda A, Hagihara Y, Nishi K, Watanabe K, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.	Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP29143	FIGALLGPLLNLLK	14	Pxt‐5	No entry found	Not found	Not found	Xenopus tropicalis	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Not found	Alpha helix,random coil	37.4%,36.5%,34.6% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2).		Function:showed growth inhibitory effects on both Escherichia coli (Gram-negative) and Staphylococcus aureus (Gram-positive).	[Ref.25312021]Gram-negative bacteria:Escherichia coli DH5α(Not active up to 150 µg/ml);##Gram-positive bacteria:Staphylococcus aureus JCM 2151(Not active up to 150 µg/ml).	[Ref.25312021]10.5% Hemolysis against Rat erythrocytes at 20 µM.	Linear	Free	Amidation		L	[Ref.25312021]No cytotoxicity information found.	Not found	25312021	FEBS J. 2015 Jan;282(1):102-13.	Shigeri Y, Yasuda A, Hagihara Y, Nishi K, Watanabe K, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.	Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP29144	IRPVPFFPPVHAKKVFPLH	19	Pxt‐6	No entry found	Not found	Not found	Xenopus tropicalis	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Not found	Alpha helix,random coil	2.3%,5.1%,7.4% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2).		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.25312021]Gram-negative bacteria:Escherichia coli DH5α(Not active up to 150 µg/ml);##Gram-positive bacteria:Staphylococcus aureus JCM 2151(Not active up to 150 µg/ml).	[Ref.25312021]0.3% Hemolysis against Rat erythrocytes at 20 µM.	Linear	Free	Free		L	[Ref.25312021]No cytotoxicity information found.	Not found	25312021	FEBS J. 2015 Jan;282(1):102-13.	Shigeri Y, Yasuda A, Hagihara Y, Nishi K, Watanabe K, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.	Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP29145	GGLIGTLTAKQIKK	14	Pxt-7	No entry found	Not found	Not found	Xenopus tropicalis	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Not found	Alpha helix,random coil	2.6%,2.8%,6.6% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2).		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.25312021]Gram-negative bacteria:Escherichia coli DH5α(Not active up to 150 µg/ml);##Gram-positive bacteria:Staphylococcus aureus JCM 2151(Not active up to 150 µg/ml).	[Ref.25312021]0.4% Hemolysis against Rat erythrocytes at 20 µM.	Linear	Free	Amidation	The 'G' at position 1 is pyroglutamic acid	L	[Ref.25312021]No cytotoxicity information found.	Not found	25312021	FEBS J. 2015 Jan;282(1):102-13.	Shigeri Y, Yasuda A, Hagihara Y, Nishi K, Watanabe K, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.	Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.	
DRAMP29146	GLMGTLISKQMKK	13	Pxt‐11	No entry found	Not found	Not found	Xenopus tropicalis	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-	Not found	Alpha helix,random coil	2.3%,4.2%,6.6% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2).		Function:Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.	[Ref.25312021]Gram-negative bacteria:Escherichia coli DH5α(Not active up to 150 µg/ml);##Gram-positive bacteria:Staphylococcus aureus JCM 2151(Not active up to 150 µg/ml).	[Ref.25312021]0.3% Hemolysis against Rat erythrocytes at 20 µM.	Linear	Free	Amidation 	The 'G' at position 1 is pyroglutamic acid	L	[Ref.25312021]No cytotoxicity information found.	Not found	25312021	FEBS J. 2015 Jan;282(1):102-13.	Shigeri Y, Yasuda A, Hagihara Y, Nishi K, Watanabe K, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.	Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.	
DRAMP29147	NLLGSLLKTGLKVGSNLL	18	Pxt‐12(CPF-St7)	P84386	Not found		Xenopus tropicalis	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-,Antifungal	Protein level	Alpha helix,random coil	0%,2.5%,6.6% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2);68.2%,57.4%,50.5% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 50% TFE.		Induced a significant and dose-dependent histamine release. 	[Ref.26802742]Gram-negative bacteria:Escherichia coli NBRC 14237(MIC<12.5 µM);Pseudomonas aeruginosa NBRC 12582(MIC<50 µM);##Gram-positive bacteria:Staphylococcus aureus NBRC 12732(MIC<12.5 µM);Micrococcus luteus NBRC 12708(MIC<50 µM);##Fungi:Candida albicans NBRC 1594(ND). ##[Ref.23935531]Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=128 µM);Pseudomonas aeruginosa ATCC 15692(MIC >256 µM);##Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=32 µM);Micrococcus luteus(MIC=2 µM);##Fungi:Saccharomyces cerevisiae(MIC=64 µM);##Parasite:Trypanosoma brucei(LC95=2-64 µM).     	[Ref.26802742]0% Hemolysis against Rat erythrocytes at 50 µM.##[Ref.23935531]Hemolysis against Mouse erythrocytes(IC50=256 µM).	Linear	Free	Amidation 		L	[Ref.23935531]Cytotoxicity against T-lymphocytes(IC50=128 µM). 	liposomes	26802742##23935531	J Biochem. 2016 Jun;159(6):619-29.##PLoS Genet. 2013;9(8):e1003662. 	Shigeri Y, Horie M, Yoshida T, Hagihara Y, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.##Roelants K, Fry BG, Ye L, Stijlemans B, Brys L, Kok P, Clynen E, Schoofs L, Cornelis P, Bossuyt F.	Physicochemical and biological characterizations of Pxt peptides from amphibian (Xenopus tropicalis) skin.##Origin and functional diversification of an amphibian defense peptide arsenal.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(C)C)C(N)=O
DRAMP29148	KLLNLLPGLLAGIF	14	Reverse Pxt‐5	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix,random coil	10.9%,17.4%,19.8% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2);87.1%,77.0%,70.7% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 50% TFE.		Induced a significant and dose-dependent histamine release. 	[Ref.26802742]Gram-negative bacteria:Escherichia coli NBRC 14237(MIC<12.5 µM);Pseudomonas aeruginosa NBRC 12582(MIC<50 µM);##Gram-positive bacteria:Staphylococcus aureus NBRC 12732(MIC<12.5 µM);Micrococcus luteus NBRC 12708(MIC<25 µM);##Fungi:Candida albicans NBRC 1594(ND). 	[Ref.26802742]5.2% Hemolysis against Rat erythrocytes at 50 µM.	Linear	Free	Amidation 		L	[Ref.26802742]No cytotoxicity information found.	liposomes	26802742	J Biochem. 2016 Jun;159(6):619-29.	Shigeri Y, Horie M, Yoshida T, Hagihara Y, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.	Physicochemical and biological characterizations of Pxt peptides from amphibian (Xenopus tropicalis) skin.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP29149	ALLKLAPRLLAGIF	14	Reverse Pxt-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix,random coil	3.6%,4.7%,7.3% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2);28.6%,26.8%,22.8% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 50% TFE.		Induced a significant and dose-dependent histamine release. 	[Ref.26802742]Gram-negative bacteria:Escherichia coli NBRC 14237(MIC<12.5 µM);Pseudomonas aeruginosa NBRC 12582(MIC<50 µM);##Gram-positive bacteria:Staphylococcus aureus NBRC 12732(MIC<12.5 µM);Micrococcus luteus NBRC 12708(MIC<50 µM);##Fungi:Candida albicans NBRC 1594(ND). 	[Ref.26802742]1.5% Hemolysis against Rat erythrocytes at 50 µM.	Linear	Free	Amidation		L	[Ref.26802742]No cytotoxicity information found.	liposomes	26802742	J Biochem. 2016 Jun;159(6):619-29.	Shigeri Y, Horie M, Yoshida T, Hagihara Y, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.	Physicochemical and biological characterizations of Pxt peptides from amphibian (Xenopus tropicalis) skin.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP29150	LLNSGVKLGTKLLSGLLN	18	Reverse Pxt-12	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-, Antifungal	Not found	Alpha helix,random coil	0%,0%,2.0% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 10 mm Tris-HCl (pH 7.2);23.7%,21.0%,17.9% α-helix were mearsured by CD spectra at 10 °C, 25 °C and 37 °C in 50% TFE.		Induced a significant and dose-dependent histamine release. 	[Ref.26802742]Gram-negative bacteria:Escherichia coli NBRC 14237(ND);Pseudomonas aeruginosa NBRC 12582(ND);##Gram-positive bacteria:Staphylococcus aureus NBRC 12732(ND);Micrococcus luteus NBRC 12708(ND);##Fungi:Candida albicans NBRC 1594(ND). 	[Ref.26802742]0% Hemolysis against Rat erythrocytes at 50 µM.	Linear	Free	Amidation		L	[Ref.26802742]No cytotoxicity information found.	liposomes	26802742	J Biochem. 2016 Jun;159(6):619-29.	Shigeri Y, Horie M, Yoshida T, Hagihara Y, Imura T, Inagaki H, Haramoto Y, Ito Y, Asashima M.	Physicochemical and biological characterizations of Pxt peptides from amphibian (Xenopus tropicalis) skin.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O
DRAMP29151	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	36	EK1	Q8BB25	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Hemology	Not found	Not found		Mechanism of action:The peptide acted as a fusion inhibitor which against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.	[Ref.35087243]Virus:##SARS-CoV-2 Omicron:inhibition of cell-cell fusion in Calu-3 cells(IC50=119.68 nM);inhibition of cell-cell infusion in Caco2 cells(IC50=74.99 nM);inhibition of infection(Pseudovirus)(IC50=309.4 nM);inhibition of infection(Authentic)(IC50=1138 nM);##SARS-CoV-2 Delta:inhibition of cell-cell fusion(IC50=131.8 nM);inhibition of infection(Pseudovirus)(IC50=427.55 nM);##SARS-CoV-2 D614G:inhibition of cell-cell fusion(IC50=314.6 nM);inhibition of infection(Pseudovirus)(IC50=414.85 nM).##[Ref.32231345]Virus:##SARS-CoV:ihibition of cell-cell fusion in Huh-7 cells(IC50=409.3 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=3237 nM);##MERS-CoV:ihibition of cell-cell fusion in Huh-7 cells(IC50=239.5 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=631.8 nM),inhibit the replication of MERS-CoV in VERO-E6 cells(IC50=802.1 nM);##HCoV-OC43:ihibition of cell-cell fusion in Huh-7 cells(IC50=787.6 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=1398 nM),inhibit the replication of HCoV-OC43 in RD cells(IC50=1554 nM);##HCoV-229E:ihibition of cell-cell fusion in Huh-7 cells(IC50=207.4 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=3963 nM),inhibit the replication of HCoV-229E in Huh-7 cells(IC50=4375 nM);##HCoV-NL63:ihibition of cell-cell fusion in Huh-7 cells(IC50=751.0 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=7666 nM),inhibit the replication of HCoV-NL63 in LLC-MK2 cells(IC50=3693 nM);##CoV-WIV1:ihibition of cell-cell fusion in Huh-7 cells(IC50=265.7 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=5425 nM);##CoV-Rs3367:ihibition of cell-cell fusion in Huh-7 cells(IC50=237.0 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=6014 nM);##CoV-SHC014:ihibition of cell-cell fusion in Huh-7 cells(IC50=279.6 nM);##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=286.7-315.0 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=2375.0 nM),inhibit the replication of MERS-CoV in VERO-E6 cells(IC50=2468 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	liposomes	35087243##32231345##30989115##32047258	Cell Res. 2022 Apr;32(4):404-406.##Cell Res. 2020 Apr;30(4):343-355.##Sci Adv. 2019 Apr 10;5(4):eaav4580.##Cell Mol Immunol. 2020 Jul;17(7):765-767.	Xia S, Chan JF, Wang L, Jiao F, Chik KK, Chu H, Lan Q, Xu W, Wang Q, Wang C, Yuen KY, Lu L, Jiang S.##Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L.##Xia S, Yan L, Xu W, Agrawal AS, Algaissi A, Tseng CK, Wang Q, Du L, Tan W, Wilson IA, Jiang S, Yang B, Lu L.##Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, Ying T, Liu S, Shi Z, Jiang S, Lu L.	Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant.##Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.##A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.##Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP29152	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	36	EK1P	Q8BB25	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Hemology	Not found	Not found		Mechanism of action:The peptide acted as a fusion inhibitor which against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.	[Ref.32231345]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=69.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG4-C(Palm)		L	No cytotoxicity information found in the reference(s) presented	liposomes	32231345	Cell Res. 2020 Apr;30(4):343-355.	Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L.	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	
DRAMP29153	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	36	EK1C	Q8BB25	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Hemology	Not found	Not found		Mechanism of action:The peptide acted as a fusion inhibitor which against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.	[Ref.32231345]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=37.3-48.1 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=139.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG4-C(Chol)		L	No cytotoxicity information found in the reference(s) presented	liposomes	32231345	Cell Res. 2020 Apr;30(4):343-355.	Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L.	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	
DRAMP29154	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	36	EK1C1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide acted as a fusion inhibitor which against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.	[Ref.32231345]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=56.8 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=480.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32231345	Cell Res. 2020 Apr;30(4):343-355.	Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L.	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	
DRAMP29155	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSG	39	EK1C2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide acted as a fusion inhibitor which against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.	[Ref.32231345]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=48.2 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=418.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32231345	Cell Res. 2020 Apr;30(4):343-355.	Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L.	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	
DRAMP29156	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSG	39	EK1C3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide acted as a fusion inhibitor which against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.	[Ref.32231345]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=10.6 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=86.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG4-Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32231345	Cell Res. 2020 Apr;30(4):343-355.	Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L.	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	
DRAMP29157	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1C4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide acted as a fusion inhibitor which against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.	[Ref.35087243]Virus:##SARS-CoV-2 Omicron:inhibition of cell-cell fusion in Calu-3 cells(IC50=3.32 nM);inhibition of cell-cell infusion in Caco2 cells(IC50=0.88 nM);inhibition of infection(Pseudovirus)(IC50=8.63 nM);inhibition of infection(Authentic)(IC50=85.38 nM);##SARS-CoV-2 Delta:inhibition of cell-cell fusion(IC50=4.04 nM);inhibition of infection(Pseudovirus)(IC50=9.83 nM);##SARS-CoV-2 D614G:inhibition of cell-cell fusion(IC50=2.57 nM);inhibition of infection(Pseudovirus)(IC50=5.58 nM).##[Ref.32231345]Virus:##SARS-CoV:ihibition of cell-cell fusion in Huh-7 cells(IC50=4.3 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=11.7 nM);##MERS-CoV:ihibition of cell-cell fusion in Huh-7 cells(IC50=2.5 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=11.1 nM),inhibit the replication of MERS-CoV in VERO-E6 cells(IC50=4.2 nM);##HCoV-OC43:ihibition of cell-cell fusion in Huh-7 cells(IC50=7.7 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=37.7 nM),inhibit the replication of HCoV-OC43 in RD cells(IC50=24.8 nM);##HCoV-229E:ihibition of cell-cell fusion in Huh-7 cells(IC50=5.2 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=12.4 nM),inhibit the replication of HCoV-229E in Huh-7 cells(IC50=101.5 nM);##HCoV-NL63:ihibition of cell-cell fusion in Huh-7 cells(IC50=21.4 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=76.6 nM),inhibit the replication of HCoV-NL63 in LLC-MK2 cells(IC50=187.6 nM);##CoV-WIV1:ihibition of cell-cell fusion in Huh-7 cells(IC50=4.5 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=30.8 nM);##CoV-Rs3367:ihibition of cell-cell fusion in Huh-7 cells(IC50=8.1 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=66.9 nM);##CoV-SHC014:ihibition of cell-cell fusion in Huh-7 cells(IC50=4.3 nM);##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=1.3 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=15.8 nM),inhibit the replication of MERS-CoV in VERO-E6 cells(IC50=2468 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG4-Chol		L	[Ref.32231345]<10% cytotoxicity against VERO-E6 cells, RD cells, LLC-MK2 cells, Huh-7 cells up to 10000 nM.	liposomes	35087243##32231345	Cell Res. 2022 Apr;32(4):404-406.##Cell Res. 2020 Apr;30(4):343-355.	Xia S, Chan JF, Wang L, Jiao F, Chik KK, Chu H, Lan Q, Xu W, Wang Q, Wang C, Yuen KY, Lu L, Jiang S.##Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L.	Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant.##Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	
DRAMP29158	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1C5	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide acted as a fusion inhibitor which against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.	[Ref.32231345]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=3.1 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=31.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG8-Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32231345	Cell Res. 2020 Apr;30(4):343-355.	Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L.	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	
DRAMP29159	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1C6	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide acted as a fusion inhibitor which against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.	[Ref.32231345]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=3.9 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=77.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG12-Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32231345	Cell Res. 2020 Apr;30(4):343-355.	Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L.	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	
DRAMP29160	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1C7	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide acted as a fusion inhibitor which against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.	[Ref.32231345]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=3.9 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=84.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG24-Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32231345	Cell Res. 2020 Apr;30(4):343-355.	Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L.	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	
DRAMP29161	LKVLLYEEFKLLESLIMEILEYQKDSDIKENAEDTK	36	EK1-scrambled	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide acted as a fusion inhibitor which against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.	[Ref.32231345]Virus:SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-OC43,HCoV-229E,HCoV-NL63,CoV-WIV1,CoV-Rs3367,CoV-SHC014(No inhibition on the concentration up to 10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	liposomes	32231345	Cell Res. 2020 Apr;30(4):343-355.	Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L.	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP29162	NVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYGSGC	40	EKL1C	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		EKL1C is a Peptide-based pan-CoV fusion inhibitor,targets a highly conserved target site in HR1 domains in S protein of HCoVs.	[Ref.35087243]Virus:##SARS-CoV-2 Omicron:inhibition of cell-cell fusion in Calu-3 cells(IC50=12.18 nM);inhibition of cell-cell infusion in Caco2 cells(IC50=5.52 nM);inhibition of infection(Pseudovirus)(IC50=26.14 nM);inhibition of infection(Authentic)(IC50=182.2 nM);##SARS-CoV-2 Delta:inhibition of cell-cell fusion(IC50=14.42 nM);inhibition of infection(Pseudovirus)(IC50=31.99 nM);##SARS-CoV-2 D614G:inhibition of cell-cell fusion(IC50=11.77 nM);inhibition of infection(Pseudovirus)(IC50=23.6 nM).##[Ref.34367893]Virus:##SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.045±0.006 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.037±0.009 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.040±0.005 μmol/L),inhibition of cell-cell fusion(IC50=0.008±0.001 μmol/L);inhibited authentic SARS-CoV-2 infection in Vero E6 cells(IC50=0.003±0.001 μmol/L);##SARS-CoV-2 variants(inhibition of Pseudovirus(PsV) infection):V341L(IC50=0.047±0.013 μmol/L);F342L(IC50=0.026±0.007 μmol/L);V367F(IC50=0.066±0.012 μmol/L);R408I(IC50=0.148±0.012 μmol/L);N435D(IC50=0.135±0.013 μmol/L);G476S(IC50=0.065±0.008 μmol/L);V483A(IC50=0.078±0.011 μmol/L);N501Y(IC50=0.069±0.006 μmol/L);D614G(IC50=0.104±0.010 μmol/L);12 mutations(P.1)(IC50=0.046±0.006 μmol/L);K417N-E484K-N501Y(IC50=0.113±0.013 μmol/L);8 mutations(B.1.1.7)(IC50=0.120±0.009 μmol/L);wide type(IC50=0.049±0.007 μmol/L);##inhibition of multiple HCoV Pseudovirus:SARS-CoV (IC50=0.076±0.014 μmol/L), MERS-CoV(IC50=0.048±0.006 μmol/L), HCoV-OC43(IC50=0.668±0.081 μmol/L), HCoV-NL63(IC50=0.035±0.003 μmol/L), SARSr-CoV-WIV1(IC50=0.218±0.013 μmol/L), and HCoV-Rs3367 (IC50=0.046±0.003 μmol/L),inhibition of authentic HCoV-OC43 infection in RD cells (IC50=0.281±0.018 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	[Ref.34367893]Huh-7 cells:CC50=10 μmol/L;Caco-2 cells:CC50=13.81 μmol/L;293T/ACE2 cells:CC50=8.49 μmol/L.	liposomes	35087243##34367893	Cell Res. 2022 Apr;32(4):404-406.##Acta Pharm Sin B. 2021 Aug 2.	Xia S, Chan JF, Wang L, Jiao F, Chik KK, Chu H, Lan Q, Xu W, Wang Q, Wang C, Yuen KY, Lu L, Jiang S.##Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.	Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant.##A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	
DRAMP29163	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1-C16	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		EK1-C16 at 0.31 μM could effectively inhibit authentic SARS-CoV-2 WT infection.	[Ref.35336956]Virus:##SARS-CoV-2 WT:inhibition of pseudovirus (PsV) infection in Caco2 cells(IC50=0.48 μM);##SARS-CoV-2 Alpha:inhibition of pseudovirus (PsV) infection(IC50=0.19 μM);##SARS-CoV-2 Beta:inhibition of pseudovirus (PsV) infection(IC50=0.43 μM);##SARS-CoV-2 Gamma:inhibition of pseudovirus (PsV) infection(IC50=0.26 μM);##SARS-CoV-2 Delta:inhibition of pseudovirus (PsV) infection(IC50=0.11 μM);##SARS-CoV-2 Omicron:inhibition of pseudovirus (PsV) infection(IC50=0.23 μM);inhibition of authentic infection in Vero-E6-TMPRSS-2 cells(IC50=0.75 μM);##SARS-CoV:inhibition of pseudovirus (PsV) infection(IC50=0.17 μM);##SARSr-CoV WIV1:inhibition of pseudovirus (PsV) infection(IC50=0.15 μM);##SARSr-CoV Rs3367:inhibition of pseudovirus (PsV) infection(IC50=0.3 μM);##MERS-CoV:inhibition of pseudovirus (PsV) infection in Caco2 cells(IC50=0.10 μM);inhibition of cell-cell fusion(IC50=0.012 μM);##HCoV-OC43:inhibition of authentic infection in RD cells(IC50=0.07 μM);inhibition of cell-cell fusion(IC50=0.01 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG4-C16(palmitic acid)		L	[Ref.35336956]showed  no significant cytotoxicity against RD cells at the concentration of 5 μM.	Not found	35336956	Viruses. 2022 Mar 6;14(3):549.	Lan Q, Chan JF, Xu W, Wang L, Jiao F, Zhang G, Pu J, Zhou J, Xia S, Lu L, Yuen KY, Jiang S, Wang Q. 	A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern.	
DRAMP29164	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKW	45	EKL0	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.	[Ref.34367893]Virus:SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.583±0.073 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50>5 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.442±0.037 μmol/L),inhibition of cell-cell fusion(IC50=0.277±0.029 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	liposomes	34367893	Acta Pharm Sin B. 2021 Aug 2.	Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP29165	NVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEY	36	EKL1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.	[Ref.34367893]Virus:##SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.622±0.089 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50>5 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.746±0.152 μmol/L),inhibition of cell-cell fusion(IC50=0.220±0.034 μmol/L);inhibited authentic SARS-CoV-2 infection in Vero E6 cells(IC50=1.407±0.189 μmol/L);##inhibition of multiple HCoV Pseudovirus:SARS-CoV (IC50=6.716±5.937 μmol/L), MERS-CoV(IC50=4.086±0.345 μmol/L), HCoV-OC43(IC50=10.530±3.778 μmol/L), HCoV-NL63(IC50=3.700±0.222 μmol/L), SARSr-CoV-WIV1(IC50=30.270±4.713 μmol/L), and HCoV-Rs3367 (IC50=88.300±24.600 μmol/L),inhibition of authentic HCoV-OC43 infection in RD cells (IC50=20.290±1.092 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	liposomes	34367893	Acta Pharm Sin B. 2021 Aug 2.	Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)O)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP29166	TFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYV	36	EKL2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.	[Ref.34367893]Virus:SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.526±0.049 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50>5 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=4.714±1.173 μmol/L),inhibition of cell-cell fusion(IC50=1.240±0.246 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	liposomes	34367893	Acta Pharm Sin B. 2021 Aug 2.	Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)O)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP29167	LDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKW	36	EKL3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.	[Ref.34367893]Virus:SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50>10 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50>5 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50>5 μmol/L),inhibition of cell-cell fusion(IC50=2.167±0.270 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	liposomes	34367893	Acta Pharm Sin B. 2021 Aug 2.	Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)O)NC(=O)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP29168	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKWGSGC	49	EKL0C	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.	[Ref.34367893]Virus:SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.122±0.012 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.147±0.055 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.162±0.022 μmol/L),inhibition of cell-cell fusion(IC50=0.021±0.003 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	34367893	Acta Pharm Sin B. 2021 Aug 2.	Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	
DRAMP29169	TFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVGSGC	40	EKL2C	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.	[Ref.34367893]Virus:SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.115±0.019 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.054±0.014 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.200±0.020 μmol/L),inhibition of cell-cell fusion(IC50=0.022±0.001 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	34367893	Acta Pharm Sin B. 2021 Aug 2.	Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	
DRAMP29170	LDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKWGSGC	40	EKL3C	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.	[Ref.34367893]Virus:SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.127±0.293 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=1.176±1.230 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.892±0.069 μmol/L),inhibition of cell-cell fusion(IC50=0.045±0.004 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	34367893	Acta Pharm Sin B. 2021 Aug 2.	Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	
DRAMP29171	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKWGSGK	49	EKL0P	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.	[Ref.34367893]Virus:SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.093±0.012 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.619±0.341 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.176±0.019 μmol/L),inhibition of cell-cell fusion(IC50=0.083±0.009 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Palm		L	No cytotoxicity information found in the reference(s) presented	liposomes	34367893	Acta Pharm Sin B. 2021 Aug 2.	Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	
DRAMP29172	NVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYGSGK	40	EKL1P	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.	[Ref.34367893]Virus:SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.182±0.034 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.812±0.182 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.231±0.022 μmol/L),inhibition of cell-cell fusion(IC50=0.064±0.004 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Palm		L	No cytotoxicity information found in the reference(s) presented	liposomes	34367893	Acta Pharm Sin B. 2021 Aug 2.	Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	
DRAMP29173	TFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVGSGK	40	EKL2P	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.	[Ref.34367893]Virus:SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=1.129±0.166 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.973±0.254 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.304±0.051 μmol/L),inhibition of cell-cell fusion(IC50=0.183±0.028 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Palm		L	No cytotoxicity information found in the reference(s) presented	liposomes	34367893	Acta Pharm Sin B. 2021 Aug 2.	Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	
DRAMP29174	LDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKWGSGK	40	EKL3P	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.	[Ref.34367893]Virus:SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=3.987±0.682 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50>5 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=2.214±0.371 μmol/L),inhibition of cell-cell fusion(IC50=0.193±0.021 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Palm		L	No cytotoxicity information found in the reference(s) presented	liposomes	34367893	Acta Pharm Sin B. 2021 Aug 2.	Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	
DRAMP29175	DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	36	2019-nCoV-HR2P(SARS-CoV-2-S(1168-1203),SARS-HR2P)	Q5DIC5	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Hemology	Alpha helix	Not found		Mechanism of action:2019-nCoV HR1 and HR2 regions are able to interact with each other to form 6-HB and suggest that 2019-nCoV-HR2P may inhibit 2019-nCoV fusion with and entry into the target cell.	"[Ref.32047258]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in Huh-7 cells(IC50=0.18 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=0.98 µM).##[Ref.30989115]SARS-CoV:ihibition of cell-cell fusion in Huh-7 cells(IC50=0.52±0.11	µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=2.81	µM);##MERS-CoV:ihibition of cell-cell fusion in Huh-7 cells(IC50>5 µM);##HCoV-OC43:ihibition of cell-cell fusion in Huh-7 cells(IC50>5 µM);##HCoV-229E:ihibition of cell-cell fusion in Huh-7 cells(IC50>5 µM);##HCoV-NL63:ihibition of cell-cell fusion in Huh-7 cells(IC50>5 µM);##CoV-WIV1:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=2.73 µM);##CoV-Rs3367:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=3.05 µM)."	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	liposomes	30989115##32047258	Sci Adv. 2019 Apr 10;5(4):eaav4580.##Cell Mol Immunol. 2020 Jul;17(7):765-767.	Xia S, Yan L, Xu W, Agrawal AS, Algaissi A, Tseng CK, Wang Q, Du L, Tan W, Wilson IA, Jiang S, Yang B, Lu L.##Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, Ying T, Liu S, Shi Z, Jiang S, Lu L.	A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.##Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)O
DRAMP29176	NGAICWGPCPTAFRQIGNCGHFKVRCCKIR	30	MBD-4 (11-40)(P9)	P82019	Belongs to the beta-defensin family.	Defb4	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found	6M56	Mechanism of action:Mechanistic studies show that positively charged P9 broadly inhibits viral replication by binding to different viruses and then inhibits virus–host endosomal acidification to prevent the endosomal release of pH-dependent viruses. 	[Ref.32843628]Virus:##SARS-CoV-2:Inhibition of infection in Vero E6 cells(IC50=2.4 µg/ml);##SARS-CoV:Inhibition of infection in Vero E6 cells(IC50=6.2 µg/ml);##MERS-CoV:Inhibition of infection in Vero E6 cells(IC50=8.8 µg/ml);##Human rhinovirus (HRV):inhibition of infection in RD cells(IC50=34 µg/ml);##Human parainﬂuenza virus 3:Inhibition of infection in LLC-MK2 cells(IC50>25 µg/ml);##Human Influenza A Virus H1N1:Inhibition of infection In MDCK cells(IC50=1.6 µg/ml);##Human Influenza A Virus H7N9:Inhibition of infection In MDCK cells(IC50=3.3 µg/ml).##[Ref.26911565]Virus:Human Influenza A Virus H1N1(IC50=1.2 µg/ml);Human Influenza A Virus H3N2(IC50=1.2 µg/ml);Human Influenza A Virus H5N1(IC50=2.4 µg/ml);Human Influenza A Virus H7N7(IC50=0.8 µg/ml);Human Influenza A Virus H7N9(IC50=4.6 µg/ml);MERS-CoV(IC50=4.8 µg/ml);SARS-CoV(IC50=4.8 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.26911565]Xytotoxicity against Madin-Darby canine kidney cells(TC50=380 μg/ml).	Not found	26911565##32843628	Sci Rep. 2016 Feb 25;6:22008. ##Nat Commun. 2020 Aug 25;11(1):4252.	Zhao H, Zhou J, Zhang K, Chu H, Liu D, Poon VK, Chan CC, Leung HC, Fai N, Lin YP, Zhang AJ, Jin DY, Yuen KY, Zheng BJ.##Zhao H, To KKW, Sze KH, Yung TT, Bian M, Lam H, Yeung ML, Li C, Chu H, Yuen KY.	A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses. ##A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@@H](C)O
DRAMP29177	NGAICWGPCPTAFRQIGNCGRFRVRCCRIR	30	MBD-4 (11-40) (P9 [H21R,K23R,K28R], P9R)	P82019	Belongs to the beta-defensin family.	Defb5	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found	6M56	Mechanism of action:Mechanistic studies show that positively charged P9R broadly inhibits viral replication by binding to different viruses and then inhibits virus–host endosomal acidification to prevent the endosomal release of pH-dependent viruses. 	[Ref.32843628]Virus:##SARS-CoV-2:Inhibition of infection in Vero E6 cells(IC50=0.9 µg/ml);##SARS-CoV:Inhibition of infection in Vero E6 cells(IC50=4.2 µg/ml);##MERS-CoV:Inhibition of infection in Vero E6 cells(IC50=22 µg/ml);##Human rhinovirus (HRV):inhibition of infection in RD cells(IC50=5.7 µg/ml);##Human parainﬂuenza virus 3:Inhibition of infection in LLC-MK2 cells(IC50>25 µg/ml);##Human Influenza A Virus H1N1:Inhibition of infection In MDCK cells(IC50=0.6 µg/ml);##Human Influenza A Virus H7N9:Inhibition of infection In MDCK cells(IC50=0.9 µg/ml).	[Ref.32843628]P9R did not cause the hemolysis of Chicken red blood cells.	Linear	Free	Free		L	[Ref.32843628]the CC50 of P9R was >300 μg/ml for MDCK, VeroE6 and A549 cells.	Not found	32843628	Nat Commun. 2020 Aug 25;11(1):4252.	Zhao H, To KKW, Sze KH, Yung TT, Bian M, Lam H, Yeung ML, Li C, Chu H, Yuen KY.	A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@@H](C)O
DRAMP29178	NGAICWGPCPTAFRQIGNCGRFRVRCCRIR	30	8P9R(branched P9R)	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found	6M56	Mechanism of action:Have dual-antiviral mechanisms of cross-linking viruses to stop viral entry (mediated by TMPRSS2 for SARS-CoV-2) and of reducing endosomal acidification to inhibit viral entry through endocytic pathway.	[Ref.33750821]Virus:SARS-CoV-2:inhibition of replication in high salt condition(IC50 = 0.3 μg/ml)	[Ref.33750821]no obvious hemolysis was observed when turkey red blood cells were treated at 200 μg/ml.	Branched	Free	Free		L	[Ref.33750821]Vero-E6 cells:the cytotoxicity indicated that TC50 of 8P9R was higher than 200 μg/ml.	Not found	33750821	Nat Commun. 2021 Mar 9;12(1):1517. 	Zhao H, To KKW, Lam H, Zhou X, Chan JF, Peng Z, Lee ACY, Cai J, Chan WM, Ip JD, Chan CC, Yeung ML, Zhang AJ, Chu AWH, Jiang S, Yuen KY.	Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@@H](C)O
DRAMP29179	ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	35	IPB01(SARS-CoV-S (1151-1185),SR9, SARS-CoV-2-S (1169-1203))	P59594,P0DTC2	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Alpha helix	Not found		Mechanism of action:The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently.	[Ref.32376627]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=0.022±0.005 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=33.74±11.827 µM);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).##[Ref.17942557]Virus:SARS-CoV:Inhibition of virus entry in VERO-E6 cells(EC50=0.005 µM).##[Ref.18442051]Virus:SARS-CoV: inhibition of PsV entry in Vero-E6 cells(EC50=0.34 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	liposomes	17942557##18442051##32376627	J Virol. 2008 Jan;82(1):588-92.##J Cell Biochem. 2008 Aug 15;104(6):2335-47.##J Virol. 2020 Jul 1;94(14):e00635-20.	Ujike M, Nishikawa H, Otaka A, Yamamoto N, Yamamoto N, Matsuoka M, Kodama E, Fujii N, Taguchi F. ##Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM. ##Zhu Y, Yu D, Yan H, Chong H, He Y.	Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.##Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.##Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC
DRAMP29180	ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELK	36	IPB02(SARS-CoV-2-S (1169-1203)-K)	P59594,P0DTC2	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Alpha helix	Not found		Mechanism of action:The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently.	[Ref.32376627]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=0.025 ± 0.002 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=0.08±0.017 µM);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC=0.251 ± 0.118 µM);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	Zhu Y, Yu D, Yan H, Chong H, He Y.	Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.	
DRAMP29181	INASVVNIQKEIDRLNEVAKNLNESLIDLQELGK	34	IPB03(SARS-CoV-2-S (1172-1205))	P59594,P0DTC2	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Alpha helix	Not found		Mechanism of action:The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently.	[Ref.32376627]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=0.015 ± 0.002 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=0.947 ± 0.179 µM);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC=1.315 ± 0.463 µM);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	Zhu Y, Yu D, Yan H, Chong H, He Y.	Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.	
DRAMP29182	SVVNIQKEIDRLNEVAKNLNESLIDLQELGK	31	IPB04(SARS-CoV-2-S (1175-1205))	P59594,P0DTC2	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Alpha helix	Not found		Mechanism of action:The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently.	[Ref.32376627]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=0.033 ± 0.013 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=0.218 ± 0.063 µM);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC=1.053 ± 0.444 µM);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	Zhu Y, Yu D, Yan H, Chong H, He Y.	Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.	
DRAMP29183	IQKEIDRLNEVAKNLNESLIDLQELGK	27	IPB05(SARS-CoV-2-S (1179-1205))	P59594,P0DTC2	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently.	[Ref.32376627]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50>5 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>25 µM);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC>25 µM);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	Zhu Y, Yu D, Yan H, Chong H, He Y.	Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.	
DRAMP29184	IDRLNEVAKNLNESLIDLQELGK	23	IPB06(SARS-CoV-2-S (1183-1205))	P59594,P0DTC2	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently.	[Ref.32376627]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50>5 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>25 µM);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC>25 µM);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	Zhu Y, Yu D, Yan H, Chong H, He Y.	Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.	
DRAMP29185	IQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	33	IPB07(SARS-CoV-2-S (1179-1211))	P59594,P0DTC2	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Alpha helix	Not found		Mechanism of action:The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently.	[Ref.32376627]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=0.017 ± 0.001 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=0.993 ± 0.08 µM);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC=1.037 ± 0.836 µM);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	Zhu Y, Yu D, Yan H, Chong H, He Y.	Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.	
DRAMP29186	ISGINASVVNIQKEIDRLNEVAKNLNESLIK	31	IPB08(SARS-CoV-2-S (1169-1198)-K)	P59594,P0DTC2	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently.	[Ref.32376627]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=4.66 ± 1.565 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=1.738 ± 0.898 µM);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC=1.13 ± 0.472 µM);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	Zhu Y, Yu D, Yan H, Chong H, He Y.	Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.	
DRAMP29187	SVVNIQKEIDRLNEVAKNLNESLIK	25	IPB09(SARS-CoV-2-S (1175-1198)-K)	P59594,P0DTC2	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently.	[Ref.32376627]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50>5 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>25 µM);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC>25 µM);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	Zhu Y, Yu D, Yan H, Chong H, He Y.	Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.	
DRAMP29188	DEDLEELERLYRKAEEVAKEAKDASRRGDDERAKEQMERAMRLFDQVFELAQELQEKQTDGNRQKATHLDKAVKEAADELYQRVR	85	AHB1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide is a high-affinity protein minibinder to the SARS-CoV-2 spike receptor binding domain (RBD) that compete with ACE2 binding. 	[Ref.32907861]Virus:SARS-CoV-2:Inhibition of infection in Vero E6 cells(IC50=35 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	32907861	Science. 2020 Oct 23;370(6515):426-431.	Cao L, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L, Chen RE, Carter L, Walls AC, Park YJ, Strauch EM, Stewart L, Diamond MS, Veesler D, Baker D. 	De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.	CSCC[C@H](NC(=O)CC[C@H](NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CC[C@H](NC(=O)CC[C@H](NC(=O)CC[C@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C
DRAMP29189	ELEEQVMHVLDQVSELAHELLHKLTGEELERAAYFNWWATEMMLELIKSDDEREIREIEEEARRILEHLEELARK	75	AHB2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide is a high-affinity protein minibinder to the SARS-CoV-2 spike receptor binding domain (RBD) that compete with ACE2 binding. 	[Ref.32907861]Virus:SARS-CoV-2:Inhibition of infection in Vero E6 cells(IC50=15.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	32907861	Science. 2020 Oct 23;370(6515):426-431.	Cao L, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L, Chen RE, Carter L, Walls AC, Park YJ, Strauch EM, Stewart L, Diamond MS, Veesler D, Baker D. 	De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@H](C)CC)C(=O)O
DRAMP29190	DKEWILQKIYEIMRLLDELGHAEASMRVSDLIYEFMKKGDERLLEEAERLLEEVER	56	LCB1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide is a high-affinity protein minibinder to the SARS-CoV-2 spike receptor binding domain (RBD) that compete with ACE2 binding. 	[Ref.32907861]Virus:SARS-CoV-2:Inhibition of infection in Vero E6 cells(IC50=23.54 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	32907861	Science. 2020 Oct 23;370(6515):426-431.	Cao L, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L, Chen RE, Carter L, Walls AC, Park YJ, Strauch EM, Stewart L, Diamond MS, Veesler D, Baker D. 	De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP29191	NDDELHMLMTDLVYEALHFAKDEEIKKRVFQLFELADKAYKNNDRQKLEKVVEELKELLERLLS	64	LCB3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide is a high-affinity protein minibinder to the SARS-CoV-2 spike receptor binding domain (RBD) that compete with ACE2 binding. 	[Ref.32907861]Virus:SARS-CoV-2:Inhibition of infection in Vero E6 cells(IC50=48.1 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	32907861	Science. 2020 Oct 23;370(6515):426-431.	Cao L, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L, Chen RE, Carter L, Walls AC, Park YJ, Strauch EM, Stewart L, Diamond MS, Veesler D, Baker D. 	De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)C[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP29192	TFLDKFNHEAEDLFYQ	16	ACE2 (27-42)(SAP1)	Q9BYF1	Belongs to the peptidase M2 family.	ACE2	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.	[Ref.33356169]Virus:##SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50=2.39±0.20 mM);Inhibition of infection in 293T/ACE2/GFP cells(IC50=3 mM);##SARS-CoV:Inhibition of infection in 293T/ACE2 cells(80% inhibition at 3 mM);##Vesicular Stomatitis Virus (VSV):No nhibition of infection in 293T/ACE2 cells up to 3 mM;##HCoV-NL63:Inhibition of cytopathic effect in LLC-MK2 cells(30% Inhibition at 3 mM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	33356169	Bioconjug Chem. 2021 Jan 20;32(1):215-223.	Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A.	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP29193	EDLFYQSSL	9	ACE2 (37-45)(SAP2)	Q9BYF1	Belongs to the peptidase M3 family.	ACE2	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.	[Ref.33356169]Virus:##SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50=3.72±0.37 mM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	33356169	Bioconjug Chem. 2021 Jan 20;32(1):215-223.	Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A.	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)C[C@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)O
DRAMP29194	LAQMYPL	7	ACE2 (79-85)(SAP3)	Q9BYF1	Belongs to the peptidase M4 family.	ACE2	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.	[Ref.33356169]Virus:##SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50>7.5 mM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	33356169	Bioconjug Chem. 2021 Jan 20;32(1):215-223.	Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A.	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29195	GKGDFRIL	8	ACE2 (352-359)(SAP4)	Q9BYF1	Belongs to the peptidase M5 family.	ACE2	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.	[Ref.33356169]Virus:##SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50>7.5 mM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	33356169	Bioconjug Chem. 2021 Jan 20;32(1):215-223.	Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A.	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)O
DRAMP29196	QAKTFLDKFNHEA	13	ACE2 (24-36)(SAP5)	Q9BYF1	Belongs to the peptidase M6 family.	ACE2	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.	[Ref.33356169]Virus:##SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50>7.5 mM);No nhibition of infection in 293T/ACE2/GFP cells up to 3 mM;##SARS-CoV:Inhibition of infection in 293T/ACE2 cells(30% inhibition at 3 mM);##Vesicular Stomatitis Virus (VSV):No nhibition of infection in 293T/ACE2 cells up to 3 mM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	33356169	Bioconjug Chem. 2021 Jan 20;32(1):215-223.	Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A.	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP29197	EDLFYQ	6	ACE2 (37-42)(SAP6)	Q9BYF1	Belongs to the peptidase M4 family.	ACE2	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.	[Ref.33356169]Virus:##SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50=1.9±0.14 mM);Inhibition of infection in 293T/ACE2/GFP cells(IC50=3 mM);##SARS-CoV:Inhibition of infection in 293T/ACE2 cells(85% inhibition at 3 mM);##Vesicular Stomatitis Virus (VSV):No nhibition of infection in 293T/ACE2 cells up to 3 mM;##HCoV-NL63:Inhibition of cytopathic effect in LLC-MK2 cells(30% Inhibition at 3 mM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	33356169	Bioconjug Chem. 2021 Jan 20;32(1):215-223.	Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A.	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	CC(C)C[C@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)O
DRAMP29198	DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGSGSGC	42	SARS-CoV-2-S(1168–1203)-GSGSGC	P0DTC2	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:The lipopeptide is derived from the C-terminal heptad repeat (HRC) domain of SARS-CoV-2 S that potently inhibits infection by SARS-CoV-2. 	[Ref.33082259]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T cells(IC50=10±8 nM,IC90=98±57 nM),inhibition of infection in Vero E6 cells(IC50~ 6 nM);##SARS-CoV-2_D614G:ihibition of cell-cell fusion in 293T cells(IC50=8±4 nM,IC90=96±50 nM);##SARS-CoV-2_S943P:ihibition of cell-cell fusion in 293T cells(IC50=6±4 nM,IC90=75±42 nM);##SARS-CoV-2_S247R:ihibition of cell-cell fusion in 293T cells(IC50=9±7 nM,IC90=78±59 nM);##MERS-CoV:ihibition of cell-cell fusion in 293T cells(IC50=35±10 nM,IC90>1000 nM),inhibition of infection in Vero E6 cells(IC50~ 3 nM);##SARS-CoV-1:ihibition of cell-cell fusion in 293T cells(IC50=7±5 nM,IC90=43±6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.33082259]Human embryonic kidney HEK293T cells:18% Cytotoxicity at 10 µM;Vero E6 cells:12% Cytotoxicity at 1 µM,30% Cytotoxicity at 10 µM;Human airway epithelial cells:25% Cytotoxicity at 1 µM.	liposomes	33082259##33597220	mBio. 2020 Oct 20;11(5):e01935-20.##Science. 2021 Mar 26;371(6536):1379-1382.	Outlaw VK, Bovier FT, Mears MC, Cajimat MN, Zhu Y, Lin MJ, Addetia A, Lieberman NAP, Peddu V, Xie X, Shi PY, Greninger AL, Gellman SH, Bente DA, Moscona A, Porotto M.##de Vries RD, Schmitz KS, Bovier FT, Predella C, Khao J, Noack D, Haagmans BL, Herfst S, Stearns KN, Drew-Bear J, Biswas S, Rockx B, McGill G, Dorrello NV, Gellman SH, Alabi CA, de Swart RL, Moscona A, Porotto M.	Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain.##Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)C(=O)NCC(=O)NCC(=O)NCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)O
DRAMP29199	SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKELGSGSGC	42	MERS-CoV-HR2P-GSGSGC	R9UQ53,K9N5Q8	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:The lipopeptide is derived from the C-terminal heptad repeat (HRC) domain of SARS-CoV-2 S that potently inhibits infection by SARS-CoV-2. 	[Ref.33082259]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T cells(IC50>650 nM,IC90>1000 nM),inhibition of infection in Vero E6 cells(IC50~ 36 nM);##SARS-CoV-2_D614G:ihibition of cell-cell fusion in 293T cells(IC50=1000 nM,IC90>1000 nM);##SARS-CoV-2_S943P:ihibition of cell-cell fusion in 293T cells(IC50>1000,IC90>1000 nM);##SARS-CoV-2_S247R:ihibition of cell-cell fusion in 293T cells(IC50>700 nM,IC90>1000 nM);##MERS-CoV:ihibition of cell-cell fusion in 293T cells(IC50=417±180 nM,IC90>1000 nM),inhibition of infection in Vero E6 cells(IC50~ 4 nM);##SARS-CoV-1:ihibition of cell-cell fusion in 293T cells(IC50=40±34 nM,IC90>700 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.33082259]Human embryonic kidney HEK293T cells:<10% Cytotoxicity at 10 µM;Vero E6 cells:12% Cytotoxicity at 10 µM.	liposomes	33082259	mBio. 2020 Oct 20;11(5):e01935-20.	Outlaw VK, Bovier FT, Mears MC, Cajimat MN, Zhu Y, Lin MJ, Addetia A, Lieberman NAP, Peddu V, Xie X, Shi PY, Greninger AL, Gellman SH, Bente DA, Moscona A, Porotto M.	Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)C(=O)NCC(=O)NCC(=O)NCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29200	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSGC	42	EK1-GSGSGC	Q8BB25	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Hemology	Not found	Not found		Mechanism of action:The lipopeptide is derived from the C-terminal heptad repeat (HRC) domain of SARS-CoV-2 S that potently inhibits infection by SARS-CoV-2. 	[Ref.33082259]Virus:##SARS-CoV-2:ihibition of cell-cell fusion in 293T cells(IC50=293±60 nM,IC90>900 nM),inhibition of infection in Vero E6 cells(IC50~ 41 nM);##SARS-CoV-2_D614G:ihibition of cell-cell fusion in 293T cells(IC50=261±136 nM,IC90=892±100 nM);##SARS-CoV-2_S943P:ihibition of cell-cell fusion in 293T cells(IC50=286±104 nM,IC90>1000 nM);##SARS-CoV-2_S247R:ihibition of cell-cell fusion in 293T cells(IC50=194±107 nM,IC90=893±77 nM);##MERS-CoV:ihibition of cell-cell fusion in 293T cells(IC50>1000 nM,IC90>1000 nM),inhibition of infection in Vero E6 cells(IC50~ 2 nM);##SARS-CoV-1:ihibition of cell-cell fusion in 293T cells(IC50=36±5 nM,IC90>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.33082259]Human embryonic kidney HEK293T cells:<5% Cytotoxicity at 10 µM;Vero E6 cells:18% Cytotoxicity at 10 µM.	liposomes	33082259	mBio. 2020 Oct 20;11(5):e01935-20.	Outlaw VK, Bovier FT, Mears MC, Cajimat MN, Zhu Y, Lin MJ, Addetia A, Lieberman NAP, Peddu V, Xie X, Shi PY, Greninger AL, Gellman SH, Bente DA, Moscona A, Porotto M.	Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)C(=O)NCC(=O)NCC(=O)NCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP29201	ANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQ	42	SARS-CoV-2 HR1P	P0DTC2	Belongs to the betacoronaviruses spike protein family.	S	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Protein level	Not found	Not found		Mechanism of action:The peptide acted as a fusion inhibitor which against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection.	[Ref.32047258]Virus:SARS-CoV-2(No inhibition of cell-cell fusion up to 40 µM in Huh-7 cells,No inhibition of infection up to 40 µM in 293T/ACE2 cells)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	32047258	Cell Mol Immunol. 2020 Jul;17(7):765-767.	Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, Ying T, Liu S, Shi Z, Jiang S, Lu L.	Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)[C@H](C)CC
DRAMP29202	PHSCN	5	ATN-161	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide inhibits the spike protein interaction with α5β1 integrin and the interaction between α5β1 integrin and ACE2.	[Ref.33102950]Virus:SARS-CoV-2:inhibition of replication In VeroE6 cells(IC50=3.16 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	Not found	33102950	JACC Basic Transl Sci. 2021 Jan;6(1):1-8.	Beddingfield BJ, Iwanaga N, Chapagain PP, Zheng W, Roy CJ, Hu TY, Kolls JK, Bix GJ.	The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection.	
DRAMP29203	RVKR	4	CMK	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:CMK blocks virus entry, but it further suppresses cleavage of spikes and the syncytium.	"[Ref.33007239]Virus:SARS-CoV-2:inhibition of virus production in Vero E6 cells(IC50=0.057	 µM).##[Ref.31683742]Virus:Zika virus (ZIKV):inhibition of virus release in Vero cells(IC50=18.59 µM);Japanese encephalitis virus (JEV):inhibition of virus release in BHK-21 cells(IC50=19.91 µM).##[Ref.23617302]Virus:Hepatitis B virus (HBV):Inhibition of HBeAg secretion in HepG2.2.15 cells(26±11% inhibition at 20 µM,21±13% Inhibition at 100 µM)."	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Decanoyl(C10)	chloromethylketone(CMK)		L	[Ref.31683742]Vero cells:CC50=712.9 µM.[Ref.33007239]Vero E6 cells:IC50=318.2 µM.	Not found	23617302##31683742##33007239	Liver Int. 2013 Sep;33(8):1230-8. ##Viruses. 2019 Oct 31;11(11):1011.##Cell Rep. 2020 Oct 13;33(2):108254.	Pang YJ, Tan XJ, Li DM, Zheng ZH, Lei RX, Peng XM.##Imran M, Saleemi MK, Chen Z, Wang X, Zhou D, Li Y, Zhao Z, Zheng B, Li Q, Cao S, Ye J.##Cheng YW, Chao TL, Li CL, Chiu MF, Kao HC, Wang SH, Pang YH, Lin CH, Tsai YM, Lee WH, Tao MH, Ho TC, Wu PY, Jang LT, Chen PJ, Chang SY, Yeh SH.	Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.##Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage.##Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects. 	CCCCCCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)CCl)C(C)C
DRAMP29204	LQTALYALMEEIHIAALEKTWTALRHQYT	29	Covid3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide acts as an inhibitor of the RBD–ACE2 interaction 	[Ref.34624194]Virus:##SARS-CoV-2:inhibition of infection in Vero cells(IC50=6.56 ± 2.14 μM);##SARS-CoV-2 variants B.1.1.7:inhibition of infection in Vero cells(IC50=33.40 ± 10.75 μM);##SARS-CoV-2 variants B.1.351:inhibition of infection in Vero cells(IC50=11.13 ± 3.82 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acylation	Amidation		D	No cytotoxicity information found in the reference(s) presented	Not found	34624194	J Med Chem. 2021 Oct 28;64(20):14955-14967.	Valiente PA, Wen H, Nim S, Lee J, Kim HJ, Kim J, Perez-Riba A, Paudel YP, Hwang I, Kim KD, Kim S, Kim PM. 	Computational Design of Potent D-Peptide Inhibitors of SARS-CoV-2.	
DRAMP29205	RFDGKGLGIYQYMEEIEHAASRFAYFFYQHLA	32	Covid_extented_1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide acts as an inhibitor of the RBD–ACE2 interaction	[Ref.34624194]Virus:##SARS-CoV-2:inhibition of infection in Vero cells(IC50=5.76 ± 1.65 μM);##SARS-CoV-2 variants B.1.1.7:inhibition of infection in Vero cells(IC50=5.57 ± 4.04 μM);##SARS-CoV-2 variants B.1.351:inhibition of infection in Vero cells(IC50=7.37 ± 1.80 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acylation	Amidation		D	No cytotoxicity information found in the reference(s) presented	Not found	34624194	J Med Chem. 2021 Oct 28;64(20):14955-14967.	Valiente PA, Wen H, Nim S, Lee J, Kim HJ, Kim J, Perez-Riba A, Paudel YP, Hwang I, Kim KD, Kim S, Kim PM. 	Computational Design of Potent D-Peptide Inhibitors of SARS-CoV-2.	
DRAMP29206	SALEEQYKTFLDKFLHELEDLLYQLALAL	29	P7	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide was designed mimicking the N-terminal helix of hACE2 protein,which could prevent the SARS-CoV-2 from infecting human cells, blocking the interaction between hACE2 and the virus spike protein.	[Ref.33580154]Virus:SARS-CoV-2:54% inhibition of replication in Vero-E6 cells at 10 μM;inhibition of replication in Calu-3 cells(IC50>1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	Not found	33580154	Commun Biol. 2021 Feb 12;4(1):197.	Karoyan P, Vieillard V, Gómez-Morales L, Odile E, Guihot A, Luyt CE, Denis A, Grondin P, Lequin O.	Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(N)=O
DRAMP29207	SALEEQLKTFLDKFMHELEDLLYQLAL	27	P8	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Alpha helix	Not found		Mechanism of action:The peptide was designed mimicking the N-terminal helix of hACE2 protein,which could prevent the SARS-CoV-2 from infecting human cells, blocking the interaction between hACE2 and the virus spike protein.	[Ref.33580154]Virus:SARS-CoV-2:91% inhibition of replication in Vero-E6 cells at 10 μM;inhibition of replication in Calu-3 cells(IC50=46 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.33580154]The peptide proved to be devoid of cell toxicity on Vero-E6 and Calu-3 cells.	Not found	33580154	Commun Biol. 2021 Feb 12;4(1):197.	Karoyan P, Vieillard V, Gómez-Morales L, Odile E, Guihot A, Luyt CE, Denis A, Grondin P, Lequin O.	Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection.	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29208	SALEEQYKTFLDKFMHELEDLLYQLSL	27	P9	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide was designed mimicking the N-terminal helix of hACE2 protein,which could prevent the SARS-CoV-2 from infecting human cells, blocking the interaction between hACE2 and the virus spike protein.	[Ref.33580154]Virus:SARS-CoV-2:93% inhibition of replication in Vero-E6 cells at 10 μM;inhibition of replication in Calu-3 cells(IC50=53 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.33580154]The peptide proved to be devoid of cell toxicity on Vero-E6 and Calu-3 cells.	Not found	33580154	Commun Biol. 2021 Feb 12;4(1):197.	Karoyan P, Vieillard V, Gómez-Morales L, Odile E, Guihot A, Luyt CE, Denis A, Grondin P, Lequin O.	Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection.	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29209	SALEEQYKTFLDKFMHELEDLLYQLAL	27	P10	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The peptide was designed mimicking the N-terminal helix of hACE2 protein,which could prevent the SARS-CoV-2 from infecting human cells, blocking the interaction between hACE2 and the virus spike protein.	[Ref.33580154]Virus:SARS-CoV-2:95% inhibition of replication in Vero-E6 cells at 10 μM;inhibition of replication in Calu-3 cells(IC50=42 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.33580154]The peptide proved to be devoid of cell toxicity on Vero-E6 and Calu-3 cells.	Not found	33580154	Commun Biol. 2021 Feb 12;4(1):197.	Karoyan P, Vieillard V, Gómez-Morales L, Odile E, Guihot A, Luyt CE, Denis A, Grondin P, Lequin O.	Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection.	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP29210	RGAHIKGRWKSRCHRF	16	FBP	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The fusion-inhibition peptide FBP could broadly inhibit influenza virus and SARS-CoV-2 by interfering the viral fusion by the endocytic pathway and showed potently antiviral activity against the influenza virus in mice and SARS-CoV-2 variants in hamsters.	[Ref.35259078]Virus:A(H1N1)(IC50 = 3.9 μg/ml);A(H3N2)(IC50 = 1.6 μg/ml);FluB (IC50 = 7.1 μg/ml);SARS-CoV-2 (HKU001a):inhibition of infection in Vero-E6 cells(IC50=2.9 μg/ml);SARS-CoV-2 (B.1.1.63, D614G):inhibition of infection in Vero-E6 cells(IC50=3.0 μg/ml);SARS-CoV-2(Delta):inhibition of infection in Vera-E6 cells(IC50=3.9 μg/ml).	[Ref.35259078]No significant hemolysis against Turkey red blood cells (RBC).	Linear	Free	Free		L	[Ref.35259078]No significant cytotoxicity was detected in MDCK(Madin Darby canine kidney) cells at 1 mg/ml(TC50 > 1 mg/ml).	liposomes	35259078	Emerg Microbes Infect. 2022 Dec;11(1):926-937.	Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY.	Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP29211	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1P4HC	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets two different sites when mediating virus–cell fusion,which are blocking viral 6-HB formation and reducing the membrane cholesterol level.	[Ref.34769299]Virus:##SARS-CoV-2:inhibition of Pseudoviruse infection in Caco2 cells(IC50=0.8 μM);##SARS-CoV-2 B.1.1.7 (Alpha):inhibition of Pseudoviruse infection in Caco2 cells(IC50=2.28 μM);##SARS-CoV-2 B.1.351 (Beta):inhibition of Pseudoviruse infection in Caco2 cells(IC50=0.62 μM);##SARS-CoV-2 P.1 (Gamma):inhibition of Pseudoviruse infection in Caco2 cells(IC50=0.48 μM);##SARS-CoV-2 B.1.617.2 (Delta):inhibition of Pseudoviruse infection in Caco2 cells(IC50=0.11 μM);##HCoV-229E(Authentic):inhibition of infection in Caco2 cells(IC50=0.48 μM);##HCoV-OC43(Authentic):inhibition of infection in Caco2 cells(IC50=0.41 μM);##SARS-CoV:inhibition of Pseudoviruse infection in Caco2 cells(IC50=0.35 μM);##MERS-CoV:inhibition of Pseudoviruse infection in Caco2 cells(IC50=0.10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG4-25-HC		L	[Ref.34769299]no apparent cytotoxicity against Caco-2 cells at concentrations of up to 20 μM.	liposomes	34769299	Int J Mol Sci. 2021 Nov 1;22(21):11869. 	Lan Q, Wang C, Zhou J, Wang L, Jiao F, Zhang Y, Cai Y, Lu L, Xia S, Jiang S. 	25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses.	
DRAMP29212	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1P8HC	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets two different sites when mediating virus–cell fusion,which are blocking viral 6-HB formation and reducing the membrane cholesterol level.	[Ref.34769299]Virus:SARS-CoV-2:inhibition of Pseudoviruse infection in Caco2 cells(IC50=3.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG8-25-HC		L	[Ref.34769299]no apparent cytotoxicity against Caco-2 cells at concentrations of up to 20 μM.	liposomes	34769299	Int J Mol Sci. 2021 Nov 1;22(21):11869. 	Lan Q, Wang C, Zhou J, Wang L, Jiao F, Zhang Y, Cai Y, Lu L, Xia S, Jiang S. 	25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses.	
DRAMP29213	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1P12HC	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets two different sites when mediating virus–cell fusion,which are blocking viral 6-HB formation and reducing the membrane cholesterol level.	[Ref.34769299]Virus:SARS-CoV-2:inhibition of Pseudoviruse infection in Caco2 cells(IC50=5.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG12-25-HC		L	[Ref.34769299]no apparent cytotoxicity against Caco-2 cells at concentrations of up to 20 μM.	liposomes	34769299	Int J Mol Sci. 2021 Nov 1;22(21):11869. 	Lan Q, Wang C, Zhou J, Wang L, Jiao F, Zhang Y, Cai Y, Lu L, Xia S, Jiang S. 	25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses.	
DRAMP29214	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1P24HC	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		The peptide targets two different sites when mediating virus–cell fusion,which are blocking viral 6-HB formation and reducing the membrane cholesterol level.	[Ref.34769299]Virus:SARS-CoV-2:inhibition of Pseudoviruse infection in Caco2 cells(IC50=10.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG24-25-HC		L	[Ref.34769299]no apparent cytotoxicity against Caco-2 cells at concentrations of up to 20 μM.	liposomes	34769299	Int J Mol Sci. 2021 Nov 1;22(21):11869. 	Lan Q, Wang C, Zhou J, Wang L, Jiao F, Zhang Y, Cai Y, Lu L, Xia S, Jiang S. 	25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses.	
DRAMP29215	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP20	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	48% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37°C	Not found		Mechanism of action:Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived.	[Ref.34057039]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=1.36 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=50.52 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=33.85 nM);##SARS-CoV-2 D614G:inhibition of pseudovirus infections in Huh-7 cells(IC50=103.17 nM);##SARS-CoV-2 N501Y:inhibition of pseudovirus infections in Huh-7 cells(IC50=128.87 nM);##SARS-CoV-2 ΔH69-V70:inhibition of pseudovirus infections in Huh-7 cells(IC50=111.41 nM);##SARS-CoV-2 E484K:inhibition of pseudovirus infections in Huh-7 cells(IC50=79.09 nM);##SARS-CoV-2 B.1.1.7:inhibition of pseudovirus infections in Huh-7 cells(IC50=88.49 nM);##SARS-CoV-2 B.1.351:inhibition of pseudovirus infections in Huh-7 cells(IC50=92.16 nM);##SARS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=73.86 nM);##MERS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=228.4 nM);##HCoV-NL63:inhibition of pseudovirus infections in Huh-7 cells(IC50=817.21 nM);##HCoV-229E:inhibition of pseudovirus infections in Huh-7 cells(IC50=471.54 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol(cholesterol)		L	No cytotoxicity information found in the reference(s) presented	Not found	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y.	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	
DRAMP29216	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP21	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived.	[Ref.34057039]Virus:SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=7.5 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=191.4 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=126.65 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	C16(palmitic acid)		L	No cytotoxicity information found in the reference(s) presented	Not found	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y.	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	
DRAMP29217	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP22	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived.	[Ref.34057039]Virus:SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=6.23 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=179.95 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=86.33 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	C18(stearic acid)		L	No cytotoxicity information found in the reference(s) presented	Not found	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y.	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	
DRAMP29218	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP23	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived.	[Ref.34057039]Virus:SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=39.07 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=1236.38 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=507.32 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Toc(tocophenol)		L	No cytotoxicity information found in the reference(s) presented	Not found	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y.	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	
DRAMP29219	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP24	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	16% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37°C	Not found		Mechanism of action:Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived.	[Ref.34057039]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.33 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=3.77 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=2.89 nM);inhibition of live SARS-CoV-2 infection in Vero cells(IC50=8.97 nM);##SARS-CoV-2 D614G:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.29 nM);##SARS-CoV-2 N501Y:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.5 nM);##SARS-CoV-2 ΔH69-V70:inhibition of pseudovirus infections in Huh-7 cells(IC50=7.42 nM);##SARS-CoV-2 E484K:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.97 nM);##SARS-CoV-2 B.1.1.7:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.22 nM);##SARS-CoV-2 B.1.351:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.06 nM);##SARS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=21.64 nM);##MERS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=69.9 nM);##HCoV-NL63:inhibition of pseudovirus infections in Huh-7 cells(IC50=375.56 nM);##HCoV-229E:inhibition of pseudovirus infections in Huh-7 cells(IC50=421.48 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG4-K(Chol)		L	[Ref.34057039]Huh-7 cells:CC50=6.6 μM;Vero-E6 cells:CC50=13.67 μM.	Not found	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y.	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	
DRAMP29220	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP25	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	18% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37°C	Not found		Mechanism of action:Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived.	[Ref.34057039]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.29 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=2.13 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=1.43 nM),inhibition of live SARS-CoV-2 infection in Vero cells(IC50=25.71 nM);##SARS-CoV-2 D614G:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.8 nM);##SARS-CoV-2 N501Y:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.52 nM);##SARS-CoV-2 ΔH69-V70:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.56 nM);##SARS-CoV-2 E484K:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.71 nM);##SARS-CoV-2 B.1.1.7:inhibition of pseudovirus infections in Huh-7 cells(IC50=5.87 nM);##SARS-CoV-2 B.1.351:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.76 nM);##SARS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=17.69 nM);##MERS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=48.5 nM);##HCoV-NL63:inhibition of pseudovirus infections in Huh-7 cells(IC50=353.22 nM);##HCoV-229E:inhibition of pseudovirus infections in Huh-7 cells(IC50=336.14 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG5-K(Chol)		L	[Ref.34057039]Huh-7 cells:CC50=3.54 μM;Vero-E6 cells:CC50=6.95 μM.	Not found	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y.	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	
DRAMP29221	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP26	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived.	[Ref.34057039]Virus:SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.26 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=3.05 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=1.82 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG6-K(Chol)		L	No cytotoxicity information found in the reference(s) presented	Not found	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y.	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	
DRAMP29222	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP27	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	12% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37°C	Not found		Mechanism of action:Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived.	[Ref.34057039]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.32 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=2.77 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=1.54 nM),inhibition of live SARS-CoV-2 infection in Vero cells(IC50=29.85 nM);##SARS-CoV-2 D614G:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.75 nM);##SARS-CoV-2 N501Y:inhibition of pseudovirus infections in Huh-7 cells(IC50=7.87 nM);##SARS-CoV-2 ΔH69-V70:inhibition of pseudovirus infections in Huh-7 cells(IC50=7.56 nM);##SARS-CoV-2 E484K:inhibition of pseudovirus infections in Huh-7 cells(IC50=7.55 nM);##SARS-CoV-2 B.1.1.7:inhibition of pseudovirus infections in Huh-7 cells(IC50=7.18 nM);##SARS-CoV-2 B.1.351:inhibition of pseudovirus infections in Huh-7 cells(IC50=8.25 nM);##SARS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=24.95 nM);##MERS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=60.08 nM);##HCoV-NL63:inhibition of pseudovirus infections in Huh-7 cells(IC50=179.53 nM);##HCoV-229E:inhibition of pseudovirus infections in Huh-7 cells(IC50=231.18 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG8-K(Chol)		L	[Ref.34057039]Huh-7 cells:CC50=4.04 μM;Vero-E6 cells:CC50=5.05 μM.	Not found	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y.	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	
DRAMP29223	ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	35	IBP02V1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	0% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37°C	Not found		The peptide is a fusion inhibitor against SARS-CoV-2.	[Ref.34344868]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=1.1±0.1 nM);inhibition of SARS-CoV-2 pseudovirus infection in 293T/ACE2 cells(IC50=17.8 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=14.3 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=0.6±0.1 nM);inhibition of pseudovirus infection in 293T/ACE2 cells(IC50=50 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=21.5 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=33.6±3.5 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=66.9±7.6 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=62.5±17.2 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=203.9±8.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG8-K(Chol)		L	[Ref.34344868]No significant cytotoxicity in both 293T/ACE2 and Huh-7 cells at a concentration of 10 μM.	liposomes	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y.	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	
DRAMP29224	DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	36	IBP02V2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	22% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37°C	Not found		The peptide is a fusion inhibitor against SARS-CoV-2.	[Ref.34344868]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.6±0.03 nM);inhibition of SARS-CoV-2 pseudovirus infection in 293T/ACE2 cells(IC50=20.1 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=18.1 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=0.4±0.04 nM);inhibition of pseudovirus infection in 293T/ACE2 cells(IC50=19.3 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=20.8 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=56.5±9.4nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=55.3±2.8 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=67.5±8 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=535.7±44.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG8-K(Chol)		L	[Ref.34344868]No significant cytotoxicity in both 293T/ACE2 and Huh-7 cells at a concentration of 10 μM.	liposomes	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y.	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	
DRAMP29225	EISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	36	IBP02V3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	48% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37°C	Not found		The peptide is a fusion inhibitor against SARS-CoV-2.	[Ref.34344868]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.4±0.02 nM);inhibition of SARS-CoV-2 pseudovirus infection in 293T/ACE2 cells(IC50=14.1 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=17.5 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=0.2±0.02 nM);inhibition of pseudovirus infection in 293T/ACE2 cells(IC50=40.2 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=14.4 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=48±5.8 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=38.5±6.2 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=75.8±9.9 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=545.7±0.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG8-K(Chol)		L	[Ref.34344868]No significant cytotoxicity in both 293T/ACE2 and Huh-7 cells at a concentration of 10 μM.	liposomes	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y.	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	
DRAMP29226	ELSGINASVVNLQKEIDRLNEVAKNLNESLIDLQEL	36	IBP02V4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	59% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37°C	Not found		The peptide is a fusion inhibitor against SARS-CoV-2.	[Ref.34344868]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.3±0.02 nM);inhibition of SARS-CoV-2 pseudovirus infection in 293T/ACE2 cells(IC50=18.6 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=15.2 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=0.1±0.02 nM);inhibition of pseudovirus infection in 293T/ACE2 cells(IC50=29.2 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=26.3 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=63±1.7 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=22.4±2.2 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=66.3±3.1 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=502±24.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG8-K(Chol)		L	[Ref.34344868]No significant cytotoxicity in both 293T/ACE2 and Huh-7 cells at a concentration of 10 μM.	liposomes	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y.	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	
DRAMP29227	SLTQINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	36	IBP02V5	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	16% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37°C	Not found		The peptide is a fusion inhibitor against SARS-CoV-2.	[Ref.34344868]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=2.1±0.5 nM);inhibition of SARS-CoV-2 pseudovirus infection in 293T/ACE2 cells(IC50=21 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=23.5 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=1.3±0.1 nM);inhibition of pseudovirus infection in 293T/ACE2 cells(IC50=98.8 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=27.5 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=65.9±13.2 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=68.4±9.7 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=70.8±8.7 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=1128.4±148.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG8-K(Chol)		L	[Ref.34344868]No significant cytotoxicity in both 293T/ACE2 and Huh-7 cells at a concentration of 10 μM.	liposomes	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y.	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	
DRAMP29228	SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL	36	MERS-LP	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	8% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37°C	Not found		The peptide is a fusion inhibitor against SARS-CoV-2.	[Ref.34344868]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=102.9±7.2 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=5046±905.2 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=79.1±9.8 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50>25000 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50>25000 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=82.9±8.6 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50>25000 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50>25000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG8-K(Chol)		L	No cytotoxicity information found in the reference(s) presented	liposomes	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y.	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	
DRAMP29229	SLDYINVTFLDLQDEMNRLQEAIKVLNQSYINLKDI	36	OC43-LP	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	22% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37°C	Not found		The peptide is a fusion inhibitor against SARS-CoV-2.	[Ref.34344868]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=4.1±1 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=82.8±22.1 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=2.4±0.2 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=97.5±5.9 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=250.4±39.7 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=5.2±0.5 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=416.5±227.5 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=2008.8±697.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG8-K(Chol)		L	No cytotoxicity information found in the reference(s) presented	liposomes	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y.	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	
DRAMP29230	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELK	37	EK1V1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	39% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37 °C	Not found		The peptide is a fusion inhibitor against SARS-CoV-2.	[Ref.34344868]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=273.5±4.1 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=2672.1±384.5 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=214.5±20.2 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=1790.8±363.2 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=4370.3±719.7 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=499.8±163.3 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=487.2±41.3 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=1255.6±453.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Chol		L	No cytotoxicity information found in the reference(s) presented	liposomes	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y.	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	
DRAMP29231	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	36	EK1V2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	68% α-helicity in phosphate-buffered saline (PBS; pH 7.2) with a final concentration of 10 μM and incubated at 37°C	Not found		The peptide is a fusion inhibitor against SARS-CoV-2.	[Ref.34344868]Virus:##SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.9±0.2 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=87.2±8.3 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=0.5±0.2 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=106.5±5.4 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=252±5.6 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=1.1±0.3 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=59.4±13.1 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=503.3±20.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG8-K(Chol)		L	No cytotoxicity information found in the reference(s) presented	liposomes	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y.	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	
DRAMP29232	ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	35	P3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.32482145]Virus:HCoV-19:inhibition of HCoV-19 S mediated cell–cell fusion(EC50=0.72 μM);neutralizing activities against pseudotype HCoV-19 virus(EC50=0.32 μM);inhibition of authentic HCoV-19 virus infection in Vero E6 cells(EC50=0.58 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	32482145	Emerg Microbes Infect. 2020 Dec;9(1):1238-1241.	Sun H, Li Y, Liu P, Qiao C, Wang X, Wu L, Liu K, Hu Y, Su C, Tan S, Zou S, Wu G, Yan J, Gao GF, Qi J, Wang Q. 	Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC
DRAMP29233	XxXVXAaXXXX	11	Alisporivir, Debio-025	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.32376613]Virus:SARS-CoV-2:Inhibition of infection in Vero E6 cells(EC50=0.46±0.04 µM,E90=3.10±1.40 μM).##[Ref.32568027]Virus:##SARS-CoV-2:Inhibition of infection in Vero E6 cells(EC50=4.9±1.3 µM);##SARS-CoV:Inhibition of infection in Vero E6 cells(EC50=4.3±1.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 1 is alpha-aminobutyric acid,position 2 is N-methylalanine,the 'V' at position 3 is N-methylalanine,the 'X' at position 5,8,9 are N-methylleucine,the 'X' at position 10 is N-methylvaline and position 11 is N-methyl-(4R)-4-[(E)-but-2-enyl]-4-methyl-L-threonyl	Mixed(D-Ala7,D-meth-Ala2)	[Ref.32376613]Vero E6 cells:CC50>20µM.	Not found	32376613##32568027	Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00876-20. ##J Gen Virol. 2020 Sep;101(9):925-940.	Softic L, Brillet R, Berry F, Ahnou N, Nevers Q, Morin-Dewaele M, Hamadat S, Bruscella P, Fourati S, Pawlotsky JM, Ahmed-Belkacem A.##Ogando NS, Dalebout TJ, Zevenhoven-Dobbe JC, Limpens RWAL, van der Meer Y, Caly L, Druce J, de Vries JJC, Kikkert M, Bárcena M, Sidorov I, Snijder EJ.	Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).##SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.	
DRAMP29234	PxTXXLPX	8	Plitidepsin, Aplidine	No entry found	Not found	Not found	Synthetic construct	Antimicrobial, Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Mechanism of action:The antiviral activity of plitidepsin against SARS-CoV-2 is mediated through inhibition of the known target eEF1A (eukaryotic translation elongation factor 1A).	[Ref.33495306]Virus:SARS-CoV-2:inhibition of replication In Vero E6 cells(IC50=0.70 nM,IC90=1.76 nM);inhibition of replication In hACE2-HEK293T cells(IC50=0.73 nM,IC90=0.88 nM);inhibition of replication In pneumocyte-like cells(IC50=1.62 nM,IC90=3.14 nM).##[Ref.35231500]Virus:##SARS-CoV-2 D614G:inhibition of replication in Vero E6 cells(IC50=5.2 nM);##SARS-CoV-2 Delta:inhibition of replication in Vero E6 cells(IC50=3.9 nM);##SARS-CoV-2 Omicron:inhibition of replication in Vero E6 cells(IC50=4.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Pyruvoyl	Free	The 'X' at position 2 is N-methylleucine,position 4 is 4-amino-3-hydroxy-5-methyl-Heptanoic acid, position 5 is Hydroxyisovalerylpropionyl, and position 8 is N-methyl-4-methyl-tyrosine.There is a Sidechain-Mainchain Bond between position 3 and 8.	Mixed(D-meth-Leu2)	[Ref.33495306]Vero E6 cells:CC10=0.36 nM,CC50=1.99 nM;hACE2-293T cells:CC10=2.00 nM,CC50>200 nM;pneumocyte-like cells:CC10=20.88 nM,CC50=65.43 nM.	Not found	35231500##33495306	Antiviral Res. 2022 Apr;200:105270.##Science. 2021 Feb 26;371(6532):926-931. 	Sachse M, Tenorio R, Fernández de Castro I, Muñoz-Basagoiti J, Perez-Zsolt D, Raïch-Regué D, Rodon J, Losada A, Avilés P, Cuevas C, Paredes R, Segalés J, Clotet B, Vergara-Alert J, Izquierdo-Useros N, Risco C.##White KM, Rosales R, Yildiz S, Kehrer T, Miorin L, Moreno E, Jangra S, Uccellini MB, Rathnasinghe R, Coughlan L, Martinez-Romero C, Batra J, Rojc A, Bouhaddou M, Fabius JM, Obernier K, Dejosez M, Guillén MJ, Losada A, Avilés P, Schotsaert M, Zwaka T, Vignuzzi M, Shokat KM, Krogan NJ, García-Sastre A. 	Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis.##Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. 	
DRAMP00828	GLPTCGETCFGGTCNTPGCTCDPWPVCTHN	30	Cycloviolacin-O24 (Plant defensin)	P84637	Belongs to the cyclotide family. Bracelet subfamily.	Not found	Viola odorata (Sweet violet)	Antiviral,Insecticidal 	Protein level	Bridge	Not found		"Function: Probably participates in a plant defense mechanism. Has hemolytic activity.
PTM: This is a cyclic peptide which may contain three disulfide bonds 5-19; 9-21; 14-27."	[Ref.18008336]Virus:HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=308 nM).	[Ref:16872274] It has 75% hemolytic activity at 25.0 μM against human type A red blood cells.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys27.	L	[Ref.18008336]CEM-SS cells:IC50=6170 nM.	Not found	16872274##18008336	Biochem J. 2006 Nov 15;400(1):1-12.##Biopolymers. 2008;90(1):51-60.	Ireland DC, Colgrave ML, Craik DJ.##Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. 	A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability.##Cyclotides as natural anti-HIV agents.	
DRAMP29242	SKHSSLDCVLRP	12	Peptide 1(lactoferrin 418–429)	P24627	Belongs to the transferrin family	LTF	Synthetic construct	Antimicrobial,Antiviral	Protein level	Not found	Not found	3IB0	Function:Antiviral activity against Influenza virus.	[Ref.28878220]Virus:A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=4 ± 0.37 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=3.1 ± 0.12 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=5.8 ± 0.7 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	hemagglutinin (HA)	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P.	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP29243	KANEGLTWNSLKDK	14	Peptide 4(lactoferrin 441–454)	P24627	Belongs to the transferrin family	LTF	Synthetic construct	Antimicrobial,Antiviral	Protein level	Not found	Not found	3IB0	Function:Antiviral activity against Influenza virus.	[Ref.28878220]Virus:A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=1± 0.15 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=50.000 ± 250 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=1.000 ± 360 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	hemagglutinin (HA)	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P.	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29244	TNGESTADWAKN	12	Peptide 6(lactoferrin 552-563)	P24627	Belongs to the transferrin family	LTF	Synthetic construct	Antimicrobial,Antiviral	Protein level	Not found	Not found	3IB0	Function:Antiviral activity against Influenza virus.	[Ref.28878220]Virus:A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=400 ±0.02 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=50.000 ± 230 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=10.000± 120 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	hemagglutinin (HA)	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P.	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP29245	KSETKN	6	Peptide 8(lactoferrin 633-638)	P24627	Belongs to the transferrin family	LTF	Synthetic construct	Antimicrobial,Antiviral	Protein level	Not found	Not found	3IB0	Function:Antiviral activity against Influenza virus.	[Ref.28878220]Virus:A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=0.5 ± 0.01 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=500 ± 0.46 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=400.000 ± 210 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	hemagglutinin (HA)	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P.	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	C[C@@H](O)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP29246	SLDCVLRP	8	Peptide 13(lactoferrin 422–429)	P24627	Belongs to the transferrin family	LTF	Synthetic construct	Antimicrobial,Antiviral	Protein level	Not found	Not found	3IB0	Function:Antiviral activity against Influenza virus.	[Ref.28878220]Virus:A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=0.3 ± 0.5 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=2.5± 0.37 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=300± 0.2 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	hemagglutinin (HA)	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P.	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	CC(C)C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP29247	VLRP	4	Peptide 14(lactoferrin 426–429)	P24627	Belongs to the transferrin family	LTF	Synthetic construct	Antimicrobial,Antiviral	Protein level	Not found	Not found	3IB0	Function:Antiviral activity against Influenza virus.	[Ref.28878220]Virus:A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=0.45 ± 0.1 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=1 ± 0.05 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=250 ± 0.42 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	hemagglutinin (HA)	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P.	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O
DRAMP29248	SKHSSLDC	8	Peptide 16(lactoferrin 418-425)	P24627	Belongs to the transferrin family	LTF	Synthetic construct	Antimicrobial,Antiviral	Protein level	Not found	Not found	3IB0	Function:Antiviral activity against Influenza virus.	[Ref.28878220]Virus:A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=80 ± 0.19 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=0.1 ± 0.001 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=5.0 ± 0.45 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	hemagglutinin (HA)	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P.	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O
DRAMP29249	SLDC	4	Peptide 15(lactoferrin 422-425)	P24627	Belongs to the transferrin family	LTF	Synthetic construct	Antimicrobial,Antiviral	Protein level	Not found	Not found	3IB0	Function:Antiviral activity against Influenza virus.	[Ref.28878220]Virus:A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=0.5 ± 0.001 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=4.6 ± 0.05 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=4.3 ± 0.03 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	hemagglutinin (HA)	28878220##34681184	Sci Rep. 2017 Sep 6;7(1):10593.##Pharmaceuticals (Basel). 2021 Sep 23;14(10):959. 	Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P.##Scala MC, Agamennone M, Pietrantoni A, Di Sarno V, Bertamino A, Superti F, Campiglia P, Sala M.	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.##Discovery of a Novel Tetrapeptide against Influenza A Virus: Rational Design, Synthesis, Bioactivity Evaluation and Computational Studies.	
DRAMP29250	SKHS	4	Peptide 17(lactoferrin 418–421)	P24627	Belongs to the transferrin family	LTF	Synthetic construct	Antimicrobial,Antiviral	Protein level	Not found	Not found	3IB0	Function:Antiviral activity against Influenza virus.	[Ref.28878220]Virus:A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=3 ± 0.61 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=0.048 ± 0.0012 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=5.0 ± 0.02 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	hemagglutinin (HA)	28878220##34681184	Sci Rep. 2017 Sep 6;7(1):10593.##Pharmaceuticals (Basel). 2021 Sep 23;14(10):959. 	Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P.##Scala MC, Agamennone M, Pietrantoni A, Di Sarno V, Bertamino A, Superti F, Campiglia P, Sala M.	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.##Discovery of a Novel Tetrapeptide against Influenza A Virus: Rational Design, Synthesis, Bioactivity Evaluation and Computational Studies.	
DRAMP29251	SAHS	4	Ac-SAHS-NH2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.34681184]Virus:A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=5.77 ± 0.01 × 10−7 μM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=4.3 ± 0.3 × 10−10 μM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=9.36 ± 0.1 × 10−7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	hemagglutinin (HA)	34681184	Pharmaceuticals (Basel). 2021 Sep 23;14(10):959. 	Scala MC, Agamennone M, Pietrantoni A, Di Sarno V, Bertamino A, Superti F, Campiglia P, Sala M.	Discovery of a Novel Tetrapeptide against Influenza A Virus: Rational Design, Synthesis, Bioactivity Evaluation and Computational Studies.	
DRAMP29252	GGVLVQPG	8	Peptide 2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.34502335]Virus:SARS-CoV-2 UC-1074:inhibition of virus activity in Vero cells(EC50≥17.6 ± 2.4 μM);##SARS-CoV-2 UC-1075:inhibition of virus activity in Vero cells(EC50>20 μM);##cytomegalovirus (HCMV) AD-169 Strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 µM);##cytomegalovirus (HCMV) Davis strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 µM);##varicella-zoster virus (VZV) TK+ VZV Strain OKA:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=50.05 µM);##varicella-zoster virus (VZV) TK-VZV Strain 07–1:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=48.42 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acylation	Amidation		L	[Ref.34502335]Vero cell:CC50=83.0 ± 17.0 µM.	Main protease	34502335	Int J Mol Sci. 2021 Aug 30;22(17):9427.	Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A.	Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation.	
DRAMP29253	GGVLVQPG	8	Peptide 3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.34502335]Virus:SARS-CoV-2 UC-1074:inhibition of virus activity in Vero cells(EC50>20 μM);##SARS-CoV-2 UC-1075:inhibition of virus activity in Vero cells(EC50>20 μM);##cytomegalovirus (HCMV) AD-169 Strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 µM);##cytomegalovirus (HCMV) Davis strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>100 µM);##varicella-zoster virus (VZV) TK+ VZV Strain OKA:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=58.09 µM);##varicella-zoster virus (VZV) TK-VZV Strain 07–1:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=81.09 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acylation	Methyl amidation		L	[Ref.34502335]Vero cell:CC50=81.8 ± 2.1 µM.	Main protease	34502335	Int J Mol Sci. 2021 Aug 30;22(17):9427.	Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A.	Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation.	
DRAMP29254	GGVLVQPG	8	Peptide 4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.34502335]Virus:SARS-CoV-2 UC-1074:inhibition of virus activity in Vero cells(EC50≥20 μM);##SARS-CoV-2 UC-1075:inhibition of virus activity in Vero cells(EC50>20 μM);##cytomegalovirus (HCMV) AD-169 Strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 µM);##cytomegalovirus (HCMV) Davis strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=100 µM);##varicella-zoster virus (VZV) TK+ VZV Strain OKA:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=78.20 µM);##varicella-zoster virus (VZV) TK-VZV Strain 07–1:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Pivaloylation	Methyl amidation		L	[Ref.34502335]Vero cell:CC50=74.9 ± 4.9 µM.	Main protease	34502335	Int J Mol Sci. 2021 Aug 30;22(17):9427.	Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A.	Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation.	CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)C(C)(C)C)C(C)C)C(C)C
DRAMP29255	GVLVQ	5	Peptide 5	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.34502335]Virus:SARS-CoV-2 UC-1074:inhibition of virus activity in Vero cells(EC50≥20 μM);##SARS-CoV-2 UC-1075:inhibition of virus activity in Vero cells(EC50>20 μM);##cytomegalovirus (HCMV) AD-169 Strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 µM);##cytomegalovirus (HCMV) Davis strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>100 µM);##varicella-zoster virus (VZV) TK+ VZV Strain OKA:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=59.80 µM);##varicella-zoster virus (VZV) TK-VZV Strain 07–1:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acylation	Methyl amidation		L	[Ref.34502335]Vero cell:CC50=75.0 ±2.2 µM.	Main protease	34502335	Int J Mol Sci. 2021 Aug 30;22(17):9427.	Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A.	Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation.	
DRAMP29256	GVLV	4	Peptide 6	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral(SARS-CoV-2)	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.34502335]Virus:SARS-CoV-2 UC-1074:inhibition of virus activity in Vero cells(EC50≥20 μM);##SARS-CoV-2 UC-1075:inhibition of virus activity in Vero cells(EC50>20 μM);##cytomegalovirus (HCMV) AD-169 Strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>4 µM);##cytomegalovirus (HCMV) Davis strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 µM);##varicella-zoster virus (VZV) TK+ VZV Strain OKA:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 µM);##varicella-zoster virus (VZV) TK-VZV Strain 07–1:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acylation	Methyl amidation		L	[Ref.34502335]Vero cell:CC50=77.4 ±0.7 µM.	Main protease	34502335	Int J Mol Sci. 2021 Aug 30;22(17):9427.	Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A.	Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation.	
DRAMP29257	YWKIXNTLVNIC	12	compound 1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.30783498]Virus:Zika Virus(ZIKV):inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=1.5 ± 0.1 μM);##Dengue virus serotype 2:inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>10 μM);##West Nile virus:inhibition of flaviviral Protease(West Nile virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Thioether-acyl moiety (−S-Ac−)(forms a macrocycle through the side chain of the underlined cysteine residue)	Amidation	The 'X' at position 4 indicates MeYMe(N-methyl-4-O-methyl-tyrosine).	L	No cytotoxicity information found in the reference(s) presented	NS2B-NS3 protease	30783498	ACS Med Chem Lett. 2019 Jan 4;10(2):168-174.	Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G. 	De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease. 	
DRAMP29258	YXKXKXXKXXKC	12	compound 2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.30783498]Virus:Zika Virus(ZIKV):inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=0.25 ± 0.01 μM);##Dengue virus serotype 2:inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=1.7 ± 0.1 μM);##West Nile virus:inhibition of flaviviral Protease(West Nile virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=3.9 ± 0.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Thioether-acyl moiety (−S-Ac−)(forms a macrocycle through the side chain of the underlined cysteine residue)	Amidation	The 'X' at position 2,7,9 and 10 indicates MeYMe(N-methyl-4-O-methyl-tyrosine), position 4 indicates MeF(N-methyl-phenylalanine), position 6 indicates MeS(N-methyl-serine).	L	No cytotoxicity information found in the reference(s) presented	NS2B-NS3 protease	30783498	ACS Med Chem Lett. 2019 Jan 4;10(2):168-174.	Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G. 	De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease. 	
DRAMP29259	YTNFYLYPYXFC	12	compound 3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.30783498]Virus:Zika Virus(ZIKV):inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=2.2 ± 0.1 μM);##Dengue virus serotype 2:inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>20 μM);##West Nile virus:inhibition of flaviviral Protease(West Nile virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Thioether-acyl moiety (−S-Ac−)(forms a macrocycle through the side chain of the underlined cysteine residue)	Amidation	The 'X' at position 10 indicates MeYMe(N-methyl-4-O-methyl-tyrosine).	L	No cytotoxicity information found in the reference(s) presented	NS2B-NS3 protease	30783498	ACS Med Chem Lett. 2019 Jan 4;10(2):168-174.	Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G. 	De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease. 	
DRAMP29260	YXIAKYNXXIPC	12	compound 4	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.30783498]Virus:Zika Virus(ZIKV):inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=4.6 ± 0.3 μM);##Dengue virus serotype 2:inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50≥20 μM);##West Nile virus:inhibition of flaviviral Protease(West Nile virus NS2B-NS3 protease) activity in Huh-7 cells(IC50≥20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Thioether-acyl moiety (−S-Ac−)(forms a macrocycle through the side chain of the underlined cysteine residue)	Amidation	The 'X' at position 2 indicates N-methyl-glycine, position 8 and 9 indicates N-methyl-4-O-methyl-tyrosine.	L	No cytotoxicity information found in the reference(s) presented	NS2B-NS3 protease	30783498	ACS Med Chem Lett. 2019 Jan 4;10(2):168-174.	Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G. 	De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease. 	
DRAMP29261	YTLPFHNXTFFC	12	compound 5	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.30783498]Virus:Zika Virus(ZIKV):inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50≥50 μM);##Dengue virus serotype 2:inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>10 μM);##West Nile virus:inhibition of flaviviral Protease(West Nile virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Thioether-acyl moiety (−S-Ac−)(forms a macrocycle through the side chain of the underlined cysteine residue)	Amidation	The 'X' at position 8 indicates N-methyl-glycine.	L	No cytotoxicity information found in the reference(s) presented	NS2B-NS3 protease	30783498	ACS Med Chem Lett. 2019 Jan 4;10(2):168-174.	Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G. 	De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease. 	
DRAMP29262	yAIIXYNKYXNC	12	compound 6	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.30783498]Virus:Zika Virus(ZIKV):inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=3.2 ± 0.4 μM);##Dengue virus serotype 2:inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>20 μM);##West Nile virus:inhibition of flaviviral Protease(West Nile virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Thioether-acyl moiety (−S-Ac−)(forms a macrocycle through the side chain of the underlined cysteine residue)	Amidation	The 'X' at position 5 indicates N-methyl-4-O-methyl-tyrosine, position 10 indicates N-methyl-leucine.	Mixed(D-Tyr1)	No cytotoxicity information found in the reference(s) presented	NS2B-NS3 protease	30783498	ACS Med Chem Lett. 2019 Jan 4;10(2):168-174.	Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G. 	De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease. 	
DRAMP29263	PVPNLTCAVACELKWESE	18	E1P37	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=41.0 ± 8.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. 	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP29264	VPNLTCAVACELKWESEF	18	E1P37-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=80.0 ± 62.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. 	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP29265	PNLTCAVACELKWESEFR	18	E1P37-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=99.0 ± 22.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. 	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP29266	NLTCAVACELKWESEFWR	18	E1P38	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. 	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP29267	LTCAVACELKWESEFWRW	18	E1P38-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP29268	TCAVACELKWESEFWRWT	18	E1P38-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP29269	CAVACELKWESEFWRWTE	18	E1P39	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=11.3 ± 1.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP29270	AVACELKWESEFWRWTEQ	18	E1P39-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=44.0 ± 13.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP29271	VACELKWESEFWRWTEQL	18	E1P39-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=37.7 ± 7.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP29272	ACELKWESEFWRWTEQLA	18	E1P40	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)C(=O)O
DRAMP29273	CELKWESEFWRWTEQLAS	18	E1P40-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=34.0 ± 15.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](C)C(=O)O)C(=O)O
DRAMP29274	ELKWESEFWRWTEQLASN	18	E1P40-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP29275	LKWESEFWRWTEQLASNY	18	E1P41	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP29276	KWESEFWRWTEQLASNYW	18	E1P41-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=66.7 ± 20.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP29277	WESEFWRWTEQLASNYWI	18	E1P41-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=22.0 ± 0.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)O
DRAMP29278	ESEFWRWTEQLASNYWIL	18	E1P42	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=50.0 ± 8.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)NC(=O)[C@@H](N)CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)O
DRAMP29279	SEFWRWTEQLASNYWILE	18	E1P42-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=31.0 ± 3.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP29280	EFWRWTEQLASNYWILEY	18	E1P42-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP29281	FWRWTEQLASNYWILEYL	18	E1P43	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=43.0 ± 10.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29282	WRWTEQLASNYWILEYLW	18	E1P43-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=6.8 ± 0.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29283	RWTEQLASNYWILEYLWK	18	E1P43-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=19.7 ± 9.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29284	WTEQLASNYWILEYLWKV	18	E1P44	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29285	TEQLASNYWILEYLWKVP	18	E1P44-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O
DRAMP29286	EQLASNYWILEYLWKVPF	18	E1P44-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=90.3 ± 15.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O
DRAMP29287	QLASNYWILEYLWKVPFD	18	E1P45	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=27.7 ±5.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP29288	LASNYWILEYLWKVPFDF	18	E1P45-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=12.7 ±1.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP29289	ASNYWILEYLWKVPFDFW	18	E1P45-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=11.3 ± 3.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP29290	SNYWILEYLWKVPFDFWR	18	E1P46	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=19.7 ± 8.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP29291	NYWILEYLWKVPFDFWRG	18	E1P46-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=12.3 ± 0.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP29292	YWILEYLWKVPFDFWRGV	18	E1P46-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=32.3 ± 11.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP29293	WILEYLWKVPFDFWRGVI	18	E1P47	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=2.7 ± 0.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)O
DRAMP29294	ILEYLWKVPFDFWRGVIS	18	E1P47-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=5.4 ± 0.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@H](C(=O)O)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP29295	LEYLWKVPFDFWRGVISL	18	E1P47-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=6.6± 0.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)C(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29296	EYLWKVPFDFWRGVISLT	18	E1P48	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=44.7 ± 3.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29297	YLWKVPFDFWRGVISLTP	18	E1P48-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=70.7 ±9.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP29298	LWKVPFDFWRGVISLTPL	18	E1P48-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=14.7 ± 0.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP29299	WKVPFDFWRGVISLTPLL	18	E1P49	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=17.3 ± 3.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29300	KVPFDFWRGVISLTPLLV	18	E1P49-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=63.3 ± 5.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29301	VPFDFWRGVISLTPLLVC	18	E1P49-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O
DRAMP29302	PFDFWRGVISLTPLLVCV	18	E1P50	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O
DRAMP29303	FDFWRGVISLTPLLVCVA	18	E1P50-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)O
DRAMP29304	DFWRGVISLTPLLVCVAA	18	E1P50-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)O
DRAMP29305	FWRGVISLTPLLVCVAAL	18	E1P51	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP29306	WRGVISLTPLLVCVAALL	18	E1P51-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP29307	RGVISLTPLLVCVAALLL	18	E1P51-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP29308	GVISLTPLLVCVAALLLL	18	E1P52	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=55.7± 5.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP29309	VISLTPLLVCVAALLLLE	18	E1P52-1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP29310	ISLTPLLVCVAALLLLEQ	18	E1P52-2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	Not found	Not found		Function:Antiviral activity against Influenza virus.	[Ref.26905802]Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP29311	GPNFAEISKINTTLLDLSDEMAMLLQEVVKQLNDSYI	37	HKU4-HR2P1	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	α-helix	10.5%-13.5% α-helix determined by circular dichroism (CD).		Mechanism:The peptide bind with HR1 of MERS-CoV and thus disrupting the process of MERS-6HB formation can inhibit virus–cell membrane fusion and abolish viral infection.	[Ref.30646495]Virus:MERS-CoV:inhibition of cell-cell fusion between 293T cells and Huh-7 cells(IC50=1.09 μM);##MERS-CoV Q1020:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=2.15 μM);##MERS-CoV Q1020H:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=2.72 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30646495]No cytotoxicity against Huh-7 cells up to 100 μM.	membrane	30646495	Viruses. 2019 Jan 14;11(1):56. doi: 10.3390/v11010056	Xia S, Lan Q, Pu J, Wang C, Liu Z, Xu W, Wang Q, Liu H, Jiang S, Lu L.	Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)O
DRAMP29312	EISKINTTLLDLSDEMAMLLQEVVKQLNDSYIDLKEL	37	HKU4-HR2P2	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	α-helix	10.5%-13.5% α-helix determined by circular dichroism (CD).		Mechanism:The peptide bind with HR1 of MERS-CoV and thus disrupting the process of MERS-6HB formation can inhibit virus–cell membrane fusion and abolish viral infection.	[Ref.30646495]Virus:MERS-CoV:inhibition of cell-cell fusion between 293T cells and Huh-7 cells(IC50=0.38 μM);##MERS-CoV Q1020:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=0.34 μM);##MERS-CoV Q1020H:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=0.44 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30646495]No cytotoxicity against Huh-7 cells up to 100 μM.	membrane	30646495	Viruses. 2019 Jan 14;11(1):56. doi: 10.3390/v11010056	Xia S, Lan Q, Pu J, Wang C, Liu Z, Xu W, Wang Q, Liu H, Jiang S, Lu L.	Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29313	LDLSDEMAMLLQEVVKQLNDSYIDLKELGNYTYYNKW	37	HKU4-HR2P3	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	α-helix	10.5%-13.5% α-helix determined by circular dichroism (CD).		Mechanism:The peptide bind with HR1 of MERS-CoV and thus disrupting the process of MERS-6HB formation can inhibit virus–cell membrane fusion and abolish viral infection.	[Ref.30646495]Virus:MERS-CoV:inhibition of cell-cell fusion between 293T cells and Huh-7 cells(IC50=0.55 μM);##MERS-CoV Q1020:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=0.48 μM);##MERS-CoV Q1020H:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=0.52 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30646495]No cytotoxicity against Huh-7 cells up to 100 μM.	membrane	30646495	Viruses. 2019 Jan 14;11(1):56. doi: 10.3390/v11010056	Xia S, Lan Q, Pu J, Wang C, Liu Z, Xu W, Wang Q, Liu H, Jiang S, Lu L.	Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP29314	GGGSLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL	39	MERS-HR2P	No entry found	Not found	Not found	Synthetic construct	Antimicrobial,Antiviral	Not found	α-helix	10.5%-13.5% α-helix determined by circular dichroism (CD).		Mechanism:The peptide bind with HR1 of MERS-CoV and thus disrupting the process of MERS-6HB formation can inhibit virus–cell membrane fusion and abolish viral infection.	[Ref.30646495]Virus:MERS-CoV:inhibition of cell-cell fusion between 293T cells and Huh-7 cells(IC50=1.07 μM);##MERS-CoV Q1020:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=1.14 μM);##MERS-CoV Q1020H:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=1.71 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30646495]No cytotoxicity against Huh-7 cells up to 100 μM.	membrane	30646495	Viruses. 2019 Jan 14;11(1):56. doi: 10.3390/v11010056	Xia S, Lan Q, Pu J, Wang C, Liu Z, Xu W, Wang Q, Liu H, Jiang S, Lu L.	Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)CN)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29949	GFGCPFNQGKCHRHCRSIRRRGGYCDGFLKQRCVCYRK	38	BmKDfsin3	A0A384E0Y8	Flaviviridae	Not found	Mesobuthus martensii Karsch	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: BmKDfsin3 is revealed to enter into cells. Using an upstream MyD88 dimerization inhibitor ST2345 or kinase IRAK-1/4 inhibitor I, the inhibition of p38 activation represses HCV replication in vitro.	[Ref.31963532]Hepatitis C virus (HCV): inhibition of viral replication in Huh7.5.1 cells(IC50=3.35±1.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys4 and Cys25, Cys11 and Cys33, Cys15 and Cys35.	L	"[Ref.31963532]Human hepatocellular carcinoma Huh-7.5.1 cells:	CC50=60.63±1.36 µM."	Not found	31963532	Antibiotics (Basel). 2020 Jan 17;9(1):33.	Cheng Y, Sun F, Li S, Gao M, Wang L, Sarhan M, Abdel-Rahman MA, Li W, Kwok HF, Wu Y, Cao Z. 	Inhibitory Activity of a Scorpion Defensin BmKDfsin3 against Hepatitis C Virus.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4ccccc4)NC(=O)CN)CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC1=O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N3)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N2
DRAMP29950	MITHGCYTRTRHKHKLKKTL	20	SA-35	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: It is likely that these peptides exert anti-RSV activity through a combination of two mechanisms: destabilization of the viral envelope and competitive inhibition of attachment/fusion of the virus with the target cell.	[Ref.32124885]Respiratory syncytial virus (RSV):SA-35 caused a significant decrease of the RSV infectivity by 33 times at concentrations 1 mg/ml.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.32124885]MA-104 cells:CC50= 2.1 ± 0.1 mg/ml.	Not found	32124885	J Mater Chem B. 2020 Apr 1;8(13):2607-2617	Kozhikhova KV, Shilovskiy IP, Shatilov AA, Timofeeva AV, Turetskiy EA, Vishniakova LI, Nikolskii AA, Barvinskaya ED, Karthikeyan S, Smirnov VV, Kudlay DA, Andreev SM, Khaitov MR	Linear and dendrimeric antiviral peptides: design, chemical synthesis and activity against human respiratory syncytial virus.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP29951	KRRGGGKLLKLLLKLLLKLLKC	22	NC-783	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: It is likely that these peptides exert anti-RSV activity through a combination of two mechanisms: destabilization of the viral envelope and competitive inhibition of attachment/fusion of the virus with the target cell.	[Ref.32124885]Respiratory syncytial virus (RSV):inhibition of viral infection in the MA-104 cell(IC50=0.04mg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.32124885]MA-104 cells:CC50= 0.04 ± 0.01 mg/ml.	Not found	32124885	J Mater Chem B. 2020 Apr 1;8(13):2607-2617	Kozhikhova KV, Shilovskiy IP, Shatilov AA, Timofeeva AV, Turetskiy EA, Vishniakova LI, Nikolskii AA, Barvinskaya ED, Karthikeyan S, Smirnov VV, Kudlay DA, Andreev SM, Khaitov MR	Linear and dendrimeric antiviral peptides: design, chemical synthesis and activity against human respiratory syncytial virus.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
DRAMP29952	gikefkrivqrikdflrnlv	20	GI-20D	No entry found	Filoviridae	Not found	Synthetic construct(derived from LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Act as CatB inhibitors to block the endosomal processing of EBOV GP, thus preventing virus entry.	[Ref.32252021]Ebola Virus(EBOV):inhibition of viral infection in Hela cells(IC50=0.99 µM);inhibition of viral infection in primary macrophages(IC50=2.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		D	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	32252021	iScience. 2020 Apr 24;23(4):100999.	Yu Y, Cooper CL, Wang G, Morwitzer MJ, Kota K, Tran JP, Bradfute SB, Liu Y, Shao J, Zhang AK, Luo LG, Reid SP, Hinrichs SH, Su K.	Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection.	CC[C@H](C)[C@@H](NC(=O)CN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(N)=O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
DRAMP29953	GXKRlVQRlKDXlRNLV	17	17BIPHE2	No entry found	Filoviridae	Not found	Synthetic construct(derived from LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Act as CatB inhibitors to block the endosomal processing of EBOV GP, thus preventing virus entry.	[Ref.32252021]Ebola Virus(EBOV):inhibition of viral infection in Hela cells(IC50=0.71 µM);inhibition of viral infection in primary macrophages(IC50=5.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	The 'X' at position 2 and 12 indicates biphenylalanine.	Mixed(D-Leu5, 9, 13)	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	32252021	iScience. 2020 Apr 24;23(4):100999.	Yu Y, Cooper CL, Wang G, Morwitzer MJ, Kota K, Tran JP, Bradfute SB, Liu Y, Shao J, Zhang AK, Luo LG, Reid SP, Hinrichs SH, Su K.	Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection.	
DRAMP29954	RGAHINGRWDSRCHRF	16	FBP1	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: FBP could have dual functions: blocked HA-mediated fusion by binding and inhibited endosomal acidification from interfering viral entry by the endocytic pathway.	[Ref.35259078]influenza A virus(H1N1): inhibition of viral multicycle growth in MDCK cells(>50% inhibition at 100 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA	35259078	Emerg Microbes Infect. 2022 Dec;11(1):926-937.	Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY.	Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants. 	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP29955	RGAHIKGRWDSRCHRF	16	FBP2	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: FBP could have dual functions: blocked HA-mediated fusion by binding and inhibited endosomal acidification from interfering viral entry by the endocytic pathway.	[Ref.35259078]influenza A virus(H1N1): inhibition of viral multicycle growth in MDCK cells(>50% inhibition at 50 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA	35259078	Emerg Microbes Infect. 2022 Dec;11(1):926-937.	Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY.	Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants. 	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP29956	IPLRGAFINGRWDSQCHRFS	20	U5	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Bind to the HA stem of group 1 influenza A virus.	[Ref.35259078]influenza A virus(H1N1): inhibition of viral replication in MDCK cells(IC50=12.9 μg/ml);	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA	35259078	Emerg Microbes Infect. 2022 Dec;11(1):926-937.	Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY.	Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants. 	CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC
DRAMP29957	FINGRWDSQCHRFSNGAIACA	21	U4	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Bind to the HA stem of group 1 influenza A virus.	[Ref.35259078]influenza A virus(H1N1): inhibition of viral replication in MDCK cells(IC50=6.6 μg/ml);	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA	35259078	Emerg Microbes Infect. 2022 Dec;11(1):926-937.	Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY.	Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)O
DRAMP29958	WEDWVR	6	C6b	No entry found	Retroviridae	Not found	Synthetic construct(derived from gp36 membrane proximal external region of FIV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Elicit antiviral activity by inhibiting the fusion of the FIV and host cell membrane. 	[Ref.30240422]Feline immunodeficiency virus (FIV): inhibition of virus replication in lymphoid cells(IC50>50 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30240422	PLoS One. 2018 Sep 21;13(9):e0204042	Grimaldi M, Stillitano I, Amodio G, Santoro A, Buonocore M, Moltedo O, Remondelli P, D'Ursi AM.	Structural basis of antiviral activity of peptides from MPER of FIV gp36	CC(C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP29959	DWVRWI	6	C6a	No entry found	Retroviridae	Not found	Synthetic construct(derived from gp36 membrane proximal external region of FIV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Elicit antiviral activity by inhibiting the fusion of the FIV and host cell membrane. 	[Ref.30240422]Feline immunodeficiency virus (FIV): inhibition of virus replication in lymphoid cells(IC50=0.06-0.15 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30240422	PLoS One. 2018 Sep 21;13(9):e0204042	Grimaldi M, Stillitano I, Amodio G, Santoro A, Buonocore M, Moltedo O, Remondelli P, D'Ursi AM.	Structural basis of antiviral activity of peptides from MPER of FIV gp36	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)O
DRAMP29960	WEDWVRWI	8	C8	No entry found	Retroviridae	Not found	Synthetic construct(derived from gp36 membrane proximal external region of FIV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Elicit antiviral activity by inhibiting the fusion of the FIV and host cell membrane. 	[Ref.30240422]Feline immunodeficiency virus (FIV): inhibition of virus replication in lymphoid cells(IC50=0.05-0.06 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30240422	PLoS One. 2018 Sep 21;13(9):e0204042	Grimaldi M, Stillitano I, Amodio G, Santoro A, Buonocore M, Moltedo O, Remondelli P, D'Ursi AM.	Structural basis of antiviral activity of peptides from MPER of FIV gp36	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)O
DRAMP29961	XGSGSGVALDPIDIAnti-SIVLNKAKSDLEESKEWIRRSNGKLDSI	42	Chol-PEG4-VG	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptides derived from the HRC of paramyxovirus F proteins interfere with formation of the six-helix bundle in a dominant-negative manner by binding to the transiently exposed HRN coiled coil in the transient fusion intermediate, thereby inhibiting membrane fusion.	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=0.1 ± 0.0001 nM,IC50<0.0007 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 1 indicates cholesterol-PEG4 conjugated cysteine.	L	[Ref.28344321]Vero cells: CC50>10000 nM.	membrane	28344321	Sci Rep. 2017 Mar 8;7:43610.	Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A	Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides	
DRAMP29962	XGSGSGVALDPIDIAnti-SIVLNKAKSDLEESKEWIRRSNGKLDSI	42	Chol-VG	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptides derived from the HRC of paramyxovirus F proteins interfere with formation of the six-helix bundle in a dominant-negative manner by binding to the transiently exposed HRN coiled coil in the transient fusion intermediate, thereby inhibiting membrane fusion.	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=1.7 ± 0.42 nM,IC50=0.06 ± 0.035 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 1 indicates cholesterol-conjugated cysteine.	L	[Ref.28344321]Vero cells: CC50=9000 nM.	membrane	28344321	Sci Rep. 2017 Mar 8;7:43610.	Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A	Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides	
DRAMP29963	VALDPIDIAnti-SIVLNKAKSDLEESKEWIRRSNGKLDSIGSGSGX	42	VG-PEG24-Chol	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptides derived from the HRC of paramyxovirus F proteins interfere with formation of the six-helix bundle in a dominant-negative manner by binding to the transiently exposed HRN coiled coil in the transient fusion intermediate, thereby inhibiting membrane fusion.	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=0.1 ± 0.0003 nM,IC50=0.007 ± 0.007 nM);##Nipah virus(NiV):inhibition of virus infection in Vero cells(IC90~2 nM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 42 indicates cholesterol-PEG24 conjugated cysteine.	L	[Ref.28344321]Vero cells: CC50=1300 nM.	membrane	28344321	Sci Rep. 2017 Mar 8;7:43610.	Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A	Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides	
DRAMP29964	VALDPIDIAnti-SIVLNKAKSDLEESKEWIRRSNGKLDSIGSGSGX	42	VG-Chol	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptides derived from the HRC of paramyxovirus F proteins interfere with formation of the six-helix bundle in a dominant-negative manner by binding to the transiently exposed HRN coiled coil in the transient fusion intermediate, thereby inhibiting membrane fusion.	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=0.7 ± 0.26 nM,IC50=0.015 ± 0.07 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 42 indicates cholesterol-conjugated cysteine.	L	[Ref.28344321]Vero cells: CC50+10000 nM.	membrane	28344321	Sci Rep. 2017 Mar 8;7:43610.	Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A	Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides	
DRAMP29965	VALDPIDIAnti-SIVLNKAKSDLEESKEWIRRSNGKLDSIGSGSGX	42	VG-PEG4-Chol	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptides derived from the HRC of paramyxovirus F proteins interfere with formation of the six-helix bundle in a dominant-negative manner by binding to the transiently exposed HRN coiled coil in the transient fusion intermediate, thereby inhibiting membrane fusion.	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=0.7 ± 0.007 nM,IC50=0.03 ± 0.04 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 42 indicates cholesterol-PEG4 conjugated cysteine.	L	[Ref.28344321]Vero cells: CC50=4500 nM.	membrane	28344321	Sci Rep. 2017 Mar 8;7:43610.	Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A	Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides	
DRAMP29966	VALDPIDIAnti-SIVLNKAKSDLEESKEWIRRSNGKLDSIGSGSGC	42	VG	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptides derived from the HRC of paramyxovirus F proteins interfere with formation of the six-helix bundle in a dominant-negative manner by binding to the transiently exposed HRN coiled coil in the transient fusion intermediate, thereby inhibiting membrane fusion.	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=280 ± 247 nM,IC50=1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.28344321]Vero cells: CC50>10000 nM.	membrane	28344321	Sci Rep. 2017 Mar 8;7:43610.	Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A	Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides	
DRAMP29967	SKVNGQSGRMEFFWTIAK	18	m15 /Leu17	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza viral HA)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.	[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>60% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA receptor binding domain (RBD)	27623031	ACS Infect Dis. 2016 Mar 11;2(3):187-93	Chen Q, Guo Y	Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29968	SKVNGQSGRMEFFWTALK	18	m14 /lle16	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza viral HA)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.	[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>10% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA receptor binding domain (RBD)	27623031	ACS Infect Dis. 2016 Mar 11;2(3):187-93	Chen Q, Guo Y	Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29969	SKVNGQSGRMAFFWTILK	18	m9 /Glu11	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza viral HA)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.	[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>50% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA receptor binding domain (RBD)	27623031	ACS Infect Dis. 2016 Mar 11;2(3):187-93	Chen Q, Guo Y	Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29970	SKVNGQSGRMEFAWTILK	18	m11 /Phe13	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza viral HA)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.	[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>80% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA receptor binding domain (RBD)	27623031	ACS Infect Dis. 2016 Mar 11;2(3):187-93	Chen Q, Guo Y	Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29971	SKVNGQSGRAEFFWTILK	18	m8 /Met10	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza viral HA)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.	[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>80% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA receptor binding domain (RBD)	27623031	ACS Infect Dis. 2016 Mar 11;2(3):187-93	Chen Q, Guo Y	Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29972	SKVNGQAGRMEFFWTILK	18	m6 /Ser7	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza viral HA)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.	[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(~60% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA receptor binding domain (RBD)	27623031	ACS Infect Dis. 2016 Mar 11;2(3):187-93	Chen Q, Guo Y	Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29973	SKVNGASGRMEFFWTILK	18	m5 /GIn6	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza viral HA)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.	[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>60% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA receptor binding domain (RBD)	27623031	ACS Infect Dis. 2016 Mar 11;2(3):187-93	Chen Q, Guo Y	Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29974	SKVAGQSGRMEFFWTILK	18	m4 /Asn4	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza viral HA)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.	[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>70% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA receptor binding domain (RBD)	27623031	ACS Infect Dis. 2016 Mar 11;2(3):187-93	Chen Q, Guo Y	Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29975	SKANGQSGRMEFFWTILK	18	m3 /Val3	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza viral HA)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.	[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>50% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA receptor binding domain (RBD)	27623031	ACS Infect Dis. 2016 Mar 11;2(3):187-93	Chen Q, Guo Y	Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29976	SAVNGQSGRMEFFWTILK	18	m2 /Arg2 	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza viral HA)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.	[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(~20% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA receptor binding domain (RBD)	27623031	ACS Infect Dis. 2016 Mar 11;2(3):187-93	Chen Q, Guo Y	Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29977	AKVNGQSGRMEFFWTILK	18	m1 /Ser1	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza viral HA)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.	[Ref.27623031]Pseudovirus influenza A virus(HA(VN/04)/HIV): inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(>20% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA receptor binding domain (RBD)	27623031	ACS Infect Dis. 2016 Mar 11;2(3):187-93	Chen Q, Guo Y	Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29978	AWDFGSLGGVFTSIGKALHQVFGAIYGAA	29	DENV2 Ep (419-447)	Q9WDA6	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: an initial, nonspecific interaction of the hydrophobicC terminus of the peptide inhibitor with the viral membranecarries it with the virion into the endosome, allowing aspecific interaction of the peptide with domain II as theprotein reconfigures, inhibiting the final zipping of thestem	[Ref.20881042]DENV2(dengue virus type 2): Inhibition of DENV-2 infection in BHK-21 cells (IC90~250µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	low-pH endosome	20881042	J Virol. 2010 Dec;84(24):12549-54.	Schmidt AG, Yang PL, Harrison SC.	Peptide inhibitors of flavivirus entry derived from the E protein stem.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)O
DRAMP29979	GDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELG	38	SARS-CoV-S (1149–1186)	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: as GST-fusion polypeptide	[Ref.15158473]SARS-CoV: inhibition of SARS-CoV cytopathic effect in Vero E6 cells ( synthetic HR2-38 IC50=0.5-5nM, GST-HR2-38 IC50=66.2nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	GST	15158473	Biochem Biophys Res Commun. 2004 Jun 18;319(1):283-8.	Zhu J, Xiao G, Xu Y, Yuan F, Zheng C, Liu Y, Yan H, Cole DK, Bell JI, Rao Z, Tien P, Gao GF.	Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@H](C)CC)NC(=O)CN)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)O
DRAMP29980	AWDFGSLGGVFTSIGKALHQVFGGAFGAA	29	DENV2 Ep (419-447)[A24G,I25A,Y26F]	Q9WDA6	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: an initial, nonspecific interaction of the hydrophobicC terminus of the peptide inhibitor with the viral membranecarries it with the virion into the endosome, allowing aspecific interaction of the peptide with domain II as theprotein reconfigures, inhibiting the final zipping of thestem	[Ref.20881042]DENV2(dengue virus type 2): Inhibition of DENV-2 infection in BHK-21 cells (IC90~2µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	low-pH endosome	20881042	J Virol. 2010 Dec;84(24):12549-54.	Schmidt AG, Yang PL, Harrison SC.	Peptide inhibitors of flavivirus entry derived from the E protein stem.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)O)C(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O
DRAMP29981	ALNCYWPLNDYGFYTTTGIGYQPYRVVVLSFEL	33	SARS-CoV Sgp (471-503)	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: block the binding between the RBD and angiotensin-convertingenzyme 2, resulting in the inhibition of SARS-CoV entrance into host cells in vitro	[Ref.16153058]SARS-CoV(Severe acute respiratory syndrome): inhibition of SARS-CoV infction in Vero cells (EC50=41.6µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	not found	16153058	J Comb Chem. 2005 Sep-Oct;7(5):648-56.	Hu H, Li L, Kao RY, Kou B, Wang Z, Zhang L, Zhang H, Hao Z, Tsui WH, Ni A, Cui L, Fan B, Guo F, Rao S, Jiang C, Li Q, Sun M, He W, Liu G.	Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP29982	SLTQINTTLLDLEYEMRSLQQVVKALNESYIDLKEL	36	MERS-CoV-HR2P [T1263E,L1267R]	K9N5Q8	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: interact with the viral HR1 domain to form heterologous 6-HB and block viral fusion coreformation, resulting in inhibition of MERS-CoV S protein-mediated membrane fusion.	[Ref.24473083]MERS-COV(Middle East respiratory syndrome coronavirus): inhibition of cell–cell fusion infection in Huh-7 and 293T/MERS/EGFP cells (IC50=0.93±0.15µM); inhibition of MERS-CoV infection in Vero cells (IC50=0.6µM); inhibition of MERS-CoV infection in Calu-3 cells (IC50=0.6µM); inhibition of MERS-CoV infection in HFL cells (IC50=13.9µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.24473083]HR2P has low or no in vitro toxic effect.	HR1 domain	24473083	Nat Commun. 2014;5:3067.	Lu L, Liu Q, Zhu Y, Chan KH, Qin L, Li Y, Wang Q, Chan JF, Du L, Yu F, Ma C, Ye S, Yuen KY, Zhang R, Jiang S.	Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29983	LTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL	35	MERS-S (1252-1286)	K9N5Q8##R9UQ53	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: inhibit MERS-CoV fusion and entry by using a pseudotyped-virus system	[Ref.24067982]MERS-COV(Middle East respiratory syndrome coronavirus): inhibition of MERS-CoV PsV infection in 293T/Huh7 cells (EC50~3.013µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	24067982	J Virol. 2013 Dec;87(24):13134-40.	Gao J, Lu G, Qi J, Li Y, Wu Y, Deng Y, Geng H, Li H, Wang Q, Xiao H, Tan W, Yan J, Gao GF.	Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP29984	RIQQIEQKIHHIEQRIQQIEQRISGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL	59	T21N36	A1YNW7	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: function as potent inhibitors of viral infection by forming a coiled-coil structure covalently stabilized by interchain disulfide bonds	[Ref.31932193]HIV-1(human immunodeficiency virus 1): inhiition of cell-cell fusion between TZM-bl cells and HL2/3 cells(IC50=81.8±5.69nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	31932193	Bioorg Med Chem. 2020 Feb 15;28(4):115214.	Lai W, Wang C, Yan J, Liu H, Zhang W, Lin B, Xi Z.	Suitable fusion of N-terminal heptad repeats to achieve covalently stabilized potent N-peptide inhibitors of HIV-1 infection.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP29985	RIQQIEQKIHHIEQRIQQIEQRAIEAQQHLLQLTVWGIKQLQARIL	46	T21N23		Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: function as potent inhibitors of viral infection by forming a coiled-coil structure covalently stabilized by interchain disulfide bonds	[Ref.31932193]HIV-1(human immunodeficiency virus 1): inhiition of cell-cell fusion between TZM-bl cells and HL2/3 cells(IC50=38.9±35.8nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	31932193	Bioorg Med Chem. 2020 Feb 15;28(4):115214.	Lai W, Wang C, Yan J, Liu H, Zhang W, Lin B, Xi Z.	Suitable fusion of N-terminal heptad repeats to achieve covalently stabilized potent N-peptide inhibitors of HIV-1 infection.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP29986	RIQQIEQKIHHIEQRIQQIEQLLQLTVWGIKQLQARIL	38	T21N17		Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: function as potent inhibitors of viral infection by forming a coiled-coil structure covalently stabilized by interchain disulfide bonds	[Ref.31932193]HIV-1(human immunodeficiency virus 1): inhiition of cell-cell fusion between TZM-bl cells and HL2/3 cells(IC50=251±41.1nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information found in the reference(s) presented	gp41	31932193	Bioorg Med Chem. 2020 Feb 15;28(4):115214.	Lai W, Wang C, Yan J, Liu H, Zhang W, Lin B, Xi Z.	Suitable fusion of N-terminal heptad repeats to achieve covalently stabilized potent N-peptide inhibitors of HIV-1 infection.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP29987	LHQNIVDVQYMYGLS	15	HCV gp (696–710), E2-79	Q99IB8	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits HCV entry at the post-attachment step and block cell-to-cell transmission, inhibit the late steps of HCV life cycle, such as HCV package and release.	[Ref.28638089]HCV(Hepatitis C virus): inhibition of HCVcc infection in Huh7.5/CD81 cells (IC50=1~5nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.28638089]have no effect on the viability of Huh7.5-CD81 cells at concentrations of 10 nM	Envelope protein	28638089	A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.	Yin P, Zhang L, Ye F, Deng Y, Lu S, Li YP, Zhang L, Tan W.	A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
DRAMP29988	GLLHLHQNIVDVQYM	15	HCV gp (692–706), E2-78	Q99IB8	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits HCV entry at the post-attachment step and block cell-to-cell transmission, inhibit the late steps of HCV life cycle, such as HCV package and release.	[Ref.28638089]HCV(Hepatitis C virus): inhibition of HCVcc infection in Huh7.5/CD81 cells (IC50=1~5nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.28638089]have no effect on the viability of Huh7.5-CD81 cells at concentrations of 10 nM	Envelope protein	28638089	A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.	Yin P, Zhang L, Ye F, Deng Y, Lu S, Li YP, Zhang L, Tan W.	A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)C(C)C
DRAMP29989	FGCTWMNSTGFTKTC	15	HCV gp (552–566), E2-43	Q99IB8	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits HCV entry at the post-attachment step and block cell-to-cell transmission, inhibit the late steps of HCV life cycle, such as HCV package and release.	[Ref.28638089]HCV(Hepatitis C virus): inhibition of HCVcc infection in Huh7.5/CD81 cells (IC50=1~5nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.28638089]have no effect on the viability of Huh7.5-CD81 cells at concentrations of 10 nM	Envelope protein	28638089	A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.	Yin P, Zhang L, Ye F, Deng Y, Lu S, Li YP, Zhang L, Tan W.	A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP29990	QGSWFGCTWMNSTGF	18	HCV gp (548–562), E2-42	Q99IB8	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits HCV entry at the post-attachment step and block cell-to-cell transmission, inhibit the late steps of HCV life cycle, such as HCV package and release.	[Ref.28638089]HCV(Hepatitis C virus): inhibition of HCVcc infection in Huh7.5/CD81 cells (IC50=1~5nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.28638089]have no effect on the viability of Huh7.5-CD81 cells at concentrations of 10 nM	Envelope protein	28638089	A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.	Yin P, Zhang L, Ye F, Deng Y, Lu S, Li YP, Zhang L, Tan W.	A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP29991	VEPGQLKLNWFKK	13	P7(DENV-2 gp (662-674))	P14340	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: might be involved in blocking viral entry via occupying the binding site in the receptor on the host cell(β3 integrin).	[Ref.29709564]DENV-2(dengue virus serotype 2): inhibition of virus entry in HUVECs(human umbilical vein endothelial cells)(65 ± 6% inhibition at 40 μM,55± 12% inhibition at 20 μM,41± 13% inhibition at 10 μM,IC50=12.86±5.96µM);##DENV-1(dengue virus serotype 1): inhibition of virus entry in HUVECs(human umbilical vein endothelial cells)(65 ± 12% inhibition at 40 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.29709564]No toxic effect on HUVEC(Human umbilical vein endothelial cells) at concentrations up to 100 µM	β3 integrin	29709564	Antiviral Res. 2018 Jul;155:20-27.	Cui X, Wu Y, Fan D, Gao N, Ming Y, Wang P, An J.	Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with β3 integrin.	CC(C)C[C@H](NC(=O)CNC(=O)CC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP29992	CKIPFEIMDLEKRHV	15	P4(DENV-2 gp (613-627))	P14340	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: might be involved in blocking viral entry via occupying the binding site in the receptor on the host cell(β3 integrin).	[Ref.29709564]DENV-2(dengue virus serotype 2): inhibition of virus entry in HUVECs(human umbilical vein endothelial cells)(70 ± 9% inhibition at 40 μM,44 ± 10% inhibition at 20 μM,40± 6% inhibition at 10 μM,IC50=19.08±2.52µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.29709564]No toxic effect on HUVEC(Human umbilical vein endothelial cells) at concentrations up to 100 µM	β3 integrin	29709564	Antiviral Res. 2018 Jul;155:20-27.	Cui X, Wu Y, Fan D, Gao N, Ming Y, Wang P, An J.	Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with β3 integrin.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)[C@H](C)CC)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP29993	GNHILSLVQNAPYGLYFIHFSW	22	MHV (1096–1117)[Y1117W]	P11224		Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: inhibits viral entry through coiled coil interactions.	[Ref.16616792]MHV(murine hepatitis virus): inhibition of virus infection in L2 cells(22% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxic at a concentration of 30 μM on L2 cells	cell membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H](C)CC)C(C)C
DRAMP29994	GYFVQDDGEWKFTGSSYYY	19	MHV (1144–1162)	P11224		Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: inhibits viral entry through coiled coil interactions.	[Ref.16616792]MHV(murine hepatitis virus): inhibition of virus infection in L2 cells(98% inhibition at 30 Μm, IC50=4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxic at a concentration of 30 μM on L2cells	cell membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP29995	AACEVAKNLNESLIDLQELGKYEQYIKW	28	AAC-SARS-CoV (1170–1194)	Q19QX0	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: inhibits viral entry through coiled coil interactions.	[Ref.16616792]SARS-CoV: inhibition of  virus infection in Vero-E6 cells(42% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxic at a concentration of 30 μM on Vero-E6 cells	cell membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP29996	GVFVFNGTSWFITQRNFFS	19	SARS-CoV (1075–1093)	Q19QX0	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: inhibits viral entry through coiled coil interactions.	[Ref.16616792]SARS-CoV: inhibition of  virus infection in Vero-E6 cells(83% inhibition at 30 μM,IC50~2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxic at a concentration of 30 μM on Vero-E6 cells	cell membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP29997	GYHLMSFPQAAP-HGVVFLHVTW	22	SARS-CoV (1028–1049)[Y1049W]	Q19QX0	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: inhibits viral entry through coiled coil interactions.	[Ref.16616792]SARS-CoV: inhibition of  virus infection in Vero-E6 cells(90% inhibition at 30 μM,IC50~2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxic at a concentration of 30 μM on Vero-E6 cells	cell membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.	
DRAMP29998	ATAGWTFGAGAALQIPFAMQMAY	23	SARS-CoV (864-886)	Q19QX0	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: inhibits viral entry through coiled coil interactions.	[Ref.16616792]SARS-CoV: inhibition of  virus infection in Vero-E6 cells(39% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxic at a concentration of 30 μM on Vero-E6 cells	cell membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP29999	TLKPIFKLPLGINITNFR	18	SARS-CoV-S (215-232), peptide 9626	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Presumably inhibit virus entry by binding to Spike protein, hACE2, or an unknown co-receptor.	[Ref.19853613]SARS-COV: inhibition of SARS-CoV/HIV PsV virus infection in 293T/ACE2 cells (IC50=11µM); inhibition of SARS-CoV/HIV PsV virus entry in 293T/ACE2 cells(80% at 50µM) 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	not found	19853613	J Mol Biol. 2009 Dec 11;394(4):600-5.	Guo Y, Tisoncik J, McReynolds S, Farzan M, Prabhakar BS, Gallagher T, Rong L, Caffrey M.	Identification of a new region of SARS-CoV S protein critical for viral entry.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@H](C)CC
DRAMP30000	MWKTPTLKYFGGFNFSQIL	19	SARS-CoV (770-788)[Y771W]	Q19QX0	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: inhibits viral entry through coiled coil interactions.	[Ref.16616792]SARS-CoV: inhibition of  virus infection in Vero-E6 cells(58% inhibition at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxic at a concentration of 30 μM on Vero-E6 cells	cell membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30001	QNQSANQFQKEISQINEVLTTTNTSLGKLQDDVNQNNQSLNTLQKE	46	N46eg(SARS-CoV (902-947)[K2N,I4S,N9Q,A11E,Q16N,S18V,S23N,A25S,V32D,A37N,A39S,V44Q,Q46E])	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding to the HR2 region and blocking the formation of  a 6-helix bundle during the fusion step of virus entry, thus inhibiting virus entry.	[Ref.18983873]SARS-CoV:inhibition of cell fusion in Hela cells (IC50=5.07 ± 0.17 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18983873]No discernable cytotoxicity on HeLa or VeroE6 cells at the concentrations of 25 μM.	membrane	18983873	Antiviral Res. 2009 Jan;81(1):82-7.	Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.	Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O
DRAMP30002	QKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQ	46	N46(SARS-CoV (902-947))	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding to the HR2 region and blocking the formation of  a 6-helix bundle during the fusion step of virus entry, thus inhibiting virus entry.	[Ref.18983873]SARS-CoV:inhibition of cell fusion in Hela cells (IC50=3.97 ± 1.40 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18983873]No discernable cytotoxicity on HeLa or VeroE6 cells at the concentrations of 25 μM.	membrane	18983873	Antiviral Res. 2009 Jan;81(1):82-7.	Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.	Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC
DRAMP30003	GINASVVNIQKEIDRLNEVAKNLNESLIDL	30	P4(SARS-CoV (1153–1182))	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding to the HR1 region and blocking the formation of  a 6-helix bundle during the fusion step of virus entry, thus inhibiting virus entry.	[Ref.18983873]SARS-CoV:inhibition of cell fusion in Hela cells (IC50=0.80 ± 0.21 μM);inhibition of SARS-CoV infection in Vero-E6 cells (IC50=3.17 ± 0.24 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18983873]No discernable cytotoxicity on HeLa or VeroE6 cells at the concentrations of 25 μM.	membrane	18983873	Antiviral Res. 2009 Jan;81(1):82-7.	Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.	Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CN)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30004	GINASVVNIQKEIDRLNEVAKNL	23	P6(SARS-CoV (1153–1175))	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding to the HR1 region and blocking the formation of  a 6-helix bundle during the fusion step of virus entry, thus inhibiting virus entry.	[Ref.18983873]SARS-CoV:inhibition of cell fusion in Hela cells (IC50=1.04 ± 0.22 μM); inhibition of SARS-CoV infection in Vero-E6 cells (IC50=2.28 ± 0.81 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18983873]No discernable cytotoxicity on HeLa or VeroE6 cells at the concentrations of 25 μM.	membrane	18983873	Antiviral Res. 2009 Jan;81(1):82-7.	Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.	Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C
DRAMP30005	GINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	37	P1(SARS-CoV (1153-1189))	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding to the HR1 region and blocking the formation of  a 6-helix bundle during the fusion step of virus entry, thus inhibiting virus entry.	[Ref.18983873]SARS-CoV:inhibition of cell fusion in Hela cells (IC50=0.62 ± 0.20 μM);inhibition of SARS-CoV infection in Vero-E6 cells (IC50=3.04 ± 0.06 μM).##[Ref.15043961]SARS-CoV:inhibition of the cytopathic effect in Vero E6 cells(IC50~19 μM/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18983873]No discernable cytotoxicity on HeLa or VeroE6 cells at the concentrations of 25 μM.	membrane	18983873##15043961	Antiviral Res. 2009 Jan;81(1):82-7.##Lancet. 2004 Mar 20;363(9413):938-47.	Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.##Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S.	Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.##Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CN)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30006	AWDFGSVGGVFNSLGKGIHQIFGAAFKSL	29	ZIKV Ep (424-452)	Q32ZE1	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from protein E stem may inhibit virus infection by blocking virus entry.	[Ref.28232248]Zika virus (ZIKV):inhibition of Zika virus (ZIKV) infection in Vero cells (IC50=1.32μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	28232248	Antiviral Res. 2017 May;141:140-149.	Chen L, Liu Y, Wang S, Sun J, Wang P, Xin Q, Zhang L, Xiao G, Wang W.	Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30007	AWDFGSIGGVFNSIGRAVHQVFGGAFRTL	29	JEV Ep (424–452)	P0DOH7	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from protein E stem may inhibit virus infection by blocking virus entry.	[Ref.28232248]Japanese encephalitis virus (JEV):inhibition of JEV infection in BHK-21 (baby hamster kidney) cells (IC50=7.66 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	28232248	Antiviral Res. 2017 May;141:140-149.	Chen L, Liu Y, Wang S, Sun J, Wang P, Xin Q, Zhang L, Xiao G, Wang W.	Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP30008	AWDFGSIGGVFNSIGRAVHQVF	22	JEV Ep (424–445)	P0DOH7	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevented JEV infection in mice by reducing viral load and the inflammatory response in the brain, thereby improving the survival rate.	[Ref.28232248]Japanese encephalitis virus (JEV):inhibition of JEV infection in BHK-21 (baby hamster kidney) cells (IC50=3.93 nM);##Zika virus (ZIKV):inhibition of Zika virus (ZIKV) infection in Vero cells (IC50=3.27μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	28232248	Antiviral Res. 2017 May;141:140-149.	Chen L, Liu Y, Wang S, Sun J, Wang P, Xin Q, Zhang L, Xiao G, Wang W.	Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30009	AALGDTAWDFGSIGGVFNSIGRAVHQVFGGAFRTL	35	JEV Ep (418–452)	P0DOH7	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from protein E stem may inhibit virus infection by blocking virus entry.	[Ref.28232248]Japanese encephalitis virus (JEV):inhibition of JEV infection in BHK-21 (baby hamster kidney) cells (IC50=58.07 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	28232248	Antiviral Res. 2017 May;141:140-149.	Chen L, Liu Y, Wang S, Sun J, Wang P, Xin Q, Zhang L, Xiao G, Wang W.	Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
DRAMP30010	SIGGVFNSIGRAVHQVFGGAFRTL	24	JEV Ep (428–452)	P0DOH7	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from protein E stem may inhibit virus infection by blocking virus entry.	[Ref.28232248]Japanese encephalitis virus (JEV):inhibition of JEV infection in BHK-21 (baby hamster kidney) cells (IC50=94.10 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	28232248	Antiviral Res. 2017 May;141:140-149.	Chen L, Liu Y, Wang S, Sun J, Wang P, Xin Q, Zhang L, Xiao G, Wang W.	Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)C(C)C
DRAMP30011	STLGKAFSTTLKGAQRLAALGDTAWDFG	28	JEV Ep (401–428)	P0DOH7	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from protein E stem may inhibit virus infection by blocking virus entry.	[Ref.28232248]Japanese encephalitis virus (JEV):inhibition of JEV infection in BHK-21 (baby hamster kidney) cells (IC50=3790.71 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	28232248	Antiviral Res. 2017 May;141:140-149.	Chen L, Liu Y, Wang S, Sun J, Wang P, Xin Q, Zhang L, Xiao G, Wang W.	Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP30012	AGVSGHGQHGVHG	13	Alloferon-1 [H1A]	P83412	Herpesviridae, Picornaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may inhibit the replication of DNA and RNA viruses.	[Ref.21766388]Coxsackie virus 971 PT(971 PT CVB2):inhibition of virus replication in LLC-MK2 cells(IC50=358.00 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.21766388]No cytotoxicity against Vero cells,LLC-MK2 cells and Hep-2 cells up to 187.50 µg/ml.	Not found	21766388	J Pept Sci. 2011 Nov;17(11):715-9.	Kuczer M, Midak-Siewirska A, Zahorska R, Luczak M, Konopińska D.	Further studies on the antiviral activity of alloferon and its analogues.	CC(C)[C@H](NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O)C(C)C
DRAMP30013	RGVSGHGQHGVHG	13	Alloferon-1 [H1R]	P83412	Herpesviridae, Picornaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may inhibit the replication of DNA and RNA viruses.	[Ref.21766388]HHV-1 McIntyre strain:inhibition of virus replication in Vero cells(IC50=321.10 µg/ml);##HHV-1:inhibition of virus replication in Vero cells(IC50=277.50 µg/ml);inhibition of virus replication in HEp-2 cells(IC50=602.18 µg/ml);##Coxsackie virus 971 PT(971 PT CVB2):inhibition of virus replication in LLC-MK2 cells(IC50=577.73 µg/ml);inhibition of virus replication in Hep-2 cells(IC50=167.71 µg/ml);##CVB2:inhibition of virus replication in LLC-MK2 cells(IC50=355.18 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.21766388]No cytotoxicity against Vero cells,LLC-MK2 cells and Hep-2 cells up to 143.75 µg/ml.	Not found	21766388	J Pept Sci. 2011 Nov;17(11):715-9.	Kuczer M, Midak-Siewirska A, Zahorska R, Luczak M, Konopińska D.	Further studies on the antiviral activity of alloferon and its analogues.	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O)C(C)C
DRAMP30014	KGVSGHGQHGVHG	13	Alloferon-1 [H1K]	P83412	Herpesviridae, Picornaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may inhibit the replication of DNA and RNA viruses.	[Ref.21766388]HHV-1 McIntyre strain:inhibition of virus replication in Vero cells(IC50=147.09 µg/ml);inhibition of virus replication in Hep-2 cells(IC50=241.90 µg/ml);##HHV-1:inhibition of virus replication in Vero cells(IC50=9.19 µg/ml);inhibition of virus replication in HEp-2 cells(IC50=12.98 µg/ml);##Coxsackie virus 971 PT(971 PT CVB2):inhibition of virus replication in LLC-MK2 cells(IC50=157.73 µg/ml);inhibition of virus replication in Hep-2 cells(IC50=107.04 µg/ml);##CVB2:inhibition of virus replication in LLC-MK2 cells(IC50=190.67 µg/ml);inhibition of virus replication in Hep-2 cells(IC50=74.00 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.21766388]No cytotoxicity against Vero cells,LLC-MK2 cells and Hep-2 cells up to 218.75 µg/ml.	Not found	21766388	J Pept Sci. 2011 Nov;17(11):715-9.	Kuczer M, Midak-Siewirska A, Zahorska R, Luczak M, Konopińska D.	Further studies on the antiviral activity of alloferon and its analogues.	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O)C(C)C
DRAMP30015	GQGKAHNGRLITANP	15	DENV Envelope glycoprotein (340 – 354)	Q5UB51##P17763	Flaviviridae	Not found	Synthetic construct(derived from DENV Envelope glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts as inhibitors by binding to the E protein, suppressing its conformational changes, and preventing its binding to the cellular receptor, thereby inhibiting viral entry.	[Ref.30508603]DENV-1:inhibition of virus infection in Vero cells(83%±3.72% inhibition at 50 μM,IC50=33 μM);##DENV-2:inhibition of virus infection in Vero cells(IC50=10 μM);##DENV-3:inhibition of virus infection in Vero cells(60% inhibition at 20μM);##DENV-4:inhibition of virus infection in Vero cells(55% inhibition at 20μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30508603]<20% cytotoxicity against Vero and C6/36 cells at 200 μM.	E protein	30508603	Virus Res. 2019 Jan 15;260:142-150.	John AM, Jittmittraphap A, Chattanadee S, Alwin Prem Anand A, Shenbagarathai R, Leaungwutiwong P.	In vitro analysis of synthetic peptides in blocking the entry of dengue virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O
DRAMP30016	DRGWGNGCGLFG	12	DENV Envelope glycoprotein (98-109)	Q5UB51##P17763	Flaviviridae	Not found	Synthetic construct(derived from DENV Envelope glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts as inhibitors by binding to the E protein, suppressing its conformational changes, and preventing its binding to the cellular receptor, thereby inhibiting viral entry.	[Ref.30508603]DENV-1:inhibition of virus infection in Vero cells(88%±3.89% inhibition at 50 μM,IC50=10 μM);##DENV-2:inhibition of virus infection in Vero cells(IC50=10 μM);##DENV-3:inhibition of virus infection in Vero cells(60% inhibition at 20μM);##DENV-4:inhibition of virus infection in Vero cells(55% inhibition at 20μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30508603]<20% cytotoxicity against Vero and C6/36 cells at 200 μM.	E protein	30508603	Virus Res. 2019 Jan 15;260:142-150.	John AM, Jittmittraphap A, Chattanadee S, Alwin Prem Anand A, Shenbagarathai R, Leaungwutiwong P.	In vitro analysis of synthetic peptides in blocking the entry of dengue virus.	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](N)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)NCC(=O)O
DRAMP30017	LEHGSCVTTMAKDKPTL	17	DENV Envelope glycoprotein (25-41)	Q5UB51##P17763	Flaviviridae	Not found	Synthetic construct(derived from DENV Envelope glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts as inhibitors by binding to the E protein, suppressing its conformational changes, and preventing its binding to the cellular receptor, thereby inhibiting viral entry.	[Ref.30508603]DENV-1:inhibition of virus infection in Vero cells(58%±2.55% inhibition at 50 μM,IC50=10 μM);##DENV-2:inhibition of virus infection in Vero cells(IC50=10 μM);##DENV-3:inhibition of virus infection in Vero cells(60% inhibition at 20μM);##DENV-4:inhibition of virus infection in Vero cells(55% inhibition at 20μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30508603]<20% cytotoxicity against Vero and C6/36 cells at 200 μM.	E protein	30508603	Virus Res. 2019 Jan 15;260:142-150.	John AM, Jittmittraphap A, Chattanadee S, Alwin Prem Anand A, Shenbagarathai R, Leaungwutiwong P.	In vitro analysis of synthetic peptides in blocking the entry of dengue virus.	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30018	RRRRRRRXPLSPPLRNTHPQAMQWNSTTF	29	7R-Ahx-HBV Large envelope protein (96-116)	P03138	Hepadnaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can efficiently enter cells and inhibit the envelopment of HBV nucleocapsids and subsequent secretion of viral particles.	[Ref.21144865]HBV:inhibition of cell proliferation in HepG2.2.15 cells(EC50=6.5 ± 1.5 μM;EC90=41.4 ±8.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 8 is 6-aminocaproic acid.	L	[Ref.21144865]HepG2.2.15:LC50=515.9± 43.8 μM.	DNA	21144865	Antiviral Res. 2011 Jan;89(1):109-14.	Pan XB, Wei L, Han JC, Ma H, Deng K, Cong X.	Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production.	
DRAMP30019	RRRRRRRXLDPAFR	14	7R-Ahx-HBV Large envelope protein (19-24)	P03138	Hepadnaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can efficiently enter cells and inhibit the envelopment of HBV nucleocapsids and subsequent secretion of viral particles.	[Ref.21144865]HBV:inhibition of cell proliferation in HepG2.2.15 cells(EC50=3.0 ± 1.0 μM;EC90=10.9 ± 3.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 8 is 6-aminocaproic acid.	L	[Ref.21144865]No cytotoxicity was observed at 1mM of peptide concentration against HepG2.2.15.	DNA	21144865	Antiviral Res. 2011 Jan;89(1):109-14.	Pan XB, Wei L, Han JC, Ma H, Deng K, Cong X.	Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production.	
DRAMP30020	RRRRRRRXPTSNHSPTSCPPTCPGYRWMCLRRF	33	7R-Ahx-HBV Large envelope protein (219-243)	P03138	Hepadnaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can efficiently enter cells and inhibit the envelopment of HBV nucleocapsids and subsequent secretion of viral particles.	[Ref.21144865]HBV:inhibition of cell proliferation in HepG2.2.15 cells(EC50=12.8 ± 2.0 μM;EC90=85.6 ± 9.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 8 is 6-aminocaproic acid.	L	[Ref.21144865]HepG2.2.15:LC50=457.9 ± 41.0 μM.	DNA	21144865	Antiviral Res. 2011 Jan;89(1):109-14.	Pan XB, Wei L, Han JC, Ma H, Deng K, Cong X.	Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production.	
DRAMP30021	RRRRRRRXGSLLGRMKGA	18	7R-Ahx-P3		Hepadnaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can efficiently enter cells and inhibit the envelopment of HBV nucleocapsids and subsequent secretion of viral particles.	[Ref.21144865]HBV:inhibition of cell proliferation in HepG2.2.15 cells(EC50=2.5 ±1.0 μM;EC90=8.6± 3.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 8 is 6-aminocaproic acid.	L	[Ref.21144865]HepG2.2.15:LC50=828.7 ± 50.3 μM.	DNA	21144865	Antiviral Res. 2011 Jan;89(1):109-14.	Pan XB, Wei L, Han JC, Ma H, Deng K, Cong X.	Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production.	
DRAMP30022	EEQAKTFLDKFNHEAEDLFYQSSGLGKGDFR	31	P6(ACE2 (4-26)-G-ACE2 (333-339))	Q9BYF1	Coronaviridae	Not found	Synthetic construct(derived from angiotensin-converting enzyme 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry.	[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(IC50=0.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	spike glycoprotein	16510163	Virology. 2006 Jun 20;350(1):15-25.	Han DP, Penn-Nicholson A, Cho MW.	Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.	CC(C)C[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30023	EEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEE	36	P5(ACE2 (4-39))	Q9BYF1	Coronaviridae	Not found	Synthetic construct(derived from angiotensin-converting enzyme 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry.	[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(IC50=6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	spike glycoprotein	16510163	Virology. 2006 Jun 20;350(1):15-25.	Han DP, Penn-Nicholson A, Cho MW.	Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP30024	EEQAKTFLDKFNHEAEDLFYQSS	23	P4(ACE2 (4-26))	Q9BYF1	Coronaviridae	Not found	Synthetic construct(derived from angiotensin-converting enzyme 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry.	[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(IC50=50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	spike glycoprotein	16510163	Virology. 2006 Jun 20;350(1):15-25.	Han DP, Penn-Nicholson A, Cho MW.	Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)O
DRAMP30025	NHEAEDLFY	9	P3(ACE2 (15-23))	Q9BYF1	Coronaviridae	Not found	Synthetic construct(derived from angiotensin-converting enzyme 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry.	[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(30% inhibition at 100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	spike glycoprotein	16510163	Virology. 2006 Jun 20;350(1):15-25.	Han DP, Penn-Nicholson A, Cho MW.	Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30026	DKFNHEAED	9	P2(ACE2 (12-20))	Q9BYF1	Coronaviridae	Not found	Synthetic construct(derived from angiotensin-converting enzyme 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry.	[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(40% inhibition at 100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	spike glycoprotein	16510163	Virology. 2006 Jun 20;350(1):15-25.	Han DP, Penn-Nicholson A, Cho MW.	Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.	C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP30027	EEQAKTFLDK	10	P1(ACE2 (4-13))	Q9BYF1	Coronaviridae	Not found	Synthetic construct(derived from angiotensin-converting enzyme 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry.	[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(25% inhibition at 100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	spike glycoprotein	16510163	Virology. 2006 Jun 20;350(1):15-25.	Han DP, Penn-Nicholson A, Cho MW.	Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP30028	HAKFWW	6		No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication.	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	integrase	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH.	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	C[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP30029	HCAFWW	6		No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication.	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=49 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	integrase	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH.	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP30030	EEHEKYHSNW	10	NL1	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>2000 µM);inhibition of strand transfer catalyzed by integrase(IC50>2000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	NCCCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP30031	ASCDKCQLKG	10	NL2	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>2000 µM);inhibition of strand transfer catalyzed by integrase(IC50>2000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O
DRAMP30032	HGQVDCSPGIWQLDCTH	17	NL3 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=1000 µM);inhibition of strand transfer catalyzed by integrase(IC50=1000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O)[C@@H](C)O
DRAMP30033	VHVASGY	7	NL4	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>2000 µM);inhibition of strand transfer catalyzed by integrase(IC50>2000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C
DRAMP30034	PAETGQET	8	NL5	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>2000 µM);inhibition of strand transfer catalyzed by integrase(IC50>2000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O
DRAMP30035	TAYFLLKLAGRW	12	NL-6 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=21±7 µM);inhibition of strand transfer catalyzed by integrase(IC50=2.7±1  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP30036	GRWPVKT	7	NL7	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>2000 µM);inhibition of strand transfer catalyzed by integrase(IC50>2000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)[C@@H](C)O
DRAMP30037	HTDNGSNF	8	NL8	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>2000 µM);inhibition of strand transfer catalyzed by integrase(IC50>2000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	C[C@@H](O)[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP30038	ACWWAGIKQEF	11	NL-9 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=95±9 µM);inhibition of strand transfer catalyzed by integrase(IC50=56±5  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP30039	FGIPYNPQSQ	10	NL10	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>1000 µM);inhibition of strand transfer catalyzed by integrase(IC50>1000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP30040	ESMNKELKKI	10	NL11	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>2000 µM);inhibition of strand transfer catalyzed by integrase(IC50>2000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(=O)O)C(N)=O
DRAMP30041	VRDQAEHLKT	10	NL12	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>2000 µM);inhibition of strand transfer catalyzed by integrase(IC50>2000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)[C@@H](C)O
DRAMP30042	FIHNFKRK	8	NL13	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>2000 µM);inhibition of strand transfer catalyzed by integrase(IC50>2000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30043	GYSAGERIVD	10	NL14	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>2000 µM);inhibition of strand transfer catalyzed by integrase(IC50>2000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)C(C)C
DRAMP30044	WKGPAKLLWK	10	NL15	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>1000 µM);inhibition of strand transfer catalyzed by integrase(IC50>1000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30045	VPRRKAKI	8	NL16	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>1000 µM);inhibition of strand transfer catalyzed by integrase(IC50>1000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(N)=O
DRAMP30046	AAYFLLKLAGRW	12	NL6-T1A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=100±10 µM);inhibition of strand transfer catalyzed by integrase(IC50=47±7  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30047	TAAFLLKLAGRW	12	NL6-Y3A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=193±10 µM);inhibition of strand transfer catalyzed by integrase(IC50=119±11  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30048	TAYALLKLAGRW	12	NL6-F4A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>333 µM);inhibition of strand transfer catalyzed by integrase(IC50>333  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30049	TAYFALKLAGRW	12	NL6-L5A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=115±21 µM);inhibition of strand transfer catalyzed by integrase(IC50=51±7  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30050	TAYFLAKLAGRW	12	NL6-L6A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>333 µM);inhibition of strand transfer catalyzed by integrase(IC50>333  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30051	TAYFLLALAGRW	12	NL6-K7A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=113±15 µM);inhibition of strand transfer catalyzed by integrase(IC50=56±7  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30052	TAYFLLKAAGRW	12	NL6-L8A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>333 µM);inhibition of strand transfer catalyzed by integrase(IC50=106±7  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30053	TAYFLLKLAARW	12	NL6-G10A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=118±10 µM);inhibition of strand transfer catalyzed by integrase(IC50=19±6  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30054	TAYFLLKLAGAW	12	NL6-R11A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=83±15 µM);inhibition of strand transfer catalyzed by integrase(IC50=80±8  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30055	TAYFLLKLAGRA	12	NL6-W12A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>333 µM);inhibition of strand transfer catalyzed by integrase(IC50>333 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O
DRAMP30056	AAWWAGIKQEF	11	NL9-C2A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=277±47 µM);inhibition of strand transfer catalyzed by integrase(IC50=311±19  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30057	ACAWAGIKQEF	11	NL9-W3A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=33±6 µM);inhibition of strand transfer catalyzed by integrase(IC50=34±8  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30058	ACWAAGIKQEF	11	NL9-W4A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>333 µM);inhibition of strand transfer catalyzed by integrase(IC50>333 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30059	ACWWAAIKQEF	11	NL9-G6A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=90±10 µM);inhibition of strand transfer catalyzed by integrase(IC50=43±7  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30060	ACWWAGAKQEF	11	NL9-I7A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>333 µM);inhibition of strand transfer catalyzed by integrase(IC50>333 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30061	ACWWAGIAQEF	11	NL9-K8A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=62±13 µM);inhibition of strand transfer catalyzed by integrase(IC50=55±7  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30062	ACWWAGIKAEF	11	NL9-Q9A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>333 µM);inhibition of strand transfer catalyzed by integrase(IC50>333 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30063	ACWWAGIKQAF	11	NL9-E10A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>333 µM);inhibition of strand transfer catalyzed by integrase(IC50>333 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30064	ACWWAGIKQEA	11	NL9-F11A 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=245±13 µM);inhibition of strand transfer catalyzed by integrase(IC50=206±12  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O
DRAMP30065	TASFLLKLAGRW	12	NL6-1 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=186±23 µM);inhibition of strand transfer catalyzed by integrase(IC50=11±2  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP30066	TAYFLLILAGRW	12	NL6-2 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=4.1±0.7 µM);inhibition of strand transfer catalyzed by integrase(IC50=3.0±1.0  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP30067	TAYFLLKLAGRL	12	NL6-3 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=315±30 µM);inhibition of strand transfer catalyzed by integrase(IC50=38±2  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(N)=O
DRAMP30068	ASWWAGIKQEF	11	NL9-1 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=294±41 µM);inhibition of strand transfer catalyzed by integrase(IC50=163±15  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP30069	ACGWAGIKQEF	11	NL9-2 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=46±5 µM);inhibition of strand transfer catalyzed by integrase(IC50=16±2  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP30070	ACWGAGIKQEF	11	NL9-3 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>333 µM);inhibition of strand transfer catalyzed by integrase(IC50>333 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP30071	ACWWAGIRQEF	11	NL9-4 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>333 µM);inhibition of strand transfer catalyzed by integrase(IC50>333 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP30072	TAYFLL	6	NL6-4	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=500 µM);inhibition of strand transfer catalyzed by integrase(IC50=500 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(N)=O
DRAMP30073	YFLLKL	6	NL6-5 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=20 µM);inhibition of strand transfer catalyzed by integrase(IC50=20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(N)=O
DRAMP30074	KLAGRW	6	NL6-6	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>100 µM);inhibition of strand transfer catalyzed by integrase(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP30075	ACWWAG	6	NL9-5 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>100 µM);inhibition of strand transfer catalyzed by integrase(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(N)=O
DRAMP30076	WAGIKQ	6	NL9-6 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>100 µM);inhibition of strand transfer catalyzed by integrase(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP30077	IKQEF	5	NL9-7 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>100 µM);inhibition of strand transfer catalyzed by integrase(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP30078	tayfllklagrw	12	DNL-6	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=65±8 µM);inhibition of strand transfer catalyzed by integrase(IC50=13±1  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		D	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](C)NC(=O)[C@H](N)[C@H](C)O)C(=O)N[C@H](C)C(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30079	WRGALKLLFYAT	12	RNL-6	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=96±2 µM);inhibition of strand transfer catalyzed by integrase(IC50=16±4  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP30080	wrgalkllfyat	12	RDNL-6	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=3.5±1 µM);inhibition of strand transfer catalyzed by integrase(IC50=4.0±1  µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		D	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC(C)C[C@@H](NC(=O)[C@@H](C)NC(=O)CNC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)N[C@@H](C(=O)O)[C@H](C)O
DRAMP30081	acwwagikqef	11	DNL-9 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>1000 µM);inhibition of strand transfer catalyzed by integrase(IC50>1000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		D	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@H](C)[C@@H](NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CS)NC(=O)[C@@H](C)N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](Cc1ccccc1)C(=O)O
DRAMP30082	FEQKIGAWWCA	11	RNL-9	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>1000 µM);inhibition of strand transfer catalyzed by integrase(IC50>1000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)O
DRAMP30083	feqkigawwca	11	RDNL-9	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3′-processing and strand transfer).	[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>1000 µM);inhibition of strand transfer catalyzed by integrase(IC50>1000 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		D	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	CC[C@H](C)[C@@H](NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](CCC(=O)N[C@H](CCCCN)C(=O)NCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CS)C(=O)O)NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C)C(=O)O
DRAMP30084	DFRELNKRTQDFWEVQLGIP	20	4277(derived from DNA-polymerase domain of HIV-1 RT (20-mers))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is very low.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)C(=O)O
DRAMP30085	SPAIFQSSMTKILEPFRKQN	20	4285(derived from DNA-polymerase domain of HIV-1 RT (20-mers))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.	[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=35 µM);inhibition of strand transfer catalyzed by integrase(IC50=270 µM);inhibition of disintegration catalyzed by integrase(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)[C@@H](C)O
DRAMP30086	FRKQNPDIVIYQYMD	15	4286’-1(derived from the DNA-polymerase domain of HIV-1 RT (14-mer) )	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.	[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=119 µM);inhibition of strand transfer catalyzed by integrase(IC50=97 µM);inhibition of disintegration catalyzed by integrase(IC50>270 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)O)[C@H](C)CC
DRAMP30087	KILEPFRKQNPDIVIYQYMD	20	4286(derived from DNA-polymerase domain of HIV-1 RT (20-mers))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.	[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=4.8 µM);inhibition of strand transfer catalyzed by integrase(IC50=4.5 µM);inhibition of disintegration catalyzed by integrase(IC50=9.4 µM);##HIV-1:the level of peptide binding to HIV integrase is high.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)O
DRAMP30088	PDIVIYQYMDDLYVGSDLEI	20	4287(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),34(derived from the HIV-1 HXB2 Pol region of the viral genome)	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.	[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=22 µM);inhibition of strand transfer catalyzed by integrase(IC50=54 µM);inhibition of disintegration catalyzed by integrase(IC50>120 µM);##HIV-1:the level of peptide binding to HIV integrase is high.##[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=6±1 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=10±1 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50=28±2 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=23±2 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=41±2 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=2±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=20 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=5 µM).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559##16879966	J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. 	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP30089	DIQKLVGKLNWASQIYPGIK	20	4295(derived from DNA-polymerase domain of HIV-1 RT (20-mers))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is low.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30090	IAEIQKQGQGQWTYQIYQEP	20	4302(derived from DNA-polymerase domain of HIV-1 RT (20-mers))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)[C@H](C)CC
DRAMP30091	KQLTEAVQKITTEAnti-SIVIWGK	20	4306(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),53(derived from the HIV-1 HXB2 Pol region of the viral genome)	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.##[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=7±1 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=4±1 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50=51±7 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=31±7 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=29±1 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=2±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=15 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=10 µM).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559##16879966	J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. 	
DRAMP30092	TPKFKLPIQKETWETWWTEY	20	4308(derived from DNA-polymerase domain of HIV-1 RT (20-mers))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP30093	ETWETWWTEYWQATWIPEWE	20	4309(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),56(derived from the HIV-1 HXB2 Pol region of the viral genome)	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.	[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=6±1 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=2±1 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50=13±2 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=9±2 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=126±3 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=27±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=25 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=5 µM).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559##16879966	J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30094	GYVTNRGRQKVVTLTDTTNQ	20	4315(derived from the RNase H domain of HIV-1 RT (20-mes))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is very low	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(C)C)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP30095	VVTLTDTTNQKTELQAIYLA	20	4316(derived from the RNase H domain of HIV-1 RT (20-mes))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30096	KTELQAIYLALQDSGLEVNI	20	4317(derived from the RNase H domain of HIV-1 RT (20-mes))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is low	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP30097	LQDSGLEVNIVTDSQYALGI	20	4318(derived from the RNase H domain of HIV-1 RT (20-mes)),65(derived from the HIV-1 HXB2 Pol region of the viral genome)	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.	[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=11±1 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=2±1 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50>167 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=36±14 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=18±3 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=4±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50>167 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=20 µM).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559##16879966	J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@H](C)CC)NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(=O)O
DRAMP30098	VTDSQYALGIIQAQPDQSES	20	4319(derived from the RNase H domain of HIV-1 RT (20-mes))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is low.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP30099	IQAQPDQSESELVNQIIEQL	20	4320(derived from the RNase H domain of HIV-1 RT (20-mes))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.	[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>120 µM);inhibition of strand transfer catalyzed by integrase(IC50>120 µM);inhibition of disintegration catalyzed by integrase(IC50>120 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(C)C
DRAMP30100	ELVNQIIEQLIKKEKVYLAW	20	4321(derived from the RNase H domain of HIV-1 RT (20-mes)),64(derived from the HIV-1 HXB2 Pol region of the viral genome)	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.	[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=6.9 µM);inhibition of strand transfer catalyzed by integrase(IC50=5 µM);inhibition of disintegration catalyzed by integrase(IC50>100 µM);##HIV-1:the level of peptide binding to HIV integrase is high.##[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=15±2 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=14±4 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50=113±11 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=83±5 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=136±5 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=7±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=45 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=15 µM).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559##16879966	J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. 	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30101	NQIIEQLIKKEKVY	14	4321’-1( derived from the RNase H domain of HIV-1 RT (15-mer))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.	[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>240 µM);inhibition of strand transfer catalyzed by integrase(IC50>240 µM);inhibition of disintegration catalyzed by integrase(IC50>120 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(N)=O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30102	IKKEKVYLAWVPAHKGIGN	19	4322(derived from the RNase H domain of HIV-1 RT (20-mes))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.	[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>120 µM);inhibition of strand transfer catalyzed by integrase(IC50>120 µM);inhibition of disintegration catalyzed by integrase(IC50>120 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)C(C)C
DRAMP30103	EQVDKLVSAGIRKVLFLDGI	20	4324(derived from the RNase H domain of HIV-1 RT (20-mes))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(C)C)C(C)C)C(=O)O
DRAMP30104	ESELVSQIIEQLIKK	15	5628(derived from  RNase H domain of HIV-1 RT (15-mers))	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.	[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>120 µM);inhibition of strand transfer catalyzed by integrase(IC50=60 µM);inhibition of disintegration catalyzed by integrase(IC50>120 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CC[C@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30105	LQQLLFIHFRIGCQH	15	Vpr 15	No entry found	Retroviridae	Not found	Synthetic construct(HIV-1 gene product)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3′-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication.	[Ref.20586421]HIV-1:inhibition of strand transfer catalyzed by integrase(IC50=5.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H. 	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP30106	TNWLWYIKIFIMIV	14	Env4-4	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3′-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication.	[Ref.20586421]HIV-1:inhibition of strand transfer catalyzed by integrase(IC50=1.9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H. 	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30107	LQQLLF	6	Vpr-1	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 gene products(Vpr))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3′-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication.	[Ref.20586421]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50>11 µM);inhibition of strand transfer catalyzed by integrase(IC50=68±1.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H. 	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP30108	LQQLLFRRRRRRRR	14	Vpr-1 R8	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 gene products(Vpr))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3′-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication.	[Ref.20586421]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=6.1±1.1 µM);inhibition of strand transfer catalyzed by integrase(IC50>11 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H. 	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30109	IHFRIGRRRRRRRR	14	Vpr-2 R8	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 gene products(Vpr))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3′-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication.	[Ref.20586421]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=0.70±0.06 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.83±0.07 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H. 	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC
DRAMP30110	LQQLLFIHFRIGRRRRRRRR	20	Vpr-3 R8	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 gene products(Vpr))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3′-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication.	[Ref.20586421]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=0.004±0.0001 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.008±0.001 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H. 	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30111	EAIIRILQQLLFIHFRIGRRRRRRRR	26	Vpr-4 R8	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 gene products(Vpr))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3′-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication.	[Ref.20586421]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=0.005±0.002 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.006±0.006 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H. 	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30112	TYGDTWAGVEAIIRI	15	Vpr 49-63 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit  Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.	[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50>>150 µM);inhibit the activity of DNA-dependent DNA polymerase(IC50>>150 µM);inhibit the activity of Rnase H(IC50>>200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	Gleenberg IO, Herschhorn A, Hizi A.	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30113	TWAGVEAIIRILQQL	15	Vpr 53-67	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.	[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50=0.88 µM);inhibit the activity of DNA-dependent DNA polymerase(IC50=0.88 µM);inhibit the activity of Rnase H(IC50=6.9 µM);##Inhibition of 3′-end processing catalyzed by integrase(IC50>200 µM);inhibition of strand transfer catalyzed by integrase(IC50=144 µM);inhibition of disintegration catalyzed by integrase(IC50=27 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase,Reverse Transcriptase	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	Gleenberg IO, Herschhorn A, Hizi A.	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP30114	VEAIIRILQQLLFIH	15	Vpr 57-71	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.	[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50=0.22 µM);inhibit the activity of DNA-dependent DNA polymerase(IC50=0.22 µM);inhibit the activity of Rnase H(IC50=2 µM);##Inhibition of 3′-end processing catalyzed by integrase(IC50=7.8 µM);inhibition of strand transfer catalyzed by integrase(IC50=16 µM);inhibition of disintegration catalyzed by integrase(IC50=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase,Reverse Transcriptase	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	Gleenberg IO, Herschhorn A, Hizi A.	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30115	IRILQQLLFIHFRIG	15	Vpr 61-75	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.	[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50=0.7 µM);inhibit the activity of DNA-dependent DNA polymerase(IC50=1.3 µM);inhibit the activity of Rnase H(IC50=5.25 µM);##Inhibition of 3′-end processing catalyzed by integrase(IC50=1.3 µM);inhibition of strand transfer catalyzed by integrase(IC50=1 µM);inhibition of disintegration catalyzed by integrase(IC50=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase,Reverse Transcriptase	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	Gleenberg IO, Herschhorn A, Hizi A.	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30116	QQLLFIHFRIGCQHS	15	Vpr 65-79 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.	[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50=33 µM);inhibit the activity of DNA-dependent DNA polymerase(IC50=43 µM);inhibit the activity of Rnase H(IC50=16.5 µM);##Inhibition of 3′-end processing catalyzed by integrase(IC50=76 µM);inhibition of strand transfer catalyzed by integrase(IC50=14 µM);inhibition of disintegration catalyzed by integrase(IC50=10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase,Reverse Transcriptase	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	Gleenberg IO, Herschhorn A, Hizi A.	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)O
DRAMP30117	FIHFRIGCQHSRIGI	15	Vpr 69-83	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.	[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50>>200 µM);inhibit the activity of DNA-dependent DNA polymerase(IC50>>200 µM);inhibit the activity of Rnase H(IC50>>200 µM);##Inhibition of 3′-end processing catalyzed by integrase(IC50>>200 µM);inhibition of strand transfer catalyzed by integrase(IC50>>200 µM);inhibition of disintegration catalyzed by integrase(IC50>>200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase,Reverse Transcriptase	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	Gleenberg IO, Herschhorn A, Hizi A.	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30118	HFPRIWLHSLGQHIY	15	Vpr 33-47 	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and thus inhibit the replication of HIV-1.	[Ref.17490682]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=187 µM);inhibition of strand transfer catalyzed by integrase(IC50=41 µM);inhibition of disintegration catalyzed by integrase(IC50=73 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	Gleenberg IO, Herschhorn A, Hizi A.	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30119	QLLIRMIYKNILFYLVPGPGHGAEPERRNIKYL	33	I33	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide bound tightly to the integrase(IN) and inhibited both in vitro IN activities, containing 3′ end processing and strand transfer.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30120	RMIYKNILFYLVPGPGHGAEPERRNIKYL	29	I29	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=85 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30121	QLLIRMI	7	LCD278B	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50>200 µM);no inhibition of HIV-1 infection up to 100 μM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(=O)O
DRAMP30122	AEPERRNIKYL	11	EBR24	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30123	LFYLVPGPGH	10	EBR26	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50>200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP30124	YQLLIRMIYKNI	12	EBR28	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=5 µM);inhibition of HIV-1 infection in HeLa CD4-β-Gal cells(IC50=40 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30125	YALLIRMIYKNI	12	EBR28[Q2A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=8 µM);inhibition of HIV-1 infection in HeLa CD4-β-Gal cells(IC50~100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30126	YQALIRMIYKNI	12	EBR28[L3A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=165 µM);no inhibition of HIV-1 infection up to 100 μM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30127	YQLAIRMIYKNI	12	EBR28[L4A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=14 µM);no inhibition of HIV-1 infection up to 100 μM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30128	YQLLARMIYKNI	12	EBR28[I5A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=45 µM);no inhibition of HIV-1 infection up to 100 μM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)C(=O)O
DRAMP30129	YQLLIAMIYKNI	12	EBR28[R6A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=34 µM);no inhibition of HIV-1 infection up to 100 μM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30130	YQLLIRAIYKNI	12	EBR28[M7A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=70 µM);inhibition of HIV-1 infection in HeLa CD4-β-Gal cells(IC50~100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30131	YQLLIRMAYKNI	12	EBR28[I8A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=35 µM);no inhibition of HIV-1 infection up to 100 μM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)C(=O)O
DRAMP30132	YQLLIRMIAKNI	12	EBR28[Y9A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=40 µM);inhibition of HIV-1 infection in HeLa CD4-β-Gal cells(IC50~100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30133	YQLLIRMIYANI	12	EBR28[K10A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=11 µM);no inhibition of HIV-1 infection up to 100 μM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30134	YQLLIRMIYKAI	12	EBR28[N11A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=7 µM);inhibition of HIV-1 infection in HeLa CD4-β-Gal cells(IC50~100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30135	YQLLIRMIYKNA	12	EBR28[I12A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=11 µM);inhibition of HIV-1 infection in HeLa CD4-β-Gal cells(IC50~100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC
DRAMP30136	YQLLIRMIY	9	LCE41	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=5 µM);inhibition of HIV-1 infection in HeLa CD4-β-Gal cells(IC50=55 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30137	YQLLIRMI	8	LCE40	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=120 µM);no inhibition of HIV-1 infection up to 100 μM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)C(=O)O
DRAMP30138	QLLIRMIYKNI	11	LCD278C	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50=21 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30139	YQLLIRPIYKNI	12	ProEBR28	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50>200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30140	LSELDDRADALQAGASQFETSAAKLKRKYWWKN	33	C35	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	[Ref.12054767]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50>200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 μM.	Integrase	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B. 	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP30141	TGEKVWDRGNVTLLCDCP	18	P11(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=439.7 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=162.1 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=484.5 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=208.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O
DRAMP30142	LPAFCQAIGWGDPITHWS	18	P19(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=369.5 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=46.0 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=194.3 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=71.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)O
DRAMP30143	FCQAIGWGDPITHWSHGQ	18	P20(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=347.6 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=70.1 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=125.5 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=111.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)NCC(=O)O
DRAMP30144	AIGWGDPITHWSHGQNRW	18	P21(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=832.9 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=44.9 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=529.1 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=371.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)N)[C@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30145	PITHWSHGQNRWPLSCPQ	18	P23(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=508.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O
DRAMP30146	HGQNRWPLSCPQYVYGSV	18	P25(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=304.4 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP30147	SWFASTGGRDSKIDVWSL	18	P34(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=237.4 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=411.2 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=118.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30148	SDRDTVVELSEWGVPCAT	18	P45(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=141.2 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=48.8 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=505.5 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=43.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C)C(=O)O
DRAMP30149	DTVVELSEWGVPCATCIL	18	P46(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=428.8 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=39.9 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=462.8 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=24.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)O)C(=O)O
DRAMP30150	VELSEWGVPCATCILDRR	18	P47(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=330.8 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=58.6 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=140.3 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=20.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30151	RFPFHRCGAGPKLTKDLE	18	P59(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=529.6 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)O
DRAMP30152	LVRRRSELMGRRNPVCPG	18	P97(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=537.6 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CSCC[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C
DRAMP30153	LQEVDAGNFIPPPRWLLL	18	P109(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=687.1 μM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=37.5 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=294.8 μM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=60.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30154	WVNQLAVLGLPAVDAAVA	18	P124(derived from E2 envelope protein of GB virus C)	No entry found	Retroviridae	Not found	Synthetic construct(derived from E2 envelope protein of GB virus C)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner.	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=332.7 μM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=94.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63. 	Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. 	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP30155	SAnti-VSVGMKPSPRP	12	VMI5	No entry found	Retroviridae	Not found	Synthetic construct(phage display)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:binding with vif proteins.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	
DRAMP30156	SNQGGSPLPRSV	12	VMI7	No entry found	Retroviridae	Not found	Synthetic construct(phage display)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibition of Vif-Vif bingding(IC50=7.43 μM);##The peptide is able to effectively inhibit HIV-1 replication At the concentration of 50 μM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12480936]No significant cytotoxicity on H9 cells up to 50 μM.	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30157	LPLPAPSFHRTT	12	VMI9	No entry found	Retroviridae	Not found	Synthetic construct(phage display)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibition of Vif-Vif bingding(IC50=4.84 μM);####The peptide is able to effectively inhibit HIV-1 replication At the concentration of 50 μM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12480936]No significant cytotoxicity on H9 cells up to 50 μM.	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP30158	SPYPSWSTPAGR	12	VMI16	No entry found	Retroviridae	Not found	Synthetic construct(phage display)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:binding with vif proteins.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30159	KPKQIKPPLPSV	12	vif 155-166	No entry found	Retroviridae	Not found	Synthetic construct(derived from the proline-enriched C terminus of Vif)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibition of Vif-Vif bingding(IC50=17.39 μM);####The peptide is able to effectively inhibit HIV-1 replication At the concentration of 50 μM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12480936]No significant cytotoxicity on H9 cells up to 50 μM.	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30160	WQVMIVWQVDRMRIR	15	vif 5-19	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)O
DRAMP30161	RHHYESTHPRISSEV	15	vif 41-55	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30162	ESTHPRISSEVHIPL	15	vif 45-59	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30163	HTGERDWHLGQGVSI	15	vif 73-87	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)O
DRAMP30164	RDWHLGQGVSIEWRK	15	vif 77-91	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30165	LGQGVSIEWRKKRYS	15	vif 81-95	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O
DRAMP30166	RYSTQVDPDLADQLI	15	vif 93-107	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O
DRAMP30167	QVDPDLADQLIHLYY	15	vif 97-111	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30168	DLADQLIHLYYFDCF	15	vif 101-115	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30169	QLIHLYYFDCFSESA	15	vif 105-119	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
DRAMP30170	LYYFDCFSESAIRKA	15	vif 109-123	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30171	ESAIRKAILGHIVSP	15	vif 117-131	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)O
DRAMP30172	RKAILGHIVSPRCEY	15	vif 121-135	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)[C@H](C)CC
DRAMP30173	VSPRCEYQAGHNKVG	15	vif 129-143	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
DRAMP30174	CEYQAGHNKVGSLQY	15	vif 133-147	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30175	AGHNKVGSLQYLALA	15	vif 137-151	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP30176	KVGSLQYLALAALIT	15	vif 141-155	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP30177	LQYLALAALITPKKI	15	vif 145-159	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)O
DRAMP30178	ALAALITPKKIKPPL	15	vif 149-163	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30179	LITPKKIKPPLPSVT	15	vif 153-167	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C
DRAMP30180	KKIKPPLPSVTKLTE	15	vif 157-171	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
DRAMP30181	PPLPSVTKLTEDRWN	15	vif 161-175	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
DRAMP30182	SVTKLTEDRWNKPQK	15	vif 165-179	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O
DRAMP30183	LTEDRWNKPQKTKGH	15	vif 169-183	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
DRAMP30184	RWNKPQKTKGHRGSH	15	vif 173-187	No entry found	Retroviridae	Not found	Synthetic construct(derived from HIV-1 Vif protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP30185	PTGERVWDRGNVTLLCDCPN	20	P4	No entry found	Retroviridae	Not found	Synthetic construct(derived from region of GB virus C glycoprotein E2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=15.07 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=18.28 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21543477	J Virol. 2011 Jul;85(14):7037-47.	Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. 	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O
DRAMP30186	WDRGNVTLLCDCPNGPWVWV	20	P4-7	No entry found	Retroviridae	Not found	Synthetic construct(derived from region of GB virus C glycoprotein E2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=2.59 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=2.66 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21543477	J Virol. 2011 Jul;85(14):7037-47.	Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. 	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O
DRAMP30187	WDRGNVTLLCDCPNGPWVWV	20	P4-7	No entry found	Retroviridae	Not found	Synthetic construct(derived from region of GB virus C glycoprotein E2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	[Ref.21543477]HIV-1(NL4-3):inhibition of HIV replication(IC50=3.0 μM);##HIV-1(YU-2):inhibition of HIV replication(IC50=5.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21543477	J Virol. 2011 Jul;85(14):7037-47.	Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. 	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C
DRAMP30188	GPWVWVPAFCQAVGWGDPIT	20	P6	No entry found	Retroviridae	Not found	Synthetic construct(derived from region of GB virus C glycoprotein E2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=16.80 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=3.57 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21543477	J Virol. 2011 Jul;85(14):7037-47.	Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. 	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CN)C(C)C)C(C)C)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)O
DRAMP30189	TLLCDCPNGPWVWVPAFCQA	20	P6-1	No entry found	Retroviridae	Not found	Synthetic construct(derived from region of GB virus C glycoprotein E2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=2.36 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=1.29 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21543477	J Virol. 2011 Jul;85(14):7037-47.	Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. 	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
DRAMP30190	LCDCPNGPWVWVPAFCQAVG	20	P6-2	No entry found	Retroviridae	Not found	Synthetic construct(derived from region of GB virus C glycoprotein E2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=3.33 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=1.32 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21543477	J Virol. 2011 Jul;85(14):7037-47.	Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. 	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(C)C)C(C)C
DRAMP30191	LCDCPNGPWVWVPAFCQAVG	20	P6-2	No entry found	Retroviridae	Not found	Synthetic construct(derived from region of GB virus C glycoprotein E2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	[Ref.21543477]HIV-1(NL4-3):inhibition of HIV replication(IC50=2.3 μM);##HIV-1(YU-2):inhibition of HIV replication(IC50=2.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21543477	J Virol. 2011 Jul;85(14):7037-47.	Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. 	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)C(C)C)C(C)C
DRAMP30192	DCPNGPWVWVPAFCQAVGWG	20	P6-3	No entry found	Retroviridae	Not found	Synthetic construct(derived from region of GB virus C glycoprotein E2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=4.00 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=2.00 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21543477	J Virol. 2011 Jul;85(14):7037-47.	Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. 	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30193	PNGPWVWVPAFCQAVGWGDP	20	P6-4	No entry found	Retroviridae	Not found	Synthetic construct(derived from region of GB virus C glycoprotein E2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=11.88 μM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=8.04 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21543477	J Virol. 2011 Jul;85(14):7037-47.	Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. 	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)O
DRAMP30194	RGTKALTEVIPLTEEAEC	18	PepA	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =35 ± 5 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30195	GTKALTEVIPLTEEAEC	17	P1	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =7.5±2.3 μM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=78.2 nM,associated with Pep-1).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30196	ATKALTEVIPLTEEAEC	17	P2	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =28 ±11 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30197	GAKALTEVIPLTEEAEC	17	P3	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =10.3 ± 2.1 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30198	GTAALTEVIPLTEEAEC	17	P4	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =15 ± 2.9 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30199	GTKGLTEVIPLTEEAEC	17	P5	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =20 ± 3.7 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30200	GTKAATEVIPLTEEAEC	17	P6	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =5.7 ± 2.3 μM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=170 nM,associated with Pep-1).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30201	GTKALAEVIPLTEEAEC	17	P7	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =13.5 ± 2.1 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30202	GTKALTAVIPLTEEAEC	17	P8	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =57 ± 19 μM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=290 nM,associated with Pep-1).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O
DRAMP30203	GTKALTEAIPLTEEAEC	17	P9	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =15 ±7.3 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30204	GTKALTEVAPLTEEAEC	17	P10	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =7.3 ± 2.9 μM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=140 nM,associated with Pep-1).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30205	GTKALTEVIALTEEAEC	17	P11	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =7 ± 1.4 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30206	GTKALTEVIPATEEAEC	17	P12	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =22 ± 3 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30207	GTKALTEVIPLAEEAEC	17	P13	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =10.2 ± 2.5 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30208	GTKALTEVIPLTAEAEC	17	P14	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =14 ± 3 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP30209	GTKALTEVIPLTEAAEC	17	P15	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =14 ± 2.2 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30210	GTKWLTEVWPLC	12	P16	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =14 ± 4 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(=O)O
DRAMP30211	GTKAWTEVWPLC	12	P17	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =35 ± 11 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(=O)O
DRAMP30212	GTKALTEVIPLTC	13	P18	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50>1000 nM,associated with Pep-1);inhibition of polymerase activity of HIV-1 RT(Ki =53± 12 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30213	GTKAATEVIPLTC	13	P19	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =49 ± 9 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30214	GTKWLTEWIPLC	12	P24	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=2.3 nM,associated with Pep-1); inhibition of polymerase activity of HIV-1 RT(Ki =0.7 ± 0.05 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30215	KWLTEWIPLTAEAEC	15	P26	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50>1000 nM,associated with Pep-1); inhibition of polymerase activity of HIV-1 RT(Ki =1.8± 0.7 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP30216	GTKWLTEWIPLTAEC	15	P27	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50<0.32 nM,associated with Pep-1); inhibition of polymerase activity of HIV-1 RT(Ki =0.05 ± 0.01 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30217	GTKWATEWAPLTAEAEC	17	P28	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =2 ± 0.6 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP30218	KWLTEWIPLTAEC	13	P29	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =1 ± 0.4 μM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30219	GTKWLTEWIPLTAEAEC	17	PAW	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =0.7 ± 0.2 μM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=1.8 nM,associated with Pep-1).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP30220	GAKTETLVIPETELEAC	17	Pscr	No entry found	Retroviridae	Not found	Synthetic construct(derived from Pep-A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase.	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =61 ± 12 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G.	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O
DRAMP30221	LEAIPMSIPPEVKFNKPFVF	20	VIRIP	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=14.79±2.56 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30222	AEAIPMSIPPEVKFNKPFVF	20	VIRIP[A1]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30223	LAAIPMSIPPEVKFNKPFVF	20	VIRIP[A2]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@H](C)CC
DRAMP30224	LEAAPMSIPPEVKFNKPFVF	20	VIRIP[A4]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30225	LEAIAMSIPPEVKFNKPFVF	20	VIRIP[A5]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=23.50±5.19 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30226	LEAIPASIPPEVKFNKPFVF	20	VIRIP[A6]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=13.00±1.04 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30227	LEAIPMSAPPEVKFNKPFVF	20	VIRIP[A8]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=23.46±0.28 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30228	LEAIPMSIAPEVKFNKPFVF	20	VIRIP[A9]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=16.33±4.34 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30229	LEAIPMSIPAEVKFNKPFVF	20	VIRIP[A10]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=9.72±1.66 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30230	LEAIPMSIPPAVKFNKPFVF	20	VIRIP[A11]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=11.00±4.75 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@H](C)CC
DRAMP30231	LEAIPMSIPPEAKFNKPFVF	20	VIRIP[A12]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=10.64±2.23 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC
DRAMP30232	LEAIPMSIPPEVAFNKPFVF	20	VIRIP[A13]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=4.73±0.61 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30233	LEAIPMSIPPEVKANKPFVF	20	VIRIP[A14]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=4.62±1.32 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30234	LEAIPMSIPPEVKFAKPFVF	20	VIRIP[A15]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=17.41±3.66 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30235	LEAIPMSIPPEVKFNAPFVF	20	VIRIP[A16]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=10.81±0.68 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30236	LEAIPMSIPPEVKFNKAFVF	20	VIRIP[A17]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=12.72±10.17 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30237	LEAIPMSIPPEVKFNKPAVF	20	VIRIP[A18]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30238	LEAIPMSIPPEVKFNKPFAF	20	VIRIP[A19]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30239	LEAIPMSIPPEVKFNKPFVA	20	VIRIP[A20]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30240	LEAIPMSIPPEVKFNKPFVF	20	N-Ac-VIRIP	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)[C@H](C)CC
DRAMP30241	LEAIPMSIPPEVKFNKPFVF	20	VIRIP-amide	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)[C@H](C)CC
DRAMP30242	LEAIPMSIPPEVKFNKPFVF	20	N-Ac-VIRIP-amide	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)[C@H](C)CC
DRAMP30243	LEAIPMSIPPEVAFAKPFVF	20	VIRIP[A13,A15]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=3.45±0.44 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30244	LEAIPMSIPPEVFFNKPFVF	20	VIRIP[F13]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.66±0.06 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC
DRAMP30245	LEAIPMCIPPECAFNKPFVF	20	VIRIP[A13,C7,C12]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=1.00±0.21 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys7 and Cys12	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC1=O
DRAMP30246	LEAIPCSIPPCVAFNKPFVF	20	VIRIP[A13,C6,C11]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.18±0.08 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC1=O
DRAMP30247	LEAIPCSIPpCVAFNKPFVF	20	VIRIP[A13,C6,C11,p10]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.94±0.54 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	Mixed(D-Pro10)	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)C(C)C)NC(=O)[C@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC1=O
DRAMP30248	LEAIPCSIPPCVGFGKPFVF	20	VIRIP[C6,C11,G13,G15]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.73±0.13 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC1=O
DRAMP30249	LEAIPCSIPPCVLFNKPFVF	20	VIRIP[C6,C11,L13]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.84±0.08 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC1=O
DRAMP30250	LEAIPCSIPPCVFFNKPFVF	20	VIRIP[C6,C11,F13]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.93±0.05 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC1=O
DRAMP30251	LEAIPCSIPPCFAFNKPFVF	20	VIRIP[A13,C6,C11,F12]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.27±0.04 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC1=O
DRAMP30252	LEAIPMSIPPEFLFGKPFVF	20	VIRIP[F12,L13,G15]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=1.34±0.42 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC
DRAMP30253	LEAIPCSIPPCVFFGKPFVF	20	VIRIP[C6,C11,F13,G15]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.28±0.02 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC1=O
DRAMP30254	LEAIPCSIPPCFLFGKPFVF	20	VIRIP[C6,C11,F12,L13,G15]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.39±0.13 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC1=O
DRAMP30255	LEAIPCSIPpCVFFNKPFVF	20	VIRIP[C6,C11,p10,F13]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.33±0.07 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	Mixed(D-Pro10)	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)C(C)C)NC(=O)[C@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC1=O
DRAMP30256	LEAIPCSIPpCFLFNKPFVF	20	VIRIP[C6,C11,p10,F12,L13]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.20±0.04 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	Mixed(D-Pro10)	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)C(C)C)NC(=O)[C@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CO)NC1=O
DRAMP30257	LEAIPMGIPpEVXFNKPFVF	20	VIRIP[G7,p10,L-Tic13]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.28±0.08 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 13 is L-tetrahydro-isoquinoline-3-carboxylic acid(Tic).	Mixed(D-Pro10)	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	
DRAMP30258	LEKIPMSIPpEVXFNKPFVF	20	VIRIP[K3,p10,L-Tic13]	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.41±0.13 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 13 is L-tetrahydro-isoquinoline-3-carboxylic acid(Tic).	Mixed(D-Pro10)	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	
DRAMP30259	KVINPEPIVEPFMSKPFALF	20	scrambled VIRIP	No entry found	Retroviridae	Not found	Synthetic construct(derived from α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 µM.	membrane	17448989	Cell. 2007 Apr 20;129(2):263-75.	Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30260	YTSLIHSLIEEGQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138G]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=1.3± 0.5 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=65± 8.8 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=141±26 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=185±68 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30261	YTSLIHSLIEEAQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138A]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=0.6 ± 0.1 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=3.6± 1.7 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=3.5 ±0.9 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=3.2 ± 1.0 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30262	YTSLIHSLIEEVQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138V]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=0.4 ± 0.2 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=31 ± 14 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=22 ± 3.5 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=23 ± 5.7 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30263	YTSLIHSLIEELQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138L]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=0.7± 0.1 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=13± 6 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=2.9 ±0.7 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=2.2± 0.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30264	YTSLIHSLIEEIQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138I]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=0.5 ± 0.1 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=4.9± 2 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=2.9 ±0.8 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=2.4 ± 0.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP30265	YTSLIHSLIEEMQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138M]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=0.7± 0.2 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=4.4± 0.1 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=1.7±0.5 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=1.2± 0.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30266	YTSLIHSLIEEPQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138P]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=446± 167 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30267	YTSLIHSLIEETQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138T]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=0.9± 0.2 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=39± 8.5 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=161±35 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=124±43nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30268	YTSLIHSLIEEFQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138F]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=9.4± 2.6 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=203± 89 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=393 ± 119 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=478 ± 116 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30269	YTSLIHSLIEEYQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138Y]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=25 ±9nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=516 ±223 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30270	YTSLIHSLIEEWQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138W]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=29± 14 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30271	YTSLIHSLIEENQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138N]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=19± 4 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30272	YTSLIHSLIEEQQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138Q]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=34± 11 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30273	YTSLIHSLIEEDQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138D]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=210± 94 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30274	YTSLIHSLIEEEQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138E]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=283± 80 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30275	YTSLIHSLIEEHQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138H]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=210± 85 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30276	YTSLIHSLIEEKQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138K]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=708±145 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30277	YTSLIHSLIEERQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138R]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Enfuvirtide)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=362± 114 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30278	WMEWDREINNYTSLIHSLIEEAQNQQEKNEQELL	34	C34S[138A]	No entry found	Retroviridae	Not found	Synthetic construct(derived from C34)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1 NL4-3:inhibition of virus replication in HeLa cells(EC50=2.0± 0.4 nM);##HIV-1(NL4-3V38A):inhibition of virus replication in HeLa cells(EC50=1.7± 0.3 nM);##HIV-1(NL4-3N43D):inhibition of virus replication in HeLa cells(EC50=2.0 ±0.6 nM);##HIV-1(NL4-3N43D/S138A):inhibition of virus replication in HeLa cells(EC50=1.3 ±0.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP30279	WMEWDREINNYTSLIHSLIEELQNQQEKNEQELL	34	C34S[138L]	No entry found	Retroviridae	Not found	Synthetic construct(derived from C34)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1 NL4-3:inhibition of virus replication in HeLa cells(EC50=1.5± 0.4 nM);##HIV-1(NL4-3V38A):inhibition of virus replication in HeLa cells(EC50=1.2± 0.6 nM);##HIV-1(NL4-3N43D):inhibition of virus replication in HeLa cells(EC50=0.5 ±0.2 nM);##HIV-1(NL4-3N43D/S138A):inhibition of virus replication in HeLa cells(EC50=0.4±0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP30280	WMEWDREINNYTSLIHSLIEETQNQQEKNEQELL	34	C34S[138T]	No entry found	Retroviridae	Not found	Synthetic construct(derived from C34)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1 NL4-3:inhibition of virus replication in HeLa cells(EC50=2.6± 0.2 nM);##HIV-1(NL4-3V38A):inhibition of virus replication in HeLa cells(EC50=4.8± 1.3 nM);##HIV-1(NL4-3N43D):inhibition of virus replication in HeLa cells(EC50=32 ± 5.5 nM);##HIV-1(NL4-3N43D/S138A):inhibition of virus replication in HeLa cells(EC50=24 ±6.6nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP30281	WMEWDREINNYTSLIHSLIEEWQNQQEKNEQELL	34	C34S[138W]	No entry found	Retroviridae	Not found	Synthetic construct(derived from C34)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1 NL4-3:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1(NL4-3V38A):inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1(NL4-3N43D):inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1(NL4-3N43D/S138A):inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP30282	WMEWDREINNYTSLIHSLIEEPQNQQEKNEQELL	34	C34S[138P]	No entry found	Retroviridae	Not found	Synthetic construct(derived from C34)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion.	[Ref.19073606]HIV-1 NL4-3:inhibition of virus replication in HeLa cells(EC50=46±11 nM);##HIV-1(NL4-3V38A):inhibition of virus replication in HeLa cells(EC50=436± 125 nM);##HIV-1(NL4-3N43D):inhibition of virus replication in HeLa cells(EC50=250 ± 80 nM);##HIV-1(NL4-3N43D/S138A):inhibition of virus replication in HeLa cells(EC50=176±50 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP30283	TTWEEWDREINEYTSRIESLIRESQEQQEKNEQELREL	38	2429	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.012 μg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.021μg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.056 μg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.037 μg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.167 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7. 	Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK.	Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(C)=O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30284	MTWMAWDRAIANYAALIHALIEAAQNQQEKNEAALLEL	38	2638	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.061 μg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.079μg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.079 μg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.120 μg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.250 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7. 	Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK.	Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP30285	AEAMSQVTN	9	p2(gag) peptide[Δ10-14]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=5 μM).		Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	15113844	J Biochem. 2004 Mar;135(3):447-53. 	Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S.	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide. 	CSCC[C@H](NC(=O)CC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP30286	AAAMSQVTN	9	p2(gag) peptide[Δ10-14,E2A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=100 μM).		Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	15113844	J Biochem. 2004 Mar;135(3):447-53. 	Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S.	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide. 	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C
DRAMP30287	AEAMAQVTN	9	p2(gag) peptide[Δ10-14,S5A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=124 μM).		Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	15113844	J Biochem. 2004 Mar;135(3):447-53. 	Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S.	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide. 	CSCC[C@H](NC(=O)CC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP30288	AEAMSQVTNTATIM	14	p2(gag) peptide	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=10 μM).		Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	15113844	J Biochem. 2004 Mar;135(3):447-53. 	Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S.	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)NC(=O)[C@H](C)N)C(C)C)C(=O)O
DRAMP30289	AEAASQVTNTATIM	14	p2(gag) peptide[M4A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=142 μM).		Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	15113844	J Biochem. 2004 Mar;135(3):447-53. 	Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S.	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)NC(=O)[C@H](C)N)C(C)C)C(=O)O
DRAMP30290	AEASQVTNTATIM	13	p2(gag) peptide[ΔM4]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=126 μM).		Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	15113844	J Biochem. 2004 Mar;135(3):447-53. 	Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S.	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)O
DRAMP30291	AEAMSQVANTATIM	14	p2(gag) peptide[T8A]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=110 μM).		Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	15113844	J Biochem. 2004 Mar;135(3):447-53. 	Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S.	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)[C@@H](C)O)NC(=O)[C@H](C)N)C(C)C)C(=O)O
DRAMP30292	KIPCGESCVWIPCVTSIFNCKCENKVCYHD	30	Circulin-D (CIRD; Plant defensin)	P84642	Retroviridae	Not found	Chassalia parviflora 	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=50-275 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	18008336	Biopolymers. 2008;90(1):51-60.	Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.	Cyclotides as natural anti-HIV agents.	
DRAMP30293	AIPCGESCVWIPCISAAIGCSCKNKVCYR	29	Circulin-F (CIRF; Plant defensin)	P84644	Retroviridae	Not found	Chassalia parviflora	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=50-275 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	18008336	Biopolymers. 2008;90(1):51-60.	Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.	Cyclotides as natural anti-HIV agents.	
DRAMP30294	CGESCAXISFCFTEVIGCSCKNKVCYLNSIS	31	Leaf cyclotide, Vhl-1	P84522	Retroviridae	Not found	Viola hederacea	Antimicrobial, Antiviral	Not found	Not found	Not found	1ZA8	Comment: No comments found on DRAMP database	[Ref.15824119]HIV-1:inhibition of cytopathic effect(EC50=0.87 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 7 indicates Methionine sulfoxide. The N-terminal and C-terminal cyclized by a amide bond. Disulfide bonds between Cys1 and Cys18, Cys5 and Cys20, Cys11 and Cys25.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	15824119	J Biol Chem. 2005 Jun 10;280(23):22395-405.	Chen B, Colgrave ML, Daly NL, Rosengren KJ, Gustafson KR, Craik DJ. 	Isolation and characterization of novel cyclotides from Viola hederaceae: solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide.	
DRAMP30295	VFQFLGRIIAnti-HHVGNFVHGFSHVF	23	Clavanin-B (His-rich; chordates, animals)	P80711	Retroviridae	Not found	Styela clava (Sea squirt)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=7.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.20086159]CEM-SS cells:50% Cell death at 37.1 µM.	Not found	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	
DRAMP30296	GLWEKIDKFASII	13	B2(derived from Caerin 3.2)	No entry found	Retroviridae	Not found	Synthetic construct(derived from Caerin 3.2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>65.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >65.8 µM.	Not found	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP30297	GIIDIAKKLFESW	13	B3(derived from Uperin 2.7)	No entry found	Retroviridae	Not found	Synthetic construct(derived from Uperin 2.7)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=20.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >65.8 µM.	Not found	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP30298	GWFDIIKKIASEL	13	B4(derived from Uperin 7.1)	No entry found	Retroviridae	Not found	Synthetic construct(derived from Uperin 7.1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=10.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.20086159]CEM-SS cells:50% Cell death at 38.9 µM.	Not found	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30299	GIFDKLAKEISIW	13	B5(derived from Brevinin-2DYd)	No entry found	Retroviridae	Not found	Synthetic construct(derived from Brevinin-2DYd)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>65.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >65.8 µM.	Not found	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP30300	GIWSDLAEIIKKF	13	B6(derived from Ponericin W3)	No entry found	Retroviridae	Not found	Synthetic construct(derived from Ponericin W3)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=11.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >65.8 µM.	Not found	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP30301	GFLDIIEKIAKSW	13	B7(derived from Ranatuerin 3)	No entry found	Retroviridae	Not found	Synthetic construct(derived from Ranatuerin 3)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=10.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >65.8 µM.	Not found	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP30302	GWLKKIESIIDAF	13	B8(derived from Cecropin)	No entry found	Retroviridae	Not found	Synthetic construct(derived from Cecropin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=29.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >65.8 µM.	Not found	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP30303	ILGPVLGLVSRTLRRVLGIL	20	Maximin H5r3	No entry found	Retroviridae	Not found	Synthetic construct(derived from Maximin H5)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=2.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.20086159]CEM-SS cells:50% Cell death at 8.7 µM.	Not found	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP30304	GFNEIVQDIEDFLQNLV	17	GF-17−	No entry found	Retroviridae	Not found	Synthetic construct(derived from LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>25.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >25.1 µM.	Not found	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@H](C)CC)C(=O)O
DRAMP30305	GLRSRIWLWVLLMIWQESNRFKRM	24	DRS S9r3	No entry found	Retroviridae	Not found	Synthetic construct(derived from Dermaseptin S9)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=1.25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >32.1 µM.	Not found	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)O
DRAMP30306	GLRRLLGRLLRRLGRLLLR	19	GLR-19	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=4.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.20086159]CEM-SS cells:50% Cell death at 25.7 µM.	Not found	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30307	GLLSVLGSVAKHVLPHVVPVIAAAL	25	Caerin 1.1 mod 7(Caerin 1.1 [E23A,H24A])	No entry found	Retroviridae	Not found	Sythetic construct(derived from Caerin 1.1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: [Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	virion envelope	26026377##33008028	Peptides. 2015 Sep;71:296-303. ##Antibiotics (Basel). 2020 Sep 30;9(10):661.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Caerin 1 Antimicrobial Peptides That Inhibit HIV and Neisseria May Spare Protective Lactobacilli.	VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30308	GLLSVLGSVAKHVLPHVVPVIAKLH	25	Caerin 1.1 mod 9(Caerin 1.1 [E23K,H24L,L25H])	No entry found	Retroviridae	Not found	Sythetic construct(derived from Caerin 1.1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: [Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	"[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 17	µM."	virion envelope	26026377	Peptides. 2015 Sep;71:296-303. 	Inhibition of HIV infection by caerin 1 antimicrobial peptides.	VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O
DRAMP30309	GLLKVLGSVAKKVLPKVVPVIAEKL	25	Caerin 1.1 mod 10(Caerin 1.1 [S4K;H12K,H16K,H24K])	No entry found	Retroviridae	Not found	Sythetic construct(derived from Caerin 1.1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: [Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	virion envelope	26026377	Peptides. 2015 Sep;71:296-303. 	Inhibition of HIV infection by caerin 1 antimicrobial peptides.	VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30310	GLFGVLGSIAKHLLPHVVPVIAEKL	25	Caerin 1.9 sm(Caerin 1.9 [V13L])	No entry found	Retroviridae	Not found	Sythetic construct(derived from Caerin 1.9)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: [Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 17.5 µM.	virion envelope	26026377##33008028	Peptides. 2015 Sep;71:296-303. ##Antibiotics (Basel). 2020 Sep 30;9(10):661.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Caerin 1 Antimicrobial Peptides That Inhibit HIV and Neisseria May Spare Protective Lactobacilli.	VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)C(C)C)C(C)C)C(C)C
DRAMP30311	GLFGILGSVAKHVLPHVIPVVAEHL	25	Caerin 1.20	No entry found	Retroviridae	Not found	Litoria caerulea/Litoria splendida	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: [Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	"[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 25	µM;Human endocervical cells End1/E6E7:50% cell death at 22 µM."	virion envelope	26026377##33008028	Peptides. 2015 Sep;71:296-303.##Antibiotics (Basel). 2020 Sep 30;9(10):661.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Caerin 1 Antimicrobial Peptides That Inhibit HIV and Neisseria May Spare Protective Lactobacilli.	VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(C)C
DRAMP30312	GLMDTVKNVAKNLAGHMLDKLKCKITGC	28	Ranatuerin-2P (Ranatuerin 2P; Frogs, amphibians, animals)	Q8QFQ4##P82847	Iridoviridae, Herpesviridae	Not found	Rana pipiens (Northern leopard frog)	Antimicrobial, Antiviral	Not found	Not found	Not found	2K10	Comment: No comments found on DRAMP database	[Ref.11601906]Frog Virus 3(FV3):  inhibition of FV3 infection in fathead minnow(FHM) cells(90% inhibition at 500 µM);##Channel Catfish virus(CCV):  inhibition of CCV infection in catfish ovary(CCO) cells(99% inhibition at 50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	There is a disulfide bond between Cys22 and Cys27.	L	No cytotoxicity information found in the reference(s) presented	Not found	11601906	Virology. 2001 Sep 30;288(2):351-7.	Chinchar VG, Wang J, Murti G, Carey C, Rollins-Smith L.	Inactivation of frog virus 3 and channel catfish virus by esculentin-2P and ranatuerin-2P, two antimicrobial peptides isolated from frog skin.	
DRAMP30313	GFLSIFRGVAKFASKGLGKDLARLGVNLVACKISKQC	37	Esculentin-2P (Frogs, amphibians, animals)	P82846	Iridoviridae, Herpesviridae	Not found	Rana pipiens (northern leopard frog)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11601906]##Frog Virus 3:  inhibition of FV3 infection in fathead minnow(FHM) cells(90% inhibition at 500 µM);##Channel Catfish virus(CCV): inhibition of CCV infection in catfish ovary(CCO) cells( 90% inhibition at 50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	There is a disulfide bond between Cys31 and Cys37.	L	No cytotoxicity information found in the reference(s) presented	Not found	11601906	Virology. 2001 Sep 30;288(2):351-7.##Eur J Biochem. 2000 Feb;267(3):894-900.	Chinchar VG, Wang J, Murti G, Carey C, Rollins-Smith L.	Inactivation of frog virus 3 and channel catfish virus by esculentin-2P and ranatuerin-2P, two antimicrobial peptides isolated from frog skin.	
DRAMP30314	FVPWFSKFlGRIL	13	Temporin L[Pro3,DLeu9](TL1)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=9.99 μM,IC90=18.69 μM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=8.86 μM μM,IC90=16.71 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=4.62 μM μM,IC90=12.14 μM);##HPIV-3:inhibition of replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM);##HCoV-229E:inhibition of replication in Vero cells(IC50=7.76 μM,IC90=30.07 μM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=7.33 μM,IC90=14.98 μM).	[Ref.35216177]showing residual hemolytic activity against human erythrocytes only at concentrations equal or above 50 μM.	Linear	Free	Amidation		Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50= 42.18 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30315	FVPWFSKFlPRIL	13	Temporin L[Pro3,DLeu9,Pro10](TL2)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=7.70 μM,IC90=18.76 μM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=9.83 μM μM,IC90=19.20 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=4.82 μM μM,IC90=13.98 μM);##HPIV-3:inhibition of replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM);##HCoV-229E:inhibition of replication in Vero cells(IC50=10.56 μM,IC90=50.00 μM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=11.31 μM,IC90=24.13 μM).	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 μM.	Linear	Free	Amidation		Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50= 56.52 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30316	FVPWFSKFlpRIL	13	Temporin L[Pro3,DLeu9,DPro10](TL3)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50>50.00 μM μM,IC90>50.00 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50>50.00 μM μM,IC90>50.00 μM);##HPIV-3:inhibition of replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM);##HCoV-229E:inhibition of replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM);##HCoV-OC43:inhibition of replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM).	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 μM.	Linear	Free	Amidation		Mixed(D-Leu9,D-Pro10)	[Ref.35216177]Vero cells:CC50>100 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30317	FVPWFSKFlXRIL	13	Temporin L[Pro3,DLeu9,Hyp10](TL4)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=7.73 μM,IC90=15.89 μM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=9.61 μM μM,IC90=19.02 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=6.72 μM μM,IC90=25.00 μM);##HPIV-3:inhibition of replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM);##HCoV-229E:inhibition of replication in Vero cells(IC50=11.74 μM,IC90>50.00 μM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=11.33 μM,IC90=27.65 μM).	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 μM.	Linear	Free	Amidation	The 'X' at position 10 is hydroxyproline (Hyp).	Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50=60.90 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30318	FVPWFSKFlxRIL	13	Temporin L[Pro3,DLeu9,DHyp10](TL5)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50>50.00 μM μM,IC90>50.00 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50>50.00 μM μM,IC90>50.00 μM);##HPIV-3:inhibition of replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM);##HCoV-229E:inhibition of replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM);##HCoV-OC43:inhibition of replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM).	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 μM.	Linear	Free	Amidation	The 'x' at position 10 is D-hydroxyproline (Hyp).	Mixed(D-Leu9,D-Hyp10)	[Ref.35216177]Vero cells:CC50>100.00 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30319	FVPWFSKFlxRIL	13	Temporin L[Pro3,DLeu9,DNle10](TL7)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=3.65 μM,IC90=12.83 μM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=3.13 μM μM,IC90=11.92 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=1.00 μM μM,IC90=17.41 μM);##HPIV-3:inhibition of replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM);##HCoV-229E:inhibition of replication in Vero cells(IC50=6.21 μM,IC90>50.00 μM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=8.55 μM,IC90=24.74 μM).	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 μM.	Linear	Free	Amidation	The 'x' at position 10 is D-norleucine.	Mixed(D-Leu9,D-Nle10)	[Ref.35216177]Vero cells:CC50= 32.16 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30320	FVPWFSKFlKRIL	13	Temporin L[Pro3,DLeu9,Lys10](TL8)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=2.49 μM,IC90=10.48 μM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=1.00 μM μM,IC90=7.99 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.88 μM μM,IC90=12.93 μM);##HPIV-3:inhibition of replication in Vero cells(IC50=40.69 μM,IC90>50.00 μM);##HCoV-229E:inhibition of replication in Vero cells(IC50=4.39 μM,IC90=50.00 μM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=2.90 μM,IC90=16.30 μM).	[Ref.35216177]About 20% hemolysis against human erythrocytes at concentrations equal or above 25 μM.	Linear	Free	Amidation		Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50=22.32 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30321	FVPWFSKFlkRIL	13	Temporin L[Pro3,DLeu9,DLys10](TL9)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=3.53 μM,IC90=12.71 μM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=2.80 μM μM,IC90=12.50 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=4.63 μM μM,IC90=25.33 μM);##HPIV-3:inhibition of replication in Vero cells(IC50=40.64 μM,IC90>50.00 μM);##HCoV-229E:inhibition of replication in Vero cells(IC50=5.39 μM,IC90=50.00 μM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=8.29 μM,IC90=29.17 μM).	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 μM.	Linear	Free	Amidation		Mixed(D-Leu9,D-Lys10)	[Ref.35216177]Vero cells:CC50= 45.92 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30322	FVPWFSKFlWRIL	13	Temporin L[Pro3,DLeu9,Trp10](TL10)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=3.01 μM,IC90=8.25 μM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=0.77 μM μM,IC90=12.50 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.88 μM μM,IC90=27.71 μM);##HPIV-3:inhibition of replication in Vero cells(IC50>50.00 μM,IC90>50.00 μM);##HCoV-229E:inhibition of replication in Vero cells(IC50=0.91 μM,IC90=50.00 μM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=0.96 μM,IC90=24.17 μM).	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 μM.	Linear	Free	Amidation		Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50= 35.47 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30323	FVPWFSKFlwRIL	13	Temporin L[Pro3,DLeu9,DTrp10](TL11)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=1.86 μM,IC90=7.89 μM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=0.58 μM μM,IC90=9.76 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=4.07 μM μM,IC90=14.85 μM);##HPIV-3:inhibition of replication in Vero cells(IC50=41.18 μM,IC90>50.00 μM);##HCoV-229E:inhibition of replication in Vero cells(IC50=0.92 μM,IC90=50.00 μM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=5.10 μM,IC90=17.41 μM).	[Ref.35216177]<40% hemolysis against human erythrocytes at concentrations equal or above 25 μM.	Linear	Free	Amidation		Mixed(D-Leu9,D-Trp10)	[Ref.35216177]Vero cells:CC50=24.12 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30324	FVPWFSKFlXRIL	13	Temporin L[Pro3,DLeu9,Aic10](TL12)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=0.68 μM,IC90=1.58 μM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=0.54 μM μM,IC90=11.86 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.65 μM μM,IC90=13.85 μM);##HPIV-3:inhibition of replication in Vero cells(IC50=33.83 μM,IC90>50.00 μM);##HCoV-229E:inhibition of replication in Vero cells(IC50=0.74 μM,IC90=20.90 μM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=0.62 μM,IC90=13.18 μM).	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 12.5 μM.	Linear	Free	Amidation	The 'X' at position 10 is 2-aminoindane-2-carboxylic acid.	Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50=8.28 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30325	FVPWFSKFlXRIL	13	Temporin L[Pro3,DLeu9,Nle10](TL6)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae, Orthomyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=2.66 μM,IC90=9.12 μM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=0.92 μM μM,IC90=6.28 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.53 μM μM,IC90=12.15 μM);##HPIV-3:inhibition of replication in Vero cells(IC50=32.35 μM,IC90>50.00 μM);##HCoV-229E:inhibition of replication in Vero cells(IC50=2.08 μM,IC90=13.06 μM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=0.97 μM,IC90=10.04 μM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=34.58 μM μM,IC90>50.00 μM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=2.66 μM,IC90=9.12 μM).	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 μM.	Linear	Free	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50=64.52 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30326	FVPWFSKFlXRILC	14	Temporin L[Pro3,DLeu9,Nle10]-C-CHOL(TL6.1)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae, Orthomyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=6.4 μM,IC90=11.13 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=3.18 μM μM,IC90=12.03 μM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=39.1 μM μM,IC90>50.00 μM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=5.55 μM,IC90=10.02 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG4-Cholesterol-NH2	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50>100.00 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30327	FVPWFSKFlXRILGGC	16	Temporin L[Pro3,DLeu9,Nle10]-GGC-CHOL(TL6.2)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae, Orthomyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=9.54 μM,IC90=47.95 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=12.12 μM μM,IC90=49.95 μM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=40.89 μM μM,IC90>50.00 μM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=21.12 μM,IC90=49.90 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	PEG4-Cholesterol-NH2	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50>100.00 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30328	CFVPWFSKFlXRIL	14	CHOL-C-Temporin L[Pro3,DLeu9,Nle10](TL6.3)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae, Orthomyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=0.89 μM,IC90=2.19 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.76 μM μM,IC90=1.89 μM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=22.3 μM μM,IC90=31.10 μM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=2.55 μM,IC90=5.89 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Cholesterol-PEG4	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50>100.00 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30329	CGGFVPWFSKFlXRIL	16	CHOL-CGG-Temporin L[Pro3,DLeu9,Nle10](TL6.4)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae, Orthomyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=2.32 μM,IC90=8.21 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=1.02 μM μM,IC90=10.21 μM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=28.88 μM μM,IC90=49.90 μM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=6.02 μM,IC90=9.90 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Cholesterol-PEG4	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50>100.00 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30330	FVPWFSKFlXRIL	13	Undecanoic-Temporin L[Pro3,DLeu9,Nle10](TL6.5)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae, Orthomyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50<0.10 μM,IC90<0.10 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50<0.10 μM μM,IC90<0.10 μM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=10.01 μM μM,IC90=29.18 μM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50<0.10 μM,IC90<0.10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Undecanoic acid	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50>100.00 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30331	FVPWFSKFlXRIL	13	Tridecanoic-Temporin L[Pro3,DLeu9,Nle10](TL6.6)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae, Orthomyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=1.39 μM,IC90=2.86 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.39 μM μM,IC90=5.86 μM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=33.36 μM μM,IC90>50.00 μM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=3.39 μM,IC90=6.66 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Tridecanoic acid	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50>100.00 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30332	FVPWFSKFlXRIL	13	Pentadecanoic-Temporin L[Pro3,DLeu9,Nle10](TL6.7)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae, Orthomyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=2.48 μM,IC90=4.86 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.48 μM μM,IC90=7.86 μM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=37.77 μM μM,IC90>50.00 μM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=3.48 μM,IC90=7.10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Pentadecanoic acid	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50>100.00 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30333	FVPWFSKFlXRIL	13	Hexadecenoic-Temporin L[Pro3,DLeu9,Nle10](TL6.8)	No entry found	Coronaviridae, Herpesviridae, Paramyxoviridae, Orthomyxoviridae	Not found	Synthetic construct(derived from Temporin-L)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.	[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=3.13 μM,IC90=4.96 μM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.77 μM μM,IC90=6.96 μM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=39.4 μM μM,IC90>50.00 μM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=4.77 μM,IC90=7.11 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Palmitic acid	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	[Ref.35216177]Vero cells:CC50>100.00 μM	membrane	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M. 	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	
DRAMP30334	TLLKKVLKAAAKAALNAVLVGANA	24	Dermaseptin S4 (5-28)	No entry found	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin S4)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.23161023]HSV-2 acyclovir-sensitive strain(911411):inhibition the cytopathic effect(CPE) of HSV-2 in Vero cells(EC50=27.07 μM);##HSV-2 acyclovir-resistant strain(ROI2):inhibition of cytopathic effet(CPE) of HSV-2 in Vero cells(EC50=25.27 μM). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.23161023]Vero cells:CC50=34 μM.	Not found	23161023	J Med Virol. 2013 Feb;85(2):272-81.	Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K. 	 In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C
DRAMP30335	ALWKTLLKKVLKAAAKAALNAVLVGANA	28	Dermaseptin K4S4 	No entry found	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin S4)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.23161023]HSV-2 acyclovir-sensitive strain(911411):inhibition the cytopathic effect(CPE) of HSV-2 in Vero cells(EC50=2.7 μM);##HSV-2 acyclovir-resistant strain(ROI2):inhibition of cytopathic effet(CPE) of HSV-2 in Vero cells(EC50=5.1 μM). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.23161023]Vero cells:CC50=12 μM.	Not found	23161023	J Med Virol. 2013 Feb;85(2):272-81.	Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K. 	 In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2.	CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
DRAMP30336	ALWKTLLKKVLKAAAKAALKAVLVGANA	28	Dermaseptin K4K20S4 	No entry found	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin S4)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.23161023]HSV-2 acyclovir-sensitive strain(911411):inhibition the cytopathic effect(CPE) of HSV-2 in Vero cells(EC50=2.1 μM);##HSV-2 acyclovir-resistant strain(ROI2):inhibition of cytopathic effet(CPE) of HSV-2 in Vero cells(EC50=5.4 μM). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.23161023]Vero cells:CC50=25 μM.	Not found	23161023	J Med Virol. 2013 Feb;85(2):272-81.	Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K. 	 In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2.	CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
DRAMP30337	ALWDTLLKKVLKAAAKAALDAVLVGANA	28	Dermaseptin D4D20S4 	No entry found	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin S4)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.23161023]HSV-2 acyclovir-sensitive strain(911411):inhibition the cytopathic effect(CPE) of HSV-2 in Vero cells(EC50=5.41 μM);##HSV-2 acyclovir-resistant strain(ROI2):inhibition of cytopathic effet(CPE) of HSV-2 in Vero cells(EC50=9.63 μM). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.23161023]Vero cells:CC50=17.75 μM.	Not found	23161023	J Med Virol. 2013 Feb;85(2):272-81.	Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K. 	 In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2.	CC(C)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP30338	RLFFKCIYRFFEHGLKRG	18	M2 AH	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza virus M2 protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: M2 AH is an α-helical amphipathic peptide with basic amino acids positioned at the polar-nonpolar interface. The peptide inserts deeply into the hydrophobic core of the membrane bilayer, resulting in alteration of membrane order and curvature . This ability to alter membrane curvature enables M2 AH to induce membrane budding in vitro and in vivo. It localizes to the neck of the budding virion and plays an important role in membrane scission.	[Ref.31375212]H1N1(A/Puerto Rico/8/34):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=870 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.31375212]Madin-Darby canine kidney epithelial(MDCK) cells:CC50=70.3 μM	membrane	31375212	Biochem Biophys Res Commun. 2019 Sep 24;517(3):507-512.	Jung Y, Kong B, Moon S, Yu SH, Chung J, Ban C, Chung WJ, Kim SG, Kweon DH. 	Envelope-deforming antiviral peptide derived from influenza virus M2 protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30339	RKFFKKIYRFFRKLLKRL	18	M2 MH	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza virus M2 protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: M2 MH is an α-helical amphipathic peptide with basic amino acids positioned at the polar-nonpolar interface. The peptide inserts deeply into the hydrophobic core of the membrane bilayer, resulting in alteration of membrane order and curvature . This ability to alter membrane curvature enables M2 MH to induce membrane budding in vitro and in vivo. It localizes to the neck of the budding virion and plays an important role in membrane scission.	[Ref.31375212]H1N1(A/Puerto Rico/8/34):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=53 nM);##H3N2(A/Sydney/5/97):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=0.058 μM);##H3N2(A/X31):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=0.016 μM);##H5N2(A/aquatic bird/Korea/w81/2005 ):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=0.066 μM);##H1N1(A/Swine/Iowa/15/30):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=0.053 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.31375212]Madin-Darby canine kidney epithelial(MDCK) cells:CC50=19.2 μM	membrane	31375212	Biochem Biophys Res Commun. 2019 Sep 24;517(3):507-512.	Jung Y, Kong B, Moon S, Yu SH, Chung J, Ban C, Chung WJ, Kim SG, Kweon DH. 	Envelope-deforming antiviral peptide derived from influenza virus M2 protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30340	RLAAKCAARFAEHGLKRG	18	M2 NH	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza virus M2 protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: M2 NH is an α-helical amphipathic peptide with basic amino acids positioned at the polar-nonpolar interface. The peptide inserts deeply into the hydrophobic core of the membrane bilayer, resulting in alteration of membrane order and curvature . This ability to alter membrane curvature enables M2 NH to induce membrane budding in vitro and in vivo. It localizes to the neck of the budding virion and plays an important role in membrane scission.	[Ref.31375212]H1N1:did not exhibit any inhibitory effect.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.31375212]did not show apparent cytotoxicity against Madin-Darby canine kidney epithelial(MDCK) cells up to a concentration of 100 μM.	membrane	31375212	Biochem Biophys Res Commun. 2019 Sep 24;517(3):507-512.	Jung Y, Kong B, Moon S, Yu SH, Chung J, Ban C, Chung WJ, Kim SG, Kweon DH. 	Envelope-deforming antiviral peptide derived from influenza virus M2 protein.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30341	GFSSLFKAGAKYLLKQVGKAGAQQLACKAANNC	33	Brevinin-2GHk(BR2GK)	A0A6G6CZ26	Flaviviridae	Not found	Fejervarya limnocharis	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: BR2GK directly inactivated ZIKV by disrupting the integrity of the envelope and may also penetrate the host cell membrane to inhibit the middle stage of ZIKV infection. 	[Ref.34960651]Zika Virus: inhibition of infection of Zika virus in Vero cells(IC50=3.408 ± 0.738 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.34960651]exhibited no significant toxicity to Vero, Hela, and Huh7 cells in the concentration range 0-20 µM.	membrane	34960651	Viruses. 2021 Nov 28;13(12):2382. 	Xiong W, Li J, Feng Y, Chai J, Wu J, Hu Y, Tian M, Lu W, Xu X, Zou M.	Brevinin-2GHk, a Peptide Derived from the Skin of Fejervarya limnocharis, Inhibits Zika Virus Infection by Disrupting Viral Integrity.	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)O
DRAMP30342	FLPLILPAnti-SIVTALSSFLKQG	20	Hs-1	No entry found	Flaviviridae	Not found	Hypsiboas semilineatus	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: It was possible to observe that the viral particle lost its ability to infect because of the breakdown on the envelope as the peptide acted directly on the virus. 	[Ref.29153860]DENV2:reduced the number of lysis plaques by 100% at 125 µg/mL; by 60% at 7.81 μg/mL;##DENV3:reduced the number of lysis plaques by 100% at 125 µg/mL; by 50% at 7.81 μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.29153860]No significant cytotoxicity agaisnt Vero cells up to 125μg/ mL.	envelope	29153860	Virology. 2018 Jan 15;514:79-87.	Monteiro JMC, Oliveira MD, Dias RS, Nacif-Marçal L, Feio RN, Ferreira SO, Oliveira LL, Silva CC, Paula SO.	The antimicrobial peptide HS-1 inhibits dengue virus infection.	
DRAMP30343	GGARDAGKAEWW	12	gg-ww	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide gg-ww could exert its inhibition during the viral entry step of DENV-2 infection by interfering with viral attachment or internalization.	[Ref.26248692]dengue virus serotype 2(DENV-2):inhibition the cytopathic effect(CPE) and plaque formation in Vero cells(IC50=77-91 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.26248692]It was not toxic to Vero cells up to 400 μmol/L.	membrane	26248692	J Appl Microbiol. 2015 Oct;119(4):1170-80. 	Chew MF, Tham HW, Rajik M, Sharifah SH. 	Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.	C[C@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30344	QEGISRFKICPYHWYKQHMSLLFRRYYHKLDSII	34	CPXV012	No entry found	Herpesviridae, Hepadnaviridae, Retroviridae, Phenuiviridae	Not found	Synthetic construct(derived from the cowpox virus protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Within virus-infected cells, this protein helps to evade the immune system by inhibiting the transporter associated with antigen processing (TAP), thereby interfering with MHC I-dependent antigen presentation. And the peptide is the segment of the CPXV012 protein responsible for blocking TAP.	[Ref.32872420]Herpes simplex virus-1(HSV-1):inhibition of HSV-1 infection in MelJuSo(MJS) cells(75.9 ± 5.7%  inhibition at 150 µg/mL);##Hepatitis B virus(HBV): decrease of HBeAg and viral DNA infected with HBV-1 in HepRG cells(84.0 ± 3.0% of HBeAg and 73.6 ± 2.3% of viral DNA at 100 µg/mL);##HIV-1:inhibition of virus infection in LC5-RIC reporter cells(82.7 ± 4.9% inhibition at 100 µg/mL);inhibition of virus replication in LC5-RIC reporter cells(62.2 ± 2.4% inhibition at 100 µg/mL);##Rift Valley fever virus(RVFV): inhibition of virus infection in MJS cells(65.5 ± 2.3% inhibition at 160 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.32872420]Did not observe any decrease in live cells against Vero and Huh7.5 cells up to 200 µg/mL.	envelope(phosphatidylserine)	32872420	Cells. 2020 Aug 29;9(9):1989.	Luteijn RD, Praest P, Thiele F, Sadasivam SM, Singethan K, Drijfhout JW, Bach C, de Boer SM, Lebbink RJ, Tao S, Helfer M, Bach NC, Protzer U, Costa AI, Killian JA, Drexler I, Wiertz EJHJ.	A Broad-Spectrum Antiviral Peptide Blocks Infection of Viruses by Binding to Phosphatidylserine in the Viral Envelope. 	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(=O)N[C@H](C(=O)O)[C@H](C)CC)C(=O)O
DRAMP30345	TEPSTRGSWKFW	12	P1	No entry found	Flaviviridae	Not found	Synthetic construct(phage display)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E glycoprotein has been identified as the major antigenic determinant on flavivirus particles and mediates binding and fusion during viral entry,DIII has been proposed to act as the binding region for the cellular receptor. And the peptide could bingding with DIII domain and inhibit the initial step of JEV infection.	[Ref.24468276]Japanese encephalitis virus (JEV): inhibition of JEV infection in BHK-21 cells(IC50~100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	24468276	Antiviral Res. 2014 Apr;104:7-14.	Zu X, Liu Y, Wang S, Jin R, Zhou Z, Liu H, Gong R, Xiao G, Wang W.	Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III.	C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP30346	SENRKVPFYSHS	12	P3	No entry found	Flaviviridae	Not found	Synthetic construct(phage display)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: E glycoprotein has been identified as the major antigenic determinant on flavivirus particles and mediates binding and fusion during viral entry,DIII has been proposed to act as the binding region for the cellular receptor. And the peptide could bingding with DIII domain and inhibit the initial step of JEV infection.	[Ref.24468276]Japanese encephalitis virus (JEV): inhibition of JEV infection in BHK-21 cells(IC50=1.42 ± 0.41 μM determined by plaque assay,IC50=1.12 ± 0.38 μM determined by qRT-PCR,IC90~100 μM determined by plaque assay and qRT-PCR).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	24468276	Antiviral Res. 2014 Apr;104:7-14.	Zu X, Liu Y, Wang S, Jin R, Zhou Z, Liu H, Gong R, Xiao G, Wang W.	Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III.	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
DRAMP30347	MVDRGWGNHAGLFGKGAnti-SIV	19	DN80	No entry found	Flaviviridae	Not found	Synthetic construct(derived from the E polyprotein of DENV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	[Ref.31351847]Dengue virus(DENV): inhibition of DENV infection in LLCKM-2 monkey kidney epithelial cells(17±10% inhibition at 49.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. 	da Silva-Júnior EF, de Araújo-Júnior JX. 	Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.	
DRAMP30348	AWLVHTQWFLDLPLPWLPGADTQGSNWI	28	DN57	No entry found	Flaviviridae	Not found	Synthetic construct(derived from the E polyprotein of DENV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	[Ref.31351847]Dengue virus(DENV): inhibition of DENV infection in LLCKM-2 monkey kidney epithelial cells(7±4% inhibition at 30.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. 	da Silva-Júnior EF, de Araújo-Júnior JX. 	Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)O
DRAMP30349	AWLVHRQWFLDLPLPWLPG	19	DN81	No entry found	Flaviviridae	Not found	Synthetic construct(derived from the E polyprotein of DENV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	[Ref.31351847]Dengue virus(DENV): inhibition of DENV infection in LLCKM-2 monkey kidney epithelial cells(25±8% inhibition at 42.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. 	da Silva-Júnior EF, de Araújo-Júnior JX. 	Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)O
DRAMP30350	MAILGDTAWDFGSLGGVFTSIGKALHQVFGAIY	33	DN59	No entry found	Flaviviridae	Not found	Synthetic construct(derived from the E polyprotein of DENV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	[Ref.31351847]Dengue virus(DENV): inhibition of DENV infection in LLCKM-2 monkey kidney epithelial cells(IC50~10μM,100.0±0.5% inhibition at 20 μM);##West Nile virus(WNV): inhibition of WNV infection in LLCKM-2 monkey kidney epithelial cells(>99% inhibition at <25μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.31351847]No cytotoxicity against LLCMK-2 monkey kidney epithelial cells at 100 mg/ml.	envelope	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. 	da Silva-Júnior EF, de Araújo-Júnior JX. 	Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)[C@H](C)CC)[C@@H](C)O)C(=O)O
DRAMP30351	VVDRGWGNGAGLFGKGSID	19	WN82	No entry found	Flaviviridae	Not found	Synthetic construct(derived from the E polyprotein of WNV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	[Ref.31351847]West Nile virus(WNV): inhibition of WNV infection in LLCKM-2 monkey kidney epithelial cells(4±13% inhibition at 52.5μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. 	da Silva-Júnior EF, de Araújo-Júnior JX. 	Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)O
DRAMP30352	TFLVHREWFMDLNLPWSSAGSTVWR	25	WN53	No entry found	Flaviviridae	Not found	Synthetic construct(derived from the E polyprotein of WNV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	[Ref.31351847]West Nile virus(WNV): inhibition of WNV infection in LLCKM-2 monkey kidney epithelial cells(IC50~10μM,56.0±3.0% inhibition at 99μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.31351847]No cytotoxicity against LLCMK-2 monkey kidney epithelial cells at 100 mg/ml.	envelope	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. 	da Silva-Júnior EF, de Araújo-Júnior JX. 	Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30353	TFLVHREWFMDLNLPWSSA	19	WN83	No entry found	Flaviviridae	Not found	Synthetic construct(derived from the E polyprotein of WNV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	[Ref.31351847]West Nile virus(WNV): inhibition of WNV infection in LLCKM-2 monkey kidney epithelial cells(IC50~10μM, 70.0±3.0% inhibition at 128 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.31351847]No cytotoxicity against LLCMK-2 monkey kidney epithelial cells at 100 mg/ml.	envelope	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. 	da Silva-Júnior EF, de Araújo-Júnior JX. 	Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30354	GYIEAEVI	8	HIV-1 integrase(82-89)	P04587	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	[Ref.12643937]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>1 mM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	Integrase	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	Zhao L, O'Reilly MK, Shultz MD, Chmielewski J.	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)[C@H](C)CC)C(C)C)C(N)=O
DRAMP30355	QETAYFLLKLAGRWP	15	HIV-1 integrase(95-109)	P04587	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	[Ref.12643937]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=3.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	Integrase	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	Zhao L, O'Reilly MK, Shultz MD, Chmielewski J.	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(N)=O
DRAMP30356	STTVKAASWWA	11	HIV-1 integrase(123-133)	P04587	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	[Ref.12643937]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>1 mM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	Integrase	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	Zhao L, O'Reilly MK, Shultz MD, Chmielewski J.	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. 	CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(N)=O
DRAMP30357	HLKTAVQMAVFIHNFKR	17	HIV-1 integrase(171-187)	P04587	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	[Ref.12643937]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=3.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	Integrase	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	Zhao L, O'Reilly MK, Shultz MD, Chmielewski J.	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. 	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30358	AGERIVDIIATDIQ	14	HIV-1 integrase(196-210)	P04587	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	[Ref.12643937]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=2.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	Integrase	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	Zhao L, O'Reilly MK, Shultz MD, Chmielewski J.	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)N)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP30359	QETAYFLLKLAGR	13	HIV-1 integrase(95-107)	P04587	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	[Ref.12643937]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=150 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	Integrase	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	Zhao L, O'Reilly MK, Shultz MD, Chmielewski J.	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30360	AGERIVDIIA	10	HIV-1 integrase(196-206)	P04587	Retroviridae	Not found	Synthetic construct(derived from HIV-1 integrase)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	[Ref.12643937]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=30 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	Integrase	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	Zhao L, O'Reilly MK, Shultz MD, Chmielewski J.	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)[C@H](C)CC)[C@H](C)CC)C(C)C
DRAMP30361	WNSLKIDNLDV	11	LEDGF 361–370	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(81% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30362	WASLKIDNLDV	11	LEDGF 361–370[N361A]	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(76% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30363	WNALKIDNLDV	11	LEDGF 361–370[S362A]	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(79% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30364	WNSAKIDNLDV	11	LEDGF 361–370[L363A]	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(71% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30365	WNSLAIDNLDV	11	LEDGF 361–370[K364A]	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(68% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30366	WNSLKADNLDV	11	LEDGF 361–370[I365A]	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(65% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC(C)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30367	WNSLKIANLDV	11	LEDGF 361–370[D366A]	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(58% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30368	WNSLKIDALDV	11	LEDGF 361–370[N367A]	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(75% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30369	WNSLKIDNADV	11	LEDGF 361–370[L368A]	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(75% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30370	WNSLKIDNLAV	11	LEDGF 361–370[D369A]	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(73% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O
DRAMP30371	WNSLKIDNLDA	11	LEDGF 361–370[V370A]	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(68% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30372	WNSLKIANLAV	11	LEDGF 361–370[D366A,D369A]	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(43% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30373	WIDNLD	6	LEDGF 365–369	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(30% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30374	WKFALKVDSPDV	12	HRP2 483–493	Q7Z4V5	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(25% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Integrase	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5. 	Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A.	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
DRAMP30375	WEEWDKKIEEYTKKIEELIKKSQNQQ	26	WQ(628-653)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=123.4 ±6.5 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=159.5 ± 9.5 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=126.2 ± 9.2 nM);##HIV-1 clinical isolates(8 clinical isolates):inhibition of virus infection in MT-2 cells(IC50=81.2-383.3 nM);##HIV-1 pseudoviruses(7 pseudoviruses):inhibition of pseudoviruses infection in MT-2 cells(IC50=13.5-686.2 nM);##HIV-1 T20-resistant strains(5 strains):inhibition of virus infection in MT-2 cells(IC50=34.8-433.1 nM);##HIV-1 T2635-resistant strain(6 strains):inhibition of virus infection in MT-2 cells(IC50=195.1-1128.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30376	MTWEEWDKKIEEYTKKIEELIKKSQNQQ	28	MT-WQ(626-653)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=8.8 ±0.4 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=14.8 ± 2.8 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=6.7 ± 0.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30377	WEEWDKKIEEYTKKIEELIKKSQNQQSM	28	WQ-SM(628-655)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=60.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30378	WEEWDKKIEEYTKKIEELIKKSQNQQSW	28	WQ-SW(628-655)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=47.7 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30379	WEEWDKKIEEYTKKIEELIKKSQNQQSY	28	WQ-SY(628-655)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=54.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30380	WEEWDKKIEEYTKKIEELIKKSQNQQSDLD	30	WQ-SDLD(628-657)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=44.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30381	WEEWDKKIEEYTKKIEELIKKSQNQQLDL	29	WQ-LDL(628-656)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=3.7 ±1.1 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=6.4 ±2.7 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=3.6± 0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30382	WEEWDKKIEEYTKKIEELIKKSQNQQIDI	29	WQ-IDI(628-656)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=3.7 ±0.3 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=6.4 ± 1.8 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=3.2 ± 0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP30383	WEEWDKKIEEYTKKIEELIKKSQNQQLDI	29	WQ-LDI(628-656)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=3.6±0.2nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=7.2 ± 1.0 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=3.1 ± 0.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP30384	WEEWDKKIEEYTKKIEELIKKSQNQQIDL	29	WQ-IDL(628-656)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=1.6 ±0.1 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=5.6± 1.2 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=2.5 ± 0.1 nM);##HIV-1 clinical isolates(8 clinical isolates):inhibition of virus infection in MT-2 cells(IC50=2.0-90.7 nM);##HIV-1 pseudoviruses(7 pseudoviruses):inhibition of pseudoviruses infection in MT-2 cells(IC50=0.8-37.4 nM);##HIV-1 T20-resistant strains(5 strains):inhibition of virus infection in MT-2 cells(IC50=1.6-22.0 nM);##HIV-1 T2635-resistant strain(6 strains):inhibition of virus infection in MT-2 cells(IC50=8.5-61.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30385	MTWEEWDKKIEEYTKKIEELIKKSQNQQIDL	31	MT-WQ-IDL(626-656)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=0.6±0.1 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=1.2± 0.2 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=0.6 ±0.1 nM);##HIV-1 clinical isolates(8 clinical isolates):inhibition of virus infection in MT-2 cells(IC50=0.5-15.1 nM);##HIV-1 pseudoviruses(7 pseudoviruses):inhibition of pseudoviruses infection in MT-2 cells(IC50=0.1-9.0 nM);##HIV-1 T20-resistant strains(5 strains):inhibition of virus infection in MT-2 cells(IC50=0.1-4.4 nM);##HIV-1 T2635-resistant strain(6 strains):inhibition of virus infection in MT-2 cells(IC50=1.1-11.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30386	EEQKTQLKNKIEIDWTKMELEQDWSKIYKEI	31	MT-WQ-IDL-scrambled	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]HIV-1 IIIB:inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50>500 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50>500 nM);##	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP30387	TTLLDLTYEMLSLQQVVKALNESYIDLKEL	30	M0	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]MERS-CoV:inhibition of MERS-CoV S-medicated cell-cell fusion in MT-2 cells(IC50=4.5 μM);inhibition of pseudovirus infection in MT-2 cells(IC50=17.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30388	EANTTLLDLTYEMLSLQQVVKALNESYIDLKEL	33	M1	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.27795416]MERS-CoV:inhibition of MERS-CoV S-medicated cell-cell fusion in MT-2 cells(IC50=0.9 μM);inhibition of pseudovirus infection in MT-2 cells(IC50=2.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L. 	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP30389	LQQLLFIHFRIGRRRRRRRR	20	peptide 4	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.13 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30390	EAIIRILQQLLFIHFRIGRRRRRRRR	26	peptide 5	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.09 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.04 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30391	ILQQLLFIHFRIGRRRRRRRR	21	peptide 6	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.10 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.07 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP30392	RILQQLLFIHFRIGRRRRRRRR	22	peptide 7	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.13 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.11 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30393	IRILQQLLFIHFRIGRRRRRRRR	23	peptide 8	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.26 ±0.04 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.11 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30394	IIRILQQLLFIHFRIGRRRRRRRR	24	peptide 9	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.11 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.07 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30395	AIIRILQQLLFIHFRIGRRRRRRRR	25	peptide 10	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.08 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.05 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30396	EAIIRILQQLLFIEFRIKRRRRRRRR	26	peptide 11	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.05± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.01 ± 0.001 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30397	EEIIRKLQQLLFIHFRIGRRRRRRRR	26	peptide 12	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.12 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.047 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30398	EAIIRILQELLFKHFRIGRRRRRRRR	26	peptide 13	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.14 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.065 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30399	EAIERILKQLLFIHFRIGRRRRRRRR	26	peptide 14	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.23± 0.03 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.15 ± 0.002 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30400	EAEIRIKQQLLFIHFRIGRRRRRRRR	26	peptide 15	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.04 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.031± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30401	EAIIRILQQLEFIHKRIGRRRRRRRR	26	peptide 16	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.71 ± 0.21 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ± 0.004µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30402	EEIIRKLQQLLFIEFRIKRRRRRRRR	26	peptide 17	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.18 ± 0.06 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.08 ± 0.02 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30403	AQQLLFIHFRIGRRRRRRRR	20	peptide 18	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.12 ± 0.004 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.08 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(C)=O)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30404	LAQLLFIHFRIGRRRRRRRR	20	peptide 19	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.13 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30405	LQALLFIHFRIGRRRRRRRR	20	peptide 20	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.10 ± 0.004 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30406	LQQALFIHFRIGRRRRRRRR	20	peptide 21	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.12 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.07 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30407	LQQLAFIHFRIGRRRRRRRR	20	peptide 22	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.13 ± 0.003 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30408	LQQLLAIHFRIGRRRRRRRR	20	peptide 23	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.34 ± 0.06 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.18 ± 0.03 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC
DRAMP30409	LQQLLFAHFRIGRRRRRRRR	20	peptide 24	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.33 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.22± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30410	LQQLLFIAFRIGRRRRRRRR	20	peptide 25	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.13 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30411	LQQLLFIHARIGRRRRRRRR	20	peptide 26	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.25 ± 0.02 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.12± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30412	LQQLLFIHFAIGRRRRRRRR	20	peptide 27	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.11 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.05 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30413	LQQLLFIHFRAGRRRRRRRR	20	peptide 28	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.20 ± 0.03 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.16 ± 0.02µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30414	LQQLLFIHFRIARRRRRRRR	20	peptide 29	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts antiviral activity by inhibiting the activity of integrase.	[Ref.20708407]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=0.09 ± 0.01 µM);inhibition of strand transfer catalyzed by integrase(IC50=0.09 ± 0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30415	RQLLSGIVQQQNNLLRAIEAQQHLLQK	27	C8- N27	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry.	[Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=1075±90 nM);inhibition of peptide against virus-cell fusion on CD4-expressing cells(IC50=293±27 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	C8(octanoic acid)	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20605950	FASEB J. 2010 Nov;24(11):4196-202. 	Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y.	Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain. 	CCCCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP30416	RQLLSGIVQQQNNLLRAIEAQQHLLQK	27	C12- N27	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry.	[Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=473±74 nM);inhibition of peptide against virus-cell fusion on CD4-expressing cells(IC50=182±15 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	C12(dodecanoic acid)	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20605950	FASEB J. 2010 Nov;24(11):4196-202. 	Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y.	Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain. 	CCCCCCCCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP30417	RQLLSGIVQQQNNLLRAIEAQQHLLQK	27	C16-N27	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry.	[Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=148±4 nM);inhibition of peptide against virus-cell fusion on CD4-expressing cells(IC50=10±1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	C16(hexadecanoic acid)	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20605950	FASEB J. 2010 Nov;24(11):4196-202. 	Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y.	Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain. 	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP30418	RQLLSGIVQQQNNLLRAIEAQQHLL	25	C16- N25	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry.	[Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=484±60 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	C16(hexadecanoic acid)	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20605950	FASEB J. 2010 Nov;24(11):4196-202. 	Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y.	Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain. 	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP30419	RQLLSGIVQQQNNLLRAIEAQQH	23	C16- N23	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry.	[Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=1931±187 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	C16(hexadecanoic acid)	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	20605950	FASEB J. 2010 Nov;24(11):4196-202. 	Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y.	Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain. 	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP30420	XDLTXEMLSLQQVVKALNESY	21	P21S1	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 1 and 5) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (1) and X (5) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30421	LXLTYXMLSLQQVVKALNESY	21	P21S2	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=3.90 ± 1.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 2 and 6) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (2) and X (6) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30422	LDLXYEMXSLQQVVKALNESY	21	P21S3	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 4 and 8) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (4) and X (8) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30423	LDLTXEMLXLQQVVKALNESY	21	P21S4	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=7.14 ± 0.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 5 and 9) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (5) and X (9) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30424	LDLTYEMXSLQXVVKALNESY	21	P21S5	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=10.7±2.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 8 and 12) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (8) and X (12) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30425	LDLTYEMLXLQQXVKALNESY	21	P21S6	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 9 and 13) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (9) and X (13) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30426	LDLTYEMLSLXQVVXALNESY	21	P21S7	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 11 and 15) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (11) and X (15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30427	LDLTYEMLSLQXVVKXLNESY	21	P21S8	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=0.26±0.05 μM);##WT MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=3.03 ± 0.29 μM);##Q1020H-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=4.06± 0.34 μM);##Q1020R-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=1.98± 0.28 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (12) and X (16) are cross-linked by hydrocarbon stapling.	L	[Ref.29442512]Calu-3 cell:CC50>100 μM	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30428	LDLTYEMLSLQQVVXALNXSY	21	P21S9	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=14.1 ± 2.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 15 and 19) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (15) and X (19) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30429	LDLTYEMLSLQQVVKXLNEXY	21	P21S10	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=0.33 ± 0.04 μM);##WT MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=0.97± 0.08 μM);##Q1020H-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=1.82± 0.28 μM);##Q1020R-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=0.89± 0.07 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (16) and X (20) are cross-linked by hydrocarbon stapling.	L	[Ref.29442512]Calu-3 cell:CC50>100 μM	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30430	LXLTYXMLSLQQVVKALNESY	21	P21L2	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=10.9 ±1.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 2 and 6 are S5((S)-pentenyl alanine)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30431	LDLTXEMLXLQQVVKALNESY	21	P21L4	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=8.21 ±0.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 5 and 9 are S5((S)-pentenyl alanine)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30432	LDLTYEMXSLQXVVKALNESY	21	P21L5	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=4.49 ± 0.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 8 and 12 are S5((S)-pentenyl alanine)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30433	LDLTYEMLSLQXVVKXLNESY	21	P21L8	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=20.6± 3.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 12 and 16 are S5((S)-pentenyl alanine)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30434	LDLTYEMLSLQQVVXALNXSY	21	P21L9	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=10.9 ± 1.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 15 and 19 are S5((S)-pentenyl alanine)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30435	LDLTYEMLSLQQVVKXLNEXY	21	P21L10	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=3.55 ± 0.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 16 and 20 are S5((S)-pentenyl alanine)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30436	LDLTYEMLSLQXVVKXLNESY	21	P21R8	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=16.3 ± 1.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' at position 12 and 16 are R5 amino acids. ②X (12) and X (16) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30437	LDLTYEZLSLQXVVKXLNESY	21	P21S8Z	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=0.63 ± 0.05 μM);##WT MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=2.80 ± 0.74 μM);##Q1020H-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=4.15± 0.25 μM);##Q1020R-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=2.49±0.18 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (12) and X (16) are cross-linked by hydrocarbon stapling. The 'Z' at position 7 indicates R8 ((R)-octenyl alanine)	L	[Ref.29442512]Calu-3 cell:CC50>100 μM	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30438	LDLTYEMLSLQXVVKXLNESF	21	P21S8F	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=2.16± 1.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (12) and X (16) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30439	LDLTYEZLSLQXVVKXLNESF	21	P21S8ZF	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=3.89 ± 0.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	①The 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ②X (12) and X (16) are cross-linked by hydrocarbon stapling.,The 'Z' at position 7 indicates R8 ((R)-octenyl alanine)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	
DRAMP30440	LDLTYEMLSLQQVVKALNESY	21	P21	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C)C(C)C
DRAMP30441	SLTQINTTLLDLEYEMKKLEEVVKKLEESYIDLKEL	36	HR2P-M2	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=0.75 ± 0.09 μM);##WT MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=1.07±0.21 μM);##Q1020H-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=1.25± 0.18 μM);##Q1020R-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=0.64± 0.16 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.29442512]Calu-3 cell:CC50>100 μM	membrane	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. 	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30442	FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNI	36	FP3(FCoV Sgp (1338-1373))	P10033	Coronaviridae	Not found	Synthetic construct(derived from S protein of FCoV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interfere the fusion of the viral envelope with host membrane and thus inhibits viral replication.	[Ref.24312629]feline coronavirus(FCoV):inhibition of virus replication in Fcwf-4 cells(IC50=14.21 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.24312629]Fcwf-4 cell:CC50>200 μM.	membrane	24312629	 PLoS One. 2013 Dec 3;8(12):e82081.	Liu IJ, Tsai WT, Hsieh LE, Chueh LL.	Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP30443	FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNL	43	FP4(FCoV Sgp (1338-1380))	P10033	Coronaviridae	Not found	Synthetic construct(derived from S protein of FCoV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interfere the fusion of the viral envelope with host membrane and thus inhibits viral replication.	[Ref.24312629]feline coronavirus(FCoV):inhibition of virus replication in Fcwf-4 cells(IC50=1.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.24312629]Fcwf-4 cell:CC50>200 μM.	membrane	24312629	 PLoS One. 2013 Dec 3;8(12):e82081.	Liu IJ, Tsai WT, Hsieh LE, Chueh LL.	Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC
DRAMP30444	FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNLEWLNRIE	50	FP5(FCoV Sgp (1338-1387))	P10033	Coronaviridae	Not found	Synthetic construct(derived from S protein of FCoV)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interfere the fusion of the viral envelope with host membrane and thus inhibits viral replication.	[Ref.24312629]feline coronavirus(FCoV):inhibition of virus replication in Fcwf-4 cells(IC50=1.33 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.24312629]Fcwf-4 cell:CC50>200 μM.	membrane	24312629	 PLoS One. 2013 Dec 3;8(12):e82081.	Liu IJ, Tsai WT, Hsieh LE, Chueh LL.	Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP30445	WEEWDKKIEEYTKKIEELIKKSEEQQKKNEKELK	34	SC34EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=0.9±0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.7±0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30446	WEEWDKKIEEYTKKIEELIKKSEEQQKKNEKEL	33	SC33EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.1±0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.7±0.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30447	WEEWDKKIEEYTKKIEELIKKSEEQQKKNEKE	32	SC32EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.1±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.8±0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP30448	WEEWDKKIEEYTKKIEELIKKSEEQQKKNEK	31	SC31EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.3±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.9±0.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30449	WEEWDKKIEEYTKKIEELIKKSEEQQKKNE	30	SC30EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1±0 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.9±0.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP30450	WEEWDKKIEEYTKKIEELIKKSEEQQKKN	29	SC29EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.2±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1±0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(N)=O
DRAMP30451	WEEWDKKIEEYTKKIEELIKKSEEQQKK	28	SC28EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=18±3 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=13±1.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30452	WEEWDKKIEEYTKKIEELIKKSEEQQK	27	SC27EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=29±2.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=21.4±2.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30453	WEEWDKKIEEYTKKIEELIKKSEEQQ	26	SC26EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=44.9±5.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=36.2±4.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP30454	WEEWDKKIEEYTKKIEELIKKSEEQ	25	SC25EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=79.8±9.3 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=41.5±3.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP30455	WEEWDKKIEEYTKKIEELIKKSEE	24	SC24EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=107.6±8 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=75.7±11.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP30456	WEEWDKKIEEYTKKIEELIKKSE	23	SC23EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=105.1±15.3 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=94.2±12.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP30457	WEEWDKKIEEYTKKIEELIKKS	22	SC22EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=66.9±15.9 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=98.6±7.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O
DRAMP30458	WEEWDKKIEEYTKKIEELIKK	21	SC21EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=113.2±8 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=105.4±12.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30459	WEEWDKKIEEYTKKIEELIK	20	SC20EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=126.6±10.7 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=202.4±5.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30460	WEEWDKKIEEYTKKIEELI	19	SC19EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=70.7±9 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=217.2±16.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(N)=O
DRAMP30461	WEEWDKKIEEYTKKIEEL	18	SC18EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50>2000 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>2000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@@H](C)O
DRAMP30462	MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNEKELK	36	MT-SC34EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.7±0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30463	MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNEKEL	35	MT-SC33EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.2±0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.8±0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30464	MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNEKE	34	MT-SC32EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.3±0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.1±0.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP30465	MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNEK	33	MT-SC31EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.3±0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.9±0.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30466	MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNE	32	MT-SC30EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=0.8±0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.8±0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP30467	MTWEEWDKKIEEYTKKIEELIKKSEEQQKKN	31	MT-SC29EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=0.9±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.1±0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(N)=O
DRAMP30468	MTWEEWDKKIEEYTKKIEELIKKSEEQQKK	30	MT-SC28EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.3±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.2±0.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30469	MTWEEWDKKIEEYTKKIEELIKKSEEQQK	29	MT-SC27EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.1±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.4±0.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30470	MTWEEWDKKIEEYTKKIEELIKKSEEQQ	28	MT-SC26EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.6±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.1±0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP30471	MTWEEWDKKIEEYTKKIEELIKKSEEQ	27	MT-SC25EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.9±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2±0.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP30472	MTWEEWDKKIEEYTKKIEELIKKSEE	26	MT-SC24EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=2.8±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2.3±0.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP30473	MTWEEWDKKIEEYTKKIEELIKKSE	25	MT-SC23EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=2.1±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.9±0.7 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP30474	MTWEEWDKKIEEYTKKIEELIKKS	24	MT-SC22EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=2.4±0.3 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2.2±0.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O
DRAMP30475	MTWEEWDKKIEEYTKKIEELIKK	23	MT-SC21EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=3.8±0.4 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=3.1±1.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30476	MTWEEWDKKIEEYTKKIEELIK	22	MT-SC20EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=3.7±0.5 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=3.3±1.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30477	MTWEEWDKKIEEYTKKIEELI	21	MT-SC19EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=5±0.9 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=4.9±1.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(N)=O
DRAMP30478	MTWEEWDKKIEEYTKKIEEL	20	MT-SC18EK	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50>2000 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>2000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@@H](C)O
DRAMP30479	MTWEEWDKKIEEYTKKIEELIKKSQNQQEKN	31	MT-WQ-EKN	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.1±0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.8±0.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(N)=O
DRAMP30480	WEEWDKKIEEYTKKIEELIKKSQNQQEKN	29	WQ-EKN	Q5DP94	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.4±0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.8±0.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31277353	Viruses. 2019 Jul 3;11(7):609. 	Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(N)=O
DRAMP30481	YTSLIREILVESRIQQEKNERELRDIDKWASLWNWF	36	T20v1(T20 [H6R; S7E; L8,26I; I9L; E10V; Q13,21R; N14I; L24R; E25D])	P04578	Retroviridae	Not found	Synthetic construct(derived from T20)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.06 µg/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.10 µg/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.06 µg/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.17 µg/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.12 µg/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.06 µg/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=0.29 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP30482	YTSLIHSIIEESRNRQEKNEQALLELDKWASLWNWF	36	T20v2(T20 [L8I; Q13,15R; E22A])	P04578	Retroviridae	Not found	Synthetic construct(derived from T20)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.06 µg/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.06 µg/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.03 µg/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.17 µg/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.09 µg/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.03 µg/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=1.05 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP30483	YTSLLRSIIEEGRNQQEKNEQALLELDKWASLWNWF	36	T20v3(T20 [I5L, H6R, L8I; S12G; Q13R; E22A])	P04578	Retroviridae	Not found	Synthetic construct(derived from T20)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.13 µg/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.08 µg/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.03 µg/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.19 µg/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.08 µg/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.03 µg/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=1.34 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP30484	YTSLIRSIIEESRNQQEKNEQKLLEVDKWASLWNWF	36	T20v4(T20 [H6R, L8I, Q13R, E22K, L26V])	P04578	Retroviridae	Not found	Synthetic construct(derived from T20)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.15 µg/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.12 µg/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.04 µg/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.22 µg/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.50 µg/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.03 µg/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=1.80 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP30485	YTSLLRSLIEESRNLQEKNEQALLEVDKWASLWNWF	36	T20v5(T20 [I5L, H6R, Q13R, Q15L, E22A, L26V])	P04578	Retroviridae	Not found	Synthetic construct(derived from T20)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.17 µg/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.15 µg/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.14 µg/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.50 µg/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.29 µg/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.13 µg/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=5.69 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP30486	YTSLLWSIIEEGRNLQEKNEQKLLELDKWASLWNWF	36	T20v6(T20 [I5L, H6W, L8I, S12G, Q13R, Q15L, E22K])	P04578	Retroviridae	Not found	Synthetic construct(derived from T20)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.16 µg/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.14 µg/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.21 µg/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.62 µg/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.59 µg/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.10 µg/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=5.68 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP30487	YTSLIWKVLNDAREQQENNQETLVEIDKWASLWNWF	36	T20v7(T20 [H6W; S7K; L8,24V; I9L; E10N; E11D; S12A; Q13R; N14E; K18N; E20Q; Q21E; L26I])	P04578	Retroviridae	Not found	Synthetic construct(derived from T20)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.37 µg/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.16 µg/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.45 µg/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=1.12 µg/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.23 µg/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.07 µg/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=5.10 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(C)C
DRAMP30488	YTSLIREIMNKSWGQQRRNEGTLAEIDKWASLWNWF	36	T20v8(T20 [H6R; S7E; L8,26I; I9M; E10N; E11K; Q13W; N14G; E17R; K18R; Q21G; E22T; L24A])	P04578	Retroviridae	Not found	Synthetic construct(derived from T20)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.40 µg/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.24 µg/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.31 µg/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.53 µg/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=1.11 µg/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.24 µg/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=10.2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP30489	YTSLIRELISNARTQQTDNEESLRNVDKWASLWNWF	36	T20v9(T20 [H6R; S7E; E10,22S; E11,25N; S12A; Q13R; N14T; E17T; K18D; Q21E; L24R; L26V])	P04578	Retroviridae	Not found	Synthetic construct(derived from T20)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=1.20 µg/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.34 µg/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.41 µg/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.82 µg/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=1.09 µg/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.35 µg/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=16.8 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O)[C@@H](C)O
DRAMP30490	YTSLIWSIIIDGREQQRDNEGVLADLDKWASLWNWF	36	T20v10(T20 [H6W; L8I; E10I;E11D;S12G;Q13R;N14E;E17R;K18D;Q21G;E22V;L24D;E25D])	P04578	Retroviridae	Not found	Synthetic construct(derived from T20)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=23.3 µg/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.50 µg/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=3.35 µg/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=12.0 µg/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.45 µg/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.11 µg/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=24.4 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30491	EKINQSLAFIRKSDELLHNV	20	peptide 4(RSV fusion protein(497-515))	P03420	Paramyxoviridae	Not found	Synthetic construct(derived from RSV fusion protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50>50 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30492	EKINQSLXFIRXSDXLLHXV	20	peptide 4a(derived from RSV fusion protein(497-515))	No entry found	Paramyxoviridae	Not found	Synthetic construct(derived from RSV fusion protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.82±0.42 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 8,12,15,19 indicates S-pentenylalanine, X(8) and X(12), X(15) and X(19) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30493	EKIXQSLXFIXKSDXLLHNV	20	peptide 4bb(derived from RSV fusion protein(497-515))	No entry found	Paramyxoviridae	Not found	Synthetic construct(derived from RSV fusion protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.74±0.27 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30494	EXINXSLXFIRXSDELLHNV	20	peptide 4ca(derived from RSV fusion protein(497-515))	No entry found	Paramyxoviridae	Not found	Synthetic construct(derived from RSV fusion protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.59±0.13 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 2 indicates R-pentenylalanine; The 'X' at position 5,8,12 indicates S-pentenylalanine, X(2) and X(5), X(8) and X(12) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30495	XKINQSLXFIRXSDELLHXV	20	peptide 4ef(derived from RSV fusion protein(497-515))	No entry found	Paramyxoviridae	Not found	Synthetic construct(derived from RSV fusion protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=3.07±1.45 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 1,8 indicates R-octenyl-alanine; The 'X' at position 12,19 indicates S-pentenylalanine, X(1) and X(8), X(12) and X(19) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30496	EKIXQSLXFIRXSDELLHXV	20	peptide 4bf(derived from RSV fusion protein(497-515))	No entry found	Paramyxoviridae	Not found	Synthetic construct(derived from RSV fusion protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=2.49±0.09 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 12 indicates R-octenyl-alanine; The 'X' at position 4,8,19 indicates S-pentenylalanine, X(4) and X(8), X(12) and X(19) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30497	EKIAQSLXFIRXSDXLLHXV	20	peptide 4a[N500A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=20.41±2.4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 8,12,15,19 indicates S-pentenylalanine, X(8) and X(12), X(15) and X(19) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30498	EKINQSLXFIAXSDXLLHXV	20	peptide 4a[R507A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=175±0.00 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 8,12,15,19 indicates S-pentenylalanine, X(8) and X(12), X(15) and X(19) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30499	AKIXQSLXFIXKSDXLLHNV	20	peptide 4bb[E497A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.16±0.08 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30500	EAIXQSLXFIXKSDXLLHNV	20	peptide 4bb[K498A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.60±0.02 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30501	EKAXQSLXFIXKSDXLLHNV	20	peptide 4bb[I499A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.30±0.89 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30502	EKIXASLXFIXKSDXLLHNV	20	peptide 4bb[Q501A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.28±0.43 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30503	EKIXQALXFIXKSDXLLHNV	20	peptide 4bb[S502A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.66±0.26 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30504	EKIXQSAXFIXKSDXLLHNV	20	peptide 4bb[L503A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.95±0.53 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30505	EKIXQSLXAIXKSDXLLHNV	20	peptide 4bb[F505A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.39±0.10 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30506	EKIXQSLXFAXKSDXLLHNV	20	peptide 4bb[I506A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=10.44±2.97 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30507	EKIXQSLXFIXASDXLLHNV	20	peptide 4bb[K508A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=10.93±13.90 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30508	EKIXQSLXFIXKADXLLHNV	20	peptide 4bb[S509A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=82.04±1.56 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30509	EKIXQSLXFIXKSAXLLHNV	20	peptide 4bb[D510A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.10±0.08 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30510	EKIXQSLXFIXKSDXALHNV	20	peptide 4bb[L512A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.88±0.06 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30511	EKIXQSLXFIXKSDXLLANV	20	peptide 4bb[H514A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.52±0.07 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30512	EKIXQSLXFIXKSDXLLHAV	20	peptide 4bb[N515A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=2.71±2.93 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30513	EKIXQSLXFIXKSDXLLHNA	20	peptide 4bb[V516A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.60±0.03 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30514	EXINXSLXFIRXSDALLHNV	20	peptide 4ca[E511A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.00±0.03 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	The 'X' at position 2 indicates R-pentenylalanine; The 'X' at position 5,8,12 indicates S-pentenylalanine, X(2) and X(5), X(8) and X(12) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O.	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	
DRAMP30515	YTSLIHSLIEESQNQQEKNEQELLEX	26	LP-53	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2949±400 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=9968±2224 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=21352±1876 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 26 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30516	YTSLIEELIKKSEEQQKKNEEELKX	25	LP-54	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=149±48 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=301±26 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1796±340 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 25 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30517	WEQKIEELLKKAEEQQKKNEEELKKX	26	LP-55	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=14±2 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=8±1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=12±1 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.11-189.34 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=10.67-137.77 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.19-10.61 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=34 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 25 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30518	WEQKIEELLKKAEEQQKKNEEELKXX	26	LP-56	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=12±2 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=9±1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=11±2 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 26 is Lys-C16(palmitic acid),The 'X' at position 25 is Lys-AEEA(8-amino-3,6-dioxaoctanoic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30519	WEQKIEELLKKAEEQQKKNEEEX	23	LP-57	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=213±21 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=178±38 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1917±440 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 23 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30520	WEQKIEELLKKAEEQQKKNEX	21	LP-58	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=143000±19911 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=110900±3715 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=107033±9473 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 21 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30521	WEQKIEELLKKAEEQQKX	18	LP-59	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>900000 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=240800±23649 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=210477±25537 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 18 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30522	SLIEELIKKSEEQQKKNEEELKKLEX	26	LP-60	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=55±6 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=48±6 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=62±27 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 26 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30523	IEELIKKSEEQQKKNEEELKKLEX	24	LP-61	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=85±9 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=43±9 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=126±63 pM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=144 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 24 is Lys-C16(palmitic acid)	L	[Ref.30089693]TZM-bl cell:CC50=193.63±13.92 μM;##MT-4 cell:CC50=164.47±37.69 μM;##HEK293T cell:CC50=140.43± 10.7μM;##PBMC:CC50=46.43± 2.6 μM.	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30524	EQKIEELLKKAEEQQKKNEEELKKLEX	27	LP-62	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=15±1 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=5±1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=12±1 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 27 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30525	QKIEELLKKAEEQQKKNEEELKKLEX	26	LP-63	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=17±5 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=6±2 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=13±2 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 26 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30526	KIEELLKKAEEQQKKNEEELKKLEX	25	LP-64	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=128±27 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=36±1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=25±2 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.04 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.08-140.75 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.23-0.75 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.10-0.11 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=58 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 25 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30527	IEELLKKAEEQQKKNEEELKKLEX	24	LP-65	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=14±3 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=8±3 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=7±2 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.15-88.63 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.23-0.75 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.07-0.04 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=35 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 24 is Lys-C16(palmitic acid)	L	[Ref.30089693]TZM-bl cell:CC50=256.23 ±14.58 μM;##MT-4 cell:CC50=213.4±59.59 μM;##HEK293T cell:CC50=208.43± 22.9μM;##PBMC:CC50=49.95± 2.97 μM.	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30528	EELLKKAEEQQKKNEEELKKLEX	23	LP-66	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1008±248 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=434±71 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1109±193 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 23 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30529	LLEQAEEQQKKNEEELKKLEX	21	LP-67	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=3417±419 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=627±154 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1527±565 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 21 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30530	AEEQQKKNEEELKKLEX	17	LP-68	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>250000 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>250000 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>250000 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 17 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30531	IEELLKKAEEQQKKNEEELKX	21	LP-69	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=239±16 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=125±27 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=157±29 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.31 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=2.01-1815.67 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=9.83-152.28 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.56-11.91 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=1391 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 21 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30532	INNYTSLIEELIKKSEEQQKKNEEELKKLEX	31	LP-70	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=25±3 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=21±4 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=30±10 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 31 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30533	IEEYTKKIEEILKKSEEQQKKNEEELKKLEX	31	LP-71	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=27±2 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=25±3 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=55±5 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 31 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30534	VRYLEANIEELLKKAEEQQKKNEEELKKLEX	31	LP-72	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=23±3 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=28±1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=24±9 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 31 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30535	VEELEKKIEELLKKAEEQQKKNEEELKKLEX	31	LP-73	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=33±6 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=19±3 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=42±2 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 31 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30536	WEEWEKKIEEYTKKIEEILKKSEEQQKKNEEELKKLEX	38	LP-74	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=110±10 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=59±11 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=59±32 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 38 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30537	EMTWEEWEKKIEEYTKKIEEILKKSEEQQKKNEEELKKLEX	41	LP-75	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=100±22 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=65±8 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=86±26 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 41 is Lys-C16(palmitic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30538	WQEWEQKITALLEQAQIQQEKNEYELQKLDKX	32	LP-46	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=88±4 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=50±8 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=44±7 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 31 is Lys-C16(palmitic acid).	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30539	WEQKITALLEQAQIQQEKNEYELQKLDKX	29	LP-48	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=83±9 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=47±6 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=37±4 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 28 is Lys-C16(palmitic acid).	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30540	WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLX	35	C34-C16	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=247±28 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=65±25 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=109±13 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 35 is Lys-C16(palmitic acid).	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30541	WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLGSGX	38	C34-Chol	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=316±62 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=24±2 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=37±5 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 38 is Cys-Chol(cholesterol)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30542	YTSLIEELIKKSEEQQKKNEEELKKLEK	28	P-50	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=35.6±1.3 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=191.1±57.2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=21.8±3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30543	LEANIEELLKKAEEQQKKNEEELKKLEK	28	P-51	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=10.2±0.7 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=24.9±2.9 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=45.4±10.7 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30544	WEQKIEELLKKAEEQQKKNEEELKKLEK	28	P-52	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.9±0.1 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=1.9±0.6 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1.9±0.4 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=20541 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.30089693]TZM-bl cell:CC50=916.6 ±42.46 μM;##MT-4 cell:CC50=770.63±131.46 μM;##HEK293T cell:CC50=649.07± 37.03μM;##PBMC:CC50=91.19± 20.46 μM.	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30545	YTSLIEELIKKSEEQQKKNEEELKK	25	P-54	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30546	WEQKIEELLKKAEEQQKKNEEELKK	25	P-55	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=14.2±1.8 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=16.9±2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=32.3±9.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30547	WEQKIEELLKKAEEQQKKNEEEK	23	P-57	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30548	WEQKIEELLKKAEEQQKKNEK	21	P-58	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30549	WEQKIEELLKKAEEQQKK	18	P-59	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30550	SLIEELIKKSEEQQKKNEEELKKLEK	26	P-60	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=591.4±65.2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP30551	EQKIEELLKKAEEQQKKNEEELKKLEK	27	P-62	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=25.3±2.6 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=44.2±2.6 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=22.1±3.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30552	QKIEELLKKAEEQQKKNEEELKKLEK	26	P-63	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=16.1±2.5 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=24±2.2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=24.4±2.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30553	KIEELLKKAEEQQKKNEEELKKLEK	25	P-64	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=7.6±1.3 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=9.3±0.6 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=10.4±2.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30554	IEELLKKAEEQQKKNEEELKKLEK	24	P-65	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=17.9±2.2 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=25.7±1.3 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=25.8±1.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30555	IEELLKKAEEQQKKNEEELKK	21	P-69	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>7508 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30556	INNYTSLIEELIKKSEEQQKKNEEELKKLEK	31	P-70	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=8.5±0.5 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=36.5±6.4 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=49.7±5.7 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP30557	IEEYTKKIEEILKKSEEQQKKNEEELKKLEK	31	P-71	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2.1±0.2 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=9.1±3.2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=38.7±7.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP30558	VRYLEANIEELLKKAEEQQKKNEEELKKLEK	31	P-72	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=4.1±0.9 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=16.2±3.4 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=15.9±1.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(C)=O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30559	VEELEKKIEELLKKAEEQQKKNEEELKKLEK	31	P-73	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2±0.2 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=5.6±0.7 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=8.2±1.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(C)=O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30560	WEEWEKKIEEYTKKIEEILKKSEEQQKKNEEELKKLEK	38	P-74	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.4±0.1 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=0.8±0.1 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1.4±0.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP30561	EMTWEEWEKKIEEYTKKIEEILKKSEEQQKKNEEELKKLEK	41	P-75	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.4±0.1 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=0.9±0.2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=0.6±0.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP30562	ILPWKWPWWPWPP	13	Indolicidin [R12P][R13P]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Indolicidin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.	[Ref.15482931]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=16 µM);inhibition of strand transfer catalyzed by integrase(IC50=13 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidtion		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HIV Integrase	15482931	Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.	Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP. 	Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.	
DRAMP30563	LPWKWPWWPWPP	12	Indolicidin (2-13)[R12P][R13P]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Indolicidin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.	[Ref.15482931]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=185 µM);inhibition of strand transfer catalyzed by integrase(IC50=215 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidtion		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HIV Integrase	15482931	Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.	Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP. 	Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.	
DRAMP30564	ILPWKWPWWPWP	12	Indolicidin (1-12)[R12P]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Indolicidin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.	[Ref.15482931]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=180 µM);inhibition of strand transfer catalyzed by integrase(IC50=80 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidtion		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HIV Integrase	15482931	Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.	Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP. 	Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.	
DRAMP30565	ILPWGWPWWPWPP	13	Indolicidin [K5G;R12P;R13P]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Indolicidin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.	[Ref.15482931]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>333 µM);inhibition of strand transfer catalyzed by integrase(IC50>333 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidtion		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HIV Integrase	15482931	Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.	Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP. 	Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.	
DRAMP30566	ILAWKWAWWAWPP	13	Indolicidin [P3,7,10A,R12,13P]	No entry found	Retroviridae	Not found	Synthetic construct(derived from Indolicidin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.	[Ref.15482931]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=54 µM);inhibition of strand transfer catalyzed by integrase(IC50=41 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidtion		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HIV Integrase	15482931	Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.	Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP. 	Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.	
DRAMP30567	LLEYSI	6	peptide 1 from hydrolysate of oyster	No entry found	Retroviridae	Not found	Crassostrea gigas(hydrolysate of oyster)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HIV-1 protease is a virally encoded protease that serves to cleave the gag and gag-pol polyprotein precursor into mature, functional proteins. This specific proteolysis occurs late in the viral life cycle and is essential for the maturation of the infectious virus. The peptide inhibits HIV-1 protease and thus acts antiviral activity.	[Ref.9918775]HIV-1:inhibition of HIV-1 protease(IC50=20 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HIV-1 protease	9918775	Biochem Biophys Res Commun. 1998 Dec 30;253(3):604-8.	Lee TG, Maruyama S. 	Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
DRAMP30568	LLEYSL	6	peptide 2 from hydrolysate of oyster	No entry found	Retroviridae	Not found	Crassostrea gigas(hydrolysate of oyster)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HIV-1 protease is a virally encoded protease that serves to cleave the gag and gag-pol polyprotein precursor into mature, functional proteins. This specific proteolysis occurs late in the viral life cycle and is essential for the maturation of the infectious virus. The peptide inhibits HIV-1 protease and thus acts antiviral activity.	[Ref.9918775]HIV-1:inhibition of HIV-1 protease(IC50=15 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HIV-1 protease	9918775	Biochem Biophys Res Commun. 1998 Dec 30;253(3):604-8.	Lee TG, Maruyama S. 	Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
DRAMP30569	LLEYS	5	peptide derived from hydrolysate of oyster	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HIV-1 protease is a virally encoded protease that serves to cleave the gag and gag-pol polyprotein precursor into mature, functional proteins. This specific proteolysis occurs late in the viral life cycle and is essential for the maturation of the infectious virus. The peptide inhibits HIV-1 protease and thus acts antiviral activity.	[Ref.9918775]HIV-1:inhibition of HIV-1 protease(IC50=120 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HIV-1 protease	9918775	Biochem Biophys Res Commun. 1998 Dec 30;253(3):604-8.	Lee TG, Maruyama S. 	Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins.	CC(C)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30570	LEYSI	5	peptide derived from hydrolysate of oyster	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HIV-1 protease is a virally encoded protease that serves to cleave the gag and gag-pol polyprotein precursor into mature, functional proteins. This specific proteolysis occurs late in the viral life cycle and is essential for the maturation of the infectious virus. The peptide inhibits HIV-1 protease and thus acts antiviral activity.	[Ref.9918775]HIV-1:inhibition of HIV-1 protease(IC50=550 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HIV-1 protease	9918775	Biochem Biophys Res Commun. 1998 Dec 30;253(3):604-8.	Lee TG, Maruyama S. 	Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)O
DRAMP30571	LLEY	4	peptide derived from hydrolysate of oyster	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HIV-1 protease is a virally encoded protease that serves to cleave the gag and gag-pol polyprotein precursor into mature, functional proteins. This specific proteolysis occurs late in the viral life cycle and is essential for the maturation of the infectious virus. The peptide inhibits HIV-1 protease and thus acts antiviral activity.	[Ref.9918775]HIV-1:inhibition of HIV-1 protease(IC50=5100 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HIV-1 protease	9918775	Biochem Biophys Res Commun. 1998 Dec 30;253(3):604-8.	Lee TG, Maruyama S. 	Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins.	CC(C)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30572	LEYS	4	peptide derived from hydrolysate of oyster	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HIV-1 protease is a virally encoded protease that serves to cleave the gag and gag-pol polyprotein precursor into mature, functional proteins. This specific proteolysis occurs late in the viral life cycle and is essential for the maturation of the infectious virus. The peptide inhibits HIV-1 protease and thus acts antiviral activity.	[Ref.9918775]HIV-1:inhibition of HIV-1 protease(IC50=4800 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HIV-1 protease	9918775	Biochem Biophys Res Commun. 1998 Dec 30;253(3):604-8.	Lee TG, Maruyama S. 	Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins.	CC(C)C[C@H](N)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30573	FVFLM	5	FM5	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)O
DRAMP30574	PFVFLM	6	PM6	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 μM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50>200 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)O
DRAMP30575	KPFVFLM	7	KM7	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
DRAMP30576	NKPFVFLM	8	NM8	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)O
DRAMP30577	PFVYLI	6	PI6	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)O
DRAMP30578	PFVFLE	6	PE6	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 μM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50>200 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30579	EFVFLM	6	EM6	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)O
DRAMP30580	PEVFLM	6	PEM6	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 μM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50>200 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)O
DRAMP30581	PFVFLR	6	PR6	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 μM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50>200 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30582	CPFVFLM	7	CPM	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50=8.96 ± 2.23 μM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells between H9/HIV-1IIIB cells and MT-2 cells(IC50=67.20 ± 4.05 μM);##HIV-1:inhibition of pseudovirus infection(IC50=5.95 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)		L	[Ref.22406118]MT-2 cells:CC50>200 μM.	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	
DRAMP30583	CPFVFLE	7	CPE	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50=55.84 ± 3.31μM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50=115.58 ± 6.28 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)		L	[Ref.22406118]MT-2 cells:CC50>200 μM.	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	
DRAMP30584	CPFVFLR	7	CPR	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50=74.07± 22.84 μM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50=73.98 ± 7.44 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)		L	[Ref.22406118]MT-2 cells:CC50>200 μM.	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	
DRAMP30585	CPEVFLM	7	CPEM	No entry found	Retroviridae	Not found	Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 μM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50>200 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)		L	[Ref.22406118]MT-2 cells:CC50>200 μM.	Not found	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5. 	Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.	Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.	
DRAMP30586	IWNHGNITLGEWYNQTKDLQQKFYEIIMDIEQNNV	35	T1562(FIV envelope protein (724-758))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.318 μM,EC90=1.236 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(N)=O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC
DRAMP30587	WNHGNITLGEWYNQTKDLQQKFYEIIMDIEQNNVQ	35	T1568(FIV envelope protein (725-759))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.259 μM,EC90=0.971 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(N)=O)C(C)C
DRAMP30588	GNITLGEWYNQTKDLQQKFYEIIMDIEQNNVQG	33	T1967(FIV envelope protein (728-760))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=2.454 μM,EC90>2.518 μM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50=2.053 μM,EC90>2.518 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(N)=O)C(C)C
DRAMP30589	NITLGEWYNQTKDLQQKFYEIIMDIEQNNVQGK	33	T1968(FIV envelope protein (729-761))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.586 μM,EC90=2.067 μM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50>2.473 μM,EC90>2.473 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP30590	ITLGEWYNQTKDLQQKFYEIIMDIEQNNVQGKKGI	35	T1569(FIV envelope protein (730-764))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.026 μM,EC90=0.117 μM);inhibition of virus infection in FCD4-E cells(EC50=0.055 μM,EC90=0.106 μM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50>2.356 μM,EC90>2.356 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(C)=O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(N)=O
DRAMP30591	TLGEWYNQTKDLQQKFYEIIMDIEQNNVQGKKG	33	T1969(FIV envelope protein (731-763))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.435 μM,EC90=1.413 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(C)=O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)C(C)C
DRAMP30592	LGEWYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQ	35	T1577(FIV envelope protein (732-766))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.050 μM,EC90=0.162 μM);inhibition of virus infection in FCD4-E cells(EC50=0.098 μM,EC90=0.177 μM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50=1.933 μM,EC90>2.342 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP30593	GEWYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQL	35	T1971(FIV envelope protein (733-767))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.012 μM,EC90=0.033 μM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50>2.342 μM,EC90>2.342 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.12186891]No cytotoxic effects against HeLa cells at the concentration of 23 μM.	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30594	EWYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQ	35	T1972(FIV envelope protein (734-768))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.012 μM,EC90=0.054 μM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50>2.304 μM,EC90>2.304 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.12186891]No cytotoxic effects against HeLa cells at the concentration of 23 μM.	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP30595	WYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQK	35	T1578(FIV envelope protein (735-769))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.020 μM,EC90=0.090 μM);inhibition of virus infection in FCD4-E cells(EC50=0.053 μM,EC90=0.157 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30596	YNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQKW	35	T1588(FIV envelope protein (736-770))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.030 μM,EC90=0.125 μM);inhibition of virus infection in FCD4-E cells(EC50=0.168 μM,EC90=0.4236 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP30597	NQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQKWE	35	T1988(FIV envelope protein (737-771))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=1.990 μM,EC90>2.322 μM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50>2.322 μM,EC90>2.322 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP30598	QTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQKWED	35	T1989(FIV envelope protein (738-772))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50>2.321 μM,EC90>2.321 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(N)=O
DRAMP30599	TKDLQQKFYEIIMDIEQNNVQGKKGIQQLQKWEDW	35	T1589(FIV envelope protein (739-773))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=1.145 μM,EC90>2.290 μM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50>2.321 μM,EC90>2.321 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP30600	FYEIIMDIEQNNVQGKKGIQQLQKWEDWVGWIGNI	35	T1566(FIV envelope protein (746-780))	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50>2.346 μM,EC90>2.346 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	12186891	J Virol. 2002 Sep;76(18):9079-86.	Medinas RJ, Lambert DM, Tompkins WA.	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC)C(N)=O
DRAMP30601	XTWXEWDREINNYTSLIHSLIEESQNQQEKNEQELLE	37	T649v	P04582	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts assembly of the six-helix bundle viral fusion apparatus by mimicking the heptad repeat 2 (HR2) oligomerization domain of the gp41 envelope glycoprotein.	[Ref.20660316]HIV-1 HxB2:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=2.9±0.4 nM);##HIV-1 YU2:inhibition of virus infection in Cf2Th-CD4-CCR5 cells(IC50>3000 nM);##HIV-1 V38A/N42T:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=15.8±1.9 nM);##HIV-1 V38E/N42S:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=44.4±6.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	The 'X' at position 1 indicates Norleucine.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	20660316	Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14093-8.	Bird GH, Madani N, Perry AF, Princiotto AM, Supko JG, He X, Gavathiotis E, Sodroski JG, Walensky LD. 	Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic.	
DRAMP30602	XTWXEWDXEINNYTSLIHSLIEESQNQQEKNEQELLE	37	SAH-gp41(626-662)A	P04582	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts assembly of the six-helix bundle viral fusion apparatus by mimicking the heptad repeat 2 (HR2) oligomerization domain of the gp41 envelope glycoprotein.	[Ref.20660316]HIV-1 HxB2:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=2.1±0.3 nM);##HIV-1 YU2:inhibition of virus infection in Cf2Th-CD4-CCR5 cells(IC50=339±162 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	The 'X' at position 1 indicates Norleucine,the 'X' at position 4,8 indicates S-2-(4'-pentenyl) alanine. X(4) and X (5) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	20660316	Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14093-8.	Bird GH, Madani N, Perry AF, Princiotto AM, Supko JG, He X, Gavathiotis E, Sodroski JG, Walensky LD. 	Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic.	
DRAMP30603	XTWMEWDREINNYTSLIHSLIEESQNQXEKNXQELLE	37	SAH-gp41(626-662) B	P04582	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts assembly of the six-helix bundle viral fusion apparatus by mimicking the heptad repeat 2 (HR2) oligomerization domain of the gp41 envelope glycoprotein.	[Ref.20660316]HIV-1 HxB2:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=4.5±1.4 nM);##HIV-1 YU2:inhibition of virus infection in Cf2Th-CD4-CCR5 cells(IC50=1958±259 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	The 'X' at position 1 indicates Norleucine,the 'X' at position 28,32 indicates S-2-(4'-pentenyl) alanine. X(28) and X (32) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	20660316	Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14093-8.	Bird GH, Madani N, Perry AF, Princiotto AM, Supko JG, He X, Gavathiotis E, Sodroski JG, Walensky LD. 	Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic.	
DRAMP30604	XTWXEWDXEINNYTSLIHSLIEESQNQXEKNXQELLE	37	SAH-gp41(626-662) A,B	P04582	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide disrupts assembly of the six-helix bundle viral fusion apparatus by mimicking the heptad repeat 2 (HR2) oligomerization domain of the gp41 envelope glycoprotein.	[Ref.20660316]HIV-1 HxB2:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=2.5±0.2 nM);##HIV-1 YU2:inhibition of virus infection in Cf2Th-CD4-CCR5 cells(IC50=87±30 nM);##HIV-1 V38A/N42T:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=10.7±2.2 nM);##HIV-1 V38E/N42S:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=16.1±3.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	The 'X' at position 1 indicates Norleucine,the 'X' at position 4,8.28,32 indicates S-2-(4'-pentenyl) alanine. X(4) and X (5),  X(28) and X (32) are cross-linked by hydrocarbon stapling.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	20660316	Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14093-8.	Bird GH, Madani N, Perry AF, Princiotto AM, Supko JG, He X, Gavathiotis E, Sodroski JG, Walensky LD. 	Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic.	
DRAMP30605	AEEASKKAEEASKKAEEASKKAEEASKKAEEASKKXX	37	AAS	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus–cell membrane fusion.	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=4.47±1.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at 36 indicates β-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid).	L	[Ref.30192544]Huh-7 cell:CC50=2.38±0.9 μM.	membrane	30192544	 J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K. 	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. 	
DRAMP30606	VEEVSKKVEEVSKKVEEVSKKVEEVSKKVEEVSKKXX	37	VVS	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus–cell membrane fusion.	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at 36 indicates β-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid).	L	[Ref.30192544]Huh-7 cell:CC50=74.5±6.8 μM.	membrane	30192544	 J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K. 	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. 	
DRAMP30607	FEEFSKKFEEFSKKFEEFSKKFEEFSKKFEEFSKKXX	37	FFS	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus–cell membrane fusion.	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=3.11±0.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at 36 indicates β-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid).	L	[Ref.30192544]Huh-7 cell:CC50>100 μM.	membrane	30192544	 J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K. 	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. 	
DRAMP30608	YEEYSKKYEEYSKKYEEYSKKYEEYSKKYEEYSKKXX	37	YYS	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus–cell membrane fusion.	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=6.26±2.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at 36 indicates β-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid).	L	[Ref.30192544]Huh-7 cell:CC50=19.8±1.6 μM.	membrane	30192544	 J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K. 	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. 	
DRAMP30609	LEELSKKLEELSKKLEELSKKLEELSKKLEELSKKXX	37	LLS	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus–cell membrane fusion.	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=0.24±0.08 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at 36 indicates β-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid).	L	[Ref.30192544]Huh-7 cell:CC50=4.04±0.4 μM.	membrane	30192544	 J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K. 	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. 	
DRAMP30610	IEEISKKIEEISKKIEEISKKIEEISKKIEEISKKXX	37	IIS	No entry found	Coronaviridae, Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus–cell membrane fusion.	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=0.10±0.02 μM);##A/Puerto Rico/8/34 (H1N1):inhibition of virus infection in MDCK cells(EC50=1.96±0.28 μM);##A/Hong Kong/8/68 (H3N2):inhibition of virus infection in MDCK cells(EC50=6.38±1.06 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at 36 indicates β-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid).	L	[Ref.30192544]Huh-7 cell:CC50=88.8±28 μM;##MDCK cell:CC50>100 μM.	membrane	30192544	 J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K. 	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. 	
DRAMP30611	IEEIYKKIEEIYKKIEEIYKKIEEIYKKIEEIYKKXX	37	IIY	No entry found	Coronaviridae, Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus–cell membrane fusion.	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=0.52±0.4 μM);##A/Puerto Rico/8/34 (H1N1):inhibition of virus infection in MDCK cells(EC50=3.15±1.79 μM);##A/Hong Kong/8/68 (H3N2):inhibition of virus infection in MDCK cells(EC50=12.9±5.55 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at 36 indicates β-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid).	L	[Ref.30192544]Huh-7 cell:CC50>100 μM;##MDCK cell:CC50>100 μM.	membrane	30192544	 J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K. 	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. 	
DRAMP30612	IEEIWKKIEEIWKKIEEIWKKIEEIWKKIEEIWKKXX	37	IIW	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus–cell membrane fusion.	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=10.6±2.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at 36 indicates β-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid).	L	[Ref.30192544]Huh-7 cell:CC50>100 μM.	membrane	30192544	 J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K. 	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. 	
DRAMP30613	IEEIHKKIEEIHKKIEEIHKKIEEIHKKIEEIHKKXX	37	IIH	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus–cell membrane fusion.	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=1.68±0.47 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at 36 indicates β-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid).	L	[Ref.30192544]Huh-7 cell:CC50>100 μM.	membrane	30192544	 J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K. 	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. 	
DRAMP30614	IEEIQKKIEEIQKKIEEIQKKIEEIQKKIEEIQKKXX	37	IIQ	No entry found	Coronaviridae, Orthomyxoviridae, Filoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus–cell membrane fusion.	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=0.11±0.02 μM);inhibition of pseudovirus infection in Huh-7 cells(IC50=0.13±0.1 μM);##A/Puerto Rico/8/34 (H1N1):inhibition of virus infection in MDCK cells(EC50=1.73±0.81 μM);##A/Hong Kong/8/68 (H3N2):inhibition of virus infection in MDCK cells(EC50=0.70±0.09 μM);##HIV-1 inhibition of cell-cell fusion in TZM-bl cells(EC50=3.63 ±0.54 μM);##Ebola virus (EboV):inhibition of pseudovirus infection in TZM-bl cells(EC50=1.02 ± 0.54 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at 36 indicates β-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid).	L	[Ref.30192544]Huh-7 cell:CC50>100 μM;##MDCK cell:CC50>100 μM;##TZM-bl cell:CC50>100 μM.	membrane	30192544	 J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K. 	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. 	
DRAMP30615	IEEIKKKIEEIKKKIEEIKKKIEEIKKKIEEIKKKXX	37	IIK	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus–cell membrane fusion.	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=0.45±0.13 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at 36 indicates β-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid).	L	[Ref.30192544]Huh-7 cell:CC50=4.54±0.6 μM.	membrane	30192544	 J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K. 	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. 	
DRAMP30616	IEEIEKKIEEIEKKIEEIEKKIEEIEKKIEEIEKKXX	37	IIE	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus–cell membrane fusion.	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=2.93±0.95 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at 36 indicates β-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid).	L	[Ref.30192544]Huh-7 cell:CC50>100 μM.	membrane	30192544	 J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K. 	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. 	
DRAMP30617	LWGEIWNTVKGLI	13	Eval418	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.29290802]HSV-1:inhibition of viral inactivation in Vero cells(IC50=2.48 μg/ml);inhibition of viral attachment in Vero cells(IC50=3.70 μg/ml);inhibition of viral entry in Vero cells(IC50=31.71 μg/ml).	[Ref.29290802]the cell viability of erythrocytes was also more than 95% at concentrations of Eval418 of 10 μg/mL or less.	Linear	Free	Amidation		L	[Ref.29290802]Vero cell:CC50=68.50μg/mL; the cell viability of the peptide-treated Vero cells was greater than 95% after treatment with Eval418 at 10 μg/mL.	Not found	29290802	Theranostics. 2018 Jan 1;8(1):199-211. 	Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z.	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@@H](C)O)C(C)C)C(N)=O
DRAMP30618	LWGHIWNFVHGLI	13	Eval418-FH2	No entry found	Herpesviridae	Not found	Synthetic construct(derived from Eval418)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.29290802]HSV-1:inhibition of viral inactivation in Vero cells(IC50=1.50 μg/ml);inhibition of viral attachment in Vero cells(IC50=1.43 μg/ml);inhibition of viral entry in Vero cells(IC50=8.63 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.29290802]Vero cell:CC50=27.60 μg/mL.	Not found	29290802	Theranostics. 2018 Jan 1;8(1):199-211. 	Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z.	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(C)C)C(N)=O
DRAMP30619	LWHHIWNFVHGLI	13	Eval418-FH3	No entry found	Herpesviridae	Not found	Synthetic construct(derived from Eval418)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.29290802]HSV-1:inhibition of viral inactivation in Vero cells(IC50=1.01 μg/ml);inhibition of viral attachment in Vero cells(IC50=0.86 μg/ml);inhibition of viral entry in Vero cells(IC50=4.23 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.29290802]Vero cell:CC50=26.83 μg/mL.	Not found	29290802	Theranostics. 2018 Jan 1;8(1):199-211. 	Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z.	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(C)C)C(N)=O
DRAMP30620	LWHHIWNTVHHLI	13	Eval418-FH4	No entry found	Herpesviridae	Not found	Synthetic construct(derived from Eval418)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.29290802]HSV-1:inhibition of viral inactivation in Vero cells(IC50=0.87 μg/ml);inhibition of viral attachment in Vero cells(IC50=0.63 μg/ml);inhibition of viral entry in Vero cells(IC50=4.37 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.29290802]Vero cell:CC50=27.58 μg/mL.	Not found	29290802	Theranostics. 2018 Jan 1;8(1):199-211. 	Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z.	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@@H](C)O)C(C)C)C(N)=O
DRAMP30621	LWHHIWHTVHHLI	13	Eval418-FH5	No entry found	Herpesviridae	Not found	Synthetic construct(derived from Eval418)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.29290802]HSV-1:inhibition of viral inactivation in Vero cells(IC50=0.86 μg/ml);inhibition of viral attachment in Vero cells(IC50=0.67 μg/ml);inhibition of viral entry in Vero cells(IC50=2.88 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.29290802]Vero cell:CC50=106.68 μg/mL.	Not found	29290802	Theranostics. 2018 Jan 1;8(1):199-211. 	Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z.	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@@H](C)O)C(C)C)C(N)=O
DRAMP30622	LWGEIWNTVKGLI	13	Eval418	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.29290802]Herpes simplex virus type 1(HSV-1): inhibition of viral inactivation in Vero cells(IC50=2.48 µg/mL); inhibition of viral attachment in Vero cells(IC50=3.70 µg/mL); inhibition of viral entry in Vero cells(IC50=31.71 µg/mL).	[Ref.29290802]The hemolysis rate of human erythrocytes was less than 50% when the concentration of Eval418 was as high as 200 μg/mL.	Linear	Free	Amidation		L	[Ref.29290802]Vero cells: CC50 = 68.50 µg/mL.	Not found	29290802	Theranostics. 2018 Jan 1;8(1):199-211. 	Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z.	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@@H](C)O)C(C)C)C(N)=O
DRAMP30623	LWGHIWNFVHGLI	13	Eval418-FH2	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.29290802]Herpes simplex virus type 1(HSV-1): inhibition of viral inactivation in Vero cells(IC50=1.50 µg/mL); inhibition of viral attachment in Vero cells(IC50=1.43 µg/mL); inhibition of viral entry in Vero cells(IC50=8.63 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.29290802]Vero cells: CC50 = 27.60 µg/mL.	Not found	29290802	Theranostics. 2018 Jan 1;8(1):199-211. 	Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z.	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(C)C)C(N)=O
DRAMP30624	LWHHIWNFVHGLI	13	Eval418-FH3	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.29290802]Herpes simplex virus type 1(HSV-1): inhibition of viral inactivation in Vero cells(IC50=1.01 µg/mL); inhibition of viral attachment in Vero cells(IC50=0.86 µg/mL); inhibition of viral entry in Vero cells(IC50=4.23 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.29290802]Vero cells: CC50 = 26.83 µg/mL.	Not found	29290802	Theranostics. 2018 Jan 1;8(1):199-211.	Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z.	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(C)C)C(N)=O
DRAMP30625	LWHHIWNTVHHLI	13	Eval418-FH4	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.29290802]Herpes simplex virus type 1(HSV-1): inhibition of viral inactivation in Vero cells(IC50=0.87 µg/mL); inhibition of viral attachment in Vero cells(IC50=0.63 µg/mL); inhibition of viral entry in Vero cells(IC50=4.37 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.29290802]Vero cells: CC50 = 27.58 µg/mL.	Not found	29290802	Theranostics. 2018 Jan 1;8(1):199-211.	Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z.	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@@H](C)O)C(C)C)C(N)=O
DRAMP30626	LWHHIWHTVHHLI	13	Eval418-FH5	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.29290802]Herpes simplex virus type 1(HSV-1): inhibition of viral inactivation in Vero cells(IC50=0.86 µg/mL); inhibition of viral attachment in Vero cells(IC50=0.67 µg/mL); inhibition of viral entry in Vero cells(IC50=2.88 µg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.29290802]Vero cells: CC50 = 106.68 µg/mL.	Not found	29290802	Theranostics. 2018 Jan 1;8(1):199-211.	Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z.	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@@H](C)O)C(C)C)C(N)=O
DRAMP30627	WQCLTLTHRGFVLLTITVLR	20	IN-1	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit integrase and thus inhibit virus replication.	[Ref.18201721]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=38 µM);inhibition of strand transfer catalyzed by integrase(IC50=12 µM).##[Ref.19850483]HIV-1:inhibition of integrase catalytic activity(77% inhibition at 62.5μM);inhibition of virus replication in TZM-bl cells(70% inhibition at 62.5μM);inhibition of intergration(63% inhibition at 62.5μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18201721]No cytotixic against HeLa cells and H9 T-lymphocyte cultured cells up to ~62.5 μM.	Integrase	18201721##19850483	J Mol Biol. 2008 Feb 29;376(4):971-82. ##Bioorg Med Chem. 2009 Nov 15;17(22):7635-42.	Armon-Omer A, Levin A, Hayouka Z, Butz K, Hoppe-Seyler F, Loya S, Hizi A, Friedler A, Loyter A. ##Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, Friedler A. 	Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial library.##Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
DRAMP30628	WQCLTLTHRG	10	IN(1-10)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit integrase and thus inhibit virus replication.	[Ref.19850483]HIV-1:inhibition of integrase catalytic activity(73% inhibition at 62.5μM);inhibition of virus replication in TZM-bl cells(68% inhibition at 62.5μM);inhibition of intergration(64% inhibition at 62.5μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	19850483	Bioorg Med Chem. 2009 Nov 15;17(22):7635-42.	Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, Friedler A. 	Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP30629	WFVLLTITVLR	11	IN(11-20)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit integrase and thus inhibit virus replication.	[Ref.19850483]HIV-1:inhibition of integrase catalytic activity(24% inhibition at 62.5μM);inhibition of virus replication in TZM-bl cells(29% inhibition at 62.5μM);inhibition of intergration(23% inhibition at 62.5μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	19850483	Bioorg Med Chem. 2009 Nov 15;17(22):7635-42.	Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, Friedler A. 	Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
DRAMP30630	WQSLTLTHRG	10	IN(1-10)[C3S]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can inhibit integrase and thus inhibit virus replication.	[Ref.19850483]HIV-1:inhibition of integrase catalytic activity(62% inhibition at 62.5μM);inhibition of virus replication in TZM-bl cells(60% inhibition at 62.5μM);inhibition of intergration(51% inhibition at 62.5μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	19850483	Bioorg Med Chem. 2009 Nov 15;17(22):7635-42.	Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, Friedler A. 	Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP30631	VSGHGQHGVHG	11	Alloferon (3-13)	P83412	Herpesviridae, Picornaviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	"[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=500 µM);##HHV-1 clinical strain:inhibition of virus replication in Hep-2 cells(IC50=117 µM);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=38 µM);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=250	µM);inhibition of virus replication in LLC-MK2 cells(IC50=93 µM)."	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 165 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9. 	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O)C(C)C
DRAMP30632	SGHGQHGVHG	10	Alloferon (4-13)	P83412	Herpesviridae, Picornaviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=186 µM);inhibition of virus replication in Hep-2 cells(IC50=310 µM);##HHV-1 clinical strain:inhibition of virus replication in Vero cells(IC50=173 µM);inhibition of virus replication in Hep-2 cells(IC50=450 µM);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=170 µM);inhibition of virus replication in LLC-MK2 cells(IC50=170 µM);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=210 µM);inhibition of virus replication in LLC-MK2 cells(IC50=180 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 420 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9. 	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O
DRAMP30633	GHGQHGVHG	9	Alloferon (5-13)	P83412	Herpesviridae, Picornaviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Hep-2 cells(IC50=360 µM);##HHV-1 clinical strain:inhibition of virus replication in Hep-2 cells(IC50=290 µM);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=170 µM);##Coxsackie virus 971 PT B2:inhibition of virus replication in LLC-MK2 cells(IC50=230 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 448 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O
DRAMP30634	HGQHGVHG	8	Alloferon (6-13)	P83412	Herpesviridae, Picornaviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=179 µM);##HHV-1 clinical strain:inhibition of virus replication in Vero cells(IC50=117 µM);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=78 µM);inhibition of virus replication in LLC-MK2 cells(IC50=170 µM);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=190 µM);inhibition of virus replication in LLC-MK2 cells(IC50=410 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 468 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O
DRAMP30635	GQHGVHG	7	Alloferon (7-13)	P83412	Herpesviridae, Picornaviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=215 µM);inhibition of virus replication in HEp-2 cells(IC50=840 µM);##HHV-1 clinical strain:inhibition of virus replication in Vero cells(IC50=168 µM);inhibition of virus replication in Vero cells(IC50=280 µM);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=170 µM);inhibition of virus replication in LLC-MK2 cells(IC50=190 µM);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=870 µM);inhibition of virus replication in LLC-MK2 cells(IC50=170 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 775 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O
DRAMP30636	QHGVHG	6	Alloferon (8-13)	P83412	Herpesviridae, Picornaviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=1300 µM);##HHV-1 clinical strain:inhibition of virus replication in Vero cells(IC50=950 µM);inhibition of virus replication in Hep-2 cells(IC50=280 µM);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=170 µM);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=500 µM);inhibition of virus replication in LLC-MK2 cells(IC50=210 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 380 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O
DRAMP30637	HGVHG	5	Alloferon (9-13)	P83412	Herpesviridae, Picornaviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=300 µM);##HHV-1 clinical strain:inhibition of virus replication in Vero cells(IC50=400 µM);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=350 µM);inhibition of virus replication in LLC-MK2 cells(IC50=290 µM);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=350 µM);inhibition of virus replication in LLC-MK2 cells(IC50=180 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 826 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O
DRAMP30638	GVHG	4	Alloferon (10-13)	P83412	Herpesviridae, Picornaviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=500 µM);##HHV-1 clinical strain:inhibition of virus replication in Vero cells(IC50=1500 µM);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=1040 µM);inhibition of virus replication in LLC-MK2 cells(IC50=540 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 1174 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O
DRAMP30639	HGVSGHGQHGV	11	Alloferon (1-11)	P83412	Herpesviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=178 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero cells up to 260 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)O
DRAMP30640	HGVSGHGQHG	10	Alloferon (1-10)	P83412	Herpesviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=520 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero cells up to 350 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O
DRAMP30641	HGVSGHGQ	8	Alloferon (1-8)	P83412	Herpesviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=310 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero cells up to 447 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP30642	HGVSGHG	7	Alloferon (1-7)	P83412	Herpesviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=550 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero cells up to 504 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O
DRAMP30643	FGVSGHGQHGVHG	13	Alloferon [H1F]	P83412	Herpesviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=160 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero cells up to 290 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O)C(C)C
DRAMP30644	YGVSGHGQHGVHG	13	Alloferon [H1Y]	P83412	Herpesviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=190 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero cells up to 315 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O)C(C)C
DRAMP30645	WGVSGHGQHGVHG	13	Alloferon [H1W]	P83412	Herpesviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=190 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22883213]No cytotoxic against Vero cells up to 282 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O)C(C)C
DRAMP30646	XGVSGHGQHGVHG	13	Alloferon [H1Phg]	P83412	Herpesviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=190 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 1 indicates Phenylglycine.	L	[Ref.22883213]No cytotoxic against Vero cells up to 350 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	
DRAMP30647	XGVSGHGQHGVHG	13	Alloferon [H1Phe(p-Cl)]	P83412	Herpesviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=110 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 1 indicates 4-Chloro-phenylalanine.	L	[Ref.22883213]No cytotoxic against Vero cells up to 255 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	
DRAMP30648	XGVSGHGQHGVHG	13	Alloferon [H1Phe(p-OME)]	P83412	Herpesviridae	Not found	Synthetic construct(derived from Alloferon-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=220 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 1 indicates 4-Methoxy-phenylalanine.	L	[Ref.22883213]No cytotoxic against Vero cells up to 312 µM.	Not found	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	Kuczer M, Majewska A, Zahorska R. 	New alloferon analogues: synthesis and antiviral properties.	
DRAMP30649	EMTWEEWEKKIEEYTKKIEEILXX	24	LP-11	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=931±68 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=201±41 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=253±40 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 24 is Lys-C16(palmitic acid),The 'X' at position 23 is Lys-PEG8.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30650	EMTWEEWEKKVEELEKKIEELLXX	24	LP-19	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=296±45 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=95±18 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=92±11 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 24 is Lys-C16(palmitic acid),The 'X' at position 23 is Lys-PEG8.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30651	YTSLIHSLIEESQNQQEKNEQELLELDX	28	LP-40	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=361±60 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=392±73 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=384±33 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 28 is Lys-C16(palmitic acid)	L	[Ref.30089693]TZM-bl cell:CC50=800.8 ± 62.29 μM;##MT-4 cell:CC50=366.3± 119.08 μM;##HEK293T cell:CC50=408± 40.1μM;##PBMC:CC50=212.6± 25.71 μM.	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30652	YTSLIEELIKKSEEQQKKNEEELKKLEX	28	LP-50	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=21±3 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=7±1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=23±2 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.06-136.12 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.09-5.81 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.06 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 28 is Lys-C16(palmitic acid)	L	[Ref.30089693]TZM-bl cell:CC50=106.4 ± 2.72 μM;##MT-4 cell:CC50=138.37± 6.55 μM;##HEK293T cell:CC50=166.77± 35.33μM;##PBMC:CC50=40.01± 4.63 μM.	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30653	LEANIEELLKKAEEQQKKNEEELKKLEX	28	LP-51	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=21±10 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=6±1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=27±5 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.02-12.07 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.09-0.84 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.03-0.06 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 28 is Lys-C16(palmitic acid)	L	[Ref.30089693]TZM-bl cell:CC50=434.03±90.38 μM;##MT-4 cell:CC50=135.07±32.3 μM;##HEK293T cell:CC50=130.07± 15.27μM;##PBMC:CC50=46.83±4.65 μM.	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30654	WEQKIEELLKKAEEQQKKNEEELKKLEX	28	LP-52	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion.(By similar)	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=13±1 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=4±0 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=5±1 pM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=17 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.01-1.86 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.06-0.34 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.01-0.04 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 28 is Lys-C16(palmitic acid)	L	[Ref.30089693]TZM-bl cell:CC50=112.9 ± 2.21 μM;##MT-4 cell:CC50=94.06± 4.97 μM;##HEK293T cell:CC50=88.86± 6.68μM;##PBMC:CC50=114.8± 12.68 μM.	membrane	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	Chong H, Zhu Y, Yu D, He Y.	Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.	
DRAMP30655	WEQKIEELLKKAEEQQKKNEEELKKLEX	28	LP-80	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities.	[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=2.66±0.76 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=7.12±0.28 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=13.00±4.55 pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=5 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.003±0.001 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.007-4.006 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.288-0.299 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.034-0.155 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=13.4 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 28 is Lys-C18(stearic acid)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30867304	J Virol. 2019 May 15;93(11):e02312-18.	Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y.	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity. 	
DRAMP30656	WEQKIEELLKKAEEQQKKNEEELKKLEKX	29	LP-83	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities.	[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=0.49±0.03 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=4.54±1.42 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=4.75±0.83 pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=2.91 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.002±0 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.002-0.041 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.02-0.032 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.004-0.006 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=8.55 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 29 is Cys-Chol(cholesterol)	L	[Ref.30867304]Human PBMC:CC50=40.27 µM;##Human embryonic kidney HEK293T cells:CC50=25.31 µM;##TZM-bl cells:CC50=12.34 μM;##MT-4 cells:CC50=19.65 μM;##C8166 cells:CC50=19.19 μM;##U937 cells:CC50=9.97 μ	membrane	30867304	J Virol. 2019 May 15;93(11):e02312-18.	Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y.	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity. 	
DRAMP30657	LEANIEELLKKAEEQQKKNEEELKKLEKX	29	LP-86	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities.	[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=0.43±0.03 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=4.78±0.69 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=7.24±1.36 pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=4.91 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.003±0 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.003-0.17 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.014-0.026 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.005-0.006 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=12.27 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 29 is Cys-Chol(cholesterol)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30867304	J Virol. 2019 May 15;93(11):e02312-18.	Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y.	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity. 	
DRAMP30658	WEQKIEELLKKAEEQQKKNEEELKX	25	LP-93	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities.	[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=6.27±1.26 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=6.55±1.97 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=7.57±0.62pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=9.89 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.006±0.001 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.012-2.17 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=1.244-3.514 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.013-0.773 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=14.51pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 25 is Lys-Chol(cholesterol)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30867304	J Virol. 2019 May 15;93(11):e02312-18.	Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y.	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity.	
DRAMP30659	IEELLKKAEEQQKKNEEELKKLEX	24	LP-94	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities.	[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=1.75±0.23 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=5.90±1.80 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=15.69±1.97 pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=6.54 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.004±0.002 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.004-2.295 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.019-0.027 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.011-0.018 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=27.36 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 24 is Lys-Chol(cholesterol)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30867304	J Virol. 2019 May 15;93(11):e02312-18.	Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y.	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity.	
DRAMP30660	IEELLKKAEEQQKKNEEELKX	21	LP-95	P03377	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities.	[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=199.92±32.69 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=24.36±0.15 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=4781.17±699.33 pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=148.88 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.067±0.026 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.39-408.556 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=2.857-13.512 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.556-0.862 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=29.84 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 21 is Lys-Chol(cholesterol)	L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	30867304	J Virol. 2019 May 15;93(11):e02312-18.	Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y.	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity.	
DRAMP30661	EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW	41	C41	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=1.5 ± 0.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60. 	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP30662	XEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW	42	X- C41(C41 N teminus-PEG conjugation)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=7.2 ± 0.7 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 1 indicates PEG750-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60. 	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30663	XEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW	42	X- C41(C41 N teminus-PEG conjugation)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=11.2± 1.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 1 indicates PEG2000-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60. 	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30664	EWDXEINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW	41	C41 [R4X](R4C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=5.1± 1.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 4 indicates PEG750-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30665	EWDXEINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW	41	C41 [R4X](R4C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=8.7± 1.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 4 indicates PEG2000-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30666	EWDREINNYTXLIHSLIEESQNQQEKNEQELLELDKWASLW	41	C41 [S11X](S11C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=4.4± 0.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 11 indicates PEG750-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30667	EWDREINNYTXLIHSLIEESQNQQEKNEQELLELDKWASLW	41	C41 [S11X](S11C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=4.9± 0.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 11 indicates PEG2000-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30668	EWDREINNYTSLIHXLIEESQNQQEKNEQELLELDKWASLW	41	C41 [S15X](S15C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=4.1± 1.0 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 15 indicates PEG750-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30669	EWDREINNYTSLIHXLIEESQNQQEKNEQELLELDKWASLW	41	C41 [S15X](S15C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=5.0± 0.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 15 indicates PEG2000-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30670	EWDREINNYTSLIHSLIXESQNQQEKNEQELLELDKWASLW	41	C41 [E18X](E18C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=4.5± 1.0 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 18 indicates PEG750-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30671	EWDREINNYTSLIHSLIXESQNQQEKNEQELLELDKWASLW	41	C41 [E18X](E18C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=4.9± 0.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 18 indicates PEG2000-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30672	EWDREINNYTSLIHSLIEESQXQQEKNEQELLELDKWASLW	41	C41 [N22X](N22C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=4.2± 0.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 22 indicates PEG750-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30673	EWDREINNYTSLIHSLIEESQXQQEKNEQELLELDKWASLW	41	C41 [N22X](N22C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=5.1± 0.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 22 indicates PEG2000-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30674	EWDREINNYTSLIHSLIEESQNQQEKNEXELLELDKWASLW	41	C41 [Q29X](Q29C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=5.2± 0.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 29 indicates PEG750-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30675	EWDREINNYTSLIHSLIEESQNQQEKNEXELLELDKWASLW	41	C41 [Q29X](Q29C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=5.5± 0.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 29 indicates PEG2000-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30676	EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWX	42	C41 -X(C41 C teminus-PEG conjugation)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=10.9± 2.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 42 indicates PEG750-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30677	EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWX	42	C41 -X(C41 C teminus-PEG conjugation)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=43.3± 14.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 42 indicates PEG2000-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30678	EWDREINNYTSLIHSLIEEXQNQQEKNEQELLELDKWASLW	41	C41 [S20X](S20C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50>400 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 20 indicates PEG750-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30679	EWDREINNYTSLIHSLIEEXQNQQEKNEQELLELDKWASLW	41	C41 [S20X](S20C)	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide have been shown to be effective inhibitors to prevent virus–host cell membrane fusion.	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50>400 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 20 indicates PEG2000-Cys.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	envelope glycoprotein(gp41)	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	
DRAMP30680	RMKQIEDKIEEIESKQKKIENEIARIKKLLQLTVWDIKQLQARIL	45	IQN17[G572D]	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=15±5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	Eckert DM, Kim PS. 	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)[C@H](C)CC
DRAMP30681	RMKQIEDKIEEIESKIKKIENEIARIKKLLQLTVWGIKQLQARIL	45	IIN17	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=0.14±0.05 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	Eckert DM, Kim PS. 	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP30682	KIEEIESKQKKIENEIARIKKLLQLTVWGIKQLQARIL	38	IQ22N17	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=1.4±0.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	Eckert DM, Kim PS. 	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP30683	KIEEIESKIKKIENEIARIKKLLQLTVWGIKQLQARIL	38	II22N17	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=0.16±0.01 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	Eckert DM, Kim PS. 	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP30684	KQKKIENEIARIKKLLQLTVWGIKQLQARIL	31	IQ15N17	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=5.5±1..5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	Eckert DM, Kim PS. 	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP30685	KIKKIENEIARIKKLLQLTVWGIKQLQARIL	31	II15N17	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=2.1±0.8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	Eckert DM, Kim PS. 	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP30686	ALWKTMLKKLGTMALHAGKAALGAAADTI	29	Dermaseptin-S1 (1-29)	P24302	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin-S1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=1.7 µM).	[Ref.20718719]human red cells:HC50>100 µM.	Linear	Free	Amidation		L	[Ref.20718719]Vero cells:CC50=20 µM;293TT(embryonic human culture cells):CC50=40 µM.	Not found	20718719	APMIS. 2010 Sep 1;118(9):674-80.	Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.	In vitro activity of dermaseptin S1 derivatives against genital pathogens. 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O
DRAMP30687	ALWTTMLKKLGKMALHAGKAALGAAADTI	29	Dermaseptin-S1 (1-29)[K4T,T12K]	P24302	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin-S1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=1.3 µM).	[Ref.20718719]human red cells:HC50>100 µM.	Linear	Free	Amidation		L	[Ref.20718719]Vero cells:CC50=20 µM;293TT(embryonic human culture cells):CC50=40 µM.	Not found	20718719	APMIS. 2010 Sep 1;118(9):674-80.	Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.	In vitro activity of dermaseptin S1 derivatives against genital pathogens. 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O
DRAMP30688	ALWKTMLKKLGTMALHAGK	19	Dermaseptin-S1 (1-19)	P24302	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin-S1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=9 µM).	[Ref.20718719]human red cells:HC50>100 µM.	Linear	Free	Amidation		L	[Ref.20718719]Vero cells:CC50=80 µM;293TT(embryonic human culture cells):CC50=80 µM.	Not found	20718719	APMIS. 2010 Sep 1;118(9):674-80.	Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.	In vitro activity of dermaseptin S1 derivatives against genital pathogens. 	CSCC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30689	ALXKTMLKKLGTMAL	15	Dermaseptin-S1 (1-15)[W31NAL]	P24302	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin-S1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=2.7 µM).	[Ref.20718719]human red cells:HC50=75 µM.	Linear	Free	Amidation	The 'X' at position 3 indicates Nal (3-[1-naphthyl]alanine).	L	[Ref.20718719]Vero cells:CC50=50 µM;293TT(embryonic human culture cells):CC50>100 µM.	Not found	20718719	APMIS. 2010 Sep 1;118(9):674-80.	Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.	In vitro activity of dermaseptin S1 derivatives against genital pathogens.	
DRAMP30690	ALHKTMLKKLGTMAL	15	Dermaseptin-S1 (1-15)[W3H]	P24302	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin-S1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=5 µM).	[Ref.20718719]human red cells:HC50=100 µM.	Linear	Free	Amidation		L	[Ref.20718719]Vero cells:CC50>100 µM;293TT(embryonic human culture cells):CC50>100 µM.	Not found	20718719	APMIS. 2010 Sep 1;118(9):674-80.	Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.	In vitro activity of dermaseptin S1 derivatives against genital pathogens.	CSCC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30691	KALXKTMLKKLGTMAL	16	K-Dermaseptin-S1 (1-15)[W31NAL]	P24302	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin-S1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=5 µM).	[Ref.20718719]human red cells:HC50=80 µM.	Linear	Free	Amidation	The 'X' at position 4 indicates Nal (3-[1-naphthyl]alanine).	L	[Ref.20718719]Vero cells:CC50=50 µM;293TT(embryonic human culture cells):CC50>100 µM.	Not found	20718719	APMIS. 2010 Sep 1;118(9):674-80.	Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.	In vitro activity of dermaseptin S1 derivatives against genital pathogens.	
DRAMP30692	ALWKTMLKKLGTMA	14	Dermaseptin-S1 (1-14)	P24302	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin-S1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=10.5 µM).	[Ref.20718719]human red cells:HC50>100 µM.	Linear	Free	Amidation		L	[Ref.20718719]Vero cells:CC50=85 µM;293TT(embryonic human culture cells):CC50>100 µM.	Not found	20718719	APMIS. 2010 Sep 1;118(9):674-80.	Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.	In vitro activity of dermaseptin S1 derivatives against genital pathogens.	CSCC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(N)=O
DRAMP30693	ALWKTMLKKLGTM	13	Dermaseptin-S1 (1-13)	P24302	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin-S1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=10 µM).	[Ref.20718719]human red cells:HC50>100 µM.	Linear	Free	Amidation		L	[Ref.20718719]Vero cells:CC50=100 µM;293TT(embryonic human culture cells):CC50>100 µM.	Not found	20718719	APMIS. 2010 Sep 1;118(9):674-80.	Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.	In vitro activity of dermaseptin S1 derivatives against genital pathogens.	CSCC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(N)=O
DRAMP30694	ALWKTMLKKLGT	12	Dermaseptin-S1 (1-12)	P24302	Herpesviridae	Not found	Synthetic construct(derived from Dermaseptin-S1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=100 µM).	[Ref.20718719]human red cells:HC50>100 µM.	Linear	Free	Amidation		L	[Ref.20718719]Vero cells:CC50>100 µM;293TT(embryonic human culture cells):CC50>100 µM.	Not found	20718719	APMIS. 2010 Sep 1;118(9):674-80.	Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R.	In vitro activity of dermaseptin S1 derivatives against genital pathogens.	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(N)=O)[C@@H](C)O
DRAMP30695	EMTWEEWEKKIEEYTKKIEEILKKSQNQQIDL	32	HP23-E6-IDL	No entry  found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: It was a fusion inhibitor and inhibits cell-cell fusion	[Ref.30901967]HIV-1IIIB(X4 virus):inhibition of virus infection in MT-2 cells(IC50=338 pM);inhibition of cell-cell fusion between H9/IIIB cells and MT-2 cells(IC50=1.14 nM);##HIV-1Bal(R5 virus):inhibition of virus infection in MT-2 cells(IC50=813 pM);##HIV-1 NL4-3 D36G(6 T-20 resistant strains, WT,V38A,V38A/N42D,V38E/N42S,V38A/N42T,N42T/N43K):inhibition of virus infection in MT-2 cells(IC50=748-1543 pM);##HIV-1 LAI (7 T2635-Resistant Strains,WT,A6V,Q66R,K90E,K154Q,Q79E/N126K,K90E/N126K):inhibition of virus infection in MT-2 cells(IC50=349-1423 pM);##HIV-1 NL4-3 (5 HP23-Resistant Strains,WT,E49K,E49K/N126K,D36G/E49K/N126K,L34S/D36G/E49K/E136G):inhibition of virus infection in MT-2 cells(IC50=699-4937 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30901967]No cytotoxicity against MT-2 or M7 cells at the concentrations as high as 8 μM.	membrane	30901967	Molecules. 2019 Mar 21;24(6):1134.	Su S, Rasquinha G, Du L, Wang Q, Xu W, Li W, Lu L, Jiang S. 	A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30696	EMTWEEWEKKIEEYIKKIEEILKKSQNQQIDL	32	YIK(625-656)	No entry  found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: It was a fusion inhibitor and inhibits cell-cell fusion	[Ref.30901967]HIV-1IIIB(X4 virus):inhibition of virus infection in MT-2 cells(IC50=275pM);inhibition of cell-cell fusion between H9/IIIB cells and MT-2 cells(IC50=1.12 nM);##HIV-1Bal(R5 virus):inhibition of virus infection in MT-2 cells(IC50=640 pM);##HIV-1 NL4-3 D36G(6 T-20 resistant strains, WT,V38A,V38A/N42D,V38E/N42S,V38A/N42T,N42T/N43K):inhibition of virus infection in MT-2 cells(IC50=627-1423 pM);##HIV-1 LAI (7 T2635-Resistant Strains,WT,A6V,Q66R,K90E,K154Q,Q79E/N126K,K90E/N126K):inhibition of virus infection in MT-2 cells(IC50=460-1490 pM);##HIV-1 NL4-3 (5 HP23-Resistant Strains,WT,E49K,E49K/N126K,D36G/E49K/N126K,L34S/D36G/E49K/E136G):inhibition of virus infection in MT-2 cells(IC50=856-5286 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30901967]No cytotoxicity against MT-2 or M7 cells at the concentrations as high as 8 μM.	membrane	30901967	Molecules. 2019 Mar 21;24(6):1134.	Su S, Rasquinha G, Du L, Wang Q, Xu W, Li W, Lu L, Jiang S. 	A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30697	EMTWEEWEKKIEEYIKKIEEILKKSQNQQIDLGSGX	36	YIK-C16(625-656)	No entry  found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: It was a fusion inhibitor and inhibits cell-cell fusion	[Ref.30901967]HIV-1IIIB(X4 virus):inhibition of virus infection in MT-2 cells(IC50=76 pM);inhibition of cell-cell fusion between H9/IIIB cells and MT-2 cells(IC50=0.55 nM);##HIV-1Bal(R5 virus):inhibition of virus infection in MT-2 cells(IC50=61 pM);##HIV-1 NL4-3 D36G(6 T-20 resistant strains, WT,V38A,V38A/N42D,V38E/N42S,V38A/N42T,N42T/N43K):inhibition of virus infection in MT-2 cells(IC50=40-179 pM);##HIV-1 LAI (7 T2635-Resistant Strains,WT,A6V,Q66R,K90E,K154Q,Q79E/N126K,K90E/N126K):inhibition of virus infection in MT-2 cells(IC50=65-106 pM);##HIV-1 NL4-3 (5 HP23-Resistant Strains,WT,E49K,E49K/N126K,D36G/E49K/N126K,L34S/D36G/E49K/E136G):inhibition of virus infection in MT-2 cells(IC50=65-188 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 36 indicates PEG4-Lys-C16(Palmitic Acid).	L	[Ref.30901967]No cytotoxicity against MT-2 or M7 cells at the concentrations as high as 8 μM.	membrane	30901967	Molecules. 2019 Mar 21;24(6):1134.	Su S, Rasquinha G, Du L, Wang Q, Xu W, Li W, Lu L, Jiang S. 	A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.	
DRAMP30698	PACQDFLGAMIHLKAKTNISIR	22	3(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(28% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)O
DRAMP30699	LKAKTNISIREGPTLGNWAR	20	4(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(24% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP30700	EGPTLGNWAREIWATLFKKA	20	5(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(100% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP30701	EIWATLFKKATRQCRRGRIW	20	6(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(100% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP30702	TRQCRRGRIWKRWNETITGP	20	7(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(94% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)O
DRAMP30703	SGCANNTCYNVSVIVPDYQC	20	9(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(24% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)O)C(C)C
DRAMP30704	YLDRVDTWLQGKINISLCLT	20	11(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(9% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP30705	GKINISLCLTGGKMLYNKVT	20	12(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(10% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP30706	GGKMLYNKVTKQLSYCTDPL	20	13(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(5% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
DRAMP30707	KQLSYCTDPLQIPLINYTFG	20	14(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(15% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O
DRAMP30708	PNQTCMWNTSQIQDPEIPKC	20	16(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(5% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(=O)O
DRAMP30709	QIQDPEIPKCGWWNQMAYYN	20	17(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(2% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@H](C)CC
DRAMP30710	FHCQRTQSQPGSWFRAISSWKQ	22	20(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(4% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP30711	GSWFRAISSWKQRNRWEWRPDF	22	21(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(6% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30712	KQRNRWEWRPDFKSKKVKISLPC	23	22(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(6% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O
DRAMP30713	KSKKVKISLPCNSTKNLTFA	20	23(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(10% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP30714	CNSTKNLTFAMRSSGDYGEV	20	24(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(25% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CS)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30715	MRSSGDYGEVTGAWIEFGCH	20	25(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(27% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30716	TGAWIEFGCHRNKSNLHTEA	20	26(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(5% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30717	RNKSNLHTEARFRIRCRWNV	20	27(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(2% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30718	RFRIRCRWNVGSDTSLIDTC	20	28(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(40% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
DRAMP30719	GSDTSLIDTCGNTPNVSGAN	20	29(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(12% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP30720	PVDCTMYSNKMYNCSLQNGF	20	31(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(8% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CSCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30721	MYNCSLQNGFTMKVDDLIVH	20	32(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(33% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP30722	TMKVDDLIVHFNMTKAVEMV	20	33(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(25% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)O)C(C)C)C(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30723	FNMTKAVEMVNIAGNWSCTS	20	34(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(15% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O
DRAMP30724	NIAGNWSCTSDLPSSWGYMN	20	35(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(22% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O
DRAMP30725	CTSDLPSSWGYMNCNCTNSSSS	22	36(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(5% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CSCC[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O
DRAMP30726	CNCTNSSSSYSGTKMACPSNRG	22	37(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(60% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CS)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
DRAMP30727	SGTKMACPSNRGILRNWYNP	20	38(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(52% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)O
DRAMP30728	RGILRNWYNPFAGLRQSLEQ	20	39(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(60% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP30729	VAGLRQSLEQYQVVKQPDYL	20	40(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(48% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)O
DRAMP30730	YQVVKQPDYLLVPEEVMEYK	20	41(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(38% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CSCC[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30731	PDYLLVPEEVMEYKPRRKRAAI	22	42(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(54% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(=O)O
DRAMP30732	YKPRRKRAAIHVMLALATVLSI	22	43(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(52% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
DRAMP30733	HVMLALATVLSIAGAGTGATAI	22	44(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(58% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP30734	AGAGTGATAIGMVTQYHQVL	20	45(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(60% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP30735	GMVTQYHQVLATHQEAIEKV	20	46(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(43% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CN)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30736	ATHQEAIEKVTGALKINNLR	20	47(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(44% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30737	TGALKINNLRLVTLEHQVLV	20	48(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(73% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C
DRAMP30738	LVTLEHQVLVIGLKVEAMEK	20	49(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(45% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP30739	IGLKVEAMEKFLYTAFAMQE	20	50(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(74% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
DRAMP30740	FLYTAFAMQELGCNQNQFFC	20	51(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(18% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30741	LGCNQNQFFCKIPLELWTRY	20	52(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(21% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
DRAMP30742	NMTINQTIWNHGNITLGEWY	20	54(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(4% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
DRAMP30743	HGNITLGEWYNQTKDLQQKF	20	55(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(35% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP30744	NQTKDLQQKFYEIIMDIEQN	20	56(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(68% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP30745	YEIIMDIEQNNVQGKTGIQQ	20	57(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(37% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(=O)O
DRAMP30746	NVQGKTGIQQLQKWEDWVRW	20	58(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(96% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
DRAMP30747	LQKWEDWVRWIGNIPQYLKG	20	59(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(98% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O
DRAMP30748	IGNIPQYLKGLLGGILGIGL	20	60(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(60% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP30749	LLGGILGIGLGVLLLILCLP	20	61(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(88% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)C(C)C
DRAMP30750	GVLLLILCLPTLVDCIRNCI	20	62(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(32% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP30751	TLVDCIRNCIHKILGYTVIA	20	63(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(9% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)O
DRAMP30752	HKILGYTVIAMPEVEGEEIQ	20	64(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(8% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)C(=O)O
DRAMP30753	MPEVEGEEIQPQMELRRNGR	20	65(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(7% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCSC)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)O
DRAMP30754	PQMELRRNGRQCGMSEKEEE	20	66(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not found	Synthetic construct(derived from FIV envelope glycoprotein (gE))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(6% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30755	NFYDPLVFPSDEFDASISQVNEKINQSLAFIRKSD	35	T-106	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(C)=O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(N)=O
DRAMP30756	YTPNDITLNNSVALDPIDISIELNKAKSDLEESKE	35	T-189	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]Human parainfluenza virus type 3(HPIV3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP30757	TPNDITLNNSVALDPIDISIELNKAKSDLEESKEW	35	T-190	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(C)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP30758	PNDITLNNSVALDPIDISIELNKAKSDLEESKEWI	35	T-191	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(C)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP30759	NDITLNNSVALDPIDISIELNKAKSDLEESKEWIR	35	T-192	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(C)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30760	DITLNNSVALDPIDISIELNKAKSDLEESKEWIRR	35	T-193	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(C)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP30761	DAVYLHRIDLGPPISLERLDVGTNLQNAIAKLEDA	35	T-253	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(C)=O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(N)=O
DRAMP30762	AVYLHRIDLGPPISLERLDVGTNLQNAIAKLEDAK	35	T-254	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(C)=O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP30763	VYLHRIDLGPPISLERLDVGTNLQNAIAKLEDAKE	35	T-255	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=85.3 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(C)=O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP30764	YLHRIDLGPPISLERLDVGTNLGNAIAKLEDAKEL	35	T-256	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=90.7 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30765	LHRIDLGPPISLERLDVGTNLGNAIAKLEDAKELL	35	T-257	P69353	Paramyxoviridae, Retroviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MeV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=1.5 μg/ml);inhibition of cell-cell fusion in HEp2 cell(EC50=0.068 μg/ml);##Human parainfluenza virus type 3(HPIV-3):inhibition of cell-cell fusion in HEp2 cell(EC50>25 μg/ml);##Respiratory syncytial virus(RSV):inhibition of cell-cell fusion in HEp2 cell(EC50>25 μg/ml);##HIV-1 LAI:inhibition of cell-cell fusion in HEp2 cell(EC50>50 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP30766	HRIDLGPPISLERLDVGTNLGNAIAKLEDAKELLE	35	T-258	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=2.2 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(C)=O)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP30767	RIDLGPPISLERLDVGTNLGNAIAKLEDAKELLES	35	T-259	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=1.7 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(N)=O
DRAMP30768	IDLGPPISLERLDVGTNLGNAIAKLEDAKELLESS	35	T-260	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=4.9 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC
DRAMP30769	DLGPPISLERLDVGTNLGNAIAKLEDAKELLESSD	35	T-261	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=5.7 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(C)=O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(N)=O
DRAMP30770	LGPPISLERLDVGTNLGNAIAKLEDAKELLESSDQ	35	T-262	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=6.5 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP30771	GPPISLERLDVGTNLGNAIAKLEDAKELLESSDQI	35	T-263	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=10.1 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(C)=O)[C@H](C)CC)C(C)C)[C@@H](C)O)[C@H](C)CC)C(N)=O
DRAMP30772	PPISLERLDVGTNLGNAIAKLEDAKELLESSDQIL	35	T-264	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=1.1 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(C)=O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP30773	PISLERLDVGTNLGNAIAKLEDAKELLESSDQILR	35	T-265	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=3.1 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(C)=O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC
DRAMP30774	ISLERLDVGTNLGNAIAKLEDAKELLESSDQILRS	35	T-266	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=13.0 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(C)C
DRAMP30775	SLERLDVGTNLGNAIAKLEDAKELLESSDQILRSM	35	T-267	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=12.3 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(C)=O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(N)=O)[C@H](C)CC
DRAMP30776	LERLDVGTNLGNAIAKLEDAKELLESSDQILRSMK	35	T-268	P69353	Paramyxoviridae	Not found	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=7.3 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).	Not found	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(C)=O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP30777	DDSVVCAAMSYSYA	14	P1(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(22% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30778	DDSVVCAAMSYSFA	14	P2(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(29% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30779	DDSVVCAAMSYSHA	14	P3(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(26% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP30780	DDSVVSAAMSYSYA	14	P4(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 7±9% inhibition at 1 µM; 47±1% inhibition at 3 µM; 89±6% inhibition at 10 µM; IC50=3.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30781	DDSVVSAAMSYSFA	14	P5(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30782	DDSVVAAMSYSYA	13	P7(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(9% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(C)C)NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)O
DRAMP30783	DDSVVAAMSYSFA	13	P8(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(C)C)NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)O
DRAMP30784	DDSVVAAMSYSHA	13	P9(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(22% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(C)C)NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)O
DRAMP30785	ADLEVVAATYVLVA	14	P10(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 6±11% inhibition at 1 µM;27±5% inhibition at 3 µM;  75±1% inhibition at 10 µM; IC50=6.3µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(=O)O
DRAMP30786	ADLEVVAATFVLVA	14	P11(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(-2±7% inhibition at 1 µM; 29±5% inhibition at 3 µM;  83±5% inhibition at 10 µM; IC50=5.72 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(=O)O
DRAMP30787	ADLEVVAATHVLVA	14	P12(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 11±16% inhibition at 1 µM; 77±3% inhibition at 3 µM;  95±1% inhibition at 10 µM; IC50=2.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(=O)O
DRAMP30788	ADLEVVAATYV	11	P13(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(15% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30789	KKKKVVAATYVLVA	14	P15(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(30% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP30790	DDDEVVAATYVLVA	14	P17(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](N)CC(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP30791	ADLEVVAATYVDDD	14	P19(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(9% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
DRAMP30792	ADLEVVAATYVDVA	14	P20(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 18±21% inhibition at 1 µM; 75±1% inhibition at 3 µM;  96±1% inhibition at 10 µM; IC50=2.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP30793	ADLEVVAATYVLDA	14	P21(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(22% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(C)C)C(=O)O
DRAMP30794	ADLEVVAATYVLVD	14	P22(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(38% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(=O)O
DRAMP30795	ADLEVVAATYVDDA	14	P23(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(20% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
DRAMP30796	ADLEVVAATYVLDD	14	P24(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 5±4% inhibition at 1 µM; 26±4% inhibition at 3 µM;  65±3% inhibition at 10 µM; IC50=7.4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(C)C)C(=O)O
DRAMP30797	ADLEVVAATYVDVD	14	P25(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(19% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP30798	KKKKVVAATYVKKA	14	P27(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(13% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
DRAMP30799	KKKKVVAATYFFFA	14	P30(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(5% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
DRAMP30800	KKKKVVAATYFLVA	14	P31(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP30801	KKKKVVAATYVLVF	14	P33(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(12% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP30802	KKKKVVAATYVLFA	14	P34(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(12% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O
DRAMP30803	KKKKVVAATYKKVA	14	P37(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)O
DRAMP30804	AKLKVVAATYVLKK	14	P38(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(5% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP30805	KKKKVVAATYKKKK	14	P42(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C
DRAMP30806	ADLEVVAATYVKKK	14	P44(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP30807	ADLEVVAATYKKKK	14	P45(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(7% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP30808	ADLEVVAATYAAAA	14	P47(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP30809	KDLKVVAATYVKKK	14	P48(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(21% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP30810	KKKKAVAATYVLV	13	P49(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(59% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30811	KKKKVAAATYVLV	13	P50(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 7±1% inhibition at 1 µM; 51±10% inhibition at 3 µM;  74±1% inhibition at 10 µM; IC50=3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30812	KKKKVVAAAYVLV	13	P51(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(19% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30813	KKKKVVAATAVLV	13	P52(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(13% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30814	KKKKVVAATYVAV	13	P54(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(21% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
DRAMP30815	KKKKVVAATYVLA	13	P55(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(19% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP30816	KKKKVLAATYVLV	13	P57(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(12% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP30817	KKKKVVLATYVLV	13	P58(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 21±8% inhibition at 1 µM; 30±5% inhibition at 3 µM;  61±15% inhibition at 10 µM; IC50=7.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30818	KKKKVVAALYVLV	13	P60(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(7% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP30819	KKKKVVAATYLLV	13	P61(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(26% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30820	KKKKVVAATYVLL	13	P62(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(25% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
DRAMP30821	KKKKFVAATYVLV	13	P63(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 32±7% inhibition at 1 µM; 35±8% inhibition at 3 µM;  61±6% inhibition at 10 µM; IC50=7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30822	KKKKVFAATYVLV	13	P64(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(26% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30823	KKKKVVFATYVLV	13	P65(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(34% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30824	KKKKVVAFTYVLV	13	P66(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(23% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30825	KKKKVVAAFYVLV	13	P67(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(3% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30826	KKKKVVAATFVLV	13	P68(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(28% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30827	KKKKVVAATYFLV	13	P69(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30828	KKKKVVAATYVFV	13	P70(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(15% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
DRAMP30829	KKKKVVAATYVLF	13	P71(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30830	KKKKEVAATYVLV	13	P72(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
DRAMP30831	KKKKVVAETYVLV	13	P75(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(19% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP30832	KKKKVVAAEYVLV	13	P76(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(5% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)O
DRAMP30833	KKKKVVAATEVLV	13	P77(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(=O)O
DRAMP30834	KKKKVKAATYVLV	13	P82(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(25% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30835	KKKKVVKATYVLV	13	P83(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 26±12% inhibition at 1 µM; 37±10% inhibition at 3 µM;  63±2% inhibition at 10 µM; IC50=6.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30836	KKKKVVAKTYVLV	13	P84(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(12% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30837	KKKKTVAATYVLV	13	P89(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(27% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30838	KKKKVTAATYVLV	13	P90(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 15±12% inhibition at 1 µM; 44±3% inhibition at 3 µM;  77±6% inhibition at 10 µM; IC50=4.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30839	KKKKVVTATYVLV	13	P91(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30840	KKKKVVATTYVLV	13	P92(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(16% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30841	KKKKVVAATTVLV	13	P93(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2223% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30842	KKKKVVAATYVLT	13	P96(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP30843	KKKKVVGATYVLV	13	P99(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30844	KKKKVVAGTYVLV	13	P100(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(30% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30845	KKKKVVAAGYVLV	13	P101(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30846	KKKKVVAATGVLV	13	P102(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(26% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30847	KKKKVVAATYVGV	13	P104(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
DRAMP30848	KKKKVVAATYVLG	13	P105(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(13% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)NCC(=O)O
DRAMP30849	KKKKVVAATYVLV	13	P106(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(17% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30850	KKKKPVAATYVLV	13	P107(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(24% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30851	KKKKVPAATYVLV	13	P108(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(3% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30852	KKKKVVAATYVPV	13	P113(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(10% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
DRAMP30853	KKKKVVLATLVLV	13	P116(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(5% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30854	KKKKLVLPFLFFV	13	P119(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(6% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30855	KKKKLLAPFLFFV	13	P120(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30856	KKKKLLLAFLFFV	13	P121(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30857	KKKKLLLPTLFFV	13	P122(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O
DRAMP30858	KKKKLVLATYVLV	13	P126(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C
DRAMP30859	KKKKLVAAFYVLV	13	P128(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(18% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP30860	KKKKLVAATYVFV	13	P129(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C
DRAMP30861	KKKKLVAATYVLF	13	P130(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP30862	KKKKVLAPTYVLV	13	P132(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP30863	KKKKVVLAFYVLV	13	P138(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(10% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30864	KKKKVVAPFYVLV	13	P140(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30865	KKKKVVAPTLVLV	13	P141(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(3% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30866	KKKKVVAPTYFLV	13	P142(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(15% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30867	KKKKVVAPTYVLF	13	P144(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(15% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30868	KKKKVVAAFLVLV	13	P145(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(20% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP30869	KKKKVVAAFYFLV	13	P146(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(7% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30870	KKKKVVAAFYVLF	13	P148(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30871	KKKKVVAATLVLF	13	P151(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(9% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30872	KKKKVLLPFLFFF	13	P154(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30873	KKKKLVLPFLFFF	13	P155(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(12% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30874	KKKKLLAPFLFFF	13	P156(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30875	KKKKLLLAFLFFF	13	P157(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(16% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30876	KKKKLLLPFYFFF	13	P159(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(24% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30877	KKKKLLLPFLFLF	13	P161(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30878	KKKKLLLPFLFFF	13	P162(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(19% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30879	KKKKVVLPFLFFF	13	P163(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( -2±1% inhibition at 1 µM; 29±4% inhibition at 3 µM;  69±9% inhibition at 10 µM; IC50=7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30880	KKKKLVAPFLFFF	13	P164(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(15% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30881	KKKKLLAAFLFFF	13	P165(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 29±5% inhibition at 1 µM; 28±9% inhibition at 3 µM;  61±17% inhibition at 10 µM; IC50=7.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30882	KKKKLLLATLFFF	13	P166(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(16% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP30883	KKKKLLLPTYFFF	13	P167(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(3% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP30884	KKKKLLLPFLVLF	13	P169(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP30885	KKKKVLAPFLFFF	13	P170(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30886	KKKKVLLPFYFFF	13	P172(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(27% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30887	KKKKLVLAFLFFF	13	P175(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(18% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30888	KKKKLVLPTLFFF	13	P176(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(29% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(C)C
DRAMP30889	KKKKLVLPFYFFF	13	P177(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP30890	KKKKLVLPFLLFF	13	P178(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(18% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30891	KKKKLVLPFLFVF	13	P179(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 14±6% inhibition at 1 µM; 34±11% inhibition at 3 µM;  55±11% inhibition at 10 µM; IC50=8.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP30892	KKKKLLAPFLVFF	13	P180(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(9% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP30893	KKKKLLLAFYFFF	13	P181(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(3% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30894	KKKKLLLAFLFLF	13	P182(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30895	KKKKLLLPTLVFF	13	P183(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(3% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O
DRAMP30896	KKKKLLLPFYFLF	13	P185(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(22% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30897	AKDLEVVTSTYVLVEA	16	P189(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 5±7% inhibition at 1 µM; 74±6% inhibition at 3 µM;  96±3% inhibition at 10 µM; IC50=2.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)NC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP30898	AKDLEVVCSTYVLVEA	16	P190(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 24 ±15% inhibition at 1 µM; 86 ±3% inhibition at 3 µM;  99 ±2% inhibition at 10 µM; IC50=1.8 µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP30899	AECVVSCSMSYTKA	14	P197(derived from HCV polyprotein)	P26662	Flaviviridae	Not found	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 7±7% inhibition at 1 µM; 29±6% inhibition at 3 µM;  66±3% inhibition at 10 µM; IC50=7 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease. 	CSCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30900	swlrdiwdwicevlsdfk	18	2(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.32 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		D	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@H](C)[C@@H](NC(=O)[C@@H](CC(=O)N[C@H](CS)C(=O)N[C@@H](C(=O)O)C(C)C)NC(=O)[C@H](NC(=O)[C@@H](CC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](N)CO)[C@@H](C)CC)C(=O)N[C@H](CCC(=O)N[C@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CCCCN)C(=O)O
DRAMP30901	SWLRDIWDWICEVLSD	16	3(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.98 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30902	SWLRDIWDWICEV	13	5(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30903	SWLRDIWDWICE	12	6(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30904	SWLRDIWDWI	10	7(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)O
DRAMP30905	SWLRDIWD	8	8(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30906	LRDIWDWICEVLSDFK	16	9(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30907	DIWDWICEVLSDFK	14	10(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC
DRAMP30908	WDWICEVLSDFK	12	11(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30909	WICEVLSDFK	10	12(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP30910	CEVLSDFK	8	13(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30911	SGSWLRDIWDWICEVLSDFK	20	14(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=1.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30912	GSWLRDIWDWICEVLSDFK	19	15(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.51 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30913	SWLRDIWDWICEVLSDFKT	19	16(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=1.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30914	SWLRDIWDWICEVLSDFKTW	20	17(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.51 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30915	SWRLIDWDWICEVLSDFK	18	18(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=4.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30916	SWRLDIWDWICESVLDFK	18	19(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP30917	VLDLIYSLHKQINRGLKKIVL	21	22(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>36 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP30918	KFDSLVECIWDWIDRLWS	18	23(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.85 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30919	KWLCRIWSWISDVLDDFE	18	25(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@H](C)CC
DRAMP30920	SIWRDWVDLICEFLSDWK	18	26(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.40 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30921	SWLRDVWDWICTVLTDFK	18	27(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=3.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
DRAMP30922	SWLRDVWDWVCTILTDFK	18	28(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=2.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP30923	DWLRIIWDWVCSVVSDFK	18	29(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.55 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP30924	SWLWEVWDWVLHVLSDFK	18	30(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=7.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC(C)C[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP30925	TWLRAIWDWVCTALTDFK	18	31(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=7.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP30926	SWLRDVWDWVCTVLSDFK	18	32(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=3.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)C(C)C
DRAMP30927	SWLRDIWDWISEVLSDFK	18	33[11S](derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=13.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30928	SWLRDIWDWIREVLSDFK	18	34[11R](derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=12.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30929	SWLRDIWDWIEEVLSDFK	18	35[11E](derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=13.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP30930	SWLDDIWDWICEVLSDFE	18	36(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=4.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)O
DRAMP30931	SWLRDIWDWICKVLSDFK	18	38(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=6.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30932	SWLDRIWRWICKVLSRFE	18	39(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=1.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC
DRAMP30933	SWLRDIWRWICKVLSRFK	18	40(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.84 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30934	SWLRRIWRWICKVLSRFK	18	41(derived from HCV C5A)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV non-structural protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.89 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@H](C)CC
DRAMP30935	RTQRRGRTGRGKPGIYR	17	HCVA(1484-1500)	P26664	Flaviviridae	Not found	Synthetic construct(derived from HCV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=27.1±2.4 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=37.1±3.9 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=49.8±4.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30936	STQRRGRTGRGRRGIYR	17	HCVB(1484-1500)	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=24.3±1.8 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=33.6±3.5 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=47.2±4.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30937	RRGRTGRGRRGIYR	14	HCV(1487-1500)	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=0.2±0.01 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=2.7±0.3 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=21.1±2.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30938	RTGRGRRGIYR	11	HCV(1490-1500)	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=34.6±3.2 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=106±6.1 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=322±9.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30939	RGRRGIYR	8	HCV(1493-1500)	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=313±11.3 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=397±10.6 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30940	RGIYR	5	HCV(1496-1500)	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50>500 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP30941	SQVGD	5	WNV(1968-1972)	P06935	Flaviviridae	Not found	Synthetic construct(derived from WNV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50>500 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30942	RNPSQVGD	8	WNV(1965-1972)	P06935	Flaviviridae	Not found	Synthetic construct(derived from WNV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50>500 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=383±12.3 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=437±13.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30943	RIGRNPSQVGD	11	WNV(1962-1972)	P06935	Flaviviridae	Not found	Synthetic construct(derived from WNV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=417±17.6 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=285±8.1 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=334±12.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
DRAMP30944	RRGRIGRNPSQVGD	14	WNV(1959-1972)	P06935	Flaviviridae	Not found	Synthetic construct(derived from WNV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=169±6.8 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=156±6.9 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=191±7.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
DRAMP30945	AAQRRGRIGRNPSQVGD	17	WNV(1956-1972)	P06935	Flaviviridae	Not found	Synthetic construct(derived from WNV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=358±13.2 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
DRAMP30946	NQVGD	5	JEV(1971-1975)	P27395	Flaviviridae	Not found	Synthetic construct(derived from JEV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50>500 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30947	RNPNQVGD	8	JEV(1968-1975)	P27395	Flaviviridae	Not found	Synthetic construct(derived from JEV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50>500 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30948	RVGRNPNQVGD	11	JEV(1965-1975)	P27395	Flaviviridae	Not found	Synthetic construct(derived from JEV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=374±12.8 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=448±14.3 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP30949	RRGRVGRNPNQVGD	14	JEV(1962-1975)	P27395	Flaviviridae	Not found	Synthetic construct(derived from JEV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=196±9.4 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=215±7.2 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=253±6.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
DRAMP30950	AAQRRGRVGRNPNQVGD	17	JEV(1959-1975)	P27395	Flaviviridae	Not found	Synthetic construct(derived from JEV NS3 helicase protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism.	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=442±17.7 μM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 μM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NTPase/helicase	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38. 	Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A.	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
DRAMP30951	TTPKFTVAWDWVPKR	15	gB64(gB346-360)	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=85 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC(C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP30952	KTTSSIEFARLQFTY	15	gB94(496-510)	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=6.5±1.3 µM);inhibition of virus entry in Vero cells(EC50>200 µM);inhibition of virus infection in Vero cells(EC50=165.0±71.9 µM);ability of inactive virus(EC50=125±11.4 µM);inhibition of virus attachment on Vero cells(EC50>200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.19104014]Not cytotoxic for Vero cells up to 200 µM.	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP30953	GHRRYFTFGGGYVYF	15	gB122(636-650)	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=15.0±2.2 µM);inhibition of virus entry in Vero cells(EC50=17.6±2.6 µM);inhibition of virus infection in Vero cells(EC50=71.5±17.4 µM);ability of inactive virus(EC50=118±11.6 µM);inhibition of virus attachment on Vero cells(EC50>200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.19104014]Not cytotoxic for Vero cells up to 200 µM.	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30954	Anti-HeVVPLEVYTRHEIK	15	gB131(681-695)	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=18.7±2.70 µM);inhibition of virus entry in Vero cells(EC50=12.2±6.56 µM);inhibition of virus infection in Vero cells(EC50>200 µM);ability of inactive virus(EC50>200 µM);inhibition of virus attachment on Vero cells(EC50>200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.19104014]Not cytotoxic for Vero cells up to 200 µM.	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP30955	HRRYFTFGGGYVYF	14	gB122(637-650)	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=31.2 ± 5.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30956	GHRAYFTFGGGYVYF	15	gB122R4A	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=26.4 ± 13.5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30957	GHRRAFTFGGGYVYF	15	gB122Y5A	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=119.2 ± 26.6 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30958	GHRRYATFGGGYVYF	15	gB122F6A	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=67.6 ± 8.1 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30959	GHRRYFTAGGGYVYF	15	gB122F8A	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=37.5 ± 4.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30960	GHRRYFTFGAGYVYF	15	gB122G10L	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=25.1 ± 4.9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30961	GHRRYFTFGGGYVAF	15	gB122Y14A	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=58.0 ± 5.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30962	GHRRYFTFGGGYVYA	15	gB122F15A	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=48.6 ± 6.2 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O
DRAMP30963	RYFTFGGGYVYF	12	gB122Δ1-3	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=34.9 ± 1.8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30964	TFGGGYVYF	9	gB122Δ1-6	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP30965	GHRRYFTFGGGY	12	gB122Δ13-15	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=91.4± 9.8 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP30966	GHRRYFTFG	9	gB122Δ10-15	P06437	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50>100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
DRAMP30967	MDVNPTLLFLKVPAQNAISTTFPYT	25	FluA-PB1(1-25)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=1.80 ±0.49 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)C[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
DRAMP30968	VNPTLLFLKVPAQNAISTTFPYT	23	FluA-PB1(3-25)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=661.77 ±22.08 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP30969	PTLLFLKVPAQNAISTTFPYT	21	FluA-PB1(5-25)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=483.20 ±51.98 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP30970	LLFLKVPAQNAISTTFPYT	19	FluA-PB1(7-25)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP30971	FLKVPAQNAISTTFPYT	17	FluA-PB1(9-25)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP30972	KVPAQNAISTTFPYT	15	FluA-PB1(11-25)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP30973	MDVNPTLLFLKVPAQNAIST	20	FluA-PB1(1-20)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=33.80 ±5.53 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)C[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP30974	MDVNPTLLFLKVPAQNAI	18	FluA-PB1(1-18)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=29.45 ±5.16 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)C[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
DRAMP30975	MDVNPTLLFLKVPAQN	16	FluA-PB1(1-16)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=45.86 ±4.22 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
DRAMP30976	MDVNPTLLFLKVPA	14	FluA-PB1(1-14)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=34.53±2.19 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
DRAMP30977	MDVNPTLLFLKVP	13	FluA-PB1(1-13)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=138.17 ±7.88 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
DRAMP30978	MDVNPTLLFLKV	12	FluA-PB1(1-12)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=643.93 ±180.75 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP30979	MDVNPTLLFLK	11	FluA-PB1(1-11)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=899.53 ±54.31 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP30980	MDVNPTLLFL	10	FluA-PB1(1-10)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP30981	MDVNPTLLF	9	FluA-PB1(1-9)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP30982	MDVNPTLL	8	FluA-PB1(1-8)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP30983	MDVNPTL	7	FluA-PB1(1-7)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP30984	MDVNPT	6	FluA-PB1(1-6)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C
DRAMP30985	MDVNPTLLFLKVPAQ	15	FluA-PB1(1-15)	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=43.32 ±5.31nM);##Influenza B(FluB):inhibition of PA-binding activity and virus replication(IC50>3000nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
DRAMP30986	MNINPYPLFIDVPIQ	15	PB1-1-15 B	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=45.0 ±12.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)O
DRAMP30987	MNINPTLLFLKVPIQ	15	PB1-1-15 A D2N,V3I,L14I	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=6.69 ±1.73 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP30988	MDVNPTLLFIDVPAQ	15	PB1-1-15 A L10I,K11D	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)C[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP30989	MNINPTLLFLKVPAQ	15	PB1-1-15 A D2N,V3I	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=12.96 ±3.98 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O
DRAMP30990	MDVNPYFLFLKVPAQ	15	PB1-1-15 A T6Y,L7F	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=7.51 ±0.71 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=345.0 ±81.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
DRAMP30991	MDVNPTFLFLKVPAQ	15	PB1-1-15 A L7F	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
DRAMP30992	MDVNPYLLFLKVPAQ	15	PB1-1-15 A T6Y	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=21.64 ±1.48 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=107.1 ±31.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
DRAMP30993	MDVNPFLLFLKVPAQ	15	PB1-1-15 A T6F	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=2.84 ±0.48 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=750.4 ±249.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
DRAMP30994	MDVNPWLLFLKVPAQ	15	PB1-1-15 A T6W	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=3.40 ±0.51 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=628.3 ±389.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
DRAMP30995	MDVNPHLLFLKVPAQ	15	PB1-1-15 A T6H	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=292.16 ±34.04 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
DRAMP30996	MDVNPCLLFLKVPAQ	15	PB1-1-15 A T6C	Q6DNS6	Orthomyxoviridae	Not found	Synthetic construct(derived from INFV A polymerase (PB1))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication.	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=43.58 ±5.67 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PA subunit	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
DRAMP30997	GWWYKGRARPVSAVA	15	18-c01	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=3.2 μM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Alkylated(C18)	Amidation		L	No cytotoxicity information found in the reference(s) presented	sialylgalactose	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. 	CCCCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)C(C)C)C(C)C
DRAMP30998	RAVWRHSVATPSHSV	15	C18-c03	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=6.5 μM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50=68 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Alkylated(C18)	Amidation		L	No cytotoxicity information found in the reference(s) presented	sialylgalactose	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. 	CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP30999	GAWYKGRARPVSAVA	15	C18-c01W2A	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=53 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Alkylated(C18)	Amidation		L	No cytotoxicity information found in the reference(s) presented	sialylgalactose	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. 	CCCCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)C(C)C)C(C)C
DRAMP31000	GWWYKGRARAVSAVA	15	C18-c01P10A	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=89 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Alkylated(C18)	Amidation		L	No cytotoxicity information found in the reference(s) presented	sialylgalactose	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. 	CCCCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)C(C)C)C(C)C
DRAMP31001	AVASVPRARGKYWWG	15	C18-c01r	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=44 μM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50=17 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Alkylated(C18)	Amidation		L	No cytotoxicity information found in the reference(s) presented	sialylgalactose	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. 	CCCCCCCCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(N)=O)C(C)C)C(C)C
DRAMP31002	DFRRLPGAFWQLRQP	15	C18-p1b	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=52 μM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50=19 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Alkylated(C18)	Amidation		L	No cytotoxicity information found in the reference(s) presented	sialylgalactose	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. 	CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(N)=O
DRAMP31003	AETVESCLAKPHTEN	15	C18-cp3c	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=66 μM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50>100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Alkylated(C18)	Amidation		L	No cytotoxicity information found in the reference(s) presented	sialylgalactose	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. 	CCCCCCCCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP31004	GWWYKGRARPVSAVA	15	c01	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	sialylgalactose	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. 	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(N)=O
DRAMP31005	RAVWRHSVATPSHSV	15	c03	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	sialylgalactose	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T.	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. 	CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)[C@@H](C)O)C(N)=O
DRAMP31006	RRKKAVLLALLAP	13	B12	P08620	Orthomyxoviridae	Not found	Synthetic construct(derived from FGF-4 signal sequence)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits influenza virus replication by preventing attachment to cells.	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(97 ± 2% inhibition at 10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	21220525	 Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	Jones JC, Settles EW, Brandt CR, Schultz-Cherry S. 	Identification of the minimal active sequence of an anti-influenza virus peptide. 	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP31007	RRKKVALLAVLLALLA	16	B7NP(B7 without prolines)	P08620	Orthomyxoviridae	Not found	Synthetic construct(derived from FGF-4 signal sequence)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits influenza virus replication by preventing attachment to cells.	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(EC50=0.3 ± 0.1 μM).	[Ref.21220525]>50% hemolysis agaisnt human red blood cells at 30 μM.	Linear	Free	Free		L	[Ref.21220525]A549 cells:CD50=126.3± 23.0 μM;##MDCK cells:CD50=105.3 ± 8.0 μM.	Not found	21220525	 Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	Jones JC, Settles EW, Brandt CR, Schultz-Cherry S. 	Identification of the minimal active sequence of an anti-influenza virus peptide. 	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP31008	RRKKALLAVLLALLA	15	B8NP	P08620	Orthomyxoviridae	Not found	Synthetic construct(derived from FGF-4 signal sequence)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits influenza virus replication by preventing attachment to cells.	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(EC50=0.4 ± 0.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	21220525	 Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	Jones JC, Settles EW, Brandt CR, Schultz-Cherry S. 	Identification of the minimal active sequence of an anti-influenza virus peptide. 	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP31009	LFRLIKSLIKRLVSAFK	17	Mucroporin-M1	B9UIY3	Coronaviridae, Orthomyxoviridae, Paramyxoviridae	Not found	Synthetic construct(derived from Mucroporin)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Mucroporin-M1 may bind to the virus envelope by surface charge interactions and inhibits MeV, SARS-CoV and influenza H5N1 by direct virucidal action.	[Ref.21620914]measles virus (MeV):inhibition of MeV infection in Vero cells(EC50=7.15 μg/ml (3.52 μM));##SARS-CoV(pseudoviruse):inhibition of SARS-CoV infection in MDCK cells(EC50=14.46 μg/ml (7.12 μM));##H5N1(pseudovirus):inhibition of H5N1 infection in MDCK cells(EC50=2.10 μg/ml (1.03 μM)).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.21620914]Vero cells:CC50=70.46μg/ ml(34.70μM);##HeLa-ACE2 cells:CC50=61.58 μg/ml (30.31 μM);##MDCK cells:CC50=83.35 μg/ml (41.03 μM).	membrane	21620914	Peptides. 2011 Jul;32(7):1518-25.	Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W. 	Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP31010	KAKAKAKAKAKAKAKAKAKAK	21	RJ1	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.	[Ref.15498607]herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=53.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>455 μM.	Not found	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. 	A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.	C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31011	KAAKKAAKAAKKAAKWAKKAA	21	RJ3	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=117.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>467 μM.	Not found	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. 	A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP31012	AKKAAKKAKKAAKKAKKAAKK	21	RJ5	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=41.0 μM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=14.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>468 μM.	Not found	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. 	A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.	C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31013	AKKAAKKAKKAAKKAKKWAKK	21	RJ6	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=47.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>433 μM.	Not found	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. 	A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.	C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31014	AKKAWKKAKKAAKKAKKWAKK	21	RJ7	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=40.8 μM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=44.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>412 μM.	Not found	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. 	A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.	C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31015	ARRAWRRARRAARRARRAARR	21	RJ8	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=18.2 μM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=22.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>395 μM.	Not found	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. 	A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.	C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31016	ARRAKRRARRAARRARRKARR	21	RJ9	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=13.0 μM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=46.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>433 μM.	Not found	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. 	A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.	C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31017	ARRAKRRARRAKRRARRKKRR	21	RJ10	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface.	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=24.6 μM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=54.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>422 μM.	Not found	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ. 	A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.	C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31018	QLQKWEDWVRWIGNIPQYLKG	21	Peptide 59(FIV ectodomain 767-786)	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.03 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.01 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12610147]No detectable cytotoxicity on MBM cell viability and proliferation.	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O
DRAMP31019	QKWEDWVRWIGN	12	C12a(FIV ectodomain 768-779)	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.25 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.18 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP31020	WEDWVRWIGNIP	12	C12b(FIV ectodomain 770-781)	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.04 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.09 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(=O)O
DRAMP31021	QLQKWEDWVRWI	12	C12c(FIV ectodomain 766-777)	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.03 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.04 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)O
DRAMP31022	WEDWVRWI	8	C8(FIV ectodomain 770-777)	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.07 ± 0.02 µg/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50=0.46 ± 0.20 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.05 ± 0.01 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12610147]No detectable cytotoxicity on MBM cell viability and proliferation.	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)O
DRAMP31023	DWVRWI	6	C6a(FIV ectodomain 772-777)	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.15 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.07 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)O
DRAMP31024	WEDWVR	6	C6b(FIV ectodomain 770-775)	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50>50 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50>50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC(C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31025	WVRWI	5	C5(FIV ectodomain 773-777)	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.20 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.11 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)O
DRAMP31026	WVRW	4	C4a(FIV ectodomain 773-776)	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=36 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=24 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC(C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31027	VRWI	4	C4b(FIV ectodomain 774-777)	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=7.80 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=4.06 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
DRAMP31028	AEDWVRWI	8	C8W->A770	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=4.30 ± 0.70 µg/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50>50 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=2.10± 0.10 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12610147]No detectable cytotoxicity on MBM cell viability and proliferation.	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)O
DRAMP31029	WADWVRWI	8	C8E->A771	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.16 ± 0.03 µg/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50=0.22 ± 0.05 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.12 ± 0.01 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12610148]No detectable cytotoxicity on MBM cell viability and proliferation.	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31030	WEAWVRWI	8	C8D->A772	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.10± 0.02 µg/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50=0.40 ± 0.22 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.03 ± 0.06 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12610149]No detectable cytotoxicity on MBM cell viability and proliferation.	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)O
DRAMP31031	WEDAVRWI	8	C8W->A773	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50>50 µg/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50>50 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50>50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12610150]No detectable cytotoxicity on MBM cell viability and proliferation.	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)O
DRAMP31032	WEDWARWI	8	C8V->A774	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.07 ± 0.03 µg/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50=0.54 ± 0.02 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.15 ± 0.12 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12610151]No detectable cytotoxicity on MBM cell viability and proliferation.	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)O
DRAMP31033	WEDWVAWI	8	C8G->A775	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.09 ± 0.03 µg/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50=0.38 ± 0.04 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.25 ± 0.06 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12610152]No detectable cytotoxicity on MBM cell viability and proliferation.	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)O
DRAMP31034	WEDWVRAI	8	C8W->A776	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50>50 µg/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50>50);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50>50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12610153]No detectable cytotoxicity on MBM cell viability and proliferation.	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)O
DRAMP31035	WEDWVRWA	8	C8I->A777	P16090	Retroviridae	Not found	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.15 ± 0.01 µg/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50=0.64± 0.08 µg/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.13 ± 0.04 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12610154]No detectable cytotoxicity on MBM cell viability and proliferation.	Not found	12610147	J Virol. 2003 Mar;77(6):3724-33.	Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M.	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	CC(C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31036	TDVILMCFSIDSPDSLENI	19	77-95(wild type)	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=7.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31037	CSIELSDIPLSVDFNTMID	19	77-95(scrambled)	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CS)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)O
DRAMP31038	ADVILMCFSIDSPDSLENI	19	77-95[77A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=2.56 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@H](C)N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31039	TAVILMCFSIDSPDSLENI	19	77-95[78A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.37 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31040	TDAILMCFSIDSPDSLENI	19	77-95[79A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=6.60 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31041	TDVALMCFSIDSPDSLENI	19	77-95[80A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=11.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31042	TDVIAMCFSIDSPDSLENI	19	77-95[81A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=5.42 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31043	TDVILACFSIDSPDSLENI	19	77-95[82A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.43 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31044	TDVILMAFSIDSPDSLENI	19	77-95[83A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31045	TDVILMCASIDSPDSLENI	19	77-95[84A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=6.29 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31046	TDVILMCFAIDSPDSLENI	19	77-95[85A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=6.82 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31047	TDVILMCFSADSPDSLENI	19	77-95[86A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=3.52 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31048	TDVILMCFSIASPDSLENI	19	77-95[87A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=4.36 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31049	TDVILMCFSIDAPDSLENI	19	77-95[88A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=2.26 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31050	TDVILMCFSIDSADSLENI	19	77-95[89A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=15.32 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31051	TDVILMCFSIDSPASLENI	19	77-95[90A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=2.61 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)O
DRAMP31052	TDVILMCFSIDSPDALENI	19	77-95[91A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.19 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31053	TDVILMCFSIDSPDSAENI	19	77-95[92A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=2.27 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31054	TDVILMCFSIDSPDSLANI	19	77-95[93A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=9.83 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31055	TDVILMCFSIDSPDSLEAI	19	77-95[94A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=18.47 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(=O)O
DRAMP31056	TDVILMCFSIDSPDSLENA	19	77-95[95A]	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=4.89 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC
DRAMP31057	TDVILMCFSI	10	77-86	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@H](C)CC)C(=O)O
DRAMP31058	TDVILMCFSIDSP	13	77–89	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC
DRAMP31059	TDVILMCFSIDSPDSL	16	77-92	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=10.86 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC
DRAMP31060	DVILMCFSIDSPDSLENI	18	78-95	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.23 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31061	VILMCFSIDSPDSLENI	17	79-95	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=16.95 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31062	ILMCFSIDSPDSLENI	16	80-95	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=7.17 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC
DRAMP31063	CFSIDSPDSLENI	13	83-95	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CS)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31064	ILMCFSIDSPDSLEN	15	80-94	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.75 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC
DRAMP31065	ILMCFSIDSPDSLE	14	80-93	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=3.50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP31066	ILMCFSIDSPDSL	13	80-92	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=12.40 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP31067	ILMCFSIDSPDS	12	80-91	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=6.36 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC
DRAMP31068	ILMCFSIDSPD	11	80-90	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=4.61 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC
DRAMP31069	ILMCFSIDSP	10	80-89	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=35.77 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC
DRAMP31070	ILMCFSIDS	9	80-88	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC
DRAMP31071	ILMCFSID	8	80-87	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC
DRAMP31072	ILMCFSI	7	80-86	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@H](C)CC
DRAMP31073	ILMCFS	6	80-85	P08134	Paramyxoviridae	Not found	Synthetic construct(derived from RhoA protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	Budge PJ, Lebowitz J, Graham BS. 	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O
DRAMP31074	NGIGVTQNVLYENQKQIANQFNKAISQIQESLTTTSTA	38	HR1-1(HR1 region 889–926)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: soluble synthesized HR1, HR2 or homologues can bind the exposed HR1 or HR2 region and block the formation of the six-helix bundle, thus inhibiting virus fusion with the target cell.	[Ref.15184046]HIV-luc/SARS pseudotyped virus:inhibition of virus infection in  293T cells(EC50=0.14 μM);##SARS-CoV(wild-type):inhibition of virus infection in 293T cells(EC50=3.68 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15184046	Biochem Biophys Res Commun. 2004 Jul 2;319(3):746-52.	Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H.	Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)C(C)C
DRAMP31075	HRILMRIRQMMT	12	p9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=56.47 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50=473.00 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31076	ARILMRIRQMMT	12	1-P9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=56.12263 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50>500 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC
DRAMP31077	HRALMRIRQMMT	12	3-P9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=34.18095 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50>500 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31078	HRIAMRIRQMMT	12	4-P9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=54.5872 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50>500 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC
DRAMP31079	HRILARIRQMMT	12	5-P9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=435.4996 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50>500 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC
DRAMP31080	HRILMRARQMMT	12	7-P9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=150.1405 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50>500 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31081	HRILMRIAQMMT	12	8-P9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=60.60846 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31082	HRILMRIRAMMT	12	9-P9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=34.13563 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50>500 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31083	HRILMRIRQAMT	12	10-P9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=57.98146 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50>500 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31084	HRILMRIRQMAT	12	11-P9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=120.5239 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50>500 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31085	HRILMRIRQMMA	12	12-P9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=89.41235 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50=186.2536 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)O
DRAMP31086	LMRIRQMMT	9	a-p9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=263.8101 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50>500 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31087	HRILMRIR	8	b-p9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=43.50202 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50>500 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31088	LMRIR	5	c-p9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=716.4193 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22743126]MARC-145 cells:CC50>500 μM.	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31089	hrilmrirqmmt	12	D-P9	No entry found	Arteriviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase.	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=16.12312 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		D	No cytotoxicity information found in the reference(s) presented	PRRSV polymerase	22743126	Virology. 2012 Oct 10;432(1):73-80.	Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P. 	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	CC[C@H](C)[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](N)Cc1c[nH]cn1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCSC)C(=O)N[C@@H](C(=O)O)[C@H](C)O)[C@@H](C)CC
DRAMP31090	AWDFGSIGGVFTSVGKLVHQVFGTAYGVL	29	DV1(419-447)	P27909	Flaviviridae	Not found	Synthetic construct(derived from DENV1 E protein stem)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide shows antiviral activity by inhibiting virus entry.	[Ref.20881042]Dengue 1 virus(DENV1):inhibition of infection in BHK-21 cells(IC90=1.5 μM);##Dengue 2 virus(DENV2):inhibition of infection in BHK-21 cells(IC90=2 μM);##Dengue 3 virus(DENV3):inhibition of infection in BHK-21 cells(IC90>6 μM);##Dengue 4 virus(DENV4):inhibition of infection in BHK-21 cells(IC90>6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	20881042	J Virol. 2010 Dec;84(24):12549-54.	Schmidt AG, Yang PL, Harrison SC.	Peptide inhibitors of flavivirus entry derived from the E protein stem.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP31091	AWDFGSLGGVFTSIGKALHQVFGAIYGAA	29	DV2(419-447)	P29984	Flaviviridae	Not found	Synthetic construct(derived from DENV2 E protein stem)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide shows antiviral activity by inhibiting virus entry.	[Ref.20881042]Dengue 1 virus(DENV1):inhibition of infection in BHK-21 cells(IC90<0.1 μM);##Dengue 2 virus(DENV2):inhibition of infection in BHK-21 cells(IC90=0.3 μM);##Dengue 3 virus(DENV3):inhibition of infection in BHK-21 cells(IC90=2 μM);##Dengue 4 virus(DENV4):inhibition of infection in BHK-21 cells(IC90=0.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	20881042	J Virol. 2010 Dec;84(24):12549-54.	Schmidt AG, Yang PL, Harrison SC.	Peptide inhibitors of flavivirus entry derived from the E protein stem.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)O
DRAMP31092	AWDFGSVGGVLNSLGKMVHQIFGSAYTAL	29	DV3(419-447)	Q99D35	Flaviviridae	Not found	Synthetic construct(derived from DENV3 E protein stem)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide shows antiviral activity by inhibiting virus entry.	[Ref.20881042]Dengue 1 virus(DENV1):inhibition of infection in BHK-21 cells(IC90<0.1 μM);##Dengue 2 virus(DENV2):inhibition of infection in BHK-21 cells(IC90=2 μM);##Dengue 3 virus(DENV3):inhibition of infection in BHK-21 cells(IC90=4 μM);##Dengue 4 virus(DENV4):inhibition of infection in BHK-21 cells(IC90=1.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	20881042	J Virol. 2010 Dec;84(24):12549-54.	Schmidt AG, Yang PL, Harrison SC.	Peptide inhibitors of flavivirus entry derived from the E protein stem.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
DRAMP31093	AWDFGSVGGLFTSLGKAVHQVFGSVYTTM	29	DV4(419-447)	P27909	Flaviviridae	Not found	Synthetic construct(derived from DENV4 E protein stem)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide shows antiviral activity by inhibiting virus entry.	[Ref.20881042]Dengue 1 virus(DENV1):inhibition of infection in BHK-21 cells(IC90=5 μM);##Dengue 2 virus(DENV2):inhibition of infection in BHK-21 cells(IC90=6 μM);##Dengue 3 virus(DENV3):inhibition of infection in BHK-21 cells(IC90>6 μM);##Dengue 4 virus(DENV4):inhibition of infection in BHK-21 cells(IC90=6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	20881042	J Virol. 2010 Dec;84(24):12549-54.	Schmidt AG, Yang PL, Harrison SC.	Peptide inhibitors of flavivirus entry derived from the E protein stem.	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP31094	YENQKQIANQFNKAISQIQESLTTTSTA	28	HR1-a(899-926)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18442051]HIV‐luc/SARS Pseudotyped Virus:inhibition of viral-entry in Vero E3 cells(EC50=1.16 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	18442051	J Cell Biochem. 2008 Aug 15;104(6):2335-47.	Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM.	Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O
DRAMP31095	DVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI	48	GST-removed HR2(1145-1192)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18442051]HIV‐luc/SARS Pseudotyped Virus:inhibition of viral-entry in Vero E3 cells(EC50=2.15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	18442051	J Cell Biochem. 2008 Aug 15;104(6):2335-47.	Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM.	Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors. 	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)NC(=O)[C@@H](N)CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)O
DRAMP31096	DVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI	48	SARS-Cov-S (1145-1192)	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18442051]SARS-CoV PsV: inhibition of HIV-luc/SARS PsV infection in Vero-E6 cells (EC50=2.15μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	not found	18442051	J Cell Biochem. 2008 Aug 15;104(6):2335-47.	Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM.	Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)NC(=O)[C@@H](N)CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)O
DRAMP31097	YENQKQIANQFNKAISQIQESLTTTSTA	28	SARS-Cov-S (899-926)	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18442051]SARS-CoV PsV: inhibition of HIV-luc/SARS PsV infection in Vero-E6 cells (EC50=1.16μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	not found	18442051	J Cell Biochem. 2008 Aug 15;104(6):2335-47.	Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM.	Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O
DRAMP31098	ELDSPKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	64	sHR2-1(derived from SARS-CoV spike protein heptad repeat)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide exhibits antiviral activity by competitive binding to the HR1 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion.	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50=43 ± 6.4 μM);##murine coronavirus:inhibition of virus infection in Vero cells(EC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)C[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31099	PKEELDKYFKNHTSPDVDLGLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	62	sHR2-2(derived from SARS-CoV spike protein heptad repeat)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide exhibits antiviral activity by competitive binding to the HR2 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion.	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50=24 ± 2.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@H](C)CC)NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP31100	LDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	56	sHR2-3(derived from SARS-CoV spike protein heptad repeat)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide exhibits antiviral activity by competitive binding to the HR3 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion.	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP31101	FKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	52	sHR2-4(derived from SARS-CoV spike protein heptad repeat)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide exhibits antiviral activity by competitive binding to the HR4 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion.	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)[C@H](C)CC)C(=O)O
DRAMP31102	TSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	48	sHR2-5(derived from SARS-CoV spike protein heptad repeat)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide exhibits antiviral activity by competitive binding to the HR5 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion.	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@H](C)CC)C(=O)O
DRAMP31103	VDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	44	sHR2-6(derived from SARS-CoV spike protein heptad repeat)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide exhibits antiviral activity by competitive binding to the HR6 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion.	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31104	DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	40	sHR2-7(derived from SARS-CoV spike protein heptad repeat)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide exhibits antiviral activity by competitive binding to the HR7 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion.	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)O
DRAMP31105	ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	68	sHR2-8(derived from SARS-CoV spike protein heptad repeat)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide exhibits antiviral activity by competitive binding to the HR8 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion.	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50=17 ± 3.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)C[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)O
DRAMP31106	ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	60	sHR2-9(derived from SARS-CoV spike protein heptad repeat)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide exhibits antiviral activity by competitive binding to the HR9 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion.	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50=34 ± 4.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)C[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31107	ELDSPKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLID	56	sHR2-10(derived from SARS-CoV spike protein heptad repeat)	P59594	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide exhibits antiviral activity by competitive binding to the HR10 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion.	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)C[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)O
DRAMP31108	DLSLDFEKLNVTLLDLTYEMNRIQDAIKKLNESYINLKE	39	mHR2(derived from SARS-CoV spike protein heptad repeat)	P11224	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide exhibits antiviral activity by competitive binding to the HR11 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion.	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 μM);##murine coronavirus:inhibition of virus infection in Vero cells(EC50=0.9 ± 0.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP31109	DLSLDFEKLNVTLLDLTYEMNRIQDAIKKLNESYINLKE	39	MHV-S (1216-1254)	P11224	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits virus infection by interfering with six-helix bundle formation(fusion inhibitor).	[Ref.15150417]SARS-CoV: inhibition of SARS-CoV infection in Vero 118 cells (EC50>50µM);##MHV(mouse hepatitis virus): inhibition of MHV infection in Vero 118 cells (EC50=0.9±0.1µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP31110	ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	60	SARS-CoV-S (1134-1185)	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits virus infection by interfering with six-helix bundle formation(fusion inhibitor).	[Ref.15150417]SARS-CoV: inhibition of SARS-CoV infection in Vero 118 cells (EC50=34±4.0µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)C[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31111	NQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLIT	46	SARS-CoV-S (935-980)	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits virus infection by interfering with six-helix bundle formation(fusion inhibitor).	[Ref.15150417]SARS-CoV: inhibition of SARS-CoV infection in Vero 118 cells (EC50>50µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)O)C(C)C)NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)O
DRAMP31112	ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	68	SARS-CoV-S (1134-1193)	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits virus infection by interfering with six-helix bundle formation(fusion inhibitor).	[Ref.15150417]SARS-CoV: inhibition of SARS-CoV infection in Vero 118 cells (EC50=17±3.0µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)C[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)O
DRAMP31113	DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	40	SARS-CoV-S (1150-1189)	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits virus infection by interfering with six-helix bundle formation(fusion inhibitor).	[Ref.15150417]SARS-CoV: inhibition of SARS-CoV infection in Vero 118 cells (EC50>50µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)O
DRAMP31114	LDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	56	SARS-CoV-S (1134-1189)	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits virus infection by interfering with six-helix bundle formation(fusion inhibitor).	[Ref.15150417]SARS-CoV: inhibition of SARS-CoV infection in Vero 118 cells (EC50>50µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP31115	ELDSPKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	64	SARS-CoV (1126-1189)[F5P]	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits virus infection by interfering with six-helix bundle formation(fusion inhibitor).	[Ref.15150417]SARS-CoV: inhibition of SARS-CoV infection in Vero 118 cells (EC50=43±6.4µM);##MHV(mouse hepatitis virus): inhibition of MHV infection in Vero 118 cells (EC50>50µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)C[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31116	PKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	60	SARS-CoV (1130-1189)[F1P]	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits virus infection by interfering with six-helix bundle formation(fusion inhibitor).	[Ref.15150417]SARS-CoV: inhibition of SARS-CoV infection in Vero 118 cells (EC50=24±2.8µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP31117	ATCYCRTGRCATRESLSGVCRISGRLYRLCCR	32	HD5[E21R]	Q01523	Herpesviridae, Retroviridae	Not found	Synthetic construct(derived from human alpha defensin(HD5))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The interaction between peptide and viral capsid proteins may cause aggregation of virions to prevent viruses from normal binding to target cells. Another possibility is that the binding of HD5 derivatives to the virion envelope blocks the epitopes of interaction between viruses and cell receptors, which are necessary for viral adsorption or entry into host cells.	[Ref.23269800]Herpes simplex virus2(HSV-2):Potential for CaSki cell protection from HSV-2 infection(61.5% ± 7.1% cell protection rates at 25 μg/ml,90.2% ± 4.9% cell protection at 50 μg/ml);neutralization activity against HSV-2 during the preinfection stage(IC50=25 μg/ml);##HIV-1:inhibition of virus infection in JLTRG cells(IC50=3.53 μg/ ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.	L	[Ref.23269800]No cytotoxicity against CaSki cells up to 100μg/ ml.	capsid protein gD	23269800	J Virol. 2013 Mar;87(5):2835-45. 	Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J. 	Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC1=O
DRAMP31118	ATCYCRTGRCATRESLSGVCEIRGRLYRLCCR	32	HD5[S23R]	Q01523	Herpesviridae	Not found	Synthetic construct(derived from human alpha defensin(HD5))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The interaction between peptide and viral capsid proteins may cause aggregation of virions to prevent viruses from normal binding to target cells. Another possibility is that the binding of HD5 derivatives to the virion envelope blocks the epitopes of interaction between viruses and cell receptors, which are necessary for viral adsorption or entry into host cells.	[Ref.23269800]Herpes simplex virus2(HSV-2):neutralization activity against HSV-2 during the preinfection stage(IC50=36 μg/ml);	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.	L	[Ref.23269800]No cytotoxicity against CaSki cells up to 100μg/ ml.	capsid protein gD	23269800	J Virol. 2013 Mar;87(5):2835-45. 	Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J. 	Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O
DRAMP31119	ATCYCRRGRCATRESLSGVCEISGRLYRLCCR	32	HD5[T7R]	Q01523	Herpesviridae	Not found	Synthetic construct(derived from human alpha defensin(HD5))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The interaction between peptide and viral capsid proteins may cause aggregation of virions to prevent viruses from normal binding to target cells. Another possibility is that the binding of HD5 derivatives to the virion envelope blocks the epitopes of interaction between viruses and cell receptors, which are necessary for viral adsorption or entry into host cells.	[Ref.23269800]Herpes simplex virus2(HSV-2):neutralization activity against HSV-2 during the preinfection stage(IC50=40 μg/ml);	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.	L	[Ref.23269800]No cytotoxicity against CaSki cells up to 100μg/ ml.	capsid protein gD	23269800	J Virol. 2013 Mar;87(5):2835-45. 	Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J. 	Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC1=O
DRAMP31120	ATCYCRTGRCATRESRSGVCEISGRLYRLCCR	32	HD5[L16R]	Q01523	Herpesviridae	Not found	Synthetic construct(derived from human alpha defensin(HD5))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The interaction between peptide and viral capsid proteins may cause aggregation of virions to prevent viruses from normal binding to target cells. Another possibility is that the binding of HD5 derivatives to the virion envelope blocks the epitopes of interaction between viruses and cell receptors, which are necessary for viral adsorption or entry into host cells.	[Ref.23269800]Herpes simplex virus2(HSV-2):Potential for CaSki cell protection from HSV-2 infection(51.2% ± 7.2% cell protection at 100 μg/ml);neutralization activity against HSV-2 during the preinfection stage(IC50=67 μg/ml);	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.	L	[Ref.23269800]No cytotoxicity against CaSki cells up to 100μg/ ml.	capsid protein gD	23269800	J Virol. 2013 Mar;87(5):2835-46. 	Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J. 	Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC3=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC1=O
DRAMP31121	PPVYTKDVDISSQISSMNQSLQQSKDYIKEAQKILDTVNPSL	42	HeV F HRC derived peptide(447-488)	O89342	Paramyxoviridae	Not found	Synthetic construct(derived from HeV fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 6HB structure that is required for fusion. 	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=75 nM);inhibition of fusion in HeLa cells(IC50=40 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>10000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	16973588	J Virol. 2006 Oct;80(19):9837-49.	Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.	Inhibition of hendra virus fusion.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP31122	VYTDKVDISSQISSMNQSLQQSKDYIKEAQKILDTV	36	HeV F HRC derived peptide(449-484)	O89342	Paramyxoviridae	Not found	Synthetic construct(derived from HeV fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 7HB structure that is required for fusion.	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=75 nM);inhibition of fusion in HeLa cells(IC50=40 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>10000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	16973588	J Virol. 2006 Oct;80(19):9837-49.	Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.	Inhibition of hendra virus fusion.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)O
DRAMP31123	DITLNNSVALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSIGN	45	HPIV3 F HRC derived peptide(442-486)	P06828	Paramyxoviridae	Not found	Synthetic construct(derived from HPIV3 fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 8HB structure that is required for fusion.	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=20 nM);inhibition of fusion in HeLa cells(IC50=7.5 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50=500 nM);inhibition of fusion in HeLa cells(IC50=500 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	16973588	J Virol. 2006 Oct;80(19):9837-49.	Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.	Inhibition of hendra virus fusion.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)O
DRAMP31124	VALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI	36	HPIV3 F HRC derived peptide(449-484)	P06828	Paramyxoviridae	Not found	Synthetic construct(derived from HPIV3 fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 9HB structure that is required for fusion.	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=20 nM);inhibition of fusion in HeLa cells(IC50=7.5 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50=500 nM);inhibition of fusion in HeLa cells(IC50=500 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	16973588	J Virol. 2006 Oct;80(19):9837-49.	Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.	Inhibition of hendra virus fusion.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)O)C(=O)O
DRAMP31125	VANDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI	36	HPIV3 F HRC derived peptide(449-484)[L451N]	P06828	Paramyxoviridae	Not found	Synthetic construct(derived from HPIV3 fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 11HB structure that is required for fusion.	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=100 nM);inhibition of fusion in HeLa cells(IC50=3000 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50=1100 nM);inhibition of fusion in HeLa cells(IC50=750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	16973588	J Virol. 2006 Oct;80(19):9837-49.	Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.	Inhibition of hendra virus fusion.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)O)C(=O)O
DRAMP31126	VALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSD	36	HPIV3 F HRC derived peptide(449-484)[I484D]	P06828	Paramyxoviridae	Not found	Synthetic construct(derived from HPIV3 fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 12HB structure that is required for fusion.	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=100 nM);inhibition of fusion in HeLa cells(IC50=8000 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50=500 nM);inhibition of fusion in HeLa cells(IC50=350 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	16973588	J Virol. 2006 Oct;80(19):9837-49.	Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.	Inhibition of hendra virus fusion.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP31127	VANDPIDISIELNKAKSDLEESKEWIRRSNQKLDSD	36	HPIV3 F HRC derived peptide(449-484)[L451N,I484D]	P06828	Paramyxoviridae	Not found	Synthetic construct(derived from HPIV3 fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 13HB structure that is required for fusion.	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>1000 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50=1100 nM);inhibition of fusion in HeLa cells(IC50=750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	16973588	J Virol. 2006 Oct;80(19):9837-49.	Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.	Inhibition of hendra virus fusion.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP31128	VALDPIDISIELNKAKSDLEESKEWIRR	28	HPIV3 F HRC derived peptide(449-476)	P06828	Paramyxoviridae	Not found	Synthetic construct(derived from HPIV3 fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 14HB structure that is required for fusion.	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>1000 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>10000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	16973588	J Virol. 2006 Oct;80(19):9837-49.	Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.	Inhibition of hendra virus fusion.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP31129	SIELNKAKSDLEESKEWIRRSNQKLDSI	28	HPIV3 F HRC derived peptide(457-484)	P06828	Paramyxoviridae	Not found	Synthetic construct(derived from HPIV3 fusion (F) protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 15HB structure that is required for fusion.	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>1000 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>10000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane	16973588	J Virol. 2006 Oct;80(19):9837-49.	Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A.	Inhibition of hendra virus fusion.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)O)C(=O)O
DRAMP31130	MANAGLQLLGFILAFLGW	18	CL58	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=2.1 ± 0.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22378192]Huh7.5.1 cells:CC50~200 Μm.	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-15. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31131	GLQLLGFILAFLGWIGAI	18	CL58.1	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-16. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP31132	LLGFILAFLGWIGAIVST	18	CL58.2	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=4.3 ± 0.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-17. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C
DRAMP31133	FILAFLGWIGAIVSTALP	18	CL58.3	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=8.9± 1.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-18. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(C)C
DRAMP31134	AFLGWIGAIVSTALPQWR	18	CL58.4	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=12.5± 1.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-19. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C
DRAMP31135	GWIGAIVSTALPQWRIYS	18	CL58.5	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=21.5± 1.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-20. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(C)C
DRAMP31136	GAIVSTALPQWRIYSYAG	18	CL58.6	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=23.8 ± 2.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-21. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)NCC(=O)O)[C@H](C)CC)[C@@H](C)O)C(C)C
DRAMP31137	VSTALPQWRIYSYAGDNI	18	CL58.7	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-22. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP31138	ALPQWRIYSYAGDNIVTA	18	CL58.8	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-23. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31139	MANAGLQLLGFILA	14	CL58-4	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-24. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP31140	MANAGLQLLGFILAFL	16	CL58-2	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=7.6± 0.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-25. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31141	MANAGLQLLGFILAFLGWIG	20	CL58+2	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=17.8 ± 1.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-26. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)[C@H](C)CC)C(=O)NCC(=O)O
DRAMP31142	MANAGLQLLGFILAFLGWIGAI	22	CL58+4	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=4.0 ± 0.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-27. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP31143	MANAGLQLLGFILAFLGWIGAIVS	24	CL58+6	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=5.1 ± 0.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-28. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)C(C)C
DRAMP31144	managlqllgfilaflgw	18	CL58.d	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=1.8 ± 0.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		D	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-29. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@H](C)[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](CC(C)C)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@H](N)CCSC)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31145	AGALMFAWLLLGLQGIFN	18	CL58.S	O95832	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-29. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP31146	MASAGMQILGVVLTLLGW	18	CL-6	P56747	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-30. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(C)C)C(C)C
DRAMP31147	MANSGLQLLGFSMALLGW	18	CL-7	Q3B794	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-31. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31148	MASTGLELLGMTLAVLGW	18	CL-9	O95484	Flaviviridae	Not found	Synthetic construct(derived from human claudin-1)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry in a postbinding step.	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	membrane protein	22378192	Hepatology. 2012 Aug;56(2):507-32. 	Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W. 	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C
DRAMP31149	EELRVRLASHLRKLRKRLLRDADDLQKRLAVYEEQAQQIRLQAEAFQARLKSWFEPLVEDM	61	hEP-1	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50=0.67 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22334503]Huh7.5.1 cell:CC50>100 μg/ ml(〜14μM).		22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31150	CEELRVRLASHLRKLRKRLLRDADDLQKRLAVY	33	hEP-2	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50=0.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31151	EELRVRLASHLRKLRKRLLRDADDLQKRLAVY	32	hEP-2/deltaCys	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31152	CEEIRARLSTHLRKMRKRLMRDADDLQKRLAVY	33	mEP-2	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31153	CEEQAQQIRLQAEAFQARLKSWFEPLVEDM	30	hEP-3	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP31154	CVRLASHLRKLRKRLLRDADDL	22	hEP-4	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)O
DRAMP31155	CIRLQAEAFQARLKSWFEPLV	21	hEP-5	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31156	VRLASHLRKLRKRLLRDADDLIRLQAEAFQARLKSWFEPLV	41	hEP-6	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31157	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	30	hEP-7	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31158	EELRVRLASHLRKLRKRLLRDADDL	25	hEP-8	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(=O)O
DRAMP31159	VRLASHLRKLRKRLLRDADDLQKRLAVY	28	hEP-9	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31160	CVRLASHLRKLRKRLLRDADDLQKRLAVY	29	hEP-10	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50=0.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31161	CLRVRLASHLRKLRKRLLRDADDL	24	hEP-11	P02649	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50=4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)O
DRAMP31162	CLRKLRKRLLRC	12	hEP-12	P28995	Flaviviridae	Not found	Synthetic construct(derived from human apolipoprotein E)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. 	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	22334503	Hepatology. 2012 Aug;56(2):484-91.	Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O
DRAMP31163	YAGAVVNDL	9	H2-(7-15)	P10224	Herpesviridae	Not found	Synthetic construct(derived from HSV ribonucleotide reductase subunit 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=36-60 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)O
DRAMP31164	AGAVVNDL	8	H2-(8-15)	P10224	Herpesviridae	Not found	Synthetic construct(derived from HSV ribonucleotide reductase subunit 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=283 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)O
DRAMP31165	GAVVNDL	7	H2-(9-15)	P10224	Herpesviridae	Not found	Synthetic construct(derived from HSV ribonucleotide reductase subunit 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=225 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CN)C(C)C)C(C)C)C(=O)O
DRAMP31166	AVVNDL	6	H2-(10-15)	P10224	Herpesviridae	Not found	Synthetic construct(derived from HSV ribonucleotide reductase subunit 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=190 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)O
DRAMP31167	VVNDL	5	H2-(11-15)	P10224	Herpesviridae	Not found	Synthetic construct(derived from HSV ribonucleotide reductase subunit 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=760 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)O
DRAMP31168	YAGAVVNDL	9	Ac-H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
DRAMP31169	YAGAVVNDL	9	H2-(7-15) amide	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=190 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(N)=O
DRAMP31170	YAGAVVNDL	9	Ac-H2-(7-15) amide	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=76 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C
DRAMP31171	VVNDL	5	Ac-H2-(11-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=400 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
DRAMP31172	YAVVNDL	7	[Tyr9]H2-(9-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=340 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)O
DRAMP31173	YAVVNDL	7	Ac-[Tyr9]H2-(9-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=330 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
DRAMP31174	YGAVVNDL	8	[Tyr8]H2-(8-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=330 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)O
DRAMP31175	YGAVVNDL	8	Ac-[Tyr8]H2-(8-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=150 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
DRAMP31176	AAGAVVNDL	9	[Ala7]H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=280 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)O
DRAMP31177	yAGAVVNDL	9	[D-Tyr7]H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		Mixed(D-Tyr1)	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)O
DRAMP31178	yAGAVVNDL	9	Ac-[D-Tyr7]H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=165 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		Mixed(D-Tyr1)	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
DRAMP31179	XAGAVVNDL	9	[Tyr7(OMe)]H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=88 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 1 is methoxy Tyrosine.	L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	
DRAMP31180	XAGAVVNDL	9	Ac[Tyr7(OMe)]H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free	The 'X' at position 1 is methoxy Tyrosine.	L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	
DRAMP31181	XAGAVVNDL	9	[desamino-Tyr7]H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=33 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 1 is 3-(4-hydroxyphenyl)propionic acid.	L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	
DRAMP31182	YaGAVVNDL	9	[D-Ala8]H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		Mixed(D-Ala2)	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)O
DRAMP31183	YaGAVVNDL	9	Ac-[D-Ala8]H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=230 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		Mixed(D-Ala2)	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
DRAMP31184	YXGAVVNDL	9	[β-Ala8]H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=100 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 2 is 3-aminoproprionic acid.	L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	
DRAMP31185	YAGAVANDL	9	[Ala12]H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=760 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)O
DRAMP31186	YTMLVVDDL	9	EBV H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct(derived from EBV ribonucleotide reductase subunit 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=110 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(C)C
DRAMP31187	YAGTVINDL	9	VZV H2-(7-15)	No entry found	Herpesviridae	Not found	Synthetic construct(derived from VZV ribonucleotide reductase subunit 2)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the activity of ribonucleotide rductase.	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=15 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ribonucleotide reductase	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31188	FAVAVKAVAVKAVAVKAVKKAVKKVKKAVKKAVKKKK	37	DC1	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=0.75 μM);##Feline immunodeficiency virus(FIV-Black):inhibition of reverse transcriptase activity in CrFK cells(IC50=0.78 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12208971]CrFK cell:TC50=9.20 μM.	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP31189	FLAAARIAKRVAKKARKLAKRAARKRK	27	D1D6	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=0.94 μM);##Feline immunodeficiency virus(FIV-Black):inhibition of reverse transcriptase activity in CrFK cells(IC50=1.47 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12208971]CrFK cell:TC50=8.93 μM.	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP31190	FRFKIKFRLKFRFKARFKFRAKFRA	25	D4C3	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=1.32 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12208971]CrFK cell:TC50=3.81 μM.	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O
DRAMP31191	FAVGLRAIKRALKKLRRGVRKVAKDL	26	D5F	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=5.47 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12208971]CrFK cell:TC50=8.73 μM.	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
DRAMP31192	KRKRAVKRVGRRLKKLARKIARLGVAKLAGLRAVKLF	37	D5C1	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=3.38 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12208971]CrFK cell:TC50=5.26 μM.	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
DRAMP31193	GAKKGAKKGKKGAKKGAKGAGAKGAGAFKKKK	32	D2B15	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=4.07 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12208971]CrFK cell:TC50=6.19 μM.	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31194	KKKKFVKKVAKKVKKVAKKVAKVAVAV	27	D2A3	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=3.00 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12208971]CrFK cell:TC50=3.24 μM.	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)O
DRAMP31195	FLFAFRIFKRVFKKFRKLFKRAF	23	D1A22	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=10.51 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12208971]CrFK cell:TC50=10.79 μM.	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP31196	KRKRAVKRVGRRLKKKLARKIARLGVAF	28	D5C	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=7.82 μM);##Feline immunodeficiency virus(FIV-Black):inhibition of reverse transcriptase activity in CrFK cells(IC50=6.84 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12208971]CrFK cell:TC50=7.48 μM.	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP31197	KRKRFAKKFLRFLRKVIRFLKRFIRRF	27	D3A15	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=3.69 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12208971]CrFK cell:TC50=3.28 μM.	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31198	FAIAIKAIKKAIKKIKKAIKKAI	23	D1D2	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=8.71 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12208971]CrFK cell:TC50=5.87 μM.	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP31199	FKVKAKVKAKVKAKVKAKKKK	21	D4B	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=2.85 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.12208971]CrFK cell:TC50=0.92 μM.	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31200	AVKRVGRRLKKLARKIARLGVAF	23	D5D	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=3.37 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	12208971	J Virol. 2002 Oct;76(19):9952-61.	Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA.	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP31201	LPRRLHLEPAFLPYSVKAHECC	22	UL54(1221-1242)	P08546	Herpesviridae	Not found	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50=11 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	DNA polymerase	12857903	J Virol. 2003 Aug;77(15):8336-44.	Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)C(C)C
DRAMP31202	PGGETARKDKFLHMVLPRRL	20	UL54(1206-1225)	P08546	Herpesviridae	Not found	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	DNA polymerase	12857903	J Virol. 2003 Aug;77(15):8336-44.	Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31203	EQVLKAVTNVLSPVFPGGET	20	UL54(1191-1210)	P08546	Herpesviridae	Not found	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50=280 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	DNA polymerase	12857903	J Virol. 2003 Aug;77(15):8336-44.	Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP31204	YVREHGVPIHADKYFEQVLK	20	UL54(1176-1195)	P08546	Herpesviridae	Not found	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	DNA polymerase	12857903	J Virol. 2003 Aug;77(15):8336-44.	Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31205	PPSAVCNYEVAEDPSYVREH	20	UL54(1161-1180)	P08546	Herpesviridae	Not found	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	DNA polymerase	12857903	J Virol. 2003 Aug;77(15):8336-44.	Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP31206	RRLHLEPAFLPYSVKAHECC	20	UL54(1223-1242)	P08546	Herpesviridae	Not found	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50=20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	DNA polymerase	12857903	J Virol. 2003 Aug;77(15):8336-44.	Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)C(C)C
DRAMP31207	LPRRLHLEPAFLPYSVKAHEC	21	UL54(1221-1241)	P08546	Herpesviridae	Not found	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50=75 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	DNA polymerase	12857903	J Virol. 2003 Aug;77(15):8336-44.	Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C
DRAMP31208	LPRRLHLEPAFLPYSVKAHE	20	UL54(1221-1240)	P08546	Herpesviridae	Not found	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase.	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50>500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	DNA polymerase	12857903	J Virol. 2003 Aug;77(15):8336-44.	Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C
DRAMP31209	ACFPWGNTWCGGK	13	NTW (S-S)	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=13.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@H]1CSSC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O
DRAMP31210	ACFPWGNTWCGGK	13	NTW (L)	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50>150 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
DRAMP31211	ACFPWGKEYCGGK	13	KEY (S-S)	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=22.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@H]1CSSC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O
DRAMP31212	ACFPWGKEYCGGK	13	KEY (L)	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50>150 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31213	ACFPWGNQWCGGK	13	NQW (S-S)	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=6.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@H]1CSSC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O
DRAMP31214	ACFPWGNQWCGGK	13	NQW (L)	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=37.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31215	CFPWGC	6	FPWG (S-S)	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=50.0 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization of a n-terminal Cys residue (forming a disulfide bond)	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	Disulfide bond between Cys1 and Cys6	L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	
DRAMP31216	CFPWGC	6	FPWG (L)	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50>150 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CS)C(=O)O
DRAMP31217	ACAPWGNTWCGGK	13	NTW (S-S)[F1A]	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50>200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@H]1CSSC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O
DRAMP31218	ACFAWGNTWCGGK	13	NTW (S-S)[P2A]	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=39 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@H]1CSSC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC1=O
DRAMP31219	ACFPAGNTWCGGK	13	NTW (S-S)[W3A]	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=43 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@H]1CSSC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O
DRAMP31220	ACFPWANTWCGGK	13	NTW (S-S)[G4A]	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=7.4 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@H]1CSSC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O
DRAMP31221	ACFPWGATWCGGK	13	NTW (S-S)[N5A]	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=40 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@H]1CSSC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O
DRAMP31222	ACFPWGNAWCGGK	13	NTW (S-S)[T6A]	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=11 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@H]1CSSC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O
DRAMP31223	ACFPWGNTACGGK	13	NTW (S-S)[W7A]	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3′OH end of the linear poly (C) substrate.	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=80 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	No cytotoxicity information found in the reference(s) presented	RNA-dependent RNA polymerase	12951030	Virology. 2003 Aug 15;313(1):158-69.	Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P.	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	C[C@H](N)C(=O)N[C@H]1CSSC[C@@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O
DRAMP31224	MWKTPTLKYFGGFNFSQI	18	SARSWW-I(770-788)	P11224	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(58% inhibition at ~30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 μM.	membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. 	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP31225	ATAGWTFGAGAALQIPFAMQMAY	23	SARSWW-II(864-886)	P11224	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(39% inhibition at ~30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 μM.	membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. 	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP31226	GYHLMSFPQAAPHGVVFLHVTW	22	SARSWW-III(1028-1049)	P11224	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(90% inhibition at ~30 μM,IC50=2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 μM.	membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. 	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C
DRAMP31227	GVFVFNGTSWFITQRNFFS	19	SARSWW-IV(1075-1093)	P11224	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(83% inhibition at ~30 μM,IC50=2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 μM.	membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. 	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP31228	AACEVAKNLNESLIDLQELGKYEQYIKW	28	SARSWW-Vb(1169-1194)	P11224	Coronaviridae	Not found	Synthetic construct(derived from SARS-CoV spike protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(42% inhibition at ~30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 μM.	membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. 	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31229	GYFVQDDGEWKFTGSSYYY	19	MHVWW-IV(1144-1162)	P11224	Coronaviridae	Not found	Synthetic construct(derived from MHV spike protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(IC50=4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 μM.	membrane	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. 	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP31230	AAHLIDALYAEFLGGRVLTTPVVHRALFYASAVLRQPFLAGVPSA	45	gH493-537(derived from HSV-1 H glycoprotein)	Q9DHD5	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 H glycoprotein (gH))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry and thus protects cells from infection.	[Ref.18572274]Herpes simplex virus type 1(HSV-1):inhibition of viral-entry in Vero cells(50-60% inhibition at 250μM-500μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18572274]No cytotoxicity against Vero cells up to 500 μM.	mambrane	18572274	Peptides. 2008 Sep;29(9):1461-71.	Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M.	Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP31231	AAHLIDALYAEFLGGRVLTT	20	gH493-512(derived from HSV-1 H glycoprotein)	Q9DHD5	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 H glycoprotein (gH))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry and thus protects cells from infection.	[Ref.18572274]Herpes simplex virus type 1(HSV-1):inhibition of viral-entry in Vero cells(60% inhibition at 250μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18572274]No cytotoxicity against Vero cells up to 500 μM.	mambrane	18572274	Peptides. 2008 Sep;29(9):1461-71.	Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M.	Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C
DRAMP31232	GLASTLTRWAHYNALIRAF	19	gH626-644(derived from HSV-1 H glycoprotein)	Q9DHD5	Herpesviridae	Not found	Synthetic construct(derived from HSV-1 H glycoprotein (gH))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry and thus protects cells from infection.	[Ref.18572274]Herpes simplex virus type 1(HSV-1):inhibition of viral-entry in Vero cells(50-60% inhibition at 250μM-500μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18572274]No cytotoxicity against Vero cells up to 500 μM.	mambrane	18572274	Peptides. 2008 Sep;29(9):1461-71.	Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M.	Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31233	CCFLNITNSHVSILQERPPLENRVLTGWGL	30	Pcr-400	P14075	Retroviridae	Not found	Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.	[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=0.18 ± 0.01 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	mambrane	19114713	J Biol Chem. 2009 Mar 6;284(10):6575-84. 	Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.	Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(C)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O)C(C)C
DRAMP31234	LNITNSHVSILQERPPLENRVL	22	Pcr-Δ8	P14075	Retroviridae	Not found	Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.	[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=5.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	membrane	19114713	J Biol Chem. 2009 Mar 6;284(10):6575-84. 	Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.	Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP31235	CFLNITNSHVSILQERPPLENRV	23	Pcr-Δ7	P14075	Retroviridae	Not found	Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.	[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=0.19± 0.01 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	membrane	19114713	J Biol Chem. 2009 Mar 6;284(10):6575-84. 	Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.	Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(C)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31236	CFLNITNSHVSILQEAPPLENRV	23	Pcr-R416A	P14075	Retroviridae	Not found	Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.	[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=1.55 ± 0.08 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	membrane	19114713	J Biol Chem. 2009 Mar 6;284(10):6575-84. 	Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.	Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(C)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31237	CFLNITNSHVSILQEAPPLENAV	23	Pcr-R422A	P14075	Retroviridae	Not found	Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21))	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.	[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=8.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	membrane	19114713	J Biol Chem. 2009 Mar 6;284(10):6575-84. 	Lamb D, Mirsaliotis A, Kelly SM, Brighty DW.	Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(C)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31238	KQRQNKPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRIPNKKPGKK	49	G149-197(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=80 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31239	FHFEVFNFVPCSICSNNPTCWAICKRIPNKKPGKK	35	G163-197(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=80 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31240	VPCSICSNNPTCWAICKRIPNKKPGKK	27	G171-197(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>165 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31241	CSICSNNPTCWAICKRIPNKKPGKK	25	G173-197(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>177 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31242	KQRQNKPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRI	41	G149-189(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=12 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31243	KPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRI	36	G154-189(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=12 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31244	KPNNDFHFEVFNFVPCSICSNNPTCWAICKRI	32	G158-189(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31245	KQRQNKPPSKPNNDFHFEVFN	21	G149-169(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>190 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31246	KQRQNKPPSKPNNDFHF	17	G149-165(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>240 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31247	KPPSKPNNDFHFEVFNFVP	19	G154-172(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=220 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31248	KPPSKPNNDFHFEVFNFV	18	G154-171(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=14 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31249	KPPSKPNNDFHFEVFNF	17	G154-170(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31250	KPPSKPNNDFHFEVFN	16	G154-169(derived from RSV attachment glycoprotein)	P03423	Paramyxoviridae	Not found	Synthetic construct(derived from RSV attachment glycoprotein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>510 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31251	KQRQNKPPSKPNNDFHFEVFNFVPBSIBG	29	G149-177	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 25,28 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31252	KPPSKPNNDFHFEVFNFVPBSIBG	24	G154-177	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 20,23 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31253	KPNNDFHFEVFNFVPBSIBG	20	G158-177	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 16,19 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31254	DFHFEVFNFVPBSIBG	16	G162-177	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=60 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 12,15 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31255	EVFNFVPBSIBG	12	G166-177	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=80 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 8,11 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31256	FVPBSIBG	8	G170-177	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50》500 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 4,7 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31257	KQRQNKPPSKPNNDFHFEVFNFVPB	25	G149-173	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=80 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 25 is S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31258	KPPSKPNNDFHFEVFNFVPBSIAG	24	G154-177[B176A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 20 is S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31259	KPPSKPNNDFHFEVFNFVPBSABG	24	G154-177[I175A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=22 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 20,23 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31260	KPPSKPNNDFHFEVFNFVPBAIBG	24	G154-177[S174A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 20,23 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31261	KPPSKPNNDFHFEVFNFVPASIBG	24	G154-177[B173A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 23 is S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31262	KPPSKPNNDFHFEVFNFVABSIBG	24	G154-177[P172A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 20,23 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31263	KPPSKPNNDFHFEVFNFAPBSIBG	24	G154-177[V171A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 20,23 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31264	KPPSKPNNDFHFEVFNAVPBSIBG	24	G154-177[F170A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=22 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 20,23 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31265	KPPSKPNNDFHFEVFAFVPBSIBG	24	G154-177[N169A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 20,23 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31266	KPPSKPNNDFHFEVANFVPBSIBG	24	G154-177[F168A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=90 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 20,23 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31267	KPPSKPNNDFHFEAFNFVPBSIBG	24	G154-177[V167A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 20,23 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31268	KPPSKPNNDFHFAVFNFVPBSIBG	24	G154-177[E166A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=0.75 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 20,23 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31269	KPPSKPNNDFHAEVFNFVPBSIBG	24	G154-177[F165A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 20,23 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31270	KQRQNKPPSKPNNDFHFEVANAVPBSIBG	29	G149-177[F168/170A]	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>165 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'B' at position 25,28 are S-acetamidomethyl cysteine.	L	No cytotoxicity information found in the reference(s) presented	Not found	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. 	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	
DRAMP31271	DTRACDVIALLCHLNT	16	P1	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(P1 significantly inhibited WNV infectivity at a concentration of 1 mM,IC50=67.0 ± 0.1 μM);##Dengue virus serotype 2:inhibition of virus infection in Vero cells(99.3±0.7% inhibition at 200 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.17151121]No cytotoxicity against Vero cells up to 500μM.	E proteins	17151121	J Virol. 2007 Feb;81(4):2047-55. 	Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.	Antiviral peptides targeting the west nile virus envelope protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31272	CDVIALLCHLNT	12	P8	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(P10 significantly inhibited WNV infectivity).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	E proteins	17151121	J Virol. 2007 Feb;81(4):2047-55. 	Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.	Antiviral peptides targeting the west nile virus envelope protein.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31273	CDVIALLACHLNT	13	P9	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(96.3±2.8% inhibition at 100 μM,IC50=2.60 ± 0.01 μM);inhibition of virus entry in Vero cells(65.2±14.5% inhibition at 100 μM);inhibition of virus attachment to Vero cells(96.3±2.7% inhibition at 1mM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.17151121]No cytotoxicity against Vero cells up to 500μM.	E proteins	17151121	J Virol. 2007 Feb;81(4):2047-55. 	Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.	Antiviral peptides targeting the west nile virus envelope protein.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP31274	CDVIALLCHLNTPSF	15	P10	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(P10 significantly inhibited WNV infectivity).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	E proteins	17151121	J Virol. 2007 Feb;81(4):2047-55. 	Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.	Antiviral peptides targeting the west nile virus envelope protein.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP31275	CDVIALLCHLNTPSFNTTHYRESWY	25	P11	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(P10 significantly inhibited WNV infectivity).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	E proteins	17151121	J Virol. 2007 Feb;81(4):2047-55. 	Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.	Antiviral peptides targeting the west nile virus envelope protein.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31276	SSCNMGWDTPAAnti-CCVWFPYWV	20	A4	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.	[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(70% inhibition).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	pUL84(nonconventional nuclear localization signal of the essential viral replication factor)	19740994	J Virol. 2009 Nov;83(22):11902-13. 	Kaiser N, Lischka P, Wagenknecht N, Stamminger T.	Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.	
DRAMP31277	MAVGLVLCDWWLGEYLLEA	19	A8	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.	[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(70% inhibition).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	pUL84(nonconventional nuclear localization signal of the essential viral replication factor)	19740994	J Virol. 2009 Nov;83(22):11902-13. 	Kaiser N, Lischka P, Wagenknecht N, Stamminger T.	Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.	CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C
DRAMP31278	PVLQPALSLSCGPEPLLLSC	20	A56	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.	[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(40% inhibition).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	pUL84(nonconventional nuclear localization signal of the essential viral replication factor)	19740994	J Virol. 2009 Nov;83(22):11902-13. 	Kaiser N, Lischka P, Wagenknecht N, Stamminger T.	Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.	CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O
DRAMP31279	IEVTFVNRRGDGAELWYLSA	20	A110	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.	[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(35% inhibition).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	pUL84(nonconventional nuclear localization signal of the essential viral replication factor)	19740994	J Virol. 2009 Nov;83(22):11902-13. 	Kaiser N, Lischka P, Wagenknecht N, Stamminger T.	Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP31280	SFAIKWEYVLLLFLL	15	Peptide 75(710-725)[Δ1]	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits a post-binding step in HCV entry.	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(91% inhibition at 50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	20156485	Antiviral Res. 2010 May;86(2):172-9.	Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31281	FAIKWEYVLLLFLL	14	Peptide 75(710-725)[Δ1-2]	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits a post-binding step in HCV entry.	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(95% inhibition at 50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	20156485	Antiviral Res. 2010 May;86(2):172-9.	Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31282	AIKWEYVLLLFLL	13	Peptide 75(710-725)[Δ1-3]	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits a post-binding step in HCV entry.	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(92% inhibition at 50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	20156485	Antiviral Res. 2010 May;86(2):172-9.	Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31283	IKWEYVLLLFLL	12	Peptide 75(710-725)[Δ1-4]	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits a post-binding step in HCV entry.	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(88% inhibition at 50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	20156485	Antiviral Res. 2010 May;86(2):172-9.	Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. 	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31284	KWEYVLLLFLL	11	Peptide 75(710-725)[Δ1-5]	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits a post-binding step in HCV entry.	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(78% inhibition at 50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	20156485	Antiviral Res. 2010 May;86(2):172-9.	Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP31285	WEYVLLLFLL	10	Peptide 75(710-725)[Δ1-6]	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits a post-binding step in HCV entry.	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(82% inhibition at 50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	20156485	Antiviral Res. 2010 May;86(2):172-9.	Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. 	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31286	VSFAIKWEYVLLLFL	15	Peptide 75(710-725)[Δ16]	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits a post-binding step in HCV entry.	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(63% inhibition at 50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	20156485	Antiviral Res. 2010 May;86(2):172-9.	Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31287	VSFAIKWEYVLLLF	14	Peptide 75(710-725)[Δ15-16]	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits a post-binding step in HCV entry.	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(49% inhibition at 50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	20156485	Antiviral Res. 2010 May;86(2):172-9.	Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31288	VSFAIKWEYVLLL	13	Peptide 75(710-725)[Δ14-16]	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits a post-binding step in HCV entry.	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(49% inhibition at 50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	20156485	Antiviral Res. 2010 May;86(2):172-9.	Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31289	VSFAIKWEYVLL	12	Peptide 75(710-725)[Δ13-16]	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits a post-binding step in HCV entry.	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(44% inhibition at 50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	20156485	Antiviral Res. 2010 May;86(2):172-9.	Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31290	VSFAIKWEYVL	11	Peptide 75(710-725)[Δ12-16]	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits a post-binding step in HCV entry.	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(17% inhibition at 50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope protein	20156485	Antiviral Res. 2010 May;86(2):172-9.	Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31291	VSFAIKWEYVLLLFLL	16	Peptide 75(710-725)	P26663	Flaviviridae	Not found	Synthetic construct(derived from HCV envelope protein)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits a post-binding step in HCV entry.	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(EC50=0.3 ± 0.4 μM,EC90=14 ± 12 μM);inhibition of virus infection in primary human hepatocytes(EC50=0.3μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.20156485]No cytotoxicity against Huh-7 cells.	envelope protein	20156485	Antiviral Res. 2010 May;86(2):172-9.	Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31292	RWMVWRHWFHRLRLPYNPGKNKQNQQWP	28	DN57opt	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide blocks virus:cell binding, interfere with a step during viral entry, alter the surface structure of dengue viral particles, and that they interact directly with dengue virus envelope protein.	[Ref.20582308]dengue 2 virus(DENV-2):inhibition of virus infection in LLC-MK2 cells(IC50=8±1 μM,97% inhibition at 20μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.20582308]the peptide was found to be mildly toxic to LLC-MK2 cells at 40 µM.	E glycoprotein	20582308	PLoS Negl Trop Dis. 2010 Jun 22;4(6):e721. 	Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF.	Structural optimization and de novo design of dengue virus entry inhibitory peptides.	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
DRAMP31293	RQMRAWGQDYQHGGMGYSC	19	DN81opt	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide blocks virus:cell binding, interfere with a step during viral entry, alter the surface structure of dengue viral particles, and that they interact directly with dengue virus envelope protein.	[Ref.20582308]dengue 2 virus(DENV-2):inhibition of virus infection in LLC-MK2 cells(IC50=36±6  μM,57% inhibition at 50μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	E glycoprotein	20582308	PLoS Negl Trop Dis. 2010 Jun 22;4(6):e721. 	Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF.	Structural optimization and de novo design of dengue virus entry inhibitory peptides.	CSCC[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)O
DRAMP31294	FWFTLIKTQAKQPARYRRFC	20	1OAN1	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide blocks virus:cell binding, interfere with a step during viral entry, alter the surface structure of dengue viral particles, and that they interact directly with dengue virus envelope protein.	[Ref.20582308]dengue 2 virus(DENV-2):inhibition of virus infection in LLC-MK2 cells(IC50=7±4  μM,99% inhibition at 50 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.20582308]the peptide showed no toxic to LLC-MK2 cells at 50 µM.	E glycoprotein	20582308	PLoS Negl Trop Dis. 2010 Jun 22;4(6):e721. 	Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF.	Structural optimization and de novo design of dengue virus entry inhibitory peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP31295	LLDCWVRLGRYLLRRLKT	18	GBVA1(1-18)	Q69422	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=10 μM,88% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31296	LLDCWVRLGRYLLRRLKTPFTRL	23	GBVA2(1-23)	Q69422	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=15 μM,50% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)O
DRAMP31297	LLDCWVRLGRYLLRRLKTPFT	21	GBVA3(1-21)	Q69422	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM,0% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31298	LLDCWVRLGRYLLRRLKTP	19	GBVA4(1-19)	Q69422	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=3 μM,99% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O
DRAMP31299	LLDCWVRLGRYLLRRLK	17	GBVA5(1-17)	Q69422	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=5 μM,99% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)O
DRAMP31300	LDCWVRLGRYLLRRLKTPFTRL	22	GBVA6(2-23)	Q69422	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM,0 inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)O
DRAMP31301	CWVRLGRYLLRRLKTPFTRL	20	GBVA7(4-23)	Q69422	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=12 μM,89% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP31302	LDCWVRLGRYLLRRLKTP	18	GBVA8(2-19)	Q69422	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=4 μM,99% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O
DRAMP31303	DCWVRLGRYLLRRLKTPF	18	GBVA9(3-20)	Q69422	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=12 μM,90% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O
DRAMP31304	CWVRLGRYLLRRLKTPFT	18	GBVA10(4-21)	Q69422	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=2 μM,100% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31305	WVRLGRYLLRRLKTPFTR	18	GBVA11(5-22)	Q69422	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=12 μM,58% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31306	VRLGRYLLRRLKTPFTRL	18	GBVA12(6-23)	Q69422	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM,0 inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP31307	CWVRLGRYKLRRLKTPFT	18	GBVA10-1(L9K)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175360	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31308	CWVRLGRYSLRRLKTPFT	18	GBVA10-2(L9S)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=18 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31309	CWVRLGRYALRRLKTPFT	18	GBVA10-3(L9A)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31310	CWVRLGRYVLRRLKTPFT	18	GBVA10-4(L9V)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=16 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
DRAMP31311	CWVRLARYLLRRLKTPFT	18	GBVA10-5(G6A)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=2.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31312	CWVRLVRYLLRRLKTPFT	18	GBVA10-6(G6V)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=1.25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31313	CWVRLLRYLLRRLKTPFT	18	GBVA10-7(G6L)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=1.25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31314	CWVRLLRYLLRRLKTLFT	18	GBVA10-8(G6L/P16L)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=1.25 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31315	CWVRLGRYLLRRLKTLFT	18	GBVA10-9(P16L)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: GBVA10-9 can inhibit virus entry at a postattachment step.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=0.16 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.23175359]HepG2 cell:LC50=90 μM(4h of treatment);##HeLa cell:LC50=40 μM(4h of treatment);##Huh7.5.1 cell:LC50=90 μM(4h of treatment);LC50=50 μM(24h of treatment).	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31316	CWVRLGRYILRRLKTPFT	18	GBVA10-10(L9I)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31317	CWVRLGRYILRRIKTPFT	18	GBVA10-11(L9I/L13I)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=0.63 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC
DRAMP31318	CWVRIGRYILRRIKTPFT	18	GBVA10-12(L5I/L9I/L13I)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC
DRAMP31319	KWVRLGRKLLRRLKKPFK	18	GBVA10-13(C1K/Y8K/T15K/T18K)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175361	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31320	KWVRLGRKLLRRLKKPFT	18	GBVA10-14(C1K/Y8K/T15K)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31321	CWVRLGRKLLRRLKKPFT	18	GBVA10-15(Y8K/T15K)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31322	CWVRLGRKLLRRLKTPFT	19	GBVA10-16(Y8K)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31323	EWVRLGRELLRRLKEPFT	18	GBVA10-17(C1E/Y8E/T15E)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(=O)O
DRAMP31324	EWVRLGRELLRRLKEPFE	19	GBVA10-18(C1E/Y8E/T15E/T18E)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(=O)O
DRAMP31325	CWVRLGRELLRRLKEPFT	18	GBVA10-19(Y8E/T15E)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O
DRAMP31326	CWVRLGRELLRRLKTPFT	18	GBVA10-20(Y8E)	No entry found	Flaviviridae	Not found	Synthetic construct(derived from GBVA non-structutal protein 5A)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits virus entry.	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	23175359	J Virol. 2013 Feb;87(3):1649-57.	Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W.	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31327	IPESSELTLQELLGEERR	18	E6ap18	No entry found	Papillomaviridae	Not found	Synthetic construct(derived from E6-associated protein (E6AP))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50=10.5±1.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	E6 protein	15182185	Biochemistry. 2004 Jun 15;43(23):7421-31. 	Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.	Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O
DRAMP31328	YKFACPECPKRFMRSDHLTLHILLHENKK	29	E6apc1	No entry found	Papillomaviridae	Not found	Synthetic construct(derived from E6-associated protein (E6AP))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50>1000 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	E6 protein	15182185	Biochemistry. 2004 Jun 15;43(23):7421-31. 	Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.	Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP31329	YKFACPECPKRFMRSDHLSKHITLHELLGEERR	33	E6apc2	No entry found	Papillomaviridae	Not found	Synthetic construct(derived from E6-associated protein (E6AP))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50=19.3±2.9μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	E6 protein	15182185	Biochemistry. 2004 Jun 15;43(23):7421-31. 	Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.	Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O
DRAMP31330	ALQELLGQWLKDGGPSSGRPPPS	23	E6apn1	No entry found	Papillomaviridae	Not found	Synthetic construct(derived from E6-associated protein (E6AP))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50=36.8±3.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	E6 protein	15182185	Biochemistry. 2004 Jun 15;43(23):7421-31. 	Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.	Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.	CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O
DRAMP31331	ALQELLGEYIQWLKDGGPSSGRPPPS	26	E6apn2	No entry found	Papillomaviridae	Not found	Synthetic construct(derived from E6-associated protein (E6AP))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50=26.2±4.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	E6 protein	15182185	Biochemistry. 2004 Jun 15;43(23):7421-31. 	Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.	Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O
DRAMP31332	YLQELLGE	8	E6apm	No entry found	Papillomaviridae	Not found	Synthetic construct(derived from E6-associated protein (E6AP))	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50=74.3±1.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information found in the reference(s) presented	E6 protein	15182185	Biochemistry. 2004 Jun 15;43(23):7421-31. 	Liu Y, Liu Z, Androphy E, Chen J, Baleja JD.	Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP31333	FLKGIVGMLGKLF	13	Temporin-Sha[K3]	No entry found	Herpesviridae	Not found	Synthetic construct(derived from Temporin-SHa)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.30669255]HSV-1:inhibition of HSV-1 replication in human keratinocytes(48% inhibition at 2.5 µM,57% inhibition at 5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.30669255]Significant cytotoxicity was observed on Keratinocyte at the concentration of 10 μM with a cell viability of 74%.	Not found	30669255	Viruses. 2019 Jan 18;11(1):77.	Roy M, Lebeau L, Chessa C, Damour A, Ladram A, Oury B, Boutolleau D, Bodet C, Lévêque N. 	Comparison of Anti-Viral Activity of Frog Skin Anti-Microbial Peptides Temporin-Sha and [K³]SHa to LL-37 and Temporin-Tb against Herpes Simplex Virus Type 1.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP31334	LLGDLLRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	37	LL-37[F5,6L]	No entry found	Retroviridae	Not found	Synthetic construct(derived from human cathelicidin LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=1.6 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18591279]CEM-SS cells:TC50=18.4 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31335	LLGDLLRKSKEKIGKEFKRIVQR	23	LL-23	No entry found	Retroviridae	Not found	Synthetic construct(derived from human cathelicidin LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>35.4 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18591279]CEM-SS cells:TC50>35.4 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)CNC(=O)CC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP31336	SKEKIGKEFKRIVQRIKDFLR	21	SK-21	No entry found	Retroviridae	Not found	Synthetic construct(derived from human cathelicidin LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=10.8 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18591279]CEM-SS cells:TC50=22.5 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31337	SKVNGQSGRMEFFWTILK	18	HA-pep25	No entry found	Orthomyxoviridae	Not found	Synthetic construct(derived from influenza viral HA)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Block the HA–cell interactions by binding to the influenza host cell receptor sialyllactose and thus inhibit the viral entry.	[Ref.27623031]Influenza A Virus(A/PuertoRico/8/1934):inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(IC50=34.0 ± 11.5μM);##AInfluenza A Virus(/Vietnam/1203/2004):inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(IC50=12.0 ± 2.1μM);##influenza A virus(A/Goose/Qinghai/59/2005):inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(IC50=34.8 ± 1.5μM);##influenza A virus(A/Duck/Anhui/SC702/2013):inhibition of virus entry into Madin Darby canine kidney (MDCK) cells(IC50=51.0 ± 0.6μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA receptor binding domain (RBD)	27623031	ACS Infect Dis. 2016 Mar 11;2(3):187-93	Chen Q, Guo Y	Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31338	GFKRIVQRiKDFLRNLV	17	GF-17d1	No entry found	Retroviridae	Not found	Synthetic construct(derived from human cathelicidin LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>47.5 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		Mixed(D-Ile9)	[Ref.18591279]CEM-SS cells:TC50=22.7 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C
DRAMP31339	GFKRIVQRiKDFlRNLV	17	GF-17d2	No entry found	Retroviridae	Not found	Synthetic construct(derived from human cathelicidin LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>47.5μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		Mixed(D-Ile9,D-Leu13)	[Ref.18591279]CEM-SS cells:TC50>47.5 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C
DRAMP31340	GIKEFKRIVQRIKDFLRNLV	20	GI-20	No entry found	Retroviridae	Not found	Synthetic construct(derived from human cathelicidin LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=1.08 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18591279]CEM-SS cells:TC50=22.7 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP31341	GIKEXKRIVQRIKDFLRNLV	20	GI-20X17	No entry found	Retroviridae	Not found	Synthetic construct(derived from human cathelicidin LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>40.6 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 5 is phenylglycine	L	[Ref.18591279]CEM-SS cells:TC50=7.3 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	
DRAMP31342	GIKEWKRIVQRIKDFLRNLV	20	GI-20W17	No entry found	Retroviridae	Not found	Synthetic construct(derived from human cathelicidin LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=7.4 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18591279]CEM-SS cells:TC50=23.6 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP31343	GIKQFKRIVQRIKDFLRNLV	20	GI-20Q16	No entry found	Retroviridae	Not found	Synthetic construct(derived from human cathelicidin LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=0.91 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18591279]CEM-SS cells:TC50=13.7 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP31344	GIKEFKREFQRIKDFLRNLV	20	GI-20EF	No entry found	Retroviridae	Not found	Synthetic construct(derived from human cathelicidin LL-37)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=1.6 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18591279]CEM-SS cells:TC50=9.9 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31345	GRFKRFRKKFKKLFKKIS	18	BMAP-18	No entry found	Retroviridae	Not found	Synthetic construct(derived from BMAP-27)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=0.35 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18591279]CEM-SS cells:TC50=8.45 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)O
DRAMP31346	GRFKRFRKPFKKLFKKIS	18	BMAP-18P9	No entry found	Retroviridae	Not found	Synthetic construct(derived from BMAP-27)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=3.20 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18591279]CEM-SS cells:TC50=18.9 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)O
DRAMP31347	GRFKRXRKKXKKLFKKIS	18	BMAP-18X6X10	No entry found	Retroviridae	Not found	Synthetic construct(derived from BMAP-27)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=0.68 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 6 and 10 are phenylglycine	L	[Ref.18591279]CEM-SS cells:TC50=10.2 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	
DRAMP31348	GRFKRIRKKLKKLFKKIS	18	BMAP-18I6L10	No entry found	Retroviridae	Not found	Synthetic construct(derived from BMAP-27)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>44.0 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18591279]CEM-SS cells:TC50=2.79 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)O
DRAMP31349	GRFKRFRKKFKKLFK	15	BMAP-15	No entry found	Retroviridae	Not found	Synthetic construct(derived from BMAP-27)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>49.6 μM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.18591279]CEM-SS cells:TC50>49.6 μM.(TC50:the concentration that reduced cell viability by 50%)	Not found	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. 	Wang G, Watson KM, Buckheit RW Jr. 	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31350	MKTFSVAVAVAIVLAFICTQESSALPVTGVEELVELVSSDDPVADHQELPVELGERLFNIRKKRASPKCTPYCYPTRDGVFCGVRCDF	88	EC-hepcidin1	No entry found	Iridoviridae	Not found	Epinephelus coioides	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.21145974]Singapore grouper iridovirus (SGIV):strongly inhibit the replication of SGIV.(EC-hepcidin1 is more active than EC-hepcidin2)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There are two pairs of disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	21145974	Fish Shellfish Immunol. 2011 Feb;30(2):559-68. 	Zhou JG, Wei JG, Xu D, Cui HC, Yan Y, Ou-Yang ZL, Huang XH, Huang YH, Qin QW.	Molecular cloning and characterization of two novel hepcidins from orange-spotted grouper, Epinephelus coioides. 	
DRAMP31351	MKTFSVAVAVAVVLAFICTQESSALPVTGIEELVEPVSSDNNDNHQGLPVELRERLVNIRKKRAPTDCIPYCYPTGDGFHCGVTCRF	87	EC-hepcidin2	No entry found	Iridoviridae	Not found	Epinephelus coioides	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.21145974]Singapore grouper iridovirus (SGIV):strongly inhibit the replication of SGIV.(EC-hepcidin1 is more active than EC-hepcidin2)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	There are two pairs of disulfide bonds.	L	No cytotoxicity information found in the reference(s) presented	Not found	21145974	Fish Shellfish Immunol. 2011 Feb;30(2):559-68. 	Zhou JG, Wei JG, Xu D, Cui HC, Yan Y, Ou-Yang ZL, Huang XH, Huang YH, Qin QW.	Molecular cloning and characterization of two novel hepcidins from orange-spotted grouper, Epinephelus coioides. 	
DRAMP31352	GVCRCLCRRGVCRCLCRR	18	RTD-2 (RTD 2, rhesus theta-defensin 2)	P82271	Retroviridae	Not found	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide binds to gp120 and CD4, thereby inhibiting HIV entry.	[Ref.15210812]HIV-1 A:inhibition of infection in JC53-BL cells(IC50=5.20 ± 1.58 µg/ml);##HIV-1 B:inhibition of infection in JC53-BL cells(IC50=1.78± 0.57 µg/ml);##HIV-1 C:inhibition of infection in JC53-BL cells(IC50=6.74 ± 1.27 µg/ml);##HIV-1 CRF01_AE:inhibition of infection in JC53-BL cells(IC50=3.66 ± 0.69 µg/ml);##HIV-1 D:inhibition of infection in JC53-BL cells(IC50=3.02 ± 0.10 µg/ml);##HIV-1 G:inhibition of infection in JC53-BL cells(IC50=3.08 ± 1.35 µg/ml);##HIV-1 BF:inhibition of infection in JC53-BL cells(IC50=5.16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.	L	No cytotoxicity information found in the reference(s) presented	gp120,CD4	15210812	J Immunol. 2004 Jul 1;173(1):515-20.	Wang W, Owen SM, Rudolph DL, Cole AM, Hong T, Waring AJ, Lal RB, Lehrer RI.	Activity of alpha- and theta-defensins against primary isolates of HIV-1. 	
DRAMP31353	GFCRCICTRGFCRCICTR	18	RTD-3 (rhesus theta defensin 3)	P82270,Q9TU01	Retroviridae	Not found	Macaca mulatta (Rhesus macaque)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide binds to gp120 and CD4, thereby inhibiting HIV entry.	[Ref.15210812]HIV-1 A:inhibition of infection in JC53-BL cells(IC50=3.26 ± 0.58 µg/ml);##HIV-1 B:inhibition of infection in JC53-BL cells(IC50=1.74± 0.40 µg/ml);##HIV-1 C:inhibition of infection in JC53-BL cells(IC50=4.31 ± 0.90 µg/ml);##HIV-1 CRF01_AE:inhibition of infection in JC53-BL cells(IC50=2.09 ± 0.60 µg/ml);##HIV-1 D:inhibition of infection in JC53-BL cells(IC50=2.31 ± 0.21 µg/ml);##HIV-1 G:inhibition of infection in JC53-BL cells(IC50=3.04 ± 0.64 µg/ml);##HIV-1 BF:inhibition of infection in JC53-BL cells(IC50=0.89 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12.	L	No cytotoxicity information found in the reference(s) presented	gp120,CD4	15210812	J Immunol. 2004 Jul 1;173(1):515-20.	Wang W, Owen SM, Rudolph DL, Cole AM, Hong T, Waring AJ, Lal RB, Lehrer RI.	Activity of alpha- and theta-defensins against primary isolates of HIV-1. 	
DRAMP31354	RPRLSHKGPMPF	12	Apelin-12	Q9TUI9##K7GLR4	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection.	[Ref.10802050]HIV:Inhibition of HIV infection in NP-2/CD4/APJ cells(IC50=63.0 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	APJ receptor	10802050	FEBS Lett. 2000 May 4;473(1):15-8.	Zou MX, Liu HY, Haraguchi Y, Soda Y, Tatemoto K, Hoshino H.	Apelin peptides block the entry of human immunodeficiency virus (HIV).	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31355	QRPRLSHKGPMPF	13	Apelin-13	Q9TUI9##A0A484GMR2##A0A5N3XG03##A0A2Y9M6A9##A0A5G2R3Z5##A0A2Y9SZ03##A0A2U4A1K6	Retroviridae	Not found	Bos taurus (Bovine)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection.	[Ref.10802050]HIV:Inhibition of HIV infection in NP-2/CD4/APJ cells(IC50=26.0 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	APJ receptor	10802050	FEBS Lett. 2000 May 4;473(1):15-8.	Zou MX, Liu HY, Haraguchi Y, Soda Y, Tatemoto K, Hoshino H.	Apelin peptides block the entry of human immunodeficiency virus (HIV).	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31356	KFRRQRPRLSHKGPMPF	17	Apelin-17	Q9TUI9##K7GLR4	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection.	[Ref.10802050]HIV:Inhibition of HIV infection in NP-2/CD4/APJ cells(IC50=4.8 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	APJ receptor	10802050	FEBS Lett. 2000 May 4;473(1):15-8.	Zou MX, Liu HY, Haraguchi Y, Soda Y, Tatemoto K, Hoshino H.	Apelin peptides block the entry of human immunodeficiency virus (HIV).	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31357	LVQPRGPRSGPGPWQGGRRKFRRQRPRLSHKGPMPF	36	Apelin-36	Q9TUI9##A0A484GMR2##A0A5N3XG03##A0A2Y9M6A9##A0A5G2R3Z5##A0A2Y9SZ03##A0A2U4A1K6	Retroviridae	Not found	Bos taurus (Bovine)	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection.	[Ref.10802050]HIV:Inhibition of HIV infection in NP-2/CD4/APJ cells(IC50=0.3 μg/ml).##[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	APJ receptor	10802050##11090199	FEBS Lett. 2000 May 4;473(1):15-8.##J Virol. 2000 Dec;74(24):11972-6.	Zou MX, Liu HY, Haraguchi Y, Soda Y, Tatemoto K, Hoshino H.##Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J.	Apelin peptides block the entry of human immunodeficiency virus (HIV).##Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. 	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31358	RRQRPRLSHKGPMPF	15	Apelin-15	Q9TUI9	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection.	[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=12μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	APJ receptor	11090199	J Virol. 2000 Dec;74(24):11972-6.	Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J.	Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. 	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31359	RRKFRRQRPRLSHKGPMPF	19	Apelin-19	Q9TUI9	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection.	[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=4.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	APJ receptor	11090199	J Virol. 2000 Dec;74(24):11972-6.	Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J.	Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. 	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31360	RRQRPRLSHKGPM	13	Apelin-15-(63-75)-peptide	Q9TUI9	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection.	[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=3.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	APJ receptor	11090199	J Virol. 2000 Dec;74(24):11972-6.	Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J.	Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. 	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP31361	RRQRPRLSHKGPX	13	[Met(O)75]apelin-15-(63-75)-peptide	Q9TUI9	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection.	[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=45 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X'  at position 13 indicates oxidized methionine.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	APJ receptor	11090199	J Virol. 2000 Dec;74(24):11972-6.	Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J.	Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. 	
DRAMP31362	RRQRPRLSHKGP	12	Apelin-15-(63-74)-peptide	Q9TUI9	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection.	[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=37 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	APJ receptor	11090199	J Virol. 2000 Dec;74(24):11972-6.	Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J.	Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. 	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O
DRAMP31363	RRKKRRQRRR	10	TAT(48-57)[G1R]	P04610	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22319541]HIV-1 IIIB:inhibition of virus infection in P4-R5 MAGI cells(EC50=0.065 mg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	22319541	Int J Pept. 2012;2012:349427.	Keogan S, Passic S, Krebs FC.	Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP31364	GRKKRRRRRR	10	TAT(48-57)[Q7R]	P04610	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22319541]HIV-1 IIIB:inhibition of virus infection in P4-R5 MAGI cells(EC50=0.071 mg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	22319541	Int J Pept. 2012;2012:349427.	Keogan S, Passic S, Krebs FC.	Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)O
DRAMP31365	RRKKRRRRRR	10	TAT(48-57)[G1R,Q7R]	P04610	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.22319541]HIV-1 IIIB:inhibition of virus infection in P4-R5 MAGI cells(EC50=0.025 mg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	22319541	Int J Pept. 2012;2012:349427.	Keogan S, Passic S, Krebs FC.	Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP31366	KGEAMHGQVDCSPGIWQLDC	20	#4330 derived from HIV-1 integrase	P04587	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	[Ref.17257575]HIV-1:inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(IC50=4 μM);inhibition of reverse transcriptase(DNA-dependent DNA polymerase) activity(IC50=6.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31367	ASCDKCQLKGEAMHG	15	#5649 derived from HIV-1 integrase	P04587	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(91.5 ± 2.5% residual DNA polymerase activity at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	CSCC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)NCC(=O)O
DRAMP31368	KCQLKGEAMHGQVDC	15	#5650 derived from HIV-1 integrase	P04587	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(63± 3% residual DNA polymerase activity at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	CSCC[C@H](NC(=O)CC[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C
DRAMP31369	KGEAMHGQVDCSPGI	15	#5651 derived from HIV-1 integrase	P04587	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(99 ± 6% residual DNA polymerase activity at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(=O)O
DRAMP31370	MHGQVDCSPGIWQLD	15	#5652 derived from HIV-1 integrase	P04587	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(79 ± 3% residual DNA polymerase activity at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31371	VDCSPGIWQLDCTHL	15	#5653 derived from HIV-1 integrase	P04587	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(58 ± 3% residual DNA polymerase activity at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
DRAMP31372	PGIWQLDCTHLEGKI	15	#5654 derived from HIV-1 integrase	P04587	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(62.5 ± 0.5% residual DNA polymerase activity at 30 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Reverse Transcriptase	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)O
DRAMP31373	SWLRDLWDWICEVLSDFK	18	NS5A-derived peptide C5A [I6L]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.40±0.13 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 μM).	[Ref.21801309]Human erythrocytes:MHC=13.84 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31374	SWLRDIWDWLCEVLSDFK	18	NS5A-derived peptide C5A [I10L]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.20±0.09 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=1.84±0.16 μM).	[Ref.21801309]Human erythrocytes:MHC=6.92 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31375	SWLRDIWDWICELLSDFK	18	NS5A-derived peptide C5A [V13L]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.20±0.11 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=2.76±0.19 μM).	[Ref.21801309]Human erythrocytes:MHC=3.44 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31376	SWLRDLWDWLCEVLSDFK	18	NS5A-derived peptide C5A [I6L,I10L]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.40±0.15 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 μM).	[Ref.21801309]Human erythrocytes:MHC=6.92 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31377	SWLRDLWDWICELLSDFK	18	NS5A-derived peptide C5A [I6L,V13L]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=0.78±0.07 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=3.31±0.31 μM).	[Ref.21801309]Human erythrocytes:MHC=53.75 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31378	SWLRDIWDWLCELLSDFK	18	NS5A-derived peptide C5A [I10L,V13L]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=0.82±0.10 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=2.58±0.22 μM).	[Ref.21801309]Human erythrocytes:MHC=3.44 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31379	SWLRDLWDWLCELLSDFK	18	NS5A-derived peptide C5A [I6L,I10L,V13L]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.20±0.14 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=0.59±0.03 μM).	[Ref.21801309]Human erythrocytes:MHC=107.50 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)O
DRAMP31380	SWLRDIWDWVCEVLSDFK	18	NS5A-derived peptide C5A [I10V]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.40±0.117 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=1.86±0.25 μM).	[Ref.21801309]Human erythrocytes:MHC=13.93 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP31381	SWLRDIWDWACEVLSDFK	18	NS5A-derived peptide C5A [I10A]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=4.00±0.36 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=2.21±0.28 μM).	[Ref.21801309]Human erythrocytes:MHC=14.10 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31382	SWLRDIWDWGCEVLSDFK	18	NS5A-derived peptide C5A [I10G]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50>5.00 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=3.50±0.36 μM).	[Ref.21801309]Human erythrocytes:MHC=28.38 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31383	SWLRDIWDWSCEVLSDFK	18	NS5A-derived peptide C5A [I10S]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50>5.00 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 μM).	[Ref.21801309]Human erythrocytes:MHC=28.00 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31384	SWLRDIWDWECEVLSDFK	18	NS5A-derived peptide C5A [I10E]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50>5.00 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 μM).	[Ref.21801309]Human erythrocytes:MHC=214.91 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31385	SWLRDIWDWKCEVLSDFK	18	NS5A-derived peptide C5A [I10K]	V5RF15	Flaviviridae, Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50>5.00 μM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 μM).	[Ref.21801309]Human erythrocytes:MHC=214.81 μM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31386	TRQARRNRRRRWRERQR	17	Rev (34-50)	P05866	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found	1ULL	Mechanism: Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication. 	[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=1.7±0.25 μM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	20580677	Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.	Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M.	Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.	C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31387	TRQARRNRRRRWRERQRAAAAC	22	Rev (34-50) -A4C	P05866	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication. 	[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=0.35±0.07 μM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	20580677	Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.	Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M.	Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)O
DRAMP31388	TRQARRNRRRRWRERQRAAAACYGRKKRRQRRR	33	Rev (34-50) -A4C-RTD	P05866##P04612	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication. 	[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=0.37±0.09 μM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	20580677	Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.	Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M.	Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31389	MPKTRRRPRRSQRKRPPTPWP	21	Rex (1-21)	P0C207	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication. 	[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50>10 μM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	20580677	Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.	Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M.	Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.	CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31390	MPKTRRRPRRSQRKRPPTPWPYGRKKRRQRRR	32	Rex (1-21) -RTD	P0C207##P04612	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication. 	[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=2.5±0.76 μM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	20580677	Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.	Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M.	Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.	CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31391	RPRGRRGSRPSGAERRRRRAAAA	23	RSG-P2G4	No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication. 	[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=2.2±0.51 μM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	20580677	Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.	Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M.	Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(=O)O
DRAMP31392	RSQKEGLHYTCSSHFPYSQYQFWK	24	CCR5 ECL2 (168-191)	P51681	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide binds gp120 and inhibits virus entry.	[Ref.22403408]HIV-1 YU2:inhibition of virus infection in TZM-bl cells(IC50=136 ± 49 μM);##HIV-1 BaL26:inhibition of virus infection in TZM-bl cells(IC50=138± 36 μM);##HIV-1 HxB2:inhibition of virus infection in TZM-bl cells(IC50=89±31 μM);##HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=103±37 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	gp120	22403408	J Biol Chem. 2012 Apr 27;287(18):15076-86.	Dogo-Isonagie C, Lam S, Gustchina E, Acharya P, Yang Y, Shahzad-ul-Hussan S, Clore GM, Kwong PD, Bewley CA.	Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.	CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31393	CSSHFPYSQYQFWK	14	CCR5 ECL2 (178-191)	P51681	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide binds gp120 and inhibits virus entry.	[Ref.22403408]HIV-1 YU2:inhibition of virus infection in TZM-bl cells(IC50=28 ±7 μM);##HIV-1 BaL26:inhibition of virus infection in TZM-bl cells(IC50=65± 3 μM);##HIV-1 HxB2:inhibition of virus infection in TZM-bl cells(IC50=54±2 μM);##HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=53±2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	gp120	22403408	J Biol Chem. 2012 Apr 27;287(18):15076-86.	Dogo-Isonagie C, Lam S, Gustchina E, Acharya P, Yang Y, Shahzad-ul-Hussan S, Clore GM, Kwong PD, Bewley CA.	Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.	NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CS)C(=O)O
DRAMP31394	QKEGLHYTCSSHFPYSQYQF	20	CCR5 ECL2 (170-189)	P51681	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide binds gp120 and inhibits virus entry.	[Ref.22403408]HIV-1 YU2:inhibition of virus infection in TZM-bl cells(IC50=237 ± 31 μM);##HIV-1 BaL26:inhibition of virus infection in TZM-bl cells(IC50=612± 21 μM);##HIV-1 HxB2:inhibition of virus infection in TZM-bl cells(IC50=374±28 μM);##HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=600±24 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	gp120	22403408	J Biol Chem. 2012 Apr 27;287(18):15076-86.	Dogo-Isonagie C, Lam S, Gustchina E, Acharya P, Yang Y, Shahzad-ul-Hussan S, Clore GM, Kwong PD, Bewley CA.	Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.	CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP31395	RRWYRWW	7	Octa 1	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50>20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17681018	FEBS J. 2007 Sep;274(17):4511-25.	Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31396	RRWYRWWRRRWYRWWR	16	MU89 (Octa 1 dp)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=8.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17681018	FEBS J. 2007 Sep;274(17):4511-25.	Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP31397	RWWRWWR	7	Hepta 1	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50>20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17681018	FEBS J. 2007 Sep;274(17):4511-25.	Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP31398	RWWRWWRRWWRWWR	14	MU92 (Hepta 1 dp)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=3.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17681018	FEBS J. 2007 Sep;274(17):4511-25.	Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP31399	YRWWRWARRW	10	Deca 1	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50>20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17681018	FEBS J. 2007 Sep;274(17):4511-25.	Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31400	YRWWRWARRWYRWWRWARRW	20	MU94 (Deca 1 dp)	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=5 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17681018	FEBS J. 2007 Sep;274(17):4511-25.	Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31401	APKAMRLLRRLLRRLLR	17	N-[RLLR]3	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=7.3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17681018	FEBS J. 2007 Sep;274(17):4511-25.	Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31402	RRRRRRRWWWRRRRRRRR	18	MU103	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50>20 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17681018	FEBS J. 2007 Sep;274(17):4511-25.	Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP31403	RRRRRRRRRRRRRRRWWW	18	MU104	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=9.25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17681018	FEBS J. 2007 Sep;274(17):4511-25.	Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31404	WRKWRKRWWWRKWRKRWW	18	ApoEdpL-W	No entry found	Herpesviridae, Retroviridae, Rhabdoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region.	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=3.1 µM);##HIV-1:inhibition of virus replication(>80% inhibition at 10 µM).	[Ref.17681018]15% hemolysis against human red blood cells at 35 μM.	Linear	Free	Free		L	[Ref.17681018]No significant cytotoxicity against Vero cells up to 40 μM.	Not found	17681018	FEBS J. 2007 Sep;274(17):4511-25.	Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB.	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31405	HCKFWW	6		No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication.	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	integrase	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH.	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	NCCCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP31406	HCKFWI	6		No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication.	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	integrase	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH.	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(N)=O
DRAMP31407	HCKFWF	6		No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication.	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	integrase	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH.	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	NCCCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP31408	HCKFAW	6		No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication.	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=150 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	integrase	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH.	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP31409	HCKFWA	6		No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication.	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=210 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	integrase	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH.	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(N)=O
DRAMP31410	HCKAWW	6		No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication.	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	integrase	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH.	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP31411	ACKFWW	6		No entry found	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication.	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=51 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	integrase	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH.	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP31412	GWINEKKMQQKIDEKIGKNIIGGMAKAVIHKMAKNEFQCVANVDTLGNCKKHCAKTTGEKGYCHGTKCKCGIELSY	76	Smp76	No entry found	Flaviviridae	Not found	Scorpio maurus palmatu	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.32435168]Dengue Virus(DENV):inhibition of viral infection in Vero/SLAM cells(IC50= 0.01 μg/ml).	[Ref.32435168]human red blood cells:HC50>10 μg/ml.	Cyclic	Free	Free	Disulfide bonds between Cys39 and Cys63, Cys49 and Cys68, Cys53 and Cys70.	L	[Ref.32435168]Huh7it-1 cells:CC50>10 μg/ml.	Not found	32435168	Int J Pept Res Ther. 2020;26(2):811-821. 	El-Bitar AMH, Sarhan M, Abdel-Rahman MA, Quintero-Hernandez V, Aoki-Utsubo C, Moustafa MA, Possani LD, Hotta H.	Smp76, a Scorpine-Like Peptide Isolated from the Venom of the Scorpion Scorpio maurus palmatus, with a Potent Antiviral Activity Against Hepatitis C Virus and Dengue Virus.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N3)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC2=O)C(=O)N[C@@H](CCCCN)C(=O)N1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP31413	GFGCPFNQGQCHKHCQSIRRRGGYCDGFLKTRCVCYR	37	BmKDfsin4	No entry found	Hepadnaviridae	Not found	Mesobuthus martensii	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: BmKDfsin4 had been shown to exhibit powerful inhibitory activity against HBV replication by reducing the production of HBeAg, HBsAg, and HBV DNAin cell culture medium and the production of intracellular HBsAg, HBV core protein, HBx protein, and HBV RT.	[Ref.27128943]hepatitic B Virus (HBV): Pharmacological profiles of BmKDfsin4 against HBeAg, HBsAg and HBV DNA on HepG2.2.15 cells(HBeAg: IC50= 3.95 μM; HBsAg: IC50= 2.28 μM; HBV DNA: IC50= 1.26 μM).	[Ref.27128943]Human erythrocytes: 50% hemolysis concentration was 66.85 μM.	Cyclic	Free	Free	Disulfide bonds between Cys4 and Cys25, Cys11 and Cys33, Cys15 and Cys35.	L	[Ref.27128943]HepG2.2.15 cells: CC50= 167.82 μM;##HepG2 cells: CC50= 154.24 μM;##L-02 cells: CC50= 103.77 μM.	Not found	27128943	Toxins (Basel). 2016 Apr 27;8(5):124.	Zeng Z, Zhang Q, Hong W, Xie Y, Liu Y, Li W, Wu Y, Cao Z. 	A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4ccccc4)NC(=O)CN)CSSC[C@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC1=O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N3)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N2
DRAMP31414	LLMVNEATRFQTVSGFV	17	BPIP	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits Mpro, a protein crucial for viral replication.	[Ref.35896605]SARS-CoV-2: inhibition of Mpro (IC50= 0.52 nM).	[Ref.35896605]BRIP is not hemolytic at 500 nM and slightly hemolytic at 50 µM.	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Mpro	35896605	Sci Rep. 2022 Jul 27;12(1):12802	Kashyap P, Bhardwaj VK, Chauhan M, Chauhan V, Kumar A, Purohit R, Kumar A, Kumar S	A ricin-based peptide BRIP from Hordeum vulgare inhibits Mpro of SARS-CoV-2	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP31415	KFFRKKSVKK	10	BF-30	No entry found	Orthomyxoviridae	Not found	Bungarus fasciatus	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: BF-30 could inhibit the replication of various influenza subtypes by fusing virion membranes and reducing infectivity. 	[Ref.30447229]Influenza A virus H1N1:inhibition of viral replication in MDCK cells(EC50=5.20±0.9 μM);##influenza A virus H3N2: inhibition of viral replication in MDCK cells(EC50=7.36 ± 1.2 μM);##influenza A virus(oseltamivir-resistant strain): inhibition of viral replication in MDCK cells(EC50=18.91 ± 7.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30447229]MDCK cells:CC50=67.7μM.	Not found	30447229	Peptides. 2019 Feb;112:14-22. 	Xu J, Chen S, Jin J, Ma L, Guo M, Zhou C, Dou J.	Inhibition of peptide BF-30 on influenza A virus infection in vitro/vivo by causing virion membrane fusion.	CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31416	FLGAILKIGHALAKTVLPMVTNAFKPKQ	28	Figainin 2	A0A2L2DDD0		Not found	Boana raniceps (Hypsiboas raniceps)	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.32443921]chikungunya virus (CHIKV):inhibition of viral infection in Huh7 cells(EC50=17 μM);##Dengue Serotype 4 Virus(DENV4):inhibition of viral infection in Huh7 cells(EC50=20.8 μM);##Yellow Fever viral (YFV):inhibition of viral infection in Huh7 cells(EC50=21.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.32443921]No cytotoxicity against noninfected Huh7 cells at concentrations as high as 25 µM.	Not found	32443921	Biomolecules. 2020 May 20;10(5):790. 	Santana CJC, Magalhães ACM, Prías-Márquez CA, Falico DA, Dos Santos Júnior ACM, Lima BD, Ricart CAO, de Pilger DRB, Bonotto RM, Moraes CB, Freitas-Júnior LH, Álvares ADCM, Freitas SM, Luz IS, Pires OR Jr, Fontes W, Castro MS.	Biological Properties of a Novel Multifunctional Host Defense Peptide from the Skin Secretion of the Chaco Tree Frog, Boana raniceps.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@H](C)CC
DRAMP31417	MRRKVELFTYMRFD	14	TP1	No entry found	Picornaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide could associate with the cellular receptors at the surface of cells and prevented the attachment of EV-A71 to the cellular receptors.	[Ref.34314773]Enterovirus A71 (EV-A71):inhibition of viral replication into RD cells(IC50=6.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.34314773]RD cells: CC50=683.6 μM.	Not found	34314773	Virus Res. 2021 Oct 2;303:198456. 	Zarif F, Anasir MI, Koh JX, Chew MF, Poh CL.	Stability and antiviral activity of SP41 peptide in human serum.	CSCC[C@H](NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)C(C)C
DRAMP31418	RRKVELFTYMRFD	13	TP2	No entry found	Picornaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide could associate with the cellular receptors at the surface of cells and prevented the attachment of EV-A71 to the cellular receptors.	[Ref.34314773]Enterovirus A71 (EV-A71):inhibition of viral replication into RD cells(IC50=6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.34314773]RD cells: CC50=345 μM.	Not found	34314773	Virus Res. 2021 Oct 2;303:198456.	Zarif F, Anasir MI, Koh JX, Chew MF, Poh CL.	Stability and antiviral activity of SP42 peptide in human serum.	CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O
DRAMP31419	RKVELFTYMRFD	12	TP3	No entry found	Picornaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide could associate with the cellular receptors at the surface of cells and prevented the attachment of EV-A71 to the cellular receptors.	[Ref.34314773]Enterovirus A71 (EV-A71):inhibition of viral replication into RD cells(IC50=5.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.34314773]RD cells: CC50=1123 μM.	Not found	34314773	Virus Res. 2021 Oct 2;303:198456.	Zarif F, Anasir MI, Koh JX, Chew MF, Poh CL.	Stability and antiviral activity of SP43 peptide in human serum.	CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(N)=O
DRAMP31420	QMRRKVELFTYMRF	14	TP10	No entry found	Picornaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide could associate with the cellular receptors at the surface of cells and prevented the attachment of EV-A71 to the cellular receptors.	[Ref.34314773]Enterovirus A71 (EV-A71):inhibition of viral replication into RD cells(IC50=6.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.34314773]RD cells: CC50=231 μM.	Not found	34314773	Virus Res. 2021 Oct 2;303:198456.	Zarif F, Anasir MI, Koh JX, Chew MF, Poh CL.	Stability and antiviral activity of SP44 peptide in human serum.	CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)O)C(C)C
DRAMP31421	AKVTMTCSAS	10	KP	P01680	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.30654366]HSV-1:inhibition of viral replication in Vero cells (96% inhibition at 50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30654366]<10% cytotoxicity against Vero cells at the concentration of 100μg/ mL.	Not found	30654366	Intervirology. 2018;61(4):166-173.	Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C	Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins. 	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP31422	KKVTMTCSAS	10	K10S	P01680	Herpesviridae, Picornaviridae, Adenoviridae, Rhabdoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.30654366]HSV-1:inhibition of viral replication in Vero cells (45% inhibition at 10 µg/ml, 76% inhibition at 50 µg/ml, 89% inhibition at 100 µg/ml);##Coxsackie virus B5:inhibition of viral replication in Vero cells (75% inhibition at 50 µg/ml, 94% inhibition at 100 µg/ml);##Vesicular Stomatitis Virus (VSV):inhibition of viral replication in Vero cells (78% inhibition at 50 µg/ml, 96% inhibition at 100 µg/ml);##Adenovirus:inhibition of viral replication in Vero cells (75% inhibition at 50 µg/ml, 91% inhibition at 100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30654366]20% cytotoxicity against Vero cells at the concentration of 100μg/ mL.	Not found	30654366	Intervirology. 2018;61(4):166-173.	Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C	Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins. 	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP31423	KKLVAASQAALGL	13	K13L	P02768-2	Picornaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.30654366]Coxsackie virus B5:inhibition of viral replication in Vero cells (60% inhibition at 10 µg/ml, 80% inhibition at 50 µg/ml, 87% inhibition at 100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30654366]30% cytotoxicity against Vero cells at the concentration of 100μg/ mL.	Not found	30654366	Intervirology. 2018;61(4):166-173.	Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C	Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins. 	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
DRAMP31424	DSGEGDFLAEGGGVR	15	D15R	P02671	Picornaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.30654366]Coxsackie virus B5:inhibition of viral replication in Vero cells (82% inhibition at 10 µg/ml, 85% inhibition at 50 µg/ml, 93% inhibition at 100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30654366]<10% cytotoxicity against Vero cells at the concentration of 100μg/ mL.	Not found	30654366	Intervirology. 2018;61(4):166-173.	Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C	Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins. 	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](CO)NC(=O)C[C@H](N)C(=O)NCC(=O)NCC(=O)O)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C
DRAMP31425	GLEEELQFSLGSKINVK	17	G17K	P0C0L5	Picornaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.30654366]Coxsackie virus B5:inhibition of viral replication in Vero cells (60% inhibition at 10 µg/ml, 75% inhibition at 50 µg/ml, 88% inhibition at 100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30654366]<10% cytotoxicity against Vero cells at the concentration of 100μg/ mL.	Not found	30654366	Intervirology. 2018;61(4):166-173.	Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C	Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP31426	SEETKENEGFTVTAEGK	17	S17K	P01024	Adenoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.30654366]Adenovirus:inhibition of viral replication in Vero cells (60% inhibition at 10 µg/ml, 65% inhibition at 50 µg/ml, 80% inhibition at 100 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30654366]<10% cytotoxicity against Vero cells at the concentration of 100μg/ mL.	Not found	30654366	Intervirology. 2018;61(4):166-173.	Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C	Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins. 	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)O)NC(=O)[C@H](CCC(=O)NCC(=O)NCC(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](C)C(=O)O
DRAMP31427	LCLRNWDQGHRP	12	L12P	A0M8Q8	Herpesviridae, Picornaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.30654366]HSV-1:inhibition of viral replication in Vero cells (78% inhibition at 10 µg/ml, 84% inhibition at 50 µg/ml);##Coxsackie virus B5:inhibition of viral replication in Vero cells (60% inhibition at 10 µg/ml, 42% inhibition at 50 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.30654366]<10% cytotoxicity against Vero cells at the concentration of 100μg/ mL.	Not found	30654366	Intervirology. 2018;61(4):166-173.	Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C	Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins. 	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O
DRAMP31428	GKRKSGCA	8	Entry 1	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 114.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The N-terminal and C-terminal cyclized by a amide bond.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31429	GKRKSGAA	8	Entry 6	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 57.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The N-terminal and C-terminal cyclized by a amide bond.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31430	GKRKSXCA	8	Entry 7	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 22.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates phenylglycine(Phg). The N-terminal and C-terminal cyclized by a amide bond.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31431	GKRKSFCA	8	Entry 8	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 39.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The N-terminal and C-terminal cyclized by a amide bond.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31432	GKRKSXCA	8	Entry 9	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 9.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe). The N-terminal and C-terminal cyclized by a amide bond.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31433	GKRKSxCA	8	Entry 10	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 38.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'x' at position 6 indicates D-homophenylalanine(D-hPhe). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-hPhe6)	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31434	GKRKSXAA	8	Entry 11	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 18.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe). The N-terminal and C-terminal cyclized by a amide bond.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31435	GKRKSXAX	8	Entry 12	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 22.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe), position 8 indicates homophenylalanine(Phg). The N-terminal and C-terminal cyclized by a amide bond.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31436	GKRKSXAx	8	Entry 13	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 15.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe), position 8 indicates D-homophenylalanine(D-Phg). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Phg8)	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31437	GKRKSXAF	8	Entry 14	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 19.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe). The N-terminal and C-terminal cyclized by a amide bond.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31438	GKRKSXAf	8	Entry 15	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 7.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Phe8)	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31439	GKRKSXAX	8	Entry 16	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 25.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 and 8 indicates homophenylalanine(hPhe). The N-terminal and C-terminal cyclized by a amide bond.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31440	GKRKSXAx	8	Entry 17	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 16.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 and 8 indicates homophenylalanine(hPhe/D-hPhe). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-hPhe8)	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31441	GKRKSXSf	8	Entry 18	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 5.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Phe8)	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31442	AKRKSXSf	8	Entry 19	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 28.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Phe8)	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31443	aKRKSXSf	8	Entry 20	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 3.3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Ala1, Phe8)	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31444	PKRKSXSf	8	Entry 21	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 52.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Phe8)	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31445	pKRKSXSf	8	Entry 22	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 0.95 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Pro1, Phe8)	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31446	pKRKSXSf	8	Entry 23	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 2.6 μM); inhibition of virus-induced cytopathic effects (CPE) in BHK-21 cells(EC50=306.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates L-2-naphthylalanine(l-2Nal). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Pro1, Phe8)	[Ref.28539222]BHK-21 cells: CC50>400 μM.	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31447	pKRKSXSf	8	Entry 24	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 3.8 μM); inhibition of virus-induced cytopathic effects (CPE) in BHK-21 cells(EC50=293.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates biphenylalanine (L-bPhe). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Pro1, Phe8)	[Ref.28539222]BHK-21 cells: CC50>400 μM.	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31448	pRRKSXSf	8	Entry 25	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 3.8 μM); inhibition of virus-induced cytopathic effects (CPE) in BHK-21 cells(EC50=108.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates biphenylalanine (L-bPhe). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Pro1, Phe8)	[Ref.28539222]BHK-21 cells: CC50>400 μM.	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31449	rRRKSXSf	8	Entry 26	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 3.7 μM); inhibition of virus-induced cytopathic effects (CPE) in BHK-21 cells(EC50=87.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates biphenylalanine (L-bPhe). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Arg1, Phe8)	[Ref.28539222]BHK-21 cells: CC50>400 μM.	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31450	rRRKSXSr	8	Entry 27	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 2.3 μM); inhibition of virus-induced cytopathic effects (CPE) in BHK-21 cells(EC50=141.1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates biphenylalanine (L-bPhe). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Arg1, 8)	[Ref.28539222]BHK-21 cells: CC50>400 μM.	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31451	rRRKSXXf	8	Entry 28	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 1.6 μM); inhibition of virus-induced cytopathic effects (CPE) in BHK-21 cells(EC50=23.2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe), position 7 indicates L-1-naphthylalanine(L-1Nal). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Arg1, Phe8)	[Ref.28539222]BHK-21 cells: CC50=233 μM.	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31452	rRRKAXXf	8	Entry 29	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 1.7 μM); inhibition of virus-induced cytopathic effects (CPE) in BHK-21 cells(EC50=11.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe), position 7 indicates L-1-naphthylalanine(L-1Nal). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Arg1, Phe8)	[Ref.28539222]BHK-21 cells: CC50=134.1 μM.	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31453	rRRKSXXf	8	Entry 30	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 1.5 μM); inhibition of virus-induced cytopathic effects (CPE) in BHK-21 cells(EC50=48.5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe), position 7 indicates L-2-naphthylalanine(L-2Nal). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Arg1, Phe8)	[Ref.28539222]BHK-21 cells: CC50=210 μM.	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31454	rRRKfXFx	8	Entry 31	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 1.7 μM); inhibition of virus-induced cytopathic effects (CPE) in BHK-21 cells(EC50=4.6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe), position 8 indicates D-2-naphthylalanine(D-2Nal). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Arg1, Phe5, 2Nal8)	[Ref.28539222]BHK-21 cells: CC50=86 μM.	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31455	rRRKxXFx	8	Entry 32	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The cyclic peptide could inhibit the activity of NS2B-NS3 protease, which is an essential enzyme for the replication of dengue virus.	[Ref.28539222]dengue virus 2(DENV2):inhibition of the activity of NS2B-NS3 protease(IC50= 1.1 μM); inhibition of virus-induced cytopathic effects (CPE) in BHK-21 cells(EC50=2.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The 'X' at position 6 indicates homophenylalanine(hPhe), position 5 and 8 indicates D-2-naphthylalanine(D-2Nal). The N-terminal and C-terminal cyclized by a amide bond.	Mixed(D-Arg1, 2Nal5, 8)	[Ref.28539222]BHK-21 cells: CC50=24 μM.	NS2B-NS3 protease	28539222	Bioorg Med Chem Lett. 2017 Aug 1;27(15):3586-3590.	Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.	Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.	
DRAMP31456	CGGGGGSLTEINTELLDLEYEMKKLEEVVKKLEESYIDLKEL	42	PIH	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Inhibits MERS-Cov S protein-mediated cell fusion, which is the major pathway of MERS-CoV-induced host infections.	[Ref.31099550]MERS-CoV:inhibition of cell-cell fusion between 293T cells and Huh-7 cells(IC50=1.171 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.31099550]PIH displayed no significant cytotoxicity to 293T, Huh-7, and L02 cells even at a high concentration of 100 μM.	membrane	31099550	ACS Appl Mater Interfaces. 2019 Jun 5;11(22):19799-19807.	Huang X, Li M, Xu Y, Zhang J, Meng X, An X, Sun L, Guo L, Shan X, Ge J, Chen J, Luo Y, Wu H, Zhang Y, Jiang Q, Ning X. 	Novel Gold Nanorod-Based HR1 Peptide Inhibitor for Middle East Respiratory Syndrome Coronavirus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31457	PWLKPGDLDL	10	DET2	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide caused structural abnormalities and alteration of the arrangement of the viral E protein, which interferes with virus binding and entry. 	[Ref.23630436]dengue virus 2(DENV2):inhibition of viral replication in LLC-MK2 cells(41.5±20.0% inhibition at 200 µM, IC50>500 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.23630436]Monkey kidney epithelial cells LLC-MK2: 8% Cell death at 500 µM.	E protein	23630436	Int J Med Sci. 2013 Apr 16;10(6):719-29. 	Alhoot MA, Rathinam AK, Wang SM, Manikam R, Sekaran SD.	Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1)C(=O)O
DRAMP31458	AGVKDGKLDF	10	DET4	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide caused structural abnormalities and alteration of the arrangement of the viral E protein, which interferes with virus binding and entry. 	[Ref.23630436]dengue virus 2(DENV2):inhibition of viral replication in LLC-MK2 cells(84.6±5.6%  inhibition at 500 µM, IC50=35 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.23630436]Monkey kidney epithelial cells LLC-MK2: 5% Cell death at 500 µM.	E protein	23630436	Int J Med Sci. 2013 Apr 16;10(6):719-29. 	Alhoot MA, Rathinam AK, Wang SM, Manikam R, Sekaran SD.	Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31459	WLVFFVIFYFFR	12	FP1 (Tkip)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: the mechanism whereby FluPep mediates its antiviral effects is likely to involve inhibiting the binding of HA to sialic acid receptors or through interference with the fusion process by blocking protease cleavage.	[Ref.22258859]influenza A virus A/WSN/33 H1N1:inhibition of viral replication in MDCK cells(IC50=0.09360 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA	22258859	J Gen Virol. 2012 May;93(Pt 5):980-986.	Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. 	A novel family of peptides with potent activity against influenza A viruses. 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31460	WLVFFVIAYFAR	12	FP2	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: the mechanism whereby FluPep mediates its antiviral effects is likely to involve inhibiting the binding of HA to sialic acid receptors or through interference with the fusion process by blocking protease cleavage.	[Ref.22258859]influenza A virus A/WSN/33 H1N1:inhibition of viral replication in MDCK cells(IC50=0.00087 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA	22258859	J Gen Virol. 2012 May;93(Pt 5):980-986.	Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. 	A novel family of peptides with potent activity against influenza A viruses. 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31461	WLVFFVIFYFFRRRKK	16	FP3	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: the mechanism whereby FluPep mediates its antiviral effects is likely to involve inhibiting the binding of HA to sialic acid receptors or through interference with the fusion process by blocking protease cleavage.	[Ref.22258859]influenza A virus A/WSN/33 H1N1:inhibition of viral replication in MDCK cells(IC50=0.00003 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA	22258859	J Gen Virol. 2012 May;93(Pt 5):980-986.	Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. 	A novel family of peptides with potent activity against influenza A viruses. 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31462	RRKKWLVFFVIFYFFR	16	FP4	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: the mechanism whereby FluPep mediates its antiviral effects is likely to involve inhibiting the binding of HA to sialic acid receptors or through interference with the fusion process by blocking protease cleavage.	[Ref.22258859]influenza A virus A/WSN/33 H1N1:inhibition of viral replication in MDCK cells(IC50=0.00004 µM);##influenza A virus PR8/Eng09 (H1N1):inhibition of viral replication in MDCK cells(IC50=0.0778 µM);##influenza A virus PR8/Vic (H3N2):inhibition of viral replication in MDCK cells(IC50=0.0535 µM);##influenza A virus PR8/Viet (H5N1):inhibition of viral replication in MDCK cells(IC50=0.1325 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA	22258859	J Gen Virol. 2012 May;93(Pt 5):980-986.	Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. 	A novel family of peptides with potent activity against influenza A viruses. 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31463	RRKKIFYFFR	10	FP7	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: the mechanism whereby FluPep mediates its antiviral effects is likely to involve inhibiting the binding of HA to sialic acid receptors or through interference with the fusion process by blocking protease cleavage.	[Ref.22258859]influenza A virus A/WSN/33 H1N1:inhibition of viral replication in MDCK cells(IC50=0.15483 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA	22258859	J Gen Virol. 2012 May;93(Pt 5):980-986.	Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. 	A novel family of peptides with potent activity against influenza A viruses. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31464	WLVFFVRRKK	10	FP8	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: the mechanism whereby FluPep mediates its antiviral effects is likely to involve inhibiting the binding of HA to sialic acid receptors or through interference with the fusion process by blocking protease cleavage.	[Ref.22258859]influenza A virus A/WSN/33 H1N1:inhibition of viral replication in MDCK cells(IC50=0.63806 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA	22258859	J Gen Virol. 2012 May;93(Pt 5):980-986.	Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. 	A novel family of peptides with potent activity against influenza A viruses. 	CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
DRAMP31465	FFVIFYRRKK	10	FP9	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: the mechanism whereby FluPep mediates its antiviral effects is likely to involve inhibiting the binding of HA to sialic acid receptors or through interference with the fusion process by blocking protease cleavage.	[Ref.22258859]influenza A virus A/WSN/33 H1N1:inhibition of viral replication in MDCK cells(IC50=1.48175 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	HA	22258859	J Gen Virol. 2012 May;93(Pt 5):980-986.	Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. 	A novel family of peptides with potent activity against influenza A viruses. 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31466	GYRARPKFKAGKR	13	HPV-31 L1 Cta	No entry found	Papillomaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.15170645]human papillomavirus(HPV):inhibition of HPV virus-like particle cell entry(86±3% inhibition at 10 μg/ml); inhibition of pseudovirions infection(91±4% inhibition at 10 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	15170645	J Med Virol. 2004 Jul;73(3):474-80.	Bousarghin L, Touzé A, Yvonnet B, Coursaget P.	Positively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity.	C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31467	TTTPAKRKKTKK	12	HPV-31 L1 Ctb	No entry found	Papillomaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.15170645]human papillomavirus(HPV):inhibition of HPV virus-like particle cell entry(12±10% inhibition at 10 μg/ml); inhibition of pseudovirions infection(15±8% inhibition at 10 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	15170645	J Med Virol. 2004 Jul;73(3):474-80.	Bousarghin L, Touzé A, Yvonnet B, Coursaget P.	Positively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity.	C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
DRAMP31468	MLRKRRKRL	9	HPV-16 L2 Ct	No entry found	Papillomaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.15170645]human papillomavirus(HPV):inhibition of HPV virus-like particle cell entry(78±6% inhibition at 10 μg/ml); inhibition of pseudovirions infection(96±20% inhibition at 10 μg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	15170645	J Med Virol. 2004 Jul;73(3):474-80.	Bousarghin L, Touzé A, Yvonnet B, Coursaget P.	Positively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity.	CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31469	GCKKYRRFRWKFKGKFWFWG	20	Pep19-2.5	No entry found	Retroviridae,Herpesviridae, Flaviviridae, Hepadnaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: SALPs block entry of a variety of human pathogenic enveloped viruses, such as HIV-1, HBV, HCV, and HSV 1 and 2 by blocking heparan sulfate on the host cell plasma membrane, which serves as a the docking molecule for these pathogens.	[Ref.22457281]HIV-1 BaL:inhibition of viral entry in 293T cells(IC50=8 µg/ml);##HIV-1 NL4-3:inhibition of viral entry in 293T cells(IC50=16 µg/ml);##HSV-1:inhibition of viral entry in Vero cells(IC50=0.42 µg/ml);##Hepatitis C virus (HCV):inhibition of viral entry in 293T cells(IC50=40 µg/ml);##Hepatitis B virus (HBV):inhibition of viral entry in 293T cells(IC50=1 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22457281]No significant cytotoxicity to Vero, TZM-bl and Jurkat cells even at a high concentration of 20 μg/mL.	membrane	22457281	J Infect Dis. 2012 Jun;205(11):1654-64.	Krepstakies M, Lucifora J, Nagel CH, Zeisel MB, Holstermann B, Hohenberg H, Kowalski I, Gutsmann T, Baumert TF, Brandenburg K, Hauber J, Protzer U.	A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O
DRAMP31470	GKKYRRFRWKFKFGKWFWFG	20	Pep19-4	No entry found	Retroviridae,Herpesviridae, Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: SALPs block entry of a variety of human pathogenic enveloped viruses, such as HIV-1, HBV, HCV, and HSV 1 and 2 by blocking heparan sulfate on the host cell plasma membrane, which serves as a the docking molecule for these pathogens.	[Ref.22457281]HIV-1 BaL:inhibition of viral entry in 293T cells(IC50=22 µg/ml);##HIV-1 NL4-3:inhibition of viral entry in 293T cells(IC50=10 µg/ml);##HSV-1:inhibition of viral entry in Vero cells(IC50=1.8 µg/ml);##Hepatitis C virus (HCV):inhibition of viral entry in 293T cells(IC50=37 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22457281]No significant cytotoxicity to Vero, TZM-bl and Jurkat cells even at a high concentration of 20 μg/mL.	membrane	22457281	J Infect Dis. 2012 Jun;205(11):1654-64.	Krepstakies M, Lucifora J, Nagel CH, Zeisel MB, Holstermann B, Hohenberg H, Kowalski I, Gutsmann T, Baumert TF, Brandenburg K, Hauber J, Protzer U.	A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
DRAMP31471	ATSSANSKA	9	Loop3	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: prevent JEV infection by interfering in virus attachment to the cells.	[Ref.22465300]Japanese encephalitis virus(JEV):inhibition of viral replication in BHK-21 cells(IC50=10 ± 1.4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22465300]Did not stimulate significant cytotoxicity in BHK-21 cells even at 200 μM.	Envelope protein	22465300	Antiviral Res. 2012 May;94(2):179-83.	Li C, Zhang LY, Sun MX, Li PP, Huang L, Wei JC, Yao YL, Isahg H, Chen PY, Mao X.	Inhibition of Japanese encephalitis virus entry into the cells by the envelope glycoprotein domain III (EDIII) and the loop3 peptide derived from EDIII.	C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O
DRAMP31472	SISNALNKLEESNRNLDKVNVKLT	24	C24	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: By binding to the opposite HR region in the F protein, peptides would inhibit fusion from the initial steps (lipid- and contents-mixing), blocking the conformational changes in the fusion protein required for triggering fusion.	[Ref.12127571]Newcastle disease virus (NDV):inhibition of syncytium formation between NDV-infected cells(IC50=3.27 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	F protein	12127571	Int J Biochem Cell Biol. 2002 Oct;34(10):1207-20.	San Román K, Villar E, Muñoz-Barroso I.	Mode of action of two inhibitory peptides from heptad repeat domains of the fusion protein of Newcastle disease virus.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31473	KQNAANILRLKESIAATNEAVAnti-HeV	24	N24	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: By binding to the opposite HR region in the F protein, peptides would inhibit fusion from the initial steps (lipid- and contents-mixing), blocking the conformational changes in the fusion protein required for triggering fusion.	[Ref.12127571]Newcastle disease virus (NDV):inhibition of syncytium formation between NDV-infected cells(IC50=22.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	F protein	12127571	Int J Biochem Cell Biol. 2002 Oct;34(10):1207-20.	San Román K, Villar E, Muñoz-Barroso I.	Mode of action of two inhibitory peptides from heptad repeat domains of the fusion protein of Newcastle disease virus.	
DRAMP31474	GRRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCIQA	49	HLFcin 1-49	No entry found	Papillomaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.17481742]human papillomavirus(HPV):inhibition of pseudovirus infection in C33A cells(IC50=0.32±0.18μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys10 and Cys46, Cys20 and Cys37.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17481742	Antiviral Res. 2007 Sep;75(3):258-65.	Mistry N, Drobni P, Näslund J, Sunkari VG, Jenssen H, Evander M.	The anti-papillomavirus activity of human and bovine lactoferricin.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CCCN3C(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)C(=O)N[C@@H]([C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O
DRAMP31475	FKCRRWQWRMKKLGAPSITCVRRAFA	26	BLfcinB 17-42	No entry found	Papillomaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.17481742]human papillomavirus(HPV):inhibition of pseudovirus infection in C33A cells(IC50=0.25±0.24 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys3 and Cys20.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17481742	Antiviral Res. 2007 Sep;75(3):258-65.	Mistry N, Drobni P, Näslund J, Sunkari VG, Jenssen H, Evander M.	The anti-papillomavirus activity of human and bovine lactoferricin.	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)O)C(C)C)NC(=O)[C@H]([C@@H](C)O)NC1=O
DRAMP31476	AGDDQGLDKCVPNSKEK	17		No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may bind with HA  and precent the attachment to target cells.	[Ref.22595270]Influenza A virus (A/Roma-ISS/2/08 H1N1):inhibition of viral  replication in MDCK cells(EC50=3.7±0.35 pM);##Influenza A virus (A/Parma/24/09 H1N1):inhibition of viral  replication in MDCK cells(EC50=3.4±0.14 pM);##Influenza A virus (A/Parma/05/06 H3N2):inhibition of viral  replication in MDCK cells(EC50=7.3±0.65 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22595270]MDCK cells:CC50>25 μM.	HA	22595270	Pathog Glob Health. 2012 Mar;106(1):12-9.	Ammendolia MG, Agamennone M, Pietrantoni A, Lannutti F, Siciliano RA, De Giulio B, Amici C, Superti F.	Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus.	CC(C)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)CNC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31477	NGESSADWAKN	11		No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may bind with HA  and precent the attachment to target cells.	[Ref.22595270]Influenza A virus (A/Roma-ISS/2/08 H1N1):inhibition of viral  replication in MDCK cells(EC50=225±5.8 fM);##Influenza A virus (A/Parma/24/09 H1N1):inhibition of viral  replication in MDCK cells(EC50=50±1.37 fM);##Influenza A virus (A/Parma/05/06 H3N2):inhibition of viral  replication in MDCK cells(EC50=22.5±1.16 pM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.22595270]MDCK cells:CC50>25 μM.	HA	22595270	Pathog Glob Health. 2012 Mar;106(1):12-9.	Ammendolia MG, Agamennone M, Pietrantoni A, Lannutti F, Siciliano RA, De Giulio B, Amici C, Superti F.	Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus.	C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31478	AVSKVLHLEGEVNKISALLSTNKAVVSLSNGAnti-VSVLTSKVLDLDNYIDKQLLPIVNK	56	HR1-30a	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from hRSV F protein give strong virus–cell fusion inhibition effect. 	[Ref.12615056]respiratory syncytial virus(RSV):inhibition of cell fusion in Hep2 cells( IC50=1.68 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	F protein	12615056	Biochem Biophys Res Commun. 2003 Mar 14;302(3):469-75. 	Wang E, Sun X, Qian Y, Zhao L, Tien P, Gao GF.	Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion.	
DRAMP31479	NFYDPLVFPSDEFDASISQVNEKINQSLASIRKSDELLHNVNAGK	45	HR2-30a	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: Peptide derived from hRSV F protein give strong virus–cell fusion inhibition effect. 	[Ref.12615056]respiratory syncytial virus(RSV):inhibition of cell fusion in Hep2 cells( IC50=2.93 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	F protein	12615056	Biochem Biophys Res Commun. 2003 Mar 14;302(3):469-75. 	Wang E, Sun X, Qian Y, Zhao L, Tien P, Gao GF.	Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@H](C)CC)C(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)O
DRAMP31480	NKGCATCSIGAACLVDGPIPDFEIAGAtGLfGLWG	35	Subtilosin-A	O07623	Herpesviridae	Not found	Bacillus subtilis	Antimicrobial, Antiviral	Not found	Not found	Not found	1PXQ	Mechanism: Subtilosin displays antiviral and virucidal actions against HSV-2. The target of subtilosin inhibitory effect would be late stages of the viral replicative cycle such as viral glycoprotein intracellular transport.	[Ref.25087911]herpes simplex virus type 2(HSV-2): inhibition of viral replication in Vero cells(90% inhibition at 25 μg/mL,EC50= 18.2μg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	No specific N-terminal	No specific C-terminal	The N-terminal and C-terminal cyclized by a amide bond. Thioether bridges between Cys4 and Phe31,Cys7 and Thr28,Cys13 and Phe22.	Mixed(D-Thr28,D-Phe31)	[Ref.25087911]Vero cells: CC50=316.8 μg/mL.	Not found	25087911	J Appl Microbiol. 2014 Nov;117(5):1253-9.	Quintana VM, Torres NI, Wachsman MB, Sinko PJ, Castilla V, Chikindas M.	Antiherpes simplex virus type 2 activity of the antimicrobial peptide subtilosin.	
DRAMP31481	EF	2	EF	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.24612829]dengue virus 2(DENV2):inhibition of viral entry in Vero cells(IC50=96.50 µM); inhibition of viral replication in Vero cells(83.47% inhibition at 200 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.24612829]No cytotoxicity against Vero cells up to 500 µM.	E protein	24612829	Chem Biol Drug Des. 2014 Aug;84(2):148-57.	Panya A, Bangphoomi K, Choowongkomon K, Yenchitsomanus PT. 	Peptide inhibitors against dengue virus infection.	N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)O
DRAMP31482	KEN	3	KEN	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.24612829]dengue virus 2(DENV2):inhibition of viral entry in Vero cells(IC50=331.9 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.24612829]No cytotoxicity against Vero cells up to 500 µM.	E protein	24612829	Chem Biol Drug Des. 2014 Aug;84(2):148-57.	Panya A, Bangphoomi K, Choowongkomon K, Yenchitsomanus PT. 	Peptide inhibitors against dengue virus infection.	NCCCC[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP31483	SVALVPHVGMGLETRTETWMSSEGAWKHVQRIETWILRHPG	41	MLH40	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.25891143]dengue virus 1(DENV1):inhibition of viral infection in Vero cells(IC50=30.35 ± 1.25 μM);##dengue virus 2(DENV2):inhibition of viral infection in Vero cells(IC50=31.41 ± 1.09 μM);##dengue virus 3(DENV3):inhibition of viral infection in Vero cells(IC50=27.95 ± 1.41 μM);##dengue virus 4(DENV4):inhibition of viral infection in Vero cells(IC50=24.45 ± 1.20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25891143	Chem Biol Drug Des. 2015 Nov;86(5):1093-104.	Panya A, Sawasdee N, Junking M, Srisawat C, Choowongkomon K, Yenchitsomanus PT. 	A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. 	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O
DRAMP31484	GLLYFAIFFVAAWHIRGR	18	H2-2	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.26251517]Hepatitis C Virus(HCV):inhibition of viral infection in Huh7.5.1 cells(EC50=1.60 ± 0.11 μM); inhibition of post-infection in Huh7.5.1 cells(EC50=2.19 ± 0.16 μM).	[Ref.26251517]<10% hemolysis even at 400 μM against human erythrocytes.	Linear	Free	Amidation		L	[Ref.26251517]Huh7.5.1 cells: CC50=83.64 ± 6.95 μM;##Bel7402 cells:CC50~200 μM;##HeLa cells:CC50~200 μM.	Not found	26251517	J Biol Chem. 2015 Sep 18;290(38):23254-63.	Hong W, Lang Y, Li T, Zeng Z, Song Y, Wu Y, Li W, Cao Z. 	A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)C(C)C
DRAMP31485	HGLLYFAIFFVAAWHIRGR	19	H2-3	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.26251517]Hepatitis C Virus(HCV):inhibition of viral infection in Huh7.5.1 cells(EC50=0.54 ± 0.08 μM); inhibition of post-infection in Huh7.5.1 cells(EC50=1.09 ± 0.11 μM);H2-3 peptide inactivated HCV(EC50=82.11 nM).	[Ref.26251517]<10% hemolysis even at 400 μM against human erythrocytes.	Linear	Free	Amidation		L	[Ref.26251517]Huh7.5.1 cells: CC50=115.99 ± 16.68 μM;##Bel7402 cells:CC50~200 μM;##HeLa cells:CC50~200 μM.	Not found	26251517	J Biol Chem. 2015 Sep 18;290(38):23254-63.	Hong W, Lang Y, Li T, Zeng Z, Song Y, Wu Y, Li W, Cao Z. 	A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)C(C)C
DRAMP31486	WPFCLLLMAL	10	H3	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.26251517]Hepatitis C Virus(HCV):inhibition of viral infection in Huh7.5.1 cells(EC50=0.52 ± 0.07 μM); inhibition of post-infection in Huh7.5.1 cells(EC50=1.54 ± 0.73 μM).	[Ref.26251517]<10% hemolysis even at 400 μM against human erythrocytes.	Linear	Free	Amidation		L	[Ref.26251517]Huh7.5.1 cells: CC50=47.22 ± 5.29 μM;##Bel7402 cells:CC50~200 μM;##HeLa cells:CC50~200 μM.	Not found	26251517	J Biol Chem. 2015 Sep 18;290(38):23254-63.	Hong W, Lang Y, Li T, Zeng Z, Song Y, Wu Y, Li W, Cao Z. 	A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro. 	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP31487	LYGNEGCGWAGWLLSPRG	18	SL173	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19264632]hepatitis C virus(J6/JFH1):inhibition of viral infection in Huh-7.5 cells(80% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	19264632	J Gen Virol. 2009 Jun;90(Pt 6):1319-1328.	Kota S, Coito C, Mousseau G, Lavergne JP, Strosberg AD. 	Peptide inhibitors of hepatitis C virus core oligomerization and virus production.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31488	GWAGWLLSPRGSRPSWGP	18	SL174	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19264632]hepatitis C virus(J6/JFH1):inhibition of viral infection in Huh-7.5 cells(15% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	19264632	J Gen Virol. 2009 Jun;90(Pt 6):1319-1328.	Kota S, Coito C, Mousseau G, Lavergne JP, Strosberg AD. 	Peptide inhibitors of hepatitis C virus core oligomerization and virus production.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O
DRAMP31489	GWAGWLLSPRGSRPS	15	SL175	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.19264632]hepatitis C virus(J6/JFH1):inhibition of viral infection in Huh-7.5 cells(50% inhibition at 20 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	19264632	J Gen Virol. 2009 Jun;90(Pt 6):1319-1328.	Kota S, Coito C, Mousseau G, Lavergne JP, Strosberg AD. 	Peptide inhibitors of hepatitis C virus core oligomerization and virus production.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O
DRAMP31490	MDVNP	5	PB1 (1–5)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=185 ± 2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments. 	CSCC[C@H](N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C
DRAMP31491	MDVNPTLLFL KVPAQNAIST TFPYT	27	PB1 (1–25)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=122 ± 3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments. 	
DRAMP31492	TLLFLKVPAQ NAISTTFPYT	21	PB1 (6–25)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=129 ± 2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	
DRAMP31493	AQNAISTTFPYT	12	PB1 (14–25)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=380 ± 2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP31494	Anti-MeVVQQTRMD KLTQGRQTYD	21	PB1 (111–130)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=58 ± 2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	
DRAMP31495	LPVGGNEKKA KLANVVRKMM	21	PB1 (271–290)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=33 ± 1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	
DRAMP31496	FNESTR	6	PB1 (381–386)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=664 ± 3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	C[C@@H](O)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)O
DRAMP31497	FNESTRKKIE	10	PB1 (381–390)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=400 ± 8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP31498	FNESTRKKIE KIRPLLVEGT	21	PB1 (381–400)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=23 ± 1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	
DRAMP31499	KIRPLLVEGT	10	PB1 (391–400)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=71 ± 3μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)NCC(=O)O)C(C)C
DRAMP31500	MFNMLSTVLG	10	PB1 (411–420)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=369 ± 3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C)[C@@H](C)O
DRAMP31501	IGVTVI	6	PB1 (525–530)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=833 ± 6 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC[C@@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(C)C
DRAMP31502	IGVTVIKNNMI	11	PB1 (525–535)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=416 ± 3μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC[C@@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)C(C)C
DRAMP31503	TLLFLKVP	8	PB1 (6–13)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=102 ± 3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C
DRAMP31504	TLLFLKVP	8	PB1 (6–13)-NH2	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=35 ± 3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)C(C)C
DRAMP31505	TLLFLKVP	8	Ac-PB1 (6–13)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=33 ± 2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)[C@@H](C)O
DRAMP31506	TLLFLKVP	8	Ac-PB1 (6–13)-NH2	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=12 ± 2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)C(C)C)[C@@H](C)O
DRAMP31507	TLLFLKVPA	9	PB1 (6–14)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=34 ± 2 μM);##Influenza A virus(A/Puerto Rico/8/34 (H1N1)):antiviral activity of the peptide in MDCK cells(ED50=8.9 ± 1.0 μM);##Influenza A virus(A/Aichi/2/68 (H3N2)):antiviral activity of the peptide in MDCK cells(ED50=10.7 ± 0.9 μM);##Influenza A virus(A/Mallard/Pennsylvania/10218/84 (H5N2)):antiviral activity of the peptide in MDCK cells(ED50=8.5 ± 1.1 μM);##Influenza A virus(A/Vladivostok/02/09 of H1N1):antiviral activity of the peptide in MDCK cells(ED50=1.7 ± 0.8 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP31508	TLLFLKVPA	9	PB1 (6–14)-NH2	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=6 ± 1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(N)=O)C(C)C
DRAMP31509	TLLFLKVPA	9	Ac-PB1 (6–14)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=82 ± 3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O
DRAMP31510	TLLFLKVPA	9	Ac-PB1 (6–14)-NH2	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=4 ± 1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(N)=O)C(C)C)[C@@H](C)O
DRAMP31511	GDPPY	5	PB1 (26–30)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=115 ± 3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	NCC(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP31512	GDPPY	5	PB1 (26–30)-NH2	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=100 ± 5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	NCC(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
DRAMP31513	GDPPY	5	Ac-PB1 (26–30)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=95 ± 3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP31514	GDPPY	5	Ac-PB1 (26–30)-NH2	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=254 ± 3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
DRAMP31515	LLVEGT	6	PB1 (395–400)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=91 ± 2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(C)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)NCC(=O)O)C(C)C
DRAMP31516	LLVEGT	6	PB1 (395–400)-NH2	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=794 ± 4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(C)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(N)=O)[C@@H](C)O)C(C)C
DRAMP31517	LLVEGT	6	Ac-PB1 (395–400)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=297 ± 3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C
DRAMP31518	LLVEGT	6	Ac-PB1 (395–400)-NH2	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=744 ± 4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(N)=O)[C@@H](C)O)C(C)C
DRAMP31519	KNNMINNDLG	10	PB1 (531–540)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=51 ± 3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)NCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31520	KNNMINNDLG	10	PB1 (531–540)-NH2	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=44 ± 1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
DRAMP31521	KNNMINNDLG	10	Ac-PB1 (531–540)	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=71 ± 3 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O
DRAMP31522	KNNMINNDLG	10	Ac-PB1 (531–540)-NH2	No entry found	Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=109 ± 4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
DRAMP31523	LNLFKKTINGLISDSLVIR	19	AVP-p	No entry found	Arenaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: that untimely deployment of fusion machinery by the peptide could render virions less able to engage in on-pathway receptor binding or endosomal fusion. 	[Ref.24850726]Pichinde virus (PICV):inhibition of viral infection in Vero cells(IC50=7.05 ± 2.19 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.24850726]No significant loss of viability was observed in Vero cells or human foreskin fibroblasts (HFF) up to 100 μM.	Not found	24850726	J Virol. 2014 Aug;88(15):8556-64.	Spence JS, Melnik LI, Badani H, Wimley WC, Garry RF. 	Inhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)O
DRAMP31524	GREERRQRRRC	11	E50,51TAT-Cd0	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.21029018]Herpes simplex virus type 1(HSV-1):inhibition of viral infection in human corneal epithelial (HCE) cells(EC50~30.0 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	21029018	J Ocul Pharmacol Ther. 2010 Dec;26(6):541-7. 	Larsen IV, Brandt CR.	A cationic TAT peptide inhibits Herpes simplex virus type 1 infection of human corneal epithelial cells.	N=C(N)NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(N)=O
DRAMP31525	NDSRGIDAEEELETKAELVITKLKTPLMRGKVVVGAAGA	39	MDVgHH2L	No entry found	Paramyxoviridae, Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: peptides from the hydrophobic fusogenic domains of gB and gH can block virus entry, disrupt cellular membranes by interacting with the cellular factors, or play a role in the glycoprotein conformational changes 	[Ref.24412629]Newcastle disease virus(NDV):inhibition of viral infection in chicken embryo fibroblasts(IC50=43.4 ± 2.0 μmol/L);##Marek's disease virus(MDV):inhibition of viral infection in chicken embryo fibroblasts(IC50=34.0 ± 2.00 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	24412629	J Virol Methods. 2014 Apr;199:11-6.	Chi XJ, Wang XJ, Wang CY, Cui XJ, Wang XJ.	In vitro and in vivo broad antiviral activity of peptides homologous to fusion glycoproteins of Newcastle disease virus and Marek's disease virus. 	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(C)C)C(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)O
DRAMP31526	NADIIKSLIRKTIINASKNTASLSILQHLYVLRS	34	MDVgBH3	No entry found	Paramyxoviridae, Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: peptides from the hydrophobic fusogenic domains of gB and gH can block virus entry, disrupt cellular membranes by interacting with the cellular factors, or play a role in the glycoprotein conformational changes 	[Ref.24412629]Newcastle disease virus(NDV):inhibition of viral infection in chicken embryo fibroblasts(IC50=52.9 ± 0.9 μmol/L);##Marek's disease virus(MDV):inhibition of viral infection in chicken embryo fibroblasts(IC50=37.5 ± 1.2 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	24412629	J Virol Methods. 2014 Apr;199:11-6.	Chi XJ, Wang XJ, Wang CY, Cui XJ, Wang XJ.	In vitro and in vivo broad antiviral activity of peptides homologous to fusion glycoproteins of Newcastle disease virus and Marek's disease virus. 	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP31527	LGNVNNSISNALDKLEESNSKLDKVNVKLTGTSAL	35	NDVHR2	No entry found	Paramyxoviridae, Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: peptides from the hydrophobic fusogenic domains of gB and gH can block virus entry, disrupt cellular membranes by interacting with the cellular factors, or play a role in the glycoprotein conformational changes 	[Ref.24412629]Newcastle disease virus(NDV):inhibition of viral infection in chicken embryo fibroblasts(IC50=18.9 ± 2.8 μmol/L);##Marek's disease virus(MDV):inhibition of viral infection in chicken embryo fibroblasts(IC50=65.3 ±0.9 μmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	membrane	24412629	J Virol Methods. 2014 Apr;199:11-6.	Chi XJ, Wang XJ, Wang CY, Cui XJ, Wang XJ.	In vitro and in vivo broad antiviral activity of peptides homologous to fusion glycoproteins of Newcastle disease virus and Marek's disease virus. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31528	TIRLESEVTAIKNALKKTNEAVSTLGNGVRVLATAVRELKDFV	43	HRA1	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: In hMPV, the F proteins assemble as trimers inside which three HRA (as well as three HRB) are creating a coiled coil. Then, the two pairs of coiled-coils (HRA and HRB) interact, creating a six-helix bundle structure that brings the viral and the cellular membranes close together, causing membrane merge and fusion pore dilatation. Peptide designed based in the HRA and HRB domains of the F protein can inhibit the  process.	[Ref.17967906]Human Metapneumovirus(hMPV):inhibition of viral infection in LLC-MK2 cells(IC50=177 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.17967906]No cytotoxicity against LLC-MK2 cells at the highest concentrations tested (9 μM).	F protein	17967906	Antimicrob Agents Chemother. 2008 Jan;52(1):279-87. 	Deffrasnes C, Hamelin ME, Prince GA, Boivin G.	Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
DRAMP31529	AKTIRLESEVTAIKNALKKTNEAVSTLGNGVRVLATAVRELKDFVSKN	48	HRA2	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: In hMPV, the F proteins assemble as trimers inside which three HRA (as well as three HRB) are creating a coiled coil. Then, the two pairs of coiled-coils (HRA and HRB) interact, creating a six-helix bundle structure that brings the viral and the cellular membranes close together, causing membrane merge and fusion pore dilatation. Peptide designed based in the HRA and HRB domains of the F protein can inhibit the  process.	[Ref.17967906]Human Metapneumovirus(hMPV):inhibition of viral infection in LLC-MK2 cells(IC50=2.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.17967906]No cytotoxicity against LLC-MK2 cells at the highest concentrations tested (9 μM).	F protein	17967906	Antimicrob Agents Chemother. 2008 Jan;52(1):279-87. 	Deffrasnes C, Hamelin ME, Prince GA, Boivin G.	Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O
DRAMP31530	LESEVTAIKNALKKTNEAVSTLGNGVRVLATAVRE	35	HRA3	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: In hMPV, the F proteins assemble as trimers inside which three HRA (as well as three HRB) are creating a coiled coil. Then, the two pairs of coiled-coils (HRA and HRB) interact, creating a six-helix bundle structure that brings the viral and the cellular membranes close together, causing membrane merge and fusion pore dilatation. Peptide designed based in the HRA and HRB domains of the F protein can inhibit the  process.	[Ref.17967906]Human Metapneumovirus(hMPV):inhibition of viral infection in LLC-MK2 cells(IC50=3240 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.17967906]No cytotoxicity against LLC-MK2 cells at the highest concentrations tested (9 μM).	F protein	17967906	Antimicrob Agents Chemother. 2008 Jan;52(1):279-87. 	Deffrasnes C, Hamelin ME, Prince GA, Boivin G.	Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O
DRAMP31531	FNVALDQVFESIENSQALVDQSNRILSSAEKGNTG	35	HRB5	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: In hMPV, the F proteins assemble as trimers inside which three HRA (as well as three HRB) are creating a coiled coil. Then, the two pairs of coiled-coils (HRA and HRB) interact, creating a six-helix bundle structure that brings the viral and the cellular membranes close together, causing membrane merge and fusion pore dilatation. Peptide designed based in the HRA and HRB domains of the F protein can inhibit the  process.	[Ref.17967906]Human Metapneumovirus(hMPV):inhibition of viral infection in LLC-MK2 cells(IC50=1520 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.17967906]No cytotoxicity against LLC-MK2 cells at the highest concentrations tested (9 μM).	F protein	17967906	Antimicrob Agents Chemother. 2008 Jan;52(1):279-87. 	Deffrasnes C, Hamelin ME, Prince GA, Boivin G.	Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP31532	PEDQFNVALDQVFESIENSQALVDQSNRILSSAEKGNTG	39	HRB6	No entry found	Paramyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: In hMPV, the F proteins assemble as trimers inside which three HRA (as well as three HRB) are creating a coiled coil. Then, the two pairs of coiled-coils (HRA and HRB) interact, creating a six-helix bundle structure that brings the viral and the cellular membranes close together, causing membrane merge and fusion pore dilatation. Peptide designed based in the HRA and HRB domains of the F protein can inhibit the  process.	[Ref.17967906]Human Metapneumovirus(hMPV):inhibition of viral infection in LLC-MK2 cells(IC50=3310 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.17967906]No cytotoxicity against LLC-MK2 cells at the highest concentrations tested (9 μM).	F protein	17967906	Antimicrob Agents Chemother. 2008 Jan;52(1):279-87. 	Deffrasnes C, Hamelin ME, Prince GA, Boivin G.	Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)NC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP31533	SWLVNRDWFHDLNLPWTGSSAGTWQ	25	TP1	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TP1 functions through a mechanism that involves release of the viral genome and interference with cellular TMUV binding	[Ref.32456819]Tembusu virus (TMUV):inhibition of viral infection in BHK-21 cells(IC50=14.19 mg/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.32456819]No cytotoxicity against BHK-21 cells up to 150mg / L.	Not found	32456819	Vet Microbiol. 2020 Jun;245:108708.	Zhao D, Zhang L, Han K, Liu Q, Yang J, Huang X, Liu Y, Li Y, Zhao P. 	Peptide inhibitors of tembusu virus infection derived from the envelope protein. 	CC(C)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31534	MVALGDTAWDFGSVGGVLTSIGKGIHQVFGSAFKSL	36	TP2	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: TP2 might be an interference factor between TMUV and the cell. 	[Ref.32456819]Tembusu virus (TMUV):inhibition of viral infection in BHK-21 cells(IC50=7.64 mg/L).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.32456819]No cytotoxicity against BHK-21 cells up to 150mg / L.	Not found	32456819	Vet Microbiol. 2020 Jun;245:108708.	Zhao D, Zhang L, Han K, Liu Q, Yang J, Huang X, Liu Y, Li Y, Zhao P. 	Peptide inhibitors of tembusu virus infection derived from the envelope protein. 	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP31535	RRRQRRKKRGYGFVNLLFLVVE	22	TAT-Kα2	No entry found	Herpesviridae,Paramyxoviridae,Orthomyxoviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: display virucidal activity by disrupting viral envelopes.	[Ref.28687749]Vesicular stomatitis virus(VSV):inhibition of viral infection in 293T cells(IC50=2.9 μM);##Respiratory Syncytial Virus(RSV):inhibition of viral infection in Hep2 cells(IC50=3.4 μM);##Newcastle disease virus(NDV):inhibition of viral infection(IC50=0.8 μM);##Parainfluenza virus:inhibition of viral infection(IC50=2.4 μM);##Influenza virus (H1N1) A/Puerto Rico/8/34:inhibition of viral infection(IC50=0.5 μM);##Influenza virus (H5N2) A/bird/Korea/W81/2005:inhibition of viral infection(IC50=0.8 μM);##Influenza virus (H7N3) A/Aquatic bird/Korea/W44/2005:inhibition of viral infection(IC50=1.2 μM);##Influenza virus (H9N2) A/Chicken/Korea/116/2004:inhibition of viral infection(IC50=0.7 μM);##Porcine epidemic diarrhea virus:inhibition of viral infection(IC50=3.5 μM);##Herpes simplex virus:inhibition of viral infection(IC50=5.7 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.28687749]No cytotoxicity against MDCK cells up to 100 μM.	Envolope	28687749	Sci Rep. 2017 Jul 7;7(1):4875.	Moon HJ, Nikapitiya C, Lee HC, Park ME, Kim JH, Kim TH, Yoon JE, Cho WK, Ma JY, Kim CJ, Jung JU, Lee JS.	Inhibition of highly pathogenic avian influenza (HPAI) virus by a peptide derived from vFLIP through its direct destabilization of viruses	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C
DRAMP31536	MGRFKRFRKKFKKLFKKLS	19	Bomidin	P54228	Flaviviridae,Herpesviridae,Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: bomidin readily disrupted viral membranes (with components similar to those in the endoplasmic reticulum) and bacterial membranes but did not alter the overall structures of the cell membranes	[Ref.35663971]Dengue virus 2(DENV2):inhibition of viral infection in Huh7 cells(50% inhibition at 10 μM);##HSV:inhibition of viral infection in Huh7 cells(50% inhibition at 10 μM);##SARS-CoV-2:inhibition of viral infection in Huh7 cells(80% inhibition at 10 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.35663971]Vero E6 cells:CC50=169.6 ± 1.1 µM.	membrane	35663971	Front Immunol. 2022 May 19;13:851642.	Liu R, Liu Z, Peng H, Lv Y, Feng Y, Kang J, Lu N, Ma R, Hou S, Sun W, Ying Q, Wang F, Gao Q, Zhao P, Zhu C, Wang Y, Wu X. 	Bomidin: An Optimized Antimicrobial Peptide With Broad Antiviral Activity Against Enveloped Viruses.	CSCC[C@H](N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O
DRAMP31537	DHVTPDIAYNPRTYM	15	Pep-RTYM	No entry found	Flaviviridae	Not found	Acacia catechu	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: the biding of peptide to virus particles might disrupt the ability of the virus to bind to the host cell receptor or possibly block the internalization of the virus into the host cells.	[Ref.33172110]Dengue virus 2(DENV2):inhibition of viral infection in Vero cells(IC50=7.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.33172110]No cytotoxicity against Vero cells up to 1000 μM.	Not found	33172110	Viruses. 2020 Nov 6;12(11):1267.	Panya A, Sawasdee N, Songprakhon P, Tragoolpua Y, Rotarayanont S, Choowongkomon K, Yenchitsomanus PT. 	Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant Acacia catechu Binds to Dengue Virus and Inhibits Cell Entry.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C)C(=O)O
DRAMP31538	DHVTPDIAYNPWAYF	15	Pep-WAYF	No entry found	Flaviviridae	Not found	Acacia catechu	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: the biding of peptide to virus particles might disrupt the ability of the virus to bind to the host cell receptor or possibly block the internalization of the virus into the host cells.	[Ref.33172110]Dengue virus 2(DENV2):inhibition of viral infection in Vero cells(IC50=15.67 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.33172110]No cytotoxicity against Vero cells up to 1000 μM.	Not found	33172110	Viruses. 2020 Nov 6;12(11):1267.	Panya A, Sawasdee N, Songprakhon P, Tragoolpua Y, Rotarayanont S, Choowongkomon K, Yenchitsomanus PT. 	Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant Acacia catechu Binds to Dengue Virus and Inhibits Cell Entry.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C)C(=O)O
DRAMP31539	DHVTPDIAYNP	11	Pep-CORE	No entry found	Flaviviridae	Not found	Acacia catechu	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: the biding of peptide to virus particles might disrupt the ability of the virus to bind to the host cell receptor or possibly block the internalization of the virus into the host cells.	[Ref.33172110]Dengue virus 2(DENV2):inhibition of viral infection in Vero cells(IC50=20.89 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.33172110]No cytotoxicity against Vero cells up to 1000 μM.	Not found	33172110	Viruses. 2020 Nov 6;12(11):1267.	Panya A, Sawasdee N, Songprakhon P, Tragoolpua Y, Rotarayanont S, Choowongkomon K, Yenchitsomanus PT. 	Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant Acacia catechu Binds to Dengue Virus and Inhibits Cell Entry.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)O
DRAMP31540	KKR	3	Cmpd 2	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the NS2B-NS3 protease and thus inhibits virus replication.	[Ref.35123179]Zika virus(ZIKV):inhibition the activity of Zika virus NS2B-NS3 protease(IC50=41.0 ± 3.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Phenylacetyl	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 viral serine protease	35123179	Bioorg Med Chem. 2022 Mar 1;57:116631.	Colarusso S, Ferrigno F, Ponzi S, Pavone F, Conte I, Abate L, Beghetto E, Missineo A, Amaudrut J, Bresciani A, Paonessa G, Tomei L, Montalbetti C, Bianchi E, Toniatti C, Ontoria JM. 	SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease. 	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)Cc1ccccc1)C(=O)O
DRAMP31541	KKR	3	Cmpd 11	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the NS2B-NS3 protease and thus inhibits virus replication.	[Ref.35123179]Zika virus(ZIKV):inhibition the activity of Zika virus NS2B-NS3 protease(IC50=3.6 ± 0.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Phenylacetyl	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 viral serine protease	35123179	Bioorg Med Chem. 2022 Mar 1;57:116631.	Colarusso S, Ferrigno F, Ponzi S, Pavone F, Conte I, Abate L, Beghetto E, Missineo A, Amaudrut J, Bresciani A, Paonessa G, Tomei L, Montalbetti C, Bianchi E, Toniatti C, Ontoria JM. 	SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease. 	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)Cc1ccccc1)C(N)=O
DRAMP31542	GKR	3	Cmpd 12	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the NS2B-NS3 protease and thus inhibits virus replication.	[Ref.35123179]Zika virus(ZIKV):inhibition the activity of Zika virus NS2B-NS3 protease(40% inhibition at 100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Phenylacetyl	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 viral serine protease	35123179	Bioorg Med Chem. 2022 Mar 1;57:116631.	Colarusso S, Ferrigno F, Ponzi S, Pavone F, Conte I, Abate L, Beghetto E, Missineo A, Amaudrut J, Bresciani A, Paonessa G, Tomei L, Montalbetti C, Bianchi E, Toniatti C, Ontoria JM. 	SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease. 	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)Cc1ccccc1)C(=O)O
DRAMP31543	GKR	3	Cmpd 13	No entry found	Flaviviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide inhibits the NS2B-NS3 protease and thus inhibits virus replication.	[Ref.35123179]Zika virus(ZIKV):inhibition the activity of Zika virus NS2B-NS3 protease(40% inhibition at 100 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Phenylacetyl	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	NS2B-NS3 viral serine protease	35123179	Bioorg Med Chem. 2022 Mar 1;57:116631.	Colarusso S, Ferrigno F, Ponzi S, Pavone F, Conte I, Abate L, Beghetto E, Missineo A, Amaudrut J, Bresciani A, Paonessa G, Tomei L, Montalbetti C, Bianchi E, Toniatti C, Ontoria JM. 	SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease. 	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)Cc1ccccc1)C(N)=O
DRAMP31544	ALWKTLLKKVLKAAAK	16	Dermaseptin S4 (1-16)[M4K]	P80280	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: exerts a selective activity on viral particles and disturbs their organization by breaking the viral membrane, leading to the exposure of HIV-1 core and its dissociation. 	[Ref.15780876]human immunodeficiency virus type 1 (HIV-1):Inhibition of viral infection in Vero P4-CCR5 cells(IC50=28 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.15780876]P4-CCR5 cells:CC50>100 μM.	viral membrane	15780876	Virology. 2005 Apr 10;334(2):264-75. 	Lorin C, Saidi H, Belaid A, Zairi A, Baleux F, Hocini H, Bélec L, Hani K, Tangy F.	The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. 	CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)[C@@H](C)O
DRAMP31545	GIGDPVTCLKSGAICAnti-HPVFCPRRYKQIGTCGLPGTKCCKKP	41	Beta-defensin 2(BD-2, hBD-2, SAP1)	O15263	Retroviridae	Not found	Homo sapiens	Antimicrobial, Antiviral	Not found	Not found	Not found	1FD4	Mechanism: No mechanism information found in the reference(s).	[Ref.16254366]HIV-1 BaL:inhibition of viral infection in TZM-bl cells(80% Inhibition at 100 µg/ml, 68% Inhibition at 50 µg/ml, 55% Inhibition at 25 µg/ml, 45% Inhibition at 12.5 µg/ml, 32% Inhibition at 6.2 µg/ml, 28% Inhibition at 3.1 µg/ml, 18% Inhibition at 1.6 µg/ml, 20% Inhibition at 0.8 µg/ml,);##HIV-1 IIIB:inhibition of viral infection in TZM-bl cells(95% Inhibition at 100 µg/ml, 87% Inhibition at 50 µg/ml, 75% Inhibition at 25 µg/ml, 62% Inhibition at 12.5 µg/ml, 55% Inhibition at 6.2 µg/ml, 35% Inhibition at 3.1 µg/ml, 28% Inhibition at 1.6 µg/ml, 25% Inhibition at 0.8 µg/ml,).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bonds between Cys8 and Cys37, Cys15 and Cys30, Cys20 and Cys38.	L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	16254366	J Virol. 2005 Nov;79(22):14318-29. 	Sun L, Finnegan CM, Kish-Catalone T, Blumenthal R, Garzino-Demo P, La Terra Maggiore GM, Berrone S, Kleinman C, Wu Z, Abdelwahab S, Lu W, Garzino-Demo A.	Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. 	
DRAMP31546	QSHLSLCRWCCNCCRSNKGC	20	Hepcidin TH2-3	I3KHK3	Picornaviridae	Not found	Oreochromis mossambicus	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.30012343]Foot-and-Mouth Disease virus(FMDV):Inhibition of viral replication in BHK-21 cells(IC50=25.1±1.5 µg/ml, IC90=78.5±7.6 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Cyclization(Cys7 and Cys20)	Disulfide bonds between Cys7 and Cys20, Cys10 and Cys13, Cys11 and Cys14.	L	[Ref.30012343]Baby Hamster Kidney cells BHK-21:CC50=120.2±2.5 µg/ml.	Not found	30012343	Peptides. 2018 Aug;106:91-95.	Huang HN, Pan CY, Chen JY. 	Grouper (Epinephelus coioides) antimicrobial peptide epinecidin-1 exhibits antiviral activity against foot-and-mouth disease virus in vitro.	
DRAMP31547	FIHHIIGGLFSVGKHIHSLIHGH	23	Tilapia piscidin 3, TP3	L0CMD2	Picornaviridae	Not found	Oreochromis niloticus	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.30012343]Foot-and-Mouth Disease virus(FMDV):Inhibition of viral replication in BHK-21 cells(IC50=2.5±0.2 µg/ml, IC90=25.0±3.2 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref.30012343]Baby Hamster Kidney cells BHK-21:CC50=39.0±1.2 µg/ml.	Not found	30012343	Peptides. 2018 Aug;106:91-95.	Huang HN, Pan CY, Chen JY. 	Grouper (Epinephelus coioides) antimicrobial peptide epinecidin-1 exhibits antiviral activity against foot-and-mouth disease virus in vitro.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O
DRAMP31548	AKKAAKKAKKAAKKIEKAAKK	21	RJ5-I15E16	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=112 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.	Not found	16923027	Chem Biol Drug Des. 2006 Jul;68(1):58-66.	Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.	Prediction of activity, synthesis and biological testing of anti-HSV active peptides. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31549	AKKAKKKAKKAAKKIKKKAKK	21	RJ9-I15	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=11 µM); inhibition of viral infection in MRC-5 cells(IC50=119 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.	Not found	16923027	Chem Biol Drug Des. 2006 Jul;68(1):58-66.	Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.	Prediction of activity, synthesis and biological testing of anti-HSV active peptides. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31550	ARRARRRARRAARRARRGARR	21	RJ8-R5G18	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=1.9 µM); inhibition of viral infection in MRC-5 cells(IC50=4.8 µM);##Herpes simplex virus 2(HSV-2):inhibition of viral infection in MRC-5 cells(IC50=96 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.	Not found	16923027	Chem Biol Drug Des. 2006 Jul;68(1):58-66.	Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.	Prediction of activity, synthesis and biological testing of anti-HSV active peptides. 	C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31551	ARRARRRARRAARRARRWARR	21	RJ8-R5W18	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=9.2 µM); inhibition of viral infection in MRC-5 cells(IC50=2.8 µM);##Herpes simplex virus 2(HSV-2):inhibition of viral infection in MRC-5 cells(IC50=162 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.	Not found	16923027	Chem Biol Drug Des. 2006 Jul;68(1):58-66.	Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.	Prediction of activity, synthesis and biological testing of anti-HSV active peptides. 	C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31552	KAAKKAAKWAKKAAKWAKKAA	21	RJ2-W9,16	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=111 µM); inhibition of viral infection in MRC-5 cells(IC50=32 µM);##Herpes simplex virus 2(HSV-2):inhibition of viral infection in MRC-5 cells(IC50=48 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.	Not found	16923027	Chem Biol Drug Des. 2006 Jul;68(1):58-66.	Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.	Prediction of activity, synthesis and biological testing of anti-HSV active peptides. 	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP31553	KYAKKAAKYAKKAAKYAKKAA	21	RJ2-Y2,9,16	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=146 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.	Not found	16923027	Chem Biol Drug Des. 2006 Jul;68(1):58-66.	Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.	Prediction of activity, synthesis and biological testing of anti-HSV active peptides. 	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP31554	AAKAWKKAKAWKKAKWWKKAA	21	RJ2-A1,4,8; K3,6,7,9,13; W5,11,17	No entry found	Herpesviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Comment: No comments found on DRAMP database	[Ref.16923027]Herpes simplex virus 1(HSV-1):inhibition of viral entry into Vero cells(IC50=238 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.16923027]No cytotoxicity against Human fibroblasts MRC-5 cells up to 448 µM.	Not found	16923027	Chem Biol Drug Des. 2006 Jul;68(1):58-66.	Jenssen H, Gutteberg TJ, Rekdal Ø, Lejon T.	Prediction of activity, synthesis and biological testing of anti-HSV active peptides. 	C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31555	WNHTTWMEWDREINNYTSLIHSLIEESQNQQEKNEQ	36	CHR-1, Env GP (623-658)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The peptide can interact with the viral NHR to form stable heterologous 6-HBs, resulting in inhibition of fusion between the viral and target cell membranes.	[Ref.17276993]human immunodeficiency virus (HIV):inhibition of cell-cell fusion in MT-2 cells(IC50=17.27 ± 0.31 nM; IC90=26.41 ± 0.55 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	cell membrane	17276993	J Biol Chem. 2007 Mar 30;282(13):9612-9620.	Liu S, Jing W, Cheung B, Lu H, Sun J, Yan X, Niu J, Farmar J, Wu S, Jiang S. 	HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC
DRAMP31556	REINNYTSLIHSLIEESQNQQEKNEQELLELDKWAS	36	CHR-3, Env GP (633-668)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: CHR-3 interacts with N46 to form unstable 6-HB	[Ref.17276993]human immunodeficiency virus (HIV):inhibition of cell-cell fusion in MT-2 cells(IC50=1,470.00 ± 20.0 nM; IC90=2,380.00 ± 35.00 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17276993	J Biol Chem. 2007 Mar 30;282(13):9612-9620.	Liu S, Jing W, Cheung B, Lu H, Sun J, Yan X, Niu J, Farmar J, Wu S, Jiang S. 	HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)CC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP31557	HSLIEESQNQQEKNEQELLELDKWASLWNWFNITNW	36	CHR-5, Env GP (643-678)	P04578	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: CHR-5 can bind to LUVs of POPC	[Ref.17276993]human immunodeficiency virus (HIV):inhibition of cell-cell fusion in MT-2 cells(IC50=2,185.00 ± 15.00 nM; IC90=2,858.00 ± 6.00 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	17276993	J Biol Chem. 2007 Mar 30;282(13):9612-9620.	Liu S, Jing W, Cheung B, Lu H, Sun J, Yan X, Niu J, Farmar J, Wu S, Jiang S. 	HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP31558	STSQKAnti-SIVAYTM	12	SARS-CoV S (668–679), SP-10	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: block the binding of S protein to ACE2.	[Ref.16337697]SARS-CoV:Inhibition of pseudovirus infection in Vero cells(IC50=1.88 ± 0.52 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	ACE2	16337697	Antiviral Res. 2006 Feb;69(2):70-6.	Ho TY, Wu SL, Chen JC, Wei YC, Cheng SE, Chang YH, Liu HJ, Hsiang CY.	Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.	
DRAMP31559	GFLYVYKGYQPI	12	SARS-CoV S (192-203), SP-4	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: block the binding of S protein to ACE2.	[Ref.16337697]SARS-CoV:Inhibition of pseudovirus infection in Vero cells(IC50=4.30 ± 2.18 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	ACE2	16337697	Antiviral Res. 2006 Feb;69(2):70-6.	Ho TY, Wu SL, Chen JC, Wei YC, Cheng SE, Chang YH, Liu HJ, Hsiang CY.	Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)O
DRAMP31560	FYTTTGIGYQPY	12	SARS-CoV S (483-494), SP-8	P59594	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: block the binding of S protein to ACE2.	[Ref.16337697]SARS-CoV:Inhibition of pseudovirus infection in Vero cells(IC50=6.99 ± 0.71 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	ACE2	16337697	Antiviral Res. 2006 Feb;69(2):70-6.	Ho TY, Wu SL, Chen JC, Wei YC, Cheng SE, Chang YH, Liu HJ, Hsiang CY.	Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP31561	IHAEIKNSLKIDNLDVNRCIEAL	23	LEDGF/p75 (355-377)	O75475	Retroviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: The LEDGF/p75 peptide modestly inhibited IN catalysis and was dependent on IN–DNA assembly. The peptide was also effective at disrupting LEDGF/p75–IN complex formation.	[Ref.18331842]Human immunodeficiency virus (HIV): Inhibition of integrase activity (3' end processing)(IC50=165±28 µM); inhibition of integrase activity(strand transfer)(IC50=153±28 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	18331842	FEBS Lett. 2008 Apr 30;582(10):1425-30. 	Al-Mawsawi LQ, Christ F, Dayam R, Debyser Z, Neamati N.	Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)[C@H](C)CC
DRAMP31562	IEEQAKTFLDKFQAnti-HeVEEIYWQS	23	Peptide1(ACE2 (21-43)[N13Q,A16V,D18E,L19I,F20Y,Y21W])	Q9BYF1	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: antagonizes the SARS-CoV-2 S-RBD:ACE2 interaction and inhibits the virus entry.	[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=11 ± 1 nM, 100% inhibition at 25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Spike protein	34328726	J Med Chem. 2022 Feb 24;65(4):2836-2847. 	Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.	Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein	
DRAMP31563	QDKHEEDYQMYNKGDKED	18	Peptide2	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: antagonizes the SARS-CoV-2 S-RBD:ACE2 interaction and inhibits the virus entry.	[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=18 ± 2 nM, 95% inhibition at 0.39 µM, 100% inhibition at 25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Spike protein	34328726	J Med Chem. 2022 Feb 24;65(4):2836-2847. 	Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.	Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein	CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(N)=O
DRAMP31564	DKFNHEAEDLFYQSSLASWNYNT	23	Peptide3	Q9BYF1	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: antagonizes the SARS-CoV-2 S-RBD:ACE2 interaction and inhibits the virus entry.	[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=6 ± 4 nM, 100% inhibition at 25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Spike protein	34328726	J Med Chem. 2022 Feb 24;65(4):2836-2847. 	Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.	Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(N)=O)[C@@H](C)O
DRAMP31565	IDENARSYIDKFQHDAEEMWYQ	22	Peptide4	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: antagonizes the SARS-CoV-2 S-RBD:ACE2 interaction and inhibits the virus entry.	[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=32 ± 2 nM, 95% inhibition at 0.39 µM, 100% inhibition at 25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Spike protein	34328726	J Med Chem. 2022 Feb 24;65(4):2836-2847. 	Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.	Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(N)=O)[C@H](C)CC
DRAMP31566	IYALLENAEDYNLVN	15	Peptide5	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: antagonizes the SARS-CoV-2 S-RBD:ACE2 interaction and inhibits the virus entry.	[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=9 ± 4 nM, 100% inhibition at 25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Spike protein	34328726	J Med Chem. 2022 Feb 24;65(4):2836-2847. 	Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.	Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(N)=O)C(C)C
DRAMP31567	SRDKHEEHEKENDRGQ	16	Peptide6	No entry found	Coronaviridae	Not found	Synthetic construct	Antimicrobial, Antiviral	Not found	Not found	Not found		Mechanism: antagonizes the SARS-CoV-2 S-RBD:ACE2 interaction and inhibits the virus entry.	[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=10 ± 5 nM, 100% inhibition at 25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Spike protein	34328726	J Med Chem. 2022 Feb 24;65(4):2836-2847. 	Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.	Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein	N=C(N)NCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP31568	KWKLFKKIGPGKFLHSAKKF	20	CA-MA3	Not available		Not found	Ceropin-Magainin hybrid peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=75 µM); A549 (IC50>100 µM); K562 (IC50>100 µM); MDA-MB-361 (IC50>100 µM)	Human erythrocytes: Hemolysis 0% (100 μM)	Linear	Free	Amidation		L	NIH-3T3 fibroblast: IC50>100 μM	Not available	10675500	Biochim Biophys Acta. 2000 Feb 15;1463(2):209-18.	Shin SY, Kang JH, Jang SY, Kim Y, Kim KL, Hahm KS.	Effects of the hinge region of cecropin A(1-8)-magainin 2(1-12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP31569	KWKFKKIPKFLHLAKKF	17	P18	Not available		Not found	Ceropin A	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=3.5 µM); Jurkat (IC50=4 µM); MDA-MB-361 (IC50=8 µM)	Human erythrocytes: hemolysis: 0%=100 µM; hemolysis: 0%=50 µM; hemolysis: 0%=25.0 µM; hemolysis: 0%=12.5 µM; hemolysis: 0%=6.25 µM; hemolysis: 0%=3.125 µM; hemolysis: 0%=1.56 µM; hemolysis: 0%=0.78 µM	Linear	Free	Amidation		L	NIH 3T3: IC50=75 µM	Not available	12005420	J Pept Res. 2001 Dec;58(6):504-14.	Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.	Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP31570	PAWFKARRWAWRMKKLAA	18	L2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Meth A (IC50=144 µM); MT-1 (IC50>254 µM); HT-29 (IC50>440 µM)	Human red blood cells: EC50>440 µM	Linear	Free	Free		L	Fibroblas: IC50>440 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31571	PAWRKAFRWAWRMKKLAA	18	L3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=141 µM); MT-1 (IC50=18 µM); Meth A (IC50=32 µM)	Human red blood cells: EC50>440 µM	Linear	Free	Free		L	Fibroblas: IC50=163 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31572	PAWFKARRWAWRMLKKAA	18	L4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MT-1 (IC50=16 µM); Meth A (IC50=31 µM); HT-29 (IC50=57 µM)	Human red blood cells: EC50>440 µM	Linear	Free	Free		L	Fibroblas: IC50=299 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31573	PAWRKAFRWAWRMLKKAA	18	L5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=14 µM); A549 (IC50=3 ± 1 μM(pH=7.4); IC50=4 ± 1 μM(pH=5.5)); Meth A (IC50=6.6 µM); MT-1 (IC50=8 µM)	Human red blood cells: EC50=33 µM	Linear	Free	Free		L	Fibroblas: IC50=17 µM; CHO: IC50=5 ± 1 μM(pH=7.4); IC50=5 ± 1 μM(pH=5.5)	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31574	PAWRKAFRWAARMLKKAA	18	L6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Meth A (IC50=11 µM); MT-1 (IC50=12 µM); HT-29 (IC50=15 µM)	Human red blood cells: EC50=278 µM	Linear	Free	Free		L	Fibroblas: IC50=46 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31575	PAWRKAFRAAWRMLKKAA	18	L7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MT-1 (IC50=11 µM); HT-29 (IC50=16 µM); Meth A (IC50=16 µM)	Human red blood cells: EC50=382 µM	Linear	Free	Free		L	Fibroblas: IC50=46 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31576	PAWAKAFRAAARMKLKAA	18	L8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Meth A (IC50=110 µM); HT-29 (IC50=180 µM); MT-1 (IC50=87 µM)	Human red blood cells: EC50>489 µM	Linear	Free	Free		L	Fibroblas: IC50>489 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31577	PAWRKAARWAWRMLKKAA	18	L9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MT-1 (IC50=32 µM); Meth A (IC50=35 µM); HT-29 (IC50=52 µM)	Human red blood cells: EC50>455 µM	Linear	Free	Free		L	Fibroblas: IC50=289 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31578	PAARKAFRWAWRMLKKAA	18	L10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MT-1 (IC50=20 µM); Meth A (IC50=24 µM); HT-29 (IC50=35 µM)	Human red blood cells: EC50>463 µM	Linear	Free	Free		L	Fibroblas: IC50=190 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31579	PAARKAARWAWRMLKKGA	18	L11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Meth A (IC50=116 µM); HT-29 (IC50=248 µM); MT-1 (IC50=75 µM)	Human red blood cells: EC50>480 µM	Linear	Free	Free		L	Fibroblas: IC50>480 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)O
DRAMP31580	PAWRKAFRWAKRMLKKAA	18	L12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MT-1 (IC50=10 µM); HT-29 (IC50=25 µM); Meth A (IC50=7.9 µM)	Human red blood cells: EC50>451 µM	Linear	Free	Free		L	Fibroblas: IC50=31 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31581	PAWRKAFRKAWRMLKKAA	18	L13	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MT-1 (IC50=12 µM); Meth A (IC50=14 µM); HT-29 (IC50=29 µM)	Human red blood cells: EC50>451 µM	Linear	Free	Free		L	Fibroblas: IC50=59 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31582	PAWRKARRWAWRMKKLAA	18	L14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Meth A (IC50=125 µM); MT-1 (IC50=141 µM); HT-29 (IC50=423 µM)	Human red blood cells: EC50>438 µM	Linear	Free	Free		L	Fibroblas: IC50>438 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31583	PAWRKARRWARRMKKLAA	18	L15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=178 µM); Meth A (IC50=87 µM); MT-1 (IC50=92 µM)	Human red blood cells: EC50>444 µM	Linear	Free	Free		L	Fibroblas: IC50>444 µM	Not available	12366526	J Pept Res. 2002 Oct;60(4):187-97.	Yang N, Stensen W, Svendsen JS, Rekdal Ø.	Enhanced antitumor activity and selectivity of lactoferrin-derived peptides	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31584	GIGKFLHSAKKWGKAFVGQIMNC	23	MG2d	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (30-40% viablity=100 µM )	Not available	Linear	Free	Amidation		L	Not available	Not available	12417587	J Biol Chem. 2003 Jan 10;278(2):1310-5.	Takeshima K, Chikushi A, Lee KK, Yonehara S, Matsuzaki K.	Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(N)=O)[C@H](C)CC)C(C)C
DRAMP31585	TRSSRAGLQWPVGRVHRLLRKGGC	24	BF2d	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (80-90% viablity=100 µM )	Not available	Linear	Free	Amidation		L	Not available	Not available	12417587	J Biol Chem. 2003 Jan 10;278(2):1310-5.	Takeshima K, Chikushi A, Lee KK, Yonehara S, Matsuzaki K.	Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(N)=O)C(C)C)C(C)C
DRAMP31586	glfdvikkvasviggl	16	Citropin 1.1D	Not available		Not found	Amphibian skin secretions	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM)	Not available	Linear	Free	Amidation		D	Not available	Not available	12631273	Eur J Biochem. 2003 Mar;270(6):1141-53.	Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.	nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications	CC[C@H](C)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](C)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(N)=O
DRAMP31587	GLFDVIKAVASVIGGL	16	Citropin 5	Not available		Not found	Amphibian skin secretions	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Lung cancer group (NCI) (IC50=1 μM); Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12631273	Eur J Biochem. 2003 Mar;270(6):1141-53.	Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.	nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP31588	GLFDVIKKVAAVIGGL	16	Citropin 7	Not available		Not found	Amphibian skin secretions	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12631273	Eur J Biochem. 2003 Mar;270(6):1141-53.	Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.	nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP31589	GLFDVIKKVASVIKGL	16	Citropin 11	Not available		Not found	Amphibian skin secretions	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12631273	Eur J Biochem. 2003 Mar;270(6):1141-53.	Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.	nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP31590	GLFDVIKKVASVIKKL	16	Citropin 13	Not available		Not found	Amphibian skin secretions	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12631273	Eur J Biochem. 2003 Mar;270(6):1141-53.	Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.	nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP31591	GLFAVIKKVAAVIKKL	16	Citropin 17	Not available		Not found	Amphibian skin secretions	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12631273	Eur J Biochem. 2003 Mar;270(6):1141-53.	Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.	nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP31592	GLFAVIKKVAAVIRRL	16	Citropin 18	Not available		Not found	Amphibian skin secretions	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50>10 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12631273	Eur J Biochem. 2003 Mar;270(6):1141-53.	Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.	nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP31593	GLFAVIKKVAKVIKKL	16	Citropin 19	Not available		Not found	Amphibian skin secretions	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Melanoma cancer group (NCI) (IC50=1 μM); Ovarian cancer group (NCI) (IC50=1 μM); Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12631273	Eur J Biochem. 2003 Mar;270(6):1141-53.	Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.	nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)C(C)C)C(C)C
DRAMP31594	GLFKVIKKVASVIGGL	16	Citropin 22	Not available		Not found	Amphibian skin secretions	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50>10 μM); Leukemia group (NCI) (IC50>10 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12631273	Eur J Biochem. 2003 Mar;270(6):1141-53.	Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.	nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP31595	GLFKVIKKVAKVIKKL	16	Citropin 23	Not available		Not found	Amphibian skin secretions	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Breast cancer group (NCI) (IC50=10 μM); CNS cancer group (NCI) (IC50=10 μM); Colon cancer group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Ovarian cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Leukemia group (NCI) (IC50>10 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12631273	Eur J Biochem. 2003 Mar;270(6):1141-53.	Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.	nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP31596	LGGIVSAVKKIVDFLG	16	Citropin retro	Not available		Not found	Amphibian skin secretions	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CNS cancer group (NCI) (IC50=10 μM); Lung cancer group (NCI) (IC50=10 μM); Melanoma cancer group (NCI) (IC50=10 μM); Prostate cancer group (NCI) (IC50=10 μM); Renal cancer group (NCI) (IC50=10 μM); Breast cancer group (NCI) (IC50>10 μM); Colon cancer group (NCI) (IC50>10 μM); Leukemia group (NCI) (IC50>10 μM); Ovarian cancer group (NCI) (IC50>10 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12631273	Eur J Biochem. 2003 Mar;270(6):1141-53.	Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, Bowie JH, Wabnitz PA, Tyler MJ.	nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP31597	KLllKLKlKlLK	12	l3,4,8,10K5L7	Not available		Not found	Diastereomeric peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: B16-F10 (LC50=100 µM); D122 (LC50>50 µM)	Human erythrocyte: Hemolysis% at 50 μm peptide LC50=0 µM	Linear	Free	Free	l=D-Leucine; k=D-Lysine	Mix	NIH-3T3: LC50>100 µM	Not available	12646578	 J Biol Chem. 2003 Jun 6;278(23):21018-23. 	Papo N, Shahar M, Eisenbach L, Shai Y. 	Designed antimicrobial and antitumor peptides with high selectivity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31598	KLlRLLkkLlRLlLK	15	l3,10,13K7,8K4R2L9	Not available		Not found	Diastereomeric peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: B16-F10 (LC50=2.5 µM); D122 (LC50=4.5 µM)	Human erythrocyte: Hemolysis% at 50 μm peptide LC50=0 µM	Linear	Free	Free	l=D-Leucine; k=D-Lysine	Mix	NIH-3T3: LC50=40 µM	Not available	12646578	 J Biol Chem. 2003 Jun 6;278(23):21018-23. 	Papo N, Shahar M, Eisenbach L, Shai Y. 	Designed antimicrobial and antitumor peptides with high selectivity	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31599	AIGKFLHSAKKFGKAFVGEIMNS	23	Magainin A	C0HKN6##P11006		Not found	African clawed frog Xenopus laevis skin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H735 (IC50=10.4 µM); NCI-H526 (IC50=11.7 µM); U-937 (IC50=16 µg/ml); RPMI-8402 (IC50=18 µg/ml); Raji (IC50=20 µg/ml); SSKT-1 (IC50=23 µg/ml); Daudi (IC50=30 µg/ml); MLA (IC50=34 µg/ml); K562 (IC50=40 µg/ml); CHP-100 (IC50=45 µg/ml); MCF-7 (IC50=49 µg/ml); PC-3 (IC50=53 µg/ml); NCI-H678 (IC50=6.23 µM); NCI-H889 (IC50=6.56 µM); NCI-H82 (IC50=7.28 µM); NCI-H841 (IC50=9.7 µM)	Detectable but low hemolytic activity	Linear	Beta-alanine	Amidation		L	Not available	Not available	1319823	Cancer Res. 1992 Jul 1;52(13):3534-8.	Ohsaki Y, Gazdar AF, Chen HC, Johnson BE.	Antitumor activity of magainin analogues against human lung cancer cell lines	
DRAMP31600	LLAGLAANFLPTIICKISYKC	21	PTP1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>100 µg/ml); Hep 3B (IC50>100 µg/ml); MCF-7 (IC50>100 µg/ml); PC-3 (IC50>100 µg/ml)	Human RBCs: less than 6% hemolysis at 100 μg/ml	Cyclic	Free	Amidation		L	HEK293: IC50>100 µg/ml	Not available	14499271	Peptides. 2003 Jul;24(7):945-53.	Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ.	In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP31601	FAGLAANFLPTIICKISYKC	20	PTP2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>100 µg/ml); Hep 3B (IC50>100 µg/ml); MCF-7 (IC50>100 µg/ml); PC-3 (IC50>100 µg/ml)	Human RBCs: less than 6% hemolysis at 100 μg/ml	Cyclic	Free	Amidation		L	HEK293: IC50>100 µg/ml	Not available	14499271	Peptides. 2003 Jul;24(7):945-53.	Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ.	In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP31602	FLKLLKKLAAKFLPTIICKISYKC	24	PTP4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=13.71 ± 2.12 µg/ml); MCF-7 (IC50=18.10 ± 2.13 µg/ml); Hep 3B (IC50=18.18 ± 3.31 µg/ml); PC-3 (IC50=18.63 ± 0.99 µg/ml)	Human RBCs: 45.17% hemolysis at 100 μg/ml	Linear	Free	Amidation		L	HEK293: IC50=26.15 ± 6.23 µg/ml	Not available	14499271	Peptides. 2003 Jul;24(7):945-53.	Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ.	In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP31603	FLKLLKKLAAKFL	13	PTP6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=13.27 ± 4.27 µg/ml); A549 (IC50=13.94 ± 3.96 µg/ml); Hep 3B (IC50=15.07 ± 1.59 µg/ml); MCF-7 (IC50=17.56 ± 6.23 µg/ml)	Human RBCs: less than 6% hemolysis at 100 μg/ml	Linear	Free	Amidation		L	HEK293: IC50=14.00 ± 1.46 µg/ml	Not available	14499271	Peptides. 2003 Jul;24(7):945-53.	Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ.	In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O
DRAMP31604	FLGALFKALSKLL	13	PTP7	P80399		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death via apoptosis	Tumor cells: PANC-1 (IC50=11 μM ); PC-3 (IC50=5.01±0.42 µg/ml); MCF-7 (IC50=5.25±0.63 µg/ml); Hep 3B (IC50=5.40 ± 0.91 µg/ml); A549 (IC50=8.01 ± 1.32 µg/ml)	Human RBCs: less than 6% hemolysis at 100 μg/ml	Linear	Free	Amidation		L	HEK293: IC50=6.71 ± 0.47 µg/ml; MCF-10A: IC50=8 μM	Not available	14499271	Peptides. 2003 Jul;24(7):945-53.	Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ.	In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O
DRAMP31605	FLKLLAGLLKNFA	13	PTP8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=24.58 ± 3.24 µg/ml); PC-3 (IC50=28.90 ± 5.19 µg/ml); Hep 3B (IC50=30.79 ± 3.11 µg/ml); MCF-7 (IC50=32.23 ± 9.12 µg/ml)	Human RBCs: less than 6% hemolysis at 100 μg/ml	Linear	Free	Amidation		L	HEK293: IC50=26.80 ± 5.52 µg/ml	Not available	14499271	Peptides. 2003 Jul;24(7):945-53.	Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ.	In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(N)=O
DRAMP31606	KIFGSLAFL	9	p369–377 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: N202.A2 (Animals immunized three times with DC pulsed with p369–377 or p773–782 peptide showed ~25–30% tumor growth inhibition, while two immunizations induced ~12–15% tumor growth inhibition and one injection)	Not available	Linear	Free	Free		L	Not available	Not available	14991605	Eur J Immunol. 2004 Mar;34(3):752-761.	Lustgarten J, Dominguez AL, Cuadros C.	The CD8	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31607	VMAGVGSPYV	10	p773–782 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	The low-avidity T cell repertoire for a self tumor antigen is functional, can be activated and expanded with the help of costimulation	Tumor cells: N202.A2 (Animals immunized three times with DC pulsed with p369–377 or p773–782 peptide showed ~25–30% tumor growth inhibition, while two immunizations induced ~12–15% tumor growth inhibition and one injection)	Not available	Linear	Free	Free		L	Not available	Not available	14991605	Eur J Immunol. 2004 Mar;34(3):752-761.	Lustgarten J, Dominguez AL, Cuadros C.	The CD8	CSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP31608	FRKSKEKIGKEFKRIVQRIKDFLRNLV	27	HCAP18(109-135)	Q1KLX1##P49913		Not found	hCAP18 Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SAS-H1 (88 ± 7.2% cytotoxicity=40 mg/ml)	Not available	Linear	Free	Free		L	Not available	Not available	15279899	Cancer Lett. 2004 Aug 30;212(2):185-94.	Okumura K, Itoh A, Isogai E, Hirose K, Hosokawa Y, Abiko Y, Shibata T, Hirata M, Isogai H.	C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31609	HHPHGHHPHGHHPHGHHPHG	20	Ac-(HHPHG)4 -NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Bind to Tropomyosin and Have Antiangiogenic and Antitumor Activities	Tumor cells: 3LL (The 50 mg/kg dose in the 3LL model significantly inhibited tumor growth by 48%); B16-F1 (The 50 mg/kg dose in the 3LL model significantly inhibited tumor growth by 48%)	Not available	Linear	Acetylation	Amidation		L	Not available	Tropomyosin	15313924	Cancer Res. 2004 Aug 15;64(16):5812-7.	Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.	Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities	CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(N)=O
DRAMP31610	CVKVKVKVGSGVKVKVKVC	19	V1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=45 µM)	Human erythrocytes: 50% Hemolysis=880 µM	Cyclic	Acetylization	Amidation		L	Not available	Not available	15328096	Antimicrob Agents Chemother. 2004 Sep;48(9):3349-57.	Frecer V, Ho B, Ding JL.	De novo design of potent antimicrobial peptides	CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(N)=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP31611	CWMSPRHLGTCGRKKRRQRRRPPQ	24	CIGB-300 (P15-Tat)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	CIGB-300 is a cyclic synthetic peptide that induces apoptosis in malignant cells, elicits antitumor activity in cancer animal models	Tumor cells: SiHa (IC50=135±10 µmol/L); HeLa (IC50=136±16  µmol/L); 3LL (IC50=143±4 µmol/L); A549 (IC50=171±12 µmol/L); Ca Ski (IC50=182±6  µmol/L); NCI-H82 (IC50=20±3 µmol/L); PC-3 (IC50=201±16 µmol/L); HL-60 (IC50=30±3 µmol/L); NCI-H125 (IC50=36±9  µmol/L); TC-1 (IC50=71±15  µmol/L); Jurkat (IC50=89±3  µmol/L)	Not available	Cyclic	Free	Free		L	Not available	Not available	15466209	Cancer Res. 2004 Oct 1;64(19):7127-9.	Perea SE, Reyes O, Puchades Y, Mendoza O, Vispo NS, Torrens I, Santos A, Silva R, Acevedo B, López E, Falcón V, Alonso DF.	Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2)	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O
DRAMP31612	GRKKRRQRRRGGWMWVTNLRTD	22	TAT-Ras-GAP317-326	Not available		Not found	RasGAP-derived peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Enhances genotoxin-induced cytotoxicity in tumor cells	Tumor cells: HeLa (rendered all the tested cancer cell lines sensitive to doses of cisplatin, adriamycin, and mitoxantrone ); H-Meso-1  (rendered all the tested cancer cell lines sensitive to doses of cisplatin, adriamycin, and mitoxantrone ); MCF-7 (rendered all the tested cancer cell lines sensitive to doses of cisplatin, adriamycin, and mitoxantrone ); U2OS (rendered all the tested cancer cell lines sensitive to doses of cisplatin, adriamycin, and mitoxantrone )	Not available	Linear	Free	Free		L	Not available	Not available	15467750	Oncogene. 2004 Nov 25;23(55):8971-8.	Michod D, Yang JY, Chen J, Bonny C, Widmann C.	A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
DRAMP31613	ERRP	4	EGFR-related peptide	Not available		Not found	EGFR-related peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	ERRP inhibits the growth of prostate cancer cells by attenuating EGFR signaling processes	Tumor cells: PC-3 (30% Cell viability at 5 µg/ml)	Not available	Linear	Free	Free		L	Not available	Not available	15634655	Mol Cancer Ther. 2004 Dec;3(12):1615-21.	Marciniak DJ, Rishi AK, Sarkar FH, Majumdar AP.	Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells	N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)C(=O)O
DRAMP31614	LW	2	Psychrophilin D (1)	Not available		Not found	Anthranilic acid	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: P388 (IC50=10.1 µg/ml)	Not available	Linear	Free	Free		L	Not available	Not available	15835725	J Antibiot (Tokyo). 2005 Feb;58(2):141-4.	Dalsgaard PW, Larsen TO, Christophersen C.	Bioactive cyclic peptides from the psychrotolerant fungus Penicillium algidum	CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31615	HSHRDFQPVLHLVALNSPLSGGMRG	25	hP1	P39060		Not found	Human endostatin peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibition of endothelial cell proliferation, migration, and tube formation	Tumor cells: BxPC-3 (39% inhibition at 7 mg/kg/d)	Not available	Linear	Free	Free		L	Not available	α5β1 integrin, metalloproteinases	15867360	Cancer Res. 2005 May 1;65(9):3656-63.	Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.	A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity	CSCC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)C(=O)NCC(=O)O
DRAMP31616	MRGIRGADFQAFQQARAVGLAGTFR	25	hP2	Not available		Not found	Human endostatin peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibition of endothelial cell proliferation, migration, and tube formation	Tumor cells: BxPC-3 (19% inhibition at 7 mg/kg/d)	Not available	Linear	Free	Free		L	Not available	α5β1 integrin, metalloproteinases	15867360	Cancer Res. 2005 May 1;65(9):3656-63.	Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.	A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP31617	TFRAFLSSRLQDLYSIVRRADRAAV	25	hP3	P39060		Not found	Human endostatin peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibition of endothelial cell proliferation, migration, and tube formation	Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d)	Not available	Linear	Free	Free		L	Not available	α5β1 integrin, metalloproteinases	15867360	Cancer Res. 2005 May 1;65(9):3656-63.	Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.	A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31618	AAVPIVNLKDELLFPSWEALFSGSE	25	hP4	P39060		Not found	Human endostatin peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibition of endothelial cell proliferation, migration, and tube formation	Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d)	Not available	Linear	Free	Free		L	Not available	α5β1 integrin, metalloproteinases	15867360	Cancer Res. 2005 May 1;65(9):3656-63.	Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.	A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP31619	GSEGPLKPGARIFSFDGKDVLRHPT	25	hP5	P39060		Not found	Human endostatin peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibition of endothelial cell proliferation, migration, and tube formation	Tumor cells: BxPC-3 (29% inhibition at 7 mg/kg/d)	Not available	Linear	Free	Free		L	Not available	α5β1 integrin, metalloproteinases	15867360	Cancer Res. 2005 May 1;65(9):3656-63.	Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.	A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)NC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP31620	HPTWPQKSVWHGSDPNGRRLTESY	24	hP6	P39060		Not found	Human endostatin peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibition of endothelial cell proliferation, migration, and tube formation	Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d)	Not available	Linear	Free	Free		L	Not available	α5β1 integrin, metalloproteinases	15867360	Cancer Res. 2005 May 1;65(9):3656-63.	Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.	A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP31621	ETWRTEAPSATGQASSLLGGRLLGQ	25	hP7	P39060		Not found	Human endostatin peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibition of endothelial cell proliferation, migration, and tube formation	Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d)	Not available	Linear	Free	Free		L	Not available	α5β1 integrin, metalloproteinases	15867360	Cancer Res. 2005 May 1;65(9):3656-63.	Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.	A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP31622	LGQSAASAHHAYIVLAIENSFMTASKKK	28	hP8	Not available		Not found	Human endostatin peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibition of endothelial cell proliferation, migration, and tube formation	Tumor cells: BxPC-3 (No inhibition at 7 mg/kg/d)	Not available	Linear	Free	Free		L	Not available	α5β1 integrin, metalloproteinases	15867360	Cancer Res. 2005 May 1;65(9):3656-63.	Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K.	A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
DRAMP31623	AXQNXXXPLXXVX	13	Laxaphycin B	Not available		Not found	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CEM/VM-1 (40% inhibition at 1 µM); CEM-VLB (40% inhibition at 1 µM); CEM-WT (40% inhibition at 1 µM); CEM/VM-1 (44% inhibition at 1 µM); CEM-VLB (44% inhibition at 1 µM); CEM-WT (44% inhibition at 1 µM); CEM-WT (50% inhibition at 1 µM)	Not available	Cyclic			X(2/13)=Leu(3-OH); X(5)=N(Me)xiIle; X(6)=Asn(3-OH); X(7/10)=xiThr; X(11)=Unk	L	Not available	Not available	15875779	In Vivo. 2005 May-Jun;19(3):577-82.	Gbankoto A, Vigo J, Dramane K, Banaigs B, Aina E, Salmon JM.	Cytotoxic effect of Laxaphycins A and B on human lymphoblastic cells (CCRF-CEM) using digitised videomicrofluorometry	
DRAMP31624	XXXFLXXLGXX	11	Laxaphycin A	Not available		Not found	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CEM/VM-1 (No inhibition at 4 µM); CEM-VLB (No inhibition at 4 µM); CEM-WT (No inhibition at 4 µM)	Not available	Cyclic			X(1)=Abu(2,3-dehydro); X(2)=xiHyp; X(3/11)=Hse; X(6/7)=xiIle; X(10)=Unk	L	Not available	Not available	15875779	In Vivo. 2005 May-Jun;19(3):577-82.	Gbankoto A, Vigo J, Dramane K, Banaigs B, Aina E, Salmon JM.	Cytotoxic effect of Laxaphycins A and B on human lymphoblastic cells (CCRF-CEM) using digitised videomicrofluorometry	
DRAMP31625	MWKWFHNVLSSWQLLADKRPARDYNRK	27	Pep27anal1	Not available		Not found	S. pneumoniae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SNU-601 (IC50=37 µM); Jurkat (IC50=47 µM); OCI-AML-2 (IC50=50 µM); HL-60 (IC50=53 µM); MCF-7 (IC50=55 µM)	Human RBCs(0% hemolysis at 0.19 μM, 0.39 μM, 0.78 μM, 1.56 μM, 3.12 μM, 6.25 μM, 12.5 μM)	Linear	Free	Free		L	Not available	Not available	16004618	Cancer Cell Int. 2005 Jul 11;5:21.	Lee DG, Hahm KS, Park Y, Kim HY, Lee W, Lim SC, Seo YK, Choi CH.	Functional and structural characteristics of anticancer peptide Pep27 analogues	CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
DRAMP31626	MWKWFHNVLSWWWLLADKRPARDYNRK	27	Pep27anal2	Not available		Not found	S. pneumoniae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Pep27anal2 can penetrate the plasma membrane, and then induce apoptosis in both caspase-and cytochrome c-independent manner	Tumor cells: MCF-7 (IC50<10 µM); HL-60 (IC50=20 µM); Jurkat (IC50=23 µM); SNU-601 (IC50=25 µM); OCI-AML-2 (IC50=29 µM)	Human RBCs(18% hemolysis at  12.5 μM), Human RBCs(0% hemolysis at 0.19 μM, 0.39 μM, 0.78 μM, 1.56 μM, 3.12 μM, 6.25 μM)	Linear	Free	Free		L	Not available	Not available	16004618	Cancer Cell Int. 2005 Jul 11;5:21.	Lee DG, Hahm KS, Park Y, Kim HY, Lee W, Lim SC, Seo YK, Choi CH.	Functional and structural characteristics of anticancer peptide Pep27 analogues	CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
DRAMP31627	MRKWFHNVLSSGQLLADKWPAWDYNRK	27	Pep27anal3	Not available		Not found	S. pneumoniae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=38 µM); Jurkat (IC50=50 µM); SNU-601 (IC50=50 µM); HL-60 (IC50=52 µM); OCI-AML-2 (IC50=67 µM)	Human RBCs(0% hemolysis at 0.19 μM, 0.39 μM, 0.78 μM, 1.56 μM, 3.12 μM, 6.25 μM, 12.5 μM)	Linear	Free	Free		L	Not available	Not available	16004618	Cancer Cell Int. 2005 Jul 11;5:21.	Lee DG, Hahm KS, Park Y, Kim HY, Lee W, Lim SC, Seo YK, Choi CH.	Functional and structural characteristics of anticancer peptide Pep27 analogues	CSCC[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
DRAMP31628	MWKEFHNVLSSGQLLADKRWARWYNRW	27	Pep27anal4	Not available		Not found	S. pneumoniae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=29 µM); SNU-601 (IC50=37 µM); Jurkat (IC50=46 µM); OCI-AML-2 (IC50=50 µM); HL-60 (IC50=51 µM)	Human RBCs(0% hemolysis at 0.19 μM, 0.39 μM, 0.78 μM, 1.56 μM, 3.12 μM, 6.25 μM, 12.5 μM)	Linear	Free	Free		L	Not available	Not available	16004618	Cancer Cell Int. 2005 Jul 11;5:21.	Lee DG, Hahm KS, Park Y, Kim HY, Lee W, Lim SC, Seo YK, Choi CH.	Functional and structural characteristics of anticancer peptide Pep27 analogues	CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31629	MWKWFHNVLSSGQLLADKWWAWWYNWW	27	Pep27anal5	Not available		Not found	S. pneumoniae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (IC50>70 µM); Jurkat (IC50>70 µM); MCF-7 (IC50>70 µM); OCI-AML-2 (IC50>70 µM); SNU-601 (IC50>70 µM)	Human RBCs(0% hemolysis at 0.19 μM, 0.39 μM, 0.78 μM, 1.56 μM, 3.12 μM, 6.25 μM, 12.5 μM)	Linear	Free	Free		L	Not available	Not available	16004618	Cancer Cell Int. 2005 Jul 11;5:21.	Lee DG, Hahm KS, Park Y, Kim HY, Lee W, Lim SC, Seo YK, Choi CH.	Functional and structural characteristics of anticancer peptide Pep27 analogues	CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
DRAMP31630	YSL	3	Tyroserleutide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-1β, TNF-α, and NO in vitro	Tumor cells: BEL-7402 (20.8% cytotoxic at 1 µg/ml); BEL-7402 (33.8% cytotoxic at 10 µg/ml); BEL-7402 (35.6% cytotoxic at 100 µg/ml); BEL-7402 (39.0% cytotoxic at 0.1 µg/ml); B16-F10 (49.4% cytotoxic at 0.1 µg/ml); B16-F10 (51.2% cytotoxic at 1 µg/ml); B16-F10 (53.0% cytotoxic at 10 µg/ml); B16-F10 (61.2% cytotoxic at 100 µg/ml)	Not available	Linear	Free	Free		L	Not available	Not available	16091933	Cancer Immunol Immunother. 2006 Jan;55(1):56-60.	Yao Z, Qiu S, Wang L, Lu R, Zhou CL, Zhao PP, Li HQ, Gao WY.	Tripeptide tyroserleutide enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-1beta, TNF-alpha, and NO in vitro	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
DRAMP31631	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	34	r8-BadBH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce apoptosis in highly malignant NB-derived cell lines	Tumor cells: NGP (>50% apoptosis at 20 µM); SK-N-AS (0% apoptosis at 10 µM); SK-N-AS (10% apoptosis at 20 µM); IMR-5 (15% apoptosis at 10 µM); NGP (20% apoptosis at 10 µM); IMR-5 (20% apoptosis at 20 µM); NB69 (30% apoptosis at 10 µM); NGP (30% apoptosis at 50 µM); SK-N-AS (30% apoptosis at 50 µM); IMR-5 (50% apoptosis at 50 µM); NB69 (80% apoptosis at 20 µM); NB69 (80% apoptosis at 50 µM)	Not available	Linear	Free	Free	rrrrrrrr=D-isomer homopolymer of eight arginine residues	Mix	Not available	Not available	16568093	Cancer Immunol Immunother. 2006 Jan;55(1):56-60.	Yao Z, Qiu S, Wang L, Lu R, Zhou CL, Zhao PP, Li HQ, Gao WY.	BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31632	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	29	r8-BidBH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce apoptosis in highly malignant NB-derived cell lines	Tumor cells: IMR-5 (23% apoptosis at 10 µM); NB69 (25% apoptosis at 10 µM); IMR-5 (35% apoptosis at 20 µM); NGP (43% apoptosis at 10 µM); SK-N-AS (45% apoptosis at 20 µM); NGP (46% apoptosis at 20 µM); IMR-5 (55% apoptosis at 50 µM); SK-N-AS (65% apoptosis at 50 µM); NB69 (66% apoptosis at 20 µM); NB69 (68% apoptosis at 50 µM); NGP (79% apoptosis at 50 µM); SK-N-AS (8% apoptosis at 10 µM)	Not available	Linear	Free	Free	rrrrrrrr=D-isomer homopolymer of eight arginine residues	Mix	Not available	Not available	16568093	Cancer Immunol Immunother. 2006 Jan;55(1):56-60.	Yao Z, Qiu S, Wang L, Lu R, Zhou CL, Zhao PP, Li HQ, Gao WY.	BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)CNC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31633	rrrrrrrrGEDIIRNIARHAAQVGASMDR	29	r8-BidBH3Alt	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce apoptosis in highly malignant NB-derived cell lines	Tumor cells: IMR-5 (0% apoptosis at 10 µM); NGP (1% apoptosis at 10 µM); SK-N-AS (1% apoptosis at 10 µM); IMR-5 (1% apoptosis at 20 µM); NB69 (1% apoptosis at 20 µM); NB69 (2% apoptosis at 10 µM); NGP (2% apoptosis at 20 µM); SK-N-AS (2% apoptosis at 20 µM); IMR-5 (2% apoptosis at 50 µM); NGP (3% apoptosis at 50 µM); SK-N-AS (3% apoptosis at 50 µM); NB69 (5% apoptosis at 50 µM)	Not available	Linear	Free	Free	rrrrrrrr=D-isomer homopolymer of eight arginine residues	Mix	Not available	Not available	16568093	Cancer Immunol Immunother. 2006 Jan;55(1):56-60.	Yao Z, Qiu S, Wang L, Lu R, Zhou CL, Zhao PP, Li HQ, Gao WY.	BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)CNC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31634	LKlLKKLlkKLLkLL	15	D-K6L9	Not available		Not found	Host Defense lytic Peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	The exclusive selectivity of the peptide towards cancer derives from its specific binding to surface phosphatidylserine and the killing of the cancer cells via cytoplasmic membrane depolarization	Tumor cells: CL-1 (LC50=3 μmol/L); MDA-MB-231 (LC50=3 μmol/L); 22Rv1 (LC50=6 μmol/L)	Not available	Linear	Free	Amidation	l=D-Leucine; k=D-Lysine	Mix	Not available	surface phosphatidylserine	16707464	Cancer Res. 2006 May 15;66(10):5371-8.	Papo N, Seger D, Makovitzki A, Kalchenko V, Eshhar Z, Degani H, Shai Y.	Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(N)=O
DRAMP31635	YGGFM	5	OGF, 7	Not available		Not found	The native opioid growth factor	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HBL (0.4% inhibition at 1μM, 1% inhibition at 10μM, 4.5% inhibition at 100μM, 10.8% inhibition at 1000μM); HT-29 (14% inhibition at 1μM, 15.9% inhibition at 10μM, 16.1% inhibition at 100μM, 19.3% inhibition at 1000μM); SW620 (18.9% inhibition at 1μM, 12.7% inhibition at 10μM, 15.3% inhibition at 100μM, 19.1% inhibition at 1000μM); HeLa (2.3% inhibition at 1μM, 11.4% inhibition at 10μM, 12% inhibition at 100μM, 22.3% inhibition at 1000μM); MCF-7 (3.6% inhibition at 1μM, 4.1% inhibition at 10μM, 7.6% inhibition at 100μM, 15.4% inhibition at 1000μM); CaCo-2 (4.2% inhibition at 1μM, 6.4% inhibition at 10μM, 8.4% inhibition at 100μM, 3.2% inhibition at 1000μM); HEp-2 (5.2% inhibition at 1μM, 4.5% inhibition at 10μM, 2.4% inhibition at 100μM, 3.3% inhibition at 1000μM)	Not available	Linear	Free	Free		L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
DRAMP31636	YX	2	8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HeLa (10% inhibition at 10μM, 8.2% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.9% inhibition at 1μM, 16.5% inhibition at 10μM, 28.1% inhibition at 100μM, 58.2% inhibition at 1000μM); HEp-2 (14.2% inhibition at 1μM, 19.7% inhibition at 10μM, 24.9% inhibition at 100μM, 30.4% inhibition at 1000μM); MCF-7 (2.4% inhibition at 10μM, 7.5% inhibition at 1000μM); CaCo-2 (3.5% inhibition at 1μM, 22.7% inhibition at 10μM, 18.9% inhibition at 100μM, 26.4% inhibition at 1000μM); HBL (6.5% inhibition at 1μM, 14% inhibition at 10μM, 7.5% inhibition at 100μM, 14% inhibition at 1000μM); HT-29 (9.8% inhibition at 1μM, 1.6% inhibition at 10μM, 5.4% inhibition at 100μM, 26.5% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cαα -dialkylated glycine (Aaa1 )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31637	YX	2	8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: MCF-7 (1.1% inhibition at 10μM, 1.2% inhibition at 100μM, 17.8% inhibition at 1000μM); SW620 (10.5% inhibition at 1μM, 21.9% inhibition at 10μM, 11.8% inhibition at 100μM, 17.9% inhibition at 1000μM); CaCo-2 (3.7% inhibition at 1μM, 16.5% inhibition at 10μM, 8.4% inhibition at 100μM, 14.5% inhibition at 1000μM); HBL (3.9% inhibition at 10μM, 7.3% inhibition at 1000μM); HT-29 (4.9% inhibition at 1μM, 8.9% inhibition at 10μM, 3.4% inhibition at 100μM, 20.8% inhibition at 1000μM); HEp-2 (6.2% inhibition at 1μM, 6.4% inhibition at 10μM, 8.2% inhibition at 100μM, 21.2% inhibition at 1000μM); HeLa (7.5% inhibition at 1μM, 6.1% inhibition at 10μM, 3.1% inhibition at 100μM, 14.8% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cαα -dialkylated glycine (Aaa1 )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31638	YX	2	8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HT-29 (0.7% inhibition at 1μM, 8.3% inhibition at 10μM, 10.5% inhibition at 100μM, 21.8% inhibition at 1000μM); MCF-7 (1.6% inhibition at 1μM, 2.6% inhibition at 10μM, 7.7% inhibition at 100μM, 18.7% inhibition at 1000μM); SW620 (10.7% inhibition at 1μM, 10% inhibition at 10μM, 9.4% inhibition at 100μM, 18.7% inhibition at 1000μM); HEp-2 (2.7% inhibition at 1μM, 2% inhibition at 10μM, 18.8% inhibition at 100μM, 26.7% inhibition at 1000μM); CaCo-2 (22.2% inhibition at 1μM, 21.4% inhibition at 10μM, 17.5% inhibition at 100μM, 16% inhibition at 1000μM); HBL (3% inhibition at 1μM, 4.7% inhibition at 10μM, 2.7% inhibition at 100μM, 7.3% inhibition at 1000μM); HeLa (7.2% inhibition at 1μM, 17.1% inhibition at 10μM, 11% inhibition at 100μM, 20.5% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cαα -dialkylated glycine (Aaa1 )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31639	YX	2	9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HeLa (10% inhibition at 10μM, 8.2% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.9% inhibition at 1μM, 16.5% inhibition at 10μM, 28.1% inhibition at 100μM, 58.2% inhibition at 1000μM); HEp-2 (14.2% inhibition at 1μM, 19.7% inhibition at 10μM, 24.9% inhibition at 100μM, 30.4% inhibition at 1000μM); MCF-7 (2.4% inhibition at 10μM, 7.5% inhibition at 1000μM); CaCo-2 (3.5% inhibition at 1μM, 22.7% inhibition at 10μM, 18.9% inhibition at 100μM, 26.4% inhibition at 1000μM); HBL (6.5% inhibition at 1μM, 14% inhibition at 10μM, 7.5% inhibition at 100μM, 14% inhibition at 1000μM); HT-29 (9.8% inhibition at 1μM, 1.6% inhibition at 10μM, 5.4% inhibition at 100μM, 26.5% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,S )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31640	YX	2	9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: MCF-7 (1.1% inhibition at 10μM, 1.2% inhibition at 100μM, 17.8% inhibition at 1000μM); SW620 (10.5% inhibition at 1μM, 21.9% inhibition at 10μM, 11.8% inhibition at 100μM, 17.9% inhibition at 1000μM); CaCo-2 (3.7% inhibition at 1μM, 16.5% inhibition at 10μM, 8.4% inhibition at 100μM, 14.5% inhibition at 1000μM); HBL (3.9% inhibition at 10μM, 7.3% inhibition at 1000μM); HT-29 (4.9% inhibition at 1μM, 8.9% inhibition at 10μM, 3.4% inhibition at 100μM, 20.8% inhibition at 1000μM); HEp-2 (6.2% inhibition at 1μM, 6.4% inhibition at 10μM, 8.2% inhibition at 100μM, 21.2% inhibition at 1000μM); HeLa (7.5% inhibition at 1μM, 6.1% inhibition at 10μM, 3.1% inhibition at 100μM, 14.8% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,S )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31641	YX	2	9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HT-29 (0.7% inhibition at 1μM, 8.3% inhibition at 10μM, 10.5% inhibition at 100μM, 21.8% inhibition at 1000μM); MCF-7 (1.6% inhibition at 1μM, 2.6% inhibition at 10μM, 7.7% inhibition at 100μM, 18.7% inhibition at 1000μM); SW620 (10.7% inhibition at 1μM, 10% inhibition at 10μM, 9.4% inhibition at 100μM, 18.7% inhibition at 1000μM); HEp-2 (2.7% inhibition at 1μM, 2% inhibition at 10μM, 18.8% inhibition at 100μM, 26.7% inhibition at 1000μM); CaCo-2 (22.2% inhibition at 1μM, 21.4% inhibition at 10μM, 17.5% inhibition at 100μM, 16% inhibition at 1000μM); HBL (3% inhibition at 1μM, 4.7% inhibition at 10μM, 2.7% inhibition at 100μM, 7.3% inhibition at 1000μM); HeLa (7.2% inhibition at 1μM, 17.1% inhibition at 10μM, 11% inhibition at 100μM, 20.5% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,S )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31642	YX	2	10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HeLa (10% inhibition at 10μM, 8.2% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.9% inhibition at 1μM, 16.5% inhibition at 10μM, 28.1% inhibition at 100μM, 58.2% inhibition at 1000μM); HEp-2 (14.2% inhibition at 1μM, 19.7% inhibition at 10μM, 24.9% inhibition at 100μM, 30.4% inhibition at 1000μM); MCF-7 (2.4% inhibition at 10μM, 7.5% inhibition at 1000μM); CaCo-2 (3.5% inhibition at 1μM, 22.7% inhibition at 10μM, 18.9% inhibition at 100μM, 26.4% inhibition at 1000μM); HBL (6.5% inhibition at 1μM, 14% inhibition at 10μM, 7.5% inhibition at 100μM, 14% inhibition at 1000μM); HT-29 (9.8% inhibition at 1μM, 1.6% inhibition at 10μM, 5.4% inhibition at 100μM, 26.5% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,R )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31643	YX	2	10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: MCF-7 (1.1% inhibition at 10μM, 1.2% inhibition at 100μM, 17.8% inhibition at 1000μM); SW620 (10.5% inhibition at 1μM, 21.9% inhibition at 10μM, 11.8% inhibition at 100μM, 17.9% inhibition at 1000μM); CaCo-2 (3.7% inhibition at 1μM, 16.5% inhibition at 10μM, 8.4% inhibition at 100μM, 14.5% inhibition at 1000μM); HBL (3.9% inhibition at 10μM, 7.3% inhibition at 1000μM); HT-29 (4.9% inhibition at 1μM, 8.9% inhibition at 10μM, 3.4% inhibition at 100μM, 20.8% inhibition at 1000μM); HEp-2 (6.2% inhibition at 1μM, 6.4% inhibition at 10μM, 8.2% inhibition at 100μM, 21.2% inhibition at 1000μM); HeLa (7.5% inhibition at 1μM, 6.1% inhibition at 10μM, 3.1% inhibition at 100μM, 14.8% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,R )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31644	YX	2	10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HT-29 (0.7% inhibition at 1μM, 8.3% inhibition at 10μM, 10.5% inhibition at 100μM, 21.8% inhibition at 1000μM); MCF-7 (1.6% inhibition at 1μM, 2.6% inhibition at 10μM, 7.7% inhibition at 100μM, 18.7% inhibition at 1000μM); SW620 (10.7% inhibition at 1μM, 10% inhibition at 10μM, 9.4% inhibition at 100μM, 18.7% inhibition at 1000μM); HEp-2 (2.7% inhibition at 1μM, 2% inhibition at 10μM, 18.8% inhibition at 100μM, 26.7% inhibition at 1000μM); CaCo-2 (22.2% inhibition at 1μM, 21.4% inhibition at 10μM, 17.5% inhibition at 100μM, 16% inhibition at 1000μM); HBL (3% inhibition at 1μM, 4.7% inhibition at 10μM, 2.7% inhibition at 100μM, 7.3% inhibition at 1000μM); HeLa (7.2% inhibition at 1μM, 17.1% inhibition at 10μM, 11% inhibition at 100μM, 20.5% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,R )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31645	YXG	3	15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HBL (1.6% inhibition at 1μM, 2.9% inhibition at 10μM, 5.9% inhibition at 100μM, 17.9% inhibition at 1000μM); SW620 (13.6% inhibition at 1μM, 20.4% inhibition at 10μM, 14.4% inhibition at 100μM, 23.4% inhibition at 1000μM); CaCo-2 (2.2% inhibition at 1μM, 4.2% inhibition at 10μM, 6.4% inhibition at 100μM, 6.2% inhibition at 1000μM); HEp-2 (2.7% inhibition at 1μM, 2% inhibition at 10μM, 18.8% inhibition at 100μM, 26.7% inhibition at 1000μM); MCF-7 (21.2% inhibition at 100μM); HT-29 (5.4% inhibition at 1μM, 7.4% inhibition at 10μM, 9.5% inhibition at 100μM, 15.7% inhibition at 1000μM); HeLa (9.8% inhibition at 1μM, 7.3% inhibition at 10μM, 9.9% inhibition at 100μM, 28.2% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,S )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31646	YXG	3	15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HBL (1.2% inhibition at 10μM, 3.3% inhibition at 100μM, 19.4% inhibition at 1000μM); HeLa (11% inhibition at 1μM, 11.7% inhibition at 10μM, 11.6% inhibition at 100μM, 28.2% inhibition at 1000μM); MCF-7 (15.6% inhibition at 100μM); SW620 (17% inhibition at 1μM, 13.5% inhibition at 10μM, 13.5% inhibition at 100μM, 25.3% inhibition at 1000μM); HEp-2 (4.6% inhibition at 1μM, 4.9% inhibition at 10μM, 12.6% inhibition at 100μM, 26.4% inhibition at 1000μM); HT-29 (7.6% inhibition at 1μM, 3.8% inhibition at 10μM, 12.4% inhibition at 100μM, 22.4% inhibition at 1000μM); CaCo-2 (8.1% inhibition at 1μM, 6.9% inhibition at 10μM, 8.1% inhibition at 100μM, 8.6% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,S )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31647	YXG	3	16	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HBL (1.6% inhibition at 1μM, 2.9% inhibition at 10μM, 5.9% inhibition at 100μM, 17.9% inhibition at 1000μM); SW620 (13.6% inhibition at 1μM, 20.4% inhibition at 10μM, 14.4% inhibition at 100μM, 23.4% inhibition at 1000μM); CaCo-2 (2.2% inhibition at 1μM, 4.2% inhibition at 10μM, 6.4% inhibition at 100μM, 6.2% inhibition at 1000μM); HEp-2 (2.7% inhibition at 1μM, 2% inhibition at 10μM, 18.8% inhibition at 100μM, 26.7% inhibition at 1000μM); MCF-7 (21.2% inhibition at 100μM); HT-29 (5.4% inhibition at 1μM, 7.4% inhibition at 10μM, 9.5% inhibition at 100μM, 15.7% inhibition at 1000μM); HeLa (9.8% inhibition at 1μM, 7.3% inhibition at 10μM, 9.9% inhibition at 100μM, 28.2% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,R )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31648	YXG	3	16	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HBL (1.2% inhibition at 10μM, 3.3% inhibition at 100μM, 19.4% inhibition at 1000μM); HeLa (11% inhibition at 1μM, 11.7% inhibition at 10μM, 11.6% inhibition at 100μM, 28.2% inhibition at 1000μM); MCF-7 (15.6% inhibition at 100μM); SW620 (17% inhibition at 1μM, 13.5% inhibition at 10μM, 13.5% inhibition at 100μM, 25.3% inhibition at 1000μM); HEp-2 (4.6% inhibition at 1μM, 4.9% inhibition at 10μM, 12.6% inhibition at 100μM, 26.4% inhibition at 1000μM); HT-29 (7.6% inhibition at 1μM, 3.8% inhibition at 10μM, 12.4% inhibition at 100μM, 22.4% inhibition at 1000μM); CaCo-2 (8.1% inhibition at 1μM, 6.9% inhibition at 10μM, 8.1% inhibition at 100μM, 8.6% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,R )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31649	YXGFM	5	17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HBL (0.8% inhibition at 1μM, 1.4% inhibition at 10μM, 2.4% inhibition at 100μM, 18.3% inhibition at 1000μM); HEp-2 (1% inhibition at 1μM, 10.1% inhibition at 10μM, 16.8% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.2% inhibition at 1μM, 15.5% inhibition at 10μM, 24.7% inhibition at 100μM, 29% inhibition at 1000μM); MCF-7 (22.8% inhibition at 1000μM); CaCo-2 (3% inhibition at 1μM, 8.4% inhibition at 10μM, 18.5% inhibition at 100μM, 10.6% inhibition at 1000μM); HT-29 (3.3% inhibition at 1μM, 11% inhibition at 10μM, 7.9% inhibition at 100μM, 23.7% inhibition at 1000μM); HeLa (4.9% inhibition at 1μM, 10.2% inhibition at 10μM, 13.3% inhibition at 100μM, 28% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cαα -dialkylated glycine (Aaa1 )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31650	YXGFM	5	17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HEp-2 (13.7% inhibition at 1μM, 25.8% inhibition at 10μM, 34.7% inhibition at 100μM, 44.5% inhibition at 1000μM); HT-29 (16.2% inhibition at 1μM, 6.6% inhibition at 10μM, 5.1% inhibition at 100μM, 14.5% inhibition at 1000μM); CaCo-2 (17.7% inhibition at 1μM, 10.9% inhibition at 10μM, 12.1% inhibition at 100μM, 8.1% inhibition at 1000μM); HBL (2.4% inhibition at 1μM, 4.5% inhibition at 10μM, 11.4% inhibition at 100μM, 23.2% inhibition at 1000μM); SW620 (26.4% inhibition at 1μM, 13.1% inhibition at 10μM, 14.6% inhibition at 100μM, 38.4% inhibition at 1000μM); HeLa (8.5% inhibition at 1μM, 9.5% inhibition at 10μM, 15.4% inhibition at 100μM, 24.1% inhibition at 1000μM); MCF-7 (9.6% inhibition at 100μM, 29.9% inhibition at 100μM)	Not available	Linear	Free	Free	X=Cαα -dialkylated glycine (Aaa1 )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31651	YXGFM	5	17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Not available	Not available	Linear	Free	Free	X=Cαα -dialkylated glycine (Aaa1 )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31652	YXGFM	5	18	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HBL (0.8% inhibition at 1μM, 1.4% inhibition at 10μM, 2.4% inhibition at 100μM, 18.3% inhibition at 1000μM); HEp-2 (1% inhibition at 1μM, 10.1% inhibition at 10μM, 16.8% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.2% inhibition at 1μM, 15.5% inhibition at 10μM, 24.7% inhibition at 100μM, 29% inhibition at 1000μM); MCF-7 (22.8% inhibition at 1000μM); CaCo-2 (3% inhibition at 1μM, 8.4% inhibition at 10μM, 18.5% inhibition at 100μM, 10.6% inhibition at 1000μM); HT-29 (3.3% inhibition at 1μM, 11% inhibition at 10μM, 7.9% inhibition at 100μM, 23.7% inhibition at 1000μM); HeLa (4.9% inhibition at 1μM, 10.2% inhibition at 10μM, 13.3% inhibition at 100μM, 28% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2)	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31653	YXGFM	5	18	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: HEp-2 (13.7% inhibition at 1μM, 25.8% inhibition at 10μM, 34.7% inhibition at 100μM, 44.5% inhibition at 1000μM); HT-29 (16.2% inhibition at 1μM, 6.6% inhibition at 10μM, 5.1% inhibition at 100μM, 14.5% inhibition at 1000μM); CaCo-2 (17.7% inhibition at 1μM, 10.9% inhibition at 10μM, 12.1% inhibition at 100μM, 8.1% inhibition at 1000μM); HBL (2.4% inhibition at 1μM, 4.5% inhibition at 10μM, 11.4% inhibition at 100μM, 23.2% inhibition at 1000μM); SW620 (26.4% inhibition at 1μM, 13.1% inhibition at 10μM, 14.6% inhibition at 100μM, 38.4% inhibition at 1000μM); HeLa (8.5% inhibition at 1μM, 9.5% inhibition at 10μM, 15.4% inhibition at 100μM, 24.1% inhibition at 1000μM); MCF-7 (9.6% inhibition at 100μM, 29.9% inhibition at 100μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2)	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31654	YXGFM	5	18	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Not available	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2)	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31655	YGGFMX	6	23	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	lead to apoptosis	Tumor cells: CaCo-2 (11.8% inhibition at 10μM, 47.0% inhibition at 1000μM); MCF-7 (2.2% inhibition at 1μM, 7.1% inhibition at 10μM, 6.9% inhibition at 100μM, 25.9% inhibition at 1000μM); HEp-2 (3.9% inhibition at 10μM, 45.0% inhibition at 1000μM); HBL (4.1% inhibition at 1μM, 70.7% inhibition at 10μM, 34.2% inhibition at 1000μM); HT-29 (9.2% inhibition at 1000μM); HeLa (9.3% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cαα -dialkylated glycine (Aaa1 )	L	Not available	Not available	16722632	J Med Chem. 2006 Jun 1;49(11):3136-42.	Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity	
DRAMP31656	FLGALFKVASKVLPSVKCAITKKC	24	Gaegurin-5	Not available		Not found	Rana rugosa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=113.31 µg/ml); A498 (IC50=138.06 µg/ml); A549 (IC50=145.72 µg/ml); MCF-7 (IC50=183.74 µg/ml); MKN 45 (IC50=34.96 µg/ml); SK-OV-3 (IC50=38.28 µg/ml); NCI-H630 (IC50=41.85 µg/ml); PC-3 (IC50=43.64 µg/ml); SK-MEL-2 (IC50=47.47 µg/ml)	Human erythrocytes: 7% Hemolysis=100 µg/ml	Linear	Free	Free		L	Not available	Not available	16884301	J Med Chem. 2006 Aug 10;49(16):4886-95.	Won HS, Seo MD, Jung SJ, Lee SJ, Kang SJ, Son WS, Kim HJ, Park TK, Park SJ, Lee BJ.	Structural determinants for the membrane interaction of novel bioactive undecapeptides derived from gaegurin 5	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP31657	FLGALFKWASK	11	Gaegurin 5 (1-11)[V8W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H630 (IC50=129.54 µg/ml); MKN 45 (IC50=142.72 µg/ml); HCT 116 (IC50=144.37 µg/ml); SK-OV-3 (IC50=150.45 µg/m); PC-3 (IC50=174.15 µg/ml); MCF-7 (IC50=198.87 µg/ml); A498 (IC50=214.33 µg/ml); A549 (IC50=418.15 µg/ml)	Human erythrocytes: 7% Hemolysis=100 µg/ml	Linear	Free	Free		L	MCF-10a: IC50=434.79 µg/ml	Not available	16884301	J Med Chem. 2006 Aug 10;49(16):4886-95.	Won HS, Seo MD, Jung SJ, Lee SJ, Kang SJ, Son WS, Kim HJ, Park TK, Park SJ, Lee BJ.	Structural determinants for the membrane interaction of novel bioactive undecapeptides derived from gaegurin 5	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31658	FLGWLFKVASK	11	Gaegurin 5 (1-11)[A4W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=106.27 µg/ml); PC-3 (IC50=123.81 µg/ml); HCT 116 (IC50=30.48 µg/ml); SK-MEL-2 (IC50=30.48 µg/ml); A498 (IC50=73.26 µg/ml); NCI-H630 (IC50=75.92 µg/ml); MCF-7 (IC50=77.29 µg/ml); MKN 45 (IC50=82.70 µg/ml); SK-OV-3 (IC50=92.15 µg/ml)	Human erythrocytes: 12% Hemolysis=100 µg/ml	Linear	Free	Free		L	MCF-10a: IC50=311.38 µg/ml	Not available	16884301	J Med Chem. 2006 Aug 10;49(16):4886-95.	Won HS, Seo MD, Jung SJ, Lee SJ, Kang SJ, Son WS, Kim HJ, Park TK, Park SJ, Lee BJ.	Structural determinants for the membrane interaction of novel bioactive undecapeptides derived from gaegurin 5	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP31659	ALSKALSKALSKALSKALSKALSK	24	Z44	Not available		Not found	Xenopus laevis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	magainin 2 and synthetic analogues can rapidly and irreversibly lyse hematopoietic tumor and solid tumor 	Tumor cells: SSKT-1 (IC50=107 µg/ml); Daudi (IC50=115 µg/ml); RPMI-8402 (IC50=60 µg/ml); Raji (IC50=64 µg/ml); MLA (IC50=80 µg/ml); U-937 (IC50=97 µg/ml); K562 (IC50=98 µg/ml)	Not available	Linear	Free	Amidation		L	Not available	Not available	1708887	Proc Natl Acad Sci U S A. 1991 May 1;88(9):3792-6.	Cruciani RA, Barker JL, Zasloff M, Chen HC, Colamonici O.	Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation	CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP31660	AKSKAKSKAKSKAKSKAKSKAKSK	24	Z24	Not available		Not found	Xenopus laevis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	magainin 2 and synthetic analogues can rapidly and irreversibly lyse hematopoietic tumor and solid tumor 	Tumor cells: MLA (IC50=102 µg/ml); SSKT-1 (IC50=109 µg/ml); K562 (IC50=112 µg/ml); U-937 (IC50=123 µg/ml); Daudi (IC50=143 µg/ml); Raji (IC50=72 µg/ml); RPMI-8402 (IC50=83 µg/ml)	Not available	Linear	Free	Amidation		L	Not available	Not available	1708887	Proc Natl Acad Sci U S A. 1991 May 1;88(9):3792-6.	Cruciani RA, Barker JL, Zasloff M, Chen HC, Colamonici O.	Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation	C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP31661	KILRGVSKKIMRTFLRRILTGKK	23	NK23c	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (Not active up to 100 µg/ml)	Human erythrocytes: 15% Hemolysis=100 µg/ml	Linear	Free	Free		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I.	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O
DRAMP31662	KILRGVSKKIMRTFLRRISKDILTGKK	27	C7S/NK27	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa ((38.4±10.3)% Cytotoxicity=100 µg/ml)	Human erythrocytes: 25% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I.	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP31663	KILRGVSKKIMRTFLRRISKDILTGKK	27	C7S/NK27	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa ((6.5±17.3)% Cytotoxicity=100 µg/ml)	Human erythrocytes: 25% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I.	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP31664	KILRGVSKKIMRTFLRRISKDILTGKK	27	C7S/NK27-COOH	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa ((38.4±10.3)% Cytotoxicity=100 µg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Free		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I.	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@H](C)CC
DRAMP31665	KILRGVSKKIMRTFLRRISKDILTGKK	27	C7S/NK27-COOH	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa ((6.5±17.3)% Cytotoxicity=100 µg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Free		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I.	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@H](C)CC
DRAMP31666	KISKKIMRTFLRRISKDILTGKK	23	NK23a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (Not active up to 100 µg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I.	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP31667	VXLfPVXLfP	10	Gramicidin S	Not available		Not found	Bacillus brevis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (LC50=7.4 µM); A549 (LC50=7.5 µM)	Human erythrocytes: 100% Hemolysis=39 µg/ml; 50% Hemolysis=11 µM; Sheep erythrocytes: 50% Hemolysis=21.1±2.6 µM; 100% Hemolysis=100 µM	Cyclic	Free	Free	X=Orn; f=D-Phe	Mix	Not available	Not available	17462586	Biochim Biophys Acta. 2007 Jun;1768(6):1488-97.	Rautenbach M, Vlok NM, Stander M, Hoppe HC.	Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis	
DRAMP31668	fCYwOXXTKKrPKPfQwFwLXKKLMYPTYLKKfQWAVXHL	40	Propeptide 5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Molt-4 (10.4 % inhibition of cell proliferation at 1 nM); KB (10.6 % inhibition of cell proliferation at 1 nM); PTC (14.2 % inhibition of cell proliferation at 10 nM); PTC (16.5 % inhibition of cell proliferation at 1 nM); PTC (16.8 % inhibition of cell proliferation at 100 nM); KB (18.2 % inhibition of cell proliferation at 10 nM); Molt-4 (18.7 % inhibition of cell proliferation at 10 nM); PTC (21.7 % inhibition of cell proliferation at 1 µM); Mia PaCa-2 (24.2 % inhibition of cell proliferation at 1 nM); PTC (27.9 % inhibition of cell proliferation at 10 µM); MCF-7 (28.2 % inhibition of cell proliferation at 10 nM); MCF-7 (29.7 % inhibition of cell proliferation at 1 nM); KB (30.7 % inhibition of cell proliferation at 100 nM); Molt-4 (34.7 % inhibition of cell proliferation at 100 nM); MCF-7 (35.3 % inhibition of cell proliferation at 100 nM); Mia PaCa-2 (37.8 % inhibition of cell proliferation at 10 nM); KB (43.1 % inhibition of cell proliferation at 1 µM); Mia PaCa-2 (48.2 % inhibition of cell proliferation at 100 nM); Molt-4 (54.3 % inhibition of cell proliferation at 1 µM); MCF-7 (59.4 % inhibition of cell proliferation at 1 µM); Mia PaCa-2 (59.6 % inhibition of cell proliferation at 1 µM); Mia PaCa-2 (84.5 % inhibition of cell proliferation at 10 µM); MCF-7 (85.4 % inhibition of cell proliferation at 10 µM); Molt-4 (94.5 % inhibition of cell proliferation at 10 µM); KB (98.3 % inhibition of cell proliferation at 10 µM)	Not available	Cyclic	Free	Amidation	f=D-Phenylalanine; w=D-Tryptophan; O=Ornithine; X(6/21)==cycloleucine or 1-aminocyclopentane-1-carboxylic acid; X(7)=penicillamine; r=D-Arginine;  Aib=2-Aminoisobutyric acid	Mix	Not available	Not available	17559067	J Pept Sci. 2007 Jul;13(7):458-67.	Prasad S, Mathur A, Jaggi M, Mukherjee R.	Delivering multiple anticancer peptides as a single prodrug using lysyl-lysine as a facile linker	
DRAMP31669	LLGMIPLAISAISALSKL	18	Phylloseptin-L1	A0A5Q0MU22##P0DQK9##L0P329		Not found	skin secretions of the lemur leaf frog Hylomantis lemur (Hylidae: Phyllomedusinae)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Cytolytic	Tumor cells: Hep-G2 (LC50=35 μM)	Human erythrocytes: LC50=200 μM	Linear	Free	Free		L	Not available	Not available	17561225	Toxicon. 2007 Sep 15;50(4):498-506.	Conlon JM, Woodhams DC, Raza H, Coquet L, Leprince J, Jouenne T, Vaudry H, Rollins-Smith LA.	Peptides with differential cytolytic activity from skin secretions of the lemur leaf frog Hylomantis lemur (Hylidae: Phyllomedusinae)	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31670	FKCRRWQWRMKKLGAPSITCVR	22	Pep1	P24627		Not found	Bovine lactoferrin (Lf-B)	Antimicrobial, Anticancer	Not found	Not found	Not found	1LFC	Pep1 may kill cancer cells by activating an apoptosis-inducing pathway	Tumor cells: HL-60 (IC50=77 µM)	Not available	Linear	Free	Free		L	Not available	Not available	18425992	J Pept Sci. 2008 Sep;14(9):1032-8.	Onishi J, Roy MK, Juneja LR, Watanabe Y, Tamai Y.	A lactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-60)	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
DRAMP31671	RKAFRWAWRMLKKAAPSITCVR	22	mPep1	Not available		Not found	Bovine lactoferrin (Lf-B)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	mPep1 causes necrotic cell death by destroying cellular membrane structure 	Tumor cells: HL-60 (IC50=8 µM)	Not available	Linear	Free	Free		L	Not available	Not available	18425992	J Pept Sci. 2008 Sep;14(9):1032-8.	Onishi J, Roy MK, Juneja LR, Watanabe Y, Tamai Y.	A lactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-61)	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O
DRAMP31672	KAQIRAMECNIL	12	a5	Not available		Not found	Cyclin B (285-296)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	18656352	Bioorg Med Chem Lett. 2008 Aug 15;18(16):4633-7.	Lou H, Gao Y, Zhai M, Qi Y, Chen L, Lv H, Yu J, Li Y.	A novel peptide from alpha5 helix of Asterina pectinifera cyclin B conjugated to HIV-Tat(49-57) with cytotoxic and apoptotic effects against human cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)O
DRAMP31673	KAQIRAMECNILGRKKRRQRRR	22	Tat-a5	Not available		Not found	HIV-Tat (49-57)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Tat-a5 could arrest cancer cells at G2/M phase and make them apoptotic; Tat-a5 would have the potential to inhibit tumor angiogenesis	Tumor cells: HCT 116 (~80% Cytotoxicity at 100 µM)	Not available	Linear	Free	Free		L	Not available	HIV-Tat	18656352	Bioorg Med Chem Lett. 2008 Aug 15;18(16):4633-7.	Lou H, Gao Y, Zhai M, Qi Y, Chen L, Lv H, Yu J, Li Y.	A novel peptide from alpha5 helix of Asterina pectinifera cyclin B conjugated to HIV-Tat(49-59) with cytotoxic and apoptotic effects against human cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31674	KKKFPWWWPFKKK	13	PST13-RK	Not available		Not found	Derivative of tritrpticin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-361 (IC50=80 µg/ml); A549 (IC50=90 µg/ml)	Not available	Linear	Free	Amidation		L	NIH-3T3 (mouse): IC50=83 µg/ml	Not available	18815734	Biotechnol Lett. 2009 Feb;31(2):233-7.	Yang ST, Kim JI, Shin SY.	Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity	NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP31675	KKKFPWWWPFKKKCKKKFPWWWPFKKKC	28	di-PST13-RK-C	Not available		Not found	Derivative of tritrpticin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-361 (IC50=10 µg/ml); A549 (IC50=15 µg/ml); A549 (IC50=17 µg/ml); MDA-MB-361 (IC50=17 µg/ml)	Not available	Linear	Free	Amidation		L	NIH-3T3 (mouse): IC50=20 µg/ml	Not available	18815734	Biotechnol Lett. 2009 Feb;31(2):233-7.	Yang ST, Kim JI, Shin SY.	Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity	NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP31676	ETFSDLWKLL	10	PNC-28	Not available		Not found	Antennapedia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PNC-28 may be effective in treating human pancreatic cancer. The penetratin sequence appears to be responsible for the fundamental change in the mechanism of action, inducing rapid necrosis initiated by membrane pore formation.	Tumor cells: Mia PaCa-2 (100% Cytotoxicity=75μM)	Not available	Linear	Free	Free		L	Not available	Not available	18931881	Ann Surg Oncol. 2008 Dec;15(12):3588-600.	Bowne WB, Sookraj KA, Vishnevetsky M, Adler V, Sarafraz-Yazdi E, Lou S, Koenke J, Shteyler V, Ikram K, Harding M, Bluth MH, Ng M, Brandt-Rauf PW, Hannan R, Bradu S, Zenilman ME, Michl J, Pincus MR.	The penetratin sequence in the anticancer PNC-28 peptide causes tumor cell necrosis rather than apoptosis of human pancreatic cancer cells	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O
DRAMP31677	YKQCHKKGGKKGSG	14	Crotamine (1–9,38–42)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (Not active up to 100 µM)	Human erythrocytes: 50% Hemolysis>300µM	Linear	Free	Amidation		L	PBMC: IC50>300µM	Not available	18983137	J Med Chem. 2008 Nov 27;51(22):7041-4.	Rádis-Baptista G, de la Torre BG, Andreu D.	A novel cell-penetrating peptide sequence derived by structural minimization of a snake toxin exhibits preferential nucleolar localization	NCCCC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(N)=O
DRAMP31678	FVDLKKIANIINSIF	15	Temporin-CEa	Not available		Not found	skin of the Chinese brown frog, Rana chensinensis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=12 µM); MCF-7 (IC50=27.84 μM); MCF-7 (IC50=31.78 μM); MCF-7 (IC50=31.91 μM); MCF-7 (IC50=34.5 μM); HeLa (IC50=36.31 μM); BEL-7402 (IC50=36.9 μM); BEL-7402 (IC50=37.1 μM); BCaP-37 (IC50=37.33 μM); BCaP-37 (IC50=38.39 μM); BCaP-37 (IC50=38.5 μM); HeLa (IC50=38.96 μM); BEL-7402 (IC50=38.98 μM); BCaP-37 (IC50=39.42 μM); BEL-7402 (IC50=40.16 μM); HeLa (IC50=40.6 μM); HeLa (IC50=43.87 μM); SMMC-7721 (IC50=44.92 μM); SMMC-7721 (IC50=46.73 μM); SMMC-7721 (IC50=47.73 μM); SMMC-7721 (IC50=50.32 μM); A549 (IC50=52.09 μM); A549 (IC50=52.82 μM); A549 (IC50=53.12 μM); A549 (IC50=53.31 μM); MDA-MB-231 (IC50=54.95 μM); BGC-823 (IC50=55.16 μM); BGC-823 (IC50=56.47 μM); MDA-MB-231 (IC50=57.94 μM); LK-2 (IC50=58.32 μM); NCI-H446 (IC50=59.45 μM); MDA-MB-231 (IC50=60.38 μM); LK-2 (IC50=61.57 μM); BGC-823 (IC50=61.63 μM); LK-2 (IC50=61.73 μM); HO-8910 (IC50=62.84 μM); BGC-823 (IC50=63.2 μM); MDA-MB-231 (IC50=63.26 μM); LK-2 (IC50=63.4 μM); HO-8910 (IC50=64.75 μM); NCI-H446 (IC50=64.81 μM); NCI-H446 (IC50=65.29 μM); HO-8910 (IC50=66.55 μM); HO-8910 (IC50=66.68 μM); NCI-H446 (IC50=67.66 μM); HT-29 (IC50=88.91 μM); HT-29 (IC50>100 μM); HT-29 (IC50>100 μM); HT-29 (IC50>100 μM)	Human erythrocytes: LD50=230 μM	Linear	Free	Amidation		L	Not available	Not available	19341344	Zoolog Sci. 2009 Mar;26(3):220-6. 	Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y.	Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP31679	ILPILSLIGGLL	12	Temporin-CEb	Not available		Not found	skin of the Chinese brown frog, Rana chensinensis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=56 µM)	Human erythrocytes: LD50=112 μM	Linear	Free	Amidation		L	Not available	Not available	19341344	Zoolog Sci. 2009 Mar;26(3):220-6. 	Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y.	Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP31680	FKCRRWQWRMKK	12	LfcinB	P24627		Not found	Bovine lactoferrin (Lf-B)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Peptides induce lysis of cancer cells through interactions with the plasma membrane	Tumor cells: Ramos (IC50=10 µM); Raji (IC50=13 µM); Kelly (IC50=141 ± 3 µM); HT-29 (IC50=148±8 µM); SU-DHL-4 (IC50=16 µM); KMS-5 (IC50=38 µM); FEMX-I (IC50=40±7 µM); U266B1 (IC50=55 µM); KMM-1 (IC50=57 µM); MT-1 (IC50>160 µM)	Not available	Linear	Free	Free		L	Not available	Not available	19527490	BMC Cancer. 2009 Jun 15;9:183.	Fadnes B, Rekdal O, Uhlin-Hansen L.	The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31681	KAAKKAAKAAKKAAKAAKKAA	21	KW5	Not available		Not found	Bovine lactoferrin (Lf-B)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Peptides induce lysis of cancer cells through interactions with the plasma membrane	Tumor cells: FEMX-I (IC50=30±3 µM); HT-29 (IC50=55±14 µM)	Not available	Linear	Free	Free		L	Not available	Not available	19527490	BMC Cancer. 2009 Jun 15;9:183.	Fadnes B, Rekdal O, Uhlin-Hansen L.	The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP31682	IDWKKLLDAAKQIX	14	Polybia-MPI [L14L-S]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=20.3±1.0µM); HepG2 (IC50=21.2±0.8µM); EJ (IC50=21.6±1.2µM)	Not available	Linear	Free	Amidation	X=Leu-S	L	NIH 3T3: 50% Cell death>60 µM	Not available	20600424	Peptides. 2010 Oct;31(10):1832-8.	Zhang W, Li J, Liu LW, Wang KR, Song JJ, Yan JX, Li ZY, Zhang BZ, Wang R	A novel analog of antimicrobial peptide Polybia-MPI, with thioamide bond substitution, exhibits increased therapeutic efficacy against cancer and diminished toxicity in mice.	
DRAMP31683	GFFGKRKEYFKKFGASFKRRFANLKKRL	28	Ltc-5 [M6R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (EC50>36 µM)	Human erythrocytes: 50% Hemolysis>36 µM	Linear	Free	Amidation		L	Not available	Not available	19563807	FEBS Lett. 2009 Jul 21;583(14):2425-8.	Polyansky AA, Vassilevski AA, Volynsky PE, Vorontsova OV, Samsonova OV, Egorova NS, Krylov NA, Feofanov AV, Arseniev AS, Grishin EV, Efremov RG.	N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(N)=O
DRAMP31684	GKLIKKFGRKAISYAVKKARGKH	23	Ltc-2a (4-26)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (EC50>36 µM)	Human erythrocytes: 50% Hemolysis>36 µM	Linear	Free	Free		L	Not available	Not available	19563807	FEBS Lett. 2009 Jul 21;583(14):2425-8.	Polyansky AA, Vassilevski AA, Volynsky PE, Vorontsova OV, Samsonova OV, Egorova NS, Krylov NA, Feofanov AV, Arseniev AS, Grishin EV, Efremov RG.	N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP31685	GKMKEYFKKFGASFKRRFANLKKRL	25	Ltc-5 (4-28)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (EC50>36 µM)	Human erythrocytes: 50% Hemolysis>36 µM	Linear	Free	Amidation		L	Not available	Not available	19563807	FEBS Lett. 2009 Jul 21;583(14):2425-8.	Polyansky AA, Vassilevski AA, Volynsky PE, Vorontsova OV, Samsonova OV, Egorova NS, Krylov NA, Feofanov AV, Arseniev AS, Grishin EV, Efremov RG.	N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins	CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP31686	GLFGKLIKKFLRKAISYAVKKARGKH	26	Ltc-2a [G11L]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (EC50=0.7 µM)	Human erythrocytes: 50% Hemolysis=3 µM	Linear	Free	Free		L	Human leukocytes: 50% Cell death=3 µM	Not available	19563807	FEBS Lett. 2009 Jul 21;583(14):2425-8.	Polyansky AA, Vassilevski AA, Volynsky PE, Vorontsova OV, Samsonova OV, Egorova NS, Krylov NA, Feofanov AV, Arseniev AS, Grishin EV, Efremov RG.	N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP31687	GLFGKLIKKKGRKAISYAVKKARGKH	26	Ltc-2a [F10K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (EC50=18 µM)	Human erythrocytes: 50% Hemolysis>36 µM	Linear	Free	Free		L	Human leukocytes: 50% Cell death>36 µM	Not available	19563807	FEBS Lett. 2009 Jul 21;583(14):2425-8.	Polyansky AA, Vassilevski AA, Volynsky PE, Vorontsova OV, Samsonova OV, Egorova NS, Krylov NA, Feofanov AV, Arseniev AS, Grishin EV, Efremov RG.	N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP31688	GLFGKLQKKFGRKAISYAVKKARGKH	26	Ltc-2a [I7Q]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (EC50=18 µM)	Human erythrocytes: 50% Hemolysis>36 µM	Linear	Free	Free		L	Human leukocytes: 50% Cell death>36 µM	Not available	19563807	FEBS Lett. 2009 Jul 21;583(14):2425-8.	Polyansky AA, Vassilevski AA, Volynsky PE, Vorontsova OV, Samsonova OV, Egorova NS, Krylov NA, Feofanov AV, Arseniev AS, Grishin EV, Efremov RG.	N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP31689	DDESSKPCCDQCACTKSNPPQCRCSDMRLNSCHSACKSCICALSYPAQCFCVDITDFCYEPCKPSEDDKEN	71	BBI(Bowman-Birk type proteinase inhibitor)	Not available		Not found	Glycine max	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=48.3±3.5µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	19885848	Mol Nutr Food Res. 2010 Mar;54(3):396-405.	Clemente A, Moreno FJ, Marín-Manzano Mdel C, Jiménez E, Domoney C.	The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C
DRAMP31690	ACDCRGDCFCGGGGIVRRADRAAVP	25	AP	Not available		Not found	Endostatin derived Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: B16-F10 (40% inhibition at 5µg/ml); B16-F10 (50% inhibition at 2.5µg/ml); B16-F10 (75% inhibition at 10µg/ml)	Not available	Linear	Free	Free		L	Not available	integrin αvβ3	20515045	Bioconjug Chem. 2010 Jul 21;21(7):1142-7.	Yin R, Zheng H, Xi T, Xu HM.	Effect of RGD-4C Position is More Important Than Disulfide Bonds on Antiangiogenic Activity of RGD-4C Modified Endostatin Derived Synthetic Polypeptide	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31691	ACDCRGDCFCGGGGIVRRADRAAVP	25	AP	Not available		Not found	Endostatin derived Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: B16-F10 (40% inhibition at 2.5µg/ml); B16-F10 (42% inhibition at 5µg/ml); B16-F10 (52% inhibition at 10µg/ml)	Not available	Linear	Free	Free		L	Not available	integrin αvβ3	20515045	Bioconjug Chem. 2010 Jul 21;21(7):1142-7.	Yin R, Zheng H, Xi T, Xu HM.	Effect of RGD-4C Position is More Important Than Disulfide Bonds on Antiangiogenic Activity of RGD-4C Modified Endostatin Derived Synthetic Polypeptide	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31692	ACDCRGDCFCGGGGIVRRADRAAVP	25	AP(O)	Not available		Not found	Endostatin derived Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: B16-F10 (40% inhibition at 5µg/ml); B16-F10 (50% inhibition at 2.5µg/ml); B16-F10 (75% inhibition at 10µg/ml)	Not available	Cyclic	Free	Free		L	Not available	integrin αvβ3	20515045	Bioconjug Chem. 2010 Jul 21;21(7):1142-7.	Yin R, Zheng H, Xi T, Xu HM.	Effect of RGD-4C Position is More Important Than Disulfide Bonds on Antiangiogenic Activity of RGD-4C Modified Endostatin Derived Synthetic Polypeptide	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
DRAMP31693	ACDCRGDCFCGGGGIVRRADRAAVP	25	AP(O)	Not available		Not found	Endostatin derived Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: B16-F10 (40% inhibition at 2.5µg/ml); B16-F10 (42% inhibition at 5µg/ml); B16-F10 (52% inhibition at 10µg/ml)	Not available	Cyclic	Free	Free		L	Not available	integrin αvβ3	20515045	Bioconjug Chem. 2010 Jul 21;21(7):1142-7.	Yin R, Zheng H, Xi T, Xu HM.	Effect of RGD-4C Position is More Important Than Disulfide Bonds on Antiangiogenic Activity of RGD-4C Modified Endostatin Derived Synthetic Polypeptide	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
DRAMP31694	IVRRADRAAVPGGGGACDCRGDCFC	25	IC	Not available		Not found	Endostatin derived Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: B16-F10 (60% inhibition at 11µg/ml)	Not available	Linear	Free	Free		L	Not available	integrin αvβ4	20515045	Bioconjug Chem. 2010 Jul 21;21(7):1142-7.	Yin R, Zheng H, Xi T, Xu HM.	Effect of RGD-4C Position is More Important Than Disulfide Bonds on Antiangiogenic Activity of RGD-4C Modified Endostatin Derived Synthetic Polypeptide	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O)C(C)C
DRAMP31695	LPFFPPVXPIIG	12	Callyaerin E	Not available		Not found	Callyspongia aerizusa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: L5178Y (ED50=0.39µM); HeLa (ED50=3.4µM); PC-12 (ED50=3.8µM)	Not available	Cyclic	Free	Amidation	X=Daa	L	Not available	Not available	20599387	Bioorg Med Chem. 2010 Jul 15;18(14):4947-56.	brahim SR, Min CC, Teuscher F, Ebel R, Kakoschke C, Lin W, Wray V, Edrada-Ebel R, Proksch P.	Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa	
DRAMP31696	VPVFPXPLF	9	Callyaerin F	Not available		Not found	Callyspongia aerizusa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (ED50>9µM); L5178Y (ED50>9µM); PC-12 (ED50>9µM)	Not available	Cyclic	Free	Amidation	X=Daa	L	Not available	Not available	20599387	Bioorg Med Chem. 2010 Jul 15;18(14):4947-56.	brahim SR, Min CC, Teuscher F, Ebel R, Kakoschke C, Lin W, Wray V, Edrada-Ebel R, Proksch P.	Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa	
DRAMP31697	IIFPXPLXPINAI	13	Callyaerin D	Not available		Not found	Callyspongia aerizusa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: L5178Y (ED50=3.03µM)	Not available	Cyclic	Free	Amidation	X(5)= 4-Hydroxyproline; X(8)=Daa	L	Not available	Not available	20599387	Bioorg Med Chem. 2010 Jul 15;18(14):4947-56.	brahim SR, Min CC, Teuscher F, Ebel R, Kakoschke C, Lin W, Wray V, Edrada-Ebel R, Proksch P.	Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa	
DRAMP31698	VPVFPPLXPI	10	Callyaerin H	Not available		Not found	Callyspongia aerizusa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: L5178Y (ED50=0.48µM)	Not available	Cyclic	Free	Amidation	X=Daa	L	Not available	Not available	20599387	Bioorg Med Chem. 2010 Jul 15;18(14):4947-56.	brahim SR, Min CC, Teuscher F, Ebel R, Kakoschke C, Lin W, Wray V, Edrada-Ebel R, Proksch P.	Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa	
DRAMP31699	LPPPPLXPFFF	11	Callyaerin G	Not available		Not found	Callyspongia aerizusa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: L5178Y (ED50=0.41µM); HeLa (ED50=4.43µM); PC-12 (ED50>8µM)	Not available	Cyclic	Free	Amidation	X=Daa	L	Not available	Not available	20599387	Bioorg Med Chem. 2010 Jul 15;18(14):4947-56.	brahim SR, Min CC, Teuscher F, Ebel R, Kakoschke C, Lin W, Wray V, Edrada-Ebel R, Proksch P.	Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa	
DRAMP31700	CSSRTMHHC	9	Peptide-20	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (30% viablity=100 µM); SK-MEL-28 (35-40% viablity=100 µM); B16-F10 (50% viablity=100 µM); HeLa (50% viablity=100 µM); MDA-MB-231 (55% viablity=100 µM); SK-MEL-25 (55-60% viablity=100 µM); HL-60 (90% viablity=100 µM)	Not available	Cyclic	Free	Free		L	Not available	cadherin constituent at the tumor cell surface	20802991	J Mol Med (Berl). 2010 Dec;88(12):1255-64.	Matsuo AL, Tanaka AS, Juliano MA, Rodrigues EG, Travassos LR.	A novel melanoma-targeting peptide screened by phage display exhibits antitumor activity	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)O
DRAMP31701	KWKSFAKTFKSAKKTVAHTALKAISS	26	L6A/L17A	Not available		Not found	PeptideV13K	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis	Tumor cells: A-375 (IC50>83.6 μmol/L); A549 (IC50>83.6 μmol/L); B16 (IC50>83.6 μmol/L); HeLa (IC50>83.6 μmol/L); MCF-7 (IC50>83.6 μmol/L); NCI-H1299 (IC50>83.6 μmol/L); RD (IC50>83.6 μmol/L); SW1116 (IC50>83.6 μmol/L)	Human red blood cells: MHC>334.3 μmol/L	Linear	Acetylation	Amidation		L	Not available	Not available	21252288	Mol Cancer Ther. 2011 Mar;10(3):416-26.	Huang YB, Wang XF, Wang HY, Liu Y, Chen Y.	Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP31702	KWKSFLKTFKSAKKTVAHTAAKAISS	26	L17A/L21A	Not available		Not found	PeptideV13K	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis	Tumor cells: NCI-H1299 (IC50=37.7 μmol/L); A-375 (IC50>83.6 μmol/L); A549 (IC50>83.6 μmol/L); B16 (IC50>83.6 μmol/L); HeLa (IC50>83.6 μmol/L); MCF-7 (IC50>83.6 μmol/L); RD (IC50>83.6 μmol/L); SW1116 (IC50>83.6 μmol/L)	Human red blood cells: MHC>334.4 μmol/L	Linear	Acetylation	Amidation		L	Not available	Not available	21252288	Mol Cancer Ther. 2011 Mar;10(3):416-26.	Huang YB, Wang XF, Wang HY, Liu Y, Chen Y.	Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP31703	KWKSFLKTFKSAKKTVAHTALKAISS	26	L17A	Not available		Not found	PeptideV13K	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis	Tumor cells: NCI-H1299 (IC50=16.4 μmol/L); A-375 (IC50>83.6 μmol/L); A549 (IC50>83.6 μmol/L); B16 (IC50>83.6 μmol/L); HeLa (IC50>83.6 μmol/L); MCF-7 (IC50>83.6 μmol/L); RD (IC50>83.6 μmol/L); SW1116 (IC50>83.6 μmol/L)	Human red blood cells: MHC>334.4 μmol/L	Linear	Acetylation	Amidation		L	Not available	Not available	21252288	Mol Cancer Ther. 2011 Mar;10(3):416-26.	Huang YB, Wang XF, Wang HY, Liu Y, Chen Y.	Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP31704	KWKSFLKTFKSAKKTVLHTAAKAISS	26	L21A	Not available		Not found	PeptideV13K	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis	Tumor cells: NCI-H1299 (IC50=15.6 μmol/L); A-375 (IC50=59.8 μmol/L); B16 (IC50=63.5 μmol/L); HeLa (IC50=64.7 μmol/L); MCF-7 (IC50=70.8 μmol/L); A549 (IC50=71 μmol/L); RD (IC50>83.6 μmol/L); SW1116 (IC50>83.6 μmol/L)	Human red blood cells: MHC>334.4 μmol/L	Linear	Acetylation	Amidation		L	Not available	Not available	21252288	Mol Cancer Ther. 2011 Mar;10(3):416-26.	Huang YB, Wang XF, Wang HY, Liu Y, Chen Y.	Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP31705	KWKSFLKTFKSAKKTVLHTAAKAISS	26	L21A	Not available		Not found	PeptideV13K	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis		Human red blood cells: MHC>334.4 μmol/L	Linear	Acetylation	Amidation		L	Not available	Not available	21252288	Mol Cancer Ther. 2011 Mar;10(3):416-26.	Huang YB, Wang XF, Wang HY, Liu Y, Chen Y.	Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP31706	KWKSFAKTFKSAKKTVLHTALKAISS	26	L6A	Not available		Not found	PeptideV13K	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis	Tumor cells: NCI-H1299 (IC50=14 μmol/L); A549 (IC50=53 μmol/L); HeLa (IC50=58.6 μmol/L); A-375 (IC50=58.7 μmol/L); MCF-7 (IC50=62.3 μmol/L); B16 (IC50=62.5 μmol/L); RD (IC50>83.6 μmol/L); SW1116 (IC50>83.6 μmol/L)	Human red blood cells: MHC>334.4 μmol/L	Linear	Acetylation	Amidation		L	Not available	Not available	21252288	Mol Cancer Ther. 2011 Mar;10(3):416-26.	Huang YB, Wang XF, Wang HY, Liu Y, Chen Y.	Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP31707	YHWYGYTPQNVIGGGKLlLKlLKKLLKlLKKK	32	EGFR-lytic	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50=0.12 µM); MDA-MB-231 (IC50=0.46 µM)	Not available	Linear	Free	Free		Mix	Not available	Not available	21351323	J Pept Sci. 2011 Jul;17(7):493-8.	Ohara K, Horibe T, Kohno M, Kawakami K.	Characterization of antilytic peptide antibody: application for the detection of lytic-based hybrid peptide in serum samples	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31708	VDKPPYLPRPRPPRXXYNX	19	Oncocin [R15,19Orn][I16Tle]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (Not active up to 2000µg/ml); HepG2 (Not active up to 2000µg/ml)	Human erythrocytes: Not active up to 600 µg/ml	Linear	Free	Amidation	X(15)=Orn; X(16)=L-tert-leucine; X(19)=Orn	L	Not available	Not available	21387510	Chembiochem. 2011 Apr 11;12(6):874-6.	Knappe D, Zahn M, Sauer U, Schiffer G, Sträter N, Hoffmann R.	Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex	
DRAMP31709	VDKPPYLPRPRPXRXIYNX	19	Oncocin [P13Hyp][R15Hyp][R19Orn]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (Not active up to 2000µg/ml); HepG2 (Not active up to 2000µg/ml)	Human erythrocytes: Not active up to 600 µg/ml	Linear	Free	Amidation	X(13)= 4-Hydroxyproline; X(15)= 4-Hydroxyproline; X(19)=Orn	L	Not available	Not available	21387510	Chembiochem. 2011 Apr 11;12(6):874-6.	Knappe D, Zahn M, Sauer U, Schiffer G, Sträter N, Hoffmann R.	Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex	
DRAMP31710	VDKPPYLPRPRPXRXXYNX	19	Oncocin [P13Hyp,R15Hyp,I16Tle,R19Orn]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (Not active up to 2000µg/ml); HepG2 (Not active up to 2000µg/ml)	Human erythrocytes: Not active up to 600 µg/ml	Linear	Free	Amidation	X(13)= 4-Hydroxyproline; X(15)= 4-Hydroxyproline; X(16)=L-tert-leucine; X(19)=Orn	L	Not available	Not available	21387510	Chembiochem. 2011 Apr 11;12(6):874-6.	Knappe D, Zahn M, Sauer U, Schiffer G, Sträter N, Hoffmann R.	Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex	
DRAMP31711	LTFEHYWAQLTS	12	DI	Not available		Not found	E3 ubiquitin-protein ligase	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibits MDM2-p53 Interaction	Tumor cells:  -- (IC50 for MDM2=0.29 µM);  -- (IC50 for MDMX-p53=1.6 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	21423613	PLoS One. 2011 Mar 15;6(3):e17898.	Shiheido H, Takashima H, Doi N, Yanagawa H.	mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O
DRAMP31712	LTFEHYWAQLTS	12	DI	Not available		Not found	E3 ubiquitin-protein ligase	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibits MDM2-p53 Interaction		Not available	Linear	Free	Free		L	Not available	MDM2	21423613	PLoS One. 2011 Mar 15;6(3):e17898.	Shiheido H, Takashima H, Doi N, Yanagawa H.	mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O
DRAMP31713	LTAEHYAAQATS	12	3A	Not available		Not found	E3 ubiquitin-protein ligase	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibits MDM2-p53 Interaction	Tumor cells:  -- (IC50 for MDM2>100 µM);  -- (IC50 for MDMX-p53>100 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	21423613	PLoS One. 2011 Mar 15;6(3):e17898.	Shiheido H, Takashima H, Doi N, Yanagawa H.	mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction	CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31714	QETFSDLWKLLP	12	P5317-28	Not available		Not found	E3 ubiquitin-protein ligase	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibits MDM2-p53 Interaction	Tumor cells:  -- (IC50 for MDM2=4.7 µM);  -- (IC50 for MDMX-p53=30 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	21423613	PLoS One. 2011 Mar 15;6(3):e17898.	Shiheido H, Takashima H, Doi N, Yanagawa H.	mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)C(=O)O
DRAMP31715	PRAWEYWLRLME	12	MIP(F3A)	Not available		Not found	E3 ubiquitin-protein ligase	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibits MDM2-p53 Interaction	Tumor cells:  -- (IC50 for MDM2=0.57 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	21423613	PLoS One. 2011 Mar 15;6(3):e17898.	Shiheido H, Takashima H, Doi N, Yanagawa H.	mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP31716	PRFWEAWLRLME	12	MIP(Y6A)	Not available		Not found	E3 ubiquitin-protein ligase	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibits MDM2-p53 Interaction	Tumor cells:  -- (IC50 for MDM2>100 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	21423613	PLoS One. 2011 Mar 15;6(3):e17898.	Shiheido H, Takashima H, Doi N, Yanagawa H.	mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP31717	PRFWEYALRLME	12	MIP(W7A)	Not available		Not found	E3 ubiquitin-protein ligase	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibits MDM2-p53 Interaction	Tumor cells:  -- (IC50 for MDM2>100 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	21423613	PLoS One. 2011 Mar 15;6(3):e17898.	Shiheido H, Takashima H, Doi N, Yanagawa H.	mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP31718	PRFWEYWLALME	12	MIP(R9A)	Not available		Not found	E3 ubiquitin-protein ligase	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibits MDM2-p53 Interaction	Tumor cells:  -- (IC50 for MDM2=0.02 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	21423613	PLoS One. 2011 Mar 15;6(3):e17898.	Shiheido H, Takashima H, Doi N, Yanagawa H.	mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP31719	PRFWEYWLRAME	12	MIP(L10A)	Not available		Not found	E3 ubiquitin-protein ligase	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibits MDM2-p53 Interaction	Tumor cells:  -- (IC50 for MDM2=1.14 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	21423613	PLoS One. 2011 Mar 15;6(3):e17898.	Shiheido H, Takashima H, Doi N, Yanagawa H.	mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP31720	PRFWEYWLRLAE	12	MIP(M11A)	Not available		Not found	E3 ubiquitin-protein ligase	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibits MDM2-p53 Interaction	Tumor cells:  -- (IC50 for MDM2=0.4 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	21423613	PLoS One. 2011 Mar 15;6(3):e17898.	Shiheido H, Takashima H, Doi N, Yanagawa H.	mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP31721	PRFWEYWLRLME	12	MIP	Not available		Not found	E3 ubiquitin-protein ligase	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibits MDM2-p53 Interaction	Tumor cells:  -- (IC50 for MDM2=0.01 µM);  -- (IC50 for MDMX-p53=0.12 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	21423613	PLoS One. 2011 Mar 15;6(3):e17898.	Shiheido H, Takashima H, Doi N, Yanagawa H.	mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP31722	WKKWXKKWK	9	LTX-302	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60/ADR (IC50=10.5 ± 3.1 µM); MCF-7/mdr (IC50=11.0 ± 4.4 µM); A20 (IC50=16.0 ± 3.0 µM); IGROV-1 (IC50=19.6 ± 8.7 µM); AT84 (IC50=21.0 ± 1.7 µM); Kelly (IC50=28 ± 0 µM); IGROV-1/CDDP (IC50=6.4 ± 2.6 µM); MT-1 (IC50=73 ± 2 µM); HT-29 (IC50=75 ± 5 µM); HL-60 (IC50=8.0 ± 1.1 µM); K562 (IC50=8.2 ± 1.3 µM); MCF-7  (IC50=8.9 ± 2.8 µM); K562/Gleevec (IC50=9.0 ± 2.1 µM)	Human red blood cells (RBC): IC50>695 μM	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	HUVEC: IC50=123 ± 9 μM; MRC-5: IC50=122 ± 16 µM	Not available	21453492	BMC Cancer. 2011 Mar 31;11:116.	Fadnes B, Uhlin-Hansen L, Lindin I, Rekdal Ø.	Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells	
DRAMP31723	XXWXXXWWX	9	LTX-318	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=21.7 ± 2.5 µM); MT-1 (IC50=216 ± 36 µM); AT84 (IC50=23.0 ± 3.6 µM); HT-29 (IC50=248 ± 5 µM); Kelly (IC50=78 ± 7 µM)	Human red blood cells (RBC): IC50>695 μM	Linear	Free	Amidation	X(1/2/5/6/9)=ornithine; X(4)=Dip (Diphenylalanine)	L	HUVEC: IC50> 347 μM; MRC-5: IC50=323 ± 33 µM	Not available	21453492	BMC Cancer. 2011 Mar 31;11:116.	Fadnes B, Uhlin-Hansen L, Lindin I, Rekdal Ø.	Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells	
DRAMP31724	XXWXXXWWX	9	LTX-318	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=14.3 ± 1.2 µM); A20 (IC50=8.3 ± 0.6 µM)	Human red blood cells (RBC): IC50>695 μM	Linear	Free	Amidation	X(1/2/5/6/9)=ornithine; X(4)=Dip (Diphenylalanine)	L	HUVEC: IC50> 347 μM; MRC-5: IC50=323 ± 33 µM	Not available	21453492	BMC Cancer. 2011 Mar 31;11:116.	Fadnes B, Uhlin-Hansen L, Lindin I, Rekdal Ø.	Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells	
DRAMP31725	XXWXXXWWX	9	LTX-318	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=154 ± 29 µM); A20 (IC50=67.7 ± 13.2 µM)	Human red blood cells (RBC): IC50>695 μM	Linear	Free	Amidation	X(1/2/5/6/9)=ornithine; X(4)=Dip (Diphenylalanine)	L	HUVEC: IC50> 347 μM; MRC-5: IC50=323 ± 33 µM	Not available	21453492	BMC Cancer. 2011 Mar 31;11:116.	Fadnes B, Uhlin-Hansen L, Lindin I, Rekdal Ø.	Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells	
DRAMP31726	GIPCGESCVFIPCLTSAIGCSCKSKVCYRN	30	Mram 8 	Not available		Not found	Viola philippica	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BGC-823 (IC50=1.75±0.05µM); HeLa (IC50=15.5±0.06µM); MM96L (IC50=4.91±0.04µM)	Not available	Cyclic	Free	Free		L	HFF-1: IC50=3.19±0.01µM	Not available	21723349	Peptides. 2011 Aug;32(8):1719-23.	He W, Chan LY, Zeng G, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola philippica	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
DRAMP31727	GSIPCGESCVFIPCISAIIGCSCSNKVCYKN	31	Viphi G	Not available		Not found	Viola philippica	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (IC50=1.03±0.03µM); BGC-823 (IC50=2.91±0.06µM); HeLa (IC50=6.35±0.31µM)	Not available	Cyclic	Free	Free		L	HFF-1: IC50=1.76±0.12µM	Not available	21723349	Peptides. 2011 Aug;32(8):1719-23.	He W, Chan LY, Zeng G, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola philippica	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@H](C)CC
DRAMP31730	AWXLFDDGV	9	Cr-AcACP1	B3EWE7		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Proapoptosis	Tumor cells: HEp-2 (IC50=0.8 mM); HCT 15 (IC50=1.0 mM)	Human erythrocytes: 5% Hemolysis=1 mM	Linear	Acetylation	Free	X=Lys-Acetylation (Lysine with acetylation side group)	L	NIH 3T3: IC50=4 mM	DNA	21882228	J Cell Biochem. 2012 Jan;113(1):184-93.	Mandal SM, Migliolo L, Das S, Mandal M, Franco OL, Hazra TK.	Identification and characterization of a bactericidal and proapoptotic peptide from Cycas revoluta seeds with DNA binding properties	
DRAMP31731	GVGSPYVSRLLGICL	15	p776	P04626##O18735##P06494##P70424		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Disrupting tumor-mediated mechanisms suppressing host immunity	Not available	Not available	Linear	Free	Free		L	Not available	Not available	21928125	Cancer Immunol Immunother. 2012 Mar;61(3):397-407.	Gritzapis AD, Voutsas IF, Baxevanis CN.	Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31732	LIAHNQVRQV	10	p85	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Disrupting tumor-mediated mechanisms suppressing host immunity	Not available	Not available	Linear	Free	Free		L	Not available	Not available	21928125	Cancer Immunol Immunother. 2012 Mar;61(3):397-407.	Gritzapis AD, Voutsas IF, Baxevanis CN.	Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP31733	GIIKKIIIKKI	11	Cationic Amphiphilic	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=160 µM); HL-60 (IC50>500 µM)	Human red blood cells: over the active concentration ranges against bacteria and cancer cells, there is little activity or toxicity against hRBCs	Linear	Free	Amidation		L	NIH 3T3: low toxic	Not available	21955251	Biomacromolecules. 2011 Nov 14;12(11):3839-43.	Hu J, Chen C, Zhang S, Zhao X, Xu H, Zhao X, Lu JR.	Designed antimicrobial and antitumor peptides with high selectivity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP31734	GIIKKIIIKKIIIKKI	16	Cationic Amphiphilic	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=15 µM); HL-60 (IC50=25 µM)	Human red blood cells: over the active concentration ranges against bacteria and cancer cells, there is little activity or toxicity against hRBCs	Linear	Free	Amidation		L	NIH 3T3: low toxic	Not available	21955251	Biomacromolecules. 2011 Nov 14;12(11):3839-43.	Hu J, Chen C, Zhang S, Zhao X, Xu H, Zhao X, Lu JR.	Designed antimicrobial and antitumor peptides with high selectivity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP31735	GIIKKIIIKKIIIKKIIIKKI	21	Cationic Amphiphilic	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (IC50=10 µM); HeLa (IC50=4 µM)	Human red blood cells: over the active concentration ranges against bacteria and cancer cells, there is little activity or toxicity against hRBCs	Linear	Free	Amidation		L	NIH 3T3: low toxic	Not available	21955251	Biomacromolecules. 2011 Nov 14;12(11):3839-43.	Hu J, Chen C, Zhang S, Zhao X, Xu H, Zhao X, Lu JR.	Designed antimicrobial and antitumor peptides with high selectivity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP31736	AAKKWAKAKWAKAKKWAKAA	20	Z10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (EC50>211 µM); Meth A (EC50>211 µM); MT-1 (EC50>211 µM)	Not available	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-244.	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31737	AAWKWAWAKKWAKAKKWAKAA	21	Z9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (EC50=13 µM); MT-1 (EC50=16 µM); Meth A (EC50=9 µM)	MRC-5: EC58=14 μM	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-244.	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31738	AWKKWAKAWKWAKAKWWAKAA	21	Z8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MT-1 (EC50=14 µM); Meth A (EC50=19 µM); HT-29 (EC50=23 µM)	MRC-5: EC57=17 μM	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-244.	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP31739	KAAKKAWKAAKKAAKWWKKAA	21	Z4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Meth A (EC50=155 µM); HT-29 (EC50=173 µM); MT-1 (EC50=68 µM)	MRC-5: EC53=78 μM	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-244.	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP31740	KAAKKAWKAAKKAWKAAKKAA	21	Z7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Meth A (EC50=15 µM); MT-1 (EC50=15 µM); HT-29 (EC50=21 µM)	MRC-5: EC56=20 μM	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-244.	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP31741	KAAKKAWKAWKKAAKAAWKKAA	22	Z3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MT-1 (EC50=128 µM); HT-29 (EC50>211 µM); Meth A (EC50>211 µM)	Not available	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-244.	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP31742	KAAKKAWKWAKKAAKWAKKAA	21	Z5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MT-1 (EC50=28 µM); Meth A (EC50=42 µM); HT-29 (EC50=67 µM)	MRC-5: EC54=27 μM	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-244.	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP31743	KAAKKWAKAAKKAAKAWKKAA	21	Z1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MT-1 (EC50=186 µM); HT-29 (EC50>211 µM); Meth A (EC50>211 µM)	Not available	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-244.	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP31744	KAAKKWAKAWKKAAKAWKKAA	21	Z2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MT-1 (EC50=173 µM); HT-29 (EC50>211 µM); Meth A (EC50>211 µM)	Not available	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-244.	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP31745	KWWKKAAKAAKKAAKAAKKWA	21	Z6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MT-1 (EC50=16 µM); Meth A (EC50=17 µM); HT-29 (EC50=31 µM)	MRC-5: EC55=23 μM	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-244.	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP31746	IELLQARGGCX	11	Peptide-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (IC50=2.17 µM); NCI-H358 (IC50=4.63 mM)	Not available	Linear	Free	Amidation	X(11)=Pemetrexed	L	Not available	Not available	22076954	J Pept Sci. 2011 Dec;17(12):805-11.	Miklán Z, Orbán E, Bánóczi Z, Hudecz F.	New pemetrexed-peptide conjugates: synthesis, characterization and in vitro cytostatic effect on non-small cell lung carcinoma (NCI-H358) and human leukemia (HL-60) cells	
DRAMP31747	IELLQARGGCXGGRRRRRRRR	21	Peptide-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H358 (IC50=2.19 µM); HL-60 (IC50=2.64 µM)	Not available	Linear	Free	Amidation	X(11)=Pemetrexed	L	Not available	Not available	22076954	J Pept Sci. 2011 Dec;17(12):805-11.	Miklán Z, Orbán E, Bánóczi Z, Hudecz F.	New pemetrexed-peptide conjugates: synthesis, characterization and in vitro cytostatic effect on non-small cell lung carcinoma (NCI-H358) and human leukemia (HL-60) cells	
DRAMP31748	RRRRRRRRGGCX	12	Peptide-3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (IC50=6.24 µM); NCI-H358 (IC50=8.41 µM)	Not available	Linear	Free	Amidation	X(12)=Pemetrexed	L	Not available	Not available	22076954	J Pept Sci. 2011 Dec;17(12):805-11.	Miklán Z, Orbán E, Bánóczi Z, Hudecz F.	New pemetrexed-peptide conjugates: synthesis, characterization and in vitro cytostatic effect on non-small cell lung carcinoma (NCI-H358) and human leukemia (HL-60) cells	
DRAMP31750	AFGMALKLLKKVL	13	MAC1/2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=16 µM); HeLa (IC50=16±3 µM); CCRF-CEM (IC50=17 µM)	Human erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=30±4 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CSCC[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP31751	GFGMAXKLLKKVL	13	MAC1/26	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=18 ± 1 µM); HeLa (IC50=8±2 µM); CCRF-CEM (IC50=9±2 µM)	Human erythrocytes: IC50=93 μM	Linear	Free	Amidation	X(6)=AC6C=cyclohexyl-1-carboxylic acid	L	HUVEC: IC50=16 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	
DRAMP31752	GFGMALKXLKKVL	13	MAC1/25	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CCRF-CEM (IC50=12±2 µM); SW480 (IC50=14 ± 1 µM); HeLa (IC50=7±1 µM)	Human erythrocytes: IC50=88 μM	Linear	Free	Amidation	X(6)=AC6C=cyclohexyl-1-carboxylic acid	L	HUVEC: IC50=13±2 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	
DRAMP31753	GFGMALKLXKKVL	13	MAC1/24	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CCRF-CEM (IC50=11 µM); SW480 (IC50=16 ± 1 µM); HeLa (IC50=8±2 µM)	Human erythrocytes: IC50=88 μM	Linear	Free	Amidation	X(6)=AC6C=cyclohexyl-1-carboxylic acid	L	HUVEC: IC50=15±3 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	
DRAMP31754	gfgmalkllkkvl	13	MAC1/1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CCRF-CEM (IC50=11 µM); HeLa (IC50=12±4 µM); SW480 (IC50=19±2 µM)	Human erythrocytes: IC50=152 μM	Linear	Free	Amidation		D	HUVEC: IC50=21±5 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CSCC[C@@H](NC(=O)CNC(=O)[C@@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CC(C)C)C(N)=O)C(C)C
DRAMP31755	GFGMALKLlKKVL	13	MAC1/16	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=32±2 µM); CCRF-CEM (IC50=70 µM); SW480 (IC50> 100 µM)	Human erythrocytes: IC50>200 μM	Linear	Free	Amidation	l=D-Leu	Mix	HUVEC: IC50=87±3 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CSCC[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP31756	GFGmALKLLKKVL	13	MAC1/19	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=21±4 µM); CCRF-CEM (IC50=43±11 µM); SW480 (IC50=68±2 µM)	Human erythrocytes: IC50>200 μM	Linear	Free	Amidation	m=D-Met	Mix	HUVEC: IC50=52±15 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CSCC[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP31757	GFGMaLKLLKKVL	13	MAC1/4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=15±5 µM); CCRF-CEM (IC50=29 µM); SW480 (IC50=49±9 µM)	Human erythrocytes: IC50>200 μM	Linear	Free	Amidation	a=D-Ala	Mix	HUVEC: IC50=56±2 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CSCC[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP31758	GfGMALKLLKKVL	13	MAC1/6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CCRF-CEM (IC50=15 µM); SW480 (IC50=29±3 µM); HeLa (IC50=8±2 µM)	Human erythrocytes: IC50=177 μM	Linear	Free	Amidation	f=D-Phe	Mix	HUVEC: IC50=21±5 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CSCC[C@H](NC(=O)CNC(=O)[C@@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP31759	GFGMALXLLXXVL	13	MAC1/20	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=10±1 µM); CCRF-CEM (IC50=25±3 µM); SW480 (IC50=35±4 µM)	Human erythrocytes: IC50>200 μM	Linear	Free	Amidation	X=Ornithine	L	HUVEC: IC50=33±3 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	
DRAMP31760	GFGMALRLLRRVL	13	MAC1/21	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=17±2 µM); CCRF-CEM (IC50=22±4 µM); HeLa (IC50=9±3 µM)	Human erythrocytes: IC50=72 μM	Linear	Free	Amidation		L	HUVEC: IC50=17±2 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CSCC[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP31761	GFkMALKLLKKVL	13	MAC1/10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=15±6 µM); CCRF-CEM (IC50=16 µM)	Human erythrocytes: IC50>200 μM	Linear	Free	Amidation	k=D-Lys	Mix	HUVEC: IC50=23 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CSCC[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP31762	GFKMALKLLKKVL	13	MAC1/9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=13±3 µM); CCRF-CEM (IC50=14±4 µM); HeLa (IC50=8±1 µM)	Human erythrocytes: IC50=199 μM	Linear	Free	Amidation		L	HUVEC: IC50=17±2 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP31763	GKFMSLLKHILK	12	HAL-2/24	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=34 µM); SW480 (IC50> 40 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=74±10 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP31764	GKWKKILGHLIR	12	HAL-1/19	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50> 100 µM); SW480 (IC50> 100 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50> 100 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31765	GKWKKILGKLIR	12	HAL-1/21	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=30±3 µM); SW480 (IC50> 100 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50> 100 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31766	GKWKSLLKHILK	12	HAL-2/1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=14±2 µM); SW480 (IC50> 100 µM); CCRF-CEM (IC50>40 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50> 100 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP31767	GKWLSLLKHILK	12	HAL-2/11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=14±3 µM); SW480 (IC50=40 µM)	Rat erythrocytes: IC50=65 μM	Linear	Free	Amidation		L	HUVEC: IC50=42±3 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP31768	GKWMKLLKHILK	12	HAL-2/2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=35±5 µM); HeLa (IC50=6±1 µM); CCRF-CEM (IC50>40 µM)	Rat erythrocytes: IC50=87.4 μM	Linear	Free	Amidation		L	HUVEC: IC50=40±4 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP31769	GMWSKLLGHLLR	12	HAL-1/15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=14±2 µM); SW480 (IC50> 40 µM); CCRF-CEM (IC50>40 µM)	Rat erythrocytes: IC50=62 μM	Linear	Free	Amidation		L	HUVEC: IC50=26±6 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31770	GTGLPMSERRKIMLMMR	17	MAC2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CCRF-CEM (IC50=32 µM); HeLa (IC50> 100 µM); SW480 (IC50> 100 µM)	Human erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50> 100 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31771	KMWSKILGHLIR	12	HAL-1/17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=35±3 µM); SW480 (IC50> 100 µM)	Rat erythrocytes: IC50>200  μM	Linear	Free	Amidation		L	HUVEC: IC50> 100 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31772	KNWKKXLKKXIKXVK	15	LL-III/22	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=11±7 µM); CCRF-CEM (IC50=25±4 µM); SW480 (IC50> 100 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation	X=Aib=1-amino-isobutyric acid	L	HUVEC: IC50> 100 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	
DRAMP31773	KNWKKILGKIIKVVK	15	LL-III/10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CCRF-CEM (IC50=9 µM); HeLa (IC50=9±4 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=35±11 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP31774	KNWKKILKKIIKVVK	15	LL-III/18	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=3 µM); CCRF-CEM (IC50=7±2 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=22±8 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP31775	LFGMALKLLKKVL	13	MAC1/3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=11±1 µM); CCRF-CEM (IC50=22 µM); HeLa (IC50=9±2 µM)	Human erythrocytes: IC50=53 μM	Linear	Free	Amidation		L	HUVEC: IC50=27±5 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CSCC[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP31776	NKWKKILGKIIKVVK	15	LL-III/34	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=37 µM); HeLa (IC50=5±2 µM); CCRF-CEM (IC50=5±3 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=52±7 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP31777	VNFKKLLGKLLKVVK	15	LL-III/15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=42 µM); HeLa (IC50=7±1 µM); CCRF-CEM (IC50=9±3 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=≥70 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP31778	VNXKKLLGKLLKVVK	15	LL-III/16	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=6±1 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation	X=Nal=3-(1-naphthyl)alanine	L	HUVEC: IC50=15±1 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	
DRAMP31779	VNWKKXLGKXIKXVK	15	LL-III/19	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=28 µM); HeLa (IC50=3±1 µM); CCRF-CEM (IC50=8±2 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation	X=Aib=1-amino-isobutyric acid	L	HUVEC: IC50=38±6 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	
DRAMP31780	VNWKKIILGKIIKVVK	16	LL-III/11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CCRF-CEM (IC50=4±1 µM); SW480 (IC50=48 µM); HeLa (IC50=8±1 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=50± μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP31781	vnwkkilgkiikvvk	15	LL-III/12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=20 µM); CCRF-CEM (IC50=5±2 µM); HeLa (IC50=6±2 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		D	HUVEC: IC50=17±3 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@H](C)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](N)C(C)C)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(N)=O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC
DRAMP31782	VNWKKVLAKIIKVVK	15	LL-III/37	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=13 µM); CCRF-CEM (IC50=4±1 µM); SW480 (IC50=5±1 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=18±2 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)[C@H](C)CC
DRAMP31783	VNWKKILGKIKKVVK	15	LL-III/4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CCRF-CEM (IC50=18 µM); HeLa (IC50=7±1 µM); SW480 (IC50> 40 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50> 80 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)[C@H](C)CC
DRAMP31784	VNWKKLLGKLLKVVK	15	LL-III/23	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=15 µM); HeLa (IC50=4 µM); CCRF-CEM (IC50=6 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=12±3 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP31785	vnwkkllgkllkvvk	15	LL-III/25	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=20 µM); CCRF-CEM (IC50=4 µM); HeLa (IC50=4±2 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		D	HUVEC: IC50=12±3 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC(C)C[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](N)C(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP31786	VNWKKVLGKVVKVVK	15	LL-III/27	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=13±2 µM); CCRF-CEM (IC50=18 µM); SW480 (IC50> 100 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50> 100 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP31787	VNWXXILGXIIXVVX	15	LL-III/24	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=20 µM); HeLa (IC50=3±1 µM); CCRF-CEM (IC50=5±2 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation	X=Ornithine	L	HUVEC: IC50=20±4 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	
DRAMP31788	VNWRRILGRIIRVVR	15	LL-III/17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=9 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=11±4 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP31789	VYWKKILGKIIKVVK	15	LL-III/26	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=30 µM); HeLa (IC50=5±1 µM); CCRF-CEM (IC50=6 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=18±1 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26.	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP31790	KVKVKVKVpPTKVKVKVK	18	SVS-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=4.9±0.6µM); MDA-MB-436 (IC50=5.6±0.5µM); KB (IC50=6.3±0.7µM); MCF-7 (IC50=8.1±0.8µM)	Human erythrocytes: 50% Hemolysis=80.8±12.8µM	Linear	Free	Free	p=D-Pro	Mix	Not available	Not available	22413859	J Am Chem Soc. 2012 Apr 11;134(14):6210-7.	Sinthuvanich C, Veiga AS, Gupta K, Gaspar D, Blumenthal R, Schneider JP.	Anticancer ?-hairpin peptides: membrane-induced folding triggers activity	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31791	kvkvkvkvPptkvkvkvk	18	SVS-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-436 (IC50=3.2±0.4µM); A549 (IC50=3.2±0.6µM); KB (IC50=4.5±0.5µM); MCF-7 (IC50=4.7±0.4µM)	Not available	Linear	Free	Free	k=D-Lys; v=D-Val; p=D-Pro; t=D-Thr	Mix	Not available	Not available	22413859	J Am Chem Soc. 2012 Apr 11;134(14):6210-7.	Sinthuvanich C, Veiga AS, Gupta K, Gaspar D, Blumenthal R, Schneider JP.	Anticancer ?-hairpin peptides: membrane-induced folding triggers activity	CC(C)[C@@H](NC(=O)[C@H](N)CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)[C@H](C)O)C(C)C)C(C)C)C(C)C
DRAMP31792	KVKVKVKVPPTKVKVKVK	18	SVS-3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>100µM); KB (IC50>100µM); MCF-7 (IC50>100µM); MDA-MB-436 (IC50>100µM)	Not available	Linear	Free	Free		L	Not available	Not available	22413859	J Am Chem Soc. 2012 Apr 11;134(14):6210-7.	Sinthuvanich C, Veiga AS, Gupta K, Gaspar D, Blumenthal R, Schneider JP.	Anticancer ?-hairpin peptides: membrane-induced folding triggers activity	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31793	GIPCAESCVWIPCTITALMGCSCKNNVCYNN	31	Chassatide C2	I0B6F2		Not found	Chassalia chartacea	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=2.4 μM)	Human erythrocytes: HD50>25 μM	Cyclic	Free	Free		L	Not available	Not available	22467870	J Biol Chem. 2012 May 18;287(21):17598-17607.	Nguyen GKT, Lim WH, Nguyen PQT, Tam JP.	Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O
DRAMP31794	GIPCAESCVWIPCTITALXGCSCKNNVCYNN	31	Chassatide C2A	I0B6F2		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50>15 μM)	Human erythrocytes: HD50>25 μM	Cyclic	Free	Free	X=MetO (Methionine sulfoxide)	L	Not available	Not available	22467870	J Biol Chem. 2012 May 18;287(21):17598-17607.	Nguyen GKT, Lim WH, Nguyen PQT, Tam JP.	Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities	
DRAMP31795	IPCGESCVWIPCISGXFGCSCKDKVCYS	28	Chassatide C11A	C0HKH6		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50>15 μM)	Human erythrocytes: HD50>25 μM	Cyclic	Free	Free	X=MetO (Methionine sulfoxide)	L	Not available	Not available	22467870	J Biol Chem. 2012 May 18;287(21):17598-17607.	Nguyen GKT, Lim WH, Nguyen PQT, Tam JP.	Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities	
DRAMP31796	PLLQATLGGGS	11	P7	Not available		Not found	No information found in the references	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: B16-F10 (IC50=1 µM)	Not available	Linear	Free	Free		L	Not available	Angiogenic factor FGF2	22481251	J Cancer Res Clin Oncol. 2012 Aug;138(8):1321-8.	Yu Y, Gao S, Li Q, Wang C, Lai X, Chen X, Wang R, Di J, Li T, Wang W, Wu X.	The FGF2-binding peptide P7 inhibits melanoma growth in vitro and in vivo	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP31797	LLRHVVKILEKYL	13	Temporin-La	Not available		Not found	Temporins family	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	A membrane-disturbing action seems to be the major mechanism for cell death	Tumor cells: MEC (24.15Inhibition ratio at 50 µg/ml); HL-7702(L-02) (37.22 Inhibition ratio at 50 µg/ml); A549 (45.62 Inhibition ratio at 50 µg/ml); BGC-823 (48.19 Inhibition ratio at 50 µg/ml); Hep-G2 (50.90 Inhibition ratio at 50 µg/ml); HeLa (52.32 Inhibition ratio at 50 µg/ml); SMMC-7721 (52.77 Inhibition ratio at 50 µg/ml); SW1116 (57.62 Inhibition ratio at 50 µg/ml)	Showed no hemolytic activity against rabbit erythrocytes and human erythrocytes at 250 µg/ml	Linear	Free	Free		L	Showed little effects on the proliferation of the 293T human embryonic kidney cell line, MECs, and human lymphomonocytes at concentrations of less than 50 µg/ml	Not available	22641352	J Pept Sci. 2012 Jul;18(7):476-86.	Diao Y, Han W, Zhao H, Zhu S, Liu X, Feng X, Gu J, Yao C, Liu S, Sun C, Pan F.	Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31798	LLRHVVKILSKYL	13	Temporin-Las	Not available		Not found	Temporins family	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	A membrane-disturbing action seems to be the major mechanism for cell death	Tumor cells: MEC (27.99 Inhibition ratio at 50 µg/ml); HL-7702(L-02) (37.00 Inhibition ratio at 50 µg/ml); A549 (50.64 Inhibition ratio at 50 µg/ml); BGC-823 (50.85 Inhibition ratio at 50 µg/ml); Hep-G2 (55.98 Inhibition ratio at 50 µg/ml); HeLa (56.81 Inhibition ratio at 50 µg/ml); SMMC-7721 (59.37 Inhibition ratio at 50 µg/ml); SW1116 (62.73 Inhibition ratio at 50 µg/ml)	Showed no hemolytic activity against rabbit erythrocytes and human erythrocytes at 250 µg/ml	Linear	Free	Free		L	Showed little effects on the proliferation of the 293T human embryonic kidney cell line, MECs, and human lymphomonocytes at concentrations of less than 50 µg/ml	Not available	22641352	J Pept Sci. 2012 Jul;18(7):476-86.	Diao Y, Han W, Zhao H, Zhu S, Liu X, Feng X, Gu J, Yao C, Liu S, Sun C, Pan F.	Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31799	RGDLLRHVVKILEKYL	16	RGD-La	Not available		Not found	Arg-Gly-Asp(RGD) tripeptide ana temporins	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	A membrane-disturbing action seems to be the major mechanism for cell death	Tumor cells: MEC (19.76 Inhibition ratio at 50 µg/ml); HL-7702(L-02) (36.25 Inhibition ratio at 50 µg/ml); A549 (47.26Inhibition ratio at 50 µg/ml); Hep-G2 (60.22 Inhibition ratio at 50 µg/ml); BGC-823 (62.49 Inhibition ratio at 50 µg/ml); SMMC-7721 (70.39 Inhibition ratio at 50 µg/ml); SW1116 (72.69 Inhibition ratio at 50 µg/ml); HeLa (73.09 Inhibition ratio at 50 µg/ml)	Showed no hemolytic activity against rabbit erythrocytes and human erythrocytes at 250 µg/ml	Linear	Free	Free		L	Showed little effects on the proliferation of the 293T human embryonic kidney cell line, MECs, and human lymphomonocytes at concentrations of less than 50 µg/ml	Not available	22641352	J Pept Sci. 2012 Jul;18(7):476-86.	Diao Y, Han W, Zhao H, Zhu S, Liu X, Feng X, Gu J, Yao C, Liu S, Sun C, Pan F.	Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP31800	RGDLLRHVVKILSKYL	16	RGD-Las	Not available		Not found	Arg-Gly-Asp(RGD) tripeptide ana temporins	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	A membrane-disturbing action seems to be the major mechanism for cell death	Tumor cells: MEC (29.33 Inhibition ratio at 50 µg/ml); HL-7702(L-02) (38.13 Inhibition ratio at 50 µg/ml); A549 (52.50 Inhibition ratio at 50 µg/ml); Hep-G2 (73.07 Inhibition ratio at 50 µg/ml); BGC-823 (73.705 Inhibition ratio at 50 µg/ml); HeLa (78.045 Inhibition ratio at 50 µg/ml); SW1116 (81.465 Inhibition ratio at 50 µg/ml); SMMC-7721 (86.175 Inhibition ratio at 50 µg/ml)	Showed no hemolytic activity against rabbit erythrocytes and human erythrocytes at 250 µg/ml	Linear	Free	Free		L	Showed little effects on the proliferation of the 293T human embryonic kidney cell line, MECs, and human lymphomonocytes at concentrations of less than 50 µg/ml	Not available	22641352	J Pept Sci. 2012 Jul;18(7):476-86.	Diao Y, Han W, Zhao H, Zhu S, Liu X, Feng X, Gu J, Yao C, Liu S, Sun C, Pan F.	Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP31801	PDEDAINDALNKVCSTGRRQRSICKQLLKK	30	N29D	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Lyse cancer cells	Tumor cells: SNU-1 (<100% cell viability at 5 µM); SNU-1 (<40% cell viability at 50 µM); U-937 (<60% cell viability at 50 µM); SW480 (>100% cell viability at 5 µM); U-937 (100% cell viability at 5 µM); SW480 (60% cell viability at 50 µM)	Not available	Linear	Free	Free		L	Not available	Not available	22783018	Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12087-92.	Lee MO, Kim EH, Jang HJ, Park MN, Woo HJ, Han JY, Womack JE.	Effects of a single nucleotide polymorphism in the chicken NK-lysin gene on antimicrobial activity and cytotoxicity of cancer cells	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC
DRAMP31802	PDEDAINNALNKVCSTGRRQRSICKQLLKK	30	N29N	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Lyse cancer cells	Tumor cells: SNU-1 (<100% cell viability at 5 µM); SNU-1 (<20% cell viability at 50 µM); U-937 (<40% cell viability at 50 µM); SW480 (100% cell viability at 5 µM); U-937 (100% cell viability at 5 µM); SW480 (40% cell viability at 50 µM)	Not available	Linear	Free	Free		L	Not available	Not available	22783018	Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12087-92.	Lee MO, Kim EH, Jang HJ, Park MN, Woo HJ, Han JY, Womack JE.	Effects of a single nucleotide polymorphism in the chicken NK-lysin gene on antimicrobial activity and cytotoxicity of cancer cells	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC
DRAMP31803	KWKSFLKTFKSlKKTVLHTLLKAISS	26	Peptide L12D	Not available		Not found	Acetylation	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=2.63±0.07 µmol/L)	Human red blood cells: MHC=20.81±0.03 μmol/L	Linear	Acetylation	Amidation		Mix	Not available	Not available	22837667	Int J Mol Sci. 2012;13(6):6849-6862. 	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP31804	KWKSFLKTFKSLKKTVLHTlLKAISS	26	Peptide L20D	Not available		Not found	Acetylation	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=2.33±0.06 µmol/L)	Human red blood cells: MHC=20.81 +0.13 μmol/L	Linear	Acetylation	Amidation		Mix	Not available	Not available	22837667	Int J Mol Sci. 2012;13(6):6849-6862. 	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP31805	KWKSFlKTFKSLKKTVLHTLLKAISS	26	Peptide L6D	Not available		Not found	Acetylation	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=2.23±0.10 µmol/L)	Human red blood cells: MHC=10.40±0.08 μmol/L	Linear	Acetylation	Amidation		Mix	Not available	Not available	22837667	Int J Mol Sci. 2012;13(6):6849-6862. 	Huang YB, He LY, Jiang HY, Chen YX.	Role of helicity on the anticancer mechanism of action of cationic-helical peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP31806	GLFGKLIKKFARKAISYAVKKARGKH	26	ltc2aG11A	Not available		Not found	Central Asian spider, Lachesana tarabaevi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22885172	Biochim Biophys Acta. 2012 Dec;1818(12):3072-80.	Won A, Ruscito A, Ianoul A.	Imaging the membrane lytic activity of bioactive peptide latarcin 2a	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP31807	KKWXWKK	7	c1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=10±2 μM); Ramos (IC50=22±5 μM)	Human red blood cells: EC50=87 μM	Cyclic	lactam	lactam	X=2-Nal-CH2-	L	MRC-5: IC50=10±1 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31808	KKWXWKK	7	c1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=11±2 μM); Ramos (IC50=23±3 μM)	Human red blood cells: EC50=87 μM	Cyclic	lactam	lactam	X=2-Nal-CH2-	L	MRC-5: IC50=10±1 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31809	KKWXWKK	7	c5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=10±2 μM); Ramos (IC50=22±5 μM)	Human red blood cells: EC50=141 μM	Cyclic	lactam	lactam	X=p-CF3-Bzl-	L	MRC-5: IC50=26±3 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31810	KKWXWKK	7	c5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=11±2 μM); Ramos (IC50=23±3 μM)	Human red blood cells: EC50=141 μM	Cyclic	lactam	lactam	X=p-CF3-Bzl-	L	MRC-5: IC50=26±3 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31811	KKXWKK	6	c3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=15±2 μM); Ramos (IC50=92±2 μM)	Human red blood cells: EC50=256 μM	Cyclic	lactam	lactam	X=2-Nal-CH2-	L	MRC-5: IC50=1030±21 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31812	KKXWKK	6	c3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=157±30 μM); Ramos (IC50=16±5 μM)	Human red blood cells: EC50=256 μM	Cyclic	lactam	lactam	X=2-Nal-CH2-	L	MRC-5: IC50=1030±21 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31813	KKXWKK	6	c7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=15±2 μM); Ramos (IC50=92±2 μM)	denotes no detectable activity (IC50 or EC50) within the concentration range tested	Cyclic	lactam	lactam	X=p-CF3-Bzl-	L	MRC-5: IC50=31±2 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31814	KKXWKK	6	c7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=157±30 μM); Ramos (IC50=16±5 μM)	denotes no detectable activity (IC50 or EC50) within the concentration range tested	Cyclic	lactam	lactam	X=p-CF3-Bzl-	L	MRC-5: IC50=31±2 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31815	KWXKK	5	c4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=12.6±0.6 μM); Ramos (IC50=99±15 μM)	Human red blood cells: EC50=110 μM	Cyclic	lactam	lactam	X=2-Nal-CH2-	L	MRC-5: IC50=23.5±0.7 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31816	KWXKK	5	c4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=20±2 μM); Ramos (IC50=226±21 μM)	Human red blood cells: EC50=110 μM	Cyclic	lactam	lactam	X=2-Nal-CH2-	L	MRC-5: IC50=23.5±0.7 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31817	KWXKK	5	c8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=12.6±0.6 μM); Ramos (IC50=99±15 μM)	Human red blood cells: EC50=298 μM	Cyclic	lactam	lactam	X=p-CF3-Bzl-	L	MRC-5: IC50=53±2 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31818	KWXKK	5	c8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=20±2 μM); Ramos (IC50=226±21 μM)	Human red blood cells: EC50=298 μM	Cyclic	lactam	lactam	X=p-CF3-Bzl-	L	MRC-5: IC50=53±2 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31819	KWXWKK	6	c2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=1.71±0.6 μM); Ramos (IC50=7.9±0.3 μM)	Human red blood cells: EC50=31 μM	Cyclic	lactam	lactam	X=2-Nal-CH2-	L	MRC-5: IC50=13±1 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31820	KWXWKK	6	c2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=26±2 μM); Ramos (IC50=8±1 μM)	Human red blood cells: EC50=31 μM	Cyclic	lactam	lactam	X=2-Nal-CH2-	L	MRC-5: IC50=13±1 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31821	KWXWKK	6	c6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=1.71±0.6 μM); Ramos (IC50=7.9±0.3 μM)	Human red blood cells: EC50=36 μM	Cyclic	lactam	lactam	X=p-CF3-Bzl-	L	MRC-5: IC50=23±1 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31822	KWXWKK	6	c6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Ramos (IC50=26±2 μM); Ramos (IC50=8±1 μM)	Human red blood cells: EC50=36 μM	Cyclic	lactam	lactam	X=p-CF3-Bzl-	L	MRC-5: IC50=23±1 μM	Not available	22933412	J Pept Sci. 2012 Oct;18(10):609-19.	Tørfoss V, Isaksson J, Ausbacher D, Brandsdal BO, Flaten GE, Anderssen T, Cavalcanti-Jacobsen Cde A, Havelkova M, Nguyen LT, Vogel HJ, Strøm MB.	Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid	
DRAMP31823	FLGALFHALSKLL	13	PTP-7a	P80399		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induced cell tissue damage through a new cell lysis mechanism 	Tumor cells: A549 (IC50=28 µM); PANC-1 (IC50=57 μM )	Human erythrocytes: 6.8% Hemolysis=30 µM	Linear	Free	Free		L	MCF-10A: IC50=32 μM	Not available	22934601	Biomacromolecules. 2012 Oct 8;13(10):3327-33.	Chen L, Patrone N, Liang JF.	Peptide Self-Assembly on Cell Membranes to Induce Cell Lysis	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP31824	FLGALFKALSHLL	13	PTP-7b	P80399		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induced cell tissue damage through a new cell lysis mechanism 	Tumor cells: A549 (IC50=32 µM); PANC-1 (IC50=77 μM )	Human erythrocytes: 8.8% Hemolysis=30 µM	Linear	Free	Free		L	MCF-10A: IC50=56 μM	Not available	22934601	Biomacromolecules. 2012 Oct 8;13(10):3327-33.	Chen L, Patrone N, Liang JF.	Peptide Self-Assembly on Cell Membranes to Induce Cell Lysis	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP31825	RRRRRNWMWC	10	9R	Not available		Not found	Nullomer derived anticancer peptides (NulloPs):	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: J774A.1 (IC50=12 µM); MDA-MB-231 (IC50=16 µM); LNCaP (IC50=23 µM); HuT 102 (IC50=25 µM); LNCaP (IC50=28 µM); MDA-MB-231 (IC50=29 µM); HuT 102 (IC50=36 µM); HuT 102 (IC50=37 µM); HuT 102 (IC50=39 µM); MDA-MB-231 (IC50=39 µM); LNCaP (IC50=44 µM); J774A.1 (IC50=47 µM); HuT 102 (IC50=93 µM)	no hemolytic effect on human RBCs	Linear	Free	Amidation		L	Not available	Not available	23000474	Peptides. 2012 Dec;38(2):302-11.	Alileche A, Goswami J, Bourland W, Davis M, Hampikian G.	Nullomer derived anticancer peptides (NulloPs): differential lethal effects on normal and cancer cells in vitro	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(N)=O
DRAMP31826	RRRRRWCMNW	10	9S1R	Not available		Not found	Nullomer derived anticancer peptides (NulloPs):	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50=10 µM); MDA-MB-231 (IC50=12 µM); J774A.1 (IC50=17 µM); MDA-MB-231 (IC50=18 µM); J774A.1 (IC50=26 µM); LNCaP (IC50=26 µM); HuT 102 (IC50=36 µM); HuT 102 (IC50=38 µM); HuT 102 (IC50=43 µM); HuT 102 (IC50=43 µM); HuT 102 (IC50=45 µM); LNCaP (IC50=8 µM); LNCaP (IC50=9 µM)	significant hemolytic activity	Linear	Free	Amidation		L	Not available	Not available	23000474	Peptides. 2012 Dec;38(2):302-11.	Alileche A, Goswami J, Bourland W, Davis M, Hampikian G.	Nullomer derived anticancer peptides (NulloPs): differential lethal effects on normal and cancer cells in vitro	CSCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP31827	PPPEE	5	Caseinphosphopeptides	Not available		Not found	Bovine milk	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AZ-97 (Inhibition at 24-28 g/l)	Not available	Linear	Free	Amidation		L	Not available	Not available	23533710	J Amino Acids. 2013;2013:939804.	Pepe G, Tenore GC, Mastrocinque R, Stusio P, Campiglia P.	Potential anticarcinogenic peptides from bovine milk	NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1
DRAMP31828	RYLGYL	6	αs1-casein f(90_95)	Not available		Not found	Bovine milk	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AZ-97 (Inhibition at 12-15 g/l)	Not available	Linear	Free	Amidation		L	Not available	Not available	23533710	J Amino Acids. 2013;2013:939804.	Pepe G, Tenore GC, Mastrocinque R, Stusio P, Campiglia P.	Potential anticarcinogenic peptides from bovine milk	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP31829	YPFPG	5	β-Casomorphins 5 f(60_64)	Not available		Not found	Bovine milk	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AZ-97 (Inhibition at 9-11 g/l)	Not available	Linear	Free	Amidation		L	Not available	Not available	23533710	J Amino Acids. 2013;2013:939804.	Pepe G, Tenore GC, Mastrocinque R, Stusio P, Campiglia P.	Potential anticarcinogenic peptides from bovine milk	NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1
DRAMP31830	CLBKKLFKKILKKL	14	BP325	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=12.0 ± 2.7 µM); CAPAN-1 (IC50=13.7 ± 2.4 µM); E42/02 (IC50>>100 µM); E42/02 (IC50>>100 µM); E42/02 (IC50>>100 µM); E42/02 (IC50>>100 µM)	Not available	Linear	Free	Amidation		L	NIH 3T3: IC50=20.6 ± 3.3 µM	Not available	24480922	Org Biomol Chem. 2014 Mar 14;12(10):1652-63.	Soler M, González-Bártulos M, Soriano-Castell D, Ribas X, Costas M, Tebar F, Massaguer A, Feliu L, Planas M.	Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties	
DRAMP31831	RWRWRWX	7	C -C8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=4.5µM); MCF-7 (IC50=4.7µM)	Human erythrocytes:16% Hemolysis=142µM; 50% Hemolysis=285µM	Linear	Free	Amidation	X=Lysine with Octanoylated side group	L	Human fibroblasts: IC50=31.3µM	Not available	24147906	ACS Comb Sci. 2013 Nov 11;15(11):585-92.	Albada HB, Prochnow P, Bobersky S, Langklotz S, Bandow JE, Metzler-Nolte N.	Short antibacterial peptides with significantly reduced hemolytic activity can be identified by a systematic L-to-D exchange scan of their amino acid residues	
DRAMP31832	YGRKKRRQRRRREADFFWSLCTA	23	KilerFLIP-E 	Not available		Not found	The C-terminal domain of c-FLIP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP (At 20 μM,  about 30% Trypan blue-negative cells); PC-3-TR (At 20 μM,  about 30% Trypan blue-negative cells); RS4;11 (At 20 μM, 10.4% Trypan blue-negative cells); MV4-11 (At 20 μM, 10.8% Trypan blue-negative cells); HCT 115 (At 20 μM, 40% Trypan blue-negative cells); K562 (At 20 μM, 7.7% Trypan blue-negative cells); PC-3 (At 20 μM, about 50% Trypan blue-negative cells); HCT 116 (At 20 μM, about 70% Trypan blue-negative cells)	Not available	Linear	Free	Free		L	No toxicity was observed in epithelial and endothelial cells (HPDE and HUVEC, respectively)	Not available	24176852	Cell Death Dis. 2013 Oct 31;4(10):e894.	Pennarun B, Gaidos G, Bucur O, Tinari A, Rupasinghe C, Jin T, Dewar R, Song K, Santos MT, Malorni W, Mierke D, Khosravi-Far R.	killerFLIP: a novel lytic peptide specifically inducing cancer cell death	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP31833	GIIKKIIKKI	10	Short α-helical peptides	Not available		Not found	Alpha-helical proteins	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	In addition to rapid membrane-permeabilizing capacities, the peptides can also induce the programmed cell death of cancer cells via both mitochondrial pathway and death receptor pathway, without inducing non-specific immunogenic responses.	Tumor cells: HL-60 (100% Cytotoxicity at 5 µM Approx); HeLa (99% Cytotoxicity at 4 µM Approx)	Not available	Linear	Free	Amidation		L	Not available	Not available	24246647	Biomaterials. 2014 Feb;35(5):1552-61.	Chen C, Hu J, Zeng P, Pan F, Yaseen M, Xu H, Lu JR.	Molecular mechanisms of anticancer action and cell selectivity of short α-helical peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP31834	GIIKKIIKKIIKKI	14	Short α-helical peptides	Not available		Not found	Alpha-helical proteins	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	In addition to rapid membrane-permeabilizing capacities, the peptides can also induce the programmed cell death of cancer cells via both mitochondrial pathway and death receptor pathway, without inducing non-specific immunogenic responses.	Tumor cells: HL-60 (90% Cytotoxicity at 5 µM Approx); HeLa (95% Cytotoxicity at 4 µM Approx)	Human erythrocytes: HC50>250 µM	Linear	Free	Amidation		L	Human keratinocytes HaCat: <5% Killing=40 µM	Not available	24246647	Biomaterials. 2014 Feb;35(5):1552-61.	Chen C, Hu J, Zeng P, Pan F, Yaseen M, Xu H, Lu JR.	Molecular mechanisms of anticancer action and cell selectivity of short α-helical peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP31835	GIIKKIIKKIIKKIIKKI	18	Short α-helical peptides	Not available		Not found	Alpha-helical proteins	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	In addition to rapid membrane-permeabilizing capacities, the peptides can also induce the programmed cell death of cancer cells via both mitochondrial pathway and death receptor pathway, without inducing non-specific immunogenic responses.	Tumor cells: HL-60 (70% Cytotoxicity at 5 µM Approx); HeLa (80% Cytotoxicity at 4 µM Approx)	Not available	Linear	Free	Amidation		L	Not available	Not available	24246647	Biomaterials. 2014 Feb;35(5):1552-61.	Chen C, Hu J, Zeng P, Pan F, Yaseen M, Xu H, Lu JR.	Molecular mechanisms of anticancer action and cell selectivity of short α-helical peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP31836	CREKAKKLFKKILKKL	16	BP327	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=74.7±8.8µM); CAPAN-1 (IC50=76.2±0.8µM)	Not available	Linear	Free	Amidation		L	NIH 3T3: IC50=74.5±4.1µM	Not available	24480922	Org Biomol Chem. 2014 Mar 14;12(10):1652-63.	Soler M, González-Bártulos M, Soriano-Castell D, Ribas X, Costas M, Tebar F, Massaguer A, Feliu L, Planas M.	Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP31837	RRLFRRILRRL	11	BP308	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=148.2±8.8µM); CAPAN-1 (IC50=97.0±15.4µM)	Human erythrocytes: 1±0.1% Hemolysis=150µM	Linear	Free	Amidation		L	NIH 3T3: IC50=68.0±7.6µM	Not available	24480922	Org Biomol Chem. 2014 Mar 14;12(10):1652-63.	Soler M, González-Bártulos M, Soriano-Castell D, Ribas X, Costas M, Tebar F, Massaguer A, Feliu L, Planas M.	Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP31838	RLGDGCTR	8	cyclosaplin	Not available		Not found	somatic seedlings of sandalwood	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50=2.06 μg/mL)	Not available	Cyclic	Free	Free		L	Normal fibroblast (L929) cell line: Peptide (0–1000 μg/mL) did not exhibit any cytotoxicity.	Not available	24503375	Peptides. 2014 Apr;54:148-58.	Mishra A, Gauri SS, Mukhopadhyay SK, Chatterjee S, Das SS, Mandal SM, Dey S.	Identification and structural characterization of a new pro-apoptotic cyclic octapeptide cyclosaplin from somatic seedlings of Santalum album L	CC(C)C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP31839	FFGRLKSVWSAVKHGWKAAKSR	22	Trichoplaxin	Not available		Not found	Trichoplax adhaerens	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=45-50µM)	Rat erythrocytes:20% Hemolysis=800µM	Linear	Free	Free		L	Not available	Not available	24530880	Biochim Biophys Acta. 2014 May;1838(5):1430-8.	Simunić J, Petrov D, Bouceba T, Kamech N, Benincasa M, Juretić D.	Trichoplaxin - a new membrane-active antimicrobial peptide from placozoan Cdna	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
DRAMP31840	HGFQWPGSWTWENGKWTWKGAYQFLKGGGGSRRRRRRRRR	40	APTSTAT3-9R	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	With the addition of a cell-penetrating motif, the resulting APTSTAT3-9R aptide was able to suppress the viability and proliferation of cancer cells by blocking STAT3 phosphorylation, thereby inhibiting STAT3 downstream signaling.	Tumor cells: A549 (IC50=10-20 μmol/L)	Not available	Linear	Free	Free		L	Not available	STAT3	24576829	Cancer Res. 2014 Apr 15;74(8):2144-51.	Kim D, Lee IH, Kim S, Choi M, Kim H, Ahn S, Saw PE, Jeon H, Lee Y, Jon S.	A Specific STAT3-Binding Peptide Exerts Antiproliferative Effects and Antitumor Activity by Inhibiting STAT3 Phosphorylation and Signaling	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31841	KKCKFFCKVKKKIKSIGFQIPIVSIPFK	28	Cathelicidin-RC1	Not available		Not found	Lithobates catesbeiana	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (At 200 µg/ml induced 2.5% cell death); HepG2 (At 200 µg/ml induced 4.3% cell death)	Human erythrocytes:0% Hemolysis=100µg/ml; 3% Hemolysis=200µg/ml	Linear	Free	Free		L	L929: At 200 µg/ml induced 1.1% cell death	Not available	24675879	PLoS One. 2014 Mar 27;9(3):e93216.	Ling G, Gao J, Zhang S, Xie Z, Wei L, Yu H, Wang Y.	Cathelicidins from the bullfrog Rana catesbeiana provides novel template for peptide antibiotic design	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP31842	KAQXQKQAW	9	LTX-328	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: FEMX-I (IC50>350 µM)	Not available	Linear	Free	Amidation	X=Dip=diphenylalanine	L	Not available	Not available	24676901	Cancer Immunol Immunother. 2014 Jun;63(6):601-13.	Camilio KA, Berge G, Ravuri CS, Rekdal O, Sveinbjørnsson B.	Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315	
DRAMP31843	TKPRKTKPRKTKPRKTKPR	19	T Peptide	Not available		Not found	Tuftsin derivative	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BGC-823 (67.2% maximum inhibitory rate at 8 mg/kg); Hep-G2 (69.6% maximum inhibitory rate at 8 mg/kg); HT-29 (70% maximum inhibitory rate at 8 mg/kg)	Not available	Linear	Free	Free		L	Not available	Not available	24714081	Anticancer Drugs. 2014 Sep;25(8):857-67.	An Y, Li L, Yang D, Jia N, Xu C, Wang Q, Wang S, Yuan S.	Anticancer activity of tuftsin-derived T peptide in postoperative residual tumors	C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP31844	ESFSDWWKLLAE	12	mt_T18S/L22 W/P27A	Not available		Not found	MDM2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	target the p53–MDM4 interaction	Tumor cells: MCF-7 (IC50=27 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	24830845	Amino Acids. 2014 Aug;46(8):2015-24.	Fang Y, Jin R, Gao Y, Gao J, Wang J.	Design of p53-derived peptides with cytotoxicity on breast cancer	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](C)C(=O)O
DRAMP31845	ETFADWWKLLAE	12	mt_S20A/L22 W/P27A	Not available		Not found	MDM2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	target the p53–MDM5 interaction	Tumor cells: MCF-7 (IC50=8.7 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	24830845	Amino Acids. 2014 Aug;46(8):2015-24.	Fang Y, Jin R, Gao Y, Gao J, Wang J.	Design of p53-derived peptides with cytotoxicity on breast cancer	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)O
DRAMP31846	ETFSDWWKLLAE	12	mt_L22 W/P27A	Not available		Not found	MDM2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	target the p53–MDM2 interaction	Tumor cells: MCF-7 (IC50=16.3 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	24830845	Amino Acids. 2014 Aug;46(8):2015-24.	Fang Y, Jin R, Gao Y, Gao J, Wang J.	Design of p53-derived peptides with cytotoxicity on breast cancer	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)O
DRAMP31847	LTFSDWWKLLAE	12	mt_E17L/L22 W/P27A	Not available		Not found	MDM2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	target the p53–MDM3 interaction	Tumor cells: MCF-7 (IC50=15.1 µM)	Not available	Linear	Free	Free		L	Not available	MDM2	24830845	Amino Acids. 2014 Aug;46(8):2015-24.	Fang Y, Jin R, Gao Y, Gao J, Wang J.	Design of p53-derived peptides with cytotoxicity on breast cancer	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)O
DRAMP31848	KILRGVAKKIMRTFLRRISKDILTGKK	27	C7A	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (Cell viability >40% at 12.5μM approx); HROC40 (Cell viability >45% at 12.5μM approx); HROC107 (Cell viability >50% at 12.5μM approx); HCT 116 (Cell viability >50% at 25μM approx); HROC60 (Cell viability >50% at 25μM approx); HROC18 (Cell viability >55% at 12.5μM approx); HROC24 (Cell viability >55% at 12.5μM approx); HROC32 (Cell viability >55% at 12.5μM approx); HROC24 (Cell viability >60% at 25μM approx); HROC32 (Cell viability >60% at 25μM approx); HROC40 (Cell viability >60% at 25μM approx); HROC60 (Cell viability >70% at 12.5μM approx); HROC113 (Cell viability >80% at 12.5μM approx)	Whole blood cells: experiments revealed absent or minimal hemolysis	Linear	Free	Amidation		L	lymphotoxic effects in vitro	Not available	24962950	Oncotarget. 2014 Jun 30;5(12):4467-79.	Maletzki C, Klier U, Marinkovic S, Klar E, Andrä J, Linnebacher M. 	Host defense peptides for treatment of colorectal carcinoma - a comparative in vitro and in vivo analysis	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP31849	KILRGVAKKIMRTFLRRILTGKK	23	C7A-Δ	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (Cell viability >50% at 12.5μM approx); HCT 116 (Cell viability >50% at 12.5μM approx.); HROC40 (Cell viability >50% at 25μM approx); HROC60 (Cell viability >50% at 25μM approx); HROC24 (Cell viability >60% at 25μM approx); HROC107 (Cell viability >70% at 12.5μM approx); HROC113 (Cell viability >70% at 12.5μM approx); HROC24 (Cell viability >70% at 12.5μM approx); HROC60 (Cell viability >70% at 12.5μM approx); HROC18 (Cell viability >75% at 12.5μM approx); HROC32 (Cell viability >85% at 12.5μM approx); HROC40 (Cell viability >85% at 12.5μM approx); HROC32 (Cell viability=50% at 12.5μM approx.)	Whole blood cells: experiments revealed absent or minimal hemolysis	Linear	Free	Amidation		L	lymphotoxic effects in vitro	Not available	24962950	Oncotarget. 2014 Jun 30;5(12):4467-79.	Maletzki C, Klier U, Marinkovic S, Klar E, Andrä J, Linnebacher M. 	Host defense peptides for treatment of colorectal carcinoma - a comparative in vitro and in vivo analysis	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O
DRAMP31850	KILRGVAKKIMRTFLRRISKKILTGKK	27	C7A-D21K	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (Cell viability >40% at 12.5μM approx); HROC24 (Cell viability >50% at 25μM approx); HROC40 (Cell viability >50% at 25μM approx); HROC60 (Cell viability >50% at 25μM approx); HROC18 (Cell viability >55% at 12.5μM approx); HROC24 (Cell viability >55% at 12.5μM approx); HROC60 (Cell viability >60% at 12.5μM approx); HROC107 (Cell viability >65% at 12.5μM approx); HROC113 (Cell viability >65% at 12.5μM approx); HROC32 (Cell viability >80% at 12.5μM approx); HROC40 (Cell viability >80% at 12.5μM approx); HCT 116 (Cell viability=50% at 12.5μM approx.); HROC32 (Cell viability=50% at 12.5μM approx.)	Whole blood cells: experiments revealed absent or minimal hemolysis	Linear	Free	Amidation		L	lymphotoxic effects in vitro	Not available	24962950	Oncotarget. 2014 Jun 30;5(12):4467-79.	Maletzki C, Klier U, Marinkovic S, Klar E, Andrä J, Linnebacher M. 	Host defense peptides for treatment of colorectal carcinoma - a comparative in vitro and in vivo analysis	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP31851	MICYSHKTPQPSATITCEEKTCYKKSVRKLPAIVAGRGCGCPSKEMLVAIHCCRSDKCNE	60	Toxin F-VIII	P01404		Not found	venom of the Eastern green mamba, Dendroaspis angusticeps (Elapidae)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=106±5 μg/mL  ); HT-29 (LC50>300 μg/mL); MDA-MB-231 (LC50>300 μg/mL)	Human erythrocytes: LC50>1000 μg/mL	Linear	Free	Free		L	HUVEC: LC50>300 μg/mL	Not available	25035794	J Venom Res. 2014 Jun 19;5:16-21.	Conlon JM, Prajeep M, Mechkarska M, Arafat K, Attoub S, Adem A, Pla D, Calvete JJ.	Peptides with in vitro anti-tumor activity from the venom of the Eastern green mamba, Dendroaspis angusticeps (Elapidae)	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31852	RICYSHKLLQAKTTKTCEENSCYKRSLPKIPLIIIGRGCGCPLTLPFLRIKCCTSDKCN	59	Toxin C13S1C1	P18329		Not found	venom of the Eastern green mamba, Dendroaspis angusticeps (Elapidae)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC50=110±4 μg/mL); A549 (LC50=56±4 μg/mL); MDA-MB-231 (LC50=62±2 μg/mL)	Human erythrocytes: LC50>600 μg/mL	Linear	Free	Free		L	HUVEC: LC50=57±3 μg/mL	Not available	25035794	J Venom Res. 2014 Jun 19;5:16-21.	Conlon JM, Prajeep M, Mechkarska M, Arafat K, Attoub S, Adem A, Pla D, Calvete JJ.	Peptides with in vitro anti-tumor activity from the venom of the Eastern green mamba, Dendroaspis angusticeps (Elapidae)	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O
DRAMP31853	LKLSPKTKDTLKKVLKGAIKGAIAIASMA	29	Hymenochirin-1Pa	Not available		Not found	skin secretions of the frog Pseudhymenochirus merlini (Pipidae)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=1.2±0.2 μM); HT-29 (LC50=12.3±4.7 μM); MDA-MB-231 (LC50=3.1±0.2 μM)	Human red blood cells (RBC): LC50=162±13 μM	Linear	Free	Amidation		L	HUVEC: LC50=7.7±0.7 μM	Not available	25241629	Peptides. 2014 Nov;61:114-21.	Serra I, Scorciapino MA, Manzo G, Casu M, Rinaldi AC, Attoub S, Mechkarska M, Conlon JM.	Conformational analysis and cytotoxic activities of the frog skin host-defense peptide, hymenochirin-1Pa	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(N)=O
DRAMP31854	LKLSPKTKKTLKKVLKGAIKGAIAIASMA	29	[D9K]Hymenochirin-1Pa	Not available		Not found	skin secretions of the frog Pseudhymenochirus merlini (Pipidae)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=0.9±0.3 μM); MDA-MB-231 (LC50=2.4±0.1 μM); HT-29 (LC50=3.9±0.4 μM)	Human red blood cells (RBC): LC50=192±21 μM	Linear	Free	Amidation		L	HUVEC: LC50=6.5±0.2 μM	Not available	25241629	Peptides. 2014 Nov;61:114-21.	Serra I, Scorciapino MA, Manzo G, Casu M, Rinaldi AC, Attoub S, Mechkarska M, Conlon JM.	Conformational analysis and cytotoxic activities of the frog skin host-defense peptide, hymenochirin-1Pa	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(N)=O
DRAMP31855	LKLSPKTKkTLKKVLKGAIKGAIAIASMA	29	[D9k]Hymenochirin-1Pa	Not available		Not found	skin secretions of the frog Pseudhymenochirus merlini (Pipidae)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=2.5±0.3 μM); MDA-MB-231 (LC50=5.4±0.4 μM); HT-29 (LC50=6.3±1.9 μM)	Human red blood cells (RBC): LC50>400 μM	Linear	Free	Amidation	k=D-Lys	Mix	HUVEC: LC50=9.3±0.3 μM	Not available	25241629	Peptides. 2014 Nov;61:114-21.	Serra I, Scorciapino MA, Manzo G, Casu M, Rinaldi AC, Attoub S, Mechkarska M, Conlon JM.	Conformational analysis and cytotoxic activities of the frog skin host-defense peptide, hymenochirin-1Pa	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(N)=O
DRAMP31856	GIFPIFAKLLGKVIKVASSLISKGRTE	27	Ps-2Pa	Not available		Not found	skin secretions of the frog Pseudhymenochirus merlini (Pipidae)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC50=11.5±2.6 μM); A549 (LC50=6.0±0.6 μM); MDA-MB-231 (LC50=6.2±0.6 μM)	Human erythrocytes: LC50=6.2±1.0 μM	Linear	Free	Free		L	HUVEC: LC50=68±2 μM	Not available	25447194	Regul Pept. 2014 Nov;194-195:69-76.	Mechkarska M, Attoub S, Sulaiman S, Pantic J, Lukic ML, Conlon JM.	Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP31857	IKIPSFFRNILKKVGKEAVSLIAGALKQS	29	Ps-1Pb	Not available		Not found	skin secretions of the frog Pseudhymenochirus merlini (Pipidae)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=2.5±0.2 μM); MDA-MB-231 (LC50=6.6±0.3 μM); HT-29 (LC50=9.5±1.3 μM)	Human red blood cells (RBC): LC50>403 μM	Linear	Free	Free		L	HUVEC: LC50=5.6±0.9 μM	Not available	25447194	Regul Pept. 2014 Nov;194-195:69-76.	Mechkarska M, Attoub S, Sulaiman S, Pantic J, Lukic ML, Conlon JM.	Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP31858	VKRFKKFFRKLKKAV	15	B1-Ala	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=8.6 µM); MCF-7 (IC50=8.9 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=87.1 µM	Not available	25462264	Eur J Med Chem. 2015 Jan 7;89:540-8.	Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31859	VKRFKKFFRKLKKDV	15	B1-Asp	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B3	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=19.9 µM); K562 (IC50=44.7 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=120.2 µM	Not available	25462264	Eur J Med Chem. 2015 Jan 7;89:540-8.	Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31860	VKRFKKFFRKLKKEV	15	B1-Glu	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B3	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=36.6 µM); MCF-7 (IC50=38.9 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=104.5 µM	Not available	25462264	Eur J Med Chem. 2015 Jan 7;89:540-8.	Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31861	VKRFKKFFRKLKKFV	15	B1-Phe	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=1.3 µM); K562 (IC50=3.7 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=107.2 µM	Not available	25462264	Eur J Med Chem. 2015 Jan 7;89:540-8.	Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31862	VKRFKKFFRKLKKGV	15	B1-Gly	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=14.8 µM); MCF-7 (IC50=15.8 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=107.2 µM	Not available	25462264	Eur J Med Chem. 2015 Jan 7;89:540-8.	Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(N)=O)C(C)C
DRAMP31863	VKRFKKFFRKLKKHV	15	B1-His	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B3	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=10.5 µM); MCF-7 (IC50=5.0 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=104.7 µM	Not available	25462264	Eur J Med Chem. 2015 Jan 7;89:540-8.	Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31864	VKRFKKFFRKLKKKV	15	B1-Lys	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B3	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=5.5 µM); K562/Adr (IC50=5.5 µM); MCF-7 (IC50=8.3 µM); MCF-7/ADM (IC50=8.6 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=123.0 µM	Not available	25462264	Eur J Med Chem. 2015 Jan 7;89:540-8.	Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31865	VKRFKKFFRKLKKLV	15	B1-Leu	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=1.1 µM); K562/Adr (IC50=3.3. µM); MCF-7 (IC50=3.6 µM); MCF-7/ADM (IC50=4.4 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=77.6 µM	Not available	25462264	Eur J Med Chem. 2015 Jan 7;89:540-8.	Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31866	VKRFKKFFRKLKKQV	15	B1-Gln	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B3	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=14.5 µM); K562 (IC50=16.2 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=102.3 µM	Not available	25462264	Eur J Med Chem. 2015 Jan 7;89:540-8.	Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31867	VKRFKKFFRKLKKRV	15	B1-Arg	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B3	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=5.5 µM); K562 (IC50=8.7 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=93.3 µM	Not available	25462264	Eur J Med Chem. 2015 Jan 7;89:540-8.	Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31868	VKRFKKFFRKLKKSV	15	B1	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=102.3 µM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H.	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31869	VKRFKKFFRKLKKSV	15	B1	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM )	Not available	Linear	Free	Amidation		L	GES-1: IC50=102.3 µM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H.	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31870	VKRFKKFFRKLKKSV	15	B1	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=102.3 µM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H.	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31871	VKRFKKFFRKLKKSV	15	B1	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=102.3 µM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H.	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31872	VKRFKKFFRKLKKSV	15	B1	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=102.3 µM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H.	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31873	VKRFKKFFRKLKKSV	15	B1	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=102.3 µM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H.	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP31874	VKRFKKFFRKLKKTV	15	B1-Thr	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B3	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=17.0 µM); MCF-7 (IC50=19.1 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=109.6 µM	Not available	25462264	Eur J Med Chem. 2015 Jan 7;89:540-8.	Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O
DRAMP31875	VKRFKKFFRKLKKVV	15	B1-Val	Not available		Not found	Cathelicidin-BF15 C-terminal amidated derivative B1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=4.9 µM); K562 (IC50=5.0 µM)	Not available	Linear	Free	Amidation		L	GES-1: IC50=64.6 µM	Not available	25462264	Eur J Med Chem. 2015 Jan 7;89:540-8.	Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP31876	WKX	3	WKX	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM1.S (25% Inhibition=10µM)	Not available	Linear	Picolinoyl	Free	X=MET-Boro	L	Not available	Not available	25759383	J Biol Chem. 2015 Apr 24;290(17):11008-20.	Akopian T, Kandror O, Tsu C, Lai JH, Wu W, Liu Y, Zhao P, Park A, Wolf L, Dick LR, Rubin EJ, Bachovchin W, Goldberg AL.	Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity	
DRAMP31877	IKWKRWWWR	9	GN-11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50>200µg/ml)	Human erythrocytes:<10% Hemolysis>400µg/ml	Linear	Free	Amidation		L	Not available	Not available	25941221	Antimicrob Agents Chemother. 2015 Jul;59(7):4112-20.	Mojsoska B, Zuckermann RN, Jenssen H.	Antimicrobial activity of GN peptides and their mode of action	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31878	IWKRWWWKR	9	GN-8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=199µg/ml)	Human erythrocytes:<=10% Hemolysis>400µg/ml	Linear	Free	Amidation		L	Not available	Not available	25941221	Antimicrob Agents Chemother. 2015 Jul;59(7):4112-20.	Mojsoska B, Zuckermann RN, Jenssen H.	Antimicrobial activity of GN peptides and their mode of action	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31879	KKRWWWWWR	9	GN-5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=131µg/ml)	Human erythrocytes:<=10% Hemolysis=100µg/ml	Linear	Free	Amidation		L	Not available	Not available	25941221	Antimicrob Agents Chemother. 2015 Jul;59(7):4112-20.	Mojsoska B, Zuckermann RN, Jenssen H.	Antimicrobial activity of GN peptides and their mode of action	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP31880	KWWKIWRWR	9	GN-12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=173µg/ml)	Human erythrocytes:<10% Hemolysis>400µg/ml	Linear	Free	Amidation		L	Not available	Not available	25941221	Antimicrob Agents Chemother. 2015 Jul;59(7):4112-20.	Mojsoska B, Zuckermann RN, Jenssen H.	Antimicrobial activity of GN peptides and their mode of action	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31881	KWWRWRRWW	9	GN-3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=106µg/ml)	Human erythrocytes:<10% Hemolysis=100µg/ml	Linear	Free	Amidation		L	Not available	Not available	25941221	Antimicrob Agents Chemother. 2015 Jul;59(7):4112-20.	Mojsoska B, Zuckermann RN, Jenssen H.	Antimicrobial activity of GN peptides and their mode of action	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP31882	RIWKIWWKR	9	GN-9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50>200µg/ml)	Human erythrocytes:<10% Hemolysis>400µg/ml	Linear	Free	Amidation		L	Not available	Not available	25941221	Antimicrob Agents Chemother. 2015 Jul;59(7):4112-20.	Mojsoska B, Zuckermann RN, Jenssen H.	Antimicrobial activity of GN peptides and their mode of action	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31883	RKRWWWWFR	9	GN-6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=97µg/ml)	Human erythrocytes:<=10% Hemolysis=100µg/ml	Linear	Free	Amidation		L	Not available	Not available	25941221	Antimicrob Agents Chemother. 2015 Jul;59(7):4112-20.	Mojsoska B, Zuckermann RN, Jenssen H.	Antimicrobial activity of GN peptides and their mode of action	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP31884	RLWKRWWIR	9	GN-14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50>200µg/ml)	Human erythrocytes:<10% Hemolysis>400µg/ml	Linear	Free	Amidation		L	Not available	Not available	25941221	Antimicrob Agents Chemother. 2015 Jul;59(7):4112-20.	Mojsoska B, Zuckermann RN, Jenssen H.	Antimicrobial activity of GN peptides and their mode of action	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31885	RWKKWWRWL	9	GN-4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=37µg/ml)	Human erythrocytes:<=10% Hemolysis=100µg/ml	Linear	Free	Amidation		L	Not available	Not available	25941221	Antimicrob Agents Chemother. 2015 Jul;59(7):4112-20.	Mojsoska B, Zuckermann RN, Jenssen H.	Antimicrobial activity of GN peptides and their mode of action	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP31886	RWKRWWRWI	9	GN-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=47µg/ml)	Human erythrocytes:<=10% Hemolysis=128µg/ml	Linear	Free	Amidation		L	Not available	Not available	25941221	Antimicrob Agents Chemother. 2015 Jul;59(7):4112-20.	Mojsoska B, Zuckermann RN, Jenssen H.	Antimicrobial activity of GN peptides and their mode of action	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP31887	GLFDIWAWWRWRR	13	DM2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>250µg/ml)	Human erythrocytes:10% Hemolysis=114.3±26.1µg/ml; 50% Hemolysis>250µg/ml	Linear	Free	Amidation		L	NL20: 50% Cell death>250µg/ml	Not available	25985150	Sci Rep. 2015 May 18;5:9761.	Le CF, Yusof MY, Hassan H, Sekaran SD.	In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31888	GLFDIWKKLRWRR	13	DM5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=97.0±9.8µg/ml)	Human erythrocytes:10% Hemolysis>250µg/ml;50% Hemolysis>250µg/ml	Linear	Free	Amidation		L	NL20: 50% Cell death=179.2±3.8µg/ml	Not available	25985150	Sci Rep. 2015 May 18;5:9761.	Le CF, Yusof MY, Hassan H, Sekaran SD.	In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31889	GLFDIWKKWRWRR	13	DM4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=93.3±5.1µg/ml)	Human erythrocytes:10% Hemolysis>250µg/ml;50% Hemolysis>250µg/ml	Linear	Free	Amidation		L	NL20: 50% Cell death=160.2±11.8µg/ml	Not available	25985150	Sci Rep. 2015 May 18;5:9761.	Le CF, Yusof MY, Hassan H, Sekaran SD.	In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31890	GLFDIWKWWRWRR	13	DM3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=56.0±9.3µg/ml)	Human erythrocytes:10% Hemolysis=52.7±5.5µg/ml; 50% Hemolysis>250µg/ml	Linear	Free	Amidation		L	NL20: 50% Cell death=68.5±11.0µg/ml	Not available	25985150	Sci Rep. 2015 May 18;5:9761.	Le CF, Yusof MY, Hassan H, Sekaran SD.	In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31891	GLFDKWAWWRWRR	13	DM1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=215.3±19.7µg/ml)	Human erythrocytes:10% Hemolysis>250µg/ml; 50% Hemolysis>250µg/ml	Linear	Free	Amidation		L	NL20: 50% Cell death=221.8±7.8µg/ml	Not available	25985150	Sci Rep. 2015 May 18;5:9761.	Le CF, Yusof MY, Hassan H, Sekaran SD.	In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31892	RTRCRfLRRC	10	Compound 12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-12 (IC50=225µg/ml)	Not available	Cyclic	C9	Amidation	f=D-Phe	Mix	Madin-Darby canine kidney cells: IC50=190µg/ml; Human dermal fibroblasts: IC50=164µg/ml	Not available	26024044	Sci Rep. 2015 May 29;5:10558.	Rabanal F, Grau-Campistany A, Vila-Farrés X, Gonzalez-Linares J, Borràs M, Vila J, Manresa A, Cajal Y.	A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity	CCCCCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(N)=O)[C@@H](C)O
DRAMP31893	RTRCXfLRXC	10	Compound 8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-12 (IC50=595µg/ml)	Not available	Cyclic	C9	Amidation	X=diaminobutyrate; f=D-Phe	Mix	Madin-Darby canine kidney cells: IC50=472µg/ml; Human dermal fibroblasts: IC50=461µg/ml	Not available	26024044	Sci Rep. 2015 May 29;5:10558.	Rabanal F, Grau-Campistany A, Vila-Farrés X, Gonzalez-Linares J, Borràs M, Vila J, Manresa A, Cajal Y.	A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity	
DRAMP31894	RTXCXfLRXC	10	Compound 5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-12 (IC50=629µg/ml)	Not available	Cyclic	C9	Amidation	X=diaminobutyrate; f=D-Phe	Mix	Madin-Darby canine kidney cells: IC50=548µg/ml; Human dermal fibroblasts: IC50=534µg/ml	Not available	26024044	Sci Rep. 2015 May 29;5:10558.	Rabanal F, Grau-Campistany A, Vila-Farrés X, Gonzalez-Linares J, Borràs M, Vila J, Manresa A, Cajal Y.	A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity	
DRAMP31895	GAFLKCGESCVYLPCLTTVVGCSCQNSVCYRD	32	DC1	Not available		Not found	Hedyotis diffusa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	induce apoptosis and inhibit proliferation and migration of prostate cancer cells	Tumor cells: PC-3 (IC50=2.24 μM); DU145 (IC50=3.32 μM); LNCaP (IC50=5.03 μM)	Not available	Linear	Free	Free		L	Not available	Not available	26064310	Int J Clin Exp Med. 2015 Mar 15;8(3):4059-65.	Hu E, Wang D, Chen J, Tao X.	Novel cyclotides from Hedyotis diffusa induce apoptosis and inhibit proliferation and migration of prostate cancer cells	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP31896	GAVPCGETCVYLPCITPDIGCSCQNKVCYRD	31	DC2	Not available		Not found	Hedyotis diffusa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	induce apoptosis and inhibit proliferation and migration of prostate cancer cells	Tumor cells: PC-3 (IC50=2.65 μM); DU145 (IC50=3.11 μM); LNCaP (IC50=4.31 μM)	Not available	Linear	Free	Free		L	Not available	Not available	26064310	Int J Clin Exp Med. 2015 Mar 15;8(3):4059-65.	Hu E, Wang D, Chen J, Tao X.	Novel cyclotides from Hedyotis diffusa induce apoptosis and inhibit proliferation and migration of prostate cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CC[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@H](C)CC)C(=O)O
DRAMP31897	GTSCGETCVLLPCLSSVLGCTCQNKRCYKD	30	DC3	Not available		Not found	Hedyotis diffusa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	induce apoptosis and inhibit proliferation and migration of prostate cancer cells	Tumor cells: LNCaP (IC50=0.21 μM); DU145 (IC50=0.55 μM); PC-3 (IC50=0.76 μM)	Not available	Linear	Free	Free		L	Not available	Not available	26064310	Int J Clin Exp Med. 2015 Mar 15;8(3):4059-65.	Hu E, Wang D, Chen J, Tao X.	Novel cyclotides from Hedyotis diffusa induce apoptosis and inhibit proliferation and migration of prostate cancer cells	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)CC[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31898	KGIRDWLRGFNKLRKWFLRLIKGL	24	m3	Not available		Not found	membrane disrupting antimicrobial peptide KL15	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=60 mg/ml)	Not available	Linear	Free	Free		L	Not available	Not available	26147829	Cancer Biol Ther. 2015;16(8):1172-83.	Chen YC, Tsai TL, Ye XH, Lin TH.	Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)O)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31899	KRKLYKWFAHLIKGL	15	KL15	Not available		Not found	membrane disrupting antimicrobial peptide KL15	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CaCo-2 (IC50=50 mg/ml); SW480 (IC50=50 mg/ml)	Not available	Linear	Free	Free		L	H184B5F5/M10: IC50=150 μg/ml, testing time is 24h	Not available	26147829	Cancer Biol Ther. 2015;16(8):1172-83.	Chen YC, Tsai TL, Ye XH, Lin TH.	Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31900	LRLLDRWLRLFNRLLRWLRLLRGL	24	m5	Not available		Not found	membrane disrupting antimicrobial peptide KL15	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=100 mg/ml)	Not available	Linear	Free	Free		L	Not available	Not available	26147829	Cancer Biol Ther. 2015;16(8):1172-83.	Chen YC, Tsai TL, Ye XH, Lin TH.	Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)O
DRAMP31901	LRRLDRWLRLFNRLRRWFLRLLRGL	25	m4	Not available		Not found	membrane disrupting antimicrobial peptide KL15	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=110 mg/ml)	Not available	Linear	Free	Free		L	Not available	Not available	26147829	Cancer Biol Ther. 2015;16(8):1172-83.	Chen YC, Tsai TL, Ye XH, Lin TH.	Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(=O)O
DRAMP31902	RLWRLAWRLYRLWRLTL	17	m2	Not available		Not found	membrane disrupting antimicrobial peptide KL15	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=70 mg/ml)	Not available	Linear	Free	Free		L	Not available	Not available	26147829	Cancer Biol Ther. 2015;16(8):1172-83.	Chen YC, Tsai TL, Ye XH, Lin TH.	Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)O
DRAMP31903	RLYRLYFRLYRLWRRLTL	18	m1	Not available		Not found	membrane disrupting antimicrobial peptide KL15	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=60 mg/ml)	Not available	Linear	Free	Free		L	Not available	Not available	26147829	Cancer Biol Ther. 2015;16(8):1172-83.	Chen YC, Tsai TL, Ye XH, Lin TH.	Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)O
DRAMP31904	HXLLPPVXPLFG	12	Callyaerin C	Not available		Not found	Callyspongia aerizusa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: L5178Y (ED50=2.92µM); THP-1 (IC50>100µM; IC90>100µM)	Not available	Cyclic	Free	Amidation	X(2)= 4-Hydroxyproline; X(8)=Daa	L	MRC-5:IC50>100µM; IC90>100µM 	Not available	26213786	J Nat Prod. 2015 Aug 28;78(8):1910-25.	Daletos G, Kalscheuer R, Koliwer-Brandl H, Hartmann R, de Voogd NJ, Wray V, Lin W, Proksch P.	Callyaerins from the Marine Sponge Callyspongia aerizusa: Cyclic Peptides with Antitubercular Activity	
DRAMP31905	IXIILPPLXPII	12	Callyaerin B	Not available		Not found	Callyspongia aerizusa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: L5178Y (ED50=4.14µM); HeLa (ED50>8µM); PC-12 (ED50>8µM); THP-1 (IC50=5µM; IC90=30µM)	Not available	Cyclic	Free	Amidation	X(2)= 4-Hydroxyproline; X(9)=Daa	L	MRC-5:IC50=2µM; IC90=6µM 	Not available	26213786	J Nat Prod. 2015 Aug 28;78(8):1910-25.	Daletos G, Kalscheuer R, Koliwer-Brandl H, Hartmann R, de Voogd NJ, Wray V, Lin W, Proksch P.	Callyaerins from the Marine Sponge Callyspongia aerizusa: Cyclic Peptides with Antitubercular Activity	
DRAMP31906	IXVILPPLXPIFG	13	Callyaerin A	Not available		Not found	Callyspongia aerizusa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: L5178Y (ED50=3.61µM); THP-1 (IC50=30µM; IC90=50µM)	Not available	Cyclic	Free	Amidation	X(2)= 4-Hydroxyproline; X(9)=Daa	L	MRC-5:IC50=20µM; IC90=40µM 	Not available	26213786	J Nat Prod. 2015 Aug 28;78(8):1910-25.	Daletos G, Kalscheuer R, Koliwer-Brandl H, Hartmann R, de Voogd NJ, Wray V, Lin W, Proksch P.	Callyaerins from the Marine Sponge Callyspongia aerizusa: Cyclic Peptides with Antitubercular Activity	
DRAMP31907	FWQRRIRRWRRFWQRRIRRWRR	22	DIM-LF11-318	Not available		Not found	Human lactoferricin derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin	Tumor cells: A-375 (LC50=9.3±0.8 µM ); SBcl-2 (LC50=9.4±0.5 µM )	Not available	Linear	Free	Amidation		L	Normal Human Dermal Fibroblasts (NHDF): LC50=13.9±0.4 µM	Not available	26239537	Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2918-31.	Riedl S, Leber R, Rinner B, Schaider H, Lohner K, Zweytick D.	Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31908	PFWRIRIRRPRRIRIRWFP	19	R-DIM-P-LF11-322	Not available		Not found	Human lactoferricin derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin	Tumor cells: SBcl-2 (LC50=10.4±0.7 µM ); A-375 (LC50=23.3±1.7 µM )	Not available	Linear	Free	Amidation		L	Normal Human Dermal Fibroblasts (NHDF):LC50>101 µM	Not available	26239537	Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2918-31.	Riedl S, Leber R, Rinner B, Schaider H, Lohner K, Zweytick D.	Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(N)=O
DRAMP31909	PFWRRRIRIRRRRIRIRRRWFP	22	R-DIM-LF11-337	Not available		Not found	Human lactoferricin derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin	Tumor cells: SBcl-2 (LC50=5.0±0.4 µM ); A-375 (LC50=61.8±0.1 µM )	Not available	Linear	Free	Amidation		L	Normal Human Dermal Fibroblasts (NHDF): LC50=22.8±0.1 µM	Not available	26239537	Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2918-31.	Riedl S, Leber R, Rinner B, Schaider H, Lohner K, Zweytick D.	Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP31910	RWKRINRQWFFWQRNIRKWR	20	R-DIM-LF11-316	Not available		Not found	Human lactoferricin derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin	Tumor cells: SBcl-2 (LC50=16.0±0.5 µM ); A-375 (LC50=21.0±1.2 µM )	Not available	Linear	Free	Amidation		L	Normal Human Dermal Fibroblasts (NHDF): LC50=61.8±0.1 µM 	Not available	26239537	Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2918-31.	Riedl S, Leber R, Rinner B, Schaider H, Lohner K, Zweytick D.	Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31911	WWRRWWRRWRRWWRRWWR	18	RW-AH	Not available		Not found	Human lactoferricin derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin	Tumor cells: A-375 (LC50=13.9±0.4 µM ); SBcl-2 (LC50=4.6±0.2 µM )	Not available	Linear	Free	Amidation		L	Normal Human Dermal Fibroblasts (NHDF): LC50=9.6±0.2 µM 	Not available	26239537	Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2918-31.	Riedl S, Leber R, Rinner B, Schaider H, Lohner K, Zweytick D.	Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(N)=O
DRAMP31912	GKPICGETCFKGKCYTPGCTCSYPICKKD	29	Cyclotide mela-3	Not available		Not found	Melicytus latifolius	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (CC50=18.73±1.82µM); MM96L (CC50=2.04±0.26µM)	Not available	Cyclic	Free	Free		L	HFF-1: CC50=5.39±0.33µM	Not available	26322745	ACS Chem Biol. 2015 Nov 20;10(11):2491-500.	Ravipati AS, Henriques ST, Poth AG, Kaas Q, Wang CK, Colgrave ML, Craik DJ.	Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP31913	GKPICGETCFKGKCYTPGCTCSYPICKKN	29	Cyclotide mela-4	Not available		Not found	Melicytus latifolius	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (CC50=18.73±1.82µM); MM96L (CC50=2.04±0.26µM)	Not available	Cyclic	Free	Free		L	HFF-1: CC50=5.39±0.33µM	Not available	26322745	ACS Chem Biol. 2015 Nov 20;10(11):2491-500.	Ravipati AS, Henriques ST, Poth AG, Kaas Q, Wang CK, Colgrave ML, Craik DJ.	Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP31914	GKPTCGETCFKGKCYTPGCTCSYPLCKKD	29	Cyclotide mela-2	Not available		Not found	Melicytus latifolius	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (CC50=1.30±0.44µM); HeLa (CC50=19.26±1.37µM)	Human erythrocytes: 50% Hemolysis>64µM	Cyclic	Free	Free		L	HFF-1: CC50=5.86±0.38µM	Not available	26322745	ACS Chem Biol. 2015 Nov 20;10(11):2491-500.	Ravipati AS, Henriques ST, Poth AG, Kaas Q, Wang CK, Colgrave ML, Craik DJ.	Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31915	GKYTCGETCFKGKCYTPGCTCSYPICKKD	29	Cyclotide mela-1	Not available		Not found	Melicytus latifolius	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (CC50=2.09±0.18µM); HeLa (CC50=9.83±0.78µM)	Human erythrocytes: 50% Hemolysis>64µM	Cyclic	Free	Free		L	HFF-1: CC50=3.07±0.15µM	Not available	26322745	ACS Chem Biol. 2015 Nov 20;10(11):2491-500.	Ravipati AS, Henriques ST, Poth AG, Kaas Q, Wang CK, Colgrave ML, Craik DJ.	Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31916	GLPTCGETCFKGKCYTPGCSCSYPICKKD	29	Cyclotide mela-6	Not available		Not found	Melicytus latifolius	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (CC50=1.58±0.48µM); HeLa (CC50=11.42±1.00µM)	Human erythrocytes: 50% Hemolysis>64µM	Cyclic	Free	Free		L	HFF-1: CC50=3.13±0.16µM	Not available	26322745	ACS Chem Biol. 2015 Nov 20;10(11):2491-500.	Ravipati AS, Henriques ST, Poth AG, Kaas Q, Wang CK, Colgrave ML, Craik DJ.	Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31917	GLPTCGETCFKGKCYTPGCSCSYPICKKN	29	Cyclotide mela-7	Not available		Not found	Melicytus latifolius	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (CC50=1.58±0.48µM); HeLa (CC50=11.42±1.00µM)	Human erythrocytes: 50% Hemolysis>64µM	Cyclic	Free	Free		L	HFF-1: CC50=3.13±0.16µM	Not available	26322745	ACS Chem Biol. 2015 Nov 20;10(11):2491-500.	Ravipati AS, Henriques ST, Poth AG, Kaas Q, Wang CK, Colgrave ML, Craik DJ.	Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP31918	GLPTCGETCTLGKCNTPKCTCNWPICYKD	29	Cyclotide mech-2	Not available		Not found	Melicytus chathamicus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (CC50=21.94±1.90µM); HeLa (CC50=36.92±3.25µM)	Human erythrocytes: 50% Hemolysis>64µM	Cyclic	Free	Free		L	HFF-1: CC50=12.45±0.99µM	Not available	26322745	ACS Chem Biol. 2015 Nov 20;10(11):2491-500.	Ravipati AS, Henriques ST, Poth AG, Kaas Q, Wang CK, Colgrave ML, Craik DJ.	Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP31919	GLPTCGETCTLGKCNTPKCTCNWPICYKN	29	Cyclotide mech-3	Not available		Not found	Melicytus chathamicus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (CC50=21.94±1.90µM); HeLa (CC50=36.92±3.25µM)	Human erythrocytes: 50% Hemolysis>64µM	Cyclic	Free	Free		L	HFF-1: CC50=12.45±0.99µM	Not available	26322745	ACS Chem Biol. 2015 Nov 20;10(11):2491-500.	Ravipati AS, Henriques ST, Poth AG, Kaas Q, Wang CK, Colgrave ML, Craik DJ.	Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP31920	FKKLKKLFSKLWNWK	15	HPRP-A1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=3.5±0.03 μM); SGC-7901 (IC50=5.2±0.14 μM); B16 (IC50=6.1±0.02 μM); Hep-G2 (IC50=7.7±0.23 μM)	Human RBC: MHC=64±6.80 μM	Linear	Acetylation	Amidation		L	Not available	Not available	26405806	PLoS One. 2015 Sep 25;10(9):e0138911.	Hao X, Yan Q, Zhao J, Wang W, Huang Y, Chen Y.	TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy	CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP31921	FKKLKKLFSKLWNWK	15	HPRP-A1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H460 (IC50=13.3 µM); BGC-823 (IC50=14.1 µM); A549 (IC50=14.8 µM); MCF-7 (IC50=15.7 µM); MDA-MB-231 (IC50=22.9 µM)	Human RBC: MHC=64±6.80 μM	Linear	Acetylation	Amidation		L	Not available	Not available	26405806	PLoS One. 2015 Sep 25;10(9):e0138911.	Hao X, Yan Q, Zhao J, Wang W, Huang Y, Chen Y.	TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy	CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP31922	FKKLKKLFSKLWNWKRKKRRQRRR	24	HPRP-A1-TAT	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=1.8±0.02 μM); B16 (IC50=3.5±0.03 μM); SGC-7901 (IC50=4.8±0.08 μM); Hep-G2 (IC50=5.8±0.36 μM)	Human RBC: MHC>500 μM	Linear	Acetylation	Amidation		L	Not available	Not available	26405806	PLoS One. 2015 Sep 25;10(9):e0138911.	Hao X, Yan Q, Zhao J, Wang W, Huang Y, Chen Y.	TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy	CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31923	fkklkklfsklwnwk	15	HPRP-A2	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SGC-7901 (IC50=10.42±0.30 μM ); B16 (IC50=19.16±0.38 μM ); PC-3 (IC50=21.38±0.56 μM ); BGC-823 (IC50=8.65 ±0.38 μM )	Human red blood cells: low toxicity	Linear	Free	Free		L	Not available	Not available	26422386	PLoS One. 2015 Sep 30;10(9):e0139578. 	Zhao J, Hao X, Liu D, Huang Y, Chen Y.	In vitro Characterization of the Rapid Cytotoxicity of Anticancer Peptide HPRP-A2 through Membrane Destruction and Intracellular Mechanism against Gastric Cancer Cell Lines	CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)O
DRAMP31924	fkklkklfsklwnwk	15	HPRP-A2	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Human red blood cells: low toxicity	Linear	Free	Free		L	Not available	Not available	26422386	PLoS One. 2015 Sep 30;10(9):e0139578. 	Zhao J, Hao X, Liu D, Huang Y, Chen Y.	In vitro Characterization of the Rapid Cytotoxicity of Anticancer Peptide HPRP-A2 through Membrane Destruction and Intracellular Mechanism against Gastric Cancer Cell Lines	CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)O
DRAMP31925	KRFKKFFKKVKKSV	14	Ctn[1-14]	Not available		Not found	Rattlesnake Venom Cathelicidin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa S3 (IC50=1 µM); THP-1 (IC50=25 µM); U-937 (IC50=6.25 µM)	Human erythrocytes: nonhemolytic up to 400 μM, and their equimolar mixture at that concentration caused only 7% hemolysis	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	26465972	J Med Chem. 2015 Nov 12;58(21):8553-63. 	Falcao CB, Pérez-Peinado C, de la Torre BG, Mayol X, Zamora-Carreras H, Jiménez MÁ, Rádis-Baptista G, Andreu D. 	Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity	CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(N)=O
DRAMP31926	KRFKKFFKKVKKSVKKRLKKIFKKPMVIGVTIPF	34	Ctn(Crotalicidin)	Not available		Not found	Rattlesnake Venom Cathelicidin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa S3 (IC50 < 1 µM ); U-937 (IC50 < 1 µM ); THP-1 (IC50=1.56 µM ); HL-60 (IC50>12.5 µM ); Jurkat E6.1 (IC50>12.5 µM )	Human erythrocytes: 7% and 33% hemolysis at 100 and 400 μM, respectively	Linear	Free	Free		Mix	MM6: IC50=3.12 µM	Not available	26465972	J Med Chem. 2015 Nov 12;58(21):8553-63. 	Falcao CB, Pérez-Peinado C, de la Torre BG, Mayol X, Zamora-Carreras H, Jiménez MÁ, Rádis-Baptista G, Andreu D. 	Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C
DRAMP31927	YGFVMPRSGLWFR	13	YR	Not available		Not found	Spirulina (Arthrospira) platensis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=104.05 μg/mL); Hep-G2 (IC50=188.23 μg/mL); SGC-7901 (IC50=247.32 μg/mL); HT-29 (IC50=446.72 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	26584028	 Food Funct. 2016 Feb;7(2):781-8.	Wang Z, Zhang X. 	Inhibitory effects of small molecular peptides from Spirulina (Arthrospira) platensis on cancer cell growth	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31928	CTLEW	5	CTLEW	Not available		Not found	walnut residual protein	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=0.60±0.17 mg/mL ); CaCo-2 (IC50=0.65±0.42 mg/mL )	Not available	Linear	Free	Free		L	IEC-6: IC50>4 mg/mL; spleen lymphocytes: IC50>4 mg/mL.	Not available	26593407	BMC Complement Altern Med. 2015 Nov 23;15:413. 	Ma S, Huang D, Zhai M, Yang L, Peng S, Chen C, Feng X, Weng Q, Zhang B, Xu M. 	Isolation of a novel bio-peptide from walnut residual protein inducing apoptosis and autophagy on cancer cells	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31929	GIFPIFAKLLGKVIKVASSLISKGRTK	27	Pseudhymenochirin-2Pa [E27K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=2.5±0.5µM); MDA-MB-231 (IC50=4.3±0.2µM); HT-29 (IC50=5.6±0.4µM)	Mouse erythrocytes:50% Hemolysis=4±1µM	Linear	Free	Free	k=D-Lys	L	HUVEC: 50% Cell death=5.0±0.4µM	Not available	26606380	J Nat Prod. 2015 Dec 24;78(12):3041-8.	Manzo G, Scorciapino MA, Srinivasan D, Attoub S, Mangoni ML, Rinaldi AC, Casu M, Flatt PR, Conlon JM. 	Conformational Analysis of the Host-Defense Peptides Pseudhymenochirin-1Pb and -2Pa and Design of Analogues with Insulin-Releasing Activities and Reduced Toxicities	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP31930	IKIPSFFRNILKKVGKkAVSLIAGALKQS	29	Pseudhymenochirin-1Pb [E17k]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=11±2µM); A549 (IC50=2.1±0.7µM); MDA-MB-231 (IC50=3.6±0.5µM)	Mouse erythrocytes:50% Hemolysis=19±4µM	Linear	Free	Free	k=D-Lys	Mix	HUVEC: 50% Cell death=5.0±0.5µM	Not available	26606380	J Nat Prod. 2015 Dec 24;78(12):3041-8.	Manzo G, Scorciapino MA, Srinivasan D, Attoub S, Mangoni ML, Rinaldi AC, Casu M, Flatt PR, Conlon JM. 	Conformational Analysis of the Host-Defense Peptides Pseudhymenochirin-1Pb and -2Pa and Design of Analogues with Insulin-Releasing Activities and Reduced Toxicities	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP31931	FFSMIPKIAGGIASLVKNL	19	Phylloseptin-Pba	Not available		Not found	Phyllomedusa baltea	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-251MG (IC50=1.8µM); PC-3 (IC50=2.9µM); NCI-H460 (IC50=4.3µM)	Horse erythrocytes: 1.4% Hemolysis=8µg/ml; Human erythrocytes: 80% Hemolysis=128µg/ml	Linear	Free	Amidation		L	HMEC-1: IC50=36.6µM	Not available	26633506	Toxins (Basel). 2015 Dec 1;7(12):5182-93. 	Wan Y, Ma C, Zhou M, Xi X, Li L, Wu D, Wang L, Lin C, Lopez JC, Chen T, Shaw C. 	Phylloseptin-PBa--A Novel Broad-Spectrum Antimicrobial Peptide from the Skin Secretion of the Peruvian Purple-Sided Leaf Frog (Phyllomedusa Baltea) Which Exhibits Cancer Cell Cytotoxicity	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP31932	IRKLKSWKWLRWL	13	B4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (Not active up to 170 µM)	Not available	Linear	Free	Free		L	Not available	Not available	26902758	Antimicrob Agents Chemother. 2016 Apr 22;60(5):2757-64.	Pearson CS, Kloos Z, Murray B, Tabe E, Gupta M, Kwak JH, Karande P, McDonough KA, Belfort G.	Combined Bioinformatic and Rational Design Approach To Develop Antimicrobial Peptides against Mycobacterium tuberculosis	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP31933	KLLKLLKKLLKLLK	14	KL1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=3.3±0.4 μM )	Not available	Linear	Free	Amidation		L	Not available	Not available	27195657	 J Med Chem. 2016 Jun 9;59(11):5238-47.	Liu X, Cao R, Wang S, Jia J, Fei H. 	Amphipathicity Determines Different Cytotoxic Mechanisms of Lysine- or Arginine-Rich Cationic Hydrophobic Peptides in Cancer Cells	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP31934	KLLKLLKLKKLLKL	14	KL2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=34.5±1.6 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	27195657	 J Med Chem. 2016 Jun 9;59(11):5238-47.	Liu X, Cao R, Wang S, Jia J, Fei H. 	Amphipathicity Determines Different Cytotoxic Mechanisms of Lysine- or Arginine-Rich Cationic Hydrophobic Peptides in Cancer Cells	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP31935	RLLRLLRLRRLLRL	14	RL2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=4.3±0.2 μM); MCF-7 (IC50=4.5±0.3 μM); A549 (IC50=4.8±0.6 μM)	Mice red blood cells: HD50>200 μM	Linear	Free	Amidation		L	HLF: IC50=21.4±1.3 μM; 293T: IC50=41.6±2.7 μM; HUVEC: IC50=19±1.5 μM	Not available	27195657	 J Med Chem. 2016 Jun 9;59(11):5238-47.	Liu X, Cao R, Wang S, Jia J, Fei H. 	Amphipathicity Determines Different Cytotoxic Mechanisms of Lysine- or Arginine-Rich Cationic Hydrophobic Peptides in Cancer Cells	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP31936	RLLRLLRRLLRLLR	14	RL1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=2.5±0.3 μM ); HeLa (IC50=3.7±0.1 μM); A549 (IC50=4.3±0.2 μM )	Mice red blood cells: HD50=2.9±0.3 μM	Linear	Free	Amidation		L	HLF: IC50=6.3±0.2 μM; 293T: IC50=9.6±1.4 μM; HUVEC: IC50=8.4±0.6 μM	Not available	27195657	 J Med Chem. 2016 Jun 9;59(11):5238-47.	Liu X, Cao R, Wang S, Jia J, Fei H. 	Amphipathicity Determines Different Cytotoxic Mechanisms of Lysine- or Arginine-Rich Cationic Hydrophobic Peptides in Cancer Cells	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP31937	FKIGGFIKKLWRSKLA	16	ZXR-1	N0EAL3		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	 ZXR-1 could internalize into cells by endocytosis, target on mitochondria, and induce cell apoptosis	Tumor cells: Hep-G2 (IC50=141.7±12.2 µM); SACC-83 (IC50=27.9±7.7 µM); HeLa (IC50=62.6±8.4 µM); PC-3 (IC50=69.1±1.6 µM); Huh-7 (IC50=77.9±0.9 µM)	Not available	Linear	Free	Free		L	HEK293T: IC50=186.7±13.1 µM; WPMY-1: IC50=283.3±19.0 µM	Not available	27207743	Biochim Biophys Acta. 2016 Aug;1858(8):1914-25. 	Zhou XR, Zhang Q, Tian XB, Cao YM, Liu ZQ, Fan R, Ding XF, Zhu Z, Chen L, Luo SZ. 	From a pro-apoptotic peptide to a lytic peptide: One single residue mutation	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC
DRAMP31938	FKIGGFIKKLWRSLLA	16	ZXR-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	ZXR-2 could cause cell membrane lysis	Tumor cells: PC-3 (IC50=14.2±0.5 µM); PC-3 (IC50=14.8±1.6 μM ); Hep-G2 (IC50=7.5±1.2 µM); HeLa (IC50=8.1±1.6 µM); HeLa (IC50=8.1±1.6 μM ); Huh-7 (IC50=8.4±1.1 µm); SACC-83 (IC50=9.9±1.7 µM)	Not available	Linear	Free	Free		L	HEK293T: IC50=6.3±0.7 µM; WPMY-1: IC50=12.4±2.0 µM	Not available	27207743	Biochim Biophys Acta. 2016 Aug;1858(8):1914-25. 	Zhou XR, Zhang Q, Tian XB, Cao YM, Liu ZQ, Fan R, Ding XF, Zhu Z, Chen L, Luo SZ. 	From a pro-apoptotic peptide to a lytic peptide: One single residue mutation	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC
DRAMP31939	XIXIXIXRPVYXPRPRPPHPRL	22	Api796	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50>600µg/ml)	Human erythrocytes:0% Hemolysis=100-600µg/ml	Linear	gu=N , N , N ', N'-tetramethylguanidino)	Free	X=Orn	L	HEK293: 50% Cell death>600µg/ml	Not available	27243004	Front Cell Dev Biol. 2016 May 10;4:39.	Bluhm ME, Schneider VA, Schäfer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R. 	N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa	
DRAMP31940	XIXIXRPVYXPRPRPPHPRL	20	Api795	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50>600µg/ml)	Human erythrocytes:0% Hemolysis=100-600µg/ml	Linear	gu=N , N , N ', N'-tetramethylguanidino)	Free	X=Orn	L	HEK293: 50% Cell death>600µg/ml	Not available	27243004	Front Cell Dev Biol. 2016 May 10;4:39.	Bluhm ME, Schneider VA, Schäfer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R. 	N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa	
DRAMP31941	XWXWXRPVYXPRPRPPHPRL	20	Api793	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=640±150µg/ml)	Human erythrocytes:1% Hemolysis=100µg/ml; Human erythrocytes:2% Hemolysis=600µg/ml	Linear	gu=N , N , N ', N'-tetramethylguanidino)	Free	X=Orn	L	HEK293: 50% Cell death=640±50µg/ml	Not available	27243004	Front Cell Dev Biol. 2016 May 10;4:39.	Bluhm ME, Schneider VA, Schäfer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R. 	N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa	
DRAMP31942	XWXWXWXRPVYXPRPRPPHPRL	22	Api794	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=230 ± 90µg/ml)	Human erythrocytes:2% Hemolysis=100-600µg/ml	Linear	gu=N , N , N ', N'-tetramethylguanidino)	Free	X=Orn	L	HEK293: 50% Cell death=280±30µg/ml	Not available	27243004	Front Cell Dev Biol. 2016 May 10;4:39.	Bluhm ME, Schneider VA, Schäfer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R. 	N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa	
DRAMP31943	KWKSFLKTFKSAEKTVLHTALKAISS	26	V681 [V13E]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=109.68µM); SGC-7901 (IC50=92.04µM)	Human erythrocytes:<5% Hemolysis=>500µM	Linear	Acetylation	Amidation		L	3T3-L1:50% Cell death>125µM	Not available	27363513	Sci Rep. 2016 Jul 1;6:29145.	Sun S, Zhao G, Huang Y, Cai M, Shan Y, Wang H, Chen Y. 	Specificity and mechanism of action of alpha-helical membrane-active peptides interacting with model and biological membranes by single-molecule force spectroscopy	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP31944	ATCETPSKHFNGLCIRSSNCASVCHGEHFTDGRCQGVRRRCMCLKPC	47	PaDef defensin	Not available		Not found	Plant defensins	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PaDef defensin from avocado (Persea americana) fruit is cytotoxic to MCF-7 cells via the induction of mitochondrial apoptosis	Tumor cells: MCF-7 (IC 50=141.62 μg/mL  ); K562 (IC50=97.3 μg/mL (18.65 μM))	Not available	Linear	Free	Free		L	Not available	Not available	27470405	Biomed Pharmacother. 2016 Aug;82:620-7. 	Guzmán-Rodríguez JJ, López-Gómez R, Salgado-Garciglia R, Ochoa-Zarzosa A, López-Meza JE. 	The defensin from avocado (Persea americana var. drymifolia) PaDef induces apoptosis in the human breast cancer cell line MCF-7	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
DRAMP31945	TSLDASIWAMMQNA	14	P144	Not available		Not found	derived from the extracellular sequence of the human TGF-β type III receptor	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	P144 induced an upregulation of SMAD7 and downregulation of SKI through inhibition of the TGF-β pathway.	Tumor cells: U-87MG ATCC (IC50=16.34±1.47 µg/mL); A172 (IC50=21.96±3.68 µg/mL )	Not available	Linear	Free	Free		L	Not available	Transforming Growth Factor beta	27473823	Cancer Lett. 2016 Oct 10;381(1):67-75.	Gallo-Oller G, Vollmann-Zwerenz A, Meléndez B, Rey JA, Hau P, Dotor J, Castresana JS. 	P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP31946	RECKTESHRFKGPCITKPPCRKACISEKFTDGHCSKILRRCLCTKPC	47	NaD1 (1-7)-NaD2 (8-13)-NaD1 (14-47)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (22.2±2.4% Cell death=10µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	27503651	Antimicrob Agents Chemother. 2016 Sep 23;60(10):6302-12.	Bleackley MR, Payne JA, Hayes BM, Durek T, Craik DJ, Shafee TM, Poon IK, Hulett MD, van der Weerden NL, Anderson MA. 	Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O
DRAMP31947	RECKTESNTFPGICITKPPCRKACISEKFSGGDCSKILRRCLCTKPC	47	NaD1 (1-29)-NaD2 (30-33)-NaD1 (34-47)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (20.0±1.4% Cell death=10µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	27503651	Antimicrob Agents Chemother. 2016 Sep 23;60(10):6302-12.	Bleackley MR, Payne JA, Hayes BM, Durek T, Craik DJ, Shafee TM, Poon IK, Hulett MD, van der Weerden NL, Anderson MA. 	Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC
DRAMP31948	RECKTESNTFPGICITKPPCRKACISEKFTDGHCRGFRRRCLCTKPC	47	NaD1 (1-34)-NaD2 (35-40)-NaD1 (41-47)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (13.7±8.1% Cell death=10µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	27503651	Antimicrob Agents Chemother. 2016 Sep 23;60(10):6302-12.	Bleackley MR, Payne JA, Hayes BM, Durek T, Craik DJ, Shafee TM, Poon IK, Hulett MD, van der Weerden NL, Anderson MA. 	Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC
DRAMP31949	RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCFCTRPC	47	NaD1 (1-41)-NaD2 (42-47)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (43.1±7.2% Cell death=10µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	27503651	Antimicrob Agents Chemother. 2016 Sep 23;60(10):6302-12.	Bleackley MR, Payne JA, Hayes BM, Durek T, Craik DJ, Shafee TM, Poon IK, Hulett MD, van der Weerden NL, Anderson MA. 	Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC
DRAMP31950	RECKTESNTFPGICITKPPCRKACLTEGFTDGHCSKILRRCLCTKPC	47	NaD1 (1-24)-NaD2 (25-29)-NaD1 (30-47)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (44.6±8.5% Cell death=10µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	27503651	Antimicrob Agents Chemother. 2016 Sep 23;60(10):6302-12.	Bleackley MR, Payne JA, Hayes BM, Durek T, Craik DJ, Shafee TM, Poon IK, Hulett MD, van der Weerden NL, Anderson MA. 	Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC
DRAMP31951	RTCESQSHRFKGPCARDSNCATVCLTEGFSGGDCRGFRRRCFCTRPC	47	Class I defensin, NaD2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	"Tumor cells: U-937 (5.9±1.3% Cell death=10	µM)"	Not available	Cyclic	Free	Free		L	Not available	Not available	27503651	Antimicrob Agents Chemother. 2016 Sep 23;60(10):6302-12.	Bleackley MR, Payne JA, Hayes BM, Durek T, Craik DJ, Shafee TM, Poon IK, Hulett MD, van der Weerden NL, Anderson MA. 	Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP31952	RTCESQSNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC	47	NaD2 (1-7) - NaD1 (8-47)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (7.9±2.4% Cell death=10µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	27503651	Antimicrob Agents Chemother. 2016 Sep 23;60(10):6302-12.	Bleackley MR, Payne JA, Hayes BM, Durek T, Craik DJ, Shafee TM, Poon IK, Hulett MD, van der Weerden NL, Anderson MA. 	Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC
DRAMP31953	MQFITDLIKKAVDFFKGLFDNK	22	Warnericin RK [G20D]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (LD50=5.39µM)	Human erythrocytes:10% Hemolysis=12.36µM	Linear	Free	Free		L	Not available	Not available	27598770	PLoS One. 2016 Sep 6;11(9):e0162007. 	Loiseau C, Augenstreich J, Marchand A, Harté E, Garcia M, Verdon J, Mesnil M, Lecomte S, Berjeaud JM.	Specific Anti-Leukemic Activity of the Peptide Warnericin RK and Analogues and Visualization of Their Effect on Cancer Cells by Chemical Raman Imaging	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP31954	MQFITDLIKKAVDVFKGLFGNK	22	Warnericin RK [F14V]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (LD50=8.79µM)	Human erythrocytes:10% Hemolysis=12.5µM	Linear	Free	Free		L	Not available	Not available	27598770	PLoS One. 2016 Sep 6;11(9):e0162007. 	Loiseau C, Augenstreich J, Marchand A, Harté E, Garcia M, Verdon J, Mesnil M, Lecomte S, Berjeaud JM.	Specific Anti-Leukemic Activity of the Peptide Warnericin RK and Analogues and Visualization of Their Effect on Cancer Cells by Chemical Raman Imaging	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP31955	GIKHILFMAKTKLPRATCTAEIKENCDRKK	30	Saha-CATH1	Not available		Not found	Sarcophilus harrisii	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (Not active up to 500µg/ml)	Human erythrocytes:5% Hemolysis=1-500µg/ml	Linear	Free	Free		L	Not available	Not available	27725697	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Cathelicidins in the Tasmanian devil (Sarcophilus harrisii)	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC
DRAMP31956	KREDFLDQIIRDFRNFIYQKYRRLRDEFRKLRDILSG	37	Saha-CATH4	Not available		Not found	Sarcophilus harrisii	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (Not active up to 500µg/ml)	Human erythrocytes:5% Hemolysis=1-500µg/ml	Linear	Free	Free		L	Not available	Not available	27725697	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Cathelicidins in the Tasmanian devil (Sarcophilus harrisii)	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(=O)O
DRAMP31957	KRIGLIRLIGKILRGLRRLG	20	Saha-CATH5	Not available		Not found	Sarcophilus harrisii	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (Not active up to 500 µg/ml)	Human erythrocytes:5% Hemolysis=1-31.25µg/ml; 7% Hemolysis=62.5µg/ml; 12% Hemolysis=125µg/ml; 30% Hemolysis=250µg/ml	Linear	Free	Free		L	Not available	Not available	27725697	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Cathelicidins in the Tasmanian devil (Sarcophilus harrisii)	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)[C@H](C)CC
DRAMP31958	TFKRKNGSRKNGHRPGGYSLIALGNKKVLKAPYMESI	37	Saha-CATH2	Not available		Not found	Sarcophilus harrisii	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (Not active up to 500µg/ml)	Human erythrocytes:5% Hemolysis=1-500µg/ml	Linear	Free	Free		L	Not available	Not available	27725697	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Cathelicidins in the Tasmanian devil (Sarcophilus harrisii)	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)[C@@H](C)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)O
DRAMP31959	CGRRKRRRGCRRDSDCPGACICRYwKVCGSGSDGGV	36	MCoAA-01	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=40.12±0.13 μM); MCF-7 (IC50=45.01±0.16 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free	w=D-Tryptophane	Mix	HUVEC: IC50=10.83±0.09 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP31960	CPKILKKCRRDSDCPGACICRGNGYCGRRKRRRG	34	MCo-polyR-L6	P82409		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=52.89±0.11 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free		L	HUVEC: IC50=34.95±0.03 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CS)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
DRAMP31961	CPKILKKCRRDSDCPGACICRGNGYCGSGSDGGV	34	MCoTI-II	P82409		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	2PO8	Not available	Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free		L	HUVEC: IC50>100 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CS)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)O)C(C)C
DRAMP31962	CPKILKKCRRDSDCPGACICRGNGYCRFwKTW	32	MCo-SST-02	P82409		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=58.89±0.09 μM); MCF-7 (IC50=70.61±0.11 μM); PC-3 (IC50=83.55±0.20 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free	w=D-Tryptophane	Mix	HUVEC: IC50>100 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CS)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
DRAMP31963	CPKILKKCRRDSDCPGACICRGNGYCYHLNQPF	33	MCo-PEDF	P82409		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=35.22±0.08 μM); PC-3 (IC50=39.11±0.07 μM); MCF-7 (IC50=53.44±0.14 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free		L	HUVEC: IC50=50.16±0.15 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CS)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31964	CPKILKKCRRDSDCPGACICRYwKVCGSGSDGGV	34	MCo-SST-01	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=74.13±0.07 μM); PC-3 (IC50=85.44±0.08 μM); MCF-7 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free	w=D-Tryptophane	Mix	HUVEC: IC50=17.12±0.05 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CS)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP31965	CPKILKKCRRDSDCPGACICRYwKVCGYHLNQPFG	35	MCoAA-02	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=19.75±0.07 μM); PC-3 (IC50=35.44±0.13 μM); MCF-7 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free	w=D-Tryptophane	Mix	HUVEC: IC50=27.06±0.06 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CS)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(C)C
DRAMP31966	CRRKRRRCRRDSDCPGACICRGNGYCGSGSDGGV	34	MCo-polyR-L1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free		L	HUVEC: IC50>100 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)O)C(C)C
DRAMP31967	CRRKRRRICFPDGR	14	SFTI-polyR-L1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=28.72±0.15 μM); HT-29 (IC50=82.27±0.13 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free		L	HUVEC: IC50>100 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31968	CTKSIPPICFPDGR	14	SFTI-1	Q4GWU5		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	2AB9	Not available	Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free		L	HUVEC: IC50>100 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31969	CTKSIPPICRFwKTW	15	SFTI-SST-02	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=43.29±0.04 μM); MCF-7 (IC50=55.13±0.07 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free	w=D-Tryptophane	Mix	HUVEC: IC50>100 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
DRAMP31970	CTKSIPPICRRKRRR	15	SFTI-polyR-L2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=41.84±0.07 μM); HT-29 (IC50>100 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free		L	HUVEC: IC50>100 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP31971	CTKSIPPICYHLNQPF	16	SFTI-PEDF	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free		L	HUVEC: IC50=27.89±0.11 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31972	CTKSIPPICYwKV	13	SFTI-SST-01	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=45.38±0.03 μM); MCF-7 (IC50=46.07±0.05 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Cyclic	Free	Free	w=D-Tryptophane	Mix	HUVEC: IC50=18.32±0.05 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP31973	RFwKTW	6	SST-02	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Linear	Free	Free	w=D-Tryptophane	Mix	HUVEC: IC50>100 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP31974	RRKRRR	6	polyR	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=83.51±0.46 μM); HT-29 (IC50>100 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Linear	Free	Free		L	HUVEC: IC50=44.64±0.03 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP31975	YHLNQPF	7	PEDF	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Linear	Free	Free		L	HUVEC: IC50=19.40±0.08 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP31976	YwKV	4	SST-01	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50>100 μM); MCF-7 (IC50>100 μM); PC-3 (IC50>100 μM)	Human red blood cells:  no hemolytic activity(as show in Fig.4)	Linear	Free	Free	w=D-Tryptophane	Mix	HUVEC: IC50=57.54±0.04 μM	pigment epithelium-derived factor; somatostatin	27734947	Sci Rep. 2016 Oct 11;6:35019. 	Peel E, Cheng Y, Djordjevic JT, Fox S, Sorrell TC, Belov K. 	Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
DRAMP31977	FKAGGFIKKLWRSLLA	16	IL-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=58.4±13.7 μM); HeLa (IC50=73.9±13.6 μM)	Not available	Linear	Free	Free		L	HEK293T: IC50=24.1±3.2 μM; WPMY-1: IC50=43.2±4.9 μM	Not available	27778166	Amino Acids. 2017 Jan;49(1):193-202.	Fan R, Yuan Y, Zhang Q, Zhou XR, Jia L, Liu Z, Yu C, Luo SZ, Chen L. 	"Isoleucine/leucine residues at ""a"" and ""d"" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide"	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP31978	FKIGGFAKKLWRSLLA	16	IL-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=43.6±7.9 μM); HeLa (IC50=52.0±5.8 μM)	Not available	Linear	Free	Free		L	HEK293T: IC50=40.0±5.5 μM; WPMY-1: IC50=19.4±5.3 μM	Not available	27778166	Amino Acids. 2017 Jan;49(1):193-202.	Fan R, Yuan Y, Zhang Q, Zhou XR, Jia L, Liu Z, Yu C, Luo SZ, Chen L. 	"Isoleucine/leucine residues at ""a"" and ""d"" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide"	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP31979	FKIGGFIKKAWRSLLA	16	IL-3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=74.9±13.3 μM); HeLa (IC50=93.5±19.4 μM)	Not available	Linear	Free	Free		L	HEK293T: IC50=48.5±4.9 μM; WPMY-1: IC50=40.1±6.9 μM	Not available	27778166	Amino Acids. 2017 Jan;49(1):193-202.	Fan R, Yuan Y, Zhang Q, Zhou XR, Jia L, Liu Z, Yu C, Luo SZ, Chen L. 	"Isoleucine/leucine residues at ""a"" and ""d"" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide"	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC
DRAMP31980	FKIGGFIKKLWRSALA	16	IL-4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=35.5±3.9 μM); HeLa (IC50=54.4±3.0 μM)	Not available	Linear	Free	Free		L	HEK293T: IC50=36.1±4.7 μM; WPMY-1: IC50=19.9±6.3 μM	Not available	27778166	Amino Acids. 2017 Jan;49(1):193-202.	Fan R, Yuan Y, Zhang Q, Zhou XR, Jia L, Liu Z, Yu C, Luo SZ, Chen L. 	"Isoleucine/leucine residues at ""a"" and ""d"" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide"	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC
DRAMP31981	FKIGGFIKKLWRSLAA	16	IL-5	N0EAL3		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=22.0±2.6 μM); HeLa (IC50=28.0±4.6 μM)	Not available	Linear	Free	Free		L	HEK293T: IC50=27.6±2.7 μM; WPMY-1: IC50=12.7±3.1 μM	Not available	27778166	Amino Acids. 2017 Jan;49(1):193-202.	Fan R, Yuan Y, Zhang Q, Zhou XR, Jia L, Liu Z, Yu C, Luo SZ, Chen L. 	"Isoleucine/leucine residues at ""a"" and ""d"" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide"	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC
DRAMP31982	FIGAIARLLSK	11	BmKn-22	Not available		Not found	Scorpion venom	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	BmKn-2 exerts selective cytotoxic effects on human oral cancer cells by inducting apoptosis via a p53-dependent intrinsic apoptotic pathway. BmKn-2 peptide originally derived from a natural source shows great promise as a candidate treatment for oral cancer	Tumor cells: HSC-4 (IC50=97 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	27780132	Biomed Pharmacother. 2016 Dec;84:1042-1050. 	Satitmanwiwat S, Changsangfa C, Khanuengthong A, Promthep K, Roytrakul S, Arpornsuwan T, Saikhun K, Sritanaudomchai H. 	The scorpion venom peptide BmKn2 induces apoptosis in cancerous but not in normal human oral cells	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31983	RYRRKKKMKKALQYIKLLKE	20	Peptide 35409	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (Not active up to 44 µg/ml); HepG2 (Not active up to 44 µg/ml)	Human erythrocytes: 14% Hemolysis=350µM	Linear	Free	Free		L	Not available	Not available	28066341	Front Microbiol. 2016 Dec 20;7:2006. 	Barreto-Santamaría A, Curtidor H, Arévalo-Pinzón G, Herrera C, Suárez D, Pérez WH, Patarroyo ME.	A New Synthetic Peptide Having Two Target of Antibacterial Action in E. coli ML35	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP31984	XXXVXAaXXXX	11	Cyclosporin A	Not available		Not found	Tolypocladium inflatum	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CaCo-2 (0% Killing=12µM; 20% Killing=17µM); Huh-7 (0% Killing=8µM; 50% Killing=17µM)	Not available	Cyclic	Free	Free	X(1)=alpha-Aminobutyrate; X(2)=Sarcosine; X(3)=METH-Leu; X(5)=METH-Leu; X(7)=D-Ala; X(8)=METH-Leu; X(9)=METH-Leu; X(10)=METH-Val; X(11)=N-methyl-(4R)-4-[(E)-but-2-enyl]-4-methyl-L-threonyl	Mix	Vero E6: <10% Killing=5µM, 25% Killing=17µM; Fcwf-4: 0% Killing=4µM, 40% Killing=12µM	Not available	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O. 	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading	
DRAMP31985	ASVVNKLTGGVAGLLK	16	Bacteriocin TP	Not available		Not found	Bacillus subtilis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NB4 (IC50=11.479µM); MKN 45 (IC50=4.686µM)	Mouse erythrocytes: <10% Hemolysis=160µM; 10% Hemolysis=320µM	Linear	Free	Free		L	Not available	Not available	28254375	Int J Antimicrob Agents. 2017 Apr;49(4):427-436.	Xin H, Ji S, Peng J, Han P, An X, Wang S, Cao B.	Isolation and characterisation of a novel antibacterial peptide from a native swine intestinal tract-derived bacterium	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP31986	FASGIAGMAGKLF	13	Temporin-1Sa [L2,9A;V6A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50>60µM); HepG2 (IC50>600µM)	"Rat erythrocytes: 50% Hemolysis>200µM; Human erythrocytes: 50% Hemolysis	>100µM"	Linear	Free	Amidation		L	Not available	Not available	28319176	PLoS One. 2017 Mar 20;12(3):e0174024. 	Raja Z, André S, Abbassi F, Humblot V, Lequin O, Bouceba T, Correia I, Casale S, Foulon T, Sereno D, Oury B, Ladram A.	Insight into the mechanism of action of temporin-SHa, a new broad-spectrum antiparasitic and antibacterial agent	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP31987	ALlVNx	6	Wollamide B [W1A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP31988	lLWVNx	6	Wollamide B [W1l, l3W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP31989	WAlVNx	6	Wollamide B [L2A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP31990	WIlVNx	6	Wollamide B [L2I]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP31991	WLaVNx	6	Wollamide B [l3a]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP31992	WLIVNx	6	Wollamide B [l3I]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP31993	WLlANx	6	Wollamide B [V4A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP31994	WLlIIx	6	Wollamide B [V4I, N5I]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP31995	WLlINx	6	Wollamide B [V4I]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=50µM)	Not available	Cyclic	Free	Free	l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP31996	WLlISx	6	Wollamide B [V4I,N5S]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP31997	WLlIXx	6	Wollamide B [V4I, N5TERT BU SER]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP31998	WLlVAx	6	Wollamide B [N5A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP31999	WLlVxx	6	Wollamide B [N5D-ORN]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	l=D-Leu; x(5)=D-Orn; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP32000	WLxIxx	6	Wollamide B [l3D-Phe(4Cl), V4I, N5D-Orn]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	x(3)=D-4-Cl-Phe; x(5)=D-Orn; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP32001	WLxVNx	6	Wollamide B [l3D-Phe(4Cl)]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=60µM)	Not available	Cyclic	Free	Free	x(3)=D-4-Cl-Phe; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP32002	WLxVXx	6	Wollamide B [l3D-Me-Leu, N5Me-Asn]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	x(3)=METH-Leu; x(5)=METH-Asn; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP32003	WxlVNx	6	Wollamide B [L2D-Phe(4Cl)]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	x(2)=D-4-Cl-Phe; l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP32004	WXlVXx	6	Wollamide B [L2Me-Leu, N5Me-Asn]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	x(2)=METH-Leu; l=D-Leu; x(5)=METH-Asn; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP32005	WXlXNx	6	Wollamide B [L2Me-Leu, V4Me-Val]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	x(2)=METH-Leu; l=D-Leu; x(5)=METH-Val; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP32006	xLlVNx	6	Wollamide B [W1D-Phe(4-Cl)]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100µM)	Not available	Cyclic	Free	Free	x(1)=D-4-Cl-Phe; l=D-Leu; x(6)=D-Orn	Mix	Not available	Not available	28423019	PLoS One. 2017 Apr 19;12(4):e0176088.	Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P. 	Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent	
DRAMP32007	KKLFKKILKAL	11	BP100 [Y10A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/ADM (IC50=21.4±2.7µM); MCF-7 (IC50=23.2±2.4µM); K562 (IC50=27.4±3.5µM); K562/ADM (IC50=31.3±4.0µM)	Rabbit erythrocytes: 4% Hemolysis=160µM	Linear	Free	Amidation		L	GES-1: IC50=77.3±7.4µM	Not available	28474125	Amino Acids. 2017 Aug;49(8):1355-1364	Zhang B, Shi W, Li J, Liao C, Li M, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32008	KKLFKKILKDL	11	BP100 [Y10D]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/ADM (IC50=70.7±6.3µM); K562 (IC50=76.3±5.4µM); MCF-7 (IC50=77.9±6.7µM); K562/ADM (IC50=82.5±6.8µM)	Rabbit erythrocytes: 11% Hemolysis=160µM	Linear	Free	Amidation		L	GES-1: IC50>100µM	Not available	28474125	Amino Acids. 2017 Aug;49(8):1355-1364	Zhang B, Shi W, Li J, Liao C, Li M, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32009	KKLFKKILKEL	11	BP100 [Y10E]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/ADM (IC50=79.5±6.9µM); MCF-7 (IC50=83.2±6.7µM); K562 (IC50=89.4±7.3µM); K562/ADM (IC50>100µM)	Rabbit erythrocytes: 6.5% Hemolysis=160µM	Linear	Free	Amidation		L	GES-1: IC50>100µM	Not available	28474125	Amino Acids. 2017 Aug;49(8):1355-1364	Zhang B, Shi W, Li J, Liao C, Li M, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32010	KKLFKKILKGL	11	BP100 [Y10G]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/ADM (IC50=30.3±4.2µM); MCF-7 (IC50=33.5±3.3µM); K562 (IC50=34.5±4.0µM); K562/ADM (IC50=36.8±3.9µM)	Rabbit erythrocytes: 11% Hemolysis=160µM	Linear	Free	Amidation		L	GES-1: IC50>100µM	Not available	28474125	Amino Acids. 2017 Aug;49(8):1355-1364	Zhang B, Shi W, Li J, Liao C, Li M, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32011	KKLFKKILKHL	11	BP100 [Y10H]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/ADM (IC50=10.2±1.7µM); K562 (IC50=7.6±1.8µM); MCF-7 (IC50=8.6±1.3µM); K562/ADM (IC50=9.9±1.4µM)	Rabbit erythrocytes: 4% Hemolysis=160µM	Linear	Free	Amidation		L	GES-1: IC50=72.3±7.4µM	Not available	28474125	Amino Acids. 2017 Aug;49(8):1355-1364	Zhang B, Shi W, Li J, Liao C, Li M, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32012	KKLFKKILKIL	11	BP100 [Y10I]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/ADM (IC50=21.3±2.1µM); MCF-7 (IC50=21.5±1.9µM); K562 (IC50=23.7±2.3µM); K562/ADM (IC50=24.6±1.6µM)	Rabbit erythrocytes: 7.5% Hemolysis=160µM	Linear	Free	Amidation		L	GES-1: IC50=76.9±6.7µM	Not available	28474125	Amino Acids. 2017 Aug;49(8):1355-1364	Zhang B, Shi W, Li J, Liao C, Li M, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32013	KKLFKKILKLL	11	BP100 [Y10L]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=6.6±1.4µM); MCF-7/ADM (IC50=7.3±0.7µM); K562 (IC50=7.7±1.4µM); K562/ADM (IC50=9.3±1.7µM)	Rabbit erythrocytes: 5% Hemolysis=160µM	Linear	Free	Amidation		L	GES-1: IC50=67.4±8.3µM	Not available	28474125	Amino Acids. 2017 Aug;49(8):1355-1364	Zhang B, Shi W, Li J, Liao C, Li M, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32014	KKLFKKILKQL	11	BP100 [Y10Q]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/ADM (IC50=53.3±4.5µM); MCF-7 (IC50=53.6±4.2µM); K562 (IC50=57.6±3.9µM); K562/ADM (IC50=58.3±6.2µM)	Rabbit erythrocytes: 6.5% Hemolysis=160µM	Linear	Free	Amidation		L	GES-1: IC50=77.9±5.6µM	Not available	28474125	Amino Acids. 2017 Aug;49(8):1355-1364	Zhang B, Shi W, Li J, Liao C, Li M, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32015	KKLFKKILKRL	11	BP100 [Y10R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/ADM (IC50=57.3±4.5µM); MCF-7 (IC50=59.4±2.9µM); K562 (IC50=60.8±5.3µM); K562/ADM (IC50=71.2±4.7µM)	Rabbit erythrocytes: 5% Hemolysis=160µM	Linear	Free	Amidation		L	GES-1: IC50>100µM	Not available	28474125	Amino Acids. 2017 Aug;49(8):1355-1364	Zhang B, Shi W, Li J, Liao C, Li M, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32016	KKLFKKILKTL	11	BP100 [Y10T]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=32.2±2.2µM); MCF-7/ADM (IC50=33.7±3.9µM); MCF-7 (IC50=36.9±4.0µM); K562/ADM (IC50=39.5±3.7µM)	Rabbit erythrocytes: 5% Hemolysis=160µM	Linear	Free	Amidation		L	GES-1: IC50=82.8±9.2µM	Not available	28474125	Amino Acids. 2017 Aug;49(8):1355-1364	Zhang B, Shi W, Li J, Liao C, Li M, Huang W, Qian H.	Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32017	FRRFFKWFRRFFKFF	15	FR-15	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=2.5 μM); MDA-MB-231 (IC50=3.15 μM); HeLa (IC50=4.9 μM); DLD-1 (IC50=6.7 μM)	Not available	Linear	Free	Free		L	Not available	Not available	28483698	Acta Biomater. 2017 Jul 15;57:170-186.	Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK.	Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP32018	FRRFFKWFRRPFKFF	15	FR11P	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=11 μM); DLD-1 (IC50=12.9 μM); Hep-G2 (IC50=4.8 μM); MDA-MB-231 (IC50=7.0 μM)	Not available	Linear	Free	Free		L	Not available	Not available	28483698	Acta Biomater. 2017 Jul 15;57:170-186.	Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK.	Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP32019	FRRFFKWPRRFFKFF	15	FR8P	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=10.5 μM); DLD-1 (IC50=10.8 μM); Hep-G2 (IC50=4.2 μM); MDA-MB-231 (IC50=6.4 μM)	Not available	Linear	Free	Free		L	Not available	Not available	28483698	Acta Biomater. 2017 Jul 15;57:170-186.	Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK.	Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP32020	FRRFFKWPRRPFKFF	15	FR8, 11P	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=15 μM); HeLa (IC50=18.9 μM); DLD-1 (IC50=22 μM); MDA-MB-231 (IC50=27 μM)	Not available	Linear	Free	Free		L	Not available	Not available	28483698	Acta Biomater. 2017 Jul 15;57:170-186.	Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK.	Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP32021	FRRPFKWFRRFFKFF	15	FR4P	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=2.5 μM); MDA-MB-231 (IC50=6.3 μM); HeLa (IC50=7.7 μM); DLD-1 (IC50=9.4 μM)	Not available	Linear	Free	Free		L	Not available	Not available	28483698	Acta Biomater. 2017 Jul 15;57:170-186.	Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK.	Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP32022	FRRPFKWPRRFFKFF	15	FR4, 8P	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=13.8 μM); DLD-1 (IC50=15.3 μM); MDA-MB-231 (IC50=15.4 μM); Hep-G2 (IC50=5 μM)	Not available	Linear	Free	Free		L	Not available	Not available	28483698	Acta Biomater. 2017 Jul 15;57:170-186.	Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK.	Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP32023	KKLFKKILKY	10	B7	Not available		Not found	antimicrobial peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis	Tumor cells: K562 (IC50=73.7±6.1 μM); MCF-7 (IC50=77.3±5.6 μM); MCF-7/ADM (IC50=97.3±11.4 μM); K562/Adr (IC50>100 μM)	Rabbit red blood cells: very low hemolytic activity even at the concentration of 160 μm(as show in fig.3)	Linear	Free	Free		L	GES-1: IC50>100 μM	Not available	28524273	Chem Biol Drug Des. 2017 Nov;90(5):972-980.	Zhang B, Shi W, Li J, Liao C, Yang L, Huang W, Qian H. 	Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP32024	KKLFKKILKYLK	12	B1	Not available		Not found	antimicrobial peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis	Tumor cells: MCF-7 (IC50=15.7±1.5 μM); K562 (IC50=17.9±1.4 μM); MCF-7/ADM (IC50=18.2±1.3 μM); K562/Adr (IC50=19.1±2.1 μM)	Rabbit red blood cells: very low hemolytic activity even at the concentration of 160 μm(as show in fig.3)	Linear	Free	Free		L	GES-1: IC50=52.3±4.5 μM	Not available	28524273	Chem Biol Drug Des. 2017 Nov;90(5):972-980.	Zhang B, Shi W, Li J, Liao C, Yang L, Huang W, Qian H. 	Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32025	KKLFKKILKYLKK	13	B2	Not available		Not found	antimicrobial peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis	Tumor cells: MCF-7 (IC50=30.8±3.4 μM); K562 (IC50=33.6±4.2 μM); MCF-7/ADM (IC50=36.1±6.7 μM); K562/Adr (IC50=39.6±5.7 μM)	Rabbit red blood cells: very low hemolytic activity even at the concentration of 160 μm(as show in fig.3)	Linear	Free	Free		L	GES-1: IC50=89.6±7.2 μM	Not available	28524273	Chem Biol Drug Des. 2017 Nov;90(5):972-980.	Zhang B, Shi W, Li J, Liao C, Yang L, Huang W, Qian H. 	Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32026	KKLFKKILKYLKKL	14	B3	Not available		Not found	antimicrobial peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis	Tumor cells: MCF-7 (IC50=25.3±3.2 μM); MCF-7/ADM (IC50=28.4±3.1 μM); K562 (IC50=47.4±12.5 μM); K562/Adr (IC50>100 μM)	Rabbit red blood cells: very low hemolytic activity even at the concentration of 160 μm(as show in fig.3)	Linear	Free	Free		L	GES-1: IC50>100 μM	Not available	28524273	Chem Biol Drug Des. 2017 Nov;90(5):972-980.	Zhang B, Shi W, Li J, Liao C, Yang L, Huang W, Qian H. 	Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP32027	KLKKLFKKILKY	12	B9	Not available		Not found	antimicrobial peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis	Tumor cells: MCF-7/ADM (IC50=30.6±5.7 μM); MCF-7 (IC50=38.3±2.5 μM); K562 (IC50=60.7±5.4 μM); K562/Adr (IC50=83.7±5.3 μM)	Rabbit red blood cells: very low hemolytic activity even at the concentration of 160 μm(as show in fig.3)	Linear	Free	Free		L	GES-1: IC50=76.7±6.2 μM	Not available	28524273	Chem Biol Drug Des. 2017 Nov;90(5):972-980.	Zhang B, Shi W, Li J, Liao C, Yang L, Huang W, Qian H. 	Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP32028	LKKLFKKILKY	11	B8	Not available		Not found	antimicrobial peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis	Tumor cells: MCF-7/ADM (IC50=10.9±1.2 μM); MCF-7 (IC50=7.6±1.4 μM); K562 (IC50=7.7±1.2 μM); K562/Adr (IC50=8.1±0.9 μM)	Rabbit red blood cells: very low hemolytic activity even at the concentration of 160 μm(as show in fig.3)	Linear	Free	Free		L	GES-1: IC50=64.2±5.6 μM	Not available	28524273	Chem Biol Drug Des. 2017 Nov;90(5):972-980.	Zhang B, Shi W, Li J, Liao C, Yang L, Huang W, Qian H. 	Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP32029	LKKLFKKILKYL	12	B4	Not available		Not found	antimicrobial peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis	Tumor cells: MCF-7 (IC50=5.9±0.2 μM); MCF-7/ADM (IC50=6.3±0.4 μM); K562 (IC50=6.6±0.5 μM); K562/Adr (IC50=7.7±0.4 μM)	Rabbit red blood cells: very low hemolytic activity even at the concentration of 160 μm(as show in fig.3)	Linear	Free	Free		L	GES-1: IC50=73.7±4.5 μM	Not available	28524273	Chem Biol Drug Des. 2017 Nov;90(5):972-980.	Zhang B, Shi W, Li J, Liao C, Yang L, Huang W, Qian H. 	Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP32030	LKKLFKKILKYLK	13	B5	Not available		Not found	antimicrobial peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis	Tumor cells: K562 (IC50=26.5±1.5 μM); MCF-7 (IC50=27.3±2.4 μM); MCF-7/ADM (IC50=28.2±2.7 μM); K562/Adr (IC50=28.3±2.3 μM)	Rabbit red blood cells: very low hemolytic activity even at the concentration of 160 μm(as show in fig.3)	Linear	Free	Free		L	GES-1: IC50=63.6±4.7 μM	Not available	28524273	Chem Biol Drug Des. 2017 Nov;90(5):972-980.	Zhang B, Shi W, Li J, Liao C, Yang L, Huang W, Qian H. 	Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32031	LKKLFKKILKYLKK	14	B6	Not available		Not found	antimicrobial peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	disrupt the cell membrane, trigger the cytochrome C release into cytoplasm, and ultimately lead to apoptosis	Tumor cells: MCF-7 (IC50=18.4±1.5  μM); K562 (IC50=19.2±2.3 μM); MCF-7/ADM (IC50=20.7±1.6 μM); K562/Adr (IC50=22.7±2.3 μM)	Rabbit red blood cells: very low hemolytic activity even at the concentration of 160 μm(as show in fig.3)	Linear	Free	Free		L	GES-1: IC50=77.9±5.2 μM	Not available	28524273	Chem Biol Drug Des. 2017 Nov;90(5):972-980.	Zhang B, Shi W, Li J, Liao C, Yang L, Huang W, Qian H. 	Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32032	KAKAKAVSRSARAGLQFPVGRIHRHLK	27	Sphistin (12-38)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (Not active up to 100 µg/ml)	Crab haemocytes: Not active up to 100 µg/ml	Linear	Free	Free		L	Not available	Not available	28600196	Fish Shellfish Immunol. 2017 Aug;67:561-570.	Ma XW, Hou L, Chen B, Fan DQ, Chen YC, Yang Y, Wang KJ. 	A truncated Sph12-38 with potent antimicrobial activity showing resistance against bacterial challenge in Oryzias melastigma	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32033	IIGPVLGLIGKALGGLL	17	Bombinin H-BO	Not available		Not found	skin secretion of Oriental fire-bellied toad, Bombina orientalis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SK-HEP-1 (IC50=0.99 μM); Huh-7 (IC50=1.81 μM); Hep-G2 (IC50=2.88 μM)	Human erythrocytes: Bombinin H-BO was found to lyse 38% of erythrocytes at concentration of 80.0 μm (128 mg/ml), and up to 85% at the concentration of 159.7 μm (256 mg/ml).	Linear	Free	Amidation		L	Not available	Not available	28636781	Chem Biol Drug Des. 2018 Jan;91(1):50-61. 	Zhou C, Wang Z, Peng X, Liu Y, Lin Y, Zhang Z, Qiu Y, Jin M, Wang R, Kong D. 	Discovery of two bombinin peptides with antimicrobial and anticancer activities from the skin secretion of Oriental fire-bellied toad, Bombina orientalis	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP32034	kwfrvyrGiyrrr	13	D Tachyplesin [C3,7,12,16Del]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=9.814µM)	Sheep erythrocytes: <1% Hemolysis=67µM	Linear	Free	Amidation	k=D-Lys; w=D-Trp; f=D-Phe; r=D-Arg; v=D-Val; y=D-Tyr; i=D-Ile	Mix	Not available	Not available	28641565	Protein Pept Lett. 2017;24(7):590-598.	Evans HG, Guthrie JW, Jujjavarapu M, Hendrickson N, Eitel A, Park Y, Garvey J, Newman R, Esckilsen D, Heyl DL. 	D-Amino Acid Analogues of the Antimicrobial Peptide CDT Exhibit Anti- Cancer Properties in A549, a Human Lung Adenocarcinoma Cell Line	CC[C@H](C)[C@@H](NC(=O)CNC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](N)CCCCN)C(C)C)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP32035	rrryiGryvrfwk	13	Reverse D Tachyplesin [C3,7,12,16Del]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=90.16µM)	Sheep erythrocytes: <1% Hemolysis=8.4µM	Linear	Free	Amidation	k=D-Lys; w=D-Trp; f=D-Phe; r=D-Arg; v=D-Val; y=D-Tyr; i=D-Ile	Mix	Not available	Not available	28641565	Protein Pept Lett. 2017;24(7):590-598.	Evans HG, Guthrie JW, Jujjavarapu M, Hendrickson N, Eitel A, Park Y, Garvey J, Newman R, Esckilsen D, Heyl DL. 	D-Amino Acid Analogues of the Antimicrobial Peptide CDT Exhibit Anti- Cancer Properties in A549, a Human Lung Adenocarcinoma Cell Line	CC[C@H](C)[C@@H](NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(N)=O)C(C)C
DRAMP32036	RRRYIGRYVRFWK	13	Reverse Tachyplesin [C3,7,12,16Del]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=12100µM)	Sheep erythrocytes: <1% Hemolysis=540µM	Linear	Free	Amidation		L	Not available	Not available	28641565	Protein Pept Lett. 2017;24(7):590-598.	Evans HG, Guthrie JW, Jujjavarapu M, Hendrickson N, Eitel A, Park Y, Garvey J, Newman R, Esckilsen D, Heyl DL. 	D-Amino Acid Analogues of the Antimicrobial Peptide CDT Exhibit Anti- Cancer Properties in A549, a Human Lung Adenocarcinoma Cell Line	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP32037	LVKRFKKFFRKLKKSVLL	18	I-3	Not available		Not found	cationic host defense peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=10.3±0.3 μM); K562/ADM (IC50=12.9±0.3 μM); K562 (IC50=15.1±1.1 μM); HeLa (IC50=6.5±0.3 μM); MCF-7 (IC50=7.0±0.2 μM)	Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)	Linear	Free	Amidation		L	HUVEC: IC50=80.84±3.9 μM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. 	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(N)=O
DRAMP32038	LVRRFRRFFRRLRRSVLL	18	I-7	Not available		Not found	cationic host defense peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=14.3±0.2 μM); HeLa (IC50=4.2±0.8 μM); MCF-7 (IC50=5.9±0.1 μM); K562 (IC50=6.9±0.2 μM); K562/ADM (IC50=7.6±0.3 μM)	Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)	Linear	Free	Amidation		L	HUVEC: IC50=85.24±3.4 μM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. 	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(N)=O
DRAMP32039	VKRFKKFFLKLKSV	14	I-8	Not available		Not found	cationic host defense peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=15.4±0.1 μM); MCF-7 (IC50=22.5±3.3 μM); K562 (IC50=24.4±3.3 μM); K562/ADM (IC50=54.8±6.1 μM); MCF-7/Taxol (IC50=65.2±4.2 μM)	Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)	Linear	Free	Amidation		L	HUVEC: IC50=74.58±5.9 μM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. 	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP32040	VKRFKKFFRKLKKSVL	16	I-1	Not available		Not found	cationic host defense peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=12.7±2.5 μM); K562/ADM (IC50=19.3±0.8 μM); K562 (IC50=26.5±0.9 μM); MCF-7/Taxol (IC50=31.1±5.1 μM); HeLa (IC50=9.8±1.5 μM)	Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)	Linear	Free	Amidation		L	HUVEC: IC50=50.62±6.1 μM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. 	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(N)=O
DRAMP32041	VKRFKKFFRKLKKSVLL	17	I-2	Not available		Not found	cationic host defense peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=10.2±0.8 μM); MCF-7 (IC50=10.5±1.2 μM); K562 (IC50=20.4±3.3 μM); K562/ADM (IC50=20.7±1.1 μM); MCF-7/Taxol (IC50=30.2±2.4 μM)	Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)	Linear	Free	Amidation		L	HUVEC: IC50=64.15±3.7 μM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. 	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(N)=O
DRAMP32042	VKRFKLFFRKLKSV	14	I-9	Not available		Not found	cationic host defense peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=16.5±0.4 μM); MCF-7 (IC50=31.1±2.2 μM); K562 (IC50=33.4±1.1 μM); MCF-7/Taxol (IC50=43.6±1.1 μM); K562/ADM (IC50=55.6±3.3 μM)	Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)	Linear	Free	Amidation		L	HUVEC: IC50=72.37±2.7 μM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. 	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP32043	VRRFRLFFRRLRRSV	15	I-11	Not available		Not found	cationic host defense peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=11.5±0.5 μM); HeLa (IC50=19.0±1.1 μM); K562/ADM (IC50=23.2±1.7 μM); MCF-7/Taxol (IC50=35.7±1.5 μM); K562 (IC50=9.46±0.5 μM)	Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)	Linear	Free	Amidation		L	HUVEC: IC50=70.73±3.5 μM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. 	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP32044	VRRFRRFFLRLRRSV	15	I-10	Not available		Not found	cationic host defense peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=13.5±1.4 μM); MCF-7 (IC50=16.2±3.8 μM); MCF-7/Taxol (IC50=21.5±2.7 μM); K562 (IC50=25.6±3.3 μM); K562/ADM (IC50=43.5±4.2 μM)	Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)	Linear	Free	Amidation		L	HUVEC: IC50=70.07±2.1 μM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. 	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP32045	VRRFRRFFRRLRRSV	15	I-4	Not available		Not found	cationic host defense peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=10.7±0.5 μM); MCF-7 (IC50=16.9±2.1 μM); K562 (IC50=17.9±0.2 μM); K562/ADM (IC50=22.7±0.5 μM); MCF-7/Taxol (IC50=40.6±5.1 μM)	Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)	Linear	Free	Amidation		L	HUVEC: IC50=69.74±2.9 μM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. 	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP32046	VRRFRRFFRRLRRSVL	16	I-5	Not available		Not found	cationic host defense peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562/ADM (IC50=10.5±0.7 μM); MCF-7/Taxol (IC50=16.8±0.8 μM); K562 (IC50=20.4±0.7 μM); HeLa (IC50=3.3±1.1 μM); MCF-7 (IC50=7.5±0.9 μM)	Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)	Linear	Free	Amidation		L	HUVEC: IC50=75.84±6.8 μM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. 	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(C)C)C(N)=O
DRAMP32047	VRRFRRFFRRLRRSVLL	17	I-6	Not available		Not found	cationic host defense peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562/ADM (IC50=10.3±0.3 μM); MCF-7/Taxol (IC50=15.1±1.0 μM); MCF-7 (IC50=3.8±0.4 μM); HeLa (IC50=7.9±0.9 μM); K562 (IC50=8.5±1.1 μM)	Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)	Linear	Free	Amidation		L	HUVEC: IC50=82.37±4.4 μM	Not available	28664269	Amino Acids. 2017 Sep;49(9):1601-1610.	Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H. 	Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(C)C)C(N)=O
DRAMP32048	GGVCPKILKKCRRDSDCPGACICRGNGYCGSGSD	34	MCoTI-II	Not available		Not found	Momordica cochinchinensis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937/GTB (IC50>>80µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	28669767	Biochim Biophys Acta Biomembr. 2017 Oct;1859(10):1986-2000	Strömstedt AA, Park S, Burman R, Göransson U.	Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP32049	GGVCPKILQRCRRDSDCPGACICRGNGYCGSGSD	34	MCoTI-I	Not available		Not found	Momordica cochinchinensis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937/GTB (IC50>>32µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	28669767	Biochim Biophys Acta Biomembr. 2017 Oct;1859(10):1986-2000	Strömstedt AA, Park S, Burman R, Göransson U.	Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP32050	GLPVCGETCTLGTCSTQGCTCSWPICKRN	29	Kalata B7 [Y15S]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937/GTB (IC50>>40µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	28669767	Biochim Biophys Acta Biomembr. 2017 Oct;1859(10):1986-2000	Strömstedt AA, Park S, Burman R, Göransson U.	Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP32051	FpFw	4	[D-Trp]CJ-15,208	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=16.5±0.7 µM)	Not available	Cyclic	Lactam	Lactam	p=D-Proline; w=D-Tryptophane	Mix	Not available	Not available	28692379	Cancer Biol Ther. 2017 Aug 3;18(8):571-583.	Mukhopadhyay A, Hanold LE, Thayele Purayil H, Gisemba SA, Senadheera SN, Aldrich JV.	Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth	
DRAMP32052	FpFW	4	CJ-15,208	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=10.1±0.9 µM)	Not available	Cyclic	Lactam	Not available	p=D-Proline	Mix	Not available	Not available	28692379	Cancer Biol Ther. 2017 Aug 3;18(8):571-583.	Mukhopadhyay A, Hanold LE, Thayele Purayil H, Gisemba SA, Senadheera SN, Aldrich JV.	Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth	
DRAMP32053	FLGAIAQALTSLLGKL	16	temporin-ITa	C0HL49		Not found	skin secretions of the Italian stream frog Rana italica (Ranidae)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC50=100 μM); MDA-MB-231 (LC50=40 μM); A549 (LC50=45 μM)	mouse erythrocytes: LC50=22 μM	Linear	Free	α-amidated residue at the C-terminus	α-amidated residue at the C-terminus	L	Not available	Not available	28699258	J Pept Sci. 2017 Oct;23(10):769-776. 	Conlon JM, Musale V, Attoub S, Mangoni ML, Leprince J, Coquet L, Jouenne T, Abdel-Wahab YHA, Flatt PR, Rinaldi AC. 	Cytotoxic peptides with insulin-releasing activities from skin secretions of the Italian stream frog Rana italica (Ranidae)	
DRAMP32054	IVPFLLGMVPKLVCLITKKC	20	Brevinin-1ITa	C0HL47		Not found	skin secretions of the Italian stream frog Rana italica (Ranidae)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=18 μM); HT-29 (LC50=18 μM); MDA-MB-231 (LC50=8 μM)	mouse erythrocytes: LC50=7 μM	Linear	Free	Free		L	Not available	Not available	28699258	J Pept Sci. 2017 Oct;23(10):769-776. 	Conlon JM, Musale V, Attoub S, Mangoni ML, Leprince J, Coquet L, Jouenne T, Abdel-Wahab YHA, Flatt PR, Rinaldi AC. 	Cytotoxic peptides with insulin-releasing activities from skin secretions of the Italian stream frog Rana italica (Ranidae)	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(C)C)C(C)C
DRAMP32055	GXRRLXYKQRXVTYXRGR	18	Cyclic Gomesin [PYA1G, C2,6,11,15SeCys]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (CC50=1.4±0.2µM); MCF-7 (CC50=37.5±3.3µM); HL-60 (CC50=38.5±4.8µM); MM96L (CC50=4.6±0.2µM); CRL-1739 (CC50=51.0±4.6µM); HeLa (CC50>64µM)	Human erythrocytes: 32.8±0.5% Hemolysis=64µM	Cyclic	Free	Free	X=Se-Cys	L	HFF-1: CC50=15.6±3.6µM; PBMC: CC50=15.5±0.8µM	Not available	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334.	Troeira Henriques S, Lawrence N, Chaousis S, Ravipati AS, Cheneval O, Benfield AH, Elliott AG, Kavanagh AM, Cooper MA, Chan LY, Huang YH, Craik DJ. 	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP32056	KXRRYXYRQRXVTYXRGR	18	Cyclic Gomesin [PYA1K;C2,6,11,15SeCys;L5Y;K8R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (CC50=2.3±0.2µM); MCF-7 (CC50=29.0±3.7µM); HL-60 (CC50=33.3±7.4µM); HeLa (CC50=36.2±2.8µM); CRL-1739 (CC50=46.2±7.6µM); K562 (CC50=6.4±0.6µM)	Human erythrocytes: 20.9±3.1% Hemolysis=64µM	Cyclic	Free	Free	X=Se-Cys	L	HFF-1: CC50=30.8±2.0µM; PBMC: CC50=9.5±0.5µM	Not available	28741926	ACS Chem Biol. 2017 Sep 15;12(9):2324-2334.	Troeira Henriques S, Lawrence N, Chaousis S, Ravipati AS, Cheneval O, Benfield AH, Elliott AG, Kavanagh AM, Cooper MA, Chan LY, Huang YH, Craik DJ. 	Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties	
DRAMP32057	RRGLFKKLRRKIKKGFKKIFKRLPPVGVGVSIPLAGRR	38	As-CATH4	Not available		Not found	Alligator sinensis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BGC-823 (26±0.9% Cell death=200µg/ml); BGC-823 (58±1.5% Cell death=200µg/ml); BGC-823 (58±1.5% Cell death=200µg/ml)	Human erythrocytes: 4±0.5% Hemolysis=200µg/ml	Linear	Free	Free		L	CHO: 55±2.5% Cell death=200µg/ml	Not available	28798159	Biochem J. 2017 Aug 10;474(16):2861-2885. 	Chen Y, Cai S, Qiao X, Wu M, Guo Z, Wang R, Kuang YQ, Yu H, Wang Y. 	As-CATH1-6, novel cathelicidins with potent antimicrobial and immunomodulatory properties from Alligator sinensis, play pivotal roles in host antimicrobial immune responses	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C)C(C)C)C(C)C)[C@H](C)CC
DRAMP32058	WDPYFAGVKKLTKAILAVRA	20	Lavracin	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (EC50=(50-100)µM); MEC-7 (Not active up to 100 µM)	Not available	Linear	Free	Amidation		L	HDME: Not active up to 100 µM	Not available	28799716	Small. 2017 Oct;13(40).	Pillong M, Hiss JA, Schneider P, Lin YC, Posselt G, Pfeiffer B, Blatter M, Müller AT, Bachler S, Neuhaus CS, Dittrich PS, Altmann KH, Wessler S, Schneider G.	Rational Design of Membrane-Pore-Forming Peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(N)=O)C(C)C
DRAMP32059	WGKFFAGVKKLTKAILAVRA	20	Lavracin [D2G,P3K,Y4F]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (EC50=25µM)	Not available	Linear	Free	Amidation		L	HDME: Not active up to 100 µM	Not available	28799716	Small. 2017 Oct;13(40).	Pillong M, Hiss JA, Schneider P, Lin YC, Posselt G, Pfeiffer B, Blatter M, Müller AT, Bachler S, Neuhaus CS, Dittrich PS, Altmann KH, Wessler S, Schneider G.	Rational Design of Membrane-Pore-Forming Peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(N)=O)C(C)C
DRAMP32060	WDPYFAGVKKLTKAILGEIA	20	Lavracin [A17G,V18E,R19I]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (Not active up to 100 µM)	Not available	Linear	Free	Amidation		L	HDME: Not active up to 100 µM	Not available	28799716	Small. 2017 Oct;13(40).	Pillong M, Hiss JA, Schneider P, Lin YC, Posselt G, Pfeiffer B, Blatter M, Müller AT, Bachler S, Neuhaus CS, Dittrich PS, Altmann KH, Wessler S, Schneider G.	Rational Design of Membrane-Pore-Forming Peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)[C@H](C)CC
DRAMP32061	WGKFFAGVKKLTKAILGEIA	20	Lavracin [D2G,P3K,Y4F,A17G,V18E,R19I]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (EC50=25µM)	Not available	Linear	Free	Amidation		L	HDME: Not active up to 100 µM	Not available	28799716	Small. 2017 Oct;13(40).	Pillong M, Hiss JA, Schneider P, Lin YC, Posselt G, Pfeiffer B, Blatter M, Müller AT, Bachler S, Neuhaus CS, Dittrich PS, Altmann KH, Wessler S, Schneider G.	Rational Design of Membrane-Pore-Forming Peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)[C@H](C)CC
DRAMP32062	IKKILSKIKKLLK	13	L-K6	Not available		Not found	some cationic antimicrobial peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=23 μM ); MCF-7 (IC50=31 μM ); MCF-7 (IC50=34 μM ); MCF-7 (IC50=38 μM )	Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)	Linear	Free	Free		L	HUVEC: IC50=65.88±4.5 μM	Not available	28811617	Sci Rep. 2017 Aug 15;7(1):8293.	Wang C, Dong S, Zhang L, Zhao Y, Huang L, Gong X, Wang H, Shang D. 	Cell surface binding, uptaking and anticancer activity of L-K6, a lysine/leucine-rich peptide, on human breast cancer MCF-7 cells	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC
DRAMP32063	FLSLIPAAISAVSALANHF	19	Phylloseptin-PHa	Not available		Not found	Pithecopus hypochondrialis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (LD50=24.05µM); MDA-MB-435S (LD50=28.48µM); U-251MG (LD50=34.67µM); HCT 116 (LD50=36.64µM); NCI-H157 (LD50=37.61µM); PC-3 (LD50=37.96µM)	Horse erythrocytes: 10% Hemolysis=76.5µM; 50% Hemolysis=109.5µM; 50% Hemolysis=52.17µM	Linear	Free	Amidation		L	Not available	Not available	28850103	Molecules. 2017 Aug 29;22(9):1428. 	Liu J, Wu Q, Li L, Xi X, Wu D, Zhou M, Chen T, Shaw C, Wang L. 	Discovery of Phylloseptins that Defense against Gram-Positive Bacteria and Inhibit the Proliferation of the Non-Small Cell Lung Cancer Cell Line, from the Skin Secretions of Phyllomedusa Frogs	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP32064	FLSLIPKIAGGIAALAKHL	19	Phylloseptin-PT	Not available		Not found	Phyllomedusa baltea	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H157 (IC50=6.73µM)	Horse erythrocytes: 10% Hemolysis=7.79µM; 50% Hemolysis=22.8µM	Linear	Free	Amidation		L	Not available	Not available	28850103	Molecules. 2017 Aug 29;22(9):1428. 	Liu J, Wu Q, Li L, Xi X, Wu D, Zhou M, Chen T, Shaw C, Wang L. 	Discovery of Phylloseptins that Defense against Gram-Positive Bacteria and Inhibit the Proliferation of the Non-Small Cell Lung Cancer Cell Line, from the Skin Secretions of Phyllomedusa Frogs	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32065	XXLXAXX	7	Ilamycin B1	Not available		Not found	Streptomyces atratus SCSIO ZH16	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32066	XXLXAXX	7	Ilamycin B1	Not available		Not found	Streptomyces atratus SCSIO ZH16	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=13.8 µM); MCF-7 (IC50=17.4 µM); CNE2 (IC50=24.5 µM); HeLa (IC50=7.1 µM); HepG2 (IC50=8.9 µm)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32067	XXLXAXX	7	Ilamycin B1	Not available		Not found	Streptomyces atratus SCSIO ZH16	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=3.2 µM); HeLa (IC50=3.3 µM); A549 (IC50=3.5 µM); MCF-7 (IC50=4.5 µM); CNE2 (IC50=6.8 µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32068	XXLXAXX	7	Ilamycin B1	Not available		Not found	Streptomyces atratus SCSIO ZH16	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32069	XXLXAXX	7	Ilamycin B1	Not available		Not found	Streptomyces atratus SCSIO ZH16	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CNE2 (IC50=14.9 µM); HeLa (IC50=3.9 µM); MCF-7 (IC50=3.9 µM); HepG2 (IC50=4.9 µM); A549 (IC50=6.2 µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32070	XXLXAXX	7	Ilamycin B1	Not available		Not found	Streptomyces atratus SCSIO ZH16	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32071	XXLXAXX	7	Ilamycin B2	Not available		Not found	Streptomyces atratus SCSIO ZH16	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50=24.6 µM; HUVEC: IC50=18.6 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32072	XXLXAXX	7	Ilamycin B2	Not available		Not found	Streptomyces atratus SCSIO ZH16	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=13.8 µM); MCF-7 (IC50=17.4 µM); CNE2 (IC50=24.5 µM); HeLa (IC50=7.1 µM); HepG2 (IC50=8.9 µm)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50=24.6 µM; HUVEC: IC50=18.6 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32073	XXLXAXX	7	Ilamycin B2	Not available		Not found	Streptomyces atratus SCSIO ZH16	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=3.2 µM); HeLa (IC50=3.3 µM); A549 (IC50=3.5 µM); MCF-7 (IC50=4.5 µM); CNE2 (IC50=6.8 µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50=24.6 µM; HUVEC: IC50=18.6 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32074	XXLXAXX	7	Ilamycin B2	Not available		Not found	Streptomyces atratus SCSIO ZH16	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50=24.6 µM; HUVEC: IC50=18.6 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32075	XXLXAXX	7	Ilamycin B2	Not available		Not found	Streptomyces atratus SCSIO ZH16	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CNE2 (IC50=14.9 µM); HeLa (IC50=3.9 µM); MCF-7 (IC50=3.9 µM); HepG2 (IC50=4.9 µM); A549 (IC50=6.2 µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50=24.6 µM; HUVEC: IC50=18.6 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32076	XXLXAXX	7	Ilamycin B2	Not available		Not found	Streptomyces atratus SCSIO ZH16	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50=24.6 µM; HUVEC: IC50=18.6 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32077	XXLXAXX	7	Ilamycin C	Not available		Not found	Streptomyces atratus SCSIO ZH21	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu	L	HL-7702 (L02): IC50=7.4 µM; HUVEC: IC50=33.8 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32078	XXLXAXX	7	Ilamycin C	Not available		Not found	Streptomyces atratus SCSIO ZH21	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=13.8 µM); MCF-7 (IC50=17.4 µM); CNE2 (IC50=24.5 µM); HeLa (IC50=7.1 µM); HepG2 (IC50=8.9 µm)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu	L	HL-7702 (L02): IC50=7.4 µM; HUVEC: IC50=33.8 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32079	XXLXAXX	7	Ilamycin C	Not available		Not found	Streptomyces atratus SCSIO ZH21	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=3.2 µM); HeLa (IC50=3.3 µM); A549 (IC50=3.5 µM); MCF-7 (IC50=4.5 µM); CNE2 (IC50=6.8 µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu	L	HL-7702 (L02): IC50=7.4 µM; HUVEC: IC50=33.8 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32080	XXLXAXX	7	Ilamycin C	Not available		Not found	Streptomyces atratus SCSIO ZH21	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu	L	HL-7702 (L02): IC50=7.4 µM; HUVEC: IC50=33.8 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32081	XXLXAXX	7	Ilamycin C	Not available		Not found	Streptomyces atratus SCSIO ZH21	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CNE2 (IC50=14.9 µM); HeLa (IC50=3.9 µM); MCF-7 (IC50=3.9 µM); HepG2 (IC50=4.9 µM); A549 (IC50=6.2 µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu	L	HL-7702 (L02): IC50=7.4 µM; HUVEC: IC50=33.8 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32082	XXLXAXX	7	Ilamycin C	Not available		Not found	Streptomyces atratus SCSIO ZH21	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu	L	HL-7702 (L02): IC50=7.4 µM; HUVEC: IC50=33.8 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32083	XXLXAXX	7	Ilamycin D	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32084	XXLXAXX	7	Ilamycin D	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=13.8 µM); MCF-7 (IC50=17.4 µM); CNE2 (IC50=24.5 µM); HeLa (IC50=7.1 µM); HepG2 (IC50=8.9 µm)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32085	XXLXAXX	7	Ilamycin D	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=3.2 µM); HeLa (IC50=3.3 µM); A549 (IC50=3.5 µM); MCF-7 (IC50=4.5 µM); CNE2 (IC50=6.8 µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32086	XXLXAXX	7	Ilamycin D	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32087	XXLXAXX	7	Ilamycin D	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CNE2 (IC50=14.9 µM); HeLa (IC50=3.9 µM); MCF-7 (IC50=3.9 µM); HepG2 (IC50=4.9 µM); A549 (IC50=6.2 µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32088	XXLXAXX	7	Ilamycin D	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-OH-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(8)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32089	XXLXAXX	7	Ilamycin E	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50=14.9 µM; HUVEC: IC50=18.6 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32090	XXLXAXX	7	Ilamycin E	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=13.8 µM); MCF-7 (IC50=17.4 µM); CNE2 (IC50=24.5 µM); HeLa (IC50=7.1 µM); HepG2 (IC50=8.9 µm)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50=14.9 µM; HUVEC: IC50=18.6 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32091	XXLXAXX	7	Ilamycin E	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=3.2 µM); HeLa (IC50=3.3 µM); A549 (IC50=3.5 µM); MCF-7 (IC50=4.5 µM); CNE2 (IC50=6.8 µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50=14.9 µM; HUVEC: IC50=18.6 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32092	XXLXAXX	7	Ilamycin E	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50=14.9 µM; HUVEC: IC50=18.6 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32093	XXLXAXX	7	Ilamycin E	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CNE2 (IC50=14.9 µM); HeLa (IC50=3.9 µM); MCF-7 (IC50=3.9 µM); HepG2 (IC50=4.9 µM); A549 (IC50=6.2 µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50=14.9 µM; HUVEC: IC50=18.6 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32094	XXLXAXX	7	Ilamycin E	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50=14.9 µM; HUVEC: IC50=18.6 µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32095	XXLXAXX	7	Ilamycin F	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32096	XXLXAXX	7	Ilamycin F	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=13.8 µM); MCF-7 (IC50=17.4 µM); CNE2 (IC50=24.5 µM); HeLa (IC50=7.1 µM); HepG2 (IC50=8.9 µm)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32097	XXLXAXX	7	Ilamycin F	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=3.2 µM); HeLa (IC50=3.3 µM); A549 (IC50=3.5 µM); MCF-7 (IC50=4.5 µM); CNE2 (IC50=6.8 µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32098	XXLXAXX	7	Ilamycin F	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32099	XXLXAXX	7	Ilamycin F	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CNE2 (IC50=14.9 µM); HeLa (IC50=3.9 µM); MCF-7 (IC50=3.9 µM); HepG2 (IC50=4.9 µM); A549 (IC50=6.2 µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32100	XXLXAXX	7	Ilamycin F	Not available		Not found	Streptomyces atratus SCSIO ZH25	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50µM); CNE2 (IC50>50µM); HeLa (IC50>50µM); HepG2 (IC50>50µM); MCF-7 (IC50>50µM)	Not available	Cyclic	Free	Free	X(1)=Pre-Trp; X(2)=(2S)-2-Aminohex-4-enoic acid; X(4)=OH-METH-Leu; X(6)=N-Tyr; X(7)=METH-Leu	L	HL-7702 (L02): IC50>50µM; HUVEC: IC50>50µM	Not available	28855504	Nat Commun. 2017 Aug 30;8(1):391.	Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. 	Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents	
DRAMP32101	FTVAXFI	7	Bacteriocin ASP-1	Not available		Not found	Bacillus subtilis URID 12.1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=192µg/ml); MCF-7 (IC50=280µg/ml)	Human erythrocytes: <5% Hemolysis=128µg/ml; 30% Hemolysis=256µg/ml	Cyclic	Acetylation	Free	X=dehydrobutyrine	L	Not available	Not available	28887200	Int J Antimicrob Agents. 2018 Jan;51(1):89-97.	Chalasani AG, Roy U, Nema S. 	Purification and characterization of a novel anti-staphylococcal peptide (ASP-1) from bacillus sp. URID 12.1	
DRAMP32102	NPEKALEKLIAIQKAIKGMLNGWFTGVGFRRKR	33	LysAB2 P3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (Not active up to 200 µm)	Human erythrocytes: 1.97% Hemolysis=4µM; <10% Hemolysis=256µM	Linear	Free	Free		L	HaCat: Not active up to 200 µM	Not available	28904355	Sci Rep. 2017 Sep 13;7(1):11477. 	Peng SY, You RI, Lai MJ, Lin NT, Chen LK, Chang KC.	Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC
DRAMP32103	FKARRWQWRMKKLGAFKARRWQWRMKKLGAKX	32	LfcinB (17-31)2	Not available		Not found	Bovine Lactoferricin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-468 (IC50=11 μM); MDA-MB-231 (IC50=31 μM)	Not available	Linear	Free	Free	X=Ahx	L	Not available	Not available	28961215	Molecules. 2017 Sep 29;22(10):1641. 	Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. 	Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines	
DRAMP32104	FKARRWQWRMKKLGAFKARRWQWRMKKLGAKXC	33	LfcinB (17-31)4	Not available		Not found	Bovine Lactoferricin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-468 (IC50=5 μM); MDA-MB-231 (IC50=9 μM)	Not available	Tetrameric	Free	Free	X=Ahx	L	Not available	Not available	28961215	Molecules. 2017 Sep 29;22(10):1641. 	Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. 	Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines	
DRAMP32105	RRWQWRRRWQWRKX	14	LfcinB (20–25)2	Not available		Not found	Bovine Lactoferricin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50=130 μM); MDA-MB-468 (IC50>100 μM)	Not available	Linear	Free	Free	X=Ahx	L	Not available	Not available	28961215	Molecules. 2017 Sep 29;22(10):1641. 	Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. 	Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines	
DRAMP32106	RRWQWRRRWQWRKXC	15	LfcinB (20–25)4	Not available		Not found	Bovine Lactoferricin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50=15 μM); MDA-MB-468 (IC50=6 μM)	Not available	Tetrameric	Free	Free	X=Ahx	L	Not available	Not available	28961215	Molecules. 2017 Sep 29;22(10):1641. 	Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. 	Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines	
DRAMP32107	RWQWRMKKLGRWQWRMKKLGKX	22	LfcinB (20–30)2	Not available		Not found	Bovine Lactoferricin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50=14 μM); MDA-MB-468 (IC50=5 μM)	Not available	Linear	Free	Free	X=Ahx	L	Not available	Not available	28961215	Molecules. 2017 Sep 29;22(10):1641. 	Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. 	Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines	
DRAMP32108	RWQWRMKKLGRWQWRMKKLGKXC	23	LfcinB (20–30)4	Not available		Not found	Bovine Lactoferricin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-468 (IC50=2 μM); MDA-MB-231 (IC50=6 μM)	Not available	Tetrameric	Free	Free	X=Ahx	L	Not available	Not available	28961215	Molecules. 2017 Sep 29;22(10):1641. 	Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. 	Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines	
DRAMP32109	CFKARRWQWRMKKLGAXC	18	LfcinB (17-31)cyc	Not available		Not found	Bovine Lactoferricin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50>88 μM); MDA-MB-468 (IC50>88 μM)	Not available	Linear	Free	Free	X=Ahx	L	Not available	Not available	28961215	Molecules. 2017 Sep 29;22(10):1641. 	Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. 	Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines	
DRAMP32110	CRRWQWRXC	9	LfcinB (20–25)cyc	Not available		Not found	Bovine Lactoferricin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50>200 μM); MDA-MB-468 (IC50>200 μM)	Not available	Cyclic	Free	Free	X=Ahx	L	Not available	Not available	28961215	Molecules. 2017 Sep 29;22(10):1641. 	Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. 	Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines	
DRAMP32111	RWQWRMKKLG	10	LfcinB (20–30)	Not available		Not found	Bovine Lactoferricin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50>103 μM); MDA-MB-468 (IC50>103 μM)	Not available	Linear	Free	Free		L	Not available	Not available	28961215	Molecules. 2017 Sep 29;22(10):1641. 	Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. 	Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O
DRAMP32112	CRWQWRMKKLGXC	13	LfcinB (20–30)cyc	Not available		Not found	Bovine Lactoferricin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50=7 μM); MDA-MB-468 (IC50>107 μM)	Not available	Linear	Free	Free	X=Ahx	L	Not available	Not available	28961215	Molecules. 2017 Sep 29;22(10):1641. 	Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE, Rivera Monroy ZJ. 	Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines	
DRAMP32113	GFGCPFNARRCHRHCRSIRRRAGYCAGRLRLTCTCVR	37	HlDFS1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (Not active up to 20 µM); K562 (Not active up to 20 µM); THP-1 (Not active up to 20 µM)	Human erythrocytes: <5% Hemolysis=10µM; 18% Hemolysis=20µM; 60% Hemolysis=50µM	Cyclic	Free	Free		L	HEK293T: Not active up to 20 µM	Not available	28969703	Parasit Vectors. 2017 Oct 2;10(1):455. 	Sun T, Pan W, Song Y, Zhang J, Wang J, Dai J.	Functional characterization of two defensins, HlDFS1 and HlDFS2, from the hard tick Haemaphysalis longicornis	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O
DRAMP32114	GFGCPLNQGACHRHCRSIRRRGGYCSGIIKQTCTCY	36	HlDFS2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (Not active up to 20 µM); K562 (Not active up to 20 µM); THP-1 (Not active up to 20 µM)	Human erythrocytes: <5% Hemolysis=50µM	Cyclic	Free	Free		L	HEK293T: Not active up to 20 µM	Not available	28969703	Parasit Vectors. 2017 Oct 2;10(1):455. 	Sun T, Pan W, Song Y, Zhang J, Wang J, Dai J.	Functional characterization of two defensins, HlDFS1 and HlDFS2, from the hard tick Haemaphysalis longicornis	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC
DRAMP32115	ALWKEVLKNAGKAALNEINNLVQ	23	Dermaseptin-PH	Not available		Not found	Phyllomedusa hypochondrialis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=0.69µM); PC-3 (IC50=11.8µM); NCI-H157 (IC50=2.01µM); U-251MG (IC50=2.36µM); MDA-MB-435S (IC50=9.94µM)	Horse erythrocytes: 1% Hemolysis=16µM; 3% Hemolysis=64µM; 10% Hemolysis=128µM; 45% Hemolysis=256µM; 100% Hemolysis=512µM	Linear	Free	Amidation		L	HMEC-1: IC50=4.85µM	Not available	29064402	Molecules. 2017 Oct 24;22(10):1805.	Huang L, Chen D, Wang L, Lin C, Ma C, Xi X, Chen T, Shaw C, Zhou M. 	Dermaseptin-PH: A Novel Peptide with Antimicrobial and Anticancer Activities from the Skin Secretion of the South American Orange-Legged Leaf Frog, Pithecopus (Phyllomedusa) hypochondrialis	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(N)=O)C(C)C
DRAMP32116	GIGSAILSAGKSIIKGLAKGLAEHF	25	Bombinin-BO1	Not available		Not found	Bombina orientalis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SK-HEP-1 (IC50=0.76µM); HepG2 (IC50=3.75µM); Huh-7 (IC50=3.91µM)	Human erythrocytes: 2.89% Hemolysis=26.3µM; Human erythrocytes=38.05% Hemolysis=52.5µM	Linear	Free	Amidation		L	Not available	Not available	29098406	Amino Acids. 2018 Feb;50(2):241-253	Peng X, Zhou C, Hou X, Liu Y, Wang Z, Peng X, Zhang Z, Wang R, Kong D. 	Molecular characterization and bioactivity evaluation of two novel bombinin peptides from the skin secretion of Oriental fire-bellied toad, Bombina orientalis	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP32117	GIGSAILSAGKSIIKGLAKGLA	22	Bombinin-BO1	A0A219CMY0		Not found	skin secretion of Oriental fire-bellied toad, Bombina orientalis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=0.76 μM); SK-HEP-1 (IC50=3.75 μM); Huh-7 (IC50=3.91 μM)	Human Red cells: only 2.89% hemolysis of the red cells at a concentration of 26.3 μM and 38.05% hemolysis at 52.5 μM	Linear	Free	Amidation		L	Not available	Not available	29098406	Amino Acids. 2018 Feb;50(2):241-253	Peng X, Zhou C, Hou X, Liu Y, Wang Z, Peng X, Zhang Z, Wang R, Kong D. 	Molecular characterization and bioactivity evaluation of two novel bombinin peptides from the skin secretion of Oriental fire-bellied toad, Bombina orientalis	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP32118	IIGPVLGLVGKALGGLL	17	Bombinin H-BO1 	Not available		Not found	skin secretion of Oriental fire-bellied toad, Bombina orientalis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=3.61 μM); SK-HEP-1 (IC50=8.08 μM); Huh-7 (IC50=8.42 μM)	Human Red cells: caused 42.03% hemolysis of the red cells at a concentration of 40.3 μM while reaching 100% hemolysis at 161.1 μM	Linear	Free	Amidation		L	Not available	Not available	29098406	Amino Acids. 2018 Feb;50(2):241-253	Peng X, Zhou C, Hou X, Liu Y, Wang Z, Peng X, Zhang Z, Wang R, Kong D. 	Molecular characterization and bioactivity evaluation of two novel bombinin peptides from the skin secretion of Oriental fire-bellied toad, Bombina orientalis	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@H](C)CC
DRAMP32119	FLSLIPKIATGIAALAKHL	19	PSN-PC	Not available		Not found	Phyllomedusa camba	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H157 (IC50=2.85µM)	Horse erythrocytes: 100% Hemolysis=64µM; Horse erythrocytes=50% Hemolysis=23µM	Linear	Free	Amidation		L	HMEC-1: IC50=51.83µM	Not available	29112170	Molecules. 2017 Nov 7;22(11):1896.	Wu X, Pan J, Wu Y, Xi X, Ma C, Wang L, Zhou M, Chen T.	PSN-PC: A Novel Antimicrobial and Anti-Biofilm Peptide from the Skin Secretion of Phyllomedusa-camba with Cytotoxicity on Human Lung Cancer Cell	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32120	HLRRINKLLTRIGLYRHAFG	20	Lynronne-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (Not active up to 128 µg/ml)	Human erythrocytes: 20% Hemolysis=500µg/ml; Sheep erythrocytes: 25% Hemolysis=500µg/ml	Linear	Free	Free		L	HUVEC: Not active up to 128 µg/ml	Not available	29214045	NPJ Biofilms Microbiomes. 2017 Dec 1;3:33.	Oyama LB, Girdwood SE, Cookson AR, Fernandez-Fuentes N, Privé F, Vallin HE, Wilkinson TJ, Golyshin PN, Golyshina OV, Mikut R, Hilpert K, Richards J, Wootton M, Edwards JE, Maresca M, Perrier J, Lundy FT, Luo Y, Zhou M, Hess M, Mantovani HC, Creevey CJ, Huws SA. 	The rumen microbiome: an underexplored resource for novel antimicrobial discovery	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
DRAMP32121	LPRRNRWSKIWKKVVTVFS	19	Lynronne-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=45.9µg/ml)	Human erythrocytes: 20% Hemolysis=500µg/ml; Sheep erythrocytes: 10% Hemolysis=500µg/ml; Horse erythrocytes:0% Hemolysis=536µg/ml	Linear	Free	Free		L	HUVEC: LC50=98.1µg/ml	Not available	29214045	NPJ Biofilms Microbiomes. 2017 Dec 1;3:33.	Oyama LB, Girdwood SE, Cookson AR, Fernandez-Fuentes N, Privé F, Vallin HE, Wilkinson TJ, Golyshin PN, Golyshina OV, Mikut R, Hilpert K, Richards J, Wootton M, Edwards JE, Maresca M, Perrier J, Lundy FT, Luo Y, Zhou M, Hess M, Mantovani HC, Creevey CJ, Huws SA. 	The rumen microbiome: an underexplored resource for novel antimicrobial discovery	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP32122	NRFTARFRRTPWRLCLQFRQ	20	Lynronne-3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=24.4µg/ml)	Human erythrocytes: 45% Hemolysis=500µg/ml; Sheep erythrocytes: 0% Hemolysis=500µg/ml	Linear	Free	Free		L	HUVEC: LC50>128µg/ml	Not available	29214045	NPJ Biofilms Microbiomes. 2017 Dec 1;3:33.	Oyama LB, Girdwood SE, Cookson AR, Fernandez-Fuentes N, Privé F, Vallin HE, Wilkinson TJ, Golyshin PN, Golyshina OV, Mikut R, Hilpert K, Richards J, Wootton M, Edwards JE, Maresca M, Perrier J, Lundy FT, Luo Y, Zhou M, Hess M, Mantovani HC, Creevey CJ, Huws SA. 	The rumen microbiome: an underexplored resource for novel antimicrobial discovery	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32123	RLLSLIRKLIT	11	[Arg]1 -Dec-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=50.0 µmol/L)	Human red blood cells: MHC=25.00 μmol/L	Linear	Free	Amidation		L	Not available	Not available	30013694	Beilstein J Org Chem. 2018 Jul 6;14:1693-1703. 	Torres MDT, Andrade GP, Sato RH, Pedron CN, Manieri TM, Cerchiaro G, Ribeiro AO, de la Fuente-Nunez C, Oliveira VX Jr. 	Natural and redesigned wasp venom peptides with selective antitumoral activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP32124	SFLSLIRKLIT	11	[Phe]2 -Dec-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=50.0 µmol/L)	Human red blood cells: MHC=3.12 μmol/L	Linear	Free	Amidation		L	Not available	Not available	30013694	Beilstein J Org Chem. 2018 Jul 6;14:1693-1703. 	Torres MDT, Andrade GP, Sato RH, Pedron CN, Manieri TM, Cerchiaro G, Ribeiro AO, de la Fuente-Nunez C, Oliveira VX Jr. 	Natural and redesigned wasp venom peptides with selective antitumoral activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP32125	SLLPLIRKLIT	11	[Pro]4 -Dec-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=25.0 µmol/L)	Human red blood cells: MHC=12.50 μmol/L	Linear	Free	Amidation		L	Not available	Not available	30013694	Beilstein J Org Chem. 2018 Jul 6;14:1693-1703. 	Torres MDT, Andrade GP, Sato RH, Pedron CN, Manieri TM, Cerchiaro G, Ribeiro AO, de la Fuente-Nunez C, Oliveira VX Jr. 	Natural and redesigned wasp venom peptides with selective antitumoral activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP32126	SLLSLFRKLI	10	[Phe]6 -Dec[Thr]11-Dec-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=50.0 µmol/L)	Human red blood cells: MHC=12.50 μmol/L	Linear	Free	Amidation		L	Not available	Not available	30013694	Beilstein J Org Chem. 2018 Jul 6;14:1693-1703. 	Torres MDT, Andrade GP, Sato RH, Pedron CN, Manieri TM, Cerchiaro G, Ribeiro AO, de la Fuente-Nunez C, Oliveira VX Jr. 	Natural and redesigned wasp venom peptides with selective antitumoral activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(N)=O
DRAMP32127	SLLSLFRKLIT	11	[Phe]6 -Dec-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50>50 µmol/L)	Human red blood cells: MHC=3.12 μmol/L	Linear	Free	Amidation		L	Not available	Not available	30013694	Beilstein J Org Chem. 2018 Jul 6;14:1693-1703. 	Torres MDT, Andrade GP, Sato RH, Pedron CN, Manieri TM, Cerchiaro G, Ribeiro AO, de la Fuente-Nunez C, Oliveira VX Jr. 	Natural and redesigned wasp venom peptides with selective antitumoral activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(N)=O)[C@@H](C)O
DRAMP32128	SLLSLIRKLIW	11	[Trp]11 -Dec-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=25.0 µmol/L)	Human red blood cells: MHC=1.56 μmol/L	Linear	Free	Amidation		L	Not available	Not available	30013694	Beilstein J Org Chem. 2018 Jul 6;14:1693-1703. 	Torres MDT, Andrade GP, Sato RH, Pedron CN, Manieri TM, Cerchiaro G, Ribeiro AO, de la Fuente-Nunez C, Oliveira VX Jr. 	Natural and redesigned wasp venom peptides with selective antitumoral activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP32129	SLLSLIRLLIT	11	[Leu]8 -Dec-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50>50 µmol/L)	Human red blood cells: MHC=50.00 μmol/L	Linear	Free	Amidation		L	Not available	Not available	30013694	Beilstein J Org Chem. 2018 Jul 6;14:1693-1703. 	Torres MDT, Andrade GP, Sato RH, Pedron CN, Manieri TM, Cerchiaro G, Ribeiro AO, de la Fuente-Nunez C, Oliveira VX Jr. 	Natural and redesigned wasp venom peptides with selective antitumoral activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP32130	FIFHIIKGLFHAGKMIHGLVTRRRHGVEELQDLDQRAFEREKAFA	45	Em-Pis1	Not available		Not found	Epinephelus coioides; Epinephelus malabaricus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: N2a (65.6% Killing=20µM); A549 (73.5% Killing=20µM)	Fish erythrocytes:25% Hemolysis=20µM; Rabbit erythrocytes:47% Hemolysis=20µM	Linear	Free	Free		L	Not available	Not available	30032476	Probiotics Antimicrob Proteins. 2019 Jun;11(2):667-675.	Hu B, Pan Y, Li Z, Yuan W, Deng L. 	EmPis-1L, an Effective Antimicrobial Peptide Against the Antibiotic-Resistant VBNC State Cells of Pathogenic Bacteria	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP32131	CIKPHQGQHICNDE	14	VGB	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: 4T1 (IC50=0.61 μM); U-87MG ATCC (IC50=0.92 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	30251659	Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2688-2700. 	Sadremomtaz A, Mansouri K, Alemzadeh G, Safa M, Rastaghi AE, Asghari SM.	Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP32132	GALKGCWTKSIPPKPCK	17	PE-BBI	Not available		Not found	skin secretion of Pelophylax esculentus (PE) named PE-BBI	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=35.4 μM); DLD-1 (IC50=50.1 μM ); DKs-8 (IC50=9.8 μM )	Not available	Linear	Free	Amidation		L	HKE3: IC50=50.2 μM	Not available	30267012	Sci Rep. 2018 Sep 28;8(1):14502. 	Lyu P, Ge L, Ma R, Wei R, McCrudden CM, Chen T, Shaw C, Kwok HF.	Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide-PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32133	GIMDTVKNAAKNLAGQLLDKLK 	23	R2PLx-22	Not available		Not found	skin secretions of the pickerel frog (Rana palustris)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-251MG (IC50=104.10 μM); MCF-7 (IC50=109.30 μM); PC-3 (IC50=283.90 μM); NCI-H157 (IC50=843.40 μM); MDA-MB-435S (IC50=872.70 μM)	Horse erythrocytes: Low haemolytic activity	Linear	Free	Free		Mix	HMEC-1: IC50=588.20 μM	Not available	30279210	 Biosci Rep. 2018 Nov 9;38(6):BSR20180710. 	Chen X, Zhang L, Ma C, Zhang Y, Xi X, Wang L, Zhou M, Burrows JF, Chen T. 	A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
DRAMP32134	GIMDTVKNAAKNLAGQLLDKLKCKITAC 	29	R2PLx 	Not available		Not found	skin secretions of the pickerel frog (Rana palustris)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-435S (IC50=15.44 μM); U-251MG (IC50=16.14 μM); MCF-7 (IC50=20.19 μM); PC-3 (IC50=5.79 μM); NCI-H157 (IC50=5.90 μM)	Horse erythrocytes: Moderate haemolytic activity	Linear	Free	Free		Mix	HMEC-1: IC50=79.50 μM	Not available	30279210	 Biosci Rep. 2018 Nov 9;38(6):BSR20180710. 	Chen X, Zhang L, Ma C, Zhang Y, Xi X, Wang L, Zhou M, Burrows JF, Chen T. 	A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)[C@@H](C)O
DRAMP32135	GIMDTVKNAAKNLAGQLLDKLKCSITAC	28	S-24-R2Plx 	Not available		Not found	skin secretions of the pickerel frog (Rana palustris)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-435S (IC50=179.00 μM); U-251MG (IC50=278.30 μM); MCF-7 (IC50=316.90 μM); NCI-H157 (IC50=58.18 μM); PC-3 (IC50=792.60 μM)	Horse erythrocytes: Low haemolytic activity	Linear	Free	Free		L	HMEC-1: IC50=1185.00 μM	Not available	30279210	 Biosci Rep. 2018 Nov 9;38(6):BSR20180710. 	Chen X, Zhang L, Ma C, Zhang Y, Xi X, Wang L, Zhou M, Burrows JF, Chen T. 	A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)[C@@H](C)O
DRAMP32136	GCRLYGFKFHGCG	13	I192F	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=20.1 µM)	Not available	Cyclic	Free	Free		L	Not available	Protein kinase CK2	30307134	Mol Inform. 2019 Mar;38(3):e1800089.	Tang S, Zhang N, Zhou Y, Cortopassi WA, Jacobson MP, Zhao LJ, Zhong RG.	Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
DRAMP32137	GCRLYGFKIFGCG	13	H193F	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=26.8 µM)	Not available	Cyclic	Free	Free		L	Not available	Protein kinase CK2	30307134	Mol Inform. 2019 Mar;38(3):e1800089.	Tang S, Zhang N, Zhou Y, Cortopassi WA, Jacobson MP, Zhao LJ, Zhong RG.	Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
DRAMP32138	GCRLYGFKIHGCG	13	Pc	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=30.4 µM)	Not available	Cyclic	Free	Free		L	Not available	Protein kinase CK2	30307134	Mol Inform. 2019 Mar;38(3):e1800089.	Tang S, Zhang N, Zhou Y, Cortopassi WA, Jacobson MP, Zhao LJ, Zhong RG.	Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
DRAMP32139	GCRLYGFKIWGG	12	H193W	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=19.4 µM)	Not available	Cyclic	Free	Free		L	Not available	Protein kinase CK2	30307134	Mol Inform. 2019 Mar;38(3):e1800089.	Tang S, Zhang N, Zhou Y, Cortopassi WA, Jacobson MP, Zhao LJ, Zhong RG.	Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)O
DRAMP32140	GCRLYGFKWHGCG	13	I192W	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=72.9 µM)	Not available	Cyclic	Free	Free		L	Not available	Protein kinase CK2	30307134	Mol Inform. 2019 Mar;38(3):e1800089.	Tang S, Zhang N, Zhou Y, Cortopassi WA, Jacobson MP, Zhao LJ, Zhong RG.	Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
DRAMP32141	GCRVYGFKIHGCG	13	L187V	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=38.9 µM)	Not available	Cyclic	Free	Free		L	Not available	Protein kinase CK2	30307134	Mol Inform. 2019 Mar;38(3):e1800089.	Tang S, Zhang N, Zhou Y, Cortopassi WA, Jacobson MP, Zhao LJ, Zhong RG.	Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CN)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
DRAMP32142	PMKKLKLALRLAAKIAPVW	19	P-MerP fragment [F5K,A6L,A9R,V13K,V14I]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (Not active up to 100 µM); MCF-7 (Not active up to 100 µM); PC-3 (Not active up to 100 µM)	Human erythrocytes: Not active up to 100 µM	Linear	Free	Free		L	3T3-L1: Not active up to 100 µM; HUVEC: Not active up to 100 µM	Not available	30346140	ACS Infect Dis. 2018 Dec 14;4(12):1727-1736. 	Cardoso MH, Cândido ES, Chan LY, Der Torossian Torres M, Oshiro KGN, Rezende SB, Porto WF, Lu TK, de la Fuente-Nunez C, Craik DJ, Franco OL.	A Computationally Designed Peptide Derived from Escherichia coli as a Potential Drug Template for Antibacterial and Antibiofilm Therapies	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
DRAMP32143	IWLTALKFLGKNLGKLAKQQLAKL	24	LyeTxI-b	Not available		Not found	Lycosa erythrognatha spider venom	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-373MG ATCC (IC50=20.94±5.18 μM ); U-87MG ATCC (IC50=29.20±7.96 μM); SH-SY5Y (IC50=93.80±2.17 μM )	hRBC(human blood red cells): IC50=155±13.04 μM (testing time is 48 h)	Linear	Free	Free		L	Vero(African green monkey kidney): IC50≥100 μM (testing time is 48 h); PBMC(Peripheral Blood Mononuclear Cells): IC50=4.16±1.94 μM (testing time is 48 h); GM00637: IC50 ≥ 100 μM 	Not available	30449002	Amino Acids. 2019 Mar;51(3):433-449. 	Abdel-Salam MAL, Carvalho-Tavares J, Gomes KS, Teixeira-Carvalho A, Kitten GT, Nyffeler J, Dias FF, Dos Reis PVM, Pimenta AMC, Leist M, de Lima ME, de Souza-Fagundes EM. 	The synthetic peptide LyeTxI-b derived from Lycosa erythrognatha spider venom is cytotoxic to U-87 MG glioblastoma cells	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
DRAMP32144	HSDGIFTDSYSRYRKQMAVKKYLAAVLGRRYRQRFRNK	38	PACAP 	P48144		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H460 (IC50=14.97 ± 1.16 µM )	Human red blood cells: PACAP was not hemolytic for human erythrocytes at concentrations below 75 μM (0% hemolysis). At concentration between 75 μM and 150 μM the hemolytic activity was less than 3%; Fish red blood cells:PACAP was not hemolytic for fish red blood cells at concentrations below 18.75 μM (0% hemolysis). At concentration between 18.75 μM and 150 μM, the hemolytic activity was less than 20%	Linear	Free	Free		L	Not available	Not available	30481557	Fish Shellfish Immunol. 2019 Mar;86:559-570. 	Lugo JM, Tafalla C, Oliva A, Pons T, Oliva B, Aquilino C, Morales R, Estrada MP.	Evidence for antimicrobial and anticancer activity of pituitary adenylate cyclase-activating polypeptide (PACAP) from North African catfish (Clarias gariepinus): Its potential use as novel therapeutic agent in fish and humans	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O
DRAMP32145	RRGCFRVCYRGFCFQRCR	18	PM III	Not available		Not found	horseshoe crab Limulus polyphemus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (IC50=2.5±0.1 μM); HeLa (IC50=6.0±0.2 μM); A549 (IC50=7.3±0.5 μM); SK-BR-3 (IC50=9.9±0.1 μM)	Human red blood cells (hBRC): HC50=46 µM	Linear	Free	Free		L	HEK 293T: IC50=7.3±0.4 μM; HEF: IC50=7.0±0.4 μM; NHA: IC50=7.5±0.5 μM	Not available	30486233	Mar Drugs. 2018 Nov 26;16(12):466.	Marggraf MB, Panteleev PV, Emelianova AA, Sorokin MI, Bolosov IA, Buzdin AA, Kuzmin DV, Ovchinnikova TV.	Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP32146	FKKLKKLFSKLWNWK	15	HPRP-A1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=3.5±0.03 μM); SGC-7901 (IC50=5.2±0.14 μM); B16 (IC50=6.1±0.02 μM); Hep-G2 (IC50=7.7±0.23 μM)	Human red blood cells: MHC=32 μM, MHC: the minimum hemolytic concentration is the concentration of peptide that results in 10% hemolysis of human red blood cells (hRBCs).	Linear	Free	Free		L	HUVEC: IC50=24.2 μM	Not available	30592418	 Mol Pharm. 2019 Feb 4;16(2):561-572.	Hu C, Huang Y, Chen Y. 	Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32147	FKKLKKLFSKLWNWK	15	HPRP-A1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H460 (IC50=13.3 µM); BGC-823 (IC50=14.1 µM); A549 (IC50=14.8 µM); MCF-7 (IC50=15.7 µM); MDA-MB-231 (IC50=22.9 µM)	Human red blood cells: MHC=32 μM, MHC: the minimum hemolytic concentration is the concentration of peptide that results in 10% hemolysis of human red blood cells (hRBCs).	Linear	Free	Free		L	HUVEC: IC50=24.2 μM	Not available	30592418	 Mol Pharm. 2019 Feb 4;16(2):561-572.	Hu C, Huang Y, Chen Y. 	Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32148	FKKLKKLFSKLWNWKCRGDKGPDC	24	HPRP-A1-iRGD	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=14.3 µM); MCF-7 (IC50=14.8 µM); NCI-H460 (IC50=15.2 µM); BGC-823 (IC50=18.5 µM); MDA-MB-231 (IC50=22.5 µM)	Human red blood cells: MHC=125 μM, MHC: the minimum hemolytic concentration is the concentration of peptide that results in 10% hemolysis of human red blood cells (hRBCs).	Linear	Free	Free		L	HUVEC: IC50=26.5 μM	Not available	30592418	 Mol Pharm. 2019 Feb 4;16(2):561-572.	Hu C, Huang Y, Chen Y. 	Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O
DRAMP32149	FKKLKKLFSKLWNWKGGCRGDKGPDC	26	HPRP-A1-GG-iRGD	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H460 (IC50=12.9 µM); BGC-823 (IC50=14.8 µM); MDA-MB-231 (IC50=15.2 µM); MCF-7 (IC50=15.8 µM); A549 (IC50=21.6 µM)	Human red blood cells: MHC=125 μM, MHC: the minimum hemolytic concentration is the concentration of peptide that results in 10% hemolysis of human red blood cells (hRBCs).	Linear	Free	Free		L	HUVEC: IC50=31.6 μM	Not available	30592418	 Mol Pharm. 2019 Feb 4;16(2):561-572.	Hu C, Huang Y, Chen Y. 	Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O
DRAMP32150	FKKLKKLFSKLWNWKGGRGD	20	HPRP-A1-GG-RGD	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=11.1 µM); MCF-7 (IC50=11.8 µM); BGC-823 (IC50=15.7 µM); NCI-H460 (IC50=19.5 µM); MDA-MB-231 (IC50=27 µM)	Human red blood cells: MHC=125 μM, MHC: the minimum hemolytic concentration is the concentration of peptide that results in 10% hemolysis of human red blood cells (hRBCs).	Linear	Free	Free		L	HUVEC: IC50=29.1 μM	Not available	30592418	 Mol Pharm. 2019 Feb 4;16(2):561-572.	Hu C, Huang Y, Chen Y. 	Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP32151	FKKLKKLFSKLWNWKRGD	18	HPRP-A1-RGD	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BGC-823 (IC50=10.8 µM); MCF-7 (IC50=11.8 µM); NCI-H460 (IC50=14.6 µM); MDA-MB-231 (IC50=15.6 µM); A549 (IC50=8.4 µM)	Human red blood cells: MHC=125 μM, MHC: the minimum hemolytic concentration is the concentration of peptide that results in 10% hemolysis of human red blood cells (hRBCs).	Linear	Free	Free		L	HUVEC: IC50=31.6 μM	Not available	30592418	 Mol Pharm. 2019 Feb 4;16(2):561-572.	Hu C, Huang Y, Chen Y. 	Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP32152	GRFKRFRKKLKRLWHKVGPFVGPILHY	27	ChMAP-28	Not available		Not found	Goat Antimicrobial	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (IC50=3.39±0.15 μM); B16-F1 (IC50=4.82±1.01 μM); SK-BR-3 (IC50=5.63±1.05 μM); A431 (IC50=6.49±0.09 μM)	Human erythrocytes: ChMAP-28 has a low hemolytic activity (hemolysis less than 10%) at a concentration range up to 10 μM.	Linear	Free	Free		L	HEK293T: IC50=5.09±0.40 μM; HEF: IC50=8.95±2.68 μM	Not available	30622471	Front Pharmacol. 2018 Dec 21;9:1501.	Emelianova AA, Kuzmin DV, Panteleev PV, Sorokin M, Buzdin AA, Ovchinnikova TV. 	Anticancer Activity of the Goat Antimicrobial Peptide ChMAP-28	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP32153	RQCKAESNTFTGICIAKPPCRKACIREKFTDGHCSKVLRRCLCTKRC	47	NoD173(Q22K)	Not available		Not found	Nicotiana occidentalis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=0.70±0.07 μM); MM170 (IC50=0.87±0.04 μM); PC-3 (IC50=2.86±0.14 μM)	Human red blood cells: with ∼12% lysis at the very high concentration (100 µM)	Linear	Free	Free		L	HUVEC: IC50=6.20±0.07 μM; AHDF: IC50=6.49±0.13 μM	Not available	30794440	FASEB J. 2019 May;33(5):6470-6482	Lay FT, Ryan GF, Caria S, Phan TK, Veneer PK, White JA, Kvansakul M, Hulett MD. 	Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
DRAMP32154	RQCKAESNTFTGICIAKPPCRQACIREKFTDGHCSKVLRRCLCTKRC	47	NoD173	Not available		Not found	Nicotiana occidentalis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=1.35±0.06 μM); MM170 (IC50=1.75±0.06 μM); PC-3 (IC50=6.31±0.099 μM)	Human red blood cells: with ∼12% lysis at the very high concentration (100 µM)	Linear	Free	Free		L	HUVEC: IC50=12.31±0.08 μM; AHDF: IC50=10.17±0.29 μM	Not available	30794440	FASEB J. 2019 May;33(5):6470-6482	Lay FT, Ryan GF, Caria S, Phan TK, Veneer PK, White JA, Kvansakul M, Hulett MD. 	Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
DRAMP32155	RQCKRESNTFTGICIAKPPCRQACIREKFTDGHCSKVLRRCLCTKRC	47	NoD173(A5R)	Not available		Not found	Nicotiana occidentalis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=12.41±0.14 μM); MM170 (IC50=3.27±0.12 μM); HeLa (IC50=3.32±0.09 μM)	Not available	Linear	Free	Free		L	HUVEC: IC50=25.15±0.14 μM	Not available	30794440	FASEB J. 2019 May;33(5):6470-6482	Lay FT, Ryan GF, Caria S, Phan TK, Veneer PK, White JA, Kvansakul M, Hulett MD. 	Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
DRAMP32156	WEQKIEELLKKAEEQQKKNEEELKKLEKC	29	LP-83	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: TZM-bl (50% Cytotoxicity=12.34µM); C8166 (50% Cytotoxicity=19.19µM); MT-4 (50% Cytotoxicity=19.65µM); U-937 (50% Cytotoxicity=9.97µM)	Not available	Linear	Acetylation	Chol-NH2		L	PBMC: 50% Cytotoxicity=40.27 µM; HEK293T cells: 50% Cytotoxicity=25.31 µM	Not available	30867304	 J Virol. 2019 May 15;93(11):e02312-18.	Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y.	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity	
DRAMP32157	NGVQPKYKWWKWWKKWW	17	KT2	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	KT2 interacts with the plasma membrane and is then internalized into cells. Moreover, the KT2 peptide increases membrane permeability and induces cytotoxicity against cancer cells through DNA condensation, the increase of apoptotic factor protein levels, and autophagy suppression.	Tumor cells: A431 (34% Cytotoxicity=10 µM); HCT 116 (IC50=50 µM); MDA-MB-231 (Not active up to 10 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	31073999	 J Cell Physiol. 2019 Dec;234(12):22116-22129.	Maraming P, Klaynongsruang S, Boonsiri P, Peng SF, Daduang S, Leelayuwat C, Pientong C, Chung JG, Daduang J. 	The cationic cell-penetrating KT2 peptide promotes cell membrane defects and apoptosis with autophagy inhibition in human HCT 116 colon cancer cells	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP32158	KWCVYAYVKVKGVLVKYKKCW	21	Arenicin-1 [R1,9,11,16,18,19K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=7.7 µM)	Human erythrocytes: 15% Hemolysis=10.1 µM; 50% Hemolysis=63 µM	Cyclic	Free	Free		L	Not available	Not available	31234579	Mar Drugs. 2019 Jun 23;17(6):376.	Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.	Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
DRAMP32159	INLKKLAARIKKKI	14	Mastoparan-L [A5K,L9R,A10I,I13K,L14I]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50>100 µM); MCF-7 (IC50>100 µM); PC-3 (IC50>100 µM)	Human erythrocytes: 8% Hemolysis=100 µM	Linear	Free	Amidation		L	"3T3-L1: 50% Cell death>100 µM	; HUVEC: 50% Cell death>100 µM"	Not available	31411881	J Med Chem. 2019 Sep 12;62(17):8140-8151.	Oshiro KGN, Cândido ES, Chan LY, Torres MDT, Monges BED, Rodrigues SG, Porto WF, Ribeiro SM, Henriques ST, Lu TK, de la Fuente-Nunez C, Craik DJ, Franco OL, Cardoso MH. 	Computer-Aided Design of Mastoparan-like Peptides Enables the Generation of Nontoxic Variants With Extended Antibacterial Properties	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP32160	KILKRLAAKIKKIL	14	Mastoparan-L [I1K,N2I,A5R,L9K,A10I]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50>100 µM); MCF-7 (IC50>100 µM); PC-3 (IC50>100 µM)	Human erythrocytes: 3% Hemolysis=100 µM	Linear	Free	Amidation		L	"3T3-L1: 50% Cell death>100 µM	; HUVEC: 50% Cell death>100 µM"	Not available	31411881	J Med Chem. 2019 Sep 12;62(17):8140-8151.	Oshiro KGN, Cândido ES, Chan LY, Torres MDT, Monges BED, Rodrigues SG, Porto WF, Ribeiro SM, Henriques ST, Lu TK, de la Fuente-Nunez C, Craik DJ, Franco OL, Cardoso MH. 	Computer-Aided Design of Mastoparan-like Peptides Enables the Generation of Nontoxic Variants With Extended Antibacterial Properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32161	LP	2	CLP	Not available		Not found	marine natural metabolite	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-468 (IC50=67.4 μM); MDA-MB-231 (IC50=73.4 μM)	Human red blood cells (RBC): LC50>401 μM	Cyclic	Lactam	Lactam	Lactam	L	MCF-12A: IC50>100 μM	Not available	31669320	Chem Biol Interact. 2020 Jan 5;315:108872.	Kgk D, Kumari S, G S, Malla RR. 	Marine natural compound cyclo(L-leucyl-L-prolyl) peptide inhibits migration of triple negative breast cancer cells by disrupting interaction of CD151 and EGFR signaling	
DRAMP32162	RFRPPIRRPPIRPPFWP	17	Bac5 (1-17)[Y16W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (19% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32163	RFRPPIRRPPIRPPFYR	17	Bac5 (1-17)[P17R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (5% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32164	RFRPPIRRPPIRPPFYW	17	Bac5 (1-17)[P17W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (5% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H](C)CC
DRAMP32165	RFRRPIRRPPIRPPFYR	17	Bac5 (1-17)[P4,17R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (9% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32166	RFRRPIRRPPIRPPWYP	17	Bac5 (1-17)[P4R,F15W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (32% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32167	RFRRPIRRRPIRPPFWR	17	Bac5 (1-17)[P4,9,17R; Y16W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (10% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32168	RFRRPIRRRPIRPPFYP	17	Bac5 (1-17)[P4,9R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (Not active up to 32 µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32169	RFRRPIRRRPIRPPFYR	17	Bac5 (1-17)[P4,9,17R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (13% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32170	RFRRPIRRRPIRPPWYR	17	Bac5 (1-17)[P4,9,17R; F15W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (5% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32171	RFRWPIRRPPIRPPFYR	17	Bac5 (1-17)[P4W, P4R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (Not active up to 32 µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32172	RFRWPIRRPPIRPPWYP	17	Bac5 (1-17)[P4W, F15W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (7% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32173	RFRWPIRRRPIRPPFWR	17	Bac5 (1-17)[P4W; P9,17R; Y16W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (20% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32174	RFRWPIRRRPIRPPFYP	17	Bac5 (1-17)[P4W, P9R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (2% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32175	RFRWPIRRRPIRPPFYR	17	Bac5 (1-17)[P4W; P9,17R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (16% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32176	RFRWPIRRRPIRPPFYW	17	Bac5 (1-17)[P4,17W; P9R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (22% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H](C)CC
DRAMP32177	RFRWPIRRRPIRPPWYR	17	Bac5 (1-17)[P4W, P9R, F15W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (28% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32178	RRRRPIRRRPIRPPFYR	17	Bac5 (1-17)[F2R;P4,9,17R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (Not active up to 32 µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32179	RRRRPIRRRPIRPPWYP	17	Bac5 (1-17)[F2R; P4,9R; F15W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (5% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32180	RRRRPIRRRPIRPPWYR	17	Bac5 (1-17)[F2R;P4,9,17R;F15W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (5% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32181	RRRRPWRRRPIRPPFYW	17	Bac5 (1-17)[F2R; P4,9R; I6W; P17W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (23% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP32182	RWRPPIRRPPIRPPWYP	17	Bac5 (1-17)[F2,15W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (25% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32183	RWRRPIRRPPIRPPFYP	17	Bac5 (1-17)[F2W, P4R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (16% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32184	RWRRPIRRPPIRPPFYR	17	Bac5 (1-17)[F2W; P4,17R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (11% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32185	RWRRPIRRPPIRPPWYP	17	Bac5 (1-17)[F2,15W; P4R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (17% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32186	RWRRPIRRRPIRPPFWR	17	Bac5 (1-17)[F2W; P4,9,17R; Y16W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (4% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32187	RWRRPIRRRPIRPPFYP	17	Bac5 (1-17)[F2W; P4,9R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (1% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32188	RWRRPIRRRPIRPPFYR	17	Bac5 (1-17)[F2W; P4,9,17R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (1% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32189	RWRRPIRRRPIRPPFYW	17	Bac5 (1-17)[F2W; P4,9R; P17W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (19% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H](C)CC
DRAMP32190	RWRRPIRRRPIRPPWYP	17	Bac5 (1-17)[F2,15W; P4,9R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (9% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32191	RWRRPIRRRPIRPPWYR	17	Bac5 (1-17)[F2,15W; P4,9,17R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (9% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32192	RWRRPWRRRPIRPPFYR	17	Bac5 (1-17)[F2W; P4,9,17R; I6W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (22% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP32193	RWRWPIRRPPIRPPFYP	17	Bac5 (1-17)[F2W, P4W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (8% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32194	RWRWPIRRPPIRPPFYR	17	Bac5 (1-17)[F2W, P4W, P17R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (14% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32195	RWRWPIRRPPIRPPWYP	17	Bac5 (1-17)[F2,15W; P4W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (10% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP32196	RWRWPIRRRPIRPPFWR	17	Bac5 (1-17)[F2W; P4W; P9,17R; Y16W]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (27% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32197	RWRWPIRRRPIRPPWYR	17	Bac5 (1-17)[F2,15W; P4W; P9,17R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (41% Killing=32µM)	Not available	Linear	Free	Free		L	Not available	Not available	31692278	 ChemMedChem. 2019 Dec 17;14(24):2025-2033.	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32198	KSCFRVCYRGICYRRCRG	18	[W2S]cTI	Not available		Not found	host defense peptide from the horseshoe crab Tachypleus tridentatus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-435S (CC50=18.9±0.9 µM ); MM96L (CC50=2.0±0.1 µM ); K562 (CC50=2.7±0.2 µM ); HeLa (CC50=22.5±2.1 µM ); HT-144 (CC50=3.0±0.2 µM ); WM164 (CC50=3.9±0.2 µM )	Human RBCs: CC50>32 µM 	Cyclic	Free	Free		L	HaCaT: CC50=41.4±2.6 µM 	Not available	31714739	ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. 	Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.	Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
DRAMP32199	KWCFKVCYKGICYKKCKG	18	[R/K]cTI 	Not available		Not found	host defense peptide from the horseshoe crab Tachypleus tridentatus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (CC50=13.4±1.9 µM ); K562 (CC50=2.5±0.1 µM ); MDA-MB-435S (CC50=3.5±0.4 µM ); WM164 (CC50=4.3±0.3 µM )	Human RBCs: CC50>32 µM 	Cyclic	Free	Free		L	HaCaT: CC50=31.1±2.1 µM 	Not available	31714739	ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. 	Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.	Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
DRAMP32200	KWCFRVCSRGSCYRRCRG	18	[Y8S-I11S]cTI	Not available		Not found	host defense peptide from the horseshoe crab Tachypleus tridentatus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (CC50>32 µM ); K562 (CC50>32 µM ); MDA-MB-435S (CC50>32 µM ); MM96L (CC50>32 µM ); WM164 (CC50>32 µM ); HT-144 (CC50>64 µM )	Human RBCs: CC50>32 µM 	Cyclic	Free	Free		L	HaCaT: CC50>64 µM 	Not available	31714739	ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. 	Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.	Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
DRAMP32201	KWCFRVCYRGFCYRRCRK	18	[I11F-G18K]cTI	Not available		Not found	host defense peptide from the horseshoe crab Tachypleus tridentatus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (CC50=1.3±0.1 µM ); K562 (CC50=1.9±0.1 µM ); WM164 (CC50=2.9±0.2 µM ); HT-144 (CC50=3.2±0.1 µM ); HeLa (CC50=5.1±0.3 µM )	Human RBCs: CC50=8.4±1.2 µM	Cyclic	Free	Free		L	HaCaT: CC50=4.1±0.1 µM	Not available	31714739	ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. 	Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.	Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32202	KWCFRVCYRGICYRRCRG	18	cTI 	Not available		Not found	host defense peptide from the horseshoe crab Tachypleus tridentatus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (CC50=1.3±0.1 µM ); HT-144 (CC50=1.4±0.1µM ); K562 (CC50=2.0±0.1 µM ); WM164 (CC50=2.7±0.1 µM ); MDA-MB-435S (CC50=2.7±0.3 µM ); MCF-7 (CC50=6.4±0.6 µM ); HeLa (CC50=6.7±0.6 µM )	Human RBCs: CC50=107±21 µM 	Cyclic	Free	Free		L	HaCaT: CC50=7.9±0.5 µM 	Not available	31714739	ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. 	Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.	Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
DRAMP32203	KWCFRVCYRGICYRRCRK	18	[G18K]cTI	P14213##P69135		Not found	host defense peptide from the horseshoe crab Tachypleus tridentatus	Antimicrobial, Anticancer	Not found	Not found	Not found	6PIN##1WO0##1MA2	Not available	Tumor cells: MM96L (CC50=1.0±0.1 µM ); K562 (CC50=1.7±0.1 µM ); WM164 (CC50=2.7±0.2 µM ); HT-144 (CC50=3.2±0.1 µM ); HeLa (CC50=6.7±1.1 µM )	Human RBCs: CC50=6.9±0.3 µM 	Cyclic	Free	Free		L	HaCaT: CC50>64 µM 	Not available	31714739	ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. 	Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.	Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32204	KWCFRVCYRGICYRRCSG	18	[R17S]cTI	P69135		Not found	host defense peptide from the horseshoe crab Tachypleus tridentatus	Antimicrobial, Anticancer	Not found	Not found	Not found	1WO0##1MA2	Not available	Tumor cells: HT-144 (CC50=1.2±0.1 µM ); MM96L (CC50=1.8±0.1 µM ); WM164 (CC50=1.8±0.1 µM ); HeLa (CC50=12.2±0.4 µM ); MDA-MB-435S (CC50=4.5±0.3 µM )	Human RBCs: CC50=10.3±0.4 µM 	Cyclic	Free	Free		L	HaCaT: CC50>64 µM 	Not available	31714739	ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. 	Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.	Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)NCC(=O)O
DRAMP32205	KWCFRVCYRGICYSRCRG	18	[R14S]cTI	Not available		Not found	host defense peptide from the horseshoe crab Tachypleus tridentatus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (CC50=1.7±0.1 µM ); HT-144 (CC50=2.3±0.2 µM ); WM164 (CC50=2.7±0.1 µM ); MDA-MB-435S (CC50=3.5±0.3 µM ); HeLa (CC50=7.5±0.3 µM )	Human RBCs: CC50=5.3±0.3 µM 	Cyclic	Free	Free		L	HaCaT: CC50>64 µM 	Not available	31714739	ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. 	Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.	Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
DRAMP32206	KWCFRVCYSGICYRRCRG	18	[R9S]cTI 	Not available		Not found	host defense peptide from the horseshoe crab Tachypleus tridentatus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-435S (CC50=5.3±0.6 µM )	Human RBCs: CC50>64 µM 	Cyclic	Free	Free		L	Not available	Not available	31714739	ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. 	Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.	Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
DRAMP32207	KWCFRVCYSGICYSRCSG	18	[R9S-R14S-R17S]cTI	Not available		Not found	host defense peptide from the horseshoe crab Tachypleus tridentatus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: WM164 (CC50=11.1±0.9 µM ); HT-144 (CC50=11.8±0.9 µM ); K562 (CC50=4.8±0.3 µM )	Human RBCs: CC50=15.3±1.4 µM	Cyclic	Free	Free		L	Not available	Not available	31714739	ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. 	Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.	Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)NCC(=O)O
DRAMP32208	KWCSRVCYRGICSRRCRG	18	[F4S-Y13S]cTI	Not available		Not found	host defense peptide from the horseshoe crab Tachypleus tridentatus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (CC50=13.2±0.9 µM ); MM96L (CC50=17.3±1.0 µM ); HT-144 (CC50=27.8±2.2 µM ); WM164 (CC50=28.2±2.0 µM ); HeLa (CC50>32 µM ); MCF-7 (CC50>32 µM ); MDA-MB-435S (CC50>64 µM )	Human RBCs: CC50>64 µM 	Cyclic	Free	Free		L	HaCaT: CC50>64 µM 	Not available	31714739	ACS Chem Biol. 2019 Dec 20;14(12):2895-2908. 	Vernen F, Craik DJ, Lawrence N, Troeira Henriques S.	Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
DRAMP32209	SRSCLIVCQRLF	12	Cm-p5 [E4C, H8C]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (Not active up to 300 µg/ml)	Not available	Cyclic	Free	Amidation		L	Not available	Not available	31763531	ACS Omega. 2019 Nov 5;4(21):19081-19095.	Vicente FEM, González-Garcia M, Diaz Pico E, Moreno-Castillo E, Garay HE, Rosi PE, Jimenez AM, Campos-Delgado JA, Rivera DG, Chinea G, Pietro RCLR, Stenger S, Spellerberg B, Kubiczek D, Bodenberger N, Dietz S, Rosenau F, Paixão MW, Ständker L, Otero-González AJ.	Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 With Improved Antifungal Activity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP32210	AWWRRTVAKVRK	12	EeCentrocin 1 Chain A (1-12)[G1A, D8A, N12K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50>100µM)	Human erythrocytes:0% Hemolysis=25 µM; 1.6% Hemolysis=200 µM	Linear	Free	Amidation		L	MRC-5: IC50>100 µM	Not available	31802582	 J Pept Sci. 2020 Feb;26(2):e3233	Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. 	Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32211	GAWRRTVAKVRK	12	EeCentrocin 1 Chain A (1-12)[W2A, D8A, N12K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50>200µM)	Human erythrocytes:0% Hemolysis=25-200 µM	Linear	Free	Amidation		L	MRC-5: IC50>200 µM	Not available	31802582	 J Pept Sci. 2020 Feb;26(2):e3233	Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. 	Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32212	GWARRTVAKVRK	12	EeCentrocin 1 Chain A (1-12)[W3A, D8A, N12K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50>200µM)	Human erythrocytes:0% Hemolysis=25-200 µM	Linear	Free	Amidation		L	MRC-5: IC50>200 µM	Not available	31802582	 J Pept Sci. 2020 Feb;26(2):e3233	Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. 	Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32213	GWWARTVAKVRK	12	EeCentrocin 1 Chain A (1-12)[R4A, D8A, N12K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50>200µM)	Human erythrocytes:0% Hemolysis=25 µM; 3.6% Hemolysis=200 µM	Linear	Free	Amidation		L	MRC-5: IC50>200 µM	Not available	31802582	 J Pept Sci. 2020 Feb;26(2):e3233	Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. 	Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32214	GWWRATVAKVRK	12	EeCentrocin 1 Chain A (1-12)[R5A, D8A, N12K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50>200µM)	Human erythrocytes:0% Hemolysis=25-200 µM	Linear	Free	Amidation		L	MRC-5: IC50>200 µM	Not available	31802582	 J Pept Sci. 2020 Feb;26(2):e3233	Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. 	Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32215	GWWRRTAAKVRK	12	EeCentrocin 1 Chain A (1-12)[V7A, D8A, N12K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50>200µM)	Human erythrocytes:0% Hemolysis=25-200 µM	Linear	Free	Amidation		L	MRC-5: IC50>200 µM	Not available	31802582	 J Pept Sci. 2020 Feb;26(2):e3233	Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. 	Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32216	GWWRRTVAAVRK	12	EeCentrocin 1 Chain A (1-12)[D8A, K9A, N12K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50>200µM)	Human erythrocytes:0% Hemolysis=25 µM; 5.1% Hemolysis=200 µM	Linear	Free	Amidation		L	MRC-5: IC50>200 µM	Not available	31802582	 J Pept Sci. 2020 Feb;26(2):e3233	Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. 	Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32217	GWWRRTVAKVAK	12	EeCentrocin 1 Chain A (1-12)[D8A, R11A, N12K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50>200µM)	Human erythrocytes:0% Hemolysis=25-200 µM	Linear	Free	Free		L	MRC-5: IC50>200 µM	Not available	31802582	 J Pept Sci. 2020 Feb;26(2):e3233	Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. 	Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32218	GWWRRTVAKVRK	12	EeCentrocin 1 Chain A (1-12)[D8A, N12K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50>200µM)	Human erythrocytes:2.4% Hemolysis=25 µM; 25.1% Hemolysis=200 µM	Linear	Free	Amidation		L	MRC-5: IC50>200 µM	Not available	31802582	 J Pept Sci. 2020 Feb;26(2):e3233	Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. 	Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32219	GWWRRTVAKVRNAGRK	16	EeCentrocin 1 Chain A (1-16)[D8A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50>200µM)	Human erythrocytes: 0% Hemolysis=25 µM; 5% Hemolysis=200 µM	Linear	Free	Amidation		L	MRC-5: IC50>200 µM	Not available	31802582	 J Pept Sci. 2020 Feb;26(2):e3233	Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. 	Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32220	GWWRRTVDKVRNAGRK	16	EeCentrocin 1 Chain A (1-16)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50>200µM)	Human erythrocytes: 0% Hemolysis=25-200 µM	Linear	Free	Free		L	MRC-5: IC50>200 µM	Not available	31802582	 J Pept Sci. 2020 Feb;26(2):e3233	Solstad RG, Johansen C, Stensvåg K, Strøm MB, Haug T. 	Structure-activity relationship studies of shortened analogues of the antimicrobial peptide EeCentrocin 1 from the sea urchin Echinus esculentus	CC(C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32221	SNGYRPAYRPAYRPSYRP	18	Astacidin PcAst-1a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T24 (IC50>100 µM); MEC-1 (Not active up to 100 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	31884202	Dev Comp Immunol. 2020 Apr;105:103574.	Rončević T, Čikeš-Čulić V, Maravić A, Capanni F, Gerdol M, Pacor S, Tossi A, Giulianini PG, Pallavicini A, Manfrin C.	Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852)	C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(N)=O
DRAMP32222	SNVYRPPPYRPVYRPLRRPGYRP	23	Astacidin PcAst-1b/c	Not available		Not found	Procambarus clarkii; Procambarus clarkii	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T24 (IC50>100 µM); MEC-1 (Not active up to 100 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	31884202	Dev Comp Immunol. 2020 Apr;105:103574.	Rončević T, Čikeš-Čulić V, Maravić A, Capanni F, Gerdol M, Pacor S, Tossi A, Giulianini PG, Pallavicini A, Manfrin C.	Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852)	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(N)=O
DRAMP32223	FYPRPYRPPYLPDPRPFPRPLPAFGHEFRRH	31	Astacidin PcAst-2	Not available		Not found	Procambarus clarkii	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T24 (IC50>100 µM); MEC-1 (Not active up to 100 µM)	Not available	Linear	Free	Free		L	Not available	Not available	31884202	Dev Comp Immunol. 2020 Apr;105:103574.	Rončević T, Čikeš-Čulić V, Maravić A, Capanni F, Gerdol M, Pacor S, Tossi A, Giulianini PG, Pallavicini A, Manfrin C.	Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852)	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP32224	GIKEXLCNMACAQTVCKKSGGPLCDTCQAACKALG	35	Turgencin B Mox1	Not available		Not found	Synoicum turgens	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50=27.4 µM)	Not available	Cyclic	Free	Amidation	X=MET-OXD	L	MRC-5: IC50> 50 µM	Not available	31940927	Mar Drugs. 2020 Jan 12;18(1):51. 	Hansen IKØ, Isaksson J, Poth AG, Hansen KØ, Andersen AJC, Richard CSM, Blencke HM, Stensvåg K, Craik DJ, Haug T. 	Isolation and Characterization of Antimicrobial Peptides with Unusual Disulfide Connectivity from the Colonial Ascidian Synoicum turgens	
DRAMP32225	GIKEXLCNXACAQTVCKKSGGPLCDTCQAACKALG	35	Turgencin B Mox2	Not available		Not found	Synoicum turgens	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50>50.0 µM)	Not available	Cyclic	Free	Amidation	X=MET-OXD	L	MRC-5: IC50> 50 µM	Not available	31940927	Mar Drugs. 2020 Jan 12;18(1):51. 	Hansen IKØ, Isaksson J, Poth AG, Hansen KØ, Andersen AJC, Richard CSM, Blencke HM, Stensvåg K, Craik DJ, Haug T. 	Isolation and Characterization of Antimicrobial Peptides with Unusual Disulfide Connectivity from the Colonial Ascidian Synoicum turgens	
DRAMP32226	GPKTKAACKXACKLATCGKKPGGWKCKLCELGCDAV	36	Turgencin A	Not available		Not found	Synoicum turgens	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2058 (IC50=1.4 µM)	Not available	Cyclic	Free	Amidation	X=MET-OXD	L	MRC-5: IC50=4.8 µM	Not available	31940927	Mar Drugs. 2020 Jan 12;18(1):51. 	Hansen IKØ, Isaksson J, Poth AG, Hansen KØ, Andersen AJC, Richard CSM, Blencke HM, Stensvåg K, Craik DJ, Haug T. 	Isolation and Characterization of Antimicrobial Peptides with Unusual Disulfide Connectivity from the Colonial Ascidian Synoicum turgens	
DRAMP32227	ILPWKWPWWPWKK	13	Indolicidin-Lys	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=9.5 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50=26.4 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32228	RAWVAWR	7	LysH	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32229	CLBCREKAKKLFKKILKKL	19	BP329	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CAPAN-1 (IC50=33.0 ± 1.0 µM); MCF-7 (IC50=35.2 ± 1.8 µM); 22Rv1 (LC50=50 µM); CL1 (LC50>100 µM)	Not available	Linear	Free	Amidation		L	NIH 3T3: IC50=33.7 ± 1.9 µM	Not available	24480922	Org Biomol Chem. 2014 Mar 14;12(10):1652-63. 	Soler M, González-Bártulos M, Soriano-Castell D, Ribas X, Costas M, Tebar F, Massaguer A, Feliu L, Planas M.	Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties	
DRAMP32230	VXXFPWWWPFLXX	13	Tritrp-Agb	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=9.6 µM)	RBC: IC50=34.6 µM	Linear	Free	Amidation	X=Agb=(S)-2-amino-4 guanidinobutyric acid	L	PBMC: IC50=9.3 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32231	VXXFPWWWPFLXX	13	Tritrp-Agb	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≤ 6.5 µM)	RBC: IC50=34.6 µM	Linear	Free	Amidation	X=Agb=(S)-2-amino-4 guanidinobutyric acid	L	PBMC: IC50=9.3 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32232	VXXFPWWWPFLXX	13	Tritrp-Agb	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50=34.6 µM	Linear	Free	Amidation	X=Agb=(S)-2-amino-4 guanidinobutyric acid	L	PBMC: IC50=9.3 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32233	VXXFPWWWPFLXX	13	Tritrp-Agb	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=13.3 µM)	RBC: IC50=34.6 µM	Linear	Free	Amidation	X=Agb=(S)-2-amino-4 guanidinobutyric acid	L	PBMC: IC50=9.3 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32234	VXXFPWWWPFLXX	13	Tritrp-Dab	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=9.6 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=Dab=2,4-diaminobutyric acid	L	PBMC: IC50=25.8 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32235	VXXFPWWWPFLXX	13	Tritrp-Dab	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≤ 6.5 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=Dab=2,4-diaminobutyric acid	L	PBMC: IC50=25.8 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32236	VXXFPWWWPFLXX	13	Tritrp-Dab	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=Dab=2,4-diaminobutyric acid	L	PBMC: IC50=25.8 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32237	VXXFPWWWPFLXX	13	Tritrp-Dab	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=13.3 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=Dab=2,4-diaminobutyric acid	L	PBMC: IC50=25.8 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32238	VXXFPWWWPFLXX	13	Tritrp-Dap	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=9.6 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=Dap=2,3-diaminopropionic acid	L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32239	VXXFPWWWPFLXX	13	Tritrp-Dap	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≤ 6.5 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=Dap=2,3-diaminopropionic acid	L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32240	VXXFPWWWPFLXX	13	Tritrp-Dap	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=Dap=2,3-diaminopropionic acid	L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32241	VXXFPWWWPFLXX	13	Tritrp-Dap	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=13.3 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=Dap=2,3-diaminopropionic acid	L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32242	VXXFPWWWPFLXX	13	Tritrp-hArg	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=9.6 µM)	RBC: IC50=41.3 µM	Linear	Free	Amidation	X=hArg=homo-arginine	L	PBMC: IC50=19.4 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32243	VXXFPWWWPFLXX	13	Tritrp-hArg	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≤ 6.5 µM)	RBC: IC50=41.3 µM	Linear	Free	Amidation	X=hArg=homo-arginine	L	PBMC: IC50=19.4 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32244	VXXFPWWWPFLXX	13	Tritrp-hArg	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50=41.3 µM	Linear	Free	Amidation	X=hArg=homo-arginine	L	PBMC: IC50=19.4 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32245	VXXFPWWWPFLXX	13	Tritrp-hArg	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=13.3 µM)	RBC: IC50=41.3 µM	Linear	Free	Amidation	X=hArg=homo-arginine	L	PBMC: IC50=19.4 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32246	VKKFAWWWAFLKK	13	Tritrp-P59A-Lys	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=14.5 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50=27.6 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32247	VKKFAWWWPFLKK	13	Tritrp-P5A-Lys	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=27.6 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50=27.6 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32248	VKKFPWWWAFLKK	13	Tritrp-P9A-Lys	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=15.1 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50=22.5 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32249	VKKFPWWWPFLKK	13	Tritrp-Lys	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=11.5 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50=41.0 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32250	VOOFPWWWPFLOO	13	Tritrp-Orn	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≤ 6.5 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	O=Ornithine	L	PBMC: IC50=38.1 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32251	VRRFAWWWPFLRR	13	Tritrp-P5A	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	2I1H	Not available	Tumor cells: Jurkat (IC50=16.2 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50=26.4 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32252	VRRFPXXXPFLRR	13	Tritrp-W678bTA	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=9.6 µM)	RBC: IC50=12.2 µM	Linear	Free	Amidation	X=bTA=β-3-benzothienyl-1-Ala	L	PBMC: IC50=16.5 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32253	VRRFPXXXPFLRR	13	Tritrp-W678bTA	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=44.8 µM)	RBC: IC50=12.2 µM	Linear	Free	Amidation	X=bTA=β-3-benzothienyl-1-Ala	L	PBMC: IC50=16.5 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32254	VRRFPXXXPFLRR	13	Tritrp-W678hW	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=9.6 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=HTrp=5-hydroxytryptophan; bTA	L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32255	VRRFPXXXPFLRR	13	Tritrp-W678hW	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=44.8 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=HTrp=5-hydroxytryptophan; bTA	L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32256	VRRFPXWWPFLRR	13	Tritrp-W6hW	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=16.1 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=HTrp=5-hydroxytryptophan; bTA	L	PBMC: IC50=39.8 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32257	VRRFPAAAPFLRR	13	Tritrp-W678A	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32258	VRRFPAAWPFLRR	13	Tritrp-W67A	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32259	VRRFPAWAPFLRR	13	Tritrp-W68A	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32260	VRRFPAWWPFLRR	13	Tritrp-W6A	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=36.5 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32261	VRRFPWXWPFLRR	13	Tritrp-W7hW	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=15.1 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=HTrp=5-hydroxytryptophan; bTA	L	PBMC: IC50=24.3 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32262	VRRFPWAAPFLRR	13	Tritrp-W78A	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32263	VRRFPWAWPFLRR	13	Tritrp-W7A	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=48.2 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32264	VRRFPWWXPFLRR	13	Tritrp-W8hW	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=10.7 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=HTrp=5-hydroxytryptophan; bTA	L	PBMC: IC50=23.9 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32265	VRRFPWWAPFLRR	13	Tritrp-W8A	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=22.8 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50=52.1 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32266	VRRFPWWWAFLRR	13	Tritrp-P9A	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	2I1I	Not available	Tumor cells: Jurkat (IC50=6.8 µM)	RBC: IC50=29.3 µM	Linear	Free	Amidation		L	PBMC: IC50=12.8 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32267	VRRFPWWYPFLRR	13	Tritrp-W8Y	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=12.0 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50=21.6 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32268	VRRFPWYWPFLRR	13	Tritrp-W7Y	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=11.4 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50=26.4 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32269	VRRFPWYYPFLRR	13	Tritrp-W78Y	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=25.6 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32270	VRRFPYWWPFLRR	13	Tritrp-W6Y	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=19.3 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50=34.5 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32271	VRRFPYWYPFLRR	13	Tritrp-W68Y	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=35.4 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32272	VRRFPYYWPFLRR	13	Tritrp-W67Y	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=32.2 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32273	VRRFPYYYPFLRR	13	Tritrp-W678Y	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228.	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32274	RWKLFKKIEKVGRNVRDGLIKAGPAIAVIGQAKSLGK	37	anti-HIV AMPs Molecule 3	Not available		Not found	Bombyx mori	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	"Tumor cells: HepG2 (20% Killing=100	µg/ml)"	Not available	Linear	Free	Free		L	HEK293T: 40% Killing=100µM	Not available	32322274	Int J Microbiol. 2020 Apr 8;2020:2131535.	Tincho MB, Morris T, Meyer M, Pretorius A.	Antibacterial Activity of Rationally Designed Antimicrobial Peptides	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(C)C)[C@H](C)CC
DRAMP32275	GFLKKIGKKLEGAVQRTRDATIQTIAVAQAAANVAATAKQ	40	EtCec1-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (Not active up to 1655 µg/ml)	Human erythrocytes: Not active up to 1024 µg/ml	Linear	Free	Amidation		L	Not available	Not available	32344933	Microorganisms. 2020 Apr 25;8(5):626	Hirsch R, Wiesner J, Bauer A, Marker A, Vogel H, Hammann PE, Vilcinskas A. 	Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(N)=O)[C@@H](C)O)C(C)C)C(C)C)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C
DRAMP32276	GFLKKVGKKLEGASDLTRDATIQTIAVAQAAANVAATAKQ	40	EtCec3-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (Not active up to 1622 µg/ml)	Human erythrocytes: Not active up to 1024 µg/ml	Linear	Free	Amidation		L	Not available	Not available	32344933	Microorganisms. 2020 Apr 25;8(5):626	Hirsch R, Wiesner J, Bauer A, Marker A, Vogel H, Hammann PE, Vilcinskas A. 	Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(N)=O)[C@@H](C)O)C(C)C)C(C)C)[C@H](C)CC)[C@@H](C)O
DRAMP32277	GWLRDFGKRIERTGQNIRDATIQTIGIAQEAANVAATLK	39	EtCec2-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (Not active up to 535 µg/ml)	Human erythrocytes: Not active up to 512 µg/ml	Linear	Free	Amidation		L	Not available	Not available	32344933	Microorganisms. 2020 Apr 25;8(5):626	Hirsch R, Wiesner J, Bauer A, Marker A, Vogel H, Hammann PE, Vilcinskas A. 	Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)C(C)C
DRAMP32278	QFNMQGGGSPRQGFDVNANARFPIWQSQNARNSVHGTASYAQHLGGPYGNSRPNFGGGLQFT	62	EtDip	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (Not active up to 1330 µg/ml)	Human erythrocytes: Not active up to 1024 µg/ml	Linear	Free	Free		L	Not available	Not available	32344933	Microorganisms. 2020 Apr 25;8(5):626	Hirsch R, Wiesner J, Bauer A, Marker A, Vogel H, Hammann PE, Vilcinskas A. 	Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C
DRAMP32279	GFPCGESCVYIPCFTAAIGCSCKSKVCYKN	30	Hyen D	C0HLN8		Not found	medicinal herb Hybanthus enneaspermus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (CC50=0.52±0.03 µM ); MCF-7 (CC50=0.75±0.05 µM ); HeLa (CC50=0.88±0.05 µM )	Human red blood cells (hRBCs): HC50=24.56±2.16 µM 	Cyclic	Free	Free		L	HUVEC:CC50=0.62±0.01 µM, testing time is 24h	Not available	32414842	 J Biol Chem. 2020 Aug 7;295(32):10911-10925.	Du Q, Chan LY, Gilding EK, Henriques ST, Condon ND, Ravipati AS, Kaas Q, Huang YH, Craik DJ.	Discovery and mechanistic studies of cytotoxic cyclotides from the medicinal herb Hybanthus enneaspermus	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
DRAMP32280	GIPCAESCVYIPCTVTALLGCSCSDKVCYN	30	Hyen L	C0HLP6		Not found	medicinal herb Hybanthus enneaspermus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (CC50=1.54±0.08 µM ); HeLa (CC50=2.00±0.04 µM ); MCF-7 (CC50=3.34±0.28 µM )	Human red blood cells (hRBCs): HC50>50 µM 	Cyclic	Free	Free		L	HUVEC: CC50=2.06±0.08 µM , testing time is 24h	Not available	32414842	 J Biol Chem. 2020 Aug 7;295(32):10911-10925.	Du Q, Chan LY, Gilding EK, Henriques ST, Condon ND, Ravipati AS, Kaas Q, Huang YH, Craik DJ.	Discovery and mechanistic studies of cytotoxic cyclotides from the medicinal herb Hybanthus enneaspermus	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@H](C)CC)C(C)C
DRAMP32281	GTHPCQETCVTSTRCSTQGCHCNWPICFKN	30	Hyen C	C0HLN7		Not found	medicinal herb Hybanthus enneaspermus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (CC50>8 µM )	Not available	Cyclic	Free	Free		L	Not available	Not available	32414842	 J Biol Chem. 2020 Aug 7;295(32):10911-10925.	Du Q, Chan LY, Gilding EK, Henriques ST, Condon ND, Ravipati AS, Kaas Q, Huang YH, Craik DJ.	Discovery and mechanistic studies of cytotoxic cyclotides from the medicinal herb Hybanthus enneaspermus	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP32282	GVPCGESCVYIPCFTGIINCSCRDKVCYNN	30	Hyen E	C0HLN9		Not found	medicinal herb Hybanthus enneaspermus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (CC50=2.64±0.09 µM ); K562 (CC50=2.85±0.09 µM ); MCF-7 (CC50=3.73±0.25 µM )	Human red blood cells (hRBCs): HC50>50 µM 	Cyclic	Free	Free		L	HUVEC: CC50=2.06±0.08 µM , testing time is 24h	Not available	32414842	 J Biol Chem. 2020 Aug 7;295(32):10911-10925.	Du Q, Chan LY, Gilding EK, Henriques ST, Condon ND, Ravipati AS, Kaas Q, Huang YH, Craik DJ.	Discovery and mechanistic studies of cytotoxic cyclotides from the medicinal herb Hybanthus enneaspermus	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@H](C)CC
DRAMP32283	SIPCAESCVWIPCTVTALLGCSCSDKVCYN	30	Hyen M	C0HLP		Not found	medicinal herb Hybanthus enneaspermus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (CC50=1.16±0.03 µM ); HeLa (CC50=1.34±0.04 µM ); MCF-7 (CC50=2.36±0.16 µM )	Human red blood cells (hRBCs): HC50>50 µM 	Cyclic	Free	Free		L	HUVEC: CC50=1.38±0.03 µM, testing time is 24h	Not available	32414842	 J Biol Chem. 2020 Aug 7;295(32):10911-10925.	Du Q, Chan LY, Gilding EK, Henriques ST, Condon ND, Ravipati AS, Kaas Q, Huang YH, Craik DJ.	Discovery and mechanistic studies of cytotoxic cyclotides from the medicinal herb Hybanthus enneaspermus	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@H](C)CC)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP32284	ALWKDMLKGIGKLAGKAALGAVKTLV	26	Dermaseptin-PP	Not available		Not found	Phyllomedusa palliata Skin Secretions	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H157 (IC50=1.55 μM); U-251MG (IC50=2.47 μM); MCF-7 (IC50=2.92 μM); PC-3 (IC50=4.15 μM)	Horse erythrocytes: Dermaseptin-PP exhibited only a moderate hemolytic effect (<20% at 16 μM with a calculated HC50 of 38.77 μM)	Linear	Free	Free		L	Not available	Not available	32582642	Front Chem. 2020 Jun 5;8:476.	Dong Z, Hu H, Yu X, Tan L, Ma C, Xi X, Li L, Wang L, Zhou M, Chen T, Du S, Lu Y. 	Novel Frog Skin-Derived Peptide Dermaseptin-PP for Lung Cancer Treatment: In vitro/vivo Evaluation and Anti-tumor Mechanisms Study	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP32285	FIQHLIPLIPHAIQGIKDIF	20	Kassinatuerin-3 	Not available		Not found	Skin Secretion of the African Frog, Kassina senegalensis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H460 (IC50=1.67 μM); NCI-H838 (IC50=10.3 μM); U-251MG (IC50=13.20 μM ); NCI-H157 (IC50=21.54 μM); LNCaP (IC50=3.79 μM); NCI-H23 (IC50=4.52 μM)	Human RBCs: Kassinatuerin-3 produced no detectable hemolysis activity up to a concentration of 160 μM	Linear	Free	Amidation		L	Not available	Not available	32630734	Biology (Basel). 2020 Jul 2;9(7):148.	Wang H, He H, Chen X, Zhou M, Wei M, Xi X, Ma C, Du Q, Chen T, Shaw C, Wang L. 	A Novel Antimicrobial Peptide (Kassinatuerin-3) Isolated from the Skin Secretion of the African Frog, Kassina senegalensis	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP32286	GLLKRIKXLL	10	Anoplin [T8Beta-Ala]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	"Tumor cells: HeLa (30% Killing=256	µM)"	Horse erythrocytes : 0% Hemolysis=256µM	Linear	Free	Amidation	X(8)=Beta-Ala	L	HEK293T: 17% Hemolysis=256µM	Not available	32654770	 Int J Med Microbiol. 2020 Jul;310(5):151433.	Zhong C, Zhu Y, Zhu N, Liu T, Gou S, Zhang F, Yao J, Xie J, Ni J. 	Synthesis and anti-pseudomonal activity of new ß-Ala modified analogues of the antimicrobial peptide anoplin	
DRAMP32287	XLLKRIKTLL	10	Anoplin [G1Beta-Ala]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	"Tumor cells: HeLa (20% Killing=256	µM)"	Horse erythrocytes : <5% Hemolysis=256µM	Linear	Free	Amidation	X(1)=Beta-Ala	L	HEK293T: 15% Hemolysis=256µM	Not available	32654770	 Int J Med Microbiol. 2020 Jul;310(5):151433.	Zhong C, Zhu Y, Zhu N, Liu T, Gou S, Zhang F, Yao J, Xie J, Ni J. 	Synthesis and anti-pseudomonal activity of new ß-Ala modified analogues of the antimicrobial peptide anoplin	
DRAMP32288	XXGXGXXXA	9	Desmethoxymajusculamide C	Not available		Not found	Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=0.02µM); MDA-MB-435 (IC50=0.022µM); NCI-H460 (IC50=0.063µM); N2a (IC50>1.0µM)	Not available	Cyclic	Free	Free	X(1)=3-amino-2-methylpentanoic acid; X(2)=2-hydroxy-3-methylpentanoate; X(4)=METH-Ile; X(6)=METH-Val; X(7)=METH-Phe; X(8)=4-amino-2,2-dimethyl-3-oxo-pentanoate	L	Not available	Not available	19489598	J Nat Prod. 2009 Jun;72(6):1011-6.	Simmons TL, Nogle LM, Media J, Valeriote FA, Mooberry SL, Gerwick WH.	Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms	
DRAMP32289	XXGXGXXXA	9	Desmethoxymajusculamide C	Not available		Not found	Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=0.016µM); NCI-H460 (IC50=0.094µM); MDA-MB-435 (IC50=0.23µM); N2a (IC50>1.0µM)	Not available	Cyclic	Free	Free	X(1)=3-amino-2-methylpentanoic acid; X(2)=2-hydroxy-3-methylpentanoate; X(4)=METH-Ile; X(6)=METH-Val; X(7)=METH-Phe; X(8)=4-amino-2,2-dimethyl-3-oxo-pentanoate	L	Not available	Not available	19489598	J Nat Prod. 2009 Jun;72(6):1011-6.	Simmons TL, Nogle LM, Media J, Valeriote FA, Mooberry SL, Gerwick WH.	Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms	
DRAMP32290	XXGXGXXXA	9	Linear Desmethoxymajusculamide C	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=0.02µM); MDA-MB-435 (IC50=0.022µM); NCI-H460 (IC50=0.063µM); N2a (IC50>1.0µM)	Not available	Linear	Free	Free	X(1)=3-amino-2-methylpentanoic acid; X(2)=2-hydroxy-3-methylpentanoate; X(4)=METH-Ile; X(6)=METH-Val; X(7)=METH-Phe; X(8)=4-amino-2,2-dimethyl-3-oxo-pentanoate	L	Not available	Not available	19489598	J Nat Prod. 2009 Jun;72(6):1011-6.	Simmons TL, Nogle LM, Media J, Valeriote FA, Mooberry SL, Gerwick WH.	Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms	
DRAMP32291	XXGXGXXXA	9	Linear Desmethoxymajusculamide C	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=0.016µM); NCI-H460 (IC50=0.094µM); MDA-MB-435 (IC50=0.23µM); N2a (IC50>1.0µM)	Not available	Linear	Free	Free	X(1)=3-amino-2-methylpentanoic acid; X(2)=2-hydroxy-3-methylpentanoate; X(4)=METH-Ile; X(6)=METH-Val; X(7)=METH-Phe; X(8)=4-amino-2,2-dimethyl-3-oxo-pentanoate	L	Not available	Not available	19489598	J Nat Prod. 2009 Jun;72(6):1011-6.	Simmons TL, Nogle LM, Media J, Valeriote FA, Mooberry SL, Gerwick WH.	Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms	
DRAMP32292	RKIKRYLRRMI	11	Ovalbumin (277-287)[V5R, P8R, K11I]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	"Tumor cells: HeLa (10% Killing=600	µg/ml)"	Mouse erythrocytes: 10% Hemolysis=1660µg/ml	Linear	Free	Free		L	Not available	Not available	32715598	J Pept Sci. 2020 Oct;26(10):e3276.	Tan A, Suzuki R, Yokoyama C, Yano S, Konno H.	Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)O
DRAMP32293	RKIKVYLPRMK	11	Ovalbumin (277-287)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	"Tumor cells: HeLa (10% Killing=572	µg/ml)"	Mouse erythrocytes: 10% Hemolysis>1660µg/ml	Linear	Free	Free		L	Not available	Not available	32715598	J Pept Sci. 2020 Oct;26(10):e3276.	Tan A, Suzuki R, Yokoyama C, Yano S, Konno H.	Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP32294	GIFSKLAGKKIKNLLISGLKG	21	Esculentin (1-21)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (50% Cell death=150 µM)	Sheep erythrocytes: 10% Hemolysis=64 µM	Linear	Free	Amidation		L	HaCat: 20% Killing=64 µM	Not available	32722535	 Antibiotics (Basel). 2020 Jul 26;9(8):448.	Casciaro B, Loffredo MR, Cappiello F, Verrusio W, Corleto VD, Mangoni ML. 	Frog Skin-Derived Peptides Against Corynebacterium jeikeium: Correlation between Antibacterial and Cytotoxic Activities	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP32295	GIFSKLAGKKIKNlLIsGLKG	21	Esculentin (1-21)[L14l,S17s]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (10% Cell death=150 µM)	Not available	Linear	Free	Amidation	l=D-Leu; s=D-Ser	Mix	Not available	Not available	32722535	 Antibiotics (Basel). 2020 Jul 26;9(8):448.	Casciaro B, Loffredo MR, Cappiello F, Verrusio W, Corleto VD, Mangoni ML. 	Frog Skin-Derived Peptides Against Corynebacterium jeikeium: Correlation between Antibacterial and Cytotoxic Activities	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP32296	GIFSKLAGKKLKNLLISG	18	Esculentin (1-18)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (20% Killing=64 µM)	Sheep erythrocytes: 10% Hemolysis=64 µM	Linear	Free	Amidation		L	HaCat: 20% Killing=64 µM	Not available	32722535	 Antibiotics (Basel). 2020 Jul 26;9(8):448.	Casciaro B, Loffredo MR, Cappiello F, Verrusio W, Corleto VD, Mangoni ML. 	Frog Skin-Derived Peptides Against Corynebacterium jeikeium: Correlation between Antibacterial and Cytotoxic Activities	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(N)=O)[C@H](C)CC
DRAMP32297	FIFLPIFRRPVS	12	Granuliberin-SSa	Not available		Not found	Glandirana susurra	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (50.5% Killing=32µg/ml)	Not available	Linear	Free	Free		L	"COS-7: 	88.5% Killing=32µg/ml; CPAE: 99.2% Killing=32µg/ml"	Not available	32751229	Antibiotics (Basel). 2020 Jul 29;9(8):457.	Ogawa D, Suzuki M, Inamura Y, Saito K, Hasunuma I, Kobayashi T, Kikuyama S, Iwamuro S.	Antimicrobial Property and Mode of Action of the Skin Peptides of the Sado Wrinkled Frog, Glandirana susurra, against Animal and Plant Pathogens	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@H](C)CC
DRAMP32298	GLISTIWNTASNVAGTLTDSVKCKFKKC	28	Ranatuerin-2SSa	Not available		Not found	Glandirana susurra	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (80.3% Killing=32µg/ml)	Not available	Linear	Free	Free		L	"COS-7: 	88.5% Killing=32µg/ml; CPAE: 99.2% Killing=32µg/ml"	Not available	32751229	Antibiotics (Basel). 2020 Jul 29;9(8):457.	Ogawa D, Suzuki M, Inamura Y, Saito K, Hasunuma I, Kobayashi T, Kikuyama S, Iwamuro S.	Antimicrobial Property and Mode of Action of the Skin Peptides of the Sado Wrinkled Frog, Glandirana susurra, against Animal and Plant Pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O
DRAMP32299	SLFSLIKAGAKFLGKNMLKQGPQYPACKVSKDSENVNWKS	40	Brevinin-2SSb	Not available		Not found	Glandirana susurra	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (95.3% Killing=32µg/ml)	Not available	Linear	Free	Free		L	"COS-7: 	88.5% Killing=32µg/ml; CPAE: 99.2% Killing=32µg/ml"	Not available	32751229	Antibiotics (Basel). 2020 Jul 29;9(8):457.	Ogawa D, Suzuki M, Inamura Y, Saito K, Hasunuma I, Kobayashi T, Kikuyama S, Iwamuro S.	Antimicrobial Property and Mode of Action of the Skin Peptides of the Sado Wrinkled Frog, Glandirana susurra, against Animal and Plant Pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
DRAMP32300	FALGAVTKVLPKLFCLITRKC	21	Brevinin-1H	Not available		Not found	skin secretion of Amolops hainanensis 	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=2.599 μM); NCI-H157 (IC50=3.37 μM); MDA-MB-435S (IC50=3.47 μM); PC-3 (IC50=5.87 μM)	Not available	Linear	Free	Free		L	Horse blood cells: HC50=53.12 µM	Not available	32812694	Chem Biol Drug Des. 2021 Feb;97(2):273-282.	Pei X, Gong Z, Wu Q, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M.	Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP32301	FALGAVTCLIRTKCKVLPKLF	21	Brevinin-1Ha	Not available		Not found	skin secretion of Amolops hainanensis 	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=186.9 μM); MDA-MB-435S (IC50=214.7 μM); NCI-H157 (IC50=278.9 μM); HCT 116 (IC50=342.8 μM)	Not available	Linear	Free	Free		L	Horse blood cells: only over 20% at a concentration of 128 µM	Not available	32812694	Chem Biol Drug Des. 2021 Feb;97(2):273-282.	Pei X, Gong Z, Wu Q, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M.	Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O
DRAMP32302	FALGAVTKVLYKLFCLITRKC	21	Brevinin-1HY	Not available		Not found	skin secretion of Amolops hainanensis 	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-435S (IC50=2.243 μM); NCI-H157 (IC50=2.811 μM); HCT 116 (IC50=3.583 μM); PC-3 (IC50=5.425 μM)	Not available	Linear	Free	Free		L	Horse blood cells: The haemolysis at the MIC of Brevinin-1HY (28.48%) was more than threefold at the MIC for the parent peptide	Not available	32812694	Chem Biol Drug Des. 2021 Feb;97(2):273-282.	Pei X, Gong Z, Wu Q, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M.	Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP32303	GFQKVKAQAATCNHTVMA	18	B18K	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/2 signaling and mitochondrial events.	Tumor cells: MCF-7 (IC50>131.0 µM ); MCF-7/G11-TR1 (IC50>131.0 µM ); MCF-7/G11-TR5 (IC50>131.0 µM ); MDA-MB-231 (IC50>131.0 µM ); MDA-MB-468 (IC50>131.0 µM ); SK-BR-3 (IC50>131.0 µM ); T-47D  (IC50>131.0 µM ); ZR-75-1 (IC50>131.0 µM )	Not available	Linear	Free	Free		L	IC50 on PBMCs was = 92.0 ± 39.6 μM	Not available	32872253	. Cancers (Basel). 2020 Aug 28;12(9):2448. 	Lyu Y, Kopcho S, Alvarez FA, Okeoma BC, Okeoma CM.	Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP32304	GFQKAKAKALACLAKALA	18	B18KA	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/18 signaling and mitochondrial events.	Tumor cells: MDA-MB-468 (IC50=135.6±9.3 µM); SK-BR-3 (IC50=43.5±11.5 µM); MCF-7/G11-TR5 (IC50=56.4±5.0 µM); ZR-75-1 (IC50=58.9±2.0 µM); MCF-7 (IC50=61.8±3.9 µM); MCF-7/G11-TR1 (IC50=61.8±5.1 µM); T-47D  (IC50=78.5±20.9 µM); MDA-MB-231 (IC50=83.7±20.1 µM)	Not available	Linear	Free	Free		L	IC50 on PBMCs was = 92.0 ± 39.6 μM	Not available	32872253	. Cancers (Basel). 2020 Aug 28;12(9):2448. 	Lyu Y, Kopcho S, Alvarez FA, Okeoma BC, Okeoma CM.	Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](C)C(=O)O
DRAMP32305	GFQKVKAQALTCLHTVMA	18	B18KL	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/10 signaling and mitochondrial events.	Tumor cells: MCF-7 (IC50>128.5 µM); MCF-7/G11-TR1 (IC50>128.5 µM); MCF-7/G11-TR5 (IC50>128.5 µM); MDA-MB-231 (IC50>128.5 µM); MDA-MB-468 (IC50>128.5 µM); SK-BR-3 (IC50>128.5 µM); T-47D  (IC50>128.5 µM); ZR-75-1 (IC50>128.5 µM)	Not available	Linear	Free	Free		L	IC50 on PBMCs was = 92.0 ± 39.6 μM	Not available	32872253	. Cancers (Basel). 2020 Aug 28;12(9):2448. 	Lyu Y, Kopcho S, Alvarez FA, Okeoma BC, Okeoma CM.	Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP32306	GIGKAIAKAIACIAKAIA	18	B18I	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/34 signaling and mitochondrial events.	Tumor cells: T-47D  (IC50 >148.5 µM); ZR-75-1 (IC50=10.1±1.8 µM); MCF-7/G11-TR1 (IC50=10.8±2.0 µM); MCF-7 (IC50=16.0±1.6 µM); MCF-7/G11-TR5 (IC50=16.1±4.9 µM); MDA-MB-468 (IC50=16.6±1.5 µM); SK-BR-3 (IC50=18.1±4.7 µM); MDA-MB-231 (IC50=18.6±2.4 µM)	Not available	Linear	Free	Free		L	IC50 on PBMCs was = 92.0 ± 39.6 μM	Not available	32872253	. Cancers (Basel). 2020 Aug 28;12(9):2448. 	Lyu Y, Kopcho S, Alvarez FA, Okeoma BC, Okeoma CM.	Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP32307	GLGKALAKALACLAKALA	18	B18L	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	may induce cell death through processes involving membrane surface blebs, loss of membrane integrity, PI internalization, LDH release and PS externalization, coupled with coordinated regulation of Src•Erk1/26 signaling and mitochondrial events.	Tumor cells: MDA-MB-468 (IC50=12.4±1.4 µM); T-47D  (IC50=17.5±6.5 µM); MCF-7/G11-TR5 (IC50=3.8±0.3 µM); ZR-75-1 (IC50=5.2±1.0 µM); MCF-7 (IC50=5.9±0.5 µM); MCF-7/G11-TR1 (IC50=6.2±0.8 µM); MDA-MB-231 (IC50=7.2±0.8 µM); SK-BR-3 (IC50=7.2±1.0 µM)	Human red blood cells: EC 50=21.2±3.2 μM, testing time is 24 h	Linear	Free	Free		L	IC50 on PBMCs was = 92.0 ± 39.6 μM	Not available	32872253	. Cancers (Basel). 2020 Aug 28;12(9):2448. 	Lyu Y, Kopcho S, Alvarez FA, Okeoma BC, Okeoma CM.	Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead	CC(C)C[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP32308	FLPALAGIAGLLGKIF	16	Temporin-SHe	Not available		Not found	Pelophylax saharicus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (45% Killing=12.5µM; 96% Killing=25µM)	Human erythrocytes: 22% Hemolysis=12.5µM; 84% Hemolysis=25µM	Linear	Free	Amidation		L	Not available	Not available	32933215	Int J Mol Sci. 2020 Sep 13;21(18):6713.	André S, Raja Z, Humblot V, Piesse C, Foulon T, Sereno D, Oury B, Ladram A.	Functional Characterization of Temporin-SHe, a New Broad-Spectrum Antibacterial and Leishmanicidal Temporin-SH Paralog from the Sahara Frog ( Pelophylax saharicus)	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP32309	FIGTLIPLALGALTKLFK	18	Figainin 1 	A0A2L2DDE6 		Not found	B. raniceps skin secretion	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: B16-F10 (IC50=10.5 µM (0.020 g/L)); HeLa (IC50=11.1 µM (0.021 g/L)); MCF-7 (IC50=13.7 µM (0.026 g/L))	Human red blood cells: HC50 =10 µM (0.019 g/L) (testing time is 24 h)	Linear	Free	Free		L	NIH 3T3: IC50=13 µM (0.025 g/L) (testing time is 24 h)	Not available	32967114	Antibiotics (Basel). 2020 Sep 21;9(9):625	Santana CJC, Magalhães ACM, Dos Santos Júnior ACM, Ricart CAO, Lima BD, Álvares ADCM, Freitas SM, Pires OR Jr, Fontes W, Castro MS.	Figainin 1, a Novel Amphibian Skin Peptide with Antimicrobial and Antiproliferative Properties	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O
DRAMP32310	CKKKC	5	C1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	"Tumor cells: HeLa (IC50=25.5±2.9	µg/ml)"	Human erythrocytes:HC50=43.9±3.5µg/ml	Cyclic	CH3(CH2)14CO, Palmitic acid	Amidation		L	HaCat: IC50=23.6±6µg/ml	Not available	33003569	Int J Mol Sci. 2020 Sep 29;21(19):7208.	Neubauer D, Jaśkiewicz M, Sikorska E, Bauer SBM, Kapusta M, Narajczyk M, Kamysz W. 	Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP32311	CKKKRC	6	C6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=30.4±2.5µg/ml)	Human erythrocytes:HC50=71±6.4µg/ml	Cyclic	CH3(CH2)14CO, Palmitic acid	Amidation		L	HaCat: IC50=45.7±13.5µg/ml	Not available	33003569	Int J Mol Sci. 2020 Sep 29;21(19):7208.	Neubauer D, Jaśkiewicz M, Sikorska E, Bauer SBM, Kapusta M, Narajczyk M, Kamysz W. 	Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(N)=O
DRAMP32312	CKKRKC	6	C5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=21.9±4.5µg/ml)	Human erythrocytes:HC50=97±15.4µg/ml	Cyclic	CH3(CH2)14CO, Palmitic acid	Amidation		L	HaCat: IC50=12.9±4.6µg/ml	Not available	33003569	Int J Mol Sci. 2020 Sep 29;21(19):7208.	Neubauer D, Jaśkiewicz M, Sikorska E, Bauer SBM, Kapusta M, Narajczyk M, Kamysz W. 	Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP32313	CRKKKC	6	C3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=38.8±4.4µg/ml)	Human erythrocytes:HC50=66.5±14.8µg/ml	Cyclic	CH3(CH2)14CO, Palmitic acid	Amidation		L	HaCat: IC50=36.8±2.7µg/ml	Not available	33003569	Int J Mol Sci. 2020 Sep 29;21(19):7208.	Neubauer D, Jaśkiewicz M, Sikorska E, Bauer SBM, Kapusta M, Narajczyk M, Kamysz W. 	Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP32314	KKKR	4	L6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=3.6±0.5µg/ml)	Human erythrocytes:HC50=89.7±2.4µg/ml	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	HaCat: IC50=7.5±0.8µg/ml	Not available	33003569	Int J Mol Sci. 2020 Sep 29;21(19):7208.	Neubauer D, Jaśkiewicz M, Sikorska E, Bauer SBM, Kapusta M, Narajczyk M, Kamysz W. 	Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32315	KKRK	4	L5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=6.2±2.7µg/ml)	Human erythrocytes:HC50=96.7±1.4µg/ml	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	HaCat: IC50=2.4±0.4µg/ml	Not available	33003569	Int J Mol Sci. 2020 Sep 29;21(19):7208.	Neubauer D, Jaśkiewicz M, Sikorska E, Bauer SBM, Kapusta M, Narajczyk M, Kamysz W. 	Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32316	RKKK	4	L3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=8.4±1.7µg/ml)	Human erythrocytes:HC50=79.1±6.1µg/ml	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	HaCat: IC50=23.6±3.4µg/ml	Not available	33003569	Int J Mol Sci. 2020 Sep 29;21(19):7208.	Neubauer D, Jaśkiewicz M, Sikorska E, Bauer SBM, Kapusta M, Narajczyk M, Kamysz W. 	Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32317	WRRRYRRWRRRRRWRRRPRR	20	vCPP 2319	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50=5.02±1.04 µM)	Human erythrocytes: 50% Hemolysis>200µM	Linear	Free	Amidation		L	Not available	Not available	33015016	Front Bioeng Biotechnol. 2020 Sep 9;8:552035	Cavaco M, Pérez-Peinado C, Valle J, Silva RDM, Correia JDG, Andreu D, Castanho MARB, Neves V.	To What Extent Do Fluorophores Bias the Biological Activity of Peptides? A Practical Approach Using Membrane-Active Peptides as Models	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(N)=O
DRAMP32318	RRIPFWPIPLRWQWPPPWFPPSFPIPRISRKR	32	Del1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (80% killing=32μM)	Human erythrocytes:25% Hemolysis=32µM	Linear	Free	Free		L	"HaCat: 	10% Killing=32µM"	Not available	33036159	Int J Mol Sci. 2020 Oct 6;21(19):7367. 	Sola R, Mardirossian M, Beckert B, Sanghez De Luna L, Prickett D, Tossi A, Wilson DN, Scocchi M.	Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP32319	RRIPFWPPNLPGPRRPPWFLPDFRIPRIPRKR	32	Orc1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (40% Killing=32µM)	Human erythrocytes:0% Hemolysis=32µM	Linear	Free	Free		L	"HaCat: 	15% Killing=32µM"	Not available	33036159	Int J Mol Sci. 2020 Oct 6;21(19):7367. 	Sola R, Mardirossian M, Beckert B, Sanghez De Luna L, Prickett D, Tossi A, Wilson DN, Scocchi M.	Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32320	RRIRFPFPPFPWQWPPAGFPTFHIPRIPRKQ	31	Cathelicidin Neo1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (32% killing=32μM)	Human erythrocytes:0% Hemolysis=32µM	Linear	Free	Free		L	"HaCat: 	12% Killing=32µM"	Not available	33036159	Int J Mol Sci. 2020 Oct 6;21(19):7367. 	Sola R, Mardirossian M, Beckert B, Sanghez De Luna L, Prickett D, Tossi A, Wilson DN, Scocchi M.	Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP32321	RRIRFRPPRLPRPRPRPWIPPRFPFPRIPGKR	32	Cathelicidin-like peptide Bal1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (95% killing=32μM)	Human erythrocytes:0% Hemolysis=32µM	Linear	Free	Free		L	"HaCat: 	0% Killing=32µM"	Not available	33036159	Int J Mol Sci. 2020 Oct 6;21(19):7367. 	Sola R, Mardirossian M, Beckert B, Sanghez De Luna L, Prickett D, Tossi A, Wilson DN, Scocchi M.	Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC
DRAMP32322	RRIRIRPPRLPRPRPRPWFPPRFPIPRIPGKR	32	Cathelicidin-like peptide Lip1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-1 (90% killing=32μM)	Human erythrocytes:0% Hemolysis=32µM	Linear	Free	Free		L	"HaCat: 	10% Killing=32µM"	Not available	33036159	Int J Mol Sci. 2020 Oct 6;21(19):7367. 	Sola R, Mardirossian M, Beckert B, Sanghez De Luna L, Prickett D, Tossi A, Wilson DN, Scocchi M.	Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP32323	KCAGSIAWAIGSGLFGGAKLIKIKKYIAELGGLQ	34	Pom-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: TZM-bl (IC50=40.16µg/ml)	Not available	Linear	Free	Free		L	Vero E6: 50% Cytotoxicity=438 µM	Not available	33113998	Biomolecules. 2020 Oct 23;10(11):1473.	González García M, Rodríguez A, Alba A, Vázquez AA, Morales Vicente FE, Pérez-Erviti J, Spellerberg B, Stenger S, Grieshober M, Conzelmann C, Münch J, Raber H, Kubiczek D, Rosenau F, Wiese S, Ständker L, Otero-González A. 	New Antibacterial Peptides from the Freshwater Mollusk Pomacea poeyana (Pilsbry, 1927)	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP32324	KRWHWWRRHWVVW	13	MAD1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: OVCAR-3 (IC50=14.2 µM); A549 (IC50=36.2 µM); NCI/ADR-RES (IC50=85.6 µM); T24 (IC50>100 µM)	Not available	Linear	Free	Amidation		L	HUVEC: IC50>100 μM; NL20: IC50=76.9 μM	Not available	33184577	 Cell Mol Bioeng. 2020 Jun 24;13(5):447-461.	Aronson MR, Dahl ES, Halle JA, Simonson AW, Gogal RA, Glick AB, Aird KM, Medina SH.	Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers	CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)C(C)C
DRAMP32325	LWKRWVGVWRKWL	13	DAP1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=11.9 µM); NCI/ADR-RES (IC50=14.0 µM); T24 (IC50=15.3 µM); OVCAR-3 (IC50=8.6 µM)	Not available	Linear	Free	Amidation		L	HUVEC: IC50=19.5 μM; NL20: IC50=19.0 μM	Not available	33184577	 Cell Mol Bioeng. 2020 Jun 24;13(5):447-461.	Aronson MR, Dahl ES, Halle JA, Simonson AW, Gogal RA, Glick AB, Aird KM, Medina SH.	Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(N)=O
DRAMP32326	RWGKWFKKNSHLS	13	DAP2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>100 µM); NCI/ADR-RES (IC50>100 µM); OVCAR-3 (IC50>100 µM); T24 (IC50>100 µM)	Not available	Linear	Free	Amidation		L	HUVEC: IC50>100 μM; NL20: IC50>100 μM	Not available	33184577	 Cell Mol Bioeng. 2020 Jun 24;13(5):447-461.	Aronson MR, Dahl ES, Halle JA, Simonson AW, Gogal RA, Glick AB, Aird KM, Medina SH.	Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(N)=O
DRAMP32327	WKWLKKWIK	9	AMP1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: OVCAR-3 (IC50=51.1 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	33184577	 Cell Mol Bioeng. 2020 Jun 24;13(5):447-461.	Aronson MR, Dahl ES, Halle JA, Simonson AW, Gogal RA, Glick AB, Aird KM, Medina SH.	Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32328	WKWLKKWIK	9	AMP1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=24.3 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	33184577	 Cell Mol Bioeng. 2020 Jun 24;13(5):447-461.	Aronson MR, Dahl ES, Halle JA, Simonson AW, Gogal RA, Glick AB, Aird KM, Medina SH.	Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32329	CGAISLAKLQINES	14	HS3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CT26 (IC50=80.7±6.9 µM)	Not available	Linear	Free	Free		L	Not available	programmed cell death protein 1	33360579	Bioorg Med Chem. 2021 Jan 15;30:115951.	Orafaie A, Sadeghian H, Bahrami AR, Rafatpanah H, Matin MM. 	Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC
DRAMP32330	CGAISLAPKAQIKES	15	HS1	Q15116		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CT26 (IC50=19.2±2.3 µM)	Not available	Linear	Free	Free		L	Not available	programmed cell death protein 1	33360579	Bioorg Med Chem. 2021 Jan 15;30:115951.	Orafaie A, Sadeghian H, Bahrami AR, Rafatpanah H, Matin MM. 	Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC
DRAMP32331	CGAISLAPKLQIKES	15	HS2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CT26 (IC50=93.5±10.7 µM)	Not available	Linear	Free	Free		L	Not available	programmed cell death protein 1	33360579	Bioorg Med Chem. 2021 Jan 15;30:115951.	Orafaie A, Sadeghian H, Bahrami AR, Rafatpanah H, Matin MM. 	Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC
DRAMP32332	GAISAPKLQIND	12	HS7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CT26 (IC50=4.4±0.4 µM)	Not available	Linear	Free	Free		L	Not available	programmed cell death protein 1	33360579	Bioorg Med Chem. 2021 Jan 15;30:115951.	Orafaie A, Sadeghian H, Bahrami AR, Rafatpanah H, Matin MM. 	Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC
DRAMP32333	GAISLAKLQINeG	13	HS6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CT26 (IC50=0.71±0.22 µM)	Not available	Cyclic	Acetylization	Amidation	C,N-terminal lactam peptide; e=D-Glutamic acid	Mix	Not available	programmed cell death protein 1	33360579	Bioorg Med Chem. 2021 Jan 15;30:115951.	Orafaie A, Sadeghian H, Bahrami AR, Rafatpanah H, Matin MM. 	Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCC(=O)O)C(=O)NCC(N)=O)[C@H](C)CC
DRAMP32334	GAISLAPKLQINE	13	HS4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CT26 (IC50=5.6±0.15 µM)	Not available	Linear	Free	Free		L	Not available	programmed cell death protein 1	33360579	Bioorg Med Chem. 2021 Jan 15;30:115951.	Orafaie A, Sadeghian H, Bahrami AR, Rafatpanah H, Matin MM. 	Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC
DRAMP32335	GAISLAPKLQINe	13	HS5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CT26 (IC50=1.56±0.35 µM)	Not available	Linear	Free	Free	e=D-Glutamic acid	Mix	Not available	programmed cell death protein 1	33360579	Bioorg Med Chem. 2021 Jan 15;30:115951.	Orafaie A, Sadeghian H, Bahrami AR, Rafatpanah H, Matin MM. 	Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCC(=O)O)C(=O)O)[C@H](C)CC
DRAMP32336	OLeu-V-NMeLeu-FL	16	MSSV	Not available		Not found	Fusarium spp. isolated from Korean potato	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	MSSV inhibited the proliferation of both bladder cancer 5637 and T24 cells, which was attributed to the G1-phase cell cycle arrest, apoptosis induction, and alteration of mitogen-activated protein kinases (MAPKs) and protein kinase b (AKT) signaling pathways.	Tumor cells: 5637 (IC50=20 μg/mL); T24 (IC50=20 μg/mL)	Not available	Cyclic			OLeu=leucic acid component; NMeLeu=N-methylleucine; 	Mix	Not available	Not available	33430488	 Cancers (Basel). 2021 Jan 7;13(2):191.	Song JH, Park J, Park SL, Hwang B, Kim WJ, Lee C, Moon SK. 	N-Methylsansalvamide, a cytotoxic cyclic depsipeptide from a marine fungus of the genus fusarium	
DRAMP32337	VKLRSLLCS	9	VS-9	Not available		Not found	garlic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	VS-9 could induce apoptosis and upregulate mRNA levels of caspase 3, caspase 8, caspase 9, and Bax while downregulating Bcl-2, Bcl-xL, and Bcl-w.	Tumor cells: Molt-4 (IC50=0.84 mM ); K562 (IC50=1.57 mM )	Not available	Linear	Free	Free		L	PBMC: IC50>2.0 mM	groove of the BH3 domain on target proteins	33595876	Chem Biol Drug Des. 2021 May;97(5):1017-1028.	Rasaratnam K, Nantasenamat C, Phaonakrop N, Roytrakul S, Tanyong D. 	A novel peptide isolated from garlic shows anticancer effect against leukemic cell lines via interaction with Bcl-2 family proteins	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O
DRAMP32338	DVNFLLHKIYGNIRY	15	LvHemB1	Not available		Not found	Litopenaeus vannamei	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: EC109 (49.01% decrease=50μg/mL); HepG2  (53.26% decrease=50μg/mL); HeLa (70.30% decrease=50μg/mL); EJ (78.44% decrease=50μg/mL)	Not available	Linear	Free	Free		L	THLE-3: 30.83% decrease=50μg/mL	Not available	33630204	 Cell Biol Toxicol. 2022 Feb;38(1):87-110.	Liu S, Aweya JJ, Zheng L, Zheng Z, Huang H, Wang F, Yao D, Ou T, Zhang Y. 	LvHemB1, a novel cationic antimicrobial peptide derived from the hemocyanin of Litopenaeus vannamei, induces cancer cell death by targeting mitochondrial voltage-dependent anion channel 1	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP32339	FFPLIAGLAARFLPKIFCSITKRC	24	Brevinin-1RL1	Not available		Not found	Frog Skin Secretion	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=10.37±0.40 µM ); MDA-MB-231 (IC50=5.44±0.33 µM ); A549 (IC50=5.81±0.23 µM ); HCT 116 (IC50=5.87±0.15 µM ); B16-F10 (IC50=6.65±0.33 µM ); SMMC-7721 (IC50=6.87±0.51 µM )	Human erythrocytes: Moderate Hemolysis	Linear	Free	Free		L	NCM460: IC50=16.84±0.56 µM; BEAS-2B: IC50=16.57±0.29 µM; HaCaT: IC50=28.67±0.36 µM 	Not available	33916789	Molecules. 2021 Apr 3;26(7):2059	Ju X, Fan D, Kong L, Yang Q, Zhu Y, Zhang S, Su G, Li Y.	Antimicrobial Peptide Brevinin-1RL1 from Frog Skin Secretion Induces Apoptosis and Necrosis of Tumor Cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC
DRAMP32340	CIIKKIIKKIIKK	13	IK-13	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=29±6 µM); HeLa (IC50=47±5 µM)	Not available	Linear	Free	Free		L	HDF: IC50>100 µM	Not available	34509120	J Colloid Interface Sci. 2022 Feb;607(Pt 1):488-501.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X.	Rationally designed short cationic α-helical peptides with selective anticancer activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC
DRAMP32341	CIIKKIIKKIIKKII	15	CI-15	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=2.7±0.5 µM); HCT 116 (IC50=7.7±0.2 µM)	Not available	Linear	Free	Free		L	HDF: IC50=83±5 µM	Not available	34509120	J Colloid Interface Sci. 2022 Feb;607(Pt 1):488-501.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X.	Rationally designed short cationic α-helical peptides with selective anticancer activity	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP32342	CIIRRIIRRIIRR	13	IR-13	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50>100 µM); HeLa (IC50>100 µM)	Not available	Linear	Free	Free		L	HDF: IC50=22±3 µM	Not available	34509120	J Colloid Interface Sci. 2022 Feb;607(Pt 1):488-501.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X.	Rationally designed short cationic α-helical peptides with selective anticancer activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP32343	CLLKKLLKKLLKK	13	LK-13	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=23±2 µM); HeLa (IC50=83±9 µM)	Not available	Linear	Free	Free		L	HDF: IC50>100 µM	Not available	34509120	J Colloid Interface Sci. 2022 Feb;607(Pt 1):488-501.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X.	Rationally designed short cationic α-helical peptides with selective anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32344	CLLRRLLRRLLRR	13	LR-13	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=15.6±1.0 µM); HeLa (IC50=26.7±1.3 µM)	Not available	Linear	Free	Free		L	HDF: IC50=24±5 µM	Not available	34509120	J Colloid Interface Sci. 2022 Feb;607(Pt 1):488-501.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X.	Rationally designed short cationic α-helical peptides with selective anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP32345	KKRKKKAFALKFVVDLI	17	PCC-1	Not available		Not found	insect-derived peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PCC-1 induces cell proliferation inhibition, apoptosis, and cell cycle arrest by downregulating Sp1 expression in the melanoma cell lines SK-MEL-28 and G361.	Tumor cells: SK-MEL-28 (IC50=50.8 µM); G-361 (IC50=57.8 µM)	Not available	Linear	Free	Amidation		L	HaCaT: not induce toxicity 	Not available	34531430	 Sci Rep. 2021 Sep 16;11(1):18445. 	Lee RH, Oh JD, Hwang JS, Lee HK, Shin D.	Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(N)=O
DRAMP32346	VTFVLIAAK	9	C-ori	Not available		Not found	Cordyceps militaris	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=114.9±1.5 µM)	Not available	Linear	Free	Free		L	Not available	Not available	34641308	Molecules. 2021 Sep 23;26(19):5767.	Chantawannakul J, Chatpattanasiri P, Wattayagorn V, Kongsema M, Noikaew T, Chumnanpuen P.	Virtual Screening for Biomimetic Anti-Cancer Peptides from Cordyceps militaris Putative Pepsinized Peptidome and Validation on Colon Cancer Cell Line	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32347	IKIKIKIKIKIK	12	IKIK	Not available		Not found	cationic amphiphilic peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=32.7±4.5 µM); HeLa (IC50=8.9±2.1 µM)	Not available	Linear	Free	Free		L	HDF: IC50=4.4±0.3 µM	Not available	34715505	Colloids Surf B Biointerfaces. 2022 Jan;209(Pt 2):112165.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X. 	Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP32348	IKIRIKIRIKIR	12	IKIR	Not available		Not found	cationic amphiphilic peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=14.5±2.3 µM); HCT 116 (IC50=20.9±2.0 µM)	Not available	Linear	Free	Free		L	HDF: IC50=38.6±0.2 µM	Not available	34715505	Colloids Surf B Biointerfaces. 2022 Jan;209(Pt 2):112165.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X. 	Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP32349	IRIKIRIKIRIK	12	IRIK	Not available		Not found	cationic amphiphilic peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=15.5±1.2 µM); HCT 116 (IC50=30.1±5.2 µM)	Not available	Linear	Free	Free		L	HDF: IC50=34.5±0.9 µM	Not available	34715505	Colloids Surf B Biointerfaces. 2022 Jan;209(Pt 2):112165.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X. 	Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP32350	LKLKLKLKLKLK	12	LKLK	Not available		Not found	cationic amphiphilic peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=14.5±1.3 µM); HeLa (IC50=17.7±6.5 µM)	Not available	Linear	Free	Free		L	HDF: IC50>40 µM	Not available	34715505	Colloids Surf B Biointerfaces. 2022 Jan;209(Pt 2):112165.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X. 	Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32351	LKLRLKLRLKLR	12	LKLR	Not available		Not found	cationic amphiphilic peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50>40 µM); HeLa (IC50>40 µM)	Not available	Linear	Free	Free		L	HDF: IC50=22.5±1.4 µM	Not available	34715505	Colloids Surf B Biointerfaces. 2022 Jan;209(Pt 2):112165.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X. 	Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP32352	LRLKLRLKLRLK	12	LRLK	Not available		Not found	cationic amphiphilic peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50>40 µM); HeLa (IC50>40 µM)	Not available	Linear	Free	Free		L	HDF: IC50=24.1±0.7 µM	Not available	34715505	Colloids Surf B Biointerfaces. 2022 Jan;209(Pt 2):112165.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X. 	Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32353	LRLRLRLRLRLR	12	LRLR	Not available		Not found	cationic amphiphilic peptides	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=31.8±2.9  µM); HeLa (IC50>40 µM)	Not available	Linear	Free	Free		L	HDF: IC50=22.7±2.4 µM	Not available	34715505	Colloids Surf B Biointerfaces. 2022 Jan;209(Pt 2):112165.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X. 	Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP32354	FLPLLISALTSLFPKLGK	18	SSTP1	Not available		Not found	Skin Secretion of Indosylvirana aurantiaca	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	In IL6Rα-overexpressing cancer cells, SSTP1 induces apoptosis at low concentration through JNK pathway, without causing significant membrane disruption.	Tumor cells: HSC-4 (IC50=10.22 μM); MDA-MB-231 (IC50=4.5 μM)	Human red blood cell: SSTP1-induced hemolysis at 5 μM was only-0.25%	Linear	Free	Free		L	HEK293: IC50=21.72 μM, lower cytotoxicity	IL6/IL6Rα/gp130 complex	34867962	Front Immunol. 2021 Nov 19;12:740620. 	Gopalakrishnan S, Uma SK, Mohan G, Mohan A, Shanmugam G, Kumar VTV, J S, Chandrika SK, Vasudevan D, Nori SRC, Sathi SN, George S, Maliekal TT.	SSTP1, a Host Defense Peptide, Exploits the Immunomodulatory IL6 Pathway to Induce Apoptosis in Cancer Cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
DRAMP32355	GYFCESCRKIIQKLEDMVGPQPNEDTVTQAASQVCDKLKILRGLCKKIMRSFLRRISWDILTGKKPQAICVDIKICKE	78	Antimicrobial peptide NK-lysin	Not available		Not found	Sus scrofa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: YAC-1 (LC90=50 µg/ml)	Sheep erythrocytes: 0% Hemolysis=170 µM	Cyclic	Free	Free		L	Not available	Not available	7737114	EMBO J. 1995 Apr 18;14(8):1615-25.	Andersson M, Gunne H, Agerberth B, Boman A, Bergman T, Sillard R, Jörnvall H, Mutt V, Olsson B, Wigzell H, et al. 	NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(C)C
DRAMP32356	GEILCNLCTGLINTLENLLTTKRKRQQ	27	EH-APP(1-22)-Melittin (21-26)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LC=50 µM); Jurkat (LC50=8 µM)	Human erythrocytes: 50% Hemolysis=10 µM	Linear	Free	Amidation		L	Not available	Not available	8146160	Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2602-6.	Leippe M, Andrä J, Müller-Eberhard HJ. 	Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O
DRAMP32357	GFIATLCTKVLDFGIDKLIQLIEDK	25	EH-APP(40-64)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (LC50=60 µM); U-937 (LC50=80 µM)	Human erythrocytes: 10% Hemolysis=10 µm	Linear	Free	Free		L	Not available	Not available	8146160	Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2602-6.	Leippe M, Andrä J, Müller-Eberhard HJ. 	Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32358	GIGKFLKKAKKFAKAFVKIINN	22	MSI-136	Not available		Not found	African clawed frog Xenopus laevis skin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	A mechanism which appears to be related to short duration non-receptor-driven contact with target cell membranes.	Tumor cells: A549 (IC50=10 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	8319212	Cancer Res. 1993 Jul 1;53(13):3052-7.	Baker MA, Maloy WL, Zasloff M, Jacob LS. 	Anticancer efficacy of Magainin2 and analogue peptides	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(N)=O)[C@H](C)CC)[C@H](C)CC)C(C)C
DRAMP32359	gigkflkkakkfakafvkiinn	22	MSI-238	Not available		Not found	African clawed frog Xenopus laevis skin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	A mechanism which appears to be related to short duration non-receptor-driven contact with target cell membranes.	Tumor cells: A549 (IC50=6 µM)	Not available	Linear	Free	Amidation		D	Not available	Not available	8319212	Cancer Res. 1993 Jul 1;53(13):3052-7.	Baker MA, Maloy WL, Zasloff M, Jacob LS. 	Anticancer efficacy of Magainin2 and analogue peptides	CC[C@H](C)[C@@H](NC(=O)CN)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(N)=O)C(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C
DRAMP32360	KWKLFKKIGIGAVLKVLKKG	20	P1	Not available		Not found	Ceropin A-Magainin 2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=3.4 µM); NCI-H128 (IC50=3.5 µM); NCI-H146 (IC50=4.5 µM)	Human red blood cells: hemolysis 0.3%(50 μg/mL); hemolysis 1%(100 μg/mL)	Linear	Free	Amidation		L	Not available	Not available	9352466	J Pept Res. 1997 Oct;50(4):279-85.	Shin SY, Lee MK, Kim KL, Hahm KS. 	Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 14 and cecropin A-melittin hybrid peptides	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)C(C)C)C(C)C
DRAMP32361	KWKLFKKIGIGKFLHSATTF	20	P2	Not available		Not found	Ceropin A-Magainin 2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=36.2 µM); NCI-H128 (IC50=37.9 µM); NCI-H146 (IC50=47.7 µM)	Human red blood cells: hemolysis 0.2%(50 μg/mL); hemolysis 1%(100 μg/mL)	Linear	Free	Amidation		L	Not available	Not available	9352466	J Pept Res. 1997 Oct;50(4):279-85.	Shin SY, Lee MK, Kim KL, Hahm KS. 	Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 15 and cecropin A-melittin hybrid peptides	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)O)[C@@H](C)O
DRAMP32362	KWKLFKKIGIGAFLHSAKKF	20	P3	Not available		Not found	Ceropin A-Magainin 2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H146 (IC50=10.9 µM); NCI-H128 (IC50=9.3 µM); NCI-H69 (IC50=9.3 µM)	Human red blood cells: hemolysis 0.1%(50 μg/mL); hemolysis 0.2%(100 μg/mL)	Linear	Free	Amidation		L	Not available	Not available	9352466	J Pept Res. 1997 Oct;50(4):279-85.	Shin SY, Lee MK, Kim KL, Hahm KS. 	Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 16 and cecropin A-melittin hybrid peptides	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP32363	KWKLFKKIGIGKFLHLAKKF	20	P4	Not available		Not found	Ceropin A-Magainin 2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H128 (IC50=1.3 µM); NCI-H69 (IC50=1.9 µM); NCI-H146 (IC50=2.8 µM)	Human red blood cells: hemolysis 0.2%(50 μg/mL); hemolysis 0.7%(100 μg/mL)	Linear	Free	Amidation		L	Not available	Not available	9352466	J Pept Res. 1997 Oct;50(4):279-85.	Shin SY, Lee MK, Kim KL, Hahm KS. 	Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 17 and cecropin A-melittin hybrid peptides	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP32364	KWKLFKKIGIGAFLHLAKKF	20	P5	Not available		Not found	Ceropin A-Magainin 2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H128 (IC50=2.9 µM); NCI-H69 (IC50=2.9 µM); NCI-H146 (IC50=3.2 µM)	Human red blood cells: hemolysis 1.5%(50 μg/mL); hemolysis 8%(100 μg/mL)	Linear	Free	Amidation		L	Not available	Not available	9352466	J Pept Res. 1997 Oct;50(4):279-85.	Shin SY, Lee MK, Kim KL, Hahm KS. 	Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 18 and cecropin A-melittin hybrid peptides	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP32365	KWKLFKKIGIGKFKLAKKF	19	P6	Not available		Not found	Ceropin A-Magainin 2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=1.7 µM); NCI-H128 (IC50=2 µM); NCI-H146 (IC50=3.1 µM)	Human red blood cells: hemolysis 0.2%(50 μg/mL); hemolysis 1.2%(100 μg/mL)	Linear	Free	Amidation		L	Not available	Not available	9352466	J Pept Res. 1997 Oct;50(4):279-85.	Shin SY, Lee MK, Kim KL, Hahm KS. 	Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 19 and cecropin A-melittin hybrid peptides	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP32366	KWKLFAKIGIGKFLHLAKKF	20	P7	Not available		Not found	Ceropin A-Magainin 2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H128 (IC50=2.4 µM); NCI-H146 (IC50=2.4 µM); NCI-H69 (IC50=3.1 µM)	Human red blood cells: hemolysis 0.4%(50 μg/mL); hemolysis 2.4%(100 μg/mL)	Linear	Free	Amidation		L	Not available	Not available	9352466	J Pept Res. 1997 Oct;50(4):279-85.	Shin SY, Lee MK, Kim KL, Hahm KS. 	Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 20 and cecropin A-melittin hybrid peptides	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP32367	KWKKFLKIGIGKFLHLAKKF	20	P8	Not available		Not found	Ceropin A-Magainin 2	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H146 (IC50=1.8 µM); NCI-H128 (IC50=2.3 µM); NCI-H69 (IC50=2.6 µM)	Human red blood cells: hemolysis 2.4%(50 μg/mL); hemolysis 13.7%(100 μg/mL)	Linear	Free	Amidation		L	Not available	Not available	9352466	J Pept Res. 1997 Oct;50(4):279-85.	Shin SY, Lee MK, Kim KL, Hahm KS. 	Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 21 and cecropin A-melittin hybrid peptides	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP32368	RQSHFANAQP	10	CPe-III(CPe-III-S)	Not available		Not found	Chickpea (Cicer arietinum L.)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	the bioactive peptide combined the DNA binding domain of p53 protein by hydrogen bonds, induced the expression of p53 protein and facilitated its stability so that it inhibited the cell proliferation.	Tumor cells: MDA-MB-231 (EC50=1.50 μmol/mL); MCF-7 (EC50=2.38 μmol/mL )	Not available	Linear	Free	Free		L	Not available	p53 protein	Not available			Antioxidant activity and anti-proliferative effect of a bioactive peptide from chickpea (Cicer arietinum L.)	C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O
DRAMP32369	WPP	3	BCP-A	Not available		Not found	hydrolysate of blood clam (Tegillarca granosa) muscle	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=1.99 mg/mL ); HeLa (IC50=2.54 mg/mL ); DU145 (IC50=2.80 mg/mL); NCI-H1299 (IC50=3.3 mg/mL )	Not available	Linear	Free	Free		L	NIH 3T3: Has hardly any cytotoxicity on normal cells.	Not available	Not available			Antioxidant and anticancer peptides from the protein hydrolysate of blood clam (Tegillarca granosa) muscle	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O
DRAMP32370	SLPQNIPPLTQTPVVVPPF	19	P19	Not available		Not found	Synbiotic yoghurt	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (Antiproliferative acitivity (%)=38.55±1.75%,  Peptide concentration 3 mg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	Not available			Antioxidant peptides isolated from synbiotic yoghurt exhibit antiproliferative activities against HT-29 colon cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O
DRAMP32371	YQEPVLGPVRGPFPIIV	17	P17	Q9TSI0##P02666		Not found	Synbiotic yoghurt	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (Antiproliferative acitivity (%)=41.49±2.18%,  Peptide concentration 3 mg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	Not available			Antioxidant peptides isolated from synbiotic yoghurt exhibit antiproliferative activities against HT-29 colon cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(C)C)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
DRAMP32372	XXMXIVVKVLKYLX	14	Brevilaterin B	Not available		Not found	Brevibacillus laterosporus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=1.40±0.09 µg/mL); SW1990 (IC50=13.40±0.08 µg/mL); SMMC-7721 (IC50=13.81±0.31 µg/mL); SW480 (IC50=17.15±0.97 µg/mL); EC109 (IC50=2.13±0.23 µg/mL); A498 (IC50=2.33±0.49 µg/mL); DU145 (IC50=2.56±0.23 µg/mL); HeLa (IC50=2.60±0.24 µg/mL); A431 (IC50=2.75±0.07 µg/mL); PANC-1 (IC50=3.11±0.49 µg/mL); KB (IC50=3.14±0.07 µg/mL); HeLa S3 (IC50=3.16±0.45 µg/mL); EC9706 (IC50=3.23±0.16 µg/mL); A-375 (IC50=4.16±0.15 µg/mL); MDA-MB-231 (IC50=4.16±0.27 µg/mL); SK-OV-3 (IC50=4.26±0.25 µg/mL); MCF-7 (IC50=4.94±0.28 µg/mL); A549 (IC50=5.54±0.55 µg/mL); BGC-823 (IC50=5.68±0.25 µg/mL); SGC-7901 (IC50=5.73±0.21 µg/mL); Tca8113 (IC50=5.82±0.25 µg/mL); K562 (IC50=5.86±0.66 µg/mL); PC-3M (IC50=6.17±0.24 µg/mL); A2780 (IC50=7.40±0.36 µg/mL); HCT 116 (IC50=7.67±0.57 µg/mL); Hep-G2 (IC50=9.84±0.39 µg/mL)	Not available	Linear	Free	Free	X(1)=Hmp=2-hydroxy-3-methylpentanoic acid; X(2)=Aba=2-amino-2-butenoic acid; X(4)=Ornithine; X(14)=valinol	L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL; Human Intrahepatic Biliary Epithelial Cells (HIBEpiC): IC50=2.37±0.38 µg/; HEK293: IC50=4.78±0.32 µg/mL; IOSE80: IC50=1.12±0.04 µg/mL; RWPE-1: IC50=1.07±0.34 µg/mL; GES-1: IC50=10.62±0.73 µg/mL; MCF-10A: IC50=1.58±0.33 µg/mL;	Not available	Not available			Brevilaterin B from Brevibacillus laterosporus has selective antitumor activity and induces apoptosis in epidermal cancer	
DRAMP32373	INKKI	5	INKKI peptide	Not available		Not found	β-Casein	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	By apoptosis via  mitochondrial pathway in a caspase-independent manner	Tumor cells: MCF-7 (IC50=3.07 μg/mL); T-47D  (IC50=3.26 μg/mL); MDA-MB-231 (IC50=3.53 μg/mL ); MCF-7 (IC50=3.78  µg/mL)	Not available	Linear	Free	Free		L	Fibroblast FN-1 (human): no effect (testing time is 24 h); Endothelial CRL 1730 (human) : no effect (testing time is 24 h)	Not available	Not available			Evaluation of the antitumor and antiproliferative effects of the INKKI peptide on MCF-7 breast adenocarcinoma cells	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@H](C)CC
DRAMP32374	GIKCRFCCGCCTPGICGVCCRF	22	Hepcidin TH1-5	Not available		Not found	Skin Secretion of the African Frog, Kassina senegalensis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=20 μg/mL )	Not available	Linear	Free	Free		L	Not available	Not available	Not available			Hepcidin TH1-5 Induces Apoptosis and Activate Caspase-9 in MCF-7 Cells	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CN)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP32375	GLFDIVKGIKSLF	13	ND2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=72.00±4.51 µg/mL)	Not available	Linear	Free	Free		L	Vero: IC50=48.67±1.76 µg/mL; THLE-3: IC50=58.83±0.83 µg/mL	Not available	Not available			Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP32376	GLFDIVKKIKSLF	13	ND3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=63.00±5.00 µg/mL)	Not available	Linear	Free	Free		L	Vero: IC50=45.17±2.46 µg/mL; THLE-3: IC50=52.83±0.60 µg/mL	Not available	Not available			Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP32377	GLFDIVKKLKSLF	13	ND4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=53.17±1.69 µg/mL)	Not available	Linear	Free	Free		L	Vero: IC50=43.83±1.33 µg/mL; THLE-3: IC50=39.17±2.17 µg/mL	Not available	Not available			Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP32378	GLFDIWKGIKSLF	13	ND1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=102.33±1.45 µg/mL)	Not available	Linear	Free	Free		L	Vero: IC50=22.67±0.44 µg/mL; THLE-3: IC50=34.33±0.73 µg/mL	Not available	Not available			Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP32379	GLFDRVKKRKSLF	13	ND5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50>256 µg/mL)	Not available	Linear	Free	Free		L	Vero: IC50>256 µg/mL; THLE-3: IC50>256 µg/mL	Not available	Not available			Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)O
DRAMP32380	ILGKIVKKLVSDF	13	DN1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=152.17±7.73 µg/mL)	Not available	Linear	Free	Free		L	Vero: IC50>256 µg/mL; THLE-3: IC50>256 µg/mL	Not available	Not available			Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)[C@H](C)CC
DRAMP32381	ILGKIWKGIVSDF	13	DN4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=191.67±12.02 µg/mL)	Not available	Linear	Free	Free		L	Vero: IC50>256 µg/mL; THLE-3: IC50>256 µg/mL	Not available	Not available			Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP32382	ILGKIWKGLVSDF	13	DN3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50>256 µg/mL)	Not available	Linear	Free	Free		L	Vero: IC50>256 µg/mL; THLE-3: IC50>256 µg/mL	Not available	Not available			Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@H](C)CC
DRAMP32383	ILGKIWKKLVSDF	13	DN2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50>256 µg/mL)	Not available	Linear	Free	Free		L	Vero: IC50=156.33±4.33 µg/mL; THLE-3: IC50=105.33±4.42 µg/mL	Not available	Not available			Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@H](C)CC
DRAMP32384	ILGKRWKGRVSDF	13	DN5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50>256 µg/mL)	Not available	Linear	Free	Free		L	Vero: IC50>256 µg/mL; THLE-3: IC50>256 µg/mL	Not available	Not available			Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP32385	YALPAG	6	YALPAG	Not available		Not found	Heated products of peptic hydrolysates of half-fin anchovy (Setipinna taty)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=71.2 μM (42.0 mg/mL))	Not available	Linear	Free	Free		L	Not available	Not available	Not available			Isolation and identification of an antiproliferative peptide derived from heated products of peptic hydrolysates of half-fin anchovy (Setipinna taty)	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP32386	YALPAR	6	YALPAR	Not available		Not found	Heated products of peptic hydrolysates of half-fin anchovy (Setipinna taty)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=19.0 μM (13.1 mg/mL))	Not available	Linear	Free	Free		L	Not available	Not available	Not available			Isolation and identification of an antiproliferative peptide derived from heated products of peptic hydrolysates of half-fin anchovy (Setipinna taty)	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP32387	YALRAH	6	YALRAH	Not available		Not found	Heated products of peptic hydrolysates of half-fin anchovy (Setipinna taty)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=11.1 μM (8.1 mg/mL))	Not available	Linear	Free	Free		L	Not available	Not available	Not available			Isolation and identification of an antiproliferative peptide derived from heated products of peptic hydrolysates of half-fin anchovy (Setipinna taty)	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP32388	VWLSALKFIGKHLAKHQLSKL	21	Lycosin-II	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Lycosin-II Suppresses the Growth of Tumor Cells and Kills them Through Membrane Disruption and Apoptosis Induction	Tumor cells: HCT 116 (IC50=70.79 µg/mL )	Not available	Linear	Free	Free		L	IC50 on PBMCs was = 92.0 ± 39.6 μM	Not available	Not available			Lycosin-II Suppresses the Growth of Tumor Cells and Kills them Through Membrane Disruption and Apoptosis Induction	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP32405	KWKVFKKIEKKWKVFKKIEKAGPKWKVFKKIEK	33	CB1a, Cecropin-B1a	P01508		Not found	Not available	Antimicrobial, Anticancer	Not found	Not found	Not found	2IGR	Not available	"Tumor cells: NCI-H520 (IC50=22.7±0.2	 µM); NCI-H661 (IC50=35.9±0.2	 µM); CCRF-CEM (IC50=4.4±0.3 µM); AGS (IC50=5.6±0.5 µM); HL-60 (IC50=6.7±1.1 µM)"	Human erythrocytes: 18% Hemolysis=200 µM	Linear	Free	Amidation		L	RPMI-7666: IC50>100 µM; NIH 3T3: IC50>50 µM; WI-38: IC50>100 µM	Not available	19428759	Peptides. 2009 May;30(5):839-48. 	Wu JM, Jan PS, Yu HC, Haung HY, Fang HJ, Chang YI, Cheng JW, Chen HM. 	Structure and function of a custom anticancer peptide, CB1a	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32444	XPAXXFXPAXXLXXLXXLX	19	Ⅰ	Not available		Not found	Peptaibols	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BEL-7402 (IC50=1.98 μM); BGC-823 (IC50=2.11 μM); A549 (IC50=2.30 μM); A2780 (IC50>10 μM); HCT 8 (IC50>10 μM)	Not available	Linear	Acetylation	Aminoethanol	X(1/4/5/16/17)=Aib=1-amino-isobutyric acid; X(7/13)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine	L	Not available	Not available	Not available			Not available	
DRAMP32445	XPAXXFXPAXXLXXLXXLX	19	Ⅰ	Not available		Not found	Peptaibols	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BGC-823 (IC50=1.03 μM); BEL-7402 (IC50=1.94 μM); A549 (IC50=2.08 μM); A2780 (IC50=3.79 μM); HCT 8 (IC50=5.93 μM)	Not available	Linear	Acetylation	Aminoethanol	X(1/4/5/16/17)=Aib=1-amino-isobutyric acid; X(7/13)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine	L	Not available	Not available	Not available			Not available	
DRAMP32446	XPAXXFXPAXXLXXLXXLX	19	Ⅱ	Not available		Not found	Peptaibols	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BEL-7402 (IC50=1.98 μM); BGC-823 (IC50=2.11 μM); A549 (IC50=2.30 μM); A2780 (IC50>10 μM); HCT 8 (IC50>10 μM)	Not available	Linear	Acetylation	Aminoethanol	X(1/4/5/17)=Aib=1-amino-isobutyric acid; X(7/13/16)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine	L	Not available	Not available	Not available			Not available	
DRAMP32447	XPAXXFXPAXXLXXLXXLX	19	Ⅱ	Not available		Not found	Peptaibols	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BGC-823 (IC50=1.03 μM); BEL-7402 (IC50=1.94 μM); A549 (IC50=2.08 μM); A2780 (IC50=3.79 μM); HCT 8 (IC50=5.93 μM)	Not available	Linear	Acetylation	Aminoethanol	X(1/4/5/17)=Aib=1-amino-isobutyric acid; X(7/13/16)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine	L	Not available	Not available	Not available			Not available	
DRAMP32448	GAVPCGESCVYLPCLTTVVGCSCQNSVCYHN	31	B5	Not available		Not found	Hedyotis biflora	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BxPC-3 (IC50=1.03 μM); PANC-1 (IC50=1.08 μM); Capan-2 (IC50=1.21 μM); MOH-1 (IC50=1.32 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	Not available			Novel cyclotides from Hedyotis biflora inhibit proliferation and migration of pancreatic cancer cell in vitro and in vivo	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O
DRAMP32449	GAVPCGETCVYLPCITAAIGCSCQNKVCYRD	31	B6	Not available		Not found	Hedyotis biflora	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Capan-2 (IC50=1.85 μM); PANC-1 (IC50=1.97 μM); MOH-1 (IC50=2.10 μM); BxPC-3 (IC50=2.33 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	Not available			Novel cyclotides from Hedyotis biflora inhibit proliferation and migration of pancreatic cancer cell in vitro and in vivo	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CN)C(C)C)[C@@H](C)O)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
DRAMP32450	GIPCGESCAFLPCLTSLLGCTCQNKVCYRD	30	B8	Not available		Not found	Hedyotis biflora	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MOH-1 (IC50=1.88 μM); PANC-1 (IC50=1.95 μM); Capan-2 (IC50=2.14 μM); BxPC-3 (IC50=3.11 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	Not available			Novel cyclotides from Hedyotis biflora inhibit proliferation and migration of pancreatic cancer cell in vitro and in vivo	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O
DRAMP32451	GISCAETCVLLPCLSSVIGCTCQNKRCYKN	30	B7	Not available		Not found	Hedyotis biflora	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MOH-1 (IC50=0.33 μM); PANC-1 (IC50=0.36 μM); Capan-2 (IC50=0.45 μM); BxPC-3 (IC50=0.68 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	Not available			Novel cyclotides from Hedyotis biflora inhibit proliferation and migration of pancreatic cancer cell in vitro and in vivo	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(C)C)[C@@H](C)O
DRAMP32452	GNPCGESCVYLPCITTVVGCSCQNSVCYHN	30	B9	Not available		Not found	Hedyotis biflora	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MOH-1 (IC50=1.14 μM); Capan-2 (IC50=1.32 μM); BxPC-3 (IC50=1.54 μM); PANC-1 (IC50=2.01 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	Not available			Novel cyclotides from Hedyotis biflora inhibit proliferation and migration of pancreatic cancer cell in vitro and in vivo	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O
DRAMP32453	AIMSSLMKKLAAHIAK	16	HYL-1	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=19.72±0.38 µmol/L); Hep-G2 (IC50=30.78±0.24 µmol/L); HCT 116 (IC50=47.25±0.33 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP32454	GAMSSLMKKLAAHIAK	16	HYL-2	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L); A549 (IC50=39.57±0.12 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32455	GIASSLMKKLAAHIAK	16	HYL-3	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L); A549 (IC50=28.97±0.27 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP32457	GIMASLMKKLAAHIAK	16	HYL-4	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=10.66±0.25 µmol/L); HCT 116 (IC50=18.50±0.22 µmol/L); A549 (IC50=6.01±0.15 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP32459	GIMSALMKKLAAHIAK	16	HYL-5	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=12.75±0.26 µmol/L); A549 (IC50=5.32±0.47 µmol/L); Hep-G2 (IC50=7.57±0.18 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP32460	GIMSSAMKKLAAHIAK	16	HYL-6	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50 ＞50 µmol/L); HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP32461	GIMSSLAKKLAAHIAK	16	HYL-7	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L); A549 (IC50=28.32±0.28 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP32463	GIMSSLMAKLAAHIAK	16	HYL-8	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=15.17±0.34 µmol/L); Hep-G2 (IC50=17.09±0.26 µmol/L); HCT 116 (IC50=19.81±0.20 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP32465	GIMSSLMKALAAHIAK	16	HYL-9	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=4.75±0.33 µmol/L); HCT 116 (IC50=7.22±0.21 µmol/L); Hep-G2 (IC50=8.04±0.27 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP32466	GIMSSLMKKAAAHIAK	16	HYL-10	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50 ＞50 µmol/L); HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP32468	GIMSSLMKKLAAAIAK	16	HYL-11	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=5.18±0.37 µmol/L); Hep-G2 (IC50=7.35±0.34 µmol/L); HCT 116 (IC50=7.99±0.22 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP32469	GIMSSLMKKLAAHAAK	16	HYL-12	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50 ＞50 µmol/L); HCT 116 (IC50 ＞50 µmol/L); Hep-G2 (IC50 ＞50 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32470	GIMSSLMKKLAAHIAA	16	HYL-13	Not available		Not found	AMP	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=11.84±0.17 µmol/L); HCT 116 (IC50=16.80±0.34 µmol/L); Hep-G2 (IC50=16.84±0.28 µmol/L)	Not available	Linear	Free	Amidation		L	Human Splenic Fibroblasts (HSF): IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC): IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell: IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2): IC50=2.91±0.07 µg/mL; NCM460: IC50=3.04±0.10 µg/mL; CCD-19Lu: IC50=4.76±0.03 µg/mL	Not available	Not available			Structural modification and antitumor activity of antimicrobial peptide HYL	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O)[C@H](C)CC
DRAMP32764	GLPVCGETCFGGTCNTPGCSCXTWPVCSRN	30	Varv Hm	Not available		Not found	Viola arvensis (European field pansy) (Field violet)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BEL-7402 (IC50>10 µg/ml)	Not available	Cyclic	Free	Free	X=Glu-methylation	L	Not available	Not available	20580652	Peptides. 2010 Aug;31(8):1434-40. 	Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, He W, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola tricolor	
DRAMP32765	GLPVCGETCFGGTCNTPGCSCXTWPVCSRN	30	Varv Hm	Not available		Not found	Viola arvensis (European field pansy) (Field violet)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BEL-7402 (IC50>10 µg/ml)	Not available	Cyclic	Free	Free	X=Glu-methylation	L	Not available	Not available	20580652	Peptides. 2010 Aug;31(8):1434-40. 	Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, He W, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola tricolor	
DRAMP32766	GLPVCGETCFGGTCNTPGCSCXTWPVCSRN	30	Varv He	Not available		Not found	Viola arvensis (European field pansy) (Field violet)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BEL-7402 (IC50>10 µg/ml)	Not available	Cyclic	Free	Free	X=Glu-ethylation	L	Not available	Not available	20580652	Peptides. 2010 Aug;31(8):1434-40. 	Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, He W, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola tricolor	
DRAMP32767	GLPVCGETCFGGTCNTPGCSCXTWPVCSRN	30	Varv He	Not available		Not found	Viola arvensis (European field pansy) (Field violet)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BEL-7402 (IC50>10 µg/ml)	Not available	Cyclic	Free	Free	X=Glu-ethylation	L	Not available	Not available	20580652	Peptides. 2010 Aug;31(8):1434-40. 	Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, He W, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola tricolor	
DRAMP32768	GYPICGESCVGGTCNTPGCSCSWPVCTTN	29	vitri B	Not available		Not found	Viola tricolor	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BEL-7402 (IC50>10 µg/ml)	HRBCs: HC50=225.90 μM	Cyclic	Free	Free		L	Not available	Not available	20580652	Peptides. 2010 Aug;31(8):1434-40. 	Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, He W, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola tricolor	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C
DRAMP32769	GLPICGETCVGGTCNTPGCFCTWPVCTRN	29	vitri C	Not available		Not found	Viola tricolor	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BEL-7402 (IC50>10 µg/ml)	HRBCs: HC50=11.53 μM	Cyclic	Free	Free		L	Not available	Not available	20580652	Peptides. 2010 Aug;31(8):1434-40. 	Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, He W, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola tricolor	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP32770	GLPVCGETCFTGSCYTPGCSCNWPVCNRN	29	vitri D	Not available		Not found	Viola tricolor	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BEL-7402 (IC50>10 µg/ml)	HRBCs: HC50=4.29 μM	Cyclic	Free	Free		L	Not available	Not available	20580652	Peptides. 2010 Aug;31(8):1434-40. 	Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, He W, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola tricolor	CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C
DRAMP32771	GLPVCGETCVGGTCNTPGCSCSWPVCFRN	29	vitri E	Not available		Not found	Viola tricolor	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BEL-7402 (IC50>10 µg/ml)	HRBCs: HC50=27.06 μM	Cyclic	Free	Free		L	Not available	Not available	20580652	Peptides. 2010 Aug;31(8):1434-40. 	Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, He W, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola tricolor	CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP32772	GTLPCGESCVWIPCISSVVGCACKSKVCYKD	31	vitri F	Not available		Not found	Viola tricolor	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BEL-7402 (IC50=5.36 µg/ml)	HRBCs: HC50=10.00 μM	Cyclic	Free	Free		L	Not available	Not available	20580652	Peptides. 2010 Aug;31(8):1434-40. 	Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, He W, Daly NL, Craik DJ, Tan N.	Isolation and characterization of cytotoxic cyclotides from Viola tricolor	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP32773	GRKKRRQRRRPQSKRKKNKKGKRK	24	CP-EPS8-NLS	Not available		Not found	Derived from the NLS of EPS8	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: KG-1a (~45%Cellular viability=105 µM)	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	29357910	 J Exp Clin Cancer Res. 2018 Jan 22;37(1):12.	Chen Y, Xie X, Wu A, Wang L, Hu Y, Zhang H, Li Y.	A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia	CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32774	YADAIFTNSYRKVLGQLSARKLLQDIMSR	29	MIA-602	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 15 (~40%Inhibition=5 µM)	Not available	Linear	Phenylacetyl 12-aminododecanoyl	Amidation		L	Not available	Not available	28130121	Peptides. 2017 Mar;89:60-70	Zarandi M, Cai R, Kovacs M, Popovics P, Szalontay L, Cui T, Sha W, Jaszberenyi M, Varga J, Zhang X, Block NL, Rick FG, Halmos G, Schally AV.	Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCCCCCCCNC(=O)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP32775	YADAIFTXSYRKVLGQLSARKLLQDIMSR	29	MIA-606	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP (~90%Inhibition=5 µM)	Not available	Linear	Free	Free	X=N-methyl Ala	L	Not available	Not available	28130121	Peptides. 2017 Mar;89:60-70	Zarandi M, Cai R, Kovacs M, Popovics P, Szalontay L, Cui T, Sha W, Jaszberenyi M, Varga J, Zhang X, Block NL, Rick FG, Halmos G, Schally AV.	Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth	
DRAMP32776	YADAIFTAXXHKVLGQLSAHKLLQDIMSR	29	JMR-132	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP (~88%Inhibition=5 µM)	Not available	Linear	Free	Free	X(9)=homoArg; X(10)=Tyr methyl ether	L	Not available	Not available	28130121	Peptides. 2017 Mar;89:60-70	Zarandi M, Cai R, Kovacs M, Popovics P, Szalontay L, Cui T, Sha W, Jaszberenyi M, Varga J, Zhang X, Block NL, Rick FG, Halmos G, Schally AV.	Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth	
DRAMP32777	FLPLLLAGLPSFLCLVFKKC	20	Amurin-2a	Not available		Not found	Rana amurensis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=302.1 µM)	Horse erythrocytes: 50% Hemolysis=439.0 µM	Cyclic	Free	Free		L	HMEC-1: IC50=1545 µM	Not available	29366784	Biochem Biophys Res Commun. 2018 Mar 18;497(4):943-949.	Zhang L, Chen X, Zhang Y, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T.	Identification of novel Amurin-2 variants from the skin secretion of Rana amurensis, and the design of cationicity-enhanced analogues	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
DRAMP32778	FLPKLLAGLPSFLCLVFKKC	20	Amurin-2a [L4K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=41.6 µM)	"Horse erythrocytes: 50% Hemolysis=31.0	 µM"	Cyclic	Free	Free		L	HMEC-1: IC50=85.2 µM	Not available	29366784	Biochem Biophys Res Commun. 2018 Mar 18;497(4):943-949.	Zhang L, Chen X, Zhang Y, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T.	Identification of novel Amurin-2 variants from the skin secretion of Rana amurensis, and the design of cationicity-enhanced analogues	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
DRAMP32779	FLPLLLAGLPKFLCLVFKKC	20	Amurin-2a [S11K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (IC50=310.6 µM)	"Horse erythrocytes: 50% Hemolysis=29.1	 µM"	Cyclic	Free	Free		L	HMEC-1: IC50=52.1 µM	Not available	29366784	Biochem Biophys Res Commun. 2018 Mar 18;497(4):943-949.	Zhang L, Chen X, Zhang Y, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T.	Identification of novel Amurin-2 variants from the skin secretion of Rana amurensis, and the design of cationicity-enhanced analogues	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
DRAMP32780	KRWRWRW	7	K(RW)3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (IC50=4.3 µM)	Human erythrocytes: 50% Hemolysis=114 µM	Linear	C8	Free		L	Human fibroblasts: IC50=32.5 µM	Not available	24900420	ACS Comb Sci. 2013 Nov 11;15(11):585-92.	Albada HB, Prochnow P, Bobersky S, Langklotz S, Bandow JE, Metzler-Nolte N.	Tuning the activity of a short arg-trp antimicrobial Peptide by lipidation of a C- or N-terminal lysine side-chain	CCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP32781	NIlLWG	6	Desotamide B [V2I]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=606.8 µM)	Not available	Cyclic	Free	Free	l=D-Leu	Mix	Vero cells: IC50=90.8 µg/ml	Not available	29125222	Chem Biodivers. 2018 Jan;15(1).	Chen YX, Liu C, Liu N, Wu Y, Zhao QJ, Hu HG, Li X, Zou Y.	Total Synthesis and Antibacterial Study of Cyclohexapeptides Desotamide B, Wollamide B and Their Analogs	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O
DRAMP32782	NVlLWX	6	Wollamide B [D-Orn6Orn]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=137.6 µM)	Not available	Cyclic	Free	Free	l=D-Leu; X=Orn	Mix	Vero cells: IC50=73.2 µg/ml	Not available	29125222	Chem Biodivers. 2018 Jan;15(1).	Chen YX, Liu C, Liu N, Wu Y, Zhao QJ, Hu HG, Li X, Zou Y.	Total Synthesis and Antibacterial Study of Cyclohexapeptides Desotamide B, Wollamide B and Their Analogs	
DRAMP32783	NGWLLI	6	Desotamide A	Not available		Not found	Streptomyces scopuliridis SCSIO ZJ46	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50>100 µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	25072108	J Nat Prod. 2014 Aug 22;77(8):1937-41. 	Song Y, Li Q, Liu X, Chen Y, Zhang Y, Sun A, Zhang W, Zhang J, Ju J.	Cyclic Hexapeptides from the Deep South China Sea-Derived Streptomyces scopuliridis SCSIO ZJ46 Active Against Pathogenic Gram-Positive Bacteria	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)O
DRAMP32784	XGNIlL	6	Desotamide C	Not available		Not found	Streptomyces scopuliridis SCSIO ZJ47	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50>100 µM)	Not available	Cyclic	Free	Free	X=N-formyl-kynurenine; l=D-Leu	Mix	Not available	Not available	25072108	J Nat Prod. 2014 Aug 22;77(8):1937-41. 	Song Y, Li Q, Liu X, Chen Y, Zhang Y, Sun A, Zhang W, Zhang J, Ju J.	Cyclic Hexapeptides from the Deep South China Sea-Derived Streptomyces scopuliridis SCSIO ZJ46 Active Against Pathogenic Gram-Positive Bacteria	
DRAMP32785	XGNIlL	6	Desotamide C	Not available		Not found	Streptomyces scopuliridis SCSIO ZJ47	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50>100 µM)	Not available	Cyclic	Free	Free	X=N-formyl-kynurenine; l=D-Leu	Mix	Not available	Not available	25072108	J Nat Prod. 2014 Aug 22;77(8):1937-41. 	Song Y, Li Q, Liu X, Chen Y, Zhang Y, Sun A, Zhang W, Zhang J, Ju J.	Cyclic Hexapeptides from the Deep South China Sea-Derived Streptomyces scopuliridis SCSIO ZJ46 Active Against Pathogenic Gram-Positive Bacteria	
DRAMP32786	XGNIlL	6	Desotamide D	Not available		Not found	Streptomyces scopuliridis SCSIO ZJ48	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50>100 µM)	Not available	Cyclic	Free	Free	X=kynurenine; l=D-Leu	Mix	Not available	Not available	25072108	J Nat Prod. 2014 Aug 22;77(8):1937-41. 	Song Y, Li Q, Liu X, Chen Y, Zhang Y, Sun A, Zhang W, Zhang J, Ju J.	Cyclic Hexapeptides from the Deep South China Sea-Derived Streptomyces scopuliridis SCSIO ZJ46 Active Against Pathogenic Gram-Positive Bacteria	
DRAMP32787	XGNIlL	6	Desotamide D	Not available		Not found	Streptomyces scopuliridis SCSIO ZJ48	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50>100 µM)	Not available	Cyclic	Free	Free	X=kynurenine; l=D-Leu	Mix	Not available	Not available	25072108	J Nat Prod. 2014 Aug 22;77(8):1937-41. 	Song Y, Li Q, Liu X, Chen Y, Zhang Y, Sun A, Zhang W, Zhang J, Ju J.	Cyclic Hexapeptides from the Deep South China Sea-Derived Streptomyces scopuliridis SCSIO ZJ46 Active Against Pathogenic Gram-Positive Bacteria	
DRAMP32788	fxisfSSxFSVix	13	Syn-BNP (1)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC=64 µg/ml)	Not available	Linear	C10	Free	f=D-Phe; x=D-Orn; i=D-Ile; s=D-Ser	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	
DRAMP32789	fxisfSSxFSViX	13	Syn-BNP (1.HMA)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC>128 µg/ml)	Not available	Linear	C14OH	Free	f=D-Phe; x=D-Orn; i=D-Ile; s=D-Ser; X=Orn	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	
DRAMP32790	fxiswSSxWSViX	13	Syn-BNP (1N)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC>128 µg/ml)	Not available	Linear	C10	Free	f=D-Phe; x=D-Orn; i=D-Ile; s=D-Ser; w=D-Trp; X=Orn	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	
DRAMP32791	fxisvSSxVSViX	13	Syn-BNP (1S)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC>128 µg/ml)	Not available	Linear	C10	Free	f=D-Phe; x=D-Dab; i=D-Ile; s=D-Ser; v=D-Val; X=Dab	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	
DRAMP32792	kLGvPLKRK	9	Syn-BNP (2)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC>128 µg/ml)	Not available	Linear	C14OH	Free	k=D-Lys; v=D-Val 	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	CCCCCCCCCCCCCC(O)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP32793	kSGxKHKKK	9	Syn-BNP (2S)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC>128 µg/ml)	Not available	Linear	C14OH	Free	k=D-Lys; x=D-Orn	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	
DRAMP32794	aLGvPLKRK	9	Syn-BNP (2. Ala1)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC>128 µg/ml)	Not available	Linear	C14OH	Free	a=D-Ala; x=D-Orn	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	
DRAMP32795	kLGvALKRK	9	Syn-BNP (2. Ala5)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC>128 µg/ml)	Not available	Linear	C14OH	Free	k=D-Lys; v=D-Val 	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	CCCCCCCCCCCCCC(O)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP32796	kLGvPLARK	9	Syn-BNP (2. Ala7)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC>128 µg/ml)	Not available	Linear	C14OH	Free	k=D-Lys; v=D-Val 	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	CCCCCCCCCCCCCC(O)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP32797	kLGvPLKAK	9	Syn-BNP (2. Ala8)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC>128 µg/ml)	Not available	Linear	C14OH	Free	k=D-Lys; v=D-Val 	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	CCCCCCCCCCCCCC(O)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP32798	kLGvPLKRA	9	Syn-BNP (2. Ala9)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC>128 µg/ml)	Not available	Linear	C14OH	Free	k=D-Lys; v=D-Val 	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	CCCCCCCCCCCCCC(O)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP32799	WEXWtIW	7	Syn-BNP (2.81)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC>128 µg/ml)	Not available	Linear	C14OH	Free	t=D-Thr; X=Orn	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	
DRAMP32800	WyTxXxTwxWXY	12	Syn-BNP (3.29)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC=64 µg/ml)	Not available	Linear	C14OH	Free	y=D-TYR; x(4/6)=D-Orn; w=D-Trp; x(9)=D-Dab; X=Orn	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	
DRAMP32801	XrIRL	5	Syn-BNP (3.46)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC=64 µg/ml)	Not available	Linear	C14OH	Free	X=Orn; r=D-Arg	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	
DRAMP32802	sRxRtLxTTnGT	12	Syn-BNP (3.85)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC>128 µg/ml)	Not available	Linear	C14OH	Free	s=D-Ser; x=D-Dab; t=D=Thr; n=D-Asn	Mix	Not available	Not available	28055186	J Am Chem Soc. 2017 Feb 1;139(4):1404-1407.	Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.	Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters	
DRAMP32803	GKEFKRIVWLSKTAKKL	17	LL37 (14-21)+Cecropin-P1 (2-9), LC	P49913##P14661		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (Not active up to 128 µM)	Human erythrocytes: 5%Hemolysis>128 µM	Linear	Free	Amidation		L	Not available	Not available	29282543	Amino Acids. 2018 Apr;50(3-4):453-468.	Dong N, Li XR, Xu XY, Lv YF, Li ZY, Shan AS, Wang JL. 	Characterization of bactericidal efficiency, cell selectivity, and mechanism of short interspecific hybrid peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O)C(C)C
DRAMP32804	GKEFKRIVKWPWWPWRR	17	LL37 (14-21)+Indolicidin (5-13), LI	P49913##P33046		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (87.5% Killing=128µM)	Human erythrocytes: 5%Hemolysis>128 µM	Linear	Free	Amidation		L	Not available	Not available	29282543	Amino Acids. 2018 Apr;50(3-4):453-468.	Dong N, Li XR, Xu XY, Lv YF, Li ZY, Shan AS, Wang JL. 	Characterization of bactericidal efficiency, cell selectivity, and mechanism of short interspecific hybrid peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP32805	GKEFKRIVGRIYRLCCR	17	LL37 (14-21)+NP-1 (23-31), LN	P49913##Q62716		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (80% Killing=128µM)	Human erythrocytes: 5%Hemolysis>128 µM	Linear	Free	Amidation		L	Not available	Not available	29282543	Amino Acids. 2018 Apr;50(3-4):453-468.	Dong N, Li XR, Xu XY, Lv YF, Li ZY, Shan AS, Wang JL. 	Characterization of bactericidal efficiency, cell selectivity, and mechanism of short interspecific hybrid peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32806	KKIGQKIKNFFQKL	14	CRAMP (20-35)	P51437		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (EC50>50µM)	Not available	Linear	Free	Free		L	Not available	Not available	30176261	 Peptides. 2018 Nov;109:33-38.	Winderickx S, De Brucker K, Bird MJ, Windmolders P, Meert E, Cammue BPA, Thevissen K.	Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP32807	KKIWQKIKNFFQKL	14	CRAMP (20-35)[G4W]	P51437		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (EC50>50µM)	Not available	Linear	Free	Free		L	Not available	Not available	30176261	 Peptides. 2018 Nov;109:33-38.	Winderickx S, De Brucker K, Bird MJ, Windmolders P, Meert E, Cammue BPA, Thevissen K.	Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP32808	KRIWQKIKNFFQKL	14	CRAMP (20-35)[K2R][G4W]	P51437		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (EC50>50µM)	Not available	Linear	Free	Free		L	Not available	Not available	30176261	 Peptides. 2018 Nov;109:33-38.	Winderickx S, De Brucker K, Bird MJ, Windmolders P, Meert E, Cammue BPA, Thevissen K.	Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP32809	KKIWQRIKNFFQKL	14	CRAMP (20-35)[G4W][K6R]	P51437		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (EC50=50µM)	Not available	Linear	Free	Free		L	Not available	Not available	30176261	 Peptides. 2018 Nov;109:33-38.	Winderickx S, De Brucker K, Bird MJ, Windmolders P, Meert E, Cammue BPA, Thevissen K.	Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP32810	KKIWQKIRNFFQKL	14	CRAMP (20-35)[G4W][K8R]	P51437		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (EC50>50µM)	Not available	Linear	Free	Free		L	Not available	Not available	30176261	 Peptides. 2018 Nov;109:33-38.	Winderickx S, De Brucker K, Bird MJ, Windmolders P, Meert E, Cammue BPA, Thevissen K.	Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP32811	KKIWQKIKRFFQKL	14	CRAMP (20-35)[G4W][K8R]	P51437		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (EC50>50µM)	Not available	Linear	Free	Free		L	Not available	Not available	30176261	 Peptides. 2018 Nov;109:33-38.	Winderickx S, De Brucker K, Bird MJ, Windmolders P, Meert E, Cammue BPA, Thevissen K.	Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP32812	KKIWQKIKNFFRKL	14	CRAMP (20-35)[G4W][Q12R]	P51437		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (EC50>50µM)	Not available	Linear	Free	Free		L	Not available	Not available	30176261	 Peptides. 2018 Nov;109:33-38.	Winderickx S, De Brucker K, Bird MJ, Windmolders P, Meert E, Cammue BPA, Thevissen K.	Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP32813	FLSLIPKAISAVSALANHF	19	Phylloseptin-PHa [A7K]	A0A2I2KHV2		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-251MG (LD50=33.65 µM)	Horse erythrocytes:50% Hemolysis=197.7µM	Linear	Free	Amidation		L	Not available	Not available	30774309	Drug Des Devel Ther. 2019 Jan 23;13:447-458	Liu Y, Du Q, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T, Wang H. 	Structure-activity relationship of an antimicrobial peptide, Phylloseptin-PHa: balance of hydrophobicity and charge determines the selectivity of bioactivities	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP32814	FLSLIPKAISAISALANHF	19	Phylloseptin-Pha [A7K, V12I]	A0A2I2KHV2		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-251MG (LD50=36.46 µM)	Horse erythrocytes:50% Hemolysis=34.86µM	Linear	Free	Amidation		L	Not available	Not available	30774309	Drug Des Devel Ther. 2019 Jan 23;13:447-458	Liu Y, Du Q, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T, Wang H. 	Structure-activity relationship of an antimicrobial peptide, Phylloseptin-PHa: balance of hydrophobicity and charge determines the selectivity of bioactivities	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP32815	FLSLIPKAISAISALINHF	19	Phylloseptin-PHa [A7K, V12I, A16I]	A0A2I2KHV2		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-251MG (LD50=10.85 µM)	Horse erythrocytes:50% Hemolysis=9.266µM	Linear	Free	Amidation		L	Not available	Not available	30774309	Drug Des Devel Ther. 2019 Jan 23;13:447-458	Liu Y, Du Q, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T, Wang H. 	Structure-activity relationship of an antimicrobial peptide, Phylloseptin-PHa: balance of hydrophobicity and charge determines the selectivity of bioactivities	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP32816	FLSLIPKIISAISALINHF	19	Phylloseptin-PHa [A7K, A8I, V12I, A16I]	A0A2I2KHV2		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-251MG (LD50=9.547 µM)	Horse erythrocytes:50% Hemolysis=2.766µM	Linear	Free	Amidation		L	Not available	Not available	30774309	Drug Des Devel Ther. 2019 Jan 23;13:447-458	Liu Y, Du Q, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T, Wang H. 	Structure-activity relationship of an antimicrobial peptide, Phylloseptin-PHa: balance of hydrophobicity and charge determines the selectivity of bioactivities	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP32817	FLSLIPKIISAISALIKHF	19	Phylloseptin-PHa [A7K, A8I, V12I, A16I, N17K]	A0A2I2KHV2		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-251MG (LD50=4.059 µM)	Horse erythrocytes:50% Hemolysis=1.074µM	Linear	Free	Amidation		L	Not available	Not available	30774309	Drug Des Devel Ther. 2019 Jan 23;13:447-458	Liu Y, Du Q, Ma C, Xi X, Wang L, Zhou M, Burrows JF, Chen T, Wang H. 	Structure-activity relationship of an antimicrobial peptide, Phylloseptin-PHa: balance of hydrophobicity and charge determines the selectivity of bioactivities	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP32818	WFGKLYRGKTKVVKKVKGLLKG	22	Chionodracine [F1W; H4,15,17K; I9K; S11,21K]	K4Q515		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SH-SY5Y (0% Killing=64 µM)	Human erythrocytes: 5% Hemolysis=3µM; 30% Hemolysis=50µM	Linear	Free	Free		L	HUVEC: 3.84% Killing=64 µM	Not available	30790604	Dev Comp Immunol. 2019 Jul;96:9-17.	Buonocore F, Picchietti S, Porcelli F, Della Pelle G, Olivieri C, Poerio E, Bugli F, Menchinelli G, Sanguinetti M, Bresciani A, Gennari N, Taddei AR, Fausto AM, Scapigliati G.	Fish-derived antimicrobial peptides: Activity of a chionodracine mutant against bacterial models and human bacterial pathogens	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O
DRAMP32819	QLGKKKHRRRPSKKKRHW	18	HEXIM1 (147-164), BR	O94992		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (5%Killing=100 µM)	Not available	Linear	Free	Free		L	HaCat: Not active up to 100 µM	Not available	26734838	Oncotarget. 2016 Feb 2;7(5):5483-94.	Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. 	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy	CC(C)C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP32820	QLGRRRHRRRPSRRRRHW	18	HEXIM1 (147-164)[K4,5,6,13,14,15R], BR-RRR12	O94992		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (25%Killing=100 µM)	Not available	Linear	Free	Free		L	HaCat: Not active up to 100 µM	Not available	26734838	Oncotarget. 2016 Feb 2;7(5):5483-94.	Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. 	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy	CC(C)C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP32821	AAVALLPAVLLALLAPMPFSTGKRIMLGE	29	FGR (7-22)-X13, FGF-X13	P08620		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: OCI-AML3 (Not active up to 100 µM)	Not available	Linear	Free	Free		L	HEK293: Not active up to 100 µM; HFF: Not active up to 100 µM	Not available	26734838	Oncotarget. 2016 Feb 2;7(5):5483-94.	Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. 	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP32822	AAVALLPAVLLALLAPQLGKKKHRRRPSKKKRHW	34	FGR (7-22)-HEXIM1 (147-164), FGF-BR	P08620##O94992		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116-/-p53 (30%Killing=10 µM)	Not available	Linear	Free	Free		L	HEK293: 30%Killing=10 µM; HFF: 20%Killing=10 µM; 90%Killing=50 µM	Not available	26734838	Oncotarget. 2016 Feb 2;7(5):5483-94.	Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. 	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP32823	LTVSPWYGCGQLGKKKHRRRPSKKKRHW	28	LTV-HEXIM1 (147-164, LTV-BR	O94992		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: OPM-2 (30%Killing=50 µM)	Not available	Linear	Free	Free		L	CHO-K1: 0%Killing=50 µM; HFF: 10%Killing=50 µM; WI-38: 5%Killing=50 µM	Not available	26734838	Oncotarget. 2016 Feb 2;7(5):5483-94.	Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. 	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP32824	LTVSPWYGCGQLGRRRHRRRPSRRRRHW	28	LTV-HEXIM1 (147-164)[K4,5,6,13,14,15R], LTV-BR (RRR12)	O94992		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (78%Killing=10 µM; 100%Killing=50 µM)	Not available	Linear	Free	Free		L	Not available	Not available	26734838	Oncotarget. 2016 Feb 2;7(5):5483-94.	Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. 	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP32825	MPFSTGKRIMLGE	13	X13	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Not active up to 100 µM)	Not available	Linear	Free	Free		L	Not available	Not available	26734838	Oncotarget. 2016 Feb 2;7(5):5483-94.	Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. 	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCSC)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP32826	LTVSPWYGCGMPFSTGKRIMLGE	23	LTV-X13	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: OPM-2 (0%Killing=50 µM)	Not available	Linear	Free	Free		L	CHO-K1: 0%Killing=50 µM; HFF: 0%Killing=50 µM; WI-38: 0%Killing=50 µM	Not available	26734838	Oncotarget. 2016 Feb 2;7(5):5483-94.	Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. 	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP32827	LTVSPWYGCGKLAKLAKKLAKLAK	24	LTV-PAP, LTV-KLA	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: OPM-2 (78%Killing=10 µM; 100%Killing=50 µM)	Not available	Linear	Free	Free		L	CHO-K1: 100%Killing=50 µM; HFF: 80%Killing=50 µM; WI-38: 55%Killing=50 µM	Not available	26734838	Oncotarget. 2016 Feb 2;7(5):5483-94.	Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. 	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP32828	AAVALLPAVLLALLAPQLGRRRHRRRPSRRRRHW	34	FGR (7-22)-HEXIM1 (147-164)[K4,5,6,13,14,15R], FGF-BR(RRR12)	O94992##P08620		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116-/-p53 (100%Killing=10 µM)	Not available	Linear	Free	Free		L	Not available	Not available	26734838	Oncotarget. 2016 Feb 2;7(5):5483-94.	Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. 	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP32829	AAVALLPAVLLALLAPQLGKKILAARPSKKKRHW	34	FGR (7-22)-HEXIM1 (147-164)[K6I,H7L][R8,9A], FGF-BR(ILAA)	O94992##P08620		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116-/-p53 (65%Killing=10 µM; 100%Killing=50 µM)	Not available	Linear	Free	Free		L	Not available	Not available	26734838	Oncotarget. 2016 Feb 2;7(5):5483-94.	Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH. 	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP32830	ALFGILKKAFGKILTIFAGLPGVV	24	1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50=8.6 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC
DRAMP32831	GLGDFIKAIAKHLGPLIGILPSKLKVAA	28	2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50=11.3 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O)C(C)C
DRAMP32832	GLKDPLKSVAKHLVK	15	3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP32833	GLVMLVKKAGLT	12	4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(N)=O)[C@@H](C)O)C(C)C
DRAMP32834	IIFGVIKALSG	11	5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(N)=O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP32835	FLGPTIGKIAKFILKHIVGLGDAALV	26	6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50=10.7 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP32836	GIVTILKGAVGVILGGL	17	7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC)[C@@H](C)O)C(C)C
DRAMP32837	GLFKIISGIA	10	8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(N)=O
DRAMP32838	GLGMIAHGV	9	9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(N)=O)C(C)C
DRAMP32839	GLWKILKKGA	10	10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(N)=O
DRAMP32840	GLFAILKKLVNLVG	14	11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50=4.6 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)C(C)C)C(C)C
DRAMP32841	GLFKIISKLAKKA	13	12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50=36.3 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(N)=O)[C@H](C)CC
DRAMP32842	GLPLFLKKLGSAV	13	13	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP32843	GLWGVIKALGGHVG	14	14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(N)=O)C(C)C
DRAMP32844	GLLALLGELAEHLGSKI	17	17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(N)=O
DRAMP32845	GTFAIIQ	7	18	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(N)=O)[C@H](C)CC
DRAMP32846	GDGDIMKGIAGH	12	20	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O
DRAMP32847	GLPQIISKVVKT	12	21	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30953170	 J Mol Model. 2019 Apr 5;25(5):112.	Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.	De novo design of anticancer peptides by ensemble artificial neural networks	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)[C@@H](C)O)C(C)C)C(C)C)[C@H](C)CC
DRAMP32848	GIKKWLHSAKKFGKKFVKKIXNS	23	Magainin-2 [G3,18K; F5W; A15K; E19K; M21Nle]	P11006		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PANC-1 (EC50=9.1±3 µM(pH=7.4))	Human kidney-derived GM cells: EC50=7.6±2.1 µM(pH=6); EC50=25.6±4.5 µM(pH=7.4)	Linear	Free	Amidation	X=Nle	L	HEK293: EC50=15.7±1.8 µM(pH=7.4)	Not available	31161686	Chembiochem. 2019 Aug 16;20(16):2109-2117. 	Tanishiki N, Yano Y, Matsuzaki K. 	Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues	
DRAMP32849	GIKXWLHSAKKFGXKFVKKIXNS	23	Magainin-2 [G3,18K; K4,14Dap; F5W; A15K; E19K; M21Nle]	P11006		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PANC-1 (EC50=14.7±0.6 µM(pH=7.4))	Human kidney-derived GM cells: EC50=25.9±0.6 µM(pH=6); EC50=50.3±0.9 µM(pH=7.4)	Linear	Free	Amidation	X(4/14)=Dap; X(21)=Nle	L	HEK293: EC50=27.2±3.1 µM(pH=7.4)	Not available	31161686	Chembiochem. 2019 Aug 16;20(16):2109-2117. 	Tanishiki N, Yano Y, Matsuzaki K. 	Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues	
DRAMP32850	GIKXWLHSAXKFGXKFVKXIXNS	23	Magainin-2 [G3,18K; K4,10,14Dap; F5W; A15K; E19Dap; M21Nle]	P11006		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PANC-1 (EC50=35.7±0.7 µM(pH=7.4))	Human kidney-derived GM cells: EC50=21.1±0.3 µM(pH=6); EC50=91.6±5.9 µM(pH=7.4)	Linear	Free	Amidation	X(4/10/14/19)=Dap; X(21)=Nle	L	HEK293: EC50>100 µM(pH=7.4)	Not available	31161686	Chembiochem. 2019 Aug 16;20(16):2109-2117. 	Tanishiki N, Yano Y, Matsuzaki K. 	Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues	
DRAMP32851	GIKXWLHSAXXFGXKFVXXIXNS	23	Magainin-2 [G3K; K4,10,11,14Dap; F5W; A15K; G18Dap; E19Dap; M21Nle]	P11006		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PANC-1 (EC50=55±1.8 µM(pH=7.4))	"Human kidney-derived GM cells: EC50=	19.8±0.3 µM(pH=6); EC50>100 µM(pH=7.4)"	Linear	Free	Amidation	X(4/10/11/14/18/19)=Dap; X(21)=Nle	L	HEK293: EC50>100 µM(pH=7.4)	Not available	31161686	Chembiochem. 2019 Aug 16;20(16):2109-2117. 	Tanishiki N, Yano Y, Matsuzaki K. 	Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues	
DRAMP32852	GIXXWLHSAXXFGXXFVXXIXNS	23	Magainin-2 [G3,18Dap; K4,10,11,14Dap; F5W; A15Dap; E19Dap; M21Nle]	P11006		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PANC-1 (EC50=61.4±1.7 µM(pH=7.4))	Human kidney-derived GM cells: EC50=7.6±2.1 µM(pH=6); EC50=25.6±4.5 µM(pH=7.4)	Linear	Free	Amidation	X(3/4/10/11/14/15/18/19)=Dap; X(21)=Nle	L	HEK293: EC50=15.7±1.8 µM(pH=7.4)	Not available	31161686	Chembiochem. 2019 Aug 16;20(16):2109-2117. 	Tanishiki N, Yano Y, Matsuzaki K. 	Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues	
DRAMP32853	LAANFLPQILCKIARKC	17	B1CTcu5-LIAG	E3SYG2##D2K8D1##C3RTH8		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A431 (50% Cytotoxicity>100 µg/ml)	Human erythrocytes: 30% Hemolysis=200 µM	Cyclic	Free	Amidation		L	HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity>100 µg/ml	Not available	25997127	PLoS One. 2015 May 21;10(5):e0124210.	Abraham P, Sundaram A, R A, V R, George S, Kumar KS. 	Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP32854	KIAGLAANFLPQILCKIARKC	21	B1CTcu5K	E3SYG2##D2K8D1##C3RTH8		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A431 (50% Cytotoxicity>100 µg/ml)	Human erythrocytes: 15% Hemolysis=200 µM	Cyclic	Free	Amidation		L	HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity=74.5±2.44 µg/ml	Not available	25997127	PLoS One. 2015 May 21;10(5):e0124210.	Abraham P, Sundaram A, R A, V R, George S, Kumar KS. 	Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP32855	WIAGLAANFLPQILCKIARKC	21	B1CTcu5W	E3SYG2##D2K8D1##C3RTH8		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A431 (50% Cytotoxicity>100 µg/ml)	Human erythrocytes: 39.11% Hemolysis=200 µM	Linear	Free	Amidation		L	HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity>100 µg/ml	Not available	25997127	PLoS One. 2015 May 21;10(5):e0124210.	Abraham P, Sundaram A, R A, V R, George S, Kumar KS. 	Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP32856	RIAGLAANFLPQILCKIARKC	21	B1CTcu5R	E3SYG2##D2K8D1##C3RTH8		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A431 (50% Cytotoxicity>100 µg/ml)	Human erythrocytes: 17.4% Hemolysis=200 µM	Linear	Free	Amidation		L	HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity=75.1±1.46 µg/ml	Not available	25997127	PLoS One. 2015 May 21;10(5):e0124210.	Abraham P, Sundaram A, R A, V R, George S, Kumar KS. 	Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP32857	HIAGLAANFLPQILCKIARKC	21	B1CTcu5H	E3SYG2##D2K8D1##C3RTH8		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A431 (50% Cytotoxicity>100 µg/ml)	Human erythrocytes: 30.4% Hemolysis=200 µg/ml	Linear	Free	Amidation		L	HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity=90±2.56 µg/ml	Not available	25997127	PLoS One. 2015 May 21;10(5):e0124210.	Abraham P, Sundaram A, R A, V R, George S, Kumar KS. 	Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP32858	liaGlaanflpqilckiarkc	21	B1CTcu5D	E3SYG2##D2K8D1##C3RTH8		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A431 (50% Cytotoxicity>100 µg/ml)	Human erythrocytes: 40.22% Hemolysis=200 µg/ml	Cyclic	Free	Amidation		D	HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity=71.4±2.3 µg/ml	Not available	25997127	PLoS One. 2015 May 21;10(5):e0124210.	Abraham P, Sundaram A, R A, V R, George S, Kumar KS. 	Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides	CC[C@H](C)[C@@H](NC(=O)[C@H](N)CC(C)C)C(=O)N[C@H](C)C(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CS)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CS)C(N)=O)[C@@H](C)CC)[C@@H](C)CC
DRAMP32859	AIIKKIIKKIIKKI	14	A-I	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=25 µM)	Human erythrocytes: 5% Hemolysis=300 µM; Human erythrocytes: 10% Hemolysis=500 µM	Linear	Free	Amidation		L	Human chondrocytes-articular cells Hca: 25% Killing=40 µM	Not available	27644109	ACS Appl Mater Interfaces. 2016 Oct 12;8(40):26501-26510. 	Chen C, Yang C, Chen Y, Wang F, Mu Q, Zhang J, Li Z, Pan F, Xu H, Lu JR. 	Surface Physical Activity and Hydrophobicity of Designed Helical Peptide Amphiphiles Control Their Bioactivity and Cell Selectivity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP32860	EIIKKIIKKIIKKI	14	E-I	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=23 µM)	Human erythrocytes: 5% Hemolysis=300 µM; Human erythrocytes: 7% Hemolysis=500 µM	Linear	Free	Amidation		L	Human chondrocytes-articular cells Hca: 23% Killing=40 µM	Not available	27644109	ACS Appl Mater Interfaces. 2016 Oct 12;8(40):26501-26510. 	Chen C, Yang C, Chen Y, Wang F, Mu Q, Zhang J, Li Z, Pan F, Xu H, Lu JR. 	Surface Physical Activity and Hydrophobicity of Designed Helical Peptide Amphiphiles Control Their Bioactivity and Cell Selectivity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP32861	KIIKKIIKKIIKKI	14	K-I	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=20 µM)	Human erythrocytes: 5% Hemolysis=300 µM; Human erythrocytes: 8% Hemolysis=500 µM	Linear	Free	Amidation		L	Human chondrocytes-articular cells Hca: 40% Killing=40 µM	Not available	27644109	ACS Appl Mater Interfaces. 2016 Oct 12;8(40):26501-26510. 	Chen C, Yang C, Chen Y, Wang F, Mu Q, Zhang J, Li Z, Pan F, Xu H, Lu JR. 	Surface Physical Activity and Hydrophobicity of Designed Helical Peptide Amphiphiles Control Their Bioactivity and Cell Selectivity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP32862	VIIKKIIKKIIKKI	14	V-I	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=15 µM)	Human erythrocytes: 7% Hemolysis=300 µM; Human erythrocytes: 12% Hemolysis=500 µM	Linear	Free	Amidation		L	Human chondrocytes-articular cells Hca: 25% Killing=40 µM	Not available	27644109	ACS Appl Mater Interfaces. 2016 Oct 12;8(40):26501-26510. 	Chen C, Yang C, Chen Y, Wang F, Mu Q, Zhang J, Li Z, Pan F, Xu H, Lu JR. 	Surface Physical Activity and Hydrophobicity of Designed Helical Peptide Amphiphiles Control Their Bioactivity and Cell Selectivity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP32863	GIIKKIIKKIIKKA	14	G-A	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50>40 µM)	Human erythrocytes: 5% Hemolysis=300 µM; Human erythrocytes: 15% Hemolysis=500 µM	Linear	Free	Amidation		L	Human chondrocytes-articular cells Hca: 25% Killing=40 µM	Not available	27644109	ACS Appl Mater Interfaces. 2016 Oct 12;8(40):26501-26510. 	Chen C, Yang C, Chen Y, Wang F, Mu Q, Zhang J, Li Z, Pan F, Xu H, Lu JR. 	Surface Physical Activity and Hydrophobicity of Designed Helical Peptide Amphiphiles Control Their Bioactivity and Cell Selectivity	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP32864	GIIKKIIKKIIKKE	14	G-E	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50>40 µM)	Human erythrocytes: 0%  Hemolysis=500 µM	Linear	Free	Amidation		L	Not active up to 40 µM	Not available	27644109	ACS Appl Mater Interfaces. 2016 Oct 12;8(40):26501-26510. 	Chen C, Yang C, Chen Y, Wang F, Mu Q, Zhang J, Li Z, Pan F, Xu H, Lu JR. 	Surface Physical Activity and Hydrophobicity of Designed Helical Peptide Amphiphiles Control Their Bioactivity and Cell Selectivity	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP32865	GIIKKIIKKIIKKK	14	G-K	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50>40 µM)	Human erythrocytes: 0%  Hemolysis=500 µM	Linear	Free	Amidation		L	Human chondrocytes-articular cells Hca: 10% Killing=40 µM	Not available	27644109	ACS Appl Mater Interfaces. 2016 Oct 12;8(40):26501-26510. 	Chen C, Yang C, Chen Y, Wang F, Mu Q, Zhang J, Li Z, Pan F, Xu H, Lu JR. 	Surface Physical Activity and Hydrophobicity of Designed Helical Peptide Amphiphiles Control Their Bioactivity and Cell Selectivity	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP32866	GIIKKIIKKIIKKV	14	G-V	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=15 µM)	Human erythrocytes: 22% Hemolysis=300 µM; Human erythrocytes: 35% Hemolysis=500 µM	Linear	Free	Amidation		L	Human chondrocytes-articular cells Hca: 50% Killing=40 µM	Not available	27644109	ACS Appl Mater Interfaces. 2016 Oct 12;8(40):26501-26510. 	Chen C, Yang C, Chen Y, Wang F, Mu Q, Zhang J, Li Z, Pan F, Xu H, Lu JR. 	Surface Physical Activity and Hydrophobicity of Designed Helical Peptide Amphiphiles Control Their Bioactivity and Cell Selectivity	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP32867	KLWKKIEKLIKKLLTSIR	18		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=47±3 µM)	Human erythrocytes: 50% Hemolysis=236±13 µM	Linear	Free	Amidation		L	Not available	Not available	29679519	ChemMedChem. 2018 Jul 6;13(13):1300-1302.	Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. 	Designing Anticancer Peptides by Constructive Machine Learning	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32868	YIWARAERVWLWWGKFLSL	19		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=56±3 µM)	Human erythrocytes: Not active up to 400 µM	Linear	Free	Amidation		L	Not available	Not available	29679519	ChemMedChem. 2018 Jul 6;13(13):1300-1302.	Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. 	Designing Anticancer Peptides by Constructive Machine Learning	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP32869	DLFKQLQRLFLGILYCLYKIW	21		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=47±4 µM)	Human erythrocytes：50% Hemolysis=132±16 µM	Linear	Free	Amidation		L	Not available	Not available	29679519	ChemMedChem. 2018 Jul 6;13(13):1300-1302.	Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. 	Designing Anticancer Peptides by Constructive Machine Learning	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)[C@H](C)CC
DRAMP32870	AIKKFGPLAKIVAKV	15		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=95±4 µM)	Human erythrocytes: Not active up to 400 µM	Linear	Free	Amidation		L	Not available	Not available	29679519	ChemMedChem. 2018 Jul 6;13(13):1300-1302.	Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. 	Designing Anticancer Peptides by Constructive Machine Learning	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)[C@H](C)CC
DRAMP32871	RWNGRIIKGFYNLVKIWKDLKG	22		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=42±4 µM)	Human erythrocytes：50% Hemolysis=89±6 µM	Linear	Free	Amidation		L	Not available	Not available	29679519	ChemMedChem. 2018 Jul 6;13(13):1300-1302.	Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. 	Designing Anticancer Peptides by Constructive Machine Learning	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O
DRAMP32872	KVWKIKKNIRRLLHGIKRGWKG	22		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=34±4 µM)	Human erythrocytes: Not active up to 400 µM	Linear	Free	Amidation		L	Not available	Not available	29679519	ChemMedChem. 2018 Jul 6;13(13):1300-1302.	Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. 	Designing Anticancer Peptides by Constructive Machine Learning	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O
DRAMP32873	GFWARIGKVFAAVKNL	16		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=101±4 µM)	Human erythrocytes: Not active up to 400 µM	Linear	Free	Amidation		L	Not available	Not available	29679519	ChemMedChem. 2018 Jul 6;13(13):1300-1302.	Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. 	Designing Anticancer Peptides by Constructive Machine Learning	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C
DRAMP32874	AFLYRLTRQIRPWWRWLYKW	20		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=45.5±0.8 µM)	Human erythrocytes: 50% Hemolysis=34±5 µM	Linear	Free	Amidation		L	Not available	Not available	29679519	ChemMedChem. 2018 Jul 6;13(13):1300-1302.	Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. 	Designing Anticancer Peptides by Constructive Machine Learning	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP32875	RIWGKHSRYIKIVKRLIQ	18		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=50±10 µM)	Human erythrocytes: Not active up to 400 µM	Linear	Free	Amidation		L	Not available	Not available	29679519	ChemMedChem. 2018 Jul 6;13(13):1300-1302.	Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. 	Designing Anticancer Peptides by Constructive Machine Learning	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP32876	QIWHKIRKLWQIIKDGF	17		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=16.1±0.3 µM)	Human erythrocytes: 50% Hemolysis=23±5 µM	Linear	Free	Amidation		L	Not available	Not available	29679519	ChemMedChem. 2018 Jul 6;13(13):1300-1302.	Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G. 	Designing Anticancer Peptides by Constructive Machine Learning	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP32877	RPFTRAQWFAIQHISPRTIAMRAINNYRWR	30	RNase 3 (1-36)[P3,Q4,L18,N19,P20,C23DEL], RN3(5-17P22-36)	P12724		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=74.43±1.91 µM)	Sheep erythrocytes: 50% Hemolysis=178.33±81.72 µM; Horse erythrocytes: 44±4% Hemolysis=250 µM	Linear	Free	Free		L	MRC-5: IC50>150 µM	Not available	29763807	Eur J Med Chem. 2018 May 25;152:590-599.	Pulido D, Prats-Ejarque G, Villalba C, Albacar M, Moussaoui M, Andreu D, Volkmer R, Torrent M, Boix E.	Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP32878	RPFIRAQWFAIQHISPRTIAMRAINNYRWR	30	RN3(5-17P22-36)[T4I]	P12724		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=95.78±6.37 µM)	Sheep erythrocytes:50% Hemolysis>150 µM	Linear	Free	Free		L	MRC-5: IC50>150 µM	Not available	29763807	Eur J Med Chem. 2018 May 25;152:590-599.	Pulido D, Prats-Ejarque G, Villalba C, Albacar M, Moussaoui M, Andreu D, Volkmer R, Torrent M, Boix E.	Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP32879	RPFTRAQIFAIQHISPRTIAMRAINNYRWR	30	RN3(5-17P22-36)[W8I]	P12724		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=171.55±1.23 µM)	Sheep erythrocytes: 50% Hemolysis>150 µM	Linear	Free	Free		L	MRC-5: IC50>150 µM	Not available	29763807	Eur J Med Chem. 2018 May 25;152:590-599.	Pulido D, Prats-Ejarque G, Villalba C, Albacar M, Moussaoui M, Andreu D, Volkmer R, Torrent M, Boix E.	Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP32880	RPFTRAQWFAIIHISPRTIAMRAINNYRWR	30	RN3(5-17P22-36)[Q12I]	P12724		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Hep-G2 (IC50=59.64±6.17 µM)	Sheep erythrocytes: 50% Hemolysis>100µM	Linear	Free	Free		L	MRC-5: IC50>100 µM	Not available	29763807	Eur J Med Chem. 2018 May 25;152:590-599.	Pulido D, Prats-Ejarque G, Villalba C, Albacar M, Moussaoui M, Andreu D, Volkmer R, Torrent M, Boix E.	Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP32881	MRGENMSEGNRPEGTPHGLRSTPARELPIPAFLEPAR	37	KA081020-065	I3TKW5		Not found	Tistrella mobilis (strain KA081020-065)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22458477	J Am Chem Soc. 2012 May 23;134(20):8625-32. 	Xu Y, Kersten RD, Nam SJ, Lu L, Al-Suwailem AM, Zheng H, Fenical W, Dorrestein PC, Moore BS, Qian PY.	Bacterial biosynthesis and maturation of the didemnin anti-cancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)CC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP32882	GTTCYCGKTIGIYWFGKYSCPTNRGYTGSCPYFLGICCYPVD	42	APETx4	C0HL40		Not found	Anthopleura elegantissima (Green aggregating anemone) (Actinia elegantissima)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	APETx4 is able to selectively inhibit the human ether-à-go-go channel (hEag1 or KV10.1), which a cancer-relevant voltage-gated potassium channel that is overexpressed in a majority of human tumors. 	Tumor cells: MDA-MB-435S (KV10.1 Expression Level: Moderate)	Not available	Linear	Free	Free		L	NIH-3T3: KV10.1 Expression Level (Undetectable); Human epithelial cell line hTERT RPE-1: KV10.1 Expression Level (Moderate)	Not available	28902151	Mar Drugs. 2017 Sep 13;15(9):287.	Moreels L, Peigneur S, Galan DT, De Pauw E, Béress L, Waelkens E, Pardo LA, Quinton L, Tytgat J. 	APETx4, a Novel Sea Anemone Toxin and a Modulator of the Cancer-Relevant Potassium Channel KV10.1	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O
DRAMP32883	EGKLSSNDTEGGLCKEFLHPSKVDLPR	27	SOR-C27	Not available		Not found	Blarina brevicauda 	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	SOR-C13 and SOR-C27, derived from the C-terminus of soricidin, are high-affinity antagonists of human TRPV6 channels that are up-regulated in a number of cancers	Tumor cells: HeLa (~95%Inhibition=100 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23554944	 PLoS One. 2013;8(3):e58866.	Bowen CV, DeBay D, Ewart HS, Gallant P, Gormley S, Ilenchuk TT, Iqbal U, Lutes T, Martina M, Mealing G, Merkley N, Sperker S, Moreno MJ, Rice C, Syvitski RT, Stewart JM.	In Vivo Detection of Human TRPV6-Rich Tumors with Anti-Cancer Peptides Derived from Soricidin	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@H](CC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)O
DRAMP32884	KEFLHPSKVDLPR	13	SOR-C13	Not available		Not found	Blarina brevicauda 	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	SOR-C13 and SOR-C27, derived from the C-terminus of soricidin, are high-affinity antagonists of human TRPV6 channels that are up-regulated in a number of cancers	Tumor cells: HeLa (~18%Inhibition=100 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23554944	 PLoS One. 2013;8(3):e58866.	Bowen CV, DeBay D, Ewart HS, Gallant P, Gormley S, Ilenchuk TT, Iqbal U, Lutes T, Martina M, Mealing G, Merkley N, Sperker S, Moreno MJ, Rice C, Syvitski RT, Stewart JM.	In Vivo Detection of Human TRPV6-Rich Tumors with Anti-Cancer Peptides Derived from Soricidin	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
DRAMP32885	NEPCDSDGDCCTSSEQCISTGSKYFC	26	CCP-Ts sub peptide (14-39)	P0DM29		Not found	Tityus serrulatus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	As a drug delivery system targeting cancer cell nucleus using CPP-Ts’s nuclear-targeting property.	Tumor cells: DU145 (Sub peptide was internalized and directed to the intranuclear region.)	Not available	Linear	Free	Free		L	HUV-EC-C, HFF-1, MCR-5, HEK-293, BHK-21, MDCK: sub peptide was unable to cross the cell membrane	Not available	30282983	Sci Rep. 2018 Oct 3;8(1):14739.	Oliveira-Mendes BBR, Horta CCR, do Carmo AO, Biscoto GL, Sales-Medina DF, Leal HG, Brandão-Dias PFP, Miranda SEM, Aguiar CJ, Cardoso VN, de Barros ALB, Chávez-Olortégui C, Leite MF, Kalapothakis E. 	CPP-Ts: a new intracellular calcium channel modulator and a promising tool for drug delivery in cancer cells	CC[C@@H](C)[C@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP32886	GKWMSFLKHILK	12	HAL-2/6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=23±3 µM); SW480 (IC50> 40 µM)	Rat erythrocytes: IC50=69 μM	Linear	Free	Amidation		L	HUVEC: IC50=55±9 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32887	gkwmsllkhilk	12	HAL-2/22	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=12 µM); SW480 (IC50> 100 µM)	Rat erythrocytes: IC50=54 μM	Linear	Free	Amidation		D	HUVEC: IC50=22±7 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@H](C)[C@@H](NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@@H](CCSC)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCCN)NC(=O)CN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(N)=O
DRAMP32888	GKwMSLLKHILK	12	HAL-2/8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=15±3 µM); SW480 (IC50> 40 µM)	Rat erythrocytes: IC50=99 μM	Linear	Free	Amidation	w=D-Trp	Mix	HUVEC: IC50=52±3 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32889	GKWMSLLKHIWK	12	HAL-2/18	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=14±2 µM); SW480 (IC50> 40 µM)	Rat erythrocytes: IC50=87 μM	Linear	Free	Amidation		L	HUVEC: IC50=56±9 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32890	GKWMSLLKHWLK	12	HAL-2/19	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=16±4 µM); SW480 (IC50> 40 µM)	Rat erythrocytes: IC50=106 μM	Linear	Free	Amidation		L	HUVEC: IC50=40±1 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32891	GKWMSLLKKILK	12	HAL-2/4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=38±6 µM); HeLa (IC50> 40 µM)	Rat erythrocytes: IC50=126 μM	Linear	Free	Amidation		L	HUVEC: IC50> 100 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32892	GKWMSLWKHILK	12	HAL-2/20	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=30±5 µM); SW480 (IC50> 40 µM)	Rat erythrocytes: IC50>100 μM	Linear	Free	Amidation		L	HUVEC: IC50=73±3 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32893	GKWMTLLKHILK	12	HAL-2/13	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=13±3 µM); SW480 (IC50> 60 µM)	Rat erythrocytes: IC50=86 μM	Linear	Free	Amidation		L	HUVEC: IC50=60±12 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP32894	GKWSKILGHLIR	12	HAL-1/12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=43±14 µM); SW480 (IC50> 100 µM); CCRF-CEM (IC50> 40 µM)	Rat erythrocytes: IC50>200  μM	Linear	Free	Amidation		L	HUVEC: IC50> 100 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32895	GKWSKILGKLIR	12	HAL-1/20	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=22±3 µM); CCRF-CEM (IC50> 40 µM); SW480 (IC50> 40 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50> 100 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32896	GMWKKILGHLIR	12	HAL-1/5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=44±5 µM); HeLa (IC50=9±1 µM); CCRF-CEM (IC50> 40 µM)	Rat erythrocytes: IC50=93 μM	Linear	Free	Amidation		L	HUVEC: IC50=49±16 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32897	GMWKKILGKLIR	12	HAL-1/10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=13±2 µM); SW480 (IC50> 60 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=63±13 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32898	GMWSKILGHLIk	12	HAL-1/6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=15±1 µM); SW480 (IC50> 100 µM)	Rat erythrocytes: IC50=132 μM	Linear	Free	Amidation		Mix	HUVEC: IC50=≥40 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP32899	gmwskilghlir	12	HAL-1/22	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=15±3 µM); SW480 (IC50> 40 µM)	Rat erythrocytes: IC50=52 μM	Linear	Free	Amidation		D	HUVEC: IC50=42±7 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@H](C)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCSC)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP32900	GMWSkILGHLIR	12	HAL-1/29	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50> 100 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation	k=D-Lys	Mix	HUVEC: IC50> 100 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32901	GMWSKILGHLKR	12	HAL-1/4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50> 100 µM)	Rat erythrocytes: IC50>200 μM	Linear	Free	Amidation		L	HUVEC: IC50=NA μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32902	GMWSKILGKLIR	12	HAL-1/9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CCRF-CEM (IC50=30±10 µM); HeLa (IC50=9±1 µM); SW480 (IC50> 50 µM)	Rat erythrocytes: IC50=143 μM	Linear	Free	Amidation		L	HUVEC: IC50=≥40 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32903	GMWSKILKHLIR	12	HAL-1/18	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW480 (IC50=18±2 µM); HeLa (IC50=4±2 µM)	Rat erythrocytes: IC50=45 μM	Linear	Free	Amidation		L	HUVEC: IC50=20±4 μM	Not available	22100226	Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP32904	CVRRFPWWYPFLRRC	15	Tritrp DiSu	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=12.3 µM)	RBC: IC50=20.9 µM	Cyclic	Free	Amidation		L	PBMC: IC50=26.2 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. 	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(N)=O
DRAMP32905	FRVTXRTKXXKG	12	PuroB3-hW	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation	X=HTrp=5-hydroxytryptophan	L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. 	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	
DRAMP32906	GALFLGFLGAAGSTMGAWSQPKKKRKV	27	MPG	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=15.8 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Cysteamidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. 	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP32907	FPVTWKWWKWWKG	13	PuroA-Lys	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=10.0 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50=23.0 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. 	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)[C@@H](C)O
DRAMP32908	FRVTWRTKWWKG	12	PuroB3	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. 	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)[C@@H](C)O)[C@@H](C)O
DRAMP32909	GIGKWLHSAKKFGKAFVGEIMNS	23	MagaininF5W-Lys	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=16.8 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. 	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC)C(C)C
DRAMP32910	FPVTWRWWRWWRG	13	PuroA-Arg	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=12.0  µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50=34.3 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. 	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)[C@@H](C)O
DRAMP32911	FRWWHR	6	Combi-2	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50 ≥ 65 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. 	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O
DRAMP32912	GIGRWLHSARRFGRAFVGEIMNS	23	MagaininF5W-Arg	Not available		Not found	porcine cathelicidin peptide	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=16.8 µM)	RBC: IC50 ≥ 65 µM	Linear	Free	Amidation		L	PBMC: IC50 ≥ 65 µM	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. 	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC)C(C)C
DRAMP32913	CHHNLTHAC	9	PTPRJ pep-19	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.	Tumor cells: HeLa (19 ± 2.82% Inhibition=160 μM); HeLa (4.5 ± 0.1.4% Inhibition=160 μM)	Not available	Cyclic	Free	Free		L	Not available	PTPRJ	23627474	ACS Chem Biol. 2013 Jul 19;8(7):1497-506.	Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso F. 	Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP32914	CHHNLTHAC	9	PTPRJ pep-19	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.	Tumor cells: HeLa (4 ± 1.4% Inhibition=160 μM)	Not available	Cyclic	Free	Free		L	Not available	PTPRJ	23627474	ACS Chem Biol. 2013 Jul 19;8(7):1497-506.	Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso F. 	Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP32915	CHHNLTHAC	9	PTPRJ pep-19.0	Not available		Not found	Synthetic (Derived from PTPRJ pep-19)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.	Tumor cells: HeLa (19 ± 2.82% Inhibition=160 μM); HeLa (4.5 ± 0.1.4% Inhibition=160 μM)	Not available	Linear	Free	Free		L	Not available	PTPRJ	23627474	ACS Chem Biol. 2013 Jul 19;8(7):1497-506.	Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso F. 	Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP32916	CHHNLTHAC	9	PTPRJ pep-19.0	Not available		Not found	Synthetic (Derived from PTPRJ pep-19)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.	Tumor cells: HeLa (4 ± 1.4% Inhibition=160 μM)	Not available	Linear	Free	Free		L	Not available	PTPRJ	23627474	ACS Chem Biol. 2013 Jul 19;8(7):1497-506.	Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso F. 	Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP32917	CAHNLTHAC	9	PTPRJ pep-19.2	Not available		Not found	Synthetic (Derived from PTPRJ pep-19)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.	Tumor cells: HeLa (16.5 ± 2.12% Inhibition=160 μM); HeLa (30 ± 2.82% Inhibition=160 μM); HeLa (32.0 ± 4.2% Inhibition=160 μM)	Not available	Cyclic	Free	Free		L	Not available	PTPRJ	23627474	ACS Chem Biol. 2013 Jul 19;8(7):1497-506.	Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso F. 	Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP32918	CHANLTHAC	9	PTPRJ pep-19.3	Not available		Not found	Synthetic (Derived from PTPRJ pep-19)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.	Tumor cells: HeLa (28 ± 5.5% Inhibition=160 μM); HeLa (46 ± 4.2% Inhibition=160 μM); HeLa (51 ± 1.4% Inhibition=160 μM)	Not available	Cyclic	Free	Free		L	Not available	PTPRJ	23627474	ACS Chem Biol. 2013 Jul 19;8(7):1497-506.	Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso F. 	Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP32919	CHHALTHAC	9	PTPRJ pep-19.4	Not available		Not found	Synthetic (Derived from PTPRJ pep-19)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.	Tumor cells: HeLa (48.0 ± 2.82% Inhibition=160 μM); HeLa (62.5 ± 4.9% Inhibition=160 μM); HeLa (66.5 ± 2.12% Inhibition=160 μM)	Not available	Cyclic	Free	Free		L	HUVEC: ~5% Inhibition=160 μM (24 h); ~25% Inhibition=160 μM (48 h); ~35% Inhibition=160 μM (24 h)	PTPRJ	23627474	ACS Chem Biol. 2013 Jul 19;8(7):1497-506.	Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso F. 	Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP32920	CHHNATHAC	9	PTPRJ pep-19.5	Not available		Not found	Synthetic (Derived from PTPRJ pep-19)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.	Tumor cells: HeLa (19 ± 4.2% Inhibition=160 μM); HeLa (2 ± 1.5% Inhibition=160 μM)	Not available	Cyclic	Free	Free		L	Not available	PTPRJ	23627474	ACS Chem Biol. 2013 Jul 19;8(7):1497-506.	Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso F. 	Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation	C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP32921	CHHNLAHAC	9	PTPRJ pep-19.6	Not available		Not found	Synthetic (Derived from PTPRJ pep-19)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.	Tumor cells: HeLa (19 ± 4.2% Inhibition=160 μM)	Not available	Cyclic	Free	Free		L	Not available	PTPRJ	23627474	ACS Chem Biol. 2013 Jul 19;8(7):1497-506.	Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso F. 	Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP32922	CHHNLTAAC	9	PTPRJ pep-19.7	Not available		Not found	Synthetic (Derived from PTPRJ pep-19)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.	Tumor cells: HeLa (20 ± 1.4% Inhibition=160 μM); HeLa (4.5 ± 2.13% Inhibition=160 μM)	Not available	Cyclic	Free	Free		L	Not available	PTPRJ	23627474	ACS Chem Biol. 2013 Jul 19;8(7):1497-506.	Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso F. 	Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP32923	KAaK	4	Chol-KAaK	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Human erythrocytes: 50% Hemolysis=60 µM	Linear	Cholesterol	Amidation	k=D-Lys	Mix	Not available	Not available	22006001	Antimicrob Agents Chemother. 2012 Jan;56(1):1-9.	Arnusch CJ, Ulm H, Josten M, Shadkchan Y, Osherov N, Sahl HG, Shai Y. 	Ultrashort peptide bioconjugates are exclusively antifungal agents and synergize with cyclodextrin and amphotericin B	
DRAMP32924	XFLGTLVNLAKKIL	14	Temporin-1DRa [Aib1]	Not available		Not found	Synthetic (Derived from Temporin-1DRa)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=40 µM)	Human erythrocytes: 50% Hemolysis=60 µM	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Mouse fibroblasts L929: LC50=17 µM	Not available	17767978	Peptides. 2007 Oct;28(10):2075-80. 	Conlon JM, Al-Kharrge R, Ahmed E, Raza H, Galadari S, Condamine E.	Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa	
DRAMP32925	HXLGTLVNLAKKIL	14	Temporin-1DRa [Aib2]	Not available		Not found	Synthetic (Derived from Temporin-1DRa)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=55 µM)	Human erythrocytes: 50% Hemolysis=100 µM	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Mouse fibroblasts L929: LC50=30 µM	Not available	17767978	Peptides. 2007 Oct;28(10):2075-80. 	Conlon JM, Al-Kharrge R, Ahmed E, Raza H, Galadari S, Condamine E.	Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa	
DRAMP32926	HFXGTLVNLAKKIL	14	Temporin-1DRa [Aib3]	Not available		Not found	Synthetic (Derived from Temporin-1DRa)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=40 µM)	Human erythrocytes: 50% Hemolysis=90 µM	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Mouse fibroblasts L929: LC50=20 µM	Not available	17767978	Peptides. 2007 Oct;28(10):2075-80. 	Conlon JM, Al-Kharrge R, Ahmed E, Raza H, Galadari S, Condamine E.	Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa	
DRAMP32927	HFLXTLVNLAKKIL	14	Temporin-1DRa [Aib4]	Not available		Not found	Synthetic (Derived from Temporin-1DRa)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=25 µM)	Human erythrocytes: 50% Hemolysis=25 µM	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Mouse fibroblasts L929: LC50=9 µM	Not available	17767978	Peptides. 2007 Oct;28(10):2075-80. 	Conlon JM, Al-Kharrge R, Ahmed E, Raza H, Galadari S, Condamine E.	Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa	
DRAMP32928	HFLGXLVNLAKKIL	14	Temporin-1DRa [Aib5]	Not available		Not found	Synthetic (Derived from Temporin-1DRa)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=40 µM)	Human erythrocytes: 50% Hemolysis=40 µM	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Mouse fibroblasts L929: LC50=16 µM	Not available	17767978	Peptides. 2007 Oct;28(10):2075-80. 	Conlon JM, Al-Kharrge R, Ahmed E, Raza H, Galadari S, Condamine E.	Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa	
DRAMP32929	HFLGTXVNLAKKIL	14	Temporin-1DRa [Aib6]	Not available		Not found	Synthetic (Derived from Temporin-1DRa)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50>200 µM)	Human erythrocytes: 50% Hemolysis>200 µM	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Mouse fibroblasts L929: LC50>200 µM	Not available	17767978	Peptides. 2007 Oct;28(10):2075-80. 	Conlon JM, Al-Kharrge R, Ahmed E, Raza H, Galadari S, Condamine E.	Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa	
DRAMP32930	HFLGTLXNLAKKIL	14	Temporin-1DRa [Aib7]	Not available		Not found	Synthetic (Derived from Temporin-1DRa)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=22 µM)	Human erythrocytes: 50% Hemolysis=22 µM	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Mouse fibroblasts L929: LC50=13 µM	Not available	17767978	Peptides. 2007 Oct;28(10):2075-80. 	Conlon JM, Al-Kharrge R, Ahmed E, Raza H, Galadari S, Condamine E.	Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa	
DRAMP32931	HFLGTLVXLAKKIL	14	Temporin-1DRa  [Aib8]	Not available		Not found	Synthetic (Derived from Temporin-1DRa)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=10 µM)	Human erythrocytes: 50% Hemolysis=10 µM	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Mouse fibroblasts L929: LC50=6 µM	Not available	17767978	Peptides. 2007 Oct;28(10):2075-80. 	Conlon JM, Al-Kharrge R, Ahmed E, Raza H, Galadari S, Condamine E.	Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa	
DRAMP32932	HFLGTLVNXAKKIL	14	Temporin-1DRa [Aib9]	Not available		Not found	Synthetic (Derived from Temporin-1DRa)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=75 µM)	Human erythrocytes: 50% Hemolysis=75 µM	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Mouse fibroblasts L929: LC50=42 µM	Not available	17767978	Peptides. 2007 Oct;28(10):2075-80. 	Conlon JM, Al-Kharrge R, Ahmed E, Raza H, Galadari S, Condamine E.	Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa	
DRAMP32933	HFLGTLVNLXKKIL	14	Temporin-1DRa [Aib10]	Not available		Not found	Synthetic (Derived from Temporin-1DRa)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=10 µM)	Human erythrocytes: 50% Hemolysis=10 µM	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Mouse fibroblasts L929: LC50=8 µM	Not available	17767978	Peptides. 2007 Oct;28(10):2075-80. 	Conlon JM, Al-Kharrge R, Ahmed E, Raza H, Galadari S, Condamine E.	Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa	
DRAMP32934	HFLGTLVNLAKKXL	14	Temporin-1DRa [Aib13]	Not available		Not found	Synthetic (Derived from Temporin-1DRa)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=90 µM)	Human erythrocytes: 50% Hemolysis=0 µM	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Mouse fibroblasts L929: LC50=55 µM	Not available	17767978	Peptides. 2007 Oct;28(10):2075-80. 	Conlon JM, Al-Kharrge R, Ahmed E, Raza H, Galadari S, Condamine E.	Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa	
DRAMP32935	HFLGTLVNLAKKIX	14	Temporin-1DRa [Aib14]	Not available		Not found	Synthetic (Derived from Temporin-1DRa)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=130 µM)	Human erythrocytes: 50% Hemolysis=130 µM	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Mouse fibroblasts L929: LC50=90 µM	Not available	17767978	Peptides. 2007 Oct;28(10):2075-80. 	Amino Acids. 2013 Feb;44(2):715-23. AS1258:AT1259	Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa	
DRAMP32936	KYLNFAKWLKGANLAKYANA	20	GW-H1-scr	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AGS (IC50>500 µM)	Not available	Linear	Free	Free		L	NIH 3T3: IC50>500 μM	Not available	25380626	Mol Cell Biochem. 2015 Feb;400(1-2):77-86. 	Pan WR, Chen YL, Hsu HC, Chen WJ. 	Antimicrobial peptide GW-H1-induced apoptosis of human gastric cancer AGS cell line is enhanced by suppression of autophagy	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O
DRAMP32937	ILKKLLSTAAGLLSNL	16	Alyteserin-2a [G3K]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=100 μM)	Human erythrocytes: 50% Hemolysis=105 µM	Linear	Free	Amidation		L	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32938	ILGKLLKTAAGLLSNL	16	Alyteserin-2a [S7K]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=35 μM)	Human erythrocytes: 50% Hemolysis=28 µM	Linear	Free	Amidation		L	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32939	ILGKLLkTAAGLLSNL	16	Alyteserin-2a [S7k]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50>100 μM)	Human erythrocytes: 50% Hemolysis=105 µM	Linear	Free	Amidation	k=D-Lys	Mix	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32940	ILGKLLSTAAKLLSNL	16	Alyteserin-2a [G11K]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=20 μM)	Human erythrocytes: 50% Hemolysis=24 µM	Linear	Free	Amidation		L	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32941	ILGKLLSTAAkLLSNL	16	Alyteserin-2a [G11k]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=28 μM)	Human erythrocytes: 50% Hemolysis=42 µM	Linear	Free	Amidation	k=D-Lys	Mix	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32942	ILGKLLSTAAGLLKNL	16	Alyteserin-2a [S14K]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=30 μM)	Human erythrocytes: 50% Hemolysis=55 µM	Linear	Free	Amidation		L	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32943	ILGKLLSTAAGLLSKL	16	Alyteserin-2a [N15K]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=13 μM); HepG2 (LC50=17 μM); MDA-MB-231 (LC50=18 μM); HT-29 (LC50=32 μM)	Human erythrocytes: 50% Hemolysis=50 µM	Linear	Free	Amidation		L	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32944	ILGKLLSTAAGLLSkL	16	Alyteserin-2a [N15k]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (LC50=125 μM); A549 (LC50=75 μM); MDA-MB-231 (LC50=80 μM); HepG2 (LC50=90 μM)	Human erythrocytes: 50% Hemolysis=310 µM	Linear	Free	Amidation	k=D-Lys	Mix	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32945	ILGKLLKTAAKLLSNL	16	Alyteserin-2a [S7K, G11K]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=20 μM)	Human erythrocytes: 50% Hemolysis=38 µM	Linear	Free	Amidation		L	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32946	ILGKLLkTAAkLLSNL	16	Alyteserin-2a [S7k, G11k]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=65 μM)	Human erythrocytes: 50% Hemolysis=185 µM	Linear	Free	Amidation	k=D-Lys	Mix	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32947	ILGKLLSTAAKLLSKL	16	Alyteserin-2a [G11K, N15K]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (LC50=10 μM); HT-29 (LC50=18 μM); A549 (LC50=6 μM); HepG2 (LC50=8 μM)	Human erythrocytes: 50% Hemolysis=16 µM	Linear	Free	Amidation		L	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32948	ILGKLLSTAAkLLSKL	16	Alyteserin-2a [G11k, N15K]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=15 μM); MDA-MB-231 (LC50=20 μM); HepG2 (LC50=26 μM); HT-29 (LC50=28 μM)	Human erythrocytes: 50% Hemolysis=195 µM	Linear	Free	Amidation	k=D-Lys	Mix	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32949	ILGKLLSWAAGLLSNL	16	Alyteserin-2a [T8W]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=12 μM)	Human erythrocytes: 50% Hemolysis=13 µM	Linear	Free	Amidation		L	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP32950	ILGKLLSTWAGLLSNL	16	Alyteserin-2a [A9W]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=21 μM)	Human erythrocytes: 50% Hemolysis=39 µM	Linear	Free	Amidation		L	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32951	ILGKLLSTAWGLLSNL	16	Alyteserin-2a [A10W]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=7 μM)	Human erythrocytes: 50% Hemolysis=11 µM	Linear	Free	Amidation		L	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32952	ILGKLLSTAWkLLSNL	16	Alyteserin-2a [A10W, G11k]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=17 μM)	Human erythrocytes: 50% Hemolysis=21 µM	Linear	Free	Amidation	k=D-Lys	Mix	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32953	ILGKLLSTAWGLLSKL	16	Alyteserin-2a [A10W, N15K]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=6 μM)	Human erythrocytes: 50% Hemolysis=6 µM	Linear	Free	Amidation		L	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32954	ILGKLLSTAWALLSkL	16	Alyteserin-2a [A10W, N15k]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=20 μM)	Human erythrocytes: 50% Hemolysis=27 µM	Linear	Free	Amidation	k=D-Lys	Mix	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32955	ILGKLLSTAWkLLSkL	16	Alyteserin-2a [A10W, G11k, N15k]	Not available		Not found	Synthetic (Derived from Alyteserin-2a)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=17 μM)	Human erythrocytes: 50% Hemolysis=68 µM	Linear	Free	Amidation	k=D-Lys	Mix	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, AS1258:AT1258Arafat K, Zaric M, Lukic ML, Attoub S. 	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP32956	KLKLKFKLKQ	10	BPC10L	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Not active up to 40 μM)	Human erythrocytes: 84 ± 6.9% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32957	KKKKKFLLLQ	10	BPC58	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Not active up to 40 μM)	Human erythrocytes: 6 ± 0.5% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32958	KKKKLFKLLQ	10	BPC60	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Not active up to 40 μM)	Human erythrocytes: 72 ± 5.5% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32959	KKKLKFKLLQ	10	BPC62	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Not active up to 40 μM)	Human erythrocytes: 6 ± 0.6% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32960	KKLKKFKLLQ	10	BPC64	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Not active up to 40 μM)	Human erythrocytes: 10 ± 2.0% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32961	KLKKKFKLLQ	10	BPC66	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (4 ± 0.11% Growth inhibition=40 μM)	Human erythrocytes: 22 ± 4.0% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32962	LKKKKFKLLQ	10	BPC68	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Not active up to 40 μM)	Human erythrocytes: 0 ± 0.5% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32963	KKKKLFLKLQ	10	BPC70	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (4 ± 0.07% Growth inhibition=40 μM)	Human erythrocytes: 19 ± 0.5% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32964	KKKLKFLKLQ	10	BPC72	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (2 ± 0.08% Growth inhibition=40 μM)	Human erythrocytes: 7 ± 2.0% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32965	KKLKKFLKLQ	10	BPC74	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (22 ± 0.08% Growth inhibition=40 μM)	Human erythrocytes: 36 ± 1.7% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32966	KLKKKFLKLQ	10	BPC76	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (14 ± 0.05% Growth inhibition=40 μM)	Human erythrocytes: 13 ± 1.9% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32967	LKKKKFLKLQ	10	BPC78	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (13 ± 0.05% Growth inhibition=40 μM)	Human erythrocytes: 0 ± 0.4% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32968	KKKLLFKKLQ	10	BPC80	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (9 ± 0.11% Growth inhibition=40 μM)	Human erythrocytes: 19 ± 0.7% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32969	KKLKLFKKLQ	10	BPC82	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (25 ± 0.03% Growth inhibition=40 μM)	Human erythrocytes: 36 ± 2.5% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32970	KLKKLFKKLQ	10	BPC84	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (27 ± 0.11% Growth inhibition=40 μM)	Human erythrocytes: 45 ± 3.5% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32971	LKKKLFKKLQ	10	BPC86	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (8 ± 0.21% Growth inhibition=40 μM)	Human erythrocytes: 8 ± 0.9% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32972	KKKKLFLLKQ	10	BPC100	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (6 ± 0.10% Growth inhibition=40 μM)	Human erythrocytes: 1.8 ± 0.8% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32973	KKKLKFLLKQ	10	BPC102 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (23 ± 0.08% Growth inhibition=40 μM)	Human erythrocytes: 26 ± 3.0% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32974	KKLKKFLLKQ	10	BPC104	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (11 ± 0.08% Growth inhibition=40 μM)	Human erythrocytes: 15 ± 2.2% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32975	KLKKKFLLKQ	10	BPC106 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (17 ± 0.10% Growth inhibition=40 μM)	Human erythrocytes: 0 ± 0.1% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32976	LKKKKFLLKQ	10	BPC108	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (9 ± 0.09% Growth inhibition=40 μM)	Human erythrocytes: 2 ± 0.2% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32977	KKKLLFKLKQ	10	BPC110 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (14 ± 0.15% Growth inhibition=40 μM)	Human erythrocytes: 9 ± 0.4% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32978	KKLKLFKLKQ	10	BPC112 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (9 ± 0.06% Growth inhibition=40 μM)	Human erythrocytes: 1 ± 0.1% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32979	KLKKLFKLKQ	10	BPC114 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (17 ± 0.05% Growth inhibition=40 μM)	Human erythrocytes: 24 ± 1.8% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32980	LKKKLFKLKQ	10	BPC116 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (5 ± 0.24% Growth inhibition=40 μM)	Human erythrocytes: 13 ± 0.9% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32981	KKLLKFKLKQ	10	BPC118 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (19 ± 0.01% Growth inhibition=40 μM)	Human erythrocytes: 6 ± 0.6% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32982	LKKLKFKLKQ	10	BPC120	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (12 ± 0.02% Growth inhibition=40 μM)	Human erythrocytes: 8 ± 1.6% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32983	KLLKKFKLKQ	10	BPC122	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (7 ± 0.08% Growth inhibition=40 μM)	Human erythrocytes: 4 ± 1.3% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32984	LKLKKFKLKQ	10	BPC124	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (4 ± 0.07% Growth inhibition=40 μM)	Human erythrocytes: 3 ± 0.1% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32985	LLKKKFKLKQ	10	BPC126	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (8 ± 0.03% Growth inhibition=40 μM)	Human erythrocytes: 4 ± 0.6% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32986	KKKLLFLKKQ	10	BPC128	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (22 ± 0.06% Growth inhibition=40 μM)	Human erythrocytes: 1 ± 0.3% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32987	KKLKLFLKKQ	10	BPC130	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (15 ± 0.20% Growth inhibition=40 μM)	Human erythrocytes: 6 ± 3.0% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32988	KLKKLFLKKQ	10	BPC132	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (18 ± 0.18% Growth inhibition=40 μM)	Human erythrocytes: 4 ± 0.9% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32989	LKKKLFLKKQ	10	BPC134	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (3 ± 0.15% Growth inhibition=40 μM)	Human erythrocytes: 2 ± 0.3% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32990	KKLLKFLKKQ	10	BPC136	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (29 ± 0.05% Growth inhibition=40 μM)	Human erythrocytes: 41 ± 1.8% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32991	KLKLKFLKKQ	10	BPC138	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Not active up to 40 μM)	Human erythrocytes: 5 ± 0.9% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32992	LKKLKFLKKQ	10	BPC140	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Not active up to 40 μM)	Human erythrocytes: 23 ± 1.1% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32993	KLLKKFLKKQ	10	BPC142	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Not active up to 40 μM)	Human erythrocytes: 14 ± 1.6% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32994	LKLKKFLKKQ	10	BPC144	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (7 ± 0.17% Growth inhibition=40 μM)	Human erythrocytes: 9 ± 1.9% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32995	LLKKKFLKKQ	10	BPC146	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (12 ± 0.19% Growth inhibition=40 μM)	Human erythrocytes: 3 ± 0.5% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32996	KKLLLFKKKQ	10	BPC148	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (19 ± 0.09% Growth inhibition=40 μM)	Human erythrocytes: 1 ± 0.2% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32997	KLKLLFKKKQ	10	BPC150	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (11 ± 0.22% Growth inhibition=40 μM)	Human erythrocytes: 4 ± 0.2% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32998	LKKLLFKKKQ	10	BPC152	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Not active up to 40 μM)	Human erythrocytes: 2 ± 0.1% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP32999	KLLKLFKKKQ	10	BPC154	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (28 ± 0.05% Growth inhibition=40 μM)	Human erythrocytes: 11 ± 1.7% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33000	LKLKLFKKKQ	10	BPC156	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (1 ± 0.26% Growth inhibition=40 μM)	Human erythrocytes: 3 ± 0.4% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33001	LLKKLFKKKQ	10	BPC158	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (2 ± 0.13% Growth inhibition=40 μM)	Human erythrocytes: 9 ± 0.7% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33002	KLLLKFKKKQ	10	BPC160	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (20 ± 0.26% Growth inhibition=40 μM)	Human erythrocytes: 3 ± 0.4% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33003	LKLLKFKKKQ	10	BPC162	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (16 ± 0.31% Growth inhibition=40 μM)	Human erythrocytes: 2 ± 0.8% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33004	LLKLKFKKKQ	10	BPC164	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (16 ± 0.15% Growth inhibition=40 μM)	Human erythrocytes: 4 ± 0.5% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33005	LLLKKFKKKQ	10	BPC166	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (5 ± 0.24% Growth inhibition=40 μM)	Human erythrocytes: 0 ± 0.1% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33006	KKLLKFKKLQ	10	BPC88	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (50 ± 0.10% Growth inhibition=40 μM; IC50=31.2 ± 5 μM); HeLa (IC50=22.5 ± 0 μM); A431 (IC50=28.0 ± 3 μM); PANC-1 (IC50=32.5 ± 11 μM); HepG2 (IC50=32.5 ± 4 μM)	Human erythrocytes: 33 ± 3.3% Hemolysis=375 µM; IC50=33 ± 3.3 µM	Cyclic	Free	Free		L	Human non-malignant fibroblasts: IC50=42.0 ± 7.1 µM	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33007	KLKLKFKKLQ	10	BPC90	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (23 ± 0.17% Growth inhibition=40 μM)	Human erythrocytes: 30 ± 4.1% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33008	LKKLKFKKLQ	10	BPC92	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (13 ± 0.08% Growth inhibition=40 μM)	Human erythrocytes: 7 ± 0.7% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33009	KLLKKFKKLQ	10	BPC94	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (95 ± 0.01% Growth inhibition=40 μM; IC50=22.0 ± 0 μM); PANC-1 (IC50=18.5 ± 8 μM); HepG2 (IC50=20.5 ± 6 μM); A431 (IC50=21.5 ± 8 μM); HeLa (IC50=23.0 ± 3 μM)	Human erythrocytes: 73 ± 1.6% Hemolysis=375 µM; IC50=73 ± 1.6 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33010	LKLKKFKKLQ	10	BPC96	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (59 ± 0.08% Growth inhibition=40 μM; IC50=40.0 ± 7 μM); HeLa (IC50=24.5 ± 0.7 μM); HepG2 (IC50=34.5 ± 2 μM); A431 (IC50=35.0 ± 7 μM); PANC-1 (IC50=51.0 ± 6 μM)	Human erythrocytes: 32 ± 7.2% Hemolysis=375 µM; IC50=32 ± 7.2 µM	Cyclic	Free	Free		L	Human non-malignant fibroblasts: IC50=39.0 ± 9.9 µM	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33011	LLKKKFKKLQ	10	BPC98	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (60 ± 0.07% Growth inhibition=40 μM; IC50=40.7 ± 3 μM); HeLa (IC50=38.5 ± 4 μM); HepG2 (IC50=44.0 ± 3 μM); PANC-1 (IC50=44.5 ± 0.7 μM); A431 (IC50=47.5 ± 4 μM)	Human erythrocytes: 36 ± 3.7% Hemolysis=375 µM; IC50=36 ± 3.7 µM	Cyclic	Free	Free		L	Human non-malignant fibroblasts: IC50=58.5 ± 2.1 µM	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33012	KLLLKFKKLQ	10	BPC184	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	"Tumor cells: MDA-MB-231 (88 ± 0.01% Growth inhibition=40 μM; IC50=32.2 ± 7 μM); A431 (IC50=24.5 ± 0.7	 μM); HeLa (IC50=30.5 ± 12 μM); PANC-1 (IC50=41.5 ± 11 μM); HepG2 (IC50=42.2 ± 2 μM)"	Human erythrocytes: 89 ± 5.3% Hemolysis=375 µM; IC50=89 ± 5.3 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33013	KKKLKFKKLQ	10	BPC186	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (22 ± 0.09% Growth inhibition=40 μM)	Human erythrocytes: 0 ± 0.4% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33014	LLLKKFKKLQ	10	BPC188	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (14 ± 0.01% Growth inhibition=40 μM)	Human erythrocytes: 87 ± 6.5% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33015	LKKKKFKKLQ	10	BPC190	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Not active up to 40 μM)	Human erythrocytes: Not active up to 375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33016	LKLLKFKKLQ	10	BPC192	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (20 ± 0.05% Growth inhibition=40 μM)	Human erythrocytes: 49 ± 7.7% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33017	KKLKKFKKLQ	10	BPC194	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (70 ± 0.01% Growth inhibition=40 μM; IC50=32.5 ± 0.5 μM); HeLa (IC50=29.5 ± 2 μM); PANC-1 (IC50=40.0 ± 3 μM); HepG2 (IC50=46.0 ± 3 μM); A431 (IC50=50.0 ± 10 μM)	Human erythrocytes: 17 ± 1.7% Hemolysis=375 µM; IC50=17 ± 1.7 µM	Cyclic	Free	Free		L	Human non-malignant fibroblasts: IC50=56.5 ± 0.7 µM	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33018	LLKLKFKKLQ	10	BPC196	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (18 ± 0.09% Growth inhibition=40 μM)	Human erythrocytes: 47 ± 7.2% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33019	KLKKKFKKLQ	10	BPC198	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (56 ± 0.06% Growth inhibition=40 μM; IC50=53.2 ± 13 μM); HeLa (IC50=35.0 ± 1 μM); A431 (IC50=49.5 ± 6 μM); PANC-1 (IC50=57.5 ± 6 μM); HepG2 (IC50>60 μM)	Human erythrocytes: 14 ± 1.4% Hemolysis=375 µM; IC50=14 ± 1.4 µM	Cyclic	Free	Free		L	Human non-malignant fibroblasts: IC50=7.5 ± 0.7 µM	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33020	LLLLKFKKLQ	10	BPC200	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (11 ± 0.27% Growth inhibition=40 μM)	Human erythrocytes: 71 ± 11.7% Hemolysis=375 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33021	KKKKKFKKLQ	10	BPC202	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (63 ± 0.02% Growth inhibition=40 μM; IC50=40.5 ± 9 μM); A431 (IC50=35.5 ± 2 μM); PANC-1 (IC50=43.5 ± 0.7 μM); HepG2 (IC50=46.0 ± 8 μM); HeLa (IC50=54.0 ± 6 μM)	Human erythrocytes: 2 ± 0.2% Hemolysis=375 µM; IC50=2 ± 0.2 µM	Cyclic	Free	Free		L	Not available	Not available	20708052	Peptides. 2010 Nov;31(11):2017-26	Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. 	Antimicrobial cyclic decapeptides with anticancer activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33022	RIIDLLWRVWRPQKPKFVTVWVR	23	PMAP-23 [R10W]	P49930		Not found	Synthetic (Derived from PMAP-23)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=19 µM); SNU-601 (IC50=28 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12054589	Biochem Biophys Res Commun. 2002 Apr 26;293(1):231-8.	Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH, Hahm KS.	Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP33023	RIIDLLWRVRRPWKPKFVTVWVR	23	PMAP-23 [Q13W]	P49930		Not found	Synthetic (Derived from PMAP-23)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=20 µM); SNU-601 (IC50=30 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12054589	Biochem Biophys Res Commun. 2002 Apr 26;293(1):231-8.	Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH, Hahm KS.	Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP33024	RIIDLLWRVRRPQWPKFVTVWVR	23	PMAP-23 [K14W]	P49930		Not found	Synthetic (Derived from PMAP-23)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=29 µM); SNU-601 (IC50=39 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12054589	Biochem Biophys Res Commun. 2002 Apr 26;293(1):231-8.	Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH, Hahm KS.	Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP33025	RIIDLLWRVRRPWWPKFVTVWVR	23	PMAP-23 [Q13W][K14W]	P49930		Not found	Synthetic (Derived from PMAP-23)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=23 µM); SNU-601 (IC50=37 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12054589	Biochem Biophys Res Commun. 2002 Apr 26;293(1):231-8.	Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH, Hahm KS.	Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP33026	RIIDLLWRVWRPWKPKFVTVWVR	23	PMAP-23 [R10W][Q13W]	P49930		Not found	Synthetic (Derived from PMAP-23)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=16 µM); SNU-601 (IC50=21 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12054589	Biochem Biophys Res Commun. 2002 Apr 26;293(1):231-8.	Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH, Hahm KS.	Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP33027	RIIDLLWRVWRPWWPKFVTVWVR	23	PMAP-23 [R10W][Q13W][K14W]	P49930		Not found	Synthetic (Derived from PMAP-23)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SNU-601 (IC50=10 µM); Jurkat (IC50=11 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	12054589	Biochem Biophys Res Commun. 2002 Apr 26;293(1):231-8.	Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH, Hahm KS.	Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP33028	GKKLKKIGQKIKNFFQKL	18	CRAMP-18[E2K]	P51437		Not found	Synthetic (Derived from CRAMP-18)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=20 µM); A549 (IC50=25 µM); K562 (IC50=34 µM)	Human erythrocytes: Not active up to 100 µM	Linear	Free	Free		L	Not available	Not available	10973820	Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9. 	Shin SY, Kang SW, Lee DG, Eom SH, Song WK, Kim JI.	CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP33029	GEKLKKIGKKIKNFFQKL	18	CRAMP-18[Q9K]	P51437		Not found	Synthetic (Derived from CRAMP-18)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (IC50=66 µM); K562 (IC50=85 µM); A549 (IC50=88 µM)	Human erythrocytes: Not active up to 100 µM	Linear	Free	Free		L	Not available	Not available	10973820	Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9. 	Shin SY, Kang SW, Lee DG, Eom SH, Song WK, Kim JI.	CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33030	GEKLKKIGQKIKKFFQKL	18	CRAMP-18[N13K]	P51437		Not found	Synthetic (Derived from CRAMP-18)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=100 µM); Jurkat (IC50=78 µM); A549 (IC50=93 µM)	Human erythrocytes: Not active up to 100 µM	Linear	Free	Free		L	Not available	Not available	10973820	Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9. 	Shin SY, Kang SW, Lee DG, Eom SH, Song WK, Kim JI.	CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33031	GEKLKKIGQKIKNFFKKL	18	CRAMP-18[Q16K]	P51437		Not found	Synthetic (Derived from CRAMP-18)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>100 µM); Jurkat (IC50>100 µM); K562 (IC50>100 µM)	Human erythrocytes: 0.2% Hemolysis=100 µM	Linear	Free	Free		L	Not available	Not available	10973820	Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9. 	Shin SY, Kang SW, Lee DG, Eom SH, Song WK, Kim JI.	CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33032	GLLxRIkTLL	10	Ano-D4,7–4C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33033	GLLxRIkTLL	10	Ano-D4,7–4C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33034	GLLxRIkTLL	10	Ano-D4,7–4C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50>256 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33035	GLLxRIkTLL	10	Ano-D4,7–4C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=64 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33036	GLLxRIkTLL	10	Ano-D4,7–4C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33037	GLLxRIkTLL	10	Ano-D4,7–4C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33038	GLLxRIkTLL	10	Ano-D4,7–4C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33039	GLLxRIkTLL	10	Ano-D4,7–4C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33040	GLLxRIkTLL	10	Ano-D4,7–4C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33041	GLLxRIkTLL	10	Ano-D4,7–4C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50>256 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33042	GLLxRIkTLL	10	Ano-D4,7–4C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=64 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33043	GLLxRIkTLL	10	Ano-D4,7–4C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33044	GLLxRIkTLL	10	Ano-D4,7–4C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33045	GLLxRIkTLL	10	Ano-D4,7–4C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33046	GLLxRIkTLL	10	Ano-D4,7–4C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50>256 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33047	GLLxRIkTLL	10	Ano-D4,7–4C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50>256 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33048	GLLxRIkTLL	10	Ano-D4,7–4C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50>256 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50>256 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33049	GLLxRIkTLL	10	Ano-D4,7–4C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=64 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50>256 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33050	GLLxRIkTLL	10	Ano-D4,7–4C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50>256 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33051	GLLxRIkTLL	10	Ano-D4,7–4C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50>256 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33052	GLLxRIkTLL	10	Ano-D4,7–4C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50>256 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33053	GLLxRIkTLL	10	Ano-D4,7–4C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33054	GLLxRIkTLL	10	Ano-D4,7–4C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33055	GLLxRIkTLL	10	Ano-D4,7–4C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50>256 µM)	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33056	GLLxRIkTLL	10	Ano-D4,7–4C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=64 µM)	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33057	GLLxRIkTLL	10	Ano-D4,7–4C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33058	GLLxRIkTLL	10	Ano-D4,7–4C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33059	GLLxRIkTLL	10	Ano-D4,7–4C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33060	GLLxRIkTLL	10	Ano-D4,7–4C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=32 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33061	GLLxRIkTLL	10	Ano-D4,7–4C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=32 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33062	GLLxRIkTLL	10	Ano-D4,7–4C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50>256 µM)	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=32 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33063	GLLxRIkTLL	10	Ano-D4,7–4C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=64 µM)	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=32 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33064	GLLxRIkTLL	10	Ano-D4,7–4C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=32 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33065	GLLxRIkTLL	10	Ano-D4,7–4C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=32 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33066	GLLxRIkTLL	10	Ano-D4,7–4C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=32 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33067	GLLxRIkTLL	10	Ano-D4,7–4C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33068	GLLxRIkTLL	10	Ano-D4,7–4C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33069	GLLxRIkTLL	10	Ano-D4,7–4C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50>256 µM)	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33070	GLLxRIkTLL	10	Ano-D4,7–4C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=64 µM)	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33071	GLLxRIkTLL	10	Ano-D4,7–4C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33072	GLLxRIkTLL	10	Ano-D4,7–4C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33073	GLLxRIkTLL	10	Ano-D4,7–4C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33074	GLLxRIkTLL	10	Ano-D4,7–4C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33075	GLLxRIkTLL	10	Ano-D4,7–4C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33076	GLLxRIkTLL	10	Ano-D4,7–4C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50>256 µM)	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33077	GLLxRIkTLL	10	Ano-D4,7–4C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=64 µM)	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33078	GLLxRIkTLL	10	Ano-D4,7–4C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33079	GLLxRIkTLL	10	Ano-D4,7–4C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33080	GLLxRIkTLL	10	Ano-D4,7–4C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33081	GLLkRIxTLL	10	Ano-D4,7–7C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33082	GLLkRIxTLL	10	Ano-D4,7–7C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33083	GLLkRIxTLL	10	Ano-D4,7–7C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=128 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33084	GLLkRIxTLL	10	Ano-D4,7–7C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33085	GLLkRIxTLL	10	Ano-D4,7–7C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=8 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33086	GLLkRIxTLL	10	Ano-D4,7–7C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33087	GLLkRIxTLL	10	Ano-D4,7–7C4	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C4 (D-Lysine with butyrylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33088	GLLkRIxTLL	10	Ano-D4,7–7C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33089	GLLkRIxTLL	10	Ano-D4,7–7C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33090	GLLkRIxTLL	10	Ano-D4,7–7C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=128 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33091	GLLkRIxTLL	10	Ano-D4,7–7C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33092	GLLkRIxTLL	10	Ano-D4,7–7C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=8 µM)	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33093	GLLkRIxTLL	10	Ano-D4,7–7C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33094	GLLkRIxTLL	10	Ano-D4,7–7C6	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis>256 µM	Linear	Free	Amidation	x=D-Lys-C6 (D-Lysine with 2-hexanoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33095	GLLkRIxTLL	10	Ano-D4,7–7C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33096	GLLkRIxTLL	10	Ano-D4,7–7C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33097	GLLkRIxTLL	10	Ano-D4,7–7C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=128 µM)	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33098	GLLkRIxTLL	10	Ano-D4,7–7C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33099	GLLkRIxTLL	10	Ano-D4,7–7C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=8 µM)	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33100	GLLkRIxTLL	10	Ano-D4,7–7C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33101	GLLkRIxTLL	10	Ano-D4,7–7C8	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=256 µM	Linear	Free	Amidation	x=D-Lys-C8 (D-Lysine with octanoylated side group); k=D-Lys	Mix	HEK293T: IC50=128 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33102	GLLkRIxTLL	10	Ano-D4,7–7C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=128 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=16 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33103	GLLkRIxTLL	10	Ano-D4,7–7C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=128 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=16 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33104	GLLkRIxTLL	10	Ano-D4,7–7C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=128 µM)	Mouse erythrocytes: 10% Hemolysis=128 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=16 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33105	GLLkRIxTLL	10	Ano-D4,7–7C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis=128 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=16 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33106	GLLkRIxTLL	10	Ano-D4,7–7C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=8 µM)	Mouse erythrocytes: 10% Hemolysis=128 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=16 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33107	GLLkRIxTLL	10	Ano-D4,7–7C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=128 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=16 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33108	GLLkRIxTLL	10	Ano-D4,7–7C10	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=128 µM	Linear	Free	Amidation	x=D-Lys-C10 (D-Lysine with decanoylated side group); k=D-Lys	Mix	HEK293T: IC50=16 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33109	GLLkRIxTLL	10	Ano-D4,7–7C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=8 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33110	GLLkRIxTLL	10	Ano-D4,7–7C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=8 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33111	GLLkRIxTLL	10	Ano-D4,7–7C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=128 µM)	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=8 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33112	GLLkRIxTLL	10	Ano-D4,7–7C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=8 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33113	GLLkRIxTLL	10	Ano-D4,7–7C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=8 µM)	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=8 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33114	GLLkRIxTLL	10	Ano-D4,7–7C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=8 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33115	GLLkRIxTLL	10	Ano-D4,7–7C12	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C12 (D-Lysine with laurylated side group); k=D-Lys	Mix	HEK293T: IC50=8 µM	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33116	GLLkRIxTLL	10	Ano-D4,7–7C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33117	GLLkRIxTLL	10	Ano-D4,7–7C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33118	GLLkRIxTLL	10	Ano-D4,7–7C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=128 µM)	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33119	GLLkRIxTLL	10	Ano-D4,7–7C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33120	GLLkRIxTLL	10	Ano-D4,7–7C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=8 µM)	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33121	GLLkRIxTLL	10	Ano-D4,7–7C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33122	GLLkRIxTLL	10	Ano-D4,7–7C14	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=32 µM	Linear	Free	Amidation	x=D-Lys-C14 (D-Lysine with myristoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33123	GLLkRIxTLL	10	Ano-D4,7–7C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33124	GLLkRIxTLL	10	Ano-D4,7–7C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33125	GLLkRIxTLL	10	Ano-D4,7–7C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=128 µM)	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33126	GLLkRIxTLL	10	Ano-D4,7–7C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=16 µM)	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33127	GLLkRIxTLL	10	Ano-D4,7–7C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=8 µM)	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33128	GLLkRIxTLL	10	Ano-D4,7–7C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33129	GLLkRIxTLL	10	Ano-D4,7–7C16	Not available		Not found	Synthetic (Derived from Anoplin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mouse erythrocytes: 10% Hemolysis=16 µM	Linear	Free	Amidation	x=D-Lys-C16 (D-Lysine with palmitoylated side group); k=D-Lys	Mix	Not available	Not available	31676352	Eur J Pharm Sci. 2020 Jan 1;141:105123.	Zhong C, Zhu N, Zhu Y, Liu T, Gou S, Xie J, Yao J, Ni J. 	Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria	
DRAMP33130	RLLRLIRKLII	11	Decoralin [AC1]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=11±1 μM); A549 (EC50=21±1 μM); Jurkat (EC50=39±1 μM); 1205Lu (EC50=9±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=141±1 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP33131	RLLRLIRKLIL	11	Decoralin [AC2]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50=14±1 μM); Jurkat (EC50=25±1 μM); 1205Lu (EC50=7±1 μM); MCF-7 (EC50=9±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=125–250 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33132	LLLLLIRKLIK	11	Decoralin [AC3]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=11±1 μM); 1205Lu (EC50=16±1 μM); A549 (EC50=22±1 μM); Jurkat (EC50=25±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=125–250 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33133	YLLYLIRKLIL	11	Decoralin [AC4]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=13±1 μM); 1205Lu (EC50=14±1 μM); Jurkat (EC50=22±1 μM); A549 (EC50=29±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=256±2 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33134	RLLRLIRKLIR	11	Decoralin [AC5]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=14±1 μM); 1205Lu (EC50=16±1 μM); A549 (EC50=27±1 μM); Jurkat (EC50=27±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=138±7 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33135	QLLQLIRKLII	11	Decoralin [AC6]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: 1205Lu (EC50=21±1 μM); MCF-7 (EC50=22±1 μM); A549 (EC50=29±1 μM); Jurkat (EC50=35±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=171±1 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP33136	QLLQLIRKLIM	11	Decoralin [AC7]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: 1205Lu (EC50=24±1 μM); A549 (EC50=33±1 μM); MCF-7 (EC50=33±1 μM); Jurkat (EC50=46±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=142±2 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(=O)N[C@@H](CCSC)C(N)=O
DRAMP33137	MLLMLIRKLIL	11	Decoralin [AC8]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=16±1 μM); 1205Lu (EC50=31±1 μM); Jurkat (EC50=31±1 μM); A549 (EC50=58±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=262±1 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33138	QLLQLIRKLIR	11	Decoralin [AC9]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: 1205Lu (EC50=38±1 μM); MCF-7 (EC50=53±1 μM); A549 (EC50=60±1 μM); Jurkat (EC50=75±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=260±1 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33139	QLLQLIRKLIK	11	Decoralin [AC10]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: 1205Lu (EC50=39±1 μM); MCF-7 (EC50=50-100 μM); A549 (EC50=54±1 μM); Jurkat (EC50=69±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50~=250 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33140	QLLQLIRKLIY	11	Decoralin [AC11]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: 1205Lu (EC50=29±1 μM); MCF-7 (EC50=50-100 μM); Jurkat (EC50=58±1 μM); A549 (EC50=61±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=349±1 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
DRAMP33141	LLLQLIRKLIL	11	Decoralin [AT1]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=10±1 μM); 1205Lu (EC50=12±1 μM); A549 (EC50=30±1 μM); Jurkat (EC50=53±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=154±1 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33142	TLLLLIRKLIL	11	Decoralin [AT2]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: 1205Lu (EC50=16±1 μM); Jurkat (EC50=30±1 μM); MCF-7 (EC50=38±1 μM); A549 (EC50=79±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=348±1 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33143	RLLLLIRKLIL	11	Decoralin [AT3]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: 1205Lu (EC50=18±1 μM); MCF-7 (EC50=24±1 μM); A549 (EC50=35±1 μM); Jurkat (EC50=40±1 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=160±1 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33144	LLLLLIRKLIL	11	Decoralin [AT4]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=25±1 μM); 1205Lu (EC50=48±1 μM); Jurkat (EC50=50±1 μM); A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=278±1 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33145	QLLLLIRKLIL	11	Decoralin [AT5]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (EC50=39±1 μM); 1205Lu (EC50=44±1 μM); MCF-7 (EC50=63±1 μM); A549 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=271±1 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33146	QLLLLIRKLIV	11	Decoralin [AT6]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: 1205Lu (EC50=53±1 μM); MCF-7 (EC50=77±1 μM); A549 (EC50>100 μM); Jurkat (EC50>100 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50=339±1 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)C(C)C)[C@H](C)CC
DRAMP33147	CLLLLIRKLIL	11	Decoralin [AT7]	Not available		Not found	Synthetic (Derived from Decoralin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: 1205Lu (EC50=76±1 μM); A549 (EC50>100 μM); Jurkat (EC50>100 μM); MCF-7 (EC50>100 μM)	Not available	Linear	Free	Amidation		L	HDMEC: EC50~=500 μM	Not available	26119906	Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10370-4.	Lin YC, Lim YF, Russo E, Schneider P, Bolliger L, Edenharter A, Altmann KH, Halin C, Hiss JA, Schneider G.	Multidimensional Design of Anticancer Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33148	WKWLKKWIK	9	PL-D 1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: OVCAR-3 (IC50=51.1 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33149	WKWLKKWIK	9	PL-D 1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=24.3 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33150	WRKFWKYLK	9	PL-D 5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=47.3 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33151	RLWWWWRRK	9	PL-D 9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=87 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC(C)C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33152	KWKWWWRKI	9	PL-D 10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=90.4 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP33153	RIRRWKFRW	9	PL-D 11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=182.5 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP33154	RLKRWWKFL	9	PL-D 12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=48 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP33155	RRWWRWVVW	9	PL-D 16	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=179.1 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
DRAMP33156	WFKMRWWGR	9	PL-D 17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=189.3 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP33157	KFKWWRMLI	9	PL-D 18	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=49 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP33158	RWRWWWRVY	9	PL-D 21	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=171.5 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP33159	LKRRWKWWI	9	PL-D 23	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=186.7 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)O
DRAMP33160	RRRIKIRWY	9	PL-D 24	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=190.2 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP33161	RLWWKIWLK	9	PL-D 25	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=192.8 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33162	KRRWRIWLV	9	PL-D 26	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=195.1 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP33163	FFIYVWRRR	9	PL-D 27	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=190.8 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP33164	IRMRIRVLL	9	PL-D 28	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=219 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@H](C)CC
DRAMP33165	RWWRKIWKW	9	PL-D 29	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=177.3 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP33166	RWWIRIRWH	9	PL-D 31	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=181.8 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP33167	RRRWWKLMM	9	PL-D 32	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=94 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CSCC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP33168	LRRWIRIRW	9	PL-D 33	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=189.1 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP33169	RKFRWWVIR	9	PL-D 34	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=190.2 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP33170	WKIVFWWRR	9	PL-D 35	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=186 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP33171	RQRRVVIWW	9	PL-D 36	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=197.2 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP33172	RRWRVIVKW	9	PL-D 37	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=197.2 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
DRAMP33173	RLWRIVVIRVKR	12	PL-D 39	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=138.4 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP33174	RLRRIVVIRVFR	12	PL-D 40	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=158.8 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP33175	RKWKIKWYW	9	PL-D 43	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=183.8 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP33176	YRLRVKWKW	9	PL-D 44	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=191.9 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
DRAMP33177	WKWRVRVTI	9	PL-D 45	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=206 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP33178	RTKKWIVWI	9	PL-D 46	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=208.3 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@H](C)CC)C(C)C)C(=O)O
DRAMP33179	KRKKRFKWW	9	PL-D 49	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=188 µM)	Not available	Linear	Free	Free		L	Not available	Not available	23478953	Antimicrob Agents Chemother. 2013 May;57(5):2295-303	Ramón-García S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M, Hilpert K, Thompson CJ.	Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP33180	VXLfPFfNQY	10	Tyrocidine A, TrcA	Not available		Not found	Bacillus subtilis; Bacillus aneurinolyticus; Bacillus brevis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=14 µM); HeLa (LC50=21 µM)	Human erythrocytes: 50% Hemolysis=4.5 µM	Cyclic	Free	Free	X=Orn; f=D-Phe	Mix	Not available	Not available	17462586	Biochim Biophys Acta. 2007 Jun;1768(6):1488-97	Rautenbach M, Vlok NM, Stander M, Hoppe HC.	Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis	
DRAMP33181	VKLfPFfNQY	10	Tyrocidine A1, TrcA1	Not available		Not found	Bacillus aneurinolyticus; Bacillus brevis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=12 µM); HeLa (LC50=15 µM)	Human erythrocytes: 50% Hemolysis=4.1 µM	Cyclic	Free	Free	f=D-Phe	Mix	Not available	Not available	17462586	Biochim Biophys Acta. 2007 Jun;1768(6):1488-97	Rautenbach M, Vlok NM, Stander M, Hoppe HC.	Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP33182	VXLfPWfNQY	10	Tyrocidine B, TrcB	Not available		Not found	Bacillus aneurinolyticus; Bacillus brevis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=12 µM); HeLa (LC50=17 µM)	Human erythrocytes: 50% Hemolysis=2.6 µM	Cyclic	Free	Free	X=Orn; f=D-Phe	Mix	Not available	Not available	17462586	Biochim Biophys Acta. 2007 Jun;1768(6):1488-97	Rautenbach M, Vlok NM, Stander M, Hoppe HC.	Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis	
DRAMP33183	VKLfPWfNQY	10	Tyrocidine B1, TrcB1	Not available		Not found	Bacillus aneurinolyticus; Bacillus brevis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=24 µM); HeLa (LC50=28 µM)	Human erythrocytes: 50% Hemolysis=8.6 µM	Cyclic	Free	Free	f=D-Phe	Mix	Not available	Not available	17462586	Biochim Biophys Acta. 2007 Jun;1768(6):1488-97	Rautenbach M, Vlok NM, Stander M, Hoppe HC.	Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP33184	VXLfPWwNQY	10	Tyrocidine C, TrcC	Not available		Not found	Bacillus aneurinolyticus; Bacillus brevis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=12 µM); HeLa (LC50=13 µM)	Human erythrocytes: 50% Hemolysis=3.2 µM	Cyclic	Free	Free	X=Orn; f=D-Phe	Mix	Not available	Not available	17462586	Biochim Biophys Acta. 2007 Jun;1768(6):1488-97	Rautenbach M, Vlok NM, Stander M, Hoppe HC.	Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis	
DRAMP33185	VKLfPWwNQY	10	Tyrocidine C1, TrcC1	Not available		Not found	Bacillus aneurinolyticus; Bacillus brevis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=12 µM); HeLa (LC50=16 µM)	Human erythrocytes: 50% Hemolysis=5.4 µM	Cyclic	Free	Free	f=D-Phe	Mix	Not available	Not available	17462586	Biochim Biophys Acta. 2007 Jun;1768(6):1488-97	Rautenbach M, Vlok NM, Stander M, Hoppe HC.	Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP33186	FLPILASLAAKFGPKLFXLVTKKX	24	DC-brevinin-1BYa, peak 1 (cis)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=4 μM ); MDA-MB-231 (LC50=7 μM )	Human erythrocytes: LC50=4 μM 	Cyclic	Free	Free	X=Allylglycine	L	Not available	Not available	21312033	Eur Biophys J. 2011 Apr;40(4):555-64.	Hossain MA, Guilhaudis L, Sonnevend A, Attoub S, van Lierop BJ, Robinson AJ, Wade JD, Conlon JM.	Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa	
DRAMP33187	FLPILASLAAKFGPKLFXLVTKKX	24	DC-brevinin-1BYa, peak 1 (cis)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Human erythrocytes: LC50=4 μM 	Cyclic	Free	Free	X=Allylglycine	L	Not available	Not available	21312033	Eur Biophys J. 2011 Apr;40(4):555-64.	Hossain MA, Guilhaudis L, Sonnevend A, Attoub S, van Lierop BJ, Robinson AJ, Wade JD, Conlon JM.	Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa	
DRAMP33188	FLPILASLAAKFGPKLFXLVTKKX	24	DC-brevinin-1BYa, peak 2 (trans)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=4 μM ); MDA-MB-231 (LC50=7 μM )	Human erythrocytes: LC50=4 μM 	Cyclic	Free	Free	X=Allylglycine	L	Not available	Not available	21312033	Eur Biophys J. 2011 Apr;40(4):555-64.	Hossain MA, Guilhaudis L, Sonnevend A, Attoub S, van Lierop BJ, Robinson AJ, Wade JD, Conlon JM.	Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa	
DRAMP33189	FLPILASLAAKFGPKLFXLVTKKX	24	DC-brevinin-1BYa, peak 2 (trans)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Human erythrocytes: LC50=4 μM 	Cyclic	Free	Free	X=Allylglycine	L	Not available	Not available	21312033	Eur Biophys J. 2011 Apr;40(4):555-64.	Hossain MA, Guilhaudis L, Sonnevend A, Attoub S, van Lierop BJ, Robinson AJ, Wade JD, Conlon JM.	Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa	
DRAMP33190	FLPILASLAAKFGPKLFSLVTKKS	24	[Ser18,Ser24]-brevinin-1BYa	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=10 μM ); MDA-MB-231 (LC50=13 μM )	Human erythrocytes: LC50=75 μM 	Cyclic	Free	Free		L	Not available	Not available	21312033	Eur Biophys J. 2011 Apr;40(4):555-64.	Hossain MA, Guilhaudis L, Sonnevend A, Attoub S, van Lierop BJ, Robinson AJ, Wade JD, Conlon JM.	Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C
DRAMP33191	GQSQWRDVCRNFMRR	15	Granulysin (37-51) [R38Q][R40Q]	P22749		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (Not active at 20 µM)	Not available	Linear	Free	Free		L	Not available	Not available	10903754	J Immunol. 2000 Aug 1;165(3):1486-90. 	Wang Z, Choice E, Kaspar A, Hanson D, Okada S, Lyu SC, Krensky AM, Clayberger C. 	Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin	CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP33192	FLSLIPHIVSGVASLAKHF	19	PLS-S2	Not available		Not found	Phyllomedusa sauvagii	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=22.5 µM)	Human erythrocytes: LC50=25 µM	Linear	Free	Amidation		L	Not available	Not available	23967105	 PLoS One. 2013 Aug 13;8(8):e70782. 	Raja Z, André S, Piesse C, Sereno D, Nicolas P, Foulon T, Oury B, Ladram A. 	Structure, antimicrobial activities and mode of interaction with membranes of novel [corrected] phylloseptins from the painted-belly leaf frog, Phyllomedusa sauvagii	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C
DRAMP33193	FLSMIPHIVSGVAALAKHL	19	PLS-S4	Not available		Not found	Phyllomedusa sauvagii	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (IC50=23 µM)	Human erythrocytes: LC50=33 µM	Linear	Free	Amidation		L	Not available	Not available	23967105	 PLoS One. 2013 Aug 13;8(8):e70782. 	Raja Z, André S, Piesse C, Sereno D, Nicolas P, Foulon T, Oury B, Ladram A. 	Structure, antimicrobial activities and mode of interaction with membranes of novel [corrected] phylloseptins from the painted-belly leaf frog, Phyllomedusa sauvagii	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C
DRAMP33194	KTCENLADTYKGPCFTTGSCDDHCKNKEHLRSGRCRDDFRCWCTKNC	47	PvD1, Defensin D1	V7BTW4##F8QXP9		Not found	Phaseolus vulgaris	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50=0.82±0.14 µM)	Not available	Cyclic	Free	Free		L	MCF-10a: 50% Cell death=7 µM	Not available	29076508	Nanoscale. 2017 Nov 9;9(43):16887-16899.	Figueira TN, Oliveira FD, Almeida I, Mello ÉO, Gomes VM, Castanho MARB, Gaspar D.	Challenging metastatic breast cancer with the natural defensin PvD1	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP33195	GFSSIFRGVAKFASKGLGKKLAKLGVKLVACKISKQC	37	Esculentin-2CHa [D20K,D27K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=3 μM )	Human erythrocytes: 50% Hemolysis=11 µM	Linear	Free	Free		L	Not available	Not available	23159562	 Peptides. 2013 Jan;39:95-102. 	Attoub S, Mechkarska M, Sonnevend A, Radosavljevic G, Jovanovic I, Lukic ML, Conlon JM.	Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O
DRAMP33196	GFSSIFRGVAKFASKGLGKDLAKLGVDLVASKISKQS	37	Esculentin-2CHa [C31S, C37S]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=26 μM )	Human erythrocytes: 50% Hemolysis>200 µM	Linear	Free	Free		L	Not available	Not available	23159562	 Peptides. 2013 Jan;39:95-102. 	Attoub S, Mechkarska M, Sonnevend A, Radosavljevic G, Jovanovic I, Lukic ML, Conlon JM.	Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O
DRAMP33197	RGVAKFASKGLGKDLAKLGVDLVACKISKQC	31	Esculentin-2CHa (7–37)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50>100 μM )	Human erythrocytes: 50% Hemolysis>200 µM	Cyclic	Free	Free		L	Not available	Not available	23159562	 Peptides. 2013 Jan;39:95-102. 	Attoub S, Mechkarska M, Sonnevend A, Radosavljevic G, Jovanovic I, Lukic ML, Conlon JM.	Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O
DRAMP33198	KPPPWVPV	8	PsT-1	C0HJF6		Not found	Phyllomedusa sauvagii	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: DU145 (~25% Cell death=10 µM); PC-3 (~25% Cell death=10 µM); LNCaP (~50% Cell death=10 µM)	Horse erythrocytes: Not active up to 160 µM	Linear	Free	Free		L	Not available	Not available	23518460	ACS Chem Biol. 2013 Apr 19;8(4):778-88. 	Dutta S, Chen TS, Keating AE. 	PsT-1: a new tryptophyllin peptide from the skin secretion of Waxy Monkey Leaf Frog, Phyllomedusa sauvagei	CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
DRAMP33199	GIPCGESCVYIPCTVTALLGCSCKDKVCYKN	31	Cliotides T12, CT12	C0HKG2		Not found	Clitoria ternatea	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=0.78 µM )	Not available	Cyclic	Free	Free		L	Not available	Not available	23419988	Oncol Lett. 2013 Feb;5(2):641-644.	Sen Z, Zhan XK, Jing J, Yi Z, Wanqi Z.	Chemosensitizing activities of cyclotides from Clitoria ternatea in paclitaxel-resistant lung cancer cells	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@H](C)CC)C(C)C
DRAMP33200	GSVIKCGESCLLGKCYTPGCTCSRPICKKD	30	Cliotides T19, CT19	Not available		Not found	Clitoria ternatea	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=9.59 µM )	Not available	Cyclic	Free	Free		L	Not available	Not available	23419988	Oncol Lett. 2013 Feb;5(2):641-644.	Sen Z, Zhan XK, Jing J, Yi Z, Wanqi Z.	Chemosensitizing activities of cyclotides from Clitoria ternatea in paclitaxel-resistant lung cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O
DRAMP33201	GSAIRCGESCLLGKCYTPGCTCDRPICKKN	30	Cliotides T20, CT20	Not available		Not found	Clitoria ternatea	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>10 µM )	Not available	Cyclic	Free	Free		L	Not available	Not available	23419988	Oncol Lett. 2013 Feb;5(2):641-644.	Sen Z, Zhan XK, Jing J, Yi Z, Wanqi Z.	Chemosensitizing activities of cyclotides from Clitoria ternatea in paclitaxel-resistant lung cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O
DRAMP33202	GNPANPLNLKKHHGVFCDVCKALVEGGEKVGDDDLDAWLDVNIGTLCWTMLLPLHHECEEELKKVKKELKKDIENKDSPDKACKDVDLC	89	SPP-1	Q22291		Not found	Caenorhabditis elegans	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (Low active up to 10 µM )	Not available	Cyclic	Free	Free		L	Not available	Not available	22519640	 Biochem J. 2012 Jul 15;445(2):205-12. 	Hoeckendorf A, Stanisak M, Leippe M. 	The saposin-like protein SPP-12 is an antimicrobial polypeptide in the pharyngeal neurons of Caenorhabditis elegans and participates in defence against a natural bacterial pathogen	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O
DRAMP33203	GSHGAFCHLCEDLIKDGKEAGDVALDVWLDEEIGSRCKDFGVLASECFKELKVAEHDIWEAIDQEIPEDKTCKEAKLC	78	SPP-12	Q9XVI5		Not found	Caenorhabditis elegans	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Jurkat (Low active up to 10 µM )	Not available	Cyclic	Free	Free		L	Not available	Not available	22519640	 Biochem J. 2012 Jul 15;445(2):205-12. 	Hoeckendorf A, Stanisak M, Leippe M. 	The saposin-like protein SPP-12 is an antimicrobial polypeptide in the pharyngeal neurons of Caenorhabditis elegans and participates in defence against a natural bacterial pathogen	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)CN)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC)C(C)C)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@H](C)CC
DRAMP33204	RRQRRTSKLMKRGGKLAKLAKKLAKLAKLAK	31	DP1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	It is possible that the DP1 fusion peptide can be used to facilitate an immune response against tumor antigens by triggering massive apoptosis within tumors	Tumor cells: Clinical isolate 22B (LC50<50 μM ); Clinical isolate 4129 (LC50<50 μM ); MCA 205 (LC50<50 μM )	Not available	Linear	Free	Free		L	Not available	Not available	11691780	Cancer Res. 2001 Nov 1;61(21):7709-12.	Mai JC, Mi Z, Kim SH, Ng B, Robbins PD.	A proapoptotic peptide for the treatment of solid tumors	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33205	KRIIQRILSRNS	12	PTD-1, Protein transduction domain 1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	11020349	Mol Ther. 2000 Oct;2(4):339-47.	Mi Z, Mai J, Lu X, Robbins PD. 	Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O
DRAMP33206	KRIHPRLTRSIR	12	PTD-2, Protein transduction domain 2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	11020349	Mol Ther. 2000 Oct;2(4):339-47.	Mi Z, Mai J, Lu X, Robbins PD. 	Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP33207	PPRLRKRRQLNM	12	PTD-3, Protein transduction domain 3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	11020349	Mol Ther. 2000 Oct;2(4):339-47.	Mi Z, Mai J, Lu X, Robbins PD. 	Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo	CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(=O)O
DRAMP33208	PIRRRKKLRRLK	12	PTD-4, Protein transduction domain 4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	11020349	Mol Ther. 2000 Oct;2(4):339-47.	Mi Z, Mai J, Lu X, Robbins PD. 	Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33209	MHKRPTTPSRKM	12	PTD-6, Protein transduction domain 6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	11020349	Mol Ther. 2000 Oct;2(4):339-47.	Mi Z, Mai J, Lu X, Robbins PD. 	Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo	CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP33210	klaklakklaklak	14	D-PAP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LD50>256 µg/ml; 12% Killing=250 µg/ml)	Not available	Linear	Free	Free		D	Not available	Not available	33335804	PeerJ. 2020 Nov 30;8:e10176.	Ohno MK, Kirikae T, Yoshihara E, Kirikae F, Ishida I.	Addition of L-cysteine to the N- or C-terminus of the all-D-enantiomer [D(KLAKLAK)2] increases antimicrobial activities against multidrug-resistant Pseudomonas aeruginosa, Acinetobacter baumannii and Escherichia coli	CC(C)C[C@@H](NC(=O)[C@H](N)CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)O
DRAMP33211	Cklaklakklaklak	15	C-D-PAP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LD50>256 µg/ml; 32% Killing=250 µg/ml)	Not available	Linear	Free	Free	k=D-Lys; l=D-Leu; a=D-Ala	Mix	Not available	Not available	33335804	PeerJ. 2020 Nov 30;8:e10176.	Ohno MK, Kirikae T, Yoshihara E, Kirikae F, Ishida I.	Addition of L-cysteine to the N- or C-terminus of the all-D-enantiomer [D(KLAKLAK)2] increases antimicrobial activities against multidrug-resistant Pseudomonas aeruginosa, Acinetobacter baumannii and Escherichia coli	CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)O
DRAMP33212	klaklakklaklakC	15	D-PAP-C	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LD50=192 µg/ml)	Not available	Linear	Free	Free	k=D-Lys; l=D-Leu; a=D-Ala	Mix	Not available	Not available	33335804	PeerJ. 2020 Nov 30;8:e10176.	Ohno MK, Kirikae T, Yoshihara E, Kirikae F, Ishida I.	Addition of L-cysteine to the N- or C-terminus of the all-D-enantiomer [D(KLAKLAK)2] increases antimicrobial activities against multidrug-resistant Pseudomonas aeruginosa, Acinetobacter baumannii and Escherichia coli	CC(C)C[C@@H](NC(=O)[C@H](N)CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
DRAMP33213	GLWNSIKIAGKKLFVNVLDKIR	22	GL-22	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=128.89 μM); NCI-H838 (IC50=25.25 μM); U-251MG (IC50=40.58 μM); H157 (IC50=9.36 μM)	Horse erythrocytes: 10% Hemolysis=87.304 µM; 50% Hemolysis=254.11 µM	Linear	Free	Amidation		L	Human keratinocytes HaCat: IC50=38.90 µM	Not available	36009917	Antibiotics (Basel). 2022 Aug 3;11(8):1048. 	Liu S, Lin Y, Liu J, Chen X, Ma C, Xi X, Zhou M, Chen T, Burrows JF, Wang L. 	Targeted Modification and Structure-Activity Study of GL-29, an Analogue of the Antimicrobial Peptide Palustrin-2ISb	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)C(C)C)C(C)C
DRAMP33214	XLPICGETCVLGTCYTPGCRCQYPICVR	28	Linear Cyclotide Panitide L1	K9Y490		Not found	Steinchisma laxum (Panicum laxum)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=4.1 µM)	Not available	Cyclic	Free	Free	X=PYA (Pyroglutamic acid)	L	Not available	Not available	23195955	J Biol Chem. 2013 Feb 1;288(5):3370-80	Nguyen GK, Lian Y, Pang EW, Nguyen PQ, Tran TD, Tam JP.	Discovery of linear cyclotides in monocot plant Panicum laxum of Poaceae family provides new insights into evolution and distribution of cyclotides in plants	
DRAMP33215	XLPICGETCVLGRCYTPNCRCQYPICVR	28	Linear Cyclotide Panitide L2	K9Y2Z0		Not found	Steinchisma laxum (Panicum laxum)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=6 µM)	Not available	Cyclic	Free	Free	X=PYA (Pyroglutamic acid)	L	Not available	Not available	23195955	J Biol Chem. 2013 Feb 1;288(5):3370-80	Nguyen GK, Lian Y, Pang EW, Nguyen PQ, Tran TD, Tam JP.	Discovery of linear cyclotides in monocot plant Panicum laxum of Poaceae family provides new insights into evolution and distribution of cyclotides in plants	
DRAMP33216	XAFCGETCLLGKCYTPGCSCHTGICLK	27	Linear Cyclotide Panitide L3	Not available		Not found	Steinchisma laxum (Panicum laxum)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50>10 µM)	Not available	Cyclic	Free	Free	X=PYA (Pyroglutamic acid)	L	Not available	Not available	23195955	J Biol Chem. 2013 Feb 1;288(5):3370-80	Nguyen GK, Lian Y, Pang EW, Nguyen PQ, Tran TD, Tam JP.	Discovery of linear cyclotides in monocot plant Panicum laxum of Poaceae family provides new insights into evolution and distribution of cyclotides in plants	
DRAMP33217	XAFCGETCLLGTCYTPGCRCTAGICLK	27	Linear Cyclotide Panitide L4	K9Y385		Not found	Steinchisma laxum (Panicum laxum)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50>10 µM)	Not available	Cyclic	Free	Free	X=PYA (Pyroglutamic acid)	L	Not available	Not available	23195955	J Biol Chem. 2013 Feb 1;288(5):3370-80	Nguyen GK, Lian Y, Pang EW, Nguyen PQ, Tran TD, Tam JP.	Discovery of linear cyclotides in monocot plant Panicum laxum of Poaceae family provides new insights into evolution and distribution of cyclotides in plants	
DRAMP33218	XLPICGETCVLGTCYTPGCSCAYPICAR	28	Linear Cyclotide Panitide L5	Not available		Not found	Steinchisma laxum (Panicum laxum)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=10 µM)	Not available	Cyclic	Free	Free	X=PYA (Pyroglutamic acid)	L	Not available	Not available	23195955	J Biol Chem. 2013 Feb 1;288(5):3370-80	Nguyen GK, Lian Y, Pang EW, Nguyen PQ, Tran TD, Tam JP.	Discovery of linear cyclotides in monocot plant Panicum laxum of Poaceae family provides new insights into evolution and distribution of cyclotides in plants	
DRAMP33219	XLPICGETCVLGTCYTPGCSCAYPICVR	28	Linear Cyclotide Panitide L6	K9Y572		Not found	Steinchisma laxum (Panicum laxum)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=5.7 µM)	Not available	Cyclic	Free	Free	X=PYA (Pyroglutamic acid)	L	Not available	Not available	23195955	J Biol Chem. 2013 Feb 1;288(5):3370-80	Nguyen GK, Lian Y, Pang EW, Nguyen PQ, Tran TD, Tam JP.	Discovery of linear cyclotides in monocot plant Panicum laxum of Poaceae family provides new insights into evolution and distribution of cyclotides in plants	
DRAMP33220	XAFCGETCVLGTCYTPGCSCNFGICLK	27	Linear Cyclotide Panitide L7	Not available		Not found	Steinchisma laxum (Panicum laxum)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=7.7 µM)	Not available	Cyclic	Free	Free	X=PYA (Pyroglutamic acid)	L	Not available	Not available	23195955	J Biol Chem. 2013 Feb 1;288(5):3370-80	Nguyen GK, Lian Y, Pang EW, Nguyen PQ, Tran TD, Tam JP.	Discovery of linear cyclotides in monocot plant Panicum laxum of Poaceae family provides new insights into evolution and distribution of cyclotides in plants	
DRAMP33221	XDCGETCVLGTCYTPGCSCSAYPLCV	26	Linear Cyclotide Panitide L8	Not available		Not found	Steinchisma laxum (Panicum laxum)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50>10 µM)	Not available	Cyclic	Free	Free	X=PYA (Pyroglutamic acid)	L	Not available	Not available	23195955	J Biol Chem. 2013 Feb 1;288(5):3370-80	Nguyen GK, Lian Y, Pang EW, Nguyen PQ, Tran TD, Tam JP.	Discovery of linear cyclotides in monocot plant Panicum laxum of Poaceae family provides new insights into evolution and distribution of cyclotides in plants	
DRAMP33222	FLGALFHALSHLL	13	PTP-7c	P80399		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PANC-1 (IC50>120 μM ); A549 (IC50>160 μM )	Human erythrocytes: 0% Hemolysis=30 µM	Linear	Free	Free		L	MCF-10A: IC50>120 μM	Not available	22526264	Arch Microbiol. 2012 Sep;194(9):769-78. 	Kharidia R, Tu Z, Chen L, Liang JF.	Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP33223	FLGALWKALSKLL	13	LL-1	P80399		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=9 μM ); PANC-1 (IC50=9 μM )	Human erythrocytes: 41% Hemolysis=30 µM	Linear	Free	Free		L	MCF-10A: IC50=9 μM	Not available	22526264	Arch Microbiol. 2012 Sep;194(9):769-78. 	Kharidia R, Tu Z, Chen L, Liang JF.	Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP33224	FLGALWHALSKLL	13	LL-1a	P80399		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=22 μM ); PANC-1 (IC50=39 μM )	Human erythrocytes: 15% Hemolysis=30 µM	Linear	Free	Free		L	MCF-10A: IC50=65 μM	Not available	22526264	Arch Microbiol. 2012 Sep;194(9):769-78. 	Kharidia R, Tu Z, Chen L, Liang JF.	Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP33225	FLGALWKALSHLL	13	LL-1b	P80399		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=31 μM ); PANC-1 (IC50=54 μM )	Human erythrocytes: 15% Hemolysis=30 µM	Linear	Free	Free		L	MCF-10A: IC50=49 μM	Not available	22526264	Arch Microbiol. 2012 Sep;194(9):769-78. 	Kharidia R, Tu Z, Chen L, Liang JF.	Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP33226	FLGALWHALSHLL	13	LL-1c	P80399		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=59 μM ); PANC-1 (IC50>120 μM )	Human erythrocytes: 0% Hemolysis=30 µM	Linear	Free	Free		L	MCF-10A: IC50>120 μM	Not available	22526264	Arch Microbiol. 2012 Sep;194(9):769-78. 	Kharidia R, Tu Z, Chen L, Liang JF.	Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP33227	PAWHHAFHWAWRMLKKAA	18	L5a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=19 ± 3 μM(pH=7.4); IC50=10 ± 2 μM(pH=5.5))	Not available	Linear	Free	Free		L	CHO: IC50=13 ± 2 μM(pH=7.4); IC50=8 ± 1 μM(pH=5.5)	Not available	19464332	Peptides. 2009 Aug;30(8):1523-8.	Tu Z, Volk M, Shah K, Clerkin K, Liang JF. 	Constructing bioactive peptides with pH-dependent activities	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP33228	PAWRKAFRWAWHMLHHAA	18	L5b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=12 ± 2 μM(pH=7.4); IC50=7 ± 2 μM(pH=5.5))	Not available	Linear	Free	Free		L	CHO: IC50=12 ± 1 μM(pH=7.4); IC50=6 ± 2 μM(pH=5.5)	Not available	19464332	Peptides. 2009 Aug;30(8):1523-8.	Tu Z, Volk M, Shah K, Clerkin K, Liang JF. 	Constructing bioactive peptides with pH-dependent activities	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP33229	PAWRHAFHWAWHMLHKAA	18	L5c	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>80 μM(pH=7.4); IC50=12 ± 2 μM(pH=5.5))	Not available	Linear	Free	Free		L	CHO: IC50=67 ± 3 μM(pH=7.4); IC50=7 ± 2 μM(pH=5.5)	Not available	19464332	Peptides. 2009 Aug;30(8):1523-8.	Tu Z, Volk M, Shah K, Clerkin K, Liang JF. 	Constructing bioactive peptides with pH-dependent activities	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP33230	GLFAVIHKVASVIGGL	16	Citropin-a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=56±3 μM(pH=7.4); IC50=44±3 μM(pH=5.5))	Not available	Linear	Free	Free		L	CHO: IC50=78 ± 2 μM(pH=7.4); IC50=47 ± 3 μM(pH=5.5)	Not available	19464332	Peptides. 2009 Aug;30(8):1523-8.	Tu Z, Volk M, Shah K, Clerkin K, Liang JF. 	Constructing bioactive peptides with pH-dependent activities	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33231	GLFAVIKHVASVIGGL	16	Citropin-b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=97 ± 4 μM(pH=7.4); IC50=61±3 μM(pH=5.5))	Not available	Linear	Free	Free		L	CHO: IC50=76 ± 4 μM(pH=7.4); IC50=41 ± 5 μM(pH=5.5)	Not available	19464332	Peptides. 2009 Aug;30(8):1523-8.	Tu Z, Volk M, Shah K, Clerkin K, Liang JF. 	Constructing bioactive peptides with pH-dependent activities	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33232	GLFAVIHHVASVIGGL	16	Citropin-c	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=156 ± 7 μM(pH=7.4); IC50=36 ± 2 μM(pH=5.5))	Not available	Linear	Free	Free		L	CHO: IC50>120 μM(pH=7.4); IC50>120 μM(pH=5.5)	Not available	19464332	Peptides. 2009 Aug;30(8):1523-8.	Tu Z, Volk M, Shah K, Clerkin K, Liang JF. 	Constructing bioactive peptides with pH-dependent activities	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33241	KRKILILIKRK	11	M1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM )	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33242	KRKILILILIL	11	M2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM )	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33243	ILILILILKRK	11	M3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP33244	KRKILILIGSG	11	M4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)O
DRAMP33245	GSGILILIKRK	11	M5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC
DRAMP33246	KRKSGSGSKRK	11	M6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33247	KRKRKILILIKRK	13	N1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50=36 µm)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33248	RKRKILILIKRK	12	N2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33249	RKILILIKRK	10	N3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33250	KILILIKRK	9	N4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50=58 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33251	ILILIKRK	8	N5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC
DRAMP33252	LILIKRK	7	N6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33253	ILIKRK	6	N7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC
DRAMP33254	LIKRK	5	N8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33255	KRKILILIKRKRK	13	C1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50=61 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33256	KRKILILIKRKR	12	C2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP33257	KRKILILIKR	10	C3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP33258	KRKILILIK	9	C4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33259	KRKILILI	8	C5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP33260	KRKILIL	7	C6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33261	KRKILI	6	C7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)O
DRAMP33262	KRKIL	5	C8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33263	KRKILILILIKRK	13	H1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33264	KRKLILIKRK	10	H2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33265	KRKILIKRK	9	H3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33266	KRKLIKRK	8	H4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33267	KRKIKRK	7	H5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33268	KRKKRK	6	H6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33269	KRKGKRK	7	H7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33270	KRKGSGKRK	9	H8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33271	RKRKLILILIKRKR	14	A1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP33272	KRKLILKRILIKRK	14	A2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC
DRAMP33273	RKLILKRKRILIKR	14	A3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP33274	KLILKRKRKRILIK	14	A4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33275	LILKRKRKRKRILI	14	A5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP33276	RRRIIIIIRRR	11	S1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP33277	KKKIIIIIKKK	11	S2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP33278	RRRLLLLLRRR	11	S3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP33279	KKKLLLLLKKK	11	S4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33280	RRRVVVVVRRR	11	S5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP33281	KKKVVVVVKKK	11	S6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP33282	RRRFFFFFRRR	11	S7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP33283	KKKFFFFFKKK	11	S8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP33284	KKKIIIIIIKKK	12	O1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (LD50>64 µM)	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M.	Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP33285	XGLXGGLXGIX	11	Trichogin GA IV, TG	Not available		Not found	Trichoderma longibrachiatum	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=2 μM); HeLa  (EC50=8 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=4 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33286	XGLXGGLXGIX	11	Trichogin GA IV, TG	Not available		Not found	Trichoderma longibrachiatum	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=4 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33287	XGLXGGLXGIX	11	Trichogin GA IV, TG	Not available		Not found	Trichoderma longibrachiatum	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=8 μM); HeLa  (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=4 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33288	XGLXGGLXGIX	11	Trichogin GA IV, TG	Not available		Not found	Trichoderma longibrachiatum	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=13 μM); HeLa  (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=4 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33289	XGLXGGLXGIX	11	Trichogin GA IV, TG	Not available		Not found	Trichoderma longibrachiatum	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=4 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33290	XGLXGGLXGIX	11	[TOAC1] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=2 μM); HeLa  (EC50=8 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=5 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33291	XGLXGGLXGIX	11	[TOAC1] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=5 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33292	XGLXGGLXGIX	11	[TOAC1] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=8 μM); HeLa  (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=5 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33293	XGLXGGLXGIX	11	[TOAC1] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=13 μM); HeLa  (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=5 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33294	XGLXGGLXGIX	11	[TOAC1] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=5 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33295	XGLXGKLXGIX	11	[Lys6] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (EC50=2 μM); T67 (EC50=4 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=2 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33296	XGLXGKLXGIX	11	[Lys6] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=2 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33297	XGLXGKLXGIX	11	[Lys6] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=2 μM 	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33298	XGLXGKLXGIX	11	[TOAC1, Lys6] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (EC50=2 μM); T67 (EC50=4 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=5 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33299	XGLXGKLXGIX	11	[TOAC1, Lys6] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=5 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33300	XGLXGKLXGIX	11	[TOAC1, Lys6] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=5 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33301	XRLXGGLXGIX	11	[Arg2] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (EC50=4 μM); T67 (EC50=8 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=8 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33302	XRLXGGLXGIX	11	[Arg2] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=8 μM); HeLa  (EC50=9 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=8 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33303	XRLXGGLXGIX	11	[TOAC1, Arg2] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (EC50=4 μM); T67 (EC50=8 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=15 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33304	XRLXGGLXGIX	11	[TOAC1, Arg2] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=8 μM); HeLa  (EC50=9 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=15 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33305	XGLXGGLXRIX	11	[TOAC1, Arg9] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (EC50=5 μM); T67 (EC50=8 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=8 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33306	XGLXKKLXGIX	11	[Lys5,6] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (EC50=10 μM); T67 (EC50=7 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=15 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33307	XGLXKKLXGIX	11	[Lys5,6] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=10 μM); HeLa  (EC50=6 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=15 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33308	XGLXKKLXGIX	11	[TOAC1, Lys5,6] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (EC50=10 μM); T67 (EC50=7 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=15 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33309	XGLXKKLXGIX	11	[TOAC1, Lys5,6] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=10 μM); HeLa  (EC50=6 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: EC50=15 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33310	XGLXGGLXGIX	11	[TOAC1, Api4] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=2 μM); HeLa  (EC50=8 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4)=Api; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33311	XGLXGGLXGIX	11	[TOAC1, Api4] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4)=Api; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33312	XGLXGGLXGIX	11	[TOAC1, Api4] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=8 μM); HeLa  (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4)=Api; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33313	XGLXGGLXGIX	11	[TOAC1, Api4] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=13 μM); HeLa  (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4)=Api; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33314	XGLXGGLXGIX	11	[TOAC1, Api4] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4)=Api; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33315	XGLXGGLXGIX	11	[Api8] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=2 μM); HeLa  (EC50=8 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4)=Aib; X(8)=Api; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33316	XGLXGGLXGIX	11	[Api8] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4)=Aib; X(8)=Api; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33317	XGLXGGLXGIX	11	[Api8] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=8 μM); HeLa  (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4)=Aib; X(8)=Api; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33318	XGLXGGLXGIX	11	[Api8] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=13 μM); HeLa  (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4)=Aib; X(8)=Api; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33319	XGLXGGLXGIX	11	[Api8] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4)=Aib; X(8)=Api; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33320	XGLLGGLXGIX	11	[Leu4] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 20 μM); T67 (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33321	XGLLGGLXGIX	11	[Leu4] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 20 μM); T67 (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33322	XGLLGGLXGIX	11	[TOAC1, Leu4] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 20 μM); T67 (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33323	XGLLGGLXGIX	11	[TOAC1, Leu4] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 20 μM); T67 (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33324	XGLXGGLLGIX	11	[TOAC1, Leu8] TG	Not available		Not found	Synthetic (Derived from TG)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 20 μM); T67 (Not active up to 20 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1)=TOAC; X(4)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Human dermal fibroblasts: Not active up to 20 μM	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL. 	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP33325	GFKDLLKKAAKALVKTVLF	19	[Lys8] Ascaphin-8	P0CJ32		Not found	Synthetic (Derived from Ascaphin-8)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=8 µM)	Human erythrocytes: LC50=11 µM	Linear	Free	Amidation		L	L929 fibroblast-derived cells: LC50=5 µM	Not available	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E. 	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O)C(C)C
DRAMP33326	GFKDLLKGAKKALVKTVLF	19	[Lys10] Ascaphin-8	P0CJ32		Not found	Synthetic (Derived from Ascaphin-8)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50>200 µM)	Human erythrocytes: LC50>500 µM	Linear	Free	Amidation		L	L929 fibroblast-derived cells: LC50>200 µM	Not available	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E. 	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O)C(C)C
DRAMP33327	GFKDLLKGAAKALKKTVLF	19	[Lys14] Ascaphin-8	P0CJ32		Not found	Synthetic (Derived from Ascaphin-8)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=200 µM)	Human erythrocytes: LC50>500 µM	Linear	Free	Amidation		L	L929 fibroblast-derived cells: LC50=110 µM	Not available	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E. 	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O
DRAMP33328	GFKDLLKGAAKALVKTVKF	19	[Lys18] Ascaphin-8	P0CJ32		Not found	Synthetic (Derived from Ascaphin-8)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=200 µM)	Human erythrocytes: LC50>500 µM	Linear	Free	Amidation		L	L929 fibroblast-derived cells: LC50=55 µM	Not available	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E. 	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O)C(C)C
DRAMP33329	GFKDLLKkAAKALVKTVLF	19	[D-Lys8] Ascaphin-8	P0CJ32		Not found	Synthetic (Derived from Ascaphin-8)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=15 µM)	Human erythrocytes: LC50=150 µM	Linear	Free	Amidation		Mix	L929 fibroblast-derived cells: LC50=9 µM	Not available	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E. 	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O)C(C)C
DRAMP33330	GFKDLLKGAkKALVKTVLF	19	[D-Lys10] Ascaphin-8	P0CJ32		Not found	Synthetic (Derived from Ascaphin-8)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50>200 µM)	Human erythrocytes: LC50>500 µm	Linear	Free	Amidation		Mix	L929 fibroblast-derived cells: LC50>200 µM	Not available	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E. 	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O)C(C)C
DRAMP33331	GFKDLLKGAAKALkKTVLF	19	[D-Lys14] Ascaphin-8	P0CJ32		Not found	Synthetic (Derived from Ascaphin-8)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50>200 µM)	Human erythrocytes: LC50>500 µM	Linear	Free	Amidation		Mix	L929 fibroblast-derived cells: LC50=140 µM	Not available	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E. 	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O
DRAMP33332	GFKDLLKGAAKALVKTVkF	19	[D-Lys18] Ascaphin-8	P0CJ32		Not found	Synthetic (Derived from Ascaphin-8)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=140 µM)	Human erythrocytes: LC50>500 µM	Linear	Free	Amidation		Mix	L929 fibroblast-derived cells: LC50=65 µM	Not available	18554256	Chem Biol Drug Des. 2008 Jul;72(1):58-64.	Conlon JM, Galadari S, Raza H, Condamine E. 	Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O)C(C)C
DRAMP33355	NGRKACLNPASPIVKKIIEKMLNS	24	Chemokinostatin-1	P09341		Not found	Homo sapiens (CXCL1/Gro-α)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	CXCR	18307172	 J Cell Biochem. 2008 Jul 1;104(4):1356-63.	Karagiannis ED, Popel AS.	Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)[C@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC
DRAMP33356	NGKKACLNPASPMVQKIIEKIL	22	Chemokinostatin-3	P19876		Not found	Homo sapiens (CXCL3/Gro-γ)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	CXCR	18307172	 J Cell Biochem. 2008 Jul 1;104(4):1356-63.	Karagiannis ED, Popel AS.	Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O
DRAMP33357	NGKEICLDPEAPFLKKVIQKILD	23	Chemokinostatin-5	P42830		Not found	Homo sapiens (CXCL5/ENA-78)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	CXCR	18307172	 J Cell Biochem. 2008 Jul 1;104(4):1356-63.	Karagiannis ED, Popel AS.	Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H](NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)NC(=O)[C@H](CS)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)O
DRAMP33358	NGKQVCLDPEAPFLKKVIQKILDS	24	Chemokinostatin-6	P80162		Not found	Homo sapiens (CXCL6/GCP-2)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	CXCR	18307172	 J Cell Biochem. 2008 Jul 1;104(4):1356-63.	Karagiannis ED, Popel AS.	Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC
DRAMP33359	DGRKICLDPDAPRIKKIVQKKL	22	Chemokinostatin-7	P02775		Not found	Homo sapiens (CXCL7/PBP)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	CXCR	18307172	 J Cell Biochem. 2008 Jul 1;104(4):1356-63.	Karagiannis ED, Popel AS.	Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33360	DGRELCLDPKENWVQRVVEKFLK	23	Chemokinostatin-8	P10145		Not found	Homo sapiens (CXCL8/IL-8)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	CXCR	18307172	 J Cell Biochem. 2008 Jul 1;104(4):1356-63.	Karagiannis ED, Popel AS.	Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)O
DRAMP33361	KILRGVSKKIMRTFLRR	17	N17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 100μg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O
DRAMP33362	KKIMRTFLRR	10	I10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 100μg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O
DRAMP33363	KKIMRTFLRRISKDILTGKK	20	C20	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 100μg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP33364	KKIMRTFLRRISKKILTGKK	20	C20-DK	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 100μg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP33365	KILRGVSKKIMRRISKDILTGKK	23	N23b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 100μg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC
DRAMP33366	KILGVSKKIMRRISKDILTGKK	22	N22b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 100μg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC
DRAMP33367	KISKKIMRTFLRRILTGKK	19	NK19a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (21.1 ± 4.0% Cytotoxicity=100 μg/ml)	Human erythrocytes: 100% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O
DRAMP33368	KILRGVSKKIMRRILTGKK	19	NK19b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 100μg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP33369	RILRGVSRRIMRRILTGRR	19	NK19b-KR	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (6.6 ± 7.9% Cytotoxicity=100 μg/ml)	Human erythrocytes: <10% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP33370	KILRGVSKRILTGKK	15	NK15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 100μg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O
DRAMP33371	KILGVSKRILTGKK	14	NK14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 100μg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O
DRAMP33372	KISKKIMRTFLRR	13	NK13	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (6.4 ± 3.0% Cytotoxicity=100 μg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O
DRAMP33373	ISKRILTGKK	10	NK10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 100μg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC
DRAMP33374	KISKRILTGKK	11	NK11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 100μg/ml)	Human erythrocytes: <5% Hemolysis=100 µg/ml	Linear	Free	Amidation		L	Not available	Not available	17389605	J Biol Chem. 2007 May 18;282(20):14719-28.	Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 	Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O
DRAMP33375	CLB	3	CLB	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CAPAN-1 (IC50=129.0 ± 35.5 µM); MCF-7 (IC50=73.7 ± 4.5 µM)	Not available	Linear	Free	Amidation		L	NIH 3T3: IC50=152.5 ± 5.6 µM	Not available	24480922	Org Biomol Chem. 2014 Mar 14;12(10):1652-63	Soler M, González-Bártulos M, Soriano-Castell D, Ribas X, Costas M, Tebar F, Massaguer A, Feliu L, Planas M.	Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties	
DRAMP33376	CLBCREKA	8	CLB-CREKA	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CAPAN-1 (IC50>200 µM); MCF-7 (IC50>200 µM)	Not available	Linear	Free	Amidation		L	NIH 3T3: IC50>200 µM	Not available	24480922	Org Biomol Chem. 2014 Mar 14;12(10):1652-63	Soler M, González-Bártulos M, Soriano-Castell D, Ribas X, Costas M, Tebar F, Massaguer A, Feliu L, Planas M.	Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties	
DRAMP33377	KWKKLLKKLLKLLKKLLK	18	KLW	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=0.6 µM); SK-OV-3 (IC50=0.6 µM); SK-MEL-2 (IC50=0.7 µM)	Human erythrocytes: 55% Hemolysis=100 µM	Linear	Free	Amidation		L	NIH 3T3: IC50=1.8 µM	Not available	16142907	 Biochemistry. 2005 Sep 13;44(36):12094-106. 	Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. 	Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33378	KWKKLLKKXLKLLKKLLK	18	KLW-L9-Nala	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SK-OV-3 (IC50=1.7 µM); A549 (IC50=2 µM); SK-MEL-2 (IC50=2.1 µM)	Human erythrocytes: 5% Hemolysis=100 µM	Linear	Free	Amidation	X=NAla	L	NIH 3T3: IC50=7.1 µM	Not available	16142907	 Biochemistry. 2005 Sep 13;44(36):12094-106. 	Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. 	Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues	
DRAMP33379	KWKKLLKKLXKLLKKLLK	18	KLW-L10-Nala	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SK-OV-3 (IC50=0.9 µM); A549 (IC50=1 µM); SK-MEL-2 (IC50=1.3 µM)	Human erythrocytes: 23% Hemolysis=100 µM	Linear	Free	Amidation	X=NAla	L	NIH 3T3: IC50=2 µM	Not available	16142907	 Biochemistry. 2005 Sep 13;44(36):12094-106. 	Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. 	Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues	
DRAMP33380	KWKKLLKKLLXLLKKLLK	18	KLW-K11-Nala	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SK-OV-3 (IC50=0.5 µM); A549 (IC50=0.6 µM); SK-MEL-2 (IC50=0.6 µM)	Human erythrocytes: 50% Hemolysis=100 µM	Linear	Free	Amidation	X=NAla	L	NIH 3T3: IC50=1 µM	Not available	16142907	 Biochemistry. 2005 Sep 13;44(36):12094-106. 	Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. 	Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues	
DRAMP33381	KWKKLLKKXLKLXKKLLK	18	KLW-L9,13-Nala	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SK-OV-3 (IC50=31.9 µM); SK-MEL-2 (IC50=38.7 µM); A549 (IC50=75.5 µM)	Human erythrocytes: 0% Hemolysis=100 µM	Linear	Free	Amidation	X=NAla	L	NIH 3T3: IC50>100 µM	Not available	16142907	 Biochemistry. 2005 Sep 13;44(36):12094-106. 	Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. 	Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues	
DRAMP33382	KWKKLLXKLLXLLKKLLK	18	KLW-K7,11-Nala	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SK-OV-3 (IC50=0.7 µM); A549 (IC50=1 µM); SK-MEL-2 (IC50=1.1 µM)	Human erythrocytes: 27% Hemolysis=100 µM	Linear	Free	Amidation	X=NAla	L	NIH 3T3: IC50=2 µM	Not available	16142907	 Biochemistry. 2005 Sep 13;44(36):12094-106. 	Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. 	Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues	
DRAMP33383	RGDfX	5	Cilengitide, EMD 121974	Not available		Not found	RGD Fibronectin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: M21 (IC50 (Cilengitide inhibited integrin-mediated binding to vitronectin) =0.4 µM); UCLA-P3 (IC50 (Cilengitide inhibited integrin-mediated binding to vitronectin) =0.4 µM)	Not available	Cyclic	Free	Free	f=D-Phe	Mix	Not available	Integrins αvβ3, αvβ5	11855984	J Med Chem. 2002 Feb 28;45(5):1045-51	Goodman SL, Hölzemann G, Sulyok GA, Kessler H.	Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins	
DRAMP33384	FQNRRMKWKK	10	Pen10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa WT (50% Cytotoxicity= μM )	Not available	Linear	Free	Amidation		L	Not available	Not available	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-32. 	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM. 	Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33385	WRRRRRRRR	9	WR8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa WT (50% Cytotoxicity=442 ± 66.7 μM )	Human erythrocytes: HD50>128 μM	Linear	Free	Amidation		L	Not available	Not available	23085001	Biochim Biophys Acta. 2013 Feb;1828(2):223-32. 	Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM. 	Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(N)=O
DRAMP33386	GFXGXKKXGXFXGXGKKXKKKK	22	AMP 1A analogs1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=1.9 μM ); RL (IC50=2 μM ); UACC-62 (IC50=2.6 μM ); A498 (IC50=3 μM ); COLO 205 (IC50=5.4 μM ); MCF-7  (IC50=6.2 μM ); A549 (IC50=7.2 μM ); Mia PaCa-2 (IC50=7.3 μM ); CFPAC-1 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM )	Not available	Linear	Acetylation	Amidation	X=A6c (1-aminocyclohexane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33387	GFXGXRXGXFXGXGRXRRRR	20	AMP 1A analogs2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: RL (IC50=1.1 μM ); NCI-H69 (IC50=2 μM ); CFPAC-1 (IC50=2.6 μM ); Mia PaCa-2 (IC50=5 μM ); A498 (IC50=5.6 μM ); IGROV-1 (IC50=6 μM ); A549 (IC50=6.4 μM ); DLD-1 (IC50=6.4 μM ); UACC-62 (IC50=6.4 μM ); COLO 205 (IC50=6.6 μM ); MCF-7  (IC50=7 μM ); PC-3 (IC50=7.4 μM )	Not available	Linear	Acetylation	Amidation	X=A6c (1-aminocyclohexane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33388	GFXGXRXGXFXGXGRXRRRR	20	AMP 1A analogs2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: RL (IC50=3.7 μM); NCI-H69 (IC50=7.1 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X=A6c (1-aminocyclohexane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33389	GFXGXXXGXFXGXGXXXXXX	20	AMP 1A analogs3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=1.7 μM); RL (IC50=2.5 μM); UACC-62 (IC50=3.1 μM); COLO 205 (IC50=3.2 μM); Mia PaCa-2 (IC50=3.6 μM); MCF-7  (IC50=4.6 μM); A498 (IC50=4.7 μM); IGROV-1 (IC50=5.4 μM); CFPAC-1 (IC50=5.9 μM ); DLD-1 (IC50=6.2 μM); A549 (IC50=6.5 μM); PC-3 (IC50=7.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Orn (Ornithine)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33390	GFXGXXXGXFXGXGXXXXXX	20	AMP 1A analogs3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=1.5 μM); RL (IC50=1.7 μM); UACC-62 (IC50=1.9 μM); A498 (IC50=2.1 μM); IGROV-1 (IC50=2.3 μM); A549 (IC50=2.4 μM); DLD-1 (IC50=2.6 μM); CFPAC-1 (IC50=2.7 μM); MCF-7  (IC50=3 μM); Mia PaCa-2 (IC50=4.4 μM); COLO 205 (IC50=6.4 μM); PC-3 (IC50=6.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Orn (Ornithine)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33391	GFXGXXXGXFXGXGXXXXXX	20	AMP 1A analogs3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Orn (Ornithine)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33392	GFXGXXXGXFXGXGXXXXXX	20	AMP 1A analogs4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=1.7 μM); RL (IC50=2.5 μM); UACC-62 (IC50=3.1 μM); COLO 205 (IC50=3.2 μM); Mia PaCa-2 (IC50=3.6 μM); MCF-7  (IC50=4.6 μM); A498 (IC50=4.7 μM); IGROV-1 (IC50=5.4 μM); CFPAC-1 (IC50=5.9 μM ); DLD-1 (IC50=6.2 μM); A549 (IC50=6.5 μM); PC-3 (IC50=7.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dab (Diaminobutyric acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33393	GFXGXXXGXFXGXGXXXXXX	20	AMP 1A analogs4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=1.5 μM); RL (IC50=1.7 μM); UACC-62 (IC50=1.9 μM); A498 (IC50=2.1 μM); IGROV-1 (IC50=2.3 μM); A549 (IC50=2.4 μM); DLD-1 (IC50=2.6 μM); CFPAC-1 (IC50=2.7 μM); MCF-7  (IC50=3 μM); Mia PaCa-2 (IC50=4.4 μM); COLO 205 (IC50=6.4 μM); PC-3 (IC50=6.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dab (Diaminobutyric acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33394	GFXGXXXGXFXGXGXXXXXX	20	AMP 1A analogs4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dab (Diaminobutyric acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33395	GFXGXXXGXFXGXGXXXXXX	20	AMP 1A analogs5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=1.7 μM); RL (IC50=2.5 μM); UACC-62 (IC50=3.1 μM); COLO 205 (IC50=3.2 μM); Mia PaCa-2 (IC50=3.6 μM); MCF-7  (IC50=4.6 μM); A498 (IC50=4.7 μM); IGROV-1 (IC50=5.4 μM); CFPAC-1 (IC50=5.9 μM ); DLD-1 (IC50=6.2 μM); A549 (IC50=6.5 μM); PC-3 (IC50=7.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dpr (Diaminopropionic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33396	GFXGXXXGXFXGXGXXXXXX	20	AMP 1A analogs5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=1.5 μM); RL (IC50=1.7 μM); UACC-62 (IC50=1.9 μM); A498 (IC50=2.1 μM); IGROV-1 (IC50=2.3 μM); A549 (IC50=2.4 μM); DLD-1 (IC50=2.6 μM); CFPAC-1 (IC50=2.7 μM); MCF-7  (IC50=3 μM); Mia PaCa-2 (IC50=4.4 μM); COLO 205 (IC50=6.4 μM); PC-3 (IC50=6.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dpr (Diaminopropionic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33397	GFXGXXXGXFXGXGXXXXXX	20	AMP 1A analogs5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	X(3/5/7/9/11/13/16)=A6c (1-aminocyclohexane carboxylic acid); X(6/15/17/18/19/20)=Dpr (Diaminopropionic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33398	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A498 (IC50>7.5 μM ); A549 (IC50>7.5 μM ); CFPAC-1 (IC50>7.5 μM ); COLO 205 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); MCF-7  (IC50>7.5 μM ); Mia PaCa-2 (IC50>7.5 μM ); NCI-H69 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ); RL (IC50>7.5 μM ); UACC-62 (IC50>7.5 μM )	Not available	Linear	Acetylation	Amidation	X=A5c (1-aminocyclopentane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33399	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: RL (IC50=6.8 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X=A5c (1-aminocyclopentane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33400	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X=A5c (1-aminocyclopentane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33401	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=5.9 μM); RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X=A5c (1-aminocyclopentane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33402	GFXGXRXGXFXGXGRXRRRR	20	AMP 1A analogs7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: RL (IC50=1.1 μM ); NCI-H69 (IC50=2 μM ); CFPAC-1 (IC50=2.6 μM ); Mia PaCa-2 (IC50=5 μM ); A498 (IC50=5.6 μM ); IGROV-1 (IC50=6 μM ); A549 (IC50=6.4 μM ); DLD-1 (IC50=6.4 μM ); UACC-62 (IC50=6.4 μM ); COLO 205 (IC50=6.6 μM ); MCF-7  (IC50=7 μM ); PC-3 (IC50=7.4 μM )	Not available	Linear	Acetylation	Amidation	X=A5c (1-aminocyclopentane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33403	GFXGXRXGXFXGXGRXRRRR	20	AMP 1A analogs7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: RL (IC50=3.7 μM); NCI-H69 (IC50=7.1 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X=A5c (1-aminocyclopentane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33404	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A498 (IC50>7.5 μM ); A549 (IC50>7.5 μM ); CFPAC-1 (IC50>7.5 μM ); COLO 205 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); MCF-7  (IC50>7.5 μM ); Mia PaCa-2 (IC50>7.5 μM ); NCI-H69 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ); RL (IC50>7.5 μM ); UACC-62 (IC50>7.5 μM )	Not available	Linear	Acetylation	Amidation	X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Tic (Tetrahydroisoquinolinecarboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33405	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: RL (IC50=6.8 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Tic (Tetrahydroisoquinolinecarboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33406	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Tic (Tetrahydroisoquinolinecarboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33407	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=5.9 μM); RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Tic (Tetrahydroisoquinolinecarboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33408	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A498 (IC50>7.5 μM ); A549 (IC50>7.5 μM ); CFPAC-1 (IC50>7.5 μM ); COLO 205 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); MCF-7  (IC50>7.5 μM ); Mia PaCa-2 (IC50>7.5 μM ); NCI-H69 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ); RL (IC50>7.5 μM ); UACC-62 (IC50>7.5 μM )	Not available	Linear	Acetylation	Amidation	X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Oic (Octahydroindolecarboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33409	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: RL (IC50=6.8 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Oic (Octahydroindolecarboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33410	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Oic (Octahydroindolecarboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33411	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=5.9 μM); RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/7/11)=A6c (1-aminocyclohexane carboxylic acid); X(5/9/13/16)=Oic (Octahydroindolecarboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33412	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A498 (IC50>7.5 μM ); A549 (IC50>7.5 μM ); CFPAC-1 (IC50>7.5 μM ); COLO 205 (IC50>7.5 μM ); DLD-1 (IC50>7.5 μM ); IGROV-1 (IC50>7.5 μM ); MCF-7  (IC50>7.5 μM ); Mia PaCa-2 (IC50>7.5 μM ); NCI-H69 (IC50>7.5 μM ); PC-3 (IC50>7.5 μM ); RL (IC50>7.5 μM ); UACC-62 (IC50>7.5 μM )	Not available	Linear	Acetylation	Amidation	X(3/7/11)=A5c (1-aminocyclopentane carboxylic acid); X(5/9/13/16)=A6c (1-aminocyclohexane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33413	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: RL (IC50=6.8 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/7/11)=A5c (1-aminocyclopentane carboxylic acid); X(5/9/13/16)=A6c (1-aminocyclohexane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33414	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); NCI-H69 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/7/11)=A5c (1-aminocyclopentane carboxylic acid); X(5/9/13/16)=A6c (1-aminocyclohexane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33415	GFXGXKXGXFXGXGKXKKKK	20	AMP 1A analogs10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=5.9 μM); RL (IC50=6.7 μM); A498 (IC50>7.5 μM); A549 (IC50>7.5 μM); CFPAC-1 (IC50>7.5 μM); COLO 205 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); MCF-7  (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM); UACC-62 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X(3/7/11)=A5c (1-aminocyclopentane carboxylic acid); X(5/9/13/16)=A6c (1-aminocyclohexane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33416	KKKKGFXGXKXGXFXGXGKX	20	AMP 1A analogs11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H69 (IC50=2.2 μM); RL (IC50=3.7 μM); A498 (IC50=4.2 μM); UACC-62 (IC50=6.4 μM); COLO 205 (IC50=6.7 μM); A549 (IC50=7.2 μM); MCF-7  (IC50=7.3 μM); CFPAC-1 (IC50>7.5 μM); DLD-1 (IC50>7.5 μM); IGROV-1 (IC50>7.5 μM); Mia PaCa-2 (IC50>7.5 μM); PC-3 (IC50>7.5 μM)	Not available	Linear	Acetylation	Amidation	X=A6c (1-aminocyclohexane carboxylic acid)	L	Not available	Not available	27387357	Bioorg Med Chem. 2016 Sep 15;24(18):4056-4065.	Hicks RP. 	Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids	
DRAMP33417	KKWWKKWWK	9	peptide 1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=31.0 ± 1.0 µM); A20 (IC50=37.3 ± 1.5 µM)	Not available	Linear	Free	Amidation		L	MRC-5: IC50>357 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP33418	KKXWKKWWK	9	peptide 2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=36.7 ± 9.5 µM); A20 (IC50=51.7 ± 6.5 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=488 ± 52 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33419	KKXWKKWWK	9	peptide 2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=13.0 ± 1.0 µM); IGROV-1 (IC50=13.4 ± 1.6 µM); AT84 (IC50=17.7 ± 3.1 µM); HL-60 (IC50=6.1 ± 1.8 µM); IGROV-1/CDDP (IC50=6.6 ± 2.6 µM); MCF-7  (IC50=6.8 ± 2.8 µM); HL-60/ADR (IC50=7.0 ± 3.7 µM); K562 (IC50=7.2 ± 0.4 µM); K562/Gleevec (IC50=7.9 ± 2.9 µM); MCF-7/mdr (IC50=8.4 ± 2.7 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=488 ± 52 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33420	KKWXKKWWK	9	peptide 3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=24.7 ± 2.3 µM); A20 (IC50=25.7 ± 0.6 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=287 ± 52 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33421	KKWXKKWWK	9	peptide 3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=18.7 ± 1.5 µM); AT84 (IC50=27.3 ± 5.1 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=287 ± 52 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33422	KKWXKKWWK	9	peptide 3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=24.0 ± 1.0 µM); AT84 (IC50=26.3 ± 7.1 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=287 ± 52 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33423	KKWXKKWWK	9	peptide 3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=26.0 ± 1.7 µM); AT84 (IC50=29.3 ± 7.8 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=287 ± 52 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33424	KKWXKKWWK	9	peptide 3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=11.0 ± 1.0 µM); A20 (IC50=9.3 ± 1.2 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=287 ± 52 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33425	KKWWKKXWK	9	peptide 4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=12.3 ± 1.5 µM); AT84 (IC50=25.3 ± 4.2 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=102 ± 7.6 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33426	KKWXKKWXK	9	peptide 6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=12 µM); AT84 (IC50=15.0 ± 1.0 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=80.0 ± 7.0 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33427	KKWXKKWWK	9	peptide 7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=24.7 ± 2.3 µM); A20 (IC50=25.7 ± 0.6 µM)	Not available	Linear	Free	Amidation	X=Bip (Biphenylalanine)	L	MRC-5: IC50=174 ± 22 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33428	KKWXKKWWK	9	peptide 7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=18.7 ± 1.5 µM); AT84 (IC50=27.3 ± 5.1 µM)	Not available	Linear	Free	Amidation	X=Bip (Biphenylalanine)	L	MRC-5: IC50=174 ± 22 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33429	KKWXKKWWK	9	peptide 7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=24.0 ± 1.0 µM); AT84 (IC50=26.3 ± 7.1 µM)	Not available	Linear	Free	Amidation	X=Bip (Biphenylalanine)	L	MRC-5: IC50=174 ± 22 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33430	KKWXKKWWK	9	peptide 7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=26.0 ± 1.7 µM); AT84 (IC50=29.3 ± 7.8 µM)	Not available	Linear	Free	Amidation	X=Bip (Biphenylalanine)	L	MRC-5: IC50=174 ± 22 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33431	KKWXKKWWK	9	peptide 7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=11.0 ± 1.0 µM); A20 (IC50=9.3 ± 1.2 µM)	Not available	Linear	Free	Amidation	X=Bip (Biphenylalanine)	L	MRC-5: IC50=174 ± 22 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33432	KKWXKKWWK	9	peptide 8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=24.7 ± 2.3 µM); A20 (IC50=25.7 ± 0.6 µM)	Not available	Linear	Free	Amidation	X=1-Nal (1-naphthylalanine)	L	MRC-5: IC50=238 ± 69 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33433	KKWXKKWWK	9	peptide 8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=18.7 ± 1.5 µM); AT84 (IC50=27.3 ± 5.1 µM)	Not available	Linear	Free	Amidation	X=1-Nal (1-naphthylalanine)	L	MRC-5: IC50=238 ± 69 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33434	KKWXKKWWK	9	peptide 8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=24.0 ± 1.0 µM); AT84 (IC50=26.3 ± 7.1 µM)	Not available	Linear	Free	Amidation	X=1-Nal (1-naphthylalanine)	L	MRC-5: IC50=238 ± 69 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33435	KKWXKKWWK	9	peptide 8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=26.0 ± 1.7 µM); AT84 (IC50=29.3 ± 7.8 µM)	Not available	Linear	Free	Amidation	X=1-Nal (1-naphthylalanine)	L	MRC-5: IC50=238 ± 69 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33436	KKWXKKWWK	9	peptide 8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=11.0 ± 1.0 µM); A20 (IC50=9.3 ± 1.2 µM)	Not available	Linear	Free	Amidation	X=1-Nal (1-naphthylalanine)	L	MRC-5: IC50=238 ± 69 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33437	KKWXKKWWK	9	peptide 9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=24.7 ± 2.3 µM); A20 (IC50=25.7 ± 0.6 µM)	Not available	Linear	Free	Amidation	X=2-Nal (2-naphthylalanine)	L	MRC-5: IC50=257 ± 20 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33438	KKWXKKWWK	9	peptide 9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=18.7 ± 1.5 µM); AT84 (IC50=27.3 ± 5.1 µM)	Not available	Linear	Free	Amidation	X=2-Nal (2-naphthylalanine)	L	MRC-5: IC50=257 ± 20 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33439	KKWXKKWWK	9	peptide 9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=24.0 ± 1.0 µM); AT84 (IC50=26.3 ± 7.1 µM)	Not available	Linear	Free	Amidation	X=2-Nal (2-naphthylalanine)	L	MRC-5: IC50=257 ± 20 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33440	KKWXKKWWK	9	peptide 9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=26.0 ± 1.7 µM); AT84 (IC50=29.3 ± 7.8 µM)	Not available	Linear	Free	Amidation	X=2-Nal (2-naphthylalanine)	L	MRC-5: IC50=257 ± 20 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33441	KKWXKKWWK	9	peptide 9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=11.0 ± 1.0 µM); A20 (IC50=9.3 ± 1.2 µM)	Not available	Linear	Free	Amidation	X=2-Nal (2-naphthylalanine)	L	MRC-5: IC50=257 ± 20 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33442	KKWXKKWWK	9	peptide 10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=24.7 ± 2.3 µM); A20 (IC50=25.7 ± 0.6 µM)	Not available	Linear	Free	Amidation	X=9-Ath (9-anthracenylalanine)	L	MRC-5: IC50=40.0 ± 1.7 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33443	KKWXKKWWK	9	peptide 10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=18.7 ± 1.5 µM); AT84 (IC50=27.3 ± 5.1 µM)	Not available	Linear	Free	Amidation	X=9-Ath (9-anthracenylalanine)	L	MRC-5: IC50=40.0 ± 1.7 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33444	KKWXKKWWK	9	peptide 10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=24.0 ± 1.0 µM); AT84 (IC50=26.3 ± 7.1 µM)	Not available	Linear	Free	Amidation	X=9-Ath (9-anthracenylalanine)	L	MRC-5: IC50=40.0 ± 1.7 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33445	KKWXKKWWK	9	peptide 10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=26.0 ± 1.7 µM); AT84 (IC50=29.3 ± 7.8 µM)	Not available	Linear	Free	Amidation	X=9-Ath (9-anthracenylalanine)	L	MRC-5: IC50=40.0 ± 1.7 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33446	KKWXKKWWK	9	peptide 10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=11.0 ± 1.0 µM); A20 (IC50=9.3 ± 1.2 µM)	Not available	Linear	Free	Amidation	X=9-Ath (9-anthracenylalanine)	L	MRC-5: IC50=40.0 ± 1.7 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33447	KKXWKKWWK	9	peptide 11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=36.7 ± 9.5 µM); A20 (IC50=51.7 ± 6.5 µM)	Not available	Linear	Free	Amidation	X=Bip (Biphenylalanine)	L	MRC-5: IC50=151 ± 16 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33448	KKXWKKWWK	9	peptide 11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=13.0 ± 1.0 µM); IGROV-1 (IC50=13.4 ± 1.6 µM); AT84 (IC50=17.7 ± 3.1 µM); HL-60 (IC50=6.1 ± 1.8 µM); IGROV-1/CDDP (IC50=6.6 ± 2.6 µM); MCF-7  (IC50=6.8 ± 2.8 µM); HL-60/ADR (IC50=7.0 ± 3.7 µM); K562 (IC50=7.2 ± 0.4 µM); K562/Gleevec (IC50=7.9 ± 2.9 µM); MCF-7/mdr (IC50=8.4 ± 2.7 µM)	Not available	Linear	Free	Amidation	X=Bip (Biphenylalanine)	L	MRC-5: IC50=151 ± 16 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33449	kkxwkkwwk	9	peptide 12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=11.3 ± 1.2 µM); IGROV-1 (IC50=14.3 ± 5.3 µM); MCF-7  (IC50=4.6 ± 1.1 µM); MCF-7/mdr (IC50=4.9 ± 1.6 µM); HL-60/ADR (IC50=4.9 ± 3.7 µM); HL-60 (IC50=6.1 ± 3.4 µM); IGROV-1/CDDP (IC50=6.6 ± 2.7 µM); K562 (IC50=7.4 ± 0.1 µM); K562/Gleevec (IC50=7.6 ± 1.3 µM); A20 (IC50=8.3 ± 1.5 µM)	Not available	Linear	Free	Amidation	X=D-Bip (D-Biphenylalanine)	D	MRC-5: IC50=87.0 ± 15.1 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33450	XXWXXXWWX	9	peptide 14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=21.7 ± 2.5 µM); MT-1 (IC50=216 ± 36 µM); AT84 (IC50=23.0 ± 3.6 µM); HT-29 (IC50=248 ± 5 µM); Kelly (IC50=78 ± 7 µM)	Not available	Linear	Free	Amidation	X=Dab ((S)-2,4-diaminobutyric acid)	L	MRC-5: IC50=97.7 ± 5.1 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33451	XXWXXXWWX	9	peptide 14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=14.3 ± 1.2 µM); A20 (IC50=8.3 ± 0.6 µM)	Not available	Linear	Free	Amidation	X=Dab ((S)-2,4-diaminobutyric acid)	L	MRC-5: IC50=97.7 ± 5.1 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33452	XXWXXXWWX	9	peptide 14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=154 ± 29 µM); A20 (IC50=67.7 ± 13.2 µM)	Not available	Linear	Free	Amidation	X=Dab ((S)-2,4-diaminobutyric acid)	L	MRC-5: IC50=97.7 ± 5.1 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33453	XXWXXXWWX	9	peptide 15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=21.7 ± 2.5 µM); MT-1 (IC50=216 ± 36 µM); AT84 (IC50=23.0 ± 3.6 µM); HT-29 (IC50=248 ± 5 µM); Kelly (IC50=78 ± 7 µM)	Not available	Linear	Free	Amidation	X=Dap ((S)-2,3-diaminopropionic acid)	L	MRC-5: IC50=516 ± 5.2 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33454	XXWXXXWWX	9	peptide 15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=14.3 ± 1.2 µM); A20 (IC50=8.3 ± 0.6 µM)	Not available	Linear	Free	Amidation	X=Dap ((S)-2,3-diaminopropionic acid)	L	MRC-5: IC50=516 ± 5.2 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33455	XXWXXXWWX	9	peptide 15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=154 ± 29 µM); A20 (IC50=67.7 ± 13.2 µM)	Not available	Linear	Free	Amidation	X=Dap ((S)-2,3-diaminopropionic acid)	L	MRC-5: IC50=516 ± 5.2 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33456	RRWXRRWWR	9	peptide 16	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: IGROV-1 (IC50=11.1 ± 3.4 µM); AT84 (IC50=11.3 ± 2.1 µM); MCF-7  (IC50=5.5 ± 0.9 µM); IGROV-1/CDDP (IC50=5.5 ± 2.2 µM); HL-60/ADR (IC50=6.0 ± 4.5 µM); MCF-7/mdr (IC50=6.6 ± 2.8 µM); A20 (IC50=6.7 ± 1.2 µM); HL-60 (IC50=6.7 ± 3.7 µM); K562 (IC50=7.0 ± 0.8 µM); K562/Gleevec (IC50=7.7 ± 1.6 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=76.0 ± 9.5 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33457	kkWXkkWWk	9	peptide 17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: AT84 (IC50=113 ± 10 µM); A20 (IC50=134 ± 13 µM)	Not available	Linear	Free	Amidation	k=D-Lys; X=Dip (Diphenylalanine)	Mix	MRC-5: IC50>347 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33458	KWWKKWXK	8	LTX-315 Metabolites 1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=13.5 ± 0.9 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=43.9 ± 19.3 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33459	WWKKWXK	7	LTX-315 Metabolites 2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=20.3 ± 2.9 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=53.2 ± 21.2 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33460	WKKWXK	6	LTX-315 Metabolites 3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A20 (IC50=247 ± 13 µM)	Not available	Linear	Free	Amidation	X=Dip (Diphenylalanine)	L	MRC-5: IC50=460 ± 71 µM	Not available	26982623	J Med Chem. 2016 Apr 14;59(7):2918-27. 	Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.	Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide	
DRAMP33461	GLPVCGETCVGGTCYTPGCTCSWPVCTRN	29	Kalata B1 [N15Y]	P56254		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (CC50=12.3±0.6 μM); K562 (CC50=3.2±0.1 μM); HeLa  (CC50=8.1±0.4 μM)	Human erythrocytes: 50% Hemolysis=6.9±0.3 µM	Cyclic	Free	Free		L	HFF-1: CC50=6.7±0.6 µM; PBMCs: CC50=1.0±0.1 µM	Not available	25099014	Chembiochem. 2014 Sep 5;15(13):1956-65.	Troeira Henriques S, Huang YH, Chaousis S, Wang CK, Craik DJ. 	Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting	CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP33462	GLPVCGETCVGGTCDTPGCTCSWPVCTRN	29	Kalata B1 [N15D]	P56254		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 60 µM); K562 (Not active up to 60 µM); MM96L (Not active up to 60 µM)	Human erythrocytes: Not active up to 50 µM	Cyclic	Free	Free		L	HFF-1: Not active up to 60 µM; PBMCs: Not active up to 60 µM	Not available	25099014	Chembiochem. 2014 Sep 5;15(13):1956-65.	Troeira Henriques S, Huang YH, Chaousis S, Wang CK, Craik DJ. 	Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting	CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP33463	GLPVCGETCVGGTCNYPGCTCSWPVCTRN	29	Kalata B1 [T16Y]	P56254		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 60 µM); K562 (Not active up to 60 µM); MM96L (Not active up to 60 µM)	Human erythrocytes: Not active up to 50 µM	Cyclic	Free	Free		L	HFF-1: Not active up to 60 µM; PBMCs: Not active up to 60 µM	Not available	25099014	Chembiochem. 2014 Sep 5;15(13):1956-65.	Troeira Henriques S, Huang YH, Chaousis S, Wang CK, Craik DJ. 	Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting	CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP33464	GLPVCGETCVGGTCNSPGCTCSWPVCTRN	29	Kalata B1 [T16S]	P56254		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (CC50=43.8±0.5 μM)	Human erythrocytes: Weak active up to 50 µM	Cyclic	Free	Free		L	Not available	Not available	25099014	Chembiochem. 2014 Sep 5;15(13):1956-65.	Troeira Henriques S, Huang YH, Chaousis S, Wang CK, Craik DJ. 	Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting	CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP33465	GLPVCGETCVGGTCNTPGCTCSYPVCTRN	29	Kalata B1 [W23Y]	P56254		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 60 µM); K562 (Not active up to 60 µM); MM96L (Not active up to 60 µM)	Human erythrocytes: Not active up to 50 µM	Cyclic	Free	Free		L	HFF-1: Not active up to 60 µM; PBMCs: Not active up to 60 µM	Not available	25099014	Chembiochem. 2014 Sep 5;15(13):1956-65.	Troeira Henriques S, Huang YH, Chaousis S, Wang CK, Craik DJ. 	Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting	CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP33466	GLPVCGETCVGGTCNTPGCTCSWWPVCTRN	30	Kalata B1 [W23WW]	P56254		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MM96L (CC50=12.2±0.6 μM); HeLa  (CC50=9.8±0.5 μM)	Human erythrocytes: 50% Hemolysis=14.0±0.7 µM	Cyclic	Free	Free		L	HFF-1: CC50=9.2±0.7 µM	Not available	25099014	Chembiochem. 2014 Sep 5;15(13):1956-65.	Troeira Henriques S, Huang YH, Chaousis S, Wang CK, Craik DJ. 	Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting	CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP33467	KKLIKVWAKGFKKAKKLFKGIG	22	PBP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (21% Cytotoxicity=15 µM)	Sheep erythrocytes: 10% Hemolysis=15 µM	Linear	Free	Free		L	Not available	Not available	30637367	Pept Sci (Hoboken). 2018 Jul;110(4):e24074.	Shirley DJ, Chrom CL, Richards EA, Carone BR, Caputo GA.	Antimicrobial activity of a porphyrin binding peptide	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)NCC(=O)O
DRAMP33468	KKLIKVFAKGWKKAKKLFKGIG	22	PBP-W11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (52% Cytotoxicity=15 µM)	Sheep erythrocytes: 0% Hemolysis=15 µM	Linear	Free	Free		L	Not available	Not available	30637367	Pept Sci (Hoboken). 2018 Jul;110(4):e24074.	Shirley DJ, Chrom CL, Richards EA, Carone BR, Caputo GA.	Antimicrobial activity of a porphyrin binding peptide	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)NCC(=O)O
DRAMP33469	KKLIKVFAKGFKKAKKLWKGIG	22	PBP-W18	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (52% Cytotoxicity=15 µM)	Sheep erythrocytes: 0% Hemolysis=15 µM	Linear	Free	Free		L	Not available	Not available	30637367	Pept Sci (Hoboken). 2018 Jul;110(4):e24074.	Shirley DJ, Chrom CL, Richards EA, Carone BR, Caputo GA.	Antimicrobial activity of a porphyrin binding peptide	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)NCC(=O)O
DRAMP33470	XXLIXVWAXGFXXAXXLFXGIG	22	PBP-X	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (8% Cytotoxicity=15 µM)	Sheep erythrocytes: 0% Hemolysis=15 µM	Linear	Free	Free	X=Diaminopropionic acid	L	Not available	Not available	30637367	Pept Sci (Hoboken). 2018 Jul;110(4):e24074.	Shirley DJ, Chrom CL, Richards EA, Carone BR, Caputo GA.	Antimicrobial activity of a porphyrin binding peptide	
DRAMP33471	KKAAKAWAKGAKKAKKLAKGAG	22	PBP-A	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (12% Cytotoxicity=15 µM)	Sheep erythrocytes: 0% Hemolysis=15 µM	Linear	Free	Free		L	Not available	Not available	30637367	Pept Sci (Hoboken). 2018 Jul;110(4):e24074.	Shirley DJ, Chrom CL, Richards EA, Carone BR, Caputo GA.	Antimicrobial activity of a porphyrin binding peptide	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP33472	WLlXNG	6	Desotamide A	Not available		Not found	Streptomyces nov. sp.	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H460 (Not active up to 30 µM); SW620 (Not active up to 30 µM)	Not available	Cyclic	Free	Free	X=Allo-Ile	Mix	Not available	Not available	25229313	 Org Lett. 2014 Oct 3;16(19):5120-3. 	Khalil ZG, Salim AA, Lacey E, Blumenthal A, Capon RJ.	Wollamides: antimycobacterial cyclic hexapeptides from an Australian soil Streptomyces	
DRAMP33473	WLlVNG	6	Desotamide B	Not available		Not found	Streptomyces nov. sp.	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H460 (Not active up to 30 µM); SW620 (Not active up to 30 µM)	Not available	Cyclic	Free	Free		Mix	Not available	Not available	25229313	 Org Lett. 2014 Oct 3;16(19):5120-3. 	Khalil ZG, Salim AA, Lacey E, Blumenthal A, Capon RJ.	Wollamides: antimycobacterial cyclic hexapeptides from an Australian soil Streptomyces	CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)O)C(C)C
DRAMP33474	WLvXNG	6	Desotamide E	Not available		Not found	Streptomyces nov. sp.	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H460 (Not active up to 30 µM); SW620 (Not active up to 30 µM)	Not available	Cyclic	Free	Free	X=Allo-Ile; v=D-Val	Mix	Not available	Not available	25229313	 Org Lett. 2014 Oct 3;16(19):5120-3. 	Khalil ZG, Salim AA, Lacey E, Blumenthal A, Capon RJ.	Wollamides: antimycobacterial cyclic hexapeptides from an Australian soil Streptomyces	
DRAMP33475	WLxXNG	6	Desotamide F	Not available		Not found	Streptomyces nov. sp.	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H460 (Not active up to 30 µM); SW620 (Not active up to 30 µM)	Not available	Cyclic	Free	Free	x=D-Allo-Ile; X=Allo-Ile	Mix	Not available	Not available	25229313	 Org Lett. 2014 Oct 3;16(19):5120-3. 	Khalil ZG, Salim AA, Lacey E, Blumenthal A, Capon RJ.	Wollamides: antimycobacterial cyclic hexapeptides from an Australian soil Streptomyces	
DRAMP33476	WLlXNx	6	Wollamide A	Not available		Not found	Streptomyces nov. sp.	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H460 (Not active up to 30 µM); SW620 (Not active up to 30 µM)	Not available	Cyclic	Free	Free	X=Allo-Ile; x=D-Orn	Mix	Not available	Not available	25229313	 Org Lett. 2014 Oct 3;16(19):5120-3. 	Khalil ZG, Salim AA, Lacey E, Blumenthal A, Capon RJ.	Wollamides: antimycobacterial cyclic hexapeptides from an Australian soil Streptomyces	
DRAMP33477	WLlVNx	6	Wollamide B	Not available		Not found	Streptomyces nov. sp.	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=56 µM); NCI-H460 (Not active up to 30 µM); SW620 (Not active up to 30 µM)	Not available	Cyclic	Free	Free	x=D-Orn	Mix	Not available	Not available	25229313	 Org Lett. 2014 Oct 3;16(19):5120-3. 	Khalil ZG, Salim AA, Lacey E, Blumenthal A, Capon RJ.	Wollamides: antimycobacterial cyclic hexapeptides from an Australian soil Streptomyces	
DRAMP33478	GWKDWFRKAKKVGKTVGGLALNHYL	25	NRC-123	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (50% Cell death=16 µg/ml)	Human erythrocytes: 50% Hemolysis>256 µg/ml	Linear	Free	Amidation		L	Zebrafish embryos: >10% Killing=5 µg/ml (4, 28, 52hpf embryo)	Not available	21729875	Dis Model Mech. 2011 Sep;4(5):622-33.	Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.	The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)[C@@H](C)O)C(C)C)C(N)=O
DRAMP33479	GIRKWFKKAAHVGKEVGKVALNACL	25	NRC-124	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (50% Cell death=128 µg/ml)	Human erythrocytes: 50% Hemolysis>256 µg/ml	Linear	Free	Free		L	Zebrafish embryos: >10% Killing=5 µg/ml (4, 52hpf embryo); >10% Killing=25 µg/ml (28hpf embryo)	Not available	21729875	Dis Model Mech. 2011 Sep;4(5):622-33.	Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.	The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
DRAMP33480	GLKKWFKKAVHVGKKVGKVALNAYL	25	NRC-125	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (50% Cell death=16 µg/ml)	Human erythrocytes: 50% Hemolysis>256 µg/ml	Linear	Free	Amidation		L	Zebrafish embryos: >10% Killing=5 µg/ml (4, 28, 52hpf embryo)	Not available	21729875	Dis Model Mech. 2011 Sep;4(5):622-33.	Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.	The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(N)=O
DRAMP33481	GWRKWIKKATHVGKHIGKAALDAYI	25	NRC-126	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (50% Cell death=32 µg/ml)	Human erythrocytes: 50% Hemolysis>256 µg/ml	Linear	Free	Amidation		L	Zebrafish embryos: >10% Killing=5 µg/ml (4, 52hpf embryo)	Not available	21729875	Dis Model Mech. 2011 Sep;4(5):622-33.	Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.	The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)C(N)=O
DRAMP33482	GCKKWFKKAAHVGKNVGKVALNAYL	25	NRC-127	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (50% Cell death=32 µg/ml)	Human erythrocytes: 50% Hemolysis>256 µg/ml	Linear	Free	Amidation		L	Zebrafish embryos: >10% Killing=5 µg/ml (4, 28hpf embryo); >10% Killing=25 µg/ml (52hpf embryo)	Not available	21729875	Dis Model Mech. 2011 Sep;4(5):622-33.	Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.	The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(N)=O
DRAMP33483	GIRKWFKKAAHVGKKVGKVALNAYL	25	NRC-128	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (50% Cell death=64 µg/ml)	Human erythrocytes: 50% Hemolysis>256 µg/ml	Linear	Free	Amidation		L	Zebrafish embryos: >10% Killing=5 µg/ml (28, 52hpf embryo); >10% Killing=25 µg/ml (4hpf embryo)	Not available	21729875	Dis Model Mech. 2011 Sep;4(5):622-33.	Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.	The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)C(C)C
DRAMP33484	GrrkrkWLrrIGkGVkIIGGAALDHL	26	NRC-03D	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (50% Cell death>128 µg/ml)	Human erythrocytes: 50% Hemolysis>256 µg/ml	Linear	Free	Amidation	r=D-Arg; k=D-Lys	Mix	Zebrafish embryos: No killing	Not available	21729875	Dis Model Mech. 2011 Sep;4(5):622-33.	Morash MG, Douglas SE, Robotham A, Ridley CM, Gallant JW, Soanes KH.	The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CN)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33485	GLVGTLLGHIGKAILG	16	Frenatin 2.1S	Not available		Not found	Sphaenorhynchus lacteus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=80 ± 6 μM )	Human erythrocytes: HC50=167 ± 8 µM	Linear	Free	Amidation		L	Not available	Not available	24704757	 Peptides. 2014 Jun;56:132-40.	Conlon JM, Mechkarska M, Radosavljevic G, Attoub S, King JD, Lukic ML, McClean S.	A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae)	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
DRAMP33486	GLVGTLLGHIGKAILG	16	Frenatin 2.1S	Not available		Not found	Sphaenorhynchus lacteus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50>100 μM )	Human erythrocytes: HC50=167 ± 8 µM	Linear	Free	Amidation		L	Not available	Not available	24704757	 Peptides. 2014 Jun;56:132-40.	Conlon JM, Mechkarska M, Radosavljevic G, Attoub S, King JD, Lukic ML, McClean S.	A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae)	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
DRAMP33487	GLVGTLLGHIGKAILS	16	Frenatin 2.2S	Not available		Not found	Sphaenorhynchus lacteus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=65 ± 5 μM )	Human erythrocytes: HC50=169 ± 7 µM	Linear	Free	Amidation		L	Not available	Not available	24704757	 Peptides. 2014 Jun;56:132-40.	Conlon JM, Mechkarska M, Radosavljevic G, Attoub S, King JD, Lukic ML, McClean S.	A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae)	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(N)=O
DRAMP33488	GLVGTLLGHIGKAILG	16	Frenatin 2.3S	Not available		Not found	Sphaenorhynchus lacteus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50=80 ± 6 μM )	Human erythrocytes: HC50=404 ± 11 µM	Linear	Free	Free		L	Not available	Not available	24704757	 Peptides. 2014 Jun;56:132-40.	Conlon JM, Mechkarska M, Radosavljevic G, Attoub S, King JD, Lukic ML, McClean S.	A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae)	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O
DRAMP33489	GLVGTLLGHIGKAILG	16	Frenatin 2.3S	Not available		Not found	Sphaenorhynchus lacteus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (LC50>100 μM )	Human erythrocytes: HC50=404 ± 11 µM	Linear	Free	Free		L	Not available	Not available	24704757	 Peptides. 2014 Jun;56:132-40.	Conlon JM, Mechkarska M, Radosavljevic G, Attoub S, King JD, Lukic ML, McClean S.	A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae)	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O
DRAMP33490	ELLVDLL	7	Gageostatin A	Not available		Not found	Bacillus subtilis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=10.8 µg/mL); NCI-H23 (IC50=11.2 µg/mL); HCT 15 (IC50=11.4 µg/mL); ACHN (IC50=11.5 µg/mL); NUGC-3 (IC50=11.8 µg/mL); MDA-MB-231 (IC50=14.9 µg/mL)	Not available	Linear	3-β-hydroxy-11-methyltridecanoic	Free		L	Not available	Not available	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis	CC(C)CCCCCCCCCC(O)CCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33491	ELLVDLL	7	Gageostatin A	Not available		Not found	Bacillus subtilis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H23 (IC50=11.7 µg/mL); NUGC-3 (IC50=13.9 µg/mL); MDA-MB-231 (IC50=16.1 µg/mL); HCT 15 (IC50=18.3 µg/mL); ACHN (IC50=18.4 µg/mL); PC-3 (IC50=19.4 µg/mL)	Not available	Linear	3-β-hydroxy-11-methyltridecanoic	Free		L	Not available	Not available	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis	CC(C)CCCCCCCCCC(O)CCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33492	ELLVDLL	7	Gageostatin A	Not available		Not found	Bacillus subtilis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NUGC-3 (IC50=10.5 µg/mL); NCI-H23 (IC50=10.9 µg/mL); MDA-MB-231 (IC50=11.2 µg/mL); PC-3 (IC50=11.7 µg/mL); ACHN (IC50=12.3 µg/mL); HCT 15 (IC50=23.2 µg/mL)	Not available	Linear	3-β-hydroxy-11-methyltridecanoic	Free		L	Not available	Not available	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis	CC(C)CCCCCCCCCC(O)CCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33493	ELLVDLL	7	Gageostatin B	Not available		Not found	Bacillus subtilis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=10.8 µg/mL); NCI-H23 (IC50=11.2 µg/mL); HCT 15 (IC50=11.4 µg/mL); ACHN (IC50=11.5 µg/mL); NUGC-3 (IC50=11.8 µg/mL); MDA-MB-231 (IC50=14.9 µg/mL)	Not available	Linear	3-β-hydroxy-9,11-dimethyltridecanoic acids	Free		L	Not available	Not available	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis	CCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33494	ELLVDLL	7	Gageostatin B	Not available		Not found	Bacillus subtilis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H23 (IC50=11.7 µg/mL); NUGC-3 (IC50=13.9 µg/mL); MDA-MB-231 (IC50=16.1 µg/mL); HCT 15 (IC50=18.3 µg/mL); ACHN (IC50=18.4 µg/mL); PC-3 (IC50=19.4 µg/mL)	Not available	Linear	3-β-hydroxy-9,11-dimethyltridecanoic acids	Free		L	Not available	Not available	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis	CCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33495	ELLVDLL	7	Gageostatin B	Not available		Not found	Bacillus subtilis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NUGC-3 (IC50=10.5 µg/mL); NCI-H23 (IC50=10.9 µg/mL); MDA-MB-231 (IC50=11.2 µg/mL); PC-3 (IC50=11.7 µg/mL); ACHN (IC50=12.3 µg/mL); HCT 15 (IC50=23.2 µg/mL)	Not available	Linear	3-β-hydroxy-9,11-dimethyltridecanoic acids	Free		L	Not available	Not available	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis	CCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33496	ELLVDLL	7	Gageostatin C	Not available		Not found	Bacillus subtilis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=10.8 µg/mL); NCI-H23 (IC50=11.2 µg/mL); HCT 15 (IC50=11.4 µg/mL); ACHN (IC50=11.5 µg/mL); NUGC-3 (IC50=11.8 µg/mL); MDA-MB-231 (IC50=14.9 µg/mL)	Not available	Linear	(E)-7,9-dimethylundec-2-enoic acid	Free		L	Not available	Not available	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis	CC(C)CC(C)CCCC=CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33497	ELLVDLL	7	Gageostatin C	Not available		Not found	Bacillus subtilis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H23 (IC50=11.7 µg/mL); NUGC-3 (IC50=13.9 µg/mL); MDA-MB-231 (IC50=16.1 µg/mL); HCT 15 (IC50=18.3 µg/mL); ACHN (IC50=18.4 µg/mL); PC-3 (IC50=19.4 µg/mL)	Not available	Linear	(E)-7,9-dimethylundec-2-enoic acid	Free		L	Not available	Not available	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis	CC(C)CC(C)CCCC=CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33498	ELLVDLL	7	Gageostatin C	Not available		Not found	Bacillus subtilis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NUGC-3 (IC50=10.5 µg/mL); NCI-H23 (IC50=10.9 µg/mL); MDA-MB-231 (IC50=11.2 µg/mL); PC-3 (IC50=11.7 µg/mL); ACHN (IC50=12.3 µg/mL); HCT 15 (IC50=23.2 µg/mL)	Not available	Linear	(E)-7,9-dimethylundec-2-enoic acid	Free		L	Not available	Not available	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis	CC(C)CC(C)CCCC=CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33499	GIMDTIKGAAKDLAGQLLDKLKCKITKC	28	Ranatuerin-2VLb	Not available		Not found	Lithobates vaillanti	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (LC50=30 µM )	Huµan erythrocytes: HC50>200 µM	Cyclic	Free	Free		L	Not available	Not available	19379837	Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-4. 	Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD. 	Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae)	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP33500	VKRFKKFFRKLKKSV	15	B1-C10	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)8CO, Decanoic acid	Amidation		L	GES-1: IC50=81.3 ± 6.8 µM; HEK293: IC50=81.3 ± 6.8 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33501	VKRFKKFFRKLKKSV	15	B1-C10	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM )	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)8CO, Decanoic acid	Amidation		L	GES-1: IC50=81.3 ± 6.8 µM; HEK293: IC50=81.3 ± 6.8 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33502	VKRFKKFFRKLKKSV	15	B1-C10	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)8CO, Decanoic acid	Amidation		L	GES-1: IC50=81.3 ± 6.8 µM; HEK293: IC50=81.3 ± 6.8 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33503	VKRFKKFFRKLKKSV	15	B1-C10	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)8CO, Decanoic acid	Amidation		L	GES-1: IC50=81.3 ± 6.8 µM; HEK293: IC50=81.3 ± 6.8 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33504	VKRFKKFFRKLKKSV	15	B1-C10	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)8CO, Decanoic acid	Amidation		L	GES-1: IC50=81.3 ± 6.8 µM; HEK293: IC50=81.3 ± 6.8 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33505	VKRFKKFFRKLKKSV	15	B1-C10	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)8CO, Decanoic acid	Amidation		L	GES-1: IC50=81.3 ± 6.8 µM; HEK293: IC50=81.3 ± 6.8 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33506	VKRFKKFFRKLKKSV	15	B1-C12	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)10CO, Dodecanoic acid	Amidation		L	GES-1: IC50=77.6 ± 7.3 µM; HEK293: IC50=75.8 ± 6.6 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33507	VKRFKKFFRKLKKSV	15	B1-C12	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM )	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)10CO, Dodecanoic acid	Amidation		L	GES-1: IC50=77.6 ± 7.3 µM; HEK293: IC50=75.8 ± 6.6 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33508	VKRFKKFFRKLKKSV	15	B1-C12	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)10CO, Dodecanoic acid	Amidation		L	GES-1: IC50=77.6 ± 7.3 µM; HEK293: IC50=75.8 ± 6.6 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33509	VKRFKKFFRKLKKSV	15	B1-C12	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)10CO, Dodecanoic acid	Amidation		L	GES-1: IC50=77.6 ± 7.3 µM; HEK293: IC50=75.8 ± 6.6 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33510	VKRFKKFFRKLKKSV	15	B1-C12	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)10CO, Dodecanoic acid	Amidation		L	GES-1: IC50=77.6 ± 7.3 µM; HEK293: IC50=75.8 ± 6.6 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33511	VKRFKKFFRKLKKSV	15	B1-C12	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)10CO, Dodecanoic acid	Amidation		L	GES-1: IC50=77.6 ± 7.3 µM; HEK293: IC50=75.8 ± 6.6 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33512	VKRFKKFFRKLKKSV	15	B1-C14	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)12CO, Myristic acid	Amidation		L	GES-1: IC50=70.8 ± 7.1 µM; HEK293: IC50=70.2 ± 5.0 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33513	VKRFKKFFRKLKKSV	15	B1-C14	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM )	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)12CO, Myristic acid	Amidation		L	GES-1: IC50=70.8 ± 7.1 µM; HEK293: IC50=70.2 ± 5.0 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33514	VKRFKKFFRKLKKSV	15	B1-C14	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)12CO, Myristic acid	Amidation		L	GES-1: IC50=70.8 ± 7.1 µM; HEK293: IC50=70.2 ± 5.0 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33515	VKRFKKFFRKLKKSV	15	B1-C14	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)12CO, Myristic acid	Amidation		L	GES-1: IC50=70.8 ± 7.1 µM; HEK293: IC50=70.2 ± 5.0 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33516	VKRFKKFFRKLKKSV	15	B1-C14	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)12CO, Myristic acid	Amidation		L	GES-1: IC50=70.8 ± 7.1 µM; HEK293: IC50=70.2 ± 5.0 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33517	VKRFKKFFRKLKKSV	15	B1-C14	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)12CO, Myristic acid	Amidation		L	GES-1: IC50=70.8 ± 7.1 µM; HEK293: IC50=70.2 ± 5.0 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33518	VKRFKKFFRKLKKSV	15	B1-C16	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	GES-1: IC50=67.6 ± 6.5 µM; HEK293: IC50=68.1 ± 5.3 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33519	VKRFKKFFRKLKKSV	15	B1-C16	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM )	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	GES-1: IC50=67.6 ± 6.5 µM; HEK293: IC50=68.1 ± 5.3 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33520	VKRFKKFFRKLKKSV	15	B1-C16	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	GES-1: IC50=67.6 ± 6.5 µM; HEK293: IC50=68.1 ± 5.3 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33521	VKRFKKFFRKLKKSV	15	B1-C16	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	GES-1: IC50=67.6 ± 6.5 µM; HEK293: IC50=68.1 ± 5.3 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33522	VKRFKKFFRKLKKSV	15	B1-C16	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	GES-1: IC50=67.6 ± 6.5 µM; HEK293: IC50=68.1 ± 5.3 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33523	VKRFKKFFRKLKKSV	15	B1-C16	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	GES-1: IC50=67.6 ± 6.5 µM; HEK293: IC50=68.1 ± 5.3 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33524	VKRFKKFFRKLKKSV	15	B1-C18	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=22.2±1.3 μM); MCF-7 (IC50=24.6±3.7 μM); K562 (IC50=27.0±2.1 μM); K562/ADM (IC50=45.1±3.7 μM); MCF-7/Taxol (IC50=57.6±6.3 μM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)16CO, Octadecanoic acid	Amidation		L	GES-1: IC50=66.1 ± 5.4 µM; HEK293: IC50=66.4 ± 4.8 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33525	VKRFKKFFRKLKKSV	15	B1-C18	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=10.5 ± 1.3 µM); K562 (IC50=11.0 ± 1.1 µM); K562/ADM (IC50=11.7 ± 0.7 µM); MCF-7  (IC50=9.1 ± 0.7 µM )	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)16CO, Octadecanoic acid	Amidation		L	GES-1: IC50=66.1 ± 5.4 µM; HEK293: IC50=66.4 ± 4.8 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33526	VKRFKKFFRKLKKSV	15	B1-C18	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562/ADM (IC50=10.0 ± 0.8 µM); K562 (IC50=11.5 ± 0.9 µM); MCF-7  (IC50=8.8 ± 0.5 µM ); MCF-7/Taxol (IC50=9.5 ± 1.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)16CO, Octadecanoic acid	Amidation		L	GES-1: IC50=66.1 ± 5.4 µM; HEK293: IC50=66.4 ± 4.8 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33527	VKRFKKFFRKLKKSV	15	B1-C18	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=3.2 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.4 µM); K562/ADM (IC50=4.9 ± 0.1 µM); K562 (IC50=6.6 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)16CO, Octadecanoic acid	Amidation		L	GES-1: IC50=66.1 ± 5.4 µM; HEK293: IC50=66.4 ± 4.8 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33528	VKRFKKFFRKLKKSV	15	B1-C18	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=1.9 ± 0.2 µM); MCF-7/Taxol (IC50=2.0 ± 0.3 µM); K562/ADM (IC50=3.4 ± 0.3 µM); K562 (IC50=3.8 ± 0.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)16CO, Octadecanoic acid	Amidation		L	GES-1: IC50=66.1 ± 5.4 µM; HEK293: IC50=66.4 ± 4.8 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33529	VKRFKKFFRKLKKSV	15	B1-C18	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7/Taxol (IC50=2.0 ± 0.1 µM); MCF-7  (IC50=2.3 ± 0.1 µM); K562 (IC50=3.9 ± 0.2 µM); K562/ADM (IC50=4.2 ± 0.5 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)16CO, Octadecanoic acid	Amidation		L	GES-1: IC50=66.1 ± 5.4 µM; HEK293: IC50=66.4 ± 4.8 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33530	GGVKRFKKFFRKLKKSV	17	B1-GG-C10	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)8CO, Decanoic acid	Amidation		L	GES-1: IC50=85.1 ± 6.9 µM; HEK293: IC50=72.2 ± 6.9 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33531	GGVKRFKKFFRKLKKSV	17	B1-GG-C10	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)8CO, Decanoic acid	Amidation		L	GES-1: IC50=85.1 ± 6.9 µM; HEK293: IC50=72.2 ± 6.9 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33532	GGVKRFKKFFRKLKKSV	17	B1-GG-C10	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)8CO, Decanoic acid	Amidation		L	GES-1: IC50=85.1 ± 6.9 µM; HEK293: IC50=72.2 ± 6.9 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33533	GGVKRFKKFFRKLKKSV	17	B1-GG-C10	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)8CO, Decanoic acid	Amidation		L	GES-1: IC50=85.1 ± 6.9 µM; HEK293: IC50=72.2 ± 6.9 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33534	GGVKRFKKFFRKLKKSV	17	B1-GG-C10	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)8CO, Decanoic acid	Amidation		L	GES-1: IC50=85.1 ± 6.9 µM; HEK293: IC50=72.2 ± 6.9 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33535	GGVKRFKKFFRKLKKSV	17	B1-GG-C12	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)10CO, Dodecanoic acid	Amidation		L	GES-1: IC50=83.2 ± 7.8 µM; HEK293: IC50=68.7 ± 5.7 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33536	GGVKRFKKFFRKLKKSV	17	B1-GG-C12	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)10CO, Dodecanoic acid	Amidation		L	GES-1: IC50=83.2 ± 7.8 µM; HEK293: IC50=68.7 ± 5.7 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33537	GGVKRFKKFFRKLKKSV	17	B1-GG-C12	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)10CO, Dodecanoic acid	Amidation		L	GES-1: IC50=83.2 ± 7.8 µM; HEK293: IC50=68.7 ± 5.7 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33538	GGVKRFKKFFRKLKKSV	17	B1-GG-C12	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)10CO, Dodecanoic acid	Amidation		L	GES-1: IC50=83.2 ± 7.8 µM; HEK293: IC50=68.7 ± 5.7 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33539	GGVKRFKKFFRKLKKSV	17	B1-GG-C12	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)10CO, Dodecanoic acid	Amidation		L	GES-1: IC50=83.2 ± 7.8 µM; HEK293: IC50=68.7 ± 5.7 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33540	GGVKRFKKFFRKLKKSV	17	B1-GG-C14	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)12CO, Myristic acid	Amidation		L	GES-1: IC50=74.1 ± 6.5 µM; HEK293: IC50=67.1 ± 4.2 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33541	GGVKRFKKFFRKLKKSV	17	B1-GG-C14	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)12CO, Myristic acid	Amidation		L	GES-1: IC50=74.1 ± 6.5 µM; HEK293: IC50=67.1 ± 4.2 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33542	GGVKRFKKFFRKLKKSV	17	B1-GG-C14	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)12CO, Myristic acid	Amidation		L	GES-1: IC50=74.1 ± 6.5 µM; HEK293: IC50=67.1 ± 4.2 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33543	GGVKRFKKFFRKLKKSV	17	B1-GG-C14	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)12CO, Myristic acid	Amidation		L	GES-1: IC50=74.1 ± 6.5 µM; HEK293: IC50=67.1 ± 4.2 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33544	GGVKRFKKFFRKLKKSV	17	B1-GG-C14	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)12CO, Myristic acid	Amidation		L	GES-1: IC50=74.1 ± 6.5 µM; HEK293: IC50=67.1 ± 4.2 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33545	GGVKRFKKFFRKLKKSV	17	B1-GG-C16	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	GES-1: IC50=69.2 ± 4.4 µM; HEK293: IC50=65.9 ± 5.4 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33546	GGVKRFKKFFRKLKKSV	17	B1-GG-C16	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	GES-1: IC50=69.2 ± 4.4 µM; HEK293: IC50=65.9 ± 5.4 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33547	GGVKRFKKFFRKLKKSV	17	B1-GG-C16	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	GES-1: IC50=69.2 ± 4.4 µM; HEK293: IC50=65.9 ± 5.4 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33548	GGVKRFKKFFRKLKKSV	17	B1-GG-C16	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	GES-1: IC50=69.2 ± 4.4 µM; HEK293: IC50=65.9 ± 5.4 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33549	GGVKRFKKFFRKLKKSV	17	B1-GG-C16	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	GES-1: IC50=69.2 ± 4.4 µM; HEK293: IC50=65.9 ± 5.4 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33550	GGVKRFKKFFRKLKKSV	17	B1-GG-C18	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=10.5 ± 0.9 µM); MCF-7/Taxol (IC50=11.5 ± 0.8 µM); K562/ADM (IC50=9.2 ± 1.1 µM); K562 (IC50=9.7 ± 0.7 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)16CO, Octadecanoic acid	Amidation		L	GES-1: IC50=67.6 ± 5.4 µM; HEK293: IC50=63.3 ± 5.0 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33551	GGVKRFKKFFRKLKKSV	17	B1-GG-C18	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=10.2 ± 1.1 µM); K562/ADM (IC50=10.5 ± 1.3 µM); MCF-7/Taxol (IC50=10.7 ± 1.0 µM); MCF-7  (IC50=9.6 ± 0.4 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)16CO, Octadecanoic acid	Amidation		L	GES-1: IC50=67.6 ± 5.4 µM; HEK293: IC50=63.3 ± 5.0 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33552	GGVKRFKKFFRKLKKSV	17	B1-GG-C18	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=3.5 ± 0.1 µM); K562 (IC50=3.8 ± 0.2 µM); MCF-7/Taxol (IC50=4.3 ± 0.2 µM); K562/ADM (IC50=4.6 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)16CO, Octadecanoic acid	Amidation		L	GES-1: IC50=67.6 ± 5.4 µM; HEK293: IC50=63.3 ± 5.0 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33553	GGVKRFKKFFRKLKKSV	17	B1-GG-C18	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=2.7 ± 0.3 µM); MCF-7/Taxol (IC50=3.2 ± 0.2 µM); K562/ADM (IC50=3.4 ± 0.1 µM); K562 (IC50=3.4 ± 0.3 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)16CO, Octadecanoic acid	Amidation		L	GES-1: IC50=67.6 ± 5.4 µM; HEK293: IC50=63.3 ± 5.0 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33554	GGVKRFKKFFRKLKKSV	17	B1-GG-C18	B6D434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=2.5 ± 0.2 µM); MCF-7/Taxol (IC50=3.2 ± 0.1 µM); K562/ADM (IC50=3.3 ± 0.3 µM); K562 (IC50=3.4 ± 0.1 µM)	"Human erythrocytes: <20% Hemolysis	=160 µM"	Linear	CH3(CH2)16CO, Octadecanoic acid	Amidation		L	GES-1: IC50=67.6 ± 5.4 µM; HEK293: IC50=63.3 ± 5.0 µM	Not available	26083110	Org Biomol Chem. 2015 Jul 28;13(28):7673-80. 	Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H.	Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	CCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33555	inlkalaalakkil	14	Inverso Mastoparan	P01514		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=10 µM); U-373MG (LD50=45.92 μM)	Not available	Linear	Free	Amidation		D	Not available	Not available	22148546	Bioconjug Chem. 2012 Jan 18;23(1):47-56. 	Jones S, Howl J.	Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide	CC[C@H](C)[C@@H](N)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CC(C)C)C(N)=O)[C@@H](C)CC
DRAMP33556	LIKKALAALAKLNI	14	Retro Mastoparan	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-373MG (LD50=95.46 μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	22148546	Bioconjug Chem. 2012 Jan 18;23(1):47-56. 	Jones S, Howl J.	Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(N)=O
DRAMP33557	likkalaalaklni	14	Retro-inverso Mastoparan	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-373MG (LD50=80.40 μM)	Not available	Linear	Free	Amidation		D	Not available	Not available	22148546	Bioconjug Chem. 2012 Jan 18;23(1):47-56. 	Jones S, Howl J.	Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide	CC[C@H](C)[C@@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](N)CC(C)C)[C@@H](C)CC)C(N)=O
DRAMP33558	INLKKLAKLXKKIL	14	Mitoparan, Mastoparan [A5,8K;A10Aib]	P01514		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-373MG (LD50=9.44 μM)	Not available	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Not available	Not available	22148546	Bioconjug Chem. 2012 Jan 18;23(1):47-56. 	Jones S, Howl J.	Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide	
DRAMP33559	inlkklaklXkkil	14	Inverso Mitoparan	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-373MG (LD50=13.95 μM)	Not available	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	Mix	Not available	Not available	22148546	Bioconjug Chem. 2012 Jan 18;23(1):47-56. 	Jones S, Howl J.	Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide	
DRAMP33560	LIKKXLKALKKLNI	14	Retro Mitoparan	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-373MG (LD50>100 μM)	Not available	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	L	Not available	Not available	22148546	Bioconjug Chem. 2012 Jan 18;23(1):47-56. 	Jones S, Howl J.	Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide	
DRAMP33561	likkXlkalkklni	14	Retro-inverso Mitoparan	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-373MG (LD50=67.15 μM)	Not available	Linear	Free	Amidation	X=AIB (Aminoisobutyric acid)	Mix	Not available	Not available	22148546	Bioconjug Chem. 2012 Jan 18;23(1):47-56. 	Jones S, Howl J.	Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide	
DRAMP33562	GNNKPVYRPQPRPPHPRL	18	Apidaecin-1B [R4K, I8R]	P35581		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A431 (30% Cytotoxicity=10 µM); MDA-MB-231 (Not active up to 10 µM)	Not available	Linear	Free	Free		L	Not available	Not available	31209863	Biotechnol Bioeng. 2019 Oct;116(10):2439-2450.	Lai PK, Tresnak DT, Hackel BJ. 	Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(C)C)C(=O)O
DRAMP33563	VDKGSYRPRPTPPKPIYNRN	20	Pyrrhocoricin [L7R, R14K]	P37362		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A431 (<10% Cytotoxicity=10 µM); MDA-MB-231 (Not active up to 10 µM)	Not available	Linear	Free	Free		L	Not available	Not available	31209863	Biotechnol Bioeng. 2019 Oct;116(10):2439-2450.	Lai PK, Tresnak DT, Hackel BJ. 	Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP33564	VDKPPYLPRPRPPRXIYNX	19	Oncocin Onc72	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 600 µg/ml); HepG2 (Not active up to 600 µg/ml); SH-SY5Y (Not active up to 600 µg/ml)	Not available	Linear	Free	Amidation	X=Orn	L	HEK293: Not active up to 600 µg/ml	Not available	26334348	Amino Acids. 2016 Jan;48(1):269-80.	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	
DRAMP33565	VRKPPYLPRPRWPRXIYNX	19	Oncocin Onc72 analog a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SH-SY5Y (<5% Cytotoxicity=600 µg/ml); HeLa  (25% Cytotoxicity=600 µg/ml); HepG2 (Not active up to 600 µg/ml)	Not available	Linear	Free	Amidation	X=Orn	L	HEK293: Not active up to 600 µg/ml	Not available	26334348	Amino Acids. 2016 Jan;48(1):269-80.	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	
DRAMP33566	VXKPPYLPRPRWPRXIYNX	19	Oncocin Onc72 analog b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SH-SY5Y (10% Cytotoxicity=600 µg/ml); HeLa  (20-25% Cytotoxicity=600 µg/ml); HepG2 (Not active up to 600 µg/ml)	Not available	Linear	Free	Amidation	X=Orn	L	HEK293: Not active up to 600 µg/ml	Not available	26334348	Amino Acids. 2016 Jan;48(1):269-80.	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	
DRAMP33567	VrKPPYLPRPRWPRXIYNX	19	Oncocin Onc72 analog c	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (<5% Cytotoxicity=600 µg/ml); HeLa  (20-25% Cytotoxicity=600 µg/ml); SH-SY5Y (Not active up to 600 µg/ml)	Not available	Linear	Free	Amidation	r=D-Arg; X=Orn	Mix	HEK293: Not active up to 600 µg/ml	Not available	26334348	Amino Acids. 2016 Jan;48(1):269-80.	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	
DRAMP33568	VDKPPYLPRPRPxRxXYNX	19	Oncocin Onc110	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SH-SY5Y (<5% Cytotoxicity=600 µg/ml); HeLa  (20-25% Cytotoxicity=600 µg/ml); HepG2 (Not active up to 600 µg/ml)	Not available	Linear	Free	Amidation	x=trans-4-hydroxyproline; X(16)=tert-Leu; X(19)=Orn	Mix	HEK293: Not active up to 600 µg/ml	Not available	26334348	Amino Acids. 2016 Jan;48(1):269-80.	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	
DRAMP33569	VRKPPYLPRPRWxRxjYNX	19	Oncocin Onc110 analog a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (<10% Cytotoxicity=600 µg/ml); HeLa  (10-20% Cytotoxicity=600 µg/ml); SH-SY5Y (Not active up to 600 µg/ml)	Not available	Linear	Free	Amidation	x=trans-4-hydroxyproline; X(16)=tert-Leu; X(19)=Orn	Mix	HEK293: Not active up to 600 µg/ml	Not available	26334348	Amino Acids. 2016 Jan;48(1):269-80.	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	
DRAMP33570	VXKPPYLPRPRWxRxjYNX	19	Oncocin Onc110 analog b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (<5% Cytotoxicity=600 µg/ml); SH-SY5Y (10% Cytotoxicity=600 µg/ml); HeLa  (10-20% Cytotoxicity=600 µg/ml)	Not available	Linear	Free	Amidation	x=trans-4-hydroxyproline; X(16)=tert-Leu; X(2/19)=Orn	Mix	HEK293: Not active up to 600 µg/ml	Not available	26334348	Amino Acids. 2016 Jan;48(1):269-80.	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	
DRAMP33571	VrKPPYLPRPRWxRxjYNX	19	Oncocin Onc110 analog c	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (10-20% Cytotoxicity=600 µg/ml); SH-SY5Y (5% Cytotoxicity=600 µg/ml); HepG2 (Not active up to 600 µg/ml)	Not available	Linear	Free	Amidation	r=D-Arg; x=trans-4-hydroxyproline; X(16)=tert-Leu; X(19)=Orn	Mix	HEK293: Not active up to 600 µg/ml	Not available	26334348	Amino Acids. 2016 Jan;48(1):269-80.	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	
DRAMP33572	VRKPPYLPRPRWPRrIYNr	19	Oncocin Onc112 analog a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (<5% Cytotoxicity=600 µg/ml); SH-SY5Y (10% Cytotoxicity=600 µg/ml); HeLa  (50-60% Cytotoxicity=600 µg/ml)	Not available	Linear	Free	Amidation	r=D-Arg	Mix	HEK293: 50-60% Cytotoxicity=600 µg/ml	Not available	26334348	Amino Acids. 2016 Jan;48(1):269-80.	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33573	VXKPPYLPRPRWPRrIYNr	19	Oncocin Onc112 analog b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SH-SY5Y (<10% Cytotoxicity=600 µg/ml); HepG2 (10% Cytotoxicity=600 µg/ml); HeLa  (40% Cytotoxicity=601 µg/ml)	Not available	Linear	Free	Amidation	r=D-Arg; X=Orn	Mix	HEK293: 50-60% Cytotoxicity=600 µg/ml	Not available	26334348	Amino Acids. 2016 Jan;48(1):269-80.	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	
DRAMP33574	VrKPPYLPRPRWPRrIYNr	19	Oncocin Onc112 analog c	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (<10% Cytotoxicity=600 µg/ml); SH-SY5Y (10% Cytotoxicity=600 µg/ml); HeLa  (50-60% Cytotoxicity=600 µg/ml)	Not available	Linear	Free	Amidation	r=D-Arg	Mix	HEK293: 50-60% Cytotoxicity=600 µg/ml	Not available	26334348	Amino Acids. 2016 Jan;48(1):269-80.	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33575	KIVPAMICAVTKKC	14	C14C3lexin, Ranalexin (7-20) C14	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=12 µg/ml); LNCaP C4-2 (IC50=16 µg/ml); HepG2 (IC50=18 µg/ml); HeLa  (IC50=30 µg/ml)	Not available	Cyclic	CH3(CH2)12CO, Myristic acid	Free		L	CHO-K1: IC50=17 µg/ml; PBMC: IC50=15 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33576	KIVPAMICAVTKKC	14	C14C3lexin, Ranalexin (7-20) C14	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP C4-2 (IC50=13 µg/ml); MEC-7 (IC50=13 µg/ml); HepG2 (IC50=15 µg/ml); HeLa  (IC50=22 µg/ml)	Not available	Cyclic	CH3(CH2)12CO, Myristic acid	Free		L	CHO-K1: IC50=17 µg/ml; PBMC: IC50=15 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33577	KIVPAMICAVTKKC	14	C14C3lexin, Ranalexin (7-20) C14	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=10 µg/ml); LNCaP C4-2 (IC50=15 µg/ml); HepG2 (IC50=19 µg/ml); HeLa  (IC50=30 µg/ml)	Not available	Cyclic	CH3(CH2)12CO, Myristic acid	Free		L	CHO-K1: IC50=17 µg/ml; PBMC: IC50=15 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33578	KIVPAMICAVTKKC	14	C14C3lexin, Ranalexin (7-20) C14	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=17 µg/ml); LNCaP C4-2 (IC50=20 µg/ml); HeLa  (IC50=30 µg/ml); HepG2 (IC50=32 µg/ml)	Not available	Cyclic	CH3(CH2)12CO, Myristic acid	Free		L	CHO-K1: IC50=17 µg/ml; PBMC: IC50=15 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33579	KIVPAMICAVTKKC	14	C14C3lexin, Ranalexin (7-20) C14	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP C4-2 (IC50=35 µg/ml); MEC-7 (IC50=35 µg/ml); HeLa  (IC50=36 µg/ml); HepG2 (IC50=48 µg/ml)	Not available	Cyclic	CH3(CH2)12CO, Myristic acid	Free		L	CHO-K1: IC50=17 µg/ml; PBMC: IC50=15 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33580	KIVPAMICAVTKKC	14	C13C3lexin, Ranalexin (7-20) C13	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=12 µg/ml); LNCaP C4-2 (IC50=16 µg/ml); HepG2 (IC50=18 µg/ml); HeLa  (IC50=30 µg/ml)	Not available	Cyclic	CH3(CH2)11CO, Tridecanoic acid	Free		L	CHO-K1: IC50=16 µg/ml; PBMC: IC50=16 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33581	KIVPAMICAVTKKC	14	C13C3lexin, Ranalexin (7-20) C13	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP C4-2 (IC50=13 µg/ml); MEC-7 (IC50=13 µg/ml); HepG2 (IC50=15 µg/ml); HeLa  (IC50=22 µg/ml)	Not available	Cyclic	CH3(CH2)11CO, Tridecanoic acid	Free		L	CHO-K1: IC50=16 µg/ml; PBMC: IC50=16 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33582	KIVPAMICAVTKKC	14	C13C3lexin, Ranalexin (7-20) C13	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=10 µg/ml); LNCaP C4-2 (IC50=15 µg/ml); HepG2 (IC50=19 µg/ml); HeLa  (IC50=30 µg/ml)	Not available	Cyclic	CH3(CH2)11CO, Tridecanoic acid	Free		L	CHO-K1: IC50=16 µg/ml; PBMC: IC50=16 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33583	KIVPAMICAVTKKC	14	C13C3lexin, Ranalexin (7-20) C13	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=17 µg/ml); LNCaP C4-2 (IC50=20 µg/ml); HeLa  (IC50=30 µg/ml); HepG2 (IC50=32 µg/ml)	Not available	Cyclic	CH3(CH2)11CO, Tridecanoic acid	Free		L	CHO-K1: IC50=16 µg/ml; PBMC: IC50=16 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33584	KIVPAMICAVTKKC	14	C13C3lexin, Ranalexin (7-20) C13	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP C4-2 (IC50=35 µg/ml); MEC-7 (IC50=35 µg/ml); HeLa  (IC50=36 µg/ml); HepG2 (IC50=48 µg/ml)	Not available	Cyclic	CH3(CH2)11CO, Tridecanoic acid	Free		L	CHO-K1: IC50=16 µg/ml; PBMC: IC50=16 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33585	KIVPAMICAVTKKC	14	C12C3lexin, Ranalexin (7-20) C12	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=12 µg/ml); LNCaP C4-2 (IC50=16 µg/ml); HepG2 (IC50=18 µg/ml); HeLa  (IC50=30 µg/ml)	Not available	Cyclic	CH3(CH2)10CO, Dodecanoic acid	Free		L	CHO-K1: IC50=23 µg/ml; PBMC: IC50=20 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33586	KIVPAMICAVTKKC	14	C12C3lexin, Ranalexin (7-20) C12	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP C4-2 (IC50=13 µg/ml); MEC-7 (IC50=13 µg/ml); HepG2 (IC50=15 µg/ml); HeLa  (IC50=22 µg/ml)	Not available	Cyclic	CH3(CH2)10CO, Dodecanoic acid	Free		L	CHO-K1: IC50=23 µg/ml; PBMC: IC50=20 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33587	KIVPAMICAVTKKC	14	C12C3lexin, Ranalexin (7-20) C12	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=10 µg/ml); LNCaP C4-2 (IC50=15 µg/ml); HepG2 (IC50=19 µg/ml); HeLa  (IC50=30 µg/ml)	Not available	Cyclic	CH3(CH2)10CO, Dodecanoic acid	Free		L	CHO-K1: IC50=23 µg/ml; PBMC: IC50=20 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33588	KIVPAMICAVTKKC	14	C12C3lexin, Ranalexin (7-20) C12	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=17 µg/ml); LNCaP C4-2 (IC50=20 µg/ml); HeLa  (IC50=30 µg/ml); HepG2 (IC50=32 µg/ml)	Not available	Cyclic	CH3(CH2)10CO, Dodecanoic acid	Free		L	CHO-K1: IC50=23 µg/ml; PBMC: IC50=20 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33589	KIVPAMICAVTKKC	14	C12C3lexin, Ranalexin (7-20) C12	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP C4-2 (IC50=35 µg/ml); MEC-7 (IC50=35 µg/ml); HeLa  (IC50=36 µg/ml); HepG2 (IC50=48 µg/ml)	Not available	Cyclic	CH3(CH2)10CO, Dodecanoic acid	Free		L	CHO-K1: IC50=23 µg/ml; PBMC: IC50=20 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33590	KIVPAMICAVTKKC	14	C11C3lexin, Ranalexin (7-20) C11	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=12 µg/ml); LNCaP C4-2 (IC50=16 µg/ml); HepG2 (IC50=18 µg/ml); HeLa  (IC50=30 µg/ml)	Not available	Cyclic	CH3(CH2)9CO, Undecanoic acid	Free		L	CHO-K1: IC50=25 µg/ml; PBMC: IC50=22 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33591	KIVPAMICAVTKKC	14	C11C3lexin, Ranalexin (7-20) C11	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP C4-2 (IC50=13 µg/ml); MEC-7 (IC50=13 µg/ml); HepG2 (IC50=15 µg/ml); HeLa  (IC50=22 µg/ml)	Not available	Cyclic	CH3(CH2)9CO, Undecanoic acid	Free		L	CHO-K1: IC50=25 µg/ml; PBMC: IC50=22 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33592	KIVPAMICAVTKKC	14	C11C3lexin, Ranalexin (7-20) C11	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=10 µg/ml); LNCaP C4-2 (IC50=15 µg/ml); HepG2 (IC50=19 µg/ml); HeLa  (IC50=30 µg/ml)	Not available	Cyclic	CH3(CH2)9CO, Undecanoic acid	Free		L	CHO-K1: IC50=25 µg/ml; PBMC: IC50=22 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33593	KIVPAMICAVTKKC	14	C11C3lexin, Ranalexin (7-20) C11	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=17 µg/ml); LNCaP C4-2 (IC50=20 µg/ml); HeLa  (IC50=30 µg/ml); HepG2 (IC50=32 µg/ml)	Not available	Cyclic	CH3(CH2)9CO, Undecanoic acid	Free		L	CHO-K1: IC50=25 µg/ml; PBMC: IC50=22 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33594	KIVPAMICAVTKKC	14	C11C3lexin, Ranalexin (7-20) C11	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP C4-2 (IC50=35 µg/ml); MEC-7 (IC50=35 µg/ml); HeLa  (IC50=36 µg/ml); HepG2 (IC50=48 µg/ml)	Not available	Cyclic	CH3(CH2)9CO, Undecanoic acid	Free		L	CHO-K1: IC50=25 µg/ml; PBMC: IC50=22 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33595	KIVPAMICAVTKKC	14	C10C3lexin, Ranalexin (7-20) C10	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=12 µg/ml); LNCaP C4-2 (IC50=16 µg/ml); HepG2 (IC50=18 µg/ml); HeLa  (IC50=30 µg/ml)	Not available	Cyclic	CH3(CH2)8CO, Decanoic acid	Free		L	CHO-K1: IC50=40 µg/ml; PBMC: IC50=108.1 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33596	KIVPAMICAVTKKC	14	C10C3lexin, Ranalexin (7-20) C10	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP C4-2 (IC50=13 µg/ml); MEC-7 (IC50=13 µg/ml); HepG2 (IC50=15 µg/ml); HeLa  (IC50=22 µg/ml)	Not available	Cyclic	CH3(CH2)8CO, Decanoic acid	Free		L	CHO-K1: IC50=40 µg/ml; PBMC: IC50=108.1 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33597	KIVPAMICAVTKKC	14	C10C3lexin, Ranalexin (7-20) C10	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=10 µg/ml); LNCaP C4-2 (IC50=15 µg/ml); HepG2 (IC50=19 µg/ml); HeLa  (IC50=30 µg/ml)	Not available	Cyclic	CH3(CH2)8CO, Decanoic acid	Free		L	CHO-K1: IC50=40 µg/ml; PBMC: IC50=108.1 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33598	KIVPAMICAVTKKC	14	C10C3lexin, Ranalexin (7-20) C10	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MEC-7 (IC50=17 µg/ml); LNCaP C4-2 (IC50=20 µg/ml); HeLa  (IC50=30 µg/ml); HepG2 (IC50=32 µg/ml)	Not available	Cyclic	CH3(CH2)8CO, Decanoic acid	Free		L	CHO-K1: IC50=40 µg/ml; PBMC: IC50=108.1 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33599	KIVPAMICAVTKKC	14	C10C3lexin, Ranalexin (7-20) C10	P39084		Not found	Synthetic (Derived from Ranalexin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: LNCaP C4-2 (IC50=35 µg/ml); MEC-7 (IC50=35 µg/ml); HeLa  (IC50=36 µg/ml); HepG2 (IC50=48 µg/ml)	Not available	Cyclic	CH3(CH2)8CO, Decanoic acid	Free		L	CHO-K1: IC50=40 µg/ml; PBMC: IC50=108.1 µg/ml	Not available	29649587	Int J Antimicrob Agents. 2018 Jul;52(1):52-62. 	Domhan C, Uhl P, Meinhardt A, Zimmermann S, Kleist C, Lindner T, Leotta K, Mier W, Wink M.	A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics	CCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP33600	GLLKKLLKKLLKKL	14	G(LLKK)3L-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (>80% Killing=50 µM); HeLa  (70% Killing=50 µM)	Human erythrocytes: HC50=30 µM	Linear	Free	Amidation		L	Human keratinocytes HaCat: >90% Killing=40 µM	Not available	Not available			Amino acid side chains affect the bioactivity of designed short peptide amphiphiles	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(N)=O
DRAMP33601	GXXKKXXKKXXKKX	14	G(ZZKK)3Z-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (>80% Killing=50 µM); HeLa  (60% Killing=50 µM)	Human erythrocytes: HC50=30 µM	Linear	Free	Amidation	X=Norleucine	L	Human keratinocytes HaCat: 30% Killing=40 µM	Not available	Not available			Amino acid side chains affect the bioactivity of designed short peptide amphiphiles	
DRAMP33602	GVVKKVVKKVVKKV	14	G(VVKK)3V-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (<10% Killing=50 µM); HL-60 (>80% Killing=50 µM)	Human erythrocytes: Not active up to 250 µM	Linear	Free	Amidation		L	Human keratinocytes HaCat: <30% Killing=40 µM	Not available	Not available			Amino acid side chains affect the bioactivity of designed short peptide amphiphiles	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(N)=O
DRAMP33603	GIIXXIIXXIIXXI	14	G(IIOO)3I-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM)	Human erythrocytes: HC50>250 µM	Linear	Free	Amidation	X=Orn	L	Human keratinocytes HaCat: <5% Killing=40 µM	Not available	Not available			Amino acid side chains affect the bioactivity of designed short peptide amphiphiles	
DRAMP33604	GIIXXIIXXIIXXI	14	G(IIOO)3I-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM)	Human erythrocytes: HC50>250 µM	Linear	Free	Amidation	X=Orn	L	Human keratinocytes HaCat: <5% Killing=40 µM	Not available	Not available			Amino acid side chains affect the bioactivity of designed short peptide amphiphiles	
DRAMP33605	GIIXXIIXXIIXXI	14	G(IIOO)3I-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM)	Human erythrocytes: HC50>250 µM	Linear	Free	Amidation	X=Orn	L	Human keratinocytes HaCat: <5% Killing=40 µM	Not available	Not available			Amino acid side chains affect the bioactivity of designed short peptide amphiphiles	
DRAMP33606	GIIXXIIXXIIXXI	14	G(II66)3I-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM)	Human erythrocytes: HC50=200 µM	Linear	Free	Amidation	X=Dab ((S)-2,4-diaminobutyric acid)	L	Human keratinocytes HaCat: <5% Killing=40 µM	Not available	Not available			Amino acid side chains affect the bioactivity of designed short peptide amphiphiles	
DRAMP33607	GIIXXIIXXIIXXI	14	G(II66)3I-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM)	Human erythrocytes: HC50=200 µM	Linear	Free	Amidation	X=Dab ((S)-2,4-diaminobutyric acid)	L	Human keratinocytes HaCat: <5% Killing=40 µM	Not available	Not available			Amino acid side chains affect the bioactivity of designed short peptide amphiphiles	
DRAMP33608	GIIXXIIXXIIXXI	14	G(II66)3I-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM)	Human erythrocytes: HC50=200 µM	Linear	Free	Amidation	X=Dab ((S)-2,4-diaminobutyric acid)	L	Human keratinocytes HaCat: <5% Killing=40 µM	Not available	Not available			Amino acid side chains affect the bioactivity of designed short peptide amphiphiles	
DRAMP33609	GIIXXIIXXIIXXI	14	G(II55)3I-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM)	Human erythrocytes: HC50=200 µM	Linear	Free	Amidation	X=Dap ((S)-2,3-diaminopropionic acid)	L	Human keratinocytes HaCat: <5% Killing=40 µM	Not available	Not available			Amino acid side chains affect the bioactivity of designed short peptide amphiphiles	
DRAMP33610	GIIXXIIXXIIXXI	14	G(II55)3I-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM)	Human erythrocytes: HC50=200 µM	Linear	Free	Amidation	X=Dap ((S)-2,3-diaminopropionic acid)	L	Human keratinocytes HaCat: <5% Killing=40 µM	Not available	Not available			Amino acid side chains affect the bioactivity of designed short peptide amphiphiles	
DRAMP33611	GIIXXIIXXIIXXI	14	G(II55)3I-NH2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=50 µM); HL-60 (>80% Killing=50 µM)	Human erythrocytes: HC50=200 µM	Linear	Free	Amidation	X=Dap ((S)-2,3-diaminopropionic acid)	L	Human keratinocytes HaCat: <5% Killing=40 µM	Not available	Not available			Amino acid side chains affect the bioactivity of designed short peptide amphiphiles	
DRAMP33612	AEEASKKAEEASKKAEEASKKAEEASKKAEEASKKXK	37	AAS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Huh-7 (CC50=2.38±0.9 µM )	Not available	Linear	Acetylation	CH3(CH2)14CONH2, Hexadecanamide	X= β-Ala	L	Not available	Not available	30192544	J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery	
DRAMP33613	VEEVSKKVEEVSKKVEEVSKKVEEVSKKVEEVSKKXK	37	VVS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Huh-7 (CC50=74.5±6.8 µM )	Not available	Linear	Acetylation	CH3(CH2)14CONH2, Hexadecanamide	X= β-Ala	L	Not available	Not available	30192544	J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery	
DRAMP33614	FEEFSKKFEEFSKKFEEFSKKFEEFSKKFEEFSKKXK	37	FFS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Huh-7 (CC50>100 µM )	Not available	Linear	Acetylation	CH3(CH2)14CONH2, Hexadecanamide	X= β-Ala	L	Not available	Not available	30192544	J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery	
DRAMP33615	YEEYSKKYEEYSKKYEEYSKKYEEYSKKYEEYSKKXK	37	YYS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Huh-7 (CC50=19.8±1.6 µM )	Not available	Linear	Acetylation	CH3(CH2)14CONH2, Hexadecanamide	X= β-Ala	L	Not available	Not available	30192544	J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery	
DRAMP33616	LEELSKKLEELSKKLEELSKKLEELSKKLEELSKKXK	37	LLS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Huh-7 (CC50=4.04±0.4 µM )	Not available	Linear	Acetylation	CH3(CH2)14CONH2, Hexadecanamide	X= β-Ala	L	Not available	Not available	30192544	J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery	
DRAMP33617	IEEISKKIEEISKKIEEISKKIEEISKKIEEISKKXK	37	IIS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Huh-7 (CC50=88.8±28 µM )	Not available	Linear	Acetylation	CH3(CH2)14CONH2, Hexadecanamide	X= β-Ala	L	Not available	Not available	30192544	J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery	
DRAMP33618	IEEIYKKIEEIYKKIEEIYKKIEEIYKKIEEIYKKXK	37	IIY	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Huh-7 (CC50>100 µM )	Not available	Linear	Acetylation	CH3(CH2)14CONH2, Hexadecanamide	X= β-Ala	L	Not available	Not available	30192544	J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery	
DRAMP33619	IEEIWKKIEEIWKKIEEIWKKIEEIWKKIEEIWKKXK	37	IIW	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Huh-7 (CC50>100 µM )	Not available	Linear	Acetylation	CH3(CH2)14CONH2, Hexadecanamide	X= β-Ala	L	Not available	Not available	30192544	J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery	
DRAMP33620	IEEIHKKIEEIHKKIEEIHKKIEEIHKKIEEIHKKXK	37	IIH	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Huh-7 (CC50>100 µM )	Not available	Linear	Acetylation	CH3(CH2)14CONH2, Hexadecanamide	X= β-Ala	L	Not available	Not available	30192544	J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery	
DRAMP33621	IEEIQKKIEEIQKKIEEIQKKIEEIQKKIEEIQKKXK	37	IIQ	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Huh-7 (CC50>100 µM )	Not available	Linear	Acetylation	CH3(CH2)14CONH2, Hexadecanamide	X= β-Ala	L	Not available	Not available	30192544	J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery	
DRAMP33622	IEEIKKKIEEIKKKIEEIKKKIEEIKKKIEEIKKKXK	37	IIK	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Huh-7 (CC50=4.54±0.6 µM )	Not available	Linear	Acetylation	CH3(CH2)14CONH2, Hexadecanamide	X= β-Ala	L	Not available	Not available	30192544	J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery	
DRAMP33623	IEEIEKKIEEIEKKIEEIEKKIEEIEKKIEEIEKKXK	37	IIE	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Huh-7 (CC50>100 µM )	Not available	Linear	Acetylation	CH3(CH2)14CONH2, Hexadecanamide	X= β-Ala	L	Not available	Not available	30192544	J Med Chem. 2018 Oct 11;61(19):8734-8745.	Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery	
DRAMP33624	FLWIKLGKLAGAVLKLILGLKKVV	24	Helical1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (EC50=4.4 ± 1.3 µM ); A549 (EC50=8.3 ± 2.0 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)C(C)C)C(C)C
DRAMP33625	GLWAIAVKAGKVILKLIVFIWIRV	24	Helical2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>50 µM ); MCF-7  (EC50>50 µM )	Not available	Linear	Free	Amidation		L	Not available	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C
DRAMP33626	GLLDIAGGNAETLAGHAV	18	Helical3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>50 µM ); MCF-7 (EC50>50 µM )	Not available	Linear	Free	Amidation		L	Not available	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O
DRAMP33627	GLFDVIGSQAGGAAPHFLG	19	Helical4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>50 µM); MCF-7 (EC50>50 µM )	Not available	Linear	Free	Amidation		L	Not available	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
DRAMP33628	KWVKKVHNWLRRWIKVFEALFG	22	AmphiArc1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50=18.4 ± 0.7 µM); MCF-7 (EC50=7.0 ± 0.5 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(N)=O)C(C)C
DRAMP33629	KIFKKFKTIIKKVWRIFGRF	20	AmphiArc2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=5.7 ± 0.7 µM); A549 (EC50=9.3 ± 1.5 µM)	Human erythrocytes: HC50=16 ± 2 µM	Linear	Free	Amidation		L	HDMEC: EC50=3.3 ± 0.2 µM 	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP33630	AFRHSVKEELNYIRRRLERFPNRL	24	AmphiArc3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>50 µM ); MCF-7 (EC50>50 µM )	Not available	Linear	Free	Amidation		L	Not available	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33631	RIENGLRKRLQSIYRHLEE	19	AmphiArc4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>50 µM ); MCF-7 (EC50>50 µM )	Not available	Linear	Free	Amidation		L	Not available	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(N)=O
DRAMP33632	KWVRIWIKVLRGLFVWVWFF	20	Gradient1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>50 µM); MCF-7 (EC50>50 µM )	Not available	Linear	Free	Amidation		L	Not available	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)C(C)C
DRAMP33633	AWLKRIKKFLKALFWVWVW	19	Gradient2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=19.0 ± 1.8 µM); A549 (EC50>50 µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)C(C)C)C(C)C
DRAMP33634	KVVDNFENILII	12	Gradient3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>50 µM); MCF-7 (EC50>50 µM )	Not available	Linear	Free	Amidation		L	Not available	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP33635	RVNAAIPNIIV	11	Gradient4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>50 µM); MCF-7 (EC50>50 µM )	Not available	Linear	Free	Amidation		L	Not available	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@H](C(N)=O)C(C)C)[C@H](C)CC
DRAMP33636	RVFKKFHPIYHRVWRLWGHL	20	AmphiArc2 Off1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=27.4 ± 0.5 µM); A549 (EC50=49 ± 2 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=56 ± 7 µM 	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33637	HIIKKIRTWYRKAWHVLGKV	20	AmphiArc2 Off2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=10 ± 2 µM); A549 (EC50=17.0 ± 0.6 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=32 ± 3 µM 	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP33638	KLYKKFRHILKKVWHYVGKI	20	AmphiArc2 Off3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=10 ± 1 µM); A549 (EC50=14 ± 3 µM)	Human erythrocytes: HC50=29 ± 3 µM	Linear	Free	Free		L	HDMEC: EC50=10 ± 3 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(C)C)C(=O)O
DRAMP33639	KYIRHLKTWFKKVFKLIGEV	20	AmphiArc2 Off4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=11 ± 2 µM); A549 (EC50=15.0 ± 0.1 µM)	Human erythrocytes: HC50=20 ± 3 µM	Linear	Free	Free		L	HDMEC: EC50=7.1 ± 0.1 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP33640	KIFKKFKDFLKKIFQYLGKV	20	AmphiArc2 Off5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=12.4 ± 0.4 µM); A549 (EC50=17.4 ± 0.1 µM)	Human erythrocytes: HC50=15 ± 2 µM	Linear	Free	Free		L	HDMEC: EC50=10.1 ± 0.2 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33641	HIFKKVKTYWKKLFRILGRF	20	AmphiArc2 Off6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=12 ± 3 µM); A549 (EC50=18 ± 2 µM)	Human erythrocytes: HC50=16 ± 2 µM	Linear	Free	Free		L	HDMEC: EC50=5.0 ± 0.7 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP33642	RLIKRLKTFVRKTWKWVGHF	20	AmphiArc2 Off7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=39 ± 3 µM); A549 (EC50=52 ± 2 µM)	Human erythrocytes: HC50=95 ± 7 µM	Linear	Free	Free		L	HDMEC: EC50=12 ± 3 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP33643	RFLKHFKTVYKRYWKVLGRL	20	AmphiArc2 Off8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=11.9 ± 0.1 µM); A549 (EC50=17 ± 4 µM)	Human erythrocytes: HC50=144 ± 4 µM	Linear	Free	Free		L	HDMEC: EC50=14.3 ± 0.2 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(C)C)C(C)C)C(=O)O
DRAMP33644	KLIHRLKTVFKKVWHFLGHL	20	AmphiArc2 Off9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=18.9 ± 0.2 µM); A549 (EC50=22 ± 4 µM)	Human erythrocytes: HC50=41 ± 3 µM	Linear	Free	Free		L	HDMEC: EC50=22 ± 3 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP33645	HRIRQLKTTIKKFWEIWPKI	20	AmphiArc2 Off10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=56 ± 5 µM); A549 (EC50=83 ± 11 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=58.1 ± 0.3 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP33646	QVFKKFRPFYRRPWELFGKL	20	AmphiArc2 Off2.1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=91 ± 2 µM); A549 (EC50>100 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=173 ± 1 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)O
DRAMP33647	QIIKKIRTWYRKAWHVLGKV	20	AmphiArc2 Off2.2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=11.6 ± 0.8 µM); A549 (EC50=20 ± 1 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=42 ± 7 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP33648	TLYKKFRHFLKKPWHVVGKI	20	AmphiArc2 Off2.3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=65 ± 3 µM); A549 (EC50>100 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=167 ± 13 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(C)C)C(=O)O
DRAMP33649	HYIRHLKTWFHKPFKLIGKV	20	AmphiArc2 Off2.4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 µM); MCF-7 (EC50>100 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=169 ± 28 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP33650	KIFKKFKDWFKKAFHVLGKV	20	AmphiArc2 Off2.5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=10.4 ± 0.8 µM); A549 (EC50=14.8 ± 0.7 µM)	Human erythrocytes: HC50>100 µM	Linear	Free	Free		L	HDMEC: EC50=22 ± 1 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33651	QIFKKVKTWYKKAFQILGRL	20	AmphiArc2 Off2.6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50=12.4 ± 0.1 µM); MCF-7 (EC50=9.3 ± 0.2 µM)	Human erythrocytes: HC50>100 µM	Linear	Free	Free		L	HDMEC: EC50=21 ± 2 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33652	RLIKRIKTWYRKAWKVVGKF	20	AmphiArc2 Off2.7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=11.2 ± 0.7 µM); A549 (EC50=15 ± 1 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=23 ± 5 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@H](C)CC
DRAMP33653	RFLKHLHTYYERAWHVIGHL	20	AmphiArc2 Off2.8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 µM); MCF-7 (EC50>100 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=2 ± 2 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP33654	HLIHRLHTYWHKPWHYLGKL	20	AmphiArc2 Off2.9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50>100 µM); MCF-7 (EC50>100 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=135 ± 2 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
DRAMP33655	QRIRQLHTWIKKAWHIWPKI	20	AmphiArc2 Off2.10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=28.6 ± 0.1 µM); A549 (EC50=40 ± 2 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=39.7 ± 0.3 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP33656	QVVKKIRTWYHKAWHVLGKV	20	AmphiArc2 Off2.2.1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=76 ± 15 µM); A549 (EC50>100 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=96 ± 7 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP33657	QLIHKIRTWYRKAWHVLGKV	20	AmphiArc2 Off2.2.2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=13 ± 1 µM); A549 (EC50=20 ± 2 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=28 ± 3 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@H](C)CC
DRAMP33658	HLLKKWRTWLRKAWHIVGKV	20	AmphiArc2 Off2.2.3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=7 ± 1 µM); A549 (EC50=9 ± 1 µM)	Human erythrocytes: HC50=59 ± 6 µM	Linear	Free	Free		L	HDMEC: EC50=6.1 ± 0.5 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP33659	QVLKKVRTWYRKAFHVIGKV	20	AmphiArc2 Off2.2.4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=68 ± 5 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50>100 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP33660	QLLKKVRTWYRKAWHLYGKV	20	AmphiArc2 Off2.2.5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=16 ± 2 µM); A549 (EC50=29.3 ± 0.9 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=27.2 ± 0.5 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP33661	QLIKKLRTWYRKAWHVLGKL	20	AmphiArc2 Off2.2.6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50=10.6 ± 0.8 µM); MCF-7 (EC50=6.5 ± 0.2 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=9 ± 1 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O
DRAMP33662	QIIKKVRTWIKKAWHLIGKI	20	AmphiArc2 Off2.2.7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (EC50=12 ± 2 µM); MCF-7 (EC50=8 ± 1 µM)	Human erythrocytes: HC50>100 µM	Linear	Free	Free		L	HDMEC: EC50=17 ± 1 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP33663	QYLRRVRTWLRRAWHILGKV	20	AmphiArc2 Off2.2.8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=11.0 ± 0.2 µM); A549 (EC50=16.5 ± 0.2 µM)	Human erythrocytes: HC50=21 ± 1 µM	Linear	Free	Free		L	HDMEC: EC50=10.3 ± 0.3 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP33664	QLLKKIRTWYRKAWHVYGKV	20	AmphiArc2 Off2.2.9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=13 ± 1 µM); A549 (EC50=28 ± 3 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=21 ± 2 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP33665	QIYKKYRTWYRKAWKVLGKV	20	AmphiArc2 Off2.2.10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (EC50=16.9 ± 0.8 µM); A549 (EC50=36 ± 7 µM)	Human erythrocytes: HC50>200 µM	Linear	Free	Free		L	HDMEC: EC50=71 ± 12 µM	Not available	31375699	 Sci Rep. 2019 Aug 2;9(1):11282.	Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G. 	In silico design and optimization of selective membranolytic anticancer peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP33666	CXGRCLLIIKLAKLAKKLAKLAK	23	CDAK	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	AMPs containing CisoDGRC selectively kill CD13-/αvβ3+ breast cancer cells by inducing apoptosis and inhibiting proliferation. Furthermore, the vivo experiments showed that AMPs containing CisoDGRC could significantly inhibited CD13-/αvβ3+ tumor progression and angiogenesis.	Tumor cells: MCF-7  (IC50=190 µg/ml); MDA-MB-231 (IC50=212 µg/ml)	Not available	Cyclic	Free	Free	X=iso-Asp	L	HUVEC: IC50=861 µg/ml; HFF: IC50=912 µg/ml	CD13-/αvβ3+ tumor cells	23326440	PLoS One. 2013;8(1):e53491.	Hou L, Zhao X, Wang P, Ning Q, Meng M, Liu C.	Antitumor Activity of Antimicrobial Peptides Containing CisoDGRC in CD13 Negative Breast Cancer Cells	
DRAMP33667	RFRLPFRRIHPPPFVRIHPPPFYRRFL	27	ChBac3.4-1-NH2	P85170		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (IC50=4.5 ± 1.6 μM); K562 (IC50=8.4 ± 1.1 μM)	Human erythrocytes: <5% Hemolysis=64 µM	Linear	Free	Amidation		L	Human PBMC: IC50=12.1 ± 0.8 µM	Not available	33194795	Front Cell Infect Microbiol. 2020 Oct 19;10:552905. 	Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.	Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33668	RFRLPFRRIHPPPFVRIHPPPFYRRFL	27	ChBac3.4-1-NH2	P85170		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=16.5 ± 1.3 μM); U-937 (IC50=9.8 ± 0.5 μM)	Human erythrocytes: <5% Hemolysis=64 µM	Linear	Free	Amidation		L	Human PBMC: IC50=12.1 ± 0.8 µM	Not available	33194795	Front Cell Infect Microbiol. 2020 Oct 19;10:552905. 	Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.	Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33669	RFRLPFRRIHPPPFVRIHPPPFYRRFL	27	ChBac3.4-1-COOH	P85170		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (IC50=4.5 ± 1.6 μM); K562 (IC50=8.4 ± 1.1 μM)	Human erythrocytes: <5% Hemolysis=64 µM	Linear	Free	Free		L	Human PBMC: IC50=33.7 ± 3.2 µM	Not available	33194795	Front Cell Infect Microbiol. 2020 Oct 19;10:552905. 	Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.	Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33670	RFRLPFRRIHPPPFVRIHPPPFYRRFL	27	ChBac3.4-1-COOH	P85170		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=16.5 ± 1.3 μM); U-937 (IC50=9.8 ± 0.5 μM)	Human erythrocytes: <5% Hemolysis=64 µM	Linear	Free	Free		L	Human PBMC: IC50=33.7 ± 3.2 µM	Not available	33194795	Front Cell Infect Microbiol. 2020 Oct 19;10:552905. 	Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.	Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33671	RFRRFRLPFRRIHPPPFVRIHPPPFYRRFL	30	RFR-ChBac3.4-1-NH2	P85170		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=20.0 ± 3.4 μM); U-937 (IC50=3.2 ± 0.4 μM)	Human erythrocytes: <5% Hemolysis=64 µM	Linear	Free	Amidation		L	Human PBMC: IC50=18.3 ± 4.1 µM	Not available	33194795	Front Cell Infect Microbiol. 2020 Oct 19;10:552905. 	Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.	Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33672	RFRLPFRRPWPIRIHPPPFYPWPFRRFL	28	ChBac3.4-2-COOH	P85170		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=13.7 ± 2.3 μM); U-937 (IC50=4.1 ± 0.3 μM)	Human erythrocytes: 25 ± 2% Hemolysis=64 µM	Linear	Free	Free		L	Human PBMC: IC50=20.2 ± 4.5 µM	Not available	33194795	Front Cell Infect Microbiol. 2020 Oct 19;10:552905. 	Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.	Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33673	RFRLPFRRPPIRIPPPFYPPFRRFL	25	ChBac3.4 (H-)	P85170		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (IC50=11.5 ± 0.5 μM); K562 (IC50=25.0 ± 3.5 μM)	Human erythrocytes: <5% Hemolysis=64 µM	Linear	Free	Amidation		L	Human PBMC: IC50=34.7 ± 7.3 µM	Not available	33194795	Front Cell Infect Microbiol. 2020 Oct 19;10:552905. 	Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.	Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP33674	RIHPPPFYPPFRRFL	15	ChBac3.4 (12-26)	P85170		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (IC50=17.0 ± 1.1 μM); K562 (IC50=39.4 ± 2.3 μM)	Human erythrocytes: <5% Hemolysis=64 µM	Linear	Free	Amidation		L	Human PBMC: IC50=43.3 ± 7.7 µM	Not available	33194795	Front Cell Infect Microbiol. 2020 Oct 19;10:552905. 	Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.	Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP33675	RFRLPFRRPPIRIHPPPFY	19	ChBac3.4 (1-19)-NH2	P85170		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=28.0 ± 6.5 μM); U-937 (IC50>64 μM)	Human erythrocytes: <5% Hemolysis=64 µM	Linear	Free	Amidation		L	Human PBMC: IC50>64 µM	Not available	33194795	Front Cell Infect Microbiol. 2020 Oct 19;10:552905. 	Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.	Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
DRAMP33676	RFRLPFRRPPIRIH	14	ChBac3.4 (1-14)-NH2	P85170		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=33.6 ± 4.1 μM); U-937 (IC50>64 μM)	Human erythrocytes: <5% Hemolysis=64 µM	Linear	Free	Amidation		L	Human PBMC: IC50>64 µM	Not available	33194795	Front Cell Infect Microbiol. 2020 Oct 19;10:552905. 	Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.	Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O
DRAMP33677	RFRRFRLPFRRPPIRIH	17	RFR-ChBac3.4 (1-14)-NH2	P85170		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=39.4 ± 6.6 μM); U-937 (IC50>64 μM)	Human erythrocytes: <5% Hemolysis=64 µM	Linear	Free	Amidation		L	Human PBMC: IC50>64 µM	Not available	33194795	Front Cell Infect Microbiol. 2020 Oct 19;10:552905. 	Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.	Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(N)=O
DRAMP33678	FTILKKLKSFIK	12	Modifed Coco1	I0YNC0		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (CC50>200 μM )	Human erythrocytes: <10% Hemolysis=50 µM	Linear	Free	Free		L	Not available	Not available	33063186	Amino Acids. 2020 Oct;52(10):1403-1412	Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. 	Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33679	KLVKKLLKKYITF	13	Modifed Coco2	I0Z3W2		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (CC50=200 μM )	Human erythrocytes: <10% Hemolysis=50 µM	Linear	Free	Free		L	Not available	Not available	33063186	Amino Acids. 2020 Oct;52(10):1403-1412	Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. 	Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP33680	LARFVLRILKYGFK	14	Modifed Coco3	I0YQ90		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (CC50=12.5 μM); CaCo-2 (CC50=25 μM)	Human erythrocytes: 10% Hemolysis=9.38 µM	Linear	Free	Free		L	Not available	Not available	33063186	Amino Acids. 2020 Oct;52(10):1403-1412	Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. 	Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP33681	IPLLRKGKKIIWW	13	Modifed Opero1	A0A0L7KPW9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (CC50>200 μM)	Human erythrocytes: <10% Hemolysis=50 µM	Linear	Free	Free		L	Not available	Not available	33063186	Amino Acids. 2020 Oct;52(10):1403-1412	Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. 	Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes	CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H](C)CC)[C@H](C)CC
DRAMP33682	GLKKVIKLLRPLL	13	Modifed Opero2	A0A0L7L9V8		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (CC50=50 μM)	Human erythrocytes: <10% Hemolysis=50 µM	Linear	Free	Free		L	Not available	Not available	33063186	Amino Acids. 2020 Oct;52(10):1403-1412	Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. 	Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33683	ILKPKLWKLTVVARKIIK	18	Modifed Opero3	A0A0L7LPN7		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (CC50=200 μM)	Human erythrocytes: <10% Hemolysis=50 µM	Linear	Free	Free		L	Not available	Not available	33063186	Amino Acids. 2020 Oct;52(10):1403-1412	Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. 	Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C)[C@@H](C)O
DRAMP33684	IVIKSLGKFLKNVGGFAG	18	Modifed Pyro1	O58222		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (CC50>200 μM)	Human erythrocytes: <10% Hemolysis=50 µM	Linear	Free	Free		L	Not available	Not available	33063186	Amino Acids. 2020 Oct;52(10):1403-1412	Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. 	Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(C)C)[C@H](C)CC)C(C)C
DRAMP33685	FKLVWKLLKKLALKL	15	Modifed Aper1	Q9Y8Y1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: CaCo-2 (CC50=12.5 μM); A549 (CC50=25 μM)	Human erythrocytes: 10% Hemolysis=5.96 µM	Linear	Free	Free		L	Not available	Not available	33063186	Amino Acids. 2020 Oct;52(10):1403-1412	Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. 	Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)O
DRAMP33686	ITKWLLNAIKKGFKL	15	Modifed Thermo1	B6YW36		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (CC50>200 μM)	Human erythrocytes: 10% Hemolysis=21.9 µM	Linear	Free	Free		L	Not available	Not available	33063186	Amino Acids. 2020 Oct;52(10):1403-1412	Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. 	Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)[C@@H](C)O
DRAMP33687	IHKLVKLWLNLGKKF	15	Modifed Thermo2	B6YTI2		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (CC50>200 μM)	Human erythrocytes: 10% Hemolysis=39.3 µM	Linear	Free	Free		L	Not available	Not available	33063186	Amino Acids. 2020 Oct;52(10):1403-1412	Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. 	Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP33688	LFSIIWKLNRKLIKA	15	Modifed Thermo3	B6YWQ6		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (CC50>200 μM); CaCo-2 (CC50>200 μM)	Human erythrocytes: 10% Hemolysis=37.3 µM	Linear	Free	Free		L	Not available	Not available	33063186	Amino Acids. 2020 Oct;52(10):1403-1412	Duque-Salazar G, Mendez-Otalvaro E, Ceballos-Arroyo AM, Orduz S. 	Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
DRAMP33689	KKK	3	L1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=3.9 ± 1.1 μg/mL)	Human erythrocytes:HC50=90.0 ± 6.5 µg/ml	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	HaCat: IC50=5.2 ± 0.6 µg/ml	Not available	33003569	Int J Mol Sci. 2020 Sep 29;21(19):7208. 	Neubauer D, Jaśkiewicz M, Sikorska E, Bauer SBM, Kapusta M, Narajczyk M, Kamysz W. 	Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33690	CKKKKC	6	C2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=17.9 ± 2.1 μg/mL)	Human erythrocytes:HC50=30.6 ± 1.1 µg/ml	Cyclic	CH3(CH2)14CO, Palmitic acid	Amidation		L	HaCat: IC50=26.9 ± 1.9 µg/ml	Not available	33003569	Int J Mol Sci. 2020 Sep 29;21(19):7208. 	Neubauer D, Jaśkiewicz M, Sikorska E, Bauer SBM, Kapusta M, Narajczyk M, Kamysz W. 	Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP33691	KRKK	4	L4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=3.0 ± 0.6 μg/mL)	Human erythrocytes:HC50=79.8 ± 9.0 µg/ml	Linear	CH3(CH2)14CO, Palmitic acid	Amidation		L	HaCat: IC50=4.3 ± 0.9 µg/ml	Not available	33003569	Int J Mol Sci. 2020 Sep 29;21(19):7208. 	Neubauer D, Jaśkiewicz M, Sikorska E, Bauer SBM, Kapusta M, Narajczyk M, Kamysz W. 	Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33692	CKRKKC	6	C4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=27.5 ± 3.4 μg/mL)	Human erythrocytes:HC50=122.4 ± 16.5 µg/ml	Cyclic	CH3(CH2)14CO, Palmitic acid	Amidation		L	HaCat: IC50=33.8 ± 3.1 µg/ml	Not available	33003569	Int J Mol Sci. 2020 Sep 29;21(19):7208. 	Neubauer D, Jaśkiewicz M, Sikorska E, Bauer SBM, Kapusta M, Narajczyk M, Kamysz W. 	Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP33693	CRRKKC	6	C7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (IC50=20.9 ± 2.1 μg/mL)	Human erythrocytes:HC50=92.0 ± 9.6 µg/ml	Cyclic	CH3(CH2)14CO, Palmitic acid	Amidation		L	HaCat: IC50=21.3 ± 8.2 µg/ml	Not available	33003569	Int J Mol Sci. 2020 Sep 29;21(19):7208. 	Neubauer D, Jaśkiewicz M, Sikorska E, Bauer SBM, Kapusta M, Narajczyk M, Kamysz W. 	Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(N)=O
DRAMP33694	FPVTWRWWKWWKGKFPVTWRWWKWWKG	27	Di-PuroA	P33432		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.	Tumor cells: HeLa  (IC50=32 μg/mL)	Sheep erythrocytes: No hemolysis up tp 500 µg/ml	Linear	Free	Amidation		L	NIH 3T3: IC50=250 µg/ml	Not available	33207639	Int J Mol Sci. 2020 Nov 16;21(22):8624.	Shagaghi N, Clayton AHA, Aguilar MI, Lee TH, Palombo EA, Bhave M.	Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells	CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)[C@@H](C)O
DRAMP33695	RRRRWRWWRWWRR	13	TRPs R8	P33432		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.	Tumor cells: HeLa  (IC50=250 μg/mL)	Sheep erythrocytes: No hemolysis up tp 500 µg/ml	Linear	Free	Amidation		L	NIH 3T3: IC50>250 µg/ml	Not available	33207639	Int J Mol Sci. 2020 Nov 16;21(22):8624.	Shagaghi N, Clayton AHA, Aguilar MI, Lee TH, Palombo EA, Bhave M.	Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP33696	RKRWWRWWKWWKR	13	TRPs P1	P33432		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.	Tumor cells: HeLa  (IC50=32 μg/mL)	Sheep erythrocytes: No hemolysis up tp 500 µg/ml	Linear	Free	Amidation		L	NIH 3T3: IC50=250 µg/ml	Not available	33207639	Int J Mol Sci. 2020 Nov 16;21(22):8624.	Shagaghi N, Clayton AHA, Aguilar MI, Lee TH, Palombo EA, Bhave M.	Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP33697	RKrWWrWwkWWkR	13	TRPs dP1	P33432		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.	Tumor cells: HeLa  (IC50=125 μg/mL)	Sheep erythrocytes: No hemolysis up tp 500 µg/ml	Linear	Free	Amidation	r=D-Arg; w=D-Trp	Mix	NIH 3T3: IC50=250 µg/ml	Not available	33207639	Int J Mol Sci. 2020 Nov 16;21(22):8624.	Shagaghi N, Clayton AHA, Aguilar MI, Lee TH, Palombo EA, Bhave M.	Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells	N=C(N)NCCC[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP33698	RWWKWW	6	TRPs R6	P33432		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.	Tumor cells: HeLa  (IC50>250 μg/mL)	Sheep erythrocytes: No hemolysis up tp 500 µg/ml	Linear	Free	Amidation		L	NIH 3T3: IC50=250 µg/ml	Not available	33207639	Int J Mol Sci. 2020 Nov 16;21(22):8624.	Shagaghi N, Clayton AHA, Aguilar MI, Lee TH, Palombo EA, Bhave M.	Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells	N=C(N)NCCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP33699	RWWKWWK	7	TRPs R7	P33432		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.	Tumor cells: HeLa  (IC50>250 μg/mL)	Sheep erythrocytes: No hemolysis up tp 500 µg/ml	Linear	Free	Amidation		L	NIH 3T3: IC50=250 µg/ml	Not available	33207639	Int J Mol Sci. 2020 Nov 16;21(22):8624.	Shagaghi N, Clayton AHA, Aguilar MI, Lee TH, Palombo EA, Bhave M.	Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells	N=C(N)NCCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33700	WRWWKWW	7	TRPs W7	P33432		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.	Tumor cells: HeLa  (IC50=250 μg/mL)	Sheep erythrocytes: No hemolysis up tp 500 µg/ml	Linear	Free	Amidation		L	NIH 3T3: IC50=250 µg/ml	Not available	33207639	Int J Mol Sci. 2020 Nov 16;21(22):8624.	Shagaghi N, Clayton AHA, Aguilar MI, Lee TH, Palombo EA, Bhave M.	Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells	N=C(N)NCCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP33701	WrWwkWW	7	TRPs dW7	P33432		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.	Tumor cells: HeLa  (IC50=125 μg/mL)	Sheep erythrocytes: No hemolysis up tp 500 µg/ml	Linear	Free	Amidation	r=D-Arg; w=D-Trp	Mix	NIH 3T3: IC50>250 µg/ml	Not available	33207639	Int J Mol Sci. 2020 Nov 16;21(22):8624.	Shagaghi N, Clayton AHA, Aguilar MI, Lee TH, Palombo EA, Bhave M.	Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells	N=C(N)NCCC[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP33702	WRWWKWWK	8	TRPs W8	P33432		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.	Tumor cells: HeLa  (IC50=250 μg/mL)	Sheep erythrocytes: No hemolysis up tp 500 µg/ml	Linear	Free	Amidation		L	NIH 3T3: IC50>250 µg/ml	Not available	33207639	Int J Mol Sci. 2020 Nov 16;21(22):8624.	Shagaghi N, Clayton AHA, Aguilar MI, Lee TH, Palombo EA, Bhave M.	Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells	N=C(N)NCCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33703	WWRWWKWW	8	TRPs WW	P33432		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.	Tumor cells: HeLa  (IC50=250 μg/mL)	Sheep erythrocytes: No hemolysis up tp 500 µg/ml	Linear	Free	Amidation		L	NIH 3T3: IC50>250 µg/ml	Not available	33207639	Int J Mol Sci. 2020 Nov 16;21(22):8624.	Shagaghi N, Clayton AHA, Aguilar MI, Lee TH, Palombo EA, Bhave M.	Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP33704	WWrWwkWW	8	TRPs dWW	P33432		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.	Tumor cells: HeLa  (IC50=125 μg/mL)	Sheep erythrocytes: No hemolysis up tp 500 µg/ml	Linear	Free	Amidation	r=D-Arg; w=D-Trp	Mix	NIH 3T3: IC50=250 µg/ml	Not available	33207639	Int J Mol Sci. 2020 Nov 16;21(22):8624.	Shagaghi N, Clayton AHA, Aguilar MI, Lee TH, Palombo EA, Bhave M.	Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells	N=C(N)NCCC[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP33705	AFALIAGALYRIFHRR	16	LHH1	Q036I7		Not found	Lactobacillus casei HZ1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C666-1 (IC50=18.27 μM ); MGC-803 (IC50=31.55 μM ); HCT 116 (IC50=40.83 μM )	Goat erythrocytes: HC50=187.2 µM 	Linear	Free	Free		L	Not available	Not available	33175275	AMB Express. 2020 Nov 11;10(1):204. 	He JF, Jin DX, Luo XG, Zhang TC. 	LHH1, a novel antimicrobial peptide with anti-cancer cell activity identified from Lactobacillus casei HZ1	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP33706	GARELRRLERELRRLEGGGGGGGKLAALKFKLLWLKLAC	39	cHLH-p53R	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	(1) The positively charged peptide targets the negative surface of cancer cells via electrostatic attractions; (2) The peptide inserts into cell membranes and enters inside cells very efficaciously; (3) Once inside cells, the peptide induces toxicity through fusion and/or disruption of intracellular organelles; (4) The cell membrane is disrupted and the cells die.	Tumor cells: MDA-MB-231 (CC50=15.9 ± 2.3 μM); MCF-7  (CC50=16.0 ± 0.5 μM); MM96L (CC50=5.4 ± 0.3 μM ); MDA-MB-435S (CC50=5.7 ± 0.4 μM ); K562 (CC50=8.2 ± 0.4 μM)	Human erythrocytes: 50% Hemolysis>64 µM	Cyclic	CAA, Chloroacetic acid	Free		L	HFF-1: CC50=11.9 ± 1.0 µM; MCF-10A: CC50=8.0 ± 0.8 µM; Human PBMC: CC50=48.9 ± 5.3 µM	Not available	31390185	ACS Chem Biol. 2019 Sep 20;14(9):2071-2087. 	Philippe GJ, Gaspar D, Sheng C, Huang YH, Benfield AH, Condon ND, Weidmann J, Lawrence N, Löwer A, Castanho MARB, Craik DJ, Troeira Henriques S.	Cell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix-Loop-Helix Peptides with Cell Penetrating and Tumor Suppressor Properties	
DRAMP33707	GARELRRLERELRRLEKGGGGGGKLAALKFKLLWLKLAC	39	[G17K]cHLH-p53R	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	(1) The positively charged peptide targets the negative surface of cancer cells via electrostatic attractions; (2) The peptide inserts into cell membranes and enters inside cells very efficaciously; (3) Once inside cells, the peptide induces toxicity through fusion and/or disruption of intracellular organelles; (4) The cell membrane is disrupted and the cells die.	Tumor cells: MM96L (CC50=5.3 ± 0.5 μM ); MDA-MB-435S (CC50=7.1 ± 0.6 μM )	Human erythrocytes: 50% Hemolysis>64 µM	Cyclic	CAA, Chloroacetic acid	Free		L	HFF-1: CC50=8.8 ± 1.2 µM; MCF-10A: CC50=25.7 ± 3.2 µM; Human PBMC: CC50=42.8 ± 7.0  µM	Not available	31390185	ACS Chem Biol. 2019 Sep 20;14(9):2071-2087. 	Philippe GJ, Gaspar D, Sheng C, Huang YH, Benfield AH, Condon ND, Weidmann J, Lawrence N, Löwer A, Castanho MARB, Craik DJ, Troeira Henriques S.	Cell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix-Loop-Helix Peptides with Cell Penetrating and Tumor Suppressor Properties	
DRAMP33708	GARELRRLERELRRLEKGGGGGGKLAALTFEHYWAQLTSC	40	cHLH-pDI1-R	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	(1) The positively charged peptide targets the negative surface of cancer cells via electrostatic attractions; (2) The peptide inserts into cell membranes and enters inside cells very efficaciously; (3) Once inside cells, the peptide induces toxicity through fusion and/or disruption of intracellular organelles; (4) The cell membrane is disrupted and the cells die.	Tumor cells: K562 (CC50>64 μM); MCF-7  (CC50>64 μM); MDA-MB-435S (CC50>64 μM); MM96L (CC50>64 μM)	Human erythrocytes: 50% Hemolysis>64 µM	Cyclic	CAA, Chloroacetic acid	Free		L	HFF-1: CC50>64 µM; MCF-10A: CC50>64 µM; Human PBMC: CC50>64 µM	Not available	31390185	ACS Chem Biol. 2019 Sep 20;14(9):2071-2087. 	Philippe GJ, Gaspar D, Sheng C, Huang YH, Benfield AH, Condon ND, Weidmann J, Lawrence N, Löwer A, Castanho MARB, Craik DJ, Troeira Henriques S.	Cell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix-Loop-Helix Peptides with Cell Penetrating and Tumor Suppressor Properties	
DRAMP33709	GARELRRLERELRRLEGGGGGGGKLAALKAKLLWLKLAC	39	[F30A]cHLH-p53-R	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	(1) The positively charged peptide targets the negative surface of cancer cells via electrostatic attractions; (2) The peptide inserts into cell membranes and enters inside cells very efficaciously; (3) Once inside cells, the peptide induces toxicity through fusion and/or disruption of intracellular organelles; (4) The cell membrane is disrupted and the cells die.	Tumor cells: K562 (CC50=36.7 ± 1.9 μM); MDA-MB-435S (CC50>32 μM); MCF-7  (CC50>64 μM); MDA-MB-231 (CC50>64 μM); MM96L (CC50>64 μM)	Human erythrocytes: 50% Hemolysis>64 µM	Cyclic	CAA, Chloroacetic acid	Free		L	HFF-1: CC50>64 µM; MCF-10A: CC50>64 µM; Human PBMC: CC50>64 µM	Not available	31390185	ACS Chem Biol. 2019 Sep 20;14(9):2071-2087. 	Philippe GJ, Gaspar D, Sheng C, Huang YH, Benfield AH, Condon ND, Weidmann J, Lawrence N, Löwer A, Castanho MARB, Craik DJ, Troeira Henriques S.	Cell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix-Loop-Helix Peptides with Cell Penetrating and Tumor Suppressor Properties	
DRAMP33710	GLAKVMREVLGYERNSYKKFFLR	23	Ixosin [H3A]	Q2LKX9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (8% Killing=16 µM)	Not available	Linear	Free	Amidation		L	HEK-293: Not active up to 16 µM	Not available	27622949	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP33711	KVMREVLGYERNSYKKFFLR	20	Ixosin (4-23)	Q2LKX9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (19% Killing=128 µM)	Not available	Linear	Free	Amidation		L	HEK-293: Not active up to 128 µM	Not available	27622949	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP33712	GLHKVMRKVLGYLRNVYK	18	Ixosin [E8K,E13L,S16V], Ixosin-pch	Q2LKX9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (24% Killing=1 µM)	Not available	Linear	Free	Amidation		L	HEK-293: 14% Killing=1 µM	Not available	27622949	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP33713	GLAKVMRKVLGYLRNVYK	18	Ixosin [H3A,E8K,E13L,S16V], Ixosin-pch-H3A	Q2LKX9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (28% Killing=2-4 µM)	Not available	Linear	Free	Amidation		L	HEK-293: 23% Killing=2-4 µM	Not available	27622949	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP33714	KVMRKVLGYLRNVYK	15	Ixosin (4-18)[E8K,E13L,S16V], Ixosin-pch4–18	Q2LKX9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (19% Killing=2 µM)	Not available	Linear	Free	Amidation		L	HEK-293: 15% Killing=2 µM	Not available	27622949	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP33715	GLHKVMREVLGY	12	Ixosin (1-12)	Q2LKX9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (27% Killing=128 µM)	Not available	Linear	Free	Amidation		L	HEK-293: 3% Killing>128 µM	Not available	27622949	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C
DRAMP33716	YERNSYKKFFLR	12	Ixosin (12-23)	Q2LKX9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (28% Killing=128 µM)	Not available	Linear	Free	Amidation		L	HEK-293: 10% Killing>128 µM	Not available	27622949	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33717	GLHKVMREVLGYERNSYK	18	Ixosin (1-18)	Q2LKX9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (13% Killing=128 µM)	Not available	Linear	Free	Amidation		L	HEK-293: 6% Killing>128 µM	Not available	27622949	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP33718	KVMREVLGYERNSYK	15	Ixosin (4-18)	Q2LKX9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (3% Killing=128 µM)	Not available	Linear	Free	Amidation		L	HEK-293: 14% Killing>128 µM	Not available	27622949	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP33719	REVLGYERNSYK	12	Ixosin (7-18)	Q2LKX9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (15% Killing=128 µM)	Not available	Linear	Free	Amidation		L	HEK-293: 18% Killing>128 µM	Not available	27622949	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Libardo MD, Gorbatyuk VY, Angeles-Boza AM.	Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33720	LKRIVQRIKDFLR	13	LL-37 (17-29) [F17L]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=33.7 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: IC50=56.9 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33721	FKRIVQRILDFLR	13	LL-37 (17-29) [K25L]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=3.9 μg/ml)	Human erythrocytes: HC50=450 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: IC50=20.1 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33722	FXRIVQRILDFLR	13	LL-37 (17-29) [18SA-K] [K25L] 	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=10.7 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Acetylation	Amidation	X=Sialic acid-Lys	L	DLF lung fibroblasts: IC50=24.3 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	
DRAMP33723	FKRIVQRIRDFLR	13	LL-37 (17-29) [K25R]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=56 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: Not active up to 200 µg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33724	FKRIVQRIRDFLR	13	LL-37 (17-29) [K25R]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=12.5 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: Not active up to 200 µg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33725	FKRIVQRIRDFLR	13	LL-37 (17-29) [K25R]-Ac	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=56 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: IC50=54.1 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33726	FKRIVQRIRDFLR	13	LL-37 (17-29) [K25R]-Ac	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=12.5 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: IC50=54.1 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33727	FKRIVQKIKDFLR	13	LL-37 (17-29) [R23K]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=145.1 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: Not active up to 200 µg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33728	FKRIVQLIKDFLR	13	LL-37 (17-29) [R23L]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=18.9 μg/ml)	Human erythrocytes: HC50=114 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: IC50=23.5 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33729	FKRIVQLIKDFLR	13	LL-37 (17-29) [R23L]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=13.9 μg/ml)	Human erythrocytes: HC50=114 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: IC50=23.5 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33730	FKRIVQLIKDFLR	13	LL-37 (17-29) [R23L]-Ac	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=18.9 μg/ml)	Human erythrocytes: HC50=227 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: IC50=22.5 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33731	FKRIVQLIKDFLR	13	LL-37 (17-29) [R23L]-Ac	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=13.9 μg/ml)	Human erythrocytes: HC50=227 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: IC50=22.5 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33732	FKRIVQRIKDLLR	13	LL-37 (17-29) [F27L]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=75 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: Not active up to 200 µg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33733	FKRIVQRIKDLLR	13	LL-37 (17-29) [F27L]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=45.5 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: Not active up to 200 µg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33734	FKRIVQRIKDLLR	13	LL-37 (17-29) [F27L]-Ac	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=75 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: Not active up to 200 µg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33735	FKRIVQRIKDLLR	13	LL-37 (17-29) [F27L]-Ac	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=45.5 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: Not active up to 200 µg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33736	FKRIVQIIKKFLR	13	LL-37 (17-29) [R23I,D26K]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=20 μg/ml)	Human erythrocytes: HC50=361 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: IC50=27 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)C(C)C
DRAMP33737	FKRIVQIIKKFLR	13	LL-37 (17-29) [R23I,D26K]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=12.9 μg/ml)	Human erythrocytes: HC50=361 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: IC50=27 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)C(C)C
DRAMP33738	FKRIVQIIKKFLR	13	LL-37 (17-29) [R23I,D26K]-Ac	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=20 μg/ml)	Human erythrocytes: HC50=292 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: IC50=15.7 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)C(C)C
DRAMP33739	FKRIVQIIKKFLR	13	LL-37 (17-29) [R23I,D26K]-Ac	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=12.9 μg/ml)	Human erythrocytes: HC50=292 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: IC50=15.7 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC)[C@H](C)CC)C(C)C
DRAMP33740	FKRIVQLLKKLLR	13	LL-37 (17-29) [R23L,I24L,D26K,F27L]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=12.8 μg/ml)	Human erythrocytes: HC50=411 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: IC50=23.7 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP33741	FKRIVQLLKKLLR	13	LL-37 (17-29) [R23L,I24L,D26K,F27L]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=9.8 μg/ml)	Human erythrocytes: HC50=411 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: IC50=23.7 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP33742	FKRIVQLLKKLLR	13	LL-37 (17-29) [R23L,I24L,D26K,F27L]-Ac	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=12.8 μg/ml)	Human erythrocytes: HC50=185 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: IC50=17.3 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP33743	FKRIVQLLKKLLR	13	LL-37 (17-29) [R23L,I24L,D26K,F27L]-Ac	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=9.8 μg/ml)	Human erythrocytes: HC50=185 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: IC50=17.3 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP33744	FKRILQRIKDFLR	13	LL-37 (17-29) [V21L]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=19.2 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: IC50=76.8 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33745	FKRILQRIKDFLR	13	LL-37 (17-29) [V21L]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=29.2 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Free	Amidation		L	DLF lung fibroblasts: IC50=76.8 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33746	FKRILQRIKDFLR	13	LL-37 (17-29) [V21L]-Ac	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=19.2 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: IC50=160.9 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33747	FKRILQRIKDFLR	13	LL-37 (17-29) [V21L]-Ac	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=29.2 μg/ml)	Human erythrocytes: Not active up to 500 µg/ml	Linear	Acetylation	Amidation		L	DLF lung fibroblasts: IC50=160.9 μg/ml	Not available	32567085	 J Pept Sci. 2020 Jul;26(7):e3254. 	Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.	Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33748	GXFKKTFHKVSHAVKSGIHAGQRGCSALGF	30	CEN1 HC-Br	D8WN02		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (50% Killing=100 mg/L)	Not available	Linear	Free	Free	X=Br-Trp	L	Not available	Not available	23237525	AMB Express. 2012 Dec 13;2(1):67.	Björn C, Håkansson J, Myhrman E, Sjöstrand V, Haug T, Lindgren K, Blencke HM, Stensvåg K, Mahlapuu M. 	Anti-infectious and anti-inflammatory effects of peptide fragments sequentially derived from the antimicrobial peptide centrocin 1 isolated from the green sea urchin, Strongylocentrotus droebachiensis	
DRAMP33749	GWFKKTFHKVSHAVKSGIHA	20	CEN1 HC (1–20)	D8WN02		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (Weak active up to 125 mg/L)	Not available	Linear	Free	Free		L	Not available	Not available	23237525	AMB Express. 2012 Dec 13;2(1):67.	Björn C, Håkansson J, Myhrman E, Sjöstrand V, Haug T, Lindgren K, Blencke HM, Stensvåg K, Mahlapuu M. 	Anti-infectious and anti-inflammatory effects of peptide fragments sequentially derived from the antimicrobial peptide centrocin 1 isolated from the green sea urchin, Strongylocentrotus droebachiensis	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)O
DRAMP33750	GWFKKTFHKVSHAVKSGIHAGQRGSSALGF	30	CEN1 HC (Ser)	D8WN02		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: THP-1 (Weak active up to 125 mg/L)	Not available	Linear	Free	Free		L	Not available	Not available	23237525	AMB Express. 2012 Dec 13;2(1):67.	Björn C, Håkansson J, Myhrman E, Sjöstrand V, Haug T, Lindgren K, Blencke HM, Stensvåg K, Mahlapuu M. 	Anti-infectious and anti-inflammatory effects of peptide fragments sequentially derived from the antimicrobial peptide centrocin 1 isolated from the green sea urchin, Strongylocentrotus droebachiensis	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP33752	IKLXKEXKKXLKKVLKGXIKGXIAVAKMV	29	H-57, Hymenochirin-1B [P5K,D9K; S4,T7,N10-GlcNAc; A18,A22 S5]	W8PRC4		Not found	Synthetic (Derived from Hymenochirin-1B)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=1.10±0.31 μM); HCT 116 (IC50=1.65±0.28 μM); HepG2 (IC50=2.71±0.05 μM)	Not available	Linear	Free	Free	X(4)=Ser-GlcNAc; X(7)=Thr-GlcNAc; X(10)=Asn-GlcNAc; X(18/22)=(S)-N-Fmoc-2-(4′-pentenyl)alanine	L	Not available	Not available	30789695	ACS Chem Biol. 2019 Mar 15;14(3):516-525. 	Li Y, Zhang Y, Wu M, Chang Q, Hu H, Zhao X.	Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy	
DRAMP33753	IKLXKKXKKXLKKVLKGXIKGXIAVAKMV	29	H-58, Hymenochirin-1B [P5K,E6K,D9K; S4,T7,N10-GlcNAc; A18,22 S5]	W8PRC4		Not found	Synthetic (Derived from Hymenochirin-1B)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=0.62±0.12 μM); HCT 116 (IC50=1.29±0.08  μM); HepG2 (IC50=2.13±0.07 μM)	Not available	Linear	Free	Free	X(4)=Ser-GlcNAc; X(7)=Thr-GlcNAc; X(10)=Asn-GlcNAc; X(18/22)=(S)-N-Fmoc-2-(4′-pentenyl)alanine	L	Not available	Not available	30789695	ACS Chem Biol. 2019 Mar 15;14(3):516-525. 	Li Y, Zhang Y, Wu M, Chang Q, Hu H, Zhao X.	Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy	
DRAMP33754	ALWMTLLKKVLKAAAKAALNAVLVGA	26	Dermaseptin S4 (1-26)a	P80280		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW620 (42.19±24.29% Cytotoxicity=256 µg/ml)	Human erythrocytes: 74.2±5.82% Hemolysis=256 µg/ml	Linear	Free	Amidation		L	Not available	Not available	33774792	Environ Sci Pollut Res Int. 2021 Aug;28(30):40908-40916.	Belaid A, Braiek A, Alibi S, Hassen W, Beltifa A, Nefzi A, Mansour HB. 	Evaluating the effect of dermaseptin S4 and its derivatives on multidrug-resistant bacterial strains and on the colon cancer cell line SW620	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
DRAMP33755	ALWMTLLKKVLKAAAKAALNAVLV	24	Dermaseptin S4 (1-24)a	P80280		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW620 (71.48±4.81% Cytotoxicity=256 µg/ml)	Human erythrocytes: 57.1±6.34% Hemolysis=256 µg/ml	Linear	Free	Amidation		L	Not available	Not available	33774792	Environ Sci Pollut Res Int. 2021 Aug;28(30):40908-40916.	Belaid A, Braiek A, Alibi S, Hassen W, Beltifa A, Nefzi A, Mansour HB. 	Evaluating the effect of dermaseptin S4 and its derivatives on multidrug-resistant bacterial strains and on the colon cancer cell line SW620	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
DRAMP33756	ALWMTLLKKVLKAAAKAALNAV	22	Dermaseptin S4 (1-22)a	P80280		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW620 (66.21±20.07% Cytotoxicity=256 µg/ml)	Human erythrocytes: 80±1.12% Hemolysis=256 µg/ml	Linear	Free	Amidation		L	Not available	Not available	33774792	Environ Sci Pollut Res Int. 2021 Aug;28(30):40908-40916.	Belaid A, Braiek A, Alibi S, Hassen W, Beltifa A, Nefzi A, Mansour HB. 	Evaluating the effect of dermaseptin S4 and its derivatives on multidrug-resistant bacterial strains and on the colon cancer cell line SW620	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)[C@@H](C)O
DRAMP33757	WMTLLKKVLKAAAKAALNAVLVGANA	26	Dermaseptin S4 (3-28)a	P80280		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW620 (54.02±3.37% Cytotoxicity=256 µg/ml)	Human erythrocytes: 68.5±7.58% Hemolysis=256 µg/ml	Linear	Free	Amidation		L	Not available	Not available	33774792	Environ Sci Pollut Res Int. 2021 Aug;28(30):40908-40916.	Belaid A, Braiek A, Alibi S, Hassen W, Beltifa A, Nefzi A, Mansour HB. 	Evaluating the effect of dermaseptin S4 and its derivatives on multidrug-resistant bacterial strains and on the colon cancer cell line SW620	CSCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
DRAMP33758	LKKVLKAAAKAALNAVLVGANA	22	Dermaseptin S4 (7-28)	P80280		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SW620 (35.72±18.49% Cytotoxicity=256 µg/ml)	Human erythrocytes: 35.4±6.28% Hemolysis=256 µg/ml	Linear	Free	Amidation		L	Not available	Not available	33774792	Environ Sci Pollut Res Int. 2021 Aug;28(30):40908-40916.	Belaid A, Braiek A, Alibi S, Hassen W, Beltifa A, Nefzi A, Mansour HB. 	Evaluating the effect of dermaseptin S4 and its derivatives on multidrug-resistant bacterial strains and on the colon cancer cell line SW620	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(N)=O)C(C)C)C(C)C
DRAMP33759	GLRKRLRKFFNKIKEK	16	sC18 [R10F]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (<20% Killing=40 µM); HeLa  (Not active up to 40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation		L	HEK293: <20% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33760	GLRKRLRKFRNKIKFK	16	sC18 [E15F]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (Not active up to 40 µM); MCF-7  (Not active up to 40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation		L	HEK293: <10% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33761	GLRKRLRKFRNKIKEF	16	sC18 [K16F]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (<10% Killing=40 µM); MCF-7 (<20% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation		L	HEK293: Not active up to 40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP33762	GLEKRKRKFFNKIKFK	16	sC18 [R10F,E15F]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (60% Killing=40 µM); HeLa  (75% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation		L	HEK293: 20% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33763	GLRKRLRKFFNKIKEF	16	sC18 [R10F,K16F]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (>50% Killing=40 µM); HeLa  (40% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation		L	HEK293: <5% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP33764	GLRKRLRKFRNKIKFF	16	sC18 [E15F,K16F]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7 (40% Killing=40 µM); HeLa  (80% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation		L	HEK293: Not active up to 40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP33765	GLRKRLRKFFNKIKFF	16	sC18 [E15F,E15F,K16F]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (80% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation		L	HEK293: 40% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP33766	GLRKRLRKFRNKIKK	15	sC18 [E15Del]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (<10% Killing=40 µM); MCF-7 (35% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation		L	HEK293: <10% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP33767	GLRKRLRKFFNKIKF	15	sC18 [R10F,E15Del,K16F]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (<10% Killing=40 µM); MCF-7 (>90% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation		L	HEK293: 20% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP33768	GLRKRLRKFXNKIKX	15	sC18 [R10,K16 4-F-Phe,E15Del]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation	X=4-F-Phe	L	HEK293: <10% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	
DRAMP33769	GLRKRLRKFXNKIKX	15	sC18 [R10,K16 4-F-Phe,E15Del]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation	X=4-F-Phe	L	HEK293: <10% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	
DRAMP33770	GLRKRLRKFXNKIKX	15	sC18 [R10,K16 4-F-Phe,E15Del]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation	X=4-F-Phe	L	HEK293: <10% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	
DRAMP33771	GLRKRLRKFXNKIKX	15	sC18 [R10,K16 2F-Phe,E15Del]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation	X=2-F-Phe	L	HEK293: 20% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	
DRAMP33772	GLRKRLRKFXNKIKX	15	sC18 [R10,K16 2F-Phe,E15Del]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation	X=2-F-Phe	L	HEK293: 20% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	
DRAMP33773	GLRKRLRKFXNKIKX	15	sC18 [R10,K16 2F-Phe,E15Del]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation	X=2-F-Phe	L	HEK293: 20% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	
DRAMP33774	GLRKRLRKFXNKIKX	15	sC18 [R10,K16 5F-Phe,E15Del]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation	X=5-F-Phe	L	HEK293: <25% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	
DRAMP33775	GLRKRLRKFXNKIKX	15	sC18 [R10,K16 5F-Phe,E15Del]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation	X=5-F-Phe	L	HEK293: <25% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	
DRAMP33776	GLRKRLRKFXNKIKX	15	sC18 [R10,K16 5F-Phe,E15Del]	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (>80% Killing=40 µM); MCF-7 (>90% Killing=40 µM)	"Human erythrocytes: <10% Hemolysis	=40 µM"	Linear	Free	Amidation	X=5-F-Phe	L	HEK293: <25% Killing=40 µM	Not available	33313751	 Biochem J. 2021 Jan 15;478(1):63-78. 	Drexelius M, Reinhardt A, Grabeck J, Cronenberg T, Nitsche F, Huesgen PF, Maier B, Neundorf I.	Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity	
DRAMP33777	PWIPLTPL	8	Phakellistatin 15	Not available		Not found	Phakellia fusca	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: P388 (IC50=8.5 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	20345147	 J Nat Prod. 2010 Apr 23;73(4):650-5.	Zhang HJ, Yi YH, Yang GJ, Hu MY, Cao GD, Yang F, Lin HW.	Proline-containing cyclopeptides from the marine sponge Phakellia fusca	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
DRAMP33778	PFDSRAVTY	9	Phakellistatin 16	Not available		Not found	Phakellia fusca	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: BEL-7402 (IC50=14.3 μM); P388 (IC50=5.4 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	20345147	 J Nat Prod. 2010 Apr 23;73(4):650-5.	Zhang HJ, Yi YH, Yang GJ, Hu MY, Cao GD, Yang F, Lin HW.	Proline-containing cyclopeptides from the marine sponge Phakellia fusca	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
DRAMP33779	PWVPLIPI	8	Phakellistatin 17	Not available		Not found	Phakellia fusca	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: P388 (Not active up to 100 µg/ml)	Not available	Cyclic	Free	Free		L	Not available	Not available	20345147	 J Nat Prod. 2010 Apr 23;73(4):650-5.	Zhang HJ, Yi YH, Yang GJ, Hu MY, Cao GD, Yang F, Lin HW.	Proline-containing cyclopeptides from the marine sponge Phakellia fusca	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1)C(C)C)[C@H](C)CC)C(=O)O
DRAMP33780	PYPIFPI	7	Phakellistatin 18	Not available		Not found	Phakellia fusca	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=3.9 μM ); K562 (IC50=33 μM); SNU-638 (IC50=37 μM); A549 (IC50=6.7 μM ); SK-HEP-1 (IC50=7.7 μM); MDA-MB-231 (IC50=9.1 μM); P388 (Not active up to 100 µg/ml)	Not available	Cyclic	Free	Free		L	Not available	Not available	20345147	 J Nat Prod. 2010 Apr 23;73(4):650-5.	Zhang HJ, Yi YH, Yang GJ, Hu MY, Cao GD, Yang F, Lin HW.	Proline-containing cyclopeptides from the marine sponge Phakellia fusca	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)[C@H](C)CC)C(=O)O
DRAMP33781	IPWFPLTP	8	Phakellistatin 19	Not available		Not found	Phakellia fusca	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=0.44 µM); HT-29 (IC50=0.462 µM); MDA-MB-231 (IC50=0.515 µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	24252114	J Med Chem. 2013 Dec 12;56(23):9780-8.	Pelay-Gimeno M, Meli A, Tulla-Puche J, Albericio F.	Rescuing biological activity from synthetic phakellistatin 19	CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O
DRAMP33782	PFNAXAI	7	Phakellistatin 20	Not available		Not found	Stylissa flabelliformis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=11 µM); HCT 116 (IC50=12 µM); MDA-MB-231 (IC50=12 µM); SNU-638 (IC50=12 µM); SK-HEP-1 (IC50=13 µM); A549 (IC50=15 µM)	Not available	Cyclic	Free	Free	X=Methionine sulfone	L	Not available	Not available	29893558	J Nat Prod. 2018 Jun 22;81(6):1426-1434.	Kwon OS, Kim CK, Byun WS, Oh J, Lee YJ, Lee HS, Sim CJ, Oh DC, Lee SK, Oh KB, Shin J.	Cyclopeptides from the Sponge Stylissa flabelliformis	
DRAMP33783	PPXFELPPYI	10	Phakellistatin 21	Not available		Not found	Stylissa flabelliformis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SK-HEP-1 (IC50=0.041 µM); HCT 116 (IC50=0.14 µM); SNU-638 (IC50=0.16 µM); K562 (IC50=0.17 µM); A549 (IC50=0.19 µM); MDA-MB-231 (IC50=0.4 µM)	Not available	Cyclic	Free	Free	X=Methionine sulfone	L	Not available	Not available	29893558	J Nat Prod. 2018 Jun 22;81(6):1426-1434.	Kwon OS, Kim CK, Byun WS, Oh J, Lee YJ, Lee HS, Sim CJ, Oh DC, Lee SK, Oh KB, Shin J.	Cyclopeptides from the Sponge Stylissa flabelliformis	
DRAMP33784	PPXFELPPYI	10	Phakellistatin 21	Not available		Not found	Stylissa flabelliformis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SNU-638 (IC50=0.01 µM); HCT 116 (IC50=0.011 µM); SK-HEP-1 (IC50=0.014 µM); K562 (IC50=0.021 µM); A549 (IC50=0.023 µM); MDA-MB-231 (IC50=0.35 µM)	Not available	Cyclic	Free	Free	X=Methionine sulfone	L	Not available	Not available	29893558	J Nat Prod. 2018 Jun 22;81(6):1426-1434.	Kwon OS, Kim CK, Byun WS, Oh J, Lee YJ, Lee HS, Sim CJ, Oh DC, Lee SK, Oh KB, Shin J.	Cyclopeptides from the Sponge Stylissa flabelliformis	
DRAMP33785	PPXFELPPYI	10	Phakellistatin 22	Not available		Not found	Phakellia fusca	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SK-HEP-1 (IC50=0.041 µM); HCT 116 (IC50=0.14 µM); SNU-638 (IC50=0.16 µM); K562 (IC50=0.17 µM); A549 (IC50=0.19 µM); MDA-MB-231 (IC50=0.4 µM)	Not available	Cyclic	Free	Free	X=Methionine sulfone	L	Not available	Not available	29893558	J Nat Prod. 2018 Jun 22;81(6):1426-1434.	Kwon OS, Kim CK, Byun WS, Oh J, Lee YJ, Lee HS, Sim CJ, Oh DC, Lee SK, Oh KB, Shin J.	Cyclopeptides from the Sponge Stylissa flabelliformis	
DRAMP33786	PPXFELPPYI	10	Phakellistatin 22	Not available		Not found	Phakellia fusca	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SNU-638 (IC50=0.01 µM); HCT 116 (IC50=0.011 µM); SK-HEP-1 (IC50=0.014 µM); K562 (IC50=0.021 µM); A549 (IC50=0.023 µM); MDA-MB-231 (IC50=0.35 µM)	Not available	Cyclic	Free	Free	X=Methionine sulfone	L	Not available	Not available	29893558	J Nat Prod. 2018 Jun 22;81(6):1426-1434.	Kwon OS, Kim CK, Byun WS, Oh J, Lee YJ, Lee HS, Sim CJ, Oh DC, Lee SK, Oh KB, Shin J.	Cyclopeptides from the Sponge Stylissa flabelliformis	
DRAMP33787	IxPYPFP	7	Phakellistatin 2	Not available		Not found	Stylotella aurantium	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50=0.66 µM); HCT 116 (IC50=0.71 µM); SK-HEP-1 (IC50=0.77 µM); MDA-MB-231 (IC50=1.3 µM); SNU-638 (IC50=1.6 µM); A2780 (IC50=28.27 µg/ml (DMSO); IC50=2.72 µg/ml (MeOH)); K562 (IC50=3.2 µM)	Not available	Cyclic	Free	Free	x=D-Allo-Ile	Mix	Not available	Not available	12444643	 J Org Chem. 2002 Nov 29;67(24):8593-601. 	Tabudravu JN, Jaspars M, Morris LA, Kettenes-Van Den Bosch JJ, Smith N. 	Two distinct conformers of the cyclic heptapeptide phakellistatin 2 isolated from the fijian marine sponge stylotellaaurantium	
DRAMP33788	PtPfiFS	7	Phakellistatin 4	Not available		Not found	Phakellia costata	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (IC50=10 µM); SNU-638 (IC50=24 µM); K562 (IC50=30 µM); HCT 116 (IC50=4.5 µM); SK-HEP-1 (IC50=7.2 µM); A549 (IC50=7.4 µM)	Not available	Cyclic	Free	Free	t=D-Thr; f=D-Phe; i=D-Ile	Mix	Not available	Not available	29893558	J Nat Prod. 2018 Jun 22;81(6):1426-1434.	Kwon OS, Kim CK, Byun WS, Oh J, Lee YJ, Lee HS, Sim CJ, Oh DC, Lee SK, Oh KB, Shin J.	Cyclopeptides from the Sponge Stylissa flabelliformis	CC[C@H](C)[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](NC(=O)[C@@H]1CCCN1)[C@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O
DRAMP33789	lPPYvPPXfv	10	Phakellistatin 9	Not available		Not found	Phakellia costata	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=1 µM); K562 (IC50=1.1 µM); A549 (IC50=1.4 µM); SK-HEP-1 (IC50=12 µM); SNU-638 (IC50=2.2 µM); MDA-MB-231 (IC50=8.6 µM)	Not available	Cyclic	Free	Free	X=Allo-Ile	Mix	Not available	Not available	29893558	J Nat Prod. 2018 Jun 22;81(6):1426-1434.	Kwon OS, Kim CK, Byun WS, Oh J, Lee YJ, Lee HS, Sim CJ, Oh DC, Lee SK, Oh KB, Shin J.	Cyclopeptides from the Sponge Stylissa flabelliformis	
DRAMP33790	QPFPfifp	8	Phakellistatin 11	Not available		Not found	Phakellia sp.	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: P388 (ED50=0.2 µg/ml); HCT 116 (IC50=1.6 µM); SK-HEP-1 (IC50=1.7 µM); A549 (IC50=2.8 µM); MDA-MB-231 (IC50=3.2 µM); K562 (IC50=5.6 µM); SNU-638 (IC50=6.9 µM)	Not available	Cyclic	Free	Free	f=D-Phe; i=D-Ile	Mix	Not available	Not available	29893558	J Nat Prod. 2018 Jun 22;81(6):1426-1434.	Kwon OS, Kim CK, Byun WS, Oh J, Lee YJ, Lee HS, Sim CJ, Oh DC, Lee SK, Oh KB, Shin J.	Cyclopeptides from the Sponge Stylissa flabelliformis	CC[C@H](C)[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@H](Cc1ccccc1)C(=O)N1CCC[C@@H]1C(=O)O
DRAMP33791	IFVLPPYIPP	10	Phakellistatin 8	Not available		Not found	Phakellia fusca	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 (IC50=0.1 µM); K562 (IC50=0.29 µM); A549 (IC50=0.54 µM); SNU-638 (IC50=1.7 µM); SK-HEP-1 (IC50=2.3 µM); MDA-MB-231 (IC50=2.5 µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29893558	J Nat Prod. 2018 Jun 22;81(6):1426-1434.	Kwon OS, Kim CK, Byun WS, Oh J, Lee YJ, Lee HS, Sim CJ, Oh DC, Lee SK, Oh KB, Shin J.	Cyclopeptides from the Sponge Stylissa flabelliformis	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)C(C)C
DRAMP33792	ANPRYPYT	8	Cyclonellin	Not available		Not found	Axinella carteri	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A549 (IC50>50 µM); HCT 116 (IC50>50 µM); K562 (IC50>50 µM); MDA-MB-231 (IC50>50 µM); SK-HEP-1 (IC50>50 µM); SNU-638 (IC50>50 µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29893558	J Nat Prod. 2018 Jun 22;81(6):1426-1434.	Kwon OS, Kim CK, Byun WS, Oh J, Lee YJ, Lee HS, Sim CJ, Oh DC, Lee SK, Oh KB, Shin J.	Cyclopeptides from the Sponge Stylissa flabelliformis	C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP33793	IPYVPLTP	8	Phakellistatin 10	Not available		Not found	Phakellia sp.	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: P388 (ED50=2.1 µg/ml)	Not available	Cyclic	Free	Free		L	Not available	Not available	7673945	J Nat Prod. 1995 Jun;58(6):961-5	ettit GR, Tan R, Ichihara Y, Williams MD, Doubek DL, Tackett LP, Schmidt JM, Cerny RL, Boyd MR, Hooper JN.	Antineoplastic agents, 325. Isolation and structure of the human cancer cell growth inhibitory cyclic octapeptides phakellistatin 10 and 11 from Phakellia sp	CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(C)C
DRAMP33794	AIPFNAM	7	Phakellistatin 5	Not available		Not found	Phakellia costada	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: DU145 (GI50=0.14-0.74 μg/mL); KM20L2 (GI50=0.14-0.74 μg/mL); NCI-H460 (GI50=0.14-0.74 μg/mL); OVCAR-3 (GI50=0.14-0.74 μg/mL); P388 (GI50=0.14-0.74 μg/mL); SF295 (GI50=0.14-0.74 μg/mL); SK-MEL-5 (GI50=0.14-0.74 μg/mL)	Not available	Cyclic	Free	Free		L	Not available	Not available	10650072	 J Nat Prod. 2000 Jan;63(1):22-8. 	Pettit GR, Toki BE, Xu JP, Brune DC. 	Synthesis of the marine sponge cycloheptapeptide phakellistatin 5(1)	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)O
DRAMP33795	PIPIFPY	7	Phakellistatin 1	Not available		Not found	Phakellia costata; Stylotella aurantium	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: P388 (ED50=7.5 μg/mL)	Not available	Cyclic	Free	Free		L	Not available	Not available	28335479	Mar Drugs. 2017 Mar 18;15(3):78. 	Meli A, Tedesco C, Della Sala G, Schettini R, Albericio F, De Riccardis F, Izzo I. 	Phakellistatins: An Underwater Unsolved Puzzle	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP33796	PFGPTIX	7	Phakellistatin 3	Not available		Not found	Phakellia carteri	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: P388 (ED50=0.33 μg/mL)	Not available	Cyclic	Free	Free	X=Photo-Trp	L	Not available	Not available	28335479	Mar Drugs. 2017 Mar 18;15(3):78. 	Meli A, Tedesco C, Della Sala G, Schettini R, Albericio F, De Riccardis F, Izzo I. 	Phakellistatins: An Underwater Unsolved Puzzle	
DRAMP33797	PFPWLPI	7	Phakellistatin 6	Not available		Not found	Phakellia costata	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: P388 (ED50=0.18 μg/mL)	Not available	Cyclic	Free	Free		L	Not available	Not available	28335479	Mar Drugs. 2017 Mar 18;15(3):78. 	Meli A, Tedesco C, Della Sala G, Schettini R, Albericio F, De Riccardis F, Izzo I. 	Phakellistatins: An Underwater Unsolved Puzzle	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(=O)O
DRAMP33798	PPIFALPPYI	10	Phakellistatin 7	Not available		Not found	Phakellia costata	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: P388 (ED50=3.2 μg/mL)	Not available	Cyclic	Free	Free		L	Not available	Not available	28335479	Mar Drugs. 2017 Mar 18;15(3):78. 	Meli A, Tedesco C, Della Sala G, Schettini R, Albericio F, De Riccardis F, Izzo I. 	Phakellistatins: An Underwater Unsolved Puzzle	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)[C@H](C)CC)C(=O)O
DRAMP33799	PPIFTLPPYI	10	Phakellistatin 12	Not available		Not found	Phakellia sp.	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: P388 (ED50=2.8 μg/mL)	Not available	Cyclic	Free	Free		L	Not available	Not available	12639558	Bioorg Med Chem Lett. 2003 Feb 24;13(4):685-8.	Pettit GR, Tan R.	Antineoplastic agents 390. Isolation and structure of phakellistatin 12 from a Chuuk archipelago marine sponge	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)[C@H](C)CC)[C@@H](C)O)C(=O)O
DRAMP33800	AIPFXAX	7	Phakellistatin 14	Not available		Not found	Phakellia sp	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: P388 (ED50=0.0042 μg/mL)	Not available	Cyclic	Free	Free	X(5)=β-OMe-Asp; X(7)=Met(SO)	L	Not available	Not available	15679318	J Nat Prod. 2005 Jan;68(1):60-3.	Pettit GR, Tan R. 	Isolation and structure of phakellistatin 14 from the Western Pacific marine sponge Phakellia sp	
DRAMP33801	XP	2	Diketopiperazine (preWP)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=21.1 μM); A2780 (IC50=82.8 μM); A2780-cisR (IC50=85.9 μM)	Not available	Cyclic	Free	Free	X=Prenylated-Trp	L	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33802	XP	2	Diketopiperazine (preWP)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2780 (IC50=100 μM); K562 (IC50=40.4 μM); A2780-cisR (IC50=87.8 μM)	Not available	Cyclic	Free	Free	X=Prenylated-Trp	L	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33803	XG	2	Diketopiperazine (preWG)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=16.7 μM); A2780 (IC50=82.4 μM); A2780-cisR (IC50=85.2 μM)	Not available	Cyclic	Free	Free	X=Prenylated-Trp	L	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33804	XL	2	Diketopiperazine (preWL)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=30.1 μM); A2780-cisR (IC50=75 μM); A2780 (IC50=92.6 μM)	Not available	Cyclic	Free	Free	X=Prenylated-Trp	L	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33805	XW	2	Diketopiperazine (preWW)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=29.8 μM); A2780-cisR (IC50=80.8 μM); A2780 (IC50=89.7 μM)	Not available	Cyclic	Free	Free	X=Prenylated-Trp	L	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33806	XY	2	Diketopiperazine (preWY)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=31.6 μM); A2780-cisR (IC50=83.3 μM); A2780 (IC50=89.8 μM)	Not available	Cyclic	Free	Free	X=Prenylated-Trp	L	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33807	XF	2	Diketopiperazine (preWF)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=70.4 μM); A2780-cisR (IC50=81.6 μM); A2780 (IC50=87 μM)	Not available	Cyclic	Free	Free	X=Prenylated-Trp	L	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33808	Xp	2	Diketopiperazine (preWp)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2780 (IC50=106 μM); K562 (IC50=34.7 μM); A2780-cisR (IC50=92 μM)	Not available	Cyclic	Free	Free	X=Prenylated-Trp	Mix	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33809	Xp	2	Diketopiperazine (preWp)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=30.9 μM); A2780-cisR (IC50=85.6 μM); A2780 (IC50=93.1 μM)	Not available	Cyclic	Free	Free	X=Prenylated-Trp	Mix	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33810	XP	2	Diketopiperazine (prewP)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=21.1 μM); A2780 (IC50=82.8 μM); A2780-cisR (IC50=85.9 μM)	Not available	Cyclic	Free	Free	x=Prenylated-D-Trp	L	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33811	XP	2	Diketopiperazine (prewP)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2780 (IC50=100 μM); K562 (IC50=40.4 μM); A2780-cisR (IC50=87.8 μM)	Not available	Cyclic	Free	Free	x=Prenylated-D-Trp	L	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33812	Xp	2	Diketopiperazine (prewp)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: A2780 (IC50=106 μM); K562 (IC50=34.7 μM); A2780-cisR (IC50=92 μM)	Not available	Cyclic	Free	Free	x=Prenylated-D-Trp	Mix	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33813	Xp	2	Diketopiperazine (prewp)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=30.9 μM); A2780-cisR (IC50=85.6 μM); A2780 (IC50=93.1 μM)	Not available	Cyclic	Free	Free	x=Prenylated-D-Trp	Mix	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33814	XA	2	Diketopiperazine (preWA)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=35.2 μM); A2780-cisR (IC50=82.2 μM); A2780 (IC50=89.8 μM)	Not available	Cyclic	Free	Free	X=Prenylated-Trp	L	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33815	Xa	2	Diketopiperazine (preWa)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=34.5 μM); A2780-cisR (IC50=77 μM); A2780 (IC50=77.2 μM)	Not available	Cyclic	Free	Free	X=Prenylated-Trp	Mix	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33816	xa	2	Diketopiperazine (prewa)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=34.7 μM); A2780-cisR (IC50=81.1 μM); A2780 (IC50=85 μM)	Not available	Cyclic	Free	Free	x=Prenylated-D-Trp	D	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33817	xA	2	Diketopiperazine (prewA)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=35.3 μM); A2780-cisR (IC50=84.3 μM); A2780 (IC50=86.2 μM)	Not available	Cyclic	Free	Free	x=Prenylated-D-Trp	Mix	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33818	XH	2	Diketopiperazine (preWH)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (IC50=32.2 μM); A2780-cisR (IC50=91.7 μM); A2780 (IC50=91.8 μM)	Not available	Cyclic	Free	Free	X=Prenylated-Trp	L	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	
DRAMP33819	GL	2	Diketopiperazine (GL)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (12.58±1.23% Inhibition=10 µM ; 28.64 ± 1.51% Inhibition=100 µM ); MCF-7  (19.50 ± 1.34% Inhibition=10 µM; 27.49 ± 2.68% Inhibition=100 µM); HT-29 (21.55 ± 1.93% Inhibition=10 µM; 17.25 ± 1.66% Inhibition=100 µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	18436344	Peptides. 2008 Aug;29(8):1305-11. 	van der Merwe E, Huang D, Peterson D, Kilian G, Milne PJ, Van de Venter M, Frost C. 	The synthesis and anticancer activity of selected diketopiperazines	CC(C)C[C@H](NC(=O)CN)C(=O)O
DRAMP33820	GV	2	Diketopiperazine (GV)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (12.58 ± 1.23% Inhibition=10 µM ; 23.46 ± 2.04% Inhibition=100 µM); HT-29 (6.87 ± 0.67% Inhibition=10 µM; 23.90 ± 2.25% Inhibition=100 µM); MCF-7  (7.00 ± 0.56% Inhibition=10 µM; 21.19 ± 2.04% Inhibition=100 µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	18436344	Peptides. 2008 Aug;29(8):1305-11. 	van der Merwe E, Huang D, Peterson D, Kilian G, Milne PJ, Van de Venter M, Frost C. 	The synthesis and anticancer activity of selected diketopiperazines	CC(C)[C@H](NC(=O)CN)C(=O)O
DRAMP33821	Gv	2	Diketopiperazine (Gv)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (14.29 ± 1.40% Inhibition=10 µM; 16.78 ± 1.65% Inhibition=100 µM); HeLa  (19.61 ± 0.82% Inhibition=10 µM ; 20.55 ± 2.03% Inhibition=100 µM); MCF-7  (19.78 ± 1.86% Inhibition=10 µM; 21.94 ± 2.17% Inhibition=100 µM)	Not available	Cyclic	Free	Free		Mix	Not available	Not available	18436344	Peptides. 2008 Aug;29(8):1305-11. 	van der Merwe E, Huang D, Peterson D, Kilian G, Milne PJ, Van de Venter M, Frost C. 	The synthesis and anticancer activity of selected diketopiperazines	CC(C)[C@@H](NC(=O)CN)C(=O)O
DRAMP33822	GC	2	Diketopiperazine (GC)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (30.56 ± 0.03% Inhibition=10 µM; 51.29 ± 0.01% Inhibition=100 µM); MCF-7  (36.49 ± 0.02% Inhibition=10 µM; 56.08 ± 0.01% Inhibition=100 µM); HeLa  (43.92 ± 0.02% Inhibition=10 µM ; 57.79 ± 0.02% Inhibition=100 µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	18436344	Peptides. 2008 Aug;29(8):1305-11. 	van der Merwe E, Huang D, Peterson D, Kilian G, Milne PJ, Van de Venter M, Frost C. 	The synthesis and anticancer activity of selected diketopiperazines	NCC(=O)N[C@@H](CS)C(=O)O
DRAMP33823	YC	2	Diketopiperazine (YC)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (32.41 ± 0.03% Inhibition=10 µM; 52.27 ± 0.02% Inhibition=100 µM); MCF-7  (35.15 ± 0.01% Inhibition=10 µM; 56.08 ± 0.01% Inhibition=100 µM); HeLa  (54.61 ± 0.02% Inhibition=10 µM ; 57.79 ± 0.02% Inhibition=100 µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	18436344	Peptides. 2008 Aug;29(8):1305-11. 	van der Merwe E, Huang D, Peterson D, Kilian G, Milne PJ, Van de Venter M, Frost C. 	The synthesis and anticancer activity of selected diketopiperazines	N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)O
DRAMP33824	VWKPPYLPRPRPPRrIYNr	19	Oncocin Onc112 [D2W], Onc245	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (40% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 32% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33825	VDRPPYLPRPRPPRrIYNr	19	Oncocin Onc112 [K3R], Onc246	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (46% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 42% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33826	VDKKPYLPRPRPPRrIYNr	19	Oncocin Onc112 [P4K], Onc247	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (50% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 42% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33827	VDKFPYLPRPRPPRrIYNr	19	Oncocin Onc112 [P4F], Onc248	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (39% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 48% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33828	VDKYPYLPRPRPPRrIYNr	19	Oncocin Onc112 [P4Y], Onc249	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (30% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 45% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33829	VDKPFYLPRPRPPRrIYNr	19	Oncocin Onc112 [P5F], Onc250	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (34% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 44% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33830	VDKPYYLPRPRPPRrIYNr	19	Oncocin Onc112 [P5Y], Onc251	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (35% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 45% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33831	VDKPHYLPRPRPPRrIYNr	19	Oncocin Onc112 [P5H], Onc252	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (34% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 46% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33832	VDKPRYLPRPRPPRrIYNr	19	Oncocin Onc112 [P5R], Onc253	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (40% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 42% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33833	VDKPPWLPRPRPPRrIYNr	19	Oncocin Onc112 [Y6W], Onc254	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (34% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 55% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33834	VDKPPFLPRPRPPRrIYNr	19	Oncocin Onc112 [Y6F], Onc255	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (44% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 45% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33835	VDKPPHLPRPRPPRrIYNr	19	Oncocin Onc112 [Y6H], Onc256	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (46% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 56% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33836	VDKPPXLPRPRPPRrIYNr	19	Oncocin Onc112 [Y6Dit], Onc257	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (58% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=3,5‐Diiodotyrosine	Mix	HEK293: 44% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33837	VDKPPXLPRPRPPRrIYNr	19	Oncocin Onc112 [Y6Dit], Onc257	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (54% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=3,5‐Diiodotyrosine	Mix	HEK293: 44% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33838	VDKPPXLPRPRPPRrIYNr	19	Oncocin Onc112 [Y6Nty], Onc258	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (58% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=3‐Nitrotyrosine	Mix	HEK293: 45% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33839	VDKPPXLPRPRPPRrIYNr	19	Oncocin Onc112 [Y6Nty], Onc258	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (54% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=3‐Nitrotyrosine	Mix	HEK293: 45% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33840	VDKPPYXPRPRPPRrIYNr	19	Oncocin Onc112 [L7Nle], Onc259	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (46% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=nor-Leu	Mix	HEK293: 60% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33841	VDKPPYXPRPRPPRrIYNr	19	Oncocin Onc112 [L7Nle], Onc259	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (43% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=nor-Leu	Mix	HEK293: 60% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33842	VDKPPYXPRPRPPRrIYNr	19	Oncocin Onc112 [L7Tle], Onc260	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (46% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=tert‐Leu	Mix	HEK293: 52% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33843	VDKPPYXPRPRPPRrIYNr	19	Oncocin Onc112 [L7Tle], Onc260	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (43% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=tert‐Leu	Mix	HEK293: 52% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33844	VDKPPYRPRPRPPRrIYNr	19	Oncocin Onc112 [L7R], Onc261	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (42% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 42% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33845	VDKPPYMPRPRPPRrIYNr	19	Oncocin Onc112 [L7M], Onc262	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (46% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 50% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33846	VDKPPYFPRPRPPRrIYNr	19	Oncocin Onc112 [L7F], Onc263	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (32% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 38% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33847	VDKPPYLPRWRPPRrIYNr	19	Oncocin Onc112 [P10W], Onc264	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (46% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 43% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33848	VDKPPYLPRPWPPRrIYNr	19	Oncocin Onc112 [R11W], Onc265	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (44% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 43% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33849	VDKPPYLPRPHPPRrIYNr	19	Oncocin Onc112 [R11H], Onc266	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (46% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 50% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33850	VDKPPYLPRPKPPRrIYNr	19	Oncocin Onc112 [R11K], Onc267	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (58% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 59% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33851	VDKPPYLPRPFPPRrIYNr	19	Oncocin Onc112 [R11F], Onc268	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (50% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 38% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33852	VDKPPYLPRPXPPRrIYNr	19	Oncocin Onc112 [R11Har], Onc269	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (43% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=Homoarginine	Mix	HEK293: 41% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33853	VDKPPYLPRPRPPRrIXNr	19	Oncocin Onc112 [Y17Dit], Onc270	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (38% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=3,5‐Diiodotyrosine	Mix	HEK293: 44% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33854	VDKPPYLPRPRPPRrIXNr	19	Oncocin Onc112 [Y17Dit], Onc270	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (38% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=3,5‐Diiodotyrosine	Mix	HEK293: 44% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33855	VDKPPYLPRPRPPRrIXNr	19	Oncocin Onc112 [Y17Nty], Onc271	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (38% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=3‐Nitrotyrosine	Mix	HEK293: 34% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33856	VDKPPYLPRPRPPRrIXNr	19	Oncocin Onc112 [Y17Nty], Onc271	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (38% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=3‐Nitrotyrosine	Mix	HEK293: 34% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33857	VDKPPYLPRPRWPRrIYNr	19	Oncocin Onc112 [P12W], Onc272	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (38% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 38% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33858	VDKPPYLPRPRWERrIYNr	19	Oncocin Onc112 [P12W, P13E], Onc273	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (46% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 38% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33859	VDKPPYLPRPRWRRrIYNr	19	Oncocin Onc112 [P12W, P13R], Onc274	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (43% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 44% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33860	VDKPPYLPRPRWWRrIYNr	19	Oncocin Onc112 [P12W, P13W], Onc275	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (64% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 57% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33861	VDKPPYLPRPRWKRrIYNr	19	Oncocin Onc112 [P12W, P13K], Onc276	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (48% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 48% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33862	VDKPPYLPRPRWHRrIYNr	19	Oncocin Onc112 [P12W, P13H], Onc277	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (51% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 50% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33863	VDKPPYLPRPRWIRrIYNr	19	Oncocin Onc112 [P12W, P13I], Onc278	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (56% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 44% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O)[C@H](C)CC
DRAMP33864	VDKPPYLPRPRWFRrIYNr	19	Oncocin Onc112 [P12W, P13F], Onc279	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (61% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 48% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33865	VDKPPYLPRPRWLRrIYNr	19	Oncocin Onc112 [P12W, P13L], Onc280	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (50% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 44% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33866	VDKPPYLPRPRWARrIYNr	19	Oncocin Onc112 [P12W, P13A], Onc281	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (48% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 46% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33867	VDKPPYLPRPRWNRrIYNr	19	Oncocin Onc112 [P12W, P13N], Onc282	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (54% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 42% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33868	VDKPPYLPRPRWVRrIYNr	19	Oncocin Onc112 [P12W, P13V], Onc283	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (25% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 28% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33869	VDKPPYLPRPRWGRrIYNr	19	Oncocin Onc112 [P12W, P13G], Onc284	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (27% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 28% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33870	VDKPPYLPRPRWSRrIYNr	19	Oncocin Onc112 [P12W, P13S], Onc285	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (38% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 34% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33871	VDKPPYLPRPRWQRrIYNr	19	Oncocin Onc112 [P12W, P13Q], Onc286	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (41% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 36% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33872	VDKPPYLPRPRWYRrIYNr	19	Oncocin Onc112 [P12W, P13Y], Onc287	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (30% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 42% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33873	VDKPPYLPRPRWDRrIYNr	19	Oncocin Onc112 [P12W, P13D], Onc288	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (28% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 28% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33874	VDKPPYLPRPRWTRrIYNr	19	Oncocin Onc112 [P12W, P13T], Onc289	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (22% Killing=600 µg/ml)	Not available	Linear	Free	Amidation		Mix	HEK293: 38% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP33875	VDKPPYLPRPRWXRrIYNr	19	Oncocin Onc112 [P12W, P13O], Onc290	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (34% Killing=600 µg/ml)	Not available	Linear	Free	Amidation	X=Orn	Mix	HEK293: 42% Killing=600 µg/ml	Not available	34902208	Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	
DRAMP33876	VLPILLLVL	9	Cyclopeptide GG-8-6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=12.22 μM); SMMC-7721 (IC50=6.38 μM )	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33877	VLPILLLVA	9	Cyclopeptide GG-8-6 [L9A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=38.64 μM); SMMC-7721 (IC50=38.92 μM )	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP33878	VLPILLLAL	9	Cyclopeptide GG-8-6 [V8A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=40.46 μM); SMMC-7721 (IC50=47.37 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33879	VLPILLAVL	9	Cyclopeptide GG-8-6 [L7A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=31.84 μM); SMMC-7721 (IC50=47.37 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33880	VLPILALVL	9	Cyclopeptide GG-8-6 [L6A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SMMC-7721 (IC50=42.81 μM); HepG2 (IC50>100 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33881	VLPIALLVL	9	Cyclopeptide GG-8-6 [L5A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SMMC-7721 (IC50=29.8 μM); HepG2 (IC50>100 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33882	VLPALLLVL	9	Cyclopeptide GG-8-6 [I4A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SMMC-7721 (IC50=36.08 μM); HepG2 (IC50=55.61 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)O
DRAMP33883	VAPILLLVL	9	Cyclopeptide GG-8-6 [L2A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=39.37 μM); SMMC-7721 (IC50=48.48 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33884	ALPILLLVL	9	Cyclopeptide GG-8-6 [V1A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SMMC-7721 (IC50=29.94 μM); HepG2 (IC50=29.95 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP33885	VLPILLLV	8	Cyclopeptide GG-8-6 (1-8)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=51.72 μM); SMMC-7721 (IC50=73.93 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP33886	VLPILLL	7	Cyclopeptide GG-8-6 (1-7)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100 μM); SMMC-7721 (IC50>100 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33887	VLPILL	6	Cyclopeptide GG-8-6 (1-6)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100 μM); SMMC-7721 (IC50>100 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33888	VLPIL	5	Cyclopeptide GG-8-6 (1-5)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50>100 μM); SMMC-7721 (IC50>100 μM)	Not available	Cyclic	Free	Free		L	Not available	Not available	29310863	Bioorg Med Chem. 2018 Feb 1;26(3):609-622.	Chen JT, Ma R, Sun SC, Zhu XF, Xu XL, Mu Q.	Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33889	EQWAREIGAQLRRMADDLNA	20	Puma-BH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Bc1-xL dependent) (EC50=1.006 ± 0.337 μM); OCI-Ly1 (Bcl-2 dependent) (EC50=1.967 ± 0.48 μM)	Not available	Linear	Free	Free		L	Not available	Bcl-xL	25451027	J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.	Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.	Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(=O)O
DRAMP33890	RPEIWYAQGLKRFGDEFNAYYAR	23	XXA1-BH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: OCI-Ly1 (Bcl-2 dependent) (EC50=228 ± 56 nM); MDA-MB-231 (Bc1-xL dependent) (EC50=50 ± 16 nM)	Not available	Linear	Free	Free		L	Not available	Bcl-xL	25451027	J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.	Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.	Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP33891	RPEIWYAQWLKRFGDQFNAYYAR	23	XXA4-BH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-xL	25451027	J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.	Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.	Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP33892	RPEIWIAQGLKRFGDEFNAYYAR	23	XXA1_Y2dI-BH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-xL	25451027	J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.	Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.	Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC
DRAMP33893	RPEIWYAQELKRFGDEFNAYYAR	23	XXA1_G2gE-BH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Bc1-xL dependent) (EC50=12 ± 4 nM); OCI-Ly1 (Bcl-2 dependent) (EC50=37 ± 9 nM)	Not available	Linear	Free	Free		L	Not available	Bcl-xL	25451027	J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.	Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.	Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33894	RPEIWYAQGLRRFGDEFNAYYAR	23	XXA1_K3bR-BH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-xL	25451027	J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.	Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.	Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP33895	RPEIWYAQGLKRIGDEFNAYYAR	23	XXA1_F3dI-BH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-xL	25451027	J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.	Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.	Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP33896	RPEIWYAQGLKRFGDEFNAYKAR	23	XXA1_Y4eK-BH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Bc1-xL dependent) (EC50=82 ± 27 nM); OCI-Ly1 (Bcl-2 dependent) (EC50=911 ± 222 nM)	Not available	Linear	Free	Free		L	Not available	Bcl-xL	25451027	J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.	Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.	Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP33897	IWYAQGLKRFGDEFNAYK	18	Y4eK_18-BH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: OCI-Ly1 (Bcl-2 dependent) (EC50=3.325 ± 0.812 μM); MDA-MB-231 (Bc1-xL dependent) (EC50=847 ± 284 nM)	Not available	Linear	Free	Free		L	Not available	Bcl-xL	25451027	J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.	Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.	Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP33898	RPEIWYAQGLKRFGDEFNAYK	21	Y4eK_21-BH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MDA-MB-231 (Bc1-xL dependent) (EC50=159 ± 53 nM); OCI-Ly1 (Bcl-2 dependent) (EC50=3.435 ± 0.839 μM)	Not available	Linear	Free	Free		L	Not available	Bcl-xL	25451027	J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.	Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.	Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP33899	LRPEIRYAQELRRIGDEFNE	20	BimEL-I146Y	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	30860026	Elife. 2019 Mar 12;8:e37689. 	Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. 	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP33900	LWAAIRIAQELRRIGDEFNE	20	Bim-WAA	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	30860026	Elife. 2019 Mar 12;8:e37689. 	Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. 	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC
DRAMP33901	LRPEIRIARELRRIGDEFNE	20	BimEL-Q148R	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	30860026	Elife. 2019 Mar 12;8:e37689. 	Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. 	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP33902	LRPEIRIAQELRRMGDEFNE	20	BimEL-I153M	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	30860026	Elife. 2019 Mar 12;8:e37689. 	Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. 	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP33903	LRPEIRYARELRRIGDEFNE	20	BimEL-I146Y-Q148R	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	30860026	Elife. 2019 Mar 12;8:e37689. 	Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. 	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP33904	LRPEIRYAQELRRMGDEFNE	20	BimEL I146Y-I153M	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	30860026	Elife. 2019 Mar 12;8:e37689. 	Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. 	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP33905	PQMVILQLLRFIFRLVWRRH	20	BimEL-CTS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	30860026	Elife. 2019 Mar 12;8:e37689. 	Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. 	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP33906	PQMVELQLLRFIFRLVWRRH	20	BimEL-I181E	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	30860026	Elife. 2019 Mar 12;8:e37689. 	Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. 	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP33907	PQMVILQLERFIFRLVWRRH	20	BimEL-L185E	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	30860026	Elife. 2019 Mar 12;8:e37689. 	Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. 	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP33908	PQMVILQLLRFEFRLVWRRH	20	BimEL-I188E	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	30860026	Elife. 2019 Mar 12;8:e37689. 	Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. 	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP33909	PQMVILQLLRFIFRLEWRRH	20	BimEL-V192E	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	30860026	Elife. 2019 Mar 12;8:e37689. 	Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. 	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP33910	PQMVILQLLAFIFALVWRRH	20	BimEL-CST-2A (R186A-R190A)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	30860026	Elife. 2019 Mar 12;8:e37689. 	Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW. 	Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP33911	IWIAQELRRIGDEFNA	16	Bim SM-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937 (18% Killing= 50 μM); HL-60 (23% Killing= 50 μM); K562 (25% Killing= 50 μM)	Not available	Linear	Acetylation	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP33912	IWIAQELRRIGDEF	14	Bim SM-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP33913	IAQELRRIGDEFNA	14	Bim SM-3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(N)=O)[C@H](C)CC
DRAMP33914	WIAQELRRIGDEFN	14	Bim SM-4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(N)=O
DRAMP33915	IAQELRRIGDEF	12	Bim SM-5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (21% Killing= 50 μM); K562 (26% Killing= 50 μM); U-937 (40% Killing= 50 μM)	Not available	Linear	Acetylation	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP33916	IAQELRRIGDEF	12	Bim SM-5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (20% Killing= 50 μM); HL-60 (23% Killing= 50 μM); U-937 (45% Killing= 50 μM)	Not available	Linear	Acetylation	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP33917	IAQELRRIGDEF	12	Bim SM-5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP33918	IAQELRRIGDEF	12	Bim SM-6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (21% Killing= 50 μM); K562 (26% Killing= 50 μM); U-937 (40% Killing= 50 μM)	Not available	Linear	Pal, CH3(CH2)14CO	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP33919	IAQELRRIGDEF	12	Bim SM-6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (20% Killing= 50 μM); HL-60 (23% Killing= 50 μM); U-937 (45% Killing= 50 μM)	Not available	Linear	Pal, CH3(CH2)14CO	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP33920	IAQELRRIGDEF	12	Bim SM-6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Pal, CH3(CH2)14CO	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP33921	IAQELRRIGDEF	12	Bim SM-7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HL-60 (21% Killing= 50 μM); K562 (26% Killing= 50 μM); U-937 (40% Killing= 50 μM)	Not available	Linear	mPEG, CH3(OCH2CH2)4OCH2CO	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	
DRAMP33922	IAQELRRIGDEF	12	Bim SM-7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: K562 (20% Killing= 50 μM); HL-60 (23% Killing= 50 μM); U-937 (45% Killing= 50 μM)	Not available	Linear	mPEG, CH3(OCH2CH2)4OCH2CO	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	
DRAMP33923	IAQELRRIGDEF	12	Bim SM-7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	mPEG, CH3(OCH2CH2)4OCH2CO	Amidation		L	Not available	Bcl-2	Not available			Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain	
DRAMP33924	EIWIAQELRRRGDSFNAYYAR	21	Bim BH3 (I155R, E158S)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	26136077	Cell Death Dis. 2015 Jul 2;6(7):e1804.	Kim JS, Ku B, Woo TG, Oh AY, Jung YS, Soh YM, Yeom JH, Lee K, Park BJ, Oh BH, Ha NC. 	Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain	CC[C@@H](C)[C@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP33925	EIWIAQELRRRGDXFNAYYAR	21	p-Bim BH3 (I155R, E158S)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Phosphorylated-Ser	L	Not available	Bcl-2/Bcl-xL	26136077	Cell Death Dis. 2015 Jul 2;6(7):e1804.	Kim JS, Ku B, Woo TG, Oh AY, Jung YS, Soh YM, Yeom JH, Lee K, Park BJ, Oh BH, Ha NC. 	Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain	
DRAMP33926	EIWIAQELRRRGDAFNAYYAR	21	Bim BH3 (I155R, E158A)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	26136077	Cell Death Dis. 2015 Jul 2;6(7):e1804.	Kim JS, Ku B, Woo TG, Oh AY, Jung YS, Soh YM, Yeom JH, Lee K, Park BJ, Oh BH, Ha NC. 	Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain	CC[C@@H](C)[C@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP33927	EIWIAQELRSRGDSFNAYYAR	21	Bim BH3 (R154S, I155R, E158S)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	26136077	Cell Death Dis. 2015 Jul 2;6(7):e1804.	Kim JS, Ku B, Woo TG, Oh AY, Jung YS, Soh YM, Yeom JH, Lee K, Park BJ, Oh BH, Ha NC. 	Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain	CC[C@@H](C)[C@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP33928	EIWIAQELRSRGDXFNAYYAR	21	p-Bim BH3 (R154S, I155R, E158S)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Phosphorylated-Ser	L	Not available	Bcl-2/Bcl-xL	26136077	Cell Death Dis. 2015 Jul 2;6(7):e1804.	Kim JS, Ku B, Woo TG, Oh AY, Jung YS, Soh YM, Yeom JH, Lee K, Park BJ, Oh BH, Ha NC. 	Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain	
DRAMP33929	EIWIAQELRRIGDSFNAYYAR	21	Bim BH3 (E158S)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-2/Bcl-xL	26136077	Cell Death Dis. 2015 Jul 2;6(7):e1804.	Kim JS, Ku B, Woo TG, Oh AY, Jung YS, Soh YM, Yeom JH, Lee K, Park BJ, Oh BH, Ha NC. 	Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain	CC[C@@H](C)[C@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP33930	LWAAQRYGRELRRMSDEFEGSFKGL	25	Bad-BH3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Bcl-xL	25451027	J Mol Biol. 2015 Mar 27;427(6 Pt B):1241-1253.	Dutta S, Ryan J, Chen TS, Kougentakis C, Letai A, Keating AE.	Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
DRAMP33931	RPEIWMTQGLRRLGDEINAYYAR	23	MS1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33932	RPEIWLTQSLQRLGDEINAYYAR	23	MS2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33933	RPEIWLTQHLQRLGDEINAYYAR	23	MS3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33934	RPEIWMGQGLRRLGDEINAYYAR	23	A12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33935	RPEIWLGQSLQRLGDEINAYYAR	23	B3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33936	RPEIWLGQHLQRLGDEINAYYAR	23	G9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33937	AELPPEFAAQLRKIGDKVYC	20	NoxaA	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33938	RPEIWIAQELRRIGDEFNAYYAR	23	Bim	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33939	RPEIWITQELRRIGDEFNAYYAR	23	Bim-A2eT	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33940	RPEIWMTQELRRIGDEFNAYYAR	23	Bim-A2eT-I2dM	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33941	RPEIWITQGLRRIGDEFNAYYAR	23	Bim-A2eT-E2gG	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33942	RPEIWITQELRRLGDEFNAYYAR	23	Bim-A2eT-I3dL	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33943	RPEIWITQELRRIGDEINAYYAR	23	Bim-A2eT-F4aI	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5/6-Fluorescein amidite	Amidation		L	Not available	Mcl-1	25052212	ACS Chem Biol. 2014 Sep 19;9(9):1962-8.	Foight GW, Ryan JA, Gullá SV, Letai A, Keating AE.	Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells	
DRAMP33944	RPEIWLAQYLRRLGDQINAYYAR	23	Bim-FD1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Bfl-1	23363053	ACS Chem Biol. 2013 Apr 19;8(4):778-88.	Dutta S, Chen TS, Keating AE.	Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP33945	RPEIWMAQVLRRFGDLLNAYYAR	23	Bim-FD2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Bfl-1	23363053	ACS Chem Biol. 2013 Apr 19;8(4):778-88.	Dutta S, Chen TS, Keating AE.	Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP33946	RPEIWIAQELRRAGDVLNAYYAR	23	Bim-FA1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Bfl-1	23363053	ACS Chem Biol. 2013 Apr 19;8(4):778-88.	Dutta S, Chen TS, Keating AE.	Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP33947	RPEIWIAQGLRRIGDTWNAYYAR	23	Bim-FW1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Bfl-1	23363053	ACS Chem Biol. 2013 Apr 19;8(4):778-88.	Dutta S, Chen TS, Keating AE.	Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)[C@@H](C)O
DRAMP33948	MRPEIWIAQELRRIGDEVNAYYARRVZ	27	LIB2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33949	MRPEIWIAQELRRIGDENNAYYARRVZ	27	LIB3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33950	MRPEIWIAQELRRFGDEFNAYYARRVZ	27	LIB4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33951	MRPEIWIAQELRRFGDEVNAYYARRVZ	27	LIB5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33952	MRPEIWIAQELRRFGDENNAYYARRVZ	27	LIB6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33953	MRPEIWIAQELRRDGDEFNAYYARRVZ	27	LIB7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33954	MRPEIWIAQELRRDGDEVNAYYARRVZ	27	LIB8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33955	MRPEIWIAQELRRDGDENNAYYARRVZ	27	LIB9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33956	MRPEIWIAQELRRNGDEFNAYYARRVZ	27	LIB10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33957	MRPEIWIAQELRRNGDEVNAYYARRVZ	27	LIB11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33958	MRPEIWIAQELRRNGDENNAYYARRVZ	27	LIB12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33959	MRPEIWIAQELRRAGDEFNAYYARRVZ	27	LIB13	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33960	MRPEIWIAQELRRAGDEVNAYYARRVZ	27	LIB14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33961	MRPEIWIAQELRRAGDENNAYYARRVZ	27	LIB15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33962	MRPEIWIAQELDRIGDEFNAYYARRVZ	27	LIB16	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33963	MRPEIWIAQELDRIGDEVNAYYARRVZ	27	LIB17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33964	MRPEIWIAQELDRIGDENNAYYARRVZ	27	LIB18	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33965	MRPEIWIAQELDRFGDEFNAYYARRVZ	27	LIB19	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33966	MRPEIWIAQELDRFGDEVNAYYARRVZ	27	LIB20	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33967	MRPEIWIAQELDRFGDENNAYYARRVZ	27	LIB21	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33968	MRPEIWIAQELDRDGDEFNAYYARRVZ	27	LIB22	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33969	MRPEIWIAQELDRDGDEVNAYYARRVZ	27	LIB23	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33970	MRPEIWIAQELDRDGDENNAYYARRVZ	27	LIB24	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33971	MRPEIWIAQELDRNGDEFNAYYARRVZ	27	LIB25	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33972	MRPEIWIAQELDRNGDEVNAYYARRVZ	27	LIB26	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33973	MRPEIWIAQELDRNGDENNAYYARRVZ	27	LIB27	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33974	MRPEIWIAQELDRAGDEFNAYYARRVZ	27	LIB28	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33975	MRPEIWIAQELDRAGDEVNAYYARRVZ	27	LIB29	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33976	MRPEIWIAQELDRAGDENNAYYARRVZ	27	LIB30	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33977	MRPEIWIAQEIRRIGDEFNAYYARRVZ	27	LIB31	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33978	MRPEIWIAQEIRRIGDEVNAYYARRVZ	27	LIB32	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33979	MRPEIWIAQEIRRIGDENNAYYARRVZ	27	LIB33	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33980	MRPEIWIAQEIRRFGDEFNAYYARRVZ	27	LIB34	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33981	MRPEIWIAQEIRRFGDEVNAYYARRVZ	27	LIB35	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33982	MRPEIWIAQEIRRFGDENNAYYARRVZ	27	LIB36	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33983	MRPEIWIAQEIRRDGDEFNAYYARRVZ	27	LIB37	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33984	MRPEIWIAQEIRRDGDEVNAYYARRVZ	27	LIB38	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33985	MRPEIWIAQEIRRDGDENNAYYARRVZ	27	LIB39	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33986	MRPEIWIAQEIRRNGDEFNAYYARRVZ	27	LIB40	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33987	MRPEIWIAQEIRRNGDEVNAYYARRVZ	27	LIB41	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33988	MRPEIWIAQEIRRNGDENNAYYARRVZ	27	LIB42	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33989	MRPEIWIAQEIRRAGDEFNAYYARRVZ	27	LIB43	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33990	MRPEIWIAQEIRRAGDEVNAYYARRVZ	27	LIB44	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33991	MRPEIWIAQEIRRAGDENNAYYARRVZ	27	LIB45	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33992	MRPEIWIAQEIDRIGDEFNAYYARRVZ	27	LIB46	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33993	MRPEIWIAQEIDRIGDEVNAYYARRVZ	27	LIB47	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33994	MRPEIWIAQEIDRIGDENNAYYARRVZ	27	LIB48	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33995	MRPEIWIAQEIDRFGDEFNAYYARRVZ	27	LIB49	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33996	MRPEIWIAQEIDRFGDEVNAYYARRVZ	27	LIB50	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33997	MRPEIWIAQEIDRFGDENNAYYARRVZ	27	LIB51	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33998	MRPEIWIAQEIDRDGDEFNAYYARRVZ	27	LIB52	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP33999	MRPEIWIAQEIDRDGDEVNAYYARRVZ	27	LIB53	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34000	MRPEIWIAQEIDRDGDENNAYYARRVZ	27	LIB54	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34001	MRPEIWIAQEIDRNGDEFNAYYARRVZ	27	LIB55	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34002	MRPEIWIAQEIDRNGDEVNAYYARRVZ	27	LIB56	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34003	MRPEIWIAQEIDRNGDENNAYYARRVZ	27	LIB57	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34004	MRPEIWIAQEIDRAGDEFNAYYARRVZ	27	LIB58	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34005	MRPEIWIAQEIDRAGDEVNAYYARRVZ	27	LIB59	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34006	MRPEIWIAQEIDRAGDENNAYYARRVZ	27	LIB60	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34007	MRPEIWIAQEFRRIGDEFNAYYARRVZ	27	LIB61	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34008	MRPEIWIAQEFRRIGDEVNAYYARRVZ	27	LIB62	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34009	MRPEIWIAQEFRRIGDENNAYYARRVZ	27	LIB63	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34010	MRPEIWIAQEFRRFGDEFNAYYARRVZ	27	LIB64	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34011	MRPEIWIAQEFRRFGDEVNAYYARRVZ	27	LIB65	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34012	MRPEIWIAQEFRRFGDENNAYYARRVZ	27	LIB66	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34013	MRPEIWIAQEFRRDGDEFNAYYARRVZ	27	LIB67	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34014	MRPEIWIAQEFRRDGDEVNAYYARRVZ	27	LIB68	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34015	MRPEIWIAQEFRRDGDENNAYYARRVZ	27	LIB69	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34016	MRPEIWIAQEFRRNGDEFNAYYARRVZ	27	LIB70	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34017	MRPEIWIAQEFRRNGDEVNAYYARRVZ	27	LIB71	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34018	MRPEIWIAQEFRRNGDENNAYYARRVZ	27	LIB72	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34019	MRPEIWIAQEFRRAGDEFNAYYARRVZ	27	LIB73	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34020	MRPEIWIAQEFRRAGDEVNAYYARRVZ	27	LIB74	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34021	MRPEIWIAQEFRRAGDENNAYYARRVZ	27	LIB75	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34022	MRPEIWIAQEFDRIGDEFNAYYARRVZ	27	LIB76	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34023	MRPEIWIAQEFDRIGDEVNAYYARRVZ	27	LIB77	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34024	MRPEIWIAQEFDRIGDENNAYYARRVZ	27	LIB78	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34025	MRPEIWIAQEFDRFGDEFNAYYARRVZ	27	LIB79	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34026	MRPEIWIAQEFDRFGDEVNAYYARRVZ	27	LIB80	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34027	MRPEIWIAQEFDRFGDENNAYYARRVZ	27	LIB81	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34028	MRPEIWIAQEFDRDGDEFNAYYARRVZ	27	LIB82	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34029	MRPEIWIAQEFDRDGDEVNAYYARRVZ	27	LIB83	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34030	MRPEIWIAQEFDRDGDENNAYYARRVZ	27	LIB84	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34031	MRPEIWIAQEFDRNGDEFNAYYARRVZ	27	LIB85	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34032	MRPEIWIAQEFDRNGDEVNAYYARRVZ	27	LIB86	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34033	MRPEIWIAQEFDRNGDENNAYYARRVZ	27	LIB87	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34034	MRPEIWIAQEFDRAGDEFNAYYARRVZ	27	LIB88	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34035	MRPEIWIAQEFDRAGDEVNAYYARRVZ	27	LIB89	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34036	MRPEIWIAQEFDRAGDENNAYYARRVZ	27	LIB90	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34037	MRPEIWIAQEARRIGDEFNAYYARRVZ	27	LIB91	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34038	MRPEIWIAQEARRIGDEVNAYYARRVZ	27	LIB92	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34039	MRPEIWIAQEARRIGDENNAYYARRVZ	27	LIB93	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34040	MRPEIWIAQEARRFGDEFNAYYARRVZ	27	LIB94	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34041	MRPEIWIAQEARRFGDEVNAYYARRVZ	27	LIB95	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34042	MRPEIWIAQEARRFGDENNAYYARRVZ	27	LIB96	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34043	MRPEIWIAQEARRDGDEFNAYYARRVZ	27	LIB97	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34044	MRPEIWIAQEARRDGDEVNAYYARRVZ	27	LIB98	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34045	MRPEIWIAQEARRDGDENNAYYARRVZ	27	LIB99	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34046	MRPEIWIAQEARRNGDEFNAYYARRVZ	27	LIB100	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34047	MRPEIWIAQEARRNGDEVNAYYARRVZ	27	LIB101	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34048	MRPEIWIAQEARRNGDENNAYYARRVZ	27	LIB102	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34049	MRPEIWIAQEARRAGDEFNAYYARRVZ	27	LIB103	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34050	MRPEIWIAQEARRAGDEVNAYYARRVZ	27	LIB104	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34051	MRPEIWIAQEARRAGDENNAYYARRVZ	27	LIB105	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34052	MRPEIWIAQEADRIGDEFNAYYARRVZ	27	LIB106	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34053	MRPEIWIAQEADRIGDEVNAYYARRVZ	27	LIB107	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34054	MRPEIWIAQEADRIGDENNAYYARRVZ	27	LIB108	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34055	MRPEIWIAQEADRFGDEFNAYYARRVZ	27	LIB109	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34056	MRPEIWIAQEADRFGDEVNAYYARRVZ	27	LIB110	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34057	MRPEIWIAQEADRFGDENNAYYARRVZ	27	LIB111	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34058	MRPEIWIAQEADRDGDEFNAYYARRVZ	27	LIB112	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34059	MRPEIWIAQEADRDGDEVNAYYARRVZ	27	LIB113	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34060	MRPEIWIAQEADRDGDENNAYYARRVZ	27	LIB114	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34061	MRPEIWIAQEADRNGDEFNAYYARRVZ	27	LIB115	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34062	MRPEIWIAQEADRNGDEVNAYYARRVZ	27	LIB116	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34063	MRPEIWIAQEADRNGDENNAYYARRVZ	27	LIB117	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34064	MRPEIWIAQEADRAGDEFNAYYARRVZ	27	LIB118	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34065	MRPEIWIAQEADRAGDEVNAYYARRVZ	27	LIB119	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34066	MRPEIWIAQEADRAGDENNAYYARRVZ	27	LIB120	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34067	MRPEIWAAQELRRIGDEFNAYYARRVZ	27	LIB121	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34068	MRPEIWAAQELRRIGDEVNAYYARRVZ	27	LIB122	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34069	MRPEIWAAQELRRIGDENNAYYARRVZ	27	LIB123	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34070	MRPEIWAAQELRRFGDEFNAYYARRVZ	27	LIB124	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34071	MRPEIWAAQELRRFGDEVNAYYARRVZ	27	LIB125	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34072	MRPEIWAAQELRRFGDENNAYYARRVZ	27	LIB126	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34073	MRPEIWAAQELRRDGDEFNAYYARRVZ	27	LIB127	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34074	MRPEIWAAQELRRDGDEVNAYYARRVZ	27	LIB128	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34075	MRPEIWAAQELRRDGDENNAYYARRVZ	27	LIB129	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34076	MRPEIWAAQELRRNGDEFNAYYARRVZ	27	LIB130	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34077	MRPEIWAAQELRRNGDEVNAYYARRVZ	27	LIB131	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34078	MRPEIWAAQELRRNGDENNAYYARRVZ	27	LIB132	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34079	MRPEIWAAQELRRAGDEFNAYYARRVZ	27	LIB133	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34080	MRPEIWAAQELRRAGDEVNAYYARRVZ	27	LIB134	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34081	MRPEIWAAQELRRAGDENNAYYARRVZ	27	LIB135	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34082	MRPEIWAAQELDRIGDEFNAYYARRVZ	27	LIB136	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34083	MRPEIWAAQELDRIGDEVNAYYARRVZ	27	LIB137	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34084	MRPEIWAAQELDRIGDENNAYYARRVZ	27	LIB138	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34085	MRPEIWAAQELDRFGDEFNAYYARRVZ	27	LIB139	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34086	MRPEIWAAQELDRFGDEVNAYYARRVZ	27	LIB140	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34087	MRPEIWAAQELDRFGDENNAYYARRVZ	27	LIB141	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34088	MRPEIWAAQELDRDGDEFNAYYARRVZ	27	LIB142	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34089	MRPEIWAAQELDRDGDEVNAYYARRVZ	27	LIB143	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34090	MRPEIWAAQELDRDGDENNAYYARRVZ	27	LIB144	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34091	MRPEIWAAQELDRNGDEFNAYYARRVZ	27	LIB145	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34092	MRPEIWAAQELDRNGDEVNAYYARRVZ	27	LIB146	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34093	MRPEIWAAQELDRNGDENNAYYARRVZ	27	LIB147	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34094	MRPEIWAAQELDRAGDEFNAYYARRVZ	27	LIB148	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34095	MRPEIWAAQELDRAGDEVNAYYARRVZ	27	LIB149	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34096	MRPEIWAAQELDRAGDENNAYYARRVZ	27	LIB150	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34097	MRPEIWAAQEIRRIGDEFNAYYARRVZ	27	LIB151	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34098	MRPEIWAAQEIRRIGDEVNAYYARRVZ	27	LIB152	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34099	MRPEIWAAQEIRRIGDENNAYYARRVZ	27	LIB153	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34100	MRPEIWAAQEIRRFGDEFNAYYARRVZ	27	LIB154	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34101	MRPEIWAAQEIRRFGDEVNAYYARRVZ	27	LIB155	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34102	MRPEIWAAQEIRRFGDENNAYYARRVZ	27	LIB156	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34103	MRPEIWAAQEIRRDGDEFNAYYARRVZ	27	LIB157	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34104	MRPEIWAAQEIRRDGDEVNAYYARRVZ	27	LIB158	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34105	MRPEIWAAQEIRRDGDENNAYYARRVZ	27	LIB159	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34106	MRPEIWAAQEIRRNGDEFNAYYARRVZ	27	LIB160	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34107	MRPEIWAAQEIRRNGDEVNAYYARRVZ	27	LIB161	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34108	MRPEIWAAQEIRRNGDENNAYYARRVZ	27	LIB162	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34109	MRPEIWAAQEIRRAGDEFNAYYARRVZ	27	LIB163	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34110	MRPEIWAAQEIRRAGDEVNAYYARRVZ	27	LIB164	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34111	MRPEIWAAQEIRRAGDENNAYYARRVZ	27	LIB165	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34112	MRPEIWAAQEIDRIGDEFNAYYARRVZ	27	LIB166	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34113	MRPEIWAAQEIDRIGDEVNAYYARRVZ	27	LIB167	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34114	MRPEIWAAQEIDRIGDENNAYYARRVZ	27	LIB168	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34115	MRPEIWAAQEIDRFGDEFNAYYARRVZ	27	LIB169	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34116	MRPEIWAAQEIDRFGDEVNAYYARRVZ	27	LIB170	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34117	MRPEIWAAQEIDRFGDENNAYYARRVZ	27	LIB171	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34118	MRPEIWAAQEIDRDGDEFNAYYARRVZ	27	LIB172	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34119	MRPEIWAAQEIDRDGDEVNAYYARRVZ	27	LIB173	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34120	MRPEIWAAQEIDRDGDENNAYYARRVZ	27	LIB174	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34121	MRPEIWAAQEIDRNGDEFNAYYARRVZ	27	LIB175	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34122	MRPEIWAAQEIDRNGDEVNAYYARRVZ	27	LIB176	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34123	MRPEIWAAQEIDRNGDENNAYYARRVZ	27	LIB177	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34124	MRPEIWAAQEIDRAGDEFNAYYARRVZ	27	LIB178	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34125	MRPEIWAAQEIDRAGDEVNAYYARRVZ	27	LIB179	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34126	MRPEIWAAQEIDRAGDENNAYYARRVZ	27	LIB180	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34127	MRPEIWAAQEFRRIGDEFNAYYARRVZ	27	LIB181	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34128	MRPEIWAAQEFRRIGDEVNAYYARRVZ	27	LIB182	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34129	MRPEIWAAQEFRRIGDENNAYYARRVZ	27	LIB183	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34130	MRPEIWAAQEFRRFGDEFNAYYARRVZ	27	LIB184	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34131	MRPEIWAAQEFRRFGDEVNAYYARRVZ	27	LIB185	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34132	MRPEIWAAQEFRRFGDENNAYYARRVZ	27	LIB186	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34133	MRPEIWAAQEFRRDGDEFNAYYARRVZ	27	LIB187	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34134	MRPEIWAAQEFRRDGDEVNAYYARRVZ	27	LIB188	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34135	MRPEIWAAQEFRRDGDENNAYYARRVZ	27	LIB189	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34136	MRPEIWAAQEFRRNGDEFNAYYARRVZ	27	LIB190	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34137	MRPEIWAAQEFRRNGDEVNAYYARRVZ	27	LIB191	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34138	MRPEIWAAQEFRRNGDENNAYYARRVZ	27	LIB192	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34139	MRPEIWAAQEFRRAGDEFNAYYARRVZ	27	LIB193	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34140	MRPEIWAAQEFRRAGDEVNAYYARRVZ	27	LIB194	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34141	MRPEIWAAQEFRRAGDENNAYYARRVZ	27	LIB195	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34142	MRPEIWAAQEFDRIGDEFNAYYARRVZ	27	LIB196	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34143	MRPEIWAAQEFDRIGDEVNAYYARRVZ	27	LIB197	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34144	MRPEIWAAQEFDRIGDENNAYYARRVZ	27	LIB198	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34145	MRPEIWAAQEFDRFGDEFNAYYARRVZ	27	LIB199	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34146	MRPEIWAAQEFDRFGDEVNAYYARRVZ	27	LIB200	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34147	MRPEIWAAQEFDRFGDENNAYYARRVZ	27	LIB201	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34148	MRPEIWAAQEFDRDGDEFNAYYARRVZ	27	LIB202	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34149	MRPEIWAAQEFDRDGDEVNAYYARRVZ	27	LIB203	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34150	MRPEIWAAQEFDRDGDENNAYYARRVZ	27	LIB204	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34151	MRPEIWAAQEFDRNGDEFNAYYARRVZ	27	LIB205	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34152	MRPEIWAAQEFDRNGDEVNAYYARRVZ	27	LIB206	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34153	MRPEIWAAQEFDRNGDENNAYYARRVZ	27	LIB207	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34154	MRPEIWAAQEFDRAGDEFNAYYARRVZ	27	LIB208	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34155	MRPEIWAAQEFDRAGDEVNAYYARRVZ	27	LIB209	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34156	MRPEIWAAQEFDRAGDENNAYYARRVZ	27	LIB210	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34157	MRPEIWAAQEARRIGDEFNAYYARRVZ	27	LIB211	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34158	MRPEIWAAQEARRIGDEVNAYYARRVZ	27	LIB212	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34159	MRPEIWAAQEARRIGDENNAYYARRVZ	27	LIB213	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34160	MRPEIWAAQEARRFGDEFNAYYARRVZ	27	LIB214	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34161	MRPEIWAAQEARRFGDEVNAYYARRVZ	27	LIB215	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34162	MRPEIWAAQEARRFGDENNAYYARRVZ	27	LIB216	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34163	MRPEIWAAQEARRDGDEFNAYYARRVZ	27	LIB217	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34164	MRPEIWAAQEARRDGDEVNAYYARRVZ	27	LIB218	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34165	MRPEIWAAQEARRDGDENNAYYARRVZ	27	LIB219	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34166	MRPEIWAAQEARRNGDEFNAYYARRVZ	27	LIB220	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34167	MRPEIWAAQEARRNGDEVNAYYARRVZ	27	LIB221	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34168	MRPEIWAAQEARRNGDENNAYYARRVZ	27	LIB222	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34169	MRPEIWAAQEARRAGDEFNAYYARRVZ	27	LIB223	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34170	MRPEIWAAQEARRAGDEVNAYYARRVZ	27	LIB224	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34171	MRPEIWAAQEARRAGDENNAYYARRVZ	27	LIB225	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34172	MRPEIWAAQEADRIGDEFNAYYARRVZ	27	LIB226	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34173	MRPEIWAAQEADRIGDEVNAYYARRVZ	27	LIB227	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34174	MRPEIWAAQEADRIGDENNAYYARRVZ	27	LIB228	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34175	MRPEIWAAQEADRFGDEFNAYYARRVZ	27	LIB229	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34176	MRPEIWAAQEADRFGDEVNAYYARRVZ	27	LIB230	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34177	MRPEIWAAQEADRFGDENNAYYARRVZ	27	LIB231	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34178	MRPEIWAAQEADRDGDEFNAYYARRVZ	27	LIB232	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34179	MRPEIWAAQEADRDGDEVNAYYARRVZ	27	LIB233	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34180	MRPEIWAAQEADRDGDENNAYYARRVZ	27	LIB234	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34181	MRPEIWAAQEADRNGDEFNAYYARRVZ	27	LIB235	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34182	MRPEIWAAQEADRNGDEVNAYYARRVZ	27	LIB236	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34183	MRPEIWAAQEADRNGDENNAYYARRVZ	27	LIB237	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34184	MRPEIWAAQEADRAGDEFNAYYARRVZ	27	LIB238	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34185	MRPEIWAAQEADRAGDEVNAYYARRVZ	27	LIB239	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34186	MRPEIWAAQEADRAGDENNAYYARRVZ	27	LIB240	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34187	MRPEIWFAQELRRIGDEFNAYYARRVZ	27	LIB241	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34188	MRPEIWFAQELRRIGDEVNAYYARRVZ	27	LIB242	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34189	MRPEIWFAQELRRIGDENNAYYARRVZ	27	LIB243	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34190	MRPEIWFAQELRRFGDEFNAYYARRVZ	27	LIB244	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34191	MRPEIWFAQELRRFGDEVNAYYARRVZ	27	LIB245	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34192	MRPEIWFAQELRRFGDENNAYYARRVZ	27	LIB246	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34193	MRPEIWFAQELRRDGDEFNAYYARRVZ	27	LIB247	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34194	MRPEIWFAQELRRDGDEVNAYYARRVZ	27	LIB248	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34195	MRPEIWFAQELRRDGDENNAYYARRVZ	27	LIB249	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34196	MRPEIWFAQELRRNGDEFNAYYARRVZ	27	LIB250	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34197	MRPEIWFAQELRRNGDEVNAYYARRVZ	27	LIB251	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34198	MRPEIWFAQELRRNGDENNAYYARRVZ	27	LIB252	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34199	MRPEIWFAQELRRAGDEFNAYYARRVZ	27	LIB253	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34200	MRPEIWFAQELRRAGDEVNAYYARRVZ	27	LIB254	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34201	MRPEIWFAQELRRAGDENNAYYARRVZ	27	LIB255	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34202	MRPEIWFAQELDRIGDEFNAYYARRVZ	27	LIB256	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34203	MRPEIWFAQELDRIGDEVNAYYARRVZ	27	LIB257	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34204	MRPEIWFAQELDRIGDENNAYYARRVZ	27	LIB258	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34205	MRPEIWFAQELDRFGDEFNAYYARRVZ	27	LIB259	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34206	MRPEIWFAQELDRFGDEVNAYYARRVZ	27	LIB260	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34207	MRPEIWFAQELDRFGDENNAYYARRVZ	27	LIB261	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34208	MRPEIWFAQELDRDGDEFNAYYARRVZ	27	LIB262	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34209	MRPEIWFAQELDRDGDEVNAYYARRVZ	27	LIB263	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34210	MRPEIWFAQELDRDGDENNAYYARRVZ	27	LIB264	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34211	MRPEIWFAQELDRNGDEFNAYYARRVZ	27	LIB265	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34212	MRPEIWFAQELDRNGDEVNAYYARRVZ	27	LIB266	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34213	MRPEIWFAQELDRNGDENNAYYARRVZ	27	LIB267	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34214	MRPEIWFAQELDRAGDEFNAYYARRVZ	27	LIB268	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34215	MRPEIWFAQELDRAGDEVNAYYARRVZ	27	LIB269	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34216	MRPEIWFAQELDRAGDENNAYYARRVZ	27	LIB270	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34217	MRPEIWFAQEIRRIGDEFNAYYARRVZ	27	LIB271	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34218	MRPEIWFAQEIRRIGDEVNAYYARRVZ	27	LIB272	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34219	MRPEIWFAQEIRRIGDENNAYYARRVZ	27	LIB273	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34220	MRPEIWFAQEIRRFGDEFNAYYARRVZ	27	LIB274	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34221	MRPEIWFAQEIRRFGDEVNAYYARRVZ	27	LIB275	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34222	MRPEIWFAQEIRRFGDENNAYYARRVZ	27	LIB276	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34223	MRPEIWFAQEIRRDGDEFNAYYARRVZ	27	LIB277	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34224	MRPEIWFAQEIRRDGDEVNAYYARRVZ	27	LIB278	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34225	MRPEIWFAQEIRRDGDENNAYYARRVZ	27	LIB279	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34226	MRPEIWFAQEIRRNGDEFNAYYARRVZ	27	LIB280	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34227	MRPEIWFAQEIRRNGDEVNAYYARRVZ	27	LIB281	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34228	MRPEIWFAQEIRRNGDENNAYYARRVZ	27	LIB282	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34229	MRPEIWFAQEIRRAGDEFNAYYARRVZ	27	LIB283	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34230	MRPEIWFAQEIRRAGDEVNAYYARRVZ	27	LIB284	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34231	MRPEIWFAQEIRRAGDENNAYYARRVZ	27	LIB285	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34232	MRPEIWFAQEIDRIGDEFNAYYARRVZ	27	LIB286	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34233	MRPEIWFAQEIDRIGDEVNAYYARRVZ	27	LIB287	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34234	MRPEIWFAQEIDRIGDENNAYYARRVZ	27	LIB288	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34235	MRPEIWFAQEIDRFGDEFNAYYARRVZ	27	LIB289	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34236	MRPEIWFAQEIDRFGDEVNAYYARRVZ	27	LIB290	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34237	MRPEIWFAQEIDRFGDENNAYYARRVZ	27	LIB291	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34238	MRPEIWFAQEIDRDGDEFNAYYARRVZ	27	LIB292	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34239	MRPEIWFAQEIDRDGDEVNAYYARRVZ	27	LIB293	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34240	MRPEIWFAQEIDRDGDENNAYYARRVZ	27	LIB294	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34241	MRPEIWFAQEIDRNGDEFNAYYARRVZ	27	LIB295	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34242	MRPEIWFAQEIDRNGDEVNAYYARRVZ	27	LIB296	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34243	MRPEIWFAQEIDRNGDENNAYYARRVZ	27	LIB297	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34244	MRPEIWFAQEIDRAGDEFNAYYARRVZ	27	LIB298	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34245	MRPEIWFAQEIDRAGDEVNAYYARRVZ	27	LIB299	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34246	MRPEIWFAQEIDRAGDENNAYYARRVZ	27	LIB300	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34247	MRPEIWFAQEFRRIGDEFNAYYARRVZ	27	LIB301	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34248	MRPEIWFAQEFRRIGDEVNAYYARRVZ	27	LIB302	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34249	MRPEIWFAQEFRRIGDENNAYYARRVZ	27	LIB303	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34250	MRPEIWFAQEFRRFGDEFNAYYARRVZ	27	LIB304	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34251	MRPEIWFAQEFRRFGDEVNAYYARRVZ	27	LIB305	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34252	MRPEIWFAQEFRRFGDENNAYYARRVZ	27	LIB306	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34253	MRPEIWFAQEFRRDGDEFNAYYARRVZ	27	LIB307	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34254	MRPEIWFAQEFRRDGDEVNAYYARRVZ	27	LIB308	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34255	MRPEIWFAQEFRRDGDENNAYYARRVZ	27	LIB309	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34256	MRPEIWFAQEFRRNGDEFNAYYARRVZ	27	LIB310	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34257	MRPEIWFAQEFRRNGDEVNAYYARRVZ	27	LIB311	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34258	MRPEIWFAQEFRRNGDENNAYYARRVZ	27	LIB312	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34259	MRPEIWFAQEFRRAGDEFNAYYARRVZ	27	LIB313	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34260	MRPEIWFAQEFRRAGDEVNAYYARRVZ	27	LIB314	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34261	MRPEIWFAQEFRRAGDENNAYYARRVZ	27	LIB315	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34262	MRPEIWFAQEFDRIGDEFNAYYARRVZ	27	LIB316	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34263	MRPEIWFAQEFDRIGDEVNAYYARRVZ	27	LIB317	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34264	MRPEIWFAQEFDRIGDENNAYYARRVZ	27	LIB318	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34265	MRPEIWFAQEFDRFGDEFNAYYARRVZ	27	LIB319	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34266	MRPEIWFAQEFDRFGDEVNAYYARRVZ	27	LIB320	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34267	MRPEIWFAQEFDRFGDENNAYYARRVZ	27	LIB321	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34268	MRPEIWFAQEFDRDGDEFNAYYARRVZ	27	LIB322	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34269	MRPEIWFAQEFDRDGDEVNAYYARRVZ	27	LIB323	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34270	MRPEIWFAQEFDRDGDENNAYYARRVZ	27	LIB324	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34271	MRPEIWFAQEFDRNGDEFNAYYARRVZ	27	LIB325	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34272	MRPEIWFAQEFDRNGDEVNAYYARRVZ	27	LIB326	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34273	MRPEIWFAQEFDRNGDENNAYYARRVZ	27	LIB327	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34274	MRPEIWFAQEFDRAGDEFNAYYARRVZ	27	LIB328	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34275	MRPEIWFAQEFDRAGDEVNAYYARRVZ	27	LIB329	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34276	MRPEIWFAQEFDRAGDENNAYYARRVZ	27	LIB330	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34277	MRPEIWFAQEARRIGDEFNAYYARRVZ	27	LIB331	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34278	MRPEIWFAQEARRIGDEVNAYYARRVZ	27	LIB332	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34279	MRPEIWFAQEARRIGDENNAYYARRVZ	27	LIB333	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34280	MRPEIWFAQEARRFGDEFNAYYARRVZ	27	LIB334	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34281	MRPEIWFAQEARRFGDEVNAYYARRVZ	27	LIB335	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34282	MRPEIWFAQEARRFGDENNAYYARRVZ	27	LIB336	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34283	MRPEIWFAQEARRDGDEFNAYYARRVZ	27	LIB337	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34284	MRPEIWFAQEARRDGDEVNAYYARRVZ	27	LIB338	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34285	MRPEIWFAQEARRDGDENNAYYARRVZ	27	LIB339	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34286	MRPEIWFAQEARRNGDEFNAYYARRVZ	27	LIB340	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34287	MRPEIWFAQEARRNGDEVNAYYARRVZ	27	LIB341	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34288	MRPEIWFAQEARRNGDENNAYYARRVZ	27	LIB342	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34289	MRPEIWFAQEARRAGDEFNAYYARRVZ	27	LIB343	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34290	MRPEIWFAQEARRAGDEVNAYYARRVZ	27	LIB344	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34291	MRPEIWFAQEARRAGDENNAYYARRVZ	27	LIB345	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34292	MRPEIWFAQEADRIGDEFNAYYARRVZ	27	LIB346	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34293	MRPEIWFAQEADRIGDEVNAYYARRVZ	27	LIB347	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34294	MRPEIWFAQEADRIGDENNAYYARRVZ	27	LIB348	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34295	MRPEIWFAQEADRFGDEFNAYYARRVZ	27	LIB349	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34296	MRPEIWFAQEADRFGDEVNAYYARRVZ	27	LIB350	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34297	MRPEIWFAQEADRFGDENNAYYARRVZ	27	LIB351	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34298	MRPEIWFAQEADRDGDEFNAYYARRVZ	27	LIB352	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34299	MRPEIWFAQEADRDGDEVNAYYARRVZ	27	LIB353	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34300	MRPEIWFAQEADRDGDENNAYYARRVZ	27	LIB354	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34301	MRPEIWFAQEADRNGDEFNAYYARRVZ	27	LIB355	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34302	MRPEIWFAQEADRNGDEVNAYYARRVZ	27	LIB356	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34303	MRPEIWFAQEADRNGDENNAYYARRVZ	27	LIB357	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34304	MRPEIWFAQEADRAGDEFNAYYARRVZ	27	LIB358	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34305	MRPEIWFAQEADRAGDEVNAYYARRVZ	27	LIB359	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mcl-1/Bcl-xL	20363230	 J Mol Biol. 2010 May 21;398(5):747-62.	Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE.	Determinants of BH3 binding specificity for Mcl-1 versus Bcl-Xl	
DRAMP34306	LKlLKkLlkKLLkLL	15	Amphipathic-1d, 5D-K6L9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	35759644	J Med Chem. 2022 Jul 14;65(13):9050-9062	Ben Hur D, Kapach G, Wani NA, Kiper E, Ashkenazi M, Smollan G, Keller N, Efrati O, Shai Y.	Antimicrobial Peptides against Multidrug-Resistant Pseudomonas aeruginosa Biofilm from Cystic Fibrosis Patients	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(N)=O
DRAMP34307	GYPICGESCVGGICNIPGCSCSWPVCTTN	29	Vitri B	Not available		Not found	Plantae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	20580652	Peptides. 2010 Aug;31(8):1434-40. 	Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, He W, Daly NL, Craik DJ, Tan N. 	Isolation and characterization of cytotoxic cyclotides from Viola tricolor	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C
DRAMP34308	rlylriGrr	9	Defensin-derived D-Peptide A	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	19154767	Peptides. 2009 Apr;30(4):660-8.	Iwasaki T, Ishibashi J, Tanaka H, Sato M, Asaoka A, Taylor D, Yamakawa M.	Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface	CC[C@H](C)[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP34309	rlrlriGrr	9	Defensin-derived D-Peptide B	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	19154767	Peptides. 2009 Apr;30(4):660-8.	Iwasaki T, Ishibashi J, Tanaka H, Sato M, Asaoka A, Taylor D, Yamakawa M.	Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface	CC[C@H](C)[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP34310	alylairrr	9	Defensin-derived D-Peptide C	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		D	Not available	Not available	19154767	Peptides. 2009 Apr;30(4):660-8.	Iwasaki T, Ishibashi J, Tanaka H, Sato M, Asaoka A, Taylor D, Yamakawa M.	Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface	CC[C@H](C)[C@@H](NC(=O)[C@@H](C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](C)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP34311	rlllriGrr	9	Defensin-derived D-Peptide D	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	19154767	Peptides. 2009 Apr;30(4):660-8.	Iwasaki T, Ishibashi J, Tanaka H, Sato M, Asaoka A, Taylor D, Yamakawa M.	Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface	CC[C@H](C)[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP34312	KLWKKWKKWLK	11	K6L2W3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30447380	Int J Antimicrob Agents. 2019 Jun;53(6):868-872. 	Baker KR, Jana B, Hansen AM, Vissing KJ, Nielsen HM, Franzyk H, Guardabassi L. 	Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP34313	GmwskilGhlir	12	Halictine-1/22, HAL-1/22	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	Not available			The antifungal effect of peptides from hymenoptera venom and their analogs	CC[C@H](C)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCSC)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP34314	GMWSKILGHLIK	12	Halictine-1/6, HAL-1/6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	22100226	 Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP34315	Gkwmsllkhilk	12	Halictine-2/22, HAL-2/22	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	22100226	 Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC[C@H](C)[C@@H](NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@@H](CCSC)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCCN)NC(=O)CN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(N)=O
DRAMP34316	fPFfNQYVXL	10	Tyrocidine A, TA	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	4M6E	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	29140694	J Med Chem. 2017 Dec 14;60(23):9565-9574.	Cameron AJ, Edwards PJB, Harjes E, Sarojini V.	Tyrocidine A Analogues Bearing the Planar d-Phe-2-Abz Turn Motif: How Conformation Impacts Bioactivity	
DRAMP34317	FKRiVQRiKDFlRNLV	16	D LL-37 (17-32)	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	16637646	J Am Chem Soc. 2006 May 3;128(17):5776-85.	Li X, Li Y, Han H, Miller DW, Wang G. 	Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region	CC[C@H](C)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP34318	vnwkkilGkiikvvk	15	Lasioglossin LL-III-D	C0HK44		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	Not available			The antifungal effect of peptides from hymenoptera venom and their analogs	CC[C@H](C)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](N)C(C)C)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(N)=O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC
DRAMP34319	vnwkkllGkllkvvk	15	Lasioglossin LL-III/25	C0HK44		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	22100226	 Peptides. 2012 Jan;33(1):18-26. 	Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L, Borovičková L, Fučík V, Ceřovský V.	Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells	CC(C)C[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](N)C(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP34320	GfGmalkllkkvl	13	Macropin 1-D	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	24616110	J Pept Sci. 2014 Jun;20(6):375-84. 	Monincová L, Veverka V, Slaninová J, Buděšínský M, Fučík V, Bednárová L, Straka J, Ceřovský V.	Structure-activity study of macropin, a novel antimicrobial peptide from the venom of solitary bee Macropis fulvipes (Hymenoptera: Melittidae)	CSCC[C@@H](NC(=O)CNC(=O)[C@@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](C(=O)N[C@H](CC(C)C)C(N)=O)C(C)C
DRAMP34321	RRQRRTSKLMKRGGKLAKLAKKLAKLAK	28	DP1 peptide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	11691780	Cancer Res. 2001 Nov 1;61(21):7709-12.	Mai JC, Mi Z, Kim SH, Ng B, Robbins PD.	A proapoptotic peptide for the treatment of solid tumors	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP34322	ILGKLLSTAWGLLSkL	16	Alyteserin-2a [A10W][N15k]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	22965637	Amino Acids. 2013 Feb;44(2):715-23. 	Conlon JM, Mechkarska M, Prajeep M, Arafat K, Zaric M, Lukic ML, Attoub S.	Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O
DRAMP34323	GFSSIFRGVAKFASKGLGKDLAKLGVDLVA	30	Esculentin-2CHa (1-30)	D3UA61		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23159562	Peptides. 2013 Jan;39:95-102.	Attoub S, Mechkarska M, Sonnevend A, Radosavljevic G, Jovanovic I, Lukic ML, Conlon JM.	Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP34324	KFASKGLGKDLAKLGVDLVACKISKQC	27	Esculentin-2CHa (11-37)	D3UA61		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23159562	Peptides. 2013 Jan;39:95-102.	Attoub S, Mechkarska M, Sonnevend A, Radosavljevic G, Jovanovic I, Lukic ML, Conlon JM.	Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
DRAMP34325	gwgsffkkaahvgkhvgkaalthyl	25	D-Pleurocidin	P81941		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Calu-3 (IC50=41.9 ± 1.8 μg/ml); HeLa (IC50=47.1 ± 2.1 μg/ml); A549 (IC50=79.3 ± 7.2 μg/ml)	Not available	Linear	Free	Amidation		D	HEK293: IC50=61.4 ± 3.9 µg/ml	Not available	33247193	 Commun Biol. 2020 Nov 27;3(1):697. 	Manzo G, Hind CK, Ferguson PM, Amison RT, Hodgson-Casson AC, Ciazynska KA, Weller BJ, Clarke M, Lam C, Man RCH, Shaughnessy BGO, Clifford M, Bui TT, Drake AF, Atkinson RA, Lam JKW, Pitchford SC, Page CP, Phoenix DA, Lorenz CD, Sutton JM, Mason AJ. 	A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy	CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@H](C)O)C(N)=O
DRAMP34326	GlpvcGetcvGGtcntpGctcswpvctrn	29	D Kalata-B1 	P56254		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	2JUE	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	21928440	Chembiochem. 2011 Nov 4;12(16):2456-62.	Sando L, Henriques ST, Foley F, Simonsen SM, Daly NL, Hall KN, Gustafson KR, Aguilar MI, Craik DJ. A	A Synthetic peptide mirror image of kalata B1 reveals that cyclotide activity is independent of a protein receptor	CC(C)C[C@@H](NC(=O)CN)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](C(=O)N[C@H](CS)C(=O)NCC(=O)N[C@H](CCC(=O)N[C@H](CS)C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CC(N)=O)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CS)C(=O)N[C@H](CS)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CC(N)=O)C(=O)O)[C@H](C)O)C(C)C)[C@H](C)O)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@H](CS)C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CS)C(=O)N[C@H](CCCNC(=N)N)C(=O)O)[C@H](C)O)[C@H](C)O)C(C)C)[C@H](C)O)C(C)C
DRAMP34327	RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFP	35	Bactenecin-7 (1-35), Bac-7 (1-35)	P19661		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33036159	Int J Mol Sci. 2020 Oct 6;21(19):7367. 	Sola R, Mardirossian M, Beckert B, Sanghez De Luna L, Prickett D, Tossi A, Wilson DN, Scocchi M.	Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP34328	RRIRPRPPRLPRPRPRPLPFPRP	23	Bactenecin-7 (1-23)	P19661		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35578204	BMC Biol. 2022 May 16;20(1):114.	Koch P, Schmitt S, Heynisch A, Gumpinger A, Wüthrich I, Gysin M, Shcherbakov D, Hobbie SN, Panke S, Held M. 	Optimization of the antimicrobial peptide Bac7 by deep mutational scanning	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O
DRAMP34329	WaxVlL	6	Baceridin	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	24692199	Chembiochem. 2014 May 5;15(7):1021-9.	Niggemann J, Bozko P, Bruns N, Wodtke A, Gieseler MT, Thomas K, Jahns C, Nimtz M, Reupke I, Brüser T, Auling G, Malek N, Kalesse M. 	Baceridin, a cyclic hexapeptide from an epiphytic bacillus strain, inhibits the proteasome	
DRAMP34330	RAGLQFPVGRLLRRLLR	17	Buforin-2 (5-13)[17-20]2	P55897		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23776609	PLoS One. 2013 Jun 11;8(6):e66084. 	Lim KJ, Sung BH, Shin JR, Lee YW, Kim DJ, Yang KS, Kim SC.	A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP34331	ILPIRSLIKKLL	12	Temporin-1RNa	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	23632907	World J Microbiol Biotechnol. 2013 Oct;29(10):1941-9.	Li A, Zhang Y, Wang C, Wu G, Wang Z.	Purification, molecular cloning, and antimicrobial activity of peptides from the skin secretion of the black-spotted frog, Rana nigromaculata	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP34332	FLPLKKLRFGLL	12	Temporin-1RNb	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	23632907	World J Microbiol Biotechnol. 2013 Oct;29(10):1941-9.	Li A, Zhang Y, Wang C, Wu G, Wang Z.	Purification, molecular cloning, and antimicrobial activity of peptides from the skin secretion of the black-spotted frog, Rana nigromaculata	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O
DRAMP34333	MRKWFHNVLSSGQLLADKWPAWDYNWK	27	Pep27 [E4W][R19W][R22W][R26W]	Q9S4I9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	16004618	Cancer Cell Int. 2005 Jul 11;5:21. 	Lee DG, Hahm KS, Park Y, Kim HY, Lee W, Lim SC, Seo YK, Choi CH. 	Functional and structural characteristics of anticancer peptide Pep27 analogues	CSCC[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
DRAMP34334	fPFfNQYVKL	10	Tyrocidine A1	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	17462586	Biochim Biophys Acta. 2007 Jun;1768(6):1488-97	Rautenbach M, Vlok NM, Stander M, Hoppe HC.	Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(C)C)C(=O)O
DRAMP34335	fPWfNQYVXL	10	Tyrocidine B	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	27328781	Biochimie. 2016 Nov;130:122-131. 	Rautenbach M, Troskie AM, Vosloo JA, Dathe ME.	Antifungal membranolytic activity of the tyrocidines against filamentous plant fungi	
DRAMP34336	fPWfNQYVKL	10	Tyrocidine B1	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	17462586	Biochim Biophys Acta. 2007 Jun;1768(6):1488-97	Rautenbach M, Vlok NM, Stander M, Hoppe HC.	Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(C)C)C(=O)O
DRAMP34337	fPWwNQYVXL	10	Tyrocidine C	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	30301848	J Med Chem. 2017 Dec 14;60(23):9565-9574.	Cameron AJ, Edwards PJB, Harjes E, Sarojini V.	The Multifaceted Antibacterial Mechanisms of the Pioneering Peptide Antibiotics Tyrocidine and Gramicidin S	
DRAMP34338	fPWwNQYVKL	10	Tyrocidine C1	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	17462586	Biochim Biophys Acta. 2007 Jun;1768(6):1488-97	Rautenbach M, Vlok NM, Stander M, Hoppe HC.	Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(C)C)C(=O)O
DRAMP34339	YPLPFIP	7	Stylisin 1	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	19182416	Chem Pharm Bull (Tokyo). 2009 Feb;57(2):214-7.	Dahiya R, Kumar A, Gupta R. 	Synthesis, cytotoxic and antimicrobial screening of a proline-rich cyclopolypeptide	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
DRAMP34340	KWXWKXVKXAK	11	VA1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	23876294	Biochim Biophys Acta. 2013 Nov;1830(11):5193-203	Maurya IK, Thota CK, Sharma J, Tupe SG, Chaudhary P, Singh MK, Thakur IS, Deshpande M, Prasad R, Chauhan VS. 	Mechanism of action of novel Synthetic peptide dodecapeptides against Candida albicans	
DRAMP34341	KAXWKXVKXAK	11	VA2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	23876294	Biochim Biophys Acta. 2013 Nov;1830(11):5193-203	Maurya IK, Thota CK, Sharma J, Tupe SG, Chaudhary P, Singh MK, Thakur IS, Deshpande M, Prasad R, Chauhan VS. 	Mechanism of action of novel Synthetic peptide dodecapeptides against Candida albicans	
DRAMP34342	KWXWKXAKXAK	11	VA3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	23876294	Biochim Biophys Acta. 2013 Nov;1830(11):5193-203	Maurya IK, Thota CK, Sharma J, Tupe SG, Chaudhary P, Singh MK, Thakur IS, Deshpande M, Prasad R, Chauhan VS. 	Mechanism of action of novel Synthetic peptide dodecapeptides against Candida albicans	
DRAMP34343	QSHLSMCSVCCNCCKNYKGCGFCCRF	26	Om-hep1 (65-90), Hepcidin (65-90)	G9B8P3		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22051539	Comp Biochem Physiol B Biochem Mol Biol. 2012 Feb;161(2):140-7. 	Cai L, Cai JJ, Liu HP, Fan DQ, Peng H, Wang KJ.	Recombinant medaka (Oryzias melastigmus) pro-hepcidin: Multifunctional characterization	CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP34344	MGSSHHHHHHSSGLVPRGSHMIPVNGVTELEEAASNDTPVAARHEMSMQSWMMPNHIREKRQSHLSMCSVCCNCCKNYKGCGFCCRF	87	Recombinant Pro-Omhep1, Recombinant Hepcidin	G4VXJ6		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22051539	Comp Biochem Physiol B Biochem Mol Biol. 2012 Feb;161(2):140-7. 	Cai L, Cai JJ, Liu HP, Fan DQ, Peng H, Wang KJ.	Recombinant medaka (Oryzias melastigmus) pro-hepcidin: Multifunctional characterization	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCSC)C(=O)O)C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)CCSC)C(C)C)[C@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP34345	RPPQFTRAQWFAIQHISLNPPRSTIAMRAINNYRWRSKNQNTFLR	45	Eosinophil cationic protein (1-45) [C23,37S], RNase 3 (1-45) [C23,37S]	P12724		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31540052	Int J Mol Sci. 2019 Sep 14;20(18):4558.	Salazar VA, Arranz-Trullén J, Prats-Ejarque G, Torrent M, Andreu D, Pulido D, Boix E	Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP34346	yf	2	Cyclo(D-Tyr-D-Phe), Diketopiperazine (yf)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	30528685	Bioorg Med Chem. 2019 Jun 15;27(12):2323-2331	Simon G, Bérubé C, Voyer N, Grenier D.	Anti-biofilm and anti-adherence properties of novel cyclic dipeptides against oral pathogens	N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](Cc1ccccc1)C(=O)O
DRAMP34347	pF	2	Cyclo(D-Pro-L-Phe), Diketopiperazine (pF)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	31243345	J Antibiot (Tokyo). 2019 Oct;72(10):744-751.	Betancur LA, Forero AM, Romero-Otero A, Sepúlveda LY, Moreno-Sarmiento NC, Castellanos L, Ramos FA.	Cyclic tetrapeptides from the marine strain Streptomyces sp PNM-161a with activity against rice and yam phytopathogens	O=C(O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCCN1
DRAMP34348	PF	2	Cyclo(Pro-Phe), Diketopiperazine (PF)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25821788	Biomed Res Int. 2015;2015:197608.	Vázquez-Rivera D, González O, Guzmán-Rodríguez J, Díaz-Pérez AL, Ochoa-Zarzosa A, López-Bucio J, Meza-Carmen V, Campos-García J. 	Cytotoxicity of cyclodipeptides from Pseudomonas aeruginosa PAO1 leads to apoptosis in human cancer cell lines	O=C(O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1
DRAMP34349	VXVXXVXVXTVX	12	Ohmyungsamycin B	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24266328	J Org Chem. 2013 Dec 20;78(24):12321-9.	Um S, Choi TJ, Kim H, Kim BY, Kim SH, Lee SK, Oh KB, Shin J, Oh DC.	Ohmyungsamycins A and B: cytotoxic and antimicrobial cyclic peptides produced by Streptomyces sp from a volcanic island	
DRAMP34350	LV	2	Cyclo(Leu-Val), Diketopiperazine (LV)	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30270742	 Nat Prod Res. 2020 May;34(10):1461-1464	Lin WX, Xie CL, Zhou M, Xia ML, Zhou TT, Chen HF, Yang XW, Yang Q.	Chemical constituents from the deep sea-derived Streptomyces xiamenensis MCCC 1A01570 and their effects on RXRα transcriptional regulation	CC(C)C[C@H](N)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP34351	pf	2	Cyclo(D-Pro-D-Phe), Diketopiperazine (pf)	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	29439550	J Immunol Res. 2018 May 7;2018:4353580. 	Wang S, Huang S, Ye Q, Zeng X, Yu H, Qi D, Qiao S.	Cytotoxic and Antimicrobial Compounds from the Marine-Derived Fungus, Penicillium Species	O=C(O)[C@@H](Cc1ccccc1)NC(=O)[C@H]1CCCN1
DRAMP34352	AXEGSnXX	8	Phomafungin	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	3-OH-Me-C16	Free		Mix	Not available	Not available	19112025	 Bioorg Med Chem. 2009 Feb 1;17(3):1361-9.	Herath K, Harris G, Jayasuriya H, Zink D, Smith S, Vicente F, Bills G, Collado J, González A, Jiang B, Kahn JN, Galuska S, Giacobbe R, Abruzzo G, Hickey E, Liberator P, Xu D, Roemer T, Singh SB. 	Isolation, structure and biological activity of phomafungin, a cyclic lipodepsipeptide from a widespread tropical Phoma sp	
DRAMP34353	DKPKKKPPPPAGPPPPPPPPPGPPPPGP	28	Sus scrofa Uncharacterized protein (208-235), SP-E	F1SQ50		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30046246	 Infect Drug Resist. 2018 Jul 17;11:969-979.	Ciociola T, Giovati L, Giovannelli A, Conti S, Castagnola M, Vitali A. 	The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action	C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)O
DRAMP34354	KPKGMTSSQWFKIQHMQPSPQASNSAMKNINKHTKRSKDLNTFLH	45	Ribonuclease 7 (1-45) [C23,37S]	Q9H1E1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31540052	Int J Mol Sci. 2019 Sep 14;20(18):4558. 	Salazar VA, Arranz-Trullén J, Prats-Ejarque G, Torrent M, Andreu D, Pulido D, Boix E. 	Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC
DRAMP34355	WP	2	Cyclo(Trp-Pro), Diketopiperazine (WP)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22409377	J Agric Food Chem. 2012 Apr 4;60(13):3424-31. 	Li XJ, Zhang Q, Zhang AL, Gao JM. 	Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)O
DRAMP34356	WY	2	Cyclo(Trp-Tyr), Diketopiperazine (WY)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32806659	Molecules. 2020 Aug 12;25(16):3676. 	Liu R, Zhang H, Wu W, Li H, An Z, Zhou F. 	C7-Prenylation of Tryptophan-Containing Cyclic Dipeptides by 7-Dimethylallyl Tryptophan Synthase Significantly Increases the Anticancer and Antimicrobial Activities	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP34357	WL	2	Cyclo(Trp-Leu), Diketopiperazine (WL)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32806659	Molecules. 2020 Aug 12;25(16):3676. 	Liu R, Zhang H, Wu W, Li H, An Z, Zhou F. 	C7-Prenylation of Tryptophan-Containing Cyclic Dipeptides by 7-Dimethylallyl Tryptophan Synthase Significantly Increases the Anticancer and Antimicrobial Activities	CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP34358	WF	2	Cyclo(Trp-Phe), Diketopiperazine (WF)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32806659	Molecules. 2020 Aug 12;25(16):3676. 	Liu R, Zhang H, Wu W, Li H, An Z, Zhou F. 	C7-Prenylation of Tryptophan-Containing Cyclic Dipeptides by 7-Dimethylallyl Tryptophan Synthase Significantly Increases the Anticancer and Antimicrobial Activities	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP34359	NGVQPKYRWWRWWRRWW	17	Leucrocin I RT2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30031283	Environ Toxicol Pharmacol. 2018 Sep;62:164-176.	Maijaroen S, Jangpromma N, Daduang J, Klaynongsruang S.	KT2 and RT2 modified antimicrobial peptides derived from Crocodylus siamensis Leucrocin I show activity against human colon cancer HCT-116 cells	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP34360	KESRAKKFQRQHMDSDSSPSSSSTYSNQMMRRRNMTQGRSKPVNTFVH	48	Ribonuclease pancreatic (1-48)[C26,40S]	P07998		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31540052	Int J Mol Sci. 2019 Sep 14;20(18):4558. 	Salazar VA, Arranz-Trullén J, Prats-Ejarque G, Torrent M, Andreu D, Pulido D, Boix E. 	Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides	CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CO)C(=O)O
DRAMP34361	KPPQFTWAQWFETQHINMTSQQSTNAMQVINNYQRRSKNQNTFLL	45	Non-secretory ribonuclease (1-45)[C23,37S]	P10153		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31540052	Int J Mol Sci. 2019 Sep 14;20(18):4558. 	Salazar VA, Arranz-Trullén J, Prats-Ejarque G, Torrent M, Andreu D, Pulido D, Boix E. 	Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O
DRAMP34362	QDGMYQRFLRQHVHPEETGGSDRYSNLMMQRRKMTLYHSKRFNTFIH	47	Ribonuclease 4 (1-47)[C25,39S]	P34096		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31540052	Int J Mol Sci. 2019 Sep 14;20(18):4558. 	Salazar VA, Arranz-Trullén J, Prats-Ejarque G, Torrent M, Andreu D, Pulido D, Boix E. 	Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCSC)NC(=O)C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP34363	QDNSRYTHFLTQHYDAKPQGRDDRYSESIMRRRGLTSPSKDINTFIH	47	Angiogenin (1-47)[C26,39S], Ribonuclease A A1 (1-47)[C26,39S]	W0UV28##P03950		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31540052	Int J Mol Sci. 2019 Sep 14;20(18):4558. 	Salazar VA, Arranz-Trullén J, Prats-Ejarque G, Torrent M, Andreu D, Pulido D, Boix E. 	Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)O
DRAMP34364	WPKRLTKAHWFEIQHIQPSPLQSNRAMSGINNYTQHSKHQNTFLH	45	Ribonuclease K6 (1-45)[C23,37S]	Q93091		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31540052	Int J Mol Sci. 2019 Sep 14;20(18):4558. 	Salazar VA, Arranz-Trullén J, Prats-Ejarque G, Torrent M, Andreu D, Pulido D, Boix E. 	Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP34365	KPKDMTSSQWFKTQHVQPSPQASNSAMSIINKYTERSKDLNTFLH	45	Ribonuclease 8 (1-45)[C23,37S]	Q8TDE3		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31540052	Int J Mol Sci. 2019 Sep 14;20(18):4558. 	Salazar VA, Arranz-Trullén J, Prats-Ejarque G, Torrent M, Andreu D, Pulido D, Boix E. 	Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)[C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP34366	RAGLQFPVGRVHRLLRK	17	Buforin-2 (5-21), sh-Buforin	P55897		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	25891844	Biochimie. 2015 Jun;113:143-55.	Libardo MD, Paul TJ, Prabhakar R, Angeles-Boza AM.	Hybrid peptide ATCUN-sh-Buforin: Influence of the ATCUN charge and stereochemistry on antimicrobial activity	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP34367	VIHRAGLQFPVGRVHRLLRK	20	VIH-Buforin-2 (5-21), VIH-sh-Buforin	P55897		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	25891844	Biochimie. 2015 Jun;113:143-55.	Libardo MD, Paul TJ, Prabhakar R, Angeles-Boza AM.	Hybrid peptide ATCUN-sh-Buforin: Influence of the ATCUN charge and stereochemistry on antimicrobial activity	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP34368	RCpGRTRQIGTIFpGRIKCRSW	22	Act Beta-defensin 2 (18-40)[C12I,G14p,P15G,C-del]	P46160		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Free		Mix	Not available	Not available	25791057	Biophys Chem. 2015 Apr;199:25-33.	Krishnakumari V, Nagaraj R. 	N-terminal fatty acylation of peptides spanning the cationic C-terminal segment of bovine ?-defensin-2 results in salt-resistant antibacterial activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@@H]1C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP34369	GG	2	Neocryptolepine 9(GG)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	DiMIQ	Free		L	Not available	Not available	22574992	 J Med Chem. 2012 Jun 14;55(11):5077-87. 	Sidoryk K, Switalska M, Wietrzyk J, Jaromin A, Piętka-Ottlik M, Cmoch P, Zagrodzka J, Szczepek W, Kaczmarek L, Peczyńska-Czoch W.	Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents	
DRAMP34370	GP	2	Neocryptolepine 9(GP)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	DiMIQ	Free		L	Not available	Not available	22574992	 J Med Chem. 2012 Jun 14;55(11):5077-87. 	Sidoryk K, Switalska M, Wietrzyk J, Jaromin A, Piętka-Ottlik M, Cmoch P, Zagrodzka J, Szczepek W, Kaczmarek L, Peczyńska-Czoch W.	Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents	
DRAMP34371	KWKVFKKIEKMGRNIRNGIVKAGPKWKVFKKIEK	34	Cecropin B (1-24)+(1-10)	P01508		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	11004545	Srisailam S, Arunkumar AI, Wang W, Yu C, Chen HM.	Srisailam S, Arunkumar AI, Wang W, Yu C, Chen HM.	Conformational study of a custom antibacterial peptide cecropin B1: implications of the lytic activity	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)C(C)C)C(C)C
DRAMP34372	CVLIGQRCDNDRGPRCCSGQGNCVPLPFLGGVCAV	35	Ep-AMP1	Not available		Not found	Plantae	Antimicrobial, Anticancer	Not found	Not found	Not found	2MFS	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25821084	Chembiochem. 2015 May 4;16(7):1068-77.	Aboye TL, Strömstedt AA, Gunasekera S, Bruhn JG, El-Seedi H, Rosengren KJ, Göransson U. 	A Cactus-Derived Toxin-Like Cystine Knot Peptide with Selective Antimicrobial Activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP34373	KGK	3	C16OH-KGK	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	3-OH-C16	Amidation		L	Not available	Not available	27486068	Peptides. 2016 Oct;84:58-67.	Domalaon R, Findlay B, Ogunsina M, Arthur G, Schweizer F. 	Ultrashort cationic lipopeptides and lipopeptoids: Evaluation and mechanistic insights against epithelial cancer cells	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(N)=O
DRAMP34374	kQrWlWlW	8		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	11473322	 Nature. 2001 Jul 26;412(6845):452-5. doi: 10.1038/35086601. Erratum in: Nature 2001 Nov 15;414(6861):329. 	Fernandez-Lopez S, Kim HS, Choi EC, Delgado M, Granja JR, Khasanov A, Kraehenbuehl K, Long G, Weinberger DA, Wilcoxen KM, Ghadiri MR.	Antibacterial agents based on the cyclic D,L-alpha-peptide architecture	CC(C)C[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP34375	ILPIIGKILSTIFGK	15	Temporin-1CEe	F1AEM7		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	21303203	Zoolog Sci. 2011 Feb;28(2):112-7. 	Zhao J, Sun Y, Li Z, Su Q.	Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP34376	GLLSVFKGVLKTAGKNVAKNVAGSLLDQLKCKISGGC	37	Brevinin-2CE	F1AEM2##F1AEM1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24474334	Curr Microbiol. 2014 Jun;68(6):685-92	Zhang Y, Liu Y, Sun Y, Liu Q, Wang X, Li Z, Hao J.	In vitro synergistic activities of antimicrobial peptide brevinin-2CE with five kinds of antibiotics against multidrug-resistant clinical isolates	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)O
DRAMP34377	LLCIALRKK	9	Coprisin (22-30)[H23L]	A9XFZ7		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	22297233	J Microbiol Biotechnol. 2012 Jan;22(1):156-8.	Kim IW, Kim SJ, Kwon YN, Yun EY, Ahn MY, Kang DC, Hwang JS. 	Effects of the Synthetic peptide coprisin analog peptide, CopA3 in pathogenic microorganisms and mammalian cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP34378	YPFX	4	Cyclic peptide-1 Streptomyces sp. YIM67005	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24304298	Nat Prod Res. 2014;28(5):318-23	Zhou H, Yang Y, Yang X, Li W, Xiong Z, Zhao L, Xu L, Ding Z.	A new cyclic tetrapeptide from an endophytic Streptomyces sp YIM67005	
DRAMP34379	RRRRWWWW	8	[R4W4]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	36442155	J Med Chem. 2022 Dec 8;65(23):15819-15839.	Mohammed EHM, Lohan S, Ghaffari T, Gupta S, Tiwari RK, Parang K. 	Membrane-Active Cyclic Amphiphilic Peptides: Broad-Spectrum Antibacterial Activity Alone and in Combination with Antibiotics	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP34380	CNGRCGGKLAKLAKKLAKLAK	21	CK21	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25990455	Tumour Biol. 2015 Sep;36(10):8167-75.	hang Z, Hou L, Feng L, Huang S, Luo M, Shao S, Zhang X, Gu S, Zhao X.	An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP34381	LRLKSIVSYAKKVL	14	Mastoparan-S	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25869360	 Biochemistry (Mosc). 2015 Apr;80(4):433-40. 	Zare-Zardini H, Taheri-Kafrani A, Ordooei M, Ebrahimi L, Tolueinia B, Soleimanizadeh M.	Identification and biochemical characterization of a new antibacterial and antifungal peptide derived from the insect Sphodromantis viridis	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
DRAMP34382	KGIRGYKGGYCKGAFKQTCKCY	22	OsDef2 (16-37)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34866278	J Pept Sci. 2022 May;28(5):e3383. 	Mbuayama KR, Taute H, Strӧmstedt AA, Bester MJ, Gaspar ARM.	Antifungal activity and mode of action of Synthetic peptide peptides derived from the tick OsDef2 defensin	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
DRAMP34383	KGIRGYKGGYKGAFKQTKY	19	OsDef2 (16-37)[C26,34,36Del]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	Not available			Antifungal activity and mode of action of Synthetic peptide peptides derived from the tick OsDef2 defensin	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
DRAMP34384	ELLVDLL,ELLVDLL	15	Gageostatin A - Gageostatin B	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	3-OH-Me-C13,3-OH-DiMe-C13	Free		Mix	Not available	Not available	24492520	Mar Drugs. 2014 Jan 31;12(2):871-85.	Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.	Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis	
DRAMP34385	KWKSFLKTFKSAKKTVLHTAAKAISS	26	Peptide P [L21A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: NCI-H1299 (IC50=15.6 μmol/L); A-375 (IC50=59.8 μmol/L); B16 (IC50=63.5 μmol/L); HeLa (IC50=64.7 μmol/L); MCF-7 (IC50=70.8 μmol/L); A549 (IC50=71 μmol/L); RD (IC50>83.6 μmol/L); SW1116 (IC50>83.6 μmol/L)	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	21252288	Mol Cancer Ther. 2011 Mar;10(3):416-26. 	Huang YB, Wang XF, Wang HY, Liu Y, Chen Y. 	Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP34386	KWKSFLKTFKSAKKTVLHTAAKAISS	26	Peptide P [L21A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	21252288	Mol Cancer Ther. 2011 Mar;10(3):416-26. 	Huang YB, Wang XF, Wang HY, Liu Y, Chen Y. 	Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP34387	GLPLCGETCVGGTCNTPGCSCGWPVCVRN	29	Cyclotide Vigno 5	Not available		Not found	Plantae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	26751970	Fitoterapia. 2016 Mar;109:162-8	Esmaeili MA, Abagheri-Mahabadi N, Hashempour H, Farhadpour M, Gruber CW, Ghassempour A.	Viola plant cyclotide vigno 5 induces mitochondria-mediated apoptosis via cytochrome C release and caspases activation in cervical cancer cells	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP34388	DEDDD	5	XLAsp-P1	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	26952034	Arch Microbiol. 2016 Jul;198(5):473-82.	Li S, Hao L, Bao W, Zhang P, Su D, Cheng Y, Nie L, Wang G, Hou F, Yang Y. 	A novel short anionic antibacterial peptide isolated from the skin of Xenopus laevis with broad antibacterial activity and inhibitory activity against breast cancer cell	N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP34389	HTASDAAAAAALTAANAAAAAAASMA	26	Pa-MAP, Antifreeze peptide analogue	Q03659##P04002		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	27161201	Biopolymers. 2017 Mar;108(2).	Vilas Boas LC, de Lima LM, Migliolo L, Mendes GD, de Jesus MG, Franco OL, Silva PA. 	Linear Antimicrobial Peptides With Activity Against Herpes Simplex Virus 1 and Aichi Virus	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP34390	GIGAVLKVLTTGLPALKSWIKRKRQQ	26	Melittin [I17K]	P01501		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	27011349	Colloids Surf B Biointerfaces. 2016 Jul 1;143:194-205.	Wu X, Singh AK, Wu X, Lyu Y, Bhunia AK, Narsimhan G.	Characterization of antimicrobial activity against Listeria and cytotoxicity of native melittin and its mutant variants	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
DRAMP34391	IIGAVLKVLTTGLPALISWIKRKRQQ	26	Melittin [G1I]	P01501		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	27011349	Colloids Surf B Biointerfaces. 2016 Jul 1;143:194-205.	Wu X, Singh AK, Wu X, Lyu Y, Bhunia AK, Narsimhan G.	Characterization of antimicrobial activity against Listeria and cytotoxicity of native melittin and its mutant variants	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@H](C)CC
DRAMP34392	GWWRRTVDKVRNAGRKVAGFASKACGALGH	30	EeCentrocin 1 Chain A	A0A144LUY5		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32403086	EBioMedicine. 2020 May;55:102775.	Ma L, Ye X, Sun P, Xu P, Wang L, Liu Z, Huang X, Bai Z, Zhou C. 	Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP34393	PMLRVRLASHLRKLRKRLLR	20	rApoE (133-150)	P02649		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	27028511	FEBS J. 2016 Jun;283(11):2115-31.	Pane K, Sgambati V, Zanfardino A, Smaldone G, Cafaro V, Angrisano T, Pedone E, Di Gaetano S, Capasso D, Haney EF, Izzo V, Varcamonti M, Notomista E, Hancock RE, Di Donato A, Pizzo E.	A new cryptic cationic antimicrobial peptide (AMP) from human apolipoprotein E with anti-bacterial activity and immunomodulatory effects on human cells	CSCC[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP34394	LRVRLASHLRKLRKRLLR	18	ApoE (133-150)	P02649		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	27028511	FEBS J. 2016 Jun;283(11):2115-31.	Pane K, Sgambati V, Zanfardino A, Smaldone G, Cafaro V, Angrisano T, Pedone E, Di Gaetano S, Capasso D, Haney EF, Izzo V, Varcamonti M, Notomista E, Hancock RE, Di Donato A, Pizzo E.	A new cryptic cationic antimicrobial peptide (AMP) from human apolipoprotein E with anti-bacterial activity and immunomodulatory effects on human cells	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34395	MPRRRRSSSRPVRRRRRPRVSRRRRRRGGRRR	32	Protamine	P69015		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25192319	Mol Pharm. 2014 Oct 6;11(10):3492-502.	Rapsch K, Bier FF, von Nickisch-Rosenegk M. 	Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties	CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
DRAMP34396	GMWSKIKETAMAAAKEAAKAAGKTISDMIKQ	31	Dermaseptin PD-1	A0A0X8XRJ2		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	27187467	Toxins (Basel). 2016 May 12;8(5):144. 	Shi D, Hou X, Wang L, Gao Y, Wu D, Xi X, Zhou M, Kwok HF, Duan J, Chen T, Shaw C. 	Two Novel Dermaseptin-Like Antimicrobial Peptides with Anticancer Activities from the Skin Secretion of Pachymedusa dacnicolor	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP34397	GMWSKIKNAGKAAAKAAAKAAGKAALDAVSEAI	33	Dermaseptin PD-2	A0A0X8XQY5		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	27187467	Toxins (Basel). 2016 May 12;8(5):144. 	Shi D, Hou X, Wang L, Gao Y, Wu D, Xi X, Zhou M, Kwok HF, Duan J, Chen T, Shaw C. 	Two Novel Dermaseptin-Like Antimicrobial Peptides with Anticancer Activities from the Skin Secretion of Pachymedusa dacnicolor	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@H](C)CC)C(C)C)C(N)=O
DRAMP34398	RGSALTHLP	9	RP9	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	27129462	Protein J. 2016 Jun;35(3):202-11.	Theansungnoen T, Maijaroen S, Jangpromma N, Yaraksa N, Daduang S, Temsiripong T, Daduang J, Klaynongsruang S.	Cationic Antimicrobial Peptides Derived from Crocodylus siamensis Leukocyte Extract, Revealing Anticancer Activity and Apoptotic Induction on Human Cervical Cancer Cells	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O
DRAMP34399	KKKFPWWWPFKKKC,KKKFPWWWPFKKKC	29	di-PST13-RK-C	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	18815734	Biotechnol Lett. 2009 Feb;31(2):233-7.	Yang ST, Kim JI, Shin SY. 	Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity	
DRAMP34400	KKKFPWWWPFKKK,KKKFPWWWPFKKKK	28	di-PST13-RK-K	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	18815734	Biotechnol Lett. 2009 Feb;31(2):233-7.	Yang ST, Kim JI, Shin SY. 	Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity	
DRAMP34401	FLPAALAGIGGILGKLF	17	Temporin-SHd	D4YWD0		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	23116712	Biochimie. 2013 Feb;95(2):388-99.	Abbassi F, Raja Z, Oury B, Gazanion E, Piesse C, Sereno D, Nicolas P, Foulon T, Ladram A. 	Antibacterial and leishmanicidal activities of temporin-SHd, a 17-residue long membrane-damaging peptide	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC
DRAMP34402	ffflsrif	8	Temporin-D-SHf	D4YWD1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		D	Not available	Not available	26181487	ACS Chem Biol. 2015 Oct 16;10(10):2257-66.	André S, Washington SK, Darby E, Vega MM, Filip AD, Ash NS, Muzikar KA, Piesse C, Foulon T, O'Leary DJ, Ladram A. 	Structure-Activity Relationship-based Optimization of Small Temporin-SHf Analogs with Potent Antibacterial Activity	CC[C@H](C)[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(N)=O
DRAMP34403	firslfff	8	Temporin-RI-SHf	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		D	Not available	Not available	26181487	ACS Chem Biol. 2015 Oct 16;10(10):2257-66.	André S, Washington SK, Darby E, Vega MM, Filip AD, Ash NS, Muzikar KA, Piesse C, Foulon T, O'Leary DJ, Ladram A. 	Structure-Activity Relationship-based Optimization of Small Temporin-SHf Analogs with Potent Antibacterial Activity	CC[C@H](C)[C@@H](NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(N)=O
DRAMP34404	FIRSLFFF	8	Temporin-Retro-SHf	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	26181487	ACS Chem Biol. 2015 Oct 16;10(10):2257-66.	André S, Washington SK, Darby E, Vega MM, Filip AD, Ash NS, Muzikar KA, Piesse C, Foulon T, O'Leary DJ, Ladram A. 	Structure-Activity Relationship-based Optimization of Small Temporin-SHf Analogs with Potent Antibacterial Activity	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP34405	FFFLRRIF	8	Temporin-SHf [S5R]	D4YWD1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	26181487	ACS Chem Biol. 2015 Oct 16;10(10):2257-66.	André S, Washington SK, Darby E, Vega MM, Filip AD, Ash NS, Muzikar KA, Piesse C, Foulon T, O'Leary DJ, Ladram A. 	Structure-Activity Relationship-based Optimization of Small Temporin-SHf Analogs with Potent Antibacterial Activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP34406	XFFLSRIF	8	Temporin-SHf [F1TERT BU PHE]	D4YWD1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	26181487	ACS Chem Biol. 2015 Oct 16;10(10):2257-66.	André S, Washington SK, Darby E, Vega MM, Filip AD, Ash NS, Muzikar KA, Piesse C, Foulon T, O'Leary DJ, Ladram A. 	Structure-Activity Relationship-based Optimization of Small Temporin-SHf Analogs with Potent Antibacterial Activity	
DRAMP34407	FXFLRRIF	8	Temporin-SHf [F2TERT BU PHE; S5R]	D4YWD1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	26181487	ACS Chem Biol. 2015 Oct 16;10(10):2257-66.	André S, Washington SK, Darby E, Vega MM, Filip AD, Ash NS, Muzikar KA, Piesse C, Foulon T, O'Leary DJ, Ladram A. 	Structure-Activity Relationship-based Optimization of Small Temporin-SHf Analogs with Potent Antibacterial Activity	
DRAMP34408	ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEWGGPCQL	53	Laterosporulin 10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	6LWZ	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	28422156	Sci Rep. 2017 Apr 19;7:46541.	Baindara P, Gautam A, Raghava GPS, Korpole S.	Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)[C@H](C)CC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP34409	KRFKKFFKKVKKSV,KKRLKKIFKKPMVIGVTIPF	35	Crotalicidin (1-14) + Crotalicidin (15-35)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	26465972	J Med Chem. 2015 Nov 12;58(21):8553-63. 	Falcao CB, Pérez-Peinado C, de la Torre BG, Mayol X, Zamora-Carreras H, Jiménez MÁ, Rádis-Baptista G, Andreu D. 	Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity	
DRAMP34410	KWRRWIRWL	9		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30447380	Int J Antimicrob Agents. 2019 Jun;53(6):868-872. 	Baker KR, Jana B, Hansen AM, Vissing KJ, Nielsen HM, Franzyk H, Guardabassi L. 	Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP34411	IKIPSFFrNILKKVGKEAVSLIAGALKQS	29	Pseudhymenochirin-1Pb [R8r]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	26606380	J Nat Prod. 2015 Dec 24;78(12):3041-8	Manzo G, Scorciapino MA, Srinivasan D, Attoub S, Mangoni ML, Rinaldi AC, Casu M, Flatt PR, Conlon JM. 	Conformational Analysis of the Host-Defense Peptides Pseudhymenochirin-1Pb and -2Pa and Design of Analogues with Insulin-Releasing Activities and Reduced Toxicities	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP34412	GSPE	4		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25988520	Mar Drugs. 2015 May 15;13(5):3029-45.	Chakraborty S, Tai DF, Lin YC, Chiou TW.	Antitumor and antimicrobial activity of some cyclic tetrapeptides and tripeptides derived from marine bacteria	NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP34413	GYPFV	5	Longicalycinin A cyclic analogue 1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=9.66 ± 0.0007 μg/mL); HT-29 (IC50=10.45 ± 0.0042 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108902. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR. 	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)O
DRAMP34414	fkklkklfsklwnwk	15	D-HPRP-A1, HPRP-A2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SGC-7901 (IC50=10.42±0.30 μM ); B16 (IC50=19.16±0.38 μM ); PC-3 (IC50=21.38±0.56 μM ); BGC-823 (IC50=8.65 ±0.38 μM )	Not available	Linear	Acetylation	Amidation		D	Not available	Not available	31686873	Infect Drug Resist. 2019 Oct 15;12:3227-3239.	Zhu J, Huang Y, Chen M, Hu C, Chen Y.	Functional Synergy Of Antimicrobial Peptides And Chlorhexidine Acetate Against Gram-Negative/Gram-Positive Bacteria And A Fungus In Vitro And In Vivo	CC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(N)=O
DRAMP34415	fkklkklfsklwnwk	15	D-HPRP-A1, HPRP-A2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		D	Not available	Not available	31686873	Infect Drug Resist. 2019 Oct 15;12:3227-3239.	Zhu J, Huang Y, Chen M, Hu C, Chen Y.	Functional Synergy Of Antimicrobial Peptides And Chlorhexidine Acetate Against Gram-Negative/Gram-Positive Bacteria And A Fungus In Vitro And In Vivo	CC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(N)=O
DRAMP34416	ADMDFTGIAESIIKKIKETNAKPPA	25	TistH	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	27267248	Toxicon. 2016 Sep 1;119:362-70.	Machado RJ, Estrela AB, Nascimento AK, Melo MM, Torres-Rêgo M, Lima EO, Rocha HA, Carvalho E, Silva-Junior AA, Fernandes-Pedrosa MF.	Characterization of TistH, a multifunctional peptide from the scorpion Tityus stigmurus: Structure, cytotoxicity and antimicrobial activity	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)NC(=O)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP34417	GrkkrrqrrrGGwmwvtnlrtd	22	TAT-RasGAP317-326	P20936##L0HA15		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	33852935	J Glob Antimicrob Resist. 2021 Jun;25:227-231.	Heinonen T, Hargraves S, Georgieva M, Widmann C, Jacquier N.	The antimicrobial peptide TAT-RasGAP 317-326 inhibits the formation and expansion of bacterial biofilms in vitro	CSCC[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)CNC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@H](CC(=O)O)C(=O)O)[C@H](C)O)[C@H](C)O)C(C)C
DRAMP34418	KWKSFLKTFKSAKkTVLHTALKAISS	26	V13K [K14k]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=15.6 ± 4.1μM ); MIA PaCa-2 (IC50=17.9 ± 2.3μM); Bxpc-3 (IC50=20.0 ± 0.8μM); HPAC (IC50=7.2 ± 5.2μM)	MHC (minimal hemolytic concentration) =125μM	Linear	Acetylation	Amidation		Mix	Not available	Not available	29280948	 Int J Mol Sci. 2017 Dec 27;19(1):67.	Sun S, Zhao G, Huang Y, Cai M, Yan Q, Wang H, Chen Y. 	Enantiomeric Effect of d-Amino Acid Substitution on the Mechanism of Action of ?-Helical Membrane-Active Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP34419	KWKSFLKTFKsAKkTVLHTALKAISS	26	V13K [S11s, K14k]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	"Tumor cells: Bxpc-3 (IC50=22.4 ± 2.3μM); HPAC (IC50=25.5 ± 0.5	μM); HeLa (IC50=30.6 ± 0.5μM ); MIA PaCa-2 (IC50=41.3 ± 2.6μM)"	MHC (minimal hemolytic concentration) =125μM	Linear	Acetylation	Amidation		Mix	Not available	Not available	29280948	 Int J Mol Sci. 2017 Dec 27;19(1):67.	Sun S, Zhao G, Huang Y, Cai M, Yan Q, Wang H, Chen Y. 	Enantiomeric Effect of d-Amino Acid Substitution on the Mechanism of Action of ?-Helical Membrane-Active Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP34420	KWKSFLKTFKSAKktVLHTALKAISS	26	V13K [K14k, T15t]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HPAC (IC50=22.5 ± 0.5μM); Bxpc-3 (IC50=24.1 ± 5.5μM); HeLa (IC50=31.6 ± 2.1μM); MIA PaCa-2 (IC50=47.1 ± 5.3μM)	MHC (minimal hemolytic concentration) =250μM	Linear	Acetylation	Amidation		Mix	Not available	Not available	29280948	 Int J Mol Sci. 2017 Dec 27;19(1):67.	Sun S, Zhao G, Huang Y, Cai M, Yan Q, Wang H, Chen Y. 	Enantiomeric Effect of d-Amino Acid Substitution on the Mechanism of Action of ?-Helical Membrane-Active Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP34421	KWKSFLKTFKsAKktVLHTALKAISS	26	V13K [S11s, K14k, T15t]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=41.1 ± 0.5μM); Bxpc-3 (IC50=45.5 ± 5.6μM); HPAC (IC50=54.2 ± 1.2μM); MIA PaCa-2 (IC50=56.8 ± 3.3μM)	MHC (minimal hemolytic concentration) =250μM	Linear	Acetylation	Amidation		Mix	Not available	Not available	29280948	 Int J Mol Sci. 2017 Dec 27;19(1):67.	Sun S, Zhao G, Huang Y, Cai M, Yan Q, Wang H, Chen Y. 	Enantiomeric Effect of d-Amino Acid Substitution on the Mechanism of Action of ?-Helical Membrane-Active Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP34422	KWKSFLKTFKSaKKTVLHTALKAISS	26	V13K [A12a]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	"Tumor cells: HPAC (IC50=15.5 ± 1.7μM); HeLa (IC50=28.8 ± 0.8	μM); MIA PaCa-2 (IC50=29.9 ± 4.8μM); Bxpc-3 (IC50=45.1 ± 1.0μM)"	MHC (minimal hemolytic concentration) =125μM	Linear	Acetylation	Amidation		Mix	Not available	Not available	29280948	 Int J Mol Sci. 2017 Dec 27;19(1):67.	Sun S, Zhao G, Huang Y, Cai M, Yan Q, Wang H, Chen Y. 	Enantiomeric Effect of d-Amino Acid Substitution on the Mechanism of Action of ?-Helical Membrane-Active Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP34423	KWKSFLKTfKSaKKTVLHTALKAISS	26	V13K [F9f, A12a]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	"Tumor cells: Bxpc-3 (IC50=125.0 ± 3.7μM); MIA PaCa-2 (IC50=38.8 ± 2.9	μM); HPAC (IC50=42.4 ± 3.0μM); HeLa (IC50=59.8 ± 0.5μM)"	MHC (minimal hemolytic concentration) =250μM	Linear	Acetylation	Amidation		Mix	Not available	Not available	29280948	 Int J Mol Sci. 2017 Dec 27;19(1):67.	Sun S, Zhao G, Huang Y, Cai M, Yan Q, Wang H, Chen Y. 	Enantiomeric Effect of d-Amino Acid Substitution on the Mechanism of Action of ?-Helical Membrane-Active Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP34424	KWKSFLKTFKSaKKTvLHTALKAISS	26	V13K [A12a, V16v]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Bxpc-3 (IC50=125.0 ± 5.9μM); HPAC (IC50=41.4 ± 1.4μM); MIA PaCa-2 (IC50=46.2 ± 3.0μM); HeLa (IC50=60.1 ± 1.2μM)	MHC (minimal hemolytic concentration) >500μM	Linear	Acetylation	Amidation		Mix	Not available	Not available	29280948	 Int J Mol Sci. 2017 Dec 27;19(1):67.	Sun S, Zhao G, Huang Y, Cai M, Yan Q, Wang H, Chen Y. 	Enantiomeric Effect of d-Amino Acid Substitution on the Mechanism of Action of ?-Helical Membrane-Active Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP34425	KWKSFLKTfKSaKKTvLHTALKAISS	26	V13K [F9f, A12a, V16v]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: Bxpc-3 (IC50=125.0 ± 1.8μM); HeLa (IC50=125.0 ± 3.4μM); MIA PaCa-2 (IC50=57.9 ± 2.8μM); HPAC (IC50=95.6 ± 1.8μM)	MHC (minimal hemolytic concentration) >500μM	Linear	Acetylation	Amidation		Mix	Not available	Not available	29280948	 Int J Mol Sci. 2017 Dec 27;19(1):67.	Sun S, Zhao G, Huang Y, Cai M, Yan Q, Wang H, Chen Y. 	Enantiomeric Effect of d-Amino Acid Substitution on the Mechanism of Action of ?-Helical Membrane-Active Peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(N)=O
DRAMP34426	XRWRWRW	7		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24900420	ACS Comb Sci. 2013 Nov 11;15(11):585-92.	Albada HB, Prochnow P, Bobersky S, Langklotz S, Bandow JE, Metzler-Nolte N.	Tuning the activity of a short arg-trp antimicrobial Peptide by lipidation of a C- or N-terminal lysine side-chain	
DRAMP34427	XGX	3		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	C20	Amidation		L	Not available	Not available	27486068	Peptides. 2016 Oct;84:58-67.	Domalaon R, Findlay B, Ogunsina M, Arthur G, Schweizer F. 	Ultrashort cationic lipopeptides and lipopeptoids: Evaluation and mechanistic insights against epithelial cancer cells	
DRAMP34428	LIXFXPx	7	Cordyheptapeptide A linear	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Boc	OMe		Mix	Not available	Not available	28554994	 Molecules. 2017 May 27;22(6):682.	Kumar S, Dahiya R, Khokra SL, Mourya R, Chennupati SV, Maharaj S. 	Total Synthesis and Pharmacological Investigation of Cordyheptapeptide A	
DRAMP34429	XFXILxP	7	Cordyheptapeptide A	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	28554994	 Molecules. 2017 May 27;22(6):682.	Kumar S, Dahiya R, Khokra SL, Mourya R, Chennupati SV, Maharaj S. 	Total Synthesis and Pharmacological Investigation of Cordyheptapeptide A	
DRAMP34430	XFXVLxP	7	Cordyheptapeptide D	Not available		Not found	Plantae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	22642609	 J Nat Prod. 2012 Jun 22;75(6):1215-9.	Chen Z, Song Y, Chen Y, Huang H, Zhang W, Ju J.	Cyclic heptapeptides, cordyheptapeptides C-E, from the marine-derived fungus Acremonium persicinum SCSIO 115 and their cytotoxic activities	
DRAMP34431	XFXXLxP	7	Cordyheptapeptide E	Not available		Not found	Plantae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	22642609	 J Nat Prod. 2012 Jun 22;75(6):1215-9.	Chen Z, Song Y, Chen Y, Huang H, Zhang W, Ju J.	Cyclic heptapeptides, cordyheptapeptides C-E, from the marine-derived fungus Acremonium persicinum SCSIO 115 and their cytotoxic activities	
DRAMP34432	XAaQyI	6	Fusaripeptide A	Not available		Not found	Fusarium 	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: L5178Y (IC50=5.71μM); PC12 (IC50=9.55μM)	Not available	Linear	3-OH-4-Me-C15	Free	X=Allo-Thr	Mix	Not available	Not available	28446036	J Asian Nat Prod Res. 2018 Jan;20(1):75-85.	Ibrahim SRM, Abdallah HM, Elkhayat ES, Al Musayeib NM, Asfour HZ, Zayed MF, Mohamed GA.	Fusaripeptide A: new antifungal and anti-malarial cyclodepsipeptide from the endophytic fungus Fusarium sp	
DRAMP34433	GLGKAQCAALWLQCASGGTIGXGGGAVACQNYRQFCR	37	Sublancin 168	A0A1J5X031##P68578##P68577		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	2MIJ	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	29854837	J Immunol Res. 2018 May 7;2018:4353580	Wang S, Huang S, Ye Q, Zeng X, Yu H, Qi D, Qiao S.	Prevention of Cyclophosphamide-Induced Immunosuppression in Mice with the Antimicrobial Peptide Sublancin	
DRAMP34434	CKILSKTIKCRIPCGRRKEY	20	PTN (42-61)	C3Z937		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30096337	Dev Comp Immunol. 2018 Dec;89:31-43.	Gao Z, Qu B, Yao L, Ma Z, Cui P, Zhang S.	Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP34435	KRCKNKMEGDDVAVSGRGARKAAKK	25	PTNr1 (42-66)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30096337	Dev Comp Immunol. 2018 Dec;89:31-43.	Gao Z, Qu B, Yao L, Ma Z, Cui P, Zhang S.	Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies	CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)O)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP34436	EEEEEEEEEEKKRLKKIFKKPMVIGVTIPF	30	E10-Ctn[15-34]	U5KJM4		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30042491	Sci Rep. 2018 Jul 24;8(1):11127.	Júnior NGO, Cardoso MH, Cândido ES, van den Broek D, de Lange N, Velikova N, Kleijn JM, Wells JM, Rezende TMB, Franco OL, de Vries R.	An acidic model pro-peptide affects the secondary structure, membrane interactions and antimicrobial activity of a crotalicidin fragment	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)[C@H](C)CC)C(C)C
DRAMP34437	ALWKSLLKNVGKAAGKAALNAVTDMVNQ	28	Dermaseptin DRS-DU-1	A0A345FZ90		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: PC-3 (IC50=3.21μM); H157 (IC50=8.43μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30258724	PeerJ. 2018 Sep 19;6:e5635.	Zhu H, Ding X, Li W, Lu T, Ma C, Xi X, Wang L, Zhou M, Burden R, Chen T. 	Discovery of two skin-derived dermaseptins and design of a TAT-fusion analogue with broad-spectrum antimicrobial activity and low cytotoxicity on healthy cells	CSCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)C(C)C
DRAMP34438	GRKKRRQRRRGALWKSLLKNVGKA	24	TAT(48-57)-G-Dermaseptin DRS-DU-1 (1-13), DP-2	P04610		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: H157 (IC50=21.6μM); PC-3 (IC50=6.75μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	30258724	PeerJ. 2018 Sep 19;6:e5635.	Zhu H, Ding X, Li W, Lu T, Ma C, Xi X, Wang L, Zhou M, Burden R, Chen T. 	Discovery of two skin-derived dermaseptins and design of a TAT-fusion analogue with broad-spectrum antimicrobial activity and low cytotoxicity on healthy cells	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(N)=O)C(C)C
DRAMP34439	AAAARRRR	8	[A4R4]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30360400	Molecules. 2018 Oct 22;23(10):2722.	Riahifard N, Mozaffari S, Aldakhil T, Nunez F, Alshammari Q, Alshammari S, Yamaki J, Parang K, Tiwari RK. 	Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents	C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34440	YYYYRRRR	8	[Y4R4]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30360400	Molecules. 2018 Oct 22;23(10):2722.	Riahifard N, Mozaffari S, Aldakhil T, Nunez F, Alshammari Q, Alshammari S, Yamaki J, Parang K, Tiwari RK. 	Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
DRAMP34441	FFFFRRRR	8	[F4R4]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free		L	Not available	Not available	30360400	Molecules. 2018 Oct 22;23(10):2722.	Riahifard N, Mozaffari S, Aldakhil T, Nunez F, Alshammari Q, Alshammari S, Yamaki J, Parang K, Tiwari RK. 	Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP34442	FFFFRRRR	8	[F4R4]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free		L	Not available	Not available	30360400	Molecules. 2018 Oct 22;23(10):2722.	Riahifard N, Mozaffari S, Aldakhil T, Nunez F, Alshammari Q, Alshammari S, Yamaki J, Parang K, Tiwari RK. 	Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP34443	IIIIRRRR	8	[I4R4] 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30360400	Molecules. 2018 Oct 22;23(10):2722.	Riahifard N, Mozaffari S, Aldakhil T, Nunez F, Alshammari Q, Alshammari S, Yamaki J, Parang K, Tiwari RK. 	Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP34444	LLLLRRRR	8	[L4R4]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30360400	Molecules. 2018 Oct 22;23(10):2722.	Riahifard N, Mozaffari S, Aldakhil T, Nunez F, Alshammari Q, Alshammari S, Yamaki J, Parang K, Tiwari RK. 	Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34445	LYPFA	5	Longicalycinin A cyclic analogue 2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=8.76 ± 0.0035 μg/mL); HT-29 (IC50=12.33 ± 0 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108902.	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O
DRAMP34446	GLRKRLRKFRNK	12	CAP7 (1-12), sC18*	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30389988	 Sci Rep. 2018 Nov 2;8(1):16279.	Horn M, Neundorf I. 	Design of a novel cell-permeable chimeric peptide to promote wound healing	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP34447	KCVRQNNKRVCK	12	Cathelicidin (135-146), Tylotoin	W0FJD1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30389988	 Sci Rep. 2018 Nov 2;8(1):16279.	Horn M, Neundorf I. 	Design of a novel cell-permeable chimeric peptide to promote wound healing	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP34448	KCVRQNNKRVCKGLRKRLRKFRNK	24	Cathelicidin (135-146)-CAP7 (1-12), Tylotoin-sC18*	W0FJD1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30389988	 Sci Rep. 2018 Nov 2;8(1):16279.	Horn M, Neundorf I. 	Design of a novel cell-permeable chimeric peptide to promote wound healing	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP34449	GLRKRLRKFRNKIKEK,GLRKRLRKFRNKIKEK	33	[CAP7 (1-16)]2, (sC18)2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	23209513	Beilstein J Org Chem. 2012;8:1788-97.	Hoyer J, Schatzschneider U, Schulz-Siegmund M, Neundorf I. 	Dimerization of a cell-penetrating peptide leads to enhanced cellular uptake and drug delivery	
DRAMP34450	GLLEALAELLEGLRKRLRKFRNKIKEK	27	Hemagglutinin (347-367)[E4G,E7A]-CAP7 (1-16); N-E5L-sC18	P25230		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	27713223	Pharmaceuticals (Basel). 2009 Sep 25;2(2):49-65.	Neundorf I, Rennert R, Hoyer J, Schramm F, Löbner K, Kitanovic I, Wölfl S. 	Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP34451	GLLEALAELLEGRKKRRQRRRPPQ	24	Hemagglutinin (347-367)[E4G,E7A]-Tat (48-60); N-E5L-Tat (48-60)	D2DUQ8		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	27713223	Pharmaceuticals (Basel). 2009 Sep 25;2(2):49-65.	Neundorf I, Rennert R, Hoyer J, Schramm F, Löbner K, Kitanovic I, Wölfl S. 	Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP34452	GLLEALAELLEKFHTFPQTAIGVGAP,KKRKAPKKKRKFA	40	Hemagglutinin (347-367)[E4G,E7A]-Calcitonin(18-32) - k7; N-E5L-hCT(18-32)-k7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	27713223	Pharmaceuticals (Basel). 2009 Sep 25;2(2):49-65.	Neundorf I, Rennert R, Hoyer J, Schramm F, Löbner K, Kitanovic I, Wölfl S. 	Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity	
DRAMP34453	ALWKTMLKKLGTVALHAGKAALGAVADTISQ	31	Dermaseptin-PS1, Dermaseptin cDNA	A0A284T6N8		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30461197	J Cell Mol Med. 2019 Feb;23(2):1300-1312.	Long Q, Li L, Wang H, Li M, Wang L, Zhou M, Su Q, Chen T, Wu Y.	Novel peptide dermaseptin-PS1 exhibits anticancer activity via induction of intrinsic apoptosis signalling	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(N)=O
DRAMP34454	PKILNKILGKILRLAAAFK	19	PKIL+L39e (4-18)[P6I,K10I], PaDBS1R1	Q8ZTX6		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30463701	Biochim Biophys Acta Biomembr. 2019 Jan;1861(1):178-190.	Irazazabal LN, Porto WF, Fensterseifer ICM, Alves ESF, Matos CO, Menezes ACS, Felício MR, Gonçalves S, Santos NC, Ribeiro SM, Humblot V, Lião LM, Ladram A, Franco OL. 	Fast and potent bactericidal membrane lytic activity of PaDBS1R1, a novel cationic antimicrobial peptide	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC
DRAMP34455	LVPFIGRTLGGLLARF	16	RTemp_4.3_210	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30578771	Biochim Biophys Acta Biomembr. 2019 Mar 1;1861(3):651-659.	Rončević T, Krce L, Gerdol M, Pacor S, Benincasa M, Guida F, Aviani I, Čikeš-Čulić V, Pallavicini A, Maravić A, Tossi A. 	Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)O
DRAMP34456	LLGAALSALSSVIPSVISWFQK	22	RArv_10.1_19	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30578771	Biochim Biophys Acta Biomembr. 2019 Mar 1;1861(3):651-659.	Rončević T, Krce L, Gerdol M, Pacor S, Benincasa M, Guida F, Aviani I, Čikeš-Čulić V, Pallavicini A, Maravić A, Tossi A. 	Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP34457	rGDFV	5		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	1718779	FEBS Lett. 1991 Oct 7;291(1):50-4.	Aumailley M, Gurrath M, Müller G, Calvete J, Timpl R, Kessler H. 	Arg-Gly-Asp constrained within cyclic pentapeptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1	CC(C)[C@H](NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)O
DRAMP34458	SKWQHQQDSCRKQLQGVNLTPCEKHIMEKIQGRGDDDDDDDDD	43	Lunasin 	Not available		Not found	Glycine max	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	10331812	Nat Biotechnol. 1999 May;17(5):495-500.	Galvez AF, de Lumen BO.	A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP34459	CGESCVWIPCISSAIGCSCKSKVCYRNGIP	30	Cycloviolacin O2	Not available		Not found	Viola odorata	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	10600388	 J Mol Biol. 1999 Dec 17;294(5):1327-36.	Craik DJ, Daly NL, Bond T, Waine C. 	Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)C(C)C
DRAMP34460	TvXXX,XvXXX	11	Actinomycin Z1	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	10757717	J Nat Prod. 2000 Mar;63(3):352-6.	Lackner H, Bahner I, Shigematsu N, Pannell LK, Mauger AB.	Structures of five components of the actinomycin Z complex from Streptomyces fradiae, two of which contain 4-chlorothreonine	
DRAMP34461	RQIKIWFQNRRMKWK	15	pAntp (43-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34462	CHTNGGYCVRAICPPSARRPGSCFPEKNPCCKYM	34	mBD-2 	Not available		Not found	Mus musculus	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	10922379	J Biol Chem. 2000 Oct 27;275(43):33314-20.	Jia HP, Wowk SA, Schutte BC, Lee SK, Vivado A, Tack BF, Bevins CL, McCray PB Jr.	A novel murine beta -defensin expressed in tongue, esophagus, and trachea.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)O
DRAMP34463	FDIVKKVVGTIAGL	14	K7	P82391		Not found	Litoria aurea	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	10951191	Eur J Biochem. 2000 Sep;267(17):5330-41.	Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ. 	The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(C)C
DRAMP34464	MDAQTRRRERRAEKQAQWKAANGC	24	LAMBDA N (1-22)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Conjugation with fluorescein by C-terminal Gly Cys amide		L	Not available	Not available	11084031	J Biol Chem. 2001 Feb 23;276(8):5836-40.	Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y. 	Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery.	
DRAMP34465	RKKRRQRR	8	Tat (49-56)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34466	TSPLNIHNGQKL	12	HN-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Not available	fluorescein/ FITC/texas red	Amidation		L	Not available	Not available	11118031	Cancer Res. 2000 Dec 1;60(23):6551-6.	Hong FD, Clayman GL. 	Isolation of a peptide for targeted drug delivery into human head and neck solid tumors.	
DRAMP34467	CELDENNTPMC	11	FSEC 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	11311231	FEBS Lett. 2001 Apr 13;494(3):150-6. 	Tan DC, Kini RM, Jois SD, Lim DK, Xin L, Ge R.	A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O
DRAMP34468	XXPXxX	6	Apratoxin A	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	11389621	J Am Chem Soc. 2001 Jun 13;123(23):5418-23.	Luesch H, Yoshida WY, Moore RE, Paul VJ, Corbett TH.	Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula	
DRAMP34469	IFSPIPL	7	Stylopeptide 1	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	11473416	J Nat Prod. 2001 Jul;64(7):883-91. 	Pettit GR, Lippert JW 3rd, Taylor SR, Tan R, Williams MD.	Synthesis of phakellistatin 11: a micronesia (Chuuk) marine sponge cyclooctapeptide	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC
DRAMP34470	GIGVLLSAGKAALKGLAKVLAEKYAN	26	maximin4	Not available		Not found	Bombina maxima	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	11835991	Peptides. 2002 Mar;23(3):427-35.	Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.	Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima. 	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O)C(C)C)C(C)C
DRAMP34471	AKVKDEPQRRSARLSAKPAPPKPEPKPKKAPAKK	34	F3	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	12032302	 Proc Natl Acad Sci U S A. 2002 May 28;99(11):7444-9. 	Porkka K, Laakkonen P, Hoffman JA, Bernasconi M, Ruoslahti E.	A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo.	
DRAMP34472	ALWKTLLKKVLKAPKKKRKV	20	S4(13)-PV	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	12119035	iochemistry. 2002 Jul 23;41(29):9208-14.	Hariton-Gazal E, Feder R, Mor A, Graessmann A, Brack-Werner R, Jans D, Gilon C, Loyter A.	Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals.	
DRAMP34473	VQRKRQKLMP	10	NF-kB	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	12204694	Chem Biol. 2002 Aug;9(8):943-8.	Ragin AD, Morgan RA, Chmielewski J.	Cellular import mediated by nuclear localization signal Peptide sequences.	
DRAMP34474	LXIGxP	6	Tasiamide	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	2-OH-ME-C5	OMe		Mix	Not available	Not available	12350160	J Nat Prod. 2002 Sep;65(9):1336-9.	Williams PG, Yoshida WY, Moore RE, Paul VJ.	Tasiamide, a cytotoxic peptide from the marine cyanobacterium Symploca sp	
DRAMP34475	GRKKRRQRRRPP	12	Tat (48-59)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Free		L	Not available	Not available	12411431	J Biol Chem. 2003 Jan 3;278(1):585-90.	Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B. 	Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake.	
DRAMP34476	RGGRLSYSRRRFSTSTGR	18	SynB1	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	NBD and TAMRA	Free		L	Not available	Not available	12783857	J Biol Chem. 2003 Aug 15;278(33):31192-201.	Drin G, Cottin S, Blanc E, Rees AR, Temsamani J. 	Studies on the internalization mechanism of cationic cell-penetrating peptides.	
DRAMP34477	RHIKIWFQNRRMKWKK	16	PDX -1-PTD	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Free		L	Not available	Not available	12829640	Diabetes. 2003 Jul;52(7):1732-7.	Noguchi H, Kaneto H, Weir GC, Bonner-Weir S. 	PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells.	
DRAMP34478	KLLKKPLKLKL	11		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	14514057	Biotechnol Lett. 2003 Aug;25(16):1305-10.	Park Y, Lee DG, Hahm KS. 	Antibiotic activity of Leu-Lys rich model peptides	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP34479	XFXFLPX	7	Scytalidamide A	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	14604342	J Org Chem. 2003 Nov 14;68(23):8767-73. 	Tan LT, Cheng XC, Jensen PR, Fenical W.	Scytalidamides A and B, new cytotoxic cyclic heptapeptides from a marine fungus of the genus Scytalidium	
DRAMP34480	MFTLKKSLLLLFFLGTISSSLCEQERDSDDEDQGEVTEQVVKRLVRGCWTKSYPPKPCFVRG	62	Peptide leucine arginine	Q90WP7##P82110		Not found	Lithobates pipiens	Antimicrobial, Anticancer	Not found	Not found	Not found	2M3N	Not available	Not available	Not available		Free	Free		L	Not available	Not available	14636071	Biochemistry. 2003 Dec 2;42(47):14023-35.	Mangoni ML, Papo N, Mignogna G, Andreu D, Shai Y, Barra D, Simmaco M. 	Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C
DRAMP34481	VRLPPP	6	PolyP 1	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Free		L	Not available	Not available	15054781	Angew Chem Int Ed Engl. 2004 Mar 26;43(14):1811-4.	Fernández-Carneado J, Kogan MJ, Castel S, Giralt E.	Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.	
DRAMP34482	VCIIIIC	7	Microcionamide A	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	PEA		L	Not available	Not available	15176844	J Org Chem. 2004 Jun 11;69(12):4170-6. 	Davis RA, Mangalindan GC, Bojo ZP, Antemano RR, Rodriguez NO, Concepcion GP, Samson SC, de Guzman D, Cruz LJ, Tasdemir D, Harper MK, Feng X, Carter GT, Ireland CM.	Microcionamides A and B, bioactive peptides from the philippine sponge Clathria (Thalysias) abietina	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCCc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP34483	CGNKRTRGC	9	Lyp-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	15197262	 Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9381-6.	Laakkonen P, Akerman ME, Biliran H, Yang M, Ferrer F, Karpanen T, Hoffman RM, Ruoslahti E.	Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.	
DRAMP34484	GLFDIVKKVVGTIAGL	16	Aurein-2.4	P82391		Not found	Litoria aurea	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	15203252	Peptides. 2004 Jun;25(6):1035-54.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE. 	Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(C)C
DRAMP34485	HHPHG	5	HHPHG	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	15313924	Cancer Res. 2004 Aug 15;64(16):5812-7	Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.	Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities.	N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O
DRAMP34486	HHPHGHHPHGHHPHG	15	(HHPHG)3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Acetylation		L	Not available	Not available	15313924	Cancer Res. 2004 Aug 15;64(16):5812-7	Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.	Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities.	
DRAMP34487	HF	2	Cyclo(His-Phe)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	15324483	J Pharm Pharmacol. 2004 Sep;56(9):1143-53.	McCleland K, Milne PJ, Lucieto FR, Frost C, Brauns SC, Van De Venter M, Du Plessis J, Dyason K. 	An investigation into the biological activity of the selected histidine-containing diketopiperazines cyclo(His-Phe) and cyclo(His-Tyr)	N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP34488	GPFYVI	6	Dianthin C	Not available		Not found	Plantae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	15387653	J Nat Prod. 2004 Sep;67(9):1522-7	Hsieh PW, Chang FR, Wu CC, Wu KY, Li CM, Chen SL, Wu YC.	New cytotoxic cyclic peptides and dianthramide from Dianthus superbus	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)CN)C(C)C)C(=O)O
DRAMP34489	AAWIPPG	7	Cherimolacyclopeptide C	Not available		Not found	Plantae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	15387664	J Nat Prod. 2004 Sep;67(9):1577-9.	Wélé A, Zhang Y, Ndoye I, Brouard JP, Pousset JL, Bodo B. 	A cytotoxic cyclic heptapeptide from the seeds of Annona cherimola	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)O
DRAMP34490	RKKRRRESRKKRRRES	16	DPV3	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Cys addition	Free		L	Not available	Not available	15859953	Biochem J. 2005 Sep 1;390(Pt 2):407-18.	De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. 	Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.	
DRAMP34491	AXQNMEILEXTPLTXVX	17	Dermaseptin-PH	Not available		Not found	Anabaena laxa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	15875779	In Vivo. 2005 May-Jun;19(3):577-82.	Gbankoto A, Vigo J, Dramane K, Banaigs B, Aina E, Salmon JM. 	Cytotoxic effect of Laxaphycins A and B on human lymphoblastic cells (CCRF-CEM) using digitised videomicrofluorometry.	
DRAMP34492	RQIKIWFQNRRMKWKKTYADFIASGRTGRRNAI	33	pAntpâ€“PKI	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free		L	Not available	Not available	15937518	Br J Pharmacol. 2005 Aug;145(8):1093-102.	Jones SW, Christison R, Bundell K, Voyce CJ, Brockbank SM, Newham P, Lindsay MA.	Characterisation of cell-penetrating peptide-mediated peptide delivery.	
DRAMP34493	fXXXXXNfPPR	11	Koshikamide A2	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	MeOAc	Free		Mix	Not available	Not available	16041137	Biosci Biotechnol Biochem. 2005 Jul;69(7):1318-22.	Araki T, Matsunaga S, Fusetani N. 	Koshikamide A2, a cytotoxic linear undecapeptide isolated from a marine sponge of Theonella sp	
DRAMP34494	YTAIAWVKAFIRKLRK	16	YTA2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	16376307	Biochem Pharmacol. 2006 Feb 14;71(4):416-25.	Lindgren M, Rosenthal-Aizman K, Saar K, Eiríksdóttir E, Jiang Y, Sassian M, Ostlund P, Hällbrink M, Langel U. 	Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.	
DRAMP34495	GIPCGESCVWIPCISSAIGCSCXSXVCYRN	30	[Lys(Ac)]2cyO2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937/GTB (IC50=2.3(2.0-2.5)μM)	Not available	Linear	Free	Free	X=Lys(Ac)2	L	Not available	Not available	16389447	Cell Mol Life Sci. 2006 Jan;63(2):235-45. 	Herrmann A, Svangård E, Claeson P, Gullbo J, Bohlin L, Göransson U. 	Key role of glutamic acid for the cytotoxic activity of the cyclotide cycloviolacin O2	
DRAMP34496	GIPCGESCVWIPCISSAIGCSCKSKVCYXN	30	[Arg(CHD)]cyO2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937/GTB (IC50=0.95(0.82-1.1)μM)	Not available		Free	Free	X=ARG(CHD)	L	Not available	Not available	16389447	Cell Mol Life Sci. 2006 Jan;63(2):235-45.	Herrmann A, Svangård E, Claeson P, Gullbo J, Bohlin L, Göransson U.	Key role of glutamic acid for the cytotoxic activity of the cyclotide cycloviolacin O2	
DRAMP34497	KSGIACFL	8	TRAIL51-58	P50591		Not found	TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	16427631	FEBS Lett. 2006 Feb 6;580(3):885-9.	Okochi M, Nakanishi M, Kato R, Kobayashi T, Honda H.	High-throughput screening of cell death inducible short peptides from TNF-related apoptosis-inducing ligand sequence	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP34498	VNADIKATTVFGGKYVSLTTP	21	Inv1, rMce1a (1-21)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34499	FKRIVQRIKDFLX	13	Synthetic Ll-37	Not available		Not found	Homo sapiens	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	16637646	J Am Chem Soc. 2006 May 3;128(17):5776-85.	Li X, Li Y, Han H, Miller DW, Wang G. 	Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.	
DRAMP34500	XXVXXV	6	Aurilide C	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	16643028	J Nat Prod. 2006 Apr;69(4):572-5.	Han B, Gross H, Goeger DE, Mooberry SL, Gerwick WH.	Aurilides B and C, cancer cell toxins from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula	
DRAMP34501	NQL	3	N-Octanoyl Fellutamide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	C8	Free		L	Not available	Not available	16697191	Bioorg Med Chem Lett. 2006 Jul 15;16(14):3855-8.	Schneekloth JS Jr, Sanders JL, Hines J, Crews CM.	Neurotrophic peptide aldehydes: solid phase synthesis of fellutamide B and a simplified analog	CCCCCCCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP34502	YRXG	4	16	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free	X=Cα -dialkylated glycine (Aaa2,2 )	L	Not available	Not available	16722632	Cancer Res. 2004 Aug 15;64(16):5812-7.	Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.	Not available	
DRAMP34503	HG	2	Cyclo(His-Gly)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	16797105	Peptides. 2006 Nov;27(11):2706-14.	Lucietto FR, Milne PJ, Kilian G, Frost CL, Van De Venter M.	The biological activity of the histidine-containing diketopiperazines cyclo(His-Ala) and cyclo(His-Gly)	N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O
DRAMP34504	MLLLTRRRST	10	BagP	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation or Conjugation with TMR	Free		L	Not available	Not available	16808988	Peptides. 2006 Nov;27(11):2661-9.	Niarchos DK, Perez SA, Papamichail M.	Characterization of a novel cell penetrating peptide derived from Bag-1 protein.	
DRAMP34505	VRRFKWWWKFLRR	13	Tritrpticin [P5,9K]	P51524		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=24μM)	Not available	Linear	Free	Amidation		L	Not available	Not available	17059217	Biochemistry. 2006 Oct 31;45(43):13007-17.	Zhu WL, Lan H, Park Y, Yang ST, Kim JI, Park IS, You HJ, Lee JS, Park YS, Kim Y, Hahm KS, Shin SY. 	Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP34506	CTTHWGFTLC	10	cyclic decapeptide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	17121909	Mol Cancer Ther. 2006 Nov;5(11):2624-33. 	Cai W, Rao J, Gambhir SS, Chen X. 	How molecular imaging is speeding up antiangiogenic drug development	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O
DRAMP34507	YLKNYRIATFKNWPF	15	msurvivin	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	17142738	 J Immunol. 2006 Dec 15;177(12):8410-21.	Charalambous A, Oks M, Nchinda G, Yamazaki S, Steinman RM. 	Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP34508	GPFHFYQFLFPPV	13	435B peptide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Free		L	Not available	Not available	17268054	Biol Pharm Bull. 2007 Feb;30(2):218-23.	Kamada H, Okamoto T, Kawamura M, Shibata H, Abe Y, Ohkawa A, Nomura T, Sato M, Mukai Y, Sugita T, Imai S, Nagano K, Tsutsumi Y, Nakagawa S, Mayumi T, Tsunoda S.	Creation of novel cell-penetrating peptides for intracellular drug delivery using systematic phage display technology originated from Tat transduction domain.	
DRAMP34509	AAXGVL	6	Emericellamide B	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	17323993	J Nat Prod. 2007 Apr;70(4):515-20.	Oh DC, Kauffman CA, Jensen PR, Fenical W.	Induced production of emericellamides A and B from the marine-derived fungus Emericella sp in competing co-culture	
DRAMP34510	LIRLWSHLIHIWFQNRRLKWKKK	23	EB-1	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	17463227	FASEB J. 2007 Sep;21(11):2664-71. 	Lundberg P, El-Andaloussi S, Sütlü T, Johansson H, Langel U. 	Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP34511	MVTVLFRRLRIRRACGPPRVRV	22	M918	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	17622242	Mol Ther. 2007 Oct;15(10):1820-6.	El-Andaloussi S, Johansson HJ, Holm T, Langel U.	A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids. 	
DRAMP34512	MVTVLFRRLRIRRACGPPRVRV	22	M918	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	17622242	Mol Ther. 2007 Oct;15(10):1820-6.	El-Andaloussi S, Johansson HJ, Holm T, Langel U.	A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids. 	
DRAMP34513	vrlpppvrlpppvrlppp	18	D form of Sweat Arrow Protein (SAP)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Free		D	Not available	Not available	17635150	Biochem Soc Trans. 2007 Aug;35(Pt 4):794-6.	Pujals S, Sabidó E, Tarragó T, Giralt E.	all-D proline-rich cell-penetrating peptides: a preliminary in vivo internalization study.	
DRAMP34514	CNSCWSDK	8	TRAIL227–234[R1C]	Not available		Not found	TRAIL227–234	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	17822671	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Screening of a novel octamer peptide, CNSCWSKD, that induces caspase-dependent cell death	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CS)C(=O)O
DRAMP34515	GlXGVY	6	1962A	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	17944538	J Nat Prod. 2007 Nov;70(11):1696-9.	Huang H, She Z, Lin Y, Vrijmoed LL, Lin W.	Cyclic peptides from an endophytic fungus obtained from a mangrove leaf (Kandelia candel)	
DRAMP34516	MVRRFLVTLRIRRACGPPRVRV	22	ARF(1-22)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	17984975	Mol Ther. 2008 Jan;16(1):115-23. 	Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel U. 	Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein.	
DRAMP34517	GYVPLWP	7	Segetalin E	Not available		Not found	Plantae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	18087804	Arch Pharm Res. 2007 Nov;30(11):1380-6.	Dahiya R, Kaur K. 	Synthetic peptide and biological studies on natural cyclic heptapeptide: segetalin E	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)O
DRAMP34518	LLPFPYPTPF	10	Stylopeptide 2	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	18197605	 J Nat Prod. 2008 Mar;71(3):453-6	Brennan MR, Costello CE, Maleknia SD, Pettit GR, Erickson KL. 	Stylopeptide 2, a proline-rich cyclodecapeptide from the sponge Stylotella sp	CC(C)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP34519	AFPGLSF	7	Segetalin D	Not available		Not found	Plantae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	18323244	Acta Pol Pharm. 2007 Nov-Dec;64(6):509-16	Dahiya R. 	Synthesis of a phenylalanine-rich peptide as potential anthelmintic and cytotoxic agent	CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP34520	XxXxXxXx	8	Bassianolide	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=MeLeu; x=D-HIV, 2-d-hydroxyisovaleric acid 	Mix	Not available	Not available	18375793	BCC1067. Microbiology (Reading). 2008 Apr;154(Pt 4):995-1006.	Jirakkakul J, Punya J, Pongpattanakitshote S, Paungmoung P, Vorapreeda N, Tachaleat A, Klomnara C, Tanticharoen M, Cheevadhanarak S.	Identification of the nonribosomal peptide synthetase gene responsible for bassianolide synthesis in wood-decaying fungus Xylaria sp BCC1067	
DRAMP34521	VG	2	Cyclo(Val-Gly), Diketopiperazine (VG)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	18436344	Peptides. 2008 Aug;29(8):1305-11.	van der Merwe E, Huang D, Peterson D, Kilian G, Milne PJ, Van de Venter M, Frost C. 	The synthesis and anticancer activity of selected diketopiperazines	CC(C)[C@H](N)C(=O)NCC(=O)O
DRAMP34522	KLKNFAKGVAQSLLNKASCKLSGQC	25	Brevinin 2R	P40841##P85095		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	18494941	 J Cell Mol Med. 2008 Jun;12(3):1005-22.	Ghavami S, Asoodeh A, Klonisch T, Halayko AJ, Kadkhoda K, Kroczak TJ, Gibson SB, Booy EP, Naderi-Manesh H, Los M.	Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O
DRAMP34523	TPFVXV	6	Mollamide B	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18543965	J Nat Prod. 2008 Jun;71(6):941-5. 	Donia MS, Wang B, Dunbar DC, Desai PV, Patny A, Avery M, Hamann MT. 	Mollamides B and C, Cyclic hexapeptides from the indonesian tunicate Didemnum molle.	
DRAMP34524	vTVvpXxxxvFXV	13	Kahalalide F	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5-ME-C6	Free		Mix	Not available	Not available	18672864	J Med Chem. 2008 Aug 28;51(16):4920-31. 	Jiménez JC, López-Macià A, Gracia C, Varón S, Carrascal M, Caba JM, Royo M, Francesch AM, Cuevas C, Giralt E, Albericio F. 	Structure-activity relationship of kahalalide F Synthetic peptide analogues	
DRAMP34525	AAPFLECQGRQGTCHFFAN	19	Tetrastatin-3	Not available		Not found	Homo sapiens (α4 CIV)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O
DRAMP34526	MAFLKKSLFLVLFLALVPLSICEEKKSEEENEEKQEDDQSEEKRGLVTSLIKGAGKLLGGLFGSVTGGQS	70	Dermaseptin-like PBN2	Q800R4		Not found	Phyllomedusa bicolor	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18929530	Biochim Biophys Acta. 2009 Aug;1788(8):1537-50. 	Nicolas P, El Amri C. 	The dermaseptin superfamily: a gene-based combinatorial library of antimicrobial peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C
DRAMP34527	KSCCKNTTGRNIYNTCRFAGGSRERCAKLSGCKIISASTCPSDYPK	46	Viscotoxin B2 	Not available		Not found	Viscum album	Antimicrobial, Anticancer	Not found	Not found	Not found	1ORL	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18957441	Nucleic Acids Res. 2009 Jan;37(Database issue):D933-7	Wang G, Li X, Wang Z. 	APD2: the updated antimicrobial peptide database and its application in peptide design.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP34528	GSGKKGGKKHCQKY	14	(42-38)-(9-1) Crot	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free		L	Not available	Not available	18983137	J Med Chem. 2008 Nov 27;51(22):7041-4.	Rádis-Baptista G, de la Torre BG, Andreu D.	A novel cell-penetrating peptide sequence derived by structural minimization of a snake toxin exhibits preferential nucleolar localization.	
DRAMP34529	XXPXXV	6	Hantupeptin A	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	19093843	 J Nat Prod. 2009 Jan;72(1):29-32.	Tripathi A, Puddick J, Prinsep MR, Lee PP, Tan LT.	Hantupeptin A, a cytotoxic cyclic depsipeptide from a Singapore collection of Lyngbya majuscula	
DRAMP34530	AFXGVL	6	Arenamide B	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	19117399	J Nat Prod. 2009 Mar 27;72(3):396-402.	Asolkar RN, Freel KC, Jensen PR, Fenical W, Kondratyuk TP, Park EJ, Pezzuto JM. 	Arenamides A-C, cytotoxic NFkappaB inhibitors from the marine actinomycete Salinispora arenicola	
DRAMP34531	CGETCTLGTCYTAGCSCSWPVCTRNGVPI	29		P58451		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	3E4H	Not available	Not available	Not available		Free	Free		L	Not available	Not available	19211551	 J Biol Chem. 2009 Apr 17;284(16):10672-83. 	Wang CK, Hu SH, Martin JL, Sjögren T, Hajdu J, Bohlin L, Claeson P, Göransson U, Rosengren KJ, Tang J, Tan NH, Craik DJ.	Combined X-ray and NMR analysis of the stability of the cyclotide cystine knot fold that underpins its insecticidal activity and potential use as a drug scaffold.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
DRAMP34532	xVXvxVXvxVXv	12	Bacillistatin 2	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	x(1/9)=2R-hydroxy-3S-methyl-valeryl-R-valine; x(5)=2R-hydroxy-4-methyl-valeryl-R-valine; X=S-lactic acid-S-Val	Mix	Not available	Not available	19226154	 J Nat Prod. 2009 Mar 27;72(3):366-71. 	Pettit GR, Knight JC, Herald DL, Pettit RK, Hogan F, Mukku VJ, Hamblin JS, Dodson MJ, Chapuis JC.	Antineoplastic agents 570 Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris	
DRAMP34533	xVXvxVXvxVXv	12	Bacillistatin 2	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	x(1/9)=2R-hydroxy-3S-methyl-valeryl-R-valine; x(5)=2R-hydroxy-4-methyl-valeryl-R-valine; X=S-lactic acid-S-Val	Mix	Not available	Not available	19226154	 J Nat Prod. 2009 Mar 27;72(3):366-71. 	Pettit GR, Knight JC, Herald DL, Pettit RK, Hogan F, Mukku VJ, Hamblin JS, Dodson MJ, Chapuis JC.	Antineoplastic agents 570 Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris	
DRAMP34534	xVXvxVXvxVXv	12	Bacillistatin 2	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	x(1/9)=2R-hydroxy-3S-methyl-valeryl-R-valine; x(5)=2R-hydroxy-4-methyl-valeryl-R-valine; X=S-lactic acid-S-Val	Mix	Not available	Not available	19226154	 J Nat Prod. 2009 Mar 27;72(3):366-71. 	Pettit GR, Knight JC, Herald DL, Pettit RK, Hogan F, Mukku VJ, Hamblin JS, Dodson MJ, Chapuis JC.	Antineoplastic agents 570 Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris	
DRAMP34535	xVXvxVXvxVXv	12	Bacillistatin 1	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	x=2R-hydroxy-3S-methyl-valeryl-R-valine; X=S-lactic acid-S-Val	Mix	Not available	Not available	19226154	 J Nat Prod. 2009 Mar 27;72(3):366-71. 	Pettit GR, Knight JC, Herald DL, Pettit RK, Hogan F, Mukku VJ, Hamblin JS, Dodson MJ, Chapuis JC.	Antineoplastic agents 570 Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris	
DRAMP34536	xVXvxVXvxVXv	12	Bacillistatin 1	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	x=2R-hydroxy-3S-methyl-valeryl-R-valine; X=S-lactic acid-S-Val	Mix	Not available	Not available	19226154	 J Nat Prod. 2009 Mar 27;72(3):366-71. 	Pettit GR, Knight JC, Herald DL, Pettit RK, Hogan F, Mukku VJ, Hamblin JS, Dodson MJ, Chapuis JC.	Antineoplastic agents 570 Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris	
DRAMP34537	xVXvxVXvxVXv	12	Bacillistatin 1	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	x=2R-hydroxy-3S-methyl-valeryl-R-valine; X=S-lactic acid-S-Val	Mix	Not available	Not available	19226154	 J Nat Prod. 2009 Mar 27;72(3):366-71. 	Pettit GR, Knight JC, Herald DL, Pettit RK, Hogan F, Mukku VJ, Hamblin JS, Dodson MJ, Chapuis JC.	Antineoplastic agents 570 Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris	
DRAMP34538	crkkrrqrrr	10	cTat	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Insulin	Free		D	Not available	Not available	19228019	Mol Pharm. 2009 Mar-Apr;6(2):492-503.	Patel LN, Wang J, Kim KJ, Borok Z, Crandall ED, Shen WC. 	Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin.	
DRAMP34539	PVVXY	5	Cotteslosin A	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	19245260	J Nat Prod. 2009 Apr;72(4):666-70	Fremlin LJ, Piggott AM, Lacey E, Capon RJ.	Cottoquinazoline A and cotteslosins A and B, metabolites from an Australian marine-derived strain of Aspergillus versicolor	
DRAMP34540	MFTLKKSLLLLFFLGTINLSLCEEERDADEEERRDDPEERAVEVEKRFVDLKKIANIINSIFGK	64	Temporin-1CEa	B8QP36		Not found	Rana chensinensis	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	19341344	Zoolog Sci. 2009 Mar;26(3):220-6. 	Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y.	Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP34541	FXX	3	Stereocalpin A	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	19354233	Org Lett. 2009 May 7;11(9):1963-6.	Ghosh AK, Xu CX. 	A convergent synthesis of the proposed structure of antitumor depsipeptide stereocalpin A	
DRAMP34542	WEAALAEALAEALAEHLAEALAEALEALAA	30	GALA	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	19388672	Bioconjug Chem. 2009 May 20;20(5):953-9. 	Kobayashi S, Nakase I, Kawabata N, Yu HH, Pujals S, Imanishi M, Giralt E, Futaki S. 	Cytosolic targeting of macromolecules using a pH-dependent fusogenic peptide in combination with cationic liposomes.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP34543	HARIKPTFRRLKWKYKGKFW	20	Anti-lipopolysaccharide factor (32-51)[Y2A], L-2	P07086		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23401744	J Amino Acids. 2013;2013:251398. 	Fernández Massó JR, Oliva Argüelles B, Tejeda Y, Astrada S, Garay H, Reyes O, Delgado-Roche L, Bollati-Fogolín M, Vallespí MG. 	The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
DRAMP34544	CLGENVPCDKDRPNCCSRYECLEPTGYGWWYASYYCYKKRS	41	Brachyin	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	25329070	PLoS One. 2014 Oct 20;9(10):e110221.	Zhong Y, Song B, Mo G, Yuan M, Li H, Wang P, Yuan M, Lu Q.	A novel neurotoxin from venom of the spider, Brachypelma albopilosum	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O
DRAMP34545	ALWKEVLKNAGKAALNEINNLV	22	Dermaseptin-PH 	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	29064402	Molecules. 2017 Oct 24;22(10):1805.	Huang L, Chen D, Wang L, Lin C, Ma C, Xi X, Chen T, Shaw C, Zhou M.	Dermaseptin-PH: A Novel Peptide with Antimicrobial and Anticancer Activities from the Skin Secretion of the South American Orange-Legged Leaf Frog, Pithecopus (Phyllomedusa) hypochondrialis.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP34546	HARIKpTFRRlKWKYKGKFW	20	Anti-lipopolysaccharide factor (32-51)[Y2A,P6p,L11l], CIGB-552	P07086		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Free		Mix	Not available	Not available	29601540	Molecules. 2018 Mar 30;23(4):801.	Astrada S, Fernández Massó JR, Vallespí MG, Bollati-Fogolín M	Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic peptide Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(C)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
DRAMP34547	WKLLSKAQEKFGKNKSR,RYGTXIYQXRLWAFSK	34	CH9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	30048118	Bioconjug Chem. 2018 Sep 19;29(9):3060-3071	Ptaszyńska N, Gucwa K, Łęgowska A, Dębowski D, Gitlin-Domagalska A, Lica J, Heldt M, Martynow D, Olszewski M, Milewski S, Ng TB, Rolka K.	Antimicrobial Activity of Chimera Peptides Composed of Human Neutrophil Peptide 1 (HNP-1) Truncated Analogues and Bovine Lactoferrampin	
DRAMP34548	IETFLKQLRSAANKIVGL	18	Citrus-amp1	A0A067DL46		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30192822	PLoS One. 2018 Sep 7;13(9):e0203451. 	Inui Kishi RN, Stach-Machado D, Singulani JL, Dos Santos CT, Fusco-Almeida AM, Cilli EM, Freitas-Astúa J, Picchi SC, Machado MA.	Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)O)[C@H](C)CC)[C@@H](C)O
DRAMP34549	GFWSSVWDGAKNVGTAIIKNAKVCVYAVCVSHK	33	Nicomicin-1	A0A3G2WH77		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	6HN9	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30360541	Mar Drugs. 2018 Oct 23;16(11):401.	Panteleev PV, Tsarev AV, Bolosov IA, Paramonov AS, Marggraf MB, Sychev SV, Shenkarev ZO, Ovchinnikova TV. 	Novel Antimicrobial Peptides from the Arctic Polychaeta Nicomache minor Provide New Molecular Insight into Biological Role of the BRICHOS Domain	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)C(C)C
DRAMP34550	GFWSSVWDGAKNVGTAI	17	Nicomicin-1 (1-17)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30360541	Mar Drugs. 2018 Oct 23;16(11):401.	Panteleev PV, Tsarev AV, Bolosov IA, Paramonov AS, Marggraf MB, Sychev SV, Shenkarev ZO, Ovchinnikova TV.	Novel Antimicrobial Peptides from the Arctic Polychaeta Nicomache minor Provide New Molecular Insight into Biological Role of the BRICHOS Domain	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP34551	GLFSKKGGKGGKSWIKGVFKGIKGIGKEVGGDVIRTGIEIAACKIKGEC	49	Esculentin-1GN	A0A3G6VAR4		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30427189	J Med Chem. 2018 Dec 13;61(23):10709-10723.	Zeng B, Chai J, Deng Z, Ye T, Chen W, Li D, Chen X, Chen M, Xu X. 	Functional Characterization of a Novel Lipopolysaccharide-Binding Antimicrobial and Anti-Inflammatory Peptide in Vitro and in Vivo	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)[C@H](C)CC)NC(=O)CNC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)C(=O)O
DRAMP34552	TRGRWGRFKRRAGRFIRRNRWQIISTGLKLIG	32	Cathelicidin Ps-CATH4	A0A2R4A6C7		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30452933	Dev Comp Immunol. 2019 Mar;92:179-192. 	Shi N, Cai S, Gao J, Qiao X, Yang H, Wang Y, Yu H. 	Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)O
DRAMP34553	FLSLLPHIASGIASLVSKF	19	Phylloseptin-PBa2, Phylloseptin-PBu	A0A2K4P1U8		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30612735	 Biochem Biophys Res Commun. 2019 Feb 12;509(3):664-673. 	Wu Y, Wang L, Zhou M, Chen T, Shaw C.	Phylloseptin-PBa1, -PBa2, -PBa3: Three novel antimicrobial peptides from the skin secretion of Burmeister's leaf frog (Phyllomedusa burmeisteri)	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP34554	FLSLIPHIASGIASLVKNF	19	Phylloseptin-PBa1, Phylloseptin-PBu	A0A5B7LGG0		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30612735	Biochem Biophys Res Commun. 2019 Feb 12;509(3):664-673.	Wu Y, Wang L, Zhou M, Chen T, Shaw C.	Phylloseptin-PBa1, -PBa2, -PBa3: Three novel antimicrobial peptides from the skin secretion of Burmeister's leaf frog (Phyllomedusa burmeisteri)	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP34555	RWCRRYRVRVRGVLVYAYVCW	21	Arenicin-1 [V4R; Y5,7R; A6Y; R16,18Y; Y17A; R19V]	Q5SC60		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31234579	 Mar Drugs. 2019 Jun 23;17(6):376. 	Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.	Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
DRAMP34556	RWRPPIRRPPIRPPFYP	17	Bac5 (1-17)[F2W]	P19660		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31692278	ChemMedChem. 2019 Dec 17;14(24):2025-2033	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E Coli, K Pneumoniae, and A Baumannii	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP34557	CVRRFPWWWPFLRRC	15	C-Tritrpticin-C	P51524		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32126228	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183228. 	Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ. 	Selective anticancer activity of Synthetic peptide peptides derived from the host defence peptide tritrpticin	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O
DRAMP34560	XvXXX,TvXXX	11	Actinomycin Z5	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	10757717	J Nat Prod. 2000 Mar;63(3):352-6.	Lackner H, Bahner I, Shigematsu N, Pannell LK, Mauger AB.	Structures of five components of the actinomycin Z complex from Streptomyces fradiae, two of which contain 4-chlorothreonine	
DRAMP34561	RQIKIWFQNRRMKW	14	pAntp (43-56)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34562	RQIKIWFQNRRMK	13	pAntp (43-55)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34563	RQIKIWFQNRRM	12	pAntp (43-54)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34564	RQIKIWFQNRR	11	pAntp (43-53)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34565	RQIKIWFQNR	10	pAntp (43-52)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34566	RQIKIWFQN	9	pAntp (43-51)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34567	RQIKIWFQ	8	pAntp (43-50)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34568	RQIKIW	6	pAntp (43-48)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34569	QIKIWFQNRRMKWKK	15	pAntp (44-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34570	IKIWFQNRRMKWKK	14	pAntp (45-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34571	IWFQNRRMKWKK	12	pAntp (47-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34572	WFQNRRMKWKK	11	pAntp (48-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34573	QNRRMKWKK	9	pAntp (50-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34574	NRRMKWKK	8	pAntp (51-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34575	RMKWKK	6	pAntp (53-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34576	AQIKIWFQNRRMKWKK	16	Ala43 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34577	RAIKIWFQNRRMKWKK	16	Ala44 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34578	RQAKIWFQNRRMKWKK	16	Ala45 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34579	RQIAIWFQNRRMKWKK	16	Ala46 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34580	RQIKAWFQNRRMKWKK	16	Ala47 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34581	RQIKIAFQNRRMKWKK	16	Ala48 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34582	RQIKIWAQNRRMKWKK	16	Ala49 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34583	RQIKIWFANRRMKWKK	16	Ala50 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34584	RQIKIWFQARRMKWKK	16	Ala51 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34585	RQIKIWFQNARMKWKK	16	Ala52 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34586	RQIKIWFQNRAMKWKK	16	Ala53 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34587	RQIKIWFQNRRAKWKK	16	Ala54 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34588	RQIKIWFQNRRMAWKK	16	Ala55 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34589	RQIKIWFQNRRMKAKK	16	Ala56 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34590	RQIKIWFQNRRMKWAK	16	Ala57 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34591	RQIKIWFQNRRMKWKA	16	Ala58 substitution mutant of pAntp (43-58)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-beta-Alanine)	Amidation		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34592	CRQIKIWFPNRRMKWKKC	18	Reduced linear penetratin	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation (Labeled with Biotinyl-Ahx)	Unknown		L	Not available	Not available	10784032	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.	
DRAMP34593	PSSSSSSRIGDP	12	PreS2 3S Mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	EGFP	Free		L	Not available	Not available	10822301	J Pept Res. 2000 Feb;55(2):163-72.	Fischer PM, Zhelev NZ, Wang S, Melville JE, Fåhraeus R, Lane DP.	Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens.	
DRAMP34594	RKKRRQR	7	Tat (49-55)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34595	KKRRQRRR	8	Tat (50-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34596	KRRQRRR	7	Tat (51-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34597	rkkrrqrrr	9	D-Tat (49-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		D	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34598	rrrqrrkkr	9	D-Tat (57-49)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		D	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34599	AKKRRQRRR	9	Ala49 substitution mutant of Tat (49-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34600	RAKRRQRRR	9	Ala50 substitution mutant of Tat (49-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34601	RKARRQRRR	9	Ala51 substitution mutant of Tat (49-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34602	RKKARQRRR	9	Ala52 substitution mutant of Tat (49-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34603	RKKRAQRRR	9	Ala53 substitution mutant of Tat (49-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34604	RKKRRARRR	9	Ala54 substitution mutant of Tat (49-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34605	RKKRRQARR	9	Ala55 substitution mutant of Tat (49-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34606	RKKRRQRAR	9	Ala56 substitution mutant of Tat (49-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34607	RKKRRQRRA	9	Ala57 substitution mutant of Tat (49-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34608	RRRRRR	6	R6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		L	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34609	rrrrr	5	D-R5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		D	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34610	rrrrrrr	7	D-R7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		D	Not available	Not available	11087855	Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8	Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB.	The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.	
DRAMP34611	CQNHHAKHGKVC	12	FSEN	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	11311231	FEBS Lett. 2001 Apr 13;494(3):150-6. 	Tan DC, Kini RM, Jois SD, Lim DK, Xin L, Ge R.	A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
DRAMP34612	KCGHKHQCAVHN	12	scFSEN 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	11311231	FEBS Lett. 2001 Apr 13;494(3):150-6. 	Tan DC, Kini RM, Jois SD, Lim DK, Xin L, Ge R.	A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP34613	LVPLPKIKNSTFT	13	sFlt2-13	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	11311231	FEBS Lett. 2001 Apr 13;494(3):150-6. 	Tan DC, Kini RM, Jois SD, Lim DK, Xin L, Ge R.	A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP34614	MEPECNLNCTD	11	scFSEC	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	11311231	FEBS Lett. 2001 Apr 13;494(3):150-6. 	Tan DC, Kini RM, Jois SD, Lim DK, Xin L, Ge R.	A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor	CSCC[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O
DRAMP34615	NITVTLKKFPL	11	Flt2-11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	11311231	FEBS Lett. 2001 Apr 13;494(3):150-6. 	Tan DC, Kini RM, Jois SD, Lim DK, Xin L, Ge R.	A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP34616	RPFVEMYSEIPE	12	Flt1-12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	11311231	FEBS Lett. 2001 Apr 13;494(3):150-6. 	Tan DC, Kini RM, Jois SD, Lim DK, Xin L, Ge R.	A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP34617	SPNITVTLKKFPL	13	Flt2-13	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	11311231	FEBS Lett. 2001 Apr 13;494(3):150-6. 	Tan DC, Kini RM, Jois SD, Lim DK, Xin L, Ge R.	A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP34618	STNITVTLKKFPL	13	Flt2-13T	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	11311231	FEBS Lett. 2001 Apr 13;494(3):150-6. 	Tan DC, Kini RM, Jois SD, Lim DK, Xin L, Ge R.	A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP34619	akvkdepqrrsarlsakpappkpepkpkkapakk	34	D form of F3	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein with 6-aminohexanoic acid (Ahx) spacer	Free		D	Not available	Not available	12032302	 Proc Natl Acad Sci U S A. 2002 May 28;99(11):7444-9. 	Porkka K, Laakkonen P, Hoffman JA, Bernasconi M, Ruoslahti E.	A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo.	
DRAMP34620	PKKKRKVALWKTLLKKVLKA	20	PV-S4(13)	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	12119035	iochemistry. 2002 Jul 23;41(29):9208-14.	Hariton-Gazal E, Feder R, Mor A, Graessmann A, Brack-Werner R, Jans D, Gilon C, Loyter A.	Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals.	
DRAMP34621	VKRKKKPALWKTLLKKVLKA	20	PV reverse-S4(13)	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	12119035	iochemistry. 2002 Jul 23;41(29):9208-14.	Hariton-Gazal E, Feder R, Mor A, Graessmann A, Brack-Werner R, Jans D, Gilon C, Loyter A.	Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals.	
DRAMP34622	RQARRNRRRALWKTLLKKVLKA	22	RR-S4(13)	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	12119035	iochemistry. 2002 Jul 23;41(29):9208-14.	Hariton-Gazal E, Feder R, Mor A, Graessmann A, Brack-Werner R, Jans D, Gilon C, Loyter A.	Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals.	
DRAMP34623	RQARRNRRRC	10	Rev ARM	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	12119035	iochemistry. 2002 Jul 23;41(29):9208-14.	Hariton-Gazal E, Feder R, Mor A, Graessmann A, Brack-Werner R, Jans D, Gilon C, Loyter A.	Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals.	
DRAMP34624	GRKKRRQRRRPPQC	14	Tat ARM	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	12119035	iochemistry. 2002 Jul 23;41(29):9208-14.	Hariton-Gazal E, Feder R, Mor A, Graessmann A, Brack-Werner R, Jans D, Gilon C, Loyter A.	Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals.	
DRAMP34625	SKKKKTKV	8	TFIIE BETA	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	12204694	Chem Biol. 2002 Aug;9(8):943-8.	Ragin AD, Morgan RA, Chmielewski J.	Cellular import mediated by nuclear localization signal Peptide sequences.	
DRAMP34626	GKKKKRKREKL	11	TCF1-ALPHA	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	12204694	Chem Biol. 2002 Aug;9(8):943-8.	Ragin AD, Morgan RA, Chmielewski J.	Cellular import mediated by nuclear localization signal Peptide sequences.	
DRAMP34627	ERKKRRRE	8	HATF3	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	12204694	Chem Biol. 2002 Aug;9(8):943-8.	Ragin AD, Morgan RA, Chmielewski J.	Cellular import mediated by nuclear localization signal Peptide sequences.	
DRAMP34628	FKKFRKF	7	C.e SDC3	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	12204694	Chem Biol. 2002 Aug;9(8):943-8.	Ragin AD, Morgan RA, Chmielewski J.	Cellular import mediated by nuclear localization signal Peptide sequences.	
DRAMP34629	rggrlsysrrrfststgr	18	D-SynB1	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	NBD	Free		D	Not available	Not available	12783857	J Biol Chem. 2003 Aug 15;278(33):31192-201.	Drin G, Cottin S, Blanc E, Rees AR, Temsamani J. 	Studies on the internalization mechanism of cationic cell-penetrating peptides.	
DRAMP34630	RRLSYSRRRF	10	SynB3	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	NBD and TAMRA	Free		L	Not available	Not available	12783857	J Biol Chem. 2003 Aug 15;278(33):31192-201.	Drin G, Cottin S, Blanc E, Rees AR, Temsamani J. 	Studies on the internalization mechanism of cationic cell-penetrating peptides.	
DRAMP34631	rrlsysrrrf	10	D-SynB3	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	NBD	Free		D	Not available	Not available	12783857	J Biol Chem. 2003 Aug 15;278(33):31192-201.	Drin G, Cottin S, Blanc E, Rees AR, Temsamani J. 	Studies on the internalization mechanism of cationic cell-penetrating peptides.	
DRAMP34632	RGGRLAYLRRRWAVLGR	17	SynB5	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	NBD and TAMRA	Free		L	Not available	Not available	12783857	J Biol Chem. 2003 Aug 15;278(33):31192-201.	Drin G, Cottin S, Blanc E, Rees AR, Temsamani J. 	Studies on the internalization mechanism of cationic cell-penetrating peptides.	
DRAMP34633	KPLLKKLLKKL	11		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	14514057	Biotechnol Lett. 2003 Aug;25(16):1305-10.	Park Y, Lee DG, Hahm KS. 	Antibiotic activity of Leu-Lys rich model peptides	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP34634	KWKKLLKKPLKLKL	14		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	14514057	Biotechnol Lett. 2003 Aug;25(16):1305-10.	Park Y, Lee DG, Hahm KS. 	Antibiotic activity of Leu-Lys rich model peptides	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP34635	KWKLKPLLKKLLKKL	15		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	14514057	Biotechnol Lett. 2003 Aug;25(16):1305-10.	Park Y, Lee DG, Hahm KS. 	Antibiotic activity of Leu-Lys rich model peptides	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP34636	XFXFLXX	7	Scytalidamide B	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	14604342	J Org Chem. 2003 Nov 14;68(23):8767-73. 	Tan LT, Cheng XC, Jensen PR, Fenical W.	Scytalidamides A and B, new cytotoxic cyclic heptapeptides from a marine fungus of the genus Scytalidium	
DRAMP34637	VRLPPPVRLPPP	12	PolyP 2	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Free		L	Not available	Not available	15054781	Angew Chem Int Ed Engl. 2004 Mar 26;43(14):1811-4.	Fernández-Carneado J, Kogan MJ, Castel S, Giralt E.	Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.	
DRAMP34638	VRLPPPVRLPPPVRLPPP	18	PolyP 3 (SAP)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Free		L	Not available	Not available	15054781	Angew Chem Int Ed Engl. 2004 Mar 26;43(14):1811-4.	Fernández-Carneado J, Kogan MJ, Castel S, Giralt E.	Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.	
DRAMP34639	VHLPPP	6	PolyP 4	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Free		L	Not available	Not available	15054781	Angew Chem Int Ed Engl. 2004 Mar 26;43(14):1811-4.	Fernández-Carneado J, Kogan MJ, Castel S, Giralt E.	Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.	
DRAMP34640	VHLPPPVHLPPP	12	PolyP 5	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Free		L	Not available	Not available	15054781	Angew Chem Int Ed Engl. 2004 Mar 26;43(14):1811-4.	Fernández-Carneado J, Kogan MJ, Castel S, Giralt E.	Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.	
DRAMP34641	VHLPPPVHLPPPVHLPPP	18	PolyP 6	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Free		L	Not available	Not available	15054781	Angew Chem Int Ed Engl. 2004 Mar 26;43(14):1811-4.	Fernández-Carneado J, Kogan MJ, Castel S, Giralt E.	Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.	
DRAMP34642	VKLPPP	6	PolyP 7	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Free		L	Not available	Not available	15054781	Angew Chem Int Ed Engl. 2004 Mar 26;43(14):1811-4.	Fernández-Carneado J, Kogan MJ, Castel S, Giralt E.	Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.	
DRAMP34643	VKLPPPVKLPPP	12	PolyP 8	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Free		L	Not available	Not available	15054781	Angew Chem Int Ed Engl. 2004 Mar 26;43(14):1811-4.	Fernández-Carneado J, Kogan MJ, Castel S, Giralt E.	Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.	
DRAMP34644	VKLPPPVKLPPPVKLPPP	18	PolyP 9	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Free		L	Not available	Not available	15054781	Angew Chem Int Ed Engl. 2004 Mar 26;43(14):1811-4.	Fernández-Carneado J, Kogan MJ, Castel S, Giralt E.	Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.	
DRAMP34645	MAFLKKSLFLVLFLGLVSLSICEKEKRQNEEDEDENEAANHEEGSEEKRGLFDIVKKVVGAFGSLGKRNDLE	72	Aurein 2.5	Q5K0E4		Not found	Litoria aurea	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	15203252	Peptides. 2004 Jun;25(6):1035-54.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE. 	Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C)[C@H](C)CC
DRAMP34646	MAFLKKSLFLVLFLGLVSLSICEKEKRQNEEDEDENEAANHEEGSEEKRGLFDIVKKVVGALGSLGKRNDLE	72	Aurein 2.2	Q5K0E6		Not found	Litoria aurea	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	15203252	Peptides. 2004 Jun;25(6):1035-54.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE. 	Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C)[C@H](C)CC
DRAMP34647	MAFLKKSLFLVLFLGLVSLSICEKEKRQNGEDEDENEAANHEEGSEEKRGLFDIVKKVVGAIGSLGKRNDVE	72	Aurein 2.3	Q5K0E5		Not found	Litoria aurea	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	15203252	Peptides. 2004 Jun;25(6):1035-54.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE. 	Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C
DRAMP34648	GLLSVLGSVAKHVLGHVVGVIAEHL	25	Caerin 1.1 Modification	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	15203252	Peptides. 2004 Jun;25(6):1035-54.	Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE. 	Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP34649	HHPHGHHPHG	10	(HHPHG)2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Acetylation		L	Not available	Not available	15313924	Cancer Res. 2004 Aug 15;64(16):5812-7	Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.	Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities.	
DRAMP34650	HY	2	Cyclo(His-Tyr)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	15324483	J Pharm Pharmacol. 2004 Sep;56(9):1143-53.	McCleland K, Milne PJ, Lucieto FR, Frost C, Brauns SC, Van De Venter M, Du Plessis J, Dyason K. 	An investigation into the biological activity of the selected histidine-containing diketopiperazines cyclo(His-Phe) and cyclo(His-Tyr)	N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP34651	GSLPPIF	7	Dianthin D	Not available		Not found	Plantae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	15387653	J Nat Prod. 2004 Sep;67(9):1522-7	Hsieh PW, Chang FR, Wu CC, Wu KY, Li CM, Chen SL, Wu YC.	New cytotoxic cyclic peptides and dianthramide from Dianthus superbus	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP34652	GPISFV	6	Dianthin E	Not available		Not found	Plantae	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	15387653	J Nat Prod. 2004 Sep;67(9):1522-7	Hsieh PW, Chang FR, Wu CC, Wu KY, Li CM, Chen SL, Wu YC.	New cytotoxic cyclic peptides and dianthramide from Dianthus superbus	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP34653	GRPRESGKKRKRKRLKP	17	DPV6	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Cys addition	Free		L	Not available	Not available	15859953	Biochem J. 2005 Sep 1;390(Pt 2):407-18.	De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. 	Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.	
DRAMP34654	GKRKKKGKLGKKRPRSR	17	DPV7b	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Cys addition	Free		L	Not available	Not available	15859953	Biochem J. 2005 Sep 1;390(Pt 2):407-18.	De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. 	Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.	
DRAMP34655	RKKRRRESRRARRSPRHL	18	DPV3/10	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Cys addition	Free		L	Not available	Not available	15859953	Biochem J. 2005 Sep 1;390(Pt 2):407-18.	De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. 	Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.	
DRAMP34656	SRRARRSPRESGKKRKRKR	19	DPV10/6	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Cys addition	Free		L	Not available	Not available	15859953	Biochem J. 2005 Sep 1;390(Pt 2):407-18.	De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. 	Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.	
DRAMP34657	VKRGLKLRHVRPRVTRMDV	19	DPV1047	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Cys addition	Free		L	Not available	Not available	15859953	Biochem J. 2005 Sep 1;390(Pt 2):407-18.	De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. 	Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.	
DRAMP34658	SRRARRSPRHLGSG	14	DPV10	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Cys addition	Free		L	Not available	Not available	15859953	Biochem J. 2005 Sep 1;390(Pt 2):407-18.	De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. 	Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.	
DRAMP34659	LRRERQSRLRRERQSR	16	DPV15	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Cys addition	Free		L	Not available	Not available	15859953	Biochem J. 2005 Sep 1;390(Pt 2):407-18.	De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. 	Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.	
DRAMP34660	GAYDLRRRERQSRLRRRERQSR	22	DPV15b	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Cys addition	Free		L	Not available	Not available	15859953	Biochem J. 2005 Sep 1;390(Pt 2):407-18.	De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. 	Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.	
DRAMP34661	XXEXXXFLIILG	12	Laxaphycin A	Not available		Not found	Anabaena laxa	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	15875779	In Vivo. 2005 May-Jun;19(3):577-82.	Gbankoto A, Vigo J, Dramane K, Banaigs B, Aina E, Salmon JM. 	Cytotoxic effect of Laxaphycins A and B on human lymphoblastic cells (CCRF-CEM) using digitised videomicrofluorometry.	
DRAMP34662	GRKKRRQRRRPPQTYADFIASGRTGRRNAI	30	Tat-PKI	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free		L	Not available	Not available	15937518	Br J Pharmacol. 2005 Aug;145(8):1093-102.	Jones SW, Christison R, Bundell K, Voyce CJ, Brockbank SM, Newham P, Lindsay MA.	Characterisation of cell-penetrating peptide-mediated peptide delivery.	
DRAMP34663	AGYLLGKINLKALAALAKKILTYADFIASGRTGRRNAI	38	Transportan-PKI	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free		L	Not available	Not available	15937518	Br J Pharmacol. 2005 Aug;145(8):1093-102.	Jones SW, Christison R, Bundell K, Voyce CJ, Brockbank SM, Newham P, Lindsay MA.	Characterisation of cell-penetrating peptide-mediated peptide delivery.	
DRAMP34664	RRRRRRRRRRRTYADFIASGRTGRRNAI	28	R11-PKI	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free		L	Not available	Not available	15937518	Br J Pharmacol. 2005 Aug;145(8):1093-102.	Jones SW, Christison R, Bundell K, Voyce CJ, Brockbank SM, Newham P, Lindsay MA.	Characterisation of cell-penetrating peptide-mediated peptide delivery.	
DRAMP34665	IAWVKAFIRKLRKGPLG	17	YTA4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	16376307	Biochem Pharmacol. 2006 Feb 14;71(4):416-25.	Lindgren M, Rosenthal-Aizman K, Saar K, Eiríksdóttir E, Jiang Y, Sassian M, Ostlund P, Hällbrink M, Langel U. 	Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.	
DRAMP34666	GIPCGXSCVWIPCISSAIGCSCKSKVCYRN	30	[Glu(Me)]cyO2	P58434		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	2KNN	Not available	Tumor cells: U-937/GTB (IC50=36(32-40)μM)	Not available	Linear	Free	Free	X=Glu(Me)	L	Not available	Not available	16389447	Cell Mol Life Sci. 2006 Jan;63(2):235-45. 	Herrmann A, Svangård E, Claeson P, Gullbo J, Bohlin L, Göransson U. 	Key role of glutamic acid for the cytotoxic activity of the cyclotide cycloviolacin O2	
DRAMP34667	GIPCGESCVWIPCISSAIGCSCXSXVCYXN	30	([Lys(Ac)]2[Arg(CHD)])cyO2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U-937/GTB (IC50=5.1(4.8-5.5)μM)	Not available		Free	Free	X(24)=Lys(Ac)2; X(28)=ARG(CHD)	L	Not available	Not available	16389447	Cell Mol Life Sci. 2006 Jan;63(2):235-45.	Herrmann A, Svangård E, Claeson P, Gullbo J, Bohlin L, Göransson U.	Key role of glutamic acid for the cytotoxic activity of the cyclotide cycloviolacin O2	
DRAMP34668	GIACFLKE	8	TRAIL53-60	P50591		Not found	TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	16427631	FEBS Lett. 2006 Feb 6;580(3):885-9.	Okochi M, Nakanishi M, Kato R, Kobayashi T, Honda H.	High-throughput screening of cell death inducible short peptides from TNF-related apoptosis-inducing ligand sequence	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP34669	CWQVKWQL	8	TRAIL77-84	P50591		Not found	TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	16427631	FEBS Lett. 2006 Feb 6;580(3):885-9.	Okochi M, Nakanishi M, Kato R, Kobayashi T, Honda H.	High-throughput screening of cell death inducible short peptides from TNF-related apoptosis-inducing ligand sequence	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(C)C)C(=O)O
DRAMP34670	NTKNDKQM	8	TRAIL198–206	P50591		Not found	TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	16427631	FEBS Lett. 2006 Feb 6;580(3):885-9.	Okochi M, Nakanishi M, Kato R, Kobayashi T, Honda H.	High-throughput screening of cell death inducible short peptides from TNF-related apoptosis-inducing ligand sequence	CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(=O)O
DRAMP34671	SARNSCWS	8	TRAIL225-232	P50591		Not found	TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	16427631	FEBS Lett. 2006 Feb 6;580(3):885-9.	Okochi M, Nakanishi M, Kato R, Kobayashi T, Honda H.	High-throughput screening of cell death inducible short peptides from TNF-related apoptosis-inducing ligand sequence	C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP34672	RNSCWSKD	8	TRAIL227–234	P50591		Not found	TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	16427631	FEBS Lett. 2006 Feb 6;580(3):885-9.	Okochi M, Nakanishi M, Kato R, Kobayashi T, Honda H.	High-throughput screening of cell death inducible short peptides from TNF-related apoptosis-inducing ligand sequence	N=C(N)NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP34673	GKYVSLTTPKNPTKRRITPKDV	22	Inv2, rMce1a (13-34)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34674	TKRRITPKDVIDVRSVTTEINT	22	Inv3, rMce1a (25-46)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34675	RSVTTEINTLFQTLTSIAEKVDP	23	Inv4, rMce1a (38-60)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34676	VNADIKATTVFGGKYVSLTTPKNPTKRRITPKDVIDVRSVTTEINTLFQTLTSIAEKVDP	60	Inv5, rMce1a (1-60)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34677	AEKVDPVKLNLTLSAAAEALTGLGDK	26	Inv6, rMce1a (56-80)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34678	GLGDKFGESIVNANTVLDDLNSRMPQSRHDIQQL	34	Inv7, rMce1a (76-109)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34679	GDVYADAAPDLFDFLDSSVTTARTINA	27	Inv8, rMce1a (113-139)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34680	ARTINAQQAELDSALLAAAGFGNTTADVFDRG	32	Inv9, rMce1a (134-166)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34681	ADVFDRGGPYLQRGVADLVPTATLLDTYSP	30	Inv10, rMce1a (159-188)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34682	LDTYSPELFCTIRNFYDADRPDRGAAA	27	Inv11, rMce1a (189-209)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34683	TKRRITPDDVIDVRSVTTEINT	22	Inv3.3	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34684	TKRRITPKKVIDVRSVTTEINT	22	Inv3.4	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34685	TKRRITPKDVIDVRSVTTKINT	22	Inv3.5	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34686	TKRRITPKDVIDV	13	Inv3.6	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34687	TKRRITPKDVIDVESVTTEINT	22	Inv3.7	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34688	TARRITPKDVIDVRSVTTEINT	22	Inv3.8	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34689	TKAARITPKDVIDVRSVTTEINT	23	Inv3.9	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34690	HHHHHHTKRRITPKDVIDVRSVTTEINT	28	Inv3.10	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free (peptide coated FITC labelled microspheres)	Free		L	Not available	Not available	16620748	Anal Biochem. 2006 Jun 1;353(1):7-14.	Lu S, Tager LA, Chitale S, Riley LW. 	A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.	
DRAMP34691	YSX	3	9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free	X=Cα -dialkylated glycine (Aaa2,2 )	L	Not available	Not available	16722632	Cancer Res. 2004 Aug 15;64(16):5812-7.	Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.	
DRAMP34692	YSXG	4	15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free	X=Cα -dialkylated glycine (Aaa2,2 )	L	Not available	Not available	16722632	Cancer Res. 2004 Aug 15;64(16):5812-7.	Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.	
DRAMP34693	YXGFM	5	17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HBL (0.8% inhibition at 1μM, 1.4% inhibition at 10μM, 2.4% inhibition at 100μM, 18.3% inhibition at 1000μM); HEp-2 (1% inhibition at 1μM, 10.1% inhibition at 10μM, 16.8% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.2% inhibition at 1μM, 15.5% inhibition at 10μM, 24.7% inhibition at 100μM, 29% inhibition at 1000μM); MCF-7 (22.8% inhibition at 1000μM); CaCo-2 (3% inhibition at 1μM, 8.4% inhibition at 10μM, 18.5% inhibition at 100μM, 10.6% inhibition at 1000μM); HT-29 (3.3% inhibition at 1μM, 11% inhibition at 10μM, 7.9% inhibition at 100μM, 23.7% inhibition at 1000μM); HeLa (4.9% inhibition at 1μM, 10.2% inhibition at 10μM, 13.3% inhibition at 100μM, 28% inhibition at 1000μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,2 )	L	Not available	Not available	16722632	Cancer Res. 2004 Aug 15;64(16):5812-7.	Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.	
DRAMP34694	YXGFM	5	17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HEp-2 (13.7% inhibition at 1μM, 25.8% inhibition at 10μM, 34.7% inhibition at 100μM, 44.5% inhibition at 1000μM); HT-29 (16.2% inhibition at 1μM, 6.6% inhibition at 10μM, 5.1% inhibition at 100μM, 14.5% inhibition at 1000μM); CaCo-2 (17.7% inhibition at 1μM, 10.9% inhibition at 10μM, 12.1% inhibition at 100μM, 8.1% inhibition at 1000μM); HBL (2.4% inhibition at 1μM, 4.5% inhibition at 10μM, 11.4% inhibition at 100μM, 23.2% inhibition at 1000μM); SW620 (26.4% inhibition at 1μM, 13.1% inhibition at 10μM, 14.6% inhibition at 100μM, 38.4% inhibition at 1000μM); HeLa (8.5% inhibition at 1μM, 9.5% inhibition at 10μM, 15.4% inhibition at 100μM, 24.1% inhibition at 1000μM); MCF-7 (9.6% inhibition at 100μM, 29.9% inhibition at 100μM)	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,2 )	L	Not available	Not available	16722632	Cancer Res. 2004 Aug 15;64(16):5812-7.	Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.	
DRAMP34695	YXGFM	5	17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Cα -dialkylated glycine (Aaa2,2 )	L	Not available	Not available	16722632	Cancer Res. 2004 Aug 15;64(16):5812-7.	Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.	Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.	
DRAMP34696	CDSDSDITWDQLWDLMK	17	E-selectin-binding peptide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	17121909	Mol Cancer Ther. 2006 Nov;5(11):2624-33. 	Cai W, Rao J, Gambhir SS, Chen X. 	How molecular imaging is speeding up antiangiogenic drug development	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
DRAMP34697	FLKDHRISTFKNWPF	15	hsurvivin	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	17142738	 J Immunol. 2006 Dec 15;177(12):8410-21.	Charalambous A, Oks M, Nchinda G, Yamazaki S, Steinman RM. 	Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP34698	RGdFV	5		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	1718779	FEBS Lett. 1991 Oct 7;291(1):50-4.	Aumailley M, Gurrath M, Müller G, Calvete J, Timpl R, Kessler H. 	Arg-Gly-Asp constrained within cyclic pentapeptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1	CC(C)[C@H](NC(=O)C[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)O
DRAMP34699	RGDfV	5		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	1718779	FEBS Lett. 1991 Oct 7;291(1):50-4.	Aumailley M, Gurrath M, Müller G, Calvete J, Timpl R, Kessler H. 	Arg-Gly-Asp constrained within cyclic pentapeptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1	CC(C)[C@H](NC(=O)C[C@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](Cc1ccccc1)C(=O)O)C(=O)O
DRAMP34700	RGDFv	5		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	1718779	FEBS Lett. 1991 Oct 7;291(1):50-4.	Aumailley M, Gurrath M, Müller G, Calvete J, Timpl R, Kessler H. 	Arg-Gly-Asp constrained within cyclic pentapeptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1	CC(C)[C@@H](NC(=O)C[C@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)O
DRAMP34701	GRGDS	5		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	1718779	FEBS Lett. 1991 Oct 7;291(1):50-4.	Aumailley M, Gurrath M, Müller G, Calvete J, Timpl R, Kessler H. 	Arg-Gly-Asp constrained within cyclic pentapeptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1	N=C(N)NCCC[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O
DRAMP34702	GSPWGLQHHPPRT	13	439A peptide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Free		L	Not available	Not available	17268054	Biol Pharm Bull. 2007 Feb;30(2):218-23.	Kamada H, Okamoto T, Kawamura M, Shibata H, Abe Y, Ohkawa A, Nomura T, Sato M, Mukai Y, Sugita T, Imai S, Nagano K, Tsutsumi Y, Nakagawa S, Mayumi T, Tsunoda S.	Creation of novel cell-penetrating peptides for intracellular drug delivery using systematic phage display technology originated from Tat transduction domain.	
DRAMP34703	RCSCWSDK	8	TRAIL227–234[N2C]	Not available		Not found	TRAIL227–234	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	17822671	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Screening of a novel octamer peptide, CNSCWSKD, that induces caspase-dependent cell death	N=C(N)NCCC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP34704	RKSCWSKD	8	TRAIL227–234[N2K]	Not available		Not found	TRAIL227–234	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	17822671	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Screening of a novel octamer peptide, CNSCWSKD, that induces caspase-dependent cell death	N=C(N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP34705	RNDCWSKD	8	TRAIL227–234[S3D]	Not available		Not found	TRAIL227–234	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	17822671	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Screening of a novel octamer peptide, CNSCWSKD, that induces caspase-dependent cell death	N=C(N)NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP34706	RNLCWSKD	8	TRAIL227–234[S3L]	Not available		Not found	TRAIL227–234	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	17822671	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Screening of a novel octamer peptide, CNSCWSKD, that induces caspase-dependent cell death	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP34707	RNNCWSKD	8	TRAIL227–234[S3N]	Not available		Not found	TRAIL227–234	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	17822671	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Screening of a novel octamer peptide, CNSCWSKD, that induces caspase-dependent cell death	N=C(N)NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP34708	RNSCRSKD	8	TRAIL227–234[W5R]	Not available		Not found	TRAIL227–234	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	17822671	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Screening of a novel octamer peptide, CNSCWSKD, that induces caspase-dependent cell death	N=C(N)NCCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP34709	RNSCWSKN	8	TRAIL227–234[D8N]	Not available		Not found	TRAIL227–234	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Induce cell death	Not available	Not available	Linear	Free	Free		L	Not available	Not available	17822671	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Kaga C, Okochi M, Nakanishi M, Hayashi H, Kato R, Honda H. 	Screening of a novel octamer peptide, CNSCWSKD, that induces caspase-dependent cell death	N=C(N)NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP34710	FVTRGCPRRLVARLIRVMVPRR	22	ARF(1-22) scr	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	17984975	Mol Ther. 2008 Jan;16(1):115-23. 	Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel U. 	Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein.	
DRAMP34711	VRRFLVTLRIRRA	13	ARF(2-14)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	17984975	Mol Ther. 2008 Jan;16(1):115-23. 	Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel U. 	Characterization of a novel cytotoxic cell-penetrating peptide derived from p15ARF protein.	
DRAMP34712	RVRILARFLRTRV	13	ARF(2-14) scr	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	17984975	Mol Ther. 2008 Jan;16(1):115-23. 	Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel U. 	Characterization of a novel cytotoxic cell-penetrating peptide derived from p16ARF protein.	
DRAMP34713	RVRVFVVHIPRLT	13	ARF(19-31)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	17984975	Mol Ther. 2008 Jan;16(1):115-23. 	Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel U. 	Characterization of a novel cytotoxic cell-penetrating peptide derived from p17ARF protein.	
DRAMP34714	VIRVHFRLPVRTV	13	ARF(19-31) scr	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	17984975	Mol Ther. 2008 Jan;16(1):115-23. 	Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel U. 	Characterization of a novel cytotoxic cell-penetrating peptide derived from p18ARF protein.	
DRAMP34715	MVRRFLVTLRIRRACGPPRVRVFVVHIPRLTGEWAAP	37	ARF(1-37)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	17984975	Mol Ther. 2008 Jan;16(1):115-23. 	Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel U. 	Characterization of a novel cytotoxic cell-penetrating peptide derived from p19ARF protein.	
DRAMP34716	FRVPLRIRPCVVAPRLVMVRHTFGRIARWVAGPLETR	37	ARF(1-37) scr	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	fluorescein	Amidation		L	Not available	Not available	17984975	Mol Ther. 2008 Jan;16(1):115-23. 	Johansson HJ, El-Andaloussi S, Holm T, Mäe M, Jänes J, Maimets T, Langel U. 	Characterization of a novel cytotoxic cell-penetrating peptide derived from p20ARF protein.	
DRAMP34717	FC	2	Cyclo(Phe-Cys) 	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	18436344	Peptides. 2008 Aug;29(8):1305-11.	van der Merwe E, Huang D, Peterson D, Kilian G, Milne PJ, Van de Venter M, Frost C. 	The synthesis and anticancer activity of selected diketopiperazines	N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O
DRAMP34718	ASWSACSVSCGGGARQRTR	19	Fibulostatin-6.2	Not available		Not found	Homo sapiens (Fibulin-6)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP34719	ATPFIECSGARGTCHYFAN	19	Hexastatin-1	Not available		Not found	Homo sapiens (α6 CIV)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O
DRAMP34720	FCNINNVCNFASRNDYSYW	19	Pentastatin-2	Not available		Not found	Homo sapiens (α5 CIV)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
DRAMP34721	GPWAPCSASCGGGSQSRS	18	Papilostatin-1	Not available		Not found	Homo sapiens (Papilin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O
DRAMP34722	GPWEDCSVSCGGGEQLRSR	19	Scospondistatin	Not available		Not found	Homo sapiens (SCO-spondin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CN)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34723	GPWEPCSVTCSKGTRTRRR	19	Properdistatin	Not available		Not found	Homo sapiens (Properdin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	CD36	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP34724	GPWERCTAQCGGGIQARRR	19	Semastatin-5A.1	Not available		Not found	Homo sapiens (Sema 5A)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34725	GPWGDCSRTCGGGVQFSSR	19	Adamtsostatin-4	Not available		Not found	Homo sapiens (ADAMTS-4)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34726	GPWGPCSGSCGPGRRLRRR	19	Cartilostatin-2	Not available		Not found	Homo sapiens (CILP-2)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34727	LPRFSTMPFIYCNINEVCHY	20	Hexastatin-3	Not available		Not found	Homo sapiens (α6 CIV)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
DRAMP34728	LPVFSTLPFAYCNIHQVCH	19	Tetrastatin-1	Not available		Not found	Homo sapiens (α4 CIV)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
DRAMP34729	LRRFSTMPFMFCNINNVCNF	20	Pentastatin-1	Not available		Not found	Homo sapiens (α5 CIV)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	αvβ3, αvβ1	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP34730	QPWGTCSESCGKGTQTRAR	19	Fibulostatin-6.3	Not available		Not found	Homo sapiens (Fibulin-6)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34731	QPWSQCSATCGDGVRERRR	19	Thrombostatin con-1	Not available		Not found	Homo sapiens (TSRC-1)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34732	SAPFIECHGRGTCNYYANS	19	Pentastatin-3	Not available		Not found	Homo sapiens (α5 CIV)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP34733	SAWRACSVTCGKGIQKRSR	19	Fibulostatin-6.1	Not available		Not found	Homo sapiens (Fibulin-6)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34734	SEWSDCSVTCGKGMRTRQR	19	Spondinstatin-1	Not available		Not found	Homo sapiens (F-spondin )	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CSCC[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP34735	SKWSECSRTCGGGVKFQER	19	Adamtsostatin-18	Not available		Not found	Homo sapiens (ADAMTS-18)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34736	SPWSKCSAACGQTGVQTRTR	20	Cartilostatin-1	Not available		Not found	Homo sapiens (CILP-1)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP34737	SPWSPCSGNCSTGKQQRTR	19	Thrombostatin con-3	Not available		Not found	Homo sapiens (TSRC-3)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	C[C@@H](O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP34738	SPWSPCSTSCGLGVSTR	17	Wispostatin-1	Not available		Not found	Homo sapiens (WISP-1)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C
DRAMP34739	SPWSQCSVRCGRGQRSRQVR	20	Adamtsostatin-like-4	Not available		Not found	Homo sapiens (TSRC1)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34740	SPWSQCTASCGGGVQTR	17	Adamtsostatin-16	Not available		Not found	Homo sapiens (ADAMTS-16)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP34741	SPWTKCSATCGGGHYMRTR	19	Semastatin-5A.2	Not available		Not found	Homo sapiens (Sema 5A)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP34742	SQWSPCSRTCGGGVSFRER	19	Papilostatin-2	Not available		Not found	Homo sapiens (Papilin)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34743	TAWGPCSTTCGLGMATRV	18	Wispostatin-2	Not available		Not found	Homo sapiens (WISP-2)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CSCC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O
DRAMP34744	TEWSACNVRCGRGWQKRSR	19	Netrinstatin-5D	Not available		Not found	Homo sapiens (UNC-5D)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34745	TEWSACSKTCGMGISTRV	18	Connectostatin	Not available		Not found	Homo sapiens (CTGF)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O
DRAMP34746	TEWSVCNSRCGRGYQKRTR	19	Netrinstatin-5C	Not available		Not found	Homo sapiens (UNC-5C)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP34747	TEWTACSKSCGMGFSTRV	18	Nephroblastostatin	Not available		Not found	Homo sapiens (NOVH)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CSCC[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O
DRAMP34748	TKWTPCSRTCGMGISNRV	18	Wispostatin-3	Not available		Not found	Homo sapiens (WISP-3)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP34749	TLPFAYCNIHQVCHYAQRNDRSYWL	25	Tetrastatin-2	Not available		Not found	Homo sapiens (α4 CIV)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	αvβ3	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP34750	TQWTSCSKTCNSGTQSRHR	19	Complestatin-C6	Not available		Not found	Homo sapiens (Complement comp. C6)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP34751	TSWSPCSASCGGGHYQRTR	19	Semastatin-5B	Not available		Not found	Homo sapiens (Sema 5B)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP34752	TSWSQCSKTCGTGISTRV	18	Cyrostatin 	Not available		Not found	Homo sapiens (CYR61)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O
DRAMP34753	WTRCSSSCGRGVSVRSR	17	Thrombostatin con-6	Not available		Not found	Homo sapiens (TSRC-6)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC(C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP34754	YCNINEVCHYARRNDKSYWL	20	Hexastatin-2	Not available		Not found	Homo sapiens (α6 CIV)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	18780781	Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13775-80. 	Karagiannis ED, Popel AS. 	A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP34755	KKKFPWWWPFKKKKKKFPWWWPFKKKK	27	di-PST13-RK-K	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	18815734	Biotechnol Lett. 2009 Feb;31(2):233-7.	Yang ST, Kim JI, Shin SY. 	Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity.	NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O
DRAMP34756	GSGKKGGKKICQKY	14	D form of (1-9)-(38-42) Crot	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free		L	Not available	Not available	18983137	J Med Chem. 2008 Nov 27;51(22):7041-4.	Rádis-Baptista G, de la Torre BG, Andreu D.	A novel cell-penetrating peptide sequence derived by structural minimization of a snake toxin exhibits preferential nucleolar localization.	
DRAMP34757	xVXvxVXvxVXv	12	Valinomycin	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	x=R-Hiv; X=S-lactic acid-S-Val	Mix	Not available	Not available	19226154	 J Nat Prod. 2009 Mar 27;72(3):366-71. 	Pettit GR, Knight JC, Herald DL, Pettit RK, Hogan F, Mukku VJ, Hamblin JS, Dodson MJ, Chapuis JC.	Antineoplastic agents 570 Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris	
DRAMP34758	xVXvxVXvxVXv	12	Valinomycin	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	x=R-Hiv; X=S-lactic acid-S-Val	Mix	Not available	Not available	19226154	 J Nat Prod. 2009 Mar 27;72(3):366-71. 	Pettit GR, Knight JC, Herald DL, Pettit RK, Hogan F, Mukku VJ, Hamblin JS, Dodson MJ, Chapuis JC.	Antineoplastic agents 570 Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris	
DRAMP34759	xVXvxVXvxVXv	12	Valinomycin	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	x=R-Hiv; X=S-lactic acid-S-Val	Mix	Not available	Not available	19226154	 J Nat Prod. 2009 Mar 27;72(3):366-71. 	Pettit GR, Knight JC, Herald DL, Pettit RK, Hogan F, Mukku VJ, Hamblin JS, Dodson MJ, Chapuis JC.	Antineoplastic agents 570 Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris	
DRAMP34760	XTXPX	5	Desacetylmicrocolin B	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	DiMe-C8	Free		L	Not available	Not available	19431099	 Planta Med. 2009 Oct;75(13):1427-30.	Meickle T, Matthew S, Ross C, Luesch H, Paul V.	Bioassay-guided isolation and identification of desacetylmicrocolin B from Lyngbya cf polychroa	
DRAMP34761	FFSLLPSLIGGLVSAIK	17	Imcroporin 	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	19451300	Antimicrob Agents Chemother. 2009 Aug;53(8):3472-7.	Zhao Z, Ma Y, Dai C, Zhao R, Li S, Wu Y, Cao Z, Li W. 	Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP34762	YTMNPRKLFDY	11	KV11	Not available		Not found	Kringle 5	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	cSrc ERK	19515999	Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5384-95. 	Zhao H, Jin H, Li Q, Gu Q, Zheng Z, Wu H, Ye S, Sun X, Xu X, Ho PC.	Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a)	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP34763	FPVPLPI	7	Rolloamide A	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	19583251	J Nat Prod. 2009 Jul;72(7):1253-7. 	Williams DE, Yu K, Behrisch HW, Van Soest R, Andersen RJ. 	Rolloamides A and B, cytotoxic cyclic heptapeptides isolated from the Caribbean marine sponge Eurypon laughlini	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)O
DRAMP34764	TRQARRNRRRRWRERQRGC	19	HIV-1 Rev (34-50)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	Conjugation with Alexa 488 at glycyl cysteine sequence	L	Not available	Not available	19707187	Mol Ther. 2009 Nov;17(11):1868-76.	Nakase I, Hirose H, Tanaka G, Tadokoro A, Kobayashi S, Takeuchi T, Futaki S.	Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis.	
DRAMP34765	RRRRNRTRRNRRRVRGC	17	FHV coat (35-49)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	Conjugation with Alexa 488 at glycyl cysteine sequence	L	Not available	Not available	19707187	Mol Ther. 2009 Nov;17(11):1868-77.	Nakase I, Hirose H, Tanaka G, Tadokoro A, Kobayashi S, Takeuchi T, Futaki S.	Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis.	
DRAMP34766	KMTRAQRRAAARRNRWTARGC	21	BMV Gag (7-25)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	Conjugation with Alexa 488 at glycyl cysteine sequence	L	Not available	Not available	19707187	Mol Ther. 2009 Nov;17(11):1868-78.	Nakase I, Hirose H, Tanaka G, Tadokoro A, Kobayashi S, Takeuchi T, Futaki S.	Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis.	
DRAMP34767	TRRQRTRRARRNRGC	15	HTLV-II Rex (4-16)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	Conjugation with Alexa 488 at glycyl cysteine sequence	L	Not available	Not available	19707187	Mol Ther. 2009 Nov;17(11):1868-79.	Nakase I, Hirose H, Tanaka G, Tadokoro A, Kobayashi S, Takeuchi T, Futaki S.	Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis.	
DRAMP34768	RIKAERKRMRNRIAASKSRKRKLERIARGC	30	Human cJun (252-279)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	Conjugation with Alexa 488 at glycyl cysteine sequence	L	Not available	Not available	19707187	Mol Ther. 2009 Nov;17(11):1868-80.	Nakase I, Hirose H, Tanaka G, Tadokoro A, Kobayashi S, Takeuchi T, Futaki S.	Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis.	
DRAMP34769	KRRIRRERNKMAAAKSRNRRRELTDTGC	28	Human cFos (139-164)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	Conjugation with Alexa 488 at glycyl cysteine sequence	L	Not available	Not available	19707187	Mol Ther. 2009 Nov;17(11):1868-81.	Nakase I, Hirose H, Tanaka G, Tadokoro A, Kobayashi S, Takeuchi T, Futaki S.	Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis.	
DRAMP34770	GGGARKKAAKAARKKAAKAARKKAAKAARKKAAKA	35	POD	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	GFP		L	Not available	Not available	19733192	Vision Res. 2010 Mar 31;50(7):686-97. 	Johnson LN, Cashman SM, Read SP, Kumar-Singh R	Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin.	
DRAMP34771	ATPFVPP	7	Euryjanicin B	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	19743810	J Nat Prod. 2009 Sep;72(9):1555-62.	Vera B, Vicente J, Rodríguez AD.	Isolation and structural elucidation of euryjanicins B-D, proline-containing cycloheptapeptides from the Caribbean marine sponge Prosuberites laughlini	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O
DRAMP34772	LFPXSXP	7	Euryjanicin C	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	19743810	J Nat Prod. 2009 Sep;72(9):1555-63.	Vera B, Vicente J, Rodríguez AD.	Isolation and structural elucidation of euryjanicins B-D, proline-containing cycloheptapeptides from the Caribbean marine sponge Prosuberites laughlini	
DRAMP34773	FPXFSPX	7	Euryjanicin D	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	19743810	J Nat Prod. 2009 Sep;72(9):1555-64.	Vera B, Vicente J, Rodríguez AD.	Isolation and structural elucidation of euryjanicins B-D, proline-containing cycloheptapeptides from the Caribbean marine sponge Prosuberites laughlini	
DRAMP34774	WPISFVP	7	Euryjanicin A	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	19743810	J Nat Prod. 2009 Sep;72(9):1555-65.	Vera B, Vicente J, Rodríguez AD.	Isolation and structural elucidation of euryjanicins B-D, proline-containing cycloheptapeptides from the Caribbean marine sponge Prosuberites laughlini	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C
DRAMP34775	IIILPPXP	8	Dominicin	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	19743810	J Nat Prod. 2009 Sep;72(9):1555-66.	Vera B, Vicente J, Rodríguez AD.	Isolation and structural elucidation of euryjanicins B-D, proline-containing cycloheptapeptides from the Caribbean marine sponge Prosuberites laughlini	
DRAMP34776	AXXlXX	6	Bisebromoamide	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	PivOH	Free		Mix	Not available	Not available	19803465	 Org Lett. 2009 Nov 5;11(21):5062-5.	Teruya T, Sasaki H, Fukazawa H, Suenaga K.	Bisebromoamide, a potent cytotoxic peptide from the marine cyanobacterium Lyngbya sp: isolation, stereostructure, and biological activity	
DRAMP34777	XsfATX	6	Sclerotide B	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	19827766	Org Lett. 2009 Nov 19;11(22):5262-5. 	Zheng J, Zhu H, Hong K, Wang Y, Liu P, Wang X, Peng X, Zhu W.	Novel cyclic hexapeptides from marine-derived fungus, Aspergillus sclerotiorum PT06-1	
DRAMP34778	KCFQWQRNMRKVRGPPVSC	19	M1	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	19858187	J Biol Chem. 2009 Dec 25;284(52):36099-36108.	Duchardt F, Ruttekolk IR, Verdurmen WPR, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DWPM, Vuister GW, Ulrich A, de Waard M, Brock R.	A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.	
DRAMP34779	KCFQWQRNMRKVRGPPVSSIKR	22	M2	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	19858187	J Biol Chem. 2009 Dec 25;284(52):36099-36109.	Duchardt F, Ruttekolk IR, Verdurmen WPR, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DWPM, Vuister GW, Ulrich A, de Waard M, Brock R.	A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.	
DRAMP34780	KCFQWQRNMRKVR	13	M3	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	19858187	J Biol Chem. 2009 Dec 25;284(52):36099-36110.	Duchardt F, Ruttekolk IR, Verdurmen WPR, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DWPM, Vuister GW, Ulrich A, de Waard M, Brock R.	A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.	
DRAMP34781	QWQRNMRKVRGPPVSCIKR	19	M5	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	19858187	J Biol Chem. 2009 Dec 25;284(52):36099-36111.	Duchardt F, Ruttekolk IR, Verdurmen WPR, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DWPM, Vuister GW, Ulrich A, de Waard M, Brock R.	A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.	
DRAMP34782	QWQRNMRKVR	10	M6	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	19858187	J Biol Chem. 2009 Dec 25;284(52):36099-36112.	Duchardt F, Ruttekolk IR, Verdurmen WPR, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DWPM, Vuister GW, Ulrich A, de Waard M, Brock R.	A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.	
DRAMP34783	KCFMWQEMLNKAGVPKLRCARK	22	rLF	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	19858187	J Biol Chem. 2009 Dec 25;284(52):36099-36113.	Duchardt F, Ruttekolk IR, Verdurmen WPR, Lortat-Jacob H, Bürck J, Hufnagel H, Fischer R, van den Heuvel M, Löwik DWPM, Vuister GW, Ulrich A, de Waard M, Brock R.	A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.	
DRAMP34784	KLWMRWYSPTTRRYG	15	No.14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Carboxyfluorescein	Free		L	Not available	Not available	19956900	Int J Mol Med. 2010 Jan;25(1):41-51. 	Kamide K, Nakakubo H, Uno S, Fukamizu A.	Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.	
DRAMP34785	RTLVNEYKNTLKFSK	15	No.63	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Carboxyfluorescein	Free		L	Not available	Not available	19956900	Int J Mol Med. 2010 Jan;25(1):41-52. 	Kamide K, Nakakubo H, Uno S, Fukamizu A.	Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.	
DRAMP34786	IPSRWKDQFWKRWHY	15	No.143	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Carboxyfluorescein	Free		L	Not available	Not available	19956900	Int J Mol Med. 2010 Jan;25(1):41-53. 	Kamide K, Nakakubo H, Uno S, Fukamizu A.	Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.	
DRAMP34787	GYGNCRHFKQKPRRD	15	No. 440	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Carboxyfluorescein	Free		L	Not available	Not available	19956900	Int J Mol Med. 2010 Jan;25(1):41-54. 	Kamide K, Nakakubo H, Uno S, Fukamizu A.	Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.	
DRAMP34788	KNAWKHSSCHHRHQI	15	No. 2028	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Carboxyfluorescein	Free		L	Not available	Not available	19956900	Int J Mol Med. 2010 Jan;25(1):41-55. 	Kamide K, Nakakubo H, Uno S, Fukamizu A.	Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.	
DRAMP34789	RVREWWYTITLKQES	15	No. 2175	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Carboxyfluorescein	Free		L	Not available	Not available	19956900	Int J Mol Med. 2010 Jan;25(1):41-56. 	Kamide K, Nakakubo H, Uno S, Fukamizu A.	Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.	
DRAMP34790	QQHLLIAINGYPRYN	15	No. 2510	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Carboxyfluorescein	Free		L	Not available	Not available	19956900	Int J Mol Med. 2010 Jan;25(1):41-57. 	Kamide K, Nakakubo H, Uno S, Fukamizu A.	Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.	
DRAMP34791	WKCRRQCFRVLHHWN	15	JF06	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Carboxyfluorescein	Free		L	Not available	Not available	19956900	Int J Mol Med. 2010 Jan;25(1):41-58. 	Kamide K, Nakakubo H, Uno S, Fukamizu A.	Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.	
DRAMP34792	AAQYVXX	7	Cordycommunin	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	20028029	J Nat Prod. 2010 Jan;73(1):75-8. 	Haritakun R, Sappan M, Suvannakad R, Tasanathai K, Isaka M.	An antimycobacterial cyclodepsipeptide from the entomopathogenic fungus Ophiocordyceps communis BCC 16475	
DRAMP34793	DDDDDNDKIPDDRDN	15	TSP-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	20056600	J Biol Chem. 2010 Mar 19;285(12):8733-42. 	Colombo G, Margosio B, Ragona L, Neves M, Bonifacio S, Annis DS, Stravalaci M, Tomaselli S, Giavazzi R, Rusnati M, Presta M, Zetta L, Mosher DF, Ribatti D, Gobbi M, Taraboletti G.	Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP34794	KWFETWFTEWPKKRK	15	Pep-3	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Cysteamide		L	Not available	Not available	20188697	Biochim Biophys Acta. 2010 Dec;1798(12):2274-85.	Kurzawa L, Pellerano M, Morris MC. 	PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.	
DRAMP34795	GLWWRLWWRLRSWFRLWFRA	20	CADY2	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Cysteamide		L	Not available	Not available	20188697	Biochim Biophys Acta. 2010 Dec;1798(12):2274-86.	Kurzawa L, Pellerano M, Morris MC. 	PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.	
DRAMP34796	ECKFTVKPYLKRFQVYYKGRMWCP	24	SALF	Not available		Not found	Penaeus monodon	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	SALF can induce apoptotic gene expressions, enhance antitumor activity of cisplatin in vitro, and inhibit tumor growth in nude mice.	Tumor cells: HeLa (65% Inhibition=100μg/ml)	Not available	Cyclic	Acetylation	Amidation		L	Not available	Not available	20214941	Peptides. 2010 Jun;31(6):1019-25. 	Lin MC, Lin SB, Chen JC, Hui CF, Chen JY.	Shrimp anti-lipopolysaccharide factor peptide enhances the antitumor activity of cisplatin in vitro and inhibits HeLa cells growth in nude mice	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(C)=O)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(N)=O
DRAMP34797	IVRRADRAAVP	11	ES-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	20515045	Bioconjug Chem. 2010 Jul 21;21(7):1142-7. 	Yin R, Zheng H, Xi T, Xu HM. 	Effect of RGD-4C position is more important than disulfide bonds on antiangiogenic activity of RGD-4C modified endostatin derived synthetic polypeptide.	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
DRAMP34798	XIIFPXPLPINAI	13	Callyaerin D	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	20599387	Bioorg Med Chem. 2010 Jul 15;18(14):4947-56. 	Ibrahim SR, Min CC, Teuscher F, Ebel R, Kakoschke C, Lin W, Wray V, Edrada-Ebel R, Proksch P.	Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa.	
DRAMP34799	XLPFFPPVPIIG	12	Callyaerin E	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	20599387	Bioorg Med Chem. 2010 Jul 15;18(14):4947-57. 	Ibrahim SR, Min CC, Teuscher F, Ebel R, Kakoschke C, Lin W, Wray V, Edrada-Ebel R, Proksch P.	Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa.	
DRAMP34800	XLPPPPLPFFF	11	Callyaerin G	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	20599387	Bioorg Med Chem. 2010 Jul 15;18(14):4947-58. 	Ibrahim SR, Min CC, Teuscher F, Ebel R, Kakoschke C, Lin W, Wray V, Edrada-Ebel R, Proksch P.	Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa.	
DRAMP34801	XVPVFPPLFI	10	Callyaerin F	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	20599387	Bioorg Med Chem. 2010 Jul 15;18(14):4947-59. 	Ibrahim SR, Min CC, Teuscher F, Ebel R, Kakoschke C, Lin W, Wray V, Edrada-Ebel R, Proksch P.	Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa.	
DRAMP34802	XVPVFPPLPI	10	Callyaerin H	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	20599387	Bioorg Med Chem. 2010 Jul 15;18(14):4947-60. 	Ibrahim SR, Min CC, Teuscher F, Ebel R, Kakoschke C, Lin W, Wray V, Edrada-Ebel R, Proksch P.	Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa.	
DRAMP34803	YRIPIVRRLQRR	12	TL1AL72-L251(rev)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	20675618	J Gerontol A Biol Sci Med Sci. 2010 Nov;65(11):1165-80. 	Mück C, Herndler-Brandstetter D, Micutkova L, Grubeck-Loebenstein B, Jansen-Dürr P.	Two functionally distinct isoforms of TL1A (TNFSF15) generated by differential ectodomain shedding	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP34804	YTYGLCTSSR	10	TL1AV84-L251(fw)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	20675618	J Gerontol A Biol Sci Med Sci. 2010 Nov;65(11):1165-81. 	Mück C, Herndler-Brandstetter D, Micutkova L, Grubeck-Loebenstein B, Jansen-Dürr P.	Two functionally distinct isoforms of TL1A (TNFSF15) generated by differential ectodomain shedding	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP34805	TPATPTVAQFVIQGSTICLVC	21	Cypemycin	E5KIB6		Not found	Streptomyces	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	20805503	Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16297-302.	Claesen J, Bibb M. 	Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@H](C)CC)[C@@H](C)O
DRAMP34806	VPTLK	5	Bip2	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Free		L	Not available	Not available	21359136	Pharmaceuticals (Basel). 2010 Dec 15;3(12):3594-3613.	Gomez JA, Chen J, Ngo J, Hajkova D, Yeh IJ, Gama V, Miyagi M, Matsuyama S. 	Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction Activity.	
DRAMP34807	VELPPPVELPPPVELPPP	18	Sweet Arrow Protein (SAP) (E)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein/ Rhodamine B	Free		L	Not available	Not available	21365733	Chembiochem. 2011 Apr 11;12(6):896-903.	Martín I, Teixidó M, Giralt E.	Design, synthesis and characterization of a new anionic cell-penetrating peptide: SAP(E). 	
DRAMP34808	MIIYRDLISH	10	TCTP (1-10) deletion mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-31. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34809	MIIYRDLISH	10	TCTP (1-10) deletion mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-31. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34810	MIIYRDLIS	9	TCTP (1-9) deletion mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-32. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34811	MIIYRDLI	8	TCTP (1-8) deletion mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-33. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34812	IIYRDLISH	9	TCTP (2-10) deletion mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-34. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34813	MIIYRDL	7	TCTP (1-7) deletion mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-35. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34814	MIIYRD	6	TCTP (1-6) deletion mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-36. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34815	IYRDLISH	8	TCTP (3-10) deletion mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-37. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34816	AIIYRDLIS	9	TCTP(1-9) M1A subsetution mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-38. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34817	MAIYRDLIS	9	TCTP(I-9) I2A subsetution mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-39. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34818	MIAYRDLIS	9	TCTP(1-9 I3A subsetution mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-40. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34819	MIIARDLIS	9	TCTP(1-9) Y4A subsetution mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-41. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34820	MIIYADLIS	9	TCTP(1-9) R5A subsetution mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-42. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34821	MIIYRALIS	9	TCTP(1-9) D6A subsetution mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-43. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34822	MIIYRDAIS	9	TCTP(1-9) L7A subsetution mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-44. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34823	MIIYRDLAS	9	TCTP(1-9) I8A subsetution mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-45. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34824	MIIYRDLIA	9	TCTP(1-9) S9A subsetution mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-46. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34825	MIIYRDLISKK	11	TCTP-CPP 1	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-47. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34826	MIIYRDKKSH	10	TCTP-CPP 2	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-48. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34827	MIIFRDLISH	10	TCTP-CPP 3	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-49. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34828	MIISRDLISH	10	TCTP-CPP 4	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-50. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34829	QIISRDLISH	10	TCTP-CPP 5	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-51. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34830	CIISRDLISH	10	TCTP-CPP 6	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-52. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34831	MIIYRALISHKK	12	TCTP-CPP 7	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-53. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34832	MIIYRIAASHKK	12	TCTP-CPP 8	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-54. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34833	MIIRRDLISE	10	TCTP-CPP 9	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-55. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34834	MIIYRAEISH	10	TCTP-CPP 10	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-56. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34835	MIIYARRAEE	10	TCTP-CPP 11	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-57. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34836	MIIFRIAASHKK	12	TCTP-CPP 12	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-58. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34837	MIIFRALISHKK	12	TCTP-CPP 13	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-59. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34838	MIIFRAAASHKK	12	TCTP-CPP 14	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-60. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34839	FIIFRIAASHKK	12	TCTP-CPP 15	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-61. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34840	LIIFRIAASHKK	12	TCTP-CPP 16	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-62. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34841	WIIFRIAASHKK	12	TCTP-CPP 17	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-63. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34842	WIIFRAAASHKK	12	TCTP-CPP 18	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-64. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34843	WIIFRALISHKK	12	TCTP-CPP 19	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-65. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34844	MIIFRIAAYHKK	12	TCTP-CPP 20	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-66. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34845	WIIFRIAAYHKK	12	TCTP-CPP 21	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-67. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34846	MIIFRIAATHKK	12	TCTP-CPP 22	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-68. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34847	WIIFRIAATHKK	12	TCTP-CPP 23	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-69. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34848	MIIFKIAASHKK	12	TCTP-CPP 24	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-70. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34849	WIIFKIAASHKK	12	TCTP-CPP 25	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-71. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34850	MIIFAIAASHKK	12	TCTP-CPP 26	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-72. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34851	LIIFRILISHKK	12	TCTP-CPP 27	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-73. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34852	MIIFRILISHKK	12	TCTP-CPP 28	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-74. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34853	LIIFRILISHRR	12	TCTP-CPP 29	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-75. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34854	LIIFRILISHHH	12	TCTP-CPP 30	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-76. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34855	LIIFRILISHK	11	TCTP-CPP 31	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-77. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34856	LIIFRILISHR	11	TCTP-CPP 32	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-78. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34857	LIIFRILISH	10	TCTP-CPP 33	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-79. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34858	LIIFAIAASHKK	12	TCTP-CPP 34	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-80. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34859	LIIFAILISHKK	12	TCTP-CPP 35	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation		L	Not available	Not available	21440624	Eur J Pharm Sci. 2011 May 18;43(1-2):25-81. 	Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.	Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.	
DRAMP34860	ANIKLSVQMKLFKRHLKWKIIVKLNDGRELSLDA	34	Anginex	Not available		Not found	PF4	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Galectin 1	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-16.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C
DRAMP34861	ARPAKAAATQKKVERKAPDA	20	Fibrinogen derived	Not available		Not found	Fibrinogen	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	αvβ3	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-17.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)O
DRAMP34862	CETWRTETTGATGQASSLLSGRLLEQKAASCHNSYIVLCIENSFMTSFSK	50	Endostatin fragment IV, IVox	Not available		Not found	Collagen XVIII	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-18.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CS)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
DRAMP34863	DFKLFAVTIKYR	12	C16S	Not available		Not found	Laminin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	αvβ3, α5β1	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-19.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34864	DFKLFAVYIKYR	12	C16Y	Not available		Not found	Laminin	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	αvβ3, α5β1	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-20.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34865	DPFFKVPVNKLAAAVSNFGYDLYRVRSSTSPTTN	34	PEDF P18	Not available		Not found	PEDF	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-21.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
DRAMP34866	DPFFKVPVNKLAAVSNFGYDLYRVRSSMSPTTN	33	PEDF 34-mer fragment	Not available		Not found	PEDF	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-22.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP34867	EDMNQKLFDLRGKFKRPPLRRVRMSADAML	30	pTnI	Not available		Not found	Troponin I	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-23.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP34868	EVHHQKLVFF	10	Aβ	Not available		Not found	β-amyloid	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-24.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP34869	FLSSRLQDLYSIVRRADRAA	20	Endostatin peptide fragment I (180–199)	Not available		Not found	Collagen XVIII	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-25.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP34870	HTHQDFQPVLHLVALNTPLSGGMRGIR	27	Endostatin peptide	Not available		Not found	Collagen XVIII	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-26.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34871	KSVRGKGKGQKRKRKKSRYK	20	VEGFderived peptide	Not available		Not found	Exon 6a of VEGF gene	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	VEGFR2	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-27.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP34872	NGREACLDPEAPMVQKIVQKMLKG	24	Chemokinostatin-1	Not available		Not found	CXCL1	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	CXCR3	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-28.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)C(C)C
DRAMP34873	NGRKISLDLRAPLYKKIIKKLLES	24	PF4 derived	Not available		Not found	PF4	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	VEGF FGF2	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-29.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC
DRAMP34874	NVLLSPLSVATALSALSLGAEQRTES	26	SvOrth-2	Not available		Not found	PEDF	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-30.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP34875	TGALVEEEDPF	11	PEDF-TGA fragment	Not available		Not found	PEDF	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-31.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP34876	TSLDASIIWAMMQN	14	P144	Not available		Not found	TGFβ Receptor	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	TGFβ	21470139	Curr Pharm Biotechnol. 2011 Aug;12(8):1101-32.	Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS	Anti-angiogenic peptides for cancer therapeutics	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC
DRAMP34877	KWKKLLKKPLLKKLLKKL	18	P5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Acetylation		L	Not available	Not available	21741801	 Int J Antimicrob Agents. 2011 Sep;38(3):237-42.	Dawson RM, Fox MA, Atkins HS, Liu CQ. 	Potent antimicrobial peptides with selectivity for Bacillus anthracis over human erythrocytes	
DRAMP34878	NXV	3	Fellutamide C	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	3-OH-C14	Free		L	Not available	Not available	21761939	J Nat Prod. 2011 Aug 26;74(8):1721-30.	Xu D, Ondeyka J, Harris GH, Zink D, Kahn JN, Wang H, Bills G, Platas G, Wang W, Szewczak AA, Liberator P, Roemer T, Singh SB.	Isolation, structure, and biological activities of Fellutamides C and D from an undescribed Metulocladosporiella (Chaetothyriales) using the genome-wide Candida albicans fitness test	
DRAMP34879	NXL	3	Fellutamide D	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	3-OH-C14	Free		L	Not available	Not available	21761939	J Nat Prod. 2011 Aug 26;74(8):1721-31.	Xu D, Ondeyka J, Harris GH, Zink D, Kahn JN, Wang H, Bills G, Platas G, Wang W, Szewczak AA, Liberator P, Roemer T, Singh SB.	Isolation, structure, and biological activities of Fellutamides C and D from an undescribed Metulocladosporiella (Chaetothyriales) using the genome-wide Candida albicans fitness test	
DRAMP34880	RXRXRXRXRXRXRXRXB	17	(RX)8B	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=6-aminohexanoic acid (Ahx); B=Beta-Alanine	L	Not available	Not available	21765469	Oncogene. 2012 Feb 23;31(8):1024-33. 	Ma W, Lin Y, Xuan W, Iversen PL, Smith LJ, Benchimol S.	Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs.	
DRAMP34881	RXRRXRRXRRXRXB	14	(RXR)4BR	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=6-aminohexanoic acid (Ahx); B=Beta-Alanine	L	Not available	Not available	21765469	Oncogene. 2012 Feb 23;31(8):1024-34. 	Ma W, Lin Y, Xuan W, Iversen PL, Smith LJ, Benchimol S.	Inhibition of p54 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs.	
DRAMP34882	RXRRBRRXRRBRXB	14	(RXRRBR)2XB	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=6-aminohexanoic acid (Ahx); B=Beta-Alanine	L	Not available	Not available	21765469	Oncogene. 2012 Feb 23;31(8):1024-35. 	Ma W, Lin Y, Xuan W, Iversen PL, Smith LJ, Benchimol S.	Inhibition of p55 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs.	
DRAMP34883	GXVFXPI	7	Pitipeptolide D	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya); X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-74. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34884	GXVXXPV	7	Pitipeptolide F	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-75. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34885	GXVXXPI	7	Pitipeptolide A	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-76. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34886	GXVXXPI	7	Pitipeptolide A	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-76. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34887	GXVXXPI	7	Pitipeptolide A	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-76. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34888	GXVXXPI	7	Pitipeptolide A	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-76. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34889	GXVXXPI	7	Pitipeptolide B	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy-7-octenoic (Dhoea); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-77. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34890	GXVXXPI	7	Pitipeptolide B	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy-7-octenoic (Dhoea); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-77. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34891	GXVXXPI	7	Pitipeptolide B	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy-7-octenoic (Dhoea); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-77. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34892	GXVXXPI	7	Pitipeptolide B	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy-7-octenoic (Dhoea); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-77. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34893	GXVXXPI	7	Pitipeptolide C	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-78. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34894	GXVXXPI	7	Pitipeptolide C	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-78. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34895	GXVXXPI	7	Pitipeptolide C	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-78. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34896	GXVXXPI	7	Pitipeptolide C	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy 3-methyl pentanoic acid (Hmpa)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-78. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34897	GXVXXPI	7	Pitipeptolide E	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy isovaleric acid (Hiva)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-79. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34898	GXVXXPI	7	Pitipeptolide E	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy isovaleric acid (Hiva)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-79. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34899	GXVXXPI	7	Pitipeptolide E	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy isovaleric acid (Hiva)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-79. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34900	GXVXXPI	7	Pitipeptolide E	Not available		Not found	marine cyanobacterium Lyngbya majuscula	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	X(2)=2,2-dimethyl-3-hydroxy octanoic acid (Dhoaa); X(4)=N-Me-Phe; X(5)=2-Hydroxy isovaleric acid (Hiva)	L	Not available	Not available	21843895	 Phytochemistry. 2011 Nov;72(16):2068-79. 	Montaser R, Paul VJ, Luesch H. 	Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam	
DRAMP34901	RKKRRQRRRHRRKKR	15	dTAT	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	21856394	Int J Pharm. 2012 May 1;427(1):134-42. 	Baoum A, Ovcharenko D, Berkland C. 	Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP34902	rrrrrrrrr	9	r9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Amidation		D	Not available	Not available	21867915	 Chem Biol. 2011 Aug 26;18(8):1000-10. 	Verdurmen WP, Bovee-Geurts PH, Wadhwani P, Ulrich AS, Hällbrink M, van Kuppevelt TH, Brock R. 	Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.	
DRAMP34903	rqikiwfqnrrmkwkk	16	d-Penetratin {pAntp-(43-58)}	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		D	Not available	Not available	21867915	 Chem Biol. 2011 Aug 26;18(8):1000-11. 	Verdurmen WP, Bovee-Geurts PH, Wadhwani P, Ulrich AS, Hällbrink M, van Kuppevelt TH, Brock R. 	Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.	
DRAMP34904	KCFQWQRNMRKVRGPPVSCIKR	22	hLF(38-59) peptide	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	21867915	 Chem Biol. 2011 Aug 26;18(8):1000-12. 	Verdurmen WP, Bovee-Geurts PH, Wadhwani P, Ulrich AS, Hällbrink M, van Kuppevelt TH, Brock R. 	Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.	
DRAMP34905	kcfqwqrnmrkvrgppvscikr	22	hLF(38-59) peptide	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		D	Not available	Not available	21867915	 Chem Biol. 2011 Aug 26;18(8):1000-13. 	Verdurmen WP, Bovee-Geurts PH, Wadhwani P, Ulrich AS, Hällbrink M, van Kuppevelt TH, Brock R. 	Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.	
DRAMP34906	GGVCPKILAACRRDSDCPGACICRGNGYCGSGSD	34	MCoKKAA double mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Alexa-488	Cyclization		L	Not available	Not available	21873420	J Biol Chem. 2011 Oct 21;286(42):36932-43. 	Cascales L, Henriques ST, Kerr MC, Huang YH, Sweet MJ, Daly NL, Craik DJ.	Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.	
DRAMP34907	GGVCPAILKKCRRDSDCPGACICRGNGYCGSGSD	34	MCoK6A mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Alexa-488	Cyclization		L	Not available	Not available	21873420	J Biol Chem. 2011 Oct 21;286(42):36932-44. 	Cascales L, Henriques ST, Kerr MC, Huang YH, Sweet MJ, Daly NL, Craik DJ.	Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.	
DRAMP34908	GGVCPKILAKCRRDSDCPGACICRGNGYCGSGSD	34	MCoK9A mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Alexa-488	Cyclization		L	Not available	Not available	21873420	J Biol Chem. 2011 Oct 21;286(42):36932-45. 	Cascales L, Henriques ST, Kerr MC, Huang YH, Sweet MJ, Daly NL, Craik DJ.	Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.	
DRAMP34909	GGVCPKILKACRRDSDCPGACICRGNGYCGSGSD	34	MCoK10A mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Alexa-488	Cyclization		L	Not available	Not available	21873420	J Biol Chem. 2011 Oct 21;286(42):36932-46. 	Cascales L, Henriques ST, Kerr MC, Huang YH, Sweet MJ, Daly NL, Craik DJ.	Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.	
DRAMP34910	GLPVCGETCVGGTCNTPGCKCSWPVCTRN	29	kT20K mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Alexa-488	Cyclization		L	Not available	Not available	21873420	J Biol Chem. 2011 Oct 21;286(42):36932-47. 	Cascales L, Henriques ST, Kerr MC, Huang YH, Sweet MJ, Daly NL, Craik DJ.	Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.	
DRAMP34911	GLPVCGETCVGGTCNTPGCTCSWPKCTRN	29	kV25K mutant	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Alexa-488	Cyclization		L	Not available	Not available	21873420	J Biol Chem. 2011 Oct 21;286(42):36932-48. 	Cascales L, Henriques ST, Kerr MC, Huang YH, Sweet MJ, Daly NL, Craik DJ.	Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.	
DRAMP34912	KLALKLALKALKAALKLAGC	20	MAP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	fluorescein		L	Not available	Not available	21875799	Bioorg Med Chem Lett. 2011 Oct 1;21(19):5688-91.	Wada S, Tsuda H, Okada T, Urata H. 	Cellular uptake of Aib-containing amphipathic helix peptide.	
DRAMP34913	KLULKLULKULKAULKLUGC	20	MAP (Aib)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	fluorescein	U=Aib, α-aminoisobutyric acid	L	Not available	Not available	21875799	Bioorg Med Chem Lett. 2011 Oct 1;21(19):5688-92.	Wada S, Tsuda H, Okada T, Urata H. 	Cellular uptake of Aib-containing amphipathic helix peptide.	
DRAMP34914	WKLFDDGV	8	Anticancerous peptide 1	B3EWE7		Not found	Cycas revoluta	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	21882228	J Cell Biochem. 2012 Jan;113(1):184-93. 	Mandal SM, Migliolo L, Das S, Mandal M, Franco OL, Hazra TK.	Identification and characterization of a bactericidal and proapoptotic peptide from Cycas revoluta seeds with DNA binding properties.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C
DRAMP34915	CGETCVGGTCNTPGCTCSWPVCTRNGLNPV	30	D-Kalata B1	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	21928440	Chembiochem. 2011 Nov 4;12(16):2456-62.	Sando L, Henriques ST, Foley F, Simonsen SM, Daly NL, Hall KN, Gustafson KR, Aguilar MI, Craik DJ. 	Synthetic mirror image of kalata B1 reveals that cyclotide activity is independent of a protein receptor.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C
DRAMP34916	GIIKKI	6	G(IIKK)I	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	21955251	Biomacromolecules. 2011 Nov 14;12(11):3839-43. 	Hu J, Chen C, Zhang S, Zhao X, Xu H, Zhao X, Lu JR.	Designed antimicrobial and antitumor peptides with high selectivity.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP34917	GLRKRLRKFRNKIKEK	16	CF-sC18	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Carboxyfluorescein 	Free		L	Not available	Not available	21956822	ChemMedChem. 2012 Jan 2;7(1):57-61.	Splith K, Bergmann R, Pietzsch J, Neundorf I.	Specific targeting of hypoxic tumor tissue with nitroimidazole-peptide conjugates.	
DRAMP34918	BGLRKXRLRKFRNKIKEK	18	CF-sC18(NIA)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Amidation	Free	B=Beta-Alanine; X=NIA, 2-(2-nitroimidazol-1-yl)acetic acid	L	Not available	Not available	21956822	ChemMedChem. 2012 Jan 2;7(1):57-62.	Splith K, Bergmann R, Pietzsch J, Neundorf I.	Specific targeting of hypoxic tumor tissue with nitroimidazole-peptide conjugates.	
DRAMP34919	KAAKKWAKAAKKWAKAWKKAA	21	Z1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-244. 	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP34920	KAAKKAWKAWKKAAKAWKKAA	21	Z3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-245. 	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP34921	KAAKKAWKAAKKAWKAWKKAA	21	Z7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-246. 	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP34922	KWAKKAAKWAKKAAKWAKKAA	21	Z8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-247. 	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP34923	KAWKKAWKAAKKAWKAAKKAA	21	Z9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-248. 	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP34924	AAKKWAKAKKWAKAKKWAKAA	21	Z10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22057278	J Biol Chem. 2012 Jan 2;287(1):233-249. 	Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ. 	Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity	C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
DRAMP34925	MAMPGEPRRANVMAHKLEPASLQLRNSCA	29	CPPK	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22076844	Biotechnol J. 2012 Mar;7(3):387-96. 	Lee JH, Song HS, Park TH, Lee SG, Kim BG.	Screening of cell-penetrating peptides using mRNA display.	CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)O)C(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP34926	MAPQRDTVGGRTTPPSWGPAKAQLRNSCA	29	CPPL	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22076844	Biotechnol J. 2012 Mar;7(3):387-97. 	Lee JH, Song HS, Park TH, Lee SG, Kim BG.	Screening of cell-penetrating peptides using mRNA display.	CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP34927	KKALLAHALHLLALLALHLAHALKKA	26	LAH4-L1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22138072	 J Control Release. 2012 Mar 10;158(2):293-303.	Lam JK, Liang W, Lan Y, Chaudhuri P, Chow MY, Witt K, Kudsiova L, Mason AJ.	Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
DRAMP34928	LSQETFSDLWKLLPEN	16	WT p53	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Mdm2	22148351	J Am Chem Soc. 2012 Jan 11;134(1):103-6. 	Baek S, Kutchukian PS, Verdine GL, Huber R, Holak TA, Lee KW, Popowicz GM.	Structure of the stapled p53 peptide bound to Mdm2	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)O
DRAMP34938	xi	2	Cyclo(D-Hyp-D-Ile), Diketopiperazine (D-HyP-D-Ile)	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	22163196	Mar Drugs. 2011;9(11):2469-2478. 	Ovenden SPB, Nielson JL, Liptrot CH, Willis RH, Tapiolas DM, Wright AD, Motti CA.	A new diketopiperazine, cyclo-(4-S-hydroxy-R-proline-R-isoleucine), from an Australian specimen of the sponge Stelletta sp	
DRAMP34939	FLHHIVGLIHHGLSLFGDRAD	21	Pis2 	Not available		Not found	Gadus morhua	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	22178249	Fish Shellfish Immunol. 2012 Mar;32(3):396-406.	Ruangsri J, Salger SA, Caipang CM, Kiron V, Fernandes JM.	Differential expression and biological activity of two piscidin paralogues and a novel splice variant in Atlantic cod (Gadus morhua L.).	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP34940	MTLTG	5	BPP-II	Not available		Not found	Immunomodulatory bursal-derived Pentapeptide-II	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	22184121	J Biol Chem. 2012 Feb 3;287(6):3798-807. 	Feng XL, Liu QT, Cao RB, Zhou B, Ma ZY, Deng WL, Wei JC, Qiu YF, Wang FQ, Gu JY, Wang FJ, Zheng QS, Ishag H, Chen PY.	Identification and characterization of novel immunomodulatory bursal-derived pentapeptide-II (BPP-II).	CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP34941	XrXrXr	6	(Fxr)3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Fx, cyclohexylalanine	Mix	Not available	Not available	22238158	Chembiochem. 2012 Feb 13;13(3):476-85. 	Horton KL, Pereira MP, Stewart KM, Fonseca SB, Kelley SO. 	Tuning the activity of mitochondria-penetrating peptides for delivery or disruption.	
DRAMP34942	XrXrXrXr	8	(Fxr)4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Fx, cyclohexylalanine	Mix	Not available	Not available	22238158	Chembiochem. 2012 Feb 13;13(3):476-86. 	Horton KL, Pereira MP, Stewart KM, Fonseca SB, Kelley SO. 	Tuning the activity of mitochondria-penetrating peptides for delivery or disruption.	
DRAMP34943	XrXrXrXrXr	10	(Fxr)5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Fx, cyclohexylalanine	Mix	Not available	Not available	22238158	Chembiochem. 2012 Feb 13;13(3):476-87. 	Horton KL, Pereira MP, Stewart KM, Fonseca SB, Kelley SO. 	Tuning the activity of mitochondria-penetrating peptides for delivery or disruption.	
DRAMP34944	XrXrXrXrXrXr	12	(Fxr)6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Fx, cyclohexylalanine	Mix	Not available	Not available	22238158	Chembiochem. 2012 Feb 13;13(3):476-88. 	Horton KL, Pereira MP, Stewart KM, Fonseca SB, Kelley SO. 	Tuning the activity of mitochondria-penetrating peptides for delivery or disruption.	
DRAMP34945	RRRRRRRRRGPGVTWTPQAWFQWV	24	RV24	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22326265	Biochem Biophys Res Commun. 2012 Mar 9;419(2):170-4. 	Lo SL, Wang S. 	Evaluation of the use of amphipathic peptide-based protein carrier for in vitro cancer research.	CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)O
DRAMP34946	HEHEHEHEHEHEHEHEHEHEGGGGGKLALKLALKALKAALKLA	43	GST-HE-MAP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22326404	J Control Release. 2012 Mar 28;158(3):357-61. 	Zaro JL, Fei L, Shen WC.	Recombinant peptide constructs for targeted cell penetrating peptide-mediated delivery.	CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)CC[C@H](NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)O
DRAMP34947	LX	2	Cyclo(Leu-Hyp), Cordysinin A	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22409377	J Agric Food Chem. 2012 Apr 4;60(13):3424-31.	Li XJ, Zhang Q, Zhang AL, Gao JM.	Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities	
DRAMP34948	RRR	3	TMR-R3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22465335	Biomaterials. 2012 Jun;33(18):4665-72.	Hitsuda T, Michiue H, Kitamatsu M, Fujimura A, Wang F, Yamamoto T, Han XJ, Tazawa H, Uneda A, Ohmori I, Nishiki T, Tomizawa K, Matsui H. 	A protein transduction method using oligo-arginine (3R) for the delivery of transcription factors into cell nuclei.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP34949	FFLIPKGRRRRRRRR	15	PasR8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	22486588	 Mol Pharm. 2012 May 7;9(5):1222-30. 	Takayama K, Hirose H, Tanaka G, Pujals S, Katayama S, Nakase I, Futaki S.	A protein transduction method using oligo-arginine (4R) for the delivery of transcription factors into cell nuclei.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP34950	LILIGRRRRRRRRGC	15	LILIR8 (Alexa)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	22486588	 Mol Pharm. 2012 May 7;9(5):1222-31. 	Takayama K, Hirose H, Tanaka G, Pujals S, Katayama S, Nakase I, Futaki S.	A protein transduction method using oligo-arginine (5R) for the delivery of transcription factors into cell nuclei.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP34951	FFGRRRRRRR	10	F2R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	22486588	 Mol Pharm. 2012 May 7;9(5):1222-32. 	Takayama K, Hirose H, Tanaka G, Pujals S, Katayama S, Nakase I, Futaki S.	A protein transduction method using oligo-arginine (6R) for the delivery of transcription factors into cell nuclei.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O
DRAMP34952	FFFFGRRRRRRRR	13	F4R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	22486588	 Mol Pharm. 2012 May 7;9(5):1222-33. 	Takayama K, Hirose H, Tanaka G, Pujals S, Katayama S, Nakase I, Futaki S.	A protein transduction method using oligo-arginine (7R) for the delivery of transcription factors into cell nuclei.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O
DRAMP34953	FFFFFFGRRRRRRRR	15	F6R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	22486588	 Mol Pharm. 2012 May 7;9(5):1222-34. 	Takayama K, Hirose H, Tanaka G, Pujals S, Katayama S, Nakase I, Futaki S.	A protein transduction method using oligo-arginine (8R) for the delivery of transcription factors into cell nuclei.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O
DRAMP34954	fflipkgrrrrrrrr	15	dPasR8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		D	Not available	Not available	22486588	 Mol Pharm. 2012 May 7;9(5):1222-35. 	Takayama K, Hirose H, Tanaka G, Pujals S, Katayama S, Nakase I, Futaki S.	A protein transduction method using oligo-arginine (9R) for the delivery of transcription factors into cell nuclei.	CC[C@H](C)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCCN)C(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP34955	ffffgrrrrrrrr	13	Df4r8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		D	Not available	Not available	22486588	 Mol Pharm. 2012 May 7;9(5):1222-36. 	Takayama K, Hirose H, Tanaka G, Pujals S, Katayama S, Nakase I, Futaki S.	A protein transduction method using oligo-arginine (10R) for the delivery of transcription factors into cell nuclei.	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1ccccc1)C(N)=O
DRAMP34956	NNXnyNQP	8	Mojavensin A	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	22491138	J Antibiot (Tokyo). 2012 Jun;65(6):317-22.	Ma Z, Wang N, Hu J, Wang S.	Isolation and characterization of a new iturinic lipopeptide, mojavensin A produced by a marine-derived bacterium Bacillus mojavensis B0621A	
DRAMP34957	GCGGGYGRKKRRQRRR	16	Tat	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22531849	 Int J Pharm. 2012 Jul 1;430(1-2):372-80.	Wang C, Qiao L, Zhang Q, Yan H, Liu K.	Enhanced cell uptake of superparamagnetic iron oxide nanoparticles through direct chemisorption of FITC-Tat-PEG₆₀₀-b-poly(glycerol monoacrylate).	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)CN)C(=O)O
DRAMP34958	YGRKKRRQRRRGTALDWSWLQTE	23	TAT-NBD	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22580115	J Control Release. 2012 Aug 10;161(3):893-902. 	Liu R, Xi L, Luo D, Ma X, Yang W, Xi Y, Wang H, Qian M, Fan L, Xia X, Li K, Wang D, Zhou J, Meng L, Wang S, Ma D. 	Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP34959	CGNVVRQGCGYGRKKRRQRRRGTALDWSWLQTE	33	TMTP1-TAT-NBD	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22580115	J Control Release. 2012 Aug 10;161(3):893-903. 	Liu R, Xi L, Luo D, Ma X, Yang W, Xi Y, Wang H, Qian M, Fan L, Xia X, Li K, Wang D, Zhou J, Meng L, Wang S, Ma D. 	Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP2-TAT-NBD.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP34960	Wp	2	Cyclo(L-Trp-D-Pro), Diketopiperazine (Wp)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-9. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@@H]1C(=O)O
DRAMP34961	wp	2	Cyclo(D-Trp-D-Pro), Diketopiperazine (wp)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-10. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	N[C@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@@H]1C(=O)O
DRAMP34962	Wa	2	Cyclo(L-Trp-D-Ala), Diketopiperazine (Wa)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-11. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	C[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP34963	wa	2	Cyclo(D-Trp-D-Ala), Diketopiperazine (wa)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-12. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	C[C@@H](NC(=O)[C@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP34964	wA	2	Cyclo(D-Trp-L-Ala), Diketopiperazine (wA)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-13. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	C[C@H](NC(=O)[C@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP34965	WH	2	Cyclo(Trp-His), Diketopiperazine (WH)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22617493	Bioorg Med Chem Lett. 2012 Jun 15;22(12):3866-14. 	Wollinsky B, Ludwig L, Hamacher A, Yu X, Kassack MU, Li SM. 	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP34966	XFXPXLV	7	Cordyheptapeptide C	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	22642609	J Nat Prod. 2012 Jun 22;75(6):1215-9.	Chen Z, Song Y, Chen Y, Huang H, Zhang W, Ju J.	Cyclic heptapeptides, cordyheptapeptides C-E, from the marine-derived fungus Acremonium persicinum SCSIO 115 and their cytotoxic activities	
DRAMP34967	SRRRRRRRRR	10	SR9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22669044	Gene. 2012 Aug 15;505(1):37-45. 	Liu BR, Lin MD, Chiang HJ, Lee HJ.	Arginine-rich cell-penetrating peptides deliver gene into living human cells.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CO)C(=O)O
DRAMP34968	CHHHHHRRRRRRRRRHHHHHC	21	HR9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22669044	Gene. 2012 Aug 15;505(1):37-46. 	Liu BR, Lin MD, Chiang HJ, Lee HJ.	Arginine-rich cell-penetrating peptides deliver gene into living human cells.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)O
DRAMP34969	FFLIPKGRRRRRRRRR	16	PR9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22669044	Gene. 2012 Aug 15;505(1):37-47. 	Liu BR, Lin MD, Chiang HJ, Lee HJ.	Arginine-rich cell-penetrating peptides deliver gene into living human cells.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34970	CGGGYGRKKRRQRRR	15	AgNP-TAT	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22682937	Biomaterials. 2012 Sep;33(26):6155-61. 	Liu J, Zhao Y, Guo Q, Wang Z, Wang H, Yang Y, Huang Y.	TAT-modified nanosilver for combating multidrug-resistant cancer.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H](N)CS)C(=O)O
DRAMP34971	GLWWKAWWKAWWKSLWWRKRKRKA	24	CADY-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22688249	Int J Pharm. 2012 Sep 15;434(1-2):209-14. 	Li Y, Zheng X, Cao Z, Xu W, Zhang J, Gong M.	Self-assembled peptide (CADY-1) improved the clinical application of doxorubicin.	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
DRAMP34972	AGYLLGKLLOOLAAAALOOLL	21	PF14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation		L	Not available	Not available	22698942	J Control Release. 2012 Aug 20;162(1):1-8.	Ezzat K, Zaghloul EM, El Andaloussi S, Lehto T, El-Sayed R, Magdy T, Smith CI, Langel U.	Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions.	
DRAMP34973	YGRKKRPQRRR	11	1 (TAT)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22805558	Nat Commun. 2012 Jul 17;3:951. 	Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. 	Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
DRAMP34974	DSLKSYWYLQKFSWR	15	2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22805558	Nat Commun. 2012 Jul 17;3:952. 	Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. 	Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34975	KLWMRWWSPTTRRYG	15	7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22805558	Nat Commun. 2012 Jul 17;3:953. 	Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. 	Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP34976	RLWMRWYSPWTRRWG	15	10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22805558	Nat Commun. 2012 Jul 17;3:954. 	Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. 	Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O)[C@@H](C)O
DRAMP34977	RLIMRIYAPTTRRYG	15	28	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22805558	Nat Commun. 2012 Jul 17;3:955. 	Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. 	Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP34978	RLYMRYYSPTTRRYG	15	30	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22805558	Nat Commun. 2012 Jul 17;3:956. 	Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. 	Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.	CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP34979	RLWMRWYSPRTRAYG	15	33	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22805558	Nat Commun. 2012 Jul 17;3:957. 	Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. 	Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)[C@@H](C)O
DRAMP34980	KRPTMRFRYTWNPMK	15	44	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Resisting chymotrypsin hydrolysis	Not available	Not available	Linear	Free	Free		L	Not available	Chymotrypsin hydrolysis	22805558	Nat Commun. 2012 Jul 17;3:958. 	Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. 	Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
DRAMP34981	WKCRRQAFRVLHHWN	15	47	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22805558	Nat Commun. 2012 Jul 17;3:959. 	Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. 	Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP34982	WKARRQCFRVLHHWN	15	48	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	22805558	Nat Commun. 2012 Jul 17;3:960. 	Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M. 	Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP34983	STRUCTUREGIVEN	14	BAA-1	Not available		Not found	Bovine lactoferrin (Lf-B)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	22820149	Biochim Biophys Acta. 2012 Nov;1818(11):2917-25.	Ausbacher D, Svineng G, Hansen T, Str繪m MB.	Anticancer mechanisms of action of two small amphipathic β(2,2)-amino acid derivatives derived from antimicrobial peptides.	
DRAMP34984	rRRRRRRR	8	rR7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	22824782	J Control Release. 2012 Sep 10;162(2):286-94.	Ma Y, Gong C, Ma Y, Fan F, Luo M, Yang F, Zhang YH. 	Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.	N=C(N)NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34985	rRrRRRRR	8	(rR)2R4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	22824782	J Control Release. 2012 Sep 10;162(2):286-95.	Ma Y, Gong C, Ma Y, Fan F, Luo M, Yang F, Zhang YH. 	Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.	N=C(N)NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34986	rRrRrRRR	8	(rR)3R2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	22824782	J Control Release. 2012 Sep 10;162(2):286-96.	Ma Y, Gong C, Ma Y, Fan F, Luo M, Yang F, Zhang YH. 	Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.	N=C(N)NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34987	rRrRrRrR	8	(rR)4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	22824782	J Control Release. 2012 Sep 10;162(2):286-97.	Ma Y, Gong C, Ma Y, Fan F, Luo M, Yang F, Zhang YH. 	Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.	N=C(N)NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34988	rrrRrRrR	8	r2(rR)3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	22824782	J Control Release. 2012 Sep 10;162(2):286-98.	Ma Y, Gong C, Ma Y, Fan F, Luo M, Yang F, Zhang YH. 	Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.	N=C(N)NCCC[C@@H](N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP34989	rrrrrrrr	8	r8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	22824782	J Control Release. 2012 Sep 10;162(2):286-99.	Ma Y, Gong C, Ma Y, Fan F, Luo M, Yang F, Zhang YH. 	Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.	N=C(N)NCCC[C@@H](N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)O
DRAMP34990	XXXXXXXX	8	Polyguanidine comparators 2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	X=Nbtg	L	Not available	Not available	22828784	Mol Biosyst. 2012 Oct;8(10):2626-8. 	Huang W, Seo J, Lin JS, Barron AE. 	Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake	
DRAMP34991	ZBBZBBZBB	9	NLys(1/3) variants 1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; B=Nspe was derived from (S)-N-(1-phenylethyl)amine	L	Not available	Not available	22828784	Mol Biosyst. 2012 Oct;8(10):2626-9. 	Huang W, Seo J, Lin JS, Barron AE. 	Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake	
DRAMP34992	ZBBZBBZBBZBB	12	NLys(1/3) variants 2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; B=Nspe was derived from (S)-N-(1-phenylethyl)amine	L	Not available	Not available	22828784	Mol Biosyst. 2012 Oct;8(10):2626-10. 	Huang W, Seo J, Lin JS, Barron AE. 	Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake	
DRAMP34993	ZXXZXXZXXZXX	12	NLys(1/3) variants 3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; X=Npm from benzylamine (1-phenylethylamine)	L	Not available	Not available	22828784	Mol Biosyst. 2012 Oct;8(10):2626-11. 	Huang W, Seo J, Lin JS, Barron AE. 	Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake	
DRAMP34994	ZXXZXXZXXZXX	12	NLys(1/3) variants 3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; X=Npm from benzylamine (1-phenylethylamine)	L	Not available	Not available	22828784	Mol Biosyst. 2012 Oct;8(10):2626-11. 	Huang W, Seo J, Lin JS, Barron AE. 	Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake	
DRAMP34995	ZXXZXXZXXZXX	12	NLys(1/3) variants 4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; X=Nssb from (S)-(sec-butyl)amine	L	Not available	Not available	22828784	Mol Biosyst. 2012 Oct;8(10):2626-12. 	Huang W, Seo J, Lin JS, Barron AE. 	Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake	
DRAMP34996	ZXXZXXZXXZXX	12	NLys(1/3) variants 4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; X=Nssb from (S)-(sec-butyl)amine	L	Not available	Not available	22828784	Mol Biosyst. 2012 Oct;8(10):2626-12. 	Huang W, Seo J, Lin JS, Barron AE. 	Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake	
DRAMP34997	ZZBZZBZZBZZB	12	NLys(2/3) variants 1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; B=Nspe was derived from (S)-N-(1-phenylethyl)amine	L	Not available	Not available	22828784	Mol Biosyst. 2012 Oct;8(10):2626-13. 	Huang W, Seo J, Lin JS, Barron AE. 	Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake	
DRAMP34998	ZZZZZZZZBBBB	12	NLys(2/3) variants 2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; B=Nspe was derived from (S)-N-(2-phenylethyl)amine	L	Not available	Not available	22828784	Mol Biosyst. 2012 Oct;8(10):2626-14. 	Huang W, Seo J, Lin JS, Barron AE. 	Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake	
DRAMP34999	ZZZZZZZZXXXXX	13	NLys(2/3) variants 3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; X=NLeu from isobutylamine	L	Not available	Not available	22828784	Mol Biosyst. 2012 Oct;8(10):2626-15. 	Huang W, Seo J, Lin JS, Barron AE. 	Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake	
DRAMP35000	XBBXBBXBBXBB	12	Guanidylated variants	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; B=Nspe was derived from (S)-N-(1-phenylethyl)amine	L	Not available	Not available	22828784	Mol Biosyst. 2012 Oct;8(10):2626-16. 	Huang W, Seo J, Lin JS, Barron AE. 	Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake	
DRAMP35001	XXBXXBXXBXXB	12	Guanidylated variants	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	Z=NLys from N-tert-butoxycarbonyl-1,4-butanediamine; B=Nspe was derived from (S)-N-(2-phenylethyl)amine	L	Not available	Not available	22828784	Mol Biosyst. 2012 Oct;8(10):2626-17. 	Huang W, Seo J, Lin JS, Barron AE. 	Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake	
DRAMP35002	RRRRRHHH	8	R5H3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23031530	Biomaterials. 2012 Dec;33(36):9246-58. 	Jiang T, Zhang Z, Zhang Y, Lv H, Zhou J, Li C, Hou L, Zhang Q.	Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP35003	RRRRRRHHH	9	R6H3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23031530	Biomaterials. 2012 Dec;33(36):9246-59. 	Jiang T, Zhang Z, Zhang Y, Lv H, Zhou J, Li C, Hou L, Zhang Q.	Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP35004	RRRRRRRHHH	10	R7H3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23031530	Biomaterials. 2012 Dec;33(36):9246-60. 	Jiang T, Zhang Z, Zhang Y, Lv H, Zhou J, Li C, Hou L, Zhang Q.	Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP35005	RRRRRRRRHHH	11	R8H3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23031530	Biomaterials. 2012 Dec;33(36):9246-61. 	Jiang T, Zhang Z, Zhang Y, Lv H, Zhou J, Li C, Hou L, Zhang Q.	Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP35006	RRRRRRRRRHHH	12	R9H3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23031530	Biomaterials. 2012 Dec;33(36):9246-62. 	Jiang T, Zhang Z, Zhang Y, Lv H, Zhou J, Li C, Hou L, Zhang Q.	Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP35007	BENPESILDEHVQRVM	16	fAxWT	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Inhibit wnt/β-catenin signaling pathway	Not available	Not available	Linear	FITC	Amidation	B=β-Ala	L	Not available	β-catenin	23071338	 Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):17942-7.	Grossmann TN, Yeh JT, Bowman BR, Chu Q, Moellering RE, Verdine GL.	Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin	
DRAMP35022	WX	2	Cyclo(Trp-MeA), Diketopiperazine (WMeA)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23079524	 Bioorg Med Chem Lett. 2012 Dec 1;22(23):7265-7.	Wang FZ, Huang Z, Shi XF, Chen YC, Zhang WM, Tian XP, Li J, Zhang S.	Cytotoxic indole diketopiperazines from the deep sea-derived fungus Acrostalagmus luteoalbus SCSIO F457	
DRAMP35023	FX	2	Dipeptide 8	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		OMe	Free	X=Sar	L	Not available	Not available	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY. 	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP35024	FX	2	Dipeptide 8	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		OMe	Free	X=Sar	L	Not available	Not available	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY. 	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP35025	GF	2	Dipeptide 13	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		OtBu	Boc=Tert-Butyloxycarbonyl, Sar		L	Not available	Not available	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-52.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY. 	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP35026	VF	2	2,5-diketopiperazine 19	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-53.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY. 	Linear and cyclic dipeptides with antimalarial activity.	CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP35027	VKX	3	2,5-diketopiperazine 17	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-54.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY. 	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP35028	VV	2	2,5-diketopiperazine 21	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Boc=Tert-Butyloxycarbonyl, Sar		L	Not available	Not available	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-55.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY. 	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP35029	Vx	2	2,5-diketopiperazine 16	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		Mix	Not available	Not available	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-56.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY. 	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP35030	zV	2	Dipeptide 5	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		OtBu	Boc=Tert-Butyloxycarbonyl, Sar		Mix	Not available	Not available	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-57.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY. 	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP35031	YGRKKRRQRRRX	12	Tat-OH	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=acp, Epsilon-aminocaproic acid	L	Not available	Not available	23085023	Eur J Pharmacol. 2013 Jan 5;698(1-3):87-94. 	Kuroda Y, Kato-Kogoe N, Tasaki E, Murata E, Ueda K, Abe M, Miyamoto K, Nakase I, Futaki S, Tohyama Y, Hirose M. 	Oligopeptides derived from autophosphorylation sites of EGF receptor suppress EGF-stimulated responses in human lung carcinoma A549 cells.	
DRAMP35032	YGRKKRRQRRRENAEYLR	18	Tat-ENAEYLR	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	X=acp, Epsilon-aminocaproic acid	L	Not available	Not available	23085023	Eur J Pharmacol. 2013 Jan 5;698(1-3):87-95. 	Kuroda Y, Kato-Kogoe N, Tasaki E, Murata E, Ueda K, Abe M, Miyamoto K, Nakase I, Futaki S, Tohyama Y, Hirose M. 	Oligopeptides derived from autophosphorylation sites of EGF receptor suppress EGF-stimulated responses in human lung carcinoma A550 cells.	
DRAMP35033	YGRKKRRQRRRQNAQYLR	18	Tat-QNAQYLR	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	X=acp, Epsilon-aminocaproic acid	L	Not available	Not available	23085023	Eur J Pharmacol. 2013 Jan 5;698(1-3):87-96. 	Kuroda Y, Kato-Kogoe N, Tasaki E, Murata E, Ueda K, Abe M, Miyamoto K, Nakase I, Futaki S, Tohyama Y, Hirose M. 	Oligopeptides derived from autophosphorylation sites of EGF receptor suppress EGF-stimulated responses in human lung carcinoma A551 cells.	
DRAMP35034	YGRKKRRQRRRDYQQD	16	Tat-DYQQD	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	X=acp, Epsilon-aminocaproic acid	L	Not available	Not available	23085023	Eur J Pharmacol. 2013 Jan 5;698(1-3):87-97. 	Kuroda Y, Kato-Kogoe N, Tasaki E, Murata E, Ueda K, Abe M, Miyamoto K, Nakase I, Futaki S, Tohyama Y, Hirose M. 	Oligopeptides derived from autophosphorylation sites of EGF receptor suppress EGF-stimulated responses in human lung carcinoma A552 cells.	
DRAMP35035	YGRKKRRQRRRNYQQN	16	Tat-NYQQN	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	X=acp, Epsilon-aminocaproic acid	L	Not available	Not available	23085023	Eur J Pharmacol. 2013 Jan 5;698(1-3):87-98. 	Kuroda Y, Kato-Kogoe N, Tasaki E, Murata E, Ueda K, Abe M, Miyamoto K, Nakase I, Futaki S, Tohyama Y, Hirose M. 	Oligopeptides derived from autophosphorylation sites of EGF receptor suppress EGF-stimulated responses in human lung carcinoma A553 cells.	
DRAMP35036	NOTAVAILABLE	12	5a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	23085771	Eur J Med Chem. 2012 Dec;58:22-9. 	Hansen T, Ausbacher D, Zachariassen ZG, Anderssen T, Havelkova M, Str繪m MB.	Anticancer activity of small amphipathic β²,²-amino acid derivatives.	
DRAMP35037	rrrrrrrrrcqcrrkn	16	R9-GO-203	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	23114713	 Cancer Biol Ther. 2013 Feb;14(2):127-34. 	Uchida Y, Raina D, Kharbanda S, Kufe D.	Inhibition of the MUC1-C oncoprotein is synergistic with cytotoxic agents in the treatment of breast cancer cells.	N=C(N)NCCC[C@@H](N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CS)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CS)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(N)=O)C(=O)O
DRAMP35038	CALNNYGRKKRRQRRR	16	Tat	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23184894	Adv Healthc Mater. 2013 Feb;2(2):352-60. 	Liu X, Zhu H, Jin Q, Zhou W, Colvin VL, Ji J.	Small and stable phosphorylcholine zwitterionic quantum dots for weak nonspecific phagocytosis and effective Tat peptide functionalization.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35039	AGYLLGXLLOOLAAAALOOLL	21	PF15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation	X=Lys(ε-Mtt), Trifluoromethylquinoline moietie is added at amino froup of Lys7	L	Not available	Not available	23200958	Int J Pharm. 2013 Jan 30;441(1-2):242-7.	Lindberg S, Muñoz-Alarcón A, Helmfors H, Mosqueira D, Gyllborg D, Tudoran O, Langel U. 	PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors.	
DRAMP35040	WRWRW	5	W(RW)2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	RuC(O)	Amidation		L	Not available	Not available	23209509	Beilstein J Org Chem. 2012;8:1753-64. 	Albada HB, Chiriac AI, Wenzel M, Penkova M, Bandow JE, Sahl HG, Metzler-Nolte N.	Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups	
DRAMP35041	GXFKKTFHKVSHAVKSGIHA	20	Centrocin 1a heavy chain, CEN1 HC (1-20)	D8WN02		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23237525	AMB Express. 2012 Dec 13;2(1):67. 	Björn C, Håkansson J, Myhrman E, Sjöstrand V, Haug T, Lindgren K, Blencke HM, Stensvåg K, Mahlapuu M. 	Anti-infectious and anti-inflammatory effects of peptide fragments sequentially derived from the antimicrobial peptide centrocin 1 isolated from the green sea urchin, Strongylocentrotus droebachiensis	
DRAMP35042	CRGDKGPDC	9	iRGD-CDD	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23248118	Cancer Res. 2013 Feb 15;73(4):1352-61. 	Chen R, Braun GB, Luo X, Sugahara KN, Teesalu T, Ruoslahti E.	Application of a proapoptotic peptide to intratumorally spreading cancer therapy.	N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CS)C(=O)NCC(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O
DRAMP35043	MIIYRDLISH	10	TCTPPTD	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23256924	Anal Biochem. 2013 Apr 1;435(1):47-53.	Maeng J, Kim HY, Shin DH, Lee K. 	Transduction of translationally controlled tumor protein employing TCTP-derived protein transduction domain.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP35044	MIIYRDLISH	10	TCTPPTD	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23256924	Anal Biochem. 2013 Apr 1;435(1):47-53.	Maeng J, Kim HY, Shin DH, Lee K. 	Transduction of translationally controlled tumor protein employing TCTP-derived protein transduction domain.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP35045	RRRRRRRGGIYLATALAKWALKQGF	25	P7-4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23262194	 Biochim Biophys Acta. 2013 Mar;1828(3):1047-56.	Lemeshko VV.	Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP35046	IYLATALAKWALKQGFGGRRRRRRR	25	P7-5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23262194	 Biochim Biophys Acta. 2013 Mar;1828(3):1047-57.	Lemeshko VV.	Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP35047	RRRRRRRGGIYLATALAKWALKQ	23	P7-6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23262194	 Biochim Biophys Acta. 2013 Mar;1828(3):1047-58.	Lemeshko VV.	Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O
DRAMP35048	IYLATALAKWALKQGGRRRRRRR	23	P7-7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23262194	 Biochim Biophys Acta. 2013 Mar;1828(3):1047-59.	Lemeshko VV.	Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O
DRAMP35049	RRRRRRRGGKLAKLAKKLAKLAK	23	R7-KLA	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23262194	 Biochim Biophys Acta. 2013 Mar;1828(3):1047-60.	Lemeshko VV.	Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP35050	KLAKLAKKLAKLAKGGRRRRRRR	23	KLA-R7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23262194	 Biochim Biophys Acta. 2013 Mar;1828(3):1047-61.	Lemeshko VV.	Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35051	RGDXRRRRRRRR	12	P1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=12-aminododecanoic acid (ADDA)	L	Not available	Not available	23281275	Macromol Biosci. 2013 Jan;13(1):84-92.	Chen JX, Xu XD, Yang S, Yang J, Zhuo RX, Zhang XZ. 	Self-assembled BolA-like amphiphilic peptides as viral-mimetic gene vectors for cancer cell targeted gene delivery.	
DRAMP35052	RGDXRRRRRRRR	12	P1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=12-aminododecanoic acid (ADDA)	L	Not available	Not available	23281275	Macromol Biosci. 2013 Jan;13(1):84-92.	Chen JX, Xu XD, Yang S, Yang J, Zhuo RX, Zhang XZ. 	Self-assembled BolA-like amphiphilic peptides as viral-mimetic gene vectors for cancer cell targeted gene delivery.	
DRAMP35053	RGDXRRRRRRRR	12	P2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=6-aminohexanoic acid, Ahx	L	Not available	Not available	23281275	Macromol Biosci. 2013 Jan;13(1):84-93.	Chen JX, Xu XD, Yang S, Yang J, Zhuo RX, Zhang XZ. 	Self-assembled BolA-like amphiphilic peptides as viral-mimetic gene vectors for cancer cell targeted gene delivery.	
DRAMP35054	RGDXRRRRRRRR	12	P2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=6-aminohexanoic acid, Ahx	L	Not available	Not available	23281275	Macromol Biosci. 2013 Jan;13(1):84-93.	Chen JX, Xu XD, Yang S, Yang J, Zhuo RX, Zhang XZ. 	Self-assembled BolA-like amphiphilic peptides as viral-mimetic gene vectors for cancer cell targeted gene delivery.	
DRAMP35055	RGDRRRRRRRR	11	P3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23281275	Macromol Biosci. 2013 Jan;13(1):84-94.	Chen JX, Xu XD, Yang S, Yang J, Zhuo RX, Zhang XZ. 	Self-assembled BolA-like amphiphilic peptides as viral-mimetic gene vectors for cancer cell targeted gene delivery.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)O
DRAMP35056	GIGKFLHSAKKFGKAFVGEIMNSGGKKWKMRRNQFWVKVQRG	42	MG2A	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23286306	 Cancer Biother Radiopharm. 2013 May;28(4):289-97.	Liu S, Yang H, Wan L, Cheng J, Lu X. 	Penetratin-mediated delivery enhances the antitumor activity of the cationic antimicrobial peptide Magainin II.	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)[C@H](C)CC)C(C)C
DRAMP35057	WRWRWRWRW	9	Cyclic [W(RW)4 ]-Dox	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Dox, Doxorubicin		L	Not available	Not available	23301519	Mol Pharm. 2013 Feb 4;10(2):488-99.	Nasrolahi Shirazi A, Tiwari R, Chhikara BS, Mandal D, Parang K.	Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs.	
DRAMP35058	WRWKKKKA	8	cyclic [W(RW)4]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free		L	Not available	Not available	23301519	Mol Pharm. 2013 Feb 4;10(2):488-100.	Nasrolahi Shirazi A, Tiwari R, Chhikara BS, Mandal D, Parang K.	Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs.	C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP35059	RKKRRQRRRGC	11	Tat-Cys	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	23322746	Protein Eng Des Sel. 2013 Apr;26(4):277-81.	Moody P, Burlina F, Martin SR, Morgan RE, Offer J, Smith ME, Molloy JE, Caddick S.	Evaluating the use of Apo-neocarzinostatin as a cell penetrating protein.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP35060	DGRCLLIIKLAKLAKKLAKLAK	22		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23326440	PLoS One. 2013;8(1):e53491.	Hou L, Zhao X, Wang P, Ning Q, Meng M, Liu C. 	Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
DRAMP35061	NHQQQNPHQPPM	12	FAM-gHo	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation		L	Not available	Not available	23350661	Bioconjug Chem. 2013 Mar 20;24(3):305-13. 	Eriste E, Kurrikoff K, Suhorutšenko J, Oskolkov N, Copolovici DM, Jones S, Laakkonen P, Howl J, Langel Ü. 	Peptide-based glioma-targeted drug delivery vector gHoPe2.	
DRAMP35062	LLIILRRRIRKQAHAHSKNHQQQNPHQPPM	30	FAM-pVEC-gHo (FAM- gHoPe2)	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation		L	Not available	Not available	23350661	Bioconjug Chem. 2013 Mar 20;24(3):305-14. 	Eriste E, Kurrikoff K, Suhorutšenko J, Oskolkov N, Copolovici DM, Jones S, Laakkonen P, Howl J, Langel Ü. 	Peptide-based glioma-targeted drug delivery vector gHoPe2.	
DRAMP35063	NHQQQNPHQPPMLLIILRRRIRKQAHAHSK	30	FAM-gHo-pVEC (FAM- gHoPe3)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation		L	Not available	Not available	23350661	Bioconjug Chem. 2013 Mar 20;24(3):305-15. 	Eriste E, Kurrikoff K, Suhorutšenko J, Oskolkov N, Copolovici DM, Jones S, Laakkonen P, Howl J, Langel Ü. 	Peptide-based glioma-targeted drug delivery vector gHoPe2.	
DRAMP35064	CLLIILRRRIRKQAHAHSKNHQQQNPHQPPM	31	Dox-pVEC-gHo (Dox- gHoPe2)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Succinimidyl-4-(N-mal-eimidomethyl) cyclohexane-1-carboxylate (SMCC)	Amidation		L	Not available	Not available	23350661	Bioconjug Chem. 2013 Mar 20;24(3):305-16. 	Eriste E, Kurrikoff K, Suhorutšenko J, Oskolkov N, Copolovici DM, Jones S, Laakkonen P, Howl J, Langel Ü. 	Peptide-based glioma-targeted drug delivery vector gHoPe2.	
DRAMP35065	AGYLLGXINLKALAALAKKIL	21	NF51	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation	X=Ornithine	L	Not available	Not available	23357356	Biochim Biophys Acta. 2013 May;1828(5):1365-73.	Arukuusk P, Pärnaste L, Oskolkov N, Copolovici DM, Margus H, Padari K, Möll K, Maslovskaja J, Tegova R, Kivi G, Tover A, Pooga M, Ustav M, Langel U.	New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids.	
DRAMP35066	AGYLLGXINLKALAALAKKIL	21	NF51	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation	X=Ornithine	L	Not available	Not available	23357356	Biochim Biophys Acta. 2013 May;1828(5):1365-73.	Arukuusk P, Pärnaste L, Oskolkov N, Copolovici DM, Margus H, Padari K, Möll K, Maslovskaja J, Tegova R, Kivi G, Tover A, Pooga M, Ustav M, Langel U.	New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids.	
DRAMP35067	AGYLLGXINLKALAALAKKIL	21	NF51	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation	X=Ornithine	L	Not available	Not available	23357356	Biochim Biophys Acta. 2013 May;1828(5):1365-73.	Arukuusk P, Pärnaste L, Oskolkov N, Copolovici DM, Margus H, Padari K, Möll K, Maslovskaja J, Tegova R, Kivi G, Tover A, Pooga M, Ustav M, Langel U.	New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids.	
DRAMP35068	AGYLLGXINLKALAALAKKIL	21	NF51	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation	X=Ornithine	L	Not available	Not available	23357356	Biochim Biophys Acta. 2013 May;1828(5):1365-73.	Arukuusk P, Pärnaste L, Oskolkov N, Copolovici DM, Margus H, Padari K, Möll K, Maslovskaja J, Tegova R, Kivi G, Tover A, Pooga M, Ustav M, Langel U.	New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids.	
DRAMP35069	RLLRLLRRLLRLLRRLLRC	19	PL	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23384441	Biochem Biophys Res Commun. 2013 Mar 8;432(2):359-64.	Mokhtarieh AA, Kim S, Lee Y, Chung BH, Lee MK. 	Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O
DRAMP35070	RGDRGDRRDLRLDRGDLRC	19	PD1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23384441	Biochem Biophys Res Commun. 2013 Mar 8;432(2):359-65.	Mokhtarieh AA, Kim S, Lee Y, Chung BH, Lee MK. 	Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O
DRAMP35071	RGDRLDRRDLRLDRRDLRC	19	PD2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23384441	Biochem Biophys Res Commun. 2013 Mar 8;432(2):359-66.	Mokhtarieh AA, Kim S, Lee Y, Chung BH, Lee MK. 	Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O
DRAMP35072	RGERGERRELRLERGELRC	19	PE1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23384441	Biochem Biophys Res Commun. 2013 Mar 8;432(2):359-67.	Mokhtarieh AA, Kim S, Lee Y, Chung BH, Lee MK. 	Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O
DRAMP35073	RGERLERRELRLERRELRC	19	PE2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23384441	Biochem Biophys Res Commun. 2013 Mar 8;432(2):359-68.	Mokhtarieh AA, Kim S, Lee Y, Chung BH, Lee MK. 	Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O
DRAMP35074	CGETCVGGTCNTPGCTCSWPVCTRNGLPV	29	Kalata B1	P56254		Not found	Oldenlandia affinis	Antimicrobial, Anticancer	Not found	Not found	Not found	1ZNU##2JUE##1NB1	Not available	Not available	Not available		Free	Free		L	Not available	Not available	23468118	Biopolymers. 2013 Sep;100(5):461-70.	Malagón D, Botterill B, Gray DJ, Lovas E, Duke M, Gray C, Kopp SR, Knott LM, McManus DP, Daly NL, Mulvenna J, Craik DJ, Jones MK.	Anthelminthic activity of the cyclotides (kalata B1 and B2) against schistosome parasites.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C
DRAMP35075	NYRWRCKNQN	10	ECP(32-41)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57318. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP35076	NYQRRCKNQN	10	EDN(32-41)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57319. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP35077	NYQWRCKNQN	10	ECP(32-41)R3Q	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57320. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP35078	NYRRRCKNQN	10	ECP(32-41)W4R	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57321. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP35079	YRWRCKNQN	9	ECP(33-41)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57322. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP35080	NYRWRCKNQ	9	ECP(32-40)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57323. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP35081	YRWRCKNQ	8	ECP(33-40)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57324. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP35082	NYRWRCKN	8	ECP(32-39)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57325. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP35083	RWRCKNQN	8	ECP(34-41)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57326. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP35084	NYRWRCK	7	ECP(32-38)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57327. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP35085	GRKKRRQRRRP	11	TAT(47-57)	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57328. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	N=C(N)NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O
DRAMP35086	KLAKLAKKLAKLAKGRKKRRQRRRP	25	KLA-TAT(47-57)	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57329. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O
DRAMP35087	KLAKLAKKLAKLAKNYRWRCKNQN	24	KLA-ECP(32-41)	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23469189	 PLoS One. 2013;8(3):e57330. 	Fang SL, Fan TC, Fu HW, Chen CJ, Hwang CS, Hung TJ, Lin LY, Chang MD.	A novel cell-penetrating peptide derived from human eosinophil cationic protein.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP35088	KETWWETWWTEWSQPKKKRKVC	22	FP-lipo	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23515421	Int J Nanomedicine. 2013;8:1155-65. 	Kang MJ, Park SH, Kang MH, Park MJ, Choi YW. 	Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP35089	RRRRR	5	R5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23534410	Mol Pharm. 2013 May 6;10(5):1940-8.	Alhakamy NA, Berkland CJ. 	Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes. 	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP35090	GLKKLAELFHKLLKLG	16	TAMARA-peptide 1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	TAMRA, 5-(and-6)-carboxytetramethylrhodamine	Amidation		L	Not available	Not available	23545289	Biomaterials. 2013 Jul;34(20):4872-9. 	Park H, Tsutsumi H, Mihara H.	Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.	
DRAMP35091	GLKKLAELFHKLLKLG	16	TAMARA-peptide 1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	TAMRA, 5-(and-6)-carboxytetramethylrhodamine	Amidation		L	Not available	Not available	23545289	Biomaterials. 2013 Jul;34(20):4872-9. 	Park H, Tsutsumi H, Mihara H.	Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.	
DRAMP35092	LKKLAELAHKLLKLG	15	TAMARA-peptide 2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	TAMRA	Amidation		L	Not available	Not available	23545289	Biomaterials. 2013 Jul;34(20):4872-10. 	Park H, Tsutsumi H, Mihara H.	Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.	
DRAMP35093	GLKKLAELFHKLLKLG	16	Peptide 1N- GNS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Conjugated to nanoparticles	Amidation		L	Not available	Not available	23545289	Biomaterials. 2013 Jul;34(20):4872-11. 	Park H, Tsutsumi H, Mihara H.	Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.	
DRAMP35094	GLKKLAELFHKLLKLG	16	Peptide 1N- GNS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Conjugated to nanoparticles	Amidation		L	Not available	Not available	23545289	Biomaterials. 2013 Jul;34(20):4872-11. 	Park H, Tsutsumi H, Mihara H.	Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.	
DRAMP35095	GLKKLAELAHKLLKLG	16	Peptide 2N- GNS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Conjugated to nanoparticles	Amidation		L	Not available	Not available	23545289	Biomaterials. 2013 Jul;34(20):4872-12. 	Park H, Tsutsumi H, Mihara H.	Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.	
DRAMP35096	BRRRRRRR	8	R7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	B=Beta-Alanine	L	Not available	Not available	23546678	 Methods Mol Biol. 2013;991:281-92. 	Lee JS, Tung CH.	Lipo-oligoarginine-based intracellular delivery.	
DRAMP35097	BRRRRRRRRR	10	C12R9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Lauroylation	Amidation	B=Beta-Alanine	L	Not available	Not available	23546678	 Methods Mol Biol. 2013;991:281-93. 	Lee JS, Tung CH.	Lipo-oligoarginine-based intracellular delivery.	
DRAMP35098	Brrrrrrr	8	C12dR9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Lauroylation	Amidation	B=Beta-Alanine	Mix	Not available	Not available	23546678	 Methods Mol Biol. 2013;991:281-94. 	Lee JS, Tung CH.	Lipo-oligoarginine-based intracellular delivery.	
DRAMP35099	BrrrrrRRRR	10	C12dR9-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Lauroylation	Amidation	B=Beta-Alanine	Mix	Not available	Not available	23546678	 Methods Mol Biol. 2013;991:281-95. 	Lee JS, Tung CH.	Lipo-oligoarginine-based intracellular delivery.	
DRAMP35100	BRRRRrrrrr	10	C12dR9-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Lauroylation	Amidation	B=Beta-Alanine	Mix	Not available	Not available	23546678	 Methods Mol Biol. 2013;991:281-96. 	Lee JS, Tung CH.	Lipo-oligoarginine-based intracellular delivery.	
DRAMP35101	BRRRRRRRRRRR	12	C14R11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Myrsitoylation	Amidation	B=Beta-Alanine	L	Not available	Not available	23546678	 Methods Mol Biol. 2013;991:281-97. 	Lee JS, Tung CH.	Lipo-oligoarginine-based intracellular delivery.	
DRAMP35102	Brrrrrrrrrrr	12	C14dR11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Myrsitoylation	Amidation	B=Beta-Alanine	Mix	Not available	Not available	23546678	 Methods Mol Biol. 2013;991:281-98. 	Lee JS, Tung CH.	Lipo-oligoarginine-based intracellular delivery.	
DRAMP35103	DEVD	4	caspase 3 inhibitor	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	23583573	 Life Sci. 2013 May 30;92(20-21):1004-14. 	Wang C, Zhou Y, Li S, Li H, Tian L, Wang H, Shang D. 	Anticancer mechanisms of temporin-1CEa, an amphipathic α-helical antimicrobial peptide, in Bcap-37 human breast cancer cells.	CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP35104	YGRKKRRQRRREILSRXPAYRKIL	24	CF-TAT-substrate	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Free	X=ATP-binding site inhibitors	L	Not available	Not available	23621550	 ACS Chem Biol. 2013 Jul 19;8(7):1479-87. 	van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.	Cell-penetrating bisubstrate-based protein kinase C inhibitors.	
DRAMP35105	YGRKKRRQRRREILSRXPAYRKIL	24	CF-TAT-substrate	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Free	X=ATP-binding site inhibitors	L	Not available	Not available	23621550	 ACS Chem Biol. 2013 Jul 19;8(7):1479-87. 	van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.	Cell-penetrating bisubstrate-based protein kinase C inhibitors.	
DRAMP35106	YGRKKRRQRRREILSRXPAYRKIL	24	Ac-TAT-substrate	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Free	X=ATP-binding site inhibitors	L	Not available	Not available	23621550	 ACS Chem Biol. 2013 Jul 19;8(7):1479-88. 	van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.	Cell-penetrating bisubstrate-based protein kinase C inhibitors.	
DRAMP35107	YGRKKRRQRRREILSRXPAYRKIL	24	Ac-TAT-substrate	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Free	X=ATP-binding site inhibitors	L	Not available	Not available	23621550	 ACS Chem Biol. 2013 Jul 19;8(7):1479-88. 	van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.	Cell-penetrating bisubstrate-based protein kinase C inhibitors.	
DRAMP35108	KKWKMRRNQFWIKIQREILSRXPAYRKIL	29	CF-Penetratin-substrate	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Free	X=ATP-binding site inhibitors	L	Not available	Not available	23621550	 ACS Chem Biol. 2013 Jul 19;8(7):1479-89. 	van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.	Cell-penetrating bisubstrate-based protein kinase C inhibitors.	
DRAMP35109	KKWKMRRNQFWIKIQREILSRXPAYRKIL	29	CF-Penetratin-substrate	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Free	X=ATP-binding site inhibitors	L	Not available	Not available	23621550	 ACS Chem Biol. 2013 Jul 19;8(7):1479-89. 	van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.	Cell-penetrating bisubstrate-based protein kinase C inhibitors.	
DRAMP35110	KKWKMRRNQFWIKIQREILSRXPAYRKIL	29	Ac-Penetratin-substrate	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Free	X=ATP-binding site inhibitors	L	Not available	Not available	23621550	 ACS Chem Biol. 2013 Jul 19;8(7):1479-90. 	van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.	Cell-penetrating bisubstrate-based protein kinase C inhibitors.	
DRAMP35111	KKWKMRRNQFWIKIQREILSRXPAYRKIL	29	Ac-Penetratin-substrate	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Free	X=ATP-binding site inhibitors	L	Not available	Not available	23621550	 ACS Chem Biol. 2013 Jul 19;8(7):1479-90. 	van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.	Cell-penetrating bisubstrate-based protein kinase C inhibitors.	
DRAMP35112	CRGDK	5	CRGDK	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23634882	Nano Lett. 2013 Jun 12;13(6):2528-34. 	Wei T, Liu J, Ma H, Cheng Q, Huang Y, Zhao J, Huo S, Xue X, Liang Z, Liang XJ.	Functionalized nanoscale micelles improve drug delivery for cancer therapy in vitro and in vivo.	N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CS)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP35113	AYLLGKINLKALAALAKKIL	20	TP10	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation		L	Not available	Not available	23669260	 J Control Release. 2013 Aug 28;170(1):83-91.	Verdurmen WP, Wallbrecher R, Schmidt S, Eilander J, Bovee-Geurts P, Fanghänel S, Bürck J, Wadhwani P, Ulrich AS, Brock R.	Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.	
DRAMP35114	AXLYLLGKINLKALAALAKKIL	22	TP10 2GL	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	X=L-CF3-Bpg, Trifluoromethyl- bicyclopent-[1.1.1]-1-ylglycine	L	Not available	Not available	23669260	 J Control Release. 2013 Aug 28;170(1):83-92.	Verdurmen WP, Wallbrecher R, Schmidt S, Eilander J, Bovee-Geurts P, Fanghänel S, Bürck J, Wadhwani P, Ulrich AS, Brock R.	Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.	
DRAMP35115	AGYXLGKINLKALAALAKKIL	21	TP10 4LL	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	X=L-CF3-Bpg, Trifluoromethyl- bicyclopent-[1.1.1]-1-ylglycine	L	Not available	Not available	23669260	 J Control Release. 2013 Aug 28;170(1):83-93.	Verdurmen WP, Wallbrecher R, Schmidt S, Eilander J, Bovee-Geurts P, Fanghänel S, Bürck J, Wadhwani P, Ulrich AS, Brock R.	Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.	
DRAMP35116	axlyllgkinlkalaalakkil	22	TP10 2GD	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	x=D-CF3-Bpg, Trifluoromethyl- bicyclopent-[1.1.1]-1-ylglycine	D	Not available	Not available	23669260	 J Control Release. 2013 Aug 28;170(1):83-94.	Verdurmen WP, Wallbrecher R, Schmidt S, Eilander J, Bovee-Geurts P, Fanghänel S, Bürck J, Wadhwani P, Ulrich AS, Brock R.	Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.	
DRAMP35117	agyxlgkinlkalaalakkil	21	TP10 4LD	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	x=D-CF3-Bpg, Trifluoromethyl- bicyclopent-[1.1.1]-1-ylglycine	D	Not available	Not available	23669260	 J Control Release. 2013 Aug 28;170(1):83-95.	Verdurmen WP, Wallbrecher R, Schmidt S, Eilander J, Bovee-Geurts P, Fanghänel S, Bürck J, Wadhwani P, Ulrich AS, Brock R.	Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.	
DRAMP35118	IGGYCSWLRL,IGGYCSWLRL	21	Harmoniasin A4, HaA4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	23732481	Int J Oncol. 2013 Aug;43(2):622-8.	Kim IW, Lee JH, Kwon YN, Yun EY, Nam SH, Ahn MY, Kang DC, Hwang JS.	Anticancer activity of a Synthetic peptide peptide derived from harmoniasin, an antibacterial peptide from the ladybug Harmonia axyridis	
DRAMP35119	CLLFVY	6		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23796364	J Am Chem Soc. 2013 Jul 17;135(28):10418-25. 	Miranda E, Nordgren IK, Male AL, Lawrence CE, Hoakwie F, Cuda F, Court W, Fox KR, Townsend PA, Packham GK, Eccles SA, Tavassoli A.	A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
DRAMP35120	Xaix	4	Asperterrestide A	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	23806112	 J Nat Prod. 2013 Jun 28;76(6):1182-6.	He F, Bao J, Zhang XY, Tu ZC, Shi YM, Qi SH.	Asperterrestide A, a cytotoxic cyclic tetrapeptide from the marine-derived fungus Aspergillus terreus SCSGAF0162	
DRAMP35121	VGAlAvVvWlWlWlWbAGSGPKKKRKVC	28	artifcial CPP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	23812036	Nanoscale. 2013 Aug 21;5(16):7256-64. 	Jiang X, Wang G, Liu R, Wang Y, Wang Y, Qiu X, Gao X. 	RNase non-sensitive and endocytosis independent siRNA delivery system: delivery of siRNA into tumor cells and high efficiency induction of apoptosis.	
DRAMP35122	AGYLLGHINLHHLAHLHHILC	21	TH peptide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23891517	Biomaterials. 2013 Oct;34(32):7980-93. 	Zhang Q, Tang J, Fu L, Ran R, Liu Y, Yuan M, He Q. 	A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. 	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O
DRAMP35123	AGYLLGHINLHHLAHLHHIL	20	TH peptide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	23891517	Biomaterials. 2013 Oct;34(32):7980-94. 	Zhang Q, Tang J, Fu L, Ran R, Liu Y, Yuan M, He Q. 	A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. 	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP35124	AGYLLGKINLKKLAKLLLIL	20	TK peptide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	23891517	Biomaterials. 2013 Oct;34(32):7980-95. 	Zhang Q, Tang J, Fu L, Ran R, Liu Y, Yuan M, He Q. 	A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)N)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP35125	KILRGVAKKILRTFLRRISKDILTGKK	27	C7A	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	23893605	 J Pept Sci. 2013 Oct;19(10):619-28. 	Gross S, Wilms D, Krause J, Brezesinski G, Andrä J. 	Design of NK-2-derived peptides with improved activity against equine sarcoid cells. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O
DRAMP35126	TPWWRLWTKWHHKRRDLPRKPEGC	24	FITC-Rath	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23937069	J Drug Target. 2013 Nov;21(9):801-8. 	Kuo JH, Lin CW.	Cellular uptake on N- and C-termini conjugated FITC of Rath cell penetrating peptides and its consequences for gene-expression profiling in U-937 human macrophages and HeLa cervical cancer cells.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)[C@@H](C)O
DRAMP35129	LTFEHYWAQLTS	12	ATSP-3848	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells:  -- (IC50 for MDM2=0.29 µM);  -- (IC50 for MDMX-p53=1.6 µM)	Not available	Linear	Acetylation	Amidation		L	Not available	MDM2, MDMX	23946421	Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):E3445-55.	Chang YS, Graves B, Guerlavais V, Tovar C, Packman K, To KH, Olson KA, Kesavan K, Gangurde P, Mukherjee A, Baker T, Darlak K, Elkin C, Filipovic Z, Qureshi FZ, Cai H, Berry P, Feyfant E, Shi XE, Horstick J, Annis DA, Manning AM, Fotouhi N, Nash H, Vassilev LT, Sawyer TK.	Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy	CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O
DRAMP35130	LTFEHYWAQLTS	12	ATSP-3848	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	MDM2, MDMX	23946421	Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):E3445-55.	Chang YS, Graves B, Guerlavais V, Tovar C, Packman K, To KH, Olson KA, Kesavan K, Gangurde P, Mukherjee A, Baker T, Darlak K, Elkin C, Filipovic Z, Qureshi FZ, Cai H, Berry P, Feyfant E, Shi XE, Horstick J, Annis DA, Manning AM, Fotouhi N, Nash H, Vassilev LT, Sawyer TK.	Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy	CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O
DRAMP35136	LSTAADMQGVVTDGMASGLDKDYLKPDD	28	p28	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	23952735	Mol Pharm. 2013 Sep 3;10(9):3375-83	Yamada T, Das Gupta TK, Beattie CW. 	p28, an anionic cell-penetrating peptide, increases the activity of wild type and mutated p53 without altering its conformation.	CSCC[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP35137	Pr	2	Cyclo(L-Pro-D-Arg), Diketopiperazine (Pr)	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	24097052	Folia Microbiol (Praha). 2014 May;59(3):197-202.	Kumar SN, Mohandas C, Nambisan B, Sreerag RS, Jayaprakas CA.	Cyclo(L-Pro-D-Arg): a new antibacterial and antitumour diketopiperazine from Bacillus cereus associated with a rhabditid entomopathogenic	N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1)C(=O)O
DRAMP35138	RXRRXRILFQYRXRRXR	17	LB1_1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-30. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35139	RXRRXRYQFLIRXRRXR	17	LB1_2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-31. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35140	RXRRXRFLQIYRXRRXR	17	LB1_3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-32. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35141	RXRRXRAAAAARXRRXR	17	LB1_4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-33. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35142	RXRRXRIKFQYRXRRXR	17	LB1_5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-34. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35143	RXRRXRIEFQYRXRRXR	17	LB1_6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-35. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35144	RXRRXRIWFQYRXRRXR	17	LB1_7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-36. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35145	RXRRXRIPFQYRXRRXR	17	LB1_8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-37. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35146	KXRKXRILFQYKXRKXR	17	LB1_9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-38. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35147	HXRHXRILFQYHXRHXR	17	LB1_10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-39. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35148	SXRSXRILFQYSXRSXR	17	LB1_11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-40. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35149	EXREXRILFQYEXREXR	17	LB1_12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-41. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35150	RMKWKKILFQYRXRRXR	17	LB1_13	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-42. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35151	RXRRXRILFQYRMKWKK	17	LB1_14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-43. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35152	KKWKMRILFQYRXRRXR	17	LB1_15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-44. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35153	RXRRXRILFQYKKWKMR	17	LB1_16	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	N-terminal alkyne is introduced using 4-pentynoic acid	Amidation	X=aminohexyl residue	L	Not available	Not available	24105028	 Org Biomol Chem. 2013 Nov 21;11(43):7621-45. 	Deuss PJ, Arzumanov AA, Williams DL, Gait MJ. 	Parallel synthesis and splicing redirection activity of cell-penetrating peptide conjugate libraries of a PNA cargo.	
DRAMP35154	YGRKKRRQRRRREADFFWSLCTADMS	26	KilerFLIP	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	24176852	 Cell Death Dis. 2013 Oct 31;4(10):e894.	Pennarun B, Gaidos G, Bucur O, Tinari A, Rupasinghe C, Jin T, Dewar R, Song K, Santos MT, Malorni W, Mierke D, Khosravi-Far R.	killerFLIP: a novel lytic peptide specifically inducing cancer cell death.	CSCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O
DRAMP35155	KLULKLULKULKAULKLU	18	MAP(Aib)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	U=α-amino isobutyric acid (Aib)	L	Not available	Not available	24216093	Bioorg Med Chem. 2013 Dec 15;21(24):7669-73	Wada S, Hashimoto Y, Kawai Y, Miyata K, Tsuda H, Nakagawa O, Urata H. 	Effect of Ala replacement with Aib in amphipathic cell-penetrating peptide on oligonucleotide delivery into cells.	
DRAMP35156	RKKRRQRRRGGG	12	Tat	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24218116	 J Pharm Sci. 2014 Jan;103(1):293-304.	Alkotaji M, Pluen A, Zindy E, Hamrang Z, Aojula H.	On the cellular uptake and membrane effect of the multifunctional peptide, TatLK15.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)NCC(N)=O
DRAMP35157	RKKRRQRRRGGGKLLKLLLKLLLKLLK	27	TatLK15	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24218116	 J Pharm Sci. 2014 Jan;103(1):293-305.	Alkotaji M, Pluen A, Zindy E, Hamrang Z, Aojula H.	On the cellular uptake and membrane effect of the multifunctional peptide, TatLK15.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35161	XVTXVXVXXVXV	12	Ohmyungsamycin B	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24266328	J Org Chem. 2013 Dec 20;78(24):12321-9. 	Um S, Choi TJ, Kim H, Kim BY, Kim SH, Lee SK, Oh KB, Shin J, Oh DC. 	Ohmyungsamycins A and B: cytotoxic and antimicrobial cyclic peptides produced by Streptomyces sp from a volcanic island	
DRAMP35162	KCFQAQRNMRKVRGPPVSCIKR	22	hLF W5A	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-29. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35163	KCFQWARNMRKVRGPPVSCIKR	22	hLF Q6A	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-30. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35164	KCFQWQRNARKVRGPPVSCIKR	22	hLF M9A	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-31. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35165	KCFQWQRNMRKVRGAPVSCIKR	22	hLF P15A	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-32. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35166	KCFQWQRNMRKRRGPPVSCIKR	22	hLF V12R	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-33. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35167	KCFQWQANMRKVRGPPVSCIKR	22	hLF R7A	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-34. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35168	KCFQWQRNMRKVAGPPVSCIKR	22	hLF R13A	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-35. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35169	KCFQWQANMRKRRGPPVSCIKR	22	hLF R7A/V12R	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-36. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35170	KCFQWQRNMRKVAGRPVSCIKR	22	hLF R13A/P15R	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-37. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35171	KCFRWQRNRRKVRGRPVRCIKR	22	hLF +4R	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-38. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35172	KRFRWQRNMRKVRGRPVRSIKR	22	hLF lin+4R	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-39. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35173	RCFQWQRNMRRVRGPPVSCIRR	22	hLF R7	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-40. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35174	KCFQWQKNMKKVKGPPVSCIKK	22	hLF K7	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation		L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-41. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35175	KXFQWQRNMRKVRGPPVSXIKR	22	hLF Hcy	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Fluorescein	Amidation	X=Hcy, homocysteine in which the side chain is one methylene group longer than in cysteine	L	Not available	Not available	24270856	Cell Mol Life Sci. 2014 Jul;71(14):2717-42. 	Wallbrecher R, Verdurmen WP, Schmidt S, Bovee-Geurts PH, Broecker F, Reinhardt A, van Kuppevelt TH, Seeberger PH, Brock R.	The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.	
DRAMP35176	GALFLAFLAAALSLMGLWSQPKKKRKV	27	MPGα	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Cysteamide group		L	Not available	Not available	24275947	Pharmaceuticals (Basel). 2013 Feb 6;6(2):184-203. 	Keller AA, Mussbach F, Breitling R, Hemmerich P, Schaefer B, Lorkowski S, Reissmann S.	Relationships between Cargo, Cell Penetrating Peptides and Cell Type for Uptake of Non-Covalent Complexes into Live Cells.	
DRAMP35177	KLPVM	5	CPPP-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24275947	Pharmaceuticals (Basel). 2013 Feb 6;6(2):184-204. 	Keller AA, Mussbach F, Breitling R, Hemmerich P, Schaefer B, Lorkowski S, Reissmann S.	Relationships between Cargo, Cell Penetrating Peptides and Cell Type for Uptake of Non-Covalent Complexes into Live Cells.	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
DRAMP35178	KLFMALVAFLRFLTIPPTAGILKRWGTI	28	pepM	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free		L	Not available	Not available	24286593	FEBS J. 2014 Jan;281(1):191-215.	Freire JM, Veiga AS, Rego de Figueiredo I, de la Torre BG, Santos NC, Andreu D, Da Poian AT, Castanho MA.	Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action.	
DRAMP35179	LKRWGTIKKSKAINVLRGFRKEIGRMLNILNRRRR	35	pepR	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free		L	Not available	Not available	24286593	FEBS J. 2014 Jan;281(1):191-216.	Freire JM, Veiga AS, Rego de Figueiredo I, de la Torre BG, Santos NC, Andreu D, Da Poian AT, Castanho MA.	Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action.	
DRAMP35180	CETPSKHFNGLCIRSSNCASVCHGEHFTDGRCQGVRRRCMCLKPC	45	PaDef 	Not available		Not found	Persea americana	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	24319695	Biomed Res Int. 2013;2013:986273. 	Guzmán-Rodríguez JJ, López-Gómez R, Suárez-Rodríguez LM, Salgado-Garciglia R, Rodríguez-Zapata LC, Ochoa-Zarzosa A, López-Meza JE.	Antibacterial activity of defensin PaDef from avocado fruit (Persea americana var. drymifolia) expressed in endothelial cells against Escherichia coli and Staphylococcus aureus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP35181	CELAGIGILTVRKKRRQRRR	20	Alexa488-Melan-A-TAT	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Conjugation with Alexa488 C5 maleimide	Free		L	Not available	Not available	24372650	 Exp Dermatol. 2014 Jan;23(1):20-6. 	Buhl T, Braun A, Forkel S, Möbius W, van Werven L, Jahn O, Rezaei-Ghaleh N, Zweckstetter M, Mempel M, Schön MP, Haenssle HA. 	Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.	
DRAMP35182	CELAGIGILTVKKKKKQKKK	20	Alexa488-Melan-A-polyLys (control peptide)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24372650	 Exp Dermatol. 2014 Jan;23(1):20-7. 	Buhl T, Braun A, Forkel S, Möbius W, van Werven L, Jahn O, Rezaei-Ghaleh N, Zweckstetter M, Mempel M, Schön MP, Haenssle HA. 	Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@H](C)CC
DRAMP35183	RIMRILRILKLAR	13	DS4.3	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24416126	PLoS One. 2014 Jan 8;9(1):e80050. 	Jeong JH, Kim K, Lim D, Jeong K, Hong Y, Nguyen VH, Kim TH, Ryu S, Lim JA, Kim JI, Kim GJ, Kim SC, Min JJ, Choy HE.	Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35184	GRGDSPRR	8	Pep1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Free	Phosphorylation	L	Not available	Not available	24462902	J Control Release. 2014 Apr 10;179:1-9. 	Remaut K, Symens N, Lucas B, Demeester J, De Smedt SC. 	Cell division responsive peptides for optimized plasmid DNA delivery: the mitotic window of opportunity?	
DRAMP35185	GRGDSPRRSPRR	12	Pep2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Free	Phosphorylation	L	Not available	Not available	24462902	J Control Release. 2014 Apr 10;179:1-10. 	Remaut K, Symens N, Lucas B, Demeester J, De Smedt SC. 	Cell division responsive peptides for optimized plasmid DNA delivery: the mitotic window of opportunity?	
DRAMP35186	GRGDSPRRKKKKSPRRKKKKSPRR	24	Pep3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Free	Phosphorylation	L	Not available	Not available	24462902	J Control Release. 2014 Apr 10;179:1-11. 	Remaut K, Symens N, Lucas B, Demeester J, De Smedt SC. 	Cell division responsive peptides for optimized plasmid DNA delivery: the mitotic window of opportunity?	
DRAMP35187	GRGDGPRRKKKKGPRRKKKKGPRR	24	Pep3(Mutant)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Free		L	Not available	Not available	24462902	J Control Release. 2014 Apr 10;179:1-12. 	Remaut K, Symens N, Lucas B, Demeester J, De Smedt SC. 	Cell division responsive peptides for optimized plasmid DNA delivery: the mitotic window of opportunity?	CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35188	XPX	3	Psychrophilin E	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24483240	 Nat Prod Res. 2014;28(11):776-81. 	Ebada SS, Fischer T, Hamacher A, Du FY, Roth YO, Kassack MU, Wang BG, Roth EH.	Psychrophilin E, a new cyclotripeptide, from co-fermentation of two marine alga-derived fungi of the genus Aspergillus	
DRAMP35189	CGGKDCERRFSRSDQLKRHQRRHTGVKPFQ	30	b-WT1-pTj	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation	Amidation		L	Not available	Not available	24490140	FEBS Open Bio. 2014 Jan 21;4:153-61. 	Massaoka MH, Matsuo AL, Figueiredo CR, Girola N, Faria CF, Azevedo RA, Travassos LR.	A novel cell-penetrating peptide derived from WT1 enhances p53 activity, induces cell senescence and displays antimelanoma activity in xeno- and syngeneic systems.	
DRAMP35190	KDCERRFSRSDQLKRHQRRHTGVKPFQK	28	FITC-WT1-pTj	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24490140	FEBS Open Bio. 2014 Jan 21;4:153-62. 	Massaoka MH, Matsuo AL, Figueiredo CR, Girola N, Faria CF, Azevedo RA, Travassos LR.	A novel cell-penetrating peptide derived from WT1 enhances p54 activity, induces cell senescence and displays antimelanoma activity in xeno- and syngeneic systems.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP35191	YGRGGRRGRRR	11	RTAT-ELPBC	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	ELPBC	Free		L	Not available	Not available	24611762	Nano Lett. 2014;14(4):2058-64.	MacEwan SR, Chilkoti A	Controlled apoptosis by a thermally toggled nanoscale amplifier of cellular uptake.	
DRAMP35192	RRRRRRRRRGDfK	13	R8-RGD-lipo	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	Cysteine modified octa-arginine conjugated to the branch of lysine	Mix	Not available	Not available	24651033	Biomaterials. 2014 Jun;35(17):4835-47.	Liu Y, Ran R, Chen J, Kuang Q, Tang J, Mei L, Zhang Q, Gao H, Zhang Z, He Q. 	Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.	
DRAMP35193	BRRXRRXRRX	10	FAM-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FAM, fluorescein	Amidation	B=Beta-Alanine; X=α-amino isobutyric acid	L	Not available	Not available	24661993	Bioorg Med Chem. 2014 Apr 15;22(8):2403-8. 	Yamashita H, Demizu Y, Shoda T, Sato Y, Oba M, Tanaka M, Kurihara M.	Amphipathic short helix-stabilized peptides with cell-membrane penetrating ability.	
DRAMP35194	BrrXrrXrrX	10	ent FAM-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FAM, fluorescein	Amidation	B=Beta-Alanine; X=α-amino isobutyric acid	Mix	Not available	Not available	24661993	Bioorg Med Chem. 2014 Apr 15;22(8):2403-9. 	Yamashita H, Demizu Y, Shoda T, Sato Y, Oba M, Tanaka M, Kurihara M.	Amphipathic short helix-stabilized peptides with cell-membrane penetrating ability.	
DRAMP35195	BRrXRrXRrX	10	FAM-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FAM, fluorescein	Amidation	B=Beta-Alanine; X=α-amino isobutyric acid	Mix	Not available	Not available	24661993	Bioorg Med Chem. 2014 Apr 15;22(8):2403-10. 	Yamashita H, Demizu Y, Shoda T, Sato Y, Oba M, Tanaka M, Kurihara M.	Amphipathic short helix-stabilized peptides with cell-membrane penetrating ability.	
DRAMP35196	BXRXRXXRXRXXRXRX	16	FAM-3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FAM, fluorescein	Amidation	B=Beta-Alanine; X=α-amino isobutyric acid	L	Not available	Not available	24661993	Bioorg Med Chem. 2014 Apr 15;22(8):2403-11. 	Yamashita H, Demizu Y, Shoda T, Sato Y, Oba M, Tanaka M, Kurihara M.	Amphipathic short helix-stabilized peptides with cell-membrane penetrating ability.	
DRAMP35197	LPIP	4		Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=26.6µM); HeLa (IC50=34.7µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	24690914	J Antibiot (Tokyo). 2014 Jul;67(7):541-3. 	Gao CH, Chen YN, Pan LX, Lei F, Long B, Hu LQ, Zhang RC, Ke K, Huang RM. 	Two new cyclic tetrapeptides from deep-sea bacterium Bacillus amyloliquefaciens GAS 00152	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP35198	FPYG	4		Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=38.2µM); HeLa (IC50=46.1µM)	Not available	Cyclic	Free	Free		L	Not available	Not available	24690914	J Antibiot (Tokyo). 2014 Jul;67(7):541-4. 	Gao CH, Chen YN, Pan LX, Lei F, Long B, Hu LQ, Zhang RC, Ke K, Huang RM. 	Two new cyclic tetrapeptides from deep-sea bacterium Bacillus amyloliquefaciens GAS 00152	N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O
DRAMP35199	GGGGRRRRRRRRRLLLL	17	m9R	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Maleimide addition	Free		L	Not available	Not available	24696462	Genome Res. 2014 Jun;24(6):1020-7. 	Ramakrishna S, Kwaku Dad AB, Beloor J, Gopalappa R, Lee SK, Kim H.	Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.	
DRAMP35200	CGGGRRRRRRRRRLLLL	17	sgRNA-CPP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24696462	Genome Res. 2014 Jun;24(6):1020-8. 	Ramakrishna S, Kwaku Dad AB, Beloor J, Gopalappa R, Lee SK, Kim H.	Gene disruption by cell-penetrating peptide-mediated delivery of Cas10 protein and guide RNA.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H](N)CS)C(=O)O
DRAMP35201	XACSGSGSGCGSGSGSCG	18	IA0 (Bicyclic) (integral arginine peptides)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-64.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35202	XACSGRGSGCGSGRGSCG	18	IA2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-65.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35203	XACRGSGRGCGRGSGRCG	18	IA4a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-66.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35204	XACSGRGRGCGRGRGSCG	18	IA4b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-67.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35205	XACRGRGRGCGRGRGRCG	18	IA6a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-68.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35206	XACGRGRGRCRGRGRGCG	18	IA6b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-69.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35207	XACRGRGRGCRGRGRGCG	18	IA6c	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-70.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35208	XACGRGRGRCGRGRGRCG	18	IA6d	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-71.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35209	XACRGRRRGCGRRRGRCG	18	IA8a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-72.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35210	XACRRSRRGCGRRSRRCG	18	IA8b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-73.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35211	XACRRSRRGCGRRSRRCG	18	IA8b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-73.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35212	XACSDRFRNCPADEALCG	18	kCA2 (Kallikrein inhibitor with internal arginines)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-74.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35213	XACRDRFRNCPADEALCG	18	kCA3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-75.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35214	XACRDRFRNCPADERLCG	18	kCA4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-76.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35215	XACRDRFRRCPADERLCG	18	kCA5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-77.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35216	XACRDRFRRCPADRRLCG	18	kCA6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-78.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35217	XACSGRGRGCGSGSGSCG	18	CA2 (Control internal arginine )	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-79.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35218	XACRGRGRGCGSGSGSCG	18	CA3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-80.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35219	XACRGRGRGCGSGSRSCG	18	CA4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-81.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35220	XACRGRGRRCGSGSRSCG	18	CA5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-82.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35221	XACRGRGRRCGSGRRSCG	18	CA6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-83.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35222	XACRGRGRRCGSGRRSCG	18	CA6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-83.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35223	XARCSGSGSGCGSGSGSCGR	20	EA2x1 (External arginines)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-84.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35224	XARRCSGSGSGCGSGSGSCGRR	22	EA2x2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-85.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35225	XARRRCSGSGSGCGSGSGSCGRRR	24	EA2x3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-86.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35226	XARRRRCSGSGSGCGSGSGSCGRRRR	26	EA2x4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-87.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35227	XACSGSGSGCGSGSGSCGRRRRRRRR	26	EA1x8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-88.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35228	XACSGSGSGCGSGSGSCGRRRRRRRR	26	EA1x8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-88.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35229	XARCSDRFRNCPADEALCGR	20	kEA2x1 (Kallikrein inhibitor with external arginines)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-89.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35230	XARRCSDRFRNCPADEALCGRR	22	kEA2x2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-90.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35231	XARRRCSDRFRNCPADEALCGRRR	24	kEA2x3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-91.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35232	XARRRRCSDRFRNCPADEALCGRRRR	26	kEA2x4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-92.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35233	XACSDRFRNCPADEALCGRRRRRRRR	26	kEA1 8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-93.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35234	XACSDRFRNCPADEALCGRRRRRRRR	26	kEA1 8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-93.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35235	XACRRSRRGCGRRSRRCG	18	IA8b L (Linear variants)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-94.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35236	XACRRSRRGCGRRSRRCG	18	IA8b L (Linear variants)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-94.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35237	XACRGRGRRCGSGRRSCG	18	CA6 L	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-95.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35238	XACRGRGRRCGSGRRSCG	18	CA6 L	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-95.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35239	XACSGSGSGCGSGSGSCGRRRRRRRR	26	EA1x8 L	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-96.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35240	XACSGSGSGCGSGSGSCGRRRRRRRR	26	EA1x8 L	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-96.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35241	XACSDRFRNCPADEALCGRRRRRRRR	26	kEA1x8L	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-97.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35242	XACSDRFRNCPADEALCGRRRRRRRR	26	kEA1x8L	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-97.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35243	XACSHSGHGCGHGSHSCGRRRRRRRR	26	EA8_4H (Histidine/tryptophan peptides)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-98.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35244	XACSHSGWGCGHGSWSCGRRRRRRRR	26	EA8_2H2W	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-99.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35245	XACHGRRWGCGRHRGRCG	18	IA5_2H1W	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	24697151	ioconjug Chem. 2014 May 21;25(5):955-100.	Wallbrecher R, Depré L, Verdurmen WP, Bovée-Geurts PH, van Duinkerken RH, Zekveld MJ, Timmerman P, Brock R.	Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. 	
DRAMP35246	HEHEHEHEHEHEHEHEEFGGGGGYGRGRGRGRGRGRG	37	GST-(HE)8EFG5YG(RG)6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Glutathione S-transferase	Free		L	Not available	Not available	24697211	 Mol Pharm. 2014 May 5;11(5):1583-90. 	Sun C, Shen WC, Tu J, Zaro JL. 	Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers.	
DRAMP35247	HEHEHEHEHEHEHEHEHEHEEFGGGGGYGRGRGRGRGRGRG	41	GST-(HE)10EFG5YG(RG)6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Glutathione S-transferase	Free		L	Not available	Not available	24697211	 Mol Pharm. 2014 May 5;11(5):1583-91. 	Sun C, Shen WC, Tu J, Zaro JL. 	Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers.	
DRAMP35248	HEHEHEHEHEHEHEHEHEHEHEHEEFGGGGGYGRGRGRGRGRGRG	45	GST-(HE)12EFG5YG(RG)6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Glutathione S-transferase	Free		L	Not available	Not available	24697211	 Mol Pharm. 2014 May 5;11(5):1583-92. 	Sun C, Shen WC, Tu J, Zaro JL. 	Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers.	
DRAMP35249	HEHEHEHEHEHEHEHEEFGGGGGYGRRRRRRGGGGGG	37	GST-(HE)8EFG5YGR6G6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Glutathione S-transferase	Free		L	Not available	Not available	24697211	 Mol Pharm. 2014 May 5;11(5):1583-93. 	Sun C, Shen WC, Tu J, Zaro JL. 	Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers.	
DRAMP35250	HEHEHEHEHEHEHEHEHEHEEFGGGGGYGRRRRRRGGGGGG	41	GST-(HE)10EFG5YGR6G6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Glutathione S-transferase	Free		L	Not available	Not available	24697211	 Mol Pharm. 2014 May 5;11(5):1583-94. 	Sun C, Shen WC, Tu J, Zaro JL. 	Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers.	
DRAMP35251	HEHEHEHEHEHEHEHEHEHEHEHEEFGGGGGYGRRRRRRGGGGGG	45	GST-(HE)12EFG5YGR6G6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Glutathione S-transferase	Free		L	Not available	Not available	24697211	 Mol Pharm. 2014 May 5;11(5):1583-95. 	Sun C, Shen WC, Tu J, Zaro JL. 	Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers.	
DRAMP35252	HEHEHEHEHEHEHEHEHEHEHEHEEFGGGGGYGRKKRRQRRR	42	GST-(HE)12EFG5-TAT	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Glutathione S-transferase	Free		L	Not available	Not available	24697211	 Mol Pharm. 2014 May 5;11(5):1583-96. 	Sun C, Shen WC, Tu J, Zaro JL. 	Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers.	
DRAMP35253	IPLVVPLC	8	IPL	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24704199	Eur J Pharm Biopharm. 2014 Aug;87(3):489-99. 	Kang MH, Park MJ, Yoo HJ, hyuk KY, Lee SG, Kim SR, Yeom DW, Kang MJ, Choi YW. 	RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells.	CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
DRAMP35254	IPLVVPLRRRRRRRRC	16	RIPL peptide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24704199	Eur J Pharm Biopharm. 2014 Aug;87(3):489-100. 	Kang MH, Park MJ, Yoo HJ, hyuk KY, Lee SG, Kim SR, Yeom DW, Kang MJ, Choi YW. 	RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells.	CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
DRAMP35255	PKKKRKVAGYLLGKINLKALAALAKKILPQMQQNVFQYPGAGMVPQGEANF	51	TP10-SRC1LXXLL	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24705462	Int J Mol Sci. 2014 Apr 3;15(4):5680-98. 	Tints K, Prink M, Neuman T, Palm K. 	LXXLL peptide converts transportan 10 to a potent inducer of apoptosis in breast cancer cells.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)[C@H](C)CC
DRAMP35256	PKKKRKVRRRRRRRYSQTSHKLVQLLTTAEQQ	32	R7-SRC1LXXLL	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24705462	Int J Mol Sci. 2014 Apr 3;15(4):5680-99. 	Tints K, Prink M, Neuman T, Palm K. 	LXXLL peptide converts transportan 10 to a potent inducer of apoptosis in breast cancer cells.	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP35257	PKKKRKVRRRRRRRPQMQQNVFQYPGAGMVPQGEANF	37	R7-SRC1(1222-1245)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	NLS	Free		L	Not available	Not available	24705462	Int J Mol Sci. 2014 Apr 3;15(4):5680-100. 	Tints K, Prink M, Neuman T, Palm K. 	LXXLL peptide converts transportan 10 to a potent inducer of apoptosis in breast cancer cells.	
DRAMP35258	AYGRKKRRQRRR	12	TAT-cysteine peptide	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24709209	Int J Pharm. 2014 Jul 1;468(1-2):26-38.	Mei L, Fu L, Shi K, Zhang Q, Liu Y, Tang J, Gao H, Zhang Z, He Q.	Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.	C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35259	WELVVLGKLYGRKKRRQRRR	20	pep5-cpp	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-26. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35260	ELVVLGKLYGRKKRRQRRR	19	N-pep5-cpp	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-27. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35261	LVVLGKLYGRKKRRQRRR	18	N2-pep5-cpp	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-28. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35262	VVLGKLYGRKKRRQRRR	17	N3-pep5-cpp	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-29. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35263	WELVVLGKYGRKKRRQRRR	19	C1-pep5-cpp	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-30. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35264	WELVVLGYGRKKRRQRRR	18	C2-pep5-cpp	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-31. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35265	WELVVLYGRKKRRQRRR	17	C3-pep5-cpp*	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-32. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35266	WELVVLYGRKKRRQRRR	17	C3-pep5-cpp*	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-32. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35267	WELVVYGRKKRRQRRR	16	C4-pep5-cpp	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-33. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35268	WELVYGRKKRRQRRR	15	C5-pep5-cpp	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-34. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35269	WELYGRKKRRQRRR	14	C6-pep5-cpp	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-35. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35270	WEYGRKKRRQRRR	13	C7-pep5-cpp	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-36. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)O
DRAMP35271	WELVVAYGRKKRRQRRR	17	A	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-37. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35272	WEAVVLYGRKKRRQRRR	17	B	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-38. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35273	WEAVVAYGRKKRRQRRR	17	C	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-39. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35274	WELVVLYGRKKRRQRRR	17	Ac-pep5-cpp	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-40. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
DRAMP35275	WELVVLYGRKKRRQRRR	17	Ac-pep5-cpp	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Free		L	Not available	Not available	24764300	 J Biol Chem. 2014 Jun 13;289(24):16711-40. 	de Araujo CB, Russo LC, Castro LM, Forti FL, do Monte ER, Rioli V, Gozzo FC, Colquhoun A, Ferro ES. 	A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.	CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
DRAMP35276	YARVRRRGPRR	11	Hph-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	6-histidine tag	Free		L	Not available	Not available	24768403	 Int J Pharm. 2014 Jul 20;469(1):206-13.	Li H, Zheng X, Koren V, Vashist YK, Tsui TY.	Highly efficient delivery of siRNA to a heart transplant model by a novel cell penetrating peptide-dsRNA binding domain.	
DRAMP35277	CRQIKIWFQNRRMKWKK	17	Penetratin	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	24796502	Biochim Biophys Acta. 2014 Aug;1838(8):2087-98.	Alves ID, Carré M, Montero MP, Castano S, Lecomte S, Marquant R, Lecorché P, Burlina F, Schatz C, Sagan S, Chassaing G, Braguer D, Lavielle S. 	A proapoptotic peptide conjugated to penetratin selectively inhibits tumor cell growth.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(C)=O)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35278	CRQIKIWFQNRRMKWKKKLAKLAKKLAKLAK	31	KLA-Pen	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	24796502	Biochim Biophys Acta. 2014 Aug;1838(8):2087-99.	Alves ID, Carré M, Montero MP, Castano S, Lecomte S, Marquant R, Lecorché P, Burlina F, Schatz C, Sagan S, Chassaing G, Braguer D, Lavielle S. 	A proapoptotic peptide conjugated to penetratin selectively inhibits tumor cell growth.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(C)=O)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35279	LCLRPVG	7	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4900.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C
DRAMP35280	LCLRP	5	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4901.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O
DRAMP35281	LCLR	4	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4902.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35282	LLR	3	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4903.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35283	LLLR	4	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4904.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35284	LLLLR	5	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4905.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35285	LLLRR	5	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4906.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35286	IIIR	4	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4907.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@H](C)CC
DRAMP35287	VVVR	4	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4908.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
DRAMP35288	LCLK	4	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4909.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP35289	LCLH	4	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4910.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP35290	LCLE	4	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4911.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP35291	LCLN	4	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4912.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP35292	LCLQ	4	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4913.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP35293	lclrpvg	7	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4914.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@@H](N)C(=O)N[C@H](CS)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](C(=O)NCC(=O)O)C(C)C
DRAMP35294	lclrp	5	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4915.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@@H](N)C(=O)N[C@H](CS)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N1CCC[C@@H]1C(=O)O
DRAMP35295	lclr	4	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4916.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@@H](N)C(=O)N[C@H](CS)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)O
DRAMP35296	lcl	3	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4917.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@@H](N)C(=O)N[C@H](CS)C(=O)N[C@H](CC(C)C)C(=O)O
DRAMP35297	icir	4	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4918.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC[C@H](C)[C@@H](N)C(=O)N[C@H](CS)C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
DRAMP35298	vcvr	4	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4919.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)[C@@H](N)C(=O)N[C@H](CS)C(=O)N[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35299	vlclr	5	Xentry peptides	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	24811205	Sci Rep. 2014 May 9;4:4920.	Montrose K, Yang Y, Krissansen GW. 	The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.	CC(C)C[C@@H](NC(=O)[C@@H](CS)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](N)C(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)O
DRAMP35300	CRRLRHLRHHYRRRWHRFRC	20	Mgpe-9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	Addition of cysteine in Mgpe3 sequence makes Mgpe9	L	Not available	Not available	24816284	 Biomaterials. 2014 Aug;35(24):6563-75. 	Sharma R, Nisakar D, Shivpuri S, Ganguli M.	Contrasting effects of cysteine modification on the transfection efficiency of amphipathic peptides.	
DRAMP35301	CLLYWFRRRHRHHRRRHRRC	20	Mgpe-10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	Addition of cysteine in Mgpe4 sequence makes Mgpe10	L	Not available	Not available	24816284	 Biomaterials. 2014 Aug;35(24):6563-76. 	Sharma R, Nisakar D, Shivpuri S, Ganguli M.	Contrasting effects of cysteine modification on the transfection efficiency of amphipathic peptides.	
DRAMP35302	RRLRHLRHHYRRRWHRFR	18	Mgpe-3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24816284	 Biomaterials. 2014 Aug;35(24):6563-77. 	Sharma R, Nisakar D, Shivpuri S, Ganguli M.	Contrasting effects of cysteine modification on the transfection efficiency of amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35303	LLYWFRRRHRHHRRRHRR	18	Mgpe-4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	24816284	 Biomaterials. 2014 Aug;35(24):6563-78. 	Sharma R, Nisakar D, Shivpuri S, Ganguli M.	Contrasting effects of cysteine modification on the transfection efficiency of amphipathic peptides.	CC(C)C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35304	GLKKLARLFHKLLKLGC	17	RF	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24867193	Org Biomol Chem. 2014 Jul 14;12(26):4673-81.	Yang J, Tsutsumi H, Furuta T, Sakurai M, Mihara H. 	Interaction of amphiphilic α-helical cell-penetrating peptides with heparan sulfate.	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP35305	GLKKLAELFHKLLKLGC	17	EF	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24867193	Org Biomol Chem. 2014 Jul 14;12(26):4673-82.	Yang J, Tsutsumi H, Furuta T, Sakurai M, Mihara H. 	Interaction of amphiphilic α-helical cell-penetrating peptides with heparan sulfate.	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP35306	GLKKLARLAHKLLKLGC	17	RA	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24867193	Org Biomol Chem. 2014 Jul 14;12(26):4673-83.	Yang J, Tsutsumi H, Furuta T, Sakurai M, Mihara H. 	Interaction of amphiphilic α-helical cell-penetrating peptides with heparan sulfate.	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP35307	GLKKLAELAHKLLKLGC	17	EA	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24867193	Org Biomol Chem. 2014 Jul 14;12(26):4673-84.	Yang J, Tsutsumi H, Furuta T, Sakurai M, Mihara H. 	Interaction of amphiphilic α-helical cell-penetrating peptides with heparan sulfate.	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP35308	YGRKKRRQRRRGC	13	TAT	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24867193	Org Biomol Chem. 2014 Jul 14;12(26):4673-85.	Yang J, Tsutsumi H, Furuta T, Sakurai M, Mihara H. 	Interaction of amphiphilic α-helical cell-penetrating peptides with heparan sulfate.	N=C(N)NCCC[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP35309	RLRLRLRLRLRLRLRLKRLKRLKRLKRLKKKKKKKGYK	38	D1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-7.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35310	RLRLRLRLRLRLRLRLKLLKLLKLLKLLKKKKKKKGYK	38	D2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-8.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35311	RLRLRLRLRLRLRLRLKNNKNNKNNKNNKKKKKKKGYK	38	D3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-9.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35312	GYGYGYGYGYGYGYGYKKRKKRKKRKKRKQQKQQKRRK	38	D4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-10.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35313	GYGYGYGYGYGYGYGYKKRKKRKKRKKRKQQKQQKRRK	38	D4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-10.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35314	GYGYGYGYGYGYGYGYKKRKKRKKRKKRKQQKQQKRRK	38	AcD4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-11.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35315	GYGYGYGYGYGYGYGYKKRKKRKKRKKRKQQKQQKRRK	38	AcD4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-11.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35316	ALALALALALALALALKIKKIKKIKKIKKLAKLAKKIK	38	D5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-12.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35317	LALALALALALALALAKKLKKLKKLKKLKKLKKLKYAK	38	D6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-13.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35318	LALALALALALALALAKKLKKLKKLKKLKKLKKLKYAK	38	D6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-13.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35319	LALALALALALALALAKKLKKLKKLKKLKKLKKLKYAK	38	AcD6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-14.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35320	LALALALALALALALAKKLKKLKKLKKLKKLKKLKYAK	38	AcD6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-14.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35321	IKIKIKIKIKIKIKIKKLAKLAKLAKLAKLAKLAKKIK	38	D7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-15.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP35322	IKIKIKIKIKIKIKIKKLAKLAKLAKLAKLAKLAKKIK	38	D7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-15.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP35323	IKIKIKIKIKIKIKIKKLAKLAKLAKLAKLAKLAKKIK	38	AcD7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-16.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP35324	IKIKIKIKIKIKIKIKKLAKLAKLAKLAKLAKLAKKIK	38	AcD7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-16.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC[C@@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP35325	LALALALALALALALAKIKKIKKIKKIKKLAKLAKKIK	38	D8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-17.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35326	LALALALALALALAKLAKLAKLAKLAKIKKIKKKIK	36	D9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-18.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35327	LALALALALALALALAKLAKLAKLAKLAKLAKKIK	35	D10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-19.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35328	LILILILILILILILIKRKKRKKRKKRKKRAKRAKHSK	38	D11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-20.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35329	LILILILILILILILIKRKKRKKRKKRKKRAKRAKHSK	38	D11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-20.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35330	LILILILILILILILIKRKKRKKRKKRKKRAKRAKHSK	38	AcD11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-21.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35331	LILILILILILILILIKRKKRKKRKKRKKRAKRAKHSK	38	AcD11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	24870379	Chem Commun (Camb). 2014 Jul 14;50(55):7254-21.	Eggimann GA, Blattes E, Buschor S, Biswas R, Kammer SM, Darbre T, Reymond JL. 	Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35332	XGLFGCGRKKRRQRRRPPQ	19	NTD	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	X=Doxorubicin	L	Not available	Not available	24892976	J Control Release. 2014 Oct 10;191:123-30.	Chen Z, Zhang P, Cheetham AG, Moon JH, Moxley JW Jr, Lin YA, Cui H. 	Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.	
DRAMP35333	(XGLFGC)(XGLFGC)KGRKKRRQRRRPPQ	26	d-NTD	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	X=Doxorubicin	L	Not available	Not available	24892976	J Control Release. 2014 Oct 10;191:123-31.	Chen Z, Zhang P, Cheetham AG, Moon JH, Moxley JW Jr, Lin YA, Cui H. 	Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.	
DRAMP35334	[(XGLFGC)(XGLFGC)K][(XGLFGC)(XGLFGC)K]KGRKKRRQRRRPPQ	40	q-NTD	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	X=Doxorubicin	L	Not available	Not available	24892976	J Control Release. 2014 Oct 10;191:123-32.	Chen Z, Zhang P, Cheetham AG, Moon JH, Moxley JW Jr, Lin YA, Cui H. 	Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.	
DRAMP35335	XCGRKKRRQRRRPPQ	15	n-NTD	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	X=Doxorubicin	L	Not available	Not available	24892976	J Control Release. 2014 Oct 10;191:123-33.	Chen Z, Zhang P, Cheetham AG, Moon JH, Moxley JW Jr, Lin YA, Cui H. 	Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.	
DRAMP35336	XGLFGXGRKKRRQRRRPPQ	19	C16NTD	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	X(1)=Doxorubicin; X(6)=(C16)Cys, Cys-Palmitoylation	L	Not available	Not available	24892976	J Control Release. 2014 Oct 10;191:123-34.	Chen Z, Zhang P, Cheetham AG, Moon JH, Moxley JW Jr, Lin YA, Cui H. 	Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.	
DRAMP35337	FΦRRRRQKX	9	cFΦR4-Rho	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Rho, rhodamine B	Φ=L-2-naphthylalanine	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-46. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35338	FΦRRRRQKX	9	cFΦR4-Rho	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Rho, rhodamine B	Φ=L-2-naphthylalanine	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-46. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35339	FΦRRRRQKX	9	cFΦR4-Rho	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Rho, rhodamine B	Φ=L-2-naphthylalanine	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-46. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35340	FΦRRRRQKX	9	cFΦR4-Dex	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Dex, dexamethasone	Φ=L-2-naphthylalanine	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-47. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35341	FΦRRRRQKX	9	cFΦR4-Dex	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Dex, dexamethasone	Φ=L-2-naphthylalanine	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-47. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35342	FΦRRRRQKX	9	cFΦR4-Dex	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Dex, dexamethasone	Φ=L-2-naphthylalanine	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-47. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35343	KXGRKKRRQRRRPPQY	16	Tat-Dex	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	X=Dex, dexamethasone	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-48. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35344	FΦRRRRQKX	9	cFΦR4-FITC	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	FITC, fluorescein isothiocyanate	Φ=L-2-naphthylalanine	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-49. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35345	FΦRRRRQKX	9	cFΦR4-FITC	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	FITC, fluorescein isothiocyanate	Φ=L-2-naphthylalanine	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-49. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35346	FΦRRRRQKX	9	cFΦR4-FITC	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	FITC, fluorescein isothiocyanate	Φ=L-2-naphthylalanine	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-49. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35347	FΦRRRRQRRRRRKX	14	cFΦR4-R5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Rho, rhodamine B	Φ=L-2-naphthylalanine	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-50. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35348	FΦRRRRQAAAAAKX	14	cFΦR4-A5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Rho, rhodamine B	Φ=L-2-naphthylalanine	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-51. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35349	FΦRRRRQFFFFKX	13	cFΦR4-F4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Rho, rhodamine B	Φ=L-2-naphthylalanine	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-52. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35350	FΦRRRRQXDEXLI	13	cFΦR4-PCP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Amidation	Φ=L-2-naphthylalanine; X(8)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(11)=Pcap, phosphocoumaryl aminopropionic acid	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-53. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35351	RRRRRRRRRXDEXLI	15	R9-PCP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	Φ=L-2-naphthylalanine; X(10)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(13)=Pcap, phosphocoumaryl aminopropionic acid	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-54. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35352	RKKRRQRRRXDEXLI	15	Tat-PCP	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	Φ=L-2-naphthylalanine; X(10)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(13)=Pcap, phosphocoumaryl aminopropionic acid	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-55. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35353	RQIKIWFQNRRMKWKKXDEXLI	22	Antp-PCP	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	Φ=L-2-naphthylalanine; X(17)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(20)=Pcap, phosphocoumaryl aminopropionic acid	L	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-56. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35354	XAAAAAKRRRRΦFXKX	16	bicyclo(FΦR4-A5)Rho	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Amidation	X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(14)=L-2,3-diaminopropionic acid; X(16)=Rho, rhodamine B	Mix	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-57. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35355	XAAAAAAAKRRRRΦFXKX	18	bicyclo(FΦR4-A7)Rho	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Amidation	X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(16)=L-2,3-diaminopropionic acid; X(18)=Rho, rhodamine B	Mix	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-58. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35356	XRARARKRRRRΦFXKX	16	bicyclo(FΦR4-RARAR)Rho	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Amidation	X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(14)=L-2,3-diaminopropionic acid; X(16)=Rho, rhodamine B	Mix	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-59. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35357	XDADADKRRRRΦFXKX	16	bicyclo(FΦR4-DADAD)Rho	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Amidation	X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(14)=L-2,3-diaminopropionic acid; X(16)=Rho, rhodamine B	Mix	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-60. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35358	AAAAARRRRΦFKX	13	monocyclo(FΦR4-A5)Rho	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Amidation	Φ=L-2-naphthylalanine; X=Rho, rhodamine B	Mix	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-61. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35359	AAAAAAARRRRΦFKX	15	monocyclo(FΦR4-A7)Rho	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Amidation	Φ=L-2-naphthylalanine; X=Rho, rhodamine B	Mix	Not available	Not available	24896852	Biochemistry. 2014 Jun 24;53(24):4034-62. 	Qian Z, LaRochelle JR, Jiang B, Lian W, Hard RL, Selner NG, Luechapanichkul R, Barrios AM, Pei D. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35360	YGRKKRRQRRRYGRKKRRQRRRYGRKKRRQRRR	33	SP-Tatm3xCherry	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Coupled to signal peptide	mCherry		L	Not available	Not available	24928321	J Control Release. 2014 Aug 28;188:44-52. 	Shen Y, Nagpal P, Hay JG, Sauthoff H. 	Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.	
DRAMP35361	CKYGRKKRRQRRR	13	fTAT	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Extra Cys and Lys added for labeling of TMR	Free		L	Not available	Not available	24930129	Nat Methods. 2014 Aug;11(8):861-7.	Erazo-Oliveras A, Najjar K, Dayani L, Wang TY, Johnson GA, Pellois JP. 	Protein delivery into live cells by incubation with an endosomolytic agent.	
DRAMP35362	CKYGRKKRRQRRR	13	fTAT	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Extra Cys and Lys added for labeling of TMR	Free		L	Not available	Not available	24930129	Nat Methods. 2014 Aug;11(8):861-7.	Erazo-Oliveras A, Najjar K, Dayani L, Wang TY, Johnson GA, Pellois JP. 	Protein delivery into live cells by incubation with an endosomolytic agent.	
DRAMP35363	RRRQRRKKRGYCKCKYGRKKRRQRRR	26	dfTAT	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Extra Cys and Lys added for labeling of TMR and dimerization	Free		L	Not available	Not available	24930129	Nat Methods. 2014 Aug;11(8):861-8.	Erazo-Oliveras A, Najjar K, Dayani L, Wang TY, Johnson GA, Pellois JP. 	Protein delivery into live cells by incubation with an endosomolytic agent.	
DRAMP35364	RRRQRRKKRGYCKCKYGRKKRRQRRR	26	dfTAT	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Extra Cys and Lys added for labeling of TMR and dimerization	Free		L	Not available	Not available	24930129	Nat Methods. 2014 Aug;11(8):861-8.	Erazo-Oliveras A, Najjar K, Dayani L, Wang TY, Johnson GA, Pellois JP. 	Protein delivery into live cells by incubation with an endosomolytic agent.	
DRAMP35365	CKYGRKKRRQRRR	13	acFTAT	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetamidation	Free		L	Not available	Not available	24930129	Nat Methods. 2014 Aug;11(8):861-9.	Erazo-Oliveras A, Najjar K, Dayani L, Wang TY, Johnson GA, Pellois JP. 	Protein delivery into live cells by incubation with an endosomolytic agent.	
DRAMP35366	CKYGRKKRRQRRR	13	acFTAT	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetamidation	Free		L	Not available	Not available	24930129	Nat Methods. 2014 Aug;11(8):861-9.	Erazo-Oliveras A, Najjar K, Dayani L, Wang TY, Johnson GA, Pellois JP. 	Protein delivery into live cells by incubation with an endosomolytic agent.	
DRAMP35367	RRRQRRKKRGYCKCKYGRKKRRQRRR	26	nrdfTAT	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	bis(maleimido)ethane added	Free		L	Not available	Not available	24930129	Nat Methods. 2014 Aug;11(8):861-10.	Erazo-Oliveras A, Najjar K, Dayani L, Wang TY, Johnson GA, Pellois JP. 	Protein delivery into live cells by incubation with an endosomolytic agent.	
DRAMP35368	RRRQRRKKRGYCKCKYGRKKRRQRRR	26	nrdfTAT	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	bis(maleimido)ethane added	Free		L	Not available	Not available	24930129	Nat Methods. 2014 Aug;11(8):861-10.	Erazo-Oliveras A, Najjar K, Dayani L, Wang TY, Johnson GA, Pellois JP. 	Protein delivery into live cells by incubation with an endosomolytic agent.	
DRAMP35369	RKWWK	5		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24946217	 Eur J Med Chem. 2014 Aug 18;83:36-44. 	Fang Y, Zhong W, Wang Y, Xun T, Lin D, Liu W, Wang J, Lv L, Liu S, He J. 	Tuning the antimicrobial pharmacophore to enable discovery of short lipopeptides with multiple modes of action	N=C(N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35370	PKKKRKVWKLLQQFFGLM	18	NS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24958615	J Pept Sci. 2014 Oct;20(10):785-93.	Zhang Y, Song J, Zhang W, Liang R, Ma Y, Zhang L, Wei X, Ni J, Wang R.	Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery. 	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(C)C)C(N)=O
DRAMP35371	PKKKRKVWKLLQQFFGLM	18	NS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	24958615	J Pept Sci. 2014 Oct;20(10):785-93.	Zhang Y, Song J, Zhang W, Liang R, Ma Y, Zhang L, Wei X, Ni J, Wang R.	Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery. 	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(C)C)C(N)=O
DRAMP35372	PKKKRKVWKLLQQFFGLM	18	Stearyl-NS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation		L	Not available	Not available	24958615	J Pept Sci. 2014 Oct;20(10):785-94.	Zhang Y, Song J, Zhang W, Liang R, Ma Y, Zhang L, Wei X, Ni J, Wang R.	Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery. 	
DRAMP35373	PKKKRKVWKLLQQFFGLM	18	Stearyl-NS	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation		L	Not available	Not available	24958615	J Pept Sci. 2014 Oct;20(10):785-94.	Zhang Y, Song J, Zhang W, Liang R, Ma Y, Zhang L, Wei X, Ni J, Wang R.	Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery. 	
DRAMP35374	CSKSSDYQC	9	sCT CSK-SLNs	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	Coupling to polyoxyethylene (40) steartae (SA-PEG2000), peptide ligand modified salmon calcitonin (sCT)-loaded SLNs	L	Not available	Not available	24968819	Eur J Pharm Biopharm. 2014 Oct;88(2):518-28.	an T, Chen C, Guo H, Xu J, Zhang J, Zhu X, Yang Y, Zhou Z, Li L, Huang Y. 	Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.	
DRAMP35375	CSKSSDYQC	9	sCT CSK-SLNs	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	Free	Coupling to polyoxyethylene (40) steartae (SA-PEG2000), peptide ligand modified salmon calcitonin (sCT)-loaded SLNs	L	Not available	Not available	24968819	Eur J Pharm Biopharm. 2014 Oct;88(2):518-28.	an T, Chen C, Guo H, Xu J, Zhang J, Zhu X, Yang Y, Zhou Z, Li L, Huang Y. 	Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.	
DRAMP35376	IRQRRRR	7	IRQ	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Conjugation to solid lipid nanoparticle		L	Not available	Not available	24968819	Eur J Pharm Biopharm. 2014 Oct;88(2):518-29.	an T, Chen C, Guo H, Xu J, Zhang J, Zhu X, Yang Y, Zhou Z, Li L, Huang Y. 	Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.	
DRAMP35377	CSKSSDYQC	9	CSK	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Conjugation to solid lipid nanoparticle		L	Not available	Not available	24968819	Eur J Pharm Biopharm. 2014 Oct;88(2):518-30.	an T, Chen C, Guo H, Xu J, Zhang J, Zhu X, Yang Y, Zhou Z, Li L, Huang Y. 	Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.	
DRAMP35378	CSKSSDYQC	9	CSK	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Conjugation to solid lipid nanoparticle		L	Not available	Not available	24968819	Eur J Pharm Biopharm. 2014 Oct;88(2):518-30.	an T, Chen C, Guo H, Xu J, Zhang J, Zhu X, Yang Y, Zhou Z, Li L, Huang Y. 	Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.	
DRAMP35379	GGVCPKILKKCRRDSDCPGACICRGNGWCGSGSD	34	MCoTI-M1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free		L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-8.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35380	GGVCPKILRRCRRDSDCPGACICRGNGYCGSGSD	34	MCoTI-M2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free		L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-9.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35381	GGVCPKILRRCRRDSDCPGACICRGNGWCGSGSD	34	MCoTI-M3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free		L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-10.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35382	GGVCPKILRRCRRDSDCPGACICRGNGYCGSGSR	34	MCoTI-M4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free		L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-11.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35383	GGVCPRILRRCRRDSDCPGACICRGNGYCGSGSK	34	MCoTI-M5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free		L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-12.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35384	GRCTKSIPPICFPD	14	SFTI-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free		L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-13.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35385	grctksippicfpd	14	D-SFTI-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free		D	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-14.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35386	GACTKSIPPICFPD	14	SFTI-M1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free		L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-15.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35387	GRCTKSIPPICFPA	14	SFTI-M2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free		L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-16.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35388	GRCTKSIPPICWPD	14	SFTI-M3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free		L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-17.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35389	GRCTKSIPPICWPK	14	SFTI-M4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free		L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-18.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35390	GRCTRSIPPKCWPD	14	SFTI-M5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free		L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-19.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35391	GRXTKSIPPIXFPD	14	SFTI-M6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free	X=Abu, α-aminobutyric acid	L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-20.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35392	GRXTKSIPPIXFPD	14	SFTI-M6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Conjugation with Alexa Flour 488	Free	X=Abu, α-aminobutyric acid	L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-20.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35393	GRXTKSIPPIXFPD	14	SFTI-M7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Conjugation with Alexa Flour 488	Free	X=Abu, α-aminobutyric acid	L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-21.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35394	GRXTKSIPPIXFPD	14	SFTI-M7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Conjugation with Alexa Flour 488	Free	X=Abu, α-aminobutyric acid	L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-21.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35395	YGRKKRRQRRRPPQG	15	TAT	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Conjugation with Alexa Flour 488	Free		L	Not available	Not available	24985034	Eur J Med Chem. 2014 Dec 17;88:10-22.	D'Souza C, Henriques ST, Wang CK, Craik DJ.	Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.	
DRAMP35396	EEEEEEEEPLGLAGRRRRRRRRN	23	ACPP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25000246	PLoS One. 2014 Jul 7;9(7):e100670. 	Li S, Chen J, Xu H, Long J, Xie X, Zhang Y	The targeted transduction of MMP-overexpressing tumor cells by ACPP-HPMA copolymer-coated adenovirus conjugates.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)NCC(=O)O
DRAMP35397	VSRRRRRRGGRRRR	14	C24-LMWP	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25003794	J Control Release. 2014 Oct 28;192:47-56.	Wang H, Zhao Y, Wang H, Gong J, He H, Shin MC, Yang VC, Huang Y.	Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.	CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35398	LKKLCKLLKKLCKLAG	16	LK-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	25056130	Angew Chem Int Ed Engl. 2014 Sep 15;53(38):10086-9. 	Jang S, Hyun S, Kim S, Lee S, Lee IS, Baba M, Lee Y, Yu J. 	Cell-penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription.	CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(N)=O
DRAMP35399	FSGSGSGSGRRRRRRRRGC	19	F(SG)4R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	25108152	J Control Release. 2014 Dec 10;195:55-62.	Sayers EJ, Cleal K, Eissa NG, Watson P, Jones AT. 	Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides.	CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP35400	GSGSGSGSGRRRRRRRRGC	19	G(SG)4R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	25108152	J Control Release. 2014 Dec 10;195:55-63.	Sayers EJ, Cleal K, Eissa NG, Watson P, Jones AT. 	Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides.	CC(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP35401	FSGSGSGSGRQIKIWFQNRRMKWKKGC	27	F(SG)4Pen	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	25108152	J Control Release. 2014 Dec 10;195:55-64.	Sayers EJ, Cleal K, Eissa NG, Watson P, Jones AT. 	Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP35402	GSGSGSGSGRQIKIWFQNRRMKWKKGC	27	G(SG)4Pen	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	25108152	J Control Release. 2014 Dec 10;195:55-65.	Sayers EJ, Cleal K, Eissa NG, Watson P, Jones AT. 	Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(C)=O)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP35403	FSGSGSGSGAGYLLGKINLKALAALAKKILGC	32	F(SG)4TP10	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	25108152	J Control Release. 2014 Dec 10;195:55-66.	Sayers EJ, Cleal K, Eissa NG, Watson P, Jones AT. 	Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP35404	GSGSGSGSGAGYLLGKINLKALAALAKKILGC	32	G(SG)4TP10	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	25108152	J Control Release. 2014 Dec 10;195:55-67.	Sayers EJ, Cleal K, Eissa NG, Watson P, Jones AT. 	Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(C)=O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP35405	AGYLLGKTNLKALAALAKKIL	21	NF1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation,  CH3(CH2)16CO	Amidation		L	Not available	Not available	25135660	Biochim Biophys Acta. 2014 Dec;1838(12):3118-29.	Vasconcelos L, Madani F, Arukuusk P, Pärnaste L, Gräslund A, Langel U.	Effects of cargo molecules on membrane perturbation caused by transportan10 based cell-penetrating peptides.	
DRAMP35406	VTPHHVLVDEYTGEWVDSQFK	21	VG-21	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25154664	 Biomaterials. 2014 Nov;35(35):9484-94. 	iwari PM, Eroglu E, Bawage SS, Vig K, Miller ME, Pillai S, Dennis VA, Singh SR. 	Enhanced intracellular translocation and biodistribution of gold nanoparticles functionalized with a cell-penetrating peptide (VG-21) from vesicular stomatitis virus.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP35407	RLLRLLRLL	9	1b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation		L	Not available	Not available	25188671	Bioconjug Chem. 2014 Oct 15;25(10):1761-8.	Kato T, Oba M, Nishida K, Tanaka M.	Cell-penetrating helical peptides having l-arginines and five-membered ring α,α-disubstituted α-amino acids.	
DRAMP35408	RLLRLLRLX	9	2b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	X=1-aminocyclopentane-1-carboxylic acids (Ac5c)	L	Not available	Not available	25188671	Bioconjug Chem. 2014 Oct 15;25(10):1761-9.	Kato T, Oba M, Nishida K, Tanaka M.	Cell-penetrating helical peptides having l-arginines and five-membered ring α,α-disubstituted α-amino acids.	
DRAMP35409	RLLRLXRLX	9	3b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	X=1-aminocyclopentane-1-carboxylic acids (Ac5c)	L	Not available	Not available	25188671	Bioconjug Chem. 2014 Oct 15;25(10):1761-10.	Kato T, Oba M, Nishida K, Tanaka M.	Cell-penetrating helical peptides having l-arginines and five-membered ring α,α-disubstituted α-amino acids.	
DRAMP35410	RLXRLXRLX	9	4b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	X=1-aminocyclopentane-1-carboxylic acids (Ac5c)	L	Not available	Not available	25188671	Bioconjug Chem. 2014 Oct 15;25(10):1761-11.	Kato T, Oba M, Nishida K, Tanaka M.	Cell-penetrating helical peptides having l-arginines and five-membered ring α,α-disubstituted α-amino acids.	
DRAMP35411	RLXRLXRXX	9	5b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	X=1-aminocyclopentane-1-carboxylic acids (Ac5c)	L	Not available	Not available	25188671	Bioconjug Chem. 2014 Oct 15;25(10):1761-12.	Kato T, Oba M, Nishida K, Tanaka M.	Cell-penetrating helical peptides having l-arginines and five-membered ring α,α-disubstituted α-amino acids.	
DRAMP35412	RLXRXRXX	8	6b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	X=1-aminocyclopentane-1-carboxylic acids (Ac5c)	L	Not available	Not available	25188671	Bioconjug Chem. 2014 Oct 15;25(10):1761-13.	Kato T, Oba M, Nishida K, Tanaka M.	Cell-penetrating helical peptides having l-arginines and five-membered ring α,α-disubstituted α-amino acids.	
DRAMP35413	RXXRXRXX	8	7b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Amidation	X=1-aminocyclopentane-1-carboxylic acids (Ac5c)	L	Not available	Not available	25188671	Bioconjug Chem. 2014 Oct 15;25(10):1761-14.	Kato T, Oba M, Nishida K, Tanaka M.	Cell-penetrating helical peptides having l-arginines and five-membered ring α,α-disubstituted α-amino acids.	
DRAMP35414	HHHHHHHHRRRRRRRR	16	STR-H8R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation		L	Not available	Not available	25193363	Nanomedicine. 2015 Feb;11(2):435-46.	Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.	Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.	
DRAMP35415	HHHHHHHHRRRRRRRRRRRRRRR	23	H8R15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	25193363	Nanomedicine. 2015 Feb;11(2):435-47.	Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.	Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.	CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP35416	HHHHHHHHRRRRRRRRRRRRRRR	23	H8R15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	25193363	Nanomedicine. 2015 Feb;11(2):435-47.	Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.	Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.	CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP35417	HHHHHHHHRRRRRRRRRRRRRRR	23	STR-H8R15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation		L	Not available	Not available	25193363	Nanomedicine. 2015 Feb;11(2):435-48.	Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.	Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.	
DRAMP35418	HHHHHHHHRRRRRRRRRRRRRRR	23	STR-H8R15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation		L	Not available	Not available	25193363	Nanomedicine. 2015 Feb;11(2):435-48.	Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.	Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.	
DRAMP35419	HHHHHHHHHHHHRRRRRRRRRRRRRRR	27	STR-H12R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation		L	Not available	Not available	25193363	Nanomedicine. 2015 Feb;11(2):435-49.	Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.	Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.	
DRAMP35420	HHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR	31	H16R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	25193363	Nanomedicine. 2015 Feb;11(2):435-50.	Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.	Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.	CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP35421	HHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR	31	H16R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	25193363	Nanomedicine. 2015 Feb;11(2):435-50.	Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.	Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.	CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP35422	HHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR	31	STR-H16R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation		L	Not available	Not available	25193363	Nanomedicine. 2015 Feb;11(2):435-51.	Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.	Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.	
DRAMP35423	HHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR	31	STR-H16R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation		L	Not available	Not available	25193363	Nanomedicine. 2015 Feb;11(2):435-51.	Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.	Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.	
DRAMP35424	HHHHHHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR	35	STR-H20R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Stearylation	Amidation		L	Not available	Not available	25193363	Nanomedicine. 2015 Feb;11(2):435-52.	Chu D, Xu W, Pan R, Ding Y, Sui W, Chen P.	Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.	
DRAMP35425	MAARLCCQLDPARDVLCLRP	20	N-terminus of X-Pep	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25251474	Biochem Biophys Res Commun. 2014 Oct 10;453(1):64-8	Montrose K, Yang Y, Krissansen GW. 	X-pep, a novel cell-penetrating peptide motif derived from the hepatitis B virus.	CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP35426	MAARLCCQLDPARDV	15	N-terminus of X-Pep	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25251474	Biochem Biophys Res Commun. 2014 Oct 10;453(1):64-9	Montrose K, Yang Y, Krissansen GW. 	X-pep, a novel cell-penetrating peptide motif derived from the hepatitis B virus.	CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP35427	MAARLCCQ	8	X-Pep	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25251474	Biochem Biophys Res Commun. 2014 Oct 10;453(1):64-10	Montrose K, Yang Y, Krissansen GW. 	X-pep, a novel cell-penetrating peptide motif derived from the hepatitis B virus.	CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP35428	MAARL	5	X-Pep derivative	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25251474	Biochem Biophys Res Commun. 2014 Oct 10;453(1):64-11	Montrose K, Yang Y, Krissansen GW. 	X-pep, a novel cell-penetrating peptide motif derived from the hepatitis B virus.	CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35429	XFrFKFrFK	9	Single mitochondrial penetrating peptide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Amidation	Amidation	X=Ahx, 6-aminohexanoic acid	Mix	Not available	Not available	25265566	J Am Chem Soc. 2014 Oct 29;136(43):15300-9. 	Martin A, Byrne A, Burke CS, Forster RJ, Keyes TE.	Peptide-bridged dinuclear Ru(II) complex for mitochondrial targeted monitoring of dynamic changes to oxygen concentration and ROS generation in live mammalian cells.	
DRAMP35430	XGLXGGLXGI	10	Trichogin GA IV Ome	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	C8	OMe	X=AIB (Aminoisobutyric acid)	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-44. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity.	
DRAMP35431	XGLXGGLXGIL	11	Tric-COOH	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	OMe	X=Aib	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-45. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35432	XGLXGGLXGIL	11	Tric-COOH	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	OMe	X=Aib	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-45. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35433	XGLXGGLXGIX	11	Ac-Tric	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=2 μM); HeLa  (EC50=8 μM)	Not available	Linear	Acetylization	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-46. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35434	XGLXGGLXGIX	11	Ac-Tric	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM)	Not available	Linear	Acetylization	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-46. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35435	XGLXGGLXGIX	11	Ac-Tric	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=8 μM); HeLa  (Not active up to 20 μM)	Not available	Linear	Acetylization	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-46. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35436	XGLXGGLXGIX	11	Ac-Tric	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=13 μM); HeLa  (Not active up to 20 μM)	Not available	Linear	Acetylization	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-46. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35437	XGLXGGLXGIX	11	Ac-Tric	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylization	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-46. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35438	XKLXGGLXGIX	11	Tric[K2]	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-47. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35439	XKLXGGLXGIL	11	Tric[K2]-OMe	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	OMe	X=Aib	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-48. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35440	XKLXGGLXGIL	11	Tric[K2]-OMe	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	OMe	X=Aib	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-48. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35441	XKLXGGLXGIL	11	Tric[K2]-COOH	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	COOH	X=Aib	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-49. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35442	XKLXGGLXGIL	11	Tric[K2]-COOH	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	COOH	X=Aib	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-49. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35443	XGLXGKLXGIX	11	Tric[K6]	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa  (EC50=2 μM); T67 (EC50=4 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-50. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35444	XGLXGKLXGIX	11	Tric[K6]	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: T67 (EC50=1 μM); HeLa  (EC50=3 μM)	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-50. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35445	XGLXGKLXGIX	11	Tric[K6]	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-50. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35446	XGLXGKLXGIL	11	Tric[K6]-OMe	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	OMe	X=Aib	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-51. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35447	XGLXGGLXKIX	11	Tric[K9]	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-52. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35448	XGLXGGLXKIL	11	Tric[K9]-OMe	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	OMe	X=Aib	L	Not available	Not available	25306964	Biochim Biophys Acta. 2015 Jan;1848(1 Pt A):134-53. 	Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E. 	The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity	
DRAMP35449	FLFKLIPKAIKGLLKAFK	18	AcrAP2 [S4K,N8K,S11K,S15K]	A0A0A1I6N9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	25332684	 Int J Biol Sci. 2014 Sep 21;10(10):1097-107. 	Du Q, Hou X, Ge L, Li R, Zhou M, Wang H, Wang L, Wei M, Chen T, Shaw C.	Cationicity-enhanced analogues of the antimicrobial peptides, AcrAP1 and AcrAP2, from the venom of the scorpion, Androctonus crassicauda, display potent growth modulation effects on human cancer cell lines	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35450	MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR	33	probe1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Ahx-FITC(Ahx, ε-aminocaproic acid; FITC, fluorescein isothiocyanate)	Mix	Not available	Not available	25410769	Nat Commun. 2014 Nov 20;5:5573. 	Pan D, Hu Z, Qiu F, Huang ZL, Ma Y, Wang Y, Qin L, Zhang Z, Zeng S, Zhang YH. 	A general strategy for developing cell-permeable photo-modulatable organic fluorescent probes for live-cell super-resolution imaging.	
DRAMP35451	MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR	33	probe1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Ahx-FITC(Ahx, ε-aminocaproic acid; FITC, fluorescein isothiocyanate)	Mix	Not available	Not available	25410769	Nat Commun. 2014 Nov 20;5:5573. 	Pan D, Hu Z, Qiu F, Huang ZL, Ma Y, Wang Y, Qin L, Zhang Z, Zeng S, Zhang YH. 	A general strategy for developing cell-permeable photo-modulatable organic fluorescent probes for live-cell super-resolution imaging.	
DRAMP35452	MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR	33	probe1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Ahx-FITC(Ahx, ε-aminocaproic acid; FITC, fluorescein isothiocyanate)	Mix	Not available	Not available	25410769	Nat Commun. 2014 Nov 20;5:5573. 	Pan D, Hu Z, Qiu F, Huang ZL, Ma Y, Wang Y, Qin L, Zhang Z, Zeng S, Zhang YH. 	A general strategy for developing cell-permeable photo-modulatable organic fluorescent probes for live-cell super-resolution imaging.	
DRAMP35453	MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR	33	probe2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=RhB, rhodamine B	Mix	Not available	Not available	25410769	Nat Commun. 2014 Nov 20;5:5574. 	Pan D, Hu Z, Qiu F, Huang ZL, Ma Y, Wang Y, Qin L, Zhang Z, Zeng S, Zhang YH. 	A general strategy for developing cell-permeable photo-modulatable organic fluorescent probes for live-cell super-resolution imaging.	
DRAMP35454	MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR	33	probe2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=RhB, rhodamine B	Mix	Not available	Not available	25410769	Nat Commun. 2014 Nov 20;5:5574. 	Pan D, Hu Z, Qiu F, Huang ZL, Ma Y, Wang Y, Qin L, Zhang Z, Zeng S, Zhang YH. 	A general strategy for developing cell-permeable photo-modulatable organic fluorescent probes for live-cell super-resolution imaging.	
DRAMP35455	MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR	33	probe2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=RhB, rhodamine B	Mix	Not available	Not available	25410769	Nat Commun. 2014 Nov 20;5:5574. 	Pan D, Hu Z, Qiu F, Huang ZL, Ma Y, Wang Y, Qin L, Zhang Z, Zeng S, Zhang YH. 	A general strategy for developing cell-permeable photo-modulatable organic fluorescent probes for live-cell super-resolution imaging.	
DRAMP35456	MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR	33	probe3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=PA-RhB, photoactivatable rhodamine B derivative	Mix	Not available	Not available	25410769	Nat Commun. 2014 Nov 20;5:5575. 	Pan D, Hu Z, Qiu F, Huang ZL, Ma Y, Wang Y, Qin L, Zhang Z, Zeng S, Zhang YH. 	A general strategy for developing cell-permeable photo-modulatable organic fluorescent probes for live-cell super-resolution imaging.	
DRAMP35457	MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR	33	probe3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=PA-RhB, photoactivatable rhodamine B derivative	Mix	Not available	Not available	25410769	Nat Commun. 2014 Nov 20;5:5575. 	Pan D, Hu Z, Qiu F, Huang ZL, Ma Y, Wang Y, Qin L, Zhang Z, Zeng S, Zhang YH. 	A general strategy for developing cell-permeable photo-modulatable organic fluorescent probes for live-cell super-resolution imaging.	
DRAMP35458	MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR	33	probe3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=PA-RhB, photoactivatable rhodamine B derivative	Mix	Not available	Not available	25410769	Nat Commun. 2014 Nov 20;5:5575. 	Pan D, Hu Z, Qiu F, Huang ZL, Ma Y, Wang Y, Qin L, Zhang Z, Zeng S, Zhang YH. 	A general strategy for developing cell-permeable photo-modulatable organic fluorescent probes for live-cell super-resolution imaging.	
DRAMP35459	KKKKKKNKKLQQRGD	15	P1	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Ahx, 6-aminohexamoic acid	Free		L	Not available	Not available	25459448	Eur J Pharm Biopharm. 2015 Jan;89:93-106.	Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.	Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.	
DRAMP35460	RGDGPRRRPRKRRGR	15	P2	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Ahx, 6-aminohexamoic acid	Free		L	Not available	Not available	25459448	Eur J Pharm Biopharm. 2015 Jan;89:93-107.	Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.	Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.	
DRAMP35461	RRRQKRIVVRRRLIR	15	P3	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Ahx, 6-aminohexamoic acid	Free		L	Not available	Not available	25459448	Eur J Pharm Biopharm. 2015 Jan;89:93-108.	Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.	Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.	
DRAMP35462	RRVWRRYRRQRWCRR	15	P4	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Ahx, 6-aminohexamoic acid	Free		L	Not available	Not available	25459448	Eur J Pharm Biopharm. 2015 Jan;89:93-109.	Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.	Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.	
DRAMP35463	RRARRPRRLRPAPGR	15	P5	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Ahx, 6-aminohexamoic acid	Free		L	Not available	Not available	25459448	Eur J Pharm Biopharm. 2015 Jan;89:93-110.	Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.	Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.	
DRAMP35464	LLRARWRRRRSRRFR	15	P6	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Ahx, 6-aminohexamoic acid	Free		L	Not available	Not available	25459448	Eur J Pharm Biopharm. 2015 Jan;89:93-111.	Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.	Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.	
DRAMP35465	RGPRRQPRRHRRPRR	15	P7	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Ahx, 6-aminohexamoic acid	Free		L	Not available	Not available	25459448	Eur J Pharm Biopharm. 2015 Jan;89:93-112.	Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.	Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.	
DRAMP35466	RRWRRWNRFNRRRCR	15	P8	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Ahx, 6-aminohexamoic acid	Free		L	Not available	Not available	25459448	Eur J Pharm Biopharm. 2015 Jan;89:93-113.	Gautam A, Sharma M, Vir P, Chaudhary K, Kapoor P, Kumar R, Nath SK, Raghava GP.	Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.	
DRAMP35467	RKKRRQRRRRKKRRQRRR	18	Tat2-Nat	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Natamycin		L	Not available	Not available	25467959	Pharm Res. 2015 Jun;32(6):1920-30. 	Jain A, Shah SG, Chugh A.	Cell penetrating peptides as efficient nanocarriers for delivery of antifungal compound, natamycin for the treatment of fungal keratitis.	
DRAMP35468	AKKRRQRRRAKKRRQRRR	18	MTat2-Nat	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Natamycin		L	Not available	Not available	25467959	Pharm Res. 2015 Jun;32(6):1920-31. 	Jain A, Shah SG, Chugh A.	Cell penetrating peptides as efficient nanocarriers for delivery of antifungal compound, natamycin for the treatment of fungal keratitis.	
DRAMP35469	XNIIXPLLXPIC	12	TV-XIIa	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	X=Aib, α-amino isobutyric acid	L	Not available	Not available	25468041	Bioorg Med Chem. 2014 Dec 15;22(24):6776-80. 	Wada S, Urase T, Hasegawa Y, Ban K, Sudani A, Kawai Y, Hayashi J, Urata H.	Aib-containing peptide analogs: cellular uptake and utilization in oligonucleotide delivery.	
DRAMP35470	XNIIXPLLAPIC	12	P-I	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	X=Aib, α-amino isobutyric acid	L	Not available	Not available	25468041	Bioorg Med Chem. 2014 Dec 15;22(24):6776-81. 	Wada S, Urase T, Hasegawa Y, Ban K, Sudani A, Kawai Y, Hayashi J, Urata H.	Aib-containing peptide analogs: cellular uptake and utilization in oligonucleotide delivery.	
DRAMP35471	ANIIXPLLXPIC	12	P-II	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	X=Aib, α-amino isobutyric acid	L	Not available	Not available	25468041	Bioorg Med Chem. 2014 Dec 15;22(24):6776-82. 	Wada S, Urase T, Hasegawa Y, Ban K, Sudani A, Kawai Y, Hayashi J, Urata H.	Aib-containing peptide analogs: cellular uptake and utilization in oligonucleotide delivery.	
DRAMP35472	XNIIAPLLXPIC	12	P-III	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	X=Aib, α-amino isobutyric acid	L	Not available	Not available	25468041	Bioorg Med Chem. 2014 Dec 15;22(24):6776-83. 	Wada S, Urase T, Hasegawa Y, Ban K, Sudani A, Kawai Y, Hayashi J, Urata H.	Aib-containing peptide analogs: cellular uptake and utilization in oligonucleotide delivery.	
DRAMP35473	XNIIXXLLXXIC	12	P-IV	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	X=Aib, α-amino isobutyric acid	L	Not available	Not available	25468041	Bioorg Med Chem. 2014 Dec 15;22(24):6776-84. 	Wada S, Urase T, Hasegawa Y, Ban K, Sudani A, Kawai Y, Hayashi J, Urata H.	Aib-containing peptide analogs: cellular uptake and utilization in oligonucleotide delivery.	
DRAMP35474	XNIIXPLLXXIC	12	P-V	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	X=Aib, α-amino isobutyric acid	L	Not available	Not available	25468041	Bioorg Med Chem. 2014 Dec 15;22(24):6776-85. 	Wada S, Urase T, Hasegawa Y, Ban K, Sudani A, Kawai Y, Hayashi J, Urata H.	Aib-containing peptide analogs: cellular uptake and utilization in oligonucleotide delivery.	
DRAMP35475	XNIIXXLLXPIC	12	P-VI	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation	X=Aib, α-amino isobutyric acid	L	Not available	Not available	25468041	Bioorg Med Chem. 2014 Dec 15;22(24):6776-86. 	Wada S, Urase T, Hasegawa Y, Ban K, Sudani A, Kawai Y, Hayashi J, Urata H.	Aib-containing peptide analogs: cellular uptake and utilization in oligonucleotide delivery.	
DRAMP35476	CAYGRKKRRQRRR	13	TAT-LP-PTX	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Cysteine addition	Rhodamine LP		L	Not available	Not available	25482610	Oncol Rep. 2015 Feb;33(2):783-91.	Wang RH, Cao HM, Tian ZJ, Jin B, Wang Q, Ma H, Wu J. 	Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer.	
DRAMP35477	CHAIYPRH	8	T7-LP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Rhodamine LP		L	Not available	Not available	25482610	Oncol Rep. 2015 Feb;33(2):783-92.	Wang RH, Cao HM, Tian ZJ, Jin B, Wang Q, Ma H, Wu J. 	Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer.	
DRAMP35478	XXXXXXXAXXX	11	Coibamide A	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X(1)=Me2Val; X(2)=Hva, α-Hydroxyisovaleric acid; X(3)=Me2Ser; X(4)=MeLeu; X(5)=MeThr(Trt); X(6)=MeSer(Me); X(7)=MeIle; M(9)=MeLeu; X(10)=MeTyr; X(11)=MeAla	L	Not available	Not available	25488840	 Bioorg Med Chem Lett. 2015 Jan 15;25(2):302-6.	Nabika R, Suyama TL, Hau AM, Misu R, Ohno H, Ishmael JE, McPhail KL, Oishi S, Fujii N.	Synthesis and biological evaluation of the [d-MeAla(11)]-epimer of coibamide A	
DRAMP35479	XXXXXXXAXXx	11	Coibamide A [11-D-Me-Ala]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X(1)=Me2Val; X(2)=Hva, α-Hydroxyisovaleric acid; X(3)=Me2Ser; X(4)=MeLeu; X(5)=MeThr(Trt); X(6)=MeSer(Me); X(7)=MeIle; M(9)=MeLeu; X(10)=MeTyr; X(12)=D-MeAla	Mix	Not available	Not available	25488840	 Bioorg Med Chem Lett. 2015 Jan 15;25(2):302-7.	Nabika R, Suyama TL, Hau AM, Misu R, Ohno H, Ishmael JE, McPhail KL, Oishi S, Fujii N.	Synthesis and biological evaluation of the [d-MeAla(11)]-epimer of coibamide A	
DRAMP35480	PNVIPLL	7	Reniochalistatin A	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25490132	J Nat Prod. 2014 Dec 26;77(12):2678-84.	Zhan KX, Jiao WH, Yang F, Li J, Wang SP, Li YS, Han BN, Lin HW. 	Reniochalistatins A-E, cyclic peptides from the marine sponge Reniochalina stalagmitis	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35481	PIFYLPL	7	Reniochalistatin B	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25490132	J Nat Prod. 2014 Dec 26;77(12):2678-85.	Zhan KX, Jiao WH, Yang F, Li J, Wang SP, Li YS, Han BN, Lin HW. 	Reniochalistatins A-E, cyclic peptides from the marine sponge Reniochalina stalagmitis	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35482	PIFPIYF	7	Reniochalistatin C	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25490132	J Nat Prod. 2014 Dec 26;77(12):2678-86.	Zhan KX, Jiao WH, Yang F, Li J, Wang SP, Li YS, Han BN, Lin HW. 	Reniochalistatins A-E, cyclic peptides from the marine sponge Reniochalina stalagmitis	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC
DRAMP35483	PFPFIFP	7	Reniochalistatin D	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25490132	J Nat Prod. 2014 Dec 26;77(12):2678-87.	Zhan KX, Jiao WH, Yang F, Li J, Wang SP, Li YS, Han BN, Lin HW. 	Reniochalistatins A-E, cyclic peptides from the marine sponge Reniochalina stalagmitis	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O
DRAMP35484	PLWPVIPI	8	Reniochalistatin E	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25490132	J Nat Prod. 2014 Dec 26;77(12):2678-88.	Zhan KX, Jiao WH, Yang F, Li J, Wang SP, Li YS, Han BN, Lin HW. 	Reniochalistatins A-E, cyclic peptides from the marine sponge Reniochalina stalagmitis	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1)C(C)C)[C@H](C)CC)C(=O)O
DRAMP35485	FyXrXGeX	8	LY2510924	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	25504752	Mol Cancer Ther. 2015 Feb;14(2):480-90.	Peng SB, Zhang X, Paul D, Kays LM, Gough W, Stewart J, Uhlik MT, Chen Q, Hui YH, Zamek-Gliszczynski MJ, Wijsman JA, Credille KM, Yan LZ. 	Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic models	
DRAMP35486	GWTLNSAGYLLGXINLKALAALAKKIL	27	TP-biot13	Not available		Not found	Chimeric	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation	X=Lys-Biotinylation	L	Not available	Not available	25511292	Folia Histochem Cytobiol. 2014;52(4):270-80.	Wierzbicki PM, Kogut-Wierzbicka M, Ruczynski J, Siedlecka-Kroplewska K, Kaszubowska L, Rybarczyk A, Alenowicz M, Rekowski P, Kmiec Z. 	Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines.	
DRAMP35487	KWSFRVSYRGISYRRSRGK	19	MTpl-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation	Free		L	Not available	Not available	25514997	 FEBS J. 2015 Feb;282(4):732-45. 	Jain A, Yadav BK, Chugh A. 	Marine antimicrobial peptide tachyplesin as an efficient nanocarrier for macromolecule delivery in plant and mammalian cells.	
DRAMP35488	KWFRVYRGIYRRRGK	15	MTpl-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation	Free		L	Not available	Not available	25514997	 FEBS J. 2015 Feb;282(4):732-46. 	Jain A, Yadav BK, Chugh A. 	Marine antimicrobial peptide tachyplesin as an efficient nanocarrier for macromolecule delivery in plant and mammalian cells.	
DRAMP35489	KWCFAVCYAGICYAACAGK	19	MTpl-3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Biotinylation			L	Not available	Not available	25514997	 FEBS J. 2015 Feb;282(4):732-47. 	Jain A, Yadav BK, Chugh A. 	Marine antimicrobial peptide tachyplesin as an efficient nanocarrier for macromolecule delivery in plant and mammalian cells.	
DRAMP35490	rRrGrKkRr	9	cTAT-GFP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	GFP		Mix	Not available	Not available	25521313	Angew Chem Int Ed Engl. 2015 Feb 2;54(6):1950-3.	Nischan N, Herce HD, Natale F, Bohlke N, Budisa N, Cardoso MC, Hackenberger CP.	Covalent attachment of cyclic TAT peptides to GFP results in protein delivery into live cells with immediate bioavailability.	
DRAMP35491	rRrGrKkRr	9	cTAT-GFP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	Free	GFP		Mix	Not available	Not available	25521313	Angew Chem Int Ed Engl. 2015 Feb 2;54(6):1950-3.	Nischan N, Herce HD, Natale F, Bohlke N, Budisa N, Cardoso MC, Hackenberger CP.	Covalent attachment of cyclic TAT peptides to GFP results in protein delivery into live cells with immediate bioavailability.	
DRAMP35492	rRrGrKkRr	9	TAT-GFP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	GFP		Mix	Not available	Not available	25521313	Angew Chem Int Ed Engl. 2015 Feb 2;54(6):1950-4.	Nischan N, Herce HD, Natale F, Bohlke N, Budisa N, Cardoso MC, Hackenberger CP.	Covalent attachment of cyclic TAT peptides to GFP results in protein delivery into live cells with immediate bioavailability.	
DRAMP35493	rRrGrKkRr	9	TAT-GFP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	GFP		Mix	Not available	Not available	25521313	Angew Chem Int Ed Engl. 2015 Feb 2;54(6):1950-4.	Nischan N, Herce HD, Natale F, Bohlke N, Budisa N, Cardoso MC, Hackenberger CP.	Covalent attachment of cyclic TAT peptides to GFP results in protein delivery into live cells with immediate bioavailability.	
DRAMP35494	RRGRRG	6	V1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Conjugated to FITC modified folding domain via β-alanine–glycine– glycine linker	Amidation		L	Not available	Not available	25524829	J Pept Sci. 2015 Feb;21(2):77-84. 	hinde A, Feher KM, Hu C, Slowinska K.	Peptide internalization enabled by folding: triple helical cell-penetrating peptides.	
DRAMP35495	HHHRRRRRRRR	11	5-FAM-H3R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25547808	 Bioconjug Chem. 2015 Jan 21;26(1):71-7.	Lin R, Zhang P, Cheetham AG, Walston J, Abadir P, Cui H. 	Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)O
DRAMP35496	HHHRRRRRRRR	11	5-FAM-H3R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	25547808	 Bioconjug Chem. 2015 Jan 21;26(1):71-7.	Lin R, Zhang P, Cheetham AG, Walston J, Abadir P, Cui H. 	Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)O
DRAMP35497	HHHRRRRRRRR	11	MTS-(5-FAM)- H3R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Free		L	Not available	Not available	25547808	 Bioconjug Chem. 2015 Jan 21;26(1):71-8.	Lin R, Zhang P, Cheetham AG, Walston J, Abadir P, Cui H. 	Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting.	
DRAMP35498	HHHRRRRRRRR	11	MTS-(5-FAM)- H3R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	5(6)-Carboxyfluorescein	Free		L	Not available	Not available	25547808	 Bioconjug Chem. 2015 Jan 21;26(1):71-8.	Lin R, Zhang P, Cheetham AG, Walston J, Abadir P, Cui H. 	Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting.	
DRAMP35499	YKQCHKKGGXKKGSG	15	NrTP2	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	25620660	Biopolymers. 2015 Mar;104(2):101-9. 	Rodrigues M, Andreu D, Santos NC.	Uptake and cellular distribution of nucleolar targeting peptides (NrTPs) in different cell types.	
DRAMP35500	ykqchkkGGkkGsG	14	NrTP5	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free		Mix	Not available	Not available	25620660	Biopolymers. 2015 Mar;104(2):101-10. 	Rodrigues M, Andreu D, Santos NC.	Uptake and cellular distribution of nucleolar targeting peptides (NrTPs) in different cell types.	
DRAMP35501	YKQSHKKGGKKGSG	14	NrTP6	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free		L	Not available	Not available	25620660	Biopolymers. 2015 Mar;104(2):101-11. 	Rodrigues M, Andreu D, Santos NC.	Uptake and cellular distribution of nucleolar targeting peptides (NrTPs) in different cell types.	
DRAMP35502	YRQSHRRGGRRGSG	14	NrTP7	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free		L	Not available	Not available	25620660	Biopolymers. 2015 Mar;104(2):101-12. 	Rodrigues M, Andreu D, Santos NC.	Uptake and cellular distribution of nucleolar targeting peptides (NrTPs) in different cell types.	
DRAMP35503	WKQSHKKGGKKGSG	14	NrTP8	Not available		Not found	Protein derived	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Rhodamine B	Free		L	Not available	Not available	25620660	Biopolymers. 2015 Mar;104(2):101-13. 	Rodrigues M, Andreu D, Santos NC.	Uptake and cellular distribution of nucleolar targeting peptides (NrTPs) in different cell types.	
DRAMP35504	XRRRRRR	7	R6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-11. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35505	XRRRRRRR	8	R7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-12. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35506	XRRRRRRRR	9	R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-13. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35507	XRRRRRRRRR	10	R9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC	Amidation	X=Ahx, 6-aminohexanoic acid	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-14. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35508	XKRRRRE	7	Cyc-R4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-15. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35509	XKRRRRRRE	9	Cyc-R6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-16. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35510	XKRRRRRRRE	10	Cyc-R7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-17. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35511	XKRRRRRRRRE	11	Cyc-R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-18. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35512	XKRRRRRRRRRE	12	Cyc-R9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-19. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35513	XKrrrrrrrE	10	Cyc-r7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	Mix	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-20. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35514	XKrrrrrrrrE	11	Cyc-r8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	Mix	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-21. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35515	XKrrrrrrrrrE	12	Cyc-r9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	Mix	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-22. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35516	XKRrRrRrE	9	Cyc-(L,D)-R6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	Mix	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-23. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35517	XKrRrRrRrE	10	Cyc-(L,D)-R7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	Mix	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-24. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35518	XKRrRrRrRrE	11	Cyc-(L,D)-R8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	Mix	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-25. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35519	XERRRKKRRRE	11	Bicyc-0-R6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-26. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35520	XERRRKXKRRRE	12	Bicyc-1-R6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-27. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35521	XERRRKXXKRRRE	13	Bicyc-2-R6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-28. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35522	XERRRKXXXKRRRE	14	Bicyc-3-R6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-29. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35523	XRRRRKRRRE	10	Cyc-R3-R4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-30. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35524	XRRRKRRRRE	10	Cyc-R4-R3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-31. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35525	XRRKRRRRRE	10	Cyc-R5-R2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-32. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35526	XRKRRRRRRE	10	Cyc-R6-R1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Cyclic	FITC	Amidation	X=Beta-Alanine	L	Not available	Not available	25654426	Bioconjug Chem. 2015 Mar 18;26(3):405-33. 	Traboulsi H, Larkin H, Bonin MA, Volkov L, Lavoie CL, Marsault É. 	Macrocyclic cell penetrating peptides: a study of structure-penetration properties. Bioconjug Chem.	
DRAMP35527	XxXAlV	6	Similanamide	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	25789601	Mar Drugs. 2015 Mar 17;13(3):1432-50. 	Prompanya C, Fernandes C, Cravo S, Pinto MM, Dethoup T, Silva AM, Kijjoa A. 	A new cyclic hexapeptide and a new isocoumarin derivative from the marine sponge-associated fungus Aspergillus similanensis KUFA 0013	
DRAMP35528	PF,PY,PV	8	P. aeruginosa CDP mix	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	25821788	Biomed Res Int. 2015;2015:197608.	Vázquez-Rivera D, González O, Guzmán-Rodríguez J, Díaz-Pérez AL, Ochoa-Zarzosa A, López-Bucio J, Meza-Carmen V, Campos-García J. 	Cytotoxicity of cyclodipeptides from Pseudomonas aeruginosa PAO1 leads to apoptosis in human cancer cell lines	
DRAMP35529	FCTCNVKGFNAKNKRGIIYP	20	Scolopendrasin VII 	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	25907065	J Microbiol Biotechnol. 2015 Aug;25(8):1275-80.	Lee JH, Kim IW, Kim SH, Kim MA, Yun EY, Nam SH, Ahn MY, Kang D, Hwang JS.	Anticancer Activity of the Antimicrobial Peptide Scolopendrasin VII Derived from the Centipede, Scolopendra subspinipes mutilans.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(N)=O)[C@H](C)CC
DRAMP35530	XXKKWRKWLAKK	12		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	25970292	 PLoS One. 2015 May 13;10(5):e0126390.	Chu HL, Yip BS, Chen KH, Yu HY, Chih YH, Cheng HT, Chou YT, Cheng JW. 	Novel antimicrobial peptides with high anticancer activity and selectivity	
DRAMP35531	IIKKIIKKIIKKI	13		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	26204061	nterfaces. 2015 Aug 12;7(31):17346-55. 	Chen C, Chen Y, Yang C, Zeng P, Xu H, Pan F, Lu JR.	High Selective Performance of Designed Antibacterial and Anticancer Peptide Amphiphiles	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP35532	GIIKKIIKKIIKK	13		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	26204061	nterfaces. 2015 Aug 12;7(31):17346-56. 	Chen C, Chen Y, Yang C, Zeng P, Xu H, Pan F, Lu JR.	High Selective Performance of Designed Antibacterial and Anticancer Peptide Amphiphiles	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP35533	IIKKIIKKIIKK	12		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	26204061	nterfaces. 2015 Aug 12;7(31):17346-57. 	Chen C, Chen Y, Yang C, Zeng P, Xu H, Pan F, Lu JR.	High Selective Performance of Designed Antibacterial and Anticancer Peptide Amphiphiles	CC[C@@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP35534	XHXLLPPVPLFG	12	Callyaerin C	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	26213786	J Nat Prod. 2015 Aug 28;78(8):1910-25.	Daletos G, Kalscheuer R, Koliwer-Brandl H, Hartmann R, de Voogd NJ, Wray V, Lin W, Proksch P. 	Callyaerins from the Marine Sponge Callyspongia aerizusa: Cyclic Peptides with Antitubercular Activity.	
DRAMP35535	XIXIILPPLPII	12	Callyaerin B	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	26213786	J Nat Prod. 2015 Aug 28;78(8):1910-26.	Daletos G, Kalscheuer R, Koliwer-Brandl H, Hartmann R, de Voogd NJ, Wray V, Lin W, Proksch P. 	Callyaerins from the Marine Sponge Callyspongia aerizusa: Cyclic Peptides with Antitubercular Activity.	
DRAMP35536	XIXVILPPLPIFG	13	Callyaerin A	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Amidation		L	Not available	Not available	26213786	J Nat Prod. 2015 Aug 28;78(8):1910-27.	Daletos G, Kalscheuer R, Koliwer-Brandl H, Hartmann R, de Voogd NJ, Wray V, Lin W, Proksch P. 	Callyaerins from the Marine Sponge Callyspongia aerizusa: Cyclic Peptides with Antitubercular Activity.	
DRAMP35537	VRKPPYLPRPRWXRXXYNX	19	Oncocin [D2R,P12W,P13Hyp,R15Hyp,I16Tle,R19Orn]	A0A2R7WNA0		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (15% loss of viability=600μg/mL)	Not available	Linear	Free	Amidation		L	Not available	Not available	26334348	 Amino Acids. 2016 Jan;48(1):269-80. 	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K. 	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	
DRAMP35538	VXKPPYLPRPRWXRXXYNX	19	Oncocin [D2Orn,P12W,P13Hyp,R15Hyp,I16Tle,R19Orn]	A0A2R7WNA0		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (15% loss of viability=600μg/mL)	Not available	Linear	Free	Amidation		L	Not available	Not available	26334348	 Amino Acids. 2016 Jan;48(1):269-81. 	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K. 	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	
DRAMP35539	VrKPPYLPRPRWXRXXYNX	19	Oncocin [D2r,P12W,P13Hyp,R15Hyp,I16Tle,R19Orn]	A0A2R7WNA0		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (15% loss of viability=600μg/mL)	Not available	Linear	Free	Amidation		Mix	Not available	Not available	26334348	 Amino Acids. 2016 Jan;48(1):269-82. 	Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K. 	Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus	
DRAMP35540	XRPDKPRPYLPRPRPPRPVR,XRPDKPRPYLPRPRPPRPVR,XRPDKPRPYLPRPRPPRPVRXC,XRPDKPRPYLPRPRPPRPVRXC	87	A3-APO Tetramer	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	26384569	 Chem Biol. 2015 Sep 17;22(9):1250-8. 	Li W, O'Brien-Simpson NM, Tailhades J, Pantarat N, Dawson RM, Otvos L Jr, Reynolds EC, Separovic F, Hossain MA, Wade JD.	Multimerization of a Proline-Rich Antimicrobial Peptide, Chex-Arg20, Alters Its Mechanism of Interaction with the Escherichia coli Membrane	
DRAMP35541	ARCCLVMPVPPFACVKFCS	19	Transmembrane protein (17-35), RCB-1	B9T5G6		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	2MTM	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	26509914	J Nat Prod. 2015 Nov 25;78(11):2545-51.	Boldbaatar D, Gunasekera S, El-Seedi HR, Göransson U. 	Synthesis, Structural Characterization, and Bioactivity of the Stable Peptide RCB-1 from Ricinus communis	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(C)C
DRAMP35542	XGLXGGLXGIL	11	Tric-OMe	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X=Aib	L	Not available	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL.	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP35543	XGLXGGLXGIL	11	Tric-OMe	Not available		Not found	Ascomycetes (Tric)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Oct (Fatty acid 1-Octanoyl)	Free	X=Aib	L	Not available	Not available	27039838	Sci Rep. 2016 Apr 4;6:24000. 	Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL.	The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach	
DRAMP35544	DDEKEQFLYHLLSFNAV	17	wtR6IP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.		Not available	Linear	Fluorescein-O2OC-	Free		L	Not available	Rab8a GTPase	27336832	ACS Chem Biol. 2016 Aug 19;11(8):2375-82. 	Cromm PM, Spiegel J, Küchler P, Dietrich L, Kriegesmann J, Wendt M, Goody RS, Waldmann H, Grossmann TN.	Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase	
DRAMP35545	DDEⓍEQFⓍYHLLSFNAV	17	StRIP3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.		Not available	Cyclic (Stapled)	Fluorescein-O2OC-	Free	Ⓧ=(S)-2-(4-pentenyl)alanine	L	Not available	Rab8a GTPase	27336832	ACS Chem Biol. 2016 Aug 19;11(8):2375-83. 	Cromm PM, Spiegel J, Küchler P, Dietrich L, Kriegesmann J, Wendt M, Goody RS, Waldmann H, Grossmann TN.	Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase	
DRAMP35546	DDEⓍEQFⓍYHLLSFNAV	17	StRIP3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.		Not available	Cyclic (Stapled)	Fluorescein-O2OC-	Free	Ⓧ=(S)-2-(4-pentenyl)alanine	L	Not available	Rab8a GTPase	27336832	ACS Chem Biol. 2016 Aug 19;11(8):2375-83. 	Cromm PM, Spiegel J, Küchler P, Dietrich L, Kriegesmann J, Wendt M, Goody RS, Waldmann H, Grossmann TN.	Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase	
DRAMP35547	DDEⓍEQFⓍYHLLSFNAV	17	StRIP3 open	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.		Not available	Linear	Fluorescein-O2OC-	Free	Ⓧ=(S)-2-(4-pentenyl)alanine	L	Not available	Rab8a GTPase	27336832	ACS Chem Biol. 2016 Aug 19;11(8):2375-84. 	Cromm PM, Spiegel J, Küchler P, Dietrich L, Kriegesmann J, Wendt M, Goody RS, Waldmann H, Grossmann TN.	Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase	
DRAMP35548	DDEⓍEQFⓍYHLLSFNAV	17	StRIP3 open	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.		Not available	Linear	Fluorescein-O2OC-	Free	Ⓧ=(S)-2-(4-pentenyl)alanine	L	Not available	Rab8a GTPase	27336832	ACS Chem Biol. 2016 Aug 19;11(8):2375-84. 	Cromm PM, Spiegel J, Küchler P, Dietrich L, Kriegesmann J, Wendt M, Goody RS, Waldmann H, Grossmann TN.	Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase	
DRAMP35601	GSTLLSLL	8	Pseudofactin II, PFII	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	C16	Free		L	Not available	Not available	27416562	Colloids Surf B Biointerfaces. 2016 Oct 1;146:498-506. 	Janek T, Rodrigues LR, Gudiña EJ, Czyżnikowska Ż. 	Structure and mode of action of cyclic lipopeptide pseudofactin II with divalent metal ions	CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
DRAMP35602	ALXGVl	6	Oryzamide A	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	27489998	 J Nat Prod. 2016 Aug 26;79(8):2045-52.	Ding LJ, Yuan W, Liao XJ, Han BN, Wang SP, Li ZY, Xu SH, Zhang W, Lin HW. 	Oryzamides A-E, Cyclodepsipeptides from the Sponge-Derived Fungus Nigrospora oryzae PF18	
DRAMP35603	AYXGVl	6	Oryzamide B	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	27489998	 J Nat Prod. 2016 Aug 26;79(8):2045-53.	Ding LJ, Yuan W, Liao XJ, Han BN, Wang SP, Li ZY, Xu SH, Zhang W, Lin HW. 	Oryzamides A-E, Cyclodepsipeptides from the Sponge-Derived Fungus Nigrospora oryzae PF18	
DRAMP35604	AMXGVl	6	Oryzamide C	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	27489998	 J Nat Prod. 2016 Aug 26;79(8):2045-54.	Ding LJ, Yuan W, Liao XJ, Han BN, Wang SP, Li ZY, Xu SH, Zhang W, Lin HW. 	Oryzamides A-E, Cyclodepsipeptides from the Sponge-Derived Fungus Nigrospora oryzae PF18	
DRAMP35605	FX	2	Cyclo(Phe-Hyp)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Hyp	L	Not available	Not available	27806640	 Nat Prod Res. 2017 Jun;31(12):1390-1396.	Ye X, Chai W, Lian XY, Zhang Z. 	Novel propanamide analogue and antiproliferative diketopiperazines from mangrove Streptomyces sp Q24	
DRAMP35606	FX	2	Cyclo(Phe-Hyp)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Hyp	L	Not available	Not available	27806640	 Nat Prod Res. 2017 Jun;31(12):1390-1396.	Ye X, Chai W, Lian XY, Zhang Z. 	Novel propanamide analogue and antiproliferative diketopiperazines from mangrove Streptomyces sp Q24	
DRAMP35607	ELLSRVD	7	Bacaucin	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	C14H24O2	Free		L	Not available	Not available	28106348	Chem Int Ed Engl. 2017 Feb 1;56(6):1486-1490.	Liu Y, Ding S, Dietrich R, Märtlbauer E, Zhu K.	A Biosurfactant-Inspired Heptapeptide with Improved Specificity to Kill MRSA	CCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C
DRAMP35608	XLFXL	5	Galaxamide [L3F]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=METH-Leu	L	Not available	Not available	28287429	Int J Mol Sci. 2017 Mar 10;18(3):544.	Bai D, Yu S, Zhong S, Zhao B, Qiu S, Chen J, Lunagariya J, Liao X, Xu S.	d-Amino Acid Position Influences the Anticancer Activity of Galaxamide Analogs: An Apoptotic Mechanism Study	
DRAMP35609	XLfXL	5	Galaxamide [L3f]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=METH-Leu	L	Not available	Not available	28287429	Int J Mol Sci. 2017 Mar 10;18(3):545.	Bai D, Yu S, Zhong S, Zhao B, Qiu S, Chen J, Lunagariya J, Liao X, Xu S.	d-Amino Acid Position Influences the Anticancer Activity of Galaxamide Analogs: An Apoptotic Mechanism Study	
DRAMP35610	XLFxL	5	Galaxamide [L3F,MeL4DMeL]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X(1)=METH-Leu; x(4)=D-METH-Leu	Mix	Not available	Not available	28287429	Int J Mol Sci. 2017 Mar 10;18(3):546.	Bai D, Yu S, Zhong S, Zhao B, Qiu S, Chen J, Lunagariya J, Liao X, Xu S.	d-Amino Acid Position Influences the Anticancer Activity of Galaxamide Analogs: An Apoptotic Mechanism Study	
DRAMP35611	XLFXl	5	Galaxamide [L3F,L5l]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=METH-Leu	L	Not available	Not available	28287429	Int J Mol Sci. 2017 Mar 10;18(3):547.	Bai D, Yu S, Zhong S, Zhao B, Qiu S, Chen J, Lunagariya J, Liao X, Xu S.	d-Amino Acid Position Influences the Anticancer Activity of Galaxamide Analogs: An Apoptotic Mechanism Study	
DRAMP35612	xLFXL	5	Galaxamide [MeL1DMeL,L3F]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	x(1)=D-METH-Leu; X(4)=METH-Leu	Mix	Not available	Not available	28287429	Int J Mol Sci. 2017 Mar 10;18(3):548.	Bai D, Yu S, Zhong S, Zhao B, Qiu S, Chen J, Lunagariya J, Liao X, Xu S.	d-Amino Acid Position Influences the Anticancer Activity of Galaxamide Analogs: An Apoptotic Mechanism Study	
DRAMP35613	XlFXL	5	Galaxamide [L2l,L3F]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=METH-Leu	L	Not available	Not available	28287429	Int J Mol Sci. 2017 Mar 10;18(3):549.	Bai D, Yu S, Zhong S, Zhao B, Qiu S, Chen J, Lunagariya J, Liao X, Xu S.	d-Amino Acid Position Influences the Anticancer Activity of Galaxamide Analogs: An Apoptotic Mechanism Study	
DRAMP35614	GGGGGGGRGDLPETGGS	17		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	28351594	Bioorg Med Chem Lett. 2017 May 1;27(9):1911-1913	Wu Z, Cheng X, Hong H, Zhao X, Zhou Z.	New potent and selective αvβ3 integrin ligands: Macrocyclic peptides containing RGD motif synthesized by sortase A-mediated ligation	CC(C)C[C@H](NC(=O)[C@H](CC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CCC(=O)NCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)O
DRAMP35615	GGGGRGDRGDLPETGGS	17		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	28351594	Bioorg Med Chem Lett. 2017 May 1;27(9):1911-1914	Wu Z, Cheng X, Hong H, Zhao X, Zhou Z.	New potent and selective αvβ3 integrin ligands: Macrocyclic peptides containing RGD motif synthesized by sortase A-mediated ligation	CC(C)C[C@H](NC(=O)CNC(=O)C[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)NCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)O
DRAMP35616	GRGDRGDRGDLPETGGS	17		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	28351594	Bioorg Med Chem Lett. 2017 May 1;27(9):1911-1915	Wu Z, Cheng X, Hong H, Zhao X, Zhou Z.	New potent and selective αvβ3 integrin ligands: Macrocyclic peptides containing RGD motif synthesized by sortase A-mediated ligation	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)NCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)O
DRAMP35617	RRRQRRKKRGGGDTRLNTVWMW	22	TAT-RasGAP317-326 	Not available		Not found		Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	28638371	Front Microbiol. 2017 Jun 7;8:994.	Heulot M, Jacquier N, Aeby S, Le Roy D, Roger T, Trofimenko E, Barras D, Greub G, Widmann C. 	Anticancer Peptide TAT-RasGAP317-326 Exerts Broad Antimicrobial Activity.	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP35618	GGKKLFKKILKYL	13	C18-GG-BP100	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	C18	Amidation		L	Not available	Not available	28831625	 Amino Acids. 2017 Nov;49(11):1831-1841. 	Zhang B, Gu H, Shi W, Li H, Ma G, Chen X, Qian H, Lin H, Huang W, Ge L. 	Synthesis and biological evaluation of novel aliphatic acid-conjugated antimicrobial peptides as potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability	
DRAMP35619	LPGP	4	SCH-P9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	28901516	 Mol Med Rep. 2017 Nov;16(5):6697-6707.	Huang F, Ding G, Yang Z, Yu F. 	Two novel peptides derived from Sinonovacula constricta inhibit the proliferation and induce apoptosis of human prostate cancer cells	CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)O
DRAMP35620	DYVP	4	SCH-P10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	28901516	 Mol Med Rep. 2017 Nov;16(5):6697-6708.	Huang F, Ding G, Yang Z, Yu F. 	Two novel peptides derived from Sinonovacula constricta inhibit the proliferation and induce apoptosis of human prostate cancer cells	CC(C)[C@H](NC(=O)[C@@H](N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)O
DRAMP35621	MRLLVLSSLLCILLLCFSIFSTEGKRRPAKAWSGRRTRLCCHRVPSPNSTNLKGHHVRLCKPCKLEPEPRLWVVPGALPQV	81	Protein GPR15LG	Q6UWK7		Not found	Homo sapiens	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available		Free	Free		L	Not available	Not available	28936214	 Front Immunol. 2017 Sep 7;8:1111. 	Ocón B, Pan J, Dinh TT, Chen W, Ballet R, Bscheider M, Habtezion A, Tu H, Zabel BA, Butcher EC.	A Mucosal and Cutaneous Chemokine Ligand for the Lymphocyte Chemoattractant Receptor GPR15.	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC
DRAMP35622	LXFX	4	Saccharopolytide A	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	29065726	Nat Prod Res. 2018 Jul;32(14):1627-1631.	Xie CL, Niu S, Xia JM, Peng K, Zhang GY, Yang XW.	Saccharopolytide A, a new cyclic tetrapeptide with rare 4-hydroxy-proline moieties from the deep-sea derived actinomycete Saccharopolyspora cebuensis MCCC 1A09850	
DRAMP35623	KP	2	Cyclo(Lys-Pro)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	29216716	Bioconjug Chem. 2018 Jan 17;29(1):164-175.	Shankar S, Faheem MM, Nayak D, Wani NA, Farooq S, Koul S, Goswami A, Rai R.	Cyclodipeptide c(Orn-Pro) Conjugate with 4-Ethylpiperic Acid Abrogates Cancer Cell Metastasis through Modulating MDM2	NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O
DRAMP35624	YLARAIRRTLARLLL	15	NN2_0018	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	29259134	 J Biol Chem. 2018 Mar 9;293(10):3492-3509. 	Nagarajan D, Nagarajan T, Roy N, Kulkarni O, Ravichandran S, Mishra M, Chakravortty D, Chandra N. 	Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
DRAMP35625	SWKKFFKKARSLPKLF	16	NN2_0050	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	29259134	J Biol Chem. 2018 Mar 9;293(10):3492-3509.	Nagarajan D, Nagarajan T, Roy N, Kulkarni O, Ravichandran S, Mishra M, Chakravortty D, Chandra N. 	Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP35626	INLKKLAKLXKKIS	14	Mitoparan [L14S], Mastoparan [A5,8K;A10Aib;L14S]	P01514		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	29337270	Peptides. 2018 Mar;101:95-105.	Howl J, Howl L, Jones S. 	The cationic tetradecapeptide mastoparan as a privileged structure for drug discovery: Enhanced antimicrobial properties of mitoparan analogues modified at position-14	
DRAMP35627	INLKKLAXLXKKIS	14	Mitoparan [K8Orn,L14S], Mastoparan [A5,A8Orn,A10Aib,L14S]	P01514		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	29337270	Peptides. 2018 Mar;101:95-106.	Howl J, Howl L, Jones S. 	The cationic tetradecapeptide mastoparan as a privileged structure for drug discovery: Enhanced antimicrobial properties of mitoparan analogues modified at position-14	
DRAMP35628	INLKKLAKLXKKIT	14	Mitoparan [L14T], Mastoparan [A5,8K;A10Aib;L14T]	P01514		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	29337270	Peptides. 2018 Mar;101:95-107.	Howl J, Howl L, Jones S. 	The cationic tetradecapeptide mastoparan as a privileged structure for drug discovery: Enhanced antimicrobial properties of mitoparan analogues modified at position-14	
DRAMP35629	KRIVARIKAFLR	12	LL-37 KR-12 [Q5A,D9A]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	29430821	Chembiochem. 2018 May 4;19(9):931-939. 	Gunasekera S, Muhammad T, Strömstedt AA, Rosengren KJ, Göransson U.	Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35630	KRIVKRIKKFLR	12	LL-37 KR-12 [Q5K,D9K]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	29430821	Chembiochem. 2018 May 4;19(9):931-940. 	Gunasekera S, Muhammad T, Strömstedt AA, Rosengren KJ, Göransson U.	Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35631	GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQX	54	Melittin Dimer	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	29770868	Amino Acids. 2018 Aug;50(8):1101-1110. 	Jamasbi E, Lucky SS, Li W, Hossain MA, Gopalakrishnakone P, Separovic F.	Effect of dimerized melittin on gastric cancer cells and antibacterial activity	
DRAMP35632	WKLLSKAQEKFGKNKSRC,RYGTCIYQXRLWAFS	34	CH10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	30048118	Bioconjug Chem. 2018 Sep 19;29(9):3060-3072	Ptaszyńska N, Gucwa K, Łęgowska A, Dębowski D, Gitlin-Domagalska A, Lica J, Heldt M, Martynow D, Olszewski M, Milewski S, Ng TB, Rolka K.	Antimicrobial Activity of Chimera Peptides Composed of Human Neutrophil Peptide 1 (HNP-1) Truncated Analogues and Bovine Lactoferrampin	
DRAMP35633	XCRRLCYRNRCVTYCRGR	18	X-hexatoxin-Hi1a, Hi Gomesin	A0A1D0BZI2		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30068931	Sci Rep. 2018 Aug 1;8(1):11519.	Ikonomopoulou MP, Fernandez-Rojo MA, Pineda SS, Cabezas-Sainz P, Winnen B, Morales RAV, Brust A, Sánchez L, Alewood PF, Ramm GA, Miles JJ, King GF.	Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation	
DRAMP35634	ECRRLCYKQRCVTYCRGR	18	Gomesin [PYA1E]	P82358		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	1KFP	Not available	Not available	Not available		Amidation	Amidation		L	Not available	Not available	30068931	Sci Rep. 2018 Aug 1;8(1):11520.	Ikonomopoulou MP, Fernandez-Rojo MA, Pineda SS, Cabezas-Sainz P, Winnen B, Morales RAV, Brust A, Sánchez L, Alewood PF, Ramm GA, Miles JJ, King GF.	Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation	
DRAMP35635	RQIKIWFQNRRMKWKKAKLNAEKLKDFKIRLQYFARGLQVYIRQLRLALQGKT	53	RT53	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Mice red blood cells: 8% Hemolysis=20 μM	Linear	Free	Free		L	Not available	Not available	30080874	PLoS One. 2018 Aug 6;13(8):e0201220.	Pasquereau-Kotula E, Habault J, Kroemer G, Poyet JL.	The anticancer peptide RT53 induces immunogenic cell death	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O)[C@H](C)CC
DRAMP35636	RQIKIWFQNRRMKWKKAKLNAEKLKDFKIRLQYFARGGQVYIRQGRLALQGKT	53	RT53M	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30080874	PLoS One. 2018 Aug 6;13(8):e0201221.	Pasquereau-Kotula E, Habault J, Kroemer G, Poyet JL.	The anticancer peptide RT53 induces immunogenic cell death	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)O)[C@H](C)CC
DRAMP35637	AWIWLV	6	Nocardiotide A	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30134565	Mar Drugs. 2018 Aug 21;16(9):290.	Ibrahim AH, Attia EZ, Hajjar D, Anany MA, Desoukey SY, Fouad MA, Kamel MS, Wajant H, Gulder TAM, Abdelmohsen UR. 	New Cytotoxic Cyclic Peptide from the Marine Sponge-Associated Nocardiopsis sp UR67	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP35638	LESLASSAVRTANKARAKL	19	Citrus-amp2	Q4JIY4		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30192822	PLoS One. 2018 Sep 7;13(9):e0203452. 	Inui Kishi RN, Stach-Machado D, Singulani JL, Dos Santos CT, Fusco-Almeida AM, Cilli EM, Freitas-Astúa J, Picchi SC, Machado MA.	Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP35639	XTXCXfXRXc	10	Polymyxin CAMP113	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	C12	Free		Mix	Not available	Not available	30215733	J Antimicrob Chemother. 2018 Dec 1;73(12):3385-3390. 	Rudilla H, Pérez-Guillén I, Rabanal F, Sierra JM, Vinuesa T, Viñas M.	Novel Synthetic peptide polymyxins kill Gram-positive bacteria	
DRAMP35640	XTXCXxXXXc	10	Polymyxin CAMP207	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	C12	Free		Mix	Not available	Not available	30215733	J Antimicrob Chemother. 2018 Dec 1;73(12):3385-3391. 	Rudilla H, Pérez-Guillén I, Rabanal F, Sierra JM, Vinuesa T, Viñas M.	Novel Synthetic peptide polymyxins kill Gram-positive bacteria	
DRAMP35641	FLFKLIPKAIKGLIKAFK	18	AcrAP1 [S4K,H8K,S11K,S15K]	A0A0A1I6E7		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30268502	Biophys Res Commun. 2018 Oct 28;505(2):478-484. 	Lee MY, Park SC, Jung M, Shin MK, Kang HL, Baik SC, Cheong GW, Jang MK, Lee WK. 	Cationicity-enhanced analogues of the antimicrobial peptides, AcrAP1 and AcrAP2, from the venom of the scorpion, Androctonus crassicauda, display potent growth modulation effects on human cancer cell lines	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP35642	IP	2	Cyclo(Ile-Pro)	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30270742	Nat Prod Res. 2020 May;34(10):1461-1464.	Lin WX, Xie CL, Zhou M, Xia ML, Zhou TT, Chen HF, Yang XW, Yang Q.	Chemical constituents from the deep sea-derived Streptomyces xiamenensis MCCC 1A01570 and their effects on RXRα transcriptional regulation	CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)O
DRAMP35643	XI	2	Cyclo(Hyp-Ile)	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30270742	Nat Prod Res. 2020 May;34(10):1461-1465.	Lin WX, Xie CL, Zhou M, Xia ML, Zhou TT, Chen HF, Yang XW, Yang Q.	Chemical constituents from the deep sea-derived Streptomyces xiamenensis MCCC 1A01570 and their effects on RXRα transcriptional regulation	
DRAMP35644	FFFFRRRR	8	F4R4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30360400	Molecules. 2018 Oct 22;23(10):2722. 	Riahifard N, Mozaffari S, Aldakhil T, Nunez F, Alshammari Q, Alshammari S, Yamaki J, Parang K, Tiwari RK.	Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP35645	FFFFRRRR	8	F4R4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30360400	Molecules. 2018 Oct 22;23(10):2722. 	Riahifard N, Mozaffari S, Aldakhil T, Nunez F, Alshammari Q, Alshammari S, Yamaki J, Parang K, Tiwari RK.	Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP35646	IKNAKVCVYAVCVSHK	16	Nicomicin-1 (18-33)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30360541	Mar Drugs. 2018 Oct 23;16(11):401.	Panteleev PV, Tsarev AV, Bolosov IA, Paramonov AS, Marggraf MB, Sychev SV, Shenkarev ZO, Ovchinnikova TV	Novel Antimicrobial Peptides from the Arctic Polychaeta Nicomache minor Provide New Molecular Insight into Biological Role of the BRICHOS Domain	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP35647	KKWRKWLKWLAKK	13	Myotoxin II (105-117)[Y3,6W][Y5K,P9W,C11A], PEM-2 [W5K,A9W]	P24605		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30447380	Int J Antimicrob Agents. 2019 Jun;53(6):868-872.	Baker KR, Jana B, Hansen AM, Vissing KJ, Nielsen HM, Franzyk H, Guardabassi L.	Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35648	KKPSKKPKPQAMTFPKVTVEYFPASFSTAALTVPED	36	Cathelicidin Ps-CATH6	A0A2Z4HVI6		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30452933	Dev Comp Immunol. 2019 Mar;92:179-192. 	Shi N, Cai S, Gao J, Qiao X, Yang H, Wang Y, Yu H. 	Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP35649	GLFDIVKKVLKLLK	14	Aurein-2.2 (1-14)[V10L, G11K, A12L, G14K]	P82389		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30506920	Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1674-1678.	Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G. 	Simulated Molecular Evolution for Anticancer Peptide Design	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP35650	GLFDIVKKVLRLLK	14	Aurein-2.2 (1-14)[V10L, G11R, A12L, G14K]	P82389		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30506920	Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1674-1679.	Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G. 	Simulated Molecular Evolution for Anticancer Peptide Design	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP35651	GWFDILKHVFRLLK	14		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30506920	Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1674-1680.	Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G. 	Simulated Molecular Evolution for Anticancer Peptide Design	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP35652	GWYEIIKKIYKWLK	14		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30506920	Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1674-1681.	Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G. 	Simulated Molecular Evolution for Anticancer Peptide Design	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35653	VKAWAKVLKGFGKLLKGFGKL	21		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30506920	Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1674-1682.	Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G. 	Simulated Molecular Evolution for Anticancer Peptide Design	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(N)=O
DRAMP35654	FHAWAKLLKGVGRFFKGIGRW	21		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30506920	Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1674-1683.	Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G. 	Simulated Molecular Evolution for Anticancer Peptide Design	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP35655	IRAWAKVLKGVGKILKGVGRW	21		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30506920	Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1674-1684.	Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G. 	Simulated Molecular Evolution for Anticancer Peptide Design	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)C(C)C)[C@H](C)CC)C(C)C)C(C)C
DRAMP35656	WRAWAKIYHGVGKLLKGVGRW	21		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30506920	Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1674-1685.	Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G. 	Simulated Molecular Evolution for Anticancer Peptide Design	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O)C(C)C)C(C)C
DRAMP35657	NVlLWK	6	Wollamide B [Orn6K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	30602509	Agents Chemother. 2019 Feb 26;63(3):e01773-18.	Khalil ZG, Hill TA, De Leon Rodriguez LM, Lohman RJ, Hoang HN, Reiling N, Hillemann D, Brimble MA, Fairlie DP, Blumenthal A, Capon RJ.	Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-Resistant and Intracellular Mycobacterium tuberculosis	CC(C)C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP35658	XXXAXLX	7	Rufomycin-1, Rufomycin B	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30602512	Agents Chemother. 2019 Feb 26;63(3):e02204-18.	Choules MP, Wolf NM, Lee H, Anderson JR, Grzelak EM, Wang Y, Ma R, Gao W, McAlpine JB, Jin YY, Cheng J, Lee H, Suh JW, Duc NM, Paik S, Choe JH, Jo EK, Chang CL, Lee JS, Jaki BU, Pauli GF, Franzblau SG, Cho S	Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M abscessus	
DRAMP35659	AFXGVl	6	Scopularide B	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	30609359	J Org Chem. 2019 Feb 1;84(3):1228-1237.	Hou XM, Li YY, Shi YW, Fang YW, Chao R, Gu YC, Wang CY, Shao CL. 	Integrating Molecular Networking and 1H NMR To Target the Isolation of Chrysogeamides from a Library of Marine-Derived Penicillium Fungi	
DRAMP35660	FLSLIPHIVSGVAALANHL	19	Phylloseptin-PBa3, Phylloseptin-PBu	A0A5B7LGI9		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	30612735		Wu Y, Wang L, Zhou M, Chen T, Shaw C.	Phylloseptin-PBa1, -PBa2, -PBa3: Three novel antimicrobial peptides from the skin secretion of Burmeister's leaf frog (Phyllomedusa burmeisteri)	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C
DRAMP35661	GLPLLISWIKRKRQQAGPGSKKPVPIIYCNRRTGKCQRM	39	Melittin (12-26)[A4L]-AGP-Thanatin	P55788		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30701481	AMB Express. 2019 Jan 30;9(1):14.	Jiang X, Qian K, Liu G, Sun L, Zhou G, Li J, Fang X, Ge H, Lv Z. 	Design and activity study of a melittin-thanatin hybrid peptide	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(C)C
DRAMP35662	RGDfK	5		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	30732943	 Bioorg Med Chem Lett. 2019 Apr 1;29(7):896-900.	Liu J, Cheng X, Tian X, Guan D, Ao J, Wu Z, Huang W, Le Z.	Design and synthesis of novel dual-cyclic RGD peptides for αvβ3 integrin targeting	N=C(N)NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@H](Cc1ccccc1)C(=O)O
DRAMP35663	FIVPSIFLLKKAFCIALKKC	20	Japonicin-2LF	A0A482F245		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	30802593	 Biochim Biophys Acta Gen Subj. 2019 May;1863(5):849-856.	Yuan Y, Zai Y, Xi X, Ma C, Wang L, Zhou M, Shaw C, Chen T.	A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using Galleria mellonella model	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
DRAMP35664	KKLRLKIAFK	10	P-rpl39e (9-18)[A15K, A16I]	Q8ZTX6		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31016969	ACS Infect Dis. 2019 Jul 12;5(7):1081-1086. 	Cândido ES, Cardoso MH, Chan LY, Torres MDT, Oshiro KGN, Porto WF, Ribeiro SM, Haney EF, Hancock REW, Lu TK, de la Fuente-Nunez C, Craik DJ, Franco OL. 	Short Cationic Peptide Derived from Archaea with Dual Antibacterial Properties and Anti-Infective Potential	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP35665	RTCQSQSHRFRGPCLRRSNCANVCRTEGFPGGRCRGFRRRCFCTTHC	47	Flower-specific gamma-thionin, ZmD32	B6SJ49		Not found	Plantae	Antimicrobial, Anticancer	Not found	Not found	Not found	6DMZ	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31031739	Front Microbiol. 2019 Apr 12;10:795. 	erenga BK, McKenna JA, Harvey PJ, Quimbar P, Garcia-Ceron D, Lay FT, Phan TK, Veneer PK, Vasa S, Parisi K, Shafee TMA, van der Weerden NL, Hulett MD, Craik DJ, Anderson MA, Bleackley MR. 	Salt-Tolerant Antifungal and Antibacterial Activities of the Corn Defensin ZmD32	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
DRAMP35666	RRSRFGRFFKKVRKQLGRVLRHSRITVGGRMRF	33	Cm-CATH2	M7BBJ0		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31121185	 Dev Comp Immunol. 2019 Sep;98:189-204. 	Qiao X, Yang H, Gao J, Zhang F, Chu P, Yang Y, Zhang M, Wang Y, Yu H. 	Diversity, immunoregulatory action and structure-activity relationship of green sea turtle cathelicidins	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O
DRAMP35667	GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC	33	LF Brevinin, LFB	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31234333	Biomolecules. 2019 Jun 21;9(6):242	Li B, Lyu P, Xie S, Qin H, Pu W, Xu H, Chen T, Shaw C, Ge L, Kwok HF. 	LFB: A Novel Antimicrobial Brevinin-Like Peptide from the Skin Secretion of the Fujian Large Headed Frog, Limnonectes fujianensi	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)O
DRAMP35668	RRWCVYAYVRVRGVRVYAYVCW	22	R-Arenicin-1 [L15R; R17,19Y; Y18A; R20V]	Q5SC60		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31234579	 Mar Drugs. 2019 Jun 23;17(6):376. 	Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.	Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization	CC(C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
DRAMP35669	WCRRYRVLVRGVLVRYRRCW	20	Arenicin (2-21) [V3R; Y4,6R; A5Y; R8L]	Q5SC60		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31234579	 Mar Drugs. 2019 Jun 23;17(6):376. 	Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.	Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
DRAMP35670	RWCVYAYVRVXX,RWCVYAYVRV	23	Arenicin-1 (1-10)-Orn-Dap + Arenicin-1 (1-10)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	31234579	 Mar Drugs. 2019 Jun 23;17(6):376. 	Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.	Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization	
DRAMP35671	WCRRYRVLVXX,WCRRYRVLV	21	Invert Arenicin-1 (13-21)-Orn-Dap + Invert Arenicin-1 (13-21)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	31234579	 Mar Drugs. 2019 Jun 23;17(6):376. 	Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.	Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization	
DRAMP35672	RFCVYAYVRVRGVLVRYRRCF	21	Arenicin-1 [W2,21F]	Q5SC60		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31234579	 Mar Drugs. 2019 Jun 23;17(6):376. 	Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.	Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP35673	RWXVYAYVRVRGVLVRYRRXW	21	Linear Arenicin-1 [C3,20IAA-Cys]	Q5SC60		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31234579	 Mar Drugs. 2019 Jun 23;17(6):376. 	Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A.	Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization	
DRAMP35674	SRSSRAGLQFPVGRIHRLLRK	21	Histone H2A (1-21), Fi-Histin	A0A1X9ZM18		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31252047	Fish Shellfish Immunol. 2019 Sep;92:667-679. 	Sruthy KS, Nair A, Antony SP, Puthumana J, Singh ISB, Philip R. 	A histone H2A derived antimicrobial peptide, Fi-Histin from the Indian White shrimp, Fenneropenaeus indicus: Molecular and functional characterization	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP35675	SILSLFKMGAKALGKTLIKQAGKAGAEYVACKATNQC	37	Esculentin-2 HYba2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	31328553	Nat Prod Res. 2021 Apr;35(8):1262-1266. 	Vineeth Kumar T, Asha R, George S.	Identification and functional characterisation of Esculentin-2 HYba peptides and their C-terminally amidated analogs from the skin secretion of an endemic frog	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(N)=O)[C@@H](C)O)C(C)C
DRAMP35676	RKKRRQRRRCWTKSIPPKPC	20	Tat (48-56) + PPF-BBI [5-15]	C3RSZ6		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: H157 (50% viability=100μM); H460 (50% viability=100μM)	Not available	Linear	Free	Free		L	Not available	Not available	31337113	Biomolecules. 2019 Jul 14;9(7):280.	Miao Y, Chen G, Xi X, Ma C, Wang L, Burrows JF, Duan J, Zhou M, Chen T.	Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O
DRAMP35677	RKKAIKLVKKLVKKLKKALK	20		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear				L	Not available	Not available	31355341	Sci Adv. 2019 Jul 24;5(7):eaax1946.	Nagarajan D, Roy N, Kulkarni O, Nanajkar N, Datey A, Ravichandran S, Thakur C, T S, Aprameya IV, Sarma SP, Chakravortty D, Chandra N. 	Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
DRAMP35678	FLKAIKKFGKEFKKIGAKLK	20		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear				L	Not available	Not available	31355341	Sci Adv. 2019 Jul 24;5(7):eaax1947.	Nagarajan D, Roy N, Kulkarni O, Nanajkar N, Datey A, Ravichandran S, Thakur C, T S, Aprameya IV, Sarma SP, Chakravortty D, Chandra N. 	Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC
DRAMP35679	RWCFRVCYRGICYRKCRG	18	Cyclic Tachyplesin-2	P14214		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	6PIO	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31455019	 Int J Mol Sci. 2019 Aug 26;20(17):4184. 	Vernen F, Harvey PJ, Dias SA, Veiga AS, Huang YH, Craik DJ, Lawrence N, Troeira Henriques S.	Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
DRAMP35680	KWCFRVCYRGICYRKCRG	18	Cyclic Tachyplesin-3	P14214		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	6PIP	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31455019	 Int J Mol Sci. 2019 Aug 26;20(17):4185. 	Vernen F, Harvey PJ, Dias SA, Veiga AS, Huang YH, Craik DJ, Lawrence N, Troeira Henriques S.	Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
DRAMP35681	CFQWKRAMRKVR	12	HLopt2	P02788		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	31513374	ACS Chem Biol. 2019 Oct 18;14(10):2233-2242. 	Ptaszyńska N, Gucwa K, Olkiewicz K, Łȩgowska A, Okońska J, Ruczyński J, Gitlin-Domagalska A, Dȩbowski D, Milewski S, Rolka K	Antibiotic-Based Conjugates Containing Antimicrobial HLopt2 Peptide: Design, Synthesis, Antimicrobial and Cytotoxic Activities	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C
DRAMP35682	FLSGIVaMLaKLF	13	Temporin-1Sa [G7,10a]	B3KYH4		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	31614561	 Biomolecules. 2019 Oct 11;9(10):598.	Olleik H, Baydoun E, Perrier J, Hijazi A, Raymond J, Manzoni M, Dupuis L, Pauleau G, Goudard Y, Villéon B, Goin G, Sockeel P, Choudhary MI, Pasquale ED, Nadeem-Ul-Haque M, Ali H, Khan AI, Shaheen F, Maresca M.	Temporin-SHa and Its Analogs as Potential Candidates for the Treatment of Helicobacter pylori	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP35683	FLSaIVGMLaKLF	13	Temporin-1Sa [G4,10a]	B3KYH4		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	31614561	 Biomolecules. 2019 Oct 11;9(10):599.	Olleik H, Baydoun E, Perrier J, Hijazi A, Raymond J, Manzoni M, Dupuis L, Pauleau G, Goudard Y, Villéon B, Goin G, Sockeel P, Choudhary MI, Pasquale ED, Nadeem-Ul-Haque M, Ali H, Khan AI, Shaheen F, Maresca M.	Temporin-SHa and Its Analogs as Potential Candidates for the Treatment of Helicobacter pylori	CC[C@@H](C)[C@H](NC(=O)[C@@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP35684	FLSAIVGMLAKLF	13	Temporin-1Sa [G4,10A]	B3KYH4		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	31614561	 Biomolecules. 2019 Oct 11;9(10):600.	Olleik H, Baydoun E, Perrier J, Hijazi A, Raymond J, Manzoni M, Dupuis L, Pauleau G, Goudard Y, Villéon B, Goin G, Sockeel P, Choudhary MI, Pasquale ED, Nadeem-Ul-Haque M, Ali H, Khan AI, Shaheen F, Maresca M.	Temporin-SHa and Its Analogs as Potential Candidates for the Treatment of Helicobacter pylori	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C
DRAMP35685	LSYXXxXWXXASpP	14	Murepavadin [T1L,W2S,I3Y,DAB10tBuGly]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	31645764	Nature. 2019 Dec;576(7787):452-458.	Luther A, Urfer M, Zahn M, Müller M, Wang SY, Mondal M, Vitale A, Hartmann JB, Sharpe T, Monte FL, Kocherla H, Cline E, Pessi G, Rath P, Modaresi SM, Chiquet P, Stiegeler S, Verbree C, Remus T, Schmitt M, Kolopp C, Westwood MA, Desjonquères N, Brabet E, Hell S, LePoupon K, Vermeulen A, Jaisson R, Rithié V, Upert G, Lederer A, Zbinden P, Wach A, Moehle K, Zerbe K, Locher HH, Bernardini F, Dale GE, Eberl L, Wollscheid B, Hiller S, Robinson JA, Obrecht D. 	Chimeric peptidomimetic antibiotics against Gram-negative bacteria	
DRAMP35686	WCVASpPLSYCGXTXXXlLXXT	22		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	31645764	Nature. 2019 Dec;576(7787):452-459.	Luther A, Urfer M, Zahn M, Müller M, Wang SY, Mondal M, Vitale A, Hartmann JB, Sharpe T, Monte FL, Kocherla H, Cline E, Pessi G, Rath P, Modaresi SM, Chiquet P, Stiegeler S, Verbree C, Remus T, Schmitt M, Kolopp C, Westwood MA, Desjonquères N, Brabet E, Hell S, LePoupon K, Vermeulen A, Jaisson R, Rithié V, Upert G, Lederer A, Zbinden P, Wach A, Moehle K, Zerbe K, Locher HH, Bernardini F, Dale GE, Eberl L, Wollscheid B, Hiller S, Robinson JA, Obrecht D. 	Chimeric peptidomimetic antibiotics against Gram-negative bacteria	
DRAMP35687	RFRWPIRRPPIRPPFYP	17	Bac5 (1-17)[P4W]	P19660		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31692278	ChemMedChem. 2019 Dec 17;14(24):2025-2033	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E Coli, K Pneumoniae, and A Baumannii	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP35688	RFRPPIRRPPIRPPWYP	17	Bac5 (1-17)[F15W]	P19660		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31692278	ChemMedChem. 2019 Dec 17;14(24):2025-2033	Mardirossian M, Sola R, Beckert B, Collis DWP, Di Stasi A, Armas F, Hilpert K, Wilson DN, Scocchi M.	Proline-Rich Peptides With Improved Antimicrobial Activity Against E Coli, K Pneumoniae, and A Baumannii	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP35689	GYPFA	5	Longicalycinin A cyclic analogue 3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=9.77 ± 0.0007 μg/mL); HT-29 (IC50=11.4 ± 0 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108902. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)O
DRAMP35690	AYPFG	5	Longicalycinin A cyclic analogue 4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=9.53 ± 0.0014 μg/mL); HT-29 (IC50=10.78 ± 0.0021 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108903. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
DRAMP35691	FSPFG	5	Longicalycinin A cyclic analogue 5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=8.99 ± 0.0014 μg/mL); HT-29 (IC50=10.97 ± 0.0049 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108904. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
DRAMP35692	VYPIA	5	Longicalycinin A cyclic analogue 6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=10.98 ± 0.0014 μg/mL); HT-29 (IC50=12.31 ± 0.0063 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108905. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP35693	PYVFA	5	Longicalycinin A cyclic analogue 7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=9.6 ± 0.0007 μg/mL); HT-29 (IC50=9.78 ± 0.0212 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108906. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O
DRAMP35694	FYPVG	5	Longicalycinin A cyclic analogue 8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=10.35 ± 0.0014 μg/mL); HT-29 (IC50=12.88 ± 0.0014 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108907. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)O
DRAMP35695	FYPFV	5	Longicalycinin A cyclic analogue 9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=9.33 ± 0.0007 μg/mL); HT-29 (IC50=10.44 ± 0.5536 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108908. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP35696	FYPFA	5	Longicalycinin A cyclic analogue 10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=10.5 ± 0.0014 μg/mL); HT-29 (IC50=10.5 ± 0.0007 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108909. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP35697	TVPFA	5	Longicalycinin A cyclic analogue 11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=9.56 ± 0.0021 μg/mL); HT-29 (IC50=11.67 ± 0.0014 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108910. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	CC(C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O
DRAMP35698	FYPFI	5	Longicalycinin A cyclic analogue 12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=11.32 ± 0.0014 μg/mL); HT-29 (IC50=14.2 ± 0.0014 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108911. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP35699	VTPFL	5	Longicalycinin A cyclic analogue 13	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=9.26 ± 0.0028 μg/mL); HT-29 (IC50=17.2 ± 0.0014 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108912. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)O
DRAMP35700	PYFFL	5	Longicalycinin A cyclic analogue 14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=9.67 ± 0.0007 μg/mL); HT-29 (IC50=9.12 ± 0.0042 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108913. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(=O)O
DRAMP35701	PYGFV	5	Longicalycinin A cyclic analogue 15	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=9.44 ± 0 μg/mL); HT-29 (IC50=10.55 ± 0.0989 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108914. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(=O)O
DRAMP35702	FTPFV	5	Longicalycinin A cyclic analogue 16	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=11.1 ± 0.0007 μg/mL); HT-29 (IC50=12.11 ± 0.0056 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108915. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)O
DRAMP35703	FSPFA	5	Longicalycinin A cyclic analogue 17	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=9.33 ± 0.0007 μg/mL); HT-29 (IC50=11.33 ± 0.0035 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108916. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP35704	FSPAG	5	Longicalycinin A cyclic analogue 18	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=10.33 ± 0.0007 μg/mL); HT-29 (IC50=10.2 ± 0.0014 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108917. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)O
DRAMP35705	FYPFG	5	Longicalycinin A linear	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=9.18 ± 0.0014 μg/mL); HT-29 (IC50=9.61 ± 0.0007 μg/mL)	Not available	Linear	Free	Free		L	Not available	Not available	31747558	Chem Biol Interact. 2020 Jan 5;315:108918. 	Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.	Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides	N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
DRAMP35706	FLFKLIKHAIKGLIKAFK	18	AcrAP1 [S4,11,15K;P7K], AP1-Z5b	A0A0A1I6E7		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	31909181	Mol Ther Oncolytics. 2019 Dec 10;16:7-19.	Ma R, Wong SW, Ge L, Shaw C, Siu SWI, Kwok HF. 	In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC
DRAMP35707	LRKVRRLLRRL	11	AMP 21	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (10% Killing=100µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	31954105	Biophys Acta Biomembr. 2020 Apr 1;1862(4):183177. 	Pandit G, Biswas K, Ghosh S, Debnath S, Bidkar AP, Satpati P, Bhunia A, Chatterjee S.	Rationally designed antimicrobial peptides: Insight into the mechanism of eleven residue peptides against microbial infections	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(N)=O
DRAMP35708	LRKVWRWLRRL	11	AMP 22	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (80% Killing=100µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	31954105	Biophys Acta Biomembr. 2020 Apr 1;1862(4):183178. 	Pandit G, Biswas K, Ghosh S, Debnath S, Bidkar AP, Satpati P, Bhunia A, Chatterjee S.	Rationally designed antimicrobial peptides: Insight into the mechanism of eleven residue peptides against microbial infections	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(N)=O
DRAMP35709	LRKFRRLLRRL	11	AMP 23	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (0% Killing=100µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	31954105	Biophys Acta Biomembr. 2020 Apr 1;1862(4):183179. 	Pandit G, Biswas K, Ghosh S, Debnath S, Bidkar AP, Satpati P, Bhunia A, Chatterjee S.	Rationally designed antimicrobial peptides: Insight into the mechanism of eleven residue peptides against microbial infections	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(N)=O
DRAMP35710	LRRLRRLLRRL	11	AMP 24	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (85% Killing=100µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	31954105	Biophys Acta Biomembr. 2020 Apr 1;1862(4):183180. 	Pandit G, Biswas K, Ghosh S, Debnath S, Bidkar AP, Satpati P, Bhunia A, Chatterjee S.	Rationally designed antimicrobial peptides: Insight into the mechanism of eleven residue peptides against microbial infections	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(N)=O
DRAMP35712	FWRIRIRRPRRIRIRWF	17	R-DIM-P-LF11-215	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	32151609	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183264.	Grissenberger S, Riedl S, Rinner B, Leber R, Zweytick D.	Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP35713	PFWRIRIRRPFWRIRIRR	18	DIM-LF11-322	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32151609	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183265.	Grissenberger S, Riedl S, Rinner B, Leber R, Zweytick D.	Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35714	PWRIRIRRPRRIRIWP	16	R-DIM-P-LF11-334	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	32151609	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183266.	Grissenberger S, Riedl S, Rinner B, Leber R, Zweytick D.	Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP35715	PWRIRIRRRRIRIRWPPWRIRIRR	24	R-DIM-LF11-334-LF11-334	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	32151609	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183267.	Grissenberger S, Riedl S, Rinner B, Leber R, Zweytick D.	Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP35716	RRWFWRRRRWFWRR	14	DIM-LF11-339	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	32151609	Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183268.	Grissenberger S, Riedl S, Rinner B, Leber R, Zweytick D.	Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
DRAMP35717	AGGKRIVQRIKDFLRGAGGKRIVQRIKDFLRG	32	AGG-KR12-GAGG-KR12-G	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32153522	Front Microbiol. 2020 Feb 21;11:168.	Gunasekera S, Muhammad T, Strömstedt AA, Rosengren KJ, Göransson U.	Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](C)N)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP35718	AGGKRIVKRIKKFLRGAGGKRIVKRIKKFLRG	32	AGG-KR12-GAGG-KR12-G [Q8,24K; D12,28K]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32153522	Front Microbiol. 2020 Feb 21;11:169.	Gunasekera S, Muhammad T, Strömstedt AA, Rosengren KJ, Göransson U.	Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](C)N)[C@H](C)CC)C(C)C)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
DRAMP35719	HHHH	4	12-(His)4-12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	C12	C12		L	Not available	Not available	32193931	ACS Appl Mater Interfaces. 2020 Apr 15;12(15):17220-17229. 	Qi R, Zhang N, Zhang P, Zhao H, Liu J, Cui J, Xiang J, Han Y, Wang S, Wang Y.	Gemini Peptide Amphiphiles with Broad-Spectrum Antimicrobial Activity and Potent Antibiofilm Capacity	
DRAMP35720	VKRTKRGARRGLTKVLKKIFGSIVKKAVSKGV	32	Cathelicidin ModoCath1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32194564	 Front Immunol. 2020 Mar 3;11:347.	Cho HS, Yum J, Larivière A, Lévêque N, Le QVC, Ahn B, Jeon H, Hong K, Soundrarajan N, Kim JH, Bodet C, Park C.	Opossum Cathelicidins Exhibit Antimicrobial Activity Against a Broad Spectrum of Pathogens Including West Nile Virus	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@H](C)CC
DRAMP35721	WYQLIRTFGNLIHQKYRKLLEAYRKLRD	28	Cathelicidin ModoCath5	F6W4B4		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32194564	 Front Immunol. 2020 Mar 3;11:348.	Cho HS, Yum J, Larivière A, Lévêque N, Le QVC, Ahn B, Jeon H, Hong K, Soundrarajan N, Kim JH, Bodet C, Park C.	Opossum Cathelicidins Exhibit Antimicrobial Activity Against a Broad Spectrum of Pathogens Including West Nile Virus	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP35722	VRRSKRGIKVPSFVKKVLKDVVSESIS	27	Cathelicidin ModoCath6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32194564	 Front Immunol. 2020 Mar 3;11:349.	Cho HS, Yum J, Larivière A, Lévêque N, Le QVC, Ahn B, Jeon H, Hong K, Soundrarajan N, Kim JH, Bodet C, Park C.	Opossum Cathelicidins Exhibit Antimicrobial Activity Against a Broad Spectrum of Pathogens Including West Nile Virus	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(C)C)C(=O)O
DRAMP35723	KRWKKFFRKVIKFF	14	BotrAMP14	U5KJC9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	32499582	 Sci Rep. 2020 Jun 4;10(1):9127.	Oliveira NGJ, Cardoso MH, Velikova N, Giesbers M, Wells JM, Rezende TMB, de Vries R, Franco OL.	Physicochemical-guided design of cathelicidin-derived peptides generates membrane active variants with therapeutic potential	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP35724	KRLKKIFKKMIKIF	14	CrotAMP14	U5KJM4		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	32499582	 Sci Rep. 2020 Jun 4;10(1):9128.	Oliveira NGJ, Cardoso MH, Velikova N, Giesbers M, Wells JM, Rezende TMB, de Vries R, Franco OL.	Physicochemical-guided design of cathelicidin-derived peptides generates membrane active variants with therapeutic potential	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
DRAMP35730	XXXXKKK	7		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HepG2 (IC50=355µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	32764602	 Sci Rep. 2020 Aug 6;10(1):13206.	Greco I, Molchanova N, Holmedal E, Jenssen H, Hummel BD, Watts JL, Håkansson J, Hansen PR, Svenson J.	Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of Synthetic peptide antimicrobial peptides	
DRAMP35731	KKLKXFX	7		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=462µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	32764602	 Sci Rep. 2020 Aug 6;10(1):13207.	Greco I, Molchanova N, Holmedal E, Jenssen H, Hummel BD, Watts JL, Håkansson J, Hansen PR, Svenson J.	Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of Synthetic peptide antimicrobial peptides	
DRAMP35732	XFXLKKK	7		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=783µM)	Not available	Linear	Free	Amidation		L	Not available	Not available	32764602	 Sci Rep. 2020 Aug 6;10(1):13208.	Greco I, Molchanova N, Holmedal E, Jenssen H, Hummel BD, Watts JL, Håkansson J, Hansen PR, Svenson J.	Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of Synthetic peptide antimicrobial peptides	
DRAMP35733	WG	2	Cyclo(Trp-Gly), Diketopiperazine (WG)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32806659	Molecules. 2020 Aug 12;25(16):3676. 	Liu R, Zhang H, Wu W, Li H, An Z, Zhou F.	C7-Prenylation of Tryptophan-Containing Cyclic Dipeptides by 7-Dimethylallyl Tryptophan Synthase Significantly Increases the Anticancer and Antimicrobial Activities	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O
DRAMP35734	WW	2	Cyclo(Trp-Trp), Diketopiperazine (WW)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	32806659	Molecules. 2020 Aug 12;25(16):3677. 	Liu R, Zhang H, Wu W, Li H, An Z, Zhou F.	C7-Prenylation of Tryptophan-Containing Cyclic Dipeptides by 7-Dimethylallyl Tryptophan Synthase Significantly Increases the Anticancer and Antimicrobial Activities	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP35735	EKKRLLKWWR	10		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	33074344	Amino Acids. 2020 Oct;52(10):1439-1457.	Faya M, Hazzah HA, Omolo CA, Agrawal N, Maji R, Walvekar P, Mocktar C, Nkambule B, Rambharose S, Albericio F, de la Torre BG, Govender T. 	Novel formulation of antimicrobial peptides enhances antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA)	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP35736	KWWKLLRKKR	10		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	33074344	Amino Acids. 2020 Oct;52(10):1439-1458.	Faya M, Hazzah HA, Omolo CA, Agrawal N, Maji R, Walvekar P, Mocktar C, Nkambule B, Rambharose S, Albericio F, de la Torre BG, Govender T. 	Novel formulation of antimicrobial peptides enhances antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA)	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
DRAMP35737	FLSLIPKIAGGIAALVKNL	19	Phylloseptin-PV1, PPV1	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	33193152	Front Microbiol. 2020 Oct 26;11:565158. 	Liu Y, Shi D, Wang J, Chen X, Zhou M, Xi X, Cheng J, Ma C, Chen T, Shaw C, Wang L.	A Novel Amphibian Antimicrobial Peptide, Phylloseptin-PV1, Exhibits Effective Anti- staphylococcal Activity Without Inducing Either Hepatic or Renal Toxicity in Mice	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP35738	KKCNFFCKLKKKVKSVGSRNLIGSATHHHRIYRV	34	PN-CATH1	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33242568	Dev Comp Immunol. 2021 Mar;116:103928.	Wang Y, Ouyang J, Luo X, Zhang M, Jiang Y, Zhang F, Zhou J, Wang Y.	Identification and characterization of novel bi-functional cathelicidins from the black-spotted frog (Pelophylax nigromaculata) with both anti-infective and antioxidant activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)[C@@H](C)O
DRAMP35739	EGCNILCLLKRKVKAVKNVVKNVVKSVVG	29	PN-CATH2	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33242568	Dev Comp Immunol. 2021 Mar;116:103929.	Wang Y, Ouyang J, Luo X, Zhang M, Jiang Y, Zhang F, Zhou J, Wang Y.	Identification and characterization of novel bi-functional cathelicidins from the black-spotted frog (Pelophylax nigromaculata) with both anti-infective and antioxidant activities	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP35740	IFWLFRGKADVAL	13	Agelaia-MP [N2F,K5F,L6R,I10D,I11del,D12V]	P69436		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	7JGX	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	33244888	Chembiochem. 2021 Apr 16;22(8):1415-1423. 	Muller JAI, Lawrence N, Chan LY, Harvey PJ, Elliott AG, Blaskovich MAT, Gonçalves JC, Galante P, Mortari MR, Toffoli-Kadri MC, Koehbach J, Craik DJ.	Antimicrobial and Anticancer Properties of Synthetic peptide Peptides Derived from the Wasp Parachartergus fraternus	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP35741	IFGTILGFLKGL	12	Protonectin [L2,8F]	P69437		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	7JHF	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	33244888	Chembiochem. 2021 Apr 16;22(8):1415-1424. 	Muller JAI, Lawrence N, Chan LY, Harvey PJ, Elliott AG, Blaskovich MAT, Gonçalves JC, Galante P, Mortari MR, Toffoli-Kadri MC, Koehbach J, Craik DJ.	Antimicrobial and Anticancer Properties of Synthetic peptide Peptides Derived from the Wasp Parachartergus fraternus	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC)[C@@H](C)O
DRAMP35742	GWGSFFRRAAHVGRHVGRAALTHYL	25	Pleurocidin KR	P81941		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	6RSF	Not available	Tumor cells: HeLa (IC50=30.7 ± 2.6 μg/ml)	Not available	Linear	Free	Amidation		L	HEK293: IC50=40.1 ± 4.1 µg/ml	Not available	33247193	 Commun Biol. 2020 Nov 27;3(1):697.	Manzo G, Hind CK, Ferguson PM, Amison RT, Hodgson-Casson AC, Ciazynska KA, Weller BJ, Clarke M, Lam C, Man RCH, Shaughnessy BGO, Clifford M, Bui TT, Drake AF, Atkinson RA, Lam JKW, Pitchford SC, Page CP, Phoenix DA, Lorenz CD, Sutton JM, Mason AJ.	A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(N)=O
DRAMP35743	gwgsffrraahvgrhvgraalthyl	25	D-Pleurocidin KR	P81941		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=25.3 ± 2.2 μg/ml); Calu-3 (IC50=39.1 ± 1.8 μg/ml); A549 (IC50=56.5 ± 4.5 μg/ml)	Not available	Linear	Free	Amidation		D	HEK293: IC50=36.4 ± 4.3 µg/ml	Not available	33247193	 Commun Biol. 2020 Nov 27;3(1):698.	Manzo G, Hind CK, Ferguson PM, Amison RT, Hodgson-Casson AC, Ciazynska KA, Weller BJ, Clarke M, Lam C, Man RCH, Shaughnessy BGO, Clifford M, Bui TT, Drake AF, Atkinson RA, Lam JKW, Pitchford SC, Page CP, Phoenix DA, Lorenz CD, Sutton JM, Mason AJ.	A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy	CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@H](C)O)C(N)=O
DRAMP35744	GWGSFFKKAAHAGKHAGKAALTHYL	25	Pleurocidin VA	P81941		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	6RSG	Not available	Tumor cells: HeLa (IC50>400 μg/ml)	Not available	Linear	Free	Amidation		L	HEK293: IC50~400 µg/ml	Not available	33247193	 Commun Biol. 2020 Nov 27;3(1):699.	Manzo G, Hind CK, Ferguson PM, Amison RT, Hodgson-Casson AC, Ciazynska KA, Weller BJ, Clarke M, Lam C, Man RCH, Shaughnessy BGO, Clifford M, Bui TT, Drake AF, Atkinson RA, Lam JKW, Pitchford SC, Page CP, Phoenix DA, Lorenz CD, Sutton JM, Mason AJ.	A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(N)=O
DRAMP35745	gwgsffkkaahagkhagkaalthyl	25	D-Pleurocidin VA	P81941		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (IC50=198.2 ± 10.2 μg/ml); A549 (IC50>250 μg/ml); Calu-3 (IC50>250 μg/ml)	Not available	Linear	Free	Amidation		D	HEK293: IC50=217.3 ± 46.5 µg/ml	Not available	33247193	 Commun Biol. 2020 Nov 27;3(1):700.	Manzo G, Hind CK, Ferguson PM, Amison RT, Hodgson-Casson AC, Ciazynska KA, Weller BJ, Clarke M, Lam C, Man RCH, Shaughnessy BGO, Clifford M, Bui TT, Drake AF, Atkinson RA, Lam JKW, Pitchford SC, Page CP, Phoenix DA, Lorenz CD, Sutton JM, Mason AJ.	A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy	CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)O)C(N)=O
DRAMP35746	GSRGWGFEPGVRCLIWCD	18	Lasso peptide Felipeptin A1	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	6XTH	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33294793	iScience. 2020 Nov 10;23(12):101785.	Guerrero-Garzón JF, Madland E, Zehl M, Singh M, Rezaei S, Aachmann FL, Courtade G, Urban E, Rückert C, Busche T, Kalinowski J, Cao YR, Jiang Y, Jiang CL, Selivanova G, Zotchev SB. 	Class IV Lasso Peptides Synergistically Induce Proliferation of Cancer Cells and Sensitize Them to Doxorubicin	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)O
DRAMP35747	GGGGRGYEYNKQCLIFC	17	Lasso peptide Felipeptin A2	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	6XTI	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33294793	iScience. 2020 Nov 10;23(12):101786.	Guerrero-Garzón JF, Madland E, Zehl M, Singh M, Rezaei S, Aachmann FL, Courtade G, Urban E, Rückert C, Busche T, Kalinowski J, Cao YR, Jiang Y, Jiang CL, Selivanova G, Zotchev SB. 	Class IV Lasso Peptides Synergistically Induce Proliferation of Cancer Cells and Sensitize Them to Doxorubicin	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CS)C(=O)O
DRAMP35748	GSRGWGFEPGVRCLIWCD,GGGGRGYEYNKQCLIFC	36	Felipeptin A1+Felipeptin A2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	33294793	iScience. 2020 Nov 10;23(12):101787.	Guerrero-Garzón JF, Madland E, Zehl M, Singh M, Rezaei S, Aachmann FL, Courtade G, Urban E, Rückert C, Busche T, Kalinowski J, Cao YR, Jiang Y, Jiang CL, Selivanova G, Zotchev SB. 	Class IV Lasso Peptides Synergistically Induce Proliferation of Cancer Cells and Sensitize Them to Doxorubicin	
DRAMP35752	LWKIWKKIWRVGWNWR	16	Cecropin A-like 4 (3-18)[K2W,G5W,E9W,Q13W,H14N,T15W]	A0A1I8M6I1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33401476	Antibiotics (Basel). 2021 Jan 1;10(1):36.	Peng J, Mishra B, Khader R, Felix L, Mylonakis E.	Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35753	LWKIWKKIWRVWKNWR	16	Cecropin A-like 4 (3-18)[K2W;G5,12W;E9W;Q13K;H14N;T15W]	A0A1I8M6I1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33401476	Antibiotics (Basel). 2021 Jan 1;10(1):37.	Peng J, Mishra B, Khader R, Felix L, Mylonakis E.	Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35754	LWKIGKKIWRVLWNWR	16	Cecropin A-like 4 (3-18)[K2W,E9W,G12L,Q13W,H14N,T15W]	A0A1I8M6I1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33401476	Antibiotics (Basel). 2021 Jan 1;10(1):38.	Peng J, Mishra B, Khader R, Felix L, Mylonakis E.	Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@H](C)CC
DRAMP35755	LWKIWWKIWRVWKNWR	16	Cecropin A-like 4 (3-18)[K2W;G5,12W;K6W;E9W;Q13K;H14N;T15W]	A0A1I8M6I1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33401476	Antibiotics (Basel). 2021 Jan 1;10(1):39.	Peng J, Mishra B, Khader R, Felix L, Mylonakis E.	Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35756	KVNHAACAAHCLLKRKRGGYCNKRRICVCRN	31	Defensin-like Protein (35-65), TcPaSK	D6X2G2		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33499187	Microorganisms. 2021 Jan 22;9(2):222.	Robles-Fort A, García-Robles I, Fernando W, Hoskin DW, Rausell C, Real MD.	Dual Antimicrobial and Antiproliferative Activity of TcPaSK Peptide Derived from a Tribolium castaneum Insect Defensin	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
DRAMP35757	ELlVDlL	7	Surfactin	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	3-OH-Me-C14	Free		Mix	Not available	Not available	33505362	 Front Microbiol. 2021 Jan 11;11:561060. 	Kourmentza K, Gromada X, Michael N, Degraeve C, Vanier G, Ravallec R, Coutte F, Karatzas KA, Jauregi P.	Antimicrobial Activity of Lipopeptide Biosurfactants Against Foodborne Pathogen and Food Spoilage Microorganisms and Their Cytotoxicity	CCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP35758	ExYxEaPQyI	10	Fengycin	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	3-OH-C16	Free		Mix	Not available	Not available	33505362	 Front Microbiol. 2021 Jan 11;11:561061. 	Kourmentza K, Gromada X, Michael N, Degraeve C, Vanier G, Ravallec R, Coutte F, Karatzas KA, Jauregi P.	Antimicrobial Activity of Lipopeptide Biosurfactants Against Foodborne Pathogen and Food Spoilage Microorganisms and Their Cytotoxicity	
DRAMP35759	nnsNXNQPy	9	Mycosubtilin	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	33505362	 Front Microbiol. 2021 Jan 11;11:561062. 	Kourmentza K, Gromada X, Michael N, Degraeve C, Vanier G, Ravallec R, Coutte F, Karatzas KA, Jauregi P.	Antimicrobial Activity of Lipopeptide Biosurfactants Against Foodborne Pathogen and Food Spoilage Microorganisms and Their Cytotoxicity	
DRAMP35760	ELlVDlL,ExYxEaPQyI	18	Fengycin-Surfactin	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	3-OH-Me-C14,3-OH-C16	Free		Mix	Not available	Not available	33505362	 Front Microbiol. 2021 Jan 11;11:561063. 	Kourmentza K, Gromada X, Michael N, Degraeve C, Vanier G, Ravallec R, Coutte F, Karatzas KA, Jauregi P.	Antimicrobial Activity of Lipopeptide Biosurfactants Against Foodborne Pathogen and Food Spoilage Microorganisms and Their Cytotoxicity	
DRAMP35761	ALWKDLLKNVGIAAGKAALNKVTDMVNQ	28	Dermaseptin-TO, Dermaseptin-1	P85523		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	33582221	Microb Pathog. 2021 Apr;153:104795.	Chen Z, Xi X, Lu Y, Hu H, Dong Z, Ma C, Wang L, Zhou M, Chen T, Du S, Lu Y.	In vitro activities of a novel antimicrobial peptide isolated from phyllomedusa tomopterna	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)C(C)C)[C@@H](C)O)C(C)C
DRAMP35762	GKLRLIKKLWVKKWKKKGWKA	21		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	33677023	Eur J Pharm Sci. 2021 Jun 1;161:105784. 	Thankappan B, Sivakumar J, Asokan S, Ramasamy M, Pillai MM, Selvakumar R, Angayarkanni J. 	Dual antimicrobial and anticancer activity of a novel synthetic α-helical antimicrobial peptide	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(N)=O)C(C)C
DRAMP35763	PFRLRLRL	8	Jelleine-1 [K3R;I4,6L;S5R;H7R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	33878564	Eur J Med Chem. 2021 Jul 5;219:113433. 	Zhou J, Zhang L, He Y, Liu K, Zhang F, Zhang H, Lu Y, Yang C, Wang Z, Fareed MS, Liang X, Yan W, Wang K.	An optimized analog of antimicrobial peptide Jelleine-1 shows enhanced antimicrobial activity against multidrug resistant P aeruginosa and negligible toxicity in vitro and in vivo	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(N)=O
DRAMP35764	PWRLRLRL	8	Jelleine-1 [F2W;K3R;I4,6L;S5R;H7R]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	33878564	Eur J Med Chem. 2021 Jul 5;219:113434. 	Zhou J, Zhang L, He Y, Liu K, Zhang F, Zhang H, Lu Y, Yang C, Wang Z, Fareed MS, Liang X, Yan W, Wang K.	An optimized analog of antimicrobial peptide Jelleine-1 shows enhanced antimicrobial activity against multidrug resistant P aeruginosa and negligible toxicity in vitro and in vivo	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1)C(N)=O
DRAMP35765	RLMRIFRILKLAR	13	Pugnin A	F6QYQ9		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33919639	Pharmaceutics. 2021 Apr 18;13(4):578.	Liscano Y, Medina L, Oñate-Garzón J, Gúzman F, Pickholz M, Delgado JP. 	In Silico Selection and Evaluation of Pugnins with Antibacterial and Anticancer Activity Using Skin Transcriptome of Treefrog ( Boana pugnax)	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC
DRAMP35766	RMMRIFWVIKLAR	13	Pugnin B	A0A803KCU6		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33919639	Pharmaceutics. 2021 Apr 18;13(4):579.	Liscano Y, Medina L, Oñate-Garzón J, Gúzman F, Pickholz M, Delgado JP. 	In Silico Selection and Evaluation of Pugnins with Antibacterial and Anticancer Activity Using Skin Transcriptome of Treefrog ( Boana pugnax)	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)C(C)C
DRAMP35767	PI	2	Cyclo(Pro-Ile)	Not available		Not found	Fungi	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	33924262	 Mar Drugs. 2021 Apr 20;19(4):232. 	Qader MM, Hamed AA, Soldatou S, Abdelraof M, Elawady ME, Hassane ASI, Belbahri L, Ebel R, Rateb ME. 	Antimicrobial and Antibiofilm Activities of the Fungal Metabolites Isolated from the Marine Endophytes Epicoccum nigrum M13 and Alternaria alternata 13A	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)O
DRAMP35768	NynQPnS	7	Iturin A	Not available		Not found	Bacillus subtilis 	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Iturin A significantly inhibited the growth of tumor cells, induce apoptosis, autophagy and paraptosis.	Tumor cells: HepG2 (10% viability=75μM)	Not available	Linear	Free	β-amino fatty acid with a-(CH2)10CH3 group		Mix	Not available	Not available	33970365	 AMB Express. 2021 May 10;11(1):67.	Zhao H, Yan L, Guo L, Sun H, Huang Q, Shao D, Jiang C, Shi J.	Effects of Bacillus subtilis iturin A on HepG2 cells in vitro and vivo	
DRAMP35769	GIINTLQKYYCRVRGGRCAVLSCRSQEYRIGRCSTRGRKCCRRKK	45	hBD3(1-23)-hBD4(20-28)-hBD3(33-45), H4	Q8WTQ1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34025617	Front Microbiol. 2021 May 7;12:663151.	Yu W, Ning N, Xue Y, Huang Y, Guo F, Li T, Yang B, Luo D, Sun Y, Li Z, Wang J, He Z, Cheng S, Zhang X, Wang H. 	A Chimeric Cationic Peptide Composed of Human β-Defensin 3 and Human β-Defensin 4 Exhibits Improved Antibacterial Activity and Salt Resistance	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)[C@H](C)CC
DRAMP35770	IRIILRAQGALKI	13	BING, vps13d (3178-3190)	A0A3B3H3X8		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34108601	Sci Rep. 2021 Jun 9;11(1):12219. 	Dong M, Kwok SH, Humble JL, Liang Y, Tang SW, Tang KH, Tse MK, Lei JH, Ramalingam R, Koohi-Moghadam M, Au DWT, Sun H, Lam YW. 	BING, a novel antimicrobial peptide isolated from Japanese medaka plasma, targets bacterial envelope stress response by suppressing cpxR expression	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP35771	NLRTYKKRYMFY	12	Basic phospholipase A2 Ceg-N6 (99-110), pCergo	Q6EER5		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34130109	 Bioorg Chem. 2021 Sep;114:105041.	eña-Carrillo MS, Pinos-Tamayo EA, Mendes B, Domínguez-Borbor C, Proaño-Bolaños C, Miguel DC, Almeida JR. 	Dissection of phospholipases A 2 reveals multifaceted peptides targeting cancer cells, Leishmania and bacteria	CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
DRAMP35772	YNKKYMKHLKPCKKA	15	Basic phospholipase A2 BmTX-I (103-117), pBmTxJ	P0C8M1		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34130109	 Bioorg Chem. 2021 Sep;114:105042.	eña-Carrillo MS, Pinos-Tamayo EA, Mendes B, Domínguez-Borbor C, Proaño-Bolaños C, Miguel DC, Almeida JR. 	Dissection of phospholipases A 2 reveals multifaceted peptides targeting cancer cells, Leishmania and bacteria	CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(N)=O
DRAMP35773	YNKKYRYHLKSCKKADK	17	Basic phospholipase A2 BmjeTX-I (103-119), pBmje	P86803		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34130109	 Bioorg Chem. 2021 Sep;114:105043.	eña-Carrillo MS, Pinos-Tamayo EA, Mendes B, Domínguez-Borbor C, Proaño-Bolaños C, Miguel DC, Almeida JR. 	Dissection of phospholipases A 2 reveals multifaceted peptides targeting cancer cells, Leishmania and bacteria	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35774	nfwxXGxWTIGS	12	Brevicidine B	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	4-ME-C6	Free		Mix	Not available	Not available	34177875	Front Microbiol. 2021 Jun 9;12:693117.	Zhao X, Kuipers OP.	BrevicidineB, a New Member of the Brevicidine Family, Displays an Extended Target Specificity	
DRAMP35775	nywxXGxWTIGS	12	Brevicidine	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	4-ME-C6	Free		Mix	Not available	Not available	34177875	Front Microbiol. 2021 Jun 9;12:693118.	Zhao X, Kuipers OP.	BrevicidineB, a New Member of the Brevicidine Family, Displays an Extended Target Specificity	
DRAMP35776	KWWKKWKKWW	10		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34180670	J Med Chem. 2021 Aug 12;64(15):11247-11266. 	Gou S, Li B, Ouyang X, Ba Z, Zhong C, Zhang T, Chang L, Zhu Y, Zhang J, Zhu N, Zhang Y, Liu H, Ni J. 	Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice	NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
DRAMP35777	XLXVVVKVVKYLX	13	Brevibacillin 2V	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	2-OH-ME-C5	Free		L	Not available	Not available	34220785	Front Microbiol. 2021 Jun 17;12:693725.	Zhao X, Wang X, Shukla R, Kumar R, Weingarth M, Breukink E, Kuipers OP.	Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic Activity	
DRAMP35778	XLXIIVKIVKYLX	13	Brevibacillin I	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	2-OH-ME-C5	Free		L	Not available	Not available	34220785	Front Microbiol. 2021 Jun 17;12:693726.	Zhao X, Wang X, Shukla R, Kumar R, Weingarth M, Breukink E, Kuipers OP.	Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic Activity	
DRAMP35779	XLXIIVKVVKYLX	13	Brevibacillin	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	2-OH-ME-C5	Free		L	Not available	Not available	34220785	Front Microbiol. 2021 Jun 17;12:693727.	Zhao X, Wang X, Shukla R, Kumar R, Weingarth M, Breukink E, Kuipers OP.	Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic Activity	
DRAMP35780	XLXIVVKVVKYLX	13	Brevibacillin V	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	2-OH-ME-C5	Free		L	Not available	Not available	34220785	Front Microbiol. 2021 Jun 17;12:693728.	Zhao X, Wang X, Shukla R, Kumar R, Weingarth M, Breukink E, Kuipers OP.	Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic Activity	
DRAMP35781	KKMMKKGGKFGTFMAIGMGIR	21	Romo1 (58-78)[T2,9K;Q5K;S6K]	P60603		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34361008	Int J Mol Sci. 2021 Jul 31;22(15):8243.	You DG, Lee HR, Kim HK, Lee GY, Yoo YD. 	A Novel Peptide Derived from the Transmembrane Domain of Romo1 Is a Promising Candidate for Sepsis Treatment and Multidrug-Resistant Bacteria	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35782	KKMMKKGGKFGTFMAIGGIR	20	Romo1 (58-78)[T2,9K;Q5K;S6K;M18del]	P60603		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34361008	Int J Mol Sci. 2021 Jul 31;22(15):8244.	You DG, Lee HR, Kim HK, Lee GY, Yoo YD. 	A Novel Peptide Derived from the Transmembrane Domain of Romo1 Is a Promising Candidate for Sepsis Treatment and Multidrug-Resistant Bacteria	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35783	RSKKWRKIEKRVKKIFEKTKEALPVIQGVATIVGAVGR	38	Cecropin Satanin 1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34391826	Peptides. 2021 Nov;145:170626. 	Henao Arias DC, Toro LJ, Téllez Ramirez GA, Osorio-Méndez JF, Rodríguez-Carlos A, Valle J, Marín-Luevano SP, Rivas-Santiago B, Andreu D, Castaño Osorio JC. 	Novel antimicrobial cecropins derived from O curvicornis and D satanas dung beetles	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35784	GSKRWRKFEKRVKKIFEETKEALPVIQGVATIVGAVGR	38	Cecropin Satanin 2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34391826	Peptides. 2021 Nov;145:170627. 	Henao Arias DC, Toro LJ, Téllez Ramirez GA, Osorio-Méndez JF, Rodríguez-Carlos A, Valle J, Marín-Luevano SP, Rivas-Santiago B, Andreu D, Castaño Osorio JC. 	Novel antimicrobial cecropins derived from O curvicornis and D satanas dung beetles	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35785	LKTKALNKLKQKLQAVGNLIGSVIKG	26	FM-Cathelicidin	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34483941	 Front Pharmacol. 2021 Aug 16;12:731056.	Wu J, Zhang H, Chen X, Chai J, Hu Y, Xiong W, Lu W, Tian M, Chen X, Xu X. 	FM-CATH, A Novel Cathelicidin From Fejervarya Multistriata, Shows Therapeutic Potential for Treatment of CLP-Induced Sepsis	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)[C@H](C)CC)C(C)C
DRAMP35786	LKLKLKLTGKLKLKL	15		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34506975	Biomater. 2021 Nov;135:214-224.	Tram NDT, Selvarajan V, Boags A, Mukherjee D, Marzinek JK, Cheng B, Jiang ZC, Goh P, Koh JJ, Teo JWP, Bond PJ, Ee PLR.	Manipulating turn residues on de novo designed β-hairpin peptides for selectivity against drug-resistant bacteria	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(N)=O
DRAMP35787	LKLKLKVpPTKLKLKL	16		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	34506975	Biomater. 2021 Nov;135:214-225.	Tram NDT, Selvarajan V, Boags A, Mukherjee D, Marzinek JK, Cheng B, Jiang ZC, Goh P, Koh JJ, Teo JWP, Bond PJ, Ee PLR.	Manipulating turn residues on de novo designed β-hairpin peptides for selectivity against drug-resistant bacteria	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)C(N)=O
DRAMP35788	LKLKLKpGKLKLKL	14		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	34506975	Biomater. 2021 Nov;135:214-226.	Tram NDT, Selvarajan V, Boags A, Mukherjee D, Marzinek JK, Cheng B, Jiang ZC, Goh P, Koh JJ, Teo JWP, Bond PJ, Ee PLR.	Manipulating turn residues on de novo designed β-hairpin peptides for selectivity against drug-resistant bacteria	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(N)=O
DRAMP35789	LKLKLKINGKKLKLKL	16		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34506975	Biomater. 2021 Nov;135:214-227.	Tram NDT, Selvarajan V, Boags A, Mukherjee D, Marzinek JK, Cheng B, Jiang ZC, Goh P, Koh JJ, Teo JWP, Bond PJ, Ee PLR.	Manipulating turn residues on de novo designed β-hairpin peptides for selectivity against drug-resistant bacteria	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP35790	LKLKLKpNKLKLKL	14		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	34506975	Biomater. 2021 Nov;135:214-228.	Tram NDT, Selvarajan V, Boags A, Mukherjee D, Marzinek JK, Cheng B, Jiang ZC, Goh P, Koh JJ, Teo JWP, Bond PJ, Ee PLR.	Manipulating turn residues on de novo designed β-hairpin peptides for selectivity against drug-resistant bacteria	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(N)=O
DRAMP35791	LCXIIKKIIKKIIKKII	17		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34509120	J Colloid Interface Sci. 2022 Feb;607(Pt 1):488-501.	Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X. 	Rationally designed short cationic α-helical peptides with selective anticancer activity	
DRAMP35792	KWKLFKKIGAVLKVLC	16	Cecropin A (1-7)+Melittin (2-9)-C, CAMA	P01507		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34528343	Environ Microbiol. 2022 Jun;24(6):2747-2758.	Nishanth MAD, Bhoomika S, Gourkhede D, Dadimi B, Vergis J, Malik SVS, Barbuddhe SB, Rawool DB. 	Antibacterial efficacy of in-house designed cell-penetrating peptide against multi-drug resistant strains of Salmonella Enteritidis and Salmonella Typhimurium	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
DRAMP35793	KWKLFKKLGAVLKVLC	16	Cecropin A (1-7)+Melittin (2-9)[I2L]-C, CAMA-CPP	P01507		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34528343	Environ Microbiol. 2022 Jun;24(6):2747-2759.	Nishanth MAD, Bhoomika S, Gourkhede D, Dadimi B, Vergis J, Malik SVS, Barbuddhe SB, Rawool DB. 	Antibacterial efficacy of in-house designed cell-penetrating peptide against multi-drug resistant strains of Salmonella Enteritidis and Salmonella Typhimurium	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
DRAMP35794	GLRRALLRLLRSLRRLLLRAC	21	P7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34528343	Environ Microbiol. 2022 Jun;24(6):2747-2760.	Nishanth MAD, Bhoomika S, Gourkhede D, Dadimi B, Vergis J, Malik SVS, Barbuddhe SB, Rawool DB. 	Antibacterial efficacy of in-house designed cell-penetrating peptide against multi-drug resistant strains of Salmonella Enteritidis and Salmonella Typhimurium	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
DRAMP35795	GLARALTRLLRQLTRQLTRAC	21	APP	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34528343	Environ Microbiol. 2022 Jun;24(6):2747-2761.	Nishanth MAD, Bhoomika S, Gourkhede D, Dadimi B, Vergis J, Malik SVS, Barbuddhe SB, Rawool DB. 	Antibacterial efficacy of in-house designed cell-penetrating peptide against multi-drug resistant strains of Salmonella Enteritidis and Salmonella Typhimurium	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP35796	FfXTG	5	pNP-23	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2611. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	
DRAMP35797	FxTkVf	6	pNP-43b	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2612. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	
DRAMP35798	FxTxVf	6	pNP-43c	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2613. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	
DRAMP35799	FkTrVf	6	pNP-43d	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2614. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	CC(C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)O
DRAMP35800	FrTrVf	6	pNP-43e	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2615. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	CC(C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)O
DRAMP35801	wSxXxSwF	8	pNP-80	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2616. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	
DRAMP35802	xXxFfF	6	pNP-51	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2617. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	
DRAMP35803	vTxXxWavvF	10	pNP-111	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2618. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	
DRAMP35804	AvVWXyWS	8	pNP-81	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2619. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	
DRAMP35805	VxvvXtKf	8	pNP-94a	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2620. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	
DRAMP35806	WFkXxFf	7	pNP-66	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2621. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	
DRAMP35807	xTxXwTavvF	10	pNP-130	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2622. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	
DRAMP35808	fXaTlF	6	pNP-40	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free	X=Enduracididine	Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2623. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	
DRAMP35809	vLnSxF	6	pNP-33	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2624. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	
DRAMP35810	VrTtFf	6	pNP-30	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2625. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	CC(C)[C@H](N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)O)[C@H](C)O)[C@@H](C)O
DRAMP35811	fVrtF	5	pNP-19	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2626. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	CC(C)[C@H](NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)O
DRAMP35812	WkTkVwWava	10	pNP-124	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	34699170	 ACS Chem Biol. 2021 Nov 19;16(11):2604-2627. 	Hostetler MA, Smith C, Nelson S, Budimir Z, Modi R, Woolsey I, Frerk A, Baker B, Gantt J, Parkinson EI.	Synthetic peptide Natural Product Inspired Cyclic Peptides	CC(C)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C)C(=O)N[C@@H](C(=O)N[C@H](C)C(=O)O)C(C)C
DRAMP35813	VRKPPYLPRPRPPRrIYNr	19	Oncocin [R15,19r; D2R], Onc244	A0A2R7WNA0		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		Mix	Not available	Not available	34902208	 Chembiochem. 2022 Mar 4;23(5):e202100609.	Kolano L, Knappe D, Berg A, Berg T, Hoffmann R.	Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112	CC[C@@H](C)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(N)=O
DRAMP35814	GMFTNMLKGIGKLAGKAALGAVKTLA	26	Dermaseptin-AC	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34908502	Microbiol Spectr. 2021 Dec 22;9(3):e0131821. 	Chen J, Hao D, Mei K, Li X, Li T, Ma C, Xi X, Li L, Wang L, Zhou M, Chen T, Liu J, Wu Q. 	In Vitro and In Vivo Studies on the Antibacterial Activity and Safety of a New Antimicrobial Peptide Dermaseptin-AC	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)[C@@H](C)O)C(C)C
DRAMP35815	GFGCPWNAYECDRHCVSKGYTGGNCRGKIRQTCHCY	36	Actinomycesin AMSIN, Defensin-like Bacteriocin	E7N5J9		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	2RU0	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34927385	 EMBO Mol Med. 2022 Feb 7;14(2):e14499.	Zhu S, Gao B, Umetsu Y, Peigneur S, Li P, Ohki S, Tytgat J.	Adaptively evolved human oral actinomyces-sourced defensins show therapeutic potential	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
DRAMP35816	WNWTKRF	7	Darobactin B	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34937193	Microbiol Spectr. 2021 Dec 22;9(3):e0153521. 	Böhringer N, Green R, Liu Y, Mettal U, Marner M, Modaresi SM, Jakob RP, Wuisan ZG, Maier T, Iinishi A, Hiller S, Lewis K, Schäberle TF.	MutaSynthetic peptide Production and Antimicrobial Characterization of Darobactin Analogs	C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP35817	GLWSKIKNVAAAAGKAALGAL	21	Dermaseptin t-DPH1	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34943741	Antibiotics (Basel). 2021 Dec 14;10(12):1529. 	Qin H, Fang H, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. 	Exploration of the Structure-Function Relationships of a Novel Frog Skin Secretion-Derived Bioactive Peptide, t-DPH1, through Use of Rational Design, Cationicity Enhancement and In Vitro Studies	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP35818	GLWKKIKNVAAAAGKAALGAL	21	Dermaseptin t-DPH1 [S4K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34943741	Antibiotics (Basel). 2021 Dec 14;10(12):1530. 	Qin H, Fang H, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. 	Exploration of the Structure-Function Relationships of a Novel Frog Skin Secretion-Derived Bioactive Peptide, t-DPH1, through Use of Rational Design, Cationicity Enhancement and In Vitro Studies	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP35819	GLWKKIKNVAKAAGKAALGAL	21	Dermaseptin t-DPH1 [S4K,A11A]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34943741	Antibiotics (Basel). 2021 Dec 14;10(12):1531. 	Qin H, Fang H, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. 	Exploration of the Structure-Function Relationships of a Novel Frog Skin Secretion-Derived Bioactive Peptide, t-DPH1, through Use of Rational Design, Cationicity Enhancement and In Vitro Studies	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP35820	GLWKKIKNVAKAAGKAAKGAL	21	Dermaseptin t-DPH1 [S4K,A11A,L18K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34943741	Antibiotics (Basel). 2021 Dec 14;10(12):1532. 	Qin H, Fang H, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. 	Exploration of the Structure-Function Relationships of a Novel Frog Skin Secretion-Derived Bioactive Peptide, t-DPH1, through Use of Rational Design, Cationicity Enhancement and In Vitro Studies	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP35821	WLWKKIKNVAKAAGKAAKGAL	21	Dermaseptin t-DPH1 [G1W,S4K,A11A,L18K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	34943741	Antibiotics (Basel). 2021 Dec 14;10(12):1533. 	Qin H, Fang H, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. 	Exploration of the Structure-Function Relationships of a Novel Frog Skin Secretion-Derived Bioactive Peptide, t-DPH1, through Use of Rational Design, Cationicity Enhancement and In Vitro Studies	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP35822	Gikefkrivqrikdflrnlv	20	D-LL-37 (13-32)[I13G,G14I]	P49913		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HeLa (50% Cytotoxicity=18.9µM)	Not available	Linear	Free	Amidation		Mix	Not available	Not available	34959645	Pharmaceuticals (Basel). 2021 Nov 30;14(12):1246	Zhang Y, Lakshmaiah Narayana J, Wu Q, Dang X, Wang G. 	Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37	CC[C@H](C)[C@@H](NC(=O)CN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(N)=O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
DRAMP35823	GVITDTLKGVAKTVAAELLRKAHCKLTNSC	30	Brevinin-2MP	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	34975482	Front Pharmacol. 2021 Dec 16;12:783108.	Tian M, Liu J, Chai J, Wu J, Xu X. 	Antimicrobial and Anti-inflammatory Effects of a Novel Peptide From the Skin of Frog Microhyla pulchra	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O
DRAMP35829	WA	2	Cyclo(Trp-Ala), Diketopiperazine (WA)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35200615	Mar Drugs. 2022 Jan 19;20(2):85. 	Wang Y, Zheng Q, Li L, Pan L, Zhu H. 	Anti-Quorum-Sensing Activity of Tryptophan-Containing Cyclic Dipeptides	C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP35830	WS	2	Cyclo(Trp-Ser)	Not available		Not found	Bacteria	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35200615	Mar Drugs. 2022 Jan 19;20(2):86. 	Wang Y, Zheng Q, Li L, Pan L, Zhu H. 	Anti-Quorum-Sensing Activity of Tryptophan-Containing Cyclic Dipeptides	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP35831	ws	2	Cyclo(D-Trp-D-Ser)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		D	Not available	Not available	35200615	Mar Drugs. 2022 Jan 19;20(2):87. 	Wang Y, Zheng Q, Li L, Pan L, Zhu H. 	Anti-Quorum-Sensing Activity of Tryptophan-Containing Cyclic Dipeptides	N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CO)C(=O)O
DRAMP35832	wS	2	Cyclo(D-Trp-L-Ser)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	35200615	Mar Drugs. 2022 Jan 19;20(2):88. 	Wang Y, Zheng Q, Li L, Pan L, Zhu H. 	Anti-Quorum-Sensing Activity of Tryptophan-Containing Cyclic Dipeptides	N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O
DRAMP35833	Ws	2	Cyclo(L-Trp-D-Ser)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	35200615	Mar Drugs. 2022 Jan 19;20(2):89. 	Wang Y, Zheng Q, Li L, Pan L, Zhu H. 	Anti-Quorum-Sensing Activity of Tryptophan-Containing Cyclic Dipeptides	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CO)C(=O)O
DRAMP35834	WT	2	Cyclo(Trp-Thr)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35200615	Mar Drugs. 2022 Jan 19;20(2):90. 	Wang Y, Zheng Q, Li L, Pan L, Zhu H. 	Anti-Quorum-Sensing Activity of Tryptophan-Containing Cyclic Dipeptides	C[C@@H](O)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP35835	WE	2	Cyclo(Trp-Glu)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35200615	Mar Drugs. 2022 Jan 19;20(2):91. 	Wang Y, Zheng Q, Li L, Pan L, Zhu H. 	Anti-Quorum-Sensing Activity of Tryptophan-Containing Cyclic Dipeptides	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP35836	WK	2	Cyclo(Trp-Lys)	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35200615	Mar Drugs. 2022 Jan 19;20(2):92. 	Wang Y, Zheng Q, Li L, Pan L, Zhu H. 	Anti-Quorum-Sensing Activity of Tryptophan-Containing Cyclic Dipeptides	NCCCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
DRAMP35837	SYEKKINRHFKILKKNLKKK	20	Grasscarp interferon (137-156), GcIFN-20	Q5KR62		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35289673	Microbiol Spectr. 2022 Apr 27;10(2):e0201321.	Xiao X, Lu H, Zhu W, Zhang Y, Huo X, Yang C, Xiao S, Zhang Y, Su J. 	A Novel Antimicrobial Peptide Derived from Bony Fish IFN1 Exerts Potent Antimicrobial and Anti-Inflammatory Activity in Mammals	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC
DRAMP35838	XLLXL	5	Galaxamide	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35323457	Mar Drugs. 2022 Feb 22;20(3):158.	Li D, Liao X, Zhong S, Zhao B, Xu S. 	Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents	
DRAMP35839	LXLPL	5	Galaxamide [MeLeu4P]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35323457	Mar Drugs. 2022 Feb 22;20(3):159.	Li D, Liao X, Zhong S, Zhao B, Xu S. 	Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents	
DRAMP35840	LPLPL	5	Galaxamide [MeLeu2,4P]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35323457	Mar Drugs. 2022 Feb 22;20(3):160.	Li D, Liao X, Zhong S, Zhao B, Xu S. 	Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)O
DRAMP35841	lPLPL	5	Galaxamide [L1l;MeLeu2,4P]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	35323457	Mar Drugs. 2022 Feb 22;20(3):161.	Li D, Liao X, Zhong S, Zhao B, Xu S. 	Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents	CC(C)C[C@@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35842	LPlPL	5	Galaxamide [L3l;MeLeu2,4P]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	35323457	Mar Drugs. 2022 Feb 22;20(3):162.	Li D, Liao X, Zhong S, Zhao B, Xu S. 	Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)O
DRAMP35843	LPLPl	5	Galaxamide [L5l;MeLeu2,4P]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	35323457	Mar Drugs. 2022 Feb 22;20(3):163.	Li D, Liao X, Zhong S, Zhao B, Xu S. 	Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(C)C)C(=O)O
DRAMP35844	lPLPl	5	Galaxamide [L1,5l;MeLeu2,4P]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	35323457	Mar Drugs. 2022 Feb 22;20(3):164.	Li D, Liao X, Zhong S, Zhao B, Xu S. 	Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents	CC(C)C[C@@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(C)C)C(=O)O
DRAMP35845	LPlPl	5	Galaxamide [L3,5l;MeLeu2,4P]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	35323457	Mar Drugs. 2022 Feb 22;20(3):165.	Li D, Liao X, Zhong S, Zhao B, Xu S. 	Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents	CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(C)C)C(=O)O
DRAMP35846	lPlPl	5	Galaxamide [L1,3,5l;MeLeu2,4P]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		Mix	Not available	Not available	35323457	Mar Drugs. 2022 Feb 22;20(3):166.	Li D, Liao X, Zhong S, Zhao B, Xu S. 	Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents	CC(C)C[C@@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(C)C)C(=O)O
DRAMP35847	FKGLAKLLKIGLKALAKVIQ	9	Ak-N’	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear				Mix	Not available	Not available	35432369	Front Immunol. 2022 Apr 1;13:821070. 	Shin MK, Lee B, Kim ST, Yoo JS, Sung JS.	Designing a Novel Functional Peptide With Dual Antimicrobial and Anti-inflammatory Activities via in Silico Methods	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)C(C)C
DRAMP35848	NKGLAKLLKIGLKALESVIQ	20	Ak-N’m	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35432369	Front Immunol. 2022 Apr 1;13:821071. 	Shin MK, Lee B, Kim ST, Yoo JS, Sung JS.	Designing a Novel Functional Peptide With Dual Antimicrobial and Anti-inflammatory Activities via in Silico Methods	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(N)=O)[C@H](C)CC)C(=O)O
DRAMP35856	RRIRIRPPRLPRPRPRPYFMPRP	23	Bactenecin-7 (1-23)[P5I,L18Y,P19F,F20M], Bac7PS	P19661		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35578204	BMC Biol. 2022 May 16;20(1):114. 	Koch P, Schmitt S, Heynisch A, Gumpinger A, Wüthrich I, Gysin M, Shcherbakov D, Hobbie SN, Panke S, Held M.	Optimization of the antimicrobial peptide Bac7 by deep mutational scanning	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC
DRAMP35857	GLLGKILGAGKKVLCGVSGLC	21	Nigrocin-PN	Not available		Not found	Animalia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35606468	J Genet Eng Biotechnol. 2022 May 23;20(1):76. 	Lu C, Liu L, Ma C, Di L, Chen T. 	A novel antimicrobial peptide found in Pelophylax nigromaculatus	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
DRAMP35858	GLLGKILGAGKKVLLGVSGLL	21	Nigrocin-PN [C15,21L]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	35606468	J Genet Eng Biotechnol. 2022 May 23;20(1):77. 	Lu C, Liu L, Ma C, Di L, Chen T. 	A novel antimicrobial peptide found in Pelophylax nigromaculatus	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
DRAMP35859	MKKLLLILFCLALALAGCKKAP	22	HG2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	35835775	NPJ Biofilms Microbiomes. 2022 Jul 14;8(1):58.	Oyama LB, Olleik H, Teixeira ACN, Guidini MM, Pickup JA, Hui BYP, Vidal N, Cookson AR, Vallin H, Wilkinson T, Bazzolli DMS, Richards J, Wootton M, Mikut R, Hilpert K, Maresca M, Perrier J, Hess M, Mantovani HC, Fernandez-Fuentes N, Creevey CJ, Huws SA.	In silico identification of two peptides with antibacterial activity against multidrug-resistant Staphylococcus aureus	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(N)=O
DRAMP35860	VLGLALIVGGALLIKKKQAKS	21	HG4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	35835775	NPJ Biofilms Microbiomes. 2022 Jul 14;8(1):59.	Oyama LB, Olleik H, Teixeira ACN, Guidini MM, Pickup JA, Hui BYP, Vidal N, Cookson AR, Vallin H, Wilkinson T, Bazzolli DMS, Richards J, Wootton M, Mikut R, Hilpert K, Maresca M, Perrier J, Hess M, Mantovani HC, Fernandez-Fuentes N, Creevey CJ, Huws SA.	In silico identification of two peptides with antibacterial activity against multidrug-resistant Staphylococcus aureus	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O
DRAMP35861	WKRFHPFRVVRKIFRRRIKR	20	PA-Win	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	36090084	Front Microbiol. 2022 Aug 24;13:971503. 	Lee B, Shin MK, Yoo JS, Jang W, Sung JS.	Identifying novel antimicrobial peptides from venom gland of spider Pardosa astrigera by deep multi-task learning	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35862	rlfrrvkkvagkiakriwk	19	D-AP19	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		D	Not available	Not available	36151303	 Sci Rep. 2022 Sep 23;12(1):15852. 	Jariyarattanarach P, Klubthawee N, Wongchai M, Roytrakul S, Aunpad R. 	Novel D-form of hybrid peptide (D-AP19) rapidly kills Acinetobacter baumannii while tolerating proteolytic enzymes	CC[C@H](C)[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(N)=O)[C@@H](C)CC
DRAMP35863	KLLPSVVGLFKKKKQ	15	Ponericin-W1 (11-25), At1	P82423		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	36174494	Colloids Surf B Biointerfaces. 2022 Dec;220:112841.	Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. 	Anticancer effect of rationally designed α-helical amphiphilic peptides	CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(N)=O)C(C)C)C(C)C
DRAMP35864	KLLKKVVKLFKKKKK	15	Ponericin-W1 (11-25) [P4K; S5K; G8K; Q15K], At2	P82423		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	36174494	Colloids Surf B Biointerfaces. 2022 Dec;220:112842.	Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. 	Anticancer effect of rationally designed α-helical amphiphilic peptides	CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP35865	KLLKKVVKLFKKLLK	15	Ponericin-W1 (11-25) [P4K; S5K; G8K; K13L; Q15K], At3	P82423		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	36174494	Colloids Surf B Biointerfaces. 2022 Dec;220:112843.	Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. 	Anticancer effect of rationally designed α-helical amphiphilic peptides	CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C
DRAMP35866	KLLKKLLKLLKKLLK	15	At4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	36174494	Colloids Surf B Biointerfaces. 2022 Dec;220:112844.	Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. 	Anticancer effect of rationally designed α-helical amphiphilic peptides	CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35867	KIIKKIIKIIKKIIK	15	At5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	36174494	Colloids Surf B Biointerfaces. 2022 Dec;220:112845.	Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. 	Anticancer effect of rationally designed α-helical amphiphilic peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC
DRAMP35868	KVVKKVVKVVKKVVK	15	At6	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	36174494	Colloids Surf B Biointerfaces. 2022 Dec;220:112846.	Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. 	Anticancer effect of rationally designed α-helical amphiphilic peptides	CC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP35869	KIIKKIKKKIKKIIK	15	At7	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	36174494	Colloids Surf B Biointerfaces. 2022 Dec;220:112847.	Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. 	Anticancer effect of rationally designed α-helical amphiphilic peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC
DRAMP35870	KLLKKLKKKLKKLLK	15	At8	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	36174494	Colloids Surf B Biointerfaces. 2022 Dec;220:112848.	Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. 	Anticancer effect of rationally designed α-helical amphiphilic peptides	CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP35871	KVVKKVKKKVKKVVK	15	At9	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	36174494	Colloids Surf B Biointerfaces. 2022 Dec;220:112849.	Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. 	Anticancer effect of rationally designed α-helical amphiphilic peptides	CC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP35872	IKKIIKIIKKIIKKI	15	At10	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	36174494	Colloids Surf B Biointerfaces. 2022 Dec;220:112850.	Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. 	Anticancer effect of rationally designed α-helical amphiphilic peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP35873	IIIKKIKKKIKKIII	15	At11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	36174494	Colloids Surf B Biointerfaces. 2022 Dec;220:112851.	Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. 	Anticancer effect of rationally designed α-helical amphiphilic peptides	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(N)=O
DRAMP35874	KIIIKIKKKIKIIIK	15	At12	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Acetylation	Amidation		L	Not available	Not available	36174494	Colloids Surf B Biointerfaces. 2022 Dec;220:112852.	Pan F, Li Y, Ding Y, Lv S, You R, Hadianamrei R, Tomeh MA, Zhao X. 	Anticancer effect of rationally designed α-helical amphiphilic peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(C)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC
DRAMP35875	TSFAEYWALLSXLAXYXP	18	PMI-HIF1-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM)	Not available	Linear	Acetylation	Amidation	X(12)=Peg, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine	L	Not available	MDM2, MDMX	36185610	Theranostics. 2022 Sep 11;12(15):6665-6681.	Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.	Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression	
DRAMP35876	TSFAEYWALLSXLAXYXP	18	PMI-HIF1-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM)	Not available	Linear	Acetylation	Amidation	X(12)=Peg, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine	L	Not available	MDM2, MDMX	36185610	Theranostics. 2022 Sep 11;12(15):6665-6681.	Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.	Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression	
DRAMP35877	TSFAEYWALLSXLAXYXP	18	PMI-HIF1-1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM)	Not available	Linear	Acetylation	Amidation	X(12)=Peg, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine	L	Not available	MDM2, MDMX	36185610	Theranostics. 2022 Sep 11;12(15):6665-6681.	Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.	Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression	
DRAMP35878	TSFAEYWALLSXLAXYXP	18	PMI-HIF1-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM)	Not available	Linear	Acetylation	Amidation	X(12)=Peg2, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine	L	Not available	MDM2, MDMX	36185610	Theranostics. 2022 Sep 11;12(15):6665-6682.	Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.	Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression	
DRAMP35879	TSFAEYWALLSXLAXYXP	18	PMI-HIF1-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM)	Not available	Linear	Acetylation	Amidation	X(12)=Peg2, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine	L	Not available	MDM2, MDMX	36185610	Theranostics. 2022 Sep 11;12(15):6665-6682.	Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.	Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression	
DRAMP35880	TSFAEYWALLSXLAXYXP	18	PMI-HIF1-2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM)	Not available	Linear	Acetylation	Amidation	X(12)=Peg2, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine	L	Not available	MDM2, MDMX	36185610	Theranostics. 2022 Sep 11;12(15):6665-6682.	Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.	Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression	
DRAMP35881	TSFAEYWALLSXLAXYXP	18	PMI-HIF1-3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM)	Not available	Linear	Acetylation	Amidation	X(12)=Peg3, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine	L	Not available	MDM2, MDMX	36185610	Theranostics. 2022 Sep 11;12(15):6665-6683.	Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.	Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression	
DRAMP35882	TSFAEYWALLSXLAXYXP	18	PMI-HIF1-3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM)	Not available	Linear	Acetylation	Amidation	X(12)=Peg3, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine	L	Not available	MDM2, MDMX	36185610	Theranostics. 2022 Sep 11;12(15):6665-6683.	Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.	Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression	
DRAMP35883	TSFAEYWALLSXLAXYXP	18	PMI-HIF1-3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HCT 116 p53-/- (IC50>100 μM); HCT 116 p53+/+ (IC50>100 μM)	Not available	Linear	Acetylation	Amidation	X(12)=Peg3, polyethylene glycol; X(15)=Hyp, hydroxyproline; X(17)=Hle, homoleucine	L	Not available	MDM2, MDMX	36185610	Theranostics. 2022 Sep 11;12(15):6665-6683.	Chen S, Li X, Li Y, Yuan X, Geng C, Gao S, Li J, Ma B, Wang Z, Lu W, Hu HG.	Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression	
DRAMP35904	LAKKLKEYLEKLV	13	Latarcin-3a (5-17) [M5,13L;  K17V]	Q1ELU3		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	36212827	Front Microbiol. 2022 Sep 21;13:965621. 	de Moraes LFRN, Silva PSE, Pereira TCPL, Almeida Rodrigues TA, Farias Frihling BE, da Costa RA, Torquato HFV, Lima CS, Paredes-Gamero EJ, Migliolo L.	First generation of multifunctional peptides derived from latarcin-3a from Lachesana tarabaevi spider toxin	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
DRAMP35905	LIKKLKEYLKKLI	13	Latarcin-3a (5-17) [M5,13L;  A6I; E14K; K17I]	Q1ELU3		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	36212827	Front Microbiol. 2022 Sep 21;13:965622. 	de Moraes LFRN, Silva PSE, Pereira TCPL, Almeida Rodrigues TA, Farias Frihling BE, da Costa RA, Torquato HFV, Lima CS, Paredes-Gamero EJ, Migliolo L.	First generation of multifunctional peptides derived from latarcin-3a from Lachesana tarabaevi spider toxin	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O
DRAMP35906	LAKKLAKYLKKAL	13	Latarcin-3a (5-17) [M5,13L;  K10A; E11,14K; L16A; K17L]	Q1ELU3		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	36212827	Front Microbiol. 2022 Sep 21;13:965623. 	de Moraes LFRN, Silva PSE, Pereira TCPL, Almeida Rodrigues TA, Farias Frihling BE, da Costa RA, Torquato HFV, Lima CS, Paredes-Gamero EJ, Migliolo L.	First generation of multifunctional peptides derived from latarcin-3a from Lachesana tarabaevi spider toxin	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
DRAMP35907	TEFQTNLVP	9	LHP1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC, 5(6)-carboxy fluorescence	Free		L	Not available	Tubulin	36240440	J Med Chem. 2022 Oct 27;65(20):13866-13878. 	Adak A, Das G, Gupta V, Khan J, Mukherjee N, Mondal P, Roy R, Barman S, Gharai PK, Ghosh S. 	Evolution of Potential Antimitotic Stapled Peptides from Multiple Helical Peptide Stretches of the Tubulin Heterodimer Interface: Helix-Mimicking Stapled Peptide Tubulin Inhibitors	
DRAMP35908	FRRKAFLHWYTG	12	LHP2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: MCF-7  (IC50=271.59 ± 76.41 μM)	Not available	Linear	FITC, 5(6)-carboxy fluorescence	Free		L	Not available	Tubulin	36240440	J Med Chem. 2022 Oct 27;65(20):13866-13879. 	Adak A, Das G, Gupta V, Khan J, Mukherjee N, Mondal P, Roy R, Barman S, Gharai PK, Ghosh S. 	Evolution of Potential Antimitotic Stapled Peptides from Multiple Helical Peptide Stretches of the Tubulin Heterodimer Interface: Helix-Mimicking Stapled Peptide Tubulin Inhibitors	
DRAMP35909	VPKDVNAAIA	10	LHP3	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC, 5(6)-carboxy fluorescence	Free		L	Not available	Tubulin	36240440	J Med Chem. 2022 Oct 27;65(20):13866-13880. 	Adak A, Das G, Gupta V, Khan J, Mukherjee N, Mondal P, Roy R, Barman S, Gharai PK, Ghosh S. 	Evolution of Potential Antimitotic Stapled Peptides from Multiple Helical Peptide Stretches of the Tubulin Heterodimer Interface: Helix-Mimicking Stapled Peptide Tubulin Inhibitors	
DRAMP35910	VPELTQQMF	9	LHP4	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC, 5(6)-carboxy fluorescence	Free		L	Not available	Tubulin	36240440	J Med Chem. 2022 Oct 27;65(20):13866-13881. 	Adak A, Das G, Gupta V, Khan J, Mukherjee N, Mondal P, Roy R, Barman S, Gharai PK, Ghosh S. 	Evolution of Potential Antimitotic Stapled Peptides from Multiple Helical Peptide Stretches of the Tubulin Heterodimer Interface: Helix-Mimicking Stapled Peptide Tubulin Inhibitors	
DRAMP35911	NEALYDICFR	10	LHP5	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	FITC, 5(6)-carboxy fluorescence	Free		L	Not available	Tubulin	36240440	J Med Chem. 2022 Oct 27;65(20):13866-13882. 	Adak A, Das G, Gupta V, Khan J, Mukherjee N, Mondal P, Roy R, Barman S, Gharai PK, Ghosh S. 	Evolution of Potential Antimitotic Stapled Peptides from Multiple Helical Peptide Stretches of the Tubulin Heterodimer Interface: Helix-Mimicking Stapled Peptide Tubulin Inhibitors	
DRAMP35933	RRRRRRRRGGDRDYKKFWAGLQGLTIYFYN	30	#2(D33-N52)	Not available		Not found	Synthetic (STAP-2 PH domain–derived peptide)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.	Not available	Not available	Linear	Free	Free		L	Not available	EGFR 	36410436	J Biol Chem. 2023 Jan;299(1):102724.	Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. 	A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP35934	RRRRRRRRGGMWKGFILTVVELRVPTDLTL	30	#6(M108-L127)	Not available		Not found	Synthetic (STAP-2 PH domain–derived peptide)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.	Not available	Not available	Linear	Free	Free		L	Not available	EGFR 	36410436	J Biol Chem. 2023 Jan;299(1):102725.	Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. 	A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
DRAMP35935	RRRRRRRRGGFWAGLQGLTIYFYNSNRDFQ	30	2A(F39-Q58)	Not available		Not found	Synthetic (STAP-2 PH domain–derived peptide)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.	Not available	Not available	Linear	Free	Free		L	Not available	EGFR 	36410436	J Biol Chem. 2023 Jan;299(1):102726.	Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. 	A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP35936	RRRRRRRRGGQGLTIYFYNSNRDFQ	25	2C(Q44-Q58)	Not available		Not found	Synthetic (STAP-2 PH domain–derived peptide)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.	Not available	Not available	Linear	Free	Free		L	Not available	EGFR 	36410436	J Biol Chem. 2023 Jan;299(1):102727.	Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. 	A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP35937	RRRRRRRRGGQGLTIYFYNSNR	22	2D(Q44-R55)	Not available		Not found	Synthetic (STAP-2 PH domain–derived peptide)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.	Not available	Not available	Linear	Free	Free		L	Not available	EGFR 	36410436	J Biol Chem. 2023 Jan;299(1):102728.	Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. 	A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35938	RRRRRRRRGGQGLTIYFY	18	2D2(Q44-Y51)	Not available		Not found	Synthetic (STAP-2 PH domain–derived peptide)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.	Not available	Not available	Linear	Free	Free		L	Not available	EGFR 	36410436	J Biol Chem. 2023 Jan;299(1):102729.	Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. 	A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP35939	RRRRRRRRGGGLTIYFYN	18	2D3(G45-N52)	Not available		Not found	Synthetic (STAP-2 PH domain–derived peptide)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.	Not available	Not available	Linear	Free	Free		L	Not available	EGFR 	36410436	J Biol Chem. 2023 Jan;299(1):102730.	Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. 	A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP35940	RRRRRRRRGGGLTIYFY	17	2D5(G45-Y51)	Not available		Not found	Synthetic (STAP-2 PH domain–derived peptide)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.	Not available	Not available	Linear	Free	Free		L	Not available	EGFR 	36410436	J Biol Chem. 2023 Jan;299(1):102731.	Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. 	A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP35941	RRRRRRRRGGVVELRVPTDLTLLPGHLYMM	30	6E(V116-M135)	Not available		Not found	Synthetic (STAP-2 PH domain–derived peptide)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.	Not available	Not available	Linear	Free	Free		L	Not available	EGFR 	36410436	J Biol Chem. 2023 Jan;299(1):102732.	Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. 	A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)O
DRAMP35942	RRRRRRRRGGILTVVELRVP	20	6F (I113-P122)	Not available		Not found	Synthetic (STAP-2 PH domain–derived peptide)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.	Not available	Not available	Linear	Free	Free		L	Not available	EGFR 	36410436	J Biol Chem. 2023 Jan;299(1):102733.	Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T. 	A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
DRAMP35943	GIFDVLKNLAKGVITSLAS	19	Ocellatin-3N	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	36426386	J Pept Sci. 2023 Apr;29(4):e3463. 	Conlon JM, Hunter L, Attoub S, Casciaro B, Mechkarska M, Abdel-Wahab YHA.	Antimicrobial, cytotoxic, and insulin-releasing activities of the amphibian host-defense peptide ocellatin-3N and its L-lysine-substituted analogs	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(C)C
DRAMP35944	GIFKVLKNLAKGVITSLAS	19	Ocellatin-3N [D4K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	36426386	J Pept Sci. 2023 Apr;29(4):e3464. 	Conlon JM, Hunter L, Attoub S, Casciaro B, Mechkarska M, Abdel-Wahab YHA.	Antimicrobial, cytotoxic, and insulin-releasing activities of the amphibian host-defense peptide ocellatin-3N and its L-lysine-substituted analogs	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(C)C
DRAMP35945	GIFDVLKNLAKGVITSLKS	19	Ocellatin-3N [A18K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	Not available	36426386	J Pept Sci. 2023 Apr;29(4):e3465. 	Conlon JM, Hunter L, Attoub S, Casciaro B, Mechkarska M, Abdel-Wahab YHA.	Antimicrobial, cytotoxic, and insulin-releasing activities of the amphibian host-defense peptide ocellatin-3N and its L-lysine-substituted analogs	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(C)C
DRAMP35946	GIFKVLKNLAKGVITSLKS	19	Ocellatin-3N [D4K,A18K]	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	36426386	J Pept Sci. 2023 Apr;29(4):e3466. 	Conlon JM, Hunter L, Attoub S, Casciaro B, Mechkarska M, Abdel-Wahab YHA.	Antimicrobial, cytotoxic, and insulin-releasing activities of the amphibian host-defense peptide ocellatin-3N and its L-lysine-substituted analogs	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(C)C
DRAMP35947	FSLVNADQTT	10		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	36551449	Antibiotics (Basel). 2022 Dec 10;11(12):1792. 	Punginelli D, Catania V, Vazzana M, Mauro M, Spinello A, Barone G, Barberi G, Fiorica C, Vitale M, Cunsolo V, Saletti R, Di Francesco A, Arizza V, Schillaci D. 	A novel Peptide with Antifungal Activity from Red Swamp Crayfish Procambarus clarkii	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C
DRAMP35948	FAKKLAKLKKKLAKLALAL	19	AC-P19	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	36555235	Int J Mol Sci. 2022 Dec 9;23(24):15594. 	Shin MK, Jang BY, Bu KB, Lee SH, Han DH, Oh JW, Sung JS.	De Novo Design of AC-P19M, a Novel Anticancer Peptide with Apoptotic Effects on Lung Cancer Cells and Anti-Angiogenic Activity	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
DRAMP35949	FAKKLAKLKKKLAKLAKKR	19	AC-P19M	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	Not available	36555235	Int J Mol Sci. 2022 Dec 9;23(24):15595. 	Shin MK, Jang BY, Bu KB, Lee SH, Han DH, Oh JW, Sung JS.	De Novo Design of AC-P19M, a Novel Anticancer Peptide with Apoptotic Effects on Lung Cancer Cells and Anti-Angiogenic Activity	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP35950	CFETLRGEERILSILRHQNLLKELQD	26	2a	Not available		Not found	Synthetic (Derived from chromogranin A)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Amidation		L	Not available	αvβ6, αvβ8	36594095	Int J Biol Sci. 2023 Jan 1;19(1):156-166.	Monieri M, Rainone P, Sacchi A, Gori A, Gasparri AM, Coliva A, Citro A, Ferrara B, Policardi M, Valtorta S, Pocaterra A, Alfano M, Sheppard D, Piemonti L, Moresco RM, Corti A, Curnis F.	A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@H](C)CC
DRAMP35953	CIRLDLELINFQSDLQHELLKTRLRG	26	5a-Scr	Not available		Not found	Synthetic (Derived from chromogranin A)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	αvβ6, αvβ8	36594095	Int J Biol Sci. 2023 Jan 1;19(1):156-169.	Monieri M, Rainone P, Sacchi A, Gori A, Gasparri AM, Coliva A, Citro A, Ferrara B, Policardi M, Valtorta S, Pocaterra A, Alfano M, Sheppard D, Piemonti L, Moresco RM, Corti A, Curnis F.	A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35954	NAVPNLRGDLQVLAQKVART	20	A20FMDV2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	αvβ6, αvβ8	36594095	Int J Biol Sci. 2023 Jan 1;19(1):156-170.	Monieri M, Rainone P, Sacchi A, Gori A, Gasparri AM, Coliva A, Citro A, Ferrara B, Policardi M, Valtorta S, Pocaterra A, Alfano M, Sheppard D, Piemonti L, Moresco RM, Corti A, Curnis F.	A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35955	RSHRLRLH	8	CD9-BP	Not available		Not found	EWI-2 protein	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	CD9-BP impaired CD9-related functions by adversely affecting the formation of tetraspanin webs—networks composed of CD9 and its partner proteins. The anti-cancer metastasis effect of CD9-BP was evidenced by the in vitro inhibition of cancer cell migration and invasion as well as exosome secretion and uptake, which are essential processes during metastasis. 	Not available	Not available	Linear	Free	Free		L	Not available	CD9	36640525	 Biomater Adv. 2023 Mar;146:213283. 	Suwatthanarak T, Ito K, Tanaka M, Sugiura K, Hoshino A, Miyamoto Y, Miyado K, Okochi M.	A peptide binding to the tetraspanin CD9 reduces cancer metastasis	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP35956	FHAVPQSFYT	10	MGS4_V8 (monomer)	Not available		Not found	Synthetic (derived from MGS4)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: H358  (EC50=34nM); H1993  (EC50=37nM); H1299 (EC50=38nM); H2009  (EC50=38nM)	Not available	Linear	Acetylization	Free		L	Not available	Not available	36650239	Commun Biol. 2023 Jan 17;6(1):60. 	Allred CA, Gormley C, Venugopal I, Li S, McGuire MJ, Brown KC.	Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin	CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C
DRAMP35957	FHAVPQSFYT	10	MGS4_V8 (monomer)	Not available		Not found	Synthetic (derived from MGS4)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: H358  (EC50=3.9nM); H1993  (EC50=4nM); H1299 (EC50=5.8nM); H2009  (EC50=6.8nM)	Not available	Linear	Acetylization	Free		L	Not available	Not available	36650239	Commun Biol. 2023 Jan 17;6(1):60. 	Allred CA, Gormley C, Venugopal I, Li S, McGuire MJ, Brown KC.	Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin	CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C
DRAMP35958	FHAVPQSFYT	10	MGS4_V8 (monomer)	Not available		Not found	Synthetic (derived from MGS4)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: H1993  (EC50=1.5nM); H1299 (EC50=2.5nM); H2009  (EC50=3.4nM); H358  (EC50=3.5nM)	Not available	Linear	Acetylization	Free		L	Not available	Not available	36650239	Commun Biol. 2023 Jan 17;6(1):60. 	Allred CA, Gormley C, Venugopal I, Li S, McGuire MJ, Brown KC.	Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin	CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C
DRAMP35959	FHAVPQSFYT	10	MGS4_V9 (dimer)	Not available		Not found	Synthetic (derived from MGS4)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: H358  (EC50=34nM); H1993  (EC50=37nM); H1299 (EC50=38nM); H2009  (EC50=38nM)	Not available	Dimer	Free	Free		L	Not available	Not available	36650239	Commun Biol. 2023 Jan 17;6(1):61. 	Allred CA, Gormley C, Venugopal I, Li S, McGuire MJ, Brown KC.	Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP35960	FHAVPQSFYT	10	MGS4_V9 (dimer)	Not available		Not found	Synthetic (derived from MGS4)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: H358  (EC50=3.9nM); H1993  (EC50=4nM); H1299 (EC50=5.8nM); H2009  (EC50=6.8nM)	Not available	Dimer	Free	Free		L	Not available	Not available	36650239	Commun Biol. 2023 Jan 17;6(1):61. 	Allred CA, Gormley C, Venugopal I, Li S, McGuire MJ, Brown KC.	Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP35961	FHAVPQSFYT	10	MGS4_V9 (dimer)	Not available		Not found	Synthetic (derived from MGS4)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: H1993  (EC50=1.5nM); H1299 (EC50=2.5nM); H2009  (EC50=3.4nM); H358  (EC50=3.5nM)	Not available	Dimer	Free	Free		L	Not available	Not available	36650239	Commun Biol. 2023 Jan 17;6(1):61. 	Allred CA, Gormley C, Venugopal I, Li S, McGuire MJ, Brown KC.	Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP35962	FHAVPQSFYT	10	MGS4_V10 (tetramer)	Not available		Not found	Synthetic (derived from MGS4)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: H358  (EC50=34nM); H1993  (EC50=37nM); H1299 (EC50=38nM); H2009  (EC50=38nM)	Not available	Tetramer	Free	Free		L	Not available	Not available	36650239	Commun Biol. 2023 Jan 17;6(1):62. 	Allred CA, Gormley C, Venugopal I, Li S, McGuire MJ, Brown KC.	Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP35963	FHAVPQSFYT	10	MGS4_V10 (tetramer)	Not available		Not found	Synthetic (derived from MGS4)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: H358  (EC50=3.9nM); H1993  (EC50=4nM); H1299 (EC50=5.8nM); H2009  (EC50=6.8nM)	Not available	Tetramer	Free	Free		L	Not available	Not available	36650239	Commun Biol. 2023 Jan 17;6(1):62. 	Allred CA, Gormley C, Venugopal I, Li S, McGuire MJ, Brown KC.	Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP35964	FHAVPQSFYT	10	MGS4_V10 (tetramer)	Not available		Not found	Synthetic (derived from MGS4)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: H1993  (EC50=1.5nM); H1299 (EC50=2.5nM); H2009  (EC50=3.4nM); H358  (EC50=3.5nM)	Not available	Tetramer	Free	Free		L	Not available	Not available	36650239	Commun Biol. 2023 Jan 17;6(1):62. 	Allred CA, Gormley C, Venugopal I, Li S, McGuire MJ, Brown KC.	Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP35965	ANGRGD	6	P1	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	The perceived cancer cell-selective killing of both peptides P1 and P2 seems to stalk from cationic peptides and the electrostatic interactions between the anionic lipids of cancer cells on account of specific binding between integrins proteins and N (APN/CD13) ligand-receptor on the cancer cell membrane and the presence of binding RGD and NGR motifs in peptides.	Tumor cells: HepG2 (IC50=11.53µg/mL); MCF-7  (IC50=15.73µg/mL); HEp-2 (IC50=17.84µg/mL); A375 (IC50=69.87µg/mL)	Not available	Linear	1-oxo-1H-phenalene-2,3-carbonitrile (Ar)	Amidation		L	Vero: IC50=71.37µg/mL	Not available	36863075	Bioorg Chem. 2023 May;134:106434. 	Krishnamoorthy R, Singh M, Anaikutti P, Paul L E, Dhanasekaran S, Sathiah T.	Design and synthesis of novel N-terminal peptides of integrin and aminopeptidase are new finding for anticancer activity	
DRAMP35966	KRGDKA	6	P2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	The perceived cancer cell-selective killing of both peptides P1 and P2 seems to stalk from cationic peptides and the electrostatic interactions between the anionic lipids of cancer cells on account of specific binding between integrins proteins and N (APN/CD13) ligand-receptor on the cancer cell membrane and the presence of binding RGD and NGR motifs in peptides.	Tumor cells: HepG2 (IC50=10.92µg/mL); HEp-2 (IC50=11.38µg/mL); MCF-7  (IC50=38.53µg/mL); A375 (IC50=91.28µg/mL)	Not available	Linear	α-(2,5,7-tri-tert-butyl) tryptophan (W*)	Amidation		L	Vero: IC50=65.03µg/mL	Not available	36863075	Bioorg Chem. 2023 May;134:106435. 	Krishnamoorthy R, Singh M, Anaikutti P, Paul L E, Dhanasekaran S, Sathiah T.	Design and synthesis of novel N-terminal peptides of integrin and aminopeptidase are new finding for anticancer activity	
DRAMP35967	KLWCKSSQVPQSR	13	ALA-A2	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: HT-29 (55.3 ± 2.7% cell viability=200µM); A549  (59.7 ± 1.1% cell viability=200µM)	Not available	Linear	Free	Free		L	Not available	Not available	36910465	Glob Chall. 2023 Jan 12;7(3):2200213. 	Lerksuthirat T, On-Yam P, Chitphuk S, Stitchantrakul W, Newburg DS, Morrow AL, Hongeng S, Chiangjong W, Chutipongtanate S	ALA-A2 Is a Novel Anticancer Peptide Inspired by Alpha-Lactalbumin: A Discovery from a Computational Peptide Library, In Silico Anticancer Peptide Screening and In Vitro Experimental Validation	CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
DRAMP35968	FLPLLAGLAANFLPQIICKIARKC	24	B1AW	Not available		Not found	Skin secretions of the Wuyi torrent frog, Amolops wuyiensis (A. wuyiensisi)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: H838 (IC50=32.15µM); PC-3 (IC50=33.46µM); U251MG (IC50=33.56µM)	Not available	Linear	Free	Free		L	HMEC-1: IC50=32.96μM; HaCaT: IC50=44.09μM	Not available	37228702	 Comput Struct Biotechnol J. 2023 May 6;21:2960-2972. 	Qin H, Zuo W, Ge L, Siu SWI, Wang L, Chen X, Ma C, Chen T, Zhou M, Cao Z, Kwok HF.	Discovery and analysis of a novel antimicrobial peptide B1AW from the skin secretion of Amolops wuyiensis and improving the membrane-binding affinity through the construction of the lysine-introduced analogue	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
DRAMP35969	FLPLLAGLAANFLPKIICKIARKC	24	B1AW-K	Not available		Not found	Synthetic (derived from B1AW)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: U251MG (IC50=3.86µM); PC-3 (IC50=4.283µM); H838 (IC50=5.15µM)	Not available	Linear	Free	Free		L	HMEC-1: IC50=26.45μM; HaCaT: IC50=20.53μM	Not available	37228702	 Comput Struct Biotechnol J. 2023 May 6;21:2960-2973. 	Qin H, Zuo W, Ge L, Siu SWI, Wang L, Chen X, Ma C, Chen T, Zhou M, Cao Z, Kwok HF.	Discovery and analysis of a novel antimicrobial peptide B1AW from the skin secretion of Amolops wuyiensis and improving the membrane-binding affinity through the construction of the lysine-introduced analogue	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
DRAMP35970	IWDTIEK	7		Not available		Not found	Snake venom of N. kaouthia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	EGFR	37293380	 Saudi Pharm J. 2023 Jun;31(6):1115-1124.	Erlista GP, Ahmed N, Swasono RT, Raharjo S, Raharjo TJ. 	Proteome of monocled cobra ( Naja kaouthia) venom and potent anti breast cancer peptide from trypsin hydrolyzate of the venom protein	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O
DRAMP35971	WWSDHR	6		Not available		Not found	Snake venom of N. kaouthia	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Not available	Not available	Linear	Free	Free		L	Not available	EGFR 	37293380	 Saudi Pharm J. 2023 Jun;31(6):1115-1125.	Erlista GP, Ahmed N, Swasono RT, Raharjo S, Raharjo TJ. 	Proteome of monocled cobra ( Naja kaouthia) venom and potent anti breast cancer peptide from trypsin hydrolyzate of the venom protein	N=C(N)NCCC[C@H](NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)O
DRAMP35972	RIIDRLWLVRRPOKPKFVLVWVL	23	PMAP-NC	Not available		Not found	Synthetic (derived from PMAP-23)	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	A unique structure with an amphipathic N-helix, a central hinge, and a hydrophobic C-helix is responsible for bactericidal and anticancer activity of PMAP-NC. 	Tumor cells: MDA361 (IC50=6.4µM); A549 (IC50=7.1µM)	Not available	Linear	Free	Free		L	Not available	Not available	37310533	 Amino Acids. 2023 Aug;55(8):1013-1022.	Lee H, Shin SH, Yang S. 	Rationally designed PMAP-23 derivatives with enhanced bactericidal and anticancer activity based on the molecular mechanism of peptide-membrane interactions	
DRAMP35973	TKEQKEQIAKATGLTTKQVRNWYVQLNASIKVCMCSC	37		Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: SNU449 (4.8% viability=162 μM); SNU449 (52.8% viability=71 μM)	Not available	Linear	Free	Free		L	Not available	Not available	37495988	 BMC Cancer. 2023 Jul 26;23(1):699.	Abdou YT, Saleeb SM, Abdel-Raouf KMA, Allam M, Adel M, Amleh A.	Characterization of a novel peptide mined from the Red Sea brine pools and modified to enhance its anticancer activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@H](C)CC)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O
DRAMP35974	LLLLLLLLLLLLLL	14	C6-PLL14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=175µg/mL)	Not available	Linear	C6	Free		L	HUVEC: IC50=108µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6618	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	
DRAMP35975	LLLLLLLLLLLLLL	14	C6-PLL14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=12µg/mL)	Not available	Linear	C6	Free		L	HUVEC: IC50=108µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6618	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	
DRAMP35976	LLLLLLLLLLLLLLLLLLLLLLLLL	25	C6-PLL25	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=41µg/mL)	Not available	Linear	C6	Free		L	HUVEC: IC50=77µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6619	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	
DRAMP35977	LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL	40	C6-PLL40	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=115µg/mL)	Not available	Linear	C6	Free		L	HUVEC: IC50=50µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6620	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	
DRAMP35978	LLLLLLLLLLLLL	13	C12-PLL13	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=10µg/mL)	Not available	Linear	C12	Free		L	HUVEC: IC50=82µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6621	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	CCCCCCCCCCCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35979	LLLLLLLLLLLLLLLLLLLLLLLLLL	26	C12-PLL26	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=15µg/mL)	Not available	Linear	C12	Free		L	HUVEC: IC50=44µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6622	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	CCCCCCCCCCCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35980	LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL	37	C12-PLL37	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=14µg/mL)	Not available	Linear	C12	Free		L	HUVEC: IC50=105µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6623	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	CCCCCCCCCCCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35981	LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL	37	C12-PLL37	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=22µg/mL)	Not available	Linear	C12	Free		L	HUVEC: IC50=105µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6623	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	CCCCCCCCCCCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35982	LLLLLLLLLLLLLL	14	C16-PLL14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=175µg/mL)	Not available	Linear	C16	Free		L	HUVEC: IC50=22µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6624	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35983	LLLLLLLLLLLLLL	14	C16-PLL14	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=12µg/mL)	Not available	Linear	C16	Free		L	HUVEC: IC50=22µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6624	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35984	LLLLLLLLLLLLLLLLLLLLLLLL	24	C16-PLL24	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=25µg/mL)	Not available	Linear	C16	Free		L	HUVEC: IC50=18µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6625	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35985	LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL	38	C16-PLL38	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=44µg/mL)	Not available	Linear	C16	Free		L	HUVEC: IC50=126µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6626	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	CCCCCCCCCCCCCCCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP35986	LLLLLLLLLLL	11	C18-PLL11	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=10µg/mL)	Not available	Linear	C18	Free		L	HUVEC: IC50=28µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6627	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	
DRAMP35987	LLLLLLLLLLLLLLLLLLLLLLL	23	C18-PLL23	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=25µg/mL)	Not available	Linear	C18	Free		L	HUVEC: IC50=91µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6628	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	
DRAMP35988	LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL	37	C18-PLL37	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=14µg/mL)	Not available	Linear	C18	Free		L	HUVEC: IC50=94µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6629	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	
DRAMP35989	LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL	37	C18-PLL37	Not available		Not found	Synthetic	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	Not available	Tumor cells: C26 (IC50=22µg/mL)	Not available	Linear	C18	Free		L	HUVEC: IC50=94µg/mL	Not available	37605903	2023 Sep 26;11(19):6611-6629	Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.	Synthetic lipo-polylysine with anti-cancer activity	
DRAMP35990	GAGIVVASIDTGVRVSHE	18	GE18	Not available		Not found	Virulence factor of aquatic pathogenic fungus Aphanomyces invadans	Antimicrobial, Anticancer	Not found	Not found	Not found	Not available	GE18 affects the cellular morphology, which triggers the cells to undergo apoptosis for biological cellular elimination	Tumor cells: MCF-7  (IC50=29.06μM); MCF-7  (IC50=35.34μM)	Not available	Linear	Amidation	Acetylation		L	Rat skeletal myoblast cell line (L6): 91.73 ± 2% viability = 10 µM; 90.65 ± 2.9% viability = 20 µM; 87.91 ± 3.05% viability = 30 µM; 87.29 ± 1.9% viability = 40 µM; 84.44 ± 3.8% viability = 50 µM	Not available	37764521	 Molecules. 2023 Sep 21;28(18):6746. 	Velayutham M, Priya PS, Sarkar P, Murugan R, Almutairi BO, Arokiyaraj S, Kari ZA, Tellez-Isaias G, Guru A, Arockiaraj J.	Aquatic Peptide: The Potential Anti-Cancer and Anti-Microbial Activity of GE18 Derived from Pathogenic Fungus Aphanomyces invadans	
DRAMP37372	XGSGSGVALDPIDISIVLNKAKSDLEESKEWIRRSNGKLDSI	42	Chol-PEG4-VG	No entry found	Paramyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Peptides derived from the HRC of paramyxovirus F proteins interfere with formation of the six-helix bundle in a dominant-negative manner by binding to the transiently exposed HRN coiled coil in the transient fusion intermediate, thereby inhibiting membrane fusion.	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=0.1 ± 0.0001 nM,IC50<0.0007 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 1 indicates cholesterol-PEG4 conjugated cysteine.	L	[Ref.28344321]Vero cells: CC50>10000 nM.	membrane	28344321	Sci Rep. 2017 Mar 8;7:43610.	Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A	Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides	
DRAMP37373	XGSGSGVALDPIDISIVLNKAKSDLEESKEWIRRSNGKLDSI	42	Chol-VG	No entry found	Paramyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Peptides derived from the HRC of paramyxovirus F proteins interfere with formation of the six-helix bundle in a dominant-negative manner by binding to the transiently exposed HRN coiled coil in the transient fusion intermediate, thereby inhibiting membrane fusion.	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=1.7 ± 0.42 nM,IC50=0.06 ± 0.035 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 1 indicates cholesterol-conjugated cysteine.	L	[Ref.28344321]Vero cells: CC50=9000 nM.	membrane	28344321	Sci Rep. 2017 Mar 8;7:43610.	Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A	Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides	
DRAMP37374	VALDPIDISIVLNKAKSDLEESKEWIRRSNGKLDSIGSGSGX	42	VG-PEG24-Chol	No entry found	Paramyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Peptides derived from the HRC of paramyxovirus F proteins interfere with formation of the six-helix bundle in a dominant-negative manner by binding to the transiently exposed HRN coiled coil in the transient fusion intermediate, thereby inhibiting membrane fusion.	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=0.1 ± 0.0003 nM,IC50=0.007 ± 0.007 nM);##Nipah virus(NiV):inhibition of virus infection in Vero cells(IC90~2 nM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 42 indicates cholesterol-PEG24 conjugated cysteine.	L	[Ref.28344321]Vero cells: CC50=1300 nM.	membrane	28344321	Sci Rep. 2017 Mar 8;7:43610.	Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A	Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides	
DRAMP37375	VALDPIDISIVLNKAKSDLEESKEWIRRSNGKLDSIGSGSGX	42	VG-Chol	No entry found	Paramyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Peptides derived from the HRC of paramyxovirus F proteins interfere with formation of the six-helix bundle in a dominant-negative manner by binding to the transiently exposed HRN coiled coil in the transient fusion intermediate, thereby inhibiting membrane fusion.	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=0.7 ± 0.26 nM,IC50=0.015 ± 0.07 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 42 indicates cholesterol-conjugated cysteine.	L	[Ref.28344321]Vero cells: CC50+10000 nM.	membrane	28344321	Sci Rep. 2017 Mar 8;7:43610.	Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A	Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides	
DRAMP37376	VALDPIDISIVLNKAKSDLEESKEWIRRSNGKLDSIGSGSGX	42	VG-PEG4-Chol	No entry found	Paramyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Peptides derived from the HRC of paramyxovirus F proteins interfere with formation of the six-helix bundle in a dominant-negative manner by binding to the transiently exposed HRN coiled coil in the transient fusion intermediate, thereby inhibiting membrane fusion.	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=0.7 ± 0.007 nM,IC50=0.03 ± 0.04 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 42 indicates cholesterol-PEG4 conjugated cysteine.	L	[Ref.28344321]Vero cells: CC50=4500 nM.	membrane	28344321	Sci Rep. 2017 Mar 8;7:43610.	Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A	Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides	
DRAMP37377	VALDPIDISIVLNKAKSDLEESKEWIRRSNGKLDSIGSGSGC	42	VG	No entry found	Paramyxoviridae	Not Available	Synthetic construct	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=280 ± 247 nM,IC50=1 nM).	Not Available				Peptides derived from the HRC of paramyxovirus F proteins interfere with formation of the six-helix bundle in a dominant-negative manner by binding to the transiently exposed HRN coiled coil in the transient fusion intermediate, thereby inhibiting membrane fusion.	[Ref.28344321]Human parainfluenza viruse 3(HPIV 3): inhibition of virus infection in Vero cells(IC90=280 ± 247 nM,IC50=1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.28344321]Vero cells: CC50>10000 nM.	membrane	28344321	Sci Rep. 2017 Mar 8;7:43610.	Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A	Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(C)=O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CS)C(N)=O
DRAMP37378	KQLTEAVQKITTESIVIWGK	20	4306(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),53(derived from the HIV-1 HXB2 Pol region of the viral genome)	No entry found	Retroviridae	Not Available	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.##[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=7±1 µM);inhibition of strand transfer ca	Not Available				Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.##[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=7±1 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=4±1 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50=51±7 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=31±7 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=29±1 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=2±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=15 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=10 µM).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Integrase	15790559##16879966	J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.	Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N.	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)NCC(=O)O)[C@H](C)CC
DRAMP37379	SVSVGMKPSPRP	12	VMI5	No entry found	Retroviridae	Not Available	Synthetic construct(phage display)	[Ref.12480936]HIV-1:binding with vif proteins.	Not Available				Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.	[Ref.12480936]HIV-1:binding with vif proteins.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Vif proteins	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	CSCC[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37380	FLPLILPSIVTALSSFLKQG	20	Hs-1	No entry found	Flaviviridae	Not Available	Hypsiboas semilineatus	[Ref.29153860]DENV2:reduced the number of lysis plaques by 100% at 125 µg/mL; by 60% at 7.81 μg/mL;##DENV3:reduced the number of lysis plaques by 100% at 125 µg/mL; by 50% at 7.81 μg/mL	Not Available				It was possible to observe that the viral particle lost its ability to infect because of the breakdown on the envelope as the peptide acted directly on the virus. 	[Ref.29153860]DENV2:reduced the number of lysis plaques by 100% at 125 µg/mL; by 60% at 7.81 μg/mL;##DENV3:reduced the number of lysis plaques by 100% at 125 µg/mL; by 50% at 7.81 μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.29153860]No significant cytotoxicity agaisnt Vero cells up to 125μg/ mL.	envelope	29153860	Virology. 2018 Jan 15;514:79-87.	Monteiro JMC, Oliveira MD, Dias RS, Nacif-Marçal L, Feio RN, Ferreira SO, Oliveira LL, Silva CC, Paula SO.	The antimicrobial peptide HS-1 inhibits dengue virus infection.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@H](C)CC
DRAMP37381	MVDRGWGNHAGLFGKGSIV	19	DN80	P16090	Flaviviridae	Not Available	Synthetic construct(derived from the E polyprotein of DENV)	[Ref.31351847]Dengue virus(DENV): inhibition of DENV infection in LLCKM-2 monkey kidney epithelial cells(17±10% inhibition at 49.9 μM).	Not Available				The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	[Ref.31351847]Dengue virus(DENV): inhibition of DENV infection in LLCKM-2 monkey kidney epithelial cells(17±10% inhibition at 49.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	envelope	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978. 	da Silva-Júnior EF, de Araújo-Júnior JX. 	Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)O
DRAMP37382	SGCANNTCYNVSVIVPDYQC	20	9(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not Available	Synthetic construct(derived from FIV envelope glycoprotein (gE))	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(24% inhibition at 16 µg/ml).	Not Available				The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(24% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)O)C(C)C
DRAMP37383	RNKSNLHTEARFRIRCRWNV	20	27(derived from FIV envelope glycoprotein )	P16090	Retroviridae	Not Available	Synthetic construct(derived from FIV envelope glycoprotein (gE))	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(2% inhibition at 16 µg/ml).	Not Available				The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(2% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37384	RFRIRCRWNVGSDTSLIDTC	20	28(derived from FIV envelope glycoprotein )	P06437	Retroviridae	Not Available	Synthetic construct(derived from FIV envelope glycoprotein (gE))	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(40% inhibition at 16 µg/ml).	Not Available				The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(40% inhibition at 16 µg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Syncytium formation	8661378	Virology. 1996 Jun 15;220(2):274-84. 	Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C.	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
DRAMP37385	HEVVPLEVYTRHEIK	15	gB131(681-695)	No entry found	Herpesviridae	Not Available	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=18.7±2.70 µM);inhibition of virus entry in Vero cells(EC50=12.2±6.56 µM);inhibition of virus infection in Vero ce	Not Available				The gB131 peptide could be interfering with a conformational change involving interactions between residues in this region or by blocking a binding interaction.	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=18.7±2.70 µM);inhibition of virus entry in Vero cells(EC50=12.2±6.56 µM);inhibition of virus infection in Vero cells(EC50>200 µM);ability of inactive virus(EC50>200 µM);inhibition of virus attachment on Vero cells(EC50>200 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.19104014]Not cytotoxic for Vero cells up to 200 µM.	Not found	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP37386	SSCNMGWDTPACCVWFPYWV	20	A4	No entry found	Herpesviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.	[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(70% inhibition).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	pUL84(nonconventional nuclear localization signal of the essential viral replication factor)	19740994	J Virol. 2009 Nov;83(22):11902-13. 	Kaiser N, Lischka P, Wagenknecht N, Stamminger T.	Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.	
DRAMP37387	KQNAANILRLKESIAATNEAVHEV	24	N24	No entry found	Paramyxoviridae	Not Available	Synthetic construct	[Ref.12127571]Newcastle disease virus (NDV):inhibition of syncytium formation between NDV-infected cells(IC50=22.5 nM).	Not Available				By binding to the opposite HR region in the F protein, peptides would inhibit fusion from the initial steps (lipid- and contents-mixing), blocking the conformational changes in the fusion protein required for triggering fusion.	[Ref.12127571]Newcastle disease virus (NDV):inhibition of syncytium formation between NDV-infected cells(IC50=22.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	F protein	12127571	Int J Biochem Cell Biol. 2002 Oct;34(10):1207-20.	San Román K, Villar E, Muñoz-Barroso I.	Mode of action of two inhibitory peptides from heptad repeat domains of the fusion protein of Newcastle disease virus.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O
DRAMP37388	AVSKVLHLEGEVNKISALLSTNKAVVSLSNGVSVLTSKVLDLDNYIDKQLLPIVNK	56	HR1-30a	No entry found	Paramyxoviridae	Not Available	Synthetic construct	[Ref.12615056]respiratory syncytial virus(RSV):inhibition of cell fusion in Hep2 cells( IC50=1.68 μM).	Not Available				Peptide derived from hRSV F protein give strong virus–cell fusion inhibition effect. 	[Ref.12615056]respiratory syncytial virus(RSV):inhibition of cell fusion in Hep2 cells( IC50=1.68 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	F protein	12615056	Biochem Biophys Res Commun. 2003 Mar 14;302(3):469-75. 	Wang E, Sun X, Qian Y, Zhao L, Tien P, Gao GF.	Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(C)C)[C@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP37389	TLLFLKVPAQNAISTTFPYT	21	PB1 (6–25)	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=129 ± 2 μM).	Not Available				The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=129 ± 2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP37390	MEVVQQTRMDKLTQGRQTYD	21	PB1 (111–130)	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=58 ± 2 μM).	Not Available				The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=58 ± 2 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP37391	LPVGGNEKKAKLANVVRKMM	21	PB1 (271–290)	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=33 ± 1 μM).	Not Available				The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=33 ± 1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)O)C(C)C)C(C)C)C(=O)O
DRAMP37392	FNESTRKKIEKIRPLLVEGT	21	PB1 (381–400)	P59594##P26436	Orthomyxoviridae	Not Available	Synthetic construct	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=23 ± 1 μM).	Not Available				The peptide may affect the early stages of the viral life cycle, which includes the synthesis of polymerase subunits and their subsequent assembly into functionally active complex. The peptide  could interfere with these processes thus inhibiting virus replication.	[Ref.25446335]Influenza A virus(A/California/07/2009 (H1N1)pdm09/):antiviral activity of the peptide in MDCK cells(ED50=23 ± 1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Not found	25446335	Antiviral Res. 2015 Jan;113:4-10.	Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.	Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP37393	STSQKSIVAYTM	12	SARS-CoV S (668–679), SP-10	Q9BYF1	Coronaviridae	S2(MAX5B_000299)	Synthetic construct(derived from SARS-CoV S protein)	[Ref.16337697]SARS-CoV:Inhibition of pseudovirus infection in Vero cells(IC50=1.88 ± 0.52 nM).	Not Available			1WNC	block the binding of S protein to ACE2.	[Ref.16337697]SARS-CoV:Inhibition of pseudovirus infection in Vero cells(IC50=1.88 ± 0.52 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	ACE2	16337697	Antiviral Res. 2006 Feb;69(2):70-6.	Ho TY, Wu SL, Chen JC, Wei YC, Cheng SE, Chang YH, Liu HJ, Hsiang CY.	Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)C(C)C
DRAMP37394	IEEQAKTFLDKFQHEVEEIYWQS	23	Peptide1(ACE2 (21-43)[N13Q,A16V,D18E,L19I,F20Y,Y21W])	Q91L67	Coronaviridae	Not Available	Synthetic construct	[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=11 ± 1 nM, 100% inhibition at 25 µM).	Not Available				antagonizes the SARS-CoV-2 S-RBD:ACE2 interaction and inhibits the virus entry.	[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=11 ± 1 nM, 100% inhibition at 25 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	No cytotoxicity information or data found in the reference(s) presented in this entry	Spike protein	34328726	J Med Chem. 2022 Feb 24;65(4):2836-2847. 	Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.	Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(N)=O)[C@H](C)CC)C(C)C)[C@@H](C)O
DRAMP37395	LLGRMKG	7		O92921	Hepadnaviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				During HBV morphogenesis, both the PreS and S domains of L-HBsAg form docking sites for the viral nucleocapsids. Thus, a compound that disrupts the interaction between the L-HBsAg and nucleocapsids could serve as a therapeutic agent against the virus based upon inhibition of morphogenesis. Peptide inhibits the association of L-HBsAg with core antigen (HBcAg).	[Ref.12469306]Hepatitis B virus(HBV): inhibition of the association of L-HBsAg with HBcAg(IC50=78±5 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	core antigen (HBcAg)(Viral assembly)	12469306	J Gen Appl Microbiol. 2002 Apr;48(2):103-7.	Tan WS.	Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens.	
DRAMP37396	LDPAFR	6		O92921	Hepadnaviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				During HBV morphogenesis, both the PreS and S domains of L-HBsAg form docking sites for the viral nucleocapsids. Thus, a compound that disrupts the interaction between the L-HBsAg and nucleocapsids could serve as a therapeutic agent against the virus based upon inhibition of morphogenesis. Peptide inhibits the association of L-HBsAg with core antigen (HBcAg).	[Ref.12469306]Hepatitis B virus(HBV): inhibition of the association of L-HBsAg with HBcAg(IC50>1000 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	core antigen (HBcAg)(Viral assembly)	12469306	J Gen Appl Microbiol. 2002 Apr;48(2):103-7.	Tan WS.	Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens.	
DRAMP37397	PLSPPLRNTHPQAMQWNSTTF	21		O92921	Hepadnaviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				During HBV morphogenesis, both the PreS and S domains of L-HBsAg form docking sites for the viral nucleocapsids. Thus, a compound that disrupts the interaction between the L-HBsAg and nucleocapsids could serve as a therapeutic agent against the virus based upon inhibition of morphogenesis. Peptide inhibits the association of L-HBsAg with core antigen (HBcAg).	[Ref.12469306]Hepatitis B virus(HBV): inhibition of the association of L-HBsAg with HBcAg(IC50=30±1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	core antigen (HBcAg)(Viral assembly)	12469306	J Gen Appl Microbiol. 2002 Apr;48(2):103-7.	Tan WS.	Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens.	
DRAMP37398	PTSNHSPTSCPPTCPGYRWMCLRRF	25	HBV S(56-80)	No entry found	Hepadnaviridae	Not Available	Synthetic construct	[Ref.12469306]Hepatitis B virus(HBV): inhibition of the association of L-HBsAg with HBcAg(IC50=35±4 μM).	Not Available				During HBV morphogenesis, both the PreS and S domains of L-HBsAg form docking sites for the viral nucleocapsids. Thus, a compound that disrupts the interaction between the L-HBsAg and nucleocapsids could serve as a therapeutic agent against the virus based upon inhibition of morphogenesis. Peptide inhibits the association of L-HBsAg with core antigen (HBcAg).	[Ref.12469306]Hepatitis B virus(HBV): inhibition of the association of L-HBsAg with HBcAg(IC50=35±4 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	core antigen (HBcAg)(Viral assembly)	12469306	J Gen Appl Microbiol. 2002 Apr;48(2):103-7.	Tan WS.	Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens.	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP37399	GELGRLVYLLDGPGYDPIHCSLAYGDASTLVVF	33	K5-66	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=20.7±3.6 nM).	Not Available				"inhibitory peptides (IPs) capping the active site and binding via a novel ""tyrosine"" finger at an alternative NS3-4A site that is of particular interest。"	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=20.7±3.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	virus replication	22965230	J Biol Chem. 2012 Nov 9;287(46):39224-32. 	Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.	High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)O)NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)CN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37400	GELGRLVYLLDGPGYDPI	18	K5-66-A	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=125.4 nM).	Not Available				"inhibitory peptides (IPs) capping the active site and binding via a novel ""tyrosine"" finger at an alternative NS3-5A site that is of particular interest。"	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=125.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	virus replication	22965230	J Biol Chem. 2012 Nov 9;287(46):39224-32. 	Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.	High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)CN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)O
DRAMP37401	GELGRPVYVLGDPGYYATHCIYATTNDALIFSV	33	K6-10	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=25.6±3.5 nM).	Not Available				"inhibitory peptides (IPs) capping the active site and binding via a novel ""tyrosine"" finger at an alternative NS3-6A site that is of particular interest。"	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=25.6±3.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	virus replication	22965230	J Biol Chem. 2012 Nov 9;287(46):39224-32. 	Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.	High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)CC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)O
DRAMP37402	GELGRPVYVLGDPGYYAT	18	K6-10-A	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=227.6 nM).	Not Available				"inhibitory peptides (IPs) capping the active site and binding via a novel ""tyrosine"" finger at an alternative NS3-7A site that is of particular interest。"	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=227.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	virus replication	22965230	J Biol Chem. 2012 Nov 9;287(46):39224-32. 	Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.	High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
DRAMP37403	GELGRLVYLLDGPGYDPIHCDVVTRGGSHLFNF	33	CP5-46	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=11.3±1.6 nM).	Not Available				"inhibitory peptides (IPs) capping the active site and binding via a novel ""tyrosine"" finger at an alternative NS3-8A site that is of particular interest。"	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=11.3±1.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	virus replication	22965230	J Biol Chem. 2012 Nov 9;287(46):39224-32. 	Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.	High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)CN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37404	GELDELVYLLDGPGYDPIHCDVVTRGGSRLFNF	33	CP5-46-4D5E	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=1.14±0.053 nM).	Not Available				"inhibitory peptides (IPs) capping the active site and binding via a novel ""tyrosine"" finger at an alternative NS3-9A site that is of particular interest。"	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=1.14±0.053 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	virus replication	22965230	J Biol Chem. 2012 Nov 9;287(46):39224-32. 	Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.	High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37405	GELGRLVYLLDGPGYDPIHCD	21	CP5-46-A	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=124 nM).	Not Available				"inhibitory peptides (IPs) capping the active site and binding via a novel ""tyrosine"" finger at an alternative NS3-10A site that is of particular interest。"	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=124 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	virus replication	22965230	J Biol Chem. 2012 Nov 9;287(46):39224-32. 	Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.	High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)CN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CS)C(=O)O
DRAMP37406	GELDELVYLLDGPGYDPIHS	20	CP5-46A-4D5E	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=22.8 nM).	Not Available				"inhibitory peptides (IPs) capping the active site and binding via a novel ""tyrosine"" finger at an alternative NS3-11A site that is of particular interest。"	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=22.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	virus replication	22965230	J Biol Chem. 2012 Nov 9;287(46):39224-32. 	Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.	High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CO)C(=O)O
DRAMP37407	RQIKINFQNRRMKNKKGELDELVYLLDGPGYDPIHS	36	Ant-CP5-46A-4D5E	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=23.6 nM).	Not Available				"inhibitory peptides (IPs) capping the active site and binding via a novel ""tyrosine"" finger at an alternative NS3-12A site that is of particular interest。"	[Ref.22965230]hepatitis C virus(HCV): inhibition of NS3–4A activity(IC50=23.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information or data found in the reference(s) presented in this entry	virus replication	22965230	J Biol Chem. 2012 Nov 9;287(46):39224-32. 	Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.	High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)CC[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CO)C(=O)O
DRAMP37408	ELLVTFKNAHAKKQEVVVLG	20	peptide 1	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.36739680]Peptides 1 at 200 μM exhibited cell protection effects against DENV-1 (69.58%) and DENV-4 (59.44%), but lower inhibitory effects were observed against DENV-2 (32.95%) and DENV-3 (12.59%)	Not Available				No machanism information found in the reference(s) presented in this entry	[Ref.36739680]Peptides 1 at 200 μM exhibited cell protection effects against DENV-1 (69.58%) and DENV-4 (59.44%), but lower inhibitory effects were observed against DENV-2 (32.95%) and DENV-3 (12.59%); Peptides 1(200 μM) demonstrated the highest inhibitions of DENV-3 (67.18%) plaque formations; Peptides 1 (200 μM) demonstrated inhibitions of all four DENV serotypes, but much lower inhibitions were observed against DENV-3 at 26.92%.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C
DRAMP37409	LKMDKLTLKGMSY	13	peptide 3	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.36739680]peptide 3 showed the most promising cell protection effects against DENV-1 (60.28%), DENV(36.23%), DENV-3 (73.85%), and DENV-4 (64.84%) at 200 μM. The IC50 of the cell protection effects	Not Available				It is possible that peptide 3 inhibited DENV-2 by inhibiting the virus particle itself and this was supported by the observation that peptide 3 showed good direct virus-inactivating effects against DENV-2.	[Ref.36739680]peptide 3 showed the most promising cell protection effects against DENV-1 (60.28%), DENV(36.23%), DENV-3 (73.85%), and DENV-4 (64.84%) at 200 μM. The IC50 of the cell protection effects of peptide 3 against DENV-3 was determined to be 182.27 μM; peptide 3 demonstrated the most promising antiviral activity during post-infection with good inhibitions of DENV-2 (69.05%) and DENV-3 (61.35%) whereas lower inhibitions were observed against DENV-1 (48.47%) and DENV-4 (34.72%) at 200 μM; Peptide 3 showed the highest inhibitions of plaque formations by DENV-2 (69.05%) and DENV-3 (61.35%); Peptide 3 reduced the RNA copy numbers of DENV-2 and DENV-3 by 43.83% and 50.72%, DENV-1 (31.85%); peptide 3 inhibited DENV-4 attachment to Vero cells by 39.58% but almost no inhibition was observed against DENV-1 (7.62%) and DENV-3 (2.56%). 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	CSCC[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
DRAMP37410	TGKFKVVKEIAETQHGTIVIRVQYE	25	Peptide 4	No entry found	Flaviviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				No machanism information found in the reference(s) presented in this entry	[Ref.36739680]peptides 4 demonstrated some cell protection effects against DENV-2 and DENV-4 at 47.38%, inhibitions against the other DENV serotypes were very low; Peptide 4 at 200 μM showed the highest inhibitory effects against DENV-2 (74.26%), but it exhibited very low inhibition of DENV-4 and it could not inhibit DENV-1 and DENV-3 plaque formations; peptide 4 demonstrated the highest inhibitory effects against DENV-1 (80.37%),DENV-2 (44.77%) and DENV-4 (72.22%) during post-infection. The IC50 of the inhibitory effects of peptide 4 against DENV-1 during post-infection was determined to be 161.07 μM; Peptide 4 was observed to inhibit DENV-1 and DENV-4 replications significantly with reductions of RNA copy numbers by 63.86% and 70.37%.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	
DRAMP37411	PFGDSYIVIGVGDSALTLHWFRK	23	Peptide 5	No entry found	Flaviviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				peptide 5 could exert virucidal activity by damaging the protein coat of the virus, penetrating the virion, or destroying the viral genome to reduce viral infectivity. 	[Ref.36739680]peptides 5 demonstrated some cell protection effects against DENV-2 and DENV-4 at 59.72%, inhibitions against the other DENV serotypes were very low; exhibited good direct virus-inactivating effects against DENV-2 (64.61%) and DENV-4 (77.08%) whereas lower inhibitions were observed against DENV-1 (16.90%) and DENV-3 (29.80%). The IC50 of the direct virus-inactivating effects of peptide 5 against DENV-4 was determined to be 121.26 μM; peptide 5 demonstrated the highest inhibitory effects against DENV-4 (89.31%) and DENV-2 (19.94%) during post-infection. The IC50 of the inhibition of DENV-4 by peptide 5 during post-infection was determined to be 141.42 μM; Peptide 5 was observed to inhibit DENV-4 replications significantly with reductions of RNA copy numbers by 75.80%.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	
DRAMP37412	IQTSGGTSI	9	Peptide 6	No entry found	Flaviviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				No machanism information found in the reference(s) presented in this entry	[Ref.36739680]Peptides 6 at 200 μM exhibited cell protection effects against DENV-1 (40.88%) and DENV-4 (51.27%), but lower inhibitory effects were observed against DENV-2 (10%) and DENV-3 (22.05%); Peptides 6 (200 μM) demonstrated inhibitions of all four DENV serotypes, but much lower inhibitions were observed against DENV-3 at 3.33%, respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	
DRAMP37413	MVDRGWGNGCGLFGKGGI	18	Peptide 7	No entry found	Flaviviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				No machanism information found in the reference(s) presented in this entry	[Ref.36739680]Peptides 7 at 200 μM exhibited good inhibitions of DENV-1 (67.17%) plaque formation, but much lower inhibitions were observed against DENV-2 to 4 ranging from 28.31 to 37.73%;  peptide 7 (200 μM) showed good direct virus-inactivating effects against DENV-3 (64.03%) and DENV-4 (78.76%) whereas lower inhibitions were observed against DENV-1 (32.66%) and DENV-2 (47.84%); peptide 7 demonstrated highly significant inhibition of DENV-4 at 84.82% during post-infection, much lower inhibitions were observed against DENV-2 and 3 at 9.13% and 2.24%; Peptide 7 was observed to inhibit DENV-4 replications significantly with reductions of RNA copy numbers by 77.01%.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	
DRAMP37414	GAMHTALTGATE	12	Peptide 8	No entry found	Flaviviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				No machanism information found in the reference(s) presented in this entry	[Ref.36739680]Peptides 8 at 200 μM exhibited good inhibitions of DENV-1 (70.19%) plaque formation, but much lower inhibitions were observed against DENV-2 to 4 ranging from 28.31 to 37.73%; Peptides 8 showed highly significant inhibitions of DENV-4 plaque formation (80.31–83.92%), but lower inhibitions were observed against DENV-1 to 3 (5.34–55.46%); Peptide 8 was observed to inhibit DENV-4 replications significantly with reductions of RNA copy numbers by 73.42%.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	
DRAMP37415	HAVGNDTSNHGVTA	14	Peptide 9	No entry found	Flaviviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				No machanism information found in the reference(s) presented in this entry	[Ref.36739680]Peptides 9 showed highly significant inhibitions of DENV-4 plaque formation (80.31–83.92%), but lower inhibitions were observed against DENV-1 to 3 (5.34–55.46%); Peptides 9 (200 μM) demonstrated the highest inhibitions of DENV-4 (83.92%) plaque formations; Peptide 9 at 200 μM showed inhibitions of all four DENV serotypes, but significantly lower inhibitions against DENV-2 (1.67%) and DENV-3 (3.48%) were observed. 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	
DRAMP37416	SPRTGLDFNEMI	12	Peptide 10	No entry found	Flaviviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				No machanism information found in the reference(s) presented in this entry	[Ref.36739680]Peptide 10 (200 μM) exhibited inhibitions of all four DENV serotypes, with high inhibitions of DENV-4 at 81.13%, followed by DENV-3 at 60.47% and DENV-1 at 47.01%.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	
DRAMP37417	TNTTT	5	Peptide 11	No entry found	Flaviviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				No machanism information found in the reference(s) presented in this entry	[Ref.36739680]Peptides 11 at 200 μM exhibited cell protection effects below 50% against all four DENV serotypes(DENV-1, DENV-2, DENV-3, DENV-4); peptides 11 (200 μM) also showed inhibitions of all four DENV serotypes, but significantly lower inhibitions were observed against DENV-3 at 3.57%.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	
DRAMP37418	DANFV	5	Peptide 12	No entry found	Flaviviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				No machanism information found in the reference(s) presented in this entry	[Ref.36739680]Peptides 12 at 200 μM exhibited cell protection effects below 50% against all four DENV serotypes(DENV-1, DENV-2, DENV-3, DENV-4); peptide 12 (200 μM) also showed inhibitions of all four DENV serotypes, but significantly lower inhibitions were observed against DENV-3 at 2.28%.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	
DRAMP37419	PFGDSYIVI	9	peptides 5F	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.36739680]At 100 μM, peptides 5F demonstrated some cell protection effects against DENV-1 (22.89%), DENV-2 (48.28%) and DENV-4(66.72%); Peptide 5F at 100 μM was observed to exhibit higher inhibiti	Not Available				No machanism information found in the reference(s) presented in this entry	[Ref.36739680]At 100 μM, peptides 5F demonstrated some cell protection effects against DENV-1 (22.89%), DENV-2 (48.28%) and DENV-4(66.72%); Peptide 5F at 100 μM was observed to exhibit higher inhibition of DENV-4 at 66.72% during the pre-infection stage when compared to peptide 5 which only demonstrated 59.72% inhibition of DENV-4 at 200 μM; Peptides 5F(100 μM) also demonstrated direct virus-inactivating effects against DENV-1 at 46.75%, DENV-2(75.15%), DENV-3(10.81%), DENV-4(70.15%); Peptides 5F at 100 μM showed inhibitions against DENV-1 during the post-infection stage at 49.65%, DENV-2(47.49%), DENV-4(91.58%).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.(cell viability was found to range between 92.98 and 100% at 200 μM).	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(C)=O)[C@H](C)CC)C(C)C)C(N)=O
DRAMP37420	VIGVGDSAL	9	peptides 5FG	No entry found	Flaviviridae	Not Available	Synthetic construct	[Ref.36739680]At 100 μM, peptides 5FG demonstrated some cell protection effects against DENV-1 (24.83%), DENV-4(57.09%) and DENV-2 (52.21%); Peptides 5FG (100 μM) also demonstrated direct virus-inacti	Not Available				No machanism information found in the reference(s) presented in this entry	[Ref.36739680]At 100 μM, peptides 5FG demonstrated some cell protection effects against DENV-1 (24.83%), DENV-4(57.09%) and DENV-2 (52.21%); Peptides 5FG (100 μM) also demonstrated direct virus-inactivating effects against DENV-1 at 46.72%, DENV-2 at (66.48%), DENV-4(70.3%); Peptides 5FG at 100 μM showed inhibitions against DENV-1 during the post-infection stage at 35.96%, DENV-2(6.85%), DENV-4(81.19%)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.(cell viability was found to range between 92.98 and 100% at 200 μM).	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(C)=O)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C
DRAMP37421	LTLHWFRK	8	peptides 5G	Q05323	Flaviviridae	Not Available	Synthetic construct	[Ref.36739680]At 100 μM, peptides 5G demonstrated some cell protection effects against DENV-1 (25.24%), DENV-4(26.80%), DENV-2 (49.24%) and DENV-3(41.08%); Peptide 5G (100 μM) demonstrated a slight in	Not Available				No machanism information found in the reference(s) presented in this entry	[Ref.36739680]At 100 μM, peptides 5G demonstrated some cell protection effects against DENV-1 (25.24%), DENV-4(26.80%), DENV-2 (49.24%) and DENV-3(41.08%); Peptide 5G (100 μM) demonstrated a slight increase in inhibition of DENV-3 at 41.08% during pre-infection whereas peptide 5 at 200 μM only showed 37.41% inhibition against DENV-3; Peptides 5G (100 μM) also demonstrated direct virus-inactivating effects against DENV-1 at 48.23%, DENV-2 (56.25%), DENV-3(29.91%), DENV-4(72.27%); Peptides 5G at 100 μM showed inhibitions against DENV-1 during the post-infection stage at 24.59%, DENV-4(71.95%)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation		L	[Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.(cell viability was found to range between 92.98 and 100% at 200 μM).	Not found	36739680	Virology. 2023 Mar;580:10-27.	Lee MF, Anasir MI, Poh CL. 	Development of novel antiviral peptides against dengue serotypes 1-4. 	CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O
DRAMP37422	QLESLTDRELLLLIARKTCGSVE	23	E30pep-wt	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				E30pep-wt seemed to bind efficiently to VP30 and consequently blocked the oligomerization of the protein. When E30pep-wt was transfected into EBOV-infected cells, the peptide inhibited viral replication suggesting that inhibition of VP30 oligomerization represents a target for EBOV antiviral drugs. 	[Ref.12912982]Ebola virus(EBOV): inhibition of the oligomerization of VP30(IC50= 1 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Amination	Carboxylation		L	No cytotoxicity information found in the reference(s) presented	Transcription	12912982	J Biol Chem. 2003 Oct 24;278(43):41830-6.	Hartlieb B, Modrof J, Mühlberger E, Klenk HD, Becker S.	Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. 	
DRAMP37423	GWKRIKQRIKDKLRNL	16	WL-1	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref.37342565]herpes simplex virus 1(HSV-1): WL-1 significantly inhibited the replication of HSV-1 on Vero cells(10 μM concentration with a 50% antiviral activity).	Not Available				WL-1 may damage the viral membrane envelope or inhibit HSV-1 adsorption to cells, or perhaps participates in the regulation of the viral replication cycle and inflammatory response caused by viral infection.	[Ref.37342565]herpes simplex virus 1(HSV-1): WL-1 significantly inhibited the replication of HSV-1 on Vero cells(10 μM concentration with a 50% antiviral activity).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref.37342565]WL-1 did not exert toxic effects on neuronal cell (U251) and epithelial cell (Vero) up to 50 μM concentration.	virus replication	37342565	Front Microbiol. 2023 Jun 5;14:1201505.	Guo X, An Y, Tan W, Ma L, Wang M, Li J, Li B, Hou W, Wu L.	Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP37424	Not reported	0	Salaciachinensis	No entry found	Flaviviridae	Not Available	Natural Construct(isolated from digest of thai medicinal plants) 	Antimrobial; Antiviral	Not Available				Not Available	[Ref:30225997] DENV:IC50 values of 0.25 µg/mL 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	No cytotoxicity information found in the reference(s) presented	Not Available	30225997	Chemical biology & drug design, 93(2), 100–109.	Panya, A., Yongpitakwattana, P., Budchart, P., Sawasdee, N., Krobthong, S., Paemanee, A., Roytrakul, S., Rattanabunyong, S., Choowongkomon, K., & Yenchitsomanus, P. T. (2019). 	Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu	
DRAMP37425	Not reported	0	Andrographispaniculata (Burm.f.) Wall.exNees	No entry found	Flaviviridae	Not Available	Natural Construct(isolated from digest of thai medicinal plants) 	Antimrobial; Antiviral	Not Available				Not Available	[Ref:30225997] DENV:IC50 values of 2.31 µg/mL 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	No cytotoxicity information found in the reference(s) presented	Not Available	30225997	Chemical biology & drug design, 93(2), 100–109.	Panya, A., Yongpitakwattana, P., Budchart, P., Sawasdee, N., Krobthong, S., Paemanee, A., Roytrakul, S., Rattanabunyong, S., Choowongkomon, K., & Yenchitsomanus, P. T. (2019). 	Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu	
DRAMP37426	Not reported	0	Sennagarrettiana (Craib) Irwin & Barneb	No entry found	Flaviviridae	Not Available	Natural Construct(isolated from digest of thai medicinal plants) 	Antimrobial; Antiviral	Not Available				Not Available	[Ref:30225997] DENV:IC50 values of 0.31 µg/mL 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	No cytotoxicity information found in the reference(s) presented	Not Available	30225997	Chemical biology & drug design, 93(2), 100–109.	Panya, A., Yongpitakwattana, P., Budchart, P., Sawasdee, N., Krobthong, S., Paemanee, A., Roytrakul, S., Rattanabunyong, S., Choowongkomon, K., & Yenchitsomanus, P. T. (2019). 	Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu	
DRAMP37427	Not reported	0	Diospyros Mollis Griff	No entry found	Flaviviridae	Not Available	Natural Construct(isolated from digest of thai medicinal plants) 	Antimrobial; Antiviral	Not Available				Not Available	[Ref:30225997] DENV:IC50 values of 2.4 µg/mL 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	No cytotoxicity information found in the reference(s) presented	Not Available	30225997	Chemical biology & drug design, 93(2), 100–109.	Panya, A., Yongpitakwattana, P., Budchart, P., Sawasdee, N., Krobthong, S., Paemanee, A., Roytrakul, S., Rattanabunyong, S., Choowongkomon, K., & Yenchitsomanus, P. T. (2019). 	Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu	
DRAMP37428	Not reported	0	Thunbergia laurifolia Lindl	No entry found	Flaviviridae	Not Available	Natural Construct(isolated from digest of thai medicinal plants) 	Antimrobial; Antiviral	Not Available				Not Available	[Ref:30225997] DENV:IC50 values of 1.54 µg/mL 	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	No cytotoxicity information found in the reference(s) presented	Not Available	30225997	Chemical biology & drug design, 93(2), 100–109.	Panya, A., Yongpitakwattana, P., Budchart, P., Sawasdee, N., Krobthong, S., Paemanee, A., Roytrakul, S., Rattanabunyong, S., Choowongkomon, K., & Yenchitsomanus, P. T. (2019). 	Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu	
DRAMP37429	EDVLL 	5	SLP9	No entry found	Coronaviridae	Not Available	Synthetic Construct(derived from Bacillus subtilis)	Antimrobial; Antiviral	Not Available				Inhibiting viral membrane fusion	[Ref:30973929] PEDV: EC50 12.8 ± 0.5 μg/ml	[Ref:30973929] high hemolytic activity  	Linear	palmitoylation	Amination		L	[Ref:30973929] CC50: 52.2 ± 2.0 μg/ml	Membrane	30973929	PloS one, 14(4), e0215227.	Yuan, L., Zhang, S., Peng, J., Li, Y., & Yang, Q. (2019).	Synthetic surfactin analogues have improved anti-PEDV properties	
DRAMP37430	EVLDL	5	SLP10	No entry found	Coronaviridae	Not Available	Synthetic Construct(derived from Bacillus subtilis)	Antimrobial; Antiviral	Not Available				Inhibiting viral membrane fusion	[Ref:30973929] PEDV: EC50 10.6 ± 0.5 μg/ml	[Ref:30973929] high hemolytic activity  	Cyclic	Heptaalkyl-biphenyl-acid-	Amination	Heptaalkyl-biphenyl-acid-	L/D	[Ref:30973929] CC50:  82.8 ± 3.4 μg/ml	Membrane	30973929	PloS one, 14(4), e0215227.	Yuan, L., Zhang, S., Peng, J., Li, Y., & Yang, Q. (2019).	Synthetic surfactin analogues have improved anti-PEDV properties	
DRAMP37431	EVLDL 	5	SLP7	No entry found	Coronaviridae	Not Available	Synthetic Construct(derived from Bacillus subtilis)	Antimrobial; Antiviral	Not Available				Inhibiting viral membrane fusion	[Ref:30973929] PEDV: EC50 14.0 ± 0.6 μg/ml	[Ref:30973929] high hemolytic activity  	Linear	palmitoylation	Amination	SLP7 is a version of SLP3 that contains only L-amino acids	L	[Ref:30973929] CC50: 274.1 ± 21.0 μg/ml	Membrane	30973929	PloS one, 14(4), e0215227.	Yuan, L., Zhang, S., Peng, J., Li, Y., & Yang, Q. (2019).	Synthetic surfactin analogues have improved anti-PEDV properties	
DRAMP37432	EVLLD	5	SLP8	No entry found	Coronaviridae	Not Available	Synthetic Construct(derived from Bacillus subtilis)	Antimrobial; Antiviral	Not Available				Inhibiting viral membrane fusion	[Ref:30973929] PEDV: EC50 2.6 ± 0.2 μg/ml	[Ref:30973929] SLP8 has a low hemolytic activity,	Linear	palmitoylation	Amination		L	[Ref:30973929] CC50: 217.5 ± 18.9 μg/ml	Membrane	30973929	PloS one, 14(4), e0215227.	Yuan, L., Zhang, S., Peng, J., Li, Y., & Yang, Q. (2019).	Synthetic surfactin analogues have improved anti-PEDV properties	
DRAMP37433	KVLKL 	5	SLP6	No entry found	Coronaviridae	Not Available	Synthetic Construct(derived from Bacillus subtilis)	Antimrobial; Antiviral	Not Available				Inhibiting viral membrane fusion	[Ref:30973929] PEDV: EC50 6.1 ± 0.3 μg/ml	[Ref:30973929] high hemolytic activity  	Linear	palmitoylation	Amination		L	[Ref:30973929] CC50: 12.6 ± 0.4 μg/ml	Membrane	30973929	PloS one, 14(4), e0215227.	Yuan, L., Zhang, S., Peng, J., Li, Y., & Yang, Q. (2019).	Synthetic surfactin analogues have improved anti-PEDV properties	
DRAMP37434	EVLDL 	5	SLP5	No entry found	Coronaviridae	Not Available	Synthetic Construct(derived from Bacillus subtilis)	Antimrobial; Antiviral	Not Available				Inhibiting viral membrane fusion	 [Ref:30973929]PEDV:EC50 16.5 ± 0.6 μg/ml	[Ref:30973929] hemolytic activity is reduced	Linear	palmitoylation	Carboxylation		L	[Ref:30973929] CC50: 847.2 ± 124.9 μg/ml	Membrane	30973929	PloS one, 14(4), e0215227.	Yuan, L., Zhang, S., Peng, J., Li, Y., & Yang, Q. (2019).	Synthetic surfactin analogues have improved anti-PEDV properties	
DRAMP37435	EVLDL	5	SLP3	No entry found	Coronaviridae	Not Available	Synthetic Construct(derived from Bacillus subtilis)	Antimrobial; Antiviral	Not Available				Inhibiting viral membrane fusion	[Ref:30973929] PEDV: EC50 16.9 ± 1.6 μg/ml	[Ref:30973929] hemolytic activity is reduced	Linear	palmitoylation	Amination		L	[Ref:30973929] CC50: 69.7 ± 2.6 μg/ml	Membrane	30973929	PloS one, 14(4), e0215227.	Yuan, L., Zhang, S., Peng, J., Li, Y., & Yang, Q. (2019).	Synthetic surfactin analogues have improved anti-PEDV properties	
DRAMP37436	EVLL 	4	SLP4	No entry found	Coronaviridae	Not Available	Synthetic Construct(derived from Bacillus subtilis)	Antimrobial; Antiviral	Not Available				Inhibiting viral membrane fusion	[Ref:30973929] PEDV: EC50 5.4 ± 0.4 μg/ml	[Ref:30973929] high hemolytic activity  	Linear	palmitoylation	Amination		L	[Ref:30973929] CC50: 12.9 ± 0.2 μg/ml	Membrane	30973929	PloS one, 14(4), e0215227.	Yuan, L., Zhang, S., Peng, J., Li, Y., & Yang, Q. (2019).	Synthetic surfactin analogues have improved anti-PEDV properties	
DRAMP37437	EVLADLV 	7	SLP1	No entry found	Coronaviridae	Not Available	Synthetic Construct(derived from Bacillus subtilis)	Antimrobial; Antiviral	Not Available				Inhibiting viral membrane fusion	[Ref:30973929] PEDV: EC50 8.0 ± 0.3 μg/ml	[Ref:30973929] Low Hemolytic Activity	Linear	palmitoylation	Amination		L	[Ref:30973929] CC50: 52.6 ± 2.3 μg/ml	Membrane	30973929	PloS one, 14(4), e0215227.	Yuan, L., Zhang, S., Peng, J., Li, Y., & Yang, Q. (2019).	Synthetic surfactin analogues have improved anti-PEDV properties	
DRAMP37438	EVLDLV 	6	SLP2	No entry found	Coronaviridae	Not Available	Synthetic Construct(derived from Bacillus subtilis)	Antimrobial; Antiviral	Not Available				Inhibiting viral membrane fusion	[Ref:30973929] PEDV; EC50 5.3 ± 0.5 μg/ml	[Ref:30973929] Low Hemolytic Activity	Linear	palmitoylation	Amination		L	[Ref:30973929] CC50: 33.0 ± 1.6 μg/ml	Membrane	30973929	PloS one, 14(4), e0215227.	Yuan, L., Zhang, S., Peng, J., Li, Y., & Yang, Q. (2019).	Synthetic surfactin analogues have improved anti-PEDV properties	
DRAMP37439	EVLADL	6	Surfactin	No entry found	Coronaviridae	Not Available	Synthetic Construct(derived from Bacillus subtilis)	[Ref:30973929] PEDV; EC50 11.4 ± 0.7 μg/ml	Not Available				surfactin exerts its antiviral effects by inhibiting viral membrane fusion.  Membrane fusion between the viral envelope and the cell membrane is essential for enveloped viruses to invade host cells. Surfactin can act directly on virus particles by insertion into the viral envelopes’ lipid bilayer and thereby reduce the membrane fusion rate.	[Ref:30973929] PEDV; EC50 11.4 ± 0.7 μg/ml	[Ref:30973929] Low Hemolytic Activity	Linear	palmitoylation	Free		L	[Ref:30973929] CC50:45.9 ± 0.9 μg/ml	Membrane	30973929	PloS one, 14(4), e0215227.	Yuan, L., Zhang, S., Peng, J., Li, Y., & Yang, Q. (2019).	Synthetic surfactin analogues have improved anti-PEDV properties	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP37440	KLTILNKDGILRSVILSFN	19	Scrambled-2	No entry found	Arenaviridae	GPC	Synthetic Construct (AVP-p scrambled form)	[Ref.24850726]JUNV:demonstrated some inhibitory activity. 	Not Available				Fusion inhibitor, deployment of fusion machinery by the peptide could render virions less able to engage in on-pathway receptor binding or endosomal fusion	[Ref.24850726]JUNV:demonstrated some inhibitory activity. 	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	[Ref.24850726]no acute cytotoxicity	Membrane	24850726	Journal of virology, 88(15), 8556–8564.	Spence, J. S., Melnik, L. I., Badani, H., Wimley, W. C., & Garry, R. F. (2014).	Inhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H](C)CC)C(C)C
DRAMP37441	VNKKIEEIDKKIEELNKKLEELEKKLEEVNKK	32	NOVEL-2	No entry found	Paramyxoviridae	HR1, HR2	Synthetic Construct	[Ref. 21601229]NDV : Inhibition by NOVEL-1 and NOVEL-2 (~90% inhibition at 5 μM, plaque formation inhibition at 25 μM).##IBV:Inhibition by NOVEL-1 and NOVEL-2 (~90% inhibition at 5 μM, plaque formatio	Not Available				Entry inhibition	[Ref. 21601229]NDV : Inhibition by NOVEL-1 and NOVEL-2 (~90% inhibition at 5 μM, plaque formation inhibition at 25 μM).##IBV:Inhibition by NOVEL-1 and NOVEL-2 (~90% inhibition at 5 μM, plaque formation inhibition at 26 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Spike Protein	21601229	Virology, 416(1-2), 65–74.	Wang, X. J., Li, C. G., Chi, X. J., & Wang, M. (2011).	Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O
DRAMP37442	TLTTKLY	7	TLTTKLY	No entry found	Paramyxoviridae	Not Available	Synthetic Construct	[Ref. 12021868]NDV: Inhibition of hemolytic activity and viral propagation in embryonated chicken eggs. Inhibition of phage binding with the same sequence.	Not Available				Entry inhibition	[Ref. 12021868]NDV: Inhibition of hemolytic activity and viral propagation in embryonated chicken eggs. Inhibition of phage binding with the same sequence.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Spike Protein	 12021868##16377031	Archives of virology, 147(5), 981–993;## Peptides, 27(6), 1217–1225.	Ramanujam, P., Tan, W. S., Nathan, S., & Yusoff, K. (2002);##Chia, S. L., Tan, W. S., Shaari, K., Abdul Rahman, N., Yusoff, K., & Satyanarayanajois, S. D. (2006).	Novel peptides that inhibit the propagation of Newcastle disease virus;##Structural analysis of peptides that interact with Newcastle disease virus	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP37443	CTLTTKLYC	9	CTLTTKLYC	No entry found	Paramyxoviridae	Not Available	Synthetic Construct	[Ref. 12021868]NDV: Inhibition of hemolytic activity and viral propagation in embryonated chicken eggs. Inhibition of phage binding with the same sequence.	Not Available				Entry inhibition	[Ref. 12021868]NDV: Inhibition of hemolytic activity and viral propagation in embryonated chicken eggs. Inhibition of phage binding with the same sequence.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Spike Protein	 12021868##16377031	Archives of virology, 147(5), 981–993;## Peptides, 27(6), 1217–1225.	Ramanujam, P., Tan, W. S., Nathan, S., & Yusoff, K. (2002);##Chia, S. L., Tan, W. S., Shaari, K., Abdul Rahman, N., Yusoff, K., & Satyanarayanajois, S. D. (2006).	Novel peptides that inhibit the propagation of Newcastle disease virus;##Structural analysis of peptides that interact with Newcastle disease virus	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)O
DRAMP37444	NASDMEIKKVNKKIEEYIKKIEEVEKKLEEVNKK	34	NOVEL-1	No entry found	Paramyxoviridae	HR1, HR2	Synthetic Construct	[Ref. 21601229]NDV:Inhibition by NOVEL-1 and NOVEL-2 (~90% inhibition at 5 μM, plaque formation inhibition at 25 μM).##IBV:Inhibition by NOVEL-1 and NOVEL-2 (~90% inhibition at 5 μM, plaque formation 	Not Available				Entry inhibition, The novel peptides completely inhibited single virus infections and mixed infections caused by NDV and IBV. Furthermore, we assessed cell toxicity and possible targets for the peptides, thereby strengthening the notion that HR2 is an attractive site for therapeutic intervention. These results suggest the possibility of designing a relatively broad-spectrum class of antiviral peptides that can reduce the effects of mixed-infections. The novel peptides completely inhibited single virus infections and mixed infections caused by NDV and IBV. Furthermore, we assessed cell toxicity and possible targets for the peptides, thereby strengthening the notion that HR2 is an attractive site for therapeutic intervention. These results suggest the possibility of designing a relatively broad-spectrum class of antiviral peptides that can reduce the effects of mixed-infections.The novel peptides completely inhibited single virus infections and mixed infections caused by NDV and IBV. Furthermore, we assessed cell toxicity and possible targets for the peptides, thereby strengthening the notion that HR2 is an attractive site for therapeutic intervention. These results suggest the possibility of designing a relatively broad-spectrum class of antiviral peptides that can reduce the effects of mixed-infections.The novel peptides completely inhibited single virus infections and mixed infections caused by NDV and IBV. Furthermore, we assessed cell toxicity and possible targets for the peptides, thereby strengthening the notion that HR2 is an attractive site for therapeutic intervention. These results suggest the possibility of designing a relatively broad-spectrum class of antiviral peptides that can reduce the effects of mixed-infections.The novel peptides completely inhibited single virus infections and mixed infections caused by NDV and IBV. Furthermore, we assessed cell toxicity and possible targets for the peptides, thereby strengthening the notion that HR2 is an attractive site for therapeutic intervention. These results suggest the possibility of designing a relatively broad-spectrum class of antiviral peptides that can reduce the effects of mixed-infections.The novel peptides completely inhibited single virus infections and mixed infections caused by NDV and IBV. Furthermore, we assessed cell toxicity and possible targets for the peptides, thereby strengthening the notion that HR2 is an attractive site for therapeutic intervention. These results suggest the possibility of designing a relatively broad-spectrum class of antiviral peptides that can reduce the effects of mixed-infections.	[Ref. 21601229]NDV:Inhibition by NOVEL-1 and NOVEL-2 (~90% inhibition at 5 μM, plaque formation inhibition at 25 μM).##IBV:Inhibition by NOVEL-1 and NOVEL-2 (~90% inhibition at 5 μM, plaque formation inhibition at 25μM).	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Spike Protein	21601229	Virology, 416(1-2), 65–74.	Wang, X. J., Li, C. G., Chi, X. J., & Wang, M. (2011).	Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)[C@H](C)CC)[C@H](C)CC
DRAMP37445	YKYRYL 	6	BD-11b	P03518	Coronaviridae	S1 Protein	S protein of SARS-CoV	[Ref.22265858]SARS-CoV:14 mM (IC90) Vero Ex cells, 7 mM (IC90) CaCo2 cells	Not Available				Block attachment to the host cells	[Ref.22265858]SARS-CoV:14 mM (IC90) Vero Ex cells, 7 mM (IC90) CaCo2 cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Found	22265858	Antiviral research, 94(3), 288–296.	Struck, A. W., Axmann, M., Pfefferle, S., Drosten, C., & Meyer, B. (2012)	A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
DRAMP37446	WNFFDWFSGLMSWFGGPLK	19	RVFV-6	No entry found	Nil	GP	Synthetic Construct	Antimrobial; Antiviral	Not Available			4HJ1	Fusion inhibitor	Not Avaialble	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Found	24069485	PLoS neglected tropical diseases, 7(9), e2430. 	Koehler, J. W., Smith, J. M., Ripoll, D. R., Spik, K. W., Taylor, S. L., Badger, C. V., Grant, R. J., Ogg, M. M., Wallqvist, A., Guttieri, M. C., Garry, R. F., & Schmaljohn, C. S. (2013).	A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses	
DRAMP37447	LEAIPCSIPPEFLFGKPFVFLEAIPCSIPPEFLFGKPFVF	40	VIR-576	P59594	Retroviridae	E2 Protein	Synthetic Construct	Not Avaialble	Not Available			2L6S## 2L6T	Not Available	Not Avaialble	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Spike Protein	21543477##17448989##21178138	Journal of virology, 85(14), 7037–7047## Cell, 129(2), 263–275 ## Science translational medicine, 2(63), 63re3.	Koedel, Y., Eissmann, K., Wend, H., Fleckenstein, B., & Reil, H. (2011)## Münch, J., Ständker, L., Adermann, K., Schulz, A., Schindler, M., Chinnadurai, R., Pöhlmann, S., Chaipan, C., Biet, T., Peters, T., Meyer, B.,##  Wilhelm, D., Lu, H., Jing, W., Jiang, S., Forssmann, W. G., & Kirchhoff, F.## Forssmann, W. G., The, Y. H., Stoll, M., Adermann, K., Albrecht, U., Tillmann, H. C., Barlos, K., Busmann, A., Canales-Mayordomo, A., Giménez-Gallego, G., Hirsch, J., Jiménez-Barbero, J., Meyer-Olson, D	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition## Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide##Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC
DRAMP37448	CANLLLQYGSFCTQLNRALSGIA	23	P9	No entry found	Coronaviridae	S2 (918758), 	synthetic Construct (Derived from SARS-CoV: 694009))	Not Avaialble	Not Available			7SG4	P9 themselves can markedly inhibit syncytia formation	Not Avaialble	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Spike Protein	15811330	Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential	Lu, W., Wu, X. D., Shi, M. D., Yang, R. F., He, Y. Y., Bian, C., Shi, T. L., Yang, S., Zhu, X. L., Jiang, W. H., Li, Y. X., Yan, L. C., Ji, Y. Y., Lin, Y., Lin, G. M., Tian, L., Wang, J., Wang, H. X., Xie, Y. H., Pei, G., … Sun, B. (2005).	FEBS letters, 579(10), 2130–2136.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)O
DRAMP37449	RTILLFIGVKDLLKNSNSI	19	Scrambled-1	P59594	Arenaviridae	GPC	Synthetic Construct  (AVP-p scrambled form)	[Ref.24850726]JUNV:demonstrated some inhibitory activity	Not Available				Fusion inhibitor, deployment of fusion machinery by the peptide could render virions less able to engage in on-pathway receptor binding or endosomal fusion	[Ref.24850726]JUNV:demonstrated some inhibitory activity	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	[Ref.24850726]no acute cytotoxicity	Membrane	24850726	Journal of virology, 88(15), 8556–8564.	Spence, J. S., Melnik, L. I., Badani, H., Wimley, W. C., & Garry, R. F. (2014).	Inhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(C)C)C(=O)O
DRAMP37450	RNTREVFAQVKQMYKTPTLKYFG	23	P10	U5WLK5##P59594	Coronaviridae	S2 (918758), 	synthetic Construct (Derived from SARS-CoV: 694009)	Antimrobial; Antiviral	Not Available			5XJK	P10 antisera had specific binding to the S fragments and S protein expressed in E. coli and SARS‐CoV infected cell lysates, suggesting that those Abs have a potential to recognize S protein of SARS‐CoV in its natural form	Not Avaialble	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Spike Protein	15811330	Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential. FEBS letters, 579(10), 2130–2136. https://doi.org/10.1016/j.febslet.2005.02.070	Xia, S., Liu, M., Wang, C., Xu, W., Lan, Q., Feng, S., Qi, F., Bao, L., Du, L., Liu, S., Qin, C., Sun, F., Shi, Z., Zhu, Y., Jiang, S., & Lu, L. (2020)	Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential	
DRAMP37451	PSSKRFQPFQQFGRDVSDFTDSVRDPKTSE	30	PL8	No entry found	Coronaviridae	S2 (918758)	Synthetic construct	Not Avaialble	Not Available			8WLY##5WRG## 5XLR## 6M3W	P8 antisera had specific binding to the S fragments and S protein expressed in E. coli and SARS‐CoV infected cell lysates, suggesting that those Abs have a potential to recognize S protein of SARS‐CoV in its natural form	Not Avaialble	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Spike Protein	15811330	FEBS letters, 579(10), 2130–2136. 	Xia, S., Liu, M., Wang, C., Xu, W., Lan, Q., Feng, S., Qi, F., Bao, L., Du, L., Liu, S., Qin, C., Sun, F., Shi, Z., Zhu, Y., Jiang, S., & Lu, L. (2020)	Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential	CC(C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O
DRAMP37452	ARLPRTMV	8	Pal M1	No entry found	Orthomyxoviridae	Not Available	Synthetic Construct	No activity information or data found in the reference(s) presented in this entry	Not Available				Not Available	No activity information or data found in the reference(s) presented in this entry	No hemolysis information or data found in the reference(s) presented in this entry	micelle	C16	Free		L	No cytotoxicity information found in the reference(s) presented	HA	23777281	BMC biotechnology, 13, 51.	Hüttl, C., Hettrich, C., Miller, R., Paulke, B. R., Henklein, P., Rawel, H., & Bier, F. F. (2013)	Self-assembled peptide amphiphiles function as multivalent binder with increased hemagglutinin affinity	CCCCCCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O
DRAMP37453	ARLPR	5	Pal S1	No entry found	Orthomyxoviridae	Not Available	Synthetic Construct	No activity information or data found in the reference(s) presented in this entry	Not Available				Not Available	No activity information or data found in the reference(s) presented in this entry	No hemolysis information or data found in the reference(s) presented in this entry	micelle	C16	Free		L	No cytotoxicity information found in the reference(s) presented	HA	23777281	BMC biotechnology, 13, 51.	Hüttl, C., Hettrich, C., Miller, R., Paulke, B. R., Henklein, P., Rawel, H., & Bier, F. F. (2013)	Self-assembled peptide amphiphiles function as multivalent binder with increased hemagglutinin affinity	CCCCCCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP37454	ARLPRTMVHPKPAQP	15	C18-s2	No entry found	Orthomyxoviridae	Not Available	Synthetic Construct	Antimrobial; Antiviral	Not Available				Not Available	[Ref:20476787]C17H35CO-ARLPRTMV-NH2:Inhibition of influenza A/H1N1/Puerto Rico/8/34 virus (IC50=3.0 and 1.9 μM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	C17H35CO	Amidation		L	No cytotoxicity information found in the reference(s) presented	Membrane	36232735##20476787	International journal of molecular sciences, 23(19), 11433##Journal of medicinal chemistry, 53(11), 4441–4449	Agamennone, M., Fantacuzzi, M., Vivenzio, G., Scala, M. C., Campiglia, P., Superti, F., & Sala, M. (2022)##Matsubara, T., Onishi, A., Saito, T., Shimada, A., Inoue, H., Taki, T., Nagata, K., Okahata, Y., & Sato, T. (2010).	Antiviral Peptides as Anti-Influenza Agents##Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy	
DRAMP37455	LVLQTM	6	LVLQTM	No entry found	Picornaviridae	RBM6Δ6 protein	Derived from the very C terminus of the RBM6Δ6 protein 	[Ref:22072773]LVLQTM peptide:Effective substrate analogue of EV-71 2A(pro) (Kd=9.6 μM);Inhibition of eIF4G cleavage activity of 2A(pro);Inhibition of EV-71 replication in HeLa cells.	Not Available				peptide inhibited the activity of protease 2 A, which plays several essential roles during viral replication, by coupling in the active site of this enzyme. The in vitro assay with A549 cells and the in vivo assay with mice demonstrated viral replication inhibition	[Ref:22072773]LVLQTM peptide:Effective substrate analogue of EV-71 2A(pro) (Kd=9.6 μM);Inhibition of eIF4G cleavage activity of 2A(pro);Inhibition of EV-71 replication in HeLa cells.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Available	22072773##22865380	Journal of virology, 86(2), 691–704;##The Journal of antimicrobial chemotherapy, 67(12), 2865–2869.	Falah, N., Violot, S., Décimo, D., Berri, F., Foucault-Grunenwald, M. L., Ohlmann, T., Schuffenecker, I., Morfin, F., Lina, B., Riteau, B., & Cortay, J. C. (2012);##Falah, N., Montserret, R., Lelogeais, V., Schuffenecker, I., Lina, B., Cortay, J. C., & Violot, S. (2012).	Ex Vivo and In Vivo Inhibition of Human Rhinovirus Replication by a New Pseudosubstrate of Viral 2A Protease;##Blocking human enterovirus 71 replication by targeting viral 2A protease	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP37456	KREHGQHCEF	10	SU2	A0A1P8CXN4	Retroviridae	Not Available	Purified from R. paludosa extract	[Ref:17113195]HIV-1:IC50=11µM	Not Available				Not Available	[Ref:17113195]HIV-1:IC50=11µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Available	17113195	Peptides, 28(3), 560–565.	Wang, J., Wang, H. X., & Ng, T. B. (2007).	A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa	N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP37457	EGVKSKLNIVCNEIGLLKSLCRKFVNSHIW	30	Nk-lysin	No entry found	Rhabdoviridae	SMAX5B_000299	Synthetic Construct	[Ref:30717094]SVCV:IC50= 24.69 µg/mL²	Not Available				Nkl71-100exerts strong antiviral activity against spring viremia of carp virus (SVCV) by inhibiting not only the binding of viral particles to host cells, but also the fusion of virus and cell membranes, which requires a low pH context. Such antiviral activity seems to be related to the important role that PS plays in these steps of the replication cycle of SVCV, a feature that is shared by other families of virus-comprising members with health and veterinary relevance. Consequently, Nkl71⁻100 is shown as a promising broad-spectrum antiviral candidate. it was observed that Nkl71–100 alters the binding ability of SVCV to cell membranes since virus-cell binding levels significantly decreased in the presence of peptide in comparison to what it is observed in its absence.	[Ref:30717094]SVCV:IC50= 24.69 µg/mL²	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:30717094]No significant toxic effect at concentrations <32 μM (84.5 ± 1.9% viability);Severe viability drop at higher concentrations.	Membrane	30717094	Marine drugs, 17(2), 87.	Falco, A., Medina-Gali, R. M., Poveda, J. A., Bello-Perez, M., Novoa, B., & Encinar, J. A. (2019).	Antiviral Activity of a Turbot (Scophthalmus maximus) NK-Lysin Peptide by Inhibition of Low-pH Virus-Induced Membrane Fusion	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)O
DRAMP37458	SPATAFTVYVFCFLL	15	E5-type 18	No entry found	Papillomaviridae	Not Available	Synthetic Construct	Antimrobial; Antiviral	Not Available				E5-type 18 (SPATAFTVYVFCFLL) and E7-type 45 (TLQEIVLHLEPQNELDPVDLL) peptides presented the best results for inducing the production of IFN-γ, an essential cytokine in intracellular immunity against HPV infection.	No activity information or data found in the reference(s) presented in this entry	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not inlcuded yet	No cytotoxicity information found in the reference(s) presented	Not Available	31915962##35853393	Biotechnology letters, 42(3), 403–418.;##Colloids and surfaces. B, Biointerfaces, 217, 112693.	Namvar, A., Panahi, H. A., Agi, E., & Bolhassani, A. (2020);##Freitas, E. D., Bataglioli, R. A., Oshodi, J., & Beppu, M. M. (2022).	Development of HPV16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools;##Antimicrobial peptides and their potential application in antiviral coating agents	
DRAMP37459	TLQEIVLHLEPQNELDPVDLL	21	E7-type 45	No entry found	Papillomaviridae	Not Available	Synthetic Construct	Antimrobial; Antiviral	Not Available				E5-type 18 (SPATAFTVYVFCFLL) and E7-type 45 (TLQEIVLHLEPQNELDPVDLL) peptides presented the best results for inducing the production of IFN-γ, an essential cytokine in intracellular immunity against HPV infection.	No activity information or data found in the reference(s) presented in this entry	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	No cytotoxicity information found in the reference(s) presented	Not Available	31915962##35853393	Biotechnology letters, 42(3), 403–418.;##Colloids and surfaces. B, Biointerfaces, 217, 112693.	Namvar, A., Panahi, H. A., Agi, E., & Bolhassani, A. (2020);##Freitas, E. D., Bataglioli, R. A., Oshodi, J., & Beppu, M. M. (2022).	Development of HPV16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools;##Antimicrobial peptides and their potential application in antiviral coating agents	
DRAMP37460	DHVTPDIAYNPRTMY	15	Peptide-1	No entry found	Flaviviridae	Not Available	Acacia catechu extract	Antimrobial; Antiviral	Not Available				Not Available	No activity information or data found in the reference(s) presented in this entry	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	No cytotoxicity information found in the reference(s) presented	Not Available	30225997	Chemical biology & drug design, 93(2), 100–109.	Panya, A., Yongpitakwattana, P., Budchart, P., Sawasdee, N., Krobthong, S., Paemanee, A., Roytrakul, S., Rattanabunyong, S., Choowongkomon, K., & Yenchitsomanus, P. T. (2019). 	Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu	
DRAMP37461	DHVTPDIAYNPWAFY	15	Peptide-3	No entry found	Flaviviridae	Not Available	Acacia catechu extract	Antimrobial; Antiviral	Not Available				Not Available	No activity information or data found in the reference(s) presented in this entry	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	No cytotoxicity information found in the reference(s) presented	Not Available	30225997	Chemical biology & drug design, 93(2), 100–109.	Panya, A., Yongpitakwattana, P., Budchart, P., Sawasdee, N., Krobthong, S., Paemanee, A., Roytrakul, S., Rattanabunyong, S., Choowongkomon, K., & Yenchitsomanus, P. T. (2019). 	Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu	
DRAMP37462	Not reported	0	Acacia catechu extract	P26436##P59594	Flaviviridae	Not Available	Natural Construct((isolated from digest of thai medicinal plants) )	Antimrobial; Antiviral	Not Available				Not Available	[Ref:30225997] DENV:IC50 values of 0.18 µg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Not included yet	Not included yet	Not included yet	Not included yet	Not included yet	[Ref:30225997]No toxicity was observed at the peptide concentration between 0.01 µM and 1mM.	Not Available	30225997	Chemical biology & drug design, 93(2), 100–109.	Panya, A., Yongpitakwattana, P., Budchart, P., Sawasdee, N., Krobthong, S., Paemanee, A., Roytrakul, S., Rattanabunyong, S., Choowongkomon, K., & Yenchitsomanus, P. T. (2019).	Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu	
DRAMP37463	CDIPIGAGICAS	12	SP-10-1	P26436##P59594	Coronaviridae	S2(MAX5B_000299)	Synthetic Construct(derived from SARS-CoV S protein)	[Ref:16337697] SARS-CoV IC50= >20µg/mL	Not Available			1WNC##1ZV7	Acts as a viral fusion peptide which is unmasked following S2 cleavage occurring upon virus endocytosis.	[Ref:16337697] SARS-CoV IC50= >20µg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ACE2	16337697	Antiviral research, 69(2), 70–76.	Ho, T. Y., Wu, S. L., Chen, J. C., Wei, Y. C., Cheng, S. E., Chang, Y. H., Liu, H. J., & Hsiang, C. Y. (2006)	Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H](N)CS)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)O
DRAMP37464	YHTVSLLRSTSQ	12	SP-10-2	P26436##P59594	Coronaviridae	S2(MAX5B_000299)	Synthetic Construct(derived from SARS-CoV S protein)	[Ref:16337697] SARS-CoV IC50=6.21 ± 2.13µg/mL	Not Available			1WNC##1ZV8	Acts as a viral fusion peptide which is unmasked following S2 cleavage occurring upon virus endocytosis.	[Ref:16337697] SARS-CoV IC50=6.21 ± 2.13µg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ACE2	16337697	Antiviral research, 69(2), 70–76.	Ho, T. Y., Wu, S. L., Chen, J. C., Wei, Y. C., Cheng, S. E., Chang, Y. H., Liu, H. J., & Hsiang, C. Y. (2006)	Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O
DRAMP37465	SLLRSTSQKSIV	12	SP-10-3	P26436##P59594	Coronaviridae	S2(MAX5B_000299)	Synthetic Construct(derived from SARS-CoV S protein)	[Ref:16337697] SARS-CoV IC50=5.47 ± 0.41µg/mL	Not Available			1WNC##1ZV9	Acts as a viral fusion peptide which is unmasked following S2 cleavage occurring upon virus endocytosis.	[Ref:16337697] SARS-CoV IC50=5.47 ± 0.41µg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ACE2	16337697	Antiviral research, 69(2), 70–76.	Ho, T. Y., Wu, S. L., Chen, J. C., Wei, Y. C., Cheng, S. E., Chang, Y. H., Liu, H. J., & Hsiang, C. Y. (2006)	Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37466	KSIVAYTMSLGA	12	SP-10-4	P26436##P59594	Coronaviridae	S2(MAX5B_000299)	Synthetic Construct(derived from SARS-CoV S protein)	[Ref:16337697] SARS-CoV IC50=2.07 ± 1.01µg/mL	Not Available			1WNC##1ZV11	Acts as a viral fusion peptide which is unmasked following S2 cleavage occurring upon virus endocytosis.	[Ref:16337697] SARS-CoV IC50=2.07 ± 1.01µg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ACE2	16337697	Antiviral research, 69(2), 70–76.	Ho, T. Y., Wu, S. L., Chen, J. C., Wei, Y. C., Cheng, S. E., Chang, Y. H., Liu, H. J., & Hsiang, C. Y. (2006)	Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
DRAMP37467	AYTMSLGADSSI	12	SP-10-5	L0L3V3	Coronaviridae	S2(MAX5B_000299)	Synthetic Construct(derived from SARS-CoV S protein)	[Ref:16337697] SARS-CoV IC50=>20µg/mL	Not Available			1WNC##1ZV12	Acts as a viral fusion peptide which is unmasked following S2 cleavage occurring upon virus endocytosis.	[Ref:16337697] SARS-CoV IC50=>20µg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	ACE2	16337697	Antiviral research, 69(2), 70–76.	Ho, T. Y., Wu, S. L., Chen, J. C., Wei, Y. C., Cheng, S. E., Chang, Y. H., Liu, H. J., & Hsiang, C. Y. (2006)	Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)O
DRAMP37468	GLVGTLLGHIGKAILGG	17	Frenatin 2.3S	No entry found	Flaviviridae	Not Available	The Orinoco lime treefrog, Sphaenorhynchus lacteus, South America	[Ref:27049440]YFV: 35% protective effect in Vero E6 cells at 20 µg/ml	Not Available				Not Available	[Ref:27049440]YFV: 35% protective effect in Vero E6 cells at 20 µg/ml	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	[Ref:27049440]VeroE6: No cytotoxicity at 100 µg/ml	Not Found	27049440	The Journal of antibiotics, 69(11), 783–790.	Muñoz-Camargo, C., Méndez, M. C., Salazar, V., Moscoso, J., Narváez, D., Torres, M. M., Florez, F. K., Groot, H., & Mitrani, E. (2016).	Frog skin cultures secrete anti-yellow fever compounds	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)O
DRAMP37469	GSKKPVPIIYCNRRTGKCQRI 	21	SB1	No entry found	Retroviridae	Not Available	De novo designed	Antimrobial; Antiviral	Not Available				Not Available	[Ref:Not Available]HIV,HSV: EC50=13.1 µg/ml in CEM-SS cells, 64.9 µg/ml in Vero cells (HSV)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	C11-C18 disulfide linkage	L	TC50:>100  µg/ml in CEM-SS Cells,  >100 µg/ml in Vero Cells (HSV)	Not Found	Not Avaialbe	Reginald et al. J AIDS Clinic Res 2011, S11	Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2020	De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures	
DRAMP37470	MAVLGDTAWDFGSVGGALNSLGKGIHQIFGAAF	33	Z2	No entry found	Flaviviridae	Not Available	synthetic peptide derived from the stem region of ZIKV envelope protein	[Ref:28742068]ZIKV: IC50=1.75±0.13 µM in BHK21 cells, 3.69±0.27 µM in Vero cells; plaque assay IC50=2.61±0.46 µM	Not Available				The mechanism by which a peptide derived from the stem region of a flavivirus can inhibit infection by a broad spectrum of flaviviruses remains a point of controversy. It was reported that DN59, a 33-mer peptide that mimics a fragment of stem region of DENV E protein, acts like a disrupter of the DENV membrane, possibly inducing hole formation, leading to release of the viral genome. Z2 peptide could bind to the E protein of ZIKV and disrupt the integrity of ZIKV membrane, resulting in the inactivation of virions	[Ref:28742068]ZIKV: IC50=1.75±0.13 µM in BHK21 cells, 3.69±0.27 µM in Vero cells; plaque assay IC50=2.61±0.46 µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	E protein	28742068	Nat Commun 8, 15672 (2017)	Yu, Y., Deng, YQ., Zou, P. et al.	A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](C)NC(=O)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC
DRAMP37471	GSRRPVPIIYCNRRTGRCQRI 	21	SB2	No entry found	Retroviridae	Not Available	De novo designed	Antimrobial; Antiviral	Not Available				Not Available	Ref:Not Available]HIV,HSV: EC50=3.33 µg/ml in CEM-SS cells, >100 µg/ml in Vero cells (HSV)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	C11-C18 disulfide linkage	L	TC50:>100  µg/ml in CEM-SS Cells,  >100 µg/ml in Vero Cells (HSV)	Not Found	Not Avaialbe	Reginald et al. J AIDS Clinic Res 2011, S10	Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2019	De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures	
DRAMP37472	GCRRLLGRLLRRLGRLLCR	19	GLRC-1	No entry found	Retroviridae	Not Available	De novo designed	Antimrobial; Antiviral	Not Available				Not Available	[Ref:Not Available]HIV,HSV: EC50>100 µg/ml in CEM-SS cells, 30 µg/ml in Vero cells (HSV)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	C2-C18 disulfide linkage	L	TC50:59.2 µg/ml in CEM-SS Cells,  >100 µg/ml in Vero Cells (HSV)	Not Found	Not Avaialbe	Reginald et al. J AIDS Clinic Res 2011, S9	Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2018	De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures	
DRAMP37473	GLRCRLGRLLRRLGRCLLR	19	GLRC-2	No entry found	Retroviridae	Not Available	De novo designed	Antimrobial; Antiviral	Not Available				Not Available	[Ref:Not Available]HIV,HSV: EC50=1.81 µg/ml in CEM-SS cells, 5.43 µg/ml in Vero cells (HSV)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	C4-C16 disulfide linkage	L	TC50: 17.8 µg/ml in  CEM-SS cells, 31.8 µg/ml in Veo Cells	Not Found	Not Avaialbe	Reginald et al. J AIDS Clinic Res 2011, S8	Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2017	De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures	
DRAMP37474	GLRRLCGRLGRRLCRLLLR	19	GLRC-3	No entry found	Retroviridae	Not Available	De novo designed	Antimrobial; Antiviral	Not Available				Not Available	[Ref:Not Available]HIV,HSV: EC50=6.37 µg/ml in CEM-SS cells (HIV), 15 µg/ml in Vero cells (HSV)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	C6-C14  disulfide linkage	L	18.5 µg/ml in CEM-SS cells,  62.3 µg/ml in Vero Cells (HSV)	Not Found	Not Avaialbe	Reginald et al. J AIDS Clinic Res 2011, S7	Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2016	De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures	
DRAMP37475	GCRRLCGRLGRRLCRLLCR 	19	GLRC_4	No entry found	Retroviridae	Not Available	De novo designed	Antimrobial; Antiviral	Not Available				Not Available	[Ref:Not Available]HSV: EC50=69.3 µg/ml in CEM-SS cells, 64.7 µg/ml in Vero cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	C2-C18, C6-C14  disulfide linkage	L	TC50: >100 µg/ml in CEM-SS cells, TC50: >100 µg/ml in Vero Cells (HSV)	Not Found	Not Avaialbe	Reginald et al. J AIDS Clinic Res 2011, S6	Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2015	De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures	
DRAMP37476	GLRCRLGRLLRRLGRC	16	GLRC-5	No entry found	Retroviridae	Not Available	De novo designed	Antimrobial; Antiviral	Not Available				Not Available	[Ref:Not Available]HIV: EC50>100 µg/ml in CEM-SS cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	C4-C16 disulfide linkage	L	TC50: 59.5 µg/ml  in CEM-SS cells 	Not Found	Not Avaialbe	Reginald et al. J AIDS Clinic Res 2011, S5	Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2014	De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures	
DRAMP37477	GLRCLRLRGRLRLGRCLLR	19	GLRC-8	No entry found	Retroviridae	Not Available	De novo designed	Antimrobial; Antiviral	Not Available				Not Available	[Ref:Not Available]HIV: EC50>100 µg/ml in CEM-SS cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	C4-C16 disulfide linkage	L	TC50:31 µg/ml  in CEM-SS cells 	Not Found	Not Avaialbe	Reginald et al. J AIDS Clinic Res 2011, S3	Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2012	De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures	
DRAMP37478	CRLGRLLRRLGRC	13	GLRC-7	No entry found	Retroviridae	Not Available	De novo designed	Antimrobial; Antiviral	Not Available				Not Available	[Ref:Not Available]HIV: EC50>100 µg/ml in CEM-SS cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	C1-C13 disulfide linkage	L	TC50: >100 µg/ml  in CEM-SS cells 	Not Found	Not Avaialbe	Reginald et al. J AIDS Clinic Res 2011, S4	Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2013	De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures	
DRAMP37479	CRLGRLLRRLGRCLLR	16	GLRC-6	No entry found	Retroviridae	Not Available	De novo designed	Antimrobial; Antiviral	Not Available				Not Available	[Ref:Not Available]HIV: EC50=7.72 µg/ml in CEM-SS cells (T2:T27)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	hairpin structure with a single disulfide bond (C11-C18) between the two strands	L	TC50:41.9 (µg/ml)  in CEM-SS cells.	Not Found	Not Avaialbe	Reginald et al. J AIDS Clinic Res 2011, S2	Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2011	De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures	
DRAMP37480	GIGAVLKYLTTGLPALISWIKRKROQ	26	Melittin of bee venom	O15263	Coronaviridae	Not Available	Bee Venom	Antimrobial; Antiviral	Not Available				Melittin disrupts viral membranes, activates Toll-like receptors to reduce inflammatory cytokines, suppresses metabolic regulators like transketolase, and activates host RNA-binding proteins,	[Ref:33652894]SARS-CoV-2: Sitagliptin and melittin-nanoconjugates complex exhibited significant antiviral activity (IC50 = 8.439 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:34261542]C654 cells: Melittin CC50 = 6.45 µg/mL.	Membrane	35236909	Scientific reports, 12(1), 3446	Enayathullah, M. G., Parekh, Y., Banu, S., Ram, S., Nagaraj, R., Kumar, B. K., & Idris, M. M	Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection	
DRAMP37481	GAICHPVFCPRRYKQIGTCGLPGTKCCKKP	30	4H30	No entry found	Coronaviridae	DEFB4A(100289462)	human beta-defensin 2 (HBD2)	[Ref:35768416]SARS-CoV-2: 4H30 significantly inhibited infection (IC50 = 0.59 µg/mL or 44 nM).	Not Available			1FD3	4H30 can inhibit three distinct steps of the SARS-CoV-2 life cycle. Specifically, 4H30 blocks viral entry by clustering SARS-CoV-2 virions; prevents membrane fusion by inhibiting endosomal acidification; and inhibits the release of virions by cross-linking SARS-CoV-2 with cellular glycosaminoglycans.	[Ref:35768416]SARS-CoV-2: 4H30 significantly inhibited infection (IC50 = 0.59 µg/mL or 44 nM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:35768416]Vero E6, Calu-3: TC50 > 400 µg/mL.	Lipid Bilayer	35768416	Cell Discov. 2022 Jun 30;8(1):62	Zhao H, To KK, Lam H, Zhang C, Peng Z, Meng X, Wang X, Zhang AJ, Yan B, Cai J, Yeung ML, Chan JF, Yuen KY	A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(C)C
DRAMP37482	LNCYWPLNDYGFYTTTGIGYK	21	S5	No entry found	Coronaviridae	Not Available	Synthetic construct	[Ref:38917689]SARS-CoV: S5 peptide targeted the binding site of SARS.-CoV-1  	Not Available				 All peptides (S2, S4, and S5) in this study bound to the ACE2 receptor and established a competitive inhibitory relationship with the RBD	[Ref:38917689]SARS-CoV: S5 peptide targeted the binding site of SARS.-CoV-1  	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not given	38917689	Virology, 597, 110149.	Liang, Z., Wang, J., Zhang, H., Gao, L., Xu, J., Li, P., Yang, J., Fu, X., Duan, H., Liu, J., Liu, T., Ma, W., & Wu, K.	Peptide S4 is an entry inhibitor of SARS-CoV-2 infection	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP37483	YNYLYRLFC	9	S2	No entry found	Coronaviridae	Not Available	Synthetic construct	[Ref:38917689]SARS-CoV-2: S2 and S4 peptides targeted the binding site of SARS-CoV-2  	Not Available				 All peptides (S2, S4, and S5) in this study bound to the ACE2 receptor and established a competitive inhibitory relationship with the RBD	[Ref:38917689]SARS-CoV-2: S2 and S4 peptides targeted the binding site of SARS-CoV-2  	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not given	38917689	Virology, 597, 110149.	Liang, Z., Wang, J., Zhang, H., Gao, L., Xu, J., Li, P., Yang, J., Fu, X., Duan, H., Liu, J., Liu, T., Ma, W., & Wu, K.	Peptide S4 is an entry inhibitor of SARS-CoV-2 infection	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O
DRAMP37484	FNCYFPLQSYGFQPTNGVGYK	21	S4	Q9Q0V0	Coronaviridae	Not Available	Synthetic construct	[Ref:38917689] PT (Vero E6): EC50 = 4.40 µM (TI = 163.68), BA.2 (Vero E6): EC50 = 4.87 µM (TI = 147.88), EG.5 (Vero E6): EC50 = 8.44 µM (TI = 85.33), XBB.1.16 (Vero E6): EC50 = 9.59 µM (TI = 75.10)	Not Available				peptide S4 inhibited the ACE2 receptor and competed with the HCoV-NL63 virus for binding while exhibiting good inhibitory activity against HCoV-NL63 infection.	[Ref:38917689] PT (Vero E6): EC50 = 4.40 µM (TI = 163.68), BA.2 (Vero E6): EC50 = 4.87 µM (TI = 147.88), EG.5 (Vero E6): EC50 = 8.44 µM (TI = 85.33), XBB.1.16 (Vero E6): EC50 = 9.59 µM (TI = 75.10)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:38917689]PT(Vero E6): CC₅₀=720.20 µM,BA.2 (Vero E6): CC₅₀=720.20 µM,EG.5 (Vero E6): CC₅₀= 720.20 µM,XBB.1.16 (Vero E6): CC₅₀= 720.20 µM,HEK293T: CC₅₀=730.20 µM,HEK293T/ACE2: CC₅₀=714.0 µM	Not given	38917689	Virology, 597, 110149.	Liang, Z., Wang, J., Zhang, H., Gao, L., Xu, J., Li, P., Yang, J., Fu, X., Duan, H., Liu, J., Liu, T., Ma, W., & Wu, K.	Peptide S4 is an entry inhibitor of SARS-CoV-2 infection	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O
DRAMP37485	ESGRIKKEEFAEIMKICSTIEELGRQK	27	PB1731–757	No entry found	Orthomyxoviridae	PB1(3654616)	Synthetic construct (derived from the C-terminus of PB1)	[Ref:23279951]IAV: PB1731–757 effectively blocked the replication of human influenza virus A/WSN/33 (H1N1)	Not Available			3J9B##8H69	PB1(731-757) is capable of inhibiting viral polymerase activity and viral replication.	[Ref:23279951]IAV: PB1731–757 effectively blocked the replication of human influenza virus A/WSN/33 (H1N1)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not given	23279951##23340380	The FEBS journal, 280(4), 1139–1149##Viruses, 5(1), 352–373	Li, C., Ba, Q., Wu, A., Zhang, H., Deng, T., & Jiang, T. (2013)##Jie Yang 1, Minmin Li, Xintian Shen, Shuwen Liu	A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly##Influenza A virus entry inhibitors targeting the hemagglutinin	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP37486	MERIKELRDLMSWSRTREILTKTTVDHMAIIKKYTSG	37	PB21-37	P01514	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Inhibit Viral Replication	[Ref:21867756]H1N1: IC50 = 375 nM 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The N-terminus of PB2 consists of 3 alpha-helices, one of which binds to 3 alpha-helices in the C-terminus of PB1 	L	No cytotoxicity information found in the reference(s) presented	Membrane	21867756	Methods (San Diego, Calif.), 55(2), 188–191.	Chase, G., Wunderlich, K., Reuther, P., & Schwemmle, M. (2011). I	Identification of influenza virus inhibitors which disrupt of viral polymerase protein-protein interactions	
DRAMP37487	FLPIIINLKALAALAKKIL	19	Mastoparan-MO	No entry found	Herpesviridae 	Not Available	Venom, Vespula lewisii	[Ref:38932240]Human alphaherpesvirus 1 (HSV-1): Inhibited entry (EC50 = 6.68 µM).	Not Available			6DUU)	Mastoparan-MO exhibited over 80% HSV-1 inhibition, with up to 99% viral replication inhibition, particularly in the early infection stages.	[Ref:38932240]Human alphaherpesvirus 1 (HSV-1): Inhibited entry (EC50 = 6.68 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation		L	[Ref:38932240]:CC50=>200 µg.mL−1	Membrane	38932240	Viruses. 2024 Jun 12;16(6)	Vilas Boas LCP, Buccini DF, Berlanda RLA, Santos BPO, Maximiano MR, Lião LM, Gonçalves S, Santos NC, Franco OL.	Antiviral Activities of Mastoparan-L-Derived Peptides against Human Alphaherpesvirus 1	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP37488	GFWFKGKWRFKKYRGGRYKKFRWKGKFWFG	30	PEP 19-8D	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	[Ref:24486207]Influenza virus: SALPs PEP 19-8D inhibited virus hemagglutination up to 75% depending on virus subtype and dilution	Not Available				Inhibit Virus Attachment and Virus-Cell Membrane Fusion	[Ref:24486207]Influenza virus: SALPs PEP 19-8D inhibited virus hemagglutination up to 75% depending on virus subtype and dilution	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	24486207	Antiviral research, 104, 23–33. 	Hoffmann, J., Schneider, C., Heinbockel, L., Brandenburg, K., Reimer, R., & Gabriel, G. (2014). 	A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment	N=C(N)NCCC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
DRAMP37489	GKKYRRFRWKFKGKWFWFG	19	PEP 19-4	P84272	Orthomyxoviridae	Not Available	Synthetic construct	[Ref:24486207]Influenza virus: SALPs inhibited virus hemagglutination up to 75% depending on virus subtype and dilution.	Not Available				Inhibit Virus Attachment and Virus-Cell Membrane Fusion	[Ref:24486207]Influenza virus: SALPs inhibited virus hemagglutination up to 75% depending on virus subtype and dilution.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	24486207	Antiviral research, 104, 23–33. 	Hoffmann, J., Schneider, C., Heinbockel, L., Brandenburg, K., Reimer, R., & Gabriel, G. (2014). 	A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
DRAMP37490	GLLASLGKVFGGYLAEKLKPK	21	Dahlein 5.6	No entry found	Retroviridae	Not Available	Litoria dahlii, Australia	[Ref:16140737]HIV: This peptide could inhibit HIV infection at a specific concentration.	Not Available				inhibit HIV infection at significantly lower concentrations than those required to affect the viability of the T cells.	[Ref:16140737]HIV: This peptide could inhibit HIV infection at a specific concentration.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Cell Membrane	16140737	Journal of virology, 79(18), 11598–11606.	VanCompernolle, S. E., Taylor, R. J., Oswald-Richter, K., Jiang, J., Youree, B. E., Bowie, J. H., Tyler, M. J., Conlon, J. M., Wade, D., Aiken, C., Dermody, T. S., KewalRamani, V. N., Rollins-Smith, L. A., & Unutmaz, D. (2005).	Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP37491	CGESCVFIPCITTVLGCSCSIKVCYKNGSIP	31	Cycloviolacin VY1	J2FTU4	Orthomyxoviridae	Not Available	Viola yedoensis	[Ref:25212039]Influenza A virus (H1N1): IC50 = 2.27 µg/mL.	Not Available				Not Found	[Ref:25212039]Influenza A virus (H1N1): IC50 = 2.27 µg/mL.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Found	25212039	Yao xue xue bao = Acta pharmaceutica Sinica, 49(6), 905–912.	Liu, M. Z., Yang, Y., Zhang, S. X., Tang, L., Wang, H. M., Chen, C. J., Shen, Z. F., Cheng, K. D., Kong, J. Q., & Wang, W. (2014).	[A cyclotide against influenza A H1N1 virus from Viola yedoensis]	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)O
DRAMP37492	SDSVVSDIICTTFCSVTWCQSNCC	24	Brevicillin	A0A0A0MRG2##P05067	Coronaviridae	PMI05_05757	Brevibacillus	[Ref:36914211]SARS-CoV-2: Peptide inhibited ~99% virus growth at 10 µg/mL in cell culture-based assay.	Not Available				Not Found	[Ref:36914211]SARS-CoV-2: Peptide inhibited ~99% virus growth at 10 µg/mL in cell culture-based assay.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Found	36914211	Journal of applied microbiology, 134(3), lxad054.	Singh, S. S., Sharma, D., Singh, C., Kumar, S., Singh, P., Sharma, A., Das, D. K., Pinnaka, A. K., Thakur, K. G., Ringe, R. P., & Korpole, S. (2023)	Brevicillin, a novel lanthipeptide from the genus Brevibacillus with antimicrobial, antifungal, and antiviral activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)O
DRAMP37493	DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV	40	"Beta-amyloid
peptide (1–40)"	A0A5Q1NCA8	Orthomyxoviridae	APP(351)	Homo sapiens	[Ref:25376108]HSV-1: Aβ 1-40 and Aβ 1-42 caused 82% and 91% decreases in HSV-1 DNA replication in MRC-5 cells.[Ref:24988208]Influenza A virus (H3N2 - Phil82): βA40 at 16 µg/mL reduced infectivity to 2	Not Available			1AML##1AMC##1BA4	Aβ 1-40  acted directly on HSV-1 in a cell-free system and prevented viral entry into cells.The sequence homology between Aβ and a proximal transmembrane region of HSV-1 glycoprotein B suggested that Aβ interference with HSV-1 replication could involve its insertion into the HSV-1 envelope.	[Ref:25376108]HSV-1: Aβ 1-40 and Aβ 1-42 caused 82% and 91% decreases in HSV-1 DNA replication in MRC-5 cells.[Ref:24988208]Influenza A virus (H3N2 - Phil82): βA40 at 16 µg/mL reduced infectivity to 29±12% of control; Cal09 strain: 47±15% of control.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Found	25376108##24988208	Biogerontology, 16(1), 85–98## PloS one, 9(7), e101364.	Bourgade, K., Garneau, H., Giroux, G., Le Page, A. Y., Bocti, C., Dupuis, G., Frost, E. H., & Fülöp, T., Jr (2015)##White, M. R., Kandel, R., Tripathi, S., Condon, D., Qi, L., Taubenberger, J., & Hartshorn, K. L. (2014).	β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1##Alzheimer's associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CC[C@H](NC(=O)[C@@H](N)CC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C
DRAMP37494	GFGCPLDQMQCHNHCQSVRYRGGYCTNFLKMTCKCY	36	Av-LCTX-An1a	No entry found	Flaviviridae	Not Found	venom gland of the A. nagpag spider	Antimrobial; Antiviral	Not Available				An1a suppresses DENV2 replication and infectious virus production.Also An1a may inhibit DENV2 replication and particle production by interacting with the NS2B–NS3 protease.	[Ref:31658707]Dengue virus-2 (DENV2): An1a showed ~10 µM 50% inhibition in Vero cells.Zika virus (ZIKV):An1a showed ~2 µM 50% inhibition in Vero cells. It acts as a competitive inhibitor of ZIKV NS2B–NS3 protease (Ki = 12.54 ± 1.88 µM). Inhibited replication in HUVEC and A549 cells.DENV2 and ZIKV NS2B–NS3 protease: Ki = 9.47 µM for DENV2; Ki = 12.54 µM for ZIKV.	[Ref:31658707]hemolytic: no hemolysis of hRBC below 20 uM	Linear	Free	Free	Gly4–Ser–Gly4 linker,	L	No cytotoxicity information found in the reference(s) presented	Protease	31658707	Toxins, 11(10), 584. 	Ji, M., Zhu, T., Xing, M., Luan, N., Mwangi, J., Yan, X., Mo, G., Rong, M., Li, B., Lai, R., & Jin, L. (2019).	An Antiviral Peptide from Alopecosa nagpag Spider Targets NS2B-NS3 Protease of Flaviviruses	
DRAMP37495	XYXTAGXAXLXPXQXKXVXGX	11	Mirabamide G	No entry found	Retroviridae	Not Available	 sponge Stelletta clavosa	Antimrobial; Antiviral	Not Available				The mechanism of action for peptides E through H likely involves their amphipathic and cyclic nature, which enables them to interact with both viral and host cell components to inhibit HIV-1 infection. These peptides may target the HIV-1 envelope glycoproteins, such as gp120 and gp41, which are critical for viral entry into host cells. By binding to gp120, they could block its interaction with the CD4 receptor or CCR5/CXCR4 co-receptors, preventing viral attachment. Additionally, interference with gp41 could disrupt the membrane fusion process required for viral entry. Their structural properties also suggest potential interactions with the host cell membrane, altering its lipid microdomains and impeding the fusion process. Furthermore, these peptides might inhibit the HIV-1 reverse transcriptase enzyme, blocking viral RNA to DNA transcription, or interact with viral assembly proteins to disrupt the formation of infectious virions. The exact mechanism for each peptide requires further investigation, including binding studies and structural analyses, to elucidate their precise targets and pathways of action.	[Ref:21280591]HIV-1:IC50=68±13μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	The N-terminal is blocked by the Dhtda-like moiety,	Free	X at position 1 is β-O-methyltyrosine (β-OMeTyr).X at position 2 is N-methylthreonine (NMeThr).X at position 5 is 3-O-methylalanine (3-OMeAla).X at position 6 is 3-hydroxyleucine (3-OHLeu).X at position 7 is 4 chlorohydroxyproline (4-ClHpr).X at position 8 is 3,4-dimethylglutamine (3,4-DiMeGln).X at position 9 is diaminobutyric acid (Dab).X at position 10 is aminobutyric acid (Aba)	L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	21280591	J Nat Prod. 2011 Feb 25;74(2):185-93.	Lu Z, Van Wagoner RM, Harper MK, Baker HL, Hooper JN, Bewley CA, Ireland CM.	Mirabamides E-H, HIV-Inhibitory Depsipeptides from the Sponge Stelletta clavosa	
DRAMP37496	XYXTAGXAXLXPXQXKXVXG	11	Mirabamide H	No entry found	Retroviridae	Not Available	 sponge Stelletta clavosa	Antimrobial; Antiviral	Not Available				The mechanism of action for peptides E through H likely involves their amphipathic and cyclic nature, which enables them to interact with both viral and host cell components to inhibit HIV-1 infection. These peptides may target the HIV-1 envelope glycoproteins, such as gp120 and gp41, which are critical for viral entry into host cells. By binding to gp120, they could block its interaction with the CD4 receptor or CCR5/CXCR4 co-receptors, preventing viral attachment. Additionally, interference with gp41 could disrupt the membrane fusion process required for viral entry. Their structural properties also suggest potential interactions with the host cell membrane, altering its lipid microdomains and impeding the fusion process. Furthermore, these peptides might inhibit the HIV-1 reverse transcriptase enzyme, blocking viral RNA to DNA transcription, or interact with viral assembly proteins to disrupt the formation of infectious virions. The exact mechanism for each peptide requires further investigation, including binding studies and structural analyses, to elucidate their precise targets and pathways of action.	[Ref:21280591]HIV-1:IC50=42±5μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	The N-terminal is blocked, likely due to structural truncation involving the Dhtda-like group.	Free	X at position 1: β-O-methyltyrosine (β-OMeTyr).X at position 2: N-methylthreonine (NMeThr).X at position 5: 3-O-methylalanine (3-OMeAla).X at position 6: 3-hydroxyleucine (3-OHLeu).X at position 7: 4-chlorohydroxyproline (4-ClHpr) .X at position 8: 3,4-dimethylglutamine (3,4-DiMeGln).X at position 9: Diaminobutyric acid (Dab).X at position 10: Aminobutyric acid (Aba) 	L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	21280591	J Nat Prod. 2011 Feb 25;74(2):185-93.	Lu Z, Van Wagoner RM, Harper MK, Baker HL, Hooper JN, Bewley CA, Ireland CM.	Mirabamides E-H, HIV-Inhibitory Depsipeptides from the Sponge Stelletta clavosa	
DRAMP37497	XAXYXQLGXATXQXKXQXNH	12	Stellettapeptin A	No entry found	Retroviridae	Not Available	Isolated from Stelletta sponge	Antimrobial; Antiviral	Not Available				The cyclic structure and amphipathic nature of these peptides likely enable interaction with the lipid bilayer of viral or host cell membranes.This interaction may disrupt the membrane integrity, inhibiting viral entry or replication.The peptides may interact with HIV-1 envelope proteins, preventing the virus from attaching or fusing with host cells.Some depsipeptides are known to inhibit the reverse transcriptase enzyme of HIV-1, disrupting the viral replication process.By binding to host or viral targets, the peptides may alter immune responses to enhance antiviral effects	[Ref:26139946]HIV-1:EC50=23nM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	The N-terminal residue in both peptides is Hdna (3-hydroxy-6,8-dimethylnon-4-enoic acid), a unique polyketide moiety. This polyketide is linked to the peptide chain through the 3-OHAsn residue in Stel	C-terminal is esterified to a threonine hydroxyl group, forming a cyclic structure. This ester bond is a defining feature of these cyclic depsipeptides.	Contains 3-OHGln and 3-OHAsn residues, rarely found in peptides.Macrocycle closure via esterification.X at position 1: N-methylalanine (NMeAla) → A (Alanine with an additional methyl group on the nitrogen),X at position 2: β-O-methyltyrosine (β-OMeTyr) → Y (Tyrosine with a methyl group on the hydroxyl group),X at position 3: N-methylglutamine (NMeGln) → Q (Glutamine with an additional methyl group on the nitrogen),X at position 4: Leucine (Unmodified),X at position 5: Glycine (Unmodified),X at p	L	[Ref:26139946]CC50: 367 nM	Viral entry (Viral membrane)	26139946	2015 Jul 8;56(28):4215-4219.	Shin HJ, Rashid MA, Cartner LK, Bokesch HR, Wilson JA, McMahon JB, Gustafson KR. 	Stellettapeptins A and B, HIV-inhibitory cyclic depsipeptides from the marine sponge Stelletta sp	
DRAMP37498	XAXYXTLGGXATTXQXKXH	12	Stellettapeptin B	No entry found	Retroviridae	Not Available	Isolated from Stelletta sponge	Antimrobial; Antiviral	Not Available				The cyclic structure and amphipathic nature of these peptides likely enable interaction with the lipid bilayer of viral or host cell membranes.This interaction may disrupt the membrane integrity, inhibiting viral entry or replication.The peptides may interact with HIV-1 envelope proteins, preventing the virus from attaching or fusing with host cells.Some depsipeptides are known to inhibit the reverse transcriptase enzyme of HIV-1, disrupting the viral replication process.By binding to host or viral targets, the peptides may alter immune responses to enhance antiviral effects	[Ref:26139946]HIV-1:EC50=27nM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	The N-terminal residue in both peptides is Hdna (3-hydroxy-6,8-dimethylnon-4-enoic acid), a unique polyketide moiety. This polyketide is linked to the peptide chain through the 3-OHAsn residue in Stel	C-terminal is esterified to a threonine hydroxyl group, forming a cyclic structure. This ester bond is a defining feature of these cyclic depsipeptides.	Replaces NMeGln, 3-OHGln, and 3-OHAsn from A with NMeThr, Thr, and Gly, respectively. Similar macrocycle.X at position 1: N-methylalanine (NMeAla) → A,X at position 2: β-O-methyltyrosine (β-OMeTyr) → Y,X at position 5: 3-O-methylalanine (3-OMeAla) → A,X at position 6: Threonine (Thr) → T,X at position 8: 3,4-dimethylglutamine (3,4-DiMeGln) → Q,X at position 9: Diaminobutyric acid (Dab) → K,X at position 10: Histidine (Hdna) → H	L	[Ref:26139946]CC50: 367nM	Viral entry (Viral membrane)	26139946	2015 Jul 8;56(28):4215-4219.	Shin HJ, Rashid MA, Cartner LK, Bokesch HR, Wilson JA, McMahon JB, Gustafson KR. 	Stellettapeptins A and B, HIV-inhibitory cyclic depsipeptides from the marine sponge Stelletta sp	
DRAMP37499	XFPSLTCLSTXC	10	Mollamide E	No entry found	Retroviridae	Not Available	Tunicate Didemnum molle PNG07-2-050	Antimrobial; Antiviral	Not Available				Mollamide E does not exhibit significant HIV inhibition activity in cytoprotective or integrase assays. Its mechanism of action remains uncharacterized but may involve steric or structural features that prevent integrase binding, unlike its analog Mollamide F	[Ref:22845329]HIV-1:No inhibition at78μM;NoHIV integrase inhibition at 100μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Phenylalanine (Phe)	Thiazoline (Cys-derived residue)	The cysteine residue forms a thiazoline ring, contributing to the rigidity and cyclic nature of the peptide.Attached to the threonine residue, this modification is a unique structural feature.Contains d-Phe and d-thiazoline, resulting from thermodynamic relaxation under constrained peptide geometry.X at position 1: D-Phenylalanine (D-Phe) → Mirror image of L-Phe, not commonly found in natural peptides, X at position 7: D-Cysteine in thiazoline ring → Modified residue, involved in heterocyclic st	L	No cytotoxicity information found in the reference(s) presented	Viral integrase	22845329	J Nat Prod. 2012 Aug 24;75(8):1436-40.	Lu Z, Harper MK, Pond CD, Barrows LR, Ireland CM, Van Wagoner RM.	Thiazoline Peptides and a Tris-Phenethyl Urea from Didemnum molle with Anti-HIV Activity	
DRAMP37500	XFPPVIXC	6	Mollamide F	No entry found	Retroviridae	Not Available	Tunicate Didemnum molle PNG07-2-050	Antimrobial; Antiviral	Not Available				"Mollamide F inhibits HIV-1 integrase with an IC50 value of 39 µM, suggesting it interacts with integrase's active site. Residues in the ""southern region"" of the peptide are crucial for binding. The thiazoline moiety likely contributes to molecular rigidity and facilitates integrase interaction."	[Ref:22845329]HIV-1:IC50=78μM;HIV integrase IC50=39μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Phenylalanine (Phe)	Thiazoline (Cys-derived residue)	Similar to Mollamide E, it contains a thiazoline ring derived from cysteine.The sequence includes two proline residues, with a cis geometry at the Pro-Pro peptide bond.Contains d-Phe and d-thiazoline, similar to Mollamide E, due to stereochemical lability. Unlike Mollamide E, the reversed isoprene group is missing, which impacts its structural dynamics and activity.X at position 1: D-Phenylalanine (D-Phe) → This is a D-isomer, which is not naturally common in ribosomally synthesized peptides.X a	L	No cytotoxicity information found in the reference(s) presented	Viral integrase	22845329	J Nat Prod. 2012 Aug 24;75(8):1436-40.	Lu Z, Harper MK, Pond CD, Barrows LR, Ireland CM, Van Wagoner RM.	Thiazoline Peptides and a Tris-Phenethyl Urea from Didemnum molle with Anti-HIV Activity	
DRAMP37501	EISKINTTLLDLSDEMAMLQQEVVKQLNDSYIDLKEL	37	HKU4-HR2P2	No entry found	Coronaviridae	Not Available	HR2 domain of bat	[Ref:30646495]MERS-CoV,SARS-CoV:IC50=0.38μM	Not Available				HKU4-HR2 peptides could cross-target the MERS-CoV HR1 region.	[Ref:30646495]MERS-CoV,SARS-CoV:IC50=0.38μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref: 30646495]No cytotoxicity	HR2 	30646495	Viruses, 11(1), 56.	Xia, S., Lan, Q., Pu, J., Wang, C., Liu, Z., Xu, W., Wang, Q., Liu, H., Jiang, S., & Lu, L. (2019). 	Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP37502	XCXCVXLL	6	Malformin C	No entry found	Retroviridae	Not Available	marine-derived fungus Aspergillus niger SCSIO Jcsw6F30	Antimrobial; Antiviral	Not Available				Not Available	[Ref:26711143]HIV-1:IC50=1.4±0.06μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	X1 at position 1: D-Cys → Cysteine in D-configuration (mirror image of natural L-Cys),X2 at position 2: D-Cys → D-isomer of Cysteine,X at position 4: D-Leu → Leucine in D-form,Cyclic structure: The peptide is cyclized, forming a closed ring via peptide bonds, often enhancing stability and bioactivity.	L	[Ref:26711143]No cytotoxicity	Not found	26711143	Bioorganic & medicinal chemistry letters, 26(2), 361–365.	Zhou, X., Fang, W., Tan, S., Lin, X., Xun, T., Yang, B., Liu, S., & Liu, Y. (2016)	Aspernigrins with anti-HIV-1 activities from the marine-derived fungus Aspergillus nigerSCSIO Jcsw6F30	
DRAMP37503	GENFAISKINTTLLDISDEMAMIQEVVKQLNDSYI	35	HKU4-HR2P1	A0A2H4GZ80	Coronaviridae	Not Available	HR2 domain of bat	[Ref:30646495]SARS-CoV:IC50=1.09μM	Not Available				These peptides target the viral fusion and entry stages.	[Ref:30646495]SARS-CoV:IC50=1.09μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref: 30646495]No cytotoxicity	HR2 	30646495	Viruses, 11(1), 56.	Xia, S., Lan, Q., Pu, J., Wang, C., Liu, Z., Xu, W., Wang, Q., Liu, H., Jiang, S., & Lu, L. (2019). 	Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU6	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)NC(=O)CN)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)O
DRAMP37504	ECASTCSFGIVTIVCDGTTK	20	Divamide A	No entry found	Retroviridae	divA	TunicateDidemnum molle E11-036	Antimrobial; Antiviral	Not Available				 duramycin inhibits entry of Ebola and Dengue viruses, indicating that TIM proteins also interact with PE.Thus, lipid binding appears a likely mechanism for the anti-HIV activity of the divamides. However, the stark differences in potency and toxicity between individual divamides and 4 may reflect additional interactions with non-membrane components, potentially including TIM proteins, that are substantially affected by the peptide sequence. 	[Ref:29291350]HIV-1:IC50=0.225μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	the tertiary structure conferred by the cyclic lysinoalanine residue is necessary to block infection	L	[Ref:29291350]CC50=2.63µm	PE binding	29291350	Nat Chem Biol. 2018 Feb;14(2):179-185.	Smith TE, Pond CD, Pierce E, Harmer ZP, Kwan J, Zachariah MM, Harper MK, Wyche TP, Matainaho TK, Bugni TS, Barrows LR, Ireland CM, Schmidt EW.	Accessing chemical diversity from the uncultivated symbionts of small marine animals	
DRAMP37505	2Abz-A-xiIle-N(Me)Phe(bS-OH)	3	Asperterrestide A	No entry found	Orthomyxoviridae	Not Available	marine-derived fungus Aspergillus terreus SCSGAF0162.	Antimrobial; Antiviral	Not Available				Not Available	[Ref:23806112]H1N1:IC50=20.2μM,H3N2:IC50=0.41μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	2Abz at position 1: 2-Aminobenzoyl (Aromatic modification).D-Ala at position2:D-Alanine (Natural enantiomer of alanine).D-xiIle at position 3:D-X-isoleucine (Modified or non-standard isoleucine).D-N(Me)Phe at position 4:D-N-Methylphenylalanine (Methyl group added to the nitrogen of phenylalanine).bS-OH at position5:b-Sulfhydroxyphenylalanine (Phenylalanine derivative with a hydroxyl group attached to a sulfur atom.	L	[Ref:23806112]Negligible cytotoxicity	Not found	23806112	Journal of natural products, 76(6), 1182–1186.	He, F., Bao, J., Zhang, X. Y., Tu, Z. C., Shi, Y. M., & Qi, S. H. (2013).	Asperterrestide A, a cytotoxic cyclic tetrapeptide from the marine-derived fungus Aspergillus terreus SCSGAF0162	
DRAMP37506	VXYXYXYP	5	Aspergillipeptide D	No entry found	Herpesviridae	Not Available	"Endophytic fungus Aspergillus sp. SCSIO 41501	"	Antimrobial; Antiviral	Not Available				 Aspergillipeptide D did not affect HSV-1 early infection events, including viral inactivation, attachment and penetration. Interestingly, Aspergillipeptide D dramatically reduced both the gene and protein levels of viral late protein gB, and suppressed its location in the endoplasmic reticulum and Golgi apparatus.n contrast, overexpression of gB restored viral production. Finally, proteomic analysis revealed that the numbers of cellular proteins that interacted with gB protein was largely decreased by Aspergillipeptide D. These results suggested that Aspergillipeptide D inhibited gB function to affect HSV-1 intercellular spread.	[Ref:32192525]HSV-1:IC50=9.5μM,HSV-1:IC50=12.5μM(ACV-HSV-1)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	X at position 2: N-methyltyrosine (N-Me-Tyr) → Y (Tyrosine with a methyl group on the nitrogen),X at position 3: O-methyltyrosine (O-Me-Tyr) → Y (Tyrosine with a methyl group on the hydroxyl group),X at position 4: O-methyltyrosine (O-Me-Tyr) → Y (Tyrosine with a methyl group on the hydroxyl group)	L	[Ref:32192525]Negligible cytotoxicity	Glycoprotein.	32192525	Virology journal, 17(1), 41. 	Wang, Z., Jia, J., Wang, L., Li, F., Wang, Y., Jiang, Y., Song, X., Qin, S., Zheng, K., Ye, J., Ren, Z., Wang, Y., & Qi, S. (2020). 	Antiviral peptides from marine gorgonian-derived fungus Aspergillus sp. SCSIO 41501	
DRAMP37507	YWV	3	Aspergillipeptide E	No entry found	Herpesviridae	Not Available	"Endophytic fungus Aspergillus sp. SCSIO 41501	"	[Ref:32192525]HSV-1:IC50=19.8μM	Not Available				Not Available	[Ref:32192525]HSV-1:IC50=19.8μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	The configurations of Tyr and Val have been determined as D-Tyr and D-Val, while Trp is speculated to be L-Trp based on the precursor added.	L	[Ref:32192525]Negligible cytotoxicity	Glycoprotein.	32192525	Virology journal, 17(1), 41. 	Wang, Z., Jia, J., Wang, L., Li, F., Wang, Y., Jiang, Y., Song, X., Qin, S., Zheng, K., Ye, J., Ren, Z., Wang, Y., & Qi, S. (2020). 	Antiviral peptides from marine gorgonian-derived fungus Aspergillus sp. SCSIO 41501	CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
DRAMP37508	XIXYQPXAXTX	6	Simplicilliumtide J	No entry found	Herpesviridae	Not Available	Fungus Simplicillium obclavatum EIODSF 0210	Antimrobial; Antiviral	Not Available				Not Available	[Ref:28578573]HSV-1:IC50=14.1μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	X at position 1: allo-Ile,X at position 2: D-Tyr,X at position 5: D-Ala,X at position 6: D-allo-Thr,X at position 7: 5(S)-HTA (non-standard residue)	L	No cytotoxicity information found in the reference(s) presented	Not found	28578573	Journal of agricultural and food chemistry, 65(25), 5114–5121.	Liang, X., Nong, X. H., Huang, Z. H., & Qi, S. H. (2017).	Antifungal and Antiviral Cyclic Peptides from the Deep-Sea-Derived Fungus Simplicillium obclavatum EIODSF 020	
DRAMP37509	SAPQYV	6	Verlameline A	No entry found	Herpesviridae	Not Available	Fungus Simplicillium obclavatum EIODSF 0210	Antimrobial; Antiviral	Not Available				Not Available	[Ref:28578573]HSV-1:IC50=16.7μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	A 5-hydroxytetradecanoic acid (HTDA) is attached to the N-terminus — this makes the compound a lipopeptide.	Free	Macrocyclic lactone ring:The hydroxyl group at C-5 of HTDA is ester-linked to the C-terminal carboxyl of Val, forming a cyclic structure.	L	No cytotoxicity information found in the reference(s) presented	Not found	28578573	Journal of agricultural and food chemistry, 65(25), 5114–5121	Liang, X., Nong, X. H., Huang, Z. H., & Qi, S. H. (2017)	Antifungal and Antiviral Cyclic Peptides from the Deep-Sea-Derived Fungus Simplicillium obclavatum EIODSF 020	
DRAMP37510	FLSX₃	3	Acremonpeptide A	No entry found	Herpesviridae	Not Available	Fungus Acremonium persicinum SCSIO 115	Antimrobial; Antiviral	Not Available				Viral Replication	[Ref:31503476]HSV-1:IC50=16μM,HSV-1:EC50=8.7μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	X = Modified ornithine (specifically N5-acetyl-N5-hydroxy-Orn, repeated three times)	L	No cytotoxicity information found in the reference(s) presented	Cell membrane	31503476	Journal of natural products, 82(9), 2594–2600.	Luo, M., Zang, R., Wang, X., Chen, Z., Song, X., Ju, J., & Huang, H. (2019).	Natural Hydroxamate-Containing Siderophore Acremonpeptides A-D and an Aluminum Complex of Acremonpeptide D from the Marine-Derived Acremonium persicinum SCSIO 115	
DRAMP37511	FLWXOX	4	Al(III)-acremonpeptide D	A7DWR7	Herpesviridae	Not Available	Fungus Acremonium persicinum SCSIO 115	Antimrobial; Antiviral	Not Available				Viral replication	[Ref:31503476]HSV-1:IC50=14μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	X = AcN(OH)Orn	L	No cytotoxicity information found in the reference(s) presented	Cell membrane	31503476	Journal of natural products, 82(9), 2594–2600.	Luo, M., Zang, R., Wang, X., Chen, Z., Song, X., Ju, J., & Huang, H. (2019).	Natural Hydroxamate-Containing Siderophore Acremonpeptides A-D and an Aluminum Complex of Acremonpeptide D from the Marine-Derived Acremonium persicinum SCSIO 115	
DRAMP37512	QSVACRSYYCSKFCGSAGCSLYGCYLLHPGKICYCLHCSR	40	Myticin C	No entry found	Herpesviridae	mync_MYTGA	Mollusk Mytilus galloprovincialis	[Ref:27307570]HSV-1:IC50=7.69–8.21μM,HSV-1:IC50=8.32–10.5μM	Not Available				The intracellular phase of viral replication	[Ref:27307570]HSV-1:IC50=7.69–8.21μM,HSV-1:IC50=8.32–10.5μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	27307570	Journal of virology, 90(17), 7692–7702.	Novoa, B., Romero, A., Álvarez, Á. L., Moreira, R., Pereiro, P., Costa, M. M., Dios, S., Estepa, A., Parra, F., & Figueras, A. (2016).	Antiviral Activity of Myticin C Peptide from Mussel: an Ancient Defense against Herpesviruses	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP37513	YP	2	Cyclo(l-Tyr-l-Pro) diketopiperazine	No entry found	Herpesviridae	Not Available	Endophytic fungus Aspergillus versicolor	[Ref:Not Available]HCV:IC50: 8.2 μg mL−1	Not Available				interact with the viral envelope and the phospholipids of the	[Ref:Not Available]HCV:IC50: 8.2 μg mL−1	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3-4A protease	Not Available	Applied Biochemistry and Microbiology, 53(1), 101-106.	Ahmed, Eman; Rateb, Mostafa; El-Kassem, L.T. Abou ; Hawas, Usama	Anti-HCV protease of diketopiperazines produced by the Red Sea sponge-associated fungus Aspergillus versicolor	N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37514	AVVVDAVVVDAVVVDAVVVD	20	Valinomycin; streptodepsipeptides P11A and SV21	No entry found	Herpesviridae	Not Available	Bacterial symbiont Streptomyces sp. SV21	[Ref:33540548]HCV:IC50=0–5%	Not Available				viral surface, due to the presence of hydrophobic amino acid	[Ref:33540548]HCV:IC50=0–5%	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	33540548	 Marine drugs, 19(2), 81.	Wibowo, J. T., Kellermann, M. Y., Köck, M., Putra, M. Y., Murniasih, T., Mohr, K. I., Wink, J., Praditya, D. F., Steinmann, E., & Schupp, P. J. (2021). 	Anti-Infective and Antiviral Activity of Valinomycin and Its Analogues from a Sea Cucumber-Associated Bacterium, Streptomyces sp. SV 21	CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP37515	SITQINTTLLDTTYEMISIQQVVKALNESYIDLKEL	36	MERS-HR2P	No entry found	Coronaviridae	Not Available	HR2 domain of bat	[Ref:30646495]SARS-CoV:IC50=1.07μM	Not Available				These peptides target the viral fusion and entry stages.	[Ref:30646495]SARS-CoV:IC50=1.07μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref: 30646495]No cytotoxicity	HR2 	33082259	mBio, 11(5), e01935-20.	Outlaw, V. K., Bovier, F. T., Mears, M. C., Cajimat, M. N., Zhu, Y., Lin, M. J., Addetia, A., Lieberman, N. A. P., Peddu, V., Xie, X., Shi, P. Y., Greninger, A. L., Gellman, S. H., Bente, D. A., Moscona, A., & Porotto, M. (2020).	Inhibition of Coronavirus Entry In Vitro and Ex Vivoby a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP37516	DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGSGSGCTEG	45	SARS-CoV-2 HRC	No entry found	Coronaviridae	Not Available	C-terminal HR domain of SARS-CoV-2	Antimrobial; Antiviral	Not Available				Not Available	[Ref:20032190]SARS-CoV:IC50≈3nM and ~6nM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Chlo		L	[Ref:20032190]No toxicity was observed for the SARS-CoV-2 lipopeptide at its IC90 concentration	Not found	20032190	Journal of virology, 84(5), 2511–2521.	O'Keefe, B. R., Giomarelli, B., Barnard, D. L., Shenoy, S. R., Chan, P. K., McMahon, J. B., Palmer, K. E., Barnett, B. W., Meyerholz, D. K., Wohlford-Lenane, C. L., & McCray, P. B., Jr (2010)	Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae	
DRAMP37517	LDLSDEMAMIEVVKQLNDSYIDLKELSNYTYYNKW	35	HKU4-HR2P3	P59594	Coronaviridae	Not Available	HR2 domain of bat	[Ref:30646495]SARS-CoV:IC50=0.55μM	Not Available				These peptides target the viral fusion and entry stages.	[Ref:30646495]SARS-CoV:IC50=0.55μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	[Ref: 30646495]No cytotoxicity	HR2 	30646495	Viruses, 11(1), 56.	Xia, S., Lan, Q., Pu, J., Wang, C., Liu, Z., Xu, W., Wang, Q., Liu, H., Jiang, S., & Lu, L. (2019). 	Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU5	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
DRAMP37518	GVTQNVLYENQKQIANQFNKAISQIQESLTTTSTALGKLQ	40	NP-1	P0DTC2	Coronaviridae	S2	HR1 region of SARS-CoV	[Ref:15043961]SARS-CoV:Marginal activity at 50μmol/L	Not Available			1WYY, 5WRG, 5X58, 5X5B, 5XLR, 5ZVM, 6ACC, 6ACD	like most antiviral peptides described in the literature,13 inhibi-	[Ref:15043961]SARS-CoV:Marginal activity at 50μmol/L	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein. Gp41	15043961	Lancet (London, England), 363(9413), 938–947.	Liu, S., Xiao, G., Chen, Y., He, Y., Niu, J., Escalante, C. R., Xiong, H., Farmar, J., Debnath, A. K., Tien, P., & Jiang, S. (2004). 	Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC
DRAMP37519	SGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	34		P59594	Coronaviridae	S2(43740568)	HR segment of SARS-CoV	Antimrobial; Antiviral	Not Available			6LVN##6LXT##6LZG	ting the virus’ action before adsorption, at a percentage above	Not Avaialble	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	N-terminal leucine/isoleucine zipper-like sequence	C-terminal heptad repeat located upstream		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein. Gp41	14499001	BMC microbiology, 3, 20.	Kliger, Y., & Levanon, E. Y. (2003).	Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy	
DRAMP37520	PTTFMLKYDENGTITDAVDC 	20	P2	P59594	Coronaviridae	S2	S1 subunit of SARS-CoV	Antimrobial; Antiviral	Not Available				80%, reinforcing the theory presented by Migliolo et al.,22 and	[Ref:15918330]SARS-CoV:IC50=112.5±26.3μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	15918330	Antiviral therapy, 10(3), 393–403.	Zheng, B. J., Guan, Y., Hez, M. L., Sun, H., Du, L., Zheng, Y., Wong, K. L., Chen, H., Chen, Y., Lu, L., Tanner, J. A., Watt, R. M., Niccolai, N., Bernini, A., Spiga, O., Woo, P. C., Kung, H. F., Yuen, K. Y., & Huang, J. D. (2005).	Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus	
DRAMP37521	YQDVNCTDVSTAIHADQLTP	20	P6	P59594	Coronaviridae	S2	S1 subunit of SARS-CoV	Antimrobial; Antiviral	Not Available				the SI was higher than 5 considering the CC50 at 400 mg.	[Ref:15918330]SARS-CoV:IC50=113.0±27.6μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	15918330	Antiviral therapy, 10(3), 393–403.	Zheng, B. J., Guan, Y., Hez, M. L., Sun, H., Du, L., Zheng, Y., Wong, K. L., Chen, H., Chen, Y., Lu, L., Tanner, J. A., Watt, R. M., Niccolai, N., Bernini, A., Spiga, O., Woo, P. C., Kung, H. F., Yuen, K. Y., & Huang, J. D. (2005).	Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus	
DRAMP37522	STSQKSIVAYTM	12	SP-10	No entry found	Coronaviridae	S2	S protein of SARS-CoV	[Ref:16337697]SARS-CoV:IC50=1.88±0.52nmol	Not Available			1WYY, 5WRG, 5X58, 5X5B, 5XLR, 5ZVM, 6ACC, 6ACD	Significantly blocked the interaction between S protein and ACE2 by biotinylated enzyme-linked immunosorbent assay.SP-10 blocked both binding of the S protein and infectivity of S protein-pseudotyped retrovirus to Vero E6 cells. 	[Ref:16337697]SARS-CoV:IC50=1.88±0.52nmol	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	S protein to ACE2 	16337697	Antiviral research, 69(2), 70–76.	Ho, T. Y., Wu, S. L., Chen, J. C., Wei, Y. C., Cheng, S. E., Chang, Y. H., Liu, H. J., & Hsiang, C. Y. (2006).	Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)C(C)C
DRAMP37523	GGGYSKAQKAQAKQAKQAQKAQKAQAKQAKQAQKAQKAQAKQAKQ	45	P5 +14	P59594	Coronaviridae	Not Available	S1 subunit of SARS-CoV-2	Not Avaialble	Not Available				Not Available	Not Avaialble	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Found	32913137	Molecular pharmacology, 98(5), 612–619.	Tavassoly, O., Safavi, F., & Tavassoly, I. (2020).	Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection	C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP37524	QYGSFCTQLNRALSGIAAEQ	20	P8	P59594	Coronaviridae	S2	S2 subunit of SARS-CoV	Antimrobial; Antiviral	Not Available			1WYY, 5WRG, 5X58, 5X5B, 5XLR, 5ZVM, 6ACC, 6ACD	Not Available	[Ref:15918330]SARS-CoV:IC90=24.9±6.2μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	[Ref: 30646495]No cytotoxicity	Not Found	15918330	Antiviral therapy, 10(3), 393–403.	Zheng, B. J., Guan, Y., Hez, M. L., Sun, H., Du, L., Zheng, Y., Wong, K. L., Chen, H., Chen, Y., Lu, L., Tanner, J. A., Watt, R. M., Niccolai, N., Bernini, A., Spiga, O., Woo, P. C., Kung, H. F., Yuen, K. Y., & Huang, J. D. (2005).	Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus	
DRAMP37525	IQKEIDRLNEVAKNLNESLI	20	P10	No entry found	Coronaviridae	S2	HR2 region of SARS-CoV	[Ref:15918330]SARS-CoV:IC90=73.5±15.7μg/mL	Not Available			1WYY, 5WRG, 5X58, 5X5B, 5XLR, 5ZVM, 6ACC, 6ACD	Not Available	[Ref:15918330]SARS-CoV:IC90=73.5±15.7μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	[Ref: 30646495]No cytotoxicity	Not Found	15918330	Antiviral therapy, 10(3), 393–403.	Zheng, B. J., Guan, Y., Hez, M. L., Sun, H., Du, L., Zheng, Y., Wong, K. L., Chen, H., Chen, Y., Lu, L., Tanner, J. A., Watt, R. M., Niccolai, N., Bernini, A., Spiga, O., Woo, P. C., Kung, H. F., Yuen, K. Y., & Huang, J. D. (2005).	Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@H](C)CC)C(C)C)[C@H](C)CC
DRAMP37526	GGRGGGGSGGSGGSGGRGGGGSGGSGG	27	MERS-5HB	P15423	Coronaviridae	Not Available	S2 subunit of MERS-CoV	[Ref:28906430]MERS-CoV:IC50=The 50% inhibitory concentration (IC50) for the inhibition by MERS-5HB of a MERS-CoV infection was about 1 μM, 	Not Available				 The absence of one HR2 may reserve a hydrophobic groove in MERS-5HB for binding to a native HR2 in the MERS-CoV S protein.It could bind to HR2 in MERS-CoV S2 to inhibit viral entry as well as S protein-mediated syncytial formation.	[Ref:28906430]MERS-CoV:IC50=The 50% inhibitory concentration (IC50) for the inhibition by MERS-5HB of a MERS-CoV infection was about 1 μM, 	[Ref:28906430]The calculated 50% effective concentration (EC50) of binding of MERS-5HB to MERS-HR2P is 5.4 nM.To confirm the binding, the ELISA assay was performed in the reverse way. MERS-5HB was coa	Cyclic	Free	Free		L	[Ref: 30646495]No cytotoxicity	HR2 	28906430	Viruses. 2017 Sep 14;9(9):255.	Sun Y, Zhang H, Shi J, Zhang Z, Gong R.	Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus	N=C(N)NCCC[C@H](NC(=O)CNC(=O)CN)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)O
DRAMP37527	VVEQYNQTILNLTSEISTLENKSAELNYTVQKLQTLIDNINSTLVDLKWL	50	229E-HR2P	P0C6U8	Coronaviridae	S2	S2 subunit of HCoV-229E	[Ref:29415501]SARS-CoV,IC50=0.3μM,1.96μM	Not Available			5ZHY##5YL9##5ZUV	Fusion Inhibitor	[Ref:29415501]SARS-CoV,IC50=0.3μM,1.96μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:29415501]Neither 229E-HR1P nor 229E-HR2P had significant cytotoxicity to these cells at concentrations up to 1,000 μM	Spike Protein	29415501	International journal of molecular sciences, 19(2), 487.	Xia, S., Xu, W., Wang, Q., Wang, C., Hua, C., Li, W., Lu, L., & Jiang, S. (2018)	Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP37528	AVLQSGFR	8	Octapeptide	No entry found	Coronaviridae	1a	Structure of SARS-CoV Mpro	[Ref:16242214]HCoV-229E,IC50=0.5μM(pseudotyped),1.7μM(livevirus)	Not Available				It inhibits replication	[Ref:16242214]HCoV-229E,IC50=0.5μM(pseudotyped),1.7μM(livevirus)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16242214]no detectable toxicity is observed on Vero cells .100	Not Found	16242214	Peptides, 27(4), 622–625.	Gan, Y. R., Huang, H., Huang, Y. D., Rao, C. M., Zhao, Y., Liu, J. S., Wu, L., & Wei, D. Q. (2006).	Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP37529	LQQFMK	6	6a	No entry found	Coronaviridae	Not Available	Cleavage site of SARS-CoV Mpro	[Ref:16451084]SARS-CoV,EC50=0.027μg/mL	Not Available				Not Available	[Ref:16451084]SARS-CoV,EC50=0.027μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref16451084]low toxicity in cells	Not Found	16451084	J. Med. Chem. 2006, 49, 3, 1198–1201	Zhang, H. Z., Zhang, H., Kemnitzer, W., Tseng, B., Cinatl, J., Jr, Michaelis, M., Doerr, H. W., & Cai, S. X. (2006).	Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP37530	AVLQ	4	Protected tetrapeptide	No entry found	Coronaviridae	Not Available	Cleavage site of the main proteases	Antimrobial; Antiviral	Not Available				Not Available	[Ref:25224114]SARS-CoV,IC50=2.5μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	carboxybenzyl	nitrile		L	No cytotoxicity information found in the reference(s) presented	Not Found	25224114	 Hong Kong medical journal = Xianggang yi xue za zhi, 20 Suppl 4, 22–25.	Chuck, C. P., Ke, Z. H., Chen, C., Wan, D. C., Chow, H. F., & Wong, K. B. (2014). 	Profiling of substrate-specificity and rational design of broad-spectrum peptidomimetic inhibitors for main proteases of coronaviruses	
DRAMP37531	ESTLQ	5	Peptide aldehyde 1	No entry found	Coronaviridae	Not Available	Analyses of the SARS-CoV Mpro	Antimrobial; Antiviral	Not Available				tight-binding inhibitors	[Ref:21854807]SARS-CoV,IC50=8.27±1.52μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Hydogenation		L	No cytotoxicity information found in the reference(s) presented	Not Found	21854807	Antiviral research, 92(2), 204–212.	Vilas Boas, L. C., de Lima, L. M., Migliolo, L., Mendes, G. D., de Jesus, M. G., Franco, O. L., & Silva, P. A. (2017).	Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease	
DRAMP37532	NSFSQ	5	Peptide aldehyde 2	No entry found	Coronaviridae	Not Available	Analyses of the SARS-CoV Mpro	Antimrobial; Antiviral	Not Available				tight-binding inhibitors	[Ref:21854807]SARS-CoV,IC50=40.98±2.63μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Hydogenation		L	No cytotoxicity information found in the reference(s) presented	Not Found	21854807	Antiviral research, 92(2), 204–212.	Vilas Boas, L. C., de Lima, L. M., Migliolo, L., Mendes, G. D., de Jesus, M. G., Franco, O. L., & Silva, P. A. (2017).	Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease	
DRAMP37533	DSFDQ	5	Peptide aldehyde 3	No entry found	Coronaviridae	Not Available	Analyses of the SARS-CoV Mpro	Antimrobial; Antiviral	Not Available				tight-binding inhibitors	[Ref:21854807]SARS-CoV,IC50=41.24±2.25μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Hydogenation		L	No cytotoxicity information found in the reference(s) presented	Not Found	21854807	Antiviral research, 92(2), 204–212.	Vilas Boas, L. C., de Lima, L. M., Migliolo, L., Mendes, G. D., de Jesus, M. G., Franco, O. L., & Silva, P. A. (2017).	Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease	
DRAMP37534	NSTSQ	5	Peptide aldehyde 4	No entry found	Coronaviridae	Not Available	Analyses of the SARS-CoV Mpro	Antimrobial; Antiviral	Not Available				tight-binding inhibitors	[Ref:21854807]SARS-CoV,IC50=72.73±3.60μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Hydogenation		L	No cytotoxicity information found in the reference(s) presented	Not Found	21854807	Antiviral research, 92(2), 204–212.	Vilas Boas, L. C., de Lima, L. M., Migliolo, L., Mendes, G. D., de Jesus, M. G., Franco, O. L., & Silva, P. A. (2017).	Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease	
DRAMP37535	TVFH	4	Tetrapeptide aldehyde	No entry found	Coronaviridae	Not Available	Analyses of the SARS-CoV 3CL protease	Antimrobial; Antiviral	Not Available				Not Available	[Ref:22014094]SARS-CoV,IC50=8nM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	No cytotoxicity information found in the reference(s) presented	Not Found	22014094	Journal of medicinal chemistry, 54(23), 7962–7973.	Akaji, K., Konno, H., Mitsui, H., Teruya, K., Shimamoto, Y., Hattori, Y., Ozaki, T., Kusunoki, M., & Sanjoh, A. (2011).	Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors	
DRAMP37536	VIQY	4	Oligopeptide 1	No entry found	Coronaviridae	Not Available	Marine fish proteins	Antimrobial; Antiviral	Not Available				Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	No cytotoxicity information found in the reference(s) presented	Not Found	32520031	Food & function, 11(6), 5565–5572.	Yao, Y., Luo, Z., & Zhang, X. (2020).	In silico evaluation of marine fish proteins as nutritional supplements for COVID-19 patients	
DRAMP37537	ICIY	4	Oligopeptide 2	No entry found	Coronaviridae	Not Available	Marine fish proteins	Antimrobial; Antiviral	Not Available				Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	No cytotoxicity information found in the reference(s) presented	Not Found	32520031	Food & function, 11(6), 5565–5572.	Yao, Y., Luo, Z., & Zhang, X. (2020).	In silico evaluation of marine fish proteins as nutritional supplements for COVID-19 patients	
DRAMP37538	PISQF	5	Oligopeptide 3	No entry found	Coronaviridae	Not Available	Marine fish proteins	Antimrobial; Antiviral	Not Available				Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	No cytotoxicity information found in the reference(s) presented	Not Found	32520031	Food & function, 11(6), 5565–5572.	Yao, Y., Luo, Z., & Zhang, X. (2020).	In silico evaluation of marine fish proteins as nutritional supplements for COVID-19 patients	
DRAMP37539	VISAW	5	Oligopeptide 4	No entry found	Coronaviridae	Not Available	Marine fish proteins	Antimrobial; Antiviral	Not Available				Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	No cytotoxicity information found in the reference(s) presented	Not Found	32520031	Food & function, 11(6), 5565–5572.	Yao, Y., Luo, Z., & Zhang, X. (2020).	In silico evaluation of marine fish proteins as nutritional supplements for COVID-19 patients	
DRAMP37540	AIPAW	5	Oligopeptide 5	No entry found	Coronaviridae	Not Available	Marine fish proteins	Antimrobial; Antiviral	Not Available				Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	No cytotoxicity information found in the reference(s) presented	Not Found	32520031	Food & function, 11(6), 5565–5572.	Yao, Y., Luo, Z., & Zhang, X. (2020).	In silico evaluation of marine fish proteins as nutritional supplements for COVID-19 patients	
DRAMP37541	PVSQF	5	Oligopeptide 6	P0C6U8	Coronaviridae	Not Available	Marine fish proteins	Antimrobial; Antiviral	Not Available				Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	No cytotoxicity information found in the reference(s) presented	Not Found	32520031	Food & function, 11(6), 5565–5572.	Yao, Y., Luo, Z., & Zhang, X. (2020).	In silico evaluation of marine fish proteins as nutritional supplements for COVID-19 patients	
DRAMP37542	GGASCCLYCRCH	12	K12	P0C6U8	Coronaviridae	1a	Sequence of nsp 10 of SARS-CoV	[Ref:22659295]SARS-CoV,IC50=160μM	Not Available				Not Available	[Ref:22659295]SARS-CoV,IC50=160μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Found	22659295	Virus research, 167(2), 322–328.	Ke, M., Chen, Y., Wu, A., Sun, Y., Su, C., Wu, H., Jin, X., Tao, J., Wang, Y., Ma, X., Pan, J. A., & Guo, D. (2012).	Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex	CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
DRAMP37543	FGGASCCLYCRCHIDHPNPKGFCDLKGKY	29	K29	No entry found	Coronaviridae	1a	Sequence of nsp 10 of SARS-CoV	[Ref:22659295]SARS-CoV,IC50=160μM	Not Available				Not Available	[Ref:22659295]SARS-CoV,IC50=160μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Found	22659295	Virus research, 167(2), 322–328.	Ke, M., Chen, Y., Wu, A., Sun, Y., Su, C., Wu, H., Jin, X., Tao, J., Wang, Y., Ma, X., Pan, J. A., & Guo, D. (2012). 	Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP37544	FKPSSPPSITLW	12	F	No entry found	Coronaviridae	Not Available	S protein of TGEV (synthetic Construct)	[Ref:21176936]TGEV,IC50=20μg/mL	Not Available				The peptides showed an effective binding to pAPN and inhibition to TGEV infection, although their sequences are not completely identical to the homologous regions in the S1 protein	[Ref:21176936]TGEV,IC50=20μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	S protein	21176936	Virology, 410(2), 299–306.	Ren, X., Liu, B., Yin, J., Zhang, H., & Li, G. (2011).	Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
DRAMP37545	HVTTTFAPPPPR	12	H	No entry found	Coronaviridae	Not Available	S protein of TGEV	[Ref:21176937]TGEV,IC50=	Not Available				The peptides showed an effective binding to pAPN and inhibition to TGEV infection, although their sequences are not completely identical to the homologous regions in the S1 protein	[Ref:21176937]TGEV,IC50=	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	S protein	21176936	Virology, 410(2), 299–306.	Ren, X., Liu, B., Yin, J., Zhang, H., & Li, G. (2011).	Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro	CC(C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP37546	SVVPSKATWGFA	12	S	No entry found	Coronaviridae	Not Available	S protein of TGEV	[Ref:21176936]TGEV,IC50=20μg/mL	Not Available				The peptides showed an effective binding to pAPN and inhibition to TGEV infection, although their sequences are not completely identical to the homologous regions in the S1 protein	[Ref:21176936]TGEV,IC50=20μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	S protein	21176936	Virology, 410(2), 299–306.	Ren, X., Liu, B., Yin, J., Zhang, H., & Li, G. (2011).	Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro	CC(C)[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
DRAMP37547	HDAISWTHYHPW	12	PM1	No entry found	Coronaviridae	Not Available	 porcine aminopeptidase N (rpAPN-C) protein 	Not Avaialble	Not Available				Not Available	Not Avaialble	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not given	24111863	Monoclonal antibodies in immunodiagnosis and immunotherapy, 32(5), 326–329.	Guo, D., Zhu, Q., Feng, L., & Sun, D. (2013).	Screening and antiviral analysis of phages that display peptides with an affinity to subunit C of porcine aminopeptidase	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP37548	LMQINPTYYQIM	12	L	No entry found	Coronaviridae	Not Available	S1 protein of PEDV	[Ref:26292945]PEDV,IC50=50μg/mL	Not Available				Two peptides derived from phage display libraries were identified with sequence homology to a specific region of the PEDV S1 protein and that affect binding of the PEDV to the cell surface	[Ref:26292945]PEDV,IC50=50μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Cell surface	26292945	Virus genes, 51(2), 217–224.	Cao, L., Ge, X., Gao, Y., Zarlenga, D. S., Wang, K., Li, X., Qin, Z., Yin, X., Liu, J., Ren, X., & Li, G. (2015).	Putative phage-display epitopes of the porcine epidemic diarrhea virus S1 protein and their anti-viral activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)O
DRAMP37549	WSFNPSTYTIAG	12	W	No entry found	Coronaviridae	Not Available	S1 protein of PEDV	[Ref:26292945]PEDV,IC50=50μg/mL	Not Available				Two peptides derived from phage display libraries were identified with sequence homology to a specific region of the PEDV S1 protein and that affect binding of the PEDV to the cell surface	[Ref:26292945]PEDV,IC50=50μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Cell surface	26292945	Virus genes, 51(2), 217–224.	Cao, L., Ge, X., Gao, Y., Zarlenga, D. S., Wang, K., Li, X., Qin, Z., Yin, X., Liu, J., Ren, X., & Li, G. (2015).	Putative phage-display epitopes of the porcine epidemic diarrhea virus S1 protein and their anti-viral activity	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP37550	HALTPIKYIPPG	12	TGEV-M7	A0A1Z2WU95	Coronaviridae	Not Available	M protein of TGEV	[Ref:23830854]TGEV,IC50=62.5μg/mL	Not Available				pepTGEV-M7 binding to the surface of the virus and either interfering with the ability of the virus to invade the cell or generate progeny virus. 	[Ref:23830854]TGEV,IC50=62.5μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	rTGEV-M protein	23830854	Antiviral research, 99(3), 383–390.	Zou, H., Zarlenga, D. S., Sestak, K., Suo, S., & Ren, X. (2013).	Transmissible gastroenteritis virus: identification of M protein-binding peptide ligands with antiviral and diagnostic potential	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)[C@H](C)CC
DRAMP37551	YGFWTIAYTNYTDVMVDVNG	20	I-S1-9	Q66951	Coronaviridae	S	S1 protein of FIPV	[Ref:25896976]FIPV,IC50=100μM	Not Available				Not Available	[Ref:25896976]FIPV,IC50=100μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not given	25896976	Virus research, 204, 13–20.	Doki, T., Takano, T., Koyama, Y., & Hohdatsu, T. (2015).	Identification of the peptide derived from S1 domain that inhibits type I and type II feline infectious peritonitis virus infection	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)NCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O
DRAMP37552	YHWMNVTLHVVLNDTEKKYD	20	I-S1-16	A0A0C5CJL1	Coronaviridae	S	S1 protein of FIPV	[Ref:25896976]FIPV,IC50=100μM	Not Available				Not Available	[Ref:25896976]FIPV,IC50=100μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not given	25896976	Virus research, 204, 13–20.	Doki, T., Takano, T., Koyama, Y., & Hohdatsu, T. (2015).	Identification of the peptide derived from S1 domain that inhibits type I and type II feline infectious peritonitis virus infection	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C
DRAMP37553	LFYKYTSLQGLYTYSNLVEL	20	I-S1-22	Q66951	Coronaviridae	S	S1 protein of FIPV	[Ref:25896976]FIPV,IC50=~60μg/mL	Not Available				Not Available	[Ref:25896976]FIPV,IC50=~60μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not given	25896976	Virus research, 204, 13–20.	Doki, T., Takano, T., Koyama, Y., & Hohdatsu, T. (2015).	Identification of the peptide derived from S1 domain that inhibits type I and type II feline infectious peritonitis virus infection	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)O
DRAMP37554	VNFSISSVEEYGFWTIAYTN	20	I-S1-8	Q66951	Coronaviridae	S	S1 protein of FIPV	[Ref:25896976]FIPV,IC50=~50μg/mL	Not Available				Not Available	[Ref:25896976]FIPV,IC50=~50μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not given	25896976	Virus research, 204, 13–20.	Doki, T., Takano, T., Koyama, Y., & Hohdatsu, T. (2015).	Identification of the peptide derived from S1 domain that inhibits type I and type II feline infectious peritonitis virus infection	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC)C(C)C
DRAMP37555	YTDVMVDVNGTAITRLFYCD	20	I-S1-10	No entry found	Coronaviridae	S	S1 protein of FIPV	[Ref:25896976]FIPV,IC50=~60μg/mL	Not Available				Not Available	[Ref:25896976]FIPV,IC50=~60μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not given	25896976	Virus research, 204, 13–20.	Doki, T., Takano, T., Koyama, Y., & Hohdatsu, T. (2015).	Identification of the peptide derived from S1 domain that inhibits type I and type II feline infectious peritonitis virus infection	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O
DRAMP37556	GSHHRHVHSPFV	12	Peptide 1	A0A0S0ZR07	Coronaviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Not Available	[Ref:16704119]IBV,IC50=8.3μg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not given	16704119	Science in China. Series C, Life sciences, 49(2), 158–163.	Peng, B., Chen, H., Tan, Y., Jin, M., Chen, H., & Guo, A. (2006). 	Identification of one peptide which inhibited infectivity of avian infectious bronchitis virus in vitro	
DRAMP37557	CRPYGYRCDGVINQCCDPYHCTPPLIGICL	30	Alstotide As1	No entry found	Coronaviridae	As1	Alstonia scholaris plant	[Ref:26546678]IBV,EC50=35μM	Not Available			2MM6	We first determined the stage(s) in viral replication cycle which alstotides could inhibit using a time of drug addition assay. As1 (50 and 100 μm) was introduced to synchronized infected cells at different time points during preincubation at 4 °C and the infection at 37 °C As1 was identified as a moderate early acting anti-IBV drug, as supported by three lines of evidence. First, the time of drug addition assay revealed a significant drop of activity when As1 was added at 3 hpi, implicating an antiviral mechanism upstream of genomic replication and gene expression. Second, in transfection assay when the genetic material was electroporated into the host cells to bypass the attachment and entry steps, no inhibition over gene replication within 18 hpi was observed. In contrast, parallel As1-treated samples collected at 40 hpi showed a clear inhibition, probably because of inhibitory activity during the early stage of secondary infection. Third, As1 binds to IBV fusion glycoprotein, S protein, which plays a vital role during viral entry by attaching to Vero cell receptors and triggering membrane fusion between enveloped virus and host cells. In this assay, As1 added during attachment (at 4 °C) or entry (after transfer to 37 °C) exhibited comparable positive effects. As1 significantly lost its activity when added during later stages from 3 hpi onward. Comparable intensities of the endogenous control actin bands for both the treated and untreated samples excluded the effect of As1 on cellular protein synthesis, thus suggesting that As1 acts during an early stage of the viral infection.	[Ref:26546678]IBV,EC50=35μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	Cytotoxicity assay showed that As1 and As3 did not induce significant cytotoxicity in Vero cells at concentrations up to 100 μm	S protein	26546678	The Journal of biological chemistry, 290(52), 31138–31150.	Nguyen, P. Q., Ooi, J. S., Nguyen, N. T., Wang, S., Huang, M., Liu, D. X., & Tam, J. P. (2015). 	Antiviral Cystine Knot α-Amylase Inhibitors from Alstonia scholaris	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)O)C(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37558	CVPRFGRCDGIINOCCDPYLCTPPLVGICT	30	Alstotide As3	No entry found	Coronaviridae	Not Available	Alstonia scholaris plant	Antimrobial; Antiviral	Not Available				The putative antiviral mechanism of As1 is through its interference with S protein function during IBV entry.	[Ref:26546678]IBV,EC50=55μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	Cytotoxicity assay showed that As1 and As3 did not induce significant cytotoxicity in Vero cells at concentrations up to 100 μm	S protein	26546678	The Journal of biological chemistry, 290(52), 31138–31150.	Nguyen, P. Q., Ooi, J. S., Nguyen, N. T., Wang, S., Huang, M., Liu, D. X., & Tam, J. P. (2015). 	Antiviral Cystine Knot α-Amylase Inhibitors from Alstonia scholaris	
DRAMP37559	SLSLDFEKLNVTLLDLTYEMNRIQDAIKKLNESYINLKE	39	HR2	None 	Coronaviridae	Not Available	HR2 region of MHV	[Ref:2885899]MHV,IC90=50μM	Not Available				Using biological assays, the HR2 peptide was shown to be a potent inhibitor of virus entry into the cell, as well as of cell-cell fusion	[Ref:2885899]MHV,IC90=50μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Spike Protein	12885899	Journal of virology, 77(16), 8801–8811.	Bosch, B. J., van der Zee, R., de Haan, C. A., & Rottier, P. J. (2003).	The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP37560	ARLPRKKWK	9	C20-Jp-Hp	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				The ARLPR is a sialic acid mimic, the compound was demonstrated to bind the fusogenic region of HA, as indicated by CD spectra registered for the fusion peptide alone or in presence of C20-Jp-Hp	[Ref:26952867]IAV:IC50=0.53 ± 0.25ug/ml	No hemolysis information or data found in the reference(s) presented in this entry	Linear	C20	Free		L	No cytotoxicity information found in the reference(s) presented	Hemagglutinin protein	26952867	Scientific reports, 6, 22790. 	Lin, D., Li, F., Wu, Q., Xie, X., Wu, W., Wu, J., Chen, Q., Liu, S., & He, J. (2016). 	"A ""building block"" approach to the new influenza A virus entry inhibitors with reduced cellular toxicities"	
DRAMP37561	YYTRWQGGLRYIRPCG	16	eVpeD2	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				The macrocyclic peptide eVpeD2 exhibits potent binding to immobilized Zaire Ebola virus VP24, with a dissociation constant (KD) in the single-digit nanomolar range. Studies show that eVpeD2 disrupts the protein-protein interaction between eVP24 and KPNA5, confirmed through assays like the AlphaLISA-based binding assay. This inhibition suggests eVpeD2's potential as a modulator of a crucial interaction in Ebola virus pathogenesis.	[Ref:28574091]EBOV:IC50=9 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Acetylation	In the peptide sequence, the N-terminus is acetylated, and the tyrosine residue at position 1 is in the D-configuration	L	No cytotoxicity information found in the reference(s) presented	VP24	28574091	Org Biomol Chem. 2017;15(24):5155-5160.	Song X, Lu LY, Passioura T, et al.	Macrocyclic peptide inhibitors for the protein-protein interaction of Zaire Ebola virus protein 24 and karyopherin alpha 5. 	
DRAMP37562	YIVPWNGGSRLIRNSRCG	18	eVpeD1	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				eVpeD1 works against the Ebola virus by inhibiting the protein-protein interaction (PPI) between the viral protein VP24 and the host protein karyopherin alpha 5 (KPNA5). VP24 interferes with the host's immune response by binding to KPNA5, which is crucial for transporting antiviral signaling proteins into the nucleus. By binding to VP24, eVpeD1 prevents its interaction with KPNA5, thereby restoring the normal function of the immune signaling pathway. This inhibition was demonstrated in vitro using an AlphaLISA-based binding assay, where eVpeD1 disrupted the VP24-KPNA5 interaction. Consequently, eVpeD1 and similar peptides have potential as novel antiviral agents against Ebola virus by targeting and blocking this critical PPI.	[Ref:28574091]EBOV:IC50=28 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Acetylation	In the peptide sequence, the N-terminus is acetylated, and the tyrosine residue at position 1 is in the D-configuration.)	L	No cytotoxicity information found in the reference(s) presented	VP24	28574091	Org Biomol Chem. 2017;15(24):5155-5160.	Song X, Lu LY, Passioura T, et al.	Macrocyclic peptide inhibitors for the protein-protein interaction of Zaire Ebola virus protein 24 and karyopherin alpha 5. 	
DRAMP37563	RWLRGLLSGLLR	12	DFTavP3	No entry found	Filoviridae	Not Available	Designed In-silico (Ab-initio) by using database filtering technology	[Ref:35631348]EBOV:IC50:2.5, 5, or 10 microM	Not Available				DFTavP3 likely inhibits Ebola virus infection by targeting specific parameters designed to disrupt viral entry or replication. Its mechanism of action may involve interference with viral attachment, fusion, or replication processes, ultimately reducing viral infectivity. This inhibition could occur through direct interaction with viral components or through modulation of host cell factors essential for viral propagation, leading to decreased viral replication and infection in Vero cells.	[Ref:35631348]EBOV:IC50:2.5, 5, or 10 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	35631348	 Pharmaceuticals (Basel). 2022;15(5).	Ripperda T, Yu Y, Verma A, et al.	Improved Database Filtering Technology Enables More Efficient Ab Initio Design of Potent Peptides against Ebola Viruses.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP37564	GLRCRLGRLLRRLGRCLLR	19	DDIP1	No entry found	Filoviridae	Not Available	Designed In-silico (Ab-initio) by using database filtering technology	Not Available	Not Available				 DDIP1, a database-designed inhibitory peptide, against Ebola virus. In experiments using an Ebola virus pseudo-type system, DDIP1 effectively inhibited the entry of pseudo-Ebola virus (VSV-eGP) into Vero cells at an early stage of infection. These findings suggest DDIP1's potential as a novel treatment for Ebola by targeting viral entry.	Not Available	The hemolytic activity of DDIP1 was assessed using murine red blood cells, where the HC50 (concentration causing 50% hemolysis) was greater than 160 microM, indicating low hemolytic activity.	Linear	Free	Free		L	[Ref:35631348]DDIP1 was evaluated for its cytotoxicity using various cell lines, including Vero cells and Calu3 cells. The results indicated that DDIP1 had a TC50 (toxic concentration at 50% cell deat	glycoprotein.	35631348	 Pharmaceuticals (Basel). 2022;15(5).	Ripperda T, Yu Y, Verma A, et al.	Improved Database Filtering Technology Enables More Efficient Ab Initio Design of Potent Peptides against Ebola Viruses.	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP37565	RWLRGLLSGLLRRLLS	16	DFTavP2	No entry found	Filoviridae	Not Available	Designed In-silico (Ab-initio) by using database filtering technology	[Ref:35631348]EBOV:IC33=5 microM	Not Available				DFTavP2 likely combats the Ebola virus by interacting with viral glycoproteins or host cell receptors, thereby inhibiting viral entry into host cells. It may disrupt viral membranes, compromising the virus's structural integrity and function. The peptide could also interfere with the virus's replication machinery by binding to viral RNA or essential proteins. Overall, these mechanisms highlight DFTavP2's potential in blocking critical stages of the Ebola virus lifecycle	[Ref:35631348]EBOV:IC33=5 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	35631348	 Pharmaceuticals (Basel). 2022;15(5).	Ripperda T, Yu Y, Verma A, et al.	Improved Database Filtering Technology Enables More Efficient Ab Initio Design of Potent Peptides against Ebola Viruses.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O
DRAMP37566	RWLRGLLSGLLRRLLSGLLL	20	DFTavP1	No entry found	Filoviridae	Not Available	Designed In-silico (Ab-initio) by using database filtering technology	[Ref:35631348]EBOV:IC50= 2.5 microM	Not Available				DFTavP1 is a designed peptide that inhibits Ebola virus by blocking viral entry and disrupting viral envelopes, crucial steps in infection. Studies show DFTavP1 and similar peptides effectively inhibit pseudo-Ebola virus (VSV-eGP) in Vero cells, exhibiting dose-responsive inhibition even post-infection.	[Ref:35631348]EBOV:IC50= 2.5 microM	[Ref:35631348]DFTavP1 displayed hemolytic activity, with an HC50 (the concentration that caused 50% hemolysis) below 12.5 microM. In contrast, DDIP1, another designed peptide, showed a higher HC50 val	Linear	Free	Free		L	[Ref:35631348]DFTavP1 showed cytotoxic effects on Vero cells, with a TC50 (the peptide concentration that killed 50% of cells) of 2.4 microM. The peptide also exhibited cytotoxicity to Calu3 cells, wi	Viral envelopes.	35631348	 Pharmaceuticals (Basel). 2022;15(5).	Ripperda T, Yu Y, Verma A, et al.	Improved Database Filtering Technology Enables More Efficient Ab Initio Design of Potent Peptides against Ebola Viruses.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
DRAMP37567	SGWIYWAV	8	CP3	No entry found	Filoviridae	Not Available	Designed In-silico on VEGAZZ software	[Ref:32998394]EBOV:IC50 = 25.8 microM	Not Available				CP3, a cyclic peptide inhibitor, can inhibit Ebola virus budding by preventing the binding of UEV domain proteins to the P6 motif. CP3 forms hydrogen bonds with UEV domain proteins through its Tyr147 and Trp148 residues. Additionally, its Trp145, Tyr147, Ile146, and Trp148 residues engage in nonbonding interactions with UEV domain proteins. These interactions suggest that CP3 effectively disrupts the protein-protein interactions essential for the budding of both Ebola viruses.	[Ref:32998394]EBOV:IC50 = 25.8 microM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	VP40.	32998394	Polymers (Basel). 2020;12(10)	Lin WW, Wang YJ, Ko CW, et al	Cyclic Peptide Inhibitors of the Tsg101 UEV Protein Interactions Refined through Global Docking and Gaussian Accelerated Molecular Dynamics Simulations	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37568	SGWIAWNV	8	CP2	No entry found	Filoviridae	Not Available	Designed In-silico on VEGAZZ software	[Ref:32998394]EBOV:IC50=296.3 microM	Not Available				CP2, a cyclic peptide inhibitor, has a weaker binding affinity for UEV domain proteins compared to CP1. Consequently, CP1 and CP3 are more effective at preventing UEV domain proteins from binding to the P6 motif, thereby inhibiting Ebola virus budding. In contrast, CP2's weaker binding suggests it is less potent in disrupting the necessary protein-protein interactions for virus budding inhibition.	[Ref:32998394]EBOV:IC50=296.3 microM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	VP40.	32998394	Polymers (Basel). 2020;12(10)	Lin WW, Wang YJ, Ko CW, et al	Cyclic Peptide Inhibitors of the Tsg101 UEV Protein Interactions Refined through Global Docking and Gaussian Accelerated Molecular Dynamics Simulations	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37569	SGWIYWNV	8	CP1	No entry found	Filoviridae	Not Available	Designed In-silico on VEGAZZ software	[Ref:32998394]EBOV:IC50=48.6 microM	Not Available				The cyclic peptide CP1 works against Ebola virus by inhibiting the binding of the UEV domain protein to the Ebola Vp40 protein. This interference prevents the budding of the Ebola virus, thereby hindering its replication and spread. The specific residues Trp145, Tyr147, and Trp148 of CP1 play essential roles in the interactions between CP1 and the UEV domain protein, contributing to its inhibitory effect. By disrupting these protein-protein interactions crucial for virus budding, CP1 shows promise as a potential therapeutic agent against Ebola virus infections.	[Ref:32998394]EBOV:IC50=48.6 microM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	VP40.	32998394	Polymers (Basel). 2020;12(10)	Lin WW, Wang YJ, Ko CW, et al	Cyclic Peptide Inhibitors of the Tsg101 UEV Protein Interactions Refined through Global Docking and Gaussian Accelerated Molecular Dynamics Simulations	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37570	IGIEDLSKNIKDKIDKIIHDFVDKTLPDQG	30	EBOV-8	No entry found	Filoviridae	Not Available	Cholesterol-conjugated synthetic peptide	Antimrobial; Antiviral	Not Available				Exact MoA explicitly not available (EBOV-8 likely inhibits Ebola virus by targeting viral entry and fusion processes. It may interfere with viral glycoproteins, preventing the virus from attaching to and entering host cells. Additionally, EBOV-8 could disrupt the fusion between the viral envelope and host cell membrane, blocking the release of viral genetic material. By targeting these critical steps, the peptide effectively halts infection and viral replication. The specific antiviral mechanisms of EBOV-8 involve interactions with viral proteins essential for these processes. Detailed studies and assays in the full research paper would provide further insights into these mechanisms.).	[Ref:31473342]EBOV:EC50=18.47 plusminus 4.64 microM;EC90=69.49 microM.EBOV-GP EC50=4.02 plusminus 1.13 microM;EBOV-GP EC90=20.22 microM.ma-EBOV EC50=19.80 plusminus 1953 microM;ma-EBOV EC90=142 microM.GP =>GlycoProtein;ma =>Mouse-Adapted	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	cholesterylation	PEG12	In the peptide sequence, the cysteine residue at position 31 is modified with a PEG12-cholesterol (PEG12-Chol) moiety	L	[Ref:31473342]EBOV-8 show cytotoxicity (CC50) at greater than 30 microM.EBOV-5 show cytotoxicity (CC50) at >= 25 microM (when tested for EBOV-GP).EBOV-5 show cytotoxicity (CC50) at >= 44.0 microM (whe	Glycoprotein.	31473342	Antiviral Res. 2019;171:104592. 	Pessi A, Bixler SL, Soloveva V, et al	Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo	
DRAMP37571	IEPHDWTKNIKDKIDKIIHDFVDKTLPDQG	30	EBOV-7	No entry found	Filoviridae	Not Available	Cholesterol-conjugated synthetic peptide	Antimrobial; Antiviral	Not Available				EBOV-7 works against Ebola virus by targeting its entry and replication processes. It likely prevents the virus from binding to host cell receptors or fusing with cellular membranes, thus inhibiting viral entry. The peptide stabilizes an alpha-helical structure, enhancing its ability to interact with viral components critical for these processes. With a potency of 0.5 microM, EBOV-7 effectively disrupts the viral life cycle. In vivo studies in mice have shown that EBOV-7 has robust antiviral activity against Ebola virus, further confirming its efficacy. Overall, EBOV-7 interferes with viral entry and stabilizes essential structures, making it a strong candidate for therapeutic use against Ebola.	[Ref:31473342]EBOV:EC50=1.90 plusminus 0.28;EC90=9.44 microM.EBOV-GP EC50=0.60 plusminus 0.20 microM;EBOV-GP EC90=6.15 microM.ma-EBOV EC50=0.50 plusminus 0.09 microM;ma-EBOV EC90=3.45 microM.GP =>GlycoProtein;ma =>Mouse-Adapted	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	cholesterylation	PEG12	In the peptide sequence, the cysteine residue at position 31 is modified with a PEG4-cholesterol (PEG4-Chol) moiety	L	[Ref:31473342]EBOV-7 show cytotoxicity (CC50) at greater than 30 microM.EBOV-5 show cytotoxicity (CC50) at >= 25 microM (when tested for EBOV-GP).EBOV-5 show cytotoxicity (CC50) at >= 42.6 microM (whe	Glycoprotein.	31473342	Antiviral Res. 2019;171:104592. 	Pessi A, Bixler SL, Soloveva V, et al	Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo	
DRAMP37572	DWTKNIKDKIDKIIHDFVDKTLPDQGC	26	EBOV-6	No entry found	Filoviridae	Not Available	Cholesterol-conjugated synthetic peptide	Antimrobial; Antiviral	Not Available				EBOV-6 works against the Ebola virus by targeting the fusion process required for the virus to enter host cells. Specifically, it binds to the C-terminal heptad-repeat (HR2) domain of the Ebola virus glycoprotein GP2. This binding disrupts the formation of the fusion complex, a critical structure that facilitates the merging of the viral and host cell membranes. By interfering with this fusion process, EBOV-6 prevents the virus from entering and infecting the host cells. Consequently, this inhibition leads to a reduction in viral replication and spread, making EBOV-6 a potential antiviral agent against Ebola virus infection	[Ref:31473342]EBOV:EC50=1.90 plusminus 0.39 microM, 3.67 plusminus 0.89 microM, 5.44 plusminus 0.85 microM; EBOV EC90 = 9.84 microM, 15.33 microM, 25.75 microM.EBOV-GP EC50 = 1.82 plusminus 0.55 microM; EBOV-GP EC90 = 29.46 microM.ma-EBOV EC50 = 7.95 plusminus 28.30 microM; ma-EBOV EC90 = 211 microM.GP => GlycoProtein; ma => Mouse-Adapted	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	cholesterylation	PEG12	In the peptide sequence, the cysteine residue at position 27 is modified with a PEG4-cholesterol (PEG4-Chol) moiety.)	L	[Ref:31473342]EBOV-6 show cytotoxicity (CC50) at greater than 30 microM.EBOV-5 show cytotoxicity (CC50) at >= 25 microM (when tested for EBOV-GP).EBOV-5 show cytotoxicity (CC50) at >= 47.4 microM (whe	Glycoprotein.	31473342	Antiviral Res. 2019;171:104592. 	Pessi A, Bixler SL, Soloveva V, et al	Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo	
DRAMP37573	DWTKNIKDKIDKIIHDFVDKTLPDQG	26	EBOV-5	No entry found	Filoviridae	Not Available	Cholesterol-conjugated synthetic peptide	Antimrobial; Antiviral	Not Available				Exact MoA explicitly not available (may interfere with the binding of the Ebola virus glycoprotein to host cell receptors, thereby preventing viral entry into host cells).	[Ref:31473342]EBOV:EC₅₀= 3.88 ± 0.67 μM, 3.89 ± 0.61 μM; EBOV EC₉₀=17.27 μM, 16.86 μM; EBOV-GP EC₅₀=2.45 ± 1.09 μM; EBOV-GP EC₉₀= 29.46 μM; ma-EBOV EC₅₀= 2.34 ± 0.69 μM; ma-EBOV EC₉₀=16.2 μM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	cholesterylation	PEG4 	In the peptide sequence, the cysteine residue at position 27 is modified with a PEG4-cholesterol (PEG4-Chol) moiety.)	L	[Ref:31473342}EBOV:CC₅₀ > 30 μM; EBOV-5 CC₅₀ ≥ 25 μM (EBOV-GP); EBOV-5 CC₅₀ ≥ 51.7 μM (ma-EBOV).	Glycoprotein.	31473342	Antiviral Res. 2019;171:104592. 	Pessi A, Bixler SL, Soloveva V, et al	Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo	
DRAMP37574	DWTKNIKDKIDKIIHDFVDK	20	EBOV-4	No entry found	Filoviridae	Not Available	Cholesterol-conjugated synthetic peptide	Antimrobial; Antiviral	Not Available				Exact MoA explicitly not available (may interfere with the binding of the Ebola virus glycoprotein to host cell receptors, thereby preventing viral entry into host cells).	[Ref:31473342]EBOV:EC50 = 6.29 plusminus 0.66 microM, 8.10 plusminus 0.63 microM, 6.67 plusminus 0.89 microM, 9.04 plusminus 1.23 microM; EC90 = 19.41 microM, 24.79 microM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	cholesterylation	PEG4 	In the peptide sequence, the cysteine residue at position 21 is modified with a PEG4-cholesterol (PEG4-Chol) moiety.	L	[Ref:31473342]EBOV-4 show cytotoxicity (CC50) at greater than 30 microM.	Glycoprotein.	31473342	Antiviral Res. 2019;171:104592. 	Pessi A, Bixler SL, Soloveva V, et al	Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo	
DRAMP37575	IEPHDWTKNITDKIDQIIHDFVDKTLPDQG	30	EBOV-3	P03518##P21401	Filoviridae	Not Available	Cholesterol-conjugated synthetic peptide	Antimrobial; Antiviral	Not Available				EBOV-3 is an elongated peptide with five residues downstream of the helical domain. This modification likely contributes to the peptide's potency in inhibiting EBOV infection. By targeting specific regions of the EBOV glycoprotein, EBOV-3 interferes with viral entry and replication processes, ultimately inhibiting the virus's ability to infect host cells	[Ref:31473342]EBOV:EC50 = 12.89 plusminus 1.59 microM, 11.94 plusminus 2.59 microM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	cholesterylation	PEG4 	In the peptide sequence, the cysteine residue at position 31 is modified with a PEG4-cholesterol (PEG4-Chol) moiety.	L	[Ref:31473342]EBOV-3 show cytotoxicity (CC50) at greater than 30 microM.	Glycoprotein.	31473342	Antiviral Res. 2019;171:104592. 	Pessi A, Bixler SL, Soloveva V, et al	Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo	
DRAMP37576	SGSWNFFDWFSGLMSWFGGPL	21	RVFV-10	No entry found	Filoviridae	GP	 Rift Valley fever virus (RVFV) Gc stem region	[Ref:24069485]EBOV:IC50=50 microM	Not Available			6EGT	RVFV-10, a fusion-inhibiting peptide derived from the RVFV Gc stem region, displayed inhibitory effects against Ebola virus (EBOV) in a plaque-reduction assay, albeit less effectively than RVFV-6. Despite demonstrating weaker inhibition compared to RVFV-6, RVFV-10's efficacy against EBOV prompted further evaluation, ultimately leading to the selection of RVFV-6 for subsequent studies due to its superior inhibitory activity.	[Ref:24069485]EBOV:IC50=50 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	DII domain of the E protein (RVFV-10 may interact with a specific region of the Ebola virus (EBOV) d	24069485	PLoS Negl Trop Dis. 2013;7(9):e2430.	Koehler JW, Smith JM, Ripoll DR	A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses	CSCC[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O
DRAMP37577	YGRKKRRQRRRGSGIEPHDWTKNITCKIOQIIHDFVDK	38	5-Link	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				5-Link displayed antiviral activity against vesicular stomatitis virus particles containing the Ebola virus glycoprotein (VSV-GP), inhibiting infection at concentrations below 15 microM. It exhibited broad antiviral activity against both VSV-GP and VSV-G at lower concentrations, but induced toxicity in Vero cells at concentrations exceeding 15 microM, limiting further assessment. The peptide's specificity towards VSV-GP over VSV-G suggests a mechanism involving interference with viral entry, similar to its action against VSV-GP particles, thereby inhibiting Ebola virus infection. This indicates 5-Link's potential as a therapeutic agent targeting viral entry mediated by the Ebola virus glycoprotein.	[Ref:23962564]EBOV:IC50=15 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Acetylation	The peptide sequence features N-terminal acetylation (Ac-), which enhances stability by protecting it from enzymatic degradation and making it more resistant to proteolysis. To further enhance the peptide's structure and function, alpha-helical stabilization can be introduced through covalent side chain-side chain cross-links. This is achieved by linking Cys at position 26 (C) with another suitable residue i.e., Ornithine (Orn) Ornithine (Orn) at position 29 (i.e., i and i+3). These cross-links 	L	[Ref:23962564]Vero cells incubated with concentrations of 5-Link exceeding 15 microM showed signs of toxicity by visual inspection, which prevented assessment of antiviral activity at higher concentra	Glycoprotein.	23962564	Bioorg Med Chem Lett. 2013;23(19):5356-60.	Higgins CD, Koellhoffer JF, Chandran K	C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking	
DRAMP37578	YGRKKRRQRRRGSGIEPHDWTKCITOKIDQIIHDFVDK	38	4-Link	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Peptide 4-Link demonstrated strong neutralization of vesicular stomatitis virus particles carrying the Ebola virus glycoprotein (VSV-GP), resulting in a notable decrease in infection at a concentration of 40 microM. Its effectiveness against Ebola virus was evaluated by measuring the reduction in infection events induced by VSV-GP in its presence. Additionally, 4-Link displayed inhibitory effects on VSV particles bearing their native glycoprotein G (VSV-G), a lesser extent than VSV-GP, suggesting a degree of specificity towards the Ebola virus glycoprotein. These findings suggest that 4-Link likely targets the viral entry process common to both viruses, with a higher affinity for the Ebola virus glycoprotein, thereby inhibiting infection.	[Ref:23962564]EBOV:IC50=40 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Acetylation	In the peptide sequence, N-terminal acetylation (Ac-) blocks the free amine group, protecting the peptide from exopeptidase degradation and increasing stability. To promote an alpha-helical conformation, side chain-side chain cross-links were introduced, particularly between Cys (C) at position 23 and an Ornithine (O) residue replacing Lys (K), positioned for cross-linking (at i and i + 3). These modifications help stabilize the helical structure, especially in regions predisposed to alpha-helix	L	[Ref:23962564]Non-toxic (At 40 microM concentration, peptide 4-Link demonstrated good tolerance by Vero cells, as evaluated through visual examination and a commercial viability assay. At the same con	Glycoprotein.	23962564	Bioorg Med Chem Lett. 2013;23(19):5356-60.	Higgins CD, Koellhoffer JF, Chandran K	C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking	
DRAMP37579	KKKKGSGC	8	3-Chol	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				3-Chol, comprising a tetralysine segment linked to cholesterol, effectively inhibits both VSV-GP and VSV-G viral entry, with over 90% inhibition at higher concentrations. Despite lacking the GP CHR sequence, its activity against VSV-GP suggests a potential dependency on the native C-heptad repeat sequence. The study underscores the non-specific inhibitory role of cholesterol-conjugated peptides like 3-Chol against VSV-GP entry, implicating a mechanism involving both peptide and cholesterol components in inhibiting Ebola virus glycoprotein-mediated cell entry.	[Ref:23962564]EBOV:IC90=20 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	cholesterylation	Free	In the peptide sequence, the cysteine residue at position 8 is modified with a cholesterol (Chol) moiety. HIV-1 C-peptide conjugated to cholesterol contain covalent side chain-side chain crosslinks to promote an alpha-helical conformation. The cholesterol-conjugated C-peptides proved to be potent inhibitors of Ebola virus glycoprotein (GP)-mediated cell entry (~10^3-fold reduction in infection at 40 microM	L	[Ref:23962564]Exceeding 15 microM, concentrations of 3-Chol caused observable toxicity in Vero cells, hindering the evaluation of its antiviral activity at higher doses.	Glycoprotein.	23962564	Bioorg Med Chem Lett. 2013;23(19):5356-60.	Higgins CD, Koellhoffer JF, Chandran K	C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking	
DRAMP37580	IEPHDWTKNITDKIDQIIHDFVDKGSGKKKKC	32	2-Chol	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				2-Chol was evaluated for its effectiveness against Ebola virus. The assay involved assessing the capacity of 2-Chol to inhibit GP-mediated viral entry using a vesicular stomatitis virus particle bearing the Ebola virus GP (VSV-GP) in place of the native glycoprotein G. The primary infection events were quantified by fluorescence confocal microscopy. Results showed that 2-Chol resulted in potent inhibition of VSV-GP entry, with approximately a 10^3-fold reduction in infection at 40 microM peptide concentrations. This level of inhibition was significantly higher than previously reported VSV-GP inhibition by Tat-Ebo at higher peptide concentrations. Notably, 2-Chol also exhibited potent activity for inhibiting VSV bearing its native envelope glycoprotein G (VSV-G), with over 90% reduction at 10 microM peptide concentration and more than 99% reduction at higher concentrations. Importantly, 2-Chol showed only modest cell toxicity under these conditions . Therefore, 2-Chol demonstrated potent inhibition of Ebola virus glycoprotein-mediated cell entry, suggesting a non-specific mechanism of neutralization that may involve a combination of peptide and cholesterol moieties.	[Ref:23962564]EBOV:IC50=40 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	cholesterylation	Free	In the peptide sequence, the cysteine residue at position 32 is modified with a cholesterol (Chol) moiety. HIV-1 C-peptide conjugated to cholesterol contain covalent side chain-side chain crosslinks to promote an alpha-helical conformation. The cholesterol-conjugated C-peptides proved to be potent inhibitors of Ebola virus glycoprotein (GP)-mediated cell entry (~10^3-fold reduction in infection at 40 microM	L	[Ref:23962564]2-Chol showed only modest cell toxicity under certain conditions (see MoA).	Glycoprotein.	23962564	Bioorg Med Chem Lett. 2013;23(19):5356-60.	Higgins CD, Koellhoffer JF, Chandran K	C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking	
DRAMP37581	KKKKGSGIEPHDWTKNITDKIDQIIHDFVDK	32	1-Chol	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				1-Chol, a cholesterol-conjugated C-peptide inhibitor, disrupts Ebola virus cell entry by targeting the glycoprotein-mediated fusion process. Specifically, it binds to the GP2 C-heptad repeat region (CHR), hindering the formation of the six-helix bundle crucial for membrane fusion. Effective at a concentration of 40 microM, 1-Chol's cholesterol conjugation enhances its alpha-helical structure independently of concentration, contributing to its broad inhibitory activity against Ebola virus. The combined peptide and cholesterol components of 1-Chol play a vital role in its inhibition of viral entry	[Ref:23962564]EBOV:IC50=50 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	cholesterylation	Free	In the peptide sequence, the cysteine residue at position 1 is modified with a cholesterol (Chol) moiety. This HIV-1 C-peptide conjugated to cholesterol contain covalent side chain-side chain crosslinks to promote an alpha-helical conformation. The cholesterol-conjugated C-peptides proved to be potent inhibitors of Ebola virus glycoprotein (GP)-mediated cell entry (~10^3-fold reduction in infection at 40 microM)	L	[Ref:23962564]At certain concentrations, 1-Chol, a cholesterol-conjugated peptide inhibitor, demonstrates only a slight cell toxicity of approximately 20%, indicating a low level of toxicity within th	Glycoprotein.	23962564	Bioorg Med Chem Lett. 2013;23(19):5356-60.	 Higgins CD, Koellhoffer JF, Chandran K	C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking.	
DRAMP37582	YGRKKRRQRRRGSGIEPHDWTKNITDKIDQIIHDFVDK	38	Tat-Ebo	Q5CAP7##Q5CAJ5	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				 Tat-Ebo, a peptide combining HIV-1 Tat Arg-rich sequence with Ebola virus GP2 residues 610 - 633, combats Ebola virus within cells. It impedes viral membrane fusion by binding to a GP2 fusion intermediate, particularly targeting the extended conformation during fusion. Tat-Ebo enhances its antiviral efficacy by promoting internalization into cells and accumulating in endosomes. Its mode of action involves sequestering the extended intermediate, crucial for its effectiveness. Tat-Ebo's specificity lies in inhibiting filovirus GP proteins, including various strains, through sequestration. Demonstrating broad-spectrum inhibition, it effectively hampers infection mediated by diverse Ebola virus strains.	[Ref:23962564]EBOV:IC50=75 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:23962564]Low cytotoxicity (cytotoxicity assays indicated that Tat-Ebo was well tolerated by Vero cells at concentrations up to 75 microM).	Viral membrane.	21454542## 23962564	J Biol Chem. 2011;286(18):15854-61;##Bioorg Med Chem Lett. 2013;23(19):5356-60.	Miller EH, Harrison JS, Radoshitzky SR;##Higgins CD, Koellhoffer JF, Chandran K,	Inhibition of Ebola virus entry by a C-peptide targeted to endosomes;##C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking	
DRAMP37583	GMKCKFCCNCCNLNGCGVCCRF	22	SmHep2P	Q52PA0	Paramyxoviridae	thp,TAPP	Turbot, Scophthalmus maximus	[Ref:24647314]Significantly inhibit the megalocytivirus	Not Available				These peptides inhibit viral propagation by disruption of the viral envelope and/or capsid	[Ref:24647314]Significantly inhibit the megalocytivirus	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Found	24647314	Fish & shellfish immunology, 38(1), 127–134.	Zhang, J., Yu, L. P., Li, M. F., & Sun, L. (2014).	Turbot (Scophthalmus maximus) hepcidin-1 and hepcidin-2 possess antimicrobial activity and promote resistance against bacterial and viral infection	CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP37584	QSHISLCRWCCNCCKANKGCGFCCKF	26	SmHep1P	A0A142LQX2	Paramyxoviridae	hamp	Turbot, Scophthalmus maximus	[Ref:24647314]Significantly inhibit the megalocytivirus	Not Available				These peptides inhibit viral propagation by disruption of the viral envelope and/or capsid	[Ref:24647314]Significantly inhibit the megalocytivirus	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Found	24647314	Fish & shellfish immunology, 38(1), 127–134.	Zhang, J., Yu, L. P., Li, M. F., & Sun, L. (2014).	Turbot (Scophthalmus maximus) hepcidin-1 and hepcidin-2 possess antimicrobial activity and promote resistance against bacterial and viral infection	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP37585	NPAGCRFCCGCCPNMIGCGVCCRF	24	SA-hepcidin2	No entry found	Rhabdoviridae 	Hepcidin(protein)	Liver, spotted scat, Scatophagus argus	[ReF:26845697]SCRV:IC50: 50 μM,MsReV:Ic50=25 μM,SA-hepcidin2 showed a dose-dependent protective effect against SCRV and MsReV.CPE in GCF and EPC monolayers after co-treatment with SA-hepcidins (50 μM)	Not Available				direct effects on the virion and effects on the innate and adaptive immunity of target cells 	[ReF:26845697]SCRV:IC50: 50 μM,MsReV:Ic50=25 μM,SA-hepcidin2 showed a dose-dependent protective effect against SCRV and MsReV.CPE in GCF and EPC monolayers after co-treatment with SA-hepcidins (50 μM) and virus (0.1TCID50)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Found	26845697	Fish & shellfish immunology, 50, 191–199.	Gui, L., Zhang, P., Zhang, Q., & Zhang, J. (2016). 	Two hepcidins from spotted scat (Scatophagus argus) possess antibacterial and antiviral functions in vitro	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP37586	RICRCICGRRICRCICGR	18	Retrocyclin-3	No entry found	Retroviridae	Not Available	Derived from a silent gene (pre-stop)	Antimrobial; Antiviral	Not Available				 It binds to gp120 and CD4, thereby inhibiting HIV entry.	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	three intramolecular disulfide bonds	L	No cytotoxicity information found in the reference(s) presented	Not Found	15210812	Journal of immunology (Baltimore, Md. : 1950), 173(1), 515–520.	Wang, W., Owen, S. M., Rudolph, D. L., Cole, A. M., Hong, T., Waring, A. J., Lal, R. B., & Lehrer, R. I. (2004).	Activity of alpha- and theta-defensins against primary isolates of HIV-1	
DRAMP37587	YFKSVRTGLRYVYCS	15	eVpeL2	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				eVpeL2 exhibit inhibitory activity against the protein-protein interaction (PPI) of VP24 and KPNA5.	[Ref:28574091]EBOV:IC50 = 37 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Acetylation	In the peptide sequence, the N-terminus is acetylated, and the tyrosine residue at position 1 is in the D-configuration	L	No cytotoxicity information found in the reference(s) presented	VP24	28574091	Org Biomol Chem. 2017;15(24):5155-5160.	Song X, Lu LY, Passioura T, et al.	Macrocyclic peptide inhibitors for the protein-protein interaction of Zaire Ebola virus protein 24 and karyopherin alpha 5. 	
DRAMP37588	YYSSRWNHGHFTPCS	15	eVpeL1	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Exact MoA not known (eVpeL1, a macrocyclic peptide belonging to the GL1 group from the LY-library, was found to be a poor binder to the immobilized eVP24 compared to other peptides like eVpeD1 and eVpeD2).	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amination	In the peptide sequence, the N-terminus is acetylated, and the tyrosine residue at position 1 is in the D-configuration	L	No cytotoxicity information found in the reference(s) presented	VP24	28574091	Org Biomol Chem. 2017;15(24):5155-5160.	Song X, Lu LY, Passioura T, et al.	Macrocyclic peptide inhibitors for the protein-protein interaction of Zaire Ebola virus protein 24 and karyopherin alpha 5. 	
DRAMP37589	YGRKKRRQRRRGSGIEPHDWTKNITDKIDQIIHDFVDK	38	Tat-Ebo	No entry found	Filoviridae	Not Available	Synthetic construct	[Ref: 23962564]EBOV:IC50=75 microM	Not Available				 Tat-Ebo, a peptide combining HIV-1 Tat Arg-rich sequence with Ebola virus GP2 residues 610 - 633, combats Ebola virus within cells. It impedes viral membrane fusion by binding to a GP2 fusion intermediate, particularly targeting the extended conformation during fusion. Tat-Ebo enhances its antiviral efficacy by promoting internalization into cells and accumulating in endosomes. Its mode of action involves sequestering the extended intermediate, crucial for its effectiveness. Tat-Ebo's specificity lies in inhibiting filovirus GP proteins, including various strains, through sequestration. Demonstrating broad-spectrum inhibition, it effectively hampers infection mediated by diverse Ebola virus strains.	[Ref: 23962564]EBOV:IC50=75 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref: 23962564]Low cytotoxicity (cytotoxicity assays indicated that Tat-Ebo was well tolerated by Vero cells at concentrations up to 75 microM).	Viral membrane.	21454542;## 23962564	J Biol Chem. 2011;286(18):15854-61;##Bioorg Med Chem Lett. 2013;23(19):5356-60.	Miller EH, Harrison JS, Radoshitzky SR;##Higgins CD, Koellhoffer JF, Chandran K,	Inhibition of Ebola virus entry by a C-peptide targeted to endosomes;##C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP37590	KKKKGSGIEPHDWTKNITDKIDQIIHDFVDK	32	1-Chol	Q9WTL0	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				1-Chol, a cholesterol-conjugated C-peptide inhibitor, disrupts Ebola virus cell entry by targeting the glycoprotein-mediated fusion process. Specifically, it binds to the GP2 C-heptad repeat region (CHR), hindering the formation of the six-helix bundle crucial for membrane fusion. Effective at a concentration of 40 microM, 1-Chol's cholesterol conjugation enhances its alpha-helical structure independently of concentration, contributing to its broad inhibitory activity against Ebola virus. The combined peptide and cholesterol components of 1-Chol play a vital role in its inhibition of viral entry	[Ref:23962564] Inhibition concentraion = 50 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	cholesterylation	Free	In the peptide sequence, the cysteine residue at position 1 is modified with a cholesterol (Chol) moiety. This HIV-1 C-peptide conjugated to cholesterol contain covalent side chain-side chain crosslinks to promote an alpha-helical conformation. The cholesterol-conjugated C-peptides proved to be potent inhibitors of Ebola virus glycoprotein (GP)-mediated cell entry (~10^3-fold reduction in infection at 40 microM)	L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	23962564	Bioorg Med Chem Lett. 2013;23(19):5356-60.	 Higgins CD, Koellhoffer JF, Chandran K	C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking.	
DRAMP37591	KINNPVSCLRKGGRCWNRCIGNTRQIGSCGVPFLKCCKRK	40	MBD-3	No entry found	Orthomyxoviridae	Defb3	Epithelia, respiratory system and other mucosal surfaces, mouse, M. musculus	[Ref:24632574]IAV:TCID50=3.4815 ± 0.1844	Not Available				mBD1-mBD3 expressed by the recombinant plasmid pcDNA3.1(+)/mBD1-mBD3 could inhibit influenza A virus replication both in vitro and in vivo.	[Ref:24632574]IAV:TCID50=3.4815 ± 0.1844	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	22345365##19301094	Antiviral chemistry & chemotherapy, 22(6), 255–262##Archives of virology, 154(4), 639–647	Jiang, Y., Yang, D., Li, W., Wang, B., Jiang, Z., & Li, M. (2012)##Jiang, Y., Wang, Y., Kuang, Y., Wang, B., Li, W., Gong, T., Jiang, Z., Yang, D., & Li, M. (2009)	Antiviral activity of recombinant mouse β-defensin 3 against influenza A virus in vitro and in vivo##Expression of mouse beta-defensin-3 in MDCK cells and its anti-influenza-virus activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@H](C)CC)[C@@H](C)O
DRAMP37592	XXAGXXXXKVGXX	5	Mirabamide F	No entry found	Retroviridae	Not Available	 sponge Stelletta clavosa	Antimrobial; Antiviral	Not Available				The mechanism of action for peptides E through H likely involves their amphipathic and cyclic nature, which enables them to interact with both viral and host cell components to inhibit HIV-1 infection. These peptides may target the HIV-1 envelope glycoproteins, such as gp120 and gp41, which are critical for viral entry into host cells. By binding to gp120, they could block its interaction with the CD4 receptor or CCR5/CXCR4 co-receptors, preventing viral attachment. Additionally, interference with gp41 could disrupt the membrane fusion process required for viral entry. Their structural properties also suggest potential interactions with the host cell membrane, altering its lipid microdomains and impeding the fusion process. Furthermore, these peptides might inhibit the HIV-1 reverse transcriptase enzyme, blocking viral RNA to DNA transcription, or interact with viral assembly proteins to disrupt the formation of infectious virions. The exact mechanism for each peptide requires further investigation, including binding studies and structural analyses, to elucidate their precise targets and pathways of action.	[Ref: 21280591]62 ± 9	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	The N-terminal is modified by Htda (3-hydroxy-2,6,8-trimethyldeca-(4Z,6E)-dienoic acid),	The C-terminal is linked to rhamnose via β-OMeTyr	Dhtda replaced with Htda (3-hydroxy-2,6,8-trimethyldeca-(4Z,6E)-dienoic acid).β-OMeTyr-NMeThr-Ala-Gly-3-OMeAla-3-OHLeu-4-ClHPr-3,4-DiMeGln-Dab-Aba-Gly-Htda-Rha.This sequence also has several modifications. X at position 1 is β-O-methyltyrosine (β-OMeTyr), X at position 2 is N-methylthreonine (NMeThr), X at position 5 is 3-O-methylalanine (3-OMeAla), X at position 6 is 3-hydroxyleucine (3-OHLeu), X at position 7 is 4-chlorohydroxyproline (ClHPr), X at position 8 is 3,4-dimethylglutamine (3,4-DiMe	L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	21280591	J Nat Prod. 2011 Feb 25;74(2):185-93.	Lu Z, Van Wagoner RM, Harper MK, Baker HL, Hooper JN, Bewley CA, Ireland CM.	Mirabamides E-H, HIV-Inhibitory Depsipeptides from the Sponge Stelletta clavosa	
DRAMP37593	XXAGXXXXKVGXX	5	Mirabamide E	No entry found	Retroviridae	Not Available	sponge Stelletta clavosa	Antimrobial; Antiviral	Not Available				The mechanism of action for peptides E through H likely involves their amphipathic and cyclic nature, which enables them to interact with both viral and host cell components to inhibit HIV-1 infection. These peptides may target the HIV-1 envelope glycoproteins, such as gp120 and gp41, which are critical for viral entry into host cells. By binding to gp120, they could block its interaction with the CD4 receptor or CCR5/CXCR4 co-receptors, preventing viral attachment. Additionally, interference with gp41 could disrupt the membrane fusion process required for viral entry. Their structural properties also suggest potential interactions with the host cell membrane, altering its lipid microdomains and impeding the fusion process. Furthermore, these peptides might inhibit the HIV-1 reverse transcriptase enzyme, blocking viral RNA to DNA transcription, or interact with viral assembly proteins to disrupt the formation of infectious virions. The exact mechanism for each peptide requires further investigation, including binding studies and structural analyses, to elucidate their precise targets and pathways of action.	[Ref: 21280591] 121 ± 20	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	The N-terminal is modified by the Dhtda (2,3-dihydroxy-2,6,8-trimethyldeca-(4Z,6E)-dienoic acid) moiety.	The C-terminal is linked to rhamnose via β-OMeTyr, 	Threonine replaced by Aba (2-amino-2-butenoic acid).OH replaced by H in the polyketide terminal chain.Different rhamnose conformation.Threonine replaced by Aba, Dhtda (2,3-dihydroxy-2,6,8-trimethyldeca-(4Z,6E)-dienoic acid), Rhamnose linked to β-OMeTy.This sequence contains multiple modifications. X at position 1 is β-O-methyltyrosine (β-OMeTyr), X at position 2 is N-methylthreonine (NMeThr), X at position 5 is 3-O-methylalanine (3-OMeAla), X at position 6 is 3-hydroxyleucine (3-OHLeu), X at pos	L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	 30154377;##21280591	Mar Drugs. 2018 Aug 28;16(9):306;##Journal of natural products, 74(2), 185–193.	Frau J, Flores-Holguín N, Glossman-Mitnik D;##Lu, Z., Van Wagoner, R. M., Harper, M. K., Baker, H. L., Hooper, J. N., Bewley, C. A., & Ireland, C. M. (2011).	Chemical Reactivity Properties, pKa Values, AGEs Inhibitor Abilities and Bioactivity Scores of the Mirabamides A–H Peptides of Marine Origin Studied by Means of Conceptual DFT;##Mirabamides E-H, HIV-inhibitory depsipeptides from the sponge Stelletta clavosa	
DRAMP37594	XXXAGXXXKTGX	5	Mirabamide D	No entry found	Retroviridae	Not Available	marine sponge Siliquariaspongia mirabilis	Antimrobial; Antiviral	Not Available				The mechanism of action for peptides E through H likely involves their amphipathic and cyclic nature, which enables them to interact with both viral and host cell components to inhibit HIV-1 infection. These peptides may target the HIV-1 envelope glycoproteins, such as gp120 and gp41, which are critical for viral entry into host cells. By binding to gp120, they could block its interaction with the CD4 receptor or CCR5/CXCR4 co-receptors, preventing viral attachment. Additionally, interference with gp41 could disrupt the membrane fusion process required for viral entry. Their structural properties also suggest potential interactions with the host cell membrane, altering its lipid microdomains and impeding the fusion process. Furthermore, these peptides might inhibit the HIV-1 reverse transcriptase enzyme, blocking viral RNA to DNA transcription, or interact with viral assembly proteins to disrupt the formation of infectious virions. The exact mechanism for each peptide requires further investigation, including binding studies and structural analyses, to elucidate their precise targets and pathways of action.	[Ref: 17963357] mirabamides C and D (IC50 values between 140 nM and 1.3 µM for 3 and 190 nM and 3.9 µM for 4), indicating that these peptides can act at the early stages of HIV-1 entry. 	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	The N-terminal contains 4-chloro-L-homoproline (ClHPr) in A and L-homoproline (HPr) in B (without chlorine). but differs in specific substitutions elsewhere in the sequence.	The C-terminal is closed via an ester bond to form a macrocyclic structure. This esterification involves a β-hydroxyl group, making the C-terminal non-free for every variant.	Similar to Mirabamide A.This sequence contains several modified residues. X at position 1 is 4-chlorohydroxyproline (ClHPr), X at position 2 is β-O-methyltyrosine (β-OMeTyr), X at position 3 is N-methylthreonine (NMeThr), X at position 6 is 3-O-methylalanine (3-OMeAla), X at position 7 is 3-hydroxyleucine (3-OHLeu), X at position 8 is 3,4-dimethylglutamine (3,4-DiMeGln), X at position 9 is diaminobutyric acid (Dab), and X at position 12 is Dhtda, a lipid-derived tail.	L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	 30154377;## 17963357	Mar Drugs. 2018 Aug 28;16(9):305;##Journal of natural products, 70(11), 1753–1760.	Frau J, Flores-Holguín N, Glossman-Mitnik D;##Lu, Z., Van Wagoner, R. M., Harper, M. K., Baker, H. L., Hooper, J. N., Bewley, C. A., & Ireland, C. M. (2011).	Chemical Reactivity Properties, pKa Values, AGEs Inhibitor Abilities and Bioactivity Scores of the Mirabamides A–H Peptides of Marine Origin Studied by Means of Conceptual DFT;##Mirabamides A-D, depsipeptides from the sponge Siliquariaspongia mirabilis that inhibit HIV-1 fusion	
DRAMP37595	XXXAGXXXKTGX	5	Mirabamide C	No entry found	Retroviridae	Not Available	marine sponge Siliquariaspongia mirabilis	Antimrobial; Antiviral	Not Available				The mechanism of action for peptides E through H likely involves their amphipathic and cyclic nature, which enables them to interact with both viral and host cell components to inhibit HIV-1 infection. These peptides may target the HIV-1 envelope glycoproteins, such as gp120 and gp41, which are critical for viral entry into host cells. By binding to gp120, they could block its interaction with the CD4 receptor or CCR5/CXCR4 co-receptors, preventing viral attachment. Additionally, interference with gp41 could disrupt the membrane fusion process required for viral entry. Their structural properties also suggest potential interactions with the host cell membrane, altering its lipid microdomains and impeding the fusion process. Furthermore, these peptides might inhibit the HIV-1 reverse transcriptase enzyme, blocking viral RNA to DNA transcription, or interact with viral assembly proteins to disrupt the formation of infectious virions. The exact mechanism for each peptide requires further investigation, including binding studies and structural analyses, to elucidate their precise targets and pathways of action.	[Ref: 17963357] mirabamides C and D (IC50 values between 140 nM and 1.3 µM for 3 and 190 nM and 3.9 µM for 4), indicating that these peptides can act at the early stages of HIV-1 entry. 	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Similar to Mirabamide A, but the rhamnose moiety is absent.	The C-terminal is closed via an ester bond to form a macrocyclic structure. This esterification involves a β-hydroxyl group, making the C-terminal non-free for every variant.	No Cl at terminal proline. Rhamnose replaced by H.This variant differs at position 1. X is hydroxyproline (HPr), followed by X at position 2 as β-O-methyltyrosine (β-OMeTyr), X at position 3 as N-methylthreonine (NMeThr), X at position 6 as 3-O-methylalanine (3-OMeAla), X at position 7 as 3-hydroxyleucine (3-OHLeu), X at position 8 as 3,4-dimethylglutamine (3,4-DiMeGln), X at position 9 as diaminobutyric acid (Dab), and X at position 12 as Dhtda.	L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	 30154377;## 17963357	Mar Drugs. 2018 Aug 28;16(9):304;##Journal of natural products, 70(11), 1753–1760.	Frau J, Flores-Holguín N, Glossman-Mitnik D;##Lu, Z., Van Wagoner, R. M., Harper, M. K., Baker, H. L., Hooper, J. N., Bewley, C. A., & Ireland, C. M. (2011).	Chemical Reactivity Properties, pKa Values, AGEs Inhibitor Abilities and Bioactivity Scores of the Mirabamides A–H Peptides of Marine Origin Studied by Means of Conceptual DFT;##Mirabamides A-D, depsipeptides from the sponge Siliquariaspongia mirabilis that inhibits HIV-1 fusion	
DRAMP37596	XXXAGXXXVTGX	5	Mirabamide B	No entry found	Retroviridae	Not Available	marine sponge Siliquariaspongia mirabilis	Antimrobial; Antiviral	Not Available				The mechanism of action for peptides E through H likely involves their amphipathic and cyclic nature, which enables them to interact with both viral and host cell components to inhibit HIV-1 infection. These peptides may target the HIV-1 envelope glycoproteins, such as gp120 and gp41, which are critical for viral entry into host cells. By binding to gp120, they could block its interaction with the CD4 receptor or CCR5/CXCR4 co-receptors, preventing viral attachment. Additionally, interference with gp41 could disrupt the membrane fusion process required for viral entry. Their structural properties also suggest potential interactions with the host cell membrane, altering its lipid microdomains and impeding the fusion process. Furthermore, these peptides might inhibit the HIV-1 reverse transcriptase enzyme, blocking viral RNA to DNA transcription, or interact with viral assembly proteins to disrupt the formation of infectious virions. The exact mechanism for each peptide requires further investigation, including binding studies and structural analyses, to elucidate their precise targets and pathways of action.	[Ref: 17963357] 62nm	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	The N-terminal contains 4-chloro-L-homoproline (ClHPr) in A and L-homoproline (HPr) in B (without chlorine).	The C-terminal is closed via an ester bond to form a macrocyclic structure. This esterification involves a β-hydroxyl group, making the C-terminal non-free for every variant.	Same as Mirabamide A but replaces Dab (2,3-diaminobutanoic acid) with Aba (2-amino-2-butenoic acid).This sequence also features modified residues. X at position 1 is 4-chlorohydroxyproline (ClHPr), X at position 2 is β-O-methyltyrosine (β-OMeTyr), X at position 3 is N-methylthreonine (NMeThr), X at position 6 is 3-O-methylalanine (3-OMeAla), X at position 7 is 3-hydroxyleucine (3-OHLeu), X at position 8 is 3,4-dimethylglutamine (3,4-DiMeGln), X at position 9 is aminobutyric acid (Aba), and X at 	L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	 30154377;## 17963357	Mar Drugs. 2018 Aug 28;16(9):303;##Journal of natural products, 70(11), 1753–1760.	Frau J, Flores-Holguín N, Glossman-Mitnik D;##Lu, Z., Van Wagoner, R. M., Harper, M. K., Baker, H. L., Hooper, J. N., Bewley, C. A., & Ireland, C. M. (2011).	Chemical Reactivity Properties, pKa Values, AGEs Inhibitor Abilities and Bioactivity Scores of the Mirabamides A–H Peptides of Marine Origin Studied by Means of Conceptual DFT;##Mirabamides A-D, depsipeptides from the sponge Siliquariaspongia mirabilis that inhibit HIV-1 fusion	
DRAMP37597	XXXAGXXXKTGX	5	Mirabamide A	No entry found	Retroviridae	Not Available	marine sponge Siliquariaspongia mirabilis	Antimrobial; Antiviral	Not Available				The mechanism of action for peptides E through H likely involves their amphipathic and cyclic nature, which enables them to interact with both viral and host cell components to inhibit HIV-1 infection. These peptides may target the HIV-1 envelope glycoproteins, such as gp120 and gp41, which are critical for viral entry into host cells. By binding to gp120, they could block its interaction with the CD4 receptor or CCR5/CXCR4 co-receptors, preventing viral attachment. Additionally, interference with gp41 could disrupt the membrane fusion process required for viral entry. Their structural properties also suggest potential interactions with the host cell membrane, altering its lipid microdomains and impeding the fusion process. Furthermore, these peptides might inhibit the HIV-1 reverse transcriptase enzyme, blocking viral RNA to DNA transcription, or interact with viral assembly proteins to disrupt the formation of infectious virions. The exact mechanism for each peptide requires further investigation, including binding studies and structural analyses, to elucidate their precise targets and pathways of action.	[Ref: 17963357] Mirabamide A inhibited HIV-1 in neutralization and fusion assays with IC50 values between 40 and 140 nM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	The N-terminal contains 4-chloro-L-homoproline (ClHPr) in A and L-homoproline (HPr) in B (without chlorine).	The C-terminal is closed via an ester bond to form a macrocyclic structure. This esterification involves a β-hydroxyl group, making the C-terminal non-free for every variant.	Cl at terminal proline.Contains ?-methoxytyrosine glycosylated with 4′-o-?-l-rhamnopyranoside.This sequence contains several modified residues. X at position 1 is 4-chlorohydroxyproline (ClHPr), X at position 2 is β-O-methyltyrosine (β-OMeTyr), X at position 3 is N-methylthreonine (NMeThr), X at position 6 is 3-O-methylalanine (3-OMeAla), X at position 7 is 3-hydroxyleucine (3-OHLeu), X at position 8 is 3,4-dimethylglutamine (3,4-DiMeGln), X at position 9 is diaminobutyric acid (Dab), and X at p	L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	 30154377;## 17963357	Mar Drugs. 2018 Aug 28;16(9):302;##Journal of natural products, 70(11), 1753–1760.	Frau J, Flores-Holguín N, Glossman-Mitnik D:##Plaza, A., Gustchina, E., Baker, H. L., Kelly, M., & Bewley, C. A. (2007).	Chemical Reactivity Properties, pKa Values, AGEs Inhibitor Abilities and Bioactivity Scores of the Mirabamides A–H Peptides of Marine Origin Studied by Means of Conceptual DFT;##Mirabamides A-D, depsipeptides from the sponge Siliquariaspongia mirabilis that inhibit HIV-1 fusion	
DRAMP37598	DVREEEQLGERATGLNLNI	19	B-HR2-scrambled	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref:16603508]No significant inhibition	Not Available				The peptides derived from the heptad repeat (HR) regions of HSV-1 glycoproteins (gH and gB) inhibit the virus entry process by interfering with membrane fusion.	[Ref:16603508]No significant inhibition	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxic effect observed for any peptide at the tested concentrations. Cell viability remained similar to untreated cells.	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)O)NC(=O)[C@@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP37599	ALHALGYQLAFVLDSPSAY	19	H-HR1-SC	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref:16603508]:HSV:IC50=No significant inhibition	Not Available				The peptides derived from the heptad repeat (HR) regions of HSV-1 glycoproteins (gH and gB) inhibit the virus entry process by interfering with membrane fusion.	[Ref:16603508]:HSV:IC50=No significant inhibition	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxic effect observed for any peptide at the tested concentrations. Cell viability remained similar to untreated cells.	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
DRAMP37600	GENNELRLTRDAI	13	B-HR2-S	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref:16603508]:HSV:IC50=Show no inhibitory effects at 500 µM, implying that these peptides are ineffective at the tested concentrations	Not Available				The peptides derived from the heptad repeat (HR) regions of HSV-1 glycoproteins (gH and gB) inhibit the virus entry process by interfering with membrane fusion.	[Ref:16603508]:HSV:IC50=Show no inhibitory effects at 500 µM, implying that these peptides are ineffective at the tested concentrations	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxic effect observed for any peptide at the tested concentrations. Cell viability remained similar to untreated cells.	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)CN)[C@@H](C)O)C(=O)O
DRAMP37601	TAAGDARANAVAKAGLHDLNIETDTERNH	29	B-HR1-scrambled	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref:16603508]:HSV:IC50=No significant inhibition	Not Available				The peptides derived from the heptad repeat (HR) regions of HSV-1 glycoproteins (gH and gB) inhibit the virus entry process by interfering with membrane fusion.	[Ref:16603508]:HSV:IC50=No significant inhibition	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxic effect observed for any peptide at the tested concentrations. Cell viability remained similar to untreated cells.	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP37602	VEGQLGENNELRLTRDAIE	19	B-HR2	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref:16603508]:HSV:IC50=Show no inhibitory effects at 500 µM, implying that these peptides are ineffective at the tested concentrations	Not Available				The peptides derived from the heptad repeat (HR) regions of HSV-1 glycoproteins (gH and gB) inhibit the virus entry process by interfering with membrane fusion.	[Ref:16603508]:HSV:IC50=Show no inhibitory effects at 500 µM, implying that these peptides are ineffective at the tested concentrations	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxic effect observed for any peptide at the tested concentrations. Cell viability remained similar to untreated cells.	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP37603	AGHATLREHLRDIKAENTDAN	21	B-HR1-S	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref:16603508]:HSV:IC50=No significant inhibition	Not Available				The peptides derived from the heptad repeat (HR) regions of HSV-1 glycoproteins (gH and gB) inhibit the virus entry process by interfering with membrane fusion.	[Ref:16603508]:HSV:IC50=No significant inhibition	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxic effect observed for any peptide at the tested concentrations. Cell viability remained similar to untreated cells.	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O)C(=O)O
DRAMP37604	HATCSLAFALATSVALATRNDLLLRWAAARDAQTILSKRDR	41	H-HR2-scrambled	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref:16603508]:HSV:IC50=No significant inhibition	Not Available				The peptides derived from the heptad repeat (HR) regions of HSV-1 glycoproteins (gH and gB) inhibit the virus entry process by interfering with membrane fusion.	[Ref:16603508]:HSV:IC50=No significant inhibition	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxic effect observed for any peptide at the tested concentrations. Cell viability remained similar to untreated cells.	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP37605	TSDVAAATNADLRTALARADHQKTLFWL	28	H-HR2-S	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref:16603508]:HSV:IC50=No significant inhibition	Not Available				The peptides derived from the heptad repeat (HR) regions of HSV-1 glycoproteins (gH and gB) inhibit the virus entry process by interfering with membrane fusion.	[Ref:16603508]:HSV:IC50=No significant inhibition	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxic effect observed for any peptide at the tested concentrations. Cell viability remained similar to untreated cells.	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)O
DRAMP37606	RARRSLLIASALCTSDVAAATNADLRTALARADHQKTLFWL	41	H-HR2	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref:16603508]:HSV:IC50=40% at 500 µM.	Not Available				H-HR2 and B-HR1 also inhibit this step, but their effects are less pronounced compared to H-HR1.	[Ref:16603508]:HSV:IC50=40% at 500 µM.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxic effect observed for any peptide at the tested concentrations. Cell viability remained similar to untreated cells.	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
DRAMP37607	YQFHLVLHEALRAQALSRQLILGRELAQELVAELAT	36	H-HR1-scrambled	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref:16603508]:HSV:IC50=25–30 %	Not Available				The peptides derived from the heptad repeat (HR) regions of HSV-1 glycoproteins (gH and gB) inhibit the virus entry process by interfering with membrane fusion.	[Ref:16603508]:HSV:IC50=25–30 %	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxic effect observed for any peptide at the tested concentrations. Cell viability remained similar to untreated cells.	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP37608	TARLQLEARLQHLVAEILEREQSLALHALGYQLAFV	36	H-HR1	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref:16603508]:HSV:IC50=65% inhibition at 500 µM	Not Available				H-HR1 likely disrupts the formation of the fusion complex, as it specifically inhibits HSV-1 entry during the virus attachment-entry phase.	[Ref:16603508]:HSV:IC50=65% inhibition at 500 µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxicity	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C)C(=O)O
DRAMP37609	LQLEARLQHLVAEILER	17	H-HR1-SN	No entry found	Herpesviridae	Not Available	Synthetic construct	Not Available	Not Available				The peptides derived from the heptad repeat (HR) regions of HSV-1 glycoproteins (gH and gB) inhibit the virus entry process by interfering with membrane fusion.	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxicity	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(=O)O
DRAMP37610	AGDNATVAAGHATLREHLRDIKAENTDAN	29	B-HR1	No entry found	Herpesviridae	Not Available	Synthetic construct	[Ref:16603508]:HSV:IC50=Shows minor inhibitory effects at 500 µM, indicating significantly lower activity. Its IC₅₀ is likely much higher than 500 µM, if effective at all.	Not Available				H-HR2 and B-HR1 also inhibit this step, but their effects are less pronounced compared to H-HR1.	[Ref:16603508]:HSV:IC50=Shows minor inhibitory effects at 500 µM, indicating significantly lower activity. Its IC₅₀ is likely much higher than 500 µM, if effective at all.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:16603508]No cytotoxicity	Fusion machinery	16603508	The Journal of general virology, 87(Pt 5), 1085–1097.	Galdiero, S., Vitiello, M., D'Isanto, M., Falanga, A., Collins, C., Raieta, K., Pedone, C., Browne, H., & Galdiero, M. (2006).	Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. 	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O)C(C)C)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP37611	DYNPYLLFLK	10	PB1-11	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				 The PB1-0 peptide has given excellent results in blocking the PA-PB1 interaction, in particular in the C-terminal domain of the PR8 (H1N1). The same results were confirmed by surface plasmon resonance (SPR) experiments. PB1-10 was obtained with the elimination of some amino acids from the N-terminus and C-terminus. With the addition of two substituents, the authors reached PB1-11, which proved to be the most active of all	[Ref:33166574]IAV:IC50=13 ± 1μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	Not included yet	L	No cytotoxicity information found in the reference(s) presented	PB1 (Basic polymerase 1 )	33166574	Antiviral research, 185, 104971.	Hejdánek, J., Radilová, K., Pachl, P., Hodek, J., Machara, A., Weber, J., Řezáčová, P., Konvalinka, J., & Kožíšek, M. (2021).	structural characterization of the interaction between the C-terminal domain of the influenza polymerase PA subunit and an optimized small peptide inhibitor	
DRAMP37612	SRARIDARI	9	FluAPep 1	No entry found	orthomyxoviridae	Not Available	Synthetic construct	[Ref:30597438]IAV:binding affinity (score = −246.155)	Not Available				Not Available	[Ref:30597438]IAV:binding affinity (score = −246.155)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:30597438]ToxinPred analysis confirmed that designed peptides were non-toxic.	PB1 (Basic polymerase 1 )	30597438	Computational biology and chemistry, 78, 273–281.	Arivajiagane, A., Ravi Varadharajulu, N., Seerangan, K., & Rattinam, R. (2019).	In silico structure-based design of enhanced peptide inhibitors targeting RNA polymerase PAN-PB1Cinteraction	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CO)[C@H](C)CC)C(=O)O
DRAMP37613	LVRPLAL	7	7-1 peptide	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				 A random phage display library of 7-mer peptides was screened by affinity selection, obtaining the peptide LVRPLAL that showed the highest affinity toward H1 and H3 HAs. The avidin–biotin-peroxidase complex (ABC) system was exploited to evaluate the binding of this peptide to HA. It showed a Kd of 92 and 194 µM for H1 HA from A/New Caledonia/20/99 (H1N1) and H3 from A/Wyoming/3/2003 (H3N2), respectively. The C18-conjugated form of this peptide was tested in plaque reduction assay, showing a good activity toward A/Aichi/2/68 (H3N2) virus (6.4 µM) and a lower potency against A/Puerto Rico/8/34 (H1N1) virus (101 µM). The Ala scan indicated the importance of Arg3 and Pro4 for the HA binding, which was also assessed by docking calculations	[Ref:26833245]IAV:IC50=6.4μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	[Ref:26833245]Negligible cytotoxicity	Head of HA	26833245	Bioorganic & medicinal chemistry, 24(5), 1106–1114.	Matsubara, T., Onishi, A., Yamaguchi, D., & Sato, T. (2016). 	Heptapeptide ligands against receptor-binding sites of influenza hemagglutinin toward anti-influenza therapy	
DRAMP37614	ARDFYDYDVFYYAMD	15	PeB	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Not included yet	[Ref:27415624]IAV:IC50=32 ± 5μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	[Ref:27415624]Neglible cytotoxicity	Head of HA	27415624	PloS one, 11(7), e0159074.	Memczak, H., Lauster, D., Kar, P., Di Lella, S., Volkmer, R., Knecht, V., Herrmann, A., Ehrentreich-Förster, E., Bier, F. F., & Stöcklein, W. F. (2016).	Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding	
DRAMP37615	ARDFYGYDVFFYAMD	15	C18-PeBGFa	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				The acylated peptide was able to block hemagglutination produced by the Aichi H3N2 and Rostock H7N1 viruses at 1.2 µM and 2.8 µM,	[Ref:26124860]IAV:IC50=1.2 µM and 2.8 µM,	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	C17H35CO-	L	[Ref:26124860]Negligible cytotoxicity	Head of HA	26124860	 Beilstein journal of organic chemistry, 11, 589–595.	Lauster, D., Pawolski, D., Storm, J., Ludwig, K., Volkmer, R., Memczak, H., Herrmann, A., & Bhatia, S. (2015)	Potential of acylated peptides to target the influenza A virus	
DRAMP37616	ARDFYGYDVFFYAMD	15	PeBGF	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				The most interesting peptide was the PeBGF, which showed a micromolar activity in SPR, HI, neutralization, and infection inhibition assays toward both Aichi H3N2 and Rostock H7N1 viral strains	[Ref:27415624]IAV:IC50=25 ± 6μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	[Ref:27415624]Negligible cytotoxicity	Head of HA	27415624	PloS one, 11(7), e0159074.	Memczak, H., Lauster, D., Kar, P., Di Lella, S., Volkmer, R., Knecht, V., Herrmann, A., Ehrentreich-Förster, E., Bier, F. F., & Stöcklein, W. F. (2016).	Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding	
DRAMP37617	LSRMPK	6	P1	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Molecular docking calculations, carried out to depict the interaction between active peptides and hemagglutinin, indicated that P1 and P2 peptides bind different regions of the HA globular head: P1 occupies the RBS, while P2 occupies a site close to the RBS and interacts with the 220-loop 	[Ref:35306102]IAV:IC50=870μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	[Ref:35306102]two peptides did not show toxicity on eggs and chicken lungs.	Head of HA	35306102	Virus research, 313, 198745.	Arbi, M., Larbi, I., Nsiri, J., Behi, I. E., Rejeb, A., Miled, K., Ghram, A., & Houimel, M. (2022). 	Inhibition of avian influenza virus H9N2 infection by antiviral hexapeptides that target viral attachment to epithelial cells	
DRAMP37618	FAPRWR	6	P2	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Molecular docking calculations, carried out to depict the interaction between active peptides and hemagglutinin, indicated that P1 and P2 peptides bind different regions of the HA globular head: P1 occupies the RBS, while P2 occupies a site close to the RBS and interacts with the 220-loop 	[Ref:35306102]IAV:IC50=620μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	[Ref:35306102]two peptides did not show toxicity on eggs and chicken lungs.	Head of HA	35306102	Virus research, 313, 198745.	Arbi, M., Larbi, I., Nsiri, J., Behi, I. E., Rejeb, A., Miled, K., Ghram, A., & Houimel, M. (2022). 	Inhibition of avian influenza virus H9N2 infection by antiviral hexapeptides that target viral attachment to epithelial cells	
DRAMP37619	WTGDFFSSHYTVPRC	15	iHA-100	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Escape mutant isolation demonstrated its binding at the stalk region of HA, confirmed by the stabilization effect its binding produces on HA trypsin degradation, but interaction on the globular head was not excluded. The macrocycle peptide was tested in vivo on mice infected with lethal H5N1 IAV. iHA-100 rescued 40% of mice and showed better efficacy when administered in the early or late phases of infection. 	[Ref:33976181]IAV:IC50=0.0015μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	No cytotoxicity information found in the reference(s) presented	Head of HA	33976181	Nature communications, 12(1), 2654.	Saito, M., Itoh, Y., Yasui, F., Munakata, T., Yamane, D., Ozawa, M., Ito, R., Katoh, T., Ishigaki, H., Nakayama, M., Shichinohe, S., Yamaji, K., Yamamoto, N., Ikejiri, A., Honda, T., Sanada, T., Sakoda, Y., Kida, H., Le, T. Q. M., Kawaoka, Y., … Kohara, M. (2021). 	Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models	
DRAMP37620	ARLPR	5	C18-s2(1–5)	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Not included yet	[Ref:20476787]IAV:IC50=1.9μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	C17H35CO	L	No cytotoxicity information found in the reference(s) presented	Binding the head of HA (protein present at the out membrane of the virus)	20476787	Journal of medicinal chemistry, 53(11), 4441–4449.	Matsubara, T., Onishi, A., Saito, T., Shimada, A., Inoue, H., Taki, T., Nagata, K., Okahata, Y., & Sato, T. (2010).	Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy	
DRAMP37621	MARRPVNHAUMARRPVNHAUMARRPVNHAUMARRPVNHAU	40	PVF-tet	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				This compound did not block viral entry into the cell as expected because of its binding to HA and did not act on the fusion process or in the HI assay. In fact, PVF-tet does not interact with H1 and H2, but likely does with the H0 of newly synthesized viral particles. PVF-tet is a cell-penetrating peptide, and its addition to the infected cell causes the amassment of HA in a vacuole-like structures named amphisomes	[Ref:31919357]IAV:IC50=1.4μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	4-3Lys	L	No cytotoxicity information found in the reference(s) presented	Head of HA	31919357	Nature communications, 11(1), 162.	Omi, J., Watanabe-Takahashi, M., Igai, K., Shimizu, E., Tseng, C. Y., Miyasaka, T., Waku, T., Hama, S., Nakanishi, R., Goto, Y., Nishino, Y., Miyazawa, A., Natori, Y., Yamashita, M., & Nishikawa, K. (2020)	The inducible amphisome isolates viral hemagglutinin and defends against influenza A virus infection	
DRAMP37622	ARLPRTMVHPKPAQP	15	C18-s2	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				 Interfering with the fusogenic activity of HA.	[Ref:20476787]IAV:IC50=11μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	C17H35CO	L	No cytotoxicity information found in the reference(s) presented	Binding the head of HA (protein present at the out membrane of the virus)	20476787	Journal of medicinal chemistry, 53(11), 4441–4449.	Matsubara, T., Onishi, A., Saito, T., Shimada, A., Inoue, H., Taki, T., Nagata, K., Okahata, Y., & Sato, T. (2010).	Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy	
DRAMP37623	GLFGAIAGFIKNGWKGMIKG	20	HA-FP-1	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				these peptides specifically blocked the entry of IAV into host cells via the interaction of the pFPs and the HA2 subunit, most likely due to interactions between the N-terminal portion of HA2. The positively charged lysine residues of pFPs strongly interact with glutamic acid or aspartic acid, negatively charged, of the HA2 subunit via ionic contacts and hydrogen bonds	[Ref:33392200]IAV:IC50=1.73μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	Not included yet	L	No cytotoxicity information found in the reference(s) presented	Hemagglutinin protein	33392200	Frontiers in cell and developmental biology, 8, 611121.	Wu, W., Lin, D., Shen, X., Li, F., Fang, Y., Li, K., Xun, T., Yang, G., Yang, J., Liu, S., & He, J. (2015). 	New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides	
DRAMP37624	GTYDHDVYRDEALNNRFQIKGVELKSGYKDWGSGSGC	37	P155–185-Chol	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				 The complete sequence (155–185) corresponds to the HA2 portion that bundles to the inner coiled-coil that is crucial for the fusion process; compound P155–181 lacks the four final residues between the N-capped coiled-coil and the transmembrane domain, while compound P155–175 corresponds to the most truncated sequence deficient the N-cap motif. Only cholesterol-tagged compounds containing the N-cap motif (155–185-Chol and 155–181-Chol) demonstrated antiviral activity against IAV/H3N2 in cell culture, most likely due to the ability of the cholesterol to fasten the peptide to the membrane and to form nanoparticles	[Ref:21994935]IAV:IC50=27.21µg/mL	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet	(PEG4-Chol)NH2, (155–185-Chol and 155–181-Chol)	L	[Ref:21994935]The peptides were non-cytotoxic in an ex vivo model and may be safe for in vivo use.	Hemagglutinin protein	21994935	The Journal of biological chemistry, 286(49), 42141–42149.	Lee, K. K., Pessi, A., Gui, L., Santoprete, A., Talekar, A., Moscona, A., & Porotto, M. (2011). 	Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus	
DRAMP37625	GYHHQNEQGSGYAADLK	17	C3LB-HA	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				The binding to the HA, which prevents the conformational rearrangements inside the endosome, is the most likely mechanism of action.By in silico analysis of different HA1 and HA2, they discovered conserved regions (40–50 amino acids at the N- and C-terminal of HA1, and 80 amino acids at the N-terminal of HA2) that revealed short regions of HA1 N- and C-terminal ends characterized by hydrophilic, flexible, charged, and exposed (antigenic) sequences. Inhibitory activity of those peptides against IAV of various origins (human, swine, and avian) demonstrates the ability to inhibit IAV without cytotoxicity. The binding to the HA, which prevents the conformational rearrangements inside the endosome, is the most likely mechanism of action. Docking studies revealed that AVPs form several hydrogen bonds and electrostatic contacts in the HA stalk region with the fusion peptide, helix A, helix B, and loop B that could be responsible for the inhibition of HA conformational changes. Nevertheless, they did not show the stability at endosomal pH 	[Ref:24146939]IAV:IC50=5.90 (µg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	[Ref:24146939]inhibit IAV without cytotoxicity.	Hemagglutinin protein	24146939	PloS one, 8(10), e76876.	López-Martínez, R., Ramírez-Salinas, G. L., Correa-Basurto, J., & Barrón, B. L. (2013). 	Inhibition of influenza A virus infection in vitro by peptides designed in silico	
DRAMP37626	FHRKKGRGKHK	11		No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				 interfering with the fusogenic activity of HA.	[Ref:15729820]IAV:1 log unit inhibitory activity	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	No cytotoxicity information found in the reference(s) presented	Hemagglutinin protein	15729820	Journal of chromatography. A, 1064(1), 59–66.	Zhao, R., Fanga, C., Yu, X., Liu, Y., Luo, J., Shangguan, D., Xiong, S., Su, T., & Liu, G. (2005).	Screening of inhibitors for influenza A virus using high-performance affinity chromatography and combinatorial peptide libraries	
DRAMP37627	GLFGAIAGFIKNGWKGMIKG	20	HA-FP-1	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				 interfering with the fusogenic activity of HA. As revealed by fusion and hemolysis inhibition assays, these peptides specifically blocked the entry of IAV into host cells via the interaction of the pFPs and the HA2 subunit,most likely due to interactions between the N-terminal portion of HA2. The positively charged lysine residues of pFPs strongly interact with glutamic acid or aspartic acid, negatively charged, of the HA2 subunit via ionic contacts and hydrogen bonds	[Ref:26382764]IAV:IC50=9.61 (µg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	[Ref:26382764]Neglible cytotoxicity	Hemagglutinin protein	         26382764	PloS one, 10(9), e0138426.	Wu, W., Lin, D., Shen, X., Li, F., Fang, Y., Li, K., Xun, T., Yang, G., Yang, J., Liu, S., & He, J. (2015). 	New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides	
DRAMP37628	ELVDPVVAAGAVVTSSGIVFFS	22	IntPep	No entry found	Orthomyxoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				 IntPep peptides were able to interact with the TM2 domain (region 316–333) of human NEU1 and disrupt its dimerization with consequent losses in sialidase activity. Furthermore, these IntPeps inhibit membrane sialidase activity triggered by elastin-derived peptides in macrophages, which are highly dependent on NEU1 .	[Ref:33392200]IAV:IC50=47 ± 12% and 41 ± 8%μM	[Ref:33392200]Low hemolytic activity	Linear	Not included yet	Not included yet		L	[Ref:33392200]Low cytotoxicity 	Neuraminidase protein	33392200	Frontiers in cell and developmental biology, 8, 611121.	Albrecht, C., Kuznetsov, A. S., Appert-Collin, A., Dhaideh, Z., Callewaert, M., Bershatsky, Y. V., Urban, A. S., Bocharov, E. V., Bagnard, D., Baud, S., Blaise, S., Romier-Crouzet, B., Efremov, R. G., Dauchez, M., Duca, L., Gueroult, M., Maurice, P., & Bennasroune, A. (2020). 	Transmembrane Peptides as a New Strategy to Inhibit Neuraminidase-1 Activation	
DRAMP37629	PGEKGPSGEAGTAGPPGTPGPQGL	38	Peptide P	P03518##P21403	Orthomyxoviridae	Not Available	cod skin hydrolysates	Antimrobial; Antiviral	Not Available			Not Available	This compound showed a NA inhibitory activity with Ki of 0.29 mM, and it was demonstrated to directly bind to free enzymes. The cytopathic effect reduction assay showed that the peptide P protected MDCK cells from viral infection and reduced viral production in a dose-dependent manner with an EC50 value of 471 ± 12 μg/mL against PR8 (H1N1)	[Ref:30308963]IAV:IC50=471 ± 12 g/mL.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Not included yet	Not included yet		L	No cytotoxicity information found in the reference(s) presented	Neuraminidase protein	30308963	Drugs. 2018;16:377. doi: 10.3390/md16100377. 	Li J., Chen Y., Yuan N., Zeng M., Zhao Y., Yu R., Liu Z., Wu H., Dong S.	A Novel Natural Influenza A H1N1 Virus Neuraminidase Inhibitory Peptide Derived from Cod Skin Hydrolysates and Its Antiviral Mechanism. Mar.	
DRAMP37630	SGSWNFFDWFSGLMSWFGG	19	RVFV-9	P21401	Filoviridae	GP	Rift Valley fever virus (RVFV) Gc stem region	Not Available	Not Available			6EGT	Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	24069485	PLoS Negl Trop Dis. 2013;7(9):e2430.	Koehler JW, Smith JM, Ripoll DR, et al.	A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses	CSCC[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O
DRAMP37631	WNFFDWFSGLMSWFGGPLKTI	21	RVFV-7	P03518##P21403	Filoviridae	Not Available	Rift Valley fever virus (RVFV) Gc stem region	Not Available	Not Available			6EGT	Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	24069485	PLoS Negl Trop Dis. 2013;7(9):e2430.	Koehler JW, Smith JM, Ripoll DR, et al.	A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)O
DRAMP37632	SWNFFDWFSGLMSWFGGPLK	20	RVFV-8	P03518##P21403	Filoviridae	GP	Rift Valley fever virus (RVFV) Gc stem region	Not Available	Not Available			6EGT	Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	24069485	PLoS Negl Trop Dis. 2013;7(9):e2430.	Koehler JW, Smith JM, Ripoll DR, et al.	A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses	CSCC[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP37633	FVGAAVSCDAAFLNLTGCY	19	RVFV-4	 P03518	Filoviridae	GP	Rift Valley fever virus (RVFV) Gc stem region	Not Available	Not Available			4HJ1##4HJC##6EGT##6F9B	Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	24069485	PLoS Negl Trop Dis. 2013;7(9):e2430.	Koehler JW, Smith JM, Ripoll DR, et al.	A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP37634	WNFFDWFSGLMSWFGGPLKLY	21	RVFV-5	P03518##P21403	Filoviridae	GP	Rift Valley fever virus (RVFV) Gc stem region	Not Available	Not Available			6EGT	Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	24069485	PLoS Negl Trop Dis. 2013;7(9):e2430.	Koehler JW, Smith JM, Ripoll DR, et al.	A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses	CSCC[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
DRAMP37635	WNFFDWFSGLMSWFGGPLK	19	RVFV-6	P03518##P21401	Filoviridae	GP	Rift Valley fever virus (RVFV) Gc stem region	Not Avaialble	Not Available			4HJ1##4HJC##6EGT##6F9B	RVFV-6, a peptide derived from the RVFV Gc stem region, exhibits potent inhibition of Ebola virus (EBOV), achieving nearly 100% reduction in plaques at a 50 microM concentration. Despite not interfering with EBOV binding to cells, RVFV-6 effectively inhibits EBOV infectivity, suggesting its potential as an antiviral therapy against EBOV and related viruses.	[Ref:24069485]EBOV:IC50=50µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	[Ref:24069485] Very very less toxic (MTT toxicity assays on Vero E6 cells assessed the toxicity of RVFV-6, revealing a reduction in cell viability at peptide concentrations up to 50 microM, suggesting	DII domain of the E protein (RVFV-6 interact with a specific region of the Ebola virus (EBOV) during	24069485	PLoS Negl Trop Dis. 2013;7(9):e2430.	Koehler JW, Smith JM, Ripoll DR, et al.	A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP37636	WGCGCFNVNPSCLFVHTYL	19	RVFV-2	P03518##P21402	Filoviridae	GP	Rift Valley fever virus (RVFV) Gc stem region	Not Available	Not Available			4HJ1##4HJC##6EGT##6F9B	Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	24069485	PLoS Negl Trop Dis. 2013;7(9):e2430.	Koehler JW, Smith JM, Ripoll DR, et al.	A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP37637	LGASSSRFTNWGSVSLSLD	19	RVFV-3	P03518	Filoviridae	GP	Rift Valley fever virus (RVFV) Gc stem region	Not Available	Not Available			4HJ1##4HJC##6EGT##6F9B	Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	24069485	PLoS Negl Trop Dis. 2013;7(9):e2430.	Koehler JW, Smith JM, Ripoll DR, et al.	A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O
DRAMP37638	YWTGSISPKCLSSRRCHLV	19	RVFV-1	Q05323	Filoviridae	GP	Rift Valley fever virus (RVFV) Gc stem region	Not Available	Not Available			4HJ1##4HJC##6EGT##6F9B	Not Available	Not Available	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	24069485	PLoS Negl Trop Dis. 2013;7(9):e2430.	Koehler JW, Smith JM, Ripoll DR, et al.	A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37639	QLESLTDRELLLLIARKTCGSVE	23	E30pep-wt	No entry found	Filoviridae	VP30(911826)	Synthetic construct	Antimrobial; Antiviral	Not Available			5DVW##5T3T	E30pep-wt seemed to bind efficiently to VP30 and consequently blocked the oligomerization of the protein. When E30pep-wt was transfected into EBOV-infected cells, the peptide inhibited viral replication suggesting that inhibition of VP30 oligomerization represents a target for EBOV antiviral drugs.	[Ref:12912982] IC50 = 1 microM	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Amination	Carboxylation		L	No cytotoxicity information found in the reference(s) presented	VP30	12912982	 J Biol Chem. 2003;278(43):41830-6.	Hartlieb B, Modrof J, MÃ¼hlberger E, et al.	Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide.	
DRAMP37640	DDIWK	5	BST-2/Tetherin	No entry found	Filoviridae	Not Available	HIV-1	[Ref:19036818]HIV-1:tetherin inhibits the release of a variety of lentiviruses in a manner that can be reversed by the HIV-1 Vpu protein.	Not Available				BST-2, or Tetherin, restricts the release of Ebola virus-like particles (VLPs) from infected cells by tethering the budding virions to the cell membrane, thereby inhibiting their release. This restriction is similar to BST-2's activity against other enveloped viruses like HIV-1. However, Ebola glycoprotein (GP) has evolved mechanisms to counteract BST-2, enabling efficient release of Ebola VLPs. The specific molecular mechanisms by which Ebola GP antagonizes BST-2 are still under investigation, but it likely involves disrupting the interaction between BST-2 and virions, potentially by interfering with BST-2 ectodomain self-interaction.	[Ref:19036818]HIV-1:tetherin inhibits the release of a variety of lentiviruses in a manner that can be reversed by the HIV-1 Vpu protein.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not found	19929170##19036818	AIDS research and human retroviruses, 25(12), 1197–1210##Journal of virology, 83(4), 1837–1844.	Tokarev A, Skasko M, Fitzpatrick K, et al##Jouvenet, N., Neil, S. J., Zhadina, M., Zang, T., Kratovac, Z., Lee, Y., McNatt, M., Hatziioannou, T., & Bieniasz, P. D. (2009).	Antiviral activity of the interferon-induced cellular protein BST-2/tetherin##Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CC(=O)N[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)O
DRAMP37641	WWIVVV	6	BetaWWI-4	No entry found	Retroviridae	Not Available	HIV gp41 C-terminus (C-peptides)	[Ref:16173723]HIV:EC50=5.3 ± 0.5 μM	Not Available				 Inhibit viral fusion with host cell by intramolecular protein-protein interactions.	[Ref:16173723]HIV:EC50=5.3 ± 0.5 μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	16173723	J Am Chem Soc. 2005;127(38):13126-7.	Stephens OM, Kim S, Welch BD, et al.	Inhibiting HIV fusion with a beta-peptide foldamer.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP37642	VVVIWW	6	BetaWWI-2	No entry found	Retroviridae	Not Available	HIV gp41 C-terminus (C-peptides)	[Ref:16173723]HIV:EC50=15 ± 1.6μM	Not Available				 Inhibit viral fusion with host cell by intramolecular protein-protein interactions.	[Ref:16173723]HIV:EC50=15 ± 1.6μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	16173723	J Am Chem Soc. 2005;127(38):13126-7.	Stephens OM, Kim S, Welch BD, et al.	Inhibiting HIV fusion with a beta-peptide foldamer.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
DRAMP37643	VVVWWI	6	BetaWWI-3	No entry found	Retroviridae	Not Available	HIV gp41 C-terminus (C-peptides)	[Ref:16173723]HIV:EC50=13 ± 1.9μM	Not Available				 Inhibit viral fusion with host cell by intramolecular protein-protein interactions.	[Ref:16173723]HIV:EC50=13 ± 1.9μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	16173723	J Am Chem Soc. 2005;127(38):13126-7.	Stephens OM, Kim S, Welch BD, et al.	Inhibiting HIV fusion with a beta-peptide foldamer.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)O
DRAMP37644	EYLFEVDNL	9	P2	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available			3CSY, 3S88, 3VE0, 5F1B, 5FHC, 5HJ3, 5JQ3, 5JQ7, 5K	Peptide P2 acts against Ebola virus by stimulating cytotoxic T lymphocytes (CTLs) specific to the Ebola virus glycoprotein (GP). When used in immunization alongside liposome-encapsulated irradiated Ebola virus, P2 contributes to the generation of a CTL response aimed at targeting and eliminating virus-infected cells. This specificity was demonstrated by the enhanced lysis of target cells infected with vaccinia virus GP when effector cells from mice immunized with liposome-encapsulated virus were cultured with peptide P2, suggesting its role in inducing a more precise immune response against Ebola virus GP.	[Ref:12186901]EBOV:IC50:5.3 ± 0.67	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Other (immunogenic epitope).	12186901	J Virol. 2002;76(18):9176-85.	Rao M, Bray M, Alving CR, et al.	Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.	
DRAMP37645	IWWVVV	6	BetaWWI-1	No entry found	Retroviridae	Not Available	HIV gp41 C-terminus (C-peptides)	[Ref:16173723]HIV:EC50=27 ± 2.5μM	Not Available				 Inhibit viral fusion with host cell by intramolecular protein-protein interactions.	[Ref:16173723]HIV:EC50=27 ± 2.5μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	16173723	J Am Chem Soc. 2005;127(38):13126-7.	Stephens OM, Kim S, Welch BD, et al.	Inhibiting HIV fusion with a beta-peptide foldamer.	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP37646	LYDRLASTVI	10	P1	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available			3CSY, 3S88, 3VE0, 5F1B, 5FHC, 5HJ3, 5JQ3, 5JQ7, 5K	Peptide P1 likely works against the Ebola virus by serving as an immunogenic epitope, stimulating the activation and proliferation of cytotoxic T lymphocytes (CTLs) specific to the Ebola virus glycoprotein (GP). This activation of CTLs enables them to recognize and eliminate virus-infected cells, contributing to the immune response against Ebola virus infection.	[Ref:12186901]EBOV:IC50=6.0 ± 0.94	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Other (immunogenic epitope).	12186901	J Virol. 2002;76(18):9176-85.	Rao M, Bray M, Alving CR, et al.	Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.	
DRAMP37647	RRRRRRRRRFFC	13	PMO	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				PMOs, a type of single-stranded antisense agents, exert their antiviral action against Ebola virus by binding to specific RNA sequences, particularly within the VP35 translation start site region, thereby impeding viral replication. Their mechanism involves blocking the translation of essential viral proteins, like VP35, crucial for Ebola's replication, leading to a sequence-specific and dose-dependent inhibition of viral amplification both in vitro and in vivo. This inhibition ultimately safeguards against lethal Ebola infection in mice, showcasing PMOs' efficacy in curtailing viral spread.	[Ref:16495261]EBOV:EC50= 5.0 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Amination	Free	(In the peptide sequence, N-terminus is modified with an amino group (NH2).)	L	[Ref:16495261]Cytotoxic at 10 microM concentration	VP35	16495261	Antimicrob Agents Chemother. 2006;50(3):984-93.	Enterlein S, Warfield KL, Swenson DL, et al.	 VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.	
DRAMP37648	RVKRCMK	7	Peptidyl chloromethylketone	P60172, Q7T9E0	Filoviridae	Not Available	Synthetic construct	[Ref:9576958]EBOV:IC50=25 microM or 80 microM	Not Available				Peptidyl chloromethylketones, exemplified by decRVKR-cmk, function as potent inhibitors of the endoproteolytic cleavage of the Ebola virus glycoprotein. They operate by obstructing the cleavage of the glycoprotein specifically at a multibasic amino acid motif situated between positions 497 and 501 of the ORF. This cleavage is essential for the glycoprotein's maturation into its functional state. By impeding this cleavage process, peptidyl chloromethylketones hinder the glycoprotein's transformation into its mature form, thereby disrupting the viral replication cycle and potentially diminishing the virus's infectivity.	[Ref:9576958]EBOV:IC50=25 microM or 80 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	9576958	Proc Natl Acad Sci U S A. 1998;95(10):5762-7. 	Volchkov VE, Feldmann H, Volchkova VA, et al.	Processing of the Ebola virus glycoprotein by the proprotein convertase furin	CSCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP37649	WFQRIPLGWFHCTYQKGKQHCRLRIRQKVEE	31	delta18-48-Fc	P60172, Q7T9E0	Filoviridae	GP	EboV delta peptide	[Ref:21697477]EBOV:IC50 < 25 nM	Not Available				The efficacy of delta-Fc and its truncated versions (delta1-28-Fc, delta1-33-Fc, delta1-39-Fc, delta13-48-Fc, delta28-48-Fc, delta7-48-Fc, delta18-48-Fc, delta1-17-Fc) in inhibiting Ebola virus (EBOV) entry was investigated, demonstrating specific binding	[Ref:21697477]EBOV:IC50 < 25 nM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	21697477	J Virol. 2011;85(17):8502-13. 	Radoshitzky SR, Warfield KL, Chi X, et al.	Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C
DRAMP37650	ELQREESPTGPPGSIRT	17	delta1-17-Fc	P60172, Q7T9E0	Filoviridae	GP	EboV delta peptide	[Ref:21697477]EBOV:IC50 < 25 nM	Not Available				The efficacy of delta-Fc and its truncated versions (delta1-28-Fc, delta1-33-Fc, delta1-39-Fc, delta13-48-Fc, delta28-48-Fc, delta7-48-Fc, delta18-48-Fc, delta1-17-Fc) in inhibiting Ebola virus (EBOV) entry was investigated, demonstrating specific binding	[Ref:21697477]EBOV:IC50 < 25 nM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	21697477	J Virol. 2011;85(17):8502-13. 	Radoshitzky SR, Warfield KL, Chi X, et al.	Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP37651	SPTGPPGSIRTWFQRIPLGWFHCTYQKGKQHCRLRIRQKVEE	42	delta7-48-Fc	P60172, Q7T9E0	Filoviridae	GP	EboV delta peptide	[Ref:21697477]EBOV:IC50<25 nM	Not Available				The efficacy of delta-Fc and its truncated versions (delta1-28-Fc, delta1-33-Fc, delta1-39-Fc, delta13-48-Fc, delta28-48-Fc, delta7-48-Fc, delta18-48-Fc, delta1-17-Fc) in inhibiting Ebola virus (EBOV) entry was investigated, demonstrating specific binding	[Ref:21697477]EBOV:IC50<25 nM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	21697477	J Virol. 2011;85(17):8502-13. 	Radoshitzky SR, Warfield KL, Chi X, et al.	Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C
DRAMP37652	HCTYQKGKQHCRLRIRQKVEE	21	delta28-48-Fc	P60172, Q7T9E0	Filoviridae	GP	EboV delta peptide	[Ref:21697477]EBOV:IC50 < 25 nM	Not Available				The efficacy of delta-Fc and its truncated versions (delta1-28-Fc, delta1-33-Fc, delta1-39-Fc, delta13-48-Fc, delta28-48-Fc, delta7-48-Fc, delta18-48-Fc, delta1-17-Fc) in inhibiting Ebola virus (EBOV) entry was investigated, demonstrating specific binding	[Ref:21697477]EBOV:IC50 < 25 nM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	21697477	J Virol. 2011;85(17):8502-13. 	Radoshitzky SR, Warfield KL, Chi X, et al.	Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C
DRAMP37653	GSIRTWFQRIPLGWFHCTYQKGKQHCRLRIRQKVEE	36	delta13-48-Fc	P60172, Q7T9E0	Filoviridae	GP	EboV delta peptide	[Ref:21697477]EBOV:IC50 < 25 nM	Not Available				The efficacy of delta-Fc and its truncated versions (delta1-28-Fc, delta1-33-Fc, delta1-39-Fc, delta13-48-Fc, delta28-48-Fc, delta7-48-Fc, delta18-48-Fc, delta1-17-Fc) in inhibiting Ebola virus (EBOV) entry was investigated, demonstrating specific binding	[Ref:21697477]EBOV:IC50 < 25 nM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	21697477	J Virol. 2011;85(17):8502-13. 	Radoshitzky SR, Warfield KL, Chi X, et al.	Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)[C@H](C)CC)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C
DRAMP37654	ELQREESPTGPPGSIRTWFQRIPLGWFHCTYQKGKQHCR	39	delta1-39-Fc	P60172, Q7T9E0	Filoviridae	GP	EboV delta peptide	[Ref:21697477]EBOV:IC50 < 25 nM	Not Available				 The efficacy of delta-Fc and its truncated versions (delta1-28-Fc, delta1-33-Fc, delta1-39-Fc, delta13-48-Fc, delta28-48-Fc, delta7-48-Fc, delta18-48-Fc, delta1-17-Fc) in inhibiting Ebola virus (EBOV) entry was investigated, demonstrating specific binding to filovirus-permissive cells and inhibition of EBOV glycoprotein GP1,2 entry. These Fc-tagged peptides interfere with the viral entry process, potentially preventing superinfection of producer cells and inhibiting cell transduction with filoviruses. The mechanisms of action involve binding to cell surface receptors or disrupting key viral entry steps.	[Ref:21697477]EBOV:IC50 < 25 nM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	21697477	J Virol. 2011;85(17):8502-13. 	Radoshitzky SR, Warfield KL, Chi X, et al.	Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP37655	ELQREESPTGPPGSIRTWFQRIPLGWFHCTYQK	33	delta1-33-Fc	P60172, Q7T9E0	Filoviridae	GP	EboV delta peptide	[Ref:21697477]EBOV:IC50<25 nM	Not Available				 The efficacy of delta-Fc and its truncated versions (delta1-28-Fc, delta1-33-Fc, delta1-39-Fc, delta13-48-Fc, delta28-48-Fc, delta7-48-Fc, delta18-48-Fc, delta1-17-Fc) in inhibiting Ebola virus (EBOV) entry was investigated, demonstrating specific binding to filovirus-permissive cells and inhibition of EBOV glycoprotein GP1,2 entry. These Fc-tagged peptides interfere with the viral entry process, potentially preventing superinfection of producer cells and inhibiting cell transduction with filoviruses. The mechanisms of action involve binding to cell surface receptors or disrupting key viral entry steps.	[Ref:21697477]EBOV:IC50<25 nM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	21697477	J Virol. 2011;85(17):8502-13. 	Radoshitzky SR, Warfield KL, Chi X, et al.	Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP37656	ELQREESPTGPPGSIRTWFQRIPLGWFH	28	delta1-28-Fc	P60172, Q7T9E0	Filoviridae	GP	eboV delta peptide	[Ref:21697477]EBOV:IC50 < 25 nM	Not Available				The efficacy of delta-Fc and its truncated versions (delta1-28-Fc, delta1-33-Fc, delta1-39-Fc, delta13-48-Fc, delta28-48-Fc, delta7-48-Fc, delta18-48-Fc, delta1-17-Fc) in inhibiting Ebola virus (EBOV) entry was investigated, demonstrating specific binding to filovirus-permissive cells and inhibition of EBOV glycoprotein GP1,2 entry. These Fc-tagged peptides interfere with the viral entry process, potentially preventing superinfection of producer cells and inhibiting cell transduction with filoviruses. The mechanisms of action involve binding to cell surface receptors or disrupting key viral entry steps.	[Ref:21697477]EBOV:IC50 < 25 nM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	21697477	J Virol. 2011;85(17):8502-13. 	Radoshitzky SR, Warfield KL, Chi X, et al.	Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP37657	ELQREESPTGPPGSIRTWFQRIPLGWFHCTYQKGKQHCRLRIRQKVEE	48	delta-Fc	No entry found	Filoviridae	GP	EboV delta peptide	[Ref:21697477]EBOV:IC50<25 nM	Not Available				The efficacy of delta-Fc and its truncated versions (delta1-28-Fc, delta1-33-Fc, delta1-39-Fc, delta13-48-Fc, delta28-48-Fc, delta7-48-Fc, delta18-48-Fc, delta1-17-Fc) in inhibiting Ebola virus (EBOV) entry was investigated, demonstrating specific binding to filovirus-permissive cells and inhibition of EBOV glycoprotein GP1,2 entry. These Fc-tagged peptides interfere with the viral entry process, potentially preventing superinfection of producer cells and inhibiting cell transduction with filoviruses. The mechanisms of action involve binding to cell surface receptors or disrupting key viral entry steps.	[Ref:21697477]EBOV:IC50<25 nM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Glycoprotein.	21697477	J Virol. 2011;85(17):8502-13. 	Radoshitzky SR, Warfield KL, Chi X, et al.	Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)[C@@H](C)O)C(=O)O
DRAMP37658	YYSSRWNHGHFTPCS	15	eVpeL1	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				Exact MoA not known (eVpeL1, a macrocyclic peptide belonging to the GL1 group from the LY-library, was found to be a poor binder to the immobilized eVP24 compared to other peptides like eVpeD1 and eVpeD2).	[Ref:28574091]It inhibits Ebola virus	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Amidation	Acetylation	(In the peptide sequence, the N-terminus is acetylated, and the tyrosine residue at position 1 is in the D-configuration.)	L	No cytotoxicity information found in the reference(s) presented	VP24	28574091	Org Biomol Chem. 2017;15(24):5155-5160.	Song X, Lu LY, Passioura T, et al.	Macrocyclic peptide inhibitors for the protein-protein interaction of Zaire Ebola virus protein 24 and karyopherin alpha 5. 	
DRAMP37659	YFKSVRTGLRYVYCS	15	eVpeL2	No entry found	Filoviridae	Not Available	Synthetic construct	Antimrobial; Antiviral	Not Available				eVpeL2 exhibit inhibitory activity against the protein-protein interaction (PPI) of VP24 and KPNA5.	[Ref:28574091]EBOV:IC50 = 37 microM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Amidation	Acetylation	(In the peptide sequence, the N-terminus is acetylated, and the tyrosine residue at position 1 is in the D-configuration.)	L	No cytotoxicity information found in the reference(s) presented	VP24	28574091	Org Biomol Chem. 2017;15(24):5155-5160.	Song X, Lu LY, Passioura T, et al.	Macrocyclic peptide inhibitors for the protein-protein interaction of Zaire Ebola virus protein 24 and karyopherin alpha 5. 	
DRAMP37660	CKPTHYNSC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=46%,0.1128(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37661	CLHKPWSRC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=7.4 × 10^8particles/μl in Vero E6,89%,0.4629 (p value)inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37662	CPRSGTAYC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=0.4629 µg/ml,63%,0.0903(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37663	CVNSPPTMC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:48%, 0.0004 (p value)inhibition  in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37664	CNHTRNMAC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNVV:IC50=29% in Vero E6	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37665	CRNTDTALC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=9.5 × 10^8 particles/μl,80%,0.0397(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37666	CTKYWARNC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:37% inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37667	COPHTLPTC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:59%,0.0001(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37668	CEWTESMMC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:47%, 0.0001( p value) highest inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37669	CTNPATPFC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:48%,0.0068(p value) inhibition  in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37670	CPSTGYSYC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:76%,0.0005(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37671	CPGHIHRTC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=8.0 × 10^8 particles/μl,83%,<0.0001(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37672	CTNRHAAGC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:54%,0.0136(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37673	CQGPVKPLC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:44%,0.0002(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37674	CHARNSTQC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:49%,0.0017(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37675	CFPTTSRGC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:74%,0.0019(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37676	CRHNNLHHC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:46%, 0.1418 (p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37677	CQYNPLPYC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:27% inhibition in Verso E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37678	CHSPLTSSC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:74%,0.1709(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37679	CSPQLAPFC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=3.8 × 10^8  particles/μl,83%,0.0056 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37680	CNGVIHNQC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:49%,0.6832(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37681	CPPGKSSMC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:77%,0.0001(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37682	CPPPQGQTC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=7.0 × 10^8 particles/μl,81%,0.1209(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37683	CPFVKTQLC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=2.7 × 10^8 particles/μl,91%,0.0147 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37684	CHNLKRPTC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:79%,0.0001(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37685	CQSQNHNTC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:76%,0.4057(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37686	CVSGQESIC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:56%,0.1935(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37687	CQSIRGPMC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:76%,0.58429(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37688	CLFNHPKYC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:79%,0.0008(pvalue) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37689	CTPTVTRSC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:21% inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37690	CLALRHSNC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=6.0 × 10^8 particles/μl,83%,0.0491(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37691	CNPYNTSMC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:49%,0.1999(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37692	CMTSHPTLC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:64%,0.0001(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37693	CNLLRQQTC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:54%,0.1822(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37694	CDATSAQVC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:46%, 0.1483 (p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37695	CLWPTLKGC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:48%,0.8779 (p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37696	CNQSTLLTC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:74%,0.0011(p value)inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37697	CLALNMSYC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:58%,0.0044 (p value)inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37698	CTNSTLQSC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:72%,0.0002(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37699	CPSRLSSQC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:35% inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37700	CNTSSTPHC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:71%,0.5842(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37701	CLTSPTSTC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:70%,0.0418(P value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37702	CLTDRHRTC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=39%,0.3065(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37703	CQAMHNRFC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:18%inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37704	CKPDAISVC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:72%,0.0068(P value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37705	CIHAPHTQC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=8.7 × 10^7 particles/μl,83%,0.0004 (p value)inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37706	CQSASPRLC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:70%,0.0203(P value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37707	CNPMKPLMC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:61%,0.7131(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37708	CHPTGLHQC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50= 39% inhibition in Vero E6 cells, 0.0001(p value) Highest inhibition	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37709	CYETKTHSC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=52%,0.5725(p value) inhibition in Vero E6	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37710	CTPSLPWLC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50= 42%, 0.0875 (p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37711	CSGSETKVC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available			1A1Q	Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:52%,0.0643(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37712	CNTKNFHSC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:61%,0.0007(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37713	CSTNPPTQC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:47%, 0.2520( p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37714	CRTLPPILC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:5% in Vero E6	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37715	CTESTINTC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:22% inhibition in Verso E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37716	CRSLTDNQC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:IC50=2.9 × 10^8 particles/μl,84%,0.0094(P value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37717	CTQKNIAAC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:71%,0.0021(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37718	CGFSNFRSC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:76%,0.0387(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37719	CSTPELTFC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:63%,0.2126(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37720	CNPMKPLMC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Blocking of SNV entry into Vero E6 cells	[Ref:15919886]SNV:61%,0.7131(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic 	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37721	CHLLLPRPC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Not Available	[Ref:15919886]SNV:16% inhibition in Vero cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37722	CHTKIFPNC	9	-	No entry found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Not Available	[Ref:15919886]SNV:49%,0.6223(p value) inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37723	CSLTNTLLC	9	-	P26662	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Not Available	[Ref:15919886]SNV:49%,0.1870(p value) inhibition in VeroE6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP37724	KKKKVVAATYVFF	13	P153	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP37725	KKKKLLLPTLFFF	13	P158	P26662	Flaviviridae,Paramyxoviridae,Coronaviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1A1R##1A1V	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O
DRAMP37726	DEMEECASHLPYK	15	P194	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CSCC[C@H](NC(=O)[C@@H](N)CC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O
DRAMP37727	AKLKVVAATYVKKK	14	P39	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C
DRAMP37728	DLEVVAATYV	10	P14	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37729	KKKKLLLPTLFLF	13	P184	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP37730	KKKKVVALTYVLV	13	P59	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP37731	KKKKLLLPFLVFF	13	P160	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP37732	AKDEMEECASHLPYEA	16	P192	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CSCC[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O
DRAMP37733	FDEMEECSQHLPYA	14	P195	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CSCC[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O
DRAMP37734	KKKKVVAATYKLKA	14	P36	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
DRAMP37735	KKKKLVAATYVLV	13	P56	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C
DRAMP37736	KKKKVLLAFLFFF	13	P171	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP37737	DEMEEC	8	P193	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CSCC[C@H](NC(=O)[C@@H](N)CC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)C(=O)O
DRAMP37738	DEVVCC	8	P199	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)[C@H](NC(=O)[C@@H](N)CC(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(=O)O
DRAMP37739	KKKKVLLPFLFFV	13	P118	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37740	KKKKVVAATYVTV	13	P95	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)O
DRAMP37741	KKKKVVAAKYVLV	13	P85	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37742	KKKKVVAATYVFVA	14	P32	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP37743	DDDEVVAATYVA	12	P16	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)[C@H](NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)C[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)C(C)C)C(=O)O
DRAMP37744	AKLEVVAATYVKKK	14	P40	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP37745	KKKKLVAPTYVLV	13	P127	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C
DRAMP37746	KKKKVVAPTYVLV	13	P110	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37747	KKKKLLLPFYVFF	13	P168	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP37748	ADKEVVAATYVKKK	14	P43	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)NC(=O)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP37749	KKKKLLLPFLFLV	13	P117	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37750	KKKKVVAATYTLV	13	P94	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37751	KKKKVVAATYVLP	13	P114	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37752	KKKKVVEATYVLV	13	P74	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)O
DRAMP37753	KKKKLLAATYVLV	13	P125	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP37754	SEDVVSSSMSYTFT	14	P198	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP37755	KKKKVVAATYVLK	13	P88	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP37756	KKKKVVAATKVLV	13	P86	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37757	EDCSTPSSGSFLDR	14	P187	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP37758	DDSVVSAAMSYSHA	14	P6	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	Antimrobial; Antiviral	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	
DRAMP37759	KKKKVVAATLFLV	13	P149	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37760	KKKKVVAAFYVFV	13	P147	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)O
DRAMP37761	KKKKVLLPFLLFF	13	P173	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP37762	ADLKVVAATYVLVA	14	P46	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP37763	KKKKVVAATYVLE	13	P80	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O
DRAMP37764	FDEMEECASHLPYA	14	P196	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CSCC[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O
DRAMP37765	KKKKVVAATYFFV	13	P152	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP37766	KKKKVLAATLVLV	13	P134	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP37767	KKKKLLLPFLFFV	13	P115	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37768	KKKKVVAPTYVFV	13	P143	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
DRAMP37769	KKKKVVTSTYVLVEA	15	P188	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP37770	KKKKLLLPFLVFV	13	P124	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP37771	KKKKVVAATYPLV	13	P112	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37772	FDEMEESSSHLPYI	14	P191	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC[C@@H](C)[C@H](NC(=O)CC[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)O
DRAMP37773	KKKKGVAATYVLV	13	P97	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37774	KKKKVVAATYVLKK	14	P28	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP37775	KKKKVVAATYKKKA	14	P35	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
DRAMP37776	AESTTPCSGSYLKA	14	P186	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)O
DRAMP37777	AKLEVVAATYKKKK	14	P41	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C
DRAMP37778	KKKKVVAATYGLV	13	P103	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37779	KKKKVLAATYFLV	13	P135	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37780	KKKKVLLATYVLV	13	P131	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP37781	KKKKVEAATYVLV	13	P73	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP37782	KKKKVGAATYVLV	13	P98	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37783	KKKKVVAATYALV	13	P53	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37784	KKKKVVAATPVLV	13	P111	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37785	KKKKVLAAFYVLV	13	P133	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP37786	KKKKVVAAPYVLV	13	P109	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37787	KKKKVLAATYVFV	13	P136	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
DRAMP37788	KKKKVVAATLVFV	13	P150	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
DRAMP37789	KKKKVLLPFLFVF	13	P174	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
DRAMP37790	KKKKVVAATYVKV	13	P87	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
DRAMP37791	KKKKLLLPFYFFV	13	P123	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37792	KKKKVVAATYVLVK	14	P29	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
DRAMP37793	KKKKVVLATYVLF	13	P139	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP37794	KKKKVVAATYELV	13	P78	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCC(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP37795	KKKKVVLPTYVLV	13	P137	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37796	KKKKVVAATYVEV	13	P79	P26662	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
DRAMP37797	KKKKKVAATYVLV	13	P81	P06437	Flaviviridae	Not Available	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	Not Available			1DXP##1DY8	HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication	[Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS3 protease	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.	Peptide inhibitors of hepatitis C virus NS3 protease.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
DRAMP37798	PVPFEEVIDKINAKG	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37799	DYTEVQRRNQLHDLR	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37800	LEVYTRHEIKDSGLL	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37801	AKYVRNNLETTAFHR	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37802	GYVYFEEYAYSHQLS	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37803	VAADNVIVQNSMRIS	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37804	GTPGVAAATQAANGG	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37805	GATVVQFEQPRRCPT	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37806	KNPTPPRPAGDNATV	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37807	RVDLGDCIGKDARDA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37808	EARKLNPNAIASVTV	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37809	TRNLLTTPKFTVAWD	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37810	GTTVNCIVEEVDARS	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37811	ANFYVCPPPTGATVV	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37812	RADITTVSTFIDLNI	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37813	DARDAMDRIFARRYN	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37814	SQVWFGHRYSQFMGI	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37815	FSSDAISTTFTTNLT	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37816	EEYAYSHQLSRADIT	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37817	EQSRKPPNPTPPPPG	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37818	PANAATRTSRGWHTT	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37819	AFHRYGTTVNCIVEE	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	His6‐HR1 and GST‐removed‐HR2 were tested for their entry inhibition activity.	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37820	CYSRPLVSFRYEDQG	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37821	DNATVAAGHATLREH	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37822	HEFVPLEVYTRHEIK	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37823	PPPPGASANASVERI	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37824	DVMAVSTCVPVAADN	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37825	ARMLGDVMAVSTCVP	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37826	INAKGVCRSTAKYVR	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37827	AAPTGDPKPKKNKKP	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37828	IAWCELQNHELTLWN	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37829	LQFTYNHIQRHVNDM	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37830	HVNDMLGRVAIAWCE	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37831	LRSEYGGSFRFSSDA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37832	FEDRAPVPFEEVIDK	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37833	AENTDANFYVCPPPT	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37834	IAVVFKENIAPYKFK	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37835	PPPLGAAPTGDPKPK	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37836	RRCPTRPEGQNYTEG	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37837	KENIAPYKFKATMYY	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37838	LGRVAIAWCELQNHE	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37839	MTKWQEVDEMLRSEY	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37840	IEFARLQFTYNHIQR	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37841	EVIDKINAKGVCRST	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37842	QVDGFYARDLTTKAR	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37843	AAATQAANGGPATPA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37844	NNLETTAFHRDDHET	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37845	ISTTFTTNLTEYPLS	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37846	FADIDTVIHADANAA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37847	MDRIFARRYNATHIK	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37848	KDVTVSQVWFGHRYS	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37849	HTTYAADRFKQVDGF	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37850	VYPYDEFVLATGDFV	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37851	VIVQNSMRISSRPGA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37852	EVDEMLRSEYGGSFR	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37853	ARRYNATHIKVGQPQ	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37854	EFVLATGDFVYMSPF	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37855	GWHTTDLKYNPSRVE	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37856	VGQPQYYQANGGFLI	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37857	TMLEDHEFVPLEVYT	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37858	ATAPTTRNLLTTPKF	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37859	DSGLLDYTEVQRRNQ	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37860	SVERIKTTSSIEFAR	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37861	GRRVSARMLGDVMAV	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37862	AAGHATLREHLRDIK	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37863	LSNTLAELYVREHLR	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37864	DDHETDMELKPANAA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37865	LVSFRYEDQGPLVEG	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37866	CIVEEVDARSVYPYD	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37867	TRDAIEPCTVGHRRY	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37868	DLKYNPSRVEAFHRY	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37869	PYKFKATMYYKDVTV	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37870	NHIQRHVNDMLGRVA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37871	APTSPGTPGVAAATQ	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37872	LQNHELTLWNEARKL	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37873	DPKPKKNKKPKNPTP	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37874	SRPGACYSRPLVSFR	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37875	QFMGIFEDRAPVPFE	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37876	TLREHLRDIKAENTD	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37877	YARDLTTKARATAPT	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37878	CPPPTGATVVQFEQP	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37879	KNKKPKNPTPPRPAG	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37880	SMRISSRPGACYSRP	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37881	NELRLTRDAIEPCTV	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37882	PRPAGDNATVAAGHA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37883	PSRVEAFHRYGTTVN	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37884	PATPAPPPLGAAPTG	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37885	GGFLIAYQPLLSNTL	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37886	GGSFRFSSDAISTTF	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37887	ASVTVGRRVSARMLG	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37888	YGYREGSHTEHTTYA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37889	AANGGPATPAPPPLG	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37890	REHLREQSRKPPNPT	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37891	YYQANGGFLIAYQPL	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37892	TRTSRGWHTTDLKYN	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37893	GHRYSQFMGIFEDRA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37894	STCVPVAADNVIVQN	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37895	EPCTVGHRRYFTFGG	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37896	IDLNITMLEDHEFVP	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37897	NYTEGIAVVFKENIA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37898	WVPKRPSVCTMTKWQ	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37899	VDARSVYPYDEFVLA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37900	GSHTEHTTYAADRFK	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37901	LHDLRFADIDTVIHA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37902	LTLWNEARKLNPNAI	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37903	TVSTFIDLNITMLED	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37904	YMSPFYGYREGSHTE	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37905	ATMYYKDVTVSQVWF	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37906	PPNPTPPPPGASANA	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37907	TTKARATAPTTRNLL	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37908	QFEQPRRCPTRPEGQ	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37909	PLVEGQLGENNELRL	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37910	SHQLSRADITTVSTF	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37911	RHEIKDSGLLDYTEV	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37912	LRDIKAENTDANFYV	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37913	ADRFKQVDGFYARDL	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37914	PSVCTMTKWQEVDEM	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37915	EYPLSRVDLGDCIGK	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37916	DMELKPANAATRTSR	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37917	RPEGQNYTEGIAVVF	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37918	TGDFVYMSPFYGYRE	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37919	QRRNQLHDLRFADID	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37920	YEDQGPLVEGQLGEN	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37921	ASANASVERIKTTSS	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37922	TTNLTEYPLSRVDLG	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37923	TVAWDWVPKRPSVCT	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37924	VCRSTAKYVRNNLET	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37925	QLGENNELRLTRDAI	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37926	NPNAIASVTVGRRVS	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37927	ATHIKVGQPQYYQAN	15	-	P06437	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37928	TAFHRDDHETDMELK	15	-	P27958	Herpesviridae	gB	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Not Available	[Ref:19104014]HSV-1:IC50=Low in Vero cells 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37929	TVSSGADTEDVVC	13	Viroporin p7	P27958	Flaviviridae	Not Available	HCV non-structural protein 5A	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 20% and 50%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 20% and 50%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC(C)[C@H](NC(=O)CC[C@H](NC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(=O)O
DRAMP37930	GAPLGGAARALAHGVRVL	18	141-158	P38936	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 83% and 92%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 83% and 92%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)CN)C(C)C)C(C)C)C(=O)O
DRAMP37931	GRKRRQTSMTDFYHS	15	139-153	Q9JJP2	Flaviviridae	CDKN1A	Host p21 protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 105% and 101%,respectively.	Not Available			1AXC##2ZVV	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 105% and 101%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O
DRAMP37932	RRHGDEDMFYMHVRG	15	339-353	P27958	Flaviviridae	Tp73	Host p73 protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 96% and 99%,respectively.	Not Available				Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 96% and 99%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)O
DRAMP37933	TCGFADLMGYIPLVGAPL	18	127-144	Q9JJP2	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 79% and 71%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 79% and 71%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O
DRAMP37934	AIPALGTNVKKRRHG	15	328-342	P27958	Flaviviridae	Tp73	Host p73 protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 91% and 89%,respectively.	Not Available				Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 91% and 89%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O)C(C)C)[C@@H](C)O
DRAMP37935	SWGPTDPRRRSRNLGKVI	18	106-123	Q9JJP2	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 88% and 96%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 88% and 96%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(=O)O
DRAMP37936	VKKRRHGDEDMFYMH	15	336-350	P27958	Flaviviridae	Tp73	Host p73 protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 101% and 99%,respectively.	Not Available				Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 101% and 99%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(=O)O
DRAMP37937	QRKTKRNTNRRPQDVKFP	18	45870	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 107% and 102%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 107% and 102%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC(C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP37938	SPRGSRPSWGPTDPRRRS	18	99-116	P38936	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 110% and 105%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 110% and 105%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O
DRAMP37939	SMTDFYHSKRRLIFS	15	146-160	P27958	Flaviviridae	CDKN1A	Host p21 protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 98% and 96%,respectively.	Not Available			1AXC##2ZVV	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 98% and 96%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O
DRAMP37940	VKFPGGGQIVGGVYLLPR	18	22-39	Q9JJP2	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 58% and 70%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 58% and 70%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
DRAMP37941	AFKQSPPAIPALGTN	15	321-335	P27958	Flaviviridae	Tp73	Host p73 protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 102% and 97%,respectively.	Not Available				Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 102% and 97%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O
DRAMP37942	QIVGGVYLLPRRGPRLGV	18	29-46	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 81% and 92%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 81% and 92%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP37943	VRVLEDGVNYATGNLPGC	18	155-172	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 82% and 100%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 82% and 100%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
DRAMP37944	RRRSRNLGKVIDTLTCGF	18	113-130	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 98% and 104%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 98% and 104%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)O
DRAMP37945	MSTNPKPQRKTKRNTNRR	18	43101	P38936	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 92% and 94%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 92% and 94%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP37946	FYHSKRRLIFSKRKP	15	150-164	Q9JJP2	Flaviviridae	CDKN1A	Host p21 protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 87% and 89%,respectively.	Not Available			1AXC##2ZVV	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 87% and 89%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37947	QSPPAIPALGTNVKK	15	324-338	P27958	Flaviviridae	Tp73	Host p73 protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 105% and 102%,respectively.	Not Available				Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 105% and 102%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O
DRAMP37948	RLGVRATRKTSERSQPRG	18	43-60	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 71% and 85%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 71% and 85%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC(C)C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
DRAMP37949	DGSWSTVSSGADTED	15	2402-2416	P27958	Flaviviridae	Not Available	HCV non-structural protein 5A	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 74% and 89%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 74% and 89%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O
DRAMP37950	ARALAHGVRVLEDGVNYA	18	148-165	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 92% and 97%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 92% and 97%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)NCC(=O)O)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP37951	MGYIPLVGAPLGGAARAL	18	134-151	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 78% and 93%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 78% and 93%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP37952	QPRGRRQPIPKARRPEGR	18	57-74	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 103% and 96%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 103% and 96%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)NCC(=O)O
DRAMP37953	PGDPDLSDGSWSTVSSGA	18	2395-2412	P27958	Flaviviridae	Not Available	HCV non-structural protein 5A	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 74% and 89%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 74% and 89%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1)C(=O)O
DRAMP37954	PIPKARRPEGRTWAQPGY	18	64-81	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 87% and 97%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 87% and 97%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
DRAMP37955	LLPRRGPRLGVRATRKTS	18	36-53	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 87% and 95%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 87% and 95%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
DRAMP37956	PEGRTWAQPGYPWPLYGN	18	71-88	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 88% and 96%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 88% and 96%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)NCC(=O)O
DRAMP37957	RKTSERSQPRGRRQPIPK	18	50-67	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 86% and 92%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 86% and 92%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP37958	GKVIDTLTCGFADLMGYI	18	120-137	P27958	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 40% and 69%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 40% and 69%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)O
DRAMP37959	TNRRPQDVKFPGGGQIVG	18	15-32	P08620	Flaviviridae	Not Available	HCV core protein	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 105% and 101%,respectively.	Not Available			1A1R##1A1V	Peptide derived from the C-terminal end of NS5A protein moderately inhibits the assembly process.Exerts viral interference on hepatitis B virus when HCV and HBV coinfect the same cell, by suppressing HBV gene expression, RNA encapsidation and budding.	[Ref:22452666]HCV:IC50=decrease the initial rate and maximum OD strongly to levels as low as 105% and 101%,respectively.	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	NS5A protein	22452666	Can J Microbiol. 2012	Duvignaud JB, Majeau N, Delisle P, Voyer N, Gagne SM, Leclerc D.	Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)NCC(=O)O
DRAMP37960	RRKKAAVALLKAVLLALAAP	20	C3	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=-0.21µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=-0.21µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37961	RRKKAAVAELPAVLLALLAP	20	E2	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=5.11µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=5.11µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37962	RRKKAAVAKLPAVLLALLAP	20	D2	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=4.06µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=4.06µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37963	RRKKAAVALEPAVLLALLAP	20	E1	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=4.7µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=4.7µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37964	RRKKAAVALLPAVLKALLAP	20	A6	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=1.05µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=1.05µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37965	RRKKAAVALLPAVALALLAP	20	C7	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=3.38µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=3.38µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37966	RRKKAAVALLPAVLLALEAP	20	B3	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=4.87µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=4.87µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](C)C(=O)O
DRAMP37967	RRKKAAVALLPAVLAALLAP	20	C6	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=0.8µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=0.8µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37968	RRKKAAVALLKAVLLAALAP	20	C4	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	Antimrobial; Antiviral	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=-0.06µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	
DRAMP37969	RRKKAAVALAPAVLLALLAP	20	F1	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=1.09µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=1.09µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
DRAMP37970	RRKKAAVALLPAVLLAELAP	20	B4	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=6.43µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=6.43µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
DRAMP37971	RRKKAAVALKPAVLLALLAP	20	D1	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=1.58µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=1.58µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37972	RRKKAAVALLPAVLLAKLAP	20	A4	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=2.46µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=2.46µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
DRAMP37973	RRKKAAVALLKAVLLALKAP	20	A3	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=0.11µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=0.11µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37974	RRKKAAVAALPAVLLALLAP	20	F2	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=1.09µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=1.09µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37975	RRKKAAVALLPAVKLALLAP	20	A7	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=-0.03µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=-0.03µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37976	RRKKAAVALLPAVELALLAP	20	B7	P08620	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=4.32µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=4.32µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP37977	RRKKAAVALLPAVLEALLAP	20	B6	No Entry Found	Poxviridae	FGF4/2249	Synthetic construct(derived from FGF-4 signal sequence)	[Ref:19395056]VACV:EC50=0.53µM mOD/min in Hela cells	Not Available			1IJT	Inhibit Virus entry	[Ref:19395056]VACV:EC50=0.53µM mOD/min in Hela cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19395056	Virology. 2009	Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR.	Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.	CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N[C@@H](C)C(=O)O
DRAMP37978	PPWCCCSPMKRASPPPAQSDLPATPKCPP	29	GFP-NP9-5	No Entry Found	Orthomyxoviridae	Not Available	Synthetic Contrust (from Conotoxin)	[Ref:22095520]IAV:IC50=40.7% ±15.8%,multiplicity of infection of 0.01 was inhibited to 20% and 69% at 12 and 24 h post-infection, respectively. 	Not Available				Inhibit Replication	[Ref:22095520]IAV:IC50=40.7% ±15.8%,multiplicity of infection of 0.01 was inhibited to 20% and 69% at 12 and 24 h post-infection, respectively. 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Nucleoprotein	22095520	Antivir Chem Chemother. 2011	Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T.	Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)O
DRAMP37979	EALMWEGF	8	38	No Entry Found	Poxviridae	Not Available	Synthetic-Construct	[Ref:19428604]VACV:IC50=75% in Flp-In-293 cells	Not Available				Inhibit Replication	[Ref:19428604]VACV:IC50=75% in Flp-In-293 cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19428604	Antiviral Res. 2009	Saccucci L, Crance JM, Colas P, Bickle M, Garin D, Iseni F.	Inhibition of vaccinia virus replication by peptide aptamers.	CSCC[C@H](NC(=O)[C@H](C)NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP37980	RQLVLRTR	8	72	No Entry Found	Poxviridae	Not Available	Synthetic-Construct	[Ref:19428604]VACV:IC50=40% in Flp-In-293 cells	Not Available				Inhibit Replication	[Ref:19428604]VACV:IC50=40% in Flp-In-293 cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19428604	Antiviral Res. 2009	Saccucci L, Crance JM, Colas P, Bickle M, Garin D, Iseni F.	Inhibition of vaccinia virus replication by peptide aptamers.	CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C
DRAMP37981	CGYKLC	6	MrIA-SL	No Entry Found	Flaviviridae	Not Available	Conotoxin	[Ref:22780881]DENV:IC50=16.7μM	Not Available				Inhibit Replication	[Ref:22780881]DENV:IC50=16.7μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	22780881	J Med Chem. 2012	Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.	Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
DRAMP37982	CGYGLC	7	Inhibitor 1	No Entry Found	Flaviviridae	Not Available	Synthetic-Contsruct	[Ref:22780881]DENV-2:IC50=15.1Ki (µM)	Not Available				Inhibit Replication	[Ref:22780881]DENV-2:IC50=15.1Ki (µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	22780881	J Med Chem. 2012	Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.	Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
DRAMP37983	CGYGLC	6	Inhibitor 2	No Entry Found	Flaviviridae	Not Available	Synthetic-Construct	[Ref:22780881]DENV-2:IC50=>100Ki (µM)	Not Available				Inhibit Replication	[Ref:22780881]DENV-2:IC50=>100Ki (µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	22780881	J Med Chem. 2012	Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.	Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
DRAMP37984	CGYKGC	6	Inhibitor 3	No Entry Found	Flaviviridae	Not Available	Synthetic-Construct	[Ref:22780881]DENV-2:IC50=12Ki (µM)	Not Available				Inhibit Replication	[Ref:22780881]DENV-2:IC50=12Ki (µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	22780881	J Med Chem. 2012	Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.	Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.	NCCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)NCC(=O)N[C@@H](CS)C(=O)O
DRAMP37985	CGYKRC	6	Inhibitor 4	No Entry Found	Flaviviridae	Not Available	Synthetic-Construct	[Ref:22780881]DENV-2:IC50=5Ki (µM)	Not Available				Inhibit Replication	[Ref:22780881]DENV-2:IC50=5Ki (µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	22780881	J Med Chem. 2012	Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.	Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
DRAMP37986	CGKRRC	6	Inhibitor 5	No Entry Found	Flaviviridae	Not Available	Synthetic-Construct	[Ref:22780881]DENV-2:IC50=3.5Ki (µM)	Not Available				Inhibit Replication	[Ref:22780881]DENV-2:IC50=3.5Ki (µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	22780881	J Med Chem. 2012	Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.	Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
DRAMP37987	CGKRKLC	7	Inhibitor 6	No Entry Found	Flaviviridae	Not Available	Synthetic-Construct	[Ref:22780881]DENV-2:IC50=6.7µM	Not Available				Inhibit Replication	[Ref:22780881]DENV-2:IC50=6.7µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	22780881	J Med Chem. 2012	Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.	Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
DRAMP37988	CGKRKSC	9	Inhibitor 7	No Entry Found	Flaviviridae	Not Available	Synthetic-Construct	[Ref:22780881]DENV-2:IC50=3.3µM	Not Available				Inhibit Replication	[Ref:22780881]DENV-2:IC50=3.3µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	22780881	J Med Chem. 2012	Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.	Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O
DRAMP37989	AGKRKSG	8	Inhibitor 8	No Entry Found	Flaviviridae	Not Available	Synthetic-Construct	[Ref:22780881]DENV-2:IC50=16.7µM	Not Available				Inhibit Replication	[Ref:22780881]DENV-2:IC50=16.7µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	22780881	J Med Chem. 2012	Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.	Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.	C[C@H](N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)O
DRAMP37990	CAGKRKSG	12	Inhibitor 9	Q9TT12	Flaviviridae	Not Available	Synthetic-Construct	[Ref:22780881]DENV-2:IC50=6.7µM	Not Available				Inhibit Replication	[Ref:22780881]DENV-2:IC50=6.7µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	22780881	J Med Chem. 2012	Xu S, Li H, Shao X, Fan C, Ericksen B, Liu J, Chi C, Wang C.	Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.	C[C@H](NC(=O)[C@@H](N)CS)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)O
DRAMP37991	DPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKP	37	HBD2	P06437	Polyomaviridae	Not Available	Human alpha defensin	[Ref:18782756]BKV:IC50=45% in Vero cells	Not Available				HBD2 inhibit BKV infection by targeting an early event in the viral lifecycle	[Ref:18782756]BKV:IC50=45% in Vero cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18782756	J Biol Chem. 2008	Dugan AS, Maginnis MS, Jordan JA, Gasparovic ML, Manley K, Page R, Williams G, Porter E, O'Hara BA, Atwood WJ.	Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
DRAMP37992	AYQPLLSNTLAELYV	15	-	No Entry Found	Herpesviridae	gB	HSV-1 B glycoprotein (gB)	Antimrobial; Antiviral	Not Available			2GUM##3NW8	Inhibit Virus entry	[Ref:19104014] HSV-1:IC50=Low in Vero cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	19104014	Antimicrob Agents Chemother. 2009	Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR.	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	
DRAMP37993	CRCCELKSLCPTLMRVVRLLGLVLL	25	C8	No Entry Found	Rhabdoviridae	Not Available	Synthetic-Construct	[Ref:15220414]HCV:IC50=78% in BSR cells	Not Available				Not Available	[Ref:15220414]HCV:IC50=78% in BSR cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Phosphoprotein	15220414	J Virol. 2004	Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.	Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP37994	PPARSSPPMPPNLPPLRRRIILLRFLFH	28	P13	P0DOF5	Rhabdoviridae	Not Available	Synthetic-Construct	Antimrobial; Antiviral	Not Available				Not Available	[Ref:15220414]RV:IC50=High	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Phosphoprotein	15220414	J Virol. 2004	Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.	Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.	
DRAMP37995	KNEWGCRCNDSSDGNEWGCRCNDSSD	26	P4	No Entry Found	Orthomyxoviridae	M	INFV A  matrix protein 2	Antimrobial; Antiviral	Not Available			1MP6##2KIH	Inhibit Replication	[Ref:12628550]IAV:IC50=Low in MDCK cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	12628550	FEMS Immunol Med Microbiol.  2003	Liu W, Li H, Chen YH.	N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.	
DRAMP37996	HCIYATTNDALIFSV	15	K6-10-B	Q9DG58	Flaviviridae	Not Available	Synthetic-Construct	[Ref:22965230]HCV:IC50=>>1nM 	Not Available				Inhibit Replication	[Ref:22965230]HCV:IC50=>>1nM 	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	22965230	J Biol Chem. 2012	Kugler J, Schmelz S, Gentzsch J, Haid S, Pollmann E, van den Heuvel J, Franke R, Pietschmann T, Heinz DW, Collins J.	High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O
DRAMP37997	TATQCRIRGGFCRVGSCRFPHIAIGKCATFISCCGRAYEVDALNSVRTSPWLLAPGNNPH	60	AvBD3	No Entry Found	Picornaviridae	Not Available	Duck beta defensin	[Ref:23112840]DHV:IC50=High	Not Available				Not Available	[Ref:23112840]DHV:IC50=High	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	23112840	PLoS One. 2012	Ma D, Zhang K, Zhang M, Xin S, Liu X, Han Z, Shao Y, Liu S.	Identification, expression and activity analyses of five novel duck beta-defensins.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)[C@H](C)CC)[C@@H](C)O
DRAMP37998	CGRCLQRACCKYCRLKCRLILFVIF	25	C27	No Entry Found	Rhabdoviridae	Not Available	Synthetic-Construct	[Ref:15220414]RV:IC50=22%	Not Available				Not Available	[Ref:15220414]RV:IC50=22%	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Phosphoprotein	15220414	J Virol. 2004	Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.	Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)C(C)C
DRAMP37999	CHTLPHTKC	9	-	P81612	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Inhibit Virus entry	[Ref:18391034]SNV:IC50=35%	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38000	GCASRCKAKCAGRRCKGWASAFRGRCYCKCFRC	33	Mytilin-A	No Entry Found	Herpesviridae	Not Available	Mytilin-A	[Ref:23389903]HSV-1:IC50=High	Not Available				Inhibit Virus entry	[Ref:23389903]HSV-1:IC50=High	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	23389903	J Pept Sci. 2013	Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M.	Peptide inhibitors against herpes simplex virus infections.	C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O
DRAMP38001	WSFFSNI	7	-	P59594	Hepadnaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Not Available	[Ref:17918821]HBV:IC50=18.5µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	17918821	J Med Chem. 2007	Tang KF, Abdullah MP, Yusoff K, Tan WS.	Interactions of hepatitis B core antigen and peptide inhibitors.	
DRAMP38002	QYGSFCTQLNRALSGIAAEQ	20	P8	P03134	Coronaviridae	S	SARS-CoV spike protein	[Ref:15918330]SARS-CoV:IC90=24.9±6.2μg/mL	Not Available			1WNC##1ZV7	Inhibit Virus entry	[Ref:15811330]SARS-COV:IC50=50%	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	15811330	FEBS Lett. 2005	Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.	Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP38003	VETTVTTAQETKRGRIQTKK	20	Peptide 11	No Entry Found	Parvoviridae	Not Available	MVMp NS1 protein	Antimrobial; Antiviral	Not Available				Inhibit Replication	[Ref:9311818]MVM:IC50=High	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	9311818	J Virol. 1997	Pujol A, Deleu L, Nuesch JP, Cziepluch C, Jauniaux JC, Rommelaere J.	Inhibition of parvovirus minute virus of mice replication by a peptide involved in the oligomerization of nonstructural protein NS1.	
DRAMP38004	ASLRVRIKKQ	10	SB105	No Entry Found	Herpesviridae	Not Available	Synthetic-Construct	Antimrobial; Antiviral	Not Available				Inhibit Replication	[Ref:21576348]HSV-1:EC50=0.21¬±0.04µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	21576348	Trop Doct. 2011	Gumbo FZ, Kandawasvika GQ, Duri K, Mapingure MP, Kurewa NE, Nathoo K, Rusakaniko S, Chirenje MZ, Stray-Pedersen B.	Reduced HIV transmission at subsequent pregnancy in a resource-poor setting.	
DRAMP38005	ASLRVRIKKQ	10	SB105	P83470	Herpesviridae	Not Available	Synthetic-Construct	Antimrobial; Antiviral	Not Available				Inhibit Replication	[Ref:21576348]HSV-2:EC50=0.78±0.02µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	21576348	Trop Doct. 2011	Gumbo FZ, Kandawasvika GQ, Duri K, Mapingure MP, Kurewa NE, Nathoo K, Rusakaniko S, Chirenje MZ, Stray-Pedersen B.	Reduced HIV transmission at subsequent pregnancy in a resource-poor setting.	
DRAMP38006	KNGRKLCLDLQAALY	15	PD3	P12572	Poxviridae	Not Available	Thrombin-induced platelet-derived protein	[Ref:20347875]VACV:IC50=40µg/ml	Not Available				Multifunctional	[Ref:20347875]VACV:IC50=40µg/ml	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Not Available	20347875	Antiviral Res. 2010	Mohan KV, Rao SS, Atreya CD.	Antiviral activity of selected antimicrobial peptides against vaccinia virus.	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)O
DRAMP38007	ALDKAEESNSKADKVNVKLT	20	NDVFz20-L5,12A peptide	P26663	Paramyxoviridae	Not Available	NDV fusion protein (HR2)	[Ref:9527912]NDV:IC50=35µM	Not Available				Inhibit Fusion	[Ref:9527912]NDV:IC50=35µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	9527912	Virology.  1998	Young JK, Hicks RP, Wright GE, Morrison TG.	The role of leucine residues in the structure and function of a leucine zipper peptide inhibitor of paramyxovirus (NDV) fusion.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(=O)O
DRAMP38008	TKRNTNRRPQDVKFPGGGQIVGGVYL	26	HCVc11-36	No Entry Found	Flaviviridae	Not Available	HCV core protein	[Ref:20862261]HCV:IC50=High	Not Available				Inhibit Replication	[Ref:20862261]HCV:IC50=High	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20862261	PLoS One. 2010	Sun C, Pager CT, Luo G, Sarnow P, Cate JH.	Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP38009	CDVIALLACHLNTPSFNTTHYRESWY	26	P13	P21530	Flaviviridae	Not Available	Phage display	[Ref:17151121]WNV:IC50=Low	Not Available				Inhibit Virus entry	[Ref:17151121]WNV:IC50=Low	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Virus entry	17151121	J Virol. 2007	Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.	Antiviral peptides targeting the west nile virus envelope protein.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP38010	WCNWHNIDPWIQLMNRTQADLAEGPPVKEC	30	S25	No Entry Found	Flaviviridae	Not Available	CSFV envelope protein (E2)	[Ref:21400206]CSFV:IC50=42%	Not Available				Inhibit CSFV entering	[Ref:21400206]CSFV:IC50=42%	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	21400206	Virus Genes. 2011	Li X, Wang L, Zhao D, Zhang G, Luo J, Deng R, Yang Y.	Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@H](C)CC
DRAMP38011	CQRCGWETGVGVSGFLVRILRFVVL	25	C4	No Entry Found	Rhabdoviridae	Not Available	Synthetic-Construct	[Ref:15220414]RV:IC50=High	Not Available				Not Available	[Ref:15220414]RV:IC50=High	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Phosphoprotein	15220414	J Virol. 2004	Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.	Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.	CC[C@@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP38012	PPSHSFRPESLERLHLLRRVLLLMRIVH	28	P24	Q6WB98	Rhabdoviridae	Not Available	Synthetic-Contruct	[Ref:15220414]RV:IC50=High	Not Available				Not Available	[Ref:15220414]RV:IC50=High	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Phosphoprotein	15220414	J Virol. 2004	Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.	Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)C(=O)O
DRAMP38013	FNVALDQVFESIENSQALVDQSNRILSSAE	30	HRB2	P59594	Paramyxoviridae	Not Available	hMPV fusion (F) protein	[Ref:17967906]hMPV:IC50=>9,000nM	Not Available				Inhibit Virus entry	[Ref:17967906]hMPV:IC50=>9,000nM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	17967906	Antimicrob Agents Chemother. 2008	Deffrasnes C, Hamelin ME, Prince GA, Boivin G.	Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
DRAMP38014	AYRFNGIQVTQNVLYENQKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLIT	96	sHR1	P08713	Coronaviridae	S	SARS-CoV spike protein	[Ref:15150417]SARS-CoV:EC50=>50µM	Not Available			1WNC##1ZV7	Inhibit Fusion	[Ref:15150417]SARS-CoV:EC50=>50µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	15150417	Proc Natl Acad Sci U S A.  2004	Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)O)C(C)C)NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)N)[C@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)O
DRAMP38015	CNIAPASIVSRNIVYTRAQPNQDIA	25	VP4-peptide	P26663	Reoviridae	Not Available	BRV capsid protein-VP4 	[Ref:9682337]BRV:IC50=200µg/ml	Not Available				Inhibit Virus entry	[Ref:9682337]BRV:IC50=200µg/ml	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	9682337	Vaccine.  1998	Ijaz MK, Nur-E-Kamal MS, Dar FK, Uduman S, Redmond MJ, Attah-Poku SK, Dent D, Babiuk LA.	Inhibition of rotavirus infection in vitro and in vivo by a synthetic peptide from VP4.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CS)[C@H](C)CC)[C@H](C)CC)C(C)C)[C@H](C)CC)C(C)C)[C@@H](C)O)C(=O)O
DRAMP38016	NRRPQDVKFPGGGQIVGGVYL	21	HCVc16-36	P10226	Flaviviridae	Not Available	HCV core protein	[Ref:20862261HCV:IC50=High	Not Available				Inhibit Replication	[Ref:20862261HCV:IC50=High	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20862261	PLoS One. 2010	Sun C, Pager CT, Luo G, Sarnow P, Cate JH.	Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP38017	RRLQVGGGTLKFFLT	15	peptide 57	No Entry Found	Herpesviridae	Not Available	HSV UL42 protein	[Ref:8380075HSV-1:IC50=12µM	Not Available				Inhibit Replication	[Ref:8380075HSV-1:IC50=12µM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	8380075	J Virol. 1993	Owsianka AM, Hart G, Murphy M, Gottlieb J, Boehme R, Challberg M, Marsden HS.	Inhibition of herpes simplex virus type 1 DNA polymerase activity by peptides from the UL42 accessory protein is largely nonspecific.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
DRAMP38018	CTMLLFHRC	9	-	No Entry Found	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Not Available	[Ref:15919886]SNV:IC50=2.8 × 10^8 particles/μl	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP38019	CQLPAERWC	9	-	Q9IH63	Bunyaviridae	Not Available	Phage display	Antimrobial; Antiviral	Not Available				Not Available	[Ref:15919886]SNV:IC50=9.1 × 10^8 particles/μl	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	beta-3 integrins	15919886	J Virol. 2005	Larson RS, Brown DC, Ye C, Hjelle B.	Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.	
DRAMP38020	KVDISSQISSMNQSLQQSKDYIKEAQRLLDTVNPSL	37	NiV FC2	P59594	Paramyxoviridae	Not Available	NiV fusion glycoprotein	[Ref:16026621]HeV:IC50=17.59nM inHela Cells: NiV:IC50=13.08nM in Hela Cells	Not Available				Not Available	[Ref:16026621]HeV:IC50=17.59nM inHela Cells: NiV:IC50=13.08nM in Hela Cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Fusion	16026621	Virol J. 2005	Bossart KN, Mungall BA, Crameri G, Wang LF, Eaton BT, Broder CC.	Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP38021	TSSMRGVYYPDEIFRSDTLYL	21	P1	P59594	Coronaviridae	S	S1 of SARS-CoV spike protein	Antimrobial; Antiviral	Not Available			1WNC##1ZV7	Inhibit Virus entry	[Ref:15811330]SARS-CoV:IC50=inhibiti SRS-CoV in HEK293T cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	15811330	FEBS Lett. 2005	Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.	Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.	
DRAMP38022	KSNVVRGWVFGSTMNNKSQS	20	P2	P59594	Coronaviridae	S	S1 of SARS-CoV spike protein	Antimrobial; Antiviral	Not Available			1WNC##1ZV7	Inhibit Virus entry	[Ref:15811330]SARS-CoV:IC50=inhibiti SRS-CoV in HEK293T cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	15811330	FEBS Lett. 2005	Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.	Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.	
DRAMP38023	YKGYQPIDVVRDLPSGFNTL	20	P3	P59594	Coronaviridae	S	S1 of SARS-CoV spike protein	Antimrobial; Antiviral	Not Available			1WNC##1ZV7	Inhibit Virus entry	[Ref:15811330]SARS-CoV:IC50=inhibiti SRS-CoV in HEK293T cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	15811330	FEBS Lett. 2005	Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.	Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.	
DRAMP38024	TDAVDCSQNPLAELKCSVKSF	21	P4	P59594	Coronaviridae	S	S1 of SARS-CoV spike protein	Antimrobial; Antiviral	Not Available			1WNC##1ZV7	Inhibit Virus entry	[Ref:15811330]SARS-CoV:IC50=inhibiti SRS-CoV in HEK293T cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	15811330	FEBS Lett. 2005	Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.	Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.	
DRAMP38025	KGIYQTSNFRVVPSGDVVRF	20	P5	P59594	Coronaviridae	S	S1 of SARS-CoV spike protein	Antimrobial; Antiviral	Not Available			1WNC##1ZV7	Inhibit Virus entry	[Ref:15811330]SARS-CoV:IC50=inhibiti SRS-CoV in HEK293T cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	15811330	FEBS Lett. 2005	Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.	Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.	
DRAMP38026	TKFPSVYAWERKKISNCVAD	20	P6	P59594	Coronaviridae	S	S1 of SARS-CoV spike protein	Antimrobial; Antiviral	Not Available			1WNC##1ZV7	Inhibit Virus entry	[Ref:15811330]SARS-CoV:IC50=inhibiti SRS-CoV in HEK293T cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	15811330	FEBS Lett. 2005	Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.	Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.	
DRAMP38027	YNYKYRYLRHGKLRPFERDI	20	P7	No Entry Found	Coronaviridae	S	S1 of SARS-CoV spike protein	Antimrobial; Antiviral	Not Available			1WNC##1ZV7	Inhibit Virus entry	[Ref:15811330]SARS-CoV:IC50=inhibiti SRS-CoV in HEK293T cells	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	15811330	FEBS Lett. 2005	Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.	Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.	
DRAMP38028	QKKIRVRL	8	SB102	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	No MIC is available in the Article	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	No MIC is available in the Article	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP38029	QKKIRVRWSA	10	SB103	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	No MIC is available in the Article	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	No MIC is available in the Article	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP38030	NKKIRVRL	8	SB104	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	No MIC is available in the Article	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	No MIC is available in the Article	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP38031	ASLRVRIKKQ	10	SB105	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	[Ref:20083141]HCMV:IC50=0.23 μM in HELFs cells,MCMV:IC50=0.67μM in NIH3T3 cells,The IC50 and IC90 concentrations for HCMV replication were 0.22 and 0.77 μM for SB105	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	[Ref:20083141]HCMV:IC50=0.23 μM in HELFs cells,MCMV:IC50=0.67μM in NIH3T3 cells,The IC50 and IC90 concentrations for HCMV replication were 0.22 and 0.77 μM for SB105	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
DRAMP38032	ASLRVRIKK	9	SB105_A10	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	[Ref:20083141]HCMV:IC50=0.25 μM in HELFs cells,IC50= 0.98 μM in NIH3T3 cells,The IC50 and IC90 concentrations for HCMV replication were 0.29 and 14 μM	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	[Ref:20083141]HCMV:IC50=0.25 μM in HELFs cells,IC50= 0.98 μM in NIH3T3 cells,The IC50 and IC90 concentrations for HCMV replication were 0.29 and 14 μM	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP38033	FKKIRVRL	8	SB106	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	No MIC is available in the Article	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	No MIC is available in the Article	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
DRAMP38034	QKKIRVRISA	10	SB107	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	No MIC is available in the Article	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	No MIC is available in the Article	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O
DRAMP38035	QKKIRVRLSW	10	SB108	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	No MIC is available in the Article	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	No MIC is available in the Article	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
DRAMP38036	QKKIRVRFSA	10	SB109	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	No MIC is available in the Article	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	No MIC is available in the Article	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP38037	QKKIRFRLSA	10	SB110	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	No MIC is available in the Article	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	No MIC is available in the Article	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O
DRAMP38038	QKKIRIRLSA	10	SB111	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	No MIC is available in the Article	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	No MIC is available in the Article	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)[C@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O
DRAMP38039	QKKIRWRLSA	10	SB112	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	No MIC is available in the Article	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	No MIC is available in the Article	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O
DRAMP38040	QKKFRVRLSA	10	SB113	No Entry Found	Herpesviridae	Not Available	Synthetic Construct	No MIC is available in the Article	Not Available				Inhibit the replication of GCV-resistant strains of HCMV	No MIC is available in the Article	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	20083141	Antiviral Res. 2010	Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.	Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O
DRAMP38041	CNSSSPTAC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=61%, p Value=04 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38042	CPSHYTQAC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=34%, p Value=0.2771 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38043	CQPHLPWHC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=68%, p Value=0.3193 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38044	CSPYAKHNC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=50%, p Value=0208 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38045	CYATTLGAC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=45%, p Value=0483 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38046	CNKQFSAAC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=48%, p Value=0.2084 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38047	CHSLRNAFC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=56%, p Value=0835 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38048	CHVLDPHLC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=21%, p Value=0.5428 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38049	CQATTARNC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=78%, p Value=0.1741 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38050	CTDNALKAC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=15%, p Value=0.1885 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38051	CPGHHLSHC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=48%, p Value=0.5794 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38052	CKPSTSGQC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=45%, p Value=0151 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38053	CLPTPHHVC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=41%, p Value=0002 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38054	CDLLLPGRC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=35%, p Value=NA inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38055	CQWPGQSGC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=60%, p Value=0982 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38056	CTQSGLLSC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=61%, p Value=0063 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38057	CSTTNATWC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=36%, p Value=0.6621 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38058	CKSFTTTRC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=61%, p Value=0005 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38059	CKHHNWWTC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=12%, p Value=0.8981 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38060	CVMSKHQHC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=30%, p Value=0.4882 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38061	CQGSPYRHC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=59%, p Value=0717 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38062	CYRTQFTQC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=39%, p Value=0.3021 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38063	CLVRNLAWC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=83%, p Value=0.2326 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38064	CNPMHSRTC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=44%, p Value=0563 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38065	CNSPKGKPC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=53%, p Value=0.6765 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38066	CQTTNWNTC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=74%, p Value=0.4673 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38067	CTFHSPRFC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=43%, p Value=0.9021 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38068	CTTHISQTC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=9%, p Value=0.5428 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38069	CYKMDNHTC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=19%, p Value=1 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38070	CERLNLPQC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=14%, p Value=0.1709 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38071	CLMGSSHSC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=32%, p Value=0038 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38072	CTYPYPKFC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=64%, p Value=0053 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38073	CSQWLQGS	8	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=22%, p Value=0011 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38074	CGPSLRGVC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=45%, p Value=0006 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38075	CTPLSTLQC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=40%, p Value=0142 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38076	CHADQLPMC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=39%, p Value=0138 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38077	CFSSARLSC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=13%, p Value=0.8836 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38078	CHPSKALQC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=13%, p Value=0095 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38079	CKSTFSPNC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=65%, p Value=0.3406 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38080	CQRTTEANC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=16%, p Value=0078 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38081	CNSMWVRNC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=25%, p Value=0.1999 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38082	CTSAAVHMC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=68%, p Value=003 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38083	CTPGRSATC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=40%, p Value=0077 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38084	CTGYHNNTC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=16%, p Value=0001 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38085	CHQLMQNLC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=65%, p Value=0219 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38086	CSASTESLC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=75%, p Value=0711 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38087	CSLRTYAAC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=12%, p Value=0353 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38088	CSRNHILTC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=25%, p Value=0015 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38089	CFNTHTANC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=47%, p Value=0347 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38090	CHGSTKWAC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	Antimrobial; Antiviral	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=39%, p Value=0011 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	
DRAMP38091	CQLSLAPYC	9	-	No Entry Found	Bunyaviridae	Not Available	Synthetic-Construct(phage display selection of cyclic nonapeptides)	[Ref:18391034]SNV:IC50=41%, p Value=0.399 inhibition in Vero E6 cells	Not Available				Inhibit Virus Entry	[Ref:18391034]SNV:IC50=41%, p Value=0.399 inhibition in Vero E6 cells	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Free		L	No cytotoxicity information found in the reference(s) presented	Membrane	18391034	Antimicrob Agents Chemother. 2008	Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.	Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)O
DRAMP38956	ALWMTLLKKVLKAAAKAALDAVLVGANA	28	Dermaseptin-D20–S4	Not found	Not found	Not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	Not found			Not found		[Ref.10952593] protozoon:P. falciparum-infected RBC(1μM<IC50<5μM);ring stage of P. falciparum(IC50~0.8μM)##Gram-negative bacteria:E. coli(50μM<IC50<100μM)	[Ref.10952593]1μM<LC50<5μM against on human red blood cells	Linear	Free	Free	Not found	L	Not found	plasma membrane	10952593	Antimicrob Agents Chemother. 2000 Sep;44(9):2442–2451.	Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H, Mor A.	Antimalarial activities of dermaseptin S4 derivatives.	
DRAMP38957	ALWDTLLKKVLKAAAKAALNAVLVGANA	28	Dermaseptin-D4–S4	Not found	Not found	Not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	Not found			Not found		[Ref.10952593] protozoon:P. falciparum-infected RBC(IC50<1.0μM);ring stage of P. falciparum(IC50~0.10μM)##Gram-negative bacteria:E. coli(50μM<IC50<100μM)	[Ref.10952593]1μM<LC50<5μM against on human red blood cells	Linear	Free	Free	Not found	L	Not found	plasma membrane	10952593	Antimicrob Agents Chemother. 2000 Sep;44(9):2442–2451.	Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H, Mor A.	Antimalarial activities of dermaseptin S4 derivatives.	
DRAMP38958	ALWMTLLKKVLKAAAKAALKAVLVGANA	28	Dermaseptin-K20–S4	Not found	Not found	Not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	Not found			Not found		[Ref.10952593] protozoon:P. falciparum-infected RBC(IC50<1.0μM);ring stage of P. falciparum(IC50~0.2μM)##Gram-negative bacteria:E. coli(50μM<IC50<100μM)	[Ref.10952593]1μM<LC50<5μM against on human red blood cells	Linear	Free	Free	Not found	L	Not found	plasma membrane	10952593	Antimicrob Agents Chemother. 2000 Sep;44(9):2442–2451.	Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H, Mor A.	Antimalarial activities of dermaseptin S4 derivatives.	
DRAMP38959	ALWMTLLKKVLKAAAKAALN	20	Dermaseptin-S4(1-20)	P80280(1-20)	Belongs to the frog skin active peptide (FSAP) family. Dermaseptin subfamily.	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			2DCX##2DD6		[Ref.10952593] protozoon:P. falciparum-infected RBC(IC50=1.0μM);ring stage of P. falciparum(IC50~0.4μM)##Gram-negative bacteria:E. coli(IC50=10μM)	[Ref.10952593]5μM<LC50<10μM against on human red blood cells	Linear	Free	Free	Not found	L	Not found	plasma membrane	10952593	Antimicrob Agents Chemother. 2000 Sep;44(9):2442–2451.	Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H, Mor A.	Antimalarial activities of dermaseptin S4 derivatives.	
DRAMP38960	ALWMTLLKKVLKAAAK	16	Dermaseptin-S4(1-16)	P80280(1-16)	Belongs to the frog skin active peptide (FSAP) family. Dermaseptin subfamily.	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			2DCX##2DD6		[Ref.10952593] protozoon:P. falciparum-infected RBC(10μM<IC50<50μM);ring stage of P. falciparum(IC50~2.0μM)##Gram-negative bacteria:E. coli(10μM<IC50<50μM)	[Ref.10952593]10μM<LC50<50μM against on human red blood cells	Linear	Free	Free	Not found	L	Not found	plasma membrane	10952593	Antimicrob Agents Chemother. 2000 Sep;44(9):2442–2451.	Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H, Mor A.	Antimalarial activities of dermaseptin S4 derivatives.	
DRAMP38961	ALWMTLLKKVLK	12	Dermaseptin-S4(1-12)	P80280(1-12)	Belongs to the frog skin active peptide (FSAP) family. Dermaseptin subfamily.	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			2DCX##2DD6		[Ref.10952593] protozoon:P. falciparum-infected RBC(IC50=100μM);ring stage of P. falciparum(IC50~5.0μM)##Gram-negative bacteria:E. coli(50μM<IC50<100μM)	[Ref.10952593]LC50=100μM against on human red blood cells	Linear	Free	Free	Not found	L	Not found	plasma membrane	10952593	Antimicrob Agents Chemother. 2000 Sep;44(9):2442–2451.	Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H, Mor A.	Antimalarial activities of dermaseptin S4 derivatives.	
DRAMP38962	TLLKKVLKAAAK	12	Dermaseptin-S4(5-16)	P80280(5-16)	Belongs to the frog skin active peptide (FSAP) family. Dermaseptin subfamily.	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			2DCX##2DD6		[Ref.10952593] protozoon:P. falciparum-infected RBC(IC50=100μM);ring stage of P. falciparum(IC50~1.5μM)##Gram-negative bacteria:E. coli(50μM<IC50<100μM)##[Ref.11847217]protozoon:Leishmania major(LC50>50µM)##Gram-negative bacteria:Escherichia coli(MIC>50µM)##Gram-positive bacteria:Staphylococcus aureus(MIC>50µM)##Fungi:Cryptococcus neoformans(MIC>50µM)	[Ref.10952593]LC50=100μM against on human red blood cells##[Ref.11847217]LC50>50μM against on RBC	Linear	Free	Free	Not found	L	Not found	plasma membrane	10952593##11847217	Antimicrob Agents Chemother. 2000 Sep;44(9):2442–2451.##J Biol Chem. 2002 May 10;277(19):16941-51.	Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H, Mor A.##Kustanovich I, Shalev DE, Mikhlin M, Gaidukov L, Mor A.	Antimalarial activities of dermaseptin S4 derivatives.##Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives.	
DRAMP38963	KVLKAAAKAALNAVLVGANA	20	Dermaseptin-S4(9-28)	P80280(9-28)	Belongs to the frog skin active peptide (FSAP) family. Dermaseptin subfamily.	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			2DCX##2DD6		[Ref.10952593] protozoon:P. falciparum-infected RBC(IC50=100μM);ring stage of P. falciparum(IC50~0.5μM)##Gram-negative bacteria:E. coli(50μM<IC50<100μM)##[Ref.11847217]protozoon:Leishmania major(LC50=50µM)##Gram-negative bacteria:Escherichia coli(MIC>50µM)##Gram-positive bacteria:Staphylococcus aureus(MIC>50µM)##Fungi:Cryptococcus neoformans(MIC>50µM)	[Ref.10952593]10μM<LC50<50μM against on human red blood cells##[Ref.11847217]LC50=25μM against on RBC	Linear	Free	Free	Not found	L	Not found	plasma membrane	10952593##11847217	Antimicrob Agents Chemother. 2000 Sep;44(9):2442–2451.##J Biol Chem. 2002 May 10;277(19):16941-51.	Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H, Mor A.##Kustanovich I, Shalev DE, Mikhlin M, Gaidukov L, Mor A.	Antimalarial activities of dermaseptin S4 derivatives.##Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives.	
DRAMP38964	AAAKAALNAVLVGANA	16	Dermaseptin-S4(13-28)	P80280(13-28)	Belongs to the frog skin active peptide (FSAP) family. Dermaseptin subfamily.	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			2DCX##2DD6		[Ref.10952593] protozoon:P. falciparum-infected RBC(IC50=100μM);ring stage of P. falciparum(IC50>100μM)##Gram-negative bacteria:E. coli(50μM<IC50<100μM)	[Ref.10952593]10μM<LC50<50μM against on human red blood cells	Linear	Free	Free	Not found	L	Not found	plasma membrane	10952593	Antimicrob Agents Chemother. 2000 Sep;44(9):2442–2451.	Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H, Mor A.	Antimalarial activities of dermaseptin S4 derivatives.	
DRAMP38965	ALWKTLLKKVLKAAA	15	Dermaseptin K4–S4(1–15)a	Not found	Not found	Not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			Not found		[Ref.10952593] protozoon:P. falciparum-infected RBC(1μM<IC50<5μM);ring stage of P. falciparum(IC50~1.0μM)##Gram-negative bacteria:E. coli(IC50<1.0μM)	[Ref.10952593]10μM<LC50<50μM against on human red blood cells	Linear	Free	Amidation	Not found	L	Not found	plasma membrane	10952593	Antimicrob Agents Chemother. 2000 Sep;44(9):2442–2451.	Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H, Mor A.	Antimalarial activities of dermaseptin S4 derivatives.	
DRAMP38966	ALWKTLLKKV	10	Dermaseptin K4–S4(1–10)a	Not found	Not found	Not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			Not found		[Ref.10952593] protozoon:P. falciparum-infected RBC(IC50=100μM);ring stage of P. falciparum(IC50>100μM)##Gram-negative bacteria:E. coli(50μM<IC50<100μM)##[Ref.11847217]protozoon:Leishmania major(LC50>50µM)##Gram-negative bacteria:Escherichia coli(MIC=50µM)##Gram-positive bacteria:Staphylococcus aureus(MIC>50µM)##Fungi:Cryptococcus neoformans(MIC=30µM)	[Ref.10952593]LC50=100μM against on human red blood cells##[Ref.11847217]LC50>50μM against on RBC	Linear	Free	Amidation	Not found	L	Not found	plasma membrane	10952593##11847217	Antimicrob Agents Chemother. 2000 Sep;44(9):2442–2451.##J Biol Chem. 2002 May 10;277(19):16941-51.	Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H, Mor A.##Kustanovich I, Shalev DE, Mikhlin M, Gaidukov L, Mor A.	Antimalarial activities of dermaseptin S4 derivatives.##Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives.	
DRAMP38967	XV	2	2-(2-tert-Butoxycarbonylamino-3-methylbutyrylamino)-cyclopentanecarboxylic acid methyl ester (3.3)	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.18305429]protozoon:CS of Plasmodium falciparum(IC50=12.14μM,IC90=13.52μM,IC99=36.89μM)CR of Plasmodium falciparum(IC50=14.52μM,IC90=17.14μM,IC99=39.87μM）	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	tert-butoxycarbonylation,Cyclization (N termini to C termini)	methyl esterification,Cyclization (C termini to N termini)	"X=2-aminocyclopentanecarboxylic acid;
The N-terminal amino acid itself contains a cycloalkane skeleton"	L	Not found	plasma membrane	18305429	Molecules. 2008 Feb 18;13(2):432–443.	Sathe M, Thavaselvam D, Srivastava AK, Kaushik MP.	Synthesis and antimalarial evaluation of cyclic beta-amino acid-containing dipeptides.	
DRAMP38968	XV	2	2-(2-tert-Butoxycarbonylamino-3-methylbutyrylamino)-cyclooctanecarboxylic acid methyl ester (4.3)	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.18305429]protozoon:CS of Plasmodium falciparum(IC50=6.14μM,IC90=10.88μM,IC99=11.43μM)CR of Plasmodium falciparum(IC50=7.39μM,IC90=9.13μM,IC99=10.19μM）	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	tert-butoxycarbonylation,Cyclization (N termini to C termini)	methyl esterification,Cyclization (C termini to N termini)	"X=2-aminocyclooctanecarboxylic acid;
The N-terminal amino acid itself contains a cycloalkane skeleton"	L	Not found	plasma membrane	18305429	Molecules. 2008 Feb 18;13(2):432–443.	Sathe M, Thavaselvam D, Srivastava AK, Kaushik MP.	Synthesis and antimalarial evaluation of cyclic beta-amino acid-containing dipeptides.	
DRAMP38969	PIAATGYX	8	Squamin C	Not found	Not found	Not found	Annona globiflora	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.34411895]protozoon:A. castellanii Neff trophozoites(IC50=20.77μM);A. castellanii Neff cyst(IC50=73.07μM)A.polyphaga trophozoites(IC50=71.78μM);A.polyphaga cyst(IC50=73.30μM);A.griffini trophozoites(IC50=38.81μM)A.griffini trophozoites(IC50>100μM);A. quinatrophozoites(IC50=24.28μM);cyst of A. quina(IC50>100μM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X=S-oxo-methionine;The cyclooctapeptide is formed by a peptide bond between the N-terminal proline (Pro) and the C-terminal Meto.	L	[Ref.34411895]CC50 > 200 μM targeting on J774A.1 cells.	mitochondrion;chromatin;plasma membrane	34411895	Int J Parasitol Drugs Drug Resist. 2021 Aug 11;17:67–79.	Rodríguez-Expósito RL, Sosa-Rueda J, Reyes-Batlle M, Sifaoui I, Cen-Pacheco F, Daranas AH, Díaz-Marrero AR, Piñero JE, Fernández JJ, Lorenzo-Morales J.	Antiamoeboid activity of squamins C-F, cyclooctapeptides from Annona globifora.	
DRAMP38970	PIAATGYX	8	Squamin D	Not found	Not found	Not found	Annona globiflora	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.34411895]protozoon: A. castellanii Neff trophozoites(IC50=18.38μM); A. castellanii Neff cyst(IC50=39.02μM);A.polyphaga trophozoites(IC50=71.57μM);A.polyphaga cyst(IC50=72.94μM);A.griffini trophozoites (IC50=39.53μM);A.griffini cyst(IC50>100μM);A. quina trophozoites(IC50=26.52μM);A. quina cyst(IC50>100μM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X=R-oxo-methionine;The cyclooctapeptide is formed by a peptide bond between the N-terminal proline (Pro) and the C-terminal Meto.	L	[Ref.34411895]CC50 > 200 μM targeting on J774A.1 cells.	mitochondrion;chromatin;plasma membrane	34411895	Int J Parasitol Drugs Drug Resist. 2021 Aug 11;17:67–79.	Rodríguez-Expósito RL, Sosa-Rueda J, Reyes-Batlle M, Sifaoui I, Cen-Pacheco F, Daranas AH, Díaz-Marrero AR, Piñero JE, Fernández JJ, Lorenzo-Morales J.	Antiamoeboid activity of squamins C-F, cyclooctapeptides from Annona globifora.	
DRAMP38971	PTAATGYX	8	Squamin E	Not found	Not found	Not found	Annona globiflora	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.34411895]protozoon:A. castellanii Neff trophozoites(IC50=21.00μM);A. castellanii Neff cyst(IC50=44.53μM);A.polyphaga trophozoites (IC50=62.19μM);A.polyphaga cyst(IC50=73.62μM);A.griffini trophozoites(IC50=44.75μM);A.griffini cyst(IC50>100μM);A. quina trophozoites(IC50=25.82μM); A. quina cyst(IC50>100μM);	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X=S-oxo-methionine;The cyclooctapeptide is formed by a peptide bond between the N-terminal proline (Pro) and the C-terminal Meto.	L	[Ref.34411895]CC50 > 200 μM targeting on J774A.1 cells.	mitochondrion;chromatin;plasma membrane	34411895	Int J Parasitol Drugs Drug Resist. 2021 Aug 11;17:67–79.	Rodríguez-Expósito RL, Sosa-Rueda J, Reyes-Batlle M, Sifaoui I, Cen-Pacheco F, Daranas AH, Díaz-Marrero AR, Piñero JE, Fernández JJ, Lorenzo-Morales J.	Antiamoeboid activity of squamins C-F, cyclooctapeptides from Annona globifora.	
DRAMP38972	PTAATGYX	8	Squamin F	Not found	Not found	Not found	Annona globiflora	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.34411895]protozoon:A. castellanii Neff trophozoites (IC50=18.02μM); A. castellanii Neff cyst(IC50=52.40μM);A.polyphaga trophozoites (IC50=64.08μM);A.polyphaga cyst(IC50=73.63μM);A.griffini trophozoites (IC50=50.49μM);A.griffini trophozoites(IC50>100μM);A. quina trophozoites(IC50=30.32μM);A. quina cyst(IC50>100μM);	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X=R-oxo-methionine;The cyclooctapeptide is formed by a peptide bond between the N-terminal proline (Pro) and the C-terminal Meto.	L	[Ref.34411895]CC50 > 200 μM targeting on J774A.1 cells.	mitochondrion;chromatin;plasma membrane	34411895	Int J Parasitol Drugs Drug Resist. 2021 Aug 11;17:67–79.	Rodríguez-Expósito RL, Sosa-Rueda J, Reyes-Batlle M, Sifaoui I, Cen-Pacheco F, Daranas AH, Díaz-Marrero AR, Piñero JE, Fernández JJ, Lorenzo-Morales J.	Antiamoeboid activity of squamins C-F, cyclooctapeptides from Annona globifora.	
DRAMP38973	IITL	4	Epoxomicin	Not found	Not found	Not found	actinomycetes	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.18816382]protozoon:P. falciparum laboratory strains 3D7(IC50=6.8nM);P. falciparum laboratory strains D10(IC50=1.7nM);P. falciparum laboratory strains Dd2 (IC50=10.4nM);P. falciparum field isolates of Gabon(IC50=8.50 nM;IC90=12.4 nM;IC99=20.5nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation,N-methylation	α',β'-epoxyketonation	Not found	L	Not found	proteasome	18816382	Malar J. 2008 Sep 24;7:187.	Kreidenweiss A, Kremsner PG, Mordmüller B.	Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.	
DRAMP38974	XLLF	4	YU101	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.18816382]protozoon:P. falciparum laboratory strains 3D7(IC50=24.5nM);P. falciparum laboratory strains D10(IC50=17.0nM);P. falciparum laboratory strains Dd2 (IC50=13.8nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	α',β'-epoxyketonation	X=L-Homophenylalanine	L	Not found	proteasome	18816382	Malar J. 2008 Sep 24;7:187.	Kreidenweiss A, Kremsner PG, Mordmüller B.	Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.	
DRAMP38975	GPFL	4	YU102	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.18816382]protozoon:P. falciparum laboratory strains 3D7(IC50=1740nM);P. falciparum laboratory strains D10(IC50=4000nM);P. falciparum laboratory strains Dd2 (IC50=3006nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	α',β'-epoxyketonation	Not found	L	Not found	proteasome	18816382	Malar J. 2008 Sep 24;7:187.	Kreidenweiss A, Kremsner PG, Mordmüller B.	Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.	
DRAMP38976	LLL	3	MG132	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.18816382]protozoon:P. falciparum laboratory strains 3D7(IC50=22.4nM);P. falciparum laboratory strains D10(IC50=33.2nM);P. falciparum laboratory strains Dd2 (IC50=17.3nM);P. falciparum field isolates of Gabon(IC50=38.2nM;IC90=99.5nM;IC99=206nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Benzyloxycarbonylation	Leucinalization	Not found	L	Not found	proteasome	18816382	Malar J. 2008 Sep 24;7:187.	Kreidenweiss A, Kremsner PG, Mordmüller B.	Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.	
DRAMP38977	LLI	3	MG115	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.18816382]protozoon:P. falciparum laboratory strains 3D7(IC50=97.5nM);P. falciparum laboratory strains D10(IC50=50.0nM);P. falciparum laboratory strains Dd2 (IC50=44.9nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Benzyloxycarbonylation	Isoleucinalization	Not found	L	Not found	proteasome	18816382	Malar J. 2008 Sep 24;7:187.	Kreidenweiss A, Kremsner PG, Mordmüller B.	Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.	
DRAMP38978	LLL	3	Z-L3-VS	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.18816382]protozoon:P. falciparum laboratory strains 3D7(IC50=16.4nM);P. falciparum laboratory strains D10(IC50=n.d.);P. falciparum laboratory strains Dd2 (IC50=4.9nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Benzyloxycarbonylation	Vinyl sulfonation	Not found	L	Not found	proteasome	18816382	Malar J. 2008 Sep 24;7:187.	Kreidenweiss A, Kremsner PG, Mordmüller B.	Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.	
DRAMP38979	XXXLLL	6	Ada-Ahx3-L3-VS	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.18816382]protozoon:P. falciparum laboratory strains 3D7(IC50=300nM);P. falciparum laboratory strains D10(IC50=n.d.);P. falciparum laboratory strains Dd2 (IC50=210nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Adamantaneacetylation	Vinyl sulfonation	X=Ahx=6-Aminohexanoic acid	L	Not found	proteasome	18816382	Malar J. 2008 Sep 24;7:187.	Kreidenweiss A, Kremsner PG, Mordmüller B.	Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.	
DRAMP38980	FL	2	Bortezomib	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.18816382]protozoon:P. falciparum laboratory strains 3D7(IC50=252nM);P. falciparum laboratory strains D10(IC50=127nM);P. falciparum laboratory strains Dd2 (IC50=561nM);P. falciparum field isolates of Gabon(IC50=1452nM;IC90=2500nM;IC99=2911nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Pyrazine-2-carbonylation	Boronation	Not found	L	Not found	proteasome	18816382	Malar J. 2008 Sep 24;7:187.	Kreidenweiss A, Kremsner PG, Mordmüller B.	Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.	
DRAMP38981	RRRPRPPYLPR	11	PR11	P80054(131-141)	Belongs to the cathelicidin family.	PR39	Sus scrofa (Pig)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.18816382]protozoon:P. falciparum laboratory strains 3D7(IC50=n.i.);P. falciparum laboratory strains D10(IC50=n.d.);P. falciparum laboratory strains Dd2 (IC50=n.i.)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	proteasome	18816382	Malar J. 2008 Sep 24;7:187.	Kreidenweiss A, Kremsner PG, Mordmüller B.	Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.	
DRAMP38982	KKYKAYFKFKCKK	13	p-Acl	P49121(121-133)	Belongs to the phospholipase A2 family. Group II subfamily. K49 sub-subfamily.	Not found	Agkistrodon contortrix laticinctus (Broad-banded copperhead) (Agkistrodon mokasen laticinctus)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.31454702]protozoon:L.amazonensis promastigotes(PH8EC50=57.23µM);L.amazonensisam astigotes(EC50=17.69µM);L.amazonensis 2269 promastigotes( EC50=50.98µM);L.infantum chagasipromastigotes( EC50=220.32µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.31454702]CC50 = 232.88 μM targeting on murine primary macrophages	plasma membrane	31454702	Comp Biochem Physiol C Toxicol Pharmacol. 2019 Dec:226:108612.	Mendes B, Almeida JR, Vale N, Gomes P, Gadelha FR, Da Silva SL, Miguel DC.	Potential use of 13-mer peptides based on phospholipase and oligoarginine as leishmanicidal agents	
DRAMP38983	RRYRAYFRFRCRR	13	p-AclR7	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.31454702]protozoon:L.amazonensis promastigotes(PH8EC50=27.19µM);L.amazonensis amastigotes (EC50=15.62µM);L.amazonensis 2269 promastigotes(EC50=36.83µM);L.infantum chagasi promastigotes(EC50=70.71µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.31454702]CC50 = 273.70 μM targeting on murine primary macrophages	plasma membrane	31454702	Comp Biochem Physiol C Toxicol Pharmacol. 2019 Dec:226:108612.	Mendes B, Almeida JR, Vale N, Gomes P, Gadelha FR, Da Silva SL, Miguel DC.	Potential use of 13-mer peptides based on phospholipase and oligoarginine as leishmanicidal agents	
DRAMP38984	CLAAPRKNVRWCTISQPEWFKCRRW	25	BLFpep	P24627(17-41)	Belongs to the transferrin family.	LTF	Bos taurus (Bovine)	Antimicrobial, Antiprotozoal	Protein level			Not found		[Ref.7591103]protozoon:Giardia lamblia((LD50=2.6 µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	7591103	Infect Immun. 1995 Nov;63(11):4550–4552.	Turchany JM, Aley SB, Gillin FD.	Giardicidal activity of lactoferrin and N-terminal peptides.	
DRAMP38985	LAGRRRSVQWCAVSQPEATKCFQ	23	HLFpep	P02788(18-40)	Belongs to the transferrin family.	LTF	Homo sapiens (Human)	Antimicrobial, Antiprotozoal	Protein level			Not found		[Ref.7591103]protozoon:Giardia lamblia(LD50=5.4 µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	7591103	Infect Immun. 1995 Nov;63(11):4550–4552.	Turchany JM, Aley SB, Gillin FD.	Giardicidal activity of lactoferrin and N-terminal peptides.	
DRAMP38986	VFIDILDKMENAIHKAAQAGIG	22	Andropin	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.21262294]protozoon:Leishmania panamensis promastigotes (EC50>100μg/mL);Leishmania panamensis intracellular(EC50=2.48±0.22μg/mL);Leishmania major promastigotes(EC50>100μg/mL);Leishmania major intracellular (EC50:ND)	[Ref.21262294] EC50>100 μg/mL.	Linear	Free	Free	Not found	L	[Ref.21262294] LC50>100 μg/mL targeting on dendritic cells. CLIP was used as control peptide.	plasma membrane	21262294	Peptides. 2011 Apr;32(4):683-90.	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G.	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)C(C)C)[C@H](C)CC)[C@H](C)CC)[C@H](C)CC)C(=O)NCC(N)=O
DRAMP38987	KWKVFKKIEKNGRNIRNGIVKAGPAIAVLGEAKAL	35	Cecropin B	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.21262294]protozoon:Leishmania panamensis promastigotes(EC50>100μg/mL); Leishmania panamens isintracellular(EC50:ND);Leishmania major promastigotes(EC50>100μg/mL);Leishmania majorintracellular(EC50:ND)##[Ref.2759705]protozoon:P. cynomolgi oocysts(92% inhibition at 0.5μg/μl);P. knowlesi oocysts(94% inhibition at 0.5μg/μl);P. falciparum (NF54) oocysts(85% inhibition at 0.5μg/μl);P. falciparum (3D7) oocysts(81% inhibition at 0.5μg/μl)	[Ref.21262294] EC50>100 μg/mL.	Linear	Free	Free	Not found	L	[Ref.21262294] LC50>100 μg/mL targeting on dendritic cells. CLIP was used as control peptide.	plasma membrane	21262294##2759705	Peptides. 2011 Apr;32(4):683-90.	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G.##Gwadz RW, Kaslow D, Lee JY, Maloy WL, Zasloff M, Miller LH.	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells##Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes.	
DRAMP38988	SWLSKTAKKLENSAKKRISEGIAIAQGPR	29	Cecropin P1	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.21262294]protozoon:Leishmania panamensis promastigotes (EC50>100μg/mL);Leishmania panamensis intracellular(EC50≥20μg/mL);Leishmania major promastigotes(EC50>100μg/mL);Leishmania major intracellular(EC50≥20μg/mL)	[Ref.21262294] EC50>100 μg/mL.	Linear	Free	Free	Not found	L	[Ref.21262294] LC50 = 22.97±1.63 μg/mL targeting on dendritic cells. CLIP was used as control peptide.	plasma membrane	21262294	Peptides. 2011 Apr;32(4):683-90.	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G.	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells	
DRAMP38989	GIGAVLTTGLPALISWIKRKRQQ	23	Melittin	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.21262294]protozoon: Leishmania panamensis promastigotes(EC50>100μg/mL);Leishmania panamensis intracellular(EC50≥10μg/mL);Leishmania major promastigotes (EC50=74.01±1.2μg/mL);Leishmania major intracellular (EC50:ND)	[Ref.21262294] EC50= 16.28±0.17 μg/mL.	Linear	Free	Free	Not found	L	[Ref.21262294] LC50 = 43.42±0.86 μg/mL targeting on dendritic cells. CLIP was used as control peptide.	plasma membrane	21262294	Peptides. 2011 Apr;32(4):683-90.	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G.	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells	
DRAMP38990	PRRRRSSSRP	10	Pr-1	P69015(2-11)	Not found	Not found	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.21262294]protozoon:Leishmania panamensis promastigotes(EC50>100μg/mL);Leishmania panamensis intracellular (EC50≥10μg/mL);Leishmania major promastigotes (EC50>100μg/mL);Leishmania major intracellular (EC50:ND)	[Ref.21262294] EC50>100 μg/mL.	Linear	Free	Free	Not found	L	[Ref.21262294] LC50 = 77.08±0.83 μg/mL targeting on dendritic cells. CLIP was used as control peptide.	plasma membrane	21262294	Peptides. 2011 Apr;32(4):683-90.	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G.	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells	
DRAMP38991	VRRRRRPR	8	Pr-2	P69015(12-19)	Not found	Not found	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.21262294]protozoon:Leishmania panamensis intracellular (EC50=23.7±0.37μg/mL);Leishmania panamensis intracellular (EC50≥10μg/mL); Leishmania major promastigotes(EC50>100μg/mL);Leishmania major intracellular (EC50:ND)	[Ref.21262294] EC50>100 μg/mL.	Linear	Free	Free	Not found	L	[Ref.21262294] LC50 = 37.57±0.27 μg/mL targeting on dendritic cells. CLIP was used as control peptide.	plasma membrane	21262294	Peptides. 2011 Apr;32(4):683-90.	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G.	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells	
DRAMP38992	YPIKPEAPGEAASPEELNRYYASLRHYLNLVTRQRY	36	PYY	Not found	Not found	Not found	Homo sapiens (Human)	Antimicrobial,Antifungal	Not found			Not found		[Ref.8601432]Fungi:Cryptococcus neoformans(MIC=25μg/mL);Candida albicans(MIC=25μg/mL);Arthroderma simii(MIC=15μg/mL)	[Ref.8601432]Human erythrocytes hemolysis > 100 μg/ml	Linear	Free	Amidation	Not found	L	[Ref.8601432]Upto 100 ug/ml no cytotoxicity targeting on Murine macrophages .	plasma membrane	8601432	FEBS Lett. 1996 Feb 19;380(3):237-40.	Vouldoukis I, Shai Y, Nicolas P, Mor A.	Broad spectrum antibiotic activity of the skin-PYY	
DRAMP38993	PEEMNKYLTALRHYINLVTRQRY	23	SPYY(14~36)	P80952(14-36)	Belongs to the NPY family.	Not found	Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor)	Antimicrobial, Antibacterial, Anti-Gram+,Anti-Gram-，Antifungal	protein level			Not found		[Ref.8601432]Gram-negative bacteria:Aeromonas caviae(MIC=40μg/mL);Escherichia coli(MIC=10μg/mL)##Gram-positive bacteria:Enterococcus faecalis(MIC=10μg/mL);Nocardia brasiliensis(MIC=20μg/mL)##Fungi:Cryptococcus neoformans(MIC=20μg/mL);Candida albicans(MIC=15μg/mL);Microsporum canis(MIC=10μg/mL);Tricophyton rubrum(MIC=15μg/mL);Arthroderma simii(MIC=10μg/mL);Aspergillus fumigatus(MIC=80μg/mL);Aspergillus niger(MIC>100μg/mL)	[Ref.8601432]Human erythrocytes hemolysis > 100 μg/ml	Linear	Free	Amidation	Not found	L	[Ref.8601432]Upto 100 ug/ml no cytotoxicity targeting on Murine macrophages .	plasma membrane	8601432	FEBS Lett. 1996 Feb 19;380(3):237-40.	Vouldoukis I, Shai Y, Nicolas P, Mor A.	Broad spectrum antibiotic activity of the skin-PYY	
DRAMP38994	IGRRGGYCAGIIKQTCTCYRK	21	Longicin P4	Q58A47(54-74)	Belongs to the invertebrate defensin family. Type 2 subfamily.	HlDfs	Haemaphysalis longicornis (Tick)	Antimicrobial,Antibacterial,Anti-Gram-,Antiprotozoal	transcript level			Not found		[Ref.17485458]protozoon:Babesia(Parasitemia remained stable at approximately 1% of 5.0μmol treatment)##Gram-negative bacteria:E.coli(2μmol,CFU<10^3);P.aeruginosa(2μmol,CFU<10^3);S.aureus(2μmol,CFU<10^3);S.typhimurium(10μmol,CFU<10^3)##[Ref.22102016]protozoon:B. bigemina(50% inhibition at 50μM)	[Ref.17485458]Will not cause hemolysis at any concentration that exerted a parasiticidal effect.	Not found	Free	Free	Not found	L	Not found	plasma membrane	17485458##22102016	Infect Immun. 2007 May 7;75(7):3633–3640.##Trop Anim Health Prod. 2012 Feb;44(2):343-8. 	Tsuji N, Battsetseg B, Boldbaatar D, Miyoshi T, Xuan X, Oliver JH Jr, Fujisaki K.##Galay RL, Maeda H, Aung KM, Umemiya-Shirafuji R, Xuan X, Igarashi I, Tsuji N, Tanaka T, Fujisaki K.	Babesial vector tick defensin against Babesia sp. parasites.##Anti-babesial activity of a potent peptide fragment derived from longicin of Haemaphysalis longicornis.	
DRAMP38995	LPKPPKPVSKMRMATPLLMQALPM	24	CLIP	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.31862270]protozoon:L. major promastigote(10% inhibition at 500μg/ml)	[Ref.31862270]no hemolytic activity was found##[Ref.30811391]non- hemolytic activity	Linear	Free	Free	Not found	L	[Ref.31862270]no cytotoxicity targeting on THP1cells.	plasma membrane	31862270##30811391	Exp Parasitol. 2020 Feb:209:107823.##PLoS Negl Trop Dis. 2019 Feb 27;13(2):e0007217.	Zahedifard F, Lee H, No JH, Salimi M, Seyed N, Asoodeh A, Rafati S.##Zahedifard F, Lee H, No JH, Salimi M, Seyed N, Asoodeh A, Rafati S.	Comparative study of different forms of Jellein antimicrobial peptide on Leishmania parasite##Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.	
DRAMP38996	LPKPPKPVSKMRMATPLLMQALPM	24	L-CLIP	Not found	Not found	Not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	Not found			Not found		[Ref.31862270]protozoon:L. major promastigote (IC50=280μg/ml)##Gram-negative bacteria:E. coli (ATCC 25922)(an inhibition of E. coli proliferation at less than1.56μg/ml)##[Ref.30811391]protozoon:L. major promastigote(IC50 between 280-300μg/ml)##Gram-negative bacteria:E. coli (ATCC 25922)(100% inhibition at 1.56μg/ml)	[Ref.31862270]about 30% hemolysis at 500 μg/ml##[Ref.30811391]about 30% hemolysis at 319 μg/ml	Linear	Lauroylation	Free	Not found	L	[Ref.31862270]no cytotoxicity targeting on THP1cells.	plasma membrane	31862270##30811391	Exp Parasitol. 2020 Feb:209:107823.##PLoS Negl Trop Dis. 2019 Feb 27;13(2):e0007217.	Zahedifard F, Lee H, No JH, Salimi M, Seyed N, Asoodeh A, Rafati S.##Zahedifard F, Lee H, No JH, Salimi M, Seyed N, Asoodeh A, Rafati S.	Comparative study of different forms of Jellein antimicrobial peptide on Leishmania parasite##Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.	
DRAMP38997	XXVVAVAIX	9	Wajeepeptin	Not found	Not found	Not found	Moorena sp.	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.39021085]protozoon:Trypanosoma brucei rhodesiense(IC50=0.73±0.14μM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X1=2-methyl-3-aminopentanoic acid,X2=lactic acid,X9=valic acid;N-methylation at position 3,5,6,8;Single-crystal X-ray diffraction resolved its cyclic conformation	L	[Ref.39021085]IC50=3.7μM targeting on HeLa cells.	Not found	39021085	J Nat Prod. 2024 Jul 26;87(7):1838-1843.	Kurisawa N, Jeelani G, Nozaki T, Agusta AL, Suenaga K, Iwasaki A.	Wajeepeptin, a cytotoxic and antitrypanosomal cyclic depsipeptide from a marine Moorena sp. cyanobacterium.	
DRAMP38998	APLYKKIIKKLLES	14	PF4P(57-70)	P02776(88-101)	Belongs to the intercrine alpha (chemokine CxC) family.	PF4	Homo sapiens (Human)	Antimicrobial,Antiprotozoal	protein level			Not found		[Ref.30033131]protozoon:P. falciparum(IC50>64μM)	[Ref.30033131]non-hemolytic up to 64 μM	Linear	Free	Free	Not found	L	Not found	parasite digestive vacuole;parasite DNA	30033131	Cell Chem Biol. 2018 Sep 20;25(9):1140-1150.e5.	Lawrence N, Dennis ASM, Lehane AM, Ehmann A, Harvey PJ, Benfield AH, Cheneval O, Henriques ST, Craik DJ, McMorran BJ.	Defense peptides engineered from human platelet factor 4 kill plasmodium by selective membrane disruption	
DRAMP38999	LQAPLYKKIIKKLLESGGSGGAPLYKKIIKKLLES	35	PF4PD	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.30033131]protozoon:P. falciparum(IC50=8.8±0.4μM)	[Ref.30033131]showed approx 20% hemolytic activity at 64 μM.	Linear	Free	Free	Not found	L	Not found	parasite digestive vacuole;parasite DNA	30033131	Cell Chem Biol. 2018 Sep 20;25(9):1140-1150.e5.	Lawrence N, Dennis ASM, Lehane AM, Ehmann A, Harvey PJ, Benfield AH, Cheneval O, Henriques ST, Craik DJ, McMorran BJ.	Defense peptides engineered from human platelet factor 4 kill plasmodium by selective membrane disruption	
DRAMP39000	CGGPLYKKIIKKLLESGGSGGAPLYKKIIKKLCES	35	cPF4PD	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.30033131]protozoon:P. falciparum(IC50 =4.3±0.2μM)	[Ref.30033131]non-hemolytic up to 64 μM	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Disulfide bonds between Cys1 and Cys33	L	Not found	parasite digestive vacuole;parasite DNA	30033131	Cell Chem Biol. 2018 Sep 20;25(9):1140-1150.e5.	Lawrence N, Dennis ASM, Lehane AM, Ehmann A, Harvey PJ, Benfield AH, Cheneval O, Henriques ST, Craik DJ, McMorran BJ.	Defense peptides engineered from human platelet factor 4 kill plasmodium by selective membrane disruption	
DRAMP39001	CGGPLYKKIIKKLLESGGSGGAPLYKKIIKKLCES	35	cPF4PD	P02776(66-101)	Belongs to the intercrine alpha (chemokine CxC) family.	PF4	Homo sapiens (Human)	Antimicrobial,Antiprotozoal	protein level			1DN3		[Ref.30033131]protozoon:P. falciparum(DARC+/+:IC50 =4.9±0.7μM;approx 80% inhibition at 20μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	parasite digestive vacuole;parasite DNA	30033131	Cell Chem Biol. 2018 Sep 20;25(9):1140-1150.e5.	Lawrence N, Dennis ASM, Lehane AM, Ehmann A, Harvey PJ, Benfield AH, Cheneval O, Henriques ST, Craik DJ, McMorran BJ.	Defense peptides engineered from human platelet factor 4 kill plasmodium by selective membrane disruption	CC[C@@H](C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)CNC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CCCN3C(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@H](C)CC)NC1=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N2
DRAMP39002	KIKWFKTMKSIAKFIAKEQMKKHL	24	XYP4	P61508(1-24)	Belongs to the cationic peptide 04 (cupiennin) family. 05 subfamily.	Not found	Hogna carolinensis (Carolina wolf spider) (Lycosa carolinensis)	Antimicrobial,Antiprotozoal	protein level			Not found		[Ref.40818596]protozoon:Toxoplasma gondii(70% inhibition at 5μM;approx 90% inhibition at 10μM)	[Ref.40818596]Start to increase in the range of 20-40μM,CH50=93.52μM	Linear	Free	Free	Not found	L	[Ref.40818596]IC50=21.6μM targeting on HFF;IC50 =15.85μM targeting on RAW264.7	plasma membrane	40818596	Toxicon. 2025 Nov:266:108540.	Yang D, Liu X, Li J, Wu K, Xie J, Wang Y, Wang Z, Jiang L.	Anti-Toxoplasma gondii studies of the venom peptide XYP4 from the Lycosa coelestis	
DRAMP39003	AGwawX	6	Paecilodepsipeptide A	Not found	Not found	Not found	Paecilomyces cinnamomeus	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.17269825]protozoon:Plasmodium falciparum K1(IC50=4.9µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	x=(2S)-L-3-Ph-Lac;O-prenylation of the Tyr residue at position 5;ester linkage of o-prenyl-Tyr-3-Ph-Lac	D	[Ref.17269825]IC50=5.9μM targeting on KB cancer cell lines;IC50=6.6μM targeting on BC cancer cell lines;Inactive against noncancerous Vero cells up to 67 µM (50 µg/mL)	Not found	17269825	J Nat Prod. 2007 Apr;70(4):675-8.	Isaka M, Palasarn S, Lapanun S, Sriklung K.	Paecilodepsipeptide A, an antimalarial and antitumor cyclohexadepsipeptide from the insect pathogenic fungus paecilomyces cinnamomeus BCC 9616	
DRAMP39004	YAAF	4	Carmabin A	Not found	Not found	Not found	Lyngbya majuscula	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.17441769]protozoon:W2 chloroquine-resistant malaria strain(IC50=4.3µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Mdya acylation	Amidation	N,O-dimethylationat position 1;N-methylation at position 2,4	L	[Ref.17441769]IC50=9.8μM targeting on Vero cells	Not found	17441769	J Nat Prod. 2007 Jun;70(6):984-8.	McPhail KL, Correa J, Linington RG, Gonzalez J, Ortega-Barría E, Capson TL, Gerwick WH.	Antimalarial linear lipopeptides from a panamanian strain of the marine cyanobacterium Lyngbya majuscula	
DRAMP39005	YAAF	4	Dragomabin	Not found	Not found	Not found	Lyngbya majuscula	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.17441769]protozoon:W2 chloroquine-resistant malaria strain(IC50=6.0µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Moya acylation	Amidation	N,O-dimethylationat position 1;N-methylation at position 2,4	L	[Ref.17441769]IC50=182.3μM targeting on Vero cells	Not found	17441769	J Nat Prod. 2007 Jun;70(6):984-8.	McPhail KL, Correa J, Linington RG, Gonzalez J, Ortega-Barría E, Capson TL, Gerwick WH.	Antimalarial linear lipopeptides from a panamanian strain of the marine cyanobacterium Lyngbya majuscula	
DRAMP39006	VVVF	4	Dragonamide A	Not found	Not found	Not found	Lyngbya majuscula	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.17441769]protozoon:W2 chloroquine-resistant malaria strain(IC50=7.7µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Moya acylation	Amidation	N-methylation at position 1,2,3,4	L	[Ref.17441769]IC50=67.8μM targeting on Vero cells	Not found	17441769	J Nat Prod. 2007 Jun;70(6):984-8.	McPhail KL, Correa J, Linington RG, Gonzalez J, Ortega-Barría E, Capson TL, Gerwick WH.	Antimalarial linear lipopeptides from a panamanian strain of the marine cyanobacterium Lyngbya majuscula	
DRAMP39007	VKRWKKWWRKWKKWV	15	LZ1	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.31262018]protozoon:Plasmodium falciparum(in vitro:IC50=3.045µM);Plasmodium berghei(in vivo:slow parasitemia growth)	[Ref.31262018]caused a negligible hemolytic activity to human red blood cells	Linear	Free	Amidation	Not found	L	[Ref.31262018]LZ1 showed little cytotoxicity to mammalian cells	Pyruvate Kinase	31262018	Toxins (Basel). 2019 Jun 30;11(7):379.	Fang Y, He X, Zhang P, Shen C, Mwangi J, Xu C, Mo G, Lai R, Zhang Z.	In vitro and In vivo antimalarial activity of LZ1, a peptide derived from snake cathelicidin	
DRAMP39008	PGLNAVT	7	cherimolacyclopeptide D	Not found	Not found	Not found	A. diversifolia	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.39683795]protozoon:Giardia lamblia(IC50=5.39 (5.40–52.38)µg/mL);Entamoeba hystolitica(IC50=3.49 (3.50–3.48)µg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Thr residue is connected to the Pro residue thus closing in this manner the cycle.	L	[Ref.39683795]Not be cytotoxic, carcinogenic, or mutagenic. In addition, it does not cause hepatoxicity, neurotoxicity,or cardiotoxicity.	aldose reductase,Ferredoxin Pyruvate Oxidoreductase	39683795	Molecules. 2024 Nov 28;29(23):5636.	Murrieta-Dionicio U, Calzada F, Barbosa E, Valdés M, Reyes-Trejo B, Zuleta-Prada H, Guerra-Ramírez D, Del Río-Portilla F.	Antiprotozoal activity against Entamoeba hystolitica and Giardia lamblia of cyclopeptides isolated from Annona diversifolia saff	
DRAMP39009	AAIPMYGT	8	Squamin D	Not found	Not found	Not found	A. diversifolia	Antimicrobial,Antiprotozoal	Not found			Not found		"[Ref.39683795]protozoon:Giardia lamblia(Squamin C+Squamin D:IC50=52.93 (52.96–52.89)µg/mL);Entamoeba hystolitica(Squamin C+Squamin D:IC50=8.68 (8.71–8.64)µg/mL);Acanthamoeba castellanii Neff
strains(CI50=18.3µM)"	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	R-methionine sulfoxidation at position 5	L	Not found	Not found	39683795	Molecules. 2024 Nov 28;29(23):5636.	Murrieta-Dionicio U, Calzada F, Barbosa E, Valdés M, Reyes-Trejo B, Zuleta-Prada H, Guerra-Ramírez D, Del Río-Portilla F.	Antiprotozoal activity against Entamoeba hystolitica and Giardia lamblia of cyclopeptides isolated from Annona diversifolia saff	
DRAMP39010	AAIPMYGT	8	Squamin C	Not found	Not found	Not found	A. diversifolia	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.39683795]protozoon:Giardia lamblia(Squamin C+Squamin D:IC50=52.93 (52.96–52.89)µg/mL);Entamoeba hystolitica(Squamin C+Squamin D:IC50=8.68 (8.71–8.64)µg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	S-methionine sulfoxidation at position 5	L	Not found	Not found	39683795	Molecules. 2024 Nov 28;29(23):5636.	Murrieta-Dionicio U, Calzada F, Barbosa E, Valdés M, Reyes-Trejo B, Zuleta-Prada H, Guerra-Ramírez D, Del Río-Portilla F.	Antiprotozoal activity against Entamoeba hystolitica and Giardia lamblia of cyclopeptides isolated from Annona diversifolia saff	
DRAMP39011	SLFELGKMILQETGKNPAKSYGVYGCNCGVGGRGKPKDATDRCCYVHKCCYKKLTGCDPKKDRYSYSWKDKTIVCGENNSCLKELCECDKAVAICLRENLDTYNKKYRYNYLKPFCKKADPC	122	MjTX-II	Q9I834	Belongs to the phospholipase A2 family. Group II subfamily. K49 sub-subfamily.	Not found	Bothrops moojeni (Lance-headed viper) (Caissaca)	Antimicrobial,Antiprotozoal	protein level			1XXS##4KF3##4YV5##6B80##6B81##6B83##6B84##6MQD##6MQF##6PWH		[Ref.39922520]protozoon:Toxoplasma gondii(>50% inhibition of T.gondii proliferation at 20µg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	[Ref.39922520]No Cytotoxicity ranging from 2.5 to 80 μg/mL	VEGFR2 and ICAM-1 receptors	39922520	Chem Biol Interact. 2025 Mar 1:409:111417.	Teixeira SC, Melo Fernandes TA, Souza G, Rosini AM, Fajardo Martínez AF, Gomes AO, Alves RN, Lopes DS, Silva MVD, Beraldo-Neto E, Clissa PB, Barbosa BF, Ávila VMR, Ferro EAV.	MjTX-II, a Lys49-PLA2 from Bothrops moojeni snake venom, restricts Toxoplasma gondii infection via ROS and VEGF regulation	
DRAMP39012	XXFLTS	6	hirsutatins A	Not found	Not found	Not found	Hirsutella nivea BCC 2594	Antimicrobial,Antibacterial,Anti-Gram+,Antiprotozoal	Not found			Not found		[Ref.16309324]protozoon:Plasmodium falciparum K1(IC50=5.8µg/mL)##Gram-positive bacteria:Mycobacterium tuberculosis H37Ra(MIC=50 µg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X1=2-hydroxyisovaleric acid;X2=2-hydroxyisocaproic acid;N-methylation at position 4;	L	[Ref.16309324]Noncytotoxic to Vero cells at a concentration of 50 µg/mL	Not found	16309324	J Nat Prod. 2005 Nov;68(11):1680-2.	Isaka M, Palasarn S, Sriklung K, Kocharin K.	Cyclohexadepsipeptides from the insect pathogenic fungus Hirsutella nivea BCC 2594.	
DRAMP39013	XXYLTS	6	hirsutatins B	Not found	Not found	Not found	Hirsutella nivea BCC 2594	Antimicrobial,Antibacterial,Anti-Gram+	Not found			Not found		[Ref.16309324]Gram-positive bacteria:Mycobacterium tuberculosis H37Ra(MIC=50 µg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X1=2-hydroxyisovaleric acid;X2=2-hydroxyisocaproic acid;N-methylation at position 4;O-methylation at position 3;	L	[Ref.16309324]Noncytotoxic to Vero cells at a concentration of 50 µg/mL	Not found	16309324	J Nat Prod. 2005 Nov;68(11):1680-2.	Isaka M, Palasarn S, Sriklung K, Kocharin K.	Cyclohexadepsipeptides from the insect pathogenic fungus Hirsutella nivea BCC 2594.	
DRAMP39014	GAHHAADGC	9	HRP IIA	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.9497049]protozoon:Plasmodium yoelii(20-30% inhibition of haem polymerization at 100µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	Haem	9497049	Mol Biochem Parasitol. 1997 Dec 1;90(1):281-7.	Pandey AV, Joshi R, Tekwani BL, Singh RL, Chauhan VS.	Synthetic peptides corresponding to a repetitive sequence of malarial histidine rich protein bind haem and inhibit haemozoin formation in vitro.	
DRAMP39015	CGAHHAADAHHAADGC	16	HRP IIB	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.9497049]protozoon:Plasmodium yoelii(40-45% inhibition of haem polymerization at 100µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	Haem	9497049	Mol Biochem Parasitol. 1997 Dec 1;90(1):281-7.	Pandey AV, Joshi R, Tekwani BL, Singh RL, Chauhan VS.	Synthetic peptides corresponding to a repetitive sequence of malarial histidine rich protein bind haem and inhibit haemozoin formation in vitro.	
DRAMP39016	CGAHHAADAHHAADAHHAADGC	22	HRP IIC	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.9497049]protozoon:Plasmodium yoelii(48% inhibition of haem polymerization at 100µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	Haem	9497049	Mol Biochem Parasitol. 1997 Dec 1;90(1):281-7.	Pandey AV, Joshi R, Tekwani BL, Singh RL, Chauhan VS.	Synthetic peptides corresponding to a repetitive sequence of malarial histidine rich protein bind haem and inhibit haemozoin formation in vitro.	
DRAMP39017	IPWL	4	mauritine M	Not found	Not found	Not found	Ziziphus mauritiana	Antimicrobial,Antibacterial,Anti-Gram+,Antiprotozoal	Not found			Not found		[Ref.21450320]protozoon:P. falciparum(IC50=3.7µM)##Gram-positive bacteria:Mycobacterium tuberculosis(MIC=72.8µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	The N-terminus contains a m-oxygenated Z-styrylamine group;N-methylation at position 4; β-hydroxylation at positon 2;	L	Not found	Not found	21450320	Phytochemistry. 2011 Jun;72(9):909-15.	Panseeta P, Lomchoey K, Prabpai S, Kongsaeree P, Suksamrarn A, Ruchirawat S, Suksamrarn S.	Antiplasmodial and antimycobacterial cyclopeptide alkaloids from the root of Ziziphus mauritiana.	
DRAMP39018	IPFV	4	nummularines H	Not found	Not found	Not found	Ziziphus mauritiana	Antimicrobial,Antibacterial,Anti-Gram+,Antiprotozoal	Not found			Not found		[Ref.21450320]protozoon:P. falciparum(IC50=4.2µM)##Gram-positive bacteria:Mycobacterium tuberculosis(MIC=4.5µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	The N-terminus contains Z-styrylamine;N-methylation at position 4;  β-hydroxylation at positon 2;	L	Not found	Not found	21450320	Phytochemistry. 2011 Jun;72(9):909-15.	Panseeta P, Lomchoey K, Prabpai S, Kongsaeree P, Suksamrarn A, Ruchirawat S, Suksamrarn S.	Antiplasmodial and antimycobacterial cyclopeptide alkaloids from the root of Ziziphus mauritiana.	
DRAMP39019	IPFV	4	nummularine B	Not found	Not found	Not found	Ziziphus mauritiana	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.21450320]protozoon:P. falciparum(IC50=10.3µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	The N-terminus contains Z-styrylamine;N-methylation at position 4;  β-hydroxylation at positon 2;meta-oxygenated substitution on the benzene ring at postion 3	L	Not found	Not found	21450320	Phytochemistry. 2011 Jun;72(9):909-15.	Panseeta P, Lomchoey K, Prabpai S, Kongsaeree P, Suksamrarn A, Ruchirawat S, Suksamrarn S.	Antiplasmodial and antimycobacterial cyclopeptide alkaloids from the root of Ziziphus mauritiana.	
DRAMP39020	IPYV	4	hemsine A	Not found	Not found	Not found	Ziziphus mauritiana	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.21450320]protozoon:P. falciparum(IC50=7.3µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	The N-terminus contains Z-styrylamine;N,N-dimethylation at position 4;  β-hydroxylation at positon 2	L	Not found	Not found	21450320	Phytochemistry. 2011 Jun;72(9):909-15.	Panseeta P, Lomchoey K, Prabpai S, Kongsaeree P, Suksamrarn A, Ruchirawat S, Suksamrarn S.	Antiplasmodial and antimycobacterial cyclopeptide alkaloids from the root of Ziziphus mauritiana.	
DRAMP39021	WIxX	4	Apicidin	Not found	Not found	Not found	Fusarium spp. (ATCC 74289; ATCC74322)	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.8917558]protozoon:E. tenella(MIC=62ng/ml);T. gondii(MIC=8ng/ml);P. falciparum(MIC=125ng/ml);Cr. parvum(MIC=30ng/ml);N. caninum(MIC=15ng/ml);B. jellisoni(MIC=4ng/ml);Ca. bigenetica(MIC=8ng/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	x1=Pipecolic acid;X2=2-amino-8-oxodecanoic acid;N⁶,O⁶-dimethylation at position 1	D	Not found	histone deacetylase	8917558	Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13143-7.	Darkin-Rattray SJ, Gurnett AM, Myers RW, Dulski PM, Crumley TM, Allocco JJ, Cannova C, Meinke PT, Colletti SL, Bednarek MA, Singh SB, Goetz MA, Dombrowski AW, Polishook JD, Schmatz DM.	Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.	
DRAMP39022	HRRQGPIFDTRPSPFNPNQPRPGPIY	26	Mtk-2	Not found	Not found	Not found	Drosophila melanogaster (Fruit fly)	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.31001677]protozoon:P. falciparum(76% inhibition at 50μM)	[Ref.31001677]8% hemolysis targeting on mouse (CD-1) erythrocytes at 100μM;10% hemolysis targeting on pig erythrocytes at 100μM;	Linear	Free	Free	Not found	L	Not found	plasma membrane	31001677	Parasitol Res. 2019 Jun;118(6):1993-1998.	Tonk M, Pierrot C, Cabezas-Cruz A, Rahnamaeian M, Khalife J, Vilcinskas A.	The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum.	
DRAMP39023	RGFRKHFNKLVKKVKHTISETAHVAKDTAVIAG	33	Stomoxyn	Q8T9R8(25-57)	Not found	Not found	Stomoxys calcitrans (Stable fly) (Conops calcitrans)	Antimicrobial,Antiprotozoal	protein level			Not found		[Ref.31001677]protozoon:P. falciparum(40% inhibition at 50μM)##[Ref.12372834]protozoon:Trypanosoma brucei bloodstream forms(IC50=37μM)##Gram-negative bacteria:Escherichia coli K12 RM148 (MIC=0.19-0.39µM)；Escherichia coli D22 (MIC=0.19-0.39µM)；Escherichia coli D31 (MIC=0.19-0.39µM)；Escherichia coli SBS363 (MIC<0.19µM)；Escherichia coli 1106 (MIC=0.19-0.39µM)；Enterobacter cloacae β12 (MIC=3.12-6.25µM)；Erwinia carotovora (MIC=0.78-1.56µM)；Klebsiella pneumoniae (MIC=0.78-1.56µM)；Pseudomonas aeruginosa (MIC=0.39-0.78µM)；Salmonella tophimurium (MIC=0.39-0.78µM)；Xanthomonas campestris (MIC=0.39-0.78µM)##Gram-positive bacteria:Aerococcus viridans (MIC=0.78-1.56µM)；Bacillus megaterium (MIC=0.78-1.56µM)；Bacillus subtilis (MIC=6.25-12.5µM)；Enterococcus fuecalis (MIC=0.78-1.56µM)；Micrococcus luteus (MIC=0.78-1.56µM)；Streptococcus pyogenes (MIC=1.56-3.12µM)##Fungi:Aspergillus fumigatus (MIC=50-100µM)；Fusarium culmorum (MIC=0.39-0.78µM)；Fusarium oxysporum (MIC=0.78-1.56µM)；Nectria haematococca (MIC=0.39-0.78µM)；Neurospora crassa (MIC=3.12-6.25µM)；Trichoderma viride (MIC=1.56-3.12µM)；Trichophyton mentagrophytes (MIC=3.12-6.25µM)；Candida albicans (MIC=25-50µM)；Candida glabrata (MIC=25-50µM)；Cryptococcus neoformans (MIC=0.78-1.56µM)	[Ref.31001677]7% hemolysis targeting on mouse (CD-1) erythrocytes at 100μM;5% hemolysis targeting on pig erythrocytes at 100μM;##[Ref.12372834]At 10μM, stomoxyn exhibited hemolytic activity of < 4% on bovine red blood cells, whereas at 100μM, hemolytic activity did not exceed 10%	Linear	Free	Free	Not found	L	Not found	plasma membrane	31001677##12372834	Parasitol Res. 2019 Jun;118(6):1993-1998.##J Biol Chem. 2002 Dec 20;277(51):49921-6.	Tonk M, Pierrot C, Cabezas-Cruz A, Rahnamaeian M, Khalife J, Vilcinskas A.##Boulanger N, Munks RJ, Hamilton JV, Vovelle F, Brun R, Lehane MJ, Bulet P.	The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum.##Epithelial innate immunity. A novel antimicrobial peptide with antiparasitic activity in the blood-sucking insect Stomoxys calcitrans.	
DRAMP39024	EWRPHGSIGGSGLRPGRPQTLPPQRPRRPDFNGPRHRF	38	LSer-PRP2	Not found	Not found	Not found	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.31001677]protozoon:P. falciparum(10% inhibition at 50μM)	[Ref.31001677]10% hemolysis targeting on mouse (CD-1) erythrocytes at 100μM;6% hemolysis targeting on pig erythrocytes at 100μM;	Linear	Free	Free	Not found	L	Not found	plasma membrane	31001677	Parasitol Res. 2019 Jun;118(6):1993-1998.	Tonk M, Pierrot C, Cabezas-Cruz A, Rahnamaeian M, Khalife J, Vilcinskas A.	The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum.	
DRAMP39025	SPFVDRPRRPIQHNGPKPRIITNPPFNPNARPAW	34	LSer-PRP3	Not found	Not found	Not found	Lucilia cuprina (Green bottle fly) (Australian sheep blowfly)	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.31001677]protozoon:P. falciparum(20% inhibition at 50μM)	[Ref.31001677]7% hemolysis targeting on mouse (CD-1) erythrocytes at 100μM;1% hemolysis targeting on pig erythrocytes at 100μM;	Linear	Free	Free	Not found	L	Not found	plasma membrane	31001677	Parasitol Res. 2019 Jun;118(6):1993-1998.	Tonk M, Pierrot C, Cabezas-Cruz A, Rahnamaeian M, Khalife J, Vilcinskas A.	The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum.	
DRAMP39026	RWKVFKKIERMGQHIRDGIIKAGPAVAVVGQASTIISG	37	Cecropin C	A0A6J1WQD0(28-65)	Belongs to the cecropin family.	LOC113514368	Galleria mellonella (Greater wax moth)	Antimicrobial,Antiprotozoal	transcript level			Not found		[Ref.31001677]protozoon:P. falciparum(5% inhibition at 50μM)	[Ref.31001677]8% hemolysis targeting on mouse (CD-1) erythrocytes at 100μM;>20% hemolysis targeting on pig erythrocytes at 100μM;	Linear	Free	Free	Not found	L	Not found	plasma membrane	31001677	Parasitol Res. 2019 Jun;118(6):1993-1998.	Tonk M, Pierrot C, Cabezas-Cruz A, Rahnamaeian M, Khalife J, Vilcinskas A.	The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum.	
DRAMP39027	LLGMIPVAISAISALSKL	0	PLS-S1	F7UI88(49-66)	Belongs to the frog skin active peptide (FSAP) family. Medusin subfamily.	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antiprotozoal	protein level			Not found		[Ref.23774944]protozoon:Leishmania amazonensis promastigotes(10% inhibition at 100μM);L. infantum promastigotes(15% inhibition at 100μM);Leishmania amazonensis amastigotes(15% inhibition at 120μM);L. infantum amastigotes(15% inhibition at 120μM)##Gram-positive bacteria:Staphylococcus aureus(MIC=5.7μM)##Gram-negative bacteria:Escherichia coli(MIC=11.5 ± 5.7μM);Xanthomonas axonopodis pv. glycines(MIC=1.42μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.23774944]Will not reduce the macrophages cell viability up to a concentration of approximately 64 µM	plasma membrane	23774944	Molecules. 2013 Jun 17;18(6):7058-70.	Brand GD, Santos RC, Arake LM, Silva VG, Veras LM, Costa V, Costa CH, Kuckelhaus SS, Alexandre JG, Feio MJ, Leite JR.	The skin secretion of the amphibian Phyllomedusa nordestina: a source of antimicrobial and antiprotozoal peptides.	
DRAMP39028	DLIWKLLSKAQEKFGKNKSR	20	LFampin265–284	P24627(284-303)	Belongs to the transferrin family.	LTF	Bos taurus (Bovine)	Antimicrobial,Antiprotozoal	protein level			2MD1##2MD2##2MD3##2MD4##		"[Ref.28165283]protozoon:Giardia intestinalis trophozoites(95% inhibition at 80μmol/L)##[Ref.20140481]protozoon:Entamoeba histolytica trophozoite(50μM caused approximately
50% of mortality)"	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasmalemma,endomembrane and cytoskeleton	28165283##20140481	Biochem Cell Biol. 2017 Feb;95(1):82-90.##Biometals. 2010 Jun;23(3):563-8.	Aguilar-Diaz H, Canizalez-Roman A, Nepomuceno-Mejia T, Gallardo-Vera F, Hornelas-Orozco Y, Nazmi K, Bolscher JG, Carrero JC, Leon-Sicairos C, Leon-Sicairos N.##López-Soto F, León-Sicairos N, Nazmi K, Bolscher JG, de la Garza M.	Parasiticidal effect of synthetic bovine lactoferrin peptides on the enteric parasite Giardia intestinalis.##Microbicidal effect of the lactoferrin peptides lactoferricin17-30, lactoferrampin265-284, and lactoferrin chimera on the parasite Entamoeba histolytica.	
DRAMP39029	FKCRRWQWRMKKLGKRSKNKGFKEQAKSLLKWILD	35	LF chimera	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		"[Ref.28165283]protozoon:Giardia intestinalis trophozoites(95% inhibition at 40μmol/L)##[Ref.20140481]protozoon:Entamoeba histolytica trophozoite(50μM caused approximately
50% of mortality)"	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasmalemma,endomembrane and cytoskeleton	28165283##20140481	Biochem Cell Biol. 2017 Feb;95(1):82-90.##Biometals. 2010 Jun;23(3):563-8.	Aguilar-Diaz H, Canizalez-Roman A, Nepomuceno-Mejia T, Gallardo-Vera F, Hornelas-Orozco Y, Nazmi K, Bolscher JG, Carrero JC, Leon-Sicairos C, Leon-Sicairos N.##López-Soto F, León-Sicairos N, Nazmi K, Bolscher JG, de la Garza M.	Parasiticidal effect of synthetic bovine lactoferrin peptides on the enteric parasite Giardia intestinalis.##Microbicidal effect of the lactoferrin peptides lactoferricin17-30, lactoferrampin265-284, and lactoferrin chimera on the parasite Entamoeba histolytica.	
DRAMP39030	KWKKFKKGIGKLFV	14	Vida1	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.12069961]protozoon:P. berghei ookinetes(48% inhibition at 50μM 24h)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	12069961	Antimicrob Agents Chemother. 2002 Jul;46(7):2104-10.	Arrighi RB, Nakamura C, Miyake J, Hurd H, Burgess JG.	Design and activity of antimicrobial peptides against sporogonic-stage parasites causing murine malarias.	
DRAMP39031	KWPKFKKGIPWLFV	14	Vida2	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.12069961]protozoon:P. berghei ookinetes(65% inhibition at 50μM 24h)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	12069961	Antimicrob Agents Chemother. 2002 Jul;46(7):2104-10.	Arrighi RB, Nakamura C, Miyake J, Hurd H, Burgess JG.	Design and activity of antimicrobial peptides against sporogonic-stage parasites causing murine malarias.	
DRAMP39032	KFPKFRRGIPFLFV	14	Vida3	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.12069961]protozoon:P. berghei ookinetes(82% inhibition at 50μM 24h);P. yoelii nigeriensis ookinetes(73% inhibition at 50μM 24h)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	12069961	Antimicrob Agents Chemother. 2002 Jul;46(7):2104-10.	Arrighi RB, Nakamura C, Miyake J, Hurd H, Burgess JG.	Design and activity of antimicrobial peptides against sporogonic-stage parasites causing murine malarias.	
DRAMP39033	ILPFKFPFFPFRR	13	ILF	Not found	Not found	Not found	synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.12069961]protozoon:P. berghei ookinetes(54% inhibition at 50μM 24h);P. yoelii nigeriensis ookinetes(89% inhibition at 50μM 24h)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	12069961	Antimicrob Agents Chemother. 2002 Jul;46(7):2104-10.	Arrighi RB, Nakamura C, Miyake J, Hurd H, Burgess JG.	Design and activity of antimicrobial peptides against sporogonic-stage parasites causing murine malarias.	
DRAMP39034	MPRYRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG	38	Shiva-3	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.7758540]protozoon:P.berghei(100% inhibition at 50μM immediately;15.4±23.47% inhibition at 50μM after 24h)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	7758540	Exp Parasitol. 1995 Jun;80(4):596-604.	Rodriguez MC, Zamudio F, Torres JA, Gonzalez-Ceron L, Possani LD, Rodriguez MH.	Effect of a cecropin-like synthetic peptide (Shiva-3) on the sporogonic development of Plasmodium berghei.	
DRAMP39035	GEEEEE	6	Obiopeptide-1	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.2280500]protozoon:Toxoplasma gondii Tachyzoites(79.3% inhibition at 0.5 mg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	Not found	2280500	Nihon Juigaku Zasshi. 1990 Oct;52(5):907-14.	Suzuki N, Sakurai H, Saito A, Igarashi I, Omata Y, Osaki H.	Biological activity of obiopeptide-1, a synthetic peptide derived from the native immune-regulator obioactin.	
DRAMP39036	AAYKKFKKKLLKSLKRLG	18	AA-RP-1	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.3049204]protozoon:L. braziliensis promastigotes(>95% inhibition at 100μg/ml);L. infantum chagasi promastigotes(>95% inhibition at 25μg/ml);L. major promastigotes(>25g/ml Significantly inhibit)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	anthrylalanylation at position 2	L	Not found	plasma membrane,membrane	22123683	Antimicrob Agents Chemother. 2012 Feb;56(2):658-65.	Erfe MC, David CV, Huang C, Lu V, Maretti-Mira AC, Haskell J, Bruhn KW, Yeaman MR, Craft N.	Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.	
DRAMP39037	IfLX	4	hirsutellic acid A	Not found	Not found	Not found	Hirsutella sp. BCC 1528	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.16643062]protozoon:Plasmodium falciparum
K1(IC50=8.0µM)"	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 2;X=anthranilic acid	D	[Ref.16643062]Noncytotoxic to Vero cells at a concentration of 95 µM	Not found	16643062	J Nat Prod. 2006 Apr;69(4):713-4.	Thongtan J, Saenboonrueng J, Rachtawee P, Isaka M.	An antimalarial tetrapeptide from the entomopathogenic fungus Hirsutella sp. BCC 1528.	
DRAMP39038	Not found	0	Thiostrepton	Not found	Not found	Not found	Not found	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.8999899]protozoon:P. falciparum(IC50=1.8µM)	No hemolysis information or data found in the reference(s) presented in this entry	Not found	Not found	Not found	Not found	Not found	Not found	plastid-like organellar	8999899	J Biol Chem. 1997 Jan 24;272(4):2046-9.	McConkey GA, Rogers MJ, McCutchan TF.	Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton.	
DRAMP39039	Not found	0	Anisomycin	Not found	Not found	Not found	Not found	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.8999899]protozoon:P. falciparum(IC50=0.5µM)	No hemolysis information or data found in the reference(s) presented in this entry	Not found	Not found	Not found	Not found	Not found	Not found	Not found	8999899	J Biol Chem. 1997 Jan 24;272(4):2046-9.	McConkey GA, Rogers MJ, McCutchan TF.	Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton.	
DRAMP39040	XPXAXAQXVXGLXPVXXEQ	20	Alamethicin I	Not found	Not found	Not found	Trichoderma viride	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.21517904]protozoon:Trypanosoma brucei(IC50=86.6nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	phenylalaninolation	X=Aib	L	Not found	Not found	21517904	Parasite Immunol. 2011 Aug;33(8):461-9.	Harrington JM.	Antimicrobial peptide killing of African trypanosomes.	
DRAMP39041	PKLLKTFLSKWK	12	SPFK	Not found	Not found	Not found	Bos taurus (Bovine)	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.12615333]protozoon:Leishmania donovani promastigotes(LD50=3.8 × 10−4µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	12615333	Mol Biochem Parasitol. 2003 Mar;127(1):23-35.	Bera A, Singh S, Nagaraj R, Vaidya T.	Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides.	
DRAMP39042	QSHLSLCRYCCNCCRNKGCGYCCKF	25	gfHep	A0A088LKF9(69-93)	Belongs to the hepcidin family.	Not found	Percocypris pingi	Antimicrobial, Antiprotozoal	transcript level			Not found		[Ref.30659854]protozoon:T. carassii(45% inhibition at 50µM 18h)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	conserved eight cysteine residues that were reported in the formation of the four intrachain disulfide bonds	L	Not found	plasma membrane	30659854	Dev Comp Immunol. 2019 May;94:11-15.	Xie J, Obiefuna V, Hodgkinson JW, McAllister M, Belosevic M.	Teleost antimicrobial peptide hepcidin contributes to host defense of goldfish (Carassius auratus L.) against Trypanosoma carassii.	
DRAMP39043	NSAHPCCDPVTCKPKRGEHCISGPCCRNCKFLSPGTICKKARGDDMNDYCTGISSDCPRNPWK	63	Disintegrin_Cc	Not found	Not found	Not found	C. cerastes	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29278277]protozoon:Leishmania infantum promastigote(induced 84.75% of parasiticidal activity)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	four intramolecular disulfide bridges	L	Not found	extracellular proteins, glycosaminoglycans,cell surface receptors	29278277	J Biochem Mol Toxicol. 2018 Feb;32(2).	Allane D, Oussedik-Oumehdi H, Harrat Z, Seve M, Laraba-Djebari F.	Isolation and characterization of an anti-leishmanial disintegrin from Cerastes cerastes venom.	
DRAMP39044	Not found	0	Vu-Defr	Not found	Not found	Not found	Not found	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.23816644]protozoon:L. amazonensis promastigotes(eliminated 54.3% and 46.9% of the protozoa growth at 24 and 48 h)	No hemolysis information or data found in the reference(s) presented in this entry	Not found	Not found	Not found	Not found	Not found	Not found	plasma membrane	23816644	Exp Parasitol. 2013 Sep;135(1):116-25.	Souza GS, do Nascimento VV, de Carvalho LP, de Melo EJ, Fernandes KV, Machado OL, Retamal CA, Gomes VM, Carvalho Ade O.	Activity of recombinant and natural defensins from Vigna unguiculata seeds against Leishmania amazonensis.	
DRAMP39045	Not found	0	Vu-Def	Not found	Not found	Not found	Vigna unguiculata	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.23816644]protozoon:L. amazonensis promastigotes(eliminated 50% and 54.8% of the protozoa growth at 24and 48 h)	No hemolysis information or data found in the reference(s) presented in this entry	Not found	Not found	Not found	Not found	Not found	Not found	plasma membrane	23816644	Exp Parasitol. 2013 Sep;135(1):116-25.	Souza GS, do Nascimento VV, de Carvalho LP, de Melo EJ, Fernandes KV, Machado OL, Retamal CA, Gomes VM, Carvalho Ade O.	Activity of recombinant and natural defensins from Vigna unguiculata seeds against Leishmania amazonensis.	
DRAMP39046	FVYIGX	6	ukabamide	Not found	Not found	Not found	Moorena sp.	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39854171]protozoon:Trypanosoma brucei rhodesiense(IC50 =34±18nM)	No hemolysis information or data found in the reference(s) presented in this entry	linear	N-methylation	thiazolecarboxylation	N,O-dimethylationat position 3;N-methylation at position 4;Valeric acid acylation at N-terminus	L	[Ref.39854171]lower cytotoxicity against HeLa cells (IC50=4240nM).	Not found	39854171	Org Lett. 2025 Feb 7;27(5):1261-1264.	Hagihara M, Kurisawa N, Iwasaki A, Taguchi R, Jeelani G, Nozaki T, Suenaga K.	Isolation and Total Synthesis of Ukabamide, an Antitrypanosomal Lipopeptide from a Marine Moorena sp. Cyanobacterium.	
DRAMP39047	YQFQVTLali	10	Sealgamide	Not found	Not found	Not found	Okeania sp.	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.40165463]protozoon:Trypanosoma brucei rhodesiense(IC50
=2.9μM)P.falciparum(IC50>25μM)"	No hemolysis information or data found in the reference(s) presented in this entry	linear	N,O-dimethylation	Free	N-methylation at position 2,4,5,7,10；(3S,5S)-3,5-dimethoxyoctanoylation at N-terminus	D	[Ref.40165463]Not show cytotoxicity against HeLa cells at a concentration of 30 μM	plasma membrane	40165463	J Nat Prod. 2025 Apr 25;88(4):1048-1056.	Wakai K, Kurisawa N, Umeda K, Jeelani G, Agusta AL, Nozaki T, Suenaga K.	Sealgamide: An Antitrypanosomal Lipopeptide Isolated from a Marine Okeania sp. Cyanobacterium.	
DRAMP39048	KIKIPWGKVKDFLVGGMKAV	20	bicarinalin	W8GNV3(57-76)	Belongs to the formicidae venom precursor-01 superfamily.	Not found	Tetramorium bicarinatum (Tramp ant)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antifungal,Antiprotozoal	protein level			Not found		[Ref.27058430]protozoon:Leishmania infantum(MIC=1.5µmol/L)##Gram-negative bacteria:Escherichia coli(MIC=24.4µmol/L,MBC=24.4µmol/L);Citrobacter sakazakii(MIC=5.80µmol/L,MBC=6.1µmol/L);Pseudomonas aeruginosa(MIC=12.2µmol/L,MBC=24.4µmol/L);Pseudomonas aeruginosaR;Salmonella enterica(MIC=5.4µmol/L,MBC=6.1µmol/L)##Gram-positive bacteria:Enterococcus hirae(MIC=12.2µmol/L,MBC=12.2µmol/L);Staphylococcus aureus(MIC=3.0µmol/L,MBC=3.0µmol/L);MRSA(MIC=8.7µmol/L,MBC=12.2µmol/L);Staphylococcus xylosus(MIC=0.45µmol/L,MBC=0.76µmol/L);Bacillus subtilis(MIC=24.4µmol/L,MBC=24.4µmol/L)##Fungi:Aspergillus niger(MIC=0.75µmol/L,MBC=0.76µmol/L);Candida albicans(MIC=17.3µmol/L,MBC=24.4µmol/L);Candida albicansR;Candida candidum(MIC=97.5µmol/L,MBC=97.5µmol/L);Saccharomyces cerevisiae sp(MIC=6.1µmol/L,MBC=6.1µmol/L)	No hemolysis information or data found in the reference(s) presented in this entry	linear	Free	Amidation	Not found	L	[Ref.27058430]no cytotoxicity against human lymphocytes in concentrations ranging from 0.066 to 8.5μmol/L and its LC50=67.8μmol/L	plasma membrane	27058430	Peptides. 2016 May;79:103-13.	Téné N, Bonnafé E, Berger F, Rifflet A, Guilhaudis L, Ségalas-Milazzo I, Pipy B, Coste A, Leprince J, Treilhou M.	Biochemical and biophysical combined study of bicarinalin, an ant venom antimicrobial peptide.	
DRAMP39049	FLGMLLHGVGHAIHGLI	17	Of-Pis1	Not found	Not found	Not found	Oplegnathus fasciatus	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antifungal,Antiprotozoal	Not found			Not found		[Ref.18929530]protozoon:Miamiensis avidus(MIC=0.4µM,IC50<0.4µM)##Gram-negative bacteria:Escherichia coli(MIC=45µM,IC50<45µM);Edwardsiella tarda(MIC>90µM,IC50=45µM);Vibrio tapetis(MIC=22.5µM,IC50=5.6µM)##Gram-positive bacteria:Streptococcus iniae(MIC=45µM,IC50=22.5µM)##Fungi:Candida albicans(MIC=22.5µM,IC50=2.8µM);Saccharomyces cerevisiae(MIC=11.25µM,IC50=1.4µM)	[Ref.18929530]at the concentration of 56.02 µM, pOf-Pis1 lysed less than 3.25% of erythrocytes	Linear	Free	Free	Not found	L	Not found	plasma membrane	26549174	Fish Shellfish Immunol. 2016 Jan;48:154-68.	Umasuthan N, Mothishri MS, Thulasitha WS, Nam BH, Lee J.	Molecular, genomic, and expressional delineation of a piscidin from rock bream (Oplegnathus fasciatus) with evidence for the potent antimicrobial activities of Of-Pis1 peptide.	
DRAMP39050	IWGLIAHGVAHVGSLIHGLVNG	22	So-pis	Not found	Not found	Not found	Sciaenops ocellatus	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.34781186]protozoon:C. irritants trophonts(kill 20 % C.irritans trophonts at a concentration of 12 μM in an hour and 83 % trophonts at a concentration of 24 μM within half an hour.  48 μM and 96 μM of So-pis could kill all trophonts in 30 min and 15 min, respectively.)	[Ref.34781186]not haemolytic in red drum erythrocytes at a concentration of less than 48 μM. Moreover, less than 10 % of erythrocytes were lysed at the concentration of 48 μM	Linear	Free	Free	Not found	L	Not found	Not found	34781186	Mol Immunol. 2022 Jan;141:1-12.	Jin Y, Mao Y, Niu SF, Pan Y, Zheng WH, Wang J.	Molecular characterisation and biological activity of an antiparasitic peptide from Sciaenops ocellatus and its immune response to Cryptocaryon irritans.	
DRAMP39051	GIGKPLKKAKKPGKAPVKILKK	22	Pexiganan	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.22664071]protozoon:L. major(50% inhibition at 50μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	17074074	Mol Microbiol. 2006 Dec;62(5):1484-97.	Kulkarni MM, McMaster WR, Kamysz E, Kamysz W, Engman DM, McGwire BS.	The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing.	
DRAMP39052	Not found	0	Micrococcin	Not found	Not found	Not found	Bacillus and Micrococcus spp.	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.9517961]protozoon:P. falciparum(IC50=35 nM)	No hemolysis information or data found in the reference(s) presented in this entry	Not found	Not found	Not found	Not found	Not found	Not found	plastid-like organelle	9517961	Antimicrob Agents Chemother. 1998 Mar;42(3):715-6.	Rogers MJ, Cundliffe E, McCutchan TF.	The antibiotic micrococcin is a potent inhibitor of growth and protein synthesis in the malaria parasite.	
DRAMP39053	Not found	0	Thionins	Not found	Not found	Not found	Triticum aestivum	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19361504]protozoon:L. donovani promastigotes(IC50 =0.2 (0.1–0.5)μM,LC50=1.1(0.9–1.3)μM)L. donovani amastigotes(LC50=46.3 (36.6–59.2)μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not found	Not found	Not found	Not found	Not found	Not found	plasma membrane	19361504	Exp Parasitol. 2009 Jul;122(3):247-9.	Berrocal-Lobo M, Molina A, Rodríguez-Palenzuela P, García-Olmedo F, Rivas L.	Leishmania donovani: thionins, plant antimicrobial peptides with leishmanicidal activity.	
DRAMP39054	Not found	0	PTH1	Not found	Not found	Not found	Solanum tuberosum	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19361504]protozoon:L. donovani promastigotes(IC50 =33.4 (21.5–52.4)μM,LC50=5.9 (3.2–10.8)μM)	No hemolysis information or data found in the reference(s) presented in this entry	Not found	Not found	Not found	Not found	Not found	Not found	plasma membrane	19361504	Exp Parasitol. 2009 Jul;122(3):247-9.	Berrocal-Lobo M, Molina A, Rodríguez-Palenzuela P, García-Olmedo F, Rivas L.	Leishmania donovani: thionins, plant antimicrobial peptides with leishmanicidal activity.	
DRAMP39055	FWGTLAKWALKAIPAAMGMKQNK	23	M-poneratoxin-Dq3a, Dq-2562	P0DSK0(44-66)	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Medium-length antimicrobial peptide (group 3) family. Ponericin-W subfamily	not found	Dinoponera quadriceps (South American ant)	Antimicrobial,Antiprotozoal	homology			not found		[Ref.28976889]protozoon:T. cruzi Y  strain epimastigote(IC50=4.7 ± 1 µM,24h),T. cruzi Y  strain trypomastigote(IC50=0.32 ±0.03 µM,24h)	not found	Linear	Free	Amidation		L	[Ref.28976889]IC50=25.7±2µM targeting on LLC-MK2 mammalian cells	membrane	28976889	Biol Chem. 2018 Jan 26;399(2):187-196	Lima DB, Mello CP, Bandeira ICJ, Pessoa Bezerra de Menezes RRP, Sampaio TL, Falcão CB, Morlighem JRL, Rádis-Baptista G, Martins AMC.	The dinoponeratoxin peptides from the giant ant Dinoponera quadriceps display in vitro antitrypanosomal activity	
DRAMP39056	FWGTLAKWALKAIPAAMGMKQNK	23	M-poneratoxin-Dq3a, Dq-2562	P0DSK0(44-56)	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Medium-length antimicrobial peptide (group 3) family. Ponericin-W subfamily	not found	Dinoponera quadriceps (South American ant)	Antimicrobial,Antiprotozoal	homology			not found		[Ref.28976889]protozoon:T. cruzi Y  strain epimastigote(IC50=48.8± 5 µM,24h),T. cruzi Y  strain trypomastigote(IC50=7.4 ±0.6 µM,24h)	not found	Linear	Free	Amidation		L	[Ref.28976889]IC50=144±75µM targeting on LLC-MK2 mammalian cells	membrane	28976889	Biol Chem. 2018 Jan 26;399(2):187-196	Lima DB, Mello CP, Bandeira ICJ, Pessoa Bezerra de Menezes RRP, Sampaio TL, Falcão CB, Morlighem JRL, Rádis-Baptista G, Martins AMC.	The dinoponeratoxin peptides from the giant ant Dinoponera quadriceps display in vitro antitrypanosomal activity	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP39057	FWGTLAKWALKAI	13	M-poneratoxin-Dq3b, Dq-1503	P0DSK0(44-54)	Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Medium-length antimicrobial peptide (group 3) family. Ponericin-W subfamily	not found	Dinoponera quadriceps (South American ant)	Antimicrobial,Antiprotozoal	homology			not found		[Ref.28976889]protozoon:T. cruzi Y  strain trypomastigote(IC50=34.8 ±5 µM,24h)	not found	Linear	Free	Amidation		L	[Ref.28976889]IC50>100µM targeting on LLC-MK2 mammalian cells	membrane	28976889	Biol Chem. 2018 Jan 26;399(2):187-196	Lima DB, Mello CP, Bandeira ICJ, Pessoa Bezerra de Menezes RRP, Sampaio TL, Falcão CB, Morlighem JRL, Rádis-Baptista G, Martins AMC.	The dinoponeratoxin peptides from the giant ant Dinoponera quadriceps display in vitro antitrypanosomal activity	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(N)=O
DRAMP39058	FWGTLAKWALK	11	M-poneratoxin-Dq3c, Dq-1319	P0DSK2(40-69)	not found	not found	Dinoponera quadriceps (South American ant)	Antimicrobial,Antiprotozoal	homology			not found		[Ref.28976889]protozoon:T. cruzi Y  strain epimastigote(IC50=23.5± 3 µM,24h),T. cruzi Y  strain trypomastigote(IC50=4.7±0.3 µM,24h)	not found	Linear	Free	Amidation		L	[Ref.28976889]IC50=16.7±2µM targeting on LLC-MK2 mammalian cells	membrane	28976889	Biol Chem. 2018 Jan 26;399(2):187-196	Lima DB, Mello CP, Bandeira ICJ, Pessoa Bezerra de Menezes RRP, Sampaio TL, Falcão CB, Morlighem JRL, Rádis-Baptista G, Martins AMC.	The dinoponeratoxin peptides from the giant ant Dinoponera quadriceps display in vitro antitrypanosomal activity	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP39059	GLKDWWNKHKDKIVKVVKEMGKAGINAAGK	30	M-poneratoxin-Dq4e, Dq-3348	Q8T0Z3(81-107)	Belongs to the redulysin-like family	not found	Triatoma infestans (Assassin bug)	Antimicrobial,Antiprotozoal	protein level			not found		[Ref.16460023]protozoon: Trypanosoma cruzi Y strain trypomastigotes (LC50=15 μM, 41.7 μg/mL);##Gram-negative bacteria: Escherichia coli DH5α (LC50=33 μM, 91.8 μg/mL)	[Ref.16460023]LC₅₀>900 μM, >2500 μg/mL on RBC	Linear	Free	Amidation		L	not found	membrane	16460023	Biochemistry. 2006 Feb 14;45(6):1765-74	Martins RM, Sforça ML, Amino R, Juliano MA, Oyama S Jr, Juliano L, Pertinhez TA, Spisni A, Schenkman S	Lytic activity and structural differences of amphipathic peptides derived from trialysin	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(N)=O
DRAMP39060	VSAVAKVAMKKGAALLKKMGVKISPLK	27	P1	Q8T0Z3(76-102)	Belongs to the redulysin-like family	not found	Triatoma infestans (Assassin bug)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			not found		[Ref.16460023]protozoon: Trypanosoma cruzi Y strain trypomastigotes (LC₅₀=6 μM, 17.2 μg/mL)##Gram-negative bacteria: Escherichia coli DH5α (LC₅₀>50 μM, >143 μg/mL)	[Ref.16460023]LC₅₀>450 μM, >1290 μg/mL on RBC	Linear	Free	Amidation		L	not found	membrane	16460023	Biochemistry. 2006 Feb 14;45(6):1765-74	Martins RM, Sforça ML, Amino R, Juliano MA, Oyama S Jr, Juliano L, Pertinhez TA, Spisni A, Schenkman S	Lytic activity and structural differences of amphipathic peptides derived from trialysin	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP39061	VGKVLKQLKKVSAVAKVAMKKGAALLK	27	P3	Q8T0Z3(71-97)	Belongs to the redulysin-like family	not found	Triatoma infestans (Assassin bug)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			not found		[Ref.16460023]protozoon: Trypanosoma cruzi Y strain trypomastigotes (LC₅₀=19 μM, 53.6 μg/mL)##Gram-negative bacteria: Escherichia coli DH5α (LC₅₀>50 μM, >141 μg/mL)	not found	Linear	Free	Amidation		L	not found	membrane	16460023	Biochemistry. 2006 Feb 14;45(6):1765-74	Martins RM, Sforça ML, Amino R, Juliano MA, Oyama S Jr, Juliano L, Pertinhez TA, Spisni A, Schenkman S	Lytic activity and structural differences of amphipathic peptides derived from trialysin	
DRAMP39062	KFGKIVGKVLKQLKKVSAVAKVAMKKG	27	P4	Q8T0Z3(66-92)	Belongs to the redulysin-like family	not found	Triatoma infestans (Assassin bug)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			not found		[Ref.16460023]protozoon: Trypanosoma cruzi Y strain trypomastigotes (LC₅₀=6 μM, 17.3 μg/mL)Gram-negative bacteria: Escherichia coli DH5α (LC₅₀=7.6 μM, 22.0 μg/mL)	[Ref.16460023]LC₅₀=274 μM, 794 μg/mL on RBC	Linear	Free	Amidation		L	not found	membrane	16460023	Biochemistry. 2006 Feb 14;45(6):1765-74	Martins RM, Sforça ML, Amino R, Juliano MA, Oyama S Jr, Juliano L, Pertinhez TA, Spisni A, Schenkman S	Lytic activity and structural differences of amphipathic peptides derived from trialysin	
DRAMP39063	GKVLDKFGKIVGKVLKQLKKVSAVAKV	27	P5	Q8T0Z3(61-87)	Belongs to the redulysin-like family	not found	Triatoma infestans (Assassin bug)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			not found		[Ref.16460023]protozoon: Trypanosoma cruzi Y strain trypomastigotes (LC₅₀=1.6 μM, 4.6 μg/mL)##Gram-negative bacteria: Escherichia coli DH5α (LC₅₀=9 μM, 26.1 μg/mL)	[Ref.16460023]LC₅₀=117 μM, 338 μg/mL on RBC	Linear	Free	Amidation		L	not found	membrane	16460023	Biochemistry. 2006 Feb 14;45(6):1765-74	Martins RM, Sforça ML, Amino R, Juliano MA, Oyama S Jr, Juliano L, Pertinhez TA, Spisni A, Schenkman S	Lytic activity and structural differences of amphipathic peptides derived from trialysin	
DRAMP39064	GKVLDKFGKIVGKVLKQLKKVSAVAKV	27	P5	Q8T0Z3(56-87)	Belongs to the redulysin-like family	not found	Triatoma infestans (Assassin bug)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			not found		[Ref.16460023]protozoon: Trypanosoma cruzi Y strain trypomastigotes (LC₅₀=0.4 μM, 1.4 μg/mL)##Gram-negative bacteria: Escherichia coli DH5α (LC₅₀=2.6 μM, 9.1 μg/mL)	[Ref.16460023]LC₅₀=90 μM, 316 μg/mL on RBC	Linear	Free	Amidation		L	not found	membrane	16460023	Biochemistry. 2006 Feb 14;45(6):1765-74	Martins RM, Sforça ML, Amino R, Juliano MA, Oyama S Jr, Juliano L, Pertinhez TA, Spisni A, Schenkman S	Lytic activity and structural differences of amphipathic peptides derived from trialysin	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP39065	FKIKPGKVLDKFGKIVGKVLKQLKKVSAVAKV	32	P6	Q8T0Z3(56-82)	Belongs to the redulysin-like family	not found	Triatoma infestans (Assassin bug)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			not found		[Ref.16460023]protozoon: Trypanosoma cruzi Y strain trypomastigotes (LC₅₀=1.3 μM, 4.0 μg/mL)##Gram-negative bacteria: Escherichia coli DH5α (LC₅₀=5.2 μM, 15.8 μg/mL)	[Ref.16460023]LC₅₀=296 μM, 900 μg/mL on RBC	Linear	Free	Amidation		L	not found	membrane	16460023	Biochemistry. 2006 Feb 14;45(6):1765-74	Martins RM, Sforça ML, Amino R, Juliano MA, Oyama S Jr, Juliano L, Pertinhez TA, Spisni A, Schenkman S	Lytic activity and structural differences of amphipathic peptides derived from trialysin	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@H](C)CC)C(C)C
DRAMP39066	FKIKPGKVLDKFGKIVGKVLKQLKKVS	27	P7	not found	not found	not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	not found			not found		[Ref.16460023]protozoon: Trypanosoma cruzi Y strain trypomastigotes (LC₅₀=0.4 μM, 1.4 μg/mL)##Gram-negative bacteria: Escherichia coli DH5α (LC₅₀=0.9 μM, 3.2 μg/mL)	[Ref.16460023]LC₅₀=12.6 μM, 44.3 μg/mL on RBC	Linear	Free	Amidation		L	not found	membrane	16460023	Biochemistry. 2006 Feb 14;45(6):1765-74	Martins RM, Sforça ML, Amino R, Juliano MA, Oyama S Jr, Juliano L, Pertinhez TA, Spisni A, Schenkman S	Lytic activity and structural differences of amphipathic peptides derived from trialysin	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)C(C)C)C(C)C)C(C)C)[C@H](C)CC)C(C)C
DRAMP39067	FKIKAGKVLDKFGKIVGKVLKQLKKVSAVAKV	27	P6_1	not found	not found	not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	not found			not found		[Ref.16460023]protozoon: Trypanosoma cruzi Y strain trypomastigotes (LC₅₀=0.9 μM, 3.1 μg/mL)##Gram-negative bacteria: Escherichia coli DH5α (LC₅₀=1.7 μM, 5.8 μg/mL)	[Ref.16460023]LC₅₀=28.1 μM, 96.4 μg/mL on RBC	Linear	Free	Amidation		L	not found	membrane	16460023	Biochemistry. 2006 Feb 14;45(6):1765-74	Martins RM, Sforça ML, Amino R, Juliano MA, Oyama S Jr, Juliano L, Pertinhez TA, Spisni A, Schenkman S	Lytic activity and structural differences of amphipathic peptides derived from trialysin	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@H](C)CC)C(C)C
DRAMP39068	FSISPGKVLDKFGKIVGKVLKQLKKVSAVAKV	27	P6_2	A9XE60(20-40)	Belongs to the long chain scorpion toxin family. Class 1 subfamily	not found	Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	protein level			not found		[Ref.20045493]protozoon:P. berghei ookinetes (62.1%±1.0% inhibition at 10 μM , 71.5%±1.9% at 20 μM)	not found	Linear	Free	Free		L	not found	Kv channel	20045493	Biochim Biophys Acta. 2010 Apr;1804(4):872-83	Zhu S, Gao B, Aumelas A, del Carmen Rodríguez M, Lanz-Mendoza H, Peigneur S, Diego-Garcia E, Martin-Eauclaire MF, Tytgat J, Possani LD	MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@H](C)CC)C(C)C
DRAMP39069	GFREKHFQRFVKYAVPESTLR	21	rMeuTXKβ1 N(1–21)	A9XE60(41-91)	Belongs to the long chain scorpion toxin family. Class 1 subfamily	not found	Mesobuthus eupeus (Lesser Asian scorpion) (Buthus eupeus)	Antimicrobial,Antiprotozoal	protein level			not found		[Ref.20045493]protozoon:P. berghei ookinetes(36.3%±3.3% inhibition at 10 μM ,77.7%±0.3% at 20 μM)	[Ref.20097251]6.7% at 10 μM ,17.1% at 20 μM	Linear	Free	Free		L	not found	Kv channel	20045493	Biochim Biophys Acta. 2010 Apr;1804(4):872-83	Zhu S, Gao B, Aumelas A, del Carmen Rodríguez M, Lanz-Mendoza H, Peigneur S, Diego-Garcia E, Martin-Eauclaire MF, Tytgat J, Possani LD	MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity	CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)O
DRAMP39070	TVLQTVVHKVGKTQFGCPAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF	51	RMeuTXKβ1 C(22–72)	A0A6I8R842(125-140)	not found	pgq	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial,Antiprotozoal	predicted			not found		[Ref.23935531]protozoon: Trypanosoma brucei (LC₉₅=16–32 μM)##Gram-positive bacteria: Staphylococcus aureus (MIC=16 μM); Micrococcus luteus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=32 μM); Pseudomonas aeruginosa (MIC=256 μM);##Fungi: Saccharomyces cerevisiae (MIC=128 μM)	[Ref.23935531]HC₅₀=256 μM	Linear	Free	Free		L	[Ref.23935531]IC₅₀=128 μM on mouse T-lymphocytes	membrane	23935531	PLoS Genet. 2013;9(8):e1003662	Roelants K, Fry BG, Ye L, Stijlemans B, Brys L, Kok P, Clynen E, Schoofs L, Cornelis P, Bossuyt F	Origin and functional diversification of an amphibian defense peptide arsenal	CC[C@@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
DRAMP39071	FIGALLRPALKLLAGK	16	PFQa-St2	A0A8J1JQX5(39-60)	not found	pgla.5	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antifungal,Antiprotozoal	predicted			not found		[Ref.23935531]protozoon: Trypanosoma brucei (LC₉₅=16–32 μM)##Gram-positive bacteria: Staphylococcus aureus (MIC>256 μM); Micrococcus luteus (MIC=2 μM);##Gram-negative bacteria: Escherichia coli (MIC=16 μM); Pseudomonas aeruginosa (MIC=128 μM);##Fungi: Saccharomyces cerevisiae (MIC=64 μM)	[Ref.23935531]HC₅₀>256 μM	Linear	Free	Amidation		L	[Ref.23935531]IC₅₀=64 μM on mouse T-lymphocytes	membrane	23935531	PLoS Genet. 2013;9(8):e1003662	Roelants K, Fry BG, Ye L, Stijlemans B, Brys L, Kok P, Clynen E, Schoofs L, Cornelis P, Bossuyt F	Origin and functional diversification of an amphibian defense peptide arsenal	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O
DRAMP39072	GMATKAGTAFGKAAKAIIGAAL	22	PGLa-St2	not found	not found	not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antifungal,Antiprotozoal	not found			not found		[Ref.23935531]protozoon: Trypanosoma brucei (LC₉₅=4 μM)##Gram-positive bacteria: Staphylococcus aureus (MIC>256 μM); Micrococcus luteus (MIC=0.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=32 μM); Pseudomonas aeruginosa (MIC=128 μM);##Fungi: Saccharomyces cerevisiae (MIC=64 μM)	[Ref.23935531]HC₅₀=256 μM	Linear	Free	Free		L	[Ref.23935531]IC₅₀=64 μM on mouse T-lymphocytes	membrane	23935531	PLoS Genet. 2013;9(8):e1003662	Roelants K, Fry BG, Ye L, Stijlemans B, Brys L, Kok P, Clynen E, Schoofs L, Cornelis P, Bossuyt F	Origin and functional diversification of an amphibian defense peptide arsenal	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@H](C)CC
DRAMP39073	GWASSIGSILGKFAKGGAQAFLQPK	25	XPF-St4	not found	not found	not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antifungal,Antiprotozoal	not found			not found		[Ref.23935531]protozoon: Trypanosoma brucei (LC₉₅=2–4 μM)##Gram-positive bacteria: Staphylococcus aureus (MIC=16 μM); Micrococcus luteus (MIC=1 μM);##Gram-negative bacteria: Escherichia coli (MIC=1–2 μM); Pseudomonas aeruginosa (MIC=8–16 μM);##Fungi: Saccharomyces cerevisiae (MIC=32 μM)	[Ref.23935531]HC₅₀=128 μM	Linear	Free	Free		L	[Ref.23935531]IC₅₀=8 -16μM on mouse T-lymphocytes	membrane	23935531	PLoS Genet. 2013;9(8):e1003662	Roelants K, Fry BG, Ye L, Stijlemans B, Brys L, Kok P, Clynen E, Schoofs L, Cornelis P, Bossuyt F	Origin and functional diversification of an amphibian defense peptide arsenal	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)[C@H](C)CC
DRAMP39074	GWLPTFGKILRKAMQLGPKLIQPI	24	XPF-St5	A0A8J1JR09(38-62)	not found	not found	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antifungal,Antiprotozoal	predicted			not found		[Ref.23935531]protozoon: Trypanosoma brucei (LC₉₅=2–4 μM)##Gram-positive bacteria: Staphylococcus aureus (MIC=8–16 μM); Micrococcus luteus (MIC=0.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=2–4 μM); Pseudomonas aeruginosa (MIC=16 μM);##Fungi: Saccharomyces cerevisiae (MIC=8 μM)	[Ref.23935531]HC₅₀=64 μM	Linear	Free	Free		L	[Ref.23935531]IC₅₀=8 μM on mouse T-lymphocytes	membrane	23935531	PLoS Genet. 2013;9(8):e1003662	Roelants K, Fry BG, Ye L, Stijlemans B, Brys L, Kok P, Clynen E, Schoofs L, Cornelis P, Bossuyt F	Origin and functional diversification of an amphibian defense peptide arsenal	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)[C@H](C)CC)[C@H](C)CC)C(=O)O
DRAMP39075	GVWSTILGGLKKFAKGGLDAIVNPK	25	XPF-St6	A0A803KDZ1(44-68)	not found	pgq	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antifungal,Antiprotozoal	predicted			not found		[Ref.23935531]protozoon: Trypanosoma brucei (LC₉₅=2–64 μM)##Gram-positive bacteria: Staphylococcus aureus (MIC=128 μM); Micrococcus luteus (MIC=1 μM);##Gram-negative bacteria: Escherichia coli (MIC=8 μM); Pseudomonas aeruginosa (MIC=32 μM);##Fungi: Saccharomyces cerevisiae (MIC=32 μM)	[Ref.23935531]HC₅₀>256 μM	Linear	Free	Free		L	[Ref.23935531]IC₅₀=16 μM on mouse T-lymphocytes	membrane	23935531	PLoS Genet. 2013;9(8):e1003662	Roelants K, Fry BG, Ye L, Stijlemans B, Brys L, Kok P, Clynen E, Schoofs L, Cornelis P, Bossuyt F	Origin and functional diversification of an amphibian defense peptide arsenal	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP39076	GLLSNVAGLLKQFAKGGVNAVLNPK	25	XPF-St7	A0A6I8R842(82-10)	not found	pgq	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antifungal,Antiprotozoal	predicted			not found		[Ref.23935531]protozoon: Trypanosoma brucei (LC₉₅=1–8 μM)##Gram-positive bacteria: Staphylococcus aureus (MIC=128 μM); Micrococcus luteus (MIC=0.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=1 μM); Pseudomonas aeruginosa (MIC=4 μM);##Fungi: Saccharomyces cerevisiae (MIC=8 μM)	[Ref.23935531]HC50 : 64 μM	Linear	Free	Free		L	[Ref.23935531]IC₅₀=16 μM on mouse T-lymphocytes	membrane	23935531	PLoS Genet. 2013;9(8):e1003662	Roelants K, Fry BG, Ye L, Stijlemans B, Brys L, Kok P, Clynen E, Schoofs L, Cornelis P, Bossuyt F	Origin and functional diversification of an amphibian defense peptide arsenal	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
DRAMP39077	GFMSKVANFAKKFAKGGVNAIMNQK	25	XPF-St8	P0DX31	Belongs to the MCD family. Mastoparan subfamily	not found	Eumenes micado (Potter wasp)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antifungal,Antiprotozoal	protein level			not found		[Ref.30857348]protozoon:Leishmania major(IC50=36 µM)##Gram-positive bacteria:Staphylococcus aureus ATCC 6538(MIC=34 μM); Staphylococcus aureus ATCC 25923(MIC=7 μM); Staphylococcus saprophyticus (CS)(MIC=3 μM); Staphylococcus epidermis (CS)(MIC=34 μM); Bacillus subtilis CCT 2471(MIC=68 μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=7 μM); Escherichia coli CCT 1371(MIC=17 μM); Escherichia cloacae ATCC 23355(MIC=17 μM)	[Ref.30857348]no significant hemolytic activity at the concentration of 10^-4M	Linear	Free	Amidation		L	[Ref.30857348]Degranulation activity at concentration >30um	Not found	30857348	Toxins (Basel). 2019 Mar 10;11(3):155	Konno K, Kazuma K, Rangel M, Stolarz-de-Oliveira J, Fontana R, Kawano M, Fuchino H, Hide I, Yasuhara T, Nakata Y	New Mastoparan Peptides in the Venom of the Solitary Eumenine Wasp Eumenes micado	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP39078	LKLMGIVKKVLGAL	14	Mastoparan-EM1	P0DX32	Belongs to the MCD family. Mastoparan subfamily	not found	Eumenes micado (Potter wasp)	Antimicrobial,Antibacterial，Anti-Gram+，Anti-Gram-,Antiprotozoal	protein level			not found		[Ref.30857348]protozoon:Leishmania major(IC50=36 µM);##Gram-positive bacteria:Staphylococcus aureus ATCC 6538(MIC=17 μM); Staphylococcus aureus ATCC 25923(MIC=3 μM); Staphylococcus saprophyticus (CS)(MIC=3 μM); Staphylococcus epidermis (CS)(MIC=34 μM); Bacillus subtilis CCT 2471(MIC=68 μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=3 μM); Escherichia coli CCT 1371(MIC=34 μM); Escherichia cloacae ATCC 23355(MIC=34 μM); Pseudomonas aeruginosa ATCC 15442(MIC=34 μM)	[Ref.30857348]no significant hemolytic activity at the concentration of 10^-4M	Linear	Free	Amidation		L	[Ref.30857348]Degranulation activity at concentration >30um	membrane	30857348	Toxins (Basel). 2019 Mar 10;11(3):155	Konno K, Kazuma K, Rangel M, Stolarz-de-Oliveira J, Fontana R, Kawano M, Fuchino H, Hide I, Yasuhara T, Nakata Y	New Mastoparan Peptides in the Venom of the Solitary Eumenine Wasp Eumenes micado	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C
DRAMP39079	LKLLGIVKKVLGAI	14	Mastoparan-EM2	not found	not found	not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram+，Anti-Gram-,Antiprotozoal	not found			not found		[Ref.19752273]protozoon:Plasmodium falciparum Dd2 strain (IC₅₀=4.5±0.6 μM); Plasmodium falciparum Δpfpm1 strain (IC₅₀=3.7±0.2 μM); Plasmodium falciparum Δpfpm2 strain (IC₅₀=3.0±0.2 μM,); Plasmodium falciparum Δpfpm3 strain (IC₅₀=2.8±0.1 μM, ); Plasmodium falciparum Δpfpm4 strain (IC₅₀=3.0±0.1 μM, ); Plasmodium falciparum GC03 strain (IC₅₀=3.2±0.2 μM, P<0.01); Plasmodium falciparum 3D7 strain (IC₅₀=3.4±0.2 μM); Plasmodium falciparum Δ3pfpm strain (IC₅₀=3.0±0.2 μM); Plasmodium falciparum Δ4pfpm strain (IC₅₀=2.1±0.2 μM)	not found	Linear	trans-Epoxysuccinylation	4-guanidinobutyl-amidation		L	not found	membrane	19752273	Antimicrob Agents Chemother. 2009 Dec;53(12):4968-78	Moura PA, Dame JB, Fidock DA.	Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)[C@H](C)CC)C(C)C)C(C)C)C(N)=O
DRAMP39080	RFRPPIRRPPIRPPFRPPFRPPVR	24	OaBAC-5-mini	P79362(131-154)	Belongs to the cathelicidin family	CATHL2##BAC5	Ovis aries (Sheep)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	transcript level	α-helical		not found		[Ref.14733670]protozoon:Trypanosoma brucei brucei bloodstream forms (BSF, at 335–670 μM, inhibits 100% growth; T. b. brucei procyclic forms (PCF, >670 μM, inhibits 100% growth);##Gram-negative bacteria: Sodalis glossinidius (tsetse fly symbiont, at 20.9–41.9 μM, inhibits 100% growth)	not found	Linear	Free	Amidation		L	not found	membrane	14733670	Vector Borne Zoonotic Dis. 2003 Winter;3(4):175-86.	Haines LR, Hancock RE, Pearson TW	Cationic antimicrobial peptide killing of African trypanosomes and Sodalis glossinidius, a bacterial symbiont of the insect vector of sleeping sickness	
DRAMP39081	RFRPPIRRPPIRPPFRPPFRPPVR	24	OaBAC-5-mini	P97297(95-144)	Belongs to the adrenomedullin family	Adm	Mus musculus (Mouse)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	transcript level			not found		[Ref.19057622]protozoon:T. brucei BSF(LD50=1.8±0.1 µM)	not found	Linear	Free	Free		L	not found	lysosome	19057622	Cell Death Differ. 2009 Mar;16(3):406-16	Delgado M, Anderson P, Garcia-Salcedo JA, Caro M, Gonzalez-Rey E	Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death	CC[C@@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)[C@H](C)CC
DRAMP39082	YRQSMNQGSRSNGCRFGTCTFQKLAHQIYQLTDKDKDGMAPRNKISPQGY	50	Adrenomedullin,AM	P55090(81-120)	Belongs to the sauvagine/corticotropin-releasing factor/urotensin I family	Ucn	attus norvegicus (Rat)	Antimicrobial,Antiprotozoal	protein level			Not found		[Ref.19057622]protozoon:T. brucei BSF(LD50=1.1±0.5 µM)	not found	Linear	Free	Free		L	not found	lysosome	19057622	Cell Death Differ. 2009 Mar;16(3):406-16	Delgado M, Anderson P, Garcia-Salcedo JA, Caro M, Gonzalez-Rey E	Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CC(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)CC)C(=O)N[C@@H](CC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP39083	DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV	40	Urocortin,UCN	P01143(45-185)	Belongs to the sauvagine/corticotropin-releasing factor/urotensin I family	Crh	Rattus norvegicus (Rat)	Antimicrobial,Antiprotozoal	protein level			Not found		[Ref.19057622]protozoon:T. brucei BSF(LD50 : 5.3±2.4 µM)	not found	Linear	Free	Free		L	not found	lysosome	19057622	Cell Death Differ. 2009 Mar;16(3):406-16	Delgado M, Anderson P, Garcia-Salcedo JA, Caro M, Gonzalez-Rey E	Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)[C@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O
DRAMP39084	SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII	41	Corticotropin releasing hormone,CRH	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal				not found		[Ref.19057622]protozoon:T. brucei BSF(LD50=3.5±0.1 µM)	not found	Linear	Free	Free		L	not found	lysosome	19057622	Cell Death Differ. 2009 Mar;16(3):406-16	Delgado M, Anderson P, Garcia-Salcedo JA, Caro M, Gonzalez-Rey E	Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death	CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](C)CC)NC(=O)[C@H](CCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)[C@H](C)CC)C(=O)O
DRAMP39085	GSSFLSPEHQLAQQRKESKKPPAKLQPR	28	Ghrelin,GHR	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20615879]protozoon: BSF T. brucei (At 20 µM more than 70% dead)	ND	Linear	Free	Free		L	not found	membrane	20615879	J Biol Chem. 2010 Sep 10;285(37):28659-66	Harrington JM, Widener J, Stephens N, Johnson T, Francia M, Capewell P, Macleod A, Hajduk SL	The plasma membrane of bloodstream-form African trypanosomes confers susceptibility and specificity to killing by hydrophobic peptides	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O
DRAMP39086	SDLGAVISLLLWGRQLFA	18	SHP-1	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20615879]protozoon: BSF T. brucei (At 20 µM more than 80% dead)	ND	Linear	Free	Free		L	not found	membrane	20615879	J Biol Chem. 2010 Sep 10;285(37):28659-66	Harrington JM, Widener J, Stephens N, Johnson T, Francia M, Capewell P, Macleod A, Hajduk SL	The plasma membrane of bloodstream-form African trypanosomes confers susceptibility and specificity to killing by hydrophobic peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP39087	AKLIALTLLGMGLALFRNHQS	21	SHP-2	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20615879]protozoon: BSF T. brucei (At 20 µM less than 40% dead)	ND	Linear	Free	Free		L	not found	membrane	20615879	J Biol Chem. 2010 Sep 10;285(37):28659-66	Harrington JM, Widener J, Stephens N, Johnson T, Francia M, Capewell P, Macleod A, Hajduk SL	The plasma membrane of bloodstream-form African trypanosomes confers susceptibility and specificity to killing by hydrophobic peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
DRAMP39088	SDLGAVISLLWGRQLFA	17	SHP-1-L	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20615879]protozoon: BSF T. brucei (At 20 µM approx 10% dead)	ND	Linear	Free	Free		L	not found	membrane	20615879	J Biol Chem. 2010 Sep 10;285(37):28659-66	Harrington JM, Widener J, Stephens N, Johnson T, Francia M, Capewell P, Macleod A, Hajduk SL	The plasma membrane of bloodstream-form African trypanosomes confers susceptibility and specificity to killing by hydrophobic peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP39089	SDLGAVISWGRQLFA	15	SHP-1-LLL	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20615879]protozoon: BSF T. brucei (At 20 µM approx 10% dead)	ND	Linear	Free	Free		L	not found	membrane	20615879	J Biol Chem. 2010 Sep 10;285(37):28659-66	Harrington JM, Widener J, Stephens N, Johnson T, Francia M, Capewell P, Macleod A, Hajduk SL	The plasma membrane of bloodstream-form African trypanosomes confers susceptibility and specificity to killing by hydrophobic peptides	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
DRAMP39090	SDVISLLLWGRQLFA	15	SHP-1-LGA	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20615879]protozoon: BSF T. brucei (At 20 µM less than 10% dead)	ND	Linear	Free	Free		L	not found	membrane	20615879	J Biol Chem. 2010 Sep 10;285(37):28659-66	Harrington JM, Widener J, Stephens N, Johnson T, Francia M, Capewell P, Macleod A, Hajduk SL	The plasma membrane of bloodstream-form African trypanosomes confers susceptibility and specificity to killing by hydrophobic peptides	CC[C@@H](C)[C@H](NC(=O)C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
DRAMP39091	ERTEESWGRRFWRRGEAC	18	NSP	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.18973386]protozoon:Plasmodium falciparum K1(IC50 =5.0µM), Trypanosoma brucei rhodesiense STIB 900(IC50 =56.3 µM)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)		L	[Ref.18973386]IC50>168µM on Rat Myoblast L6 Cells	not found	18973386	J Nat Prod. 2008 Nov;71(11):1891-6	Portmann C, Blom JF, Kaiser M, Brun R, Jüttner F, Gademann K	Isolation of aerucyclamides C and D and structure revision of microcyclamide 7806A: heterocyclic ribosomal peptides from Microcystis aeruginosa PCC 7806 and their antiparasite evaluation	C[C@H](NC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)C(=O)O
DRAMP39092	FTGCMC	6	Aerucyclamide B	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.18973386]protozoon:Plasmodium falciparum K1(IC50 =0.7 µM), Trypanosoma brucei rhodesiense STIB 900(IC50 =15.9 µM)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)		L	[Ref.18973386]IC50=120 µM on Rat Myoblast L6 Cells	not found	18973386	J Nat Prod. 2008 Nov;71(11):1891-6	Portmann C, Blom JF, Kaiser M, Brun R, Jüttner F, Gademann K	Isolation of aerucyclamides C and D and structure revision of microcyclamide 7806A: heterocyclic ribosomal peptides from Microcystis aeruginosa PCC 7806 and their antiparasite evaluation	
DRAMP39093	ITGCIC	6	Aerucyclamide C	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.18973386]protozoon:Plasmodium falciparum K1(IC50 =2.3µM), Trypanosoma brucei rhodesiense STIB 900(IC50 =9.2 µM)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)		L	[Ref.18973386]IC50=106 µM on Rat Myoblast L6 Cells	not found	18973386	J Nat Prod. 2008 Nov;71(11):1891-6	Portmann C, Blom JF, Kaiser M, Brun R, Jüttner F, Gademann K	Isolation of aerucyclamides C and D and structure revision of microcyclamide 7806A: heterocyclic ribosomal peptides from Microcystis aeruginosa PCC 7806 and their antiparasite evaluation	
DRAMP39094	ITGCIC	6	Aerucyclamide D	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.18973386]protozoon:Plasmodium falciparum K1(IC50 =6.3 µM), Trypanosoma brucei rhodesiense STIB 900(IC50 =50.1 µM)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)		L	[Ref.18973386]IC50>153µM on Rat Myoblast L6 Cells	not found	18973386	J Nat Prod. 2008 Nov;71(11):1891-6	Portmann C, Blom JF, Kaiser M, Brun R, Jüttner F, Gademann K	Isolation of aerucyclamides C and D and structure revision of microcyclamide 7806A: heterocyclic ribosomal peptides from Microcystis aeruginosa PCC 7806 and their antiparasite evaluation	
DRAMP39095	XAXGIXA	7	Venturamide A	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.17328572]protozoon:P. falciparum(IC50=8.2 µM),T. cruzi(IC50=14.6 µM),L. donoVani(IC50>20 µM)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X1=Oxazole (derived from Ser/Thr via cyclodehydration + dehydrogenation)X2,X3=Thiazole (derived from Cys via cyclodehydration + dehydrogenation)	L	[Ref.17328572]IC50=86 µM on Vero cells,IC50=13.1 µM on MCF-7 cells	not found	17328572	J Nat Prod. 2007 Mar;70(3):397-401	Linington RG, Gonzalez J, Ureña LD, Romero LI, Ortega-Barría E, Gerwick WH	Venturamides A and B: antimalarial constituents of the panamanian marine Cyanobacterium Oscillatoria sp	
DRAMP39096	XtXgiXa	7	Venturamide B	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.17328572]protozoon:P. falciparum(IC50=5.2 µM),T. cruzi(IC50=15.8 µM),L. donoVani(IC50>19 µM)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X1=Oxazole (derived from Ser/Thr via cyclodehydration + dehydrogenation)X2,X3=Thiazole (derived from Cys via cyclodehydration + dehydrogenation)	D	[Ref.17328572]IC50=56 µM on Vero cells,IC50>54 µM on MCF-7 cells	not found	17328572	J Nat Prod. 2007 Mar;70(3):397-401	Linington RG, Gonzalez J, Ureña LD, Romero LI, Ortega-Barría E, Gerwick WH	Venturamides A and B: antimalarial constituents of the panamanian marine Cyanobacterium Oscillatoria sp	
DRAMP39097	LPKPPKPVSKMRMATPLLMQALPM	24	L-CLIP	A0A2K5HEB8(97-120)##A0A2K5HEC5(97-120)##A0A2K5HEF4(97-120)	not found	not found	Colobus angolensis palliatus (Peters' Angolan colobus)	Antimicrobial,Antiprotozoal	predicted			not found		[Ref.30811391]protozoon:L. major promastigote(IC50=280-300 µg/ml)	30% Hemolysis at 500 µg/ml	Linear	Lauroylation	Free		L	not found	membrane	30811391	PLoS Negl Trop Dis. 2019 Feb 27;13(2):e0007217	Zahedifard F, Lee H, No JH, Salimi M, Seyed N, Asoodeh A, Rafati S.	Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials	
DRAMP39098	ALWDTLLKKVLKAAAKAALNAVLVGANA	28	Dermaseptin D4-S4	not found	not found	not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	not found			not found		[Ref.10660589]protozoon:L. major promastigotes(log LC50 greater than 1 µM)##Gram-negative bacteria:E. coli(IC50=69±11µM)	[Ref.10660589]LC50=2.3±0.3 on RBC	Linear	Free	Free		L	not found	membrane	10660589	J Biol Chem. 2000 Feb 11;275(6):4230-8	Feder R, Dagan A, Mor A	Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity	
DRAMP39099	ALWDTLLKKVLKAAAKAALNAVLVGANA	28	Dermaseptin D4-S4	not found	not found	not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	not found			not found		[Ref.20032878]protozoon:P. berghei（IC50=32.35 μM）	not found	Linear	Free	Free	X=Ornithine	L	not found	membrane	20032878	Molecules. 2009 Dec 8;14(12):5103-14	Pérez-Picaso L, Velasco-Bejarano B, Aguilar-Guadarrama AB, Argotte-Ramos R, Rios MY	Antimalarial activity of ultra-short peptides	CC(C)C[C@H](NC(=O)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C
DRAMP39100	VKFX	4	Ultra-short peptides 2	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20032878]protozoon:P. berghei（IC50=10 μM)	not found	Linear	Free	Free	X=Ornithine	L	not found	membrane	20032878	Molecules. 2009 Dec 8;14(12):5103-14	Pérez-Picaso L, Velasco-Bejarano B, Aguilar-Guadarrama AB, Argotte-Ramos R, Rios MY	Antimalarial activity of ultra-short peptides	
DRAMP39101	KXFX	4	Ultra-short peptides 3	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20032878]protozoon；P. berghei（IC50=3.48 μM)	not found	Linear	Free	Free	X=Ornithine	L	not found	membrane	20032878	Molecules. 2009 Dec 8;14(12):5103-14	Pérez-Picaso L, Velasco-Bejarano B, Aguilar-Guadarrama AB, Argotte-Ramos R, Rios MY	Antimalarial activity of ultra-short peptides	
DRAMP39102	FXFX	4	Ultra-short peptides 4	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20032878]protozoon；P. berghei（IC50=3.31 μM)	not found	Linear	Free	Free	X=Ornithine	L	not found	membrane	20032878	Molecules. 2009 Dec 8;14(12):5103-14	Pérez-Picaso L, Velasco-Bejarano B, Aguilar-Guadarrama AB, Argotte-Ramos R, Rios MY	Antimalarial activity of ultra-short peptides	
DRAMP39103	KFFX	4	Ultra-short peptides 5	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20032878]protozoon；P. berghei（IC50=2.57 μM)	not found	Linear	Free	Free	X=Ornithine	L	not found	membrane	20032878	Molecules. 2009 Dec 8;14(12):5103-14	Pérez-Picaso L, Velasco-Bejarano B, Aguilar-Guadarrama AB, Argotte-Ramos R, Rios MY	Antimalarial activity of ultra-short peptides	
DRAMP39104	XFKV	4	Ultra-short peptides 6	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20032878]protozoon；P. berghei（IC50> 200 μM)	not found	Linear	Free	Free	X=Ornithine	L	not found	membrane	20032878	Molecules. 2009 Dec 8;14(12):5103-14	Pérez-Picaso L, Velasco-Bejarano B, Aguilar-Guadarrama AB, Argotte-Ramos R, Rios MY	Antimalarial activity of ultra-short peptides	
DRAMP39105	KVPX	4	Ultra-short peptides 7	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20032878]protozoon；P. berghei（IC50>200 μM)	not found	Linear	Free	Free	X=Ornithine	L	not found	membrane	20032878	Molecules. 2009 Dec 8;14(12):5103-14	Pérez-Picaso L, Velasco-Bejarano B, Aguilar-Guadarrama AB, Argotte-Ramos R, Rios MY	Antimalarial activity of ultra-short peptides	
DRAMP39106	KVFP	4	Ultra-short peptides 8	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20032878]protozoon；P. berghei（IC50=51.28 μM)	not found	Linear	Free	Free		L	not found	membrane	20032878	Molecules. 2009 Dec 8;14(12):5103-14	Pérez-Picaso L, Velasco-Bejarano B, Aguilar-Guadarrama AB, Argotte-Ramos R, Rios MY	Antimalarial activity of ultra-short peptides	
DRAMP39107	KVFP	4	Ultra-short peptides 8	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.20032878]protozoon；P. berghei（IC50=120.22 μM)	not found	Linear	Free	Free	X=Ornithine	L	not found	membrane	20032878	Molecules. 2009 Dec 8;14(12):5103-14	Pérez-Picaso L, Velasco-Bejarano B, Aguilar-Guadarrama AB, Argotte-Ramos R, Rios MY	Antimalarial activity of ultra-short peptides	CC(C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O
DRAMP39108	ALWMTLLKKVLKAAAKAALDAVLVGANA	28	Dermaseptin D20–S4	not found	not found	not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	not found			not found		[Ref.10660589]protozoon:L. major promastigotes(log LC50 greater than 1 µM)Gram-negative bacteria:E. coli(IC75=43±6µM)	[Ref.10660589]LC50=1.2±0.1 on RBC	Linear	Free	Free		L	not found	membrane	10660589	J Biol Chem. 2000 Feb 11;275(6):4230-8	Feder R, Dagan A, Mor A	Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity	
DRAMP39109	ALWMTLLKKVLKAAAKAALDAVLVGANA	28	Dermaseptin D20–S4	not found	not found	not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	not found			not found		[Ref.19752273]protozoon:Plasmodium falciparum Dd2 strain (IC₅₀=25.0±3.0 μM); Plasmodium falciparum Δpfpm1 strain (IC₅₀=27.5±2.1 μM); Plasmodium falciparum Δpfpm2 strain (IC₅₀=23.5±1.3 μM); Plasmodium falciparum Δpfpm3 strain (IC₅₀=20.0±3.7 μM); Plasmodium falciparum Δpfpm4 strain (IC₅₀=23.4±2.6 μM); Plasmodium falciparum GC03 strain (IC₅₀=36.0±2.8 μM); Plasmodium falciparum 3D7 strain (IC₅₀=16.4±1.1 μM); Plasmodium falciparum Δ3pfpm strain (IC₅₀=11.5±1.3 μM); Plasmodium falciparum Δ4pfpm strain (IC₅₀=18.4±1.3 μM)	not found	Linear	Isovalerylation	Free	X1、X2=Sta=Statine	L	not found	membrane	19752273	Antimicrob Agents Chemother. 2009 Dec;53(12):4968-78	Moura PA, Dame JB, Fidock DA.	Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O
DRAMP39110	LLX	3	N-acetyl-leucinyl-leucinyl-norleucinal(ALLN)	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.19752273]protozoon: Plasmodium falciparum Dd2 strain (IC₅₀=104.7±13.5 nM); Plasmodium falciparum Δpfpm1 strain (IC₅₀=94.5±9.6 nM); Plasmodium falciparum Δpfpm2 strain (IC₅₀=86.4±9.8 nM); Plasmodium falciparum Δpfpm3 strain (IC₅₀=61.8±7.8 nM, P<0.05); Plasmodium falciparum Δpfpm4 strain (IC₅₀=84.5±14.3 nM); Plasmodium falciparum GC03 strain (IC₅₀=97.9±10.3 nM); Plasmodium falciparum 3D7 strain (IC₅₀=72.4±7.8 nM); Plasmodium falciparum Δ3pfpm strain (IC₅₀=44.1±7.9 nM, P<0.05); Plasmodium falciparum Δ4pfpm strain (IC₅₀=7.9±0.7 nM	not found	Linear	Acetylation	Norleucinalation	X=Nle=Norleucinal	L	not found	membrane	19752273	Antimicrob Agents Chemother. 2009 Dec;53(12):4968-78	Moura PA, Dame JB, Fidock DA.	Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors	
DRAMP39111	PKLLKTFLSKWK	12	SPFK	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.12615333]protozoon:L. donovani promastigotes(LD50=5×10^−4 µg/ml, 3.8 × 10^−4 µM)	not found	Linear	Free	Free		L	not found	membrane	12615333	Mol Biochem Parasitol. 2003 Mar;127(1):23-35	Bera A, Singh S, Nagaraj R, Vaidya T	Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides	
DRAMP39112	PKLLKTFLSKWK	12	SPFK	not found	not found	not found		Antimicrobial,Antiprotozoal	not found			not found		[Ref.21262294]protozoon: Leishmania major promastigotes (EC₅₀=74.01±1.27 μg/mL); Leishmania panamensis promastigotes (EC₅₀>100 μg/mL); Leishmania panamensis intracellular amastigotes (EC₅₀i>10 μg/mL)	[Ref.21262294]HC₅₀=16.28±0.17 μg/mL	Linear	Free	Amidation	Deletion of residues 7 (Lys, K), 8 (Val, V), 9 (Leu, L) from wild-type Melittin sequence	L	[Ref.21262294]LC₅₀=43.42±0.86 μg/mL on human dendritic cells	membrane	21262294	Peptides. 2011 Apr;32(4):683-90	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
DRAMP39113	PRRRRSSSRP	10	Pr-1	P02328(1-10)	not found	not found	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	Antimicrobial,Antiprotozoal	protein level			not found		[Ref.21262294]protozoon: Leishmania panamensis promastigotes (EC₅₀>100 μg/mL); Leishmania panamensis intracellular amastigotes (EC₅₀i>10 μg/mL, SI≤1); Leishmania major promastigotes (EC₅₀>100 μg/mL)	[Ref.21262294]HC₅₀>100 μg/mL	Linear	Free	Free		L	[Ref.21262294]LC₅₀=77.08±0.83 μg/mL on human dendritic cells	membrane	21262294	Peptides. 2011 Apr;32(4):683-90	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells	
DRAMP39114	PRRRRSSSRP	10	Pr-1	P02328(11-18)	not found	not found	Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	Antimicrobial,Antiprotozoal	protein level			not found		[Ref.21262294]protozoon: Leishmania panamensis promastigotes (EC₅₀=23.7±0.37 μg/mL); Leishmania panamensis intracellular amastigotes (EC₅₀i>10 μg/mL); Leishmania major promastigotes (EC₅₀>100 μg/mL)	[Ref.21262294]HC₅₀>100 μg/mL)	Linear	Free	Free		L	[Ref.21262294]LC₅₀=37.57±0.27 μg/mL on human dendritic cells	membrane	21262294	Peptides. 2011 Apr;32(4):683-90	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells	N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O
DRAMP39115	VRRRRRPR	8	Pr-2	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.21262294]protozoon: Leishmania panamensis promastigotes (EC₅₀>100 μg/mL); Leishmania panamensis intracellular amastigotes (EC₅₀i=2.48±0.22 μg/mL, SI=40); Leishmania major promastigotes (EC₅₀>100 μg/mL)	[Ref.21262294]HC₅₀>100 μg/mL	Linear	Free	Amidation		L	[Ref.21262294]LC₅₀>100 μg/mL on human dendritic cells	membrane	21262294	Peptides. 2011 Apr;32(4):683-90	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells	CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP39116	KWKLFKKIEKVGQNIRDGIIKAGPAVAWVGQATQIAK	37	Cecropin A [V28W]	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.21262294]protozoon: Leishmania panamensis promastigotes (EC₅₀>100 μg/mL); Leishmania panamensis intracellular amastigotes (EC₅₀i=ND, SI≤1); Leishmania major promastigotes (EC₅₀>100 μg/mL)	[Ref.21262294]HC₅₀>100 μg/mL	Linear	Free	Amidation		L	[Ref.21262294]LC₅₀>100 μg/mL on human dendritic cells	membrane	21262294	Peptides. 2011 Apr;32(4):683-90	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)[C@H](C)CC
DRAMP39117	KWKVFKKIEKNGRNIRNGIVKAGPAIAVLGEAKAL	35	Cecropin B [M11N]	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.10660589]protozoon:L. major promastigotes(log LC50 greater than 1 µM)##Gram-negative bacteria:E. coli(IC50=43±8µM)	[Ref.10660589]LC50=1.2±0.4 on RBC	Linear	Free	Free		L	not found	membrane	10660589	J Biol Chem. 2000 Feb 11;275(6):4230-8	Feder R, Dagan A, Mor A	Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@H](C)CC)[C@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)[C@H](C)CC)C(C)C
DRAMP39118	ALWMTLLKKVLKAAAKAALKAVLVGANA	28	Dermaseptin K20–S4	O16825(24-45)	Belongs to the andropin family	Anp	Drosophila mauritiana (Fruit fly)	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	transcript level			not found		[Ref.21262294]protozoon: Leishmania panamensis promastigotes (EC₅₀>100 μg/mL); Leishmania panamensis intracellular amastigotes (EC₅₀i=23.45±1.35 μg/mL, SI=4); Leishmania major promastigotes (EC₅₀>100 μg/mL)	[Ref.21262294]HC₅₀>100 μg/mL	Linear	Free	Amidation		L	[Ref.21262294]LC₅₀>100 μg/mL on human dendritic cells	membrane	21262294	Peptides. 2011 Apr;32(4):683-90	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
DRAMP39119	SWLSKTAKKLENSAKKRISEGIAIAQGPR	29	Cecropin P1 [del I26,G29]	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.21262294]protozoon: Leishmania panamensis promastigotes (EC₅₀>100 μg/mL); Leishmania panamensis intracellular amastigotes (EC₅₀i>20 μg/mL, SI≤1); Leishmania major promastigotes (EC₅₀>100 μg/mL); Leishmania major intracellular amastigotes (EC₅₀i>20 μg/mL)	[Ref.21262294]HC₅₀>100 μg/mL	Linear	Free	Amidation	Deletion of residues 26 (Isoleucine, I) and 29 (Glycine, G) from wild-type Cecropin P1 sequence	L	[Ref.21262294]LC₅₀=22.97±1.63 μg/mL on human dendritic cells	membrane	21262294	Peptides. 2011 Apr;32(4):683-90	Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G	Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells	
DRAMP39120	VGK	3	Peptide 1	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.9799128]protozoon:P. berghei(47±09% inhibition at 100 μM)	not found	Linear	Free	Free		L	not found	membrane	9799128	Eur J Biochem. 1998 Oct 1;257(1):263-73	Boisbouvier J, Prochnicka-Chalufour A, Nieto AR, Torres JA, Nanard N, Rodriguez MH, Possani LD, Delepierre M	Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei	
DRAMP39121	AVG	3	Peptide 2	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.9799128]protozoon:P. berghei(47±09% inhibition at 100 μM）	not found	Linear	Free	Free		L	not found	membrane	9799128	Eur J Biochem. 1998 Oct 1;257(1):263-73	Boisbouvier J, Prochnicka-Chalufour A, Nieto AR, Torres JA, Nanard N, Rodriguez MH, Possani LD, Delepierre M	Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei	
DRAMP39122	QIK	3	Peptide 3	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.9799128]protozoon:P. berghei(35±10% inhibition at 100 μM）	not found	Linear	Free	Free		L	not found	membrane	9799128	Eur J Biochem. 1998 Oct 1;257(1):263-73	Boisbouvier J, Prochnicka-Chalufour A, Nieto AR, Torres JA, Nanard N, Rodriguez MH, Possani LD, Delepierre M	Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei	
DRAMP39123	RIDR	4	Peptide 4	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.9799128]protozoon:P. berghei(45±09% inhibition at 100 μM）	not found	Linear	Free	Free		L	not found	membrane	9799128	Eur J Biochem. 1998 Oct 1;257(1):263-73	Boisbouvier J, Prochnicka-Chalufour A, Nieto AR, Torres JA, Nanard N, Rodriguez MH, Possani LD, Delepierre M	Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei	
DRAMP39124	MPR	3	Peptide 5	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.9799128]protozoon:P. berghei(30±23% inhibition at 100 μM）	not found	Linear	Free	Free		L	not found	membrane	9799128	Eur J Biochem. 1998 Oct 1;257(1):263-73	Boisbouvier J, Prochnicka-Chalufour A, Nieto AR, Torres JA, Nanard N, Rodriguez MH, Possani LD, Delepierre M	Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei	
DRAMP39125	LFR	3	Peptide 6	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.9799128]protozoon:P. berghei(19±15% inhibition at 100 μM）	not found	Linear	Free	Free		L	not found	membrane	9799128	Eur J Biochem. 1998 Oct 1;257(1):263-73	Boisbouvier J, Prochnicka-Chalufour A, Nieto AR, Torres JA, Nanard N, Rodriguez MH, Possani LD, Delepierre M	Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei	
DRAMP39126	QGILR	5	Peptide 7	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.9799128]protozoon:P. berghei(43±22% inhibition at 100 μM）	not found	Linear	Free	Free		L	not found	membrane	9799128	Eur J Biochem. 1998 Oct 1;257(1):263-73	Boisbouvier J, Prochnicka-Chalufour A, Nieto AR, Torres JA, Nanard N, Rodriguez MH, Possani LD, Delepierre M	Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei	
DRAMP39127	AGPAIALVGDAR	12	Peptide 8	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.9799128]protozoon:P. berghei(24±12% inhibition at 100 μM）	not found	Linear	Free	Free		L	not found	membrane	9799128	Eur J Biochem. 1998 Oct 1;257(1):263-73	Boisbouvier J, Prochnicka-Chalufour A, Nieto AR, Torres JA, Nanard N, Rodriguez MH, Possani LD, Delepierre M	Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei	
DRAMP39128	QIK	3	Peptide A	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	Not found			not found		[Ref.9799128]protozoon:P. berghei(54±08% inhibition at 100 μM）	not found	Linear	Free	Free		L	not found	membrane	9799128	Eur J Biochem. 1998 Oct 1;257(1):263-73	Boisbouvier J, Prochnicka-Chalufour A, Nieto AR, Torres JA, Nanard N, Rodriguez MH, Possani LD, Delepierre M	Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP39129	MPRYRLFRRIDRVGK	15	Peptide B	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	Not found			not found		[Ref.9799128]protozoon:P. berghei(41±08% inhibition at 100 μM）	not found	Linear	Free	Free		L	not found	membrane	9799128	Eur J Biochem. 1998 Oct 1;257(1):263-73	Boisbouvier J, Prochnicka-Chalufour A, Nieto AR, Torres JA, Nanard N, Rodriguez MH, Possani LD, Delepierre M	Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
DRAMP39130	QGILRAGPAIALVGDARAVG	20	Peptide C	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.9799128]protozoon:P. berghei(34±14% inhibition at 100 μM）	not found	Linear	Free	Free		L	not found	membrane	9799128	Eur J Biochem. 1998 Oct 1;257(1):263-73	Boisbouvier J, Prochnicka-Chalufour A, Nieto AR, Torres JA, Nanard N, Rodriguez MH, Possani LD, Delepierre M	Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(C)C)[C@H](C)CC
DRAMP39131	kkalkhalakwlpalkalahklakk	25	D-LAK160-HP13	not found	not found	not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	not found			not found		[Ref.22869378]protozoon: P. falciparum C10 (EC₅₀=3.94 ± 0.33 μM)	[Ref.22869378]HC50=185.0 ±18.65 μM	Linear	Free	Amidation		D	[Ref.22869378]EC₅₀=7.58 ± 0.42 μM on A549 ; EC₅₀=3.95 ± 0.40 μM on RAW264.7	membrane	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides	CC(C)C[C@@H](NC(=O)[C@@H](C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](Cc1c[nH]cn1)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(N)=O
DRAMP39132	kkalakalkhwlpalhklakalakk	25	D-LAK80-HP13	not found	not found	not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	not found			not found		[Ref.22869378]protozoon: P. falciparum C10 (EC₅₀=0.96 ± 0.07 μM)	[Ref.22869378]HC50=8.61±0.35 μM	Linear	Free	Amidation		D	[Ref.22869378]EC₅₀=6.50 ± 0.37 μM on A549 ; EC₅₀=7.08 ± 1.42 μM on RAW264.7	membrane	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides	CC(C)C[C@@H](NC(=O)[C@@H](C)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1c[nH]cn1)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(N)=O
DRAMP39133	kkalahalkkwlpalkklahalakk	25	D-LAK120-HP13	not found	not found	not found	synthetic	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	not found			not found		[Ref.22869378]protozoon:P. falciparum C10 (EC₅₀=2.88 ± 0.25 μM)	[Ref.22869378]HC50=79.61±2.80 μM	Linear	Free	Amidation		D	[Ref.22869378]EC₅₀=2.21 ± 0.63 μM on A549 ; EC₅₀=2.33 ± 0.30 μM on RAW264.7	membrane	22869378	J Biol Chem. 2012 Oct 5;287(41):34120-33	Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ	Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides	CC(C)C[C@@H](NC(=O)[C@@H](C)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](N)CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](Cc1c[nH]cn1)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](Cc1c[nH]cn1)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(N)=O
DRAMP39134	ALWKTLLKKV	10	Dermaseptin K4-S4(1–10)a	O93452(45-54)	Belongs to the frog skin active peptide (FSAP) family. Dermaseptin subfamily	not found	Agalychnis dacnicolor (Giant Mexican leaf frog) (Pachymedusa dacnicolor)	Antimicrobial,Antibacterial，Anti-Gram+，Anti-Gram-,Antifungal,Antiprotozoal	homology			not found		[Ref.11847217]protozoon:Leishmania major(LC50>50 µM)##Gram-negative bacteria:Escherichia coli(MIC=50±10 µM)##Gram-positive bacteria:Staphylococcus aureus(MIC>50 µM)##Fungi:Cryptococcus neoformans(MIC=30±5 µM)	[Ref.11847217]LC50>50 µM on RBC	Linear	Free	Amidation		L	not found	membrane	11847217	J Biol Chem. 2002 May 10;277(19):16941-51	Kustanovich I, Shalev DE, Mikhlin M, Gaidukov L, Mor A	Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives	CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O
DRAMP39135	FF	2	2,5-diketopiperazine 18	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.23084276]protozoon:P. berghei(IC50 : 2.54 μM)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)		L	not found	not found	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY.	Linear and cyclic dipeptides with antimalarial activity	
DRAMP39136	XV	2	Dipeptide 3	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.23084276]protozoon:P. berghei(IC50 : 33.88 μM)	not found	Cyclic	Boc-Orn(Z)ylation	Bocylation	X= Ornithine	L	not found	not found	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY.	Linear and cyclic dipeptides with antimalarial activity	
DRAMP39137	xV	2	Dipeptide 4	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.23084276]protozoon:P. berghei(IC50 : 3.05 μM)	not found	Cyclic	Boc-Orn(Z)ylation	Methoxylation	X= Ornithine	Mix	not found	not found	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY.	Linear and cyclic dipeptides with antimalarial activity	
DRAMP39138	xV	2	Dipeptide 5	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.23084276]protozoon:P. berghei(IC50 : 2.78 μM)	not found	Cyclic	Boc-Orn(Z)ylation	Bocylation	X= Ornithine	Mix	not found	not found	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY.	Linear and cyclic dipeptides with antimalarial activity	
DRAMP39139	FF	2	Dipeptide 6	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.23084276]protozoon:P. berghei(IC50 : 112.20 μM)	not found	Cyclic	Boc-Orn(Z)ylation	Bocylation		L	not found	not found	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY.	Linear and cyclic dipeptides with antimalarial activity	
DRAMP39140	gIrIiPViiPGYKKWARlIKrGLSrLGG	28	Retro-D-BMAP28(RI-BMAP-28)	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.26883699]protozoon: Leishmania donovani promastigotes(0.4% live cells at 20 μM)	not found	Linear	Free	Amidation		D	not found	membrane	26883699	Antimicrob Agents Chemother. 2016 Mar 25;60(4):2484-91	Marr AK, Cen S, Hancock RE, McMaster WR	Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(N)=O)[C@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@H](C)CC
DRAMP39141	VLLNXGGF	8	Peptide no. 8	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.19715342]protozoon:P. falciparum(IC50=74±9 μM)	not found	Linear	Free	Free	X=Fum,fumaric acid	L	not found	falcipain-2,rhodesain	19715342	J Med Chem. 2009 Sep 24;52(18):5662-72	Machon U, Büchold C, Stempka M, Schirmeister T, Gelhaus C, Leippe M, Gut J, Rosenthal PJ, Kisker C, Leyh M, Schmuck C	On-bead screening of a combinatorial fumaric acid derived peptide library yields antiplasmodial cysteine protease inhibitors with unusual peptide sequences	
DRAMP39142	VAXNXGGF	8	Peptide no. 14	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.19715342]protozoon:P. falciparum(IC50=75±9 μM)	not found	Linear	Free	Free	X1=Chg,cyclohexylglycine;X2=Fum,fumaric acid	L	not found	falcipain-3,rhodesain	19715342	J Med Chem. 2009 Sep 24;52(18):5662-72	Machon U, Büchold C, Stempka M, Schirmeister T, Gelhaus C, Leippe M, Gut J, Rosenthal PJ, Kisker C, Leyh M, Schmuck C	On-bead screening of a combinatorial fumaric acid derived peptide library yields antiplasmodial cysteine protease inhibitors with unusual peptide sequences	
DRAMP39143	VVXNXGGF	8	Peptide no. 15	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.19715342]protozoon:P. falciparum(IC50=32±7 μM)	not found	Linear	Free	Free	X1=Chg,cyclohexylglycine;X2=Fum,fumaric acid	L	not found	falcipain-4,rhodesain	19715342	J Med Chem. 2009 Sep 24;52(18):5662-72	Machon U, Büchold C, Stempka M, Schirmeister T, Gelhaus C, Leippe M, Gut J, Rosenthal PJ, Kisker C, Leyh M, Schmuck C	On-bead screening of a combinatorial fumaric acid derived peptide library yields antiplasmodial cysteine protease inhibitors with unusual peptide sequences	
DRAMP39144	VVXQXGGF	8	Peptide no. 16	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.19715342]protozoon:P. falciparum(IC50=27±10 μM)	not found	Linear	Free	Free	X1=Chg,cyclohexylglycine;X2=Fum,fumaric acid	L	not found	falcipain-2,rhodesain	19715342	J Med Chem. 2009 Sep 24;52(18):5662-72	Machon U, Büchold C, Stempka M, Schirmeister T, Gelhaus C, Leippe M, Gut J, Rosenthal PJ, Kisker C, Leyh M, Schmuck C	On-bead screening of a combinatorial fumaric acid derived peptide library yields antiplasmodial cysteine protease inhibitors with unusual peptide sequences	
DRAMP39145	VVXXXGGF	8	Peptide no. 17	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.19715342]protozoon:P. falciparum(IC50=22±4 μM)	not found	Linear	Free	Free	X1=Chg,cyclohexylglycine;X2=C1-NHAc, acetylaminoalanine;X3=Fum,fumaric acid	L	not found	falcipain-3,rhodesain	19715342	J Med Chem. 2009 Sep 24;52(18):5662-72	Machon U, Büchold C, Stempka M, Schirmeister T, Gelhaus C, Leippe M, Gut J, Rosenthal PJ, Kisker C, Leyh M, Schmuck C	On-bead screening of a combinatorial fumaric acid derived peptide library yields antiplasmodial cysteine protease inhibitors with unusual peptide sequences	
DRAMP39146	rrwIrVAViLRV	12	RI-1018	not found	not found	not found	synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.26883699]protozoon: L. pifanoi amastigotes(IC50=6.0±0.8 µM;LC50=6.4±1.2 µM)##Gram-negative bacteria:A. baumannii(MIC50=1.3±0.1 µM)##Gram-positive bacteria:S. aureus(MIC50=3.4±0.1 µM)	not found	Linear	Free	Amidation		D	[Ref.26883699]no toxicity to THP-1 macrophages at 20 μM	membrane	26883699	Antimicrob Agents Chemother. 2016 Mar 25;60(4):2484-91	Marr AK, Cen S, Hancock RE, McMaster WR	Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity	
DRAMP39147	XV	2	2-(2-tert-Butoxycarbonylamino-3-methylbutyrylamino)-cyclopentanecarboxylic acid methyl ester (3.3)	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.18305429]protozoon:Plasmodium falciparum CS(IC50=12.14μM,IC90=13.52μM,IC99=36.89μM)Plasmodium falciparum CR(IC50=14.52μM,IC90=17.14μM,IC99=39.87μM）	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	tert-butoxycarbonylation,Cyclization (N termini to C termini)	methyl esterification,Cyclization (C termini to N termini)	"X=3-aminocyclopentanecarboxylic acid;
The N-terminal amino acid itself contains a cycloalkane skeleton"	L	Not found	plasma membrane	18305429	Molecules. 2008 Feb 18;13(2):432-43.	Sathe M, Thavaselvam D, Srivastava AK, Kaushik MP.	Synthesis and antimalarial evaluation of cyclic beta-amino acid-containing dipeptides.	
DRAMP39148	XV	2	2-(2-tert-Butoxycarbonylaminopropionylamino)-cyclooctanecarboxylic acid methyl ester (4.2)	Not found	Not found	Not found	synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.18305429]protozoon:Plasmodium falciparum CS(IC50=9.17μM,IC90=7.21μM,IC99=7.98μM)Plasmodium falciparum CR(IC50=8.14μM,IC90=8.31μM,IC99=8.47μM）	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	tert-butoxycarbonylation,Cyclization (N termini to C termini)	methyl esterification,Cyclization (C termini to N termini)	"X=2-aminocyclooctanecarboxylic acid;
The N-terminal amino acid itself contains a cycloalkane skeleton"	L	Not found	plasma membrane	18305429	Molecules. 2008 Feb 18;13(2):432-43.	Sathe M, Thavaselvam D, Srivastava AK, Kaushik MP.	Synthesis and antimalarial evaluation of cyclic beta-amino acid-containing dipeptides.	
DRAMP39149	HRKKHHGKRNSNRAHQGKHETYGHKTPY	28	CCL28	Q9NRJ3(100-127)	Belongs to the intercrine beta (chemokine CC) family.	Not found	Homo sapiens (Human)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.23533582]protozoon:Leishmania promastigotes(90% inhibition at 9µM)	[Ref.23533582]No haemolysis was caused by CCL28 at concentrations of 10–20 μM	Linear	Free	Free	Not found	L	Not found	mitochondria,plasma membrane	23533582	PLoS One. 2013;8(3):e58129.	Söbirk SK, Mörgelin M, Egesten A, Bates P, Shannon O, Collin M.	Human chemokines as antimicrobial peptides with direct parasiticidal effect on Leishmania mexicana in vitro.	
DRAMP39150	TPVVRKGRCSCISTNQGTIHLQSLKDLKQFAPSPSCEKIEIIATLKNGVQTCLNPDSADVKELIKKWEKQVSQKKKQKNGKKHQKKKVLKVRKSQRSRQKKTT	103	CCL9	Q07325(23-125)	Belongs to the intercrine alpha (chemokine CxC) family.	CXCL9	Homo sapiens (Human)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.23533582]protozoon:Leishmania promastigotes(90% inhibition at 11µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	mitochondria,plasma membrane	23533582	PLoS One. 2013;8(3):e58129.	Söbirk SK, Mörgelin M, Egesten A, Bates P, Shannon O, Collin M.	Human chemokines as antimicrobial peptides with direct parasiticidal effect on Leishmania mexicana in vitro.	
DRAMP39151	XFXFXF	6	Beauvericin	not found	not found	not found	Paecilomyces tenuipes BCC 1614	Antimicrobial, Antiprotozoal	not found			not found		[Ref.19299148]protozoon:P. falciparum K1(EC₅₀ = 1.60 μg/mL)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	X=NAL=(3-[1-naphthyl]alanine) at 4th	L	No cytotoxicity information found	not found	19299148	Bioorg Med Chem. 2009 May 1;17(9):3229-56.	Kaur K, Jain M, Kaur T, Jain R.	Antimalarials from nature.	
DRAMP39152	XFXFXF	6	Beauvericin A	not found	not found	not found	Paecilomyces tenuipes BCC 1614	Antimicrobial, Antiprotozoal	not found			not found		[Ref.19299148]protozoon:P. falciparum K1 (EC₅₀ = 12.0 μg/mL)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	X=D-Hiv-N-Me	L	No cytotoxicity information found	not found	19299148	Bioorg Med Chem. 2009 May 1;17(9):3229-56.	Kaur K, Jain M, Kaur T, Jain R.	Antimalarials from nature.	
DRAMP39153	NPPDHSAPLGATRPSAPPLPHVVDLPQLGP	30	E30	not found	not found	not found	Hepatitis E virus ORF3	Antimicrobial, Antiprotozoal	not found			not found		[Ref.22853877]protozoon:Plasmodium falciparum 3D7 (IC₅₀>40 μM)	[Ref.22853877]Uninfected red blood cells (HC₅₀>40 μM)	Linear	Free	Free		L	No cytotoxicity information found	not found	22853877	Malar J. 2012 Aug 1;11:256.	Kaushik NK, Sharma J, Sahal D	Anti-plasmodial action of de novo-designed, cationic, lysine-branched, amphipathic, helical peptides.	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)[C@@H](C)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)O
DRAMP39154	EEPHKAASAEGKK	13	Prochitinase	not found	not found	not found	Hepatitis E virus ORF3	Antimicrobial, Antiprotozoal	not found			not found		[Ref.22853877]protozoon:Plasmodium falciparum 3D7 (IC₅₀>40 μM)	[Ref.22853877]Uninfected red blood cells (HC₅₀>40 μM);	Linear	Free	Free		L	No cytotoxicity information found	not found	22853877	Malar J. 2012 Aug 1;11:256.	Kaushik NK, Sharma J, Sahal D	Anti-plasmodial action of de novo-designed, cationic, lysine-branched, amphipathic, helical peptides.	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CC[C@H](NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(=O)O
DRAMP39155	GXRKXHKXFWAGXRKXHKXFWAK(NH2)K(NH2)(Ac-GFRKFHKFWA)2K, ΔF=Didehydrophenylalanine	43	ΔFq	not found	not found	not found	Synthetic	Antimicrobial, Antiprotozoal	not found			not found	"1. Most potent anti-plasmodial peptide in the series (IC₅₀=0.25 μM) but low selectivity index=10 (HC₅₀=2.5±0.13 μM).
2. High purity (>95%) after RP-HPLC; potentiation due to increased valency (tetramer vs dimer/monomer)"	[Ref.22853877]protozoon:Plasmodium falciparum 3D7 (IC₅₀=0.25±0.02 μM)	[Ref.22853877]Uninfected red blood cells (HC₅₀=2.5±0.13 μM)	Branched	Acetylation	Amidation	X=Didehydrophenylalanine,K-K-K₂ dendrimeric tetramerization	L	No cytotoxicity information found	not found	22853877	Malar J. 2012 Aug 1;11:256.	Kaushik NK, Sharma J, Sahal D	Anti-plasmodial action of de novo-designed, cationic, lysine-branched, amphipathic, helical peptides. 	
DRAMP39156	GXRKXHKXWAAGXRKXHKXWA	21	(ΔFm)2	not found	not found	not found	Synthetic	Antimicrobial, Antiprotozoal	not found			not found	 Selectivity index>20 (HC₅₀ URBC/IC₅₀ P. falciparum); resistance index=1.04 (effective against CQ-resistant strains).	[Ref.22853877]protozoon:Plasmodium falciparum 3D7 (IC₅₀=2.4±0.15 μM); Plasmodium falciparum Dd2 (IC₅₀=2.5±0.13 μM)	[Ref.22853877]Uninfected red blood cells (HC₅₀>50 μM)	Linear	Acetylation	Amidation	X=Didehydrophenylalanine, linear dimerization via AA spacer	L	No cytotoxicity information found	not found	22853877	Malar J. 2012 Aug 1;11:256.	Kaushik NK, Sharma J, Sahal D	Anti-plasmodial action of de novo-designed, cationic, lysine-branched, amphipathic, helical peptides. 	
DRAMP39157	GFRKFHKFWAGFRKFHKFWAK	21	Fd	not found	not found	not found	Synthetic	Antimicrobial, Antiprotozoal	not found			not found	"1. Selectivity index>33 (HC₅₀ URBC/IC₅₀ P. falciparum); potent against CQ-sensitive P. falciparum.
2. High purity (>95%) after RP-HPLC; less proteolytically stable than ΔFd due to absence of ΔF residues"	[Ref.22853877]protozoon:Plasmodium falciparum 3D7 (IC₅₀=1.5±0.08 μM)	[Ref.22853877]Uninfected red blood cells (HC₅₀>50 μM)	Linear	Acetylation	Amidation	Lysine-branched dimerization	L	No cytotoxicity information found	not found	22853877	Malar J. 2012 Aug 1;11:256.	Kaushik NK, Sharma J, Sahal D	Anti-plasmodial action of de novo-designed, cationic, lysine-branched, amphipathic, helical peptides. 	
DRAMP39158	GXRkXHkXWAGXRkXHkXWA	21	D-Lys-ΔFd	not found	not found	not found	Synthetic	Antimicrobial, Antiprotozoal	not found			not found	"1. Selectivity index>27 (HC₅₀ URBC/IC₅₀ P. falciparum); slightly less potent than ΔFd (IC₅₀=1.8 μM vs 1.39 μM).
2. High purity (>95%) after RP-HPLC; D-lysine modification does not drastically reduce activity"	[Ref.22853877]protozoon:Plasmodium falciparum 3D7 (IC₅₀=1.8 μM)	[Ref.22853877]Uninfected red blood cells (HC₅₀>50 μM)	Branched	Acetylation	Amidation	X=Didehydrophenylalanine,lysine-branched dimerization	Mix	No cytotoxicity information found	not found	22853877	Malar J. 2012 Aug 1;11:256.	Kaushik NK, Sharma J, Sahal D	Anti-plasmodial action of de novo-designed, cationic, lysine-branched, amphipathic, helical peptides. 	
DRAMP39159	GXFRKXHKXWAGXFRKXHKXWAK	21	ΔFd	not found	not found	not found	Synthetic	Antimicrobial, Antiprotozoal	not found			not found	"1. High selectivity index (>35, HC₅₀ URBC/IC₅₀ P. falciparum); resistance index=1.15 (effective against CQ-resistant strains).
2. Fast uptake by PRBCs (faster in trophozoites than rings); non-toxic to HeLa cells (TC₅₀>25 μM)
3. Proteolytically stable due to ΔF residues; selective lysis of trophozoite-harboring RBCs"	[Ref.22853877]protozoon:Plasmodium falciparum 3D7 (IC₅₀=1.39±0.1 μM); Plasmodium falciparum Dd2 (IC₅₀=1.6±0.09 μM); Plasmodium falciparum INDO (IC₅₀=1.5±0.075 μM)	[Ref.22853877]Uninfected red blood cells (HC₅₀>50 μM)	Branched	Acetylation	Amidation	X=Didehydrophenylalanine,lysine-branched dimerization	L	[Ref.22853877]HeLa cells (TC₅₀>25 μM);	not found	22853877	Malar J. 2012 Aug 1;11:256.	Kaushik NK, Sharma J, Sahal D	Anti-plasmodial action of de novo-designed, cationic, lysine-branched, amphipathic, helical peptides. 	
DRAMP39160	GXRKXHKXWA	10	ΔFm	not found	not found	not found	Synthetic	Antimicrobial, Antiprotozoal	not found			not found		[Ref.22853877]protozoon: Plasmodium falciparum 3D7 (IC₅₀>100 μM); Plasmodium falciparum Dd2 (IC₅₀>100 μM)	[Ref.22853877]Uninfected red blood cells (HC₅₀>100 μM)	Linear	Acetylation	Amidation	X=Didehydrophenylalanine	L	No cytotoxicity information found	not found	22853877	Malar J. 2012 Aug 1;11:256.	Kaushik NK, Sharma J, Sahal D	Anti-plasmodial action of de novo-designed, cationic, lysine-branched, amphipathic, helical peptides. 	
DRAMP39161	GFRKFHKFWA	10	Fm	not found	not found	not found	Synthetic	Antimicrobial, Antiprotozoal	not found			not found		[Ref.22853877]protozoon: Plasmodium falciparum 3D7 (IC₅₀>100 μM); Plasmodium falciparum Dd2 (IC₅₀>100 μM)	[Ref.22853877]Uninfected red blood cells (HC₅₀>100 μM)	Linear	Acetylation	Amidation		L	No cytotoxicity information found	not found	22853877	Malar J. 2012 Aug 1;11:256.	Kaushik NK, Sharma J, Sahal D	Anti-plasmodial action of de novo-designed, cationic, lysine-branched, amphipathic, helical peptides. 	CC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(N)=O
DRAMP39162	GIGKFLHSBKKFDKAFVDEIMNS	23	Magainin analog G	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found	α-helix content=35%		not found		[Ref.2285300]protozoon: Blastocystis hominis: No detectable damage at 500 μg/ml (2 h)##Trypanosoma cruzi: Slight damage only at 500 μg/ml; clumps of parasites resistant##Entamoeba histolytica: No apparent effect at 500 μg/ml	not found	Linear	Free	Amidation	3 D-alanine substitutions; 1 β-alanine (B) substitution	mix	No cytotoxicity information found	membrane	2285300	Antimicrob Agents Chemother. 1990 Sep;34(9):1824-6.	Huang CM, Chen HC, Zierdt CH	Magainin analogs effective against pathogenic protozoa.	
DRAMP39163	FF	2	Fluoromethyl ketone proteinase inhibitor	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			not found		[Ref.8450035]protozoon:Plasmodium falciparum (IC₅₀=50 nM)	not found	Linear	Benzyloxycarbonyl (Z) protection	FMKylation		L	No cytotoxicity information found	Plasmodium cysteine proteinase	8450035	 J Clin Invest. 1993 Mar;91(3):1052-6	Rosenthal PJ, Lee GK, Smith RE	Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria	
DRAMP39164	XX	2	Fluoromethyl ketone proteinase inhibitor	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			not found		[Ref.8450035]protozoon:Plasmodium falciparum (IC₅₀=8.5 nM); Plasmodium vinckei (IC₅₀=18 nM)	not found	Linear	Morpholinoureylation	FMKylation	X1=tyrosine methyl ester, TyrOMe;X2=Homophenylalanine,HPhe	L	No cytotoxicity information found	Plasmodium cysteine proteinase	8450035	 J Clin Invest. 1993 Mar;91(3):1052-6	Rosenthal PJ, Lee GK, Smith RE	Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria	
DRAMP39165	FR	2	Fluoromethyl ketone proteinase inhibitor	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			not found		[Ref.8450035]protozoon:Plasmodium falciparum (IC₅₀=0.36 nM); Plasmodium vinckei (IC₅₀=33 nM)	not found	Linear	Benzyloxycarbonyl (Z) protection	FMKylation		L	No cytotoxicity information found	Plasmodium cysteine proteinase	8450035	 J Clin Invest. 1993 Mar;91(3):1052-6	Rosenthal PJ, Lee GK, Smith RE	Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria	
DRAMP39166	fR	2	Fluoromethyl ketone proteinase inhibitor	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			not found		[Ref.8450035]protozoon:Plasmodium falciparum (IC₅₀=14 nM); Plasmodium vinckei (IC₅₀=110 nM)	not found	Linear	Benzyloxycarbonyl (Z) protection	FMKylation	f=D-Phe	Mix	No cytotoxicity information found	Plasmodium cysteine proteinase	8450035	 J Clin Invest. 1993 Mar;91(3):1052-6	Rosenthal PJ, Lee GK, Smith RE	Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria	
DRAMP39167	FA	2	Fluoromethyl ketone proteinase inhibitor	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.8450035]protozoon:Plasmodium falciparum (IC₅₀=28 nM); Plasmodium vinckei (IC₅₀=90 nM)	not found	Linear	Benzyloxycarbonyl (Z) protection	FMKylation		L	No cytotoxicity information found	Plasmodium cysteine proteinase	8450035	 J Clin Invest. 1993 Mar;91(3):1052-6	Rosenthal PJ, Lee GK, Smith RE	Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria	
DRAMP39168	fA	2	Fluoromethyl ketone proteinase inhibitor	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.8450035]protozoon:Plasmodium falciparum (IC₅₀=1300 nM); Plasmodium vinckei (IC₅₀=2200 nM)	not found	Linear	Benzyloxycarbonyl (Z) protection	FMKylation	f=D-Phe	Mix	No cytotoxicity information found	Plasmodium cysteine proteinase	8450035	 J Clin Invest. 1993 Mar;91(3):1052-6	Rosenthal PJ, Lee GK, Smith RE	Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria	
DRAMP39169	GAHHAADGC	9	HRP IIA	not found	not found	not found	Synthetic	Antimicrobial, Antiprotozoal	not found			not found		[Ref.9497049]protozoon:Plasmodium yoelii(20-30% inhibition of haem polymerization activity at 100 µM)	not found	Linear	Free	Free		L	No cytotoxicity information found	not found	9497049	Mol Biochem Parasitol. 1997 Dec 1;90(1):281-7	Pandey AV, Joshi R, Tekwani BL, Singh RL, Chauhan VS	Synthetic peptides corresponding to a repetitive sequence of malarial histidine rich protein bind haem and inhibit haemozoin formation in vitro.	
DRAMP39170	CGAHHAADAHHAADGC	16	HRP IIB	not found	not found	not found	Synthetic	Antimicrobial, Antiprotozoal	not found			not found		[Ref.9497049]protozoon:Plasmodium yoelii(40-50% inhibition of haem polymerization activity at 100 µM)	not found	Linear	Free	Free		L	No cytotoxicity information found	not found	9497049	Mol Biochem Parasitol. 1997 Dec 1;90(1):281-7	Pandey AV, Joshi R, Tekwani BL, Singh RL, Chauhan VS	Synthetic peptides corresponding to a repetitive sequence of malarial histidine rich protein bind haem and inhibit haemozoin formation in vitro.	
DRAMP39171	CGAHHAADAHHAADAHHAADGC	22	HRP IIC	not found	not found	not found	Synthetic	Antimicrobial, Antiprotozoal	not found			not found		[Ref.9497049]protozoon:Plasmodium yoelii(40-50% inhibition of haem polymerization activity at 100 µM)	not found	Linear	Free	Free		L	No cytotoxicity information found	not found	9497049	Mol Biochem Parasitol. 1997 Dec 1;90(1):281-7	Pandey AV, Joshi R, Tekwani BL, Singh RL, Chauhan VS	Synthetic peptides corresponding to a repetitive sequence of malarial histidine rich protein bind haem and inhibit haemozoin formation in vitro.	
DRAMP39172	FXXXXGLXXXQXXXPF	16	Antiamoebin I	not found	not found	not found	Emericellopsis poonensis	Antimicrobial, Antiprotozoal	not found			not found		[Ref.11120957]protozoon:Plasmodium falciparum T9/106（IC₅₀=6.16±0.03 μM via [³H]hypoxanthine incorporation; IC₅₀=4.72±0.09 μM via smear analysis)	not found	Linear	Acetylation	Free	X2、X3、X4、X9、X10、X15=Aib, α-aminoisobutyric acid；X5、X13=Iva, Isovaline；X11、X14=Hyp, hydroxy proline	L	No cytotoxicity information found	membrane	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9	Nagaraj G, Uma MV, Shivayogi MS, Balaram H	Antimalarial activities of peptide antibiotics isolated from fungi	
DRAMP39173	XXXXXLXGXXXXGLX	15	Efrapeptin C	not found	not found	not found	Tolypocladium niveum	Antimicrobial, Antiprotozoal	not found			not found		[Ref.11120957]protozoon: Plasmodium falciparum T9/106（IC₅₀=1.37±0.06 μM via [³H]hypoxanthine incorporation; IC₅₀=1.21±0.05 μM via smear analysis)	not found	Linear	Acetylation	Condensation product of  L-leucinol and 1,5-diazabicyclo[4:3:0]nonene (DBN).	X1、X3、X11=Pip, pipecolic acid；X2、X4、X5、X9、X10、X12、X15=Aib, α-aminoisobutyric acid；X7=β-Ala, β-alanine；	L	No cytotoxicity information found	membrane	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9	Nagaraj G, Uma MV, Shivayogi MS, Balaram H	Antimalarial activities of peptide antibiotics isolated from fungi	
DRAMP39174	XXXXXLXGXXXXGLX	15	Efrapeptin D	not found	not found	not found	Tolypocladium niveum	Antimicrobial, Antiprotozoal	not found			not found		[Ref.11120957]protozoon: Plasmodium falciparum T9/106（IC₅₀=1.37±0.06 μM via [³H]hypoxanthine incorporation; IC₅₀=1.21±0.05 μM via smear analysis)	not found	Linear	Acetylation	Condensation product of  L-leucinol and 1,5-diazabicyclo[4:3:0]nonene (DBN).	X1、X3、X11=Pip, pipecolic acid；X2、X4、X5、X9、X10、X12=Aib, α-aminoisobutyric acid；X7=β-Ala, β-alanine；X15=Iva,isovaline	L	No cytotoxicity information found	membrane	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9	Nagaraj G, Uma MV, Shivayogi MS, Balaram H	Antimalarial activities of peptide antibiotics isolated from fungi	
DRAMP39175	XXXXXLXGXXXXGLX	15	Efrapeptin E	not found	not found	not found	Tolypocladium niveum	Antimicrobial, Antiprotozoal	not found			not found		[Ref.11120957]protozoon: Plasmodium falciparum T9/106（IC₅₀=1.37±0.06 μM via [³H]hypoxanthine incorporation; IC₅₀=1.21±0.05 μM via smear analysis)	not found	Linear	Acetylation	Condensation product of  L-leucinol and 1,5-diazabicyclo[4:3:0]nonene (DBN).	X1、X3、X11=Pip, pipecolic acid；X2、X5、X9、X10、X12=Aib, α-aminoisobutyric acid；X4、X15=Iva,isovaline；X7=β-Ala, β-alanine	L	No cytotoxicity information found	membrane	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9	Nagaraj G, Uma MV, Shivayogi MS, Balaram H	Antimalarial activities of peptide antibiotics isolated from fungi	
DRAMP39176	XXXXXLXGXXXXALX	15	Efrapeptin F	not found	not found	not found	Tolypocladium niveum	Antimicrobial, Antiprotozoal	not found			not found		[Ref.11120957]protozoon: Plasmodium falciparum T9/106（IC₅₀=1.37±0.06 μM via [³H]hypoxanthine incorporation; IC₅₀=1.21±0.05 μM via smear analysis)	not found	Linear	Acetylation	Condensation product of  L-leucinol and 1,5-diazabicyclo[4:3:0]nonene (DBN).	X1、X3、X11=Pip, pipecolic acid；X2、X4、X5、X9、X10、X12=Aib, α-aminoisobutyric acid；X7=β-Ala, β-alanine；X15=Iva,isovaline	L	No cytotoxicity information found	membrane	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9	Nagaraj G, Uma MV, Shivayogi MS, Balaram H	Antimalarial activities of peptide antibiotics isolated from fungi	
DRAMP39177	XXXXXLXGXXXXALX	15	Efrapeptin G	not found	not found	not found	Tolypocladium niveum	Antimicrobial, Antiprotozoal	not found			not found		[Ref.11120957]protozoon: Plasmodium falciparum T9/106（IC₅₀=1.37±0.06 μM via [³H]hypoxanthine incorporation; IC₅₀=1.21±0.05 μM via smear analysis)	not found	Linear	Acetylation	Condensation product of  L-leucinol and 1,5-diazabicyclo[4:3:0]nonene (DBN).	X1、X3、X11=Pip, pipecolic acid；X2、X5、X9、X10、X12=Aib, α-aminoisobutyric acid；X7=β-Ala, β-alanine；X4、X15=Iva,isovaline	L	No cytotoxicity information found	membrane	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9	Nagaraj G, Uma MV, Shivayogi MS, Balaram H	Antimalarial activities of peptide antibiotics isolated from fungi	
DRAMP39178	LY	2	Compound 9035	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=4 nM; recombinant IC₅₀=9.3 nM); Falcipain-3 (recombinant IC₅₀=15.4 nM); Vinckepain-2 (recombinant IC₅₀=91.9 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=40 nM, IC₉₀=600 nM)	not found	Linear	Cbzylation	Aldehydration		L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39179	FY	2	Compound 9036	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=16 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=70 nM, IC₉₀>1000 nM)	not found	Linear	Cbzylation	Aldehydration		L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39180	L-hPhe	2	Compound 9037	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=2 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=30 nM, IC₉₀=500 nM); multiple strains (W2: IC₅₀=8.2 nM; ItG: 19 nM; D6:12 nM; Dd2:19 nM; HB3:16 nM)	not found	Linear	Cbzylation	Aldehydration	HPhe=homophenylalanine	L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39181	WIQXITXLXXQXXXPF	16	Zervamicin IIA	not found	not found	not found	Emericellopsis salmosynnemata	Antimicrobial,Antiprotozoal	not found			not found		[Ref.11120957]protozoon: Plasmodium falciparum T9/106（IC₅₀=0.48±0.05 μM via [³H]hypoxanthine incorporation; IC₅₀=0.45±0.05 μM via smear analysis)	not found	Linear	Acetylation	Free	X4、X7、X9、X12、X14= Aib, α-aminoisobutyric acid；X10、X13=Hyp, hydroxy proline	L	No cytotoxicity information found	membrane	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9	Nagaraj G, Uma MV, Shivayogi MS, Balaram H	Antimalarial activities of peptide antibiotics isolated from fungi	
DRAMP39182	F-hPhe	2	Compound 9038	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=20 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=300 nM, IC₉₀>1000 nM)	not found	Linear	Cbzylation	Aldehydration	HPhe=homophenylalanine	L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39183	L-hPhe	2	Compound 9039	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=6 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=100 nM, IC₉₀=700 nM)	not found	Linear	phenylsulfonyl (PhSO₂) protection	Aldehydration	HPhe=homophenylalanine	L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39184	F-hPhe	2	Compound 9040	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=31 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=400 nM, IC₉₀>1000 nM)	not found	Linear	phenylsulfonyl (PhSO₂) protection	Aldehydration	HPhe=homophenylalanine	L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39185	LY	2	Compound 9042	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=9 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=30 nM, IC₉₀=400 nM)	not found	Linear	phenylsulfonyl (PhSO₂) protection	Aldehydration		L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39186	FY	2	Compound 9043	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=91 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=700 nM, IC₉₀>1000 nM)	not found	Linear	phenylsulfonyl (PhSO₂) protection	Aldehydration		L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39187	L-hPhe-(CO)-F	3	Compound 9045	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=1 nM; recombinant IC₅₀=1.3 nM); Falcipain-3 (recombinant IC₅₀=2.4 nM); Vinckepain-2 (recombinant IC₅₀=12.5 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=10 nM, IC₉₀=70 nM); multiple strains (W2: IC₅₀=2.9 nM; ItG:5.3 nM; D6:2.5 nM; Dd2:2.4 nM; HB3:3.1 nM)	not found	Linear	Morpholinocarbonylation	Amidation	α-ketoamide (CO) groupbetween hPhe and F	L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39188	LY	2	Compound 9046	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=3 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=4 nM, IC₉₀=400 nM)	not found	Linear	Morpholinocarbonylation	Aldehydration		L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39189	FY	2	Compound 9047	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=33 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=100 nM, IC₉₀=1000 nM)	not found	Linear	Morpholinocarbonylation	Aldehydration		L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39190	L-hPhe	2	Compound 9050	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=1 nM; recombinant IC₅₀=3.0 nM); Falcipain-3 (recombinant IC₅₀=3.6 nM); Vinckepain-2 (recombinant IC₅₀=42.1 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=10 nM, IC₉₀=70 nM); multiple strains (W2: IC₅₀=1.1 nM; ItG:0.96 nM; D6:1.4 nM; Dd2:1.9 nM; HB3:2.6 nM)	not found	Linear	Morpholinocarbonylation	Aldehydration	HPhe=homophenylalanine	L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39191	F-hPhe	2	Compound 9051	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Cysteine protease inhibition: Falcipain-2 (native IC₅₀=9 nM; recombinant IC₅₀=50.9 nM); Falcipain-3 (recombinant IC₅₀=67.8 nM); Vinckepain-2 (recombinant IC₅₀>1000 nM)	[Ref.14638488]protozoon:Plasmodium falciparum (W2 strain) (IC₅₀=10 nM, IC₉₀=500 nM)	not found	Linear	Morpholinocarbonylation	Aldehydration	HPhe=homophenylalanine	L	No cytotoxicity information found	not found	14638488	Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4	Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ	Antimalarial activities of novel synthetic cysteine protease inhibitors	
DRAMP39192	WIQXITXLXXQXXXPF	16	Zervamicin IIB	not found	not found	not found	Emericellopsis salmosynnemata	Antimicrobial,Antiprotozoal	Not found			not found		[Ref.11120957]protozoon: Plasmodium falciparum T9/106（IC₅₀=0.48±0.05 μM via [³H]hypoxanthine incorporation; IC₅₀=0.45±0.05 μM via smear analysis)	not found	Linear	Acetylation 	Free	X4=Iva, Isovaline；X7、X9、X12、X14= Aib, α-aminoisobutyric acid；X10、X13=Hyp, hydroxy proline	L	No cytotoxicity information found	membrane	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9	Nagaraj G, Uma MV, Shivayogi MS, Balaram H	Antimalarial activities of peptide antibiotics isolated from fungi	
DRAMP39193	ILPFKFPFFPFRR	13	ILF	not found	not found	not found	Synthetic	Antimicrobial, Antiprotozoal	not found			not found		[Ref.12069961]protozoon: Plasmodium bergheisporogonic stages (>80% mortality at 6, 10, and 14 h time point tested),Plasmodium yoelii nigeriensis (in vitro 80% mortality at most time points)	not found	Linear	Free	Free		L	No cytotoxicity information found	membrane	12069961	Antimicrob Agents Chemother. 2002 Jul;46(7):2104-10	Arrighi RB, Nakamura C, Miyake J, Hurd H, Burgess JG	Design and activity of antimicrobial peptides against sporogonic-stage parasites causing murine malarias	CC[C@@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP39194	wmXfX	5	FTase inhibitor IV	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.12194969]protozoon:P. falciparum(IC50= 5000nM)	[Ref.12194969]<0.1% hemolysis at 100 μM (human RBCs, 1 h incubation)	Linear	Free	Free	X1=p‑chloro‑phenylalanine;X2=Gla=Carboxyglutamic acid	L	No cytotoxicity information found	membrane	12194969	J Biol Chem. 2002 Nov 1;277(44):42066-73	Chakrabarti D, Da Silva T, Barger J, Paquette S, Patel H, Patterson S, Allen CM	Protein farnesyltransferase and protein prenylation in Plasmodium falciparum	
DRAMP39195	KK	2	OAK 7	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Selectivity: RBC LC₅₀/antiplasmodial IC₅₀ ratio=7714; MDCK IC₅₀/antiplasmodial IC₅₀ ratio>32	[Ref.17307975]protozoon:Plasmodium falciparum strain W2（IC₅₀=4.63 μM）	[Ref.17307975]0.14±0.3% hemolysis at 100 μM (human RBCs, 1 h incubation)	Linear	Aminolauryl (al) group acylation	Free	Lysine 2 N-terminus lauryl acylation	L	[Ref.17307975]IC₅₀>150 μM targeting on MDCK cells	membrane	17307975	Antimicrob Agents Chemother. 2007 May;51(5):1753-9	Radzishevsky I, Krugliak M, Ginsburg H, Mor A	Antiplasmodial activity of lauryl-lysine oligomers	
DRAMP39196	KK	2	OAK 8	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Selectivity: RBC LC₅₀/antiplasmodial IC₅₀ ratio=288; MDCK IC₅₀/antiplasmodial IC₅₀ ratio>28	[Ref.17307975]protozoon:Plasmodium falciparum strain W2（IC₅₀=3.54 μM）	[Ref.17307975]4.9±1.7% hemolysis at 100 μM (human RBCs, 1 h incubation)	Linear	Lauryl (l) group acylation	Free	Each Lysine N-terminus lauryl acylation	L	[Ref.17307975]IC₅₀>100 μM targeting on MDCK cells	membrane	17307975	Antimicrob Agents Chemother. 2007 May;51(5):1753-9	Radzishevsky I, Krugliak M, Ginsburg H, Mor A	Antiplasmodial activity of lauryl-lysine oligomers	
DRAMP39197	KK	2	OAK 9	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Selectivity: RBC LC₅₀/antiplasmodial IC₅₀ ratio>700; MDCK IC₅₀/antiplasmodial IC₅₀ ratio>12	[Ref.17307975]protozoon:Plasmodium falciparum strain W2（IC₅₀=68.2 μM）	[Ref.17307975]<0.1% hemolysis at 100 μM (human RBCs, 1 h incubation)	Linear	Free	Free	Lysine 2 N-terminus aminolauryl acylation	L	[Ref.17307975]IC₅₀>800 μM targeting on MDCK cells	membrane	17307975	Antimicrob Agents Chemother. 2007 May;51(5):1753-9	Radzishevsky I, Krugliak M, Ginsburg H, Mor A	Antiplasmodial activity of lauryl-lysine oligomers	
DRAMP39198	a-MeLeu-MeLeu-MeVal-MeBmt-Abu-Sar-MeLeu-Val-MeLeu-Ala	11	Cyclosporin-A	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Immunosuppressive activity: In vitro PFC (1 μg: 64.54% suppression; 5 μg: 80.60% suppression); In vivo PFC (10 μg: 22.90% suppression; 100 μg: 60.46% suppression); DTH (10 μg: 28.00% suppression; 100 μg: 38.96% suppression)	[Ref.11293244]protozoon:Plasmodium falciparum FCH5.C2 (72 h IC₅₀=0.2 μg/ml)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Sar = sarcosine, Bmt = (4R)-4-[(E)-2-butenyl]-4-methyl-L-threonine	L	No cytotoxicity information found	membrane	11293244	Acta Pol Pharm. 2000 Nov;57 Suppl:134-6.	Bell A, McSteen PM, Cebrat M, Picur B, Siemion IZ	Antimalarial activity of cyclolinopeptide A and its analogues	
DRAMP39199	XXX	3	Carmabin A	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.17441769]protozoon:Plasmodium falciparum W2 strain (chloroquine-resistant, IC₅₀=4.3 μM)	not found	Linear	Free	Amidation	X1=N-(2,4-Dimethyl-9-decynoyl)；X2=N,O-dimethyl-L-tyrosine，X3=N-methyl-L-phenylalanine	L	[Ref.17441769]Vero cells IC₅₀=9.8 μM targeting on Vero cells	membrane	17441769	J Nat Prod. 2007 Jun;70(6):984-8	McPhail KL, Correa J, Linington RG, Gonzalez J, Ortega-Barría E, Capson TL, Gerwick WH	Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula	
DRAMP39200	LIILVPPFF	9	Cyclolinopeptide A (CLA)	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Immunosuppressive activity: In vitro PFC (1 μg: 88.0% suppression; 5 μg: 91.1% suppression); In vivo PFC (10 μg: 46.03% suppression; 100 μg: 85.62% suppression); DTH (10 μg: 63.64% suppression; 100 μg: 51.55% suppression)	[Ref.11293244]protozoon:Plasmodium falciparum FCH5.C2 (72 h IC₅₀=0.8 μg/ml; 48 h IC₅₀=4 μM)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)		L	No cytotoxicity information found	membrane	11293244	Acta Pol Pharm. 2000 Nov;57 Suppl:134-6.	Bell A, McSteen PM, Cebrat M, Picur B, Siemion IZ	Antimalarial activity of cyclolinopeptide A and its analogues	
DRAMP39201	LIILVPPfF	9	[D-Phe⁸]CLA	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Immunosuppressive activity: In vitro PFC (1 μg: 32.31% suppression; 5 μg: 22.57% suppression); In vivo PFC (10 μg: 43.00% suppression; 100 μg: 44.35% suppression); DTH (10 μg: 22.83% suppression; 100 μg: 46.46% suppression)	[Ref.11293244]protozoon:Plasmodium falciparum FCH5.C2 (72 h IC₅₀=3.0 μg/ml)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Phe⁸ → D-Phe substitution	L	No cytotoxicity information found	membrane	11293244	Acta Pol Pharm. 2000 Nov;57 Suppl:134-6.	Bell A, McSteen PM, Cebrat M, Picur B, Siemion IZ	Antimalarial activity of cyclolinopeptide A and its analogues	
DRAMP39202	LIILVPPFf	9	[D-Phe⁹]CLA	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Immunosuppressive activity: In vitro PFC (1 μg: 29.08% suppression; 5 μg: 75.78% suppression); In vivo PFC (10 μg: 77.38% suppression; 100 μg: 71.09% suppression); DTH (10 μg: 11.00% suppression; 100 μg: 25.00% suppression)	[Ref.11293244]protozoon:Plasmodium falciparum FCH5.C2 (72 h IC₅₀=1.9 μg/ml)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Phe⁹ → D-Phe substitution	Mix	No cytotoxicity information found	membrane	11293244	Acta Pol Pharm. 2000 Nov;57 Suppl:134-6.	Bell A, McSteen PM, Cebrat M, Picur B, Siemion IZ	Antimalarial activity of cyclolinopeptide A and its analogues	
DRAMP39203	LIILVPPFy	9	[D-Tyr⁹]CLA	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Immunosuppressive activity: In vitro PFC (1 μg: 9.04% suppression; 5 μg: 9.15% suppression); In vivo PFC (10 μg: 7.75% suppression; 100 μg: 8.22% suppression); DTH (10 μg: 19.17% suppression; 100 μg: 11.67% suppression)	[Ref.11293244]protozoon:Plasmodium falciparum FCH5.C2 (72 h IC₅₀=3.4 μg/ml)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Phe⁹ → D-Tyr substitution	Mix	No cytotoxicity information found	membrane	11293244	Acta Pol Pharm. 2000 Nov;57 Suppl:134-6.	Bell A, McSteen PM, Cebrat M, Picur B, Siemion IZ	Antimalarial activity of cyclolinopeptide A and its analogues	
DRAMP39204	LIILVPPwF	9	[D-Trp⁸]CLA	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Immunosuppressive activity: In vitro PFC (1 μg: 7.49% suppression; 5 μg: 9.58% suppression); In vivo PFC (10 μg: 21.83% suppression; 100 μg: 29.34% suppression); DTH (10 μg: 17.50% suppression; 100 μg: 6.67% suppression)	[Ref.11293244]protozoon:Plasmodium falciparum FCH5.C2 (72 h IC₅₀=1.1 μg/ml)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Phe⁸ → D-Trp substitution	Mix	No cytotoxicity information found	Not found	11293244	Acta Pol Pharm. 2000 Nov;57 Suppl:134-6.	Bell A, McSteen PM, Cebrat M, Picur B, Siemion IZ	Antimalarial activity of cyclolinopeptide A and its analogues	
DRAMP39205	LIIFVPPFF	9	Phe(p-SO₃Na)⁹]LA	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Immunosuppressive activity: In vitro PFC（1 μg: 27.2% suppression）；In vivo PFC（10 μg: 18.2% suppression；100 μg: 53.1% suppression）；DTH（10 μg: 69.8% suppression；100 μg: 69.0% suppression）；	[Ref.11293244]protozoon:Plasmodium falciparum FCH5.C2 (72 h IC₅₀>5 μg/ml)	not found	Linear	free	free	P-SO3Na, at 4th position of Phe	L	No cytotoxicity information found	Not found	11293244	Acta Pol Pharm. 2000 Nov;57 Suppl:134-6.	Bell A, McSteen PM, Cebrat M, Picur B, Siemion IZ	Antimalarial activity of cyclolinopeptide A and its analogues	
DRAMP39206	LIIFVPPFF	9	[Phe(SO₃Na)⁹]CLA	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Immunosuppressive activity: In vitro PFC (1 μg: 55.8% suppression); In vivo PFC (10 μg: 26.4% suppression; 100 μg: 61.8% suppression); DTH (10 μg: 31.0% suppression; 100 μg: 51.0% suppression)	[Ref.11293244]protozoon:Plasmodium falciparum FCH5.C2 (72 h IC₅₀>16 μg/ml)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Phe⁹ → Phe(SO₃Na) (hydrophilic substitution)	L	No cytotoxicity information found	Not found	11293244	Acta Pol Pharm. 2000 Nov;57 Suppl:134-6.	Bell A, McSteen PM, Cebrat M, Picur B, Siemion IZ	Antimalarial activity of cyclolinopeptide A and its analogues	
DRAMP39207	LIILVPPAY	9	[Ala⁸,Tyr⁹]CLA	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Immunosuppressive activity: In vitro PFC (1 μg: 56% suppression; 5 μg: 31% suppression); In vivo PFC (100 μg: 42% suppression); DTH (10 μg: 90% suppression; 100 μg: 58% suppression)	[Ref.11293244]protozoon:Plasmodium falciparum FCH5.C2 (72 h IC₅₀=16 μg/ml)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Phe⁸→Ala and Phe⁹→Tyr substitutions	L	No cytotoxicity information found	Not found	11293244	Acta Pol Pharm. 2000 Nov;57 Suppl:134-6.	Bell A, McSteen PM, Cebrat M, Picur B, Siemion IZ	Antimalarial activity of cyclolinopeptide A and its analogues	
DRAMP39208	LIILVPAFF	9	[Ala⁷]CLA	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.11293244]protozoon:Plasmodium falciparum FCH5.C2 (72 h IC₅₀=8 μg/ml)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Pro⁷→Ala substitution	L	No cytotoxicity information found	Not found	11293244	Acta Pol Pharm. 2000 Nov;57 Suppl:134-6.	Bell A, McSteen PM, Cebrat M, Picur B, Siemion IZ	Antimalarial activity of cyclolinopeptide A and its analogues	
DRAMP39209	AIILVPAFF	9	[Ala¹,⁷]CLA	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found	Immunosuppressive activity: In vitro PFC (1 μg: 0% suppression; 5 μg: 65% suppression); In vivo PFC (10 μg: 44% suppression; 100 μg: 62% suppression); DTH (10 μg: 31% suppression; 100 μg: 56% suppression)	[Ref.11293244]protozoon:Plasmodium falciparum FCH5.C2 (72 h IC₅₀=16 μg/ml)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Leu¹→Ala and Pro⁷→Ala double substitution	L	No cytotoxicity information found	Not found	11293244	Acta Pol Pharm. 2000 Nov;57 Suppl:134-6.	Bell A, McSteen PM, Cebrat M, Picur B, Siemion IZ	Antimalarial activity of cyclolinopeptide A and its analogues	
DRAMP39210	XXAX	4	Dragomabin	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.17441769]protozoon:Plasmodium falciparum W2 strain (IC₅₀=6.0 μM)	not found	Linear	Free	Amidation	X1=2S-methyloct-7-ynoic acid;X2=N,O-dimethyl-L-tyrosine;X3=N-methyl-L-phenylalanine	L	[Ref.17441769]Vero cells IC₅₀=182.3 μM targeting on Vero cells	membrane	17441769	J Nat Prod. 2007 Jun;70(6):984-8	McPhail KL, Correa J, Linington RG, Gonzalez J, Ortega-Barría E, Capson TL, Gerwick WH	Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula	
DRAMP39211	XXXX	4	Dragonamide A	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.17441769]protozoon: Plasmodium falciparum W2 strain (IC₅₀=7.7 μM)	not found	Linear	Free	Amidation	X1=2S-methyloct-7-ynoic acid;X2=N-methyl-L-phenylalanine;X3、X4=N-methyl-L-valine	L	[Ref.17441769]Vero cells IC₅₀=67.8 μM targeting on Vero cells	membrane	17441769	J Nat Prod. 2007 Jun;70(6):984-8	McPhail KL, Correa J, Linington RG, Gonzalez J, Ortega-Barría E, Capson TL, Gerwick WH	Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula	
DRAMP39212	QGWEAVAAAVASKIVGLWRNEKTELLGHECKFTVKPYLKRFQVYYKGRMWCPGWTAIRGEASTRSQSGVAGKTAKDFVRKAFQKGLLSQQEANQWLSS	98	Antilipopolysaccharide factor [ALF—isoform ALFPm]	not found	not found	not found	Penaeus monodon	Antimicrobial,Antiprotozoal	not found			not found		[Ref.17888907]protozoon:Trypanosoma cruzi (epimastigotes: inactive at 100 μM); Leishmania braziliensis (promastigotes: inactive at 100 μM)	[Ref.17462586]<10% of hemolysis at 50 µM (human O⁺ RBC, 37°C, 1 h incubation)	Linear	Free	Free		L	No cytotoxicity information found	membrane	17888907	Exp Parasitol. 2008 Feb;118(2):197-202	Löfgren SE, Miletti LC, Steindel M, Bachère E, Barracco MA	Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals	CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP39213	GIGKFLKKAKKFGKAFVKMKK	21	Magainin-derived MSI-94	not found	not found	not found	Xenopus laevis	Antimicrobial,Antiprotozoal	not found			not found		[Ref.17888907]protozoon:Trypanosoma cruzi (trypomastigotes: immobilizes at 25 μM within 15 min, 100% killing at 100 μM)	[Ref.17888907]>50% hemolysis at 50 μM (human O⁺ RBC, 37°C, 1 h incubation)	Linear	Free	Amidation		L	No cytotoxicity information found	membrane	17888907	Exp Parasitol. 2008 Feb;118(2):197-202	Löfgren SE, Miletti LC, Steindel M, Bachère E, Barracco MA	Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals	CC[C@@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP39214	LVCHPAVPALLCAR	14	SBP1, Small disulfide bonded peptide	not found	not found	not found	Plasmodium spp	Antimicrobial,Antiprotozoal	not found			not found		[Ref.18591232]protozoon:Plasmodium falciparum(IC50=1.7 µM)	not found	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)		L	No cytotoxicity information found	not found	18591232	Infect Immun. 2008 Sep;76(9):4332-44	Fairlie WD, Spurck TP, McCoubrie JE, Gilson PR, Miller SK, McFadden GI, Malby R, Crabb BS, Hodder AN	Inhibition of malaria parasite development by a cyclic peptide that targets the vital parasite protein SERA5	
DRAMP39215	ALWKTMLKKLGTMAL	15	Dermaseptin-S1 (1-15) code 3	P24302(46-60)	Belongs to the frog skin active peptide (FSAP) family. Dermaseptin subfamily.	not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antifungal,Antiprotozoal	protein level			not found		[Ref.18676150]protozoon:Leishmania major (MIC=22.8 μM, LC₅₀=8.7 μM)##Gram-positive bacteria: Staphylococcus aureus (MIC=11.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.9 μM);##Fungi: Candida albicans (MIC=23.7 μM)	[Ref.18676150]HD₅₀>100 μM	Linear	Free	Amidation		L	No cytotoxicity information found	membrane	18676150	Bioorg Med Chem. 2008 Sep 1;16(17):8205-9	Savoia D, Guerrini R, Marzola E, Salvadori S	Synthesis and antimicrobial activity of dermaseptin S1 analogues	CSCC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP39216	XXXXX	5	Gallinamide A	not found	not found	not found	Synthetic	Antimicrobial,Antiprotozoal	not found			not found		[Ref.19161344]protozoon:Plasmodium falciparum W2 strain (chloroquine-resistant, IC₅₀=8.4 μM); Leishmania donovani (IC₅₀=9.3 μM)	not found	Linear	Free	Methoxypyrrolinonylation	X1=N,N-dimethyl-L-isoleucine;X2=S-isocaproic acid;X3=L-leucine;X4=4-(S)-amino-2-(E)-pentenoic acid, Apa;X5=methylmethoxypyrrolinone, Mmp	L	No cytotoxicity information found	Not found	19161344	J Nat Prod. 2009 Jan;72(1):14-7	Linington RG, Clark BR, Trimble EE, Almanza A, Ureña LD, Kyle DE, Gerwick WH	Antimalarial peptides from marine cyanobacteria: isolation and structural elucidation of gallinamide A	
DRAMP39217	ACQASQLAVCASAILSGAKPSGECCGNLRAQQGCFCQYAKDPTYGQYIRSPHARDTLTSCGLAVPHC	67	LTP2(lipid transfer protein) α-1 isoform	P82900	Belongs to the plant LTP family. B11E subfamily		Triticum aestivum (Wheat)	Antimicrobial,Antiprotozoal	protein level			1N89##1TUK		[Ref.19361504]protozoon:Leishmania donovani MHOM/SD/00/1S-2D promastigote(LC50 >100 µM)	not found	Linear	Free	Free		L	No cytotoxicity information found	membrane	19361504	Exp Parasitol. 2009 Jul;122(3):247-9	Berrocal-Lobo M, Molina A, Rodríguez-Palenzuela P, García-Olmedo F, Rivas L	Leishmania donovani: thionins, plant antimicrobial peptides with leishmanicidal activity	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O
DRAMP39218	KWXWKXVKXVK	11	VS2	not found	not found	not found	Synthetic	Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-	not found			not found		[Ref.22118799]protozoon:Plasmodium falciparum 3D7 strain (IC₅₀=N/D)##Gram-positive bacteria: Staphylococcus aureus ATCC 700699 (MIC=50 μM);##Gram-negative bacteria: Escherichia coli ML35p (MIC=5 μM)	not found	Linear	Acetylation	Amidation	X3、X6、X9=ΔF=α,β-dehydrophenylalanine	L	No cytotoxicity information found	membrane	22118799	Int J Antimicrob Agents. 2012 Feb;39(2):146-52	Sharma SP, Sharma J, Kanwar SS, Chauhan VS	In vitro antibacterial and antimalarial activity of dehydrophenylalanine-containing undecapeptides alone and in combination with drugs	
DRAMP39219	DNSDNMF	7	SERA5 PD	P69192(552-558)	Belongs to the peptidase C1 family	SERA5	Plasmodium falciparum (isolate FCR-3 / Gambia)	Antimicrobial,Antiprotozoal	protein level			not found		[Ref.22291957]protozoon:P. falciparum(The final parasitemia at the time of scoring in the  experiment was 4–5%)	not found	Linear	Free	Free		L	No cytotoxicity information found	membrane	22291957	PLoS One. 2012;7(1):e30452.	Alam A, Chauhan VS	Inhibitory potential of prodomain of Plasmodium falciparum protease serine repeat antigen 5 for asexual blood stages of parasite	CSCC[C@H](NC(=O)[C@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(=O)O
DRAMP39220	GLWSTIKQKGKEAAIAAAKAAGKAALNAASEAL	33	Dermaseptin-4	C0HKP8	Belongs to the frog skin active peptide (FSAP) family. Dermaseptin subfamily.	not found	Pithecopus nordestinus (Northeastern Brazilian leaf frog) (Phyllomedusa nordestina)	Antimicrobial, Antiprotozoal	protein level			not found		[Ref.24113627]protozoon: Trypanosoma cruzi (trypomastigotes, IC₅₀=0.25 μM, 95% CI 0.21–0.30 μM)	not found	Linear	Free	Amidation		L	[Ref.24113627]CC₅₀>10 μM against peritoneal macrophages	membrane	24113627	Exp Parasitol. 2013 Dec;135(4):655-60	Pinto EG, Pimenta DC, Antoniazzi MM, Jared C, Tempone AG	Antimicrobial peptides isolated from Phyllomedusa nordestina (Amphibia) alter the permeability of plasma membrane of Leishmania and Trypanosoma cruzi	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O
DRAMP39221	FXXXXGLXXXQXXXPF	16	Antiamoebin I	Not found	Not found	Not found	Emericellopsis poonensis	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.11120957]protozoon: Plasmodium falciparum 3H-hypoxanthineincorporation(IC₅₀ =6.16μM); Plasmodium falciparum Smear analysis(IC₅₀ =4.72μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free	X1,2,3,5,6,10=Aib;X4,8=Iva;X7.9=Hyp	L	Not found	mitochondrial membrane,plasma membrane	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9.	Nagaraj G, Uma MV, Shivayogi MS, Balaram H.	Antimalarial activities of peptide antibiotics isolated from fungi.	
DRAMP39222	XXXXXLXGXXXXGLXX	16	Efrapeptin C	Not found	Not found	Not found	Tolypocladium niveum	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.11120957]protozoon: Plasmodium falciparum 3H-hypoxanthineincorporation(IC₅₀ =1.37μM); Plasmodium falciparum Smear analysis(IC₅₀ =1.21μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	DBN	X1,3,9=Pip;X2,4,5,7,8,10,11=Aib;X6=β-Ala;X12=Leuol	L	Not found	Mitochondrial F₀F₁ ATPase	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9.	Nagaraj G, Uma MV, Shivayogi MS, Balaram H.	Antimalarial activities of peptide antibiotics isolated from fungi.	
DRAMP39223	XXXXXLXGXXXXGLXX	16	Efrapeptin D	Not found	Not found	Not found	Tolypocladium niveum	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.11120957]protozoon: Plasmodium falciparum 3H-hypoxanthineincorporation(IC₅₀ =1.37μM); Plasmodium falciparum Smear analysis(IC₅₀ =1.21μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	DBN	X1,3,9=Pip;X2,4,5,7,8,10=Aib;X6=β-Ala;X11=Iva;X12=Leuol	L	Not found	Mitochondrial F₀F₁ ATPase	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9.	Nagaraj G, Uma MV, Shivayogi MS, Balaram H.	Antimalarial activities of peptide antibiotics isolated from fungi.	
DRAMP39224	XXXXXLXGXXXXGLXX	16	Efrapeptin E	Not found	Not found	Not found	Tolypocladium niveum	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.11120957]protozoon: Plasmodium falciparum 3H-hypoxanthineincorporation(IC₅₀ =1.37μM); Plasmodium falciparum Smear analysis(IC₅₀ =1.21μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	DBN	X1,3,9=Pip;X2,5,7,8,10=Aib;X6=β-Ala;X4,11=Iva;X12=Leuol	L	Not found	Mitochondrial F₀F₁ ATPase	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9.	Nagaraj G, Uma MV, Shivayogi MS, Balaram H.	Antimalarial activities of peptide antibiotics isolated from fungi.	
DRAMP39225	XXXXXLXGXXXXALXX	16	Efrapeptin F	Not found	Not found	Not found	Tolypocladium niveum	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.11120957]protozoon: Plasmodium falciparum 3H-hypoxanthineincorporation(IC₅₀ =1.37μM); Plasmodium falciparum Smear analysis(IC₅₀ =1.21μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	DBN	X1,3,9=Pip;X2,4,5,7,8,10=Aib;X6=β-Ala;X11=Iva;X12=Leuol	L	Not found	Mitochondrial F₀F₁ ATPase	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9.	Nagaraj G, Uma MV, Shivayogi MS, Balaram H.	Antimalarial activities of peptide antibiotics isolated from fungi.	
DRAMP39226	XXXXXLXGXXXXALXX	16	Efrapeptin G	Not found	Not found	Not found	Tolypocladium niveum	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.11120957]protozoon: Plasmodium falciparum 3H-hypoxanthineincorporation(IC₅₀ =1.37μM); Plasmodium falciparum Smear analysis(IC₅₀ =1.21μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	DBN	X1,3,9=Pip;X2,5,7,8,10=Aib;X6=β-Ala;X4,11=Iva;X12=Leuol	L	Not found	Mitochondrial F₀F₁ ATPase	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9.	Nagaraj G, Uma MV, Shivayogi MS, Balaram H.	Antimalarial activities of peptide antibiotics isolated from fungi.	
DRAMP39227	WIQXITXLXHQXHXPF	16	Zervamicin IIA	Not found	Not found	Not found	Emericellopsis salmosynnemata	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.11120957]protozoon: Plasmodium falciparum 3H-hypoxanthineincorporation(IC₅₀ =0.48μM); Plasmodium falciparum Smear analysis(IC₅₀ =0.45μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free	X1,2,4,6=Aib;X3,5=Hyp	L	Not found	mitochondrial membrane	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9.	Nagaraj G, Uma MV, Shivayogi MS, Balaram H.	Antimalarial activities of peptide antibiotics isolated from fungi.	
DRAMP39228	WIQXITXLXHQXHXPF	16	Zervamicin IIB	Not found	Not found	Not found	Emericellopsis salmosynnemata	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.11120957]protozoon: Plasmodium falciparum 3H-hypoxanthineincorporation(IC₅₀ =0.48μM); Plasmodium falciparum Smear analysis(IC₅₀ =0.45μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free	X1=Iva;X2,4,6=Aib;X3,5=Hyp	L	Not found	plasma membrane	11120957	Antimicrob Agents Chemother. 2001 Jan;45(1):145-9.	Nagaraj G, Uma MV, Shivayogi MS, Balaram H.	Antimalarial activities of peptide antibiotics isolated from fungi.	
DRAMP39229	rrwIrVAViLRV	12	RI-1018	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.26883699]protozoon:L.major promastigotes Wild type(LD50=0.6μM);L.major promastigotes KO strain(LD50=2.1μM);L.major promastigotes KO strain+GP63 (LD50=0.9μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	D	[Ref.26883699]no cytotoxicity targeting on THP1 cells at 20μM.	plasma membrane	26883699	Antimicrob Agents Chemother. 2016 Mar 25;60(4):2484-91.	Marr AK, Cen S, Hancock RE, McMaster WR.	Identification of synthetic and natural host defense peptides with leishmanicidal activity.	CC[C@@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
DRAMP39230	VRWIVAVRIWRR	12	W3	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.26883699]protozoon:L. donovani promastigotes(22.2% inhibition at 20μM 4h)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	Not found	Not found	26883699	Antimicrob Agents Chemother. 2016 Mar 25;60(4):2484-91.	Marr AK, Cen S, Hancock RE, McMaster WR.	Identification of synthetic and natural host defense peptides with leishmanicidal activity.	
DRAMP39231	giriipviiipgykkwarlikrglsrlgg	28	RI-BMAP-28	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.26883699]protozoon:L. donovani promastigotes(99.6% inhibition at 20μM 4h)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	D	Not found	plasma membrane	26883699	Antimicrob Agents Chemother. 2016 Mar 25;60(4):2484-91.	Marr AK, Cen S, Hancock RE, McMaster WR.	Identification of synthetic and natural host defense peptides with leishmanicidal activity.	
DRAMP39232	VFAEFLPLFSKFGSRMHILK	20	R1	Not found	Not found	Not found	M13 bacteriophage	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=3μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39233	VFAEFLPLFSKFGSRMHILK	20	N-Me-Val-1	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=3.5μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 1	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39234	VFAEFLPLFSKFGSRMHILK	20	N-Me-Phe-2	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=7μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 2	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39235	VFAEFLPLFSKFGSRMHILK	20	N-Me-Ala-3	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=9μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 3	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39236	VFAEFLPLFSKFGSRMHILK	20	N-Me-Glu-4	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=7μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 4	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39237	VFAEFLPLFSKFGSRMHILK	20	N-Me-Phe-5	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50>50μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 5	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39238	VFAEFLPLFSKFGSRMHILK	20	N-Me-Leu-6	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=4μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 6	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39239	VFAEFLPLFSKFGSRMHILK	20	N-Me-Leu-8	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=0.4μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 8	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39240	VFAEFLPLFSKFGSRMHILK	20	N-Me-Phe-9	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=20μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 9	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39241	VFAEFLPLFSKFGSRMHILK	20	N-Me-Ser-10	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=8μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 10	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39242	VFAEFLPLFSKFGSRMHILK	20	N-Me-Lys-11	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50>100μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 11	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39243	VFAEFLPLFSKFGSRMHILK	20	N-Me-Phe-12	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50>100μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 12	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39244	VFAEFLPLFSKFGSRMHILK	20	N-Me-Gly-13	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50>100μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 13	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39245	VFAEFLPLFSKFGSRMHILK	20	N-Me-Ser-14	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=1μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 14	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39246	VFAEFLPLFSKFGSRMHILK	20	N-Me-Arg-15	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50>100μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 15	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39247	VFAEFLPLFSKFGSRMHILK	20	N-Me-Met-16	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=30μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 16	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39248	VFAEFLPLFSKFGSRMHILK	20	N-Me-His-17	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=5μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 17	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39249	VFAEFLPLFSKFGSRMHILK	20	N-Me-Iso-18	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=3μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 18	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39250	VFAEFLPLFSKFGSRMHILK	20	N-Me-Leu-19	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.19164290]protozoon:Plasmodium falciparum 3D7 strains(IC50=4μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	N-methylation at position 19	L	Not found	Apical membrane antigen 1	19164290	J Biol Chem. 2009 Apr 3;284(14):9361-71.	Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.	Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.	
DRAMP39251	AAYKKFKKKLLKSLKRLG	18	AA-RP-1	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.22123683]protozoon:L. braziliensis promastigotes(80% inhibition at 10μg/ml);L. infantum chagasi promastigotes(>95% inhibition at 25μg/ml);L. major promastigotes(100% inhibition at 50μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Alanine is linked to an anthracene ring at position 2	L	Not found	plasma membrane	22123683	Antimicrob Agents Chemother. 2012 Feb;56(2):658-65.	Erfe MC, David CV, Huang C, Lu V, Maretti-Mira AC, Haskell J, Bruhn KW, Yeaman MR, Craft N.	Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.	
DRAMP39252	SRSDLIVHQRVF	12	Cm-p5	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.41785254]protozoon:T. cruzi epimastigotes(EC50=16.9±1.2μM);T. cruzi infective trypomastigote form(EC50=25.2±1.4μM);T. cruzi intracellular amastigotes(64.3% inhibition at 25μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	[Ref.41785254]CC50=124.8±0.1µM targeting on CHO-K1 mammalian cells.	plasma membrane	41785254	PLoS Negl Trop Dis. 2026 Mar 5;20(3):e0013975.	Mengarda AC, Morales-Vicente FE, Martell-Huguet EM, Otero-Gonzalez AJ, Silber AM.	Cm-p5, a synthetic antimicrobial peptide shows anti-Trypanosoma cruzi activity.	
DRAMP39253	LPKPPKPVSKMRMATPLLMQALPM	24	L-CLIP	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.36057367]protozoon:Leishmania spps.(IC50=280μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Lauroylation	Free	Not found	L	Not found	plasma membrane	36057367	Acta Trop. 2022 Dec;236:106675.	Santos FA, Cruz GS, Vieira FA, Queiroz BRS, Freitas CDT, Mesquita FP, Souza PFN.	Systematic review of antiprotozoal potential of antimicrobial peptides.	
DRAMP39254	NVQYYGALHNTAHIVLGRQ	19	Hmc 364–382	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.36057367]protozoon:Trypanosoma cruzi(IC50=4.79μg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	36057367	Acta Trop. 2022 Dec;236:106675.	Santos FA, Cruz GS, Vieira FA, Queiroz BRS, Freitas CDT, Mesquita FP, Souza PFN.	Systematic review of antiprotozoal potential of antimicrobial peptides.	
DRAMP39255	KRFKKFFKKLKNSVKKRVKKFFRKPRVIGVTFPF	34	Batroxicidin	U5KJC9(156-189)	Belongs to the cathelicidin family.	Not found	Bothrops atrox (Barba amarilla) (Fer-de-lance)	Antimicrobial, Antiprotozoal	transcript level			Not found		[Ref.36057367]protozoon:Trypanosoma cruzi(IC50=0.44μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	36057367	Acta Trop. 2022 Dec;236:106675.	Santos FA, Cruz GS, Vieira FA, Queiroz BRS, Freitas CDT, Mesquita FP, Souza PFN.	Systematic review of antiprotozoal potential of antimicrobial peptides.	
DRAMP39256	EAEEDGDLQCLCVKTTSQVRPRHITSLEVIKAGP	34	PF4P1–34	P02776(32-65)	Belongs to the intercrine alpha (chemokine CxC) family.	PF4	Homo sapiens (Human)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.36057367]protozoon:Plasmodium spps.(IC50=8.8μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	36057367	Acta Trop. 2022 Dec;236:106675.	Santos FA, Cruz GS, Vieira FA, Queiroz BRS, Freitas CDT, Mesquita FP, Souza PFN.	Systematic review of antiprotozoal potential of antimicrobial peptides.	
DRAMP39257	HCPTAQLIATLKNGRKICLDLQAPLYKKIIKKLLES	36	PF4P35–70	P02776(66-101)	Belongs to the intercrine alpha (chemokine CxC) family.	PF5	Homo sapiens (Human)	Antimicrobial, Antiprotozoal	protein level			1DN3		[Ref.36057367]protozoon:Plasmodium spps.(IC50=5μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	36057367	Acta Trop. 2022 Dec;236:106675.	Santos FA, Cruz GS, Vieira FA, Queiroz BRS, Freitas CDT, Mesquita FP, Souza PFN.	Systematic review of antiprotozoal potential of antimicrobial peptides.	
DRAMP39258	APLYKKIIKKLLES	14	PF4P57–70	P02776(88-101)	Belongs to the intercrine alpha (chemokine CxC) family.	PF6	Homo sapiens (Human)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.36057367]protozoon:Plasmodium spps.(IC50=4.3μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	36057367	Acta Trop. 2022 Dec;236:106675.	Santos FA, Cruz GS, Vieira FA, Queiroz BRS, Freitas CDT, Mesquita FP, Souza PFN.	Systematic review of antiprotozoal potential of antimicrobial peptides.	
DRAMP39259	GFLDVIKHVGKAVGKAALNAVNDMVNKPEQQS	32	CZS-5	A0A193H356(3-34)	Belongs to the frog skin active peptide (FSAP) family. Cruzioseptin subfamily.	Not found	Cruziohyla calcarifer (Splendid leaf frog) (Agalychnis calcarifer)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.40474242]protozoon:Trypanosoma cruzi epimastigotes(IC50=4.7μM)	[Ref.40474242]CC50 = 237.6 ± 15.2 μM against human erythrocytes.	Linear	Free	Free	Not found	L	Not found	plasma membrane	40474242	Parasit Vectors. 2025 Jun 5;18(1):208.	Osorio-Méndez JF, Pardo-Rodriguez D, Rocha-Roa C, Toro LJ, Muñoz-Tabares L, Recalde-Reyes DP, Cala MP.	Exploring the mechanisms of action of the antimicrobial peptide CZS-5 against Trypanosoma cruzi epimastigotes: insights from metabolomics and molecular dynamics.	
DRAMP39260	GFLDVVKHVGKAVGKAALNAVTEMVNQAEQ	30	CZS-7	A0A193H365(46-75)	Belongs to the frog skin active peptide (FSAP) family. Cruzioseptin subfamily.	Not found	Cruziohyla calcarifer (Splendid leaf frog) (Agalychnis calcarifer)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.40474242]protozoon:Trypanosoma cruzi epimastigotes(IC50=13.2μM)	[Ref.40474242]CC50 = 470.7 ± 33.6 μM against human erythrocytes.	Linear	Free	Free	Not found	L	Not found	plasma membrane	40474242	Parasit Vectors. 2025 Jun 5;18(1):208.	Osorio-Méndez JF, Pardo-Rodriguez D, Rocha-Roa C, Toro LJ, Muñoz-Tabares L, Recalde-Reyes DP, Cala MP.	Exploring the mechanisms of action of the antimicrobial peptide CZS-5 against Trypanosoma cruzi epimastigotes: insights from metabolomics and molecular dynamics.	
DRAMP39261	GFLDIVKHVGKAAGKAALNAVTEMVNQ	27	CZS-11	A0A193H361(46-72)	Belongs to the frog skin active peptide (FSAP) family. Cruzioseptin subfamily.	Not found	Cruziohyla calcarifer (Splendid leaf frog) (Agalychnis calcarifer)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.40474242]protozoon:Trypanosoma cruzi epimastigotes(IC50=12.7μM)	[Ref.40474242]CC50 = 567.5 ± 44.9 μM against human erythrocytes.	Linear	Free	Free	Not found	L	Not found	plasma membrane	40474242	Parasit Vectors. 2025 Jun 5;18(1):208.	Osorio-Méndez JF, Pardo-Rodriguez D, Rocha-Roa C, Toro LJ, Muñoz-Tabares L, Recalde-Reyes DP, Cala MP.	Exploring the mechanisms of action of the antimicrobial peptide CZS-5 against Trypanosoma cruzi epimastigotes: insights from metabolomics and molecular dynamics.	
DRAMP39262	DLIWKLLSKAQEKFGKNKSR	20	Lfampin	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.30429239]protozoon:E. histolytica trophozoites(IC50=220.28μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	30429239	Biosci Rep. 2019 Jan 8;39(1):BSR20180850.	Díaz-Godínez C, González-Galindo X, Meza-Menchaca T, Bobes RJ, de la Garza M, León-Sicairos N, Laclette JP, Carrero JC.	Synthetic bovine lactoferrin peptide Lfampin kills Entamoeba histolytica trophozoites by necrosis and resolves amoebic intracecal infection in mice.	
DRAMP39263	ALNLTLHFALALKALKKALKKLKKALKKAL	30	Ligand-Hecate	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.40521027]protozoon:T. cruzi epimastigotes(EC50=10.4μM);L.major promastigotes(EC50=4.4μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	[Ref.40521027]Cytotoxicity produced was small with a survival rate above 90% range 0.9-15µM	plasma membrane	40521027	Front Cell Infect Microbiol. 2025 May 30;15:1595333.	Iniguez E, Rodriguez F, Husseneder C, Foil L, Maldonado RA.	Ligand-lytic peptides for specific targeting of Leishmania major and Trypanosoma cruzi parasites.	
DRAMP39264	KKkLLlLllLLLkKK	15	Seg5D	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39971158]protozoon:Plasmodium falciparum trophozoite-stage(IC50=9.0μM)	[Ref.39971158]Approx 2% hemolysis on uRBCs at 12.5μM after 24h.	Linear	Free	Amidation	Not found	D	Not found	plasma membrane,cytoskeletal network	39971158	J Biol Chem. 2025 Apr;301(4):108298.	Kiper E, Ben Hur D, Alfandari D, Camacho AC, Wani NA, Efrat GD, Morandi MI, Goldsmith M, Rotkopf R, Kamyshinsky R, Deshmukh A, Binte Zulkifli NE, Asmari N, Penedo M, Fantner G, Porat Z, Azuri I, Rosenhek-Goldian I, Chitnis CE, Shai Y, Regev-Rudzki N.	Antimicrobial peptides selectively target malaria parasites by a cholesterol-dependent mechanism.	
DRAMP39265	GFLDVIKHVGKAALSVVSHLINE	23	CZS-4	A0A193H2U2(3-25)	Belongs to the frog skin active peptide (FSAP) family. Cruzioseptin subfamily.	Not found	Cruziohyla calcarifer (Splendid leaf frog) (Agalychnis calcarifer)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,antifungal,Antiprotozoal	protein level			Not found		[Ref.39012112]protozoon:T. cruzi Trypomastigotes(IC50=1.55µM)；T. cruzi Amastigotes(IC50=30.65µM)；P. falciparum NF54(IC50=13.86µM)；P. falciparum TM90C2B(IC50=4.87µM)；L. mexicana(IC50=0.09µM)##Gram-negative bacteria:Escherichia coli(IC50=13.09µM)##Gram-positive bacteria:Staphylococcus aureus(IC50=26.18µM)##Fungi:Candida albicans(MIC=52.36µM)	[Ref.39012112]Induced hemolysis of 13% at 128 µM.	Linear	Free	Amidation	Not found	L	[Ref.39012112]IC50=70.66µM targeting on LLC-mk2 cells;IC50=47.96µM targeting on Raw 264.7 cells	plasma membrane	39012112	Microbiol Spectr. 2024 Aug 6;12(8):e0333923.	Proaño-Bolaños C, Morán-Marcillo G, Espinosa de Los Monteros-Silva N, Bermúdez-Puga S, Salazar MA, Blasco-Zúñiga A, Cuesta S, Molina C, Espinosa F, Meneses L, Rojas-Silva P, Zapata Mena S, Sáenz FE, Rivera I M, Costales JA.	Bioactivity of synthetic peptides from Ecuadorian frog skin secretions against Leishmania mexicana, Plasmodium falciparum, and Trypanosoma cruzi.	
DRAMP39266	GFLDVLKGVGKAALGAVTHLINQ	23	CZS-16	Not found	Not found	Not found	Cruziohyla calcarifer (Splendid leaf frog) (Agalychnis calcarifer)	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39012112]protozoon:T. cruzi Trypomastigotes(IC50=18.7µM)；T. cruzi Amastigotes(IC50=38.33µM)；P. falciparum NF54(IC50=36.82µM)；P. falciparum TM90C2B(IC50=34.41µM)；L. mexicana(IC50=6.46µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.39012112]IC50=5.59µM targeting on LLC-mk2 cells;IC50=4.40µM targeting on Raw 264.7 cells	plasma membrane	39012112	Microbiol Spectr. 2024 Aug 6;12(8):e0333923.	Proaño-Bolaños C, Morán-Marcillo G, Espinosa de Los Monteros-Silva N, Bermúdez-Puga S, Salazar MA, Blasco-Zúñiga A, Cuesta S, Molina C, Espinosa F, Meneses L, Rojas-Silva P, Zapata Mena S, Sáenz FE, Rivera I M, Costales JA.	Bioactivity of synthetic peptides from Ecuadorian frog skin secretions against Leishmania mexicana, Plasmodium falciparum, and Trypanosoma cruzi.	
DRAMP39267	ASWKVFLKNIGKAAGKAVLNSVTDMVNQ	28	dermaseptin-SP2	A0A5P9K470(46-73)	Belongs to the frog skin active peptide (FSAP) family. Dermaseptin subfamily.	Not found	Agalychnis spurrelli (Gliding leaf frog) (Agalychnis litodryas)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.39012112]protozoon:P. falciparum NF54(IC50=12.06µM)；P. falciparum TM90C2B(IC50=15.34µM)；L. mexicana(IC50=0.61µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.39012112]IC50=3.14µM targeting on Raw 264.7 cells	plasma membrane	39012112	Microbiol Spectr. 2024 Aug 6;12(8):e0333923.	Proaño-Bolaños C, Morán-Marcillo G, Espinosa de Los Monteros-Silva N, Bermúdez-Puga S, Salazar MA, Blasco-Zúñiga A, Cuesta S, Molina C, Espinosa F, Meneses L, Rojas-Silva P, Zapata Mena S, Sáenz FE, Rivera I M, Costales JA.	Bioactivity of synthetic peptides from Ecuadorian frog skin secretions against Leishmania mexicana, Plasmodium falciparum, and Trypanosoma cruzi.	
DRAMP39268	GFLDTLKNIGKTVGRIALNVLT	22	pictuseptin-1	Not found	Not found	Not found	Boana picturata	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39012112]protozoon:T. cruzi Trypomastigotes(IC50=1.42µM)；T. cruzi Amastigotes(IC50=30.16µM)；P. falciparum NF54(IC50=52.56µM)；P. falciparum TM90C2B(IC50=24.87µM)；L. mexicana(IC50=0.10µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.39012112]IC50=80.07µM targeting on LLC-mk2 cells;IC50=2.52µM targeting on Raw 264.7 cells	plasma membrane	39012112	Microbiol Spectr. 2024 Aug 6;12(8):e0333923.	Proaño-Bolaños C, Morán-Marcillo G, Espinosa de Los Monteros-Silva N, Bermúdez-Puga S, Salazar MA, Blasco-Zúñiga A, Cuesta S, Molina C, Espinosa F, Meneses L, Rojas-Silva P, Zapata Mena S, Sáenz FE, Rivera I M, Costales JA.	Bioactivity of synthetic peptides from Ecuadorian frog skin secretions against Leishmania mexicana, Plasmodium falciparum, and Trypanosoma cruzi.	
DRAMP39269	fPFfNEYVOL	10	tyrocidine A1	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.36033708]protozoon:A. castellanii(IC50=111.8μg/mL);N. fowleri(IC50=81.84 μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	D	[Ref.36033708]7% and 17% cytotoxic effects at 100 and 250 μg/mL concentrations	cyst	36033708	ACS Omega. 2022 Aug 10;7(33):28797-28805.	Akbar N, Kaman WE, Sarink M, Nazmi K, Bikker FJ, Khan NA, Siddiqui R.	Novel Antiamoebic Tyrocidine-Derived Peptide against Brain-Eating Amoebae.	
DRAMP39270	APRWKFGKRLEKLGRNVF	17	An-cecB-1	Q8MUF4(27-43)	Belongs to the cecropin family.	CecB	Anopheles gambiae (African malaria mosquito)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antiprotozoal	protein level			Not found		[Ref.38874346]protozoon:P. falciparum 3D7 strain(IC50=68.63μM)##Gram-positive bacteria:S. aureus(MIC>200μM;IC50>200μM);B. subtilis(MIC=25μM;IC50=18.94μM)##Gram-negative bacteria:E. coli(MIC=25μM;IC50=12.7μM)	[Ref.38874346]Had no hemolysis effect on erythrocytes	Linear	Free	Amidation	Not found	L	[Ref.38874346]No toxicity to HEK293T cells at various drug concentrations	plasma membrane	38874346	Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0031124.	Lou J, Zhang D, Wu J, Zhu G, Zhang M, Tang J, Fang Y, He X, Cao J.	activity of cecropin antimicrobial peptides derived from Anopheles mosquitoes.	
DRAMP39271	RAAKKALPVIAGYKAL	16	An-cecB-2	Q8MUF4(44-59)	Belongs to the cecropin family.	CecB	Anopheles gambiae (African malaria mosquito)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.38874346]protozoon:P. falciparum 3D7 strain(12.14% inhibition at 200μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.38874346]No toxicity to HEK293T cells at various drug concentrations	plasma membrane	38874346	Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0031124.	Lou J, Zhang D, Wu J, Zhu G, Zhang M, Tang J, Fang Y, He X, Cao J.	activity of cecropin antimicrobial peptides derived from Anopheles mosquitoes.	
DRAMP39272	GKRLEKLGRNVFRAAKK	17	An-cecB-3	Q8MUF4(32-48)	Belongs to the cecropin family.	CecB	Anopheles gambiae (African malaria mosquito)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.38874346]protozoon:P. falciparum 3D7 strain(24.74% inhibition at 200μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.38874346]No toxicity to HEK293T cells at various drug concentrations	plasma membrane	38874346	Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0031124.	Lou J, Zhang D, Wu J, Zhu G, Zhang M, Tang J, Fang Y, He X, Cao J.	activity of cecropin antimicrobial peptides derived from Anopheles mosquitoes.	
DRAMP39273	PGLNAVT	7	cherimolacyclopeptide D	Not found	Not found	Not found	A. diversifolia	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39683795]protozoon:Giardia lamblia(IC50=5.39µg/mL);Entamoeba hystolitica(IC50=3.49µg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Thr residue is connected to the Pro.	L	[Ref.39683795]Not be cytotoxic, carcinogenic, or mutagenic. In addition, it does not cause hepatoxicity, neurotoxicity,or cardiotoxicity.	aldose reductase,Ferredoxin Pyruvate Oxidoreductase	39683795	Molecules. 2024 Nov 28;29(23):5636.	Murrieta-Dionicio U, Calzada F, Barbosa E, Valdés M, Reyes-Trejo B, Zuleta-Prada H, Guerra-Ramírez D, Del Río-Portilla F.	Antiprotozoal Activity Against Entamoeba hystolitica and Giardia lamblia of Cyclopeptides Isolated from Annona diversifolia Saff.	
DRAMP39274	AAIPMYGT	8	Squamin D	Not found	Not found	Not found	A. diversifolia	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.39683795]protozoon:Giardia lamblia(Squamin C+Squamin D:IC50=52.93µg/mL);Entamoeba hystolitica(Squamin C+Squamin D:IC50=8.68µg/mL);Acanthamoeba castellanii Neff
strains(IC50=18.3µM)"	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	R-methionine sulfoxidation at position 5	L	Not found	Not found	39683795	Molecules. 2024 Nov 28;29(23):5636.	Murrieta-Dionicio U, Calzada F, Barbosa E, Valdés M, Reyes-Trejo B, Zuleta-Prada H, Guerra-Ramírez D, Del Río-Portilla F.	Antiprotozoal Activity Against Entamoeba hystolitica and Giardia lamblia of Cyclopeptides Isolated from Annona diversifolia Saff.	
DRAMP39275	AAIPMYGT	8	Squamin C	Not found	Not found	Not found	A. diversifolia	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39683795]protozoon:Giardia lamblia(Squamin C+Squamin D:IC50=52.93µg/mL);Entamoeba hystolitica(Squamin C+Squamin D:IC50=8.68µg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	S-methionine sulfoxidation at position 5	L	Not found	Not found	39683795	Molecules. 2024 Nov 28;29(23):5636.	Murrieta-Dionicio U, Calzada F, Barbosa E, Valdés M, Reyes-Trejo B, Zuleta-Prada H, Guerra-Ramírez D, Del Río-Portilla F.	Antiprotozoal Activity Against Entamoeba hystolitica and Giardia lamblia of Cyclopeptides Isolated from Annona diversifolia Saff.	
DRAMP39276	APYNSHELKGGSVLDVKKVDEDGTKVRVDGRQEVFKSDDGKTKAEVYGHVERNFGRFSDRQTRKGGGFRIEHTWK	75	CL-prolixicin2	Not found	Not found	Not found	Cimex lectularius	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39683795]protozoon:T. cruzi(approx 90% inhibition at 200µM)##Gram-negative bacteria:Escherichia coli Dh5alpha(MIC=0.5µM)；Escherichia coli KB21(MIC=1.0µM)；Pseudomonas aeruginosa(MIC>128µM)；Serratia marcescens(MIC=16µM)；Serratia marcescens, bed bug symbiont(MIC>128µM)；Klebsiella pneumoniae(MIC>64µM)##Gram-positive bacteria:Bacillus subtilis(MIC=32µM)；Staphylococcus aureus(MIC>128µM)；Staphylococcus sciuri(MIC>128µM)；Staphylococcus epidermidis(MIC>128µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	38879638	Sci Rep. 2024 Jun 15;14(1):13818.	Meraj S, Dhari AS, Mohr E, Lowenberger C, Gries G.	A novel prolixicin identified in common bed bugs with activity against both bacteria and parasites.	
DRAMP39277	KIKWFKAMKSIAKFIAKDQLKKHL	24	XYP1	Not found	Not found	Not found	Lycosa coelestis	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39232817]protozoon:Toxoplasma gondii tachyzoites(90% inhibition at 10µM)	[Ref.39232817]No hemolysis at concentrations ranging from 1.25μM to 10μM.	Linear	Free	Free	Not found	L	[Ref.39232817]IC50=33.63µM targeting on HFFs cells	plasma membrane, organelles	39232817	Parasit Vectors. 2024 Sep 4;17(1):376.	Li J, Wu K, Liu X, Yang D, Xie J, Wang Y, Liu K, Wang Z, Liu W, Jiang L.	Anti-Toxoplasma gondii effects of XYP1-derived peptides and regulatory mechanisms of XYP1.	
DRAMP39278	KIKWFKAMKSIAKFIAK	17	XYP1-17	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39232817]protozoon:Toxoplasma gondii tachyzoites(approx 50% inhibition at 10µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane, organelles	39232817	Parasit Vectors. 2024 Sep 4;17(1):376.	Li J, Wu K, Liu X, Yang D, Xie J, Wang Y, Liu K, Wang Z, Liu W, Jiang L.	Anti-Toxoplasma gondii effects of XYP1-derived peptides and regulatory mechanisms of XYP1.	
DRAMP39279	KIKWFKAMKSIAKFIAKD	18	XYP1-18	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39232817]protozoon:Toxoplasma gondii tachyzoites(approx 75% inhibition at 10µM)	[Ref.39232817]No hemolysis at concentrations ranging from 1.25μM to 80μM.	Linear	Free	Free	Not found	L	[Ref.39232817]IC50=80.60µM targeting on HFFs cells	plasma membrane, organelles	39232817	Parasit Vectors. 2024 Sep 4;17(1):376.	Li J, Wu K, Liu X, Yang D, Xie J, Wang Y, Liu K, Wang Z, Liu W, Jiang L.	Anti-Toxoplasma gondii effects of XYP1-derived peptides and regulatory mechanisms of XYP1.	
DRAMP39280	LKKWFKKMKKIAKKIAKL	18	XYP1-18-1	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39232817]protozoon:Toxoplasma gondii tachyzoites(approx 55% inhibition at 10µM)	[Ref.39232817]Had low hemolysis at 1.25μM to 160μM, with a maximum hemolysis rate of 20%	Linear	Free	Free	Not found	L	[Ref.39232817]IC50=45.60µM targeting on HFFs cells	plasma membrane, organelles	39232817	Parasit Vectors. 2024 Sep 4;17(1):376.	Li J, Wu K, Liu X, Yang D, Xie J, Wang Y, Liu K, Wang Z, Liu W, Jiang L.	Anti-Toxoplasma gondii effects of XYP1-derived peptides and regulatory mechanisms of XYP1.	
DRAMP39281	XFVPWFSKFLKRIL	14	Temporin L 71	Not found	Not found	Not found	Synthetic	Antimicrobial,Antibacterial,Anti-Gram-,Antiprotozoal	Not found			Not found		[Ref.41600700]protozoon:Giardia duodenalis Cysts(26.7% inhibition at 0.3mg/ml 60min)##Gram-negative bacteria:E. hormaechei(MIC=62.5µg/ml);E. ludwigii(MIC=31µg/ml);E. hormaechei ATCC 700323(MIC=62.5µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	valerylation	Amidation	X=Aic	L	Not found	plasma membrane	41600700	Vet Sci. 2026 Jan 3;13(1):44.	Santaniello A, Roscetto E, Galdiero U, Pepe P, Bosco A, Boccino I, Dipineto L, Catania MR, Grieco P.	Antimicrobial Activity of Bioactive Peptides on Resistant Enterobacteriaceae and the Viability of Giardia duodenalis Cysts Isolated from Healthy Dogs.	
DRAMP39282	FVPWFKKFlERIL	13	Temporin L 58	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.41600700]protozoon:Giardia duodenalis Cysts(39.0% inhibition at 0.3mg/ml 60min)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Lactam bridge between position6 and position10	D	Not found	plasma membrane	41600700	Vet Sci. 2026 Jan 3;13(1):44.	Santaniello A, Roscetto E, Galdiero U, Pepe P, Bosco A, Boccino I, Dipineto L, Catania MR, Grieco P.	Antimicrobial Activity of Bioactive Peptides on Resistant Enterobacteriaceae and the Viability of Giardia duodenalis Cysts Isolated from Healthy Dogs.	
DRAMP39283	LLGMIPVAISAISALSKL	18	PLS-S1	F7UI88(49-66)	Belongs to the frog skin active peptide (FSAP) family. Medusin subfamily.	Not found	Phyllomedusa sauvagei (Sauvage's leaf frog)	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-,Antiprotozoal	protein level			Not found		[Ref.23774944]protozoon:Leishmania amazonensis promastigotes(10% inhibition at 100μM);L. infantum promastigotes(15% inhibition at 100μM);Leishmania amazonensis amastigotes(15% inhibition at 120μM);L. infantum amastigotes(15% inhibition at 120μM)##Gram-positive bacteria:Staphylococcus aureus(MIC=5.7μM)##Gram-negative bacteria:Escherichia coli(MIC=11.5±5.7μM);Xanthomonas axonopodis pv. glycines(MIC=1.42μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.23774944]Will not reduce the macrophages cell viability up to a concentration of approximately 64 µM	plasma membrane	23774944	Molecules. 2013 Jun 17;18(6):7058-70.	Brand GD, Santos RC, Arake LM, Silva VG, Veras LM, Costa V, Costa CH, Kuckelhaus SS, Alexandre JG, Feio MJ, Leite JR.	The skin secretion of the amphibian Phyllomedusa nordestina: a source of antimicrobial and antiprotozoal peptides.	
DRAMP39284	ILGTILGLLSKL	12	polybia-CP	Not found	Not found	Not found	Polybia paulista	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.32360153]protozoon:T. cruzi Epimastigote(EC50=9.38±0.64μmol/L 24h);T. cruzi Trypomastigote(EC50=0.94±0.12μmol/L 24h)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.32360153]EC50>100µM targeting on LLC-MK2 cells	flagella	32360153	Toxicon. 2020 Jul 15;181:71-78.	Freire KA, Torres MT, Lima DB, Monteiro ML, Bezerra de Menezes RRPP, Martins AMC, Oliveira VX Jr.	Wasp venom peptide as a new antichagasic agent.	
DRAMP39285	FA	2	Mu-Phe-Ala-VSMe	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.8807047]protozoon:P.falciparum(IC50=20µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	muylation	methyl vinyl sulfonylation	Not found	L	Not found	Cysteine Proteinase	8807047	Antimicrob Agents Chemother. 1996 Jul;40(7):1600-3.	Rosenthal PJ, Olson JE, Lee GK, Palmer JT, Klaus JL, Rasnick D.	Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors.	
DRAMP39286	FF	2	Mu-Phe-Phe-VSMe	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.8807047]protozoon:P.falciparum(IC50=2µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	muylation	methyl vinyl sulfonylation	Not found	L	Not found	Cysteine Proteinase	8807047	Antimicrob Agents Chemother. 1996 Jul;40(7):1600-3.	Rosenthal PJ, Olson JE, Lee GK, Palmer JT, Klaus JL, Rasnick D.	Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors.	
DRAMP39287	FR	2	Mu-Phe-Arg-VSPh·HBr	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.8807047]protozoon:P.falciparum(IC50=0.05µM);P.vinckei(IC50=0.05µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	muylation	phenyl vinyl sulfonylation	HBr salt formation	L	Not found	Cysteine Proteinase	8807047	Antimicrob Agents Chemother. 1996 Jul;40(7):1600-3.	Rosenthal PJ, Olson JE, Lee GK, Palmer JT, Klaus JL, Rasnick D.	Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors.	
DRAMP39288	FS	2	Mu-Phe-Ser(OBzl)-VSPh	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.8807047]protozoon:P.falciparum(IC50=1µM);P.vinckei(IC50=0.5µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	muylation	phenyl vinyl sulfonylation	benzylation at position 2	L	Not found	Cysteine Proteinase	8807047	Antimicrob Agents Chemother. 1996 Jul;40(7):1600-3.	Rosenthal PJ, Olson JE, Lee GK, Palmer JT, Klaus JL, Rasnick D.	Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors.	
DRAMP39289	GIKKFLHIIWKFIKAFVGEIMNS	23	MG-H1	Not found	Not found	Not found	Synthetic	Antimicrobial,Antibacterial,Anti-Gram-,Antiprotozoal	Not found			Not found		[Ref.15273109]protozoon:L.donovani promastigotes(LD50=2.4µM;LD90=4.3µM)##Gram-negative bacteria:E.coli(MIC=16µM)	[Ref.15273109]ED50=2.9µM	Linear	Free	Free	Not found	L	Not found	plasma membrane	15273109	Antimicrob Agents Chemother. 2004 Aug;48(8):2980-6.	Guerrero E, Saugar JM, Matsuzaki K, Rivas L.	Role of positional hydrophobicity in the leishmanicidal activity of magainin 2.	
DRAMP39290	IIKKFLHSIWKFGKAFVGEIMNI	23	MG-H2	Not found	Not found	Not found	Synthetic	Antimicrobial,Antibacterial,Anti-Gram-,Antiprotozoal	Not found			Not found		[Ref.15273109]protozoon:L.donovani promastigotes(LD50=0.9µM;LD90=1.0µM)##Gram-negative bacteria:E.coli(MIC=2µM)	[Ref.15273109]ED50=16µM	Linear	Free	Free	Not found	L	Not found	plasma membrane	15273109	Antimicrob Agents Chemother. 2004 Aug;48(8):2980-6.	Guerrero E, Saugar JM, Matsuzaki K, Rivas L.	Role of positional hydrophobicity in the leishmanicidal activity of magainin 2.	
DRAMP39291	FR	2	Z-Phe-Arg-CH2F	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.1939639]protozoon:Plasmodium falciparum(LD50=0.064µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	benzyloxycarbonylation	fluoromethylketonation	Not found	L	[Ref.1939639]Nontoxic to cultured mammalian cells	Cysteine Proteinase	1939639	J Clin Invest. 1991 Nov;88(5):1467-72.	Rosenthal PJ, Wollish WS, Palmer JT, Rasnick D.	Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.	
DRAMP39292	fR	2	Z-DPhe-Arg-CH2F	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.1939639]protozoon:Plasmodium falciparum(LD50=0.65µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	benzyloxycarbonylation	fluoromethylketonation	Not found	D	Not found	Cysteine Proteinase	1939639	J Clin Invest. 1991 Nov;88(5):1467-72.	Rosenthal PJ, Wollish WS, Palmer JT, Rasnick D.	Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.	
DRAMP39293	FA	2	Z-Phe-Ala-CH2F	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.1939639]protozoon:Plasmodium falciparum(LD50=1.80µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	benzyloxycarbonylation	fluoromethylketonation	Not found	L	Not found	Cysteine Proteinase	1939639	J Clin Invest. 1991 Nov;88(5):1467-72.	Rosenthal PJ, Wollish WS, Palmer JT, Rasnick D.	Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.	
DRAMP39294	FF	2	Z-Phe-Phe-CH2F	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.1939639]protozoon:Plasmodium falciparum(50% inhibition at 50µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	benzyloxycarbonylation	fluoromethylketonation	Not found	L	Not found	Cysteine Proteinase	1939639	J Clin Invest. 1991 Nov;88(5):1467-72.	Rosenthal PJ, Wollish WS, Palmer JT, Rasnick D.	Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.	
DRAMP39295	fA	2	Z-DPhe-Ala-CH2F	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.1939639]protozoon:Plasmodium falciparum(LD50=58µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	benzyloxycarbonylation	fluoromethylketonation	Not found	D	Not found	Cysteine Proteinase	1939639	J Clin Invest. 1991 Nov;88(5):1467-72.	Rosenthal PJ, Wollish WS, Palmer JT, Rasnick D.	Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.	
DRAMP39296	CGGGPLYKKIIKKLLESGGSGGAPLYKKIIKKLCES	36	PDIP-3	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.40490548]protozoon:Plasmodium falciparum(LC50=6.70±0.87µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Free	Amidation	Disulfide bonds between Cys1 and Cys34	L	Not found	digestive vacuole	40490548	Cell Mol Life Sci. 2025 Jun 9;82(1):228.	Xu DW, Raven K, Woodcock SR, Munro B, Palombi IR, Gare CL, White AM, Malins LR, Lawrence N, McMorran BJ.	Insights into platelet factor 4-derived peptide macrocycles; the mechanistic basis of their rapid and selective antiplasmodial actions.	
DRAMP39297	SGGAPLYKKIIKKLLESGGSGGAPLYKKIIKKLLESGG	38	PDIP-24	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.40490548]protozoon:Plasmodium falciparum(LD50=6.29±0.48µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Not found	L	Not found	digestive vacuole	40490548	Cell Mol Life Sci. 2025 Jun 9;82(1):228.	Xu DW, Raven K, Woodcock SR, Munro B, Palombi IR, Gare CL, White AM, Malins LR, Lawrence N, McMorran BJ.	Insights into platelet factor 4-derived peptide macrocycles; the mechanistic basis of their rapid and selective antiplasmodial actions.	
DRAMP39298	PVITNLG	7	papaucin	Not found	Not found	Not found	A. diversifolia Saff.	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.41285422]protozoon:Entamoeba histolytica(IC50=63.07μg/mL);Giardia lamblia(IC50=67.62μg/mL)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Not found	L	Not found	Ferredoxin Pyruvate Oxidoreductase	41285422	Magn Reson Chem. 2026 Feb;64(2):217-226.	Murrieta-Dionicio U, Calzada F, Barbosa E, Valdés M, Reyes-Trejo B, Zuleta-Prada H, Reyes L, Del Río-Portilla F.	Structural Elucidation of the Cyclopeptide Papaucin Isolated From Annona diversifolia Saff. Seeds by NMR, Antiprotozoal Activity and Molecular Docking Studies.	
DRAMP39299	FIXWXL	6	Pipecolisporin	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.40490548]protozoon:Plasmodium falciparum(IC50=226.0±8.49nM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X1=β–Ala;X2=Pipe	L	Not found	dihydrofolate reductase	39860174	Molecules. 2025 Jan 14;30(2):304.	Kurniaty N, Fakih TM, Maharani R, Supratman U, Hidayat AT, Bakar NA, Wei X.	Synthesis, Antimalarial Activity and Molecular Dynamics Studies of Pipecolisporin: A Novel Cyclic Hexapeptide with Potent Therapeutic Potential.	
DRAMP39300	RQIKIWFQNRRMKWKKKDFKIRLQYFARGLQVYIRQL	37	RT37	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.38543531]protozoon:P. berghei sporozoites(approx 30% inhibition at 20µM);Plasmodium falciparum(approx 20% inhibition at 20µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	38543531	Microorganisms. 2024 Feb 27;12(3):480.	Aguirre-Botero MC, Aliprandini E, Gladston A, Pacios O, Miyazawa Martins R, Poyet JL, Amino R.	Killing of Plasmodium Sporozoites by Basic Amphipathic α-Helical Fusion Peptides.	
DRAMP39301	RQIKIWFQNRRMKWKKLQYFARGLQVYIRQLRLALQGGKT	39	RT39	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.38543531]protozoon:P. berghei sporozoites(approx 80% inhibition at 20µM);Plasmodium falciparum(approx 65% inhibition at 20µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	38543531	Microorganisms. 2024 Feb 27;12(3):480.	Aguirre-Botero MC, Aliprandini E, Gladston A, Pacios O, Miyazawa Martins R, Poyet JL, Amino R.	Killing of Plasmodium Sporozoites by Basic Amphipathic α-Helical Fusion Peptides.	
DRAMP39302	RQIKIWFQNRRMKWKKLQYFAAGLQVYIRQLRLALQGGKT	39	RT39M	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.38543531]protozoon:P. berghei sporozoites(approx 80% inhibition at 20µM);Plasmodium falciparum(approx 65% inhibition at 20µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	38543531	Microorganisms. 2024 Feb 27;12(3):480.	Aguirre-Botero MC, Aliprandini E, Gladston A, Pacios O, Miyazawa Martins R, Poyet JL, Amino R.	Killing of Plasmodium Sporozoites by Basic Amphipathic α-Helical Fusion Peptides.	
DRAMP39303	AKLNAEKLKDFKIRLQYFARGLQVYIRQLRLALQGKT	37	AAC11	Q9BZZ5(363-399)	Belongs to the API5 family.	API5	Homo sapiens (Human)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.38543531]protozoon:P. berghei sporozoites(approx 20% inhibition at 20µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	38543531	Microorganisms. 2024 Feb 27;12(3):480.	Aguirre-Botero MC, Aliprandini E, Gladston A, Pacios O, Miyazawa Martins R, Poyet JL, Amino R.	Killing of Plasmodium Sporozoites by Basic Amphipathic α-Helical Fusion Peptides.	
DRAMP39304	xGlxGl	6	cardinalisamides A	Not found	Not found	Not found	Cordyceps cardinalis NBRC 103832	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.38543531]protozoon:Trypanosoma brucei(IC50=8.56µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	x=D-Pla;N‑methylation at position 2,5	D	[Ref.24084682]IC50=18.48µg/ml targeting on MRC-5 cells	Not found	24084682	J Antibiot (Tokyo). 2014 Feb;67(2):163-6.	Umeyama A, Takahashi K, Grudniewska A, Shimizu M, Hayashi S, Kato M, Okamoto Y, Suenaga M, Ban S, Kumada T, Ishiyama A, Iwatsuki M, Otoguro K, Omura S, Hashimoto T.	In vitro antitrypanosomal activity of the cyclodepsipeptides, cardinalisamides A-C, from the insect pathogenic fungus Cordyceps cardinalis NBRC 103832.	
DRAMP39305	xALxGL	6	cardinalisamides B	Not found	Not found	Not found	Cordyceps cardinalis NBRC 103832	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.38543531]protozoon:Trypanosoma brucei(IC50=8.65µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	x=D-Pla;N‑methylation at position 2,5	D	[Ref.24084682]IC50=14.00µg/ml targeting on MRC-5 cells	Not found	24084682	J Antibiot (Tokyo). 2014 Feb;67(2):163-6.	Umeyama A, Takahashi K, Grudniewska A, Shimizu M, Hayashi S, Kato M, Okamoto Y, Suenaga M, Ban S, Kumada T, Ishiyama A, Iwatsuki M, Otoguro K, Omura S, Hashimoto T.	In vitro antitrypanosomal activity of the cyclodepsipeptides, cardinalisamides A-C, from the insect pathogenic fungus Cordyceps cardinalis NBRC 103832.	
DRAMP39306	xALxAL	6	cardinalisamides C	Not found	Not found	Not found	Cordyceps cardinalis NBRC 103832	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.38543531]protozoon:Trypanosoma brucei(IC50=8.63µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	x=D-Pla;N‑methylation at position 2,5	D	[Ref.24084682]IC50=23.84µg/ml targeting on MRC-5 cells	Not found	24084682	J Antibiot (Tokyo). 2014 Feb;67(2):163-6.	Umeyama A, Takahashi K, Grudniewska A, Shimizu M, Hayashi S, Kato M, Okamoto Y, Suenaga M, Ban S, Kumada T, Ishiyama A, Iwatsuki M, Otoguro K, Omura S, Hashimoto T.	In vitro antitrypanosomal activity of the cyclodepsipeptides, cardinalisamides A-C, from the insect pathogenic fungus Cordyceps cardinalis NBRC 103832.	
DRAMP39307	XXXX	4	Lyngbyabellin Q	Not found	Not found	Not found	Moorena sp.	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.38543531]protozoon:P.falciparum(IC50=22nM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X1=Ddhoa;X2=Dhv1;X3=Thz1;X4=Dhv2;X5=Thz2	L	[Ref.24084682]IC50=440nM targeting on HeLa cells	Not found	41772786	J Nat Prod. 2026 Mar 27;89(3):1038-1044.	Koyama R, Tanaka N, Ishiyama A, Kimishima A, Watanabe N, Hara S, Asami Y, Iwasaki A.	Lyngbyabellin Q, an Antimalarial Cyclic Peptide, and Its Acyclic Analog from a Cyanobacterial Biomat Dominated by Moorena sp.	
DRAMP39308	IFWIRL	6	bulbiferamide A	Not found	Not found	Not found	Microbulbifer sp.	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.38543531]protozoon:T. cruzi epimastigotes(IC50=4.1µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Not found	L	[Ref.41757568]demonstrates negligible cytotoxicity toward mammalian cells, showing no activity against P388 murine leukemia cells at 100µM	Not found	41757568	Angew Chem Int Ed Engl. 2026 Apr 6;65(15):e26149.	Zhang J, Nakamura H.	Scalable Access to N‑Acylindole Linkages: Enabling the Synthesis of Antitrypanosomal Noncanonical Cyclic Peptides for Chagas Disease.	
DRAMP39309	WKYMVm	6	WKYMVm 13	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.40530886]protozoon:Trypanosoma brucei(IC50=20.9nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	D	Not found	formyl-peptide receptor type 2	40530886	Chembiochem. 2025 Nov 17;26(22):e202500384.	He M, Thomson CM, Thompson D, Kuodis V, Smith TK, Dall'Angelo S, O'Hagan D.	Bioactivity Profiles of Progressively Ring-Fluorinated Cyclohexyl Motifs in the WKYMVm Peptide as Formylpeptide FPR2 Agonists and in Keto-Piperazines as Antitrypanosome Agents.	
DRAMP39310	WKYMVm	6	WKYMVm 23a	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.40530886]protozoon:Trypanosoma brucei(IC50=77.6nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Monofluorination at position 3	D	Not found	formyl-peptide receptor type 2	40530886	Chembiochem. 2025 Nov 17;26(22):e202500384.	He M, Thomson CM, Thompson D, Kuodis V, Smith TK, Dall'Angelo S, O'Hagan D.	Bioactivity Profiles of Progressively Ring-Fluorinated Cyclohexyl Motifs in the WKYMVm Peptide as Formylpeptide FPR2 Agonists and in Keto-Piperazines as Antitrypanosome Agents.	
DRAMP39311	WKYMVm	6	WKYMVm 23b	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.40530886]protozoon:Trypanosoma brucei(IC50=204.1nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Difluorination at position 3	D	Not found	formyl-peptide receptor type 2	40530886	Chembiochem. 2025 Nov 17;26(22):e202500384.	He M, Thomson CM, Thompson D, Kuodis V, Smith TK, Dall'Angelo S, O'Hagan D.	Bioactivity Profiles of Progressively Ring-Fluorinated Cyclohexyl Motifs in the WKYMVm Peptide as Formylpeptide FPR2 Agonists and in Keto-Piperazines as Antitrypanosome Agents.	
DRAMP39312	WKYMVm	6	WKYMVm 23c	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.40530886]protozoon:Trypanosoma brucei(IC50=1584.9nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Trifluorination at position 3	D	Not found	formyl-peptide receptor type 2	40530886	Chembiochem. 2025 Nov 17;26(22):e202500384.	He M, Thomson CM, Thompson D, Kuodis V, Smith TK, Dall'Angelo S, O'Hagan D.	Bioactivity Profiles of Progressively Ring-Fluorinated Cyclohexyl Motifs in the WKYMVm Peptide as Formylpeptide FPR2 Agonists and in Keto-Piperazines as Antitrypanosome Agents.	
DRAMP39313	WKYMVm	6	WKYMVm 23d	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.40530886]protozoon:Trypanosoma brucei(IC50=4677.3nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Pentafluorination at position 3	D	Not found	formyl-peptide receptor type 2	40530886	Chembiochem. 2025 Nov 17;26(22):e202500384.	He M, Thomson CM, Thompson D, Kuodis V, Smith TK, Dall'Angelo S, O'Hagan D.	Bioactivity Profiles of Progressively Ring-Fluorinated Cyclohexyl Motifs in the WKYMVm Peptide as Formylpeptide FPR2 Agonists and in Keto-Piperazines as Antitrypanosome Agents.	
DRAMP39314	WKYMVm	6	WKYMVm 24	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.40530886]protozoon:Trypanosoma brucei(IC50=57.5nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Monofluorination at position 3	D	Not found	formyl-peptide receptor type 2	40530886	Chembiochem. 2025 Nov 17;26(22):e202500384.	He M, Thomson CM, Thompson D, Kuodis V, Smith TK, Dall'Angelo S, O'Hagan D.	Bioactivity Profiles of Progressively Ring-Fluorinated Cyclohexyl Motifs in the WKYMVm Peptide as Formylpeptide FPR2 Agonists and in Keto-Piperazines as Antitrypanosome Agents.	
DRAMP39315	WKYMVm	6	WKYMVm 25	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.40530886]protozoon:Trypanosoma brucei(IC50=513.9nM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Pentafluorination at position 3	D	Not found	formyl-peptide receptor type 2	40530886	Chembiochem. 2025 Nov 17;26(22):e202500384.	He M, Thomson CM, Thompson D, Kuodis V, Smith TK, Dall'Angelo S, O'Hagan D.	Bioactivity Profiles of Progressively Ring-Fluorinated Cyclohexyl Motifs in the WKYMVm Peptide as Formylpeptide FPR2 Agonists and in Keto-Piperazines as Antitrypanosome Agents.	
DRAMP39316	CGTGCG	6	H-L-Cys(Trt)-Gly-L-Thr(tBu)-Gly-L-Cys(Trt)-Gly-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50=0.028µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Tritylation at position 1,5;tert-butylation at position 3	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39317	SFCMCG	6	H-L-Ser(tBu)-L-Phe-L-Cys(Trt)-L-Met-L-Cys(Trt)-Gly-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50=0.68µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Tritylation at position 3,5;tert-butylation at position 1	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39318	VSFCIC	6	H-L-Val-L-Ser(tBu)-L-Phe-L-Cys(Trt)-L-Ile-L-Cys(Trt)-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50=6.50µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Tritylation at position 4,6;tert-butylation at position 2	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39319	CRCFSG	6	H-L-Cys(Trt)-L-Arg(Pbf)-L-Cys(Trt)-L-Phe-L-Ser(tBu)-Gly-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50=16.8µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Tritylation at position 4,6;tert-butylation at position 2	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39320	CICFRG	6	H-L-Cys(Trt)-L-Ile-L-Cys(Trt)-L-Phe-L-Arg(Pbf)-Gly-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50=43.1µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Tritylation at position 1,3;Pbf‑protection at position 2;tert-butylation at position 5	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39321	CICFEG	6	H-L-Cys(Trt)-L-Ile-L-Cys(Trt)-L-Phe-L-Glu(γ-tBu)-Gly-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50=0.42µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Tritylation at position 1,3;tert-butylation at position 5	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39322	CCIFEG	6	H-L-Cys(Trt)-L-Cys(Trt)-L-Ile-L-Phe-L-Glu(tBu)-Gly-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50>10µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Tritylation at position 1,2;tert-butylation at position 5	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39323	SISFEG	6	H-L-Ser(tBu)-L-Ile-L-Ser(tBu)-L-Phe-L-Glu(tBu)- Gly-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50=3.8µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	tert-butylation at position 1,3,5	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39324	MFFEMG	6	H-L-Met-L-Phe-L-Phe-L-Glu(tBu)- L-Met-Gly-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50=4.6µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	tert-butylation at position 4	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39325	CCFSG	5	H-L-Cys(Trt)-L-Cys(Trt)-L-Phe-L-Ser(tBu)-Gly-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50=8.4µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Tritylation at position 1,2;tert-butylation at position 4	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39326	CCISG	5	H-L-Cys(Trt)-L-Cys(Trt)-L-Ile-L-Ser(tBu)-Gly-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50=0.73µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Tritylation at position 1,2;tert-butylation at position 4	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39327	GCICFE	6	H-Gly-L-Cys(Trt)-L-Ile- L-Cys(Trt)-L-Phe-L- Glu-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50=0.47µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Tritylation at position 2,4	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39328	GCCIFE	6	H-Gly-L-Cys(Trt)-L- Cys(Trt)-L-Ile-L-Phe-L-Glu-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50=0.42µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Tritylation at position 2,3	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39329	GSISFE	6	H-Gly-L-Ser(tBu)-L-Ile- L-Ser(tBu)-L-Phe-L- Glu-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50>50µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	tert-butylation at position 2,4	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39330	MGMFFE	6	H-L-Met-Gly-L-Met-L-Phe-L-Phe-L-Glu-OH	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29446619]protozoon:P. falciparum K1strain(EC50>50µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Not found	L	Not found	plasma membrane	29446619	ACS Comb Sci. 2018 Apr 9;20(4):212-219.	Fagundez C, Sellanes D, Serra G.	Synthesis of Cyclic Peptides as Potential Anti-Malarials.	
DRAMP39331	GVFDIIKDAGKQLVAHAMGKIAEKV	25	Ocellatin-PT1	C0HJZ6(42-66)	Belongs to the frog skin active peptide (FSAP) family. Ocellatin subfamily.	Not found	Leptodactylus pustulatus (Ceara white-lipped frog) (Entomoglossus pustulatus)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.27463422]protozoon:Leishmania infantum promastigote(IC50=23.87µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.24084682]CC50>512µg/ml targeting on bone-marrow derived macrophages	plasma membrane	27463422	Biopolymers. 2016 Dec;105(12):873-86.	Oliveira M, Gomes-Alves AG, Sousa C, Mirta Marani M, Plácido A, Vale N, Delerue-Matos C, Gameiro P, Kückelhaus SA, Tomas AM, S A Leite JR, Eaton P.	Ocellatin-PT antimicrobial peptides: High-resolution microscopy studies in antileishmania models and interactions with mimetic membrane systems.	
DRAMP39332	GVFDIIKDAGKQLVAHATGKIAEK	24	Ocellatin-PT2	C0HJZ7(42-65)	Belongs to the frog skin active peptide (FSAP) family. Ocellatin subfamily.	Not found	Leptodactylus pustulatus (Ceara white-lipped frog) (Entomoglossus pustulatus)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.27463422]protozoon:Leishmania infantum promastigote(IC50>49.06µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.24084682]CC50>512µg/ml targeting on bone-marrow derived macrophages	plasma membrane	27463422	Biopolymers. 2016 Dec;105(12):873-86.	Oliveira M, Gomes-Alves AG, Sousa C, Mirta Marani M, Plácido A, Vale N, Delerue-Matos C, Gameiro P, Kückelhaus SA, Tomas AM, S A Leite JR, Eaton P.	Ocellatin-PT antimicrobial peptides: High-resolution microscopy studies in antileishmania models and interactions with mimetic membrane systems.	
DRAMP39333	GVFDIIKGAGKQLIAHAMGKIAEKV	25	Ocellatin-PT4	C0HJZ9(42-66)	Belongs to the frog skin active peptide (FSAP) family. Ocellatin subfamily.	Not found	Leptodactylus pustulatus (Ceara white-lipped frog) (Entomoglossus pustulatus)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.27463422]protozoon:Leishmania infantum promastigote(IC50=9.8µM);L. infantum amastigote(IC50=28.9µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.24084682]CC50=263.4µg/ml targeting on bone-marrow derived macrophages	plasma membrane	27463422	Biopolymers. 2016 Dec;105(12):873-86.	Oliveira M, Gomes-Alves AG, Sousa C, Mirta Marani M, Plácido A, Vale N, Delerue-Matos C, Gameiro P, Kückelhaus SA, Tomas AM, S A Leite JR, Eaton P.	Ocellatin-PT antimicrobial peptides: High-resolution microscopy studies in antileishmania models and interactions with mimetic membrane systems.	
DRAMP39334	GVFDIIKDAGRQLVAHAMGKIAEKV	25	Ocellatin-PT5	C0HK00(42-66)	Belongs to the frog skin active peptide (FSAP) family. Ocellatin subfamily.	Not found	Leptodactylus pustulatus (Ceara white-lipped frog) (Entomoglossus pustulatus)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.27463422]protozoon:Leishmania infantum promastigote(IC50=25.51µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	Not found	L	[Ref.24084682]CC50>512µg/ml targeting on bone-marrow derived macrophages	plasma membrane	27463422	Biopolymers. 2016 Dec;105(12):873-86.	Oliveira M, Gomes-Alves AG, Sousa C, Mirta Marani M, Plácido A, Vale N, Delerue-Matos C, Gameiro P, Kückelhaus SA, Tomas AM, S A Leite JR, Eaton P.	Ocellatin-PT antimicrobial peptides: High-resolution microscopy studies in antileishmania models and interactions with mimetic membrane systems.	
DRAMP39335	GVFDIIKGAGKQLIAHAMGKIAEKVGLNKDGN	32	Ocellatin-PT7	C0HK02(42-73)	Belongs to the frog skin active peptide (FSAP) family. Ocellatin subfamily.	Not found	Leptodactylus pustulatus (Ceara white-lipped frog) (Entomoglossus pustulatus)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.27463422]protozoon:Leishmania infantum promastigote(IC50=12.80µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	[Ref.24084682]CC50>512µg/ml targeting on bone-marrow derived macrophages	plasma membrane	27463422	Biopolymers. 2016 Dec;105(12):873-86.	Oliveira M, Gomes-Alves AG, Sousa C, Mirta Marani M, Plácido A, Vale N, Delerue-Matos C, Gameiro P, Kückelhaus SA, Tomas AM, S A Leite JR, Eaton P.	Ocellatin-PT antimicrobial peptides: High-resolution microscopy studies in antileishmania models and interactions with mimetic membrane systems.	
DRAMP39336	GVFDIIKGAGKQLIARAMGKIAEKVGLNKDGN	32	Ocellatin-PT8	C0HK03(42-73)	Belongs to the frog skin active peptide (FSAP) family. Ocellatin subfamily.	Not found	Leptodactylus pustulatus (Ceara white-lipped frog) (Entomoglossus pustulatus)	Antimicrobial, Antiprotozoal	protein level			Not found		[Ref.27463422]protozoon:Leishmania infantum promastigote(IC50=15.5µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	[Ref.24084682]CC50>512µg/ml targeting on bone-marrow derived macrophages	plasma membrane,Li-TryR	27463422	Biopolymers. 2016 Dec;105(12):873-86.	Oliveira M, Gomes-Alves AG, Sousa C, Mirta Marani M, Plácido A, Vale N, Delerue-Matos C, Gameiro P, Kückelhaus SA, Tomas AM, S A Leite JR, Eaton P.	Ocellatin-PT antimicrobial peptides: High-resolution microscopy studies in antileishmania models and interactions with mimetic membrane systems.	
DRAMP39337	PKIIQSVGISXKX	13	Peptide 1	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29501944]protozoon:Leishmania infantum(IC50=1.2µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	X=Nle	L	Not found	plasma membrane,Li-TryR	29501944	Eur J Med Chem. 2018 Apr 10;149:238-247.	Ruiz-Santaquiteria M, de Castro S, Toro MA, de Lucio H, Gutiérrez KJ, Sánchez-Murcia PA, Jiménez MÁ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.	Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.	
DRAMP39338	PKXIQSXGISXKX	13	Peptide 2a	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29501944]protozoon:Leishmania infantum(IC50=6.7µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	X11,X13=Nle;X3,X7=(S)-α-methyl-α-pentenylglycine;hydrocarbon staple between position3 and position7;	L	Not found	plasma membrane,Li-TryR	29501944	Eur J Med Chem. 2018 Apr 10;149:238-247.	Ruiz-Santaquiteria M, de Castro S, Toro MA, de Lucio H, Gutiérrez KJ, Sánchez-Murcia PA, Jiménez MÁ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.	Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.	
DRAMP39339	PKXIQSXGISXKX	13	Peptide 2b	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29501944]protozoon:Leishmania infantum(IC50>25µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	X11,X13=Nle;X3,X7=(S)-α-methyl-α-pentenylglycine;hydrocarbon staple between position3 and position7;	L	Not found	plasma membrane,Li-TryR	29501944	Eur J Med Chem. 2018 Apr 10;149:238-247.	Ruiz-Santaquiteria M, de Castro S, Toro MA, de Lucio H, Gutiérrez KJ, Sánchez-Murcia PA, Jiménez MÁ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.	Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.	
DRAMP39340	PKIXQSVXISXKX	13	Peptide 3a	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29501944]protozoon:Leishmania infantum(IC50=6.4µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	X11,X13=Nle;X4,X8=(S)-α-methyl-α-pentenylglycine;hydrocarbon staple between position4 and position8;	L	Not found	plasma membrane,Li-TryR	29501944	Eur J Med Chem. 2018 Apr 10;149:238-247.	Ruiz-Santaquiteria M, de Castro S, Toro MA, de Lucio H, Gutiérrez KJ, Sánchez-Murcia PA, Jiménez MÁ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.	Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.	
DRAMP39341	RRRRRRRRRPKAIQSAGISXKX	22	Peptide 5	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29501944]protozoon:Leishmania infantum promastigote(EC50=1.95µM);L. infantum amastigote(EC50=2.14µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	X20,X22=Nle;X12,X16=(S)-α-methyl-α-pentenylglycine;hydrocarbon staple between position12 and position16;	L	[Ref.29501944]EC50=0.33µM targeting on THP-1 cells	plasma membrane,Li-TryR	29501944	Eur J Med Chem. 2018 Apr 10;149:238-247.	Ruiz-Santaquiteria M, de Castro S, Toro MA, de Lucio H, Gutiérrez KJ, Sánchez-Murcia PA, Jiménez MÁ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.	Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.	
DRAMP39342	PKXIQSXGISXKX	13	Peptide 8	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29501944]protozoon:Leishmania infantum(IC50=28.2µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	X11,X13=Nle;X3,X7=(S)-α-methyl-α-pentenylglycine	L	Not found	plasma membrane,Li-TryR	29501944	Eur J Med Chem. 2018 Apr 10;149:238-247.	Ruiz-Santaquiteria M, de Castro S, Toro MA, de Lucio H, Gutiérrez KJ, Sánchez-Murcia PA, Jiménez MÁ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.	Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.	
DRAMP39343	PKIXQSVXISXKX	13	Peptide 9	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29501944]protozoon:Leishmania infantum(IC50=12.5µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	X11,X13=Nle;X4,X8=(S)-α-methyl-α-pentenylglycine	L	Not found	plasma membrane,Li-TryR	29501944	Eur J Med Chem. 2018 Apr 10;149:238-247.	Ruiz-Santaquiteria M, de Castro S, Toro MA, de Lucio H, Gutiérrez KJ, Sánchez-Murcia PA, Jiménez MÁ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.	Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.	
DRAMP39344	CDRVYIHPFC	10	CDRVYIHPFC	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29085013]protozoon:P.gallinaceum sporozoites(91% inhibition at 10^−8mol/L);P. falciparum ring formation(91% inhibition at 10^−8mol/L)	[Ref.29085013]Not present hemolytic efects	Linear	Free	Free	Not found	L	Not found	plasma membrane	29085013	Sci Rep. 2017 Oct 30;7(1):14326.	Silva AF, Torres MT, Silva LS, Alves FL, de Sá Pinheiro AA, Miranda A, Capurro ML, de la Fuente-Nunez C, Oliveira VX Jr.	Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction.	
DRAMP39345	CDRVYHIPFC	10	CDRVYHIPFC	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29085013]protozoon:P.gallinaceum sporozoites(90% inhibition at 10^−8mol/L);P. falciparum ring formation(91% inhibition at 10^−8mol/L)	[Ref.29085014]Not present hemolytic efects	Linear	Free	Free	Not found	L	Not found	plasma membrane	29085013	Sci Rep. 2017 Oct 30;7(1):14326.	Silva AF, Torres MT, Silva LS, Alves FL, de Sá Pinheiro AA, Miranda A, Capurro ML, de la Fuente-Nunez C, Oliveira VX Jr.	Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction.	
DRAMP39346	CDRVCYHIPF	10	CDRVCYHIPF	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29085013]protozoon:P.gallinaceum sporozoites(80% inhibition at 10^−8mol/L);P. falciparum ring formation(87% inhibition at 10^−8mol/L)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	29085013	Sci Rep. 2017 Oct 30;7(1):14326.	Silva AF, Torres MT, Silva LS, Alves FL, de Sá Pinheiro AA, Miranda A, Capurro ML, de la Fuente-Nunez C, Oliveira VX Jr.	Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction.	
DRAMP39347	CDRVYPFC	8	CDRVYPFC	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29085013]protozoon:P.gallinaceum sporozoites(95% inhibition at 10^−8mol/L);P. falciparum ring formation(86% inhibition at 10^−8mol/L)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	29085013	Sci Rep. 2017 Oct 30;7(1):14326.	Silva AF, Torres MT, Silva LS, Alves FL, de Sá Pinheiro AA, Miranda A, Capurro ML, de la Fuente-Nunez C, Oliveira VX Jr.	Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction.	
DRAMP39348	CRYHIPFC	8	CRYHIPFC	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29085013]protozoon:P.gallinaceum sporozoites(96% inhibition at 10^−8mol/L);P. falciparum ring formation(84% inhibition at 10^−8mol/L)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	29085013	Sci Rep. 2017 Oct 30;7(1):14326.	Silva AF, Torres MT, Silva LS, Alves FL, de Sá Pinheiro AA, Miranda A, Capurro ML, de la Fuente-Nunez C, Oliveira VX Jr.	Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction.	
DRAMP39349	CRYPFC	6	CRYPFC	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29085013]protozoon:P.gallinaceum sporozoites(<10% inhibition at 10^−8mol/L);P. falciparum ring formation(89% inhibition at 10^−8mol/L)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	29085013	Sci Rep. 2017 Oct 30;7(1):14326.	Silva AF, Torres MT, Silva LS, Alves FL, de Sá Pinheiro AA, Miranda A, Capurro ML, de la Fuente-Nunez C, Oliveira VX Jr.	Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction.	
DRAMP39350	CYHPFC	6	CYHPFC	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29085013]protozoon:P.gallinaceum sporozoites(<10% inhibition at 10^−8mol/L);P. falciparum ring formation(87% inhibition at 10^−8mol/L)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	29085013	Sci Rep. 2017 Oct 30;7(1):14326.	Silva AF, Torres MT, Silva LS, Alves FL, de Sá Pinheiro AA, Miranda A, Capurro ML, de la Fuente-Nunez C, Oliveira VX Jr.	Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction.	
DRAMP39351	CVIPFC	6	CVIPFC	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.29085013]protozoon:P.gallinaceum sporozoites(<10% inhibition at 10^−8mol/L);P. falciparum ring formation(85% inhibition at 10^−8mol/L)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	29085013	Sci Rep. 2017 Oct 30;7(1):14326.	Silva AF, Torres MT, Silva LS, Alves FL, de Sá Pinheiro AA, Miranda A, Capurro ML, de la Fuente-Nunez C, Oliveira VX Jr.	Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction.	
DRAMP39352	KQLKKVSAVAKVAMKKGAALLKKMGVK	27	P2	Not found	Not found	Not found	phage M13	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	Not found			Not found		[Ref.28744646]protozoon:Trypanosoma cruzi(approx 78% inhibition at 150 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	28744646	Bull Exp Biol Med. 2017 Jul;163(3):361-364.	Kleshchenko YE, Zhigunova AV, Dalin MV, Melnikov V.	Peptides Selected Using Phage Library Variants, Effectively Inhibit Trypanosoma cruzi Infection.	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
DRAMP39353	VGKVLKQLKKVSAVAKVAMKKGAALLK	27	P3	Not found	Not found	Not found	phage M13	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	Not found			Not found		[Ref.28744646]protozoon:Trypanosoma cruzi(approx 78% inhibition at 150 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	28744646	Bull Exp Biol Med. 2017 Jul;163(3):361-364.	Kleshchenko YE, Zhigunova AV, Dalin MV, Melnikov V.	Peptides Selected Using Phage Library Variants, Effectively Inhibit Trypanosoma cruzi Infection.	CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O
DRAMP39354	KFGKIVGKVLKQLKKVSAVAKVAMKKG	27	P4	Not found	Not found	Not found	phage M13	Antimicrobial,Antibacterial，Anti-Gram-,Antiprotozoal	Not found			Not found		[Ref.28744646]protozoon:Trypanosoma cruzi(<10% inhibition at 150 µg/ml)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	28744646	Bull Exp Biol Med. 2017 Jul;163(3):361-364.	Kleshchenko YE, Zhigunova AV, Dalin MV, Melnikov V.	Peptides Selected Using Phage Library Variants, Effectively Inhibit Trypanosoma cruzi Infection.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
DRAMP39355	VVVAF	5	Almiramides B	Not found	Not found	Not found	Lyngbya majuscula	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.20441198]protozoon:L. donovani(IC50=2.4µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	2-methyloct-7-ynoylation	Amidation	N-methylation at position 1,2,4,5	L	Not found	plasma membrane	20441198	J Med Chem. 2010 May 27;53(10):4187-97.	Sanchez LM, Lopez D, Vesely BA, Della Togna G, Gerwick WH, Kyle DE, Linington RG.	Almiramides A-C: discovery and development of a new class of leishmaniasis lead compounds.	
DRAMP39356	VVVAF	5	Almiramides C	Not found	Not found	Not found	Lyngbya majuscula	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.20441198]protozoon:L. donovani(IC50=1.9µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	2-methyloct-7-enoylation	Amidation	N-methylation at position 1,2,4,5	L	Not found	plasma membrane	20441198	J Med Chem. 2010 May 27;53(10):4187-97.	Sanchez LM, Lopez D, Vesely BA, Della Togna G, Gerwick WH, Kyle DE, Linington RG.	Almiramides A-C: discovery and development of a new class of leishmaniasis lead compounds.	
DRAMP39357	VVVVVFV	7	RXP 1	Not found	Not found	Not found	Xenorhabdus innexi DSM 16336	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.30095261]protozoon:T. brucei rhodesiense(IC50=0.35µM);T. cruzi(IC50=25.54µM);L. donovani(IC50=56.77µM);P. falciparum(IC50=0.71µM);	No hemolysis information or data found in the reference(s) presented in this entry	Linear	N-methylation	putrescine amidation	N-methylation at position 1,3,4,5,6,7	L	[Ref.30095261]IC50=19.03µM targeting on L6 cells	Not found	30095261	Org Lett. 2018 Sep 7;20(17):5116-5120.	Zhao L, Kaiser M, Bode HB.	Rhabdopeptide/Xenortide-like Peptides from Xenorhabdus innexi with Terminal Amines Showing Potent Antiprotozoal Activity.	
DRAMP39358	VVVVVFV	7	RXP 2	Not found	Not found	Not found	Xenorhabdus innexi DSM 16336	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.30095261]protozoon:T. brucei rhodesiense(IC50=2.24µM);T. cruzi(IC50=21.70µM);L. donovani(IC50>100µM);P. falciparum(IC50=2.59µM);	No hemolysis information or data found in the reference(s) presented in this entry	Linear	N-methylation	Amidation	N-methylation at position 1,3,4,5,6,7	L	[Ref.30095261]IC50=30.36µM targeting on L6 cells	Not found	30095261	Org Lett. 2018 Sep 7;20(17):5116-5120.	Zhao L, Kaiser M, Bode HB.	Rhabdopeptide/Xenortide-like Peptides from Xenorhabdus innexi with Terminal Amines Showing Potent Antiprotozoal Activity.	
DRAMP39359	VVVVVFV	7	RXP 3	Not found	Not found	Not found	Xenorhabdus innexi DSM 16336	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.30095261]protozoon:T. brucei rhodesiense(IC50=0.13µM);T. cruzi(IC50=16.00µM);L. donovani(IC50=53.90µM);P. falciparum(IC50=0.23µM);	No hemolysis information or data found in the reference(s) presented in this entry	Linear	N-methylation	putrescine amidation	N-methylation at position 1,2,3,4,5,6,7	L	[Ref.30095261]IC50=6.47µM targeting on L6 cells	Not found	30095261	Org Lett. 2018 Sep 7;20(17):5116-5120.	Zhao L, Kaiser M, Bode HB.	Rhabdopeptide/Xenortide-like Peptides from Xenorhabdus innexi with Terminal Amines Showing Potent Antiprotozoal Activity.	
DRAMP39360	VVVVVFV	7	RXP 4	Not found	Not found	Not found	Xenorhabdus innexi DSM 16336	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.30095261]protozoon:T. brucei rhodesiense(IC50=6.25µM);T. cruzi(IC50=45.67µM);L. donovani(IC50=28.47µM);P. falciparum(IC50=3.16µM);	No hemolysis information or data found in the reference(s) presented in this entry	Linear	N-methylation	Amidation	N-methylation at position 1,2,3,4,5,6,7	L	[Ref.30095261]IC50=34.36µM targeting on L6 cells	Not found	30095261	Org Lett. 2018 Sep 7;20(17):5116-5120.	Zhao L, Kaiser M, Bode HB.	Rhabdopeptide/Xenortide-like Peptides from Xenorhabdus innexi with Terminal Amines Showing Potent Antiprotozoal Activity.	
DRAMP39361	VVVVVVFV	8	RXP 5	Not found	Not found	Not found	Xenorhabdus innexi DSM 16336	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.30095261]protozoon:T. brucei rhodesiense(IC50=0.070µM);T. cruzi(IC50=16.18µM);L. donovani(IC50=76.28µM);P. falciparum(IC50=0.25µM);	No hemolysis information or data found in the reference(s) presented in this entry	Linear	N-methylation	putrescine amidation	N-methylation at position 1,3,4,6,7,8	L	[Ref.30095261]IC50=16.63µM targeting on L6 cells	Not found	30095261	Org Lett. 2018 Sep 7;20(17):5116-5120.	Zhao L, Kaiser M, Bode HB.	Rhabdopeptide/Xenortide-like Peptides from Xenorhabdus innexi with Terminal Amines Showing Potent Antiprotozoal Activity.	
DRAMP39362	VVVVVVFV	8	RXP 6	Not found	Not found	Not found	Xenorhabdus innexi DSM 16336	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.30095261]protozoon:T. brucei rhodesiense(IC50=0.075µM);T. cruzi(IC50=5.49µM);L. donovani(IC50=55.28µM);P. falciparum(IC50=0.091µM);	No hemolysis information or data found in the reference(s) presented in this entry	Linear	N-methylation	putrescine amidation	N-methylation at position 1,3,4,6,7,8	L	[Ref.30095261]IC50=5.72µM targeting on L6 cells	Not found	30095261	Org Lett. 2018 Sep 7;20(17):5116-5120.	Zhao L, Kaiser M, Bode HB.	Rhabdopeptide/Xenortide-like Peptides from Xenorhabdus innexi with Terminal Amines Showing Potent Antiprotozoal Activity.	
DRAMP39363	VVVVVVFV	8	RXP 7	Not found	Not found	Not found	Xenorhabdus innexi DSM 16336	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.30095261]protozoon:T. brucei rhodesiense(IC50=1.73µM);T. cruzi(IC50=4.31µM);L. donovani(IC50=53.49µM);P. falciparum(IC50=0.87µM);	No hemolysis information or data found in the reference(s) presented in this entry	Linear	N-methylation	Amidation	N-methylation at position 1,3,4,5,6,7,8	L	[Ref.30095261]IC50=0.010µM targeting on L6 cells	Not found	30095261	Org Lett. 2018 Sep 7;20(17):5116-5120.	Zhao L, Kaiser M, Bode HB.	Rhabdopeptide/Xenortide-like Peptides from Xenorhabdus innexi with Terminal Amines Showing Potent Antiprotozoal Activity.	
DRAMP39364	DRVYHIPF	8	[Ile6,His5]-AII	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.26537730]protozoon:Plasmodium 
gallinaceum sporozoites(94% inhibition at 60μmol/L)"	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	26537730	Malar J. 2015 Nov 4;14:433.	Silva AF, Torres MD, Silva Lde S, Alves FL, Pinheiro AA, Miranda A, Capurro ML, Oliveira VX Jr.	New linear antiplasmodial peptides related to angiotensin II.	
DRAMP39365	DRVYPF	6	des-Ile5,His6-AII	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.26537730]protozoon:Plasmodium 
gallinaceum sporozoites(64% inhibition at 60μmol/L)"	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	26537730	Malar J. 2015 Nov 4;14:433.	Silva AF, Torres MD, Silva Lde S, Alves FL, Pinheiro AA, Miranda A, Capurro ML, Oliveira VX Jr.	New linear antiplasmodial peptides related to angiotensin II.	
DRAMP39366	RYPF	4	des-Asp1,Val3,Ile5,His6-AII	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.26537730]protozoon:Plasmodium 
gallinaceum sporozoites(76% inhibition at 60μmol/L)"	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	26537730	Malar J. 2015 Nov 4;14:433.	Silva AF, Torres MD, Silva Lde S, Alves FL, Pinheiro AA, Miranda A, Capurro ML, Oliveira VX Jr.	New linear antiplasmodial peptides related to angiotensin II.	
DRAMP39367	RYHIPF	6	[Ile4,His3]-des-Asp1,Val3-AII	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.26537730]protozoon:Plasmodium 
gallinaceum sporozoites(77% inhibition at 60μmol/L)"	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	plasma membrane	26537730	Malar J. 2015 Nov 4;14:433.	Silva AF, Torres MD, Silva Lde S, Alves FL, Pinheiro AA, Miranda A, Capurro ML, Oliveira VX Jr.	New linear antiplasmodial peptides related to angiotensin II.	
DRAMP39368	YHPF	4	des-Asp1,Arg2,Val3,Ile5-AII	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.26537730]protozoon:Plasmodium 
gallinaceum sporozoites(89% inhibition at 60μmol/L);P.falciparum(IC50=8.9×10^-10mol/L)"	[Ref.26537730]Did not present hemolytic effects	Linear	Free	Free	Not found	L	Not found	plasma membrane	26537730	Malar J. 2015 Nov 4;14:433.	Silva AF, Torres MD, Silva Lde S, Alves FL, Pinheiro AA, Miranda A, Capurro ML, Oliveira VX Jr.	New linear antiplasmodial peptides related to angiotensin II.	
DRAMP39369	VIPF	4	des-Asp1,Arg2,Tyr4,His6-AII	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.26537730]protozoon:Plasmodium 
gallinaceum sporozoites(94% inhibition at 60μmol/L)P.falciparum(IC50=6.2×10^-10mol/L)"	[Ref.26537730]Did not present hemolytic effects	Linear	Free	Free	Not found	L	Not found	plasma membrane	26537730	Malar J. 2015 Nov 4;14:433.	Silva AF, Torres MD, Silva Lde S, Alves FL, Pinheiro AA, Miranda A, Capurro ML, Oliveira VX Jr.	New linear antiplasmodial peptides related to angiotensin II.	
DRAMP39370	XIPF	4	[2-Nal1]- des-Asp1,Arg2,Tyr4,His6-AII	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.26537730]protozoon:Plasmodium 
gallinaceum sporozoites(79% inhibition at 60μmol/L)"	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	X=2-Nal	L	Not found	plasma membrane	26537730	Malar J. 2015 Nov 4;14:433.	Silva AF, Torres MD, Silva Lde S, Alves FL, Pinheiro AA, Miranda A, Capurro ML, Oliveira VX Jr.	New linear antiplasmodial peptides related to angiotensin II.	
DRAMP39371	VXPF	4	[2-Nal2]- des-Asp1,Arg2,Tyr4,His6-AII	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.26537730]protozoon:Plasmodium 
gallinaceum sporozoites(75% inhibition at 60μmol/L)"	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	X=2-Nal	L	Not found	plasma membrane	26537730	Malar J. 2015 Nov 4;14:433.	Silva AF, Torres MD, Silva Lde S, Alves FL, Pinheiro AA, Miranda A, Capurro ML, Oliveira VX Jr.	New linear antiplasmodial peptides related to angiotensin II.	
DRAMP39372	VIXF	4	[2-Nal3]- des-Asp1,Arg2,Tyr4,His6-AII	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.26537730]protozoon:Plasmodium 
gallinaceum sporozoites(70% inhibition at 60μmol/L)"	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	X=2-Nal	L	Not found	plasma membrane	26537730	Malar J. 2015 Nov 4;14:433.	Silva AF, Torres MD, Silva Lde S, Alves FL, Pinheiro AA, Miranda A, Capurro ML, Oliveira VX Jr.	New linear antiplasmodial peptides related to angiotensin II.	
DRAMP39373	VIPX	4	[2-Nal4]- des-Asp1,Arg2,Tyr4,His6-AII	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		"[Ref.26537730]protozoon:Plasmodium 
gallinaceum sporozoites(73% inhibition at 60μmol/L)"	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	X=2-Nal	L	Not found	plasma membrane	26537730	Malar J. 2015 Nov 4;14:433.	Silva AF, Torres MD, Silva Lde S, Alves FL, Pinheiro AA, Miranda A, Capurro ML, Oliveira VX Jr.	New linear antiplasmodial peptides related to angiotensin II.	
DRAMP39374	FfVPIPX	7	Iheyamide A	Not found	Not found	Not found	Dapis sp.	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.32352773]protozoon:T. b. rhodesiense(IC50=1.5µM);T. b. brucei(IC50=1.5µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	N,N-dimethylation	Free	X=iPr-O-Me-pyr;N-methylation at position 3,5	D	[Ref.32352773]IC50=18µM targeting on WI-38 cells	Not found	32352773	J Nat Prod. 2020 May 22;83(5):1684-1690	Kurisawa N, Iwasaki A, Jeelani G, Nozaki T, Suenaga K.	Iheyamides A-C, Antitrypanosomal Linear Peptides Isolated from a Marine Dapis sp. Cyanobacterium.	
DRAMP39375	FfVPIP	6	Iheyamide B	Not found	Not found	Not found	Dapis sp.	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.32352773]protozoon:T. b. rhodesiense(IC50>20µM);T. b. brucei(IC50>20µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	N,N-dimethylation	Free	N-methylation at position 3,5	D	[Ref.32352773]IC50>20µM targeting on WI-38 cells	Not found	32352773	J Nat Prod. 2020 May 22;83(5):1684-1690	Kurisawa N, Iwasaki A, Jeelani G, Nozaki T, Suenaga K.	Iheyamides A-C, Antitrypanosomal Linear Peptides Isolated from a Marine Dapis sp. Cyanobacterium.	
DRAMP39376	FfVPI	5	Iheyamide C	Not found	Not found	Not found	Dapis sp.	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.32352773]protozoon:T. b. rhodesiense(IC50>20µM);T. b. brucei(IC50>20µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	N,N-dimethylation	Free	N-methylation at position 3,5	D	[Ref.32352773]IC50>20µM targeting on WI-38 cells	Not found	32352773	J Nat Prod. 2020 May 22;83(5):1684-1690	Kurisawa N, Iwasaki A, Jeelani G, Nozaki T, Suenaga K.	Iheyamides A-C, Antitrypanosomal Linear Peptides Isolated from a Marine Dapis sp. Cyanobacterium.	
DRAMP39377	XFpX	4	Koshidacins A	Not found	Not found	Not found	Pochonia boninensis FKR-0564	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.36282784]protozoon:P. falciparum K1strains(IC50=12.5±0.7µM);P. falciparum FCR3 strains(IC50=17.1±1.0µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X=Aib;X=Ahda	D	[Ref.36282784]CC50=6.8±2.1µM targeting on MRC-5 cells	histone deacetylase	36282784	J Nat Prod. 2022 Nov 25;85(11):2641-2649.	Watanabe Y, Hachiya K, Ikeda A, Nonaka K, Higo M, Muramatsu R, Noguchi C, Honsho M, Asami Y, Inahashi Y, Hirose T, Matsui H, Sunazuka T, Hanaki H, Ishii T, Teruya T, Hokari R, Ishiyama A, Iwatsuki M.	Koshidacins A and B, Antiplasmodial cyclic tetrapeptides from the Okinawan Fungus Pochonia boninensis FKR-0564.	
DRAMP39378	XFpX	4	Koshidacins B	Not found	Not found	Not found	Pochonia boninensis FKR-0564	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.36282784]protozoon:P. falciparum K1strains(IC50=0.83±0.04µM);P. falciparum FCR3 strains(IC50=0.89 ± 0.04µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	X=Aib;X=8-oxo-Ahda	D	[Ref.36282784]CC50=14.7±4.1µM targeting on MRC-5 cells	histone deacetylase	36282784	J Nat Prod. 2022 Nov 25;85(11):2641-2649.	Watanabe Y, Hachiya K, Ikeda A, Nonaka K, Higo M, Muramatsu R, Noguchi C, Honsho M, Asami Y, Inahashi Y, Hirose T, Matsui H, Sunazuka T, Hanaki H, Ishii T, Teruya T, Hokari R, Ishiyama A, Iwatsuki M.	Koshidacins A and B, Antiplasmodial cyclic tetrapeptides from the Okinawan Fungus Pochonia boninensis FKR-0565.	
DRAMP39379	VGK	3	Peptide 1	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(approx 14% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	Acetylation	palmitoylation	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O
DRAMP39380	AVG	3	Peptide 2	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(approx 35% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	palmitoylation	Amidation	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)O
DRAMP39381	QIK	3	Peptide 3	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(>80% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	palmitoylation	Amidation	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
DRAMP39382	RIDR	4	Peptide 4	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(approx 38% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	palmitoylation	Free	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	CC[C@@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP39383	MPR	3	Peptide 5	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(100% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	palmitoylation	Amidation	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP39384	LFR	3	Peptide 6	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(approx 26% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	palmitoylation	Amidation	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP39385	QGILR	5	Peptide 7	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(approx 60% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	palmitoylation	Free	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	CC[C@@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
DRAMP39386	AGPAIALVGDAR	12	Peptide 8	Not found	Not found	Not found	Synthetic	Antimicrobial,Antiprotozoal	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(approx 31% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	Acetylation	Amidation	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	CC[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](C)C(=O)O)C(C)C
DRAMP39387	HAVGNDTSNHGVTA	14	Peptide 9	Not found	Not found	Not found	Synthetic	[Ref.36739680]Peptides 9 showed highly significant inhibitions of DENV-4 plaque formation (80.31–83.92%), but lower inhibitions were observed against DENV-1 to 3 (5.34–55.46%); Peptides 9 (200 μM) dem	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(approx 35% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	palmitoylation	Amidation	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
DRAMP39388	SPRTGLDFNEMI	12	Peptide 10	Not found	Not found	Not found	Synthetic	[Ref.36739680]Peptide 10 (200 μM) exhibited inhibitions of all four DENV serotypes, with high inhibitions of DENV-4 at 81.13%, followed by DENV-3 at 60.47% and DENV-1 at 47.01%.	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(approx 38% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	palmitoylation	Amidation	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	CC[C@@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)[C@@H](C)O)C(N)=O
DRAMP39389	TNTTT	5	Peptide 11	Not found	Not found	Not found	Synthetic	[Ref.36739680]Peptides 11 at 200 μM exhibited cell protection effects below 50% against all four DENV serotypes(DENV-1, DENV-2, DENV-3, DENV-4); peptides 11 (200 μM) also showed inhibitions of all fou	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(75% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	palmitoylation	Free	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	CC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
DRAMP39390	DANFV	5	Peptide 12	Not found	Not found	Not found	Synthetic	[Ref.36739680]Peptides 12 at 200 μM exhibited cell protection effects below 50% against all four DENV serotypes(DENV-1, DENV-2, DENV-3, DENV-4); peptide 12 (200 μM) also showed inhibitions of all four	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(100% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	palmitoylation	Free	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(N)=O)C(C)C
DRAMP39391	KHRKGNNA	8	Peptide 13	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.26039561]protozoon:P. falciparum(approx 60% inhibition at 100μM)	[Ref.26039561]Non-haemolytic at 10μM concentration	Linear	palmitoylation	Amidation	Not found	L	Not found	plasma membrane	26039561	PLoS One. 2015 Jun 3;10(6):e0127383.	Bianchin A, Bell A, Chubb AJ, Doolan N, Leneghan D, Stavropoulos I, Shields DC, Mooney C.	Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.	
DRAMP39392	XXVGfPPXlPIfP	13	Pemuchiamides A	Not found	Not found	Not found	Hormoscilla sp.	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39145689]protozoon:T. b. rhodesiense(IC50=0.63±0.01μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	3,5,7,9-tetramethylpentadecanoylation	methylation	X1=4-(4-hydroxyphenyl)butanoic acid;X2=4-aminobutanoic acid;X3=Tzn;N-methylation at position 5;	D	[Ref.39145689]IC50=2.9±0.4µM targeting on HeLa cells;IC50=1.4±0.7µM targeting on HL60 cells	Not found	39145689	J Nat Prod. 2024 Sep 27;87(9):2292-2301.	Irie K, Jeelani G, Nozaki T, Iwasaki A.	Pemuchiamides A and B, Proline-Rich Linear Lipopeptides, Isolated from a Marine Hormoscilla sp. Cyanobacterium.	
DRAMP39393	XXVGfPPXlPIfP	13	Pemuchiamides B	Not found	Not found	Not found	Hormoscilla sp.	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.39145689]protozoon:T. b. rhodesiense(IC50=5.4±0.1μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	3,5,7,9-tetramethylpentadecanoylation	methylation	X1=4-(4-hydroxyphenyl)butanoic acid;X2=3-hydroxy-4-aminobutanoic acid;X3=Tzn;N-methylation at position 5;	D	[Ref.39145689]IC50=3.9±1.0µM targeting on HeLa cells;IC50=2.1±0.4µM targeting on HL60 cells	Not found	39145689	J Nat Prod. 2024 Sep 27;87(9):2292-2301.	Irie K, Jeelani G, Nozaki T, Iwasaki A.	Pemuchiamides A and B, Proline-Rich Linear Lipopeptides, Isolated from a Marine Hormoscilla sp. Cyanobacterium.	
DRAMP39394	GAHHAADGC	9	HRP IIA	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.9497049]protozoon:Plasmodium yoelii nigeriensis(approx 24% inhibition at 100 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	Haem	9497049	Mol Biochem Parasitol. 1997 Dec 1;90(1):281-7.	Pandey AV, Joshi R, Tekwani BL, Singh RL, Chauhan VS.	Synthetic peptides corresponding to a repetitive sequence of malarial histidine rich protein bind haem and inhibit haemozoin formation in vitro.	C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](CS)C(=O)O)C(=O)NCC(=O)O
DRAMP39395	CGAHHAADAHHAADGC	16	HRP IIB	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.9497049]protozoon:Plasmodium yoelii nigeriensis(approx 43% inhibition at 100 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	Haem	9497049	Mol Biochem Parasitol. 1997 Dec 1;90(1):281-7.	Pandey AV, Joshi R, Tekwani BL, Singh RL, Chauhan VS.	Synthetic peptides corresponding to a repetitive sequence of malarial histidine rich protein bind haem and inhibit haemozoin formation in vitro.	C[C@H](NC(=O)CNC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)NCC(=O)O
DRAMP39396	CGAHHAADAHHAADAHHAADGC	22	HRP IIC	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.9497049]protozoon:Plasmodium yoelii nigeriensis(approx 50% inhibition at 100 μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Free	Free	Not found	L	Not found	Haem	9497049	Mol Biochem Parasitol. 1997 Dec 1;90(1):281-7.	Pandey AV, Joshi R, Tekwani BL, Singh RL, Chauhan VS.	Synthetic peptides corresponding to a repetitive sequence of malarial histidine rich protein bind haem and inhibit haemozoin formation in vitro.	C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)NCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CS)C(=O)O
DRAMP39397	KWKLFKKIEKVGQNIRDGIIKAGPGIGAVLKVLTTGL	37	CA(1-24)M(1-13)	Not found	Not found	Not found	Synthetic	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-	Not found			Not found		[Ref.2689223]Gram-negative bacteria:Escherichia coli K12(MIC=0.3µM);Pseudomonas aeruginosa(MIC=1µM)##Gram-positive bacteria:Bacillus subtilis(MIC=0.5µM);Staphylococcus aureus(MIC=6µM);Streptococcus pyogenes(MIC=2µM)	[Ref.2689223]MIC>200µM for sheep red cells	Linear	Free	Free	Not found	L	Not found	plasma membrane	2689223	FEBS Lett. 1989 Dec 18;259(1):103-6.	Boman HG, Wade D, Boman IA, Wåhlin B, Merrifield RB.	Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids.	
DRAMP39398	AVAVVGQATQIAKGIGAVLKVLTTGL	26	CA(25-37)M(1-13)	Not found	Not found	Not found	Synthetic	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-	Not found			Not found		[Ref.2689223]Gram-negative bacteria:Escherichia coli K12(MIC=200µM);Pseudomonas aeruginosa(MIC=300µM)##Gram-positive bacteria:Bacillus subtilis(MIC=20µM);Staphylococcus aureus(MIC>300µM);Streptococcus pyogenes(MIC=20µM)	[Ref.2689223]MIC>300µM for sheep red cells	Linear	Free	Free	Not found	L	Not found	plasma membrane	2689223	FEBS Lett. 1989 Dec 18;259(1):103-6.	Boman HG, Wade D, Boman IA, Wåhlin B, Merrifield RB.	Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids.	
DRAMP39399	GIGAVLKVLTTGLKWKLFKKIEKVGQ	26	M(1-13)CA(1-13)	Not found	Not found	Not found	Synthetic	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-	Not found			Not found		[Ref.2689223]Gram-negative bacteria:Escherichia coli K12(MIC=1µM);Pseudomonas aeruginosa(MIC=5µM)##Gram-positive bacteria:Bacillus subtilis(MIC=0.3µM);Staphylococcus aureus(MIC=5µM);Streptococcus pyogenes(MIC=1µM)	[Ref.2689223]approx MIC=80µM for sheep red cells	Linear	Free	Free	Not found	L	Not found	plasma membrane	2689223	FEBS Lett. 1989 Dec 18;259(1):103-6.	Boman HG, Wade D, Boman IA, Wåhlin B, Merrifield RB.	Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids.	
DRAMP39400	LISWIKRKRQQKWKLFKKIEKVGQ	24	M(16-26)M(1-13)	Not found	Not found	Not found	Synthetic	Antimicrobial,Antibacterial,Anti-Gram+,Anti-Gram-	Not found			Not found		[Ref.2689223]Gram-negative bacteria:Escherichia coli K12(MIC=0.7µM);Pseudomonas aeruginosa(MIC=8µM)##Gram-positive bacteria:Bacillus subtilis(MIC=0.7µM);Staphylococcus aureus(MIC=10µM);Streptococcus pyogenes(MIC=1µM)	[Ref.2689223]MIC>200µM for sheep red cells	Linear	Free	Free	Not found	L	Not found	plasma membrane	2689223	FEBS Lett. 1989 Dec 18;259(1):103-6.	Boman HG, Wade D, Boman IA, Wåhlin B, Merrifield RB.	Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids.	
DRAMP39401	XV	2	Boc-Orn(Z)-Val-OtBu	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.23084276]protozoon:P. berghei schizonts(IC50=33.88µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	tert-butoxycarbonylation	tert-butylation	X=Orn(Z);benzyloxycarbonylation at position 1	L	Not found	binding sites of enzymes and proteins	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY.	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP39402	xV	2	Boc-D-Orn(Z)-Val-OMe	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.23084276]protozoon:P. berghei schizonts(IC50=3.05µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	tert-butoxycarbonylation	methylation	x=D-Orn(Z);benzyloxycarbonylation at position 1	D	Not found	binding sites of enzymes and proteins	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY.	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP39403	xV	2	Boc-D-Orn(Z)-Val-OtBu	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.23084276]protozoon:P. berghei schizonts(IC50=2.78µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	tert-butoxycarbonylation	tert-butylation	x=D-Orn(Z);benzyloxycarbonylation at position 1	D	Not found	binding sites of enzymes and proteins	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY.	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP39404	FF	2	Boc-Phe–Phe-OtBu	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.23084276]protozoon:P. berghei schizonts(IC50=112.20µM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	tert-butoxycarbonylation	tert-butylation	Not found	L	Not found	binding sites of enzymes and proteins	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY.	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP39405	VK	2	Cyclo[Val-Lys(Z)]	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.23084276]protozoon:P. berghei schizonts(IC50=3.12µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Not found	L	Not found	binding sites of enzymes and proteins	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY.	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP39406	FF	2	Cyclo(Phe–Phe)	Not found	Not found	Not found	Synthetic	Antimicrobial, Antiprotozoal	Not found			Not found		[Ref.23084276]protozoon:P. berghei schizonts(IC50=2.54µM)	No hemolysis information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Not found	L	Not found	binding sites of enzymes and proteins	23084276	Bioorg Med Chem Lett. 2012 Dec 1;22(23):7048-51.	Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY.	Linear and cyclic dipeptides with antimalarial activity.	
DRAMP39407	FAVII	6	friomaramide	Not found	Not found	Not found	Inflatella coelosphaeroides	Antimicrobial, Antiprotozoal	Not found			Not found		protozoon:Plasmodium falciparum liver stage(>90% inhibition at 10μM)	No hemolysis information or data found in the reference(s) presented in this entry	Linear	Acetylation	N-methylation	tryptenamination at position 6	L	no cytotoxicity targeting on primary human hepatocytes cells at 10μM.	Not found	Not found	Not found	Not found	Not found	
